PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Ghatak, S; Hascall, VC; Markwald, RR; Misra, S				Ghatak, Shibnath; Hascall, Vincent C.; Markwald, Roger R.; Misra, Suniti			Stromal Hyaluronan Interaction with Epithelial CD44 Variants Promotes Prostate Cancer Invasiveness by Augmenting Expression and Function of Hepatocyte Growth Factor and Androgen Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANCHORAGE-INDEPENDENT GROWTH; CONSTITUTIVELY REGULATES ACTIVATION; MARROW ENDOTHELIAL-CELLS; MAMMARY-CARCINOMA CELLS; HUMAN SKIN FIBROBLASTS; TUMOR-GROWTH; PHOSPHOINOSITIDE 3-KINASE; GENE-EXPRESSION; FACTOR-I; METASTASIS	The main aim of our study is to determine the significance of the stromal microenvironment in the malignant behavior of prostate cancer. The stroma-derived growth factors/cytokines and hyaluronan act in autocrine/paracrine ways with their receptors, including receptor-tyrosine kinases and CD44 variants (CD44v), to potentiate and support tumor epithelial cell survival. Overexpression of hyaluronan, CD44v9 variants, and stroma-derived growth factors/cytokines are specific features in many cancers, including prostate cancer. Androgen/androgen receptor interaction has a critical role in regulating prostate cancer growth. Our previous study showed that 1) that increased synthesis of hyaluronan in normal epithelial cells promotes expression of CD44 variants; 2) hyaluronan interaction with CD44v6-v9 promotes activation of receptor-tyrosine kinase, which stimulates phosphatidylinositol 3-kinase-induced cell survival pathways; and 3) CD44v6/short hairpin RNA reduces colon tumor growth in vivo (Misra, S., Hascall, V. C., De Gio-vanni, C., Markwald, R. R., and Ghatak, S. ( 2009) J. Biol. Chem. 284, 12432-12446). Our results now show that hepatocyte growth factor synthesized by myofibroblasts associated with prostate cancer cells induces activation of HGF-receptor/cMet and stimulates hyaluronan/CD44v9 signaling. This, in turn, stabilizes the androgen receptor functions in prostate cancer cells. The stroma-derived HGF induces a lipid raft-associated signaling complex that contains CD44v9, cMet/phosphatidylinositol 3-kinase, HSP90 and androgen receptor. CD44v9/short hairpin RNA reverses the assembly of these components in the complex and inhibits androgen receptor function. Our results provide new insight into the hyaluronan/CD44v9-regulated androgen receptor function and the consequent malignant activities in prostate cancer cells. The present study describes a physiologically relevant in vitro model for studying the molecular mechanisms by which stroma-derived HGF and hyaluronan influence androgen receptor and CD44 functions in the secretory epithelia during prostate carcinogenesis.	[Ghatak, Shibnath; Markwald, Roger R.; Misra, Suniti] Med Univ S Carolina, Dept Regenerat Med & Cell Biol, Charleston, SC 29425 USA; [Ghatak, Shibnath; Misra, Suniti] Med Univ S Carolina, Div Rheumatol & Immunol, Dept Med, Charleston, SC 29425 USA; [Hascall, Vincent C.] Cleveland Clin, Dept Biomed Engn ND20, Cleveland, OH 44195 USA	Medical University of South Carolina; Medical University of South Carolina; Cleveland Clinic Foundation	Ghatak, S (corresponding author), Med Univ S Carolina, Dept Regenerat Med & Cell Biol, 171 Ashley Ave, Charleston, SC 29425 USA.	ghatak@musc.edu; misra@musc.edu			National Institutes of Health [P20RR021949, P20RR016434, HL RO1 33756, 1 P30AR050953]; Mitral-07 CVD 04; Medical University of South Carolina [2204000-24330, 2204000-24329]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021949, P20RR016434] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL033756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR050953] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mitral-07 CVD 04; Medical University of South Carolina; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants P20RR021949 (to S.G.) and P20RR016434 (to S.M., S.G., and R.R.M.), HL RO1 33756 and 1 P30AR050953 (to V.C.H.). This work was also supported by Mitral-07 CVD 04 (to R.R.M.), Medical University of South Carolina University Research Council Project 2204000-24330 (to S.M.) and 2204000-24329 (to S.G.).	Aaltomaa S, 2002, UROL INT, V69, P266, DOI 10.1159/000066123; Bardelli A, 1999, ONCOGENE, V18, P1139, DOI 10.1038/sj.onc.1202607; Bartolazzi A, 1996, J CELL BIOL, V132, P1199, DOI 10.1083/jcb.132.6.1199; BARTOLAZZI A, 1994, J EXP MED, V180, P53, DOI 10.1084/jem.180.1.53; Bourguignon LYW, 2003, J BIOL CHEM, V278, P29420, DOI 10.1074/jbc.M301885200; Bourguignon LYW, 2001, J MAMMARY GLAND BIOL, V6, P287, DOI 10.1023/A:1011371523994; Camenisch TD, 2002, NAT MED, V8, P850, DOI 10.1038/nm742; CULTY M, 1994, J CELL PHYSIOL, V160, P275, DOI 10.1002/jcp.1041600209; Duffy MJ, 2008, J PATHOL, V214, P283, DOI 10.1002/path.2282; Esser C, 2004, INT IMMUNOPHARMACOL, V4, P805, DOI 10.1016/j.intimp.2004.03.006; Fujita K, 2008, PROSTATE, V68, P872, DOI 10.1002/pros.20755; Ghatak S, 2005, J BIOL CHEM, V280, P8875, DOI 10.1074/jbc.M410882200; Ghatak S, 2002, J BIOL CHEM, V277, P38013, DOI 10.1074/jbc.M202404200; GOHDA E, 1994, CYTOKINE, V6, P633, DOI 10.1016/1043-4666(94)90051-5; Gordon LB, 2003, HUM GENET, V113, P178, DOI 10.1007/s00439-003-0958-9; Grossmann ME, 2001, JNCI-J NATL CANCER I, V93, P1687, DOI 10.1093/jnci/93.22.1687; GUNTHERT U, 1991, CELL, V65, P13, DOI 10.1016/0092-8674(91)90403-L; Halevy O, 2004, EXP CELL RES, V297, P224, DOI 10.1016/j.yexcr.2004.03.024; HE Q, 1992, J CELL BIOL, V119, P1711, DOI 10.1083/jcb.119.6.1711; Itano N, 2002, P NATL ACAD SCI USA, V99, P3609, DOI 10.1073/pnas.052026799; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kosaki R, 1999, CANCER RES, V59, P1141; Levesque MC, 1997, J IMMUNOL, V159, P6184; Lin SL, 2007, CARCINOGENESIS, V28, P310, DOI 10.1093/carcin/bgl134; Lipponen P, 2001, EUR J CANCER, V37, P849, DOI 10.1016/S0959-8049(00)00448-2; Lokeshwar VB, 2001, J BIOL CHEM, V276, P11922, DOI 10.1074/jbc.M008432200; Marieb EA, 2004, CANCER RES, V64, P1229, DOI 10.1158/0008-5472.CAN-03-2832; MATSUMOTO K, 1995, J BIOCHEM-TOKYO, V117, P458, DOI 10.1093/jb/117.2.458; MATSUMOTO K, 1992, BIOCHEM BIOPH RES CO, V188, P235, DOI 10.1016/0006-291X(92)92375-8; MATSUMOTO K, 1992, P NATL ACAD SCI USA, V89, P3800, DOI 10.1073/pnas.89.9.3800; MATSUNAGA T, 1994, EXP CELL RES, V210, P326, DOI 10.1006/excr.1994.1045; Misra S, 2005, J BIOL CHEM, V280, P20310, DOI 10.1074/jbc.M500737200; Misra S, 2003, J BIOL CHEM, V278, P25285, DOI 10.1074/jbc.C300173200; Misra S, 2008, CONNECT TISSUE RES, V49, P219, DOI 10.1080/03008200802143356; Misra S, 2008, J BIOL CHEM, V283, P14335, DOI 10.1074/jbc.M703811200; Misra S, 2006, J BIOL CHEM, V281, P34936, DOI 10.1074/jbc.C600138200; Misra S, 2009, J BIOL CHEM, V284, P12432, DOI 10.1074/jbc.M806772200; Miyake H, 1998, J UROLOGY, V160, P1562, DOI 10.1016/S0022-5347(01)62613-2; Miyake H, 1998, J UROLOGY, V160, P2004, DOI 10.1016/S0022-5347(01)62225-0; Munster PN, 2002, CANCER RES, V62, P3132; Naor D, 2002, CRIT REV CL LAB SCI, V39, P527, DOI 10.1080/10408360290795574; Naughton M, 2001, J UROLOGY, V165, P1325, DOI 10.1016/S0022-5347(01)69893-8; NOBLE PW, 1993, J CLIN INVEST, V91, P2368, DOI 10.1172/JCI116469; Noordzij MA, 1997, CLIN CANCER RES, V3, P805; Omara-Opyene AL, 2004, LAB INVEST, V84, P894, DOI 10.1038/labinvest.3700112; Orian-Rousseau V, 2002, GENE DEV, V16, P3074, DOI 10.1101/gad.242602; Pratt WB, 1999, CELL SIGNAL, V11, P839, DOI 10.1016/S0898-6568(99)00064-9; Reeder JA, 1998, CANCER RES, V58, P3719; SEITER S, 1993, J EXP MED, V177, P443, DOI 10.1084/jem.177.2.443; Simpson MA, 2002, AM J PATHOL, V161, P849, DOI 10.1016/S0002-9440(10)64245-9; Simpson MA, 2002, J BIOL CHEM, V277, P10050, DOI 10.1074/jbc.M110069200; Simpson MA, 2001, J BIOL CHEM, V276, P17949, DOI 10.1074/jbc.M010064200; Skrtic S, 1997, ENDOCRINOLOGY, V138, P4683, DOI 10.1210/en.138.11.4683; Sleeman J, 1996, J CELL BIOL, V135, P1139, DOI 10.1083/jcb.135.4.1139; SY MS, 1991, J EXP MED, V174, P859, DOI 10.1084/jem.174.4.859; THALMANN GN, 1994, CANCER RES, V54, P2577; Tsatas D, 2002, J CLIN NEUROSCI, V9, P282, DOI 10.1054/jocn.2001.1063; VANDENHOOFF A, 1988, ADV CANCER RES, V50, P159, DOI 10.1016/S0065-230X(08)60437-6; VANWEERING DHJ, 1993, PCR METH APPL, V3, P100; VELDSCHOLTE J, 1990, BIOCHEM BIOPH RES CO, V173, P534, DOI 10.1016/S0006-291X(05)80067-1; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; Webber MM, 1996, PROSTATE, V29, P386, DOI 10.1002/(SICI)1097-0045(199612)29:6<386::AID-PROS7>3.0.CO;2-6; Yu Q, 1997, J EXP MED, V186, P1985, DOI 10.1084/jem.186.12.1985; Zeng CX, 1998, INT J CANCER, V77, P396; Zhu XP, 2000, UROLOGY, V56, P1071, DOI 10.1016/S0090-4295(00)00795-0; Zoltan-Jones A, 2003, J BIOL CHEM, V278, P45801, DOI 10.1074/jbc.M308168200	66	60	63	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					19821	19832		10.1074/jbc.M110.104273	http://dx.doi.org/10.1074/jbc.M110.104273			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20200161	Green Published, hybrid			2022-12-25	WOS:000279012000015
J	Lim, SY; Raftery, MJ; Goyette, J; Geczy, CL				Lim, Su Yin; Raftery, Mark J.; Goyette, Jesse; Geczy, Carolyn L.			S-Glutathionylation Regulates Inflammatory Activities of S100A9	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-BINDING PROTEIN; MICROVASCULAR ENDOTHELIAL-CELLS; OXIDATIVE STRESS; HUMAN NEUTROPHILS; ARACHIDONIC-ACID; TRANSENDOTHELIAL MIGRATION; REDOX REGULATION; NADPH OXIDASE; MRP14 S100A9; ANTIMICROBIAL ACTIVITY	Reactive oxygen species generated by activated neutrophils can cause oxidative stress and tissue damage. S100A8 (A8) and S100A9 (A9), abundant in neutrophil cytoplasm, are exquisitely sensitive to oxidation, which may alter their functions. Murine A8 is a neutrophil chemoattractant, but it suppresses leukocyte transmigration in the microcirculation when S-nitrosylated. Glutathione (GSH) modulates intracellular redox, and S-glutathionylation can protect susceptible proteins from oxidative damage and regulate function. We characterized S-glutathionylation of A9; GSSG and GSNO generated S-glutathionylated A8 (A8-SSG) and A9 (A9-SSG) in vitro, whereas only A9-SSG was detected in cytosol of neutrophils activated with phorbol myristate acetate (PMA) but not with fMLP or opsonized zymosan. S-Glutathionylation exposed more hydrophobic regions in Zn2+-bound A9 but did not alter Zn2+ binding affinity. A9-SSG had reduced capacity to form heterocomplexes with A8, but the arachidonic acid binding capacities of A8/A9 and A8/A9-SSG were similar. A9 and A8/A9 bind endothelial cells; S-glutathionylation reduced binding. We found little effect of A9 or A9-SSG on neutrophil CD11b/CD18 expression or neutrophil adhesion to endothelial cells. However, A9, A9-SSG and A8/A9 promoted neutrophil adhesion to fibronectin but, in the presence of A8, A9-mediated adhesion was abrogated by glutathionylation. S-Glutathionylation of A9 may protect its oxidation to higher oligomers and reduce neutrophil binding to the extracellular matrix. This may regulate the magnitude of neutrophil migration in the extravasculature, and together with the functional changes we reported for S-nitrosylated A8, particular oxidative modifications of these proteins may limit tissue damage in acute inflammation.	Univ New S Wales, Ctr Infect & Inflammat Res, Sydney, NSW 2052, Australia; [Raftery, Mark J.] Univ New S Wales, Sch Med Sci, Bioanalyt Mass Spectrometry Facil, Sydney, NSW 2052, Australia	University of New South Wales Sydney; University of New South Wales Sydney		c.geczy@unsw.edu.au	Goyette, Jesse/AAW-4701-2021	Goyette, Jesse/0000-0002-1008-1890; Lim, Su Yin/0000-0001-9576-5441	National Health and Medical Research Council of Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported in part by grants from the National Health and Medical Research Council of Australia.	Achilli C, 2008, J LEUKOCYTE BIOL, V83, P181, DOI 10.1189/jlb.0707492; Al-Abed Y, 2001, MOL MED, V7, P619, DOI 10.1007/BF03401868; Anceriz N, 2007, BIOCHEM BIOPH RES CO, V354, P84, DOI 10.1016/j.bbrc.2006.12.203; Atienza JM, 2006, ASSAY DRUG DEV TECHN, V4, P597, DOI 10.1089/adt.2006.4.597; BENGISGARBER C, 1993, J LEUKOCYTE BIOL, V54, P114, DOI 10.1002/jlb.54.2.114; BERNTZEN HB, 1990, SCAND J CLIN LAB INV, V50, P769, DOI 10.3109/00365519009091071; Burlak C, 2006, MOL CELL PROTEOMICS, V5, P620, DOI 10.1074/mcp.M500336-MCP200; CHAI YC, 1994, ARCH BIOCHEM BIOPHYS, V310, P273, DOI 10.1006/abbi.1994.1167; Corbin BD, 2008, SCIENCE, V319, P962, DOI 10.1126/science.1152449; Dalle-Donne I, 2007, FREE RADICAL BIO MED, V43, P883, DOI 10.1016/j.freeradbiomed.2007.06.014; Davis DA, 2002, METHOD ENZYMOL, V348, P249, DOI 10.1016/S0076-6879(02)48643-0; De Lorenzo BHP, 2010, IMMUNOBIOLOGY, V215, P341, DOI 10.1016/j.imbio.2009.05.013; DeCoursey TE, 2005, CELL MOL LIFE SCI, V62, P2173, DOI 10.1007/s00018-005-5177-1; Eckert RL, 2004, J INVEST DERMATOL, V123, P23, DOI 10.1111/j.0022-202X.2004.22719.x; EDGEWORTH J, 1991, J BIOL CHEM, V266, P7706; EDGEWORTH J, 1989, NATURE, V342, P189, DOI 10.1038/342189a0; El-Benna J, 2005, ARCH IMMUNOL THER EX, V53, P199; Endoh Y, 2009, J IMMUNOL, V182, P2258, DOI 10.4049/jimmunol.0802683; Eue I, 2002, INT IMMUNOL, V14, P287, DOI 10.1093/intimm/14.3.287; Fiaschi T, 2006, J BIOL CHEM, V281, P22983, DOI 10.1074/jbc.M603040200; Fratelli M, 2002, P NATL ACAD SCI USA, V99, P3505, DOI 10.1073/pnas.052592699; Gallogly MM, 2007, CURR OPIN PHARMACOL, V7, P381, DOI 10.1016/j.coph.2007.06.003; Ghavami S, 2004, J LEUKOCYTE BIOL, V76, P169, DOI 10.1189/jlb.0903435; Ghezzi P, 2005, FREE RADICAL RES, V39, P573, DOI 10.1080/10715760500072172; Ghezzi P, 2002, MOL IMMUNOL, V38, P773, DOI 10.1016/S0161-5890(01)00114-6; Giustarini D, 2004, J CELL MOL MED, V8, P201, DOI 10.1111/j.1582-4934.2004.tb00275.x; Giustarini D, 2005, ANTIOXID REDOX SIGN, V7, P930, DOI 10.1089/ars.2005.7.930; Goch G, 2005, FEBS J, V272, P2557, DOI 10.1111/j.1742-4658.2005.04680.x; Grimbaldeston MA, 2003, J INVEST DERMATOL, V121, P1168, DOI 10.1046/j.1523-1747.2003.12561.x; Hampton MB, 1998, BLOOD, V92, P3007, DOI 10.1182/blood.V92.9.3007.421k47_3007_3017; Harrison CA, 1999, J BIOL CHEM, V274, P8561, DOI 10.1074/jbc.274.13.8561; Herndon BL, 2003, J LAB CLIN MED, V141, P110, DOI 10.1067/mlc.2003.17; HESSIAN PA, 1993, J LEUKOCYTE BIOL, V53, P197, DOI 10.1002/jlb.53.2.197; Hetland G, 1998, J CLIN PATHOL-MOL PA, V51, P143, DOI 10.1136/mp.51.3.143; HOGG N, 1989, EUR J IMMUNOL, V19, P1053, DOI 10.1002/eji.1830190615; Holmgren A, 2005, BIOCHEM SOC T, V33, P1375, DOI 10.1042/BST0331375; Hou LM, 2004, J AM CHEM SOC, V126, P1992, DOI 10.1021/ja036813f; Hsu K, 2005, J IMMUNOL, V174, P2318, DOI 10.4049/jimmunol.174.4.2318; Hultqvist M, 2009, TRENDS IMMUNOL, V30, P201, DOI 10.1016/j.it.2009.03.004; IISMAA SE, 1994, DNA CELL BIOL, V13, P183, DOI 10.1089/dna.1994.13.183; Kerkhoff C, 2005, FASEB J, V19, P467, DOI 10.1096/fj.04-2377fje; Kerkhoff C, 1999, J BIOL CHEM, V274, P32672, DOI 10.1074/jbc.274.46.32672; Kerkhoff C, 1999, PATHOBIOLOGY, V67, P230, DOI 10.1159/000028098; Kerkhoff C, 1998, BBA-MOL CELL RES, V1448, P200, DOI 10.1016/S0167-4889(98)00144-X; Kerkhoff C, 1999, FEBS LETT, V460, P134, DOI 10.1016/S0014-5793(99)01322-8; Klatt P, 2000, EUR J BIOCHEM, V267, P4928, DOI 10.1046/j.1432-1327.2000.01601.x; Klempt M, 1997, FEBS LETT, V408, P81, DOI 10.1016/S0014-5793(97)00394-3; Kocher M, 1996, INFECT IMMUN, V64, P1342, DOI 10.1128/IAI.64.4.1342-1350.1996; Kumar RK, 2001, J LEUKOCYTE BIOL, V70, P59; LEMARCHAND P, 1992, J BIOL CHEM, V267, P19379; Leukert N, 2006, J MOL BIOL, V359, P961, DOI 10.1016/j.jmb.2006.04.009; Levine RL, 1996, P NATL ACAD SCI USA, V93, P15036, DOI 10.1073/pnas.93.26.15036; Lim SY, 2008, J IMMUNOL, V181, P5627, DOI 10.4049/jimmunol.181.8.5627; Lind C, 2002, ARCH BIOCHEM BIOPHYS, V406, P229, DOI 10.1016/S0003-9861(02)00468-X; Lindbom L, 2002, SEMIN IMMUNOL, V14, P115, DOI 10.1006/smim.2001.0348; Lominadze G, 2005, J IMMUNOL, V174, P7257, DOI 10.4049/jimmunol.174.11.7257; MARKERT M, 1984, BLUT, V49, P447, DOI 10.1007/BF00320487; Martinez-Ruiz A, 2007, CARDIOVASC RES, V75, P220, DOI 10.1016/j.cardiores.2007.03.016; McCormick MM, 2005, J BIOL CHEM, V280, P41521, DOI 10.1074/jbc.M509442200; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; MIYASAKI KT, 1993, J DENT RES, V72, P517, DOI 10.1177/00220345930720020801; Moskovitz J, 2005, BBA-PROTEINS PROTEOM, V1703, P213, DOI 10.1016/j.bbapap.2004.09.003; Newton RA, 1998, J IMMUNOL, V160, P1427; Niwa T, 2000, CLIN CHEM, V46, P82; Niwa T, 2007, J CHROMATOGR B, V855, P59, DOI 10.1016/j.jchromb.2006.12.029; Piemonte F, 2001, EUR J CLIN INVEST, V31, P1007, DOI 10.1046/j.1365-2362.2001.00922.x; Pineda-Molina E, 2001, BIOCHEMISTRY-US, V40, P14134, DOI 10.1021/bi011459o; Poole LB, 2004, ANNU REV PHARMACOL, V44, P325, DOI 10.1146/annurev.pharmtox.44.101802.121735; Qanungo S, 2007, J BIOL CHEM, V282, P18427, DOI 10.1074/jbc.M610934200; Raftery MJ, 2001, J BIOL CHEM, V276, P33393, DOI 10.1074/jbc.M101566200; Rahimi F, 2005, FEBS J, V272, P2811, DOI 10.1111/j.1742-4658.2005.04703.x; Rammes A, 1997, J BIOL CHEM, V272, P9496; RAVICHANDRAN V, 1994, J BIOL CHEM, V269, P25010; Richie JP, 1996, CLIN CHEM, V42, P64; Robinson MJ, 2002, J BIOL CHEM, V277, P3658, DOI 10.1074/jbc.M102950200; ROTH J, 1993, BLOOD, V82, P1875; Roulin K, 1999, EXP CELL RES, V247, P410, DOI 10.1006/excr.1998.4382; Ryckman C, 2003, J IMMUNOL, V170, P3233, DOI 10.4049/jimmunol.170.6.3233; Ryter SW, 2007, ANTIOXID REDOX SIGN, V9, P49, DOI 10.1089/ars.2007.9.49; Schoneich C, 2005, BBA-PROTEINS PROTEOM, V1703, P111, DOI 10.1016/j.bbapap.2004.09.009; Shelton MD, 2008, MOL CELLS, V25, P332; Siegenthaler G, 1997, J BIOL CHEM, V272, P9371; SMITH JA, 1994, J LEUKOCYTE BIOL, V56, P672, DOI 10.1002/jlb.56.6.672; SOHNLE PG, 1991, J INFECT DIS, V163, P187, DOI 10.1093/infdis/163.1.187; Srikrishna G, 2001, J IMMUNOL, V166, P4678, DOI 10.4049/jimmunol.166.7.4678; Sroussi HY, 2006, J DENT RES, V85, P829, DOI 10.1177/154405910608500910; Sroussi HY, 2007, J LEUKOCYTE BIOL, V81, P818, DOI 10.1189/jlb.0706433; Sroussi HY, 2009, FEMS IMMUNOL MED MIC, V55, P55, DOI 10.1111/j.1574-695X.2008.00498.x; Suryono, 2005, J PERIODONTOL, V76, P437, DOI 10.1902/jop.2005.76.3.437; TEIGELKAMP S, 1991, J BIOL CHEM, V266, P13462; Vandal K, 2003, J IMMUNOL, V171, P2602, DOI 10.4049/jimmunol.171.5.2602; vandenBos C, 1996, J IMMUNOL, V156, P1247; Viemann D, 2005, BLOOD, V105, P2955, DOI 10.1182/blood-2004-07-2520; Voganatsi A, 2001, J LEUKOCYTE BIOL, V70, P130; Vogl T, 2004, BLOOD, V104, P4260, DOI 10.1182/blood-2004-02-0446; Vogl T, 2007, NAT MED, V13, P1042, DOI 10.1038/nm1638; VOGT W, 1995, FREE RADICAL BIO MED, V18, P93, DOI 10.1016/0891-5849(94)00158-G; Xu K, 2001, J IMMUNOL, V166, P6358, DOI 10.4049/jimmunol.166.10.6358; Yen T, 1997, BLOOD, V90, P4812, DOI 10.1182/blood.V90.12.4812.4812_4812_4821; Yui S, 1995, J LEUKOCYTE BIOL, V58, P650, DOI 10.1002/jlb.58.6.650; Zhukova L, 2004, BBA-MOL CELL RES, V1742, P191, DOI 10.1016/j.bbamcr.2004.10.002	101	53	53	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14377	14388		10.1074/jbc.M109.075242	http://dx.doi.org/10.1074/jbc.M109.075242			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20223829	Green Published, hybrid			2022-12-25	WOS:000277299700035
J	Kongkham, PN; Northcott, PA; Croul, SE; Smith, CA; Taylor, MD; Rutka, JT				Kongkham, P. N.; Northcott, P. A.; Croul, S. E.; Smith, C. A.; Taylor, M. D.; Rutka, J. T.			The SFRP family of WNT inhibitors function as novel tumor suppressor genes epigenetically silenced in medulloblastoma	ONCOGENE			English	Article						medulloblastoma; WNT signaling; epigenetics; methylation; tumor suppressor gene	BETA-CATENIN; METHYLATION; ANTAGONIST; MUTATIONS; SUBTYPES; CANCER; BRAIN; CELLS; MYC	Medulloblastoma (MB) is the most common malignant pediatric brain tumor. Dysregulation of WNT signaling occurs in up to 20% of cases. Using a genome-wide approach, we identified the secreted frizzled-related protein 1, 2 and 3 (SFRP1, SFRP2 and SFRP3) family of WNT inhibitors as putative tumor suppressor genes silenced by promoter region methylation in MB. SFRP1, SFRP2 and SFRP3 expression increased after 5-aza-2'-deoxycytidine treatment. SFRP1, SFRP2 and SFRP3 methylation was identified in 23.5, 3.9 and 15.7% of primary MB specimens, respectively, by methylation-specific PCR. Stable SFRP1, SFRP2 and SFRP3 expression reduced phospho-DVL2 levels and hindered MB cell proliferation and colony formation in soft agar in vitro. In 60% of primary tumors, SFRP1 was expressed at levels twofold lower than that in normal cerebellum. SFRP1 expression impaired tumor formation in vivo in flank and orthotopic intracerebellar xenograft models and conferred a significant survival advantage (P<0.0001). We identify for the first time tumor suppressor gene function of SFRP genes in MB, and suggest that loss of WNT pathway inhibition due to SFRP gene silencing is an additional mechanism that may contribute to excessive WNT signaling in this disease. Oncogene (2010) 29, 3017-3024; doi:10.1038/onc.2010.32; published online 8 March 2010	[Kongkham, P. N.; Northcott, P. A.; Smith, C. A.; Taylor, M. D.; Rutka, J. T.] Hosp Sick Children, Div Neurosurg, Arthur & Sonia Labatt Brain Tumor Res Ctr, Toronto, ON M5G 1X8, Canada; [Kongkham, P. N.; Smith, C. A.; Rutka, J. T.] Univ Toronto, Hosp Sick Children, Cell Biol Program, Toronto, ON M5G 1X8, Canada; [Northcott, P. A.; Taylor, M. D.] Univ Toronto, Hosp Sick Children, Program Dev & Stem Cell Biol, Toronto, ON M5G 1X8, Canada; [Croul, S. E.] Univ Toronto, Univ Hlth Network, Dept Pathol, Toronto, ON M5G 1X8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; University Health Network Toronto	Rutka, JT (corresponding author), Hosp Sick Children, Div Neurosurg, Arthur & Sonia Labatt Brain Tumor Res Ctr, Suite 1503,555 Univ Ave, Toronto, ON M5G 1X8, Canada.	james.rutka@sickkids.ca	Northcott, Paul A/N-4022-2018	Northcott, Paul A/0000-0002-1220-5252; Kongkham, Paul/0000-0002-1047-9305; Taylor, Michael/0000-0001-7009-3466; Croul, Sidney/0000-0002-2224-5485	Canadian Cancer Society, National Cancer Institute of Canada [019073]; Pediatric Brain Tumor Foundation; Wiley Fund at the Hospital for Sick Children and B.r.a.i.n.child; National Cancer Institute of Canada Terry Fox Foundation; Surgeon Scientist Program (University of Toronto); National Cancer Institute of Canada Terry Fox Foundation clinical research fellowship; RESTRACOMP, The Hospital for Sick Children, Toronto	Canadian Cancer Society, National Cancer Institute of Canada; Pediatric Brain Tumor Foundation; Wiley Fund at the Hospital for Sick Children and B.r.a.i.n.child; National Cancer Institute of Canada Terry Fox Foundation; Surgeon Scientist Program (University of Toronto)(University of Toronto); National Cancer Institute of Canada Terry Fox Foundation clinical research fellowship; RESTRACOMP, The Hospital for Sick Children, Toronto	This work was supported by grants from the Canadian Cancer Society, National Cancer Institute of Canada (019073), the Pediatric Brain Tumor Foundation, the Wiley Fund at the Hospital for Sick Children and B.r.a.i.n.child. James Rutka is a scientist of the Canadian Institutes of Health Research. Paul Kongkham was supported by the Surgeon Scientist Program (University of Toronto), the National Cancer Institute of Canada Terry Fox Foundation clinical research fellowship and a research studentship from RESTRACOMP, The Hospital for Sick Children, Toronto.	Baeza N, 2003, ONCOGENE, V22, P632, DOI 10.1038/sj.onc.1206156; Bovolenta P, 2008, J CELL SCI, V121, P737, DOI 10.1242/jcs.026096; Chang Q, 2005, HUM PATHOL, V36, P1265, DOI 10.1016/j.humpath.2005.09.004; Cowling VH, 2007, MOL CELL BIOL, V27, P5135, DOI 10.1128/MCB.02282-06; Dahl E, 2007, ONCOGENE, V26, P5680, DOI 10.1038/sj.onc.1210345; Eberhart CG, 2000, J NEUROPATH EXP NEUR, V59, P333, DOI 10.1093/jnen/59.4.333; Ellison DW, 2005, J CLIN ONCOL, V23, P7951, DOI 10.1200/JCO.2005.01.5479; Fan X, 2008, J CLIN ONCOL, V26, P2821, DOI 10.1200/JCO.2007.15.2264; Gilbertson RJ, 2008, ANNU REV PATHOL-MECH, V3, P341, DOI 10.1146/annurev.pathmechdis.3.121806.151518; Habas Raymond, 2005, J Biol, V4, P2, DOI 10.1186/jbiol22; HAMILTON SR, 1995, NEW ENGL J MED, V332, P839, DOI 10.1056/NEJM199503303321302; Katoh Y, 2006, INT J MOL MED, V17, P171; Koch A, 2007, INT J CANCER, V121, P284, DOI 10.1002/ijc.22675; Kongkham PN, 2008, CANCER RES, V68, P9945, DOI 10.1158/0008-5472.CAN-08-2169; Kool M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003088; Lee Y, 2003, CANCER RES, V63, P5428; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; Northcott PA, 2009, NAT GENET, V41, P465, DOI 10.1038/ng.336; Northcott PA, 2009, CANCER RES, V69, P3249, DOI 10.1158/0008-5472.CAN-08-4710; Suzuki H, 2004, NAT GENET, V36, P417, DOI 10.1038/ng1330; Thompson MC, 2006, J CLIN ONCOL, V24, P1924, DOI 10.1200/JCO.2005.04.4974; Vibhakar R, 2007, NEURO-ONCOLOGY, V9, P135, DOI 10.1215/15228517-2006-038	22	80	86	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAY	2010	29	20					3017	3024		10.1038/onc.2010.32	http://dx.doi.org/10.1038/onc.2010.32			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	599DM	20208569				2022-12-25	WOS:000277890400012
J	Rossi, A; Trotta, E; Brandi, R; Arisi, I; Coccia, M; Santoro, MG				Rossi, Antonio; Trotta, Edoardo; Brandi, Rossella; Arisi, Ivan; Coccia, Marta; Santoro, M. Gabriella			AIRAP, a New Human Heat Shock Gene Regulated by Heat Shock Factor 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR-1; MOLECULAR CHAPERONES; PROSTAGLANDIN A(1); DAMAGED PROTEINS; KAPPA-B; STRESS; DROSOPHILA; PROTEOTOXICITY; DEGRADATION; ACTIVATION	Heat shock factor-1 (HSF1) is the central regulator of heat-induced transcriptional responses leading to rapid expression of molecular chaperones that protect mammalian cells against proteotoxic stress. The main targets for HSF1 are specific promoter elements (HSE) located upstream of heat shock genes encoding a variety of heat shock proteins, including HSP70, HSP90, HSP27, and other proteins of the network. Herein we report that the zinc finger AN1-type domain-2a gene, also known as AIRAP, behaves as a canonical heat shock gene, whose expression is temperature-dependent and strictly controlled by HSF1. Transcription is triggered at temperatures above 40 degrees C in different types of human cancer and primary cells, including peripheral blood monocytes. As shown by ChIP analysis, HSF1 is recruited to the AIRAP promoter rapidly after heat treatment, with a kinetics that parallels HSP70 promoter HSF1-recruitment. In transfection experiments HSF1-silencing abolished heat-induced AIRAP promoter-driven transcription, which could be rescued by exogenous Flag-HSF1 expression. The HSF1 binding HSE sequence in the AIRAP promoter critical for heat-induced transcription was identified. Because its expression is induced at febrile temperatures in human cells, AIRAP may represent a new potential component of the protective response during fever in humans.	[Coccia, Marta; Santoro, M. Gabriella] Univ Roma Tor Vergata, Dept Biol, I-00133 Rome, Italy; [Brandi, Rossella; Arisi, Ivan] European Brain Res Inst, I-00143 Rome, Italy; [Rossi, Antonio; Trotta, Edoardo; Coccia, Marta; Santoro, M. Gabriella] CNR, Inst Neurobiol & Mol Med, I-00133 Rome, Italy	University of Rome Tor Vergata; Consiglio Nazionale delle Ricerche (CNR)	Santoro, MG (corresponding author), Univ Roma Tor Vergata, Dept Biol, Via Ric Sci, I-00133 Rome, Italy.	santoro@bio.uniroma2.it	Trotta, Edoardo/AAW-4697-2020; Arisi, Ivan/AAM-1152-2021	Trotta, Edoardo/0000-0002-1417-9238; Arisi, Ivan/0000-0002-0536-2508; ROSSI, ANTONIO/0000-0003-0383-3828; Santoro, Maria Gabriella/0000-0003-1432-4949	Italian Ministry of University and Scientific Research; Italian Ministry of Public Health; EU	Italian Ministry of University and Scientific Research(Ministry of Education, Universities and Research (MIUR)); Italian Ministry of Public Health(Ministry of Health, Italy); EU(European Commission)	This work was supported in part by the Italian Ministry of University and Scientific Research, the Italian Ministry of Public Health (ISS project), and the EU EICOSANOX Project.	ABRAVAYA K, 1991, GENE DEV, V5, P2117, DOI 10.1101/gad.5.11.2117; Anckar J, 2007, ADV EXP MED BIOL, V594, P78; Cascio P, 2002, EMBO J, V21, P2636, DOI 10.1093/emboj/21.11.2636; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Elia G, 1999, EUR J BIOCHEM, V264, P736, DOI 10.1046/j.1432-1327.1999.00610.x; FERNANDES M, 1994, NUCLEIC ACIDS RES, V22, P167, DOI 10.1093/nar/22.2.167; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Hayashida N, 2006, EMBO J, V25, P4773, DOI 10.1038/sj.emboj.7601370; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Hohfeld J, 2001, EMBO REP, V2, P885, DOI 10.1093/embo-reports/kve206; Holmberg CI, 2002, TRENDS BIOCHEM SCI, V27, P619, DOI 10.1016/S0968-0004(02)02207-7; Jaattela M, 1999, ANN MED, V31, P261, DOI 10.3109/07853899908995889; Morimoto RI, 1998, NAT BIOTECHNOL, V16, P833, DOI 10.1038/nbt0998-833; Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; PARSELL DA, 1993, ANNU REV GENET, V27, P437, DOI 10.1146/annurev.ge.27.120193.002253; RITOSSA F, 1962, EXPERIENTIA, V18, P571, DOI 10.1007/BF02172188; Rossi A, 2000, NATURE, V403, P103, DOI 10.1038/47520; Rossi A, 1997, P NATL ACAD SCI USA, V94, P746, DOI 10.1073/pnas.94.2.746; Rossi A, 2006, CANCER RES, V66, P7678, DOI 10.1158/0008-5472.CAN-05-4282; Sandqvist A, 2009, MOL BIOL CELL, V20, P1340, DOI 10.1091/mbc.E08-08-0864; Sok J, 2001, CELL STRESS CHAPERON, V6, P6, DOI 10.1379/1466-1268(2001)006<0006:AIRAPA>2.0.CO;2; Stanhill A, 2006, MOL CELL, V23, P875, DOI 10.1016/j.molcel.2006.07.023; Trinklein ND, 2004, MOL BIOL CELL, V15, P1254, DOI 10.1091/mbc.E03-10-0738; Vilaboa NE, 2000, J BIOL CHEM, V275, P24970, DOI 10.1074/jbc.M909136199; Westerheide SD, 2009, SCIENCE, V323, P1063, DOI 10.1126/science.1165946; XIAO H, 1991, CELL, V64, P585, DOI 10.1016/0092-8674(91)90242-Q; Yoo HY, 1999, J BIOL CHEM, V274, P23887, DOI 10.1074/jbc.274.34.23887; Yun C, 2008, P NATL ACAD SCI USA, V105, P7094, DOI 10.1073/pnas.0707025105; Zhao YH, 2009, ONCOGENE, V28, P3689, DOI 10.1038/onc.2009.229	31	25	25	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13607	13615		10.1074/jbc.M109.082693	http://dx.doi.org/10.1074/jbc.M109.082693			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20185824	hybrid, Green Published			2022-12-25	WOS:000276987700034
J	Chokas, AL; Trivedi, CM; Lu, MM; Tucker, PW; Li, SR; Epstein, JA; Morrisey, EE				Chokas, Ann L.; Trivedi, Chinmay M.; Lu, Min Min; Tucker, Philip W.; Li, Shanru; Epstein, Jonathan A.; Morrisey, Edward E.			Foxp1/2/4-NuRD Interactions Regulate Gene Expression and Epithelial Injury Response in the Lung via Regulation of Interleukin-6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL REPRESSION; DEVELOPMENTAL DIFFERENCES; CARDIAC MORPHOGENESIS; COMPLEX; CELL; PULMONARY; PROTEINS; FOXP2; COMPONENTS; GATA6	To determine the underlying mechanism of Foxp1/2/4-mediated transcriptional repression, a yeast two-hybrid screen was performed that identified p66 beta, a transcriptional repressor and component of the NuRD chromatin-remodeling complex. We show that direct interactions between Foxp1/4 and p66 beta are mediated by the CR2 domain within p66 beta and the zinc finger/leucine zipper repression domain found in Foxp1/2/4. These direct interactions are functionally relevant as overexpression of p66 beta in combination with Foxp factors cooperatively represses Foxp target gene expression, whereas loss of p66 and Foxp factors results in de-repression of endogenous Foxp target genes in lung epithelial cells. Moreover, the NuRD components HDAC1/2 associate in a macromolecular complex with Foxp proteins, and loss of expression or inhibition of HDAC1/2 activity leads to de-repression of Foxp target gene expression. Importantly, we show in vivo that Foxp1 and HDAC2 act cooperatively to regulate expression of the cytoprotective cytokine interleukin-6, which results in increased resistance to hyperoxic lung injury in Foxp1/HDAC2 compound mutant animals. These data reveal an important interaction between the Foxp transcription factors and the NuRD chromatin-remodeling complex that modulates transcriptional	[Chokas, Ann L.; Trivedi, Chinmay M.; Lu, Min Min; Li, Shanru; Morrisey, Edward E.] Univ Penn, Dept Med, Philadelphia, PA 19104 USA; [Epstein, Jonathan A.; Morrisey, Edward E.] Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Chokas, Ann L.; Trivedi, Chinmay M.; Lu, Min Min; Li, Shanru; Epstein, Jonathan A.; Morrisey, Edward E.] Univ Penn, Cardiovasc Inst, Philadelphia, PA 19104 USA; [Epstein, Jonathan A.; Morrisey, Edward E.] Univ Penn, Inst Regenerat Med, Philadelphia, PA 19104 USA; [Tucker, Philip W.] Univ Texas Austin, Inst Cellular & Mol Biol Mol Genet & Microbiol, Austin, TX 78712 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Texas System; University of Texas Austin	Morrisey, EE (corresponding author), Univ Penn, Dept Med, 956 BRB 2-3,421 Curie Blvd, Philadelphia, PA 19104 USA.	emorrise@mail.med.upenn.edu	Trivedi, Chinmay M/ABA-4097-2021	Trivedi, Chinmay/0000-0002-3544-0474; Epstein, Jonathan/0000-0001-8637-4465	National Institutes of Health [HL071589, HL064632]; University of Pennsylvania Institute for Environmental Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064632, R01HL071589] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Pennsylvania Institute for Environmental Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL071589 and HL064632 ( to E. E. M.).; Supported by an NIH postdoctoral training fellowship in the University of Pennsylvania Institute for Environmental Medicine.	ADAMSON IYR, 1974, LAB INVEST, V30, P35; Bhandari V, 2002, FRONT BIOSCI-LANDMRK, V7, pD1624, DOI 10.2741/bhan; Brackertz M, 2006, NUCLEIC ACIDS RES, V34, P397, DOI 10.1093/nar/gkj437; Brackertz M, 2002, J BIOL CHEM, V277, P40958, DOI 10.1074/jbc.M207467200; Buckley S, 1999, AM J PHYSIOL-LUNG C, V277, pL159, DOI 10.1152/ajplung.1999.277.1.L159; Chetty A, 2008, PEDIATR PULM, V43, P297, DOI 10.1002/ppul.20777; Choo-Wing R, 2007, AM J PHYSIOL-LUNG C, V293, pL142, DOI 10.1152/ajplung.00434.2006; Dos Santos CC, 2007, CRIT CARE, V11, DOI 10.1186/cc5733; EVANS MJ, 1973, AM J PATHOL, V70, P175; Feng Q, 2002, MOL CELL BIOL, V22, P536, DOI 10.1128/MCB.22.2.536-546.2002; Fleischer TC, 2003, MOL CELL BIOL, V23, P3456, DOI 10.1128/MCB.23.10.3456-3467.2003; Fujita N, 2004, CELL, V119, P75, DOI 10.1016/j.cell.2004.09.014; Hong W, 2005, EMBO J, V24, P2367, DOI 10.1038/sj.emboj.7600703; Ito K, 2005, NEW ENGL J MED, V352, P1967, DOI 10.1056/NEJMoa041892; Jepsen K, 2008, GENE DEV, V22, P740, DOI 10.1101/gad.1637108; Jin SG, 2005, J BIOL CHEM, V280, P12700, DOI 10.1074/jbc.M413492200; Johnston CJ, 1997, EXP LUNG RES, V23, P537, DOI 10.3109/01902149709039242; Kalin TV, 2008, P NATL ACAD SCI USA, V105, P19330, DOI 10.1073/pnas.0806748105; Kim J, 1999, IMMUNITY, V10, P345, DOI 10.1016/S1074-7613(00)80034-5; Li SR, 2004, SCIENCE, V305, P1619, DOI 10.1126/science.1098674; Li SR, 2004, MOL CELL BIOL, V24, P809, DOI 10.1128/MCB.24.2.809-822.2004; Lotem J, 1996, P NATL ACAD SCI USA, V93, P12507, DOI 10.1073/pnas.93.22.12507; Lu MM, 2002, MECH DEVELOP, V119, pS197, DOI 10.1016/S0925-4773(03)00116-3; Luo JY, 2000, NATURE, V408, P377, DOI 10.1038/35042612; Mahlapuu M, 2001, DEVELOPMENT, V128, P2397; Montgomery RL, 2007, GENE DEV, V21, P1790, DOI 10.1101/gad.1563807; Nogueira-Silva C, 2006, PEDIATR RES, V60, P530, DOI 10.1203/01.pdr.0000242300.09427.3b; Pal S, 2003, MOL CELL BIOL, V23, P7475, DOI 10.1128/MCB.23.21.7475-7487.2003; Ramirez MI, 2003, DEV BIOL, V256, P61, DOI 10.1016/S0012-1606(02)00098-2; Ramirez MI, 1999, DEV DYNAM, V215, P319, DOI 10.1002/(SICI)1097-0177(199908)215:4<319::AID-AJA4>3.0.CO;2-B; Rath N, 2005, MOL CELL BIOL, V25, P8864, DOI 10.1128/MCB.25.20.8864-8873.2005; Roche AE, 2008, J MOL CELL CARDIOL, V44, P352, DOI 10.1016/j.yjmcc.2007.10.023; Rousso DL, 2008, NEURON, V59, P226, DOI 10.1016/j.neuron.2008.06.025; Shu WG, 2007, DEVELOPMENT, V134, P1991, DOI 10.1242/dev.02846; Shu WG, 2005, P NATL ACAD SCI USA, V102, P9643, DOI 10.1073/pnas.0503739102; Shu WG, 2001, J BIOL CHEM, V276, P27488, DOI 10.1074/jbc.M100636200; Trivedi CM, 2007, NAT MED, V13, P324, DOI 10.1038/nm1552; Wan HJ, 2005, J BIOL CHEM, V280, P13809, DOI 10.1074/jbc.M414122200; Wang B, 2004, DEVELOPMENT, V131, P4477, DOI 10.1242/dev.01287; Ward NS, 2000, AM J RESP CELL MOL, V22, P535, DOI 10.1165/ajrcmb.22.5.3808; Weidenfeld J, 2002, J BIOL CHEM, V277, P21061, DOI 10.1074/jbc.M111702200; Xu D, 2006, AM J PHYSIOL-LUNG C, V291, pL966, DOI 10.1152/ajplung.00045.2006; Yin Z, 2006, AM J PHYSIOL-LUNG C, V291, pL191, DOI 10.1152/ajplung.00385.2005; You YJ, 2004, AM J PHYSIOL-LUNG C, V286, pL650, DOI 10.1152/ajplung.00170.2003; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924; Zhou BY, 2008, AM J RESP CELL MOL, V38, P750, DOI 10.1165/rcmb.2007-0350OC	46	44	47	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					13304	13313		10.1074/jbc.M109.088468	http://dx.doi.org/10.1074/jbc.M109.088468			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20185820	Green Published, hybrid			2022-12-25	WOS:000276787800085
J	Dai, MS; Sun, XX; Lu, H				Dai, Mu-Shui; Sun, Xiao-Xin; Lu, Hua			Ribosomal Protein L11 Associates with c-Myc at 5 S rRNA and tRNA Genes and Regulates Their Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMERASE-III TRANSCRIPTION; DIAMOND-BLACKFAN ANEMIA; ACTIVATES P53; CELL-CYCLE; INHIBITION; IDENTIFICATION; MDM2; BIOGENESIS; MUTATIONS; PATHWAY	The c-Myc oncoprotein promotes cell growth by enhancing ribosomal biogenesis. Overexpression of c-Myc and aberrant ribosomal biogenesis lead to deregulated cell growth and tumorigenesis. Hence, c-Myc activity and ribosomal biogenesis must be tightly coordinated during normal homeostasis. We previously found that ribosomal protein L11 inhibits c-Myc activity by blocking the recruitment of its co-activator transformation/transcription domain-associated protein (TRRAP) to the promoter regions of c-Myc target genes that are transcribed by RNA polymerases I and II. In this study, we extended the role of L11 to the regulation of c-Myc-driven transcription of the 5 S rRNA and tRNA genes by RNA polymerase III. L11 co-resided with c-Myc at the 5 S rRNA and tRNA genes and significantly inhibited the binding of TRRAP to these genes. Knocking down endogenous L11 enhanced c-Myc-dependent transcription of these genes. Interestingly, in response to ribosomal stress induced by the treatment of cells with a low dose of actinomycin Dor serum starvation, L11 binding to these genes was increased, and inversely TRRAP binding to these genes was decreased. Consistently, knockdown of L11 rescued the reduction of the expression of these genes by the two treatments. These results demonstrate that L11 suppresses c-Myc-dependent and RNA polymerase III-catalyzed transcription of 5 S rRNA and tRNA genes in response to ribosomal stress, ensuring a tight coordination between c-Myc activity and ribosomal biogenesis.	[Dai, Mu-Shui; Sun, Xiao-Xin] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Sch Med, Portland, OR 97239 USA; [Dai, Mu-Shui; Sun, Xiao-Xin] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97239 USA; [Lu, Hua] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA	Oregon Health & Science University; Oregon Health & Science University; Indiana University System; Indiana University-Purdue University Indianapolis	Dai, MS (corresponding author), Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Sch Med, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	daim@ohsu.edu; hualu@iupui.edu			National Institutes of Health [K99-CA124137, CA93614, CA095441, CA079721, CA129828]; Oregon Health and Science University; NATIONAL CANCER INSTITUTE [R01CA129828, R01CA079721, R01CA093614, R00CA127134, R01CA095441] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oregon Health and Science University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant K99-CA124137 (to M.-S. D.) and Grants CA93614, CA095441, CA079721, and CA129828 (to H. L.). This work was also supported by startup funds from Oregon Health and Science University (to M.-S. D.).	ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; Arabi A, 2005, NAT CELL BIOL, V7, P303, DOI 10.1038/ncb1225; Bhat KP, 2004, EMBO J, V23, P2402, DOI 10.1038/sj.emboj.7600247; Boon K, 2001, EMBO J, V20, P1383, DOI 10.1093/emboj/20.6.1383; Cmejla R, 2009, HUM MUTAT, V30, P321, DOI 10.1002/humu.20874; Coller HA, 2000, P NATL ACAD SCI USA, V97, P3260, DOI 10.1073/pnas.97.7.3260; Dai MS, 2004, MOL CELL BIOL, V24, P7654, DOI 10.1128/MCB.24.17.7654-7668.2004; Dai MS, 2008, MOL CELL BIOL, V28, P4365, DOI 10.1128/MCB.01662-07; Dai MS, 2007, CELL CYCLE, V6, P2735, DOI 10.4161/cc.6.22.4895; Dai MS, 2007, EMBO J, V26, P3332, DOI 10.1038/sj.emboj.7601776; Dai MS, 2006, J BIOL CHEM, V281, P24304, DOI 10.1074/jbc.M602596200; Dai MS, 2008, J CELL BIOCHEM, V105, P670, DOI 10.1002/jcb.21895; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Felsher DW, 1999, MOL CELL, V4, P199, DOI 10.1016/S1097-2765(00)80367-6; Gazda HT, 2008, AM J HUM GENET, V83, P769, DOI 10.1016/j.ajhg.2008.11.004; Gomez-Roman N, 2003, NATURE, V421, P290, DOI 10.1038/nature01327; Grandori C, 2005, NAT CELL BIOL, V7, P311, DOI 10.1038/ncb1224; Grewal SS, 2005, NAT CELL BIOL, V7, P295, DOI 10.1038/ncb1223; Guo QM, 2000, CANCER RES, V60, P5922; Kenneth NS, 2007, P NATL ACAD SCI USA, V104, P14917, DOI 10.1073/pnas.0702909104; Lohrum MAE, 2003, CANCER CELL, V3, P577, DOI 10.1016/S1535-6108(03)00134-X; Marshall L, 2008, CELL, V133, P78, DOI 10.1016/j.cell.2008.02.035; Menssen A, 2002, P NATL ACAD SCI USA, V99, P6274, DOI 10.1073/pnas.082005599; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Nesbit CE, 1999, ONCOGENE, V18, P3004, DOI 10.1038/sj.onc.1202746; Oskarsson T, 2005, NAT CELL BIOL, V7, P215, DOI 10.1038/ncb0305-215; Pelengaris S, 1999, MOL CELL, V3, P565, DOI 10.1016/S1097-2765(00)80350-0; Pelengaris S, 2002, CELL, V109, P321, DOI 10.1016/S0092-8674(02)00738-9; Ruggero D, 2003, NAT REV CANCER, V3, P179, DOI 10.1038/nrc1015; Zhang YP, 2003, MOL CELL BIOL, V23, P8902, DOI 10.1128/MCB.23.23.8902-8912.2003	30	45	47	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12587	12594		10.1074/jbc.M109.056259	http://dx.doi.org/10.1074/jbc.M109.056259			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20194507	hybrid, Green Published			2022-12-25	WOS:000276787800016
J	Karakasiliotis, I; Vashist, S; Bailey, D; Abente, EJ; Green, KY; Roberts, LO; Sosnovtsev, SV; Goodfellow, IG				Karakasiliotis, Ioannis; Vashist, Surender; Bailey, Dalan; Abente, Eugenio J.; Green, Kim Y.; Roberts, Lisa O.; Sosnovtsev, Stanislav V.; Goodfellow, Ian G.			Polypyrimidine Tract Binding Protein Functions as a Negative Regulator of Feline Calicivirus Translation	PLOS ONE			English	Article							RIBOSOME ENTRY SITE; NUCLEAR-PORE COMPLEX; VIRUS GENOMIC RNA; MOUTH-DISEASE VIRUS; CELLULAR-PROTEINS; MAMMALIAN-CELLS; CAPSID PROTEIN; INFECTED-CELLS; NONSTRUCTURAL POLYPROTEIN; POLY(A)-BINDING PROTEIN	Background: Positive strand RNA viruses rely heavily on host cell RNA binding proteins for various aspects of their life cycle. Such proteins interact with sequences usually present at the 59 or 39 extremities of the viral RNA genome, to regulate viral translation and/or replication. We have previously reported that the well characterized host RNA binding protein polypyrimidine tract binding protein (PTB) interacts with the 5'end of the feline calicivirus (FCV) genomic and subgenomic RNAs, playing a role in the FCV life cycle. Principal Findings: We have demonstrated that PTB interacts with at least two binding sites within the 5'end of the FCV genome. In vitro translation indicated that PTB may function as a negative regulator of FCV translation and this was subsequently confirmed as the translation of the viral subgenomic RNA in PTB siRNA treated cells was stimulated under conditions in which RNA replication could not occur. We also observed that PTB redistributes from the nucleus to the cytoplasm during FCV infection, partially localizing to viral replication complexes, suggesting that PTB binding may be involved in the switch from translation to replication. Reverse genetics studies demonstrated that synonymous mutations in the PTB binding sites result in a cell-type specific defect in FCV replication. Conclusions: Our data indicates that PTB may function to negatively regulate FCV translation initiation. To reconcile this with efficient virus replication in cells, we propose a putative model for the function of PTB in the FCV life cycle. It is possible that during the early stages of infection, viral RNA is translated in the absence of PTB, however, as the levels of viral proteins increase, the nuclear-cytoplasmic shuttling of PTB is altered, increasing the cytoplasmic levels of PTB, inhibiting viral translation. Whether PTB acts directly to repress translation initiation or via the recruitment of other factors remains to be determined but this may contribute to the stimulation of viral RNA replication via clearance of ribosomes from viral RNA.	[Karakasiliotis, Ioannis; Vashist, Surender; Bailey, Dalan; Goodfellow, Ian G.] Univ London Imperial Coll Sci Technol & Med, Dept Virol, London, England; [Abente, Eugenio J.; Green, Kim Y.; Sosnovtsev, Stanislav V.] NIAID, Infect Dis Lab, NIH, Bethesda, MD 20892 USA; [Abente, Eugenio J.] Univ Maryland, Dept Mol Genet & Cell Biol, College Pk, MD 20742 USA; [Roberts, Lisa O.] Univ Surrey, Fac Hlth & Med Sci, Guildford GU2 5XH, Surrey, England	Imperial College London; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University System of Maryland; University of Maryland College Park; University of Surrey	Karakasiliotis, I (corresponding author), BSRC Alexander Fleming, Lab Post Transcript Control, Vari, Greece.	I.Goodfellow@imperial.ac.uk	Roberts, Lisa/E-6365-2010; Vashist, Surender/H-5879-2013; Karakasiliotis, Ioannis/ABG-9709-2021; Karakasiliotis, Yannis/AAP-5973-2021	Vashist, Surender/0000-0003-1343-8514; Karakasiliotis, Ioannis/0000-0003-3004-8104; Goodfellow, Ian/0000-0002-9483-510X; Bailey, Dalan/0000-0002-5640-2266; Abente, Eugenio/0000-0002-3390-2786	Wellcome Trust; Biotechnology and Biological Sciences Research Council (BBSRC); National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health, US; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000897] Funding Source: NIH RePORTER; BBSRC [BB/D007755/1, BB/D007607/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D007607/1, BB/D007755/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health, US(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Wellcome Trust, Biotechnology and Biological Sciences Research Council (BBSRC) and in part by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health, US. I.G. is a Wellcome Senior Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABENTE EJ, 2010, VIROLOGY IN PRESS; Al-Molawi N, 2003, J GEN VIROL, V84, P1237, DOI 10.1099/vir.0.18840-0; Anwar A, 2000, J BIOL CHEM, V275, P34231, DOI 10.1074/jbc.M006343200; Anwar A, 2009, J BIOL CHEM, V284, P17021, DOI 10.1074/jbc.M109.006239; Asanaka M, 2005, P NATL ACAD SCI USA, V102, P10327, DOI 10.1073/pnas.0408529102; Auweter SD, 2007, J MOL BIOL, V367, P174, DOI 10.1016/j.jmb.2006.12.053; Agis-Juarez RA, 2009, J GEN VIROL, V90, P2893, DOI 10.1099/vir.0.013433-0; Back SH, 2002, J VIROL, V76, P2529, DOI 10.1128/JVI.76.5.2529-2542.2002; Barton DJ, 1999, J VIROL, V73, P10104, DOI 10.1128/JVI.73.12.10104-10112.1999; Belsham GJ, 2000, TRENDS MICROBIOL, V8, P330, DOI 10.1016/S0966-842X(00)01788-1; Besse F, 2009, GENE DEV, V23, P195, DOI 10.1101/gad.505709; Brocard M, 2007, VIRUS GENES, V35, P5, DOI 10.1007/s11262-006-0038-z; Castelo-Branco P, 2004, MOL CELL BIOL, V24, P4174, DOI 10.1128/MCB.24.10.4174-4183.2004; Chang KO, 2006, VIROLOGY, V353, P463, DOI 10.1016/j.virol.2006.06.006; Chaudhry Y, 2006, J BIOL CHEM, V281, P25315, DOI 10.1074/jbc.M602230200; Cote CA, 1999, MOL CELL, V4, P431, DOI 10.1016/S1097-2765(00)80345-7; Daughenbaugh KF, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-33; Daughenbaugh KF, 2003, EMBO J, V22, P2852, DOI 10.1093/emboj/cdg251; DREW J, 1994, J VIROL, V68, P697, DOI 10.1128/JVI.68.2.697-703.1994; Fahrenkrog B, 2006, CAN J PHYSIOL PHARM, V84, P279, DOI 10.1139/Y05-100; Gamarnik AV, 1998, GENE DEV, V12, P2293, DOI 10.1101/gad.12.15.2293; Geissler K, 1999, J VIROL, V73, P834, DOI 10.1128/JVI.73.1.834-838.1999; Geissler K, 1999, VET MICROBIOL, V69, P63, DOI 10.1016/S0378-1135(99)00089-9; Goodfellow I, 2005, EMBO REP, V6, P968, DOI 10.1038/sj.embor.7400510; Green KY, 2002, J VIROL, V76, P8582, DOI 10.1128/JVI.76.17.8582-8595.2002; Grover R, 2008, CELL CYCLE, V7, P2189, DOI 10.4161/cc.7.14.6271; Guest S, 2004, J VIROL, V78, P11097, DOI 10.1128/JVI.78.20.11097-11107.2004; Guix S, 2007, J VIROL, V81, P12238, DOI 10.1128/JVI.01489-07; Gustin KE, 2002, J VIROL, V76, P8787, DOI 10.1128/JVI.76.17.8787-8796.2002; Gustin KE, 2001, EMBO J, V20, P240, DOI 10.1093/emboj/20.1.240; Gutierrez AL, 1997, J VIROL, V71, P3826; Gutierrez-Escolano AL, 2003, BIOCHEM BIOPH RES CO, V311, P759, DOI 10.1016/j.bbrc.2003.10.066; Gutierrez-Escolano AL, 2000, J VIROL, V74, P8558, DOI 10.1128/JVI.74.18.8558-8562.2000; Henics T, 2006, CELL BIOL INT, V30, P480, DOI 10.1016/j.cellbi.2006.01.001; Herbert TP, 1997, J GEN VIROL, V78, P1033, DOI 10.1099/0022-1317-78-5-1033; HONDA M, 2004, BIOMEDICAL REV, V15, P37; Izquierdo JM, 2005, MOL CELL, V19, P475, DOI 10.1016/j.molcel.2005.06.015; Jiang LB, 2009, BIOCHEM BIOPH RES CO, V385, P187, DOI 10.1016/j.bbrc.2009.05.036; Joachims M, 1999, J VIROL, V73, P718, DOI 10.1128/JVI.73.1.718-727.1999; Kafasla P, 2009, MOL CELL, V34, P556, DOI 10.1016/j.molcel.2009.04.015; Kaminski A, 1998, RNA, V4, P626, DOI 10.1017/S1355838298971898; Karakasiliotis I, 2006, J GEN VIROL, V87, P3339, DOI 10.1099/vir.0.82153-0; Kuyumcu-Martinez M, 2004, J VIROL, V78, P8172, DOI 10.1128/JVI.78.15.8172-8182.2004; Li HP, 1999, J VIROL, V73, P772, DOI 10.1128/JVI.73.1.772-777.1999; Lopmam BA, 2003, EMERG INFECT DIS, V9, P90; Mitchell SA, 2003, MOL CELL, V11, P757, DOI 10.1016/S1097-2765(03)00093-5; Niepmann M, 1997, J VIROL, V71, P8330, DOI 10.1128/JVI.71.11.8330-8339.1997; Perez I, 1997, RNA, V3, P764; Peritz T, 2006, NAT PROTOC, V1, P577, DOI 10.1038/nprot.2006.82; Pickering BM, 2004, MOL CELL BIOL, V24, P5595, DOI 10.1128/MCB.24.12.5595-5605.2004; Pilipenko EV, 2001, EMBO J, V20, P6899, DOI 10.1093/emboj/20.23.6899; Sandoval-Jaime C, 2009, VIROLOGY, V387, P322, DOI 10.1016/j.virol.2009.02.041; SINGH R, 1995, SCIENCE, V268, P1173, DOI 10.1126/science.7761834; Song YT, 2005, RNA, V11, P1809, DOI 10.1261/rna.7430405; SOSNOVTSEV S, 1995, VIROLOGY, V210, P383, DOI 10.1006/viro.1995.1354; Sosnovtsev SV, 2006, J VIROL, V80, P7816, DOI 10.1128/JVI.00532-06; Sosnovtsev SV, 2002, J VIROL, V76, P7060, DOI 10.1128/JVI.76.14.7060-7072.2002; Straub TM, 2007, EMERG INFECT DIS, V13, P396, DOI 10.3201/eid1303.060549; Tischendorf JJW, 2004, ARCH VIROL, V149, P1955, DOI 10.1007/s00705-004-0341-8; vanKuppeveld FJM, 1997, EMBO J, V16, P3519, DOI 10.1093/emboj/16.12.3519; Vashist S, 2009, FUTURE VIROL, V4, P353, DOI 10.2217/FVL.09.18; Xie JY, 2003, P NATL ACAD SCI USA, V100, P8776, DOI 10.1073/pnas.1432696100; ZUCKER M, 1981, NUCLEIC ACIDS RES, V9, P133; Zuniga S, 2009, VIRUS RES, V139, P253, DOI 10.1016/j.virusres.2008.06.015	64	26	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2010	5	3							e9562	10.1371/journal.pone.0009562	http://dx.doi.org/10.1371/journal.pone.0009562			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565XE	20224775	Green Submitted, gold, Green Published			2022-12-25	WOS:000275328800009
J	Krieglstein, J; Kewitz, T; Kirchhefer, U; Hofnagel, O; Weissen-Plenz, G; Reinbold, M; Klumpp, S				Krieglstein, Josef; Kewitz, Tobias; Kirchhefer, Uwe; Hofnagel, Oliver; Weissen-Plenz, Gabriele; Reinbold, Michael; Klumpp, Susanne			Damage of Guinea Pig Heart and Arteries by a Trioleate-Enriched Diet and of Cultured Cardiomyocytes by Oleic Acid	PLOS ONE			English	Article							ENDOTHELIAL-CELL APOPTOSIS; PHOSPHATASE TYPE 2C; FATTY-ACIDS; LIPOPROTEIN; CHOLESTEROL; EXPRESSION; 2C-ALPHA; 2C-BETA	Background: Mono-unsaturated fatty acids (MUFAs) like oleic acid have been shown to cause apoptosis of cultured endothelial cells by activating protein phosphatase type 2C alpha and beta (PP2C). The question arises whether damage of endothelial or other cells could be observed in intact animals fed with a trioleate-enriched diet. Methodology/Principal Findings: Dunkin-Hartley guinea pigs were fed with a trioleate-enriched diet for 5 months. Advanced atherosclerotic changes of the aorta and the coronary arteries could not be seen but the arteries appeared in a pre-atherosclerotic stage of vascular remodelling. However, the weight and size of the hearts were lower than in controls and the number of apoptotic myocytes increased in the hearts of trioleate-fed animals. To confirm the idea that oleic acid may have caused this apoptosis by activation of PP2C, cultured cardiomyocytes from guinea pigs and mice were treated with various lipids. It was demonstrable that oleic acid dose-dependently caused apoptosis of cardiomyocytes from both species, yet, similar to previous experiments with cultured neurons and endothelial cells, stearic acid, elaidic acid and oleic acid methylester did not. The apoptotic effect caused by oleic acid was diminished when PP2C alpha and beta were downregulated by siRNA showing that PP2C was causally involved in apoptosis caused by oleic acid. Conclusions/Significance: The glycerol trioleate diet given to guinea pigs for 5 months did not cause marked atherosclerosis but clearly damaged the hearts by activating PP2C alpha and beta. The diet used with 24% (wt/wt) glycerol trioleate is not comparable to human diets. The detrimental role of MUFAs for guinea pig heart tissue in vivo is shown for the first time. Whether it is true for humans remains to be shown.	[Krieglstein, Josef; Kewitz, Tobias; Reinbold, Michael; Klumpp, Susanne] Univ Munster, Inst Pharmazut & Med Chem, Munster, Germany; [Kirchhefer, Uwe] Univ Klinikum Muenster, Inst Pharmakol & Toxikol, Munster, Germany; [Hofnagel, Oliver; Weissen-Plenz, Gabriele] Univ Klinikum Munster, Leibniz Inst Fuer Arterioskleroseforsch, Munster, Germany	University of Munster; University of Munster; University of Munster	Krieglstein, J (corresponding author), Univ Munster, Inst Pharmazut & Med Chem, Munster, Germany.	krieglst@uni-muenster.de			Deutsche Forschungsgemeinschaft [KR 354/17-1, KL 601/9-3, KI 653/13-1,2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Studies were supported by grants from the Deutsche Forschungsgemeinschaft (DFG: KR 354/17-1, KL 601/9-3 and KI 653/13-1,2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badimon L, 2006, CURR MOL MED, V6, P439, DOI 10.2174/156652406778018725; BRAUN JEA, 1992, BIOCHEM J, V287, P337, DOI 10.1042/bj2870337; Chen CH, 2003, CIRCULATION, V107, P2102, DOI 10.1161/01.CIR.0000065220.70220.F7; Choy JC, 2001, J MOL CELL CARDIOL, V33, P1673, DOI 10.1006/jmcc.2001.1419; Cos E, 2001, LIPIDS, V36, P1209, DOI 10.1007/s11745-001-0834-1; Cullen P, 2005, HANDB EXP PHARM, V170, P3; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; FERNANDEZ ML, 1989, METABOLISM, V38, P1094, DOI 10.1016/0026-0495(89)90046-2; Fernandez ML, 2001, J NUTR, V131, P10, DOI 10.1093/jn/131.1.10; Hufnagel B, 2005, ATHEROSCLEROSIS, V180, P245, DOI 10.1016/j.atherosclerosis.2004.12.021; KEYS A, 1970, CIRCULATION, V41, P191; Kliche K, 2006, CELL PHYSIOL BIOCHEM, V18, P265, DOI 10.1159/000097673; Klumpp S, 2006, BIOCHEM SOC T, V34, P1370, DOI 10.1042/BST0341370; Klumpp S, 2000, METHOD ENZYMOL, V315, P570; Klumpp S, 2002, NEUROCHEM INT, V41, P251, DOI 10.1016/S0197-0186(02)00020-7; Klumpp S, 1998, FEBS LETT, V437, P229, DOI 10.1016/S0014-5793(98)01237-X; Krieglstein J, 2008, EUR J PHARM SCI, V35, P397, DOI 10.1016/j.ejps.2008.08.007; Lifschitz-Mercer B, 2001, HISTOCHEM CELL BIOL, V116, P31; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Marley AE, 1998, FEBS LETT, V431, P121, DOI 10.1016/S0014-5793(98)00708-X; Mensink RP, 2003, AM J CLIN NUTR, V77, P1146, DOI 10.1093/ajcn/77.5.1146; Reinbold M, 2008, MOL NUTR FOOD RES, V52, P581, DOI 10.1002/mnfr.200700321; Rossig L, 2001, BASIC RES CARDIOL, V96, P11, DOI 10.1007/s003950170073; Schwarz S, 2006, APOPTOSIS, V11, P1111, DOI 10.1007/s10495-006-6982-1; STINS MF, 1992, ARTERIOSCLER THROMB, V12, P1437, DOI 10.1161/01.ATV.12.12.1437; Thijssen MA, 2005, HANDB EXP PHARM, V170, P165; Tricot O, 2000, CIRCULATION, V101, P2450, DOI 10.1161/01.CIR.101.21.2450	27	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2010	5	3					A61	A70	e9561	10.1371/journal.pone.0009561	http://dx.doi.org/10.1371/journal.pone.0009561			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565WZ	20221399	Green Submitted, gold, Green Published			2022-12-25	WOS:000275328200006
J	Lee, MJE; Veiseh, O; Bhattarai, N; Sun, C; Hansen, SJ; Ditzler, S; Knoblaugh, S; Lee, D; Ellenbogen, R; Zhang, MQ; Olson, JM				Lee, Michelle Jeung-Eun; Veiseh, Omid; Bhattarai, Narayan; Sun, Conroy; Hansen, Stacey J.; Ditzler, Sally; Knoblaugh, Sue; Lee, Donghoon; Ellenbogen, Richard; Zhang, Miqin; Olson, James M.			Rapid Pharmacokinetic and Biodistribution Studies Using Cholorotoxin-Conjugated Iron Oxide Nanoparticles: A Novel Non-Radioactive Method	PLOS ONE			English	Article							TUMOR; CHALLENGES	Background: Recent advances in nanotechnology have led to the development of biocompatible nanoparticles for in vivo molecular imaging and targeted therapy. Many nanoparticles have undesirable tissue distribution or unacceptably low serum half-lives. Pharmacokinetic (PK) and biodistribution studies can help inform decisions determining particle size, coatings, or other features early in nanoparticle development. Unfortunately, these studies are rarely done in a timely fashion because many nanotechnology labs lack the resources and expertise to synthesize radioactive nanoparticles and evaluate them in mice. Methodology/Principal Findings: To address this problem, we developed an economical, radioactivity-free method for assessing serum half-life and tissue distribution of nanoparticles in mice. Iron oxide nanoparticles coated with chitosan and polyethylene glycol that utilize chlorotoxin as a targeting molecule have a serum half-life of 7-8 hours and the particles remain stable for extended periods of time in physiologic fluids and in vivo. Nanoparticles preferentially distribute to spleen and liver, presumably due to reticuloendothelial uptake. Other organs have very low levels of nanoparticles, which is ideal for imaging most cancers in the future. No acute toxicity was attributed to the nanoparticles. Conclusions/Significance: We report here a simple near-infrared fluorescence based methodology to assess PK properties of nanoparticles in order to integrate pharmacokinetic data into early nanoparticle design and synthesis. The nanoparticles tested demonstrate properties that are excellent for future clinical imaging strategies and potentially suitable for targeted therapy.	[Lee, Michelle Jeung-Eun; Hansen, Stacey J.; Ditzler, Sally; Olson, James M.] Univ Washington, Div Clin Res, Seattle, WA 98195 USA; [Knoblaugh, Sue] Univ Washington, Fred Hutchinson Canc Res Ctr, Seattle, WA 98195 USA; [Lee, Michelle Jeung-Eun; Olson, James M.] Univ Washington, Neurobiol & Behav Program, Seattle, WA 98195 USA; [Veiseh, Omid; Bhattarai, Narayan; Sun, Conroy; Zhang, Miqin] Univ Washington, Dept Mat Sci, Seattle, WA 98195 USA; [Lee, Donghoon] Univ Washington, Dept Radiol, Seattle, WA 98195 USA; [Ellenbogen, Richard; Zhang, Miqin] Univ Washington, Dept Neurosurg, Seattle, WA 98195 USA; [Olson, James M.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Ellenbogen, Richard; Olson, James M.] Seattle Childrens Hosp, Seattle, WA USA	University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Seattle Children's Hospital	Lee, MJE (corresponding author), Univ Washington, Div Clin Res, Seattle, WA 98195 USA.	jolson@fhcrc.org	Sun, Conroy/B-5611-2013; Veiseh, Omid/A-9972-2012; Veiseh, Omid/N-1137-2019; Veiseh, Omid/GLS-9547-2022; Sun, Conroy/S-3222-2019; Zhang, Miqin/F-5537-2010	Sun, Conroy/0000-0001-5193-6907; Veiseh, Omid/0000-0003-1153-8079; Sun, Conroy/0000-0001-5193-6907; Zhang, Miqin/0000-0001-8974-1494; Bhattarai, Narayan/0000-0002-0583-7913	National Institutes of Health [R01 CA119408, R01 CA134213, R01 EB006043, R01 CA112350]; Seattle Children's Hospital Neuro-Oncology Endowment; NATIONAL CANCER INSTITUTE [R01CA135491, R01CA134213, R01CA112350, R01CA119408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB006043] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Seattle Children's Hospital Neuro-Oncology Endowment; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by National Institutes of Health grants R01 CA119408, R01 CA134213, R01 EB006043, R01 CA112350 and the Seattle Children's Hospital Neuro-Oncology Endowment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexis F, 2008, MOL PHARMACEUT, V5, P505, DOI 10.1021/mp800051m; Emerich DF, 2006, BIOMOL ENG, V23, P171, DOI 10.1016/j.bioeng.2006.05.026; Fang C, 2009, SMALL, V5, P1637, DOI 10.1002/smll.200801647; Ferrari M, 2005, NAT REV CANCER, V5, P161, DOI 10.1038/nrc1566; Josephson L, 2002, BIOCONJUGATE CHEM, V13, P554, DOI 10.1021/bc015555d; Kaul G, 2004, J DRUG TARGET, V12, P585, DOI 10.1080/10611860400013451; Kircher MF, 2003, CANCER RES, V63, P8122; Laurent S, 2008, CHEM REV, V108, P2064, DOI 10.1021/cr068445e; Peer D, 2007, NAT NANOTECHNOL, V2, P751, DOI 10.1038/nnano.2007.387; Pirollo KF, 2008, TRENDS BIOTECHNOL, V26, P552, DOI 10.1016/j.tibtech.2008.06.007; Rossin R, 2005, J NUCL MED, V46, P1210; Sanhai WR, 2008, NAT NANOTECHNOL, V3, P242, DOI 10.1038/nnano.2008.114; Sheng Y, 2009, BIOMATERIALS, V30, P2340, DOI 10.1016/j.biomaterials.2008.12.070; Veiseh O, 2009, CANCER RES, V69, P6200, DOI 10.1158/0008-5472.CAN-09-1157	14	77	91	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2010	5	3							e9536	10.1371/journal.pone.0009536	http://dx.doi.org/10.1371/journal.pone.0009536			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	564EW	20209054	Green Published, Green Submitted, gold			2022-12-25	WOS:000275197100016
J	Segu, L; Lecomte, MJ; Wolff, M; Santamaria, J; Hen, R; Dumuis, A; Berrard, S; Bockaert, J; Buhot, MC; Compan, V				Segu, Luis; Lecomte, Marie-Jose; Wolff, Mathieu; Santamaria, Julie; Hen, Rene; Dumuis, Aline; Berrard, Sylvie; Bockaert, Joel; Buhot, Marie-Christine; Compan, Valerie			Hyperfunction of Muscarinic Receptor Maintains Long-Term Memory in 5-HT4 Receptor Knock-Out Mice	PLOS ONE			English	Article							OBJECT RECOGNITION MEMORY; RAT FRONTAL-CORTEX; ACETYLCHOLINE-RELEASE; PARTIAL AGONIST; WORKING-MEMORY; SPATIAL MEMORY; WATER-MAZE; DIFFERENTIAL MODULATION; HIPPOCAMPAL-NEURONS; DORSAL HIPPOCAMPUS	Patients suffering from dementia of Alzheimer's type express less serotonin 4 receptors (5-HTR4), but whether an absence of these receptors modifies learning and memory is unexplored. In the spatial version of the Morris water maze, we show that 5-HTR4 knock-out (KO) and wild-type (WT) mice performed similarly for spatial learning, short-and long-term retention. Since 5-HTR4 control mnesic abilities, we tested whether cholinergic system had circumvented the absence of 5-HTR4. Inactivating muscarinic receptor with scopolamine, at an ineffective dose (0.8 mg/kg) to alter memory in WT mice, decreased long-term but not short-term memory of 5-HTR4 KO mice. Other changes included decreases in the activity of choline acetyltransferase (ChAT), the required enzyme for acetylcholine synthesis, in the septum and the dorsal hippocampus in 5-HTR4 KO under baseline conditions. Training- and scopolamine-induced increase and decrease, respectively in ChAT activity in the septum in WT mice were not detected in the 5-HTR4 KO animals. Findings suggest that adaptive changes in cholinergic systems may circumvent the absence of 5-HTR4 to maintain long-term memory under baseline conditions. In contrast, despite adaptive mechanisms, the absence of 5-HTR4 aggravates scopolamine-induced memory impairments. The mechanisms whereby 5-HTR4 mediate a tonic influence on ChAT activity and muscarinic receptors remain to be determined.	[Segu, Luis; Wolff, Mathieu; Buhot, Marie-Christine] Bordeaux Univ, CNRS, UMR5228, Ctr Neurosci Integrat & Cognit, Talence, France; [Lecomte, Marie-Jose; Santamaria, Julie; Berrard, Sylvie] CNRS, UMR7225, INSERM, Inst Cerveau & Moelle Epiniere,Ctr Rech,UMR S975, Paris, France; [Hen, Rene] Columbia Univ, Ctr Neurobiol & Behav, New York, NY 10032 USA; [Dumuis, Aline; Bockaert, Joel; Compan, Valerie] Nimes Univ, Montpellier Univ 1&2, INSERM, CNRS,UMR5203,U661,Inst Genom Fonct, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Columbia University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier		Valerie.Compan@igf.cnrs.fr	INCIA, NeurexTeam/D-6197-2014; Wolff, Mathieu/F-2276-2013	Wolff, Mathieu/0000-0003-3037-3038; COMPAN, Valerie/0000-0002-4634-2765	CNRS; INSERM	CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	CNRS and INSERM provided the financial support for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beiko J, 1997, BEHAV BRAIN RES, V88, P201, DOI 10.1016/S0166-4328(97)02298-5; Bert B, 2005, NEUROBIOL LEARN MEM, V84, P57, DOI 10.1016/j.nlm.2005.03.005; Bickmeyer U, 2002, EUR J NEUROSCI, V16, P209, DOI 10.1046/j.1460-9568.2002.02072.x; Bijak M, 1997, NEUROSCIENCE, V78, P1017, DOI 10.1016/S0306-4522(96)00666-5; Bockaert J, 2004, CNS NEUROL DISORD-DR, V3, P39, DOI 10.2174/1568007043482615; BOCKAERT J, 1992, TRENDS PHARMACOL SCI, V13, P141, DOI 10.1016/0165-6147(92)90051-7; BRILEY M, 1990, PSYCHOPHARMACOLOGY, V101, P187, DOI 10.1007/BF02244124; Buhot HC, 2000, ANN MED, V32, P210, DOI 10.3109/07853890008998828; BUHOT MC, 1991, BEHAV BRAIN RES, V44, P67, DOI 10.1016/S0166-4328(05)80240-2; Cachard-Chastel M, 2008, BEHAV BRAIN RES, V187, P455, DOI 10.1016/j.bbr.2007.10.008; Cai X, 2002, J PHYSIOL-LONDON, V540, P743; Carli M, 1999, BRIT J PHARMACOL, V128, P1207, DOI 10.1038/sj.bjp.0702915; Chapin EM, 2002, NEUROSCI LETT, V324, P1; Compan V, 1996, EUR J NEUROSCI, V8, P2591, DOI 10.1111/j.1460-9568.1996.tb01553.x; Compan V, 2004, J NEUROSCI, V24, P412, DOI 10.1523/JNEUROSCI.2806-03.2004; Compan V, 2007, FRONT NEUROSCI, P157; Conductier G, 2006, EUR J NEUROSCI, V24, P1053, DOI 10.1111/j.1460-9568.2006.04943.x; CONSOLO S, 1994, NEUROREPORT, V5, P1230, DOI 10.1097/00001756-199406020-00018; Cornea-Hebert V, 1999, J COMP NEUROL, V409, P187, DOI 10.1002/(SICI)1096-9861(19990628)409:2<187::AID-CNE2>3.0.CO;2-P; Egashira N, 2006, BRAIN RES, V1069, P54, DOI 10.1016/j.brainres.2005.10.103; Feng J, 2001, J NEUROSCI, V21, P6502, DOI 10.1523/JNEUROSCI.21-17-06502.2001; Fontana DJ, 1997, NEUROPHARMACOLOGY, V36, P689, DOI 10.1016/S0028-3908(97)00055-5; Franklin KBJ, 2008, MOUSE BRAIN STEREOTA, V3rd; Inui K, 2004, NEUROTOX RES, V6, P153, DOI 10.1007/BF03033218; JAFFARD R, 1993, HIPPOCAMPUS, V3, P203; JARRARD LE, 1993, BEHAV NEURAL BIOL, V60, P9, DOI 10.1016/0163-1047(93)90664-4; Klemenhagen KC, 2006, NEUROPSYCHOPHARMACOL, V31, P101, DOI 10.1038/sj.npp.1300774; Lamirault L, 2003, PROG NEURO-PSYCHOPH, V27, P185, DOI 10.1016/S0278-5846(02)00351-2; Lamirault L, 2001, NEUROPHARMACOLOGY, V41, P844, DOI 10.1016/S0028-3908(01)00123-X; Lelong V, 2003, N-S ARCH PHARMACOL, V367, P621, DOI 10.1007/s00210-003-0743-2; Levallet G, 2009, PSYCHOPHARMACOLOGY, V202, P125, DOI 10.1007/s00213-008-1283-8; Malleret G, 1999, J NEUROSCI, V19, P6157, DOI 10.1523/JNEUROSCI.19-14-06157.1999; Manuel-Apolinar L, 2004, BEHAV BRAIN RES, V148, P179, DOI 10.1016/S0166-4328(03)00186-4; Marchetti E, 2000, NEUROPHARMACOLOGY, V39, P2017, DOI 10.1016/S0028-3908(00)00038-1; Matsumoto M, 2001, J PHARMACOL EXP THER, V296, P676; Moser PC, 2002, J PHARMACOL EXP THER, V302, P731, DOI 10.1124/jpet.102.034249; OHNO M, 1993, EUR J PHARMACOL, V234, P29; OKEEFE J, 1975, EXP NEUROL, V48, P152, DOI 10.1016/0014-4886(75)90230-7; PATEL S, 1995, NEUROSCIENCE, V69, P1159, DOI 10.1016/0306-4522(95)00314-9; Ruotsalainen S, 1998, J PSYCHOPHARMACOL, V12, P177, DOI 10.1177/026988119801200210; Santamaria J, 2009, J NEUROSCI RES, V87, P532, DOI 10.1002/jnr.21866; Terry AV, 1998, PSYCHOPHARMACOLOGY, V135, P407, DOI 10.1007/s002130050529; Topic B, 2007, HIPPOCAMPUS, V17, P68, DOI 10.1002/hipo.20246; Torres GE, 1996, MOL PHARMACOL, V50, P1316; Vilaro MT, 2005, J COMP NEUROL, V484, P418, DOI 10.1002/cne.20447; WAEBER C, 1994, NEUROPHARMACOLOGY, V33, P527, DOI 10.1016/0028-3908(94)90084-1; Warburton EC, 1997, BEHAV BRAIN RES, V84, P247; Yamaguchi T, 1997, N-S ARCH PHARMACOL, V356, P712, DOI 10.1007/PL00005110	48	22	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2010	5	3							e9529	10.1371/journal.pone.0009529	http://dx.doi.org/10.1371/journal.pone.0009529			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	564EW	20209108	Green Published, Green Submitted, gold			2022-12-25	WOS:000275197100014
J	Jung, AG; Labarerra, C; Jansen, AM; Qvortrup, K; Wild, K; Kjaerulff, O				Jung, Anita G.; Labarerra, Christina; Jansen, Anna M.; Qvortrup, Klaus; Wild, Klemens; Kjaerulff, Ole			A Mutational Analysis of the Endophilin-A N-BAR Domain Performed in Living Flies	PLOS ONE			English	Article							MEMBRANE CURVATURE; STRUCTURAL BASIS; DROSOPHILA; ENDOCYTOSIS; INVAGINATION; SYNAPTOJANIN; PATHWAY; MECHANISMS; DYNAMIN	Background: Endophilin is a cytoplasmic protein with an important function in clathrin-dependent endocytosis at synapses and elsewhere. Endophilin has a BAR (Bin/Amphiphysin/Rvs-homology) domain, which is implicated in the sensing and induction of membrane curvature. Previous structure-function studies of the endophilin-A BAR domain have almost exclusively been made in reduced systems, either in vitro or ex vivo in cultured cells. To extend and complement this work, we have analyzed the role played by the structural features of the endophilin-A BAR domain in Drosophila in vivo. Methodology/Principal Findings: The study is based on genetic rescue of endophilin-A (endoA) null mutants with wild type or mutated endoA transgenes. We evaluated the viability of the rescuants, the locomotor behavior in adult flies and the neurotransmission at the larval neuromuscular junction. Whereas mutating the endophilin BAR domain clearly affected adult flies, larval endophilin function was surprisingly resistant to mutagenesis. Previous reports have stressed the importance of a central appendage on the convex BAR surface, which forms a hydrophobic ridge able to directly insert into the lipid bilayer. We found that the charge-negative substitution A66D, which targets the hydrophobic ridge and was reported to completely disrupt the ability of endophilin-BAR to tubulate liposomes in vitro, rescued viability and neurotransmission with the same efficiency as wild type endoA transgenes, even in adults. A similar discrepancy was found for the hydrophilic substitutions A63S/A66S and A63S/A66S/M70Q. The A66W mutation, which introduces a bulky hydrophobic side chain and induces massive vesiculation of liposomes in vitro, strongly impeded eye development, even in presence of the endogenous endoA gene. Substantial residual function was observed in larvae rescued with the EndoA(Arf) transgene, which encodes a form of endophilin-A that completely lacks the central appendage. Whereas a mutation (D151P) designed to increase the BAR curvature was functional, another mutation (P143A, DLEN) designed to decrease the curvature was not. Conclusions/Significance: Our results provide novel insight into the structure/function relationship of the endophilin-A BAR domain in vivo, especially with relation to synaptic function.	[Jung, Anita G.; Labarerra, Christina; Jansen, Anna M.; Kjaerulff, Ole] Univ Copenhagen, Dept Neurosci & Pharmacol, Copenhagen, Denmark; [Qvortrup, Klaus] Univ Copenhagen, Dept Biomed Sci, Copenhagen, Denmark; [Wild, Klemens] Heidelberg Univ, Biochem Ctr, Heidelberg, Germany	University of Copenhagen; University of Copenhagen; Ruprecht Karls University Heidelberg	Jung, AG (corresponding author), Univ Copenhagen, Dept Neurosci & Pharmacol, Copenhagen, Denmark.	o.kjaerulff@mfi.ku.dk	Kjaerulff, Ole/Q-6996-2018	Kjaerulff, Ole/0000-0002-8654-1435; Qvortrup, Klaus/0000-0001-8811-0260	Danish MRC; Lundbeck Foundation; Novo Nordisk Foundation; Faculty of Health, University of Copenhagen	Danish MRC(Danish Medical Research Council); Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Faculty of Health, University of Copenhagen	Funded by the Danish MRC, the Lundbeck Foundation, the Novo Nordisk Foundation and the Faculty of Health, University of Copenhagen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman D.G., 1999, PRACTICAL STAT MED R, pXII; Amin N, 2009, P NATL ACAD SCI USA, V106, P8941, DOI 10.1073/pnas.0812469106; Bergmann A, 1998, CELL, V95, P331, DOI 10.1016/S0092-8674(00)81765-1; Bhatia VK, 2009, EMBO J, V28, P3303, DOI 10.1038/emboj.2009.261; BRAND AH, 1993, DEVELOPMENT, V118, P401; Craft GE, 2008, MOL CELL PROTEOMICS, V7, P1146, DOI 10.1074/mcp.M700351-MCP200; Dickman DK, 2005, CELL, V123, P521, DOI 10.1016/j.cell.2005.09.026; Dikic I, 2003, BIOCHEM SOC T, V31, P1178; Doroquez DB, 2006, CRIT REV BIOCHEM MOL, V41, P339, DOI 10.1080/10409230600914344; Eun SH, 2007, GENETICS, V175, P1163, DOI 10.1534/genetics.106.067959; Fabian-Fine R, 2003, J NEUROSCI, V23, P10732; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; FLEISS JL, 2003, STAT METHODS RATES P, pR27; Frost A, 2008, CELL, V132, P807, DOI 10.1016/j.cell.2007.12.041; Gad H, 2000, NEURON, V27, P301, DOI 10.1016/S0896-6273(00)00038-6; Gallop JL, 2006, EMBO J, V25, P2898, DOI 10.1038/sj.emboj.7601174; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Guichet A, 2002, EMBO J, V21, P1661, DOI 10.1093/emboj/21.7.1661; Henne WM, 2007, STRUCTURE, V15, P839, DOI 10.1016/j.str.2007.05.002; Huttner WB, 2002, TRENDS CELL BIOL, V12, P155, DOI 10.1016/S0962-8924(02)02252-3; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; Kang HL, 2002, P NATL ACAD SCI USA, V99, P838, DOI 10.1073/pnas.022631999; Masuda M, 2006, EMBO J, V25, P2889, DOI 10.1038/sj.emboj.7601176; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Powell K, 2009, NATURE, V460, P318, DOI 10.1038/460318a; Rikhy R, 2002, J NEUROSCI, V22, P7478; Ringstad N, 1997, P NATL ACAD SCI USA, V94, P8569, DOI 10.1073/pnas.94.16.8569; Ringstad N, 1999, NEURON, V24, P143, DOI 10.1016/S0896-6273(00)80828-4; Schuske KR, 2003, NEURON, V40, P749, DOI 10.1016/S0896-6273(03)00667-6; Shimada A, 2007, CELL, V129, P761, DOI 10.1016/j.cell.2007.03.040; Soubeyran P, 2002, NATURE, V416, P183, DOI 10.1038/416183a; Tarricone C, 2001, NATURE, V411, P215, DOI 10.1038/35075620; Verstreken P, 2002, CELL, V109, P101, DOI 10.1016/S0092-8674(02)00688-8; Verstreken P, 2003, NEURON, V40, P733, DOI 10.1016/S0896-6273(03)00644-5; Wang Q, 2008, STRUCTURE, V16, P1574, DOI 10.1016/j.str.2008.07.016; Wang WD, 2004, DEVELOPMENT, V131, P5367, DOI 10.1242/dev.01413; Weber U, 2000, DEVELOPMENT, V127, P3619; Weissenhorn W, 2005, J MOL BIOL, V351, P653, DOI 10.1016/j.jmb.2005.06.013; Zar J.H., 2009, BIOSTATISTICAL ANAL	39	10	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2010	5	3							e9492	10.1371/journal.pone.0009492	http://dx.doi.org/10.1371/journal.pone.0009492			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	562OZ	20209138	gold, Green Published			2022-12-25	WOS:000275063400007
J	Singh, R; Singh, S; Sharma, PK; Singh, UP; Briles, DE; Hollingshead, SK; Lillard, JW				Singh, Rajesh; Singh, Shailesh; Sharma, Praveen K.; Singh, Udai P.; Briles, David E.; Hollingshead, Susan K.; Lillard, James W., Jr.			Helper T Cell Epitope-Mapping Reveals MHC-Peptide Binding Affinities That Correlate with T Helper Cell Responses to Pneumococcal Surface Protein A	PLOS ONE			English	Article							CLASS-II MOLECULES; HLA-DR ANTIGENS; STREPTOCOCCUS-PNEUMONIAE; INVARIANT CHAIN; CATHEPSIN-S; IN-VIVO; ASPARAGINYL ENDOPEPTIDASE; STRUCTURAL POLYMORPHISM; MURINE MODEL; BETA-CHAIN	Understanding the requirements for protection against pneumococcal carriage and pneumonia will greatly benefit efforts in controlling these diseases. Several proteins and polysaccharide capsule have recently been implicated in the virulence of and protective immunity against Streptococcus pneumonia. Pneumococcal surface protein A (PspA) is highly conserved among S. pneumonia strains, inhibits complement activation, binds lactoferrin, elicits protective systemic immunity against pneumococcal infection, and is necessary for full pneumococcal virulence. Identification of PspA peptides that optimally bind human leukocyte antigen (HLA) would greatly contribute to global vaccine efforts, but this is hindered by the multitude of HLA polymorphisms. Here, we have used an experimental data set of 54 PspA peptides and in silico methods to predict peptide binding to HLA and murine major histocompatibility complex (MHC) class II. We also characterized spleen- and cervical lymph node (CLN)-derived helper T lymphocyte (HTL) cytokine responses to these peptides after S. pneumonia strain EF3030-challenge in mice. Individual, yet overlapping peptides, 15 amino acids in length revealed residues 199 to 246 of PspA (PspA(199-246)) consistently caused the greatest IFN-gamma, IL-2, IL-5 and proliferation as well as moderate IL-10 and IL-4 responses by ex vivo stimulated splenic and CLN CD4(+) T cells isolated from S. pneumonia strain EF3030-challeged F(1) (B6xBALB/c) mice. IEDB, RANKPEP, SVMHC, MHCPred, and SYFPEITHI in silico analysis tools revealed peptides in PspA(199-246) also interact with a broad range of HLA-DR, -DQ, and -DP allelles. These data suggest that predicted MHC class II-peptide binding affinities do not always correlate with T helper (Th) cytokine or proliferative responses to PspA peptides, but when used together with in vivo validation can be a useful tool to choose candidate pneumococcal HTL epitopes.	[Singh, Rajesh; Lillard, James W., Jr.] Morehouse Sch Med, Dept Microbiol Biochem & Immunol, Atlanta, GA 30310 USA; [Singh, Shailesh; Sharma, Praveen K.] Univ Louisville, Sch Med, Dept Microbiol & Immunol, Louisville, KY 40292 USA; [Singh, Udai P.] Univ S Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC USA; [Briles, David E.; Hollingshead, Susan K.] Univ Alabama, Sch Med, Dept Microbiol, Birmingham, AL 35294 USA	Morehouse School of Medicine; University of Louisville; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of Alabama System; University of Alabama Birmingham	Singh, R (corresponding author), Morehouse Sch Med, Dept Microbiol Biochem & Immunol, Atlanta, GA 30310 USA.	lillard@msm.edu	Sharma, Praveen/M-2810-2014	Sharma, Praveen/0000-0002-7020-3570; Singh, Udai/0000-0002-7048-4325	National Institutes of Health [AI057808, GM09248, MD00525, RR03034]; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003034] Funding Source: NIH RePORTER; NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES [P60MD000525] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057808] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by funds from the National Institutes of Health Grants AI057808, GM09248, MD00525, and RR03034. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AABERGE IS, 1995, MICROB PATHOGENESIS, V18, P141, DOI 10.1016/S0882-4010(95)90125-6; Alrutz MA, 2001, MOL MICROBIOL, V42, P689, DOI 10.1046/j.1365-2958.2001.02676.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; AMIGORENA S, 1995, J EXP MED, V181, P1729, DOI 10.1084/jem.181.5.1729; Antoniou AN, 2000, IMMUNITY, V12, P391, DOI 10.1016/S1074-7613(00)80191-0; BERRY AM, 1989, INFECT IMMUN, V57, P2037, DOI 10.1128/IAI.57.7.2037-2042.1989; Bignell GR, 2004, GENOME RES, V14, P287, DOI 10.1101/gr.2012304; BLUM JS, 1988, P NATL ACAD SCI USA, V85, P3975, DOI 10.1073/pnas.85.11.3975; BONO MR, 1982, NATURE, V299, P836, DOI 10.1038/299836a0; Briles DE, 2000, INFECT IMMUN, V68, P796, DOI 10.1128/IAI.68.2.796-800.2000; Briles DE, 2003, J INFECT DIS, V188, P339, DOI 10.1086/376571; BRILES DE, 1992, INFECT IMMUN, V60, P111, DOI 10.1128/IAI.60.1.111-116.1992; Brooks-Walter A, 1999, INFECT IMMUN, V67, P6533; Castellino F, 1998, J IMMUNOL, V161, P4048; Chen JM, 1998, FEBS LETT, V441, P361, DOI 10.1016/S0014-5793(98)01574-9; Chen JM, 1997, J BIOL CHEM, V272, P8090, DOI 10.1074/jbc.272.12.8090; Chou KC, 2000, ANAL BIOCHEM, V286, P1, DOI 10.1006/abio.2000.4757; CORTE G, 1981, P NATL ACAD SCI-BIOL, V78, P534, DOI 10.1073/pnas.78.1.534; Costantino HR, 2002, J PHARM SCI-US, V91, P388, DOI 10.1002/jps.10059; Cunha-Neto E, 1999, BRAZ J MED BIOL RES, V32, P199, DOI 10.1590/S0100-879X1999000200008; Donnes P, 2006, NUCLEIC ACIDS RES, V34, pW194, DOI 10.1093/nar/gkl284; Ertl HCJ, 1996, J IMMUNOL, V156, P3579; Fuchs PFJ, 2005, PROTEINS, V59, P828, DOI 10.1002/prot.20461; FullerEspie SL, 1997, CELL IMMUNOL, V177, P49, DOI 10.1006/cimm.1997.1081; GREGERSEN PK, 1989, LAB INVEST, V61, P5; Gu Y, 2003, SCIENCE, V302, P445, DOI 10.1126/science.1088485; Hollingshead SK, 2000, INFECT IMMUN, V68, P5889, DOI 10.1128/IAI.68.10.5889-5900.2000; Hooper DC, 2001, EMERG INFECT DIS, V7, P337, DOI 10.3201/eid0702.010239; HURLEY CK, 1982, J IMMUNOL, V129, P2103; Jedrzejas MJ, 2001, J BIOL CHEM, V276, P33121, DOI 10.1074/jbc.M103304200; Kadioglu A, 2000, INFECT IMMUN, V68, P492, DOI 10.1128/IAI.68.2.492-501.2000; Kadioglu A, 2000, INFECT IMMUN, V68, P2390, DOI 10.1128/IAI.68.4.2390-2390.2000; Kang CI, 2009, CLIN EXP IMMUNOL, V156, P552, DOI 10.1111/j.1365-2249.2009.03925.x; Kang H, 2005, INT J ONCOL, V26, P1429; Kaur H, 2002, BIOINFORMATICS, V18, P1508, DOI 10.1093/bioinformatics/18.11.1508; Khan AQ, 2002, INFECT IMMUN, V70, P749, DOI 10.1128/IAI.70.2.749-761.2002; Kouro T, 2009, INT IMMUNOL, V21, P1303, DOI 10.1093/intimm/dxp102; Lu YJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000159; Lynch JM, 2003, INFECT IMMUN, V71, P4780, DOI 10.1128/IAI.71.8.4780-4788.2003; Mack DG, 1999, INT J PARASITOL, V29, P1351, DOI 10.1016/S0020-7519(99)00152-6; Malley R, 2006, INFECT IMMUN, V74, P2187, DOI 10.1128/IAI.74.4.2187-2195.2006; Manoury B, 2002, NAT IMMUNOL, V3, P169, DOI 10.1038/ni754; Manoury B, 1998, NATURE, V396, P695, DOI 10.1038/25379; MCDANIEL LS, 1994, MICROB PATHOGENESIS, V17, P323, DOI 10.1006/mpat.1994.1078; MCDANIEL LS, 1987, J EXP MED, V165, P381, DOI 10.1084/jem.165.2.381; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; MEISTER GE, 1995, VACCINE, V13, P581, DOI 10.1016/0264-410X(94)00014-E; MENAHEM S, 1992, PEDIATR CARDIOL, V13, P214, DOI 10.1007/BF00838779; Morita JY, 2002, CLIN INFECT DIS, V35, P420, DOI 10.1086/341897; Murtaugh MP, 2009, DEV COMP IMMUNOL, V33, P344, DOI 10.1016/j.dci.2008.06.014; Nasrin D, 1999, J PAEDIATR CHILD H, V35, P558, DOI 10.1046/j.1440-1754.1999.00416.x; OTTENHOFF THM, 1990, EUR J IMMUNOL, V20, P2347, DOI 10.1002/eji.1830201027; Palaniappan R, 2006, J IMMUNOL, V176, P2346, DOI 10.4049/jimmunol.176.4.2346; Palaniappan R, 2005, INFECT IMMUN, V73, P1006, DOI 10.1128/IAI.73.2.1006-1013.2005; Parry CS, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-44; Pluger EBE, 2002, EUR J IMMUNOL, V32, P467, DOI 10.1002/1521-4141(200202)32:2<467::AID-IMMU467>3.0.CO;2-Y; RAMMENSEE HG, 1995, CURR OPIN IMMUNOL, V7, P85, DOI 10.1016/0952-7915(95)80033-6; Reche PA, 2004, IMMUNOGENETICS, V56, P405, DOI 10.1007/s00251-004-0709-7; Reche PA, 2003, J MOL BIOL, V331, P623, DOI 10.1016/S0022-2836(03)00750-2; Richter SS, 2002, CLIN INFECT DIS, V34, P330, DOI 10.1086/338065; Ridgway WM, 1999, CURR OPIN IMMUNOL, V11, P638, DOI 10.1016/S0952-7915(99)00030-8; Riese RJ, 1996, IMMUNITY, V4, P357, DOI 10.1016/S1074-7613(00)80249-6; Rosloniec EF, 1998, J IMMUNOL, V160, P2573; Rubins JB, 1997, INFECT IMMUN, V65, P2975, DOI 10.1128/IAI.65.7.2975-2977.1997; SHACKELFORD DA, 1980, J EXP MED, V151, P144, DOI 10.1084/jem.151.1.144; SILVER J, 1979, TRANSPLANT P, V11, P1743; Sturniolo T, 1999, NAT BIOTECHNOL, V17, P555, DOI 10.1038/9858; Sun K, 2008, NAT MED, V14, P558, DOI 10.1038/nm1765; Tsuchiya K, 2008, ANN OTO RHINOL LARYN, V117, P630, DOI 10.1177/000348940811700814; vanderPoll T, 1996, J INFECT DIS, V174, P994, DOI 10.1093/infdis/174.5.994; Villadangos JA, 1997, J EXP MED, V186, P549, DOI 10.1084/jem.186.4.549; WALKER LE, 1980, MOL IMMUNOL, V17, P1443, DOI 10.1016/0161-5890(80)90169-8; Watts C, 2001, CURR OPIN IMMUNOL, V13, P26, DOI 10.1016/S0952-7915(00)00177-1; WEIGENT DA, 1986, MICROB PATHOGENESIS, V1, P399, DOI 10.1016/0882-4010(86)90071-9; YU JJ, 2009, CLIN VACCINE IMMUNOL; Yu XH, 2004, J ALLERGY CLIN IMMUN, V114, P328, DOI 10.1016/j.jaci.2004.04.051	76	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2010	5	2							e9432	10.1371/journal.pone.0009432	http://dx.doi.org/10.1371/journal.pone.0009432			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SY	20195541	Green Published, Green Submitted, gold			2022-12-25	WOS:000274924300019
J	Goel, A; Nagasaka, T; Hamelin, R; Boland, CR				Goel, Ajay; Nagasaka, Takeshi; Hamelin, Richard; Boland, C. Richard			An Optimized Pentaplex PCR for Detecting DNA Mismatch Repair-Deficient Colorectal Cancers	PLOS ONE			English	Article							MICROSATELLITE-INSTABILITY STATUS; MONONUCLEOTIDE REPEATS; COLON-CANCER; TUMORS; MUTATION; HMLH1	Purpose: Microsatellite instability (MSI) is used to screen colorectal cancers (CRC) for Lynch Syndrome, and to predict outcome and response to treatment. The current technique for measuring MSI requires DNA from normal and neoplastic tissues, and fails to identify tumors with specific DNA mismatch repair (MMR) defects. We tested a panel of five quasi-monomorphic mononucleotide repeat markers amplified in a single multiplex PCR reaction (pentaplex PCR) to detect MSI. Experimental Design: We investigated a cohort of 213 CRC patients, comprised of 114 MMR-deficient and 99 MMR-proficient tumors. Immunohistochemical (IHC) analysis evaluated the expression of MLH1, MSH2, PMS2 and MSH6. MSI status was defined by differences in the quasi-monomorphic variation range (QMVR) from a pool of normal DNA samples, and measuring differences in allele lengths in tumor DNA. Results: Amplification of 426 normal alleles allowed optimization of the QMVR at each marker, and eliminated the requirement for matched reference DNA to define MSI in each sample. Using >= 2/5 unstable markers as the criteria for MSI resulted in a sensitivity of 95.6% (95% CI = 90.1-98.1%) and a positive predictive value of 100% (95% CI = 96.6%-100%). Detection of MSH6-deficiency was limited using all techniques. Data analysis with a three-marker panel (BAT26, NR21 and NR27) was comparable in sensitivity (97.4%) and positive predictive value (96.5%) to the five marker panel. Both approaches were superior to the standard approach to measuring MSI. Conclusions: An optimized pentaplex (or triplex) PCR offers a facile, robust, very inexpensive, highly sensitive, and specific assay for the identification of MSI in CRC.	[Goel, Ajay; Nagasaka, Takeshi; Boland, C. Richard] Baylor Univ, Med Ctr, Dept Internal Med, Div Gastroenterol, Dallas, TX USA; [Goel, Ajay; Nagasaka, Takeshi; Boland, C. Richard] Charles A Sammons Canc Ctr, Dallas, TX USA; [Hamelin, Richard] INSERM, U762, Paris, France	Baylor University; Baylor University Medical Center; Baylor University Medical Center; Institut National de la Sante et de la Recherche Medicale (Inserm)	Goel, A (corresponding author), Baylor Univ, Med Ctr, Dept Internal Med, Div Gastroenterol, Dallas, TX USA.	ajayg@baylorhealth.edu; rickbo@baylorhealth.edu		Nagasaka, Takeshi/0000-0002-4236-350X; Goel, Ajay/0000-0003-1396-6341	National Cancer Institute, National Institutes of Health [RO1 CA 72851, RO1 CA 129286]; Baylor Research Institute; NATIONAL CANCER INSTITUTE [R01CA072851, R01CA129286] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Baylor Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The present work was supported by grants RO1 CA 72851 (to CRB) and RO1 CA 129286 (to AG and CRB) from the National Cancer Institute, National Institutes of Health, and funds from the Baylor Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boland CR, 1998, CANCER RES, V58, P5248; BRONNER CE, 1994, NATURE, V368, P258, DOI 10.1038/368258a0; Buhard O, 2006, J CLIN ONCOL, V24, P241, DOI 10.1200/JCO.2005.02.7227; Buhard O, 2004, DIS MARKERS, V20, P251, DOI 10.1155/2004/159347; Goel A, 2003, CANCER RES, V63, P1608; Goel A, 2007, GASTROENTEROLOGY, V132, P127, DOI 10.1053/j.gastro.2006.09.018; IONOV Y, 1993, NATURE, V363, P558, DOI 10.1038/363558a0; Kane MF, 1997, CANCER RES, V57, P808; Laghi L, 2008, ONCOGENE, V27, P6313, DOI 10.1038/onc.2008.217; Modrich P, 2006, J BIOL CHEM, V281, P30305, DOI 10.1074/jbc.R600022200; Pastrello C, 2006, EUR J HUM GENET, V14, P63, DOI 10.1038/sj.ejhg.5201517; Perucho M, 1999, CANCER RES, V59, P249; Ribic CM, 2003, NEW ENGL J MED, V349, P247, DOI 10.1056/NEJMoa022289; Suraweera N, 2002, GASTROENTEROLOGY, V123, P1804, DOI 10.1053/gast.2002.37070; THIBODEAU SN, 1993, SCIENCE, V260, P816, DOI 10.1126/science.8484122; Umar A, 2004, J NATL CANCER I, V96, P261, DOI 10.1093/jnci/djh034; Verma L, 1999, J MED GENET, V36, P678; Xicola RM, 2007, JNCI-J NATL CANCER I, V99, P244, DOI 10.1093/jnci/djk033	18	113	119	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2010	5	2							e9393	10.1371/journal.pone.0009393	http://dx.doi.org/10.1371/journal.pone.0009393			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SX	20195377	Green Published, Green Submitted, gold			2022-12-25	WOS:000274924200015
J	Lavebratt, C; Sjoholm, LK; Soronen, P; Paunio, T; Vawter, MP; Bunney, WE; Adolfsson, R; Forsell, Y; Wu, JC; Kelsoe, JR; Partonen, T; Schalling, M				Lavebratt, Catharina; Sjoholm, Louise K.; Soronen, Pia; Paunio, Tiina; Vawter, Marquis P.; Bunney, William E.; Adolfsson, Rolf; Forsell, Yvonne; Wu, Joseph C.; Kelsoe, John R.; Partonen, Timo; Schalling, Martin			CRY2 Is Associated with Depression	PLOS ONE			English	Article							CONVERGENT FUNCTIONAL GENOMICS; SEASONAL AFFECTIVE-DISORDER; BLUE-LIGHT PHOTORECEPTORS; REST-ACTIVITY DISTURBANCES; BIPOLAR-I-DISORDER; CIRCADIAN-CLOCK; SUPRACHIASMATIC NUCLEUS; CANDIDATE GENES; MELATONIN SUPPRESSION; MOOD	Background: Abnormalities in the circadian clockwork often characterize patients with major depressive and bipolar disorders. Circadian clock genes are targets of interest in these patients. CRY2 is a circadian gene that participates in regulation of the evening oscillator. This is of interest in mood disorders where a lack of switch from evening to morning oscillators has been postulated. Principal Findings: We observed a marked diurnal variation in human CRY2 mRNA levels from peripheral blood mononuclear cells and a significant up-regulation (P = 0.020) following one-night total sleep deprivation, a known antidepressant. In depressed bipolar patients, levels of CRY2 mRNA were decreased (P = 0.029) and a complete lack of increase was observed following sleep deprivation. To investigate a possible genetic contribution, we undertook SNP genotyping of the CRY2 gene in two independent population-based samples from Sweden (118 cases and 1011 controls) and Finland (86 cases and 1096 controls). The CRY2 gene was significantly associated with winter depression in both samples (haplotype analysis in Swedish and Finnish samples: OR = 1.8, P = 0.0059 and OR = 1.8, P = 0.00044, respectively). Conclusions: We propose that a CRY2 locus is associated with vulnerability for depression, and that mechanisms of action involve dysregulation of CRY2 expression.	[Lavebratt, Catharina; Sjoholm, Louise K.; Schalling, Martin] Karolinska Univ, Hosp Solna, Karolinska Inst, Neurogenet Unit,Dept Mol Med & Surg, Stockholm, Sweden; [Soronen, Pia; Paunio, Tiina] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Publ Hlth Genom Unit, Helsinki, Finland; [Vawter, Marquis P.; Bunney, William E.; Wu, Joseph C.] Univ Calif Irvine, Sch Med, Dept Psychiat & Human Behav, Funct Genom Lab, Irvine, CA 92717 USA; [Adolfsson, Rolf] Umea Univ, Dept Clin Sci, Div Psychiat, Umea, Sweden; [Forsell, Yvonne] Karolinska Univ, Hosp Solna, Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden; [Kelsoe, John R.] Univ Calif San Diego, Sch Med, Dept Psychiat, La Jolla, CA 92093 USA; [Partonen, Timo] Natl Inst Hlth & Welf, Dept Mental Hlth & Substance Abuse Serv, Mood Depress & Suicidal Behaviour Unit, Helsinki, Finland	Karolinska Institutet; Karolinska University Hospital; Finland National Institute for Health & Welfare; University of California System; University of California Irvine; Umea University; Karolinska Institutet; Karolinska University Hospital; University of California System; University of California San Diego; Finland National Institute for Health & Welfare	Lavebratt, C (corresponding author), Karolinska Univ, Hosp Solna, Karolinska Inst, Neurogenet Unit,Dept Mol Med & Surg, Stockholm, Sweden.	catharina.lavebratt@ki.se	Schalling, Martin/F-1518-2015; Forsell, Yvonne/ABB-8879-2020; Partonen, Timo/G-1105-2012	Schalling, Martin/0000-0001-5011-2922; Partonen, Timo/0000-0003-1951-2455; Lavebratt, Catharina/0000-0003-4987-2718; Adolfsson, Rolf/0000-0001-9785-8473	Academy of Finland [201097, 210262, 203425]; Helsinki University Central Hospital [TYH538]; Swedish Research Council [2005-6245, 2006-4670]; Stockholm County Council; Karolinska Institutet Foundations; National Center for Research Resource [M01 RR00827]; National Institute of Mental Health [MH 024370]; William Lion Penzner Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000827] Funding Source: NIH RePORTER	Academy of Finland(Academy of Finland); Helsinki University Central Hospital; Swedish Research Council(Swedish Research CouncilEuropean Commission); Stockholm County Council(Stockholm County Council); Karolinska Institutet Foundations(Karolinska Institutet); National Center for Research Resource(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); William Lion Penzner Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was supported in part by grants from Academy of Finland (#201097 and #210262, www.aka.fi) and The Finnish Medical Foundation to Dr. Partonen, from Academy of Finland (#203425, www. suomenlaaketieteensaatio.fi) and Helsinki University Central Hospital (TYH538) to Dr. Paunio, from the Swedish Research Council (2005-6245, 2006-4670, www.vr.se), the Stockholm County Council (ALF, www. forskningsstod.sll.se) and Karolinska Institutet Foundations (www.ki.se) to Drs. Lavebratt and Schalling, by Public Health Service research grant M01 RR00827 from the National Center for Research Resource (www.ncrr.nih.gov) to UCI, Biomarker research grant MH 024370 to Dr. Vawter from the National Institute of Mental Health (www.nimh.nih.gov), and from the William Lion Penzner Foundation to Drs. Vawter and Bunney. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Buijs RM, 1999, EUR J NEUROSCI, V11, P1535, DOI 10.1046/j.1460-9568.1999.00575.x; Bunney WE, 2000, NEUROPSYCHOPHARMACOL, V22, P335, DOI 10.1016/S0893-133X(99)00145-1; Cameron MA, 2008, J BIOL RHYTHM, V23, P489, DOI 10.1177/0748730408325874; CZEISLER CA, 1987, PSYCHIAT CLIN N AM, V10, P687; Daan S, 2001, J BIOL RHYTHM, V16, P105, DOI 10.1177/074873001129001809; Dardente H, 2007, BIOCHEM J, V402, P525, DOI 10.1042/BJ20060827; de la Iglesia HO, 2002, NEUROREPORT, V13, P857, DOI 10.1097/00001756-200205070-00024; ELSASS P, 1979, ACTA PSYCHIAT SCAND, V60, P263, DOI 10.1111/j.1600-0447.1979.tb00274.x; FAEDDA GL, 1993, ARCH GEN PSYCHIAT, V50, P17; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gao XY, 2008, GENET EPIDEMIOL, V32, P361, DOI 10.1002/gepi.20310; Germain A, 2008, HUM PSYCHOPHARM CLIN, V23, P571, DOI 10.1002/hup.964; Glod CA, 1997, J AM ACAD CHILD PSY, V36, P188, DOI 10.1097/00004583-199702000-00009; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hampp G, 2008, CURR BIOL, V18, P678, DOI 10.1016/j.cub.2008.04.012; Hoang N, 2008, PLOS BIOL, V6, P1559, DOI 10.1371/journal.pbio.0060160; Hsu DS, 1996, BIOCHEMISTRY-US, V35, P13871, DOI 10.1021/bi962209o; Johansson C, 2003, NEUROPSYCHOPHARMACOL, V28, P734, DOI 10.1038/sj.npp.1300121; Kanazawa T, 2008, AM J MED GENET B, V147B, P686, DOI 10.1002/ajmg.b.30664; Kieseppa T, 2004, AM J PSYCHIAT, V161, P1814, DOI 10.1176/appi.ajp.161.10.1814; Koorengevel KM, 2002, J BIOL RHYTHM, V17, P463, DOI 10.1177/074873002237140; Kripke Daniel F, 2009, J Circadian Rhythms, V7, P2, DOI 10.1186/1740-3391-7-2; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Lamont Elaine Waddington, 2007, Dialogues Clin Neurosci, V9, P333; Lappalainen T, 2009, ANN HUM GENET, V73, P61, DOI 10.1111/j.1469-1809.2008.00487.x; LAVEBRATT C, 2009, AM J MED GENE B 0819; Le-Niculescu H, 2009, AM J MED GENET B, V150B, P155, DOI 10.1002/ajmg.b.30887; LEWY AJ, 1987, SCIENCE, V235, P352, DOI 10.1126/science.3798117; Lewy AJ, 2006, P NATL ACAD SCI USA, V103, P7414, DOI 10.1073/pnas.0602425103; Lincoln GA, 2003, J NEUROENDOCRINOL, V15, P390, DOI 10.1046/j.1365-2826.2003.00990.x; Liu AC, 2007, CELL, V129, P605, DOI 10.1016/j.cell.2007.02.047; Lundberg I, 2005, SOC PSYCH PSYCH EPID, V40, P475, DOI 10.1007/s00127-005-0911-4; Luo AH, 2009, EUR J NEUROSCI, V29, P748, DOI 10.1111/j.1460-9568.2008.06606.x; Mansour HA, 2006, GENES BRAIN BEHAV, V5, P150, DOI 10.1111/j.1601-183X.2005.00147.x; McClung CA, 2007, PHARMACOL THERAPEUT, V114, P222, DOI 10.1016/j.pharmthera.2007.02.003; Mirsky HP, 2009, P NATL ACAD SCI USA, V106, P11107, DOI 10.1073/pnas.0904837106; Miyamoto Y, 1998, P NATL ACAD SCI USA, V95, P6097, DOI 10.1073/pnas.95.11.6097; Miyazaki K, 2004, BIOCHEM J, V380, P95, DOI 10.1042/BJ20031308; Niculescu AB, 2000, PHYSIOL GENOMICS, V4, P83, DOI 10.1152/physiolgenomics.2000.4.1.83; Nievergelt CM, 2006, AM J MED GENET B, V141B, P234, DOI 10.1002/ajmg.b.30252; Nurnberger JI, 2000, ARCH GEN PSYCHIAT, V57, P572, DOI 10.1001/archpsyc.57.6.572; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Ogden CA, 2004, MOL PSYCHIATR, V9, P1007, DOI 10.1038/sj.mp.4001547; Oster H, 2002, GENE DEV, V16, P2633, DOI 10.1101/gad.233702; Ozgur S, 2003, BIOCHEMISTRY-US, V42, P2926, DOI 10.1021/bi026963n; Partonen T, 1998, LANCET, V352, P1369, DOI 10.1016/S0140-6736(98)01015-0; Partonen T, 2007, ANN MED, V39, P229, DOI 10.1080/07853890701278795; Perala J, 2007, ARCH GEN PSYCHIAT, V64, P19, DOI 10.1001/archpsyc.64.1.19; Pirkola SP, 2005, SOC PSYCH PSYCH EPID, V40, P1, DOI 10.1007/s00127-005-0848-7; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qin ZHS, 2002, AM J HUM GENET, V71, P1242, DOI 10.1086/344207; ROSENTHAL NE, 1984, ARCH GEN PSYCHIAT, V41, P72; Shi JJ, 2008, AM J MED GENET B, V147B, P1047, DOI 10.1002/ajmg.b.30714; SOUETRE E, 1989, PSYCHIAT RES, V28, P263, DOI 10.1016/0165-1781(89)90207-2; Spoelstra K, 2008, J COMP PHYSIOL A, V194, P235, DOI 10.1007/s00359-007-0301-3; Sprouse J, 2006, BIOL PSYCHIAT, V60, P896, DOI 10.1016/j.biopsych.2006.03.003; Srinivasan V, 2009, PSYCHIAT RES, V165, P201, DOI 10.1016/j.psychres.2007.11.020; Teicher MH, 1997, ARCH GEN PSYCHIAT, V54, P124; THOMPSON C, 1990, LANCET, V336, P703, DOI 10.1016/0140-6736(90)92202-S; Thompson C, 1997, BRIT J PSYCHIAT, V170, P431, DOI 10.1192/bjp.170.5.431; Thompson CL, 2002, ONCOGENE, V21, P9043, DOI 10.1038/sj.onc.1205958; Thresher RJ, 1998, SCIENCE, V282, P1490, DOI 10.1126/science.282.5393.1490; Tsinkalovsky O, 2007, J BIOL RHYTHM, V22, P140, DOI 10.1177/0748730406299078; Ukai-Tadenuma M, 2008, NAT CELL BIOL, V10, P1154, DOI 10.1038/ncb1775; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vitaterna MH, 1999, P NATL ACAD SCI USA, V96, P12114, DOI 10.1073/pnas.96.21.12114; Wehr TA, 2001, ARCH GEN PSYCHIAT, V58, P1108, DOI 10.1001/archpsyc.58.12.1108; Yin L, 2006, SCIENCE, V311, P1002, DOI 10.1126/science.1121613; Zhang EE, 2009, CELL, V139, P199, DOI 10.1016/j.cell.2009.08.031	73	98	101	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2010	5	2							e9407	10.1371/journal.pone.0009407	http://dx.doi.org/10.1371/journal.pone.0009407			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SX	20195522	Green Published, gold			2022-12-25	WOS:000274924200027
J	Retamal, P; Castillo-Ruiz, M; Villagra, NA; Morgado, J; Mora, GC				Retamal, Patricio; Castillo-Ruiz, Mario; Villagra, Nicolas A.; Morgado, Juan; Mora, Guido C.			Modified Intracellular-Associated Phenotypes in a Recombinant Salmonella Typhi Expressing S. Typhimurium SPI-3 Sequences	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHI; COMPARATIVE GENOMICS; ESCHERICHIA-COLI; CHOLERA-TOXIN; H-NS; MYCOBACTERIUM-TUBERCULOSIS; SEROTYPE TYPHIMURIUM; VIRULENCE FACTOR; GENE; MGTC	A bioinformatics comparison of Salmonella Pathogenicity Island 3 sequences from S. Typhi and S. Typhimurium serovars showed that ten genes are highly conserved. However three of them are pseudogenes in S. Typhi. Our aim was to understand what functions are lost in S. Typhi due to pseudogenes by constructing a S. Typhi genetic hybrid carrying the SPI-3 region of S. Typhimurium instead of its own SPI-3. We observed that under stressful conditions the hybrid strain showed a clear impairment in resistance to hydrogen peroxide and decreased survival within U937 culture monocytes. We hypothesized that the marT-fidL operon, encoded in SPI-3, was responsible for the new phenotypes because marT is a pseudogen in S. Typhi and has a demonstrated role as a transcriptional regulator in S. Typhimurium. Therefore we cloned and transferred the S. Typhimurium marT-fidL operon into S. Typhi and confirmed that invasion of monocytes was dramatically decreased. Finally, our findings suggest that the genomic and functional differences between SPI-3 sequences have implications in the host specificity of Typhi and Typhimurium serovars.	[Retamal, Patricio] Univ Chile, Dept Med Prevent Anim, Santiago, Chile; [Castillo-Ruiz, Mario; Villagra, Nicolas A.; Morgado, Juan; Mora, Guido C.] Univ Andres Bello, Dept Ciencias Biol, Santiago, Chile	Universidad de Chile; Universidad Andres Bello	Retamal, P (corresponding author), Univ Chile, Dept Med Prevent Anim, Santiago, Chile.	gmora@unab.cl	Retamal, Patricio/G-3054-2013	Retamal, Patricio/0000-0001-8597-9550; Castillo-Ruiz, Mario/0000-0002-0005-408X	FONDECYT [1060999]; UNAB [0404]; CONICYT; PUC	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); UNAB; CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); PUC	This study was supported by FONDECYT grant 1060999, UNAB grant 0404 and predoctoral fellowships from CONICYT and PUC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amavisit P, 2003, J BACTERIOL, V185, P3624, DOI 10.1128/JB.185.12.3624-3635.2003; Baker S, 2007, CLIN INFECT DIS, V45, pS29, DOI 10.1086/518143; Blanc-Potard AB, 2003, J MOL EVOL, V57, P479, DOI 10.1007/s00239-003-2496-4; Blanc-Potard AB, 1999, J BACTERIOL, V181, P998, DOI 10.1128/JB.181.3.998-1004.1999; BlancPotard AB, 1997, EMBO J, V16, P5376, DOI 10.1093/emboj/16.17.5376; Bucarey SA, 2005, INFECT IMMUN, V73, P6210, DOI 10.1128/IAI.73.10.6210-6219.2005; Buchmeier N, 2000, MOL MICROBIOL, V35, P1375, DOI 10.1046/j.1365-2958.2000.01797.x; Chaudhuri RR, 2004, NUCLEIC ACIDS RES, V32, pD296, DOI 10.1093/nar/gkh031; Connor BA, 2005, LANCET INFECT DIS, V5, P623, DOI 10.1016/S1473-3099(05)70239-5; Contreras I, 1997, MICROBIOL-UK, V143, P2665, DOI 10.1099/00221287-143-8-2665; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Deng W, 2003, J BACTERIOL, V185, P2330, DOI 10.1128/JB.185.7.2330-2337.2003; Dorman CJ, 2004, NAT REV MICROBIOL, V2, P391, DOI 10.1038/nrmicro883; Dorsey CW, 2005, MOL MICROBIOL, V57, P196, DOI 10.1111/j.1365-2958.2005.04666.x; Fierer J, 2001, J CLIN INVEST, V107, P775, DOI 10.1172/JCI12561; FRITZ G, 2009, J MOL BIOL; Haraga A, 2008, NAT REV MICROBIOL, V6, P53, DOI 10.1038/nrmicro1788; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Lavigne JP, 2005, INFECT IMMUN, V73, P3160, DOI 10.1128/IAI.73.5.3160-3163.2005; MILLER VL, 1989, J BACTERIOL, V171, P1288, DOI 10.1128/jb.171.3.1288-1293.1989; Moncrief MBC, 1998, INFECT IMMUN, V66, P3802, DOI 10.1128/IAI.66.8.3802-3809.1998; Morgan E, 2004, MOL MICROBIOL, V54, P994, DOI 10.1111/j.1365-2958.2004.04323.x; Navarre WW, 2006, SCIENCE, V313, P236, DOI 10.1126/science.1128794; Parkhill J, 2001, NATURE, V413, P848, DOI 10.1038/35101607; Pfau JD, 1996, MOL MICROBIOL, V20, P213, DOI 10.1111/j.1365-2958.1996.tb02502.x; Pfau JD, 1998, J BACTERIOL, V180, P4724, DOI 10.1128/JB.180.17.4724-4733.1998; Retamal P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005551; Sambrook J., 2002, MOL CLONING LAB MANU; Santiviago CA, 2001, MICROBIOL-SGM, V147, P1897, DOI 10.1099/00221287-147-7-1897; SCHMIEGER H, 1972, MOL GEN GENET, V119, P75, DOI 10.1007/BF00270447; Tukel C, 2007, J BACTERIOL, V189, P3922, DOI 10.1128/JB.01746-06; Williamson HS, 2005, MOL MICROBIOL, V55, P808, DOI 10.1111/j.1365-2958.2004.04421.x	32	13	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2010	5	2							e9394	10.1371/journal.pone.0009394	http://dx.doi.org/10.1371/journal.pone.0009394			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SX	20195364	Green Submitted, Green Published, gold			2022-12-25	WOS:000274924200016
J	Zijnge, V; van Leeuwen, MBM; Degener, JE; Abbas, F; Thurnheer, T; Gmur, R; Harmsen, HJM				Zijnge, Vincent; van Leeuwen, M. Barbara M.; Degener, John E.; Abbas, Frank; Thurnheer, Thomas; Gmuer, Rudolf; Harmsen, Hermie J. M.			Oral Biofilm Architecture on Natural Teeth	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; DENTAL PLAQUE; OLIGONUCLEOTIDE PROBES; FUSOBACTERIUM-NUCLEATUM; ACTINOMYCES-NAESLUNDII; DIRECT VISUALIZATION; PERIODONTAL HEALTH; IDENTIFICATION; LOCALIZATION; BACTERIA	Periodontitis and caries are infectious diseases of the oral cavity in which oral biofilms play a causative role. Moreover, oral biofilms are widely studied as model systems for bacterial adhesion, biofilm development, and biofilm resistance to antibiotics, due to their widespread presence and accessibility. Despite descriptions of initial plaque formation on the tooth surface, studies on mature plaque and plaque structure below the gum are limited to landmark studies from the 1970s, without appreciating the breadth of microbial diversity in the plaque. We used fluorescent in situ hybridization to localize in vivo the most abundant species from different phyla and species associated with periodontitis on seven embedded teeth obtained from four different subjects. The data showed convincingly the dominance of Actinomyces sp., Tannerella forsythia, Fusobacterium nucleatum, Spirochaetes, and Synergistetes in subgingival plaque. The latter proved to be new with a possibly important role in host-pathogen interaction due to its localization in close proximity to immune cells. The present study identified for the first time in vivo that Lactobacillus sp. are the central cells of bacterial aggregates in subgingival plaque, and that Streptococcus sp. and the yeast Candida albicans form corncob structures in supragingival plaque. Finally, periodontal pathogens colonize already formed biofilms and form microcolonies therein. These in vivo observations on oral biofilms provide a clear vision on biofilm architecture and the spatial distribution of predominant species.	[Zijnge, Vincent; Abbas, Frank] Univ Groningen, Ctr Dent & Oral Hyg, Groningen, Netherlands; [Zijnge, Vincent; Degener, John E.; Harmsen, Hermie J. M.] Univ Groningen, Dept Med Microbiol, Groningen, Netherlands; [van Leeuwen, M. Barbara M.] Univ Groningen, Dept Biomed Engn, Groningen, Netherlands; [Thurnheer, Thomas; Gmuer, Rudolf] Univ Zurich, Inst Oral Biol, Zurich, Switzerland	University of Groningen; University of Groningen; University of Groningen; University of Zurich	Zijnge, V (corresponding author), Univ Groningen, Ctr Dent & Oral Hyg, Groningen, Netherlands.	h.j.m.harmsen@med.umcg.nl		Thurnheer, Thomas/0000-0002-8615-8209	University Medical Center of the University of Groningen	University Medical Center of the University of Groningen	This work was supported by the Junior Scientific Master class program of the University Medical Center of the University of Groningen. RG and TT were supported by the University of Zurich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Ahmad A, 2007, J MED MICROBIOL, V56, P681, DOI 10.1099/jmm.0.47094-0; AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; Auschill TM, 2001, ARCH ORAL BIOL, V46, P471, DOI 10.1016/S0003-9969(00)00136-9; Bos R, 1999, FEMS MICROBIOL REV, V23, P179, DOI 10.1016/S0168-6445(99)00004-2; Busscher H J, 1997, Adv Dent Res, V11, P24; Daly K, 2003, FEMS MICROBIOL ECOL, V44, P243, DOI 10.1016/S0168-6496(03)00032-1; Diaz PI, 2006, APPL ENVIRON MICROB, V72, P2837, DOI 10.1128/AEM.72.4.2837-2848.2006; Dige I, 2009, MICROBIOL-SGM, V155, P2116, DOI 10.1099/mic.0.027706-0; Franks AH, 1998, APPL ENVIRON MICROB, V64, P3336; Gmur R, 2007, J MICROBIOL METH, V69, P402, DOI 10.1016/j.mimet.2006.12.012; Gmur R, 2004, EUR J ORAL SCI, V112, P33, DOI 10.1111/j.0909-8836.2004.00103.x; Gmur R, 2002, MICROBIOL-SGM, V148, P1379, DOI 10.1099/00221287-148-5-1379; Guggenheim M, 2001, APPL ENVIRON MICROB, V67, P1343, DOI 10.1128/AEM.67.3.1343-1350.2001; Hannig C, 2007, ARCH ORAL BIOL, V52, P1048, DOI 10.1016/j.archoralbio.2007.05.006; Hugenholtz P, 2009, ENVIRON MICROBIOL, V11, P1327, DOI 10.1111/j.1462-2920.2009.01949.x; Kampinga G A, 2002, Ned Tijdschr Geneeskd, V146, P73; Kempf VAJ, 2000, J CLIN MICROBIOL, V38, P830, DOI 10.1128/JCM.38.2.830-838.2000; Kolenbrander PE, 2006, PERIODONTOL 2000, V42, P47, DOI 10.1111/j.1600-0757.2006.00187.x; KOLENBRANDER PE, 1993, J BACTERIOL, V175, P3247, DOI 10.1128/jb.175.11.3247-3252.1993; LAI CH, 1975, INFECT IMMUN, V11, P200, DOI 10.1128/IAI.11.1.200-210.1975; Li J, 2004, J APPL MICROBIOL, V97, P1311, DOI 10.1111/j.1365-2672.2004.02420.x; LISTGARTEN MA, 1975, J PERIODONTOL, V46, P10, DOI 10.1902/jop.1975.46.1.10; LISTGARTEN MA, 1976, J PERIODONTOL, V47, P1, DOI 10.1902/jop.1976.47.1.1; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Manz W, 1996, MICROBIOL-SGM, V142, P1097, DOI 10.1099/13500872-142-5-1097; Moter A, 1998, J CLIN MICROBIOL, V36, P1399, DOI 10.1128/JCM.36.5.1399-1403.1998; Moter A, 2000, J MICROBIOL METH, V41, P85, DOI 10.1016/S0167-7012(00)00152-4; Netuschil L, 1998, ARCH ORAL BIOL, V43, P277, DOI 10.1016/S0003-9969(97)00121-0; Noiri Y, 2001, J DENT RES, V80, P1930, DOI 10.1177/00220345010800101301; Noiri Y, 1997, J PERIODONTAL RES, V32, P598, DOI 10.1111/j.1600-0765.1997.tb00937.x; Palmer RJ, 2003, J BACTERIOL, V185, P3400, DOI 10.1128/JB.185.11.3400-3409.2003; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Reese S, 2007, MICROSC RES TECHNIQ, V70, P816, DOI 10.1002/jemt.20471; Sharma A, 2005, ORAL MICROBIOL IMMUN, V20, P39, DOI 10.1111/j.1399-302X.2004.00175.x; Socransky SS, 2005, PERIODONTOL 2000, V38, P135, DOI 10.1111/j.1600-0757.2005.00107.x; Socransky SS, 2002, PERIODONTOL 2000, V28, P12, DOI 10.1034/j.1600-0757.2002.280102.x; Sunde PT, 2003, MICROBIOL-SGM, V149, P1095, DOI 10.1099/mic.0.26077-0; Takahashi N, 1999, CRIT REV ORAL BIOL M, V10, P487, DOI 10.1177/10454411990100040501; Vartoukian SR, 2009, APPL ENVIRON MICROB, V75, P3777, DOI 10.1128/AEM.02763-08; Wecke J, 2000, FEMS MICROBIOL LETT, V191, P95, DOI 10.1016/S0378-1097(00)00376-1; Wildeboer-Veloo ACM, 2007, CLIN MICROBIOL INFEC, V13, P985, DOI 10.1111/j.1469-0691.2007.01803.x; Wood SR, 2000, J DENT RES, V79, P21, DOI 10.1177/00220345000790010201; WYSS C, 1989, INFECT IMMUN, V57, P1757, DOI 10.1128/IAI.57.6.1757-1759.1989; Yao Y, 2003, J BIOL CHEM, V278, P5300, DOI 10.1074/jbc.M206333200; Zaura-Arite E, 2001, J DENT RES, V80, P1436, DOI 10.1177/00220345010800051001; Zuger J, 2007, MICROBIOL-SGM, V153, P3809, DOI 10.1099/mic.0.2007/010926-0	46	387	403	6	121	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2010	5	2							e9321	10.1371/journal.pone.0009321	http://dx.doi.org/10.1371/journal.pone.0009321			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SX	20195365	Green Published, gold, Green Submitted			2022-12-25	WOS:000274924200005
J	Spencer, JL; Bernanke, JA; Buczek-Thomas, JA; Nugent, MA				Spencer, Jean L.; Bernanke, Joel A.; Buczek-Thomas, Jo Ann; Nugent, Matthew A.			A Computational Approach for Deciphering the Organization of Glycosaminoglycans	PLOS ONE			English	Article							HEPARAN-SULFATE; STRUCTURAL FEATURES; SEQUENCE-ANALYSIS; DOMAIN-STRUCTURE; LIGAND-BINDING; FINE-STRUCTURE; SPECIFICITY; INHIBITION; MODEL; OLIGOSACCHARIDES	Background: Increasing evidence has revealed important roles for complex glycans as mediators of normal and pathological processes. Glycosaminoglycans are a class of glycans that bind and regulate the function of a wide array of proteins at the cell-extracellular matrix interface. The specific sequence and chemical organization of these polymers likely define function; however, identification of the structure-function relationships of glycosaminoglycans has been met with challenges associated with the unique level of complexity and the nontemplate-driven biosynthesis of these biopolymers. Methodology/Principal Findings: To address these challenges, we have devised a computational approach to predict fine structure and patterns of domain organization of the specific glycosaminoglycan, heparan sulfate (HS). Using chemical composition data obtained after complete and partial digestion of mixtures of HS chains with specific degradative enzymes, the computational analysis produces populations of theoretical HS chains with structures that meet both biosynthesis and enzyme degradation rules. The model performs these operations through a modular format consisting of input/output sections and three routines called chainmaker, chainbreaker, and chainsorter. We applied this methodology to analyze HS preparations isolated from pulmonary fibroblasts and epithelial cells. Significant differences in the general organization of these two HS preparations were observed, with HS from epithelial cells having a greater frequency of highly sulfated domains. Epithelial HS also showed a higher density of specific HS domains that have been associated with inhibition of neutrophil elastase. Experimental analysis of elastase inhibition was consistent with the model predictions and demonstrated that HS from epithelial cells had greater inhibitory activity than HS from fibroblasts. Conclusions/Significance: This model establishes the conceptual framework for a new class of computational tools to use to assess patterns of domain organization within glycosaminoglycans. These tools will provide a means to consider high-level chain organization in deciphering the structure-function relationships of polysaccharides in biology.	[Spencer, Jean L.; Bernanke, Joel A.; Buczek-Thomas, Jo Ann; Nugent, Matthew A.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Spencer, Jean L.; Nugent, Matthew A.] Boston Univ, Sch Med, Dept Ophthalmol, Boston, MA 02118 USA; [Nugent, Matthew A.] Boston Univ, Dept Biomed Engn, Boston, MA 02118 USA	Boston University; Boston University; Boston University	Spencer, JL (corresponding author), Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA.	spencerj@bu.edu		Buczek-Thomas, JoAnn/0000-0003-2784-9453; Bernanke, Joel/0000-0003-2507-6282; Spencer, Jean/0000-0001-7822-4619; Nugent, Matthew/0000-0002-8630-4712	US National Institutes of Health [HL56200, HL088672]; Massachusetts Lions Eye Research Fund, Inc; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088572, R01HL056200] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Massachusetts Lions Eye Research Fund, Inc; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by grants from the US National Institutes of Health (HL56200, HL088672) and by a departmental grant from the Massachusetts Lions Eye Research Fund, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afreixo V, 2004, DIGIT SIGNAL PROCESS, V14, P523, DOI 10.1016/j.dsp.2004.08.001; Alberts B., 1994, MOL BIOL CELL; Ashikari-Hada S, 2004, J BIOL CHEM, V279, P12346, DOI 10.1074/jbc.M313523200; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; BOURIN MC, 1993, BIOCHEM J, V289, P313, DOI 10.1042/bj2890313; Buczek-Thomas JA, 2008, J CELL BIOCHEM, V105, P108, DOI 10.1002/jcb.21803; Capila I, 2002, ANGEW CHEM INT EDIT, V41, P391; COHEN DM, 1990, BIOPOLYMERS, V30, P733, DOI 10.1002/bip.360300708; Conrad H.E., 1998, HEPARIN BINDING PROT, V1st ed., P527; DESAI UR, 1993, ARCH BIOCHEM BIOPHYS, V306, P461, DOI 10.1006/abbi.1993.1538; Drummond KJ, 2001, PROTEOMICS, V1, P304, DOI 10.1002/1615-9861(200102)1:2<304::AID-PROT304>3.0.CO;2-B; ERNST S, 1995, CRIT REV BIOCHEM MOL, V30, P387, DOI 10.3109/10409239509083490; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5; Fiore MM, 2001, BIOCHEM BIOPH RES CO, V284, P384, DOI 10.1006/bbrc.2001.4978; Forsten KE, 1997, J CELL PHYSIOL, V172, P209, DOI 10.1002/(SICI)1097-4652(199708)172:2<209::AID-JCP8>3.0.CO;2-S; FOSTER JA, 1990, J BIOL CHEM, V265, P15544; Fryer A, 1997, J PHARMACOL EXP THER, V282, P208; GALLAGHER JT, 1992, ADV EXP MED BIOL, V313, P49; Gallagher JT, 2001, J CLIN INVEST, V108, P357, DOI 10.1172/JCI13713; Gandhi NS, 2008, CHEM BIOL DRUG DES, V72, P455, DOI 10.1111/j.1747-0285.2008.00741.x; Guerrini M, 2002, GLYCOBIOLOGY, V12, P713, DOI 10.1093/glycob/cwf084; Hvala N, 2005, COMPUT CHEM ENG, V29, P1507, DOI 10.1016/j.compchemeng.2004.11.013; KATO M, 1994, J BIOL CHEM, V269, P18881; Kreuger J, 2001, J BIOL CHEM, V276, P30744, DOI 10.1074/jbc.M102628200; Kreuger J, 2006, J CELL BIOL, V174, P323, DOI 10.1083/jcb.200604035; Lawrence R, 2008, NAT METHODS, V5, P291, DOI 10.1038/nmeth0408-291; Levine RA, 1998, EXP CELL RES, V239, P264, DOI 10.1006/excr.1997.3898; Lindahl U, 2007, THROMB HAEMOSTASIS, V98, P109, DOI 10.1160/Th07-04-0310; LINHARDT RJ, 1982, BIOCHIM BIOPHYS ACTA, V702, P197; LINHARDT RJ, 1989, BIOCHEMISTRY-US, V28, P2888, DOI 10.1021/bi00433a021; LINHARDT RJ, 1985, BIOCHEMISTRY-US, V24, P7805, DOI 10.1021/bi00347a045; Maccarana M, 1996, J BIOL CHEM, V271, P17804, DOI 10.1074/jbc.271.30.17804; Merry CLR, 1999, J BIOL CHEM, V274, P18455, DOI 10.1074/jbc.274.26.18455; Mulloy B, 2000, GLYCOBIOLOGY, V10, P1147, DOI 10.1093/glycob/10.11.1147; Murphy KJ, 2004, J BIOL CHEM, V279, P27239, DOI 10.1074/jbc.M401774200; Nugent MA, 2000, P NATL ACAD SCI USA, V97, P10301, DOI 10.1073/pnas.97.19.10301; Park Y, 1997, BBA-PROTEIN STRUCT M, V1337, P217, DOI 10.1016/S0167-4838(96)00167-7; Powell AK, 2004, GLYCOBIOLOGY, V14, p17R, DOI 10.1093/glycob/cwh051; Rabenstein DL, 2002, NAT PROD REP, V19, P312, DOI 10.1039/b100916h; Rackovsky S, 1998, P NATL ACAD SCI USA, V95, P8580, DOI 10.1073/pnas.95.15.8580; RADOFF S, 1984, J BIOL CHEM, V259, P166; Raman R, 2005, NAT METHODS, V2, P817, DOI 10.1038/NMETH807; Saad OM, 2005, ANAL CHEM, V77, P5902, DOI 10.1021/ac050793d; SANDERSON RD, 1994, J BIOL CHEM, V269, P13100; Sasisekharan R, 2006, ANNU REV BIOMED ENG, V8, P181, DOI 10.1146/annurev.bioeng.8.061505.095745; Shriver Z, 2000, P NATL ACAD SCI USA, V97, P10359, DOI 10.1073/pnas.97.19.10359; Skidmore MA, 2006, J CHROMATOGR A, V1135, P52, DOI 10.1016/j.chroma.2006.09.064; Spencer JL, 2006, BIOCHEMISTRY-US, V45, P9104, DOI 10.1021/bi060338r; Stringer SE, 2002, BLOOD, V100, P1543, DOI 10.1182/blood.V100.5.1543.h81702001543_1543_1550; THOMPSON AB, 1995, EUR RESPIR J, V8, P127, DOI 10.1183/09031936.95.08010127; Togo S, 2008, AM J RESP CRIT CARE, V178, P248, DOI 10.1164/rccm.200706-929OC; Turnbull JE, 1999, P NATL ACAD SCI USA, V96, P2698, DOI 10.1073/pnas.96.6.2698; TURNBULL JE, 1991, BIOCHEM J, V273, P553, DOI 10.1042/bj2730553; Venkataraman G, 1999, SCIENCE, V286, P537, DOI 10.1126/science.286.5439.537; Vives RR, 1999, BIOCHEM J, V339, P767, DOI 10.1042/0264-6021:3390767; Volpi N, 1996, BBA-GEN SUBJECTS, V1290, P299, DOI 10.1016/0304-4165(96)00033-5; WALSH RL, 1991, CLIN SCI, V81, P341, DOI 10.1042/cs0810341; Westling C, 2002, J BIOL CHEM, V277, P49247, DOI 10.1074/jbc.M209139200; YAMADA S, 1995, J BIOL CHEM, V270, P8696; Zaia J, 2008, CHEM BIOL, V15, P881, DOI 10.1016/j.chembiol.2008.07.016; [No title captured]	64	19	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2010	5	2							e9389	10.1371/journal.pone.0009389	http://dx.doi.org/10.1371/journal.pone.0009389			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SV	20186334	Green Published, Green Submitted, gold			2022-12-25	WOS:000274924000025
J	Thompson, RF; Fazzari, MJ; Niu, HS; Barzilai, N; Simmons, RA; Greally, JM				Thompson, Reid F.; Fazzari, Melissa J.; Niu, Hongshun; Barzilai, Nir; Simmons, Rebecca A.; Greally, John M.			Experimental Intrauterine Growth Restriction Induces Alterations in DNA Methylation and Gene Expression in Pancreatic Islets of Rats	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CELL FAILURE; DIETARY-PROTEIN RESTRICTION; CYTOSINE METHYLATION; EXTRACELLULAR-MATRIX; DEVELOPMENTAL ORIGINS; INSULIN-RESISTANCE; MASS-SPECTROMETRY; GENOME; RETARDATION; SECRETION	Intrauterine growth restriction (IUGR) increases susceptibility to age-related diseases, including type 2 diabetes (T2DM), and is associated with permanent and progressive changes in gene expression. Our study was designed to test whether epigenomic dysregulation mediates the cellular memory of this intrauterine event. To test this hypothesis, we isolated pancreatic islets from control and IUGR (induced by bilateral uterine artery ligation at day 18 of fetal life) animals at 7 weeks of age. Using the HELP (HpaII tiny fragment enrichment by ligation-mediated PCR) assay, we generated the first DNA methylation map at almost 1 million unique sites throughout the rat genome in normal pancreatic islet cells, allowing us to identify the changes that occur as a consequence of IUGR. We validated candidate dysregulated loci with quantitative assays of cytosine methylation and gene expression. IUGR changes cytosine methylation at similar to 1,400 loci (false discovery rate of 4.2%) in male rats at 7 weeks of age, preceding the development of diabetes and thus representing candidate loci for mediating the pathogenesis of metabolic disease that occurs later in life. Epigenetic dysregulation occurred preferentially at conserved intergenic sequences, frequently near genes regulating processes known to be abnormal in IUGR islets, such as vascularization, beta-cell proliferation, insulin secretion, and cell death, associated with concordant changes in mRNA expression. These results demonstrate that epigenetic dysregulation is a strong candidate for propagating the cellular memory of intrauterine events, causing changes in expression of nearby genes and long term susceptibility to type 2 diabetes.	[Niu, Hongshun; Simmons, Rebecca A.] Univ Penn, Med Ctr, Ctr Res Reprod & Womens Hlth, Philadelphia, PA 19104 USA; [Thompson, Reid F.; Fazzari, Melissa J.; Greally, John M.] Albert Einstein Coll Med, Dept Genet Computat Genet, Bronx, NY 10461 USA; [Fazzari, Melissa J.] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10461 USA; [Barzilai, Nir; Greally, John M.] Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA; [Thompson, Reid F.; Fazzari, Melissa J.; Greally, John M.] Albert Einstein Coll Med, Ctr Epigenom, Bronx, NY 10461 USA	University of Pennsylvania; Pennsylvania Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Simmons, RA (corresponding author), Univ Penn, Med Ctr, Ctr Res Reprod & Womens Hlth, 421 Curie Blvd,1308 Biomed Res Bldg 2-3, Philadelphia, PA 19104 USA.	rsimmons@mail.med.upenn.edu; john.greally@einstein.yu.edu	Greally, John/AAF-9540-2019; Stefanadis, Christodoulos/ABH-2232-2020	Greally, John/0000-0001-6069-7960; Fazzari, Melissa/0000-0002-5674-3589; Stefanadis, Christodoulos/0000-0001-5974-6454; Simmons, Rebecca/0000-0002-2901-8904; Thompson, Reid/0000-0003-3661-5296	National Institutes of Health [HG004401, HD044078, DK55704, DK062965, AG21654, AG18381]; Einstein's Center for Epigenomics; Albert Einstein Diabetes Research and Training Center [DK 20541]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD044078] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004401] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020541, R01DK062965, P30DK020541, R01DK055704] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG018381, R37AG018381, P01AG021654] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Einstein's Center for Epigenomics; Albert Einstein Diabetes Research and Training Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants HG004401 and HD044078 (to J. M. G.), DK55704 and DK062965 (to R. A. S.), and AG21654 and AG18381 (to N. B.). This work was also supported by Einstein's Center for Epigenomics and by the Core laboratories of the Albert Einstein Diabetes Research and Training Center (Grant DK 20541).	Akpinar P, 2005, CELL METAB, V2, P385, DOI 10.1016/j.cmet.2005.11.001; Antoniades C, 2008, J AM COLL CARDIOL, V52, P158, DOI 10.1016/j.jacc.2007.12.062; Arantes VC, 2002, J NUTR, V132, P3030, DOI 10.1093/jn/131.10.3030; Barker DJP, 2007, J INTERN MED, V261, P412, DOI 10.1111/j.1365-2796.2007.01809.x; Barker DJP, 2006, CLIN OBSTET GYNECOL, V49, P270, DOI 10.1097/00003081-200606000-00009; Barreto G, 2007, NATURE, V445, P671, DOI 10.1038/nature05515; BIRD A, 1985, CELL, V40, P91, DOI 10.1016/0092-8674(85)90312-5; Brawley L, 2003, PEDIATR RES, V54, P83, DOI 10.1203/01.PDR.0000065731.00639.02; Cui YZ, 1998, EMBO J, V17, P4735, DOI 10.1093/emboj/17.16.4735; DAHRI S, 1991, DIABETES, V40, P115, DOI 10.2337/diab.40.2.S115; Davis GE, 2005, CIRC RES, V97, P1093, DOI 10.1161/01.RES.0000191547.64391.e3; Ehrich M, 2005, P NATL ACAD SCI USA, V102, P15785, DOI 10.1073/pnas.0507816102; FINEGOOD DT, 1995, DIABETES, V44, P249, DOI 10.2337/diabetes.44.3.249; Glass JL, 2007, NUCLEIC ACIDS RES, V35, P6798, DOI 10.1093/nar/gkm489; Goldin A, 2006, CIRCULATION, V114, P597, DOI 10.1161/CIRCULATIONAHA.106.621854; Goulley J, 2007, CELL METAB, V5, P207, DOI 10.1016/j.cmet.2007.01.009; Ham JN, 2009, PEDIATR RES, V66, P42, DOI 10.1203/PDR.0b013e3181a282a5; Hart AW, 2000, NATURE, V408, P864, DOI 10.1038/35048589; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Kaido T, 2004, J BIOL CHEM, V279, P17731, DOI 10.1074/jbc.M308425200; Kaido T, 2006, DIABETES, V55, P2723, DOI 10.2337/db06-0120; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Khatib AM, 2001, J BIOL CHEM, V276, P30686, DOI 10.1074/jbc.M101725200; Khulan B, 2006, GENOME RES, V16, P1046, DOI 10.1101/gr.5273806; Kilkenny DM, 2008, MOL ENDOCRINOL, V22, P196, DOI 10.1210/me.2007-0241; Kulkarni RN, 2002, NAT GENET, V31, P111, DOI 10.1038/ng872; Lillycrop KA, 2005, J NUTR, V135, P1382, DOI 10.1093/jn/135.6.1382; Martin-Gronert MS, 2007, J INTERN MED, V261, P437, DOI 10.1111/j.1365-2796.2007.01800.x; Meininger CJ, 2004, FASEB J, V18, P1900, DOI 10.1096/fj.04-1702fje; Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327; Nikolova G, 2006, DEV CELL, V10, P397, DOI 10.1016/j.devcel.2006.01.015; Oda M, 2009, NUCLEIC ACIDS RES, V37, P3829, DOI 10.1093/nar/gkp260; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Park JH, 2008, J CLIN INVEST, V118, P2316, DOI [10.1172/JC133655, 10.1172/JCI33655]; Parnaud G, 2006, DIABETES, V55, P1413, DOI 10.2337/db05-1388; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Simmons RA, 2005, J BIOL CHEM, V280, P28785, DOI 10.1074/jbc.M505695200; Simmons RA, 2001, DIABETES, V50, P2279, DOI 10.2337/diabetes.50.10.2279; Simmons RA, 2007, PEDIATR RES, V61, p64R, DOI 10.1203/pdr.0b013e3180457623; Stawowy P, 2004, CIRCULATION, V109, P770, DOI 10.1161/01.CIR.0000112583.50762.DE; Stoffers DA, 2003, DIABETES, V52, P734, DOI 10.2337/diabetes.52.3.734; Thompson RF, 2008, BIOINFORMATICS, V24, P1161, DOI 10.1093/bioinformatics/btn096; Thompson RF, 2009, BIOINFORMATICS, V25, P2164, DOI 10.1093/bioinformatics/btp382; Torrens C, 2006, HYPERTENSION, V47, P982, DOI 10.1161/01.HYP.0000215580.43711.d1; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vuguin P, 2004, DIABETES, V53, P2617, DOI 10.2337/diabetes.53.10.2617; Yang AS, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh032	47	118	126	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15111	15118		10.1074/jbc.M109.095133	http://dx.doi.org/10.1074/jbc.M109.095133			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20194508	hybrid, Green Published			2022-12-25	WOS:000277399000032
J	Gutierrez, GJ; Tsuji, T; Cross, JV; Davis, RJ; Templeton, DJ; Jiang, W; Ronai, ZA				Gutierrez, Gustavo J.; Tsuji, Toshiya; Cross, Janet V.; Davis, Roger J.; Templeton, Dennis J.; Jiang, Wei; Ronai, Ze'ev A.			JNK-mediated Phosphorylation of Cdc25C Regulates Cell Cycle Entry and G(2)/M DNA Damage Checkpoint	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							JUN NH2-TERMINAL KINASE; N-TERMINAL KINASE; ACTIVATED PROTEIN-KINASES; SIGNAL-TRANSDUCTION; TUMOR-GROWTH; S-PHASE; APOPTOSIS; INHIBITION; ARREST; ENDOREDUPLICATION	c-Jun NH2-terminal Kinases (JNKs) play a central role in the cellular response to a wide variety of stress signals. After their activation, JNKs induce phosphorylation of substrates, which control proliferation, migration, survival, and differentiation. Recent studies suggest that JNKs may also play a role in cell cycle control, although the underlying mechanisms are largely unexplored. Here we show that JNK directly phosphorylates Cdc25C at serine 168 during G(2) phase of the cell cycle. Cdc25C phosphorylation by JNK negatively regulates its phosphatase activity and thereby Cdk1 activation, enabling a timely control of mitosis onset. Unrestrained phosphorylation by JNK, as obtained by a cell cycle-stabilized form of JNK or as seen in some human tumors, results in aberrant cell cycle progression. Additionally, UV irradiation-induced G(2)/M checkpoint requires inactivation of Cdc25C by JNK phosphorylation. JNK phosphorylation of Cdc25C as well as Cdc25A establishes a novel link between stress signaling and unperturbed cell cycle and checkpoint pathways.	[Ronai, Ze'ev A.] Sanford Burnham Med Res Inst, Ctr Canc, Signal Transduct Program, La Jolla, CA 92037 USA; [Cross, Janet V.; Templeton, Dennis J.] Univ Virginia, Dept Pathol, Charlottesville, VA 22908 USA; [Davis, Roger J.] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA; [Davis, Roger J.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA	Sanford Burnham Prebys Medical Discovery Institute; University of Virginia; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Ronai, ZA (corresponding author), Sanford Burnham Med Res Inst, Ctr Canc, Signal Transduct Program, La Jolla, CA 92037 USA.	ronai@burnham.org	Gutierrez, Gustavo/AAO-9957-2021; Cross, Janet V/F-8276-2011; Gutierrez, Gustavo/B-6771-2013; Templeton, Dennis J/F-7695-2011	Gutierrez, Gustavo/0000-0001-8652-972X; Gutierrez, Gustavo/0000-0003-4133-5002; RONAI, ZEEV/0000-0002-3859-0400; Jiang, Wei/0000-0002-2309-9571; Davis, Roger/0000-0002-0130-1652	National Institutes of Health [CA78419]; Sass Foundation; NATIONAL CANCER INSTITUTE [R01CA078419, R01CA138143] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sass Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA78419 (NCI; to Z. A. R.).; Supported by a postdoctoral fellowship from the Sass Foundation.	Alexaki VI, 2008, PIGM CELL MELANOMA R, V21, P429, DOI 10.1111/j.1755-148X.2008.00466.x; Antonyak MA, 2002, ONCOGENE, V21, P5038, DOI 10.1038/sj.onc.1205593; Boutros R, 2006, CURR OPIN CELL BIOL, V18, P185, DOI 10.1016/j.ceb.2006.02.003; Boutros R, 2007, NAT REV CANCER, V7, P495, DOI 10.1038/nrc2169; Bulavin DV, 2001, NATURE, V411, P102, DOI 10.1038/35075107; Busino L, 2003, NATURE, V426, P87, DOI 10.1038/nature02082; Cha HJ, 2007, J BIOL CHEM, V282, P22984, DOI 10.1074/jbc.M700735200; Chuang JY, 2008, MOL BIOL CELL, V19, P1139, DOI 10.1091/mbc.E07-09-0881; Cui J, 2006, CANCER RES, V66, P10024, DOI 10.1158/0008-5472.CAN-06-0136; Davis PK, 2001, BIOTECHNIQUES, V30, P1322, DOI 10.2144/01306rv01; Gonzalez ME, 2009, CELL SIGNAL, V21, P477, DOI 10.1016/j.cellsig.2008.11.007; Goss VL, 2003, CELL SIGNAL, V15, P709, DOI 10.1016/S0898-6568(03)00009-3; Gutierrez GJ, 2006, NAT CELL BIOL, V8, P1084, DOI 10.1038/ncb1472; Gutierrez GJ, 2006, TRENDS BIOCHEM SCI, V31, P324, DOI 10.1016/j.tibs.2006.04.001; Jaeschke A, 2006, MOL CELL, V23, P899, DOI 10.1016/j.molcel.2006.07.028; Karin M, 2005, IUBMB LIFE, V57, P283, DOI 10.1080/15216540500097111; Lee K, 2008, CELL CYCLE, V7, P216, DOI 10.4161/cc.7.2.5155; Lopez-Bergami P, 2007, CANCER CELL, V11, P447, DOI 10.1016/j.ccr.2007.03.009; Lu CR, 2006, MOL CELL, V23, P121, DOI 10.1016/j.molcel.2006.05.023; MacCorkle RA, 2005, CELL BIOCHEM BIOPHYS, V43, P451, DOI 10.1385/CBB:43:3:451; MacCorkle RA, 2004, J BIOL CHEM, V279, P40112, DOI 10.1074/jbc.M405481200; Malumbres M, 2005, TRENDS BIOCHEM SCI, V30, P630, DOI 10.1016/j.tibs.2005.09.005; Manke IA, 2005, MOL CELL, V17, P37, DOI 10.1016/j.molcel.2004.11.021; Mingo-Sion AM, 2004, ONCOGENE, V23, P596, DOI 10.1038/sj.onc.1207147; Moon DO, 2009, EXP MOL MED, V41, P665, DOI 10.3858/emm.2009.41.9.073; Oktay K, 2008, CELL CYCLE, V7, P533, DOI 10.4161/cc.7.4.5660; Peng CY, 1997, SCIENCE, V277, P1501, DOI 10.1126/science.277.5331.1501; Perry JA, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-12; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Pimienta G, 2007, CELL CYCLE, V6, P1762, DOI 10.4161/cc.6.14.4434; Potapova O, 2000, MOL CELL BIOL, V20, P1713, DOI 10.1128/MCB.20.5.1713-1722.2000; Potapova O, 2002, CANCER RES, V62, P3257; Potapova O, 2000, J BIOL CHEM, V275, P24767, DOI 10.1074/jbc.M904591199; Reinhardt HC, 2009, CURR OPIN CELL BIOL, V21, P245, DOI 10.1016/j.ceb.2009.01.018; Ronai Z, 2004, MOL CELL, V15, P843, DOI 10.1016/j.molcel.2004.09.011; Sabapathy K, 2004, MOL CELL, V15, P713, DOI 10.1016/j.molcel.2004.08.028; Sanchez Y, 1997, SCIENCE, V277, P1497, DOI 10.1126/science.277.5331.1497; Sluss HK, 2006, MOL CELL, V23, P152, DOI 10.1016/j.molcel.2006.07.001; Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870; Tsuiki H, 2003, CANCER RES, V63, P250; Uchida S, 2009, CANCER RES, V69, P6438, DOI 10.1158/0008-5472.CAN-09-0869; Ventura JJ, 2006, MOL CELL, V21, P701, DOI 10.1016/j.molcel.2006.01.018; Wang RN, 2007, CELL, V128, P1119, DOI 10.1016/j.cell.2006.11.053; Weston CR, 2007, CURR OPIN CELL BIOL, V19, P142, DOI 10.1016/j.ceb.2007.02.001; Xia HHX, 2006, CANCER LETT, V241, P268, DOI 10.1016/j.canlet.2005.10.031; Yang SH, 2007, TOXICON, V49, P966, DOI 10.1016/j.toxicon.2007.01.005; Yang YM, 2003, CLIN CANCER RES, V9, P391	47	59	62	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14217	14228		10.1074/jbc.M110.121848	http://dx.doi.org/10.1074/jbc.M110.121848			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20220133	hybrid, Green Published			2022-12-25	WOS:000277299700018
J	Walz, HA; Shi, XR; Chouinard, M; Bue, CA; Navaroli, DM; Hayakawa, A; Zhou, QL; Nadler, J; Leonard, DM; Corvera, S				Walz, Helena A.; Shi, Xiarong; Chouinard, My; Bue, Catherine A.; Navaroli, Deanna M.; Hayakawa, Akira; Zhou, Qiong L.; Nadler, Jonathan; Leonard, Deborah M.; Corvera, Silvia			Isoform-specific Regulation of Akt Signaling by the Endosomal Protein WDFY2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FYVE PROTEIN; PHOSPHOINOSITIDE 3-KINASES; ENDOCYTIC TRAFFICKING; PLASMA-MEMBRANE; MICE LACKING; APPL1; GROWTH; BINDS; BETA; TRANSDUCTION	Recent work has led to the identification of novel endocytic compartments with functional roles in both protein trafficking and growth factor signal transduction. The phosphatidylinositol 3-phosphate binding, FYVE domain-containing protein WDFY2 is localized to a distinct subset of early endosomes, which are localized close to the plasma membrane. Here, we find that the serine/threonine kinase Akt interacts with these endosomes in an isoform-specific manner. Using quantitative fluorescence microscopy we demonstrate specific co-localization of WDFY2 with endogenous Akt2, but not Akt1. Moreover, depletion of WDFY2 leads to impaired phosphorylation of Akt in response to insulin due to isoform specific reduction of Akt2, but not Akt1, protein levels, and to a marked reduction in the insulin-stimulated phosphorylation of numerous Akt substrates. This is accompanied by an impairment in insulin-stimulated glucose transport and, after prolonged silencing, a reduction in the level of expression of adipogenic genes. We propose that WDFY2-enriched endosomes serve as a scaffold that enables specificity of insulin signaling through Akt2.	[Walz, Helena A.; Shi, Xiarong; Chouinard, My; Bue, Catherine A.; Navaroli, Deanna M.; Hayakawa, Akira; Zhou, Qiong L.; Nadler, Jonathan; Leonard, Deborah M.; Corvera, Silvia] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01604 USA	University of Massachusetts System; University of Massachusetts Worcester	Corvera, S (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, 373 Plantat St, Worcester, MA 01604 USA.	silvia.corvera@umassmed.edu	Jones, Helena/C-8847-2013	Jones, Helena/0000-0002-3948-161X	NIDDK/National Institutes of Health [5 P30 DK32520, DK60837]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520, R01DK060837] Funding Source: NIH RePORTER	NIDDK/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by NIDDK/National Institutes of Health Grant 5 P30 DK32520 (to the imaging core services) and by Grant DK60837.	Bellve KD, 2006, J BIOL CHEM, V281, P16139, DOI 10.1074/jbc.M511370200; Brognard J, 2007, MOL CELL, V25, P917, DOI 10.1016/j.molcel.2007.02.017; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Corvera S, 1999, CURR OPIN CELL BIOL, V11, P460, DOI 10.1016/S0955-0674(99)80066-0; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Driscoll PC, 2001, NAT STRUCT BIOL, V8, P287, DOI 10.1038/86144; Dummler B, 2007, BIOCHEM SOC T, V35, P231, DOI 10.1042/BST0350231; Easton RM, 2005, MOL CELL BIOL, V25, P1869, DOI 10.1128/MCB.25.5.1869-1878.2005; Evans DRH, 2004, BIOTECHNIQUES, V37, P840, DOI 10.2144/04375PT02; Franke TF, 2008, ONCOGENE, V27, P6473, DOI 10.1038/onc.2008.313; Fritzius T, 2008, EMBO J, V27, P1399, DOI 10.1038/emboj.2008.67; Fritzius T, 2007, FEBS J, V274, P1552, DOI 10.1111/j.1742-4658.2007.05702.x; Fritzius T, 2006, BIOCHEM J, V399, P9, DOI 10.1042/BJ20060511; Garofalo RS, 2003, J CLIN INVEST, V112, P197, DOI 10.1172/JCI200316885; Hanada M, 2004, BBA-PROTEINS PROTEOM, V1697, P3, DOI 10.1016/j.bbapap.2003.11.009; Hayakawa A, 2006, P NATL ACAD SCI USA, V103, P11928, DOI 10.1073/pnas.0508832103; Hayes S, 2002, J CELL BIOL, V158, P1239, DOI 10.1083/jcb.200204088; Jiang ZY, 2003, P NATL ACAD SCI USA, V100, P7569, DOI 10.1073/pnas.1332633100; Kittler JT, 2001, TRAFFIC, V2, P437, DOI 10.1034/j.1600-0854.2001.20702.x; Lakadamyali M, 2006, CELL, V124, P997, DOI 10.1016/j.cell.2005.12.038; Leevers SJ, 1999, CURR OPIN CELL BIOL, V11, P219, DOI 10.1016/S0955-0674(99)80029-5; Leonard D, 2008, J CELL SCI, V121, P3445, DOI 10.1242/jcs.031484; Lin DC, 2006, MOL CELL BIOL, V26, P8928, DOI 10.1128/MCB.00228-06; Lindmo K, 2006, J CELL SCI, V119, P605, DOI 10.1242/jcs.02855; Mao XM, 2006, NAT CELL BIOL, V8, P516, DOI 10.1038/ncb1404; Medina EA, 2005, ENDOCRINOLOGY, V146, P2726, DOI 10.1210/en.2004-1074; Miaczynska M, 2004, CELL, V116, P445, DOI 10.1016/S0092-8674(04)00117-5; Mosesson Y, 2008, NAT REV CANCER, V8, P835, DOI 10.1038/nrc2521; Nechamen CA, 2007, MOL CELL ENDOCRINOL, V260, P93, DOI 10.1016/j.mce.2006.08.014; Raiborg C, 2001, BIOCHEM SOC T, V29, P472, DOI 10.1042/BST0290472; Saito T, 2007, J BIOL CHEM, V282, P32280, DOI 10.1074/jbc.M704150200; Schenck A, 2008, CELL, V133, P486, DOI 10.1016/j.cell.2008.02.044; von Zastrow M, 2001, BIOCHEM SOC T, V29, P500, DOI 10.1042/BST0290500; Wiley HS, 2001, TRAFFIC, V2, P12, DOI 10.1034/j.1600-0854.2001.020103.x; Xiang T, 2008, CANCER RES, V68, P10040, DOI 10.1158/0008-5472.CAN-08-3009; Yan D, 2006, J CELL BIOL, V174, P415, DOI 10.1083/jcb.200511028; Zoncu R, 2009, CELL, V136, P1110, DOI 10.1016/j.cell.2009.01.032	38	29	33	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14101	14108		10.1074/jbc.M110.110536	http://dx.doi.org/10.1074/jbc.M110.110536			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20189988	Green Published, hybrid			2022-12-25	WOS:000277299700005
J	Kang, WH; Park, YH; Park, HM				Kang, Won-Hwa; Park, Yun-Hee; Park, Hee-Moon			The LAMMER Kinase Homolog, Lkh1, Regulates Tup Transcriptional Repressors through Phosphorylation in Schizosaccharomyces pombe	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST TUP1-LIKE REPRESSORS; SR SPLICING FACTORS; FISSION YEAST; PROTEIN-KINASE; SACCHAROMYCES-CEREVISIAE; IN-VIVO; NEURONAL DIFFERENTIATION; CYC8-TUP1 COREPRESSOR; OXIDATIVE-STRESS; BINDING PROTEIN	Disruption of the fission yeast LAMMER kinase, Lkh1, gene resulted in diverse phenotypes, including adhesive filamentous growth and oxidative stress sensitivity, but an exact cellular function had not been assigned to Lkh1. Through an in vitro pull down approach, a transcriptional repressor, Tup12, was identified as an Lkh1 binding partner. Interactions between Lkh1 and Tup11 or Tup12 were confirmed by in vitro and in vivo binding assays. Tup proteins were phosphorylated by Lkh1 in a LAMMER motif dependent manner. The LAMMER motif was also necessary for substrate recognition in vitro and cellular function in vivo. Transcriptional activity assays using promoters negatively regulated by Tup11 and Tup12 showed 6 or 2 times higher activity in the Delta lkh1 mutant than the wild type, respectively. Northern analysis revealed derepressed expression of the fbp1(+) mRNA in Delta lkh1 and in Delta tup11 Delta tup12 mutant cells under repressed conditions. Delta lkh1 and Delta tup11 Delta tup12 mutant cells showed flocculation, which was reversed by coexpression of Tup11 and 12 with Ssn6. Here, we presented a new aspect of the LAMMER kinase by demonstrating that the activities of global transcriptional repressors, Tup11 and Tup12, were positively regulated by Lkh1 mediated phosphorylation.	[Kang, Won-Hwa; Park, Yun-Hee; Park, Hee-Moon] Chungnam Natl Univ, Dept Microbiol, Sch Biosci & Biotechnol, Taejon 305764, South Korea	Chungnam National University	Park, HM (corresponding author), Chungnam Natl Univ, Dept Microbiol, Sch Biosci & Biotechnol, Gung Dong 220, Taejon 305764, South Korea.	hmpark@cnu.ac.kr	Heemoon, Park/F-5783-2013	Heemoon, Park/0000-0001-6780-9283	Korea Science and Engineering Foundation [R01-2004-000-10082-0]	Korea Science and Engineering Foundation(Korea Science and Engineering Foundation)	This work was supported by Basic Research Program of the Korea Science and Engineering Foundation Grant R01-2004-000-10082-0.	ALFA C, 1993, EXPT FISSION YEAST L, P95; BALCIUNAS D, 1995, NUCLEIC ACIDS RES, V23, P4421, DOI 10.1093/nar/23.21.4421; BENDAVID Y, 1991, EMBO J, V10, P317, DOI 10.1002/j.1460-2075.1991.tb07952.x; Braun BR, 1997, SCIENCE, V277, P105, DOI 10.1126/science.277.5322.105; BYRNE SM, 1993, J CELL SCI, V105, P1095; Colwill K, 1996, EMBO J, V15, P265, DOI 10.1002/j.1460-2075.1996.tb00357.x; Courey AJ, 2001, GENE DEV, V15, P2786; Davie JK, 2003, J BIOL CHEM, V278, P50158, DOI 10.1074/jbc.M309753200; Davie JK, 2002, MOL CELL BIOL, V22, P693, DOI 10.1128/MCB.22.3.693-703.2002; Du C, 1998, MOL CELL, V2, P741, DOI 10.1016/S1097-2765(00)80289-0; Duncan PI, 1997, MOL CELL BIOL, V17, P5996, DOI 10.1128/MCB.17.10.5996; Edmondson DG, 1996, GENE DEV, V10, P1247, DOI 10.1101/gad.10.10.1247; Fagerstrom-Billai F, 2005, MOL CELL BIOL, V25, P716, DOI 10.1128/MCB.25.2.716-727.2005; Fagerstrom-Billai F, 2007, MOL CELL BIOL, V27, P1069, DOI 10.1128/MCB.01674-06; Fisher AL, 1998, GENE DEV, V12, P1931, DOI 10.1101/gad.12.13.1931; Flores-Saaib RD, 2000, NUCLEIC ACIDS RES, V28, P4189, DOI 10.1093/nar/28.21.4189; Greenall A, 2002, MOL BIOL CELL, V13, P2977, DOI 10.1091/mbc.01-12-0568; Gromoller A, 2000, EMBO J, V19, P6845, DOI 10.1093/emboj/19.24.6845; Hengen PN, 1996, TRENDS BIOCHEM SCI, V21, P75, DOI 10.1016/0968-0004(96)80871-1; Hirota K, 2003, GENETICS, V165, P505; HOWELL BW, 1991, MOL CELL BIOL, V11, P568, DOI 10.1128/MCB.11.1.568; Huang MX, 1998, CELL, V94, P595, DOI 10.1016/S0092-8674(00)81601-3; Janoo RTK, 2001, GENETICS, V157, P1205; Kang WH, 2007, FEBS LETT, V581, P3473, DOI 10.1016/j.febslet.2007.06.053; Kim KH, 2001, BIOCHEM BIOPH RES CO, V289, P1237, DOI 10.1006/bbrc.2001.6128; Kobayashi Y, 2008, BIOCHEM BIOPH RES CO, V368, P50, DOI 10.1016/j.bbrc.2008.01.033; KOMACHI K, 1994, GENE DEV, V8, P2857, DOI 10.1101/gad.8.23.2857; Komachi K, 1997, MOL CELL BIOL, V17, P6023, DOI 10.1128/MCB.17.10.6023; Kovacikova Michaela, 2006, Endocr Regul, V40, P21; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; Labbe S, 2007, BIOMETALS, V20, P523, DOI 10.1007/s10534-006-9056-5; Lee K, 1996, J BIOL CHEM, V271, P27299, DOI 10.1074/jbc.271.44.27299; Lee M, 2000, GENETICS, V155, P1535; LIPKE PN, 1984, J BACTERIOL, V159, P797, DOI 10.1128/JB.159.2.797-799.1984; Mennella TA, 2003, EUKARYOT CELL, V2, P1288, DOI 10.1128/EC.2.6.1288-1303.2003; MOCHIZUKI N, 1992, MOL GEN GENET, V233, P17, DOI 10.1007/BF00587556; Moeslein FM, 1999, J BIOL CHEM, V274, P26697, DOI 10.1074/jbc.274.38.26697; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Mukai Y, 1999, MOL CELL BIOL, V19, P8461; MYERS MP, 1994, MOL CELL BIOL, V14, P6954, DOI 10.1128/MCB.14.10.6954; Nikolakaki E, 2002, BIOCHEMISTRY-US, V41, P2055, DOI 10.1021/bi011521h; Nuthall HN, 2004, MOL CELL BIOL, V24, P8395, DOI 10.1128/MCB.24.19.8395-8407.2004; PADMANABHA R, 1991, MOL GEN GENET, V229, P1; Papamichos-Chronakis M, 2000, J BIOL CHEM, V275, P8397, DOI 10.1074/jbc.275.12.8397; Park YD, 2003, BIOCHEM BIOPH RES CO, V311, P1078, DOI 10.1016/j.bbrc.2003.10.110; Pelletier B, 2002, J BIOL CHEM, V277, P22950, DOI 10.1074/jbc.M202682200; Proft M, 2001, EMBO J, V20, P1123, DOI 10.1093/emboj/20.5.1123; Redd MJ, 1997, J BIOL CHEM, V272, P11193; ROSE M, 1983, METHOD ENZYMOL, V101, P167; ROTH SY, 1995, CURR OPIN GENET DEV, V5, P168, DOI 10.1016/0959-437X(95)80004-2; Savaldi-Goldstein S, 2000, PLANT J, V21, P91, DOI 10.1046/j.1365-313x.2000.00657.x; Savaldi-Goldstein S, 2003, PLANT CELL, V15, P926, DOI 10.1105/tpc.011056; Sessa G, 1996, PLANT CELL, V8, P2223, DOI 10.1105/tpc.8.12.2223; Smith RL, 2000, TRENDS BIOCHEM SCI, V25, P325, DOI 10.1016/S0968-0004(00)01592-9; Stettler S, 1996, J CELL SCI, V109, P1927; Tang ZH, 2003, EXP CELL RES, V283, P101, DOI 10.1016/S0014-4827(02)00022-8; TREITEL MA, 1995, P NATL ACAD SCI USA, V92, P3132, DOI 10.1073/pnas.92.8.3132; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Wan YQ, 2008, MOL CELL BIOCHEM, V307, P177, DOI 10.1007/s11010-007-9597-0; Watson AD, 2000, GENE DEV, V14, P2737, DOI 10.1101/gad.829100; YUN B, 1994, GENE DEV, V8, P1160, DOI 10.1101/gad.8.10.1160; Znaidi S, 2004, J BIOL CHEM, V279, P9462, DOI 10.1074/jbc.M312787200	62	20	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13797	13806		10.1074/jbc.M110.113555	http://dx.doi.org/10.1074/jbc.M110.113555			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20200159	Green Published, hybrid			2022-12-25	WOS:000276987700055
J	Gold, DA; Dunphy, WG				Gold, Daniel A.; Dunphy, William G.			Drf1-dependent Kinase Interacts with Claspin through a Conserved Protein Motif	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							XENOPUS EGG EXTRACTS; DNA-REPLICATION CHECKPOINT; REPEATED PHOSPHOPEPTIDE MOTIFS; S-PHASE CHECKPOINT; CDC7 KINASE; REGULATED PROTEIN; DAMAGE CHECKPOINT; MAMMALIAN-CELLS; CHK1; PHOSPHORYLATION	The Dbf4/Drf1-dependent kinase (DDK) is required for the initiation of DNA replication in eukaryotes. Another protein, Claspin, mediates the activation of a cellular checkpoint response to stalled replication forks and is also a regulator of replication. In this study, we found that DDK phosphorylates Claspin in vitro and forms a nuclear complex containing Cdc7, Drf1, and Claspin in Xenopus egg extracts. In addition, purified Claspin and DDK are capable of a direct in vitro interaction. We identified a conserved binding site on Claspin required for its interaction with DDK. This site corresponds to the first of two sequence repeats in the Chk1-binding domain of Claspin. Furthermore, we have established that two amino acids in this motif, Asp861 and Gln866, are essential for the interaction between Claspin and DDK. We found that mutant forms of Claspin incapable of interacting with DDK are still able to associate with and activate Chk1 in response to DNA replication blockages. However, Claspin-depleted egg extracts that have been reconstituted with these mutants of Claspin undergo DNA replication more slowly. These findings suggest that the interaction of DDK with Claspin mediates a checkpoint-independent function of Claspin related to DNA replication.	[Gold, Daniel A.; Dunphy, William G.] CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Dunphy, WG (corresponding author), CALTECH, Div Biol 147 75, Pasadena, CA 91125 USA.	dunphy@caltech.edu			National Institutes of Health [GM043974, GM070891]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043974, R01GM070891, R37GM043974] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM043974 and GM070891 (to W.G.D.).	Aparicio T, 2009, NUCLEIC ACIDS RES, V37, P2087, DOI 10.1093/nar/gkp065; Arias EE, 2007, GENE DEV, V21, P497, DOI 10.1101/gad.1508907; Chini CCS, 2006, J BIOL CHEM, V281, P33276, DOI 10.1074/jbc.M604373200; Christiano C, 2003, J BIOL CHEM, V278, P30057, DOI 10.1074/jbc.M301136200; Clarke CAL, 2005, BIOCHEM J, V388, P705, DOI 10.1042/BJ20041966; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Hodgson B, 2007, MOL BIOL CELL, V18, P3894, DOI 10.1091/mbc.E07-05-0500; Jeong SY, 2003, J BIOL CHEM, V278, P46782, DOI 10.1074/jbc.M304551200; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Katou Y, 2003, NATURE, V424, P1078, DOI 10.1038/nature01900; Kim JM, 2008, ONCOGENE, V27, P3475, DOI 10.1038/sj.onc.1210994; Kumagai A, 2000, MOL CELL, V6, P839, DOI 10.1016/S1097-2765(00)00082-4; Kumagai A, 2003, NAT CELL BIOL, V5, P161, DOI 10.1038/ncb921; Kumagai A, 2004, J BIOL CHEM, V279, P49599, DOI 10.1074/jbc.M408353200; Kumagai A, 1998, J CELL BIOL, V142, P1559, DOI 10.1083/jcb.142.6.1559; Kumagai A, 1996, SCIENCE, V273, P1377, DOI 10.1126/science.273.5280.1377; Kumagai H, 1999, MOL CELL BIOL, V19, P5083; Lee J, 2005, MOL BIOL CELL, V16, P5269, DOI 10.1091/mbc.E05-07-0671; Lee J, 2003, MOL CELL, V11, P329, DOI 10.1016/S1097-2765(03)00045-5; Lin SY, 2004, P NATL ACAD SCI USA, V101, P6484, DOI 10.1073/pnas.0401847101; Lou HQ, 2008, MOL CELL, V32, P106, DOI 10.1016/j.molcel.2008.08.020; Masai H, 2002, J CELL PHYSIOL, V190, P287, DOI 10.1002/jcp.10070; Masai H, 2006, J BIOL CHEM, V281, P39249, DOI 10.1074/jbc.M608935200; Melo J, 2002, CURR OPIN CELL BIOL, V14, P237, DOI 10.1016/S0955-0674(02)00312-5; Montagnoli A, 2002, EMBO J, V21, P3171, DOI 10.1093/emboj/cdf290; Moyer SE, 2006, P NATL ACAD SCI USA, V103, P10236, DOI 10.1073/pnas.0602400103; Osborn AJ, 2003, GENE DEV, V17, P1755, DOI 10.1101/gad.1098303; Pacek M, 2006, MOL CELL, V21, P581, DOI 10.1016/j.molcel.2006.01.030; Petermann E, 2008, MOL BIOL CELL, V19, P2373, DOI 10.1091/mbc.E07-10-1035; Roberts BT, 1999, P NATL ACAD SCI USA, V96, P2800, DOI 10.1073/pnas.96.6.2800; Sar F, 2004, J BIOL CHEM, V279, P39289, DOI 10.1074/jbc.M405793200; Sheu YJ, 2006, MOL CELL, V24, P101, DOI 10.1016/j.molcel.2006.07.033; Silva T, 2006, J BIOL CHEM, V281, P11569, DOI 10.1074/jbc.M510278200; Strom L, 2007, SCIENCE, V317, P242, DOI 10.1126/science.1140649; Szyjka SJ, 2005, MOL CELL, V19, P691, DOI 10.1016/j.molcel.2005.06.037; Takahashi TS, 2008, GENE DEV, V22, P1894, DOI 10.1101/gad.1683308; Takahashi TS, 2005, GENE DEV, V19, P2295, DOI 10.1101/gad.1339805; Takeda DY, 2005, ONCOGENE, V24, P2827, DOI 10.1038/sj.onc.1208616; Tenca P, 2007, J BIOL CHEM, V282, P208, DOI 10.1074/jbc.M604457200; Tourriere H, 2005, MOL CELL, V19, P699, DOI 10.1016/j.molcel.2005.07.028; Tsuji T, 2008, MOL CELL, V32, P862, DOI 10.1016/j.molcel.2008.12.005; Tsuji T, 2006, MOL BIOL CELL, V17, P4459, DOI 10.1091/mbc.E06-03-0241; Walter JC, 2000, J BIOL CHEM, V275, P39773, DOI 10.1074/jbc.M008107200; Yanow SK, 2003, J BIOL CHEM, V278, P41083, DOI 10.1074/jbc.M307144200; Yoo HY, 2006, GENE DEV, V20, P772, DOI 10.1101/gad.1398806; Zou L, 2000, MOL CELL BIOL, V20, P3086, DOI 10.1128/MCB.20.9.3086-3096.2000	46	5	5	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12638	12646		10.1074/jbc.M109.077370	http://dx.doi.org/10.1074/jbc.M109.077370			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20190277	hybrid, Green Published, Green Accepted			2022-12-25	WOS:000276787800022
J	Sarafian, TA; Montes, C; Imura, T; Qi, JW; Coppola, G; Geschwind, DH; Sofroniew, MV				Sarafian, Theodore A.; Montes, Cindy; Imura, Tetsuya; Qi, Jingwei; Coppola, Giovanni; Geschwind, Daniel H.; Sofroniew, Michael V.			Disruption of Astrocyte STAT3 Signaling Decreases Mitochondrial Function and Increases Oxidative Stress In Vitro	PLOS ONE			English	Article							UP-REGULATION; GLUTATHIONE BIOSYNTHESIS; SUPEROXIDE; GLIA; ASTROGLIOSIS; ACTIVATION; EXPRESSION; PROTECTION; NEURONS; TRANSCRIPTION-3	Background: Astrocytes exert a wide variety of functions in health and disease and respond to a wide range of signaling pathways, including members of the Janus-kinase signal transducers and activators of transcription (Jak-STAT) family. We have recently shown that STAT3 is an important regulator of astrocyte reactivity after spinal cord injury in vivo [1]. Methodology/Principal Findings: Here, we used both a conditional gene deletion strategy that targets the deletion of STAT3 selectively to astrocytes (STAT3-CKO), and a pharmacological inhibitor of JAK-2, AG490, in cultured astrocytes in vitro, to investigate potential functions and molecules influenced by STAT3 signaling in relation to mitochondrial function and oxidative stress. Our findings show that the absence of STAT3 signaling in astrocytes leads to (i) increased production of superoxide anion and other reactive oxygen species and decreased level of glutathione, (ii) decreased mitochondrial membrane potential and decreased ATP production, and (iii) decreased rate of cell proliferation. Many of the differences observed in STAT3-CKO astrocytes were distinctly altered by exposure to rotenone, suggesting a role for complex I of the mitochondrial electron transport chain. Gene expression microarray studies identified numerous changes in STAT3-CKO cells that may have contributed to the identified deficits in cell function. Conclusions/Significance: Taken together, these STAT3-dependent alterations in cell function and gene expression have relevance to both reactive gliosis and to the support and protection of surrounding cells in neural tissue.	[Sarafian, Theodore A.; Montes, Cindy; Imura, Tetsuya; Qi, Jingwei; Sofroniew, Michael V.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA; [Coppola, Giovanni; Geschwind, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Sarafian, TA (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA.	tsarafian@mednet.ucla.edu	Sofroniew, Michael/ABE-8857-2020		National Institutes of Health [5R01NS057624, DA021580]; Adelson Medical Research Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057624] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA021580] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Adelson Medical Research Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health grants 5R01NS057624 (MVS) and DA021580 (TS) and by the Adelson Medical Research Foundation (www.adelsonfoundation.org) (Adelson Program in Neural Rehabilitation and Repair). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 1996, JPN J PHARMACOL, V72, P299, DOI 10.1254/jjp.72.299; Adam-Vizi V, 2005, ANTIOXID REDOX SIGN, V7, P1140, DOI 10.1089/ars.2005.7.1140; Aschner M, 1997, ANN NY ACAD SCI, V825, P334, DOI 10.1111/j.1749-6632.1997.tb48445.x; BASS DA, 1983, J IMMUNOL, V130, P1910; Benov L, 1998, FREE RADICAL BIO MED, V25, P826, DOI 10.1016/S0891-5849(98)00163-4; Brantley EC, 2008, MOL CANCER RES, V6, P675, DOI 10.1158/1541-7786.MCR-07-2180; Brown DR, 2000, MOL CELL NEUROSCI, V15, P465, DOI 10.1006/mcne.2000.0840; Carpentier PA, 2008, VIROLOGY, V375, P24, DOI 10.1016/j.virol.2008.01.024; Chauhan VS, 2009, GLIA, V57, P414, DOI 10.1002/glia.20770; Corley SM, 2001, GLIA, V36, P281, DOI 10.1002/glia.1116; Damiani CL, 2007, J NEUROCHEM, V100, P720, DOI 10.1111/j.1471-4159.2006.04321.x; Dlaskova A, 2008, INT J BIOCHEM CELL B, V40, P1792, DOI 10.1016/j.biocel.2008.01.012; GENTLEMAN R, BIOINFORMATICS COMPU; Gough DJ, 2009, SCIENCE, V324, P1713, DOI 10.1126/science.1171721; Grivennikova VG, 2006, BBA-BIOENERGETICS, V1757, P553, DOI 10.1016/j.bbabio.2006.03.013; Guo ZH, 2008, J BIOL CHEM, V283, P1754, DOI 10.1074/jbc.M703753200; Han YH, 2009, LUNG CANCER, V63, P201, DOI 10.1016/j.lungcan.2008.05.005; He F, 2005, NAT NEUROSCI, V8, P616, DOI 10.1038/nn1440; Herrmann JE, 2008, J NEUROSCI, V28, P7231, DOI 10.1523/JNEUROSCI.1709-08.2008; Hodge DR, 2005, EUR J CANCER, V41, P2502, DOI 10.1016/j.ejca.2005.08.016; Hollensworth SB, 2000, FREE RADICAL BIO MED, V28, P1161, DOI 10.1016/S0891-5849(00)00214-8; Imura T, 2006, GLIA, V53, P277, DOI 10.1002/glia.20281; Imura T, 2003, J NEUROSCI, V23, P2824; Lamarche F, 2004, ALCOHOL, V33, P127, DOI 10.1016/S0741-8329(04)00100-4; Lamigeon C, 2001, J NEUROCHEM, V77, P598, DOI 10.1046/j.1471-4159.2001.00278.x; Levison SW, 2000, GLIA, V32, P328, DOI 10.1002/1098-1136(200012)32:3<328::AID-GLIA110>3.0.CO;2-7; Li JX, 2008, J BIOL CHEM, V283, P34260, DOI 10.1074/jbc.M806087200; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; Milner PI, 2007, OSTEOARTHR CARTILAGE, V15, P735, DOI 10.1016/j.joca.2007.01.008; Myhre O, 2003, BIOCHEM PHARMACOL, V65, P1575, DOI 10.1016/S0006-2952(03)00083-2; Negoro S, 2001, CIRCULATION, V104, P979, DOI 10.1161/hc3401.095947; Presley AD, 2003, J CHROMATOGR B, V793, P141, DOI 10.1016/S1570-0232(03)00371-4; Robinson KM, 2006, P NATL ACAD SCI USA, V103, P15038, DOI 10.1073/pnas.0601945103; Sarafian TA, 2003, AM J PHYSIOL-LUNG C, V284, pL298, DOI 10.1152/ajplung.00157.2002; SARAFIAN TA, 1994, TOXICOL LETT, V74, P149, DOI 10.1016/0378-4274(94)90093-0; Scacco Salvatore, 2006, Ital J Biochem, V55, P254; Sengupta A, 2007, NEUROTOXICOLOGY, V28, P478, DOI 10.1016/j.neuro.2006.10.005; Seth P, 2008, J BIOSCIENCES, V33, P405, DOI 10.1007/s12038-008-0060-5; Shih AY, 2003, J NEUROSCI, V23, P3394, DOI 10.1523/jneurosci.23-08-03394.2003; Smyth GK, BIOINFORMATICS COMPU; Sofroniew MV, 2005, NEUROSCIENTIST, V11, P400, DOI 10.1177/1073858405278321; Sortino MA, 2004, ENDOCRINOLOGY, V145, P5080, DOI 10.1210/en.2004-0973; Sriram K, 2004, J BIOL CHEM, V279, P19936, DOI 10.1074/jbc.M309304200; Sugimoto K, 2008, WORLD J GASTROENTERO, V14, P5110, DOI 10.3748/wjg.14.5110; Terui K, 2004, J HEPATOL, V41, P957, DOI 10.1016/j.jhep.2004.08.019; TRAVIS J, 1994, SCIENCE, V266, P970, DOI 10.1126/science.7973679; Tretter L, 2007, NEUROCHEM INT, V50, P139, DOI 10.1016/j.neuint.2006.07.010; Vargas MR, 2006, J NEUROCHEM, V97, P687, DOI 10.1111/j.1471-4159.2006.03742.x; Vila M, 2001, CURR OPIN NEUROL, V14, P483, DOI 10.1097/00019052-200108000-00009; Wegrzyn J, 2009, SCIENCE, V323, P793, DOI 10.1126/science.1164551; White LD, 2007, TOXICOL APPL PHARM, V225, P1, DOI 10.1016/j.taap.2007.08.001; Willis CL, 2008, CURR PHARM DESIGN, V14, P1625, DOI 10.2174/138161208784705414; Yajima D, 2009, CELL BIOCHEM FUNCT, V27, P338, DOI 10.1002/cbf.1578	53	129	133	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2010	5	3							e9532	10.1371/journal.pone.0009532	http://dx.doi.org/10.1371/journal.pone.0009532			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565XE	20224768	Green Published, Green Submitted, gold			2022-12-25	WOS:000275328800005
J	Meir, O; Dvash, E; Werman, A; Rubinstein, M				Meir, Ofir; Dvash, Efrat; Werman, Ariel; Rubinstein, Menachem			C/EBP-beta Regulates Endoplasmic Reticulum Stress-Triggered Cell Death in Mouse and Human Models	PLOS ONE			English	Article							BINDING-PROTEIN-BETA; TRANSCRIPTIONAL INHIBITORY PROTEIN; GENE-EXPRESSION; ER STRESS; TUMOR-CELLS; SKIN TUMORIGENESIS; SURVIVAL; CANCER; APOPTOSIS; PROMOTES	Endoplasmic reticulum (ER) stress elicits the unfolded protein response (UPR), initially aimed at coping with the stress, but triggering cell death upon further stress. ER stress induces the C/EBP-H variant Liver-enriched Activating Protein (LAP), followed by the dominant-negative variant, Liver Inhibitory Protein (LIP). However, the distinct role of LAP and LIP in ER stress is unknown. We found that the kinetics of the ER stress-induced expression of LIP overlapped with that of the cell death in mouse B16 melanoma cells. Furthermore, inducible over-expression of LIP augmented ER stress-triggered cell death whereas over-expression of LAP attenuated cell death. Similar results were obtained in human 293T cells. Limited vasculature in tumors triggers hypoxia, nutrient shortage and accumulation of toxic metabolites, all of which eliciting continuous ER stress. We found that LAP promoted and LIP inhibited B16 melanoma tumor progression without affecting angiogenesis or accelerating the cell cycle. Rather, LAP attenuated, whereas LIP augmented tumor ER stress. We therefore suggest that C/EBP-H regulates the transition from the protective to the death-promoting phase of the UPR. We further suggest that the over-expression of LAP observed in many solid tumors promotes tumor progression by attenuating ER stress-triggered tumor cell death.	[Meir, Ofir; Dvash, Efrat; Werman, Ariel; Rubinstein, Menachem] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Meir, O (corresponding author), Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel.	Menachem.rubinstein@weizmann.ac.il	Dvash, Efrat/P-5205-2015; Riesenfeld, Efrat Dvash/AAB-3343-2020	Dvash, Efrat/0000-0002-9503-2229; Riesenfeld, Efrat Dvash/0000-0002-9503-2229; Rubinstein, Menachem/0000-0002-3472-6614	Merck-Serono International SA; M. D. Moross Institute for Cancer Research	Merck-Serono International SA; M. D. Moross Institute for Cancer Research	This study was supported in part by Merck-Serono International SA and by the M. D. Moross Institute for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagi T, 2008, BLOOD, V111, P2999, DOI 10.1182/blood-2007-04-087213; Arnett Brenda, 2003, Mol Cancer, V2, P21, DOI 10.1186/1476-4598-2-21; Brewer JW, 1999, P NATL ACAD SCI USA, V96, P8505, DOI 10.1073/pnas.96.15.8505; BUCK M, 1994, EMBO J, V13, P851, DOI 10.1002/j.1460-2075.1994.tb06328.x; Buck M, 2001, MOL CELL, V8, P807, DOI 10.1016/S1097-2765(01)00374-4; Bundy LM, 2003, ONCOGENE, V22, P869, DOI 10.1038/sj.onc.1206216; BUSTIN M, 2002, SCI STKE, pPE39; Chen C, 2004, J BIOL CHEM, V279, P27948, DOI 10.1074/jbc.M313920200; Chen H, 2004, J BIOL CHEM, V279, P50829, DOI 10.1074/jbc.M409173200; Cortes-Canteli M, 2002, J BIOL CHEM, V277, P5460, DOI 10.1074/jbc.M108761200; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; Eaton EM, 2001, J CELL PHYSIOL, V189, P91, DOI 10.1002/jcp.1139; Endl E, 2000, EXP CELL RES, V257, P231, DOI 10.1006/excr.2000.4888; Fels DR, 2008, CANCER RES, V68, P9323, DOI 10.1158/0008-5472.CAN-08-2873; Gade P, 2008, MOL CELL BIOL, V28, P2528, DOI 10.1128/MCB.00784-07; Guerzoni C, 2006, BLOOD, V107, P4080, DOI 10.1182/blood-2005-08-3181; Halterman MW, 2008, MOL CELL NEUROSCI, V38, P125, DOI 10.1016/j.mcn.2008.01.014; Hersey P, 2008, PIGM CELL MELANOMA R, V21, P358, DOI 10.1111/j.1755-148X.2008.00467.x; Homma J, 2006, ONCOL REP, V15, P595; Kamaraju AK, 2004, J BIOL CHEM, V279, P3852, DOI 10.1074/jbc.M310443200; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Kokame K, 2000, J BIOL CHEM, V275, P32846, DOI 10.1074/jbc.M002063200; Lamb J, 2003, CELL, V114, P323, DOI 10.1016/S0092-8674(03)00570-1; Lee AS, 2006, CANCER BIOL THER, V5, P721, DOI 10.4161/cbt.5.7.3120; Li WL, 2005, CANCER RES, V65, P2592, DOI 10.1158/0008-5472.CAN-04-1532; Li Y, 2008, J BIOL CHEM, V283, P22443, DOI 10.1074/jbc.M801046200; Lin JH, 2008, ANNU REV PATHOL-MECH, V3, P399, DOI 10.1146/annurev.pathmechdis.3.121806.151434; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; Marshall J, 2003, NEURON, V39, P625, DOI 10.1016/S0896-6273(03)00496-3; Moenner M, 2007, CANCER RES, V67, P10631, DOI 10.1158/0008-5472.CAN-07-1705; Mukherjee D, 2001, HEPATOLOGY, V33, P1166, DOI 10.1053/jhep.2001.24032; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; Pirot P, 2007, DIABETES, V56, P1069, DOI 10.2337/db06-1253; Piva R, 2006, J CLIN INVEST, V116, P3171, DOI 10.1172/JCI29401; Rahman SM, 2007, HEPATOLOGY, V45, P1108, DOI 10.1002/hep.21614; Regalo G, 2006, J PATHOL, V210, P398, DOI 10.1002/path.2063; Rutkowski DT, 2007, TRENDS BIOCHEM SCI, V32, P469, DOI 10.1016/j.tibs.2007.09.003; Sebastian T, 2006, CELL CYCLE, V5, P953, DOI 10.4161/cc.5.9.2733; Shimizu Y, 2007, CANCER SCI, V98, P1706, DOI 10.1111/j.1349-7006.2007.00596.x; Sterneck E, 2006, ONCOGENE, V25, P1272, DOI 10.1038/sj.onc.1209144; Sun L, 2005, CELL RES, V15, P770, DOI 10.1038/sj.cr.7290346; Wessells J, 2004, MOL CELL BIOL, V24, P3238, DOI 10.1128/MCB.24.8.3238-3250.2004; Yoon K, 2007, ONCOGENE, V26, P360, DOI 10.1038/sj.onc.1209797; Zhu SY, 2002, P NATL ACAD SCI USA, V99, P207, DOI 10.1073/pnas.012437299; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	45	43	51	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2010	5	3							e9516	10.1371/journal.pone.0009516	http://dx.doi.org/10.1371/journal.pone.0009516			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	562OZ	20209087	Green Published, Green Submitted, gold			2022-12-25	WOS:000275063400021
J	Chen, CS; Bellier, A; Kao, CY; Yang, YL; Chen, HD; Los, FCO; Aroian, RV				Chen, Chang-Shi; Bellier, Audrey; Kao, Cheng-Yuan; Yang, Ya-Luen; Chen, Huan-Da; Los, Ferdinand C. O.; Aroian, Raffi V.			WWP-1 Is a Novel Modulator of the DAF-2 Insulin-Like Signaling Network Involved in Pore-Forming Toxin Cellular Defenses in Caenorhabditis elegans	PLOS ONE			English	Article							C-ELEGANS; LIFE-SPAN; PROTEIN TOXINS; CRYSTAL PROTEINS; STRESS-RESPONSE; BACTERIAL; LONGEVITY; IMMUNITY; MUTANTS; LONG	Pore-forming toxins (PFTs) are the single largest class of bacterial virulence factors. The DAF-2 insulin/insulin-like growth factor-1 signaling pathway, which regulates lifespan and stress resistance in Caenorhabditis elegans, is known to mutate to resistance to pathogenic bacteria. However, its role in responses against bacterial toxins and PFTs is as yet unexplored. Here we reveal that reduction of the DAF-2 insulin-like pathway confers the resistance of Caenorhabditis elegans to cytolitic crystal (Cry) PFTs produced by Bacillus thuringiensis. In contrast to the canonical DAF-2 insulin-like signaling pathway previously defined for aging and pathogenesis, the PFT response pathway diverges at 3-phosphoinositide-dependent kinase 1 (PDK-1) and appears to feed into a novel insulin-like pathway signal arm defined by the WW domain Protein 1 (WWP-1). In addition, we also find that WWP-1 not only plays an important role in the intrinsic cellular defense (INCED) against PFTs but also is involved in innate immunity against pathogenic bacteria Pseudomonas aeruginosa and in lifespan regulation. Taken together, our data suggest that WWP-1 and DAF-16 function in parallel within the fundamental DAF-2 insulin/IGF-1 signaling network to regulate fundamental cellular responses in C. elegans.	[Chen, Chang-Shi; Chen, Huan-Da] Natl Cheng Kung Univ, Dept Biochem & Mol Biol, Tainan 70101, Taiwan; [Chen, Chang-Shi; Yang, Ya-Luen] Natl Cheng Kung Univ, Inst Basic Med Sci, Tainan 70101, Taiwan; [Bellier, Audrey; Kao, Cheng-Yuan; Los, Ferdinand C. O.; Aroian, Raffi V.] Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92093 USA	National Cheng Kung University; National Cheng Kung University; University of California System; University of California San Diego	Chen, CS (corresponding author), Natl Cheng Kung Univ, Dept Biochem & Mol Biol, Tainan 70101, Taiwan.	raroian@ucsd.edu	KAO, CHENG-YUAN/A-7531-2010; bellier, audrey/D-7649-2015; Chen, Chang-Shi/B-9251-2009	KAO, CHENG-YUAN/0000-0003-0946-9270; bellier, audrey/0000-0002-3106-4547; Chen, Chang-Shi/0000-0002-8201-3635	NIH [AI056189, GM071603]; NSF [MCB0517718]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056189] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071603] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by NIH grant AI056189 (CSC, AB), NSF grant MCB0517718 (CSC), and NIH grant GM071603 (CYK, FCOL) to RVA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alouf JE, 2003, FOLIA MICROBIOL, V48, P5, DOI 10.1007/BF02931271; Banfield KL, 2008, J GERONTOL A-BIOL, V63, P798, DOI 10.1093/gerona/63.8.798; Baumeister R, 2006, J ENDOCRINOL, V190, P191, DOI 10.1677/joe.1.06856; BELLIER A, 2009, PLOS PATHOG IN PRESS; Bellier A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000689; Bischof Larry J., 2006, V351, P139; Bischof LJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000176; Bravo A, 2007, TOXICON, V49, P423, DOI 10.1016/j.toxicon.2006.11.022; BRENNER S, 1974, GENETICS, V77, P71; Cappello M, 2006, P NATL ACAD SCI USA, V103, P15154, DOI 10.1073/pnas.0607002103; Carrano AC, 2009, NATURE, V460, P396, DOI 10.1038/nature08130; de Maagd RA, 2003, ANNU REV GENET, V37, P409, DOI 10.1146/annurev.genet.37.110801.143042; Dillin A, 2002, SCIENCE, V298, P830, DOI 10.1126/science.1074240; Evans EA, 2008, AGING CELL, V7, P879, DOI 10.1111/j.1474-9726.2008.00435.x; Finch CE, 2001, ANNU REV GENOM HUM G, V2, P435, DOI 10.1146/annurev.genom.2.1.435; Finney D.J., 1980, PROBIT ANAL, V3rd; Gami MS, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-45; Garsin DA, 2003, SCIENCE, V300, P1921, DOI 10.1126/science.1080147; Gomez TA, 2007, DEV BIOL, V303, P493, DOI 10.1016/j.ydbio.2006.11.023; Gonzalez MR, 2008, CELL MOL LIFE SCI, V65, P493, DOI 10.1007/s00018-007-7434-y; Hertweck M, 2004, DEV CELL, V6, P577, DOI 10.1016/S1534-5807(04)00095-4; Hu PJ, 2006, PLOS GENET, V2, P930, DOI 10.1371/journal.pgen.0020099; Huang K, 2000, GENE, V252, P137, DOI 10.1016/S0378-1119(00)00216-X; Huffman DL, 2004, INT J MED MICROBIOL, V293, P599, DOI 10.1078/1438-4221-00303; Huffman DL, 2004, P NATL ACAD SCI USA, V101, P10995, DOI 10.1073/pnas.0404073101; Iacovache I, 2008, BBA-BIOMEMBRANES, V1778, P1611, DOI 10.1016/j.bbamem.2008.01.026; KAGAN RM, 1995, BIOCHEMISTRY-US, V34, P10794, DOI 10.1021/bi00034a012; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kerry S, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000077; Kurz CL, 2004, AGING CELL, V3, P185, DOI 10.1111/j.1474-9728.2004.00108.x; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Marroquin LD, 2000, GENETICS, V155, P1693; Mukhopadhyay A, 2007, TRENDS CELL BIOL, V17, P65, DOI 10.1016/j.tcb.2006.12.004; Mukhopadhyay A, 2006, EXP GERONTOL, V41, P928, DOI 10.1016/j.exger.2006.05.020; Parker MW, 2005, PROG BIOPHYS MOL BIO, V88, P91, DOI 10.1016/j.pbiomolbio.2004.01.009; Samuelson AV, 2007, GENE DEV, V21, P2976, DOI 10.1101/gad.1588907; Singh V, 2006, P NATL ACAD SCI USA, V103, P13092, DOI 10.1073/pnas.0604050103; Singh V, 2009, J BIOL CHEM, V284, P35580, DOI 10.1074/jbc.M109.060905; Tan MW, 1999, P NATL ACAD SCI USA, V96, P2408, DOI 10.1073/pnas.96.5.2408; Wei JZ, 2003, P NATL ACAD SCI USA, V100, P2760, DOI 10.1073/pnas.0538072100; Wiles TJ, 2008, MOL BIOL CELL, V19, P1427, DOI 10.1091/mbc.E07-07-0638; Zarse K, 2007, FASEB J, V21, P1271, DOI 10.1096/fj.06-6994com; Zhang YM, 2008, DEV BIOL, V315, P290, DOI 10.1016/j.ydbio.2007.12.032	47	35	43	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2010	5	3							e9494	10.1371/journal.pone.0009494	http://dx.doi.org/10.1371/journal.pone.0009494			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	562OY	20209166	Green Published, gold, Green Submitted			2022-12-25	WOS:000275063300010
J	Hsu, YH; Traugh, JA				Hsu, Yuan-Hao; Traugh, Jolinda A.			Reciprocally Coupled Residues Crucial for Protein Kinase Pak2 Activity Calculated by Statistical Coupling Analysis	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; GAMMA-PAK; CATALYTIC SUBUNIT; PEPTIDE INHIBITOR; C-SRC; ACTIVATION; AUTOPHOSPHORYLATION; CONFORMATION; CDC42; DOMAIN	Regulation of Pak2 activity involves at least two mechanisms: (i) phosphorylation of the conserved Thr(402) in the activation loop and (ii) interaction of the autoinhibitory domain (AID) with the catalytic domain. We collected 482 human protein kinase sequences from the kinome database and globally mapped the evolutionary interactions of the residues in the catalytic domain with Thr(402) by sequence-based statistical coupling analysis (SCA). Perturbation of Thr(402) (34.6%) suggests a communication pathway between Thr(402) in the activation loop, and Phe(387) (Delta Delta E(387F,402T) = 2.80) in the magnesium positioning loop, Trp(427) (Delta Delta E(427W),(402T) = 3.12) in the F-helix, and Val(404) (Delta Delta E(404V,402T) = 4.43) and Gly(405) (Delta Delta E(405G,402T) = 2.95) in the peptide positioning loop. When compared to the cAMP-dependent protein kinase (PKA) and Src, the perturbation pattern of threonine phosphorylation in the activation loop of Pak2 is similar to that of PKA, and different from the tyrosine phosphorylation pattern of Src. Reciprocal coupling analysis by SCA showed the residues perturbed by Thr(402) and the reciprocal coupling pairs formed a network centered at Trp(427) in the F-helix. Nine pairs of reciprocal coupling residues crucial for enzymatic activity and structural stabilization were identified. Pak2, PKA and Src share four pairs. Reciprocal coupling residues exposed to the solvent line up as an activation groove. This is the inhibitor (PKI) binding region in PKA and the activation groove for Pak2. This indicates these evolutionary conserved residues are crucial for the catalytic activity of PKA and Pak2.	[Hsu, Yuan-Hao; Traugh, Jolinda A.] Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA	University of California System; University of California Riverside	Hsu, YH (corresponding author), Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA.	y2hsu@ucsd.edu	hsu, yuan-hao/B-5744-2009		National Institutes of Health (NIH) [GM26738]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026738] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported by National Institutes of Health (NIH) grant GM26738 to Jolinda A. Traugh. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akamine P, 2003, J MOL BIOL, V327, P159, DOI 10.1016/S0022-2836(02)01446-8; Deminoff SJ, 2006, GENETICS, V173, P1909, DOI 10.1534/genetics.106.059238; Deminoff SJ, 2009, GENETICS, V182, P529, DOI 10.1534/genetics.109.102178; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Estabrook RA, 2005, P NATL ACAD SCI USA, V102, P994, DOI 10.1073/pnas.0409128102; Frost JA, 1998, J BIOL CHEM, V273, P28191, DOI 10.1074/jbc.273.43.28191; Gatti A, 1999, J BIOL CHEM, V274, P8022, DOI 10.1074/jbc.274.12.8022; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hatley ME, 2003, P NATL ACAD SCI USA, V100, P14445, DOI 10.1073/pnas.1835919100; Hsu YH, 2008, J BIOL CHEM, V283, P36397, DOI 10.1074/jbc.M805581200; HUBBARD SR, 1994, NATURE, V372, P746, DOI 10.1038/372746a0; Jaffer ZM, 2002, INT J BIOCHEM CELL B, V34, P713, DOI 10.1016/S1357-2725(01)00158-3; Jakobi R, 2000, EUR J BIOCHEM, V267, P4414, DOI 10.1046/j.1432-1327.2000.01488.x; Johnson DA, 2001, CHEM REV, V101, P2243, DOI 10.1021/cr000226k; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; Jung JH, 2005, J BIOL CHEM, V280, P40025, DOI 10.1074/jbc.M509075200; Kannan N, 2005, J MOL BIOL, V351, P956, DOI 10.1016/j.jmb.2005.06.057; Kannan N, 2007, PLOS BIOL, V5, P467, DOI 10.1371/journal.pbio.0050017; KARLSSON R, 1993, ACTA CRYSTALLOGR D, V49, P381, DOI 10.1107/S0907444993002306; Kim C, 2005, SCIENCE, V307, P690, DOI 10.1126/science.1104607; Kornev AP, 2008, P NATL ACAD SCI USA, V105, P14377, DOI 10.1073/pnas.0807988105; Lei M, 2000, CELL, V102, P387, DOI 10.1016/S0092-8674(00)00043-X; Lei M, 2005, STRUCTURE, V13, P769, DOI 10.1016/j.str.2005.03.007; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Parrini MC, 2002, MOL CELL, V9, P73, DOI 10.1016/S1097-2765(01)00428-2; Roig J, 2001, VITAM HORM, V62, P167, DOI 10.1016/S0083-6729(01)62004-1; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Shulman AI, 2004, CELL, V116, P417, DOI 10.1016/S0092-8674(04)00119-9; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; Suel GM, 2003, NAT STRUCT BIOL, V10, P59, DOI 10.1038/nsb881; Torkamani A, 2008, P NATL ACAD SCI USA, V105, P9011, DOI 10.1073/pnas.0802403105; Tu H, 1999, MOL CELL BIOL, V19, P602; Tuazon PT, 1998, BIOCHEMISTRY-US, V37, P17024, DOI 10.1021/bi982103o; Walter BN, 1998, J BIOL CHEM, V273, P28733, DOI 10.1074/jbc.273.44.28733; Williams JC, 1997, J MOL BIOL, V274, P757, DOI 10.1006/jmbi.1997.1426; Wu H, 2003, BIOCHEMISTRY-US, V42, P1129, DOI 10.1021/bi026857l; Xu F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005913; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Xu WQ, 1999, MOL CELL, V3, P629, DOI 10.1016/S1097-2765(00)80356-1; Zhao ZS, 1998, MOL CELL BIOL, V18, P2153, DOI 10.1128/MCB.18.4.2153; ZHENG JH, 1993, ACTA CRYSTALLOGR D, V49, P362, DOI 10.1107/S0907444993000423; ZHENG JH, 1993, BIOCHEMISTRY-US, V32, P2154, DOI 10.1021/bi00060a005	44	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2010	5	3							e9455	10.1371/journal.pone.0009455	http://dx.doi.org/10.1371/journal.pone.0009455			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	561RT	20209159	Green Published, Green Submitted, gold			2022-12-25	WOS:000274997100005
J	Wiens, CJ; Tong, YF; Esmail, MA; Oh, E; Gerdes, JM; Wang, JH; Tempel, W; Rattner, JB; Katsanis, N; Park, HW; Leroux, MR				Wiens, Cheryl J.; Tong, Yufeng; Esmail, Muneer A.; Oh, Edwin; Gerdes, Jantje M.; Wang, Jihong; Tempel, Wolfram; Rattner, Jerome B.; Katsanis, Nicholas; Park, Hee-Won; Leroux, Michel R.			Bardet-Biedl Syndrome-associated Small GTPase ARL6 (BBS3) Functions at or near the Ciliary Gate and Modulates Wnt Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBOSYLATION FACTOR 6; INTRAFLAGELLAR TRANSPORT; PRIMARY CILIUM; CHLAMYDOMONAS-REINHARDTII; ACTIVATING PROTEIN; FLAGELLA MUTANTS; BINDING PROTEINS; GENETIC-ANALYSIS; ARF FAMILY; CILIOGENESIS	The expansive family of metazoan ADP-ribosylation factor and ADP-ribosylation factor-like small GTPases is known to play essential roles in modulating membrane trafficking and cytoskeletal functions. Here, we present the crystal structure of ARL6, mutations in which cause Bardet-Biedl syndrome (BBS3), and reveal its unique ring-like localization at the distal end of basal bodies, in proximity to the so-called ciliary gate where vesicles carrying ciliary cargo fuse with the membrane. Overproduction of GDP- or GTP-locked variants of ARL6/BBS3 in vivo influences primary cilium length and abundance. ARL6/BBS3 also modulates Wnt signaling, a signal transduction pathway whose association with cilia in vertebrates is just emerging. Importantly, this signaling function is lost in ARL6 variants containing BBS-associated point mutations. By determining the structure of GTP-bound ARL6/BBS3, coupled with functional assays, we provide a mechanistic explanation for such pathogenic alterations, namely altered nucleotide binding. Our findings therefore establish a previously unknown role for ARL6/BBS3 in mammalian ciliary (dis)assembly and Wnt signaling and provide the first structural information for a BBS protein.	[Wiens, Cheryl J.; Esmail, Muneer A.; Leroux, Michel R.] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada; [Tong, Yufeng; Wang, Jihong; Tempel, Wolfram; Park, Hee-Won] Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L5, Canada; [Park, Hee-Won] Univ Toronto, Dept Pharmacol, Toronto, ON M5G 1L5, Canada; [Gerdes, Jantje M.; Katsanis, Nicholas] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; [Rattner, Jerome B.] Univ Calgary, Dept Cell Biol & Anat, Calgary, AB T2N 4N1, Canada; [Oh, Edwin; Katsanis, Nicholas] Duke Univ, Dept Cell Biol, Ctr Human Dis Modeling, Durham, NC 27708 USA	Simon Fraser University; University of Toronto; Structural Genomics Consortium; University of Toronto; Johns Hopkins University; University of Calgary; Duke University	Leroux, MR (corresponding author), Simon Fraser Univ, Dept Mol Biol & Biochem, 8888 Univ Dr, Burnaby, BC V5A 1S6, Canada.	leroux@sfu.ca	Katsanis, Nicholas/E-1837-2012; Gerdes, Jantje Mareike/M-9868-2014; Tong, Yufeng/D-2785-2011	Gerdes, Jantje Mareike/0000-0001-6885-5441; Tong, Yufeng/0000-0001-7740-1812; Katsanis, Nicholas/0000-0002-2480-0171	National Institutes of Health; NICHD [R01HD04260]; NIDDK [R01DK072301, DK075972]; National Institute of Mental Health; Canadian Institutes of Health Research [MOP-82870]; Heart and Stroke Foundation of British Columbia; Yukon grant; Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research; Canadian Foundation for Innovation; Genome Canada through the Ontario Genomics Institute,; GlaxoSmithKline; Karolinska Institutet; Knut and Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Merck; Novartis Research Foundation; Swedish Agency for Innovation Systems; Swedish Foundation for Strategic Research; Wellcome Trust; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD042601] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075972, R01DK072301] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of British Columbia; Yukon grant; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Genome Canada through the Ontario Genomics Institute,(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Karolinska Institutet(Karolinska Institutet); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Merck(Merck & Company); Novartis Research Foundation; Swedish Agency for Innovation Systems(Vinnova); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Wellcome Trust(Wellcome TrustEuropean Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01HD04260 from NICHD (to N.K.) and R01DK072301 and DK075972 from NIDDK (to N.K.). This work was also supported by a Conte Center grant from the National Institute of Mental Health (to N.K.), Canadian Institutes of Health Research Grant MOP-82870 (to M. R. L.), Heart and Stroke Foundation of British Columbia and Yukon grant (to M. R. L.), Natural Sciences and Engineering Research Council of Canada grant (to J.B.R.), and in part by the Structural Genomics Consortium, a registered charity (number 1097737) that receives funds from Canadian Institutes of Health Research, Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet, the Knut and Alice Wallenberg Foundation, Ontario Innovation Trust, Ontario Ministry for Research and Innovation, Merck, Novartis Research Foundation, Swedish Agency for Innovation Systems, Swedish Foundation for Strategic Research, and the Wellcome Trust.	Altschuler Y, 1999, J CELL BIOL, V147, P7, DOI 10.1083/jcb.147.1.7; Ansley SJ, 2003, NATURE, V425, P628, DOI 10.1038/nature02030; Asleson CM, 1998, GENETICS, V148, P693; Avidor-Reiss T, 2004, CELL, V117, P527, DOI 10.1016/S0092-8674(04)00412-X; Badano JL, 2006, ANNU REV GENOM HUM G, V7, P125, DOI 10.1146/annurev.genom.7.080505.115610; BARSEL SE, 1988, GENETICS, V118, P637; Beales PL, 2005, CURR OPIN GENET DEV, V15, P315, DOI 10.1016/j.gde.2005.04.006; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bialas NJ, 2009, J CELL SCI, V122, P611, DOI 10.1242/jcs.028621; Blacque OE, 2006, CELL MOL LIFE SCI, V63, P2145, DOI 10.1007/s00018-006-6180-x; Blacque OE, 2004, GENE DEV, V18, P1630, DOI 10.1101/gad.1194004; Blacque OE, 2005, CURR BIOL, V15, P935, DOI 10.1016/j.cub.2005.04.059; Blacque OE, 2008, FRONT BIOSCI-LANDMRK, V13, P2633, DOI 10.2741/2871; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Caspary T, 2007, DEV CELL, V12, P767, DOI 10.1016/j.devcel.2007.03.004; Chiang AP, 2004, AM J HUM GENET, V75, P475, DOI 10.1086/423903; Chiu J, 2008, J MICROBIOL METH, V73, P195, DOI 10.1016/j.mimet.2008.02.013; Corbit KC, 2008, NAT CELL BIOL, V10, P70, DOI 10.1038/ncb1670; Cuvillier A, 2000, J CELL SCI, V113, P2065; DASCHER C, 1994, J BIOL CHEM, V269, P1437; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; Dawe HR, 2007, HUM MOL GENET, V16, P173, DOI 10.1093/hmg/ddl459; Deane JA, 2001, CURR BIOL, V11, P1586, DOI 10.1016/S0960-9822(01)00484-5; Dejgaard SY, 2008, J CELL SCI, V121, P2768, DOI 10.1242/jcs.021808; DERETIC D, 1991, J CELL BIOL, V113, P1281, DOI 10.1083/jcb.113.6.1281; Ding M, 1996, J BIOL CHEM, V271, P24005, DOI 10.1074/jbc.271.39.24005; Eggenschwiler JT, 2007, ANNU REV CELL DEV BI, V23, P345, DOI 10.1146/annurev.cellbio.23.090506.123249; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fan YL, 2004, NAT GENET, V36, P989, DOI 10.1038/ng1414; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; Gerdes JM, 2007, NAT GENET, V39, P1350, DOI 10.1038/ng.2007.12; Gerdes JM, 2008, CURR TOP DEV BIOL, V85, P175, DOI 10.1016/S0070-2153(08)00807-7; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; Hu JH, 2007, MOL BIOL CELL, V18, P3277, DOI 10.1091/mbc.E07-03-0239; Huang HY, 2009, DEV DYNAM, V238, P232, DOI 10.1002/dvdy.21832; Huang P, 2009, DEVELOPMENT, V136, P3089, DOI 10.1242/dev.041343; Ingley E, 1999, FEBS LETT, V459, P69, DOI 10.1016/S0014-5793(99)01188-6; Insinna C, 2008, DEV DYNAM, V237, P1982, DOI 10.1002/dvdy.21554; Jekely G, 2006, BIOESSAYS, V28, P191, DOI 10.1002/bies.20369; Kahn RA, 2005, BIOCHEM SOC T, V33, P1269, DOI 10.1042/BST0331269; Kim JC, 2005, J CELL SCI, V118, P1007, DOI 10.1242/jcs.01676; Kim JC, 2004, NAT GENET, V36, P462, DOI 10.1038/ng1352; Kim J, 2008, HUM MOL GENET, V17, P3796, DOI 10.1093/hmg/ddn277; Klein S, 2006, J BIOL CHEM, V281, P12352, DOI 10.1074/jbc.M601021200; Kobayashi T, 2009, BIOCHEM BIOPH RES CO, V381, P439, DOI 10.1016/j.bbrc.2009.02.087; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; KUCHKA MR, 1987, GENETICS, V115, P685; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lechtreck KF, 2009, J CELL BIOL, V187, P1117, DOI 10.1083/jcb.200909183; Leroux MR, 2007, CELL, V129, P1041, DOI 10.1016/j.cell.2007.05.049; Li C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000044; Loktev AV, 2008, DEV CELL, V15, P854, DOI 10.1016/j.devcel.2008.11.001; Luby-Phelps K, 2008, VISION RES, V48, P413, DOI 10.1016/j.visres.2007.08.022; Marshall WF, 2007, J CELL BIOCHEM, V100, P916, DOI 10.1002/jcb.21117; Mazelova J, 2009, EMBO J, V28, P183, DOI 10.1038/emboj.2008.267; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; MCVITTIE A, 1972, J GEN MICROBIOL, V71, P525, DOI 10.1099/00221287-71-3-525; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Ocbina PJR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006839; Omori Y, 2008, NAT CELL BIOL, V10, P437, DOI 10.1038/ncb1706; Otto EA, 2003, NAT GENET, V34, P413, DOI 10.1038/ng1217; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ou G, 2007, MOL BIOL CELL, V18, P1554, DOI 10.1091/mbc.E06-09-0805; Ou YC, 2000, CELL MOTIL CYTOSKEL, V47, P13, DOI 10.1002/1097-0169(200009)47:1<13::AID-CM2>3.0.CO;2-C; PAI EF, 1990, EMBO J, V9, P2351, DOI 10.1002/j.1460-2075.1990.tb07409.x; Pasqualato S, 2002, EMBO REP, V3, P1035, DOI 10.1093/embo-reports/kvf221; Pedersen LB, 2008, DEV DYNAM, V237, P1993, DOI 10.1002/dvdy.21521; Pedersen LB, 2008, CURR TOP DEV BIOL, V85, P23, DOI 10.1016/S0070-2153(08)00802-8; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Pugacheva EN, 2007, CELL, V129, P1351, DOI 10.1016/j.cell.2007.04.035; Quarmby LM, 2005, J CELL BIOL, V169, P707, DOI 10.1083/jcb.200503053; Quinlan RJ, 2008, CURR TOP DEV BIOL, V84, P249, DOI 10.1016/S0070-2153(08)00605-4; Radhakrishna H, 1997, J CELL BIOL, V139, P49, DOI 10.1083/jcb.139.1.49; ROSENBAU.JL, 1969, J CELL BIOL, V41, P600, DOI 10.1083/jcb.41.2.600; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Santos N, 2008, DEV DYNAM, V237, P1972, DOI 10.1002/dvdy.21540; Satir P, 2007, ANNU REV PHYSIOL, V69, P377, DOI 10.1146/annurev.physiol.69.040705.141236; SCHOEPFER R, 1993, GENE, V124, P83, DOI 10.1016/0378-1119(93)90764-T; Scholey JM, 2008, J CELL BIOL, V180, P23, DOI 10.1083/jcb.200709133; Schrick JJ, 2006, AM J PATHOL, V168, P1288, DOI 10.2353/ajpath.2006.050941; Shah AS, 2008, P NATL ACAD SCI USA, V105, P3380, DOI 10.1073/pnas.0712327105; Sharma N, 2008, CURR TOP DEV BIOL, V85, P371, DOI 10.1016/S0070-2153(08)00813-2; Silverman MA, 2009, TRENDS CELL BIOL, V19, P306, DOI 10.1016/j.tcb.2009.04.002; Singla V, 2006, SCIENCE, V313, P629, DOI 10.1126/science.1124534; Stephan A, 2007, TRAFFIC, V8, P1323, DOI 10.1111/j.1600-0854.2007.00611.x; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Tayeh MK, 2008, HUM MOL GENET, V17, P1956, DOI 10.1093/hmg/ddn093; Tobin JL, 2008, P NATL ACAD SCI USA, V105, P6714, DOI 10.1073/pnas.0707057105; Tobin JL, 2007, PEDIATR NEPHROL, V22, P926, DOI 10.1007/s00467-007-0435-0; Veltel S, 2008, NAT STRUCT MOL BIOL, V15, P373, DOI 10.1038/nsmb.1396; WAGNER P, 1992, METHOD ENZYMOL, V219, P369; Watanabe D, 2003, DEVELOPMENT, V130, P1725, DOI 10.1242/dev.00407; WEISS O, 1989, J BIOL CHEM, V264, P21066; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Yen HJ, 2006, HUM MOL GENET, V15, P667, DOI 10.1093/hmg/ddi468; Yoshimura S, 2007, J CELL BIOL, V178, P363, DOI 10.1083/jcb.200703047; Zaghloul NA, 2009, J CLIN INVEST, V119, P428, DOI 10.1172/JCI37041; Zhou CJ, 2006, MOL BIOL CELL, V17, P2476, DOI 10.1091/mbc.E05-10-0929	100	72	75	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					16218	16230		10.1074/jbc.M109.070953	http://dx.doi.org/10.1074/jbc.M109.070953			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20207729	Green Published, hybrid			2022-12-25	WOS:000277715900058
J	Sanchez-Alvarez, M; Montes, M; Sanchez-Hernandez, N; Hernandez-Munain, C; Sune, C				Sanchez-Alvarez, Miguel; Montes, Marta; Sanchez-Hernandez, Noemi; Hernandez-Munain, Cristina; Sune, Carlos			Differential Effects of Sumoylation on Transcription and Alternative Splicing by Transcription Elongation Regulator 1 (TCERG1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; PRE-MESSENGER-RNA; INHERITED DEMENTIA FTDP-17; C-TERMINAL DOMAIN; IN-VIVO; SUMO MODIFICATION; CA150 BIND; FF DOMAINS; PROTEIN; SPLICEOSOME	Modification of proteins by small ubiquitin-like modifier (SUMO) is emerging as an important control of transcription and RNA processing. The human factor TCERG1 (also known as CA150) participates in transcriptional elongation and alternative splicing of pre-mRNAs. Here, we report that SUMO family proteins modify TCERG1. Furthermore, TCERG1 binds to the E2 SUMO-conjugating enzyme Ubc9. Two lysines (Lys-503 and Lys-608) of TCERG1 are the major sumoylation sites. Sumoylation does not affect localization of TCERG1 to the splicing factor-rich nuclear speckles or the alternative splicing function of TCERG1. However, mutation of the SUMO acceptor lysine residues enhanced TCERG1 transcriptional activity, indicating that SUMO modification negatively regulates TCERG1 transcriptional activity. These results reveal a regulatory role for sumoylation in controlling the activity of a transcription factor that modulates RNA polymerase II elongation and mRNA alternative processing, which are discriminated differently by this post-translational modification.	[Sanchez-Alvarez, Miguel; Montes, Marta; Sanchez-Hernandez, Noemi; Sune, Carlos] CSIC, Inst Parasitol & Biomed Lopez Neyra, Dept Mol Biol, Granada 18100, Spain; [Sanchez-Alvarez, Miguel; Hernandez-Munain, Cristina] CSIC, Inst Parasitol & Biomed Lopez Neyra, Dept Cell Biol & Immunol, Granada 18100, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN)	Sune, C (corresponding author), CSIC, Inst Parasitol & Biomed Lopez Neyra, Dept Mol Biol, Parque Tecnol Ciencias Salud,Ave Conocimiento S-N, Granada 18100, Spain.	csune@ipb.csic.es	Sánchez, Noemí/V-7150-2017; Montes, Marta/G-2751-2016; Montes, Marta/ABF-8298-2020; SÁNCHEZ-ÁLVAREZ, MIGUEL/AAA-4507-2019; Suñé, Carlos/AAA-8198-2019; de Munain, Cristina Hernandez Lopez/S-4389-2018	Sánchez, Noemí/0000-0002-1697-2352; Montes, Marta/0000-0003-1223-8385; Montes, Marta/0000-0003-1223-8385; SÁNCHEZ-ÁLVAREZ, MIGUEL/0000-0001-5287-1420; Suñé, Carlos/0000-0002-7991-0458; de Munain, Cristina Hernandez Lopez/0000-0002-6058-2458	Spanish Ministry of Science and Innovation [BFU2008-01599, BFU2008- 01651]; Fundacion para la Investigacion y la Prevencion del SIDA en Espana [36768]; Fundacion de Investigacion Medica Mutua Madrilena	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacion para la Investigacion y la Prevencion del SIDA en Espana; Fundacion de Investigacion Medica Mutua Madrilena	This work was supported in part by Spanish Ministry of Science and Innovation Grant BFU2008-01599, Fundacion para la Investigacion y la Prevencion del SIDA en Espana Grant 36768 (to C. S.), Spanish Ministry of Science and Innovation Grant BFU2008- 01651, and Fundacion de Investigacion Medica Mutua Madrilena (to C.H.-M.).	Allen M, 2002, J MOL BIOL, V323, P411, DOI 10.1016/S0022-2836(02)00968-3; Amelio AL, 2009, EMBO J, V28, P2733, DOI 10.1038/emboj.2009.216; Andresen JM, 2007, J MED GENET, V44, P44, DOI 10.1136/jmg.2006.045153; Arango M, 2006, J NEUROSCI, V26, P4649, DOI 10.1523/JNEUROSCI.5409-05.2006; Auboeuf D, 2002, SCIENCE, V298, P416, DOI 10.1126/science.1073734; Barboric M, 2001, MOL CELL, V8, P327, DOI 10.1016/S1097-2765(01)00314-8; Batsche E, 2006, NAT STRUCT MOL BIOL, V13, P22, DOI 10.1038/nsmb1030; Bedford MT, 1998, P NATL ACAD SCI USA, V95, P10602, DOI 10.1073/pnas.95.18.10602; Bourquin JP, 1997, NUCLEIC ACIDS RES, V25, P2055, DOI 10.1093/nar/25.11.2055; Boyer-Guittaut M, 2005, J BIOL CHEM, V280, P9937, DOI 10.1074/jbc.M414149200; Carty SM, 2000, P NATL ACAD SCI USA, V97, P9015, DOI 10.1073/pnas.160266597; Carty SM, 2002, MOL CELL PROTEOMICS, V1, P598, DOI 10.1074/mcp.M200029-MCP200; Cheng DH, 2007, MOL CELL, V25, P71, DOI 10.1016/j.molcel.2006.11.019; Cramer P, 1997, P NATL ACAD SCI USA, V94, P11456, DOI 10.1073/pnas.94.21.11456; de la Mata M, 2003, MOL CELL, V12, P525, DOI 10.1016/j.molcel.2003.08.001; Deckert J, 2006, MOL CELL BIOL, V26, P5528, DOI 10.1128/MCB.00582-06; Delattre C, 2006, CELLULOSE, V13, P63, DOI 10.1007/s10570-005-9031-2; Desterro JMP, 2005, MOL BIOL CELL, V16, P5115, DOI 10.1091/mbc.E05-06-0536; Emili A, 2002, RNA, V8, P1102, DOI 10.1017/S1355838202025037; Evdokimov E, 2008, J CELL SCI, V121, P4106, DOI 10.1242/jcs.038570; Fernandez-Lloris R, 2006, FEBS LETT, V580, P1215, DOI 10.1016/j.febslet.2006.01.031; Fong YW, 2001, NATURE, V414, P929, DOI 10.1038/414929a; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gill G, 2005, CURR OPIN GENET DEV, V15, P536, DOI 10.1016/j.gde.2005.07.004; Girdwood D, 2003, MOL CELL, V11, P1043, DOI 10.1016/S1097-2765(03)00141-2; Goldstrohm AC, 2001, MOL CELL BIOL, V21, P7617, DOI 10.1128/MCB.21.22.7617-7628.2001; Goldstrohm AC, 2001, GENE, V277, P31, DOI 10.1016/S0378-1119(01)00695-3; Golebiowski F, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000282; Grover A, 1999, J BIOL CHEM, V274, P15134, DOI 10.1074/jbc.274.21.15134; HARLOW E, 1999, USING ANTIBODIES LAB, P521; HARRISON MJ, 2010, NUCL ACIDS RES; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hirose Y, 2000, GENE DEV, V14, P1415; Holmstrom S, 2003, P NATL ACAD SCI USA, V100, P15758, DOI 10.1073/pnas.2136933100; House AE, 2006, NAT STRUCT MOL BIOL, V13, P937, DOI 10.1038/nsmb1149; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Kadener S, 2001, EMBO J, V20, P5759, DOI 10.1093/emboj/20.20.5759; Kalbfuss B, 2001, J BIOL CHEM, V276, P42986, DOI 10.1074/jbc.M105113200; Kameoka S, 2004, EMBO J, V23, P1782, DOI 10.1038/sj.emboj.7600187; Kao HY, 1996, MOL CELL BIOL, V16, P960; Kim E, 1997, J CELL BIOL, V136, P19, DOI 10.1083/jcb.136.1.19; Kornblihtt AR, 2005, CURR OPIN CELL BIOL, V17, P262, DOI 10.1016/j.ceb.2005.04.014; Kornblihtt AR, 2004, RNA, V10, P1489, DOI 10.1261/rna.7100104; Li TW, 2004, P NATL ACAD SCI USA, V101, P8551, DOI 10.1073/pnas.0402889101; Lin KT, 2004, MOL CELL BIOL, V24, P9176, DOI 10.1128/MCB.24.20.9176-9185.2004; Mabon SA, 2005, PLOS BIOL, V3, P1893, DOI 10.1371/journal.pbio.0030374; Makarov EM, 2002, SCIENCE, V298, P2205, DOI 10.1126/science.1077783; Misteli T, 1999, MOL CELL, V3, P697, DOI 10.1016/S1097-2765(01)80002-2; MITCHELL T, 1995, J VIROL, V69, P2968, DOI 10.1128/JVI.69.5.2968-2976.1995; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Montanuy I, 2008, J BIOL CHEM, V283, P7368, DOI 10.1074/jbc.M706243200; Morris DP, 2000, J BIOL CHEM, V275, P39935, DOI 10.1074/jbc.M004118200; Mukherjee S, 2009, J BIOL CHEM, V284, P21296, DOI 10.1074/jbc.M109.011494; Neubauer G, 1998, NAT GENET, V20, P46, DOI 10.1038/1700; Nogues G, 2002, J BIOL CHEM, V277, P43110, DOI 10.1074/jbc.M208418200; Nojima M, 2008, J MOL BIOL, V382, P275, DOI 10.1016/j.jmb.2008.07.017; Orphanides G, 2002, CELL, V108, P439, DOI 10.1016/S0092-8674(02)00655-4; Pearson JL, 2008, J BIOL CHEM, V283, P7949, DOI 10.1074/jbc.M709402200; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; Proudfoot NJ, 2002, CELL, V108, P501, DOI 10.1016/S0092-8674(02)00617-7; Sanchez-Alvarez M, 2006, MOL CELL BIOL, V26, P4998, DOI 10.1128/MCB.01991-05; Shimada M, 1999, J BIOCHEM-TOKYO, V126, P1033, DOI 10.1093/oxfordjournals.jbchem.a022547; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; Smith MJ, 2004, MOL CELL BIOL, V24, P9274, DOI 10.1128/MCB.24.21.9274-9285.2004; Subramaniam S, 2009, SCIENCE, V324, P1327, DOI 10.1126/science.1172871; Sune C, 1999, MOL CELL BIOL, V19, P4719; Sune C, 1997, MOL CELL BIOL, V17, P6029, DOI 10.1128/MCB.17.10.6029; Vertegaal ACO, 2006, MOL CELL PROTEOMICS, V5, P2298, DOI 10.1074/mcp.M600212-MCP200; Vethantham V, 2007, MOL CELL BIOL, V27, P8848, DOI 10.1128/MCB.01186-07; Yan J, 2007, BIOCHEM BIOPH RES CO, V362, P132, DOI 10.1016/j.bbrc.2007.07.158; Yang SH, 2004, MOL CELL, V13, P611, DOI 10.1016/S1097-2765(04)00060-7; Yang SH, 2006, EMBO J, V25, P5083, DOI 10.1038/sj.emboj.7601383; Yuryev A, 1996, P NATL ACAD SCI USA, V93, P6975, DOI 10.1073/pnas.93.14.6975	73	22	22	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15220	15233		10.1074/jbc.M109.063750	http://dx.doi.org/10.1074/jbc.M109.063750			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20215116	Green Published, hybrid			2022-12-25	WOS:000277399000043
J	Haberland, M; Carrer, M; Mokalled, MH; Montgomery, RL; Olson, EN				Haberland, Michael; Carrer, Michele; Mokalled, Mayssa H.; Montgomery, Rusty L.; Olson, Eric N.			Redundant Control of Adipogenesis by Histone Deacetylases 1 and 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHAIN FATTY-ACIDS; INHIBITORS; DIFFERENTIATION; HYPERTROPHY; ROLES	Adipocyte differentiation is a well defined process that is under the control of transcriptional activators and repressors. We show that histone deacetylase (HDAC) inhibitors efficiently block adipocyte differentiation in vitro. This effect is specific to adipogenesis, as another mesenchymal differentiation process, osteoblastogenesis, is enhanced upon HDAC inhibition. Through the systematic genetic deletion of HDAC genes in cultured mesenchymal precursor cells, we show that deletion of HDAC1 and HDAC2 leads to reduced lipid accumulation, revealing redundant and requisite roles of these class I HDACs in adipogenesis. These findings unveil a previously unrecognized role for HDACs in the control of adipogenesis.	[Haberland, Michael; Carrer, Michele; Mokalled, Mayssa H.; Montgomery, Rusty L.; Olson, Eric N.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Olson, EN (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Biol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Eric.Olson@utsouthwestern.edu		Carrer, Michele/0000-0002-6464-9584	National Institutes of Health [5-R01-HL083371]; Donald W. Reynolds Center for Clinical Cardiovascular Research; Robert A. Welch Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083371, R01HL093039] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Donald W. Reynolds Center for Clinical Cardiovascular Research; Robert A. Welch Foundation(The Welch Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant 5-R01-HL083371 (to E.N.O.). This work was also supported by the Donald W. Reynolds Center for Clinical Cardiovascular Research and the Robert A. Welch Foundation.	Antos CL, 2003, J BIOL CHEM, V278, P28930, DOI 10.1074/jbc.M303113200; Bakker A, 2003, METH MOLEC MED, V80, P19; Dokmanovic M, 2007, MOL CANCER RES, V5, P981, DOI 10.1158/1541-7786.MCR-07-0324; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Fischer A, 2007, NATURE, V447, P178, DOI 10.1038/nature05772; Haberland M, 2009, P NATL ACAD SCI USA, V106, P7751, DOI 10.1073/pnas.0903139106; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Hockly E, 2003, P NATL ACAD SCI USA, V100, P2041, DOI 10.1073/pnas.0437870100; Hong YH, 2005, ENDOCRINOLOGY, V146, P5092, DOI 10.1210/en.2005-0545; Jiang JC, 2002, EXP GERONTOL, V37, P1023, DOI 10.1016/S0531-5565(02)00064-5; Kee HJ, 2006, CIRCULATION, V113, P51, DOI 10.1161/CIRCULATIONAHA.105.559724; Kim S, 1999, MOL BIOL CELL, V10, P3125, DOI 10.1091/mbc.10.10.3125; Knutson SK, 2008, EMBO J, V27, P1017, DOI 10.1038/emboj.2008.51; Kong YL, 2006, CIRCULATION, V113, P2579, DOI 10.1161/CIRCULATIONAHA.106.625467; Lefterova MI, 2008, GENE DEV, V22, P2941, DOI 10.1101/gad.1709008; Mann BS, 2007, ONCOLOGIST, V12, P1247, DOI 10.1634/theoncologist.12-10-1247; Montgomery RL, 2008, J CLIN INVEST, V118, P3588, DOI 10.1172/JCI35847; Montgomery RL, 2007, GENE DEV, V21, P1790, DOI 10.1101/gad.1563807; Ohata A, 2005, NUTRITION, V21, P838, DOI 10.1016/j.nut.2004.12.004; Rogina B, 2002, SCIENCE, V298, P1745, DOI 10.1126/science.1078986; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Ryu H, 2003, P NATL ACAD SCI USA, V100, P4281, DOI 10.1073/pnas.0737363100; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; Waldecker M, 2008, J NUTR BIOCHEM, V19, P587, DOI 10.1016/j.jnutbio.2007.08.002; Wiper-Bergeron N, 2003, EMBO J, V22, P2135, DOI 10.1093/emboj/cdg218; Xiong YM, 2004, P NATL ACAD SCI USA, V101, P1045, DOI 10.1073/pnas.2637002100; Yoo EJ, 2006, J BIOL CHEM, V281, P6608, DOI 10.1074/jbc.M508982200	29	94	101	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14663	14670		10.1074/jbc.M109.081679	http://dx.doi.org/10.1074/jbc.M109.081679			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20190228	Green Published, hybrid			2022-12-25	WOS:000277299700064
J	Pirngruber, J; Johnsen, SA				Pirngruber, J.; Johnsen, S. A.			Induced G1 cell-cycle arrest controls replication-dependent histone mRNA 3 ' end processing through p21, NPAT and CDK9	ONCOGENE			English	Article						P53; CDK; histone; mRNA processing	S-PHASE ENTRY; GENE-EXPRESSION; DNA-DAMAGE; E/CDK2 SUBSTRATE; CAJAL BODIES; TRANSCRIPTION; P53; ACTIVATION; P220(NPAT); PHOSPHORYLATION	Proper cell cycle-dependent expression of replication-dependent histones is essential for packaging of DNA into chromatin during replication. We previously showed that cyclin-dependent kinase-9 (CDK9) controls histone H2B monoubiquitination (H2Bub1) to direct the recruitment of specific mRNA 3' end processing proteins to replication-dependent histone genes and promote proper pre-mRNA 3' end processing. We now show that p53 decreases the expression of the histone-specific transcriptional regulator Nuclear Protein, Ataxia-Telangiectasia Locus (NPAT) by inducing a G1 cell-cycle arrest, thereby affecting E2F-dependent transcription of the NPAT gene. Furthermore, NPAT is essential for histone mRNA 3' end processing and recruits CDK9 to replication-dependent histone genes. Reduced NPAT expression following p53 activation or small interfering RNA knockdown decreases CDK9 recruitment and replication-dependent histone gene transcription but increases the polyadenylation of remaining histone mRNAs. Thus, we present evidence that the induction of a G1 cell-cycle arrest (for example, following p53 accumulation) alters histone mRNA 3' end processing and uncover the first mechanism of a regulated switch in the mode of pre-mRNA 3' end processing during a normal cellular process, which may be altered during tumorigenesis. Oncogene (2010) 29, 2853-2863; doi: 10.1038/onc.2010.42; published online 1 March 2010	[Pirngruber, J.; Johnsen, S. A.] Univ Gottingen, Dept Mol Oncol, Gottingen Ctr Mol Biosci, D-37073 Gottingen, Lower Saxony, Germany	University of Gottingen	Johnsen, SA (corresponding author), Univ Gottingen, Dept Mol Oncol, Gottingen Ctr Mol Biosci, Justus von Liebig Weg 11, D-37073 Gottingen, Lower Saxony, Germany.	sjohnse@gwdg.de	Johnsen, Steven/AAX-2322-2020	Johnsen, Steven/0000-0003-1198-5805	Gottingen Graduate School for Neurosciences and Molecular Biosciences (GGNB); Forschungsforderungsprogramm at the University of Gottingen Medical Center; Deutsche Forschungsgemeinschaft [JO 815/1]	Gottingen Graduate School for Neurosciences and Molecular Biosciences (GGNB); Forschungsforderungsprogramm at the University of Gottingen Medical Center; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank J Zhao for graciously providing the NPAT antibody and for helpful advice; O Karpiuk, T Prenzel and A Shchebet for suggestions, discussions and technical help; S Emmert for advice and enabling us to test some interesting medically relevant hypotheses; and M Dobbelstein for advice and extensive scientific discussions regarding the p53/RB/E2F axis. JP was supported by an Excellence Fellowship from the Gottingen Graduate School for Neurosciences and Molecular Biosciences (GGNB). This work was supported by grants from the Forschungsforderungsprogramm at the University of Gottingen Medical Center and the Deutsche Forschungsgemeinschaft (JO 815/1) to SAJ.	Abba MC, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-37; Carvajal D, 2005, CANCER RES, V65, P1918, DOI 10.1158/0008-5472.CAN-04-3576; Choi HS, 2005, CANCER RES, V65, P5818, DOI 10.1158/0008-5472.CAN-05-0197; COLLART D, 1991, BIOCHEMISTRY-US, V30, P1610, DOI 10.1021/bi00220a024; Deran M, 2008, MOL CELL BIOL, V28, P435, DOI 10.1128/MCB.00607-07; Gao G, 2003, MOL CELL BIOL, V23, P2821, DOI 10.1128/MCB.23.8.2821-2833.2003; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Johnsen SA, 2002, J BIOL CHEM, V277, P30754, DOI 10.1074/jbc.M204812200; KIRSH AL, 1989, GENE DEV, V3, P2172, DOI 10.1101/gad.3.12b.2172; Kranz D, 2008, J CELL BIOL, V182, P197, DOI 10.1083/jcb.200712014; Kranz D, 2006, CANCER RES, V66, P10274, DOI 10.1158/0008-5472.CAN-06-1527; Lemm I, 2006, MOL BIOL CELL, V17, P3221, DOI 10.1091/mbc.E06-03-0247; Lohr K, 2003, J BIOL CHEM, V278, P32507, DOI 10.1074/jbc.M212517200; Ma TL, 2000, GENE DEV, V14, P2298, DOI 10.1101/gad.829500; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Martinez I, 2007, EUR J CANCER, V43, P415, DOI 10.1016/j.ejca.2006.09.001; Marzluff WF, 2008, NAT REV GENET, V9, P843, DOI 10.1038/nrg2438; Narita T, 2007, MOL CELL, V26, P349, DOI 10.1016/j.molcel.2007.04.011; Pirngruber J, 2009, CELL CYCLE, V8, P3636, DOI 10.4161/cc.8.22.9890; Pirngruber J, 2009, EMBO REP, V10, P894, DOI 10.1038/embor.2009.108; Rappold I, 2001, J CELL BIOL, V153, P613, DOI 10.1083/jcb.153.3.613; Saintigny Y, 2001, EMBO J, V20, P3861, DOI 10.1093/emboj/20.14.3861; Shin S, 2007, CANCER RES, V67, P7572, DOI 10.1158/0008-5472.CAN-06-4652; Simone C, 2002, ONCOGENE, V21, P4158, DOI 10.1038/sj.onc.1205511; Sims RJ, 2007, MOL CELL, V28, P665, DOI 10.1016/j.molcel.2007.11.010; Su C, 2004, EMBO J, V23, P1133, DOI 10.1038/sj.emboj.7600120; Takahashi Y, 2000, GENE DEV, V14, P804; VAIRO G, 1995, GENE DEV, V9, P869, DOI 10.1101/gad.9.7.869; Wagner EJ, 2007, MOL CELL, V28, P692, DOI 10.1016/j.molcel.2007.10.009; Wang HB, 2006, MOL CELL, V22, P383, DOI 10.1016/j.molcel.2006.03.035; Wei Y, 2003, MOL CELL BIOL, V23, P3669, DOI 10.1128/MCB.23.10.3669-3680.2003; Yan B, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r78; Ye X, 2003, MOL CELL BIOL, V23, P8586, DOI 10.1128/MCB.23.23.8586-8600.2003; Zhao HJ, 2004, MOL BIOL CELL, V15, P2523, DOI 10.1091/mbc.E03-11-0786; Zhao JY, 2000, GENE DEV, V14, P2283, DOI 10.1101/gad.827700; Zhao JY, 1998, GENE DEV, V12, P456, DOI 10.1101/gad.12.4.456; ZURHAUSEN H, 1994, ANNU REV MICROBIOL, V48, P427, DOI 10.1146/annurev.micro.48.1.427	37	32	33	1	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAY	2010	29	19					2853	2863		10.1038/onc.2010.42	http://dx.doi.org/10.1038/onc.2010.42			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	595DW	20190802				2022-12-25	WOS:000277591900010
J	Guevara, T; Yiallouros, I; Kappelhoff, R; Bissdorf, S; Stocker, W; Gomis-Ruth, FX				Guevara, Tibisay; Yiallouros, Irene; Kappelhoff, Reinhild; Bissdorf, Steffen; Stoecker, Walter; Xavier Gomis-Rueth, F.			Proenzyme Structure and Activation of Astacin Metallopeptidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; CYSTEINE SWITCH; ACTIVE-SITE; 3-DIMENSIONAL STRUCTURE; ZINC-ENDOPEPTIDASE; CATALYTIC DOMAIN; SNAKE-VENOM; MECHANISM; FAMILY; COMPLEX	Proteolysis is regulated by inactive (latent) zymogens, with a prosegment preventing access of substrates to the active-site cleft of the enzyme. How latency is maintained often depends on the catalytic mechanism of the protease. For example, in several families of the metzincin metallopeptidases, a "cysteine switch" mechanism involves a conserved prosegment motif with a cysteine residue that coordinates the catalytic zinc ion. Another family of metzincins, the astacins, do not possess a cysteine switch, so latency is maintained by other means. We have solved the high resolution crystal structure of proastacin from the European crayfish, Astacus astacus. Its prosegment is the shortest structurally reported for a metallopeptidase, and it has a unique structure. It runs through the active-site cleft in reverse orientation to a genuine substrate. Moreover, a conserved aspartate, projected by a wide loop of the prosegment, coordinates the zinc ion instead of the catalytic solvent molecule found in the mature enzyme. Activation occurs through two-step limited proteolysis and entails major rearrangement of a flexible activation domain, which becomes rigid and creates the base of the substrate-binding cleft. Maturation also requires the newly formed N terminus to be precisely trimmed so that it can participate in a buried solvent-mediated hydrogen-bonding network, which includes an invariant active-site residue. We describe a novel mechanism for latency and activation, which shares some common features both with other metallopeptidases and with serine peptidases.	[Guevara, Tibisay; Xavier Gomis-Rueth, F.] CSIC, Mol Biol Inst Barcelona, Proteolysis Lab, Dept Biol Struct, E-08028 Barcelona, Spain; [Yiallouros, Irene; Kappelhoff, Reinhild; Bissdorf, Steffen; Stoecker, Walter] Johannes Gutenberg Univ Mainz, Inst Zool Cell & Matrix Biol, D-55128 Mainz, Germany	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); Johannes Gutenberg University of Mainz	Gomis-Ruth, FX (corresponding author), CSIC, Mol Biol Inst Barcelona, Proteolysis Lab, Dept Biol Struct, Barcelona Sci Pk,Helix Bldg,C Baldiri Reixac 15-2, E-08028 Barcelona, Spain.	fxgr@ibmb.csic.es	Stöcker, Walter/AAB-9704-2019	Stöcker, Walter/0000-0002-1515-6994; Gomis-Ruth, F. Xavier/0000-0002-6848-6874; Guevara Puig, Tibisay/0000-0002-1366-8507	Deutsche Forschungsgemeinschaft [Sto185/3-3]; European Synchrotron Radiation Facility;  [Strep FP7-223101-AntiPathoGN];  [BIO2008-04080-E];  [BIO2009-10334];  [CSD2006-00015];  [PSE-010000-2009-8];  [2009SGR1036]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Synchrotron Radiation Facility; ; ; ; ; ; 	This work was supported by grants from European, Spanish, and Catalan public agencies (Strep FP7-223101-AntiPathoGN, BIO2008-04080-E, BIO2009-10334, CSD2006-00015, PSE-010000-2009-8, and 2009SGR1036) and by Deutsche Forschungsgemeinschaft Grant Sto185/3-3. Funding for data collection was provided by the European Synchrotron Radiation Facility.	ABRAMOWITZ N, 1967, BIOCHEM BIOPH RES CO, V29, P862, DOI 10.1016/0006-291X(67)90299-9; AVILES FX, 1993, EUR J BIOCHEM, V211, P381, DOI 10.1111/j.1432-1033.1993.tb17561.x; Bayes A, 2007, BIOCHEMISTRY-US, V46, P6921, DOI 10.1021/bi700480b; BECKER JW, 1995, PROTEIN SCI, V4, P1966, DOI 10.1002/pro.5560041002; Bochtler M, 2004, PROTEIN SCI, V13, P854, DOI 10.1110/ps.03515704; BODE W, 1978, FEBS LETT, V90, P265, DOI 10.1016/0014-5793(78)80382-2; BODE W, 1992, NATURE, V358, P164, DOI 10.1038/358164a0; BODE W, 1993, FEBS LETT, V331, P134, DOI 10.1016/0014-5793(93)80312-I; BOND JS, 1995, PROTEIN SCI, V4, P1247, DOI 10.1002/pro.5560040701; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bryan PN, 2002, CHEM REV, V102, P4805, DOI 10.1021/cr010190b; Carranza C., 1999, AFMB ACTIVITY REPORT, P89; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Demidyuk IV, 2008, PROTEIN J, V27, P343, DOI 10.1007/s10930-008-9143-2; Demidyuk IV, 2010, J BIOL CHEM, V285, P2003, DOI 10.1074/jbc.M109.015396; Elkins PA, 2002, ACTA CRYSTALLOGR D, V58, P1182, DOI 10.1107/S0907444902007849; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; EVANS SV, 1993, J MOL GRAPHICS, V11, P134, DOI 10.1016/0263-7855(93)87009-T; Firczuk M, 2005, J MOL BIOL, V354, P578, DOI 10.1016/j.jmb.2005.09.082; Gomis-Ruth FX, 2003, MOL BIOTECHNOL, V24, P157, DOI 10.1385/MB:24:2:157; GOMISRUTH FX, 1993, J MOL BIOL, V229, P945, DOI 10.1006/jmbi.1993.1098; Grams F, 1996, NAT STRUCT BIOL, V3, P671, DOI 10.1038/nsb0896-671; GRAMS F, 1993, FEBS LETT, V335, P76, DOI 10.1016/0014-5793(93)80443-X; HOLZER H, 1980, ANNU REV BIOCHEM, V49, P63, DOI 10.1146/annurev.bi.49.070180.000431; Johnson GD, 1997, J BIOL CHEM, V272, P28126, DOI 10.1074/jbc.272.44.28126; Jozic D, 2005, J BIOL CHEM, V280, P9578, DOI 10.1074/jbc.M411084200; Kabsch W., 2001, INT TABLES CRYSTALLO, P730, DOI [10.1107/97809553602060000001, DOI 10.1107/97809553602060000001]; KAPPELHOFF R, 2002, I ZOOPHYSIOLOGY, P77; Khan AR, 1998, PROTEIN SCI, V7, P815; Loechel F, 1999, J BIOL CHEM, V274, P13427, DOI 10.1074/jbc.274.19.13427; McCall KA, 2000, J NUTR, V130, p1437S, DOI 10.1093/jn/130.5.1437S; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mittl PRE, 2006, CURR OPIN STRUC BIOL, V16, P769, DOI 10.1016/j.sbi.2006.10.014; Morgunova E, 1999, SCIENCE, V284, P1667, DOI 10.1126/science.284.5420.1667; Morgunova E, 2002, P NATL ACAD SCI USA, V99, P7414, DOI 10.1073/pnas.102185399; Nagase H, 1997, BIOL CHEM, V378, P151; Nicholas K.B., 1997, EMBNEW NEWS, V4, P14, DOI DOI 10.11118/ACTAUN201361041061; Odintsov SG, 2004, J MOL BIOL, V335, P775, DOI 10.1016/j.jmb.2003.11.009; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; REINEMER P, 1994, FEBS LETT, V338, P227, DOI 10.1016/0014-5793(94)80370-6; Reyda S, 1999, BIOCHEM J, V344, P851, DOI 10.1042/0264-6021:3440851; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; SPRINGMAN EB, 1990, P NATL ACAD SCI USA, V87, P364, DOI 10.1073/pnas.87.1.364; STOCKER W, 1993, EUR J BIOCHEM, V214, P215, DOI 10.1111/j.1432-1033.1993.tb17915.x; STOCKER W, 1995, METHOD ENZYMOL, V248, P305; STOCKER W, 1995, CURR OPIN STRUC BIOL, V5, P383, DOI 10.1016/0959-440X(95)80101-4; STOCKER W, 1995, PROTEIN SCI, V4, P823; STOCKER W, 1991, COMP BIOCHEM PHYS B, V98, P501, DOI 10.1016/0305-0491(91)90244-8; STOCKER W, 2004, HDB PROTEOLYTIC ENZY, P595; Tallant C, 2006, J BIOL CHEM, V281, P17920, DOI 10.1074/jbc.M600907200; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; VALLEE BL, 1990, BIOCHEMISTRY-US, V29, P5647, DOI 10.1021/bi00476a001; VANWART HE, 1990, P NATL ACAD SCI USA, V87, P5578, DOI 10.1073/pnas.87.14.5578; Vendrell J, 2000, BBA-PROTEIN STRUCT M, V1477, P284, DOI 10.1016/S0167-4838(99)00280-0; Gomis-Ruth FX, 2008, CRIT REV BIOCHEM MOL, V43, P319, DOI 10.1080/10409230802376375 ; Gomis-Ruth FX, 2009, J BIOL CHEM, V284, P15353, DOI 10.1074/jbc.R800069200; Yiallouros I, 2000, FEBS LETT, V484, P224, DOI 10.1016/S0014-5793(00)02163-3; Yiallouros I, 2002, J MOL BIOL, V324, P237, DOI 10.1016/S0022-2836(02)01102-6	59	58	60	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13958	13965		10.1074/jbc.M109.097436	http://dx.doi.org/10.1074/jbc.M109.097436			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20202938	hybrid, Green Published			2022-12-25	WOS:000276987700070
J	Kim, S; Leal, SS; Ben Halevy, D; Gomes, CM; Lev, S				Kim, SoHui; Leal, Sonia S.; Ben Halevy, Daniel; Gomes, Claudio M.; Lev, Sima			Structural Requirements for VAP-B Oligomerization and Their Implication in Amyotrophic Lateral Sclerosis-associated VAP-B(P56S) Neurotoxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-ASSOCIATED PROTEIN; OXYSTEROL-BINDING PROTEIN; MOTOR-NEURON DISEASE; ENDOPLASMIC-RETICULUM; GOLGI-APPARATUS; NEURITE OUTGROWTH; FFAT MOTIF; MEMBRANE; VAMP; MUTATION	The integral endoplasmic reticulum (ER)-membrane protein VAP-B interacts with various lipid-transfer/binding proteins containing an FFAT motif through its N-terminal MSP domain. A genetic mutation within its MSP domain, P56S, was identified in familial forms of motor neuron diseases. This mutation induces the formation of insoluble VAP-B(P56S) protein aggregates by an unknown mechanism. In this study, we defined the structural requirements for VAP-B oligomerization and demonstrated their contribution for VAP-B(P56S) aggregation and neurotoxicity. We show that the oligomerization of VAP-B is mainly mediated by its coiled-coil domain and that the GXXXG dimerization motif within the transmembrane domain mediates transmembrane domains self-association but is insufficient to drive VAP-B oligomerization. We further show that the oligomerization of the wild-type VAP-B is independent of its MSP domain. However, we found that the P56S mutation induces conformational changes within the MSP domain and facilitates its propensity to aggregate by exposing hydrophobic patches to the solvent. These conformational changes have no direct effect on FFAT binding. Rather, they enhance VAP-B(P56S) oligomerization driven by the combined contributions of the coiled-coil and the transmembrane domains, thereby preventing accessibility to FFAT-binding site, facilitating the production of VAP-B(P56S)-insoluble aggregates and consequently its neurotoxicity. These results shed light on the mechanism by which VAP-B(P56S) aggregates are formed and induce familial motor neuron diseases.	[Kim, SoHui; Ben Halevy, Daniel; Lev, Sima] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; [Leal, Sonia S.; Gomes, Claudio M.] Univ Nova Lisboa, Inst Tecnol Quim & Biol, P-2780157 Oeiras, Portugal	Weizmann Institute of Science; Universidade Nova de Lisboa	Lev, S (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel.	sima.lev@weizmann.ac.il	Leal, Sónia/F-1129-2015; Lev, Sima/AAP-7880-2020; Benhalevy, Daniel/AGG-5321-2022; Gomes, Cláudio M./A-8152-2008	Leal, Sónia/0000-0001-8445-0065; Lev, Sima/0000-0002-2108-3330; Benhalevy, Daniel/0000-0001-6998-1933; Gomes, Cláudio M./0000-0003-4662-6933	Federal German Ministry for Education and Research; Israel Science Foundation [548/08]; Fundacao para a Ciencia e Tecnologia/Ministerio da Ciencia e Ensino Superior, Portugal	Federal German Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); Israel Science Foundation(Israel Science Foundation); Fundacao para a Ciencia e Tecnologia/Ministerio da Ciencia e Ensino Superior, Portugal(Portuguese Foundation for Science and Technology)	This work was supported by the Minerva foundation with funding from the Federal German Ministry for Education and Research and by Israel Science Foundation Grant 548/08.; Recipient of a Postdoctoral fellowship from Fundacao para a Ciencia e Tecnologia/Ministerio da Ciencia e Ensino Superior, Portugal.	Amarilio R, 2005, J BIOL CHEM, V280, P5934, DOI 10.1074/jbc.M409566200; Brickner JH, 2004, PLOS BIOL, V2, P1843, DOI 10.1371/journal.pbio.0020342; Brosig B, 1998, PROTEIN SCI, V7, P1052; Brown RH, 2001, SEMIN NEUROL, V21, P131; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; CARDAMONE M, 1992, BIOCHEM J, V282, P589, DOI 10.1042/bj2820589; de Pril R, 2006, NEUROBIOL AGING, V27, P515, DOI 10.1016/j.neurobiolaging.2005.04.016; Foster LJ, 2000, TRAFFIC, V1, P512, DOI 10.1034/j.1600-0854.2000.010609.x; Gkogkas C, 2008, HUM MOL GENET, V17, P1517, DOI 10.1093/hmg/ddn040; Gros-Louis F, 2006, BBA-MOL BASIS DIS, V1762, P956, DOI 10.1016/j.bbadis.2006.01.004; Kaiser SE, 2005, STRUCTURE, V13, P1035, DOI 10.1016/j.str.2005.04.010; Kanekura K, 2006, J BIOL CHEM, V281, P30223, DOI 10.1074/jbc.M605049200; Kawano M, 2006, J BIOL CHEM, V281, P30279, DOI 10.1074/jbc.M605032200; Kundu B, 2002, BIOCHEM BIOPH RES CO, V293, P572, DOI 10.1016/S0006-291X(02)00257-7; Leal SS, 2007, PROTEINS, V68, P606, DOI 10.1002/prot.21448; Lehto M, 2005, EXP CELL RES, V310, P445, DOI 10.1016/j.yexcr.2005.08.003; Lev S, 2008, TRENDS CELL BIOL, V18, P282, DOI 10.1016/j.tcb.2008.03.006; Litvak V, 2005, NAT CELL BIOL, V7, P225, DOI 10.1038/ncb1221; Loewen CJR, 2004, SCIENCE, V304, P1644, DOI 10.1126/science.1096083; Loewen CJR, 2003, EMBO J, V22, P2025, DOI 10.1093/emboj/cdg201; Marques VD, 2006, MUSCLE NERVE, V34, P731, DOI 10.1002/mus.20657; Martin Stephen R, 2002, Methods Mol Biol, V173, P43; MCCLURE WO, 1966, BIOCHEMISTRY-US, V5, P1908, DOI 10.1021/bi00870a018; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nishimura AL, 2004, AM J HUM GENET, V75, P822, DOI 10.1086/425287; Nishimura AL, 2005, HUM GENET, V118, P499, DOI 10.1007/s00439-005-0031-y; Nishimura Y, 1999, BIOCHEM BIOPH RES CO, V254, P21, DOI 10.1006/bbrc.1998.9876; Orrell RW, 2000, NEUROMUSCULAR DISORD, V10, P63, DOI 10.1016/S0960-8966(99)00071-1; Pasinelli P, 2006, NAT REV NEUROSCI, V7, P710, DOI 10.1038/nrn1971; Pennetta G, 2002, NEURON, V35, P291, DOI 10.1016/S0896-6273(02)00769-9; Peretti D, 2008, MOL BIOL CELL, V19, P3871, DOI 10.1091/mbc.E08-05-0498; Perry RJ, 2006, MOL BIOL CELL, V17, P2604, DOI 10.1091/mbc.E06-01-0060; Ratnaparkhi A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002334; Ross CA, 2005, NAT REV MOL CELL BIO, V6, P891, DOI 10.1038/nrm1742; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489; Senes A, 2004, CURR OPIN STRUC BIOL, V14, P465, DOI 10.1016/j.sbi.2004.07.007; Shaw PJ, 2005, J NEUROL NEUROSUR PS, V76, P1046, DOI 10.1136/jnnp.2004.048652; SKEHEL PA, 1995, SCIENCE, V269, P1580, DOI 10.1126/science.7667638; Skehel PA, 2000, P NATL ACAD SCI USA, V97, P1101, DOI 10.1073/pnas.97.3.1101; Soussan L, 1999, J CELL BIOL, V146, P301, DOI 10.1083/jcb.146.2.301; STRYER LUBERT, 1965, J MOL BIOL, V13, P482; Suzuki H, 2009, J NEUROCHEM, V108, P973, DOI [10.1111/j.1471-4159.2008.05857.x, 10.1111/j.0022-3042.2008.05857.x]; Takeuchi H, 2002, BRAIN RES, V949, P11, DOI 10.1016/S0006-8993(02)02568-4; Teuling E, 2007, J NEUROSCI, V27, P9801, DOI 10.1523/JNEUROSCI.2661-07.2007; Thompson AJ, 2002, CURR MED CHEM, V9, P1751; Tiwari A, 2005, J BIOL CHEM, V280, P29771, DOI 10.1074/jbc.M504039200; Tiwari A, 2009, J BIOL CHEM, V284, P27746, DOI 10.1074/jbc.M109.043729; Tsuda H, 2008, CELL, V133, P963, DOI 10.1016/j.cell.2008.04.039; Vetri V, 2005, BIOPHYS CHEM, V113, P83, DOI 10.1016/j.bpc.2004.07.042; Weir ML, 1998, BIOCHEM J, V333, P247, DOI 10.1042/bj3330247; Weir ML, 2001, BIOCHEM BIOPH RES CO, V286, P616, DOI 10.1006/bbrc.2001.5437; Wyles JP, 2002, J BIOL CHEM, V277, P29908, DOI 10.1074/jbc.M201191200; Wyles JP, 2004, EXP CELL RES, V297, P533, DOI 10.1016/j.yexcr.2004.03.052; Ye CF, 2008, NEUROSCI LETT, V442, P63, DOI 10.1016/j.neulet.2008.05.119	55	52	53	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13839	13849		10.1074/jbc.M109.097345	http://dx.doi.org/10.1074/jbc.M109.097345			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20207736	Green Published, hybrid			2022-12-25	WOS:000276987700059
J	Lott, K; Bhardwaj, A; Mitrousis, G; Pante, N; Cingolani, G				Lott, Kaylen; Bhardwaj, Anshul; Mitrousis, Gregory; Pante, Nelly; Cingolani, Gino			The Importin beta Binding Domain Modulates the Avidity of Importin beta for the Nuclear Pore Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPLICEOSOMAL U-SNRNPS; STRUCTURAL BASIS; PROTEIN IMPORT; NUCLEOCYTOPLASMIC TRANSPORT; LOCALIZATION SIGNAL; MAMMALIAN-CELLS; MOLECULAR-BASIS; IN-VIVO; EXPORT; RECEPTOR	Importin beta mediates active passage of cellular substrates through the nuclear pore complex (NPC). Adaptors such as importin alpha and snurportin associate with importin beta via an importin beta binding (IBB) domain. The intrinsic structural flexibility of importin beta allows its concerted interactions with IBB domains, phenylalanine-glycine nucleoporins, and the GTPase Ran during transport. In this paper, we provide evidence that the nature of the IBB domain modulates the affinity of the import complex for the NPC. In permeabilized cells, importin beta imports a cargo fused to the snurportin IBB (sIBB) with similar to 70% reduced energy requirement as compared with the classical importin alpha IBB. At the molecular level, this is explained by similar to 200-fold reduced affinity of importin beta for Nup62, when bound to the sIBB. Consistently, in vivo, the importin beta center dot sIBB complex has greatly reduced persistence inside the central channel of the NPC. We propose that by controlling the degree of strain in the tertiary structure of importin beta, the IBB domain modulates the affinity of the import complex for nucleoporins, thus dictating its persistence inside the NPC.	[Lott, Kaylen; Bhardwaj, Anshul; Cingolani, Gino] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA; [Lott, Kaylen; Mitrousis, Gregory] SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA; [Mitrousis, Gregory] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; [Pante, Nelly] Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada	Jefferson University; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; University of Colorado System; University of Colorado Boulder; University of British Columbia	Cingolani, G (corresponding author), Thomas Jefferson Univ, Dept Biochem & Mol Biol, 233 S 10th St, Philadelphia, PA 19107 USA.	gino.cingolani@jefferson.edu	Pante, Nelly/GVR-8478-2022	Bhardwaj, Anshul/0000-0002-0897-979X	National Institutes of Health [GM074846-01A1]; Natural Sciences and Engineering Research Council of Canada; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074846] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM074846-01A1 (to G. C.). This work was also supported by a grant from Natural Sciences and Engineering Research Council of Canada (to N.P.).	ADAM SA, 1990, J CELL BIOL, V111, P807, DOI 10.1083/jcb.111.3.807; Bayliss R, 2000, CELL, V102, P99, DOI 10.1016/S0092-8674(00)00014-3; Bayliss R, 2002, J BIOL CHEM, V277, P50597, DOI 10.1074/jbc.M209037200; Bednenko J, 2003, J CELL BIOL, V162, P391, DOI 10.1083/jcb.200303085; Ben-Efraim I, 2001, J CELL BIOL, V152, P411, DOI 10.1083/jcb.152.2.411; Chen MH, 2005, J BIOL CHEM, V280, P10599, DOI 10.1074/jbc.M413194200; Chook YM, 1999, NATURE, V399, P230, DOI 10.1038/20375; Cingolani G, 2000, FEBS LETT, V484, P291, DOI 10.1016/S0014-5793(00)02154-2; Cingolani G, 2002, MOL CELL, V10, P1345, DOI 10.1016/S1097-2765(02)00727-X; Cingolani G, 1999, NATURE, V399, P221, DOI 10.1038/20367; Cook A, 2005, MOL CELL, V18, P355, DOI 10.1016/j.molcel.2005.03.021; Cook A, 2007, ANNU REV BIOCHEM, V76, P647, DOI 10.1146/annurev.biochem.76.052705.161529; Cook AG, 2009, NATURE, V461, P60, DOI 10.1038/nature08394; Deane R, 1997, MOL CELL BIOL, V17, P5087, DOI 10.1128/MCB.17.9.5087; Dong XH, 2009, NATURE, V458, P1136, DOI 10.1038/nature07975; Englmeier L, 1999, CURR BIOL, V9, P30, DOI 10.1016/S0960-9822(99)80044-X; Fukuhara N, 2004, J BIOL CHEM, V279, P2176, DOI 10.1074/jbc.M309112200; Goldfarb DS, 2004, TRENDS CELL BIOL, V14, P505, DOI 10.1016/j.tcb.2004.07.016; Gorlich D, 2003, EMBO J, V22, P1088, DOI 10.1093/emboj/cdg113; Hu TH, 1996, J CELL BIOL, V134, P589, DOI 10.1083/jcb.134.3.589; Huber J, 1998, EMBO J, V17, P4114, DOI 10.1093/emboj/17.14.4114; Huber J, 2002, J CELL BIOL, V156, P467, DOI 10.1083/jcb.200108114; Hutten S, 2006, MOL CELL BIOL, V26, P6772, DOI 10.1128/MCB.00342-06; Isgro TA, 2005, STRUCTURE, V13, P1869, DOI 10.1016/j.str.2005.09.007; Jakel S, 1998, EMBO J, V17, P4491, DOI 10.1093/emboj/17.15.4491; Kehlenbach RH, 1999, J CELL BIOL, V145, P645, DOI 10.1083/jcb.145.4.645; Kent HM, 1996, J STRUCT BIOL, V116, P326, DOI 10.1006/jsbi.1996.0049; Kutay U, 1997, EMBO J, V16, P1153, DOI 10.1093/emboj/16.6.1153; Lee BJ, 2006, CELL, V126, P543, DOI 10.1016/j.cell.2006.05.049; Lee SJ, 2005, NATURE, V435, P693, DOI 10.1038/nature03578; Lee SJ, 2003, SCIENCE, V302, P1571, DOI 10.1126/science.1088372; Lyman SK, 2002, J CELL BIOL, V159, P55, DOI 10.1083/jcb.200204163; Madrid AS, 2006, CHROMOSOMA, V115, P98, DOI 10.1007/s00412-005-0043-3; Matsuura Y, 2004, NATURE, V432, P872, DOI 10.1038/nature03144; Melchior F, 1998, METH MOL B, V88, P265; Mitrousis G, 2008, J BIOL CHEM, V283, P7877, DOI 10.1074/jbc.M709093200; Monecke T, 2009, SCIENCE, V324, P1087, DOI 10.1126/science.1173388; Mosammaparast N, 2004, TRENDS CELL BIOL, V14, P547, DOI 10.1016/j.tcb.2004.09.004; Nachury MV, 1999, P NATL ACAD SCI USA, V96, P9622, DOI 10.1073/pnas.96.17.9622; Nevo R, 2003, NAT STRUCT BIOL, V10, P553, DOI 10.1038/nsb940; Palacios I, 1997, EMBO J, V16, P6783, DOI 10.1093/emboj/16.22.6783; Pante Nelly, 2006, V322, P301; Patel SS, 2008, MOL CELL PROTEOMICS, V7, P121, DOI 10.1074/mcp.M700407-MCP200; Patel SS, 2007, CELL, V129, P83, DOI 10.1016/j.cell.2007.01.044; Pemberton LF, 2005, TRAFFIC, V6, P187, DOI 10.1111/j.1600-0854.2005.00270.x; REXACH M, 1995, CELL, V83, P683, DOI 10.1016/0092-8674(95)90181-7; Rollenhagen C, 2003, MOL BIOL CELL, V14, P2104, DOI 10.1091/mbc.e02-06-0372; Rollenhagen C, 2006, CAN J PHYSIOL PHARM, V84, P367, DOI 10.1139/Y05-101; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; Strasser A, 2005, EMBO J, V24, P2235, DOI 10.1038/sj.emboj.7600701; Suel KE, 2006, METHODS, V39, P342, DOI 10.1016/j.ymeth.2006.06.015; Weis K, 2003, CELL, V112, P441, DOI 10.1016/S0092-8674(03)00082-5; Weis K, 1996, EMBO J, V15, P7120, DOI 10.1002/j.1460-2075.1996.tb01103.x; Wohlwend D, 2007, J MOL BIOL, V374, P1129, DOI 10.1016/j.jmb.2007.09.065; Zachariae U, 2008, STRUCTURE, V16, P906, DOI 10.1016/j.str.2008.03.007; Zachariae U, 2006, STRUCTURE, V14, P1469, DOI 10.1016/j.str.2006.08.001; Zeitler B, 2004, J CELL BIOL, V167, P583, DOI 10.1083/jcb.200407156	57	34	36	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13769	13780		10.1074/jbc.M109.095760	http://dx.doi.org/10.1074/jbc.M109.095760			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20197273	Green Published, hybrid			2022-12-25	WOS:000276987700052
J	Lye, MF; Fanning, AS; Su, Y; Anderson, JM; Lavie, A				Lye, Ming F.; Fanning, Alan S.; Su, Ying; Anderson, James M.; Lavie, Arnon			Insights into Regulated Ligand Binding Sites from the Structure of ZO-1 Src Homology 3-Guanylate Kinase Module	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-CELLS; INTRAMOLECULAR INTERACTION; DISCS LARGE; PROTEIN; JUNCTIONS; MEMBRANE; OCCLUDIN; IDENTIFICATION; LOCALIZATION; CYTOSKELETON	Tight junctions are dynamic components of epithelial and endothelial cells that regulate the paracellular transport of ions, solutes, and immune cells. The assembly and permeability of these junctions is dependent on the zonula occludens (ZO) proteins, members of the membrane-associated guanylate kinase homolog (MAGUK) protein family, which are characterized by a core Src homology 3 (SH3)-GUK module that coordinates multiple protein-protein interactions. The structure of the ZO-1 SH3-GUK domain confirms that the interdependent folding of the SH3 and GUK domains is a conserved feature of MAGUKs, but differences in the orientation of the GUK domains in three different MAGUKs reveal interdomain flexibility of the core unit. Using pull-down assays, we show that an effector loop, the U6 region in ZO-1, forms a novel intramolecular interaction with the core module. This interaction is divalent cation-dependent and overlaps with the binding site for the regulatory molecule calmodulin on the GUK domain. These findings provide insight into the previously observed ability of the U6 region to regulate TJ assembly in vivo and the structural basis for the complex protein interactions of the MAGUK family.	[Lye, Ming F.; Su, Ying; Lavie, Arnon] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA; [Fanning, Alan S.; Anderson, James M.] Univ N Carolina, Dept Cell & Mol Physiol, Chapel Hill, NC 27599 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of North Carolina; University of North Carolina Chapel Hill	Lavie, A (corresponding author), Univ Illinois, Dept Biochem & Mol Genet, 900 S Ashland Ave,Mol Biol Res Bldg,Rm 1108, Chicago, IL 60607 USA.	lavie@uic.edu	Lavie, Arnon/H-4927-2012	Lavie, Arnon/0000-0001-5591-8722; Anderson, James/0000-0003-2765-7996	National Institutes of Health (NIH) [R01DK061397]; NIH, NIDDK [T32DK07739]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061397, T32DK007739] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health (NIH) Grant R01DK061397 and NIH, NIDDK, Institutional Training Grant T32DK07739, "Training Program in Signal Transduction and Cellular Endocrinology."	Cohen AR, 1998, J CELL BIOL, V142, P129, DOI 10.1083/jcb.142.1.129; Fanning AS, 2007, MOL BIOL CELL, V18, P721, DOI 10.1091/mbc.E06-08-0764; Fanning AS, 2009, ANN NY ACAD SCI, V1165, P113, DOI 10.1111/j.1749-6632.2009.04440.x; Funke L, 2005, ANNU REV BIOCHEM, V74, P219, DOI 10.1146/annurev.biochem.74.082803.133339; Hanada T, 2003, J BIOL CHEM, V278, P34445, DOI 10.1074/jbc.M305209200; Hough CD, 1997, GENE DEV, V11, P3242, DOI 10.1101/gad.11.23.3242; Ikenouchi J, 2007, J CELL BIOL, V176, P779, DOI 10.1083/jcb.200612080; Jones TA, 1997, METHOD ENZYMOL, V277, P173, DOI 10.1016/S0076-6879(97)77012-5; KABSCH W, 1977, J MOL BIOL, V117, P999, DOI 10.1016/S0022-2836(77)80009-0; KISTNER U, 1995, FEBS LETT, V359, P159, DOI 10.1016/0014-5793(95)00030-D; Li YH, 2005, J MOL BIOL, V352, P151, DOI 10.1016/j.jmb.2005.07.017; MARFATIA SM, 1995, J BIOL CHEM, V270, P715, DOI 10.1074/jbc.270.2.715; Masuko N, 1999, J BIOL CHEM, V274, P5782, DOI 10.1074/jbc.274.9.5782; McGee AW, 2001, MOL CELL, V8, P1291, DOI 10.1016/S1097-2765(01)00411-7; McNeil E, 2006, MOL BIOL CELL, V17, P1922, DOI 10.1091/mbc.E05-07-0650; Muller SL, 2005, J BIOL CHEM, V280, P3747, DOI 10.1074/jbc.M411365200; Murakami T, 2009, J BIOL CHEM, V284, P21036, DOI 10.1074/jbc.M109.016766; Sabio G, 2005, EMBO J, V24, P1134, DOI 10.1038/sj.emboj.7600578; Shin HW, 2000, J NEUROSCI, V20, P3580, DOI 10.1523/JNEUROSCI.20-10-03580.2000; Tavares GA, 2001, MOL CELL, V8, P1313, DOI 10.1016/S1097-2765(01)00416-6; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P1863, DOI 10.1107/S0907444999010033; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Umeda K, 2006, CELL, V126, P741, DOI 10.1016/j.cell.2006.06.043; Van Itallie CM, 2009, MOL BIOL CELL, V20, P3930, DOI 10.1091/mbc.E09-04-0320; Van Itallie CM, 2006, ANNU REV PHYSIOL, V68, P403, DOI 10.1146/annurev.physiol.68.040104.131404; Woods DF, 1996, J CELL BIOL, V134, P1469, DOI 10.1083/jcb.134.6.1469; Wu HJ, 2000, EMBO J, V19, P5740, DOI 10.1093/emboj/19.21.5740	27	28	31	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13907	13917		10.1074/jbc.M109.093674	http://dx.doi.org/10.1074/jbc.M109.093674			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20200156	hybrid, Green Published			2022-12-25	WOS:000276987700065
J	Papandreou, MJ; Barbouche, R; Guieu, R; Rivera, S; Fantini, J; Khrestchatisky, M; Jones, IM; Fenouillet, E				Papandreou, Marie-Jeanne; Barbouche, Rym; Guieu, Regis; Rivera, Santiago; Fantini, Jacques; Khrestchatisky, Michel; Jones, Ian M.; Fenouillet, Emmanuel			Mapping of Domains on HIV Envelope Protein Mediating Association with Calnexin and Protein-disulfide Isomerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCLONAL-ANTIBODIES; GLYCOPROTEIN GP120; RECOMBINANT GP120; MEMBRANE-FUSION; V3 LOOP; BINDING; BONDS; GLYCOSYLATION; CONFORMATION; ENTRY	The cell catalysts calnexin (CNX) and protein-disulfide isomerase (PDI) cooperate in establishing the disulfide bonding of the HIV envelope (Env) glycoprotein. Following HIV binding to lymphocytes, cell-surface PDI also reduces Env to induce the fusogenic conformation. We sought to define the contact points between Env and these catalysts to illustrate their potential as therapeutic targets. In lysates of Env-expressing cells, 15% of the gp160 precursor, but not gp120, coprecipitated with CNX, whereas only 0.25% of gp160 and gp120 coprecipitated with PDI. Under in vitro conditions, which mimic the Env/PDI interaction during virus/cell contact, PDI readily associated with Env. The domains of Env interacting in cellulo with CNX or in vitro with PDI were then determined using anti-Env antibodies whose binding site was occluded by CNX or PDI. Antibodies against domains V1/V2, C2, and the C terminus of V3 did not bind CNX-associated Env, whereas those against C1, V1/V2, and the CD4-binding domain did not react with PDI-associated Env. In addition, a mixture of the latter antibodies interfered with PDI-mediated Env reduction. Thus, Env interacts with intracellular CNX and extracellular PDI via discrete, largely nonover-lapping, regions. The sites of interaction explain the mode of action of compounds that target these two catalysts and may enable the design of further new competitive agents.	[Papandreou, Marie-Jeanne; Barbouche, Rym; Rivera, Santiago; Khrestchatisky, Michel; Fenouillet, Emmanuel] Univ Aix Marseille 1, Fac Med Nord, CNRS, F-13015 Marseille, France; [Guieu, Regis] Hop La Timone, F-13005 Marseille, France; [Fantini, Jacques] Univ Aix Marseille 3, F-13013 Marseille, France; [Jones, Ian M.] Univ Reading, Sch Biol Sci, Reading RG6 6AJ, Berks, England	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; University of Reading	Barbouche, R (corresponding author), Univ Aix Marseille 1, Fac Med Nord, CNRS, Bd P Dramard, F-13015 Marseille, France.	rym.barbouche@univmed.fr; emmanuel.fenouillet@univmed.fr	Jones, Ian/AAF-4986-2019	Jones, Ian/0000-0002-7738-2516; Fantini, Jacques/0000-0001-8653-5521; Khrestchatisky, Michel/0000-0003-4797-8332	Agence Nationale de Recherche sur le Sida; United Kingdom Medical Research Council; MRC [G0200000] Funding Source: UKRI; Medical Research Council [G0200000] Funding Source: researchfish	Agence Nationale de Recherche sur le Sida(ANRSFrench National Research Agency (ANR)); United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Agence Nationale de Recherche sur le Sida (to E.F., R.B., and I.M.J.) and the United Kingdom Medical Research Council (to I.M.J.).	Apperizeller-Herzog C, 2008, BBA-MOL CELL RES, V1783, P535, DOI 10.1016/j.bbamcr.2007.11.010; AVRIL LE, 1993, FEBS LETT, V317, P167, DOI 10.1016/0014-5793(93)81515-2; Barbouche R, 2005, MOL PHARMACOL, V67, P1111, DOI 10.1124/mol.104.008276; Barbouche R, 2003, J BIOL CHEM, V278, P3131, DOI 10.1074/jbc.M205467200; Billington J, 2007, J VIROL, V81, P4604, DOI 10.1128/JVI.02138-06; Brockmeier A, 2009, J BIOL CHEM, V284, P3433, DOI 10.1074/jbc.M804866200; Caramelo JJ, 2008, J BIOL CHEM, V283, P10221, DOI 10.1074/jbc.R700048200; Chen B, 2005, NATURE, V433, P834, DOI 10.1038/nature03327; Crublet E, 2008, J BIOL CHEM, V283, P15193, DOI 10.1074/jbc.M800066200; Dettenhofer M, 2001, J BIOL CHEM, V276, P5985, DOI 10.1074/jbc.M008933200; FENOUILLET E, 1993, J VIROL, V67, P150, DOI 10.1128/JVI.67.1.150-160.1993; FENOUILLET E, 1992, VIROLOGY, V187, P825, DOI 10.1016/0042-6822(92)90487-A; Fenouillet E, 2001, J INFECT DIS, V183, P744, DOI 10.1086/318823; Fenouillet E, 2007, ANTIOXID REDOX SIGN, V9, P1009, DOI 10.1089/ars.2007.1639; Ferrari DM, 1999, BIOCHEM J, V339, P1, DOI 10.1042/0264-6021:3390001; FISCHER P, 1995, J VIROL, V69, P5791, DOI 10.1128/JVI.69.9.5791-5797.1995; Free RB, 2007, J BIOL CHEM, V282, P21285, DOI 10.1074/jbc.M701555200; Gallina A, 2002, J BIOL CHEM, V277, P50579, DOI 10.1074/jbc.M204547200; Ihara Y, 1999, MOL CELL, V4, P331, DOI 10.1016/S1097-2765(00)80335-4; Jessop CE, 2009, J BIOL CHEM, V284, P2194, DOI 10.1074/jbc.M808054200; JONES DH, 1995, VACCINE, V13, P991, DOI 10.1016/0264-410X(95)00019-W; JONES IM, 1991, NATURE, V352, P198, DOI 10.1038/352198b0; KIENY MP, 1988, PROTEIN ENG, V2, P219; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Land A, 2003, FASEB J, V17, P1058, DOI 10.1096/fj.02-0811com; Land A, 2001, BIOCHIMIE, V83, P783, DOI 10.1016/S0300-9084(01)01314-1; LEONARD CK, 1990, J BIOL CHEM, V265, P10373; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; Markovic I, 2004, BLOOD, V103, P1586, DOI 10.1182/blood-2003-05-1390; MCKEATING JA, 1993, J VIROL, V67, P4932, DOI 10.1128/JVI.67.8.4932-4944.1993; MCKEATING JA, 1992, VIROLOGY, V190, P134, DOI 10.1016/0042-6822(92)91199-5; MOORE JP, 1993, J VIROL, V67, P6136, DOI 10.1128/JVI.67.10.6136-6151.1993; MOORE JP, 1990, AIDS, V4, P307, DOI 10.1097/00002030-199004000-00004; MORIKAWA Y, 1990, AIDS RES HUM RETROV, V6, P765, DOI 10.1089/aid.1990.6.765; Nagradova N, 2007, CURR PROTEIN PEPT SC, V8, P273, DOI 10.2174/138920307780831866; Otteken A, 1996, J VIROL, V70, P3407, DOI 10.1128/JVI.70.6.3407-3415.1996; Otteken A, 1996, J BIOL CHEM, V271, P97, DOI 10.1074/jbc.271.1.97; Ou W, 2006, VIROLOGY, V350, P406, DOI 10.1016/j.virol.2006.01.041; Pancera M, 2010, P NATL ACAD SCI USA, V107, P1166, DOI 10.1073/pnas.0911004107; Papandreou MJ, 2002, MOL PHARMACOL, V61, P186, DOI 10.1124/mol.61.1.186; Papandreou MJ, 1996, FEBS LETT, V379, P171, DOI 10.1016/0014-5793(95)01505-1; Pfeiffer T, 1997, J GEN VIROL, V78, P1745, DOI 10.1099/0022-1317-78-7-1745; Pierson TC, 2003, CURR TOP MICROBIOL, V281, P1; Rider CC, 1997, GLYCOCONJUGATE J, V14, P639, DOI 10.1023/A:1018596728605; ROTH RA, 1981, BIOCHEMISTRY-US, V20, P6594, DOI 10.1021/bi00526a012; Ryser HJP, 2005, DRUG DISCOV TODAY, V10, P1085, DOI 10.1016/S1359-6446(05)03550-6; RYSER HJP, 1994, P NATL ACAD SCI USA, V91, P4559, DOI 10.1073/pnas.91.10.4559; Wanamaker CP, 2005, J BIOL CHEM, V280, P33800, DOI 10.1074/jbc.M501813200; Wang JZ, 2008, J BIOL CHEM, V283, P32644, DOI 10.1074/jbc.M806099200; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514	50	14	15	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13788	13796		10.1074/jbc.M109.066670	http://dx.doi.org/10.1074/jbc.M109.066670			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20202930	Green Published, hybrid			2022-12-25	WOS:000276987700054
J	Sol, D; Garcia, N; Iwaniuk, A; Davis, K; Meade, A; Boyle, WA; Szekely, T				Sol, Daniel; Garcia, Nuria; Iwaniuk, Andrew; Davis, Katie; Meade, Andrew; Boyle, W. Alice; Szekely, Tamas			Evolutionary Divergence in Brain Size between Migratory and Resident Birds	PLOS ONE			English	Article							ANCESTRAL CHARACTER STATES; PHYLOGENETIC ANALYSIS; DISCRETE CHARACTERS; COGNITION; PATTERNS; ECOLOGY; INTELLIGENCE; PREDICTS; COSTS; WORLD	Despite important recent progress in our understanding of brain evolution, controversy remains regarding the evolutionary forces that have driven its enormous diversification in size. Here, we report that in passerine birds, migratory species tend to have brains that are substantially smaller (relative to body size) than those of resident species, confirming and generalizing previous studies. Phylogenetic reconstructions based on Bayesian Markov chain methods suggest an evolutionary scenario in which some large brained tropical passerines that invaded more seasonal regions evolved migratory behavior and migration itself selected for smaller brain size. Selection for smaller brains in migratory birds may arise from the energetic and developmental costs associated with a highly mobile life cycle, a possibility that is supported by a path analysis. Nevertheless, an important fraction (over 68%) of the correlation between brain mass and migratory distance comes from a direct effect of migration on brain size, perhaps reflecting costs associated with cognitive functions that have become less necessary in migratory species. Overall, our results highlight the importance of retrospective analyses in identifying selective pressures that have shaped brain evolution, and indicate that when it comes to the brain, larger is not always better.	[Sol, Daniel; Garcia, Nuria] Autonomous Univ Barcelona, Ctr Ecol Res & Appl Forestries CREAF, Bellaterra, Catalonia, Spain; [Sol, Daniel] CEAB CSIC Ctr Adv Studies Blanes Spanish Natl Res, Blanes, Catalonia, Spain; [Iwaniuk, Andrew] Univ Lethbridge, Dept Neurosci, Canadian Ctr Behav Neurosci, Lethbridge, AB T1K 3M4, Canada; [Davis, Katie] Univ Reading, Sch Biol Sci, Reading, Berks, England; [Meade, Andrew] Univ Glasgow, Div Ecol & Evolutionary Biol, Glasgow, Lanark, Scotland; [Boyle, W. Alice] Univ Western Ontario, Dept Biol, London, ON, Canada; [Szekely, Tamas] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England	Autonomous University of Barcelona; Centro de Investigacion Ecologica y Aplicaciones Forestales (CREAF); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB); University of Lethbridge; University of Reading; University of Glasgow; Western University (University of Western Ontario); University of Bath	Sol, D (corresponding author), Autonomous Univ Barcelona, Ctr Ecol Res & Appl Forestries CREAF, Bellaterra, Catalonia, Spain.	d.sol@creaf.uab.es	Sol, Daniel/A-5238-2008; Szekely, Tamas/I-7089-2016; Boyle, W. Alice/G-1872-2010; Iwaniuk, Andrew/H-7255-2019	Sol, Daniel/0000-0001-6346-6949; Szekely, Tamas/0000-0003-2093-0056; Boyle, W. Alice/0000-0002-2880-142X; Iwaniuk, Andrew/0000-0001-9273-3655	Proyecto de Investigacion [CGL2007-66257]; Consolider project [CSD 2008-00040]	Proyecto de Investigacion; Consolider project(Spanish Government)	This work was supported by a Proyecto de Investigacion (CGL2007-66257) and a Consolider project (CSD 2008-00040). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allman J.M., 2000, EVOLVING BRAINS; [Anonymous], 2002, CAUSE CORRELATION BI; Arbuckle J. L., 2007, AMOS USERS GUIDE VER; BENNETT PM, 1985, J ZOOL, V207, P151; BERTHOLD P, 1991, ANNU REV ECOL SYST, V22, P357, DOI 10.1146/annurev.es.22.110191.002041; Bininda-Emonds O.R., 2004, COMPU BIOL, P267; Boerner M, 2008, EVOLUTION, V62, P3157, DOI 10.1111/j.1558-5646.2008.00490.x; Boyle WA, 2007, AM NAT, V169, P344, DOI 10.1086/511335; Chesser RT, 1998, AM NAT, V152, P311, DOI 10.1086/286171; COX GW, 1985, AM NAT, V126, P451, DOI 10.1086/284432; Cristol DA, 2003, ANIM BEHAV, V66, P317, DOI 10.1006/anbe.2003.2194; Darwin G., 1871, P423; Davis KE, 2008, THESIS U GLASGOW GLA; Deaner Robert O., 2003, P233; Dunbar RIM, 2007, SCIENCE, V317, P1344, DOI 10.1126/science.1145463; Dunbar RIM, 2007, PHILOS T R SOC B, V362, P649, DOI 10.1098/rstb.2006.2001; Fox J, 2006, STRUCT EQU MODELING, V13, P465, DOI 10.1207/s15328007sem1303_7; Francis RC, 2005, TRENDS ECOL EVOL, V20, P476, DOI 10.1016/j.tree.2005.07.002; Freckleton RP, 2009, J EVOLUTION BIOL, V22, P1367, DOI 10.1111/j.1420-9101.2009.01757.x; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; Garamszegi LZ, 2002, P ROY SOC B-BIOL SCI, V269, P961, DOI 10.1098/rspb.2002.1967; GARLAND T, 1993, SYST BIOL, V42, P265, DOI 10.2307/2992464; Gibson KR, 2002, BRAIN BEHAV EVOLUT, V59, P10, DOI 10.1159/000063730; Goloboff P, 2008, CLADISTICS, V24, P91; Grace JB., 2015, STRUCTURAL EQUATION; GRAFEN A, 1989, PHILOS T R SOC B, V326, P119, DOI 10.1098/rstb.1989.0106; Healy SD, 2007, P ROY SOC B-BIOL SCI, V274, P453, DOI 10.1098/rspb.2006.3748; Isler K, 2006, BIOL LETTERS, V2, P557, DOI 10.1098/rsbl.2006.0538; Isler K, 2006, J HUM EVOL, V51, P228, DOI 10.1016/j.jhevol.2006.03.006; Iwaniuk AN, 2003, CAN J ZOOL, V81, P1913, DOI 10.1139/Z03-190; Iwaniuk AN, 2002, CAN J ZOOL, V80, P16, DOI 10.1139/Z01-204; Jerison HJ., 1973, EVOLUTION BRAIN INTE; Lefebvre L, 1997, ANIM BEHAV, V53, P549, DOI 10.1006/anbe.1996.0330; Lefebvre L, 2008, BRAIN BEHAV EVOLUT, V72, P135, DOI 10.1159/000151473; LEVEY DJ, 1992, AM NAT, V140, P447, DOI 10.1086/285421; Li C., 1975, PATH ANAL A PRIMER; LOSOS JB, 1994, ANNU REV ECOL SYST, V25, P467, DOI 10.1146/annurev.es.25.110194.002343; Mettke-Hofmann C, 2005, BEHAVIOUR, V142, P1357, DOI 10.1163/156853905774539427; Mettke-Hofmann Claudia, 2005, P114; Newton I, 1996, J ANIM ECOL, V65, P137, DOI 10.2307/5716; Newton I, 2008, MIGRATION ECOLOGY OF BIRDS, P1; Overington SE, 2009, ANIM BEHAV, V78, P1001, DOI 10.1016/j.anbehav.2009.06.033; Pagel M, 1999, SYST BIOL, V48, P612, DOI 10.1080/106351599260184; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Pagel M, 2004, SYST BIOL, V53, P673, DOI 10.1080/10635150490522232; PAGEL M, 1994, P ROY SOC LOND B, V144; Pagel M, 2006, AM NAT, V167, P808, DOI 10.1086/503444; PAGEL MD, 1992, J THEOR BIOL, V156, P431, DOI 10.1016/S0022-5193(05)80637-X; Paradis E, 2006, ANAL PHYLOGENETICS E; Perez-Barberia FJ, 2007, EVOLUTION, V61, P2811, DOI 10.1111/j.1558-5646.2007.00229.x; Perez-Barberia FJ, 2002, EVOLUTION, V56, P1276; Phillimore AB, 2006, AM NAT, V168, P220, DOI 10.1086/505763; Pravosudov VV, 2007, ANIM BEHAV, V73, P535, DOI 10.1016/j.anbehav.2006.10.005; Rappole JH., 1995, ECOLOGY MIGRANT BIRD; Reader SM, 2002, P NATL ACAD SCI USA, V99, P4436, DOI 10.1073/pnas.062041299; Safi K, 2005, BIOL LETT-UK, V1, P283, DOI 10.1098/rsbl.2005.0333; Schuck-Paim C, 2008, BRAIN BEHAV EVOLUT, V71, P200, DOI 10.1159/000119710; Shultz S, 2005, P ROY SOC B-BIOL SCI, V272, P2305, DOI 10.1098/rspb.2005.3250; Sol D, 2005, P NATL ACAD SCI USA, V102, P5460, DOI 10.1073/pnas.0408145102; Sol D, 2008, AM NAT, V172, pS63, DOI 10.1086/588304; Sol Daniel, 2003, P63; Timmermans S, 2000, BRAIN BEHAV EVOLUT, V56, P196, DOI 10.1159/000047204; Winkler H, 2004, J ORNITHOL, V145, P238, DOI 10.1007/s10336-004-0040-y; WINKLER H, 2003, BIRDS 2 WORLDS; Zink RM, 2002, J AVIAN BIOL, V33, P433, DOI 10.1034/j.1600-048X.2002.03081.x; [No title captured]	66	58	59	1	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2010	5	3							e9617	10.1371/journal.pone.0009617	http://dx.doi.org/10.1371/journal.pone.0009617			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565XE	20224776	Green Published, Green Submitted, gold			2022-12-25	WOS:000275328800015
J	Rippe, V; Dittberner, L; Lorenz, VN; Drieschner, N; Nimzyk, R; Sendt, W; Junker, K; Belge, G; Bullerdiek, J				Rippe, Volkhard; Dittberner, Lea; Lorenz, Verena N.; Drieschner, Norbert; Nimzyk, Rolf; Sendt, Wolfgang; Junker, Klaus; Belge, Gazanfer; Bullerdiek, Joern			The Two Stem Cell MicroRNA Gene Clusters C19MC and miR-371-3 Are Activated by Specific Chromosomal Rearrangements in a Subgroup of Thyroid Adenomas	PLOS ONE			English	Article							CYTOGENETIC INVESTIGATIONS; EXPRESSION; TUMORS; DNA; DIFFERENTIATION; IDENTIFICATION; BREAKPOINTS; INVASION; CANCER	Thyroid adenomas are common benign human tumors with a high prevalence of about 5% of the adult population even in iodine sufficient areas. Rearrangements of chromosomal band 19q13.4 represent a frequent clonal cytogenetic deviation in these tumors making them the most frequent non-random chromosomal translocations in human epithelial tumors at all. Two microRNA (miRNA) gene clusters i.e. C19MC and miR-371-3 are located in close proximity to the breakpoint region of these chromosomal rearrangements and have been checked for a possible up-regulation due to the genomic alteration. In 4/5 cell lines established from thyroid adenomas with 19q13.4 rearrangements and 5/5 primary adenomas with that type of rearrangement both the C19MC and miR-371-3 cluster were found to be significantly overexpressed compared to controls lacking that particular chromosome abnormality. In the remaining cell line qRT-PCR revealed overexpression of members of the miR-371-3 cluster only which might be due to a deletion accompanying the chromosomal rearrangement in that case. In depth molecular characterization of the breakpoint in a cell line from one adenoma of this type reveals the existence of large Pol-II mRNA fragments as the most likely source of up-regulation of the C19MC cluster. The up-regulation of the clusters is likely to be causally associated with the pathogenesis of the corresponding tumors. Of note, the expression of miRNAs miR-520c and miR-373 is known to characterize stem cells and in terms of molecular oncology has been implicated in invasive growth of epithelial cells in vitro and in vivo thus allowing to delineate a distinct molecular subtype of thyroid adenomas. Besides thyroid adenomas rearrangements of 19q13.4 are frequently found in other human neoplasias as well, suggesting that activation of both clusters might be a more general phenomenon in human neoplasias.	[Rippe, Volkhard; Dittberner, Lea; Lorenz, Verena N.; Drieschner, Norbert; Nimzyk, Rolf; Belge, Gazanfer; Bullerdiek, Joern] Univ Bremen, Ctr Human Genet, Bremen, Germany; [Sendt, Wolfgang] St Joseph Stift, Dept Gen & Visceral Surg, Bremen, Germany; [Junker, Klaus] Hosp Bremen Mitte, Dept Pathol, Bremen, Germany; [Bullerdiek, Joern] Univ Vet Med, Small Anim Clin, Hannover, Germany; [Bullerdiek, Joern] Univ Vet Med, Res Cluster Excellence REBIRTH, Hannover, Germany	University of Bremen; Klinikum Bremen-Mitte; University of Veterinary Medicine Hannover, Foundation; University of Veterinary Medicine Hannover, Foundation	Rippe, V (corresponding author), Univ Bremen, Ctr Human Genet, Bremen, Germany.	bullerd@uni-bremen.de	Rippe, Volkhard/I-1927-2013	Rippe, Volkhard/0000-0001-8758-6013	University of Bremen	University of Bremen	The work was supported by the University of Bremen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELGE G, 1992, CELL BIOL INT REP, V16, P339, DOI 10.1016/S0309-1651(06)80139-6; Belge G, 1998, CANCER GENET CYTOGEN, V101, P42, DOI 10.1016/S0165-4608(97)00057-5; Belge G, 1997, GENE CHROMOSOME CANC, V20, P201, DOI 10.1002/(SICI)1098-2264(199710)20:2<201::AID-GCC11>3.0.CO;2-T; Belge G, 2001, CYTOGENET CELL GENET, V93, P48, DOI 10.1159/000056947; Bol S, 2001, CYTOGENET CELL GENET, V95, P189, DOI 10.1159/000059344; Bortolin-Cavaille ML, 2009, NUCLEIC ACIDS RES, V37, P3464, DOI 10.1093/nar/gkp205; Bousquet M, 2008, J EXP MED, V205, P2499, DOI 10.1084/jem.20080285; Calin GA, 2006, ONCOGENE, V25, P6202, DOI 10.1038/sj.onc.1209910; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Crosby ME, 2009, CANCER RES, V69, P1221, DOI 10.1158/0008-5472.CAN-08-2516; DELELLIS RA, 2004, ED CONS C LYON FRANC; Fehr A, 2008, CANCER GENET CYTOGEN, V180, P135, DOI 10.1016/j.cancergencyto.2007.10.007; Foekens JA, 2008, P NATL ACAD SCI USA, V105, P13021, DOI 10.1073/pnas.0803304105; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; KIEVITS T, 1990, CYTOMETRY, V11, P105, DOI 10.1002/cyto.990110112; Laurent LC, 2008, STEM CELLS, V26, P1506, DOI 10.1634/stemcells.2007-1081; Li MH, 2009, CANCER CELL, V16, P533, DOI 10.1016/j.ccr.2009.10.025; Li SSL, 2009, J CELL BIOCHEM, V106, P1020, DOI 10.1002/jcb.22084; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOMELIN D, 2009, GENOME RES; Ren JQ, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-20; ROQUE L, 1993, CANCER GENET CYTOGEN, V67, P1, DOI 10.1016/0165-4608(93)90036-L; Spassov DS, 2002, GENE, V299, P195, DOI 10.1016/S0378-1119(02)01060-0; SPELEMAN F, 1989, CANCER GENET CYTOGEN, V40, P29, DOI 10.1016/0165-4608(89)90142-8; Szabo A, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-8-r59; Tabaska JE, 1999, GENE, V231, P77, DOI 10.1016/S0378-1119(99)00104-3; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Yang K, 2009, INT J CLIN EXP PATHO, V2, P361; Yu SL, 2008, CANCER CELL, V13, P48, DOI 10.1016/j.ccr.2007.12.008; Zhao JJ, 2009, CHILD NERV SYST, V25, P13, DOI 10.1007/s00381-008-0701-x	31	88	94	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2010	5	3							e9485	10.1371/journal.pone.0009485	http://dx.doi.org/10.1371/journal.pone.0009485			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	562OZ	20209130	Green Published, Green Submitted, gold			2022-12-25	WOS:000275063400005
J	Ezak, MJ; Ferkey, DM				Ezak, Meredith J.; Ferkey, Denise M.			The C. elegans D2-Like Dopamine Receptor DOP-3 Decreases Behavioral Sensitivity to the Olfactory Stimulus 1-Octanol	PLOS ONE			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; ARACHIDONIC-ACID RELEASE; HAMSTER OVARY CELLS; IN-VIVO; CHEMOSENSORY RECEPTORS; MOLECULAR-MECHANISMS; SIGNALING PATHWAY; AMINE RECEPTORS; PHOSPHOLIPASE-D; ASH NEURONS	We previously found that dopamine signaling modulates the sensitivity of wild-type C. elegans to the aversive odorant 1-octanol. C. elegans lacking the CAT-2 tyrosine hydroxylase enzyme, which is required for dopamine biosynthesis, are hypersensitive in their behavioral avoidance of dilute concentrations of octanol. Dopamine can also modulate the context-dependent response of C. elegans lacking RGS-3 function, a negative regulator of G alpha signaling. rgs-3 mutant animals are defective in their avoidance of 100% octanol when they are assayed in the absence of food (E. coli bacterial lawn), but their response is restored when they are assayed in the presence of food or exogenous dopamine. However, it is not known which receptor might be mediating dopamine's effects on octanol avoidance. Herein we describe a role for the C. elegans D2-like receptor DOP-3 in the regulation of olfactory sensitivity. We show that DOP-3 is required for the ability of food and exogenous dopamine to rescue the octanol avoidance defect of rgs-3 mutant animals. In addition, otherwise wild-type animals lacking DOP-3 function are hypersensitive to dilute octanol, reminiscent of cat-2 mutants. Furthermore, we demonstrate that DOP-3 function in the ASH sensory neurons is sufficient to rescue the hypersensitivity of dop-3 mutant animals, while dop-3 RNAi knockdown in ASH results in octanol hypersensitivity. Taken together, our data suggest that dopaminergic signaling through DOP-3 normally acts to dampen ASH signaling and behavioral sensitivity to octanol.	[Ezak, Meredith J.; Ferkey, Denise M.] SUNY Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Ezak, MJ (corresponding author), SUNY Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA.	dmferkey@buffalo.edu			Ellison Medical Foundation [AG0380-07]	Ellison Medical Foundation(Lawrence Ellison Foundation)	This work was supported by a New Scholar in Aging Award from The Ellison Medical Foundation (http://www.ellisonfoundation.org/index.jsp, AG0380-07 to D. M. F.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AVERY L, 1990, J EXP ZOOL, V253, P263, DOI 10.1002/jez.1402530305; BARGMANN CI, 1990, COLD SH Q B, V55, P529; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; Benton R, 2008, CURR OPIN NEUROBIOL, V18, P357, DOI 10.1016/j.conb.2008.08.012; Berke JD, 2000, NEURON, V25, P515, DOI 10.1016/S0896-6273(00)81056-9; BRENNER S, 1974, GENETICS, V77, P71; Caille I, 1996, BRAIN RES, V730, P17, DOI 10.1016/0006-8993(96)00424-6; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Chao MY, 2004, P NATL ACAD SCI USA, V101, P15512, DOI 10.1073/pnas.0403369101; Chase DL, 2004, NAT NEUROSCI, V7, P1096, DOI 10.1038/nn1316; CHIO CL, 1994, J BIOL CHEM, V269, P11813; Colbert HA, 1997, LEARN MEMORY, V4, P179, DOI 10.1101/lm.4.2.179; Esposito G, 2007, GENE, V395, P170, DOI 10.1016/j.gene.2007.03.002; Ferkey DM, 2007, NEURON, V53, P39, DOI 10.1016/j.neuron.2006.11.015; Fukushige T, 1998, DEV BIOL, V198, P286, DOI 10.1016/S0012-1606(98)80006-7; Fukuto HS, 2004, NEURON, V42, P581, DOI 10.1016/S0896-6273(04)00252-1; Ganguly-Fitzgerald I, 2006, SCIENCE, V313, P1775, DOI 10.1126/science.1130408; Gonon F, 1997, J NEUROSCI, V17, P5972; Goodman A, 2008, BIOCHEM PHARMACOL, V75, P266, DOI 10.1016/j.bcp.2007.07.030; Harris GP, 2009, J NEUROSCI, V29, P1446, DOI 10.1523/JNEUROSCI.4585-08.2009; Hart AC, 1999, J NEUROSCI, V19, P1952; Hilliard MA, 2005, EMBO J, V24, P63, DOI 10.1038/sj.emboj.7600493; Hilliard MA, 2004, EMBO J, V23, P1101, DOI 10.1038/sj.emboj.7600107; Hills T, 2004, J NEUROSCI, V24, P1217, DOI 10.1523/JNEUROSCI.1569-03.2004; Hollinger S, 2002, PHARMACOL REV, V54, P527, DOI 10.1124/pr.54.3.527; HORVITZ HR, 1982, SCIENCE, V216, P1012, DOI 10.1126/science.6805073; Kahn-Kirby AH, 2004, CELL, V119, P889, DOI 10.1016/j.cell.2004.11.005; KANTERMAN RY, 1991, MOL PHARMACOL, V39, P364; KAPLAN JM, 1993, P NATL ACAD SCI USA, V90, P2227, DOI 10.1073/pnas.90.6.2227; Kindt KS, 2007, NEURON, V55, P662, DOI 10.1016/j.neuron.2007.07.023; Lints R, 1999, DEVELOPMENT, V126, P5819; McDonald PW, 2007, J NEUROSCI, V27, P14216, DOI 10.1523/JNEUROSCI.2992-07.2007; McDonald PW, 2006, CELL MOL NEUROBIOL, V26, P593, DOI 10.1007/s10571-006-9003-6; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Mitchell R, 1998, NATURE, V392, P411, DOI 10.1038/32937; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; Neve KA, 2004, J RECEPT SIG TRANSD, V24, P165, DOI 10.1081/LRST-200029981; Nilsson CL, 1999, LIFE SCI, V64, P939, DOI 10.1016/S0024-3205(99)00020-X; Nuttley WM, 2002, P NATL ACAD SCI USA, V99, P12449, DOI 10.1073/pnas.192101699; Penn RB, 2000, TRENDS CARDIOVAS MED, V10, P81, DOI 10.1016/S1050-1738(00)00053-0; PERKINS LA, 1986, DEV BIOL, V117, P456, DOI 10.1016/0012-1606(86)90314-3; PIOMELLI D, 1991, NATURE, V353, P164, DOI 10.1038/353164a0; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; Prasad BC, 1999, TRENDS GENET, V15, P150, DOI 10.1016/S0168-9525(99)01695-9; Premont RT, 2007, ANNU REV PHYSIOL, V69, P511, DOI 10.1146/annurev.physiol.69.022405.154731; RANKIN CH, 1992, BEHAV NEUROSCI, V106, P239, DOI 10.1037/0735-7044.106.2.239; RANKIN CH, 1990, BEHAV BRAIN RES, V37, P89, DOI 10.1016/0166-4328(90)90074-O; Redgrave P, 2006, NAT REV NEUROSCI, V7, P967, DOI 10.1038/nrn2022; Rios M, 1999, J NEUROSCI, V19, P3519; Rongo C, 1998, CELL, V94, P751, DOI 10.1016/S0092-8674(00)81734-1; Ronnett GV, 2002, ANNU REV PHYSIOL, V64, P189, DOI 10.1146/annurev.physiol.64.082701.102219; Sanyal S, 2004, EMBO J, V23, P473, DOI 10.1038/sj.emboj.7600057; Sawin ER, 2000, NEURON, V26, P619, DOI 10.1016/S0896-6273(00)81199-X; SCHAFER WR, 1995, NATURE, V375, P73, DOI 10.1038/375073a0; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Schwaerzel M, 2003, J NEUROSCI, V23, P10495, DOI 10.1523/jneurosci.23-33-10495.2003; SEGALAT L, 1995, SCIENCE, V267, P1648, DOI 10.1126/science.7886454; Senogles SE, 2000, MOL PHARMACOL, V58, P455, DOI 10.1124/mol.58.2.455; Sugiura M, 2005, J NEUROCHEM, V94, P1146, DOI 10.1111/j.1471-4159.2005.03268.x; SULSTON J, 1975, J COMP NEUROL, V163, P215, DOI 10.1002/cne.901630207; Suo S, 2003, J NEUROCHEM, V86, P869, DOI 10.1046/j.1471-4159.2003.01896.x; Suo S, 2002, NEUROSCI LETT, V319, P13, DOI 10.1016/S0304-3940(01)02477-6; Suo S, 2009, EMBO J, V28, P2437, DOI 10.1038/emboj.2009.194; Touhara K, 2009, ANNU REV PHYSIOL, V71, P307, DOI 10.1146/annurev.physiol.010908.163209; Troemel ER, 1999, BIOESSAYS, V21, P1011, DOI 10.1002/(SICI)1521-1878(199912)22:1&lt;1011::AID-BIES5&gt;3.0.CO;2-V; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; VIAL D, 1995, J NEUROCHEM, V64, P2765; WARD S, 1975, J COMP NEUROL, V160, P313, DOI 10.1002/cne.901600305; WARE RW, 1975, J COMP NEUROL, V162, P71, DOI 10.1002/cne.901620106; WEINSHENKER D, 1995, J NEUROSCI, V15, P6975; White JG, 1986, PHILOS T R SOC LON B, P1, DOI [10.1098/rstb.1986.0056, DOI 10.1098/RSTB.1986.0056]; Wragg RT, 2007, J NEUROSCI, V27, P13402, DOI 10.1523/JNEUROSCI.3495-07.2007; YUNG KKL, 1995, NEUROSCIENCE, V65, P709, DOI 10.1016/0306-4522(94)00536-E	73	33	36	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2010	5	3							e9487	10.1371/journal.pone.0009487	http://dx.doi.org/10.1371/journal.pone.0009487			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	562OY	20209143	Green Published, gold, Green Submitted			2022-12-25	WOS:000275063300007
J	Soebiyanto, RP; Adimi, F; Kiang, RK				Soebiyanto, Radina P.; Adimi, Farida; Kiang, Richard K.			Modeling and Predicting Seasonal Influenza Transmission in Warm Regions Using Climatological Parameters	PLOS ONE			English	Article							EPIDEMICS	Background: Influenza transmission is often associated with climatic factors. As the epidemic pattern varies geographically, the roles of climatic factors may not be unique. Previous in vivo studies revealed the direct effect of winter-like humidity on air-borne influenza transmission that dominates in regions with temperate climate, while influenza in the tropics is more effectively transmitted through direct contact. Methodology/Principal Findings: Using time series model, we analyzed the role of climatic factors on the epidemiology of influenza transmission in two regions characterized by warm climate: Hong Kong (China) and Maricopa County (Arizona, USA). These two regions have comparable temperature but distinctly different rainfall. Specifically we employed Autoregressive Integrated Moving Average (ARIMA) model along with climatic parameters as measured from ground stations and NASA satellites. Our studies showed that including the climatic variables as input series result in models with better performance than the univariate model where the influenza cases depend only on its past values and error signal. The best model for Hong Kong influenza was obtained when Land Surface Temperature (LST), rainfall and relative humidity were included as input series. Meanwhile for Maricopa County we found that including either maximum atmospheric pressure or mean air temperature gave the most improvement in the model performances. Conclusions/Significance: Our results showed that including the environmental variables generally increases the prediction capability. Therefore, for countries without advanced influenza surveillance systems, environmental variables can be used for estimating influenza transmission at present and in the near future.	[Soebiyanto, Radina P.; Adimi, Farida; Kiang, Richard K.] NASA, Goddard Space Flight Ctr, Global Change Data Ctr, Greenbelt, MD 20771 USA; [Soebiyanto, Radina P.] Univ Maryland Baltimore Cty, Goddard Earth Sci & Technol Ctr, Baltimore, MD 21228 USA; [Adimi, Farida] Wyle Int, Mclean, VA USA	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University System of Maryland; University of Maryland Baltimore County	Soebiyanto, RP (corresponding author), NASA, Goddard Space Flight Ctr, Global Change Data Ctr, Greenbelt, MD 20771 USA.	richard.kiang@nasa.gov			NASA Applied Sciences Public Health Program	NASA Applied Sciences Public Health Program	This study is supported by NASA Applied Sciences Public Health Program (http://nasascience.nasa.gov/earth-science/applied-sciences). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso WJ, 2007, AM J EPIDEMIOL, V165, P1434, DOI 10.1093/aje/kwm012; Box G.E.P., 2009, TIME SERIES ANAL FOR, Vthird; Chatfield C., 2000, TIME SERIES FORECAST; Chew FT, 1998, EPIDEMIOL INFECT, V121, P121, DOI 10.1017/S0950268898008905; Chumkiew S, 2007, PROC WRLD ACAD SCI E, V19, P364; du Prel JB, 2009, CLIN INFECT DIS, V49, P861, DOI 10.1086/605435; Flood Control District of Maricopa, 2009, WEATH INF; Hampson AW, 1999, VACCINE, V17, pS19, DOI 10.1016/S0264-410X(99)00100-0; *HONG KONG DEP HLT, HONG KONG DEP HLTH F; *HONG KONG OBS, HONG KONG OBS EXTR M; Kiang R, 2006, GEOSPATIAL HEALTH, V1, P71, DOI 10.4081/gh.2006.282; Kummerow C, 1998, J ATMOS OCEAN TECH, V15, P809, DOI 10.1175/1520-0426(1998)015<0809:TTRMMT>2.0.CO;2; Lofgren E, 2007, J VIROL, V81, P5429, DOI 10.1128/JVI.01680-06; Lowen AC, 2008, J VIROL, V82, P5650, DOI 10.1128/JVI.00325-08; Lowen AC, 2007, PLOS PATHOG, V3, P1470, DOI 10.1371/journal.ppat.0030151; *MAR DEP PUBL HLTH, MAR DEP PUBL HLTH MA; Moura FEA, 2009, AM J TROP MED HYG, V81, P180, DOI 10.4269/ajtmh.2009.81.180; *NASA GODD EARTH S, GES DISC INT ONL VIS; *NASA GODD SPAC FL, 2009, MODIS; *NASA GODD SPAC FL, 2009, GLOB PREC MEAS; *NASA GODD SPAC FL, 2009, TROP RAINF MEAS MISS; Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945; Russell CA, 2008, VACCINE, V26, pD31, DOI 10.1016/j.vaccine.2008.07.078; Sagripanti JL, 2007, PHOTOCHEM PHOTOBIOL, V83, P1278, DOI 10.1111/j.1751-1097.2007.00177.x; Shaman J, 2009, P NATL ACAD SCI USA, V106, P3243, DOI 10.1073/pnas.0806852106; SMITH E, 2006, MEASURING PRECIPITAT; Urashima M, 2003, JPN J INFECT DIS, V56, P43; Viboud C, 2004, EUR J EPIDEMIOL, V19, P1055, DOI 10.1007/s10654-004-2450-9; Viboud C, 2003, AM J EPIDEMIOL, V158, P996, DOI 10.1093/aje/kwg239; Viboud C, 2006, PLOS MED, V3, P468, DOI 10.1371/journal.pmed.0030089; WHO, 2009, INFL SEAS; Wong CM, 2006, PLOS MED, V3, P485, DOI 10.1371/journal.pmed.0030121; XIAO X, 2007, J WILDLIFE DIS, V43	33	124	129	4	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2010	5	3							e9450	10.1371/journal.pone.0009450	http://dx.doi.org/10.1371/journal.pone.0009450			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	561RT	20209164	Green Submitted, Green Published, gold			2022-12-25	WOS:000274997100003
J	Takao, K; Tanda, K; Nakamura, K; Kasahara, J; Nakao, K; Katsuki, M; Nakanishi, K; Yamasaki, N; Toyama, K; Adachi, M; Umeda, M; Araki, T; Fukunaga, K; Kondo, H; Sakagami, H; Miyakawa, T				Takao, Keizo; Tanda, Koichi; Nakamura, Kenji; Kasahara, Jiro; Nakao, Kazuki; Katsuki, Motoya; Nakanishi, Kazuo; Yamasaki, Nobuyuki; Toyama, Keiko; Adachi, Minami; Umeda, Masahiro; Araki, Tsutomu; Fukunaga, Kohji; Kondo, Hisatake; Sakagami, Hiroyuki; Miyakawa, Tsuyoshi			Comprehensive Behavioral Analysis of Calcium/Calmodulin-Dependent Protein Kinase IV Knockout Mice	PLOS ONE			English	Article							ELEMENT-BINDING PROTEIN; RAT HIPPOCAMPAL-NEURONS; ELEVATED PLUS-MAZE; SYNAPTIC PLASTICITY; DEFICIENT MICE; FEAR MEMORY; PPP3CC GENE; SCHIZOPHRENIA; CALCINEURIN; TRANSCRIPTION	Calcium-calmodulin dependent protein kinase IV (CaMKIV) is a protein kinase that activates the transcription factor CREB, the cyclic AMP-response element binding protein. CREB is a key transcription factor in synaptic plasticity and memory consolidation. To elucidate the behavioral effects of CaMKIV deficiency, we subjected CaMKIV knockout (CaMKIV KO) mice to a battery of behavioral tests. CaMKIV KO had no significant effects on locomotor activity, motor coordination, social interaction, pain sensitivity, prepulse inhibition, attention, or depression-like behavior. Consistent with previous reports, CaMKIV KO mice exhibited impaired retention in a fear conditioning test 28 days after training. In contrast, however, CaMKIV KO mice did not show any testing performance deficits in passive avoidance, one of the most commonly used fear memory paradigms, 28 days after training, suggesting that remote fear memory is intact. CaMKIV KO mice exhibited intact spatial reference memory learning in the Barnes circular maze, and normal spatial working memory in an eight-arm radial maze. CaMKIV KO mice also showed mildly decreased anxiety-like behavior, suggesting that CaMKIV is involved in regulating emotional behavior. These findings indicate that CaMKIV might not be essential for fear memory or spatial memory, although it is possible that the activities of other neural mechanisms or signaling pathways compensate for the CaMKIV deficiency.	[Takao, Keizo; Tanda, Koichi; Nakanishi, Kazuo; Yamasaki, Nobuyuki; Toyama, Keiko; Miyakawa, Tsuyoshi] Kyoto Univ, Grad Sch Med, Frontier Technol Ctr, Genet Engn & Funct Genom Grp, Kyoto, Japan; [Takao, Keizo; Toyama, Keiko; Miyakawa, Tsuyoshi] Fujita Hlth Univ, Inst Comprehens Med Sci, Div Syst Med Sci, Toyoake, Aichi, Japan; [Takao, Keizo; Toyama, Keiko; Miyakawa, Tsuyoshi] Japan Sci & Technol Agcy JST, CREST, Kawaguchi, Saitama, Japan; [Nakamura, Kenji] Mitsubishi Kagaku Inst Life Sci, Mouse Genome Technol Lab, Tokyo, Japan; [Kasahara, Jiro; Adachi, Minami; Umeda, Masahiro; Araki, Tsutomu] Univ Tokushima, Grad Sch Hlth Biosci, Dept Neurobiol & Therapeut, Tokushima 770, Japan; [Kasahara, Jiro; Fukunaga, Kohji] Tohoku Univ, Grad Sch Pharmaceut Sci, Dept Pharmacol, Sendai, Miyagi 980, Japan; [Nakao, Kazuki] RIKEN, Ctr Dev Biol, Lab Anim Resources & Genet Engn, Chuo Ku, Kobe, Hyogo, Japan; [Katsuki, Motoya] Natl Inst Nat Sci, Minato Ku, Tokyo 1050001, Japan; [Kondo, Hisatake] Tohoku Bunka Gakuen Univ, Fac Med Sci & Welf, Dept Rehabil, Sendai, Miyagi, Japan; [Sakagami, Hiroyuki] Kitasato Univ, Sch Med, Dept Anat, Sagamihara, Kanagawa 228, Japan	Kyoto University; Fujita Health University; Japan Science & Technology Agency (JST); Mitsubishi Kagaku Institute of Life Sciences (MITILS); Tokushima University; Tohoku University; RIKEN; National Institutes of Natural Sciences (NINS) - Japan; Kitasato University	Takao, K (corresponding author), Kyoto Univ, Grad Sch Med, Frontier Technol Ctr, Genet Engn & Funct Genom Grp, Kyoto, Japan.	miyakawa@fujita-hu.ac.jp	Takao, Keizo/B-9527-2008; Fukunaga, Kohji/AAI-8811-2021; Miyakawa, Tsuyoshi/A-7741-2008	Takao, Keizo/0000-0002-4734-3583; Miyakawa, Tsuyoshi/0000-0003-0137-8200; zhong wei, he gui/0000-0002-3066-3564; Fukunaga, Kohji/0000-0001-8526-2824	KAKENHI [20016013, 20023017, 16680015, 19653081]; Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan; National Institute of Biomedical Innovation (NIBIO); Neuroinformatics Japan Center (NIJC); CREST & BIRD of Japan Science and Technology Agency (JST)	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute of Biomedical Innovation (NIBIO)(National Institute of Biomedical Innovation); Neuroinformatics Japan Center (NIJC); CREST & BIRD of Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST))	This work was supported by KAKENHI (Grant-in-Aid for Scientific Research) on Priority Areas "Systems Genomics'' (20016013), on Priority Areas "Pathomechanisms of Brain Disorders'' (20023017), Young Scientists A (16680015), Exploratory Research (19653081), and Integrative Brain Research (IBR-shien) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan; Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO); Neuroinformatics Japan Center (NIJC), and by grants from CREST & BIRD of Japan Science and Technology Agency (JST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arguello PA, 2006, NEURON, V52, P179, DOI 10.1016/j.neuron.2006.09.023; Arron JR, 2006, NATURE, V441, P595, DOI 10.1038/nature04678; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; BRAUN AP, 1995, ANNU REV PHYSIOL, V57, P417, DOI 10.1146/annurev.ph.57.030195.002221; Fernandes C, 1996, PHARMACOL BIOCHEM BE, V54, P31, DOI 10.1016/0091-3057(95)02171-X; FRANGAKIS MV, 1991, J BIOL CHEM, V266, P17592; FRANGAKIS MV, 1991, J BIOL CHEM, V266, P11309; FUKUNAGA K, 1988, J NEUROCHEM, V51, P1070, DOI 10.1111/j.1471-4159.1988.tb03070.x; Fukushima H, 2008, J NEUROSCI, V28, P9910, DOI 10.1523/JNEUROSCI.2625-08.2008; Gainetdinov RR, 2001, TRENDS NEUROSCI, V24, P527, DOI 10.1016/S0166-2236(00)01886-5; Gerber DJ, 2003, P NATL ACAD SCI USA, V100, P8993, DOI 10.1073/pnas.1432927100; Ho N, 2000, J NEUROSCI, V20, P6459, DOI 10.1523/JNEUROSCI.20-17-06459.2000; Horiuchi Y, 2007, MOL PSYCHIATR, V12, P891, DOI 10.1038/sj.mp.4002019; Impey S, 1998, NAT NEUROSCI, V1, P595, DOI 10.1038/2830; Kang HJ, 2001, CELL, V106, P771, DOI 10.1016/S0092-8674(01)00497-4; Kasahara J, 1999, J BIOL CHEM, V274, P9061, DOI 10.1074/jbc.274.13.9061; Kasahara J, 2001, J BIOL CHEM, V276, P24044, DOI 10.1074/jbc.M100247200; Ko SW, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-10; Komada M., 2008, J VIS EXP, V1088; KUEHN MR, 1987, NATURE, V326, P295, DOI 10.1038/326295a0; Liu YL, 2007, MOL PSYCHIATR, V12, P966, DOI 10.1038/sj.mp.4001977; Maldonado R, 1999, P NATL ACAD SCI USA, V96, P14094, DOI 10.1073/pnas.96.24.14094; Mansuy IM, 2003, BIOCHEM BIOPH RES CO, V311, P1195, DOI 10.1016/j.bbrc.2003.10.046; Mathieu F, 2008, BEHAV BRAIN FUNCT, V4, DOI 10.1186/1744-9081-4-2; Matsuo N, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.003.2009; MATTHEWS RP, 1994, MOL CELL BIOL, V14, P6107, DOI 10.1128/MCB.14.9.6107; MEANS AR, 1991, MOL CELL BIOL, V11, P3960, DOI 10.1128/MCB.11.8.3960; Miyakawa T, 2003, P NATL ACAD SCI USA, V100, P8987, DOI 10.1073/pnas.1432926100; NAKAMURA Y, 1995, NEUROSCIENCE, V68, P181, DOI 10.1016/0306-4522(95)00092-W; OHMSTEDE CA, 1989, J BIOL CHEM, V264, P5866; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; Powell CM, 2006, BIOL PSYCHIAT, V59, P1198, DOI 10.1016/j.biopsych.2006.05.008; Sakagami H, 2004, EUR J NEUROSCI, V19, P863, DOI 10.1111/j.0953-816X.2004.03195.x; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Shi JJ, 2008, SCHIZOPHR RES, V104, P96, DOI 10.1016/j.schres.2008.06.016; Shum FWF, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-22; Takao K., 2006, J VIS EXP, V104; Takao K, 2007, NEUROSCI RES, V58, P124, DOI 10.1016/j.neures.2007.02.009; Tanda K, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-19; Tiraboschi E, 2004, NEUROPSYCHOPHARMACOL, V29, P1831, DOI 10.1038/sj.npp.1300488; Uezu A, 2002, J NEUROCHEM, V82, P585, DOI 10.1046/j.1471-4159.2002.00984.x; Valverde O, 2004, NEUROPSYCHOPHARMACOL, V29, P1122, DOI 10.1038/sj.npp.1300416; Wei F, 2002, NAT NEUROSCI, V5, P573, DOI 10.1038/nn0602-855; West AE, 2002, NAT REV NEUROSCI, V3, P921, DOI 10.1038/nrn987; Wu JY, 2000, NAT GENET, V25, P448, DOI 10.1038/78153; Wu LJ, 2008, EUR J NEUROSCI, V27, P1923, DOI 10.1111/j.1460-9568.2008.06183.x; Yamada K, 2007, P NATL ACAD SCI USA, V104, P2815, DOI 10.1073/pnas.0610765104; Yamasaki N, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-6; Zeng HK, 2001, CELL, V107, P617, DOI 10.1016/S0092-8674(01)00585-2	49	55	58	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2010	5	3							e9460	10.1371/journal.pone.0009460	http://dx.doi.org/10.1371/journal.pone.0009460			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	561RT	20209163	Green Submitted, Green Published, gold			2022-12-25	WOS:000274997100007
J	Bolego, C; Rossoni, G; Fadini, GP; Vegeto, E; Pinna, C; Albiero, M; Boscaro, E; Agostini, C; Avogaro, A; Gaion, RM; Cignarella, A				Bolego, Chiara; Rossoni, Giuseppe; Fadini, Gian Paolo; Vegeto, Elisabetta; Pinna, Christian; Albiero, Mattia; Boscaro, Elisa; Agostini, Carlo; Avogaro, Angelo; Gaion, Rosa Maria; Cignarella, Andrea			Selective estrogen receptor-alpha agonist provides widespread heart and vascular protection with enhanced endothelial progenitor cell mobilization in the absence of uterotrophic action	FASEB JOURNAL			English	Article						tissue selectivity; ischemia-reperfusion; endothelial function; pharmacology	ISCHEMIA-REPERFUSION INJURY; ER-ALPHA; MYOCARDIAL-INFARCTION; FEMALE RATS; IN-VIVO; BETA; MICE; ACTIVATION; GENE; ESTRADIOL	The beneficial effects of estrogens on the cardiovascular system are associated with adverse effects on reproductive tissues. On the basis of previous work indicating a major role for estrogen receptor (ER)-alpha in maintaining cardiovascular health, we evaluated the tissue selectivity of the ER alpha-selective agonist propyl pyrazole triol (PPT) compared with 17 beta-estradiol (E2) in vivo. Four weeks postovariectomy, equimolar doses of PPT and E2 were administered to rats in subcutaneous implants for 5 d. Both treatments restored rapid vasorelaxation of aortic tissue to estrogenic agents and prevented coronary hyperresponsiveness to angiotensin II in isolated heart preparations. Accordingly, multiple endpoints of myocardial ischemia-reperfusion injury exacerbated by ovariectomy returned to baseline following treatment. These protective effects were linked to increased in vivo levels of endothelial progenitor cells (EPCs). Human EPC function was enhanced in vitro after PPT treatment. In sharp contrast to E2, PPT treatment had no effect on uterine weight and histomorphology except for vessel density, and failed to up-regulate classic estrogen target genes. Dissection of the effects on vascular reactivity and uterine morphology was also observed following increased exposure to PPT at a higher dose for longer time. These data provide the first in vivo evidence for tissue-specific ER alpha activation. By conferring cardiovascular protection dissected from unwanted uterotrophic effects, ER alpha-selective agonists may represent a potential safer alternative to natural hormones.-Bolego, C., Rossoni, G., Fadini, G. P., Vegeto, E., Pinna, C., Albiero, M., Boscaro, E., Agostini, C., Avogaro, A., Gaion, R. M., Cignarella, A. Selective estrogen receptor-alpha agonist provides widespread heart and vascular protection with enhanced endothelial progenitor cell mobilization in the absence of uterotrophic action. FASEB J. 24, 2262-2272 (2010). www.fasebj.org	[Bolego, Chiara; Gaion, Rosa Maria; Cignarella, Andrea] Univ Padua, Dept Pharmacol & Anesthesiol, I-35131 Padua, Italy; [Rossoni, Giuseppe] Univ Milan, Dept Pharmacol Chemotherapy & Med Toxicol, Milan, Italy; [Vegeto, Elisabetta; Pinna, Christian] Univ Milan, Dept Pharmacol Sci, Milan, Italy; [Fadini, Gian Paolo; Albiero, Mattia; Boscaro, Elisa; Agostini, Carlo; Avogaro, Angelo] Padua Univ Hosp, Dept Clin & Expt Med, Padua, Italy	University of Padua; University of Milan; University of Milan; University of Padua; Azienda Ospedaliera - Universita di Padova	Bolego, C (corresponding author), Univ Padua, Dept Pharmacol & Anesthesiol, Largo Meneghetti 2, I-35131 Padua, Italy.	chiara.bolego@unipd.it	Albiero, Mattia/AAG-4257-2019; Fadini, Gian Paolo/M-4575-2019; Albiero, Mattia/J-4145-2012; Avogaro, Angelo/S-3808-2016; Agostini, Carlo/J-3103-2012	Albiero, Mattia/0000-0003-4142-9738; Fadini, Gian Paolo/0000-0002-6510-2097; Albiero, Mattia/0000-0003-4142-9738; Agostini, Carlo/0000-0001-7786-3574; AVOGARO, ANGELO/0000-0002-1177-0516; Cignarella, Andrea/0000-0002-4820-4876; VEGETO, ELISABETTA/0000-0003-4351-3650	Milan University; Padua University; Heart Repair consortium; Italian Ministry of University and Research [2006065483_003]	Milan University; Padua University; Heart Repair consortium; Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR))	This study was funded by grants from Milan University, Padua University, the Heart Repair consortium (http://www.heartrepair.eu), and the Italian Ministry of University and Research (PRIN grant 2006065483_003).	Ball LJ, 2009, MOL CELL ENDOCRINOL, V299, P204, DOI 10.1016/j.mce.2008.10.050; BERGMEYER HU, 1970, Z KLIN CHEM KLIN BIO, V8, P658; Bolego C, 2005, J PHARMACOL EXP THER, V313, P1203, DOI 10.1124/jpet.104.082867; Bolego C, 2006, ARTERIOSCL THROM VAS, V26, P2192, DOI 10.1161/01.ATV.0000242186.93243.25; Booth EA, 2005, AM J PHYSIOL-HEART C, V289, pH2039, DOI 10.1152/ajpheart.00479.2005; Brewer LD, 2009, J NEUROSCI, V29, P6058, DOI 10.1523/JNEUROSCI.5253-08.2009; Carthew P, 1999, TOXICOL SCI, V48, P197, DOI 10.1093/toxsci/48.2.197; Deroo BJ, 2006, J CLIN INVEST, V116, P561, DOI 10.1172/JCI27987; Dupont S, 2000, DEVELOPMENT, V127, P4277; Egan KM, 2004, SCIENCE, V306, P1954, DOI 10.1126/science.1103333; Fadini GP, 2006, DIABETOLOGIA, V49, P3075, DOI 10.1007/s00125-006-0401-6; Fadini GP, 2008, ATHEROSCLEROSIS, V197, P496, DOI 10.1016/j.atherosclerosis.2007.12.039; Fadini GP, 2008, ARTERIOSCL THROM VAS, V28, P997, DOI 10.1161/ATVBAHA.107.159558; Fadini GP, 2006, ARTERIOSCL THROM VAS, V26, P2140, DOI 10.1161/01.ATV.0000237750.44469.88; GRADY D, 1995, OBSTET GYNECOL, V85, P304, DOI 10.1016/0029-7844(94)00383-O; Hamada H, 2006, CIRCULATION, V114, P2261, DOI 10.1161/CIRCULATIONAHA.106.631465; Harris HA, 2002, ENDOCRINOLOGY, V143, P4172, DOI 10.1210/en.2002-220403; Harris HA, 2007, MOL ENDOCRINOL, V21, P1, DOI 10.1210/me.2005-0459; HOHORST HJ, 1963, METHOD ENZYMAT AN, P215; Karas RH, 1999, P NATL ACAD SCI USA, V96, P15133, DOI 10.1073/pnas.96.26.15133; Karas RH, 2001, CIRC RES, V89, P534, DOI 10.1161/hh1801.097239; Kraichely DM, 2000, ENDOCRINOLOGY, V141, P3534, DOI 10.1210/en.141.10.3534; Le Saux M, 2006, J NEUROENDOCRINOL, V18, P25, DOI 10.1111/j.1365-2826.2005.01380.x; Lindberg MK, 2003, MOL ENDOCRINOL, V17, P203, DOI 10.1210/me.2002-0206; Liu J, 2002, J BIOL CHEM, V277, P20927, DOI 10.1074/jbc.M110712200; LUBAHN DB, 1993, P NATL ACAD SCI USA, V90, P11162, DOI 10.1073/pnas.90.23.11162; Makela S, 1999, P NATL ACAD SCI USA, V96, P7077, DOI 10.1073/pnas.96.12.7077; McDonnell DP, 2002, SCIENCE, V296, P1642, DOI 10.1126/science.1071884; Morani A, 2006, P NATL ACAD SCI USA, V103, P7165, DOI 10.1073/pnas.0602194103; Novotny JL, 2009, ENDOCRINOLOGY, V150, P889, DOI 10.1210/en.2008-0708; O'Lone R, 2007, MOL ENDOCRINOL, V21, P1281, DOI 10.1210/me.2006-0497; Pare G, 2002, CIRC RES, V90, P1087, DOI 10.1161/01.RES.0000021114.92282.FA; Pelzer T, 2005, CARDIOVASC RES, V67, P604, DOI 10.1016/j.cardiores.2005.04.035; Pendaries C, 2002, P NATL ACAD SCI USA, V99, P2205, DOI 10.1073/pnas.042688499; Pinna C, 2008, HYPERTENSION, V51, P1210, DOI 10.1161/HYPERTENSIONAHA.107.106807; Rosenzweig A, 2005, NEW ENGL J MED, V353, P1055, DOI 10.1056/NEJMe058134; Rossoni G, 1998, J CARDIOVASC PHARM, V32, P260, DOI 10.1097/00005344-199808000-00013; Schrepfer S, 2006, MENOPAUSE, V13, P489, DOI 10.1097/01.gme.0000185941.63497.10; Schuit SCE, 2004, JAMA-J AM MED ASSOC, V291, P2969, DOI 10.1001/jama.291.24.2969; Urbich C, 2004, CIRC RES, V95, P343, DOI 10.1161/01.RES.0000137877.89448.78; WATSON RE, 1986, BRAIN RES, V398, P157, DOI 10.1016/0006-8993(86)91261-8; Wu HJ, 2005, NATURE, V438, P981, DOI 10.1038/nature04225; Xing DQ, 2009, ARTERIOSCL THROM VAS, V29, P289, DOI 10.1161/ATVBAHA.108.182279	43	25	32	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JUL	2010	24	7					2262	2272		10.1096/fj.09-139220	http://dx.doi.org/10.1096/fj.09-139220			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	618HV	20203089	Green Submitted			2022-12-25	WOS:000279343600013
J	Lindberg, MJ; Popko-Scibor, AE; Hansson, ML; Wallberg, AE				Lindberg, Mikael J.; Popko-Scibor, Anita E.; Hansson, Magnus L.; Wallberg, Annika E.			SUMO modification regulates the transcriptional activity of MAML1	FASEB JOURNAL			English	Article						HDAC; coactivator; Notch	UBIQUITIN-LIKE PROTEIN; NEUROGENIC LOCUS MASTERMIND; COACTIVATOR MAML1; SUBNUCLEAR LOCALIZATION; DROSOPHILA MASTERMIND; COVALENT MODIFICATION; NOTCH COACTIVATOR; IN-VITRO; SUMOYLATION; ACTIVATION	The Mastermindlike ( MAML) family, comprising human MAML1, MAML2, and MAML3, are transcriptional regulators in Notch signaling. MAML proteins contain two consensus sites for SUMOylation at Lysine217 and Lysine299 that are conserved in humans, mice, and Xenopus. In this report, we show that MAML1 is SUMOylated at both sites. The E2-conjugating enzyme UBC9 is essential for MAML1 SUMOylation, and the E3 ligase PIAS1 stimulates this activity. Mutation of the lysines abolishes SUMOylation of MAML1 and strongly increases MAML1-activated transcription in cell culture assays. The protease SENP1 reverses SUMOylation of MAML1 and potentiates the transcription factor activity of MAML1. Furthermore, SUMOylation enhances MAML1 interaction with HDAC7, which decreases MAML1 transcriptional activity. Taken together, our data indicate that SUMOylation of MAML1 is a mechanism for repressing MAML1 activity by influencing its interaction with HDAC7.-Lindberg, M.J., Popko-Scibor, A.E., Hansson, M.L., Wallberg, A. E. SUMO modification regulates the transcriptional activity of MAML1. FASEB J. 24, 2396-2404 (2010). www.fasebj.org	[Lindberg, Mikael J.; Popko-Scibor, Anita E.; Hansson, Magnus L.; Wallberg, Annika E.] Karolinska Inst, Dept Biosci & Nutr, S-14186 Huddinge, Sweden	Karolinska Institutet	Wallberg, AE (corresponding author), Karolinska Inst, Dept Biosci & Nutr, Halsovagen 7-9, S-14186 Huddinge, Sweden.	annika.wallberg@ki.se		Lindberg, Mikael/0000-0001-8595-8901	Swedish Research Council; Swedish Cancer Society; Swedish Children's Cancer Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Swedish Children's Cancer Foundation	The authors thank Dr. Frances Fuller-Pace (University of Dundee, Dundee, UK), Dr. Ron Hay (University of Dundee), Dr. Peter O'Hare (Marie Curie Research Institute, Osted, UK), Dr. Jorma Palvimo (University of Kuopio, Kuopio, Finland), Dr. Ed Seto (University of South Florida, Tampa, FL, USA), and Dr. Eric Jensen (University of Minnesota School of Dentistry, Minneapolis, MN, USA) for generously providing expression plasmids described in Materials and Methods. This work was supported by grants from the Swedish Research Council, the Swedish Cancer Society, and the Swedish Children's Cancer Foundation to A.E.W. M.J.L. was supported by a fellowship from the Swedish Children's Cancer Foundation and a grant from Alex and Eva Wallstrom foundation.	Alves-Guerra MC, 2007, CANCER RES, V67, P8690, DOI 10.1158/0008-5472.CAN-07-1720; Anckar J, 2007, BIOCHEM SOC T, V35, P1409, DOI 10.1042/BST0351409; Cheng J, 2007, CELL, V131, P584, DOI 10.1016/j.cell.2007.08.045; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; Desterro JMP, 1999, J BIOL CHEM, V274, P10618, DOI 10.1074/jbc.274.15.10618; Dressel U, 2001, J BIOL CHEM, V276, P17007, DOI 10.1074/jbc.M101508200; Fryer CJ, 2004, MOL CELL, V16, P509, DOI 10.1016/j.molcel.2004.10.014; Fryer CJ, 2002, GENE DEV, V16, P1397, DOI 10.1101/gad.991602; Fu CH, 2005, ONCOGENE, V24, P5401, DOI 10.1038/sj.onc.1208714; Gao CZ, 2008, MOL CELL BIOL, V28, P5658, DOI 10.1128/MCB.00874-08; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Girdwood D, 2003, MOL CELL, V11, P1043, DOI 10.1016/S1097-2765(03)00141-2; Gong LM, 1999, FEBS LETT, V448, P185, DOI 10.1016/S0014-5793(99)00367-1; Gregoire S, 2005, MOL CELL BIOL, V25, P2273, DOI 10.1128/MCB.25.6.2273-2287.2005; Gregoire S, 2006, J BIOL CHEM, V281, P4423, DOI 10.1074/jbc.M509471200; Hansson ML, 2009, NUCLEIC ACIDS RES, V37, P2996, DOI 10.1093/nar/gkp163; Hay RT, 2007, TRENDS CELL BIOL, V17, P370, DOI 10.1016/j.tcb.2007.08.002; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hochstrasser M, 2001, CELL, V107, P5, DOI 10.1016/S0092-8674(01)00519-0; Hofmann WA, 2009, J CELL BIOL, V186, P193, DOI 10.1083/jcb.200905016; Jackson PK, 2001, GENE DEV, V15, P3053, DOI 10.1101/gad.955501; Jacobs AMF, 2007, ONCOGENE, V26, P5866, DOI 10.1038/sj.onc.1210387; Jeffries S, 2002, MOL CELL BIOL, V22, P3927, DOI 10.1128/MCB.22.11.3927-3941.2002; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Johnson ES, 1997, J BIOL CHEM, V272, P26799, DOI 10.1074/jbc.272.43.26799; Ribeiro MSJ, 2007, BIOCHEM J, V404, P289, DOI 10.1042/BJ20061900; Kagey MH, 2003, CELL, V113, P127, DOI 10.1016/S0092-8674(03)00159-4; Kao HY, 2000, GENE DEV, V14, P55; Kitagawa M, 2001, MOL CELL BIOL, V21, P4337, DOI 10.1128/MCB.21.13.4337-4346.2001; Kurooka K, 2000, J BIOL CHEM, V275, P17211, DOI 10.1074/jbc.M000909200; Lin DY, 2006, MOL CELL, V24, P341, DOI 10.1016/j.molcel.2006.10.019; Lin SE, 2002, J BIOL CHEM, V277, P50612, DOI 10.1074/jbc.M209529200; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; Melchior F, 2000, ANNU REV CELL DEV BI, V16, P591, DOI 10.1146/annurev.cellbio.16.1.591; Meulmeester E, 2008, NATURE, V452, P709, DOI 10.1038/452709a; Okuma T, 1999, BIOCHEM BIOPH RES CO, V254, P693, DOI 10.1006/bbrc.1998.9995; Oswald F, 2001, MOL CELL BIOL, V21, P7761, DOI 10.1128/MCB.21.22.7761-7774.2001; Petcherski AG, 2000, CURR BIOL, V10, pR471, DOI 10.1016/S0960-9822(00)00577-7; Pichler A, 2002, CELL, V108, P109, DOI 10.1016/S0092-8674(01)00633-X; Poukka H, 2000, P NATL ACAD SCI USA, V97, P14145, DOI 10.1073/pnas.97.26.14145; Ribeiro MSJ, 2009, NUCLEIC ACIDS RES, V37, P6691, DOI 10.1093/nar/gkp724; Rodriguez MS, 1999, EMBO J, V18, P6455, DOI 10.1093/emboj/18.22.6455; Ross S, 2002, MOL CELL, V10, P831, DOI 10.1016/S1097-2765(02)00682-2; Shen HX, 2006, GENE DEV, V20, P675, DOI 10.1101/gad.1383706; SMOLLER D, 1990, GENE DEV, V4, P1688, DOI 10.1101/gad.4.10.1688; Stankovic-Valentin N, 2007, MOL CELL BIOL, V27, P2661, DOI 10.1128/MCB.01098-06; Steffan JS, 2004, SCIENCE, V304, P100, DOI 10.1126/science.1092194; Sternsdorf T, 1997, J CELL BIOL, V139, P1621, DOI 10.1083/jcb.139.7.1621; Thompson PR, 2004, NAT STRUCT MOL BIOL, V11, P308, DOI 10.1038/nsmb740; Vethantham V, 2008, GENE DEV, V22, P499, DOI 10.1101/gad.1628208; Wallberg AE, 2002, MOL CELL BIOL, V22, P7812, DOI 10.1128/MCB.22.22.7812-7819.2002; Wu L, 2002, MOL CELL BIOL, V22, P7688, DOI 10.1128/MCB.22.21.7688-7700.2002; Wu LZ, 2000, NAT GENET, V26, P484, DOI 10.1038/82644; Wu SY, 2009, EMBO J, V28, P1246, DOI 10.1038/emboj.2009.83; Yamaguchi T, 2005, MOL CELL BIOL, V25, P5171, DOI 10.1128/MCB.25.12.5171-5182.2005; Yang SH, 2004, MOL CELL, V13, P611, DOI 10.1016/S1097-2765(04)00060-7; YEDVOBNICK B, 1988, GENETICS, V118, P483; Yeh ETH, 2009, J BIOL CHEM, V284, P8223, DOI 10.1074/jbc.R800050200; Zhang XD, 2008, MOL CELL, V29, P729, DOI 10.1016/j.molcel.2008.01.013; Zhao J, 2007, CELL MOL LIFE SCI, V64, P3017, DOI 10.1007/s00018-007-7137-4; Zhao X, 2005, MOL CELL BIOL, V25, P8456, DOI 10.1128/MCB.25.19.8456-8464.2005; Zhao YT, 2007, J BIOL CHEM, V282, P11969, DOI 10.1074/jbc.M608974200	62	18	18	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2010	24	7					2396	2404		10.1096/fj.09-149401	http://dx.doi.org/10.1096/fj.09-149401			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	618HV	20203086				2022-12-25	WOS:000279343600026
J	McNeish, J; Roach, M; Hambor, J; Mather, RJ; Weibley, L; Lazzaro, J; Gazard, J; Schwarz, J; Volkmann, R; Machacek, D; Stice, S; Zawadzke, L; O'Donnell, C; Hurst, R				McNeish, John; Roach, Marsha; Hambor, John; Mather, Robert J.; Weibley, Laura; Lazzaro, John; Gazard, Justin; Schwarz, Jacob; Volkmann, Robert; Machacek, David; Stice, Steve; Zawadzke, Laura; O'Donnell, Christopher; Hurst, Raymond			High-throughput Screening in Embryonic Stem Cell-derived Neurons Identifies Potentiators of alpha-Amino-3-hydroxyl-5-methyl-4-isoxazolepropionate-type Glutamate Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OBJECT RECOGNITION TASK; AMPA RECEPTORS; POSITIVE MODULATION; IPS CELLS; HUMAN ES; DIFFERENTIATION; ACID; PROLIFERATION; HIPPOCAMPAL; EXPRESSION	Stem cell biology offers advantages to investigators seeking to identify new therapeutic molecules. Specifically, stem cells are genetically stable, scalable for molecular screening, and function in cellular assays for drug efficacy and safety. A key hurdle for drug discoverers of central nervous system disease is a lack of high quality neuronal cells. In the central nervous system, alpha-amino-3-hydroxyl-5-methyl-4-isoxazolepropionate (AMPA) subtype glutamate receptors mediate the vast majority of excitatory neurotransmissions. Embryonic stem (ES) cell protocols were developed to differentiate into neuronal sub-types that express AMPA receptors and were pharmacologically responsive to standard compounds for AMPA potentiation. Therefore, we hypothesized that stem cell-derived neurons should be predictive in high-throughput screens (HTSs). Here, we describe a murine ES cell-based HTS of a 2.4 x 10(6) compound library, the identification of novel chemical "hits" for AMPA potentiation, structure function relationship of compounds and receptors, and validation of chemical leads in secondary assays using human ES cell-derived neurons. This reporting of murine ES cell derivatives being formatted to deliver HTS of greater than 10(6) compounds for a specific drug target conclusively demonstrates a new application for stem cells in drug discovery. In the future new molecular entities may be screened directly in human ES or induced pluripotent stem cell derivatives.	[McNeish, John; Roach, Marsha; Hambor, John] Pfizer Global Res & Dev, Genetically Modified Models COE, Groton, CT 06340 USA; [Mather, Robert J.; Weibley, Laura; Lazzaro, John; Gazard, Justin; Zawadzke, Laura; Hurst, Raymond] Pfizer Global Res & Dev, Neurosci Biol, Groton, CT 06340 USA; [Schwarz, Jacob; Volkmann, Robert; O'Donnell, Christopher] Pfizer Global Res & Dev, Neurosci Chem, Groton, CT 06340 USA; [Machacek, David; Stice, Steve] ArunA Biomed, Athens, GA 30602 USA	Pfizer; Pfizer; Pfizer	McNeish, J (corresponding author), Pfizer Regenerat Med, 620 Mem Dr, Cambridge, MA 02139 USA.	john.d.mcneish@pfizer.com						Bai F, 2003, NEUROPHARMACOLOGY, V44, P1013, DOI 10.1016/S0028-3908(03)00104-7; Baumbarger PJ, 2001, J PHARMACOL EXP THER, V298, P86; Bertheleme N., 2008, Patent No. [WO 2008/113795 A1, 2008113795]; Black MD, 2005, PSYCHOPHARMACOLOGY, V179, P154, DOI 10.1007/s00213-004-2065-6; Borowiak M, 2009, CELL STEM CELL, V4, P348, DOI 10.1016/j.stem.2009.01.014; Bradley D. M., 2008, Patent No. [WO 2008/148832 A1, 2008148832]; Bradley D. M., 2008, Patent No. [WO 2008/148836 A1, 2008148836]; BRADLEY DM, 2007, Patent No. 2007107539; BRADLEY DM, 2008, Patent No. 2008110566; Cardullo F., 2008, [No title captured], Patent No. [WO 2008/053031 A1, 2008053031, 2008053031 A1]; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chen S, 2009, NAT CHEM BIOL, V5, P258, DOI 10.1038/nchembio.154; Desbordes SC, 2008, CELL STEM CELL, V2, P602, DOI 10.1016/j.stem.2008.05.010; Desos P, 1996, J MED CHEM, V39, P197, DOI 10.1021/jm950323j; Donevan SD, 1998, NEUROSCIENCE, V87, P615, DOI 10.1016/S0306-4522(98)00109-2; Francotte Pierre, 2006, Recent Pat CNS Drug Discov, V1, P239, DOI 10.2174/157488906778773661; Gillen K.J., 2008, Patent No. [WO 2008/003452 A1, 2008003452]; Kato AS, 2008, NEURON, V59, P986, DOI 10.1016/j.neuron.2008.07.034; Kew JNC, 2005, PSYCHOPHARMACOLOGY, V179, P4, DOI 10.1007/s00213-005-2200-z; Lang RJ, 2004, EUR J NEUROSCI, V20, P3209, DOI 10.1111/j.1460-9568.2004.03782.x; Lauterborn JC, 2000, J NEUROSCI, V20, P8, DOI 10.1523/JNEUROSCI.20-01-00008.2000; Lebrun C, 2000, EUR J PHARMACOL, V401, P205, DOI 10.1016/S0014-2999(00)00429-5; LEVIN ED, 1988, NEUROSCI BIOBEHAV R, V12, P169, DOI 10.1016/S0149-7634(88)80008-3; Lynch G, 2006, CURR OPIN PHARMACOL, V6, P82, DOI 10.1016/j.coph.2005.09.005; Lynch G, 2004, CURR OPIN PHARMACOL, V4, P4, DOI 10.1016/j.coph.2003.09.009; Lynch G, 1997, EXP NEUROL, V145, P89, DOI 10.1006/exnr.1997.6447; Mackowiak M, 2002, NEUROPHARMACOLOGY, V43, P1, DOI 10.1016/S0028-3908(02)00066-7; McNeish J, 2004, NAT REV DRUG DISCOV, V3, P70, DOI 10.1038/nrd1281; McNeish JD, 2007, CURR OPIN PHARMACOL, V7, P515, DOI 10.1016/j.coph.2007.06.005; Miret JJ, 2005, J BIOMOL SCREEN, V10, P780, DOI 10.1177/1087057105279493; Miu P, 2001, NEUROPHARMACOLOGY, V40, P976, DOI 10.1016/S0028-3908(01)00027-2; O'Neill MJ, 2007, IDRUGS, V10, P185; OLTON DS, 1987, PHYSIOL BEHAV, V40, P793, DOI 10.1016/0031-9384(87)90286-1; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Roach M L, 2002, Methods Mol Biol, V185, P1; Robas Nicola M, 2005, Methods Mol Biol, V306, P17; Rorick-Kehn LM, 2005, PSYCHOPHARMACOLOGY, V183, P226, DOI 10.1007/s00213-005-0169-2; Schoft VK, 2007, NUCLEIC ACIDS RES, V35, P3723, DOI 10.1093/nar/gkm314; Shin SJ, 2006, STEM CELLS, V24, P125, DOI 10.1634/stemcells.2004-0150; Silvers JM, 2007, J NEUROSCI METH, V166, P99, DOI 10.1016/j.jneumeth.2007.06.032; Song ZH, 2009, CELL RES, V19, P1233, DOI 10.1038/cr.2009.107; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang DH, 2009, CELL RES, V19, P429, DOI 10.1038/cr.2009.28; Zhang JH, 2009, CIRC RES, V104, pE30, DOI 10.1161/CIRCRESAHA.108.192237; ZIVKOVIC I, 1995, J PHARMACOL EXP THER, V272, P300	47	56	57	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					17209	17217		10.1074/jbc.M109.098814	http://dx.doi.org/10.1074/jbc.M109.098814			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20212047	Green Published, hybrid			2022-12-25	WOS:000277982600083
J	Sauliere-Nzeh, AN; Millot, C; Corbani, M; Mazeres, S; Lopez, A; Salome, L				Sauliere-Nzeh, Aude Ndong; Millot, Claire; Corbani, Maithe; Mazeres, Serge; Lopez, Andre; Salome, Laurence			Agonist-selective Dynamic Compartmentalization of Human Mu Opioid Receptor as Revealed by Resolutive FRAP Analysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; PLASMA-MEMBRANE; LIVING CELLS; LIPID RAFTS; FLUORESCENCE RECOVERY; SH-SY5Y CELLS; ENDOCYTOSIS; MECHANISMS; DESENSITIZATION; MICRODOMAINS	Techniques for analyzing the membrane diffusion of molecules are the most promising methods for investigating the compartmentalization of G-protein-coupled receptors, particularly as relevant to receptor signaling processes. Here, we report fluorescence recovery after photobleaching (FRAP) measurements performed at variable spot radius for human mu opioid (hMOP) receptors on SH-SY5Y neuroblastoma cells in the presence of ligands. Although an antagonist did not affect the behavior of the receptors compared with the basal state, two different agonists, DAMGO and morphine, caused markedly different changes to receptor diffusion. Like receptors in the absence of ligand, receptors bound to morphine exhibited diffusion confined to joined semipermeable domains, but with smaller domain size and diffusion coefficient. This effect was inhibited by pertussis toxin, strongly suggesting that this dynamic behavior is associated with early steps of signaling. In the presence of DAMGO, half of the receptors displayed free long-range diffusion and the other half were confined to smaller isolated domains. Hypertonic sucrose buffer suppressed this effect, which we attribute to receptor entry into clathrin-coated pits. It is likely that the observation of distinct receptor dynamics in the presence of DAMGO and morphine involves the agonist-selective phosphorylation of the receptor.	[Salome, Laurence] CNRS, IPBS, F-31077 Toulouse, France; Univ Toulouse, IPBS, UPS, F-31077 Toulouse, France	Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Salome, L (corresponding author), CNRS, IPBS, 205 Route Narbonne, F-31077 Toulouse, France.	laurence.salome@ipbs.fr		MAZERES, Serge/0000-0002-0263-634X; SALOME, Laurence/0000-0001-9667-4154	CNRS; MENESR	CNRS(Centre National de la Recherche Scientifique (CNRS)); MENESR	This work was supported by the CNRS and MENESR joint DRAB program.	Andre A, 2008, BBA-BIOMEMBRANES, V1778, P1483, DOI 10.1016/j.bbamem.2008.03.017; Baker A, 2007, EUR BIOPHYS J BIOPHY, V36, P849, DOI 10.1007/s00249-007-0214-7; Baker AM, 2007, J BIOL CHEM, V282, P35163, DOI 10.1074/jbc.M705617200; BELCHEVA MM, 1992, MOL PHARMACOL, V42, P445; Bockaert J, 1999, EMBO J, V18, P1723, DOI 10.1093/emboj/18.7.1723; Bunemann M, 1999, J PHYSIOL-LONDON, V517, P5, DOI 10.1111/j.1469-7793.1999.0005z.x; Cao TT, 1998, J BIOL CHEM, V273, P24592, DOI 10.1074/jbc.273.38.24592; Cezanne L, 2004, J BIOL CHEM, V279, P45057, DOI 10.1074/jbc.M404811200; Chidiac P, 1998, BIOCHEM PHARMACOL, V55, P549, DOI 10.1016/S0006-2952(97)00361-4; DAUMAS F, 2002, THESIS U P SABATIER; Destainville Nicolas, 2008, J Chem Biol, V1, P37, DOI 10.1007/s12154-008-0005-3; Engelman DM, 2005, NATURE, V438, P578, DOI 10.1038/nature04394; Gaibelet G, 2008, MOL MEMBR BIOL, V25, P423, DOI 10.1080/09687680802203380; Hegener O, 2004, BIOCHEMISTRY-US, V43, P6190, DOI 10.1021/bi035928t; HEUSER JE, 1989, J CELL BIOL, V108, P389, DOI 10.1083/jcb.108.2.389; Hur EM, 2002, CELL SIGNAL, V14, P397, DOI 10.1016/S0898-6568(01)00258-3; Ivanov Andrei I., 2008, V440, P15, DOI 10.1007/978-1-59745-178-9_2; Jacquier V, 2006, P NATL ACAD SCI USA, V103, P14325, DOI 10.1073/pnas.0603942103; Johnson EA, 2006, MOL PHARMACOL, V70, P676, DOI 10.1124/mol.106.022376; Kelly E, 2008, BRIT J PHARMACOL, V153, pS379, DOI 10.1038/sj.bjp.0707604; KRUEGER KM, 1995, CLIN MICROBIOL REV, V8, P34, DOI 10.1128/CMR.8.1.34; Lill Y, 2005, CHEMPHYSCHEM, V6, P1633, DOI 10.1002/cphc.200500111; LOPEZ A, 1988, BIOPHYS J, V53, P963, DOI 10.1016/S0006-3495(88)83177-1; Lopez A, 2009, CELL MOL LIFE SCI, V66, P2093, DOI 10.1007/s00018-009-0008-4; Luttrell LM, 2008, MOL BIOTECHNOL, V39, P239, DOI 10.1007/s12033-008-9031-1; Marguet D, 2006, EMBO J, V25, P3446, DOI 10.1038/sj.emboj.7601204; Minnis JG, 2003, NEUROSCIENCE, V119, P33, DOI 10.1016/S0306-4522(03)00135-0; Mouledous L, 2008, BIOCHEM BIOPH RES CO, V373, P80, DOI 10.1016/j.bbrc.2008.05.174; NEUBIG RR, 1994, FASEB J, V8, P939, DOI 10.1096/fasebj.8.12.8088459; Ostrom RS, 2004, BRIT J PHARMACOL, V143, P235, DOI 10.1038/sj.bjp.0705930; Ostrom RS, 2002, MOL PHARMACOL, V61, P473, DOI 10.1124/mol.61.3.473; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Pike LJ, 2003, J LIPID RES, V44, P655, DOI 10.1194/jlr.R200021-JLR200; PRATHER PL, 1994, J PHARMACOL EXP THER, V270, P177; Pucadyil TJ, 2006, PROG LIPID RES, V45, P295, DOI 10.1016/j.plipres.2006.02.002; Salome L, 1998, EUR BIOPHYS J BIOPHY, V27, P391, DOI 10.1007/s002490050146; Sauliere A, 2006, FEBS LETT, V580, P5227, DOI 10.1016/j.febslet.2006.08.056; Smith SML, 2006, ENDOCRINOLOGY, V147, P1789, DOI 10.1210/en.2005-1046; Vereb G, 2003, P NATL ACAD SCI USA, V100, P8053, DOI 10.1073/pnas.1332550100; Wolfe BL, 2007, TRAFFIC, V8, P462, DOI 10.1111/j.1600-0854.2007.00551.x	40	33	33	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14514	14520		10.1074/jbc.M109.076695	http://dx.doi.org/10.1074/jbc.M109.076695			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20197280	Green Published, hybrid			2022-12-25	WOS:000277299700048
J	Voolstra, O; Beck, K; Oberegelsbacher, C; Pfannstiel, J; Huber, A				Voolstra, Olaf; Beck, Katherina; Oberegelsbacher, Claudia; Pfannstiel, Jens; Huber, Armin			Light-dependent Phosphorylation of the Drosophila Transient Receptor Potential Ion Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; IN-VIVO; RETINAL DEGENERATION; POTASSIUM CHANNEL; TRP CHANNELS; GENE; MECHANISM; COMPLEX; DEACTIVATION; MAINTENANCE	The Drosophila phototransduction cascade terminates in the opening of an ion channel, designated transient receptor potential (TRP). TRP has been shown to become phosphorylated in vitro, suggesting regulation of the ion channel through post-translational modification. However, except for one phosphorylation site, Ser(982), which was analyzed by functional in vivo studies (Popescu, D. C., Ham, A. J., and Shieh, B. H. (2006) J. Neurosci. 26, 8570-8577), nothing is known about the role of TRP phosphorylation in vivo. Here, we report the identification of 21 TRP phosphorylation sites by a mass spectrometry approach. 20 phosphorylation sites are located in the C-terminal portion of the channel, and one site is located near the N terminus. All 21 phosphorylation sites were also identified in the inaC(P209) mutant, indicating that phosphorylation of TRP at these sites occurred independently from the eye-enriched protein kinase C. Relative quantification of phosphopeptides revealed that at least seven phosphorylation sites were predominantly phosphorylated in the light, whereas one site, Ser(936), was predominantly phosphorylated in the dark. We show that TRP phosphorylated at Ser(936) was located in the rhabomere. Light-dependent changes in the phosphorylation state of this site occurred within minutes. The dephosphorylation of TRP at Ser(936) required activation of the phototransduction cascade.	[Voolstra, Olaf] Univ Hohenheim, Dept Biosensor, Inst Physiol, D-70599 Stuttgart, Germany; [Pfannstiel, Jens; Huber, Armin] Univ Hohenheim, Life Sci Ctr, D-70599 Stuttgart, Germany	University Hohenheim; University Hohenheim	Voolstra, O (corresponding author), Univ Hohenheim, Dept Biosensor, Inst Physiol, Garbenstr 30, D-70599 Stuttgart, Germany.	voolstra@uni-hohenheim.de	Huber, Armin/GYU-6322-2022	Huber, Armin/0000-0003-3977-089X	Deutsche Forschungsgemeinschaft [Hu 839/2-5]; German-Israeli Foundation [I 1001-96.13/2008]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German-Israeli Foundation(German-Israeli Foundation for Scientific Research and Development)	This work was supported by Deutsche Forschungsgemeinschaft Grant Hu 839/2-5 and by German-Israeli Foundation for Scientific Research and Development Grant I 1001-96.13/2008.	Bantscheff M, 2007, ANAL BIOANAL CHEM, V389, P1017, DOI 10.1007/s00216-007-1486-6; Barford D, 1996, TRENDS BIOCHEM SCI, V21, P407, DOI 10.1016/S0968-0004(96)10060-8; Becker EBE, 2009, P NATL ACAD SCI USA, V106, P6706, DOI 10.1073/pnas.0810599106; Bhave G, 2003, P NATL ACAD SCI USA, V100, P12480, DOI 10.1073/pnas.2032100100; BLOOMQUIST BT, 1988, CELL, V54, P723, DOI 10.1016/S0092-8674(88)80017-5; BYK T, 1993, P NATL ACAD SCI USA, V90, P1907, DOI 10.1073/pnas.90.5.1907; Chorna-Ornan I, 2005, J CELL BIOL, V171, P143, DOI 10.1083/jcb.200503014; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Hisatsune C, 2004, J BIOL CHEM, V279, P18887, DOI 10.1074/jbc.M311274200; Hong YS, 2002, J BIOL CHEM, V277, P33884, DOI 10.1074/jbc.M204075200; Huber A, 1998, FEBS LETT, V425, P317, DOI 10.1016/S0014-5793(98)00248-8; Huber A, 1996, J BIOL CHEM, V271, P11710, DOI 10.1074/jbc.271.20.11710; Huber A, 2009, GENE DEV, V23, P1929, DOI 10.1101/gad.532109; Jung JY, 2004, J BIOL CHEM, V279, P7048, DOI 10.1074/jbc.M311448200; KOMORI N, 1994, INSECT BIOCHEM MOLEC, V24, P607, DOI 10.1016/0965-1748(94)90097-3; Kwan HY, 2004, P NATL ACAD SCI USA, V101, P2625, DOI 10.1073/pnas.0304471101; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liu MY, 2000, J BIOL CHEM, V275, P12194, DOI 10.1074/jbc.275.16.12194; Mecklenburg KL, 2010, J NEUROSCI, V30, P1238, DOI 10.1523/JNEUROSCI.4464-09.2010; Meyer NE, 2008, FLY, V2, P36, DOI 10.4161/fly.5773; Minke B, 2006, ANNU REV PHYSIOL, V68, P649, DOI 10.1146/annurev.physiol.68.040204.100939; Montell Craig, 2005, Sci STKE, V2005, pre3, DOI 10.1126/stke.2722005re3; Numazaki M, 2002, J BIOL CHEM, V277, P13375, DOI 10.1074/jbc.C200104200; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; OTOUSA JE, 1985, CELL, V40, P839, DOI 10.1016/0092-8674(85)90343-5; Pak W.L., 1979, P67; Park KS, 2006, SCIENCE, V313, P976, DOI 10.1126/science.1124254; PLANGGER A, 1994, J BIOL CHEM, V269, P26969; POLLOCK JA, 1995, J NEUROSCI, V15, P3747; Popescu DC, 2006, J NEUROSCI, V26, P8570, DOI 10.1523/JNEUROSCI.1478-06.2006; Premkumar LS, 2000, NATURE, V408, P985, DOI 10.1038/35050121; Rathee PK, 2002, J NEUROSCI, V22, P4740, DOI 10.1523/JNEUROSCI.22-11-04740.2002; Reuss H, 1997, NEURON, V19, P1249, DOI 10.1016/S0896-6273(00)80416-X; Rinner O, 2007, NAT BIOTECHNOL, V25, P345, DOI 10.1038/nbt1289; Ruse CI, 2002, ANAL CHEM, V74, P1658, DOI 10.1021/ac0157122; Sadygov RG, 2006, ANAL CHEM, V78, P8207, DOI 10.1021/ac060923y; SCHAEFFER E, 1989, CELL, V57, P403, DOI 10.1016/0092-8674(89)90915-X; SCOTT K, 1995, NEURON, V15, P919, DOI 10.1016/0896-6273(95)90182-5; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; SMITH DP, 1991, SCIENCE, V254, P1478, DOI 10.1126/science.1962207; STEELE F, 1990, NEURON, V4, P883, DOI 10.1016/0896-6273(90)90141-2; Steen H, 2005, P NATL ACAD SCI USA, V102, P3948, DOI 10.1073/pnas.0409536102; Steen JAJ, 2008, P NATL ACAD SCI USA, V105, P6069, DOI 10.1073/pnas.0709807104; Vazquez G, 2004, J BIOL CHEM, V279, P40521, DOI 10.1074/jbc.M405280200; Venkatachalam K, 2003, J BIOL CHEM, V278, P29031, DOI 10.1074/jbc.M302751200; Wang N, 2008, J NEUROSCI, V28, P1444, DOI 10.1523/JNEUROSCI.5134-07.2008; Yang JW, 2007, P NATL ACAD SCI USA, V104, P20055, DOI 10.1073/pnas.0708574104; Yoon J, 2000, J NEUROSCI, V20, P649, DOI 10.1523/JNEUROSCI.20-02-00649.2000; Zhang L, 2001, J BIOL CHEM, V276, P13331, DOI 10.1074/jbc.M008914200; ZUKER CS, 1985, CELL, V40, P851, DOI 10.1016/0092-8674(85)90344-7	51	24	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14275	14284		10.1074/jbc.M110.102053	http://dx.doi.org/10.1074/jbc.M110.102053			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20215118	Green Published, hybrid			2022-12-25	WOS:000277299700024
J	Wang, XJ; Han, YX; Dang, Y; Fu, W; Zhou, T; Ptak, RG; Zheng, YH				Wang, Xiaojun; Han, Yanxing; Dang, Ying; Fu, William; Zhou, Tao; Ptak, Roger G.; Zheng, Yong-Hui			Moloney Leukemia Virus 10 (MOV10) Protein Inhibits Retrovirus Replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOX RNA HELICASE; MESSENGER-RNAS; ANTIRETROVIRAL FACTOR; HIV-1 REPLICATION; ANTIVIRAL PROTEIN; STRESS GRANULES; HUMAN-CELLS; APOBEC3G; GENE; IDENTIFICATION	Moloney leukemia virus 10 (MOV10) protein is a superfamily-1 RNA helicase, and it is also a component of the RNA-induced silencing complex. Recent studies have shown that MOV10 plays an active role in the RNA interference pathway. Here, we report that MOV10 inhibits retrovirus replication. When it was overexpressed in viral producer cells, MOV10 was able to reduce the infectivity of human immunodeficiency virus type 1 (HIV-1), simian immunodeficiency virus, and murine leukemia virus. Conversely, when MOV10 expression was reduced by small interfering RNAs, HIV-1 infectivity was increased. Consistently, silencing of MOV10 expression in a human T cell line enhanced HIV-1 replication. Furthermore, we found that MOV10 interacts with HIV-1 nucleocapsid protein in an RNA-dependent manner and is packaged into virions. It blocks HIV-1 replication at a postentry step. In addition, we also found that HIV-1 could suppress MOV10 protein expression to counteract this cellular resistance. All of these results indicate that MOV10 has a broad antiretroviral activity that can target a wide range of retroviruses, and it could be actively involved in host defense against retroviral infection.	[Zheng, Yong-Hui] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA; [Fu, William; Ptak, Roger G.] So Res Inst, Frederick, MD 21701 USA	Michigan State University	Zheng, YH (corresponding author), Michigan State Univ, Dept Microbiol & Mol Genet, 2215 Biomed Phys Sci Bldg, E Lansing, MI 48824 USA.	zhengyo@msu.edu	Han, Yanxing/GRO-5138-2022; Zheng, Yong-Hui/AAP-4492-2021; Zhou, Tao/B-5757-2017	Zheng, Yong-Hui/0000-0002-1098-7385; Zhou, Tao/0000-0002-3648-9923; Wang, Xiaojun/0000-0003-4521-4099	National Institutes of Health [AI063944, AI080225]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI063944, K02AI080225, R01AI063944] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI063944 and AI080225 (to Y.-H.Z.).	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Caruthers JM, 2002, CURR OPIN STRUC BIOL, V12, P123, DOI 10.1016/S0959-440X(02)00298-1; Cavrois M, 2002, NAT BIOTECHNOL, V20, P1151, DOI 10.1038/nbt745; Chen GF, 2008, P NATL ACAD SCI USA, V105, P4352, DOI 10.1073/pnas.0712276105; Chendrimada TP, 2007, NATURE, V447, P823, DOI 10.1038/nature05841; Cook HA, 2004, CELL, V116, P817, DOI 10.1016/S0092-8674(04)00250-8; Dalmay T, 2001, EMBO J, V20, P2069, DOI 10.1093/emboj/20.8.2069; Dang Y, 2008, J BIOL CHEM, V283, P13124, DOI 10.1074/jbc.M708728200; Dang Y, 2006, J VIROL, V80, P10522, DOI 10.1128/JVI.01123-06; Fang JH, 2004, VIROLOGY, V330, P471, DOI 10.1016/j.virol.2004.09.039; Gallois-Montbrun S, 2008, J VIROL, V82, P5636, DOI 10.1128/JVI.00287-08; Gallois-Montbrun S, 2007, J VIROL, V81, P2165, DOI 10.1128/JVI.02287-06; Han YX, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002796; HARBERS K, 1982, NUCLEIC ACIDS RES, V10, P2521, DOI 10.1093/nar/10.8.2521; JAENISCH R, 1981, CELL, V24, P519, DOI 10.1016/0092-8674(81)90343-3; Jeang KT, 2006, NUCLEIC ACIDS RES, V34, P4198, DOI 10.1093/nar/gkl398; KOONIN EV, 1992, TRENDS BIOCHEM SCI, V17, P495, DOI 10.1016/0968-0004(92)90338-A; Kozak SL, 2006, J BIOL CHEM, V281, P29105, DOI 10.1074/jbc.M601901200; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lindbo JA, 2005, ANNU REV PHYTOPATHOL, V43, P191, DOI 10.1146/annurev.phyto.43.040204.140228; Margottin F, 1998, MOL CELL, V1, P565, DOI 10.1016/S1097-2765(00)80056-8; Meister G, 2005, CURR BIOL, V15, P2149, DOI 10.1016/j.cub.2005.10.048; Meister G, 2007, CELL, V131, P25, DOI 10.1016/j.cell.2007.09.021; MOOSLEHNER K, 1991, MOL CELL BIOL, V11, P886, DOI 10.1128/MCB.11.2.886; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Peters L, 2007, MOL CELL, V26, P611, DOI 10.1016/j.molcel.2007.05.001; Robb GB, 2007, MOL CELL, V26, P523, DOI 10.1016/j.molcel.2007.04.016; Roy BB, 2006, J BIOL CHEM, V281, P12625, DOI 10.1074/jbc.M510596200; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Wang XJ, 2007, J BIOL CHEM, V282, P1585, DOI 10.1074/jbc.M610150200; Wiegand HL, 2004, EMBO J, V23, P2451, DOI 10.1038/sj.emboj.7600246; Yedavalli VSRK, 2004, CELL, V119, P381, DOI 10.1016/j.cell.2004.09.029; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Zeng Y, 2002, MOL CELL, V9, P1327, DOI 10.1016/S1097-2765(02)00541-5; Zheng YH, 2004, J VIROL, V78, P6073, DOI 10.1128/JVI.78.11.6073-6076.2004; Zheng YH, 2003, NAT CELL BIOL, V5, P611, DOI 10.1038/ncb1000	36	89	91	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14346	14355		10.1074/jbc.M110.109314	http://dx.doi.org/10.1074/jbc.M110.109314			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20215113	Green Published, hybrid			2022-12-25	WOS:000277299700032
J	Sauer, L; Gitenay, D; Vo, C; Baron, VT				Sauer, L.; Gitenay, D.; Vo, C.; Baron, V. T.			Mutant p53 initiates a feedback loop that involves Egr-1/EGF receptor/ERK in prostate cancer cells	ONCOGENE			English	Article						p53; Egr-1; prostate cancer; EGF receptor; SV40 large T-antigen	GROWTH-FACTOR-BETA; EGR1 TARGET GENES; LARGE T-ANTIGEN; TUMOR-SUPPRESSOR; CARCINOMA-CELLS; IMMUNE-RESPONSE; IN-VIVO; EXPRESSION; TRANSCRIPTION; LINE	Early growth response-1 (Egr-1) is overexpressed in human prostate tumors and contributes to cancer progression. On the other hand, mutation of p53 is associated with advanced prostate cancer, as well as with metastasis and hormone independence. This study shows that in prostate cell lines in culture, Egr-1 overexpression correlated with an alteration of p53 activity because of the expression of SV40 large Tantigen or because of a mutation in the TP53 gene. In cells containing altered p53 activity, Egr-1 expression was abolished by pharmacological inhibition or RNAi silencing of p53. Although forced expression of wild-type p53 was not sufficient to trigger Egr-1 transcription, four different mutants of p53 were shown to induce Egr-1. Direct binding of p53 to the EGR1 promoter could not be detected. Instead, Egr-1 transcription was driven by the ERK1/2 pathway, as it was abrogated by specific inhibitors of MEK. Egr-1 increased the transcription of HB-EGF (epidermal growth factor), amphiregulin and epiregulin, resulting in autocrine activation of the EGF receptor (EGFR) and downstream MEK/ERK cascade. Thus, mutant p53 initiates a feedback loop that involves ERK1/2-mediated transactivation of Egr-1, which in turn increases the secretion of EGFR ligands and stimulates the EGFR signaling pathway. Finally, p53 may further regulate this feedback loop by altering the level of EGFR expression. Oncogene (2010) 29, 2628-2637; doi:10.1038/onc.2010.24; published online 1 March 2010	[Sauer, L.; Gitenay, D.; Vo, C.; Baron, V. T.] VRISD, San Diego, CA 92121 USA		Baron, VT (corresponding author), VRISD, 10835 Rd Cure,Suite 150, San Diego, CA 92121 USA.	vbaron@sdibr.org		Gitenay, Delphine/0000-0002-6043-4519; Schenk, Lysann/0000-0002-5146-8485	NIH/NCI [RO1 CA102688]; NATIONAL CANCER INSTITUTE [R01CA102688] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Ruth Gjerset (Torrey Pines Institute for Molecular Studies, San Diego, CA) for comments and critical reading of the paper. We are grateful to Dr Eileen Adamson and Dr Dan Mercola (University of California, Irvine, CA) for their support and many suggestions. This work was supported by a Grant from NIH/NCI-RO1 CA102688 (V Baron).	Abdulkadir SA, 2001, NAT MED, V7, P101, DOI 10.1038/83231; BAE VL, 1994, INT J CANCER, V58, P721, DOI 10.1002/ijc.2910580517; BAKER SJ, 1990, SCIENCE, V249, P912, DOI 10.1126/science.2144057; Baron V, 2003, ONCOGENE, V22, P4194, DOI 10.1038/sj.onc.1206560; Bello D, 1997, CARCINOGENESIS, V18, P1215, DOI 10.1093/carcin/18.6.1215; Biswas S, 2006, CLIN CANCER RES, V12, P4142, DOI 10.1158/1078-0432.CCR-06-0952; Bocchetta M, 2008, CANCER RES, V68, P1022, DOI 10.1158/0008-5472.CAN-07-5203; CAO XM, 1993, J BIOL CHEM, V268, P16949; CONNOLLY JM, 1991, PROSTATE, V19, P173, DOI 10.1002/pros.2990190210; DEB SP, 1994, ONCOGENE, V9, P1341; DEFFIE A, 1993, MOL CELL BIOL, V13, P3415, DOI 10.1128/MCB.13.6.3415; Eid MA, 1998, CANCER RES, V58, P2461; Gitenay D, 2009, FUTURE ONCOL, V5, P993, DOI 10.2217/FON.09.67; Gurova KV, 2003, CANCER RES, V63, P2905; Horoszewicz J S, 1980, Prog Clin Biol Res, V37, P115; ISAACS WB, 1991, CANCER RES, V51, P4716; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; KAIGHN ME, 1979, INVEST UROL, V17, P16; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; Lilyestrom W, 2006, GENE DEV, V20, P2373, DOI 10.1101/gad.1456306; LONG SB, 1995, ANTICANCER RES, V15, P1375; LudesMeyers JH, 1996, MOL CELL BIOL, V16, P6009; Nishi H, 2002, CANCER RES, V62, P827; PARDA DS, 1993, PROSTATE, V23, P91, DOI 10.1002/pros.2990230202; Ramsamooj P, 1997, Radiat Oncol Investig, V5, P269, DOI 10.1002/(SICI)1520-6823(1997)5:6<269::AID-ROI2>3.0.CO;2-W; Shin SY, 2006, EMBO J, V25, P1093, DOI 10.1038/sj.emboj.7600987; Silverman ES, 1999, AM J PATHOL, V154, P665, DOI 10.1016/S0002-9440(10)65312-6; Sramkoski RM, 1999, IN VITRO CELL DEV-AN, V35, P403; STONE KR, 1978, INT J CANCER, V21, P274, DOI 10.1002/ijc.2910210305; Svaren J, 2000, J BIOL CHEM, V275, P38524, DOI 10.1074/jbc.M005220200; Teicher BA, 2007, CLIN CANCER RES, V13, P6247, DOI 10.1158/1078-0432.CCR-07-1654; Thiel G, 2002, J CELL PHYSIOL, V193, P287, DOI 10.1002/jcp.10178; Thigpen AE, 1996, J UROLOGY, V155, P975, DOI 10.1016/S0022-5347(01)66361-4; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Virolle T, 2003, J BIOL CHEM, V278, P11802, DOI 10.1074/jbc.M210279200; Weisz L, 2004, CANCER RES, V64, P8318, DOI 10.1158/0008-5472.CAN-04-1145; Wrzesinski SH, 2007, CLIN CANCER RES, V13, P5262, DOI 10.1158/1078-0432.CCR-07-1157; Wu GS, 2004, CANCER BIOL THER, V3, P156, DOI 10.4161/cbt.3.2.614; Yang SZ, 2003, J BIOL CHEM, V278, P39906, DOI 10.1074/jbc.M307250200; Yu J, 2007, CELL DEATH DIFFER, V14, P436, DOI 10.1038/sj.cdd.4402029	40	62	64	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAY 6	2010	29	18					2628	2637		10.1038/onc.2010.24	http://dx.doi.org/10.1038/onc.2010.24			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	592DC	20190820	Green Accepted			2022-12-25	WOS:000277354600003
J	Craig-Barnes, HA; Doumouras, BS; Palaniyar, N				Craig-Barnes, Hayley A.; Doumouras, Barbara S.; Palaniyar, Nades			Surfactant Protein D Interacts with alpha(2)-Macroglobulin and Increases Its Innate Immune Potential	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MANNOSE-BINDING LECTIN; CYSTIC-FIBROSIS; BACTERIAL LIPOPOLYSACCHARIDES; HUMAN ALPHA-2-MACROGLOBULIN; BRONCHOALVEOLAR LAVAGE; LUNG COLLECTINS; RECOGNITION; ALPHA; FLUID; LOCALIZATION	Surfactant protein D (SP-D) is an innate immune collectin that recognizes microbes via its carbohydrate recognition domains, agglutinates bacteria, and forms immune complexes. During microbial infections, proteases, such as elastases, cleave the carbohydrate recognition domains and can inactivate the innate immune functions of SP-D. Host responses to counterbalance the reduction of SP-D-mediated innate immune response under these conditions are not clearly understood. We have unexpectedly identified that SP-D could interact with protein fractions containing ovomucin and ovomacroglobulin. Here, we show that SP-D interacts with human alpha(2)-macroglobulin (A2M), a protease inhibitor present in the lungs and serum. Using enzyme-linked immunosorbent assays, surface plasmon resonance, and carbohydrate competition assays, we show that SP-D interacts with A2M both in solid phase (K-D of 7.33 nM) and in solution via lectin-carbohydrate interactions under physiological calcium conditions. Bacterial agglutination assays further show that SP-D.A2M complexes increase the ability of SP-D to agglutinate bacteria. Western blot analyses show that SP-D, but not A2M, avidly binds bacteria. Interestingly, intact and activated A2M also protect SP-D against elastase-mediated degradation, and the cleaved A2M still interacts with SP-D and is able to enhance its agglutination abilities. We also found that SP-D and A2M can interact with each other in the airway-lining fluid. Therefore, we propose that SP-D utilizes a novel mechanism in which the collectin interacts with protease inhibitor A2M to decrease its degradation and to concurrently increase its innate immune function. These interactions particularly enhance bacterial agglutination and immune complex formation.	[Palaniyar, Nades] Hosp Sick Children, Program Physiol & Expt Med, Lung Innate Immun Res Lab, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Palaniyar, N (corresponding author), Hosp Sick Children, Program Physiol & Expt Med, Lung Innate Immun Res Lab, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	nades.palaniyar@sickkids.ca		Palaniyar, Nades/0000-0002-2170-8548	center for the study of the complex childhood diseases at the Hospital for Sick Children; Canadian Institutes of Health Research [MOP-84312]	center for the study of the complex childhood diseases at the Hospital for Sick Children; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	ProteON analyses were performed in the Analytical Laboratory for Bioactive Materials of the Canada Foundation for Innovation-funded center for the study of the complex childhood diseases at the Hospital for Sick Children.; This work was supported by Canadian Institutes of Health Research Grant MOP-84312 (to N.P.).	Akiyama J, 2002, J HISTOCHEM CYTOCHEM, V50, P993, DOI 10.1177/002215540205000713; Alcorn JF, 2004, J BIOL CHEM, V279, P30871, DOI 10.1074/jbc.M400796200; Areschoug Thomas, 2008, V15, P45, DOI 10.1159/000135685; Armstrong PB, 2006, IMMUNOBIOLOGY, V211, P263, DOI 10.1016/j.imbio.2006.01.002; Arnold JN, 2006, J BIOL CHEM, V281, P6955, DOI 10.1074/jbc.M511432200; Baker CS, 2000, RESPIRATION, V67, P533, DOI 10.1159/000067469; BARRETT AJ, 1979, BIOCHEM J, V181, P401, DOI 10.1042/bj1810401; BARRETT AJ, 1973, BIOCHEM J, V133, P709, DOI 10.1042/bj1330709; BORTH W, 1992, FASEB J, V6, P3345, DOI 10.1096/fasebj.6.15.1281457; Brinker KG, 2001, AM J PHYSIOL-LUNG C, V281, pL1453, DOI 10.1152/ajplung.2001.281.6.L1453; Cai ML, 1998, PROTEIN SCI, V7, P2669, DOI 10.1002/pro.5560071221; Cooley J, 2008, J LEUKOCYTE BIOL, V83, P946, DOI 10.1189/jlb.1007684; Craig A, 2009, INFECT IMMUN, V77, P568, DOI 10.1128/IAI.00832-08; Crouch E, 2007, BIOCHEMISTRY-US, V46, P5160, DOI 10.1021/bi700037x; ECCLESTON ED, 1985, J BIOL CHEM, V260, P169; FELDMAN SR, 1985, P NATL ACAD SCI USA, V82, P5700, DOI 10.1073/pnas.82.17.5700; Ferguson JS, 1999, J IMMUNOL, V163, P312; Gardai SJ, 2003, CELL, V115, P13, DOI 10.1016/S0092-8674(03)00758-X; Hakansson K, 1999, STRUCTURE, V7, P255, DOI 10.1016/S0969-2126(99)80036-7; Haley KJ, 2002, AM J PHYSIOL-LUNG C, V282, pL573, DOI 10.1152/ajplung.00117.2001; Hirche TO, 2004, J BIOL CHEM, V279, P27688, DOI 10.1074/jbc.M402936200; Holmskov U, 1997, J BIOL CHEM, V272, P13743, DOI 10.1074/jbc.272.21.13743; HOWARD JB, 1983, ANN NY ACAD SCI, V421, P160, DOI 10.1111/j.1749-6632.1983.tb18106.x; Ikegami M, 2007, CHEST, V132, P1447, DOI 10.1378/chest.07-0864; KUAN SF, 1992, J CLIN INVEST, V90, P97, DOI 10.1172/JCI115861; Lausen M, 1999, J BIOL CHEM, V274, P32234, DOI 10.1074/jbc.274.45.32234; LIM BL, 1994, J BIOL CHEM, V269, P11820; Madsen J, 2000, J IMMUNOL, V164, P5866, DOI 10.4049/jimmunol.164.11.5866; Mariencheck WI, 2003, AM J RESP CELL MOL, V28, P528, DOI 10.1165/rcmb.2002-0141OC; Nadesalingam J, 2005, J IMMUNOL, V175, P1785, DOI 10.4049/jimmunol.175.3.1785; Nadesalingam J, 2005, FEBS LETT, V579, P4449, DOI 10.1016/j.febslet.2005.07.012; Nadesalingam J, 2003, J BIOL CHEM, V278, P25678, DOI 10.1074/jbc.M210186200; NIELSON DW, 1988, PEDIATR RES, V24, P322, DOI 10.1203/00006450-198809000-00009; Palaniyar N, 2004, J BIOL CHEM, V279, P32728, DOI 10.1074/jbc.M403763200; Palaniyar N, 2002, IMMUNOBIOLOGY, V205, P575, DOI 10.1078/0171-2985-00156; Postle AD, 1999, AM J RESP CELL MOL, V20, P90, DOI 10.1165/ajrcmb.20.1.3253; Ratjen F, 2002, THORAX, V57, P930, DOI 10.1136/thorax.57.11.930; Russo TA, 2002, AM J PHYSIOL-LUNG C, V283, pL655, DOI 10.1152/ajplung.00071.2002; SOTTRUPJENSEN L, 1989, J BIOL CHEM, V264, P15781; SOTTRUPJENSEN L, 1986, FEBS LETT, V205, P20, DOI 10.1016/0014-5793(86)80857-2; Stahlman MT, 2002, J HISTOCHEM CYTOCHEM, V50, P651, DOI 10.1177/002215540205000506; VANVYVE T, 1995, J ALLERGY CLIN IMMUN, V95, P60, DOI 10.1016/S0091-6749(95)70153-2; von Bredow C, 2003, LUNG, V181, P79, DOI 10.1007/s00408-003-1008-z; Wang H, 2008, BIOCHEMISTRY-US, V47, P710, DOI 10.1021/bi7020553; Wang L, 2008, BIOCHEMISTRY-US, V47, P8103, DOI 10.1021/bi800626h; Wright JR, 2005, NAT REV IMMUNOL, V5, P58, DOI 10.1038/nri1528; [No title captured]	47	23	25	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13461	13470		10.1074/jbc.M110.108837	http://dx.doi.org/10.1074/jbc.M110.108837			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20207732	Green Published, hybrid			2022-12-25	WOS:000276987700018
J	Francisco, AB; Singh, R; Li, SA; Vani, AK; Yang, L; Munroe, RJ; Diaferia, G; Cardano, M; Biunno, I; Qi, L; Schimenti, JC; Long, QM				Francisco, Adam B.; Singh, Rajni; Li, Shuai; Vani, Anish K.; Yang, Liu; Munroe, Robert J.; Diaferia, Giuseppe; Cardano, Marina; Biunno, Ida; Qi, Ling; Schimenti, John C.; Long, Qiaoming			Deficiency of Suppressor Enhancer Lin12 1 Like (SEL1L) in Mice Leads to Systemic Endoplasmic Reticulum Stress and Embryonic Lethality	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; UBIQUITIN LIGASE COMPLEX; QUALITY-CONTROL; CELL-DEATH; SECRETORY PATHWAY; MESSENGER-RNA; ER; DEGRADATION; EXPRESSION; ALPHA-1-ANTITRYPSIN	Stress in the endoplasmic reticulum (ER) plays an important causal role in the pathogenesis of several chronic diseases such as Alzheimer, Parkinson, and diabetes mellitus. Insight into the genetic determinants responsible for ER homeostasis will greatly facilitate the development of therapeutic strategies for the treatment of these debilitating diseases. Suppressor enhancer Lin12 1 like (SEL1L) is an ER membrane protein and was thought to be involved in the quality control of secreted proteins. Here we show that the mice homozygous mutant for SEL1L were embryonic lethal. Electron microscopy studies revealed a severely dilated ER in the fetal liver of mutant embryos, indicative of alteration in ER homeostasis. Consistent with this, several ER stress responsive genes were significantly up-regulated in the mutant embryos. Mouse embryonic fibroblast cells deficient in SEL1L exhibited activated unfolded protein response at the basal state, impaired ER-associated protein degradation, and reduced protein secretion. Furthermore, markedly increased apoptosis was observed in the forebrain and dorsal root ganglions of mutant embryos. Taken together, our results demonstrate an essential role for SEL1L in protein quality control during mouse embryonic development.	[Francisco, Adam B.; Singh, Rajni; Li, Shuai; Vani, Anish K.; Long, Qiaoming] Cornell Univ, Coll Agr & Life Sci, Dept Anim Sci, Ithaca, NY 14850 USA; [Yang, Liu; Qi, Ling] Cornell Univ, Coll Agr & Life Sci, Div Nutr Sci, Ithaca, NY 14850 USA; [Munroe, Robert J.; Schimenti, John C.] Cornell Univ, Coll Vet Med, Dept Biomed Sci, Ithaca, NY 14850 USA; [Diaferia, Giuseppe; Cardano, Marina] BioRep, I-20090 Milan, Italy; [Cardano, Marina] Univ Milan, Doctorate Sch Mol Med, I-20090 Milan, Italy; [Biunno, Ida] CNR, Inst Biomed Technol, I-20090 Milan, Italy	Cornell University; Cornell University; Cornell University; University of Milan; Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR)	Long, QM (corresponding author), Cornell Univ, Coll Agr & Life Sci, Dept Anim Sci, 321 Morrison Hall,Tower Rd, Ithaca, NY 14850 USA.	ql39@cornell.edu	Diaferia, Giuseppe/AAN-5910-2020; Li, Shuai/ABD-5132-2021; Long, Qiaoming/L-5074-2017	Diaferia, Giuseppe/0000-0003-4022-8483; Li, Shuai/0000-0002-9574-9609; Long, Qiaoming/0000-0001-8243-589X; , IDA_2/0000-0002-1068-4763; Francisco, Adam B./0000-0001-8462-6569; Qi, Ling/0000-0001-8229-0184	College of Agricultural and Life Science, Cornell University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082582] Funding Source: NIH RePORTER	College of Agricultural and Life Science, Cornell University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a grant from the College of Agricultural and Life Science, Cornell University (to Q. M. L.).	Acosta-Alvear D, 2007, MOL CELL, V27, P53, DOI 10.1016/j.molcel.2007.06.011; Aridor M, 2007, ADV DRUG DELIVER REV, V59, P759, DOI 10.1016/j.addr.2007.06.002; Badr CE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000571; Biunno I, 1997, GENOMICS, V46, P284, DOI 10.1006/geno.1997.5018; Biunno I, 2006, J CELL PHYSIOL, V208, P23, DOI 10.1002/jcp.20574; Brodsky JL, 2007, BIOCHEM J, V404, P353, DOI 10.1042/BJ20061890; Cattaneo M, 2004, GENE, V326, P149, DOI 10.1016/j.gene.2003.10.021; Cattaneo M, 2008, J CELL PHYSIOL, V215, P794, DOI 10.1002/jcp.21364; Cattaneo M, 2009, J BIOL CHEM, V284, P11405, DOI 10.1074/jbc.M805408200; Christianson JC, 2008, NAT CELL BIOL, V10, P272, DOI 10.1038/ncb1689; Cormier JH, 2009, MOL CELL, V34, P627, DOI 10.1016/j.molcel.2009.05.018; Donoviel DB, 1998, MECH DEVELOP, V78, P203, DOI 10.1016/S0925-4773(98)00146-4; Fels DR, 2006, CANCER BIOL THER, V5, P723, DOI 10.4161/cbt.5.7.2967; Gardner RG, 2000, J CELL BIOL, V151, P69, DOI 10.1083/jcb.151.1.69; Gass JN, 2002, J BIOL CHEM, V277, P49047, DOI 10.1074/jbc.M205011200; HAMMOND C, 1994, J CELL BIOL, V126, P41, DOI 10.1083/jcb.126.1.41; Hampton RY, 2002, CURR OPIN CELL BIOL, V14, P476, DOI 10.1016/S0955-0674(02)00358-7; Heazlewood CK, 2008, PLOS MED, V5, P440, DOI 10.1371/journal.pmed.0050054; Hosokawa N, 2008, J BIOL CHEM, V283, P20914, DOI 10.1074/jbc.M709336200; Isler JA, 2005, J VIROL, V79, P6890, DOI 10.1128/JVI.79.11.6890-6899.2005; Kaneko M, 2007, FEBS LETT, V581, P5355, DOI 10.1016/j.febslet.2007.10.033; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee JW, 2006, NATURE, V443, P50, DOI 10.1038/nature05096; Li JZ, 2006, CURR MOL MED, V6, P45, DOI 10.2174/156652406775574523; Lipson KL, 2006, CELL METAB, V4, P245, DOI 10.1016/j.cmet.2006.07.007; Ma YJ, 2004, J CHEM NEUROANAT, V28, P51, DOI 10.1016/j.jchemneu.2003.08.007; Mueller B, 2008, P NATL ACAD SCI USA, V105, P12325, DOI 10.1073/pnas.0805371105; Mueller B, 2006, J CELL BIOL, V175, P261, DOI 10.1083/jcb.200605196; Ni M, 2007, FEBS LETT, V581, P3641, DOI 10.1016/j.febslet.2007.04.045; Oresic K, 2009, BIOSCIENCE REP, V29, P173, DOI 10.1042/BSR20080143; Orlandi R, 2002, INT J BIOL MARKER, V17, P104, DOI 10.1177/172460080201700205; Proud CG, 2005, SEMIN CELL DEV BIOL, V16, P3, DOI 10.1016/j.semcdb.2004.11.004; Rao RV, 2004, CELL DEATH DIFFER, V11, P372, DOI 10.1038/sj.cdd.4401378; Rao RV, 2006, CELL DEATH DIFFER, V13, P415, DOI 10.1038/sj.cdd.4401761; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Roybal CN, 2005, INVEST OPHTH VIS SCI, V46, P3973, DOI 10.1167/iovs.05-0070; Rutkowski DT, 2006, PLOS BIOL, V4, P2024, DOI 10.1371/journal.pbio.0040374; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SIFERS RN, 1988, J BIOL CHEM, V263, P7330; Sommer T, 2002, DEV CELL, V3, P1, DOI 10.1016/S1534-5807(02)00210-1; Urano F, 2000, J CELL SCI, V113, P3697; van Anken E, 2005, CRIT REV BIOCHEM MOL, V40, P269, DOI 10.1080/10409230500315352; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang J, 1999, J CLIN INVEST, V103, P27, DOI 10.1172/JCI4431; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Wu J, 2007, DEV CELL, V13, P351, DOI 10.1016/j.devcel.2007.07.005; Wasef SZY, 2006, AM J PHYSIOL-ENDOC M, V291, pE1274, DOI 10.1052/ajpendo.00117.2006; Yamamoto K, 2007, DEV CELL, V13, P365, DOI 10.1016/j.devcel.2007.07.018; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	50	56	56	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13694	13703		10.1074/jbc.M109.085340	http://dx.doi.org/10.1074/jbc.M109.085340			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20197277	hybrid, Green Published			2022-12-25	WOS:000276987700044
J	Milbradt, J; Webel, R; Auerochs, S; Sticht, H; Marschall, M				Milbradt, Jens; Webel, Rike; Auerochs, Sabrina; Sticht, Heinrich; Marschall, Manfred			Novel Mode of Phosphorylation-triggered Reorganization of the Nuclear Lamina during Nuclear Egress of Human Cytomegalovirus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE PUL97; TO-TAIL POLYMERS; CELL-CYCLE; VIRAL-PROTEINS; CDC2 KINASE; WW-DOMAINS; IN-VITRO; INHIBITORS; INFECTION; PHASE	The nucleocytoplasmic egress of viral capsids is a rate-limiting step in the replication of the human cytomegalovirus (HCMV). As reported recently, an HCMV-specific nuclear egress complex is composed of viral and cellular proteins, in particular protein kinases with the capacity to induce destabilization of the nuclear lamina. Viral protein kinase pUL97 and cellular protein kinase C (PKC) play important roles by phosphorylating several types of nuclear lamins. Using pUL97 mutants, we show that the lamin-phosphorylating activity of pUL97 is associated with a reorganization of nuclear lamin A/C. Either pUL97 or PKC has the potential to induce distinct punctate lamina-depleted areas at the periphery of the nuclear envelope, which were detectable in transiently transfected and HCMV-infected cells. Using recombinant HCMV, which produces green fluorescent protein-labeled viral capsids, the direct transition of viral capsids through these areas could be visualized. This process was sensitive to an inhibitor of pUL97/PKC activity. The pUL97-mediated phosphorylation of lamin A/C at Ser(22) generated a novel binding motif for the peptidyl-prolyl cis/trans-isomerase Pin1. In HCMV-infected fibroblasts, the physiological localization of Pin1 was altered, leading to recruitment of Pin1 to viral replication centers and to the nuclear lamina. The local increase in Pin1 peptidyl-prolyl cis/trans-isomerase activity may promote conformational modulation of lamins. Thus, we postulate a novel phosphorylation-triggered mechanism for the reorganization of the nuclear lamina in HCMV-infected cells.	[Milbradt, Jens; Webel, Rike; Auerochs, Sabrina; Marschall, Manfred] Univ Erlangen Nurnberg, Inst Clin & Mol Virol, D-95104 Erlangen, Germany; [Sticht, Heinrich] Univ Erlangen Nurnberg, Div Bioinformat, Inst Biochem, D-95104 Erlangen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg	Marschall, M (corresponding author), Univ Erlangen Nurnberg, Inst Clin & Mol Virol, Schlossgarten 4, D-95104 Erlangen, Germany.	manfred.marschall@viro.med.uni-erlangen.de		Sticht, Heinrich/0000-0001-5644-045X; Milbradt, Jens/0000-0003-2172-7471	Deutsche Forschungsgemeinschaft [SFB 796, MA 1289/4-1, MA 1289/6-1]; Argus Foundation (Berlin)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Argus Foundation (Berlin)	This work was supported by Deutsche Forschungsgemeinschaft Grants SFB 796 (C3 and A2), MA 1289/4-1, and MA 1289/6-1 and by the Argus Foundation (Berlin).	Bain M, 2007, REV MED VIROL, V17, P423, DOI 10.1002/rmv.551; Broers JLV, 2005, EXP CELL RES, V304, P582, DOI 10.1016/j.yexcr.2004.11.020; Buser C, 2007, J VIROL, V81, P3042, DOI 10.1128/JVI.01564-06; Camozzi D, 2008, J GEN VIROL, V89, P731, DOI 10.1099/vir.0.83377-0; Cross T, 2000, ONCOGENE, V19, P2331, DOI 10.1038/sj.onc.1203555; Dinkel H, 2007, BIOINFORMATICS, V23, P3297, DOI 10.1093/bioinformatics/btm524; DREW WL, 1992, CLIN MICROBIOL REV, V5, P204, DOI 10.1128/CMR.5.2.204-210.1992; Goekjian PG, 1999, CURR MED CHEM, V6, P877; Goldman RD, 2002, GENE DEV, V16, P533, DOI 10.1101/gad.960502; Gruenbaum Y, 2005, NAT REV MOL CELL BIO, V6, P21, DOI 10.1038/nrm1550; Hamirally S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000275; HEALD R, 1990, CELL, V61, P579, DOI 10.1016/0092-8674(90)90470-Y; Isobe K, 2007, BIOSCI BIOTECH BIOCH, V71, P1252, DOI 10.1271/bbb.60674; Kato Y, 2002, J BIOL CHEM, V277, P10173, DOI 10.1074/jbc.M110490200; Krosky PM, 2003, J VIROL, V77, P905, DOI 10.1128/JVI.77.2.905-914.2003; Likhacheva E V, 2001, Membr Cell Biol, V14, P565; Lippens G, 2007, FEBS J, V274, P5211, DOI 10.1111/j.1742-4658.2007.06057.x; Lotzerich M, 2006, J VIROL, V80, P73, DOI 10.1128/JVI.80.1.73-84.2006; Lu KP, 2007, NAT REV MOL CELL BIO, V8, P904, DOI 10.1038/nrm2261; Lu KP, 2007, NAT CHEM BIOL, V3, P619, DOI 10.1038/nchembio.2007.35; Marschall M, 2005, J BIOL CHEM, V280, P33357, DOI 10.1074/jbc.M502672200; Marschall M, 2003, VIROLOGY, V311, P60, DOI 10.1016/S0042-6822(03)00147-8; Marschall M, 2002, J GEN VIROL, V83, P1013, DOI 10.1099/0022-1317-83-5-1013; Marschall M, 2001, J GEN VIROL, V82, P1439, DOI 10.1099/0022-1317-82-6-1439; Maul GG, 2008, MED MICROBIOL IMMUN, V197, P241, DOI 10.1007/s00430-008-0078-1; Mettenleiter TC, 2006, VET MICROBIOL, V113, P163, DOI 10.1016/j.vetmic.2005.11.040; Mettenleiter TC, 2004, VIRUS RES, V106, P167, DOI 10.1016/j.virusres.2004.08.013; Mettenleiter TC, 2009, VIRUS RES, V143, P222, DOI 10.1016/j.virusres.2009.03.018; Meydan N, 1996, NATURE, V379, P645, DOI 10.1038/379645a0; Michel D, 1996, J VIROL, V70, P6340, DOI 10.1128/JVI.70.9.6340-6346.1996; Milbradt J, 2007, J GEN VIROL, V88, P2642, DOI 10.1099/vir.0.82924-0; Milbradt J, 2009, J GEN VIROL, V90, P579, DOI 10.1099/vir.0.005231-0; Mocarski ES., 2007, FIELDS VIROLOGY, P2702; Muranyi W, 2002, SCIENCE, V297, P854, DOI 10.1126/science.1071506; Park R, 2006, J VIROL, V80, P494, DOI 10.1128/JVI.80.1.494-504.2006; PETER M, 1990, CELL, V61, P591, DOI 10.1016/0092-8674(90)90471-P; PETER M, 1991, EMBO J, V10, P1535, DOI 10.1002/j.1460-2075.1991.tb07673.x; Puntervoll P, 2003, NUCLEIC ACIDS RES, V31, P3625, DOI 10.1093/nar/gkg545; Sampaio KL, 2005, J VIROL, V79, P2754, DOI 10.1128/JVI.79.5.2754-2767.2005; Sanchez V, 2002, SCIENCE, V297, P778, DOI 10.1126/science.1075102; Sudol M, 2001, FEBS LETT, V490, P190, DOI 10.1016/S0014-5793(01)02122-6; Tavalai N, 2006, J VIROL, V80, P8006, DOI 10.1128/JVI.00743-06; Thomas M, 2009, J GEN VIROL, V90, P567, DOI 10.1099/vir.0.005827-0; Thompson LJ, 1996, J BIOL CHEM, V271, P15045, DOI 10.1074/jbc.271.25.15045; Vancikova Z., 2001, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V1, P179; Verdecia MA, 2000, NAT STRUCT BIOL, V7, P639, DOI 10.1038/77929; WARD GE, 1990, CELL, V61, P561, DOI 10.1016/0092-8674(90)90469-U; Wolf DG, 2001, P NATL ACAD SCI USA, V98, P1895, DOI 10.1073/pnas.98.4.1895	48	83	83	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13979	13989		10.1074/jbc.M109.063628	http://dx.doi.org/10.1074/jbc.M109.063628			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20202933	Green Published, hybrid			2022-12-25	WOS:000276987700072
J	Viana, AAB; Li, M; Schnell, DJ				Viana, Antonio A. B.; Li, Ming; Schnell, Danny J.			Determinants for Stop-transfer and Post-import Pathways for Protein Targeting to the Chloroplast Inner Envelope Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSERTION; PLASTIDS; TIC40; COMPONENTS; BACTERIAL; PEPTIDE; REGION; DOMAIN	The inner envelope membrane (IEM) of the chloroplast plays key roles in controlling metabolite transport between the organelle and cytoplasm and is a major site of lipid and membrane synthesis within the organelle. IEM biogenesis requires the import and integration of nucleus-encoded membrane proteins. Previous reports have led to the conclusion that membrane proteins are inserted into the IEM during protein import from the cytoplasm via a stop-transfer mechanism or are completely imported into the stroma and then inserted into the IEM in a post-import mechanism. In this study, we examined the determinants for each pathway by comparing the targeting of APG1 (albino or pale green mutant 1), an example of a stop-transfer substrate, and atTic40, an example of a post-import substrate. We show that the APG1 transmembrane domain is sufficient to direct stop-transfer insertion. The APG1 transmembrane domain also functions as a topology determinant. We also show that the ability of the post-import signals within atTic40 to target proteins to the IEM is dependent upon their context within the full protein sequence. In the incorrect context, the atTic40 signals can behave as stop-transfer signals or fail to target fusion proteins to the IEM. These data suggest that the post-import pathway signals are complex and have evolved to avoid stop-transfer insertion.	[Viana, Antonio A. B.; Schnell, Danny J.] Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA; [Li, Ming] Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Schnell, DJ (corresponding author), 710 N Pleasant St LGRT 914, Amherst, MA 01003 USA.	dschnell@biochem.umass.edu	Li, Ming/AAU-5026-2020; Viana, Antonio/F-5426-2011; Li, Ming/A-1493-2011	Li, Ming/0000-0002-1247-2377; Viana, Antonio/0000-0001-7011-1724; 	National Institutes of Health [GM-61893]; CAPES/Fulbright-Brazil fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061893] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CAPES/Fulbright-Brazil fellowship(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-61893 (to D. J. S.). This work was also supported by a CAPES/Fulbright-Brazil fellowship (to A. A. B. V.).	Akita M, 1997, J CELL BIOL, V136, P983, DOI 10.1083/jcb.136.5.983; Block MA, 2007, PHOTOSYNTH RES, V92, P225, DOI 10.1007/s11120-007-9195-8; BRINK S, 1995, J BIOL CHEM, V270, P20808, DOI 10.1074/jbc.270.35.20808; Chiu CC, 2008, PLANT J, V56, P793, DOI 10.1111/j.1365-313X.2008.03638.x; Chou ML, 2003, EMBO J, V22, P2970, DOI 10.1093/emboj/cdg281; Dalbey RE, 1999, TRENDS BIOCHEM SCI, V24, P17, DOI 10.1016/S0968-0004(98)01333-4; Dalbey RE, 2000, ANNU REV CELL DEV BI, V16, P51, DOI 10.1146/annurev.cellbio.16.1.51; Firlej-Kwoka E, 2008, PLANT MOL BIOL, V68, P505, DOI 10.1007/s11103-008-9387-4; Herrmann JM, 2003, IUBMB LIFE, V55, P219, DOI 10.1080/1521654031000123349; Herrmann JM, 2004, J BIOL CHEM, V279, P2507, DOI 10.1074/jbc.M310468200; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; HORTON RM, 1993, METHOD ENZYMOL, V217, P270; Inaba T, 2005, PLANT CELL, V17, P1482, DOI 10.1105/tpc.105.030700; Inaba T, 2008, BIOCHEM J, V413, P15, DOI 10.1042/BJ20080490; Jarvis P, 2004, CURR BIOL, V14, pR1064, DOI 10.1016/j.cub.2004.11.049; Jarvis P, 2004, CURR BIOL, V14, pR317, DOI 10.1016/j.cub.2004.03.054; Jarvis P, 2008, NEW PHYTOL, V179, P257, DOI 10.1111/j.1469-8137.2008.02452.x; KEEGSTRA K, 1986, METHOD ENZYMOL, V118, P316; KNIGHT JS, 1995, PLANT CELL, V7, P1421, DOI 10.1105/tpc.7.9.1421; KO K, 1989, EMBO J, V8, P3187, DOI 10.1002/j.1460-2075.1989.tb08477.x; Kobayashi K, 2009, PLANT PHYSIOL BIOCH, V47, P518, DOI 10.1016/j.plaphy.2008.12.012; Kouranov A, 1998, J CELL BIOL, V143, P991, DOI 10.1083/jcb.143.4.991; LI HM, 1992, J BIOL CHEM, V267, P18999; Li M, 2006, J CELL BIOL, V175, P249, DOI 10.1083/jcb.200605162; Lopez-Juez E, 2005, INT J DEV BIOL, V49, P557, DOI 10.1387/ijdb.051997el; Lubeck J, 1997, J CELL BIOL, V137, P1279, DOI 10.1083/jcb.137.6.1279; Meier S, 2005, J CELL BIOL, V170, P881, DOI 10.1083/jcb.200505126; SCHNELL DJ, 1994, SCIENCE, V266, P1007, DOI 10.1126/science.7973649; Singh ND, 2008, PLANT CELL, V20, P3405, DOI 10.1105/tpc.108.063172; SMEEKENS S, 1986, CELL, V46, P365, DOI 10.1016/0092-8674(86)90657-4; SMITH MD, 2003, CURRENT PROTOCOLS CE; SOLL J, 1985, ARCH BIOCHEM BIOPHYS, V238, P290, DOI 10.1016/0003-9861(85)90167-5; Tripp J, 2007, PLANT J, V52, P824, DOI 10.1111/j.1365-313X.2007.03279.x; Vitha S, 2003, PLANT CELL, V15, P1918, DOI 10.1105/tpc.013292	35	40	41	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12948	12960		10.1074/jbc.M110.109744	http://dx.doi.org/10.1074/jbc.M110.109744			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20194502	Green Published, hybrid			2022-12-25	WOS:000276787800053
J	Kucerova, E; Clifton, SW; Xia, XQ; Long, F; Porwollik, S; Fulton, L; Fronick, C; Minx, P; Kyung, K; Warren, W; Fulton, R; Feng, DY; Wollam, A; Shah, N; Bhonagiri, V; Nash, WE; Hallsworth-Pepin, K; Wilson, RK; McClelland, M; Forsythe, SJ				Kucerova, Eva; Clifton, Sandra W.; Xia, Xiao-Qin; Long, Fred; Porwollik, Steffen; Fulton, Lucinda; Fronick, Catrina; Minx, Patrick; Kyung, Kim; Warren, Wesley; Fulton, Robert; Feng, Dongyan; Wollam, Aye; Shah, Neha; Bhonagiri, Veena; Nash, William E.; Hallsworth-Pepin, Kymberlie; Wilson, Richard K.; McClelland, Michael; Forsythe, Stephen J.			Genome Sequence of Cronobacter sakazakii BAA-894 and Comparative Genomic Hybridization Analysis with Other Cronobacter Species	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; ENTEROBACTER-SAKAZAKII; ESCHERICHIA-COLI; O-ANTIGEN; VISUALIZATION TOOLS; MOLECULAR ANALYSIS; VIBRIO-CHOLERAE; INFANT FORMULA; BRAIN-ABSCESS; GENE LOCUS	Background: The genus Cronobacter (formerly called Enterobacter sakazakii) is composed of five species; C. sakazakii, C. malonaticus, C. turicensis, C. muytjensii, and C. dublinensis. The genus includes opportunistic human pathogens, and the first three species have been associated with neonatal infections. The most severe diseases are caused in neonates and include fatal necrotizing enterocolitis and meningitis. The genetic basis of the diversity within the genus is unknown, and few virulence traits have been identified. Methodology/Principal Findings: We report here the first sequence of a member of this genus, C. sakazakii strain BAA-894. The genome of Cronobacter sakazakii strain BAA-894 comprises a 4.4 Mb chromosome (57% GC content) and two plasmids; 31 kb (51% GC) and 131 kb (56% GC). The genome was used to construct a 387,000 probe oligonucleotide tiling DNA microarray covering the whole genome. Comparative genomic hybridization (CGH) was undertaken on five other C. sakazakii strains, and representatives of the four other Cronobacter species. Among 4,382 annotated genes inspected in this study, about 55% of genes were common to all C. sakazakii strains and 43% were common to all Cronobacter strains, with 10-17% absence of genes. Conclusions/Significance: CGH highlighted 15 clusters of genes in C. sakazakii BAA-894 that were divergent or absent in more than half of the tested strains; six of these are of probable prophage origin. Putative virulence factors were identified in these prophage and in other variable regions. A number of genes unique to Cronobacter species associated with neonatal infections (C. sakazakii, C. malonaticus and C. turicensis) were identified. These included a copper and silver resistance system known to be linked to invasion of the blood-brain barrier by neonatal meningitic strains of Escherichia coli. In addition, genes encoding for multidrug efflux pumps and adhesins were identified that were unique to C. sakazakii strains from outbreaks in neonatal intensive care units.	[Kucerova, Eva; Forsythe, Stephen J.] Nottingham Trent Univ, Sch Sci & Technol, Nottingham, England; [Xia, Xiao-Qin; Long, Fred; Porwollik, Steffen; McClelland, Michael] Vaccine Res Inst San Diego, San Diego, CA USA; [Clifton, Sandra W.; Fulton, Lucinda; Fronick, Catrina; Minx, Patrick; Kyung, Kim; Warren, Wesley; Fulton, Robert; Feng, Dongyan; Wollam, Aye; Shah, Neha; Bhonagiri, Veena; Nash, William E.; Hallsworth-Pepin, Kymberlie; Wilson, Richard K.] Washington Univ, Sch Med, Genome Ctr, St Louis, MO USA	Nottingham Trent University; Washington University (WUSTL)	Kucerova, E (corresponding author), Nottingham Trent Univ, Sch Sci & Technol, Nottingham, England.	mcclelland.michael@gmail.com	McClelland, Michael/A-8583-2011; Wilson, Richard K./AAF-4139-2019	Wilson, Richard K./0000-0002-1992-1358; xia, xiao qin/0000-0002-8034-1096; McClelland, Michael/0000-0003-1788-9347; Forsythe, Stephen/0000-0002-6709-0712	National Institutes of Health (NIH) [R01AI52237, R01AI075093, R01AI073971]; Nottingham Trent University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052237, R01AI073971, R01AI075093] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nottingham Trent University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (NIH) grants R01AI52237, R01AI075093, and R01AI073971, and by a grant from Nottingham Trent University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham SN, 1998, CURR OPIN MICROBIOL, V1, P75, DOI 10.1016/S1369-5274(98)80145-8; Baldwin A, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-223; BIERING G, 1989, J CLIN MICROBIOL, V27, P2054, DOI 10.1128/JCM.27.9.2054-2056.1989; Boyd EF, 2002, TRENDS MICROBIOL, V10, P521, DOI 10.1016/S0966-842X(02)02459-9; Brussow H, 2004, MICROBIOL MOL BIOL R, V68, P560, DOI 10.1128/MMBR.68.3.560-602.2004; Burdette JH, 2000, PEDIATR RADIOL, V30, P33, DOI 10.1007/s002470050009; Campellone KG, 2003, CURR OPIN MICROBIOL, V6, P82, DOI 10.1016/S1369-5274(03)00005-5; Caubilla-Barron J, 2007, J CLIN MICROBIOL, V45, P3979, DOI 10.1128/JCM.01075-07; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Collyn F, 2004, INFECT IMMUN, V72, P4784, DOI 10.1128/IAI.72.8.4784-4790.2004; CZERWICKA M, 2010, CARBOHYDRAT IN PRESS; Das S, 2002, BIOCHEM BIOPH RES CO, V295, P922, DOI 10.1016/S0006-291X(02)00782-9; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; FARMER JJ, 1980, INT J SYST BACTERIOL, V30, P569, DOI 10.1099/00207713-30-3-569; Florea L, 2000, NUCLEIC ACIDS RES, V28, P3486, DOI 10.1093/nar/28.18.3486; Florea L, 2003, NUCLEIC ACIDS RES, V31, P3527, DOI 10.1093/nar/gkg551; Folkesson A, 2002, RES MICROBIOL, V153, P537, DOI 10.1016/S0923-2508(02)01348-7; Franke S, 2003, J BACTERIOL, V185, P3804, DOI 10.1128/JB.185.13.3804-3812.2003; Friedemann M, 2007, INT J FOOD MICROBIOL, V116, P1, DOI 10.1016/j.ijfoodmicro.2006.12.018; Gordon D, 2001, GENOME RES, V11, P614, DOI 10.1101/gr.171401; Gurtler JB, 2005, INT J FOOD MICROBIOL, V104, P1, DOI 10.1016/j.ijfoodmicro.2005.02.013; Himelright I, 2002, JAMA-J AM MED ASSOC, V287, P2204; Huang SH, 1999, INFECT IMMUN, V67, P2103, DOI 10.1128/IAI.67.5.2103-2109.1999; Huang SH, 2001, J INFECT DIS, V183, P1071, DOI 10.1086/319290; Huang XQ, 2003, GENOME RES, V13, P2164, DOI 10.1101/gr.1390403; Iversen C, 2004, J CLIN MICROBIOL, V42, P5368, DOI 10.1128/JCM.42.11.5368-5370.2004; Iversen C, 2008, INT J SYST EVOL MICR, V58, P1442, DOI 10.1099/ijs.0.65577-0; KADO CI, 1981, J BACTERIOL, V145, P1365, DOI 10.1128/JB.145.3.1365-1373.1981; Kandhai MC, 2004, LANCET, V363, P39, DOI 10.1016/S0140-6736(03)15169-0; Kaper JB, 1998, JPN J MED SCI BIOL, V51, pS101, DOI 10.7883/yoken1952.51.Supplement1_S101; Kim CC, 2002, GENOME BIOL, V3; Kim KP, 2008, INFECT IMMUN, V76, P562, DOI 10.1128/IAI.00937-07; KLINE MW, 1988, J PEDIATR-US, V113, P430, DOI 10.1016/S0022-3476(88)80623-1; Kothary MH, 2007, APPL ENVIRON MICROB, V73, P4142, DOI 10.1128/AEM.02729-06; Lai KK, 2001, MEDICINE, V80, P113, DOI 10.1097/00005792-200103000-00004; LAZDUNSKI CJ, 1988, BIOCHIMIE, V70, P1291, DOI 10.1016/0300-9084(88)90197-6; Lehner A, 2006, FEMS MICROBIOL LETT, V265, P244, DOI 10.1111/j.1574-6968.2006.00500.x; Lima-Mendez G, 2008, BIOINFORMATICS, V24, P863, DOI 10.1093/bioinformatics/btn043; MacLean LL, 2009, BIOCHEM CELL BIOL, V87, P927, DOI 10.1139/O09-059; MacLean LL, 2009, BIOCHEM CELL BIOL, V87, P459, DOI 10.1139/O09-004; MacLean LL, 2009, CARBOHYD RES, V344, P667, DOI 10.1016/j.carres.2009.01.020; Mougous JD, 2006, P NATL ACAD SCI USA, V103, P4258, DOI 10.1073/pnas.0510861103; Mullane N, 2008, APPL ENVIRON MICROB, V74, P3783, DOI 10.1128/AEM.02302-07; NYSTROM T, 1994, MOL MICROBIOL, V11, P537, DOI 10.1111/j.1365-2958.1994.tb00334.x; Osaili T, 2009, INT J FOOD MICROBIOL, V136, P214, DOI 10.1016/j.ijfoodmicro.2009.08.006; Pagotto FJ, 2003, J FOOD PROTECT, V66, P370, DOI 10.4315/0362-028X-66.3.370; Pickard D, 2008, J BACTERIOL, V190, P2580, DOI 10.1128/JB.01654-07; Porwollik S, 2002, P NATL ACAD SCI USA, V99, P8956, DOI 10.1073/pnas.122153699; Prasadarao NV, 1996, INFECT IMMUN, V64, P146, DOI 10.1128/IAI.64.1.146-153.1996; Pukatzki S, 2006, P NATL ACAD SCI USA, V103, P1528, DOI 10.1073/pnas.0510322103; Schlieker C, 2005, BIOL CHEM, V386, P1115, DOI 10.1515/BC.2005.128; Townsend S, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-64; Townsend SM, 2007, MICROBIOL-SGM, V153, P3538, DOI 10.1099/mic.0.2007/009316-0; Van Acker J, 2001, J CLIN MICROBIOL, V39, P293, DOI 10.1128/JCM.39.1.293-297.2001; Wang Y, 1999, INFECT IMMUN, V67, P4751, DOI 10.1128/IAI.67.9.4751-4756.1999; WILLIS J, 1988, PEDIATR INFECT DIS J, V7, P196, DOI 10.1097/00006454-198803000-00012; WORKMAN C, 2002, GENOME BIOL, V3; Xia XQ, 2009, BIOINFORMATICS, V25, P2425, DOI 10.1093/bioinformatics/btp430	58	164	800	0	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2010	5	3					A51	A60	e9556	10.1371/journal.pone.0009556	http://dx.doi.org/10.1371/journal.pone.0009556			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565WZ	20221447	gold, Green Published			2022-12-25	WOS:000275328200005
J	Philipot, O; Joliot, V; Ait-Mohamed, O; Pellentz, C; Robin, P; Fritsch, L; Ait-Si-Ali, S				Philipot, Ophelie; Joliot, Veronique; Ait-Mohamed, Ouardia; Pellentz, Celine; Robin, Philippe; Fritsch, Lauriane; Ait-Si-Ali, Slimane			The Core Binding Factor CBF Negatively Regulates Skeletal Muscle Terminal Differentiation	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; HISTONE DEACETYLASES; TRANSCRIPTION FACTOR; IN-VIVO; MYOGENIC DIFFERENTIATION; HEMATOPOIETIC-CELLS; NERVOUS-SYSTEM; STEM-CELLS; BETA-SMMHC; GENE	Background: Core Binding Factor or CBF is a transcription factor composed of two subunits, Runx1/AML-1 and CBF beta or CBF beta. CBF was originally described as a regulator of hematopoiesis. Methodology/Principal Findings: Here we show that CBF is involved in the control of skeletal muscle terminal differentiation. Indeed, downregulation of either Runx1 or CBF beta protein level accelerates cell cycle exit and muscle terminal differentiation. Conversely, overexpression of CBF beta in myoblasts slows terminal differentiation. CBF interacts directly with the master myogenic transcription factor MyoD, preferentially in proliferating myoblasts, via Runx1 subunit. In addition, we show a preferential recruitment of Runx1 protein to MyoD target genes in proliferating myoblasts. The MyoD/CBF complex contains several chromatin modifying enzymes that inhibits MyoD activity, such as HDACs, Suv39h1 and HP1 beta. When overexpressed, CBF beta induced an inhibition of activating histone modification marks concomitant with an increase in repressive modifications at MyoD target promoters. Conclusions/Significance: Taken together, our data show a new role for Runx1/CBF beta in the control of the proliferation/differentiation in skeletal myoblasts.	CNRS, Inst Andre Lwoff, FRE2944, Villejuif, France; Univ Paris 11, Villejuif, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Philipot, O (corresponding author), CNRS, Epigenet & Destin Cellulaire UMR7216, Paris, France.	slimane.aitsiali@univ-paris-diderot.fr			Association Francaise contre les Myopathies (AFM); Fondation Bettencourt-Schueller; Agence Nationale de la Recherche (ANR); Ligue Nationale contre le Cancer; Association pour la Recherche sur le Cancer (ARC); CNRS; Universite Paris-Sud; Universite Paris Diderot; Ministere de la Recherche; "Programme franco-algerien de formation superieure en France''	Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); Fondation Bettencourt-Schueller; Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite Paris-Sud; Universite Paris Diderot; Ministere de la Recherche(Ministry of Science and Innovation, Spain (MICINN)Ministry of Research, France); "Programme franco-algerien de formation superieure en France''	This work was supported by the Association Francaise contre les Myopathies (AFM); the Fondation Bettencourt-Schueller; the Agence Nationale de la Recherche (ANR); the Ligue Nationale contre le Cancer; the Association pour la Recherche sur le Cancer (ARC), the CNRS; the Universite Paris-Sud and the Universite Paris Diderot. PO was recipient of fellowships from the Ministere de la Recherche and the ARC. AO was recipient of a fellowship from the "Programme franco-algerien de formation superieure en France''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Si-Ali S, 2004, EMBO J, V23, P605, DOI 10.1038/sj.emboj.7600074; Andreu N, 2006, J HUM GENET, V51, P92, DOI 10.1007/s10038-005-0328-7; Asakura A, 2001, DIFFERENTIATION, V68, P245, DOI 10.1046/j.1432-0436.2001.680412.x; Ayyanathan K, 2003, GENE DEV, V17, P1855, DOI 10.1101/gad.1102803; Britos-Bray M, 1998, BLOOD, V92, P4344, DOI 10.1182/blood.V92.11.4344.423a01_4344_4352; Buckingham M, 2001, CURR OPIN GENET DEV, V11, P440, DOI 10.1016/S0959-437X(00)00215-X; Buckingham M, 1996, BIOCHEM SOC T, V24, P506, DOI 10.1042/bst0240506; BUCKINGHAM M, 1992, TRENDS GENET, V8, P144, DOI 10.1016/0168-9525(92)90373-C; Cao WS, 1998, J BIOL CHEM, V273, P31534, DOI 10.1074/jbc.273.47.31534; Cenciarelli C, 1999, MOL CELL BIOL, V19, P5203; Chakraborty S, 2003, ONCOGENE, V22, P5229, DOI 10.1038/sj.onc.1206600; Chen CL, 2006, NEURON, V49, P365, DOI 10.1016/j.neuron.2005.10.036; Chiba N, 1997, ONCOGENE, V14, P2543, DOI 10.1038/sj.onc.1201109; de Aguilar JLG, 2008, PHYSIOL GENOMICS, V32, P207, DOI 10.1152/physiolgenomics.00017.2007; de la Serna IL, 2001, NAT GENET, V27, P187, DOI 10.1038/84826; Fulco M, 2003, MOL CELL, V12, P51, DOI 10.1016/S1097-2765(03)00226-0; Gersbach CA, 2004, EXP CELL RES, V300, P406, DOI 10.1016/j.yexcr.2004.07.031; GOLUB TR, 1995, P NATL ACAD SCI USA, V92, P4917, DOI 10.1073/pnas.92.11.4917; HALEVY O, 1995, SCIENCE, V267, P1018, DOI 10.1126/science.7863327; Hewitt J, 2008, ENDOCRINOLOGY, V149, P3698, DOI 10.1210/en.2007-1556; Ichikawa M, 2004, NAT MED, V10, P299, DOI 10.1038/nm997; Inoue K, 2002, NAT NEUROSCI, V5, P946, DOI 10.1038/nn925; Ishibashi J, 2005, J CELL BIOL, V171, P471, DOI 10.1083/jcb.200502101; Ito H, 2001, EXP CELL RES, V266, P213, DOI 10.1006/excr.2001.5220; Komaki M, 2004, J CELL SCI, V117, P1457, DOI 10.1242/jcs.00965; Komori T, 1998, CURR OPIN GENET DEV, V8, P494, DOI 10.1016/S0959-437X(98)80123-8; Le XF, 1999, J BIOL CHEM, V274, P21651, DOI 10.1074/jbc.274.31.21651; Lee KS, 2000, MOL CELL BIOL, V20, P8783, DOI 10.1128/MCB.20.23.8783-8792.2000; Levanon D, 1996, DNA CELL BIOL, V15, P175, DOI 10.1089/dna.1996.15.175; LEVANON D, 1994, GENOMICS, V23, P425, DOI 10.1006/geno.1994.1519; Lian JB, 2003, J CELL PHYSIOL, V196, P301, DOI 10.1002/jcp.10316; Mal A, 2003, P NATL ACAD SCI USA, V100, P1735, DOI 10.1073/pnas.0437843100; Mal AK, 2006, EMBO J, V25, P3323, DOI 10.1038/sj.emboj.7601229; Meyers S, 1996, ONCOGENE, V13, P303; Mikhail FM, 2006, J CELL PHYSIOL, V207, P582, DOI 10.1002/jcp.20538; MIYOSHI H, 1991, P NATL ACAD SCI USA, V88, P10431, DOI 10.1073/pnas.88.23.10431; Ohkawa Y, 2006, EMBO J, V25, P490, DOI 10.1038/sj.emboj.7600943; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Osorio KM, 2008, DEVELOPMENT, V135, P1059, DOI 10.1242/dev.012799; Ouararhni K, 2006, GENE DEV, V20, P3324, DOI 10.1101/gad.396106; Puri PL, 2001, MOL CELL, V8, P885, DOI 10.1016/S1097-2765(01)00373-2; Raveh E, 2006, MECH DEVELOP, V123, P842, DOI 10.1016/j.mod.2006.08.002; Reed-Inderbitzin E, 2006, ONCOGENE, V25, P5777, DOI 10.1038/sj.onc.1209591; Robin P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-r270; SIMON AM, 1993, MOL CELL BIOL, V13, P5133, DOI 10.1128/MCB.13.9.5133; Smith RC, 1997, CIRCULATION, V96, P1899, DOI 10.1161/01.CIR.96.6.1899; Tanaka T, 2008, MOL CELL BIOL, V28, P1147, DOI 10.1128/MCB.01771-07; Taniuchi I, 2004, ONCOGENE, V23, P4341, DOI 10.1038/sj.onc.1207671; Theriault FM, 2005, J NEUROSCI, V25, P2050, DOI 10.1523/JNEUROSCI.5108-04.2005; Wang Q, 1996, CELL, V87, P697, DOI 10.1016/S0092-8674(00)81389-6; Wang Q, 1996, P NATL ACAD SCI USA, V93, P3444, DOI 10.1073/pnas.93.8.3444; Wang XX, 2005, GENE DEV, V19, P1715, DOI 10.1101/gad.1318305; Wotton SF, 2004, ONCOGENE, V23, P5476, DOI 10.1038/sj.onc.1207729; Yahi H, 2008, J BIOL CHEM, V283, P23692, DOI 10.1074/jbc.M802647200; Yoshida N, 2005, MOL CELL BIOL, V25, P1003, DOI 10.1128/MCB.25.3.1003-1012.2005; Zhang CL, 2002, MOL CELL BIOL, V22, P7302, DOI 10.1128/MCB.22.20.7302-7312.2002; Zhang DE, 1996, CURR TOP MICROBIOL, V211, P137; Zhang LS, 2008, BLOOD, V111, P1193, DOI 10.1182/blood-2007-08-109702; ZHU XJ, 1994, MOL CELL BIOL, V14, P8051, DOI 10.1128/MCB.14.12.8051	59	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2010	5	2							e9425	10.1371/journal.pone.0009425	http://dx.doi.org/10.1371/journal.pone.0009425			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SY	20195544	Green Published, gold, Green Submitted			2022-12-25	WOS:000274924300013
J	Watve, MM; Dahanukar, N; Watve, MG				Watve, Mukta M.; Dahanukar, Neelesh; Watve, Milind G.			Sociobiological Control of Plasmid Copy Number in Bacteria	PLOS ONE			English	Article							CONJUGATIVE TRANSFER; REPLICATION; EVOLUTION; MAINTENANCE; RESISTANCE; MECHANISMS; SELECTION; HOST	All genes critical for plasmid replication regulation are located on the plasmid rather than on the host chromosome. It is possible therefore that there can be copy-up "cheater'' mutants. In spite of this possibility, low copy number plasmids appear to exist stably in host populations. We examined this paradox using a multilevel selection model. Simulations showed that, a slightly higher copy number mutant could out-compete the wild type. Consequently, another mutant with still higher copy number could invade the first invader. However, the realized benefit of increasing intra-host fitness was saturating whereas that of inter-host fitness was exponential. As a result, above a threshold, intra-host selection was overcompensated by inter-host selection and the low copy number wild type plasmid could back invade a very high copy number plasmid. This led to a rock-paper-scissor (RPS) like situation that allowed the coexistence of plasmids with varied copy numbers. Furthermore, another type of cheater that had lost the genes required for conjugation but could hitchhike on a conjugal plasmid, could further reduce the advantage of copy-up mutants. These sociobiological interactions may compliment molecular mechanisms of replication regulation in stabilizing the copy numbers.	[Watve, Mukta M.; Dahanukar, Neelesh; Watve, Milind G.] Indian Inst Sci Educ & Res, Pune, Maharashtra, India	Indian Institute of Science Education & Research (IISER) Pune	Watve, MM (corresponding author), Indian Inst Sci Educ & Res, Pune, Maharashtra, India.	milind@iiserpune.ac.in	Dahanukar, Neelesh/B-2816-2012	Dahanukar, Neelesh/0000-0001-7162-9023				Abhyankar MM, 2004, J BIOL CHEM, V279, P6711, DOI 10.1074/jbc.M312052200; Acebo P, 1996, FEMS MICROBIOL LETT, V140, P85; Andrup L, 1998, PLASMID, V40, P30, DOI 10.1006/plas.1998.1346; Bergstrom CT, 2000, GENETICS, V155, P1505; CHATTORAJ D, 1984, P NATL ACAD SCI-BIOL, V81, P6456, DOI 10.1073/pnas.81.20.6456; Corchero JL, 1998, BIOTECHNOL BIOENG, V58, P625, DOI 10.1002/(SICI)1097-0290(19980620)58:6<625::AID-BIT8>3.3.CO;2-1; Dahlberg C, 2003, GENETICS, V165, P1641; Das N, 2005, P NATL ACAD SCI USA, V102, P2856, DOI 10.1073/pnas.0409790102; De Gelder L, 2004, GENETICS, V168, P1131, DOI 10.1534/genetics.104.033431; del Solar G, 1998, MICROBIOL MOL BIOL R, V62, P434, DOI 10.1128/MMBR.62.2.434-464.1998; Dionisio F, 2005, BIOL LETT-UK, V1, P250, DOI 10.1098/rsbl.2004.0275; FLETT F, 1981, J GEN MICROBIOL, V125, P123; FRETER R, 1983, INFECT IMMUN, V39, P60, DOI 10.1128/IAI.39.1.60-84.1983; GELDER LD, 2007, MICROBIOL, V153, P452; Hauert C, 2002, SCIENCE, V296, P1129, DOI 10.1126/science.1070582; Kerr B, 2002, NATURE, V418, P171, DOI 10.1038/nature00823; LENSKI RE, 1994, J BACTERIOL, V176, P3140, DOI 10.1128/jb.176.11.3140-3147.1994; Lili LN, 2007, GENETICS, V177, P399, DOI 10.1534/genetics.107.077420; Mideo N, 2008, TRENDS ECOL EVOL, V23, P511, DOI 10.1016/j.tree.2008.05.009; NOVICK RP, 1987, MICROBIOL REV, V51, P381, DOI 10.1128/MMBR.51.4.381-395.1987; NOWAK MA, 1994, P ROY SOC B-BIOL SCI, V255, P81, DOI 10.1098/rspb.1994.0012; Paulsson J, 2002, GENETICS, V161, P1373; Paulsson J, 2001, Q REV BIOPHYS, V34, P1, DOI 10.1017/S0033583501003663; PROJAN SJ, 1987, J BACTERIOL, V169, P5131, DOI 10.1128/jb.169.11.5131-5139.1987; Sinervo B, 1996, NATURE, V380, P240, DOI 10.1038/380240a0; Smith J, 2001, P ROY SOC B-BIOL SCI, V268, P61, DOI 10.1098/rspb.2000.1330; Smith MA, 1998, CAN J MICROBIOL, V44, P351, DOI 10.1139/cjm-44-4-351; Summers D.K., 1996, BIOL PLASMIDS; Udo EE, 1997, ANTIMICROB AGENTS CH, V41, P693, DOI 10.1128/AAC.41.3.693; Velmurugan S, 2003, J BIOSCIENCES, V28, P623, DOI 10.1007/BF02703338; WILLIAMS PA, 2004, MICROBIOL TODAY, V31, P168; Yarmolinsky MB, 2000, MOL MICROBIOL, V38, P1, DOI 10.1046/j.1365-2958.2000.02127.x; Zielenkiewicz U, 2001, ACTA BIOCHIM POL, V48, P1003	33	18	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2010	5	2							e9328	10.1371/journal.pone.0009328	http://dx.doi.org/10.1371/journal.pone.0009328			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SX	20195362	gold, Green Submitted, Green Published			2022-12-25	WOS:000274924200006
J	Burke, JR; Deshong, AJ; Pelton, JG; Rubin, SM				Burke, Jason R.; Deshong, Alison J.; Pelton, Jeffrey G.; Rubin, Seth M.			Phosphorylation-induced Conformational Changes in the Retinoblastoma Protein Inhibit E2F Transactivation Domain Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-PRODUCT; TUMOR-SUPPRESSOR; CELL-CYCLE; TRANSCRIPTION FACTOR; IMPROVED SENSITIVITY; GROWTH SUPPRESSION; CRYSTAL-STRUCTURE; COMPLEX-FORMATION; STRUCTURAL BASIS; PRB	Inactivation of the retinoblastoma protein (Rb) through phosphorylation is an important step in promoting cell cycle progression, and hyperphosphorylated Rb is commonly found in tumors. Rb phosphorylation prevents its association with the E2F transcription factor; however, the molecular basis for complex inhibition has not been established. We identify here the key phosphorylation events and conformational changes that occur in Rb to inhibit the specific association between the E2F transactivation domain (E2F(TD)) and the Rb pocket domain. Calorimetry assays demonstrate that phosphorylation of Rb reduces the affinity of E2F(TD) binding similar to 250-fold and that phosphorylation at Ser(608)/Ser(612) and Thr(356)/Thr(373) is necessary and sufficient for this effect. An NMR assay identifies phosphorylation-driven conformational changes in Rb that directly inhibit E2F(TD) binding. We find that phosphorylation at Ser(608)/Ser(612) promotes an intramolecular association between a conserved sequence in the flexible pocket linker and the pocket domain of Rb that occludes the E2F(TD) binding site. We also find that phosphorylation of Thr(356)/Thr(373) inhibits E2F(TD) binding in a manner that requires the Rb N-terminal domain. Taken together, our results suggest two distinct mechanisms for how phosphorylation of Rb modulates association between E2F(TD) and the Rb pocket and describe for the first time a function for the structured N-terminal domain in Rb inactivation.	[Burke, Jason R.; Deshong, Alison J.; Rubin, Seth M.] Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA; [Pelton, Jeffrey G.] Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94706 USA	University of California System; University of California Santa Cruz; University of California System; University of California Berkeley	Rubin, SM (corresponding author), Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA.	srubin@ucsc.edu		Rubin, Seth/0000-0002-1670-4147; Burke, Jason/0000-0002-2572-8298	National Institutes of Health [CA132685, GM68933, SS10-RR20939]; NATIONAL CANCER INSTITUTE [R01CA132685] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR020939] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM068933] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA132685 (to S. M. R.) and GM68933 (to support the Central California 900-MHz facility), and SS10-RR20939 (to support the University of California Santa Cruz mass spectrometry facility).	Adams P.D., 2001, BIOCHIM BIOPHYS ACTA, V1471, P123; Brown VD, 1999, MOL CELL BIOL, V19, P3246; BUCHKOVICH K, 1989, CELL, V58, P1097, DOI 10.1016/0092-8674(89)90508-4; CHELLAPPAN SP, 1991, CELL, V65, P1053, DOI 10.1016/0092-8674(91)90557-F; CHEN PL, 1989, CELL, V58, P1193, DOI 10.1016/0092-8674(89)90517-5; Chew YP, 1998, ONCOGENE, V17, P2177, DOI 10.1038/sj.onc.1202443; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; FATTAEY A, 1993, PHILOS T ROY SOC B, V340, P333, DOI 10.1098/rstb.1993.0075; FLEMINGTON EK, 1993, P NATL ACAD SCI USA, V90, P6914, DOI 10.1073/pnas.90.15.6914; Harbour JW, 1999, CELL, V98, P859, DOI 10.1016/S0092-8674(00)81519-6; Hassler M, 2007, MOL CELL, V28, P371, DOI 10.1016/j.molcel.2007.08.023; HIEBERT SW, 1993, MOL CELL BIOL, V13, P3384, DOI 10.1128/MCB.13.6.3384; HIEBERT SW, 1992, GENE DEV, V6, P177, DOI 10.1101/gad.6.2.177; HINDS PW, 1992, CELL, V70, P993, DOI 10.1016/0092-8674(92)90249-C; Jeffrey PD, 2000, GENE DEV, V14, P3115, DOI 10.1101/gad.851100; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kitagawa M, 1996, EMBO J, V15, P7060, DOI 10.1002/j.1460-2075.1996.tb01097.x; Knudsen ES, 1996, J BIOL CHEM, V271, P8313, DOI 10.1074/jbc.271.14.8313; Knudsen ES, 1997, MOL CELL BIOL, V17, P5771, DOI 10.1128/MCB.17.10.5771; Lee C, 2002, GENE DEV, V16, P3199, DOI 10.1101/gad.1046102; Lee JO, 1998, NATURE, V391, P859, DOI 10.1038/36038; LEES JA, 1991, EMBO J, V10, P4279, DOI 10.1002/j.1460-2075.1991.tb05006.x; Lents NH, 2006, CELL CYCLE, V5, P1699, DOI 10.4161/cc.5.15.3126; LIN BTY, 1991, EMBO J, V10, P857, DOI 10.1002/j.1460-2075.1991.tb08018.x; Lundberg AS, 1998, MOL CELL BIOL, V18, P753, DOI 10.1128/MCB.18.2.753; MORI S, 1995, J MAGN RESON SER B, V108, P94, DOI 10.1006/jmrb.1995.1109; MUHANDIRAM DR, 1994, J MAGN RESON SER B, V103, P203, DOI 10.1006/jmrb.1994.1032; NORWOOD TJ, 1990, J MAGN RESON, V87, P488, DOI 10.1016/0022-2364(90)90306-T; QIN XQ, 1992, GENE DEV, V6, P953, DOI 10.1101/gad.6.6.953; Rubin SM, 2005, CELL, V123, P1093, DOI 10.1016/j.cell.2005.09.044; Russo AA, 1997, METHOD ENZYMOL, V283, P3; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Singh M, 2005, J BIOL CHEM, V280, P37868, DOI 10.1074/jbc.M504877200; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; WITTEKIND M, 1993, J MAGN RESON SER B, V101, P201, DOI 10.1006/jmrb.1993.1033; Xiao B, 2003, P NATL ACAD SCI USA, V100, P2363, DOI 10.1073/pnas.0436813100; Zarkowska T, 1997, J BIOL CHEM, V272, P12738, DOI 10.1074/jbc.272.19.12738	37	96	100	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					16286	16293		10.1074/jbc.M110.108167	http://dx.doi.org/10.1074/jbc.M110.108167			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20223825	Green Published, hybrid			2022-12-25	WOS:000277715900065
J	Mohan, SK; Rani, SG; Yu, C				Mohan, Sepuru K.; Rani, Sandhya G.; Yu, Chin			The Heterohexameric Complex Structure, a Component in the Non-classical Pathway for Fibroblast Growth Factor 1 (FGF1) Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBROBLAST-GROWTH-FACTOR; SHOCK IN-VITRO; BINDING-AFFINITY; MAMMALIAN-CELLS; SYNAPTOTAGMIN-I; RELEASE COMPLEX; PLASMA-MEMBRANE; TERMINAL DOMAIN; KEY COMPONENT; NMR	Fibroblast growth factors (FGFs) are key regulators of cell proliferation, tumor-induced angiogenesis, and migration. FGFs are essential for early embryonic development, organ formation, and angiogenesis. FGF1 also plays an important role in inflammation, wound healing, and restenosis. The biological effects of FGF1 are mediated through the activation of the four transmembrane phosphotyrosine kinase fibroblast growth factor receptors in the presence of heparin sulfate proteoglycans and, therefore, require the release of the protein into the extracellular space. FGF1 is exported through a non-classical release pathway involving the formation of a specific multiprotein complex. The protein constituents of this complex include FGF1, S100A13, and the p40 form of synaptotagmin 1 (Syt1). Because FGF1 plays an important role in tumor formation, it is clear that preventing the formation of the multiprotein complex would be an effective strategy to inhibit a wide range of cancers. To understand the molecular events in the FGF1 release pathway, we studied the FGF1-S100A13 tetrameric and FGF1-S100A13-C2A hexameric complex structures, which are both complexes possibly formed during the non-classical pathway of FGF1 release.	[Mohan, Sepuru K.; Rani, Sandhya G.; Yu, Chin] Natl Tsing Hua Univ, Dept Chem, Hsinchu 30013, Taiwan	National Tsing Hua University	Yu, C (corresponding author), Natl Tsing Hua Univ, Dept Chem, Hsinchu 30013, Taiwan.	cyu.nthu@gmail.com	Sepuru, Krishna Mohan/K-5321-2014	Sepuru, Krishna Mohan/0000-0002-3675-6294	National Science Council of Taiwan [NSC 98-2113-M-007-018-MYZ]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by National Science Council of Taiwan Grant NSC 98-2113-M-007-018-MYZ.	Ababou A, 2007, J BIOL CHEM, V282, P9204, DOI 10.1074/jbc.M610899200; Arunkumar AI, 2002, PROTEIN SCI, V11, P1050, DOI 10.1110/ps.2270102; Bevers EM, 1999, BBA-MOL CELL BIOL L, V1439, P317, DOI 10.1016/S1388-1981(99)00110-9; Bhattacharya S, 2003, STRUCTURE, V11, P738, DOI 10.1016/S0969-2126(03)00132-1; Blobel G, 2000, CHEMBIOCHEM, V1, P87; Breeze AL, 2000, PROG NUCL MAG RES SP, V36, P323, DOI 10.1016/S0079-6565(00)00020-0; Carreira CM, 1998, J BIOL CHEM, V273, P22224, DOI 10.1074/jbc.273.35.22224; Carreira CM, 2001, GROWTH FACTORS, V18, P277, DOI 10.3109/08977190109029116; Chang YG, 2006, PROTEIN SCI, V15, P1248, DOI 10.1110/ps.051995006; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; Diaz AR, 2008, J BIOL CHEM, V283, P2962, DOI 10.1074/jbc.M709032200; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; ENGLEKA KA, 1992, J BIOL CHEM, V267, P11307; Fischer K, 2006, BLOOD, V108, P4094, DOI 10.1182/blood-2006-03-011742; Garcia J, 2004, NAT STRUCT MOL BIOL, V11, P45, DOI 10.1038/nsmb707; Garrett DS, 1997, BIOCHEMISTRY-US, V36, P4393, DOI 10.1021/bi970221q; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Gerber SH, 2002, DIABETES, V51, pS12, DOI 10.2337/diabetes.51.2007.S12; Goddard T.D., SPARKY 3; Graziani I, 2006, BIOCHEM BIOPH RES CO, V349, P192, DOI 10.1016/j.bbrc.2006.08.021; GRZESIEK S, 1993, J MAGN RESON SER B, V102, P103, DOI 10.1006/jmrb.1993.1069; GRZESIEK S, 1993, J BIOMOL NMR, V3, P185; Hall DA, 2001, P NATL ACAD SCI USA, V98, P9521, DOI 10.1073/pnas.171168898; Hayrabedyan S, 2005, J REPROD IMMUNOL, V67, P87, DOI 10.1016/j.jri.2005.07.001; Hubbard S. J., 1993, NACCESS; JACKSON A, 1995, J BIOL CHEM, V270, P33, DOI 10.1074/jbc.270.1.33; JACKSON A, 1992, P NATL ACAD SCI USA, V89, P10691, DOI 10.1073/pnas.89.22.10691; KAY LE, 1994, J MAGN RESON SER A, V109, P129, DOI 10.1006/jmra.1994.1145; Landriscina M, 2001, J BIOL CHEM, V276, P25549, DOI 10.1074/jbc.M102925200; Landriscina M, 2001, J BIOL CHEM, V276, P22544, DOI 10.1074/jbc.M100546200; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; LaVallee TM, 1998, J BIOL CHEM, V273, P22217, DOI 10.1074/jbc.273.35.22217; Linge JP, 2001, METHOD ENZYMOL, V339, P71, DOI 10.1016/S0076-6879(01)39310-2; Mohan SK, 2009, BIOCHEM BIOPH RES CO, V380, P514, DOI 10.1016/j.bbrc.2009.01.143; Nickel W, 2005, TRAFFIC, V6, P607, DOI 10.1111/j.1600-0854.2005.00302.x; PASCAL SM, 1994, J MAGN RESON SER B, V103, P197, DOI 10.1006/jmrb.1994.1031; Pellegrini L, 2001, CURR OPIN STRUC BIOL, V11, P629, DOI 10.1016/S0959-440X(00)00258-X; Pierce MM, 1999, METHODS, V19, P213, DOI 10.1006/meth.1999.0852; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Pomorski T, 2001, SEMIN CELL DEV BIOL, V12, P139, DOI 10.1006/scdb.2000.0231; Prudovsky I, 2003, J CELL SCI, V116, P4871, DOI 10.1242/jcs.00872; Prudovsky I, 2008, J CELL BIOCHEM, V103, P1327, DOI 10.1002/jcb.21513; Ptitsyn OB, 1995, ADV PROTEIN CHEM, V47, P83, DOI 10.1016/S0065-3233(08)60546-X; Rajalingam D, 2005, BIOCHEMISTRY-US, V44, P14431, DOI 10.1021/bi051387r; Rajalingam D, 2007, BIOCHEMISTRY-US, V46, P9225, DOI 10.1021/bi7002586; Raman R, 2003, P NATL ACAD SCI USA, V100, P2357, DOI 10.1073/pnas.0437842100; Riek R, 2000, TRENDS BIOCHEM SCI, V25, P462, DOI 10.1016/S0968-0004(00)01665-0; Rieping W, 2007, BIOINFORMATICS, V23, P381, DOI 10.1093/bioinformatics/btl589; Shi JP, 1997, J BIOL CHEM, V272, P1142, DOI 10.1074/jbc.272.2.1142; Shishibori T, 1999, BIOCHEM J, V338, P583, DOI 10.1042/0264-6021:3380583; Sivaraja V, 2006, BIOPHYS J, V91, P1832, DOI [10.1529/biophysj.105.079988, 10.1529/biophysj.106.079988]; Soldi R, 2007, EXP CELL RES, V313, P3308, DOI 10.1016/j.yexcr.2007.05.031; Sparvero LJ, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-17; Wang AJ, 1996, CURR OPIN BIOTECH, V7, P403, DOI 10.1016/S0958-1669(96)80115-7; Williams C, 2007, STRUCTURE, V15, P1065, DOI 10.1016/j.str.2007.07.007; WITTEKIND M, 1993, J MAGN RESON SER B, V101, P201, DOI 10.1006/jmrb.1993.1033	57	19	23	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15464	15475		10.1074/jbc.M109.066357	http://dx.doi.org/10.1074/jbc.M109.066357			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20220137	hybrid, Green Published			2022-12-25	WOS:000277399000066
J	Palmitessa, A; Benovic, JL				Palmitessa, Aimee; Benovic, Jeffrey L.			Arrestin and the Multi-PDZ Domain-containing Protein MPZ-1 Interact with Phosphatase and Tensin Homolog (PTEN) and Regulate Caenorhabditis elegans Longevity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-I RECEPTOR; AGE-1 PI3 KINASE; C-ELEGANS; LIFE-SPAN; DAUER FORMATION; BETA-ARRESTINS; FAMILY-MEMBER; DAF-16; INSULIN/IGF-1; DIAPAUSE	Arrestins are multifunctional adaptor proteins best known for their role in regulating G protein-coupled receptor signaling. Arrestins also regulate other types of receptors, including the insulin-like growth factor receptor (IGF-1R), although the mechanism by which this occurs is not well understood. In Caenorhabditis elegans, the IGF-1R ortholog DAF-2 regulates dauer formation, stress resistance, metabolism, and lifespan through a conserved signaling cascade. To further elucidate the role of arrestin in IGF-1R signaling, we employed an in vivo approach to investigate the role of ARR-1, the sole arrestin ortholog in C. elegans, on longevity. Here, we report that ARR-1 functions to positively regulate DAF-2 signaling in C. elegans. arr-1 mutant animals exhibit increased longevity and enhanced nuclear localization of DAF-16, an indication of decreased DAF-2 signaling, whereas animals overexpressing ARR-1 have decreased longevity. Genetic and biochemical analysis reveal that ARR-1 functions to regulate DAF-2 signaling via direct interaction with MPZ-1, a multi-PDZ domain-containing protein, via a C-terminal PDZ binding domain in ARR-1. Interestingly, ARR-1 and MPZ-1 are found in a complex with the phosphatase and tensin homolog (PTEN) ortholog DAF-18, which normally serves as a suppressor of DAF-2 signaling, suggesting that these three proteins work together to regulate DAF-2 signaling. Our results suggest that the ARR-1-MPZ-1-DAF-18 complex functions to regulate DAF-2 signaling in vivo and provide insight into a novel mechanism by which arrestin is able to regulate IGF-1R signaling and longevity.	[Palmitessa, Aimee; Benovic, Jeffrey L.] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA	Jefferson University	Benovic, JL (corresponding author), Thomas Jefferson Univ, Dept Biochem & Mol Biol, 233 S 10th St, Philadelphia, PA 19107 USA.	benovic@mail.jci.tju.edu			National Institutes of Health [R37 GM047417]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM047417] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R37 GM047417 (to J. L. B.).	Antebi A, 2007, PLOS GENET, V3, P1565, DOI 10.1371/journal.pgen.0030129; Barbieri M, 2003, AM J PHYSIOL-ENDOC M, V285, pE1064, DOI 10.1152/ajpendo.00296.2003; Barki-Harrington L, 2008, PHYSIOLOGY, V23, P17, DOI 10.1152/physiol.00042.2007; BASERGA R, 1995, CANCER RES, V55, P249; BRENNER S, 1974, GENETICS, V77, P71; Celver J, 2002, J BIOL CHEM, V277, P9043, DOI 10.1074/jbc.M107400200; Das S, 2003, P NATL ACAD SCI USA, V100, P7491, DOI 10.1073/pnas.0932835100; DORMAN JB, 1995, GENETICS, V141, P1399; Gericke A, 2006, GENE, V374, P1, DOI 10.1016/j.gene.2006.02.024; Gil EB, 1999, P NATL ACAD SCI USA, V96, P2925, DOI 10.1073/pnas.96.6.2925; Girnita L, 2005, J BIOL CHEM, V280, P24412, DOI 10.1074/jbc.M501129200; Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700; Hansen M, 2005, PLOS GENET, V1, P119, DOI 10.1371/journal.pgen.0010017; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Hertweck M, 2004, DEV CELL, V6, P577, DOI 10.1016/S1534-5807(04)00095-4; Hunt-Newbury R, 2007, PLOS BIOL, V5, P1981, DOI 10.1371/journal.pbio.0050237; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; LARSEN PL, 1995, GENETICS, V139, P1567; Larsson O, 2005, BRIT J CANCER, V92, P2097, DOI 10.1038/sj.bjc.6602627; Lee RYN, 2001, CURR BIOL, V11, P1950, DOI 10.1016/S0960-9822(01)00595-4; Lefkowitz RJ, 2006, MOL CELL, V24, P643, DOI 10.1016/j.molcel.2006.11.007; Lin FT, 1998, J BIOL CHEM, V273, P31640, DOI 10.1074/jbc.273.48.31640; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Luan B, 2009, NATURE, V457, P1146, DOI 10.1038/nature07617; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Mihaylova VT, 1999, P NATL ACAD SCI USA, V96, P7427, DOI 10.1073/pnas.96.13.7427; Morris JZ, 1996, NATURE, V382, P536, DOI 10.1038/382536a0; Ogg S, 1998, MOL CELL, V2, P887, DOI 10.1016/S1097-2765(00)80303-2; Padmanabhan S, 2009, CELL, V136, P939, DOI 10.1016/j.cell.2009.01.025; Palmitessa A, 2005, J BIOL CHEM, V280, P24649, DOI 10.1074/jbc.M502637200; Paradis S, 1999, GENE DEV, V13, P1438, DOI 10.1101/gad.13.11.1438; Paradis S, 1998, GENE DEV, V12, P2488, DOI 10.1101/gad.12.16.2488; Patel DS, 2008, GENETICS, V178, P931, DOI 10.1534/genetics.107.070813; Philipp S, 1997, FEBS LETT, V413, P243, DOI 10.1016/S0014-5793(97)00877-6; Povsic TJ, 2003, J BIOL CHEM, V278, P51334, DOI 10.1074/jbc.M309968200; Scott BA, 2002, SCIENCE, V296, P2388, DOI 10.1126/science.1072302; Shaw WM, 2007, CURR BIOL, V17, P1635, DOI 10.1016/j.cub.2007.08.058; Solari F, 2005, ONCOGENE, V24, P20, DOI 10.1038/sj.onc.1207978; Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447; Tsunoda S, 1997, NATURE, V388, P243, DOI 10.1038/40805; Wang T, 2007, PFLUG ARCH EUR J PHY, V454, P821, DOI 10.1007/s00424-007-0251-1; Wolkow CA, 2000, SCIENCE, V290, P147, DOI 10.1126/science.290.5489.147; Xiao H, 2006, DEV BIOL, V298, P379, DOI 10.1016/j.ydbio.2006.06.044	46	18	23	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15187	15200		10.1074/jbc.M110.104612	http://dx.doi.org/10.1074/jbc.M110.104612			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20207731	Green Published, hybrid			2022-12-25	WOS:000277399000040
J	Xu, T; Shively, CA; Jin, R; Eckwahl, MJ; Dobry, CJ; Song, QX; Kumar, A				Xu, Tao; Shively, Christian A.; Jin, Rui; Eckwahl, Matthew J.; Dobry, Craig J.; Song, Qingxuan; Kumar, Anuj			A Profile of Differentially Abundant Proteins at the Yeast Cell Periphery during Pseudohyphal Growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CEREVISIAE FILAMENTOUS-GROWTH; HAPLOID INVASIVE GROWTH; SACCHAROMYCES-CEREVISIAE; SIGNALING SPECIFICITY; TRANSCRIPTION FACTOR; FLUORESCENT PROTEIN; GENE-EXPRESSION; KINASE PATHWAY; MAP KINASE; FLO11	Yeast filamentous growth is a stress response to conditions of nitrogen deprivation, wherein yeast colonies form pseudohyphal filaments of elongated and connected cells. As proteins mediating adhesion and transport are required for this growth transition, we expect that the protein complement at the yeast cell periphery plays a critical and tightly regulated role in pseudohyphal filamentation. To identify proteins differentially abundant at the yeast cell periphery during pseudohyphal growth, we generated quantitative proteomic profiles of plasma membrane protein preparations under conditions of vegetative growth and filamentation. By isobaric tags for relative and absolute quantification chemistry and two-dimensional liquid chromatography-tandem mass spectrometry, we profiled 2463 peptides and 356 proteins, identifying 11 differentially abundant proteins that localize to the yeast cell periphery. This protein set includes Ylr414cp, herein renamed Pun1p, a previously uncharacterized protein localized to the plasma membrane compartment of Can1. Pun1p abundance is doubled under conditions of nitrogen stress, and deletion of PUN1 abolishes filamentous growth in haploids and diploids; pun1 Delta mutants are noninvasive, lack surface-spread filamentation, grow slowly, and exhibit impaired cell adhesion. Conversely, overexpression of PUN1 results in exaggerated cell elongation under conditions of nitrogen stress. PUN1 contributes to yeast nitrogen signaling, as pun1 Delta mutants misregulate amino acid biosynthetic genes during nitrogen stress. By chromatin immunoprecipitation and reverse transcription-PCR, we find that the filamentous growth factor Mss11p directly binds the PUN1 promoter and regulates its transcription. In total, this study provides the first profile of differential protein abundance during pseudohyphal growth, identifying a previously uncharacterized membrane compartment of Can1 protein required for wild-type nitrogen signaling and filamentous growth.	Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Kumar, A (corresponding author), Life Sci Inst 6026, 210 Washtenaw Ave, Ann Arbor, MI 48109 USA.	anujk@umich.edu		Kumar, Anuj/0000-0002-8923-297X	National Institutes of Health [1R21A1084539-01]; American Cancer Society [RSG-06-179-01-MBC]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007315] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R21A1084539-01 (to A. K.). This work was also supported by Grant RSG-06-179-01-MBC from the American Cancer Society.	Abdullah U, 2009, EUKARYOT CELL, V8, P1362, DOI 10.1128/EC.00015-09; Ahn SH, 1999, MOL BIOL CELL, V10, P3301, DOI 10.1091/mbc.10.10.3301; Alvarez FJ, 2008, MOL BIOL CELL, V19, P5214, DOI 10.1091/mbc.E08-05-0479; Bao MZ, 2004, CELL, V119, P991, DOI 10.1016/j.cell.2004.11.052; BAUDIN A, 1993, NUCLEIC ACIDS RES, V21, P3329, DOI 10.1093/nar/21.14.3329; Bharucha N, 2008, MOL BIOL CELL, V19, P2708, DOI 10.1091/mbc.E07-11-1199; Birkaya B, 2009, EUKARYOT CELL, V8, P1118, DOI 10.1128/EC.00006-09; Borneman AR, 2006, GENE DEV, V20, P435, DOI 10.1101/gad.1389306; CARLSON M, 1981, GENETICS, V98, P25; CELENZA JL, 1984, MOL CELL BIOL, V4, P49, DOI 10.1128/MCB.4.1.49; Chandarlapaty S, 1998, MOL CELL BIOL, V18, P2884, DOI 10.1128/MCB.18.5.2884; Chang A, 2002, METHOD ENZYMOL, V351, P339; Cook JG, 1997, NATURE, V390, P85, DOI 10.1038/36355; Cullen PJ, 2000, P NATL ACAD SCI USA, V97, P13619, DOI 10.1073/pnas.240345197; Cullen PJ, 2004, GENE DEV, V18, P1695, DOI 10.1101/gad.1178604; Douglas LM, 2007, EUKARYOT CELL, V6, P2214, DOI 10.1128/EC.00284-06; Edgington NP, 1999, MOL CELL BIOL, V19, P1369; Elbing K, 2006, BIOCHEM J, V393, P797, DOI 10.1042/BJ20051213; Erdman S, 2001, GENETICS, V159, P919; Forsberg H, 2001, MOL CELL BIOL, V21, P814, DOI 10.1128/MCB.21.3.814-826.2001; Gagiano M, 1999, MOL MICROBIOL, V31, P103, DOI 10.1046/j.1365-2958.1999.01151.x; Gagiano M, 2003, MOL MICROBIOL, V47, P119, DOI 10.1046/j.1365-2958.2003.03247.x; Gancedo JM, 2001, FEMS MICROBIOL REV, V25, P107, DOI 10.1016/S0168-6445(00)00056-5; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; GIMENO CJ, 1992, CELL, V68, P1077, DOI 10.1016/0092-8674(92)90079-R; Gingras AC, 2005, J PHYSIOL-LONDON, V563, P11, DOI 10.1113/jphysiol.2004.080440; GRENSON M, 1966, BIOCHIM BIOPHYS ACTA, V127, P339, DOI 10.1016/0304-4165(66)90388-6; Grossmann G, 2008, J CELL BIOL, V183, P1075, DOI 10.1083/jcb.200806035; Guo B, 2000, P NATL ACAD SCI USA, V97, P12158, DOI 10.1073/pnas.220420397; GUTHRIE C, 1991, GUIDE YEAST GENETICS, P12; Halme A, 2004, CELL, V116, P405, DOI 10.1016/S0092-8674(04)00118-7; Jin R, 2008, MOL BIOL CELL, V19, P284, DOI 10.1091/mbc.E07-05-0519; Juan Hsueh-Fen, 2007, V382, P405, DOI 10.1007/978-1-59745-304-2_25; Keshamouni VG, 2009, J PROTEOME RES, V8, P35, DOI 10.1021/pr8006478; Kim TS, 2004, MOL CELL BIOL, V24, P9542, DOI 10.1128/MCB.24.21.9542-9556.2004; Kobayashi O, 1996, MOL GEN GENET, V251, P707, DOI 10.1007/s004380050220; KRON SJ, 1994, MOL BIOL CELL, V5, P1003, DOI 10.1091/mbc.5.9.1003; Kubler E, 1997, J BIOL CHEM, V272, P20321, DOI 10.1074/jbc.272.33.20321; Kuchin S, 2002, MOL CELL BIOL, V22, P3994, DOI 10.1128/MCB.22.12.3994-4000.2002; Leberer E, 1997, EMBO J, V16, P83, DOI 10.1093/emboj/16.1.83; Li JY, 2002, J BIOL CHEM, V277, P9069, DOI 10.1074/jbc.M110467200; Li WS, 1997, GENETICS, V145, P63; Liu HP, 1996, GENETICS, V144, P967; LIU HP, 1993, SCIENCE, V262, P1741, DOI 10.1126/science.8259520; Lo HJ, 1997, CELL, V90, P939, DOI 10.1016/S0092-8674(00)80358-X; Lo WS, 1996, J BACTERIOL, V178, P7144, DOI 10.1128/jb.178.24.7144-7151.1996; Lo WS, 1998, MOL BIOL CELL, V9, P161, DOI 10.1091/mbc.9.1.161; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lorenz MC, 2000, MOL BIOL CELL, V11, P183, DOI 10.1091/mbc.11.1.183; Lorenz MC, 1998, GENETICS, V150, P1443; Lorenz MC, 1998, EMBO J, V17, P1236, DOI 10.1093/emboj/17.5.1236; Ma J, 2008, AUTOPHAGY, V4, P792, DOI 10.4161/auto.6308; Ma J, 2007, GENETICS, V177, P205, DOI 10.1534/genetics.107.076596; Madhani HD, 1997, SCIENCE, V275, P1314, DOI 10.1126/science.275.5304.1314; Madhani HD, 1997, CELL, V91, P673, DOI 10.1016/S0092-8674(00)80454-7; Miled C, 2001, MOL CELL BIOL, V21, P3714, DOI 10.1128/MCB.21.11.3714-3724.2001; Mir SS, 2009, MOL CELL BIOL, V29, P187, DOI 10.1128/MCB.02271-07; Mosch HU, 1999, MOL BIOL CELL, V10, P1325, DOI 10.1091/mbc.10.5.1325; Mosch HU, 1996, P NATL ACAD SCI USA, V93, P5352, DOI 10.1073/pnas.93.11.5352; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Pan XW, 2002, MOL CELL BIOL, V22, P3981, DOI 10.1128/MCB.22.12.3981-3993.2002; Pan XW, 1999, MOL CELL BIOL, V19, P4874; Peter M, 1996, EMBO J, V15, P7046, DOI 10.1002/j.1460-2075.1996.tb01096.x; Ramsook CB, 2010, EUKARYOT CELL, V9, P393, DOI 10.1128/EC.00068-09; Ranish JA, 2003, NAT GENET, V33, P349, DOI 10.1038/ng1101; Reynolds TB, 2001, SCIENCE, V291, P878, DOI 10.1126/science.291.5505.878; Robertson LS, 1998, P NATL ACAD SCI USA, V95, P13783, DOI 10.1073/pnas.95.23.13783; Rodriguez-Pena JM, 2005, MICROBIOL-SGM, V151, P2241, DOI 10.1099/mic.0.27989-0; Rupp S, 1999, EMBO J, V18, P1257, DOI 10.1093/emboj/18.5.1257; Rutherford JC, 2008, MOL BIOL CELL, V19, P3028, DOI 10.1091/mbc.E08-01-0033; Stradalova V, 2009, J CELL SCI, V122, P2887, DOI 10.1242/jcs.051227; Su C, 2009, EUKARYOT CELL, V8, P1780, DOI 10.1128/EC.00190-09; van Dyk D, 2005, GENETICS, V169, P91, DOI 10.1534/genetics.104.033704; Voynov V, 2006, P NATL ACAD SCI USA, V103, P14423, DOI 10.1073/pnas.0606546103; Vyas VK, 2003, MOL CELL BIOL, V23, P1341, DOI 10.1128/MCB.23.4.1341-1348.2003; Young ME, 2002, MOL CELL BIOL, V22, P927, DOI 10.1128/MCB.22.3.927-934.2002	76	30	32	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15476	15488		10.1074/jbc.M110.114926	http://dx.doi.org/10.1074/jbc.M110.114926			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20228058	Green Published, hybrid			2022-12-25	WOS:000277399000067
J	Gagnon, KB; Delpire, E				Gagnon, Kenneth B.; Delpire, Eric			Multiple Pathways for Protein Phosphatase 1 (PP1) Regulation of Na-K-2Cl Cotransporter (NKCC1) Function THE N-TERMINAL TAIL OF THE Na-K-2Cl COTRANSPORTER SERVES AS A REGULATORY SCAFFOLD FOR Ste20-RELATED PROLINE/ALANINE-RICH KINASE (SPAK) AND PP1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							K-CL COTRANSPORTER; MEDULLARY COLLECTING DUCT; NA+-K+-2CL(-) COTRANSPORTER; MOLECULAR-CLONING; PHOSPHORYLATION; KINASES; CALYCULIN; MODULATION; ACTIVATION; EXPRESSION	The Na-K-2Cl cotransporter (NKCC1) participates in epithelial transport and in cell volume maintenance by mediating the movement of ions and water across plasma membranes. Functional studies have previously demonstrated that NKCC1 activity is stimulated by protein phosphatase 1 (PP1) inhibitors. In this study, we utilized both in vivo (heterologous cRNA expression in Xenopus laevis oocytes) and in vitro (P-32-phosphorylation assays with glutathione S-transferase fusion proteins) experiments to determine whether PP1 exerts its inhibitory effect directly on the cotransporter, or indirectly by affecting the activating kinase. We found that PP1 reduced NKCC1 activity in oocytes under both isotonic and hypertonic conditions to the same level as in water-injected controls. Interestingly, mutation of key residues in the PP1 binding motif located in the N-terminal tail of NKCC1 significantly reduced the inhibitory effect of PP1. In vitro experiments performed with recombinant PP1, SPAK (Ste20-related proline/alanine-rich kinase, which activates NKCC1), and the N terminus of NKCC1 fused to glutathione S-transferase demonstrated that PP1 dephosphorylated both the kinase and the cotransporter in a time-dependent manner. More importantly, PP1 dephosphorylation of SPAK was significantly greater when protein-protein interaction between the kinase and the N-terminal tail of NKCC1 was present in the reaction, indicating the necessity of scaffolding the phosphatase and kinase in proximity to one another. Taken together, our data are consistent with PP1 inhibiting NKCC1 activity directly by dephosphorylating the cotransporter and indirectly by dephosphorylating SPAK.	[Gagnon, Kenneth B.; Delpire, Eric] Vanderbilt Univ, Med Ctr, Dept Anesthesiol, Nashville, TN 37221 USA	Vanderbilt University	Delpire, E (corresponding author), T-4202 Med Ctr N,1161 21st Ave S, Nashville, TN 37232 USA.	eric.delpire@vanderbilt.edu		Gagnon, Kenneth/0000-0001-7602-6379	National Institutes of Health [GM074771]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074771] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM074771 (to E. D.).	Darman RB, 2002, J BIOL CHEM, V277, P37542, DOI 10.1074/jbc.M206293200; Darman RB, 2001, J BIOL CHEM, V276, P34359, DOI 10.1074/jbc.C100368200; DELPIRE E, 1994, J BIOL CHEM, V269, P25677; Dowd BFX, 2003, J BIOL CHEM, V278, P27347, DOI 10.1074/jbc.M301899200; Fagerholm AE, 2010, MAR DRUGS, V8, P122, DOI 10.3390/md80100122; GAGNON KB, 2010, FASEB J, V24; Gagnon KBE, 2006, MOL CELL BIOL, V26, P689, DOI 10.1128/MCB.26.2.689-698.2006; Gagnon KBE, 2006, AM J PHYSIOL-CELL PH, V290, pC134, DOI 10.1152/ajpcell.00037.2005; Gagnon KBE, 2007, CELL PHYSIOL BIOCHEM, V20, P131, DOI 10.1159/000104161; Gagnon KBE, 2007, AM J PHYSIOL-CELL PH, V292, pC1809, DOI 10.1152/ajpcell.00580.2006; Gamba G, 2005, PHYSIOL REV, V85, P423, DOI 10.1152/physrev.00011.2004; Kaplan MR, 1996, J CLIN INVEST, V98, P723, DOI 10.1172/JCI118844; LYTLE C, 1992, J BIOL CHEM, V267, P25438; Lytle C, 1996, AM J PHYSIOL-CELL PH, V270, pC437, DOI 10.1152/ajpcell.1996.270.2.C437; Lytle C, 1997, J BIOL CHEM, V272, P15069, DOI 10.1074/jbc.272.24.15069; Mori T, 2005, J BIOL CHEM, V280, P9345, DOI 10.1074/jbc.M411122200; Muzyamba MC, 1999, J PHYSIOL-LONDON, V517, P421, DOI 10.1111/j.1469-7793.1999.0421t.x; ODonnell ME, 1995, AM J PHYSIOL-CELL PH, V269, pC1513, DOI 10.1152/ajpcell.1995.269.6.C1513; PALFREY HC, 1993, PFLUG ARCH EUR J PHY, V425, P321, DOI 10.1007/BF00374182; Piechotta K, 2003, J BIOL CHEM, V278, P52848, DOI 10.1074/jbc.M309436200; Piechotta K, 2002, J BIOL CHEM, V277, P50812, DOI 10.1074/jbc.M208108200; Roy J, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2100re9; Russell JM, 2000, PHYSIOL REV, V80, P211, DOI 10.1152/physrev.2000.80.1.211; Traweger A, 2008, P NATL ACAD SCI USA, V105, P10402, DOI 10.1073/pnas.0804102105; Vitari AC, 2006, BIOCHEM J, V397, P223, DOI 10.1042/BJ20060220; XU JC, 1994, P NATL ACAD SCI USA, V91, P2201, DOI 10.1073/pnas.91.6.2201; Zhang J, 1996, BIOCHEMISTRY-US, V35, P6276, DOI 10.1021/bi952954l	27	41	41	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14115	14121		10.1074/jbc.M110.112672	http://dx.doi.org/10.1074/jbc.M110.112672			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20223824	Green Published, hybrid			2022-12-25	WOS:000277299700007
J	Ito, I; Hanyu, A; Wayama, M; Goto, N; Katsuno, Y; Kawasaki, S; Nakajima, Y; Kajiro, M; Komatsu, Y; Fujimura, A; Hirota, R; Murayama, A; Kimura, K; Imamur, T; Yanagisawa, J				Ito, Ichiaki; Hanyu, Aki; Wayama, Mitsutoshi; Goto, Natsuka; Katsuno, Yoko; Kawasaki, Shohei; Nakajima, Yuka; Kajiro, Masashi; Komatsu, Yoko; Fujimura, Akiko; Hirota, Ryuichi; Murayama, Akiko; Kimura, Keiji; Imamur, Takeshi; Yanagisawa, Junn			Estrogen Inhibits Transforming Growth Factor beta Signaling by Promoting Smad2/3 Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E3 UBIQUITIN LIGASE; PROTEASOME-DEPENDENT DEGRADATION; MAD-RELATED PROTEIN; TGF-BETA; TRANSCRIPTION FACTORS; RECEPTOR-ALPHA; BREAST-CANCER; REGULATED TRANSCRIPTION; NUCLEAR RECEPTORS; I RECEPTOR	Estrogen is a growth factor that stimulates cell proliferation. The effects of estrogen are mediated through the estrogen receptors, ER alpha and ER beta, which function as ligand-induced transcription factors and belong to the nuclear receptor superfamily. On the other hand, TGF-beta acts as a cell growth inhibitor, and its signaling is transduced by Smads. Although a number of studies have been made on the cross-talk between estrogen/ER alpha and TGF-beta/Smad signaling, whose molecular mechanisms remain to be determined. Here, we show that ER alpha inhibits TGF-beta signaling by decreasing Smad protein levels. ER alpha-mediated reductions in Smad levels did not require the DNA binding ability of ER alpha, implying that ER alpha opposes the effects of TGF-beta via a novel non-genomic mechanism. Our analysis revealed that ER alpha formed a protein complex with Smad and the ubiquitin ligase Smurf, and enhanced Smad ubiquitination and subsequent degradation in an estrogen-dependent manner. Our observations provide new insight into the molecular mechanisms governing the non-genomic functions of ER alpha	[Hanyu, Aki; Katsuno, Yoko; Imamur, Takeshi] Japanese Fdn Canc Res, Inst Canc, Dept Biochem, Koto Ku, Tokyo 1358550, Japan; [Ito, Ichiaki; Wayama, Mitsutoshi; Goto, Natsuka; Kawasaki, Shohei; Nakajima, Yuka; Kajiro, Masashi; Komatsu, Yoko; Fujimura, Akiko; Hirota, Ryuichi; Murayama, Akiko; Kimura, Keiji; Yanagisawa, Junn] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan; [Murayama, Akiko; Yanagisawa, Junn] Univ Tsukuba, TARA Ctr, Tsukuba, Ibaraki 3058572, Japan	Japanese Foundation for Cancer Research; University of Tsukuba; University of Tsukuba	Imamur, T (corresponding author), Japanese Fdn Canc Res, Inst Canc, Dept Biochem, Koto Ku, 3-10-6 Ariake, Tokyo 1358550, Japan.	timamura-ind@umin.ac.jp; junny@agbi.tsukuba.ac.jp	Hirota, Ryuichi/Q-3138-2016	Hirota, Ryuichi/0000-0003-3959-5892	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a nuclear system to decipher operation code (DECODE) and Targeted Proteins Research Program (TPRP) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan.	Abdollah S, 1997, J BIOL CHEM, V272, P27678, DOI 10.1074/jbc.272.44.27678; Burdette JE, 2007, ENDOCR-RELAT CANCER, V14, P679, DOI 10.1677/ERC-07-0054; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; Cherlet T, 2007, MOL CELL BIOCHEM, V306, P33, DOI 10.1007/s11010-007-9551-1; Ebisawa T, 2001, J BIOL CHEM, V276, P12477, DOI 10.1074/jbc.C100008200; Ehata S, 2007, CANCER SCI, V98, P127, DOI 10.1111/j.1349-7006.2006.00357.x; Eppert K, 1996, CELL, V86, P543, DOI 10.1016/S0092-8674(00)80128-2; Fan MY, 2005, MOL ENDOCRINOL, V19, P2901, DOI 10.1210/me.2005-0111; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Giacomini D, 2009, MOL ENDOCRINOL, V23, P1102, DOI 10.1210/me.2008-0425; Hayashi H, 1997, CELL, V89, P1165, DOI 10.1016/S0092-8674(00)80303-7; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Imamura T, 1997, NATURE, V389, P622, DOI 10.1038/39355; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Lagna G, 1996, NATURE, V383, P832, DOI 10.1038/383832a0; Lin X, 2000, J BIOL CHEM, V275, P36818, DOI 10.1074/jbc.C000580200; Liu XD, 1997, P NATL ACAD SCI USA, V94, P10669, DOI 10.1073/pnas.94.20.10669; Lonard DM, 2000, MOL CELL, V5, P939, DOI 10.1016/S1097-2765(00)80259-2; Luo KX, 1997, EMBO J, V16, P1970, DOI 10.1093/emboj/16.8.1970; Malek D, 2006, EUR J PHARMACOL, V534, P39, DOI 10.1016/j.ejphar.2006.01.025; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Matsuda T, 2001, J BIOL CHEM, V276, P42908, DOI 10.1074/jbc.M105316200; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Nawaz Z, 1999, P NATL ACAD SCI USA, V96, P1858, DOI 10.1073/pnas.96.5.1858; Ohtake F, 2007, NATURE, V446, P562, DOI 10.1038/nature05683; Perissi V, 2004, CELL, V116, P511, DOI 10.1016/S0092-8674(04)00133-3; Reid G, 2003, MOL CELL, V11, P695, DOI 10.1016/S1097-2765(03)00090-X; Ren YS, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-111; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; SPORN MB, 1990, CELL REGUL, V1, P875, DOI 10.1091/mbc.1.12.875; Tateishi Y, 2004, EMBO J, V23, P4813, DOI 10.1038/sj.emboj.7600472; TORA L, 1989, CELL, V59, P477, DOI 10.1016/0092-8674(89)90031-7; Verma S, 2004, MOL CELL BIOL, V24, P8716, DOI 10.1128/MCB.24.19.8716-8726.2004; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; Yamamoto T, 2002, ENDOCRINOLOGY, V143, P2635, DOI 10.1210/en.143.7.2635; Zhang Y, 2001, P NATL ACAD SCI USA, V98, P974, DOI 10.1073/pnas.98.3.974; Zhang Y, 1996, NATURE, V383, P168, DOI 10.1038/383168a0; Zhu HT, 1999, NATURE, V400, P687, DOI 10.1038/23293	41	108	113	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14747	14755		10.1074/jbc.M109.093039	http://dx.doi.org/10.1074/jbc.M109.093039			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20207742	hybrid, Green Published			2022-12-25	WOS:000277299700072
J	Lee, J; Padhye, A; Sharma, A; Song, GS; Miao, J; Mo, YY; Wang, L; Kemper, JK				Lee, Jiyoung; Padhye, Amruta; Sharma, Abhilasha; Song, Guisheng; Miao, Ji; Mo, Yin-Yuan; Wang, Li; Kemper, Jongsook Kim			A Pathway Involving Farnesoid X Receptor and Small Heterodimer Partner Positively Regulates Hepatic Sirtuin 1 Levels via MicroRNA-34a Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BILE-ACID; METABOLIC DISEASE; LIPID-METABOLISM; FXR; SHP; P53; PGC-1-ALPHA; ACTIVATION; PROTECTS; GLUCOSE	Sirtuin 1 (SIRT1) is a NAD-dependent deacetylase that is critically involved in diverse cellular processes including metabolic disease, cancer, and possibly aging. Despite extensive studies on SIRT1 function, how SIRT1 levels are regulated remains relatively unknown. Here, we report that the nuclear bile acid receptor farnesoid X receptor (FXR) inhibits microRNA-34a (miR34a) in the liver, which results in a positive regulation of SIRT1 levels. Activation of FXR by the synthetic agonist GW4064 decreases hepatic miR-34a levels in normal mice, and consistently, hepatic miR-34a levels are elevated in FXR-null mice. FXR induces expression of small heterodimer partner (SHP), an orphan nuclear receptor and transcriptional corepressor, which in turn results in repression of p53, a key activator of the miR34a gene, by inhibiting p53 occupancy at the promoter. MiR-34a decreased SIRT1 levels by binding to the 3'-untranslated region of SIRT1 mRNA, and adenovirus-mediated overexpression of miR-34a substantially decreased SIRT1 protein levels in mouse liver. Remarkably, miR-34a levels were elevated, and SIRT1 protein levels were reduced in diet-induced obese mice, and FXR activation in these mice reversed the miR-34a and SIRT1 levels, indicating an intriguing link among FXR activation, decreased miR-34a, and subsequently, increased SIRT1 levels. Our study demonstrates an unexpected role of the FXR/SHP pathway in controlling SIRT1 levels via miR-34a inhibition and that elevated miR-34a levels in obese mice contribute to decreased SIRT1 levels. Manipulation of this regulatory network may be useful for treating diseases of aging, such as metabolic disease and cancer.	[Lee, Jiyoung; Padhye, Amruta; Sharma, Abhilasha; Miao, Ji; Kemper, Jongsook Kim] Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA; [Song, Guisheng; Wang, Li] Univ Utah, Sch Med, Huntsman Canc Inst, Dept Med, Salt Lake City, UT 84132 USA; [Song, Guisheng; Wang, Li] Univ Utah, Sch Med, Huntsman Canc Inst, Dept Oncol Sci, Salt Lake City, UT 84132 USA; [Mo, Yin-Yuan] So Illinois Univ, Sch Med, Dept Med Microbiol Immunol & Cell Biol, Springfield, IL 62794 USA	University of Illinois System; University of Illinois Urbana-Champaign; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Southern Illinois University System; Southern Illinois University	Kemper, JK (corresponding author), 407 S Goodwin Ave, Urbana, IL 61801 USA.	jongsook@uiuc.edu	Mo, Yin-Yuan/R-8255-2019; Padhye, Amruta/ABB-3858-2020; song, guisheng/E-4913-2011; Miao, Ji/F-9398-2015	Padhye, Amruta/0000-0002-1524-5612; Miao, Ji/0000-0003-0869-4492	National Institutes of Health [DK062777, DK080032]; American Diabetes Association Basic Science Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080440, R01DK062777, R01DK080032, R56DK062777] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association Basic Science Award(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK062777 and DK080032. This work was also supported by an American Diabetes Association Basic Science Award (to J.K.K.).	Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Cariou B, 2005, FEBS LETT, V579, P4076, DOI 10.1016/j.febslet.2005.06.033; Cariou B, 2007, TRENDS PHARMACOL SCI, V28, P236, DOI 10.1016/j.tips.2007.03.002; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Coste A, 2008, P NATL ACAD SCI USA, V105, P17187, DOI 10.1073/pnas.0808207105; Duran-Sandoval D, 2005, J BIOL CHEM, V280, P29971, DOI 10.1074/jbc.M501931200; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Fang SS, 2007, MOL CELL BIOL, V27, P1407, DOI 10.1128/MCB.00944-06; Fang S, 2008, J BIOL CHEM, V283, P35086, DOI 10.1074/jbc.M803531200; Feige JN, 2008, CELL METAB, V8, P347, DOI 10.1016/j.cmet.2008.08.017; Fiorucci S, 2007, TRENDS MOL MED, V13, P298, DOI 10.1016/j.molmed.2007.06.001; Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4; Guarente L, 2007, COLD SPRING HARB SYM, V72, P483, DOI 10.1101/sqb.2007.72.024; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Hobert O, 2008, SCIENCE, V319, P1785, DOI 10.1126/science.1151651; Hou XY, 2008, J BIOL CHEM, V283, P20015, DOI 10.1074/jbc.M802187200; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kemper JK, 2004, MOL CELL BIOL, V24, P7707, DOI 10.1128/MCB.24.17.7707-7719.2004; Kemper JK, 2009, CELL METAB, V10, P392, DOI 10.1016/j.cmet.2009.09.009; Krutzfeldt J, 2007, NUCLEIC ACIDS RES, V35, P2885, DOI 10.1093/nar/gkm024; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lee FY, 2006, TRENDS BIOCHEM SCI, V31, P572, DOI 10.1016/j.tibs.2006.08.002; Lee YK, 2000, MOL CELL BIOL, V20, P187, DOI 10.1128/MCB.20.1.187-195.2000; Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Ma K, 2006, J CLIN INVEST, V116, P1102, DOI 10.1172/JCI25604; Miao J, 2009, GENE DEV, V23, P986, DOI 10.1101/gad.1773909; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Rodgers JT, 2008, FEBS LETT, V582, P46, DOI 10.1016/j.febslet.2007.11.034; Rodgers JT, 2007, P NATL ACAD SCI USA, V104, P12861, DOI 10.1073/pnas.0702509104; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Sinal CJ, 2000, CELL, V102, P731, DOI 10.1016/S0092-8674(00)00062-3; Song GS, 2008, NUCLEIC ACIDS RES, V36, P5727, DOI 10.1093/nar/gkn567; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; Watanabe M, 2004, J CLIN INVEST, V113, P1408, DOI 10.1172/JCI200421025; Yamakuchi M, 2008, P NATL ACAD SCI USA, V105, P13421, DOI 10.1073/pnas.0801613105; Yamakuchi M, 2009, CELL CYCLE, V8, P712, DOI 10.4161/cc.8.5.7753; Zhang YQ, 2004, GENE DEV, V18, P157, DOI 10.1101/gad.1138104; Zhang YQ, 2006, P NATL ACAD SCI USA, V103, P1006, DOI 10.1073/pnas.0506982103	40	185	191	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12604	12611		10.1074/jbc.M109.094524	http://dx.doi.org/10.1074/jbc.M109.094524			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20185821	Green Published, hybrid			2022-12-25	WOS:000276787800018
J	Tovey, SC; Dedos, SG; Rahman, T; Taylor, EJA; Pantazaka, E; Taylor, CW				Tovey, Stephen C.; Dedos, Skarlatos G.; Rahman, Taufiq; Taylor, Emily J. A.; Pantazaka, Evangelia; Taylor, Colin W.			Regulation of Inositol 1,4,5-Trisphosphate Receptors by cAMP Independent of cAMP-dependent Protein Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC-AMP; TRISPHOSPHATE RECEPTOR; INTRACELLULAR CA2+; FUNCTIONAL-CHARACTERIZATION; SIGNALING COMPLEX; IP3 RECEPTORS; ACINAR-CELLS; PHOSPHORYLATION; RELEASE; CALCIUM	In HEK cells stably expressing type 1 receptors for parathyroid hormone (PTH), PTH causes a sensitization of inositol 1,4,5-trisphosphate receptors (IP3R) to IP3 that is entirely mediated by cAMP and requires cAMP to pass directly from type 6 adenylyl cyclase (AC6) to IP(3)R2. Using DT40 cells expressing single subtypes of mammalian IP3R, we demonstrate that high concentrations of cAMP similarly sensitize all IP3R isoforms to IP3 by a mechanism that does not require cAMP-dependent protein kinase (PKA). IP3 binding to IP(3)R2 is unaffected by cAMP, and sensitization is not mediated by the site through which ATP potentiates responses to IP3. In single channel recordings from excised nuclear patches of cells expressing IP(3)R2, cAMP alone had no effect, but it increased the open probability of IP(3)R2 activated by a submaximal concentration of IP3 alone or in combination with a maximally effective concentration of ATP. These results establish that cAMP itself increases the sensitivity of all IP3R subtypes to IP3. For IP(3)R2, this sensitization results from cAMP binding to a novel site that increases the efficacy of IP3. Using stably expressed short hairpin RNA to reduce expression of the G-protein, G alpha(s), we demonstrate that attenuation of AC activity by loss of G alpha(s) more substantially reduces sensitization of IP3R by PTH than does comparable direct inhibition of AC. This suggests that G alpha(s) may also specifically associate with each AC.IP3R complex. We conclude that all three subtypes of IP3R are regulated by cAMP independent of PKA. In HEK cells, where IP(3)R2 selectively associates with AC6, G alpha s also associates with the AC.IP3R signaling junction.	[Tovey, Stephen C.; Dedos, Skarlatos G.; Rahman, Taufiq; Taylor, Emily J. A.; Pantazaka, Evangelia; Taylor, Colin W.] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England	University of Cambridge	Taylor, CW (corresponding author), Univ Cambridge, Dept Pharmacol, Tennis Court Rd, Cambridge CB2 1PD, England.	cwt1000@cam.ac.uk	rahman, taufiq/E-9806-2013; rahman, taufiq/GON-8210-2022; Dedos, Skarlatos G./A-5345-2008; Taylor, Colin/G-2447-2010	rahman, taufiq/0000-0003-3830-5160; rahman, taufiq/0000-0003-3830-5160; Dedos, Skarlatos G./0000-0002-0432-338X; Taylor, Emily/0000-0001-7974-1538; Taylor, Colin/0000-0001-7771-1044; PANTAZAKA, EVANGELIA/0000-0001-6737-8428	Wellcome Trust [085295]; Medical Research Council, UK [G0700843]; Biotechnology and Biological Sciences Research Council, UK [BB/E004660/1]; Biotechnology and Biological Sciences Research Council [BB/E004660/1] Funding Source: researchfish; Medical Research Council [G0700843] Funding Source: researchfish; BBSRC [BB/E004660/1] Funding Source: UKRI; MRC [G0700843] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council, UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported in part by The Wellcome Trust (Grant 085295), the Medical Research Council, UK (Grant G0700843), and the Biotechnology and Biological Sciences Research Council, UK (Grant BB/E004660/1).	Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Betzenhauser MJ, 2008, J BIOL CHEM, V283, P21579, DOI 10.1074/jbc.M801680200; Betzenhauser MJ, 2009, J BIOL CHEM, V284, P25116, DOI 10.1074/jbc.M109.010132; BEZPROZVANNY I, 1993, NEURON, V10, P1175, DOI 10.1016/0896-6273(93)90065-Y; BLONDEL O, 1993, J BIOL CHEM, V268, P11356; Brooker G, 1979, Adv Cyclic Nucleotide Res, V10, P1; Bruce JIE, 2003, CELL CALCIUM, V34, P431, DOI 10.1016/S0143-4160(03)00150-7; Bruce JIE, 2002, J BIOL CHEM, V277, P1340, DOI 10.1074/jbc.M106609200; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; BURGESS GM, 1991, J BIOL CHEM, V266, P4772; CAMERON AM, 1995, CELL, V83, P463, DOI 10.1016/0092-8674(95)90124-8; Cardy TJA, 1997, BIOCHEM J, V328, P785, DOI 10.1042/bj3280785; Collado-Hilly M, 2009, BIOL CELL, V101, P469, DOI 10.1042/BC20080184; Dellis O, 2006, SCIENCE, V313, P229, DOI 10.1126/science.1125203; deSouza N, 2002, J BIOL CHEM, V277, P39397, DOI 10.1074/jbc.M207059200; Dyer JL, 2003, BIOCHEM BIOPH RES CO, V302, P121, DOI 10.1016/S0006-291X(03)00120-7; Giovannucci DR, 2000, J BIOL CHEM, V275, P33704, DOI 10.1074/jbc.M004278200; Iwai M, 2005, J BIOL CHEM, V280, P10305, DOI 10.1074/jbc.M413824200; Iwai M, 2007, J BIOL CHEM, V282, P12755, DOI 10.1074/jbc.M609833200; LeBeau AP, 1999, J GEN PHYSIOL, V113, P851, DOI 10.1085/jgp.113.6.851; MIGNERY GA, 1990, J BIOL CHEM, V265, P12679; Mongillo M, 2006, CIRC RES, V98, P226, DOI 10.1161/01.RES.0000200178.34179.93; NAKADE S, 1994, J BIOL CHEM, V269, P6735; Nerou EP, 2001, BIOCHEM J, V355, P59, DOI 10.1042/bj3550059; QUINTON TM, 1992, BIOCHEM BIOPH RES CO, V184, P893, DOI 10.1016/0006-291X(92)90675-B; Schlossmann J, 2000, NATURE, V404, P197, DOI 10.1038/35004606; Scott JD, 2009, SCIENCE, V326, P1220, DOI 10.1126/science.1175668; Short AD, 2000, J BIOL CHEM, V275, P1807, DOI 10.1074/jbc.275.3.1807; Soulsby MD, 2007, CELL CALCIUM, V42, P261, DOI 10.1016/j.ceca.2006.12.002; Soulsby MD, 2005, BIOCHEM J, V392, P493, DOI 10.1042/BJ20051325; Sugawara H, 1997, EMBO J, V16, P3078, DOI 10.1093/emboj/16.11.3078; Sun Y, 2008, BIOCHEM J, V416, P243, DOI 10.1042/BJ20080861; SUPATTAPONE S, 1988, P NATL ACAD SCI USA, V85, P8747, DOI 10.1073/pnas.85.22.8747; Tang TS, 2003, J NEUROSCI, V23, P403, DOI 10.1523/JNEUROSCI.23-02-00403.2003; TaufiqUrRahman, 2009, NATURE, V458, P655, DOI 10.1038/nature07763; Tovey SC, 2003, BRIT J PHARMACOL, V138, P81, DOI 10.1038/sj.bjp.0705011; Tovey SC, 2008, J CELL BIOL, V183, P297, DOI 10.1083/jcb.200803172; Tovey SC, 2006, NAT PROTOC, V1, P259, DOI 10.1038/nprot.2006.40; Tu HP, 2005, BIOPHYS J, V88, P1046, DOI 10.1529/biophysj.104.049593; Tu HP, 2004, J BIOL CHEM, V279, P19375, DOI 10.1074/jbc.M313476200; Wagner LE, 2008, J PHYSIOL-LONDON, V586, P3577, DOI 10.1113/jphysiol.2008.152314; Wagner LE, 2004, J BIOL CHEM, V279, P46242, DOI 10.1074/jbc.M405849200; Wagner LE, 2003, J BIOL CHEM, V278, P45811, DOI 10.1074/jbc.M306270200; Werry TD, 2003, BIOCHEM J, V374, P281, DOI 10.1042/BJ20030312; Willoughby D, 2007, PHYSIOL REV, V87, P965, DOI 10.1152/physrev.00049.2006; Wojcikiewicz RJH, 1998, J BIOL CHEM, V273, P5670, DOI 10.1074/jbc.273.10.5670; Zaccolo M, 2006, BIOCHEM SOC T, V34, P495, DOI 10.1042/BST0340495	47	42	44	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12979	12989		10.1074/jbc.M109.096016	http://dx.doi.org/10.1074/jbc.M109.096016			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20189985	hybrid, Green Published			2022-12-25	WOS:000276787800056
J	Qu, ZX; Fu, J; Yan, PR; Hu, J; Cheng, SY; Xiao, GT				Qu, Zhaoxia; Fu, Jing; Yan, Pengrong; Hu, Jing; Cheng, Shi-Yuan; Xiao, Gutian			Epigenetic Repression of PDZ-LIM Domain-containing Protein 2 IMPLICATIONS FOR THE BIOLOGY AND TREATMENT OF BREAST CANCER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; DNA METHYLATION; INDEPENDENT GROWTH; KINASE NIK; DEGRADATION; ACTIVATION; AUTOPHAGY; TAX; DEREGULATION; TERMINATION	The NF-kappa B transcription factor plays a pivotal role in breast cancer progression and therapy resistance. However, the mechanisms by which the tightly regulated NF-kappa B becomes constitutively activated during breast cancer pathogenesis remain obscure. Here, we report that PDZ-LIM domain-containing protein 2 (PDLIM2), an essential terminator of NF-kappa B activation, is repressed in both estrogen receptor-positive and estrogen receptor-negative breast cancer cells, suggesting one important mechanism for the constitutive activation of NF-kappa B. Indeed, PDLIM2 reexpression inhibited constitutive NF-kappa B activation and expression of NF-kappa B-targeted genes in those breast cancer cells. Importantly, PDLIM2, but not its mutants defective in NF-kappa B termination, could suppress in vitro anchorage-independent growth and in vivo tumor formation of those malignant breast cells. In addition, we have shown that PDLIM2 repression involves promoter methylation. Accordingly, treatment of the breast cancer cells with the DNA methyltransferase inhibitor 5-aza-2'-deoxycytidine reverses the methylation of the PDLIM2 promoter, restored PDLIM2 expression, and suppressed tumorigenicities of human breast cancer cells both in vitro and in vivo. These studies thus provide important mechanistic insights into breast cancer pathogenesis. These studies also suggest a tumor suppression function of PDLIM2 and a therapeutic strategy for breast cancer.	[Qu, Zhaoxia; Fu, Jing; Yan, Pengrong; Hu, Jing; Cheng, Shi-Yuan; Xiao, Gutian] Univ Pittsburgh, Inst Canc, Pittsburgh, PA 15213 USA; [Qu, Zhaoxia; Fu, Jing; Yan, Pengrong; Xiao, Gutian] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Xiao, GT (corresponding author), Hillman Canc Ctr Res Pavil,5117 Ctr Ave, Pittsburgh, PA 15213 USA.	xiaog2@upmc.edu	Hu, Jing/M-3130-2014; fu, jing/G-6084-2012; Yan, Pengrong/H-1150-2012; Fu, Jing/C-7921-2016	Fu, Jing/0000-0002-3894-722X; Yan, Pengrong/0000-0003-0021-6461	NCI/National Institutes of Health [R01 CA116616, R01 CA102011, R01 CA130966]; American Cancer Society [RSG-06-066-01-MGO, RSG-CSM-107144]; Pennsylvania Department of Health; Hillman Innovative Research Scholar; Hillman Innovative Cancer Research Award; NATIONAL CANCER INSTITUTE [R01CA130966, R01CA116616, R01CA102011] Funding Source: NIH RePORTER	NCI/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); Pennsylvania Department of Health; Hillman Innovative Research Scholar; Hillman Innovative Cancer Research Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported, in whole or in part, by NCI/National Institutes of Health Grants R01 CA116616, R01 CA102011, and R01 CA130966. This work was also supported by American Cancer Society Grants RSG-06-066-01-MGO and RSG-CSM-107144, grants from the Pennsylvania Department of Health, and a Hillman Innovative Research Scholar and a Hillman Innovative Cancer Research Award (to G. X. and S. Y. C.).	Biswas DK, 2006, J CELL PHYSIOL, V209, P645, DOI 10.1002/jcp.20785; Cao YX, 2003, J MAMMARY GLAND BIOL, V8, P215, DOI 10.1023/A:1025905008934; Cvijic ME, 2003, J IMMUNOL METHODS, V278, P293, DOI 10.1016/S0022-1759(03)00191-1; Garcia-Manero G, 2008, CURR OPIN ONCOL, V20, P705, DOI 10.1097/CCO.0b013e328313699c; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Lo PK, 2008, PHARMACOGENOMICS, V9, P1879, DOI 10.2217/14622416.9.12.1879; Loughran G, 2005, MOL BIOL CELL, V16, P1811, DOI 10.1091/mbc.E04-12-1052; Luczak MW, 2006, FOLIA HISTOCHEM CYTO, V44, P143; Nakshatri H, 1997, MOL CELL BIOL, V17, P3629, DOI 10.1128/MCB.17.7.3629; Pratt MAC, 2009, ONCOGENE, V28, P2710, DOI 10.1038/onc.2009.131; Qing GL, 2005, J BIOL CHEM, V280, P18, DOI 10.1074/jbc.M406619200; Qing GL, 2005, J BIOL CHEM, V280, P40578, DOI 10.1074/jbc.M508776200; Qing GL, 2007, CELL RES, V17, P520, DOI 10.1038/cr.2007.47; Qing GL, 2007, P NATL ACAD SCI USA, V104, P5324, DOI 10.1073/pnas.0609914104; Qing GL, 2006, CELL RES, V16, P895, DOI 10.1038/sj.cr.7310109; Qu ZX, 2010, CANCER RES, V70, P1766, DOI 10.1158/0008-5472.CAN-09-3263; Qu ZX, 2004, J BIOL CHEM, V279, P44563, DOI 10.1074/jbc.M403689200; Saccani S, 2004, J EXP MED, V200, P107, DOI 10.1084/jem.20040196; Samlowski WE, 2005, J CLIN ONCOL, V23, P3897, DOI 10.1200/JCO.2005.06.118; Sun SC, 2003, CANCER METAST REV, V22, P405, DOI 10.1023/A:1023733231406; Tanaka T, 2005, IMMUNITY, V22, P729, DOI 10.1016/j.immuni.2005.04.008; Tanaka T, 2007, NAT IMMUNOL, V8, P584, DOI 10.1038/ni1464; Torrado M, 2004, INVEST OPHTH VIS SCI, V45, P3955, DOI 10.1167/iovs.04-0721; Wu JT, 2005, J SURG RES, V123, P158, DOI 10.1016/j.jss.2004.06.006; Xiao GT, 2007, CYTOKINE GROWTH F R, V18, P233, DOI 10.1016/j.cytogfr.2007.04.006; Xiao GT, 2006, CYTOKINE GROWTH F R, V17, P281, DOI 10.1016/j.cytogfr.2006.04.005; Yan PR, 2009, NEOPLASIA, V11, P1036, DOI 10.1593/neo.09752; Yan PR, 2009, BLOOD, V113, P4370, DOI 10.1182/blood-2008-10-185660	28	46	48	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					11786	11792		10.1074/jbc.M109.086561	http://dx.doi.org/10.1074/jbc.M109.086561			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20185823	Green Published, hybrid			2022-12-25	WOS:000276787100005
J	Manful, T; Mulindwa, J; Frank, FM; Clayton, CE; Matovu, E				Manful, Theresa; Mulindwa, Julius; Frank, Fernanda M.; Clayton, Christine E.; Matovu, Enock			A Search for Trypanosoma brucei rhodesiense Diagnostic Antigens by Proteomic Screening and Targeted Cloning	PLOS ONE			English	Article							HUMAN AFRICAN TRYPANOSOMIASIS; SLEEPING SICKNESS; RECOMBINANT ANTIGENS; TRYPTECT CIATT(R); ANTIBODY-ELISA; INFECTION; IDENTIFICATION; MELARSOPROL; GLYCOSOMES; CANDIDATE	Background: The only available diagnostic method for East African trypanosomiasis is light microscopy of blood samples. A simple immunodiagnostic would greatly aid trypanosomiasis control. Methodology and Principal Findings: To find trypanosome proteins that are specifically recognised by sera from human sleeping sickness patients, we have screened the Trypanosoma brucei brucei proteome by Western blotting. Using cytosolic, cytoskeletal and glycosomal fractions, we found that the vast majority of abundant trypanosome proteins is not specifically recognised by patient sera. We identified phosphoglycerate kinase (PGKC), heat shock protein (HSP70), and histones H2B and H3 as possible candidate diagnostic antigens. These proteins, plus paraflagellar rod protein 1, rhodesain (a cysteine protease), and an extracellular fragment of the Trypanosoma brucei nucleoside transporter TbNT10, were expressed in E. coli and tested for reactivity with patient and control sera. Only TbHSP70 was preferentially recognized by patient sera, but the sensitivity and specificity were insufficient for use of TbHSP70 alone as a diagnostic. Immunoprecipitation using a native protein extract revealed no specifically reacting proteins. Conclusions: No abundant T. brucei soluble, glycosomal or cytoskeletal protein is likely to be useful in diagnosis. To find useful diagnostic antigens it will therefore be necessary to use more sophisticated proteomic methods, or to test a very large panel of candidate proteins.	[Manful, Theresa; Mulindwa, Julius; Clayton, Christine E.] Heidelberg Univ, Zentrum Mol Biol, DKFZ ZMBH Alliance, D-6900 Heidelberg, Germany; [Mulindwa, Julius; Matovu, Enock] Makerere Univ, Fac Vet Med, Kampala, Uganda; [Frank, Fernanda M.] Catedra Inmunol IDEHU UBA CONICET, Fac Farm & Bioquim UBA, Buenos Aires, DF, Argentina	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Makerere University; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Manful, T (corresponding author), Heidelberg Univ, Zentrum Mol Biol, DKFZ ZMBH Alliance, D-6900 Heidelberg, Germany.	cclayton@zmbh.uni-heidelberg.de	Clayton, Christine/K-7700-2019; Mulindwa, Julius/AAX-6204-2020	Matovu, Enock/0000-0003-0714-7032; Clayton, Christine/0000-0002-6384-0731; Fernanda M., Frank/0000-0003-4521-1306; Mulindwa, Julius/0000-0002-5419-2760	World Health Organisation/World Bank/United Nations [A60193, A50367]; Hartmut Hoffmann-Berling International Graduate School of Molecular and Cellular Biology (HBIGS) (DFG)	World Health Organisation/World Bank/United Nations(World Health Organization); Hartmut Hoffmann-Berling International Graduate School of Molecular and Cellular Biology (HBIGS) (DFG)(German Research Foundation (DFG))	This study was partially supported by the World Health Organisation/World Bank/United Nations special programme for research and training in tropical diseases (TDR) grants A60193 to CC and ID A50367 to EM and FF. JM is supported in Heidelberg by a fellowship from the Hartmut Hoffmann-Berling International Graduate School of Molecular and Cellular Biology (HBIGS) (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akol MN, 1999, E AFR MED J, V76, P38; Asonganyi T, 1998, ANN TROP MED PARASIT, V92, P837, DOI 10.1080/00034989858871; Barrett MP, 2006, LANCET, V367, P1377, DOI 10.1016/S0140-6736(06)68591-7; Blum J, 2001, TROP MED INT HEALTH, V6, P390, DOI 10.1046/j.1365-3156.2001.00710.x; BROCKMOLLER J, 1985, BIOL CHEM H-S, V366, P901, DOI 10.1515/bchm3.1985.366.2.901; Burri C, 2000, LANCET, V355, P1419, DOI 10.1016/S0140-6736(00)02141-3; Caffrey CR, 2001, MOL BIOCHEM PARASIT, V118, P61, DOI 10.1016/S0166-6851(01)00368-1; Chappuis F, 2005, CLIN MICROBIOL REV, V18, P133, DOI 10.1128/CMR.18.1.133-146.2005; CLAYTON CE, 1987, J CELL BIOL, V105, P2649, DOI 10.1083/jcb.105.6.2649; Clayton CE, 1987, J CELL BIOL; Cooley G, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000316; Desquesnes M, 2009, PREV VET MED, V90, P233, DOI 10.1016/j.prevetmed.2009.04.011; Desquesnes M, 2009, VET PARASITOL, V162, P214, DOI 10.1016/j.vetpar.2009.03.033; Flechas ID, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-186; Forgber M, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000040; Gupta SK, 2007, PROTEOMICS, V7, P816, DOI 10.1002/pmic.200600725; HEUKESHOVEN J, 1988, ELECTROPHORESIS, V9, P60, DOI 10.1002/elps.1150090112; Hutchinson OC, 2004, TRENDS PARASITOL, V20, P519, DOI 10.1016/j.pt.2004.08.007; Jannin J, 2004, CURR OPIN INFECT DIS, V17, P565, DOI 10.1097/00001432-200412000-00009; Lalmanach G, 2002, BIOL CHEM, V383, P739, DOI 10.1515/BC.2002.077; Landfear SM, 2004, EUKARYOT CELL, V3, P245, DOI 10.1128/EC.3.2.245-254.2004; MAINA NW, 2007, T R SOC TROP MED HYG; MULLER N, 1992, PARASITOLOGY, V104, P111, DOI 10.1017/S0031182000060856; MULLER N, 1993, PARASITOLOGY, V107, P411, DOI 10.1017/S0031182000067767; Nantulya VM, 1997, T ROY SOC TROP MED H, V91, P551, DOI 10.1016/S0035-9203(97)90023-7; Njiru ZK, 2008, INT J PARASITOL, V38, P589, DOI 10.1016/j.ijpara.2007.09.006; OPPERDOES FR, 1984, J CELL BIOL, V98, P1178, DOI 10.1083/jcb.98.4.1178; Radwanska M, 2002, AM J TROP MED HYG, V67, P684, DOI 10.4269/ajtmh.2002.67.684; ROBINSON D, 1991, METHOD ENZYMOL, V196, P285; Umezawa ES, 2003, TRANSFUSION, V43, P91, DOI 10.1046/j.1537-2995.2003.00279.x	30	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2010	5	3							e9630	10.1371/journal.pone.0009630	http://dx.doi.org/10.1371/journal.pone.0009630			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565XE	20224787	Green Published, gold, Green Submitted			2022-12-25	WOS:000275328800025
J	Sintchenko, V; Anthony, S; Phan, XH; Lin, F; Coiera, EW				Sintchenko, Vitali; Anthony, Stephen; Phan, Xuan-Hieu; Lin, Frank; Coiera, Enrico W.			A PubMed-Wide Associational Study of Infectious Diseases	PLOS ONE			English	Article							GENOME; INTEGRATION; FEATURES; GENES	Background: Computational discovery is playing an ever-greater role in supporting the processes of knowledge synthesis. A significant proportion of the more than 18 million manuscripts indexed in the PubMed database describe infectious disease syndromes and various infectious agents. This study is the first attempt to integrate online repositories of text-based publications and microbial genome databases in order to explore the dynamics of relationships between pathogens and infectious diseases. Methodology/Principal Findings: Herein we demonstrate how the knowledge space of infectious diseases can be computationally represented and quantified, and tracked over time. The knowledge space is explored by mapping of the infectious disease literature, looking at dynamics of literature deposition, zooming in from pathogen to genome level and searching for new associations. Syndromic signatures for different pathogens can be created to enable a new and clinically focussed reclassification of the microbial world. Examples of syndrome and pathogen networks illustrate how multilevel network representations of the relationships between infectious syndromes, pathogens and pathogen genomes can illuminate unexpected biological similarities in disease pathogenesis and epidemiology. Conclusions/Significance: This new approach based on text and data mining can support the discovery of previously hidden associations between diseases and microbial pathogens, clinically relevant reclassification of pathogenic microorganisms and accelerate the translational research enterprise.	[Sintchenko, Vitali; Anthony, Stephen; Phan, Xuan-Hieu; Lin, Frank; Coiera, Enrico W.] Univ New S Wales, Ctr Hlth Informat, Sydney, NSW, Australia; [Sintchenko, Vitali] Univ Sydney, Ctr Infect Dis & Microbiol, Sydney Med Sch, Sydney, NSW 2006, Australia; [Sintchenko, Vitali] Westmead Hosp, Inst Clin Pathol & Med Res, Sydney W Area Hlth Serv, Sydney, NSW, Australia	University of New South Wales Sydney; University of Sydney; University of Sydney	Sintchenko, V (corresponding author), Univ New S Wales, Ctr Hlth Informat, Sydney, NSW, Australia.	vitali.sintchenko@sydney.edu.au	Lin, Frank/R-1275-2019	Lin, Frank/0000-0001-9250-6874; Sintchenko, Vitali/0000-0002-9261-3650; Coiera, Enrico/0000-0002-6444-6584; Phan, Xuan-Hieu/0000-0002-7640-9190	Australian Research Council [LP0667531]; National Health and Medical Research Council; Cerebral Palsy Institute	Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Cerebral Palsy Institute	We acknowledge the financial support from the Australian Research Council (LP0667531), National Health and Medical Research Council and the Cerebral Palsy Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alako BTF, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-51; [Anonymous], 2005, PRINCIPLES PRACTICE; Arakawa K, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-31; Baron EJ, 2007, MANUAL OF CLINICAL MICROBIOLOGY, 9TH ED, P1; Browne Allen C, 2003, AMIA Annu Symp Proc, P798; Butte AJ, 2006, NAT BIOTECHNOL, V24, P55, DOI 10.1038/nbt1150; Chagoyen M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-41; Chaussabel Damien, 2004, Am J Pharmacogenomics, V4, P383, DOI 10.2165/00129785-200404060-00005; Davies V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006948; Divangahi M, 2009, NAT IMMUNOL, V10, P899, DOI 10.1038/ni.1758; *DOE, DOE FUND GEN ENC BAC; *EUR BIOINF I, EUR BIOINF I DAT; Fielding AH, 2007, CLUSTER AND CLASSIFICATION TECHNIQUES FOR THE BIOSCIENCES, P1, DOI 10.2277/ 0521618002; Garner HR, 2007, IEEE ENG MED BIOL, V26, P73, DOI 10.1109/MEMB.2007.364934; Goh CS, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-257; Gonzalo-Asensio J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003496; Hanks P., 1990, COMPUT LINGUIST, V16, P22, DOI DOI 10.3115/981623.981633; Hickey TBM, 2009, INFECT IMMUN, V77, P3389, DOI 10.1128/IAI.00143-09; Hu YH, 2003, J PROTEOME RES, V2, P405, DOI 10.1021/pr0340227; Jelier R, 2005, BIOINFORMATICS, V21, P2049, DOI 10.1093/bioinformatics/bti268; Jensen LJ, 2006, NAT REV GENET, V7, P119, DOI 10.1038/nrg1768; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; King RD, 2009, SCIENCE, V324, P85, DOI 10.1126/science.1165620; Korbel JO, 2005, PLOS BIOL, V3, P815, DOI 10.1371/journal.pbio.0030134; Koshland DE, 2007, SCIENCE, V317, P761, DOI 10.1126/science.1147166; KRALLINGER M, 2008, GENOME BIOL S2, V9, P58; Liu Y, 2006, PLOS COMPUT BIOL, V2, P1419, DOI 10.1371/journal.pcbi.0020159; MohamedMohaideen NN, 2008, BIOCHEMISTRY-US, V47, P6092, DOI 10.1021/bi701929m; Parish T, 2002, MICROBIOL-SGM, V148, P3069, DOI 10.1099/00221287-148-10-3069; R Development Core Team, 2005, R LANG ENV STAT COMP; Rodriguez-Esteban R, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000597; Rzhetsky A, 2008, CELL, V134, P9, DOI 10.1016/j.cell.2008.06.029; Sayers EW, 2009, NUCLEIC ACIDS RES, V37, pD5, DOI 10.1093/nar/gkp967; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sintchenko V, 2007, NAT REV MICROBIOL, V5, P464, DOI 10.1038/nrmicro1656; Slayden RA, 2009, J ANTIMICROB CHEMOTH, V63, P451, DOI 10.1093/jac/dkn507; Smith SGJ, 2007, FEMS MICROBIOL LETT, V273, P1, DOI 10.1111/j.1574-6968.2007.00778.x; Stein LD, 2002, GENOME RES, V12, P1599, DOI 10.1101/gr.403602; SWANSON DR, 1986, PERSPECT BIOL MED, V30, P7; Vargas-Quesada B., 2007, VISUALIZING STRUCTUR; Wren JD, 2004, BIOINFORMATICS, V20, P389, DOI 10.1093/bioinformatics/btg421; Wu XB, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.27; Xiang ZS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r150; Yu S, 2008, BIOINFORMATICS, V24, pI119, DOI 10.1093/bioinformatics/btn291; Yu W, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-528; Zaremba S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-177	46	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2010	5	3							e9535	10.1371/journal.pone.0009535	http://dx.doi.org/10.1371/journal.pone.0009535			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565XE	20224767	Green Published, gold, Green Submitted			2022-12-25	WOS:000275328800007
J	Bachler, E; Hahn, S; Schaub, M; Arlettaz, R; Jenni, L; Fox, JW; Afanasyev, V; Liechti, F				Baechler, Erich; Hahn, Steffen; Schaub, Michael; Arlettaz, Raphael; Jenni, Lukas; Fox, James W.; Afanasyev, Vsevolod; Liechti, Felix			Year-Round Tracking of Small Trans-Saharan Migrants Using Light-Level Geolocators	PLOS ONE			English	Article							MIGRATION; BIRDS; ACCURACY	Since 1899 ringing (or banding) remained the most important source of information about migration routes, stopover sites and wintering grounds for birds that are too small to carry satellite-based tracking systems. Despite the large quantity of migrating birds ringed in their breeding areas in Europe, the number of ring recoveries from sub-Saharan Africa is very low and therefore the whereabouts of most small bird species outside the breeding season remain a mystery. With new miniaturized light-level geolocators it is now possible to look beyond the limits of ring recovery data. Here we show for the first time year round tracks of a near passerine trans-Saharan migrant, the European Hoopoe (Upupa epops epops). Three birds wintered in the Sahel zone of Western Africa where they remained stationary for most of the time. One bird chose a south-easterly route following the Italian peninsula. Birds from the same breeding population used different migration routes and wintering sites, suggesting a low level of migratory connectivity between breeding and wintering areas. Our tracking of a near passerine bird, the European Hoopoe, with light-level geolocators opens a new chapter in the research of Palaearctic-African bird migration as this new tool revolutionizes our ability to discover migration routes, stopover sites and wintering grounds of small birds.	[Baechler, Erich; Hahn, Steffen; Schaub, Michael; Arlettaz, Raphael; Jenni, Lukas; Liechti, Felix] Swiss Ornithol Inst, Sempach, Switzerland; [Schaub, Michael; Arlettaz, Raphael] Univ Bern, Inst Ecol & Evolut, Bern, Switzerland; [Fox, James W.; Afanasyev, Vsevolod] British Antarctic Survey, Nat Environm Res Council, Cambridge CB3 0ET, England	Swiss Ornithological Institute; University of Bern; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey	Bachler, E (corresponding author), Swiss Ornithol Inst, Sempach, Switzerland.	erich.baechler@vogelwarte.ch	Arlettaz, Raphaël/O-2182-2016	Arlettaz, Raphaël/0000-0001-6360-5339; Schaub, Michael/0000-0003-2745-0557; Hahn, Steffen/0000-0002-4924-495X	Swiss Ornithological Institute; Natural Environment Research Council [bas0100025, bas010011] Funding Source: researchfish; NERC [bas0100025, bas010011] Funding Source: UKRI	Swiss Ornithological Institute; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by the Swiss Ornithological Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alerstam T, 2003, AVIAN MIGRATION, P253; Bairlein F, 2001, ARDEA, V89, P7; Farmer A, 2008, OECOLOGIA, V158, P183, DOI 10.1007/s00442-008-1143-6; FRANSSON T, 1995, J AVIAN BIOL, V26, P39, DOI 10.2307/3677211; Hahn S, 2009, OIKOS, V118, P624, DOI 10.1111/j.1600-0706.2009.17309.x; Hill Roger D., 1994, P227; Hobson K. A., 2008, TRACKING ANIMAL MIGR, P144; Moreau R., 1972, PALAEARCTIC AFRICAN; Naef-Daenzer B, 2007, J AVIAN BIOL, V38, P404, DOI 10.1111/j.2007.0908-8857.03863.x; Newton I, 2008, MIGRATION ECOLOGY OF BIRDS, P333; Norris D. Ryan, 2006, Ornithological Monographs, V61, P79; Phillips RA, 2004, MAR ECOL PROG SER, V266, P265, DOI 10.3354/meps266265; Reichlin TS, 2009, J ORNITHOL, V150, P393, DOI 10.1007/s10336-008-0361-3; Rodriguez A, 2009, DIVERS DISTRIB, V15, P1010, DOI 10.1111/j.1472-4642.2009.00600.x; Sanderson FJ, 2006, BIOL CONSERV, V131, P93, DOI 10.1016/j.biocon.2006.02.008; Stutchbury BJM, 2009, SCIENCE, V323, P896, DOI 10.1126/science.1166664; Waser PM, 1998, TRENDS ECOL EVOL, V13, P43, DOI 10.1016/S0169-5347(97)01255-X; Webster MS, 2002, TRENDS ECOL EVOL, V17, P76, DOI 10.1016/S0169-5347(01)02380-1; Wendeln Helmut, 1999, Ringing and Migration, V19, P210; ZINK G, 1995, ATLAS WIEDERFUNDE BE, V3	20	129	139	1	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2010	5	3							e9566	10.1371/journal.pone.0009566	http://dx.doi.org/10.1371/journal.pone.0009566			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	564EX	20221266	Green Published, Green Accepted, gold			2022-12-25	WOS:000275197200015
J	Bain, JM; Ziegler, A; Yang, ZG; Levison, SW; Sen, E				Bain, Jennifer M.; Ziegler, Amber; Yang, Zhengang; Levison, Steven W.; Sen, Ellora			TGF beta 1 Stimulates the Over-Production of White Matter Astrocytes from Precursors of the "Brain Marrow'' in a Rodent Model of Neonatal Encephalopathy	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; LEUKEMIA INHIBITORY FACTOR; HYPOXIC-ISCHEMIC INJURY; PERINATAL SUBVENTRICULAR ZONE; STEM-CELLS; TGF-BETA; OLIGODENDROCYTE PROGENITORS; IMMATURE OLIGODENDROCYTES; DEVELOPMENTAL-CHANGES; GLIAL RESPONSES	Background: In children born prematurely and those surviving cerebral ischemia there are white matter abnormalities that correlate with neurological dysfunction. Since this injury occurs in the immature brain, when the majority of subventricular zone (SVZ) cells generate white matter oligodendrocytes, we sought to study the effect this injury has on gliogenesis from the SVZ. We hypothesized that there is aberrant glial cell generation from the SVZ after neonatal hypoxia ischemia (H/I) that contributes to an increased astrogliogenesis with concomitant oligodendroglial insufficiency. Mechanistically we hypothesized that an increase in specific locally produced cytokines during recovery from injury were modifying the differentiation of glial progenitors towards astrocytes at the expense of the more developmentally-appropriate oligodendrocytes. Methodology/Principal Finding: For these studies we used the Vannucci H/I rat model where P6 rats are subjected to unilateral common carotid ligation followed by 75 min of systemic hypoxia. Retroviral lineage tracing studies combined with morphological and immunohistochemical analyses revealed the preferential generation of SVZ-derived white matter astrocytes instead of oligodendrocytes post hypoxia/ischemia. Microarray and QRT-PCR analyses of the damaged SVZ showed increased expression of several cytokines and receptors that are known to promote astrocyte differentiation, such as EGF, LIF and TGF beta signaling components. Using gliospheres to model the neonatal SVZ, we evaluated the effects of these cytokines on signal transduction pathways regulating astrocyte generation, proliferation and differentiation. These studies demonstrated that combinations of EGF, LIF and TGF beta 1 reconstituted the increased astrogliogenesis. TGF beta 1-induced Smad 2/3 phosphorylation and the combination of EGF, LIF and TGF beta 1 synergistically increased STAT3 phosphorylation over single or double cytokine combinations. Pharmacologically inhibiting ALK5 signaling in vitro antagonized the TGF beta 1-induced increase in astrocyte generation and antagonizing ALK5 signaling in vivo similarly inhibited astrogliogenesis within the SVZ during recovery from H/I. Conclusion/Significance: Altogether, these data indicate that there is aberrant specification of glial precursors within the neonatal SVZ during recovery from neonatal H/I that is a consequence of altered cytokine signaling. Our studies further suggest that antagonizing the ALK5 receptor will restore the normal pattern of cell differentiation after injury to the immature brain.	[Bain, Jennifer M.; Ziegler, Amber; Levison, Steven W.] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Neurol & Neurosci, UH Canc Ctr, Newark, NJ 07103 USA; [Bain, Jennifer M.; Ziegler, Amber; Levison, Steven W.] Univ Med & Dent New Jersey, New Jersey Med Sch, Grad Sch Biomed Sci, Newark, NJ 07103 USA; [Sen, Ellora] Natl Brain Res Ctr, Manesar, Haryana, India; [Yang, Zhengang] Fudan Univ, Inst Brain Sci, Shanghai 200433, Peoples R China; [Yang, Zhengang] Fudan Univ, State Key Lab Med Neurobiol, Shanghai 200433, Peoples R China	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Department of Biotechnology (DBT) India; National Brain Research Centre (NBRC); Fudan University; Fudan University	Bain, JM (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Neurol & Neurosci, UH Canc Ctr, 185 S Orange Ave, Newark, NJ 07103 USA.	steve.levison@umdnj.edu; ellora@nbrc.ac.in	Levison, Steven W./Q-6903-2019	Levison, Steven W./0000-0002-1264-7309; Sen, Ellora/0000-0001-6842-7850	National Institute of Neurological Disorders and Stroke [F31NS062629]; National Institute of Mental Health [MH59950]; Department of Biotechnology, Government of India [BT/PR6615/MED/14/857/2005]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD052064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059950] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS062629] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institute of Neurological Disorders and Stroke #F31NS062629 awarded to JMB, the National Institute of Mental Health #MH59950 awarded to SWL, and the Department of Biotechnology #BT/PR6615/MED/14/857/2005, Government of India, awarded to ES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnihotri S, 2009, ONCOGENE, V28, P3033, DOI 10.1038/onc.2009.159; Alagappan D, 2009, ASN NEURO, V1, DOI 10.1042/AN20090002; Back SA, 2005, NAT MED, V11, P966, DOI 10.1038/nm1279; Back SA, 2002, J NEUROPATH EXP NEUR, V61, P197, DOI 10.1093/jnen/61.2.197; Back SA, 1998, J NEUROSCI, V18, P6241; BAIN J, 2009, GLIAL DYSGENESIS CAU; Basu A, 2002, J NEUROSCI, V22, P6071; Billiards SS, 2008, BRAIN PATHOL, V18, P153, DOI 10.1111/j.1750-3639.2007.00107.x; Brazel CY, 2004, DEV NEUROSCI-BASEL, V26, P266, DOI 10.1159/000082143; BRAZEL CY, 2003, THESIS PENNSYLVANIA; Buffo A, 2008, P NATL ACAD SCI USA, V105, P3581, DOI 10.1073/pnas.0709002105; Burrows RC, 1997, NEURON, V19, P251, DOI 10.1016/S0896-6273(00)80937-X; BURTRUM D, 1994, EXP NEUROL, V126, P112, DOI 10.1006/exnr.1994.1047; Chang A, 2002, NEW ENGL J MED, V346, P165, DOI 10.1056/NEJMoa010994; CHAO CC, 1992, J CLIN INVEST, V90, P1786, DOI 10.1172/JCI116053; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; Covey MV, 2007, NEUROSCIENCE, V148, P501, DOI 10.1016/j.neuroscience.2007.06.015; DALESSANDRO JS, 1994, GROWTH FACTORS, V11, P53, DOI 10.3109/08977199409015051; Dohgu S, 2005, BRAIN RES, V1038, P208, DOI 10.1016/j.brainres.2005.01.027; Duggal N, 1997, BRAIN RES, V768, P1, DOI 10.1016/S0006-8993(97)00588-X; Felling RJ, 2006, J NEUROSCI, V26, P4359, DOI 10.1523/JNEUROSCI.1898-05.2006; Fern R, 2000, J NEUROSCI, V20, P34, DOI 10.1523/JNEUROSCI.20-01-00034.2000; Graham EM, 2004, NEUROBIOL DIS, V17, P89, DOI 10.1016/j.nbd.2004.05.007; GRESSENS P, 1992, BIOL NEONATE, V61, P4; HUNTER KE, 1993, GLIA, V7, P203, DOI 10.1002/glia.440070303; Inder TE, 2005, PEDIATRICS, V115, P286, DOI 10.1542/peds.2004-0326; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; Kakita A, 1999, NEURON, V23, P461, DOI 10.1016/S0896-6273(00)80800-4; Kinney H C, 1998, Semin Pediatr Neurol, V5, P180, DOI 10.1016/S1071-9091(98)80033-8; Laping NJ, 2002, MOL PHARMACOL, V62, P58, DOI 10.1124/mol.62.1.58; LAZAR LM, 1992, J NEUROSCI, V12, P1688; Levison SW, 2002, DEV NEUROSCI-BASEL, V24, P459; Levison SW, 1997, J NEUROSCI RES, V48, P83, DOI 10.1002/(SICI)1097-4547(19970415)48:2<83::AID-JNR1>3.0.CO;2-8; LEVISON SW, 1993, NEURON, V10, P201, DOI 10.1016/0896-6273(93)90311-E; Levison SW, 2001, DEV NEUROSCI-BASEL, V23, P234, DOI 10.1159/000046149; LEVISON SW, 1993, DEVELOPMENT, V119, P611; LEVISON SW, 1999, J NEUROCHEMISTRY, V70; LOO DT, 1994, NEUROREPORT, V5, P1585, DOI 10.1097/00001756-199408150-00011; MAEDA Y, 1994, J EXP MED, V180, P2297, DOI 10.1084/jem.180.6.2297; Matute C, 1997, P NATL ACAD SCI USA, V94, P8830, DOI 10.1073/pnas.94.16.8830; Mehler MF, 2000, DEV NEUROSCI-BASEL, V22, P74, DOI 10.1159/000017429; Milosevic A, 2002, J COMP NEUROL, V452, P192, DOI 10.1002/cne.10384; Molne M, 2000, J NEUROSCI RES, V59, P301, DOI 10.1002/(SICI)1097-4547(20000201)59:3<301::AID-JNR3>3.0.CO;2-H; Nakashima K, 1999, FEBS LETT, V457, P43, DOI 10.1016/S0014-5793(99)00997-7; Nedergaard M, 2005, GLIA, V50, P281, DOI 10.1002/glia.20205; Ness JK, 2002, MOL CELL NEUROSCI, V20, P476, DOI 10.1006/mcne.2002.1149; Ness JK, 2001, DEV NEUROSCI-BASEL, V23, P203, DOI 10.1159/000046144; Northington FJ, 2001, DEV NEUROSCI-BASEL, V23, P186, DOI 10.1159/000046141; Northington FJ, 2001, J NEUROSCI, V21, P1931, DOI 10.1523/JNEUROSCI.21-06-01931.2001; Ong J, 2005, PEDIATR RES, V58, P600, DOI 10.1203/01.PDR.0000179381.86809.02; Parnavelas JG, 1999, EXP NEUROL, V156, P418, DOI 10.1006/exnr.1999.7044; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Plane JM, 2004, NEUROBIOL DIS, V16, P585, DOI 10.1016/j.nbd.2004.04.003; RICE JE, 1981, ANN NEUROL, V9, P131, DOI 10.1002/ana.410090206; Richards LJ, 1996, EUR J NEUROSCI, V8, P291, DOI 10.1111/j.1460-9568.1996.tb01213.x; RIVKIN MJ, 1995, ANN NEUROL, V38, P92, DOI 10.1002/ana.410380116; Robe PA, 2000, NEUROREPORT, V11, P2837, DOI 10.1097/00001756-200009110-00003; ROESSMANN U, 1986, ACTA NEUROPATHOL, V70, P302, DOI 10.1007/BF00686088; Romanko MJ, 2004, J CEREBR BLOOD F MET, V24, P814, DOI 10.1097/01.WCB.0000123906.17746.00; ROMANKO MJ, 2000, SOC NEUR ABST, V26, P281; RONALDSON PT, 2009, J CEREB BLOOD FLOW M; Saliba E, 2001, BIOL NEONATE, V79, P224; Segovia KN, 2008, ANN NEUROL, V63, P520, DOI 10.1002/ana.21359; Sizonenko SV, 2008, INT J DEV NEUROSCI, V26, P37, DOI 10.1016/j.ijdevneu.2007.08.014; Stoll G, 1998, PROG NEUROBIOL, V56, P149, DOI 10.1016/S0301-0082(98)00034-3; Sun PZ, 2003, J MAGN RESON, V161, P168, DOI 10.1016/S1090-7807(02)00199-4; Swanson RA, 2004, CURR MOL MED, V4, P193, DOI 10.2174/1566524043479185; TRAYSTMAN RJ, 1991, J APPL PHYSIOL, V71, P1185, DOI 10.1152/jappl.1991.71.4.1185; Vannucci RC, 2005, DEV NEUROSCI-BASEL, V27, P81, DOI 10.1159/000085978; VANNUCCI RC, 1988, STROKE, V19, P245, DOI 10.1161/01.STR.19.2.245; Vannucci RC, 1999, J NEUROSCI RES, V55, P158, DOI 10.1002/(SICI)1097-4547(19990115)55:2<158::AID-JNR3>3.0.CO;2-1; Viti J, 2003, J NEUROSCI, V23, P3385; WELSH FA, 1982, J CEREBR BLOOD F MET, V2, P221, DOI 10.1038/jcbfm.1982.22; Woodruff RH, 1999, GLIA, V25, P216, DOI 10.1002/(SICI)1098-1136(19990201)25:3<216::AID-GLIA2>3.0.CO;2-L; Yang Z, 2006, NEUROSCIENCE, V139, P555, DOI 10.1016/j.neuroscience.2005.12.059; Yang ZG, 2007, DEV NEUROSCI-BASEL, V29, P331, DOI 10.1159/000105474; Yang ZG, 2007, ANN NEUROL, V61, P199, DOI 10.1002/ana.21068; Young GM, 1997, J NEUROSCI METH, V77, P163, DOI 10.1016/S0165-0270(97)00123-4; YOUNG GM, 1996, SOC NEUR ABST, V22; Zaidi AU, 2004, GLIA, V46, P380, DOI 10.1002/glia.20013; Zerlin M, 2004, DEV BIOL, V270, P200, DOI 10.1016/j.ydbio.2004.02.024	82	30	34	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2010	5	3							e9567	10.1371/journal.pone.0009567	http://dx.doi.org/10.1371/journal.pone.0009567			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	564EX	20221422	gold, Green Published, Green Submitted			2022-12-25	WOS:000275197200016
J	Brorsson, C; Hansen, NT; Bergholdt, R; Brunak, S; Pociot, F				Brorsson, Caroline; Hansen, Niclas Tue; Bergholdt, Regine; Brunak, Soren; Pociot, Flemming			The Type 1 Diabetes - HLA Susceptibility Interactome - Identification of HLA Genotype-Specific Disease Genes for Type 1 Diabetes	PLOS ONE			English	Article							PROTEIN-KINASE CK2; T1D SUSCEPTIBILITY; HUMAN MACROPHAGES; COMPLEX; REGION; HSP70; EXPRESSION; INHIBITOR; MELLITUS; NETWORKS	Background: The individual contribution of genes in the HLA region to the risk of developing type 1 diabetes (T1D) is confounded by the high linkage disequilibrium (LD) in this region. Using a novel approach we have combined genetic association data with information on functional protein-protein interactions to elucidate risk independent of LD and to place the genetic association into a functional context. Methodology/Principal Findings: Genetic association data from 2300 single nucleotide polymorphisms (SNPs) in the HLA region was analysed in 2200 T1D family trios divided into six risk groups based on HLA-DRB1 genotypes. The best SNP signal in each gene was mapped to proteins in a human protein interaction network and their significance of clustering in functional network modules was evaluated. The significant network modules identified through this approach differed between the six HLA risk groups, which could be divided into two groups based on carrying the DRB1*0301 or the DRB1*0401 allele. Proteins identified in networks specific for DRB1*0301 carriers were involved in stress response and inflammation whereas in DRB1*0401 carriers the proteins were involved in antigen processing and presentation. Conclusions/Significance: In this study we were able to hypothesise functional differences between individuals with T1D carrying specific DRB1 alleles. The results point at candidate proteins involved in distinct cellular processes that could not only help the understanding of the pathogenesis of T1D, but also the distinction between individuals at different genetic risk for developing T1D.	[Brorsson, Caroline; Bergholdt, Regine; Pociot, Flemming] Hagedorn Res Inst, Gentofte, Denmark; [Brorsson, Caroline; Bergholdt, Regine; Pociot, Flemming] Steno Diabet Ctr, DK-2820 Gentofte, Denmark; [Hansen, Niclas Tue; Brunak, Soren] Tech Univ Denmark, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark; [Pociot, Flemming] Lund Univ, Dept Clin Sci, Malmo, Sweden; [Pociot, Flemming] Univ Copenhagen, Dept Biomed Sci, Copenhagen, Denmark	Novo Nordisk; Hagedorn Research Institute; Steno Diabetes Center; Technical University of Denmark; Lund University; University of Copenhagen	Brorsson, C (corresponding author), Hagedorn Res Inst, Gentofte, Denmark.	cbss@hagedorn.dk	; Brunak, Soren/O-6621-2016	Brorsson, Caroline Anna/0000-0003-3473-1744; Brunak, Soren/0000-0003-0316-5866; Pociot, Flemming/0000-0003-3274-5448	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National Institute of Allergy and Infectious Diseases (NIAID); National Human Genome Research Institute (NHGRI); National Institute of Child Health and Human Development (NICHD); Juvenile Diabetes Research Foundation International (JDRF) [U01 DK062418]; EFSD/JDRF/Novo Nordisk; Danish Medical Research Council [271-05-0672]; Juvenile Diabetes Research Foundation [33-2008-391]; Novo Nordisk A/S; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK062418] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Juvenile Diabetes Research Foundation International (JDRF)(Juvenile Diabetes Research Foundation); EFSD/JDRF/Novo Nordisk(Novo NordiskJuvenile Diabetes Research Foundation); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Novo Nordisk A/S(Novo Nordisk); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research utilizes resources provided by the Type 1 Diabetes Genetics Consortium, a collaborative clinical study sponsored by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institute of Allergy and Infectious Diseases (NIAID), National Human Genome Research Institute (NHGRI), National Institute of Child Health and Human Development (NICHD), and Juvenile Diabetes Research Foundation International (JDRF) and supported by U01 DK062418. This study was funded by research grants from EFSD/JDRF/Novo Nordisk, the Danish Medical Research Council (271-05-0672), the Juvenile Diabetes Research Foundation (33-2008-391) and Novo Nordisk A/S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abulafia-Lapid R, 2003, J AUTOIMMUN, V20, P313, DOI 10.1016/S0896-8411(03)00038-6; Basler M, 2004, J IMMUNOL, V173, P3925, DOI 10.4049/jimmunol.173.6.3925; Bergholdt R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r253; Berka N, 2007, J NATL MED ASSOC, V99, P715; BRAY P, 1991, P NATL ACAD SCI USA, V88, P9563, DOI 10.1073/pnas.88.21.9563; Brorsson C, 2009, DIABETES OBES METAB, V11, P60, DOI 10.1111/j.1463-1326.2008.01004.x; Brown WM, 2009, DIABETES OBES METAB, V11, P2, DOI 10.1111/j.1463-1326.2008.00997.x; CAPLEN NJ, 1990, IMMUNOGENETICS, V32, P427; Chen KG, 2005, PIGM CELL RES, V18, P102, DOI 10.1111/j.1600-0749.2005.00214.x; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Cucca F, 2001, HUM MOL GENET, V10, P2025, DOI 10.1093/hmg/10.19.2025; Delneste Y, 2002, IMMUNITY, V17, P353, DOI 10.1016/S1074-7613(02)00388-6; Eike MC, 2009, GENES IMMUN, V10, P56, DOI 10.1038/gene.2008.74; EIKE MC, 2008, GENES IMMUN; Eisemann J, 2009, IMMUNOBIOLOGY, V214, P861, DOI 10.1016/j.imbio.2009.06.020; FICHARD A, 1995, MATRIX BIOL, V14, P515, DOI 10.1016/S0945-053X(05)80001-0; Frank NY, 2003, J BIOL CHEM, V278, P47156, DOI 10.1074/jbc.M308700200; Fraser HB, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r252; Gaudreault N, 2004, DIABETOLOGIA, V47, P2081, DOI 10.1007/s00125-004-1583-4; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; HELQVIST S, 1991, DIABETOLOGIA, V34, P150, DOI 10.1007/BF00418268; Howson JMM, 2009, DIABETES OBES METAB, V11, P31, DOI 10.1111/j.1463-1326.2008.01001.x; Inoue S, 2009, CLIN EXP IMMUNOL, V156, P172, DOI 10.1111/j.1365-2249.2008.03872.x; Johansson S, 2003, GENES IMMUN, V4, P46, DOI 10.1038/sj.gene.6363917; KAWAGUCHI Y, 1993, DIABETES RES CLIN PR, V21, P103, DOI 10.1016/0168-8227(93)90056-B; Kerr JR, 2005, J VET MED B, V52, P335, DOI 10.1111/j.1439-0450.2005.00859.x; Kimura HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007857; Lage K, 2007, NAT BIOTECHNOL, V25, P309, DOI 10.1038/nbt1295; Larsen L, 2007, DIABETOLOGIA, V50, P779, DOI 10.1007/s00125-006-0562-3; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Lie BA, 1999, AM J HUM GENET, V64, P793, DOI 10.1086/302283; Lindfors K, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-53; Litchfield DW, 2003, BIOCHEM J, V369, P1, DOI 10.1042/BJ20021469; MATSUKI K, 1992, LANCET, V339, P1052, DOI 10.1016/0140-6736(92)90571-J; Matsuyama W, 2004, J IMMUNOL, V172, P2332, DOI 10.4049/jimmunol.172.4.2332; Mehta JL, 1998, BIOCHEM BIOPH RES CO, V248, P511, DOI 10.1006/bbrc.1998.9004; Mishra N, 2003, J CLIN INVEST, V111, P539, DOI 10.1172/JC1200316153; Muchamuel T, 2009, NAT MED, V15, P781, DOI 10.1038/nm.1978; Nejentsev S, 2000, DIABETES, V49, P2217, DOI 10.2337/diabetes.49.12.2217; Nejentsev S, 2007, NATURE, V450, P887, DOI 10.1038/nature06406; NERUP J, 1974, LANCET, V2, P864; Nishida K, 2004, ARTHRITIS RHEUM-US, V50, P3365, DOI 10.1002/art.20709; Noble JA, 2002, HUM IMMUNOL, V63, P657, DOI 10.1016/S0198-8859(02)00421-4; Palazzo M, 2008, J IMMUNOL, V181, P3126, DOI 10.4049/jimmunol.181.5.3126; POCIOT F, 1993, SCAND J IMMUNOL, V38, P491, DOI 10.1111/j.1365-3083.1993.tb02593.x; Pociot F, 2002, GENES IMMUN, V3, P235, DOI 10.1038/sj.gene.6363875; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rebbeck TR, 2008, INT J CANCER, V123, P1385, DOI 10.1002/ijc.23687; Roach JC, 2006, AM J HUM GENET, V79, P614, DOI 10.1086/507876; She JX, 1996, IMMUNOL TODAY, V17, P323, DOI 10.1016/0167-5699(96)10014-1; Sia Charles, 2005, Rev Diabet Stud, V2, P40, DOI 10.1900/RDS.2005.2.40; Siebold C, 2004, P NATL ACAD SCI USA, V101, P1999, DOI 10.1073/pnas.0308458100; Singh NN, 2008, J MOL MED, V86, P887, DOI 10.1007/s00109-008-0352-0; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Spiridonov NA, 2005, MOL CELL BIOL, V25, P4250, DOI 10.1128/MCB.25.10.4250-4261.2005; Svejgaard A, 2008, IMMUNOGENETICS, V60, P275, DOI 10.1007/s00251-008-0295-1; TU L, 2009, EUR J IMMUNOL; Valdes AM, 2009, DIABETES OBES METAB, V11, P46, DOI 10.1111/j.1463-1326.2008.01002.x; Valdes AM, 2005, HUM IMMUNOL, V66, P301, DOI 10.1016/j.humimm.2004.12.001; Valdes AM, 2005, TISSUE ANTIGENS, V65, P115, DOI 10.1111/j.1399-0039.2005.00348.x; van Driel MA, 2006, EUR J HUM GENET, V14, P535, DOI 10.1038/sj.ejhg.5201585; Viiri KM, 2006, NUCLEIC ACIDS RES, V34, P3288, DOI 10.1093/nar/gkl401; Visekruna A, 2006, J CLIN INVEST, V116, P3195, DOI 10.1172/JCI28804; WELSH N, 1991, AUTOIMMUNITY, V9, P33, DOI 10.3109/08916939108997121; Wermeling F, 2007, J EXP MED, V204, P2259, DOI 10.1084/jem.20070600; Wu XB, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.27; Xu JF, 2002, NAT GENET, V32, P321, DOI 10.1038/ng994; Yoshida H, 1998, BIOCHEM J, V334, P9, DOI 10.1042/bj3340009	69	20	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2010	5	3							e9576	10.1371/journal.pone.0009576	http://dx.doi.org/10.1371/journal.pone.0009576			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	564EX	20221424	Green Submitted, Green Published, gold			2022-12-25	WOS:000275197200019
J	MacLeod, IJ; Minson, T				MacLeod, Iain J.; Minson, Tony			Binding of Herpes Simplex Virus Type-1 Virions Leads to the Induction of Intracellular Signalling in the Absence of Virus Entry	PLOS ONE			English	Article							NF-KAPPA-B; EPSTEIN-BARR-VIRUS; GLYCOPROTEIN-H; HUMAN CYTOMEGALOVIRUS; MONOCLONAL-ANTIBODIES; ENVELOPED VIRIONS; KINASE-ACTIVITY; CELL-GROWTH; C-MYC; ALPHA	The envelope of HSV-1 contains a number of glycoproteins, four of which are essential for virus entry. Virus particles lacking gB, gD, gH or gL are entry-defective, although these viruses retain the ability to bind to the plasma membrane via the remaining glycoproteins. Soluble forms of gD have been shown to trigger the nuclear translocation of the NF-kappa B transcriptional complex in addition to stimulating the production of Type I interferon. By taking advantage of the entry-defective phenotype of glycoprotein-deficient HSV-1 virus particles, the results presented here show that binding of virions to cellular receptors on the plasma membrane is sufficient to stimulate a change in cellular gene expression. Preliminary microarray studies, validated by quantitative real-time PCR, identified the differential expression of cellular genes associated with the NF-kappa B, PI3K/Akt, Jak/Stat and related Jak/Src pathways by virions lacking gB or gH but not gD. Gene induction occurred at a few particles per cell, corresponding to physiological conditions during primary infection. Reporter assay studies determined that NF-kappa B transcriptional activity is stimulated within an hour of HSV-1 binding, peaks between two and three hours post-binding and declines to background levels by five hours after induction. The immediate, transient nature of these signalling events suggests that HSV-1 glycoproteins, particularly gD, may alter the cellular environment pre-entry so as to condition the cell for viral replication.	[MacLeod, Iain J.; Minson, Tony] Univ Cambridge, Dept Pathol, Div Virol, Cambridge CB2 1QP, England	University of Cambridge	MacLeod, IJ (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, 665 Huntington Ave, Boston, MA 02115 USA.	imacleod@hsph.harvard.edu	Li, Chia Cheng/D-9906-2015	MacLeod, Iain/0000-0001-5608-634X	Wellcome Trust [WT073049MA]; MRC [G9800943] Funding Source: UKRI; Medical Research Council [G9800943] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Wellcome Trust grant WT073049MA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Advani SJ, 2000, J VIROL, V74, P7842, DOI 10.1128/JVI.74.17.7842-7850.2000; Amici C, 2006, J BIOL CHEM, V281, P7110, DOI 10.1074/jbc.M512366200; Ankel H, 1998, VIROLOGY, V251, P317, DOI 10.1006/viro.1998.9432; Aubert M, 2003, GENE THER, V10, P1437, DOI 10.1038/sj.gt.3302004; Babic N, 1999, J GEN VIROL, V80, P2403, DOI 10.1099/0022-1317-80-9-2403; Beier R, 2000, EMBO J, V19, P5813, DOI 10.1093/emboj/19.21.5813; Boursnell MEG, 1997, J INFECT DIS, V175, P16, DOI 10.1093/infdis/175.1.16; Browne H, 1996, J VIROL, V70, P4311, DOI 10.1128/JVI.70.7.4311-4316.1996; Browne HM, 2009, PROTEIN PEPTIDE LETT, V16, P760, DOI 10.2174/092986609788681850; CAL WH, 1988, J VIROL, V62, P2596, DOI 10.1128/JVI.62.8.2596-2604.1988; Coller HA, 2000, P NATL ACAD SCI USA, V97, P3260, DOI 10.1073/pnas.97.7.3260; Collins SE, 2004, J VIROL, V78, P1706, DOI 10.1128/JVI.78.4.1706-1717.2004; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; D'Addario M, 2001, J MOL BIOL, V308, P501, DOI 10.1006/jmbi.2001.4589; D'Addario M, 2000, J MOL BIOL, V298, P765, DOI 10.1006/jmbi.2000.3717; Dang CV, 1999, MOL CELL BIOL, V19, P1; FORRESTER A, 1992, J VIROL, V66, P341, DOI 10.1128/JVI.66.1.341-348.1992; Gregory D, 2004, J VIROL, V78, P13582, DOI 10.1128/JVI.78.24.13582-13590.2004; Heldwein EE, 2008, CELL MOL LIFE SCI, V65, P1653, DOI 10.1007/s00018-008-7570-z; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Hossain A, 1997, J GEN VIROL, V78, P3341, DOI 10.1099/0022-1317-78-12-3341; Huang DCS, 1997, ONCOGENE, V14, P405, DOI 10.1038/sj.onc.1200848; Johnson RA, 2001, J VIROL, V75, P6022, DOI 10.1128/JVI.75.13.6022-6032.2001; LAUDE H, 1992, J VIROL, V66, P743, DOI 10.1128/JVI.66.2.743-749.1992; LIGAS MW, 1988, J VIROL, V62, P1486, DOI 10.1128/JVI.62.5.1486-1494.1988; MCLEAN C, 1982, J GEN VIROL, V63, P297, DOI 10.1099/0022-1317-63-2-297; Medici MA, 2003, J BIOL CHEM, V278, P36059, DOI 10.1074/jbc.M306198200; MINSON AC, 1986, J GEN VIROL, V67, P1001, DOI 10.1099/0022-1317-67-6-1001; Naldinho-Souto R, 2006, J VIROL, V80, P2582, DOI 10.1128/JVI.80.5.2582-2584.2006; Noyce RS, 2006, J VIROL, V80, P226, DOI 10.1128/JVI.80.1.226-235.2006; Paludan SR, 2001, J VIROL, V75, P10170, DOI 10.1128/JVI.75.21.10170-10178.2001; Parry C, 2005, J GEN VIROL, V86, P7, DOI 10.1099/vir.0.80567-0; Patel A, 1998, VIROLOGY, V247, P212, DOI 10.1006/viro.1998.9243; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Preston CM, 2001, J VIROL, V75, P8909, DOI 10.1128/JVI.75.19.8909-8916.2001; Rodger G, 2001, J VIROL, V75, P710, DOI 10.1128/JVI.75.2.710-716.2001; ROOP C, 1993, J VIROL, V67, P2285, DOI 10.1128/JVI.67.4.2285-2297.1993; ROSENWALD IB, 1993, P NATL ACAD SCI USA, V90, P6175, DOI 10.1073/pnas.90.13.6175; Rozen S, 2000, Methods Mol Biol, V132, P365; Satoh T, 2008, CELL, V132, P935, DOI 10.1016/j.cell.2008.01.043; Schang LM, 1998, J VIROL, V72, P5626, DOI 10.1128/JVI.72.7.5626-5637.1998; Sciortino MT, 2007, ANN NY ACAD SCI, V1096, P89, DOI 10.1196/annals.1397.074; Sciortino MT, 2008, BIOCHEM PHARMACOL, V76, P1522, DOI 10.1016/j.bcp.2008.07.030; Simmen KA, 2001, P NATL ACAD SCI USA, V98, P7140, DOI 10.1073/pnas.121177598; Taddeo B, 2002, P NATL ACAD SCI USA, V99, P17031, DOI 10.1073/pnas.252588599; THOMPSON JF, 1991, GENE, V103, P171, DOI 10.1016/0378-1119(91)90270-L; WATSON DH, 1963, VIROLOGY, V19, P250, DOI 10.1016/0042-6822(63)90062-X	47	32	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2010	5	3							e9560	10.1371/journal.pone.0009560	http://dx.doi.org/10.1371/journal.pone.0009560			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	564EX	20221426	gold, Green Published, Green Submitted			2022-12-25	WOS:000275197200012
J	Sommerfeld, MR; Muller, G; Tschank, G; Seipke, G; Habermann, P; Kurrle, R; Tennagels, N				Sommerfeld, Mark R.; Mueller, Guenter; Tschank, Georg; Seipke, Gerhard; Habermann, Paul; Kurrle, Roland; Tennagels, Norbert			In Vitro Metabolic and Mitogenic Signaling of Insulin Glargine and Its Metabolites	PLOS ONE			English	Article							RECEPTOR ISOFORM-A; GROWTH-FACTOR-II; ANALOG GLARGINE; IGF-II; SUBCUTANEOUS INJECTION; HYBRID RECEPTORS; LIGAND-BINDING; NPH INSULIN; AFFINITY; CANCER	In Background: Insulin glargine (Lantus (R)) is a long-acting basal insulin analog that demonstrates effective day-long glycemic control and a lower incidence of hypoglycemia than NPH insulin. After subcutaneous injection insulin glargine is partly converted into the two main metabolites M1 ([GlyA(21)] insulin) and M2 ([GlyA(21), des-Thr(B30)]insulin). The aim of this study was to characterize the glargine metabolites in vitro with regard to their insulin receptor (IR) and IGF-1 receptor (IGF1R) binding and signaling properties as well as their metabolic and mitogenic activities. Methods: The affinity of human insulin, insulin glargine and its metabolites to the IR isoforms A and B or IGF1R was analyzed in a competitive binding assay using SPA technology. Receptor autophosphorylation activities were studied via In-Cell Western in CHO and MEF cells overexpressing human IR-A and IR-B or IGF1R, respectively. The metabolic response of the insulins was studied as stimulation of lipid synthesis using primary rat adipocytes. Thymidine incorporation in Saos-2 cells was used to characterize the mitogenic activity. Conclusions: The binding of insulin glargine and its metabolites M1 and M2 to the IR were similar and correlated well with their corresponding autophosphorylation and metabolic activities in vitro. No differences were found towards the two IR isoforms A or B. Insulin glargine showed a higher affinity for IGF1R than insulin, resulting in a lower EC50 value for autophosphorylation of the receptor and a more potent stimulation of thymidine incorporation in Saos-2 cells. In contrast, the metabolites M1 and M2 were significantly less active in binding to and activation of the IGF1R and their mitogenicity in Saos-2 cells was equal to human insulin. These findings strongly support the idea that insulin glargine metabolites contribute with the same potency as insulin glargine to blood glucose control but lead to significantly reduced growth-promoting activity.	[Sommerfeld, Mark R.; Mueller, Guenter; Tschank, Georg; Kurrle, Roland; Tennagels, Norbert] Sanofi Aventis Deutschland GmbH, Res & Dev TD Metab, Frankfurt, Germany; [Seipke, Gerhard; Habermann, Paul] Sanofi Aventis Deutschland GmbH, Proc Dev Biotechnol, Frankfurt, Germany	Sanofi-Aventis; Sanofi-Aventis	Sommerfeld, MR (corresponding author), Sanofi Aventis Deutschland GmbH, Res & Dev TD Metab, Frankfurt, Germany.	Norbert.Tennagels@sanofi-aventis.com		Muller, Gunter/0000-0001-6178-8215	Sanofi-Aventis	Sanofi-Aventis(Sanofi-Aventis)	This work was funded by Sanofi-Aventis. The funders had a role in the decision to publish but no role in study design, data collection and analysis or preparation of the manuscript.	Agin A, 2007, DIABETES METAB, V33, P205, DOI 10.1016/j.diabet.2006.12.002; BAKER EN, 1988, PHILOS T ROY SOC B, V319, P369, DOI 10.1098/rstb.1988.0058; Baus D, 2008, CELL SIGNAL, V20, P2237, DOI 10.1016/j.cellsig.2008.08.010; Becker RHA, 2008, DIABETES OBES METAB, V10, P1105, DOI 10.1111/j.1463-1326.2008.00874.x; Benyoucef S, 2007, BIOCHEM J, V403, P603, DOI 10.1042/BJ20061709; Berchtold H, 1999, BIOPOLYMERS, V51, P165, DOI 10.1002/(SICI)1097-0282(1999)51:2<165::AID-BIP6>3.3.CO;2-O; Brange J, 1999, ADV DRUG DELIVER REV, V35, P307, DOI 10.1016/S0169-409X(98)00079-9; BRANGE J, 1990, DIABETES CARE, V13, P923, DOI 10.2337/diacare.13.9.923; Chantelau Ernst, 2009, Archives of Physiology and Biochemistry, V115, P47, DOI 10.1080/13813450802709029; COOK N, 2002, CURR PROTOC PROTEIN, pCH19; De Meyts P, 2002, NAT REV DRUG DISCOV, V1, P769, DOI 10.1038/nrd917; Denley A, 2004, MOL ENDOCRINOL, V18, P2502, DOI 10.1210/me.2004-0183; Dideriksen LH, 1992, DIABETES S1, V41, p143A; DREJER K, 1992, DIABETES METAB REV, V8, P259, DOI 10.1002/dmr.5610080305; Eckardt Kristin, 2008, Archives of Physiology and Biochemistry, V114, P45, DOI 10.1080/13813450801983369 ; *EMEA, 2000, EPAR AUTH MED PROD H; Frasca F, 1999, MOL CELL BIOL, V19, P3278, DOI 10.1128/mcb.19.5.3278; Frasca Francesco, 2008, Archives of Physiology and Biochemistry, V114, P23, DOI [10.1080/13813450801969715, 10.1080/13813450801969715 ]; Frick W, 1998, BIOCHEMISTRY-US, V37, P13421, DOI 10.1021/bi9806201; Frystyk J, 2004, GROWTH HORM IGF RES, V14, P337, DOI 10.1016/j.ghir.2004.06.001; GAMMELTOFT S, 1984, PHYSIOL REV, V64, P1321, DOI 10.1152/physrev.1984.64.4.1321; Gerich J, 2006, DIABETES TECHNOL THE, V8, P237, DOI 10.1089/dia.2006.8.237; Goykhman S, 2009, EXPERT OPIN PHARMACO, V10, P705, DOI [10.1517/14656560902775677 , 10.1517/14656560902775677]; Hansen BF, 1996, BIOCHEM J, V315, P271; Heise T, 2004, DIABETES, V53, P1614, DOI 10.2337/diabetes.53.6.1614; Heise T, 2002, DIABETIC MED, V19, P490, DOI 10.1046/j.1464-5491.2002.00723.x; Hennige AM, 1999, DIABETOLOGIA, V42, pA178; HILGENFELD R, 1992, DIABETOLOGIA, V35, pA193; Home PD, 2002, DIABETES-METAB RES, V18, pS57, DOI 10.1002/dmrr.317; Kohn WD, 2007, PEPTIDES, V28, P935, DOI 10.1016/j.peptides.2007.01.012; Kristensen C, 1997, J BIOL CHEM, V272, P12978, DOI 10.1074/jbc.272.20.12978; Kristensen C, 1999, J BIOL CHEM, V274, P37351, DOI 10.1074/jbc.274.52.37351; Kuerzel GU, 2003, CURR MED RES OPIN, V19, P34, DOI 10.1185/030079902125001416; Kuerzel GU, 2001, DIABETOLOGIA, V44, pA208; Kurtzhals P, 2000, DIABETES, V49, P999, DOI 10.2337/diabetes.49.6.999; Le Roith D, 2007, DIABETES-METAB RES, V23, P593, DOI 10.1002/dmrr.776; Lepore M, 2000, DIABETES, V49, P2142, DOI 10.2337/diabetes.49.12.2142; LeRoith D, 2007, NAT CLIN PRACT ENDOC, V3, P302, DOI 10.1038/ncpendmet0427; Levien TL, 2002, ANN PHARMACOTHER, V36, P1019; Liefvendahl E, 2008, HORM METAB RES, V40, P369, DOI 10.1055/s-2008-1062739; Monzavi R, 2002, BEST PRACT RES CL EN, V16, P433, DOI 10.1053/beem.2002.0212; MULLER G, 1993, DIABETES, V42, P1852, DOI 10.2337/diabetes.42.12.1852; MULLER G, 2007, DRUG DISCOVERY EVALU, P1323; Pandini G, 2002, J BIOL CHEM, V277, P39684, DOI 10.1074/jbc.M202766200; Rissler K, 1996, J CHROMATOGR B, V679, P21, DOI 10.1016/0378-4347(96)00022-9; Rosskamp RH, 1999, DIABETES CARE, V22, pB109; Sandow Juergen, 2009, Archives of Physiology and Biochemistry, V115, P72, DOI 10.1080/13813450902835690; Sciacca L, 1999, ONCOGENE, V18, P2471, DOI 10.1038/sj.onc.1202600; Sciacca L, 2002, ONCOGENE, V21, P8240, DOI 10.1038/sj.onc.1206058; SEIPKE G, 2000, END SOC 82 ANN M 200; Serrano R, 2005, J MOL ENDOCRINOL, V34, P153, DOI 10.1677/jme.1.01635; Shukla A, 2009, ENDOCR-RELAT CANCER, V16, P429, DOI 10.1677/ERC-08-0240; Slieker LJ, 1997, DIABETOLOGIA, V40, pS54, DOI 10.1007/s001250051402; Smith U, 2009, DIABETOLOGIA, V52, P1699, DOI 10.1007/s00125-009-1441-5; Staiger K, 2007, HORM METAB RES, V39, P65, DOI 10.1055/s-2007-957352; Stammberger I, 2002, INT J TOXICOL, V21, P171, DOI 10.1080/10915810290096306; Vella V, 2002, J CLIN ENDOCR METAB, V87, P245, DOI 10.1210/jc.87.1.245; Weinstein D, 2009, DIABETES-METAB RES, V25, P41, DOI 10.1002/dmrr.912; YAMAGUCHI Y, 1993, ENDOCRINOLOGY, V132, P1132, DOI 10.1210/en.132.3.1132	59	101	106	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2010	5	3							e9540	10.1371/journal.pone.0009540	http://dx.doi.org/10.1371/journal.pone.0009540			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	564EW	20209060	Green Published, Green Submitted, gold			2022-12-25	WOS:000275197100020
J	Yuen, DA; Connelly, KA; Advani, A; Liao, C; Kuliszewski, MA; Trogadis, J; Thai, K; Advani, SL; Zhang, Y; Kelly, DJ; Leong-Poi, H; Keating, A; Marsden, PA; Stewart, DJ; Gilbert, RE				Yuen, Darren A.; Connelly, Kim A.; Advani, Andrew; Liao, Christine; Kuliszewski, Michael A.; Trogadis, Judy; Thai, Kerri; Advani, Suzanne L.; Zhang, Yuan; Kelly, Darren J.; Leong-Poi, Howard; Keating, Armand; Marsden, Philip A.; Stewart, Duncan J.; Gilbert, Richard E.			Culture-Modified Bone Marrow Cells Attenuate Cardiac and Renal Injury in a Chronic Kidney Disease Rat Model via a Novel Antifibrotic Mechanism	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; ACUTE TUBULAR INJURY; DIABETIC-NEPHROPATHY; TGF-BETA; ANGIOTENSIN-II; DIASTOLIC DYSFUNCTION; FIBROTIC RESPONSE; PROGENITOR CELLS; STROMAL CELLS; HUMAN HEART	Background: Most forms of chronic kidney disease are characterized by progressive renal and cardiac fibrosis leading to dysfunction. Preliminary evidence suggests that various bone marrow-derived cell populations have antifibrotic effects. In exploring the therapeutic potential of bone marrow derived cells in chronic cardio-renal disease, we examined the antifibrotic effects of bone marrow-derived culture modified cells (CMCs) and stromal cells (SCs). Methodology/Principal Findings: In vitro, CMC-conditioned medium, but not SC-conditioned medium, inhibited fibroblast collagen production and cell signalling in response to transforming growth factor-beta. The antifibrotic effects of CMCs and SCs were then evaluated in the 5/6 nephrectomy model of chronic cardio-renal disease. While intravascular infusion of 10(6) SCs had no effect, 10(6) CMCs reduced renal fibrosis compared to saline in the glomeruli (glomerulosclerosis index: 0.8 +/- 0.1 v 1.9 +/- 0.2 arbitrary units) and the tubulointersitium (% area type IV collagen: 1.2 +/- 0.3 v 8.4 +/- 2.0, p < 0.05 for both). Similarly, 10(6) CMCs reduced cardiac fibrosis compared to saline (% area stained with picrosirius red: 3.2 +/- 0.3 v 5.1 +/- 0.4, p < 0.05), whereas 10(6) SCs had no effect. Structural changes induced by CMC therapy were accompanied by improved function, as reflected by reductions in plasma creatinine (58 +/- 3 v 81 +/- 11 mu mol/L), urinary protein excretion (9x/41 v 646/41 mg/day), and diastolic cardiac stiffness (left ventricular end-diastolic pressure-volume relationship: 0.030 +/- 0.003 v 0.058 +/- 0.011 mm Hg/mu L, p < 0.05 for all). Despite substantial improvements in structure and function, only rare CMCs were present in the kidney and heart, whereas abundant CMCs were detected in the liver and spleen. Conclusions/Significance: Together, these findings provide the first evidence suggesting that CMCs, but not SCs, exert a protective action in cardio-renal disease and that these effects may be mediated by the secretion of diffusible anti-fibrotic factor(s).	[Yuen, Darren A.; Connelly, Kim A.; Advani, Andrew; Liao, Christine; Kuliszewski, Michael A.; Trogadis, Judy; Thai, Kerri; Advani, Suzanne L.; Leong-Poi, Howard; Marsden, Philip A.; Gilbert, Richard E.] Univ Toronto, St Michaels Hosp, Dept Med, Li Ka Shing Knowledge Inst,Keenan Res Ctr, Toronto, ON M5B 1W8, Canada; [Zhang, Yuan; Kelly, Darren J.] Univ Melbourne, St Vincents Hosp, Dept Med, Melbourne, Vic, Australia; [Keating, Armand] Univ Toronto, Princess Margaret Hosp, Dept Med, Toronto, ON M5B 1W8, Canada; [Stewart, Duncan J.] Univ Ottawa, Ottawa Hlth Res Inst, Ottawa, ON, Canada	University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; St Vincent's Hospital Melbourne; University of Melbourne; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Ottawa; Ottawa Hospital Research Institute	Yuen, DA (corresponding author), Univ Toronto, St Michaels Hosp, Dept Med, Li Ka Shing Knowledge Inst,Keenan Res Ctr, Toronto, ON M5B 1W8, Canada.	richard.gilbert@utoronto.ca	Connelly, Kim A/S-5160-2017; Marsden, Philip A/B-1441-2012	Connelly, Kim A/0000-0002-1031-3137; Kelly, Darren/0000-0003-4850-3929	Canadian Institutes of Health Research (CIHR; Physicians' Services Incorporated Foundation of Ontario; KRESCENT; Heart and Stroke Foundation of Ontario; Canadian Diabetes Association.; Ministry of Research and Innovation, Ontario, Canada	Canadian Institutes of Health Research (CIHR(Canadian Institutes of Health Research (CIHR)); Physicians' Services Incorporated Foundation of Ontario; KRESCENT; Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Canadian Diabetes Association.; Ministry of Research and Innovation, Ontario, Canada(Ministry of Research and Innovation, Ontario)	This work was supported by grants from the Canadian Institutes of Health Research (CIHR) and the Physicians' Services Incorporated Foundation of Ontario. Dr. Yuen is supported by a KRESCENT postdoctoral fellowship. Dr. Gilbert is supported by a generous donation from George and Diane Mara. Dr. Connelly is supported by a Clinician Scientist award from the Heart and Stroke Foundation of Ontario. Dr. Advani is supported by a Clinician Scientist award from the Canadian Diabetes Association. Dr. Leong- Poi is supported by a Phase II Clinician Scientist Award from the Heart and Stroke Foundation of Ontario and an Early Researcher Award from the Ministry of Research and Innovation, Ontario, Canada. Dr. Keating holds the Gloria and Seymour Epstein Chair in Cell Therapy and Transplantation at the University Health Network and the University of Toronto. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Advani A, 2007, P NATL ACAD SCI USA, V104, P14448, DOI 10.1073/pnas.0703577104; Advani A, 2009, HYPERTENSION, V54, P261, DOI 10.1161/HYPERTENSIONAHA.109.128645; Advani A, 2009, J AM SOC NEPHROL, V20, P730, DOI 10.1681/ASN.2008020142; Amann K, 1998, J AM SOC NEPHROL, V9, P1018; AMANN K, 1992, KIDNEY INT, V42, P1079, DOI 10.1038/ki.1992.390; Bi B, 2007, J AM SOC NEPHROL, V18, P2486, DOI 10.1681/ASN.2007020140; Border WA, 1998, HYPERTENSION, V31, P181, DOI 10.1161/01.HYP.31.1.181; BORDER WA, 1994, NEW ENGL J MED, V331, P1286; Bruno S, 2009, J AM SOC NEPHROL, V20, P1053, DOI 10.1681/ASN.2008070798; Burt RK, 2008, JAMA-J AM MED ASSOC, V299, P925, DOI 10.1001/jama.299.8.925; Campbell AIM, 1999, AM J RESP CELL MOL, V21, P567, DOI 10.1165/ajrcmb.21.5.3640; Caplice NM, 2005, NAT CLIN PRACT CARD, V2, P37, DOI 10.1038/ncpcardio0073; Connelly KA, 2007, CARDIOVASC RES, V76, P280, DOI 10.1016/j.cardiores.2007.06.022; Connelly KA, 2006, AM J PHYSIOL-HEART C, V290, pH1699, DOI 10.1152/ajpheart.00577.2005; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Dutly AE, 2006, LAB INVEST, V86, P409, DOI 10.1038/labinvest.3700399; Eddy AA, 2005, ADV CHRONIC KIDNEY D, V12, P353, DOI 10.1053/j.ackd.2005.07.011; Fried LF, 2003, J AM COLL CARDIOL, V41, P1364, DOI 10.1016/S0735-1097(03)00163-3; Frustaci A, 2000, CIRC RES, V87, P1123, DOI 10.1161/01.RES.87.12.1123; Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826; Gross ML, 2008, SEMIN DIALYSIS, V21, P308, DOI 10.1111/j.1525-139X.2008.00454.x; Hein S, 2003, CIRCULATION, V107, P984, DOI 10.1161/01.CIR.0000051865.66123.B7; Hirschi KK, 2008, ARTERIOSCL THROM VAS, V28, P1584, DOI 10.1161/ATVBAHA.107.155960; Kang DH, 2001, J AM SOC NEPHROL, V12, P1448, DOI 10.1681/ASN.V1271448; Kelly DJ, 2007, AM J PHYSIOL-HEART C, V293, pH2860, DOI 10.1152/ajpheart.01167.2006; Kelly DJ, 2005, J AM SOC NEPHROL, V16, P1654, DOI 10.1681/ASN.2004070578; Kelly DJ, 2004, J AM SOC NEPHROL, V15, P2619, DOI 10.1097/01.ASN.0000139066.77892.04; KLAHR S, 1994, NEW ENGL J MED, V330, P877, DOI 10.1056/NEJM199403313301301; Kocher AA, 2001, NAT MED, V7, P430, DOI 10.1038/86498; Kupfahl C, 2000, CARDIOVASC RES, V46, P463, DOI 10.1016/S0008-6363(00)00037-7; Kuwahara F, 2002, CIRCULATION, V106, P130, DOI 10.1161/01.CIR.0000020689.12472.E0; Lai KN, 2009, NEPHROL DIAL TRANSPL, V24, P62, DOI 10.1093/ndt/gfn441; Langham RG, 2006, DIABETES CARE, V29, P2670, DOI 10.2337/dc06-0911; Lapointe N, 2002, J AM COLL CARDIOL, V39, P1692, DOI 10.1016/S0735-1097(02)01837-5; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Leask A, 2007, CARDIOVASC RES, V74, P207, DOI 10.1016/j.cardiores.2006.07.012; Lebrin F, 2005, CARDIOVASC RES, V65, P599, DOI 10.1016/j.cardiores.2004.10.036; Lehr HA, 1999, J HISTOCHEM CYTOCHEM, V47, P119, DOI 10.1177/002215549904700113; Lopez B, 2008, KIDNEY INT, V74, pS19, DOI 10.1038/ki.2008.512; Martin J, 2005, CARDIOVASC RES, V65, P694, DOI 10.1016/j.cardiores.2004.10.041; Nakamura T, 2007, GASTROENTEROLOGY, V133, P91, DOI 10.1053/j.gastro.2007.03.110; NATH KA, 1992, AM J KIDNEY DIS, V20, P1; Nygren JM, 2004, NAT MED, V10, P494, DOI 10.1038/nm1040; Olfert ED, 1993, GUIDE CARE USE EXPT; Orlic D, 2001, ANN NY ACAD SCI, V938, P221; Ortiz LA, 2003, P NATL ACAD SCI USA, V100, P8407, DOI 10.1073/pnas.1432929100; PARFREY PS, 1991, J AM SOC NEPHROL, V2, P2; Sakharova OV, 2001, CURR OPIN NEPHROL HY, V10, P727, DOI 10.1097/00041552-200111000-00001; Schultz JEJ, 2002, J CLIN INVEST, V109, P787, DOI 10.1172/JCI200214190; Spinale FG, 2007, PHYSIOL REV, V87, P1285, DOI 10.1152/physrev.00012.2007; Tateishi-Yuyama E, 2002, LANCET, V360, P427, DOI 10.1016/S0140-6736(02)09670-8; Vandervelde S, 2005, J MOL CELL CARDIOL, V39, P363, DOI 10.1016/j.yjmcc.2005.05.012; Wu LL, 1997, KIDNEY INT, V51, P1553, DOI 10.1038/ki.1997.214; Wynn TA, 2007, J CLIN INVEST, V117, P524, DOI 10.1172/JCI31487; Yingling JM, 2004, NAT REV DRUG DISCOV, V3, P1011, DOI 10.1038/nrd1580; Zhao YDD, 2005, CIRC RES, V96, P442, DOI 10.1161/01.RES.0000157672.70560.7b; Ziyadeh FN, 2000, P NATL ACAD SCI USA, V97, P8015, DOI 10.1073/pnas.120055097	57	53	55	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2010	5	3							e9543	10.1371/journal.pone.0009543	http://dx.doi.org/10.1371/journal.pone.0009543			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	564EW	20209052	Green Published, gold			2022-12-25	WOS:000275197100022
J	Chen, G; League, GP; Nam, SC				Chen, Geng; League, Garrett P.; Nam, Sang-Chul			Role of Spastin in Apical Domain Control along the Rhabdomere Elongation in Drosophila Photoreceptor	PLOS ONE			English	Article							MICROTUBULE STABILITY; RETINITIS-PIGMENTOSA; NUCLEAR MIGRATION; PROTEIN; CRUMBS; GENE; MORPHOGENESIS; EYE; PARAPLEGIA; MUTATIONS	Background: Mutations in spastin are the most common cause of hereditary spastin paraplegia, a neurodegenerative disease. In this study, the role of spastin was examined in Drosophila photoreceptor development. Methodology/Principal Findings: The spastin mutation in developing pupal eyes causes a mild mislocalization of the apical membrane domain at the distal section, but the apical domain was dramatically reduced at the proximal section of the developing pupal eye. Since the rhabdomeres in developing pupal eyes grow from distal to proximal, this phenotype strongly suggests that spastin is required for apical domain maintenance during rhabdomere elongation. This role of spastin in apical domain modulation was further supported by spastin's gain-of-function phenotype. Spastin overexpression in photoreceptors caused the expansion of the apical membrane domain from apical to basolateral in the developing photoreceptor. Although the localizations of the apical domain and adherens junctions (AJs) were severely expanded, there were no defects in cell polarity. Conclusions/Significance: These results strongly suggest that spastin is essential for apical domain biogenesis during rhabdomere elongation in Drosophila photoreceptor morphogenesis.	[Chen, Geng; League, Garrett P.; Nam, Sang-Chul] Baylor Univ, Dept Biol, Waco, TX 76798 USA	Baylor University	Nam, SC (corresponding author), Baylor Univ, Dept Biol, Waco, TX 76798 USA.	Sang-Chul_Nam@baylor.edu	Nam, Sang-Chul/J-5518-2014	Nam, Sang-Chul/0000-0001-7176-601X	Baylor University	Baylor University	The authors thank Manzoor Bhat, Hugo Bellen, Kendal Broadie, KwangWook Choi, Kyung-Ok Cho, Yang Hong, Yuh-Nung Jan, Nina Tang Sherwood, Kai Zinn, Developmental Studies Hybridoma Bank, Bloomington Stock Center for fly stocks and reagents, and Alicia Rogers for technical assistance. Confocal Microscopy was supported by Baylor University.	Bhat MA, 1999, CELL, V96, P833, DOI 10.1016/S0092-8674(00)80593-0; Casari G, 2001, CURR OPIN GENET DEV, V11, P336, DOI 10.1016/S0959-437X(00)00199-4; Charvin D, 2003, HUM MOL GENET, V12, P71, DOI 10.1093/hmg/ddg004; Chen TW, 2009, GENESIS, V47, P744, DOI 10.1002/dvg.20555; Choi KW, 2007, FLY, V1, P235, DOI 10.4161/fly.4954; den Hollander AI, 1999, NAT GENET, V23, P217, DOI 10.1038/13848; den Hollander AI, 2001, AM J HUM GENET, V69, P198; Errico A, 2002, HUM MOL GENET, V11, P153, DOI 10.1093/hmg/11.2.153; Evans KJ, 2005, J CELL BIOL, V168, P599, DOI 10.1083/jcb.200409058; Fan SS, 1997, DEVELOPMENT, V124, P1497; Freeman M, 1996, CELL, V87, P651, DOI 10.1016/S0092-8674(00)81385-9; Hazan J, 1999, NAT GENET, V23, P296, DOI 10.1038/15472; Hong Y, 2001, NATURE, V414, P634, DOI 10.1038/414634a; Izaddoost S, 2002, NATURE, V416, P178, DOI 10.1038/nature720; Kammermeier L, 2003, DEV GENES EVOL, V213, P412, DOI 10.1007/s00427-003-0340-x; Lee OK, 2003, NAT CELL BIOL, V5, P987, DOI 10.1038/ncb1055; Lei YD, 2000, DEV BIOL, V226, P57, DOI 10.1006/dbio.2000.9848; LONGLEY RL, 1995, DEV BIOL, V171, P415, DOI 10.1006/dbio.1995.1292; Mosley-Bishop KL, 1999, CURR BIOL, V9, P1211, DOI 10.1016/S0960-9822(99)80501-6; Nam SC, 2007, DEV BIOL, V306, P624, DOI 10.1016/j.ydbio.2007.03.522; Nam SC, 2006, DEV DYNAM, V235, P1501, DOI 10.1002/dvdy.20726; Nam SC, 2003, DEVELOPMENT, V130, P4363, DOI 10.1242/dev.00648; Pellikka M, 2002, NATURE, V416, P143, DOI 10.1038/nature721; PIPERNO G, 1985, J CELL BIOL, V101, P2085, DOI 10.1083/jcb.101.6.2085; Roll-Mecak A, 2006, J CELL BIOL, V175, P849, DOI 10.1083/jcb.200611149; Salinas S, 2005, J NEUROCHEM, V95, P1411, DOI 10.1111/j.1471-4159.2005.03472.x; SCHULZE E, 1987, J CELL BIOL, V105, P2167, DOI 10.1083/jcb.105.5.2167; SCHULZE E, 1987, J CELL BIOL, V104, P277, DOI 10.1083/jcb.104.2.277; Sherwood NT, 2004, PLOS BIOL, V2, P2094, DOI 10.1371/journal.pbio.0020429; Trotta N, 2004, CURR BIOL, V14, P1135, DOI 10.1016/j.cub.2004.06.058; Whited JL, 2004, DEVELOPMENT, V131, P4677, DOI 10.1242/dev.01366; WOLF N, 1988, DEVELOPMENT, V102, P311; Wood JD, 2006, HUM MOL GENET, V15, P2763, DOI 10.1093/hmg/ddl212; XU T, 1993, DEVELOPMENT, V117, P1223	34	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2010	5	3							e9480	10.1371/journal.pone.0009480	http://dx.doi.org/10.1371/journal.pone.0009480			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	562OZ	20209135	gold, Green Published, Green Submitted			2022-12-25	WOS:000275063400004
J	de Meis, L; Ketzer, LA; da Costa, RM; de Andrade, IR; Benchimol, M				de Meis, Leopoldo; Ketzer, Luisa A.; da Costa, Rodrigo Madeiro; de Andrade, Ivone Rosa; Benchimol, Marlene			Fusion of the Endoplasmic Reticulum and Mitochondrial Outer Membrane in Rats Brown Adipose Tissue: Activation of Thermogenesis by Ca2+	PLOS ONE			English	Article							HEAT-PRODUCTION; CA2+-ATPASE; ATPASE; ENERGY; WATER; IDENTIFICATION; TEMPERATURE; HYDROLYSIS; LIVER	Brown adipose tissue (BAT) mitochondria thermogenesis is regulated by uncoupling protein 1 (UCP 1), GDP and fatty acids. In this report, we observed fusion of the endoplasmic reticulum (ER) membrane with the mitochondrial outer membrane of rats BAT. Ca2+-ATPase (SERCA 1) was identified by immunoelectron microscopy in both ER and mitochondria. This finding led us to test the Ca2+ effect in BAT mitochondria thermogenesis. We found that Ca2+ increased the rate of respiration and heat production measured with a microcalorimeter both in coupled and uncoupled mitochondria, but had no effect on the rate of ATP synthesis. The Ca2+ concentration needed for half-maximal activation varied between 0.08 and 0.11 mu M. The activation of respiration was less pronounced than that of heat production. Heat production and ATP synthesis were inhibited by rotenone and KCN. Liver mitochondria have no UCP1 and during respiration synthesize a large amount of ATP, produce little heat, GDP had no effect on mitochondria coupling, Ca2+ strongly inhibited ATP synthesis and had little or no effect on the small amount of heat released. These finding indicate that Ca2+ activation of thermogenesis may be a specific feature of BAT mitochondria not found in other mitochondria such as liver.	[de Meis, Leopoldo; Ketzer, Luisa A.; da Costa, Rodrigo Madeiro] Univ Fed Rio de Janeiro, Ctr Ciencias Saude, Inst Bioquim Med, Rio De Janeiro, Brazil; [de Andrade, Ivone Rosa; Benchimol, Marlene] Univ Santa Ursula, Lab Ultraestrutura Celular, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro	de Meis, L (corresponding author), Univ Fed Rio de Janeiro, Ctr Ciencias Saude, Inst Bioquim Med, Rio De Janeiro, Brazil.	demeis@bioqmed.ufrj.br	Ketzer, Luisa Andrea/J-1652-2015	Ketzer, Luisa Andrea/0000-0002-1127-116X	PRONEX - Financiadora de Estudos e Projetos (FINEP; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)	PRONEX - Financiadora de Estudos e Projetos (FINEP(Financiadora de Inovacao e Pesquisa (Finep)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was supported by grants from PRONEX - Financiadora de Estudos e Projetos (FINEP), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ). LAK and RMC are recipients of post doctoral fellowships from CNPq and FAPERJ, respectively. IRA is PhD student. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anunciado-Koza R, 2008, J BIOL CHEM, V283, P27688, DOI 10.1074/jbc.M804268200; BAFFY G, 2009, HEPATOLOGY, V50, P1204; Bedeaux D, 2008, PHYS CHEM CHEM PHYS, V10, P7304, DOI 10.1039/b810374g; Boncompagni S, 2009, MOL BIOL CELL, V20, P1058, DOI 10.1091/mbc.E08-07-0783; BRACKER CE, 1971, PROTOPLASMA, V73, P15, DOI 10.1007/BF01286408; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Csordas G, 2006, J CELL BIOL, V174, P915, DOI 10.1083/jcb.200604016; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; de Meis L, 2003, J BIOL CHEM, V278, P41856, DOI 10.1074/jbc.M308280200; de Meis L, 2001, J BIOL CHEM, V276, P25078, DOI 10.1074/jbc.M103318200; de Meis L, 1977, Biochemistry, V16, P4455, DOI 10.1021/bi00639a020; de Meis L, 2006, J BIOL CHEM, V281, P16384, DOI 10.1074/jbc.M600678200; DEMEIS L, 1980, BIOCHEMISTRY-US, V19, P4252, DOI 10.1021/bi00559a017; DEMEIS L, 1989, BIOCHIM BIOPHYS ACTA, V973, P333, DOI 10.1016/S0005-2728(89)80440-2; DEMEIS L, 1979, ANNU REV BIOCHEM, V48, P275; DEMEIS L, 1988, METHOD ENZYMOL, V157, P190; DEMEIS L, 1982, J BIOL CHEM, V257, P1289; Dirksen RT, 2009, APPL PHYSIOL NUTR ME, V34, P389, DOI 10.1139/H09-044; FABIATO A, 1979, J PHYSIOL-PARIS, V75, P463; FRANKE WW, 1971, PROTOPLASMA, V73, P35, DOI 10.1007/BF01286409; Hayashi T, 2009, TRENDS CELL BIOL, V19, P81, DOI 10.1016/j.tcb.2008.12.002; INESI G, 1985, ANNU REV PHYSIOL, V47, P573, DOI 10.1146/annurev.ph.47.030185.003041; JUNGALWA.FB, 1970, BIOCHEM J, V117, P481, DOI 10.1042/bj1170481; JURGEN AW, 2009, J STRUCT BIOL, V166, P1; KLINGENBERG M, 2006, BIOCHIM BIOPHYS ACTA, V1778, P1978; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leaver EV, 2002, AM J PHYSIOL-CELL PH, V282, pC1016, DOI 10.1152/ajpcell.00204.2001; LICHTENBELT WDM, 2009, NEW ENGL J MED, V360, P1518; Mall S, 2006, J BIOL CHEM, V281, P36597, DOI 10.1074/jbc.M606869200; MORRE DJ, 1971, PROTOPLASMA, V73, P43, DOI 10.1007/BF01286410; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; Nicholls DG, 2006, BBA-BIOENERGETICS, V1757, P459, DOI 10.1016/j.bbabio.2006.02.005; NICHOLLS DG, 1999, J BIOENERGETIC BIOME, V3, P166; NICHOLLS JG, 1984, RES MOTIVATION ED ST, V1, P64; RICQUIER D, 1979, FEBS LETT, V99, P203, DOI 10.1016/0014-5793(79)80279-3; Rizzuto R, 2009, BBA-BIOENERGETICS, V1787, P1342, DOI 10.1016/j.bbabio.2009.03.015; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Sluse FE, 2006, BBA-BIOENERGETICS, V1757, P480, DOI 10.1016/j.bbabio.2006.02.004; SPACEK J, 1980, J CELL SCI, V46, P129; STAUFFER CE, 1975, ANAL BIOCHEM, V69, P646, DOI 10.1016/0003-2697(75)90172-4; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Zingaretti MC, 2009, FASEB J, V23, P3113, DOI 10.1096/fj.09-133546	43	32	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2010	5	3							e9439	10.1371/journal.pone.0009439	http://dx.doi.org/10.1371/journal.pone.0009439			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	562OY	20209153	Green Published, Green Submitted, gold			2022-12-25	WOS:000275063300002
J	Boyer, JG; Bhanot, K; Kothary, R; Boudreau-Lariviere, C				Boyer, Justin G.; Bhanot, Kunal; Kothary, Rashmi; Boudreau-Lariviere, Celine			Hearts of Dystonia musculorum Mice Display Normal Morphological and Histological Features but Show Signs of Cardiac Stress	PLOS ONE			English	Article							BULLOUS PEMPHIGOID ANTIGEN-1; CROSS-LINKING FACTOR; MUSCLE CYTOARCHITECTURE; INTERMEDIATE-FILAMENTS; SKELETAL-MUSCLE; BPAG1 LOCUS; ACTIN; PLECTIN; HYPERTROPHY; INTEGRITY	Dystonin is a giant cytoskeletal protein belonging to the plakin protein family and is believed to crosslink the major filament systems in contractile cells. Previous work has demonstrated skeletal muscle defects in dystonin-deficient dystonia musculorum (dt) mice. In this study, we show that the dystonin muscle isoform is localized at the Z-disc, the H zone, the sarcolemma and intercalated discs in cardiac tissue. Based on this localization pattern, we tested whether dystonin-deficiency leads to structural defects in cardiac muscle. Desmin intermediate filament, microfilament, and microtubule subcellular organization appeared normal in dt hearts. Nevertheless, increased transcript levels of atrial natriuretic factor (ANF, 66%) beta-myosin heavy chain (beta-MHC, 95%) and decreased levels of sarcoplasmic reticulum calcium pump isoform 2A (SERCA2a, 26%), all signs of cardiac muscle stress, were noted in dt hearts. Hearts from two-week old dt mice were assessed for the presence of morphological and histological alterations. Heart to body weight ratios as well as left ventricular wall thickness and left chamber volume measurements were similar between dt and wild-type control mice. Hearts from dt mice also displayed no signs of fibrosis or calcification. Taken together, our data provide new insights into the intricate structure of the sarcomere by situating dystonin in cardiac muscle fibers and suggest that dystonin does not significantly influence the structural organization of cardiac muscle fibers during early postnatal development.	[Boyer, Justin G.; Boudreau-Lariviere, Celine] Laurentian Univ, Dept Biol, Sudbury, ON P3E 2C6, Canada; [Boudreau-Lariviere, Celine] Laurentian Univ, Sch Human Kinet, Sudbury, ON P3E 2C6, Canada; [Boudreau-Lariviere, Celine] Laurentian Univ, Biomol Sci Program, Sudbury, ON P3E 2C6, Canada; [Boyer, Justin G.; Bhanot, Kunal; Kothary, Rashmi] Ottawa Hosp, Res Inst, Regenerat Med Program, Ottawa, ON, Canada; [Boyer, Justin G.; Bhanot, Kunal; Kothary, Rashmi] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada	Laurentian University; Laurentian University; Laurentian University; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa	Boyer, JG (corresponding author), Laurentian Univ, Dept Biol, Sudbury, ON P3E 2C6, Canada.	cboudreaulariviere@laurentian.ca		Kothary, Rashmi/0000-0002-9239-7310	National Science and Engineering Research Council of Canada; Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada	National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by research grants from the National Science and Engineering Research Council of Canada (C. B.- L.) and Canadian Institutes of Health Research (R. K.). J. G. B. was a recipient of a Canada Graduate Scholarship from Natural Sciences and Engineering Research Council of Canada at the time this study was completed. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andra K, 1997, GENE DEV, V11, P3143, DOI 10.1101/gad.11.23.3143; Boudreau-Lariviere C, 2002, DIFFERENTIATION, V70, P247, DOI 10.1046/j.1432-0436.2002.700603.x; BOYER JG, 2009, PLAKINS STRIATED MUS; BROWN A, 1995, NAT GENET, V10, P301, DOI 10.1038/ng0795-301; Clark KA, 2002, ANNU REV CELL DEV BI, V18, P637, DOI 10.1146/annurev.cellbio.18.012502.105840; Dalpe G, 1999, DEV BIOL, V210, P367, DOI 10.1006/dbio.1999.9263; Depre C, 1998, NAT MED, V4, P1269, DOI 10.1038/3253; Dorn GW, 2003, CIRC RES, V92, P1171, DOI 10.1161/01.RES.0000077012.11088.BC; DUCHEN LW, 1964, BRAIN, V87, P367, DOI 10.1093/brain/87.2.367; DUCHEN LW, 1962, J PHYS, V165, P7; FRANCH HA, 1988, CIRC RES, V62, P31, DOI 10.1161/01.RES.62.1.31; Hijikata T, 2008, J CELL SCI, V121, P2062, DOI 10.1242/jcs.021634; Holtwick R, 2003, J CLIN INVEST, V111, P1399, DOI 10.1172/JCI200317061; Huen AC, 2002, J CELL BIOL, V159, P1005, DOI 10.1083/jcb.200206098; Jefferson JJ, 2004, NAT REV MOL CELL BIO, V5, P542, DOI 10.1038/nrm1425; Jefferson JJ, 2006, EXP CELL RES, V312, P2712, DOI 10.1016/j.yexcr.2006.04.025; KARTENBECK J, 1983, EMBO J, V2, P735, DOI 10.1002/j.1460-2075.1983.tb01493.x; Konieczny P, 2008, J CELL BIOL, V181, P667, DOI 10.1083/jcb.200711058; Konieczny P, 2008, ADV EXP MED BIOL, V642, P165; KOTHARY R, 1988, NATURE, V335, P435, DOI 10.1038/335435a0; Leung CL, 2001, J CELL BIOL, V154, P691, DOI 10.1083/jcb.200012098; Lin CM, 2005, J CELL SCI, V118, P3727, DOI 10.1242/jcs.02510; Okumura M, 2002, J BIOL CHEM, V277, P6682, DOI 10.1074/jbc.M109209200; Pool M, 2005, MAMM GENOME, V16, P909, DOI 10.1007/s00335-005-0073-4; Rezniczek GA, 2007, J CELL BIOL, V176, P965, DOI 10.1083/jcb.200604179; SAWAMURA D, 1991, J BIOL CHEM, V266, P17784; Sonnenberg A, 2007, EXP CELL RES, V313, P2189, DOI 10.1016/j.yexcr.2007.03.039; Steiner-Champliaud MF, 2010, EXP CELL RES, V316, P297, DOI 10.1016/j.yexcr.2009.11.010; TANAKA T, 1991, J BIOL CHEM, V266, P12555; Winter L, 2008, J CELL BIOL, V181, P903, DOI 10.1083/jcb.200710151; Yang YM, 1996, CELL, V86, P655, DOI 10.1016/S0092-8674(00)80138-5; Young KG, 2008, EXP CELL RES, V314, P2750, DOI 10.1016/j.yexcr.2008.06.021; Young KG, 2007, CELL MOTIL CYTOSKEL, V64, P897, DOI 10.1002/cm.20235; Young KG, 2005, EXP CELL RES, V312, P121, DOI 10.1016/j.yexcr.2005.10.002; Young KG, 2003, J CELL SCI, V116, P4543, DOI 10.1242/jcs.00764	35	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2010	5	3							e9465	10.1371/journal.pone.0009465	http://dx.doi.org/10.1371/journal.pone.0009465			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	561RT	20209123	Green Published, Green Submitted, gold			2022-12-25	WOS:000274997100012
J	Keckeis, M; Lattova, Z; Maurovich-Horvat, E; Beitinger, PA; Birkmann, S; Lauer, CJ; Wetter, TC; Wilde-Frenz, J; Pollmacher, T				Keckeis, Marietta; Lattova, Zuzana; Maurovich-Horvat, Eszter; Beitinger, Pierre A.; Birkmann, Steffen; Lauer, Christoph J.; Wetter, Thomas C.; Wilde-Frenz, Johanna; Pollmaecher, Thomas			Impaired Glucose Tolerance in Sleep Disorders	PLOS ONE			English	Article							RESTLESS LEGS SYNDROME; FASTING PLASMA-GLUCOSE; OBESITY; INDEX; APNEA; RISK; EPIDEMIOLOGY; ASSOCIATION	Background: Recent epidemiological and experimental data suggest a negative influence of shortened or disturbed night sleep on glucose tolerance. Due to the high prevalence of sleep disorders this might be a major health issue. However, no comparative studies of carbohydrate metabolism have been conducted in clinical sleep disorders. Methodology/Principal Findings: We performed oral glucose tolerance tests (OGTT) and assessed additional parameters of carbohydrate metabolism in patients suffering from obstructive sleep apnea syndrome (OSAS, N = 25), restless legs syndrome (RLS, N = 18) or primary insomnia (N = 21), and in healthy controls (N = 33). Compared to controls, increased rates of impaired glucose tolerance were found in OSAS (OR: 4.9) and RLS (OR: 4.7) patients, but not in primary insomnia patients (OR: 1.6). In addition, HbA1c values were significantly increased in the same two patient groups. Significant positive correlations were found between 2-h plasma glucose values measured during the OGTT and the apnea-arousal-index in OSAS (r = 0.56; p < 0.05) and the periodic leg movement-arousal-index in RLS (r = 0.56, p, 0.05), respectively. Sleep duration and other quantitative aspects of sleep were similar between patient groups. Conclusions/Significance: Our findings suggest that some, but not all sleep disorders considerably compromise glucose metabolism. Repeated arousals during sleep might be a pivotal causative factor deserving further experimental investigations to reveal potential novel targets for the prevention of metabolic diseases.	[Keckeis, Marietta; Lattova, Zuzana; Maurovich-Horvat, Eszter; Beitinger, Pierre A.; Wetter, Thomas C.; Pollmaecher, Thomas] Max Planck Inst Psychiat, Munich, Germany; [Keckeis, Marietta; Lattova, Zuzana; Maurovich-Horvat, Eszter; Birkmann, Steffen; Lauer, Christoph J.; Wilde-Frenz, Johanna; Pollmaecher, Thomas] Klinikum Ingolstadt, Ctr Mental Hlth, Ingolstadt, Germany	Max Planck Society	Keckeis, M (corresponding author), Max Planck Inst Psychiat, Munich, Germany.	thomas.pollmaecher@klinikum-ingolstadt.de			European Union Framework 6 [MCRTN-CT-2004-512362]	European Union Framework 6(European Commission)	This study was supported by the European Union Framework 6 (MCRTN-CT-2004-512362). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen RP, 2003, SLEEP MED, V4, P101, DOI 10.1016/S1389-9457(03)00010-8; American Academy of Sleep Medicine, 2005, INT CLASS SLEEP DIS; BONNET M, 1993, SLEEP, V16, P748; BONNET MH, 1992, SLEEP, V15, P526; Bosco D, 2009, J NEUROL SCI, V287, P60, DOI 10.1016/j.jns.2009.09.008; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Coughlin SR, 2004, EUR HEART J, V25, P735, DOI 10.1016/j.ehj.2004.02.021; Gao X, 2009, NEUROLOGY, V72, P1255, DOI 10.1212/01.wnl.0000345673.35676.1c; Garcia-Borreguero D, 2006, EUR J NEUROL, V13, P15, DOI 10.1111/j.1468-1331.2006.01587.x; Genuth S, 2003, DIABETES CARE, V26, P3160; Guh DP, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-88; Heidemann C, 2009, EUR J EPIDEMIOL, V24, P281, DOI 10.1007/s10654-009-9338-7; Hornyak M, 2007, SLEEP, V30, P861, DOI 10.1093/sleep/30.7.861; Inoue K, 2008, DIABETIC MED, V25, P1157, DOI 10.1111/j.1464-5491.2008.02572.x; Inoue K, 2007, DIABETES RES CLIN PR, V77, P451, DOI 10.1016/j.diabres.2007.01.024; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Knutson KL, 2008, ANN NY ACAD SCI, V1129, P287, DOI 10.1196/annals.1417.033; Ko GTC, 2000, DIABETES CARE, V23, P1290, DOI 10.2337/diacare.23.9.1290; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Merlino G, 2007, SLEEP, V30, P866, DOI 10.1093/sleep/30.7.866; Narkiewicz K, 2003, ACTA PHYSIOL SCAND, V177, P385, DOI 10.1046/j.1365-201X.2003.01091.x; Ohayon MM, 2002, SLEEP MED REV, V6, P97, DOI 10.1053/smrv.2002.0186; Pollmacher T, 2007, SLEEP MED CLIN, V2, P293, DOI 10.1016/j.jsmc.2007.03.002; Rechtschaffen A., MANUAL STANDARDIZED; Reichmuth KJ, 2005, AM J RESP CRIT CARE, V172, P1590, DOI 10.1164/rccm.200504-637OC; Schuld A, 2000, LANCET, V355, P1274, DOI 10.1016/S0140-6736(05)74704-8; Spiegel K, 1999, LANCET, V354, P1435, DOI 10.1016/S0140-6736(99)01376-8; Takahashi Masaki, 2001, Journal of the Japan Diabetes Society, V44, P745; Tasali E, 2008, CHEST, V133, P496, DOI 10.1378/chest.07-0828; Tasali E, 2008, P NATL ACAD SCI USA, V105, P1044, DOI 10.1073/pnas.0706446105; Voderholzer U, 2003, DEPRESS ANXIETY, V17, P162, DOI 10.1002/da.10101; Walters AS, 2009, SLEEP, V32, P589, DOI 10.1093/sleep/32.5.589; Walters AS, 2003, SLEEP MED, V4, P121, DOI 10.1016/S1389-9457(02)00258-7; WOLEVER TMS, 1986, AM J CLIN NUTR, V43, P167, DOI 10.1093/ajcn/43.1.167	35	49	50	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2010	5	3							e9444	10.1371/journal.pone.0009444	http://dx.doi.org/10.1371/journal.pone.0009444			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	561RT	20209158	gold, Green Published, Green Submitted			2022-12-25	WOS:000274997100002
J	Silver, KL; Zhong, K; Leke, RGF; Taylor, DW; Kain, KC				Silver, Karlee L.; Zhong, Kathleen; Leke, Rose G. F.; Taylor, Diane Wallace; Kain, Kevin C.			Dysregulation of Angiopoietins Is Associated with Placental Malaria and Low Birth Weight	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; INTRAUTERINE GROWTH RESTRICTION; PLASMODIUM-FALCIPARUM; CHONDROITIN SULFATE; ENDOTHELIAL-CELLS; PRETERM DELIVERY; INFANT-MORTALITY; CEREBRAL MALARIA; FACTOR-ALPHA; PREGNANCY	Background: Placental malaria (PM) is associated with adverse pregnancy outcomes including low birth weight (LBW). However, the precise mechanisms by which PM induces LBW are poorly defined. Based on the essential role of angiopoietin (ANG)-1 and -2 in normal placental vascular development, we hypothesized that PM may result in the dysregulation of angiopoietins and thereby contribute to LBW outcomes. Methods and Findings: In a mouse model of PM, we show that Plasmodium berghei ANKA infection of pregnant mice resulted in dysregulated angiopoietin levels and fetal growth restriction. PM lead to decreased ANG-1, increased ANG-2, and an elevated ratio of ANG-2/ANG-1 in the placenta and the serum. These observations were extended to malaria-exposed pregnant women: In a study of primigravid women prospectively followed over the course of pregnancy, Plasmodium falciparum infection was associated with a decrease in maternal plasma ANG-1 levels (P = 0.031) and an increase in the ANG2: ANG-1 ratio (P = 0.048). ANG-1 levels recovered with successful treatment of peripheral parasitemia (P = 0.010). In a cross-sectional study of primigravidae at delivery, angiopoietin dysregulation was associated with PM (P = 0.002) and LBW (P = 0.041). Women with PM who delivered LBW infants had increased ANG-2: ANG-1 ratios (P = 0.002) compared to uninfected women delivering normal birth weight infants. Conclusions: These data support the hypothesis that dysregulation of angiopoietins is associated with PM and LBW outcomes, and suggest that ANG-1 and ANG-2 levels may be clinically informative biomarkers to identify P. falciparum-infected mothers at risk of LBW deliveries.	[Silver, Karlee L.; Zhong, Kathleen; Kain, Kevin C.] Univ Toronto, Univ Hlth Network, McLaughlin Ctr Mol Med, McLaughlin Rotman Ctr Global Hlth, Toronto, ON, Canada; [Leke, Rose G. F.] Univ Yaounde I, Fac Med & Biomed Sci, Yaounde, Cameroon; [Taylor, Diane Wallace] Georgetown Univ, Dept Biol, Washington, DC 20057 USA; [Taylor, Diane Wallace] Univ Hawaii, John A Burns Sch Med, Dept Trop Med, Honolulu, HI 96822 USA; [Kain, Kevin C.] Univ Toronto, Toronto Gen Hosp, Dept Med, Div Infect Dis,Trop Dis Unit, Toronto, ON M5G 1L7, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Yaounde I; Georgetown University; University of Hawaii System; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital	Silver, KL (corresponding author), Univ Toronto, Univ Hlth Network, McLaughlin Ctr Mol Med, McLaughlin Rotman Ctr Global Hlth, Toronto, ON, Canada.	kevin.kain@uhn.on.ca		Kain, Kevin/0000-0001-6068-1272	Canadian Institutes of Health Research (CIHR) [MT-13721]; CIHR Team Grant in Malaria (KCK); Genome Canada through the Ontario Genomics Institute (KCK); National Institute of Allergy and Infectious Diseases (NIAID); National Institutes of Health (NIH) [5UO1AI43888]; CIHR Canada Research Chair; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI043888] Funding Source: NIH RePORTER	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR Team Grant in Malaria (KCK)(Canadian Institutes of Health Research (CIHR)); Genome Canada through the Ontario Genomics Institute (KCK)(Genome Canada); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIHR Canada Research Chair(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a Canadian Institutes of Health Research (CIHR) grant (MT-13721 (KCK)), CIHR Team Grant in Malaria (KCK) and Genome Canada through the Ontario Genomics Institute (KCK). Recruitment of women in Cameroon was supported by a National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) (5UO1AI43888 (DWT)). KCK is supported as a CIHR Canada Research Chair, and KLS is supported by a CIHR Postdoctoral Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APELSARID L, 2009, ARCH GYNECOL OBSTET; Arbeille P, 2003, PARASITOLOGY, V126, P513, DOI 10.1017/S0031182003003160; Babischkin JS, 2007, PLACENTA, V28, P212, DOI 10.1016/j.placenta.2006.02.003; BOLIN M, 2009, AM J HYPERTENS; Brabin BJ, 2005, J REPROD IMMUNOL, V65, P1, DOI 10.1016/j.jri.2004.09.006; CLARK IA, 1988, AM J TROP MED HYG, V39, P246, DOI 10.4269/ajtmh.1988.39.246; Conroy A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004953; Conroy AL, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-295; Davison BB, 2006, J INFECT DIS, V194, P123, DOI 10.1086/504694; Dorman EK, 2002, ULTRASOUND OBST GYN, V19, P165, DOI 10.1046/j.0960-7692.2001.00545.x; Dunk C, 2000, AM J PATHOL, V156, P2185, DOI 10.1016/S0002-9440(10)65089-4; Fiedler U, 2004, BLOOD, V103, P4150, DOI 10.1182/blood-2003-10-3685; Fiedler U, 2006, NAT MED, V12, P235, DOI 10.1038/nm1351; Fried M, 1996, SCIENCE, V272, P1502, DOI 10.1126/science.272.5267.1502; Geva E, 2002, J CLIN ENDOCR METAB, V87, P4213, DOI 10.1210/jc.2002-020195; Guyatt HL, 2004, CLIN MICROBIOL REV, V17, P760, DOI 10.1128/CMR.17.4.760-769.2004; Guyatt HL, 2001, T ROY SOC TROP MED H, V95, P569, DOI 10.1016/S0035-9203(01)90082-3; Hegen A, 2004, ARTERIOSCL THROM VAS, V24, P1803, DOI 10.1161/01.ATV.0000140819.81839.0e; Hirokoshi K, 2005, AM J HYPERTENS, V18, P1181, DOI 10.1016/j.amjhyper.2005.03.745; Kabyemela ER, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-26; Kaufmann P, 2004, PLACENTA, V25, P114, DOI 10.1016/j.placenta.2003.10.009; Kingdom JCP, 1997, PLACENTA, V18, P613, DOI 10.1016/S0143-4004(97)90000-X; Krebs C, 1996, AM J OBSTET GYNECOL, V175, P1534, DOI 10.1016/S0002-9378(96)70103-5; Krishnegowda G, 2005, J BIOL CHEM, V280, P8606, DOI 10.1074/jbc.M413541200; Lackman F, 2001, AM J OBSTET GYNECOL, V184, P946, DOI 10.1067/mob.2001.111719; LEKE RFG, 2002, J CAMEROON ACAD SCI, V2, P203; Lovegrove FE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004912; Lucchi NW, 2006, PLACENTA, V27, P384, DOI 10.1016/j.placenta.2005.04.009; MacDorman M F, 1999, Natl Vital Stat Rep, V47, P1; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Mayhew TM, 2003, PLACENTA, V24, P219, DOI 10.1053/plac.2002.0900; MCCORMICK MC, 1985, NEW ENGL J MED, V312, P82, DOI 10.1056/NEJM198501103120204; McElrath TF, 2008, AM J EPIDEMIOL, V168, P980, DOI 10.1093/aje/kwn202; Morken NH, 2006, AM J OBSTET GYNECOL, V195, P154, DOI 10.1016/j.ajog.2006.01.019; Muehlenbachs A, 2006, PLOS MED, V3, P2124, DOI 10.1371/journal.pmed.0030446; Muthusamy A, 2007, AM J PATHOL, V170, P1989, DOI 10.2353/ajpath.2007.061238; Nebl T, 2005, PARASITOLOGY, V130, pS45, DOI 10.1017/S0031182005008152; Neres R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001608; Oh H, 1999, J BIOL CHEM, V274, P15732, DOI 10.1074/jbc.274.22.15732; Ong S, 2000, BEST PRACT RES CL OB, V14, P969, DOI 10.1053/beog.2000.0138; Ordi J, 1998, AM J SURG PATHOL, V22, P1006, DOI 10.1097/00000478-199808000-00011; Poovassery JS, 2009, J IMMUNOL, V183, P5342, DOI 10.4049/jimmunol.0901669; Rogerson SJ, 2003, INFECT IMMUN, V71, P267, DOI 10.1128/IAI.71.1.267-270.2003; Romero R, 2006, BJOG-INT J OBSTET GY, V113, P17, DOI 10.1111/j.1471-0528.2006.01120.x; Schiessl B, 2009, PLACENTA, V30, P79, DOI 10.1016/j.placenta.2008.10.004; Seval Y, 2008, PLACENTA, V29, P809, DOI 10.1016/j.placenta.2008.06.009; Steketee RW, 2001, AM J TROP MED HYG, V64, P28, DOI 10.4269/ajtmh.2001.64.28; Suguitan AL, 2003, J INFECT DIS, V188, P1074, DOI 10.1086/378500; Sullivan AD, 1999, J INFECT DIS, V179, P1580, DOI 10.1086/314752; Tako EA, 2005, AM J TROP MED HYG, V72, P236, DOI 10.4269/ajtmh.2005.72.236; Thevenon AD, 2009, INFECT IMMUN, V77, P1483, DOI 10.1128/IAI.01069-08; Thurston G, 2000, NAT MED, V6, P460, DOI 10.1038/74725; Thurston G, 1999, SCIENCE, V286, P2511, DOI 10.1126/science.286.5449.2511; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang Y, 2007, BJOG-INT J OBSTET GY, V114, P1427, DOI 10.1111/j.1471-0528.2007.01511.x; Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215; Yeo TW, 2008, P NATL ACAD SCI USA, V105, P17097, DOI 10.1073/pnas.0805782105; Yuan HT, 2009, MOL CELL BIOL, V29, P2011, DOI 10.1128/MCB.01472-08; Zhou Y, 2003, DEV BIOL, V263, P114, DOI 10.1016/S0012-1606(03)00449-4	59	51	51	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2010	5	3							e9481	10.1371/journal.pone.0009481	http://dx.doi.org/10.1371/journal.pone.0009481			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	561RT	20208992	Green Published, gold, Green Submitted			2022-12-25	WOS:000274997100020
J	Androutsellis-Theotokis, A; Rueger, MA; Park, DM; Boyd, JD; Padmanabhan, R; Campanati, L; Stewart, CV; LeFranc, Y; Plenz, D; Walbridge, S; Lonser, RR; McKay, RDG				Androutsellis-Theotokis, Andreas; Rueger, Maria A.; Park, Deric M.; Boyd, Justin D.; Padmanabhan, Raji; Campanati, Loraine; Stewart, Craig V.; LeFranc, Yann; Plenz, Dietmar; Walbridge, Stuart; Lonser, Russell R.; McKay, Ronald D. G.			Angiogenic Factors Stimulate Growth of Adult Neural Stem Cells	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; SUBVENTRICULAR ZONE; IN-VIVO; DENTATE GYRUS; PROGENITOR PROLIFERATION; MAMMALIAN FOREBRAIN; ISCHEMIC-STROKE; MOUSE BRAIN; NEUROGENESIS; NEURONS	Background: The ability to grow a uniform cell type from the adult central nervous system (CNS) is valuable for developing cell therapies and new strategies for drug discovery. The adult mammalian brain is a source of neural stem cells (NSC) found in both neurogenic and non-neurogenic zones but difficulties in culturing these hinders their use as research tools [1,2,3,4,5,6]. Methodology/Principal Findings: Here we show that NSCs can be efficiently grown in adherent cell cultures when angiogenic signals are included in the medium. These signals include both anti-angiogenic factors (the soluble form of the Notch receptor ligand, DII4) and pro-angiogenic factors (the Tie-2 receptor ligand, Angiopoietin 2). These treatments support the self renewal state of cultured NSCs and expression of the transcription factor Hes3, which also identifies the cancer stem cell population in human tumors. In an organotypic slice model, angiogenic factors maintain vascular structure and increase the density of dopamine neuron processes. Conclusions/Significance: We demonstrate new properties of adult NSCs and a method to generate efficient adult NSC cultures from various central nervous system areas. These findings will help establish cellular models relevant to cancer and regeneration.	[Androutsellis-Theotokis, Andreas; Rueger, Maria A.; Park, Deric M.; Boyd, Justin D.; Campanati, Loraine; McKay, Ronald D. G.] NCI, Mol Biol Lab, NIH, Bethesda, MD 20892 USA; [Walbridge, Stuart; Lonser, Russell R.] NINDS, Surg Neurol Branch, NIH, Bethesda, MD 20892 USA; [Stewart, Craig V.; LeFranc, Yann; Plenz, Dietmar] NIMH, Lab Syst Neurosci, NIH, Bethesda, MD 20892 USA; [Padmanabhan, Raji] NCI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Androutsellis-Theotokis, A (corresponding author), Acad Athens, Biomed Res Fdn, Athens, Greece.	AndreasTheotokis@gmail.com	Park, Deric/C-5675-2013; Campanati, Loraine/V-2632-2018; Neurociencia, Inct/I-1011-2013	Campanati, Loraine/0000-0001-9172-1951; Boyd, Justin/0000-0002-5197-4724; Androutsellis-Theotokis, Andreas/0000-0002-1985-4589	National Institute of Neurological Disorders; Stroke at the National Institutes of Health; Michael J. Fox Foundation; National Parkinson's Foundation; Tuchman Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002797] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002981, ZIANS003051, ZIANS002881] Funding Source: NIH RePORTER	National Institute of Neurological Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Stroke at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Michael J. Fox Foundation; National Parkinson's Foundation; Tuchman Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Intramural Research Program of the National Institute of Neurological Disorders and Stroke at the National Institutes of Health, the Michael J. Fox Foundation, the National Parkinson's Foundation, and the Tuchman Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Androutsellis-Theotokis A, 2008, COLD SH Q B, V73, P403, DOI 10.1101/sqb.2008.73.018; Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Androutsellis-Theotokis A, 2009, P NATL ACAD SCI USA, V106, P13570, DOI 10.1073/pnas.0905125106; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Arboleda-Velasquez JF, 2008, P NATL ACAD SCI USA, V105, P4856, DOI 10.1073/pnas.0709867105; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Bull ND, 2005, J NEUROSCI, V25, P10815, DOI 10.1523/JNEUROSCI.3249-05.2005; CAMERON HA, 1993, NEUROSCIENCE, V56, P337, DOI 10.1016/0306-4522(93)90335-D; Craig CG, 1996, J NEUROSCI, V16, P2649; Curtis MA, 2003, P NATL ACAD SCI USA, V100, P9023, DOI 10.1073/pnas.1532244100; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Duarte A, 2004, GENE DEV, V18, P2474, DOI 10.1101/gad.1239004; FREDERIKSEN K, 1988, J NEUROSCI, V8, P1144; Holmberg J, 2005, GENE DEV, V19, P462, DOI 10.1101/gad.326905; Jackson EL, 2006, NEURON, V51, P187, DOI 10.1016/j.neuron.2006.06.012; Jiao JW, 2008, P NATL ACAD SCI USA, V105, P8778, DOI 10.1073/pnas.0708861105; Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Kuo CT, 2006, CELL, V127, P1253, DOI 10.1016/j.cell.2006.10.041; Lee A, 2005, NAT NEUROSCI, V8, P723, DOI 10.1038/nn1473; Liu JL, 1998, J NEUROSCI, V18, P7768; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; Magavi SS, 2000, NATURE, V405, P951, DOI 10.1038/35016083; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Martens DJ, 2002, EUR J NEUROSCI, V16, P1045, DOI 10.1046/j.1460-9568.2002.02181.x; Miraglia S, 1997, BLOOD, V90, P5013, DOI 10.1182/blood.V90.12.5013.5013_5013_5021; Mizutani K, 2007, NATURE, V449, P351, DOI 10.1038/nature06090; MORSHEAD CM, 1994, NEURON, V13, P1071, DOI 10.1016/0896-6273(94)90046-9; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; Nyfeler Y, 2005, EMBO J, V24, P3504, DOI 10.1038/sj.emboj.7600816; Plenz D, 1998, J NEUROSCI, V18, P266; Pola R, 2001, NAT MED, V7, P706, DOI 10.1038/89083; Ravin R, 2008, CELL STEM CELL, V3, P670, DOI 10.1016/j.stem.2008.09.012; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Routsellis-Theotokis Andreas, 2008, V438, P31, DOI 10.1007/978-1-59745-133-8_4; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; Taupin P, 2002, J NEUROSCI RES, V69, P745, DOI 10.1002/jnr.10378; Uemura A, 2002, J CLIN INVEST, V110, P1619, DOI 10.1172/JCI200215621; Weigmann A, 1997, P NATL ACAD SCI USA, V94, P12425, DOI 10.1073/pnas.94.23.12425; Zappone MV, 2000, DEVELOPMENT, V127, P2367; Zhang RL, 2008, NEUROPHARMACOLOGY, V55, P345, DOI 10.1016/j.neuropharm.2008.05.027	44	36	39	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2010	5	2							e9414	10.1371/journal.pone.0009414	http://dx.doi.org/10.1371/journal.pone.0009414			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	561RS	20195471	gold, Green Published, Green Submitted			2022-12-25	WOS:000274997000007
J	Gao, N; Kumar, A; Jyot, J; Yu, FS				Gao, Nan; Kumar, Ashok; Jyot, Jeevan; Yu, Fu-Shin			Flagellin-Induced Corneal Antimicrobial Peptide Production and Wound Repair Involve a Novel NF-kappa B-Independent and EGFR-Dependent Pathway	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; PSEUDOMONAS-AERUGINOSA FLAGELLIN; INNATE IMMUNE-RESPONSE; GROWTH-FACTOR RECEPTOR; EPITHELIAL INFLAMMATORY RESPONSES; URINARY-TRACT-INFECTION; HB-EGF; BACTERIAL FLAGELLIN; MD-2 EXPRESSION; GENE-EXPRESSION	Background: The bacterial protein flagellin plays a major role in stimulating mucosal surface innate immune response to bacterial infection and uniquely induces profound cytoprotection against pathogens, chemicals, and radiation. This study sought to determine signaling pathways responsible for the flagellin-induced inflammatory and cytoprotective effects on human corneal epithelial cells (HCECs). Methodology/Principal Findings: Flagellin purified from Pseudomonas aeruginosa (strain PAK) or live bacteria were used to challenge cultured HCECs. The activation of signaling pathways was assessed with Western blot, and the secretion of cytokine/chemokine and production of antimicrobial peptides (AMPs) were measured with ELISA and dot blot, respectively. Effects of flagellin on wound healing were assessed in cultured porcine corneas. L94A (a site mutation in TLR5 binding region) flagellin and PAK expressing L94A flagellin were unable to stimulate NF-kappa B activation, but were potent in eliciting EGFR signaling in a TGF-alpha-related pathway in HCECs. Concomitant with the lack of NF-kappa B activation, L94A flagellin was ineffective in inducing IL-6 and IL-8 production in HCECs. Surprisingly, the secretion of two inducible AMPs, LL-37 and hBD2, was not affected by L94A mutation. Similar to wild-type flagellin, L94A induced epithelial wound closure in cultured porcine cornea through maintaining EGFR-mediated signaling. Conclusions/Significance: Our data suggest that inflammatory response mediated by NF-kappa B can be uncoupled from epithelial innate defense machinery (i e., AMP expression) and major epithelial proliferation/repair pathways mediated by EGFR, and that flagellin and its derivatives may have broad therapeutic applications in cytoprotection and in controlling infection in the cornea and other mucosal tissues.	[Gao, Nan; Kumar, Ashok; Yu, Fu-Shin] Wayne State Univ, Sch Med, Dept Ophthalmol, Detroit, MI 48202 USA; [Gao, Nan; Kumar, Ashok; Yu, Fu-Shin] Wayne State Univ, Sch Med, Dept Anat, Detroit, MI USA; [Gao, Nan; Kumar, Ashok; Yu, Fu-Shin] Wayne State Univ, Sch Med, Dept Cell Biol, Detroit, MI USA; [Jyot, Jeevan] Univ Florida, Dept Med Infect Dis, Gainesville, FL USA	Wayne State University; Wayne State University; Wayne State University; State University System of Florida; University of Florida	Gao, N (corresponding author), Wayne State Univ, Sch Med, Dept Ophthalmol, Detroit, MI 48202 USA.	fyu@med.wayne.edu			NIH [R01 EY017960, EY010869, P30EY004068]; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [P30EY004068, R01EY017960, R01EY010869] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by NIH grants R01 EY017960, EY010869, as well as P30EY004068 and Research to Prevent Blindness (Unrestricted grant to KEI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu MT, 2002, J BIOL CHEM, V277, P20431, DOI 10.1074/jbc.M110333200; Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Andersen-Nissen E, 2007, J IMMUNOL, V178, P4717, DOI 10.4049/jimmunol.178.8.4717; Bhattacharjee Y, 2008, SCIENCE, V320, P163, DOI 10.1126/science.320.5873.163; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Burdelya LG, 2008, SCIENCE, V320, P226, DOI 10.1126/science.1154986; CAMPODONICO VL, 2009, INFECT IMMUN; Cheng KH, 1999, LANCET, V354, P181, DOI 10.1016/S0140-6736(98)09385-4; Diamond G, 2008, J DENT RES, V87, P915, DOI 10.1177/154405910808701011; DIMANGO E, 1995, J CLIN INVEST, V96, P2204, DOI 10.1172/JCI118275; Du JW, 2006, INVEST OPHTH VIS SCI, V47, P4810, DOI 10.1167/iovs.06-0250; Feldman M, 1998, INFECT IMMUN, V66, P43, DOI 10.1128/IAI.66.1.43-51.1998; Feuillet V, 2006, P NATL ACAD SCI USA, V103, P12487, DOI 10.1073/pnas.0605200103; Franchi L, 2007, EUR J IMMUNOL, V37, P3030, DOI 10.1002/eji.200737532; Gewirtz AT, 2001, J IMMUNOL, V167, P1882, DOI 10.4049/jimmunol.167.4.1882; Gipson IK, 2003, INVEST OPHTH VIS SCI, V44, P2496, DOI 10.1167/iovs.02-0851; Hazlett LD, 2004, PROG RETIN EYE RES, V23, P1, DOI 10.1016/j.preteyeres.2003.10.002; Hazlett Linda D, 2007, Chem Immunol Allergy, V92, P185, DOI 10.1159/000099269; Higashiyama S, 2005, BBA-PROTEINS PROTEOM, V1751, P110, DOI 10.1016/j.bbapap.2004.11.009; Higashiyama S, 2008, CANCER SCI, V99, P214, DOI 10.1111/j.1349-7006.2007.00676.x; Holgate ST, 2007, TRENDS IMMUNOL, V28, P248, DOI 10.1016/j.it.2007.04.007; Jia HP, 2004, AM J PHYSIOL-LUNG C, V287, pL428, DOI 10.1152/ajplung.00377.2003; Koff JL, 2008, AM J PHYSIOL-LUNG C, V294, pL1068, DOI 10.1152/ajplung.00025.2008; Kumar A, 2006, MICROBES INFECT, V8, P380, DOI 10.1016/j.micinf.2005.07.006; Kumar A, 2008, INFECT IMMUN, V76, P89, DOI 10.1128/IAI.01232-07; Kumar A, 2007, INVEST OPHTH VIS SCI, V48, P4664, DOI 10.1167/iovs.07-0473; Kumar H, 2009, BIOCHEM BIOPH RES CO, V388, P621, DOI 10.1016/j.bbrc.2009.08.062; Lai Yuping, 2008, Infectious Disorders - Drug Targets, V8, P144; Liu K, 2008, J BIOL CHEM, V283, P9977, DOI 10.1074/jbc.M710257200; Lyons S, 2004, J CELL SCI, V117, P5771, DOI 10.1242/jcs.01500; Mayer AK, 2007, ARCH IMMUNOL THER EX, V55, P353, DOI 10.1007/s00005-007-0041-7; McDermott AM, 2009, OPHTHALMIC RES, V41, P60, DOI 10.1159/000187622; McNamara N, 2006, AM J RESP CELL MOL, V34, P653, DOI 10.1165/rcmb.2005-0441OC; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Miao EA, 2008, P NATL ACAD SCI USA, V105, P2562, DOI 10.1073/pnas.0712183105; Michelsen KS, 2007, CURR OPIN HEMATOL, V14, P48, DOI 10.1097/00062752-200701000-00010; Naik S, 2001, J PEDIATR GASTR NUTR, V32, P449, DOI 10.1097/00005176-200104000-00011; Ni MJ, 2008, FEMS IMMUNOL MED MIC, V54, P177, DOI 10.1111/j.1574-695X.2008.00461.x; Ramos HC, 2004, TRENDS MICROBIOL, V12, P509, DOI 10.1016/j.tim.2004.09.002; Randhawa AK, 2008, EXPERT REV ANTI-INFE, V6, P479, DOI 10.1586/14787210.6.4.479; Rhee SH, 2005, P NATL ACAD SCI USA, V102, P13610, DOI 10.1073/pnas.0502174102; Rheinwald JG, 2002, MOL CELL BIOL, V22, P5157, DOI 10.1128/MCB.22.14.5157-5172.2002; Roepstorff K, 2009, TRAFFIC, V10, P1115, DOI 10.1111/j.1600-0854.2009.00943.x; RUDNER XWL, 1992, CURR EYE RES, V11, P727, DOI 10.3109/02713689209000747; Sanders CJ, 2009, EUR J IMMUNOL, V39, P359, DOI 10.1002/eji.200838804; Shaykhiev R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001393; Sibilia M, 2007, DIFFERENTIATION, V75, P770, DOI 10.1111/j.1432-0436.2007.00238.x; Smith KD, 2003, NAT IMMUNOL, V4, P1247, DOI 10.1038/ni1011; Steiner TS, 2007, INFECT IMMUN, V75, P545, DOI 10.1128/IAI.01506-06; Steiner TS, 2000, J CLIN INVEST, V105, P1769, DOI 10.1172/JCI8892; Tseng J, 2006, AM J PHYSIOL-CELL PH, V290, pC678, DOI 10.1152/ajpcell.00166.2005; Uematsu S, 2006, NAT IMMUNOL, V7, P868, DOI 10.1038/ni1362; Verma A, 2005, INFECT IMMUN, V73, P8237, DOI 10.1128/IAI.73.12.8237-8246.2005; Vijay-Kumar M, 2008, J IMMUNOL, V180, P8280, DOI 10.4049/jimmunol.180.12.8280; Weichhart T, 2008, EUR J CLIN INVEST, V38, P29, DOI 10.1111/j.1365-2362.2008.02006.x; Xu KP, 2007, INVEST OPHTH VIS SCI, V48, P636, DOI 10.1167/iovs.06-0203; Xu KP, 2004, INVEST OPHTH VIS SCI, V45, P813, DOI 10.1167/iovs.03-0851; Yin J, 2009, INVEST OPHTH VIS SCI, V50, P132, DOI 10.1167/iovs.08-2246; Yin J, 2007, J CELL SCI, V120, P815, DOI 10.1242/jcs.03389; Yu FSX, 2006, INVEST OPHTH VIS SCI, V47, P1255, DOI 10.1167/iovs.05-0956; Zhang J, 2003, INVEST OPHTH VIS SCI, V44, P4247, DOI 10.1167/iovs.03-0219; Zhang J, 2009, IMMUNOL CELL BIOL, V87, P141, DOI 10.1038/icb.2008.75; Zhang Z, 2005, INFECT IMMUN, V73, P7151, DOI 10.1128/IAI.73.11.7151-7160.2005; Zhu L, 2009, AM J RESP CELL MOL, V40, P610, DOI 10.1165/rcmb.2008-0223OC	64	30	30	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2010	5	2							e9351	10.1371/journal.pone.0009351	http://dx.doi.org/10.1371/journal.pone.0009351			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	561RS	20195469	Green Submitted, Green Published, gold			2022-12-25	WOS:000274997000002
J	Tong, JC; Simarmata, D; Lin, RTP; Renia, L; Ng, LFP				Tong, Joo Chuan; Simarmata, Diane; Lin, Raymond T. P.; Renia, Laurent; Ng, Lisa F. P.			HLA Class I Restriction as a Possible Driving Force for Chikungunya Evolution	PLOS ONE			English	Article							T-CELL EPITOPES; VIRUS-INFECTION; DENGUE; REEMERGENCE; THAILAND; SEQUENCE; FEATURES; DATABASE; BIOLOGY; BINDING	After two decades of quiescence, epidemic resurgence of Chikungunya fever (CHIKF) was reported in Africa, several islands in the Indian Ocean, South-East Asia and the Pacific causing unprecedented morbidity with some cases of fatality. Early phylogenetic analyses based on partial sequences of Chikungunya virus (CHIKV) have led to speculation that the virus behind recent epidemics may result in greater pathogenicity. To understand the reasons for these new epidemics, we first performed extensive analyses of existing CHIKV sequences from its introduction in 1952 to 2009. Our results revealed the existence of a continuous genotypic lineage, suggesting selective pressure is active in CHIKV evolution. We further showed that CHIKV is undergoing mild positive selection, and that site-specific mutations may be driven by cell-mediated immune pressure, with occasional changes that resulted in the loss of human leukocyte antigen (HLA) class I-restricting elements. These findings provide a basis to understand Chikungunya virus evolution and reveal the power of post-genomic analyses to understand CHIKV and other viral epidemiology. Such an approach is useful for studying the impact of host immunity on pathogen evolution, and may help identify appropriate antigens suitable for subunit vaccine formulations.	[Tong, Joo Chuan] Inst Infocomm Res, Data Min Dept, Singapore, Singapore; [Tong, Joo Chuan; Ng, Lisa F. P.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore; [Simarmata, Diane; Renia, Laurent; Ng, Lisa F. P.] Singapore Immunol Network, Singapore, Singapore; [Lin, Raymond T. P.] Minist Hlth, Communicable Dis Div, Natl Publ Hlth Lab, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute for Infocomm Research (I2R); National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); Ministry of Health-Singapore	Tong, JC (corresponding author), Inst Infocomm Res, Data Min Dept, Singapore, Singapore.	jctong@i2r.a-star.edu.sg; lisa_ng@immunol.a-star.edu.sg	Renia, Laurent/E-2117-2011	Renia, Laurent/0000-0003-0349-1557; Ng, Lisa/0000-0003-4071-5222	Agency of Science, Technology and Research (A*STAR)	Agency of Science, Technology and Research (A*STAR)(Agency for Science Technology & Research (A*STAR))	The work was supported by a joint council office (JCO) research grant of the Agency of Science, Technology and Research (A*STAR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbuBakar S, 2007, EMERG INFECT DIS, V13, P147, DOI 10.3201/eid1301.060617; Arankalle VA, 2007, J GEN VIROL, V88, P1967, DOI 10.1099/vir.0.82714-0; BARNARD JM, 1992, J CHEM INF COMP SCI, V32, P644, DOI 10.1021/ci00010a010; Beltrame A, 2007, EMERG INFECT DIS, V13, P1264, DOI 10.3201/eid1308.070161; Benson DA, 2006, NUCLEIC ACIDS RES, V34, pD16, DOI 10.1093/nar/gkj157; BERTOLETTI A, 1994, NATURE, V369, P407, DOI 10.1038/369407a0; Bhattacharya T, 2007, SCIENCE, V315, P1583, DOI 10.1126/science.1131528; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; BOORMAN JPT, 1968, T ROY SOC TROP MED H, V62, P269, DOI 10.1016/0035-9203(68)90168-5; Borgherini G, 2007, CLIN INFECT DIS, V44, P1401, DOI 10.1086/517537; Bouvier NM, 2008, VACCINE, V26, pD49, DOI 10.1016/j.vaccine.2008.07.039; Bui HH, 2005, IMMUNOGENETICS, V57, P304, DOI 10.1007/s00251-005-0798-y; Chevillon C, 2008, TRENDS MICROBIOL, V16, P80, DOI 10.1016/j.tim.2007.12.003; DECAMPOSLIMA PO, 1994, J EXP MED, V179, P1297, DOI 10.1084/jem.179.4.1297; Dudley ME, 2003, NAT REV CANCER, V3, P666, DOI 10.1038/nrc1167; HALSTEAD SB, 1969, AM J TROP MED HYG, V18, P1022, DOI 10.4269/ajtmh.1969.18.1022; HALSTEAD SB, 1969, AM J TROP MED HYG, V18, P997, DOI 10.4269/ajtmh.1969.18.997; HALSTEAD SB, 1966, B WORLD HEALTH ORGAN, V35, P3; Jaffar-Bandjee MC, 2009, MICROBES INFECT, V11, P1206, DOI 10.1016/j.micinf.2009.10.001; Kam YW, 2009, MICROBES INFECT, V11, P1186, DOI 10.1016/j.micinf.2009.09.003; Khan AH, 2002, J GEN VIROL, V83, P3075, DOI 10.1099/0022-1317-83-12-3075; Khan AM, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S5-S4; KLENERMAN P, 1994, NATURE, V369, P403, DOI 10.1038/369403a0; Kowalzik S, 2008, MED MICROBIOL IMMUN, V197, P381, DOI 10.1007/s00430-008-0090-5; Lakshmi V, 2008, CLIN INFECT DIS, V46, P1436, DOI 10.1086/529444; Laras K, 2005, T ROY SOC TROP MED H, V99, P128, DOI 10.1016/j.trstmh.2004.03.013; Lemant J, 2008, CRIT CARE MED, V36, P2536, DOI 10.1097/CCM.0b013e318183f2d2; LUMSDEN W. H. R., 1955, TANGANYIKA TERRITORY IN 1952 53 II TRANS ROY SOC TROP MED AND HYG, V49, P33, DOI 10.1016/0035-9203(55)90081-X; Middleton D, 2003, TISSUE ANTIGENS, V61, P403, DOI 10.1034/j.1399-0039.2003.00062.x; NEI M, 1986, MOL BIOL EVOL, V3, P418; Ng LC, 2009, EMERG INFECT DIS, V15, P1243, DOI 10.3201/eid1508.081486; Nielsen M, 2003, PROTEIN SCI, V12, P1007, DOI 10.1110/ps.0239403; Parham P, 1996, SCIENCE, V272, P67, DOI 10.1126/science.272.5258.67; Parola P, 2006, EMERG INFECT DIS, V12, P1493, DOI 10.3201/eid1210.060610; Pastorino B, 2004, J MED VIROL, V74, P277, DOI 10.1002/jmv.20168; Peters B, 2005, PLOS BIOL, V3, P379, DOI 10.1371/journal.pbio.0030091; Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X; RAO T. R., 1966, Science and Culture, V32, P215; ROBINSON M C, 1955, Trans R Soc Trop Med Hyg, V49, P28, DOI [10.1016/0035-9203(57)90022-6, 10.1016/0035-9203(55)90080-8]; Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263; SHANNON CE, 1951, BELL SYST TECH J, V30, P50, DOI 10.1002/j.1538-7305.1951.tb01366.x; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; SURTEES G, 1970, T ROY SOC TROP MED H, V64, P511, DOI 10.1016/0035-9203(70)90071-4; Suzuki Y, 1999, MOL BIOL EVOL, V16, P1315, DOI 10.1093/oxfordjournals.molbev.a026042; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201; Tsetsarkin KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006835; Udhayakumar V, 1997, EUR J IMMUNOL, V27, P1952, DOI 10.1002/eji.1830270819; WHO, 2006, WKLY EPIDEMIOL REC, V81, P105; Zhang Q, 2008, NUCLEIC ACIDS RES, V36, pW513, DOI 10.1093/nar/gkn254	50	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2010	5	2							e9291	10.1371/journal.pone.0009291	http://dx.doi.org/10.1371/journal.pone.0009291			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	561RS	20195467	gold, Green Published, Green Submitted			2022-12-25	WOS:000274997000001
J	Hofreiter, M; Kreuz, E; Eriksson, J; Schubert, G; Hohmann, G				Hofreiter, Michael; Kreuz, Eva; Eriksson, Jonas; Schubert, Grit; Hohmann, Gottfried			Vertebrate DNA in Fecal Samples from Bonobos and Gorillas: Evidence for Meat Consumption or Artefact?	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; SALONGA NATIONAL-PARK; PAN-PANISCUS; WILD CHIMPANZEES; ANCIENT DNA; IDENTIFICATION; TROGLODYTES; COOPERATION; BEHAVIOR; DIET	Background: Deciphering the behavioral repertoire of great apes is a challenge for several reasons. First, due to their elusive behavior in dense forest environments, great ape populations are often difficult to observe. Second, members of the genus Pan are known to display a great variety in their behavioral repertoire; thus, observations from one population are not necessarily representative for other populations. For example, bonobos (Pan paniscus) are generally believed to consume almost no vertebrate prey. However, recent observations show that at least some bonobo populations may consume vertebrate prey more commonly than previously believed. We investigated the extent of their meat consumption using PCR amplification of vertebrate mitochondrial DNA (mtDNA) segments from DNA extracted from bonobo feces. As a control we also attempted PCR amplifications from gorilla feces, a species assumed to be strictly herbivorous. Principal Findings: We found evidence for consumption of a variety of mammalian species in about 16% of the samples investigated. Moreover, 40% of the positive DNA amplifications originated from arboreal monkeys. However, we also found duiker and monkey mtDNA in the gorilla feces, albeit in somewhat lower percentages. Notably, the DNA sequences isolated from the two ape species fit best to the species living in the respective regions. This result suggests that the sequences are of regional origin and do not represent laboratory contaminants. Conclusions: Our results allow at least three possible and mutually not exclusive conclusions. First, all results may represent contamination of the feces by vertebrate DNA from the local environment. Thus, studies investigating a species' diet from feces DNA may be unreliable due to the low copy number of DNA originating from diet items. Second, there is some inherent difference between the bonobo and gorilla feces, with only the later ones being contaminated. Third, similar to bonobos, for which the consumption of monkeys has only recently been documented, the gorilla population investigated (for which very little observational data are as yet available) may occasionally consume small vertebrates. Although the last explanation is speculative, it should not be discarded a-priori given that observational studies continue to unravel new behaviors in great ape species.	[Hofreiter, Michael; Kreuz, Eva] Max Planck Inst Evolutionary Anthropol, Res Grp Mol Ecol, Leipzig, Germany; [Hofreiter, Michael] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England; [Eriksson, Jonas; Schubert, Grit; Hohmann, Gottfried] Max Planck Inst Evolutionary Anthropol, Dept Primatol, Leipzig, Germany; [Eriksson, Jonas] Uppsala Univ, EBC, Uppsala, Sweden	Max Planck Society; University of York - UK; Max Planck Society; Uppsala University	Hofreiter, M (corresponding author), Max Planck Inst Evolutionary Anthropol, Res Grp Mol Ecol, Leipzig, Germany.	msh503@york.ac.uk	Hofreiter, Michael/A-3996-2017	Hofreiter, Michael/0000-0003-0441-4705	Max Planck Society	Max Planck Society(Max Planck Society)	This work was funded by the Max Planck Society (http://www.mpg.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BOESCH C, 1994, ANIM BEHAV, V48, P653, DOI 10.1006/anbe.1994.1285; Boesch C, 2002, BEHAVIOURAL DIVERSITY IN CHIMPANZEES AND BONOBOS, P1, DOI 10.1017/CBO9780511606397.002; Deagle BE, 2005, MOL ECOL, V14, P1831, DOI 10.1111/j.1365-294X.2005.02531.x; Doran DM, 2002, BEHAVIOURAL DIVERSITY IN CHIMPANZEES AND BONOBOS, P14, DOI 10.1017/CBO9780511606397.004; FURUICHI T, 1994, BEHAVIOUR, V130, P211, DOI 10.1163/156853994X00532; Gilbert MTP, 2005, TRENDS ECOL EVOL, V20, P541, DOI 10.1016/j.tree.2005.07.005; Goodall J., 1986, CHIMPANZEES GOMBE PA; HOHMANN G, 1993, FOLIA PRIMATOL, V60, P225, DOI 10.1159/000156695; Hohmann G., 1996, FOOD STATUS QUEST, P47; Hohmann G., 2003, PAN AFRICAN NEWS, V10; Hohmann G, 2008, FOLIA PRIMATOL, V79, P103, DOI 10.1159/000110679; IHOBE H, 1992, PRIMATES, V33, P247, DOI 10.1007/BF02382754; Kano T., 1992, LAST APE PYGMY CHIMP; Kilger C, 1997, BIOTECHNIQUES, V22, P412, DOI 10.2144/97223bm08; KWOK S, 1990, NUCLEIC ACIDS RES, V18, P999, DOI 10.1093/nar/18.4.999; Leonard JA, 2007, J ARCHAEOL SCI, V34, P1361, DOI 10.1016/j.jas.2006.10.023; McGrew William, 2004, CULTURED CHIMPANZEE; Milton K, 1999, EVOL ANTHROPOL, V8, P11, DOI 10.1002/(SICI)1520-6505(1999)8:1<11::AID-EVAN6>3.3.CO;2-D; Mitani JC, 2000, ANIM BEHAV, V59, P885, DOI 10.1006/anbe.1999.1389; Morin PA, 2001, MOL ECOL, V10, P1835, DOI 10.1046/j.0962-1083.2001.01308.x; Murphy MA, 2003, MOL ECOL, V12, P2261, DOI 10.1046/j.1365-294X.2003.01863.x; Nishida Toshisada, 1996, P114, DOI 10.1017/CBO9780511752414.011; Nsubuga AM, 2004, MOL ECOL, V13, P2089, DOI 10.1111/j.1365-294X.2004.02207.x; Paabo S, 2004, ANNU REV GENET, V38, P645, DOI 10.1146/annurev.genet.37.110801.143214; Parish AR, 1996, HUM NATURE-INT BIOS, V7, P61, DOI 10.1007/BF02733490; POPOVICH DG, 1997, MANAGEMENT GORILLAS, P138; Shanks OC, 2005, J ARCHAEOL SCI, V32, P27, DOI 10.1016/j.jas.2004.06.004; Stanford CB, 1996, AM ANTHROPOL, V98, P96, DOI 10.1525/aa.1996.98.1.02a00090; Stanford CB, 1998, BEHAVIOUR, V135, P513, DOI 10.1163/156853998793066212; Surbeck M, 2008, CURR BIOL, V18, pR906, DOI 10.1016/j.cub.2008.08.040; Surbeck M, 2009, AM J PRIMATOL, V71, P171, DOI 10.1002/ajp.20634; TUTIN CEG, 1992, AM J PRIMATOL, V28, P29, DOI 10.1002/ajp.1350280103; Vervaecke H, 2000, PRIMATES, V41, P249, DOI 10.1007/BF02557595; Watts DP, 2002, INT J PRIMATOL, V23, P1, DOI 10.1023/A:1013270606320; Whiten A, 1999, NATURE, V399, P682, DOI 10.1038/21415; Wrangham R.W., 1986, P352; [No title captured]	38	21	21	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2010	5	2							e9419	10.1371/journal.pone.0009419	http://dx.doi.org/10.1371/journal.pone.0009419			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SY	20195539	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000274924300009
J	Brochu, CA; Njau, J; Blumenschine, RJ; Densmore, LD				Brochu, Christopher A.; Njau, Jackson; Blumenschine, Robert J.; Densmore, Llewellyn D.			A New Horned Crocodile from the Plio-Pleistocene Hominid Sites at Olduvai Gorge, Tanzania	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; CROCODYLUS-NILOTICUS; LATE NEOGENE; LAND-USE; HOMO; VERTEBRATE; MORPHOLOGY; MITOCHONDRIAL; DIVERGENCE; MADAGASCAR	Background: The fossil record reveals surprising crocodile diversity in the Neogene of Africa, but relationships with their living relatives and the biogeographic origins of the modern African crocodylian fauna are poorly understood. A Plio-Pleistocene crocodile from Olduvai Gorge, Tanzania, represents a new extinct species and shows that high crocodylian diversity in Africa persisted after the Miocene. It had prominent triangular "horns'' over the ears and a relatively deep snout, these resemble those of the recently extinct Malagasy crocodile Voay robustus, but the new species lacks features found among osteolaemines and shares derived similarities with living species of Crocodylus. Methodology/Principal Findings: The holotype consists of a partial skull and skeleton and was collected on the surface between two tuffs dated to approximately 1.84 million years (Ma), in the same interval near the type localities for the hominids Homo habilis and Australopithecus boisei. It was compared with previously-collected material from Olduvai Gorge referable to the same species. Phylogenetic analysis places the new form within or adjacent to crown Crocodylus. Conclusions/Significance: The new crocodile species was the largest predator encountered by our ancestors at Olduvai Gorge, as indicated by hominid specimens preserving crocodile bite marks from these sites. The new species also reinforces the emerging view of high crocodylian diversity throughout the Neogene, and it represents one of the few extinct species referable to crown genus Crocodylus.	[Brochu, Christopher A.] Univ Iowa, Dept Geosci, Iowa City, IA 52242 USA; [Njau, Jackson] Univ Calif Berkeley, Dept Integrat Biol, Human Evolut Res Ctr, Berkeley, CA 94720 USA; [Njau, Jackson] Natl Museum Nat Hist, Arusha, Tanzania; [Blumenschine, Robert J.] Rutgers State Univ, Dept Anthropol, Ctr Human Evolutionary Studies, New Brunswick, NJ 08903 USA; [Densmore, Llewellyn D.] Texas Tech Univ, Dept Biol Sci, Lubbock, TX 79409 USA	University of Iowa; University of California System; University of California Berkeley; Rutgers State University New Brunswick; Texas Tech University System; Texas Tech University	Brochu, CA (corresponding author), Univ Iowa, Dept Geosci, Iowa City, IA 52242 USA.	chris-brochu@uiowa.edu			National Science Foundation [NSF DEB 0444133, NSF DEB 0228648]; Wenner-Gren Foundation; Rutgers University Center; National Geographic Committee	National Science Foundation(National Science Foundation (NSF)); Wenner-Gren Foundation; Rutgers University Center; National Geographic Committee(National Geographic Society)	National Science Foundation (www.nsf.gov): NSF DEB 0444133, NSF DEB 0228648. Wenner-Gren Foundation for Anthropological Research (www.wennergren.org). Rutgers University Center for Human Evolutionary Studies (evolution.rutgers.edu). National Geographic Committee for Research and Exploration (www.nationalgeographic.com/field/grants-programs/cre.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrasar Eduardo Llinas, 2003, Annales de Paleontologie, V89, P103, DOI 10.1016/S0753-3969(03)00006-5; Agrasar EL, 2004, GEODIVERSITAS, V26, P309; AOKI R, 1992, AFRICAN STUDY MONOGR, V17, P67; BARBOUR T, 1918, B MUS COMP ZOOL HARV, V14, P479; BELL CJ, QUATERNARY IN PRESS; Bickelmann C, 2009, FOSS REC, V12, P13, DOI 10.1002/mmng.200800007; Blumenschine RJ, 2003, SCIENCE, V299, P1217, DOI 10.1126/science.1075374; BLUMENSCHINE RJ, ENV HOMININ IN PRESS; Boulenger GA, 1920, CR HEBD ACAD SCI, V170, P913; BRAZAITIS P, 1973, Zoologica (New York), V58, P59; BRAZAITIS P, 1973, ZOOLOGICA; Brochu CA, 2001, CROCODILIAN BIOLOGY AND EVOLUTION, P9; Brochu CA, 2000, COPEIA, P657, DOI 10.1643/0045-8511(2000)000[0657:PRADTO]2.0.CO;2; Brochu CA, 2003, ANNU REV EARTH PL SC, V31, P357, DOI 10.1146/annurev.earth.31.100901.141308; Brochu C, 2008, J VERTEBR PALEONTOL, V28, p57A; Brochu CA, 2007, ZOOL J LINN SOC-LOND, V150, P835, DOI 10.1111/j.1096-3642.2007.00315.x; Brochu CA, 2006, COPEIA, P149; Brunet M, 2000, J VERTEBR PALEONTOL, V20, P205, DOI 10.1671/0272-4634(2000)020[0205:CDOAVF]2.0.CO;2; BUFFETAUT E, 1984, NEUES JB GEOLOGIE PA, P513; COLBERT EH, 1946, COPEIA, P12; Delfino M, 2004, RIV ITAL PALEONTOL S, V110, P51, DOI 10.13130/2039-4942/5764; Delfino M, 2008, J PALEONTOL, V82, P336, DOI 10.1666/06-079.1; Delfino M, 2007, ZOOL J LINN SOC-LOND, V149, P293; Dempsey P, 2009, NATURE, V461, P341, DOI 10.1038/461341a; DENSMORE LD, 1991, COPEIA, P602, DOI 10.2307/1446388; DENSMORE LD, 1983, EVOL BIOL, V16, P397; Eaton MJ, 2009, MOL PHYLOGENET EVOL, V50, P496, DOI 10.1016/j.ympev.2008.11.009; Fourtau R, 1920, CONTRIBUTION ETUDE V; FUCHS K, 1974, Salamandra, V10, P107; Gatesy J, 2003, SYST BIOL, V52, P403, DOI 10.1080/10635150390197037; Ghinassi M, 2009, PALAEOGEOGR PALAEOCL, V280, P415, DOI 10.1016/j.palaeo.2009.06.029; Ginsburg L., 1978, GE OLOGIE ME DITERRA, V5, P291; Goloboff P.A., 2008, TNT TREE ANAL USING; Harrison T, 1997, NEOGENE PALEONTOLOGY, P361; Hecht Max K., 1987, P101; HEKKALA ER, CONSERVATIO IN PRESS; Ji Xue-Feng, 2006, Acta Zoologica Sinica, V52, P810; Joleaud M.L., 1930, CROCODILIENS PLIOCEN, P411; Joordens JCA, 2009, J HUM EVOL, V57, P656, DOI 10.1016/j.jhevol.2009.06.003; KALIN JOSEF ALOIS, 1933, ZOOL JAHRB ABT ANAT U ONT, V57, P535; LEAKEY LSB, 1964, NATURE, V202, P7, DOI 10.1038/202007a0; LEAKEY LSB, 1965, OLDUVAI GORGE 1951 6, V1, P70; LEAKEY LSB, 1959, NATURE; Leakey M. D., 1971, OLDUVAI GORGE EXCAVA; Maccagno A. M., 1952, Rendiconti Accademia Nazionale dei XL (4), V3, P73; MACCAGNO AM, 1948, ATTI R ACCAD 8 SFMN, V1, P63; McAliley LR, 2006, MOL PHYLOGENET EVOL, V39, P16, DOI 10.1016/j.ympev.2006.01.012; Mook CC, 1921, B AM MUS NAT HIST, V44, P25; MOOK CHARLES C., 1927, AMER MUS NOVITATES, V289, P1; Muller L., 1923, Palaeontologia Hungarica, V1, P109; Nesbitt SJ, 2008, J VERTEBR PALEONTOL, V28, P1063, DOI 10.1671/0272-4634-28.4.1063; Njau J., J HUMAN EVO IN PRESS; Njau J. K., 2006, J HUM EVOL, V50, P102; NJAU JK, 2007, PALEOANTHROPOLOGY, pA21; OWEN R, 1850, PHIL T ROY SOC LON 1, V27, P521; PETERS CR, 1995, J HUM EVOL, V29, P321, DOI 10.1006/jhev.1995.1062; Pickford M., 1994, GEOLOGY PALAEOBIOLOG, VII, P137; Pickford Martin, 1996, Annales de Paleontologie, V82, P235; Pickford Martin, 2003, Geological Survey of Namibia Memoir, V19, P51; Pickford Martin, 2000, Annales de Paleontologie, V86, P59, DOI 10.1016/S0753-3969(00)88724-8; Prat S, 2005, J HUM EVOL, V49, P230, DOI 10.1016/j.jhevol.2005.03.009; Rauhe M, 1999, FOSSIL VERTEBRATES OF ARABIA, P163; Ray DA, 2001, CROCODILIAN BIOLOGY AND EVOLUTION, P58; Ristori G., 1890, RENDICONTI I STUDI S, P1; Schmitz A, 2003, CR PALEVOL, V2, P703, DOI 10.1016/j.crpv.2003.07.002; SCHRENK F, 1995, J HUM EVOL, V28, P59, DOI 10.1006/jhev.1995.1006; Storrs Glenn W., 2003, P137; SUSMAN RL, 1982, SCIENCE, V217, P931, DOI 10.1126/science.217.4563.931; Swinton W. E., 1926, Uganda Geol Surv Dept Occ Paper, V2, P37; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; TCHERNOV E, 1978, Palaeontology (Oxford), V21, P857; Tchernov E., 1986, EVOLUTION CROCODILES; Tobias P.V., 1991, HOMO HABILIS SKULLS, V4a et 4b; Vignaud P, 2002, NATURE, V418, P152, DOI 10.1038/nature00880; WERMUTH H, 1953, MITT ZOOL MUS BERLIN, V29, P376; White PS, 2001, CROCODILIAN BIOLOGY AND EVOLUTION, P29; Willis RE, 2009, MOL PHYLOGENET EVOL, V53, P1049, DOI 10.1016/j.ympev.2009.09.003; WITMER LM, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P19	78	55	56	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2010	5	2							e9333	10.1371/journal.pone.0009333	http://dx.doi.org/10.1371/journal.pone.0009333			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SX	20195356	Green Published, Green Submitted, gold			2022-12-25	WOS:000274924200008
J	Sirovich, L; Stoeckle, MY; Zhang, Y				Sirovich, Lawrence; Stoeckle, Mark Y.; Zhang, Yu			Structural Analysis of Biodiversity	PLOS ONE			English	Article							NUCLEOTIDE SUBSTITUTIONS; DNA; NUMBER	Large, recently-available genomic databases cover a wide range of life forms, suggesting opportunity for insights into genetic structure of biodiversity. In this study we refine our recently-described technique using indicator vectors to analyze and visualize nucleotide sequences. The indicator vector approach generates correlation matrices, dubbed Klee diagrams, which represent a novel way of assembling and viewing large genomic datasets. To explore its potential utility, here we apply the improved algorithm to a collection of almost 17000 DNA barcode sequences covering 12 widely-separated animal taxa, demonstrating that indicator vectors for classification gave correct assignment in all 11000 test cases. Indicator vector analysis revealed discontinuities corresponding to species-and higher-level taxonomic divisions, suggesting an efficient approach to classification of organisms from poorly-studied groups. As compared to standard distance metrics, indicator vectors preserve diagnostic character probabilities, enable automated classification of test sequences, and generate high-information density single-page displays. These results support application of indicator vectors for comparative analysis of large nucleotide data sets and raise prospect of gaining insight into broad-scale patterns in the genetic structure of biodiversity.	[Sirovich, Lawrence; Zhang, Yu] Mt Sinai Sch Med, Lab Appl Math, New York, NY 10029 USA; [Stoeckle, Mark Y.] Rockefeller Univ, Program Human Environm, New York, NY 10021 USA	Icahn School of Medicine at Mount Sinai; Rockefeller University	Sirovich, L (corresponding author), Mt Sinai Sch Med, Lab Appl Math, New York, NY 10029 USA.	lsirovich@rockefeller.edu	Stoeckle, Mark/D-3729-2011	Stoeckle, Mark/0000-0002-8280-4795	NIH/NEI [EY16224]; NIH/NIGMS [1 P50 GM071558]; Alfred P. Sloan Foundation [2009-5-22]; NATIONAL EYE INSTITUTE [R01EY016224] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071558] Funding Source: NIH RePORTER	NIH/NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. LS received funding from NIH/NEI EY16224, NIH/NIGMS 1 P50 GM071558 and The Alfred P. Sloan Foundation, 2009-5-22 DNAB. YZ received funding from NIH/NIGMS 1 P50 GM071558 and The Alfred P. Sloan Foundation, 2009-5-22 DNAB.	Atteson K, 1999, ALGORITHMICA, V25, P251, DOI 10.1007/PL00008277; Ausubel JH, 2009, P NATL ACAD SCI USA, V106, P12569, DOI 10.1073/pnas.0906757106; Bryant D, 2005, J CLASSIF, V22, P3, DOI 10.1007/s00357-005-0003-x; Castoe TA, 2009, P NATL ACAD SCI USA, V106, P8986, DOI 10.1073/pnas.0900233106; Caterino MS, 2001, SYST BIOL, V50, P106, DOI 10.1080/106351501750107530; CHAPMAN AD, 2009, NUMBERS LIVING SPECI; DEROSNAY J, 1979, MACROSCOPE NEW WORLD; Eldredge N., 1972, P82; GASCUEL O, 1994, MOL BIOL EVOL, V11, P961; Goloboff PA, 2009, CLADISTICS, V25, P211, DOI 10.1111/j.1096-0031.2009.00255.x; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; KALLERSJO M, 1988, PLANT SYST EVOL, V213, P259; Kerr Kevin C R, 2007, Mol Ecol Notes, V7, P535; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; McMahon MM, 2006, SYST BIOL, V55, P818, DOI 10.1080/10635150600999150; Mihaescu R, 2009, ALGORITHMICA, V54, P1, DOI 10.1007/s00453-007-9116-4; Moritz C, 2004, PLOS BIOL, V2, P1529, DOI 10.1371/journal.pbio.0020354; PETERSEN K, 1990, ERGODIC THEORY CAMBR; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sanderson MJ, 2006, BIOINFORMATICS, V22, P1004, DOI 10.1093/bioinformatics/btl044; Sirovich L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007051; Smith SA, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-37; TAMURA K, 1992, MOL BIOL EVOL, V9, P678; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; 2009, AMERICAN ORNITHOLOGI	27	37	41	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2010	5	2							e9266	10.1371/journal.pone.0009266	http://dx.doi.org/10.1371/journal.pone.0009266			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SX	20195371	Green Published, Green Submitted, gold			2022-12-25	WOS:000274924200001
J	Labonte, ED; Pfluger, PT; Cash, JG; Kuhel, DG; Roja, JC; Magness, DP; Jandacek, RJ; Tschop, MH; Hui, DY				Labonte, Eric D.; Pfluger, Paul T.; Cash, James G.; Kuhel, David G.; Roja, Juan C.; Magness, Daniel P.; Jandacek, Ronald J.; Tschoep, Matthias H.; Hui, David Y.			Postprandial lysophospholipid suppresses hepatic fatty acid oxidation: the molecular link between group 1B phospholipase A(2) and diet-induced obesity	FASEB JOURNAL			English	Article						energy expenditure; lipid absorption; peroxisome proliferator-activated receptors	BRUSH-BORDER MEMBRANES; ENERGY-EXPENDITURE; GENE-EXPRESSION; ABSORPTION; MICE; CARBOHYDRATE; TRANSPORT; GLUCOSE; PPAR; PHOSPHATIDYLCHOLINE	Decrease in fat catabolic rate on consuming a high-fat diet contributes to diet-induced obesity. This study used group 1B phospholipase A(2) (Pla2g1b)-deficient mice, which are resistant to hyperglycemia, to test the hypothesis that Pla2g1b and its lipolytic product lysophospholipid suppress hepatic fat utilization and energy metabolism in promoting diet-induced obesity. The metabolic consequences of hypercaloric diet, including body weight gain, energy expenditure, and fatty acid oxidation, were compared between Pla2g1b(+/+) and Pla2g1b(-/-) mice. The Pla2g1b(-/-) mice displayed normal energy balance when fed chow, but were resistant to obesity when challenged with a hypercaloric diet. Obesity resistance in Pla2g1b(-/-) mice is due to their ability to maintain elevated energy expenditure and core body temperature when subjected to hypercaloric diet, which was not observed in Pla2g1b(-/-) mice. The Pla2g1b(-/-) mice also displayed increased postprandial hepatic fat utilization due to increased expression of peroxisome proliferator-activated receptor (PPAR)-alpha, PPAR-delta, PPAR-gamma, cd36/Fat, and Ucp2, which coincided with reduced postprandial plasma lysophospholipid levels. Lysophospholipids produced by Pla2g1b hydrolysis suppress hepatic fat utilization and down-regulate energy expenditure, thereby preventing metabolically beneficial adaptation to a high-fat diet exposure in promoting diet-induced obesity and type 2 diabetes.-Labonte, E.D., Pfluger, P.T., Cash, J.G., Kuhel, D.G., Rojas, J.C., Magness, D.P., Jandacek, R.J., Tschop, M.H., Hui, D.Y. Postprandial lysophospholipid suppresses hepatic fatty acid oxidation: the molecular link between group 1B phospholipase A(2) and diet-induced obesity. FASEB J. 24, 2516-2524 (2010). www.fasebj.org	[Labonte, Eric D.; Cash, James G.; Kuhel, David G.; Roja, Juan C.; Magness, Daniel P.; Jandacek, Ronald J.; Hui, David Y.] Univ Cincinnati, Coll Med, Dept Pathol & Lab Med, Cincinnati, OH 45237 USA; [Pfluger, Paul T.; Tschoep, Matthias H.] Univ Cincinnati, Coll Med, Dept Med, Metab Dis Inst, Cincinnati, OH 45237 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Hui, DY (corresponding author), Univ Cincinnati, Coll Med, Dept Pathol ML0507, 2120 E Galbraith Rd, Cincinnati, OH 45237 USA.	huidy@ucmail.uc.edu	Pfluger, Paul T/A-3770-2019; Tschoep, Matthias H/I-5443-2014	Pfluger, Paul T/0000-0002-8118-7588; Tschoep, Matthias/0000-0002-4744-371X	U.S. National Institutes of Health [RO1 DK69967]; American Heart Association [0525340B]; National Institute of Diabetes and Digestive and Kidney Diseases [DK59630]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK059630, R01DK069967] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Eliza Wynn and Beth Coburn for their superb technical assistance. The authors also thank Josh Basford, Dr. Dean Gilham, Dr. Diego Perez-Tilve, and Dr. Susanna Hofmann for their helpful discussions and advice. This work was supported by U.S. National Institutes of Health grant RO1 DK69967 (to D.Y.H.) and a Postdoctoral Fellowship (0525340B) from the Ohio Affiliates of the American Heart Association to E.D.L. Energy expenditure and fat absorption measurements were performed in the Cincinnati Mouse Metabolic Phenotype Center, supported by the National Institute of Diabetes and Digestive and Kidney Diseases (DK59630).	ABBOTT WGH, 1990, AM J PHYSIOL, V258, pE347, DOI 10.1152/ajpendo.1990.258.2.E347; CAREY MC, 1983, ANNU REV PHYSIOL, V45, P651, DOI 10.1146/annurev.ph.45.030183.003251; Chakravarthy MV, 2005, CELL METAB, V1, P309, DOI 10.1016/j.cmet.2005.04.002; Coutant F, 2004, J IMMUNOL, V172, P54, DOI 10.4049/jimmunol.172.1.54; de Jonge L, 1997, OBES RES, V5, P622, DOI 10.1002/j.1550-8528.1997.tb00584.x; DENNIS EA, 1994, J BIOL CHEM, V269, P13057; DIJKSTRA BW, 1983, J MOL BIOL, V168, P163, DOI 10.1016/S0022-2836(83)80328-3; Feingold KR, 2008, J LIPID RES, V49, P2179, DOI 10.1194/jlr.M800233-JLR200; Galili O, 2007, AM J PHYSIOL-HEART C, V292, pH904, DOI 10.1152/ajpheart.00628.2006; Gavrilova O, 1999, P NATL ACAD SCI USA, V96, P14623, DOI 10.1073/pnas.96.25.14623; Gilham D, 2007, J BIOL CHEM, V282, P24642, DOI 10.1074/jbc.M702530200; Hofmann SM, 2007, J CLIN INVEST, V117, P3271, DOI 10.1172/JCI31929; Huggins KW, 2002, AM J PHYSIOL-ENDOC M, V283, pE994, DOI 10.1152/ajpendo.00110.2002; Hui DY, 2009, BRIT J PHARMACOL, V157, P1263, DOI 10.1111/j.1476-5381.2009.00308.x; HURNI M, 1982, BRIT J NUTR, V47, P33, DOI 10.1079/BJN19820006; IKEDA I, 1987, BIOCHIM BIOPHYS ACTA, V921, P245; Jandacek RJ, 2004, GASTROENTEROLOGY, V127, P139, DOI 10.1053/j.gastro.2004.04.007; Kirchner H, 2009, NAT MED, V15, P741, DOI 10.1038/nm.1997; Kishimoto T, 2002, CLIN BIOCHEM, V35, P411, DOI 10.1016/S0009-9120(02)00327-2; KLEIBER M, 1961, Annu Rev Physiol, V23, P5; Kleiner S, 2009, J BIOL CHEM, V284, P18624, DOI 10.1074/jbc.M109.008797; Labonte ED, 2006, DIABETES, V55, P935, DOI 10.2337/diabetes.55.04.06.db05-1286; LEAN MEJ, 1988, INT J OBESITY, V12, P15; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Mackay K, 1997, J BIOL CHEM, V272, P13380, DOI 10.1074/jbc.272.20.13380; Pietilainen KH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000218; PIND S, 1991, BIOCHEM CELL BIOL, V69, P346, DOI 10.1139/o91-054; RABINI RA, 1994, DIABETES, V43, P915, DOI 10.2337/diabetes.43.7.915; RAVUSSIN E, 1988, NEW ENGL J MED, V318, P467, DOI 10.1056/NEJM198802253180802; Richmond BL, 2001, GASTROENTEROLOGY, V120, P1193, DOI 10.1053/gast.2001.23254; Schaloske RH, 2006, BBA-MOL CELL BIOL L, V1761, P1246, DOI 10.1016/j.bbalip.2006.07.011; Schoonjans K, 1996, J LIPID RES, V37, P907; SCHWARTZ RS, 1985, METABOLISM, V34, P285, DOI 10.1016/0026-0495(85)90014-9; Tojo H, 1998, J BIOL CHEM, V273, P2214, DOI 10.1074/jbc.273.4.2214; Unger RH, 2001, FASEB J, V15, P312, DOI 10.1096/fj.00-0590; Villarroya F, 2007, PPAR RES, V2007, DOI 10.1155/2007/74364; West GB, 1999, SCIENCE, V284, P1677, DOI 10.1126/science.284.5420.1677; Wilson SG, 2006, EUR J HUM GENET, V14, P340, DOI 10.1038/sj.ejhg.5201551; Young SC, 1999, BIOCHEM J, V339, P615, DOI 10.1042/0264-6021:3390615	39	45	45	2	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JUL	2010	24	7					2516	2524		10.1096/fj.09-144436	http://dx.doi.org/10.1096/fj.09-144436			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	618HV	20215528	Green Published			2022-12-25	WOS:000279343600038
J	Parkitna, JR; Bilbao, A; Rieker, C; Engblom, D; Piechota, M; Nordheim, A; Spanagel, R; Schutz, G				Parkitna, Jan Rodriguez; Bilbao, Ainhoa; Rieker, Claus; Engblom, David; Piechota, Marcin; Nordheim, Alfred; Spanagel, Rainer; Schuetz, Guenther			Loss of the serum response factor in the dopamine system leads to hyperactivity	FASEB JOURNAL			English	Article						activity-dependent transcription; Egr; SRF; murine; motor activity; striatum	C-FOS GENE; CRE RECOMBINASE; BINDING SITE; TRANSCRIPTION; EXPRESSION; SRF; PROTEIN; STIMULATION; NEURONS; IDENTIFICATION	The serum response factor (SRF) is a key regulator of neural development and cellular plasticity, which enables it to act as a regulator of long-term adaptations in neurons. Here we performed a comprehensive analysis of SRF function in the murine dopamine system. We found that loss of SRF in dopaminoceptive, but not dopaminergic, neurons is responsible for the development of a hyperactivity syndrome, characterized by reduced body weight into adulthood, enhanced motor activity, and deficits in habituation processes. Most important, the hyperactivity also develops when the ablation of SRF is induced in adult animals. On the molecular level, the loss of SRF in dopaminoceptive cells is associated with altered expression of neuronal plasticity-related genes, in particular transcripts involved in calcium ion binding, formation of the cytoskeleton, and transcripts encoding neuropeptide precursors. Furthermore, abrogation of SRF causes specific deficits in activity-dependent transcription, especially a complete lack of psychostimulant-induced expression of the Egr genes. We inferred that alterations in SRF-dependent gene expression underlie the observed hyperactive behavior. Thus, SRF depletion in dopaminoceptive neurons might trigger molecular mechanisms responsible for development of psychopathological conditions involving hyperactivity.-Parkitna, J.R., Bilbao, A., Rieker, C., Engblom, D., Piechota, M., Nordheim, A., Spanagel, R., Schutz, G. Loss of the serum response factor in the dopamine system leads to hyperactivity. FASEB J. 24, 2427-2435 (2010). www.fasebj.org	[Parkitna, Jan Rodriguez; Rieker, Claus; Engblom, David; Schuetz, Guenther] German Canc Res Ctr, D-69120 Heidelberg, Germany; [Parkitna, Jan Rodriguez; Piechota, Marcin] Polish Acad Sci, Inst Pharmacol, Dept Mol Neuropharmacol, Krakow, Poland; [Bilbao, Ainhoa; Spanagel, Rainer] Cent Inst Mental Hlth, Dept Psychopharmacol, D-6800 Mannheim, Germany; [Nordheim, Alfred] Univ Tubingen, Inst Cell Biol, Dept Mol Biol, Tubingen, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Polish Academy of Sciences; Central Institute of Mental Health; Eberhard Karls University of Tubingen	Schutz, G (corresponding author), German Canc Res Ctr, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	g.schuetz@dkfz.de	Piechota, Marcin/G-9464-2011; Bilbao, Ainhoa/AAW-6230-2020; Rodriguez, Jan/I-2910-2012	Rodriguez, Jan/0000-0003-0367-2331; Nordheim, Alfred/0000-0003-4680-0778; Piechota, Marcin/0000-0003-2468-151X	Deutsche Forschungsgemeinschaft (DFG) [SFB 488, SFB 636, NO120/12-3]; Sachbeihilfe Schu [51/7-2]; Fonds der Chemischen Industrie; European Union [LSHM-CT-2005-018652, LSHM-CT-2004-005166]; Bundesministerium fur Bildung und Forschung [FZK 01GS01117, FZK 01GS0477, KGCV1/01GS0416]; German-Polish Cooperation [01GZ0310]; Systems Biology [0313074C]; Polish Ministry of Science and Higher Education [PBZ-MNiI-2/1/2005]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Sachbeihilfe Schu; Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); European Union(European Commission); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); German-Polish Cooperation; Systems Biology; Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	The authors thank Dr. Bernd Knoll for commenting on the manuscript. The authors thank Tabea Arnsperger, Katja Lankisch, Magdalena Westphal, and Ralph Klaren for their excellent technical assistance. The authors also thank Dr. Norbert Gretz for his assistance in performing the DNA microarray experiments. A.B., J.R.P., C.R., D.E., and G.S. were supported by the Deutsche Forschungsgemeinschaft (DFG) through Collaborative Research Centres SFB 488 and SFB 636 and Sachbeihilfe Schu 51/7-2; the Fonds der Chemischen Industrie; the European Union through grant LSHM-CT-2005-018652 (CRESCENDO); the Bundesministerium fur Bildung und Forschung through Nationales Genomforschungsnetz Deutschland grants FZK 01GS01117, FZK 01GS0477, and KGCV1/01GS0416; German-Polish Cooperation project 01GZ0310; and Systems Biology projects 0313074C (HepatoSys) and NW5 (CoReNe). A.B. and R.S. were supported by an EU (IMAGEN) grant to R.S. M.P. was supported by EU grant LSHM-CT-2004-005166 and Polish Ministry of Science and Higher Education grant PBZ-MNiI-2/1/2005. A.N. acknowledges financial support from DFG grant NO120/12-3. The authors declare no conflicts of interest.	Alberti S, 2005, P NATL ACAD SCI USA, V102, P6148, DOI 10.1073/pnas.0501191102; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Antrop I, 2000, J CHILD PSYCHOL PSYC, V41, P225, DOI 10.1017/S0021963099005302; Bilbao A, 2008, P NATL ACAD SCI USA, V105, P17549, DOI 10.1073/pnas.0803959105; Brudno M, 2003, GENOME RES, V13, P721, DOI 10.1101/gr.926603; Buchwalter G, 2004, GENE, V324, P1, DOI 10.1016/j.gene.2003.09.028; Cen B, 2003, MOL CELL BIOL, V23, P6597, DOI 10.1128/MCB.23.18.6597-6608.2003; Erdmann G, 2008, ENDOCRINOLOGY, V149, P3446, DOI 10.1210/en.2007-1786; Etkin A, 2006, NEURON, V50, P127, DOI 10.1016/j.neuron.2006.03.013; Faraone SV, 2005, BIOL PSYCHIAT, V57, P1313, DOI 10.1016/j.biopsych.2004.11.024; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; GRAYBIEL AM, 1990, P NATL ACAD SCI USA, V87, P6912, DOI 10.1073/pnas.87.17.6912; GREENBERG ME, 1984, NATURE, V311, P433, DOI 10.1038/311433a0; Guan L, 2009, MOL PSYCHIATR, V14, P546, DOI 10.1038/sj.mp.4002139; HERDEGEN T, 1994, MOL BRAIN RES, V26, P259, DOI 10.1016/0169-328X(94)90098-1; Herdegen T, 1997, NEUROSCIENCE, V81, P199, DOI 10.1016/S0306-4522(97)00170-X; HIPSKIND RA, 1991, NATURE, V354, P531, DOI 10.1038/354531a0; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kalita K, 2006, J NEUROSCI, V26, P10020, DOI 10.1523/JNEUROSCI.2644-06.2006; Knoll B, 2009, TRENDS NEUROSCI, V32, P432, DOI 10.1016/j.tins.2009.05.004; Knoll B, 2006, NAT NEUROSCI, V9, P195, DOI 10.1038/nn1627; Lasky-Su J, 2008, AM J MED GENET B, V147B, P1345, DOI 10.1002/ajmg.b.30867; Lemberger T, 2008, FASEB J, V22, P2872, DOI 10.1096/fj.08-107888; Lemberger T, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-4; Lenhard B, 2002, BIOINFORMATICS, V18, P1135, DOI 10.1093/bioinformatics/18.8.1135; Li DW, 2006, HUM MOL GENET, V15, P2276, DOI 10.1093/hmg/ddl152; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Nikitin V P, 2007, Neurosci Behav Physiol, V37, P83, DOI 10.1007/s11055-007-0153-x; Niu Z, 2008, P NATL ACAD SCI USA, V105, P17824, DOI 10.1073/pnas.0805491105; Parkitna Jan Rodriguez, 2009, V530, P325, DOI 10.1007/978-1-59745-471-1_17; Parlato R, 2006, GENESIS, V44, P454, DOI 10.1002/dvg.20236; Ramanan N, 2005, NAT NEUROSCI, V8, P759, DOI 10.1038/nn1462; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Stringer JL, 2002, DEV BRAIN RES, V138, P81, DOI 10.1016/S0165-3806(02)00467-4; Stritt C, 2009, NAT NEUROSCI, V12, P418, DOI 10.1038/nn.2280; Suehiro J, 2010, BLOOD, V115, P2520, DOI 10.1182/blood-2009-07-233478; TREISMAN R, 1987, EMBO J, V6, P2711, DOI 10.1002/j.1460-2075.1987.tb02564.x; TREISMAN R, 1986, CELL, V46, P567, DOI 10.1016/0092-8674(86)90882-2; Wang DZ, 2002, P NATL ACAD SCI USA, V99, P14855, DOI 10.1073/pnas.222561499; Weinhold B, 2000, EMBO J, V19, P5835, DOI 10.1093/emboj/19.21.5835; Wiebel FF, 2002, GENESIS, V32, P124, DOI 10.1002/gene.10049	42	37	37	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2010	24	7					2427	2435		10.1096/fj.09-151423	http://dx.doi.org/10.1096/fj.09-151423			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	618HV	20223941				2022-12-25	WOS:000279343600029
J	Wei, G; Pazgier, M; de Leeuw, E; Rajabi, M; Li, J; Zou, GZ; Jung, G; Yuan, WR; Lu, WY; Lehrer, RI; Lu, WY				Wei, Gang; Pazgier, Marzena; de Leeuw, Erik; Rajabi, Mohsen; Li, Jing; Zou, Guozhang; Jung, Grace; Yuan, Weirong; Lu, Wei-Yue; Lehrer, Robert I.; Lu, Wuyuan			Trp-26 Imparts Functional Versatility to Human alpha-Defensin HNP1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONSERVED SALT BRIDGE; HUMAN BETA-DEFENSINS; ANTIMICROBIAL PEPTIDES; MOUSE CRYPTDIN-4; ANTIBACTERIAL ACTIVITY; BACTERICIDAL ACTIVITY; MAMMALIAN DEFENSINS; SERINE PROTEINASES; CHEMICAL LIGATION; INNATE IMMUNITY	We performed a comprehensive alanine scan of human alpha-defensin HNP1 and tested the ability of the resulting analogs to kill Staphylococcus aureus, inhibit anthrax lethal factor, and bind human immunodeficiency virus-1 gp120. By far, the most deleterious mutation for all of these functions was W26A. The activities lost by W26A-HNP1 were restored progressively by replacing W26 with non-coded, straight-chain aliphatic amino acids of increasing chain length. The hydrophobicity of residue 26 also correlated with the ability of the analogs to bind immobilized wild type HNP1 and to undergo further self-association. Thus, the hydrophobicity of residue 26 is not only a key determinant of the direct interactions of HNP1 with target molecules, but it also governs the ability of this peptide to form dimers and more complex quaternary structures at micromolar concentrations. Although all defensin peptides are cationic, their amphipathicity is at least as important as their positive charge in enabling them to participate in innate host defense.	[Jung, Grace; Lehrer, Robert I.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Wei, Gang; Pazgier, Marzena; de Leeuw, Erik; Rajabi, Mohsen; Li, Jing; Zou, Guozhang; Yuan, Weirong; Lu, Wuyuan] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA; [Wei, Gang; Lu, Wei-Yue] Fudan Univ, Sch Pharm, Shanghai 201203, Peoples R China	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University System of Maryland; University of Maryland Baltimore; Fudan University	Lehrer, RI (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, 10833 LeConte Ave, Los Angeles, CA 90095 USA.	rlehrer@mednet.ucla.edu; wlu@ihv.umaryland.edu	Wei, Gang/AAH-7377-2019; Pazgier, Marzena/B-7295-2012; Lu, Weiyue/E-7938-2010; Lu, Wuyuan/B-2268-2010; Lu, Wuyuan/J-8452-2017	Wei, Gang/0000-0002-9600-0982; Lu, Wuyuan/0000-0003-1318-9968	National Institutes of Health [AI072732, AI061482]; National Natural Science Foundation of China [30701060]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072732, R01AI061482] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI072732 and AI061482 (to W. L.).; Supported in part by National Natural Science Foundation of China Grant 30701060.	Bevins CL, 2006, BIOCHEM SOC T, V34, P263, DOI 10.1042/BST0340263; BRAUNSCHWEILER L, 1983, J MAGN RESON, V53, P521, DOI 10.1016/0022-2364(83)90226-3; Buck CB, 2006, P NATL ACAD SCI USA, V103, P1516, DOI 10.1073/pnas.0508033103; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; DAWSON PE, 1994, SCIENCE, V266, P776, DOI 10.1126/science.7973629; Dawson PE, 2000, ANNU REV BIOCHEM, V69, P923, DOI 10.1146/annurev.biochem.69.1.923; de Leeuw E, 2007, FEBS LETT, V581, P515, DOI 10.1016/j.febslet.2006.12.036; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dill KA, 1997, J BIOL CHEM, V272, P701, DOI 10.1074/jbc.272.2.701; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ericksen B, 2005, ANTIMICROB AGENTS CH, V49, P269, DOI 10.1128/AAC.49.1.269-275.2005; Figueredo SM, 2009, J BIOL CHEM, V284, P6826, DOI 10.1074/jbc.M807024200; FUJII G, 1993, PROTEIN SCI, V2, P1301, DOI 10.1002/pro.5560020813; GABAY JE, 1989, P NATL ACAD SCI USA, V86, P5610, DOI 10.1073/pnas.86.14.5610; GANZ T, 1985, J CLIN INVEST, V76, P1427, DOI 10.1172/JCI112120; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Giesemann T, 2008, GASTROENTEROLOGY, V134, P2049, DOI 10.1053/j.gastro.2008.03.008; HABERMAN.E, 1972, SCIENCE, V177, P314, DOI 10.1126/science.177.4046.314; Harder J, 2001, J BIOL CHEM, V276, P5707, DOI 10.1074/jbc.M008557200; Harder J, 1997, NATURE, V387, P861, DOI 10.1038/43088; Hazrati E, 2006, J IMMUNOL, V177, P8658, DOI 10.4049/jimmunol.177.12.8658; HILL CP, 1991, SCIENCE, V251, P1481, DOI 10.1126/science.2006422; JONES DE, 1993, FEBS LETT, V315, P187, DOI 10.1016/0014-5793(93)81160-2; JONES DE, 1992, J BIOL CHEM, V267, P23216; KAGAN BL, 1990, P NATL ACAD SCI USA, V87, P210, DOI 10.1073/pnas.87.1.210; Keller R., 2004, COMPUTER AIDED RESON, V1; Kim C, 2005, P NATL ACAD SCI USA, V102, P4830, DOI 10.1073/pnas.0500508102; Klotman ME, 2006, NAT REV IMMUNOL, V6, P447, DOI 10.1038/nri1860; Kortemme T, 2002, P NATL ACAD SCI USA, V99, P14116, DOI 10.1073/pnas.202485799; Kouno T, 2008, BIOCHEMISTRY-US, V47, P10611, DOI 10.1021/bi800957n; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; Lehrer RI, 2004, NAT REV MICROBIOL, V2, P727, DOI 10.1038/nrmicro976; LEHRER RI, 1989, J CLIN INVEST, V84, P553, DOI 10.1172/JCI114198; Lehrer RI, 2009, J IMMUNOL, V183, P480, DOI 10.4049/jimmunol.0900244; Lehrer RI, 2009, INFECT IMMUN, V77, P4028, DOI 10.1128/IAI.00232-09; Llenado RA, 2009, INFECT IMMUN, V77, P5035, DOI 10.1128/IAI.00695-09; Lu SM, 2001, P NATL ACAD SCI USA, V98, P1410, DOI 10.1073/pnas.031581398; Lu WY, 1997, J MOL BIOL, V266, P441, DOI 10.1006/jmbi.1996.0781; Maemoto A, 2004, J BIOL CHEM, V279, P44188, DOI 10.1074/jbc.M406154200; Massova I, 1999, J AM CHEM SOC, V121, P8133, DOI 10.1021/ja990935j; Mayer-Scholl A, 2005, PLOS PATHOG, V1, P179, DOI 10.1371/journal.ppat.0010023; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Pazgier M, 2006, CELL MOL LIFE SCI, V63, P1294, DOI 10.1007/s00018-005-5540-2; Qasim MA, 2003, BIOCHEMISTRY-US, V42, P6460, DOI 10.1021/bi027186u; Rajabi M, 2008, J BIOL CHEM, V283, P21509, DOI 10.1074/jbc.M801851200; Rehaume LM, 2008, CRIT REV IMMUNOL, V28, P185, DOI 10.1615/CritRevImmunol.v28.i3.10; Rosengren KJ, 2006, J BIOL CHEM, V281, P28068, DOI 10.1074/jbc.M604992200; Rosengren KJ, 2003, J BIOL CHEM, V278, P8606, DOI 10.1074/jbc.M211147200; SAITO T, 1995, J BIOCHEM-TOKYO, V117, P1131, DOI 10.1093/oxfordjournals.jbchem.a124818; Schibli DJ, 2002, J BIOL CHEM, V277, P8279, DOI 10.1074/jbc.M108830200; SCHNOLZER M, 1992, INT J PEPT PROT RES, V40, P180; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; SELSTED ME, 1985, J CLIN INVEST, V76, P1436, DOI 10.1172/JCI112121; Semple CAM, 2006, BIOCHEM SOC T, V34, P257, DOI 10.1042/BST0340257; Siebert HC, 2009, CARBOHYD RES, V344, P1515, DOI 10.1016/j.carres.2009.06.002; Smith JG, 2008, CELL HOST MICROBE, V3, P11, DOI 10.1016/j.chom.2007.12.001; STEINER H, 1981, NATURE, V292, P246, DOI 10.1038/292246a0; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Szyk A, 2006, PROTEIN SCI, V15, P2749, DOI 10.1110/ps.062336606; Tanabe H, 2004, J BIOL CHEM, V279, P11976, DOI 10.1074/jbc.M310251200; Wang W, 2003, J IMMUNOL, V170, P4708, DOI 10.4049/jimmunol.170.9.4708; Wei G, 2009, J BIOL CHEM, V284, P29180, DOI 10.1074/jbc.M109.018085; WELLS JA, 1990, BIOCHEMISTRY-US, V29, P8509, DOI 10.1021/bi00489a001; WILDE CG, 1989, J BIOL CHEM, V264, P11200; Wu Z, 2003, J PEPT RES, V62, P53, DOI 10.1034/j.1399-3011.2003.00068.x; Wu ZB, 2005, J BIOL CHEM, V280, P43039, DOI 10.1074/jbc.M510562200; Wu ZB, 2003, J AM CHEM SOC, V125, P2402, DOI 10.1021/ja0294257; Wu ZB, 2007, J MOL BIOL, V368, P537, DOI 10.1016/j.jmb.2007.02.040; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Xie C, 2005, J BIOL CHEM, V280, P32921, DOI 10.1074/jbc.M503084200; Yang D, 2004, ANNU REV IMMUNOL, V22, P181, DOI 10.1146/annurev.immunol.22.012703.104603; ZASLOFF M, 1987, P NATL ACAD SCI USA, V84, P5449, DOI 10.1073/pnas.84.15.5449; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; ZHANG XL, 1992, BIOCHEMISTRY-US, V31, P11348, DOI 10.1021/bi00161a012; Zou GZ, 2008, J MOL BIOL, V381, P1281, DOI 10.1016/j.jmb.2008.06.066; Zou GZ, 2007, J BIOL CHEM, V282, P19653, DOI 10.1074/jbc.M611003200	79	46	47	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					16275	16285		10.1074/jbc.M110.102749	http://dx.doi.org/10.1074/jbc.M110.102749			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20220136	hybrid, Green Published			2022-12-25	WOS:000277715900064
J	Walter, K; Cockerill, PN; Barlow, R; Clarke, D; Hoogenkamp, M; Follows, GA; Richards, SJ; Cullen, MJ; Bonifer, C; Tagoh, H				Walter, K.; Cockerill, P. N.; Barlow, R.; Clarke, D.; Hoogenkamp, M.; Follows, G. A.; Richards, S. J.; Cullen, M. J.; Bonifer, C.; Tagoh, H.			Aberrant expression of CD19 in AML with t(8;21) involves a poised chromatin structure and PAX5	ONCOGENE			English	Article						t(8;21); mixed lineage phenotype; PAX5; CD19; chromatin structure; epigenetic regulation	ACUTE MYELOID-LEUKEMIA; B-LYMPHOPOIESIS; GENE-EXPRESSION; FUSION PROTEIN; AML1-ETO; TRANSCRIPTION; TARGET; CELLS; METHYLATION; TRANSLOCATION	Correct hematopoietic differentiation requires the tightly regulated execution of lineage-specific and stage-restricted gene expression programs. This process is disturbed in hematological malignancies that typically show incomplete differentiation but often also display a mixed lineage phenotype. Co-expression of lymphoid and myeloid molecules is a well-known feature of acute myeloblastic leukemia (AML) with t(8;21). These cells consistently express the B-cell-specific transcription factor PAX5, and the B-cell-specific cell surface protein CD19. However, the functional consequences of PAX5 expression are unknown. To address this question, we studied the chromatin features of CD19, which is a direct target of PAX5 in cells with and without the t( 8; 21) chromosomal translocation. We show that CD19 chromatin exists in a poised configuration in myeloid progenitors and that this poised chromatin structure facilitates PAX5-dependent CD19 activation. Our results also show a positive correlation between PAX5 and CD19 expression in t(8;21)-positive AML cells and demonstrate that PAX5 binds to the promoter and enhancer of CD19 gene and remodels chromatin structure at the promoter. This study shows that expression of PAX5 in leukemic cells has functional consequences and points to an important role of a progenitor-specific chromatin configuration in myeloid leukemia. Oncogene (2010) 29, 2927-2937; doi:10.1038/onc.2010.56; published online 8 March 2010	[Walter, K.; Cockerill, P. N.; Barlow, R.; Clarke, D.; Hoogenkamp, M.; Follows, G. A.; Bonifer, C.; Tagoh, H.] Univ Leeds, St Jamess Univ Hosp, Leeds Inst Mol Med, Sect Expt Haematol, Leeds, W Yorkshire, England; [Richards, S. J.; Cullen, M. J.] St Jamess Inst Oncol, Haematol Malignancy Diagnost Serv, Leeds, W Yorkshire, England	Saint James's University Hospital; University of Leeds; Saint James's University Hospital	Tagoh, H (corresponding author), Res Inst Mol Pathol, Dr Bohr Gasse 7, A-1030 Vienna, Austria.	hiromi.tagoh@imp.ac.at	Tagoh, Hiromi/B-2954-2009	Tagoh, Hiromi/0000-0001-9905-6992; Richards, Stephen/0000-0002-8421-5353; Bonifer, Constanze/0000-0002-4267-0825; Cockerill, Peter/0000-0002-4410-8174; Hoogenkamp, Maarten/0000-0003-2429-1271	Leukaemia & Lymphoma Research; Kay Kendall Leukaemia Fund; Research Council UK	Leukaemia & Lymphoma Research; Kay Kendall Leukaemia Fund; Research Council UK(UK Research & Innovation (UKRI))	We thank M Busslinger for providing reagents including antibodies and plasmids and S Valeaux and A Ebert for technical assistance. This work was supported by Leukaemia & Lymphoma Research and by the Kay Kendall Leukaemia Fund. HT holds a Research Council UK academic fellowship.	Amann JM, 2001, MOL CELL BIOL, V21, P6470, DOI 10.1128/MCB.21.19.6470-6483.2001; Attema JL, 2007, P NATL ACAD SCI USA, V104, P12371, DOI 10.1073/pnas.0704468104; Berg T, 2008, HAEMATOL-HEMATOL J, V93, P1728, DOI 10.3324/haematol.13044; Bonifer C, 2005, CELL CYCLE, V4, P211; Cobaleda C, 2007, NAT IMMUNOL, V8, P463, DOI 10.1038/ni1454; Decker T, 2009, IMMUNITY, V30, P508, DOI 10.1016/j.immuni.2009.01.012; DREXLER HG, 1991, LEUKEMIA, V5, P637; DREXLER HG, 1993, LEUKEMIA, V7, P489; Elagib KE, 2007, CANCER LETT, V251, P179, DOI 10.1016/j.canlet.2006.10.010; Follows GA, 2003, EMBO J, V22, P2798, DOI 10.1093/emboj/cdg250; Gibson SE, 2006, AM J CLIN PATHOL, V126, P916, DOI 10.1309/UJUL60UPUP3YJE93; Graf T, 2002, BLOOD, V99, P3089, DOI 10.1182/blood.V99.9.3089; KAGOSHIMA H, 1993, TRENDS GENET, V9, P338, DOI 10.1016/0168-9525(93)90026-E; KITA K, 1992, BLOOD, V80, P470; Kohler C, 2008, TRENDS CELL BIOL, V18, P236, DOI 10.1016/j.tcb.2008.02.005; Kondo M, 2000, NATURE, V407, P383, DOI 10.1038/35030112; KOZMIK Z, 1992, MOL CELL BIOL, V12, P2662, DOI 10.1128/MCB.12.6.2662; Kwon K, 2008, IMMUNITY, V28, P751, DOI 10.1016/j.immuni.2008.04.014; Lefevre P, 2005, J BIOL CHEM, V280, P27552, DOI 10.1074/jbc.M502422200; Linggi B, 2002, NAT MED, V8, P743, DOI 10.1038/nm726; MATOZAKI S, 1995, BRIT J HAEMATOL, V89, P805; Mikhail FM, 2002, CANCER GENET CYTOGEN, V135, P96, DOI 10.1016/S0165-4608(01)00633-1; Miyamoto T, 2000, P NATL ACAD SCI USA, V97, P7521, DOI 10.1073/pnas.97.13.7521; Miyamoto T, 1996, BLOOD, V87, P4789, DOI 10.1182/blood.V87.11.4789.bloodjournal87114789; Moreau T, 2004, MOL THER, V10, P45, DOI 10.1016/j.ymthe.2004.04.005; Mulloy JC, 2005, P NATL ACAD SCI USA, V102, P4016, DOI 10.1073/pnas.0404701102; Nishida S, 2006, BLOOD, V107, P3303, DOI 10.1182/blood-2005-04-1656; Nutt SL, 1998, EMBO J, V17, P2319, DOI 10.1093/emboj/17.8.2319; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Orford K, 2008, DEV CELL, V14, P798, DOI 10.1016/j.devcel.2008.04.002; Pabst T, 2001, NAT MED, V7, P444, DOI 10.1038/86515; Peterson LF, 2007, LEUKEMIA, V21, P2010, DOI 10.1038/sj.leu.2404849; Peterson LF, 2007, BLOOD, V110, P799, DOI 10.1182/blood-2006-11-019265; READING CL, 1993, BLOOD, V81, P3083; Roessler S, 2007, MOL CELL BIOL, V27, P579, DOI 10.1128/MCB.01192-06; Schessl C, 2005, J CLIN INVEST, V115, P2159, DOI 10.1172/JCI24225; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Seet CS, 2004, J EXP MED, V199, P1689, DOI 10.1084/jem.20032202; Speck NA, 2002, NAT REV CANCER, V2, P502, DOI 10.1038/nrc840; Tagoh H, 2006, EMBO J, V25, P1070, DOI 10.1038/sj.emboj.7600997; Tagoh H, 2004, EMBO J, V23, P4275, DOI 10.1038/sj.emboj.7600421; Tiacci E, 2004, CANCER RES, V64, P7399, DOI 10.1158/0008-5472.CAN-04-1865; Tonks A, 2007, LEUKEMIA, V21, P2495, DOI 10.1038/sj.leu.2404961; Valbuena JR, 2006, AM J CLIN PATHOL, V126, P235, DOI 10.1309/LG0Q0VXYBETJ4VHE; Walter K, 2008, BLOOD, V112, P1673, DOI 10.1182/blood-2008-02-142786; Wang Q, 1996, P NATL ACAD SCI USA, V93, P3444, DOI 10.1073/pnas.93.8.3444; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2	49	21	22	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2010	29	20					2927	2937		10.1038/onc.2010.56	http://dx.doi.org/10.1038/onc.2010.56			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	599DM	20208555				2022-12-25	WOS:000277890400004
J	Gohil, VM; Nilsson, R; Belcher-Timme, CA; Luo, B; Root, DE; Mootha, VK				Gohil, Vishal M.; Nilsson, Roland; Belcher-Timme, Casey A.; Luo, Biao; Root, David E.; Mootha, Vamsi K.			Mitochondrial and Nuclear Genomic Responses to Loss of LRPPRC Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PENTATRICOPEPTIDE REPEAT PROTEINS; CYCLOOXYGENASE-2 EXPRESSION; INTEGRATIVE GENOMICS; OXIDASE DEFICIENCY; GENE-EXPRESSION; COMPLEX; DYSFUNCTION; LRP130; CELL; RNA	Rapid advances in genotyping and sequencing technology have dramatically accelerated the discovery of genes underlying human disease. Elucidating the function of such genes and understanding their role in pathogenesis, however, remain challenging. Here, we introduce a genomic strategy to characterize such genes functionally, and we apply it to LRPPRC, a poorly studied gene that is mutated in Leigh syndrome, French-Canadian type (LSFC). We utilize RNA interference to engineer an allelic series of cellular models in which LRPPRC has been stably silenced to different levels of knockdown efficiency. We then combine genome-wide expression profiling with gene set enrichment analysis to identify cellular responses that correlate with the loss of LRPPRC. Using this strategy, we discovered a specific role for LRPPRC in the expression of all mitochondrial DNA-encoded mRNAs, but not the rRNAs, providing mechanistic insights into the enzymatic defects observed in the disease. Our analysis shows that nuclear genes encoding mitochondrial proteins are not collectively affected by the loss of LRPPRC. We do observe altered expression of genes related to hexose metabolism, prostaglandin synthesis, and glycosphingolipid biology that may either play an adaptive role in cell survival or contribute to pathogenesis. The combination of genetic perturbation, genomic profiling, and pathway analysis represents a generic strategy for understanding disease pathogenesis.	[Gohil, Vishal M.; Nilsson, Roland; Belcher-Timme, Casey A.; Mootha, Vamsi K.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Gohil, Vishal M.; Nilsson, Roland; Belcher-Timme, Casey A.; Luo, Biao; Root, David E.; Mootha, Vamsi K.] Broad Inst Massachusetts Inst Technol & Harvard, Cambridge, MA 02142 USA; [Gohil, Vishal M.; Nilsson, Roland; Belcher-Timme, Casey A.; Mootha, Vamsi K.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02446 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School	Mootha, VK (corresponding author), Massachusetts Gen Hosp, Ctr Human Genet Res, 185 Cambridge St,CPZN 5-806, Boston, MA 02114 USA.	vamsi@hms.harvard.edu	Nilsson, Roland/AAJ-3519-2021	Gohil, Vishal/0000-0002-9920-2563; Nilsson, Roland/0000-0002-6020-7498	National Institutes of Health [R01DK081457]; United Mitochondrial Disease Foundation; Broad Institute Scientific Planning and Allocation of Resources Committee; American Diabetes Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081457] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United Mitochondrial Disease Foundation; Broad Institute Scientific Planning and Allocation of Resources Committee; American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01DK081457 (to V. K. M.). This work was also supported by grants from the United Mitochondrial Disease Foundation (to V. M. G.), the Broad Institute Scientific Planning and Allocation of Resources Committee, and the American Diabetes Association.	Behan A, 2005, MITOCHONDRION, V5, P173, DOI 10.1016/j.mito.2005.03.002; Bonawitz ND, 2006, MOL CELL, V24, P813, DOI 10.1016/j.molcel.2006.11.024; Butow RA, 2004, MOL CELL, V14, P1, DOI 10.1016/S1097-2765(04)00179-0; Cillero-Pastor B, 2008, ARTHRITIS RHEUM-US, V58, P2409, DOI 10.1002/art.23644; Cooper MP, 2008, J BIOL CHEM, V283, P31960, DOI 10.1074/jbc.M805431200; Cooper MP, 2006, GENE DEV, V20, P2996, DOI 10.1101/gad.1483906; Giallourakis C, 2005, ANNU REV GENOM HUM G, V6, P381, DOI 10.1146/annurev.genom.6.080604.162234; Greenhough A, 2009, CARCINOGENESIS, V30, P377, DOI 10.1093/carcin/bgp014; Heddi A, 1999, J BIOL CHEM, V274, P22968, DOI 10.1074/jbc.274.33.22968; Lee N, 2001, AM J HUM GENET, V68, P397, DOI 10.1086/318197; Lurin C, 2004, PLANT CELL, V16, P2089, DOI 10.1105/tpc.104.022236; Ma HW, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100177; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; MERANTE F, 1993, AM J HUM GENET, V53, P481; Mili S, 2003, MOL CELL BIOL, V23, P4972, DOI 10.1128/MCB.23.14.4972-4982.2003; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Mootha VK, 2003, P NATL ACAD SCI USA, V100, P605, DOI 10.1073/pnas.242716699; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Reinecke F, 2009, BBA-MOL BASIS DIS, V1792, P1113, DOI 10.1016/j.bbadis.2009.04.003; Schmitz-Linneweber C, 2008, TRENDS PLANT SCI, V13, P663, DOI 10.1016/j.tplants.2008.10.001; Tomura H, 2008, J BONE MINER RES, V23, P1129, DOI 10.1359/JBMR.080236; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Xu FH, 2004, BIOCHEM J, V382, P331, DOI 10.1042/BJ20040469	25	61	63	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13742	13747		10.1074/jbc.M109.098400	http://dx.doi.org/10.1074/jbc.M109.098400			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20220140	hybrid, Green Published			2022-12-25	WOS:000276987700049
J	Myeni, SK; Zhou, DG				Myeni, Sebenzile K.; Zhou, Daoguo			The C Terminus of SipC Binds and Bundles F-actin to Promote Salmonella Invasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOST-CELLS; TYPHIMURIUM ENTRY; PROTEIN DELIVERY; NUCLEATION; CYTOSKELETON; DIMERIZATION; COMPLEX; FIMBRIN; VILLIN	Salmonella enterica serovar Typhimurium invade non-phagocytic cells by injecting bacterial effector proteins to exploit the host actin cytoskeleton network. SipC is such a Salmonella effector known to nucleate actin, bundle F-actin, and translocate type III effectors. The molecular mechanism of how SipC bundles F-actin and SipC domains responsible for these activities are not well characterized. We successfully separated these activities through a series of genetic deletion/insertions in SipC. We found that the C terminus (amino acids 200-409) of SipC bundled actin filaments using in vitro biochemical assays. We further demonstrated that amino acid residues 221-260 and 381-409 of full-length SipC were indispensable for its actin binding and bundling activities. Furthermore, Salmonella mutant strains lacking the actin bundling activity were less invasive into HeLa cells. These studies indicate that the C terminus of SipC bundles F-actin to promote Salmonella invasion.	[Myeni, Sebenzile K.; Zhou, Daoguo] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Zhou, DG (corresponding author), Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA.	zhoud@purdue.edu						Blanchoin L, 2000, NATURE, V404, P1007, DOI 10.1038/35010008; Cain RJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000037; Chang JH, 2005, MOL MICROBIOL, V55, P1379, DOI 10.1111/j.1365-2958.2004.04480.x; Chang JH, 2007, MOL MICROBIOL, V66, P1548, DOI 10.1111/j.1365-2958.2007.06024.x; DEARRUDA MV, 1990, J CELL BIOL, V111, P1069, DOI 10.1083/jcb.111.3.1069; Fu YX, 1998, MOL MICROBIOL, V27, P359, DOI 10.1046/j.1365-2958.1998.00684.x; Fu YX, 1999, NATURE, V401, P293, DOI 10.1038/45829; Galan JE, 2000, P NATL ACAD SCI USA, V97, P8754, DOI 10.1073/pnas.97.16.8754; Galan JE, 1999, SCIENCE, V284, P1322, DOI 10.1126/science.284.5418.1322; Galan JE, 1999, CURR OPIN MICROBIOL, V2, P46, DOI 10.1016/S1369-5274(99)80008-3; GALAN JE, 1989, P NATL ACAD SCI USA, V86, P6383, DOI 10.1073/pnas.86.16.6383; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; George SP, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M703617200; Hardt WD, 1998, CELL, V93, P815, DOI 10.1016/S0092-8674(00)81442-7; Hayward RD, 1999, EMBO J, V18, P4926, DOI 10.1093/emboj/18.18.4926; HUECK CJ, 1995, MOL MICROBIOL, V18, P479, DOI 10.1111/j.1365-2958.1995.mmi_18030479.x; Jepson MA, 2001, CELL MICROBIOL, V3, P417, DOI 10.1046/j.1462-5822.2001.00124.x; KANIGA K, 1995, J BACTERIOL, V177, P3965, DOI 10.1128/jb.177.14.3965-3971.1995; KANIGA K, 1991, GENE, V109, P137, DOI 10.1016/0378-1119(91)90599-7; KANIGA K, 1995, J BACTERIOL, V177, P7078, DOI 10.1128/jb.177.24.7078-7085.1995; Kubori T, 1998, SCIENCE, V280, P602, DOI 10.1126/science.280.5363.602; MATSUDAIRA P, 1983, NATURE, V301, P209, DOI 10.1038/301209a0; McGhie EJ, 2001, EMBO J, V20, P2131, DOI 10.1093/emboj/20.9.2131; Miao EA, 1999, MOL MICROBIOL, V34, P850, DOI 10.1046/j.1365-2958.1999.01651.x; OBERT S, 1994, MOL CELL BIOL, V14, P1333, DOI 10.1128/MCB.14.2.1333; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; TSUKITA S, 1988, CELL MOTIL CYTOSKEL, V10, P451, DOI 10.1002/cm.970100402; Yamagishi A, 2004, J BIOL CHEM, V279, P14929, DOI 10.1074/jbc.M309408200; Zhou D, 1999, SCIENCE, V283, P2092, DOI 10.1126/science.283.5410.2092; Zhou DG, 2001, MICROBES INFECT, V3, P1293, DOI 10.1016/S1286-4579(01)01489-7; Zhou DG, 2001, MOL MICROBIOL, V39, P248, DOI 10.1046/j.1365-2958.2001.02230.x	31	52	55	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13357	13363		10.1074/jbc.M109.094045	http://dx.doi.org/10.1074/jbc.M109.094045			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20212042	Green Published, hybrid			2022-12-25	WOS:000276987700006
J	Xia, GQ; Maier, L; Sanchez-Carballo, P; Li, M; Otto, M; Holst, O; Peschel, A				Xia, Guoqing; Maier, Lisa; Sanchez-Carballo, Patricia; Li, Min; Otto, Michael; Holst, Otto; Peschel, Andreas			Glycosylation of Wall Teichoic Acid in Staphylococcus aureus by TarM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-ACETYLGLUCOSAMINYLRIBITOL LINKAGES; BACTERIOPHAGE-RESISTANT MUTANTS; IN-VITRO RECONSTITUTION; BACILLUS-SUBTILIS 168; CELL-WALL; LISTERIA-MONOCYTOGENES; ENZYMATIC SYNTHESIS; STREPTOCOCCUS-PNEUMONIAE; NASAL COLONIZATION; GLYCEROL PHOSPHATE	Wall teichoic acid (WTA) glycopolymers are major constituents of cell envelopes in Staphylococcus aureus and related Gram-positive bacteria with important roles in cell wall maintenance, susceptibility to antimicrobial molecules, biofilm formation, and host interaction. Most S. aureus strains express polyribitol phosphate WTA substituted with D-alanine and N-acetylglucosamine (GlcNAc). WTA sugar modifications are highly variable and have been implicated in bacteriophage susceptibility and immunogenicity, but the pathway and enzymes of staphylococcal WTA glycosylation have remained unknown. Revisiting the structure of S. aureus RN4220 WTA by NMR analysis revealed the presence of canonical polyribitol phosphate WTA bearing only alpha-linked GlcNAc substituents. A RN4220 transposon mutant resistant to WTA-dependent phages was identified and shown to produce altered WTA, which exhibited faster electrophoretic migration and lacked completely the WTA alpha-GlcNAc residues. Disruption of a gene of unknown function, renamed tarM, was responsible for this phenotype. Recombinant TarM was capable of glycosylating WTA in vitro in a UDP-GlcNAc-dependent manner, thereby confirming its WTA GlcNAc-transferase activity. Deletion of the last seven amino acids from the C terminus abolished the activity of TarM. tarM-related genes were found in the genomes of several WTA-producing bacteria, suggesting that TarM-mediated WTA glycosylation is a general pathway in Gram-positive bacteria. Our study represents a basis for dissecting the biosynthesis and function of glycosylated WTA in S. aureus and other bacteria.	[Xia, Guoqing; Maier, Lisa; Peschel, Andreas] Univ Tubingen, Div Cellular & Mol Microbiol, Interfac Inst Microbiol & Infect Med, D-72076 Tubingen, Germany; [Sanchez-Carballo, Patricia; Holst, Otto] Leibniz Ctr Med & Biosci, Div Struct Biochem, Res Ctr Borstel, D-23845 Borstel, Germany; [Li, Min; Otto, Michael] NIAID, Lab Human Bacterial Pathogenesis, NIH, Bethesda, MD 20892 USA	Eberhard Karls University of Tubingen; Forschungszentrum Borstel; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Peschel, A (corresponding author), Univ Tubingen, Div Cellular & Mol Microbiol, Interfac Inst Microbiol & Infect Med, Elfriede Aulhorn Str 6, D-72076 Tubingen, Germany.	andreas.peschel@uni-tuebingen.de	Xia, Guoqing/C-2365-2015; Maier, Lisa/ABH-1893-2021	Xia, Guoqing/0000-0003-4492-9156; Maier, Lisa/0000-0002-6473-4762; Sanchez Carballo, Patricia M./0000-0003-1061-7023; Otto, Michael/0000-0002-2222-4115	German Research Foundation [SFB34, SFB766, GKR685]; German Ministry of Education and Technology; National Institutes of Health [AI000904-08]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000904, ZIAAI000904] Funding Source: NIH RePORTER	German Research Foundation(German Research Foundation (DFG)); German Ministry of Education and Technology; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by German Research Foundation Grants TR-SFB34, SFB766, and GKR685 and by the German Ministry of Education and Technology (SkinStaph) (to A. P.) and also in part by the National Institutes of Health Intramural Research Program of NIAIDZIA AI000904-08 (to M. L. and M. O.).	Bae Taeok, 2008, V416, P103, DOI 10.1007/978-1-59745-321-9_7; Bhavsar AP, 2006, MOL MICROBIOL, V60, P1077, DOI 10.1111/j.1365-2958.2006.05169.x; Bhavsar AP, 2005, J BIOL CHEM, V280, P36691, DOI 10.1074/jbc.M507154200; Brown S, 2008, CHEM BIOL, V15, P12, DOI 10.1016/j.chembiol.2007.11.011; BRUCKNER R, 1992, GENE, V122, P187, DOI 10.1016/0378-1119(92)90048-T; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; CHATTERJEE AN, 1969, J BACTERIOL, V98, P519, DOI 10.1128/JB.98.2.519-527.1969; CHATTERJEE AN, 1969, J BACTERIOL, V100, P846, DOI 10.1128/JB.100.2.846-853.1969; Clarke SR, 2006, ADV MICROB PHYSIOL, V51, P187, DOI 10.1016/S0065-2911(06)51004-5; D'Elia MA, 2006, J BACTERIOL, V188, P4183, DOI 10.1128/JB.00197-06; Damjanovic M, 2007, J BACTERIOL, V189, P7105, DOI 10.1128/JB.00681-07; Debabov DV, 1996, J BACTERIOL, V178, P3869, DOI 10.1128/jb.178.13.3869-3876.1996; ENDL J, 1983, ARCH MICROBIOL, V135, P215, DOI 10.1007/BF00414483; Formstone A, 2008, J BACTERIOL, V190, P1812, DOI 10.1128/JB.01394-07; GERWIG GJ, 1979, CARBOHYD RES, V77, P1, DOI 10.1016/S0008-6215(00)83788-X; Ginsberg C, 2006, ACS CHEM BIOL, V1, P25, DOI 10.1021/cb0500041; GLASER L, 1966, BIOCHIM BIOPHYS ACTA, V124, P415, DOI 10.1016/0304-4165(66)90211-X; HONEYMAN AL, 1989, MOL MICROBIOL, V3, P1257, DOI 10.1111/j.1365-2958.1989.tb00276.x; Jenni R, 1998, ARCH MICROBIOL, V170, P171, DOI 10.1007/s002030050630; JUERGENS WG, 1963, J EXP MED, V117, P925, DOI 10.1084/jem.117.6.925; Kohler T, 2009, J BACTERIOL, V191, P4482, DOI 10.1128/JB.00221-09; Lei XH, 2001, J BACTERIOL, V183, P1133, DOI 10.1128/JB.183.4.1133-1139.2001; Li M, 2009, ANTIMICROB AGENTS CH, V53, P4200, DOI 10.1128/AAC.00428-09; LOWRY OH, 1954, J BIOL CHEM, V207, P39; MAUEL C, 1989, MOL GEN GENET, V215, P388, DOI 10.1007/BF00427034; Meredith TC, 2008, J BACTERIOL, V190, P3046, DOI 10.1128/JB.01880-07; NATHENSON SG, 1962, J BIOL CHEM, V237, P3839; NATHENSON SG, 1963, J BIOL CHEM, V238, P3161; NATHENSON SG, 1966, J BIOL CHEM, V241, P651; Neuhaus FC, 2003, MICROBIOL MOL BIOL R, V67, P686, DOI 10.1128/MMBR.67.4.686-723.2003; O'Flaherty S, 2005, APPL ENVIRON MICROB, V71, P1836, DOI 10.1128/AEM.71.4.1836-1842.2005; Pantucek R, 2004, ARCH VIROL, V149, P1689, DOI 10.1007/s00705-004-0335-6; PARK JT, 1974, ANN NY ACAD SCI, V236, P54, DOI 10.1111/j.1749-6632.1974.tb41481.x; PEREGO M, 1995, J BIOL CHEM, V270, P15598, DOI 10.1074/jbc.270.26.15598; Peschel A, 2000, ANTIMICROB AGENTS CH, V44, P2845, DOI 10.1128/AAC.44.10.2845-2847.2000; Peschel A, 1999, J BIOL CHEM, V274, P8405, DOI 10.1074/jbc.274.13.8405; POLLACK JH, 1994, J BACTERIOL, V176, P7252, DOI 10.1128/JB.176.23.7252-7259.1994; Promadej N, 1999, J BACTERIOL, V181, P418, DOI 10.1128/JB.181.2.418-425.1999; SANDERSON AR, 1962, J BIOL CHEM, V237, P3603; Schertzer JW, 2003, J BIOL CHEM, V278, P18002, DOI 10.1074/jbc.M300706200; Schlag M, 2010, MOL MICROBIOL, V75, P864, DOI 10.1111/j.1365-2958.2009.07007.x; SHAW DRD, 1970, J BIOL CHEM, V245, P5101; Spears PA, 2008, INFECT IMMUN, V76, P4046, DOI 10.1128/IAI.00283-08; STROMINGER JL, 1959, J BIOL CHEM, V234, P3263; Swoboda JG, 2010, CHEMBIOCHEM, V11, P35, DOI 10.1002/cbic.200900557; TORII M, 1964, J EXP MED, V120, P13, DOI 10.1084/jem.120.1.13; UCHIKAWA KI, 1986, J BIOCHEM-TOKYO, V99, P315, DOI 10.1093/oxfordjournals.jbchem.a135486; Vergara-Irigaray M, 2008, MICROBIOL-SGM, V154, P865, DOI 10.1099/mic.0.2007/013292-0; Vinogradov E, 2006, CARBOHYD RES, V341, P738, DOI 10.1016/j.carres.2006.01.012; Vollmer W, 2001, MOL MICROBIOL, V39, P1610, DOI 10.1046/j.1365-2958.2001.02349.x; Wann ER, 1999, FEMS MICROBIOL LETT, V170, P97; Weidenmaier C, 2005, J INFECT DIS, V191, P1771, DOI 10.1086/429692; Weidenmaier C, 2004, NAT MED, V10, P243, DOI 10.1038/nm991; Weidenmaier C, 2008, INT J MED MICROBIOL, V298, P505, DOI 10.1016/j.ijmm.2007.11.006; Weidenmaier C, 2008, NAT REV MICROBIOL, V6, P276, DOI 10.1038/nrmicro1861; Wendlinger G, 1996, MICROBIOL-UK, V142, P985, DOI 10.1099/00221287-142-4-985; Xia GQ, 2010, INT J MED MICROBIOL, V300, P148, DOI 10.1016/j.ijmm.2009.10.001; YOUNG FE, 1967, P NATL ACAD SCI USA, V58, P2377, DOI 10.1073/pnas.58.6.2377	58	100	103	8	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13405	13415		10.1074/jbc.M109.096172	http://dx.doi.org/10.1074/jbc.M109.096172			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20185825	Green Published, hybrid			2022-12-25	WOS:000276987700012
J	Zhang, LL; Xie, P; Wang, JZ; Yang, QW; Fang, CQ; Zhou, S; Li, JC				Zhang, Lili; Xie, Peng; Wang, Jingzhou; Yang, Qingwu; Fang, Chuanqin; Zhou, Shuang; Li, Jingcheng			Impaired Peroxisome Proliferator-activated Receptor-gamma Contributes to Phenotypic Modulation of Vascular Smooth Muscle Cells during Hypertension	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PPAR-GAMMA; GENE-EXPRESSION; MIGRATION; PHOSPHORYLATION; INSULIN; ROSIGLITAZONE; GROWTH; INHIBITION; NUCLEAR; ALPHA	The phenotypic modulation of vascular smooth muscle cells (VSMCs) plays a pivotal role in hypertension-induced vascular changes including vascular remodeling. The precise mechanisms underlying VSMC phenotypic modulation remain elusive. Here we test the role of peroxisome proliferator-activated receptor (PPAR)-gamma in the VSMC phenotypic modulation during hypertension. Both spontaneously hypertensive rat (SHR) aortas and SHR-derived VSMCs exhibited reduced PPAR-gamma expression and excessive VSMC phenotypic modulation identified by reduced contractile proteins, alpha-smooth muscle actin (alpha-SMA) and smooth muscle 22 alpha (SM22 alpha), and enhanced proliferation and migration. PPAR-gamma overexpression rescued the expression of alpha-SMA and SM22 alpha, and inhibited the proliferation and migration in SHR-derived VSMCs. In contrast, PPAR-gamma silencing exerted the opposite effect. Activating PPAR-gamma using rosiglitazone in vivo up-regulated aortic alpha-SMA and SM22 alpha expression and attenuated aortic remodeling in SHRs. Increased activation of phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT) signaling was observed in SHR-derived VSMCs. PI3K inhibitor LY294002 rescued the impaired expression of contractile proteins, and inhibited proliferation and migration in VSMCs from SHRs, whereas constitutively active PI3K mutant had the opposite effect. Overexpression or silencing of PPAR-gamma inhibited or excited PI3K/Akt activity, respectively. LY294002 counteracted the PPAR-gamma silencing induced proliferation and migration in SHR-derived VSMCs, whereas active PI3K mutant had the opposite effect. In contrast, reduced proliferation and migration by PPAR-gamma overexpression were reversed by the active PI3K mutant, and further inhibited by LY294002. We conclude that PPAR-gamma inhibits VSMC phenotypic modulation through inhibiting PI3K/Akt signaling. Impaired PPAR-gamma expression is responsible for VSMC phenotypic modulation during hypertension. These findings highlight an attractive therapeutic target for hypertension-related vascular disorders.	[Zhang, Lili; Wang, Jingzhou; Yang, Qingwu; Fang, Chuanqin; Li, Jingcheng] Third Mil Med Univ, Daping Hosp, Dept Neurol, Chongqing 400042, Peoples R China; [Xie, Peng] Chongqing Univ Med Sci, Affiliated Hosp 1, Dept Neurol, Chongqing 400016, Peoples R China; [Zhou, Shuang] Second Mil Med Univ, Dept Tradit Chinese Med, Shanghai 200433, Peoples R China	Army Medical University; Chongqing Medical University; Naval Medical University	Li, JC (corresponding author), Third Mil Med Univ, Daping Hosp, Dept Neurol, Chongqing 400042, Peoples R China.	lijingcheng11@gmail.com			National Natural Science Foundation of China [30800444]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China Grant 30800444.	Barroso I, 1999, NATURE, V402, P880, DOI 10.1038/47254; Bruemmer D, 2003, AM J MED, V115, P87, DOI 10.1016/j.amjmed.2003.09.014; Chen L, 2006, J BIOL CHEM, V281, P24575, DOI 10.1074/jbc.M604147200; Choi D, 2004, DIABETES CARE, V27, P2654, DOI 10.2337/diacare.27.11.2654; Choi KH, 2010, CARDIOVASC RES, V85, P836, DOI 10.1093/cvr/cvp359; Chuang CC, 2007, ENDOCRINOLOGY, V148, P4267, DOI 10.1210/en.2007-0179; Diep QN, 2001, HYPERTENSION, V38, P249, DOI 10.1161/01.HYP.38.2.249; Dimmeler S, 2000, FEBS LETT, V477, P258, DOI 10.1016/S0014-5793(00)01657-4; Fernandez-Hernando C, 2009, ARTERIOSCL THROM VAS, V29, P2033, DOI 10.1161/ATVBAHA.109.196394; GALIS ZS, 1994, CIRC RES, V75, P181, DOI 10.1161/01.RES.75.1.181; Gensch C, 2007, ATHEROSCLEROSIS, V192, P67, DOI 10.1016/j.atherosclerosis.2006.06.026; Giri S, 2004, J IMMUNOL, V173, P5196, DOI 10.4049/jimmunol.173.8.5196; Goetze S, 2002, BIOCHEM BIOPH RES CO, V293, P1431, DOI 10.1016/S0006-291X(02)00385-6; Goetze S, 2001, J CARDIOVASC PHARM, V38, P909, DOI 10.1097/00005344-200112000-00013; Hattori Y, 2000, BIOCHEM BIOPH RES CO, V273, P1144, DOI 10.1006/bbrc.2000.3084; Hayashi K, 2009, J MECH BEHAV BIOMED, V2, P3, DOI 10.1016/j.jmbbm.2008.05.002; Hegner B, 2009, ARTERIOSCL THROM VAS, V29, P232, DOI 10.1161/ATVBAHA.108.179457; Hsueh WA, 2004, HYPERTENSION, V43, P297, DOI 10.1161/01.HYP.0000113626.76571.5b; Kliewer SA, 2001, RECENT PROG HORM RES, V56, P239, DOI 10.1210/rp.56.1.239; Kondapaka SB, 2004, CLIN CANCER RES, V10, P7192, DOI 10.1158/1078-0432.CCR-04-0772; Law RE, 2000, CIRCULATION, V101, P1311, DOI 10.1161/01.CIR.101.11.1311; Lee SJ, 2009, INT IMMUNOPHARMACOL, V9, P837, DOI 10.1016/j.intimp.2009.03.010; Marx N, 2004, CIRC RES, V94, P1168, DOI 10.1161/01.RES.0000127122.22685.0A; Marx N, 1998, CIRC RES, V83, P1097, DOI 10.1161/01.RES.83.11.1097; Mitra AK, 2009, J CELL MOL MED, V13, P177, DOI 10.1111/j.1582-4934.2008.00311.x; Morales-Ruiz M, 2000, CIRC RES, V86, P892, DOI 10.1161/01.RES.86.8.892; Nakagawa M, 2007, BIOL PHARM BULL, V30, P1754, DOI 10.1248/bpb.30.1754; Ogawa D, 2006, CIRC RES, V98, pE50, DOI 10.1161/01.RES.0000218271.93076.c3; OGIHARA T, 1995, AM J HYPERTENS, V8, P316, DOI 10.1016/0895-7061(95)96214-5; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Poon M, 1996, J CLIN INVEST, V98, P2277, DOI 10.1172/JCI119038; Potenza MA, 2006, DIABETES, V55, P3594, DOI 10.2337/db06-0667; Sidhu JS, 2004, ARTERIOSCL THROM VAS, V24, P930, DOI 10.1161/01.ATV.0000124890.40436.77; Sobue K, 1999, MOL CELL BIOCHEM, V190, P105, DOI 10.1023/A:1006941621170; Sung HJ, 2005, ANN BIOMED ENG, V33, P1546, DOI 10.1007/s10439-005-7545-2; Takata Y, 2002, CIRC RES, V91, P427, DOI 10.1161/01.RES.0000031271.20771.4F; Wakino S, 2000, J BIOL CHEM, V275, P22435, DOI 10.1074/jbc.M910452199; Wang ZB, 2005, NEUROSCI LETT, V373, P38, DOI 10.1010/j.neulet.2004.09.068; Xiong C, 2005, LIFE SCI, V77, P3037, DOI 10.1016/j.lfs.2005.02.032; Xu XB, 2007, ARTERIOSCL THROM VAS, V27, P2355, DOI 10.1161/ATVBAHA.107.151704	40	43	55	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13666	13677		10.1074/jbc.M109.087718	http://dx.doi.org/10.1074/jbc.M109.087718			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20212046	Green Published, hybrid			2022-12-25	WOS:000276987700041
J	Zheng, YX; Brash, AR				Zheng, Yuxiang; Brash, Alan R.			Formation of a Cyclopropyl Epoxide via a Leukotriene A Synthase-related Pathway in an Anaerobic Reaction of Soybean Lipoxygenase-1 with 15S-Hydroperoxyeicosatetraenoic Acid EVIDENCE THAT OXYGEN ACCESS IS A DETERMINANT OF SECONDARY REACTIONS WITH FATTY ACID HYDROPEROXIDES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARACHIDONIC-ACID; LINOLEIC-ACID; PORCINE LEUKOCYTES; RETICULOCYTE LIPOXYGENASE; LIQUID-CHROMATOGRAPHY; MAST-CELLS; ENZYME; TRANSFORMATION; HYDROPEROXIDE; BIOSYNTHESIS	The further conversion of an arachidonic acid hydroperoxide to a leukotriene A (LTA) type epoxide by specific lipoxygenase (LOX) enzymes constitutes a key step in inflammatory mediator biosynthesis. Whereas mammalian 5-LOX transforms its primary product (5S-hydroperoxyeicosatetraenoic acid; 5S-HPETE) almost exclusively to LTA(4), the model enzyme, soybean LOX-1, normally produces no detectable leukotrienes and instead further oxygenates its primary product 15S-HPETE to 5,15- and 8,15-dihydroperoxides. Mammalian 15-LOX-1 displays both types of activity. We reasoned that availability of molecular oxygen within the LOX active site favors oxygenation, whereas lack of O-2 promotes LTA epoxide synthesis. To test this, we reacted 15S-HPETE with soybean LOX-1 under anaerobic conditions and identified the products by high pressure liquid chromatography, UV, mass spectrometry, and NMR. Among the products, we identified a pair of 8,15-dihydroxy diastereomers with all-trans-conjugated trienes that incorporated O-18 from H-2 O-18 at C-8, indicative of the formation of 14,15-LTA(4). A pair of 5,15-dihydroxy diastereomers containing two trans, trans-conjugated dienes (6E, 8E, 11E, 13E) and that incorporated O-18 from H-2 O-18 at C-5 was deduced to arise from hydrolysis of a novel epoxide containing a cyclopropyl ring, 14,15-epoxy-[9,10,11-cyclopropyl]-eicosa-5Z, 7E, 13E-trienoic acid. Also identified was the delta-lactone of the 5,15-diol, a derivative that exhibited no O-18 incorporation due to its formation by intramolecular reaction of the carboxyl anion with the proposed epoxide intermediate. Our results support a model in which access to molecular oxygen within the active site directs the outcome from competing pathways in the secondary reactions of lipoxygenases.	[Brash, Alan R.] Vanderbilt Univ, Dept Pharmacol, Sch Med, Nashville, TN 37232 USA; Vanderbilt Univ, Vanderbilt Inst Chem Biol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Zheng, YX (corresponding author), Vanderbilt Univ, Dept Pharmacol, Sch Med, 23rd Ave S Pierce, Nashville, TN 37232 USA.	alan.brash@vanderbilt.edu			National Institutes of Health [AR-051968]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051968] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant AR-051968 (to A. R. B.).	Axelrod B., 1981, METH ENZYMOL, V441, P451, DOI [10.1016/0076-6879(81)71055-3, DOI 10.1016/0076-6879(81)71055-3]; BORGEAT P, 1976, J BIOL CHEM, V251, P7816; Brash AR, 2007, FEBS J, V274, P3494, DOI 10.1111/j.1742-4658.2007.05909.x; Brash AR, 1999, J BIOL CHEM, V274, P23679, DOI 10.1074/jbc.274.34.23679; Brash AR, 1996, METHOD ENZYMOL, V272, P250, DOI 10.1016/S0076-6879(96)72030-X; BRYANT RW, 1982, J BIOL CHEM, V257, P6050; BRYANT RW, 1985, J BIOL CHEM, V260, P3548; CHRISTIE WW, 1989, J CHROMATOGR, V469, P261, DOI 10.1016/S0021-9673(01)96461-1; COREY EJ, 1980, J AM CHEM SOC, V102, P1435, DOI 10.1021/ja00524a044; COREY EJ, 1989, J AM CHEM SOC, V111, P1452, DOI 10.1021/ja00186a046; COREY EJ, 1983, TETRAHEDRON LETT, V24, P4921, DOI 10.1016/S0040-4039(01)99811-9; DEGROOT JJM, 1975, BIOCHIM BIOPHYS ACTA, V377, P71, DOI 10.1016/0005-2744(75)90287-9; DEGROOT JJM, 1973, BIOCHIM BIOPHYS ACTA, V326, P279, DOI 10.1016/0005-2760(73)90254-3; DEGROOT JJM, 1975, FEBS LETT, V56, P50, DOI 10.1016/0014-5793(75)80109-8; Feltenmark S, 2008, P NATL ACAD SCI USA, V105, P680, DOI 10.1073/pnas.0710127105; Ferreri C, 2004, J AM CHEM SOC, V126, P1063, DOI 10.1021/ja038072o; Fukushige H, 2005, J AGR FOOD CHEM, V53, P5691, DOI 10.1021/jf047958o; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Gao XQ, 2008, PLANTA, V227, P491, DOI 10.1007/s00425-007-0634-8; GARDNER HW, 1991, BIOCHIM BIOPHYS ACTA, V1084, P221, DOI 10.1016/0005-2760(91)90063-N; GARSSEN GJ, 1976, EUR J BIOCHEM, V62, P33, DOI 10.1111/j.1432-1033.1976.tb10094.x; GARSSEN GJ, 1971, BIOCHEM J, V122, P327, DOI 10.1042/bj1220327; GARSSEN GJ, 1972, BIOCHEM J, V130, P435, DOI 10.1042/bj1300435; GRILLER D, 1980, ACCOUNTS CHEM RES, V13, P317, DOI 10.1021/ar50153a004; HAMBERG M, 1983, BIOCHIM BIOPHYS ACTA, V752, P353, DOI 10.1016/0005-2760(83)90134-0; HAMBERG M, 1983, BIOCHIM BIOPHYS ACTA, V752, P191, DOI 10.1016/0005-2760(83)90112-1; KEMAL C, 1987, BIOCHEMISTRY-US, V26, P7064, DOI 10.1021/bi00396a031; Knapp MJ, 2003, BIOCHEMISTRY-US, V42, P11466, DOI 10.1021/bi0300884; MAAS RL, 1982, J BIOL CHEM, V257, P7056; MAAS RL, 1981, P NATL ACAD SCI-BIOL, V78, P5523, DOI 10.1073/pnas.78.9.5523; MAAS RL, 1983, P NATL ACAD SCI-BIOL, V80, P2884, DOI 10.1073/pnas.80.10.2884; MAAS RL, 1985, J BIOL CHEM, V260, P4217; MOUSSEBOIS C, 1966, J CHEM SOC C, P260, DOI 10.1039/j39660000260; POWELL WS, 1982, METHOD ENZYMOL, V86, P530; Radmark O, 2007, TRENDS BIOCHEM SCI, V32, P332, DOI 10.1016/j.tibs.2007.06.002; Saam J, 2007, P NATL ACAD SCI USA, V104, P13319, DOI 10.1073/pnas.0702401104; Schneider C, 2000, ANAL BIOCHEM, V287, P186, DOI 10.1006/abio.2000.4847; Schneider C, 2007, CHEM BIOL, V14, P473, DOI 10.1016/j.chembiol.2007.04.007; SHIMIZU T, 1984, P NATL ACAD SCI-BIOL, V81, P689, DOI 10.1073/pnas.81.3.689; SHIMIZU T, 1986, P NATL ACAD SCI USA, V83, P4175, DOI 10.1073/pnas.83.12.4175; SOK DE, 1983, BIOCHEM BIOPH RES CO, V110, P273, DOI 10.1016/0006-291X(83)91291-3; VANOS CPA, 1981, BIOCHIM BIOPHYS ACTA, V663, P177, DOI 10.1016/0005-2760(81)90204-6; Vliegenthart J. F. G., 1982, FREE RADICAL BIO MED, P29; YOKOYAMA C, 1986, J BIOL CHEM, V261, P6714; Yu ZY, 2003, P NATL ACAD SCI USA, V100, P9162, DOI 10.1073/pnas.1633612100	45	12	12	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13427	13436		10.1074/jbc.M109.084632	http://dx.doi.org/10.1074/jbc.M109.084632			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20194505	hybrid, Green Published			2022-12-25	WOS:000276987700014
J	Bueno, LL; Morais, CG; Araujo, FF; Gomes, JAS; Correa-Oliveira, R; Soares, IS; Lacerda, MV; Fujiwara, RT; Braga, EM				Bueno, Lilian Lacerda; Morais, Cristiane Guimaraes; Araujo, Fernanda Fortes; Silva Gomes, Juliana Assis; Correa-Oliveira, Rodrigo; Soares, Irene Silva; Lacerda, Marcus Vinicius; Fujiwara, Ricardo Toshio; Braga, Erika Martins			Plasmodium vivax: Induction of CD4(+)CD25(+)FoxP3(+) Regulatory T Cells during Infection Are Directly Associated with Level of Circulating Parasites	PLOS ONE			English	Article							IN-VITRO EXPANSION; TGF-BETA; DENDRITIC CELLS; MALARIA; FALCIPARUM; RESPONSES; ANTIGEN; CTLA-4; FOXP3; GITR	Circulation CD4(+)CD25(+)FoxP3(+) regulatory T cells (Tregs) have been associated with the delicate balancing between control of overwhelming acute malaria infection and prevention of immune pathology due to disproportionate inflammatory responses to erythrocytic stage of the parasite. While the role of Tregs has been well-documented in murine models and P. falciparum infection, the phenotype and function of Tregs in P. vivax infection is still poorly characterized. In the current study, we demonstrated that patients with acute P. vivax infection presented a significant augmentation of circulating Tregs producing anti-inflammatory (IL-10 and TGF-beta) as well as pro-inflammatory (IFN-gamma, IL-17) cytokines, which was further positively correlated with parasite burden. Surface expression of GITR molecule and intracellular expression of CTLA-4 were significantly upregulated in Tregs from infected donors, presenting also a positive association between either absolute numbers of CD4(+)CD25(+)FoxP3(+)GITR(+) or CD4(+)CD25(+)FoxP3(+)CTLA-4(+) and parasite load. Finally, we demonstrate a suppressive effect of Treg cells in specific T cell proliferative responses of P. vivax infected subjects after antigen stimulation with Pv-AMA-1. Our findings indicate that malaria vivax infection lead to an increased number of activated Treg cells that are highly associated with parasite load, which probably exert an important contribution to the modulation of immune responses during P. vivax infection.	[Bueno, Lilian Lacerda; Morais, Cristiane Guimaraes; Fujiwara, Ricardo Toshio; Braga, Erika Martins] Univ Fed Minas Gerais, Dept Parasitol, Inst Ciencias Biol, Belo Horizonte, MG, Brazil; [Araujo, Fernanda Fortes; Silva Gomes, Juliana Assis; Correa-Oliveira, Rodrigo; Fujiwara, Ricardo Toshio] Fiocruz MS, Lab Imunol Celular & Mol, Inst Rene Rachou, Belo Horizonte, MG, Brazil; [Silva Gomes, Juliana Assis] Univ Fed Minas Gerais, Dept Morfol, Inst Ciencias Biol, Belo Horizonte, MG, Brazil; [Soares, Irene Silva] Univ Sao Paulo, Dept Anal Clin & Toxicol, Sao Paulo, Brazil; [Lacerda, Marcus Vinicius] Fundacao Med Trop Amazonas, Manaus, Amazonas, Brazil	Universidade Federal de Minas Gerais; Fundacao Oswaldo Cruz; Universidade Federal de Minas Gerais; Universidade de Sao Paulo	Bueno, LL (corresponding author), Univ Fed Minas Gerais, Dept Parasitol, Inst Ciencias Biol, Belo Horizonte, MG, Brazil.	embraga@icb.ufmg.br	Soares, Irene/GQF-1984-2022; Gomes, Juliana A. S./M-4083-2017; Braga, Erika Martins/A-6776-2008; Bueno, Lilian/AAQ-1939-2020; Soares, Irene Silva/C-5974-2012; Fujiwara, Ricardo Toshio/J-7579-2012	Gomes, Juliana A. S./0000-0002-8332-2907; Braga, Erika Martins/0000-0001-5550-7157; Bueno, Lilian/0000-0003-3510-4590; Soares, Irene Silva/0000-0002-3336-6856; Fujiwara, Ricardo Toshio/0000-0002-4713-575X; Correa-Oliveira, Rodrigo/0000-0001-6419-9459	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais/FAPEMIG [CBB APQ-0997-4.01/07]; Brazilian National Research Council (CNPq/Brazil)	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais/FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Brazilian National Research Council (CNPq/Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was financially supported by Fundacao de Amparo a Pesquisa do Estado de Minas Gerais/FAPEMIG (Grant # CBB APQ-0997-4.01/07). Lilian Bueno is supported by a Doctoral degree fellowship from Brazilian National Research Council (CNPq/Brazil). Irene Soares, Ricardo Fujiwara, Rodrigo Correa-Oliveira and Erika Braga are supported by CNPq fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alegre ML, 2001, NAT REV IMMUNOL, V1, P220, DOI 10.1038/35105024; Amante FH, 2007, AM J PATHOL, V171, P548, DOI 10.2353/ajpath.2007.061033; Artavanis-Tsakonas K, 2003, CLIN EXP IMMUNOL, V133, P145, DOI 10.1046/j.1365-2249.2003.02174.x; Artavanis-Tsakonas K, 2002, J IMMUNOL, V169, P2956, DOI 10.4049/jimmunol.169.6.2956; Baird JK, 2007, TRENDS PARASITOL, V23, P533, DOI 10.1016/j.pt.2007.08.011; Belkaid Y, 2005, NAT IMMUNOL, V6, P353, DOI 10.1038/ni1181; Belkaid Y, 2007, NAT REV IMMUNOL, V7, P875, DOI 10.1038/nri2189; Bour-Jordan H, 2002, J CLIN IMMUNOL, V22, P1, DOI 10.1023/A:1014256417651; Bourreau E, 2009, INFECT IMMUN, V77, P1465, DOI 10.1128/IAI.01398-08; Braga EM, 2002, AM J TROP MED HYG, V66, P299, DOI 10.4269/ajtmh.2002.66.299; Bueno LL, 2008, VACCINE, V26, P1204, DOI 10.1016/j.vaccine.2007.12.031; Cambos M, 2008, INT J PARASITOL, V38, P229, DOI 10.1016/j.ijpara.2007.07.006; Chen WJ, 1998, J EXP MED, V188, P1849, DOI 10.1084/jem.188.10.1849; Cools N, 2008, J CELL MOL MED, V12, P690, DOI 10.1111/j.1582-4934.2007.00084.x; Ebinuma H, 2008, J VIROL, V82, P5043, DOI 10.1128/JVI.01548-07; Fallarino F, 2003, NAT IMMUNOL, V4, P1206, DOI 10.1038/ni1003; Finney CAM, 2007, EUR J IMMUNOL, V37, P1874, DOI 10.1002/eji.200636751; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; GERSHON RK, 1970, IMMUNOLOGY, V18, P723; GERSHON RK, 1971, IMMUNOLOGY, V21, P903; Guerra CA, 2006, TRENDS PARASITOL, V22, P353, DOI 10.1016/j.pt.2006.06.006; Hay SI, 2004, LANCET INFECT DIS, V4, P327, DOI 10.1016/S1473-3099(04)01043-6; Healer J, 2002, INFECT IMMUN, V70, P5751, DOI 10.1128/IAI.70.10.5751-5758.2002; Hisaeda H, 2005, EUR J IMMUNOL, V35, P3516, DOI 10.1002/eji.200526073; Hisaeda H, 2004, NAT MED, V10, P29, DOI 10.1038/nm975; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hougardy JM, 2007, MICROBES INFECT, V9, P1325, DOI 10.1016/j.micinf.2007.06.004; Ing R, 2006, J IMMUNOL, V176, P441, DOI 10.4049/jimmunol.176.1.441; Jacobs P, 1996, INFECT IMMUN, V64, P44, DOI 10.1128/IAI.64.1.44-49.1996; Jacobs T, 2002, J IMMUNOL, V169, P2323, DOI 10.4049/jimmunol.169.5.2323; Jangpatarapongsa K, 2008, EUR J IMMUNOL, V38, P2697, DOI 10.1002/eji.200838186; Kochar DK, 2005, EMERG INFECT DIS, V11, P132, DOI 10.3201/eid1101.040519; KRUMMEL MF, 1995, J EXP MED, V182, P459, DOI 10.1084/jem.182.2.459; Levings MK, 2002, INT ARCH ALLERGY IMM, V129, P263, DOI 10.1159/000067596; Long TTA, 2003, INT J PARASITOL, V33, P175, DOI 10.1016/S0020-7519(02)00261-8; Matera G, 2008, DIAGN MICR INFEC DIS, V62, P280, DOI 10.1016/j.diagmicrobio.2008.06.015; McHugh RS, 2002, IMMUNITY, V16, P311, DOI 10.1016/S1074-7613(02)00280-7; McSorley HJ, 2008, J IMMUNOL, V181, P6456, DOI 10.4049/jimmunol.181.9.6456; Mendis K, 2001, AM J TROP MED HYG, V64, P97, DOI 10.4269/ajtmh.2001.64.97; Minigo G, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000402; NARUM DL, 1994, MOL BIOCHEM PARASIT, V67, P59, DOI 10.1016/0166-6851(94)90096-5; Nie CQ, 2007, INFECT IMMUN, V75, P2275, DOI 10.1128/IAI.01783-06; Nishioka T, 2008, IMMUNOL LETT, V121, P97, DOI 10.1016/j.imlet.2008.09.003; Nocentini G, 2007, EUR J IMMUNOL, V37, P1165, DOI 10.1002/eji.200636933; Prakash J, 2003, J Assoc Physicians India, V51, P265; Riley EM, 2006, PARASITE IMMUNOL, V28, P35, DOI 10.1111/j.1365-3024.2006.00775.x; ROCKETT KA, 1991, INFECT IMMUN, V59, P3280, DOI 10.1128/IAI.59.9.3280-3283.1991; Rodrigues OR, 2009, IMMUNOBIOLOGY, V214, P101, DOI 10.1016/j.imbio.2008.07.001; Sakaguchi S, 2007, SCIENCE, V317, P627, DOI 10.1126/science.1142331; Schofield L, 2005, NAT REV IMMUNOL, V5, P722, DOI 10.1038/nri1686; Scholzen A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000543; Scopel KKG, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-8; Shevach EM, 2008, EUR J IMMUNOL, V38, P915, DOI 10.1002/eji.200738111; Shevach EM, 2006, NAT REV IMMUNOL, V6, P613, DOI 10.1038/nri1867; Shimizu J, 2002, NAT IMMUNOL, V3, P135, DOI 10.1038/ni759; Todryk SM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002027; Torcia MG, 2008, P NATL ACAD SCI USA, V105, P646, DOI 10.1073/pnas.0709969105; Vigario AM, 2007, INT J PARASITOL, V37, P963, DOI 10.1016/j.ijpara.2007.01.004; Volkman SK, 2001, SCIENCE, V293, P482, DOI 10.1126/science.1059878; von Boehmer H, 2005, NAT IMMUNOL, V6, P338, DOI 10.1038/ni1180; Walther M, 2005, IMMUNITY, V23, P287, DOI 10.1016/j.immuni.2005.08.006; Walther M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000364; WALUNAS TL, 1994, IMMUNITY, V1, P405, DOI 10.1016/1074-7613(94)90071-X; Watanabe K, 2009, PARASITE IMMUNOL, V31, P440, DOI 10.1111/j.1365-3024.2009.01127.x; Wu Y, 2007, EXP PARASITOL, V115, P301, DOI 10.1016/j.exppara.2006.09.015; Yagi H, 2004, INT IMMUNOL, V16, P1643, DOI 10.1093/intimm/dxh165	66	63	65	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2010	5	3							e9623	10.1371/journal.pone.0009623	http://dx.doi.org/10.1371/journal.pone.0009623			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565XE	20224778	Green Published, gold			2022-12-25	WOS:000275328800018
J	Muller, MP; McGeer, AJ; Hassan, K; Marshall, J; Christian, M				Muller, Matthew P.; McGeer, Allison J.; Hassan, Kazi; Marshall, John; Christian, Michael		Toronto Invasive Bacterial Dis	Evaluation of Pneumonia Severity and Acute Physiology Scores to Predict ICU Admission and Mortality in Patients Hospitalized for Influenza	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; CRITICAL-CARE; UNITED-STATES; VALIDATION; TRIAGE; RULE; DERIVATION; RESOURCES; NEED; TOOL	Background: The demand for inpatient medical services increases during influenza season. A scoring system capable of identifying influenza patients at low risk death or ICU admission could help clinicians make hospital admission decisions. Methods: Hospitalized patients with laboratory confirmed influenza were identified over 3 influenza seasons at 25 Ontario hospitals. Each patient was assigned a score for 6 pneumonia severity and 2 sepsis scores using the first data available following their registration in the emergency room. In-hospital mortality and ICU admission were the outcomes. Score performance was assessed using the area under the receiver operating characteristic curve (AUC) and the sensitivity and specificity for identifying low risk patients (risk of outcome < 5%). Results: The cohort consisted of 607 adult patients. Mean age was 76 years, 12% of patients died (71/607) and 9% required ICU care (55/607). None of the scores examined demonstrated good discriminatory ability (AUC >= 0.80). The Pneumonia Severity Index (AUC 0.78, 95% CI 0.72-0.83) and the Mortality in Emergency Department Sepsis score (AUC 0.77, 95% 0.71-0.83) demonstrated fair predictive ability (AUC >= 0.70) for in-hospital mortality. The best predictor of ICU admission was SMART-COP (AUC 0.73, 95% CI 0.67-0.79). All other scores were poor predictors (AUC < 0.70) of either outcome. If patients classified as low risk for in-hospital mortality using the PSI were discharged, 35% of admissions would have been avoided. Conclusions: None of the scores studied were good predictors of in-hospital mortality or ICU admission. The PSI and MEDS score were fair predictors of death and if these results are validated, their use could reduce influenza admission rates significantly.	[Muller, Matthew P.] Univ Toronto, St Michaels Hosp, Dept Med, Toronto, ON M5B 1W8, Canada; [McGeer, Allison J.] Univ Toronto, Mt Sinai Hosp, Dept Lab Med & Pathobiol, Toronto, ON M5B 1W8, Canada; [Marshall, John] Univ Toronto, St Michaels Hosp, Dept Surg, Toronto, ON M5B 1W8, Canada; [Christian, Michael] Univ Toronto, Mt Sinai Hosp, Dept Med, Toronto, ON M5B 1W8, Canada; [Christian, Michael] Univ Toronto, Univ Hlth Network, Toronto, ON M5B 1W8, Canada; [Christian, Michael] Canadian Forces Hlth Serv, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Muller, MP (corresponding author), Univ Toronto, St Michaels Hosp, Dept Med, Toronto, ON M5B 1W8, Canada.	mullerm@smh.toronto.on.ca; Michael.christian@utoronto.ca	Christian, Michael/AAZ-4452-2020; mcgeer, allison/H-7747-2014; McGeer, Allison/AAB-6885-2020; Christian, Mike/AAO-6338-2020	Christian, Michael/0000-0001-9644-9950; mcgeer, allison/0000-0001-5647-6137; McGeer, Allison/0000-0001-5647-6137; Christian, Mike/0000-0001-9644-9950	Canadian Institutes for Health Research (CIHR) [CAT 86859]	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This study was funded by the Canadian Institutes for Health Research (CIHR) grant # CAT 86859 (http://www.cihr-irsc.gc.ca/e/193.html). The CIHR had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartlett John G., 2000, Clinical Infectious Diseases, V31, P347, DOI 10.1086/313954; *BRIT THOR SOC STA, 2001, THORAX S4, V56, pS1; Capelastegul A, 2006, EUR RESPIR J, V27, P151, DOI 10.1183/09031936.06.00062505; Challen K, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-33; Charles PGP, 2008, CLIN INFECT DIS, V47, P375, DOI 10.1086/589754; Christian MD, 2006, CAN MED ASSOC J, V175, P1377, DOI 10.1503/cmaj.060911; Conte HA, 1999, AM J MED, V106, P20, DOI 10.1016/S0002-9343(98)00369-6; Devereaux AV, 2008, CHEST, V133, p51S, DOI 10.1378/chest.07-2693; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Haukoos JS, 2005, ACAD EMERG MED, V12, P360, DOI 10.1197/j.aem.2004.11.018; Hick JL, 2006, ACAD EMERG MED, V13, P223, DOI [10.1111/j.1553-2712.2006.tb01677.x, 10.1197/j.aem.2005.07.037]; Kramer AA, 2007, CRIT CARE MED, V35, P2052, DOI 10.1097/01.CCM.0000275267.64078.B0; Lim WS, 2003, THORAX, V58, P377, DOI 10.1136/thorax.58.5.377; Marrie TJ, 2000, JAMA-J AM MED ASSOC, V283, P749, DOI 10.1001/jama.283.6.749; McGeer A, 2007, CLIN INFECT DIS, V45, P1568, DOI 10.1086/523584; Naughton BJ, 2000, J AM GERIATR SOC, V48, P1292, DOI 10.1111/j.1532-5415.2000.tb02604.x; Powell T, 2008, DISASTER MED PUBLIC, V2, P20, DOI 10.1097/DMP.0b013e3181620794; Schafer JL, 1999, STAT METHODS MED RES, V8, P3, DOI 10.1191/096228099671525676; Shapiro NI, 2003, CRIT CARE MED, V31, P670, DOI 10.1097/01.CCM.0000054867.01688.D1; Steyerberg EW, 2001, J CLIN EPIDEMIOL, V54, P774, DOI 10.1016/S0895-4356(01)00341-9; Talmor D, 2007, CRIT CARE MED, V35, P1251, DOI 10.1097/01.CCM.0000262385.95721.CC; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; ZWEIG MH, 1993, CLIN CHEM, V39, P561	25	36	37	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2010	5	3							e9563	10.1371/journal.pone.0009563	http://dx.doi.org/10.1371/journal.pone.0009563			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	564EX	20221431	Green Published, gold, Green Submitted			2022-12-25	WOS:000275197200013
J	Boyko, A; Blevins, T; Yao, YL; Golubov, A; Bilichak, A; Ilnytskyy, Y; Hollander, J; Meins, F; Kovalchuk, I				Boyko, Alex; Blevins, Todd; Yao, Youli; Golubov, Andrey; Bilichak, Andriy; Ilnytskyy, Yaroslav; Hollander, Jens; Meins, Frederick, Jr.; Kovalchuk, Igor			Transgenerational Adaptation of Arabidopsis to Stress Requires DNA Methylation and the Function of Dicer-Like Proteins	PLOS ONE			English	Article							HOMOLOGOUS RECOMBINATION; RNA BIOGENESIS; GENOMIC DNA; PICEA-ABIES; PLANTS; TEMPERATURE; RADIATION; PATHWAY; SIRNAS; MEMORY	Epigenetic states and certain environmental responses in mammals and seed plants can persist in the next sexual generation. These transgenerational effects have potential adaptative significance as well as medical and agronomic ramifications. Recent evidence suggests that some abiotic and biotic stress responses of plants are transgenerational. For example, viral infection of tobacco plants and exposure of Arabidopsis thaliana plants to UVC and flagellin can induce transgenerational increases in homologous recombination frequency (HRF). Here we show that exposure of Arabidopsis plants to stresses, including salt, UVC, cold, heat and flood, resulted in a higher HRF, increased global genome methylation, and higher tolerance to stress in the untreated progeny. This transgenerational effect did not, however, persist in successive generations. Treatment of the progeny of stressed plants with 5-azacytidine was shown to decrease global genomic methylation and enhance stress tolerance. Dicer-like (DCL) 2 and DCL3 encode Dicer activities important for small RNA-dependent gene silencing. Stress-induced HRF and DNA methylation were impaired in dcl2 and dcl3 deficiency mutants, while in dcl2 mutants, only stress-induced stress tolerance was impaired. Our results are consistent with the hypothesis that stress-induced transgenerational responses in Arabidopsis depend on altered DNA methylation and smRNA silencing pathways.	[Boyko, Alex; Yao, Youli; Golubov, Andrey; Bilichak, Andriy; Ilnytskyy, Yaroslav; Kovalchuk, Igor] Univ Lethbridge, Dept Biol Sci, Lethbridge, AB T1K 3M4, Canada; [Blevins, Todd] Friedrich Miescher Inst Biomed Res, Basel, Switzerland; [Hollander, Jens; Meins, Frederick, Jr.] Univ Ghent VIB, Dept Plant Syst Biol, B-9052 Ghent, Belgium; [Hollander, Jens] Univ Ghent, Dept Mol Genet, B-9000 Ghent, Belgium	University of Lethbridge; Friedrich Miescher Institute for Biomedical Research; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University	Boyko, A (corresponding author), Univ Lethbridge, Dept Biol Sci, Lethbridge, AB T1K 3M4, Canada.	igor.kovalchuk@uleth.ca	Golubov, Andrey/P-7993-2019; Hollunder, Jens/G-6588-2016	Golubov, Andrey/0000-0003-0111-8273; Hollunder, Jens/0000-0003-3234-6762	Human Frontiers Research Program; National Science and Engineering Research Council of Canada	Human Frontiers Research Program; National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was funded by the Human Frontiers Research Program, National Science and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agorio A, 2007, PLANT CELL, V19, P3778, DOI 10.1105/tpc.107.054494; Baubec T, 2009, PLANT J, V57, P542, DOI 10.1111/j.1365-313X.2008.03699.x; Blevins T, 2006, NUCLEIC ACIDS RES, V34, P6233, DOI 10.1093/nar/gkl886; Blodner C, 2007, PLANT CELL ENVIRON, V30, P165, DOI 10.1111/j.1365-3040.2006.01615.x; Bock C, 2005, BIOINFORMATICS, V21, P4067, DOI 10.1093/bioinformatics/bti652; Bond DM, 2007, TRENDS PLANT SCI, V12, P211, DOI 10.1016/j.tplants.2007.03.010; Borsani O, 2005, CELL, V123, P1279, DOI 10.1016/j.cell.2005.11.035; Boyko A, 2006, PLANT CELL PHYSIOL, V47, P736, DOI 10.1093/pcp/pcj045; Boyko A, 2007, NUCLEIC ACIDS RES, V35, P1714, DOI 10.1093/nar/gkm029; Daxinger L, 2009, EMBO J, V28, P48, DOI 10.1038/emboj.2008.260; Dyachenko OV, 2006, BIOCHEMISTRY-MOSCOW+, V71, P461, DOI 10.1134/S000629790604016X; Ebbs ML, 2006, PLANT CELL, V18, P1166, DOI 10.1105/tpc.106.041400; Galloway LF, 2007, SCIENCE, V318, P1134, DOI 10.1126/science.1148766; Gasciolli V, 2005, CURR BIOL, V15, P1494, DOI 10.1016/j.cub.2005.07.024; Grant-Downton RT, 2006, ANN BOT-LONDON, V97, P11, DOI 10.1093/aob/mcj001; Hartung F, 2006, NUCLEIC ACIDS RES, V34, P4438, DOI 10.1093/nar/gkl576; He YH, 2003, SCIENCE, V302, P1751, DOI 10.1126/science.1091109; Huettel B, 2007, BBA-GENE STRUCT EXPR, V1769, P358, DOI 10.1016/j.bbaexp.2007.03.001; Ilnytskyy Y, 2004, MUTAT RES-GEN TOX EN, V559, P189, DOI 10.1016/j.mrgentox.2004.02.001; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Johnsen O, 2005, NEW PHYTOL, V168, P589, DOI 10.1111/j.1469-8137.2005.01538.x; Kaina B, 2004, CYTOGENET GENOME RES, V104, P77, DOI 10.1159/000077469; Koturbash I, 2006, INT J RADIAT ONCOL, V66, P327, DOI 10.1016/j.ijrobp.2006.06.012; Kovalchuk I, 2004, PLANT PHYSIOL, V135, P357, DOI 10.1104/pp.104.040477; Kovalchuk O, 2003, MUTAT RES-FUND MOL M, V529, P13, DOI 10.1016/S0027-5107(03)00103-9; Kurihara Y, 2004, P NATL ACAD SCI USA, V101, P12753, DOI 10.1073/pnas.0403115101; Kvaalen H, 2008, NEW PHYTOL, V177, P49, DOI 10.1111/j.1469-8137.2007.02222.x; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Matzke M, 2007, CURR OPIN PLANT BIOL, V10, P512, DOI 10.1016/j.pbi.2007.06.007; Molinier J, 2006, NATURE, V442, P1046, DOI 10.1038/nature05022; Naumann K, 2005, EMBO J, V24, P1418, DOI 10.1038/sj.emboj.7600604; Pecinka A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005202; Pembrey ME, 2006, EUR J HUM GENET, V14, P159, DOI 10.1038/sj.ejhg.5201538; Pikaard CS, 2006, COLD SPRING HARB SYM, V71, P473, DOI 10.1101/sqb.2006.71.046; Richards EJ, 2008, CURR OPIN GENET DEV, V18, P221, DOI 10.1016/j.gde.2008.01.014; Shukla LI, 2008, BBA-GENE REGUL MECH, V1779, P743, DOI 10.1016/j.bbagrm.2008.04.004; Slotkin RK, 2009, CELL, V136, P461, DOI 10.1016/j.cell.2008.12.038; Sridhar VV, 2007, NATURE, V447, P735, DOI 10.1038/nature05864; Steward N, 2002, J BIOL CHEM, V277, P37741, DOI 10.1074/jbc.M204050200; Sung DY, 2003, TRENDS PLANT SCI, V8, P179, DOI 10.1016/S1360-1385(03)00047-5; SWOBODA P, 1994, EMBO J, V13, P484, DOI 10.1002/j.1460-2075.1994.tb06283.x; Turunen M, 2005, ENVIRON POLLUT, V137, P390, DOI 10.1016/j.envpol.2005.01.030; Wada Y, 2004, MOL GENET GENOMICS, V271, P658, DOI 10.1007/s00438-004-1018-4; Wyatt MD, 2006, CHEM RES TOXICOL, V19, P1580, DOI 10.1021/tx060164e; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Yoshikawa M, 2005, GENE DEV, V19, P2164, DOI 10.1101/gad.1352605; Zhou XF, 2008, BBA-GENE REGUL MECH, V1779, P780, DOI 10.1016/j.bbagrm.2008.04.005; Zilberman D, 2007, NAT GENET, V39, P61, DOI 10.1038/ng1929	48	314	337	5	165	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2010	5	3							e9514	10.1371/journal.pone.0009514	http://dx.doi.org/10.1371/journal.pone.0009514			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	562OZ	20209086	Green Published, gold, Green Accepted			2022-12-25	WOS:000275063400019
J	Margeli, M; Cirauqui, B; Castella, E; Tapia, G; Costa, C; Gimenez-Capitan, A; Barnadas, A; Ronco, MS; Benlloch, S; Taron, M; Rosell, R				Margeli, Mireia; Cirauqui, Beatriz; Castella, Eva; Tapia, Gustavo; Costa, Carlota; Gimenez-Capitan, Ana; Barnadas, Agusti; Sanchez Ronco, Maria; Benlloch, Susana; Taron, Miquel; Rosell, Rafael			The Prognostic Value of BRCA1 mRNA Expression Levels Following Neoadjuvant Chemotherapy in Breast Cancer	PLOS ONE			English	Article							LUNG-CANCER; INCREASED SENSITIVITY; SPORADIC BREAST; CHEMORESISTANCE; PROMOTER; SURVIVAL; SUBTYPES; MARKERS; PREDICT; AGENTS	Background: A fraction of sporadic breast cancers has low BRCA1 expression. BRCA1 mutation carriers are more likely to achieve a pathological complete response with DNA-damage-based chemotherapy compared to non-mutation carriers. Furthermore, sporadic ovarian cancer patients with low levels of BRCA1 mRNA have longer survival following platinum-based chemotherapy than patients with high levels of BRCA1 mRNA. Methodology/Principal Findings: Tumor biopsies were obtained from 86 breast cancer patients who were candidates for neoadjuvant chemotherapy, treated with four cycles of neoadjuvant fluorouracil, epirubicin and cyclophosphamide. Estrogen receptor (ER), progesterone receptor (PR), HER2, cytokeratin 5/6 and vimentin were examined by tissue microarray. HER2 were also assessed by chromogenic in situ hybridization, and BRCA1 mRNA was analyzed in a subset of 41 patients for whom sufficient tumor tissue was available by real-time quantitative PCR. Median time to progression was 42 months and overall survival was 55 months. In the multivariate analysis for time to progression and overall survival for 41 patients in whom BRCA1 could be assessed, low levels of BRCA1 mRNA, positive PR and negative lymph node involvement predicted a significantly lower risk of relapse, low levels of BRCA1 mRNA and positive PR were the only variables associated with significantly longer survival. Conclusions/Significance: We provide evidence for a major role for BRCA1 mRNA expression as a marker of time to progression and overall survival in sporadic breast cancers treated with anthracycline-based chemotherapy. These findings can be useful for customizing chemotherapy.	[Margeli, Mireia; Cirauqui, Beatriz; Taron, Miquel; Rosell, Rafael] Hosp Badalona Germans Trias & Pujol, Dept Med, Catalan Inst Oncol, Med Oncol Serv, Badalona, Spain; [Margeli, Mireia; Cirauqui, Beatriz; Taron, Miquel; Rosell, Rafael] Autonomous Univ Barcelona, Badalona, Spain; [Castella, Eva; Tapia, Gustavo] Hosp Badalona Germans Trias & Pujol, Pathol Serv, Badalona, Spain; [Costa, Carlota; Gimenez-Capitan, Ana; Benlloch, Susana; Taron, Miquel; Rosell, Rafael] USP Dexeus Univ Inst, Pangaea Biotech SA, Barcelona, Spain; [Sanchez Ronco, Maria] Univ Alcala de Henares, Madrid, Spain; [Barnadas, Agusti] Hosp Santa Creu & Sant Pau, Dept Med Oncol, Barcelona, Spain	Catalan Institute of Oncology; Hospital Germans Trias i Pujol; Autonomous University of Barcelona; Hospital Germans Trias i Pujol; Universidad de Alcala; Hospital of Santa Creu i Sant Pau	Margeli, M (corresponding author), Hosp Badalona Germans Trias & Pujol, Dept Med, Catalan Inst Oncol, Med Oncol Serv, Badalona, Spain.	33198mmv@comb.es; rrosell@ico.scs.es	Tapia, Gustavo/M-9938-2017; Giménez-Capitán, Ana/AAX-1433-2021; Castellà, Eva/K-4140-2017	Tapia Melendo, Gustavo/0000-0003-1882-0368	Redes de Cancer [RD06/0056/0020]	Redes de Cancer	This study was partially supported by a grant from Redes de Cancer (RD06/0056/0020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bache KG, 2004, EMBO J, V23, P2707, DOI 10.1038/sj.emboj.7600292; Boukovinas I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003695; Brenton JD, 2005, J CLIN ONCOL, V23, P7350, DOI 10.1200/JCO.2005.03.3845; BYRSKI T, 2007, BREAST CANC RES TREA; Carey KD, 2006, CANCER RES, V66, P8163, DOI 10.1158/0008-5472.CAN-06-0453; Chapppuis PO, 2002, J MED GENET, V39, P608, DOI 10.1136/jmg.39.8.608; Einspahr JG, 2003, CANCER RES, V63, P3891; Esteller M, 2000, JNCI-J NATL CANCER I, V92, P564, DOI 10.1093/jnci/92.7.564; Fedier A, 2003, INT J ONCOL, V22, P1169; Fisher B, 1998, J CLIN ONCOL, V16, P2672, DOI 10.1200/JCO.1998.16.8.2672; Font A, 2008, J CLIN ONCOL, V26; Grushko TA, 2004, CLIN CANCER RES, V10, P499, DOI 10.1158/1078-0432.CCR-0976-03; Husain A, 1998, CANCER RES, V58, P1120; Kirova YM, 2005, EUR J CANCER, V41, P2304, DOI 10.1016/j.ejca.2005.02.037; Korsching E, 2005, J PATHOL, V206, P451, DOI 10.1002/path.1797; Lafarge S, 2001, ONCOGENE, V20, P6597, DOI 10.1038/sj.onc.1204812; LIEDTKE C, 2006, AACR M; Livasy CA, 2006, MODERN PATHOL, V19, P264, DOI 10.1038/modpathol.3800528; Maione P, 2005, J CLIN ONCOL, V23, P6865, DOI 10.1200/JCO.2005.02.527; Masters SC, 2001, MOL PHARMACOL, V60, P1325, DOI 10.1124/mol.60.6.1325; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Oehme F, 2002, BIOCHEM BIOPH RES CO, V296, P343, DOI 10.1016/S0006-291X(02)00862-8; Ogston KN, 2003, BREAST, V12, P320, DOI 10.1016/S0960-9776(03)00106-1; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Quinn JE, 2003, CANCER RES, V63, P6221; Quinn JE, 2007, CLIN CANCER RES, V13, P7413, DOI 10.1158/1078-0432.CCR-07-1083; Rakha EA, 2008, HUM PATHOL, V39, P857, DOI 10.1016/j.humpath.2007.10.011; Rice JC, 1998, ONCOGENE, V17, P1807, DOI 10.1038/sj.onc.1202086; Rosell R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001129; Rosell R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005133; Rosell Rafael, 2008, P231, DOI 10.1007/978-1-60327-088-5_13; Rouzier R, 2005, CLIN CANCER RES, V11, P5678, DOI 10.1158/1078-0432.CCR-04-2421; SALEH EM, 2009, CELL BIOCH BIOPHYS; Scholl SM, 1995, EUR J CANCER, V31A, P1969, DOI 10.1016/0959-8049(95)00454-8; Sgagias MK, 2004, CELL CYCLE, V3, P1451, DOI 10.4161/cc.3.11.1211; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Tanner M, 2000, AM J PATHOL, V157, P1467, DOI 10.1016/S0002-9440(10)64785-2; Taron M, 2004, HUM MOL GENET, V13, P2443, DOI 10.1093/hmg/ddh260; Wang LF, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-97; Weberpals J, 2009, INT J CANCER, V124, P806, DOI 10.1002/ijc.23987	40	29	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2010	5	3							e9499	10.1371/journal.pone.0009499	http://dx.doi.org/10.1371/journal.pone.0009499			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	562OZ	20209131	Green Submitted, gold, Green Published			2022-12-25	WOS:000275063400009
J	Hauser, PV; Pippin, JW; Kaiser, C; Krofft, RD; Brinkkoetter, PT; Hudkins, KL; Kerjaschki, D; Reiser, J; Alpers, CE; Shankland, SJ				Hauser, Peter V.; Pippin, Jeffrey W.; Kaiser, Cora; Krofft, Ronald D.; Brinkkoetter, Paul T.; Hudkins, Kelly L.; Kerjaschki, Dontscho; Reiser, Jochen; Alpers, Charles E.; Shankland, Stuart J.			Novel siRNA Delivery System to Target Podocytes In Vivo	PLOS ONE			English	Article							FOCAL SEGMENTAL GLOMERULOSCLEROSIS; PARIETAL EPITHELIAL-CELLS; DOUBLE-STRANDED-RNA; GLOMERULAR PODOCYTES; INTERFERING RNAS; ANGIOTENSIN-II; MICE; EXPRESSION; APOPTOSIS; DIFFERENTIATION	Podocytes are injured in several glomerular diseases. To alter gene expression specifically in podocytes in vivo, we took advantage of their active endocytotic machinery and developed a method for the targeted delivery of small interfering ribonucleic acids (siRNA). We generated an anti-mouse podocyte antibody that binds to rat and mouse podocytes in vivo. The polyclonal IgG antibody was cleaved into monovalent fragments, while preserving the antigen recognition sites. One Neutravidin molecule was linked to each monovalent IgG via the available sulfohydryl group. Protamine, a polycationic nuclear protein and universal adaptor for anionic siRNA, was linked to the neutravidin via biotin. The delivery system was named shamporter (sheep antimouse podocyte transporter). Injection of shamporter coupled with either nephrin siRNA or TRPC6 siRNA via tail vein into normal rats substantially reduced the protein levels of nephrin or TRPC6 respectively, measured by western blot analysis and immunostaining. The effect was target specific because other podocyte-specific genes remained unchanged. Shamporter + nephrin siRNA induced transient proteinuria in rats. Control rats injected with shamporter coupled to control-siRNA showed no changes. These results show for the first time that siRNA can be delivered efficiently and specifically to podocytes in vivo using an antibody-delivery system.	[Hauser, Peter V.; Pippin, Jeffrey W.; Kaiser, Cora; Krofft, Ronald D.; Brinkkoetter, Paul T.; Shankland, Stuart J.] Univ Washington, Div Nephrol, Seattle, WA 98195 USA; [Hudkins, Kelly L.; Alpers, Charles E.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Kerjaschki, Dontscho] Vienna Med Univ, Dept Clin Pathol, Vienna, Austria; [Reiser, Jochen] Univ Miami, Div Nephrol & Hypertens, Miami, FL USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Medical University of Vienna; University of Miami	Hauser, PV (corresponding author), Univ Turin, Ctr Mol Biotechnol, Turin, Italy.	scooby@u.washington.edu	Hauser, Peter Viktor/D-4255-2009	Hauser, Peter Viktor/0000-0003-1168-034X	National Institute of Health [DK60525, DK56799, DK51096, F32 DK070434, K08DK076970]; American Diabetes Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056799, K08DK076970, R01DK051096, R01DK060525, F32DK070434] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institute of Health (DK60525, DK56799, DK51096; F32 DK070434 and K08DK076970), and by the American Diabetes Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; ADLER S, 1993, KIDNEY INT, V44, P278, DOI 10.1038/ki.1993.242; Akilesh S, 2008, P NATL ACAD SCI USA, V105, P967, DOI 10.1073/pnas.0711515105; Appel D, 2009, J AM SOC NEPHROL, V20, P333, DOI 10.1681/ASN.2008070795; Bao LH, 2009, J CLIN INVEST, V119, P1264, DOI 10.1172/JCI36000; Bariety J, 2006, J AM SOC NEPHROL, V17, P2770, DOI 10.1681/ASN.2006040325; BRONSON SK, 1994, J BIOL CHEM, V269, P27155; Davidson I., 1969, CLIN DIAGNOSIS LAB M; Done S, 2008, KIDNEY INT, V73, P697, DOI 10.1038/sj.ki.5002707; Durvasula RV, 2003, METH MOLEC MED, V86, P47; Durvasula RV, 2006, CURR OPIN NEPHROL HY, V15, P1, DOI 10.1097/01.mnh.0000199012.79670.0b; Eyre J, 2007, AM J PHYSIOL-RENAL, V292, pF674, DOI 10.1152/ajprenal.00272.2006; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Gawlik A, 2005, CURR MOL MED, V5, P527, DOI 10.2174/1566524054553522; Griffin SV, 2004, AM J PATHOL, V165, P1175, DOI 10.1016/S0002-9440(10)63378-0; Grippo PJ, 2002, GENESIS, V32, P277, DOI 10.1002/gene.10080; Harlow E, 1998, ANTIBODIES LAB MANUA; HAUSER PV, 2006, NOVEL ANTIPODOCYTES; Hiromura K, 1999, J CLIN INVEST, V103, P597, DOI 10.1172/JCI5461; Hiromura K, 2002, KIDNEY INT, V61, P1312, DOI 10.1046/j.1523-1755.2002.00257.x; Hiromura K, 2001, KIDNEY INT, V60, P2235, DOI 10.1046/j.1523-1755.2001.00057.x; Hoffmann S, 2004, J AM SOC NEPHROL, V15, P1475, DOI 10.1097/01.ASN.0000127988.42710.A7; Ingelfinger JR, 1999, AM J PHYSIOL-RENAL, V276, pF218, DOI 10.1152/ajprenal.1999.276.2.F218; Isaka Yoshitaka, 2006, Clin Exp Nephrol, V10, P229, DOI 10.1007/s10157-006-0442-7; Junghans M, 2005, EUR J PHARM BIOPHARM, V60, P287, DOI 10.1016/j.ejpb.2005.01.006; Junghans M, 2000, Nucleic Acids Res, V28, pE45, DOI 10.1093/nar/28.10.e45; Kawachi H, 2002, MICROSC RES TECHNIQ, V57, P236, DOI 10.1002/jemt.10081; Kirkman T. W., 1996, STAT USE; Kittler R, 2007, NAT METHODS, V4, P337, DOI 10.1038/NMETH1025; Logar CM, 2007, KIDNEY INT, V72, P489, DOI 10.1038/sj.ki.5002362; Mayer G, 2003, J CELL SCI, V116, P1763, DOI 10.1242/jcs.00394; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Meyer TN, 2007, KIDNEY INT, V72, P841, DOI 10.1038/sj.ki.5002450; Mundel P, 1997, EXP CELL RES, V236, P248, DOI 10.1006/excr.1997.3739; *NAT I DIAB DIG KI, 2006, NIDDK USRDS ANN DAT; O'Neal Kelly R, 2007, Methods Mol Biol, V366, P309; Ohse T, 2009, AM J PHYSL RENAL PHY; Ohse T, 2008, J AM SOC NEPHROL, V19, P1879, DOI 10.1681/ASN.2007101087; PAGTALUNAN ME, 1995, AM J PHYSIOL-RENAL, V268, pF82, DOI 10.1152/ajprenal.1995.268.1.F82; Patrakka J, 2000, KIDNEY INT, V58, P972, DOI 10.1046/j.1523-1755.2000.00254.x; Regele HM, 2000, J AM SOC NEPHROL, V11, P403, DOI 10.1681/ASN.V113403; Reiser J, 2005, NAT GENET, V37, P739, DOI 10.1038/ng1592; Ronconi E, 2009, J AM SOC NEPHROL, V20, P322, DOI 10.1681/ASN.2008070709; RUSK N, 2007, NATURE METHODS, V4, P196; Sagrinati C, 2006, J AM SOC NEPHROL, V17, P2443, DOI 10.1681/ASN.2006010089; Sassone-Corsi P, 2002, SCIENCE, V296, P2176, DOI 10.1126/science.1070963; SEEGAN GW, 1979, P NATL ACAD SCI USA, V76, P907, DOI 10.1073/pnas.76.2.907; Sever S, 2007, J CLIN INVEST, V117, P2095, DOI 10.1172/JCI32022; SLOT C, 1965, SCAND J CLIN LAB INV, V17, P381, DOI 10.3109/00365516509077065; Song EW, 2005, NAT BIOTECHNOL, V23, P709, DOI 10.1038/nbt1101; Sorgi FL, 1997, GENE THER, V4, P961, DOI 10.1038/sj.gt.3300484; Wada T, 2005, J AM SOC NEPHROL, V16, P2615, DOI 10.1681/ASN.2005020142; WIEDERMANN G, 1963, P SOC EXP BIOL MED, V113, P609; YOSHIKAWA N, 1986, ARCH PATHOL LAB MED, V110, P394	54	44	44	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2010	5	3							e9463	10.1371/journal.pone.0009463	http://dx.doi.org/10.1371/journal.pone.0009463			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	561RT	20209128	gold, Green Submitted, Green Published			2022-12-25	WOS:000274997100010
J	Liu, S				Liu, Song			Increasing Alternative Promoter Repertories Is Positively Associated with Differential Expression and Disease Susceptibility	PLOS ONE			English	Article							PSEUDOHYPOPARATHYROIDISM TYPE IB; IDIOPATHIC HYPEREOSINOPHILIC SYNDROME; GENOME-WIDE ANALYSIS; GENE-EXPRESSION; TRANSCRIPTIONAL PROMOTER; BIOLOGICAL NETWORKS; MAMMALIAN GENOMES; NCBI GEO; CELLS; FUSION	Background: Alternative Promoter (AP) usages have been shown to enable diversified transcriptional regulation of individual gene in a context-specific (e. g., pathway, cell lineage, tissue type, and development stage et. ac.) way. Aberrant uses of APs have been directly linked to mechanism of certain human diseases. However, whether or not there exists a general link between a gene's AP repertoire and its expression diversity is currently unknown. The general relation between a gene's AP repertoire and its disease susceptibility also remains largely unexplored. Methodology/Principal Findings: Based on the differential expression ratio inferred from all human microarray data in NCBI GEO and the list of disease genes curated in public repositories, we systemically analyzed the general relation of AP repertoire with expression diversity and disease susceptibility. We found that genes with APs are more likely to be differentially expressed and/or disease associated than those with Single Promoter (SP), and genes with more APs are more likely differentially expressed and disease susceptible than those with less APs. Further analysis showed that genes with increased number of APs tend to have increased length in all aspects of gene structure including 3'UTR, be associated with increased duplicability, and have increased connectivity in protein-protein interaction network. Conclusions: Our genome-wide analysis provided evidences that increasing alternative promoter repertories is positively associated with differential expression and disease susceptibility.	[Liu, Song] Roswell Pk Canc Inst, Dept Biostat, Buffalo, NY 14263 USA; [Liu, Song] SUNY Buffalo, Sch Publ Hlth & Hlth Profess, Dept Biostat, Buffalo, NY 14260 USA; [Liu, Song] SUNY Buffalo, New York State Ctr Excellence Bioinformat & Life, Buffalo, NY 14260 USA	Roswell Park Cancer Institute; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Liu, S (corresponding author), Roswell Pk Canc Inst, Dept Biostat, Buffalo, NY 14263 USA.	songliu@buffalo.edu			Health Research, Incorporated (HRI); Roswell Park Cancer Institute (RPCI)	Health Research, Incorporated (HRI); Roswell Park Cancer Institute (RPCI)	This work was supported by Health Research, Incorporated (HRI) affiliated with the Roswell Park Cancer Institute (RPCI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assenov Y, 2008, BIOINFORMATICS, V24, P282, DOI 10.1093/bioinformatics/btm554; Ayoubi TAY, 1996, FASEB J, V10, P453, DOI 10.1096/fasebj.10.4.8647344; Baek D, 2007, GENOME RES, V17, P145, DOI 10.1101/gr.5872707; Barrett T, 2007, NUCLEIC ACIDS RES, V35, pD760, DOI 10.1093/nar/gkl887; Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; Bastepe M, 2005, NAT GENET, V37, P25, DOI 10.1038/ng1487; Chen R, 2007, NAT METHODS, V4, P879, DOI 10.1038/nmeth1107-879; Chen R, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r170; Chiu IM, 2001, PROG NUCLEIC ACID RE, V70, P155, DOI 10.1016/S0079-6603(01)70016-5; CHOTANI MA, 1995, NUCLEIC ACIDS RES, V23, P434, DOI 10.1093/nar/23.3.434; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Conrad B, 2007, ANNU REV GENOM HUM G, V8, P17, DOI 10.1146/annurev.genom.8.021307.110233; Cools J, 2003, NEW ENGL J MED, V348, P1201, DOI 10.1056/NEJMoa025217; Cooper SJ, 2006, GENOME RES, V16, P1, DOI 10.1101/gr.4222606; Davuluri RV, 2008, TRENDS GENET, V24, P167, DOI 10.1016/j.tig.2008.01.008; De Gobbi M, 2006, SCIENCE, V312, P1215, DOI 10.1126/science.1126431; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Goring HHH, 2007, NAT GENET, V39, P1208, DOI 10.1038/ng2119; Griffin JH, 2003, P NATL ACAD SCI USA, V100, P7830, DOI 10.1073/pnas.0932698100; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Hayward BE, 2001, J CLIN INVEST, V107, pR31, DOI 10.1172/JCI11887; Heinrich MC, 2003, SCIENCE, V299, P708, DOI 10.1126/science.1079666; Hsu YC, 2009, DEV DYNAM, V238, P302, DOI 10.1002/dvdy.21753; Ideker T, 2008, GENOME RES, V18, P644, DOI 10.1101/gr.071852.107; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Juven-Gershon T, 2006, BIOCHEM SOC T, V34, P1047, DOI 10.1042/BST0341047; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Kimura K, 2006, GENOME RES, V16, P55, DOI 10.1101/gr.4039406; Kraft HJ, 1996, J BIOL CHEM, V271, P12873, DOI 10.1074/jbc.271.22.12873; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lalande M, 2001, J CLIN INVEST, V107, P793, DOI 10.1172/JCI12645; Landry JR, 2003, TRENDS GENET, V19, P640, DOI 10.1016/j.tig.2003.09.014; Landry JR, 2002, GENOMICS, V80, P499, DOI 10.1006/geno.2002.6863; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; Linglart A, 2005, AM J HUM GENET, V76, P804, DOI 10.1086/429932; Liu J, 2000, J CLIN INVEST, V106, P1167, DOI 10.1172/JCI10431; MARCU KB, 1992, ANNU REV BIOCHEM, V61, P809, DOI 10.1146/annurev.bi.61.070192.004113; MOSSELMAN S, 1994, CANCER RES, V54, P220; MUENKE M, 1994, NAT GENET, V8, P269, DOI 10.1038/ng1194-269; MYERS RL, 1995, J BIOL CHEM, V270, P8257, DOI 10.1074/jbc.270.14.8257; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Rouhi A, 2008, MAMM GENOME, V19, P517, DOI 10.1007/s00335-008-9133-x; Roumiantsev S, 2004, CANCER CELL, V5, P287, DOI 10.1016/S1535-6108(04)00053-4; SCHIBLER U, 1983, CELL, V33, P501, DOI 10.1016/0092-8674(83)90431-2; Simon MP, 1997, NAT GENET, V15, P95, DOI 10.1038/ng0197-95; Singer GAC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-349; Sironi M, 2005, HUM MOL GENET, V14, P2533, DOI 10.1093/hmg/ddi257; Smedley D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-22; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Sun K, 2006, CLIN HEMORHEOL MICRO, V34, P103; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107; Wakaguri H, 2008, NUCLEIC ACIDS RES, V36, pD97, DOI 10.1093/nar/gkm901; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Weinstein LS, 2007, PHARMACOL THERAPEUT, V115, P271, DOI 10.1016/j.pharmthera.2007.03.013; Weinstein LS, 1999, TRENDS ENDOCRIN MET, V10, P81, DOI 10.1016/S1043-2760(98)00124-6; Wilhelm BT, 2003, J IMMUNOL, V171, P4219, DOI 10.4049/jimmunol.171.8.4219; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Wu CH, 2006, NUCLEIC ACIDS RES, V34, pD187, DOI 10.1093/nar/gkj161; Xin DD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002377; Yu XP, 2008, NUCLEIC ACIDS RES, V36, P6494, DOI 10.1093/nar/gkn712; Zhu QQ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-9	66	13	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2010	5	3							e9482	10.1371/journal.pone.0009482	http://dx.doi.org/10.1371/journal.pone.0009482			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	561RT	20208995	Green Submitted, gold, Green Published			2022-12-25	WOS:000274997100021
J	Zautner, AE; Krause, M; Stropahl, G; Holtfreter, S; Frickmann, H; Maletzki, C; Kreikemeyer, B; Pau, HW; Podbielski, A				Zautner, Andreas E.; Krause, Merit; Stropahl, Gerhard; Holtfreter, Silva; Frickmann, Hagen; Maletzki, Claudia; Kreikemeyer, Bernd; Pau, Hans Wilhelm; Podbielski, Andreas			Intracellular Persisting Staphylococcus aureus Is the Major Pathogen in Recurrent Tonsillitis	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; FINE-NEEDLE-ASPIRATION; STREPTOCOCCUS-PYOGENES; PERITONSILLAR ABSCESS; BIOFILM FORMATION; CORE CULTURES; BACTERIOLOGY; CHILDREN; SURFACE; INTERNALIZATION	Background: The two major indications for tonsillectomy are recurrent tonsillitis (RT) and peritonsillar abscess (PTA). Unlike PTAs, which are primarily treated surgically, RT is often cured by tonsillectomy only after a series of failed drug therapy attempts. Although the bacteriological background of RT has been studied, the reason for the lack of success of conservative therapeutic approaches is not well understood. Methods: In a prospective study, tonsil specimens from 130 RT patients and 124 PTA patients were examined for the presence of extra-and intracellular bacteria using antibiotic protection assays. Staphylococcus aureus isolates from RT patients were characterized by pulsed-field gel electrophoresis (PFGE), spa-typing and MSCRAMM-gene-PCR. Their ability for biofilm formation was tested and their cell invasiveness was confirmed by a flow cytometric invasion assay (FACS), fluorescent in situ hybridization (FISH) and immunohistochemistry. Findings: S. aureus was the predominant species (57.7%) in RT patients, whereas Streptococcus pyogenes was most prevalent (20.2%) in PTA patients. Three different assays (FACS, FISH, antibiotic protection assay) showed that nearly all RT-associated S. aureus strains were located inside tonsillar cells. Correspondingly, the results of the MSCRAMM-gene-PCRs confirmed that 87% of these S. aureus isolates were invasive strains and not mere colonizers. Based upon PFGE analyses of genomic DNA and on spa-gene typing the vast majority of the S. aureus isolates belonged to different clonal lineages. Conclusions: Our results demonstrate that intracellular residing S. aureus is the most common cause of RT and indicate that S. aureus uses this location to survive the effects of antibiotics and the host immune response. A German translation of the Abstract is provided as supplementary material (Abstract S1).	[Zautner, Andreas E.; Frickmann, Hagen; Maletzki, Claudia; Kreikemeyer, Bernd; Podbielski, Andreas] Inst Med Microbiol Virol & Hyg, Rostock, Germany; [Krause, Merit; Pau, Hans Wilhelm] Otto Korner, Dept Otorhinolaryngol Head & Neck Surg, Rostock, Germany; [Stropahl, Gerhard] Univ Hosp Rostock, Inst Pathol, Rostock, Germany; [Holtfreter, Silva] Ernst Moritz Arndt Univ Greifswald, Inst Immunol & Transfus Med, Greifswald, Germany	University of Rostock; Ernst Moritz Arndt Universitat Greifswald	Zautner, AE (corresponding author), Inst Med Microbiol Virol & Hyg, Rostock, Germany.	azautne@gwdg.de	Zautner, Andreas Erich/AAE-7425-2019; Zautner, Andreas Erich/ABA-9655-2020	Zautner, Andreas Erich/0000-0003-0984-013X; Zautner, Andreas Erich/0000-0003-0984-013X; Holtfreter, Silva/0000-0002-2672-8230; Kreikemeyer, Bernd/0000-0001-9527-5098	University of Rostock	University of Rostock	The study was exclusively funded by the regular research budget of the University of Rostock. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2003, BRIT J DERMATOL, V148, P526, DOI 10.1046/j.1365-2133.2003.05162.x; Alexander EH, 2001, APPL MICROBIOL BIOT, V56, P361, DOI 10.1007/s002530100703; AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; Baldassarri L, 2007, J CLIN MICROBIOL, V45, P1284, DOI 10.1128/JCM.02119-06; Bogaert D, 2004, LANCET, V363, P1871, DOI 10.1016/S0140-6736(04)16357-5; Brojerdian S, 2000, Acta Otorhinolaryngol Belg, V54, P459; BROOK I, 1995, CLIN INFECT DIS, V21, P171, DOI 10.1093/clinids/21.1.171; Brook I, 2000, LARYNGOSCOPE, V110, P994, DOI 10.1097/00005537-200006000-00021; BROOK I, 1989, AM J OTOLARYNG, V10, P227, DOI 10.1016/0196-0709(89)90001-X; Brook I, 2005, INT J PEDIATR OTORHI, V69, P9, DOI 10.1016/j.ijporl.2004.08.007; Brook I, 2004, J ORAL MAXIL SURG, V62, P1545, DOI 10.1016/j.joms.2003.12.043; Cherukuri S, 2002, LARYNGOSCOPE, V112, P18, DOI 10.1097/00005537-200201000-00003; Chole RA, 2003, ARCH OTOLARYNGOL, V129, P634, DOI 10.1001/archotol.129.6.634; CHRISTENSEN GD, 1985, J CLIN MICROBIOL, V22, P996, DOI 10.1128/JCM.22.6.996-1006.1985; Clement S, 2005, J INFECT DIS, V192, P1023, DOI 10.1086/432735; Courvalin P, 2001, CLIN INFECT DIS, V33, pS138, DOI 10.1086/321840; Ekdahl K, 1997, CLIN INFECT DIS, V25, P1113, DOI 10.1086/516103; Endo LH, 1996, ACTA OTO-LARYNGOL, P130; Gaffney RJ, 1998, CLIN OTOLARYNGOL, V23, P181; GAFFNEY RJ, 1991, RESP MED, V85, P383, DOI 10.1016/S0954-6111(06)80182-4; Galli J, 2007, Acta Otorhinolaryngol Ital, V27, P134; Garzoni C, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-171; Garzoni C, 2009, TRENDS MICROBIOL, V17, P59, DOI 10.1016/j.tim.2008.11.005; Gavriel H, 2008, MEDICINE, V87, P33, DOI 10.1097/MD.0b013e318162a0fb; Guarner J, 2006, HUM PATHOL, V37, P1482, DOI 10.1016/j.humpath.2006.05.011; Gul M, 2007, AM J OTOLARYNG, V28, P173, DOI 10.1016/j.amjoto.2006.08.010; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Holtfreter S, 2007, J CLIN MICROBIOL, V45, P2669, DOI 10.1128/JCM.00204-07; Inci E, 2003, J INT MED RES, V31, P307; Innocentin S, 2009, APPL ENVIRON MICROB, V75, P4870, DOI 10.1128/AEM.00825-09; Jeong JH, 2007, LARYNGOSCOPE, V117, P2146, DOI 10.1097/MLG.0b013e31814543c8; Kania RE, 2007, ARCH OTOLARYNGOL, V133, P115, DOI 10.1001/archotol.133.2.115; Kasenomm P, 2005, BMC EAR NOSE THROAT, V5, DOI 10.1186/1472-6815-5-7; Kempf VAJ, 2000, J CLIN MICROBIOL, V38, P830, DOI 10.1128/JCM.38.2.830-838.2000; Knobloch JKM, 2002, MED MICROBIOL IMMUN, V191, P101, DOI 10.1007/s00430-002-0124-3; Koziel J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005210; Krimmer V, 1999, J CLIN MICROBIOL, V37, P2667, DOI 10.1128/JCM.37.8.2667-2673.1999; KUHN JJ, 1995, ANN OTO RHINOL LARYN, V104, P646, DOI 10.1177/000348949510400810; Lemaire S, 2008, CLIN MICROBIOL INFEC, V14, P766, DOI 10.1111/j.1469-0691.2008.02035.x; Lembke C, 2006, APPL ENVIRON MICROB, V72, P2864, DOI 10.1128/AEM.72.4.2864-2875.2006; Lindroos R, 2000, ACTA OTO-LARYNGOL, P206; Loganathan A., 2006, SMJ Singapore Medical Journal, V47, P271; Lowy FD, 2000, TRENDS MICROBIOL, V8, P341, DOI 10.1016/S0966-842X(00)01803-5; Mahakit CP, 2006, CLIN THER, V28, P99, DOI 10.1016/j.clinthera.2006.01.006; McDougal LK, 2003, J CLIN MICROBIOL, V41, P5113, DOI 10.1128/JCM.41.11.5113-5120.2003; MITCHELMORE IJ, 1994, EUR J CLIN MICROBIOL, V13, P542, DOI 10.1007/BF01971304; Niederfuhr A, 2008, ALLERGY, V63, P1359, DOI 10.1111/j.1398-9995.2008.01798.x; Niederfuhr A, 2009, ARCH OTOLARYNGOL, V135, P131, DOI 10.1001/archoto.2008.531; Nilsson P, 2006, J CLIN MICROBIOL, V44, P3334, DOI 10.1128/JCM.00880-06; Orrling A, 1997, ACTA OTO-LARYNGOL, V117, P618, DOI 10.3109/00016489709113448; Osterlund A, 1997, LARYNGOSCOPE, V107, P640; PARADISE JL, 1984, NEW ENGL J MED, V310, P674, DOI 10.1056/NEJM198403153101102; Payne SC, 2007, CLIN INFECT DIS, V45, pE121, DOI 10.1086/522763; Peacock SJ, 2002, INFECT IMMUN, V70, P4987, DOI 10.1128/IAI.70.9.4987-4996.2002; Pichichero ME, 2007, OTOLARYNG HEAD NECK, V137, P851, DOI 10.1016/j.otohns.2007.07.033; Pils S, 2006, J MICROBIOL METH, V65, P301, DOI 10.1016/j.mimet.2005.08.013; Plouin-Gaudon I, 2006, RHINOLOGY, V44, P249; Podbielski A, 2003, INT J MED MICROBIOL, V293, P179, DOI 10.1078/1438-4221-00253; Post J Christopher, 2007, Curr Opin Otolaryngol Head Neck Surg, V15, P347, DOI 10.1097/MOO.0b013e3282b97327; Regev-Yochay G, 2004, JAMA-J AM MED ASSOC, V292, P716, DOI 10.1001/jama.292.6.716; Sandberg A, 2009, ANTIMICROB AGENTS CH, V53, P1874, DOI 10.1128/AAC.01605-07; Schraff S, 2001, INT J PEDIATR OTORHI, V57, P213, DOI 10.1016/S0165-5876(00)00447-X; Sclafani AP, 1998, PEDIATRICS, V101, P675, DOI 10.1542/peds.101.4.675; Sinha B, 1999, CELL MICROBIOL, V1, P101, DOI 10.1046/j.1462-5822.1999.00011.x; Sinha B, 2000, INFECT IMMUN, V68, P6871, DOI 10.1128/IAI.68.12.6871-6878.2000; Skoulakis C, 2008, SCAND J INFECT DIS, V40, P899, DOI 10.1080/00365540802419048; Stenz L, 2008, FEMS MICROBIOL LETT, V287, P149, DOI 10.1111/j.1574-6968.2008.01316.x; Stepanovic S, 2001, EUR J CLIN MICROBIOL, V20, P502; Stjernquist-Desatnik A, 1999, ACTA OTO-LARYNGOL, V119, P102; Summers AO, 2002, CLIN INFECT DIS, V34, pS85, DOI 10.1086/340245; Swidsinski A, 2007, J CLIN PATHOL, V60, P253, DOI 10.1136/jcp.2006.037309; Szuhay G, 1998, J OTOLARYNGOL, V27, P206; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; TIMON CI, 1990, RESP MED, V84, P395, DOI 10.1016/S0954-6111(08)80074-1; Tristan A, 2003, J CLIN MICROBIOL, V41, P4465, DOI 10.1128/JCM.41.9.4465-4467.2003; van der Veen EL, 2006, EUR ARCH OTO-RHINO-L, V263, P750, DOI 10.1007/s00405-006-0046-6; van Staaij BK, 2003, ACTA OTO-LARYNGOL, V123, P873, DOI 10.1080/00016480310000395; VandenBergh MFQ, 1999, J LAB CLIN MED, V133, P525, DOI 10.1016/S0022-2143(99)90181-6; WOLF M, 1995, INT J PEDIATR OTORHI, V31, P43, DOI 10.1016/0165-5876(94)01072-6; Woolford TJ, 1999, INT J CLIN PRACT, V53, P96	80	72	77	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2010	5	3							e9452	10.1371/journal.pone.0009452	http://dx.doi.org/10.1371/journal.pone.0009452			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	561RT	20209109	gold, Green Submitted, Green Published			2022-12-25	WOS:000274997100004
J	Seet, LF; Su, R; Barathi, VA; Lee, WS; Poh, R; Heng, YM; Manser, E; Vithana, EN; Aung, T; Weaver, M; Sage, EH; Wong, TT				Seet, Li-Fong; Su, Roseline; Barathi, V. A.; Lee, Wing Sum; Poh, Rebekah; Heng, Yee Meng; Manser, Ed; Vithana, Eranga N.; Aung, Tin; Weaver, Matt; Sage, E. Helene; Wong, Tina T.			SPARC Deficiency Results in Improved Surgical Survival in a Novel Mouse Model of Glaucoma Filtration Surgery	PLOS ONE			English	Article							TISSUE GROWTH-FACTOR; TGF-BETA; NORMAL FIBROBLASTS; COLLAGEN MATRIX; EXPRESSION; ACTIVATION; MECHANISMS; MITOMYCIN; ENDOPHTHALMITIS; MYOFIBROBLASTS	Glaucoma is a disease frequently associated with elevated intraocular pressure that can be alleviated by filtration surgery. However, the post-operative subconjunctival scarring response which blocks filtration efficiency is a major hurdle to the achievement of long-term surgical success. Current application of anti-proliferatives to modulate the scarring response is not ideal as these often give rise to sight-threatening complications. SPARC (secreted protein, acidic and rich in cysteine) is a matricellular protein involved in extracellular matrix (ECM) production and organization. In this study, we investigated postoperative surgical wound survival in an experimental glaucoma filtration model in SPARC-null mice. Loss of SPARC resulted in a marked (87.5%) surgical wound survival rate compared to 0% in wild-type (WT) counterparts. The larger SPARC-null wounds implied that aqueous filtration through the subconjunctival space was more efficient in comparison to WT wounds. The pronounced increase in both surgical survival and filtration efficiency was associated with a less collagenous ECM, smaller collagen fibril diameter, and a loosely-organized subconjunctival matrix in the SPARC-null wounds. In contrast, WT wounds exhibited a densely packed collagenous ECM with no evidence of filtration capacity. Immunolocalization assays confirmed the accumulation of ECM proteins in the WT but not in the SPARC-null wounds. The observations in vivo were corroborated by complementary data performed on WT and SPARC-null conjunctival fibroblasts in vitro. These findings indicate that depletion of SPARC bestows an inherent change in post-operative ECM remodeling to favor wound maintenance. The evidence presented in this report is strongly supportive for the targeting of SPARC to increase the success of glaucoma filtration surgery.	[Seet, Li-Fong; Su, Roseline; Barathi, V. A.; Lee, Wing Sum; Poh, Rebekah; Wong, Tina T.] Singapore Eye Res Inst, Ocular Wound Healing & Therapeut Grp, Singapore, Singapore; [Aung, Tin; Wong, Tina T.] Singapore Natl Eye Ctr, Dept Glaucoma, Singapore, Singapore; [Aung, Tin; Wong, Tina T.] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore 117595, Singapore; [Heng, Yee Meng; Manser, Ed] ASTAR, Inst Med Biol, Singapore, Singapore; [Vithana, Eranga N.; Aung, Tin] Singapore Eye Res Inst, Ocular Genet Grp, Singapore, Singapore; [Weaver, Matt; Sage, E. Helene] Benaroya Res Inst Virginia Mason, Seattle, WA USA	National University of Singapore; Singapore National Eye Center; Singapore National Eye Center; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); National University of Singapore; Singapore National Eye Center; Benaroya Research Institute; Virginia Mason Medical Center	Seet, LF (corresponding author), Singapore Eye Res Inst, Ocular Wound Healing & Therapeut Grp, Singapore, Singapore.	ttl_wong@hotmail.com	Manser, Edward/ABD-2301-2020		National Research Foundation Translational and Clinical Research (TCR) Programme Grant [R617/38/2008]; National Medical Research Council (NMRC) [R606/27/2008]; SingHealth Foundation [SHF/PD002/2006]	National Research Foundation Translational and Clinical Research (TCR) Programme Grant; National Medical Research Council (NMRC)(National Medical Research Council, Singapore); SingHealth Foundation(SingHealth)	This study is supported by the National Research Foundation Translational and Clinical Research (TCR) Programme Grant (R617/38/2008) and a research grant from the National Medical Research Council (NMRC, R606/27/2008) to T. Wong. L.-F. Seet is supported by a research grant from the SingHealth Foundation (SHF/PD002/2006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora PD, 1999, AM J PATHOL, V154, P871, DOI 10.1016/S0002-9440(10)65334-5; Basu A, 2001, BMC CELL BIOL, V2, DOI 10.1186/1471-2121-2-15; Bornstein P, 2002, CURR OPIN CELL BIOL, V14, P608, DOI 10.1016/S0955-0674(02)00361-7; Bradshaw AD, 2003, J INVEST DERMATOL, V120, P949, DOI 10.1046/j.1523-1747.2003.12241.x; Branton MH, 1999, MICROBES INFECT, V1, P1349, DOI 10.1016/S1286-4579(99)00250-6; Brekken Rolf A., 2001, Matrix Biology, V19, P816; Clark R., 1996, Mezhdunarodnyi Sel'skokhozyaistvennyi Zhurnal, P3; Daniels JT, 2003, AM J PATHOL, V163, P2043, DOI 10.1016/S0002-9440(10)63562-6; Deryugina EI, 1998, CANCER RES, V58, P3743; Dhore CR, 2001, ARTERIOSCL THROM VAS, V21, P1998, DOI 10.1161/hq1201.100229; Diegelmann RF, 1997, J UROLOGY, V157, P298, DOI 10.1016/S0022-5347(01)65364-3; EHRLICH HP, 1990, TISSUE CELL, V22, P407, DOI 10.1016/0040-8166(90)90070-P; Esson DW, 2004, INVEST OPHTH VIS SCI, V45, P485, DOI 10.1167/iovs.03-0485; FRIZELL E, 1995, HEPATOLOGY, V21, P847, DOI 10.1002/hep.1840210335; Greenfield DS, 1996, ARCH OPHTHALMOL-CHIC, V114, P943, DOI 10.1001/archopht.1996.01100140151007; Grinnell F, 2003, TRENDS CELL BIOL, V13, P264, DOI 10.1016/S0962-8924(03)00057-6; GRINNELL F, 1994, J CELL BIOL, V124, P401, DOI 10.1083/jcb.124.4.401; Higginbotham EJ, 1996, OPHTHALMOLOGY, V103, P650, DOI 10.1016/S0161-6420(96)30639-8; Itoh S, 2003, J BIOL CHEM, V278, P3751, DOI 10.1074/jbc.M208258200; JUNQUEIRA LCU, 1979, HISTOCHEM J, V11, P447, DOI 10.1007/BF01002772; Kanauchi M, 2000, DIABETOLOGIA, V43, P1076; KITAZAWA Y, 1991, ARCH OPHTHALMOL-CHIC, V109, P1693, DOI 10.1001/archopht.1991.01080120077030; Ko MK, 2005, INVEST OPHTH VIS SCI, V46, P4495, DOI 10.1167/iovs.05-0818; KUHN C, 1995, AM J PATHOL, V147, P1759; Martinek N, 2007, J DENT RES, V86, P296, DOI 10.1177/154405910708600402; McClung HM, 2007, NEUROSCI LETT, V419, P172, DOI 10.1016/j.neulet.2007.04.037; Mehta JS, 2008, CORNEA, V27, P722, DOI 10.1097/QAI.0b013e31815e92ac; Moretti FA, 2007, J BIOL CHEM, V282, P28057, DOI 10.1074/jbc.M611315200; Pichler RH, 1996, KIDNEY INT, V50, P1978, DOI 10.1038/ki.1996.520; Quigley HA, 2006, BR J OPHTHALMOL, V90, P151, DOI DOI 10.1136/BJ0.2005.081224; Ramirez F, 2006, MATRIX BIOL, V25, P365, DOI 10.1016/j.matbio.2006.05.002; REDDICK R, 1985, ANN OPHTHALMOL, V17, P200; Rentz TJ, 2007, J BIOL CHEM, V282, P22062, DOI 10.1074/jbc.M700167200; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; SATO H, 1994, NATURE, V370, P61, DOI 10.1038/370061a0; Schellings MWM, 2009, J EXP MED, V206, P113, DOI 10.1084/jem.20081244; Schiemann BJ, 2003, MOL BIOL CELL, V14, P3977, DOI 10.1091/mbc.E03-01-0001; SCHIFFMAN J, 1989, AM J OPHTHALMOL, V108, P625; SELTZER JL, 1994, EXP CELL RES, V213, P365, DOI 10.1006/excr.1994.1211; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; SKUTA GL, 1992, OPHTHALMOLOGY, V99, P438; Strandjord TP, 1999, AM J PHYSIOL-LUNG C, V277, pL628, DOI 10.1152/ajplung.1999.277.3.L628; Tamariz E, 2002, MOL BIOL CELL, V13, P3915, DOI 10.1091/mbc.E02-05-0291; Van Veldhuisen PC, 2000, AM J OPHTHALMOL, V130, P429; Willis BC, 2007, AM J PHYSIOL-LUNG C, V293, pL525, DOI 10.1152/ajplung.00163.2007; Wynn TA, 2007, J CLIN INVEST, V117, P524, DOI 10.1172/JCI31487; Zhou XD, 2002, ARTHRITIS RHEUM-US, V46, P2990, DOI 10.1002/art.10601; Zhou XD, 2006, ARTHRITIS RHEUM-US, V54, P2626, DOI 10.1002/art.21973	48	49	54	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2010	5	2							e9415	10.1371/journal.pone.0009415	http://dx.doi.org/10.1371/journal.pone.0009415			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SY	20195533	Green Submitted, gold, Green Published			2022-12-25	WOS:000274924300006
J	Gamazon, ER; Zhang, W; Dolan, ME; Cox, NJ				Gamazon, Eric R.; Zhang, Wei; Dolan, M. Eileen; Cox, Nancy J.			Comprehensive Survey of SNPs in the Affymetrix Exon Array Using the 1000 Genomes Dataset	PLOS ONE			English	Article							HUMAN GENE-EXPRESSION; INDUCED CYTOTOXICITY; PHARMACOGENOMIC DISCOVERY; HAPLOTYPE MAP; VARIANTS; POPULATION; PROJECT; IMPACT; POLYMORPHISMS; SEQUENCES	Microarray gene expression data has been used in genome-wide association studies to allow researchers to study gene regulation as well as other complex phenotypes including disease risks and drug response. To reach scientifically sound conclusions from these studies, however, it is necessary to get reliable summarization of gene expression intensities. Among various factors that could affect expression profiling using a microarray platform, single nucleotide polymorphisms ( SNPs) in target mRNA may lead to reduced signal intensity measurements and result in spurious results. The recently released 1000 Genomes Project dataset provides an opportunity to evaluate the distribution of both known and novel SNPs in the International HapMap Project lymphoblastoid cell lines (LCLs). We mapped the 1000 Genomes Project genotypic data to the Affymetrix GeneChip Human Exon 1.0ST array (exon array), which had been used in our previous studies and for which gene expression data had been made publicly available. We also evaluated the potential impact of these SNPs on the differentially spliced probesets we had identified previously. Though the 1000 Genomes Project data allowed a comprehensive survey of the SNPs in this particular array, the same approach can certainly be applied to other microarray platforms. Furthermore, we present a detailed catalogue of SNP-containing probesets (exon-level) and transcript clusters (gene-level), which can be considered in evaluating findings using the exon array as well as benefit the design of follow-up experiments and data re-analysis.	[Gamazon, Eric R.; Cox, Nancy J.] Univ Chicago, Dept Med, Med Genet Sect, Chicago, IL 60637 USA; [Zhang, Wei; Dolan, M. Eileen] Univ Chicago, Dept Med, Hematol Oncol Sect, Chicago, IL 60637 USA; [Cox, Nancy J.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago	Gamazon, ER (corresponding author), Univ Chicago, Dept Med, Med Genet Sect, 5841 S Maryland Ave, Chicago, IL 60637 USA.	ncox@medicine.bsd.uchicago.edu	Gamazon, Eric/I-6873-2018	Gamazon, Eric/0000-0003-4204-8734	National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS) [U01GM61393]; National Institutes of Health/National Cancer Institute (NIH/NCI) [P50 CA125183]; University of Chicago Cancer Research Center Pilot; NIH/NIGMS [U01GM61374]; NATIONAL CANCER INSTITUTE [P50CA125183] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM061374, U01GM061393] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health/National Cancer Institute (NIH/NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); University of Chicago Cancer Research Center Pilot; NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded through the Pharmacogenetics of Anticancer Agents Research Group (http://www.pharmacogenetics.org/) by the National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS) grant U01GM61393, National Institutes of Health/National Cancer Institute (NIH/NCI) Breast SPORE P50 CA125183 and University of Chicago Cancer Research Center Pilot Project Program. Data deposits are supported by the NIH/NIGMS grant U01GM61374 (http://www.pharmgkb.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000622; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Auer Herbert, 2009, V509, P35, DOI 10.1007/978-1-59745-372-1_3; Benovoy D, 2008, NUCLEIC ACIDS RES, V36, P4417, DOI 10.1093/nar/gkn409; Duan SW, 2009, RNA BIOL, V6, P412, DOI 10.4161/rna.6.4.8830; Duan SW, 2008, BIOINFORMATION, V2, P469, DOI 10.6026/97320630002469; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; GAMAZON E, PHARMACOGEN IN PRESS; Gamazon ER, 2010, BIOINFORMATICS, V26, P259, DOI 10.1093/bioinformatics/btp644; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Harismendy O, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r32; Hartford CM, 2009, BLOOD, V113, P2145, DOI 10.1182/blood-2008-05-154302; Huang RS, 2008, MOL CANCER THER, V7, P3038, DOI 10.1158/1535-7163.MCT-08-0248; Huang RS, 2008, CANCER RES, V68, P3161, DOI 10.1158/0008-5472.CAN-07-6381; Huang RS, 2007, P NATL ACAD SCI USA, V104, P9758, DOI 10.1073/pnas.0703736104; Huang RS, 2007, AM J HUM GENET, V81, P427, DOI 10.1086/519850; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kwan T, 2008, NAT GENET, V40, P225, DOI 10.1038/ng.2007.57; Mardis ER, 2008, ANNU REV GENOM HUM G, V9, P387, DOI 10.1146/annurev.genom.9.081307.164359; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Sliwerska E, 2007, BIOL PSYCHIAT, V61, P13, DOI 10.1016/j.biopsych.2006.01.023; Spielman RS, 2007, NAT GENET, V39, P226, DOI 10.1038/ng1955; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Takeuchi F, 2008, J HUM GENET, V53, P96, DOI 10.1007/s10038-007-0221-7; Tantoso E, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-238; Taylor JA, 2006, CANCER EPIDEM BIOMAR, V15, P133, DOI 10.1158/1055-9965.EPI-05-0641; Tishkoff SA, 2002, NAT REV GENET, V3, P611, DOI 10.1038/nrg865; Welsh M, 2009, PHARMACOL REV, V61, P413, DOI 10.1124/pr.109.001461; Zhang W, 2008, CURR BIOINFORM, V3, P178, DOI 10.2174/157489308785909232; Zhang W, 2008, BIOINFORM BIOL INSIG, V2, P15; Zhang W, 2008, AM J HUM GENET, V82, P631, DOI 10.1016/j.ajhg.2007.12.015; Zhang W, 2010, PHARMACOGENOMICS, V11, P249, DOI [10.2217/pgs.09.173, 10.2217/PGS.09.173]; Zhang W, 2009, HUM GENET, V125, P81, DOI 10.1007/s00439-008-0601-x	36	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2010	5	2							e9366	10.1371/journal.pone.0009366	http://dx.doi.org/10.1371/journal.pone.0009366			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SV	20186275	Green Published, gold, Green Submitted			2022-12-25	WOS:000274924000009
J	Jansma, AL; Kirkpatrick, JP; Hsu, AR; Handel, TM; Nietlispach, D				Jansma, Ariane L.; Kirkpatrick, John P.; Hsu, Andro R.; Handel, Tracy M.; Nietlispach, Daniel			NMR Analysis of the Structure, Dynamics, and Unique Oligomerization Properties of the Chemokine CCL27	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-3; GLYCOSAMINOGLYCAN-BINDING-SITE; IN-VIVO ACTIVITY; CHEMICAL-EXCHANGE; CC-CHEMOKINE; ROTATIONAL DIFFUSION; RELAXATION DATA; IDENTIFICATION; INFLAMMATION; SYSTEM	Chemokines have two essential interactions in vivo, with G protein-coupled receptors, which activate intracellular signaling pathways, and with glycosaminoglycans (GAGs), which are involved in cell surface localization and transport. Although it has been shown that chemokines bind and activate their respective G protein-coupled receptors as monomers, many chemokines oligomerize upon GAG binding, and the ability to oligomerize and bind GAGs is required for in vivo function. In this study, we investigated the structure, dynamics, and oligomerization behavior of cutaneous T-cell-attracting chemokine (CTACK, also known as CCL27) by NMR. N-15 relaxation and translational self-diffusion rates indicate that CCL27 oligomerizes, but in contrast to many other chemokines that form relatively discrete oligomers, CCL27 transitions between monomer, dimer, and tetramer species over a relatively narrow concentration range. A three-dimensional structure determination was pursued under conditions where CCL27 is primarily dimeric, revealing the standard motif for a chemokine monomer. Analysis of chemical shift perturbations of H-1-N-15 HSQC spectra, relaxation-dispersion experiments, and filtered nuclear Over-hauser effects suggest that CCL27 does not adopt a discrete CXC or CC dimer motif. Instead, CCL27 has uncommon oligomerization behavior, where several equilibria involving relatively low affinity interactions between different interfaces seem to be simultaneously at work. However, interaction with heparin avidly promotes oligomerization under conditions where CCL27 is monomeric by itself. We hypothesize that the plasticity in the oligomerization state may enable CCL27 to adopt different oligomeric structures, depending on the nature of the GAG binding partner, thereby providing a mechanism for increased diversity and specificity in GAG-binding and GAG-related functions.	Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Jansma, Ariane L.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Kirkpatrick, John P.; Nietlispach, Daniel] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England	University of California System; University of California San Diego; University of California System; University of California San Diego; University of Cambridge		thandel@ucsd.edu; dn206@bioc.cam.ac.uk		Nietlispach, Daniel/0000-0003-4364-9291	National Institutes of Health [RO1-AI37113, RO1-GM081763, GM08326]; Biotechnology and Biological Sciences and Research Council (BBSRC); BBSRC [BB/G011915/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G011915/1, BB/E013228/1] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI037113] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008326, R01GM081763] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences and Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1-AI37113 and RO1-GM081763 (to T. M. H.) and NIH Molecular Biophysics Training Grant GM08326 (to A. L. J.). The NMR facility of the Biochemistry Department in Cambridge is supported by the Biotechnology and Biological Sciences and Research Council (BBSRC).	Ali S, 2005, J IMMUNOL, V175, P1257, DOI 10.4049/jimmunol.175.2.1257; Allen SJ, 2007, ANNU REV IMMUNOL, V25, P787, DOI 10.1146/annurev.immunol.24.021605.090529; ALTIERI AS, 1995, J AM CHEM SOC, V117, P7566, DOI 10.1021/ja00133a039; Baggiolini M, 1998, NATURE, V392, P565, DOI 10.1038/33340; Baggiolini M, 1997, ANNU REV IMMUNOL, V15, P675, DOI 10.1146/annurev.immunol.15.1.675; Baysal C, 2001, PROTEINS, V43, P150, DOI 10.1002/1097-0134(20010501)43:2<150::AID-PROT1027>3.0.CO;2-M; Bernado P, 2002, J BIOMOL NMR, V23, P139, DOI 10.1023/A:1016359412284; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Blain KY, 2007, BIOCHEMISTRY-US, V46, P10008, DOI 10.1021/bi700936w; Brini E, 2009, J NEUROIMMUNOL, V209, P33, DOI 10.1016/j.jneuroim.2009.01.022; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Campanella GSV, 2006, J IMMUNOL, V177, P6991, DOI 10.4049/jimmunol.177.10.6991; Carrasco B, 1999, BIOPHYS J, V76, P3044, DOI 10.1016/S0006-3495(99)77457-6; Catanzariti AM, 2004, PROTEIN SCI, V13, P1331, DOI 10.1110/ps.04618904; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; CHUNG CW, 1995, BIOCHEMISTRY-US, V34, P9307, DOI 10.1021/bi00029a005; CLORE GM, 1990, BIOCHEMISTRY-US, V29, P1689, DOI 10.1021/bi00459a004; CLORE GM, 1990, J AM CHEM SOC, V112, P4989, DOI 10.1021/ja00168a070; Colobran R, 2007, CLIN EXP IMMUNOL, V148, P208, DOI 10.1111/j.1365-2249.2007.03344.x; Czaplewski LG, 1999, J BIOL CHEM, V274, P16077, DOI 10.1074/jbc.274.23.16077; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dosset P, 2000, J BIOMOL NMR, V16, P23, DOI 10.1023/A:1008305808620; FAIRBROTHER WJ, 1994, J MOL BIOL, V242, P252, DOI 10.1006/jmbi.1994.1577; Fernandez EJ, 2002, ANNU REV PHARMACOL, V42, P469, DOI 10.1146/annurev.pharmtox.42.091901.115838; Ghose R, 1998, J MAGN RESON, V134, P308, DOI 10.1006/jmre.1998.1499; Handel TM, 1996, BIOCHEMISTRY-US, V35, P6569, DOI 10.1021/bi9602270; Handel TM, 2008, J LEUKOCYTE BIOL, V84, P1101, DOI 10.1189/jlb.0108061; Hartley O, 2003, J VIROL, V77, P6637, DOI 10.1128/JVI.77.12.6637-6644.2003; Holmes WD, 2001, PROTEIN EXPRES PURIF, V21, P367, DOI 10.1006/prep.2001.1402; Homey B, 2000, J IMMUNOL, V164, P3465, DOI 10.4049/jimmunol.164.7.3465; Homey B, 2002, NAT MED, V8, P157, DOI 10.1038/nm0202-157; Hoogewerf AJ, 1997, BIOCHEMISTRY-US, V36, P13570, DOI 10.1021/bi971125s; Hwang TL, 1997, J AM CHEM SOC, V119, P6203, DOI 10.1021/ja970160j; Imberty A, 2007, CARBOHYD RES, V342, P430, DOI 10.1016/j.carres.2006.12.019; Jabeen T, 2008, ACTA CRYSTALLOGR D, V64, P611, DOI 10.1107/S0907444908007026; Jansma A, 2009, METHOD ENZYMOL, V461, P31, DOI 10.1016/S0076-6879(09)05402-0; Jin HJ, 2005, BIOCHEM BIOPH RES CO, V338, P987, DOI 10.1016/j.bbrc.2005.10.062; Johnson Z, 2005, CYTOKINE GROWTH F R, V16, P625, DOI 10.1016/j.cytogfr.2005.04.006; Kanelis V, 2001, IUBMB LIFE, V52, P291, DOI 10.1080/152165401317291147; Kim KS, 1996, FEBS LETT, V395, P277, DOI 10.1016/0014-5793(96)01024-1; Koopmann W, 1997, J BIOL CHEM, V272, P10103; Kroenke CD, 1998, J AM CHEM SOC, V120, P7905, DOI 10.1021/ja980832l; Kuloglu ES, 2002, J BIOL CHEM, V277, P17863, DOI 10.1074/jbc.M200402200; Kunkel EJ, 2002, IMMUNITY, V16, P1, DOI 10.1016/S1074-7613(01)00261-8; Kuschert GSV, 1999, BIOCHEMISTRY-US, V38, P12959, DOI 10.1021/bi990711d; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lau EK, 2004, ADV PROTEIN CHEM, V68, P351; Lau EK, 2004, J BIOL CHEM, V279, P22294, DOI 10.1074/jbc.M311224200; Linge JP, 2001, METHOD ENZYMOL, V339, P71, DOI 10.1016/S0076-6879(01)39310-2; Loria JP, 1999, J AM CHEM SOC, V121, P2331, DOI 10.1021/ja983961a; Lubkowski J, 1997, NAT STRUCT BIOL, V4, P64, DOI 10.1038/nsb0197-64; MAYO KH, 1995, BIOCHEMISTRY-US, V34, P11399, DOI 10.1021/bi00036a012; Murakami T, 2004, J DERMATOL SCI, V36, P71, DOI 10.1016/j.jdermsci.2004.03.002; Murphy JW, 2007, J BIOL CHEM, V282, P10018, DOI 10.1074/jbc.M608796200; Nilges M, 1998, PROG NUCL MAG RES SP, V32, P107, DOI 10.1016/S0079-6565(97)00025-3; O'Hayre M, 2008, BIOCHEM J, V409, P635, DOI 10.1042/BJ20071493; Proudfoot AEI, 2003, P NATL ACAD SCI USA, V100, P1885, DOI 10.1073/pnas.0334864100; Bono MR, 2007, CYTOKINE GROWTH F R, V18, P33, DOI 10.1016/j.cytogfr.2007.01.004; Swaminathan GJ, 2003, STRUCTURE, V11, P521, DOI 10.1016/S0969-2126(03)00070-4; Veldkamp CT, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160755; Veldkamp CT, 2005, PROTEIN SCI, V14, P1071, DOI 10.1110/ps.041219505; Volkman BF, 2009, METHOD ENZYMOL, V461, P51, DOI 10.1016/S0076-6879(09)05403-2; Wang CY, 2003, J AM CHEM SOC, V125, P8968, DOI 10.1021/ja035139z; Yu YH, 2005, J BIOL CHEM, V280, P32200, DOI 10.1074/jbc.M505738200	65	47	48	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14424	14437		10.1074/jbc.M109.091108	http://dx.doi.org/10.1074/jbc.M109.091108			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20200157	Green Published, hybrid			2022-12-25	WOS:000277299700039
J	Kim, MJ; Park, IJ; Yun, H; Kang, I; Choe, W; Kim, SS; Ha, J				Kim, Min-Jung; Park, In-Ja; Yun, Hee; Kang, Insug; Choe, Wonchae; Kim, Sung-Soo; Ha, Joohun			AMP-activated Protein Kinase Antagonizes Pro-apoptotic Extracellular Signal-regulated Kinase Activation by Inducing Dual-specificity Protein Phosphatases in Response to Glucose Deprivation in HCT116 Carcinoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAP-KINASES; CARDIAC FIBROBLASTS; CELL PROLIFERATION; GENOTOXIC STRESS; GROWTH; P53; EXPRESSION; MITOGEN; PATHWAY; ERK	Mitogen-activated protein kinase (MAPK) pathways are involved in the regulation of cellular responses, including cell proliferation, differentiation, cell growth, and apoptosis. Because these responses are tightly related to cellular energy level, AMP-activated protein kinase (AMPK), which plays an essential role in energy homeostasis, has emerged as another key regulator. In the present study, we demonstrate a novel signal network between AMPK and MAPK in HCT116 human colon carcinoma. Glucose deprivation activated AMPK and three MAPK subfamilies, extracellular signal-regulated kinase (ERK), c-Jun NH2-terminal kinase (JNK), and p38 MAPK. Under these conditions, inhibition of endogenous AMPK by expressing a dominant-negative form significantly potentiated ERK activation, indicating that glucose deprivation-induced AMPK is specifically antagonizing ERK activity in HCT116 cells. Moreover, we provide novel evidence that AMPK activity is critical for p53-dependent expression of dual-specificity phosphatase (DUSP) 1 & 2, which are negative regulators of ERK. Notably, ERK exhibits pro-apoptotic effects in HCT116 cells under glucose deprivation. Collectively, our data suggest that AMPK protects HCT116 cancer cells from glucose deprivation, in part, via inducing DUSPs, which suppresses pro-apoptotic ERK, further implying that a signal network between AMPK and ERK is a critical regulatory point in coupling the energy status of the cell to the regulation of cell survival.	[Ha, Joohun] Kyung Hee Univ, Sch Med, Dept Biochem & Mol Biol, Med Res Ctr, Seoul 130701, South Korea; Kyung Hee Univ, Sch Med, Inst Biomed Sci, Seoul 130701, South Korea	Kyung Hee University; Kyung Hee University	Ha, J (corresponding author), Kyung Hee Univ, Sch Med, Dept Biochem & Mol Biol, Med Res Ctr, 1 Hoegidong, Seoul 130701, South Korea.	hajh@khu.ac.kr	Kim, Sung Soo/S-2540-2017	Kim, Sung Soo/0000-0002-6817-7668	Korean government (MEST) [20090080996, 20090091345]	Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by Korea Science and Engineering Foundation (KOSEF) grants funded by the Korean government (MEST) (20090080996 and 20090091345).	Budanov AV, 2008, CELL, V134, P451, DOI 10.1016/j.cell.2008.06.028; Camps M, 2000, FASEB J, V14, P6, DOI 10.1096/fasebj.14.1.6; Cao C, 2008, J BIOL CHEM, V283, P28897, DOI 10.1074/jbc.M804144200; Chen HC, 2002, J BIOL CHEM, V277, P23554, DOI 10.1074/jbc.M201152200; Corradetti MN, 2004, GENE DEV, V18, P1533, DOI 10.1101/gad.1199104; Du JH, 2008, BIOCHEM BIOPH RES CO, V368, P402, DOI 10.1016/j.bbrc.2008.01.099; Fan MY, 2001, DRUG RESIST UPDATE, V4, P253, DOI 10.1054/drup.2001.0214; Feng ZH, 2007, CANCER RES, V67, P3043, DOI 10.1158/0008-5472.CAN-06-4149; Foller M, 2009, FASEB J, V23, P1072, DOI 10.1096/fj.08-121772; Fukuda T, 2007, J NEUROENDOCRINOL, V19, P621, DOI 10.1111/j.1365-2826.2007.01570.x; Galban S, 2003, MOL CELL BIOL, V23, P7083, DOI 10.1128/MCB.23.20.7083-7095.2003; HA J, 1994, J BIOL CHEM, V269, P22162; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; Hattori Y, 2006, HYPERTENSION, V47, P265, DOI 10.1161/01.HYP.0000198425.21604.aa; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hong SP, 2003, P NATL ACAD SCI USA, V100, P8839, DOI 10.1073/pnas.1533136100; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Janes KA, 2005, SCIENCE, V310, P1646, DOI 10.1126/science.1116598; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; KEYSE SM, 1992, NATURE, V359, P644, DOI 10.1038/359644a0; Keyse SM, 2008, CANCER METAST REV, V27, P253, DOI 10.1007/s10555-008-9123-1; Kim J, 2001, J BIOL CHEM, V276, P19102, DOI 10.1074/jbc.M011579200; Li HL, 2007, J CELL BIOCHEM, V100, P1086, DOI 10.1002/jcb.21197; Li J, 2001, MOL CELL BIOL, V21, P8213, DOI 10.1128/MCB.21.23.8213-8224.2001; Li MX, 2003, J BIOL CHEM, V278, P41059, DOI 10.1074/jbc.M307149200; LIU YS, 1995, J BIOL CHEM, V270, P8377, DOI 10.1074/jbc.270.15.8377; Longnus SL, 2005, DIABETOLOGIA, V48, P2591, DOI 10.1007/s00125-005-0016-3; Lu ZM, 2006, IUBMB LIFE, V58, P621, DOI 10.1080/15216540600957438; Nagata D, 2004, CIRCULATION, V110, P444, DOI 10.1161/01.CIR.0000136025.96811.76; Okoshi R, 2008, J BIOL CHEM, V283, P3979, DOI 10.1074/jbc.M705232200; Paraskevas S, 1999, FEBS LETT, V455, P203, DOI 10.1016/S0014-5793(99)00882-0; Patterson KI, 2009, BIOCHEM J, V418, P475, DOI 10.1042/BJ20082234; Ryan KM, 1998, MOL CELL BIOL, V18, P3692, DOI 10.1128/MCB.18.7.3692; Sasaki K, 2004, MOL BIOL CELL, V15, P1387, DOI 10.1091/mbc.E03-06-0367; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Shaul YD, 2007, BBA-MOL CELL RES, V1773, P1213, DOI 10.1016/j.bbamcr.2006.10.005; Shibata R, 2005, NAT MED, V11, P1096, DOI 10.1038/nm1295; Su B, 1996, CURR OPIN IMMUNOL, V8, P402, DOI 10.1016/S0952-7915(96)80131-2; WASKIEWICZ AJ, 1995, CURR OPIN CELL BIOL, V7, P798, DOI 10.1016/0955-0674(95)80063-8; Williamson DL, 2006, AM J PHYSIOL-ENDOC M, V291, pE80, DOI 10.1152/ajpendo.00566.2005; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yin YX, 2003, NATURE, V422, P527, DOI 10.1038/nature01519; Zheng B, 2009, MOL CELL, V33, P237, DOI 10.1016/j.molcel.2008.12.026; Zhuang SG, 2006, J PHARMACOL EXP THER, V319, P991, DOI 10.1124/jpet.106.107367	46	40	41	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14617	14627		10.1074/jbc.M109.085456	http://dx.doi.org/10.1074/jbc.M109.085456			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20220132	hybrid, Green Published			2022-12-25	WOS:000277299700059
J	Millour, J; Constantinidou, D; Stavropoulou, AV; Wilson, MSC; Myatt, SS; Kwok, JMM; Sivanandan, K; Coombes, RC; Medema, RH; Hartman, J; Lykkesfeldt, AE; Lam, EWF				Millour, J.; Constantinidou, D.; Stavropoulou, A. V.; Wilson, M. S. C.; Myatt, S. S.; Kwok, J. M-M; Sivanandan, K.; Coombes, R. C.; Medema, R. H.; Hartman, J.; Lykkesfeldt, A. E.; Lam, E. W-F			FOXM1 is a transcriptional target of ER alpha and has a critical role in breast cancer endocrine sensitivity and resistance	ONCOGENE			English	Article						breast cancer; forkhead; estrogen receptor; FOXM1; endocrine resistance; transcription	ESTROGEN-RECEPTOR-ALPHA; CYCLIN D1; HEPATOCYTE ENTRY; REGULATED GENES; FACTOR HFH-11B; GROWTH-FACTOR; CELL-LINES; S-PHASE; EXPRESSION; MOUSE	In this study, we investigated the regulation of FOXM1 expression by estrogen receptor alpha (ER alpha) and its role in hormonal therapy and endocrine resistance. FOXM1 protein and mRNA expression was regulated by ER-ligands, including estrogen, tamoxifen (OHT) and fulvestrant (ICI182780; ICI) in breast carcinoma cell lines. Depletion of ER alpha by RNA interference (RNAi) in MCF-7 cells downregulated FOXM1 expression. Reporter gene assays showed that ER alpha activates FOXM1 transcription through an estrogen-response element ( ERE) located within the proximal promoter region. The direct binding of ER alpha to the FOXM1 promoter was confirmed in vitro by mobility shift and DNA pull-down assays and in vivo by chromatin immunoprecipitation (ChIP) analysis. Our data also revealed that upon OHT treatment ER alpha recruits histone deacetylases to the ERE site of the FOXM1 promoter, which is associated with a decrease in histone acetylation and transcription activity. Importantly, silencing of FOXM1 by RNAi abolished estrogen-induced MCF-7 cell proliferation and overcame acquired tamoxifen resistance. Conversely, ectopic expression of FOXM1 abrogated the cell cycle arrest mediated by the antiestrogen OHT. OHT repressed FOXM1 expression in endocrine sensitive but not resistant breast carcinoma cell lines. Furthermore, qRT-PCR analysis of breast cancer patient samples revealed that there was a strong and significant positive correlation between ERa and FOXM1 mRNA expression. Collectively, these results show FOXM1 to be a key mediator of the mitogenic functions of ER alpha and estrogen in breast cancer cells, and also suggest that the deregulation of FOXM1 may contribute to anti-estrogen insensitivity. Oncogene (2010) 29, 2983-2995; doi:10.1038/onc.2010.47; published online 8 March 2010	[Lam, E. W-F] Univ London Imperial Coll Sci Technol & Med, CR UK Labs, Dept Surg & Canc, London W12 0NN, England; [Medema, R. H.] Univ Med Ctr Utrecht, Dept Med Oncol, Utrecht, Netherlands; [Hartman, J.] Karolinska Inst, Dept Pathol & Oncol, Stockholm, Sweden; [Lykkesfeldt, A. E.] Danish Canc Soc, Inst Canc Biol, Dept Breast Canc Res, Copenhagen, Denmark	Imperial College London; Utrecht University; Utrecht University Medical Center; Karolinska Institutet; Danish Cancer Society	Lam, EWF (corresponding author), Univ London Imperial Coll Sci Technol & Med, CR UK Labs, Dept Surg & Canc, Hammersmith Campus,Du Cane Rd, London W12 0NN, England.	eric.lam@imperial.ac.uk	Wilson, Miranda/W-1453-2019; Medema, Rene H/E-2981-2013; Hartman, Johan/N-1406-2015; Medema, Rene H/G-5415-2011; Teh, Muy-Teck/B-9284-2016; Lam, Eric W-F/AAW-8566-2020	Wilson, Miranda/0000-0001-7521-4036; Hartman, Johan/0000-0002-6500-8527; Teh, Muy-Teck/0000-0002-7725-8355; Lam, Eric W-F/0000-0003-1274-3576; Coombes, Raoul Charles/0000-0002-4811-1100	Breast Cancer Campaign; Cancer Research UK; Biotechnology and Biological Sciences Research Council; Cancer Research UK [12011] Funding Source: researchfish	Breast Cancer Campaign; Cancer Research UK(Cancer Research UK); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK)	Grant support was given by Breast Cancer Campaign (J Millour and EW-F Lam), Cancer Research UK (SS Myatt, K-K Ho, RC Coombes, EW-F Lam), Biotechnology and Biological Sciences Research Council (MSC Wilson and EW-F Lam).	Ali S, 2002, NAT REV CANCER, V2, P101, DOI 10.1038/nrc721; Bourdeau V, 2004, MOL ENDOCRINOL, V18, P1411, DOI 10.1210/me.2003-0441; BRUNNER N, 1989, CANCER CELL-MON REV, V1, P81; Butt AJ, 2005, ENDOCR-RELAT CANCER, V12, pS47, DOI 10.1677/erc.1.00993; Carroll JS, 2006, MOL ENDOCRINOL, V20, P1707, DOI 10.1210/me.2005-0334; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Cicatiello L, 2004, J MOL ENDOCRINOL, V32, P719, DOI 10.1677/jme.0.0320719; Collado M, 2000, J BIOL CHEM, V275, P21960, DOI 10.1074/jbc.M000759200; DIAZARIAS AA, 1993, DIAGN CYTOPATHOL, V9, P516, DOI 10.1002/dc.2840090509; Elkak AE, 2001, CURR MED RES OPIN, V17, P282, DOI 10.1185/030079901753403180; Essafi A, 2005, ONCOGENE, V24, P2317, DOI 10.1038/sj.onc.1208421; Essafi Abdelkader, 2009, V462, P201, DOI 10.1007/978-1-60327-115-8_13; Fellowes VS, 2004, INT J ONCOL, V24, P861; Finn RS, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2419; Fung TK, 2005, SEMIN CELL DEV BIOL, V16, P335, DOI 10.1016/j.semcdb.2005.02.014; GAPINSKI PV, 1980, SURGERY, V88, P386; Goss PE, 2008, CLIN BREAST CANCER, V8, P411, DOI 10.3816/CBC.2008.n.049; Korver W, 1997, GENOMICS, V46, P435, DOI 10.1006/geno.1997.5065; Korver W, 1997, NUCLEIC ACIDS RES, V25, P1715, DOI 10.1093/nar/25.9.1715; Kothari MS, 2003, BRIT J CANCER, V88, P1071, DOI 10.1038/sj.bjc.6600866; Kwok JMM, 2008, MOL CANCER THER, V7, P2022, DOI 10.1158/1535-7163.MCT-08-0188; Laoukili J, 2005, NAT CELL BIOL, V7, P126, DOI 10.1038/ncb1217; Laoukili J, 2008, CELL CYCLE, V7, P2720, DOI 10.4161/cc.7.17.6580; Laoukili J, 2008, MOL CELL BIOL, V28, P3076, DOI 10.1128/MCB.01710-07; Leung TWC, 2001, FEBS LETT, V507, P59, DOI 10.1016/S0014-5793(01)02915-5; Lundgren K, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2150; Luscher-Firzlaff JM, 2006, FEBS LETT, V580, P1716, DOI 10.1016/j.febslet.2006.02.021; LYKKESFELDT AE, 1994, CANCER RES, V54, P1587; LYKKESFELDT AE, 1986, BREAST CANCER RES TR, V7, P83; Ma RYM, 2005, J CELL SCI, V118, P795, DOI 10.1242/jcs.01657; Madsen MW, 1997, CANCER RES, V57, P585; Madureira PA, 2006, J BIOL CHEM, V281, P25167, DOI 10.1074/jbc.M603906200; Major ML, 2004, MOL CELL BIOL, V24, P2649, DOI 10.1128/MCB.24.7.2649-2661.2004; Martin KJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002994; MASIAKOWSKI P, 1982, NUCLEIC ACIDS RES, V10, P7895, DOI 10.1093/nar/10.24.7895; McGovern UB, 2009, MOL CANCER THER, V8, P582, DOI 10.1158/1535-7163.MCT-08-0805; Myatt SS, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-6; OSBORNE CK, 1979, B CANCER, V66, P203; Park HJ, 2008, ONCOGENE, V27, P1696, DOI 10.1038/sj.onc.1210814; Pilarsky C, 2004, NEOPLASIA, V6, P744, DOI 10.1593/neo.04277; Schug Jonathan, 2008, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0206s21; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Tashiro E, 2007, CANCER SCI, V98, P629, DOI 10.1111/j.1349-7006.2007.00449.x; WANG XD, 2005, J ORGAN DYSFUNCT, V1, P2; Wang XH, 2002, P NATL ACAD SCI USA, V99, P16881, DOI 10.1073/pnas.252570299; Wang XH, 2001, HEPATOLOGY, V33, P1404, DOI 10.1053/jhep.2001.24666; Wang Y, 2008, CANCER RES, V68, P5628, DOI 10.1158/0008-5472.CAN-07-3170; Wierstra I, 2006, BIOCHEM BIOPH RES CO, V348, P99, DOI 10.1016/j.bbrc.2006.07.008; Wierstra I, 2006, BIOL CHEM, V387, P949, DOI 10.1515/BC.2006.119; Yamashita H, 2008, INT J CLIN ONCOL, V13, P380, DOI 10.1007/s10147-008-0818-7; Yamashita H, 2009, CANCER SCI, V100, P2028, DOI 10.1111/j.1349-7006.2009.01274.x; Yan L, 2003, CANCER BIOL THER, V2, P552, DOI 10.4161/cbt.2.5.469; Ye HG, 1999, MOL CELL BIOL, V19, P8570; Zwart W, 2009, MOL ENDOCRINOL, V23, P1335, DOI 10.1210/me.2008-0268	54	112	119	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2010	29	20					2983	2995		10.1038/onc.2010.47	http://dx.doi.org/10.1038/onc.2010.47			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	599DM	20208560	Green Accepted, Green Submitted			2022-12-25	WOS:000277890400009
J	Zanella, F; Renner, O; Garcia, B; Callejas, S; Dopazo, A; Peregrina, S; Carnero, A; Link, W				Zanella, F.; Renner, O.; Garcia, B.; Callejas, S.; Dopazo, A.; Peregrina, S.; Carnero, A.; Link, W.			Human TRIB2 is a repressor of FOXO that contributes to the malignant phenotype of melanoma cells	ONCOGENE			English	Article						TRIB2; FOXO; melanoma; RNAi; screening	TRANSCRIPTION FACTORS; PROTEINS; TRIBBLES; SCREEN; MORPHOGENESIS; METASTASIS; EXPRESSION; DROSOPHILA; SURVIVAL; LINEAGE	FOXO transcription factors are evolutionarily conserved proteins that orchestrate gene expression programs known to control a variety of cellular processes such as cell cycle, apoptosis, DNA repair and protection from oxidative stress. As the abrogation of FOXO function is a key feature of many tumor cells, regulation of FOXO factors is receiving increasing attention in cancer research. In order to discover genes involved in the regulation of FOXO activity, we performed a large-scale RNA-mediated interference (RNAi) screen using cell-based reporter systems that monitor transcriptional activity and subcellular localization of FOXO. We identified genes previously implicated in phosphoinositide 3-kinase/Akt signaling events, which are known to be important for FOXO function. In addition, we discovered a previously unrecognized FOXO-repressor function of TRIB2, the mammalian homolog of the Drosophila gene tribbles. A cancer-profiling array revealed specific overexpression of TRIB2 in malignant melanoma, but not in other types of skin cancer. We provide experimental evidence that TRIB2 transcript levels correlate with the degree of cytoplasmic localization of FOXO3a. Moreover, we show that TRIB2 is important in the maintenance of the oncogenic properties of melanoma cells, as its silencing reduces cell proliferation, colony formation and wound healing. Tumor growth was also substantially reduced upon RNAi-mediated TRIB2 knockdown in an in vivo melanoma xenograft model. Our studies suggest that TRIB2 provides the melanoma cells with growth and survival advantages through the abrogation of FOXO function. Altogether, our results show the potential of large-scale cell-based RNAi screens to identify promising diagnostic markers and therapeutic targets. Oncogene (2010) 29, 2973-2982; doi:10.1038/onc.2010.58; published online 8 March 2010	[Zanella, F.; Renner, O.; Garcia, B.; Peregrina, S.; Carnero, A.; Link, W.] CNIO, Expt Therapeut Program, Madrid 28029, Spain; [Callejas, S.; Dopazo, A.] CNIC, Genom Unit, Madrid 28029, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Cardiovasculares (CNIC)	Link, W (corresponding author), CNIO, Expt Therapeut Program, Melchor Fernandez Almagro 3, Madrid 28029, Spain.	wlink@cnio.es	Renner, Oliver/M-7002-2015; Dopazo, Ana/N-1159-2014; Link, Wolfgang/F-4435-2012; IBIS, CANCER/P-3323-2015	Renner, Oliver/0000-0002-4046-0517; Dopazo, Ana/0000-0002-4910-1684; Link, Wolfgang/0000-0002-3340-5165; Callejas, Sergio/0000-0003-3351-4940; Carnero, Amancio/0000-0003-4357-3979	Spanish MEC [BIO2006-02432]; Marie Curie Fellowship	Spanish MEC(Spanish Government); Marie Curie Fellowship(European Commission)	This work was supported by a grant from the Spanish MEC (project BIO2006-02432). FZ is the recipient of a Marie Curie Fellowship. We acknowledge the expert technical assistance of D Megias, J C Cigudosa, J Monsech and O Dominguez. We thank M Hu, T Unterman and E Kiss-Toth for providing plasmids and JF Martinez for helpful discussions and critical reading of this paper. We are indebted to R Bernards for advice and for providing us with the NKI shRNA library.	Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Birmingham A, 2006, NAT METHODS, V3, P199, DOI 10.1038/NMETH854; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Dansen TB, 2008, TRENDS CELL BIOL, V18, P421, DOI 10.1016/j.tcb.2008.07.004; Gomes AR, 2008, CELL CYCLE, V7, P3133, DOI 10.4161/cc.7.20.6920; Grosshans J, 2000, CELL, V101, P523, DOI 10.1016/S0092-8674(00)80862-4; Gupta PB, 2005, NAT GENET, V37, P1047, DOI 10.1038/ng1634; Hegedus Z, 2007, CELL SIGNAL, V19, P238, DOI 10.1016/j.cellsig.2006.06.010; Hegedus Z, 2006, CELL MOL LIFE SCI, V63, P1632, DOI 10.1007/s00018-006-6007-9; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hilmi C, 2008, PIGM CELL MELANOMA R, V21, P139, DOI 10.1111/j.1755-148X.2008.00440.x; Hou L, 2000, DEVELOPMENT, V127, P5379; Hu MCT, 2004, CELL, V117, P225, DOI 10.1016/S0092-8674(04)00302-2; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; Hui RCY, 2008, MOL CANCER THER, V7, P670, DOI 10.1158/1535-7163.MCT-07-0397; Keeshan K, 2006, CANCER CELL, V10, P401, DOI 10.1016/j.ccr.2006.09.012; Mata J, 2000, CELL, V101, P511, DOI 10.1016/S0092-8674(00)80861-2; Meier F, 2007, BRIT J DERMATOL, V156, P1204, DOI 10.1111/j.1365-2133.2007.07821.x; Myatt SS, 2007, NAT REV CANCER, V7, P847, DOI 10.1038/nrc2223; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Rosado A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001823; Segura MF, 2009, P NATL ACAD SCI USA, V106, P1814, DOI 10.1073/pnas.0808263106; Soengas MS, 2003, ONCOGENE, V22, P3138, DOI 10.1038/sj.onc.1206454; Yang HL, 2005, ONCOGENE, V24, P1924, DOI 10.1038/sj.onc.1208352; Zanella F, 2008, CHEMBIOCHEM, V9, P2229, DOI 10.1002/cbic.200800255; Zanella F, 2007, ASSAY DRUG DEV TECHN, V5, P333, DOI 10.1089/adt.2007.058; Zanella F, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-14	28	82	83	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAY	2010	29	20					2973	2982		10.1038/onc.2010.58	http://dx.doi.org/10.1038/onc.2010.58			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	599DM	20208562				2022-12-25	WOS:000277890400008
J	Biyashev, D; Veliceasa, D; Kwiatek, A; Sutanto, MM; Cohen, RN; Volpert, OV				Biyashev, Dauren; Veliceasa, Dorina; Kwiatek, Angela; Sutanto, Maria M.; Cohen, Ronald N.; Volpert, Olga V.			Natural Angiogenesis Inhibitor Signals through Erk5 Activation of Peroxisome Proliferator-activated Receptor gamma (PPAR gamma)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; TRANSCRIPTIONAL ACTIVATION; EXPRESSION; APOPTOSIS; CELLS; REQUIREMENT; INVOLVEMENT; SUPPRESSION; BMK1/ERK5; P38-ALPHA	Erk-5, a member of the MAPK superfamily, has a catalytic domain similar to Erk1/2 and a unique C-terminal domain enabling binding with transcription factors. Aberrant vascularization in the Erk5-null mice suggested a link to angiogenesis. Ectopic expression of constitutively active Erk5 blocks endothelial cell morphogenesis and causes HIF1-alpha destabilization/degradation. However the mechanisms by which endogenous Erk5 regulates angiogenesis remain unknown. We show that Erk5 and its activating kinase MEK5 are the upstream mediators of the anti-angiogenic signal by the natural angiogenesis inhibitor, pigment epithelial-derived factor (PEDF). We demonstrate that Erk5 phosphorylation allows activation of PPAR alpha transcription factor by displacement of SMRT co-repressor. PPAR alpha, in turn is critical for NF kappa B activation, PEDF-dependent apoptosis, and anti-angiogenesis. The dominant negative MEK5 mutant and Erk5 shRNA diminished PEDF-dependent apoptosis, inhibition of the endothelial cell chemotaxis, and angiogenesis. This is the first evidence of Erk5-dependent transduction of signals by endogenous angiogenesis inhibitors.	[Biyashev, Dauren; Veliceasa, Dorina; Volpert, Olga V.] Northwestern Univ, Feinberg Sch Med, Dept Urol, Chicago, IL 60611 USA; [Biyashev, Dauren; Veliceasa, Dorina; Volpert, Olga V.] Northwestern Univ, Feinberg Sch Med, RH Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Kwiatek, Angela] Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA; [Cohen, Ronald N.] Univ Chicago, Dept Med, Sect Endocrinol Diabet & Metab, Chicago, IL 60637 USA; [Sutanto, Maria M.] Univ Chicago, Comm Mol Metab & Nutr, Chicago, IL 60637 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; Northwestern University; Feinberg School of Medicine; University of Chicago; University of Chicago	Volpert, OV (corresponding author), 303 E Chicago Ave, Chicago, IL 60611 USA.	olgavolp@northwestern.edu			National Institutes of Health [NIH R01 HL68033, NIH R01 HL077471, NIDDK R01DK078125]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077471, R01HL068033] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078125] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants NIH R01 HL68033, HL077471 (to O. V. V.), and NIDDK R01DK078125 (to R. N. C.).	Akaike M, 2004, MOL CELL BIOL, V24, P8691, DOI 10.1128/MCB.24.19.8691-8704.2004; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; AURORA AB, 2010, BLOOD IN PRESS; Bernard A, 2009, J BIOL CHEM, V284, P10480, DOI 10.1074/jbc.M809259200; Chung JH, 2008, AGEING RES REV, V7, P126, DOI 10.1016/j.arr.2008.01.001; Duan SZ, 2008, CIRC RES, V102, P283, DOI 10.1161/CIRCRESAHA.107.164384; Filleur S, 2005, CANCER RES, V65, P5144, DOI 10.1158/0008-5472.CAN-04-3744; GOOD DJ, 1990, P NATL ACAD SCI USA, V87, P6624, DOI 10.1073/pnas.87.17.6624; Griffin MD, 2007, ARCH BIOCHEM BIOPHYS, V460, P218, DOI 10.1016/j.abb.2007.01.034; Ho TC, 2007, CARDIOVASC RES, V76, P213, DOI 10.1016/j.cardiores.2007.06.032; Ho TC, 2008, MOL IMMUNOL, V45, P898, DOI 10.1016/j.molimm.2007.08.004; Ho TC, 2009, AM J PHYSIOL-CELL PH, V296, pC273, DOI 10.1152/ajpcell.00432.2008; Kasler HG, 2000, MOL CELL BIOL, V20, P8382, DOI 10.1128/MCB.20.22.8382-8389.2000; Kato Y, 1997, EMBO J, V16, P7054, DOI 10.1093/emboj/16.23.7054; Kato Y, 1998, NATURE, V395, P713, DOI 10.1038/27234; Lin Q, 1997, SCIENCE, V276, P1404, DOI 10.1126/science.276.5317.1404; Liss C, 2001, INT J CANCER, V93, P781, DOI 10.1002/ijc.1407; Liu CJ, 2003, BIOCHEM BIOPH RES CO, V312, P780, DOI 10.1016/j.bbrc.2003.10.186; Mirochnik Y, 2008, CURR DRUG TARGETS, V9, P851, DOI 10.2174/138945008785909347; Mudgett JS, 2000, P NATL ACAD SCI USA, V97, P10454, DOI 10.1073/pnas.180316397; Notari L, 2006, J BIOL CHEM, V281, P38022, DOI 10.1074/jbc.M600353200; Nyberg P, 2005, CANCER RES, V65, P3967, DOI 10.1158/0008-5472.CAN-04-2427; PASSANITI A, 1992, LAB INVEST, V67, P519; Regan CP, 2002, P NATL ACAD SCI USA, V99, P9248, DOI 10.1073/pnas.142293999; Sohn SJ, 2005, MOL CELL BIOL, V25, P8553, DOI 10.1128/MCB.25.19.8553-8566.2005; Sohn SJ, 2002, J BIOL CHEM, V277, P43344, DOI 10.1074/jbc.M207573200; Sutton KM, 2007, ONCOGENE, V26, P3920, DOI 10.1038/sj.onc.1210168; Tamura K, 2000, CELL, V102, P221, DOI 10.1016/S0092-8674(00)00027-1; Veliceasa D, 2008, PPAR RES, V2008, DOI 10.1155/2008/945275; Volpert OV, 2002, NAT MED, V8, P349, DOI 10.1038/nm0402-349; Yan C, 1999, J BIOL CHEM, V274, P143, DOI 10.1074/jbc.274.1.143; Yang CC, 1998, NUCLEIC ACIDS RES, V26, P4771, DOI 10.1093/nar/26.20.4771; Yang JH, 2000, NAT GENET, V24, P309, DOI 10.1038/73550; Zaichuk TA, 2004, J EXP MED, V199, P1513, DOI 10.1084/jem.20040474	34	21	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13517	13524		10.1074/jbc.M110.117374	http://dx.doi.org/10.1074/jbc.M110.117374			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20185831	hybrid, Green Published			2022-12-25	WOS:000276987700024
J	Widau, RC; Jin, YJ; Dixon, SA; Wadzinski, BE; Gallagher, PJ				Widau, Ryan C.; Jin, Yijun; Dixon, Shelley A.; Wadzinski, Brian E.; Gallagher, Patricia J.			Protein Phosphatase 2A (PP2A) Holoenzymes Regulate Death-associated Protein Kinase (DAPK) in Ceramide-induced Anoikis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRACELLULAR CA2+ RELEASE; INDUCED APOPTOSIS; PHOSPHORYLATION; ACTIVATION; SUBUNIT; IDENTIFICATION; INHIBITORS; COMPLEX	The tumor suppressor, death-associated protein kinase (DAPK), is a Ca2+/calmodulin-regulated Ser/Thr kinase with an important role in regulating cytoskeletal dynamics. Autophosphorylation within the calmodulin-binding domain at Ser-308 inhibits DAPK catalytic activity. Dephosphorylation of Ser-308 by a previously unknown phosphatase enhances kinase activity and proteasome-mediated degradation of DAPK. In these studies, we identified two holoenzyme forms of protein phosphatase 2A (PP2A), AB alpha C and AB delta C, as DAPK-interacting proteins. These phosphatase holoenzymes dephosphorylate DAPK at Ser-308 in vitro and in vivo resulting in enhanced kinase activity of DAPK. The enzymatic activity of PP2A also negatively regulates DAPK levels by enhancing proteasome-mediated degradation of the kinase. Overexpression of wild type DAPK induces cell rounding and detachment in HEK293 cells; however, this effect is not observed following expression of an inactive DAPK S308E mutant. Finally, activation of DAPK by PP2A was found to be required for ceramide-induced anoikis. Together, our results provide a mechanism by which PP2A and DAPK activities control cell adhesion and anoikis.	[Widau, Ryan C.; Dixon, Shelley A.; Gallagher, Patricia J.] Indiana Univ, Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA; [Jin, Yijun] Louisiana State Univ, Dept Mol & Cellular Physiol, Hlth Sci Ctr, Shreveport, LA 71130 USA; [Wadzinski, Brian E.] Vanderbilt Univ, Dept Pharmacol, Med Ctr, Nashville, TN 37232 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Vanderbilt University	Gallagher, PJ (corresponding author), Indiana Univ, Sch Med, Dept Cellular & Integrat Physiol, 635 Barnhill Dr, Indianapolis, IN 46202 USA.	pgallag@iupui.edu			National Institutes of Health [DK62810, HLB54118, GM051366, DK070787, T32 CA111198]; DeVault Endowment Cancer Training Fellowship; NATIONAL CANCER INSTITUTE [T32CA111198] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054118] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070787, R01DK062810] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051366, R56GM051366] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DeVault Endowment Cancer Training Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK62810 and HLB54118 (to P. J. G.) and GM051366 and DK070787 (to B. E. W.). This work was also supported by a DeVault Endowment Cancer Training Fellowship.; Supported by National Institutes of Health Training Grant T32 CA111198.	Adams Deanna G., 2007, V365, P101; Adams DG, 2005, J BIOL CHEM, V280, P42644, DOI 10.1074/jbc.M502464200; Bialik S, 2004, CELL DEATH DIFFER, V11, P631, DOI 10.1038/sj.cdd.4401386; Bialik S, 2006, ANNU REV BIOCHEM, V75, P189, DOI 10.1146/annurev.biochem.75.103004.142615; Chalfant CE, 1999, J BIOL CHEM, V274, P20313, DOI 10.1074/jbc.274.29.20313; Chalfant CE, 2004, J LIPID RES, V45, P496, DOI 10.1194/jlr.M300347-JLR200; Cohen O, 1997, EMBO J, V16, P998, DOI 10.1093/emboj/16.5.998; COHEN P, 1989, J BIOL CHEM, V264, P21435; DOBROWSKY RT, 1993, J BIOL CHEM, V268, P15523; Eichhorn PJA, 2009, BBA-REV CANCER, V1795, P1, DOI 10.1016/j.bbcan.2008.05.005; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; GOLDBERG J, 1995, NATURE, V376, P745, DOI 10.1038/376745a0; Gozuacik D, 2008, CELL DEATH DIFFER, V15, P1875, DOI 10.1038/cdd.2008.121; Hu W, 2005, MOL BIOL CELL, V16, P1555, DOI 10.1091/mbc.E04-07-0594; Inbal B, 1997, NATURE, V390, P180, DOI 10.1038/36599; ISHIHARA H, 1989, BIOCHEM BIOPH RES CO, V159, P871, DOI 10.1016/0006-291X(89)92189-X; Jin YJ, 2006, J BIOL CHEM, V281, P39033, DOI 10.1074/jbc.M605097200; Jin YJ, 2002, J BIOL CHEM, V277, P46980, DOI 10.1074/jbc.M208585200; Jin YJ, 2001, J BIOL CHEM, V276, P39667, DOI 10.1074/jbc.M101886200; Kuo JC, 2006, J CELL BIOL, V172, P619, DOI 10.1083/jcb.200505138; Lin Y, 2007, J BIOL CHEM, V282, P16792, DOI 10.1074/jbc.M611559200; Lin Y, 2009, MOL CELL BIOCHEM, V328, P101, DOI 10.1007/s11010-009-0079-4; Liu Z, 2008, J NEUROCHEM, V106, P2463, DOI 10.1111/j.1471-4159.2008.05562.x; Liu Z, 2007, J CELL PHYSIOL, V213, P151, DOI 10.1002/jcp.21106; Ma J, 2007, ONCOGENE, V26, P5145, DOI 10.1038/sj.onc.1210323; MACKINTOSH C, 1990, FEBS LETT, V264, P187, DOI 10.1016/0014-5793(90)80245-E; Mao LM, 2005, J BIOL CHEM, V280, P12602, DOI 10.1074/jbc.M411709200; Mukhopadhyay R, 2008, MOL CELL, V32, P371, DOI 10.1016/j.molcel.2008.09.019; Neviani P, 2007, J CLIN INVEST, V117, P2408, DOI 10.1172/JCI31095; Pelled D, 2002, J BIOL CHEM, V277, P1957, DOI 10.1074/jbc.M104677200; Raval A, 2007, CELL, V129, P879, DOI 10.1016/j.cell.2007.03.043; Ruvolo PP, 1999, J BIOL CHEM, V274, P20296, DOI 10.1074/jbc.274.29.20296; Shohat G, 2001, J BIOL CHEM, V276, P47460, DOI 10.1074/jbc.M105133200; Strack S, 1999, FEBS LETT, V460, P462, DOI 10.1016/S0014-5793(99)01377-0; Swingle Mark, 2007, V365, P23; Wang WJ, 2002, J CELL BIOL, V159, P169, DOI 10.1083/jcb.200204050; Westphal RS, 1999, J BIOL CHEM, V274, P687, DOI 10.1074/jbc.274.2.687; Westphal RS, 1998, SCIENCE, V280, P1258, DOI 10.1126/science.280.5367.1258; Yamamoto M, 2002, EUR J BIOCHEM, V269, P139, DOI 10.1046/j.0014-2956.2002.00029.x; Yan L, 2008, J BIOL CHEM, V283, P7411, DOI 10.1074/jbc.M708083200; Zalckvar E, 2009, AUTOPHAGY, V5, P720, DOI 10.4161/auto.5.5.8625; Zhang LG, 2007, J BIOL CHEM, V282, P11795, DOI 10.1074/jbc.M610430200; Zhou JL, 2009, ARTERIOSCL THROM VAS, V29, P921, DOI 10.1161/ATVBAHA.109.187229	43	42	46	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13827	13838		10.1074/jbc.M109.085076	http://dx.doi.org/10.1074/jbc.M109.085076			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20220139	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000276987700058
J	Gardner, RL				Gardner, Richard L.			Normal Bias in the Direction of Fetal Rotation Depends on Blastomere Composition during Early Cleavage in the Mouse	PLOS ONE			English	Article							LEFT-RIGHT ASYMMETRY; EMBRYO CULTURE; 4-CELL STAGE; BLASTOCYST; AXIS; FLOW; ORIENTATION; HANDEDNESS; REVERSAL; POLARITY	Interest in establishing the basis of left/right asymmetry during embryogenesis has burgeoned in recent years. Relevant studies in mammals, focused largely on the mouse, have revealed involvement of a variety of genes that are common to the process in other animals. In the mouse, lateral differences in gene expression are first evident late in gastrulation when directional rotation of nodal cilia has been implicated in effecting the normally very strong bias in handedness. Reconstructing cleavage stages with correspondingly positioned blastomeres from appropriate numbers of conceptuses with similar division planes provides a way of testing whether they differ in potency without the confounding effects of reduced cell number. In a study using this strategy, 4-cell stage conceptuses reconstructed from blastomeres produced by equatorial as opposed to meridional second cleavage were found to be compromised in their ability to support normal development. Here, in more refined reconstructions undertaken at both the 4- and 8-cell stage, no significant impairment of development to the 9(th) or 12(th) day of gestation was found for products of equatorial second cleavage or their 8-cell stage progeny. Most surprisingly, however, a significant increase in reversal of the direction of axial rotation was found specifically among fetuses developing from conceptuses reconstructed from 8-cell stage progeny of products of equatorial second cleavage. Hence, manipulations during early cleavage some 6 days before fetal asymmetries are first evident can perturb the normally very strong bias in specification of a facet of left-right asymmetry.	Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England	University of York - UK	Gardner, RL (corresponding author), Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England.	rlg534@york.ac.uk			Royal Society; March of Dimes [1-FY03-84]	Royal Society(Royal Society of London); March of Dimes(March of Dimes)	This work was funded by personal support from the Royal Society (http://www.google.com/search?client=safari&rls=en&rls=en&q=royal+society+of+london&ie=UTF-8&ie=UTF-8&oe=UTF-8) - no grant number - and a project grant from the March of Dimes (http://www.google.com/search?client= safari&rls=en&rls=en&q=march+of+dimes+foundation&ie=UTF-8&ie=UTF-8&oe=UTF-8) Grant1-FY03-84. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DS, 2006, DEVELOPMENT, V133, P1657, DOI 10.1242/dev.02341; Bischoff M, 2008, DEVELOPMENT, V135, P953, DOI 10.1242/dev.014316; Dietrich JE, 2007, DEVELOPMENT, V134, P4219, DOI 10.1242/dev.003798; ENDO A, 1987, ANAT EMBRYOL, V176, P133, DOI 10.1007/BF00309761; FUJINAGA M, 1995, TOXICOL IN VITRO, V9, P593, DOI 10.1016/0887-2333(95)00068-J; Gardner RL, 2007, HUM REPROD, V22, P798, DOI 10.1093/humrep/del424; Gardner RL, 2002, HUM REPROD, V17, P3178, DOI 10.1093/humrep/17.12.3178; Gardner RL, 2006, REPROD BIOMED ONLINE, V12, P144, DOI 10.1016/S1472-6483(10)60853-X; Gardner RL, 2003, PHILOS T ROY SOC B, V358, P1331, DOI 10.1098/rstb.2003.1322; Hadjantonakis AK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002511; Hibino T, 2006, DEV GENES EVOL, V216, P265, DOI 10.1007/s00427-005-0051-6; Hiiragi T, 2006, REPROD BIOMED ONLINE, V12, P150, DOI 10.1016/S1472-6483(10)60854-1; Hirokawa N, 2006, CELL, V125, P33, DOI 10.1016/j.cell.2006.03.002; KITAZAWA C, 2007, J EXP ZOOL PART A, V307, P1; Kuroda R, 2009, NATURE, V462, P790, DOI 10.1038/nature08597; Kurotaki Y, 2007, SCIENCE, V316, P719, DOI 10.1126/science.1138591; LAYTON WM, 1976, J HERED, V67, P336, DOI 10.1093/oxfordjournals.jhered.a108749; Levin M, 2007, BIOESSAYS, V29, P271, DOI 10.1002/bies.20545; Louvet-Vallee S, 2005, CURR BIOL, V15, P464, DOI 10.1016/j.cub.2004.12.078; Maisonneuve C, 2009, DEVELOPMENT, V136, P3019, DOI 10.1242/dev.038174; McCarthy A, 1998, REPROD TOXICOL, V12, P177, DOI 10.1016/S0890-6238(97)00150-0; Motosugi N, 2005, GENE DEV, V19, P1081, DOI 10.1101/gad.1304805; Piotrowska-Nitsche K, 2005, DEVELOPMENT, V132, P479, DOI 10.1242/dev.01602; Shibazaki Y, 2004, CURR BIOL, V14, P1462, DOI 10.1016/j.cub.2004.08.018; SUZUKI H, 1995, BIOL REPROD, V53, P78, DOI 10.1095/biolreprod53.1.78; Takaoka K, 2007, CURR OPIN GENET DEV, V17, P344, DOI 10.1016/j.gde.2007.06.001; WOOD WB, 1991, NATURE, V349, P536, DOI 10.1038/349536a0; Zernicka-Goetz M, 2006, CURR OPIN GENET DEV, V16, P406, DOI 10.1016/j.gde.2006.06.011	28	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2010	5	3							e9610	10.1371/journal.pone.0009610	http://dx.doi.org/10.1371/journal.pone.0009610			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565XE	20224769	Green Published, gold, Green Submitted			2022-12-25	WOS:000275328800013
J	Levesque, MV; Levesque, D; Briere, FP; Perreault, JP				Levesque, Michel V.; Levesque, Dominique; Briere, Francis P.; Perreault, Jean-Pierre			Investigating a New Generation of Ribozymes in Order to Target HCV	PLOS ONE			English	Article							HEPATITIS-C VIRUS; SMALL INTERFERING RNAS; DELTA-RIBOZYME; IN-VITRO; INTRACELLULAR-LOCALIZATION; REPLICATION COMPLEX; MAMMALIAN-CELLS; VIRAL-RNA; GENE; INHIBITION	For a long time nucleic acid-based approaches directed towards controlling the propagation of Hepatitis C Virus (HCV) have been considered to possess high potential. Towards this end, ribozymes (i.e. RNA enzymes) that specifically recognize and subsequently catalyze the cleavage of their RNA substrate present an attractive molecular tool. Here, the unique properties of a new generation of ribozymes are taken advantage of in order to develop an efficient and durable ribozyme-based technology with which to target HCV (+) RNA strands. These ribozymes resulted from the coupling of a specific on/off adaptor (SOFA) to the ribozyme domain derived from the Hepatitis Delta Virus (HDV). The former switches cleavage activity "on" solely in the presence of the desired RNA substrate, while the latter was the first catalytic RNA reported to function naturally in human cells, specifically in hepatocytes. In order to maximize the chances for success, a step-by-step approach was used for both the design and the selection of the ribozymes. This approach included the use of both bioinformatics and biochemical methods for the identification of the sites possessing the greatest potential for targeting, and the subsequent in vitro testing of the cleavage activities of the corresponding SOFA-HDV ribozymes. These efforts led to a significant improvement in the ribozymes' designs. The ability of the resulting SOFA-HDV ribozymes to inhibit HCV replication was further examined using a luciferase-based replicon. Although some of the ribozymes exhibited high levels of cleavage activity in vitro, none appears to be a potential long term inhibitor in cellulo. Analysis of recent discoveries in the cellular biology of HCV might explain this failure, as well as provide some ideas on the potential limits of using nucleic acid-based drugs to control the propagation of HCV. Finally, the above conclusions received support from experiments performed using a collection of SOFA-HDV ribozymes directed against HCV (-) strands.	[Levesque, Michel V.; Levesque, Dominique; Briere, Francis P.; Perreault, Jean-Pierre] Univ Sherbrooke, Dept Biochim, Fac Med & Sci Sante, Sherbrooke, PQ J1K 2R1, Canada	University of Sherbrooke	Levesque, MV (corresponding author), Univ Sherbrooke, Dept Biochim, Fac Med & Sci Sante, Sherbrooke, PQ J1K 2R1, Canada.	Jean-Pierre.Perreault@USherbrooke.ca			Canadian Institute of Health Research (CIHR) [EOP-38322]; Universite de Sherbrooke; Fonds de Recherche en Sante du Quebec	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Universite de Sherbrooke; Fonds de Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec)	This work was supported by a grant from the Canadian Institute of Health Research (CIHR; grant number EOP-38322) to JPP. The RNA group is supported by grants from both CIHR (Resource program) and Universite de Sherbrooke. ML is the recipient of a predoctoral fellowship from the Fonds de Recherche en Sante du Quebec. JPP holds the Canada Research Chairs in genomics and catalytic RNAs, and is a member of the Centre de Recherche Clinique Etienne Lebel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Anouti F, 2002, ANTISENSE NUCLEIC A, V12, P275, DOI 10.1089/108729002320351593; Alaoui-Ismaili MH, 2000, ANTIVIR RES, V46, P181, DOI 10.1016/S0166-3542(00)00085-1; Ananvoranich S, 1999, NUCLEIC ACIDS RES, V27, P1473, DOI 10.1093/nar/27.6.1473; Ananvoranich S, 1998, J BIOL CHEM, V273, P13182, DOI 10.1074/jbc.273.21.13182; Asif-Ullah M, 2007, CURR GENE THER, V7, P205, DOI 10.2174/156652307780859008; Beaulieu Pierre L, 2004, Curr Opin Investig Drugs, V5, P838; Bergeron LJ, 2005, RNA, V11, P1858, DOI 10.1261/rna.2112705; Bergeron LJ, 2005, NUCLEIC ACIDS RES, V33, P1240, DOI 10.1093/nar/gki278; Bergeron LJ, 2003, CURR MED CHEM, V10, P2589, DOI 10.2174/0929867033456486; Bergeron LJ, 2002, NUCLEIC ACIDS RES, V30, P4682, DOI 10.1093/nar/gkf598; Bertrand E, 1997, RNA, V3, P75; Boudreau F, 2007, FASEB J, V21, P3853, DOI 10.1096/fj.07-8113com; Chisari FV, 2005, NATURE, V436, P930, DOI 10.1038/nature04076; D'Anjou FO, 2004, J BIOL CHEM, V279, P14232, DOI 10.1074/jbc.M310632200; De Francesco R, 2005, NATURE, V436, P953, DOI 10.1038/nature04080; Deschenes P, 2000, ANTISENSE NUCLEIC A, V10, P53, DOI 10.1089/oli.1.2000.10.53; Egger D, 2002, J VIROL, V76, P5974, DOI 10.1128/JVI.76.12.5974-5984.2002; Fiola K, 2006, APPL ENVIRON MICROB, V72, P869, DOI 10.1128/AEM.72.1.869-879.2006; FONG TL, 1991, J CLIN INVEST, V88, P1058, DOI 10.1172/JCI115368; Griffiths J, 2002, HEPATOLOGY, V35, P709, DOI 10.1053/jhep.2002.31258; Junemann C, 2007, J BIOL CHEM, V282, P132, DOI 10.1074/jbc.M608750200; Kapadia SB, 2003, P NATL ACAD SCI USA, V100, P2014, DOI 10.1073/pnas.252783999; Kato Y, 2001, J BIOL CHEM, V276, P15378, DOI 10.1074/jbc.M010570200; Kim DH, 2004, NAT BIOTECHNOL, V22, P321, DOI 10.1038/nbt940; KROKE J, 2004, J VIROL, V78, P3436; Kronke J, 2004, J VIROL, V78, P3436, DOI 10.1128/JVI.78.7.3436-3446.2004; Lamarre D, 2003, NATURE, V426, P186, DOI 10.1038/nature02099; Levesque D, 2002, RNA, V8, P464, DOI 10.1017/S1355838202020289; Lindenbach BD, 2005, NATURE, V436, P933, DOI 10.1038/nature04077; Liu Q, 2008, NUCLEIC ACIDS RES, V36, P5391, DOI 10.1093/nar/gkn522; Macejak DG, 2000, HEPATOLOGY, V31, P769, DOI 10.1002/hep.510310331; Marques JT, 2005, NAT BIOTECHNOL, V23, P1399, DOI 10.1038/nbt1161; Mathews DH, 1999, RNA, V5, P1458, DOI 10.1017/S1355838299991148; McLauchlan J, 2009, BIOCHEM SOC T, V37, P986, DOI 10.1042/BST0370986; Miller S, 2008, NAT REV MICROBIOL, V6, P363, DOI 10.1038/nrmicro1890; Miyanari Y, 2003, J BIOL CHEM, V278, P50301, DOI 10.1074/jbc.M305684200; Moradpour D, 2002, TRENDS MOL MED, V8, P476, DOI 10.1016/S1471-4914(02)02395-X; Ogawa K, 2009, P JPN ACAD B-PHYS, V85, P217, DOI 10.2183/pjab.85.217; Ohkawa K, 1997, J HEPATOL, V27, P78, DOI 10.1016/S0168-8278(97)80283-8; Olsen DB, 2004, ANTIMICROB AGENTS CH, V48, P3944, DOI 10.1128/AAC.48.10.3944-3953.2004; Peracchi A, 2004, REV MED VIROL, V14, P47, DOI 10.1002/rmv.415; Pereira AA, 2009, NAT REV GASTRO HEPAT, V6, P403, DOI 10.1038/nrgastro.2009.92; Quinkert D, 2005, J VIROL, V79, P13594, DOI 10.1128/JVI.79.21.13594-13605.2005; Randall G, 2003, P NATL ACAD SCI USA, V100, P235, DOI 10.1073/pnas.0235524100; Robichaud GA, 2008, NUCLEIC ACIDS RES, V36, P4609, DOI 10.1093/nar/gkn432; Sakamoto N, 2008, J GASTROEN HEPATOL, V23, P1437, DOI 10.1111/j.1440-1746.2007.05076.x; Seo MY, 2003, J VIROL, V77, P810, DOI 10.1128/JVI.77.1.810-812.2003; Sledz CA, 2003, NAT CELL BIOL, V5, P834, DOI 10.1038/ncb1038; Smith RM, 2007, J VIRAL HEPATITIS, V14, P194, DOI 10.1111/j.1365-2893.2006.00794.x; Smith RM, 2002, J VIROL, V76, P9563, DOI 10.1128/JVI.76.19.9563-9574.2002; Spahn CMT, 2001, SCIENCE, V291, P1959, DOI 10.1126/science.1058409; Trepanier J, 2006, J VIRAL HEPATITIS, V13, P131, DOI 10.1111/j.1365-2893.2005.00684.x; Vrolijk JM, 2003, J VIROL METHODS, V110, P201, DOI 10.1016/S0166-0934(03)00134-4; Watanabe T, 2007, J HEPATOL, V47, P744, DOI 10.1016/j.jhep.2007.06.015; Welch PJ, 1996, GENE THER, V3, P994; Wilson JA, 2003, P NATL ACAD SCI USA, V100, P2783, DOI 10.1073/pnas.252758799; Yokota T, 2003, EMBO REP, V4, P602, DOI 10.1038/sj.embor.embor840	57	11	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2010	5	3							e9627	10.1371/journal.pone.0009627	http://dx.doi.org/10.1371/journal.pone.0009627			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565XE	20224783	Green Published, gold, Green Submitted			2022-12-25	WOS:000275328800022
J	Emerson, KJ; Bradshaw, WE; Holzapfel, CM				Emerson, Kevin J.; Bradshaw, William E.; Holzapfel, Christina M.			Microarrays Reveal Early Transcriptional Events during the Termination of Larval Diapause in Natural Populations of the Mosquito, Wyeomyia smithii	PLOS ONE			English	Article							PITCHER-PLANT MOSQUITO; MAMMALIAN SORBITOL DEHYDROGENASE; PHOTOPERIODIC TIME MEASUREMENT; DROSOPHILA-MELANOGASTER; EVOLUTIONARY DIVERGENCE; GENE-EXPRESSION; SEASONAL PHOTOPERIODISM; CLIMATE-CHANGE; PEA APHID; PROTEIN	Background: The mosquito Wyeomyia smithii overwinters in a larval diapause that is initiated, maintained and terminated by day length (photoperiod). We use a forward genetic approach to investigate transcriptional events involved in the termination of diapause following exposure to long-days. Methods/Principal Findings: We incorporate a novel approach that compares two populations that differentially respond to a single day length. We identify 30 transcripts associated with differential response to day length. Most genes with a previously annotated function are consistent with their playing a role in the termination of diapause, in downstream developmental events, or in the transition from potentially oxygen-poor to oxygen-rich environments. One gene emerges from three separate forward genetic screens as a leading candidate for a gene contributing to the photoperiodic timing mechanism itself (photoperiodic switch). We name this gene photoperiodic response gene 1 (ppdrg1). WsPpdrg1 is up-regulated under long-day response conditions, is located under a QTL for critical photoperiod and is associated with critical photoperiod after 25 generations of recombination from a cross between extreme phenotypes. Conclusions: Three independent forward genetic approaches identify WsPpdrg1 as a gene either involved in the photoperiodic switch mechanism or very tightly linked to a gene that is. We conclude that continued forward genetic approaches will be central to understanding not only the molecular basis of photoperiodism and diapause, but also the evolutionary potential of temperate and polar animal populations when confronted with rapid climate change.	[Emerson, Kevin J.; Bradshaw, William E.; Holzapfel, Christina M.] Univ Oregon, Ctr Ecol & Evolutionary Biol, Eugene, OR 97403 USA	University of Oregon	Emerson, KJ (corresponding author), Univ Oregon, Ctr Ecol & Evolutionary Biol, Eugene, OR 97403 USA.	kemerson@uoregon.edu	Emerson, Kevin/AAC-8207-2020	Emerson, Kevin/0000-0003-3283-0693	National Science Foundation (NSF) [DEB-0413573, DEB-0917827, IOB-0445710, IOB-0839998, DGE-0504727]; National Institutes of Health (NIH) Genetics Training Grant [5-T32-GMO7413]	National Science Foundation (NSF)(National Science Foundation (NSF)); National Institutes of Health (NIH) Genetics Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by generous funding through National Science Foundation (NSF) Grants DEB-0413573, DEB-0917827, IOB-0445710, and IOB-0839998 to WEB. During this research KJE was supported by an National Institutes of Health (NIH) Genetics Training Grant 5-T32-GMO7413 to George Sprague and an National Science Foundation (NSF) IGERT Training Grant DGE-0504727 to John Postlethwait, Patrick Phillips and Karen Guilleman. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	B?nning E., 1936, BER DEUT BOT GES, V54, P590, DOI DOI 10.1038/424033A; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bradshaw WE, 2008, MOL ECOL, V17, P157, DOI 10.1111/j.1365-294X.2007.03509.x; Bradshaw WE, 2005, GENETICS, V169, P485, DOI 10.1534/genetics.104.031971; BRADSHAW WE, 1976, NATURE, V262, P384, DOI 10.1038/262384b0; Bradshaw WE, 2004, EVOLUTION, V58, P1748, DOI 10.1111/j.0014-3820.2004.tb00458.x; Bradshaw WE, 2003, AM NAT, V161, P735, DOI 10.1086/374344; BRADSHAW WE, 1977, EVOLUTION, V31, P546, DOI [10.2307/2407521, 10.1111/j.1558-5646.1977.tb01044.x]; Bradshaw WE, 2001, P NATL ACAD SCI USA, V98, P14509, DOI 10.1073/pnas.241391498; BRADSHAW WE, 2010, ANN REV PHY IN PRESS; Bradshaw W, 2007, SCIENCE, V316, P1851, DOI 10.1126/science.1145053; Bradshaw WE, 2007, ANNU REV ECOL EVOL S, V38, P1, DOI 10.1146/annurev.ecolsys.37.091305.110115; Cornman RS, 2009, INSECT MOL BIOL, V18, P607, DOI 10.1111/j.1365-2583.2009.00902.x; Danilevskii A.S., 1965, PHOTOPERIODISM SEASO; Danks HV, 1987, INSECT DORMANCY ECOL; Denlinger DL, 2002, ANNU REV ENTOMOL, V47, P93, DOI 10.1146/annurev.ento.47.091201.145137; Emerson KJ, 2008, J COMP PHYSIOL A, V194, P611, DOI 10.1007/s00359-008-0334-2; Emerson KJ, 2009, TRENDS GENET, V25, P217, DOI 10.1016/j.tig.2009.03.009; Emerson KJ, 2009, J COMP PHYSIOL A, V195, P385, DOI 10.1007/s00359-009-0416-9; Feala JD, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100139; Gomi T, 2007, ENTOMOL EXP APPL, V125, P179, DOI 10.1111/j.1570-7458.2007.00616.x; Goto SG, 2002, J INSECT PHYSIOL, V48, P803, DOI 10.1016/S0022-1910(02)00108-7; HARD JJ, 1993, AM NAT, V142, P457, DOI 10.1086/285549; Hoback WW, 2001, J INSECT PHYSIOL, V47, P533, DOI 10.1016/S0022-1910(00)00153-0; Hoy M.A., 1978, P101; Hynes RO, 2000, J CELL BIOL, V150, pF89, DOI 10.1083/jcb.150.2.F89; Kim E, 2008, INSECT MOL BIOL, V17, P537, DOI 10.1111/j.1365-2583.2008.00822.x; Kostal V, 2006, J INSECT PHYSIOL, V52, P113, DOI 10.1016/j.jinsphys.2005.09.008; Kostal V, 2008, J INSECT PHYSIOL, V54, P77, DOI 10.1016/j.jinsphys.2007.08.004; Kyriacou CP, 2008, TRENDS GENET, V24, P124, DOI 10.1016/j.tig.2007.12.003; Lair KP, 1997, GENETICS, V147, P1873; Le Trionnaire G, 2007, INSECT BIOCHEM MOLEC, V37, P1094, DOI 10.1016/j.ibmb.2007.06.008; Le Trionnaire G, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-456; Leather S. R., 1993, ECOLOGY INSECT OVERW; Luque T, 1998, J BIOL CHEM, V273, P34293, DOI 10.1074/jbc.273.51.34293; Mathias D, 2006, J BIOL RHYTHM, V21, P132, DOI [10.1177/0748730406286320, 10.1177/0748730405286320]; Mathias D, 2005, J INSECT PHYSIOL, V51, P661, DOI 10.1016/j.jinsphys.2005.03.011; Mathias D, 2007, GENETICS, V176, P391, DOI 10.1534/genetics.106.068726; NIIMI T, 1993, COMP BIOCHEM PHYS B, V106, P437, DOI 10.1016/0305-0491(93)90326-Z; NIIMI T, 1993, EUR J BIOCHEM, V213, P1125, DOI 10.1111/j.1432-1033.1993.tb17862.x; PATERSON CG, 1971, CAN J ZOOLOG, V49, P1455, DOI 10.1139/z71-214; Pratt C. W., 2004, ESSENTIAL BIOCH, V3rd; R Development Core Team, 2007, R LANG ENV STAT COMP; Robich RM, 2007, J INSECT PHYSIOL, V53, P235, DOI 10.1016/j.jinsphys.2006.08.008; SAUNDERS DS, 1989, P NATL ACAD SCI USA, V86, P3748, DOI 10.1073/pnas.86.10.3748; SAUNDERS DS, 1990, J BIOL RHYTHM, V5, P315, DOI 10.1177/074873049000500404; Saunders DS, 2002, INSECT CLOCKS; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Sokal RR, 1995, BIOMETRY; Stehlik J, 2008, J BIOL RHYTHM, V23, P129, DOI 10.1177/0748730407313364; Tan CG, 2003, DEVELOPMENT, V130, P671, DOI 10.1242/dev.00298; Tauber E, 2008, FUNCT ECOL, V22, P19, DOI 10.1111/j.1365-2435.2007.01343.x; Tauber E, 2007, SCIENCE, V316, P1895, DOI 10.1126/science.1138412; Tauber M.J., 1986, SEASONAL ADAPTATIONS; TAYLOR F, 1980, THEOR POPUL BIOL, V18, P125, DOI 10.1016/0040-5809(80)90044-1; Torok I, 1999, MOL CELL BIOL, V19, P2308; Verras M, 2004, ARCH INSECT BIOCHEM, V56, P133, DOI 10.1002/arch.20004	58	43	46	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2010	5	3							e9574	10.1371/journal.pone.0009574	http://dx.doi.org/10.1371/journal.pone.0009574			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	564EX	20221437	Green Submitted, Green Published, gold			2022-12-25	WOS:000275197200018
J	Wakeel, A; Zhang, XF; McBride, JW				Wakeel, Abdul; Zhang, Xiaofeng; McBride, Jere W.			Mass Spectrometric Analysis of Ehrlichia chaffeensis Tandem Repeat Proteins Reveals Evidence of Phosphorylation and Absence of Glycosylation	PLOS ONE			English	Article							ANOMALOUS ELECTROPHORETIC BEHAVIOR; MAJOR IMMUNOREACTIVE PROTEIN; CHLAMYDIA-TRACHOMATIS TARP; TYROSINE PHOSPHORYLATION; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION FACTORS; ANAPLASMA-MARGINALE; ANTIBODY-RESPONSES; MEMBRANE-PROTEIN; ACIDIC PROTEIN	Background: Ehrlichia chaffeensis has a small subset of immunoreactive secreted, acidic (pI similar to 4), tandem repeat (TR)-containing proteins (TRPs), which exhibit abnormally large electrophoretic masses that have been associated with glycosylation of the TR domain. Methodology/Principal Findings: In this study, we examined the extent and nature of posttranslational modifications on the native TRP47 and TRP32 using mass spectrometry. Matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) demonstrated that the mass of native TRP47 (33,104.5 Da) and TRP32 (22,736.8 Da) were slightly larger (179- and 288-Da, respectively) than their predicted masses. The anomalous migration of native and recombinant TRP47, and the recombinant TR domain (C-terminal region) were normalized by 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC) modification of negatively charged carboxylates to neutral amides. Exhaustive tandem mass spectrometric analysis (92% coverage) performed on trypsin and Asp-N digested native TRP47 identified peptides consistent with their predicted masses. Two TRP47 peptides not identified were located in the normally migrating amino (N)-terminal region of TRP47 and contained predicted phosphorylation sites (tyrosine and serine residues). Moreover, native TRP47 was immunoprecipitated from E. chaffeensis-infected cell lysate with anti-phosphotyrosine (anti-pTyr) antibody. Conclusions/Significance: TRP47 and TRP32 are not modified by glycans and the substantial net negative charge of the ehrlichial TRPs, and particularly the highly acidic TRs present within the ehrlichial TRPs, is responsible for larger-than-predicted masses. Furthermore, this study provides evidence that the N-terminal region of the TRP47 is tyrosine phosphorylated.	[Wakeel, Abdul; Zhang, Xiaofeng; McBride, Jere W.] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA; [McBride, Jere W.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX USA; [McBride, Jere W.] Univ Texas Med Branch, Ctr Biodefense & Emerging Infect Dis, Galveston, TX USA; [McBride, Jere W.] Univ Texas Med Branch, Sealy Ctr Vaccine Dev, Galveston, TX USA; [McBride, Jere W.] Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Wakeel, A (corresponding author), Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.	jemcbrid@utmb.edu			National Institute of Allergy and Infectious Diseases [AI 071145]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI071145] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institute of Allergy and Infectious Diseases (AI 071145). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebersold R, 2001, CHEM REV, V101, P269, DOI 10.1021/cr990076h; Alves VS, 2005, BIOCHEM BIOPH RES CO, V332, P450, DOI 10.1016/j.bbrc.2005.04.151; Alves VS, 2004, BIOCHEM BIOPH RES CO, V314, P229, DOI 10.1016/j.bbrc.2003.12.086; ARMSTRONG DJ, 1993, BIOCHEM BIOPH RES CO, V192, P1380, DOI 10.1006/bbrc.1993.1569; Backert S, 2005, TRENDS MICROBIOL, V13, P476, DOI 10.1016/j.tim.2005.08.002; Barnewall RE, 1997, INFECT IMMUN, V65, P1455, DOI 10.1128/IAI.65.4.1455-1461.1997; Benz I, 2002, MOL MICROBIOL, V45, P267, DOI 10.1046/j.1365-2958.2002.03030.x; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chen SM, 1997, CLIN DIAGN LAB IMMUN, V4, P731, DOI 10.1128/CDLI.4.6.731-735.1997; CHEN SM, 1994, AM J TROP MED HYG, V50, P52, DOI 10.4269/ajtmh.1994.50.1.TM0500010052; Clifton DR, 2005, INFECT IMMUN, V73, P3860, DOI 10.1128/IAI.73.7.3860-3868.2005; de la Fuente J, 2004, VET MICROBIOL, V98, P313, DOI 10.1016/j.vetmic.2003.11.001; de la Fuente Jose, 2001, Animal Health Research Reviews, V2, P163; Doyle CK, 2006, INFECT IMMUN, V74, P711, DOI 10.1128/IAI.74.1.711-720.2006; Hotopp JCD, 2006, PLOS GENET, V2, P208, DOI 10.1371/journal.pgen.0020021; GAILLARD JL, 1991, CELL, V65, P1127, DOI 10.1016/0092-8674(91)90009-N; Garcia-Garcia JC, 2004, INFECT IMMUN, V72, P3022, DOI 10.1128/IAI.72.5.3022-3030.2004; Garcia-Ortega L, 2005, ELECTROPHORESIS, V26, P3407, DOI 10.1002/elps.200500261; GRACEFFA P, 1992, ARCH BIOCHEM BIOPHYS, V297, P46, DOI 10.1016/0003-9861(92)90639-E; Grangeasse C, 2007, TRENDS BIOCHEM SCI, V32, P86, DOI 10.1016/j.tibs.2006.12.004; Hegge FT, 2004, P NATL ACAD SCI USA, V101, P10798, DOI 10.1073/pnas.0402397101; Hu XM, 2006, J PROTEOME RES, V5, P2396, DOI 10.1021/pr060209x; Jewett TJ, 2008, BIOCHEM BIOPH RES CO, V371, P339, DOI 10.1016/j.bbrc.2008.04.089; Jordan P, 2003, BMC MICROBIOL, V3, DOI 10.1186/1471-2180-3-23; Kling DE, 1997, INFECT IMMUN, V65, P1462, DOI 10.1128/IAI.65.4.1462-1467.1997; Lee EH, 1998, INFECT IMMUN, V66, P2514, DOI 10.1128/IAI.66.6.2514-2520.1998; Lin M, 2004, CELL MICROBIOL, V6, P175, DOI 10.1046/j.1462-5822.2003.00355.x; Lin MQ, 2007, CELL MICROBIOL, V9, P2644, DOI 10.1111/j.1462-5822.2007.00985.x; Luo T, 2008, INFECT IMMUN, V76, P1572, DOI 10.1128/IAI.01466-07; Luo T, 2009, CLIN VACCINE IMMUNOL, V16, P982, DOI 10.1128/CVI.00048-09; Mavromatis K, 2006, J BACTERIOL, V188, P4015, DOI 10.1128/JB.01837-05; McBride JW, 2007, INFECT IMMUN, V75, P74, DOI 10.1128/IAI.01494-06; McBride JW, 2003, INFECT IMMUN, V71, P2516, DOI 10.1128/IAI.71.5.2516-2524.2003; McBride JW, 2000, INFECT IMMUN, V68, P13, DOI 10.1128/IAI.68.1.13-18.2000; MCGAREY DJ, 1994, INFECT IMMUN, V62, P4594, DOI 10.1128/IAI.62.10.4594-4601.1994; McNally DJ, 2007, J BIOL CHEM, V282, P14463, DOI 10.1074/jbc.M611027200; Mehlitz A, 2008, FEMS MICROBIOL LETT, V289, P233, DOI 10.1111/j.1574-6968.2008.01390.x; Palmer GH, 2007, TRENDS PARASITOL, V23, P408, DOI 10.1016/j.pt.2007.07.008; Popov VL, 2000, MICROB PATHOGENESIS, V28, P71, DOI 10.1006/mpat.1999.0327; RIKIHISA Y, 1994, J CLIN MICROBIOL, V32, P2107, DOI 10.1128/JCM.32.9.2107-2112.1994; Sarkar M, 2008, INFECT IMMUN, V76, P2090, DOI 10.1128/IAI.01594-07; Schirm M, 2003, MOL MICROBIOL, V48, P1579, DOI 10.1046/j.1365-2958.2003.03527.x; Schmidt MA, 2003, TRENDS MICROBIOL, V11, P554, DOI 10.1016/j.tim.2003.10.004; Selbach M, 2009, CELL HOST MICROBE, V5, P397, DOI 10.1016/j.chom.2009.03.004; Shak JR, 2009, J BACTERIOL, V191, P6900, DOI 10.1128/JB.00706-09; Singu V, 2005, INFECT IMMUN, V73, P79, DOI 10.1128/IAI.73.1.79-87.2005; Singu V, 2006, CELL MICROBIOL, V8, P1475, DOI 10.1111/j.1462-5822.2006.00727.x; Sterba J, 2008, J BACTERIOL, V190, P2619, DOI 10.1128/JB.01885-07; STIMSON E, 1995, MOL MICROBIOL, V17, P1201, DOI 10.1111/j.1365-2958.1995.mmi_17061201.x; Storey JR, 1998, INFECT IMMUN, V66, P1356, DOI 10.1128/IAI.66.4.1356-1363.1998; Szymanski CM, 2005, NAT REV MICROBIOL, V3, P225, DOI 10.1038/nrmicro1100; Troese MJ, 2009, INFECT IMMUN, V77, P1746, DOI 10.1128/IAI.01530-08; Upreti RK, 2003, PROTEOMICS, V3, P363, DOI 10.1002/pmic.200390052; Voisin S, 2007, J BACTERIOL, V189, P151, DOI 10.1128/JB.01224-06; Wakeel A, 2009, INFECT IMMUN, V77, P1734, DOI 10.1128/IAI.00027-09; Wang J, 2009, VACCINE, V27, P2967, DOI 10.1016/j.vaccine.2009.02.095; WREN BW, 1991, MOL MICROBIOL, V5, P797, DOI 10.1111/j.1365-2958.1991.tb00752.x; Yu XJ, 1996, J CLIN MICROBIOL, V34, P2853, DOI 10.1128/JCM.34.11.2853-2855.1996	58	19	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2010	5	3							e9552	10.1371/journal.pone.0009552	http://dx.doi.org/10.1371/journal.pone.0009552			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	564EW	20209062	Green Submitted, gold, Green Published			2022-12-25	WOS:000275197100026
J	Kawabe, T; Shirai, N; Wada, Y; Miura, K; Kanazawa, S; Yamaguchi, MK				Kawabe, Takahiro; Shirai, Nobu; Wada, Yuji; Miura, Kayo; Kanazawa, So; Yamaguchi, Masami K.			The Audiovisual Tau Effect in Infancy	PLOS ONE			English	Article							VISUAL-MOTION PERCEPTION; SOUND; ILLUSIONS; VISION; ATTENTION; OBJECTS; FUSION; SPACE	Background: Perceived spatial intervals between successive flashes can be distorted by varying the temporal intervals between them (the "tau effect''). A previous study showed that a tau effect for visual flashes could be induced when they were accompanied by auditory beeps with varied temporal intervals (an audiovisual tau effect). Methodology/Principal Findings: We conducted two experiments to investigate whether the audiovisual tau effect occurs in infancy. Forty-eight infants aged 5-8 months took part in this study. In Experiment 1, infants were familiarized with audiovisual stimuli consisting of three pairs of two flashes and three beeps. The onsets of the first and third pairs of flashes were respectively matched to those of the first and third beeps. The onset of the second pair of flashes was separated from that of the second beep by 150 ms. Following the familiarization phase, infants were exposed to a test stimulus composed of two vertical arrays of three static flashes with different spatial intervals. We hypothesized that if the audiovisual tau effect occurred in infancy then infants would preferentially look at the flash array with spatial intervals that would be expected to be different from the perceived spatial intervals between flashes they were exposed to in the familiarization phase. The results of Experiment 1 supported this hypothesis. In Experiment 2, the first and third beeps were removed from the familiarization stimuli, resulting in the disappearance of the audiovisual tau effect. This indicates that the modulation of temporal intervals among flashes by beeps was essential for the audiovisual tau effect to occur (Experiment 2). Conclusions/Significance: These results suggest that the cross-modal processing that underlies the audiovisual tau effect occurs even in early infancy. In particular, the results indicate that audiovisual modulation of temporal intervals emerges by 5-8 months of age.	[Kawabe, Takahiro] Kyushu Univ, Inst Adv Study, Fukuoka 812, Japan; [Shirai, Nobu] Niigata Univ, Dept Psychol, Niigata, Japan; [Wada, Yuji] Natl Food Res Inst, Sensory & Cognit Food Sci Lab, Tsukuba, Ibaraki 305, Japan; [Kawabe, Takahiro; Miura, Kayo] Kyushu Univ, Fac Human Environm Studies, Fukuoka 812, Japan; [Kanazawa, So] Japan Womens Univ, Dept Psychol, Kawasaki Ku, Kanagawa, Japan; [Yamaguchi, Masami K.] Chuo Univ, Dept Psychol, Tokyo 112, Japan; [Yamaguchi, Masami K.] Japan Sci & Technol Agcy, Kawaguchi, Saitama, Japan	Kyushu University; Niigata University; National Agriculture & Food Research Organization - Japan; National Food Research Institute - Japan; Kyushu University; Japan Womens University; Chuo University; Japan Science & Technology Agency (JST)	Kawabe, T (corresponding author), Kyushu Univ, Inst Adv Study, Fukuoka 812, Japan.	tkawabe@hes.kyushu-u.ac.jp			Japan Society for the Promotion of Science [18000090, 19-1464]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was financially supported by the Kyushu University Superstar Program (http://www. srp. kyushu-u. ac. jp/ssp_ home/e_ top. html) to T. K.; the Foundation of Technology Supporting the Creation of Digital Media Contents from the Japan Science and Technology Agency (http://www. media. jst. go. jp/ english/index. html) to M. K. Y; and Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (http://www. jsps. go. jp/english/index. html) 18000090 to M. K. Y and 19-1464 to N. S.. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen TS, 2004, COGNITIVE BRAIN RES, V21, P301, DOI 10.1016/j.cogbrainres.2004.06.004; Bahrick LE, 2000, DEV PSYCHOL, V36, P190, DOI 10.1037//0012-1649.36.2.190; BAHRICK LE, 1994, DEV INTERSENSORY PER, P165; Benussi V, 1913, ARCH GES PSYCHOL, V36, P59; Burr D, 2009, EXP BRAIN RES, V198, P49, DOI 10.1007/s00221-009-1933-z; Calvert GA, 2001, CEREB CORTEX, V11, P1110, DOI 10.1093/cercor/11.12.1110; DODD B, 1979, COGNITIVE PSYCHOL, V11, P478, DOI 10.1016/0010-0285(79)90021-5; Driver J, 2000, CURR BIOL, V10, pR731, DOI 10.1016/S0960-9822(00)00740-5; FANTZ RL, 1964, SCIENCE, V146, P668, DOI 10.1126/science.146.3644.668; Freeman E, 2008, CURR BIOL, V18, P1262, DOI 10.1016/j.cub.2008.07.066; Goldreich D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000333; Helson H, 1930, Science, V71, P536, DOI 10.1126/science.71.1847.536; Helson H, 1931, J EXP PSYCHOL, V14, P202, DOI 10.1037/h0071164; Kawabe T, 2008, ACTA PSYCHOL, V128, P249, DOI 10.1016/j.actpsy.2008.01.004; Kawabe T, 2009, EXP BRAIN RES, V198, P195, DOI 10.1007/s00221-009-1877-3; Kawabe T, 2006, PERCEPT PSYCHOPHYS, V68, P750, DOI 10.3758/BF03193698; Lewkowicz DJ, 2000, PSYCHOL BULL, V126, P281, DOI 10.1037/0033-2909.126.2.281; LEWKOWICZ DJ, 1980, DEV PSYCHOL, V16, P597; LEWKOWICZ DJ, 1994, DEV PSYCHOL, V30, P880, DOI 10.1037/0012-1649.30.6.880; Lewkowicz DJ, 1994, DEV INTERSENSORY PER, P165; MAURER D, 2004, ATTENTION PERFORM, V21, P193; Mishra J, 2007, J NEUROSCI, V27, P4120, DOI 10.1523/JNEUROSCI.4912-06.2007; Mishra J, 2008, BRAIN RES, V1242, P102, DOI 10.1016/j.brainres.2008.05.023; Neil PA, 2006, DEVELOPMENTAL SCI, V9, P454, DOI 10.1111/j.1467-7687.2006.00512.x; Quinn PC, 1996, J EXP CHILD PSYCHOL, V63, P189, DOI 10.1006/jecp.1996.0047; Roder BJ, 2000, INFANCY, V1, P491, DOI 10.1207/S15327078IN0104_9; Sarrazin JC, 2007, PSYCHOL RES-PSYCH FO, V71, P201, DOI 10.1007/s00426-005-0019-1; Scheier C, 2003, DEVELOPMENTAL SCI, V6, P233, DOI 10.1111/1467-7687.00276; Sekuler R, 1997, NATURE, V385, P308, DOI 10.1038/385308a0; Shams L, 2000, NATURE, V408, P788, DOI 10.1038/35048669; Spector F, 2009, DEV PSYCHOL, V45, P175, DOI 10.1037/a0014171; SPELKE ES, 1983, PERCEPTION, V12, P719, DOI 10.1068/p120719; Violentyev A, 2005, NEUROREPORT, V16, P1107, DOI 10.1097/00001756-200507130-00015; Vroomen J, 2000, J EXP PSYCHOL HUMAN, V26, P1583, DOI 10.1037/0096-1523.26.5.1583; Wada Y, 2009, J EXP CHILD PSYCHOL, V102, P315, DOI 10.1016/j.jecp.2008.07.002; Walsh V, 2003, TRENDS COGN SCI, V7, P483, DOI 10.1016/j.tics.2003.09.002; Watanabe K, 2001, PSYCHOL SCI, V12, P109, DOI 10.1111/1467-9280.00319	37	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2010	5	3							e9503	10.1371/journal.pone.0009503	http://dx.doi.org/10.1371/journal.pone.0009503			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	562OZ	20209137	Green Published, Green Submitted, gold			2022-12-25	WOS:000275063400011
J	Shahaf, G; Cancro, MP; Mehr, R				Shahaf, Gitit; Cancro, Michael P.; Mehr, Ramit			Kinetic Modeling Reveals a Common Death Niche for Newly Formed and Mature B Cells	PLOS ONE			English	Article							VITRO TOLERANCE INDUCTION; BONE-MARROW; LYMPHOCYTE DEVELOPMENT; CLONAL DELETION; SELF-TOLERANCE; MATURATION; SELECTION; DIFFERENTIATION; REPERTOIRE; ANTIBODY	Background: B lymphocytes are subject to elimination following strong BCR ligation in the absence of appropriate second signals, and this mechanism mediates substantial cell losses during late differentiation steps in the bone marrow and periphery. Mature B cells may also be eliminated through this mechanism as well as through normal turnover, but the population containing mature cells destined for elimination has not been identified. Herein, we asked whether the transitional 3 (T3) subset, which contains most newly formed cells undergoing anergic death, could also include mature B cells destined for elimination. Methodology/Principal Findings: To interrogate this hypothesis and its implications, we applied mathematical models to previously generated in vivo labeling data. Our analyses reveal that the death rate of T3 B cells is far higher than the death rates of all other splenic B cell subpopulations. Further, the model, in which the T3 pool includes both newly formed and mature primary B cells destined for apoptotic death, shows that this cell loss may account for nearly all mature B cell turnover. Conclusions/Significance: This finding has implications for the mechanism of normal mature B cell turnover.	[Shahaf, Gitit; Mehr, Ramit] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel; [Cancro, Michael P.] Univ Penn, Sch Med, Pathol & Lab Med, Philadelphia, PA 19104 USA	Bar Ilan University; University of Pennsylvania	Shahaf, G (corresponding author), Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel.	mehrra@mail.biu.ac.il		Cancro, Michael/0000-0002-8659-3227; Mehr, Ramit/0000-0002-4303-6834	Israel Science Foundation [759/01-1, 546]; Israel Cancer Research Fund; Human Frontiers Science Program; Swedish Foundation for Strategic Research; Mina and Everard Goodman Faculty of Life Sciences; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073939] Funding Source: NIH RePORTER	Israel Science Foundation(Israel Science Foundation); Israel Cancer Research Fund; Human Frontiers Science Program(Human Frontier Science Program); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Mina and Everard Goodman Faculty of Life Sciences; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the following grants (to R. M.): Israel Science Foundation grants number 759/01-1 and 546; Israel Cancer Research Fund project grant; and indirectly by a Human Frontiers Science Program grant and a Swedish Foundation for Strategic Research grant funding the Strategic Research Center for studies on Integrative Recognition in the Immune System, Karolinska Institute, Stockholm, Sweden. G. S. was supported by a Dean's excellence PhD scholarship of The Mina and Everard Goodman Faculty of Life Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agenes F, 1997, EUR J IMMUNOL, V27, P1801, DOI 10.1002/eji.1830270731; Allman D, 2004, IMMUNOL REV, V197, P147, DOI 10.1111/j.0105-2896.2004.0108.x; Allman D, 2001, J IMMUNOL, V167, P6834, DOI 10.4049/jimmunol.167.12.6834; Allman D, 2008, CURR OPIN IMMUNOL, V20, P149, DOI 10.1016/j.coi.2008.03.014; ALLMAN DM, 1993, J IMMUNOL, V151, P4431; BASTEN A, 1991, IMMUNOL REV, V122, P5, DOI 10.1111/j.1600-065X.1991.tb00593.x; Cambier JC, 2007, NAT REV IMMUNOL, V7, P633, DOI 10.1038/nri2133; Cancro MP, 2004, IMMUNOL REV, V197, P89, DOI 10.1111/j.0105-2896.2004.0099.x; FULCHER DA, 1994, J EXP MED, V179, P125, DOI 10.1084/jem.179.1.125; Fulcher DA, 1996, J EXP MED, V183, P2313, DOI 10.1084/jem.183.5.2313; GOODNOW CC, 1989, NATURE, V342, P385, DOI 10.1038/342385a0; Gorfine M, 2003, B MATH BIOL, V65, P1131, DOI 10.1016/S0092-8240(03)00062-4; Hardy RR, 2000, IMMUNOL REV, V175, P23, DOI 10.1111/j.1600-065X.2000.imr017517.x; Loder F, 1999, J EXP MED, V190, P75, DOI 10.1084/jem.190.1.75; Martin D, 2002, BRILLS TIBET STU LIB, V2, P335; Mehr R, 2003, INT IMMUNOL, V15, P301, DOI 10.1093/intimm/dxg025; Merrell KT, 2006, IMMUNITY, V25, P953, DOI 10.1016/j.immuni.2006.10.017; METCALF ES, 1977, J IMMUNOL, V118, P2111; METCALF ES, 1976, J EXP MED, V143, P1327, DOI 10.1084/jem.143.6.1327; Monroe JG, 2003, IMMUNOL RES, V27, P427, DOI 10.1385/IR:27:2-3:427; NEMAZEE D, 1989, P NATL ACAD SCI USA, V86, P8039, DOI 10.1073/pnas.86.20.8039; NEMAZEE DA, 1989, NATURE, V337, P562, DOI 10.1038/337562a0; NOSSAL GJV, 1975, J EXP MED, V141, P904; NOSSAL GJV, 1983, ANNU REV IMMUNOL, V1, P33, DOI 10.1146/annurev.iy.01.040183.000341; Osmond D G, 1990, Semin Immunol, V2, P173; OSMOND DG, 1976, NATURE, V260, P328, DOI 10.1038/260328a0; Rolink A, 1996, IMMUNOL LETT, V54, P157, DOI 10.1016/S0165-2478(96)02666-1; Rolink AG, 2000, J EXP MED, V191, P23, DOI 10.1084/jem.191.1.23; Rolink AG, 1998, EUR J IMMUNOL, V28, P3738, DOI 10.1002/(SICI)1521-4141(199811)28:11<3738::AID-IMMU3738>3.0.CO;2-Q; RUSSELL DM, 1991, NATURE, V354, P308, DOI 10.1038/354308a0; Shahaf G, 2006, INT IMMUNOL, V18, P31, DOI 10.1093/intimm/dxh346; Shahaf G, 2004, INT IMMUNOL, V16, P1081, DOI 10.1093/intimm/dxh109; Srivastava B, 2005, J EXP MED, V202, P1225, DOI 10.1084/jem.20051038	33	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2010	5	3							e9497	10.1371/journal.pone.0009497	http://dx.doi.org/10.1371/journal.pone.0009497			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	562OY	20209168	Green Published, Green Submitted, gold			2022-12-25	WOS:000275063300013
J	Ding, F; Li, HH; Li, J; Myers, RM; Francke, U				Ding, Feng; Li, Hong Hua; Li, Jun; Myers, Richard M.; Francke, Uta			Neonatal Maternal Deprivation Response and Developmental Changes in Gene Expression Revealed by Hypothalamic Gene Expression Profiling in Mice	PLOS ONE			English	Article							PRADER-WILLI-SYNDROME; PITUITARY-ADRENAL-AXIS; GENOME MICROARRAY ANALYSIS; BREAST-CANCER METASTASIS; GERM-CELL DEVELOPMENT; SMALL NUCLEOLAR RNAS; NANOS PROTEINS; FOOD-INTAKE; MOUSE; RAT	Neonatal feeding problems are observed in several genetic diseases including Prader-Willi syndrome (PWS). Later in life, individuals with PWS develop hyperphagia and obesity due to lack of appetite control. We hypothesized that failure to thrive in infancy and later-onset hyperphagia are related and could be due to a defect in the hypothalamus. In this study, we performed gene expression microarray analysis of the hypothalamic response to maternal deprivation in neonatal wild-type and Snord116del mice, a mouse model for PWS in which a cluster of imprinted C/D box snoRNAs is deleted. The neonatal starvation response in both strains was dramatically different from that reported in adult rodents. Genes that are affected by adult starvation showed no expression change in the hypothalamus of 5 day-old pups after 6 hours of maternal deprivation. Unlike in adult rodents, expression levels of Nanos2 and Pdk4 were increased, and those of Pgpep1, Ndp, Brms1l, Mett10d, and Snx1 were decreased after neonatal deprivation. In addition, we compared hypothalamic gene expression profiles at postnatal days 5 and 13 and observed significant developmental changes. Notably, the gene expression profiles of Snord116del deletion mice and wild-type littermates were very similar at all time points and conditions, arguing against a role of Snord116 in feeding regulation in the neonatal period.	[Ding, Feng; Li, Hong Hua; Li, Jun; Myers, Richard M.; Francke, Uta] Stanford Univ, Dept Genet, Stanford, CA 94305 USA	Stanford University	Ding, F (corresponding author), Xiamen Univ, Dept Biomed Sci, Sch Life Sci, Xiamen, Peoples R China.	ufrancke@stanford.edu	Ding, Feng/E-5112-2012; Ding, Feng/AAH-7335-2019	Li, Jun/0000-0001-6727-0812	NIH/NICHD; Foundation for Prader-Willi Research	NIH/NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Foundation for Prader-Willi Research	This work was supported by research grants (to U.F.) from the NIH/NICHD and the Foundation for Prader-Willi Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARKER DD, 1992, GENE DEV, V6, P2312, DOI 10.1101/gad.6.12a.2312; BERTIN R, 1990, AM J PHYSIOL, V259, pR90, DOI 10.1152/ajpregu.1990.259.1.R90; Bittel DC, 2007, AM J MED GENET A, V143A, P422, DOI 10.1002/ajmg.a.31504; Bittel DC, 2007, AM J MED GENET A, V143A, P430, DOI 10.1002/ajmg.a.31606; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bonifacino JS, 2008, CURR OPIN CELL BIOL, V20, P427, DOI 10.1016/j.ceb.2008.03.009; Bouret SG, 2004, ENDOCRINOLOGY, V145, P2621, DOI 10.1210/en.2004-0231; Cassidy S.B., 2005, MANAGEMENT GENETIC S, P429; CIRULLI F, 1992, PSYCHOBIOLOGY, V20, P143; Cummings DE, 2002, NAT MED, V8, P643, DOI 10.1038/nm0702-643; Cummins PM, 1998, BBA-PROTEIN STRUCT M, V1429, P1, DOI 10.1016/S0167-4838(98)00248-9; de Smith AJ, 2009, HUM MOL GENET, V18, P3257, DOI 10.1093/hmg/ddp263; DelPparigi A, 2002, J CLIN ENDOCR METAB, V87, P5461, DOI 10.1210/jc.2002-020871; Ding F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001709; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Franklin KBJ, 2008, MOUSE BRAIN STEREOTA, V3rd; Gecz J, 2006, EUR J HUM GENET, V14, P1233, DOI 10.1038/sj.ejhg.5201639; Grill HJ, 2002, ENDOCRINOLOGY, V143, P239, DOI 10.1210/en.143.1.239; Gullapalli A, 2006, MOL BIOL CELL, V17, P1228, DOI 10.1091/mbc.E05-09-0899; Hedley BD, 2008, CLIN EXP METASTAS, V25, P727, DOI 10.1007/s10585-008-9184-0; HOFER MA, 1993, DEV PSYCHOBIOL, V26, P483, DOI 10.1002/dev.420260806; Holland A, 2003, LANCET, V362, P989, DOI 10.1016/S0140-6736(03)14370-X; HOLM VA, 1993, PEDIATRICS, V91, P398; Hurst DR, 2008, J BIOL CHEM, V283, P7438, DOI 10.1074/jbc.M709446200; Jordan C, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-36; Kishore S, 2006, SCIENCE, V311, P230, DOI 10.1126/science.1118265; Larrinaga G, 2005, NEUROSCI LETT, V383, P136, DOI 10.1016/j.neulet.2005.03.061; LAU C, 1984, PHYSIOL BEHAV, V33, P809, DOI 10.1016/0031-9384(84)90052-0; Li JY, 2002, J BIOL CHEM, V277, P9069, DOI 10.1074/jbc.M110467200; Lim CR, 2004, GENE, V333, P3, DOI 10.1016/j.gene.2004.02.026; Luhmann UFO, 2008, EUR J NEUROSCI, V27, P2619, DOI 10.1111/j.1460-9568.2008.06237.x; Malik SS, 2003, AM J PHYSIOL-REG I, V285, pR1366, DOI 10.1152/ajpregu.00280.2003; Meehan WJ, 2003, CLIN EXP METASTAS, V20, P45, DOI 10.1023/A:1022542519586; Miki R, 2001, P NATL ACAD SCI USA, V98, P2199, DOI 10.1073/pnas.041605498; Mody M, 2001, P NATL ACAD SCI USA, V98, P8862, DOI 10.1073/pnas.141244998; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; Nieuwenhuizen AG, 2008, PHYSIOL BEHAV, V94, P169, DOI 10.1016/j.physbeh.2007.12.011; Nikolaev AY, 2004, BIOCHEM BIOPH RES CO, V323, P1216, DOI 10.1016/j.bbrc.2004.08.227; Perlman JH, 1997, BIOCHEMISTRY-US, V36, P15670, DOI 10.1021/bi9713310; R CDT, 2008, R LANG ENV STAT COMP; Rinaman L, 2006, DEV PSYCHOBIOL, V48, P389, DOI 10.1002/dev.20146; Roche TE, 2007, CELL MOL LIFE SCI, V64, P830, DOI 10.1007/s00018-007-6380-z; Schmidt M, 2004, J NEUROENDOCRINOL, V16, P52, DOI 10.1111/j.1365-2826.2004.01123.x; Schmidt MV, 2006, J NEUROENDOCRINOL, V18, P865, DOI 10.1111/j.1365-2826.2006.01482.x; Schmidt MV, 2008, J ENDOCRINOL, V197, P421, DOI 10.1677/JOE-07-0634; Spriet LL, 2004, J APPL PHYSIOL, V96, P2082, DOI 10.1152/japplphysiol.01318.2003; Stefan M, 2005, GENOMICS, V85, P630, DOI 10.1016/j.ygeno.2005.02.004; Suzuki A, 2007, DEVELOPMENT, V134, P77, DOI 10.1242/dev.02697; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; Tsuda M, 2003, SCIENCE, V301, P1239, DOI 10.1126/science.1085222; Tsuda M, 2006, MECH DEVELOP, V123, P440, DOI 10.1016/j.mod.2006.04.002; Vannucci RC, 2000, SEMIN PERINATOL, V24, P107, DOI 10.1053/sp.2000.6361; Vitali P, 2005, J CELL BIOL, V169, P745, DOI 10.1083/jcb.200411129; Wadhwa PD, 2009, SEMIN REPROD MED, V27, P358, DOI 10.1055/s-0029-1237424; Wang XW, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng154; White SM, 2004, AM J MED GENET A, V127A, P118, DOI 10.1002/ajmg.a.20674; Xu AW, 2007, ENDOCRINOLOGY, V148, P72, DOI 10.1210/en.2006-1119; Xu Q, 2004, CELL, V116, P883, DOI 10.1016/S0092-8674(04)00216-8	58	22	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2010	5	2							e9402	10.1371/journal.pone.0009402	http://dx.doi.org/10.1371/journal.pone.0009402			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SX	20195375	gold, Green Published, Green Submitted			2022-12-25	WOS:000274924200023
J	Patel, BP; Safdar, A; Raha, S; Tarnopolsky, MA; Hamadeh, MJ				Patel, Barkha P.; Safdar, Adeel; Raha, Sandeep; Tarnopolsky, Mark A.; Hamadeh, Mazen J.			Caloric Restriction Shortens Lifespan through an Increase in Lipid Peroxidation, Inflammation and Apoptosis in the G93A Mouse, an Animal Model of ALS	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; CU/ZN-SUPEROXIDE-DISMUTASE; HEAT-SHOCK PROTEINS; SKELETAL-MUSCLE; OXIDATIVE STRESS; GENE-EXPRESSION; DIETARY RESTRICTION; MITOCHONDRIAL-DNA; UP-REGULATION; RADICAL GENERATION	Caloric restriction (CR) extends lifespan through a reduction in oxidative stress, delays the onset of morbidity and prolongs lifespan. We previously reported that long-term CR hastened clinical onset, disease progression and shortened lifespan, while transiently improving motor performance in G93A mice, a model of amyotrophic lateral sclerosis (ALS) that shows increased free radical production. To investigate the long-term CR-induced pathology in G93A mice, we assessed the mitochondrial bioenergetic efficiency and oxidative capacity (CS - citrate synthase content and activity, cytochrome c oxidase - COX activity and protein content of COX subunit-I and IV and UCP3- uncoupling protein 3), oxidative damage (MDA - malondialdehyde and PC - protein carbonyls), antioxidant enzyme capacity (Mn-SOD, Cu/Zn-SOD and catalase), inflammation (TNF-alpha), stress response (Hsp70) and markers of apoptosis (Bax, Bcl-2, caspase 9, cleaved caspase 9) in their skeletal muscle. At age 40 days, G93A mice were divided into two groups: Ad libitum (AL; n = 14; 7 females) or CR (n = 13; 6 females), with a diet equal to 60% of AL. COX/CS enzyme activity was lower in CR vs. AL male quadriceps (35%), despite a 2.3-fold higher COX-IV/CS protein content. UCP3 was higher in CR vs. AL females only. MnSOD and Cu/Zn-SOD were higher in CR vs. AL mice and CR vs. AL females. MDA was higher (83%) in CR vs. AL red gastrocnemius. Conversely, PC was lower in CR vs. AL red (62%) and white (30%) gastrocnemius. TNF-alpha was higher (52%) in CR vs. AL mice and Hsp70 was lower (62%) in CR vs. AL quadriceps. Bax was higher in CR vs. AL mice (41%) and CR vs. AL females (52%). Catalase, Bcl-2 and caspases did not differ. We conclude that CR increases lipid peroxidation, inflammation and apoptosis, while decreasing mitochondrial bioenergetic efficiency, protein oxidation and stress response in G93A mice.	[Patel, Barkha P.; Hamadeh, Mazen J.] York Univ, Sch Kinesiol & Hlth Sci, Toronto, ON M3J 2R7, Canada; [Patel, Barkha P.; Hamadeh, Mazen J.] York Univ, Muscle Hlth Res Ctr, Toronto, ON M3J 2R7, Canada; [Safdar, Adeel; Raha, Sandeep; Tarnopolsky, Mark A.; Hamadeh, Mazen J.] McMaster Univ, Dept Pediat, Hamilton, ON, Canada; [Safdar, Adeel; Tarnopolsky, Mark A.] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Safdar, Adeel] McMaster Univ, Dept Kinesiol, Hamilton, ON, Canada	York University - Canada; York University - Canada; McMaster University; McMaster University; McMaster University	Patel, BP (corresponding author), York Univ, Sch Kinesiol & Hlth Sci, Toronto, ON M3J 2R7, Canada.	hamadeh@yorku.ca	Patel, Barkha/AAJ-2355-2020; Raha, Sandeep/AAF-3655-2020	Raha, Sandeep/0000-0001-7307-3292; Safdar, Adeel/0000-0003-2469-0467; Hamadeh, Mazen/0000-0002-3511-4345; Safdar, Adeel/0000-0002-7453-7770	Hamilton Health Sciences; Hamilton Health Sciences Foundation New Investigator Fund; National Sciences and Engineering Research Council of Canada; York University-Faculty of Health; Hamilton Health Sciences Foundation William E. Noonan Research Career Award; Canadian Institute of Health Research - Institute of Aging Doctoral Research Award	Hamilton Health Sciences; Hamilton Health Sciences Foundation New Investigator Fund; National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); York University-Faculty of Health; Hamilton Health Sciences Foundation William E. Noonan Research Career Award; Canadian Institute of Health Research - Institute of Aging Doctoral Research Award(Canadian Institutes of Health Research (CIHR))	This research was funded by Hamilton Health Sciences, Hamilton Health Sciences Foundation New Investigator Fund, the National Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/) and York University-Faculty of Health. M. J. Hamadeh was recipient of the Hamilton Health Sciences Foundation William E. Noonan Research Career Award. A. Safdar was recipient of the Canadian Institute of Health Research - Institute of Aging Doctoral Research Award (http://www.cihr.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEBI H, 1984, METHOD ENZYMOL, V105, P121; Alexianu ME, 2001, NEUROLOGY, V57, P1282, DOI 10.1212/WNL.57.7.1282; Ando K, 2002, MICROSC RES TECHNIQ, V59, P293, DOI 10.1002/jemt.10207; Andrews ZB, 2005, NAT REV NEUROSCI, V6, P829, DOI 10.1038/nrn1767; Andrus PK, 1998, J NEUROCHEM, V71, P2041; Barber SC, 2006, BBA-MOL BASIS DIS, V1762, P1051, DOI 10.1016/j.bbadis.2006.03.008; BARJA G, 1994, COMP BIOCHEM PHYS B, V108, P501, DOI 10.1016/0305-0491(94)90103-1; Bartlett JB, 2004, NAT REV CANCER, V4, P314, DOI 10.1038/nrc1323; Batulan Z, 2003, J NEUROSCI, V23, P5789; BECKER J, 1994, EUR J BIOCHEM, V219, P11, DOI 10.1111/j.1432-1033.1994.tb19910.x; Beere HM, 2000, NAT CELL BIOL, V2, P469, DOI 10.1038/35019501; BEHRENS WA, 1977, J BIOENERG BIOMEMBR, V9, P41, DOI 10.1007/BF00745042; Bevilacqua L, 2005, AM J PHYSIOL-ENDOC M, V289, pE429, DOI 10.1152/ajpendo.00435.2004; Bogdanov MB, 1998, J NEUROCHEM, V71, P1321; Borras C, 2003, FREE RADICAL BIO MED, V34, P546, DOI 10.1016/S0891-5849(02)01356-4; Bruening W, 1999, J NEUROCHEM, V72, P693, DOI 10.1046/j.1471-4159.1999.0720693.x; Chen S, 2007, CELL STRESS CHAPERON, V12, P51, DOI 10.1379/CSC-236R.1; Civitarese AE, 2007, PLOS MED, V4, P485, DOI 10.1371/journal.pmed.0040076; Corral LG, 1999, ANN RHEUM DIS, V58, P107, DOI 10.1136/ard.58.2008.i107; DAVIS LJ, 1993, MECH AGEING DEV, V72, P155, DOI 10.1016/0047-6374(93)90097-B; Desport JC, 1999, NEUROLOGY, V53, P1059, DOI 10.1212/WNL.53.5.1059; Dirks AJ, 2004, FREE RADICAL BIO MED, V36, P27, DOI 10.1016/j.freeradbiomed.2003.10.003; Dirks AJ, 2006, J NUTR BIOCHEM, V17, P501, DOI 10.1016/j.jnutbio.2005.11.002; Dupuis L, 2003, FASEB J, V17, P2091, DOI 10.1096/fj.02-1182fje; Durham HD, 1997, J NEUROPATH EXP NEUR, V56, P523, DOI 10.1097/00005072-199705000-00008; ESTERBAUER H, 1990, METHOD ENZYMOL, V186, P407; Fergani A, 2007, J LIPID RES, V48, P1571, DOI 10.1194/jlr.M700017-JLR200; Finucane DM, 1999, J BIOL CHEM, V274, P2225, DOI 10.1074/jbc.274.4.2225; Gianni P, 2004, EXP GERONTOL, V39, P1391, DOI 10.1016/j.exger.2004.06.002; Gifondorwa DJ, 2007, J NEUROSCI, V27, P13173, DOI 10.1523/JNEUROSCI.4057-07.2007; Goodall Emily F., 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S1462399406010854; Gredilla R, 2001, FASEB J, V15, P1589, DOI 10.1096/fj.00-0764fje; Gredilla R, 2001, J BIOENERG BIOMEMBR, V33, P279, DOI 10.1023/A:1010603206190; Gruber J, 2008, FRONT BIOSCI-LANDMRK, V13, P6554, DOI 10.2741/3174; Guegn C, 2001, J NEUROSCI, V21, P6569, DOI 10.1523/JNEUROSCI.21-17-06569.2001; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Gursoy E, 2001, EXP BIOL MED, V226, P97, DOI 10.1177/153537020122600206; Hall ED, 1998, GLIA, V23, P249, DOI 10.1002/(SICI)1098-1136(199807)23:3<249::AID-GLIA7>3.0.CO;2-#; Hamadeh MJ, 2006, MUSCLE NERVE, V34, P709, DOI 10.1002/mus.20630; Hamadeh MJ, 2005, MUSCLE NERVE, V31, P214, DOI 10.1002/mus.20255; HAMADEH MJ, 2005, ANN NUTR METAB S1, V49, P164; HAVERKAMP LJ, 1995, BRAIN, V118, P707, DOI 10.1093/brain/118.3.707; Heddi A, 1999, J BIOL CHEM, V274, P22968, DOI 10.1074/jbc.274.33.22968; Hensley K, 2003, NEUROBIOL DIS, V14, P74, DOI 10.1016/S0969-9961(03)00087-1; Higami Y, 2003, FASEB J, V17, P415, DOI 10.1096/fj.03-0678fje; HILL JO, 1986, J NUTR, V116, P2000, DOI 10.1093/jn/116.10.2000; HOCKENBERY DM, 1993, CELL, V75, P241, DOI 10.1016/0092-8674(93)80066-N; Joseph AM, 2004, AM J PHYSIOL-CELL PH, V286, pC867, DOI 10.1152/ajpcell.00191.2003; Judge S, 2004, AM J PHYSIOL-REG I, V286, pR254, DOI 10.1152/ajpregu.00502.2003; Kalain R, 2006, J GERONTOL A-BIOL, V61, P211, DOI 10.1093/gerona/61.3.211; Kasarskis EJ, 1996, AM J CLIN NUTR, V63, P130, DOI 10.1093/ajcn/63.1.130; Kiaei M, 2006, J NEUROSCI, V26, P2467, DOI 10.1523/JNEUROSCI.5253-05.2006; Kim JD, 1996, FREE RADICAL BIO MED, V20, P83, DOI 10.1016/0891-5849(95)02023-3; KOIZUMI A, 1987, J NUTR, V117, P361, DOI 10.1093/jn/117.2.361; Kostic V, 1997, SCIENCE, V277, P559, DOI 10.1126/science.277.5325.559; Lass A, 1998, FREE RADICAL BIO MED, V25, P1089, DOI 10.1016/S0891-5849(98)00144-0; Lee CK, 2002, P NATL ACAD SCI USA, V99, P14988, DOI 10.1073/pnas.232308999; Lee CK, 2004, FREE RADICAL BIO MED, V36, P1043, DOI 10.1016/j.freeradbiomed.2004.01.015; Lee JH, 2004, EXP GERONTOL, V39, P1361, DOI 10.1016/j.exger.2004.06.015; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Lopez-Lluch G, 2006, P NATL ACAD SCI USA, V103, P1768, DOI 10.1073/pnas.0510452103; Mahoney DJ, 2006, MUSCLE NERVE, V33, P809, DOI 10.1002/mus.20542; Mair W, 2003, SCIENCE, V301, P1731, DOI 10.1126/science.1086016; Mattson MP, 2007, NEUROMOL MED, V9, P17, DOI 10.1385/NMM:9:1:17; Mhatre M, 2004, J ALZHEIMERS DIS, V6, P147; Minamiyama Y, 2007, J PHARMACOL EXP THER, V320, P535, DOI 10.1124/jpet.106.110460; Mittendorfer B, 2001, AM J PHYSIOL-ENDOC M, V281, pE1333, DOI 10.1152/ajpendo.2001.281.6.E1333; Moien-Afshari F, 2008, DIABETOLOGIA, V51, P1327, DOI 10.1007/s00125-008-0996-x; Morimoto RI, 1997, ESSAYS BIOCHEM, V32, P17; Nisoli E, 2005, SCIENCE, V310, P314, DOI 10.1126/science.1117728; Okado-Matsumoto A, 2002, P NATL ACAD SCI USA, V99, P9010, DOI 10.1073/pnas.132260399; Phillips T, 2005, FASEB J, V19, P668, DOI 10.1096/fj.04-2870fje; Pollack M, 2002, ANN NY ACAD SCI, V959, P93, DOI 10.1111/j.1749-6632.2002.tb02086.x; Ramsey JJ, 2000, FREE RADICAL BIO MED, V29, P946, DOI 10.1016/S0891-5849(00)00417-2; Roy J, 1998, J NEUROSCI, V18, P9673; Sango K, 1996, NAT GENET, V14, P348, DOI 10.1038/ng1196-348; Sato A, 1998, BIOL PHARM BULL, V21, P1271, DOI 10.1248/bpb.21.1271; Selman C, 2003, EXP GERONTOL, V38, P897, DOI 10.1016/S0531-5565(03)00091-3; Selsby JT, 2005, EXP GERONTOL, V40, P37, DOI 10.1016/j.exger.2004.08.012; Sen CK, 1997, J APPL PHYSIOL, V83, P189, DOI 10.1152/jappl.1997.83.1.189; Seng JE, 2003, TOXICOL APPL PHARM, V193, P281, DOI 10.1016/j.taap.2003.07.008; Shelke RRJ, 2003, FASEB J, V17, P494, DOI 10.1096/fj.02-0803fje; Simpson EP, 2003, CURR OPIN RHEUMATOL, V15, P730, DOI 10.1097/00002281-200311000-00008; Sinclair DA, 2005, MECH AGEING DEV, V126, P987, DOI 10.1016/j.mad.2005.03.019; Siu PM, 2004, FASEB J, V18, P1150, DOI 10.1096/fj.03-1291fje; Slee EA, 1999, J CELL BIOL, V144, P281, DOI 10.1083/jcb.144.2.281; SLOWIE LA, 1983, J AM DIET ASSOC, V83, P44; Stein O, 2003, BIOCHEM BIOPH RES CO, V308, P29, DOI 10.1016/S0006-291X(03)01313-5; Valle A, 2007, AM J PHYSIOL-CELL PH, V293, pC1302, DOI 10.1152/ajpcell.00203.2007; Vina J, 2003, ANTIOXID REDOX SIGN, V5, P549, DOI 10.1089/152308603770310194; Vukosavic S, 1999, J NEUROCHEM, V73, P2460, DOI 10.1046/j.1471-4159.1999.0732460.x; Weydt P, 2003, NEUROREPORT, V14, P1051, DOI 10.1097/01.wnr.0000073685.00308.89; Wong LJC, 2007, MITOCHONDRION, V7, P45, DOI 10.1016/j.mito.2006.11.025; Wu AG, 2003, NEUROSCI LETT, V339, P166, DOI 10.1016/S0304-3940(03)00008-9; Yenari MA, 2005, ANN NY ACAD SCI, V1053, P74, DOI 10.1196/annals.1344.007	95	54	55	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2010	5	2							e9386	10.1371/journal.pone.0009386	http://dx.doi.org/10.1371/journal.pone.0009386			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SX	20195368	Green Submitted, gold, Green Published			2022-12-25	WOS:000274924200013
J	Mossberg, AK; Puchades, M; Halskau, O; Baumann, A; Lanekoff, I; Chao, YX; Martinez, A; Svanborg, C; Karlsson, R				Mossberg, Ann-Kristin; Puchades, Maja; Halskau, Oyvind; Baumann, Anne; Lanekoff, Ingela; Chao, Yinxia; Martinez, Aurora; Svanborg, Catharina; Karlsson, Roger			HAMLET Interacts with Lipid Membranes and Perturbs Their Structure and Integrity	PLOS ONE			English	Article							HUMAN ALPHA-LACTALBUMIN; PLASMA-MEMBRANE; MOLTEN-GLOBULE; MODEL MEMBRANES; TUMOR-CELLS; OLEIC ACID; BINDING; PROTEIN; VESICLES; CONFORMATIONS	Background: Cell membrane interactions rely on lipid bilayer constituents and molecules inserted within the membrane, including specific receptors. HAMLET ( human alpha-lactalbumin made lethal to tumor cells) is a tumoricidal complex of partially unfolded alpha-lactalbumin (HLA) and oleic acid that is internalized by tumor cells, suggesting that interactions with the phospholipid bilayer and/or specific receptors may be essential for the tumoricidal effect. This study examined whether HAMLET interacts with artificial membranes and alters membrane structure. Methodology/Principal Findings: We show by surface plasmon resonance that HAMLET binds with high affinity to surface adherent, unilamellar vesicles of lipids with varying acyl chain composition and net charge. Fluorescence imaging revealed that HAMLET accumulates in membranes of vesicles and perturbs their structure, resulting in increased membrane fluidity. Furthermore, HAMLET disrupted membrane integrity at neutral pH and physiological conditions, as shown by fluorophore leakage experiments. These effects did not occur with either native HLA or a constitutively unfolded Cys-Ala HLA mutant (rHLA(all-Ala)). HAMLET also bound to plasma membrane vesicles formed from intact tumor cells, with accumulation in certain membrane areas, but the complex was not internalized by these vesicles or by the synthetic membrane vesicles. Conclusions/Significance: The results illustrate the difference in membrane affinity between the fatty acid bound and fatty acid free forms of partially unfolded HLA and suggest that HAMLET engages membranes by a mechanism requiring both the protein and the fatty acid. Furthermore, HAMLET binding alters the morphology of the membrane and compromises its integrity, suggesting that membrane perturbation could be an initial step in inducing cell death.	[Mossberg, Ann-Kristin; Svanborg, Catharina] Lund Univ, Inst Lab Med, Sect Microbiol Immunol & Glycobiol, Lund, Sweden; [Puchades, Maja; Lanekoff, Ingela; Karlsson, Roger] Univ Gothenburg, Dept Chem, Gothenburg, Sweden; [Halskau, Oyvind; Baumann, Anne; Martinez, Aurora] Univ Bergen, Dept Biomed, Bergen, Norway; [Chao, Yinxia; Svanborg, Catharina] ASTAR, Singapore Immunol Network, Singapore, Singapore	Lund University; University of Gothenburg; University of Bergen; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN)	Mossberg, AK (corresponding author), Lund Univ, Inst Lab Med, Sect Microbiol Immunol & Glycobiol, Lund, Sweden.	Catharina_Svanborg@immunol.a-star.edu.sg	Karlsson, Roger/A-7701-2010; Puchades, Maja/D-5835-2013; Karlsson, Roger/AFX-3165-2022; Martinez, Aurora/M-3088-2019	Puchades, Maja/0000-0002-4536-8197; Karlsson, Roger/0000-0002-5919-2639; Martinez, Aurora/0000-0003-1643-6506; Chao, Yinxia/0000-0003-1185-3511; Halskau, Oyvind/0000-0003-2517-1060; Lanekoff, Ingela/0000-0001-9040-3230	Swedish Cancer Society; Sharon D. Lund Foundation; Soderberg Foundation; Inga-Britt and Arne Lundberg Foundation; Medical Faculty (Lund University); Anna-Lisa and Sven-Erik Lundgren Foundation for Medical Research; Maggie Stephens Foundation; HJ Forssman Foundation for Medical Research; Royal Physiographic Society; Norwegian Cancer Society; Research Council of Norway; Wallenberg Foundation	Swedish Cancer Society(Swedish Cancer Society); Sharon D. Lund Foundation; Soderberg Foundation; Inga-Britt and Arne Lundberg Foundation; Medical Faculty (Lund University); Anna-Lisa and Sven-Erik Lundgren Foundation for Medical Research; Maggie Stephens Foundation; HJ Forssman Foundation for Medical Research; Royal Physiographic Society; Norwegian Cancer Society(Norwegian Cancer Society); Research Council of Norway(Research Council of Norway); Wallenberg Foundation(European Commission)	This work was supported by the Swedish Cancer Society, the Sharon D. Lund Foundation grant, the Soderberg Foundation, the Inga-Britt and Arne Lundberg Foundation, the Medical Faculty (Lund University), the Anna-Lisa and Sven-Erik Lundgren Foundation for Medical Research, the Maggie Stephens Foundation, the HJ Forssman Foundation for Medical Research, the Royal Physiographic Society, Norwegian Cancer Society, the Research Council of Norway, and the Wallenberg Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agasoster AV, 2003, J BIOL CHEM, V278, P21790, DOI 10.1074/jbc.M211466200; Almeida PF, 2009, BIOCHEMISTRY-US, V48, P8083, DOI 10.1021/bi900914g; Banuelos S, 1996, BIOCHEMISTRY-US, V35, P3892, DOI 10.1021/bi951468v; BANUELOS S, 1995, J BIOL CHEM, V270, P29910, DOI 10.1074/jbc.270.50.29910; Baritaki S, 2007, ADV CANCER RES, V98, P149, DOI 10.1016/S0065-230X(06)98005-1; Bauer B, 2006, LANGMUIR, V22, P9329, DOI 10.1021/la060828k; Bauer B, 2009, ANGEW CHEM INT EDIT, V48, P1656, DOI 10.1002/anie.200803898; Baumgart T, 2007, P NATL ACAD SCI USA, V104, P3165, DOI 10.1073/pnas.0611357104; BURGESS SW, 1992, BIOCHEMISTRY-US, V31, P2653, DOI 10.1021/bi00125a004; Cho WW, 2001, ANAL BIOCHEM, V296, P153, DOI 10.1006/abio.2001.5225; CRIADO M, 1987, FEBS LETT, V224, P172, DOI 10.1016/0014-5793(87)80442-8; Duringer C, 2003, J BIOL CHEM, V278, P42131, DOI 10.1074/jbc.M306462200; ELLENS H, 1984, BIOCHEMISTRY-US, V23, P1532, DOI 10.1021/bi00302a029; Fridriksson EK, 1999, BIOCHEMISTRY-US, V38, P8056, DOI 10.1021/bi9828324; Gustafsson L, 2004, NEW ENGL J MED, V350, P2663, DOI 10.1056/NEJMoa032454; Gustafsson L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005229; HAKANSSON A, 1995, P NATL ACAD SCI USA, V92, P8064, DOI 10.1073/pnas.92.17.8064; Halskau O, 2005, J MOL BIOL, V349, P1072, DOI 10.1016/j.jmb.2005.04.020; Halskau O, 2002, J MOL BIOL, V321, P99, DOI 10.1016/S0022-2836(02)00565-X; Halskau O, 2009, CURR PROTEIN PEPT SC, V10, P339, DOI 10.2174/138920309788922199; Halskau O, 2008, P NATL ACAD SCI USA, V105, P8625, DOI 10.1073/pnas.0709881105; Halskau O, 2009, J BIOL CHEM, V284, P32758, DOI 10.1074/jbc.M109.027706; Hamilton JA, 1998, J LIPID RES, V39, P467; Johnson JE, 2003, J BIOL CHEM, V278, P514, DOI 10.1074/jbc.M206072200; Kleinfeld AM, 2000, J MEMBRANE BIOL, V175, P79, DOI 10.1007/s002320001056; Kohler C, 2001, EUR J BIOCHEM, V268, P186, DOI 10.1046/j.1432-1327.2001.01870.x; Lajoie P, 2009, J CELL BIOL, V185, P381, DOI 10.1083/jcb.200811059; MAYER LD, 1986, CHEM PHYS LIPIDS, V40, P333, DOI 10.1016/0009-3084(86)90077-0; MAYER LD, 1985, BIOCHIM BIOPHYS ACTA, V817, P193, DOI 10.1016/0005-2736(85)90084-7; Mossberg AK, 2007, INT J CANCER, V121, P1352, DOI 10.1002/ijc.22810; PENG ZY, 1995, BIOCHEMISTRY-US, V34, P3248, DOI 10.1021/bi00010a014; PETTERSSONKASTB.J, 2009, J MOL BIOL IN PRESS; Rodland I, 2005, BBA-BIOMEMBRANES, V1717, P11, DOI 10.1016/j.bbamem.2005.09.004; Svensson M, 2000, P NATL ACAD SCI USA, V97, P4221, DOI 10.1073/pnas.97.8.4221; VANDERGOOT FG, 1991, NATURE, V354, P408, DOI 10.1038/354408a0; Zherelova OM, 2009, J BIOENERG BIOMEMBR, V41, P229, DOI 10.1007/s10863-009-9222-x	36	55	59	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2010	5	2							e9384	10.1371/journal.pone.0009384	http://dx.doi.org/10.1371/journal.pone.0009384			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SV	20186341	Green Published, gold			2022-12-25	WOS:000274924000023
J	Andreu, JM; Schaffner-Barbero, C; Huecas, S; Alonso, D; Lopez-Rodriguez, ML; Ruiz-Avila, LB; Nunez-Ramirez, R; Llorca, O; Martin-Galiano, AJ				Andreu, Jose M.; Schaffner-Barbero, Claudia; Huecas, Sonia; Alonso, Dulce; Lopez-Rodriguez, Maria L.; Ruiz-Avila, Laura B.; Nunez-Ramirez, Rafael; Llorca, Oscar; Martin-Galiano, Antonio J.			The Antibacterial Cell Division Inhibitor PC190723 Is an FtsZ Polymer-stabilizing Agent That Induces Filament Assembly and Condensation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-BETA-TUBULIN; ESCHERICHIA-COLI; PROTEIN FTSZ; STRUCTURAL INSIGHTS; IN-VITRO; Z-RING; MICROTUBULE; PROTOFILAMENTS; GTP; DYNAMICS	Cell division protein FtsZ can form single-stranded filaments with a cooperative behavior by self-switching assembly. Subsequent condensation and bending of FtsZ filaments are important for the formation and constriction of the cytokinetic ring. PC190723 is an effective bactericidal cell division inhibitor that targets FtsZ in the pathogen Staphylococcus aureus and Bacillus subtilis and does not affect Escherichia coli cells, which apparently binds to a zone equivalent to the binding site of the antitumor drug taxol in tubulin (Haydon, D. J., Stokes, N. R., Ure, R., Galbraith, G., Bennett, J. M., Brown, D. R., Baker, P. J., Barynin, V. V., Rice, D. W., Sedelnikova, S. E., Heal, J. R., Sheridan, J. M., Aiwale, S. T., Chauhan, P. K., Srivastava, A., Taneja, A., Collins, I., Errington, J., and Czaplewski, L. G. (2008) Science 312, 16731675). We have found that the benzamide derivative PC190723 is an FtsZ polymer-stabilizing agent. PC190723 induced nucleated assembly of Bs-FtsZ into single-stranded coiled protofilaments and polymorphic condensates, including bundles, coils, and toroids, whose formation could be modulated with different solution conditions. Under conditions for reversible assembly of Bs-FtsZ, PC190723 binding reduced the GTPase activity and induced the formation of straight bundles and ribbons, which was also observed with Sa-FtsZ but not with nonsusceptible Ec-FtsZ. The fragment 2,6-difluoro-3-methoxybenzamide also induced Bs-FtsZ bundling. We propose that polymer stabilization by PC190723 suppresses in vivo FtsZ polymer dynamics and bacterial division. The biochemical action of PC190723 on FtsZ parallels that of the microtubule-stabilizing agent taxol on the eukaryotic structural homologue tubulin. Both taxol and PC190723 stabilize polymers against disassembly by preferential binding to each assembled protein. It is yet to be investigated whether both ligands target structurally related assembly switches.	[Andreu, Jose M.; Schaffner-Barbero, Claudia; Huecas, Sonia; Ruiz-Avila, Laura B.; Nunez-Ramirez, Rafael; Llorca, Oscar; Martin-Galiano, Antonio J.] CSIC, Ctr Invest Biol, Madrid 28040, Spain; [Alonso, Dulce; Lopez-Rodriguez, Maria L.] Univ Complutense Madrid, Fac Ciencias Quim, Dept Quim Organ, E-28040 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Complutense University of Madrid	Andreu, JM (corresponding author), CSIC, Ctr Invest Biol, Ramiro de Maeztu 9, Madrid 28040, Spain.	j.m.andreu@cib.csic.es	Llorca, Oscar/P-2784-2019; Huecas, Sonia/P-2542-2019; Physics, Biophym IEM-CSIC Macromolecular/C-7939-2011; Huecas, Sonia/K-1754-2014; Lopez-Rodriguez, Maria L/S-6342-2016; Llorca, Oscar/K-1144-2014	Llorca, Oscar/0000-0001-5705-0699; Huecas, Sonia/0000-0002-6419-441X; Huecas, Sonia/0000-0002-6419-441X; Lopez-Rodriguez, Maria L/0000-0001-8607-1085; Llorca, Oscar/0000-0001-5705-0699; Andreu, Jose M/0000-0001-8064-6933; Martin-Galiano, Antonio Javier/0000-0002-6662-329X; Nunez, Rafael/0000-0002-2949-8709	Ministerio de Ciencia (MCINN) [BFU2008-00013, SAF2007-67008, S-SAL-249-2006, SAF2008-00451]; Comunidad Autonoma de Madrid [S-BIO-0214-2006]; Red Tematica de Investigacion Cooperativa en Cancer [RD06-0020-1001]; Human Frontiers Science Program [RGP39-2008]; Formacion de Personal Investigation; Consejo Superior de Investigaciones Cientificas i3p; Juan de la Cierva	Ministerio de Ciencia (MCINN); Comunidad Autonoma de Madrid(Comunidad de Madrid); Red Tematica de Investigacion Cooperativa en Cancer; Human Frontiers Science Program(Human Frontier Science Program); Formacion de Personal Investigation; Consejo Superior de Investigaciones Cientificas i3p; Juan de la Cierva(Instituto de Salud Carlos III)	This work was supported by Grants Ministerio de Ciencia (MCINN) BFU2008-00013 (to J. M. A.), Comunidad Autonoma de Madrid S-BIO-0214-2006 (to J. M. A. and O. L.), MCINN SAF2007-67008 (to M. L. L.-R.), S-SAL-249-2006 (to M. L. L.-R.), SAF2008-00451 (to O. L.), Red Tematica de Investigacion Cooperativa en Cancer RD06-0020-1001 (to O. L.), Human Frontiers Science Program RGP39-2008 (to O. L.) and contracts Formacion de Personal Investigation (to C. S.-B.), Consejo Superior de Investigaciones Cientificas i3p (to S. H.), and Juan de la Cierva (to A. J. M.-G.).	Abal M, 2001, CELL MOTIL CYTOSKEL, V49, P1, DOI 10.1002/cm.1016; Adams DW, 2009, NAT REV MICROBIOL, V7, P642, DOI 10.1038/nrmicro2198; ANDREU JM, 1982, BIOCHEMISTRY-US, V21, P534, DOI 10.1021/bi00532a019; Bennett MJ, 2009, BIOCHEMISTRY-US, V48, P4858, DOI 10.1021/bi900200q; Beuria TK, 2009, BIOCHEM J, V423, P61, DOI 10.1042/BJ20090817; BI E, 1991, NATURE, V354, P161, DOI 10.1038/354161a0; Buey RM, 2006, BIOCHEMISTRY-US, V45, P5933, DOI 10.1021/bi060334m; CASPAR DLD, 1980, BIOPHYS J, V32, P103, DOI 10.1016/S0006-3495(80)84929-0; Chen YD, 2009, BIOCHEMISTRY-US, V48, P6664, DOI 10.1021/bi8022653; Czaplewski LG, 2009, BIOORG MED CHEM LETT, V19, P524, DOI 10.1016/j.bmcl.2008.11.021; Dajkovic A, 2006, J MOL MICROB BIOTECH, V11, P140, DOI 10.1159/000094050; Diaz JF, 2009, TOP CURR CHEM, V286, P121, DOI 10.1007/128_2008_12; DIAZ JF, 1993, BIOCHEMISTRY-US, V32, P10067, DOI 10.1021/bi00089a023; Elie-Caille C, 2007, CURR BIOL, V17, P1765, DOI 10.1016/j.cub.2007.08.063; Erickson HP, 2009, P NATL ACAD SCI USA, V106, P9238, DOI 10.1073/pnas.0902258106; Gebremichael Y, 2008, BIOPHYS J, V95, P2487, DOI 10.1529/biophysj.108.129072; Goh S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006061; Gonzalez JM, 2003, J BIOL CHEM, V278, P37664, DOI 10.1074/jbc.M305230200; Haydon DJ, 2008, SCIENCE, V321, P1673, DOI 10.1126/science.1159961; Huecas S, 2008, BIOPHYS J, V94, P1796, DOI 10.1529/biophysj.107.115493; Huecas S, 2007, J BIOL CHEM, V282, P37515, DOI 10.1074/jbc.M706399200; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Lan GH, 2008, BIOPHYS J, V95, P4045, DOI 10.1529/biophysj.108.132837; Lappchen T, 2008, CHEM BIOL, V15, P189, DOI 10.1016/j.chembiol.2007.12.013; Larsen RA, 2007, GENE DEV, V21, P1340, DOI 10.1101/gad.1546107; Li Z, 2007, EMBO J, V26, P4694, DOI 10.1038/sj.emboj.7601895; Lowe J, 1999, EMBO J, V18, P2364, DOI 10.1093/emboj/18.9.2364; Margalit DN, 2004, P NATL ACAD SCI USA, V101, P11821, DOI 10.1073/pnas.0404439101; Margolin W, 2005, NAT REV MOL CELL BIO, V6, P862, DOI 10.1038/nrm1745; Marrington R, 2004, J BIOL CHEM, V279, P48821, DOI 10.1074/jbc.M404944200; Michie KA, 2006, ANNU REV BIOCHEM, V75, P467, DOI 10.1146/annurev.biochem.75.103004.142452; Miraldi ER, 2008, BIOPHYS J, V95, P2470, DOI 10.1529/biophysj.107.126219; Monahan LG, 2009, MOL MICROBIOL, V74, P1004, DOI 10.1111/j.1365-2958.2009.06914.x; Nogales E, 1999, CELL, V96, P79, DOI 10.1016/S0092-8674(00)80961-7; Nogales E, 1998, NAT STRUCT BIOL, V5, P451, DOI 10.1038/nsb0698-451; Nova E, 2007, ARCH BIOCHEM BIOPHYS, V465, P315, DOI 10.1016/j.abb.2007.06.032; Oliva MA, 2004, NAT STRUCT MOL BIOL, V11, P1243, DOI 10.1038/nsmb855; Oliva MA, 2003, J BIOL CHEM, V278, P33562, DOI 10.1074/jbc.M303798200; Oliva MA, 2007, J MOL BIOL, V373, P1229, DOI 10.1016/j.jmb.2007.08.056; Osawa M, 2008, SCIENCE, V320, P792, DOI 10.1126/science.1154520; Osawa M, 2009, EMBO J, V28, P3476, DOI 10.1038/emboj.2009.277; Popp D, 2009, BIOPOLYMERS, V91, P340, DOI 10.1002/bip.21136; Rice LM, 2008, P NATL ACAD SCI USA, V105, P5378, DOI 10.1073/pnas.0801155105; Rivas G, 2000, J BIOL CHEM, V275, P11740, DOI 10.1074/jbc.275.16.11740; Santra MK, 2004, J BIOL CHEM, V279, P25959, DOI 10.1074/jbc.M312473200; SCHIFF PB, 1979, NATURE, V277, P665, DOI 10.1038/277665a0; Stricker J, 2002, P NATL ACAD SCI USA, V99, P3171, DOI 10.1073/pnas.052595099; Vollmer W, 2006, APPL MICROBIOL BIOT, V73, P37, DOI 10.1007/s00253-006-0586-0; Xiao H, 2006, P NATL ACAD SCI USA, V103, P10166, DOI 10.1073/pnas.0603704103; Yu XC, 1997, EMBO J, V16, P5455, DOI 10.1093/emboj/16.17.5455	51	128	131	1	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14239	14246		10.1074/jbc.M109.094722	http://dx.doi.org/10.1074/jbc.M109.094722			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20212044	Green Published, hybrid			2022-12-25	WOS:000277299700020
J	Budzynski, E; Gross, AK; McAlear, SD; Peachey, NS; Shukla, M; He, F; Edwards, M; Won, J; Hicks, WL; Wensel, TG; Naggert, JK; Nishina, PM				Budzynski, Ewa; Gross, Alecia K.; McAlear, Suzanne D.; Peachey, Neal S.; Shukla, Meera; He, Feng; Edwards, Malia; Won, Jungyeon; Hicks, Wanda L.; Wensel, Theodore G.; Naggert, Jurgen K.; Nishina, Patsy M.			Mutations of the Opsin Gene (Y102H and I307N) Lead to Light-induced Degeneration of Photoreceptors and Constitutive Activation of Phototransduction in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOMINANT RETINITIS-PIGMENTOSA; RHODOPSIN MUTATION; TRANSGENIC MICE; MUTANT OPSIN; MOUSE MODEL; IN-VIVO; ROD PHOTOTRANSDUCTION; DARK-ADAPTATION; INDUCED DAMAGE; GENERATION	Mutations in the Rhodopsin (Rho) gene can lead to autosomal dominant retinitis pigmentosa (RP) in humans. Transgenic mouse models with mutations in Rho have been developed to study the disease. However, it is difficult to know the source of the photoreceptor (PR) degeneration in these transgenic models because overexpression of wild type (WT) Rho alone can lead to PR degeneration. Here, we report two chemically mutagenized mouse models carrying point mutations in Rho (Tvrm1 with an Y102H mutation and Tvrm4 with an I307N mutation). Both mutants express normal levels of rhodopsin that localize to the PR outer segments and do not exhibit PR degeneration when raised in ambient mouse room lighting; however, severe PR degeneration is observed after short exposures to bright light. Both mutations also cause a delay in recovery following bleaching. This defect might be due to a slower rate of chromophore binding by the mutant opsins compared with the WT form, and an increased rate of transducin activation by the unbound mutant opsins, which leads to a constitutive activation of the phototransduction cascade as revealed by in vitro biochemical assays. The mutant-free opsins produced by the respective mutant Rho genes appear to be more toxic to PRs, as Tvrm1 and Tvrm4 mutants lacking the 11-cis chromophore degenerate faster than mice expressing WT opsin that also lack the chromophore. Because of their phenotypic similarity to humans with B1 Rho mutations, these mutants will be important tools in examining mechanisms underlying Rho-induced RP and for testing therapeutic strategies.	[Budzynski, Ewa; Edwards, Malia; Won, Jungyeon; Hicks, Wanda L.; Naggert, Jurgen K.; Nishina, Patsy M.] Jackson Lab, Bar Harbor, ME 04609 USA; [Gross, Alecia K.; McAlear, Suzanne D.] Univ Alabama Birmingham, Dept Vis Sci, Birmingham, AL 35294 USA; [Peachey, Neal S.; Shukla, Meera] Cleveland Clin Fdn, Cole Eye Inst, Cleveland, OH 44195 USA; [Peachey, Neal S.] Cleveland Vet Affairs Med Ctr, Res Serv, Cleveland, OH 44106 USA; [Peachey, Neal S.] Case Western Reserve Univ, Lerner Coll Med, Dept Ophthalmol, Cleveland, OH 44195 USA; [He, Feng; Wensel, Theodore G.] Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Wensel, Theodore G.] Baylor Coll Med, Dept Neurosci & Ophthalmol, Houston, TX 77030 USA	Jackson Laboratory; University of Alabama System; University of Alabama Birmingham; Cleveland Clinic Foundation; Case Western Reserve University; Baylor College of Medicine; Baylor College of Medicine	Nishina, PM (corresponding author), 600 Main St, Bar Harbor, ME 04609 USA.	patsy.nishina@jax.org	Peachey, Neal/G-5533-2010; Gross, Alecia K./AAJ-1792-2021	Peachey, Neal/0000-0002-4419-7226; Gross, Alecia K./0000-0003-1857-6633; Wensel, Theodore/0000-0003-3518-9352	NCI [CA-34196]; Maine Institute of Human Genetics Health; Foundation Fighting Blindness; National Institutes of Health [EY016510, EY07981]; Research to Prevent Blindness; Prevent Blindness Ohio; Medical Research Service Department of Veterans Affairs; Hope for Vision; EyeSight Foundation of Alabama; Karl Kirchgessner Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007065] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA034196] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY019311, R01EY007981, R01EY016501] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066099] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Maine Institute of Human Genetics Health; Foundation Fighting Blindness(European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Prevent Blindness Ohio; Medical Research Service Department of Veterans Affairs(US Department of Veterans Affairs); Hope for Vision; EyeSight Foundation of Alabama; Karl Kirchgessner Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant CA-34196 from the NCI, grants from the Maine Institute of Human Genetics & Health (to P. M. N.), Foundation Fighting Blindness (to P. M. N.), National Institutes of Health Grant EY016510 (to P. M. N.), Research to Prevent Blindness (to N. S. P.), Prevent Blindness Ohio (to M. S.), the Medical Research Service Department of Veterans Affairs (to N. S. P.), Hope for Vision (to N. S. P.), EyeSight Foundation of Alabama (to A. K. G.), the Karl Kirchgessner Foundation (to A. K. G.), and National Institutes of Health Grant EY07981 (to T. G. W.).	BERSON EL, 1993, INVEST OPHTH VIS SCI, V34, P1659; Chang B, 2005, VISUAL NEUROSCI, V22, P587, DOI 10.1017/S0952523805225075; CHEN J, 1995, SCIENCE, V267, P374, DOI 10.1126/science.7824934; Cideciyan AV, 1998, P NATL ACAD SCI USA, V95, P7103, DOI 10.1073/pnas.95.12.7103; Cideciyan AV, 2005, P NATL ACAD SCI USA, V102, P5233, DOI 10.1073/pnas.0408892102; DRYJA TP, 1993, NAT GENET, V4, P280, DOI 10.1038/ng0793-280; FERRETTI L, 1986, P NATL ACAD SCI USA, V83, P599, DOI 10.1073/pnas.83.3.599; FRANKE RR, 1988, J BIOL CHEM, V263, P2119; Gal A, 1997, PROG RETIN EYE RES, V16, P51, DOI 10.1016/S1350-9462(96)00021-3; Garwin GG, 2000, METHOD ENZYMOL, V316, P313; Goto Y, 1996, J OPT SOC AM A, V13, P577, DOI 10.1364/JOSAA.13.000577; Groenendijk G W, 1980, Methods Enzymol, V67, P203; GROENENDIJK GWT, 1980, BIOCHIM BIOPHYS ACTA, V617, P430, DOI 10.1016/0005-2760(80)90009-0; Gross AK, 2003, BIOCHEMISTRY-US, V42, P2009, DOI 10.1021/bi020613j; Gross AK, 2003, BIOCHEMISTRY-US, V42, P2002, DOI 10.1021/bi020612r; Gu D, 2007, INVEST OPHTH VIS SCI, V48, P4907, DOI 10.1167/iovs.07-0428; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Hawes N L, 1999, Mol Vis, V5, P22; Herron BJ, 2002, NAT GENET, V30, P185, DOI 10.1038/ng812; Hetling JR, 1999, J PHYSIOL-LONDON, V516, P593, DOI 10.1111/j.1469-7793.1999.0593v.x; Humphries MM, 1997, NAT GENET, V15, P216, DOI 10.1038/ng0297-216; Justice MJ, 1997, METHODS, V13, P423, DOI 10.1006/meth.1997.0548; KEMP CM, 1992, AM J OPHTHALMOL, V113, P165, DOI 10.1016/S0002-9394(14)71529-6; Kijas JW, 2002, P NATL ACAD SCI USA, V99, P6328, DOI 10.1073/pnas.082714499; Kim TS, 2005, J BIOL CHEM, V280, P8694, DOI 10.1074/jbc.M413172200; Kondo M, 2009, INVEST OPHTH VIS SCI, V50, P1371, DOI 10.1167/iovs.08-2863; Lamb T D, 1996, Aust N Z J Ophthalmol, V24, P105, DOI 10.1111/j.1442-9071.1996.tb01562.x; Lamb TD, 2006, INVEST OPHTH VIS SCI, V47, P5138, DOI 10.1167/iovs.06-0849; Lee Y, 2005, MOL CELL NEUROSCI, V30, P160, DOI 10.1016/j.mcn.2005.07.009; Lem J, 1999, P NATL ACAD SCI USA, V96, P736, DOI 10.1073/pnas.96.2.736; LI TS, 1995, P NATL ACAD SCI USA, V92, P3551, DOI 10.1073/pnas.92.8.3551; Li TS, 1998, P NATL ACAD SCI USA, V95, P11933, DOI 10.1073/pnas.95.20.11933; Melia TJ, 1997, BIOPHYS J, V73, P3182, DOI 10.1016/S0006-3495(97)78344-9; Naash MI, 1996, J NEUROSCI, V16, P7853; NAASH MI, 1993, P NATL ACAD SCI USA, V90, P5499, DOI 10.1073/pnas.90.12.5499; OLSSON JE, 1992, NEURON, V9, P815, DOI 10.1016/0896-6273(92)90236-7; Pang JJ, 2005, MOL VIS, V11, P152; Pepperberg DR, 1996, J OPT SOC AM A, V13, P586, DOI 10.1364/JOSAA.13.000586; Petters RM, 1997, NAT BIOTECHNOL, V15, P965, DOI 10.1038/nbt1097-965; Pinto LH, 2005, VISUAL NEUROSCI, V22, P619, DOI 10.1017/S0952523805225117; RAO VR, 1994, NATURE, V367, P639, DOI 10.1038/367639a0; RIM J, 1995, BIOCHEMISTRY-US, V34, P11938, DOI 10.1021/bi00037a035; Salom D, 2006, P NATL ACAD SCI USA, V103, P16123, DOI 10.1073/pnas.0608022103; SUNG CH, 1991, P NATL ACAD SCI USA, V88, P8840, DOI 10.1073/pnas.88.19.8840; Tan E, 2001, INVEST OPHTH VIS SCI, V42, P589; Toda K, 1999, VISUAL NEUROSCI, V16, P391, DOI 10.1017/S0952523899162187; Vaughan DK, 2003, INVEST OPHTH VIS SCI, V44, P848, DOI 10.1167/iovs.02-0709; Wang M, 1997, VISUAL NEUROSCI, V14, P55, DOI 10.1017/S0952523800008750; White DA, 2007, INVEST OPHTH VIS SCI, V48, P1942, DOI 10.1167/iovs.06-1131; Xie GF, 2003, BIOCHEMISTRY-US, V42, P1995, DOI 10.1021/bi020611z; Zeitz C, 2008, INVEST OPHTH VIS SCI, V49, P4105, DOI 10.1167/iovs.08-1717	51	28	28	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14521	14533		10.1074/jbc.M110.112409	http://dx.doi.org/10.1074/jbc.M110.112409			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20207741	hybrid, Green Published			2022-12-25	WOS:000277299700049
J	Aleksandrov, A; Simonson, T				Aleksandrov, Alexey; Simonson, Thomas			Molecular Dynamics Simulations Show That Conformational Selection Governs the Binding Preferences of Imatinib for Several Tyrosine Kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FREE-ENERGY CALCULATIONS; INDUCED FIT MECHANISM; LIGAND-BINDING; C-SRC; STI-571 INHIBITION; STRUCTURAL BASIS; SURFACE-AREA; BCR-ABL; RESISTANCE; DOMAIN	mechanism, involving their phosphorylation and switching between inactive and active conformations. The cancer drug imatinib binds tightly to several homologous kinases, including Abl, but weakly to others, including Src. Imatinib specifically targets the inactive, so-called "DFG-out" conformation of Abl, which differs from the preferred, "DFG-in" conformation of Src in the orientation of a conserved Asp-Phe-Gly (DFG) activation loop. However, recent x-ray structures showed that Src can also adopt the DFG-out conformation and uses it to bind imatinib. The Src/Abl-binding free energy difference can thus be decomposed into two contributions. Contribution i measures the different protein-imatinib interactions when either kinase is in its DFG-out conformation. Contribution ii depends on the ability of imatinib to select or induce this conformation, i. e. on the relative stabilities of the DFG-out and DFG-in conformations of each kinase. Neither contribution has been measured experimentally. We use molecular dynamics simulations to show that contribution i is very small, 0.2 +/- 0.6 kcal/mol; imatinib interactions are very similar in the two kinases, including long range electrostatic interactions with the imatinib positive charge. Contribution ii, deduced using the experimental binding free energy difference, is much larger, 4.4 +/- 0.9 kcal/mol. Thus, conformational selection, easy in Abl, difficult in Src, underpins imatinib specificity. Contribution ii has a simple interpretation; it closely approximates the stability difference between the DFG-out and DFG- in conformations of apo-Src. Additional calculations show that conformational selection also governs the relative binding of imatinib to the kinases c-Kit and Lck. These results should help clarify the current framework for engineering kinase signaling.	[Aleksandrov, Alexey; Simonson, Thomas] Ecole Polytech, CNRS, Dept Biol, Lab Biochim,UMR7654, F-91128 Palaiseau, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut Polytechnique de Paris	Simonson, T (corresponding author), Ecole Polytech, CNRS, Dept Biol, Lab Biochim,UMR7654, F-91128 Palaiseau, France.	thomas.simonson@polytechnique.fr		Simonson, Thomas/0000-0002-5117-7338; Aleksandrov, Alexey/0000-0002-8150-3931	French Agence Nationale pour la Recherche	French Agence Nationale pour la Recherche(French National Research Agency (ANR))	This work was supported by the French Agence Nationale pour la Recherche.	ALEKSANDROV A, 2010, J COMP CHEM IN PRESS; Aleksandrov A, 2010, J MOL RECOGNIT, V23, P117, DOI 10.1002/jmr.980; Archontis G, 2001, J MOL BIOL, V306, P307, DOI 10.1006/jmbi.2000.4285; Azam M, 2003, CELL, V112, P831, DOI 10.1016/S0092-8674(03)00190-9; Azam M, 2006, P NATL ACAD SCI USA, V103, P9244, DOI 10.1073/pnas.0600001103; Banavali NK, 2005, STRUCTURE, V13, P1715, DOI 10.1016/j.str.2005.09.005; BEGLOV D, 1994, J CHEM PHYS, V100, P9050, DOI 10.1063/1.466711; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Carlsson J, 2006, J PHYS CHEM B, V110, P12034, DOI 10.1021/jp056929t; Chen JP, 2007, BIOINFORMATICS, V23, P563, DOI 10.1093/bioinformatics/btl666; Chipot C, 2005, J COMPUT AID MOL DES, V19, P765, DOI 10.1007/s10822-005-9021-3; Cowan-Jacob SW, 2007, ACTA CRYSTALLOGR D, V63, P80, DOI 10.1107/S0907444906047287; Deininger M, 2005, BLOOD, V105, P2640, DOI 10.1182/blood-2004-08-3097; Deng YQ, 2006, J CHEM THEORY COMPUT, V2, P1255, DOI 10.1021/ct060037v; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; Fairlie DP, 2000, J MED CHEM, V43, P1271, DOI 10.1021/jm990315t; Fernandez A, 2007, CANCER RES, V67, P4028, DOI 10.1158/0008-5472.CAN-07-0345; Froloff N, 1997, PROTEIN SCI, V6, P1293, DOI 10.1002/pro.5560060617; Gambacorti-Passerini CB, 2003, LANCET ONCOL, V4, P75, DOI 10.1016/S1470-2045(03)00979-3; Giles FJ, 2009, LEUKEMIA, V23, P1698, DOI 10.1038/leu.2009.111; Hammes GG, 2009, P NATL ACAD SCI USA, V106, P13737, DOI 10.1073/pnas.0907195106; Hubbard SR, 2000, ANNU REV BIOCHEM, V69, P373, DOI 10.1146/annurev.biochem.69.1.373; Hunenberger PH, 1999, BIOCHEMISTRY-US, V38, P2358, DOI 10.1021/bi982064g; Im W, 1998, COMPUT PHYS COMMUN, V111, P59, DOI 10.1016/S0010-4655(98)00016-2; Jacobs MD, 2008, PROTEINS, V70, P1451, DOI 10.1002/prot.21633; Jencks WP, 1986, CATALYSIS CHEM ENZYM; Jiao D, 2008, P NATL ACAD SCI USA, V105, P6290, DOI 10.1073/pnas.0711686105; Johnson LN, 2009, Q REV BIOPHYS, V42, P1, DOI 10.1017/S0033583508004745; JonesHertzog DK, 1997, J MED CHEM, V40, P1539, DOI 10.1021/jm960684e; Jorgensen WL, 2004, SCIENCE, V303, P1813, DOI 10.1126/science.1096361; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; JORGENSEN WL, 1988, J CHEM PHYS, V89, P3742, DOI 10.1063/1.454895; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Kinnings SL, 2009, J CHEM INF MODEL, V49, P318, DOI 10.1021/ci800289y; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Kuriyan J, 2007, NATURE, V450, P983, DOI 10.1038/nature06524; Lange OF, 2008, SCIENCE, V320, P1471, DOI 10.1126/science.1157092; Lee GM, 2009, SCIENCE, V324, P213, DOI 10.1126/science.1169378; Levinson NM, 2006, PLOS BIOL, V4, P753, DOI 10.1371/journal.pbio.0040144; Levy RM, 2003, J AM CHEM SOC, V125, P9523, DOI 10.1021/ja029833a; Liu SY, 2006, PROTEINS, V64, P68, DOI 10.1002/prot.20954; Liu Y, 2006, NAT CHEM BIOL, V2, P358, DOI 10.1038/nchembio799; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Marvin JS, 2001, NAT STRUCT BIOL, V8, P795, DOI 10.1038/nsb0901-795; McCammon JA, 2005, THEORY AND APPLICATIONS OF COMPUTATIONAL CHEMISTRY: THE FIRST FORTY YEARS, P41, DOI 10.1016/B978-044451719-7/50046-9; Mol CD, 2004, J BIOL CHEM, V279, P31655, DOI 10.1074/jbc.M403319200; Nagar B, 2003, CELL, V112, P859, DOI 10.1016/S0092-8674(03)00194-6; Ozkirimli E, 2006, PROTEIN SCI, V15, P1051, DOI 10.1110/ps.051999206; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Pearlman DA, 2005, J MED CHEM, V48, P7796, DOI 10.1021/jm050306m; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Robinson DR, 2000, ONCOGENE, V19, P5548, DOI 10.1038/sj.onc.1203957; Roux B, 1996, BIOPHYS J, V71, P670, DOI 10.1016/S0006-3495(96)79267-6; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; Schindler T, 1999, MOL CELL, V3, P639, DOI 10.1016/S1097-2765(00)80357-3; Schutz CN, 2001, PROTEINS, V44, P400, DOI 10.1002/prot.1106; Seeliger MA, 2007, STRUCTURE, V15, P299, DOI 10.1016/j.str.2007.01.015; Seeliger MA, 2009, CANCER RES, V69, P2384, DOI 10.1158/0008-5472.CAN-08-3953; Setny P, 2005, PROTEINS, V58, P511, DOI 10.1002/prot.20350; Shah NP, 2002, CANCER CELL, V2, P117, DOI 10.1016/S1535-6108(02)00096-X; Shan YB, 2009, P NATL ACAD SCI USA, V106, P139, DOI 10.1073/pnas.0811223106; Simonson T, 2002, ACCOUNTS CHEM RES, V35, P430, DOI 10.1021/ar010030m; Son MY, 2008, REPRODUCTION, V136, P423, DOI 10.1530/REP-08-0080; STOTE RH, 1991, J CHIM PHYS PCB, V88, P2419, DOI 10.1051/jcp/1991882419; Sullivan SM, 2008, P NATL ACAD SCI USA, V105, P13829, DOI 10.1073/pnas.0805364105; Vajpai N, 2008, J BIOL CHEM, V283, P18292, DOI 10.1074/jbc.M801337200; Verkhivker GM, 2006, BIOINFORMATICS, V22, P1846, DOI 10.1093/bioinformatics/btl199; Vogtherr M, 2006, ANGEW CHEM INT EDIT, V45, P993, DOI 10.1002/anie.200502770; Wang J, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.188101; Wang W, 2001, J AM CHEM SOC, V123, P3986, DOI 10.1021/ja003164o; Weisberg E, 2007, NAT REV CANCER, V7, P345, DOI 10.1038/nrc2126; Wlodarski T, 2009, P NATL ACAD SCI USA, V106, P19346, DOI 10.1073/pnas.0906966106; Wong CF, 2001, J MED CHEM, V44, P1530, DOI 10.1021/jm000443d; Wong S, 2008, PROTEINS, V71, P153, DOI 10.1002/prot.21666; Xu WQ, 1999, MOL CELL, V3, P629, DOI 10.1016/S1097-2765(00)80356-1; Yang G, 2006, J MED CHEM, V49, P5478, DOI 10.1021/jm060288o; Yang S, 2009, P NATL ACAD SCI USA, V106, P3776, DOI 10.1073/pnas.0808261106; Zhou RH, 2001, J PHYS CHEM B, V105, P10388, DOI 10.1021/jp011480z	80	65	66	2	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13807	13815		10.1074/jbc.M110.109660	http://dx.doi.org/10.1074/jbc.M110.109660			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20200154	Green Published, hybrid			2022-12-25	WOS:000276987700056
J	Zhu, QS; Kao, L; Azimov, R; Newman, D; Liu, WX; Pushkin, A; Abuladze, N; Kurtz, I				Zhu, Quansheng; Kao, Liyo; Azimov, Rustam; Newman, Debra; Liu, Weixin; Pushkin, Alexander; Abuladze, Natalia; Kurtz, Ira			Topological Location and Structural Importance of the NBCe1-A Residues Mutated in Proximal Renal Tubular Acidosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COTRANSPORTER NBCE1-A; OCULAR ABNORMALITIES; FUNCTIONAL-ANALYSIS; TRANSPORT; MUTATIONS; MUTAGENESIS; PNBC1; HCO3	NBCe1-A electrogenically cotransports Na+ and HCO3- across the basolateral membrane of renal proximal tubule cells. Eight missense mutations and 3 nonsense mutations in NBCe1-A cause severe proximal renal tubular acidosis (pRTA). In this study, the topologic properties and structural importance of the 8 endogenous residues mutated in pRTA and the in situ topology of NBCe1-A were examined by the substituted cysteine accessibility method. Of the 55 analyzed individually introduced cysteines, 8 were labeled with both membrane permeant (biotin maleimide (BM)) and impermeant (2-((5(6)-tetra-methylrhodamine)carboxylamino)ethyl methanethiosulfonate (MTS-TAMRA)) sulfhydryl reagents, 4 with only BM, and 3 with only MTS-TAMRA. The location of the labeled and unlabeled introduced cysteines clearly indicates that the transmembrane region of NBCe1-A contains 14 transmembrane segments (TMs). In this in situ based NBCe1-A topology, residues mutated in pRTA (pRTA residues) are assigned as: Ser(427), TM1; Thr(485) and Gly(486), TM3; Arg(510) and Leu(522), TM4; Ala(799), TM10; and Arg(881), TM12. Substitution of pRTA residues with cysteines impaired the membrane trafficking of R510C and R881C, the remaining membrane-processed constructs had various impaired transport function. Surprisingly, none of the membrane-processed constructs was accessible to labeling with BM and MTS-TAMRA, nor were they functionally sensitive to the inhibition by (2-aminoethyl) methanethiosulfonate. Functional analysis of Thr(485) with different amino acid substitutions indicated it resides in a unique region important for NBCe1-A function. Our findings demonstrate that the pRTA residues in NBCe1-A are buried in the protein complex/lipid bilayer where they perform important structural roles.	[Zhu, Quansheng; Kao, Liyo; Azimov, Rustam; Newman, Debra; Liu, Weixin; Pushkin, Alexander; Abuladze, Natalia; Kurtz, Ira] Univ Calif Los Angeles, David Geffen Sch Med, Div Nephrol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Kurtz, I (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Div Nephrol, 10833 Le Conte Ave,Rm 7 155 Factor Bldg, Los Angeles, CA 90095 USA.	ikurtz@mednet.ucla.edu			National Institutes of Health [DK077162, DK058563]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077162, R01DK058563] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK077162 and DK058563.	Bok D, 2001, AM J PHYSIOL-RENAL, V281, pF920, DOI 10.1152/ajprenal.2001.281.5.F920; Boron WF, 2006, J AM SOC NEPHROL, V17, P2368, DOI 10.1681/ASN.2006060620; Boron WF, 2009, J EXP BIOL, V212, P1697, DOI 10.1242/jeb.028563; Chang MH, 2008, J BIOL CHEM, V283, P18402, DOI 10.1074/jbc.M709819200; Cordat E, 2009, BIOCHEM J, V417, P423, DOI 10.1042/BJ20081634; Dinour D, 2004, J BIOL CHEM, V279, P52238, DOI 10.1074/jbc.M406591200; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; Horita S, 2005, J AM SOC NEPHROL, V16, P2270, DOI 10.1681/ASN.2004080667; Igarashi T, 1999, NAT GENET, V23, P264, DOI 10.1038/15440; Kao LY, 2008, J BIOL CHEM, V283, P26782, DOI 10.1074/jbc.M804006200; Karlin A, 1998, METHOD ENZYMOL, V293, P123; KURTZ I, 1987, J CLIN INVEST, V80, P928, DOI 10.1172/JCI113184; Li HC, 2005, AM J PHYSIOL-RENAL, V289, pF61, DOI 10.1152/ajprenal.00032.2005; LIN S, 2009, J AM SOC NEPHROL, V20, pA33; Lu J, 2007, AM J PHYSIOL-CELL PH, V292, pC1787, DOI 10.1152/ajpcell.00267.2006; McAlear SD, 2006, J BIOL CHEM, V281, P32417, DOI 10.1074/jbc.M607253200; Pushkin A, 2006, AM J PHYSIOL-RENAL, V290, pF580, DOI 10.1152/ajprenal.00252.2005; Suzuki M, 2008, PFLUG ARCH EUR J PHY, V455, P583, DOI 10.1007/s00424-007-0319-y; Tatishchev S, 2003, BIOCHEMISTRY-US, V42, P755, DOI 10.1021/bi026826q; Toye AM, 2006, AM J PHYSIOL-CELL PH, V291, pC788, DOI 10.1152/ajpcell.00094.2006; Yang HS, 2009, J BIOL CHEM, V284, P15970, DOI 10.1074/jbc.M109.001438; Zhu QS, 2003, J BIOL CHEM, V278, P3112, DOI 10.1074/jbc.M207797200; Zhu QS, 2007, METHODS, V41, P439, DOI 10.1016/j.ymeth.2006.08.004; Zhu QS, 2009, J BIOL CHEM, V284, P8909, DOI 10.1074/jbc.M806674200	24	34	35	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13416	13426		10.1074/jbc.M109.093286	http://dx.doi.org/10.1074/jbc.M109.093286			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20197274	Green Published, hybrid			2022-12-25	WOS:000276987700013
J	Pan, CE; Cheung, B; Tan, SY; Li, CL; Li, L; Liu, SW; Jiang, SB				Pan, Chungen; Cheung, Byron; Tan, Suiyi; Li, Chunling; Li, Lin; Liu, Shuwen; Jiang, Shibo			Genomic Signature and Mutation Trend Analysis of Pandemic (H1N1) 2009 Influenza A Virus	PLOS ONE			English	Article							NS1 PROTEIN; ORIGIN; OSELTAMIVIR; HOST; INTERFERON; ACTIVATION; RESPONSES; MUTANTS	A novel swine-origin pandemic influenza A(H1N1) virus (H1N1pdm, also referred to as S-OIV) was identified as the causative agent of the 21(st) century's first influenza pandemic, but molecular features conferring its ability of human-to-human transmission has not been identified. Here we compared the protein sequences of 2009 H1N1pdm strains with those causing other pandemics and the viruses isolated from humans, swines and avians, and then analyzed the mutation trend of the residues at the signature and non-signature positions, which are species-and non-species-associated, respectively, in the proteins of H1N1pdm during the pandemic of 2009. We confirmed that the host-specific genomic signatures of 2009 H1N1pdm, which are mainly swine-like, were highly identical to those of the 1918 H1N1pdm. During the short period of time when the pandemic alert level was raised from phase 4 to phase 6, one signature residue at the position of NP-100 mutated from valine to isoleucine. Four non-signature residues, at positions NA-91, NA-233, HA-206, and NS1-123, also changed during the epidemic in 2009. All these mutant residues, except that at NA-91, are located in the viral functional domains, suggesting that they may play roles in the human adaption and virulence of 2009 H1N1pdm.	[Pan, Chungen; Cheung, Byron; Tan, Suiyi; Li, Lin; Jiang, Shibo] New York Blood Ctr, Lindsley F Kimball Res Inst, New York, NY 10021 USA; [Pan, Chungen] Peking Univ, Coll Life Sci, Beijing 100871, Peoples R China; [Tan, Suiyi; Li, Lin; Liu, Shuwen; Jiang, Shibo] So Med Univ, Guangzhou, Guangdong, Peoples R China; [Li, Chunling] Guangdong Acad Agr Sci, Inst Vet Med, Guangzhou, Guangdong, Peoples R China	New York Blood Center; Peking University; Southern Medical University - China; Guangdong Academy of Agricultural Sciences	Pan, CE (corresponding author), New York Blood Ctr, Lindsley F Kimball Res Inst, New York, NY 10021 USA.	sjiang@nybloodcenter.org	li, li/HII-4157-2022; Jiang, Shibo/L-4500-2014; LI, LI/GVS-5344-2022; Li, Li/AEM-3636-2022	Jiang, Shibo/0000-0001-8283-7135; Pan, Chungen/0000-0003-0359-533X; Liu, Shuwen/0000-0001-6346-5006	China Scholarship Council	China Scholarship Council(China Scholarship Council)	Chungen Pan is partly supported by a scholarship from China Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baz M, 2009, NEW ENGL J MED, V361, P2296, DOI 10.1056/NEJMc0910060; Biswas SK, 1998, J VIROL, V72, P5493, DOI 10.1128/JVI.72.7.5493-5501.1998; Bornholdt ZA, 2008, NATURE, V456, P985, DOI 10.1038/nature07444; *CDC, 2009, MMWR-MORBID MORTAL W, V58, P402; Chen GW, 2006, EMERG INFECT DIS, V12, P1353, DOI 10.3201/eid1209.060276; CHEN GW, 2009, VIRUS EMERG INFECT D, V15, P1897; Chen HL, 2009, EMERG INFECT DIS, V15, P1970, DOI 10.3201/eid1512.091057; Collins PJ, 2008, NATURE, V453, P1258, DOI 10.1038/nature06956; Cutler J, 2009, CAN MED ASSOC J, V181, P159, DOI 10.1503/cmaj.090859; DeLano W.L., PYMOL MOL GRAPHICS S; Fisman DN, 2009, NEW ENGL J MED, V361, P2000, DOI 10.1056/NEJMc0907256; Gabriel G, 2005, P NATL ACAD SCI USA, V102, P18590, DOI 10.1073/pnas.0507415102; Gamblin SJ, 2004, SCIENCE, V303, P1838, DOI 10.1126/science.1093155; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Gubareva LV, 2001, J INFECT DIS, V183, P523, DOI 10.1086/318537; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Kim CU, 1997, J AM CHEM SOC, V119, P681, DOI 10.1021/ja963036t; Miller MA, 2009, NEW ENGL J MED, V360, P2595, DOI 10.1056/NEJMp0903906; Naffakh N, 2008, ANNU REV MICROBIOL, V62, P403, DOI 10.1146/annurev.micro.62.081307.162746; Pan CE, 2009, BIOCHEM BIOPH RES CO, V385, P402, DOI 10.1016/j.bbrc.2009.05.064; ROGERS GN, 1983, VIROLOGY, V127, P361, DOI 10.1016/0042-6822(83)90150-2; Seo SH, 2002, NAT MED, V8, P950, DOI 10.1038/nm757; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Talon J, 2000, J VIROL, V74, P7989, DOI 10.1128/JVI.74.17.7989-7996.2000; Vana G, 2008, MOL PHYLOGENET EVOL, V47, P1100, DOI 10.1016/j.ympev.2008.02.003; VON IM, 1993, NATURE, V363, P418; Wang XY, 2000, J VIROL, V74, P11566, DOI 10.1128/JVI.74.24.11566-11573.2000; Ye QZ, 2006, NATURE, V444, P1078, DOI 10.1038/nature05379	29	77	82	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2010	5	3					A31	A37	e9549	10.1371/journal.pone.0009549	http://dx.doi.org/10.1371/journal.pone.0009549			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565WZ	20221396	Green Published, Green Submitted, gold			2022-12-25	WOS:000275328200003
J	Soulsbury, CD				Soulsbury, Carl D.			Genetic Patterns of Paternity and Testes Size in Mammals	PLOS ONE			English	Article							EXTRA-PAIR PATERNITY; SPERM COMPETITION; MULTIPLE PATERNITY; OVULATION MODE; EVOLUTION; BIRDS; QUALITY; POPULATIONS; SELECTION; QUANTITY	Background: Testes size is used as a proxy of male intrasexual competition, with larger testes indicative of greater competition. It has been shown that in some taxa, social mating systems reflect variance in testes size, but results are not consistent, and instead it has been suggested that genetic patterns of mating may reflect testes size. However, there are different measures of genetic patterns of mating. Multiple paternity rates are the most widely used measure but are limited to species that produce multi-offspring litters, so, at least for group living species, other measures such as loss of paternity to males outside the social group (extra group paternity) or the proportion of offspring sired by the dominant male (alpha paternity) might be appropriate. This study examines the relationship between testes size and three genetic patterns of mating: multiple paternity, extragroup paternity and alpha paternity. Methodology/Principal Findings: Using data from mammals, phylogenetically corrected general linear models demonstrate that both multiple paternity and alpha paternity, but not extra group paternity, relate to testes size. Testes size is greater in species with high multiple paternity rates, whereas the converse is found for alpha paternity. Additionally, length of mating season, ovulation mode and litter size significantly influenced testes size in one model. Conclusions/Significance: These results demonstrate that patterns of mating (multiple paternity and alpha paternity rates) determined by genetic analysis can provide reliable indicators of male postcopulatory intrasexual competition (testes size), and that other variables (length of mating season, ovulation mode, litter size) may also be important.	Univ Bristol, Sch Biol Sci, Bristol, Avon, England	University of Bristol	Soulsbury, CD (corresponding author), Univ Bristol, Sch Biol Sci, Bristol, Avon, England.	carl.soulsbury@bristol.ac.uk	Soulsbury, Carl D./F-3137-2010; Soulsbury, Carl/P-1492-2019	Soulsbury, Carl D./0000-0001-8808-5210; Soulsbury, Carl/0000-0001-8808-5210				Bininda-Emonds ORP, 2008, NATURE, V456, P274, DOI 10.1038/nature07347; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; BIRKHEAD T, 1993, TRENDS ECOL EVOL, V8, P100, DOI 10.1016/0169-5347(93)90060-3; Birkhead T.R., 1998, P579, DOI 10.1016/B978-012100543-6/50039-8; Birkhead T. R., 1996, PARTNERSHIPS BIRDS S, P323; BIRKHEAD TR, 1987, BEHAVIOUR, V101, P101, DOI 10.1163/156853987X00396; BIRKHEAD TR, 1999, MALE FERTILITY INFER, P18; Bryja J, 2008, BEHAV ECOL SOCIOBIOL, V63, P251, DOI 10.1007/s00265-008-0656-7; Calhim S, 2007, BEHAV ECOL, V18, P271, DOI 10.1093/beheco/arl076; Clutton-Brock TH, 2006, BIOL LETTERS, V2, P513, DOI 10.1098/rsbl.2006.0531; Cohas A, 2009, BIOL LETTERS, V5, P313, DOI 10.1098/rsbl.2008.0760; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; Daly-Engel TS, 2006, ENVIRON BIOL FISH, V76, P419, DOI 10.1007/s10641-006-9008-5; DeWoody JA, 2001, J HERED, V92, P167, DOI 10.1093/jhered/92.2.167; East ML, 2003, P ROY SOC B-BIOL SCI, V270, P1247, DOI 10.1098/rspb.2003.2363; Eccard JA, 2009, ANIM BEHAV, V78, P563, DOI 10.1016/j.anbehav.2009.04.008; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; Firman RC, 2008, J EVOLUTION BIOL, V21, P1524, DOI 10.1111/j.1420-9101.2008.01612.x; Freckleton RP, 2009, J EVOLUTION BIOL, V22, P1367, DOI 10.1111/j.1420-9101.2009.01757.x; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; Gomenido Montserrat, 1998, P667, DOI 10.1016/B978-012100543-6/50041-6; Griffith SC, 2002, MOL ECOL, V11, P2195, DOI 10.1046/j.1365-294X.2002.01613.x; GRUBBS FE, 1969, TECHNOMETRICS, V11, P1, DOI 10.2307/1266761; GULLBERG A, 1992, HEREDITAS, V117, P103, DOI 10.1111/j.1601-5223.1992.tb00164.x; HARCOURT AH, 1981, NATURE, V293, P55, DOI 10.1038/293055a0; HESKE EJ, 1990, J MAMMAL, V71, P510, DOI 10.2307/1381789; Hosken DJ, 2001, ECOL LETT, V4, P10, DOI 10.1046/j.1461-0248.2001.00198.x; Iossa G, 2008, FUNCT ECOL, V22, P655, DOI 10.1111/j.1365-2435.2008.01409.x; Iossa G, 2009, BEHAV ECOL, V20, P385, DOI 10.1093/beheco/arn149; Isvaran K, 2007, P ROY SOC B-BIOL SCI, V274, P219, DOI 10.1098/rspb.2006.3723; Kappeler PM, 1997, BEHAV ECOL, V8, P10, DOI 10.1093/beheco/8.1.10; KENAGY GJ, 1986, J MAMMAL, V67, P1, DOI 10.2307/1380997; Lack D., 1968, pvii; MOLLER AP, 1995, BEHAV ECOL SOCIOBIOL, V36, P357, DOI 10.1007/BF00167797; MOLLER AP, 1988, J HUM EVOL, V17, P479, DOI 10.1016/0047-2484(88)90037-1; Myers EM, 2004, MOL ECOL, V13, P1951, DOI 10.1111/j.1365-294X.2004.02208.x; Nakagawa S, 2007, BIOL REV, V82, P591, DOI 10.1111/j.1469-185X.2007.00027.x; Olsson M., 1998, P503, DOI 10.1016/B978-012100543-6/50038-6; Ostner J, 2008, BEHAV ECOL, V19, P1150, DOI 10.1093/beheco/arn093; Parker GA, 2005, BIOL LETTERS, V1, P235, DOI 10.1098/rsbl.2004.0273; Parker GA, 1997, P ROY SOC B-BIOL SCI, V264, P1793, DOI 10.1098/rspb.1997.0249; PARKER GA, 1970, BIOL REV, V45, P525, DOI 10.1111/j.1469-185X.1970.tb01176.x; PARKER GA, 1998, SPERM COMPETITION SE, P1; Pitcher TE, 2005, J EVOLUTION BIOL, V18, P557, DOI 10.1111/j.1420-9101.2004.00874.x; Ramm SA, 2005, P ROY SOC B-BIOL SCI, V272, P949, DOI 10.1098/rspb.2004.3048; RIBBLE DO, 1992, FUNCT ECOL, V6, P455, DOI 10.2307/2389283; SAY L, 2006, BIOL LETT, V43, P41; Schulke O, 2004, BEHAV ECOL SOCIOBIOL, V55, P293, DOI 10.1007/s00265-003-0709-x; Simmons L. W., 2001, MG BEH ECOL; Soulsbury CD, 2010, EVOL ECOL, V24, P879, DOI 10.1007/s10682-009-9344-y; Soulsbury CD, 2010, BIOL LETTERS, V6, P39, DOI 10.1098/rsbl.2009.0703; Uller T, 2008, MOL ECOL, V17, P2566, DOI 10.1111/j.1365-294X.2008.03772.x; Wedell N, 2002, TRENDS ECOL EVOL, V17, P313, DOI 10.1016/S0169-5347(02)02533-8; Westneat DF, 2003, ANNU REV ECOL EVOL S, V34, P365, DOI 10.1146/annurev.ecolsys.34.011802.132439; Westneat DF, 1997, BEHAV ECOL SOCIOBIOL, V41, P205, DOI 10.1007/s002650050381; Whittingham MJ, 2006, J ANIM ECOL, V75, P1182, DOI 10.1111/j.1365-2656.2006.01141.x; Wink Michael, 1999, Acta Ornithologica (Warsaw), V34, P91; Wolff JO, 2004, TRENDS ECOL EVOL, V19, P127, DOI 10.1016/j.tree.2003.12.009; Zuur Alain F., 2009, P1	59	101	102	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2010	5	3					A152	A157	e9581	10.1371/journal.pone.0009581	http://dx.doi.org/10.1371/journal.pone.0009581			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565WZ	20221392	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000275328200014
J	Yang, L; Chen, J; Shi, LM; Hudock, MP; Wang, KJ; He, L				Yang, Lun; Chen, Jian; Shi, Leming; Hudock, Michael P.; Wang, Kejian; He, Lin			Identifying Unexpected Therapeutic Targets via Chemical-Protein Interactome	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITORS; HUMAN ACETYLCHOLINESTERASE; DOCKING; LIGAND; IDENTIFICATION; SYSTEM; VISUALIZATION; PHARMACOLOGY; STRATEGIES; RESIDUES	Drug medications inevitably affect not only their intended protein targets but also other proteins as well. In this study we examined the hypothesis that drugs that share the same therapeutic effect also share a common therapeutic mechanism by targeting not only known drug targets, but also by interacting unexpectedly on the same cryptic targets. By constructing and mining an Alzheimer's disease (AD) drug-oriented chemical-protein interactome (CPI) using a matrix of 10 drug molecules known to treat AD towards 401 human protein pockets, we found that such cryptic targets exist. We recovered from CPI the only validated therapeutic target of AD, acetylcholinesterase (ACHE), and highlighted several other putative targets. For example, we discovered that estrogen receptor (ER) and histone deacetylase (HDAC), which have recently been identified as two new therapeutic targets of AD, might already have been targeted by the marketed AD drugs. We further established that the CPI profile of a drug can reflect its interacting character towards multi-protein sets, and that drugs with the same therapeutic attribute will share a similar interacting profile. These findings indicate that the CPI could represent the landscape of chemical-protein interactions and uncover "behind-the-scenes" aspects of the therapeutic mechanisms of existing drugs, providing testable hypotheses of the key nodes for network pharmacology or brand new drug targets for one-target pharmacology paradigm.	[Yang, Lun; Chen, Jian; Hudock, Michael P.; Wang, Kejian; He, Lin] Shanghai Jiao Tong Univ, Minist Educ, Key Lab Genet Dev & Neuropsychiat Disorders, Bio Ctr X, Shanghai 200030, Peoples R China; [Yang, Lun; Chen, Jian; He, Lin] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Shi, Leming] US FDA, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA; [He, Lin] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Shanghai, Peoples R China	Shanghai Jiao Tong University; Fudan University; US Food & Drug Administration (FDA); Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Yang, L (corresponding author), Shanghai Jiao Tong Univ, Minist Educ, Key Lab Genet Dev & Neuropsychiat Disorders, Bio Ctr X, Shanghai 200030, Peoples R China.	lunyang@gmail.com; helinhelin@gmail.com	Yang, Lun/B-4859-2012; Shi, Leming/B-3150-2010	Shi, Leming/0000-0002-7143-2033	National Natural Science Foundation of China [30900841]; Postdoctoral Science Foundation of China [200902243]; China Postdoctoral Science Foundation [20070420660]; Shanghai Postdoctoral Science Foundation [61444]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Postdoctoral Science Foundation of China(China Postdoctoral Science Foundation); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Shanghai Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by National Natural Science Foundation of China [ 30900841], Special Reward Funding from Postdoctoral Science Foundation of China (200902243), China Postdoctoral Science Foundation (20070420660) and Shanghai Postdoctoral Science Foundation (No. 61444). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Campillos M, 2008, SCIENCE, V321, P263, DOI 10.1126/science.1158140; Carageorgiou H, 2005, BASIC CLIN PHARMACOL, V97, P320, DOI 10.1111/j.1742-7843.2005.pto_174.x; Carswell HVO, 2004, AM J PHYSIOL-HEART C, V287, pH1501, DOI 10.1152/ajpheart.00227.2004; Chang CI, 1998, AM J PHYSIOL-HEART C, V274, pH342, DOI 10.1152/ajpheart.1998.274.1.H342; Chen X, 2002, NUCLEIC ACIDS RES, V30, P412, DOI 10.1093/nar/30.1.412; Chen YZ, 2001, PROTEINS, V43, P217, DOI 10.1002/1097-0134(20010501)43:2<217::AID-PROT1032>3.0.CO;2-G; Ewing TJA, 2001, J COMPUT AID MOL DES, V15, P411, DOI 10.1023/A:1011115820450; Fang H, 2008, CURR DRUG METAB, V9, P1038, DOI 10.2174/138920008786927802; Finnin MS, 1999, NATURE, V401, P188, DOI 10.1038/43710; Fischer A, 2007, NATURE, V447, P178, DOI 10.1038/nature05772; Gao ZT, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-104; Gordus A, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.72; Hahnen E, 2008, EXPERT OPIN INV DRUG, V17, P169, DOI 10.1517/13543784.17.2.169; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ji ZL, 2003, DRUG SAFETY, V26, P685, DOI 10.2165/00002018-200326100-00002; Kazantsev AG, 2008, NAT REV DRUG DISCOV, V7, P854, DOI 10.1038/nrd2681; Keiser MJ, 2007, NAT BIOTECHNOL, V25, P197, DOI 10.1038/nbt1284; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Li CY, 2007, CELL RES, V17, P357, DOI 10.1038/cr.2007.27; Li HL, 2006, NUCLEIC ACIDS RES, V34, pW219, DOI 10.1093/nar/gkl114; Lomenick B, 2009, P NATL ACAD SCI USA, V106, P21984, DOI 10.1073/pnas.0910040106; Morales LBJ, 2006, J NEUROSCI, V26, P6823, DOI 10.1523/JNEUROSCI.0453-06.2006; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Nacasch N, 1998, CLIN NEUROPHARMACOL, V21, P132; Nicholson JK, 2003, NAT REV DRUG DISCOV, V2, P668, DOI 10.1038/nrd1157; Ong SE, 2009, P NATL ACAD SCI USA, V106, P4617, DOI 10.1073/pnas.0900191106; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rich RL, 2001, ANAL BIOCHEM, V296, P197, DOI 10.1006/abio.2001.5314; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Schatz RA, 2003, ANN PHARMACOTHER, V37, P1321, DOI 10.1345/aph.1D050; Schmitt S, 2002, J MOL BIOL, V323, P387, DOI 10.1016/S0022-2836(02)00811-2; Shafferman A, 1996, BIOCHEM J, V318, P833, DOI 10.1042/bj3180833; SHAFFERMAN A, 1992, J BIOL CHEM, V267, P17640; Shimohama S, 1998, NEUROSCI LETT, V245, P159, DOI 10.1016/S0304-3940(98)00209-2; Strimmer K, 2008, BIOINFORMATICS, V24, P1461, DOI 10.1093/bioinformatics/btn209; Tiwari-Woodruff S, 2007, P NATL ACAD SCI USA, V104, P14813, DOI 10.1073/pnas.0703783104; Vecsey CG, 2007, J NEUROSCI, V27, P6128, DOI 10.1523/JNEUROSCI.0296-07.2007; Vigers GPA, 2004, J MED CHEM, V47, P80, DOI 10.1021/jm030161o; von Rechenberg M, 2005, PROTEOMICS, V5, P1764, DOI 10.1002/pmic.200301088; VURAL H, 2008, BIOL TRACE ELEM RES; Warren GL, 2006, J MED CHEM, V49, P5912, DOI 10.1021/jm050362n; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958; Xie L, 2007, PLOS COMPUT BIOL, V3, P2324, DOI 10.1371/journal.pcbi.0030217; Yamanishi Y, 2008, BIOINFORMATICS, V24, pI232, DOI 10.1093/bioinformatics/btn162; YANG L, 2009, PLOS COMPUT IN PRESS; Yang L, 2009, NUCLEIC ACIDS RES, V37, pW406, DOI 10.1093/nar/gkp312; Zhang JX, 2007, BIOINFORMATICS, V23, P1710, DOI 10.1093/bioinformatics/btm139	48	40	44	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2010	5	3					A71	A81	e9568	10.1371/journal.pone.0009568	http://dx.doi.org/10.1371/journal.pone.0009568			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565WZ	20221449	Green Published, Green Submitted, gold			2022-12-25	WOS:000275328200007
J	Zhao, Y; Xu, DS; Jiang, YJ; Zhang, LW				Zhao, Yong; Xu, Dongsheng; Jiang, Yanjun; Zhang, Luwen			Dual Functions of Interferon Regulatory Factors 7C in Epstein-Barr Virus-Mediated Transformation of Human B Lymphocytes	PLOS ONE			English	Article							MEMBRANE-PROTEIN 1; INNATE ANTIVIRAL RESPONSE; TRANSCRIPTION FACTORS; LATENT MEMBRANE-PROTEIN-1; LYMPHOMA CELLS; GROWTH TRANSFORMATION; POSITIVE FEEDBACK; ALPHA-INTERFERON; FACTOR RECEPTOR; HOST-DEFENSE	Epstein-Barr virus (EBV) infection is associated with several human malignancies. Interferon (IFN) regulatory factor 7 (IRF-7) has several splicing variants, and at least the major splicing variant (IRF-7A) has oncogenic potential and is associated with EBV transformation processes. IRF-7C is an alternative splicing variant with only the DNA-binding domain of IRF-7. Whether IRF-7C is present under physiological conditions and its functions in viral transformation are unknown. In this report, we prove the existence of IRF-7C protein and RNA in certain cells under physiological conditions, and find that high levels of IRF-7C are associated with EBV transformation of human primary B cells in vitro as well as EBV type III latency. EBV latent membrane protein 1 (LMP-1) stimulates IRF-7C expression in B lymphocytes. IRF-7C has oncogenic potential in rodent cells and partially restores the growth properties of EBV-transformed cells under a growth-inhibition condition. A tumor array experiment has identified six primary tumor specimens with high levels of IRF-7C protein-all of them are lymphomas. Furthermore, we show that the expression of IRF-7C is apparently closely associated with other IRF-7 splicing variants. IRF-7C inhibits the function of IRF-7 in transcriptional regulation of IFN genes. These data suggest that EBV may use splicing variants of IRF-7 for its transformation process in two strategies: to use oncogenic properties of various IRF-7 splicing variants, but use one of its splicing variants (IRF-7C) to block the IFN-induction function of IRF-7 that is detrimental for viral transformation. The work provides a novel relation of host/virus interactions, and has expanded our knowledge about IRFs in EBV transformation.	[Zhao, Yong; Xu, Dongsheng; Jiang, Yanjun; Zhang, Luwen] Univ Nebraska, Sch Biol Sci, Lincoln, NE 68588 USA; [Zhang, Luwen] Univ Nebraska, Nebraska Ctr Virol, Lincoln, NE USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Zhao, Y (corresponding author), Univ Nebraska, Sch Biol Sci, Lincoln, NE 68588 USA.	lzhang2@unlnotes.unl.edu			National Institutes of Health [CA138213Z, CA108951, CA108951Z]; National Center for Research Resources Centers [RR15635]; NATIONAL CANCER INSTITUTE [R01CA108951] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015635] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources Centers(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported in part by grants from National Institutes of Health grants CA138213Z, CA108951, CA108951Z, and National Center for Research Resources Centers of Biomedical Research Excellence grant RR15635 (LZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Au WC, 1998, J BIOL CHEM, V273, P29210, DOI 10.1074/jbc.273.44.29210; Barnes B, 2002, J INTERF CYTOK RES, V22, P59, DOI 10.1089/107999002753452665; Barnes BJ, 2003, CANCER RES, V63, P6424; BENBASSAT H, 1977, INT J CANCER, V19, P27, DOI 10.1002/ijc.2910190105; CALENDER A, 1987, P NATL ACAD SCI USA, V84, P8060, DOI 10.1073/pnas.84.22.8060; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Fries KL, 1996, J VIROL, V70, P8653, DOI 10.1128/JVI.70.12.8653-8659.1996; FUJITA T, 1979, J GEN VIROL, V45, P301, DOI 10.1099/0022-1317-45-2-301; GARNER JG, 1984, INFECT IMMUN, V43, P920, DOI 10.1128/IAI.43.3.920-924.1984; Geiger TR, 2006, J VIROL, V80, P11638, DOI 10.1128/JVI.01570-06; GIRES O, 1997, EMBO J, V16; HAVELL EA, 1972, ANTIMICROB AGENTS CH, V2, P476, DOI 10.1128/AAC.2.6.476; Hiscott J, 2007, CYTOKINE GROWTH F R, V18, P483, DOI 10.1016/j.cytogfr.2007.06.002; Hiscott J, 2007, J BIOL CHEM, V282, P15325, DOI 10.1074/jbc.R700002200; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Hu GD, 2005, CANCER RES, V65, P7403, DOI 10.1158/0008-5472.CAN-05-0583; Hu GD, 2006, EXPERT REV ANTICANC, V6, P775, DOI 10.1586/14737140.6.5.775; Izumi KM, 1997, P NATL ACAD SCI USA, V94, P1447, DOI 10.1073/pnas.94.4.1447; KANDA K, 1992, MOL CELL BIOL, V12, P4930, DOI 10.1128/MCB.12.11.4930; KAYE KM, 1993, P NATL ACAD SCI USA, V90, P9150, DOI 10.1073/pnas.90.19.9150; KIEFF E, 1996, FIELDS VIROLOGY, V3, P2343; KIKUTA H, 1986, Hokkaido Journal of Medical Science, V61, P46; Kilger E, 1998, EMBO J, V17, P1700, DOI 10.1093/emboj/17.6.1700; Levy DE, 2002, J INTERF CYTOK RES, V22, P87, DOI 10.1089/107999002753452692; LIN JC, 1989, J INFECT DIS, V159, P248, DOI 10.1093/infdis/159.2.248; Lin RT, 2000, J BIOL CHEM, V275, P34320, DOI 10.1074/jbc.M002814200; Mamane Y, 2002, J INTERF CYTOK RES, V22, P135, DOI 10.1089/107999002753452746; Marie I, 1998, EMBO J, V17, P6660, DOI 10.1093/emboj/17.22.6660; Martin HJ, 2007, J VIROL, V81, P9748, DOI 10.1128/JVI.01122-07; MILLER WE, 1995, J VIROL, V69, P4390, DOI 10.1128/JVI.69.7.4390-4398.1995; Mori T, 2002, ONCOGENE, V21, P2914, DOI 10.1038/sj.onc.1205459; NGUYEN H, 1995, ONCOGENE, V11, P537; Ning S, 2003, J VIROL, V77, P9359, DOI 10.1128/JVI.77.17.9359-9368.2003; Nonkwelo C, 1996, J VIROL, V70, P623, DOI 10.1128/JVI.70.1.623-627.1996; Pagano JS, 1999, P ASSOC AM PHYSICIAN, V111, P573, DOI 10.1046/j.1525-1381.1999.t01-1-99220.x; RICKINSON AB, 1996, FIELDS VIROLOGY, V3, P2397; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Song L, 2008, EXCLI J, V7, P1; STEWART WE, 1971, J VIROL, V7, P792, DOI 10.1128/JVI.7.6.792-801.1971; Takaoka A, 2008, CANCER SCI, V99, P467, DOI 10.1111/j.1349-7006.2007.00720.x; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208; WANG D, 1985, CELL, V43, P831, DOI 10.1016/0092-8674(85)90256-9; WANG F, 1990, J VIROL, V64, P2309, DOI 10.1128/JVI.64.5.2309-2318.1990; Wathelet MG, 1998, MOL CELL, V1, P507, DOI 10.1016/S1097-2765(00)80051-9; XU D, 2008, J VIROL; Xu DS, 2006, J BIOL CHEM, V281, P9163, DOI 10.1074/jbc.M511884200; Yanai H, 2007, P NATL ACAD SCI USA, V104, P3402, DOI 10.1073/pnas.0611559104; Yoshizaki T, 1998, P NATL ACAD SCI USA, V95, P3621, DOI 10.1073/pnas.95.7.3621; Zhang J, 2005, J VIROL, V79, P5640, DOI 10.1128/JVI.79.9.5640-5652.2005; Zhang J, 2004, J BIOL CHEM, V279, P46335, DOI 10.1074/jbc.M403966200; Zhang LW, 2004, J VIROL, V78, P12987, DOI 10.1128/JVI.78.23.12987-12995.2004; Zhang LW, 2004, VIROLOGY, V323, P141, DOI 10.1016/j.virol.2004.03.007; Zhang LW, 1997, MOL CELL BIOL, V17, P5748, DOI 10.1128/MCB.17.10.5748; Zhang LW, 2000, MOL BIOTECHNOL, V14, P73, DOI 10.1385/MB:14:1:73; Zhang LW, 2002, J INTERF CYTOK RES, V22, P95, DOI 10.1089/107999002753452700; Zhang LW, 2001, SEMIN CANCER BIOL, V11, P445, DOI 10.1006/scbi.2001.0411; Zhang LW, 2001, J VIROL, V75, P12393, DOI 10.1128/JVI.75.24.12393-12401.2001; Zhang LW, 2001, J VIROL, V75, P341, DOI 10.1128/JVI.75.1.341-350.2001; Zhang LW, 1999, MOL CELL BIOL, V19, P3216; Zhang LW, 2000, J VIROL, V74, P1061, DOI 10.1128/JVI.74.3.1061-1068.2000	62	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2010	5	3							e9459	10.1371/journal.pone.0009459	http://dx.doi.org/10.1371/journal.pone.0009459			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	564EW	20209099	Green Published, gold			2022-12-25	WOS:000275197100004
J	De Majumdar, S; Sharma, D; Vashist, A; Kaur, K; Taneja, NK; Chauhan, S; Challu, VK; Ramanathan, VD; Balasangameshwara, V; Kumar, P; Tyagi, JS				De Majumdar, Shyamasree; Sharma, Deepak; Vashist, Atul; Kaur, Kohinoor; Taneja, Neetu Kumra; Chauhan, Santosh; Challu, Vijay K.; Ramanathan, V. D.; Balasangameshwara, V.; Kumar, Prahlad; Tyagi, Jaya Sivaswami			Co-Expression of DevR and DevR(N)-Aph Proteins Is Associated with Hypoxic Adaptation Defect and Virulence Attenuation of Mycobacterium tuberculosis	PLOS ONE			English	Article							RESPONSE REGULATOR; 2-COMPONENT SYSTEM; BINDING-SITES; GUINEA-PIG; CROSS-TALK; TRANSCRIPTION; IDENTIFICATION; EXPRESSION; GRANULOMAS; CLONING	Background: The DevR response regulator is implicated in both hypoxic adaptation and virulence of Mycobacterium tuberculosis (M. tb). DevR regulon genes are powerfully induced in vivo implicating them in bacterial adaptation to host control strategies. A better understanding of DevR function will illumine the way for new strategies to control and treat tuberculosis. Methodology/Principal Findings: Towards this objective, we used a combination of genetic, microbiological, biochemical, cell biological tools and a guinea pig virulence assay to compare the hypoxic adaptation and virulence properties of two novel M. tb strains, namely, a devR disruption mutant, Mut1, that expresses C-terminal truncated N-terminal domain of DevR (DevR(NTD)) as a fusion protein with AphI (DevR(N)-Kan), and its complemented strain, Comp1, that expresses intact DevR along with DevRN-Kan. Comp1 bacteria exhibit a defect in DevR-mediated phosphosignalling, hypoxic induction of HspX and also hypoxic survival. In addition, we find that Comp1 is attenuated in virulence in guinea pigs and shows decreased infectivity of THP-1 cells. While Mut1 bacilli are also defective in hypoxic adaptation and early growth in spleen, they exhibit an overall virulence comparable to that of wild-type bacteria. Conclusions/Significance: The hypoxic defect of Comp1 is associated to a defect in DevR expression level. The demonstrated repression of DevR function by DevR(N)-Kan suggests that such a knockdown approach could be useful for evaluating the activity of DevRS and other two-component signaling pathways. Further investigation is necessary to elucidate the mechanism underlying Comp1 attenuation.	[De Majumdar, Shyamasree; Sharma, Deepak; Vashist, Atul; Kaur, Kohinoor; Taneja, Neetu Kumra; Chauhan, Santosh; Tyagi, Jaya Sivaswami] All India Inst Med Sci, Dept Biotechnol, New Delhi 110029, India; [Ramanathan, V. D.] TB Res Ctr, Dept Pathol, Chennai, Tamil Nadu, India; [Challu, Vijay K.; Balasangameshwara, V.; Kumar, Prahlad] Natl TB Inst, Bangalore, Karnataka, India	All India Institute of Medical Sciences (AIIMS) New Delhi; Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT)	De Majumdar, S (corresponding author), All India Inst Med Sci, Dept Biotechnol, New Delhi 110029, India.	jstyagi@aiims.ac.in	Chauhan, Santosh/K-3031-2019; Vashist, Atul/AAX-6219-2021; Kaur, Kohinoor/HEB-9125-2022	Chauhan, Santosh/0000-0001-9167-5107; Vashist, Atul/0000-0002-2843-1166; TANEJA, NEETU/0000-0002-2390-7647	CSIR; DBT, Government of India	CSIR(Council of Scientific & Industrial Research (CSIR) - India); DBT, Government of India(Department of Biotechnology (DBT) India)	D.M., D.S., N.K.T. and S.C. are each thankful to CSIR for a Senior Research Fellowship. K. K. is thankful to UGC for a Senior Research Fellowship and A.V. is thankful to DBT for a Junior Research Fellowship. Financial support from DBT, Government of India to J.S.T., V.K.C. and V.D.R. is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Av-Gay Y, 2005, TUBERCULOSIS AND THE TUBERCLE BACILLUS, P359; Bagchi G, 2005, MICROBIOL-SGM, V151, P4045, DOI 10.1099/mic.0.28333-0; Behr MA, 1999, SCIENCE, V284, P1520, DOI 10.1126/science.284.5419.1520; Boon C, 2002, J BACTERIOL, V184, P6760, DOI 10.1128/JB.184.24.6760-6767.2002; Chauhan A, 2006, J BACTERIOL, V188, P1856, DOI 10.1128/JB.188.5.1856-1865.2006; Chauhan S, 2008, J BACTERIOL, V190, P5394, DOI 10.1128/JB.00488-08; Chauhan S, 2008, J BACTERIOL, V190, P4301, DOI 10.1128/JB.01308-07; Chauhan S, 2009, J BACTERIOL, V191, P6075, DOI 10.1128/JB.00310-09; Cole ST, 1998, NOVART FDN SYMP, V217, P160, DOI 10.1002/0470846526.ch12; Converse PJ, 2009, INFECT IMMUN, V77, P1230, DOI 10.1128/IAI.01117-08; Dasgupta N, 2000, TUBERCLE LUNG DIS, V80, P141, DOI 10.1054/tuld.2000.0240; Karakousis PC, 2004, J EXP MED, V200, P647, DOI 10.1084/jem.20040646; KINGER AK, 1993, GENE, V131, P113, DOI 10.1016/0378-1119(93)90678-V; Lukey P T, 2001, Methods Mol Med, V54, P271, DOI 10.1385/1-59259-147-7:271; Malhotra V, 2004, FEMS MICROBIOL LETT, V231, P237, DOI 10.1016/S0378-1097(04)00002-3; MITCHISON D, 1961, B WORLD HEALTH ORGAN, V25, P285; MITCHISON D A, 1960, Tubercle, V41, P1, DOI 10.1016/S0041-3879(60)80019-0; Parish T, 2003, INFECT IMMUN, V71, P1134, DOI 10.1128/IAI.71.3.1134-1140.2003; Park HD, 2003, MOL MICROBIOL, V48, P833, DOI 10.1046/j.1365-2958.2003.03474.x; Ramanathan VD, 1999, INDIAN J MED RES, V109, P212; Roberts DM, 2004, J BIOL CHEM, V279, P23082, DOI 10.1074/jbc.M401230200; Rodrigue S, 2007, J BACTERIOL, V189, P1505, DOI 10.1128/JB.01371-06; Rustad TR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001502; Saini DK, 2004, FEBS LETT, V565, P75, DOI 10.1016/j.febslet.2004.02.092; Saini DK, 2004, MICROBIOL-SGM, V150, P865, DOI 10.1099/mic.0.26218-0; Saini DK, 2002, PROTEIN EXPRES PURIF, V25, P203, DOI 10.1006/prep.2002.1628; Sharma D, 2006, FEMS IMMUNOL MED MIC, V48, P329, DOI 10.1111/j.1574-695X.2006.00160.x; Sherman DR, 2001, P NATL ACAD SCI USA, V98, P7534, DOI 10.1073/pnas.121172498; Shi LB, 2003, P NATL ACAD SCI USA, V100, P241, DOI 10.1073/pnas.0136863100; Tailleux L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001403; Tyagi JS, 2004, CURR SCI INDIA, V86, P93; Voskuil MI, 2003, J EXP MED, V198, P705, DOI 10.1084/jem.20030205	32	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2010	5	2							e9448	10.1371/journal.pone.0009448	http://dx.doi.org/10.1371/journal.pone.0009448			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	561RS	20195478	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000274997000014
J	Deregnaucourt, S				Deregnaucourt, Sebastien			Interspecific Hybridization as a Tool to Understand Vocal Divergence: The Example of Crowing in Quail (Genus Coturnix)	PLOS ONE			English	Article							DOVE STREPTOPELIA-CAPICOLA; JAPANESE-QUAIL; SEXUAL SELECTION; EUROPEAN QUAIL; HYBRID ZONE; C.-COTURNIX; SPECIES-DIFFERENCES; SONG SIMILARITY; CALLS; JAPONICA	Understanding the mechanisms that lead organisms to be separated into distinct species remains a challenge in evolutionary biology. Interspecific hybridization, which results from incomplete reproductive isolation, is a useful tool to investigate such mechanisms. In birds, interspecific hybridization is relatively frequent, despite the fact that closed species exhibit morphological and behavioural differences. Evolution of behaviour is difficult to investigate on a large timescale since it does not `fossilize'. Here I propose that calls of hybrid non-songbirds that develop without the influence of learning may help in understanding the gradual process that leads to vocal divergence during speciation. I recorded crows produced by the European quail (Coturnix c. coturnix), the domestic Japanese quail (Coturnix c. japonica) and their hybrids (F1, F2 and backcrosses). Most crowing patterns were intermediate to those of the parental species; some were similar to one or the other parental species, or not present in either parental species. I also observed vocal changes in hybrid crows during the breeding season and from one year to the other. This vocal variability resembles those observed during the ontogeny of the crow in quails. It is likely that similar mechanisms involved in vocal changes during ontogeny might have driven vocal divergence in the species of Palearctic quails. I suggest that hybrid crows might have resembled those produced by intermediary forms of quails during speciation.	[Deregnaucourt, Sebastien] Max Planck Inst Ornithol, Seewiesen, Germany; [Deregnaucourt, Sebastien] Univ Rennes 1, CNRS, UMR Ethol Evolut Ecol 6552, Rennes, France	Max Planck Society; Centre National de la Recherche Scientifique (CNRS); Universite de Rennes	Deregnaucourt, S (corresponding author), Max Planck Inst Ornithol, Seewiesen, Germany.	seb@orn.mpg.de			Office National de la Chasse et de la Faune Sauvage [ONC 97/27]; Max Planck Society	Office National de la Chasse et de la Faune Sauvage; Max Planck Society(Max Planck SocietyFoundation CELLEX)	This work was supported by the Office National de la Chasse et de la Faune Sauvage (research convention ONC 97/27) and the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALATALO RV, 1990, J EVOLUTION BIOL, V3, P375, DOI 10.1046/j.1420-9101.1990.3050375.x; Aubin T, 2007, POLAR BIOL, V30, P1027, DOI 10.1007/s00300-007-0262-6; BAKER JA, 1987, CAN J ZOOL, V65, P1010, DOI 10.1139/z87-160; Balaban E, 1997, P NATL ACAD SCI USA, V94, P2001, DOI 10.1073/pnas.94.5.2001; Baptista Luis F., 1996, P39; Barilani M, 2005, BIOL CONSERV, V126, P445, DOI 10.1016/j.biocon.2005.06.027; Becker P.H., 1982, P213; Beckers GJL, 2003, ANIM BEHAV, V65, P605, DOI 10.1006/anbe.2003.2080; Bloomer P, 1998, MOL PHYLOGENET EVOL, V9, P236, DOI 10.1006/mpev.1997.0469; Brainard MS, 2002, NATURE, V417, P351, DOI 10.1038/417351a; CARIOU M-L, 1969, Bulletin Biologique de la France et de la Belgique, V103, P323; Castellan NJ, 1988, NONPARAMETRIC STAT B; Catchpole CK, 2008, BIRD SONG: BIOLOGICAL THEMES AND VARIATIONS, 2ND EDITION, P1, DOI 10.1017/CBO9780511754791; Ceugniet M, 1999, CR ACAD SCI III-VIE, V322, P887, DOI 10.1016/S0764-4469(00)86655-X; Collins SA, 1998, ETHOLOGY, V104, P977; de Kort SR, 2002, BEHAV ECOL SOCIOBIOL, V51, P378, DOI 10.1007/s00265-001-0449-8; de Kort SR, 2002, J AVIAN BIOL, V33, P150, DOI 10.1034/j.1600-048X.2002.330205.x; Delport W, 2004, AUK, V121, P565, DOI 10.1642/0004-8038(2004)121[0565:SOAARH]2.0.CO;2; Deregnaucourt S, 2005, IBIS, V147, P25, DOI 10.1111/j.1474-919x.2004.00313.x; Deregnaucourt S, 2003, ETHOLOGY, V109, P107, DOI 10.1046/j.1439-0310.2003.00854.x; Deregnaucourt S, 2002, ARDEA, V90, P15; Deregnaucourt S, 2001, BEHAV PROCESS, V56, P103, DOI 10.1016/S0376-6357(01)00188-7; Deregnaucourt S, 2009, P ROY SOC B-BIOL SCI, V276, P2153, DOI 10.1098/rspb.2009.0016; Dobzhansky T., 1951, COPEIA; Dowsett-Lemaire F, 1999, OSTRICH, V70, P123, DOI 10.1080/00306525.1999.9634526; Ellers J, 2003, ANIM BEHAV, V65, P671, DOI 10.1006/anbe.2003.2081; EMLEN ST, 1972, BEHAVIOUR, V41, P130, DOI 10.1163/156853972X00248; Gee JM, 2005, BIOL J LINN SOC, V86, P253, DOI 10.1111/j.1095-8312.2005.00538.x; Goodson JL, 1997, CONDOR, V99, P990, DOI 10.2307/1370153; Grant BR, 2008, PHILOS T R SOC B, V363, P2821, DOI 10.1098/rstb.2008.0051; GRANT PR, 1992, SCIENCE, V256, P193, DOI 10.1126/science.256.5054.193; GROOTHUIS T, 1992, ANIM BEHAV, V43, P1, DOI 10.1016/S0003-3472(05)80067-3; Guyomarc'h J.C., 1998, BWP UPDATE, V2, P27; Guyomarc'h JC, 1998, ETHOL ECOL EVOL, V10, P333, DOI 10.1080/08927014.1998.9522847; Guyomarch JC, 1996, CR ACAD SCI III-VIE, V319, P827; Haavie J, 2004, J EVOLUTION BIOL, V17, P227, DOI 10.1111/j.1420-9101.2003.00682.x; Haeckel E. H., 1866, GENERELLE MORPHOLOGI; KOLLAR EJ, 1980, SCIENCE, V207, P993, DOI 10.1126/science.7352302; Konishi M., 1969, P29; Lachlan RF, 2004, EVOLUTION, V58, P2049; LADE BI, 1964, NATURE, V202, P366, DOI 10.1038/202366a0; Lengagne T, 2001, BEHAVIOUR, V138, P1407, DOI 10.1163/156853901317367663; Mayr E., 1963, ANIMAL SPECIES EVOLU, P797; McCracken KG, 1997, P NATL ACAD SCI USA, V94, P3833, DOI 10.1073/pnas.94.8.3833; MCGRATH TA, 1972, NATURE, V237, P47, DOI 10.1038/237047a0; MEDICUS G, 1992, HUM DEV, V35, P1, DOI 10.1159/000277108; MILLER DB, 1978, Z TIERPSYCHOL, V47, P182; Miller E.H., 1982, P253; Mills AD, 1997, NEUROSCI BIOBEHAV R, V21, P261, DOI 10.1016/S0149-7634(96)00028-0; Mitsiadis TA, 2003, P NATL ACAD SCI USA, V100, P6541, DOI 10.1073/pnas.1137104100; MOREAU RE, 1968, ARDEA, V56, P209; Mousseau TA, 1998, EVOLUTION, V52, P1104, DOI [10.2307/2411240, 10.1111/j.1558-5646.1998.tb01837.x]; NOTTEBOHM F, 1971, ANIM BEHAV, V19, P313, DOI 10.1016/S0003-3472(71)80012-X; Panhuis TM, 2001, TRENDS ECOL EVOL, V16, P364, DOI 10.1016/S0169-5347(01)02160-7; Pfennig KS, 1998, P ROY SOC B-BIOL SCI, V265, P1743, DOI 10.1098/rspb.1998.0497; POTASH LM, 1972, PSYCHON SCI, V26, P252; Price TD, 2002, GENETICA, V116, P311, DOI 10.1023/A:1021248913179; Qvarnstrom A, 2006, J EVOLUTION BIOL, V19, P1202, DOI 10.1111/j.1420-9101.2006.01140.x; ROTELLA JJ, 1988, CONDOR, V90, P304, DOI 10.2307/1368558; RYAN MJ, 1995, SCIENCE, V269, P390, DOI 10.1126/science.269.5222.390; RYAN MJ, 1990, EVOLUTION, V44, P305, DOI 10.1111/j.1558-5646.1990.tb05200.x; SACHS B. D., 1969, Horm. Behav., V1, P7, DOI 10.1016/0018-506X(69)90002-6; SCHLEIDT W M, 1973, Zeitschrift fuer Tierpsychologie, V33, P35; Secondi J, 2003, BIOL J LINN SOC, V80, P507, DOI 10.1046/j.1095-8312.2003.00248.x; Shaw KL, 2000, EVOLUTION, V54, P1303, DOI 10.1111/j.0014-3820.2000.tb00563.x; Slabbekoorn H, 1999, ETHOLOGY, V105, P377, DOI 10.1046/j.1439-0310.1999.00420.x; Tchernichovski O, 2000, ANIM BEHAV, V59, P1167, DOI 10.1006/anbe.1999.1416; Tchernichovski O, 2004, ANN NY ACAD SCI, V1016, P348, DOI 10.1196/annals.1298.031; Tirosh I, 2009, SCIENCE, V324, P659, DOI 10.1126/science.1169766; Walcott C, 2006, ANIM BEHAV, V71, P673, DOI 10.1016/j.anbehav.2005.07.011; White C.M., 1994, NEW WORLD VULTURES G; Wittkopp PJ, 2008, NAT GENET, V40, P346, DOI 10.1038/ng.77; Zeigler HP, 2008, NEUROSCIENCE BIRDSON; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	79	5	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2010	5	2							e9451	10.1371/journal.pone.0009451	http://dx.doi.org/10.1371/journal.pone.0009451			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	561RS	20195481	Green Published, Green Submitted, gold			2022-12-25	WOS:000274997000016
J	Dyrda, A; Cytlak, U; Ciuraszkiewicz, A; Lipinska, A; Cueff, A; Bouyer, G; Egee, S; Bennekou, P; Lew, VL; Thomas, SLY				Dyrda, Agnieszka; Cytlak, Urszula; Ciuraszkiewicz, Anna; Lipinska, Agnieszka; Cueff, Anne; Bouyer, Guillaume; Egee, Stephane; Bennekou, Poul; Lew, Virgilio L.; Thomas, Serge L. Y.			Local Membrane Deformations Activate Ca2+-Dependent K+ and Anionic Currents in Intact Human Red Blood Cells	PLOS ONE			English	Article							HUMAN-ERYTHROCYTES; CATION PERMEABILITY; POTASSIUM-TRANSPORT; MECHANICAL-STRESS; ION-TRANSPORT; CHANNEL; ANEMIA; VOLUME; MODEL; PUMP	Background: The mechanical, rheological and shape properties of red blood cells are determined by their cortical cytoskeleton, evolutionarily optimized to provide the dynamic deformability required for flow through capillaries much narrower than the cell's diameter. The shear stress induced by such flow, as well as the local membrane deformations generated in certain pathological conditions, such as sickle cell anemia, have been shown to increase membrane permeability, based largely on experimentation with red cell suspensions. We attempted here the first measurements of membrane currents activated by a local and controlled membrane deformation in single red blood cells under on-cell patch clamp to define the nature of the stretch-activated currents. Methodology/Principal Findings: The cell-attached configuration of the patch-clamp technique was used to allow recordings of single channel activity in intact red blood cells. Gigaohm seal formation was obtained with and without membrane deformation. Deformation was induced by the application of a negative pressure pulse of 10 mmHg for less than 5 s. Currents were only detected when the membrane was seen domed under negative pressure within the patchpipette. K+ and Cl- currents were strictly dependent on the presence of Ca2+. The Ca2+-dependent currents were transient, with typical decay half-times of about 5-10 min, suggesting the spontaneous inactivation of a stretch-activated Ca2+ permeability (PCa). These results indicate that local membrane deformations can transiently activate a Ca2+ permeability pathway leading to increased [Ca2+](i), secondary activation of Ca2+-sensitive K+ channels (Gardos channel, IK1, KCa3.1), and hyperpolarization-induced anion currents. Conclusions/Significance: The stretch-activated transient PCa observed here under local membrane deformation is a likely contributor to the Ca2+-mediated effects observed during the normal aging process of red blood cells, and to the increased Ca2+ content of red cells in certain hereditary anemias such as thalassemia and sickle cell anemia.	[Dyrda, Agnieszka; Cytlak, Urszula; Ciuraszkiewicz, Anna; Lipinska, Agnieszka; Cueff, Anne; Bouyer, Guillaume; Egee, Stephane; Thomas, Serge L. Y.] Univ Paris 06, CNRS, UMR 7150, Roscoff, France; [Bennekou, Poul] Univ Copenhagen, Inst Biol, Copenhagen, Denmark; [Cytlak, Urszula; Ciuraszkiewicz, Anna] Wroclaw Univ Technol, Inst Phys, PL-50370 Wroclaw, Poland; [Lew, Virgilio L.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; University of Copenhagen; Wroclaw University of Science & Technology; University of Cambridge	Dyrda, A (corresponding author), Univ Paris 06, CNRS, UMR 7150, Roscoff, France.	thomas@sb-roscoff.fr	Cytlak, Urszula/Y-2382-2019; Dyrda, Agnieszka/AAB-9420-2021	Cytlak, Urszula/0000-0002-2536-6012; Dyrda, Agnieszka/0000-0001-8796-2402; Bouyer, guillaume/0000-0002-5808-0539	CNRS; UPMC [UMR7150]	CNRS(Centre National de la Recherche Scientifique (CNRS)); UPMC	CNRS and UPMC fundings supported the work (UMR7150). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVAREZ J, 1987, BIOCHIM BIOPHYS ACTA, V903, P543, DOI 10.1016/0005-2736(87)90062-9; Bouyer G, 2006, BLOOD CELL MOL DIS, V36, P248, DOI 10.1016/j.bcmd.2006.01.005; Bouyer G, 2007, P NATL ACAD SCI USA, V104, P11044, DOI 10.1073/pnas.0704582104; Brain MC, 2004, BLOOD CELL MOL DIS, V32, P349, DOI 10.1016/j.bcmd.2004.01.005; BRUGNARA C, 1986, SCIENCE, V232, P388, DOI 10.1126/science.3961486; BRUGNARA C, 1993, J BIOL CHEM, V268, P8760; CLARK MR, 1988, PHYSIOL REV, V68, P503, DOI 10.1152/physrev.1988.68.2.503; Decherf G, 2004, BLOOD CELL MOL DIS, V32, P366, DOI 10.1016/j.bcmd.2004.01.008; Decherf G, 2007, BLOOD CELL MOL DIS, V39, P24, DOI 10.1016/j.bcmd.2007.02.014; Egee S, 2002, J PHYSIOL-LONDON, V542, P795, DOI 10.1113/jphysiol.2002.022970; GARDOS G, 1956, ACTA PHYSL, V4, P185; GRYGORCZYK R, 1983, CELL CALCIUM, V4, P499, DOI 10.1016/0143-4160(83)90025-8; GRYGORCZYK R, 1987, BIOCHIM BIOPHYS ACTA, V902, P159, DOI 10.1016/0005-2736(87)90291-4; HUNTER MJ, 1977, J PHYSIOL-LONDON, V268, P35, DOI 10.1113/jphysiol.1977.sp011845; JOHNSON RM, 1990, AM J PHYSIOL, V259, pC746, DOI 10.1152/ajpcell.1990.259.5.C746; JOHNSON RM, 1992, BIOCHIM BIOPHYS ACTA, V1107, P314, DOI 10.1016/0005-2736(92)90418-L; JOHNSON RM, 1994, BIOPHYS J, V67, P1876, DOI 10.1016/S0006-3495(94)80669-1; JOINER CH, 1993, AM J PHYSIOL, V264, pC251, DOI 10.1152/ajpcell.1993.264.2.C251; LARSEN FL, 1981, NATURE, V294, P667, DOI 10.1038/294667a0; Lew VL, 2007, TRENDS PARASITOL, V23, P481, DOI 10.1016/j.pt.2007.08.001; Lew VL, 2007, BLOOD, V110, P1334, DOI 10.1182/blood-2006-11-057232; LEW VL, 1986, J MEMBRANE BIOL, V92, P57, DOI 10.1007/BF01869016; Lew VL, 2005, PHYSIOL REV, V85, P179, DOI 10.1152/physrev.00052.2003; Lew VL, 2003, BLOOD, V102, P4206, DOI 10.1182/blood-2003-06-1787; Lew VL, 1997, J CLIN INVEST, V99, P2727, DOI 10.1172/JCI119462; LEW VL, 1976, NATURE, V263, P336, DOI 10.1038/263336a0; LEW VL, 1982, NATURE, V296, P742, DOI 10.1038/296742a0; LEW VL, 1982, NATURE, V298, P478, DOI 10.1038/298478a0; LUTZ HU, 1988, BLOOD CELLS, V14, P76; Mason MJ, 2005, BIOPHYS J, V88, P739, DOI 10.1529/biophysj.104.049866; ORTIZ OE, 1986, BLOOD, V67, P710; ORTIZ OE, 1990, J PHYSIOL-LONDON, V427, P211, DOI 10.1113/jphysiol.1990.sp018168; PLISHKER GA, 1992, J BIOL CHEM, V267, P21839; PORZIG H, 1975, J PHYSIOL-LONDON, V249, P27, DOI 10.1113/jphysiol.1975.sp011001; Romero PJ, 1997, CELL CALCIUM, V21, P353, DOI 10.1016/S0143-4160(97)90028-2; SIMONS TJB, 1976, J PHYSIOL-LONDON, V256, P227, DOI 10.1113/jphysiol.1976.sp011322; Tiffert T, 2001, CELL CALCIUM, V30, P337, DOI 10.1054/ceca.2001.0241; TOSTESON DC, 1955, J GEN PHYSIOL, V39, P31, DOI 10.1085/jgp.39.1.31; TOSTESON DC, 1952, J CLIN INVEST, V31, P406, DOI 10.1172/JCI102623; Vandorpe DH, 1998, J BIOL CHEM, V273, P21542, DOI 10.1074/jbc.273.34.21542	40	53	58	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2010	5	2							e9447	10.1371/journal.pone.0009447	http://dx.doi.org/10.1371/journal.pone.0009447			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	561RS	20195477	gold, Green Published			2022-12-25	WOS:000274997000013
J	Doucet, D; Badami, C; Palange, D; Bonitz, RP; Lu, Q; Xu, DZ; Kannan, KB; Colorado, I; Feinman, R; Deitch, EA				Doucet, Danielle; Badami, Chirag; Palange, David; Bonitz, R. Paul; Lu, Qi; Xu, Da-Zhong; Kannan, Kolenkode B.; Colorado, Iriana; Feinman, Rena; Deitch, Edwin A.			Estrogen Receptor Hormone Agonists Limit Trauma Hemorrhage Shock-Induced Gut and Lung Injury in Rats	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; SEX-HORMONES; BACTERIAL TRANSLOCATION; NEUTROPHIL ACTIVATION; HEMODYNAMIC-RESPONSE; MESENTERIC LYMPH; UP-REGULATION; BETA AGONIST; GENDER; DYSFUNCTION	Background: Acute lung injury (ALI) and the development of the multiple organ dysfunction syndrome (MODS) is a major cause of death in trauma patients. Earlier studies in trauma hemorrhagic shock (T/HS) have documented that splanchnic ischemia leading to gut inflammation and loss of barrier function is an initial triggering event that leads to gut-induced ARDS and MODS. Since sex hormones have been shown to modulate the response to T/HS and proestrous (PE) females are more resistant to T/HS-induced gut and distant organ injury, the goal of our study was to determine the contribution of estrogen receptor (ER)alpha and ER beta in modulating the protective response of female rats to T/HS-induced gut and lung injury. Methods/Principal Findings: The incidence of gut and lung injury was assessed in PE and ovariectomized (OVX) female rats subjected to T/HS or trauma sham shock (T/SS) as well as OVX rats that were administered estradiol (E2) or agonists for ER alpha or ER beta immediately prior to resuscitation. Marked gut and lung injury was observed in OVX rats subjected to T/HS as compared to PE rats or E2-treated OVX rats subjected to T/HS. Both ER alpha and ER beta agonists were equally effective in limiting T/HS-induced morphologic villous injury and bacterial translocation, whereas the ER beta agonist was more effective than the ER alpha agonist in limiting T/HS-induced lung injury as determined by histology, Evan's blue lung permeability, bronchoalevolar fluid/plasma protein ratio and myeloperoxidase levels. Similarly, treatment with either E2 or the ER beta agonist attenuated the induction of the intestinal iNOS response in OVX rats subjected to T/HS whereas the ER alpha agonist was only partially protective. Conclusions/Significance: Our study demonstrates that estrogen attenuates T/HS-induced gut and lung injury and that its protective effects are mediated by the activation of ER alpha, ER beta or both receptors.	[Doucet, Danielle; Badami, Chirag; Palange, David; Bonitz, R. Paul; Lu, Qi; Xu, Da-Zhong; Kannan, Kolenkode B.; Colorado, Iriana; Feinman, Rena; Deitch, Edwin A.] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Surg, Newark, NJ 07103 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Doucet, D (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Surg, Newark, NJ 07103 USA.	edeitch@umdnj.edu		Xu, Dazhong/0000-0001-9264-3342	NIH [1P50GM069790, T32-GM069330]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM069330, P50GM069790] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants 1P50GM069790 (to EAD and RF) and T32-GM069330 (to DD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams CA, 2000, AM SURGEON, V66, P905; Ananthakrishnan P, 2005, SURGERY, V137, P56, DOI 10.1016/j.surg.2004.04.037; ANATHAKRISHNAN P, 2003, XX VS XY, V1, P108; Angele MK, 2000, SHOCK, V14, P81, DOI 10.1097/00024382-200014020-00001; BA ZF, 2003, AM J PHYSIOL-HEART C, V284; BAKER HJ, 1979, LAB RAT, V1, P54; BAKER JW, 1988, J TRAUMA, V28, P896, DOI 10.1097/00005373-198807000-00002; Bjornstrom L, 2005, MOL ENDOCRINOL, V19, P833, DOI 10.1210/me.2004-0486; Caruso JM, 2003, J TRAUMA, V55, P531, DOI 10.1097/01.TA.0000025584.46870.95; Chen Z, 1999, J CLIN INVEST, V103, P401, DOI 10.1172/JCI5347; Deitch EA, 2004, SHOCK, V22, P221, DOI 10.1097/01.shk.0000133592.55400.83; Deitch EA, 1998, SHOCK, V9, P1, DOI 10.1097/00024382-199801000-00001; Deitch EA, 2008, J TRAUMA, V65, P566, DOI 10.1097/TA.0b013e31814b2c38; Deitch EA, 2007, ANN SURG, V246, P447, DOI 10.1097/SLA.0b013e318148566; Deitch EA, 2006, AM J PHYSIOL-HEART C, V291, pH1456, DOI 10.1152/ajpheart.00694.2005; Dossett LA, 2008, SURG INFECT, V9, P41, DOI 10.1089/sur.2007.037; Doucet DR, 2010, J TRAUMA, V68, P35, DOI 10.1097/TA.0b013e3181bbbddb; Edwin A, 2006, J ORGAN DYSFUNCTION, V2, P70, DOI 10.1080/17471060600551772; Forsythe RM, 2002, SHOCK, V17, P180, DOI 10.1097/00024382-200203000-00004; HENDRICKSE CW, 1993, BRIT J SURG, V80, P636, DOI 10.1002/bjs.1800800531; Jarrar D, 2000, SURGERY, V128, P246, DOI 10.1067/msy.2000.107376; Kauser K, 1997, AM J PHYSIOL-HEART C, V273, pH506, DOI 10.1152/ajpheart.1997.273.1.H506; Kuiper GGJM, 1997, ENDOCRINOLOGY, V138, P863, DOI 10.1210/en.138.3.863; Machiedo GW, 2004, J TRAUMA, V56, P837, DOI 10.1097/01.TA.0000058128.04007.90; Magnotti LJ, 1998, ANN SURG, V228, P518, DOI 10.1097/00000658-199810000-00008; Magnotti LJ, 2008, J AM COLL SURGEONS, V206, P984, DOI 10.1016/j.jamcollsurg.2007.12.038; Mendelsohn ME, 1999, NEW ENGL J MED, V340, P1801, DOI 10.1056/NEJM199906103402306; Meyers MJ, 2001, J MED CHEM, V44, P4230, DOI 10.1021/jm010254a; Proctor KG, 2008, AM J PHYSIOL-REG I, V294, pR1822, DOI 10.1152/ajpregu.90301.2008; Raju R, 2008, MOL MED, V14, P213, DOI 10.2119/2008-00001.Raju; Reilly PM, 2001, SHOCK, V15, P329, DOI 10.1097/00024382-200115050-00001; Salzman A L, 1995, New Horiz, V3, P33; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; Scheingraber S, 2005, SURG TODAY, V35, P846, DOI 10.1007/s00595-005-3044-1; Senthil M, 2006, J TRAUMA, V60, P958, DOI 10.1097/01.ta.0000215500.00018.47; Sifri ZC, 2006, SHOCK, V25, P12, DOI 10.1097/01.shk.0000188708.97153.ce; Sifri ZC, 2007, CRIT CARE MED, V35, P864, DOI 10.1097/01.CCM.0000256839.50053.1D; Suzuki T, 2007, J APPL PHYSIOL, V102, P163, DOI 10.1152/japplphysiol.00964.2006; Suzuki Y, 2000, CRIT CARE MED, V28, P3692, DOI 10.1097/00003246-200011000-00026; Szabo C, 1995, New Horiz, V3, P2; THOMAS ML, 1993, ENDOCRINOLOGY, V132, P426, DOI 10.1210/en.132.1.426; Unno N, 1997, AM J PHYSIOL-GASTR L, V272, pG923, DOI 10.1152/ajpgi.1997.272.5.G923; Xu DZ, 2002, SHOCK, V17, P139, DOI 10.1097/00024382-200202000-00010; Yu HP, 2006, AM J PHYSIOL-LUNG C, V290, pL1004, DOI 10.1152/ajplung.00504.2005; Yu HP, 2006, J MOL CELL CARDIOL, V40, P185, DOI 10.1016/j.yjmcc.2005.10.001; Yu HP, 2006, J LEUKOCYTE BIOL, V79, P963, DOI 10.1189/jlb.1005596	46	50	57	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2010	5	2							e9421	10.1371/journal.pone.0009421	http://dx.doi.org/10.1371/journal.pone.0009421			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SY	20195535	Green Published, gold, Green Submitted			2022-12-25	WOS:000274924300011
J	Wenzel, K; Wallukat, G; Qadri, F; Hubner, N; Schulz, H; Hummel, O; Herse, F; Heuser, A; Fischer, R; Heidecke, H; Luft, FC; Muller, DN; Dietz, R; Dechend, R				Wenzel, Katrin; Wallukat, Gerd; Qadri, Fatimunnisa; Hubner, Norbert; Schulz, Herbert; Hummel, Oliver; Herse, Florian; Heuser, Arnd; Fischer, Robert; Heidecke, Harald; Luft, Friedrich C.; Muller, Dominik N.; Dietz, Rainer; Dechend, Ralf			alpha(1A)-Adrenergic Receptor-Directed Autoimmunity Induces Left Ventricular Damage and Diastolic Dysfunction in Rats	PLOS ONE			English	Article							MYOSIN HEAVY-CHAIN; SARCOPLASMIC-RETICULUM CA2+-ATPASE; IDIOPATHIC DILATED CARDIOMYOPATHY; SPONTANEOUSLY HYPERTENSIVE-RATS; ADENOVIRAL GENE-TRANSFER; ALPHA(1)-ADRENERGIC RECEPTOR; HEART-FAILURE; CARDIAC-HYPERTROPHY; EXPRESSION; COLLAGEN	Background: Agonistic autoantibodies to the alpha(1)-adrenergic receptor occur in nearly half of patients with refractory hypertension; however, their relevance is uncertain. Methods/Principal Findings: We immunized Lewis rats with the second extracellular-loop peptides of the human alpha(1A)-adrenergic receptor and maintained them for one year. alpha(1A)-adrenergic antibodies (alpha(1A)-AR-AB) were monitored with a neonatal cardiomyocyte contraction assay by ELISA, and by ERK1/2 phosphorylation in human alpha(1A)-adrenergic receptor transfected Chinese hamster ovary cells. The rats were followed with radiotelemetric blood pressure measurements and echocardiography. At 12 months, the left ventricles of immunized rats had greater wall thickness than control rats. The fractional shortening and dp/dt(max) demonstrated preserved systolic function. A decreased E/A ratio in immunized rats indicated a diastolic dysfunction. Invasive hemodynamics revealed increased left ventricular end-diastolic pressures and decreased dp/dt(min). Mean diameter of cardiomyocytes showed hypertrophy in immunized rats. Long-term blood pressure values and heart rates were not different. Genes encoding sarcomeric proteins, collagens, extracellular matrix proteins, calcium regulating proteins, and proteins of energy metabolism in immunized rat hearts were upregulated, compared to controls. Furthermore, fibrosis was present in immunized hearts, but not in control hearts. A subset of immunized and control rats was infused with angiotensin (Ang) II. The stressor raised blood pressure to a greater degree and led to more cardiac fibrosis in immunized, than in control rats. Conclusions/Significance: We show that alpha(1A)-AR-AB cause diastolic dysfunction independent of hypertension, and can increase the sensitivity to Ang II. We suggest that alpha(1A)-AR-AB could contribute to cardiovascular endorgan damage.	[Wenzel, Katrin; Qadri, Fatimunnisa; Herse, Florian; Fischer, Robert; Dietz, Rainer] Fac Med Charite, Berlin, Germany; [Wenzel, Katrin; Wallukat, Gerd; Hubner, Norbert; Schulz, Herbert; Hummel, Oliver; Heuser, Arnd; Fischer, Robert; Luft, Friedrich C.; Muller, Dominik N.; Dechend, Ralf] Max Delbruck Ctr Mol Med, Berlin, Germany; [Wenzel, Katrin; Wallukat, Gerd; Hubner, Norbert; Schulz, Herbert; Hummel, Oliver; Heuser, Arnd; Fischer, Robert; Luft, Friedrich C.; Muller, Dominik N.; Dechend, Ralf] Expt & Clin Res Ctr, Berlin, Germany; [Heidecke, Harald] CellTrend, Luckenwalde, Germany; [Luft, Friedrich C.; Dechend, Ralf] Franz Volhard Clin, HELIOS Clin Berlin, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Franz-Volhard Clinical Research Center	Wenzel, K (corresponding author), Fac Med Charite, Berlin, Germany.	katrin.wenzel@charite.de	Bader, Michael/K-2124-2013	Heuser, Arnd/0000-0002-3334-960X; Luft, Friedrich/0000-0002-8635-1199; Muller, Dominik N/0000-0003-3650-5644; Herse, Florian/0000-0002-9305-8134	Deutsche Forschungsgemeinschaft; Helmholtz Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Helmholtz Foundation(Helmholtz Association)	The Deutsche Forschungsgemeinschaft supported Ralf Dechend and Dominik N. Muller with grants in-aid. The Helmholtz Foundation also supported the studies. Dominik N. Muller is a Helmholtz Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham WT, 2002, MOL MED, V8, P750, DOI 10.1007/BF03402039; Arany Z, 2006, P NATL ACAD SCI USA, V103, P10086, DOI 10.1073/pnas.0603615103; Bishop JE, 1998, MOL MED TODAY, V4, P69, DOI 10.1016/S1357-4310(97)01193-3; BROCKWAY BP, 1991, CLIN EXP HYPERTENS A, V13, P885, DOI 10.3109/10641969109042094; CHAPMAN D, 1990, CIRC RES, V67, P787, DOI 10.1161/01.RES.67.4.787; deBlois D, 1996, ARTERIOSCL THROM VAS, V16, P1122, DOI 10.1161/01.ATV.16.9.1122; del Monte F, 2001, CIRCULATION, V104, P1424, DOI 10.1161/hc3601.095574; Du XJ, 2006, CARDIOVASC RES, V71, P735, DOI 10.1016/j.cardiores.2006.06.015; FU MLX, 1994, LANCET, V344, P1660, DOI 10.1016/S0140-6736(94)90456-1; GunjaSmith Z, 1996, AM J PATHOL, V148, P1639; Haase H, 1996, J MOL MED-JMM, V74, P99; HOLUBARSCH C, 1985, CIRC RES, V56, P78, DOI 10.1161/01.RES.56.1.78; Huss JM, 2004, CIRC RES, V95, P568, DOI 10.1161/01.RES.0000141774.29937.e3; Ito K, 2001, CIRC RES, V89, P422, DOI 10.1161/hh1701.095522; Jahns R, 2004, J CLIN INVEST, V113, P1419, DOI 10.1172/JCI200420149; James J, 2005, CIRCULATION, V111, P2339, DOI 10.1161/01.CIR.0000164233.09448.B1; Jones WK, 1996, J CLIN INVEST, V98, P1906, DOI 10.1172/JCI118992; Kawase Y, 2008, J AM COLL CARDIOL, V51, P1112, DOI 10.1016/j.jacc.2007.12.014; Liao YH, 2002, HYPERTENS RES, V25, P641; Luther HP, 1997, HYPERTENSION, V29, P678, DOI 10.1161/01.HYP.29.2.678; MERCADIER JJ, 1981, CIRC RES, V49, P525, DOI 10.1161/01.RES.49.2.525; Miyamoto MI, 2000, P NATL ACAD SCI USA, V97, P793, DOI 10.1073/pnas.97.2.793; Nakayama H, 2002, FASEB J, V16, P61, DOI 10.1096/fj.02-0474fje; PATEL MB, 1991, CIRCULATION, V84, P2091, DOI 10.1161/01.CIR.84.5.2091; Piascik MT, 2001, J PHARMACOL EXP THER, V298, P403; Rysa J, 2005, HYPERTENSION, V45, P927, DOI 10.1161/01.HYP.0000161873.27088.4c; Sakata S, 2007, AM J PHYSIOL-HEART C, V292, pH1204, DOI 10.1152/ajpheart.00892.2006; Schmidt U, 2000, CIRCULATION, V101, P790, DOI 10.1161/01.CIR.101.7.790; Sugiura S, 1998, CIRC RES, V82, P1029, DOI 10.1161/01.RES.82.10.1029; Tanoue A, 2002, LIFE SCI, V71, P2207, DOI 10.1016/S0024-3205(02)02012-X; van Heerebeek L, 2006, CIRCULATION, V113, P1966, DOI 10.1161/CIRCULATIONAHA.105.587519; Verlohren S, 2009, HYPERTENSION, V54, P439, DOI 10.1161/HYPERTENSIONAHA.108.120253; VILLARREAL FJ, 1992, AM J PHYSIOL, V262, pH1861, DOI 10.1152/ajpheart.1992.262.6.H1861; WALLUKAT G, 1995, J HYPERTENS, V13, P1031, DOI 10.1097/00004872-199509000-00014; Wallukat G, 2003, MOL CELL BIOCHEM, V251, P67, DOI 10.1023/A:1025469515963; WEBER KT, 1994, J MOL CELL CARDIOL, V26, P279, DOI 10.1006/jmcc.1994.1036; Wenzel K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003742; Zhou ZH, 2005, CLIN IMMUNOL, V114, P164, DOI 10.1016/j.clim.2004.09.011	38	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2010	5	2							e9409	10.1371/journal.pone.0009409	http://dx.doi.org/10.1371/journal.pone.0009409			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SX	20195525	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000274924200029
J	Ueda, S; Kitazawa, S; Ishida, K; Nishikawa, Y; Matsui, M; Matsumoto, H; Aoki, T; Nozaki, S; Takeda, T; Tamori, Y; Aiba, A; Kahn, CR; Kataoka, T; Satoh, T				Ueda, Shuji; Kitazawa, Sohei; Ishida, Kota; Nishikawa, Yuki; Matsui, Megumi; Matsumoto, Hikaru; Aoki, Takuji; Nozaki, Shinsuke; Takeda, Tomoya; Tamori, Yoshikazu; Aiba, Atsu; Kahn, C. Ronald; Kataoka, Tohru; Satoh, Takaya			Crucial role of the small GTPase Rac1 in insulin-stimulated translocation of glucose transporter 4 to the mouse skeletal muscle sarcolemma	FASEB JOURNAL			English	Article						GLUT4; Akt; AS160; electron microscopy	LIVING MICE; T-TUBULES; GLUT4; GLUCOSE; CELLS; ACTIN; COMPARTMENTS; ACTIVATION; RESISTANCE; DISRUPTION	The Rho family GTPase Rac1 has been implicated in the regulation of glucose uptake in myoblast cell lines. However, no evidence for the role of Rac1 has been provided by a mouse model. The purpose of this study is to test the involvement of Rac1 in insulin action in mouse skeletal muscle. Intravenous administration of insulin indeed elicited Rac1 activation in gastrocnemius muscle, suggesting the involvement of Rac1 in this signaling pathway. We then examined whether insulin-stimulated translocation of the facilitative glucose transporter GLUT4 from its storage sites to the skeletal muscle sarcolemma depends on Rac1. We show that ectopic expression of constitutively activated Rac1, as well as intravenous administration of insulin, caused translocation of GLUT4 to the gastrocnemius muscle sarcolemma, as revealed by immunofluorescent staining of a transiently expressed exofacial epitope-tagged GLUT4 reporter. Of particular note, insulin-dependent, but not constitutively activated Rac1-induced, GLUT4 translocation was markedly suppressed in skeletal muscle-specific rac1-knockout mice compared to control mice. Immunogold electron microscopic analysis of endogenous GLUT4 gave similar results. Collectively, we propose a critical role of Rac1 in insulin-dependent GLUT4 translocation to the skeletal muscle sarcolemma, which has heretofore been predicted solely by cell culture studies.-Ueda, S., Kitazawa, S., Ishida, K., Nishikawa, Y., Matsui, M., Matsumoto, H., Aoki, T., Nozaki, S., Takeda, T., Tamori, Y., Aiba, A., Kahn, C. R., Kataoka, T., Satoh, T. Crucial role of the small GTPase Rac1 in insulin-stimulated translocation of glucose transporter 4 to the mouse skeletal muscle sarcolemma. FASEB J. 24, 2254-2261 (2010). www.fasebj.org	[Satoh, Takaya] Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Mol Biol,Chuo Ku, Kobe, Hyogo 6500017, Japan; [Kitazawa, Sohei] Kobe Univ, Grad Sch Med, Dept Pathol, Div Mol Pathol, Kobe, Hyogo 6500017, Japan; [Tamori, Yoshikazu] Kobe Univ, Grad Sch Med, Dept Internal Med, Div Diabet Metab & Endocrinol, Kobe, Hyogo 6500017, Japan; [Aiba, Atsu] Kobe Univ, Grad Sch Med, Dept Physiol & Cell Biol, Div Mol Genet, Kobe, Hyogo 6500017, Japan; [Kahn, C. Ronald] Harvard Univ, Sch Med, Joslin Diabet Ctr, Boston, MA 02115 USA	Kobe University; Kobe University; Kobe University; Kobe University; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.	Satoh, T (corresponding author), Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Mol Biol,Chuo Ku, 5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	tkysato@med.kobe-u.ac.jp	Kahn, Ronald/AAY-2435-2021; Satoh, Takaya/K-2628-2014; Kitazawa, Sohei/E-5602-2010	Kahn, Ronald/0000-0002-7583-9228; Kitazawa, Sohei/0000-0002-7466-7356; Aiba, Atsu/0000-0002-8192-0778	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Takeda Science Foundation	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF))	The authors are grateful to Jonathan Bogan (Yale University School of Medicine, New Haven, CT, USA), Harvey Lodish (Whitehead Institute for Biomedical Research, Massachusetts Institute of Technology, Cambridge, MA, USA), and Jun-ichi Miyazaki (Osaka University, Osaka, Japan) for plasmid DNAs. The authors also thank Masato Kasuga (International Medical Center of Japan) for critical reading of the manuscript and valuable suggestions and Nobuyuki Takenaka (Kobe University) for technical assistance. This investigation was supported by Grants-in-Aid for Scientific Research on Priority Areas (Systems Genomics and Life Surveyor), Scientific Research (B), the 21st Century COE Program (Center of Excellence for Signal Transduction Disease: Diabetes Mellitus as Model), and the Global COE Program (Global Center for Education and Research in Integrative Membrane Biology) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, and by a grant from the Takeda Science Foundation.	Aihara H, 1998, NAT BIOTECHNOL, V16, P867, DOI 10.1038/nbt0998-867; Biddinger SB, 2006, ANNU REV PHYSIOL, V68, P123, DOI 10.1146/annurev.physiol.68.040104.124723; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Bogan JS, 2001, MOL CELL BIOL, V21, P4785, DOI 10.1128/MCB.21.14.4785-4806.2001; Brozinick JT, 2004, J BIOL CHEM, V279, P40699, DOI 10.1074/jbc.M402697200; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Chiang SH, 2001, NATURE, V410, P944, DOI 10.1038/35073608; Fazakerley DJ, 2009, J CELL SCI, V122, P727, DOI 10.1242/jcs.041178; Huang SH, 2007, CELL METAB, V5, P237, DOI 10.1016/j.cmet.2007.03.006; Ishikura S, 2008, ACTA PHYSIOL, V192, P61, DOI 10.1111/j.1748-1716.2007.01778.x; Jebailey L, 2004, MOL ENDOCRINOL, V18, P359, DOI 10.1210/me.2003-0294; JeBailey L, 2007, DIABETES, V56, P394, DOI 10.2337/db06-0823; Kassai H, 2008, EUR J NEUROSCI, V28, P257, DOI 10.1111/j.1460-9568.2008.06343.x; Khayat ZA, 2000, J CELL SCI, V113, P279; Kitazawa S, 2006, J STRUCT BIOL, V153, P64, DOI 10.1016/j.jsb.2005.09.010; KLIP A, 1990, DIABETES CARE, V13, P228, DOI 10.2337/diacare.13.3.228; Lauritzen HPMM, 2008, DIABETES, V57, P315, DOI 10.2337/db06-1578; Lauritzen HPMM, 2008, DIABETES, V57, P13, DOI 10.2337/db07-0516; Lauritzen HPMM, 2006, DIABETES, V55, P1300, DOI 10.2337/db05-1216; MARETTE A, 1992, DIABETES, V41, P1562, DOI 10.2337/diabetes.41.12.1562; Mayhew TM, 2004, HISTOCHEM CELL BIOL, V122, P171, DOI 10.1007/s00418-004-0685-x; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Ploug T, 1998, J CELL BIOL, V142, P1429, DOI 10.1083/jcb.142.6.1429; Randhawa VK, 2008, J BIOL CHEM, V283, P27208, DOI 10.1074/jbc.M804282200; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Schertzer JD, 2009, ENDOCRINOLOGY, V150, P1935, DOI 10.1210/en.2008-1372; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Ueda S, 2008, BIOL CELL, V100, P645, DOI 10.1042/BC20070160; Zisman A, 2000, NAT MED, V6, P924, DOI 10.1038/78693	29	88	90	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2010	24	7					2254	2261		10.1096/fj.09-137380	http://dx.doi.org/10.1096/fj.09-137380			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	618HV	20203090	Green Published			2022-12-25	WOS:000279343600012
J	Lopez, H; Zhang, LQ; George, NM; Liu, XQ; Pang, XM; Evans, JJD; Targy, NM; Luo, X				Lopez, Hernando; Zhang, Liqiang; George, Nicholas M.; Liu, Xiaoqiong; Pang, Xiaming; Evans, Jacquelynn J. D.; Targy, Natalie M.; Luo, Xu			Perturbation of the Bcl-2 Network and an Induced Noxa/Bcl-xL Interaction Trigger Mitochondrial Dysfunction after DNA Damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BH3-ONLY PROTEINS; CELL-DEATH; MEMBRANE PERMEABILIZATION; FAMILY-MEMBERS; CYTOCHROME-C; APOPTOTIC RESPONSES; BH3 DOMAINS; BAX; ACTIVATION; MCL-1	How most apoptotic stimuli trigger mitochondrial dysfunction remains to be resolved. We screened the entire Bcl-2 network for its involvement in DNA damage-induced apoptosis in HeLa cells. Although the anti-apoptotic member Bcl-xL served as a major suppressor, apoptosis initiated only when both Mcl-1 and Bcl-xL were eliminated. The pro-apoptotic members Bak, Bad, Bim, and Noxa were required for apoptosis induced by DNA damaging agents camptothecin and UV. We, therefore, used a His-tagged Bcl-xL expression system to capture the relevant BH3-only proteins that bind to Bcl-xL in response to DNA damage. Surprisingly, unlike Bad and Bim, which bound Bcl-xL constitutively, Noxa became "Mcl-1-free" and interacted with Bcl-xL after DNA damage but not after death receptor engagement. Similar observations were also made in A431 cells. Importantly, this induced interaction caused cytochrome c release and apoptosis and was directly inhibited by Mcl-1, a protein eliminated or inactivated after DNA damage. These results suggest that the loss/inactivation of Mcl-1 in conjunction with an induced Noxa/Bcl-xL interaction may serve as a trigger for mitochondrial dysfunction during DNA damage-induced apoptosis.	[Lopez, Hernando; Zhang, Liqiang; George, Nicholas M.; Liu, Xiaoqiong; Pang, Xiaming; Evans, Jacquelynn J. D.; Targy, Natalie M.; Luo, Xu] Univ Nebraska, Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center	Luo, X (corresponding author), Univ Nebraska, Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA.	xuluo@unmc.edu	Zhang, Liqiang/B-6889-2011; Lopez, Hernando/AAY-7655-2020	Lopez, Hernando/0000-0001-6618-1092	National Institutes of Health [GM76237, GM76237-04S1]; Nebraska Center for Cellular Signaling; Eppley Institute; University of Nebraska Medical Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076237] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nebraska Center for Cellular Signaling; Eppley Institute; University of Nebraska Medical Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM76237 and GM76237-04S1. This work was also supported by a pilot grant from the Nebraska Center for Cellular Signaling ( to X. L.).; Supported by a student fellowship from the Nebraska Center for Cellular Signaling.; Supported by the Eppley Institute and a graduate fellowship from the University of Nebraska Medical Center.	Adams JM, 2007, CURR OPIN IMMUNOL, V19, P488, DOI 10.1016/j.coi.2007.05.004; Bouillet P, 2002, J CELL SCI, V115, P1567; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Chipuk JE, 2008, TRENDS CELL BIOL, V18, P157, DOI 10.1016/j.tcb.2008.01.007; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Cuconati A, 2003, GENE DEV, V17, P2922, DOI 10.1101/gad.1156903; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Gavathiotis E, 2008, NATURE, V455, P1076, DOI 10.1038/nature07396; George NM, 2007, GENE DEV, V21, P1937, DOI 10.1101/gad.1553607; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Huang DCS, 2000, CELL, V103, P839, DOI 10.1016/S0092-8674(00)00187-2; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Leber B, 2007, APOPTOSIS, V12, P897, DOI 10.1007/s10495-007-0746-4; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Lovell JF, 2008, CELL, V135, P1074, DOI 10.1016/j.cell.2008.11.010; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Minn AJ, 1999, EMBO J, V18, P632, DOI 10.1093/emboj/18.3.632; Naik E, 2007, J CELL BIOL, V176, P415, DOI 10.1083/jcb.200608070; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Nijhawan D, 2003, GENE DEV, V17, P1475, DOI 10.1101/gad.1093903; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Ranger AM, 2003, P NATL ACAD SCI USA, V100, P9324, DOI 10.1073/pnas.1533446100; Shibue T, 2003, GENE DEV, V17, P2233, DOI 10.1101/gad.1103603; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Walensky LD, 2006, MOL CELL, V24, P199, DOI 10.1016/j.molcel.2006.08.020; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wei MC, 2000, GENE DEV, V14, P2060; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Willis SN, 2005, CURR OPIN CELL BIOL, V17, P617, DOI 10.1016/j.ceb.2005.10.001; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1	42	47	48	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15016	15026		10.1074/jbc.M109.086231	http://dx.doi.org/10.1074/jbc.M109.086231			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20223826	Green Published, hybrid			2022-12-25	WOS:000277399000023
J	Doyle, S; Pyndiah, S; De Gois, S; Erickson, JD				Doyle, Sukhjeevan; Pyndiah, Slovenie; De Gois, Stephanie; Erickson, Jeffrey D.			Excitation-Transcription Coupling via Calcium/Calmodulin-dependent Protein Kinase/ERK1/2 Signaling Mediates the Coordinate Induction of VGLUT2 and Narp Triggered by a Prolonged Increase in Glutamatergic Synaptic Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; VESICULAR ACETYLCHOLINE TRANSPORTER; RAT CEREBRAL-CORTEX; GYRUS IN-VIVO; NEUROTROPHIC FACTOR; GENE-EXPRESSION; HIPPOCAMPAL-NEURONS; QUANTAL SIZE; HOMEOSTATIC PLASTICITY; ELECTROCONVULSIVE SEIZURE	Homeostatic scaling of glutamatergic and GABAergic transmission is triggered by prolonged alterations in synaptic neuronal activity . We have previously described a presynaptic mechanism for synaptic homeostasis and plasticity that involves scaling the level of vesicular glutamate (VGLUT1) and gamma-aminobutyric acid (GABA) (VGAT) transporter biosynthesis. These molecular determinants of vesicle filling and quantal size are regulated by neuronal activity in an opposite manner and bi-directionally. Here, we report that a striking induction of VGLUT2 mRNA and synaptic protein is triggered by a prolonged increase in glutamatergic synaptic activity in mature neocortical neuronal networks in vitro together with two determinants of inhibitory synaptic strength, the neuronal activity-regulated pentraxin (Narp), and glutamate decarboxylase(GAD65). Activity-dependent induction of VGLUT2 and Narp exhibits a similar intermediate-early gene response that is blocked by actinomycin D and tetrodotoxin, by inhibitors of ionotropic glutamate receptors and L-type voltage-gated calcium channels, and is dependent on downstream signaling via calmodulin, calcium/calmodulin-dependent protein kinase(CaMK) and extracellular signal-regulated kinase 1/2 (ERK1/2). The co-induction of VGLUT2 and Narp triggered by prolonged gamma-aminobutyric acid type A receptor blockade is independent of brain-derived nerve growth factor and TrkB receptor signaling. VGLUT2 protein induction occurs on a subset of cortically derived synaptic vesicles in excitatory synapses on somata and dendritic processes of multipolar GABAergic interneurons, recognized sites for the clustering of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate glutamate receptors by Narp. We propose that VGLUT2 and Narp induction by excitation transcription coupling leads to increased glutamatergic transmission at synapses on GABAergic inhibitory feedback neurons as part of a coordinated program of Ca2+-signal transcription involved in mechanisms of homeostatic plasticity after prolonged hyperactivity.	[Doyle, Sukhjeevan; Pyndiah, Slovenie; De Gois, Stephanie; Erickson, Jeffrey D.] Louisiana State Univ, Hlth Sci Ctr, Neurosci Ctr Excellence, New Orleans, LA 70112 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Erickson, JD (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Neurosci Ctr Excellence, 2020 Gravier St, New Orleans, LA 70112 USA.	jerick@lsuhsc.edu			National Institutes of Health [NS36936]; National Alliance for Research on Schizophrenia and Depression (NARSAD); Louisiana State University Health Sciences Center; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036936] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Alliance for Research on Schizophrenia and Depression (NARSAD)(French National Research Agency (ANR)NARSAD); Louisiana State University Health Sciences Center; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS36936. This work was also supported by a National Alliance for Research on Schizophrenia and Depression (NARSAD) Independent Investigator Award (NARSAD Southwest Florida Investigator) and a Research Enhancement Fund by Louisiana State University Health Sciences Center (to J. D. E.).	AGOSTON DV, 1991, J NEUROSCI RES, V28, P140, DOI 10.1002/jnr.490280115; Atkins CM, 1998, NAT NEUROSCI, V1, P602, DOI 10.1038/2836; Bading H, 2000, EUR J BIOCHEM, V267, P5280, DOI 10.1046/j.1432-1327.2000.01565.x; Barbado M, 2009, BBA-MOL CELL RES, V1793, P1096, DOI 10.1016/j.bbamcr.2009.02.004; Boulland JL, 2004, J COMP NEUROL, V480, P264, DOI 10.1002/cne.20354; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Burgoyne RD, 2007, NAT REV NEUROSCI, V8, P182, DOI 10.1038/nrn2093; Choe ES, 2002, NEUROSCIENCE, V114, P557, DOI 10.1016/S0306-4522(02)00318-4; Cohen S, 2008, ANNU REV CELL DEV BI, V24, P183, DOI 10.1146/annurev.cellbio.24.110707.175235; Daniels RW, 2006, NEURON, V49, P11, DOI 10.1016/j.neuron.2005.11.032; Daniels RW, 2004, J NEUROSCI, V24, P10466, DOI 10.1523/JNEUROSCI.3001-04.2004; Davis GW, 2006, ANNU REV NEUROSCI, V29, P307, DOI 10.1146/annurev.neuro.28.061604.135751; Davis S, 2000, J NEUROSCI, V20, P4563, DOI 10.1523/JNEUROSCI.20-12-04563.2000; De Gois S, 2005, J NEUROSCI, V25, P7121, DOI 10.1523/JNEUROSCI.5221-04.2005; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; Dolmetsch Ricardo, 2003, Sci STKE, V2003, pPE4; Engel D, 2001, J PHYSIOL-LONDON, V535, P473, DOI 10.1111/j.1469-7793.2001.00473.x; Erickson JD, 2006, NEUROCHEM INT, V48, P643, DOI 10.1016/j.neuint.2005.12.029; Finkbeiner S, 1997, NEURON, V19, P1031, DOI 10.1016/S0896-6273(00)80395-5; Frank CA, 2006, NEURON, V52, P663, DOI 10.1016/j.neuron.2006.09.029; Frank CA, 2009, NEURON, V61, P556, DOI 10.1016/j.neuron.2008.12.028; Fremeau RT, 2001, NEURON, V31, P247, DOI 10.1016/S0896-6273(01)00344-0; Gras C, 2005, NEUROPHARMACOLOGY, V49, P901, DOI 10.1016/j.neuropharm.2005.07.023; Han EB, 2009, P NATL ACAD SCI USA, V106, P10817, DOI 10.1073/pnas.0903603106; Hartman KN, 2006, NAT NEUROSCI, V9, P642, DOI 10.1038/nn1677; Hartmann K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002979; HEAULME M, 1986, BRAIN RES, V384, P224, DOI 10.1016/0006-8993(86)91158-3; HENDRY SHC, 1988, NEURON, V1, P701, DOI 10.1016/0896-6273(88)90169-9; Herzog E, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-22-j0001.2001; Herzog E, 2006, J NEUROCHEM, V99, P1011, DOI 10.1111/j.1471-4159.2006.04144.x; Ibata K, 2008, NEURON, V57, P819, DOI 10.1016/j.neuron.2008.02.031; Impey S, 1998, NEURON, V21, P869, DOI 10.1016/S0896-6273(00)80602-9; ISACKSON PJ, 1991, NEURON, V6, P937, DOI 10.1016/0896-6273(91)90234-Q; Kilman V, 2002, J NEUROSCI, V22, P1328, DOI 10.1523/JNEUROSCI.22-04-01328.2002; Kinney JW, 2006, J NEUROSCI, V26, P1604, DOI 10.1523/JNEUROSCI.4722-05.2006; Kirmse K, 2008, J PHYSIOL-LONDON, V586, P5665, DOI 10.1113/jphysiol.2008.161943; Kurt S, 2006, HEARING RES, V212, P224, DOI 10.1016/j.heares.2005.12.002; Liguz-Lecznar M, 2007, INT J DEV NEUROSCI, V25, P107, DOI 10.1016/j.ijdevneu.2006.12.005; Limback-Stokin K, 2004, J NEUROSCI, V24, P10858, DOI 10.1523/JNEUROSCI.1022-04.2004; LINDHOLM D, 1994, J NEUROBIOL, V25, P1362, DOI 10.1002/neu.480251105; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Mao XH, 2004, EXP CELL RES, V292, P304, DOI 10.1016/j.yexcr.2003.09.012; MATTHEWS RP, 1994, MOL CELL BIOL, V14, P6107, DOI 10.1128/MCB.14.9.6107; Mi RF, 2002, J NEUROSCI, V22, P7606; Minelli A, 2003, NEUROSCIENCE, V117, P337, DOI 10.1016/S0306-4522(02)00864-3; Minelli A, 2003, DEV BRAIN RES, V140, P309, DOI 10.1016/S0165-3806(02)00617-X; Moechars D, 2006, J NEUROSCI, V26, P12055, DOI 10.1523/JNEUROSCI.2556-06.2006; MURPHY TH, 1991, NEURON, V7, P625, DOI 10.1016/0896-6273(91)90375-A; MURPHY TH, 1991, J NEUROCHEM, V57, P1862, DOI 10.1111/j.1471-4159.1991.tb06396.x; NAKAMURA Y, 1995, NEUROSCIENCE, V68, P181, DOI 10.1016/0306-4522(95)00092-W; NIBUYA M, 1995, J NEUROSCI, V15, P7539; O'Brien R, 2002, J NEUROSCI, V22, P4487, DOI 10.1523/JNEUROSCI.22-11-04487.2002; O'Brien RJ, 1998, NEURON, V21, P1067, DOI 10.1016/S0896-6273(00)80624-8; O'Brien RJ, 1999, NEURON, V23, P309, DOI 10.1016/S0896-6273(00)80782-5; Ploski JE, 2006, J NEUROCHEM, V99, P1122, DOI 10.1111/j.1471-4159.2006.04156.x; Reti IM, 2008, NEUROSCIENCE, V151, P352, DOI 10.1016/j.neuroscience.2007.10.040; Reti IM, 2002, J NEUROCHEM, V82, P935, DOI 10.1046/j.1471-4159.2002.01051.x; Reti IM, 2000, NEUROPSYCHOPHARMACOL, V23, P439, DOI 10.1016/S0893-133X(00)00120-2; Rutherford LC, 1998, NEURON, V21, P521, DOI 10.1016/S0896-6273(00)80563-2; Rutherford LC, 1997, J NEUROSCI, V17, P4527; Sakata-Haga H, 2001, BRAIN RES, V902, P143, DOI 10.1016/S0006-8993(01)02290-9; Saliba RS, 2007, J NEUROSCI, V27, P13341, DOI 10.1523/JNEUROSCI.3277-07.2007; Saliba RS, 2009, J BIOL CHEM, V284, P32544, DOI 10.1074/jbc.M109.040071; Schafer MKH, 2002, J BIOL CHEM, V277, P50734, DOI 10.1074/jbc.M206738200; Schallier A, 2009, NEUROCHEM INT, V55, P41, DOI 10.1016/j.neuint.2008.12.019; Seeburg DP, 2008, NEURON, V58, P571, DOI 10.1016/j.neuron.2008.03.021; Shieh PB, 1999, J NEUROBIOL, V41, P127, DOI 10.1002/(SICI)1097-4695(199910)41:1<127::AID-NEU16>3.0.CO;2-J; Shieh PB, 1998, NEURON, V20, P727, DOI 10.1016/S0896-6273(00)81011-9; Soderling TR, 1999, TRENDS BIOCHEM SCI, V24, P232, DOI 10.1016/S0968-0004(99)01383-3; Soghomonian JJ, 1998, TRENDS PHARMACOL SCI, V19, P500, DOI 10.1016/S0165-6147(98)01270-X; Sulzer D, 2000, NEURON, V28, P5; Swanwick CC, 2006, MOL CELL NEUROSCI, V31, P481, DOI 10.1016/j.mcn.2005.11.002; Tabuchi A, 2000, J BIOL CHEM, V275, P17269, DOI 10.1074/jbc.M909538199; Takamori S, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-22-j0002.2001; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; Tauskela JS, 2008, J BIOL CHEM, V283, P34667, DOI 10.1074/jbc.M805624200; Thiagarajan TC, 2007, NEUROPHARMACOLOGY, V52, P156, DOI 10.1016/j.neuropharm.2006.07.030; Thiagarajan TC, 2002, NEURON, V36, P1103, DOI 10.1016/S0896-6273(02)01049-8; Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346; Tsuda M, 1996, NEUROCHEM INT, V29, P443, DOI 10.1016/0197-0186(96)00014-9; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Turrigiano G, 2007, CURR OPIN NEUROBIOL, V17, P318, DOI 10.1016/j.conb.2007.04.004; Ueno S, 1997, J NEUROSCI, V17, P625; Varoqui H, 1996, J BIOL CHEM, V271, P27229, DOI 10.1074/jbc.271.44.27229; Varoqui H, 2002, J NEUROSCI, V22, P142, DOI 10.1523/JNEUROSCI.22-01-00142.2002; Wallen-Mackenzie A, 2009, J NEUROSCI, V29, P2238, DOI 10.1523/JNEUROSCI.5851-08.2009; Wayman GA, 2008, NEURON, V59, P914, DOI 10.1016/j.neuron.2008.08.021; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; WETMORE C, 1994, J NEUROSCI, V14, P1688, DOI 10.1523/JNEUROSCI.14-03-01688.1994; Wheeler DG, 2008, J CELL BIOL, V183, P849, DOI 10.1083/jcb.200805048; Wibrand K, 2006, EUR J NEUROSCI, V23, P1501, DOI 10.1111/j.1460-9568.2006.04687.x; Wierenga CJ, 2005, J NEUROSCI, V25, P2895, DOI 10.1523/JNEUROSCI.5217-04.2005; Wierenga CJ, 2006, J NEUROPHYSIOL, V96, P2127, DOI 10.1152/jn.00107.2006; Wilson NR, 2005, J NEUROSCI, V25, P6221, DOI 10.1523/JNEUROSCI.3003-04.2005; Wojcik SM, 2004, P NATL ACAD SCI USA, V101, P7158, DOI 10.1073/pnas.0401764101; Wu XS, 2007, J NEUROSCI, V27, P3046, DOI 10.1523/JNEUROSCI.4415-06.2007; Xia ZG, 1996, J NEUROSCI, V16, P5425; Ying SW, 2002, J NEUROSCI, V22, P1532, DOI 10.1523/JNEUROSCI.22-05-01532.2002; ZAFRA F, 1990, EMBO J, V9, P3545, DOI 10.1002/j.1460-2075.1990.tb07564.x; ZAFRA F, 1991, P NATL ACAD SCI USA, V88, P10037, DOI 10.1073/pnas.88.22.10037; Zhu HM, 2001, J BIOL CHEM, V276, P41580, DOI 10.1074/jbc.M103550200	102	31	34	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14366	14376		10.1074/jbc.M109.080069	http://dx.doi.org/10.1074/jbc.M109.080069			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20212045	hybrid, Green Published			2022-12-25	WOS:000277299700034
J	Gustot, A; Smriti; Ruysschaert, JM; Mchaourab, H; Govaerts, C				Gustot, Adelin; Smriti; Ruysschaert, Jean-Marie; Mchaourab, Hassane; Govaerts, Cedric			Lipid Composition Regulates the Orientation of Transmembrane Helices in HorA, an ABC Multidrug Transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFORM INFRARED-SPECTROSCOPY; INTEGRAL MEMBRANE-PROTEINS; BIOLOGICAL-MEMBRANES; ALTERNATING ACCESS; EXCHANGE; BINDING; TOPOLOGY; SPECTRA; MODEL; MSBA	ATP-binding cassette (ABC) transporters constitute a large class of molecular pumps whose central role in chemotherapy resistance has highlighted their clinical relevance. We investigated whether the lipid composition of the membrane affects the function and structure of HorA, a bacterial ABC multidrug transporter. When the transporter was reconstituted in a bilayer where phosphatidylethanolamine (PE), the main lipid of the bacterial membrane, was replaced with phosphatidylcholine (PC), ATP hydrolysis and substrate transport became uncoupled. Although ATPase activity was maintained, HorA lost its ability to extrude the prototypical substrate Hoechst33342. Attenuated Total Reflection-Fourier Transform Infrared spectroscopy (ATR-FTIR) revealed that, although the secondary structure of the protein was unaffected, the orientation of the transmembrane helices (TM) was modified by the change in lipid composition. The orientation of the backbone carbonyls indicated that the helices opened wider in PE versus PC-containing liposomes, with 10 degrees difference. This was supported by hydrogen/deuterium exchange studies showing increased protection of the backbone from the solvent in PC-containing liposomes. Electron Paramagnetic Resonance was used to further probe the structural change. In the PC-containing liposomes we observed increased mobility of the spin label in TM4, along with increased exposure to molecular oxygen, used as a hydrophobic quencher. This indicates that the lipid change induced modification of the orientation of TM4, exposing Cys-180 to the lipid phase. The lipid composition of the bilayer thus modulates the structure of HorA, and in turn its ability to extrude its substrates.	[Gustot, Adelin; Ruysschaert, Jean-Marie; Govaerts, Cedric] Univ Libre Bruxelles, Struct Biol & Bioinformat Ctr, Dept Struct & Funct Biol Membranes, B-1050 Brussels, Belgium; [Smriti; Mchaourab, Hassane] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA	Universite Libre de Bruxelles; Vanderbilt University	Govaerts, C (corresponding author), Univ Libre Bruxelles, Struct Biol & Bioinformat Ctr, Dept Struct & Funct Biol Membranes, CP206-2,Blvd Triomphe, B-1050 Brussels, Belgium.	cgovaert@ulb.ac.be	Mishra, Smriti/D-4034-2009	Mishra, Smriti/0000-0002-6765-5007	National Institutes of Health [GMR01-077659]; Actions de Recherche Concertees de la Communaute Francaise, Belgium; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077659] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Actions de Recherche Concertees de la Communaute Francaise, Belgium; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GMR01-077659. This work was also supported by the Actions de Recherche Concertees de la Communaute Francaise, Belgium.	Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Altenbach C, 2005, BIOPHYS J, V89, P2103, DOI 10.1529/biophysj.105.059063; BAYKOV AA, 1988, ANAL BIOCHEM, V171, P266, DOI 10.1016/0003-2697(88)90484-8; Bechinger B, 1999, BIOPHYS J, V76, P552, DOI 10.1016/S0006-3495(99)77223-1; Bogdanov M, 2002, EMBO J, V21, P2107, DOI 10.1093/emboj/21.9.2107; Bogdanov M, 1996, J BIOL CHEM, V271, P11615, DOI 10.1074/jbc.271.20.11615; Botelho AV, 2002, BIOCHEMISTRY-US, V41, P6354, DOI 10.1021/bi011995g; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; deJongh HHJ, 1997, BIOCHEMISTRY-US, V36, P13603, DOI 10.1021/bi971337p; Dowhan W, 2009, ANNU REV BIOCHEM, V78, P515, DOI 10.1146/annurev.biochem.77.060806.091251; Fringeli U P, 1981, Mol Biol Biochem Biophys, V31, P270; Goormaghtigh E, 1999, BBA-REV BIOMEMBRANES, V1422, P105, DOI 10.1016/S0304-4157(99)00004-0; Goormaghtigh E, 1994, Subcell Biochem, V23, P363; GOORMAGHTIGH E, 1990, EUR J BIOCHEM, V193, P409, DOI 10.1111/j.1432-1033.1990.tb19354.x; Hakizimana P, 2008, J BIOL CHEM, V283, P9369, DOI 10.1074/jbc.M708427200; Lange C, 2001, EMBO J, V20, P6591, DOI 10.1093/emboj/20.23.6591; Lee AG, 2004, BBA-BIOMEMBRANES, V1666, P62, DOI 10.1016/j.bbamem.2004.05.012; Lee AG, 2003, BBA-BIOMEMBRANES, V1612, P1, DOI 10.1016/S0005-2736(03)00056-7; Lensink MF, 2010, J BIOL CHEM, V285, P10519, DOI 10.1074/jbc.M109.068890; Nogi T, 2000, P NATL ACAD SCI USA, V97, P13561, DOI 10.1073/pnas.240224997; Pilot JD, 2001, BIOCHEMISTRY-US, V40, P8188, DOI 10.1021/bi0103258; Raussens V, 2004, APPL SPECTROSC, V58, P68, DOI 10.1366/000370204322729496; Sakamoto K, 2001, J BACTERIOL, V183, P5371, DOI 10.1128/JB.183.18.5371-5375.2001; SINGER SJ, 1972, SCIENCE, V175, P720, DOI 10.1126/science.175.4023.720; Vigano C, 2000, BIOPOLYMERS, V55, P373, DOI 10.1002/1097-0282(2000)55:5<373::AID-BIP1011>3.0.CO;2-U; Wang XY, 2002, EMBO J, V21, P5673, DOI 10.1093/emboj/cdf571; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; WARREN GB, 1974, BIOCHEMISTRY-US, V13, P5501, DOI 10.1021/bi00724a008; Zou P, 2009, J MOL BIOL, V393, P574, DOI 10.1016/j.jmb.2009.08.051	29	33	33	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14144	14151		10.1074/jbc.M109.079673	http://dx.doi.org/10.1074/jbc.M109.079673			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20223819	hybrid, Green Published			2022-12-25	WOS:000277299700010
J	Dimitrova, YN; Li, JO; Lee, YT; Rios-Esteves, J; Friedman, DB; Choi, HJ; Weis, WI; Wang, CY; Chazin, WJ				Dimitrova, Yoana N.; Li, Jiong; Lee, Young-Tae; Rios-Esteves, Jessica; Friedman, David B.; Choi, Hee-Jung; Weis, William I.; Wang, Cun-Yu; Chazin, Walter J.			Direct Ubiquitination of beta-Catenin by Siah-1 and Regulation by the Exchange Factor TBL1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL ACTIVATION; UP-REGULATION; PROTEIN; BINDING; DEGRADATION; PATHWAY; LIGASE; COMPLEX; P53; RECOGNITION	beta-Catenin is a key component of the Wnt signaling pathway that functions as a transcriptional co-activator of Wnt target genes. Upon UV-induced DNA damage, beta-catenin is recruited for polyubiquitination and subsequent proteasomal degradation by a unique, p53-induced SCF-like complex (SCF(TBL1)), comprised of Siah-1, Siah-1-interacting protein (SIP), Skp1, transducin beta-like 1 (TBL1), and adenomatous polyposis coli (APC). Given the complexity of the various factors involved and the novelty of ubiquitination of the non-phosphorylated beta-catenin substrate, we have investigated Siah-1-mediated ubiquitination of beta-catenin in vitro and in cells. Overexpression and purification protocols were developed for each of the SCF(TBL1) proteins, enabling a systematic analysis of beta-catenin ubiquitination using an in vitro ubiquitination assay. This study revealed that Siah-1 alone was able to polyubiquitinate beta-catenin. In addition, TBL1 was shown to play a role in protecting beta-catenin from Siah-1 ubiquitination in vitro and from Siah-1-targeted proteasomal degradation in cells. Siah-1 and TBL1 were found to bind to the same armadillo repeat domain of beta-catenin, suggesting that polyubiquitination of beta-catenin is regulated by competition between Siah-1 and TBL1 during Wnt signaling.	[Dimitrova, Yoana N.; Lee, Young-Tae; Rios-Esteves, Jessica; Chazin, Walter J.] Vanderbilt Univ, Struct Biol Ctr, Nashville, TN 37232 USA; [Dimitrova, Yoana N.; Lee, Young-Tae; Rios-Esteves, Jessica; Friedman, David B.; Chazin, Walter J.] Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA; [Chazin, Walter J.] Vanderbilt Univ, Dept Chem, Nashville, TN 37232 USA; [Friedman, David B.] Vanderbilt Univ, Mass Spectrometry Res Ctr, Nashville, TN 37232 USA; [Li, Jiong; Wang, Cun-Yu] Univ Calif Los Angeles, Sch Dent, Lab Mol Signaling, Div Oral Biol & Med, Los Angeles, CA 90095 USA; [Choi, Hee-Jung; Weis, William I.] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; [Choi, Hee-Jung; Weis, William I.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; University of California System; University of California Los Angeles; Stanford University; Stanford University	Chazin, WJ (corresponding author), Vanderbilt Univ, Struct Biol Ctr, 465 21st Ave S,Ste 5140, Nashville, TN 37232 USA.	walter.chazin@vanderbilt.edu	Weis, William I/G-1437-2011	Weis, William I/0000-0002-5583-6150; Dimitrova, Yoana/0000-0003-1547-5781; Lee, Young-Tae/0000-0002-3522-9361; Choi, Hee-Jung/0000-0002-1167-1526	National Institutes of Health [R01 GM75156, R01 GM2112, R37DE13848, R01DE15964, R01DE16513, T35 HL007717, P30 CA68485, P50 ES0026]; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T35HL007717] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE016513, R37DE013848, R01DE015964] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075156] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Operating Grants (R01 GM75156 and R01 GM2112 to W. J. C.; R37DE13848, R01DE15964, and R01DE16513 to C.-Y. W.), Training Grant T35 HL007717, and grants to support access to facilities (P30 CA68485 and P50 ES0026).	Bhattacharya S, 2005, BIOCHEMISTRY-US, V44, P9462, DOI 10.1021/bi0502689; Boulton SJ, 2000, EMBO J, V19, P5376, DOI 10.1093/emboj/19.20.5376; Brzovic PS, 2003, P NATL ACAD SCI USA, V100, P5646, DOI 10.1073/pnas.0836054100; Chang PJ, 2008, DEVELOPMENT, V135, P3021, DOI 10.1242/dev.021923; Chien AJ, 2009, J INVEST DERMATOL, V129, P1614, DOI 10.1038/jid.2008.445; Chitalia VC, 2008, NAT CELL BIOL, V10, P1208, DOI 10.1038/ncb1781; Choi HJ, 2006, J BIOL CHEM, V281, P1027, DOI 10.1074/jbc.M511338200; Christensen DE, 2007, NAT STRUCT MOL BIOL, V14, P941, DOI 10.1038/nsmb1295; Durocher Y, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e9; EKLOF SK, 2001, EMBO J, V20, P6203; Fujita Y, 2002, NAT CELL BIOL, V4, P222, DOI 10.1038/ncb758; Goddard T. D., 2006, SPARKY 3; Gwak J, 2009, BIOCHEM BIOPH RES CO, V387, P444, DOI 10.1016/j.bbrc.2009.07.027; Hao B, 2005, MOL CELL, V20, P9, DOI 10.1016/j.molcel.2005.09.003; House CM, 2006, STRUCTURE, V14, P695, DOI 10.1016/j.str.2005.12.013; Hu G, 1997, GENE DEV, V11, P2701, DOI 10.1101/gad.11.20.2701; Huber AH, 1997, CELL, V90, P871, DOI 10.1016/S0092-8674(00)80352-9; Jang KL, 2005, P NATL ACAD SCI USA, V102, P18431, DOI 10.1073/pnas.0504054102; Jin LY, 2008, CELL, V133, P653, DOI 10.1016/j.cell.2008.04.012; Kim CJ, 2004, ONCOGENE, V23, P8591, DOI 10.1038/sj.onc.1208113; Kirkpatrick DS, 2005, NAT CELL BIOL, V7, P750, DOI 10.1038/ncb0805-750; Latres E, 1999, ONCOGENE, V18, P849, DOI 10.1038/sj.onc.1202653; Li J, 2008, NAT CELL BIOL, V10, P160, DOI 10.1038/ncb1684; Liani E, 2004, P NATL ACAD SCI USA, V101, P5500, DOI 10.1073/pnas.0401081101; Liu J, 2001, MOL CELL, V7, P927, DOI 10.1016/S1097-2765(01)00241-6; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Matsuo H, 1999, J AM CHEM SOC, V121, P9903, DOI 10.1021/ja991881g; Matsuzawa S, 2001, MOL CELL, V7, P915, DOI 10.1016/S1097-2765(01)00242-8; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Nastasi T, 2004, DEV CELL, V6, P269, DOI 10.1016/S1534-5807(04)00020-6; Ning XX, 2007, MOL CANCER RES, V5, P1254, DOI 10.1158/1541-7786.MCR-06-0426; Park S, 2006, MOL PHARMACOL, V70, P960, DOI 10.1124/mol.106.024729; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Perissi V, 2004, CELL, V116, P511, DOI 10.1016/S0092-8674(04)00133-3; Polakis P, 1999, CURR OPIN GENET DEV, V9, P15, DOI 10.1016/S0959-437X(99)80003-3; Santelli E, 2005, J BIOL CHEM, V280, P34278, DOI 10.1074/jbc.M506707200; Schulman BA, 2000, NATURE, V408, P381, DOI 10.1038/35042620; Su YY, 2008, MOL CELL, V32, P652, DOI 10.1016/j.molcel.2008.10.023; Sun SR, 2007, BIOCHEM BIOPH RES CO, V356, P864, DOI 10.1016/j.bbrc.2007.03.080; Takeuchi K, 2006, CURR OPIN STRUC BIOL, V16, P109, DOI 10.1016/j.sbi.2006.01.006; Tang AH, 1997, CELL, V90, P459, DOI 10.1016/S0092-8674(00)80506-1; Tanikawa J, 2000, J BIOL CHEM, V275, P15578, DOI 10.1074/jbc.M000372200; Willert K, 2006, GENE DEV, V20, P1394, DOI 10.1101/gad.1424006; Winer IS, 2006, J BIOL CHEM, V281, P26181, DOI 10.1074/jbc.M604217200; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443; Zhang JS, 1998, GENE DEV, V12, P1775, DOI 10.1101/gad.12.12.1775; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a	49	67	68	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13507	13516		10.1074/jbc.M109.049411	http://dx.doi.org/10.1074/jbc.M109.049411			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20181957	hybrid, Green Published			2022-12-25	WOS:000276987700023
J	Soltoff, SP; Hedden, L				Soltoff, Stephen P.; Hedden, Lee			Isoproterenol and cAMP Block ERK Phosphorylation and Enhance [Ca2+](i) Increases and Oxygen Consumption by Muscarinic Receptor Stimulation in Rat Parotid and Submandibular Acinar Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; EPIDERMAL-GROWTH-FACTOR; SALIVARY SECRETION; K+-ATPASE; GLAND; CARBACHOL; PATHWAYS; EPAC; LINE; MECHANISMS	Salivary glands are innervated by sympathetic and parasympathetic neurons, which release neurotransmitters that promote fluid secretion and exocytosis when they bind to muscarinic and beta-adrenergic receptors, respectively. Signaling pathways downstream of these receptors are mainly distinct, but there is cross-talk that affects receptor-dependent events. Here we report that the beta-adrenergic ligand isoproterenol blocks increases in extracellular signal-related kinase (ERK) phosphorylation, a protein kinase C-dependent event promoted by the muscarinic receptor ligand carbachol in freshly dispersed rat parotid acinar cells. The inhibitory action of isoproterenol was reproduced by cAMP stimuli (forskolin) and mimetics (dibutyryl-cAMP, 8-(4-chlorophenylthio)-cAMP), including one highly selective for protein kinase A (N-6-benzoyl-cAMP). In contrast, Epac (exchange proteins directly activated by cAMP)selective activators did not mimic the blockade of ERK by isoproterenol, suggesting that inhibition involved protein kinase A. Isoproterenol also blocked ERK downstream of phorbol 12-myristate 13-acetate and the P2X(7) and epidermal growth factor receptors. Isoproterenol and forskolin blocked MEK phosphorylation, reduced RAF phosphorylation on a stimulatory site (Ser-338), and increased RAF phosphorylation on an inhibitory site (Ser-259). Inhibitory effects on ERK were also observed in freshly dispersed rat submandibular acinar cells but not in three immortalized/cancer salivary cell lines (Par-C10, HSY, HSG), indicating significant differences between native cells and cell lines. Notably, in native parotid cells isoproterenol enhanced the carbachol-promoted increases in [Ca2+](i) and oxygen consumption, events that initiate and accompany, respectively, the stimulation of fluid secretion by muscarinic ligands. Thus, isoproterenol produces opposite effects on prominent events downstream of the muscarinic receptor second messengers diacylglycerol (decrease in ERK phosphorylation) and inositol trisphosphate (increase in [Ca2+](i) and fluid secretion).	[Soltoff, Stephen P.; Hedden, Lee] Beth Israel Deaconess Med Ctr, Div Signal Transduct, Dept Med, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center	Soltoff, SP (corresponding author), Beth Israel Deaconess Med Ctr, Div Signal Transduct, Dept Med, 330 Brookline Ave,EC CLS 406, Boston, MA 02215 USA.	ssoltoff@bidmc.harvard.edu			National Institutes of Health (NIDCR) [DE-10877]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE010877] Funding Source: NIH RePORTER	National Institutes of Health (NIDCR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grant DE-10877 (NIDCR).	Beeram M, 2005, J CLIN ONCOL, V23, P6771, DOI 10.1200/JCO.2005.08.036; Benes C, 1998, J BIOL CHEM, V273, P15507, DOI 10.1074/jbc.273.25.15507; Benes C, 2001, AM J PHYSIOL-CELL PH, V280, pC1498, DOI 10.1152/ajpcell.2001.280.6.C1498; Betzenhauser MJ, 2009, J BIOL CHEM, V284, P25116, DOI 10.1074/jbc.M109.010132; BOBYOCK E, 1989, J DENT RES, V68, P1489, DOI 10.1177/00220345890680110401; Bockman CS, 2001, J PHARMACOL EXP THER, V297, P718; Bradford MD, 2002, BIOCHEM J, V366, P745, DOI 10.1042/BJ20020358; Bradford MD, 1998, EUR J MORPHOL, V36, P176; Bruce JIE, 2002, J BIOL CHEM, V277, P1340, DOI 10.1074/jbc.M106609200; Budd DC, 1999, MOL PHARMACOL, V56, P813; Cahalan MD, 2009, NAT CELL BIOL, V11, P669, DOI 10.1038/ncb0609-669; Chaudhuri A, 2007, AM J PHYSIOL-GASTR L, V292, pG1403, DOI 10.1152/ajpgi.00478.2005; Christensen AE, 2003, J BIOL CHEM, V278, P35394, DOI 10.1074/jbc.M302179200; DAI YS, 1991, AM J PHYSIOL, V261, pC1063, DOI 10.1152/ajpcell.1991.261.6.C1063; Dang H, 2008, DIFFERENTIATION, V76, P546, DOI 10.1111/j.1432-0436.2007.00251.x; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Dougherty MK, 2005, MOL CELL, V17, P215, DOI 10.1016/j.molcel.2004.11.055; Dumaz N, 2005, FEBS J, V272, P3491, DOI 10.1111/j.1742-4658.2005.04763.x; Dumaz N, 2003, J BIOL CHEM, V278, P29819, DOI 10.1074/jbc.C300182200; Enserink JM, 2002, NAT CELL BIOL, V4, P901, DOI 10.1038/ncb874; FULLER CM, 1984, J PHYSIOL-LONDON, V356, P335, DOI 10.1113/jphysiol.1984.sp015468; Gerits N, 2008, CELL SIGNAL, V20, P1592, DOI 10.1016/j.cellsig.2008.02.022; Handra-Luca A, 2003, AM J PATHOL, V163, P957, DOI 10.1016/S0002-9440(10)63455-4; Holz GG, 2006, J PHYSIOL-LONDON, V577, P5, DOI 10.1113/jphysiol.2006.119644; Kashimata M, 2000, DEV BIOL, V220, P183, DOI 10.1006/dbio.2000.9639; LANIYONU A, 1990, EUR J PHARM-MOLEC PH, V188, P171, DOI 10.1016/0922-4106(90)90052-Y; LARSSON O, 1989, ACTA PHYSIOL SCAND, V137, P231, DOI 10.1111/j.1748-1716.1989.tb08743.x; LEE KM, 1993, J BIOL CHEM, V268, P9945; Lefkimmiatis K, 2009, NAT CELL BIOL, V11, P433, DOI 10.1038/ncb1850; Lin AL, 2008, AM J PHYSIOL-CELL PH, V294, pC1454, DOI 10.1152/ajpcell.00151.2007; Luo JS, 2008, MOL PHARMACOL, V74, P338, DOI 10.1124/mol.107.044750; MARTIN SC, 1994, AM J PHYSIOL, V267, pC255, DOI 10.1152/ajpcell.1994.267.1.C255; MAZARIEGOS MR, 1984, J DENT RES, V63, P1102, DOI 10.1177/00220345840630090101; Melvin JE, 2005, ANNU REV PHYSIOL, V67, P445, DOI 10.1146/annurev.physiol.67.041703.084745; MURAKAMI M, 1990, J PHYSIOL-LONDON, V426, P127, DOI 10.1113/jphysiol.1990.sp018130; Nagy K, 2007, ACTA PHYSIOL HUNG, V94, P301, DOI 10.1556/APhysiol.94.2007.4.2; PAULAIS M, 1992, J BIOL CHEM, V267, P21558; Pisitkun T, 2008, AM J PHYSIOL-RENAL, V295, pF1030, DOI 10.1152/ajprenal.90339.2008; Plourde D, 2006, AM J PHYSIOL-CELL PH, V290, pC702, DOI 10.1152/ajpcell.00213.2005; Proctor GB, 2007, AUTON NEUROSCI-BASIC, V133, P3, DOI 10.1016/j.autneu.2006.10.006; Ryberg AT, 2008, ARCH ORAL BIOL, V53, P66, DOI 10.1016/j.archoralbio.2007.07.012; SCHNEYER CA, 1989, CELL TISSUE RES, V256, P361; SCHNEYER CA, 1962, AM J PHYSIOL, V203, P232, DOI 10.1152/ajplegacy.1962.203.2.232; Shimomura H, 2004, ARCH BIOCHEM BIOPHYS, V431, P124, DOI 10.1016/j.abb.2004.07.021; Soltoff SP, 2004, J BIOL CHEM, V279, P10910, DOI 10.1074/jbc.M305396200; SOLTOFF SP, 1989, J GEN PHYSIOL, V93, P285, DOI 10.1085/jgp.93.2.285; Soltoff SP, 2008, AM J PHYSIOL-CELL PH, V295, pC590, DOI 10.1152/ajpcell.00140.2008; Tanimura A, 1999, AM J PHYSIOL-CELL PH, V276, pC1282, DOI 10.1152/ajpcell.1999.276.6.C1282; Ten Hagen KG, 2002, PHYSIOL GENOMICS, V8, P107, DOI 10.1152/physiolgenomics.00039.2001; Turner JT, 1998, AM J PHYSIOL-CELL PH, V275, pC367, DOI 10.1152/ajpcell.1998.275.2.C367; WATSON EL, 1993, AM J PHYSIOL, V265, pC1061; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; Wu WS, 2006, CANCER LETT, V239, P27, DOI 10.1016/j.canlet.2005.07.034; Yamada K, 2006, PATHOBIOLOGY, V73, P1, DOI 10.1159/000093086; Yeh CK, 2005, AM J PHYSIOL-CELL PH, V288, pC1357, DOI 10.1152/ajpcell.00370.2004; Yoshimura K, 2000, J PHYSIOL-LONDON, V522, P403, DOI 10.1111/j.1469-7793.2000.t01-1-00403.x	56	22	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13337	13348		10.1074/jbc.M110.112094	http://dx.doi.org/10.1074/jbc.M110.112094			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20207737	hybrid, Green Published			2022-12-25	WOS:000276987700004
J	Yan, W; Cao, QJ; Arenas, RB; Bentley, B; Shao, R				Yan, Wei; Cao, Qing Jackie; Arenas, Richard B.; Bentley, Brooke; Shao, Rong			GATA3 Inhibits Breast Cancer Metastasis through the Reversal of Epithelial-Mesenchymal Transition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR GATA-3; E-CADHERIN EXPRESSION; LUMINAL CELL FATE; ESTROGEN-RECEPTOR; GENE-EXPRESSION; DNA-BINDING; TUMOR PROGRESSION; TH2 DEVELOPMENT; MAMMARY-GLAND; FACTOR SNAIL	GATA3, a transcription factor that regulates T lymphocyte differentiation and maturation, is exclusively expressed in early stage well differentiated breast cancers but not in advanced invasive cancers. However, little is understood regarding its activity and the mechanisms underlying this differential expression in cancers. Here, we employed GATA3-positive, non-invasive (MCF-7) and GATA3-negative, invasive (MDA-MB-231) breast cancer cells to define its role in the transformation between these two distinct phenotypes. Ectopic expression of GATA3 in MDA-MB-231 cells led to a cuboidal-like epithelial phenotype and reduced cell invasive activity. These cells also increased E-cadherin expression but decreased levels of vimentin, N-cadherin, and MMP-9. Further, MDA-MB-231 cells expressing GATA3 grew smaller primary tumors without metastasis compared with larger metastatic tumors derived from control MDA-MB-231 cells in xenografted mice. GATA3 was found to induce E-cadherin expression through binding GATA-like motifs located in the E-cadherin promoter. Blockade of GATA3 using small interfering RNA gene knockdown in MCF-7 cells triggered fibroblastic transformation and cell invasion, resulting in distant metastasis. Studies of human breast cancer showed that GATA3 expression correlated with elevated E-cadherin levels, ER expression, and long disease-free survival. These data suggest that GATA3 drives invasive breast cancer cells to undergo the reversal of epithelial-mesenchymal transition, leading to the suppression of cancer metastasis.	[Yan, Wei; Bentley, Brooke; Shao, Rong] Univ Massachusetts, Pioneer Valley Life Sci Inst, Springfield, MA 01107 USA; [Cao, Qing Jackie] Baystate Med Ctr, Dept Pathol, Springfield, MA 01199 USA; [Arenas, Richard B.] Baystate Med Ctr, Dept Surg, Springfield, MA 01199 USA; [Shao, Rong] Univ Massachusetts, Dept Vet & Anim Sci, Amherst, MA 01003 USA; [Shao, Rong] Univ Massachusetts, Program Mol & Cellular Biol, Morrill Sci Ctr, Amherst, MA 01003 USA	University of Massachusetts System; Baystate Medical Center; Baystate Medical Center; University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Shao, R (corresponding author), Univ Massachusetts Amherst, Pioneer Valley Life Sci Inst, Springfield, MA 01107 USA.	rong.shao@bhs.org			National Institutes of Health, NCI [R01 CA120659]; United States Department of Defense [W81XWH-06-01-0563]; NATIONAL CANCER INSTITUTE [R01CA120659] Funding Source: NIH RePORTER	National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); United States Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health, NCI, Grant R01 CA120659 (to R. S.). This work was also supported in part by United States Department of Defense Grant W81XWH-06-01-0563.	Asselin-Labat ML, 2007, NAT CELL BIOL, V9, P201, DOI 10.1038/ncb1530; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Bertucci F, 1999, ONCOGENE, V18, P3905, DOI 10.1038/sj.onc.1202731; Bertucci F, 2000, HUM MOL GENET, V9, P2981, DOI 10.1093/hmg/9.20.2981; Birchmeier C, 1996, ACTA ANAT, V156, P217; Boyer B, 1996, ACTA ANAT, V156, P227; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Cui W, 1996, CELL, V86, P531, DOI 10.1016/S0092-8674(00)80127-0; DeLeeuw WJF, 1997, J PATHOL, V183, P404, DOI 10.1002/(SICI)1096-9896(199712)183:4<404::AID-PATH1148>3.0.CO;2-9; Eastham AM, 2007, CANCER RES, V67, P11254, DOI 10.1158/0008-5472.CAN-07-2253; Eeckhoute J, 2007, CANCER RES, V67, P6477, DOI 10.1158/0008-5472.CAN-07-0746; Garcia-Closas M, 2007, CANCER EPIDEM BIOMAR, V16, P2269, DOI 10.1158/1055-9965.EPI-07-0449; Graff JR, 2000, J BIOL CHEM, V275, P2727, DOI 10.1074/jbc.275.4.2727; Hernandez-Hoyos G, 2003, IMMUNITY, V19, P83, DOI 10.1016/S1074-7613(03)00176-6; Hoch RV, 1999, INT J CANCER, V84, P122; Huber MA, 2004, J CLIN INVEST, V114, P569, DOI 10.1172/JCI200421358; Janda E, 2002, J CELL BIOL, V156, P299, DOI 10.1083/jcb.200109037; KO LJ, 1993, MOL CELL BIOL, V13, P4011, DOI 10.1128/MCB.13.7.4011; Kouros-Mehr H, 2008, CURR OPIN CELL BIOL, V20, P164, DOI 10.1016/j.ceb.2008.02.003; Kouros-Mehr H, 2008, CANCER CELL, V13, P141, DOI 10.1016/j.ccr.2008.01.011; Kouros-Mehr H, 2006, CELL, V127, P1041, DOI 10.1016/j.cell.2006.09.048; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mehra R, 2005, CANCER RES, V65, P11259, DOI 10.1158/0008-5472.CAN-05-2495; MERIKA M, 1993, MOL CELL BIOL, V13, P3999, DOI 10.1128/MCB.13.7.3999; Munshi HG, 2002, J BIOL CHEM, V277, P38159, DOI 10.1074/jbc.M202384200; Nass SJ, 2000, CANCER RES, V60, P4346; Nawrocki-Raby B, 2003, AM J PATHOL, V163, P653, DOI 10.1016/S0002-9440(10)63692-9; Nesbit MA, 2004, J BIOL CHEM, V279, P22624, DOI 10.1074/jbc.M401797200; Ouyang W, 1998, IMMUNITY, V9, P745, DOI 10.1016/S1074-7613(00)80671-8; Ouyang WJ, 2000, IMMUNITY, V12, P27, DOI 10.1016/S1074-7613(00)80156-9; Parikh P, 2005, J AM COLL SURGEONS, V200, P705, DOI 10.1016/j.jamcollsurg.2004.12.025; Patient RK, 2002, CURR OPIN GENET DEV, V12, P416, DOI 10.1016/S0959-437X(02)00319-2; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Putz E, 1999, CANCER RES, V59, P241; Ranganath S, 2001, MOL CELL BIOL, V21, P2716, DOI 10.1128/MCB.21.8.2716-2725.2001; Saito T, 2004, ONCOGENE, V23, P8629, DOI 10.1038/sj.onc.1207960; Savagner P, 2001, BIOESSAYS, V23, P912, DOI 10.1002/bies.1132; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thiery JP, 1999, CANCER METAST REV, V18, P31, DOI 10.1023/A:1006256219004; Thompson EW, 2005, CANCER RES, V65, P5991, DOI 10.1158/0008-5472.CAN-05-0616; Ting CN, 1996, NATURE, V384, P474, DOI 10.1038/384474a0; Usary J, 2004, ONCOGENE, V23, P7669, DOI 10.1038/sj.onc.1207966; Van Esch H, 2000, NATURE, V406, P419, DOI 10.1038/35019088; Voduc D, 2008, CANCER EPIDEM BIOMAR, V17, P365, DOI 10.1158/1055-9965.EPI-06-1090; Wheelock MJ, 2008, J CELL SCI, V121, P727, DOI 10.1242/jcs.000455; Yan W, 2006, J BIOL CHEM, V281, P19700, DOI 10.1074/jbc.M601856200; Yang GP, 1999, NUCLEIC ACIDS RES, V27, P1517, DOI 10.1093/nar/27.6.1517; YANG ZY, 1994, MOL CELL BIOL, V14, P2201, DOI 10.1128/MCB.14.3.2201; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8	50	147	153	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					14042	14051		10.1074/jbc.M110.105262	http://dx.doi.org/10.1074/jbc.M110.105262			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20189993	hybrid, Green Published			2022-12-25	WOS:000276987700077
J	Leeansyah, E; Zhou, JL; Paukovics, G; Lewin, SR; Crowe, SM; Jaworowski, A				Leeansyah, Edwin; Zhou, Jingling; Paukovics, Geza; Lewin, Sharon R.; Crowe, Suzanne M.; Jaworowski, Anthony			Decreased NK Cell FcR gamma in HIV-1 Infected Individuals Receiving Combination Antiretroviral Therapy: a Cross Sectional Study	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CD8 T-LYMPHOCYTES; HIV-1 INFECTION; IMMUNE ACTIVATION; SIGNALING CHAIN; ZETA MOLECULES; EXPRESSION; DEPLETION; CD3-ZETA; PHAGOCYTOSIS	Background: FcR gamma is an immunoreceptor tyrosine-based activation motif (ITAM)-signalling protein essential for immunoreceptor signaling and monocyte, macrophage and NK cell function. Previous study from our laboratory showed that FcR gamma is down-regulated in HIV-infected macrophages in vitro. FcR gamma expression in immune cells present in HIV-infected individuals is unknown. Methodology/Principal Findings: We compared FcR gamma expression in peripheral blood mononuclear cells isolated from HIV-1-infected individuals receiving combination antiretroviral therapy and healthy, HIV-1-uninfected individuals. FcR gamma mRNA and protein levels were measured using quantitative real-time PCR and immunoblotting, respectively. CD56(+) CD94(+) lymphocytes isolated from blood of HIV-1 infected individuals had reduced FcR gamma protein expression compared to HIV-uninfected individuals (decrease = 76.8%, n = 18 and n = 12 respectively, p = 0.0036). In a second group of patients, highly purified NK cells had reduced FcR gamma protein expression compared to uninfected controls (decrease = 50.2%, n = 9 and n = 8 respectively, p = 0.021). Decreased FcR gamma expression in CD56(+) CD94(+) lymphocytes was associated with reduced mRNA (51.7%, p = 0.021) but this was not observed for the smaller group of patients analysed for NK cell expression (p = 0.36). Conclusion/Significance: These data suggest biochemical defects in ITAM-dependent signalling within NK cells in HIV-infected individuals which is present in the context of treatment with combination antiretroviral therapy.	[Leeansyah, Edwin; Zhou, Jingling; Paukovics, Geza; Lewin, Sharon R.; Crowe, Suzanne M.; Jaworowski, Anthony] Macfarlane Burnet Inst Med Res & Publ Hlth, Ctr Virol, Melbourne, Vic, Australia; [Leeansyah, Edwin; Lewin, Sharon R.; Crowe, Suzanne M.; Jaworowski, Anthony] Monash Univ, Dept Med, Melbourne, Vic 3004, Australia; [Lewin, Sharon R.] Monash Univ, Alfred Hosp, Infect Dis Unit, Melbourne, Vic 3181, Australia	Burnet Institute; Monash University; Florey Institute of Neuroscience & Mental Health; Monash University	Leeansyah, E (corresponding author), Macfarlane Burnet Inst Med Res & Publ Hlth, Ctr Virol, Melbourne, Vic, Australia.	anthonyj@burnet.edu.au	Lewin, Sharon/Z-3297-2019; Leeansyah, Edwin/J-1017-2019	Leeansyah, Edwin/0000-0003-0505-4967; Lewin, Sharon Ruth/0000-0002-0330-8241; jaworowski, anthony/0000-0002-3844-805X	National Health and Medical Research Council (NHMRC) [358399, 543137]; Australian Postgraduate Award; NHMRC	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Postgraduate Award(Australian Government); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the National Health and Medical Research Council (NHMRC) Grants 358399 and 543137. EL was a recipient of an Australian Postgraduate Award and SMC is of an NHMRC Principal Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram C.L., 2007, SCI STKE, V2007, pre2; Alter G, 2005, BLOOD, V106, P3366, DOI 10.1182/blood-2005-03-1100; Alter G, 2004, J IMMUNOL, V173, P5305, DOI 10.4049/jimmunol.173.8.5305; Arase H, 2001, J IMMUNOL, V166, P21, DOI 10.4049/jimmunol.166.1.21; Arase N, 1997, J EXP MED, V186, P1957, DOI 10.1084/jem.186.12.1957; Baniyash M, 2004, NAT REV IMMUNOL, V4, P675, DOI 10.1038/nri1434; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; FAHEY JL, 1990, NEW ENGL J MED, V322, P166, DOI 10.1056/NEJM199001183220305; French MA, 2009, J INFECT DIS, V200, P1212, DOI 10.1086/605890; Geertsma MF, 1999, J INFECT DIS, V180, P649, DOI 10.1086/314941; Geertsma MF, 1999, FEMS IMMUNOL MED MIC, V26, P249, DOI 10.1016/S0928-8244(99)00151-0; Giorgi JV, 1999, J INFECT DIS, V179, P859, DOI 10.1086/314660; Gomez G, 2005, J IMMUNOL, V174, P5987, DOI 10.4049/jimmunol.174.10.5987; Guadalupe M, 2003, J VIROL, V77, P11708, DOI 10.1128/JVI.77.21.11708-11717.2003; HIBBS ML, 1989, SCIENCE, V246, P1608, DOI 10.1126/science.2531918; Hunt PW, 2003, J INFECT DIS, V187, P1534, DOI 10.1086/374786; Juang YT, 2007, J IMMUNOL, V179, P4884, DOI 10.4049/jimmunol.179.7.4884; Kedzierska K, 2002, J IMMUNOL, V168, P2895, DOI 10.4049/jimmunol.168.6.2895; Leeansyah E, 2007, J IMMUNOL, V178, P1096, DOI 10.4049/jimmunol.178.2.1096; Mavilio D, 2005, P NATL ACAD SCI USA, V102, P2886, DOI 10.1073/pnas.0409872102; Mavilio D, 2003, P NATL ACAD SCI USA, V100, P15011, DOI 10.1073/pnas.2336091100; Mehandru S, 2004, J EXP MED, V200, P761, DOI 10.1084/jem.20041196; Park SY, 1998, J CLIN INVEST, V102, P1229, DOI 10.1172/JCI3256; Rellahan BL, 1998, J IMMUNOL, V160, P2794; Solomon A, 2003, J INFECT DIS, V187, P1915, DOI 10.1086/375351; TAKAI T, 1994, CELL, V76, P519, DOI 10.1016/0092-8674(94)90115-5; Tarazona R, 2002, J CLIN IMMUNOL, V22, P176, DOI 10.1023/A:1015476114409; Tridandapani S, 2003, J IMMUNOL, V170, P4572, DOI 10.4049/jimmunol.170.9.4572; Trimble LA, 2000, J VIROL, V74, P7320, DOI 10.1128/JVI.74.16.7320-7330.2000; Trimble LA, 1998, BLOOD, V91, P585, DOI 10.1182/blood.V91.2.585.585_585_594	30	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2010	5	3							e9643	10.1371/journal.pone.0009643	http://dx.doi.org/10.1371/journal.pone.0009643			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565XE	20224795	Green Published, gold			2022-12-25	WOS:000275328800034
J	McDonald, RI; Forman, RTT; Kareiva, P				McDonald, Robert I.; Forman, Richard T. T.; Kareiva, Peter			Open Space Loss and Land Inequality in United States' Cities, 1990-2000	PLOS ONE			English	Article							PROTECTED AREAS; URBAN SPRAWL; SMART GROWTH; URBANIZATION; FUTURE; COVER	Urban growth reduces open space in and around cities, impacting biodiversity and ecosystem services. Using land-cover and population data, we examined land consumption and open space loss between 1990 and 2000 for all 274 metropolitan areas in the contiguous United States. Nationally, 1.4 million ha of open space was lost, and the amount lost in a given city was correlated with population growth (r(272) = 0.85, P < 0.001). In 2000, cities varied in per capita land consumption by an order of magnitude, from 459 m(2)/person in New York to 5393 m(2)/person in Grand Forks, ND. The per capita land consumption (m(2)/person) of most cities decreased on average over the decade from 1,564 to 1,454 m(2)/person, but there was substantial regional variation and some cities even increased. Cities with greater conservation funding or more reformminded zoning tended to decrease in per capita land consumption more than other cities. The majority of developed area in cities is in low-density neighborhoods housing a small proportion of urban residents, with Gini coefficients that quantify this developed land inequality averaging 0.63. Our results suggest conservation funding and reform-minded zoning decrease per capita open space loss.	[McDonald, Robert I.] Nature Conservancy, Worldwide Off, Arlington, VA USA; [Forman, Richard T. T.] Harvard Univ, Grad Sch Design, Cambridge, MA 02138 USA; [Kareiva, Peter] Nature Conservancy, Seattle Off, Seattle, WA USA	Nature Conservancy; Harvard University; Nature Conservancy	McDonald, RI (corresponding author), Nature Conservancy, Worldwide Off, 1815 N Lynn St, Arlington, VA USA.	rob_mcdonald@TNC.ORG		McDonald, Robert/0000-0002-7273-6549	Nature Conservancy; D. H. Smith Fellowship; Harvard University	Nature Conservancy; D. H. Smith Fellowship; Harvard University	The authors were financially supported by The Nature Conservancy (R. I. M., P. K.), the D. H. Smith Fellowship (R. I. M.) and Harvard University (R. T. T. F.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1976, LAND USE LAND COVER; [Anonymous], 2000, FED REG, V65, P82228; Brown DG, 2006, ECOL SOC, V11; Calthorpe P., 1993, NEXT AM METROPOLIS E; Danielsen KA, 1999, HOUS POLICY DEBATE, V10, P513; Duany A., 2000, SUBURBAN NATION RISE; Forman R. T. T., 2008, URBAN REGIONS ECOLOG, V1th; Fulton W., 2001, WHO SPRAWLS MOST GRO; Gini C., 1921, ECON J, V31, P124, DOI [10.2307/2223319, DOI 10.2307/2223319]; Grimm NB, 2008, SCIENCE, V319, P756, DOI 10.1126/science.1150195; Handy S, 2005, INT REGIONAL SCI REV, V28, P146, DOI 10.1177/0160017604273626; Hansen AJ, 2007, ECOL APPL, V17, P974, DOI 10.1890/05-1098; Hobbs F, 2002, CENSR4 US CENS BUR; Irwin EG, 2007, P NATL ACAD SCI USA, V104, P20672, DOI 10.1073/pnas.0705527105; Jackson K., 1985, CRABGRASS FRONTIER; Kenworthy JR, 1999, TRANSPORT RES A-POL, V33, P691, DOI 10.1016/S0965-8564(99)00006-3; Luck GW, 2007, BIOL REV, V82, P607, DOI 10.1111/j.1469-185X.2007.00028.x; MacDonald K, 2005, APPL GEOGR, V25, P67, DOI 10.1016/j.apgeog.2004.07.001; Mcdonald RI, 2008, BIOL CONSERV, V141, P1695, DOI 10.1016/j.biocon.2008.04.025; McDonald RI, 2008, FRONT ECOL ENVIRON, V6, P99, DOI 10.1890/070038; McDonald RI, 2006, BIOL INVASIONS, V8, P1049, DOI 10.1007/s10530-005-5227-5; Pendall Rolf, 2006, TRADITIONAL REFORMED; PISARSKI, 2006, COMMUTING AM, V3; Porter D., 2002, MAKING SMART GROWTH; Radeloff VC, 2005, ECOL APPL, V15, P799, DOI 10.1890/04-1413; Talen Emily., 2005, NEW URBANISM AM PLAN; Theobald D.M., 2005, ECOL SOC, V10, P34, DOI [10.5751/ES-01390-100132, DOI 10.5751/ES-01390-100132]; Theobald DM, 2001, GEOGR REV, V91, P544, DOI 10.2307/3594740; Walker R, 2001, ECOL ECON, V37, P357, DOI 10.1016/S0921-8009(01)00178-1	29	48	49	3	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2010	5	3							e9509	10.1371/journal.pone.0009509	http://dx.doi.org/10.1371/journal.pone.0009509			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	562OZ	20209082	gold, Green Published, Green Submitted			2022-12-25	WOS:000275063400015
J	Latif, R; Michalek, K; Morshed, SA; Davies, TF				Latif, Rauf; Michalek, Krzysztof; Morshed, Syed Ahmed; Davies, Terry F.			A Tyrosine Residue on the TSH Receptor Stabilizes Multimer Formation	PLOS ONE			English	Article							HUMAN THYROTROPIN RECEPTOR; PROTEIN-COUPLED RECEPTORS; NEGATIVE COOPERATIVITY; STIMULATING-HORMONE; LIPID RAFTS; OLIGOMERIZATION; COMPLEX; ECTODOMAIN; AUTOANTIBODIES; DIMERIZATION	Background: The thyrotropin stimulating hormone receptor (TSHR) is a G protein coupled receptor (GPCR) with a large ectodomain. The ligand, TSH, acting via this receptor regulates thyroid growth and thyroid hormone production and secretion. The TSH receptor (TSHR) undergoes complex post -translational modifications including intramolecular cleavage and receptor multimerization. Since monomeric and multimeric receptors coexist in cells, understanding the functional role of just the TSHR multimers is difficult. Therefore, to help understand the physiological significance of receptor multimerization, it will be necessary to abrogate multimer formation, which requires identifying the ectodomain and endodomain interaction sites on the TSHR. Here, we have examined the contribution of the ectodomain to constitutive multimerization of the TSHR and determined the possible residue(s) that may be involved in this interaction. Methodology/Principal Findings: We studied ectodomain multimer formation by expressing the extracellular domain of the TSHR linked to a glycophosphotidyl (GPI) anchor in both stable and transient expression systems. Using co-immunoprecipitation and FRET of tagged receptors, we established that the TSH receptor ectodomain was capable of multimerization even when totally devoid of the transmembrane domain. Further, we studied the effect of two residues that likely made critical contact points in this interaction. We showed that a conserved tyrosine residue (Y116) on the convex surface of the LRR3 was a critical residue in ectodomain multimer formation since mutation of this residue to serine totally abrogated ectodomain multimers. This abrogation was not seen with the mutation of cysteine 176 on the inner side of the LRR5, demonstrating that inter-receptor disulfide bonding was not involved in ectodomain multimer formation. Additionally, the Y116 mutation in the intact wild type receptor enhanced receptor degradation. Conclusions/Significance: These data establish the TSH receptor ectodomain as one site of multimerization, independent of the transmembrane region, and that this interaction was primarily via a conserved tyrosine residue in LRR3.	[Latif, Rauf; Michalek, Krzysztof; Morshed, Syed Ahmed; Davies, Terry F.] Mt Sinai Sch Med, James J Peters VA Med Ctr, Thyroid Res Unit, New York, NY 10029 USA; [Michalek, Krzysztof] Poznan Univ Med Sci, Dept Endocrinol Metab & Internal Dis, Poznan, Poland	Icahn School of Medicine at Mount Sinai; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; Poznan University of Medical Sciences	Latif, R (corresponding author), Mt Sinai Sch Med, James J Peters VA Med Ctr, Thyroid Res Unit, New York, NY 10029 USA.	rauf.latif@mssm.edu	latif, rauf/AAR-1634-2020; Latif, Rauf/ABH-4394-2020	Latif, Rauf/0000-0002-4226-3728	National Institutes of Health (NIH) [DK069713, DK052464]; VA Merit Award program; David Owen Segal Endowment; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052464, R01DK069713] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Merit Award program; David Owen Segal Endowment; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	National Institutes of Health (NIH) grants DK069713, DK052464, the VA Merit Award program (TFD) and the David Owen Segal Endowment (to KM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando T, 2007, J ENDOCRINOL, V195, P179, DOI 10.1677/JOE-07-0058; BDALLA S, 1999, J BIOL CHEM, V274, P26079; Bouvier M, 2001, NAT REV NEUROSCI, V2, P274, DOI 10.1038/35067575; Breitwieser GE, 2004, CIRC RES, V94, P17, DOI 10.1161/01.RES.0000110420.68526.19; Calebiro D, 2005, HUM MOL GENET, V14, P2991, DOI 10.1093/hmg/ddi329; Chazenbalk GD, 1997, ENDOCRINOLOGY, V138, P2893, DOI 10.1210/en.138.7.2893; Chazenbalk GD, 1996, ENDOCRINOLOGY, V137, P4586, DOI 10.1210/en.137.11.4586; Costa MJ, 2004, ENDOCRINOLOGY, V145, P1464, DOI 10.1210/en.2003-1432; Couet J, 1996, J BIOL CHEM, V271, P4545; Da Costa CR, 1998, J BIOL CHEM, V273, P11874, DOI 10.1074/jbc.273.19.11874; Davies T, 2002, J CLIN INVEST, V110, P161, DOI 10.1172/JCI200216234; Davies TF, 2005, J CLIN INVEST, V115, P1972, DOI 10.1172/JCI26031; de Bernard S, 1999, J BIOL CHEM, V274, P101, DOI 10.1074/jbc.274.1.101; DE MP, 1976, J SUPRAMOL STRUCT, V4, P241; Devi LA, 2000, TRENDS PHARMACOL SCI, V21, P324, DOI 10.1016/S0165-6147(00)01519-4; DOHLMAN HG, 1990, BIOCHEMISTRY-US, V29, P2335, DOI 10.1021/bi00461a018; Fan QR, 2005, NATURE, V433, P269, DOI 10.1038/nature03206; Fanelli F, 2007, MOL CELL ENDOCRINOL, V260, P59, DOI 10.1016/j.mce.2005.12.054; Filizola M, 2002, PROTEIN ENG, V15, P881, DOI 10.1093/protein/15.11.881; Filizola M, 2005, FEBS J, V272, P2926, DOI 10.1111/j.1742-4658.2005.04730.x; Gama Lucio, 2002, Methods Mol Biol, V182, P77; Graves PN, 1996, ENDOCRINOLOGY, V137, P3915, DOI 10.1210/en.137.9.3915; Guan RB, 2010, CELL SIGNAL, V22, P247, DOI 10.1016/j.cellsig.2009.09.023; Gurevich VV, 2008, TRENDS NEUROSCI, V31, P74, DOI 10.1016/j.tins.2007.11.007; Hebert TE, 1998, BIOCHEM CELL BIOL, V76, P1, DOI 10.1139/bcb-76-1-1; Kaezur V, 2007, J MOL RECOGNIT, V20, P392, DOI 10.1002/jmr.851; Latif R, 2007, ENDOCRINOLOGY, V148, P3164, DOI 10.1210/en.2006-1580; Latif R, 2001, J BIOL CHEM, V276, P45217, DOI 10.1074/jbc.M103727200; LATIF R, 2002, J BIOL CHEM; Lewandowicz AM, 2006, BRIT J PHARMACOL, V147, P422, DOI 10.1038/sj.bjp.0706624; MICAHALEK K, 2008, END SOC M; Oda Y, 1998, J MOL ENDOCRINOL, V20, P233, DOI 10.1677/jme.0.0200233; Periasamy A, 2001, J BIOMED OPT, V6, P287, DOI 10.1117/1.1383063; Persani L, 2007, NAT CLIN PRACT ENDOC, V3, P180, DOI 10.1038/ncpendmet0401; Puett D, 2007, MOL CELL ENDOCRINOL, V260, P126, DOI 10.1016/j.mce.2006.05.009; Rapoport B, 1998, ENDOCR REV, V19, P673, DOI 10.1210/er.19.6.673; Roess DA, 2000, ENDOCRINOLOGY, V141, P4518, DOI 10.1210/en.141.12.4518; Sanders J, 2007, THYROID, V17, P395, DOI 10.1089/thy.2007.0034; Szidonya L, 2008, J ENDOCRINOL, V196, P435, DOI 10.1677/JOE-07-0573; Szkudlinski MW, 2002, PHYSIOL REV, V82, P473, DOI 10.1152/physrev.00031.2001; Urizar E, 2005, EMBO J, V24, P1954, DOI 10.1038/sj.emboj.7600686; VAN DJ, 2006, MOL ENDOCRINOL, V20, P2247; VASSART G, 1992, ENDOCR REV, V13, P596, DOI 10.1210/er.13.3.596	43	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2010	5	2							e9449	10.1371/journal.pone.0009449	http://dx.doi.org/10.1371/journal.pone.0009449			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	561RS	20195479	Green Published, Green Submitted, gold			2022-12-25	WOS:000274997000015
J	Mitsuya, S; El-Shami, M; Sparkes, IA; Charlton, WL; Lousa, CD; Johnson, B; Baker, A				Mitsuya, Shiro; El-Shami, Mahmoud; Sparkes, Imogen A.; Charlton, Wayne L.; Lousa, Carine De Marcos; Johnson, Barbara; Baker, Alison			Salt Stress Causes Peroxisome Proliferation, but Inducing Peroxisome Proliferation Does Not Improve NaCl Tolerance in Arabidopsis thaliana	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; SIGNAL-TRANSDUCTION; PLANT PEROXISOMES; MEMBRANE-PROTEIN; TOBACCO PLANTS; PEA-PLANTS; EXPRESSION; JASMONATE; DIVISION	The PEX11 family of peroxisome membrane proteins have been shown to be involved in regulation of peroxisome size and number in plant, animals, and yeast cells. We and others have previously suggested that peroxisome proliferation as a result of abiotic stress may be important in plant stress responses, and recently it was reported that several rice PEX11 genes were up regulated in response to abiotic stress. We sought to test the hypothesis that promoting peroxisome proliferation in Arabidopsis thaliana by over expression of one PEX11 family member, PEX11e, would give increased resistance to salt stress. We could demonstrate up regulation of PEX11e by salt stress and increased peroxisome number by both PEX11e over expression and salt stress, however our experiments failed to find a correlation between PEX11e over expression and increased peroxisome metabolic activity or resistance to salt stress. This suggests that although peroxisome proliferation may be a consequence of salt stress, it does not affect the ability of Arabidopsis plants to tolerate saline conditions.	[Mitsuya, Shiro; El-Shami, Mahmoud; Sparkes, Imogen A.; Charlton, Wayne L.; Lousa, Carine De Marcos; Johnson, Barbara; Baker, Alison] Univ Leeds, Ctr Plant Sci, Leeds, W Yorkshire, England	University of Leeds	Mitsuya, S (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan.	a.baker@leeds.ac.uk		De Marcos Lousa, Carine/0000-0002-5041-6261; Baker, Alison/0000-0003-2181-4057	Biotechnology and Biological Sciences Research Council (United Kingdom) [24/P13265]; Japan Society for Promotion of Science [20780011];  [JPA1811]; BBSRC [BB/D524875/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D524875/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (United Kingdom)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); ; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors acknowledge financial support from the Biotechnology and Biological Sciences Research Council (United Kingdom) (www.bbsrc.ac.uk), grant number 24/P13265, and Japan partnering award JPA1811. SM acknowledges the support of the grant 'KAKENHI (20780011)' from the Japan Society for Promotion of Science (http://www.jsps.go.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker A, 2006, TRENDS PLANT SCI, V11, P124, DOI 10.1016/j.tplants.2006.01.005; Brown LA, 2008, MOL MEMBR BIOL, V25, P363, DOI 10.1080/09687680802130583; Charlton WL, 2005, PLANT CELL ENVIRON, V28, P513, DOI 10.1111/j.1365-3040.2004.01293.x; Chini A, 2007, NATURE, V448, P666, DOI 10.1038/nature06006; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; CORPAS FJ, 1993, J PLANT PHYSL, V141; Cutler SR, 2000, P NATL ACAD SCI USA, V97, P3718, DOI 10.1073/pnas.97.7.3718; DEFELIPE MR, 1988, J PLANT PHYSIOL, V132, P67, DOI 10.1016/S0176-1617(88)80185-8; del Rio LA, 2006, PLANT PHYSIOL, V141, P330, DOI 10.1104/pp.106.078204; Desai M, 2008, PLANT PHYSIOL, V146, P1117, DOI 10.1104/pp.107.113555; Dietrich D, 2009, MOL BIOL CELL, V20, P530, DOI 10.1091/mbc.E08-07-0745; ERDMANN R, 1995, J CELL BIOL, V128, P509, DOI 10.1083/jcb.128.4.509; Fagarasanu A, 2007, ANNU REV CELL DEV BI, V23, P321, DOI 10.1146/annurev.cellbio.23.090506.123456; Favaro R, 2003, PLANT CELL, V15, P2603, DOI 10.1105/tpc.015123; FERREIRA RMB, 1989, J EXP BOT, V40, P1029, DOI 10.1093/jxb/40.9.1029; Finkelstein RR, 2000, PLANT CELL, V12, P599, DOI 10.1105/tpc.12.4.599; GIRAUDAT J, 1992, PLANT CELL, V4, P1251, DOI 10.1105/tpc.4.10.1251; Gurvitz A, 2006, BBA-MOL CELL RES, V1763, P1392, DOI 10.1016/j.bbamcr.2006.07.011; HESS R, 1965, NATURE, V208, P856, DOI 10.1038/208856a0; Himmelbach A, 2003, CURR OPIN PLANT BIOL, V6, P470, DOI 10.1016/S1369-5266(03)00090-6; Hoepfner D, 2005, CELL, V122, P85, DOI 10.1016/j.cell.2005.04.025; HOFGEN R, 1988, NUCLEIC ACIDS RES, V16, P9877, DOI 10.1093/nar/16.20.9877; Hu JP, 2007, J INTEGR PLANT BIOL, V49, P1112, DOI 10.1111/j.1672-9072.2007.00537.x; Kim PK, 2006, J CELL BIOL, V173, P521, DOI 10.1083/jcb.200601036; Kishitani S, 2000, PLANT CELL ENVIRON, V23, P107, DOI 10.1046/j.1365-3040.2000.00527.x; Kobayashi S, 2007, EXP CELL RES, V313, P1675, DOI 10.1016/j.yexcr.2007.02.028; Leung J, 1997, PLANT CELL, V9, P759, DOI 10.1105/tpc.9.5.759; Li XL, 2003, J BIOL CHEM, V278, P17012, DOI 10.1074/jbc.M212031200; Li XL, 2002, MOL CELL BIOL, V22, P4358, DOI 10.1128/MCB.22.12.4358-4365.2002; Li XL, 2002, MOL CELL BIOL, V22, P8226, DOI 10.1128/MCB.22.23.8226-8240.2002; Li YJ, 2009, PLANT BREEDING, V128, P404, DOI 10.1111/j.1439-0523.2008.01593.x; Lingard MJ, 2008, PLANT CELL, V20, P1567, DOI 10.1105/tpc.107.057679; Lingard MJ, 2006, J CELL SCI, V119, P1961, DOI 10.1242/jcs.02904; Lorenzo O, 2004, PLANT CELL, V16, P1938, DOI 10.1105/tpc.022319; Mano S, 2004, PLANT J, V38, P487, DOI 10.1111/j.1365-313X.2004.02063.x; Marshall PA, 1996, J CELL BIOL, V135, P123, DOI 10.1083/jcb.135.1.123; MARSHALL PA, 1995, J CELL BIOL, V129, P345, DOI 10.1083/jcb.129.2.345; McCarthy I, 2001, PLANT CELL ENVIRON, V24, P1065, DOI 10.1046/j.1365-3040.2001.00750.x; MORRE DJ, 1990, PROTOPLASMA, V155, P58, DOI 10.1007/BF01322615; Mullen RT, 2006, BBA-MOL CELL RES, V1763, P1655, DOI 10.1016/j.bbamcr.2006.09.011; NAMBARA E, 1992, PLANT J, V2, P435, DOI 10.1111/j.1365-313X.1992.00435.x; Nayidu NK, 2008, GENE, V412, P59, DOI 10.1016/j.gene.2008.01.006; Nito K, 2007, PLANT CELL PHYSIOL, V48, P763, DOI 10.1093/pcp/pcm053; Nyathi Y, 2006, BBA-MOL CELL RES, V1763, P1478, DOI 10.1016/j.bbamcr.2006.08.031; Oksanen E, 2004, NEW PHYTOL, V161, P791, DOI 10.1111/j.1469-8137.2003.00981.x; Orth T, 2007, PLANT CELL, V19, P333, DOI 10.1105/tpc.106.045831; PALMA JM, 1987, PLANT PHYSIOL, V85, P570, DOI 10.1104/pp.85.2.570; PALMA JM, 1991, ARCH BIOCHEM BIOPHYS, V287, P68, DOI 10.1016/0003-9861(91)90389-Z; Rahim G, 2009, J EXP BOT, V60, P257, DOI 10.1093/jxb/ern283; Rottensteiner H, 2003, MOL BIOL CELL, V14, P4316, DOI 10.1091/mbc.E03-03-0153; Rouster J, 1997, PLANT J, V11, P513, DOI 10.1046/j.1365-313X.1997.11030513.x; Schrader M, 1998, J BIOL CHEM, V273, P29607, DOI 10.1074/jbc.273.45.29607; Schrader M, 2006, BBA-MOL CELL RES, V1763, P531, DOI 10.1016/j.bbamcr.2006.01.004; Seki M, 2002, PLANT J, V31, P279, DOI 10.1046/j.1365-313X.2002.01359.x; Sparkes IA, 2005, PLANT PHYSIOL, V139, P690, DOI 10.1104/pp.105.065094; Sparkes IA, 2006, NAT PROTOC, V1, P2019, DOI 10.1038/nprot.2006.286; Staswick PE, 2004, PLANT CELL, V16, P2117, DOI 10.1105/tpc.104.023549; Staswick PE, 2002, PLANT CELL, V14, P1405, DOI 10.1105/tpc.000885; Tam YYC, 2005, J BIOL CHEM, V280, P34933, DOI 10.1074/jbc.M506208200; Tam YYC, 2003, MOL BIOL CELL, V14, P4089, DOI 10.1091/mbc.E03-03-0150; Thines B, 2007, NATURE, V448, P661, DOI 10.1038/nature05960; Thoms S, 2005, FEBS J, V272, P5169, DOI 10.1111/j.1742-4658.2005.04939.x; Tugal HB, 1999, PLANT PHYSIOL, V120, P309, DOI 10.1104/pp.120.1.309; van der Klei IJ, 2006, BBA-MOL CELL RES, V1763, P1453, DOI 10.1016/j.bbamcr.2006.07.016; Vizeacoumar FJ, 2004, MOL BIOL CELL, V15, P665, DOI 10.1091/mbc.E03-09-0681; Vizeacoumar FJ, 2003, J CELL BIOL, V161, P321, DOI 10.1083/jcb.200210130; Zhang XC, 2008, MOL PLANT, V1, P1036, DOI 10.1093/mp/ssn056; Zhang XC, 2009, PLANT J, V57, P146, DOI 10.1111/j.1365-313X.2008.03677.x; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367	70	38	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2010	5	2							e9408	10.1371/journal.pone.0009408	http://dx.doi.org/10.1371/journal.pone.0009408			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SX	20195524	Green Published, gold			2022-12-25	WOS:000274924200028
J	Miyamoto-Sato, E; Fujimori, S; Ishizaka, M; Hirai, N; Masuoka, K; Saito, R; Ozawa, Y; Hino, K; Washio, T; Tomita, M; Yamashita, T; Oshikubo, T; Akasaka, H; Sugiyama, J; Matsumoto, Y; Yanagawa, H				Miyamoto-Sato, Etsuko; Fujimori, Shigeo; Ishizaka, Masamichi; Hirai, Naoya; Masuoka, Kazuyo; Saito, Rintaro; Ozawa, Yosuke; Hino, Katsuya; Washio, Takanori; Tomita, Masaru; Yamashita, Tatsuhiro; Oshikubo, Tomohiro; Akasaka, Hidetoshi; Sugiyama, Jun; Matsumoto, Yasuo; Yanagawa, Hiroshi			A Comprehensive Resource of Interacting Protein Regions for Refining Human Transcription Factor Networks	PLOS ONE			English	Article							IN-VITRO SELECTION; FUNCTIONAL-ANALYSIS; INTRINSIC DISORDER; BINDING PROTEINS; INTERACTION MAP; HUB PROTEINS; C-ELEGANS; TGF-BETA; YEAST; COMPLEXES	Large-scale data sets of protein-protein interactions (PPIs) are a valuable resource for mapping and analysis of the topological and dynamic features of interactome networks. The currently available large-scale PPI data sets only contain information on interaction partners. The data presented in this study also include the sequences involved in the interactions (i.e., the interacting regions, IRs) suggested to correspond to functional and structural domains. Here we present the first large-scale IR data set obtained using mRNA display for 50 human transcription factors (TFs), including 12 transcription-related proteins. The core data set (966 IRs; 943 PPIs) displays a verification rate of 70%. Analysis of the IR data set revealed the existence of IRs that interact with multiple partners. Furthermore, these IRs were preferentially associated with intrinsic disorder. This finding supports the hypothesis that intrinsically disordered regions play a major role in the dynamics and diversity of TF networks through their ability to structurally adapt to and bind with multiple partners. Accordingly, this domain-based interaction resource represents an important step in refining protein interactions and networks at the domain level and in associating network analysis with biological structure and function.	[Miyamoto-Sato, Etsuko; Fujimori, Shigeo; Hirai, Naoya; Masuoka, Kazuyo; Hino, Katsuya; Yanagawa, Hiroshi] Keio Univ, Adv Res Ctr, Yokohama, Kanagawa 223, Japan; [Miyamoto-Sato, Etsuko; Ishizaka, Masamichi; Hino, Katsuya; Washio, Takanori; Yamashita, Tatsuhiro; Oshikubo, Tomohiro; Akasaka, Hidetoshi; Sugiyama, Jun; Matsumoto, Yasuo; Yanagawa, Hiroshi] Keio Univ, Fac Sci & Technol, Dept Biosci & Informat, Yokohama, Kanagawa 223, Japan; [Saito, Rintaro; Tomita, Masaru] Keio Univ, Dept Environm & Informat Studies, Fujisawa, Kanagawa, Japan; [Ozawa, Yosuke] Keio Univ, Grad Sch Media & Governance, Syst Biol Program, Fujisawa, Kanagawa, Japan; [Yamashita, Tatsuhiro] Fujitsu Ltd, BioIT Business Dev Unit, Chiba, Japan; [Oshikubo, Tomohiro; Akasaka, Hidetoshi] Fujitsu Adv Engn Ltd, Solut & Serv Dept, Prod Solut Div, Prod Solut Business Unit, Tokyo, Japan; [Sugiyama, Jun] Invitrogen Japan KK, Haneda Labs, Custom Primer Prod Dept, Special Suite Team, Tokyo, Japan; [Matsumoto, Yasuo] QIAGEN KK, Tokyo, Japan	Keio University; Keio University; Keio University; Keio University; Fujitsu Ltd; Fujitsu Ltd	Miyamoto-Sato, E (corresponding author), Keio Univ, Adv Res Ctr, Yokohama, Kanagawa 223, Japan.	nekoneko@educ.cc.keio.ac.jp; hyana@bio.keio.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Funding was received from the Genome Network Project of the Ministry of Education, Culture, Sports, Science and Technology, Japan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There is no other funder in the study.	Bader GD, 2002, NAT BIOTECHNOL, V20, P991, DOI 10.1038/nbt1002-991; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barrios-Rodiles M, 2005, SCIENCE, V307, P1621, DOI 10.1126/science.1105776; Boxem M, 2008, CELL, V134, P534, DOI 10.1016/j.cell.2008.07.009; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Chen L, 1998, NATURE, V392, P42, DOI 10.1038/32100; Chinenov Y, 2001, ONCOGENE, V20, P2438, DOI 10.1038/sj.onc.1204385; Dosztanyi Z, 2006, J PROTEOME RES, V5, P2985, DOI 10.1021/pr060171o; Dunker AK, 2001, NAT BIOTECHNOL, V19, P805, DOI 10.1038/nbt0901-805; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Ewing RM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100134; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; FromontRacine M, 1997, NAT GENET, V16, P277, DOI 10.1038/ng0797-277; Garza AS, 2009, LIFE SCI, V84, P189, DOI 10.1016/j.lfs.2008.12.002; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Graham DL, 2002, CHEM BIOL, V9, P375, DOI 10.1016/S1074-5521(02)00112-6; Guglielmi B, 2004, NUCLEIC ACIDS RES, V32, P5379, DOI 10.1093/nar/gkh878; Hakes L, 2008, NAT BIOTECHNOL, V26, P69, DOI 10.1038/nbt0108-69; Hammond PW, 2001, J BIOL CHEM, V276, P20898, DOI 10.1074/jbc.M011641200; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; Haynes C, 2006, PLOS COMPUT BIOL, V2, P890, DOI 10.1371/journal.pcbi.0020100; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Kim PM, 2006, SCIENCE, V314, P1938, DOI 10.1126/science.1136174; LaCount DJ, 2005, NATURE, V438, P103, DOI 10.1038/nature04104; LAWSON DM, 1991, NATURE, V349, P541, DOI 10.1038/349541a0; Legrain P, 2000, FEBS LETT, V480, P32, DOI 10.1016/S0014-5793(00)01774-9; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Liberati NT, 1999, P NATL ACAD SCI USA, V96, P4844, DOI 10.1073/pnas.96.9.4844; Lobley A, 2007, PLOS COMPUT BIOL, V3, P1567, DOI 10.1371/journal.pcbi.0030162; Miyamoto-Sato E, 2005, GENOME RES, V15, P710, DOI 10.1101/gr.3510505; Miyamoto-Sato E, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng078; Miyamoto-Sato E, 2000, NUCLEIC ACIDS RES, V28, P1176, DOI 10.1093/nar/28.5.1176; Miyamoto-Sato E, 2006, J DRUG TARGET, V14, P505, DOI 10.1080/10611860600845017; Nemoto N, 1997, FEBS LETT, V414, P405, DOI 10.1016/S0014-5793(97)01026-0; Park J, 2001, J MOL BIOL, V307, P929, DOI 10.1006/jmbi.2001.4526; Patil A, 2006, FEBS LETT, V580, P2041, DOI 10.1016/j.febslet.2006.03.003; Radivojac P, 2007, BIOPHYS J, V92, P1439, DOI 10.1529/biophysj.106.094045; Rhodes DR, 2005, NAT BIOTECHNOL, V23, P951, DOI 10.1038/nbt1103; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Roberts RW, 1997, P NATL ACAD SCI USA, V94, P12297, DOI 10.1073/pnas.94.23.12297; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shen XC, 2005, P NATL ACAD SCI USA, V102, P5969, DOI 10.1073/pnas.0407928102; Singh GP, 2007, PROTEINS, V66, P761, DOI 10.1002/prot.21281; Singh GP, 2007, PROTEINS, V68, P602, DOI 10.1002/prot.21497; Singhal M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-199; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; UVERSKY VN, 2008, ANNU REV BIOPHYS, V215, P246; Verrecchia F, 2001, ONCOGENE, V20, P3332, DOI 10.1038/sj.onc.1204448; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526; Zhang Y, 1998, NATURE, V394, P909, DOI 10.1038/29814	57	46	48	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2010	5	2							e9289	10.1371/journal.pone.0009289	http://dx.doi.org/10.1371/journal.pone.0009289			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SX	20195357	gold, Green Published, Green Submitted			2022-12-25	WOS:000274924200002
J	Gjuvsland, AB; Plahte, E; Adnoy, T; Omholt, SW				Gjuvsland, Arne B.; Plahte, Erik; Adnoy, Tormod; Omholt, Stig W.			Allele Interaction - Single Locus Genetics Meets Regulatory Biology	PLOS ONE			English	Article							DOSAGE COMPENSATION; MOLECULAR-BASIS; AUTOREGULATION; TRANSCRIPTION; EXPRESSION; NETWORKS; MODEL; ANEUPLOIDY; EFFICIENCY; STABILITY	Background: Since the dawn of genetics, additive and dominant gene action in diploids have been defined by comparison of heterozygote and homozygote phenotypes. However, these definitions provide little insight into the underlying intralocus allelic functional dependency and thus cannot serve directly as a mediator between genetics theory and regulatory biology, a link that is sorely needed. Methodology/Principal Findings: We provide such a link by distinguishing between positive, negative and zero allele interaction at the genotype level. First, these distinctions disclose that a biallelic locus can display 18 qualitatively different allele interaction sign motifs (triplets of +,- and 0). Second, we show that for a single locus, Mendelian dominance is not related to heterozygote allele interaction alone, but is actually a function of the degrees of allele interaction in all the three genotypes. Third, we demonstrate how the allele interaction in each genotype is directly quantifiable in gene regulatory models, and that there is a unique, one-to-one correspondence between the sign of autoregulatory feedback loops and the sign of the allele interactions. Conclusion/Significance: The concept of allele interaction refines single locus genetics substantially, and it provides a direct link between classical models of gene action and gene regulatory biology. Together with available empirical data, our results indicate that allele interaction can be exploited experimentally to identify and explain intricate intra- and inter-locus feedback relationships in eukaryotes.	[Gjuvsland, Arne B.; Plahte, Erik] Norwegian Univ Life Sci, Dept Math Sci & Technol, Ctr Integrat Genet CIGENE, As, Norway; [Adnoy, Tormod; Omholt, Stig W.] Norwegian Univ Life Sci, Dept Anim & Aquacultural Sci, Ctr Integrat Genet CIGENE, As, Norway	Norwegian University of Life Sciences; Norwegian University of Life Sciences	Gjuvsland, AB (corresponding author), Norwegian Univ Life Sci, Dept Math Sci & Technol, Ctr Integrat Genet CIGENE, As, Norway.	stig.omholt@umb.no		Gjuvsland, Arne/0000-0002-4391-3411	National Program for Research in Functional Genomics in Norway (FUGE) [NFR151924/S10]; Norwegian eScience program (eVITA) [NFR178901/V30]	National Program for Research in Functional Genomics in Norway (FUGE); Norwegian eScience program (eVITA)	This study was supported by the National Program for Research in Functional Genomics in Norway (FUGE) (RCN grant no. NFR151924/S10) and by the Norwegian eScience program (eVITA) (RCN grant no. NFR178901/V30). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bateman E, 1998, PROG NUCLEIC ACID RE, V60, P133, DOI 10.1016/S0079-6603(08)60892-2; Benfey PN, 2008, SCIENCE, V320, P495, DOI 10.1126/science.1153716; Blanchard EM, 1997, CIRC RES, V81, P1005; Brazhnik P, 2002, TRENDS BIOTECHNOL, V20, P467, DOI 10.1016/S0167-7799(02)02053-X; CABRERA CV, 1984, J MOL BIOL, V174, P85, DOI 10.1016/0022-2836(84)90366-8; Capon F, 2004, HUM MOL GENET, V13, P2361, DOI 10.1093/hmg/ddh273; Chamary JV, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-9-r75; CHEVERUD JM, 1995, GENETICS, V139, P1455; dAri R., 1990, BIOL FEEDBACK; Davidson EH, 2006, REG GEN GEN REG; Duan JB, 2003, J MOL EVOL, V57, P694, DOI 10.1007/s00239-003-2519-1; Duncan IW, 2002, ANNU REV GENET, V36, P521, DOI 10.1146/annurev.genet.36.060402.100441; Falconer D. S, 1996, INTRO QUANTITATIVE G; Gehring NH, 2001, NAT GENET, V28, P389, DOI 10.1038/ng578; Gerstein MB, 2007, GENOME RES, V17, P669, DOI 10.1101/gr.6339607; Giaever G, 1999, NAT GENET, V21, P278, DOI 10.1038/6791; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gjuvsland AB, 2007, GENETICS, V175, P411, DOI 10.1534/genetics.106.058859; Gjuvsland AB, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-57; Gjuvsland AB, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-32; Gove P. B., 2002, WEBSTERS 3 NEW INT D; Guidi CJ, 2004, J BIOL CHEM, V279, P4180, DOI 10.1074/jbc.M312043200; Hansen TF, 2001, THEOR POPUL BIOL, V59, P61, DOI 10.1006/tpbi.2000.1508; Hochholdinger F, 2007, TRENDS PLANT SCI, V12, P427, DOI 10.1016/j.tplants.2007.08.005; Hoogendoorn B, 2003, HUM MOL GENET, V12, P2249, DOI 10.1093/hmg/ddg246; Hughes TR, 2000, NAT GENET, V25, P333, DOI 10.1038/77116; Johnson NA, 2001, GENETICA, V112, P45, DOI 10.1023/A:1013371201773; KACSER H, 1981, GENETICS, V97, P639; Lippman ZB, 2007, TRENDS GENET, V23, P60, DOI 10.1016/j.tig.2006.12.006; Lynch M., 1998, GENETICS ANAL QUANTI; Mayo AE, 2006, PLOS BIOL, V4, P555, DOI 10.1371/journal.pbio.0040045; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; Mendel JG., 1865, VERHANDLUNGEN NATURF, V4, P3, DOI DOI 10.1093/OXFORDJOURNALS.JHERED.A106151; Minamisawa S, 1999, J BIOL CHEM, V274, P10066, DOI 10.1074/jbc.274.15.10066; Omholt SW, 2000, GENETICS, V155, P969; OMHOLT SW, 1994, J THEOR BIOL, V168, P231, DOI 10.1006/jtbi.1994.1103; OMHOLT SW, 2006, BIOL DOMINANCE GEORG; Peccoud J, 2004, GENETICS, V166, P1715, DOI 10.1534/genetics.166.4.1715; Peng J, 2005, RNA, V11, P958, DOI 10.1261/rna.2020805; Prescott K, 2005, HUM GENET, V116, P486, DOI 10.1007/s00439-005-1274-3; Rajasingh H, 2008, GENETICS, V179, P1113, DOI 10.1534/genetics.108.087064; Rockman MV, 2006, NAT REV GENET, V7, P862, DOI 10.1038/nrg1964; Rockman MV, 2002, MOL BIOL EVOL, V19, P1991, DOI 10.1093/oxfordjournals.molbev.a004023; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Smolen P, 2000, B MATH BIOL, V62, P247, DOI 10.1006/bulm.1999.0155; Straub T, 2007, NAT REV GENET, V8, P47, DOI 10.1038/nrg2013; Torres EM, 2007, SCIENCE, V317, P916, DOI 10.1126/science.1142210; Trieu M, 2003, DEVELOPMENT, V130, P111, DOI 10.1242/dev.00194; Wang J, 1999, J MOL BIOL, V286, P315, DOI 10.1006/jmbi.1998.2489; Wang KLC, 1998, MOL CELL BIOL, V18, P4368, DOI 10.1128/MCB.18.7.4368; Wang RL, 1999, NATURE, V398, P236, DOI 10.1038/18435; WARMKE J, 1992, J CELL BIOL, V119, P1523, DOI 10.1083/jcb.119.6.1523; Welch SM, 2005, AUST J AGR RES, V56, P919, DOI 10.1071/AR05155; Wray GA, 2007, NAT REV GENET, V8, P206, DOI 10.1038/nrg2063; Yan H, 2004, CURR OPIN ONCOL, V16, P39, DOI 10.1097/00001622-200401000-00008; Yan Z, 2009, GENETICS, V182, P623, DOI 10.1534/genetics.109.103036	56	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2010	5	2							e9379	10.1371/journal.pone.0009379	http://dx.doi.org/10.1371/journal.pone.0009379			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SV	20186347	Green Submitted, gold, Green Published			2022-12-25	WOS:000274924000020
J	Shin, YJ; Nourani, M				Shin, Yong-Jun; Nourani, Mehrdad			Statecharts for Gene Network Modeling	PLOS ONE			English	Article							REGULATORY NETWORKS; FEEDFORWARD LOOP; SYNTHETIC BIOLOGY; INPUT FUNCTIONS; EXPRESSION; SYSTEMS; MOTIFS; LOGIC	State diagrams (stategraphs) are suitable for describing the behavior of dynamic systems. However, when they are used to model large and complex systems, determining the states and transitions among them can be overwhelming, due to their flat, unstratified structure. In this article, we present the use of statecharts as a novel way of modeling complex gene networks. Statecharts extend conventional state diagrams with features such as nested hierarchy, recursion, and concurrency. These features are commonly utilized in engineering for designing complex systems and can enable us to model complex gene networks in an efficient and systematic way. We modeled five key gene network motifs, simple regulation, autoregulation, feed-forward loop, single-input module, and dense overlapping regulon, using statecharts. Specifically, utilizing nested hierarchy and recursion, we were able to model a complex interlocked feed-forward loop network in a highly structured way, demonstrating the potential of our approach for modeling large and complex gene networks.	[Shin, Yong-Jun; Nourani, Mehrdad] Univ Texas Dallas, Dept Elect Engn, Richardson, TX 75083 USA	University of Texas System; University of Texas Dallas	Shin, YJ (corresponding author), Univ Texas Dallas, Dept Elect Engn, Richardson, TX 75083 USA.	yshin@utdallas.edu						Abdullah-Sayani A, 2006, NAT CLIN PRACT ONCOL, V3, P501, DOI 10.1038/ncponc0587; Alon U., 2006, INTRO SYSTEMS BIOL D; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Andrianantoandro E, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100073; Batt G, 2005, BIOINFORMATICS, V21, pI19, DOI 10.1093/bioinformatics/bti1048; Becskei A, 2001, EMBO J, V20, P2528, DOI 10.1093/emboj/20.10.2528; Bolouri H, 2002, BIOESSAYS, V24, P1118, DOI 10.1002/bies.10189; Bolouri H, 2008, COMPUTATIONAL MODELI; BROWN S, 2005, FUNDAMENTALS DIGITAL; Cox CD, 2006, CHAOS, V16, DOI 10.1063/1.2204354; Cuccato G, 2009, HEREDITY, V102, P527, DOI 10.1038/hdy.2009.18; Demongeot L, 2000, CR ACAD SCI III-VIE, V323, P69, DOI 10.1016/S0764-4469(00)00112-8; Dunlop MJ, 2008, NAT GENET, V40, P1493, DOI 10.1038/ng.281; Eichenberger P, 2004, PLOS BIOL, V2, P1664, DOI 10.1371/journal.pbio.0020328; Endler L, 2009, J R SOC INTERFACE, V6, DOI 10.1098/rsif.2009.0035.focus; Garg A, 2008, BIOINFORMATICS, V24, P1917, DOI 10.1093/bioinformatics/btn336; GLASS L, 1973, J THEOR BIOL, V39, P103, DOI 10.1016/0022-5193(73)90208-7; Goutsias J, 2007, CURR PHARM DESIGN, V13, P1415, DOI 10.2174/138161207780765945; Guido NJ, 2006, NATURE, V439, P856, DOI 10.1038/nature04473; HAREL D, 1987, SCI COMPUT PROGRAM, V8, P231, DOI 10.1016/0167-6423(87)90035-9; Hasty J, 2001, NAT REV GENET, V2, P268, DOI 10.1038/35066056; Hetherington JPJ, 2006, J R SOC INTERFACE, V3, P319, DOI 10.1098/rsif.2005.0101; Hooshangi S, 2006, CHAOS, V16, DOI 10.1063/1.2208927; Iranfar N, 2006, DEV BIOL, V290, P460, DOI 10.1016/j.ydbio.2005.11.035; Kaplan S, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.43; Kaplan S, 2008, MOL CELL, V29, P786, DOI 10.1016/j.molcel.2008.01.021; Karlebach G, 2008, NAT REV MOL CELL BIO, V9, P770, DOI 10.1038/nrm2503; KOHANE IS, 2005, MICROARRAYS INTEGRAT; Lu TK, 2009, NAT BIOTECHNOL, V27, P1139, DOI 10.1038/nbt.1591; Maiwald T, 2008, BIOINFORMATICS, V24, P2037, DOI 10.1093/bioinformatics/btn350; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Pepperkok R, 2006, NAT REV MOL CELL BIO, V7, P690, DOI 10.1038/nrm1979; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Rinaudo K, 2007, NAT BIOTECHNOL, V25, P795, DOI 10.1038/nbt1307; Sahoo D, 2007, NUCLEIC ACIDS RES, V35, P3705, DOI 10.1093/nar/gkm284; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Schilstra MJ, 2008, ARTIF LIFE, V14, P121, DOI 10.1162/artl.2008.14.1.121; Shmulevich I, 2003, COMP FUNCT GENOM, V4, P601, DOI 10.1002/cfg.342; Shmulevich I, 2002, BIOINFORMATICS, V18, P1319, DOI 10.1093/bioinformatics/18.10.1319; Simpson ML, 2003, P NATL ACAD SCI USA, V100, P4551, DOI 10.1073/pnas.0736140100; Smolen P, 2000, B MATH BIOL, V62, P247, DOI 10.1006/bulm.1999.0155; Steggles LJ, 2007, BIOINFORMATICS, V23, P336, DOI 10.1093/bioinformatics/btl596; THOMAS R, 1973, J THEOR BIOL, V42, P563, DOI 10.1016/0022-5193(73)90247-6; Wu FX, 2008, INT J DATA MIN BIOIN, V2, P1, DOI 10.1504/IJDMB.2008.016753; Yuh Chiou-Hwa, 2001, P73	46	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2010	5	2							e9376	10.1371/journal.pone.0009376	http://dx.doi.org/10.1371/journal.pone.0009376			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SV	20186343	Green Submitted, Green Published, gold			2022-12-25	WOS:000274924000017
J	Sanchez-Zamora, Y; Terrazas, LI; Vilches-Flores, A; Leal, E; Juarez, I; Whitacre, C; Kithcart, A; Pruitt, J; Sielecki, T; Satoskar, AR; Rodriguez-Sosa, M				Sanchez-Zamora, Yuriko; Terrazas, Luis I.; Vilches-Flores, Alonso; Leal, Emmanuel; Juarez, Imelda; Whitacre, Caroline; Kithcart, Aaron; Pruitt, James; Sielecki, Thais; Satoskar, Abhay R.; Rodriguez-Sosa, Miriam			Macrophage migration inhibitory factor is a therapeutic target in treatment of non-insulin-dependent diabetes mellitus	FASEB JOURNAL			English	Article						MIF; cytokines; type 2 diabetes	AUGSBURG CASE-COHORT; RHEUMATOID-ARTHRITIS; FACTOR MIF; GLUCOSE-METABOLISM; PROMOTER POLYMORPHISM; FACTOR GENE; CYTOKINE; MICE; DISEASE; ATHEROSCLEROSIS	Macrophage migration inhibitory factor (MIF) is a proinflammatory cytokine involved in the pathogenesis of a variety of autoimmune inflammatory diseases. Here, we investigated the role of MIF in the pathogenesis of non-insulin-dependent diabetes mellitus ( NIDDM) using MIF-/- mice and a mouse model of streptozotocin (STZ)-induced NIDDM. Following single injection of STZ, MIF-/- BALB/c mice showed a significant increase in blood glucose levels, developed polyuria, and succumbed to disease. In contrast, no such increase in blood glucose was observed in MIF-/- BALB/c mice treated with STZ. These mice produced significantly less inflammatory cytokines and resistin as compared with MIF-/- mice and failed to develop clinical disease. Finally, oral administration of a small-molecule MIF antagonist, CPSI-1306, to outbred ICR mice following induction of NIDDM significantly lowered blood glucose levels in the majority of animals, which was also associated with a significant reduction in the levels of the proinflammatory cytokines IL-6 and TNF-alpha in the sera. Taken together, these results demonstrate that MIF is involved in the pathogenesis of NIDDM and is a therapeutic target to treat this disease.-Sanchez- Zamora, Y., Terrazas, L.I., VilchesFlores, A., Leal, E., Juarez, I., Whitacre, C., Kithcart, A., Pruitt, J., Sielecki, T., Satoskar, A.R., Rodriguez-Sosa, M. Macrophage migration inhibitory factor is a therapeutic target in treatment of non-insulin-dependent diabetes mellitus. FASEB J. 24, 2583-2590 (2010). www.fasebj.org	[Satoskar, Abhay R.] Ohio State Univ, Med Ctr, Dept Pathol, Columbus, OH 43210 USA; [Sanchez-Zamora, Yuriko; Terrazas, Luis I.; Vilches-Flores, Alonso; Leal, Emmanuel; Juarez, Imelda; Whitacre, Caroline; Kithcart, Aaron; Rodriguez-Sosa, Miriam] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Sanchez-Zamora, Yuriko; Terrazas, Luis I.; Vilches-Flores, Alonso; Leal, Emmanuel; Juarez, Imelda; Rodriguez-Sosa, Miriam] Univ Nacl Autonoma Mexico, FES Iztacala, Unidad Biomed, Tlalnepantla 54090, Edo De Mexico, Mexico; [Pruitt, James; Sielecki, Thais] Cytokine PharmaSci, King Of Prussia, PA USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Universidad Nacional Autonoma de Mexico	Satoskar, AR (corresponding author), Ohio State Univ, Med Ctr, Dept Pathol, Columbus, OH 43210 USA.	satoskar.2@osu.edu; rodriguezm@campus.iztacala.unam.mx	Terrazas, Luis I/AAV-8858-2020; Vilches-Flores, Alonso/A-3225-2013; Satoskar, Abhay/AAB-7748-2019	Vilches-Flores, Alonso/0000-0001-6185-6257; Sanchez Zamora, Yuriko Itzel/0000-0002-0769-8523; Rodriguez-Sosa, Miriam/0000-0003-2911-9390; Terrazas, Luis I./0000-0003-1635-9467	Council of Science and Technology of Mexico (CONACYT) [49812-Q]; Programa de Apoyo a los Profesores de Carrera para la Formacion de Grupos de Investigacion (PAPCA)	Council of Science and Technology of Mexico (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Programa de Apoyo a los Profesores de Carrera para la Formacion de Grupos de Investigacion (PAPCA)	This work was supported in part by grants from the Council of Science and Technology of Mexico (CONACYT) 49812-Q and Programa de Apoyo a los Profesores de Carrera para la Formacion de Grupos de Investigacion (PAPCA) Facultad de Estudios Superiores-Iztacala, Universidad Nacional Autonoma de Mexico.	Adeghate E, 2004, CELL MOL LIFE SCI, V61, P2485, DOI 10.1007/s00018-004-4083-2; Alexandraki K, 2006, ANN NY ACAD SCI, V1084, P89, DOI 10.1196/annals.1372.039; Arner P, 2005, CURR MOL MED, V5, P333, DOI 10.2174/1566524053766022; Atsumi T, 2007, J IMMUNOL, V179, P5399, DOI 10.4049/jimmunol.179.8.5399; Ayoub S, 2008, NAT CLIN PRACT RHEUM, V4, P98, DOI 10.1038/ncprheum0701; Barnes KM, 2009, CURR PROTEIN PEPT SC, V10, P96, DOI 10.2174/138920309787315239; Bastard JP, 2006, EUR CYTOKINE NETW, V17, P4; Baugh JA, 2002, GENES IMMUN, V3, P170, DOI 10.1038/sj.gene.6363867; Bojunga J, 2003, CYTOKINE, V21, P179, DOI 10.1016/S1043-4666(03)00076-0; Bozza M, 1999, J EXP MED, V189, P341, DOI 10.1084/jem.189.2.341; Burger-Kentischer A, 2002, CIRCULATION, V105, P1561, DOI 10.1161/01.CIR.0000012942.49244.82; Chen ZP, 2004, ARTERIOSCL THROM VAS, V24, P709, DOI 10.1161/01.ATV.0000119356.35748.9e; Crook M, 2004, DIABETIC MED, V21, P203, DOI 10.1046/j.1464-5491.2003.01030.x; Cvetkovic I, 2005, ENDOCRINOLOGY, V146, P2942, DOI 10.1210/en.2004-1393; de Jager W, 2007, ANN RHEUM DIS, V66, P589, DOI 10.1136/ard.2006.061853; de Jong YP, 2001, NAT IMMUNOL, V2, P1061, DOI 10.1038/ni720; Fain JN, 2006, VITAM HORM, V74, P443, DOI 10.1016/S0083-6729(06)74018-3; Goldstein BJ, 2002, AM J CARDIOL, V90, p3G; Hanifi-Moghaddam P, 2003, DIABETES, V52, P1137, DOI 10.2337/diabetes.52.5.1137; Hayashi K, 2006, BIOL PHARM BULL, V29, P1110, DOI 10.1248/bpb.29.1110; Herder C, 2008, DIABETOLOGIA, V51, P276, DOI 10.1007/s00125-007-0800-3; Herder C, 2006, DIABETES CARE, V29, P368, DOI 10.2337/diacare.29.02.06.dc05-1474; Herder C, 2008, ATHEROSCLEROSIS, V200, P380, DOI 10.1016/j.atherosclerosis.2007.12.025; Herder C, 2006, DIABETES, V55, P2340, DOI 10.2337/db05-1320; Hoi AY, 2006, J IMMUNOL, V177, P5687, DOI 10.4049/jimmunol.177.8.5687; Ito M, 2001, ENVIRON TOXICOL PHAR, V9, P71, DOI 10.1016/S1382-6689(00)00064-8; Ito M, 1999, BIOL PHARM BULL, V22, P988; Kochan Zdzislaw, 2003, Przegl Lek, V60, P40; Leech M, 1999, ARTHRITIS RHEUM, V42, P1601, DOI 10.1002/1529-0131(199908)42:8<1601::AID-ANR6>3.0.CO;2-B; McTernan PG, 2003, J CLIN ENDOCR METAB, V88, P6098, DOI 10.1210/jc.2003-030898; Mikulowska A, 1997, J IMMUNOL, V158, P5514; Mizue Y, 2005, P NATL ACAD SCI USA, V102, P14410, DOI 10.1073/pnas.0507189102; Mojiminiyi OA, 2007, SCAND J CLIN LAB INV, V67, P215, DOI 10.1080/00365510601032532; Morand EF, 2006, NAT REV DRUG DISCOV, V5, P399, DOI 10.1038/nrd2029; Morand EF, 2002, RHEUMATOLOGY, V41, P558, DOI 10.1093/rheumatology/41.5.558; Sakaue S, 2006, INT J OBESITY, V30, P238, DOI 10.1038/sj.ijo.0803148; Santos LL, 2009, CLIN CHIM ACTA, V399, P1, DOI 10.1016/j.cca.2008.09.014; Stosic-Grujicic S, 2008, J CELL PHYSIOL, V215, P665, DOI 10.1002/jcp.21346; Toso C, 2008, DIABETOLOGIA, V51, P1937, DOI 10.1007/s00125-008-1063-3; Vozarova B, 2002, DIABETOLOGIA, V45, P1739, DOI 10.1007/s00125-002-0896-4; Waeber G, 1997, P NATL ACAD SCI USA, V94, P4782, DOI 10.1073/pnas.94.9.4782; Waeber G, 1999, DIABETES-METAB RES, V15, P47, DOI 10.1002/(SICI)1520-7560(199901/02)15:1<47::AID-DMRR9>3.0.CO;2-J; Wang B, 2006, J IMMUNOL, V177, P5779, DOI 10.4049/jimmunol.177.9.5779	43	44	45	1	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2010	24	7					2583	2590		10.1096/fj.09-147066	http://dx.doi.org/10.1096/fj.09-147066			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	618HV	20203087				2022-12-25	WOS:000279343600045
J	Haller, D; Mackiewicz, M; Gerber, S; Beyer, D; Kullmann, B; Schneider, I; Ahmed, JS; Seitzer, U				Haller, D.; Mackiewicz, M.; Gerber, S.; Beyer, D.; Kullmann, B.; Schneider, I.; Ahmed, J. S.; Seitzer, U.			Cytoplasmic sequestration of p53 promotes survival in leukocytes transformed by Theileria	ONCOGENE			English	Article						apoptosis; cytoplasmic sequestration; p53; Theileria annulata	WILD-TYPE P53; PARASITE THEILERIA; NUCLEAR EXCLUSION; COLORECTAL ADENOCARCINOMA; PROTEIN; CELLS; ACTIVATION; PARVA; LYMPHOCYTES; ONCOPROTEIN	The function of the p53 protein as the central effector molecule of the p53 apoptotic pathway was investigated in a reversible model of epigenetic transformation. The infection of bovine leukocytes by the intracellular protozoan parasite Theileria annulata results in parasite-dependent transformation and proliferation of the host cells. We found p53 to be largely localized in the host cell cytoplasm and associated with the parasite membrane of isolated schizonts. Curing infected cells of the parasite with the theilericidal drug buparvaquone resulted in a time-dependent translocation of p53 into the host cell nucleus and the upregulation of the proapoptotic Bax and Apaf-1 and the downregulation of the anti-apoptotic Bcl-2 proteins. Although buparvaquone treatment led to apoptosis of the host cell, inhibition of either p53 or Bax significantly reduced buparvaquone-induced apoptosis of the transformed cells. Thus, the p53 apoptotic pathway of host cells is not induced by infection and transformation with Theileria by a mechanism involving cytoplasmic sequestration of p53. The close association of host cell p53 with the parasite membrane implies that the parasite either interacts directly with p53 or mediates cytoplasmic sequestration of p53 by interacting with other host cell proteins regulating p53 localization. Oncogene (2010) 29, 3079-3086; doi: 10.1038/onc.2010.61; published online 8 March 2010	[Haller, D.; Mackiewicz, M.; Gerber, S.; Beyer, D.; Kullmann, B.; Schneider, I.; Ahmed, J. S.; Seitzer, U.] Res Ctr Borstel, Dept Immunol & Cell Biol, Div Vet Infect Biol & Immunol, D-23845 Borstel, Schleswig Holst, Germany	Forschungszentrum Borstel	Seitzer, U (corresponding author), Res Ctr Borstel, Dept Immunol & Cell Biol, Div Vet Infect Biol & Immunol, Pk Allee 22, D-23845 Borstel, Schleswig Holst, Germany.	useitzer@fz-borstel.de			European Commission [ICA4-CT-2000-30028]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported in part by a grant from the European Commission INCO-DEV Program (Contract Grant Number: ICA4-CT-2000-30028).	Adams JM, 2002, CURR OPIN CELL BIOL, V14, P715, DOI 10.1016/S0955-0674(02)00381-2; Ahmed JS, 1999, PARASITOL RES, V85, P527, DOI 10.1007/s004360050592; AHMED JS, 1989, J VET MED B, V36, P584, DOI 10.1111/j.1439-0450.1989.tb00649.x; Bakheit MA, 2006, PARASITOL RES, V100, P161, DOI 10.1007/s00436-006-0255-3; Bakheit MA, 2006, ANN NY ACAD SCI, V1081, P453, DOI 10.1196/annals.1373.064; BOSARI S, 1995, AM J PATHOL, V147, P790; BOYD JM, 1994, CELL, V79, P341, DOI 10.1016/0092-8674(94)90202-X; DOBBELAERE DAE, 1988, P NATL ACAD SCI USA, V85, P4730, DOI 10.1073/pnas.85.13.4730; Fortin A, 2001, J CELL BIOL, V155, P207, DOI 10.1083/jcb.200105137; Galley Y, 1997, P NATL ACAD SCI USA, V94, P5119, DOI 10.1073/pnas.94.10.5119; Gardner MJ, 2005, SCIENCE, V309, P134, DOI 10.1126/science.1110439; Guergnon J, 2003, BIOCHIMIE, V85, P771, DOI 10.1016/j.biochi.2003.09.013; Heussler VT, 2001, CELL MICROBIOL, V3, P537, DOI 10.1046/j.1462-5822.2001.00134.x; Heussler VT, 2002, SCIENCE, V298, P1033, DOI 10.1126/science.1075462; Knippschild U, 1996, ONCOGENE, V12, P1755; LANE DP, 1979, NATURE, V278, P261, DOI 10.1038/278261a0; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Liang SH, 2001, EUR J BIOCHEM, V268, P2779, DOI 10.1046/j.1432-1327.2001.02227.x; McHardy N., 1985, Immunization against theileriosis in Africa. Proceedings of a Joint Workshop, 1-5 October 1984, Nairobi, Kenya, ILRAD & FAO., P88; MCHARDY N, 1985, RES VET SCI, V39, P1; MIYASHITA T, 1995, CELL, V80, P293; MOLL UM, 1995, P NATL ACAD SCI USA, V92, P4407, DOI 10.1073/pnas.92.10.4407; Moll UM, 1996, MOL CELL BIOL, V16, P1126; MOLL UM, 1992, P NATL ACAD SCI USA, V89, P7262, DOI 10.1073/pnas.89.15.7262; Nikolaev AY, 2003, CELL, V112, P29, DOI 10.1016/S0092-8674(02)01255-2; O'Brate A, 2003, DRUG RESIST UPDATE, V6, P313, DOI 10.1016/j.drup.2003.10.004; OLINER JD, 1993, NATURE, V362, P857, DOI 10.1038/362857a0; Pain A, 2005, SCIENCE, V309, P131, DOI 10.1126/science.1110418; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; Schlamp CL, 1997, J NATL CANCER I, V89, P1530, DOI 10.1093/jnci/89.20.1530; Schneider I, 2004, PARASITOL RES, V94, P405, DOI 10.1007/s00436-004-1226-1; Seitzer U, 2006, ANN NY ACAD SCI, V1081, P473, DOI 10.1196/annals.1373.069; Shayan P, 1999, PARASITOL RES, V85, P613, DOI 10.1007/s004360050605; Shimizu S, 1999, NATURE, V399, P483, DOI 10.1038/20959; SUN XF, 1992, LANCET, V340, P1369, DOI 10.1016/0140-6736(92)92558-W; Toye P, 1996, INFECT IMMUN, V64, P1832, DOI 10.1128/IAI.64.5.1832-1838.1996; UEDA H, 1995, NAT GENET, V9, P41, DOI 10.1038/ng0195-41; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wu YL, 2001, ONCOGENE, V20, P240, DOI 10.1038/sj.onc.1204067	39	27	30	2	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAY 27	2010	29	21					3079	3086		10.1038/onc.2010.61	http://dx.doi.org/10.1038/onc.2010.61			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	602IQ	20208567				2022-12-25	WOS:000278133100005
J	Rajasekar, K; Muntaha, ST; Tame, JRH; Kommareddy, S; Morris, G; Wharton, CW; Thomas, CM; White, SA; Hyde, EI; Scott, DJ				Rajasekar, Karthik; Muntaha, Sidra Tul; Tame, Jeremy R. H.; Kommareddy, Sireesha; Morris, Gordon; Wharton, Christopher W.; Thomas, Christopher M.; White, Scott A.; Hyde, Eva I.; Scott, David J.			Order and Disorder in the Domain Organization of the Plasmid Partition Protein KorB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SECONDARY STRUCTURE ANALYSES; CIRCULAR-DICHROISM SPECTRA; PROMISCUOUS INCP PLASMIDS; RAY SOLUTION SCATTERING; CENTRAL CONTROL REGION; PARB HOMOLOG KORB; X-RAY; BIOLOGICAL MACROMOLECULES; GLOBAL REGULATOR; BINDING-SITES	The plasmid partition protein KorB has a dual role: it is essential for the correct segregation of the low copy number broad host range RK2 plasmid while also being an important regulator of transcription. KorB belongs to the ParB family of proteins, and partitioning in RK2 has been studied as a simplified model of bacterial chromosome segregation. Structural information on full-length ParB proteins is limited, mainly due to the inability to grow crystals suitable for diffraction studies. We show, using CD and NMR, that KorB has regions of significant intrinsic disorder and hence it adopts a multiplicity of conformations in solution. The biophysical data are consistent with bioinformatic predictions based on the amino acid sequence that the N-terminal region and also the region between the central DNA-binding domain and the C-terminal dimerization domain are intrinsically disordered. We have used small angle x-ray scattering data to determine the ensemble of solution conformations for KorB and selected deletion mutants, based on models of the known domain structures. This conformational range of KorB is likely to be biologically required for DNA partitioning and for binding to a diverse set of partner proteins.	[Wharton, Christopher W.; Thomas, Christopher M.; White, Scott A.; Hyde, Eva I.] Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England; [Tame, Jeremy R. H.] Yokohama City Univ, Prot Design Lab, Tsurumi Ku, Kanagawa 2300045, Japan; [Morris, Gordon; Scott, David J.] Univ Nottingham, Sch Biosci, Natl Ctr Macromol Hydrodynam, Loughborough LE12 5RD, Leics, England	University of Birmingham; Yokohama City University; University of Nottingham	Hyde, EI (corresponding author), Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England.	e.i.hyde@bham.ac.uk; dj.scott@nottingham.ac.uk	Hyde, Eva/GPC-8431-2022	Scott, David/0000-0002-6726-2078; White, Scott/0000-0002-0202-6154; Rajasekar, Karthik/0000-0002-8146-6560; Morris, Gordon/0000-0003-2588-6349; Hyde, Eva/0000-0003-3440-2799	Deutsches Elektronen-Synchrotron, Hamburg; Henry Wellcome Building NMR Centre; Higher Education Funding Council for England; Wellcome Trust	Deutsches Elektronen-Synchrotron, Hamburg; Henry Wellcome Building NMR Centre; Higher Education Funding Council for England(UK Research & Innovation (UKRI)Higher Education Funding Council for England (HEFCE)); Wellcome Trust(Wellcome TrustEuropean Commission)	D. J. S. and E. I. H. are grateful for Beamtime awards at Deutsches Elektronen-Synchrotron, Hamburg, and we are grateful to Peter Konarov of European Molecular Biology Laboratory, Hamburg, for help with data collection. We also thank Sara Whittaker and Christian Ludwig of the Henry Wellcome Building NMR Centre for support. NMR spectra were collected at the Henry Wellcome Building NMR Centre at the University of Birmingham, funded by the Higher Education Funding Council for England and the Wellcome Trust.	Batt SM, 2009, J MOL BIOL, V385, P1361, DOI 10.1016/j.jmb.2008.12.016; BERNADO P, 2010, EUR BIOPHYS J, DOI DOI 10.1007/S00249-00009-00549-00243; Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Bhattacharyya A, 2001, J MOL BIOL, V310, P51, DOI 10.1006/jmbi.2001.4729; Bignell C, 2001, J BIOTECHNOL, V91, P1, DOI 10.1016/S0168-1656(01)00293-0; Bingle LEH, 2005, J MOL BIOL, V349, P302, DOI 10.1016/j.jmb.2005.03.062; Chenal A, 2009, J BIOL CHEM, V284, P1781, DOI 10.1074/jbc.M807312200; Chiu CM, 2008, PLASMID, V59, P163, DOI 10.1016/j.plasmid.2008.02.001; Delbruck H, 2002, J BIOL CHEM, V277, P4191, DOI 10.1074/jbc.M110103200; Harding SE, 1997, PROG BIOPHYS MOL BIO, V68, P207, DOI 10.1016/S0079-6107(97)00027-8; Haynes C, 2006, PLOS COMPUT BIOL, V2, P890, DOI 10.1371/journal.pcbi.0020100; Jagura-Burdzy G, 1999, MOL MICROBIOL, V32, P519, DOI 10.1046/j.1365-2958.1999.01365.x; Jagura-Burdzy G, 1999, J BACTERIOL, V181, P2807, DOI 10.1128/JB.181.9.2807-2815.1999; Jagura-Burdzy G, 1997, J MOL BIOL, V265, P507, DOI 10.1006/jmbi.1996.0747; Khare D, 2004, NAT STRUCT MOL BIOL, V11, P656, DOI 10.1038/nsmb773; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kostelidou K, 2000, J MOL BIOL, V295, P411, DOI 10.1006/jmbi.1999.3359; Kostelidou K, 1999, J MOL BIOL, V289, P211, DOI 10.1006/jmbi.1999.2761; Leonard TA, 2004, MOL MICROBIOL, V53, P419, DOI 10.1111/j.1365-2958.2004.04133.x; Lukaszewicz M, 2002, NUCLEIC ACIDS RES, V30, P1046, DOI 10.1093/nar/30.4.1046; Lund O, 2002, CASP5 C; Macartney DP, 1997, MICROBIOL-UK, V143, P2167, DOI 10.1099/00221287-143-7-2167; PANSEGRAU W, 1994, J MOL BIOL, V239, P623, DOI 10.1006/jmbi.1994.1404; Petoukhov MV, 2007, CURR OPIN STRUC BIOL, V17, P562, DOI 10.1016/j.sbi.2007.06.009; Potterton E, 2002, ACTA CRYSTALLOGR D, V58, P1955, DOI 10.1107/S0907444902015391; Receveur-Brechot V, 2006, PROTEINS, V62, P24, DOI 10.1002/prot.20750; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schumacher MA, 2005, NATURE, V438, P516, DOI 10.1038/nature04149; Schumacher MA, 2007, J BIOL CHEM, V282, P10456, DOI 10.1074/jbc.M610603200; Scott DJ, 2005, ANALYTICAL ULTRACENTRIFUGATION: TECHNIQUES AND METHODS, P1, DOI 10.1039/9781847552617-00001; Sickmeier M, 2007, NUCLEIC ACIDS RES, V35, pD786, DOI 10.1093/nar/gkl893; Sreerama N, 2000, ANAL BIOCHEM, V287, P243, DOI 10.1006/abio.2000.4879; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1993, J APPL CRYSTALLOGR, V26, P258, DOI 10.1107/S0021889892011828; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Szilagyi A, 2008, BIOPHYS J, V95, P1612, DOI 10.1529/biophysj.108.131151; Uversky VN, 2002, PROTEIN SCI, V11, P739, DOI 10.1110/ps.4210102; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Williams DR, 1998, MICROBIOL-UK, V144, P3369, DOI 10.1099/00221287-144-12-3369; WILLIAMS DR, 1993, NUCLEIC ACIDS RES, V21, P1141, DOI 10.1093/nar/21.5.1141; Zatyka M, 2001, J BACTERIOL, V183, P1022, DOI 10.1128/JB.183.3.1022-1031.2001; ZATYKA M, 1994, MICROBIOL-SGM, V140, P2981, DOI 10.1099/13500872-140-11-2981	45	9	10	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15440	15449		10.1074/jbc.M109.096099	http://dx.doi.org/10.1074/jbc.M109.096099			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20200158	Green Published, hybrid			2022-12-25	WOS:000277399000064
J	Susaki, E; Kaneko-Oshikawa, C; Miyata, K; Tabata, M; Yamada, T; Oike, Y; Katagiri, H; Nakayama, KI				Susaki, Etsuo; Kaneko-Oshikawa, Chie; Miyata, Keishi; Tabata, Mitsuhisa; Yamada, Tetsuya; Oike, Yuichi; Katagiri, Hideki; Nakayama, Keiichi I.			Increased E4 Activity in Mice Leads to Ubiquitin-containing Aggregates and Degeneration of Hypothalamic Neurons Resulting in Obesity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MELANOCYTE-STIMULATING HORMONE; UNCOUPLING PROTEIN EXPRESSION; INCLUSION-BODY FORMATION; MUTANT ALPHA-SYNUCLEIN; PROTEASOME SYSTEM; PARAVENTRICULAR NUCLEUS; HUNTINGTONS-DISEASE; ALZHEIMERS-DISEASE; NERVOUS-SYSTEM; FOOD-INTAKE	Obesity has become a serious worldwide public health problem. Although neural degeneration in specific brain regions has been suggested to contribute to obesity phenotype in humans, a causal relationship between these two conditions has not been demonstrated experimentally. We now show that E4B (also known as UFD2a), a mammalian ubiquitin chain elongation factor (E4), induces the formation of intracellular aggregates positive for ubiquitin and the adaptor protein p62 when overexpressed in cultured cells or the brain. Mice transgenic for E4B manifested neural degeneration in association with aggregate formation, and they exhibited functional impairment specifically in a subset of hypothalamic neurons that regulate food intake and energy expenditure, resulting in development of hyperphagic obesity and related metabolic abnormalities. The neural pathology of E4B transgenic mice was similar to that of human neurodegenerative diseases associated with the formation of intracellular ubiquitin-positive deposits, indicating the existence of a link between such diseases and obesity and related metabolic disorders. Our findings thus provide experimental evidence for a role of hypothalamic neurodegeneration in obesity, and the E4B transgenic mouse should prove to be a useful animal model for studies of the relationship between neurodegenerative diseases and obesity.	[Susaki, Etsuo; Kaneko-Oshikawa, Chie; Nakayama, Keiichi I.] Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Higashi Ku, Fukuoka 8128582, Japan; [Susaki, Etsuo; Kaneko-Oshikawa, Chie; Nakayama, Keiichi I.] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol CREST, Kawaguchi, Saitama 3320012, Japan; [Miyata, Keishi; Tabata, Mitsuhisa; Oike, Yuichi] Kumamoto Univ, Grad Sch Med Sci, Dept Mol Genet, Kumamoto 8608556, Japan; [Yamada, Tetsuya; Katagiri, Hideki] Tohoku Univ, Grad Sch Med, Ctr Translat & Adv Anim Res, Div Adv Therapeut Metab Dis,Aoba Ku, Sendai, Miyagi 9808575, Japan	Kyushu University; Japan Science & Technology Agency (JST); Kumamoto University; Tohoku University	Nakayama, KI (corresponding author), Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	nakayak1@bioreg.kyushu-u.ac.jp	Miyata, Keishi/HGF-1876-2022	Miyata, Keishi/0000-0003-0336-1859; Susaki, Etsuo/0000-0001-5621-7311	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Takeda Science Foundation	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported in part by a grant from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and by a research grant from the Takeda Science Foundation.	Almeida CG, 2006, J NEUROSCI, V26, P4277, DOI 10.1523/JNEUROSCI.5078-05.2006; Baran K, 2002, DIABETES, V51, P152, DOI 10.2337/diabetes.51.1.152; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bennett EJ, 2005, MOL CELL, V17, P351, DOI 10.1016/j.molcel.2004.12.021; Bennett EJ, 2007, NATURE, V448, P704, DOI 10.1038/nature06022; Berciano MT, 2004, HUM MOL GENET, V13, P829, DOI 10.1093/hmg/ddh101; Borchelt DR, 1996, GENET ANAL-BIOMOL E, V13, P159, DOI 10.1016/S1050-3862(96)00167-2; Bruce-Keller AJ, 2009, BBA-MOL BASIS DIS, V1792, P395, DOI 10.1016/j.bbadis.2008.10.004; Casper RC, 2008, PSYCHOPHARMACOLOGY, V199, P313, DOI 10.1007/s00213-008-1102-2; Chung KKK, 2001, NAT MED, V7, P1144, DOI 10.1038/nm1001-1144; Ciechanover A, 2003, NEURON, V40, P427, DOI 10.1016/S0896-6273(03)00606-8; Cone RD, 2005, NAT NEUROSCI, V8, P571, DOI 10.1038/nn1455; Cummings CJ, 1998, NAT GENET, V19, P148, DOI 10.1038/502; Deng HW, 2002, AM J HUM GENET, V70, P1138, DOI 10.1086/339934; Elmquist JK, 1999, NEURON, V22, P221, DOI 10.1016/S0896-6273(00)81084-3; Esser C, 2004, BBA-MOL CELL RES, V1695, P171, DOI 10.1016/j.bbamcr.2004.09.020; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Gal J, 2007, J BIOL CHEM, V282, P11068, DOI 10.1074/jbc.M608787200; Garcia-Mata R, 1999, J CELL BIOL, V146, P1239, DOI 10.1083/jcb.146.6.1239; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hatakeyama S, 2001, J BIOL CHEM, V276, P33111, DOI 10.1074/jbc.M102755200; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Imai Y, 2001, CELL, V105, P891, DOI 10.1016/S0092-8674(01)00407-X; Imai Y, 2002, MOL CELL, V10, P55, DOI 10.1016/S1097-2765(02)00583-X; Ishida N, 2002, J BIOL CHEM, V277, P14355, DOI 10.1074/jbc.C100762200; Ishigaki Y, 2005, DIABETES, V54, P322, DOI 10.2337/diabetes.54.2.322; Ishii T, 1996, BIOCHEM BIOPH RES CO, V226, P456, DOI 10.1006/bbrc.1996.1377; Jana NR, 2001, HUM MOL GENET, V10, P1049, DOI 10.1093/hmg/10.10.1049; Jobst EE, 2004, TRENDS ENDOCRIN MET, V15, P488, DOI 10.1016/j.tem.2004.10.007; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Kaneko C, 2003, BIOCHEM BIOPH RES CO, V300, P297, DOI 10.1016/S0006-291X(02)02834-6; Kaneko-Oshikawa C, 2005, MOL CELL BIOL, V25, P10953, DOI 10.1128/MCB.25.24.10953-10964.2005; Keck S, 2003, J NEUROCHEM, V85, P115, DOI 10.1046/j.1471-4159.2003.01642.x; Keller JN, 2000, J NEUROCHEM, V75, P436, DOI 10.1046/j.1471-4159.2000.0750436.x; Kim MS, 2000, DIABETES, V49, P177, DOI 10.2337/diabetes.49.2.177; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Korolchuk VI, 2009, MOL CELL, V33, P517, DOI 10.1016/j.molcel.2009.01.021; Kublaoui BM, 2006, MOL ENDOCRINOL, V20, P2483, DOI 10.1210/me.2005-0483; KWAK S, 1991, NEUROSCI LETT, V128, P21, DOI 10.1016/0304-3940(91)90751-E; LEIBOWITZ SF, 1981, PHYSIOL BEHAV, V27, P1031, DOI 10.1016/0031-9384(81)90366-8; Masaki T, 2003, ENDOCRINOLOGY, V144, P3547, DOI 10.1210/en.2003-0301; Masaki T, 2003, ENDOCRINOLOGY, V144, P2741, DOI 10.1210/en.2003-0031; Matsumoto M, 2004, EMBO J, V23, P659, DOI 10.1038/sj.emboj.7600081; McNaught KSP, 2001, NEUROSCI LETT, V297, P191, DOI 10.1016/S0304-3940(00)01701-8; Nagaoka U, 2004, J NEUROCHEM, V91, P57, DOI 10.1111/j.1471-4159.2004.02692.x; Nezis IP, 2008, J CELL BIOL, V180, P1065, DOI 10.1083/jcb.200711108; Oh S, 2005, MECH AGEING DEV, V126, P1292, DOI 10.1016/j.mad.2005.07.006; Oike Y, 2005, NAT MED, V11, P400, DOI 10.1038/nm1214; Okumura F, 2004, J BIOL CHEM, V279, P53533, DOI 10.1074/jbc.M402916200; Petrucelli L, 2002, NEURON, V36, P1007, DOI 10.1016/S0896-6273(02)01125-X; Petrucelli L, 2004, HUM MOL GENET, V13, P703, DOI 10.1093/hmg/ddh083; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Ristow M, 2004, J MOL MED, V82, P510, DOI 10.1007/s00109-004-0552-1; Salon ML, 2003, EXP NEUROL, V180, P131, DOI 10.1016/S0014-4886(02)00060-2; Salon ML, 2000, J NEUROSCI RES, V62, P302, DOI 10.1002/1097-4547(20001015)62:2<302::AID-JNR15>3.0.CO;2-L; Sarkar S, 2002, BRAIN RES, V945, P50, DOI 10.1016/S0006-8993(02)02619-7; Scarpace PJ, 1998, AM J PHYSIOL-ENDOC M, V275, pE259, DOI 10.1152/ajpendo.1998.275.2.E259; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Seo H, 2004, ANN NEUROL, V56, P319, DOI 10.1002/ana.20207; Shimura H, 2004, J BIOL CHEM, V279, P4869, DOI 10.1074/jbc.M305838200; Small CJ, 2001, DIABETES, V50, P248, DOI 10.2337/diabetes.50.2.248; Song S, 2003, MOL CELL, V12, P553, DOI 10.1016/j.molcel.2003.08.005; Stefanis L, 2001, J NEUROSCI, V21, P9549, DOI 10.1523/JNEUROSCI.21-24-09549.2001; Stone S, 2002, AM J HUM GENET, V70, P1459, DOI 10.1086/340670; Susaki E, 2009, P NATL ACAD SCI USA, V106, P5192, DOI 10.1073/pnas.0811712106; Tanaka Y, 2001, HUM MOL GENET, V10, P919, DOI 10.1093/hmg/10.9.919; Taylor JP, 2002, SCIENCE, V296, P1991, DOI 10.1126/science.1067122; Tseng BP, 2008, NEUROBIOL AGING, V29, P1607, DOI 10.1016/j.neurobiolaging.2007.04.014; Waelter S, 2001, MOL BIOL CELL, V12, P1393, DOI 10.1091/mbc.12.5.1393; Wang CF, 2000, NEUROREPORT, V11, P3251, DOI 10.1097/00001756-200009280-00040; Wang JJ, 2008, J CELL BIOL, V180, P1177, DOI 10.1083/jcb.200709080; Wigley WC, 1999, J CELL BIOL, V145, P481; Wirth MM, 2001, PEPTIDES, V22, P129, DOI 10.1016/S0196-9781(00)00367-3; Yasuda T, 2003, NEUROSCI LETT, V349, P75, DOI 10.1016/S0304-3940(03)00789-4; Zatloukal K, 2002, AM J PATHOL, V160, P255, DOI 10.1016/S0002-9440(10)64369-6	76	13	16	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15538	15547		10.1074/jbc.M110.105841	http://dx.doi.org/10.1074/jbc.M110.105841			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20190229	Green Published, hybrid			2022-12-25	WOS:000277399000072
J	Groger, N; Frohlich, H; Maier, H; Olbrich, A; Kostin, S; Braun, T; Boettger, T				Groeger, Nicole; Froehlich, Henning; Maier, Hannes; Olbrich, Andrea; Kostin, Sawa; Braun, Thomas; Boettger, Thomas			SLC4A11 Prevents Osmotic Imbalance Leading to Corneal Endothelial Dystrophy, Deafness, and Polyuria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AQUAPORIN-1 WATER CHANNELS; DESCENDING THIN LIMBS; NULL MICE; MUTATIONS; TRANSPORTERS; MECHANISM; KIDNEY; FLUID; BORON; GENE	Maintenance of ion concentration gradients is essential for the function of many organs, including the kidney, the cornea, and the inner ear. Ion concentrations and fluid content in the cornea are regulated by endothelial cells that separate the collagenous avascular corneal stroma from the anterior eye chamber. Failure to maintain correct ion concentrations leads to swelling and destruction of the cornea. In the inner ear, the stria vascularis is responsible for generating proper ion concentrations in the endolymph, which is essential for hearing. Mutations of SLC4A11 in humans lead to syndromes associated with corneal dystrophy and perceptive deafness. The molecular mechanisms underlying these symptoms are poorly understood, impeding therapeutic interventions. The ion transporter SLC4A11 mediates sodium-dependent transport of borate as well as flux of sodium and hydroxyl ions in vitro. Here, we show that SLC4A11 is expressed in the endothelial cells of the cornea where it prevents severe morphological changes of the cornea caused by increased sodium chloride concentrations in the stroma. In the inner ear, SLC4A11 is located in fibrocytes underlying the stria vascularis. Loss of SLC4A11 leads to morphological changes in the fibrocytes and deafness. Wedemonstrate that SLC4A11 is essential for the generation of the endocochlear potential but not for regulation of potassium concentrations in the endolymph. In the kidney, SLC4A11 is expressed in the thin descending limb of Henle loop. SLC4A11 is essential for urinary concentration, suggesting that SLC4A11 participates in the countercurrent multiplication that concentrates urine in the kidney medulla.	[Boettger, Thomas] Max Planck Inst Heart & Lung Res, D-61231 Bad Nauheim, Germany; [Maier, Hannes] Hannover Med Sch, Dept Expt Otol, D-30625 Hannover, Germany; [Olbrich, Andrea] Univ Gottingen, Busgen Inst, Dept Forest Bot & Tree Physiol, D-37077 Gottingen, Germany	Max Planck Society; Hannover Medical School; University of Gottingen		thomas.braun@mpi-bn.mpg.de; thomas.boettger@mpi-bn.mpg.de	Hannes, Maier/AAE-5070-2020; Boettger, Thomas/E-3406-2012; Hannes, Maier/A-9457-2012; Braun, Thomas/B-2310-2008	Hannes, Maier/0000-0001-8457-5327; Boettger, Thomas/0000-0003-4280-8449; Hannes, Maier/0000-0001-8457-5327; Braun, Thomas/0000-0002-6165-4804	Max-Planck-Society; Deutsche Forschungsgemeinschaft [BO1970/1]	Max-Planck-Society(Max Planck Society); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Max-Planck-Society and by Deutsche Forschungsgemeinschaft Grant BO1970/1.	Aldave AJ, 2007, CORNEA, V26, P896, DOI 10.1097/ICO.0b013e318074bb01; Bonanno JA, 2003, PROG RETIN EYE RES, V22, P69, DOI 10.1016/S1350-9462(02)00059-9; Chou CL, 1999, J CLIN INVEST, V103, P491, DOI 10.1172/JCI5704; Damkier HH, 2007, AM J PHYSIOL-REG I, V293, pR2136, DOI 10.1152/ajpregu.00356.2007; Desir J, 2007, J MED GENET, V44, P322, DOI 10.1136/jmg.2006.046904; Diecke FPJ, 2007, BBA-BIOMEMBRANES, V1768, P2043, DOI 10.1016/j.bbamem.2007.05.020; Dordas C, 2001, BIOL TRACE ELEM RES, V81, P127, DOI 10.1385/BTER:81:2:127; Fenton RA, 2007, PHYSIOL REV, V87, P1083, DOI 10.1152/physrev.00053.2006; Fischbarg J, 2006, J MEMBRANE BIOL, V210, P117, DOI 10.1007/s00232-005-0850-8; Fritz E, 2007, MICROSC MICROANAL, V13, P233, DOI 10.1017/S1431927607070420; Frommer WB, 2002, NATURE, V420, P282, DOI 10.1038/420282a; HARBOYAN G, 1971, ARCH OPHTHALMOL-CHIC, V85, P27, DOI 10.1001/archopht.1971.00990050029005; Hemadevi B, 2008, ARCH OPHTHALMOL-CHIC, V126, P700, DOI 10.1001/archopht.126.5.700; JAMISON RL, 1973, AM J PHYSIOL, V224, P180, DOI 10.1152/ajplegacy.1973.224.1.180; KUHN W, 1959, HELV CHIM ACTA, V42, P628, DOI 10.1002/hlca.19590420303; Lee T, 2007, MOL HUM REPROD, V13, P771, DOI 10.1093/molehr/gam069; Lopez IA, 2009, J BIOL CHEM, V284, P26882, DOI 10.1074/jbc.M109.008102; Ma TH, 1998, J BIOL CHEM, V273, P4296, DOI 10.1074/jbc.273.8.4296; Morris RG, 2005, AM J PHYSIOL-RENAL, V289, pF194, DOI 10.1152/ajprenal.00121.2004; Nielsen S, 2002, PHYSIOL REV, V82, P205, DOI 10.1152/physrev.00024.2001; NIELSEN S, 1995, AM J PHYSIOL-RENAL, V268, pF1023, DOI 10.1152/ajprenal.1995.268.6.F1023; Park M, 2004, MOL CELL, V16, P331, DOI 10.1016/j.molcel.2004.09.030; Parker MD, 2001, BIOCHEM BIOPH RES CO, V282, P1103, DOI 10.1006/bbrc.2001.4692; Pushkin A, 2006, AM J PHYSIOL-RENAL, V290, pF580, DOI 10.1152/ajprenal.00252.2005; Ramprasad Vedam L, 2007, Hum Mutat, V28, P522, DOI 10.1002/humu.9487; Rickheit G, 2008, EMBO J, V27, P2907, DOI 10.1038/emboj.2008.203; Romero MF, 2005, CURR OPIN NEPHROL HY, V14, P495, DOI 10.1097/01.mnh.0000168333.01831.2c; Schnermann J, 1998, P NATL ACAD SCI USA, V95, P9660, DOI 10.1073/pnas.95.16.9660; Skarnes WC, 2005, P NATL ACAD SCI USA, V102, P13001, DOI 10.1073/pnas.0506279102; Takano J, 2002, NATURE, V420, P337, DOI 10.1038/nature01139; Vithana EN, 2008, HUM MOL GENET, V17, P656, DOI 10.1093/hmg/ddm337; Vithana EN, 2006, NAT GENET, V38, P755, DOI 10.1038/ng1824; Voss AK, 1997, EXP CELL RES, V230, P45, DOI 10.1006/excr.1996.3418; WIRZ H, 1951, HELV PHYSIOL PHARM A, V9, P196; Zhai XY, 2007, J AM SOC NEPHROL, V18, P2937, DOI 10.1681/ASN.2007010056	35	54	56	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14467	14474		10.1074/jbc.M109.094680	http://dx.doi.org/10.1074/jbc.M109.094680			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20185830	Green Published, hybrid			2022-12-25	WOS:000277299700043
J	Ryu, H; Al-Ani, G; Deckert, K; Kirkpatrick, D; Gygi, SP; Dasso, M; Azuma, Y				Ryu, Hyunju; Al-Ani, Gada; Deckert, Katelyn; Kirkpatrick, Donald; Gygi, Steven P.; Dasso, Mary; Azuma, Yoshiaki			PIASy Mediates SUMO-2/3 Conjugation of Poly(ADP-ribose) Polymerase 1 (PARP1) on Mitotic Chromosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOPOISOMERASE-II; SACCHAROMYCES-CEREVISIAE; PROTEIN SUMOYLATION; ACTIVE CENTROMERES; ENZYME; INTERACTS; CENPB; YEAST; BUB3	PIASy is a small ubiquitin-related modifier (SUMO) ligase that modifies chromosomal proteins in mitotic Xenopus egg extracts and plays an essential role in mitotic chromosome segregation. We have isolated a novel SUMO-2/3-modified mitotic chromosomal protein and identified it as poly(ADP-ribose) polymerase 1 (PARP1). PARP1 was robustly conjugated to SUMO-2/ 3 on mitotic chromosomes but not on interphase chromatin. PIASy promotes SUMOylation of PARP1 both in egg extracts and in vitro reconstituted SUMOylation assays. Through tandem mass spectrometry analysis of mitotically SUMOylated PARP1, we identified a residue within the BRCA1 C-terminal domain of PARP1 (lysine 482) as its primary SUMOylation site. Mutation of this residue significantly reduced PARP1 SUMOylation in egg extracts and enhanced the accumulation of species derived from modification of secondary lysine residues in assays using purified components. SUMOylation of PARP1 did not alter in vitro PARP1 enzyme activity, poly-ADP-ribosylation (PARylation), nor did inhibition of SUMOylation of PARP1 alter the accumulation of PARP1 on mitotic chromosomes, suggesting that SUMOylation regulates neither the intrinsic activity of PARP1 nor its localization. However, loss of SUMOylation increased PARP1-dependent PARylation on isolated chromosomes, indicating SUMOylation controls the capacity of PARP1 to modify other chromatin-associated proteins.	[Azuma, Yoshiaki] Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA; [Kirkpatrick, Donald; Gygi, Steven P.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Dasso, Mary] NICHD, Lab Gene Regulat & Dev, NIH, Bethesda, MD 20852 USA	University of Kansas; Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Azuma, Y (corresponding author), 1200 Sunnyside Ave,Haworth Hall,Rm 3037, Lawrence, KS 66045 USA.	azumay@ku.edu		Kirkpatrick, Donald/0000-0003-3091-2804; Dasso, Mary/0000-0002-5410-1371	National Institutes of Health [P20 RR015563, GM80278, GM67945]; Department of Molecular Biosciences at University of Kansas; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001902] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015563] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080278, R01GM067945] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Molecular Biosciences at University of Kansas; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants P20 RR015563 (National Center for Research Resources COBRE-Center for Cancer Experimental Therapeutics) and GM80278 and GM67945 (NIGMS to S. P. G.). This work was also supported in part by a start-up grant from Department of Molecular Biosciences at University of Kansas.	Ame JC, 2004, BIOESSAYS, V26, P882, DOI 10.1002/bies.20085; Azuma Y, 2003, J CELL BIOL, V163, P477, DOI 10.1083/jcb.200304088; Azuma Y, 2001, FASEB J, V15, P1825, DOI 10.1096/fj.00-0818fje; Azuma Y, 2005, EMBO J, V24, P2172, DOI 10.1038/sj.emboj.7600700; Bernier-Villamor V, 2002, CELL, V108, P345, DOI 10.1016/S0092-8674(02)00630-X; Caiafa P, 2009, FASEB J, V23, P672, DOI 10.1096/fj.08-123265; Chang P, 2005, NAT CELL BIOL, V7, P1133, DOI 10.1038/ncb1322; Chang P, 2004, NATURE, V432, P645, DOI 10.1038/nature03061; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; Dasso M, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-5; Denison C, 2005, MOL CELL PROTEOMICS, V4, P246, DOI 10.1074/mcp.M400154-MCP200; Diaz-Martinez LA, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000053; Earle E, 2000, HUM MOL GENET, V9, P187, DOI 10.1093/hmg/9.2.187; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Glover JNM, 2004, TRENDS BIOCHEM SCI, V29, P579, DOI 10.1016/j.tibs.2004.09.010; Hannich JT, 2005, J BIOL CHEM, V280, P4102, DOI 10.1074/jbc.M413209200; Heun P, 2007, CURR OPIN CELL BIOL, V19, P350, DOI 10.1016/j.ceb.2007.04.014; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kane S, 2002, J BIOL CHEM, V277, P22115, DOI 10.1074/jbc.C200198200; Kim MY, 2005, GENE DEV, V19, P1951, DOI 10.1101/gad.1331805; KORNBLUTH S, 2001, CURRENT PROTOCOLS CE; Masson M, 1997, GENE, V190, P287, DOI 10.1016/S0378-1119(97)00015-2; Messner S, 2009, FASEB J, V23, P3978, DOI 10.1096/fj.09-137695; Monaco L, 2005, P NATL ACAD SCI USA, V102, P14244, DOI 10.1073/pnas.0506252102; Palvimo JJ, 2007, BIOCHEM SOC T, V35, P1405, DOI 10.1042/BST0351405; Panse VG, 2004, J BIOL CHEM, V279, P41346, DOI 10.1074/jbc.M407950200; Pichler A, 2002, CELL, V108, P109, DOI 10.1016/S0092-8674(01)00633-X; Quenet D, 2009, INT J BIOCHEM CELL B, V41, P60, DOI 10.1016/j.biocel.2008.07.023; Saxena A, 2002, J BIOL CHEM, V277, P26921, DOI 10.1074/jbc.M200620200; Saxena A, 2002, HUM MOL GENET, V11, P2319, DOI 10.1093/hmg/11.19.2319; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Seeler JS, 2007, CURR TOP MICROBIOL, V313, P49; Takahashi Y, 2006, GENETICS, V172, P783, DOI 10.1534/genetics.105.047167; Wohlschlegel JA, 2004, J BIOL CHEM, V279, P45662, DOI 10.1074/jbc.M409203200; Wong KA, 2004, MOL CELL BIOL, V24, P5577, DOI 10.1128/MCB.24.12.5577-5586.2004; Yunus AA, 2009, MOL CELL, V35, P669, DOI 10.1016/j.molcel.2009.07.013	36	35	36	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14415	14423		10.1074/jbc.M109.074583	http://dx.doi.org/10.1074/jbc.M109.074583			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20228053	Green Published, hybrid			2022-12-25	WOS:000277299700038
J	Krndija, D; Schmid, H; Eismann, JL; Lother, U; Adler, G; Oswald, F; Seufferlein, T; von Wichert, G				Krndija, D.; Schmid, H.; Eismann, J-L; Lother, U.; Adler, G.; Oswald, F.; Seufferlein, T.; von Wichert, G.			Substrate stiffness and the receptor-type tyrosine-protein phosphatase alpha regulate spreading of colon cancer cells through cytoskeletal contractility	ONCOGENE			English	Article						spreading; force; colon cancer; tyrosine-phosphatase; contractility; invasion	SRC-FAMILY KINASES; RPTP-ALPHA; MECHANICAL FORCE; LEADING-EDGE; PTP-ALPHA; FIBROBLASTS; EXPRESSION; ADHESION; MATRIX; ACTIVATION	Microenvironmental clues are critical to cell behavior. One of the key elements of migration is the generation and response to forces. Up to now, there is no definitive concept on how the generation and responses to cellular forces influence cancer-cell behavior. Here, we show that expression of receptor-type tyrosine-protein phosphatase alpha (RPTP alpha) in human SW480 colon cancer cells sets a threshold for the response to matrix forces by changing cellular contractility. This can be explained as an RPTP alpha-mediated increase in contractility with a consecutive increase in number and size of adhesion sites and stress fibers. These effects are mediated through myosin light chain kinase and largely independent of Rho/Rho-kinase (ROCK) signaling. In addition, we report that RPTPa influences spreading on low-rigidity surfaces, binding of collagen-coated beads and expression of RPTPa is required for invasion into the chorioallantoic membrane. These data suggest that force-responsive proteins such as RPTPa can influence cancer-cell behavior and identify potential targets for cancer therapy. Oncogene (2010) 29, 2724-2738; doi:10.1038/onc.2010.25; published online 8 March 2010	[Krndija, D.; Schmid, H.; Eismann, J-L; Lother, U.; Adler, G.; Oswald, F.; Seufferlein, T.; von Wichert, G.] Univ Ulm, Dept Internal Med 1, D-89081 Ulm, Baden Wuerttemb, Germany	Ulm University	von Wichert, G (corresponding author), Univ Ulm, Dept Internal Med 1, Albert Einstein Allee 23, D-89081 Ulm, Baden Wuerttemb, Germany.	goetz.wichert@uniklinik-ulm.de	Krndija, Denis/AAR-5918-2020; Seufferlein, Thomas TW/P-7147-2018; Oswald, Franz/AAO-9584-2020	Krndija, Denis/0000-0001-8686-7542; 	DFG; Deutsche Krebshilfe	DFG(German Research Foundation (DFG)); Deutsche Krebshilfe(Deutsche Krebshilfe)	This work was supported by the DFG to GvW and FO and the Deutsche Krebshilfe to GvW and TS.	Ardini E, 2000, ONCOGENE, V19, P4979, DOI 10.1038/sj.onc.1203869; Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532; Benoliel AM, 2003, ANTICANCER RES, V23, P4891; Berndt A, 1999, HISTOCHEM CELL BIOL, V111, P399, DOI 10.1007/s004180050373; Bodrikov V, 2005, J CELL BIOL, V168, P127, DOI 10.1083/jcb.200405073; Choquet D, 1997, CELL, V88, P39, DOI 10.1016/S0092-8674(00)81856-5; DENHERTOG J, 1993, EMBO J, V12, P3789, DOI 10.1002/j.1460-2075.1993.tb06057.x; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Han B, 2004, J BIOL CHEM, V279, P54793, DOI 10.1074/jbc.M406880200; Harder KW, 1998, J BIOL CHEM, V273, P31890, DOI 10.1074/jbc.273.48.31890; HARRIS AK, 1981, NATURE, V290, P249, DOI 10.1038/290249a0; Ingber DE, 2003, ANN MED, V35, P564, DOI 10.1080/07853890310016333; Jiang GY, 2006, BIOPHYS J, V90, P1804, DOI 10.1529/biophysj.105.072462; Kostic A, 2006, MOL BIOL CELL, V17, P2684, DOI 10.1091/mbc.E05-12-1161; Kunzi-Rapp K, 2001, J UROLOGY, V166, P1502, DOI 10.1016/S0022-5347(05)65820-X; Lee W, 1996, J CELL PHYSIOL, V168, P695, DOI 10.1002/(SICI)1097-4652(199609)168:3<695::AID-JCP22>3.0.CO;2-X; Munevar S, 2001, BIOPHYS J, V80, P1744, DOI 10.1016/S0006-3495(01)76145-0; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Petrone A, 2000, J CELL SCI, V113, P2345; Sahai E, 2002, NAT CELL BIOL, V4, P408, DOI 10.1038/ncb796; Sawada Y, 2006, CELL, V127, P1015, DOI 10.1016/j.cell.2006.09.044; Su J, 1999, CURR BIOL, V9, P505, DOI 10.1016/S0960-9822(99)80234-6; TABITI K, 1995, CANCER LETT, V93, P239, DOI 10.1016/0304-3835(95)03816-F; Thamilselvan V, 2004, GASTROENTEROLOGY, V126, P8, DOI 10.1053/j.gastro.2003.10.078; Totsukawa G, 2004, J CELL BIOL, V164, P427, DOI 10.1083/jcb.200306172; von Wichert G, 2003, J CELL BIOL, V161, P143, DOI 10.1083/jcb.200211061; Wang YL, 1998, METHOD ENZYMOL, V298, P489, DOI 10.1016/S0076-6879(98)98041-7; Wang YX, 2005, NATURE, V434, P1040, DOI 10.1038/nature03469; Wells RG, 2008, HEPATOLOGY, V47, P1394, DOI 10.1002/hep.22193; Wozniak MA, 2003, J CELL BIOL, V163, P583, DOI 10.1083/jcb.200305010; Wu CW, 2006, CANCER LETT, V242, P95, DOI 10.1016/j.canlet.2005.10.046; Zeng L, 2003, J CELL BIOL, V160, P137, DOI 10.1083/jcb.200206049; Zeng L, 1999, J CELL BIOL, V147, P707, DOI 10.1083/jcb.147.4.707; ZHENG XM, 1992, NATURE, V359, P336, DOI 10.1038/359336a0	34	37	38	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAY 6	2010	29	18					2724	2738		10.1038/onc.2010.25	http://dx.doi.org/10.1038/onc.2010.25			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	592DC	20208566				2022-12-25	WOS:000277354600012
J	Sena, CBC; Fukuda, T; Miyanagi, K; Matsumoto, S; Kobayashi, K; Murakami, Y; Maeda, Y; Kinoshita, T; Morita, YS				Sena, Chubert B. C.; Fukuda, Takeshi; Miyanagi, Kana; Matsumoto, Sohkichi; Kobayashi, Kazuo; Murakami, Yoshiko; Maeda, Yusuke; Kinoshita, Taroh; Morita, Yasu S.			Controlled Expression of Branch-forming Mannosyltransferase Is Critical for Mycobacterial Lipoarabinomannan Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRUNCATED STRUCTURAL VARIANTS; PHOSPHATIDYLINOSITOL MANNOSIDES; CORYNEBACTERIUM-GLUTAMICUM; CONSERVED GENE; CELL-WALL; TUBERCULOSIS; SMEGMATIS; IDENTIFICATION; LIPOMANNAN; PHLEI	Lipomannan (LM) and lipoarabinomannan (LAM) are phosphatidylinositol-anchored glycans present in the mycobacterial cell wall. In Mycobacterium smegmatis, the mannan core of LM/LAM constitutes a linear chain of 20-25 alpha 1,6-mannoses elaborated by 8-9 alpha 1,2-monomannose side branches. At least two alpha 1,6-mannosyltransferases mediate the linear mannose chain elongation, and one branching alpha 1,2-mannosyltransferase (encoded by MSMEG_4247) transfers monomannose branches. An MSMEG_4247 deletion mutant accumulates branchless LAM and interestingly fails to accumulate LM, suggesting an unexpected role of mannose branching for LM synthesis or maintenance. To understand the roles of MSMEG_4247-mediated branching more clearly, we analyzed the MSMEG_4247 deletion mutant in detail. Our study showed that the deletion mutant restored the synthesis of wild-type LM and LAM upon the expression of MSMEG_4247 at wild-type levels. In striking contrast, overexpression of MSMEG_4247 resulted in the accumulation of dwarfed LM/LAM, although monomannose branching was restored. The dwarfed LAM carried a mannan chain less than half the length of wild-type LAM and was elaborated by an arabinan that was about 4 times smaller. Induced overexpression of an elongating alpha 1,6-mannosyltransferase competed with the overexpressed branching enzyme, alleviating the dwarfing effect of the branching enzyme. In wild-type cells, LM and LAM decreased in quantity in the stationary phase, and the expression levels of branching and elongating mannosyltransferases were reduced in concert, presumably to avoid producing abnormal LM/LAM. These data suggest that the coordinated expressions of branching and elongating mannosyltransferases are critical for mannan backbone elongation.	[Morita, Yasu S.] Osaka Univ, Microbial Dis Res Inst, Dept Immunoregulat, Suita, Osaka 5650871, Japan; [Sena, Chubert B. C.; Fukuda, Takeshi; Miyanagi, Kana; Murakami, Yoshiko; Maeda, Yusuke; Kinoshita, Taroh; Morita, Yasu S.] Osaka Univ, WPI Immunol Frontier Res Ctr, Suita, Osaka 5650871, Japan; [Matsumoto, Sohkichi] Osaka City Univ, Grad Sch Med, Dept Bacteriol, Osaka 5458585, Japan; [Kobayashi, Kazuo] Natl Inst Infect Dis, Dept Immunol, Tokyo 1628640, Japan	Osaka University; Osaka University; Osaka Metropolitan University; National Institute of Infectious Diseases (NIID)	Morita, YS (corresponding author), Osaka Univ, Microbial Dis Res Inst, Dept Immunoregulat, 3-1 Yamada Oka, Suita, Osaka 5650871, Japan.	ymorita@biken.osaka-u.ac.jp	Kinoshita, Taroh/C-7353-2009	Matsumoto, Sohkichi/0000-0002-6106-7538; Morita, Yasu/0000-0002-4514-9242; Sena, Chubert/0000-0002-2328-9885	Ministry of Health, Labor, and Welfare; Ministry of Education, Culture, Sports, Science, and Technology; Japan Health Sciences Foundation; United States-Japan Cooperative Medical Science Program against Tuberculosis and Leprosy; Knowledge Cluster Initiative of the Ministry of Education, Culture, Sports, Science, and Technology; International Human Frontier Science Program; Japan Society for the Promotion of Science [KAKENHI 20590441]	Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Health Sciences Foundation; United States-Japan Cooperative Medical Science Program against Tuberculosis and Leprosy; Knowledge Cluster Initiative of the Ministry of Education, Culture, Sports, Science, and Technology; International Human Frontier Science Program(Human Frontier Science Program); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Supported by grants from the Ministry of Health, Labor, and Welfare (Research on Emerging and Re-emerging Infectious Diseases), Ministry of Education, Culture, Sports, Science, and Technology, Japan Health Sciences Foundation, and the United States-Japan Cooperative Medical Science Program against Tuberculosis and Leprosy.; Supported by the Knowledge Cluster Initiative of the Ministry of Education, Culture, Sports, Science, and Technology.; Supported by grants from the International Human Frontier Science Program and Japan Society for the Promotion of Science (KAKENHI 20590441).	Alderwick LJ, 2007, BIOCHEM SOC T, V35, P1325, DOI 10.1042/BST0351325; Besra GS, 1997, J BIOL CHEM, V272, P18460, DOI 10.1074/jbc.272.29.18460; BRENNAN P, 1967, J BIOL CHEM, V242, P3046; BRENNAN P, 1968, J BIOL CHEM, V243, P2975; Brennan PJ, 2003, TUBERCULOSIS, V83, P91, DOI 10.1016/S1472-9792(02)00089-6; Briken V, 2004, MOL MICROBIOL, V53, P391, DOI 10.1111/j.1365-2958.2004.04183.x; CHATTERJEE D, 1992, J BIOL CHEM, V267, P6228; Crellin PK, 2008, J BACTERIOL, V190, P3690, DOI 10.1128/JB.00200-08; Gilleron M, 1997, J BIOL CHEM, V272, P117; Guerin ME, 2009, J BIOL CHEM, V284, P25687, DOI 10.1074/jbc.M109.030593; Haites RE, 2005, J BIOL CHEM, V280, P10981, DOI 10.1074/jbc.M413443200; Kaur D, 2007, J BIOL CHEM, V282, P27133, DOI 10.1074/jbc.M703389200; Kaur D, 2006, P NATL ACAD SCI USA, V103, P13664, DOI 10.1073/pnas.0603049103; Kaur D, 2008, P NATL ACAD SCI USA, V105, P17973, DOI 10.1073/pnas.0807761105; KHOO KH, 1995, J BIOL CHEM, V270, P12380, DOI 10.1074/jbc.270.21.12380; Khoo KH, 1996, J BIOL CHEM, V271, P28682, DOI 10.1074/jbc.271.45.28682; KHOO KH, 1995, GLYCOBIOLOGY, V5, P117, DOI 10.1093/glycob/5.1.117; Kordulakova J, 2003, J BIOL CHEM, V278, P36285, DOI 10.1074/jbc.M303639200; Kordulakova J, 2002, J BIOL CHEM, V277, P31335, DOI 10.1074/jbc.M204060200; Kovacevic S, 2006, J BIOL CHEM, V281, P9011, DOI 10.1074/jbc.M511709200; LEE YC, 1964, J BIOL CHEM, V239, P1316; Mishra AK, 2008, MOL MICROBIOL, V68, P1595, DOI 10.1111/j.1365-2958.2008.06265.x; Mishra AK, 2007, MOL MICROBIOL, V65, P1503, DOI 10.1111/j.1365-2958.2007.05884.x; Morita YS, 2006, J BIOL CHEM, V281, P25143, DOI 10.1074/jbc.M604214200; Morita YS, 2005, J BIOL CHEM, V280, P21645, DOI 10.1074/jbc.m414181200; Morita YS, 2004, BIOCHEM J, V378, P589, DOI 10.1042/BJ20031372; Pitarque S, 2008, TUBERCULOSIS, V88, P560, DOI 10.1016/j.tube.2008.04.002; Sauton B, 1912, CR HEBD ACAD SCI, V155, P860; SCHNEIDER P, 1993, ANAL BIOCHEM, V210, P106, DOI 10.1006/abio.1993.1158; Shi LB, 2006, J BIOL CHEM, V281, P19512, DOI 10.1074/jbc.M513846200; SNAPPER SB, 1988, P NATL ACAD SCI USA, V85, P6987, DOI 10.1073/pnas.85.18.6987; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Torrelles JB, 2004, J BIOL CHEM, V279, P41227, DOI 10.1074/jbc.M405180200; Triccas JA, 1998, FEMS MICROBIOL LETT, V167, P151, DOI 10.1111/j.1574-6968.1998.tb13221.x	34	32	32	5	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13326	13336		10.1074/jbc.M109.077297	http://dx.doi.org/10.1074/jbc.M109.077297			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20215111	hybrid, Green Published			2022-12-25	WOS:000276987700003
J	White, CN; Liu, CC; Garcia, A; Hamilton, EJ; Chia, KKM; Figtree, GA; Rasmussen, HH				White, Caroline N.; Liu, Chia-Chi; Garcia, Alvaro; Hamilton, Elisha J.; Chia, Karin K. M.; Figtree, Gemma A.; Rasmussen, Helge H.			Activation of cAMP-dependent Signaling Induces Oxidative Modification of the Cardiac Na+-K+ Pump and Inhibits Its Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-A; CFTR CL-CHANNELS; MEDIATED ACTIVATION; NADPH OXIDASE; PHOSPHORYLATION; PHOSPHOLEMMAN; HEART; STIMULATION; DOPAMINE; MYOCYTES	Cellular signaling can inhibit the membrane Na+-K+ pump via protein kinase C (PKC)-dependent activation of NADPH oxidase and a downstream oxidative modification, glutathionylation, of the beta(1) subunit of the pump alpha/beta heterodimer. It is firmly established that cAMP-dependent signaling also regulates the pump, and we have now examined the hypothesis that such regulation can be mediated by glutathionylation. Exposure of rabbit cardiac myocytes to the adenylyl cyclase activator forskolin increased the co-immunoprecipitation of NADPH oxidase subunits p47(phox) and p22(phox), required for its activation, and increased superoxide-sensitive fluorescence. Forskolin also increased glutathionylation of the Na+-K+ pump beta(1) subunit and decreased its co-immunoprecipitation with the alpha(1) subunit, findings similar to those already established for PKC-dependent signaling. The decrease in co-immunoprecipitation indicates a decrease in the alpha(1)/beta(1) subunit interaction known to be critical for pump function. In agreement with this, forskolin decreased ouabain-sensitive electrogenic Na+-K+ pump current (arising from the 3:2 Na+:K+ exchange ratio) of voltage-clamped, internally perfused myocytes. The decrease was abolished by the inclusion of superoxide dismutase, the inhibitory peptide for the epsilon-isoform of PKC or inhibitory peptide for NADPH oxidase in patch pipette solutions that perfuse the intracellular compartment. Pump inhibition was also abolished by inhibitors of protein kinase A and phospholipase C. We conclude that cAMP- and PKC-dependent inhibition of the cardiac Na+-K+ pump occurs via a shared downstream oxidative signaling pathway involving NADPH oxidase activation and glutathionylation of the pump beta(1) subunit.	[White, Caroline N.; Garcia, Alvaro; Chia, Karin K. M.; Figtree, Gemma A.; Rasmussen, Helge H.] Royal N Shore Hosp, Dept Cardiol, St Leonards, NSW 2065, Australia; [White, Caroline N.; Liu, Chia-Chi; Garcia, Alvaro; Hamilton, Elisha J.; Chia, Karin K. M.; Figtree, Gemma A.; Rasmussen, Helge H.] Univ Sydney, Kolling Inst, N Shore Heart Res Grp, Sydney, NSW 2065, Australia	Royal North Shore Hospital; University of Sydney; Kolling Institute of Medical Research	Rasmussen, HH (corresponding author), Royal N Shore Hosp, Dept Cardiol, St Leonards, NSW 2065, Australia.	helge.rasmussen@sydney.edu.au	Hamilton, Elisha/F-8187-2010; Garcia, Alvaro/E-6573-2015	Hamilton, Elisha/0000-0002-1892-352X; Rasmussen, Helge/0000-0003-2409-4083; Garcia, Alvaro/0000-0002-1159-4567	North Shore Heart Research Foundation; National Health and Medical Research Council; Royal Australian College of Physicians/High Blood Pressure Research Foundation Fellowship; Sydney Medical Foundation	North Shore Heart Research Foundation; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Royal Australian College of Physicians/High Blood Pressure Research Foundation Fellowship; Sydney Medical Foundation	The work was supported by grants from the North Shore Heart Research Foundation and the National Health and Medical Research Council.; Supported by a Royal Australian College of Physicians/High Blood Pressure Research Foundation Fellowship and the University of Sydney Medical Foundation.	Adachi T, 2004, NAT MED, V10, P1200, DOI 10.1038/nm1119; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Bibert S, 2008, J BIOL CHEM, V283, P476, DOI 10.1074/jbc.M705830200; Blanco G, 1998, AM J PHYSIOL-RENAL, V275, pF633, DOI 10.1152/ajprenal.1998.275.5.F633; Bossuyt J, 2009, J BIOL CHEM, V284, P26749, DOI 10.1074/jbc.M109.047357; Buhagiar KA, 2001, AM J PHYSIOL-CELL PH, V281, pC1059, DOI 10.1152/ajpcell.2001.281.3.C1059; Cheng XD, 2008, ACTA BIOCH BIOPH SIN, V40, P651, DOI 10.1111/j.1745-7270.2008.00438.x; Despa S, 2005, CIRC RES, V97, P252, DOI 10.1161/01.RES.0000176532.97731.e5; Despa S, 2008, CIRCULATION, V117, P1849, DOI 10.1161/CIRCULATIONAHA.107.754051; Despa S, 2007, AM J PHYSIOL-CELL PH, V293, pC321, DOI 10.1152/ajpcell.00597.2006; Erlenkamp S, 2002, PFLUG ARCH EUR J PHY, V444, P251, DOI 10.1007/s00424-002-0802-4; Feschenko MS, 2000, J BIOL CHEM, V275, P34693, DOI 10.1074/jbc.M005869200; Figtree GA, 2009, CIRC RES, V105, P185, DOI 10.1161/CIRCRESAHA.109.199547; Fuller W, 2009, AM J PHYSIOL-CELL PH, V296, pC1346, DOI 10.1152/ajpcell.00523.2008; GAO J, 1992, J PHYSIOL-LONDON, V449, P689, DOI 10.1113/jphysiol.1992.sp019109; Gao J, 1998, PFLUG ARCH EUR J PHY, V435, P479, DOI 10.1007/s004240050542; GARCIA A, 2008, 12 INT ATPASE C AARH; Geering K, 2008, CURR OPIN NEPHROL HY, V17, P526, DOI 10.1097/MNH.0b013e3283036cbf; Gomes P, 2004, EUR J PHARMACOL, V488, P51, DOI 10.1016/j.ejphar.2004.02.011; Gomes P, 2002, AM J PHYSIOL-RENAL, V282, pF1084, DOI 10.1152/ajprenal.00318.2001; Hansen PS, 2000, AM J PHYSIOL-CELL PH, V278, pC546, DOI 10.1152/ajpcell.2000.278.3.C546; Hoffmann C, 2004, N-S ARCH PHARMACOL, V369, P151, DOI 10.1007/s00210-003-0860-y; HOOL LC, 1995, AM J PHYSIOL-CELL PH, V268, pC366, DOI 10.1152/ajpcell.1995.268.2.C366; Kim YM, 2005, CIRC RES, V97, P629, DOI 10.1161/01.RES.0000183735.09871.61; Klein L, 2003, AM J CARDIOL, V91, p18F, DOI 10.1016/S0002-9149(02)03336-2; Kockskamper J, 2000, J PHYSIOL-LONDON, V523, P561, DOI 10.1111/j.1469-7793.2000.t01-2-00561.x; Kockskamper J, 2001, PFLUG ARCH EUR J PHY, V441, P807, DOI 10.1007/s004240000485; Mihailidou AS, 1998, AM J PHYSIOL-CELL PH, V274, pC175, DOI 10.1152/ajpcell.1998.274.1.C175; Murdoch CE, 2006, CURR OPIN PHARMACOL, V6, P148, DOI 10.1016/j.coph.2005.10.008; NAKAO M, 1989, J GEN PHYSIOL, V94, P539, DOI 10.1085/jgp.94.3.539; Oestreich EA, 2007, J BIOL CHEM, V282, P5488, DOI 10.1074/jbc.M608495200; PACKER M, 1991, NEW ENGL J MED, V325, P1468, DOI 10.1056/NEJM199111213252103; Park JW, 1997, J BIOL CHEM, V272, P11035; Pieske B, 2003, CARDIOVASC RES, V57, P874, DOI 10.1016/S0008-6363(02)00841-6; Pieske B, 2003, CARDIOVASC RES, V57, P871, DOI 10.1016/S0008-6363(02)00849-0; Silverman BD, 2005, CARDIOVASC RES, V65, P93, DOI 10.1016/j.cardiores.2004.09.005; Therien AG, 2000, AM J PHYSIOL-CELL PH, V279, pC541, DOI 10.1152/ajpcell.2000.279.3.C541; White CN, 2008, AM J PHYSIOL-CELL PH, V294, pC572, DOI 10.1152/ajpcell.00242.2007; White CN, 2009, AM J PHYSIOL-CELL PH, V296, pC693, DOI 10.1152/ajpcell.00648.2008; William M, 2005, J PHYSIOL-LONDON, V565, P815, DOI 10.1113/jphysiol.2005.086447; Winterbourn CC, 2008, NAT CHEM BIOL, V4, P278, DOI 10.1038/nchembio.85; Yao L, 2008, MOL PHARMACOL, V73, P1105, DOI 10.1124/mol.107.042580; *ZAM SEV HEART FAI, 1990, LANCET, V336, P1	43	45	49	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13712	13720		10.1074/jbc.M109.090225	http://dx.doi.org/10.1074/jbc.M109.090225			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20194511	hybrid, Green Published			2022-12-25	WOS:000276987700046
J	Wright, TM; Rathmell, WK				Wright, Tricia M.; Rathmell, W. Kimryn			Identification of Ror2 as a Hypoxia-inducible Factor Target in von Hippel-Lindau-associated Renal Cell Carcinoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR PROTEIN; TYROSINE KINASE ROR2; HIF-ALPHA; UBIQUITIN LIGASE; VHL; GENE; COMPLEX; FAMILY; EXPRESSION; MUTATIONS	Ror2 is an orphan receptor tyrosine kinase with expression normally restricted to early stages of development. However, emerging evidence has placed aberrantly expressed Ror2, leading to an invasive phenotype, in several cancers including renal cell carcinoma (RCC). Although Ror2 is currently identified as up-regulated in an assortment of cancers, neither the regulatory role or mechanism of action have been delineated. Wesought to place Ror2 in the most commonly mutated pathway of RCC, the loss of the tumor suppressor von Hippel-Lindau (VHL), which causes hypoxia-inducible factor (HIF)-1 alpha and -2 alpha stabilization and the transcriptional activation of a broad repertoire of response genes. We found that Ror2 was indeed associated with the pVHL loss in RCC as well as with VHL somatic mutations tightly coordinated with the induction of RCC. Additionally, knockdown and rescue analysis of HIF expression suggests that Ror2 is dependent on pathologic stabilization of either HIF-1 alpha or HIF-2 alpha. Subsequent evaluation of the ROR2 promoter suggests that HIF-2 alpha and its dimerization partner, aryl hydrocarbon nuclear transferase localize to the ROR2 promoter via a cryptic transcriptional element. This data substantiates a unique regulation pattern for Ror2 in the VHL-HIF axis that has the potential to be applied to other cancer etiologies.	[Wright, Tricia M.; Rathmell, W. Kimryn] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Genet Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Rathmell, WK (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Genet Curriculum Genet & Mol Biol, 450 W Dr,CB 7295, Chapel Hill, NC 27599 USA.	rathmell@med.unc.edu	, UNC Flow Cytometry Core/AGU-9839-2022		National Institutes of Health [F31CA132543, R01 CA121781]; NCI; Doris Duke Charitable Fund; NATIONAL CANCER INSTITUTE [F31CA132543, R01CA121781] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Doris Duke Charitable Fund(Doris Duke Charitable Foundation (DDCF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health NRSA Program Grants F31CA132543 (to T. M. W.) and R01 CA121781 (to W. K. R.) from the NCI and a grant from the Doris Duke Charitable Fund (to W. K. R.).	Al-Shawi R, 2001, DEV GENES EVOL, V211, P161, DOI 10.1007/s004270100140; Benita Y, 2009, NUCLEIC ACIDS RES, V37, P4587, DOI 10.1093/nar/gkp425; Billiard J, 2005, MOL ENDOCRINOL, V19, P90, DOI 10.1210/me.2004-0153; Bishop T, 2004, PLOS BIOL, V2, P1549, DOI 10.1371/journal.pbio.0020289; Forrester WC, 2002, CELL MOL LIFE SCI, V59, P83, DOI 10.1007/s00018-002-8407-9; GNARRA JR, 1994, NAT GENET, V7, P85, DOI 10.1038/ng0594-85; Gnarra JR, 1997, P NATL ACAD SCI USA, V94, P9102, DOI 10.1073/pnas.94.17.9102; Gordan JD, 2007, CURR OPIN GENET DEV, V17, P71, DOI 10.1016/j.gde.2006.12.006; Gordan JD, 2008, CANCER CELL, V14, P435, DOI 10.1016/j.ccr.2008.10.016; Hacker KE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003801; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Iliopoulos O, 1996, P NATL ACAD SCI USA, V93, P10595, DOI 10.1073/pnas.93.20.10595; Ivan M, 2002, P NATL ACAD SCI USA, V99, P13459, DOI 10.1073/pnas.192342099; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Iwai K, 1999, P NATL ACAD SCI USA, V96, P12436, DOI 10.1073/pnas.96.22.12436; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jiang YD, 2003, MOL CANCER RES, V1, P453; Kamura T, 1999, SCIENCE, V284, P657, DOI 10.1126/science.284.5414.657; KIBEL A, 1995, SCIENCE, V269, P1444, DOI 10.1126/science.7660130; Kobayashi M, 2009, ORAL SURG ORAL MED O, V107, P398, DOI 10.1016/j.tripleo.2008.08.018; Kondo K, 2003, PLOS BIOL, V1, P439, DOI 10.1371/journal.pbio.0000083; Kondo K, 2002, GENE CHROMOSOME CANC, V34, P58, DOI 10.1002/gcc.10054; Kondo K, 2002, CANCER CELL, V1, P237, DOI 10.1016/S1535-6108(02)00043-0; Kubo T, 2009, CARCINOGENESIS, V30, P1857, DOI 10.1093/carcin/bgp206; Lee CM, 2009, ONCOGENE, V28, P1694, DOI 10.1038/onc.2009.12; Mandriota SJ, 2002, CANCER CELL, V1, P459, DOI 10.1016/S1535-6108(02)00071-5; MASIAKOWSKI P, 1992, J BIOL CHEM, V267, P26181; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Mikels A, 2009, J BIOL CHEM, V284, P30167, DOI 10.1074/jbc.M109.041715; Morioka K, 2009, CANCER SCI, V100, P1227, DOI 10.1111/j.1349-7006.2009.01165.x; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Pause A, 1997, P NATL ACAD SCI USA, V94, P2156, DOI 10.1073/pnas.94.6.2156; Schwabe GC, 2004, DEV DYNAM, V229, P400, DOI 10.1002/dvdy.10466; Shen C, 2005, J BIOL CHEM, V280, P20580, DOI 10.1074/jbc.M501894200; SHUIN T, 1994, CANCER RES, V54, P2852; Wright TM, 2009, ONCOGENE, V28, P2513, DOI 10.1038/onc.2009.116; Zhou MI, 2004, CANCER RES, V64, P1278, DOI 10.1158/0008-5472.CAN-03-0884	37	19	19	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12916	12924		10.1074/jbc.M109.073924	http://dx.doi.org/10.1074/jbc.M109.073924			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20185829	hybrid, Green Published			2022-12-25	WOS:000276787800050
J	Creighton, CJ; Benham, AL; Zhu, HF; Khan, MF; Reid, JG; Nagaraja, AK; Fountain, MD; Dziadek, O; Han, D; Ma, L; Kim, J; Hawkins, SM; Anderson, ML; Matzuk, MM; Gunaratne, PH				Creighton, Chad J.; Benham, Ashley L.; Zhu, Huifeng; Khan, Mahjabeen F.; Reid, Jeffrey G.; Nagaraja, Ankur K.; Fountain, Michael D., Jr.; Dziadek, Olivia; Han, Derek; Ma, Lang; Kim, Jong; Hawkins, Shannon M.; Anderson, Matthew L.; Matzuk, Martin M.; Gunaratne, Preethi H.			Discovery of Novel MicroRNAs in Female Reproductive Tract Using Next Generation Sequencing	PLOS ONE			English	Article							EXPRESSION PROFILES; RNA; IDENTIFICATION; GENES	MicroRNAs (miRNAs) are small non-coding RNAs that mediate post-transcriptional gene silencing. Over 700 human miRNAs have currently been identified, many of which are mutated or de-regulated in diseases. Here we report the identification of novel miRNAs through deep sequencing the small RNAome (<30 nt) of over 100 tissues or cell lines derived from human female reproductive organs in both normal and disease states. These specimens include ovarian epithelium and ovarian cancer, endometrium and endometriomas, and uterine myometrium and uterine smooth muscle tumors. Sequence reads not aligning with known miRNAs were each mapped to the genome to extract flanking sequences. These extended sequence regions were folded in silico to identify RNA hairpins. Sequences demonstrating the ability to form a stem loop structure with low minimum free energy (<-225 kcal) and predicted Drosha and Dicer cut sites yielding a mature miRNA sequence matching the actual sequence were considered putative novel miRNAs. Additional confidence was achieved when putative novel hairpins assembled a collection of sequences highly similar to the putative mature miRNA but with heterogeneous 3'-ends. A confirmed novel miRNA fulfilled these criteria and had its "star" sequence in our collection. We found 7 distinct confirmed novel miRNAs, and 51 additional novel miRNAs that represented highly confident predictions but without detectable star sequences. Our novel miRNAs were detectable in multiple samples, but expressed at low levels and not specific to any one tissue or cell type. To date, this study represents the largest set of samples analyzed together to identify novel miRNAs.	[Creighton, Chad J.] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Creighton, Chad J.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Khan, Mahjabeen F.; Nagaraja, Ankur K.; Fountain, Michael D., Jr.; Dziadek, Olivia; Han, Derek; Ma, Lang; Anderson, Matthew L.; Matzuk, Martin M.; Gunaratne, Preethi H.] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; [Reid, Jeffrey G.; Gunaratne, Preethi H.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Nagaraja, Ankur K.; Matzuk, Martin M.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Matzuk, Martin M.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Benham, Ashley L.; Zhu, Huifeng; Kim, Jong; Gunaratne, Preethi H.] Univ Houston, Dept Biol & Biochem, Houston, TX USA; [Hawkins, Shannon M.; Anderson, Matthew L.] Baylor Coll Med, Dept Obstet & Gynecol, Houston, TX 77030 USA; [Fountain, Michael D., Jr.; Matzuk, Martin M.] Baylor Coll Med, Translat Biol & Mol Med Program, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Houston System; University of Houston; Baylor College of Medicine; Baylor College of Medicine	Creighton, CJ (corresponding author), Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA.	phgunaratne@uh.edu	Hawkins, Shannon/AAX-5216-2020; Hawkins, Shannon M/B-7095-2015; Anderson, Matthew/C-4755-2019	Hawkins, Shannon/0000-0002-0727-3971; Hawkins, Shannon M/0000-0002-0727-3971; Anderson, Matthew/0000-0002-2081-4672	Ovarian Cancer Research Fund; Young Texans Against Cancer; National Institutes of Health [CA60651, P30 CA125123, K12 HD01426-02]; Specialized Cooperative Centers in Reproductive & Infertility Research [U54HD07495]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD007495] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K12HD001426] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA125123, P50CA083639, R01CA060651] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM056929] Funding Source: NIH RePORTER	Ovarian Cancer Research Fund; Young Texans Against Cancer; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Specialized Cooperative Centers in Reproductive & Infertility Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by a Program Project Development Grant from the Ovarian Cancer Research Fund (CJC, JGR, MLA, MMM, PHG), the Young Texans Against Cancer (MLA, MMM), and National Institutes of Health Grants CA60651 (MMM), P30 CA125123 (CJC), and K12 HD01426-02 (MLA), and the Specialized Cooperative Centers in Reproductive & Infertility Research U54HD07495 (CJC, SMH, MMM, PHG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Garcia I, 2005, DEVELOPMENT, V132, P4653, DOI 10.1242/dev.02073; Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Aravin A, 2005, FEBS LETT, V579, P5830, DOI 10.1016/j.febslet.2005.08.009; Bar M, 2008, STEM CELLS, V26, P2496, DOI 10.1634/stemcells.2008-0356; Berezikov E, 2006, NAT GENET, V38, P1375, DOI 10.1038/ng1914; CREIGHTON C, CANC RES IN PRESS; Creighton CJ, 2009, BRIEF BIOINFORM, V10, P490, DOI 10.1093/bib/bbp019; Ender C, 2008, MOL CELL, V32, P519, DOI 10.1016/j.molcel.2008.10.017; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; GISH W, COMMUNICATION; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; Lai EC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r42; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Marsh EE, 2008, FERTIL STERIL, V89, P1771, DOI 10.1016/j.fertnstert.2007.05.074; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Nagaraja AK, 2010, MOL ENDOCRINOL, V24, P447, DOI 10.1210/me.2009-0295; Nam EJ, 2008, CLIN CANCER RES, V14, P2690, DOI 10.1158/1078-0432.CCR-07-1731; Oulas A, 2009, NUCLEIC ACIDS RES, V37, P3276, DOI 10.1093/nar/gkp120; Ozen M, 2008, ONCOGENE, V27, P1788, DOI 10.1038/sj.onc.1210809; Pan Q, 2007, MOL HUM REPROD, V13, P797, DOI 10.1093/molehr/gam063; Reid JG, 2008, GENOME RES, V18, P1571, DOI 10.1101/gr.078246.108; Teague EMCO, 2009, MOL ENDOCRINOL, V23, P265, DOI 10.1210/me.2008-0387; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Zhang L, 2008, P NATL ACAD SCI USA, V105, P7004, DOI 10.1073/pnas.0801615105	29	76	150	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2010	5	3							e9637	10.1371/journal.pone.0009637	http://dx.doi.org/10.1371/journal.pone.0009637			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565XE	20224791	Green Published, Green Submitted, gold			2022-12-25	WOS:000275328800031
J	Leidner, AK; Haddad, NM; Lovejoy, TE				Leidner, Allison K.; Haddad, Nick M.; Lovejoy, Thomas E.			Does Tropical Forest Fragmentation Increase Long-Term Variability of Butterfly Communities?	PLOS ONE			English	Article							PLANT-SPECIES RICHNESS; HABITAT FRAGMENTATION; DEFORESTATION; EXTINCTIONS; LANDSCAPE; ABUNDANCE; RESPONSES; DECAY; BIRDS	Habitat fragmentation is a major driver of biodiversity loss. Yet, the overall effects of fragmentation on biodiversity may be obscured by differences in responses among species. These opposing responses to fragmentation may be manifest in higher variability in species richness and abundance (termed hyperdynamism), and in predictable changes in community composition. We tested whether forest fragmentation causes long-term hyperdynamism in butterfly communities, a taxon that naturally displays large variations in species richness and community composition. Using a dataset from an experimentally fragmented landscape in the central Amazon that spanned 11 years, we evaluated the effect of fragmentation on changes in species richness and community composition through time. Overall, adjusted species richness (adjusted for survey duration) did not differ between fragmented forest and intact forest. However, spatial and temporal variation of adjusted species richness was significantly higher in fragmented forests relative to intact forest. This variation was associated with changes in butterfly community composition, specifically lower proportions of understory shade species and higher proportions of edge species in fragmented forest. Analysis of rarefied species richness, estimated using indices of butterfly abundance, showed no differences between fragmented and intact forest plots in spatial or temporal variation. These results do not contradict the results from adjusted species richness, but rather suggest that higher variability in butterfly adjusted species richness may be explained by changes in butterfly abundance. Combined, these results indicate that butterfly communities in fragmented tropical forests are more variable than in intact forest, and that the natural variability of butterflies was not a buffer against the effects of fragmentation on community dynamics.	[Leidner, Allison K.; Haddad, Nick M.] N Carolina State Univ, Dept Biol, Raleigh, NC 27695 USA; [Lovejoy, Thomas E.] H John Heinz III Ctr Sci Econ & Environm, Washington, DC USA; [Lovejoy, Thomas E.] Inst Nacl de Pesquisas da Amazonia, Biol Dynam Forest Fragments Project, Manaus, Amazonas, Brazil; [Lovejoy, Thomas E.] Smithsonian Trop Res Inst, Manaus, Amazonas, Brazil; [Lovejoy, Thomas E.] George Mason Univ, Dept Environm Sci & Policy, Fairfax, VA 22030 USA	University of North Carolina; North Carolina State University; Institute Nacional de Pesquisas da Amazonia; Smithsonian Institution; Smithsonian Tropical Research Institute; George Mason University	Leidner, AK (corresponding author), Univ Maryland, Dept Plant Sci & Landscape Architecture, College Pk, MD 20742 USA.	Leidner@umd.edu			Andrew W. Mellon Foundation; CitiCorp; Smithsonian Institution; Man and the Biosphere Program (MAB); World Wildlife Fund	Andrew W. Mellon Foundation; CitiCorp; Smithsonian Institution(Smithsonian Institution); Man and the Biosphere Program (MAB); World Wildlife Fund	The Andrew W. Mellon Foundation, CitiCorp, the Smithsonian Institution, the Man and the Biosphere Program (MAB), and World Wildlife Fund helped fund the Biological Dynamics of Forest Fragments Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benitez-Malvido J, 2003, CONSERV BIOL, V17, P389, DOI 10.1046/j.1523-1739.2003.01120.x; Boulinier T, 1998, P NATL ACAD SCI USA, V95, P7497, DOI 10.1073/pnas.95.13.7497; Brook BW, 2003, NATURE, V424, P420, DOI 10.1038/nature01795; Brown Keith S. Jr., 1997, P91; Colwell RK, 2004, ECOLOGY, V85, P2717, DOI 10.1890/03-0557; Damschen EI, 2006, SCIENCE, V313, P1284, DOI 10.1126/science.1130098; Debinski DM, 2000, CONSERV BIOL, V14, P342, DOI 10.1046/j.1523-1739.2000.98081.x; Didham RK, 1998, ECOL MONOGR, V68, P295, DOI 10.1890/0012-9615(1998)068[0295:BSRTTF]2.0.CO;2; ERWIN TL, 1997, BIODIVERSITY, V2; Ewers RM, 2006, BIOL REV, V81, P117, DOI 10.1017/S1464793105006949; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Ferraz G, 2007, SCIENCE, V315, P238, DOI 10.1126/science.1133097; Gascon C, 1999, BIOL CONSERV, V91, P223, DOI 10.1016/S0006-3207(99)00080-4; Henle K, 2004, BIODIVERS CONSERV, V13, P207, DOI 10.1023/B:BIOC.0000004319.91643.9e; KAREIVA P, 1990, PHILOS T R SOC B, V330, P175, DOI 10.1098/rstb.1990.0191; Krauss J, 2003, J BIOGEOGR, V30, P889, DOI 10.1046/j.1365-2699.2003.00878.x; Laurance W.F., 1997, TROPICAL FOREST REMN, V1st; Laurance WF, 2002, J VEG SCI, V13, P595, DOI 10.1111/j.1654-1103.2002.tb02086.x; Laurance WF, 2002, CONSERV BIOL, V16, P605, DOI 10.1046/j.1523-1739.2002.01025.x; Laurance WF, 2006, P NATL ACAD SCI USA, V103, P19010, DOI 10.1073/pnas.0609048103; Malcolm Jay R., 1997, P207; Morris W. F., 2002, QUANTITATIVE CONSERV; Pimm S.L., 1991, BALANCE NATURE; Samways MJ, 1996, BIODIVERS CONSERV, V5, P1047, DOI 10.1007/BF00052715; SAUNDERS DA, 1991, CONSERV BIOL, V5, P18, DOI 10.1111/j.1523-1739.1991.tb00384.x; Shahabuddin G, 2005, BIODIVERS CONSERV, V14, P1137, DOI 10.1007/s10531-004-7842-3; Steffan-Dewenter I, 2000, ECOL LETT, V3, P449, DOI 10.1046/j.1461-0248.2000.00175.x; STORK NE, 1993, BIODIVERS CONSERV, V2, P215, DOI 10.1007/BF00056669; Stratford JA, 1999, CONSERV BIOL, V13, P1416, DOI 10.1046/j.1523-1739.1999.98494.x; Thomas JA, 2004, SCIENCE, V303, P1879, DOI 10.1126/science.1095046; TOUCHER MD, 1997, TROPICAL FOREST REMN; Uehara-Prado M, 2007, GLOBAL ECOL BIOGEOGR, V16, P43, DOI 10.1111/j.1466-8238.2006.00267.x; WOLDA H, 1992, OECOLOGIA, V89, P47, DOI 10.1007/BF00319014; WOLDA H, 1978, AM NAT, V112, P1017, DOI 10.1086/283344; Yaacobi G, 2007, P ROY SOC B-BIOL SCI, V274, P2409, DOI 10.1098/rspb.2007.0674; Yamamoto N, 2007, P NATL ACAD SCI USA, V104, P10524, DOI 10.1073/pnas.0701583104	36	34	35	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2010	5	3							e9534	10.1371/journal.pone.0009534	http://dx.doi.org/10.1371/journal.pone.0009534			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565XE	20224772	Green Published, gold, Green Submitted			2022-12-25	WOS:000275328800006
J	Galmbacher, K; Heisig, M; Hotz, C; Wischhusen, J; Galmiche, A; Bergmann, B; Gentschev, I; Goebel, W; Rapp, UR; Fensterle, J				Galmbacher, Katharina; Heisig, Martin; Hotz, Christian; Wischhusen, Joerg; Galmiche, Antoine; Bergmann, Birgit; Gentschev, Ivaylo; Goebel, Werner; Rapp, Ulf R.; Fensterle, Joachim			Shigella Mediated Depletion of Macrophages in a Murine Breast Cancer Model Is Associated with Tumor Regression	PLOS ONE			English	Article							SALMONELLA-TYPHIMURIUM; THERAPY; PROGRESSION; FLEXNERI; VIRULENCE; PLASMID; CELLS; ACCUMULATION; APOPTOSIS; PROTEINS	A tumor promoting role of macrophages has been described for a transgenic murine breast cancer model. In this model tumor-associated macrophages (TAMs) represent a major component of the leukocytic infiltrate and are associated with tumor progression. Shigella flexneri is a bacterial pathogen known to specificly induce apotosis in macrophages. To evaluate whether Shigella-induced removal of macrophages may be sufficient for achieving tumor regression we have developed an attenuated strain of S. flexneri (M90T Delta aroA) and infected tumor bearing mice. Two mouse models were employed, xenotransplantation of a murine breast cancer cell line and spontanous breast cancer development in MMTV-HER2 transgenic mice. Quantitative analysis of bacterial tumor targeting demonstrated that attenuated, invasive Shigella flexneri primarily infected TAMs after systemic administration. A single i.v. injection of invasive M90TDaroA resulted in caspase-1 dependent apoptosis of TAMs followed by a 74% reduction in tumors of transgenic MMTV-HER-2 mice 7 days post infection. TAM depletion was sustained and associated with complete tumor regression. These data support TAMs as useful targets for antitumor therapy and highlight attenuated bacterial pathogens as potential tools.	[Galmbacher, Katharina; Heisig, Martin; Hotz, Christian; Galmiche, Antoine; Bergmann, Birgit; Gentschev, Ivaylo; Rapp, Ulf R.; Fensterle, Joachim] Univ Wurzburg, Inst Med Strahlenkunde & Zellforsch, Wurzburg, Germany; [Heisig, Martin; Bergmann, Birgit; Goebel, Werner] Univ Wurzburg, Biozentrum, Inst Mikrobiol, Wurzburg, Germany; [Wischhusen, Joerg] Univ Frauen Klin Wurzburg, Wurzburg, Germany	University of Wurzburg; University of Wurzburg; University of Wurzburg	Galmbacher, K (corresponding author), INTERLAB Cent Lab Serv GmbH, Munich, Germany.	jfensterle@aezsinc.com	Gentschev, Ivaylo/F-9454-2011; Gentschev, Ivaylo/AAJ-5819-2021	Gentschev, Ivaylo/0000-0003-3743-6329; Hotz, Christian/0000-0001-6148-9821	International DFG Research Training Group [1141]; Franco-German University [ED-31-04]; Aeterna Zentaris	International DFG Research Training Group; Franco-German University; Aeterna Zentaris	KG, CH and MH were supported by the International DFG Research Training Group 1141 Wuerzburg/Nice (GCWN. de) and the Franco-German University (ED-31-04;http://www.dfh-ufa.org/). This work was supported in part by Aeterna Zentaris (http://www.aeternazentaris.com/) and in part by the Bavarian Research Cooperations Abayfor (Foringen; http://www.bayfor.org/de/geschaeftsbereiche/forschungsverbuende/welt-des-lebens/foringen.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. JF is currently employed by Aeterna Zentaris and during this study he was the group leader in the unit and supervisor of Mrs. Galmbacher.	Agrawal N, 2004, P NATL ACAD SCI USA, V101, P15172, DOI 10.1073/pnas.0406242101; Buchrieser C, 2000, MOL MICROBIOL, V38, P760, DOI 10.1046/j.1365-2958.2000.02179.x; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Cheng HL, 2002, J CLIN ONCOL, V20, P1544, DOI 10.1200/JCO.20.6.1544; COLEY WB, 1991, CLIN ORTHOP RELAT R, P3; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; ELSINGHORST EA, 1994, METHOD ENZYMOL, V236, P405; Fensterle J, 2008, CANCER GENE THER, V15, P85, DOI 10.1038/sj.cgt.7701109; Forbes NS, 2003, CANCER RES, V63, P5188; Fridlender ZG, 2009, CANCER CELL, V16, P183, DOI 10.1016/j.ccr.2009.06.017; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; Kasinskas RW, 2007, CANCER RES, V67, P3201, DOI 10.1158/0008-5472.CAN-06-2618; KURAHARA H, 2009, J SURG RES; Lewis C, 2005, AM J PATHOL, V167, P627, DOI 10.1016/S0002-9440(10)62038-X; Lewis CE, 2006, CANCER RES, V66, P605, DOI 10.1158/0008-5472.CAN-05-4005; Lin EY, 2001, J EXP MED, V193, P727, DOI 10.1084/jem.193.6.727; Lin EY, 2002, J MAMMARY GLAND BIOL, V7, P147, DOI 10.1023/A:1020399802795; Loessner H, 2008, INT J MED MICROBIOL, V298, P21, DOI 10.1016/j.ijmm.2007.07.005; Low KB, 1999, NAT BIOTECHNOL, V17, P37, DOI 10.1038/5205; Mantovani A, 2006, CANCER METAST REV, V25, P315, DOI 10.1007/s10555-006-9001-7; MAURELLI AT, 1984, INFECT IMMUN, V43, P195, DOI 10.1128/IAI.43.1.195-201.1984; Mueller MM, 2004, NAT REV CANCER, V4, P839, DOI 10.1038/nrc1477; Pawelek JM, 1997, CANCER RES, V57, P4537; Pilgrim S, 2003, GENE THER, V10, P2036, DOI 10.1038/sj.gt.3302105; Qian BZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006562; RYMSA B, 1990, RES COMMUN CHEM PATH, V68, P263; SANSONETTI PJ, 1986, INFECT IMMUN, V51, P461, DOI 10.1128/IAI.51.2.461-469.1986; SANSONETTI PJ, 1982, INFECT IMMUN, V35, P852, DOI 10.1128/IAI.35.3.852-860.1982; Van Mellaert L, 2006, TRENDS MICROBIOL, V14, P190, DOI 10.1016/j.tim.2006.02.002; Vassaux G, 2006, J PATHOL, V208, P290, DOI 10.1002/path.1865; Volpers C, 2003, J VIROL, V77, P2093, DOI 10.1128/JVI.77.3.2093-2104.2003; WEIBEL S, 2008, CELL MICROBIOL; Westphal K, 2008, CANCER RES, V68, P2952, DOI 10.1158/0008-5472.CAN-07-2984; Yu YA, 2004, NAT BIOTECHNOL, V22, P313, DOI 10.1038/nbt937; Zeisberger SM, 2006, BRIT J CANCER, V95, P272, DOI 10.1038/sj.bjc.6603240; Zhao M, 2005, P NATL ACAD SCI USA, V102, P755, DOI 10.1073/pnas.0408422102; Zhao M, 2006, CANCER RES, V66, P7647, DOI 10.1158/0008-5472.CAN-06-0716; ZYCHLINSKY A, 1994, MOL MICROBIOL, V11, P619, DOI 10.1111/j.1365-2958.1994.tb00341.x	38	36	40	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2010	5	3					A93	A103	e9572	10.1371/journal.pone.0009572	http://dx.doi.org/10.1371/journal.pone.0009572			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565WZ	20221397	Green Published, gold, Green Submitted			2022-12-25	WOS:000275328200009
J	Ghosh, R; Lipson, KL; Sargent, KE; Mercurio, AM; Hunt, JS; Ron, D; Urano, F				Ghosh, Rajarshi; Lipson, Kathryn L.; Sargent, Karen E.; Mercurio, Arthur M.; Hunt, Joan S.; Ron, David; Urano, Fumihiko			Transcriptional Regulation of VEGF-A by the Unfolded Protein Response Pathway	PLOS ONE			English	Article							PANCREATIC BETA-CELLS; FACTOR MESSENGER-RNA; PLACENTAL DEVELOPMENT; ER STRESS; MAMMALIAN-CELLS; TUMOR-GROWTH; KINASE IRE1; ACGT CORE; IN-VIVO; HYPOXIA	Background: Angiogenesis is crucial to many physiological and pathological processes including development and cancer cell survival. Vascular endothelial growth factor-A (VEGFA) is the predominant mediator of angiogenesis in the VEGF family. During development, adverse environmental conditions like nutrient deprivation, hypoxia and increased protein secretion occur. IRE1 alpha, PERK, and ATF6 alpha, master regulators of the unfolded protein response (UPR), are activated under these conditions and are proposed to have a role in mediating angiogenesis. Principal Findings: Here we show that IRE1 alpha, PERK, and ATF6 alpha powerfully regulate VEGFA mRNA expression under various stress conditions. In Ire1 alpha(-/-) and Perk(-/-) mouse embryonic fibroblasts and ATF6 alpha-knockdown HepG2 cells, induction of VEGFA mRNA by endoplasmic reticulum stress is attenuated as compared to control cells. Embryonic lethality of Ire1 alpha(-/-) mice is due to the lack of VEGFA induction in labyrinthine trophoblast cells of the developing placenta. Rescue of IRE1 alpha and PERK in Ire1 alpha(-/-) and Perk(-/-) cells respectively, prevents VEGFA mRNA attenuation. We further report that the induction of VEGFA by IRE1 alpha, PERK and ATF6 involves activation of transcription factors, spliced-XBP-1, ATF4 and cleaved ATF6 respectively. Conclusions/Significance: Our results reveal that the IRE1 alpha-XBP-1, PERK-ATF4, and ATF6a pathways constitute novel upstream regulatory pathways of angiogenesis by modulating VEGF transcription. Activation of these pathways helps the rapidly growing cells to obtain sufficient nutrients and growth factors for their survival under the prevailing hostile environmental conditions. These results establish an important role of the UPR in angiogenesis.	[Ghosh, Rajarshi; Lipson, Kathryn L.; Sargent, Karen E.; Urano, Fumihiko] Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01605 USA; [Urano, Fumihiko] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA USA; [Mercurio, Arthur M.] Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA USA; [Lipson, Kathryn L.] Western New England Coll, Dept Phys & Biol Sci, Springfield, MA USA; [Hunt, Joan S.] Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66103 USA; [Ron, David] NYU, Sch Med, Skirball Inst, New York, NY USA; [Ron, David] Univ Cambridge, Inst Metab Sci, Cambridge, England	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Western New England University; University of Kansas; University of Kansas Medical Center; New York University; University of Cambridge	Ghosh, R (corresponding author), Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01605 USA.	Fumihiko.Urano@umassmed.edu	Urano, Fumihiko/AAF-4492-2020; Longo, Kenneth A/A-5631-2010	Ron, David/0000-0002-3014-5636; Ghosh, Rajarshi/0000-0002-5780-8241	National Institutes of Health (NIH) [R01DK067493]; Diabetes and Endocrinology Research Center at the University of Massachusetts Medical School [DK032520]; Juvenile Diabetes Research Foundation [1-2008-593]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067493, P30DK032520] Funding Source: NIH RePORTER; Medical Research Council [G0600717B] Funding Source: researchfish	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Diabetes and Endocrinology Research Center at the University of Massachusetts Medical School; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Research in the laboratory of F. Urano is supported by a National Institutes of Health (NIH) R01DK067493 grant, a grant from the Diabetes and Endocrinology Research Center at the University of Massachusetts Medical School (DK032520), and a Juvenile Diabetes Research Foundation Regular Research Grant (1-2008-593). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abcouwer SF, 2002, INVEST OPHTH VIS SCI, V43, P2791; Adelman DM, 2000, GENE DEV, V14, P3191, DOI 10.1101/gad.853700; Blais JD, 2006, MOL CELL BIOL, V26, P9517, DOI 10.1128/MCB.01145-06; Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529; Clauss IM, 1996, NUCLEIC ACIDS RES, V24, P1855, DOI 10.1093/nar/24.10.1855; Drogat B, 2007, CANCER RES, V67, P6700, DOI 10.1158/0008-5472.CAN-06-3235; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Genbacev O, 1997, SCIENCE, V277, P1669, DOI 10.1126/science.277.5332.1669; Han D, 2009, CELL, V138, P562, DOI 10.1016/j.cell.2009.07.017; Hollien J, 2006, SCIENCE, V313, P104, DOI 10.1126/science.1129631; Hollien J, 2009, J CELL BIOL, V186, P323, DOI 10.1083/jcb.200903014; Iwawaki T, 2009, P NATL ACAD SCI USA, V106, P16657, DOI 10.1073/pnas.0903775106; Kanemoto S, 2005, BIOCHEM BIOPH RES CO, V331, P1146, DOI 10.1016/j.bbrc.2005.04.039; Koumenis C, 2007, METHOD ENZYMOL, V435, P275, DOI 10.1016/S0076-6879(07)35014-3; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lipson KL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001648; Lipson KL, 2006, CELL METAB, V4, P245, DOI 10.1016/j.cmet.2006.07.007; Oskolkova OV, 2008, BLOOD, V112, P330, DOI 10.1182/blood-2007-09-112870; Rinkenberger J, 2000, NAT GENET, V25, P248, DOI 10.1038/76985; Romero-Ramirez L, 2004, CANCER RES, V64, P5943, DOI 10.1158/0008-5472.CAN-04-1606; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rossant J, 2002, ANNU REV CELL DEV BI, V18, P541, DOI 10.1146/annurev.cellbio.18.012502.105825; Rossant J, 2001, NAT REV GENET, V2, P538, DOI 10.1038/35080570; Roybal CN, 2005, J BIOL CHEM, V280, P20331, DOI 10.1074/jbc.M411275200; Rutkowski DT, 2007, TRENDS BIOCHEM SCI, V32, P469, DOI 10.1016/j.tibs.2007.09.003; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Selesniemi K, 2005, STEM CELLS DEV, V14, P697, DOI 10.1089/scd.2005.14.697; SHWEIKI D, 1995, P NATL ACAD SCI USA, V92, P768, DOI 10.1073/pnas.92.3.768; SHWEIKI D, 1992, NATURE, V359, P845; STEIN I, 1995, MOL CELL BIOL, V15, P5363; Tirasophon W, 2000, GENE DEV, V14, P2725, DOI 10.1101/gad.839400; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zhang KZ, 2005, J CLIN INVEST, V115, P268, DOI 10.1172/JCI200521848	36	185	197	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2010	5	3					A104	A115	e9575	10.1371/journal.pone.0009575	http://dx.doi.org/10.1371/journal.pone.0009575			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565WZ	20221394	Green Published, gold, Green Submitted			2022-12-25	WOS:000275328200010
J	Teramoto, T; Sternick, LA; Kage-Nakadai, E; Sajjadi, S; Siembida, J; Mitani, S; Iwasaki, K; Lambie, EJ				Teramoto, Takayuki; Sternick, Laura A.; Kage-Nakadai, Eriko; Sajjadi, Shirine; Siembida, Jakub; Mitani, Shohei; Iwasaki, Kouichi; Lambie, Eric J.			Magnesium Excretion in C. elegans Requires the Activity of the GTL-2 TRPM Channel	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; CATION CHANNEL; FUNCTIONAL-CHARACTERIZATION; SECONDARY HYPOCALCEMIA; MG2+ TRANSPORTER; NEURONS; GENE; ABSORPTION; INTESTINE; CELLS	Systemic magnesium homeostasis in mammals is primarily governed by the activities of the TRPM6 and TRPM7 cation channels, which mediate both uptake by the intestinal epithelial cells and reabsorption by the distal convoluted tubule cells in the kidney. In the nematode, C. elegans, intestinal magnesium uptake is dependent on the activities of the TRPM channel proteins, GON-2 and GTL-1. In this paper we provide evidence that another member of the TRPM protein family, GTL-2, acts within the C. elegans excretory cell to mediate the excretion of excess magnesium. Thus, the activity of GTL-2 balances the activities of the paralogous TRPM channel proteins, GON-2 and GTL-1.	[Teramoto, Takayuki] Kyushu Univ, Dept Biol, Higashi Ku, Fukuoka 812, Japan; [Sternick, Laura A.; Sajjadi, Shirine; Lambie, Eric J.] Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA; [Siembida, Jakub; Iwasaki, Kouichi] Northwestern Univ, Feinberg Sch Med, Dept Mol Pharmacol & Biol Chem, Chicago, IL 60611 USA; [Kage-Nakadai, Eriko; Mitani, Shohei] Tokyo Womens Med Univ, Sch Med, Dept Physiol, Tokyo, Japan	Kyushu University; Dartmouth College; Northwestern University; Feinberg School of Medicine; Tokyo Women's Medical University	Teramoto, T (corresponding author), Kyushu Univ, Dept Biol, Higashi Ku, Fukuoka 812, Japan.	eric.j.lambie@dartmouth.edu	Lambie, Eric/K-5657-2014	Lambie, Eric/0000-0002-7371-128X; Teramoto, Takayuki/0000-0001-7060-7148	Ministry of Education; NIH National Center for Research Resources; Northwestern University; National Institutes of Health [GM49785, GM082133]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082133] Funding Source: NIH RePORTER	Ministry of Education; NIH National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Northwestern University; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The allele tm1463 was isolated by the National Bioresource Project for the Experimental Animal C. elegans, which is funded by the Ministry of Education (http://www. mext. go. jp/english/). Some strains used in this work were provided by the Caenorhabditis Genetics Center, which is funded by the NIH National Center for Research Resources (http://www. ncrr. nih. gov/). This work was supported by funds from Northwestern University (http://www. northwestern. edu/) (to K. I.) and the National Institutes of Health (http://www. nih. gov/) to E. J. L. (GM49785) and K. I. (GM082133). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berry KL, 2003, SCIENCE, V302, P2134, DOI 10.1126/science.1087667; Christensen M, 2002, NEURON, V33, P503, DOI 10.1016/S0896-6273(02)00591-3; Church DL, 2003, GENETICS, V165, P563; Espelt MV, 2005, J GEN PHYSIOL, V126, P379, DOI 10.1085/jgp.200509355; Estevez AY, 2005, J PHYSIOL-LONDON, V567, P239, DOI 10.1113/jphysiol.2005.091900; Estevez AY, 2003, J GEN PHYSIOL, V122, P207, DOI 10.1085/jgp.200308804; FINE KD, 1991, J CLIN INVEST, V88, P396, DOI 10.1172/JCI115317; Fleig A, 2004, TRENDS PHARMACOL SCI, V25, P633, DOI 10.1016/j.tips.2004.10.004; Gadsby DC, 2009, PHILOS T R SOC B, V364, P229, DOI 10.1098/rstb.2008.0243; Goytain A, 2005, PHYSIOL GENOMICS, V21, P337, DOI 10.1152/physiolgenomics.00261.2004; Goytain A, 2005, BIOCHEM BIOPH RES CO, V330, P701, DOI 10.1016/j.bbrc.2005.03.037; HARDIE RC, 1992, NEURON, V8, P643, DOI 10.1016/0896-6273(92)90086-S; Hofmann T, 2003, CURR BIOL, V13, P1153, DOI 10.1016/S0960-9822(03)00431-7; Inada H, 2006, GENETICS, V172, P2239, DOI 10.1534/genetics.105.050013; Jin J, 2008, SCIENCE, V322, P756, DOI 10.1126/science.1163493; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; KAYNE LH, 1993, MINER ELECTROL METAB, V19, P210; Kemp BJ, 2009, GENETICS, V181, P581, DOI 10.1534/genetics.108.094870; Kolisek M, 2008, J BIOL CHEM, V283, P16235, DOI 10.1074/jbc.M707276200; Levitt MD, 1996, J CLIN INVEST, V97, P2308, DOI 10.1172/JCI118673; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; NELSON FK, 1983, J ULTRA MOL STRUCT R, V82, P156; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; Quamme GA, 1997, KIDNEY INT, V52, P1180, DOI 10.1038/ki.1997.443; Sahni J, 2007, BIOCHEM J, V401, P505, DOI 10.1042/BJ20060673; Schlingmann KP, 2007, BBA-MOL BASIS DIS, V1772, P813, DOI 10.1016/j.bbadis.2007.03.009; Schlingmann KP, 2005, J PHYSIOL-LONDON, V566, P301, DOI 10.1113/jphysiol.2004.080200; Schlingmann KP, 2002, NAT GENET, V31, P166, DOI 10.1038/ng889; Schmitz C, 2007, MAGNESIUM RES, V20, P6; Schweigel M, 2000, FRONT BIOSCI-LANDMRK, V5, pD666, DOI 10.2741/Schweigel; Sherman T, 2005, AM J PHYSIOL-CELL PH, V289, pC341, DOI 10.1152/ajpcell.00071.2005; Teramoto T, 2005, CELL METAB, V1, P343, DOI 10.1016/j.cmet.2005.04.007; Voets T, 2004, J BIOL CHEM, V279, P19, DOI 10.1074/jbc.M311201200; Walder RY, 2002, NAT GENET, V31, P171, DOI 10.1038/ng901; West RJ, 2001, GENE, V266, P103, DOI 10.1016/S0378-1119(01)00373-0; Xing J, 2008, J GEN PHYSIOL, V131, P245, DOI 10.1085/jgp.200709914	37	23	27	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2010	5	3					A228	A235	e9589	10.1371/journal.pone.0009589	http://dx.doi.org/10.1371/journal.pone.0009589			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565WZ	20221407	Green Submitted, gold, Green Published			2022-12-25	WOS:000275328200021
J	Kobayashi, H; Huang, JH; Ye, F; Shyr, Y; Blackwell, TS; Lin, PC				Kobayashi, Hanako; Huang, Jianhua; Ye, Fei; Shyr, Yu; Blackwell, Timothy S.; Lin, P. Charles			Interleukin-32 beta Propagates Vascular Inflammation and Exacerbates Sepsis in a Mouse Model	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; TUMOR ANGIOGENESIS; T-CELLS; IL-32; RECEPTOR; ALPHA; TIE2; IL-1-BETA; CYTOKINE; MEDIATOR	Background: Inflammation is associated with most diseases, which makes understanding the mechanisms of inflammation vitally important. Methodology/Principal Findings: Here, we demonstrate a critical function of interleukin-32 beta (IL-32 beta) in vascular inflammation. IL-32 beta is present in tissues from humans, but is absent in rodents. We found that the gene is highly expressed in endothelial cells. Three isoforms of IL-32, named IL-32 alpha, beta, and e, were cloned from human endothelial cells, with IL-32 beta being the major isoform. Pro-inflammatory cytokines (TNF alpha and IL-1 beta) induced IL-32 beta expression through NF-kappa B. Conversely, IL-32 beta propagated vascular inflammation via induction of vascular cell adhesion molecules and inflammatory cytokines. Accordingly, IL-32 beta increased adhesion of inflammatory cells to activated endothelial cells, a paramount process in inflammation. These results illustrate a positive feedback regulation that intensifies and prolongs inflammation. Importantly, endothelial/hematopoietic expression of IL-32 beta in transgenic mice elevated inflammation and worsened sepsis. This was demonstrated by significant elevation of leukocyte infiltration and serum levels of TNF alpha and IL-1 beta, increased vascular permeability and lung damage, and accelerated animal death. Together, our results reveal an important function of IL-32 in vascular inflammation and sepsis development. Conclusions/Significance: Our results reveal an important function of IL-32 in vascular inflammation and sepsis development.	[Kobayashi, Hanako; Huang, Jianhua; Lin, P. Charles] Vanderbilt Univ, Med Ctr, Dept Radiat Oncol, Nashville, TN 37235 USA; [Ye, Fei; Shyr, Yu] Vanderbilt Univ, Med Ctr, Dept Prevent Med, Nashville, TN USA; [Blackwell, Timothy S.] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN USA; [Blackwell, Timothy S.; Lin, P. Charles] Vanderbilt Univ, Med Ctr, Dept Canc Biol, Nashville, TN USA; [Blackwell, Timothy S.; Lin, P. Charles] Vanderbilt Univ, Med Ctr, Dept Cell & Dev Biol, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Kobayashi, H (corresponding author), Vanderbilt Univ, Med Ctr, Dept Radiat Oncol, Nashville, TN 37235 USA.	Charles.lin@vanderbilt.edu		Kobayashi, Hanako/0000-0001-5064-2616	National Institutes of Health [CA108856, NS45888, AR053718]; NATIONAL CANCER INSTITUTE [ZIABC011390, R01CA108856] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053718] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045888] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work is supported in part by grants from the National Institutes of Health (CA108856, NS45888 and AR053718) to PCL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aird WC, 2004, CRIT CARE MED, V32, pS271, DOI 10.1097/01.CCM.0000129669.21649.40; BAKER CC, 1983, SURGERY, V94, P331; DAHL CA, 1992, J IMMUNOL, V148, P597; De Palma M, 2005, CANCER CELL, V8, P211, DOI 10.1016/j.ccr.2005.08.002; DeBusk LM, 2003, ARTHRITIS RHEUM-US, V48, P2461, DOI 10.1002/art.11213; DeBusk LM, 2004, EXP CELL RES, V298, P167, DOI 10.1016/j.yexcr.2004.04.013; Folkman J, 2001, SEMIN ONCOL, V28, P536, DOI 10.1053/sonc.2001.29543; Goda C, 2006, INT IMMUNOL, V18, P233, DOI 10.1093/intimm/dxh339; Joosten LAB, 2006, P NATL ACAD SCI USA, V103, P3298, DOI 10.1073/pnas.0511233103; Kamiyama M, 2006, ONCOGENE, V25, P7019, DOI 10.1038/sj.onc.1209694; Kim SH, 2005, IMMUNITY, V22, P131, DOI 10.1016/j.immuni.2004.12.003; Kobayashi H, 2009, CYTOKINE, V46, P351, DOI 10.1016/j.cyto.2009.03.007; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Lin PN, 1997, J CLIN INVEST, V100, P2072, DOI 10.1172/JCI119740; Netea MG, 2005, P NATL ACAD SCI USA, V102, P16309, DOI 10.1073/pnas.0508237102; NEWMAN PJ, 1990, SCIENCE, V247, P1219, DOI 10.1126/science.1690453; Nold-Petry CA, 2009, P NATL ACAD SCI USA, V106, P3883, DOI 10.1073/pnas.0813334106; Pober JS, 2007, NAT REV IMMUNOL, V7, P803, DOI 10.1038/nri2171; Shoda H, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2074; STOCKINGER H, 1990, J IMMUNOL, V145, P3889	20	54	56	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2010	5	3							e9458	10.1371/journal.pone.0009458	http://dx.doi.org/10.1371/journal.pone.0009458			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	564EX	20221440	gold, Green Published, Green Submitted			2022-12-25	WOS:000275197200001
J	Stelzer, RJ; Chittka, L; Carlton, M; Ings, TC				Stelzer, Ralph J.; Chittka, Lars; Carlton, Marc; Ings, Thomas C.			Winter Active Bumblebees (Bombus terrestris) Achieve High Foraging Rates in Urban Britain	PLOS ONE			English	Article							HYMENOPTERA; PATTERNS; SUCCESS; POLLEN; NECTAR	Background: Foraging bumblebees are normally associated with spring and summer in northern Europe. However, there have been sightings of the bumblebee Bombus terrestris during the warmer winters in recent years in southern England. But what floral resources are they relying upon during winter and how much winter forage can they collect? Methodology/Principal Findings: To test if urban areas in the UK provide a rich foraging niche for bees we set up colonies of B. terrestris in the field during two late winter periods (2005/6 & 2006/7) in London, UK, and measured their foraging performance. Fully automatic radio-frequency identification (RFID) technology was used in 2006/7 to enable us to record the complete foraging activity of individually tagged bees. The number of bumblebees present during winter (October 2007 to March 2008) and the main plants they visited were also recorded during transect walks. Queens and workers were observed throughout the winter, suggesting a second generation of bee colonies active during the winter months. Mass flowering shrubs such as Mahonia spp. were identified as important food resources. The foraging experiments showed that bees active during the winter can attain nectar and pollen foraging rates that match, and even surpass, those recorded during summer. Conclusions/Significance: B. terrestris in the UK are now able to utilise a rich winter foraging resource in urban parks and gardens that might at present still be under-exploited, opening up the possibility of further changes in pollinator phenology.	[Stelzer, Ralph J.; Chittka, Lars; Ings, Thomas C.] Queen Mary Univ London, Sch Biol & Chem Sci, London, England; [Carlton, Marc] London Nat Hist Soc, London, England	University of London; Queen Mary University London	Stelzer, RJ (corresponding author), Queen Mary Univ London, Sch Biol & Chem Sci, London, England.	t.c.ings@qmul.ac.uk	Chittka, Lars/C-3110-2012; Ings, Thomas C/J-3439-2012	Chittka, Lars/0000-0001-8153-1732; Ings, Thomas C/0000-0002-7496-1977	Westfield Trust; University of London [CRFT1C7R]; Natural Environment Research Council [NE/D012813/1]; Leverhulme Early Career Fellowship [ECF/2009/0180]; NERC [NE/D012813/1] Funding Source: UKRI	Westfield Trust; University of London; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Leverhulme Early Career Fellowship(Leverhulme Trust); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work has been supported by a Westfield Trust (http://www.qmul.ac.uk/) Studentship (RS), a University of London (http://www.lon.ac.uk/) Central Research Fund grant CRFT1C7R (TI), Natural Environment Research Council (http://www.nerc.ac.uk/) Grant NE/D012813/1 (TI & LC) and a Leverhulme Early Career Fellowship (http://www.leverhulme.ac.uk/) ECF/2009/0180 (TI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alford DV, 1975, BUMBLEBEES; BENTON T, 2008, BUMBLEBEES; Comba L, 1999, ANN BOT-LONDON, V83, P369, DOI 10.1006/anbo.1998.0835; CUMBER RA, 1949, T R ENT SOC LOND, P1; EDWARDS M, 2006, BWARS NEWSLETTER SPR, P20; Farmer S, 2006, BWARS NEWSLETTER, P21; FERTON C, 1901, COMPT AFAS C AJ; GOULSON D, 2003, BUMBLEBEES THEIR BEH; Gurel F, 2008, INSECT SOC, V55, P123, DOI 10.1007/s00040-008-0984-7; HEINRICH B, 1979, J EXP BIOL, V80, P217; Heinrich B., 1979, BUMBLEBEE EC; Ings TC, 2006, J APPL ECOL, V43, P940, DOI 10.1111/j.1365-2664.2006.01199.x; Ings TC, 2005, ENTOMOL GEN, V28, P233; Ings TC, 2005, OECOLOGIA, V144, P508, DOI 10.1007/s00442-005-0081-9; INGS TC, 2007, THESIS U LONDON LOND; Molet M, 2008, BEHAV ECOL SOCIOBIOL, V62, P1919, DOI 10.1007/s00265-008-0623-3; PARKER DE, 1992, INT J CLIMATOL, V12, P317, DOI 10.1002/joc.3370120402; Pelletier L, 2003, OIKOS, V103, P688, DOI 10.1034/j.1600-0706.2003.12592.x; PRYSJONES O, 1982, THESIS U CAMBRIDGE C; Raine NE, 2008, P R SOC B, V275, P803, DOI 10.1098/rspb.2007.1652; Raine NE, 2007, NATURWISSENSCHAFTEN, V94, P459, DOI 10.1007/s00114-006-0184-0; Rasmont P, 2005, J ECON ENTOMOL, V98, P656, DOI 10.1603/0022-0493-98.3.656; Rasmont P, 2008, ANN SOC ENTOMOL FR, V44, P243, DOI 10.1080/00379271.2008.10697559; ROBERTSON A, 1991, Entomologist's Monthly Magazine, V127, P165; Robinson EJH, 2009, BEHAV ECOL SOCIOBIOL, V63, P627, DOI 10.1007/s00265-008-0696-z; Roth M., 2002, EFFECTS CITIES LOCAL, P1; SLADEN FWL, 1912, HUMBLE BEE ITS LIFE; Spaethe J, 2002, INSECT SOC, V49, P142, DOI 10.1007/s00040-002-8293-z; Streit S, 2003, ZOOLOGY, V106, P169, DOI 10.1078/0944-2006-00113; Wilson E.O., 1975, P1; Yeninar H, 2000, J APICULT RES, V39, P107, DOI 10.1080/00218839.2000.11101030	31	68	70	7	101	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2010	5	3							e9559	10.1371/journal.pone.0009559	http://dx.doi.org/10.1371/journal.pone.0009559			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	564EX	20221445	Green Submitted, gold, Green Published			2022-12-25	WOS:000275197200011
J	Harrington, LS; Moreno, L; Reed, A; Wort, SJ; Desvergne, B; Garland, C; Zhao, L; Mitchell, JA				Harrington, Louise S.; Moreno, Laura; Reed, Anna; Wort, Stephen J.; Desvergne, Beatrice; Garland, Christopher; Zhao, Lan; Mitchell, Jane A.			The PPAR beta/delta Agonist GW0742 Relaxes Pulmonary Vessels and Limits Right Heart Hypertrophy in Rats with Hypoxia-Induced Pulmonary Hypertension	PLOS ONE			English	Article							ARTERIAL-HYPERTENSION; PROSTACYCLIN; MODULATION; SURVIVAL; INFLAMMATION; ENDOTHELIUM; RECEPTORS; THERAPY; DISEASE; LIGAND	Background: Pulmonary vascular diseases are increasingly recognised as important clinical conditions. Pulmonary hypertension associated with a range of aetiologies is difficult to treat and associated with progressive morbidity and mortality. Current therapies for pulmonary hypertension include phosphodiesterase type 5 inhibitors, endothelin receptor antagonists, or prostacyclin mimetics. However, none of these provide a cure and the clinical benefits of these drugs individually decline over time. There is, therefore, an urgent need to identify new treatment strategies for pulmonary hypertension. Methodology/Principal Findings: Here we show that the PPAR beta/delta agonist GW0742 induces vasorelaxation in systemic and pulmonary vessels. Using tissue from genetically modified mice, we show that the dilator effects of GW0742 are independent of the target receptor PPAR beta/delta or cell surface prostacyclin (IP) receptors. In aortic tissue, vascular relaxant effects of GW0742 were not associated with increases in cGMP, cAMP or hyperpolarisation, but were attributed to inhibition of RhoA activity. In a rat model of hypoxia-induced pulmonary hypertension, daily oral dosing of animals with GW0742 (30 mg/kg) for 3 weeks significantly reduced the associated right heart hypertrophy and right ventricular systolic pressure. GW0742 had no effect on vascular remodelling induced by hypoxia in this model. Conclusions/Significance: These observations are the first to show a therapeutic benefit of 'PPAR beta/delta' agonists in experimental pulmonary arterial hypertension and provide pre-clinical evidence to favour clinical trials in man.	[Harrington, Louise S.; Moreno, Laura; Reed, Anna; Mitchell, Jane A.] Univ London Imperial Coll Sci Technol & Med, NHLI, London, England; [Wort, Stephen J.] Royal Brompton Hosp, NHLI, London SW3 6LY, England; [Desvergne, Beatrice] Univ Lausanne, Ctr Integrat Genom, Lausanne, Switzerland; [Garland, Christopher] Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England; [Zhao, Lan] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, London, England	Imperial College London; Imperial College London; Royal Brompton Hospital; University of Lausanne; University of Oxford; Imperial College London	Harrington, LS (corresponding author), Univ London Imperial Coll Sci Technol & Med, NHLI, London, England.	j.a.mitchell@ic.ac.uk	Mackenzie, Louise/AAY-7585-2020; Reed, Anna/GQY-8730-2022; Mitchell, Jane A/A-1991-2009; Moreno, Laura/A-9433-2010; Desvergne, Beatrice/C-8892-2016	Mackenzie, Louise/0000-0003-4271-379X; Moreno, Laura/0000-0001-9028-2299; Desvergne, Beatrice/0000-0001-5483-288X	British Heart Foundation; Wellcome Trust	British Heart Foundation(British Heart Foundation); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was funded by the British Heart Foundation and Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbiyik F, 2004, BLOOD, V104, P1361, DOI 10.1182/blood-2004-03-0926; Ali FY, 2006, FASEB J, V20, P326, DOI 10.1096/fj.05-4395fje; Ali FY, 2009, ARTERIOSCL THROM VAS, V29, P706, DOI 10.1161/ATVBAHA.108.183160; Ali FY, 2006, AM J RESP CELL MOL, V34, P242, DOI 10.1165/rcmb.2005-0289OC; ALI FY, 2009, ARTERIOSCLER THROMB; Barst RJ, 2009, J AM COLL CARDIOL, V54, pS78, DOI 10.1016/j.jacc.2009.04.017; Belvisi MG, 2009, BRIT J PHARMACOL, V158, P994, DOI 10.1111/j.1476-5381.2009.00373.x; BishopBailey D, 1997, ARTERIOSCL THROM VAS, V17, P1644, DOI 10.1161/01.ATV.17.9.1644; Chen SJ, 1995, J APPL PHYSIOL, V79, P2122, DOI 10.1152/jappl.1995.79.6.2122; Cheng Y, 2002, SCIENCE, V296, P539, DOI 10.1126/science.1068711; Cogolludo A, 2009, CARDIOVASC RES, V82, P296, DOI 10.1093/cvr/cvn349; Crossno JT, 2007, AM J PHYSIOL-LUNG C, V292, pL885, DOI 10.1152/ajplung.00258.2006; DALONZO GE, 1991, ANN INTERN MED, V115, P343, DOI 10.7326/0003-4819-115-5-343; Dora KA, 2008, CIRC RES, V102, P1247, DOI 10.1161/CIRCRESAHA.108.172379; Galie N, 2009, EUR RESPIR J, V34, P1219, DOI 10.1183/09031936.00139009; Galie N, 2009, EUR HEART J, V30, P2493, DOI 10.1093/eurheartj/ehp297; Guignabert C, 2006, CIRC RES, V98, P1323, DOI 10.1161/01.RES.0000222546.45372.a0; Harrington LS, 2007, AM J PHYSIOL-HEART C, V293, pH1682, DOI 10.1152/ajpheart.00389.2007; Hart CM, 2008, J INVEST MED, V56, P518, DOI 10.2310/JIM.0b013e318165e921; Haskova Z, 2008, INFLAMM RES, V57, P314, DOI 10.1007/s00011-007-7157-4; Humbert M, 2004, NEW ENGL J MED, V351, P1425, DOI 10.1056/NEJMra040291; Lee CH, 2003, SCIENCE, V302, P453, DOI 10.1126/science.1087344; Matsuda Yasushi, 2005, Nihon Kokyuki Gakkai Zasshi, V43, P283; McLaughlin VV, 2002, CIRCULATION, V106, P1477, DOI 10.1161/01.CIR.0000029100.82385.58; Mitchell JA, 2008, EXP PHYSIOL, V93, P141, DOI 10.1113/expphysiol.2007.038588; MULVANY MJ, 1977, CIRC RES, V41, P19, DOI 10.1161/01.RES.41.1.19; Sitbon O, 2002, J AM COLL CARDIOL, V40, P780, DOI 10.1016/S0735-1097(02)02012-0; Sznaidman ML, 2003, BIOORG MED CHEM LETT, V13, P1517, DOI 10.1016/S0960-894X(03)00207-5; Tan NS, 2001, GENE DEV, V15, P3263, DOI 10.1101/gad.207501; Weissmann N, 2009, AM J PHYSIOL-LUNG C, V297, pL658, DOI 10.1152/ajplung.00189.2009; Wise H, 2003, ACTA PHARMACOL SIN, V24, P625; Wort SJ, 2001, AM J RESP CELL MOL, V25, P104, DOI 10.1165/ajrcmb.25.1.4331; Zhao L, 2001, CIRCULATION, V104, P424, DOI 10.1161/hc2901.093117	33	39	39	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2010	5	3							e9526	10.1371/journal.pone.0009526	http://dx.doi.org/10.1371/journal.pone.0009526			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	564EW	20209098	Green Published, Green Submitted, gold			2022-12-25	WOS:000275197100011
J	Soscia, SJ; Kirby, JE; Washicosky, KJ; Tucker, SM; Ingelsson, M; Hyman, B; Burton, MA; Goldstein, LE; Duong, S; Tanzi, RE; Moir, RD				Soscia, Stephanie J.; Kirby, James E.; Washicosky, Kevin J.; Tucker, Stephanie M.; Ingelsson, Martin; Hyman, Bradley; Burton, Mark A.; Goldstein, Lee E.; Duong, Scott; Tanzi, Rudolph E.; Moir, Robert D.			The Alzheimer's Disease-Associated Amyloid beta-Protein Is an Antimicrobial Peptide	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; PRECURSOR-LIKE PROTEIN; A-BETA; APOLIPOPROTEIN-E; INNATE IMMUNITY; ALAMAR-BLUE; CELL-DEATH; BRAIN; BACTERIAL; BINDING	Background: The amyloid beta-protein (A beta) is believed to be the key mediator of Alzheimer's disease (AD) pathology. A beta is most often characterized as an incidental catabolic byproduct that lacks a normal physiological role. However, A beta has been shown to be a specific ligand for a number of different receptors and other molecules, transported by complex trafficking pathways, modulated in response to a variety of environmental stressors, and able to induce pro-inflammatory activities. Methodology/Principal Findings: Here, we provide data supporting an in vivo function for A beta as an antimicrobial peptide (AMP). Experiments used established in vitro assays to compare antimicrobial activities of A beta and LL-37, an archetypical human AMP. Findings reveal that A beta exerts antimicrobial activity against eight common and clinically relevant microorganisms with a potency equivalent to, and in some cases greater than, LL-37. Furthermore, we show that AD whole brain homogenates have significantly higher antimicrobial activity than aged matched non-AD samples and that AMP action correlates with tissue A beta levels. Consistent with A beta-mediated activity, the increased antimicrobial action was ablated by immunodepletion of AD brain homogenates with anti-A beta antibodies. Conclusions/Significance: Our findings suggest A beta is a hitherto unrecognized AMP that may normally function in the innate immune system. This finding stands in stark contrast to current models of A beta-mediated pathology and has important implications for ongoing and future AD treatment strategies.	[Soscia, Stephanie J.; Washicosky, Kevin J.; Tucker, Stephanie M.; Hyman, Bradley; Tanzi, Rudolph E.; Moir, Robert D.] Massachusetts Gen Hosp, Mass Gen Inst Neurodegenerat Dis, Genet & Aging Res Unit, Charlestown, MA USA; [Soscia, Stephanie J.; Washicosky, Kevin J.; Tucker, Stephanie M.; Hyman, Bradley; Tanzi, Rudolph E.; Moir, Robert D.] Massachusetts Gen Hosp, Dept Neurol, Charlestown, MA USA; [Soscia, Stephanie J.] Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02118 USA; [Kirby, James E.; Duong, Scott] Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA; [Ingelsson, Martin] Uppsala Univ, Dept Publ Hlth Geriatr, Uppsala, Sweden; [Hyman, Bradley; Tanzi, Rudolph E.; Moir, Robert D.] Harvard Univ, Sch Med, Boston, MA USA; [Burton, Mark A.; Goldstein, Lee E.] Boston Univ, Sch Med, Coll Engn, Mol Aging & Dev Lab,Photon Ctr, Boston, MA 02118 USA; [Burton, Mark A.; Goldstein, Lee E.] Boston Univ, Alzheimers Dis Ctr, Boston, MA 02118 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Boston University; Harvard University; Beth Israel Deaconess Medical Center; Uppsala University; Harvard University; Harvard Medical School; Boston University; Boston University	Soscia, SJ (corresponding author), Massachusetts Gen Hosp, Mass Gen Inst Neurodegenerat Dis, Genet & Aging Res Unit, Charlestown, MA USA.	tanzi@helix.mgh.harvard.edu	Kirby, James/K-4438-2019; Moir, Robert D./M-7612-2017; Tanzi, Rudolph/AAE-9622-2019	Moir, Robert D./0000-0001-5431-3553; Tanzi, Rudolph/0000-0002-7032-1454; Goldstein, Lee/0000-0001-8419-9800	Cure Alzheimer's Disease Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081990] Funding Source: NIH RePORTER	Cure Alzheimer's Disease Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the Cure Alzheimer's Disease Fund (http://www.curealzfund.org/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarbiou J, 2006, INFLAMM RES, V55, P119, DOI 10.1007/s00011-005-0062-9; Ando Y, 2002, LAB INVEST, V82, P757, DOI 10.1097/01.LAB.0000017170.26718.89; Araki-Sasaki K, 2005, BRIT J OPHTHALMOL, V89, P684, DOI 10.1136/bjo.2004.056804; Bechinger B, 2006, BBA-BIOMEMBRANES, V1758, P1529, DOI 10.1016/j.bbamem.2006.07.001; Bergman P, 2005, J NEUROCHEM, V93, P1132, DOI 10.1111/j.1471-4159.2005.03081.x; Bergman P, 2006, INFECT IMMUN, V74, P6982, DOI 10.1128/IAI.01043-06; Bertram L, 2008, AM J HUM GENET, V83, P623, DOI 10.1016/j.ajhg.2008.10.008; Bolintineanu D, 2010, PEPTIDES, V31, P1, DOI 10.1016/j.peptides.2009.11.010; Brogden KA, 2005, NAT IMMUNOL, V6, P558, DOI 10.1038/ni1209; Chakrabarti A, 2007, NEUROL INDIA, V55, P191, DOI 10.4103/0028-3886.35679; Chauhan A, 2000, NEUROCHEM RES, V25, P423, DOI 10.1023/A:1007509608440; Chen Xi, 2006, Current Alzheimer Research, V3, P515, DOI 10.2174/156720506779025215; Chen YN, 2006, BIOCHEM BIOPH RES CO, V341, P1, DOI 10.1016/j.bbrc.2005.12.150; Cherny RA, 1999, J BIOL CHEM, V274, P23223, DOI 10.1074/jbc.274.33.23223; Chi EY, 2008, PROTEINS, V72, P1, DOI 10.1002/prot.21887; Ciornei Cristina D, 2006, BMC Cardiovasc Disord, V6, P49, DOI 10.1186/1471-2261-6-49; Dennison SR, 2006, FEBS J, V273, P3792, DOI 10.1111/j.1742-4658.2006.05387.x; Dominguez D, 2005, J BIOL CHEM, V280, P30797, DOI 10.1074/jbc.M505249200; Eckert GP, 2001, J NEURAL TRANSM, V108, P1051, DOI 10.1007/s007020170024; Edstrom AML, 2008, J IMMUNOL, V181, P3413, DOI 10.4049/jimmunol.181.5.3413; Glukhov E, 2005, J BIOL CHEM, V280, P33960, DOI 10.1074/jbc.M507042200; Goumon Y, 1998, J BIOL CHEM, V273, P29847, DOI 10.1074/jbc.273.45.29847; Green RC, 2009, JAMA-J AM MED ASSOC, V302, P2557, DOI 10.1001/jama.2009.1866; Gudmundsson GH, 1996, EUR J BIOCHEM, V238, P325, DOI 10.1111/j.1432-1033.1996.0325z.x; Hamid R, 2004, TOXICOL IN VITRO, V18, P703, DOI 10.1016/j.tiv.2004.03.012; Heber S, 2000, J NEUROSCI, V20, P7951; Herms J, 2004, EMBO J, V23, P4106, DOI 10.1038/sj.emboj.7600390; Huang XD, 1997, J BIOL CHEM, V272, P26464, DOI 10.1074/jbc.272.42.26464; Itzhaki RE, 2004, NEUROBIOL AGING, V25, P619, DOI 10.1016/j.neurobiolaging.2003.12.021; Itzhaki RF, 1997, LANCET, V349, P241, DOI 10.1016/S0140-6736(96)10149-5; Jacobsen KT, 2009, CELL MOL LIFE SCI, V66, P2299, DOI 10.1007/s00018-009-0020-8; Kee KH, 2008, ANN DIAGN PATHOL, V12, P235, DOI 10.1016/j.anndiagpath.2007.12.004; Kirkitadze MD, 2002, J NEUROSCI RES, V69, P567, DOI 10.1002/jnr.10328; Kobayashi N, 2008, BIOCONTROL SCI, V13, P49, DOI 10.4265/bio.13.49; Koldamova RP, 2001, BIOCHEMISTRY-US, V40, P3553, DOI 10.1021/bi002186k; Kountouras J, 2006, NEUROLOGY, V66, P938, DOI 10.1212/01.wnl.0000203644.68059.5f; Kuo YM, 1996, J BIOL CHEM, V271, P4077; Le YY, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-02-j0003.2001; Lee M, 2002, BIOCHEM J, V366, P937, DOI 10.1042/BJ20020453; Leib SL, 1999, INFECT DIS CLIN N AM, V13, P527, DOI 10.1016/S0891-5520(05)70093-3; Li QM, 2004, J BIOL CHEM, V279, P10542, DOI 10.1074/jbc.M310001200; Linke RP, 2005, J LAB CLIN MED, V145, P187, DOI 10.1016/j.lab.2005.02.002; Maezawa I, 2004, J NEUROCHEM, V91, P1312, DOI 10.1111/j.1471-4159.2004.02818.x; Magara F, 1999, P NATL ACAD SCI USA, V96, P4656, DOI 10.1073/pnas.96.8.4656; McCafferty DG, 1999, CURR OPIN CHEM BIOL, V3, P672, DOI 10.1016/S1367-5931(99)00025-3; Miklossy J, 2006, NEUROBIOL AGING, V27, P228, DOI 10.1016/j.neurobiolaging.2005.01.018; Minogue AM, 2009, BRAIN RES, V1262, P89, DOI 10.1016/j.brainres.2009.01.008; *NAT COMM CLIN LAB, M26A NCCLS; Ong PY, 2002, NEW ENGL J MED, V347, P1151, DOI 10.1056/NEJMoa021481; Oren Z, 1999, BIOCHEM J, V341, P501, DOI 10.1042/0264-6021:3410501; Paris D, 1999, EXP NEUROL, V157, P211, DOI 10.1006/exnr.1999.7055; Pastorino L, 2004, MOL CELL NEUROSCI, V25, P642, DOI 10.1016/j.mcn.2003.12.013; Putsep K, 2002, LANCET, V360, P1144, DOI 10.1016/S0140-6736(02)11201-3; Repp KK, 2007, MED MYCOL, V45, P603, DOI 10.1080/13693780701581458; Risso A, 2002, MOL CELL BIOL, V22, P1926, DOI 10.1128/MCB.22.6.1926-1935.2002; ROBERTS GW, 1991, LANCET, V338, P1422, DOI 10.1016/0140-6736(91)92724-G; Rodrigues CMP, 2000, MOL MED, V6, P936, DOI 10.1007/BF03401828; Roher AE, 1996, J BIOL CHEM, V271, P20631, DOI 10.1074/jbc.271.34.20631; Sal-Man N, 2002, BIOCHEMISTRY-US, V41, P11921, DOI 10.1021/bi0260482; Shiloh MU, 1997, INFECT IMMUN, V65, P3193, DOI 10.1128/IAI.65.8.3193-3198.1997; SHOOSHTARIZADEH P, 2009, REGULATORY IN PRESS; Sieprawska-Lupa M, 2004, ANTIMICROB AGENTS CH, V48, P4673, DOI 10.1128/AAC.48.12.4673-4679.2004; Sood R, 2008, BBA-BIOMEMBRANES, V1778, P983, DOI 10.1016/j.bbamem.2007.11.016; Steffen H, 2006, ANTIMICROB AGENTS CH, V50, P2608, DOI 10.1128/AAC.00181-06; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Subasinghe S, 2003, J NEUROCHEM, V84, P471, DOI 10.1046/j.1471-4159.2003.01552.x; Tanzi RE, 1996, NEUROBIOL DIS, V3, P159, DOI 10.1006/nbdi.1996.0016; Tanzi RE, 2004, NEURON, V43, P605, DOI 10.1016/j.neuron.2004.08.024; Tesco G, 2007, NEURON, V54, P721, DOI 10.1016/j.neuron.2007.05.012; TOMSKI SJ, 1992, ARCH BIOCHEM BIOPHYS, V294, P630, DOI 10.1016/0003-9861(92)90735-F; Townsend KP, 2002, ANN NY ACAD SCI, V977, P65, DOI 10.1111/j.1749-6632.2002.tb04799.x; Tuppo EE, 2005, INT J BIOCHEM CELL B, V37, P289, DOI 10.1016/j.biocel.2004.07.009; Turner J, 1998, ANTIMICROB AGENTS CH, V42, P2206, DOI 10.1128/AAC.42.9.2206; Urosevic N, 2008, J ALZHEIMERS DIS, V13, P421; von Haussen J, 2008, LUNG CANCER, V59, P12, DOI 10.1016/j.lungcan.2007.07.014; Walsh DM, 2005, BIOCHEM SOC T, V33, P1087, DOI 10.1042/BST0331087; WASCO W, 1993, GENOMICS, V15, P237, DOI 10.1006/geno.1993.1047; WASCO W, 1992, P NATL ACAD SCI USA, V89, P10758, DOI 10.1073/pnas.89.22.10758; Wogulis M, 2005, J NEUROSCI, V25, P1071, DOI 10.1523/JNEUROSCI.2381-04.2005; Xie ZC, 2006, J GERONTOL A-BIOL, V61, P1300, DOI 10.1093/gerona/61.12.1300; Youngsteadt E, 2008, SCIENCE, V320, P1577, DOI 10.1126/science.320.5883.1577a; Zaiou M, 2007, J MOL MED, V85, P317, DOI 10.1007/s00109-006-0143-4; Zanetti M, 2004, J LEUKOCYTE BIOL, V75, P39, DOI 10.1189/jlb.0403147; ZHENG H, 1995, CELL, V81, P525, DOI 10.1016/0092-8674(95)90073-X; Zlokovic BV, 2000, NAT MED, V6, P718, DOI 10.1038/77397	85	701	718	1	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2010	5	3							e9505	10.1371/journal.pone.0009505	http://dx.doi.org/10.1371/journal.pone.0009505			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	562OZ	20209079	Green Published, gold			2022-12-25	WOS:000275063400012
J	Litvinova, EA; Goncharova, EP; Zaydman, AM; Zenkova, MA; Moshkin, MP				Litvinova, Ekaterina A.; Goncharova, Elena P.; Zaydman, Alla M.; Zenkova, Marina A.; Moshkin, Mikhail P.			Female Scent Signals Enhance the Resistance of Male Mice to Influenza	PLOS ONE			English	Article							AEROBIC PERFORMANCE; INNATE IMMUNITY; GAS-EXCHANGE; LUNG INJURY; TESTOSTERONE; INFLAMMATION; PNEUMONIA; MECHANICS; PROTECTS; MODEL	Background: The scent from receptive female mice functions as a signal, which stimulates male mice to search for potential mating partners. This searching behavior is coupled with infection risk due to sniffing both scent marks as well as nasal and anogenital areas of females, which harbor bacteria and viruses. Consideration of host evolution under unavoidable parasitic pressures, including helminthes, bacteria, viruses, etc., predicts adaptations that help protect hosts against the parasites associated with mating. Methods and Findings: We propose that the perception of female signals by BALB/c male mice leads to adaptive redistribution of the immune defense directed to protection against respiratory infection risks. Our results demonstrate migration of macrophages and neutrophils to the upper airways upon exposure to female odor stimuli, which results in an increased resistance of the males to experimental influenza virus infection. This moderate leukocyte intervention had no negative effect on the aerobic performance in male mice. Conclusions: Our data provide the first demonstration of the adaptive immunological response to female odor stimuli through induction of nonspecific immune responses in the upper respiratory tract.	[Litvinova, Ekaterina A.; Moshkin, Mikhail P.] Russian Acad Sci, Siberian Branch, Inst Systemat & Ecol Anim, Lab Physiol Adaptat Anim, Novosibirsk, Russia; [Goncharova, Elena P.; Zenkova, Marina A.] Russian Acad Sci, Siberian Branch, Inst Chem Biol & Fundamental Med, Lab Nucle Acids Biochem, Novosibirsk, Russia; [Zaydman, Alla M.] Novosibirsk Inst Traumatol, Dept Histol, Novosibirsk, Russia; [Moshkin, Mikhail P.] Russian Acad Sci, Inst Cytol & Genet, Siberian Branch, Dept Anim Genet Resources, Novosibirsk 630090, Russia	Russian Academy of Sciences; Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Russian Academy of Sciences; Novosibirsk Research Institute of Traumatology & Orthopaedics; Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS	Litvinova, EA (corresponding author), Russian Acad Sci, Siberian Branch, Inst Systemat & Ecol Anim, Lab Physiol Adaptat Anim, Novosibirsk, Russia.	mmp@bionet.nsc.ru	Goncharova, Elena P/G-5099-2013; Zenkova, Marina A/G-5088-2013; Zaydman, Alla/AAE-6100-2019; Litvinova, Ekaterina/ADP-2658-2022; Moshkin, Mikhail P./N-7620-2014; Zenkova, Marina A./H-4666-2014	Zenkova, Marina/0000-0003-4044-1049; Litvinova, Ekaterina/0000-0001-6398-7154	Russian Foundation for Basic Research [N 08-04-00406a]; Program of Interdisciplinary Studies of Siberian Branch [RAS N 15, 94]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Program of Interdisciplinary Studies of Siberian Branch	This project was supported by the Russian Foundation for Basic Research N 08-04-00406a (www.rfbr.ru) and Program of Interdisciplinary Studies of Siberian Branch of RAS N 15, 94 (www.sbras.nsc.ru). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amstislavskaya TG, 2004, HORM BEHAV, V46, P544, DOI 10.1016/j.yhbeh.2004.05.010; Baker DG, 1998, CLIN MICROBIOL REV, V11, P231, DOI 10.1128/CMR.11.2.231; Bals R, 2004, EUR RESPIR J, V23, P327, DOI 10.1183/09031936.03.00098803; Bals R, 2000, Respir Res, V1, P141, DOI 10.1186/rr25; Braude S, 1999, BEHAV ECOL, V10, P345, DOI 10.1093/beheco/10.3.345; BRONSON FH, 1979, Q REV BIOL, V54, P265, DOI 10.1086/411295; BRUGH M, 1994, HDB ZOONOSES VIRAL, P385; Clement CG, 2008, AM J RESP CRIT CARE, V177, P1322, DOI 10.1164/rccm.200607-1038OC; Dawson TC, 2000, AM J PATHOL, V156, P1951, DOI 10.1016/S0002-9440(10)65068-7; Dugan HA, 2003, J CLIN PHARM THER, V28, P123, DOI 10.1046/j.1365-2710.2003.00471.x; HANLY P, 1987, LUNG, V165, P305, DOI 10.1007/BF02714447; Kemming GI, 2005, ANESTHESIOLOGY, V103, P585, DOI 10.1097/00000542-200509000-00022; Koyama S, 2000, PHYSIOL BEHAV, V71, P415, DOI 10.1016/S0031-9384(00)00361-9; Liles W C, 2001, Semin Respir Infect, V16, P11; LINDSTEDT SL, 1988, INT J SPORTS MED, V9, P210, DOI 10.1055/s-2007-1025008; Litvinova EA, 2009, ZH OBSHCH BIOL, V70, P46; Litvinova EA, 2009, INTEGR ZOOL, V4, P285, DOI 10.1111/j.1749-4877.2009.00162.x; MACRIDES F, 1975, SCIENCE, V189, P1104, DOI 10.1126/science.1162363; Maines TR, 2009, SCIENCE, V325, P484, DOI 10.1126/science.1177238; Mizgerd JP, 2003, AM J RESP CRIT CARE, V168, P810, DOI 10.1164/rccm.200303-412OC; Mizutani A, 2008, J APPL PHYSIOL, V105, P678, DOI 10.1152/japplphysiol.00232.2007; Okulewicz A., 2003, Polish Journal of Veterinary Sciences, V6, P51; REED LJ, 1938, AM J HYG, V27; Rezende EL, 2006, J EXP BIOL, V209, P115, DOI 10.1242/jeb.01883; Riviere S, 2009, NATURE, V459, P574, DOI 10.1038/nature08029; Rojas M, 2005, AM J PHYSIOL-LUNG C, V288, pL333, DOI 10.1152/ajplung.00334.2004; ROSENMANN M, 1974, AM J PHYSIOL, V226, P490, DOI 10.1152/ajplegacy.1974.226.3.490; Santuz P, 1997, EUR RESPIR J, V10, P1254, DOI 10.1183/09031936.97.10061254; Tumpey TM, 2005, SCIENCE, V310, P77, DOI 10.1126/science.1119392; Tuvim MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004176; Vaahtovuo J, 2003, FEMS MICROBIOL ECOL, V44, P131, DOI 10.1016/S0168-6496(02)00460-9; Vandenbergh John G., 1994, P343; Ward AC, 1997, VIRUS GENES, V14, P187, DOI 10.1023/A:1007979709403; Yao GH, 2003, INT IMMUNOPHARMACOL, V3, P1853, DOI 10.1016/j.intimp.2003.09.002	34	15	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2010	5	3							e9473	10.1371/journal.pone.0009473	http://dx.doi.org/10.1371/journal.pone.0009473			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	561RT	20208997	Green Submitted, Green Published, gold			2022-12-25	WOS:000274997100019
J	Qin, WM; Shi, Y; Zhao, BT; Yao, CG; Jin, L; Ma, JX; Jin, YX				Qin, Wenming; Shi, Yi; Zhao, Botao; Yao, Chengguo; Jin, Li; Ma, Jiexian; Jin, Youxin			miR-24 Regulates Apoptosis by Targeting the Open Reading Frame (ORF) Region of FAF1 in Cancer Cells	PLOS ONE			English	Article							FAS-ASSOCIATED FACTOR-1; PROSTATE-CANCER; MICRORNAS; EXPRESSION; REPRESSION; RECEPTOR; GENE	Background: microRNAs (miRNAs) are small noncoding RNAs that regulate cognate mRNAs at the post-transcriptional stage. Several studies have shown that miRNAs modulate gene expression in mammalian cells by base pairing to complementary sites in the 3'-untranslated region (3'-UTR) of the target mRNAs. Methodology/Principal Findings: In the present study, miR-24 was found to target fas associated factor 1(FAF1) by binding to its amino acid coding sequence (CDS) region, thereby regulating apoptosis in DU-145 cells. This result supports an augmented model whereby animal miRNAs can exercise their effects through binding to the CDS region of the target mRNA. Transfection of miR-24 antisense oligonucleotide (miR-24-ASO) also induced apoptosis in HGC-27, MGC-803 and HeLa cells. Conclusions/Significance: We found that miR-24 regulates apoptosis by targeting FAF1 in cancer cells. These findings suggest that miR-24 could be an effective drug target for treatment of hormone-insensitive prostate cancer or other types of cancers. Future work may further develop miR-24 for therapeutic applications in cancer biology.	[Qin, Wenming; Shi, Yi; Zhao, Botao; Yao, Chengguo; Ma, Jiexian; Jin, Youxin] Chinese Acad Sci, Shanghai Inst Biol Sci, State Key Lab Mol Biol, Shanghai, Peoples R China; [Jin, Li] St Lukes Hosp, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Qin, WM (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, State Key Lab Mol Biol, Shanghai, Peoples R China.	yxjin@sibs.ac.cn	Jackson, Benjamin L/C-4297-2012; Zhao, Botao/J-5201-2015		National Key Basic Research and Development Program [2005CB724602]; Programs from the Chinese Academy of Sciences [KSCX-2-SW-228, KSCX1-YW-R-64]	National Key Basic Research and Development Program(National Basic Research Program of China); Programs from the Chinese Academy of Sciences	This work was supported by the National Key Basic Research and Development Program (2005CB724602) and Programs from the Chinese Academy of Sciences (KSCX-2-SW-228 and KSCX1-YW-R-64). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alimirah F, 2006, FEBS LETT, V580, P2294, DOI 10.1016/j.febslet.2006.03.041; Alvarez-Garcia I, 2005, DEVELOPMENT, V132, P4653, DOI 10.1242/dev.02073; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Axtell MJ, 2008, BBA-GENE REGUL MECH, V1779, P725, DOI 10.1016/j.bbagrm.2008.02.007; Barmoshe S, 2006, EXPERT OPIN PHARMACO, V7, P1685, DOI 10.1517/14656566.7.13.1685; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bjorling-Poulsen M, 2003, INT J ONCOL, V23, P1015; Chen CZ, 2005, NEW ENGL J MED, V353, P1768, DOI 10.1056/NEJMp058190; CHU KT, 1995, P NATL ACAD SCI USA, V92, P11894, DOI 10.1073/pnas.92.25.11894; Decembrini S, 2009, P NATL ACAD SCI USA, V106, P21179, DOI 10.1073/pnas.0909167106; FORMAN J, 2008, P NATL ACAD SCI USA, V105, P6; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Ghosh A.K., 2009, CANC LETT; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Karginov FV, 2007, P NATL ACAD SCI USA, V104, P19291, DOI 10.1073/pnas.0709971104; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; KERR JFR, 1965, J PATHOL BACTERIOL, V90, P419, DOI 10.1002/path.1700900210; Ko HY, 2009, FEBS J, V276, P4854, DOI 10.1111/j.1742-4658.2009.07185.x; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Lal A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001864; LEE KH, 2009, ONCOGENE; Lu LF, 2009, IMMUNOLOGY, V127, P291, DOI 10.1111/j.1365-2567.2009.03092.x; Menges CW, 2009, CELL CYCLE, V8, P2528, DOI 10.4161/cc.8.16.9280; Mishra PJ, 2008, CELL CYCLE, V7, P853, DOI 10.4161/cc.7.7.5666; NAKANO H, 2009, INT J CANC; OLENA AF, J CELL PHYSL, V222, P540; Ploner A, 2009, RNA, V15, P1797, DOI 10.1261/rna.1740009; Pulukuri SM, 2005, J BIOL CHEM, V280, P36529, DOI 10.1074/jbc.M503111200; Rosa A, 2009, CELL CYCLE, V8, P3513, DOI 10.4161/cc.8.21.9847; Ryu SW, 2003, J BIOL CHEM, V278, P24003, DOI 10.1074/jbc.M302200200; Ryu SW, 2001, BIOCHEM BIOPH RES CO, V286, P1027, DOI 10.1006/bbrc.2001.5505; Shenouda SK, 2009, CANCER METAST REV, V28, P369, DOI 10.1007/s10555-009-9188-5; STONE KR, 1978, INT J CANCER, V21, P274, DOI 10.1002/ijc.2910210305; SUBRAMANIAN S, J CELL PHYSL; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Trang P, 2008, Oncogene, V27 Suppl 2, pS52, DOI 10.1038/onc.2009.353; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Walker JC, 2009, GENE DEV, V23, P1046, DOI 10.1101/gad.1777709; Wang XH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002557; Xiong Y, 2009, HEPATOLOGY; Yamakuchi M, 2008, P NATL ACAD SCI USA, V105, P13421, DOI 10.1073/pnas.0801613105; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434	43	186	204	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2010	5	2							e9429	10.1371/journal.pone.0009429	http://dx.doi.org/10.1371/journal.pone.0009429			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SY	20195546	Green Published, gold, Green Submitted			2022-12-25	WOS:000274924300017
J	Popp, D; Narita, A; Maeda, K; Fujisawa, T; Ghoshdastider, U; Iwasa, M; Maeda, Y; Robinson, RC				Popp, David; Narita, Akihiro; Maeda, Kayo; Fujisawa, Tetsuro; Ghoshdastider, Umesh; Iwasa, Mitsusada; Maeda, Yuichiro; Robinson, Robert C.			Filament Structure, Organization, and Dynamics in MreB Sheets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SHAPE; ESCHERICHIA-COLI; CAULOBACTER-CRESCENTUS; BACILLUS-SUBTILIS; BINDING PROTEINS; ACTIN-FILAMENTS; POLYMERIZATION; BACTERIA; ROLES; FLUORESCENCE	In vivo fluorescence microscopy studies of bacterial cells have shown that the bacterial shape-determining protein and actin homolog, MreB, forms cable-like structures that spiral around the periphery of the cell. The molecular structure of these cables has yet to be established. Here we show by electron microscopy that Thermatoga maritime MreB forms complex, several mu m long multilayered sheets consisting of diagonally interwoven filaments in the presence of either ATP or GTP. This architecture, in agreement with recent rheological measurements on MreB cables, may have superior mechanical properties and could be an important feature for maintaining bacterial cell shape. MreB polymers within the sheets appear to be single-stranded helical filaments rather than the linear protofilaments found in the MreB crystal structure. Sheet assembly occurs over a wide range of pH, ionic strength, and temperature. Polymerization kinetics are consistent with a cooperative assembly mechanism requiring only two steps: monomer activation followed by elongation. Steady-state TIRF microscopy studies of MreB suggest filament treadmilling while high pressure small angle x-ray scattering measurements indicate that the stability of MreB polymers is similar to that of F-actin filaments. In the presence of ADP or GDP, long, thin cables formed in which MreB was arranged in parallel as linear protofilaments. This suggests that the bacterial cell may exploit various nucleotides to generate different filament structures within cables for specific MreB-based functions.	[Popp, David; Narita, Akihiro; Maeda, Kayo; Iwasa, Mitsusada; Maeda, Yuichiro] RIKEN Harima Inst Spring 8, Japan Sci & Technol Corp, ERATO Actin Filament Dynam Project, Sayo, Hyogo 6795148, Japan; [Popp, David; Robinson, Robert C.] Inst Mol & Cell Biol, Proteos 138673, Singapore; [Narita, Akihiro; Maeda, Kayo; Ghoshdastider, Umesh; Maeda, Yuichiro] Nagoya Univ, Grad Sch Sci, Struct Biol Res Ctr, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Narita, Akihiro; Maeda, Kayo; Ghoshdastider, Umesh; Maeda, Yuichiro] Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Fujisawa, Tetsuro] Gifu Univ, Grad Sch Engn, Dept Biomol Sci, Gifu 5011193, Japan	Japan Science & Technology Agency (JST); RIKEN; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Nagoya University; Nagoya University; Gifu University	Popp, D (corresponding author), RIKEN Harima Inst Spring 8, Japan Sci & Technol Corp, ERATO Actin Filament Dynam Project, 1-1-1 Kouto, Sayo, Hyogo 6795148, Japan.	dpopp@imcb.a-star.edu.sg	Robinson, Robert/G-9702-2011; Fujisawa, Tetsuro/AAA-5202-2019; Ghoshdastider, Umesh/O-5327-2015	Robinson, Robert/0000-0001-6367-6903; Ghoshdastider, Umesh/0000-0003-4471-9394	Agency for Science, Technology and Research (A*STAR), Singapore	Agency for Science, Technology and Research (A*STAR), Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by the Agency for Science, Technology and Research (A*STAR), Singapore ( to R. C. R.).	Bean GJ, 2008, BIOCHEMISTRY-US, V47, P826, DOI 10.1021/bi701538e; CAYLEY S, 1991, J MOL BIOL, V222, P281, DOI 10.1016/0022-2836(91)90212-O; Chen YD, 2005, BIOPHYS J, V88, P505, DOI 10.1529/biophysj.104.044149; COOPER JA, 1983, BIOCHEMISTRY-US, V22, P2193, DOI 10.1021/bi00278a021; Daniel RA, 2003, CELL, V113, P767, DOI 10.1016/S0092-8674(03)00421-5; Divakaruni AV, 2005, P NATL ACAD SCI USA, V102, P18602, DOI 10.1073/pnas.0507937102; Dye NA, 2005, P NATL ACAD SCI USA, V102, P18608, DOI 10.1073/pnas.0507708102; Esue O, 2006, J BACTERIOL, V188, P968, DOI 10.1128/JB.188.3.968-976.2006; Esue O, 2005, J BIOL CHEM, V280, P2628, DOI 10.1074/jbc.M410298200; FUJIMORI H, 2000, JAMSTECR, V42, P105; Fujiwara I, 2002, NAT CELL BIOL, V4, P666, DOI 10.1038/ncb841; Gitai Z, 2004, P NATL ACAD SCI USA, V101, P8643, DOI 10.1073/pnas.0402638101; Gital Z, 2005, CELL, V120, P329, DOI 10.1016/j.cell.2005.01.007; Ikeuchi Y, 2002, EUR J BIOCHEM, V269, P364, DOI 10.1046/j.0014-2956.2001.02664.x; Iwasa M, 2008, J BIOL CHEM, V283, P21045, DOI 10.1074/jbc.M800570200; Jewett MC, 2009, J BACTERIOL, V191, P1083, DOI 10.1128/JB.00852-08; Jones LJF, 2001, CELL, V104, P913, DOI 10.1016/S0092-8674(01)00287-2; Kim SY, 2006, P NATL ACAD SCI USA, V103, P10929, DOI 10.1073/pnas.0604503103; KRULWICH TA, 1985, J BACTERIOL, V162, P768, DOI 10.1128/JB.162.2.768-772.1985; Kruse T, 2005, MOL MICROBIOL, V55, P78, DOI 10.1111/j.1365-2958.2004.04367.x; Kruse T, 2003, EMBO J, V22, P5283, DOI 10.1093/emboj/cdg504; Kurner J, 2005, SCIENCE, V307, P436, DOI 10.1126/science.1104031; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Leaver M, 2005, MOL MICROBIOL, V57, P1196, DOI 10.1111/j.1365-2958.2005.04736.x; Margolin W, 2009, CURR BIOL, V19, pR812, DOI 10.1016/j.cub.2009.06.033; Nishikawa Y, 2001, NUCL INSTRUM METH A, V467, P1384, DOI 10.1016/S0168-9002(01)00738-0; Palmer A, 1999, BIOPHYS J, V76, P1063, DOI 10.1016/S0006-3495(99)77271-1; Popp D, 2008, BIOPOLYMERS, V89, P711, DOI 10.1002/bip.20999; Popp D, 2008, EMBO J, V27, P570, DOI 10.1038/sj.emboj.7601978; Sukow C, 1998, J MOL BIOL, V284, P1039, DOI 10.1006/jmbi.1998.2211; UPCHURCH RG, 1980, J BACTERIOL, V143, P274, DOI 10.1128/JB.143.1.274-284.1980; van den Ent F, 2001, NATURE, V413, P39, DOI 10.1038/35092500; WACHI M, 1987, J BACTERIOL, V169, P4935, DOI 10.1128/jb.169.11.4935-4940.1987; WEBB MR, 1992, P NATL ACAD SCI USA, V89, P4884, DOI 10.1073/pnas.89.11.4884	34	41	42	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					15858	15865		10.1074/jbc.M109.095901	http://dx.doi.org/10.1074/jbc.M109.095901			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20223832	Green Published, hybrid			2022-12-25	WOS:000277715900023
J	Kihira, Y; Hermanstyne, TO; Misonou, H				Kihira, Yoshitaka; Hermanstyne, Tracey O.; Misonou, Hiroaki			Formation of Heteromeric Kv2 Channels in Mammalian Brain Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROMULTIMERIC POTASSIUM CHANNELS; K+ CHANNEL; DELAYED RECTIFIER; RAT-BRAIN; ALPHA-SUBUNITS; MODULATION; LOCALIZATIONS; PHOSPHORYLATION; IDENTIFICATION; DETERMINANTS	The formation of heteromeric tetramers is a common feature of voltage-gated potassium (Kv) channels. This results in the generation of a variety of tetrameric Kv channels that exhibit distinct biophysical and biochemical characteristics. Kv2 delayed rectifier channels are, however, unique exceptions. It has been previously shown that mammalian Kv2.1 and Kv2.2 are localized in distinct domains of neuronal membranes and are not capable of forming heteromeric channels with each other (Hwang, P. M., Glatt, C. E., Bredt, D. S., Yellen, G., and Snyder, S. H. (1992) Neuron 8, 473-481). In this study, we report a novel form of rat Kv2.2, Kv2.2(long), which has not been previously recognized. Our data indicate that Kv2.2(long) is the predominant form of Kv2.2 expressed in cortical pyramidal neurons. In contrast to the previous findings, we also found that rat Kv2.1 and Kv2.2(long) are colocalized in the somata and proximal dendrites of cortical pyramidal neurons and are capable of forming functional heteromeric delayed rectifier channels. Our results suggest that the delayed rectifier currents, which regulate action potential firing, are encoded by heteromeric Kv2 channels in cortical neurons.	[Kihira, Yoshitaka; Hermanstyne, Tracey O.; Misonou, Hiroaki] Univ Maryland, Sch Dent, Dept Neural & Pain Sci, Baltimore, MD 21201 USA; [Hermanstyne, Tracey O.; Misonou, Hiroaki] Univ Maryland, Program Neurosci, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Misonou, H (corresponding author), Univ Maryland, Sch Dent, Dept Neural & Pain Sci, Baltimore, MD 21201 USA.	hmisono@umaryland.edu		Misono, Hiroaki/0000-0001-5892-1804	American Heart Association; National Institutes of Health [U24NS050606]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U24NS050606] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the American Heart Association. The University of California Davis/National Institutes of Health NeuroMab Facility is supported by National Institutes of Health Grant U24NS050606.	Bixby KA, 1999, NAT STRUCT BIOL, V6, P38; Blaine JT, 1998, J NEUROSCI, V18, P9585; CHRISTIE MJ, 1990, NEURON, V4, P405, DOI 10.1016/0896-6273(90)90052-H; FRECH GC, 1989, NATURE, V340, P642, DOI 10.1038/340642a0; Guan D, 2007, J PHYSIOL-LONDON, V581, P941, DOI 10.1113/jphysiol.2007.128454; Hille B., 2001, IONIC CHANNELS EXCIT, P814; HWANG PM, 1993, J NEUROSCI, V13, P1569; HWANG PM, 1993, NEUROSCIENCE, V55, P613, DOI 10.1016/0306-4522(93)90427-H; HWANG PM, 1992, NEURON, V8, P473, DOI 10.1016/0896-6273(92)90275-I; ISACOFF EY, 1990, NATURE, V345, P530, DOI 10.1038/345530a0; Johnston J, 2008, J PHYSIOL-LONDON, V586, P3493, DOI 10.1113/jphysiol.2008.153734; Ju M, 2003, J BIOL CHEM, V278, P12769, DOI 10.1074/jbc.M212973200; Kerschensteiner D, 2005, P NATL ACAD SCI USA, V102, P6160, DOI 10.1073/pnas.0500468102; Kramer JW, 1998, AM J PHYSIOL-CELL PH, V274, pC1501, DOI 10.1152/ajpcell.1998.274.6.C1501; Li Q, 2004, J NEUROSCI, V24, P4070, DOI 10.1523/JNEUROSCI.0346-04.2004; Lim ST, 2000, NEURON, V25, P385, DOI 10.1016/S0896-6273(00)80902-2; MALETICSAVATIC M, 1995, J NEUROSCI, V15, P3840; Malin SA, 2002, J NEUROSCI, V22, P10094; Schnitzler MMY, 2009, J BIOL CHEM, V284, P4695, DOI 10.1074/jbc.M808786200; Misonou H, 2006, J COMP NEUROL, V496, P289, DOI 10.1002/cne.20931; Misonou H, 2005, J NEUROSCI, V25, P11184, DOI 10.1523/JNEUROSCI.3370-05.2005; Misonou H, 2004, NAT NEUROSCI, V7, P711, DOI 10.1038/nn1260; Misonou H, 2006, J NEUROSCI, V26, P13505, DOI 10.1523/JNEUROSCI.3970-06.2006; Mohapatra DP, 2006, J NEUROSCI, V26, P685, DOI 10.1523/JNEUROSCI.4620-05.2006; Mohapatra DP, 2008, J NEUROSCI, V28, P4982, DOI 10.1523/JNEUROSCI.0186-08.2008; Murakoshi H, 1999, J NEUROSCI, V19, P1728; O'Connell KMS, 2005, J CELL SCI, V118, P2155, DOI 10.1242/jcs.02348; Park KS, 2006, SCIENCE, V313, P976, DOI 10.1126/science.1124254; Post MA, 1996, FEBS LETT, V399, P177, DOI 10.1016/S0014-5793(96)01316-6; Rhodes KJ, 2006, J NEUROSCI, V26, P8017, DOI 10.1523/JNEUROSCI.2728-06.2006; RUPPERSBERG JP, 1990, NATURE, V345, P535, DOI 10.1038/345535a0; Salinas M, 1997, J BIOL CHEM, V272, P8774, DOI 10.1074/jbc.272.13.8774; Saper CB, 2005, J COMP NEUROL, V493, P477, DOI 10.1002/cne.20839; SHENG M, 1993, NATURE, V365, P72, DOI 10.1038/365072a0; Stocker M, 1998, BIOCHEM BIOPH RES CO, V248, P927, DOI 10.1006/bbrc.1998.9072; Trimmer JS, 2001, POTASSIUM CHANNELS IN CARDIOVASCULAR BIOLOGY, P163; TRIMMER JS, 1991, P NATL ACAD SCI USA, V88, P10764, DOI 10.1073/pnas.88.23.10764; Wray D, 2004, EUR BIOPHYS J BIOPHY, V33, P194, DOI 10.1007/s00249-003-0363-2; Yu FH, 2005, PHARMACOL REV, V57, P387, DOI 10.1124/pr.57.4.13	39	41	44	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15048	15055		10.1074/jbc.M109.074260	http://dx.doi.org/10.1074/jbc.M109.074260			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20202934	Green Published, hybrid			2022-12-25	WOS:000277399000026
J	Ash, MR; Guilfoyle, A; Clarke, RJ; Guss, M; Maher, MJ; Jormakka, M				Ash, Miriam-Rose; Guilfoyle, Amy; Clarke, Ronald J.; Guss, Mitchell; Maher, Megan J.; Jormakka, Mika			Potassium-activated GTPase Reaction in the G Protein-coupled Ferrous Iron Transporter B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; STRUCTURAL BASIS; SALMONELLA-TYPHIMURIUM; ABC TRANSPORTER; G-DOMAIN; DIMERIZATION; GDP; COMPLEX; FEOB; SUBUNIT	FeoB is a prokaryotic membrane protein responsible for the import of ferrous iron (Fe2+). A defining feature of FeoB is that it includes an N-terminal 30-kDa soluble domain with GTPase activity, which is required for iron transport. However, the low intrinsic GTP hydrolysis rate of this domain appears to be too slow for FeoB either to function as a channel or to possess an active Fe2+ membrane transport mechanism. Here, we present crystal structures of the soluble domain of FeoB from Streptococcus thermophilus in complex with GDP and with the GTP analogue derivative 2'-(or -3')-O-(N-methylanthraniloyl)-beta,gamma-imidoguanosine 5'-triphosphate (mant-GMPPNP). Unlike recent structures of the G protein domain, the mant-GMPPNP-bound structure shows clearly resolved, active conformations of the critical Switch motifs. Importantly, biochemical analyses demonstrate that the GTPase activity of FeoB is activated by K+, which leads to a 20-fold acceleration in its hydrolysis rate. Analysis of the structure identified a conserved asparagine residue likely to be involved in K+ coordination, and mutation of this residue abolished K+-dependent activation. We suggest that this, together with a second asparagine residue that we show is critical for the structure of the Switch I loop, allows the prediction of K+-dependent activation in G proteins. In addition, the accelerated hydrolysis rate opens up the possibility that FeoB might indeed function as an active transporter.	[Guilfoyle, Amy; Maher, Megan J.; Jormakka, Mika] Centenary Inst, Struct Biol Program, Sydney, NSW 2042, Australia; [Ash, Miriam-Rose; Guss, Mitchell] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia; [Clarke, Ronald J.] Univ Sydney, Sch Chem, Sydney, NSW 2006, Australia; [Jormakka, Mika] Univ Sydney, Fac Med, Cent Clin Sch, Sydney, NSW 2006, Australia	University of Sydney; Centenary Institute; University of Sydney; University of Sydney; University of Sydney	Jormakka, M (corresponding author), Centenary Inst, Struct Biol Program, Locked Bag 6, Sydney, NSW 2042, Australia.	m.jormakka@centenary.org.au	Guss, Jules Mitchell/N-1387-2019; Maher, Megan/B-2239-2012; Clarke, Ronald J/L-5259-2016	Guss, Jules Mitchell/0000-0003-4259-6079; Clarke, Ronald J/0000-0002-0950-8017; Maher, Megan/0000-0003-0848-9640; Ash, Miriam-Rose/0000-0002-0573-9854	National Health and Medical Research Council [570784, 632703]; Australian Government; University of Sydney	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Government(Australian GovernmentCGIAR); University of Sydney(University of Sydney)	This work was supported by National Health and Medical Research Council Grants 570784 and 632703 and in part by the Australian Government's Major National Research Facilities program and the University of Sydney.	AMOR JC, 1994, NATURE, V372, P704, DOI 10.1038/372704a0; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Benabdelhak H, 2005, BIOCHEM J, V386, P489, DOI 10.1042/BJ20041282; BIGAY J, 1985, FEBS LETT, V191, P181, DOI 10.1016/0014-5793(85)80004-1; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Cachero TG, 1998, CELL, V93, P1077, DOI 10.1016/S0092-8674(00)81212-X; CALES C, 1988, NATURE, V332, P548, DOI 10.1038/332548a0; Cohen SX, 2004, ACTA CRYSTALLOGR D, V60, P2222, DOI 10.1107/S0907444904027556; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Di Cera E, 2006, J BIOL CHEM, V281, P1305, DOI 10.1074/jbc.R500023200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eng ET, 2008, J MOL BIOL, V375, P1086, DOI 10.1016/j.jmb.2007.11.027; Finlin BS, 2006, J BIOL CHEM, V281, P23557, DOI 10.1074/jbc.M604867200; Geyer M, 1996, BIOCHEMISTRY-US, V35, P10308, DOI 10.1021/bi952858k; Guilfoyle A, 2009, EMBO J, V28, P2677, DOI 10.1038/emboj.2009.208; Hattori M, 2009, STRUCTURE, V17, P1345, DOI 10.1016/j.str.2009.08.007; JOHN J, 1993, J BIOL CHEM, V268, P923; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; Koster S, 2009, J MOL BIOL, V392, P405, DOI 10.1016/j.jmb.2009.07.020; LEHRER SS, 1971, BIOCHEMISTRY-US, V10, P3254, DOI 10.1021/bi00793a015; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; Marlovits TC, 2002, P NATL ACAD SCI USA, V99, P16243, DOI 10.1073/pnas.242338299; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MEURY J, 1981, EUR J BIOCHEM, V119, P165, DOI 10.1111/j.1432-1033.1981.tb05589.x; Meyer S, 2009, J MOL BIOL, V392, P910, DOI 10.1016/j.jmb.2009.07.004; MORBACH S, 1993, J BIOL CHEM, V268, P18617; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nikaido K, 1997, J BIOL CHEM, V272, P27745, DOI 10.1074/jbc.272.44.27745; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Petermann N, 2010, FEBS LETT, V584, P733, DOI 10.1016/j.febslet.2009.12.045; Rittinger K, 1997, NATURE, V388, P693, DOI 10.1038/41805; Schaafsma D, 2008, CELL SIGNAL, V20, P1705, DOI 10.1016/j.cellsig.2008.04.012; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; SCHEFFZEK K, 1995, NATURE, V374, P378, DOI 10.1038/374378a0; Scrima A, 2006, EMBO J, V25, P2940, DOI 10.1038/sj.emboj.7601171; Spoerner M, 2005, BIOCHEMISTRY-US, V44, P2225, DOI 10.1021/bi0488000; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; VIITANEN PV, 1990, BIOCHEMISTRY-US, V29, P5665, DOI 10.1021/bi00476a003; Wang J, 2003, J MOL BIOL, V327, P843, DOI 10.1016/S0022-2836(03)00184-0; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Yamanaka K, 2000, J BACTERIOL, V182, P7078, DOI 10.1128/JB.182.24.7078-7082.2000	43	44	45	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14594	14602		10.1074/jbc.M110.111914	http://dx.doi.org/10.1074/jbc.M110.111914			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20220129	hybrid, Green Published			2022-12-25	WOS:000277299700056
J	Wang, YK; Zhao, GY; Li, Y; Chen, XL; Xie, BB; Su, HN; Lv, YH; He, HL; Liu, H; Hu, J; Zhou, BC; Zhang, YZ				Wang, Yu-Kai; Zhao, Guo-Yan; Li, Yang; Chen, Xiu-Lan; Xie, Bin-Bin; Su, Hai-Nan; Lv, Yao-Hui; He, Hai-Lun; Liu, Hong; Hu, Jun; Zhou, Bai-Cheng; Zhang, Yu-Zhong			Mechanistic Insight into the Function of the C-terminal PKD Domain of the Collagenolytic Serine Protease Deseasin MCP-01 from Deep Sea Pseudoalteromonas sp SM9913 BINDING OF THE PKD DOMAIN TO COLLAGEN RESULTS IN COLLAGEN SWELLING BUT DOES NOT UNWIND THE COLLAGEN TRIPLE HELIX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIPLE-HELICAL COLLAGEN; SUBSTRATE-SPECIFICITY; CRYSTAL-STRUCTURE; GELATINASE-A; GENE; CONFORMATION; DEGRADATION; EXPRESSION; CHITINASE; BACTERIUM	Deseasin MCP-01 is a bacterial collagenolytic serine protease. Its catalytic domain alone can degrade collagen, and its C-terminal PKD domain is a collagen-binding domain (CBD) that can improve the collagenolytic efficiency of the catalytic domain by an unknown mechanism. Here, scanning electron microscopy (SEM), atomic force microscopy (AFM), zeta potential, and circular dichroism spectroscopy were used to clarify the functional mechanism of the PKD domain in MCP-01 collagenolysis. The PKD domain observably swelled insoluble collagen. Its collagen-swelling ability and its improvement to the collagenolysis of the catalytic domain are both temperature-dependent. SEM observation showed the PKD domain swelled collagen fascicles with an increase of their diameter from 5.3 mu m to 8.8 mu m after 1 h of treatment, and the fibrils forming the fascicles were dispersed. AFM observation directly showed that the PKD domain bound collagen, swelled the microfibrils, and exposed the monomers. The PKD mutant W36A neither bound collagen nor disturbed its structure. Zeta potential results demonstrated that PKD treatment increased the net positive charges of the collagen surface. PKD treatment caused no change in the content or the thermostability of the collagen triple helix. Furthermore, the PKD-treated collagen could not be degraded by gelatinase. Therefore, though the triple helix monomers were exposed, the PKD domain could not unwind the collagen triple helix. Our study reveals the functional mechanism of the PKD domain of the collagenolytic serine protease MCP-01 in collagen degradation, which is distinct from that of the CBDs of mammalian matrix metalloproteases.	[Wang, Yu-Kai; Zhao, Guo-Yan; Li, Yang; Chen, Xiu-Lan; Xie, Bin-Bin; Su, Hai-Nan; He, Hai-Lun; Zhou, Bai-Cheng; Zhang, Yu-Zhong] Shandong Univ, Marine Biotechnol Res Ctr, State Key Lab Microbial Technol, Jinan 250100, Peoples R China; [Lv, Yao-Hui; Liu, Hong] Shandong Univ, State Key Lab Crystal Mat, Jinan 250100, Peoples R China; [Hu, Jun] Chinese Acad Sci, Shanghai Inst Appl Phys, Shanghai 201800, Peoples R China	Shandong University; Shandong University; Chinese Academy of Sciences; Shanghai Institute of Applied Physics, CAS	Zhang, YZ (corresponding author), Shandong Univ, Marine Biotechnol Res Ctr, State Key Lab Microbial Technol, Jinan 250100, Peoples R China.	zhangyz@sdu.edu.cn	Liu, Hong/AAR-8837-2020; Liu, Hong/D-7288-2019	Liu, Hong/0000-0003-1640-9620	National Natural Science Foundation of China [30770040, 50925205]; Hi-Tech Research and Development program of China [2007AA091903]; COMRA Program [DYXM-115-02-2-6]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hi-Tech Research and Development program of China(National High Technology Research and Development Program of China); COMRA Program	This work was supported by National Natural Science Foundation of China (30770040 and 50925205), Hi-Tech Research and Development program of China (2007AA091903), and COMRA Program (DYXM-115-02-2-6).	Ahsan MM, 1996, J BACTERIOL, V178, P5732, DOI 10.1128/jb.178.19.5732-5740.1996; Bauer M, 2006, ENVIRON MICROBIOL, V8, P2201, DOI 10.1111/j.1462-2920.2006.01152.x; Buehler MJ, 2006, P NATL ACAD SCI USA, V103, P12285, DOI 10.1073/pnas.0603216103; Bycroft M, 1999, EMBO J, V18, P297, DOI 10.1093/emboj/18.2.297; Chen XL, 2007, MICROBIOL-SGM, V153, P2116, DOI 10.1099/mic.0.2007/006056-0; Chung LD, 2004, EMBO J, V23, P3020, DOI 10.1038/sj.emboj.7600318; CLARK IM, 1989, BIOCHEM J, V263, P201, DOI 10.1042/bj2630201; DeSouza SJ, 1996, FASEB J, V10, P927, DOI 10.1096/fasebj.10.8.8666171; GLUCKSMANNKUIS MA, 1995, CELL, V81, P289; GomisRuth FX, 1996, J MOL BIOL, V264, P556, DOI 10.1006/jmbi.1996.0661; Ikoma T, 2003, INT J BIOL MACROMOL, V32, P199, DOI 10.1016/S0141-8130(03)00054-0; Itoi Y, 2006, J BACTERIOL, V188, P6572, DOI 10.1128/JB.00767-06; Jing H, 2002, STRUCTURE, V10, P1453, DOI 10.1016/S0969-2126(02)00840-7; KADLER K, 1994, PROTEIN PROFILE, V1, P519; Kadler KE, 1996, BIOCHEM J, V316, P1; Knauper V, 1997, J BIOL CHEM, V272, P7608, DOI 10.1074/jbc.272.12.7608; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Miyamoto K, 2002, J BACTERIOL, V184, P1865, DOI 10.1128/JB.184.7.1865-1872.2002; Monaco S, 2006, PROTEIN SCI, V15, P2805, DOI 10.1110/ps.062430706; MURPHY G, 1992, J BIOL CHEM, V267, P9612; Nerenberg PS, 2008, PROTEINS, V70, P1154, DOI 10.1002/prot.21687; Oda K, 1996, J BIOCHEM, V120, P564; Orikoshi H, 2005, J APPL MICROBIOL, V99, P551, DOI 10.1111/j.1365-2672.2005.02630.x; Overall CM, 2002, MOL BIOTECHNOL, V22, P51, DOI 10.1385/MB:22:1:051; PERRAKIS A, 1994, STRUCTURE, V2, P1169, DOI 10.1016/S0969-2126(94)00119-7; Perumal S, 2008, P NATL ACAD SCI USA, V105, P2824, DOI 10.1073/pnas.0710588105; Poenitzsch VZ, 2006, MICROSC MICROANAL, V12, P221, DOI 10.1017/S1431927606060314; Shoulders MD, 2009, ANNU REV BIOCHEM, V78, P929, DOI 10.1146/annurev.biochem.77.032207.120833; Tam EM, 2004, J BIOL CHEM, V279, P43336, DOI 10.1074/jbc.M407186200; Tam EM, 2002, J BIOL CHEM, V277, P39005, DOI 10.1074/jbc.M206874200; Usha R, 2002, J APPL POLYM SCI, V84, P975, DOI 10.1002/app.10262; Wilson JJ, 2003, EMBO J, V22, P1743, DOI 10.1093/emboj/cdg172; Zhao GY, 2008, J BIOL CHEM, V283, P36100, DOI 10.1074/jbc.M804438200	33	35	37	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14285	14291		10.1074/jbc.M109.087023	http://dx.doi.org/10.1074/jbc.M109.087023			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20207733	Green Published, hybrid			2022-12-25	WOS:000277299700025
J	Gao, MQ; Choi, YP; Kang, S; Youn, JH; Cho, NH				Gao, M-Q; Choi, Y-P; Kang, S.; Youn, J. H.; Cho, N-H			CD24(+) cells from hierarchically organized ovarian cancer are enriched in cancer stem cells	ONCOGENE			English	Article						CD24; ovarian cancer; cancer stem cell; tumorigenicity	PROSPECTIVE IDENTIFICATION; SIDE POPULATION; CD133; RESISTANCE; INSIGHTS; MARKERS; GROWTH	Cancer stem cells (CSCs) have been identified in solid tumors and cancer cell lines. In this study, we isolated a series of cancer cell clones, which were heterogeneous in growth rate, cell cycle distribution and expression profile of genes and proteins, from ovarian tumor specimens of a patient and identified a sub-population enriched for ovarian CSCs defined by CD24 phenotype. Experiments in vitro demonstrated CD24(+) sub-population possessed stem cell-like characteristics of remaining quiescence and more chemoresistant compared with CD24(-) fraction, as well as a specific capacity for self-renewal and differentiation. In addition, injection of 5 x 10(3) CD24(+) cells was able to form tumor xenografts in nude mice, whereas equal number of CD24(-) cells remained nontumorigenic. We also found that CD24(+) cells expressed higher mRNA levels of some 'stemness' genes, including Nestin, beta-catenin, Bmi-1, Oct4, Oct3/4, Notch1 and Notch4 which were involved in modulating many functions of stem cells, and lower E-cadherin mRNA level than CD24(-) cells. Altogether, these observations suggest human ovarian tumor cells are organized as a hierarchy and CD24 demarcates an ovarian cancer-initiating cell population. These findings will have important clinical applications for developing effective therapeutic strategies to treat ovarian cancer. Oncogene (2010) 29, 2672-2680; doi:10.1038/onc.2010.35; published online 1 March 2010	[Choi, Y-P; Kang, S.; Cho, N-H] Yonsei Univ, Coll Med, Dept Pathol, Seoul 120749, South Korea; [Gao, M-Q] Yonsei Univ, Coll Med, Brain Korea Project Med Sci 21, Seoul 120749, South Korea; [Youn, J. H.] Yonsei Univ, Coll Med, Res Ctr Human Nat Def Syst, Seoul 120749, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Cho, NH (corresponding author), Yonsei Univ, Coll Med, Dept Pathol, 134 Shinchon Dong, Seoul 120749, South Korea.	cho1988@yuhs.ac		jo, namhun/0000-0002-0045-6441; KANG, SUKI/0000-0002-9957-3479	Ministry for Health, Welfare and Family Affairs, Republic of Korea [A062598]; National Research Foundation of Korea (NRF); Korea Government (MEST) [20090079165]	Ministry for Health, Welfare and Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korea Government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by Korea Healthcare Technology R&D Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea (A062598; NHC) and by the National Research Foundation of Korea (NRF) grant funded by the Korea Government (MEST) (No. 20090079165; CNH).	Ahn SM, 2008, PROTEOMICS, V8, P4946, DOI 10.1002/pmic.200800312; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Baba T, 2009, ONCOGENE, V28, P209, DOI 10.1038/onc.2008.374; Bapat SA, 2005, CANCER RES, V65, P3025, DOI 10.1158/0008-5472.CAN-04-3931; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Cannistra SA, 2004, NEW ENGL J MED, V351, P2519, DOI 10.1056/NEJMra041842; Chambers I, 2004, ONCOGENE, V23, P7150, DOI 10.1038/sj.onc.1207930; Cheng T, 2004, ONCOGENE, V23, P7256, DOI 10.1038/sj.onc.1207945; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; DEININGER M, 2004, CELL CYCLE GROWTH 5, P667; Doyle LA, 2003, ONCOGENE, V22, P7340, DOI 10.1038/sj.onc.1206938; Ferrandina G, 2008, INT J GYNECOL CANCER, V18, P506, DOI 10.1111/j.1525-1438.2007.01056.x; Friel AM, 2008, CELL CYCLE, V7, P242, DOI 10.4161/cc.7.2.5207; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Goranov AI, 2009, GENE DEV, V23, P1408, DOI 10.1101/gad.1777309; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Jaksch M, 2008, CANCER RES, V68, P7882, DOI 10.1158/0008-5472.CAN-08-0723; Kristiansen G, 2002, AM J PATHOL, V161, P1215, DOI 10.1016/S0002-9440(10)64398-2; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Monzani E, 2007, EUR J CANCER, V43, P935, DOI 10.1016/j.ejca.2007.01.017; Naora H, 2005, NAT REV CANCER, V5, P355, DOI 10.1038/nrc1611; Pardal R, 2003, NAT REV CANCER, V3, P895, DOI 10.1038/nrc1232; Patrawala L, 2005, CANCER RES, V65, P6207, DOI 10.1158/0008-5472.CAN-05-0592; Schmalhofer O, 2009, CANCER METAST REV, V28, P151, DOI 10.1007/s10555-008-9179-y; Seigel GM, 2007, MOL VIS, V13, P823; Song J, 2007, CLIN CANCER RES, V13, P6842, DOI 10.1158/1078-0432.CCR-07-0569; Stupp R, 2007, NAT BIOTECHNOL, V25, P193, DOI 10.1038/nbt0207-193; Szotek PP, 2006, P NATL ACAD SCI USA, V103, P11154, DOI 10.1073/pnas.0603672103; Wicha MS, 2006, CANCER RES, V66, P1883, DOI 10.1158/0008-5472.CAN-05-3153; Zhang S, 2008, CANCER RES, V68, P4311, DOI 10.1158/0008-5472.CAN-08-0364	30	279	293	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 6	2010	29	18					2672	2680		10.1038/onc.2010.35	http://dx.doi.org/10.1038/onc.2010.35			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	592DC	20190812				2022-12-25	WOS:000277354600007
J	Byeon, IJL; Dao, KK; Jung, JW; Keen, J; Leiros, I; Doskeland, SO; Martinez, A; Gronenborn, AM				Byeon, In-Ja L.; Dao, Khanh K.; Jung, Jinwon; Keen, Jeffrey; Leiros, Ingar; Doskeland, Stein O.; Martinez, Aurora; Gronenborn, Angela M.			Allosteric Communication between cAMP Binding Sites in the RI Subunit of Protein Kinase A Revealed by NMR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							I REGULATORY SUBUNIT; PHYSIOLOGICAL CONDITIONS; DEPENDENT ACTIVATION; CYCLIC-NUCLEOTIDES; CATALYTIC SUBUNITS; ALPHA SUBUNIT; PKA; MECHANISM; HOLOENZYME; MUTATIONS	The activation of protein kinase A involves the synergistic binding of cAMP to two cAMP binding sites on the inhibitory R subunit, causing release of the C subunit, which subsequently can carry out catalysis. We used NMR to structurally characterize in solution the RI alpha-(98-381) subunit, a construct comprising both cyclic nucleotide binding (CNB) domains, in the presence and absence of cAMP, and map the effects of cAMP binding at single residue resolution. Several conformationally disordered regions in free RI alpha become structured upon cAMP binding, including the interdomain alpha C:A and alpha C':A helices that connect CNB domains A and B and are primary recognition sites for the C subunit. NMR titration experiments with cAMP, B site-selective 2-Cl-8-hexylamino-cAMP, and A site-selective N-6-monobutyryl-cAMP revealed that cyclic nucleotide binding to either the B or A site affected the interdomain helices. The NMR resonances of this interdomain region exhibited chemical shift changes upon ligand binding to a single site, either site B or A, with additional changes occurring upon binding to both sites. Such distinct, stepwise conformational changes in this region reflect the synergistic interplay between the two sites and may underlie the positive cooperativity of cAMP activation of the kinase. Furthermore, nucleotide binding to the A site also affected residues within the B domain. The present NMR study provides the first structural evidence of unidirectional allosteric communication between the sites. Trp(262), which lines the CNB A site but resides in the sequence of domain B, is an important structural determinant for intersite communication.	[Dao, Khanh K.; Keen, Jeffrey; Doskeland, Stein O.; Martinez, Aurora] Univ Bergen, Dept Biomed, N-5009 Bergen, Norway; [Byeon, In-Ja L.; Jung, Jinwon; Gronenborn, Angela M.] Univ Pittsburgh, Sch Med, Dept Biol Struct, Pittsburgh, PA 15260 USA; [Leiros, Ingar] Univ Tromso, Dept Chem, Norwegian Struct Biol Ctr Norstruct, N-9037 Tromso, Norway	University of Bergen; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; UiT The Arctic University of Tromso	Martinez, A (corresponding author), Univ Bergen, Dept Biomed, Jonas Lies Vei 91, N-5009 Bergen, Norway.	aurora.martinez@biomed.uib.no; amg100@pitt.edu	Leiros, Ingar/AAM-2940-2020; Martinez, Aurora/M-3088-2019; Jung, Jinwon/F-6038-2010	Martinez, Aurora/0000-0003-1643-6506; Jung, Jinwon/0000-0002-7981-3316; Gronenborn, Angela M/0000-0001-9072-3525; Leiros, Ingar/0000-0001-9333-4541; Doskeland, Stein Ove/0000-0002-4009-4756	Research Council of Norway (RCN), Helse-Vest; Norwegian Cancer Society; Commonwealth of Pennsylvania [SAP 4100026429]; RCN	Research Council of Norway (RCN), Helse-Vest(Research Council of Norway); Norwegian Cancer Society(Norwegian Cancer Society); Commonwealth of Pennsylvania; RCN	This work was supported by grants from The Research Council of Norway (RCN), Helse-Vest, and the Norwegian Cancer Society (to A. M. and S. O. D.) and Commonwealth of Pennsylvania Grant SAP 4100026429 (to A. M. G.). NorStruct is supported by a grant from the National Program in Functional Genomics of the RCN.	Abu-Abed M, 2007, PROTEINS, V69, P112, DOI 10.1002/prot.21446; BAX A, 1993, ACCOUNTS CHEM RES, V26, P131, DOI 10.1021/ar00028a001; Beavo JA, 2002, NAT REV MOL CELL BIO, V3, P710, DOI 10.1038/nrm911; BUILDER SE, 1980, J BIOL CHEM, V255, P3514; Canaves JM, 2000, BIOCHEMISTRY-US, V39, P15022, DOI 10.1021/bi001563q; Cheng CY, 2009, J BIOL CHEM, V284, P35916, DOI 10.1074/jbc.M109.059493; Christensen A.E., 2003, HDB CELL SIGNALING, P549; Christensen AE, 2003, J BIOL CHEM, V278, P35394, DOI 10.1074/jbc.M302179200; Clore GM, 1998, TRENDS BIOTECHNOL, V16, P22, DOI 10.1016/S0167-7799(97)01135-9; Dao KK, 2006, J BIOL CHEM, V281, P21500, DOI 10.1074/jbc.M603116200; Das R, 2007, P NATL ACAD SCI USA, V104, P93, DOI 10.1073/pnas.0609033103; Das R, 2007, J BIOL CHEM, V282, P581, DOI 10.1074/jbc.M607706200; Das R, 2006, J AM CHEM SOC, V128, P8406, DOI 10.1021/ja060046d; Das R, 2009, J BIOL CHEM, V284, P23682, DOI 10.1074/jbc.M109.011700; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DOSKELAND SO, 1993, BIOCHIM BIOPHYS ACTA, V1178, P249, DOI 10.1016/0167-4889(93)90201-Y; DOSKELAND SO, 1984, J BIOL CHEM, V259, P2291; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; EIGENTHALER M, 1992, EUR J BIOCHEM, V205, P471, DOI 10.1111/j.1432-1033.1992.tb16803.x; Gibson RM, 1997, J BIOL CHEM, V272, P16343, DOI 10.1074/jbc.272.26.16343; GOSSE ME, 1994, BIOCHEM J, V297, P79, DOI 10.1042/bj2970079; Gullingsrud J, 2006, STRUCTURE, V14, P141, DOI 10.1016/j.str.2005.09.019; Hahnefeld C, 2005, BIOL CHEM, V386, P623, DOI 10.1515/BC.2005.073; Herberg FW, 1996, BIOCHEMISTRY-US, V35, P2934, DOI 10.1021/bi951647c; HOUGE G, 1990, J BIOL CHEM, V265, P19507; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Kim C, 2007, CELL, V130, P1032, DOI 10.1016/j.cell.2007.07.018; Kopperud R, 2002, J BIOL CHEM, V277, P13443, DOI 10.1074/jbc.M109869200; Kornev AP, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000056; Martin BR, 2007, CHEM BIOL, V14, P1031, DOI 10.1016/j.chembiol.2007.07.017; OGREID D, 1982, FEBS LETT, V150, P161, DOI 10.1016/0014-5793(82)81326-4; Rehmann H, 2007, NAT REV MOL CELL BIO, V8, P63, DOI 10.1038/nrm2082; RINGHEIM GE, 1990, J BIOL CHEM, V265, P19472; ROSEN OM, 1975, J BIOL CHEM, V250, P7788; Salzmann M, 1999, J AM CHEM SOC, V121, P844, DOI 10.1021/ja9834226; Schwede F, 2000, BIOCHEMISTRY-US, V39, P8803, DOI 10.1021/bi000304y; SPERA S, 1991, J AM CHEM SOC, V113, P5490, DOI 10.1021/ja00014a071; SU Y, 1995, SCIENCE, V269, P807, DOI 10.1126/science.7638597; Taylor SS, 2005, BBA-PROTEINS PROTEOM, V1754, P25, DOI 10.1016/j.bbapap.2005.08.024; Teilum K, 2009, CELL MOL LIFE SCI, V66, P2231, DOI 10.1007/s00018-009-0014-6; Uversky VN, 2005, J MOL RECOGNIT, V18, P343, DOI 10.1002/jmr.747; Viste K, 2005, J BIOL CHEM, V280, P13279, DOI 10.1074/jbc.M413065200; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Wright PE, 2009, CURR OPIN STRUC BIOL, V19, P31, DOI 10.1016/j.sbi.2008.12.003; Wu J, 2004, BIOCHEMISTRY-US, V43, P6620, DOI 10.1021/bi0302503; Wu J, 2004, STRUCTURE, V12, P1057, DOI 10.1016/j.str.2004.03.022	46	13	13	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					14062	14070		10.1074/jbc.M110.106666	http://dx.doi.org/10.1074/jbc.M110.106666			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20197278	Green Published, hybrid			2022-12-25	WOS:000276987700079
J	Guo, SL; Vanderford, NL; Stein, R				Guo, Shuangli; Vanderford, Nathan L.; Stein, Roland			Phosphorylation within the MafA N Terminus Regulates C-terminal Dimerization and DNA Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BZIP TRANSCRIPTION FACTOR; PANCREATIC BETA-CELLS; LEUCINE-ZIPPER; IN-VIVO; INSULIN-SECRETION; SEGMENTATION GENE; CRYSTAL-STRUCTURE; BASIC DOMAIN; DIFFERENTIATION; EXPRESSION	Phosphorylation regulates transcription factor activity by influencing dimerization, cellular localization, activation potential, and/or DNA binding. Nevertheless, precisely how this post-translation modification mediates these processes is poorly understood. Here, we examined the role of phosphorylation on the DNA-binding properties of MafA and MafB, closely related transcriptional activators of the basic-leucine zipper (b-Zip) family associated with cell differentiation and oncogenesis. Many common phosphorylation sites were identified by mass spectrometry. However, dephosphorylation only precluded the detection of MafA dimers and consequently dramatically reduced DNA-binding ability. Analysis of MafA/B chimeras revealed that sensitivity to the phosphorylation status of MafA was imparted by sequences spanning the C-terminal dimerization region (amino acids (aa) 279-359), whereas the homologous MafB region (aa 257-323) conveyed phosphorylation-independent DNA binding. Mutational analysis showed that formation of MafA dimers capable of DNA binding required phosphorylation within the distinct N-terminal transactivation domain (aa 1-72) and not the C-terminal b-Zip region. These results demonstrate a novel relationship between the phosphoamino acid-rich transactivation and b-Zip domains in controlling MafA DNA-binding activity.	[Guo, Shuangli; Vanderford, Nathan L.; Stein, Roland] Vanderbilt Univ, Med Ctr, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA	Vanderbilt University	Stein, R (corresponding author), Vanderbilt Univ, Med Ctr, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA.	roland.stein@vanderbilt.edu			National Institutes of Health [P01 DK42502]; Diabetes and Endocrinology [5T32 DK007061-34]; Juvenile Diabetes Foundation Postdoctoral Training [3-2009-555]; Vanderbilt University Diabetes Research [P60 DK20593]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020593, P01DK042502, T32DK007061] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Diabetes and Endocrinology; Juvenile Diabetes Foundation Postdoctoral Training; Vanderbilt University Diabetes Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant P01 DK42502 (to R. S.). This work was also supported by Postdoctoral Research Training Grant in Diabetes and Endocrinology 5T32 DK007061-34 (to N. L. V.), Juvenile Diabetes Foundation Postdoctoral Training Grant 3-2009-555 (to S. G.), and the Vanderbilt University Diabetes Research and Training Center Molecular Biology Core Laboratory (Public Health Service Grant P60 DK20593).	Artner I, 2006, DIABETES, V55, P297, DOI 10.2337/diabetes.55.02.06.db05-0946; Artner I, 2008, J ENDOCRINOL, V198, P271, DOI 10.1677/JOE-08-0063; Artner I, 2007, P NATL ACAD SCI USA, V104, P3853, DOI 10.1073/pnas.0700013104; Benkhelifa S, 1998, ONCOGENE, V17, P247, DOI 10.1038/sj.onc.1201898; Benkhelifa S, 2001, MOL CELL BIOL, V21, P4441, DOI 10.1128/MCB.21.14.4441-4452.2001; Blanchi B, 2003, NAT NEUROSCI, V6, P1091, DOI 10.1038/nn1129; Braunstein J, 2003, J BIOL CHEM, V278, P34133, DOI 10.1074/jbc.M304531200; CORDES SP, 1994, CELL, V79, P1025, DOI 10.1016/0092-8674(94)90033-7; ELLENBERGER TE, 1992, CELL, V71, P1223, DOI 10.1016/S0092-8674(05)80070-4; Eychene A, 2008, NAT REV CANCER, V8, P683, DOI 10.1038/nrc2460; Ferdous A, 2008, MOL BIOSYST, V4, P1116, DOI 10.1039/b809291e; FUJIWARA KT, 1993, ONCOGENE, V8, P2371; GLOVER JNM, 1995, NATURE, V373, P257, DOI 10.1038/373257a0; Guo SL, 2009, J BIOL CHEM, V284, P759, DOI 10.1074/jbc.M806314200; Han S, 2007, MOL CELL BIOL, V27, P6593, DOI 10.1128/MCB.01573-06; HUNTER T, 1992, CELL, V70, P375, DOI 10.1016/0092-8674(92)90162-6; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; Hurt EM, 2004, CANCER CELL, V5, P191, DOI 10.1016/S1535-6108(04)00019-4; KERPPOLA TK, 1994, ONCOGENE, V9, P3149; Kim JI, 1999, P NATL ACAD SCI USA, V96, P3781, DOI 10.1073/pnas.96.7.3781; KOUZARIDES T, 1988, NATURE, V336, P646, DOI 10.1038/336646a0; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Kurokawa H, 2009, MOL CELL BIOL, V29, P6232, DOI 10.1128/MCB.00708-09; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; MacLean HE, 2003, DEV BIOL, V262, P51, DOI 10.1016/S0012-1606(03)00324-5; Matsuoka T, 2001, J BIOL CHEM, V276, P22071, DOI 10.1074/jbc.M010321200; Matsuoka T, 2004, P NATL ACAD SCI USA, V101, P2930, DOI 10.1073/pnas.0306233101; Matsuoka TA, 2007, MOL ENDOCRINOL, V21, P2764, DOI 10.1210/me.2007-0028; Matsushima-Hibiya Y, 1998, BIOCHEM BIOPH RES CO, V245, P412, DOI 10.1006/bbrc.1998.8447; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; Morito N, 2006, CANCER RES, V66, P812, DOI 10.1158/0008-5472.CAN-05-2154; Motohashi H, 2000, CELL, V103, P865, DOI 10.1016/S0092-8674(00)00190-2; Motohashi H, 1997, NUCLEIC ACIDS RES, V25, P2953, DOI 10.1093/nar/25.15.2953; Muniappan Latha, 2007, BMC Physiology, V7, P11, DOI 10.1186/1472-6793-7-11; Murakami YI, 2007, AM J SURG PATHOL, V31, P1695, DOI 10.1097/PAS.0b013e318054dbcf; Nishimura W, 2006, DEV BIOL, V293, P526, DOI 10.1016/j.ydbio.2006.02.028; Nishizawa M, 2003, ONCOGENE, V22, P7882, DOI 10.1038/sj.onc.1206526; Nomura S, 2006, BIOCHEM BIOPH RES CO, V349, P136, DOI 10.1016/j.bbrc.2006.08.032; Ogino H, 1998, SCIENCE, V280, P115, DOI 10.1126/science.280.5360.115; Rocques N, 2007, MOL CELL, V28, P584, DOI 10.1016/j.molcel.2007.11.009; Sadl VS, 2002, DEV BIOL, V249, P16, DOI 10.1006/dbio.2002.0751; SASSONECORSI P, 1988, NATURE, V336, P692, DOI 10.1038/336692a0; Sehgal PB, 2000, CELL SIGNAL, V12, P525, DOI 10.1016/S0898-6568(00)00098-X; Shao CL, 2009, J BIOL CHEM, V284, P3117, DOI 10.1074/jbc.M806286200; SHUAI K, 1994, CELL, V76, P821, DOI 10.1016/0092-8674(94)90357-3; Song YD, 2007, BIOCHEM BIOPH RES CO, V354, P334, DOI 10.1016/j.bbrc.2006.12.216; Soufi A, 2009, NUCLEIC ACIDS RES, V37, P3288, DOI 10.1093/nar/gkp197; Stancato LF, 1996, J BIOL CHEM, V271, P4134; Takagi Y, 2004, BIOCHEM BIOPH RES CO, V320, P62, DOI 10.1016/j.bbrc.2004.05.131; Vinson C, 2002, MOL CELL BIOL, V22, P6321, DOI 10.1128/MCB.22.18.6321-6335.2002; Vinson C, 2006, BBA-GENE STRUCT EXPR, V1759, P4, DOI 10.1016/j.bbaexp.2005.12.005; Zhang C, 2005, MOL CELL BIOL, V25, P4969, DOI 10.1128/MCB.25.12.4969-4976.2005; Zhao L, 2000, J BIOL CHEM, V275, P10532, DOI 10.1074/jbc.275.14.10532	53	20	21	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12655	12661		10.1074/jbc.M110.105759	http://dx.doi.org/10.1074/jbc.M110.105759			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20208071	Green Published, hybrid			2022-12-25	WOS:000276787800024
J	Wei, Z; Liu, CD; Wu, X; Xu, NN; Zhou, B; Liang, C; Zhu, G				Wei, Zhun; Liu, Changdong; Wu, Xing; Xu, Naining; Zhou, Bo; Liang, Chun; Zhu, Guang			Characterization and Structure Determination of the Cdt1 Binding Domain of Human Minichromosome Maintenance (Mcm) 6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TORSION ANGLE DYNAMICS; DNA-REPLICATION; PROTEIN STRUCTURES; CHEMICAL-SHIFT; NMR; COMPLEXES; INITIATION; CEREVISIAE; RESTRAINTS; DATABASE	The minichromosome maintenance (Mcm) 2-7 complex is the replicative helicase in eukaryotic species, and it plays essential roles in the initiation and elongation phases of DNA replication. During late M and early G1, the Mcm 2-7 complex is loaded on to chromatin to form prereplicative complex in a Cdt1-dependent manner. However, the detailed molecular mechanism of this loading process is still elusive. In this study, we demonstrate that the previously uncharacterized Cterminal domain of human Mcm6 is the Cdt1 binding domain (CBD) and present its high resolution NMR structure. The structure of CBD exhibits a typical "winged helix" fold that is generally involved in protein-nucleic acid interaction. Nevertheless, the CBD failed to interact with DNA in our studies, indicating that it is specific for proteinprotein interaction. The CBD-Cdt1 interaction involves the helix-turn-helix motif of CBD. The results reported here provide insight into the molecular mechanism of Mcm2-7 chromatin loading and prereplicative complex assembly.	[Wei, Zhun; Liu, Changdong; Wu, Xing; Xu, Naining; Zhou, Bo; Liang, Chun; Zhu, Guang] Hong Kong Univ Sci & Technol, Dept Biochem, Kowloon, Hong Kong, Peoples R China; [Wei, Zhun; Liu, Changdong] E China Normal Univ, Dept Phys, Shanghai 200062, Peoples R China; [Wei, Zhun; Liu, Changdong] E China Normal Univ, Shanghai Key Lab Magnet Resonance, Shanghai 200062, Peoples R China; [Wei, Zhun; Liu, Changdong; Wu, Xing; Xu, Naining; Zhou, Bo; Liang, Chun; Zhu, Guang] Hong Kong Univ Sci & Technol, Ctr Canc Res, Kowloon, Hong Kong, Peoples R China	Hong Kong University of Science & Technology; East China Normal University; East China Normal University; Hong Kong University of Science & Technology	Liang, C (corresponding author), Hong Kong Univ Sci & Technol, Dept Biochem, Kowloon, Hong Kong, Peoples R China.	bccliang@ust.hk; gzhu@ust.hk	WEI, ZHUN/AAT-9380-2020	Zhou, Bo/0000-0002-7856-029X; LIU, Changdong/0000-0001-7356-9765	Hong Kong Research Grants Council [HKUST6436/06M]	Hong Kong Research Grants Council(Hong Kong Research Grants Council)	This work was supported by a grant from the Hong Kong Research Grants Council (Grant HKUST6436/06M to G. Z. and C. L.).	Aparicio OM, 1997, CELL, V91, P59, DOI 10.1016/S0092-8674(01)80009-X; Arentson E, 2002, ONCOGENE, V21, P1150, DOI 10.1038/sj.onc.1205175; BAX A, 1993, ACCOUNTS CHEM RES, V26, P131, DOI 10.1021/ar00028a001; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Berjanskii MV, 2005, J AM CHEM SOC, V127, P14970, DOI 10.1021/ja054842f; Bochman ML, 2008, MOL CELL, V31, P287, DOI 10.1016/j.molcel.2008.05.020; Brunger A.T., 2001, CRYSTALLOGRAPHY NMR; CHONG JPJ, 1995, NATURE, V375, P418, DOI 10.1038/375418a0; Clore GM, 1998, TRENDS BIOTECHNOL, V16, P22, DOI 10.1016/S0167-7799(97)01135-9; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Davey MJ, 2003, J BIOL CHEM, V278, P4491, DOI 10.1074/jbc.M210511200; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Diffley JFX, 2004, CURR BIOL, V14, pR778, DOI 10.1016/j.cub.2004.09.019; Ferenbach A, 2005, NUCLEIC ACIDS RES, V33, P316, DOI 10.1093/nar/gki176; Forsburg SL, 2004, MICROBIOL MOL BIOL R, V68, P109, DOI 10.1128/MMBR.68.1.109-131.2004; Gajiwala KS, 2000, CURR OPIN STRUC BIOL, V10, P110, DOI 10.1016/S0959-440X(99)00057-3; Goddard T. D, 2007, SPARKY 3; GRONENBORN AM, 1991, SCIENCE, V253, P657, DOI 10.1126/science.1871600; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Hubbard SJ, 1993, NACCESS COMPUTER PRO; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Labib K, 2000, SCIENCE, V288, P1643, DOI 10.1126/science.288.5471.1643; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; LIANG C, 1995, CELL, V81, P667, DOI 10.1016/0092-8674(95)90528-6; Lin DH, 2002, J BIOMOL NMR, V23, P317, DOI 10.1023/A:1020225206644; MAINE GT, 1984, GENETICS, V106, P365; Maiorano D, 2000, NATURE, V404, P622, DOI 10.1038/35007104; Masai Hisao, 1999, Frontiers in Bioscience, V4, pd834, DOI 10.2741/Masai; Nederveen AJ, 2005, PROTEINS, V59, P662, DOI 10.1002/prot.20408; Neuwald AF, 1999, GENOME RES, V9, P27; Remus D, 2009, CELL, V139, P719, DOI 10.1016/j.cell.2009.10.015; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Schwacha A, 2001, MOL CELL, V8, P1093, DOI 10.1016/S1097-2765(01)00389-6; Seo J, 2005, ONCOGENE, V24, P8176, DOI 10.1038/sj.onc.1208881; Tatsumi Y, 2006, J CELL SCI, V119, P3128, DOI 10.1242/jcs.03031; Teer JK, 2008, J BIOL CHEM, V283, P6817, DOI 10.1074/jbc.M708767200; Tjandra N, 1997, SCIENCE, V278, P1111, DOI 10.1126/science.278.5340.1111; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Yanagi K, 2002, J BIOL CHEM, V277, P40871, DOI 10.1074/jbc.M206202200; You ZY, 2008, J BIOL CHEM, V283, P24469, DOI 10.1074/jbc.M803212200; Zhang YX, 2002, CELL, V109, P849, DOI 10.1016/S0092-8674(02)00805-X; Zhou P, 2001, J BIOMOL NMR, V20, P11, DOI 10.1023/A:1011258906244; ZHU G, 1992, J MAGN RESON, V100, P202, DOI 10.1016/0022-2364(92)90379-L; 2006, J AM CHEM SOC, V128, P7566	46	38	39	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12469	12473		10.1074/jbc.C109.094599	http://dx.doi.org/10.1074/jbc.C109.094599			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20202939	Green Published, hybrid			2022-12-25	WOS:000276787800002
J	Heinlen, LD; McClain, MT; Ritterhouse, LL; Bruner, BF; Edgerton, CC; Keith, MP; James, JA; Harley, JB				Heinlen, Latisha D.; McClain, Micah T.; Ritterhouse, Lauren L.; Bruner, Benjamin F.; Edgerton, Colin C.; Keith, Michael P.; James, Judith A.; Harley, John B.			60 kD Ro and nRNP A Frequently Initiate Human Lupus Autoimmunity	PLOS ONE			English	Article							ANTI-SM ANTIBODIES; CLINICAL-SIGNIFICANCE; PEPTIDE IMMUNIZATION; HUMORAL AUTOIMMUNITY; SURFACE-STRUCTURES; REVISED CRITERIA; ERYTHEMATOSUS; AUTOANTIBODIES; DIAGNOSIS; NEPHRITIS	Systemic lupus erythematosus (SLE) is a clinically heterogeneous, humoral autoimmune disorder. The unifying feature among SLE patients is the production of large quantities of autoantibodies. Serum samples from 129 patients collected before the onset of SLE and while in the United States military were evaluated for early pre-clinical serologic events. The first available positive serum sample frequently already contained multiple autoantibody specificities (65%). However, in 34 SLE patients the earliest pre-clinical serum sample positive for any detectable common autoantibody bound only a single autoantigen, most commonly 60 kD Ro (29%), nRNP A (24%), anti-phospholipids (18%) or rheumatoid factor (15%). We identified several recurrent patterns of autoantibody onset using these pre-diagnostic samples. In the serum samples available, anti-nRNP A appeared before or simultaneously with anti-nRNP 70 K in 96% of the patients who had both autoantibodies at diagnosis. Anti-60 kD Ro antibodies appeared before or simultaneously with anti-La (98%) or anti-52 kD Ro (95%). The autoantibody response in SLE patients begins simply, often binding a single specific autoantigen years before disease onset, followed by epitope spreading to additional autoantigenic specificities that are accrued in recurring patterns.	[Heinlen, Latisha D.; McClain, Micah T.; Ritterhouse, Lauren L.; Bruner, Benjamin F.; James, Judith A.] Oklahoma Med Res Fdn, Dept Clin Immunol, Oklahoma City, OK 73104 USA; [Heinlen, Latisha D.; Ritterhouse, Lauren L.; James, Judith A.; Harley, John B.] Univ Oklahoma, Hlth Sci Ctr, Dept Internal Med, Oklahoma City, OK USA; [Heinlen, Latisha D.; Ritterhouse, Lauren L.; James, Judith A.; Harley, John B.] Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK USA; [Edgerton, Colin C.] Walter Reed Army Med Ctr, Washington, DC 20307 USA; [Keith, Michael P.] Natl Naval Med Ctr, Bethesda, MD USA; [Harley, John B.] US Dept Vet Affairs, Oklahoma City, OK USA; [Harley, John B.] Oklahoma Med Res Fdn, Dept Arthrit & Immunol, Oklahoma City, OK 73104 USA	Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; United States Department of Defense; United States Army; Walter Reed National Military Medical Center; Walter Reed National Military Medical Center; US Department of Veterans Affairs; Oklahoma Medical Research Foundation	Heinlen, LD (corresponding author), Oklahoma Med Res Fdn, Dept Clin Immunol, 825 NE 13th St, Oklahoma City, OK 73104 USA.	harley@omrf.org			National Institutes of Health [AI31584, AR48045, AR49084, AR45084, AR45451, RR15577, AR48940, RR20143, AI62629, AI50350]; Kirkland Scholar Awards; United States Department of Veterans Affairs; Lou Kerr Chair in Biomedical Research; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015577, P20RR020143, P30RR031152] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI031584, U19AI062629, R01AI024717, R41AI050350, R37AI024717, T32AI007633] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P50AR048940, R29AR045451, P30AR053483, R01AR048045, P01AR049084, R01AR045451, R03AR045084] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103510] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kirkland Scholar Awards; United States Department of Veterans Affairs(US Department of Veterans Affairs); Lou Kerr Chair in Biomedical Research; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by grants from the National Institutes of Health (AI31584, AR48045, AR49084, AR45084, AR45451, RR15577, AR48940, RR20143, AI62629, AI50350), Kirkland Scholar Awards (JBH and JAJ) and the United States Department of Veterans Affairs. This work was also supported in part by the Lou Kerr Chair in Biomedical Research to JAJ. Bio-Rad provided the ANA test kits and selected the laboratory as a beta-test site for their commercial bead based assay. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbuckle MR, 1999, SCAND J IMMUNOL, V50, P447; Arbuckle MR, 2003, LUPUS, V12, P99, DOI 10.1191/0961203303lu334oa; Arbuckle MR, 2001, SCAND J IMMUNOL, V54, P211, DOI 10.1046/j.1365-3083.2001.00959.x; Arbuckle MR, 2003, NEW ENGL J MED, V349, P1526, DOI 10.1056/NEJMoa021933; ARNETT FC, 1988, J RHEUMATOL, V15, P1773; Binder SR, 2006, LUPUS, V15, P412, DOI 10.1191/0961203306lu2326oa; Binder SR, 2005, CLIN DIAGN LAB IMMUN, V12, P1353, DOI 10.1128/CDLI.12.12.1353-1357.2005; CLOTET B, 1984, SCAND J RHEUMATOL, V13, P15, DOI 10.3109/03009748409102662; FIELD M, 1988, ANN RHEUM DIS, V47, P820, DOI 10.1136/ard.47.10.820; FISHER DE, 1985, ARTHRITIS RHEUM-US, V28, P1348, DOI 10.1002/art.1780281206; Gomez-Puerta JA, 2008, AUTOIMMUN REV, V7, P606, DOI 10.1016/j.autrev.2008.06.005; Greidinger EL, 2001, ARTHRITIS RHEUM, V44, P368; Hahn BH, 1998, NEW ENGL J MED, V338, P1359, DOI 10.1056/NEJM199805073381906; Heinlen LD, 2007, ARTHRITIS RHEUM, V56, P2344, DOI 10.1002/art.22665; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; James JA, 1996, J IMMUNOL, V156, P4018; James JA, 1997, ANN NY ACAD SCI, V815, P124, DOI 10.1111/j.1749-6632.1997.tb52054.x; James JA, 1998, IMMUNOL REV, V164, P185, DOI 10.1111/j.1600-065X.1998.tb01220.x; JAMES JA, 1995, CLIN EXP RHEUMATOL, V13, P299; JAMES JA, 1992, J IMMUNOL, V148, P2074; JAMES JA, 1995, J EXP MED, V181, P453, DOI 10.1084/jem.181.2.453; KRISHNAN C, 1967, J CLIN INVEST, V46, P569, DOI 10.1172/JCI105558; MADDISON PJ, 1977, ARTHRITIS RHEUM, V20, P819, DOI 10.1002/art.1780200310; MARCHINI B, 1994, J AUTOIMMUN, V7, P179, DOI 10.1006/jaut.1994.1014; McClain MT, 2005, NAT MED, V11, P85, DOI 10.1038/nm1167; McClain MT, 2002, J IMMUNOL, V168, P2054, DOI 10.4049/jimmunol.168.4.2054; McClain MT, 2004, ARTHRITIS RHEUM-US, V50, P1226, DOI 10.1002/art.20120; McCluskey J, 1998, IMMUNOL REV, V164, P209, DOI 10.1111/j.1600-065X.1998.tb01222.x; Moder KG, 2007, J RHEUMATOL, V34, P978; POOLE BD, 2009, ARTHRITIS R IN PRESS; Poole BD, 2008, J AUTOIMMUN, V31, P362, DOI 10.1016/j.jaut.2008.08.007; Reichlin M, 2003, CLIN IMMUNOL, V108, P69, DOI 10.1016/S1521-6616(03)00063-9; Scofield RH, 1997, CLIN EXP IMMUNOL, V109, P480, DOI 10.1046/j.1365-2249.1997.4791374.x; Scofield RH, 1999, ARTHRITIS RHEUM, V42, P1017, DOI 10.1002/1529-0131(199905)42:5<1017::AID-ANR22>3.0.CO;2-7; Shovman O, 2005, ANN NY ACAD SCI, V1050, P380, DOI 10.1196/annals.1313.120; Sundar K, 2004, J AUTOIMMUN, V23, P127, DOI 10.1016/j.jaut.2004.06.001; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Tseng CE, 2006, ARTHRITIS RHEUM-US, V54, P3623, DOI 10.1002/art.22198; Yung S, 2008, AUTOIMMUN REV, V7, P317, DOI 10.1016/j.autrev.2007.12.001	39	39	39	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2010	5	3							e9599	10.1371/journal.pone.0009599	http://dx.doi.org/10.1371/journal.pone.0009599			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565XE	20224770	Green Submitted, Green Published, gold			2022-12-25	WOS:000275328800012
J	Pfannkuche, K; Fatima, A; Gupta, MK; Dieterich, R; Hescheler, J				Pfannkuche, Kurt; Fatima, Azra; Gupta, Manoj K.; Dieterich, Rebecca; Hescheler, Juergen			Initial Colony Morphology-Based Selection for iPS Cells Derived from Adult Fibroblasts Is Substantially Improved by Temporary UTF1-Based Selection	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; SELF-RENEWAL; INDUCTION; OCT4; UTF1; DIFFERENTIATION; EXPRESSION; MAINTAIN; OCT-3/4; GENE	Background: Somatic cells can be reprogrammed into induced pluripotent stem (iPS) cells. Recently, selection of fully reprogrammed cells was achieved based on colony morphology reminiscent of embryonic stem (ES) cells. The maintenance of pluripotency was analysed. Methodology/Principal Findings: Clonal murine iPS cell line TiB7-4, which was derived from adult fibroblasts, was analysed for maintenance of pluripotency. Colony morphology, expression of pluripotency factors and stage specific embryonic antigen 1 (SSEA1) were analysed by real time PCR and flow cytometry. We found the iPS cell line TiB7-4 and its subclones to be rather diverse and exhibiting a tendency towards spontaneous differentiation and loss of pluripotency independent of their initial colony morphology. In contrast an undifferentiated transcription factor 1 (UTF1) promoter-driven G418 (Neo) resistance significantly improved the quality of these iPS cells. After selection with UTF-Neo for two weeks iPS subclones could be stably maintained for at least 40 passages in culture and differentiate into all three germ layers. As control, a construct expressing G418 resistance under the control of the ubiquitously active SV40 early promoter formed subclones with different colony morphology. Some of these subclones could be cultured for at least 12 passages without loosing their pluripotency, but loss of pluripotency eventually occured in an unpredictable manner and was independent of the subclones' initial morphology and SSEA1 expression. A UTF-Neo-based selection of a whole population of TiB7-4 without further subcloning resulted in the generation of cultures with up to 99% SSEA1 positive cells under stringent selection conditions. Conclusions: Our data indicate that temporary selection using a genetic UTF1-based system can generate homogenous pluripotent iPS cells that can be maintained without permanent selection pressure.	[Pfannkuche, Kurt; Fatima, Azra; Gupta, Manoj K.; Dieterich, Rebecca; Hescheler, Juergen] Univ Cologne, Inst Neurophysiol, Ctr Physiol & Pathophysiol, Cologne, Germany; [Hescheler, Juergen] Ctr Mol Med Cologne, Cologne, Germany	University of Cologne; University of Cologne	Pfannkuche, K (corresponding author), Univ Cologne, Inst Neurophysiol, Ctr Physiol & Pathophysiol, Cologne, Germany.	Kurt.Pfannkuche@uni-koeln.de		Pfannkuche, Kurt Paul/0000-0002-4284-774X	North Rhine Westphalian Stem Cell Network [314-40000808]	North Rhine Westphalian Stem Cell Network	This project was supported by a grant from the North Rhine Westphalian Stem Cell Network (Grant No. 314-40000808). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Amit M, 2000, DEV BIOL, V227, P271, DOI 10.1006/dbio.2000.9912; Cai JL, 2006, STEM CELLS, V24, P516, DOI 10.1634/stemcells.2005-0143; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; Eiges R, 2001, CURR BIOL, V11, P514, DOI 10.1016/S0960-9822(01)00144-0; Hotta A, 2008, J CELL BIOCHEM, V105, P940, DOI 10.1002/jcb.21912; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Nishimoto M, 1999, MOL CELL BIOL, V19, P5453; Nishimoto M, 2001, BIOCHEM BIOPH RES CO, V285, P945, DOI 10.1006/bbrc.2001.5265; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Okuda A, 1998, EMBO J, V17, P2019, DOI 10.1093/emboj/17.7.2019; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Pesce M, 2001, STEM CELLS, V19, P271, DOI 10.1634/stemcells.19-4-271; Pfannkuche K, 2009, CELL PHYSIOL BIOCHEM, V24, P73, DOI 10.1159/000227815; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; Shi Y, 2008, CELL STEM CELL, V3, P568, DOI 10.1016/j.stem.2008.10.004; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Stewart MH, 2006, NAT METHODS, V3, P807, DOI 10.1038/nmeth939; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tan SM, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm704; Wei CL, 2005, STEM CELLS, V23, P166, DOI 10.1634/stemcells.2004-0162; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; YU J, 2009, SCIENCE; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhao Y, 2008, CELL STEM CELL, V3, P475, DOI 10.1016/j.stem.2008.10.002	29	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2010	5	3					A140	A151	e9580	10.1371/journal.pone.0009580	http://dx.doi.org/10.1371/journal.pone.0009580			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565WZ	20221450	Green Published, gold, Green Submitted			2022-12-25	WOS:000275328200013
J	Balaji, V; Daley, P; Anand, AA; Sudarsanam, T; Michael, JS; Sahni, RD; Chordia, P; George, IA; Thomas, K; Ganesh, A; John, KR; Mathai, D				Balaji, V.; Daley, Peter; Anand, Alok Azad; Sudarsanam, Thambu; Michael, Joy Sarojini; Sahni, Rani Diana; Chordia, Poorvi; George, Ige Abraham; Thomas, Kurien; Ganesh, Alka; John, K. R.; Mathai, Dilip			Risk Factors for MDR and XDR-TB in a Tertiary Referral Hospital in India	PLOS ONE			English	Article							DRUG-RESISTANT TUBERCULOSIS; MULTIDRUG-RESISTANT; TREATMENT OUTCOMES	Background: India has a high burden of drug resistant TB, although there are few data on XDR-TB. Although XDR-TB has existed previously in India, the definition has not been widely applied, and surveillance using second line drug susceptibility testing has not been performed. Our objective was to analyze clinical and demographic risk factors associated with isolation of MDR and XDR-TB as compared to susceptible controls, at a tertiary center. Methodology/Findings: Retrospective chart review based on positive cultures isolated in a high volume mycobacteriology laboratory between 2002 and 2007. 47 XDR, 30 MDR and 117 susceptible controls were examined. Drug resistant cases were less likely to be extrapulmonary, and had received more previous treatment regimens. Significant risk factors for XDR-TB included residence outside the local state (OR 7.43, 3.07-18.0) and care costs subsidized (OR 0.23, 0.097-0.54) in bivariate analysis and previous use of a fluoroquinolone and injectable agent (other than streptomycin) (OR 7.00, 95% C.I. 1.14-43.03) and an initial treatment regimen which did not follow national guidelines (OR 5.68, 1.24-25.96) in multivariate analysis. Cavitation and HIV did not influence drug resistance. Conclusions/Significance: There is significant selection bias in the sample available. Selection pressure from previous treatment and an inadequate initial regimen increases risk of drug resistance. Local patients and those requiring financial subsidies may be at lower risk of XDR-TB.	[Balaji, V.; Michael, Joy Sarojini; Sahni, Rani Diana] Christian Med Coll Vellore, Dept Microbiol, Vellore, Tamil Nadu, India; [Daley, Peter; Sudarsanam, Thambu; Chordia, Poorvi; George, Ige Abraham; Thomas, Kurien; Ganesh, Alka; Mathai, Dilip] Christian Med Coll Vellore, Dept Med, Vellore, Tamil Nadu, India; [Anand, Alok Azad] Tufts Univ, Sch Med, Boston, MA 02111 USA; [John, K. R.] Christian Med Coll Vellore, Dept Community Med, Vellore, Tamil Nadu, India	Christian Medical College & Hospital (CMCH) Vellore; Christian Medical College & Hospital (CMCH) Vellore; Tufts University; Christian Medical College & Hospital (CMCH) Vellore	Balaji, V (corresponding author), Christian Med Coll Vellore, Dept Microbiol, Vellore, Tamil Nadu, India.	daleyp@cmcvellore.ac.in	SAHNI, RANI DIANA/AAB-1007-2022; Daley, Peter/J-8908-2017	Daley, Peter/0000-0001-7068-8056				[Anonymous], 2006, WKLY EPIDEMIOL REC, V81, P430; [Anonymous], 2008, 4 WHO; Atre SR, 2005, J PUBLIC HEALTH POL, V26, P96, DOI 10.1057/palgrave.jphp.3200014; *CENTR TB DIV, 2006, DOTSPLUS GUID; Chan ED, 2008, NEW ENGL J MED, V359, P657, DOI 10.1056/NEJMc0706556; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Holtz TH, 2006, INT J TUBERC LUNG D, V10, P649; JAIN S, 2007, HIGH PREVALENCE XDR, pA510; Johnson Jasmin, 2003, Indian J Chest Dis Allied Sci, V45, P105; Law WS, 2008, INT J TUBERC LUNG D, V12, P1065; Migliori GB, 2008, EUR RESPIR J, V31, P1155, DOI 10.1183/09031936.00028708; Migliori GB, 2007, EUR RESPIR J, V30, P623, DOI 10.1183/09031936.00077307; Mitnick CD, 2008, NEW ENGL J MED, V359, P563, DOI 10.1056/NEJMoa0800106; MONDAL R, 2007, EMERG INFECT DIS; Paramasivan CN, 2004, INDIAN J MED RES, V120, P377; *REV NAT TB CONTR, 2008, TB IND 2008 RNTCP ST; Shah NS, 2008, JAMA-J AM MED ASSOC, V300, P2153, DOI 10.1001/jama.300.18.2153; Sharma SK, 2003, INFECT GENET EVOL, V3, P183, DOI 10.1016/S1567-1348(03)00086-8; Singh A, 2007, EUR RESPIR J, V30, P178, DOI 10.1183/09031936.00025407; Singh S, 2007, AIDS, V21, P2345, DOI 10.1097/QAD.0b013e3282f125c9; SUAREZGARCIA I, 2008, EUR J CLIN MICROBIOL; Thomas Aleyamma, 2007, Indian J Tuberc, V54, P117; Udwadia ZF, 2007, LANCET INFECT DIS, V7, P441, DOI 10.1016/S1473-3099(07)70141-X; Uplekar M, 1998, INT J TUBERC LUNG D, V2, P324; WHO, 2009, GLOB TUB CONTR 2009; World Health Organization, 2006, GUID PROGR MAN DRUG; 2006, MMWR MORB MORTAL WKL, V55, P301	27	36	38	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2010	5	3							e9527	10.1371/journal.pone.0009527	http://dx.doi.org/10.1371/journal.pone.0009527			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	564EW	20209106	Green Submitted, gold, Green Published			2022-12-25	WOS:000275197100012
J	Nichol, KL; Tummers, K; Hoyer-Leitzel, A; Marsh, J; Moynihan, M; McKelvey, S				Nichol, Kristin L.; Tummers, Kate; Hoyer-Leitzel, Alanna; Marsh, Jennifer; Moynihan, Matt; McKelvey, Steven			Modeling Seasonal Influenza Outbreak in a Closed College Campus: Impact of Pre-Season Vaccination, In-Season Vaccination and Holidays/Breaks	PLOS ONE			English	Article							UNIVERSITY-STUDENTS; RESPIRATORY ILLNESSES; MIXING PATTERNS; SCHOOL CLOSURE; HAND HYGIENE; TRANSMISSION; HEALTH; SPREAD; ADULTS; SIMULATION	Background: College and university students experience substantial morbidity from influenza and influenza-like illness, and they can benefit substantially from vaccination. Public health authorities encourage vaccination not only before the influenza season but also into and even throughout the influenza season. We conducted the present study to assess the impact of various vaccination strategies including delayed (i.e., in-season) vaccination on influenza outbreaks on a college campus. Methods/Findings: We used a Susceptible R Infected R Recovered (SIR) framework for our mathematical models to simulate influenza epidemics in a closed, college campus. We included both students and faculty/staff in the model and derived values for the model parameters from the published literature. The values for key model parameters were varied to assess the impact on the outbreak of various pre-season and delayed vaccination rates; one-way sensitivity analyses were conducted to test the sensitivity of the model outputs to changes in selected parameter values. In the base case, with a pre-season vaccination rate of 20%, no delayed vaccination, and 1 student index case, the total attack rate (total percent infected, TAR) was 45%. With higher pre-season vaccination rates TARs were lower. Even if vaccinations were given 30 days after outbreak onset, TARs were still lower than the TAR of 69% in the absence of vaccination. Varying the proportions of vaccinations given pre-season versus delayed until after the onset of the outbreak gave intermediate TAR values. Base case outputs were sensitive to changes in infectious contact rates and infectious periods and a holiday/break schedule. Conclusion: Delayed vaccination and holidays/breaks can be important adjunctive measures to complement traditional pre-eason influenza vaccination for controlling and preventing influenza in a closed college campus.	[Nichol, Kristin L.] Vet Affairs Med Ctr, Res Serv, Minneapolis, MN 55417 USA; [Nichol, Kristin L.] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA; [Tummers, Kate; Hoyer-Leitzel, Alanna; Marsh, Jennifer; Moynihan, Matt; McKelvey, Steven] St Olaf Coll, Dept Math Stat & Comp Sci, Northfield, MN 55057 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; University of Minnesota System; University of Minnesota Twin Cities; Saint Olaf College	Nichol, KL (corresponding author), Vet Affairs Med Ctr, Res Serv, Minneapolis, MN 55417 USA.	nicho014@umn.edu			Minneapolis Veterans Affairs Medical Center; St. Olaf College	Minneapolis Veterans Affairs Medical Center; St. Olaf College	This project was supported in part by the Minneapolis Veterans Affairs Medical Center and St. Olaf College. These institutions had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There were no external sources of funding for this project.	Aiello AE, 2010, J INFECT DIS, V201, P491, DOI 10.1086/650396; Allen L.J.S., 2010, INTRO STOCHASTIC PRO; American College Health Association, 2006, NAT COLL HLTH ASS RE; Beutels P, 2006, EPIDEMIOL INFECT, V134, P1158, DOI 10.1017/S0950268806006418; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; Carrat F, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-26; Cauchemez S, 2008, NATURE, V452, P750, DOI 10.1038/nature06732; CDC, 2008, MMWR EARLY RELEASE, V57, P1; COUCH RB, 1993, ANN NY ACAD SCI, V685, P803, DOI 10.1111/j.1749-6632.1993.tb35946.x; Cowling BJ, 2009, ANN INTERN MED, V151, P437, DOI 10.7326/0003-4819-151-7-200910060-00142; Edmunds WJ, 2006, EMERG THEMES EPIDEMI, V3, DOI 10.1186/1742-7622-3-10; Edmunds WJ, 1997, P ROY SOC B-BIOL SCI, V264, P949, DOI 10.1098/rspb.1997.0131; ELVEBACK LR, 1976, AM J EPIDEMIOL, V103, P152, DOI 10.1093/oxfordjournals.aje.a112213; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Heymann A, 2004, PEDIATR INFECT DIS J, V23, P675, DOI 10.1097/01.inf.0000128778.54105.06; Jefferson T, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006207.pub2; Jefferson TO, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001269.pub3; Jordan R, 2006, VACCINE, V24, P1047, DOI 10.1016/j.vaccine.2005.09.017; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; King JC, 2006, NEW ENGL J MED, V355, P2523, DOI 10.1056/NEJMoa055414; LAYDE PM, 1980, J INFECT DIS, V142, P347, DOI 10.1093/infdis/142.3.347; LONGINI IM, 1984, INT J EPIDEMIOL, V13, P496, DOI 10.1093/ije/13.4.496; MOGABGAB WJ, 1968, AM REV RESPIR DIS, V98, P359; Molinari NAM, 2007, VACCINE, V25, P5086, DOI 10.1016/j.vaccine.2007.03.046; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Nichol KL, 2006, VACCINE, V24, P6724, DOI 10.1016/j.vaccine.2006.05.033; Nichol KL, 2005, CLIN INFECT DIS, V40, P1263, DOI 10.1086/429237; Nichol KL, 2008, ARCH PEDIAT ADOL MED, V162, P1113, DOI 10.1001/archpedi.162.12.1113; Orenstein WA, 2008, AM J MED, V121, pS22, DOI 10.1016/j.amjmed.2008.05.004; Piedra PA, 2005, VACCINE, V23, P1540, DOI 10.1016/j.vaccine.2004.09.025; Poland GA, 2008, AM J MED, V121, pS3, DOI 10.1016/j.amjmed.2008.05.002; PONS VG, 1980, AM J EPIDEMIOL, V111, P23, DOI 10.1093/oxfordjournals.aje.a112871; SOBAL J, 1982, PUBLIC HEALTH REP, V97, P66; TRUSCOTT J, 2009, PLOS CURR INFLU 1103; Viboud C, 2004, BRIT J GEN PRACT, V54, P684; Wallinga J, 2006, AM J EPIDEMIOL, V164, P936, DOI 10.1093/aje/kwj317; Xu Y, 2007, J THEOR BIOL, V248, P179, DOI 10.1016/j.jtbi.2007.05.009	38	37	39	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2010	5	3							e9548	10.1371/journal.pone.0009548	http://dx.doi.org/10.1371/journal.pone.0009548			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	564EW	20209058	Green Published, Green Submitted, gold			2022-12-25	WOS:000275197100025
J	Jambou, R; Martinelli, A; Pinto, J; Gribaldo, S; Legrand, E; Niang, M; Kim, N; Pharath, L; Volnay, B; Ekala, MT; Bouchier, C; Fandeur, T; Berzosa, P; Benito, A; Ferreira, ID; Ferreira, C; Vieira, PP; Alecrim, MD; Mercereau-Puijalon, O; Cravo, P				Jambou, Ronan; Martinelli, Axel; Pinto, Joao; Gribaldo, Simonetta; Legrand, Eric; Niang, Makhtar; Kim, Nimol; Pharath, Lim; Volnay, Beatrice; Ekala, Marie Therese; Bouchier, Christiane; Fandeur, Thierry; Berzosa, Pedro; Benito, Agustin; Ferreira, Isabel Dinis; Ferreira, Cynthia; Vieira, Pedro Paulo; Alecrim, Maria das Gracas; Mercereau-Puijalon, Odile; Cravo, Pedro			Geographic Structuring of the Plasmodium falciparum Sarco(endo)plasmic Reticulum Ca2+ATPase (PfSERCA) Gene Diversity	PLOS ONE			English	Article							ARTEMISININ-RESISTANT MALARIA; CA2+ ATPASE; CHLOROQUINE-RESISTANCE; ARTESUNATE-MEFLOQUINE; COMBINATION THERAPY; S-GLUTATHIOLATION; POINT MUTATIONS; CA2+-ATPASE; SERCA; SEQUENCE	Artemisinin, a thapsigargin-like sesquiterpene has been shown to inhibit the Plasmodium falciparum sarco/endoplasmic reticulum calcium-ATPase PfSERCA. To collect baseline pfserca sequence information before field deployment of Artemisinin-based Combination therapies that may select mutant parasites, we conducted a sequence analysis of 100 isolates from multiple sites in Africa, Asia and South America. Coding sequence diversity was large, with 29 mutated codons, including 32 SNPs (average of one SNP/115 bp), of which 19 were novel mutations. Most SNP detected in this study were clustered within a region in the cytosolic head of the protein. The PfSERCA functional domains were very well conserved, with non synonymous mutations located outside the functional domains, except for the S769N mutation associated in French Guiana with elevated IC50 for artemether. The S769N mutation is located close to the hinge of the headpiece, which in other species modulates calcium affinity and in consequence efficacy of inhibitors, possibly linking calcium homeostasis to drug resistance. Genetic diversity was highest in Senegal, Brazil and French Guiana, and few mutations were identified in Asia. Population genetic analysis was conducted for a partial fragment of the gene encompassing nucleotide coordinates 87-2862 (unambiguous sequence available for 96 isolates). This supported a geographic clustering, with a separation between Old and New World samples and one dominant ancestral haplotype. Genetic drift alone cannot explain the observed polymorphism, suggesting that other evolutionary mechanisms are operating. One possible contributor could be the frequency of haemoglobinopathies that are associated with calcium dysregulation in the erythrocyte.	[Jambou, Ronan; Niang, Makhtar] Inst Pasteur, Dakar, Senegal; [Jambou, Ronan; Gribaldo, Simonetta; Ekala, Marie Therese; Bouchier, Christiane] Inst Pasteur, Paris, France; [Martinelli, Axel; Pinto, Joao; Ferreira, Isabel Dinis; Mercereau-Puijalon, Odile; Cravo, Pedro] Univ Nova Lisboa, UEI Malaria, UEI Biol Mol, Ctr Malaria & Outras Doencas Tropicais IHMT, Lisbon, Portugal; [Legrand, Eric; Volnay, Beatrice] Inst Pasteur, Cayenne, French Guiana; [Kim, Nimol; Pharath, Lim; Fandeur, Thierry] Inst Pasteur Cambodge, Phnom Penh, Cambodia; [Berzosa, Pedro; Benito, Agustin] Inst Salud Carlos III, Ctr Nacl Med Trop, Madrid, Spain; [Ferreira, Cynthia; Vieira, Pedro Paulo; Alecrim, Maria das Gracas] Fundacao Med Trop Amazonas, Manaus, Amazonas, Brazil	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Cambodia; Instituto de Salud Carlos III; Centro Nacional de Medicina Tropical (CNMT)	Jambou, R (corresponding author), Inst Pasteur, BP 220, Dakar, Senegal.	rjambou@pasteur.fr	JAMBOU, RONAN/CAG-3718-2022; Cravo, Pedro/AET-0639-2022; Pinto, Joao/C-2208-2012; J., Pinto/H-6177-2019; gribaldo, simonetta/AAW-4377-2020; Cravo, Pedro VL/G-3532-2012; Mercereau-Puijalon, Odile/AAA-2242-2020	Cravo, Pedro/0000-0003-1675-4504; Pinto, Joao/0000-0001-8572-7708; J., Pinto/0000-0001-8572-7708; gribaldo, simonetta/0000-0002-7662-021X; Cravo, Pedro VL/0000-0003-1675-4504; Legrand, Eric/0000-0003-4725-0712; Berzosa, Pedro/0000-0002-8768-717X; Lim, Pharath/0000-0002-1012-2461; Benito, Agustin/0000-0001-8229-5540	Louis D. Foundation (Academie des Sciences, Paris, France); FSP-RAI programme (Ministere francais des Affaires etrangeres); European Commission [QLK2-CT20021-1503]; FAPEAM/CNPq; Red de Investigacion Cooperativa en Enfermedades Tropicales (RICET)	Louis D. Foundation (Academie des Sciences, Paris, France); FSP-RAI programme (Ministere francais des Affaires etrangeres); European Commission(European CommissionEuropean Commission Joint Research Centre); FAPEAM/CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Red de Investigacion Cooperativa en Enfermedades Tropicales (RICET)	This study was supported by the Louis D. Foundation (Academie des Sciences, Paris, France), the FSP-RAI programme (Ministere francais des Affaires etrangeres), the European Commission (contract QLK2-CT20021-1503) ResMalChip project, the FAPEAM/CNPq. P. Berzosa was supported by the Red de Investigacion Cooperativa en Enfermedades Tropicales (RICET). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi T, 2004, NAT MED, V10, P1200, DOI 10.1038/nm1119; Afonso A, 2006, ANTIMICROB AGENTS CH, V50, P480, DOI 10.1128/AAC.50.2.480-489.2006; Anderson TJC, 2000, MOL BIOL EVOL, V17, P1467, DOI 10.1093/oxfordjournals.molbev.a026247; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Carrara VI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004551; Christensen SB, 2009, ANTI-CANCER AGENT ME, V9, P276, DOI 10.2174/1871520610909030276; Cohen RA, 2006, TRENDS CARDIOVAS MED, V16, P109, DOI 10.1016/j.tcm.2006.02.001; Cojean S, 2006, EMERG INFECT DIS, V12, P1798, DOI 10.3201/eid1211.060903; CRANDALL KA, 1993, GENETICS, V134, P959; Dahlstrom S, 2008, INFECT GENET EVOL, V8, P340, DOI 10.1016/j.meegid.2008.02.002; Eckstein-Ludwig U, 2003, NATURE, V424, P957, DOI 10.1038/nature01813; Ekala MT, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-164; Ferreira ID, 2007, TROP MED INT HEALTH, V12, P353, DOI 10.1111/j.1365-3156.2006.01789.x; Foller M, 2008, IUBMB LIFE, V60, P661, DOI 10.1002/iub.106; FU YX, 1993, GENETICS, V133, P693; Gardner MJ, 1998, SCIENCE, V282, P1126, DOI 10.1126/science.282.5391.1126; Hebbel R P, 1981, Prog Clin Biol Res, V51, P321; HUDSON RR, 1992, GENETICS, V132, P583; Hunt P, 2004, MOL BIOCHEM PARASIT, V133, P27, DOI 10.1016/j.molbiopara.2003.08.010; Ibrahim ML, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-28; Inesi G, 2008, J BIOL CHEM, V283, P1189, DOI 10.1074/jbc.M707189200; Inesi G, 2006, BIOCHEMISTRY-US, V45, P13769, DOI 10.1021/bi061255d; Jambou R, 2005, LANCET, V366, P1960, DOI 10.1016/S0140-6736(05)67787-2; Jeffares DC, 2007, NAT GENET, V39, P120, DOI 10.1038/ng1931; Joy DA, 2003, SCIENCE, V300, P318, DOI 10.1126/science.1081449; Jung M, 2005, BIOORG MED CHEM LETT, V15, P2994, DOI 10.1016/j.bmcl.2005.04.041; KAWAZOE U, 2008, EXPT PARASITOLOGY, V118, P2; Kidgell C, 2006, PLOS PATHOG, V2, P562, DOI 10.1371/journal.ppat.0020057; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; KIMURA M, 1993, J CELL SCI, V104, P1129; Krishna S, 2006, TRENDS MOL MED, V12, P200, DOI 10.1016/j.molmed.2006.03.005; Legrand E, 2007, EMERG INFECT DIS, V13, P808, DOI 10.3201/eid1305.061442; Lim P, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-11; Ma HL, 2005, BIOCHEMISTRY-US, V44, P8090, DOI 10.1021/bi050332m; Maude RJ, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-31; Mehlotra RK, 2008, ANTIMICROB AGENTS CH, V52, P2212, DOI 10.1128/AAC.00089-08; Menegon M, 2008, PARASITOL INT, V57, P233, DOI 10.1016/j.parint.2007.12.004; MENTZER WC, 1983, BIOMEMBRANE, V11, P79; Modell B, 2008, B WORLD HEALTH ORGAN, V86, P480, DOI 10.2471/BLT.06.036673; Montigny C, 2007, BIOCHEMISTRY-US, V46, P15162, DOI 10.1021/bi701855r; Mu JB, 2005, PLOS BIOL, V3, P1734, DOI 10.1371/journal.pbio.0030335; Mu JB, 2007, NAT GENET, V39, P126, DOI 10.1038/ng1924; Nagamune K, 2007, EUKARYOT CELL, V6, P2147, DOI 10.1128/EC.00262-07; Nagamune K, 2007, ANTIMICROB AGENTS CH, V51, P3816, DOI 10.1128/AAC.00582-07; Nagamune K, 2006, MOL BIOL EVOL, V23, P1613, DOI 10.1093/molbev/msl026; Neafsey DE, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r171; Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011; Rogers WO, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-10; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tanabe K, 2004, J MOL EVOL, V59, P687, DOI 10.1007/s00239-004-2662-3; TEMPLETON AR, 1992, GENETICS, V132, P619; Thomas O, 1902, P ZOOL SOC LOND, V1902, P2; TOSHIHIKO T, 1992, J BIOL CHEM, V267, P14490; Toyoshima C, 2004, ANNU REV BIOCHEM, V73, P269, DOI 10.1146/annurev.biochem.73.011303.073700; Toyoshima C, 2003, FEBS LETT, V555, P106, DOI 10.1016/S0014-5793(03)01086-X; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; Toyoshima C, 2008, ARCH BIOCHEM BIOPHYS, V476, P3, DOI 10.1016/j.abb.2008.04.017; Toyoshima C, 2009, BBA-MOL CELL RES, V1793, P941, DOI 10.1016/j.bbamcr.2008.10.008; Uhlemann AC, 2005, NAT STRUCT MOL BIOL, V12, P628, DOI 10.1038/nsmb947; Volkman SK, 2007, NAT GENET, V39, P113, DOI 10.1038/ng1930; World Health Organization, 2008, WORLD MAL REP; Wu SN, 2003, CURR MED CHEM, V10, P649, DOI 10.2174/0929867033457863; Wuytack F, 2002, CELL CALCIUM, V32, P279, DOI 10.1016/S0143416002001847; Xu C, 2004, J BIOL CHEM, V279, P17973, DOI 10.1074/jbc.M313263200; Yu MH, 1999, ARCH BIOCHEM BIOPHYS, V362, P225, DOI 10.1006/abbi.1998.1049	67	30	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2010	5	2							e9424	10.1371/journal.pone.0009424	http://dx.doi.org/10.1371/journal.pone.0009424			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SY	20195531	gold, Green Published			2022-12-25	WOS:000274924300012
J	Zuccolo, J; Bau, J; Childs, SJ; Goss, GG; Sensen, CW; Deans, JP				Zuccolo, Jonathan; Bau, Jeremy; Childs, Sarah J.; Goss, Greg G.; Sensen, Christoph W.; Deans, Julie P.			Phylogenetic Analysis of the MS4A and TMEM176 Gene Families	PLOS ONE			English	Article							EPSILON-RI-BETA; T-CELLS; CD20; PROTEIN; IDENTIFICATION; EXPRESSION; RITUXIMAB; CHANNEL; LOCALIZATION; LYMPHOCYTES	Background: The MS4A gene family in humans includes CD20 (MS4A1), FcRb (MS4A2), Htm4 (MS4A3), and at least 13 other syntenic genes encoding membrane proteins, most having characteristic tetraspanning topology. Expression of MS4A genes is variable in tissues throughout the body; however, several are limited to cells in the hematopoietic system where they have known roles in immune cell functions. Genes in the small TMEM176 group share significant sequence similarity with MS4A genes and there is evidence of immune function of at least one of the encoded proteins. In this study, we examined the evolutionary history of the MS4A/TMEM176 families as well as tissue expression of the phylogenetically earliest members, in order to investigate their possible origins in immune cells. Principal Findings: Orthologs of human MS4A genes were found only in mammals; however, MS4A gene homologs were found in most jawed vertebrates. TMEM176 genes were found only in mammals and bony fish. Several unusual MS4A genes having 2 or more tandem MS4A sequences were identified in the chicken (Gallus gallus) and early mammals ( opossum, Monodelphis domestica and platypus, Ornithorhyncus anatinus). A large number of highly conserved MS4A and TMEM176 genes was found in zebrafish ( Danio rerio). The most primitive organism identified to have MS4A genes was spiny dogfish ( Squalus acanthus). Tissue expression of MS4A genes in S. acanthias and D. rerio showed no evidence of expression restricted to the hematopoietic system. Conclusions/Significance: Our findings suggest that MS4A genes first appeared in cartilaginous fish with expression outside of the immune system, and have since diversified in many species into their modern forms with expression and function in both immune and nonimmune cells.	[Zuccolo, Jonathan; Bau, Jeremy; Childs, Sarah J.; Sensen, Christoph W.; Deans, Julie P.] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada; [Zuccolo, Jonathan; Bau, Jeremy; Deans, Julie P.] Univ Calgary, Fac Med, Immunol Res Grp, Inst Infect Immun & Inflammat, Calgary, AB, Canada; [Sensen, Christoph W.] Univ Calgary, Fac Med, Sun Ctr Excellence Visual Genom, Calgary, AB, Canada; [Goss, Greg G.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Goss, Greg G.] Bamfield Marine Sci Ctr, Bamfield, BC, Canada	University of Calgary; University of Calgary; University of Calgary; University of Alberta; Simon Fraser University	Zuccolo, J (corresponding author), Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada.	jdeans@ucalgary.ca	Sensen, Christoph W./C-1798-2013; Childs, Sarah/AAG-5111-2021; Goss, Greg G/A-2646-2014; Goss, Greg/D-2723-2015	Sensen, Christoph W./0000-0001-9604-8962; Goss, Greg/0000-0003-0786-8868; Bau, Jeremy/0000-0002-8264-0698; Childs, Sarah/0000-0003-2261-580X	Canadian Institutes of Health Research [15095]; Alberta Cancer Research Institute; Alberta Heritage Foundation for Medical Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Cancer Research Institute; Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric)	Research was supported by operating grant no. 15095 from the Canadian Institutes of Health Research (www.cihr-irsc.gc.ca). JZ is supported by a graduate studentship from the Alberta Cancer Research Institute. JB was supported by a summer studentship from the Alberta Heritage Foundation for Medical Research. SJC is a Senior Scholar of the Alberta Heritage Foundation for Medical Research and holds a Tier II Canada Research Chair. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker YT, 2006, TRANSPL INT, V19, P621, DOI 10.1111/j.1432-2277.2006.00345.x; BUBIEN JK, 1993, J CELL BIOL, V121, P1121, DOI 10.1083/jcb.121.5.1121; Cooper MD, 2006, CELL, V124, P815, DOI 10.1016/j.cell.2006.02.001; Dombrowicz D, 1998, IMMUNITY, V8, P517, DOI 10.1016/S1074-7613(00)80556-7; Donato JL, 2002, J CLIN INVEST, V109, P51, DOI 10.1172/JCI14025; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Geer LY, 2002, GENOME RES, V12, P1619, DOI 10.1101/gr.278202; Gopal AK, 1999, J LAB CLIN MED, V134, P445, DOI 10.1016/S0022-2143(99)90164-6; Howie D, 2009, J IMMUNOL, V183, P4197, DOI 10.4049/jimmunol.0901070; Hulett MD, 2001, BIOCHEM BIOPH RES CO, V280, P374, DOI 10.1006/bbrc.2000.4088; Ishibashi K, 2001, GENE, V264, P87, DOI 10.1016/S0378-1119(00)00598-9; Ju YK, 2003, J CELL PHYSIOL, V197, P53, DOI 10.1002/jcp.10347; KANZAKI M, 1995, J BIOL CHEM, V270, P13099, DOI 10.1074/jbc.270.22.13099; Kasahara M, 2004, TRENDS IMMUNOL, V25, P105, DOI 10.1016/j.it.2003.11.005; Koslowski M, 2008, CANCER RES, V68, P3458, DOI 10.1158/0008-5472.CAN-07-5768; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li HD, 2003, J BIOL CHEM, V278, P42427, DOI 10.1074/jbc.M308802200; Liang YH, 2001, GENOMICS, V72, P119, DOI 10.1006/geno.2000.6472; Liang YH, 2001, IMMUNOGENETICS, V53, P357, DOI 10.1007/s002510100339; Louvet C, 2005, AM J TRANSPLANT, V5, P2143, DOI 10.1111/j.1600-6143.2005.01007.x; Maeda Y, 2006, BRAIN RES, V1104, P18, DOI 10.1016/j.brainres.2006.05.068; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; Nicholas KB., 1997, GENEDOC TOOL EDITING; Pescovitz MD, 2006, AM J TRANSPLANT, V6, P859, DOI 10.1111/j.1600-6143.2006.01288.x; Polyak MJ, 2008, J BIOL CHEM, V283, P18545, DOI 10.1074/jbc.M800784200; Rastetter W, 2004, ANNU REV MED, V55, P477, DOI 10.1146/annurev.med.55.091902.104249; Rost B, 1996, PROTEIN SCI, V5, P1704, DOI 10.1002/pro.5560050824; SANDFORD AJ, 1995, EUR J HUM GENET, V3, P188; THISSE C, 1993, DEVELOPMENT, V119, P1203; Venkataraman C, 2000, J IMMUNOL, V165, P632, DOI 10.4049/jimmunol.165.2.632; Wang Y, 2002, J IMMUNOL, V169, P1102, DOI 10.4049/jimmunol.169.2.1102; Westerfield M, 1993, ZEBRAFISH BOOK; Xiao YL, 2008, J IMMUNOL, V181, P1071, DOI 10.4049/jimmunol.181.2.1071; Xu H, 2006, BLOOD, V107, P2400, DOI 10.1182/blood-2005-08-3340	35	50	53	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2010	5	2							e9369	10.1371/journal.pone.0009369	http://dx.doi.org/10.1371/journal.pone.0009369			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SV	20186339	Green Submitted, gold, Green Published			2022-12-25	WOS:000274924000012
J	Turm, H; Maoz, M; Katz, V; Yin, YJ; Offermanns, S; Bar-Shavit, R				Turm, Hagit; Maoz, Myriam; Katz, Vered; Yin, Yong-Jun; Offermanns, Steffan; Bar-Shavit, Rachel			Protease-activated Receptor-1 (PAR1) Acts via a Novel G alpha(13)-Dishevelled Axis to Stabilize beta-Catenin Levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DROSOPHILA DISHEVELLED GENE; HETEROTRIMERIC G-PROTEINS; WNT SIGNALING PATHWAY; COLORECTAL-CANCER; ENDOTHELIAL-CELLS; HUMAN COUNTERPART; PROSTATE-CANCER; UP-REGULATION; DIX DOMAIN; G12 FAMILY	We have previously shown a novel link between hPar-1 (human protease-activated receptor-1) and beta-catenin stabilization. Although it is well recognized that Wnt signaling leads to beta-catenin accumulation, the role of PAR1 in the process is unknown. We provide here evidence that PAR1 induces beta-catenin stabilization independent of Wnt, Fz (Frizzled), and the co-receptor LRP5/6 (low density lipoprotein-related protein 5/6) and identify selective mediators of the PAR1-beta-catenin axis. Immunohistological analyses of hPar1-transgenic (TG) mouse mammary tissues show the expression of both G alpha(12) and G alpha(13) compared with age-matched control counterparts. However, only G alpha(13) was found to be actively involved in PAR1-induced beta-catenin stabilization. Indeed, a dominant negative form of G alpha(13) inhibited both PAR1-induced Matrigel invasion and Lef/Tcf (lymphoid enhancer factor/T cell factor) transcription activity. PAR1-G alpha(13) association is followed by the recruitment of DVL (Dishevelled), an upstream Wnt signaling protein via the DIX domain. Small interfering RNA-Dvl silencing leads to a reduction in PAR1-induced Matrigel invasion, inhibition of Lef/Tcf transcription activity, and decreased beta-catenin accumulation. It is of note that PAR1 also promotes the binding of beta-arrestin-2 to DVL, suggesting a role for beta-arrestin-2 in PAR1-induced DVL phosphorylation dynamics. Although infection of small interfering RNA-LRP5/6 or the use of the Wnt antagonists, SFRP2 (soluble Frizzled-related protein 2) or SFRP5 potently reduced Wnt3A-mediated beta-catenin accumulation, no effect was observed on PAR1-induced beta-catenin stabilization. Collectively, our data show that PAR1 mediates beta-catenin stabilization independent of Wnt. We propose here a novel cascade of PAR1-induced G alpha(13)-DVL axis in cancer and beta-catenin stabilization.	[Turm, Hagit; Maoz, Myriam; Katz, Vered; Yin, Yong-Jun; Bar-Shavit, Rachel] Hadassah Hebrew Univ, Med Ctr, Dept Oncol, IL-91120 Jerusalem, Israel; [Offermanns, Steffan] Max Planck Inst Heart & Lung Res, Dept Pharmacol, D-61231 Bad Nauheim, Germany	Hebrew University of Jerusalem; Hadassah University Medical Center; Max Planck Society	Bar-Shavit, R (corresponding author), Hadassah Univ Hosp, Dept Oncol, POB 12000, IL-91120 Jerusalem, Israel.	rachel.bar-shavit@ekmd.huji.ac.il	Offermanns, Stefan/L-3313-2017	Offermanns, Stefan/0000-0001-8676-6805	Israel Science Foundation; Fritz-Thyssen Stiftung	Israel Science Foundation(Israel Science Foundation); Fritz-Thyssen Stiftung	This work was supported by grants from the Israel Science Foundation (to R.B.-S.) and the Fritz-Thyssen Stiftung (to R.B.-S. and S.O.).	ALBINI A, 1987, CANCER RES, V47, P3239; Angers S, 2006, NAT CELL BIOL, V8, P348, DOI 10.1038/ncb1381; Arora P, 2008, ONCOGENE, V27, P4434, DOI 10.1038/onc.2008.84; Axelrod JD, 1998, GENE DEV, V12, P2610, DOI 10.1101/gad.12.16.2610; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Boutros M, 1999, MECH DEVELOP, V83, P27, DOI 10.1016/S0925-4773(99)00046-5; Bryja V, 2007, P NATL ACAD SCI USA, V104, P6690, DOI 10.1073/pnas.0611356104; Cadigan KM, 2006, J CELL SCI, V119, P395, DOI 10.1242/jcs.02826; Castellone MD, 2005, SCIENCE, V310, P1504, DOI 10.1126/science.1116221; CHAN AML, 1993, MOL CELL BIOL, V13, P762, DOI 10.1128/MCB.13.2.762; Cong F, 2004, DEVELOPMENT, V131, P5103, DOI 10.1242/dev.01318; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; da Costa LT, 1999, ONCOGENE, V18, P5010, DOI 10.1038/sj.onc.1202872; Dery O, 1998, AM J PHYSIOL-CELL PH, V274, pC1429, DOI 10.1152/ajpcell.1998.274.6.C1429; Egger-Adam D, 2010, DEV DYNAM, V239, P168, DOI 10.1002/dvdy.22060; Eshleman JR, 1996, ONCOGENE, V12, P1425; Even-Ram S, 1998, NAT MED, V4, P909, DOI 10.1038/nm0898-909; Feigin ME, 2007, J CELL SCI, V120, P3404, DOI 10.1242/jcs.011254; Fujino H, 2001, J BIOL CHEM, V276, P12489, DOI 10.1074/jbc.C100039200; Gan XQ, 2008, J CELL BIOL, V180, P1087, DOI 10.1083/jcb.200710050; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; Greco TL, 1996, MAMM GENOME, V7, P475, DOI 10.1007/s003359900144; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hsu W, 1999, J BIOL CHEM, V274, P3439, DOI 10.1074/jbc.274.6.3439; ISHII K, 1994, J BIOL CHEM, V269, P1125; Julius MA, 2000, BIOCHEM BIOPH RES CO, V276, P1162, DOI 10.1006/bbrc.2000.3607; Kaplan DD, 2001, J BIOL CHEM, V276, P44037, DOI 10.1074/jbc.M106121200; Kelly P, 2006, J BIOL CHEM, V281, P26483, DOI 10.1074/jbc.M604376200; Kelly P, 2006, P NATL ACAD SCI USA, V103, P8173, DOI 10.1073/pnas.0510254103; Kikuchi A, 2006, EXP MOL MED, V38, P1, DOI 10.1038/emm.2006.1; Kishida S, 1999, MOL CELL BIOL, V19, P4414; Lee YN, 2008, CELL SIGNAL, V20, P443, DOI 10.1016/j.cellsig.2007.11.005; Li L, 2002, J BIOL CHEM, V277, P5977, DOI 10.1074/jbc.M111131200; Liu GZ, 2005, MOL CELL BIOL, V25, P3475, DOI 10.1128/MCB.25.9.3475-3482.2005; Liu XX, 2005, CURR BIOL, V15, P1989, DOI 10.1016/j.cub.2005.10.050; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Luo W, 2005, J BIOL CHEM, V280, P5054, DOI 10.1074/jbc.M412340200; Macfarlane SR, 2001, PHARMACOL REV, V53, P245; Malbon CC, 2006, CURR TOP DEV BIOL, V72, P153, DOI 10.1016/S0070-2153(05)72002-0; Marinissen MJ, 2003, J BIOL CHEM, V278, P46814, DOI 10.1074/jbc.M305709200; Mizutani K, 2005, TUMORI J, V91, P546, DOI 10.1177/030089160509100616; Nialbon C. C., 2005, SCI STKE, V2005, ppe35; Nierodzik ML, 2006, CANCER CELL, V10, P355, DOI 10.1016/j.ccr.2006.10.002; Offermanns S, 1997, SCIENCE, V275, P533, DOI 10.1126/science.275.5299.533; Okino K, 2003, ONCOL REP, V10, P1219; Paing MM, 2002, J BIOL CHEM, V277, P1292, DOI 10.1074/jbc.M109160200; Pan WJ, 2004, CELL RES, V14, P324, DOI 10.1038/sj.cr.7290232; Pizzuti A, 1996, HUM MOL GENET, V5, P953, DOI 10.1093/hmg/5.7.953; Polakis P, 2000, GENE DEV, V14, P1837; Ponting CP, 1996, TRENDS BIOCHEM SCI, V21, P245, DOI 10.1016/S0968-0004(96)30027-3; Reiter E, 2006, TRENDS ENDOCRIN MET, V17, P159, DOI 10.1016/j.tem.2006.03.008; Ruppel KM, 2005, P NATL ACAD SCI USA, V102, P8281, DOI 10.1073/pnas.0503326102; Sakanaka C, 1999, P NATL ACAD SCI USA, V96, P12548, DOI 10.1073/pnas.96.22.12548; Schwarz-Romond T, 2007, J CELL SCI, V120, P2402, DOI 10.1242/jcs.002956; Schwarz-Romond T, 2007, NAT STRUCT MOL BIOL, V14, P484, DOI 10.1038/nsmb1247; Schweizer L, 2003, BMC CELL BIOL, V4, DOI 10.1186/1471-2121-4-4; Semenov MV, 1997, GENOMICS, V42, P302, DOI 10.1006/geno.1997.4713; Shiomi K, 2003, CURR BIOL, V13, P73, DOI 10.1016/S0960-9822(02)01398-2; Tiruppathi C, 2000, P NATL ACAD SCI USA, V97, P7440, DOI 10.1073/pnas.97.13.7440; Uematsu K, 2003, ONCOGENE, V22, P7218, DOI 10.1038/sj.onc.1206817; Uematsu K, 2003, CANCER RES, V63, P4547; van de Wetering M, 2001, CANCER RES, V61, P278; Vogt S, 2003, J BIOL CHEM, V278, P28743, DOI 10.1074/jbc.M304570200; Wallingford JB, 2005, DEVELOPMENT, V132, P4421, DOI 10.1242/dev.02068; Wharton KA, 2003, DEV BIOL, V253, P1, DOI 10.1006/dbio.2002.0869; Wong HC, 2003, MOL CELL, V12, P1251, DOI 10.1016/S1097-2765(03)00427-1; XU NZ, 1993, P NATL ACAD SCI USA, V90, P6741, DOI 10.1073/pnas.90.14.6741; Yang M, 2005, P NATL ACAD SCI USA, V102, P6027, DOI 10.1073/pnas.0501535102; Yin YJ, 2006, CANCER RES, V66, P5224, DOI 10.1158/0008-5472.CAN-05-4234; Zeng X, 2008, DEVELOPMENT, V135, P367, DOI 10.1242/dev.013540	70	23	23	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15137	15148		10.1074/jbc.M109.072843	http://dx.doi.org/10.1074/jbc.M109.072843			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20223821	hybrid, Green Published			2022-12-25	WOS:000277399000035
J	Ochiai, H; Takenobu, H; Nakagawa, A; Yamaguchi, Y; Kimura, M; Ohira, M; Okimoto, Y; Fujimura, Y; Koseki, H; Kohno, Y; Nakagawara, A; Kamijo, T				Ochiai, H.; Takenobu, H.; Nakagawa, A.; Yamaguchi, Y.; Kimura, M.; Ohira, M.; Okimoto, Y.; Fujimura, Y.; Koseki, H.; Kohno, Y.; Nakagawara, A.; Kamijo, T.			Bmi1 is a MYCN target gene that regulates tumorigenesis through repression of KIF1B beta and TSLC1 in neuroblastoma	ONCOGENE			English	Article						Bmi1; MYCN; neuroblastoma; TSLC1; KIF1B beta	SELF-RENEWAL; STEM-CELLS; N-MYC; EXPRESSION; CANCER; METHYLATION; PROTEINS; HYPERMETHYLATION; PROLIFERATION; AMPLIFICATION	Recent advances in neuroblastoma (NB) research addressed that epigenetic alterations such as hypermethylation of promoter sequences, with consequent silencing of tumor-suppressor genes, can have significant roles in the tumorigenesis of NB. However, the exact role of epigenetic alterations, except for DNA hypermethylation, remains to be elucidated in NB research. In this paper, we clarified the direct binding of MYCN to Bmi1 promoter and upregulation of Bmi1 transcription by MYCN. Mutation introduction into an MYCN binding site in the Bmi1 promoter suggests that MYCN has more important roles in the transcription of Bmi1 than E2F-related Bmi1 regulation. A correlation between MYCN and polycomb protein Bmi1 expression was observed in primary NB tumors. Expression of Bmi1 resulted in the acceleration of proliferation and colony formation in NB cells. Bmi1-related inhibition of NB cell differentiation was confirmed by neurite extension assay and analysis of differentiation marker molecules. Intriguingly, the above-mentioned Bmi1-related regulation of the NB cell phenotype seems not to be mediated only by p14ARF/p16INK4a in NB cells. Expression profiling analysis using a tumor-specific cDNA microarray addressed the Bmi1-dependent repression of KIF1B beta and TSLC1, which have important roles in predicting the prognosis of NB. Chromatin immunoprecipitation assay showed that KIF1Bb and TSLC1 are direct targets of Bmi1 in NB cells. These findings suggest that MYCN induces Bmi1 expression, resulting in the repression of tumor suppressors through Polycomb group gene-mediated epigenetic chromosome modification. NB cell proliferation and differentiation seem to be partially dependent on the MYCN/Bmi1/tumor-suppressor pathways. Oncogene (2010) 29, 2681-2690; doi:10.1038/onc.2010.22; published online 1 March 2010	[Kamijo, T.] Chiba Canc Ctr, Res Inst, Div Biochem & Mol Carcinogenesis, Chuo Ku, Chiba 2608717, Japan; [Ochiai, H.; Kohno, Y.] Chiba Univ, Dept Pediat, Grad Sch Med, Chiba, Japan; [Nakagawa, A.] Natl Ctr Child Hlth & Dev, Dept Pathol, Tokyo, Japan; [Ohira, M.] Chiba Canc Ctr, Res Inst, Lab Canc Genom, Chiba 2608717, Japan; [Okimoto, Y.] Chiba Childrens Hosp, Dept Hematol & Oncol, Chiba, Japan; [Fujimura, Y.; Koseki, H.] RIKEN, Res Ctr Allergy & Immunol, Dev Genet Grp, Yokohama, Kanagawa, Japan; [Nakagawara, A.] Chiba Canc Ctr, Res Inst, Div Innovat Canc Therapeut, Chiba 2608717, Japan	Chiba Cancer Center; Chiba University; National Center for Child Health & Development - Japan; Chiba Cancer Center; Chiba Children's Hospital; RIKEN; Chiba Cancer Center	Kamijo, T (corresponding author), Chiba Canc Ctr, Res Inst, Div Biochem & Mol Carcinogenesis, Chuo Ku, 666-2 Nitona, Chiba 2608717, Japan.	tkamijo@chiba-cc.jp	Koseki, Haruhiko/I-3825-2014	Koseki, Haruhiko/0000-0001-8424-5854; Takenobu, Hisanori/0000-0001-7355-1565	Sankyo Foundation of Life Science; Ministry of Health, Labor, and Welfare; Ministry of Health, Labor, and Welfare of Japan [20-13]; Ministry of Education, Culture, Sports, Science and Technology, Japan; Grants-in-Aid for Scientific Research [21390317] Funding Source: KAKEN	Sankyo Foundation of Life Science; Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan); Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank K Sakurai for technical assistance, and Daniel Mrozek, Medical English Service, for editorial assistance. This study was supported in part by a grant-in-aid from the Sankyo Foundation of Life Science, a grant-in-aid from the Ministry of Health, Labor, and Welfare for Third Term Comprehensive Control Research for Cancer, a grant-in-aid for Cancer Research (20-13) from the Ministry of Health, Labor, and Welfare of Japan, and a grant-in-aid from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Ando K, 2008, INT J CANCER, V123, P2087, DOI 10.1002/ijc.23776; Atsuta T, 2001, HYBRIDOMA, V20, P43, DOI 10.1089/027245701300060427; BRODEUR GM, 1984, SCIENCE, V224, P1121, DOI 10.1126/science.6719137; Bruggeman SWM, 2007, CANCER CELL, V12, P328, DOI 10.1016/j.ccr.2007.08.032; Cao R, 2005, MOL CELL, V20, P845, DOI 10.1016/j.molcel.2005.12.002; Caren H, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-10; CARON H, 1995, MED PEDIATR ONCOL, V24, P215, DOI 10.1002/mpo.2950240402; Cui HJ, 2007, AM J PATHOL, V170, P1370, DOI 10.2353/ajpath.2007.060754; Cui HJ, 2006, J BIOL CHEM, V281, P34696, DOI 10.1074/jbc.M604009200; Easton J, 1998, CANCER RES, V58, P2624; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; Fujimura Y, 2006, DEVELOPMENT, V133, P2371, DOI 10.1242/dev.02405; Guney I, 2006, P NATL ACAD SCI USA, V103, P3645, DOI 10.1073/pnas.0600069103; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Iwama A, 2004, IMMUNITY, V21, P843, DOI 10.1016/j.immuni.2004.11.004; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Kamminga LM, 2006, STEM CELLS, V24, P1143, DOI 10.1634/stemcells.2005-0345; Kamminga LM, 2006, BLOOD, V107, P2170, DOI 10.1182/blood-2005-09-3585; Kramps C, 2004, J BIOL CHEM, V279, P5110, DOI 10.1074/jbc.M304758200; Kurata K, 2008, ONCOGENE, V27, P741, DOI 10.1038/sj.onc.1210672; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Leung C, 2004, NATURE, V428, P337, DOI 10.1038/nature02385; Lutz W, 1996, ONCOGENE, V13, P803; Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Munirajan AK, 2008, J BIOL CHEM, V283, P24426, DOI 10.1074/jbc.M802316200; Murakami Y, 2005, CANCER SCI, V96, P543, DOI 10.1111/j.1349-7006.2005.00089.x; Nowak K, 2006, NUCLEIC ACIDS RES, V34, P1745, DOI 10.1093/nar/gkl119; Ohira M, 2005, CANCER CELL, V7, P337, DOI 10.1016/j.ccr.2005.03.019; Orlando V, 1997, METHODS, V11, P205, DOI 10.1006/meth.1996.0407; Pietersen AM, 2008, CURR OPIN CELL BIOL, V20, P201, DOI 10.1016/j.ceb.2008.01.004; Rajasekhar VK, 2007, STEM CELLS, V25, P2498, DOI 10.1634/stemcells.2006-0608; Schwartz YB, 2008, CURR OPIN CELL BIOL, V20, P266, DOI 10.1016/j.ceb.2008.03.002; Sherr CJ, 2004, CELL, V116, P235, DOI 10.1016/S0092-8674(03)01075-4; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Strieder V, 2003, J BIOL CHEM, V278, P2983, DOI 10.1074/jbc.M207596200; Sugino Y, 2007, ONCOGENE, V26, P7401, DOI 10.1038/sj.onc.1210550; Teitz T, 2000, NAT MED, V6, P529, DOI 10.1038/75007; Valk-Lingbeek ME, 2004, CELL, V118, P409, DOI 10.1016/j.cell.2004.08.005; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Westermann F, 2002, CANCER LETT, V184, P127, DOI 10.1016/S0304-3835(02)00199-4; Yan P, 2003, GENE CHROMOSOME CANC, V36, P129, DOI 10.1002/gcc.10150; Yang JC, 2007, P NATL ACAD SCI USA, V104, P10494, DOI 10.1073/pnas.0704001104; Yang QW, 2004, CLIN CANCER RES, V10, P8493, DOI 10.1158/1078-0432.CCR-04-1331; Yang QW, 2003, CANCER RES, V63, P6299	46	64	66	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAY 6	2010	29	18					2681	2690		10.1038/onc.2010.22	http://dx.doi.org/10.1038/onc.2010.22			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	592DC	20190806				2022-12-25	WOS:000277354600008
J	Pommier, AJC; Alves, G; Viennois, E; Bernard, S; Communal, Y; Sion, B; Marceau, G; Damon, C; Mouzat, K; Caira, F; Baron, S; Lobaccaro, JMA				Pommier, A. J. C.; Alves, G.; Viennois, E.; Bernard, S.; Communal, Y.; Sion, B.; Marceau, G.; Damon, C.; Mouzat, K.; Caira, F.; Baron, S.; Lobaccaro, J. M. A.			Liver X Receptor activation downregulates AKT survival signaling in lipid rafts and induces apoptosis of prostate cancer cells	ONCOGENE			English	Article						LXRs; cholesterol; lipid rafts; apoptosis; prostate	FATTY-ACID SYNTHASE; AKT/PROTEIN KINASE-B; TUMOR-GROWTH; NUCLEAR RECEPTORS; PLASMA-MEMBRANE; ATHYMIC MICE; CHOLESTEROL; INHIBITION; PROLIFERATION; EXPRESSION	Cholesterol is a structural component of lipid rafts within the plasma membrane. These domains, used as platforms for various signaling molecules, regulate cellular processes including cell survival. Cholesterol contents are tightly correlated with the structure and function of lipid rafts. Liver X receptors (LXRs) have a central role in the regulation of cholesterol homeostasis within the cell. Therefore, we investigated whether these nuclear receptors could modulate lipid raft signaling and consequently alter prostate cancer (PCa) cell survival. Treatment with the synthetic LXR agonist T0901317 downregulated the AKT survival pathway and thus induced apoptosis of LNCaP PCa cells in both xenografted nude mice and cell culture. The decrease in tumor cholesterol content resulted from the upregulation of ABCG1 and the subsequent increase in reverse cholesterol transport. RNA interference experiments showed that these effects were mediated by LXRs. Atomic force microscopy scanning of the inner plasma membrane sheet showed smaller and thinner lipid rafts after LXR stimulation, associated with the downregulation of AKT phosphorylation in these lipid rafts. Replenishment of cell membranes with exogenous cholesterol antagonized these effects, showing that cholesterol is a key modulator in this process. Altogether, pharmacological modulation of LXR activity could thus reduce prostate tumor growth by enhancing apoptosis in a lipid raft-dependent manner. Oncogene (2010) 29, 2712-2723; doi:10.1038/onc.2010.30; published online 1 March 2010	[Lobaccaro, J. M. A.] Clermont Univ, CNRS, GReD, UMR 6247, F-63177 Aubiere, France; [Pommier, A. J. C.; Alves, G.; Viennois, E.; Damon, C.; Caira, F.; Baron, S.; Lobaccaro, J. M. A.] Univ Clermont Ferrand, Clermont Univ, Clermont Ferrand, France; [Pommier, A. J. C.; Alves, G.; Viennois, E.; Caira, F.; Baron, S.; Lobaccaro, J. M. A.] Ctr Rech Nutr Humaine Auvergne, Clermont Ferrand, France; [Bernard, S.] Univ Paris 05, CNRS, UPR 2228, Paris, France; [Communal, Y.] Ctr Jean Perrin, Dept Oncogenet, Clermont Ferrand, France; [Sion, B.] Univ Auvergne, Equipe Accueil EA975, Clermont Ferrand, France; [Marceau, G.] Univ Auvergne, Clermont Univ, Clermont Ferrand, France; [Marceau, G.] Ctr Hosp Univ, Serv Biochim, Clermont Ferrand, France; [Mouzat, K.] Ctr Hosp Univ, Serv Biochim, Nimes, France	Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; UNICANCER; Centre Jean Perrin; Universite Clermont Auvergne (UCA); Universite Clermont Auvergne (UCA); CHU Clermont Ferrand; Universite de Montpellier; CHU de Nimes	Lobaccaro, JMA (corresponding author), Clermont Univ, CNRS, GReD, UMR 6247, Campus Cezeaux,24 Ave Landais, F-63177 Aubiere, France.	j-marc.lobaccaro@univ-bpclermont.fr	Lobaccaro, Jean-Marc/Q-3926-2019; Sion, Benoit/K-2268-2015; LOBACCARO, Jean-Marc/L-6151-2015	Lobaccaro, Jean-Marc/0000-0001-9890-2392; MARCEAU, GEOFFROY/0000-0003-4713-7162; Viennois, Emilie/0000-0002-3104-620X	Association de Recherche sur les Tumeurs Prostatiques; Ligue Allier contre le Cancer; FRM; Fondation BNP-Paribas; MNERT and Region Auvergne; Region Auvergne	Association de Recherche sur les Tumeurs Prostatiques; Ligue Allier contre le Cancer; FRM(Fondation pour la Recherche Medicale); Fondation BNP-Paribas; MNERT and Region Auvergne(Region Auvergne-Rhone-Alpes); Region Auvergne(Region Auvergne-Rhone-Alpes)	This study was supported by Association de Recherche sur les Tumeurs Prostatiques, Ligue Allier contre le Cancer, FRM and Fondation BNP-Paribas research grants. A Pommier and E Viennois are funded by MNERT and Region Auvergne grants, respectively, and G Alves is funded by Region Auvergne program. We are grateful to ICCF-Imagerie Confocale Clermont-Ferrand-for the help in confocal analyses. We thank JP Saru and A De Haze for molecular biology technical assistance, and C Puchol and S Plantade for animal facilities. We also thank Dr P Val, Dr A Martinez, Dr L Morel and Dr C White for their help in the editing of the paper and for fruitful scientific discussions.	Adam RM, 2007, CANCER RES, V67, P6238, DOI 10.1158/0008-5472.CAN-07-0288; Ahmed NN, 1997, P NATL ACAD SCI USA, V94, P3627, DOI 10.1073/pnas.94.8.3627; Beckers A, 2007, CANCER RES, V67, P8180, DOI 10.1158/0008-5472.CAN-07-0389; Bravi F, 2006, ANN ONCOL, V17, P1014, DOI 10.1093/annonc/mdl080; Brusselmans K, 2005, CANCER RES, V65, P6719, DOI 10.1158/0008-5472.CAN-05-0571; Brusselmans K, 2007, J BIOL CHEM, V282, P18777, DOI 10.1074/jbc.M611763200; Carson JP, 1999, CANCER RES, V59, P1449; Choe SS, 2007, DIABETES, V56, P1534, DOI 10.2337/db06-1059; Chuu CP, 2006, CANCER RES, V66, P6482, DOI 10.1158/0008-5472.CAN-06-0632; Demierre MF, 2005, NAT REV CANCER, V5, P930, DOI 10.1038/nrc1751; Dwyer JR, 2007, J BIOL CHEM, V282, P8959, DOI 10.1074/jbc.M611741200; Fan L, 2004, ENDOCRINOLOGY, V145, P3961, DOI 10.1210/en.2004-0079; Frankel DJ, 2006, BIOPHYS J, V90, P2404, DOI 10.1529/biophysj.105.073692; Freeman MR, 2004, J CELL BIOCHEM, V91, P54, DOI 10.1002/jcb.10724; Fukuchi J, 2004, CANCER RES, V64, P7682, DOI 10.1158/0008-5472.CAN-04-2647; Fukuchi J, 2004, CANCER RES, V64, P7686, DOI 10.1158/0008-5472.CAN-04-2332; Grizard G, 2000, J CHROMATOGR B, V740, P101, DOI 10.1016/S0378-4347(00)00039-6; Hill MM, 2002, CURR BIOL, V12, P1251, DOI 10.1016/S0960-9822(02)00973-9; Karhadkar SS, 2004, NATURE, V431, P707, DOI 10.1038/nature02962; Karpen HE, 2001, J BIOL CHEM, V276, P19503, DOI 10.1074/jbc.M010832200; Kim HJ, 2009, P NATL ACAD SCI USA, V106, P558, DOI 10.1073/pnas.0811295106; Laffitte BA, 2003, P NATL ACAD SCI USA, V100, P5419, DOI 10.1073/pnas.0830671100; Lawrence JC, 2003, BIOPHYS J, V84, P1827, DOI 10.1016/S0006-3495(03)74990-X; Li YC, 2006, AM J PATHOL, V168, P1107, DOI 10.2353/ajpath.2006.050959; Liao YD, 2003, INT J CANCER, V107, P676, DOI 10.1002/ijc.11471; Magura L, 2008, CANCER CAUSE CONTROL, V19, P1259, DOI 10.1007/s10552-008-9197-7; Meng ZX, 2009, DIABETOLOGIA, V52, P125, DOI 10.1007/s00125-008-1174-x; Mo HB, 2004, EXP BIOL MED, V229, P567, DOI 10.1177/153537020422900701; Mouzat K, 2009, ENDOCRINOLOGY, V150, P3369, DOI 10.1210/en.2008-1519; Murtola TJ, 2008, NAT CLIN PRACT UROL, V5, P376, DOI 10.1038/ncpuro1146; Pizer ES, 2001, PROSTATE, V47, P102, DOI 10.1002/pros.1052; Poynter JN, 2005, NEW ENGL J MED, V352, P2184, DOI 10.1056/NEJMoa043792; Rossi S, 2003, MOL CANCER RES, V1, P707; Rusinol AE, 2004, J BIOL CHEM, V279, P1392, DOI 10.1074/jbc.M308619200; Sanchez P, 2004, P NATL ACAD SCI USA, V101, P12561, DOI 10.1073/pnas.0404956101; Sekine Y, 2008, BIOCHEM BIOPH RES CO, V372, P356, DOI 10.1016/j.bbrc.2008.05.043; Shannon J, 2005, AM J EPIDEMIOL, V162, P318, DOI 10.1093/aje/kwi203; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Solomon KR, 1996, P NATL ACAD SCI USA, V93, P6053, DOI 10.1073/pnas.93.12.6053; Swinnen JV, 2002, INT J CANCER, V98, P19, DOI 10.1002/ijc.10127; Swyer GIM, 1942, CANCER RES, V2, P372; Tontonoz P, 2003, MOL ENDOCRINOL, V17, P985, DOI 10.1210/me.2003-0061; Ukomadu C, 2003, J BIOL CHEM, V278, P4840, DOI 10.1074/jbc.M208658200; Umekita Y, 1996, P NATL ACAD SCI USA, V93, P11802, DOI 10.1073/pnas.93.21.11802; Volle DH, 2007, MOL CELL ENDOCRINOL, V265, P183, DOI 10.1016/j.mce.2006.12.018; Walczak R, 2004, J BIOL CHEM, V279, P9905, DOI 10.1074/jbc.M310587200; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; White CP, 1909, J PATHOL BACTERIOL, V13, P3, DOI 10.1002/path.1700130103; Yang G, 1998, CLIN CANCER RES, V4, P1873; Yang L, 2000, BIOCHEM BIOPH RES CO, V278, P557, DOI 10.1006/bbrc.2000.3855; Yuan XJ, 2002, ONCOGENE, V21, P319, DOI 10.1038/sj/onc/1205054; Zhuang LY, 2005, J CLIN INVEST, V115, P959	52	144	153	4	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 6	2010	29	18					2712	2723		10.1038/onc.2010.30	http://dx.doi.org/10.1038/onc.2010.30			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	592DC	20190811				2022-12-25	WOS:000277354600011
J	Sato, T; Nakashima, A; Guo, L; Coffman, K; Tamanoi, F				Sato, T.; Nakashima, A.; Guo, L.; Coffman, K.; Tamanoi, F.			Single amino-acid changes that confer constitutive activation of mTOR are discovered in human cancer	ONCOGENE			English	Article						mTORC1; rapamycin; cancer genome database; kinase activity	CDC25 PHOSPHATASES; SIGNALING NETWORK; PROTEIN; GROWTH; RAPAMYCIN; PATHWAY; TARGET	Mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates a variety of cellular functions such as growth, proliferation and autophagy. In a variety of cancer cells, overactivation of mTOR has been reported. In addition, mTOR inhibitors, such as rapamycin and its derivatives, are being evaluated in clinical trials as anticancer drugs. However, no active mutants of mTOR have been identified in human cancer. Here, we report that two different point mutations, S2215Y and R2505P, identified in human cancer genome database confer constitutive activation of mTOR signaling even under nutrient starvation conditions. S2215Y was identified in large intestine adenocarcinoma whereas R2505P was identified in renal cell carcinoma. mTOR complex 1 prepared from cells expressing the mutant mTOR after nutrient starvation still retains the activity to phosphorylate 4E-BP1 in vitro. The cells expressing the mTOR mutant show increased percentage of S-phase cells and exhibit resistance to cell size decrease by amino-acid starvation. The activated mutants are still sensitive to rapamycin. However, they show increased resistance to 1-butanol. Our study points to the idea that mTOR activating mutations can be identified in a wide range of human cancer. Oncogene (2010) 29, 2746-2752; doi:10.1038/onc.2010.28; published online 1 March 2010	[Sato, T.; Nakashima, A.; Guo, L.; Coffman, K.; Tamanoi, F.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Inst Mol Biol, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA	UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles	Tamanoi, F (corresponding author), Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Inst Mol Biol, Jonsson Comprehens Canc Ctr, 1602 Mol Sci Bldg,609 Charles E Young Dr E, Los Angeles, CA 90095 USA.	fuyut@microbio.ucla.edu			National Institutes of Health [CA41996]; NATIONAL CANCER INSTITUTE [R01CA041996] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grant CA41996.	Aressy B, 2008, ANTI-CANCER AGENT ME, V8, P818, DOI 10.2174/187152008786847756; Chiang GG, 2007, TRENDS MOL MED, V13, P433, DOI 10.1016/j.molmed.2007.08.001; Edinger AL, 2004, ONCOGENE, V23, P5654, DOI 10.1038/sj.onc.1207738; English D, 1996, CHEM PHYS LIPIDS, V80, P117, DOI 10.1016/0009-3084(96)02549-2; Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Inoki K, 2005, NAT GENET, V37, P19, DOI 10.1038/ng1494; Karbowniczek M, 2008, J INVEST DERMATOL, V128, P980, DOI 10.1038/sj.jid.5701074; Kranenburg O, 2005, BBA-REV CANCER, V1756, P81, DOI 10.1016/j.bbcan.2005.10.001; Kristjansdottir K, 2004, CHEM BIOL, V11, P1043, DOI 10.1016/j.chembiol.2004.07.007; Molinolo AA, 2007, CLIN CANCER RES, V13, P4964, DOI 10.1158/1078-0432.CCR-07-1041; Ohne Y, 2008, J BIOL CHEM, V283, P31861, DOI 10.1074/jbc.M801546200; Patel J, 2002, EUR J BIOCHEM, V269, P3076, DOI 10.1046/j.1432-1033.2002.02992.x; Ray D, 2007, CELL CYCLE, V6, P3039, DOI 10.4161/cc.6.24.5104; Reiling JH, 2006, ONCOGENE, V25, P6373, DOI 10.1038/sj.onc.1209889; Robb VA, 2007, J UROLOGY, V177, P346, DOI 10.1016/j.juro.2006.08.076; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sato T, 2009, J BIOL CHEM, V284, P12783, DOI 10.1074/jbc.M809207200; Toschi A, 2009, MOL CELL BIOL, V29, P1411, DOI 10.1128/MCB.00782-08; Urano J, 2007, P NATL ACAD SCI USA, V104, P3514, DOI 10.1073/pnas.0608510104; Wang X, 2009, TRENDS CELL BIOL, V19, P260, DOI 10.1016/j.tcb.2009.03.005; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016	23	153	162	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAY 6	2010	29	18					2746	2752		10.1038/onc.2010.28	http://dx.doi.org/10.1038/onc.2010.28			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	592DC	20190810	Green Accepted			2022-12-25	WOS:000277354600014
J	Chai, S; Li, MH; Branigan, D; Xiong, ZG; Simon, RP				Chai, Sunghee; Li, Minghua; Branigan, Deborah; Xiong, Zhi-Gang; Simon, Roger P.			Activation of Acid-sensing Ion Channel 1a (ASIC1a) by Surface Trafficking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ROOT GANGLION NEURONS; ENDOPLASMIC-RETICULUM; CORTICAL-NEURONS; SODIUM-CHANNELS; REDOX REAGENTS; PROTEIN PICK1; NMDA RECEPTOR; NA+ CHANNEL; MODULATION; BRAIN	Acid-sensing ion channels (ASICs) are voltage-independent Na+ channels activated by extracellular protons. ASIC1a is expressed in neurons in mammalian brain and is implicated in long term potentiation of synaptic transmission that contributes to learning and memory. In ischemic brain injury, however, activation of this Ca2+-permeable channel plays a critical role in acidosis-mediated, glutamate-independent, Ca2+ toxicity. We report here the identification of insulin as a regulator of ASIC1a surface expression. In modeled ischemia using Chinese hamster ovary cells, serum depletion caused a significant increase in ASIC1a surface expression that resulted in the potentiation of ASIC1a activity. Among the components of serum, insulin was identified as the key factor that maintains a low level of ASIC1a on the plasma membrane. Neurons subjected to insulin depletion increased surface expression of ASIC1a with resultant potentiation of ASIC1a currents. Intracellularly, ASIC1a is predominantly localized to the endoplasmic reticulum in Chinese hamster ovary cells, and this intracellular localization is also observed in neurons. Under conditions of serum or insulin depletion, the intracellular ASIC1a is translocated to the cell surface, increasing the surface expression level. These results reveal an important trafficking mechanism of ASIC1a that is relevant to both the normal physiology and the pathological activity of this channel.	[Chai, Sunghee; Li, Minghua; Branigan, Deborah; Xiong, Zhi-Gang; Simon, Roger P.] Legacy Res, Robert S Dow Neurobiol Labs, Portland, OR 97232 USA		Chai, S (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97232 USA.	chaisu@ohsu.edu			National Institutes of Health [R01NS050610, R01NS047506]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047506, R01NS050610] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01NS050610 (to R. P. S.) and R01NS047506 (to Z. G. X.).	Arteaga MF, 2008, P NATL ACAD SCI USA, V105, P4459, DOI 10.1073/pnas.0800958105; Bassilana F, 1997, J BIOL CHEM, V272, P28819, DOI 10.1074/jbc.272.46.28819; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Cadiou H, 2007, J NEUROSCI, V27, P13251, DOI 10.1523/JNEUROSCI.2135-07.2007; Chai SH, 2007, J BIOL CHEM, V282, P22668, DOI 10.1074/jbc.M703624200; Cho JH, 2007, AM J PHYSIOL-CELL PH, V292, pC2161, DOI 10.1152/ajpcell.00598.2006; Chu XP, 2006, J NEUROSCI, V26, P5329, DOI 10.1523/JNEUROSCI.0938-06.2006; Donier E, 2005, J BIOL CHEM, V280, P38666, DOI 10.1074/jbc.M505981200; Duggan A, 2002, J BIOL CHEM, V277, P5203, DOI 10.1074/jbc.M104748200; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; Gao J, 2005, NEURON, V48, P635, DOI 10.1016/j.neuron.2005.10.011; GarciaAnoveros J, 1997, P NATL ACAD SCI USA, V94, P1459, DOI 10.1073/pnas.94.4.1459; Girard C, 2002, EMBO J, V21, P4439, DOI 10.1093/emboj/cdf469; Greger IH, 2002, NEURON, V34, P759, DOI 10.1016/S0896-6273(02)00693-1; Herrera Y, 2008, J PHARMACOL EXP THER, V327, P491, DOI 10.1124/jpet.108.143974; Hruska-Hageman AM, 2002, BIOCHEM J, V361, P443, DOI 10.1042/0264-6021:3610443; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Lingueglia E, 1997, J BIOL CHEM, V272, P29778, DOI 10.1074/jbc.272.47.29778; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; Misonou H, 2004, NAT NEUROSCI, V7, P711, DOI 10.1038/nn1260; NEDERGAARD M, 1991, AM J PHYSIOL, V260, P581; Pignataro G, 2007, BRAIN, V130, P151, DOI 10.1093/brain/awl325; Sherwood TW, 2008, J BIOL CHEM, V283, P1818, DOI 10.1074/jbc.M705118200; Skeberdis VA, 2001, P NATL ACAD SCI USA, V98, P3561, DOI 10.1073/pnas.051634698; Standley S, 2000, NEURON, V28, P887, DOI 10.1016/S0896-6273(00)00161-6; Teasdale RD, 1996, ANNU REV CELL DEV BI, V12, P27, DOI 10.1146/annurev.cellbio.12.1.27; Tiwari S, 2007, AM J PHYSIOL-RENAL, V293, pF178, DOI 10.1152/ajprenal.00447.2006; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Wan Q, 1997, NATURE, V388, P686, DOI 10.1038/41792; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Wemmie JA, 2004, P NATL ACAD SCI USA, V101, P3621, DOI 10.1073/pnas.0308753101; Wemmie JA, 2003, J NEUROSCI, V23, P5496; Xie JH, 2003, J NEUROPHYSIOL, V89, P2459, DOI 10.1152/jn.00707.2002; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Yermolaieva O, 2004, P NATL ACAD SCI USA, V101, P6752, DOI 10.1073/pnas.0308636100; Zha XM, 2006, P NATL ACAD SCI USA, V103, P16556, DOI 10.1073/pnas.0608018103	38	41	43	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					13002	13011		10.1074/jbc.M109.086041	http://dx.doi.org/10.1074/jbc.M109.086041			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20185828	hybrid, Green Published			2022-12-25	WOS:000276787800058
J	Du, WG; Zhao, B; Shine, R				Du, Wei-Guo; Zhao, Bo; Shine, Richard			Embryos in the Fast Lane: High-Temperature Heart Rates of Turtles Decline After Hatching	PLOS ONE			English	Article							CHELYDRA-SERPENTINA; OXYGEN-CONSUMPTION; CHRYSEMYS-PICTA; LIZARD EMBRYOS; METABOLIC-RATE; INCUBATION; MECHANISMS; REPTILES; BASKING; SCRIPTA	In ectotherms such as turtles, the relationship between cardiovascular function and temperature may be subject to different selective pressures in different life-history stages. Because embryos benefit by developing as rapidly as possible, and can "afford" to expend energy to do so (because they have access to the yolk for nutrition), they benefit from rapid heart (and thus, developmental) rates. In contrast, hatchlings do not have a guaranteed food supply, and maximal growth rates may not enhance fitness-and so, we might expect a lower heart rate, especially at high temperatures where metabolic costs are greatest. Our data on two species of emydid turtles, Chrysemys picta, and Graptemys pseudogeographica kohnii, support these predictions. Heart rates of embryos and hatchlings were similar at low temperatures, but heart rates at higher temperatures were much greater before than after hatching.	[Du, Wei-Guo; Zhao, Bo] Hangzhou Normal Univ, Coll Biol & Environm Sci, Hangzhou, Zhejiang, Peoples R China; [Du, Wei-Guo; Shine, Richard] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia	Hangzhou Normal University; University of Sydney	Du, WG (corresponding author), Hangzhou Normal Univ, Coll Biol & Environm Sci, Hangzhou, Zhejiang, Peoples R China.	dwghz@126.com	Du, Wei-Guo/K-1071-2014		Natural Science Foundation of China [30970362]; University of Sydney	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); University of Sydney(University of Sydney)	Natural Science Foundation of China (30970362). The University of Sydney. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angilletta MJ, 2006, PHYSIOL BIOCHEM ZOOL, V79, P573, DOI 10.1086/501062; Angilletta MJ, 2009, BIO HABIT, P1, DOI 10.1093/acprof:oso/9780198570875.001.1; Angilletta MJ, 2001, ECOLOGY, V82, P3044, DOI 10.1890/0012-9658(2001)082[3044:TAPCOE]2.0.CO;2; Ar A, 1999, COMP BIOCHEM PHYS A, V124, P491, DOI 10.1016/S1095-6433(99)00142-7; Birchard GF, 1996, J COMP PHYSIOL B, V166, P461, DOI 10.1007/s003600050033; Birchard GF, 2000, J THERM BIOL, V25, P287, DOI 10.1016/S0306-4565(99)00100-X; BOBYN ML, 1994, CAN J ZOOL, V72, P28, DOI 10.1139/z94-005; Booth DT, 2000, AUST J ZOOL, V48, P369, DOI 10.1071/ZO00055; Brown RP, 2005, J THERM BIOL, V30, P79, DOI 10.1016/j.jtherbio.2004.07.005; Clark TD, 2006, FUNCT ECOL, V20, P105, DOI 10.1111/j.1365-2435.2006.01066.x; Coleman JL, 2008, CHELONIAN CONSERV BI, V7, P276, DOI 10.2744/CCB-0708.1; Crossley DA, 2003, J EXP BIOL, V206, P2703, DOI 10.1242/jeb.00476; Du WG, 2009, J EXP BIOL, V212, P1302, DOI 10.1242/jeb.027425; Dzialowski EM, 2001, PHYSIOL BIOCHEM ZOOL, V74, P679, DOI 10.1086/322929; Ernst CH, 2009, TURTLES US CANADA; Ewert M.A., 1985, Biology of Reptilia, V14, P75; Galli G, 2004, J EXP BIOL, V207, P1471, DOI 10.1242/jeb.00912; GATTEN RE, 1974, COMP BIOCHEM PHYSIOL, V48, P619, DOI 10.1016/0300-9629(74)90606-9; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; Grayson KL, 2004, HERPETOLOGICA, V60, P325, DOI 10.1655/03-43; Huey R. B., 1996, ANIMALS TEMPERATURE, P205; Ji X, 2000, HERPETOL J, V10, P13; Morjan CL, 2003, BEHAV ECOL SOCIOBIOL, V53, P254, DOI 10.1007/s00265-002-0570-3; Nagle RD, 1998, COMP BIOCHEM PHYS B, V120, P145, DOI 10.1016/S0305-0491(98)10003-2; Nechaeva MV, 2007, COMP BIOCHEM PHYS A, V148, P599, DOI 10.1016/j.cbpa.2007.08.005; Olsson M, 2002, EVOLUTION, V56, P1867; Overgaard J, 2007, J EXP BIOL, V210, P1687, DOI 10.1242/jeb.001925; Pearson JT, 1999, J COMP PHYSIOL B, V169, P256, DOI 10.1007/s003600050219; Pike DA, 2008, ECOLOGY, V89, P607, DOI 10.1890/06-2162.1; Pough E. H., 1998, HERPETOLOGY; Radder R, 2006, BIOL LETTERS, V2, P415, DOI 10.1098/rsbl.2006.0495; Seebacher F, 2005, J COMP PHYSIOL B, V175, P533, DOI 10.1007/s00360-005-0007-1; Tazawa H, 2005, AVIAN POULT BIOL REV, V16, P123, DOI 10.3184/147020605783437977; VOIGT WG, 1975, COMP BIOCHEM PHYS A, V52, P527, DOI 10.1016/S0300-9629(75)80076-4; Warner DA, 2007, OECOLOGIA, V154, P65, DOI 10.1007/s00442-007-0809-9	35	13	16	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2010	5	3							e9557	10.1371/journal.pone.0009557	http://dx.doi.org/10.1371/journal.pone.0009557			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565XE	20224773	Green Published, gold			2022-12-25	WOS:000275328800008
J	Tang, JM; Malhotra, R; Song, W; Brill, I; Hu, LY; Farmer, PK; Mulenga, J; Allen, S; Hunter, E; Kaslow, RA				Tang, Jianming; Malhotra, Rakhi; Song, Wei; Brill, Ilene; Hu, Liangyuan; Farmer, Paul K.; Mulenga, Joseph; Allen, Susan; Hunter, Eric; Kaslow, Richard A.			Human Leukocyte Antigens and HIV Type 1 Viral Load in Early and Chronic Infection: Predominance of Evolving Relationships	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; MAJOR HISTOCOMPATIBILITY COMPLEX; CELL-SURFACE EXPRESSION; CLASS-I ALLELES; HLA-C ALLELES; HETEROSEXUAL TRANSMISSION; DISCORDANT COUPLES; IMMUNOLOGICAL CONTROL; GAG; ASSOCIATION	Background: During untreated, chronic HIV-1 infection, plasma viral load (VL) is a relatively stable quantitative trait that has clinical and epidemiological implications. Immunogenetic research has established various human genetic factors, especially human leukocyte antigen (HLA) variants, as independent determinants of VL set-point. Methodology/Principal Findings: To identify and clarify HLA alleles that are associated with either transient or durable immune control of HIV-1 infection, we evaluated the relationships of HLA class I and class II alleles with VL among 563 seroprevalent Zambians (SPs) who were seropositive at enrollment and 221 seroconverters (SCs) who became seropositive during quarterly follow-up visits. After statistical adjustments for non-genetic factors (sex and age), two unfavorable alleles (A*3601 and DRB1*0102) were independently associated with high VL in SPs (p < 0.01) but not in SCs. In contrast, favorable HLA variants, mainly A*74, B*13, B*57 (or Cw*18), and one HLA-A and HLA-C combination (A*30+Cw*03), dominated in SCs; their independent associations with low VL were reflected in regression beta estimates that ranged from 20.47+/-0.23 to 20.92+/-0.32 log(10) in SCs (p < 0.05). Except for Cw*18, all favorable variants had diminishing or vanishing association with VL in SPs (p <= 0.86). Conclusions/Significance: Overall, each of the three HLA class I genes had at least one allele that might contribute to effective immune control, especially during the early course of HIV-1 infection. These observations can provide a useful framework for ongoing analyses of viral mutations induced by protective immune responses.	[Tang, Jianming; Kaslow, Richard A.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Malhotra, Rakhi; Song, Wei; Brill, Ilene; Hu, Liangyuan; Kaslow, Richard A.] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL 35294 USA; [Farmer, Paul K.; Hunter, Eric] Emory Univ, Vaccine Res Ctr, Atlanta, GA 30322 USA; [Mulenga, Joseph; Allen, Susan] Rwanda Zambia HIV 1 Res Grp, Lusaka, Zambia; [Allen, Susan] Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Emory University; Emory University	Tang, JM (corresponding author), Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA.	jtang@uab.edu; rkaslow@uab.edu	Tang, Jianming "James"/O-4980-2019	Tang, Jianming "James"/0000-0003-0137-7486	National Institute of Allergy and Infectious Diseases (NIAID) [AI040951, AI071906, AI064060, AI76123]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI071906, R01AI040951, R01AI064060, K02AI076123] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institute of Allergy and Infectious Diseases (NIAID), through grants AI040951 (to S. A.), AI071906 (to R. A. K.), and AI064060 (to E. H). J.T. is the recipient of an Independent Scientist Award (AI76123) from NIAID. The funders had no role in study design, data collection, data analyses, decision to publish, or preparation of this manuscript.	Allen S, 2003, AIDS, V17, P733, DOI 10.1097/00002030-200303280-00012; Bansal A, 2007, AIDS, V21, P2387, DOI 10.1097/QAD.0b013e3282f13823; Bhattacharya T, 2007, SCIENCE, V315, P1583, DOI 10.1126/science.1131528; Brenchley JM, 2006, NAT IMMUNOL, V7, P235, DOI 10.1038/ni1316; Brumme Z, 2009, CLIN INFECT DIS, V49, P956, DOI 10.1086/605503; Brumme ZL, 2008, J VIROL, V82, P9216, DOI 10.1128/JVI.01041-08; Brumme ZL, 2007, PLOS PATHOG, V3, P913, DOI 10.1371/journal.ppat.0030094; Cano P, 2007, HUM IMMUNOL, V68, P392, DOI 10.1016/j.humimm.2007.01.014; Cantin R, 1997, J VIROL, V71, P1922, DOI 10.1128/JVI.71.3.1922-1930.1997; Cantin R, 1997, BLOOD, V90, P1091, DOI 10.1182/blood.V90.3.1091.1091_1091_1100; Cao K, 2001, HUM IMMUNOL, V62, P1009, DOI 10.1016/S0198-8859(01)00298-1; Catano G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003636; Crawford H, 2007, J VIROL, V81, P8346, DOI 10.1128/JVI.00465-07; Crawford H, 2009, J EXP MED, V206, P909, DOI 10.1084/jem.20081984; Dalmasso C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003907; Dawkins R, 1999, IMMUNOL REV, V167, P275, DOI 10.1111/j.1600-065X.1999.tb01399.x; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; DORAK MT, 2002, ASS HLA B22 INCREASE; Douek DC, 2002, NATURE, V417, P95, DOI 10.1038/417095a; Emu B, 2008, J VIROL, V82, P5398, DOI 10.1128/JVI.02176-07; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Fellay J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000791; Fideli OS, 2001, AIDS RES HUM RETROV, V17, P901, DOI 10.1089/088922201750290023; Gao XJ, 2001, NEW ENGL J MED, V344, P1668, DOI 10.1056/NEJM200105313442203; Geldmacher C, 2007, J VIROL, V81, P2440, DOI 10.1128/JVI.01847-06; Goepfert PA, 2008, J EXP MED, V205, P1009, DOI 10.1084/jem.20072457; HANSEN JA, 2006, IMMUNOBIOLOGY HUMAN, P1551; Harrer EG, 2005, AIDS, V19, P734, DOI 10.1097/01.aids.0000166099.36638.56; Hendel H, 1999, J IMMUNOL, V162, P6942; Holdsworth R, 2009, TISSUE ANTIGENS, V73, P95, DOI 10.1111/j.1399-0039.2008.01183.x; Honeyborne I, 2007, J VIROL, V81, P3667, DOI 10.1128/JVI.02689-06; Honeyborne I, 2006, J IMMUNOL, V176, P4699, DOI 10.4049/jimmunol.176.8.4699; Horton R, 2004, NAT REV GENET, V5, P889, DOI 10.1038/nrg1489; Hughes AL, 2002, IMMUNOL REV, V190, P161, DOI 10.1034/j.1600-065X.2002.19012.x; IDAGHDOUR Y, 2009, NAT GENET; Karlsson AC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000225; Kaslow RA, 1996, NAT MED, V2, P405, DOI 10.1038/nm0496-405; Kawashima Y, 2009, NATURE, V458, P641, DOI 10.1038/nature07746; Kempf MC, 2008, JAIDS-J ACQ IMM DEF, V47, P116, DOI 10.1097/QAI.0b013e31815d2f3f; Kiepiela P, 2004, NATURE, V432, P769, DOI 10.1038/nature03113; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Kulkarni S, 2008, AIDS RES HUM RETROV, V24, P1159, DOI 10.1089/aid.2007.0296; LAZARYAN A, 2010, J VIROL IN PRESS; Lazaryan A, 2006, J VIROL, V80, P6056, DOI 10.1128/JVI.02119-05; Le Clerc S, 2009, J INFECT DIS, V200, P1194, DOI 10.1086/605892; Leslie A, 2005, J EXP MED, V201, P891, DOI 10.1084/jem.20041455; Leslie AJ, 2004, NAT MED, V10, P282, DOI 10.1038/nm992; Li YF, 2009, HUM GENET, V126, P685, DOI 10.1007/s00439-009-0720-z; Limou S, 2009, J INFECT DIS, V199, P419, DOI 10.1086/596067; Lyles RH, 2000, J INFECT DIS, V181, P872, DOI 10.1086/315339; MacDonald KS, 2001, IMMUNOL LETT, V79, P151, DOI 10.1016/S0165-2478(01)00277-2; Malhotra U, 2001, J CLIN INVEST, V107, P505, DOI 10.1172/JCI11275; Mann DL, 1998, J INFECT DIS, V178, P1799, DOI 10.1086/314519; Marsh SGE, 2005, HUM IMMUNOL, V66, P571, DOI 10.1016/j.humimm.2005.02.002; Mellors JW, 2007, JAMA-J AM MED ASSOC, V297, P2349, DOI 10.1001/jama.297.21.2349; Mellors JW, 1996, SCIENCE, V272, P1167, DOI 10.1126/science.272.5265.1167; Miretti MM, 2005, AM J HUM GENET, V76, P634, DOI 10.1086/429393; Modjarrad K, 2008, AIDS, V22, P2179, DOI 10.1097/QAD.0b013e328312c756; Moore CB, 2002, SCIENCE, V296, P1439, DOI 10.1126/science.1069660; Novitsky V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007727; Pellegrin I, 1996, J ACQ IMMUN DEF SYND, V11, P438, DOI 10.1097/00042560-199604150-00003; Prado JG, 2009, J VIROL, V83, P1018, DOI 10.1128/JVI.01882-08; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Ramduth D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005013; Robinson J, 2009, NUCLEIC ACIDS RES, V37, pD1013, DOI 10.1093/nar/gkn662; Romero V, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-14; Saag MS, 1996, NAT MED, V2, P625, DOI 10.1038/nm0696-625; Schindler M, 2003, J VIROL, V77, P10548, DOI 10.1128/JVI.77.19.10548-10556.2003; Schreuder GMT, 2005, HUM IMMUNOL, V66, P170, DOI 10.1016/j.humimm.2004.09.017; Sidney J, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-1; Smith WP, 2006, GENOMICS, V87, P561, DOI 10.1016/j.ygeno.2005.11.020; Song W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007157; Stumptner-Cuvelette P, 2001, P NATL ACAD SCI USA, V98, P12144, DOI 10.1073/pnas.221256498; Tang JM, 2008, J IMMUNOL, V181, P2626, DOI 10.4049/jimmunol.181.4.2626; Tang Jianming, 2003, AIDS, V17 Suppl 4, pS51, DOI 10.1097/00002030-200317004-00006; Tang JM, 2004, J INFECT DIS, V189, P1696, DOI 10.1086/383280; Tang JM, 2002, AIDS, V16, P2275, DOI 10.1097/00002030-200211220-00007; Tang JM, 2002, J VIROL, V76, P8276, DOI 10.1128/JVI.76.16.8276-8284.2002; Thomas R, 2009, NAT GENET, V41, P1290, DOI 10.1038/ng.486; Trask SA, 2002, J VIROL, V76, P397, DOI 10.1128/JVI.76.1.397-405.2002; Treurnicht FK, 2010, VIROLOGY, V396, P213, DOI 10.1016/j.virol.2009.10.002; Yu XG, 2007, J VIROL, V81, P1619, DOI 10.1128/JVI.01580-06; Yunis EJ, 2003, TISSUE ANTIGENS, V62, P1, DOI 10.1034/j.1399-0039.2003.00098.x	83	35	35	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2010	5	3							e9629	10.1371/journal.pone.0009629	http://dx.doi.org/10.1371/journal.pone.0009629			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565XE	20224785	Green Published, Green Submitted, gold			2022-12-25	WOS:000275328800024
J	Hodges, AP; Dai, DJ; Xiang, ZS; Woolf, P; Xi, CW; He, YQ				Hodges, Andrew P.; Dai, Dongjuan; Xiang, Zuoshuang; Woolf, Peter; Xi, Chuanwu; He, Yongqun			Bayesian Network Expansion Identifies New ROS and Biofilm Regulators	PLOS ONE			English	Article							ESCHERICHIA-COLI RESPONSE; OXIDATIVE-STRESS; GENE-EXPRESSION; TRANSCRIPTIONAL REGULATION; HYDROGEN-PEROXIDE; MICROARRAY DATA; SEED GENES; DATABASE; PROTEIN; CELLS	Signaling and regulatory pathways that guide gene expression have only been partially defined for most organisms. However, given the increasing number of microarray measurements, it may be possible to reconstruct such pathways and uncover missing connections directly from experimental data. Using a compendium of microarray gene expression data obtained from Escherichia coli, we constructed a series of Bayesian network models for the reactive oxygen species (ROS) pathway as defined by EcoCyc. A consensus Bayesian network model was generated using those networks sharing the top recovered score. This microarray-based network only partially agreed with the known ROS pathway curated from the literature and databases. A top network was then expanded to predict genes that could enhance the Bayesian network model using an algorithm we termed 'BN+1'. This expansion procedure predicted many stress-related genes (e. g., dusB and uspE), and their possible interactions with other ROS pathway genes. A term enrichment method discovered that biofilm-associated microarray data usually contained high expression levels of both uspE and gadX. The predicted involvement of gene uspE in the ROS pathway and interactions between uspE and gadX were confirmed experimentally using E. coli reporter strains. Genes gadX and uspE showed a feedback relationship in regulating each other's expression. Both genes were verified to regulate biofilm formation through gene knockout experiments. These data suggest that the BN+1 expansion method can faithfully uncover hidden or unknown genes for a selected pathway with significant biological roles. The presently reported BN+1 expansion method is a generalized approach applicable to the characterization and expansion of other biological pathways and living systems.	[Hodges, Andrew P.; Woolf, Peter; He, Yongqun] Univ Michigan, Ctr Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Dai, Dongjuan; Xi, Chuanwu] Univ Michigan, Dept Environm Hlth Sci, Ann Arbor, MI 48109 USA; [Xiang, Zuoshuang; He, Yongqun] Univ Michigan, Unit Lab Anim Med, Ann Arbor, MI 48109 USA; [Woolf, Peter] Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA; [Woolf, Peter] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA; [He, Yongqun] Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Hodges, AP (corresponding author), Univ Michigan, Ctr Computat Med & Bioinformat, Ann Arbor, MI 48109 USA.	yongqunh@umich.edu		He, Yongqun/0000-0001-9189-9661; Xi, Chuanwu/0000-0002-7554-1915	National Institutes of Health (NIH) [U54-DA-021519, 5 T32 GM070449-04]; University of Michigan; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM070449] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [U54DA021519] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan(University of Michigan System); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported in part by National Institutes of Health (NIH) Grant U54-DA-021519. A. P. H. was also supported by a NIH Training Grant (5 T32 GM070449-04) and a 2008 Rackham Spring/Summer Research Grant at the University of Michigan. Additional support for A. P. H. was provided by the University of Michigan Bioinformatics Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bansal M, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100120; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Battistoni A, 2000, INFECT IMMUN, V68, P30, DOI 10.1128/IAI.68.1.30-37.2000; Beloin C, 2004, MOL MICROBIOL, V51, P659, DOI 10.1046/j.1365-2958.2003.03865.x; Bidaut G, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-99; Bloemberg GV, 2000, MOL PLANT MICROBE IN, V13, P1170, DOI 10.1094/MPMI.2000.13.11.1170; Bose R, 2006, P NATL ACAD SCI USA, V103, P9773, DOI 10.1073/pnas.0603948103; Chen YL, 2007, PLOS COMPUT BIOL, V3, P602, DOI 10.1371/journal.pcbi.0030063; COOPER GF, 1992, MACH LEARN, V9, P309, DOI 10.1007/BF00994110; Djebbari A, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-57; Domka J, 2007, ENVIRON MICROBIOL, V9, P332, DOI 10.1111/j.1462-2920.2006.01143.x; Faith JJ, 2008, NUCLEIC ACIDS RES, V36, pD866, DOI 10.1093/nar/gkm815; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Gat-Viks I, 2007, GENOME RES, V17, P358, DOI 10.1101/gr.5750507; Hashimoto RF, 2004, BIOINFORMATICS, V20, P1241, DOI 10.1093/bioinformatics/bth074; HECKERMAN D, 1995, MACH LEARN, V20, P197, DOI 10.1007/BF00994016; Herrgard MJ, 2003, GENOME RES, V13, P2423, DOI 10.1101/gr.1330003; Heydorn A, 2000, MICROBIOL-SGM, V146, P2395, DOI 10.1099/00221287-146-10-2395; Huerta AM, 1998, NUCLEIC ACIDS RES, V26, P55, DOI 10.1093/nar/26.1.55; Ideker Trey, 2002, Bioinformatics, V18 Suppl 1, pS233; Ihmels J, 2002, NAT GENET, V31, P370, DOI 10.1038/ng941; Junker LM, 2006, MICROBIOL-SGM, V152, P2233, DOI 10.1099/mic.0.28767-0; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Keseler IM, 2005, NUCLEIC ACIDS RES, V33, pD334, DOI 10.1093/nar/gki108; Laval J, 1996, PATHOL BIOL, V44, P14; Lee JT, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-42; Luke I, 2008, ARCH MICROBIOL, V190, P685, DOI 10.1007/s00203-008-0420-4; Margolin LG, 2006, J TURBUL, V7, P1, DOI 10.1080/14685240500331595; Morett E, 1998, FEBS LETT, V433, P108, DOI 10.1016/S0014-5793(98)00888-6; Nachin L, 2005, J BACTERIOL, V187, P6265, DOI 10.1128/JB.187.18.6265-6272.2005; Novak BA, 2006, BIOINFORMATICS, V22, P233, DOI 10.1093/bioinformatics/bti764; NUNOSHIBA T, 1993, P NATL ACAD SCI USA, V90, P9993, DOI 10.1073/pnas.90.21.9993; Patrauchan MA, 2007, MICROBIOL-SGM, V153, P3838, DOI 10.1099/mic.0.2007/010371-0; Pena JM, 2005, BIOINFORMATICS, V21, P224, DOI 10.1093/bioinformatics/bti1137; Rice JJ, 2005, BIOINFORMATICS, V21, P765, DOI 10.1093/bioinformatics/bti064; Sachs K, 2005, SCIENCE, V308, P523, DOI 10.1126/science.1105809; Salgado H, 1999, NUCLEIC ACIDS RES, V27, P59, DOI 10.1093/nar/27.1.59; Sherman BT, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-426; Smith VA, 2006, PLOS COMPUT BIOL, V2, P1436, DOI 10.1371/journal.pcbi.0020161; Soranzo N, 2007, BIOINFORMATICS, V23, P1640, DOI 10.1093/bioinformatics/btm163; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tanay A, 2001, Bioinformatics, V17 Suppl 1, pS270; Tourancheau AB, 1999, PROTIST, V150, P137, DOI 10.1016/S1434-4610(99)70017-9; UPTON GJG, 1992, J ROY STAT SOC A STA, V155, P395, DOI 10.2307/2982890; Volkert MR, 2000, P NATL ACAD SCI USA, V97, P14530, DOI 10.1073/pnas.260495897; Weinstein-Fischer D, 2000, MOL MICROBIOL, V35, P1413, DOI 10.1046/j.1365-2958.2000.01805.x; Woolf PJ, 2005, BIOINFORMATICS, V21, P741, DOI 10.1093/bioinformatics/bti056; XIANG Z, 2007, BIOINFORMATICS; Zaslaver A, 2006, NAT METHODS, V3, P623, DOI 10.1038/NMETH895; Zheng M, 2001, J BACTERIOL, V183, P4562, DOI 10.1128/JB.183.15.4562-4570.2001	51	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2010	5	3							e9513	10.1371/journal.pone.0009513	http://dx.doi.org/10.1371/journal.pone.0009513			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	562OZ	20209085	Green Published, Green Submitted, gold			2022-12-25	WOS:000275063400018
J	Fritzsch, B; Dillard, M; Lavado, A; Harvey, NL; Jahan, I				Fritzsch, Bernd; Dillard, Miriam; Lavado, Alfonso; Harvey, Natasha L.; Jahan, Israt			Canal Cristae Growth and Fiber Extension to the Outer Hair Cells of the Mouse Ear Require Prox1 Activity	PLOS ONE			English	Article							MAMMALIAN INNER-EAR; AUDITORY SENSORY EPITHELIUM; CELLULAR-DIFFERENTIATION; FATE DETERMINATION; ORGAN DEVELOPMENT; VERTEBRATE EAR; DROSOPHILA EYE; CYCLE EXIT; STEM-CELLS; NULL MICE	Background: The homeobox gene Prox1 is required for lens, retina, pancreas, liver, and lymphatic vasculature development and is expressed in inner ear supporting cells and neurons. Methodology/Principal Findings: We have investigated the role of Prox1 in the developing mouse ear taking advantage of available standard and conditional Prox1 mutant mouse strains using Tg(Pax2-Cre) and Tg(Nes-Cre). A severe reduction in the size of the canal cristae but not of other vestibular organs or the cochlea was identified in the E18.5 Prox1(Flox/Flox); Tg(Pax2-Cre) mutant ear. In these mutant embryos, hair cell differentiated; however, their distribution pattern was slightly disorganized in the cochlea where the growth of type II nerve fibers to outer hair cells along Prox1 expressing supporting cells was severely disrupted. In the case of Nestin-Cre, we found that newborn Prox1(Flox/Flox); Tg(Nestin-Cre) exhibit only a disorganized innervation of outer hair cells despite apparently normal cellular differentiation of the organ of Corti, suggesting a cell-autonomous function of Prox1 in neurons. Conclusions/Significance: These results identify a dual role of Prox1 during inner ear development; growth of the canal cristae and fiber guidance of Type II fibers along supporting cells in the cochlea.	[Fritzsch, Bernd; Jahan, Israt] Univ Iowa, Dept Biol, Iowa City, IA 52242 USA; [Dillard, Miriam; Lavado, Alfonso; Harvey, Natasha L.] St Jude Childrens Hosp, Dept Genet & Tumor Cell Biol, Memphis, TN 38105 USA	University of Iowa; St Jude Children's Research Hospital	Fritzsch, B (corresponding author), Univ Iowa, Dept Biol, Iowa City, IA 52242 USA.	bernd-fritzsch@uiowa.edu		Harvey, Natasha/0000-0001-9839-8966; Fritzsch, Bernd/0000-0002-4882-8398	NIH [R01-DC005590]; EPSCoR [EPS-0346476, CFD 47.076]; Carver Center for Imaging; Roy J. Carver Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005590] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EPSCoR(National Science Foundation (NSF)NSF - Office of the Director (OD)); Carver Center for Imaging; Roy J. Carver Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by NIH grant R01-DC005590 (to BF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors acknowledge the use of the confocal microscope facility of the NCCB, supported by EPSCoR EPS-0346476 (CFD 47.076) and the Carver Center for Imaging, supported by the Roy J. Carver Foundation.	Adam J, 1998, DEVELOPMENT, V125, P4645; Behan KJ, 2005, DEV GENES EVOL, V215, P423, DOI 10.1007/s00427-005-0490-0; BenArie N, 1997, NATURE, V390, P169, DOI 10.1038/36579; Bermingham NA, 1999, SCIENCE, V284, P1837, DOI 10.1126/science.284.5421.1837; Bermingham-McDonogh O, 2006, J COMP NEUROL, V496, P172, DOI 10.1002/cne.20944; Betz UAK, 1996, CURR BIOL, V6, P1307, DOI 10.1016/S0960-9822(02)70717-3; Bruce LL, 1997, INT J DEV NEUROSCI, V15, P671, DOI 10.1016/S0736-5748(96)00120-7; Burke Z, 2002, MECH DEVELOP, V118, P147, DOI 10.1016/S0925-4773(02)00240-X; Caldwell JC, 2002, J NEUROBIOL, V53, P172, DOI 10.1002/neu.10126; Chang W, 2004, DEVELOPMENT, V131, P4201, DOI 10.1242/dev.01292; Chen P, 2002, DEVELOPMENT, V129, P2495; Chen P, 1999, DEVELOPMENT, V126, P1581; Colvin JS, 1996, NAT GENET, V12, P390, DOI 10.1038/ng0496-390; Cook T, 2003, DEV CELL, V4, P853, DOI 10.1016/S1534-5807(03)00156-4; Dabdoub A, 2008, P NATL ACAD SCI USA, V105, P18396, DOI 10.1073/pnas.0808175105; Domingos PM, 2004, DEV BIOL, V273, P121, DOI 10.1016/j.ydbio.2004.05.026; Dyer MA, 2003, NAT GENET, V34, P53, DOI 10.1038/ng1144; Farinas I, 2001, J NEUROSCI, V21, P6170, DOI 10.1523/JNEUROSCI.21-16-06170.2001; Fritzsch B, 2004, PROG BRAIN RES, V146, P265, DOI 10.1016/S0079-6123(03)46017-2; Fritzsch B, 2000, NEUROREPORT, V11, pR35, DOI 10.1097/00001756-200011270-00013; Fritzsch B, 2005, BRAIN RES BULL, V66, P249, DOI 10.1016/j.brainresbull.2005.05.016; Fritzsch B, 2005, DEV DYNAM, V233, P570, DOI 10.1002/dvdy.20370; Fritzsch B, 2003, BRAIN RES BULL, V60, P423, DOI 10.1016/S0361-9230(03)00048-0; Fritzsch B, 2006, BRAIN RES, V1091, P151, DOI 10.1016/j.brainres.2006.02.078; Fritzsch B, 2006, BIOESSAYS, V28, P1181, DOI 10.1002/bies.20502; Glasgow E, 1998, MECH DEVELOP, V76, P175, DOI 10.1016/S0925-4773(98)00121-X; Harvey NL, 2005, NAT GENET, V37, P1072, DOI 10.1038/ng1642; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Hayashi T, 2001, MECH DEVELOP, V108, P13, DOI 10.1016/S0925-4773(01)00466-X; Hayashi T, 2007, DEV DYNAM, V236, P525, DOI 10.1002/dvdy.21026; Hidalgo A, 2004, CELL CYCLE, V3, P1118; Huang LC, 2007, DEVELOPMENT, V134, P2925, DOI 10.1242/dev.001925; Jensen-Smith Heather, 2007, Immunol Invest, V36, P763, DOI 10.1080/08820130701706711; Johnson NC, 2008, GENE DEV, V22, P3282, DOI 10.1101/gad.1727208; Jones C, 2007, BIOESSAYS, V29, P120, DOI 10.1002/bies.20526; Karis A, 2001, J COMP NEUROL, V429, P615, DOI 10.1002/1096-9861(20010122)429:4<615::AID-CNE8>3.0.CO;2-F; Kelley MW, 2006, NAT REV NEUROSCI, V7, P837, DOI 10.1038/nrn1987; KELLEY MW, 2006, HAIR CELL DEV COMMIT; Kiernan AE, 2005, NATURE, V434, P1031, DOI 10.1038/nature03487; Kirjavainen A, 2008, DEV BIOL, V322, P33, DOI 10.1016/j.ydbio.2008.07.004; Koundakjian EJ, 2007, J NEUROSCI, V27, P14078, DOI 10.1523/JNEUROSCI.3765-07.2007; Lavado A, 2007, DEV DYNAM, V236, P518, DOI 10.1002/dvdy.21024; Lee YS, 2006, DEVELOPMENT, V133, P2817, DOI 10.1242/dev.02453; Li HW, 2003, NAT MED, V9, P1293, DOI 10.1038/nm925; Ma QF, 2000, JARO-J ASSOC RES OTO, V1, P129, DOI 10.1007/s101620010017; Matei V, 2005, DEV DYNAM, V234, P633, DOI 10.1002/dvdy.20551; Matei VA, 2006, BRAIN RES BULL, V70, P33, DOI 10.1016/j.brainresbull.2005.11.007; Misra K, 2008, DEV DYNAM, V237, P393, DOI 10.1002/dvdy.21422; Morris JK, 2006, BRAIN RES, V1091, P186, DOI 10.1016/j.brainres.2006.02.090; Morsli H, 1998, J NEUROSCI, V18, P3327; Nichols DH, 2008, CELL TISSUE RES, V334, P339, DOI 10.1007/s00441-008-0709-2; Ohyama T, 2006, DEVELOPMENT, V133, P865, DOI 10.1242/dev.02271; Ohyama T, 2004, GENESIS, V38, P195, DOI 10.1002/gene.20017; OLIVER G, 1993, MECH DEVELOP, V44, P3, DOI 10.1016/0925-4773(93)90012-M; Pauley S, 2008, PANMINERVA MED, V50, P41; Pauley S, 2003, DEV DYNAM, V227, P203, DOI 10.1002/dvdy.10297; Pauley S, 2006, DEV DYNAM, V235, P2470, DOI 10.1002/dvdy.20839; Petrova TV, 2008, CANCER CELL, V13, P407, DOI 10.1016/j.ccr.2008.02.020; Pirvola U, 2000, J NEUROSCI, V20, P6125, DOI 10.1523/JNEUROSCI.20-16-06125.2000; Pirvola U, 2002, NEURON, V35, P671, DOI 10.1016/S0896-6273(02)00824-3; Puligilla C, 2007, DEV DYNAM, V236, P1905, DOI 10.1002/dvdy.21192; Reddy GV, 1999, DEVELOPMENT, V126, P4617; Risebro CA, 2009, DEVELOPMENT, V136, P495, DOI 10.1242/dev.030007; Rubel EW, 2002, ANNU REV NEUROSCI, V25, P51, DOI 10.1146/annurev.neuro.25.112701.142849; Ruben RJ, 1967, ACTA OTO LARYNGOLOGI, V220, P221; Sen A, 2003, DEV BIOL, V254, P79, DOI 10.1016/S0012-1606(02)00021-0; Shim K, 2005, DEV CELL, V8, P553, DOI 10.1016/j.devcel.2005.02.009; Simmons DD, 2002, J NEUROBIOL, V53, P228, DOI 10.1002/neu.10130; SRINIVASAN RS, 2007, GENES DEV IN PRESS; Stone JS, 2003, J COMP NEUROL, V460, P487, DOI 10.1002/cne.10662; von Bartheld CS, 2001, TRENDS NEUROSCI, V24, P504, DOI 10.1016/S0166-2236(00)01960-3; Wang JF, 2005, DEV BIOL, V286, P182, DOI 10.1016/j.ydbio.2005.07.021; WARD TS, 2007, MICROSC RES TECH; Wigle JT, 1999, NAT GENET, V21, P318, DOI 10.1038/6844; Wigle JT, 1999, CELL, V98, P769, DOI 10.1016/S0092-8674(00)81511-1; Wigle JT, 2002, EMBO J, V21, P1505, DOI 10.1093/emboj/21.7.1505; Xiang MQ, 1998, DEVELOPMENT, V125, P3935	77	54	54	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2010	5	2							e9377	10.1371/journal.pone.0009377	http://dx.doi.org/10.1371/journal.pone.0009377			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SV	20186345	gold, Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000274924000018
J	Spanaki, C; Zaganas, I; Kleopa, KA; Plaitakis, A				Spanaki, Cleanthe; Zaganas, Ioannis; Kleopa, Kleopas A.; Plaitakis, Andreas			Human GLUD2 Glutamate Dehydrogenase Is Expressed in Neural and Testicular Supporting Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TISSUE-SPECIFIC GLUD2; SERTOLI-CELLS; NEUROLOGICAL DISORDERS; HUMAN-LIVER; EVOLUTION; MITOCHONDRIA; METABOLISM; ASTROCYTES; MECHANISMS; GENE	Mammalian glutamate dehydrogenase (GDH) is an allosterically regulated enzyme that is expressed widely. Its activity is potently inhibited by GTP and thought to be controlled by the need of the cell for ATP. In addition to this housekeeping human (h) GDH1, humans have acquired (via a duplication event) a highly homologous isoenzyme (hGDH2) that is resistant to GTP. Although transcripts of GLUD2, the gene encoding hGDH2, have been detected in human neural and testicular tissues, data on the endogenous protein are lacking. Here, we developed an antibody specific for hGDH2 and used it to study human tissues. Western blot analyses revealed, to our surprise, that endogenous hGDH2 is more densely expressed in testis than in brain. At the subcellular level, hGDH2 localized to mitochondria. Study of testicular tissue using immunocytochemical and immunofluorescence methods revealed that the Sertoli cells were strongly labeled by our anti-hGDH2 antibody. In human cerebral cortex, a robust labeling of astrocytes was detected, with neurons showing faint hGDH2 immunoreactivity. Astrocytes and Sertoli cells are known to support neurons and germ cells, respectively, providing them with lactate that largely derives from the tricarboxylic acid cycle via conversion of glutamate to alpha-ketoglutarate (GDH reaction). As hGDH2 is not subject to GTP control, the enzyme is able to metabolize glutamate even when the tricarboxylic acid cycle generates GTP amounts sufficient to inactivate the housekeeping hGDH1 protein. Hence, the selective expression of hGDH2 by astrocytes and Sertoli cells may provide a significant biological advantage by facilitating metabolic recycling processes essential to the supportive role of these cells.	Univ Crete, Dept Neurol, Sch Hlth Sci, Fac Med, Iraklion 71003, Crete, Greece; [Kleopa, Kleopas A.] Cyprus Inst Neurol & Genet, Neurosci Lab, CY-1683 Nicosia, Cyprus; [Kleopa, Kleopas A.] Cyprus Inst Neurol & Genet, Neurol Clin, CY-1683 Nicosia, Cyprus	University of Crete		plaitak@med.uoc.gr	Zaganas, Ioannis/AAE-5441-2020	Zaganas, Ioannis/0000-0002-0774-5772; Kleopa, Kleopas/0000-0002-4103-8094	Association for Research and Treatment of Neurologic Disorders of Crete; Cyprus Research Promotion Foundation	Association for Research and Treatment of Neurologic Disorders of Crete; Cyprus Research Promotion Foundation	This work was supported by grants from the Association for Research and Treatment of Neurologic Disorders of Crete (EY ZHN) and by the Cyprus Research Promotion Foundation (to K.A.K.).	AUMULLER G, 1988, ANAT EMBRYOL, V178, P129, DOI 10.1007/BF02463646; Burki F, 2004, NAT GENET, V36, P1061, DOI 10.1038/ng1431; Choi MM, 2005, FEBS LETT, V579, P4125, DOI 10.1016/j.febslet.2005.06.041; Choi SY, 1999, J NEUROCHEM, V72, P2162, DOI 10.1046/j.1471-4159.1999.0722162.x; CLARK JB, 1970, J BIOL CHEM, V245, P4724; ERECINSKA M, 1990, J NEUROCHEM, V54, P1335, DOI 10.1111/j.1471-4159.1990.tb01967.x; Fawcett D W, 1973, Adv Biosci, V10, P83; GRISWOLD MD, 1995, BIOL REPROD, V52, P211, DOI 10.1095/biolreprod52.2.211; GRISWOLD MD, 1977, MOL CELL ENDOCRINOL, V7, P151, DOI 10.1016/0303-7207(77)90064-8; HUDSON RC, 1993, COMP BIOCHEM PHYS B, V106, P767, DOI 10.1016/0305-0491(93)90031-Y; HUSSAIN MM, 1989, J BIOL CHEM, V264, P20730; Hutson SM, 1998, J NEUROCHEM, V71, P863; JULLIARD JH, 1979, J BIOL CHEM, V254, P3427; Kanavouras K, 2007, J NEUROSCI RES, V85, P1101, DOI 10.1002/jnr.21197; Kanavouras K, 2009, J NEUROCHEM, V109, P167, DOI 10.1111/j.1471-4159.2009.05914.x; Lee WK, 2000, J CELL BIOCHEM, V76, P244; Mastorodemos V, 2005, J NEUROSCI RES, V79, P65, DOI 10.1002/jnr.20353; Mastorodemos V, 2009, BIOCHEM CELL BIOL, V87, P505, DOI [10.1139/O09-008, 10.1139/o09-008]; MAVROTHALASSITIS G, 1988, P NATL ACAD SCI USA, V85, P3494, DOI 10.1073/pnas.85.10.3494; McKenna MC, 1996, DEV NEUROSCI-BASEL, V18, P380, DOI 10.1159/000111431; Morand JPF, 2005, J BIOL CHEM, V280, P17626, DOI 10.1074/jbc.M413343200; Plaitakis A, 2000, J NEUROCHEM, V75, P1862, DOI 10.1046/j.1471-4159.2000.0751862.x; Plaitakis A, 2003, NEUROCHEM INT, V43, P401, DOI 10.1016/S0197-0186(03)00028-7; PLAITAKIS A, 1984, ANN NEUROL, V15, P144, DOI 10.1002/ana.410150206; Plaitakis A, 2010, EUR J HUM GENET, V18, P336, DOI 10.1038/ejhg.2009.179; Rosso L, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000150; Sharpe Richard M., 1994, P1363; Shashidharan P, 1997, J NEUROCHEM, V68, P1804; SHASHIDHARAN P, 1994, J BIOL CHEM, V269, P16971; SMITH EL, 1979, P AM PHILOS SOC, V123, P73; SONNEWALD U, 1993, J NEUROCHEM, V61, P1179, DOI 10.1111/j.1471-4159.1993.tb03641.x; Waagepetersen HS, 2000, J NEUROCHEM, V75, P471, DOI 10.1046/j.1471-4159.2000.0750471.x; Zaganas I, 2002, J BIOL CHEM, V277, P26422, DOI 10.1074/jbc.M200022200; Zaganas I, 2009, NEUROCHEM INT, V55, P52, DOI 10.1016/j.neuint.2009.03.001	34	47	51	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16748	16756		10.1074/jbc.M109.092999	http://dx.doi.org/10.1074/jbc.M109.092999			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20194501	hybrid, Green Published			2022-12-25	WOS:000277982600038
J	Chelico, L; Prochnow, C; Erie, DA; Chen, XS; Goodman, MF				Chelico, Linda; Prochnow, Courtney; Erie, Dorothy A.; Chen, Xiaojiang S.; Goodman, Myron F.			Structural Model for Deoxycytidine Deamination Mechanisms of the HIV-1 Inactivation Enzyme APOBEC3G	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRUS-LIKE PARTICLES; CYTIDINE DEAMINASE; VIF PROTEIN; FUNCTIONAL IMPLICATIONS; CRYSTAL-STRUCTURE; TYPE-1 VIF; WILD-TYPE; 7SL RNA; DNA; DOMAIN	APOBEC3G (Apo3G) is a single-stranded DNA-dependent deoxycytidine deaminase, which, in the absence of the human immunodeficiency virus (HIV) viral infectivity factor, is encapsulated into HIV virions. Subsequently, Apo3G triggers viral inactivation by processively deaminating C -> U, with 3'-> 5' polarity, on nascent minus-strand cDNA. Apo3G has a catalytically inactive N-terminal CD1 domain and an active C-terminal CD2 domain. Apo3G exists as monomers, dimers, tetramers, and higher order oligomers whose distributions depend on DNA substrate and salt. Here we use multiangle light scattering and atomic force microscopy to identify oligomerization states of Apo3G. A double mutant (F126A/W127A), designed to disrupt dimerization at the predicted CD1-CD1 dimer interface, predominantly converts Apo3G to a monomer that binds single-stranded DNA, Alu RNA, and catalyzes processive C -> U deaminations with 3'-> 5' deamination polarity, similar to native Apo3G. The CD1 domain is essential for both processivity and polarity. We propose a structure-based model to explain the scanning and catalytic behavior of Apo3G.	[Chelico, Linda; Prochnow, Courtney; Chen, Xiaojiang S.; Goodman, Myron F.] Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA; [Chen, Xiaojiang S.; Goodman, Myron F.] Univ So Calif, Dept Chem, Los Angeles, CA 90089 USA; [Erie, Dorothy A.] Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA; [Erie, Dorothy A.] Univ N Carolina, Appl & Mat Sci Curriculum, Chapel Hill, NC 27599 USA	University of Southern California; University of Southern California; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Goodman, MF (corresponding author), 1050 Childs Way, Los Angeles, CA 90089 USA.	mgoodman@usc.edu		Chelico, Linda/0000-0003-4673-8978	National Institutes of Health [ESO13192, R37GM21422, GM080294, GM079480, GM087986]; California HIV/AIDS Research Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079480, R01GM087986, R37GM021422, R01GM080294] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California HIV/AIDS Research Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants ESO13192 and R37GM21422 (to M. F. G.), GM080294 and GM079480 (to D. A. E.), and GM087986 (to X. S. C.). This work was also supported by a California HIV/AIDS Research Program grant (to X. S. C.).	Alce TM, 2004, J BIOL CHEM, V279, P34083, DOI 10.1074/jbc.C400235200; Bach D, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-54; Batzer MA, 2002, NAT REV GENET, V3, P370, DOI 10.1038/nrg798; Bennett RP, 2008, J BIOL CHEM, V283, P33329, DOI 10.1074/jbc.M803726200; Bertram JG, 2004, J BIOL CHEM, V279, P33047, DOI 10.1074/jbc.C400265200; Bogerd HP, 2008, RNA, V14, P1228, DOI 10.1261/rna.964708; Bransteitter R, 2004, J BIOL CHEM, V279, P51612, DOI 10.1074/jbc.M408135200; Burnett A, 2007, J VIROL, V81, P5000, DOI 10.1128/JVI.02237-06; Cen S, 2004, J BIOL CHEM, V279, P33177, DOI 10.1074/jbc.M402062200; Chelico L, 2006, NAT STRUCT MOL BIOL, V13, P392, DOI 10.1038/nsmb1086; Chelico L, 2008, J BIOL CHEM, V283, P13780, DOI 10.1074/jbc.M801004200; Chen KM, 2008, NATURE, V452, P116, DOI 10.1038/nature06638; Chen KM, 2007, FEBS LETT, V581, P4761, DOI 10.1016/j.febslet.2007.08.076; Chiu YL, 2006, P NATL ACAD SCI USA, V103, P15588, DOI 10.1073/pnas.0604524103; Chiu YL, 2005, NATURE, V435, P108, DOI 10.1038/nature03493; Creighton S, 1995, METHOD ENZYMOL, V262, P232; Douaisi M, 2004, BIOCHEM BIOPH RES CO, V321, P566, DOI 10.1016/j.bbrc.2004.07.005; Furukawa A, 2009, EMBO J, V28, P440, DOI 10.1038/emboj.2008.290; Goila-Gaur R, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-51; Hache G, 2005, J BIOL CHEM, V280, P10920, DOI 10.1074/jbc.M500382200; Holden LG, 2008, NATURE, V456, P121, DOI 10.1038/nature07357; Huthoff H, 2007, J VIROL, V81, P3807, DOI 10.1128/JVI.02795-06; Huthoff H, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000330; Kao S, 2003, J VIROL, V77, P11398, DOI 10.1128/JVI.77.21.11398-11407.2003; Khan MA, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-48; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Marin M, 2003, NAT MED, V9, P1398, DOI 10.1038/nm946; Navarro F, 2005, VIROLOGY, V333, P374, DOI 10.1016/j.virol.2005.01.011; Nowarski R, 2008, NAT STRUCT MOL BIOL, V15, P1059, DOI 10.1038/nsmb.1495; Prochnow C, 2007, NATURE, V445, P447, DOI 10.1038/nature05492; Ratcliff GC, 2001, J AM CHEM SOC, V123, P5632, DOI 10.1021/ja005750n; Rausch JW, 2009, J BIOL CHEM, V284, P7047, DOI 10.1074/jbc.M807258200; Salter JD, 2009, BIOCHEMISTRY-US, V48, P10685, DOI 10.1021/bi901642c; Shaikh TH, 1997, J MOL BIOL, V271, P222, DOI 10.1006/jmbi.1997.1161; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Smith JL, 2009, TRENDS PHARMACOL SCI, V30, P638, DOI 10.1016/j.tips.2009.09.006; Soros VB, 2007, PLOS PATHOG, V3, P152, DOI 10.1371/journal.ppat.0030015; Stopak K, 2003, MOL CELL, V12, P591, DOI 10.1016/S1097-2765(03)00353-8; Strebel K, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-55; Suspene R, 2006, NUCLEIC ACIDS RES, V34, P4677, DOI 10.1093/nar/gkl555; Svarovskaia ES, 2004, J BIOL CHEM, V279, P35822, DOI 10.1074/jbc.M405761200; Wang T, 2007, J VIROL, V81, P13112, DOI 10.1128/JVI.00892-07; Wang WY, 1999, BIOTECHNIQUES, V26, P680, DOI 10.2144/99264st03; Wedekind JE, 2006, J BIOL CHEM, V281, P38122, DOI 10.1074/jbc.C600253200; WYATT PJ, 1993, ANAL CHIM ACTA, V272, P1, DOI 10.1016/0003-2670(93)80373-S; Yang Y, 2003, METHODS, V29, P175, DOI 10.1016/S1046-2023(02)00308-0; Yu Q, 2004, NAT STRUCT MOL BIOL, V11, P435, DOI 10.1038/nsmb758; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707; Zhang X, 2009, BIOPHYS J, V96, P1884, DOI 10.1016/j.bpj.2008.12.3890	51	95	96	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					16195	16205		10.1074/jbc.M110.107987	http://dx.doi.org/10.1074/jbc.M110.107987			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20212048	Green Published, hybrid			2022-12-25	WOS:000277715900056
J	Layer, JH; Miller, SG; Weil, PA				Layer, Justin H.; Miller, Scott G.; Weil, P. Anthony			Direct Transactivator-Transcription Factor IID (TFIID) Contacts Drive Yeast Ribosomal Protein Gene Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATOR-SPECIFIC RECRUITMENT; IN-VIVO; SACCHAROMYCES-CEREVISIAE; CRYSTAL-STRUCTURE; BINDING; COMPLEX; COACTIVATOR; PROMOTER; MEDIATOR; GENOME	Transcription factor IID (TFIID) plays a key role in regulating eukaryotic gene expression by directly binding promoters and enhancer-bound transactivator proteins. However, the precise mechanisms and outcomes of transactivator-TFIID interaction remain unclear. Transcription of yeast ribosomal protein genes requires TFIID and the DNA-binding transactivator Rap1. We have previously shown that Rap1 directly binds to the TFIID complex through interaction with its TATA-binding protein-associated factor (Taf) subunits Taf4, -5, and -12. Here, we identify and characterize the Rap1 binding domains (RBDs) of Taf4 and Taf5. These RBDs are essential for viability but dispensable for Taf-Taf interactions and TFIID stability. Cells expressing altered Rap1 binding domains exhibit conditional growth, synthetic phenotypes when expressed in combination or with altered Rap1, and are selectively defective in ribosomal protein gene transcription. Taf4 and Taf5 proteins with altered RBDs bind Rap1 with reduced affinity. We propose that collectively the Taf4, Taf5, and Taf12 subunits of TFIID represent the physical and functional targets for Rap1 interaction and, furthermore, that these interactions drive ribosomal protein gene transcription.	[Layer, Justin H.; Miller, Scott G.; Weil, P. Anthony] Vanderbilt Univ, Dept Mol Physiol & Biophys, Sch Med, Nashville, TN 37232 USA	Vanderbilt University	Weil, PA (corresponding author), Vanderbilt Univ, Dept Mol Physiol & Biophys, Sch Med, Nashville, TN 37232 USA.	tony.weil@vanderbilt.edu			National Institutes of Health [GM52461]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R56GM052461, R01GM052461] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM52461.	Albright SR, 2000, GENE, V242, P1, DOI 10.1016/S0378-1119(99)00495-3; Andel F, 1999, SCIENCE, V286, P2153, DOI 10.1126/science.286.5447.2153; Andrau JC, 2006, MOL CELL, V22, P179, DOI 10.1016/j.molcel.2006.03.023; Ansari SA, 2009, P NATL ACAD SCI USA, V106, P16734, DOI 10.1073/pnas.0905103106; Bhattacharya S, 2007, P NATL ACAD SCI USA, V104, P1189, DOI 10.1073/pnas.0610297104; Boyer-Guittaut M, 2005, J BIOL CHEM, V280, P9937, DOI 10.1074/jbc.M414149200; Brand M, 1999, SCIENCE, V286, P2151, DOI 10.1126/science.286.5447.2151; Cler E, 2009, CELL MOL LIFE SCI, V66, P2123, DOI 10.1007/s00018-009-0009-3; Durso RJ, 2001, MOL CELL BIOL, V21, P7331, DOI 10.1128/MCB.21.21.7331-7344.2001; Elmlund H, 2009, STRUCTURE, V17, P1442, DOI 10.1016/j.str.2009.09.007; Fadloun A, 2008, ONCOGENE, V27, P477, DOI 10.1038/sj.onc.1210657; Fan XC, 2006, NAT STRUCT MOL BIOL, V13, P117, DOI 10.1038/nsmb1049; Fan XC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005029; Gamper AM, 2008, MOL CELL BIOL, V28, P2517, DOI 10.1128/MCB.01461-07; Garbett KA, 2007, MOL CELL BIOL, V27, P297, DOI 10.1128/MCB.01558-06; Grob P, 2006, STRUCTURE, V14, P511, DOI 10.1016/j.str.2005.11.020; Guermah M, 2001, MOL CELL BIOL, V21, P6882, DOI 10.1128/MCB.21.20.6882-6894.2001; Guven-Ozkan T, 2008, CELL, V135, P149, DOI 10.1016/j.cell.2008.07.040; Huisinga KL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r46; Klein J, 2003, J BIOL CHEM, V278, P6779, DOI 10.1074/jbc.M212514200; Koerber RT, 2009, MOL CELL, V35, P889, DOI 10.1016/j.molcel.2009.09.011; Kuras L, 1999, NATURE, V399, P609, DOI 10.1038/21239; Lempiainen H, 2009, MOL CELL, V33, P704, DOI 10.1016/j.molcel.2009.01.034; Leurent C, 2004, EMBO J, V23, P719, DOI 10.1038/sj.emboj.7600111; Leurent C, 2002, EMBO J, V21, P3424, DOI 10.1093/emboj/cdf342; Li XY, 2000, SCIENCE, V288, P1242, DOI 10.1126/science.288.5469.1242; Lieb JD, 2001, NAT GENET, V28, P327, DOI 10.1038/ng569; Liu WL, 2008, MOL CELL, V29, P81, DOI 10.1016/j.molcel.2007.11.003; Liu WL, 2009, GENE DEV, V23, P1510, DOI 10.1101/gad.1790709; Mencia M, 2002, MOL CELL, V9, P823, DOI 10.1016/S1097-2765(02)00490-2; Mengus G, 2005, EMBO J, V24, P2753, DOI 10.1038/sj.emboj.7600748; Mischerikow N, 2009, J PROTEOME RES, V8, P5020, DOI 10.1021/pr900449e; Moqtaderi Z, 1996, P NATL ACAD SCI USA, V93, P14654, DOI 10.1073/pnas.93.25.14654; Olave I, 1998, GENE DEV, V12, P1621, DOI 10.1101/gad.12.11.1621; Papai G, 2009, STRUCTURE, V17, P363, DOI 10.1016/j.str.2009.01.006; POON D, 1995, P NATL ACAD SCI USA, V92, P8224, DOI 10.1073/pnas.92.18.8224; Prochasson P, 2003, MOL CELL, V12, P983, DOI 10.1016/S1097-2765(03)00366-6; Ptashne M, 1997, NATURE, V386, P569, DOI 10.1038/386569a0; Reeves WM, 2005, MOL CELL BIOL, V25, P9092, DOI 10.1128/MCB.25.20.9092-9102.2005; Rohde JR, 2003, MOL CELL BIOL, V23, P629, DOI 10.1128/MCB.23.2.629-635.2003; Romier C, 2007, J MOL BIOL, V368, P1292, DOI 10.1016/j.jmb.2007.02.039; Rudra D, 2004, GENE DEV, V18, P2431, DOI 10.1101/gad.1256704; Sanders SL, 2002, MOL CELL BIOL, V22, P6000, DOI 10.1128/MCB.22.16.6000-6013.2002; Sanders SL, 2002, MOL CELL BIOL, V22, P4723, DOI 10.1128/MCB.22.13.4723-4738.2002; Schawalder SB, 2004, NATURE, V432, P1058, DOI 10.1038/nature03200; Shao HS, 2005, MOL CELL BIOL, V25, P206, DOI 10.1128/MCB.25.1.206-219.2005; Taatjes DJ, 2004, NAT REV MOL CELL BIO, V5, P403, DOI 10.1038/nrm1369; Takahashi H, 2009, J BIOL CHEM, V284, P32405, DOI 10.1074/jbc.M109.017954; Thomas MC, 2006, CRIT REV BIOCHEM MOL, V41, P105, DOI 10.1080/10409230600648736; Thuault S, 2002, J BIOL CHEM, V277, P45510, DOI 10.1074/jbc.M206556200; Tora L, 2002, GENE DEV, V16, P673, DOI 10.1101/gad.976402; TSANG JSH, 1990, NUCLEIC ACIDS RES, V18, P7331, DOI 10.1093/nar/18.24.7331; Venters BJ, 2009, GENOME RES, V19, P360, DOI 10.1101/gr.084970.108; Wang XP, 2007, P NATL ACAD SCI USA, V104, P7839, DOI 10.1073/pnas.0608570104; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Werten S, 2002, J BIOL CHEM, V277, P45502, DOI 10.1074/jbc.M206587200; Wright KJ, 2006, P NATL ACAD SCI USA, V103, P12347, DOI 10.1073/pnas.0605499103; Zanton SJ, 2006, GENE DEV, V20, P2250, DOI 10.1101/gad.1437506; Zhu XF, 2006, MOL CELL, V22, P169, DOI 10.1016/j.molcel.2006.03.032	59	26	26	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15489	15499		10.1074/jbc.M110.104810	http://dx.doi.org/10.1074/jbc.M110.104810			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20189987	Green Published, hybrid			2022-12-25	WOS:000277399000068
J	Karlsen, JR; Borregaard, N; Cowland, JB				Karlsen, Joachim R.; Borregaard, Niels; Cowland, Jack B.			Induction of Neutrophil Gelatinase-associated Lipocalin Expression by Co-stimulation with Interleukin-17 and Tumor Necrosis Factor-alpha Is Controlled by I kappa B-zeta but neither by C/EBP-beta nor C/EBP-delta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REACTIVE PROTEIN EXPRESSION; EPITHELIAL-CELLS; GENE-EXPRESSION; TRANSCRIPTION; IDENTIFICATION; BINDING; NGAL; RECEPTOR; PATTERN; TARGET	Neutrophil gelatinase-associated lipocalin (NGAL) is a siderophore-binding antimicrobial protein that is up-regulated in epithelial tissues during inflammation. We demonstrated previously that the gene encoding NGAL (LCN2) is strongly up-regulated by interleukin (IL)-1 beta in an NF-kappa B-dependent manner but not by tumor necrosis factor (TNF)-alpha, another potent activator of NF-kappa B. This is due to an IL-1 beta-specific synthesis of the NF-kappa B-binding co-factor I kappa B-zeta, which is essential for NGAL induction. We demonstrate here that NGAL is strongly induced by stimulation with TNF-alpha in the presence of IL-17, a pro-inflammatory cytokine produced by the newly discovered subset of CD4(+) T helper cells, TH-17. In contrast to the murine NGAL orthologue, 24p3/lipocalin 2, we found no requirement for C/EBP-beta or C/EBP-delta for NGAL induction by IL-17 and TNF-alpha as neither small interfering RNAs against the two C/EBP mRNAs nor mutation of the C/EBP sites in the LCN2 promoter abolished IL-17- and TNF-alpha-induced up-regulation of NGAL. NGAL induction is governed solely by NF-kappa B and its co-factor I kappa B-zeta. This was demonstrated by a pronounced reduction in the amount of NGAL mRNA and NGAL protein synthesized in cells treated with small interfering RNA against I kappa B-zeta and a total lack of activation of an LCN2 promoter construct with a mutated NF-kappa B site. As IL-17 stimulation stabilizes the I kappa B-zeta transcript, we propose a model where TNF-alpha induces activation and binding of NF-kappa B to the promoters of both NFKBIZ and LCN2 genes but induce only transcription of I kappa B-zeta. Co-stimulation with IL-17 leads to accumulation of I kappa B-zeta mRNA and I kappa B-zeta protein, which can bind to NF-kappa B on the LCN2 promoter and thus induce NGAL expression.	[Karlsen, Joachim R.; Borregaard, Niels; Cowland, Jack B.] Univ Copenhagen, Rigshosp, Granulocyte Res Lab, Dept Hematol 93 2 2, DK-2100 Copenhagen, Denmark	Rigshospitalet; University of Copenhagen	Cowland, JB (corresponding author), Univ Copenhagen, Rigshosp, Granulocyte Res Lab, Dept Hematol 93 2 2, 9 Blegdamsvej, DK-2100 Copenhagen, Denmark.	jcowland@rh.dk		Cowland, Jack Bernard/0000-0002-7429-5388	Danish Medical Research Council; Novo Nordisk Foundation; Lundbeck Foundation; A.P. Moller Foundation	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck Foundation(Lundbeckfonden); A.P. Moller Foundation	This work was supported by grants from the Danish Medical Research Council, the Novo Nordisk Foundation, the Lundbeck Foundation, and the A.P. Moller Foundation for the Advancement of Medical Science.	Agrawal A, 2003, MOL IMMUNOL, V40, P373, DOI 10.1016/S0161-5890(03)00148-2; Bettelli E, 2008, NATURE, V453, P1051, DOI 10.1038/nature07036; Cowland JB, 2006, J IMMUNOL, V176, P5559, DOI 10.4049/jimmunol.176.9.5559; Cowland JB, 1997, GENOMICS, V45, P17, DOI 10.1006/geno.1997.4896; Cowland JB, 2003, J IMMUNOL, V171, P6630, DOI 10.4049/jimmunol.171.12.6630; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; DEWET JR, 1987, MOL CELL BIOL, V7, P725, DOI 10.1128/MCB.7.2.725; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; Flower DR, 1996, BIOCHEM J, V318, P1; Fossiez F, 1996, J EXP MED, V183, P2593, DOI 10.1084/jem.183.6.2593; Friedl A, 1999, HISTOCHEM J, V31, P433, DOI 10.1023/A:1003708808934; Goetz DH, 2002, MOL CELL, V10, P1033, DOI 10.1016/S1097-2765(02)00708-6; Gombart AF, 2005, FASEB J, V19, P1067, DOI 10.1096/fj.04-3284com; Hartupee J, 2007, J IMMUNOL, V179, P4135, DOI 10.4049/jimmunol.179.6.4135; Hoffmann E, 2002, J LEUKOCYTE BIOL, V72, P847; Hu HM, 1998, J IMMUNOL, V160, P2334; Kao CY, 2004, J IMMUNOL, V173, P3482, DOI 10.4049/jimmunol.173.5.3482; Kjeldsen L, 1996, J IMMUNOL METHODS, V198, P155, DOI 10.1016/S0022-1759(96)00153-6; KJELDSEN L, 1994, BLOOD, V83, P799; Klausen P, 2005, EUR J HAEMATOL, V75, P332, DOI 10.1111/j.1600-0609.2005.00511.x; LIU QS, 1995, J BIOL CHEM, V270, P22565, DOI 10.1074/jbc.270.38.22565; Matsuo S, 2007, BIOCHEM J, V405, P605, DOI 10.1042/BJ20061797; Motoyama M, 2005, J BIOL CHEM, V280, P7444, DOI 10.1074/jbc.M412738200; Nielsen BS, 1996, GUT, V38, P414, DOI 10.1136/gut.38.3.414; Nourbakhsh M, 2001, J BIOL CHEM, V276, P4501, DOI 10.1074/jbc.M007532200; Patel DN, 2007, J BIOL CHEM, V282, P27229, DOI 10.1074/jbc.M703250200; Roger T, 1998, BIOCHEM J, V330, P429, DOI 10.1042/bj3300429; Shen F, 2005, J LEUKOCYTE BIOL, V77, P388, DOI 10.1189/jlb.0904490; Shen F, 2006, J BIOL CHEM, V281, P24138, DOI 10.1074/jbc.M604597200; Sorensen OE, 2005, J IMMUNOL, V174, P4870, DOI 10.4049/jimmunol.174.8.4870; Sorensen OE, 2003, J IMMUNOL, V170, P5583, DOI 10.4049/jimmunol.170.11.5583; Yamamoto M, 2004, NATURE, V430, P218, DOI 10.1038/nature02738; Yamazaki S, 2005, J BIOL CHEM, V280, P1678, DOI 10.1074/jbc.M409983200	34	110	116	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14088	14100		10.1074/jbc.M109.017129	http://dx.doi.org/10.1074/jbc.M109.017129			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20220144	hybrid, Green Published			2022-12-25	WOS:000277299700004
J	Luckner, SR; Liu, NN; Ende, CWA; Tonge, PJ; Kisker, C				Luckner, Sylvia R.; Liu, Nina; Ende, Christopher W. Am; Tonge, Peter J.; Kisker, Caroline			A Slow, Tight Binding Inhibitor of InhA, the Enoyl-Acyl Carrier Protein Reductase from Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESIDENCE TIME; ACP REDUCTASE; DRUG-TARGET; TRICLOSAN; AFFINITY; BIOSYNTHESIS; FABL; GENE	InhA, the enoyl-ACP reductase in Mycobacterium tuberculosis is an attractive target for the development of novel drugs against tuberculosis, a disease that kills more than two million people each year. InhA is the target of the current first line drug isoniazid for the treatment of tuberculosis infections. Compounds that directly target InhA and do not require activation by the mycobacterial catalase-peroxidase KatG are promising candidates for treating infections caused by isoniazid-resistant strains. Previously we reported the synthesis of several diphenyl ethers with nanomolar affinity for InhA. However, these compounds are rapid reversible inhibitors of the enzyme, and based on the knowledge that long drug target residence times are an important factor for in vivo drug activity, we set out to generate a slow onset inhibitor of InhA using structure-based drug design. 2-(o-Tolyloxy)-5-hexylphenol (PT70) is a slow, tight binding inhibitor of InhA with a K-1 value of 22 pM. PT70 binds preferentially to the InhA center dot NAD(+) complex and has a residence time of 24 min on the target, which is 14,000 times longer than that of the rapid reversible inhibitor from which it is derived. The 1.8 angstrom crystal structure of the ternary complex between InhA, NAD(+), and PT70 reveals the molecular details of enzyme-inhibitor recognition and supports the hypothesis that slow onset inhibition is coupled to ordering of an active site loop, which leads to the closure of the substrate-binding pocket.	[Liu, Nina; Ende, Christopher W. Am; Tonge, Peter J.] SUNY Stony Brook, Dept Chem, Inst Chem Biol & Drug Discovery, Stony Brook, NY 11794 USA; Univ Wurzburg, Inst Biol Struct, Rudolf Virchow Ctr Expt Biomed, D-97080 Wurzburg, Germany	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Wurzburg	Tonge, PJ (corresponding author), SUNY Stony Brook, Dept Chem, Inst Chem Biol & Drug Discovery, Stony Brook, NY 11794 USA.	tonge@sunysb.edu; caroline.kisker@virchow.uni-wuerzburg.de	Liu, Nina/G-2837-2013; Kisker, Caroline/T-1724-2019; Tonge, Peter J/A-7443-2009	Tonge, Peter J/0000-0003-1606-3471; Kisker, Caroline/0000-0002-0216-6026	National Institutes of Health [AI44639]; Deutsche Forschungsgemeinschaft [SFB 630]; Forschungszentrum [FZ82]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI044639, R01AI044639] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Forschungszentrum; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI44639 (to P. J. T.). This work was also supported by Deutsche Forschungsgemeinschaft Grant SFB 630 and Forschungszentrum Grant FZ82 (to C. K.).	BANERJEE A, 1994, SCIENCE, V263, P227, DOI 10.1126/science.8284673; Barry CE, 1998, PROG LIPID RES, V37, P143, DOI 10.1016/S0163-7827(98)00008-3; COPELAND RA, 2005, EVALUATION ENZYME IN, P141; Copeland RA, 2006, NAT REV DRUG DISCOV, V5, P730, DOI 10.1038/nrd2082; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ende CWA, 2008, BIOORG MED CHEM LETT, V18, P3029, DOI 10.1016/j.bmcl.2008.04.038; Freundlich JS, 2009, CHEMMEDCHEM, V4, P241, DOI 10.1002/cmdc.200800261; He X, 2006, J MED CHEM, V49, P6308, DOI 10.1021/jm060715y; Heinig M, 2004, NUCLEIC ACIDS RES, V32, pW500, DOI 10.1093/nar/gkh429; Jain A, 2008, FEMS IMMUNOL MED MIC, V53, P145, DOI 10.1111/j.1574-695X.2008.00400.x; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P67, DOI 10.1107/S0021889887009737; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB; Lewandowicz A, 2003, J BIOL CHEM, V278, P31465, DOI 10.1074/jbc.C300259200; Lu H, 2008, ACCOUNTS CHEM RES, V41, P11, DOI 10.1021/ar700156e; Lu H, 2009, ACS CHEM BIOL, V4, P221, DOI 10.1021/cb800306y; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McMurry LM, 1998, NATURE, V394, P531, DOI 10.1038/28970; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Parikh S, 1999, BIOCHEMISTRY-US, V38, P13623, DOI 10.1021/bi990529c; Parikh SL, 2000, BIOCHEMISTRY-US, V39, P7645, DOI 10.1021/bi0008940; Rafi SB, 2006, J MED CHEM, V49, P4574, DOI 10.1021/jm060222t; Rawat R, 2003, P NATL ACAD SCI USA, V100, P13881, DOI 10.1073/pnas.2235848100; Rozwarski DA, 1999, J BIOL CHEM, V274, P15582, DOI 10.1074/jbc.274.22.15582; Sivaraman S, 2004, J MED CHEM, V47, P509, DOI 10.1021/jm030182i; Sullivan TJ, 2006, ACS CHEM BIOL, V1, P43, DOI 10.1021/cb0500042; Tummino PJ, 2008, BIOCHEMISTRY-US, V47, P5481, DOI 10.1021/bi8002023; Vilcheze C, 2000, J BACTERIOL, V182, P4059, DOI 10.1128/JB.182.14.4059-4067.2000; Vilcheze C, 2006, NAT MED, V12, P1027, DOI 10.1038/nm1466; Ward WHJ, 1999, BIOCHEMISTRY-US, V38, P12514, DOI 10.1021/bi9907779; *WHO, 2007, WHO REP; WILLIAMS JW, 1979, BIOCHEMISTRY-US, V18, P2567, DOI 10.1021/bi00579a021; ZHANG Y, 1992, NATURE, V358, P591, DOI 10.1038/358591a0	34	138	145	2	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14330	14337		10.1074/jbc.M109.090373	http://dx.doi.org/10.1074/jbc.M109.090373			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20200152	Green Published, hybrid			2022-12-25	WOS:000277299700030
J	Nho, RS; Kahm, J				Nho, Richard Seonghun; Kahm, Judy			beta 1-Integrin-Collagen Interaction Suppresses FoxO3a by the Coordination of Akt and PP2A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR FKHR; COLLAGEN MATRIX CONTRACTION; PROTEIN-KINASE B; EXTRACELLULAR-MATRIX; CELL-PROLIFERATION; SIGNALING PATHWAY; IN-VITRO; EPITHELIAL-CELLS; DOWN-REGULATION; CYCLIN-D	When cells attach to the extracellular matrix (ECM) a proliferation permissive signal is engaged. The mechanism involves activation of the integrin/PI3K/Akt signal pathway. FoxO3a is a transcriptional activator and inhibits cell proliferation via up-regulating the expression of the cell cycle inhibitor p27. Furthermore, it is known that activated Akt can suppress FoxO3a function. However, it is not known whether integrin interaction with the ECM regulates FoxO3a function. We examined whether the beta 1-integrin-mediated signaling pathway promotes fibroblast proliferation via FoxO3a suppression. We found that when fibroblasts are attached to collagen, PTEN protein expression and activity are inhibited due to promotion of PTEN degradation. This decrease in PTEN function permits FoxO3a suppression via the PI3K/Akt pathway. In contrast, the inhibition of PI3K/Akt or reconstitution of PTEN restores FoxO3a expression on collagen. Furthermore, we found that the serine/threonine phosphatase PP2A also regulates FoxO3a. PP2A expression/activity is low when fibroblasts are attached to collagen, and PP2A overexpression augments FoxO3a levels. Thus the mechanism involves a coordinated decrease in PTEN and PP2A phosphatase activity and increase in PI3K/Akt activity. We show that beta 1-integrin-ECM interaction decreases FoxO3a protein levels via caspase-3-mediated cleavage. Our novel finding indicates that during fibroblast interaction with ECM, activation of beta 1-integrin/PI3K/Akt by inhibiting PTEN in combination with low PP2A phosphatase activity synergistically inhibits FoxO3a, promoting fibroblast proliferation.	[Nho, Richard Seonghun; Kahm, Judy] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Nho, RS (corresponding author), Univ Minnesota, Dept Med, Box 276,420 Delaware St SE, Minneapolis, MN 55455 USA.	nhoxx002@umn.edu			American Heart Association; American Lung Association	American Heart Association(American Heart Association); American Lung Association	This work was supported by Scientist Development and Pulmonary Fibrosis Research grants from the American Heart Association and the American Lung Association (to R. S. N.).	Aoshiba K, 1997, AM J PHYSIOL-LUNG C, V272, pL28, DOI 10.1152/ajplung.1997.272.1.L28; Behzad H, 2007, CYTOKINE, V38, P74, DOI 10.1016/j.cyto.2007.05.004; Bertoli C, 2009, ONCOGENE, V28, P721, DOI 10.1038/onc.2008.425; Brunet A, 2001, MOL CELL BIOL, V21, P952, DOI 10.1128/MCB.21.3.952-965.2001; Chahdi A, 2008, MOL BIOL CELL, V19, P2609, DOI 10.1091/mbc.E07-05-0424; Choe G, 2003, CANCER RES, V63, P2742; Depraetere H, 1997, THROMB HAEMOSTASIS, V77, P981; Diao LR, 2007, CELL RES, V17, P291, DOI 10.1038/cr.2007.24; Fu W, 2009, J BIOL CHEM, V284, P13987, DOI 10.1074/jbc.M901758200; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; Jokinen J, 2004, J BIOL CHEM, V279, P31956, DOI 10.1074/jbc.M401409200; Khwaja A, 1997, EMBO J, V16, P2783, DOI 10.1093/emboj/16.10.2783; Kuo YC, 2008, J BIOL CHEM, V283, P1882, DOI 10.1074/jbc.M709585200; Lee JW, 2000, MOL BIOL CELL, V11, P1973, DOI 10.1091/mbc.11.6.1973; Liu XP, 1997, EXP EYE RES, V65, P117, DOI 10.1006/exer.1997.0317; Nakae J, 1999, J BIOL CHEM, V274, P15982, DOI 10.1074/jbc.274.23.15982; Nakae J, 2000, EMBO J, V19, P989, DOI 10.1093/emboj/19.5.989; Nakao T, 2008, CELL CYCLE, V7, P257, DOI 10.4161/cc.7.2.5148; Nho RS, 2006, J BIOL CHEM, V281, P33291, DOI 10.1074/jbc.M606450200; Nho RS, 2005, J BIOL CHEM, V280, P26630, DOI 10.1074/jbc.M411798200; Radu A, 2003, MOL CELL BIOL, V23, P6139, DOI 10.1128/MCB.23.17.6139-6149.2003; Rena G, 1999, J BIOL CHEM, V274, P17179, DOI 10.1074/jbc.274.24.17179; Schmidt M, 2002, MOL CELL BIOL, V22, P7842, DOI 10.1128/MCB.22.22.7842-7852.2002; Singh A, 2010, MOL BIOL CELL, V21, P1140, DOI 10.1091/mbc.E09-09-0795; Tang ED, 1999, J BIOL CHEM, V274, P16741, DOI 10.1074/jbc.274.24.16741; Tian B, 2002, J BIOL CHEM, V277, P24667, DOI 10.1074/jbc.M203565200; Upadhyay J, 2003, J UROLOGY, V169, P750, DOI 10.1016/S0022-5347(05)64007-4; Valiente M, 2005, J BIOL CHEM, V280, P28936, DOI 10.1074/jbc.M504761200; Wallner EI, 1998, AM J PHYSIOL-RENAL, V275, pF467, DOI 10.1152/ajprenal.1998.275.4.F467; Xia H, 2008, J EXP MED, V205, P1659, DOI 10.1084/jem.20080001; Xia H, 2008, J BIOL CHEM, V283, P20350, DOI 10.1074/jbc.M707489200; Yang JY, 2008, NAT CELL BIOL, V10, P138, DOI 10.1038/ncb1676; Yang JY, 2006, INT J ONCOL, V29, P643; Yang WS, 2008, NAT CELL BIOL, V10, P125, DOI 10.1038/ncb0208-125; Yusuf I, 2004, BLOOD, V104, P784, DOI 10.1182/blood-2003-09-3071; Zhao YM, 2008, EUR J HAEMATOL, V81, P83, DOI 10.1111/j.1600-0609.2008.01077.x; Zheng WH, 2000, J BIOL CHEM, V275, P39152, DOI 10.1074/jbc.M002417200	37	19	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14195	14209		10.1074/jbc.M109.052845	http://dx.doi.org/10.1074/jbc.M109.052845			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20223831	Green Published, hybrid			2022-12-25	WOS:000277299700016
J	Compton, SA; Ozgur, S; Griffith, JD				Compton, Sarah A.; Ozgur, Sezgin; Griffith, Jack D.			Ring-shaped Rad51 Paralog Protein Complexes Bind Holliday Junctions and Replication Forks as Visualized by Electron Microscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRAND BREAK REPAIR; HOMOLOGOUS RECOMBINATION; NUCLEOPROTEIN FILAMENT; IONIZING-RADIATION; DNA-DAMAGE; IN-VIVO; XRCC3; CELLS; MICE; IDENTIFICATION	In mammals, there are five Rad51 paralogs that form two distinct complexes in vivo. One complex is composed of Rad51B-Rad51C-Rad51D-Xrcc2 (BCDX2) and the other Rad51C-Xrcc3 (CX3). We co-expressed and purified human BCDX2 and CX3 protein complexes from insect cells and investigated their binding preferences and structure using transmission electron microscopy (TEM). We visualized the binding of BCDX2 and CX3 to DNA templates containing replication forks and Holliday junctions, intermediates observed during DNA replication and recombination, respectively. We show that both complexes bind with exceptionally high specificity to the DNA junctions with little binding observed elsewhere on the DNAs. Further analysis of the structure of free or DNA-bound BCDX2 and CX3 complexes revealed a multimeric ring structure whose subunits are arranged into a flat disc around a central channel. This work provides the first EM visualization of BCDX2 and CX3 binding to Holliday junctions and forked DNAs and suggests the complexes form ring-shaped structures.	[Compton, Sarah A.; Ozgur, Sezgin; Griffith, Jack D.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Compton, SA (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, CB 7295,Mason Farm Rd, Chapel Hill, NC 27599 USA.	compton@med.unc.edu			National Institutes of Health [GM077900, GM31819, ES013773]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES013773] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM077900, R01GM031819] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Postdoctoral Fellowship Grant GM077900 (to S. A. C.) and Grants GM31819 and ES013773 (to J. D. G.).	Alani E, 1997, J MOL BIOL, V265, P289, DOI 10.1006/jmbi.1996.0743; Alexeev A, 2003, NAT STRUCT BIOL, V10, P182, DOI 10.1038/nsb901; Benson FE, 1998, NATURE, V391, P401, DOI 10.1038/34937; Bishop DK, 1998, J BIOL CHEM, V273, P21482, DOI 10.1074/jbc.273.34.21482; Braybrooke JP, 2003, J BIOL CHEM, V278, P48357, DOI 10.1074/jbc.M308838200; Cousineau I, 2005, CANCER RES, V65, P11384, DOI 10.1158/0008-5472.CAN-05-2156; Deans B, 2003, CANCER RES, V63, P8181; FOWLER WE, 1979, J MOL BIOL, V134, P241, DOI 10.1016/0022-2836(79)90034-2; FULLER LF, 1988, MUTAT RES, V193, P109, DOI 10.1016/0167-8817(88)90041-7; Griffith JD, 2002, J BIOL CHEM, V277, P15233, DOI 10.1074/jbc.C200129200; Henry-Mowatt J, 2003, MOL CELL, V11, P1109, DOI 10.1016/S1097-2765(03)00132-1; Jang YK, 1996, MOL GEN GENET, V251, P167; JONES NJ, 1987, MUTAT RES, V183, P279, DOI 10.1016/0167-8817(87)90011-3; Kurumizaka H, 2002, J BIOL CHEM, V277, P14315, DOI 10.1074/jbc.M105719200; Kurumizaka H, 2001, P NATL ACAD SCI USA, V98, P5538, DOI 10.1073/pnas.091603098; Lee SM, 1997, J BIOL CHEM, V272, P7532, DOI 10.1074/jbc.272.11.7532; Liu YL, 2004, SCIENCE, V303, P243, DOI 10.1126/science.1093037; Masson JY, 2001, GENE DEV, V15, P3296, DOI 10.1101/gad.947001; Masson JY, 2001, P NATL ACAD SCI USA, V98, P8440, DOI 10.1073/pnas.111005698; Mazin AV, 2000, MOL CELL, V6, P583, DOI 10.1016/S1097-2765(00)00057-5; Pittman DL, 2000, GENESIS, V26, P167, DOI 10.1002/(SICI)1526-968X(200003)26:3<167::AID-GENE1>3.0.CO;2-M; Shinohara M, 2000, P NATL ACAD SCI USA, V97, P10814, DOI 10.1073/pnas.97.20.10814; SHOTTON DM, 1979, J MOL BIOL, V131, P303, DOI 10.1016/0022-2836(79)90078-0; Shu ZG, 1999, MOL CELL BIOL, V19, P8686; Stansel RM, 2001, EMBO J, V20, P5532; Stasiak AZ, 2000, CURR BIOL, V10, P337, DOI 10.1016/S0960-9822(00)00385-7; Sung P, 2003, J BIOL CHEM, V278, P42729, DOI 10.1074/jbc.R300027200; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; Takata M, 2000, MOL CELL BIOL, V20, P6476, DOI 10.1128/MCB.20.17.6476-6482.2000; Takata M, 2001, MOL CELL BIOL, V21, P2858, DOI 10.1128/MCB.21.8.2858-2866.2001; Thacker J, 2004, DNA REPAIR, V3, P1081, DOI 10.1016/j.dnarep.2004.04.012; Yokoyama H, 2004, NUCLEIC ACIDS RES, V32, P2556, DOI 10.1093/nar/gkh578; Yokoyama H, 2003, J BIOL CHEM, V278, P2767, DOI 10.1074/jbc.M210899200; Yuan SSF, 1999, CANCER RES, V59, P3547	34	25	31	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13349	13356		10.1074/jbc.M109.074286	http://dx.doi.org/10.1074/jbc.M109.074286			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20207730	hybrid, Green Published			2022-12-25	WOS:000276987700005
J	Mak, SK; McCormack, AL; Manning-Bog, AB; Cuervo, AM; Di Monte, DA				Mak, Sally K.; McCormack, Alison L.; Manning-Bog, Amy B.; Cuervo, Ana Maria; Di Monte, Donato A.			Lysosomal Degradation of alpha-Synuclein in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHAPERONE-MEDIATED AUTOPHAGY; RAT-LIVER LYSOSOMES; OXIDATIVE STRESS; PARKINSONS-DISEASE; HERBICIDE PARAQUAT; SELECTIVE UPTAKE; DEGENERATION; CLEARANCE; PROTEINS; NEURODEGENERATION	Pathologic accumulation of alpha-synuclein is a feature of human parkinsonism and other neurodegenerative diseases. This accumulation may be counteracted by mechanisms of protein degradation that have been investigated in vitro but remain to be elucidated in animal models. In this study, lysosomal clearance of alpha-synuclein in vivo was indicated by the detection of alpha-synuclein in the lumen of lysosomes isolated from the mouse midbrain. When neuronal alpha-synuclein expression was enhanced as a result of toxic injury (i.e. treatment of mice with the herbicide paraquat) or transgenic protein overexpression, the intralysosomal content of alpha-synuclein was also significantly increased. This effect was paralleled by a marked elevation of the lysosome-associated membrane protein type 2A (LAMP-2A) and the lysosomal heat shock cognate protein of 70 kDa (hsc70), two essential components of chaperone-mediated autophagy (CMA). Immunofluorescence microscopy revealed an increase in punctate (lysosomal) LAMP-2A staining that co-localized with alpha-synuclein within nigral dopaminergic neurons of paraquat-treated and alpha-synuclein-overexpressing animals. The data provide in vivo evidence of lysosomal degradation of alpha-synuclein under normal conditions and, quite importantly, under conditions of enhanced protein burden. In the latter, increased lysosomal clearance of alpha-synuclein was mediated, at least in part, by CMA induction. It is conceivable that these neuronal mechanisms of protein clearance play an important role in neurodegenerative processes characterized by abnormal alpha-synuclein buildup.	[Mak, Sally K.] Parkinsons Inst, Sunnyvale, CA 94085 USA; [McCormack, Alison L.; Manning-Bog, Amy B.; Di Monte, Donato A.] SRI Int, Ctr Hlth Sci, Menlo Pk, CA 94025 USA; [Cuervo, Ana Maria] Albert Einstein Coll Med, Bronx, NY 10461 USA	SRI International; Yeshiva University; Albert Einstein College of Medicine	Di Monte, DA (corresponding author), 333 Ravenswood Ave, Menlo Pk, CA 94025 USA.	donato.dimonte@sri.com		Di Monte, Donato/0000-0002-8296-836X; Cuervo, Ana Maria/0000-0002-0771-700X	National Institutes of Health [ES12077]; Backus Foundation; Parkinson's Disease Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U54ES012077] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Backus Foundation; Parkinson's Disease Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant ES12077, the Backus Foundation, and the Parkinson's Disease Foundation.	ANIENTO F, 1993, J BIOL CHEM, V268, P10463; Bennett MC, 1999, J BIOL CHEM, V274, P33855, DOI 10.1074/jbc.274.48.33855; Chandra S, 2005, CELL, V123, P383, DOI 10.1016/j.cell.2005.09.028; CHIANG HL, 1989, SCIENCE, V246, P382, DOI 10.1126/science.2799391; Cuervo AM, 2000, TRAFFIC, V1, P570, DOI 10.1034/j.1600-0854.2000.010707.x; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Cuervo AM, 1997, J BIOL CHEM, V272, P5606, DOI 10.1074/jbc.272.9.5606; Cuervo AM, 2000, J CELL SCI, V113, P4441; CUERVO AM, 1995, AM J PHYSIOL-CELL PH, V269, pC1200, DOI 10.1152/ajpcell.1995.269.5.C1200; Cuervo AM, 1996, SCIENCE, V273, P501, DOI 10.1126/science.273.5274.501; Eslamboli A, 2007, BRAIN, V130, P799, DOI 10.1093/brain/awl382; Farrer M, 2004, ANN NEUROL, V55, P174, DOI 10.1002/ana.10846; Kiffin R, 2004, MOL BIOL CELL, V15, P4829, DOI 10.1091/mbc.E04-06-0477; Lee HJ, 2004, J NEUROSCI, V24, P1888, DOI 10.1523/JNEUROSCI.3809-03.2004; Lo BC, 2002, P NATL ACAD SCI USA, V99, P10813; Manning-Bog AB, 2003, J NEUROSCI, V23, P3095; Manning-Bog AB, 2002, J BIOL CHEM, V277, P1641, DOI 10.1074/jbc.C100560200; Martinez-Vicente M, 2008, J CLIN INVEST, V118, P777, DOI 10.1172/JCI32806; Massey AC, 2006, P NATL ACAD SCI USA, V103, P5805, DOI 10.1073/pnas.0507436103; Massey AC, 2006, CURR TOP DEV BIOL, V73, P205, DOI 10.1016/S0070-2153(05)73007-6; McCormack AL, 2006, NEUROSCIENCE, V141, P929, DOI 10.1016/j.neuroscience.2006.03.069; McCormack AL, 2005, J NEUROCHEM, V93, P1030, DOI 10.1111/j.1471-4159.2005.03088.x; McCormack AL, 2002, NEUROBIOL DIS, V10, P119, DOI 10.1006/nbdi.2002.0507; McCormack AL, 2008, J NEUROPATH EXP NEUR, V67, P793, DOI 10.1097/NEN.0b013e318180f0bd; OHSUMI Y, 1983, J BIOCHEM, V93, P547; Sarkar S, 2007, J BIOL CHEM, V282, P5641, DOI 10.1074/jbc.M609532200; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Vogiatzi T, 2008, J BIOL CHEM, V283, P23542, DOI 10.1074/jbc.M801992200; WATTIAUX R, 1978, J CELL BIOL, V78, P349, DOI 10.1083/jcb.78.2.349; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Yu WH, 2009, AM J PATHOL, V175, P736, DOI 10.2353/ajpath.2009.080928; Zhang C, 2008, NAT MED, V14, P959, DOI 10.1038/nm.1851	32	258	261	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13621	13629		10.1074/jbc.M109.074617	http://dx.doi.org/10.1074/jbc.M109.074617			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20200163	Green Published, hybrid			2022-12-25	WOS:000276987700036
J	Chen, SH; Albuquerque, CP; Liang, J; Suhandynata, RT; Zhou, HL				Chen, Sheng-hong; Albuquerque, Claudio P.; Liang, Jason; Suhandynata, Raymond T.; Zhou, Huilin			A Proteome-wide Analysis of Kinase-Substrate Network in the DNA Damage Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; CHECKPOINT KINASE; IN-VIVO; RAD53 PHOSPHORYLATION; REPLICATION FORKS; GENOME STABILITY; C-TERMINUS; ATM; YEAST; PATHWAYS	The DNA damage checkpoint, consisting of an evolutionarily conserved protein kinase cascade, controls the DNA damage response in eukaryotes. Knowledge of the in vivo substrates of the checkpoint kinases is essential toward understanding their functions. Here we used quantitative mass spectrometry to identify 53 new and 34 previously known targets of Mec1/Tel1, Rad53, and Dun1 in Saccharomyces cerevisiae. Analysis of replication protein A (RPA)-associated proteins reveals extensive physical interactions between RPA-associated proteins and Mec1/Tel1-specific substrates. Among them, multiple subunits of the chromatin remodeling complexes including ISW1, ISW2, INO80, SWR1, RSC, and SWI/SNF are identified and they undergo DNA damage-induced phosphorylation by Mec1 and Tel1. Taken together, this study greatly expands the existing knowledge of the targets of DNA damage checkpoint kinases and provides insights into the role of RPA-associated chromatins in mediating Mec1 and Tel1 substrate phosphorylation in vivo.	Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Zhou, Huilin] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego	Zhou, HL (corresponding author), CMM E, Rm 2070,9500 Gilman Dr, La Jolla, CA 92093 USA.	huzhou@ucsd.edu	Chen, Sheng-hong/AAU-4018-2021	Chen, Sheng-hong/0000-0002-7722-2221; Zhou, Huilin/0000-0002-1350-4430	National Institutes of Health [GM080463]; Ludwig Institute for Cancer Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080469] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ludwig Institute for Cancer Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM080463 and the Ludwig Institute for Cancer Research.	Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Albuquerque CP, 2008, MOL CELL PROTEOMICS, V7, P1389, DOI 10.1074/mcp.M700468-MCP200; Bashkirov VI, 2003, MOL CELL BIOL, V23, P1441, DOI 10.1128/MCB.23.4.1441-1452.2003; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Bodenmiller B, 2007, NAT METHODS, V4, P231, DOI 10.1038/nmeth1005; Brush GS, 1996, P NATL ACAD SCI USA, V93, P15075, DOI 10.1073/pnas.93.26.15075; Cartagena-Lirola H, 2006, CELL CYCLE, V5, P1549, DOI 10.4161/cc.5.14.2916; Chai B, 2005, GENE DEV, V19, P1656, DOI 10.1101/gad.1273105; Chen SH, 2007, J BIOL CHEM, V282, P986, DOI 10.1074/jbc.M609322200; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; COLE GM, 1989, MOL CELL BIOL, V9, P3314, DOI 10.1128/MCB.9.8.3314; Craven RJ, 2002, GENETICS, V161, P493; Desany BA, 1998, GENE DEV, V12, P2956, DOI 10.1101/gad.12.18.2956; Downs JA, 2000, NATURE, V408, P1001, DOI 10.1038/35050000; Emili A, 1998, MOL CELL, V2, P183, DOI 10.1016/S1097-2765(00)80128-8; Falck J, 2005, NATURE, V434, P605, DOI 10.1038/nature03442; GREENWELL PW, 1995, CELL, V82, P823, DOI 10.1016/0092-8674(95)90479-4; Harrison JC, 2006, ANNU REV GENET, V40, P209, DOI 10.1146/annurev.genet.40.051206.105231; Huang MX, 1998, CELL, V94, P595, DOI 10.1016/S0092-8674(00)81601-3; Kim ST, 1999, J BIOL CHEM, V274, P37538, DOI 10.1074/jbc.274.53.37538; Kolodner RD, 2002, SCIENCE, V297, P552, DOI 10.1126/science.1075277; Lee SJ, 2003, MOL CELL BIOL, V23, P6300, DOI 10.1128/MCB.23.17.6300-6314.2003; Liang B, 2007, CURR BIOL, V17, P1432, DOI 10.1016/j.cub.2007.07.035; Lopes M, 2001, NATURE, V412, P557, DOI 10.1038/35087613; Mallory JC, 2000, P NATL ACAD SCI USA, V97, P13749, DOI 10.1073/pnas.250475697; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Morin I, 2008, EMBO J, V27, P2400, DOI 10.1038/emboj.2008.171; Morrison AJ, 2004, CELL, V119, P767, DOI 10.1016/j.cell.2004.11.037; Morrison AJ, 2007, CELL, V130, P499, DOI 10.1016/j.cell.2007.06.010; Morrison AJ, 2009, NAT REV MOL CELL BIO, V10, P373, DOI 10.1038/nrm2693; Myung KJ, 2001, CELL, V104, P397, DOI 10.1016/S0092-8674(01)00227-6; Nakada D, 2005, MOL BIOL CELL, V16, P5227, DOI 10.1091/mbc.E05-05-0405; Nyberg KA, 2002, ANNU REV GENET, V36, P617, DOI 10.1146/annurev.genet.36.060402.113540; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Osborn AJ, 2003, GENE DEV, V17, P1755, DOI 10.1101/gad.1098303; Putnam CD, 2009, NATURE, V460, P984, DOI 10.1038/nature08217; Roberts TM, 2006, MOL BIOL CELL, V17, P539, DOI 10.1091/mbc.E05-08-0785; Sanchez Y, 1996, SCIENCE, V271, P357, DOI 10.1126/science.271.5247.357; Sanchez Y, 1999, SCIENCE, V286, P1166, DOI 10.1126/science.286.5442.1166; Segurado M, 2008, GENE DEV, V22, P1816, DOI 10.1101/gad.477208; Shim EY, 2005, MOL CELL BIOL, V25, P3934, DOI 10.1128/MCB.25.10.3934-3944.2005; Smolka MB, 2007, P NATL ACAD SCI USA, V104, P10364, DOI 10.1073/pnas.0701622104; Stokes MP, 2007, P NATL ACAD SCI USA, V104, P19855, DOI 10.1073/pnas.0707579104; Sun ZX, 1996, GENE DEV, V10, P395, DOI 10.1101/gad.10.4.395; Tanaka K, 2001, NAT CELL BIOL, V3, P966, DOI 10.1038/ncb1101-966; Tseng SF, 2006, NUCLEIC ACIDS RES, V34, P6327, DOI 10.1093/nar/gkl786; Usui T, 2001, MOL CELL, V7, P1255, DOI 10.1016/S1097-2765(01)00270-2; You ZS, 2005, MOL CELL BIOL, V25, P5363, DOI 10.1128/MCB.25.13.5363-5379.2005; Zhao XL, 1998, MOL CELL, V2, P329, DOI 10.1016/S1097-2765(00)80277-4; Zhao XL, 2002, P NATL ACAD SCI USA, V99, P3746, DOI 10.1073/pnas.062502299; ZHOU Z, 1993, CELL, V75, P1119, DOI 10.1016/0092-8674(93)90321-G; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	55	96	97	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12803	12812		10.1074/jbc.M110.106989	http://dx.doi.org/10.1074/jbc.M110.106989			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20190278	Green Published, hybrid			2022-12-25	WOS:000276787800038
J	Meloni, A; Fiorillo, E; Corda, D; Incani, F; Serra, ML; Contini, A; Cao, A; Rosatelli, MC				Meloni, Allesandra; Fiorillo, Edoardo; Corda, Denise; Incani, Federica; Serra, Maria Luisa; Contini, Antonella; Cao, Antonio; Rosatelli, Maria Cristina			DAXX Is a New AIRE-interacting Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUTOIMMUNE REGULATOR PROTEIN; CREB-BINDING PROTEIN; TRANSCRIPTIONAL ACTIVITY; PHD FINGER; IMMUNOLOGICAL-TOLERANCE; FUNCTIONAL DOMAINS; GENE-EXPRESSION; CHROMATIN; APOPTOSIS; COMPLEX	The AIRE protein plays a remarkable role as a regulator of central tolerance by controlling the promiscuous expression of tissue-specific antigens in thymic medullary epithelial cells. Defects in the AIRE gene cause the autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy, a rare disease frequent in Iranian Jews, Finns, and Sardinian population. To this day, the precise function of the AIRE protein in regulating transcription and its interacting proteins has yet to be entirely clarified. The knowledge of novel AIRE interactors and their precise role will improve our knowledge of its biological activity and address some of the foremost autoimmunity-related questions. In this study, we have used a yeast two-hybrid system to identify AIRE-interacting proteins. This approach led us to the discovery of a new AIRE-interacting protein called DAXX. The protein is known to be a multifunctional adaptor with functions both in apoptosis and in transcription regulation pathways. The interaction between AIRE and DAXX has been validated by in vivo coimmunoprecipitation analysis and colocalization study in mammalian cells. The interaction has been further confirmed by showing in transactivation assays that DAXX exerts a strong repressive role on the transcriptional activity of AIRE.	[Fiorillo, Edoardo; Corda, Denise; Incani, Federica; Serra, Maria Luisa; Contini, Antonella; Rosatelli, Maria Cristina] Univ Cagliari, Dept Sci Biomed & Biotecnol, I-09121 Cagliari, Italy; [Meloni, Allesandra; Cao, Antonio] Univ Cagliari, CNR, Ist Neurogenet & Neurofarmacol, I-09121 Cagliari, Italy	University of Cagliari; Consiglio Nazionale delle Ricerche (CNR); University of Cagliari	Rosatelli, MC (corresponding author), Univ Cagliari, Dept Sci Biomed & Biotecnol, Via Jenner S-N, I-09121 Cagliari, Italy.	rosatelli@unica.it	Fiorillo, Edoardo/AAY-3804-2020	incani, federica/0000-0003-2699-8035; ROSATELLI, MARIA CRISTINA/0000-0001-6821-3190	EURAPS [2006-2008]; Sardinian Regional Government	EURAPS; Sardinian Regional Government(Regione Sardegna)	This work was supported in part by grants from the Community Sixth Framework Programme, Project "EURAPS"-Autoimmune Polyendocrine Syndrome Type I, 2006-2008.; Supported by "Master and Back" fellowship from the Sardinian Regional Government.	AASLAND R, 1995, TRENDS BIOCHEM SCI, V20, P56, DOI 10.1016/S0968-0004(00)88957-4; Abramson J, 2010, CELL, V140, P123, DOI 10.1016/j.cell.2009.12.030; Agger K, 2008, CURR OPIN GENET DEV, V18, P159, DOI 10.1016/j.gde.2007.12.003; AHONEN P, 1990, NEW ENGL J MED, V322, P1829, DOI 10.1056/NEJM199006283222601; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Bjorses P, 2000, AM J HUM GENET, V66, P378, DOI 10.1086/302765; Bottomley MJ, 2005, J BIOL CHEM, V280, P11505, DOI 10.1074/jbc.M413959200; Bouchier-Hayes L, 2002, EMBO REP, V3, P616, DOI 10.1093/embo-reports/kvf139; Chang CC, 2005, J BIOL CHEM, V280, P10164, DOI 10.1074/jbc.M409161200; De Santa F, 2007, CELL, V130, P1083, DOI 10.1016/j.cell.2007.08.019; Derbinski J, 2005, J EXP MED, V202, P33, DOI 10.1084/jem.20050471; Ferguson BJ, 2008, J BIOL CHEM, V283, P1723, DOI 10.1074/jbc.M707211200; Gavanescu I, 2007, P NATL ACAD SCI USA, V104, P4583, DOI 10.1073/pnas.0700259104; Gibson TJ, 1998, TRENDS BIOCHEM SCI, V23, P242, DOI 10.1016/S0968-0004(98)01231-6; Gu HD, 2009, J VIROL, V83, P4376, DOI 10.1128/JVI.02515-08; Halonen M, 2004, HUM MUTAT, V23, P245, DOI 10.1002/humu.20003; Hayakawa T, 2007, GENES CELLS, V12, P811, DOI 10.1111/j.1365-2443.2007.01089.x; Hiscott J, 2006, TRENDS MOL MED, V12, P53, DOI 10.1016/j.molmed.2005.12.003; Hollenbach AD, 1999, EMBO J, V18, P3702, DOI 10.1093/emboj/18.13.3702; Hollenbach AD, 2002, J CELL SCI, V115, P3319; Hong GS, 2002, J BIOCHEM MOL BIOL, V35, P19; Ilmarinen T, 2006, FEBS J, V273, P315, DOI 10.1111/j.1742-4658.2005.05065.x; Ilmarinen T, 2008, MOL IMMUNOL, V45, P1847, DOI 10.1016/j.molimm.2007.10.045; Ishov AM, 1999, J CELL BIOL, V147, P221, DOI 10.1083/jcb.147.2.221; Klose RJ, 2006, NATURE, V442, P312, DOI 10.1038/nature04853; Koh AS, 2008, P NATL ACAD SCI USA, V105, P15878, DOI 10.1073/pnas.0808470105; Kuo HY, 2005, P NATL ACAD SCI USA, V102, P16973, DOI 10.1073/pnas.0504460102; Lalioti VS, 2002, J BIOL CHEM, V277, P19783, DOI 10.1074/jbc.M110294200; Li H, 2000, MOL CELL BIOL, V20, P1784, DOI 10.1128/MCB.20.5.1784-1796.2000; Li RZ, 2000, ONCOGENE, V19, P745, DOI 10.1038/sj.onc.1203385; Liiv I, 2008, BBA-MOL CELL RES, V1783, P74, DOI 10.1016/j.bbamcr.2007.09.003; Lin DY, 2004, MOL CELL BIOL, V24, P10529, DOI 10.1128/MCB.24.24.10529-10541.2004; Lin DY, 2003, J BIOL CHEM, V278, P15958, DOI 10.1074/jbc.M300387200; Liston A, 2003, NAT IMMUNOL, V4, P350, DOI 10.1038/ni906; Martinon F, 2004, CELL, V117, P561, DOI 10.1016/j.cell.2004.05.004; Meloni A, 2002, J CLIN ENDOCR METAB, V87, P841, DOI 10.1210/jc.87.2.841; Meloni A, 2008, MOL IMMUNOL, V45, P805, DOI 10.1016/j.molimm.2007.06.156; Michaelson JS, 1999, GENE DEV, V13, P1918, DOI 10.1101/gad.13.15.1918; Mittaz L, 1999, BIOCHEM BIOPH RES CO, V255, P483, DOI 10.1006/bbrc.1999.0223; Muromoto R, 2004, BIOCHEM BIOPH RES CO, V316, P827, DOI 10.1016/j.bbrc.2004.02.126; Org T, 2008, EMBO REP, V9, P370, DOI [10.1038/embor.2008.11, 10.1038/sj.embor.2008.11]; Org T, 2009, HUM MOL GENET, V18, P4699, DOI 10.1093/hmg/ddp433; Park J, 2007, J MOL BIOL, V368, P388, DOI 10.1016/j.jmb.2007.02.047; Pasini D, 2008, GENE DEV, V22, P1345, DOI 10.1101/gad.470008; Perheentupa J, 2002, ENDOCRIN METAB CLIN, V31, P295, DOI 10.1016/S0889-8529(01)00013-5; Perheentupa J, 1999, ANN MED INTERNE, V150, P313; Pitkanen J, 2005, BIOCHEM BIOPH RES CO, V333, P944, DOI 10.1016/j.bbrc.2005.05.187; Pitkanen J, 2000, J BIOL CHEM, V275, P16802, DOI 10.1074/jbc.M908944199; Ramsey C, 2002, HUM MOL GENET, V11, P3299, DOI 10.1093/hmg/11.26.3299; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Tang J, 2004, J BIOL CHEM, V279, P20369, DOI 10.1074/jbc.M401321200; Tao YX, 2006, MOL IMMUNOL, V43, P335, DOI 10.1016/j.molimm.2005.02.018; Tonooka A, 2009, BIOCHEM BIOPH RES CO, V379, P765, DOI 10.1016/j.bbrc.2008.12.123; Uchida D, 2004, J EXP MED, V199, P167, DOI 10.1084/jem.20031291; Xue YT, 2003, P NATL ACAD SCI USA, V100, P10635, DOI 10.1073/pnas.1937626100; Yang XL, 1997, CELL, V89, P1067, DOI 10.1016/S0092-8674(00)80294-9; Zhao LY, 2004, J BIOL CHEM, V279, P50566, DOI 10.1074/jbc.M406743200; Zhao LY, 2003, J VIROL, V77, P11809, DOI 10.1128/JVI.77.21.11809-11821.2003; Zhong S, 2000, J EXP MED, V191, P631, DOI 10.1084/jem.191.4.631	59	16	18	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					13012	13021		10.1074/jbc.M109.037747	http://dx.doi.org/10.1074/jbc.M109.037747			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20185822	Green Published, hybrid			2022-12-25	WOS:000276787800059
J	Baur, F; Nau, K; Sadic, D; Allweiss, L; Elsasser, HP; Gillemans, N; de Wit, T; Kruger, I; Vollmer, M; Philipsen, S; Suske, G				Baur, Frank; Nau, Kerstin; Sadic, Dennis; Allweiss, Lena; Elsaesser, Hans-Peter; Gillemans, Nynke; de Wit, Ton; Krueger, Imme; Vollmer, Marion; Philipsen, Sjaak; Suske, Guntram			Specificity Protein 2 (Sp2) Is Essential for Mouse Development and Autonomous Proliferation of Mouse Embryonic Fibroblasts	PLOS ONE			English	Article							TRANSCRIPTION FACTOR SP3; BOX-BINDING-PROTEINS; CRE RECOMBINASE; EXPRESSION PATTERN; TRANSGENIC MOUSE; MAMMALIAN-CELLS; GENE-EXPRESSION; MICE; FAMILY; GROWTH	Background: The zinc finger protein Sp2 (specificity protein 2) is a member of the glutamine-rich Sp family of transcription factors. Despite its close similarity to Sp1, Sp3 and Sp4, Sp2 does not bind to DNA or activate transcription when expressed in mammalian cell lines. The expression pattern and the biological relevance of Sp2 in the mouse are unknown. Methodology/Principal Findings: Whole-mount in situ hybridization of mouse embryos between E7.5 and E9.5 revealed abundant expression in most embryonic and extra-embryonic tissues. In order to unravel the biological relevance of Sp2, we have targeted the Sp2 gene by a tri-loxP strategy. Constitutive Sp2null and conditional Sp2cko knockout alleles were obtained by crossings with appropriate Cre recombinase expressing mice. Constitutive disruption of the mouse Sp2 gene (Sp2null) resulted in severe growth retardation and lethality before E9.5. Mouse embryonic fibroblasts (MEFs) derived from Sp2null embryos at E9.5 failed to grow. Cre-mediated ablation of Sp2 in Sp2cko/cko MEFs obtained from E13.5 strongly impaired cell proliferation. Conclusions/Significance: Our results demonstrate that Sp2 is essential for early mouse development and autonomous proliferation of MEFs in culture. Comparison of the Sp2 knockout phenotype with the phenotypes of Sp1, Sp3 and Sp4 knockout strains shows that, despite their structural similarity and evolutionary relationship, all four glutamine-rich members of the Sp family of transcription factors have distinct non-redundant functions in vivo.	[Baur, Frank; Nau, Kerstin; Sadic, Dennis; Allweiss, Lena; Krueger, Imme; Vollmer, Marion; Suske, Guntram] Univ Marburg, Inst Mol Biol & Tumorforsch, D-3550 Marburg, Germany; [Elsaesser, Hans-Peter] Univ Marburg, Inst Zytobiol & Zytopathol, D-3550 Marburg, Germany; [Gillemans, Nynke; de Wit, Ton; Philipsen, Sjaak] Erasmus MC, Dept Cell Biol, Rotterdam, Netherlands	Philipps University Marburg; Philipps University Marburg; Erasmus University Rotterdam; Erasmus MC	Baur, F (corresponding author), Univ Marburg, Inst Mol Biol & Tumorforsch, Emil Mannkopff Str 2, D-3550 Marburg, Germany.	Suske@imt.uni-marburg.de		Suske, Guntram/0000-0002-4807-0513	Deutsche Forschungsgemeinschaft [GRK767]; Dutch Organisation for Scientific Research [DN 82-294]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Dutch Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This work was supported by grants of the Deutsche Forschungsgemeinschaft to GS (GRK767) and the Dutch Organisation for Scientific Research (Nederlandse Organisatie voor Wetenschappelijk Onderzoek, NWO) to SP (DN 82-294). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belo JA, 1997, MECH DEVELOP, V68, P45, DOI 10.1016/S0925-4773(97)00125-1; Bouwman P, 2002, MOL CELL ENDOCRINOL, V195, P27, DOI 10.1016/S0303-7207(02)00221-6; Bouwman P, 2000, EMBO J, V19, P655, DOI 10.1093/emboj/19.4.655; Buchholz F, 1996, NUCLEIC ACIDS RES, V24, P3118, DOI 10.1093/nar/24.15.3118; de Wit T, 1998, NUCLEIC ACIDS RES, V26, P676, DOI 10.1093/nar/26.2.676; Gollner H, 2001, MECH DEVELOP, V106, P77, DOI 10.1016/S0925-4773(01)00420-8; Gollner H, 2001, GENES CELLS, V6, P689, DOI 10.1046/j.1365-2443.2001.00455.x; HAGEN G, 1992, NUCLEIC ACIDS RES, V20, P5519, DOI 10.1093/nar/20.21.5519; KINGSLEY C, 1992, MOL CELL BIOL, V12, P4251, DOI 10.1128/MCB.12.10.4251; Krempler A, 2002, J BIOL CHEM, V277, P43216, DOI 10.1074/jbc.M207662200; Kruger I, 2007, DEV DYNAM, V236, P2235, DOI 10.1002/dvdy.21222; Leneuve P, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng021; Loonstra A, 2001, P NATL ACAD SCI USA, V98, P9209, DOI 10.1073/pnas.161269798; Marin M, 1997, CELL, V89, P619, DOI 10.1016/S0092-8674(00)80243-3; Moorefield KS, 2006, MOL BIOL CELL, V17, P1711, DOI 10.1091/mbc.E05-11-1063; Moorefield KS, 2004, J BIOL CHEM, V279, P13911, DOI 10.1074/jbc.M313589200; MOUNTFORD P, 1994, P NATL ACAD SCI USA, V91, P4303, DOI 10.1073/pnas.91.10.4303; Nguyen-Tran VTB, 2000, CELL, V102, P671, DOI 10.1016/S0092-8674(00)00089-1; Philipsen S, 1999, NUCLEIC ACIDS RES, V27, P2991, DOI 10.1093/nar/27.15.2991; Rivera-Perez JA, 2005, DEV BIOL, V288, P363, DOI 10.1016/j.ydbio.2005.09.012; Sakai K, 1997, BIOCHEM BIOPH RES CO, V237, P318, DOI 10.1006/bbrc.1997.7111; Silver DP, 2001, MOL CELL, V8, P233, DOI 10.1016/S1097-2765(01)00295-7; St Amand TR, 2006, DEV BIOL, V291, P208, DOI 10.1016/j.ydbio.2005.10.018; Supp DM, 1996, DEV BIOL, V176, P284, DOI 10.1006/dbio.1996.0134; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1; Suske G, 2005, GENOMICS, V85, P551, DOI 10.1016/j.ygeno.2005.01.005; Tewari R, 1996, DEVELOPMENT, V122, P3991; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; van Loo,PF, 2007, MOL CELL BIOL, V27, P8571, DOI 10.1128/MCB.01350-07; WILKINSON DG, 1990, NATURE, V343, P657, DOI 10.1038/343657a0	30	18	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2010	5	3					A202	A212	e9587	10.1371/journal.pone.0009587	http://dx.doi.org/10.1371/journal.pone.0009587			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565WZ	20221402	Green Published, gold, Green Submitted			2022-12-25	WOS:000275328200019
J	Cooper, WJ; Parsons, K; McIntyre, A; Kern, B; McGee-Moore, A; Albertson, RC				Cooper, W. James; Parsons, Kevin; McIntyre, Alyssa; Kern, Brittany; McGee-Moore, Alana; Albertson, R. Craig			Bentho-Pelagic Divergence of Cichlid Feeding Architecture Was Prodigious and Consistent during Multiple Adaptive Radiations within African Rift-Lakes	PLOS ONE			English	Article							COREGONUS-LAVARETUS L.; PHENOTYPIC PLASTICITY; MORPHOLOGICAL INTEGRATION; PUMPKINSEED SUNFISH; ARCTIC CHARR; ECOLOGICAL SPECIATION; FUNCTIONAL-MORPHOLOGY; TROPHIC POLYMORPHISM; PARALLEL EVOLUTION; NATURAL-SELECTION	Background: How particular changes in functional morphology can repeatedly promote ecological diversification is an active area of evolutionary investigation. The African rift-lake cichlids offer a calibrated time series of the most dramatic adaptive radiations of vertebrate trophic morphology yet described, and the replicate nature of these events provides a unique opportunity to test whether common changes in functional morphology have repeatedly facilitated their ecological success. Methodology/Principal Findings: Specimens from 87 genera of cichlid fishes endemic to Lakes Tanganyka, Malawi and Victoria were dissected in order to examine the functional morphology of cichlid feeding. We quantified shape using geometric morphometrics and compared patterns of morphological diversity using a series of analytical tests. The primary axes of divergence were conserved among all three radiations, and the most prevalent changes involved the size of the preorbital region of the skull. Even the fishes from the youngest of these lakes (Victoria), which exhibit the lowest amount of skull shape disparity, have undergone extensive preorbital evolution relative to other craniofacial traits. Such changes have large effects on feeding biomechanics, and can promote expansion into a wide array of niches along a bentho-pelagic ecomorphological axis. Conclusions/Significance: Here we show that specific changes in trophic anatomy have evolved repeatedly in the African rift lakes, and our results suggest that simple morphological alterations that have large ecological consequences are likely to constitute critical components of adaptive radiations in functional morphology. Such shifts may precede more complex shape changes as lineages diversify into unoccupied niches. The data presented here, combined with observations of other fish lineages, suggest that the preorbital region represents an evolutionary module that can respond quickly to natural selection when fishes colonize new lakes. Characterizing the changes in cichlid trophic morphology that have contributed to their extraordinary adaptive radiations has broad evolutionary implications, and such studies are necessary for directing future investigations into the proximate mechanisms that have shaped these spectacular phenomena.	[Cooper, W. James; Parsons, Kevin; Kern, Brittany; McGee-Moore, Alana; Albertson, R. Craig] Syracuse Univ, Dept Biol, Syracuse, NY 13244 USA; [McIntyre, Alyssa] Univ Connecticut, Sch Dent Med, Storrs, CT USA	Syracuse University; University of Connecticut	Cooper, WJ (corresponding author), Syracuse Univ, Dept Biol, Syracuse, NY 13244 USA.	wjcooper@syr.edu		Cooper, W. James/0000-0003-4204-4266	Department of Biology at Syracuse University; United States National Institute of Dental and Craniofacial Research [1R21DE019223]; United States National Institute on Aging [RO1AG031922]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R21DE019223] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG031922] Funding Source: NIH RePORTER	Department of Biology at Syracuse University; United States National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); United States National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by funding from the Department of Biology at Syracuse University, grant 1R21DE019223 from the United States National Institute of Dental and Craniofacial Research (www.nidcr.nih.gov/), and grant RO1AG031922 from the United States National Institute on Aging (www.nia.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams CE, 2004, BIOL J LINN SOC, V81, P611, DOI 10.1111/j.1095-8312.2004.00314.x; Adams CE, 2003, BIOL J LINN SOC, V78, P43, DOI 10.1046/j.1095-8312.2003.00126.x; Adams CE, 1998, J FISH BIOL, V52, P1259, DOI 10.1111/j.1095-8649.1998.tb00970.x; Albertson RC, 2007, DEV BIOL, V306, P505, DOI 10.1016/j.ydbio.2007.03.025; Albertson RC, 1999, P NATL ACAD SCI USA, V96, P5107, DOI 10.1073/pnas.96.9.5107; Albertson RC, 2005, P NATL ACAD SCI USA, V102, P16287, DOI 10.1073/pnas.0506649102; Albertson RC, 2003, P NATL ACAD SCI USA, V100, P5252, DOI 10.1073/pnas.0930235100; Albertson RC, 2003, J HERED, V94, P291, DOI 10.1093/jhered/esg071; Amundsen PA, 2004, ANN ZOOL FENN, V41, P301; AVISE JC, 1990, NATURE, V347, P512, DOI 10.1038/347512a0; Azuma Y, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-215; Barlow G., 2002, CICHLID FISHES NATUR; Bernatchez L, 1999, BIOL J LINN SOC, V68, P173, DOI 10.1111/j.1095-8312.1999.tb01165.x; Boughman JW, 2005, EVOLUTION, V59, P361; Boughman JW, 2001, NATURE, V411, P944, DOI 10.1038/35082064; Bouton N, 2002, BIOL J LINN SOC, V77, P185, DOI 10.1046/j.1095-8312.2002.00093.x; CHEVERUD JM, 1989, EVOLUTION, V43, P1737, DOI 10.1111/j.1558-5646.1989.tb02623.x; CHEVERUD JM, 1989, SYST ZOOL, V38, P201, DOI 10.2307/2992282; Cole NJ, 2003, CURR BIOL, V13, pR951, DOI 10.1016/S0960-9822(03)00881-9; Collar DC, 2009, EVOLUTION, V63, P1557, DOI 10.1111/j.1558-5646.2009.00626.x; Collar DC, 2005, EVOLUTION, V59, P1783, DOI 10.1111/j.0014-3820.2005.tb01826.x; Colosimo PF, 2005, SCIENCE, V307, P1928, DOI 10.1126/science.1107239; Colosimo PF, 2004, PLOS BIOL, V2, P635, DOI 10.1371/journal.pbio.0020109; Cooper WJ, 2008, DEV BIOL, V321, P295, DOI 10.1016/j.ydbio.2008.06.025; Cooper WJ, 2009, MOL PHYLOGENET EVOL, V52, P1, DOI 10.1016/j.ympev.2008.12.010; Cooper WJ, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-24; Cresko WA, 2004, P NATL ACAD SCI USA, V101, P6050, DOI 10.1073/pnas.0308479101; Danley PD, 2001, MOL ECOL, V10, P1075, DOI 10.1046/j.1365-294X.2001.01283.x; Dynes J, 1999, J FISH BIOL, V54, P955, DOI 10.1111/j.1095-8649.1999.tb00850.x; Eschmeyer WN, 2009, CATALOG FISHES ELECT; Feder ME, 2003, NAT REV GENET, V4, P651, DOI 10.1038/nrg1128; Ferry-Graham LA, 2002, MAR BIOL, V141, P819, DOI 10.1007/s00227-002-0882-x; Ferry-Graham LA, 2001, J EXP MAR BIOL ECOL, V256, P167, DOI 10.1016/S0022-0981(00)00312-9; FOOTE M, 1993, PALEOBIOLOGY, V19, P403, DOI 10.1017/S0094837300014056; Foster SA, 2004, TRENDS ECOL EVOL, V19, P456, DOI 10.1016/j.tree.2004.07.004; Fraser D, 1998, ECOL FRESHW FISH, V7, P184, DOI 10.1111/j.1600-0633.1998.tb00185.x; Genner MJ, 2007, MOL BIOL EVOL, V24, P1269, DOI 10.1093/molbev/msm050; Gillespie GJ, 2003, J FISH BIOL, V62, P1099, DOI 10.1046/j.1095-8649.2003.00100.x; Greenwood PH, 1974, CICHLID FISHES LAKE; Grubich JR, 2008, ZOOLOGY, V111, P16, DOI 10.1016/j.zool.2007.05.003; Hegrenes S, 2001, ECOL FRESHW FISH, V10, P35, DOI 10.1034/j.1600-0633.2001.100105.x; Herrera CM, 2002, J EVOLUTION BIOL, V15, P108, DOI 10.1046/j.1420-9101.2002.00365.x; Hjelm J, 2001, OIKOS, V95, P311, DOI 10.1034/j.1600-0706.2001.950213.x; Holzman R, 2008, J EXP BIOL, V211, P3296, DOI 10.1242/jeb.020909; Holzman R, 2008, J R SOC INTERFACE, V5, P1445, DOI 10.1098/rsif.2008.0159; Hulsey CD, 2005, FUNCT ECOL, V19, P487, DOI 10.1111/j.1365-2435.2005.00987.x; Jastrebski CJ, 2004, EVOL ECOL RES, V6, P285; Jonsson B, 2001, J FISH BIOL, V58, P605, DOI 10.1006/jfbi.2000.1515; Kahilainen K, 2006, J FISH BIOL, V68, P63, DOI 10.1111/j.0022-1112.2006.00876.x; Kammerer CF, 2006, J MORPHOL, V267, P1017, DOI 10.1002/jmor.10293; Kaufman L.S., 1982, Breviora, P1; Klingenberg CP, 2008, ANNU REV ECOL EVOL S, V39, P115, DOI 10.1146/annurev.ecolsys.37.091305.110054; Klingenberg CP, 2001, AM NAT, V157, P11, DOI 10.1086/317002; Klingenberg CP, 2000, EVOLUTION, V54, P1273, DOI 10.1111/j.0014-3820.2000.tb00560.x; Konings A., 2001, MALAWI CICHLIDS THEI; Konings A, 2015, TANGANYIKA CICHLIDS; Kornfield I, 2000, ANNU REV ECOL SYST, V31, P163, DOI 10.1146/annurev.ecolsys.31.1.163; Kristjansson BK, 2002, BIOL J LINN SOC, V76, P247, DOI 10.1046/j.1095-8312.2002.00063.x; LeClair EE, 2009, DEV DYNAM, V238, P2550, DOI 10.1002/dvdy.22086; Levin DA, 2004, SYST BOT, V29, P807, DOI 10.1600/0363644042451134; Loh YHE, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-r113; Lu GQ, 1999, EVOLUTION, V53, P1491, DOI 10.1111/j.1558-5646.1999.tb05413.x; MALMQUIST HJ, 1992, OECOLOGIA, V92, P354, DOI 10.1007/BF00317461; MEYER A, 1990, NATURE, V347, P550, DOI 10.1038/347550a0; Morrison D.F., 2004, MULTIVARIATE STAT ME; Nagel L, 1998, EVOLUTION, V52, P209, DOI 10.1111/j.1558-5646.1998.tb05154.x; Ostbye K, 2006, MOL ECOL, V15, P3983, DOI 10.1111/j.1365-294X.2006.03062.x; Ostbye K, 2005, J EVOLUTION BIOL, V18, P683, DOI 10.1111/j.1420-9101.2004.00844.x; Papa R, 2008, CURR OPIN GENET DEV, V18, P559, DOI 10.1016/j.gde.2008.11.007; Parsons KJ, 2007, J EVOLUTION BIOL, V20, P673, DOI 10.1111/j.1420-9101.2006.01249.x; Parsons KJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007957; Peres-Neto PR, 2004, OECOLOGIA, V140, P36, DOI 10.1007/s00442-004-1562-y; Rice AN, 2008, BIOL J LINN SOC, V93, P289, DOI 10.1111/j.1095-8312.2007.00915.x; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; RIDGWAY MS, 1984, CAN J ZOOL, V62, P1813, DOI 10.1139/z84-264; Riopel C, 2008, ENVIRON BIOL FISH, V82, P409, DOI 10.1007/s10641-007-9303-9; Robinson BW, 2000, ECOLOGY, V81, P2799, DOI 10.1890/0012-9658(2000)081[2799:APAOCR]2.0.CO;2; ROBINSON BW, 1995, COPEIA, P294; Robinson BW, 1996, EVOL ECOL, V10, P631, DOI 10.1007/BF01237711; Robinson BW, 2002, CAN J FISH AQUAT SCI, V59, P1819, DOI 10.1139/F02-144; ROBINSON BW, 1993, EVOL ECOL, V7, P451, DOI 10.1007/BF01237641; Rohlf F.J., 2006, TPSDIG2; Rundle HD, 2000, SCIENCE, V287, P306, DOI 10.1126/science.287.5451.306; Ruzzante DE, 1998, BIOL J LINN SOC, V65, P191, DOI 10.1111/j.1095-8312.1998.tb00355.x; Salzburger W, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-17; Salzburger W, 2002, SYST BIOL, V51, P113, DOI 10.1080/106351502753475907; Schlosser G, 2004, MODULARITY IN DEVELOPMENT AND EVOLUTION, P1; SCHLUTER D, 1992, AM NAT, V140, P85, DOI 10.1086/285404; Schluter D, 1996, PHILOS T R SOC B, V351, P807, DOI 10.1098/rstb.1996.0075; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Seehausen O, 2008, NATURE, V455, P620, DOI 10.1038/nature07285; Shapiro MD, 2006, NATURE, V439, P1014, DOI 10.1038/nature04500; Stauffer JR, 2004, ANIM BIOL, V54, P137, DOI 10.1163/1570756041445191; STIASSNY M L J, 1987, Bulletin of the Museum of Comparative Zoology, V151, P269; Stiassny MLJ, 1999, SCI AM, V280, P64, DOI 10.1038/scientificamerican0299-64; Sturmbauer C, 2003, HYDROBIOLOGIA, V500, P51, DOI 10.1023/A:1024680201436; Terai Y, 2002, MOL BIOL EVOL, V19, P1628, DOI 10.1093/oxfordjournals.molbev.a004225; Turner GF, 2001, MOL ECOL, V10, P793, DOI 10.1046/j.1365-294x.2001.01200.x; Turner GF., 1996, OFFSHORE CICHLIDS LA; Van Valen Leigh, 2005, P29, DOI 10.1016/B978-012088777-4/50005-3; Verheyen E, 2003, SCIENCE, V300, P325, DOI 10.1126/science.1080699; WAGNER GP, 1990, Z ZOOL SYST EVOL, V28, P48; WAGNER GP, 1984, J MATH BIOL, V21, P77, DOI 10.1007/BF00275224; Wainwright PC, 2004, BIOL J LINN SOC, V82, P1, DOI 10.1111/j.1095-8312.2004.00313.x; Wainwright PC, 2000, EXPTL BIOL REV, P207; WAINWRIGHT PC, 1995, ENVIRON BIOL FISH, V44, P97, DOI 10.1007/BF00005909; Walker JA, 1997, BIOL J LINN SOC, V61, P3, DOI 10.1111/j.1095-8312.1997.tb01777.x; Walker JA, 2000, J ZOOL, V252, P293; Waltzek TB, 2003, J MORPHOL, V257, P96, DOI 10.1002/jmor.10111; West-Eberhard Mary Jane, 2003, pi; Westneat MW, 2006, FISH PHYSIOL, V23, P29, DOI 10.1016/S1546-5098(05)23002-9; Westneat MW, 2005, P ROY SOC B-BIOL SCI, V272, P993, DOI 10.1098/rspb.2004.3013; Westneat MW, 1999, AM ZOOL, V39, p100A; Westneat MW, 2003, J THEOR BIOL, V223, P269, DOI 10.1016/S0022-5193(03)00058-4; WESTNEAT MW, 1990, J MORPHOL, V205, P269, DOI 10.1002/jmor.1052050304; WESTNEAT MW, 1995, SYST BIOL, V44, P361, DOI 10.2307/2413598; WESTNEAT MW, 1994, ZOOMORPHOLOGY, V114, P103, DOI 10.1007/BF00396643; Westneat MW, 2004, INTEGR COMP BIOL, V44, P378, DOI 10.1093/icb/44.5.378; Wund MA, 2008, AM NAT, V172, P449, DOI 10.1086/590966; Young KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004740; Young NM, 2006, J ANAT, V209, P623, DOI 10.1111/j.1469-7580.2006.00639.x	121	115	115	3	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2010	5	3					A38	A50	e9551	10.1371/journal.pone.0009551	http://dx.doi.org/10.1371/journal.pone.0009551			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565WZ	20221400	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000275328200004
J	Goswami, A; Polly, PD				Goswami, Anjali; Polly, P. David			The Influence of Modularity on Cranial Morphological Disparity in Carnivora and Primates (Mammalia)	PLOS ONE			English	Article							QUANTITATIVE GENETICS; DEVELOPMENTAL INTEGRATION; VARIATION PATTERNS; GEOMETRIC SHAPE; SAKIS PITHECIA; EVOLUTION; PHYLOGENY; SAGUINUS; ONTOGENY; MODULES	Background: Although variation provides the raw material for natural selection and evolution, few empirical data exist about the factors controlling morphological variation. Because developmental constraints on variation are expected to act by influencing trait correlations, studies of modularity offer promising approaches that quantify and summarize patterns of trait relationships. Modules, highly-correlated and semi-autonomous sets of traits, are observed at many levels of biological organization, from genes to colonies. The evolutionary significance of modularity is considerable, with potential effects including constraining the variation of individual traits, circumventing pleiotropy and canalization, and facilitating the transformation of functional structures. Despite these important consequences, there has been little empirical study of how modularity influences morphological evolution on a macroevolutionary scale. Here, we conduct the first morphometric analysis of modularity and disparity in two clades of placental mammals, Primates and Carnivora, and test if trait integration within modules constrains or facilitates morphological evolution. Principal Findings: We used both randomization methods and direct comparisons of landmark variance to compare disparity in the six cranial modules identified in previous studies. The cranial base, a highly-integrated module, showed significantly low disparity in Primates and low landmark variance in both Primates and Carnivora. The vault, zygomatic-pterygoid and orbit modules, characterized by low trait integration, displayed significantly high disparity within Carnivora. 14 of 24 results from analyses of disparity show no significant relationship between module integration and morphological disparity. Of the ten significant or marginally significant results, eight support the hypothesis that integration within modules constrains morphological evolution in the placental skull. Only the molar module, a highly-integrated and functionally important module, showed significantly high disparity in Carnivora, in support of the facilitation hypothesis. Conclusions: This analysis of within-module disparity suggested that strong integration of traits had little influence on morphological evolution over large time scales. However, where significant results were found, the primary effect of strong integration of traits was to constrain morphological variation. Thus, within Primates and Carnivora, there was some support for the hypothesis that integration of traits within cranial modules limits morphological evolution, presumably by limiting the variation of individual traits.	[Goswami, Anjali] UCL, Dept Genet Evolut & Environm, London, England; [Goswami, Anjali] UCL, Dept Earth Sci, London, England; [Polly, P. David] Indiana Univ, Dept Geol Sci, Bloomington, IN 47405 USA	University of London; University College London; University of London; University College London; Indiana University System; Indiana University Bloomington	Goswami, A (corresponding author), UCL, Dept Genet Evolut & Environm, London, England.	a.goswami@ucl.ac.uk	Polly, P. David/ABC-6597-2020; Goswami, Anjali/B-3440-2010	Polly, P. David/0000-0001-7338-8526; 	U.S. National Science Foundation International Research Fellowship OISE [0502186]; U.S. National Science Foundation DDIG [0308765]; Field Museum Women-in-Science Fellowship; Society of Vertebrate Paleontology Predoctoral Fellowship; American Museum of Natural History Collections Study Grant; University of California Samuel P. and Doris Welles Fund; University of Chicago Hinds Fund	U.S. National Science Foundation International Research Fellowship OISE; U.S. National Science Foundation DDIG(National Science Foundation (NSF)); Field Museum Women-in-Science Fellowship; Society of Vertebrate Paleontology Predoctoral Fellowship; American Museum of Natural History Collections Study Grant; University of California Samuel P. and Doris Welles Fund(University of California System); University of Chicago Hinds Fund	This study is based upon research supported by the U.S. National Science Foundation International Research Fellowship OISE #0502186 (to AG). Morphometric data was collected during AG's doctoral research, supported by U.S. National Science Foundation DDIG # 0308765, the Field Museum Women-in-Science Fellowship, the Society of Vertebrate Paleontology Predoctoral Fellowship, the American Museum of Natural History Collections Study Grant, the University of California Samuel P. and Doris Welles Fund, and the University of Chicago Hinds Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann RR, 2000, AM J PHYS ANTHROPOL, V111, P489, DOI 10.1002/(SICI)1096-8644(200004)111:4<489::AID-AJPA5>3.0.CO;2-U; Ackermann RR, 2004, PHENOTYPIC INTEGRATION: STUDYING THE ECOLOGY AND EVOLUTION OF COMPLEX PHENOTYPES, P302; ATCHLEY WR, 1991, BIOL REV, V66, P101, DOI 10.1111/j.1469-185X.1991.tb01138.x; Atchley WR, 1993, SKULL, V1, P207; Badyaev AV, 2005, AM NAT, V166, P382, DOI 10.1086/432559; Bastir M, 2005, AM J PHYS ANTHROPOL, V128, P26, DOI 10.1002/ajpa.20191; Bastir M, 2006, ARCH ORAL BIOL, V51, P814, DOI 10.1016/j.archoralbio.2006.03.009; Bruner E, 2008, AM J PHYS ANTHROPOL, V137, P30, DOI 10.1002/ajpa.20837; Calabretta R, 2000, ARTIF LIFE, V6, P69, DOI 10.1162/106454600568320; Carroll SB, 2005, PLOS BIOL, V3, P1159, DOI 10.1371/journal.pbio.0030245; Chernoff B., 1999, MORPHOLOGICAL INTEGR, P319; Cheverud JM, 2004, J EXP ZOOL PART B, V302B, P424, DOI 10.1002/jez.b.21008; CHEVERUD JM, 1988, AM J PHYS ANTHROPOL, V75, P195; CHEVERUD JM, 1982, EVOLUTION, V36, P499, DOI 10.1111/j.1558-5646.1982.tb05070.x; CHEVERUD JM, 1989, EVOLUTION, V43, P1737, DOI 10.1111/j.1558-5646.1989.tb02623.x; CHEVERUD JM, 1995, AM NAT, V145, P63, DOI 10.1086/285728; Cheverud JM, 1996, AM ZOOL, V36, P44; Cheverud JM, 2004, MODULARITY IN DEVELOPMENT AND EVOLUTION, P132; Cheverud JM, 1997, EVOLUTION, V51, P2006, DOI [10.1111/j.1558-5646.1997.tb05122.x, 10.2307/2411021]; Cheverud JM, 1996, J EVOLUTION BIOL, V9, P5, DOI 10.1046/j.1420-9101.1996.9010005.x; CHEVERUD JM, 1984, J THEOR BIOL, V110, P155, DOI 10.1016/S0022-5193(84)80050-8; CHEVERUD JM, 1983, EVOLUTION, V37, P895, DOI 10.1111/j.1558-5646.1983.tb05619.x; Eble GJ, 2004, PHENOTYPIC INTEGRATION: STUDYING THE ECOLOGY AND EVOLUTION OF COMPLEX PHENOTYPES, P253; Foote M, 1997, ANNU REV ECOL SYST, V28, P129, DOI 10.1146/annurev.ecolsys.28.1.129; Gilbert BM, 1990, MAMMALIAN OSTEOLOGY; Goswami A, 2006, EVOLUTION, V60, P169; Goswami A, 2006, AM NAT, V168, P270, DOI 10.1086/505758; Goswami A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000995; Hallgrimsson B, 2004, J EXP ZOOL PART B, V302B, P207, DOI 10.1002/jez.b.21002; Klaauw C. J. van der, 1948, Archives Neerlandaises de Zoologie, V9, P1; Klingenberg CP, 2004, PHENOTYPIC INTEGRATION: STUDYING THE ECOLOGY AND EVOLUTION OF COMPLEX PHENOTYPES, P213; Klingenberg CP, 2004, GENETICS, V166, P1909, DOI 10.1534/genetics.166.4.1909; Klingenberg CP, 2002, GENE, V287, P3, DOI 10.1016/S0378-1119(01)00867-8; Klingenberg CP, 2003, EVOL DEV, V5, P522, DOI 10.1046/j.1525-142X.2003.03057.x; Klingenberg CP, 1999, EVOLUTION, V53, P358, DOI [10.2307/2640773, 10.1111/j.1558-5646.1999.tb03772.x]; Klingenberg CP, 2001, EVOLUTION, V55, P2342; Klingenberg CP, 2001, AM NAT, V157, P11, DOI 10.1086/317002; Lieberman DE, 2000, J HUM EVOL, V38, P291, DOI 10.1006/jhev.1999.0335; Lieberman DE, 2000, YEARB PHYS ANTHROPOL, V43, P117; Marroig G, 2004, J EVOLUTION BIOL, V17, P144, DOI 10.1046/j.1420-9101.2003.00653.x; Marroig G, 2001, EVOLUTION, V55, P2576; Marroig G, 2005, EVOLUTION, V59, P1128; Marroig G, 2004, AM J PHYS ANTHROPOL, V125, P266, DOI 10.1002/ajpa.10421; Martin DP, 2005, PLOS GENET, V1, P475, DOI 10.1371/journal.pgen.0010051; Mitteroecker P, 2007, SYST BIOL, V56, P818, DOI 10.1080/10635150701648029; Myers P., 2022, ANIMAL DIVERSITY WEB; Olson E. C., 1958, MORPHOLOGICAL INTEGR; OLSON EC, 1951, EVOLUTION, V5, P325, DOI 10.2307/2405677; Polly PD, 2001, BEYOND HETEROCHRONY, P305; Rohlf FJ, 1990, P MICH MORPH WORKSH, P227; Rose KD., 2005, RISE PLACENTAL MAMMA; Schlosser G, 2004, MODULARITY IN DEVELOPMENT AND EVOLUTION, P1; Sears KE, 2007, EVOL DEV, V9, P555, DOI 10.1111/j.1525-142X.2007.00196.x; Shubin NH, 2004, MODULARITY IN DEVELOPMENT AND EVOLUTION, P429; Strait DS, 2001, AM J PHYS ANTHROPOL, V114, P273, DOI 10.1002/ajpa.1041; VERMEIJ GJ, 1973, SYST ZOOL, V22, P466, DOI 10.2307/2412953; Wagner GP, 1996, AM ZOOL, V36, P36; Wagner GP, 1995, LECT NOTES ARTIF INT, V929, P317; Wagner GP, 1996, EVOLUTION, V50, P967, DOI 10.1111/j.1558-5646.1996.tb02339.x; Wang Z, 2007, PLOS COMPUT BIOL, V3, P1011, DOI 10.1371/journal.pcbi.0030107; Wesley-Hunt GD, 2005, J SYST PALAEONTOL, V3, P1; Zelditch M.L., 2004, GEOMETRIC MORPHOMETR, DOI DOI 10.1016/B978-0-12-778460-1.X5000-5; ZELDITCH ML, 1988, EVOLUTION, V42, P28, DOI 10.1111/j.1558-5646.1988.tb04105.x; Zelditch ML, 2004, PHENOTYPIC INTEGRATION: STUDYING THE ECOLOGY AND EVOLUTION OF COMPLEX PHENOTYPES, P274; ZELDITCH ML, 1989, EVOLUTION, V43, P814, DOI 10.1111/j.1558-5646.1989.tb05179.x; ZELDITCH ML, 1989, J MAMMAL, V70, P477, DOI 10.2307/1381419	66	144	145	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2010	5	3							e9517	10.1371/journal.pone.0009517	http://dx.doi.org/10.1371/journal.pone.0009517			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	562OZ	20209089	Green Published, Green Submitted, gold			2022-12-25	WOS:000275063400022
J	De la Fuente, IM; Vadillo, F; Perez-Samartin, AL; Perez-Pinilla, MB; Bidaurrazaga, J; Vera-Lopez, A				De la Fuente, Ildefonso M.; Vadillo, Fernando; Luis Perez-Samartin, Alberto; Perez-Pinilla, Martin-Blas; Bidaurrazaga, Joseba; Vera-Lopez, Antonio			Global Self-Regulation of the Cellular Metabolic Structure	PLOS ONE			English	Article							LONG-RANGE CORRELATIONS; PANCREATIC BETA-CELL; AUTONOMOUS OSCILLATIONS; WAVELET ANALYSIS; KINETIC-MODEL; TIME-SERIES; CYCLE; COMPARTMENTATION; ORGANIZATION; DYNAMICS	Background: Different studies have shown that cellular enzymatic activities are able to self-organize spontaneously, forming a metabolic core of reactive processes that remain active under different growth conditions while the rest of the molecular catalytic reactions exhibit structural plasticity. This global cellular metabolic structure appears to be an intrinsic characteristic common to all cellular organisms. Recent work performed with dissipative metabolic networks has shown that the fundamental element for the spontaneous emergence of this global self-organized enzymatic structure could be the number of catalytic elements in the metabolic networks. Methodology/Principal Findings: In order to investigate the factors that may affect the catalytic dynamics under a global metabolic structure characterized by the presence of metabolic cores we have studied different transitions in catalytic patterns belonging to a dissipative metabolic network. The data were analyzed using non-linear dynamics tools: power spectra, reconstructed attractors, long-term correlations, maximum Lyapunov exponent and Approximate Entropy; and we have found the emergence of self-regulation phenomena during the transitions in the metabolic activities. Conclusions/Significance: The analysis has also shown that the chaotic numerical series analyzed correspond to the fractional Brownian motion and they exhibit long-term correlations and low Approximate Entropy indicating a high level of predictability and information during the self-regulation of the metabolic transitions. The results illustrate some aspects of the mechanisms behind the emergence of the metabolic self-regulation processes, which may constitute an important property of the global structure of the cellular metabolism.	[De la Fuente, Ildefonso M.; Perez-Pinilla, Martin-Blas; Vera-Lopez, Antonio] Univ Basque Country, Dept Math, Vizcaya, Spain; [Vadillo, Fernando] Univ Basque Country, Dept Appl Math & Stat, Vizcaya, Spain; [Luis Perez-Samartin, Alberto] Univ Basque Country, Dept Neurosci, Vizcaya, Spain; [Bidaurrazaga, Joseba] Basque Govt, Dept Hlth, Vizcaya, Spain	University of Basque Country; University of Basque Country; University of Basque Country; Basque Government	De la Fuente, IM (corresponding author), Univ Basque Country, Dept Math, Vizcaya, Spain.	mtpmadei@ehu.es	Samartín, Alberto Pérez/AAB-6428-2019; Pérez-Pinillla, Martín-Blas/K-9042-2017; Samartín, Alberto Pérez/AAB-1336-2019; Vadillo, Fernando/AAW-5629-2021; Vera-López, Antonio/P-3022-2016	Pérez-Pinillla, Martín-Blas/0000-0002-3461-9990; Samartín, Alberto Pérez/0000-0003-0834-0424; Vadillo, Fernando/0000-0001-6524-360X; De la Fuente, Ildefonso/0000-0001-6548-7583; Vera-Lopez, Antonio/0000-0002-0351-2701	Spanish Ministry of Science and Education [MTM2007-62186, MTM2005-01504]; Basque Government [GIC07/151-IT-254-07, IT-305-07]	Spanish Ministry of Science and Education(Spanish Government); Basque Government(Basque Government)	This work was supported by the Spanish Ministry of Science and Education Grants with the projects MTM2007-62186 and MTM2005-01504 and by the Basque Government grants GIC07/151-IT-254-07 and IT-305-07. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainscow EK, 2002, J PHYSIOL-LONDON, V544, P429, DOI 10.1113/jphysiol.2002.022434; Allegrini P, 1998, PHYS REV E, V57, P4558, DOI 10.1103/PhysRevE.57.4558; Almaas E, 2007, J EXP BIOL, V210, P1548, DOI 10.1242/jeb.003731; Almaas E, 2005, PLOS COMPUT BIOL, V1, P557, DOI 10.1371/journal.pcbi.0010068; Aon MA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003624; Audit B, 2004, J BIOL PHYS, V30, P33, DOI 10.1023/B:JOBP.0000016438.86794.8e; BARIL EF, 1968, J NUTR, V95, P228, DOI 10.1093/jn/95.2.228; BASSINGTHWAIGHTE JB, 1995, ANN BIOMED ENG, V23, P491, DOI 10.1007/BF02584449; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Bier M, 1996, BIOPHYS CHEM, V62, P15, DOI 10.1016/S0301-4622(96)02195-3; BLAKELY NJ, 2004, SYSTEMS PHYS REV LET, V92; BRODSKY VY, 1992, J CELL SCI, V103, P363; Cannon MJ, 1997, PHYSICA A, V241, P606, DOI 10.1016/S0378-4371(97)00252-5; Chabot JR, 2007, NATURE, V450, P1249, DOI 10.1038/nature06395; Chiam KH, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.061901; CLEGG JS, 1984, AM J PHYSIOL, V246, pR133, DOI 10.1152/ajpregu.1984.246.2.R133; Das M, 2003, J NEUROPHYSIOL, V89, P833, DOI 10.1152/jn.00757.2002; De La Fuente IM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003100; De la Fuente IM, 2006, ANN BIOMED ENG, V34, P295, DOI 10.1007/s10439-005-9026-z; De La Fuente IM, 1999, B MATH BIOL, V61, P573, DOI 10.1006/bulm.1999.0103; De la Fuente IM, 1999, BIOSYSTEMS, V50, P83, DOI 10.1016/S0303-2647(98)00094-X; De la Fuente IM, 1998, FRACTALS, V6, P95, DOI 10.1142/S0218348X98000110; De la Fuentea IM, 1999, J BIOL SYST, V7, P113, DOI 10.1142/S0218339099000103; DelaFuente IM, 1996, BIOSYSTEMS, V39, P87, DOI 10.1016/0303-2647(95)01603-1; delaFuente IM, 1996, BIOPHYS J, V71, P2375, DOI 10.1016/S0006-3495(96)79431-6; DELAFUENTE IM, 1995, BIOSYSTEMS, V35, P1, DOI 10.1016/0303-2647(94)01473-K; DIXON CJ, 1995, BIOCHEM J, V309, P145, DOI 10.1042/bj3090145; Dronov V, 2004, CHAOS, V14, P30, DOI 10.1063/1.1622352; Dyachok O, 2006, NATURE, V439, P349, DOI 10.1038/nature04410; Eke A, 2000, PFLUG ARCH EUR J PHY, V439, P403, DOI 10.1007/s004249900135; Eke A, 2002, PHYSIOL MEAS, V23, pR1, DOI 10.1088/0967-3334/23/1/201; FUENTES JM, 1994, ARCH INT PHYSIOL BIO, V102, P237, DOI 10.3109/13813459409003936; FULTON AB, 1982, CELL, V30, P345, DOI 10.1016/0092-8674(82)90231-8; Futcher B, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-107; GARFINKEL A, 1992, SCIENCE, V257, P1230, DOI 10.1126/science.1519060; Garmendia-Torres C, 2007, CURR BIOL, V17, P1044, DOI 10.1016/j.cub.2007.05.032; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Getty L, 2000, J CLIN INVEST, V106, P421, DOI 10.1172/JCI7815; Gillette MU, 2005, SCIENCE, V309, P1196, DOI 10.1126/science.1111420; Goldberger AL, 2002, P NATL ACAD SCI USA, V99, P2466, DOI 10.1073/pnas.012579499; GOLDBETER A, 1972, BIOPHYS J, V12, P1302, DOI 10.1016/S0006-3495(72)86164-2; Goldbeter A., 1990, RYTHMES CHAOS SYSTEM; Goldbeter A, 2007, ADV CHEM PHYS, V135, P253; Gonze D, 2004, INT J QUANTUM CHEM, V98, P228, DOI 10.1002/qua.10875; Haimovich AD, 2006, J COMPUT BIOL, V13, P1289, DOI 10.1089/cmb.2006.13.1289; Hans MA, 2003, BIOTECHNOL BIOENG, V82, P143, DOI 10.1002/bit.10553; Hartig K, 2005, PLANT BIOLOGY, V7, P33, DOI 10.1055/s-2004-830474; Hess B, 2000, NATURWISSENSCHAFTEN, V87, P199, DOI 10.1007/s001140050704; Holz GG, 2008, AM J PHYSIOL-CELL PH, V294, pC4, DOI 10.1152/ajpcell.00522.2007; Huang XY, 2001, ANNU REV BIOCHEM, V70, P149, DOI 10.1146/annurev.biochem.70.1.149; Hudder A, 2003, MOL CELL BIOL, V23, P9318, DOI 10.1128/MCB.23.24.9318-9326.2003; Hungerbuehler AK, 2007, EUKARYOT CELL, V6, P473, DOI 10.1128/EC.00273-06; Ishii K, 2006, EMBO REP, V7, P390, DOI 10.1038/sj.embor.7400620; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Jorgensen K, 2005, CURR OPIN PLANT BIOL, V8, P280, DOI 10.1016/j.pbi.2005.03.014; Jovanovic S, 2007, J MOL BIOL, V371, P349, DOI 10.1016/j.jmb.2007.05.081; Jules M, 2005, FEBS J, V272, P1490, DOI 10.1111/j.1742-4658.2005.04588.x; Kantz H., 1997, NONLINEAR TIME SERIE; Kass L, 1996, J PHOTOCH PHOTOBIO B, V35, P105, DOI 10.1016/1011-1344(96)07301-0; Kazachenko VN, 2007, BIOCHEM MOSC SUPPL S, V1, P169, DOI 10.1134/S1990747807020109; KHOLODENKO BN, 1992, EUR J BIOCHEM, V210, P147, DOI 10.1111/j.1432-1033.1992.tb17402.x; Kindzelskii AL, 1998, BIOPHYS J, V74, P90, DOI 10.1016/S0006-3495(98)77770-7; Klevecz RR, 2004, P NATL ACAD SCI USA, V101, P1200, DOI 10.1073/pnas.0306490101; Klevecz RR, 2001, MOL BIOL REP, V28, P73, DOI 10.1023/A:1017909012215; Korzeniewski B, 2001, BIOPHYS CHEM, V92, P17, DOI 10.1016/S0301-4622(01)00184-3; KURGANOV BI, 1993, TRENDS BIOCHEM SCI, V18, P405, DOI 10.1016/0968-0004(93)90133-8; LANGE G, 2004, FEBS, V178, P61; LEBRUN P, 1985, BIOPHYS J, V48, P529, DOI 10.1016/S0006-3495(85)83809-1; Lee YK, 2007, J FLUID MECH, V575, P425, DOI 10.1017/S0022112006004289; Lloyd D, 2002, FEBS LETT, V519, P41, DOI 10.1016/S0014-5793(02)02704-7; Lunn JE, 2007, J EXP BOT, V58, P35, DOI 10.1093/jxb/erl134; Lyubarev AE, 1997, BIOSYSTEMS, V42, P103, DOI 10.1016/S0303-2647(96)01698-X; MacDonald MJ, 2003, J BIOL CHEM, V278, P51894, DOI 10.1074/jbc.M309038200; Marquez S, 2004, FASEB J, V18, P519, DOI 10.1096/fj.03-0417fje; Mellon D, 1999, J NEUROPHYSIOL, V81, P1231, DOI 10.1152/jn.1999.81.3.1231; Mogilevskaya E, 2006, J BIOL PHYS, V32, P245, DOI 10.1007/s10867-006-9015-y; Moller AC, 1998, BIOPHYS CHEM, V72, P63, DOI 10.1016/S0301-4622(98)00123-9; Nelson L. D., 2004, LEHNINGER PRINCIPLES; Nicolis G., 1977, SELF ORG NONEQUILIBR; Nielsen K, 1998, BIOPHYS CHEM, V72, P49, DOI 10.1016/S0301-4622(98)00122-7; Ott E., 1993, CHAOS DYNAMICAL SYST; Ovadi J, 2004, MOL CELL BIOCHEM, V256, P83, DOI 10.1023/B:MCBI.0000009860.86969.72; Ovadi J, 2004, MOL CELL BIOCHEM, V256, P5, DOI 10.1023/B:MCBI.0000009855.14648.2c; Ovadi J, 2000, INT REV CYTOL, V192, P255; OVADI J, 1995, J CELL ARCHITECTURE; Pincus SM, 2001, ANN NY ACAD SCI, V954, P245; Placantonakis DG, 2001, J PHYSIOL-LONDON, V534, P123, DOI 10.1111/j.1469-7793.2001.t01-1-00123.x; Ramanujan VK, 2006, BIOPHYS J, V90, pL70, DOI 10.1529/biophysj.106.083501; Raymond GM, 2003, PHYSICA A, V322, P169, DOI 10.1016/S0378-4371(02)01748-X; Rosenspire AJ, 2001, J CELL SCI, V114, P1515; Saks V, 2008, INT J MOL SCI, V9, P751, DOI 10.3390/ijms9050751; Saks V, 2009, INT J MOL SCI, V10, P1161, DOI 10.3390/ijms10031161; Sanchez-Armass S, 2006, AM J PHYSIOL-CELL PH, V290, pC524, DOI 10.1152/ajpcell.00290.2005; Sear RP, 2005, J PHYS-CONDENS MAT, V17, pS3587, DOI 10.1088/0953-8984/17/45/052; Shannon CE, 1997, MATH THEORY COMMUNIC; Shaul O, 1996, P NATL ACAD SCI USA, V93, P4868, DOI 10.1073/pnas.93.10.4868; SINAI YG, 1959, DOKL AKAD NAUK SSSR, V124, P768; Smrcinova M, 1998, INT J BIFURCAT CHAOS, V8, P2467, DOI 10.1142/S0218127498001984; Sprott JC, 2003, CHAOS TIME SERIES AN; SRERE PA, 1997, CHANNELING INTERMEDI; Tian B, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-137; Tonozuka H, 2001, J BIOCHEM-TOKYO, V130, P589, DOI 10.1093/oxfordjournals.jbchem.a003023; TYSON JJ, 1991, P NATL ACAD SCI USA, V88, P7328, DOI 10.1073/pnas.88.16.7328; Viswanathan GM, 1997, BIOPHYS J, V72, P866, DOI 10.1016/S0006-3495(97)78721-6; WALTER H., 1999, INT REV CYTOLOGY, V192; WELCH GR, 1985, ORG MULTYENZYME SYST; WEST IC, 1997, CHANNELLING INTERMED; Wittmann C, 2005, BIOTECHNOL BIOENG, V89, P839, DOI 10.1002/bit.20408; WOLF A, 1985, PHYSICA D, V16, P285, DOI 10.1016/0167-2789(85)90011-9; Yang CR, 2005, J BIOL CHEM, V280, P11224, DOI 10.1074/jbc.M411471200	113	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2010	5	3							e9484	10.1371/journal.pone.0009484	http://dx.doi.org/10.1371/journal.pone.0009484			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	562OY	20209156	Green Published, gold, Green Submitted			2022-12-25	WOS:000275063300005
J	Filippone, C; Franssila, R; Kumar, A; Saikko, L; Kovanen, PE; Soderlund-Venermo, M; Hedman, K				Filippone, Claudia; Franssila, Rauli; Kumar, Arun; Saikko, Leena; Kovanen, Panu E.; Soderlund-Venermo, Maria; Hedman, Klaus			Erythroid Progenitor Cells Expanded from Peripheral Blood without Mobilization or Preselection: Molecular Characteristics and Functional Competence	PLOS ONE			English	Article							HUMAN PARVOVIRUS B19; CANDIDATE RECOMBINANT VACCINE; IN-VITRO; BONE-MARROW; PRODUCTIVE INFECTION; ANTIGEN-EXPRESSION; STEM-CELLS; REPLICATION; PROLIFERATION; DIFFERENTIATION	Background: Continued development of in-vitro procedures for expansion and differentiation of erythroid progenitor cells (EPC) is essential not only in hematology and stem cell research but also virology, in light of the strict erythrotropism of the clinically important human parvovirus B19. Methodology/Principal Findings: We cultured EPC directly from ordinary blood samples, without ex vivo stem cell mobilization or CD34+ cell in vitro preselection. Profound increase in the absolute cell number and clustering activity were observed during culture. The cells obtained expressed the EPC marker combination CD36, CD71 and glycophorin, but none of the lymphocyte, monocyte or NK markers. The functionality of the generated EPC was examined by an in vitro infection assay with human parvovirus B19, tropic for BFU-E and CFU-E cells. Following infection (i) viral DNA replication and mRNA production were confirmed by quantitative PCR, and (ii) structural and nonstructural proteins were expressed in >50% of the cells. As the overall cell number increased 100-200 fold, and the proportion of competent EPC (CD34+ to CD36+) rose from <0.5% to >50%, the in vitro culture procedure generated the EPC at an efficiency of >10 000-fold. Comparative culturing of unselected PBMC and ex vivo-preselected CD34+ cells produced qualitatively and quantitatively similar yields of EPC. Conclusions/Significance: This approach yielding EPC directly from unmanipulated peripheral blood is gratifyingly robust and will facilitate the study of myeloid infectious agents such as the B19 virus, as well as the examination of erythropoiesis and its cellular and molecular mechanisms.	[Filippone, Claudia; Franssila, Rauli; Kumar, Arun; Soderlund-Venermo, Maria; Hedman, Klaus] Univ Helsinki, Dept Virol, Haartman Inst, Helsinki, Finland; [Filippone, Claudia; Franssila, Rauli; Kumar, Arun; Soderlund-Venermo, Maria; Hedman, Klaus] Univ Helsinki, Lab Div, Helsinki, Finland; [Saikko, Leena; Kovanen, Panu E.] Univ Helsinki, Dept Pathol, Haartman Inst, Helsinki, Finland	University of Helsinki; University of Helsinki; University of Helsinki	Filippone, C (corresponding author), Univ Helsinki, Dept Virol, Haartman Inst, Helsinki, Finland.	claudia.filippone@pasteur.fr	Söderlund-Venermo, Maria/AAX-2112-2020; Hedman, Klaus/D-5379-2009; Kumar, Arun/C-9466-2013	Kumar, Arun/0000-0003-4483-7585; Hedman, Klaus/0000-0003-1779-7960	Helsinki University Central Hospital Research and Education and Research and Development; Academy of Finland [1122539]; Sigrid Juselius Foundation; Medical Society of Finland; Centre for International Mobility (CIMO)	Helsinki University Central Hospital Research and Education and Research and Development; Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Medical Society of Finland; Centre for International Mobility (CIMO)	This work was supported by the Helsinki University Central Hospital Research and Education and Research and Development funds, the Academy of Finland (project 1122539), the Sigrid Juselius Foundation, the Medical Society of Finland (FLS), and the Centre for International Mobility (CIMO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balducci E, 2003, STEM CELLS, V21, P33, DOI 10.1634/stemcells.21-1-33; Barrett L, 2007, J LEUKOCYTE BIOL, V82, P152, DOI 10.1189/jlb.0806521; Bonvicini F, 2006, VIROLOGY, V347, P447, DOI 10.1016/j.virol.2005.12.014; Bonvicini F, 2008, VIROLOGY, V381, P168, DOI 10.1016/j.virol.2008.09.002; Bony V, 1999, BRIT J HAEMATOL, V107, P263, DOI 10.1046/j.1365-2141.1999.01721.x; Broliden K, 2006, J INTERN MED, V260, P285, DOI 10.1111/j.1365-2796.2006.01697.x; BROWN KE, 1993, SCIENCE, V262, P114, DOI 10.1126/science.8211117; BROWN KE, 1991, J GEN VIROL, V72, P741, DOI 10.1099/0022-1317-72-3-741; CORREA PN, 1991, BLOOD, V78, P2823; DEWOLF JTM, 1994, BLOOD, V84, P59, DOI 10.1182/blood.V84.1.59.bloodjournal84159; EMERSON SG, 1989, BLOOD, V74, P49; Febbraio M, 2001, J CLIN INVEST, V108, P785, DOI 10.1172/JCI200114006; FIBACH E, 1989, BLOOD, V73, P100; Franssila R, 2004, VACCINE, V22, P3809, DOI 10.1016/j.vaccine.2003.06.003; Franssila R, 2001, J INFECT DIS, V183, P805, DOI 10.1086/318819; Freyssinier JM, 1999, BRIT J HAEMATOL, V106, P912; Gallinella G, 2000, VIROLOGY, V278, P361, DOI 10.1006/viro.2000.0673; Giarratana MC, 2005, NAT BIOTECHNOL, V23, P69, DOI 10.1038/nbt1047; Gigler A, 1999, J VIROL, V73, P1974, DOI 10.1128/JVI.73.3.1974-1979.1999; Guan WX, 2008, J VIROL, V82, P9951, DOI 10.1128/JVI.01162-08; Guo M, 1999, CYTOTHERAPY, V1, P183, DOI 10.1080/14653249910001591266; Hokynar K, 2004, J CLIN MICROBIOL, V42, P2013, DOI 10.1128/JCM.42.5.2013-2019.2004; Huh HY, 1996, BLOOD, V87, P2020; Kaikkonen L, 1999, J CLIN MICROBIOL, V37, P3952, DOI 10.1128/JCM.37.12.3952-3956.1999; Kaikkonen L, 2001, J MED VIROL, V64, P360, DOI 10.1002/jmv.1059; Liu XL, 2007, J LEUKOCYTE BIOL, V82, P986, DOI 10.1189/jlb.0107014; Migliaccio G, 2002, BLOOD CELL MOL DIS, V28, P169, DOI 10.1006/bcmd.2002.0502; Miller JL, 1999, EXP HEMATOL, V27, P624, DOI 10.1016/S0301-472X(98)00086-1; Miyagawa E, 1999, J VIROL METHODS, V83, P45, DOI 10.1016/S0166-0934(99)00105-6; MORTIMER PP, 1983, NATURE, V302, P426, DOI 10.1038/302426a0; NAKAHATA T, 1994, LEUKEMIA LYMPHOMA, V13, P401, DOI 10.3109/10428199409049629; NATHAN DG, 1978, J EXP MED, V147, P324, DOI 10.1084/jem.147.2.324; Norja P, 2006, P NATL ACAD SCI USA, V103, P7450, DOI 10.1073/pnas.0602259103; OKUMURA N, 1992, BLOOD, V80, P642; OZAWA K, 1987, BLOOD, V70, P384, DOI 10.1182/blood.V70.2.384.384; Pierzchalska M, 2007, J PHYSIOL PHARMACOL, V58, P207; SATO N, 1993, BLOOD, V82, P3600; SCHWARZ TF, 1992, J VIROL, V66, P1273, DOI 10.1128/JVI.66.2.1273-1276.1992; SERKE S, 1991, BRIT J HAEMATOL, V79, P6, DOI 10.1111/j.1365-2141.1991.tb07999.x; SHIMOMURA S, 1992, BLOOD, V79, P18; SODERLUND M, 1995, J INFECT DIS, V171, P710, DOI 10.1093/infdis/171.3.710; SODERLUND M, 1995, J INFECT DIS, V172, P1431, DOI 10.1093/infdis/172.6.1431; SRIVASTAVA A, 1988, J VIROL, V62, P3059, DOI 10.1128/JVI.62.8.3059-3063.1988; SRIVASTAVA CH, 1992, VIROLOGY, V189, P456, DOI 10.1016/0042-6822(92)90569-B; Sugawara H, 2001, TRANSFUSION, V41, P456, DOI 10.1046/j.1537-2995.2001.41040456.x; TAKAHASHI T, 1990, BLOOD, V75, P603; WADA H, 1990, BLOOD, V75, P505, DOI 10.1182/blood.V75.2.505.505; Wong S, 2008, J VIROL, V82, P2470, DOI 10.1128/JVI.02247-07; YAEGASHI N, 1989, J VIROL, V63, P2422, DOI 10.1128/JVI.63.6.2422-2426.1989; Young NS, 2004, NEW ENGL J MED, V350, P586, DOI 10.1056/NEJMra030840; ZUCKERMAN KS, 1981, J CLIN INVEST, V67, P702, DOI 10.1172/JCI110086	51	32	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2010	5	3							e9496	10.1371/journal.pone.0009496	http://dx.doi.org/10.1371/journal.pone.0009496			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	562OY	20209110	Green Published, Green Submitted, gold			2022-12-25	WOS:000275063300012
J	Zahid, M; Velez-Fort, M; Papagiakoumou, E; Ventalon, C; Angulo, MC; Emiliani, V				Zahid, Morad; Velez-Fort, Mateo; Papagiakoumou, Eirini; Ventalon, Cathie; Angulo, Maria Cecilia; Emiliani, Valentina			Holographic Photolysis for Multiple Cell Stimulation in Mouse Hippocampal Slices	PLOS ONE			English	Article							CA1 PYRAMIDAL NEURONS; RAT BARREL CORTEX; ILLUMINATION MICROSCOPY; AMPA RECEPTORS; REMOTE-CONTROL; GLUTAMATE; SYNAPSES; PLASTICITY; LIGHT; ACTIVATION	Background: Advanced light microscopy offers sensitive and non-invasive means to image neural activity and to control signaling with photolysable molecules and, recently, light-gated channels. These approaches require precise and yet flexible light excitation patterns. For synchronous stimulation of subsets of cells, they also require large excitation areas with millisecond and micrometric resolution. We have recently developed a new method for such optical control using a phase holographic modulation of optical wave-fronts, which minimizes power loss, enables rapid switching between excitation patterns, and allows a true 3D sculpting of the excitation volumes. In previous studies we have used holographic photololysis to control glutamate uncaging on single neuronal cells. Here, we extend the use of holographic photolysis for the excitation of multiple neurons and of glial cells. Methods/Principal Findings: The system combines a liquid crystal device for holographic patterned photostimulation, high-resolution optical imaging, the HiLo microscopy, to define the stimulated regions and a conventional Ca2+ imaging system to detect neural activity. By means of electrophysiological recordings and calcium imaging in acute hippocampal slices, we show that the use of excitation patterns precisely tailored to the shape of multiple neuronal somata represents a very efficient way for the simultaneous excitation of a group of neurons. In addition, we demonstrate that fast shaped illumination patterns also induce reliable responses in single glial cells. Conclusions/Significance: We show that the main advantage of holographic illumination is that it allows for an efficient excitation of multiple cells with a spatiotemporal resolution unachievable with other existing approaches. Although this paper focuses on the photoactivation of caged molecules, our approach will surely prove very efficient for other probes, such as light-gated channels, genetically encoded photoactivatable proteins, photoactivatable fluorescent proteins, and voltage-sensitive dyes.	[Zahid, Morad; Papagiakoumou, Eirini; Ventalon, Cathie; Emiliani, Valentina] Univ Paris 05, INSERM, Wavefront Engn Microscopy Grp,U603, Neurophysiol & New Microscopies Lab,CNRS UMR 8154, Paris, France; [Velez-Fort, Mateo; Angulo, Maria Cecilia] Univ Paris 05, INSERM, Neuron Glia Interact Grp,U603, Neurophysiol & New Microscopies Lab,CNRS UMR 8154, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Zahid, M (corresponding author), Univ Paris 05, INSERM, Wavefront Engn Microscopy Grp,U603, Neurophysiol & New Microscopies Lab,CNRS UMR 8154, Paris, France.	valentina.emiliani@parisdescartes.fr	Papagiakoumou, Eirini/B-1150-2017; Angulo, Maria Cecilia/B-8236-2014; Papagiakoumou, Eirini/ABC-7935-2021; PAPAGIAKOUMOU, Eirini/Q-4472-2019	Papagiakoumou, Eirini/0000-0002-7333-8796; Angulo, Maria Cecilia/0000-0002-0758-0496; PAPAGIAKOUMOU, Eirini/0000-0002-7333-8796; Ventalon, Cathie/0000-0001-8174-7840; Velez-Fort, Mateo/0000-0002-2640-4666; Emiliani, Valentina/0000-0003-2992-9510	Network of European Neuroscience Institutes (ENINET) [LSHM-CT-2005-19063]; European Science Fondation (ESF); "Centre National de la Recherche Scientifique'' (CNRS); European Commission [LSHM-CT-2007-037765]; "Agence Nationale de la Recherche'' (ANR); "Region Ile-de-France'' and "Ligue Francaise contre la Sclerose En Plaques'' (LFSEP)	Network of European Neuroscience Institutes (ENINET); European Science Fondation (ESF); "Centre National de la Recherche Scientifique'' (CNRS)(Centre National de la Recherche Scientifique (CNRS)); European Commission(European CommissionEuropean Commission Joint Research Centre); "Agence Nationale de la Recherche'' (ANR)(French National Research Agency (ANR)); "Region Ile-de-France'' and "Ligue Francaise contre la Sclerose En Plaques'' (LFSEP)(Region Ile-de-France)	This work was supported by the Network of European Neuroscience Institutes (ENINET, contract number LSHM-CT-2005-19063), the European Science Fondation (ESF) and the "Centre National de la Recherche Scientifique'' (CNRS) through the European Young Investigator program (EURYI), the European Commission FP6 Specific Targeted Project "PHOTOLYSIS'' (contract number LSHM-CT-2007-037765). M. C. A. was supported by a young investigator grant from the "Agence Nationale de la Recherche'' (ANR). M.V.-F. was supported by fellowships from "Region Ile-de-France'' and "Ligue Francaise contre la Sclerose En Plaques'' (LFSEP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravanis AM, 2007, J NEURAL ENG, V4, pS143, DOI 10.1088/1741-2560/4/3/S02; Banghart M, 2004, NAT NEUROSCI, V7, P1381, DOI 10.1038/nn1356; Bergles DE, 2000, NATURE, V405, P187, DOI 10.1038/35012083; Canepari M, 2001, J NEUROSCI METH, V112, P29, DOI 10.1016/S0165-0270(01)00451-4; Dantzker JL, 2000, NAT NEUROSCI, V3, P701, DOI 10.1038/76656; DiGregorio DA, 2007, J NEUROSCI, V27, P8344, DOI 10.1523/JNEUROSCI.2399-07.2007; FARAH N, 2007, C P IEEE ENG MED BIO, P6369; Fellin T, 2004, NEURON, V43, P729, DOI 10.1016/j.neuron.2004.08.011; Gasparini S, 2006, J NEUROSCI, V26, P2088, DOI 10.1523/JNEUROSCI.4428-05.2006; Ge WP, 2006, SCIENCE, V312, P1533, DOI 10.1126/science.1124669; Golan L, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/6/066004; Gordon GRJ, 2009, NEURON, V64, P391, DOI 10.1016/j.neuron.2009.10.021; Gorostiza P, 2008, SCIENCE, V322, P395, DOI 10.1126/science.1166022; Gradinaru V, 2009, SCIENCE, V324, P354, DOI 10.1126/science.1167093; HORNBECK LJ, 1983, IEEE T ELECTRON DEV, V30, P539, DOI 10.1109/T-ED.1983.21163; Judkewitz B, 2006, NEURON, V50, P180, DOI 10.1016/j.neuron.2006.04.011; Lim D, 2008, OPT LETT, V33, P1819, DOI 10.1364/OL.33.001819; Liu QS, 2004, P NATL ACAD SCI USA, V101, P3172, DOI 10.1073/pnas.0306731101; Losonczy A, 2006, NEURON, V50, P291, DOI 10.1016/j.neuron.2006.03.016; Lutz C, 2008, NAT METHODS, V5, P821, DOI 10.1038/NMETH.1241; Matsuzaki M, 2008, J NEUROPHYSIOL, V99, P1535, DOI 10.1152/jn.01127.2007; Matthias K, 2003, J NEUROSCI, V23, P1750; Metea MR, 2006, J NEUROSCI, V26, P2862, DOI 10.1523/JNEUROSCI.4048-05.2006; MOHANTY SK, 2008, BIOPHYS J; Mulligan SJ, 2004, NATURE, V431, P195, DOI 10.1038/nature02827; Nikolenko V, 2007, NAT METHODS, V4, P943, DOI 10.1038/NMETH1105; Nikolenko V, 2008, FRONT NEURAL CIRCUIT, V2, DOI 10.3389/neuro.04.005.2008; Nishiyama A, 2009, NAT REV NEUROSCI, V10, P9, DOI 10.1038/nrn2495; Oron D, 2005, OPT EXPRESS, V13, P1468, DOI 10.1364/OPEX.13.001468; Papagiakoumou E, 2008, OPT EXPRESS, V16, P22039, DOI 10.1364/OE.16.022039; Perea G, 2007, SCIENCE, V317, P1083, DOI 10.1126/science.1144640; Polin M, 2005, OPT EXPRESS, V13, P5831, DOI 10.1364/OPEX.13.005831; Rickgauer JP, 2009, P NATL ACAD SCI USA, V106, P15025, DOI 10.1073/pnas.0907084106; Santos S, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3130266; Shepherd GMG, 2005, J NEUROSCI, V25, P5670, DOI 10.1523/JNEUROSCI.1173-05.2005; Shepherd GMG, 2003, NEURON, V38, P277, DOI 10.1016/S0896-6273(03)00152-1; Shoham S, 2005, NAT METHODS, V2, P837, DOI 10.1038/nmeth793; Szobota S, 2007, NEURON, V54, P535, DOI 10.1016/j.neuron.2007.05.010; TANG CM, 2006, CURR PROTOC NEUROSCI, pCH6; Thompson SM, 2005, J NEUROSCI, V25, P10358, DOI 10.1523/JNEUROSCI.3515-05.2005; Trigo FF, 2009, J NEUROSCI METH, V180, P9, DOI 10.1016/j.jneumeth.2009.01.032; Velez-Fort M, 2009, GLIA, V57, P1104, DOI 10.1002/glia.20834; Ventalon C, 2007, OPT LETT, V32, P1417, DOI 10.1364/OL.32.001417; Wang S, 2007, NANO LETT, V7, P3859, DOI 10.1021/nl072783t; Wyart C, 2009, NATURE, V461, P407, DOI 10.1038/nature08323; WYROWSKI F, 1988, J OPT SOC AM A, V5, P1058, DOI 10.1364/JOSAA.5.001058; Zhang Guang Lan, 2006, Immunome Res, V2, P3, DOI 10.1186/1745-7580-2-3; Ziskin JL, 2007, NAT NEUROSCI, V10, P321, DOI 10.1038/nn1854	48	38	38	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2010	5	2							e9431	10.1371/journal.pone.0009431	http://dx.doi.org/10.1371/journal.pone.0009431			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SY	20195547	gold, Green Published, Green Submitted			2022-12-25	WOS:000274924300018
J	Brown, JW; McKnight, CJ				Brown, Jeffrey W.; McKnight, C. James			Molecular Model of the Microvillar Cytoskeleton and Organization of the Brush Border	PLOS ONE			English	Article							PARALLEL ACTIN BUNDLES; MYOSIN-I; F-ACTIN; CRYSTAL-STRUCTURE; CONFORMATIONAL-CHANGES; ELECTRON-MICROSCOPY; MEMBRANE SKELETON; BINDING PROTEIN; LIPID RAFTS; VILLIN	Background: Brush border microvilli are similar to 1-mu m long finger-like projections emanating from the apical surfaces of certain, specialized absorptive epithelial cells. A highly symmetric hexagonal array of thousands of these uniformly sized structures form the brush border, which in addition to aiding in nutrient absorption also defends the large surface area against pathogens. Here, we present a molecular model of the protein cytoskeleton responsible for this dramatic cellular morphology. Methodology/Principal Findings: The model is constructed from published crystallographic and microscopic structures reported by several groups over the last 30+ years. Our efforts resulted in a single, unique, self-consistent arrangement of actin, fimbrin, villin, brush border myosin (Myo1A), calmodulin, and brush border spectrin. The central actin core bundle that supports the microvillus is nearly saturated with fimbrin and villin cross-linkers and has a density similar to that found in protein crystals. The proposed model accounts for all major proteinaceous components, reproduces the experimentally determined stoichiometry, and is consistent with the size and morphology of the biological brush border membrane. Conclusions/Significance: The model presented here will serve as a structural framework to explain many of the dynamic cellular processes occurring over several time scales, such as protein diffusion, association, and turnover, lipid raft sorting, membrane deformation, cytoskeletal-membrane interactions, and even effacement of the brush border by invading pathogens. In addition, this model provides a structural basis for evaluating the equilibrium processes that result in the uniform size and structure of the highly dynamic microvilli.	[Brown, Jeffrey W.; McKnight, C. James] Boston Univ, Sch Med, Dept Physiol & Biophys, Boston, MA 02118 USA	Boston University	Brown, JW (corresponding author), Boston Univ, Sch Med, Dept Physiol & Biophys, Boston, MA 02118 USA.	cjmck@bu.edu	Brown, Jeffrey Wade/ABA-7141-2021	Brown, Jeffrey Wade/0000-0002-3992-9613; McKnight, Christopher/0000-0002-3237-0896	Boston University Graduate Student Research Fellowship; National Institutes of Health (NIH) [GM62886]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062886] Funding Source: NIH RePORTER	Boston University Graduate Student Research Fellowship; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Financial support was provided by a Boston University Graduate Student Research Fellowship to J.W.B. and National Institutes of Health (NIH) Grant GM62886 to C.J.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abyzov A, 2005, BIOINFORMATICS, V21, P3677, DOI 10.1093/bioinformatics/bti602; [Anonymous], 2004, PERS VIS RAYTR VERS; Athman R, 2005, CELL MICROBIOL, V7, P1109, DOI 10.1111/j.1462-5822.2005.00535.x; Bartles JR, 2000, CURR OPIN CELL BIOL, V12, P72, DOI 10.1016/S0955-0674(99)00059-9; Bartles JR, 1998, J CELL BIOL, V143, P107, DOI 10.1083/jcb.143.1.107; Barylko B, 2000, BBA-MOL CELL RES, V1496, P23, DOI 10.1016/S0167-4889(00)00006-9; Borrego-Diaz E, 2006, J STRUCT BIOL, V155, P230, DOI 10.1016/j.jsb.2006.01.013; BRETSCHER A, 1980, CELL, V20, P839, DOI 10.1016/0092-8674(80)90330-X; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; COHEN CM, 1980, CELL, V21, P875, DOI 10.1016/0092-8674(80)90451-1; COLUCCIO LM, 1989, J CELL BIOL, V108, P495, DOI 10.1083/jcb.108.2.495; Coluccio LM, 1997, AM J PHYSIOL-CELL PH, V273, pC347, DOI 10.1152/ajpcell.1997.273.2.C347; CRAIG SW, 1980, CELL, V22, P739, DOI 10.1016/0092-8674(80)90550-4; Croce A, 2004, NAT CELL BIOL, V6, P1173, DOI 10.1038/ncb1198; Danielsen EM, 2003, BBA-BIOMEMBRANES, V1617, P1, DOI 10.1016/j.bbamem.2003.09.005; DEROSIER DJ, 1980, NATURE, V287, P291, DOI 10.1038/287291a0; Ferrary E, 1999, J CELL BIOL, V146, P819, DOI 10.1083/jcb.146.4.819; Galkin VE, 2002, NAT STRUCT BIOL, V9, P518, DOI 10.1038/nsb811; Galkin VE, 2008, P NATL ACAD SCI USA, V105, P1494, DOI 10.1073/pnas.0708667105; GLENNEY JR, 1981, CELL, V24, P471, DOI 10.1016/0092-8674(81)90338-X; GLENNEY JR, 1982, CELL, V28, P843, DOI 10.1016/0092-8674(82)90063-0; Goodsell DS, 2000, ANNU REV BIOPH BIOM, V29, P105, DOI 10.1146/annurev.biophys.29.1.105; GRANGER B, 1950, ANAT REC, V107, P423, DOI 10.1002/ar.1091070409; Hampton CM, 2008, STRUCTURE, V16, P1882, DOI 10.1016/j.str.2008.09.015; Hansen GH, 2001, J BIOL CHEM, V276, P32338, DOI 10.1074/jbc.M102667200; HAYDEN SM, 1990, J CELL BIOL, V111, P443, DOI 10.1083/jcb.111.2.443; HESTERBERG LK, 1983, J BIOL CHEM, V258, P359; HIROKAWA N, 1983, CELL, V32, P953, DOI 10.1016/0092-8674(83)90080-6; HIROKAWA N, 1982, J CELL BIOL, V94, P425, DOI 10.1083/jcb.94.2.425; HIROKAWA N, 1981, J CELL BIOL, V91, P399, DOI 10.1083/jcb.91.2.399; Holmes KC, 2003, NATURE, V425, P423, DOI 10.1038/nature02005; Houdusse A, 2006, P NATL ACAD SCI USA, V103, P19326, DOI 10.1073/pnas.0609436103; Iizumi Y, 2007, CELL HOST MICROBE, V2, P383, DOI 10.1016/j.chom.2007.09.012; Ilyin VA, 2004, PROTEIN SCI, V13, P1865, DOI 10.1110/ps.04672604; Jewett AI, 2003, BIOINFORMATICS, V19, P625, DOI 10.1093/bioinformatics/btg035; JONTES JD, 1995, NATURE, V378, P751, DOI 10.1038/378751a0; Jontes JD, 1997, J CELL BIOL, V139, P683, DOI 10.1083/jcb.139.3.683; Jontes JD, 1997, J MOL BIOL, V266, P331, DOI 10.1006/jmbi.1996.0777; Kantardjieff KA, 2003, PROTEIN SCI, V12, P1865, DOI 10.1110/ps.0350503; Kleywegt G. J., UNPUB; Kollmar M, 2002, EMBO J, V21, P2517, DOI 10.1093/emboj/21.11.2517; Kumar N, 2004, J BIOL CHEM, V279, P3096, DOI 10.1074/jbc.M308878200; Kusunoki H, 2004, J MOL BIOL, V344, P495, DOI 10.1016/j.jmb.2004.09.019; Lauwaet T, 2003, J BIOL CHEM, V278, P22650, DOI 10.1074/jbc.M300142200; Lilic M, 2003, SCIENCE, V301, P1918, DOI 10.1126/science.1088433; Loomis PA, 2003, J CELL BIOL, V163, P1045, DOI 10.1083/jcb.200309093; MATSUDAIRA P, 1983, NATURE, V301, P209, DOI 10.1038/301209a0; MATSUDAIRA PT, 1982, J CELL BIOL, V92, P657, DOI 10.1083/jcb.92.3.657; MATSUDAIRA PT, 1979, J CELL BIOL, V83, P667, DOI 10.1083/jcb.83.3.667; MATSUDAIRA PT, 1983, CIBA F SYMP, V95, P233; MATSUDAIRA PT, 1981, COLD SPRING HARB SYM, V46, P845; Mattoo S, 2008, DEV CELL, V14, P8, DOI 10.1016/j.devcel.2007.12.016; McConnell RE, 2007, J CELL BIOL, V177, P671, DOI 10.1083/jcb.200701144; MCGOUGH AM, 1990, P NATL ACAD SCI USA, V87, P5208, DOI 10.1073/pnas.87.13.5208; Mogilner A, 2003, BIOPHYS J, V84, P1591, DOI 10.1016/S0006-3495(03)74969-8; MOOSEKER MS, 1975, J CELL BIOL, V67, P725, DOI 10.1083/jcb.67.3.725; MOOSEKER MS, 1980, J CELL BIOL, V87, P809, DOI 10.1083/jcb.87.3.809; MOOSEKER MS, 1983, CELL, V35, P11, DOI 10.1016/0092-8674(83)90202-7; MOOSEKER MS, 1989, J CELL BIOL, V109, P1153, DOI 10.1083/jcb.109.3.1153; MOOSEKER MS, 1982, J CELL BIOL, V95, P223, DOI 10.1083/jcb.95.1.223; NERMUT MV, 1981, EUR J CELL BIOL, V25, P265; Oda T, 2009, NATURE, V457, P441, DOI 10.1038/nature07685; OHNO SI, 1992, J ANAT, V180, P315; Panebra A, 2001, AM J PHYSIOL-CELL PH, V281, pC1046, DOI 10.1152/ajpcell.2001.281.3.C1046; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PINDER JC, 1983, J CELL BIOL, V96, P768, DOI 10.1083/jcb.96.3.768; Pinson KI, 1998, DEV DYNAM, V211, P109, DOI 10.1002/(SICI)1097-0177(199801)211:1<109::AID-AJA10>3.0.CO;2-7; Rzadzinska AK, 2004, J CELL BIOL, V164, P887, DOI 10.1083/jcb.200310055; Saotome I, 2004, DEV CELL, V6, P855, DOI 10.1016/j.devcel.2004.05.007; Smirnov SL, 2007, BIOCHEMISTRY-US, V46, P7488, DOI 10.1021/bi700110v; Smith WJ, 2003, J BIOL CHEM, V278, P4949, DOI 10.1074/jbc.M210601200; STECK TL, 1974, J CELL BIOL, V62, P1, DOI 10.1083/jcb.62.1.1; Swihart AH, 2001, J MICROSC-OXFORD, V204, P212, DOI 10.1046/j.1365-2818.2001.00960.x; Takeuchi M, 1998, BIOPHYS J, V74, P2171, DOI 10.1016/S0006-3495(98)77926-3; Tyska MJ, 2002, BIOPHYS J, V82, P1869, DOI 10.1016/S0006-3495(02)75537-9; Tyska MJ, 2005, MOL BIOL CELL, V16, P2443, DOI 10.1091/mbc.e04-12-1116; Tyska MJ, 2004, J CELL BIOL, V165, P395, DOI 10.1083/jcb.200310031; URSITTI JA, 1991, CELL MOTIL CYTOSKEL, V19, P227, DOI 10.1002/cm.970190402; Veigel C, 1999, NATURE, V398, P530, DOI 10.1038/19104; Volkmann N, 2001, J CELL BIOL, V153, P947, DOI 10.1083/jcb.153.5.947; Wolfrum U, 1998, CELL MOTIL CYTOSKEL, V40, P261, DOI 10.1002/(SICI)1097-0169(1998)40:3<261::AID-CM5>3.3.CO;2-#; Zheng LL, 2000, CELL, V102, P377, DOI 10.1016/S0092-8674(00)00042-8; Zhou D, 1999, SCIENCE, V283, P2092, DOI 10.1126/science.283.5410.2092; Zhou DG, 1999, P NATL ACAD SCI USA, V96, P10176, DOI 10.1073/pnas.96.18.10176	84	44	46	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2010	5	2							e9406	10.1371/journal.pone.0009406	http://dx.doi.org/10.1371/journal.pone.0009406			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SX	20195380	Green Published, gold, Green Submitted			2022-12-25	WOS:000274924200026
J	Hensen, U; Lange, OF; Grubmuller, H				Hensen, Ulf; Lange, Oliver F.; Grubmueller, Helmut			Estimating Absolute Configurational Entropies of Macromolecules: The Minimally Coupled Subspace Approach	PLOS ONE			English	Article							FREE-ENERGY; MOLECULAR-DYNAMICS; SIMULATION; EFFICIENT; WATER	We develop a general minimally coupled subspace approach (MCSA) to compute absolute entropies of macromolecules, such as proteins, from computer generated canonical ensembles. Our approach overcomes limitations of current estimates such as the quasi-harmonic approximation which neglects non-linear and higher-order correlations as well as multi-minima characteristics of protein energy landscapes. Here, Full Correlation Analysis, adaptive kernel density estimation, and mutual information expansions are combined and high accuracy is demonstrated for a number of test systems ranging from alkanes to a 14 residue peptide. We further computed the configurational entropy for the full 67-residue cofactor of the TATA box binding protein illustrating that MCSA yields improved results also for large macromolecular systems.	[Hensen, Ulf; Grubmueller, Helmut] Max Planck Inst Biophys Chem, Dept Theoret & Computat Biophys, Gottingen, Germany; [Lange, Oliver F.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA	Max Planck Society; University of Washington; University of Washington Seattle	Hensen, U (corresponding author), Max Planck Inst Biophys Chem, Dept Theoret & Computat Biophys, Gottingen, Germany.	olange@u.washington.edu	Lange, Oliver/K-5749-2012; Lange, Oliver/G-1366-2010	Lange, Oliver/0000-0002-4018-7020; 	Deutsche Forschungsgemeinschaft [782]; Human Frontiers of Science Program; Volkswagen Foundation [I/80436]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Human Frontiers of Science Program(Human Frontier Science Program); Volkswagen Foundation(Volkswagen)	U. H. was supported by the Deutsche Forschungsgemeinschaft (research training group 782). O.F.L. was supported by the Human Frontiers of Science Program and by the Volkswagen Foundation, Grant I/80436. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attard P, 1997, PHYS REV E, V56, P4052, DOI 10.1103/PhysRevE.56.4052; Attard P, 1999, STAT PHYS EVE 21 CEN; BARANYAI A, 1989, PHYS REV A, V40, P3817, DOI 10.1103/PhysRevA.40.3817; Baron Riccardo, 2006, Trends in Physical Chemistry, V11, P87; Baron R, 2006, J PHYS CHEM B, V110, P8464, DOI 10.1021/jp055888y; Baron R, 2008, CHEMPHYSCHEM, V9, P983, DOI 10.1002/cphc.200700857; Bellman R., 1961, ADAPTIVE CONTROL PRO; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; BEVERIDGE DL, 1989, ANNU REV BIOPHYS BIO, V18, P431, DOI 10.1146/annurev.bb.18.060189.002243; Chang CE, 2005, J CHEM THEORY COMPUT, V1, P1017, DOI 10.1021/ct0500904; Chang CE, 2003, J PHYS CHEM B, V107, P1048, DOI 10.1021/jp027149c; Chang CEA, 2007, P NATL ACAD SCI USA, V104, P1534, DOI 10.1073/pnas.0610494104; Cheluvaraja S, 2004, P NATL ACAD SCI USA, V101, P9241, DOI 10.1073/pnas.0308201101; Cheluvaraja S, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2208608; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Gilson MK, 2007, ANNU REV BIOPH BIOM, V36, P21, DOI 10.1146/annurev.biophys.36.040306.132550; HENNIG M, 2007, THESIS U JENA; Hensen U, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.011913; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2002, J CHEM PHYS, V116, P209, DOI 10.1063/1.1421362; Hnizdo V, 2008, J COMPUT CHEM, V29, P1605, DOI 10.1002/jcc.20919; Hnizdo V, 2007, J COMPUT CHEM, V28, P655, DOI 10.1002/jcc.20589; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kaminski GA, 2001, J PHYS CHEM B, V105, P6474, DOI 10.1021/jp003919d; Karplus M, 2002, NAT STRUCT BIOL, V9, P646, DOI 10.1038/nsb0902-646; KARPLUS M, 1981, MACROMOLECULES, V14, P325, DOI 10.1021/ma50003a019; Killian BJ, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2746329; KOLLMAN P, 1993, CHEM REV, V93, P2395, DOI 10.1021/cr00023a004; Kolossvary I, 1997, J PHYS CHEM A, V101, P9900, DOI 10.1021/jp972794i; Kraskov A, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066138; Lange OF, 2006, PROTEINS, V62, P1053, DOI 10.1002/prot.20784; Lange OF, 2008, PROTEINS, V70, P1294, DOI 10.1002/prot.21618; Meirovitch H, 2007, CURR OPIN STRUC BIOL, V17, P181, DOI 10.1016/j.sbi.2007.03.016; Minh DDL, 2005, BIOPHYS J, V89, pL25, DOI 10.1529/biophysj.105.069336; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Pereira CS, 2006, BIOPHYS J, V90, P4337, DOI 10.1529/biophysj.106.081539; Peter C, 2004, J CHEM PHYS, V120, P2652, DOI 10.1063/1.1636153; Reinhard F, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2400220; SCHLITTER J, 1993, CHEM PHYS LETT, V215, P617, DOI 10.1016/0009-2614(93)89366-P; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; STRAATSMA TP, 1992, ANNU REV PHYS CHEM, V43, P407; Tyka MD, 2006, J PHYS CHEM B, V110, P17212, DOI 10.1021/jp060734j; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; VANGUNSTEREN WF, 1998, GROMOS FORCE FIELD, P1211	44	54	54	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2010	5	2							e9179	10.1371/journal.pone.0009179	http://dx.doi.org/10.1371/journal.pone.0009179			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SV	20186277	Green Submitted, Green Published, gold			2022-12-25	WOS:000274924000001
J	Hurst, DP; Grossfield, A; Lynch, DL; Feller, S; Romo, TD; Gawrisch, K; Pitman, MC; Reggio, PH				Hurst, Dow P.; Grossfield, Alan; Lynch, Diane L.; Feller, Scott; Romo, Tod D.; Gawrisch, Klaus; Pitman, Michael C.; Reggio, Patricia H.			A Lipid Pathway for Ligand Binding Is Necessary for a Cannabinoid G Protein-coupled Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED CONFORMATIONAL-CHANGES; CRYSTAL-STRUCTURE; IONIC LOCK; BETA(2)-ADRENERGIC RECEPTOR; FUNCTIONAL MICRODOMAINS; METARHODOPSIN-II; PROTON UPTAKE; RHODOPSIN; ACTIVATION; CB2	Recent isothiocyanate covalent labeling studies have suggested that a classical cannabinoid, (-)-7'-isothiocyanato-11-hydroxy-1',1'dimethylheptyl-hexahydrocannabinol (AM841), enters the cannabinoid CB2 receptor via the lipid bilayer (Pei, Y., Mercier, R. W., Anday, J. K., Thakur, G. A., Zvonok, A. M., Hurst, D., Reggio, P. H., Janero, D. R., and Makriyannis, A. (2008) Chem. Biol. 15, 1207-1219). However, the sequence of steps involved in such a lipid pathway entry has not yet been elucidated. Here, we test the hypothesis that the endogenous cannabinoid sn-2-arachidonoylglycerol (2-AG) attains access to the CB2 receptor via the lipid bilayer. To this end, we have employed microsecond time scale all-atom molecular dynamics (MD) simulations of the interaction of 2-AG with CB2 via a palmitoyl-oleoyl-phosphatidylcholine lipid bilayer. Results suggest the following: 1) 2-AG first partitions out of bulk lipid at the transmembrane alpha-helix (TMH) 6/7 interface; 2) 2-AG then enters the CB2 receptor binding pocket by passing between TMH6 and TMH7; 3) the entrance of the 2-AG headgroup into the CB2 binding pocket is sufficient to trigger breaking of the intracellular TMH3/6 ionic lock and the movement of the TMH6 intracellular end away from TMH3; and 4) subsequent to protonation at D3.49/D6.30, further 2-AG entry into the ligand binding pocket results in both a W6.48 toggle switch change and a large influx of water. To our knowledge, this is the first demonstration via unbiased molecular dynamics that a ligand can access the binding pocket of a class A G protein-coupled receptor via the lipid bilayer and the first demonstration via molecular dynamics of G protein-coupled receptor activation triggered by a ligand binding event.	[Reggio, Patricia H.] Univ N Carolina, Dept Chem & Biochem, Ctr Drug Discovery, Greensboro, NC 27402 USA; [Grossfield, Alan; Romo, Tod D.] Univ Rochester, Med Ctr, Dept Biochem & Biophys, Rochester, NY 14642 USA; [Feller, Scott] Wabash Coll, Dept Chem, Crawfordsville, IN 47933 USA; [Gawrisch, Klaus] NIAAA, NIH, Bethesda, MD 20892 USA; [Pitman, Michael C.] IBM Corp, Thomas J Watson Res Ctr, Computat Biol Ctr, Yorktown Hts, NY 10598 USA	University of North Carolina; University of North Carolina Greensboro; University of Rochester; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); International Business Machines (IBM)	Reggio, PH (corresponding author), Univ N Carolina, Dept Chem & Biochem, POB 26170, Greensboro, NC 27412 USA.	phreggio@uncg.edu		Grossfield, Alan/0000-0002-5877-2789	National Institutes of Health, NIDA [DA003934, DA021358]; NIAAA; National Science Foundation [MCB-0543124]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000003] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K05DA021358, R01DA003934] Funding Source: NIH RePORTER	National Institutes of Health, NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIAAA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants DA003934 and DA021358 (to P. H. R.) from NIDA and by grants from NIAAA, Intramural Research program (to K. G.). This work was also supported by National Science Foundation Grant MCB-0543124 (to S. F.).	ANDERSEN HC, 1983, J COMPUT PHYS, V52, P24, DOI 10.1016/0021-9991(83)90014-1; ARNIS S, 1993, P NATL ACAD SCI USA, V90, P7849, DOI 10.1073/pnas.90.16.7849; ARNIS S, 1994, J BIOL CHEM, V269, P23879; Ballesteros J, 1998, J BIOL CHEM, V273, P10445, DOI 10.1074/jbc.273.17.10445; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Ballesteros JA, 2001, J BIOL CHEM, V276, P29171, DOI 10.1074/jbc.M103747200; Benito C, 2003, J NEUROSCI, V23, P11136; Borhan B, 2000, SCIENCE, V288, P2209, DOI 10.1126/science.288.5474.2209; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Di Marzo V, 2008, NAT REV DRUG DISCOV, V7, P438, DOI 10.1038/nrd2553; Dinh TP, 2002, P NATL ACAD SCI USA, V99, P10819, DOI 10.1073/pnas.152334899; Dror RO, 2009, P NATL ACAD SCI USA, V106, P4689, DOI 10.1073/pnas.0811065106; FAHMY K, 1993, P NATL ACAD SCI USA, V90, P10206, DOI 10.1073/pnas.90.21.10206; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; Feller SE, 2000, J PHYS CHEM B, V104, P7510, DOI 10.1021/jp0007843; Fitch BG, 2003, J PARALLEL DISTR COM, V63, P759, DOI 10.1016/S0743-7315(03)00084-4; Fitch BG, 2006, LECT NOTES COMPUT SC, V3992, P846, DOI 10.1007/11758525_113; GALIEGUE S, 1995, EUR J BIOCHEM, V232, P54, DOI 10.1111/j.1432-1033.1995.tb20780.x; Gara A, 2005, IBM J RES DEV, V49, P195, DOI 10.1147/rd.492.0195; Ghanouni P, 2000, J BIOL CHEM, V275, P3121, DOI 10.1074/jbc.275.5.3121; Ghanouni P, 2001, P NATL ACAD SCI USA, V98, P5997, DOI 10.1073/pnas.101126198; Grossfield A, 2006, P NATL ACAD SCI USA, V103, P4888, DOI 10.1073/pnas.0508352103; Grossfield A, 2008, J MOL BIOL, V381, P478, DOI 10.1016/j.jmb.2008.05.036; Hildebrand PW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004382; Howlett AC, 2002, PHARMACOL REV, V54, P161, DOI 10.1124/pr.54.2.161; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Javitch JA, 1997, J BIOL CHEM, V272, P18546, DOI 10.1074/jbc.272.30.18546; Jensen AD, 2001, J BIOL CHEM, V276, P9279, DOI 10.1074/jbc.M004871200; Kimura T, 2009, BIOPHYS J, V96, P4916, DOI 10.1016/j.bpj.2009.03.033; Knierim B, 2007, P NATL ACAD SCI USA, V104, P20290, DOI 10.1073/pnas.0710393104; Kobilka BK, 2007, TRENDS PHARMACOL SCI, V28, P397, DOI 10.1016/j.tips.2007.06.003; Lau PW, 2007, J MOL BIOL, V372, P906, DOI 10.1016/j.jmb.2007.06.047; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; Lin SW, 1996, BIOCHEMISTRY-US, V35, P11149, DOI 10.1021/bi960858u; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mahalingam M, 2008, P NATL ACAD SCI USA, V105, P17795, DOI 10.1073/pnas.0804541105; Martinez-Mayorga K, 2006, J AM CHEM SOC, V128, P16502, DOI 10.1021/ja0671971; MAVROMOUSTAKOS T, 1991, PHARMACOL BIOCHEM BE, V40, P547, DOI 10.1016/0091-3057(91)90361-5; McAllister SD, 2004, J BIOL CHEM, V279, P48024, DOI 10.1074/jbc.M406648200; MECHOULAM R, 1995, BIOCHEM PHARMACOL, V50, P83, DOI 10.1016/0006-2952(95)00109-D; MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0; MUSAFIA B, 1995, J MOL BIOL, V254, P761, DOI 10.1006/jmbi.1995.0653; Nakanishi J, 2006, BIOCHEM BIOPH RES CO, V343, P1191, DOI 10.1016/j.bbrc.2006.03.064; Nebane NM, 2006, FEBS LETT, V580, P5392, DOI 10.1016/j.febslet.2006.09.001; Nebane NM, 2008, BIOCHEMISTRY-US, V47, P13811, DOI 10.1021/bi8007802; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Okada T, 2002, P NATL ACAD SCI USA, V99, P5982, DOI 10.1073/pnas.082666399; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Pei Y, 2008, CHEM BIOL, V15, P1207, DOI 10.1016/j.chembiol.2008.10.011; Picone RP, 2005, MOL PHARMACOL, V68, P1623, DOI 10.1124/mol.105.014407; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Pitman MC, 2004, BIOCHEMISTRY-US, V43, P15318, DOI 10.1021/bi048231w; Pitman MC, 2005, J AM CHEM SOC, V127, P4576, DOI 10.1021/ja042715y; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Reggio PH, 2006, AAPS J, V8, pE322; Rhee MH, 2000, FEBS LETT, V466, P300, DOI 10.1016/S0014-5793(00)01094-2; Romo TD, 2009, IEEE ENG MED BIO, P2332, DOI 10.1109/IEMBS.2009.5335065; Romo TD, 2010, BIOPHYS J, V98, P76, DOI 10.1016/j.bpj.2009.09.046; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Shi L, 2002, J BIOL CHEM, V277, P14777, DOI 10.1074/jbc.M108967200; Song ZH, 1999, MOL PHARMACOL, V56, P834; Soubias O, 2006, J BIOL CHEM, V281, P33233, DOI 10.1074/jbc.M603059200; SUGIURA T, 1995, BIOCHEM BIOPH RES CO, V215, P89, DOI 10.1006/bbrc.1995.2437; SWOPE WC, 1982, J CHEM PHYS, V76, P637, DOI 10.1063/1.442716; Tian XY, 2005, J BIOL CHEM, V280, P29788, DOI 10.1074/jbc.M502925200; Van Sickle MD, 2005, SCIENCE, V310, P329, DOI 10.1126/science.1115740; Vanni S, 2009, BIOCHEMISTRY-US, V48, P4789, DOI 10.1021/bi900299f; Visiers I, 2002, INT J QUANTUM CHEM, V88, P65, DOI 10.1002/qua.10078; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Wess J, 1997, FASEB J, V11, P346, DOI 10.1096/fasebj.11.5.9141501; Zhang RD, 2005, MOL PHARMACOL, V68, P69, DOI 10.1124/mol.104.007823	74	174	174	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17954	17964		10.1074/jbc.M109.041590	http://dx.doi.org/10.1074/jbc.M109.041590			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20220143	hybrid, Green Published			2022-12-25	WOS:000278133400071
J	Bekhouche, M; Kronenberg, D; Vadon-Le Goff, S; Bijakowski, C; Lim, NH; Font, B; Kessler, E; Colige, A; Nagase, H; Murphy, G; Hulmes, DJS; Moali, C				Bekhouche, Mourad; Kronenberg, Daniel; Vadon-Le Goff, Sandrine; Bijakowski, Cecile; Lim, Ngee Han; Font, Bernard; Kessler, Efrat; Colige, Alain; Nagase, Hideaki; Murphy, Gillian; Hulmes, David J. S.; Moali, Catherine			Role of the Netrin-like Domain of Procollagen C-Proteinase Enhancer-1 in the Control of Metalloproteinase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE MORPHOGENETIC PROTEIN-1; FRIZZLED-RELATED PROTEINS; ALPHA-CONVERTING-ENZYME; HUMAN TISSUE INHIBITOR; I PROCOLLAGEN; MATRIX-METALLOPROTEINASES; TERMINAL DOMAIN; SULFATED GLYCOSAMINOGLYCANS; PLASMINOGEN ACTIVATION; FIBRILLAR PROCOLLAGENS	The netrin-like (NTR) domain is a feature of several extracellular proteins, most notably the N-terminal domain of tissue inhibitors of metalloproteinases (TIMPs), where it functions as a strong inhibitor of matrix metalloproteinases and some other members of the metzincin superfamily. The presence of a C-terminal NTR domain in procollagen C-proteinase enhancers (PCPEs), proteins that stimulate the activity of astacin-like tolloid proteinases, raises the possibility that this might also have inhibitory activity. Here we show that both long and short forms of the PCPE-1 NTR domain, the latter beginning at the N-terminal cysteine known to be critical for TIMP activity, show no inhibition, at micromolar concentrations, of several members of the metzincin superfamily, including matrix metalloproteinase-2, bone morphogenetic protein-1 (a tolloid proteinase), and different ADAMTS (a disintegrin and a metalloproteinase with thrombospondin motifs) proteinases from the adamalysin family. In contrast, we report that the NTR domain within PCPE-1 leads to superstimulation of bone morphogenetic protein-1 activity in the presence of heparin and heparan sulfate. These observations point to a new mechanism whereby binding to cell surface-associated or extracellular heparin-like sulfated glycosaminoglycans might provide a means to accelerate procollagen processing in specific cellular and extracellular microenvironments.	[Bekhouche, Mourad; Kronenberg, Daniel; Vadon-Le Goff, Sandrine; Bijakowski, Cecile; Font, Bernard; Hulmes, David J. S.; Moali, Catherine] Univ Lyon, Inst Biol & Chim Prot, CNRS, IFR128,UMR 5086, F-69367 Lyon 7, France; [Kronenberg, Daniel] Johannes Gutenberg Univ Mainz, Inst Zool Cell & Matrix Biol, D-55128 Mainz, Germany; [Lim, Ngee Han; Nagase, Hideaki] Univ London Imperial Coll Sci Technol & Med, Kennedy Inst Rheumatol, London W6 8LH, England; [Kessler, Efrat] Tel Aviv Univ, Chaim Sheba Med Ctr, Sackler Fac Med, Maurice & Gabriela Goldschleger Eye Res Inst, IL-52621 Tel Hashomer, Israel; [Colige, Alain] Univ Liege, Lab Connect Tissues Biol, B-4000 Liege, Belgium; [Murphy, Gillian] Univ Cambridge, Li Ka Shing Ctr, Dept Oncol, Cambridge CB2 0RE, England	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Johannes Gutenberg University of Mainz; Imperial College London; University of Oxford; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; University of Liege; CRUK Cambridge Institute; University of Cambridge	Hulmes, DJS (corresponding author), Univ Lyon, Inst Biol & Chim Prot, CNRS, IFR128,UMR 5086, 7 Passage Vercors, F-69367 Lyon 7, France.	d.hulmes@ibcp.fr	Bekhouche, Mourad/ABA-6557-2020; Bekhouche, Mourad/ABA-7355-2020; Kronenberg, Daniel/ABA-9255-2020; Bekhouche, Mourad/J-2230-2015; le goff, sandrine/AAE-1990-2019; Lim, Ngee Han/B-4226-2011	Bekhouche, Mourad/0000-0003-3786-2563; Kronenberg, Daniel/0000-0001-6807-7328; Bekhouche, Mourad/0000-0003-3786-2563; vadon-le goff, sandrine/0000-0002-4582-2273; Hulmes, David/0000-0002-0651-1317; MOALI, Catherine/0000-0003-2479-4290; Lim, Ngee Han/0000-0002-8520-7857	National Institutes of Health [AR40994]; La Ligue Contre le Cancer; Agence Nationale de la Recherche; Region Rhone-Alpes; Centre National de la Recherche Scientifique; Universite Claude Bernard Lyon 1; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040994] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); La Ligue Contre le Cancer(Ligue nationale contre le cancer); Agence Nationale de la Recherche(French National Research Agency (ANR)); Region Rhone-Alpes(Region Auvergne-Rhone-Alpes); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Universite Claude Bernard Lyon 1; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant AR40994. This work was also supported by La Ligue Contre le Cancer, the Agence Nationale de la Recherche, the Region Rhone-Alpes, the Centre National de la Recherche Scientifique, and the Universite Claude Bernard Lyon 1.	ADAR R, 1986, COLLAGEN REL RES, V6, P267; Amour A, 1998, FEBS LETT, V435, P39, DOI 10.1016/S0014-5793(98)01031-X; Banyai L, 1999, PROTEIN SCI, V8, P1636, DOI 10.1110/ps.8.8.1636; Bernocco S, 2003, J BIOL CHEM, V278, P7199, DOI 10.1074/jbc.M210857200; Bernocco S, 2001, J BIOL CHEM, V276, P48930, DOI 10.1074/jbc.M108611200; Berry R, 2009, P NATL ACAD SCI USA, V106, P8561, DOI 10.1073/pnas.0812178106; Bezakova G, 2003, NAT REV MOL CELL BIO, V4, P295, DOI 10.1038/nrm1074; Blanc G, 2007, J BIOL CHEM, V282, P16924, DOI 10.1074/jbc.M701610200; Bovolenta P, 2008, J CELL SCI, V121, P737, DOI 10.1242/jcs.026096; Bramham J, 2005, J BIOL CHEM, V280, P10636, DOI 10.1074/jbc.M413126200; Brunner G, 1998, EXP CELL RES, V239, P301, DOI 10.1006/excr.1997.3877; Butler GS, 1999, J BIOL CHEM, V274, P10846, DOI 10.1074/jbc.274.16.10846; Cirulli V, 2007, NAT REV MOL CELL BIO, V8, P296, DOI 10.1038/nrm2142; COLIGE A, 1995, J BIOL CHEM, V270, P16724, DOI 10.1074/jbc.270.28.16724; Colige A, 2005, J BIOL CHEM, V280, P34397, DOI 10.1074/jbc.M506458200; Dean RA, 2007, MOL CELL PROTEOMICS, V6, P611, DOI 10.1074/mcp.M600341-MCP200; Dementiev A, 2004, NAT STRUCT MOL BIOL, V11, P863, DOI 10.1038/nsmb810; Di Lullo GA, 2002, J BIOL CHEM, V277, P4223, DOI 10.1074/jbc.M110709200; EDELBERG JM, 1991, BIOCHEMISTRY-US, V30, P10999, DOI 10.1021/bi00109a027; Fernandez-Catalan C, 1998, EMBO J, V17, P5238, DOI 10.1093/emboj/17.17.5238; GALLOWAY WA, 1983, BIOCHEM J, V209, P741, DOI 10.1042/bj2090741; Ge GX, 2006, J BIOL CHEM, V281, P10786, DOI 10.1074/jbc.M511111200; Gendron C, 2007, J BIOL CHEM, V282, P18294, DOI 10.1074/jbc.M701523200; Gerhard DS, 2004, GENOME RES, V14, P2121, DOI 10.1101/gr.2596504; GomisRuth FX, 1997, NATURE, V389, P77, DOI 10.1038/37995; HOJIMA Y, 1994, ANAL BIOCHEM, V223, P173, DOI 10.1006/abio.1994.1569; Hopkins DR, 2007, MATRIX BIOL, V26, P508, DOI 10.1016/j.matbio.2007.05.004; Huang GR, 2009, J BIOL CHEM, V284, P25879, DOI 10.1074/jbc.M109.024125; Inomata H, 2008, CELL, V134, P854, DOI 10.1016/j.cell.2008.07.008; Kappler J, 2000, BIOCHEM BIOPH RES CO, V271, P287, DOI 10.1006/bbrc.2000.2583; Kashiwagi M, 2004, J BIOL CHEM, V279, P10109, DOI 10.1074/jbc.M312123200; Kashiwagi M, 2001, J BIOL CHEM, V276, P12501, DOI 10.1074/jbc.C000848200; KESSLER E, 1989, EUR J BIOCHEM, V186, P115, DOI 10.1111/j.1432-1033.1989.tb15184.x; KNIGHT CG, 1992, FEBS LETT, V296, P263, DOI 10.1016/0014-5793(92)80300-6; Kobayashi K, 2009, NAT CELL BIOL, V11, P46, DOI 10.1038/ncb1811; Kondas K, 2008, J BIOL CHEM, V283, P23677, DOI 10.1074/jbc.M803025200; Kronenberg D, 2009, J BIOL CHEM, V284, P33437, DOI 10.1074/jbc.M109.046128; Lee HX, 2006, CELL, V124, P147, DOI 10.1016/j.cell.2005.12.018; Li W, 2004, NAT STRUCT MOL BIOL, V11, P857, DOI 10.1038/nsmb811; Li W, 2008, P NATL ACAD SCI USA, V105, P4661, DOI 10.1073/pnas.0711055105; Liepinsh E, 2003, J BIOL CHEM, V278, P25982, DOI 10.1074/jbc.M302734200; Moali C, 2005, J BIOL CHEM, V280, P24188, DOI 10.1074/jbc.M501486200; Moschcovich L, 2001, EUR J BIOCHEM, V268, P2991, DOI 10.1046/j.1432-1327.2001.02189.x; Mott JD, 2000, J BIOL CHEM, V275, P1384, DOI 10.1074/jbc.275.2.1384; Muraoka O, 2006, NAT CELL BIOL, V8, P329, DOI 10.1038/ncb1379; MURPHY G, 1992, BIOCHEM J, V283, P637, DOI 10.1042/bj2830637; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Petropoulou V, 2005, J BIOL CHEM, V280, P22616, DOI 10.1074/jbc.M413468200; Ricard-Blum S, 2004, J BIOL CHEM, V279, P2927, DOI 10.1074/jbc.M309868200; Ricard-Blum S, 2002, J BIOL CHEM, V277, P33864, DOI 10.1074/jbc.M205018200; RICARDBLUM S, 2006, FED EUR CONN TISS SO; Scott IC, 2001, NATURE, V410, P475, DOI 10.1038/35068572; Stetefeld J, 2001, NAT STRUCT BIOL, V8, P705, DOI 10.1038/90422; STOCKER W, 1995, PROTEIN SCI, V4, P823; TAKADA Y, 1994, THROMB RES, V73, P301, DOI 10.1016/0049-3848(94)90026-4; Troeberg L, 2008, FASEB J, V22, P3515, DOI 10.1096/fj.08-112680; Wang WM, 2006, BIOCHEM J, V398, P515, DOI 10.1042/BJ20060630; Wayne GJ, 2007, J BIOL CHEM, V282, P20991, DOI 10.1074/jbc.M610721200; Wei S, 2005, J BIOL CHEM, V280, P32877, DOI 10.1074/jbc.C500220200; WEISS T, 2008, FED EUR CONN TISS SO; Williamson RA, 2008, MOL BIOSYST, V4, P417, DOI 10.1039/b717901d; Wingfield PT, 1999, J BIOL CHEM, V274, P21362, DOI 10.1074/jbc.274.30.21362; Wisniewska M, 2008, J MOL BIOL, V381, P1307, DOI 10.1016/j.jmb.2008.06.088; Yang ZR, 2005, BIOINFORMATICS, V21, P3369, DOI 10.1093/bioinformatics/bti534; Yu WH, 2000, J BIOL CHEM, V275, P31226, DOI 10.1074/jbc.M000907200	65	33	33	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					15950	15959		10.1074/jbc.M109.086447	http://dx.doi.org/10.1074/jbc.M109.086447			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20207734	Green Published, hybrid			2022-12-25	WOS:000277715900032
J	Maiuri, T; Ho, J; Stambolic, V				Maiuri, Tamara; Ho, Jason; Stambolic, Vuk			Regulation of Adipocyte Differentiation by Distinct Subcellular Pools of Protein Kinase B (PKB/Akt)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FORKHEAD TRANSCRIPTION FACTOR; MITOTIC CLONAL EXPANSION; CELL-SURVIVAL; PEPTIDE INHIBITORS; AKT SUBSTRATE; PHOSPHORYLATION; ADIPOGENESIS; AKT/PKB; LOCALIZATION; ACTIVATION	The phosphatidylinositol 3-kinase (PI3K)-protein kinase B (PKB)/Akt-PTEN signal transduction pathway orchestrates a variety of fundamental cell processes and its deregulation is implicated in many human diseases. Although the importance of this pathway to many cellular functions is well established, the mechanisms by which it achieves context-specific physiological outcomes in response to a variety of stimuli, using a relatively limited pool of effectors, remain largely unknown. Spatial restriction of signaling events is one means by which cells coordinate specific responses using common molecules. To investigate the subcellular location-specific roles of the major PI3K effector PKB/Akt in various cell processes, we have developed a novel experimental system employing cellular compartment-directed PKB/Akt pseudosubstrate inhibitors. Subcellular location-restricted PKB/Akt inhibition in the 3T3L1 adipocyte differentiation model revealed that nuclear and plasma membrane, but not cytoplasmic, PKB/Akt activity is required for terminal adipocyte differentiation. Nuclear and plasma membrane pools of PKB/Akt were found to contribute to distinct stages of adipocyte differentiation, revealing that PKB/Akt activity impacts multiple points of this program. Our work establishes the use of localized pseudosubstrate PKB/Akt inhibitors as an effective method for the dissection of PKB/Akt signaling.	Univ Toronto, Ontario Canc Inst, Univ Hlth Network, Toronto, ON M5G 2M9, Canada; Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2M9, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Stambolic, V (corresponding author), 610 Univ Ave,Rm 10-123, Toronto, ON M5G 2M9, Canada.	vuks@uhnres.utoronto.ca		Stambolic, Vuk/0000-0001-8853-3239; Maiuri, Tamara/0000-0002-6103-5835	Canadian Breast Cancer Foundation (Ontario branch)	Canadian Breast Cancer Foundation (Ontario branch)	This work was supported by funding from the Canadian Breast Cancer Foundation (Ontario branch) ( to V. S.).	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Alfaro-Lopez J, 1998, J MED CHEM, V41, P2252, DOI 10.1021/jm9707885; Andjelkovic M, 1997, J BIOL CHEM, V272, P31515, DOI 10.1074/jbc.272.50.31515; Bonny C, 2001, DIABETES, V50, P77, DOI 10.2337/diabetes.50.1.77; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Carpten JD, 2007, NATURE, V448, P439, DOI 10.1038/nature05933; Chang L, 2007, ENDOCRINOLOGY, V148, P27, DOI 10.1210/en.2006-1167; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Dijkers PF, 2000, MOL CELL BIOL, V20, P9138, DOI 10.1128/MCB.20.24.9138-9148.2000; Ding JX, 2009, MOL CELL BIOL, V29, P1459, DOI 10.1128/MCB.00754-08; Dummler B, 2007, BIOCHEM SOC T, V35, P231, DOI 10.1042/BST0350231; Enomoto A, 2005, DEV CELL, V9, P389, DOI 10.1016/j.devcel.2005.08.001; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Geshi N, 2004, PLANTA, V218, P862, DOI 10.1007/s00425-003-1168-3; Gonzalez E, 2009, P NATL ACAD SCI USA, V106, P7004, DOI 10.1073/pnas.0901933106; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; HARRIS TE, 1995, BIOCHEM SOC T, V23, pS187, DOI 10.1042/bst023187s; HOUSE C, 1987, SCIENCE, V238, P1726, DOI 10.1126/science.3686012; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Jaken S, 1996, CURR OPIN CELL BIOL, V8, P168, DOI 10.1016/S0955-0674(96)80062-7; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Kane S, 2002, J BIOL CHEM, V277, P22115, DOI 10.1074/jbc.C200198200; Kim JE, 2004, DIABETES, V53, P2748, DOI 10.2337/diabetes.53.11.2748; Kolsch V, 2008, J CELL SCI, V121, P551, DOI 10.1242/jcs.023333; Kovacina KS, 2003, J BIOL CHEM, V278, P10189, DOI 10.1074/jbc.M210837200; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Marshall JG, 2001, J CELL BIOL, V153, P1369, DOI 10.1083/jcb.153.7.1369; Martelli AM, 2006, CELL SIGNAL, V18, P1101, DOI 10.1016/j.cellsig.2006.01.011; Menghini R, 2005, CIRCULATION, V111, P1946, DOI 10.1161/01.CIR.0000161814.02942.B2; MITOMA JY, 1992, EMBO J, V11, P4197, DOI 10.1002/j.1460-2075.1992.tb05513.x; O'Neill RE, 1998, EMBO J, V17, P288, DOI 10.1093/emboj/17.1.288; Obata T, 2000, J BIOL CHEM, V275, P36108, DOI 10.1074/jbc.M005497200; Peng XD, 2003, GENE DEV, V17, P1352, DOI 10.1101/gad.1089403; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Scheid MP, 2001, NAT REV MOL CELL BIO, V2, P760, DOI 10.1038/35096067; Schenck A, 2008, CELL, V133, P486, DOI 10.1016/j.cell.2008.02.044; Shah OJ, 2004, CURR BIOL, V14, P1650, DOI 10.1016/j.cub.2004.08.026; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P44, DOI 10.1073/pnas.0137044100; Tang QQ, 1999, GENE DEV, V13, P2231, DOI 10.1101/gad.13.17.2231; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Wang RW, 2006, CELL SIGNAL, V18, P1722, DOI 10.1016/j.cellsig.2006.01.020; Whitmarsh AJ, 2006, BIOCHEM SOC T, V34, P828, DOI 10.1042/BST0340828; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; Xu JF, 2004, J BIOL CHEM, V279, P35914, DOI 10.1074/jbc.M402297200; Yarmo MN, 2009, EXP CELL RES, V315, P411, DOI 10.1016/j.yexcr.2008.10.036; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245; Yun SJ, 2008, BIOCHEM BIOPH RES CO, V371, P138, DOI 10.1016/j.bbrc.2008.04.029; Zhang HH, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0006189, 10.1371/journal.pone.0007826]	50	20	21	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15038	15047		10.1074/jbc.M110.121434	http://dx.doi.org/10.1074/jbc.M110.121434			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20223817	Green Published, hybrid			2022-12-25	WOS:000277399000025
J	Mantuano, E; Jo, M; Gonias, SL; Campana, WM				Mantuano, Elisabetta; Jo, Minji; Gonias, Steven L.; Campana, W. Marie			Low Density Lipoprotein Receptor-related Protein (LRP1) Regulates Rac1 and RhoA Reciprocally to Control Schwann Cell Adhesion and Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B PATHWAY; PLASMINOGEN-ACTIVATOR; EXTRACELLULAR-MATRIX; UROKINASE RECEPTOR; DEPENDENT PATHWAY; KINASE FUNCTIONS; BINDING; GTPASES; MOTILITY; FAMILY	LDL receptor-related protein (LRP1) is expressed by Schwann cells in vivo mainly after injury to the peripheral nervous system (PNS). Schwann cells in primary culture, which provide a model of Schwann cells in the injured PNS, also express abundant LRP1. Herein, we show that LRP1 gene-silencing or treatment with receptor-associated protein (RAP) promotes Schwann cell adhesion and inhibits cell migration on fibronectin. LRP1 gene-silencing also resulted in the formation of prominent focal adhesions and actin stress fibers. These changes, which were induced by loss of LRP1 expression or activity, were explained mechanistically by an increase in activated RhoA, coupled with a decrease in activated Rac1. Known LRP1 ligands, including matrix metalloprotease-9, tissue-type plasminogen activator, and alpha(2)-macroglobulin activated Rac1 in LRP1-expressing Schwann cells. An inhibitor of Rac1 activation promoted Schwann cell adhesion. Conversely, in cells in which LRP1 was silenced, a Rho kinase inhibitor promoted migration and inhibited adhesion. These results demonstrate that direct binding of ligands to LRP1 controls activation of small Rho family GTPases. The effects of LRP1 gene-silencing and RAP implicate autocrine pathways involving endogenously produced LRP1 ligands. Regulation of Schwann cell migration by LRP1 may be important in PNS injury.	[Mantuano, Elisabetta; Campana, W. Marie] Univ Calif San Diego, Dept Anesthesiol, La Jolla, CA 92093 USA; [Mantuano, Elisabetta; Jo, Minji; Gonias, Steven L.] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Campana, WM (corresponding author), 9500 Gilman Dr, La Jolla, CA 92093 USA.	wcampana@ucsd.edu	Mantuano, Elisabetta/C-1769-2015	Mantuano, Elisabetta/0000-0001-5728-9261	National Institutes of Health [R01 NS57456, R01 NS54671]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054671, R01NS057456] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 NS57456 and R01 NS54671.	Akassoglou K, 2002, NEURON, V33, P861, DOI 10.1016/S0896-6273(02)00617-7; BOTTENSTEIN JE, 1980, EXP CELL RES, V129, P361, DOI 10.1016/0014-4827(80)90504-2; Campana WM, 2006, J NEUROSCI, V26, P11197, DOI 10.1523/JNEUROSCI.2709-06.2006; Campana WM, 1998, FASEB J, V12, P307, DOI 10.1096/fasebj.12.3.307; Carstanjen D, 2005, TRANSFUSION, V45, P1192, DOI 10.1111/j.1537-2995.2005.00172.x; Chan JR, 2007, J CELL BIOL, V177, P953, DOI 10.1083/jcb.200705105; Chen ZL, 2007, ANNU REV NEUROSCI, V30, P209, DOI 10.1146/annurev.neuro.30.051606.094337; Cheng HL, 2000, MOL CELL ENDOCRINOL, V170, P211, DOI 10.1016/S0303-7207(00)00324-5; DeMali KA, 2004, TRENDS BIOCHEM SCI, V29, P565, DOI 10.1016/j.tibs.2004.09.001; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Feltri ML, 2008, GLIA, V56, P1508, DOI 10.1002/glia.20752; Gaultier A, 2008, BLOOD, V111, P5316, DOI 10.1182/blood-2007-12-127613; Gaultier A, 2009, J CELL SCI, V122, P1155, DOI 10.1242/jcs.040717; Gonias SL, 2004, THROMB HAEMOSTASIS, V91, P1056, DOI 10.1160/TH04-01-0023; HERZ J, 1991, J BIOL CHEM, V266, P21232; Hu KB, 2006, J BIOL CHEM, V281, P2120, DOI 10.1074/jbc.M504988200; Ide C, 1996, NEUROSCI RES, V25, P101; Inoue G, 2010, GLIA, V58, P399, DOI 10.1002/glia.20931; Jessen KR, 1999, ADV EXP MED BIOL, V468, P3; Jo M, 2003, J BIOL CHEM, V278, P1642, DOI 10.1074/jbc.M210877200; Kawkitinarong K, 2004, AM J RESP CELL MOL, V31, P517, DOI 10.1165/rcmb.2003-0432OC; Kjoller L, 2001, J CELL BIOL, V152, P1145, DOI 10.1083/jcb.152.6.1145; Krause S, 2008, J PERIPHER NERV SYST, V13, P188, DOI 10.1111/j.1529-8027.2008.00177.x; Leiss M, 2008, CURR OPIN CELL BIOL, V20, P502, DOI 10.1016/j.ceb.2008.06.001; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Ma Z, 2002, J CELL BIOL, V159, P1061, DOI 10.1083/jcb.200207070; Machacek M, 2009, NATURE, V461, P99, DOI 10.1038/nature08242; Mantuano E, 2008, J NEUROSCI, V28, P11571, DOI 10.1523/JNEUROSCI.3053-08.2008; Mantuano E, 2008, J BIOL CHEM, V283, P19904, DOI 10.1074/jbc.M801762200; Milner R, 1997, DEV BIOL, V185, P215, DOI 10.1006/dbio.1997.8547; Nakayama M, 2008, DEV CELL, V14, P205, DOI 10.1016/j.devcel.2007.11.021; Nguyen DHD, 1998, J BIOL CHEM, V273, P8502, DOI 10.1074/jbc.273.14.8502; Nguyen DHD, 1999, J CELL BIOL, V146, P149, DOI 10.1083/jcb.146.1.149; Nimnual AS, 2003, NAT CELL BIOL, V5, P236, DOI 10.1038/ncb938; Pankov R, 2005, J CELL BIOL, V170, P793, DOI 10.1083/jcb.200503152; Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665; Petrie RJ, 2009, NAT REV MOL CELL BIO, V10, P538, DOI 10.1038/nrm2729; Rebeck GW, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.268pe28; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Rosenfeldt Hans, 2006, J Mol Signal, V1, P8, DOI 10.1186/1750-2187-1-8; Sander EE, 1999, J CELL BIOL, V147, P1009, DOI 10.1083/jcb.147.5.1009; Shi Y, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000188; Strickland DK, 2002, TRENDS ENDOCRIN MET, V13, P66, DOI 10.1016/S1043-2760(01)00526-4; Webb DJ, 2000, J CELL SCI, V113, P123; Weiner JA, 2001, J NEUROSCI, V21, P7069, DOI 10.1523/JNEUROSCI.21-18-07069.2001; Wiggan ON, 2006, CELL SIGNAL, V18, P1501, DOI 10.1016/j.cellsig.2005.12.002; Yamauchi J, 2005, P NATL ACAD SCI USA, V102, P5198, DOI 10.1073/pnas.0501160102; Yamauchi J, 2004, P NATL ACAD SCI USA, V101, P8774, DOI 10.1073/pnas.0402795101; Yamauchi J, 2008, J CELL BIOL, V181, P351, DOI 10.1083/jcb.200709033; Zhang XH, 2007, AM J PATHOL, V171, P1281, DOI 10.2353/ajpath.2007.070472	51	55	55	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14259	14266		10.1074/jbc.M109.085126	http://dx.doi.org/10.1074/jbc.M109.085126			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20197276	Green Published, hybrid			2022-12-25	WOS:000277299700022
J	Breig, O; Theoleyre, O; Douablin, A; Baklouti, F				Breig, O.; Theoleyre, O.; Douablin, A.; Baklouti, F.			Subtle distinct regulations of late erythroid molecular events by PI3K/AKT- mediated activation of Spi-1/PU.1 oncogene autoregulation loop	ONCOGENE			English	Article						erythroleukemia; mRNA splicing; cell differentiation; cell signaling	PRE-MESSENGER-RNA; TRANSCRIPTION FACTOR PU.1; FOCUS-FORMING VIRUS; PHOSPHATIDYLINOSITOL 3-KINASE; FRIEND-ERYTHROLEUKEMIA; PHOSPHOINOSITIDE 3-KINASE; TARGET GENES; ERYTHROPOIETIN; KINASE; PHOSPHORYLATION	Spi-1/PU.1 oncogene is downregulated as proerythroblasts undergo terminal differentiation. Insertion of the Friend virus upstream of the Spi-1/PU.1 locus leads to the constitutive upregulation of Spi-1/PU.1, and a subsequent block in the differentiation of the affected erythroblasts. We have shown that sustained overexpression of Spi-1/PU.1 also inhibits the erythroid splicing of protein 4.1R exon 16, irrespective of chemical induction of differentiation. Here, we show a positive feedback loop that couples constitutive phosphatidylinositol 3-kinase (PI3K)/protein kinase B (AKT) signaling to high expression of Spi-1/PU.1 in Friend erythroleukemia cells. Inhibition of PI3K/AKT results in Spi-1/PU.1 downregulation in a stepwise manner and induces cell differentiation. Chromatin immunoprecipitation assays further supported the positive autoregulatory effect of Spi-1/PU.1. Mutational analysis indicated that Ser41, but not Ser148, is necessary for Spi1/PU.1-mediated repression of hemoglobin expression, whereas both Ser residues are required for Spi-1/PU.1 inhibition of the erythroid splicing event. We further show that inhibition of the erythroid transcriptional and splicing events are strictly dependent on distinct Spi-1/PU.1 phosphorylation modifications rather than Spi-1/PU.1 expression level per se. Our data further support the fact that Spi-1/PU.1 inhibits 4.1R erythroid splicing through two different pathways, and bring new insights into the extracellular signal impact triggered by erythropoietin on late erythroid regulatory program, including pre-mRNA splicing. Oncogene (2010) 29, 2807-2816; doi: 10.1038/onc.2010.29; published online 1 March 2010	[Breig, O.; Theoleyre, O.; Douablin, A.; Baklouti, F.] Univ Lyon 1, mRNA Metab Normal & Pathol Cells, CGMC, CNRS,UMR 5534, F-69622 Villeurbanne, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Baklouti, F (corresponding author), Univ Lyon 1, mRNA Metab Normal & Pathol Cells, CGMC, CNRS,UMR 5534, Bat Gregor Mendel,16,Rue R, F-69622 Villeurbanne, France.	faouzi.baklouti@univ-lyon1.fr	BAKLOUTI, Faouzi/E-7670-2013	BAKLOUTI, Faouzi/0000-0002-2830-292X	Ligue contre le Cancer, Comite de la Loire; INSERM; Ligue contre le Cancer, Comite du Doubs	Ligue contre le Cancer, Comite de la Loire; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Ligue contre le Cancer, Comite du Doubs	We thank Dr I Merida (Department of Immunology and Oncology, Centro Nacional de Biotecnologia, Madrid, Spain) for pEFbosEGFP_C1 plasmid, Dr F Moreau-Gachelin (Inserm U830, Institut Curie, Paris, France) for anti-Spi-1/PU.1 antibody, G Giraud for helping with the ChIP assay and Dr G Mouchiroud and Dr F Morle (CGMC, Villeurbanne, France) for sharing reagents, including anti-p85 antibody. This work was supported by grants from the 'Ligue contre le Cancer, Comite de la Loire'. Authors were supported by the INSERM, the 'Ligue contre le Cancer, Comite de la Loire', the 'Ligue contre le Cancer, Comite du Doubs'	Afrikanova I, 2002, ONCOGENE, V21, P1272, DOI 10.1038/sj.onc.1205183; Back J, 2004, BLOOD, V103, P3615, DOI 10.1182/blood-2003-11-4089; Baklouti F, 1996, BLOOD, V87, P3934, DOI 10.1182/blood.V87.9.3934.bloodjournal8793934; Bao HF, 1999, BLOOD, V93, P3757, DOI 10.1182/blood.V93.11.3757.411a34_3757_3773; Barnache S, 2001, BLOOD, V98, P2372, DOI 10.1182/blood.V98.8.2372; Bavelloni A, 2000, CELL DEATH DIFFER, V7, P112, DOI 10.1038/sj.cdd.4400591; Blaustein M, 2005, NAT STRUCT MOL BIOL, V12, P1037, DOI 10.1038/nsmb1020; Blaustein M, 2007, INT J BIOCHEM CELL B, V39, P2031, DOI 10.1016/j.biocel.2007.04.004; Blaybel R, 2008, CELL RES, V18, P834, DOI 10.1038/cr.2008.68; Bouscary D, 2003, BLOOD, V101, P3436, DOI 10.1182/blood-2002-07-2332; Cataldi A, 2000, CELL SIGNAL, V12, P667, DOI 10.1016/S0898-6568(00)00109-1; CHASIS JA, 1993, J CLIN INVEST, V91, P329, DOI 10.1172/JCI116189; CHENG ADY, 1995, GRAVITATION COSMOLOG, V1, P1; Deguillien M, 2001, BLOOD, V98, P3809, DOI 10.1182/blood.V98.13.3809; DELGADO MD, 1994, ONCOGENE, V9, P1723; Delva L, 2004, ONCOGENE, V23, P4389, DOI 10.1038/sj.onc.1207578; EISENBEIS CF, 1995, GENE DEV, V9, P1377, DOI 10.1101/gad.9.11.1377; Fisher RC, 2004, LEUKEMIA RES, V28, P83, DOI 10.1016/S0145-2126(03)00178-4; Ghaffari S, 2003, MIL DRUG TH, P65; Jelkmann W, 2007, EUR J HAEMATOL, V78, P183, DOI 10.1111/j.1600-0609.2007.00818.x; Juban G, 2009, MOL CELL BIOL, V29, P2852, DOI 10.1128/MCB.01435-08; Maillet P, 1996, HUM MUTAT, V7, P61, DOI 10.1002/(SICI)1098-1004(1996)7:1<61::AID-HUMU9>3.3.CO;2-T; Moreau-Gachelin F, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-99; MOREAUGACHELIN F, 1989, ONCOGENE, V4, P1449; Myklebust JH, 2002, EXP HEMATOL, V30, P990, DOI 10.1016/S0301-472X(02)00868-8; Nerlov C, 2000, BLOOD, V95, P2543, DOI 10.1182/blood.V95.8.2543.008k19_2543_2551; Nishigaki K, 2000, J VIROL, V74, P3037, DOI 10.1128/JVI.74.7.3037-3045.2000; Nishigaki K, 2006, J VIROL, V80, P5678, DOI 10.1128/JVI.02651-05; Okuno Y, 2005, MOL CELL BIOL, V25, P2832, DOI 10.1128/MCB.25.7.2832-2845.2005; Patel NA, 2005, J BIOL CHEM, V280, P14302, DOI 10.1074/jbc.M411485200; PAUL R, 1991, J VIROL, V65, P464, DOI 10.1128/JVI.65.1.464-467.1991; PONGUBALA JMR, 1993, SCIENCE, V259, P1622, DOI 10.1126/science.8456286; Rao G, 1997, ONCOGENE, V14, P123, DOI 10.1038/sj.onc.1200807; Rekhtman N, 1999, GENE DEV, V13, P1398, DOI 10.1101/gad.13.11.1398; Rieske P, 2001, J BIOL CHEM, V276, P8460, DOI 10.1074/jbc.M007482200; Sanjuan MA, 2001, J CELL BIOL, V153, P207, DOI 10.1083/jcb.153.1.207; SCHUETZE S, 1992, MOL CELL BIOL, V12, P2967, DOI 10.1128/MCB.12.7.2967; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; Sivertsen EA, 2006, BRIT J HAEMATOL, V135, P117, DOI 10.1111/j.1365-2141.2006.06252.x; Tarn WY, 2007, J BIOMED SCI, V14, P517, DOI 10.1007/s11373-007-9161-7; Theoleyre O, 2004, ONCOGENE, V23, P920, DOI 10.1038/sj.onc.1207206; Yamada T, 1997, BLOOD, V89, P1383, DOI 10.1182/blood.V89.4.1383; Zhang P, 1999, P NATL ACAD SCI USA, V96, P8705, DOI 10.1073/pnas.96.15.8705	43	12	12	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2010	29	19					2807	2816		10.1038/onc.2010.29	http://dx.doi.org/10.1038/onc.2010.29			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	595DW	20190819				2022-12-25	WOS:000277591900006
J	Hsu, YC; Liao, WC; Kao, CY; Chiu, IM				Hsu, Yi-Chao; Liao, Wei-Chih; Kao, Chien-Yu; Chiu, Ing-Ming			Regulation of FGF1 Gene Promoter through Transcription Factor RFX1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURAL STEM/PROGENITOR CELLS; STEM-CELLS; GROWTH-FACTOR; HEPARAN-SULFATE; SELF-RENEWAL; 1B PROMOTER; FACTOR-X; ADULT; EXPRESSION; PROTEIN	Fibroblast growth factor 1 (FGF1) has been suggested to have an important role in cell growth, proliferation, and neurogenesis. Human FGF1 gene 1B promoter (-540 to +31)-driven green fluorescence (F1BGFP) has been shown to monitor endogenous FGF1 expression. F1BGFP could also be used to isolate neural stem/progenitor cells from embryonic, neonatal, and adult mouse brains or to isolate glioblastoma stem cells (GBM-SCs) from human glioblastoma tissues. Here, we present evidence that transcription factor RFX1 could bind the 18-bp cis-elements (-484 to -467) of the F1B promoter, modulate F1BGFP expression and endogenous FGF1 expression, and further regulate the maintenance of GBM-SCs. These observations were substantiated by using yeast one-hybrid assay, electrophoretic mobility shift assay, chromatin immunoprecipitation assay, gain-and loss-of-function assays, and neurosphere assays. Overexpression of RFX1 was shown to down-regulate FGF-1B mRNA expression and neurosphere formation in human glioblastoma cells, whereas RNA interference knockdown of RFX1 demonstrated the opposite effects. Our findings provide insight into FGF1 gene regulation and suggest that the roles of FGF1 and RFX1 in the maintenance of GBM-SCs. RFX1 may negatively regulate the self-renewal of GBM-SCs through modulating FGF-1B and FGF1 expression levels by binding the 18-bp cis-elements of the F1B promoter.	[Hsu, Yi-Chao; Liao, Wei-Chih; Kao, Chien-Yu; Chiu, Ing-Ming] Natl Hlth Res Inst, Inst Cellular & Syst Med, Div Regenerat Med, Zhunan 35053, Miaoli County, Taiwan; [Liao, Wei-Chih; Kao, Chien-Yu; Chiu, Ing-Ming] Natl Tsing Hua Univ, Grad Program Biotechnol Med, Inst Biotechnol, Hsinchu 30013, Taiwan; [Liao, Wei-Chih; Kao, Chien-Yu; Chiu, Ing-Ming] Natl Tsing Hua Univ, Dept Life Sci, Hsinchu 30013, Taiwan; [Chiu, Ing-Ming] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Chiu, Ing-Ming] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA; [Chiu, Ing-Ming] Natl Chung Hsing Univ, Dept Life Sci, Taichung 250, Taiwan	National Health Research Institutes - Taiwan; National Tsing Hua University; National Tsing Hua University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; National Chung Hsing University	Chiu, IM (corresponding author), Natl Hlth Res Inst, Inst Cellular & Syst Med, Div Regenerat Med, 35 Keyan Rd, Zhunan 35053, Miaoli County, Taiwan.	ingming@nhri.org.tw	Hsu, Yi-Chao/AAK-7478-2021; Chiu, Ing-Ming/B-1534-2008		National Science Council, Taiwan; National Health Research Institutes, Taiwan	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan)	This work was supported by the National Science Council, Taiwan, and the National Health Research Institutes, Taiwan.	Abdouh M, 2009, J NEUROSCI, V29, P8884, DOI 10.1523/JNEUROSCI.0968-09.2009; Aftab S, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-226; Alam KY, 1996, J BIOL CHEM, V271, P30263, DOI 10.1074/jbc.271.47.30263; Aubert J, 2003, P NATL ACAD SCI USA, V100, P11836, DOI 10.1073/pnas.1734197100; Blake M, 1996, J VIROL, V70, P6060, DOI 10.1128/JVI.70.9.6060-6066.1996; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chen L, 2000, J BIOL CHEM, V275, P32227, DOI 10.1074/jbc.M002645200; Chiu IM, 2000, ONCOGENE, V19, P6229, DOI 10.1038/sj.onc.1204021; Chiu IM, 2001, PROG NUCLEIC ACID RE, V70, P155, DOI 10.1016/S0079-6603(01)70016-5; Chojnacki A, 2008, NAT PROTOC, V3, P935, DOI 10.1038/nprot.2008.55; Chotani MA, 2000, J BIOL CHEM, V275, P30432, DOI 10.1074/jbc.M003545200; Cordey M, 2008, STEM CELLS, V26, P2586, DOI 10.1634/stemcells.2008-0498; Corti S, 2007, EXP NEUROL, V205, P547, DOI 10.1016/j.expneurol.2007.03.021; D'Amour KA, 2003, P NATL ACAD SCI USA, V100, P11866, DOI 10.1073/pnas.1834200100; Dubruille R, 2002, DEVELOPMENT, V129, P5487, DOI 10.1242/dev.00148; Ducrest AL, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf064; Durand B, 2000, GENE, V246, P285, DOI 10.1016/S0378-1119(00)00093-7; ECKENSTEIN FP, 1994, PROG BRAIN RES, V103, P55; Emery P, 1996, NUCLEIC ACIDS RES, V24, P803, DOI 10.1093/nar/24.5.803; Feng CZ, 2009, BIOCHEM BIOPH RES CO, V386, P715, DOI 10.1016/j.bbrc.2009.06.111; GAGE FH, 1995, ANNU REV NEUROSCI, V18, P159, DOI 10.1146/annurev.neuro.18.1.159; Gajiwala KS, 2000, NATURE, V403, P916, DOI 10.1038/35002634; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Galli Rosselia, 2008, V438, P67, DOI 10.1007/978-1-59745-133-8_7; Hsu SH, 2009, ARTIF ORGANS, V33, P26, DOI 10.1111/j.1525-1594.2008.00671.x; Hsu YC, 2009, DEV DYNAM, V238, P302, DOI 10.1002/dvdy.21753; Ignatova TN, 2002, GLIA, V39, P193, DOI 10.1002/glia.10094; Imayoshi I, 2006, GENESIS, V44, P233, DOI 10.1002/dvg.20212; Iwama A, 1999, MOL CELL BIOL, V19, P3940; Johnson CE, 2007, STEM CELLS, V25, P1913, DOI 10.1634/stemcells.2006-0445; Katan-Khaykovich Y, 1998, J BIOL CHEM, V273, P24504, DOI 10.1074/jbc.273.38.24504; Katan-Khaykovich Y, 2001, EUR J BIOCHEM, V268, P3108, DOI 10.1046/j.1432-1327.2001.02211.x; Kuhn HG, 1997, J NEUROSCI, V17, P5820; Laurencon A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r195; Lee DC, 2009, MOL CELL NEUROSCI, V41, P348, DOI 10.1016/j.mcn.2009.04.010; Lin YL, 2008, SURG NEUROL, V70, P9, DOI 10.1016/j.surneu.2008.01.057; Liu MS, 1999, J BIOL CHEM, V274, P15433, DOI 10.1074/jbc.274.22.15433; Lubelsky Y, 2005, MOL CELL BIOL, V25, P10665, DOI 10.1128/MCB.25.23.10665-10673.2005; Ma BF, 2006, NEUROREPORT, V17, P377, DOI 10.1097/01.wnr.0000204981.36995.db; Ma KW, 2006, J BIOL CHEM, V281, P21250, DOI 10.1074/jbc.M600521200; MYERS RL, 1995, ONCOGENE, V11, P785; MYERS RL, 1995, J BIOL CHEM, V270, P8257, DOI 10.1074/jbc.270.14.8257; MYERS RL, 1993, ONCOGENE, V8, P341; Nakamura Y, 2003, LAB INVEST, V83, P479, DOI 10.1097/01.LAB.0000063930.75913.B3; Nakayama A, 2003, J BIOL CHEM, V278, P233, DOI 10.1074/jbc.M209574200; NURCOMBE V, 1993, SCIENCE, V260, P103, DOI 10.1126/science.7682010; Park JH, 2007, NEUROSCI LETT, V421, P185, DOI 10.1016/j.neulet.2007.02.069; PAYSON RA, 1993, NUCLEIC ACIDS RES, V21, P489, DOI 10.1093/nar/21.3.489; Pollard SM, 2009, CELL STEM CELL, V4, P568, DOI 10.1016/j.stem.2009.03.014; Poltavtseva R. A., 2003, Ontogenez, V34, P211; Ray SK, 1997, J BIOL CHEM, V272, P7546, DOI 10.1074/jbc.272.11.7546; REITH W, 1994, MOL CELL BIOL, V14, P1230, DOI 10.1128/MCB.14.2.1230; REYNOLDS BA, 1992, J NEUROSCI, V12, P4565, DOI 10.1523/jneurosci.12-11-04565.1992; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Rietze RL, 2006, METHOD ENZYMOL, V419, P3, DOI 10.1016/S0076-6879(06)19001-1; Sengupta P, 2005, J BIOL CHEM, V280, P21004, DOI 10.1074/jbc.M413191200; Sengupta PK, 2002, J BIOL CHEM, V277, P24926, DOI 10.1074/jbc.M111712200; Sengupta PK, 1999, J BIOL CHEM, V274, P36649, DOI 10.1074/jbc.274.51.36649; Senti G, 2008, MOL BIOL CELL, V19, P5517, DOI 10.1091/mbc.E08-04-0416; Sherry MM, 2009, STEM CELLS, V27, P2383, DOI 10.1002/stem.185; SIEGRIST CA, 1993, MOL CELL BIOL, V13, P6375, DOI 10.1128/MCB.13.10.6375; Singec I, 2006, NAT METHODS, V3, P801, DOI 10.1038/nmeth926; Singh SK, 2003, CANCER RES, V63, P5821; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002; Swoboda P, 2000, MOL CELL, V5, P411, DOI 10.1016/S1097-2765(00)80436-0; Ueba T, 1999, J BIOL CHEM, V274, P10382, DOI 10.1074/jbc.274.15.10382; Wang KR, 2007, J BIOL CHEM, V282, P26167, DOI 10.1074/jbc.M703448200; Weiss S, 1996, J NEUROSCI, V16, P7599; Xu Y, 2006, J BIOL CHEM, V281, P9260, DOI 10.1074/jbc.M511724200; Yuan XP, 2004, ONCOGENE, V23, P9392, DOI 10.1038/sj.onc.1208311	70	24	26	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13885	13895		10.1074/jbc.M109.081463	http://dx.doi.org/10.1074/jbc.M109.081463			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20189986	hybrid, Green Published			2022-12-25	WOS:000276987700063
J	Li, M; Wang, H; Huang, T; Wang, JY; Ding, Y; Li, ZF; Zhang, JK; Li, L				Li, Meng; Wang, He; Huang, Tao; Wang, Jiyong; Ding, Yu; Li, Zhenfei; Zhang, Jinkuo; Li, Lin			TAB2 Scaffolds TAK1 and NLK in Repressing Canonical Wnt Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEMO-LIKE-KINASE; MAP-KINASE; KAPPA-B; BETA-CATENIN; NEURAL INDUCTION; PROTEIN-KINASES; PATHWAY; ACTIVATION; TRANSCRIPTION; IL-1	The TAK1-NLK cascade is a mitogen-activated protein kinase-related pathway that plays an inhibitory role in canonical Wnt/beta-catenin signaling through regulating the LEF1/TCF family transcriptional factors. TAB2 (TAK1-binding protein 2) is a putative TAK1 interacting protein that is involved in the regulation of TAK1. Here, we found that TAB2 could directly interact with NLK and function as a scaffold protein to facilitate the interaction between TAK1 and NLK. Knocking down TAB2 using small interfering RNA abolished the interaction of TAK1 with NLK in mammalian cells. The intermediate region (residues 292-417) of TAB2 was mapped for its binding to NLK. TAB2-Delta M, a TAB2 mutant lacking this region, showed a lower affinity for NLK and became defective in its scaffolding function. In addition, TAB2, but not TAB2-Delta M, mediated TAK1-dependent activation of NLK and LEF1 polyubiquitylation, resulting in the inhibition of canonical Wnt signaling. Moreover, Wnt3a stimulation led to an increase in the interaction of TAB2 with NLK and the formation of a TAK1.TAB2.NLK complex, suggesting that this TAK1-TAB2-NLK pathway may constitute a negative feedback mechanism for canonical Wnt signaling.	[Li, Meng; Wang, He; Huang, Tao; Wang, Jiyong; Ding, Yu; Li, Zhenfei; Zhang, Jinkuo; Li, Lin] Chinese Acad Sci, Shanghai Inst Biol Sci, State Key Lab Mol Biol, Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Li, L (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, State Key Lab Mol Biol, Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China.	lli@sibs.ac.cn	Li, Zhenfei/AAU-1097-2020; li, li/HII-4157-2022; Li, Li/AEM-3636-2022; Ding, Yu/A-2949-2013; LI, LI/GVS-5344-2022	Li, Zhenfei/0000-0001-6520-431X; 	Ministry of Science and Technology of China [2010CB912100, 2007CB914500]; Natural Science Foundation of China [30821065, 30930052, 90813024, 30600305]; Science and Technology Commission of Shanghai Municipality	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by Ministry of Science and Technology of China Grants 2010CB912100 and 2007CB914500, by Natural Science Foundation of China Grants 30821065, 30930052, and 90813024 (to L. L.) and 30600305 (to J. W.), and by Science and Technology Commission of Shanghai Municipality grants.	Behrens J, 2000, J CELL SCI, V113, P911; Besse A, 2007, J BIOL CHEM, V282, P3918, DOI 10.1074/jbc.M608867200; Brott BK, 1998, P NATL ACAD SCI USA, V95, P963, DOI 10.1073/pnas.95.3.963; Chen T, 2009, J BIOL CHEM, V284, P6683, DOI 10.1074/jbc.M807753200; Cheung PCF, 2004, BIOCHEM J, V378, P27, DOI 10.1042/BJ20031794; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Coulombe P, 2007, BBA-MOL CELL RES, V1773, P1376, DOI 10.1016/j.bbamcr.2006.11.001; Dard N, 2006, BIOESSAYS, V28, P146, DOI 10.1002/bies.20351; Dhanasekaran DN, 2007, ONCOGENE, V26, P3185, DOI 10.1038/sj.onc.1210411; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Gan XQ, 2008, J CELL BIOL, V180, P1087, DOI 10.1083/jcb.200710050; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; Hyodo-Miura J, 2002, GENES CELLS, V7, P487, DOI 10.1046/j.1365-2443.2002.00536.x; Irie T, 2000, FEBS LETT, V467, P160, DOI 10.1016/S0014-5793(00)01146-7; Ishitani T, 2003, MOL CELL BIOL, V23, P1379, DOI 10.1128/MCB.23.4.1379-1389.2003; Ishitani T, 1999, NATURE, V399, P798, DOI 10.1038/21674; Ishitani T, 2003, MOL CELL BIOL, V23, P131, DOI 10.1128/MCB.23.1.131-139.2003; Ishitani T, 2003, EMBO J, V22, P6277, DOI 10.1093/emboj/cdg605; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Jin G, 2004, P NATL ACAD SCI USA, V101, P2028, DOI 10.1073/pnas.0307314101; Kanayama A, 2004, MOL CELL, V15, P535, DOI 10.1016/j.molcel.2004.08.008; Kanei-Ishii C, 2004, GENE DEV, V18, P816, DOI 10.1101/gad.1170604; Kojima H, 2005, P NATL ACAD SCI USA, V102, P4524, DOI 10.1073/pnas.0500679102; Liu QH, 2009, NAT CELL BIOL, V11, P154, DOI 10.1038/ncb1823; Liu WG, 2000, NAT GENET, V26, P146, DOI 10.1038/79859; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Masui O, 2002, INT J MOL MED, V9, P489; Meneghini MD, 1999, NATURE, V399, P793, DOI 10.1038/21666; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Morrison DK, 2003, ANNU REV CELL DEV BI, V19, P91, DOI 10.1146/annurev.cellbio.19.111401.091942; Munoz-Sanjuan I, 2002, DEVELOPMENT, V129, P5529, DOI 10.1242/dev.00097; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Ohkawara B, 2004, GENE DEV, V18, P381, DOI 10.1101/gad.1166904; Ono K, 2001, J BIOL CHEM, V276, P24396, DOI 10.1074/jbc.M102631200; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Rottinger E, 2006, DEVELOPMENT, V133, P4341, DOI 10.1242/dev.02603; Shibuya H, 1996, SCIENCE, V272, P1179, DOI 10.1126/science.272.5265.1179; Shin TH, 1999, MOL CELL, V4, P275, DOI 10.1016/S1097-2765(00)80375-5; Shitashige M, 2008, CANCER SCI, V99, P631, DOI 10.1111/j.1349-7006.2007.00716.x; Smit L, 2004, J BIOL CHEM, V279, P17232, DOI 10.1074/jbc.M307801200; Stadeli R, 2006, CURR BIOL, V16, pR378, DOI 10.1016/j.cub.2006.04.019; Takada I, 2007, NAT CELL BIOL, V9, P1273, DOI 10.1038/ncb1647; Takaesu G, 2000, MOL CELL, V5, P649, DOI 10.1016/S1097-2765(00)80244-0; Takaesu G, 2001, MOL CELL BIOL, V21, P2475, DOI 10.1128/MCB.21.7.2475-2484.2001; Thorpe CJ, 2004, DEVELOPMENT, V131, P2899, DOI 10.1242/dev.01171; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Xia ZP, 2009, NATURE, V461, P114, DOI 10.1038/nature08247; Yamada M, 2006, J BIOL CHEM, V281, P20749, DOI 10.1074/jbc.M602089200; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; Yan D, 2001, P NATL ACAD SCI USA, V98, P14973, DOI 10.1073/pnas.261574498; Zeng YA, 2004, DEVELOPMENT, V131, P2911, DOI 10.1242/dev.01177	52	25	29	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13397	13404		10.1074/jbc.M109.083246	http://dx.doi.org/10.1074/jbc.M109.083246			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20194509	hybrid, Green Published			2022-12-25	WOS:000276987700011
J	Li, ZY; Zhang, GY; Liu, JL; Stojanovic, A; Ruan, CG; Lowell, CA; Du, XP				Li, Zhenyu; Zhang, Guoying; Liu, Junling; Stojanovic, Aleksandra; Ruan, Changgeng; Lowell, Clifford A.; Du, Xiaoping			An Important Role of the Src Family Kinase Lyn in Stimulating Platelet Granule Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; RECEPTOR-GAMMA-CHAIN; SIGNALING PATHWAY; GLYCOPROTEIN-VI; NITRIC-OXIDE; THROMBOXANE A(2); GUANYLYL CYCLASE; ACTIVATION; COLLAGEN; AGGREGATION	The Src family kinases (SFKs) have been proposed to play stimulatory and inhibitory roles in platelet activation. The mechanisms for these apparently contradictory roles are unclear. Here we show that SFK, mainly Lyn, is important in stimulating a common signaling pathway leading to secretion of platelet granules. Lyn knock-out or an isoform-nonselective SFK inhibitor, PP2, inhibited platelet secretion of both dense and alpha granules and the secretion-dependent platelet aggregation induced by thrombin, collagen, and thromboxane A(2). The inhibitory effect of Lyn knock-out on platelet aggregation was reversed by supplementing granule content ADP, indicating that the primary role of Lyn is to stimulate granule secretion. Inhibitory effect of PP2 on platelet aggregation induced by thrombin and thromboxane A(2) were also reversed by supplementing ADP. Furthermore, PP2 treatment or Lyn knock-out diminished agonist-induced Akt activation and cyclic GMP production. The inhibitory effect of PP2 or Lyn knock-out on platelet response can be corrected by supplementing cyclic GMP. These data indicate that Lyn stimulates platelet secretion by activating the phosphoinositide 3-kinase-Akt-nitric oxide (NO)-cyclic GMP pathway and also provide an explanation why Lyn can both stimulate and inhibit platelet activation.	[Li, Zhenyu; Zhang, Guoying] Univ Kentucky, Gill Heart Inst, Div Cardiovasc Med, Lexington, KY 40536 USA; [Li, Zhenyu; Zhang, Guoying; Liu, Junling; Stojanovic, Aleksandra; Du, Xiaoping] Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL 60612 USA; [Li, Zhenyu; Ruan, Changgeng; Du, Xiaoping] Soochow Univ, Affiliated Hosp 1, Jiangsu Inst Hematol, Suzhou 215006, Peoples R China; [Liu, Junling] Shanghai Jiao Tong Univ, Sch Med, Dept Mol & Cell Biol, Shanghai 200025, Peoples R China; [Lowell, Clifford A.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA	University of Kentucky; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Soochow University - China; Shanghai Jiao Tong University; University of California System; University of California San Francisco	Li, ZY (corresponding author), Univ Kentucky, Gill Heart Inst, Div Cardiovasc Med, 741 S Limestone St,BBSRB Bldg,Rm B251, Lexington, KY 40536 USA.	zhenyuli08@uky.edu			National Institutes of Health (NIH); NHLBI [HL68819, HL62350, 080264]; NIH/National Center for Research Resources Centers of Biomedical Research Excellence in Obesity and Cardiovascular Disease [P20 RR021954-01A1]; American Heart Association (AHA) National Scientist Development [0430095N]; AHA Midwes [0855698G]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021954] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068819, R01HL062350] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH/National Center for Research Resources Centers of Biomedical Research Excellence in Obesity and Cardiovascular Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); American Heart Association (AHA) National Scientist Development(American Heart Association); AHA Midwes(American Heart Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Institutes of Health (NIH), NHLBI, Grants HL68819, HL62350, and 080264 (to X.D.) and by NIH/National Center for Research Resources Centers of Biomedical Research Excellence in Obesity and Cardiovascular Disease Grant P20 RR021954-01A1. This work was also supported by American Heart Association (AHA) National Scientist Development Grant 0430095N and AHA Midwest Affiliate Grand-in-aid 0855698G (to Z. L.).	Arias-Salgado EG, 2005, J CELL BIOL, V170, P837, DOI 10.1083/jcb.200503125; Arias-Salgado EG, 2003, P NATL ACAD SCI USA, V100, P13298, DOI 10.1073/pnas.2336149100; Briddon SJ, 1999, BIOCHEM J, V338, P203, DOI 10.1042/0264-6021:3380203; Chan VWF, 1997, IMMUNITY, V7, P69, DOI 10.1016/S1074-7613(00)80511-7; Chen JH, 2004, BLOOD, V104, P1703, DOI 10.1182/blood-2003-10-3428; CHIANG TM, 1976, J LAB CLIN MED, V88, P215; Cho MJ, 2002, BLOOD, V99, P2442, DOI 10.1182/blood.V99.7.2442; Clemetson KJ, 2001, THROMB HAEMOSTASIS, V86, P189; de Virgilio M, 2004, J CELL BIOL, V165, P305, DOI 10.1083/jcb.200402064; Djellas Y, 1999, J BIOL CHEM, V274, P14325, DOI 10.1074/jbc.274.20.14325; Dorsam RT, 2005, BLOOD, V105, P2749, DOI 10.1182/blood-2004-07-2821; Du XP, 2007, CURR OPIN HEMATOL, V14, P262, DOI 10.1097/MOH.0b013e3280dce51a; Ezumi Y, 1998, J EXP MED, V188, P267, DOI 10.1084/jem.188.2.267; Flevaris P, 2007, J CELL BIOL, V179, P553, DOI 10.1083/jcb.200703185; Flevaris P, 2009, BLOOD, V113, P893, DOI 10.1182/blood-2008-05-155978; Foster CJ, 2001, J CLIN INVEST, V107, P1591, DOI 10.1172/JCI12242; Gambaryan S, 2008, J THROMB HAEMOST, V6, P1376, DOI 10.1111/j.1538-7836.2008.03014.x; Garcia A, 2005, BLOOD, V106, P3410, DOI 10.1182/blood-2005-05-1933; Herr AB, 2009, J BIOL CHEM, V284, P19781, DOI 10.1074/jbc.R109.013219; Kahner BN, 2006, J THROMB HAEMOST, V4, P2317, DOI 10.1111/j.1538-7836.2006.02192.x; Kim S, 2004, J BIOL CHEM, V279, P4186, DOI 10.1074/jbc.M306162200; Lemons PP, 1997, BLOOD, V90, P1490, DOI 10.1182/blood.V90.4.1490.1490_1490_1500; Leon C, 1999, J CLIN INVEST, V104, P1731, DOI 10.1172/JCI8399; Li ZY, 2001, J BIOL CHEM, V276, P42226, DOI 10.1074/jbc.M106129200; Li ZY, 2004, J BIOL CHEM, V279, P42469, DOI 10.1074/jbc.M401532200; Li ZY, 2003, J BIOL CHEM, V278, P30725, DOI 10.1074/jbc.M301838200; Li ZY, 2003, CELL, V112, P77, DOI 10.1016/S0092-8674(02)01254-0; Liu JL, 2005, BLOOD, V106, P2750, DOI 10.1182/blood-2005-04-1667; Locke D, 2003, J BIOL CHEM, V278, P15441, DOI 10.1074/jbc.M212338200; Marjanovic JA, 2005, J BIOL CHEM, V280, P37430, DOI 10.1074/jbc.M506518200; Marshall SJ, 2004, BLOOD, V103, P2601, DOI 10.1182/blood-2003-09-3319; Maxwell MJ, 2004, J BIOL CHEM, V279, P32196, DOI 10.1074/jbc.M400746200; MOROI M, 1989, J CLIN INVEST, V84, P1440, DOI 10.1172/JCI114318; Morrell CN, 2005, P NATL ACAD SCI USA, V102, P3782, DOI 10.1073/pnas.0408310102; Nanamori M, 2007, J IMMUNOL, V178, P416, DOI 10.4049/jimmunol.178.1.416; Offermanns S, 1997, NATURE, V389, P183, DOI 10.1038/38284; Pestina TI, 1997, ARTERIOSCL THROM VAS, V17, P3278, DOI 10.1161/01.ATV.17.11.3278; Poole A, 1997, EMBO J, V16, P2333, DOI 10.1093/emboj/16.9.2333; Quek LS, 2000, BLOOD, V96, P4246; Randriamboavonjy V, 2004, J EXP MED, V199, P347, DOI 10.1084/jem.20030694; Reed GL, 2000, BLOOD, V96, P3334; Ren QS, 2007, MOL BIOL CELL, V18, P24, DOI 10.1091/mbc.E06-09-0785; RETTORI V, 1993, P NATL ACAD SCI USA, V90, P10130, DOI 10.1073/pnas.90.21.10130; Riba R, 2008, J THROMB HAEMOST, V6, P2121, DOI 10.1111/j.1538-7836.2008.03179.x; Ruggeri ZM, 2002, NAT MED, V8, P1227, DOI 10.1038/nm1102-1227; Sambrano GR, 2001, NATURE, V413, P74, DOI 10.1038/35092573; Shankar H, 2006, BLOOD, V108, P3027, DOI 10.1182/blood-2006-03-010330; Stojanovic A, 2006, J BIOL CHEM, V281, P16333, DOI 10.1074/jbc.M512378200; Suzuki-Inoue K, 2002, J BIOL CHEM, V277, P21561, DOI 10.1074/jbc.M201012200; TANDON NN, 1989, J BIOL CHEM, V264, P7576; Thamilselvan V, 2007, FASEB J, V21, P1730, DOI 10.1096/fj.06-6545com; Thomas DW, 1998, J CLIN INVEST, V102, P1994, DOI 10.1172/JCI5116; Watson SP, 2005, J THROMB HAEMOST, V3, P1752, DOI 10.1111/j.1538-7836.2005.01429.x; Wildemann B, 1999, J NEUROBIOL, V39, P337, DOI 10.1002/(SICI)1097-4695(19990605)39:3<337::AID-NEU1>3.0.CO;2-9; Woulfe D, 2004, J CLIN INVEST, V113, P441, DOI 10.1172/JCI200420267; Yin H, 2008, BLOOD, V112, P1139, DOI 10.1182/blood-2008-02-140970; Yin H, 2008, BLOOD, V111, P658, DOI 10.1182/blood-2007-04-085514	57	31	32	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12559	12570		10.1074/jbc.M109.098756	http://dx.doi.org/10.1074/jbc.M109.098756			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20189992	Green Published, hybrid			2022-12-25	WOS:000276787800013
J	Manning, JA; Shalini, S; Risk, JM; Day, CL; Kumar, S				Manning, Jantina A.; Shalini, Sonia; Risk, Joanna M.; Day, Catherine L.; Kumar, Sharad			A Direct Interaction with NEDD1 Regulates gamma-Tubulin Recruitment to the Centrosome	PLOS ONE			English	Article							MICROTUBULE NUCLEATION; RING COMPLEX; SPINDLE; PROTEIN; LOCALIZATION; CEP192	The centrosome is the primary microtubule organizing centre of the cell. gamma-tubulin is a core component of the centrosome and is required for microtubule nucleation and centrosome function. The recruitment of gamma-tubulin to centrosomes is mediated by its interaction with NEDD1, a WD40-repeat containing protein. Here we demonstrate that NEDD1 is likely to be oligomeric in vivo and binds directly to gamma-tubulin through a small region of just 62 residues at the carboxyl-terminus of the protein. This carboxyl-terminal domain that binds gamma-tubulin has a helical structure and is a stable tetramer in solution. Mutation of residues in NEDD1 that disrupt binding to gamma-tubulin result in a mis-localization of gamma-tubulin away from the centrosome. Hence, this study defines the binding site on NEDD1 that is required for its interaction with gamma-tubulin, and shows that this interaction is required for the correct localization of gamma-tubulin.	[Manning, Jantina A.; Shalini, Sonia; Kumar, Sharad] SA Pathol, Ctr Canc Biol, Adelaide, SA, Australia; [Manning, Jantina A.; Kumar, Sharad] Univ Adelaide, Dept Med, Adelaide, SA 5001, Australia; [Risk, Joanna M.; Day, Catherine L.] Univ Otago, Dept Biochem, Dunedin, New Zealand	Centre for Cancer Biology; SA Pathology; University of Adelaide; University of Otago	Manning, JA (corresponding author), SA Pathol, Ctr Canc Biol, Adelaide, SA, Australia.	sharad.kumar@health.sa.gov.au	Kumar, Sharad/AAX-7787-2020; Risk, Joanna/A-1998-2010; Manning, Jantina/AAP-3810-2020	Kumar, Sharad/0000-0001-7126-9814; Manning, Jantina/0000-0001-9142-6135; Day, Catherine/0000-0003-1571-4367; Shah, Sonia Shalini/0000-0002-9106-2324	Cancer Council of South Australia; Australian Postgraduate Award; National Health and Medical Research Council of Australia (NHMRC) [399300]	Cancer Council of South Australia(Cancer Council South Australia); Australian Postgraduate Award(Australian Government); National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported in part by a grant from the Cancer Council of South Australia (http://www.cancersa.org.au/). JAM was supported by an Australian Postgraduate Award. SK is a Senior Principal Research Fellow of the National Health and Medical Research Council of Australia (http://www.nhmrc.gov.au/) (NHMRC Grant ID 399300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHEN YH, 1974, BIOCHEMISTRY-US, V13, P3350, DOI 10.1021/bi00713a027; Doxsey S, 2005, ANNU REV CELL DEV BI, V21, P411, DOI 10.1146/annurev.cellbio.21.122303.120418; Doxsey S, 2001, NAT REV MOL CELL BIO, V2, P688, DOI 10.1038/35089575; Fong KW, 2008, MOL BIOL CELL, V19, P115, DOI 10.1091/mbc.E07-04-0371; Foot NJ, 2008, BLOOD, V112, P4268, DOI 10.1182/blood-2008-04-150953; Gomez-Ferreria MA, 2007, CURR BIOL, V17, P1960, DOI 10.1016/j.cub.2007.10.019; Haren L, 2006, J CELL BIOL, V172, P505, DOI 10.1083/jcb.200510028; Haren L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005976; Harvey KF, 1999, J BIOL CHEM, V274, P12525, DOI 10.1074/jbc.274.18.12525; KUMAR S, 1994, J BIOL CHEM, V269, P11318; Liu L, 2008, J CELL SCI, V121, P578, DOI 10.1242/jcs.018937; Luders J, 2006, NAT CELL BIOL, V8, P137, DOI 10.1038/ncb1349; MANNING JA, 2010, CELL DEATH IN PRESS; Manning J, 2007, INT J BIOCHEM CELL B, V39, P7, DOI 10.1016/j.biocel.2006.08.012; Manning JA, 2008, HISTOCHEM CELL BIOL, V129, P751, DOI 10.1007/s00418-008-0392-0; Murphy SM, 2001, MOL BIOL CELL, V12, P3340, DOI 10.1091/mbc.12.11.3340; Oshimori N, 2009, EMBO J, V28, P2066, DOI 10.1038/emboj.2009.161; Shearwin-Whyatt LM, 2004, J CELL SCI, V117, P3679, DOI 10.1242/jcs.01212; Tillement V, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-10; Wiese C, 1999, CURR OPIN STRUC BIOL, V9, P250, DOI 10.1016/S0959-440X(99)80035-9; Zhang XY, 2009, J CELL SCI, V122, P2240, DOI 10.1242/jcs.042747; Zhu F, 2008, CURR BIOL, V18, P136, DOI 10.1016/j.cub.2007.12.055; Zhu H, 2008, J CELL BIOL, V183, P835, DOI 10.1083/jcb.200807046; Zhu YH, 2009, J FOOD SAFETY, V29, P1, DOI 10.1111/j.1745-4565.2008.00144.x	24	31	33	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2010	5	3							e9618	10.1371/journal.pone.0009618	http://dx.doi.org/10.1371/journal.pone.0009618			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565XE	20224777	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000275328800016
J	Saari, S; Hilvo, M; Pan, PW; Gros, G; Hanke, N; Waheed, A; Sly, WS; Parkkila, S				Saari, Sina; Hilvo, Mika; Pan, Peiwen; Gros, Gerolf; Hanke, Nina; Waheed, Abdul; Sly, William S.; Parkkila, Seppo			The Most Recently Discovered Carbonic Anhydrase, CA XV, Is Expressed in the Thick Ascending Limb of Henle and in the Collecting Ducts of Mouse Kidney	PLOS ONE			English	Article							RENAL-CELL CARCINOMA; H+-SECRETING CELLS; SUBCELLULAR-LOCALIZATION; INTERCALATED CELLS; PROXIMAL TUBULE; KNOCKOUT MICE; RAT-KIDNEY; WILD-TYPE; IV; MEMBRANE	Background: Carbonic anhydrases (CAs) are key enzymes for physiological pH regulation, including the process of urine acidification. Previous studies have identified seven cytosolic or membrane-bound CA isozymes in the kidney. Recently, we showed by in situ hybridization that the mRNA for the most novel CA isozyme, CA XV, is present in the renal cortex. CA XV is a unique isozyme among mammalian CAs, because it has become a pseudogene in primates even though expressed in several other species. Methodology/Principal Findings: In the present study, we raised a polyclonal antibody against recombinant mouse CA XV that was produced in a baculovirus/insect cell expression system, and the antibody was used for immunohistochemical analysis in different mouse tissues. Positive immunoreactions were found only in the kidney, where the enzyme showed a very limited distribution pattern. Parallel immunostaining experiments with several other anti-CA sera indicated that CA XV is mainly expressed in the thick ascending limb of Henle and collecting ducts, and the reactions were most prominent in the cortex and outer medulla. Conclusion/Significance: Although other studies have proposed a role for CA XV in cell proliferation, its tightly limited distribution may point to a specialized function in the regulation of acid-base homeostasis.	[Saari, Sina; Hilvo, Mika; Pan, Peiwen; Parkkila, Seppo] Univ Tampere, Inst Med Technol, FIN-33101 Tampere, Finland; [Saari, Sina; Parkkila, Seppo] Univ Tampere, Sch Med, FIN-33101 Tampere, Finland; [Hilvo, Mika; Pan, Peiwen; Parkkila, Seppo] Tampere Univ Hosp, Ctr Lab Med, Tampere, Finland; [Hilvo, Mika] VTT Tech Res Ctr Finland, Espoo, Finland; [Gros, Gerolf; Hanke, Nina] Hannover Med Sch, Zentrum Physiol, D-30623 Hannover, Germany; [Waheed, Abdul; Sly, William S.] St Louis Univ, Sch Med, Edward A Doisy Dept Biochem & Mol Biol, St Louis, MO 63104 USA	Tampere University; Tampere University; Tampere University; Tampere University Hospital; VTT Technical Research Center Finland; Hannover Medical School; Saint Louis University	Saari, S (corresponding author), Univ Tampere, Inst Med Technol, FIN-33101 Tampere, Finland.	seppo.parkkila@uta.fi	Wahhed, Abdul/AAA-3099-2020; Hilvo, Mika/AAC-7468-2020; Gros, Gerolf/K-8421-2012	Hilvo, Mika/0000-0003-0663-5843; Saari, Sina/0000-0003-4663-022X; Parkkila, Seppo/0000-0001-7323-8536	European Union; Tampere University Hospital [9L071]; Academy of Finland	European Union(European Commission); Tampere University Hospital; Academy of Finland(Academy of Finland)	This work was supported by the grants from the European Union FP6 Programme (DeZnIT), the Competitive Research Funding of the Tampere University Hospital (Grant 9L071), and the Academy of Finland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALPERN RJ, 1985, AM J PHYSIOL, V248, pF272, DOI 10.1152/ajprenal.1985.248.2.F272; Brion LP, 1997, AM J PHYSIOL-RENAL, V273, pF234, DOI 10.1152/ajprenal.1997.273.2.F234; BROWN D, 1990, P NATL ACAD SCI USA, V87, P7457, DOI 10.1073/pnas.87.19.7457; BROWN D, 1982, HISTOCHEMISTRY, V75, P209, DOI 10.1007/BF00496012; BROWN D, 1983, AM J PHYSIOL, V245, pF110, DOI 10.1152/ajprenal.1983.245.1.F110; CAPASSO G, 1991, J CLIN INVEST, V88, P430, DOI 10.1172/JCI115322; CAPASSO G, 1994, KIDNEY INT, V45, P1543, DOI 10.1038/ki.1994.204; Cheval L, 2006, PHYSIOL GENOMICS, V27, P271, DOI 10.1152/physiolgenomics.00069.2006; Dorai T, 2005, EUR J CANCER, V41, P2935, DOI 10.1016/j.ejca.2005.09.011; Fleming RE, 1995, J CLIN INVEST, V96, P2907, DOI 10.1172/JCI118362; Gailly P, 2008, KIDNEY INT, V74, P52, DOI 10.1038/sj.ki.5002794; Hilvo M, 2008, CURR PHARM DESIGN, V14, P672, DOI 10.2174/138161208783877811; Hilvo M, 2005, BIOCHEM J, V392, P83, DOI 10.1042/BJ20051102; Hilvo M, 2007, CURR TOP MED CHEM, V7, P893, DOI 10.2174/156802607780636672; Hilvo M, 2009, J MED CHEM, V52, P646, DOI 10.1021/jm801267c; Ivanov S, 2001, AM J PATHOL, V158, P905, DOI 10.1016/S0002-9440(10)64038-2; Ivanov SV, 1998, P NATL ACAD SCI USA, V95, P12596, DOI 10.1073/pnas.95.21.12596; Kallio H, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-22; KARHUKORPI EK, 1991, ACTA HISTOCHEM, V90, P11, DOI 10.1016/S0065-1281(11)80151-0; Kaunisto K, 2002, KIDNEY INT, V61, P2111, DOI 10.1046/j.1523-1755.2002.00371.x; Kyllonen MS, 2003, J HISTOCHEM CYTOCHEM, V51, P1217, DOI 10.1177/002215540305100912; Lehtonen J, 2004, J BIOL CHEM, V279, P2719, DOI 10.1074/jbc.M308984200; LONNERHOLM G, 1984, KIDNEY INT, V25, P886, DOI 10.1038/ki.1984.106; MCKINLEY DN, 1976, BIOCHIM BIOPHYS ACTA, V445, P780, DOI 10.1016/0005-2744(76)90128-5; OOSTERWIJK E, 1986, INT J CANCER, V38, P489, DOI 10.1002/ijc.2910380406; Parkkila S, 1996, HEPATOLOGY, V24, P1104; Parkkila S, 2001, P NATL ACAD SCI USA, V98, P1918, DOI 10.1073/pnas.98.4.1918; Parkkila S, 2000, J HISTOCHEM CYTOCHEM, V48, P1601, DOI 10.1177/002215540004801203; Parkkila Seppo, 2002, BMC Gastroenterol, V2, P13, DOI 10.1186/1471-230X-2-13; Premikumar L, 2005, P NATL ACAD SCI USA, V102, P7493, DOI 10.1073/pnas.0502829102; Purkerson JM, 2007, KIDNEY INT, V71, P407, DOI 10.1038/sj.ki.5002071; Purkerson JM, 2007, KIDNEY INT, V71, P103, DOI 10.1038/sj.ki.5002020; Scheibe RJ, 2006, J HISTOCHEM CYTOCHEM, V54, P1379, DOI 10.1369/jhc.6A7003.2006; Schwartz GJ, 2002, J NEPHROL, V15, pS61; Schwartz GJ, 2000, AM J PHYSIOL-RENAL, V278, pF894, DOI 10.1152/ajprenal.2000.278.6.F894; Sender S, 1998, J HISTOCHEM CYTOCHEM, V46, P855, DOI 10.1177/002215549804600709; Shah GN, 2005, P NATL ACAD SCI USA, V102, P16771, DOI 10.1073/pnas.0508449102; Tamai S, 1996, P NATL ACAD SCI USA, V93, P13647, DOI 10.1073/pnas.93.24.13647; Tureci O, 1998, P NATL ACAD SCI USA, V95, P7608, DOI 10.1073/pnas.95.13.7608; Wetzel P, 2007, AM J PHYSIOL-CELL PH, V293, pC358, DOI 10.1152/ajpcell.00057.2007; WISTRAND PJ, 1977, PFLUG ARCH EUR J PHY, V370, P121, DOI 10.1007/BF00581684; ZHU XL, 1990, J BIOL CHEM, V265, P8795	42	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2010	5	3							e9624	10.1371/journal.pone.0009624	http://dx.doi.org/10.1371/journal.pone.0009624			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565XE	20224780	Green Published, Green Submitted, gold			2022-12-25	WOS:000275328800019
J	Xu, C; Lo, A; Yammanuru, A; Tallarico, ASC; Brady, K; Murakami, A; Barteneva, N; Zhu, Q; Marasco, WA				Xu, Chen; Lo, Agnes; Yammanuru, Anuradha; Tallarico, Aimee St. Clair; Brady, Kristen; Murakami, Akikazu; Barteneva, Natasha; Zhu, Quan; Marasco, Wayne A.			Unique Biological Properties of Catalytic Domain Directed Human Anti-CAIX Antibodies Discovered through Phage-Display Technology	PLOS ONE			English	Article							RENAL-CELL CARCINOMA; CARBONIC-ANHYDRASE-IX; DIAGNOSTIC BIOMARKER; IN-VITRO; CANCER; PROTEIN; THERAPY; IDENTIFICATION; EXPRESSION; KIDNEY	Carbonic anhydrase IX (CAIX, gene G250/MN-encoded transmembrane protein) is highly expressed in various human epithelial tumors such as renal clear cell carcinoma (RCC), but absent from the corresponding normal tissues. Besides the CA signal transduction activity, CAIX may serve as a biomarker in early stages of oncogenesis and also as a reliable marker of hypoxia, which is associated with tumor resistance to chemotherapy and radiotherapy. Although results from preclinical and clinical studies have shown CAIX as a promising target for detection and therapy for RCC, only a limited number of murine monoclonal antibodies (mAbs) and one humanized mAb are available for clinical testing and development. In this study, paramagnetic proteoliposomes of CAIX (CAIX-PMPLs) were constructed and used for anti-CAIX antibody selection from our 27 billion human single-chain antibody (scFv) phage display libraries. A panel of thirteen human scFvs that specifically recognize CAIX expressed on cell surface was identified, epitope mapped primarily to the CA domain, and affinity-binding constants (KD) determined. These human anti-CAIX mAbs are diverse in their functions including induction of surface CAIX internalization into endosomes and inhibition of the carbonic anhydrase activity, the latter being a unique feature that has not been previously reported for anti-CAIX antibodies. These human anti-CAIX antibodies are important reagents for development of new immunotherapies and diagnostic tools for RCC treatment as well as extending our knowledge on the basic structure-function relationships of the CAIX molecule.	[Xu, Chen; Lo, Agnes; Yammanuru, Anuradha; Tallarico, Aimee St. Clair; Brady, Kristen; Murakami, Akikazu; Zhu, Quan; Marasco, Wayne A.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; [Barteneva, Natasha] Harvard Univ, Sch Med, Immune Dis Inst, Boston, MA 02115 USA; [Barteneva, Natasha] Harvard Univ, Sch Med, Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Xu, Chen; Lo, Agnes; Zhu, Quan; Marasco, Wayne A.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Barteneva, Natasha] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Xu, C (corresponding author), Beijing Tri Prime Genet Engn Corp Ltd, Beijing, Peoples R China.	quan_zhu@dfci.harvard.edu; wayne_marasco@dfci.harvard.edu	Barteneva, Natasha/B-9094-2017; Barteneva, Natalie/V-3826-2019	Barteneva, Natalie/0000-0002-8109-1754; Marasco, Wayne/0000-0003-3764-4611; Murakami, Akikazu/0000-0003-3064-3237	National Institutes of Health (NIH) [R21DK072282, 1S10RR23459-01]; Kidney SPORE [5P50CA101942]; PI; National Foundation for Cancer Research;  [R21AI058804]; NATIONAL CANCER INSTITUTE [P50CA101942] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023459] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI058804] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK072282] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kidney SPORE; PI; National Foundation for Cancer Research; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by National Institutes of Health (NIH) grants R21DK072282 to WAM, in part by the Kidney SPORE grant 5P50CA101942 where WAM is a subcontract PI, and in part by R21AI058804 to QKZ. The Flow and Imaging Cytometry Resource (FICR) and Imagestream 100 instrument used in this study were funded, in part, under NIH grant 1S10RR23459-01. The FACS Calibur used for flow cytometric analysis performed in this study was funded through the National Foundation for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amato RJ, 2005, ANN ONCOL, V16, P7, DOI 10.1093/annonc/mdi002; Atkins M, 2005, CLIN CANCER RES, V11, P3714, DOI 10.1158/1078-0432.CCR-04-2019; Atkins MB, 2009, CANCER-AM CANCER SOC, V115, P2327, DOI 10.1002/cncr.24231; Atkins MB, 2009, CANCER-AM CANCER SOC, V115, P2247, DOI 10.1002/cncr.24229; Bargou R, 2008, SCIENCE, V321, P974, DOI 10.1126/science.1158545; Baselga J, 1998, CANCER RES, V58, P2825; Beavon IRG, 2000, EUR J CANCER, V36, P1607, DOI 10.1016/S0959-8049(00)00158-1; Bleumer I, 2003, EUR UROL, V44, P65, DOI 10.1016/S0302-2838(03)00191-X; Bleumer I, 2004, BRIT J CANCER, V90, P985, DOI 10.1038/sj.bjc.6601617; Bleumer Ivar, 2006, Can J Urol, V13 Suppl 2, P57; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Brouwers AH, 2002, NUCL MED COMMUN, V23, P229, DOI 10.1097/00006231-200203000-00005; Bui MHT, 2003, CLIN CANCER RES, V9, P802; Cohen HT, 2005, NEW ENGL J MED, V353, P2477, DOI 10.1056/NEJMra043172; Davis Ian D, 2007, Cancer Immun, V7, P14; Davis Ian D, 2007, Cancer Immun, V7, P13; Divgi CR, 2007, LANCET ONCOL, V8, P304, DOI 10.1016/S1470-2045(07)70044-X; DOEGE KJ, 1991, J BIOL CHEM, V266, P894; Dorai T, 2005, EUR J CANCER, V41, P2935, DOI 10.1016/j.ejca.2005.09.011; Grabmaier K, 2004, ONCOGENE, V23, P5624, DOI 10.1038/sj.onc.1207764; Grabmaier K, 2000, INT J CANCER, V85, P865, DOI 10.1002/(SICI)1097-0215(20000315)85:6<865::AID-IJC21>3.0.CO;2-Q; Guilford P, 1999, MOL MED TODAY, V5, P172, DOI 10.1016/S1357-4310(99)01461-6; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hilvo M, 2008, J BIOL CHEM, V283, P27799, DOI 10.1074/jbc.M800938200; Ivanov S, 2001, AM J PATHOL, V158, P905, DOI 10.1016/S0002-9440(10)64038-2; Klatte T, 2009, CANCER-AM CANCER SOC, V115, P1448, DOI 10.1002/cncr.24163; Kumar P, 2008, CELL, V134, P577, DOI 10.1016/j.cell.2008.06.034; LIAO SY, 1994, AM J PATHOL, V145, P598; Liao SY, 1997, CANCER RES, V57, P2827; Maher J, 2002, NAT BIOTECHNOL, V20, P70, DOI 10.1038/nbt0102-70; Michael A, 2003, LANCET ONCOL, V4, P215, DOI 10.1016/S1470-2045(03)01044-1; Mirzabekov T, 2000, NAT BIOTECHNOL, V18, P649, DOI 10.1038/76501; MOSTFI FK, 1998, WHO INT HISTOLOGICAL; Motzer RJ, 2000, J UROLOGY, V163, P408, DOI 10.1016/S0022-5347(05)67889-5; Motzer RJ, 2000, J CLIN ONCOL, V18, P1928, DOI 10.1200/JCO.2000.18.9.1928; OOSTERWIJK E, 1986, INT J CANCER, V38, P489, DOI 10.1002/ijc.2910380406; Opavsky R, 1996, GENOMICS, V33, P480, DOI 10.1006/geno.1996.0223; Parkkila S, 2000, P NATL ACAD SCI USA, V97, P2220, DOI 10.1073/pnas.040554897; PASTOREK J, 1994, ONCOGENE, V9, P2877; PASTOREKOVA S, 1992, VIROLOGY, V187, P620, DOI 10.1016/0042-6822(92)90464-Z; Pastorekova S, 2006, ADV CLIN CHEM, V42, P167, DOI 10.1016/S0065-2423(06)42005-9; Pinthus JH, 2003, CANCER RES, V63, P2470; Powles T, 2007, LANCET ONCOL, V8, P279, DOI 10.1016/S1470-2045(07)70080-3; Purkerson JM, 2007, KIDNEY INT, V71, P103, DOI 10.1038/sj.ki.5002020; Schmitt A, 2009, INT J ONCOL, V34, P629, DOI 10.3892/ijo_00000188; Song EW, 2005, NAT BIOTECHNOL, V23, P709, DOI 10.1038/nbt1101; Stillebroer Alexander B, 2007, Cancer Imaging, V7, P179, DOI 10.1102/1470-7330.2007.0025; Surfus JE, 1996, J IMMUNOTHER, V19, P184, DOI 10.1097/00002371-199605000-00003; Svastova E, 2003, EXP CELL RES, V290, P332, DOI 10.1016/S0014-4827(03)00351-3; Svastova E, 2004, FEBS LETT, V577, P439, DOI 10.1016/j.febslet.2004.10.043; Xu C, 2007, J IMMUNOL, V179, P2408, DOI 10.4049/jimmunol.179.4.2408; Zat'ovicova M, 2003, J IMMUNOL METHODS, V282, P117, DOI 10.1016/j.jim.2003.08.011; Zavada J, 2000, BRIT J CANCER, V82, P1808, DOI 10.1054/bjoc.2000.1111; ZAVADA J, 1993, INT J CANCER, V54, P268, DOI 10.1002/ijc.2910540218	54	33	38	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2010	5	3							e9625	10.1371/journal.pone.0009625	http://dx.doi.org/10.1371/journal.pone.0009625			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565XE	20224781	Green Submitted, Green Published, gold			2022-12-25	WOS:000275328800020
J	Burman, JL; Hamlin, JNR; McPherson, PS				Burman, Jonathon L.; Hamlin, Jason N. R.; McPherson, Peter S.			Scyl1 Regulates Golgi Morphology	PLOS ONE			English	Article							RECESSIVE FORM; PROTEIN; COPI; DYNAMICS; GENE; CLONING; TRAFFICKING; TRANSPORT; SUBUNIT; ENCODES	Background: Membrane trafficking is a defining feature of eukaryotic cells, and is essential for the maintenance of organelle homeostasis and identity. We previously identified Scy1-like 1 (Scyl1), a member of the Scy1-like family of catalytically inactive protein kinases, as a high-affinity binding partner of COPI coats. COPI-coated vesicles control Golgi to endoplasmic reticulum trafficking and we observed that disruption of Scyl1 function leads to a decrease in trafficking of the KDEL receptor via the COPI pathway. We reasoned that if Scyl1 plays a major role in COPI trafficking its disruption could influence Golgi homeostasis. Methodology/Principal Findings: We performed Scyl1 knock down in cultured cells using previously established methods and observed an alteration in Golgi morphology. Both the surface area and volume of the Golgi is increased in Scyl1-depleted cells, but the continuity and polarity of the organelle is unperturbed. At the ultrastructural level we observe a decrease in the orderly structure of the Golgi with an increase in cisternal luminal width, while the number of Golgi cisternae remains unchanged. The golgin family of proteins forms a detergent resistant network that controls Golgi homeostasis. Disruption of this protein network by knock down of the golgin p115 disrupts the Golgi localization of Scyl1. Moreover, we find that Scyl1 interacts with 58K/formiminotransferase cyclodeaminase (FTCD), a protein that is tightly associated with the cis face of the Golgi. Conclusions/Significance: Our results place Scyl1 at an interface between the golgin network and COPI trafficking and demonstrate that Scyl1 is required for the maintenance of Golgi morphology. Coupled with the observation from others that Scyl1 is the gene product responsible for the neurodegenerative mouse model mdf, our results additionally implicate the regulation of COPI trafficking and Golgi homeostasis in neurodegeneration.	[Burman, Jonathon L.; Hamlin, Jason N. R.; McPherson, Peter S.] McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada	McGill University	Burman, JL (corresponding author), Univ Washington, Dept Genome Sci, Genome Sci Ctr, Seattle, WA 98195 USA.	peter.mcpherson@mcgill.ca			Canadian Institutes of Health Research (CIHR) [t MOP 62684]; Great-West Life; London Life; Canada Life Experimental Therapeutics Fund at the Montreal Neurological Institute; ALS society	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Great-West Life; London Life; Canada Life Experimental Therapeutics Fund at the Montreal Neurological Institute; ALS society	This work was supported by Canadian Institutes of Health Research (CIHR) grant MOP 62684 awarded to PSM and a grant from the Great-West Life, London Life and Canada Life Experimental Therapeutics Fund at the Montreal Neurological Institute. JLB was supported by a studentship from the CIHR. JNRH holds a studentship from the ALS society. PSM holds the James McGill Chair. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Al-Dosari M, 2009, AM J MED GENET A, V149A, P2093, DOI 10.1002/ajmg.a.32996; Barr FA, 2003, CURR OPIN CELL BIOL, V15, P405, DOI 10.1016/S0955-0674(03)00054-1; BURMAN JL, 2009, UCSD NATURE MOL PAGE, DOI DOI 10.1038/MP.A003453.01; Burman JL, 2008, J BIOL CHEM, V283, P22774, DOI 10.1074/jbc.M801869200; Cole NB, 1996, MOL BIOL CELL, V7, P631, DOI 10.1091/mbc.7.4.631; Cole NB, 1996, SCIENCE, V273, P797, DOI 10.1126/science.273.5276.797; Dejgaard SY, 2007, J HISTOCHEM CYTOCHEM, V55, P709, DOI 10.1369/jhc.6A7090.2007; Di YJ, 2003, J HUM GENET, V48, P315, DOI 10.1007/s10038-003-0031-5; Dominguez M, 1998, J CELL BIOL, V140, P751, DOI 10.1083/jcb.140.4.751; DONALDSON JG, 1992, NATURE, V360, P350, DOI 10.1038/360350a0; Elsner M, 2003, EMBO REP, V4, P1000, DOI 10.1038/sj.embor.embor942; Fridmann-Sirkis Y, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-18; Gao YS, 1998, J BIOL CHEM, V273, P33825, DOI 10.1074/jbc.273.50.33825; Gao YS, 2001, J CELL BIOL, V152, P877, DOI 10.1083/jcb.152.5.877; Gilchrist A, 2006, CELL, V127, P1265, DOI 10.1016/j.cell.2006.10.036; Guo YS, 2008, MOL BIOL CELL, V19, P2830, DOI 10.1091/mbc.E07-12-1236; Guo YS, 2006, J CELL BIOL, V174, P53, DOI 10.1083/jcb.200604058; Hennies HC, 2008, NAT GENET, V40, P1410, DOI 10.1038/ng.252; Horton AC, 2004, NAT CELL BIOL, V6, P585, DOI 10.1038/ncb0704-585; HOSOBUCHI M, 1992, NATURE, V360, P603, DOI 10.1038/360603a0; Hsu VW, 2009, NAT REV MOL CELL BIO, V10, P360, DOI 10.1038/nrm2663; Kirchhausen T, 2000, NAT REV MOL CELL BIO, V1, P187, DOI 10.1038/35043117; Ladinsky MS, 1999, J CELL BIOL, V144, P1135, DOI 10.1083/jcb.144.6.1135; Liu SCH, 2000, BBA-GENE STRUCT EXPR, V1517, P148, DOI 10.1016/S0167-4781(00)00234-7; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Majoul I, 1998, J CELL BIOL, V143, P601, DOI 10.1083/jcb.143.3.601; Malsam J, 2005, SCIENCE, V307, P1095, DOI 10.1126/science.1108061; Presley JF, 2002, NATURE, V417, P187, DOI 10.1038/417187a; Puthenveedu MA, 2006, NAT CELL BIOL, V8, P238, DOI 10.1038/ncb1366; Puthenveedu MA, 2004, P NATL ACAD SCI USA, V101, P1253, DOI 10.1073/pnas.0306373101; Rabouille C, 2005, NAT REV MOL CELL BIO, V6, P812, DOI 10.1038/nrm1735; Schmidt WM, 2007, EMBO REP, V8, P691, DOI 10.1038/sj.embor.7401001; Short B, 2005, BBA-MOL CELL RES, V1744, P383, DOI 10.1016/j.bbamcr.2005.02.001; Storrie B, 2000, TRENDS CELL BIOL, V10, P385, DOI 10.1016/S0962-8924(00)01818-3; STURGESS JM, 1972, J CELL BIOL, V55, P524, DOI 10.1083/jcb.55.2.524; Sun Y, 2007, MOL BIOL CELL, V18, P4129, DOI 10.1091/mbc.E07-01-0080; Weide T, 2001, EMBO REP, V2, P336, DOI 10.1093/embo-reports/kve065	38	43	43	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2010	5	3							e9537	10.1371/journal.pone.0009537	http://dx.doi.org/10.1371/journal.pone.0009537			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	564EW	20209057	Green Published, gold, Green Submitted			2022-12-25	WOS:000275197100017
J	Maunoury, N; Redondo-Nieto, M; Bourcy, M; Van de Velde, W; Alunni, B; Laporte, P; Durand, P; Agier, N; Marisa, L; Vaubert, D; Delacroix, H; Duc, G; Ratet, P; Aggerbeck, L; Kondorosi, E; Mergaert, P				Maunoury, Nicolas; Redondo-Nieto, Miguel; Bourcy, Marie; Van de Velde, Willem; Alunni, Benoit; Laporte, Philippe; Durand, Patricia; Agier, Nicolas; Marisa, Laetitia; Vaubert, Daniele; Delacroix, Herve; Duc, Gerard; Ratet, Pascal; Aggerbeck, Lawrence; Kondorosi, Eva; Mergaert, Peter			Differentiation of Symbiotic Cells and Endosymbionts in Medicago truncatula Nodulation Are Coupled to Two Transcriptome-Switches	PLOS ONE			English	Article							MITOTIC INHIBITOR CCS52; SINORHIZOBIUM-MELILOTI; NODULE DEVELOPMENT; NITROGEN-FIXATION; ALFALFA NODULES; GENE-EXPRESSION; PERIBACTEROID MEMBRANE; PLANT DEFENSE; ROOT-NODULES; LIPID-A	The legume plant Medicago truncatula establishes a symbiosis with the nitrogen-fixing bacterium Sinorhizobium meliloti which takes place in root nodules. The formation of nodules employs a complex developmental program involving organogenesis, specific cellular differentiation of the host cells and the endosymbiotic bacteria, called bacteroids, as well as the specific activation of a large number of plant genes. By using a collection of plant and bacterial mutants inducing nonfunctional, Fix 2 nodules, we studied the differentiation processes of the symbiotic partners together with the nodule transcriptome, with the aim of unravelling links between cell differentiation and transcriptome activation. Two waves of transcriptional reprogramming involving the repression and the massive induction of hundreds of genes were observed during wild-type nodule formation. The dominant features of this "nodule-specific transcriptome'' were the repression of plant defense-related genes, the transient activation of cell cycle and protein synthesis genes at the early stage of nodule development and the activation of the secretory pathway along with a large number of transmembrane and secretory proteins or peptides throughout organogenesis. The fifteen plant and bacterial mutants that were analyzed fell into four major categories. Members of the first category of mutants formed non-functional nodules although they had differentiated nodule cells and bacteroids. This group passed the two transcriptome switch-points similarly to the wild type. The second category, which formed nodules in which the plant cells were differentiated and infected but the bacteroids did not differentiate, passed the first transcriptome switch but not the second one. Nodules in the third category contained infection threads but were devoid of differentiated symbiotic cells and displayed a root-like transcriptome. Nodules in the fourth category were free of bacteria, devoid of differentiated symbiotic cells and also displayed a root-like transcriptome. A correlation thus exists between the differentiation of symbiotic nodule cells and the first wave of nodule specific gene activation and between differentiation of rhizobia to bacteroids and the second transcriptome wave in nodules. The differentiation of symbiotic cells and of bacteroids may therefore constitute signals for the execution of these transcriptome-switches.	[Maunoury, Nicolas; Redondo-Nieto, Miguel; Bourcy, Marie; Van de Velde, Willem; Alunni, Benoit; Laporte, Philippe; Durand, Patricia; Vaubert, Daniele; Ratet, Pascal; Kondorosi, Eva; Mergaert, Peter] CNRS, Unite Propre Rech 2355, Inst Sci Vegetal, Gif Sur Yvette, France; [Agier, Nicolas; Marisa, Laetitia; Delacroix, Herve; Aggerbeck, Lawrence] CNRS, Ctr Genet Mol, Gif Sur Yvette, France; [Delacroix, Herve] Univ Paris 11, Orsay, France; [Duc, Gerard] INRA, Genet & Ecophysiol Legumineuses Graines, F-21034 Dijon, France; [Kondorosi, Eva] Bay Zoltan Fdn Appl Res, Inst Plant Genom Human Biotechnol & Bioenergy, Szeged, Hungary	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; INRAE	Maunoury, N (corresponding author), INRA, Inst Jean Pierre Bourgin, F-78026 Versailles, France.	peter.mergaert@isv.cnrs-gif.fr	Redondo-Nieto, Miguel/A-6169-2011; Mergaert, Peter/M-1265-2019; Ratet, Pascal/GPP-3654-2022	Redondo-Nieto, Miguel/0000-0002-3361-520X; Mergaert, Peter/0000-0002-5919-7317; Ratet, Pascal/0000-0002-8621-1495; Kondorosi, Eva/0000-0002-4065-8515	Agence National de la Recherche [ANR-05-BLAN-0129-01]; IFR115 Genomes: Structure, Fonction et Evolution; Universite Paris Sud XI; CNRS; Institut Curie; French Ministry of Research; Spanish Ministerio de Educacion y Ciencia; Institut de Chimie des Substances Naturelles, CNRS	Agence National de la Recherche(French National Research Agency (ANR)); IFR115 Genomes: Structure, Fonction et Evolution; Universite Paris Sud XI; CNRS(Centre National de la Recherche Scientifique (CNRS)); Institut Curie; French Ministry of Research(Ministry of Research, FranceEuropean Commission); Spanish Ministerio de Educacion y Ciencia(Spanish Government); Institut de Chimie des Substances Naturelles, CNRS(Centre National de la Recherche Scientifique (CNRS))	This work was supported by grant N degrees ANR-05-BLAN-0129-01 from the Agence National de la Recherche to P. M. The GODMAP platform was funded by the IFR115 Genomes: Structure, Fonction et Evolution, the Universite Paris Sud XI (Plan Pluri-Formation "Plate-forme Puces-a-ADN 2006-2009''), the CNRS and the Institut Curie. N. M. and B. A. were the beneficiaries of PhD fellowships from the French Ministry of Research. M. R-N. was funded by the Spanish Ministerio de Educacion y Ciencia Progam Becas Postdoctorales. L. M. was supported by the Institut de Chimie des Substances Naturelles, CNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albus U, 2001, NEW PHYTOL, V151, P597, DOI 10.1046/j.0028-646x.2001.00214.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Alunni B, 2007, MOL PLANT MICROBE IN, V20, P1138, DOI 10.1094/MPMI-20-9-1138; BENABEN V, 1995, PLANT PHYSIOL, V107, P53, DOI 10.1104/pp.107.1.53; Benedito VA, 2008, PLANT J, V55, P504, DOI 10.1111/j.1365-313X.2008.03519.x; BOIVIN C, 1990, PLANT CELL, V2, P1157, DOI 10.1105/tpc.2.12.1157; Borisov AY, 2003, PLANT PHYSIOL, V131, P1009, DOI 10.1104/pp.102.016071; Campbell GRO, 2002, P NATL ACAD SCI USA, V99, P3938, DOI 10.1073/pnas.062425699; Catalano CM, 2007, PLANTA, V225, P541, DOI 10.1007/s00425-006-0369-y; Cebolla A, 1999, EMBO J, V18, P4476, DOI 10.1093/emboj/18.16.4476; Cheng HP, 1998, J BACTERIOL, V180, P5183, DOI 10.1128/JB.180.19.5183-5191.1998; Combier JP, 2007, PLANT PHYSIOL, V144, P703, DOI 10.1104/pp.106.092585; Combier JP, 2006, GENE DEV, V20, P3084, DOI 10.1101/gad.402806; COOK D, 1995, PLANT CELL, V7, P43, DOI 10.1105/tpc.7.1.43; Coque L, 2008, MOL PLANT MICROBE IN, V21, P404, DOI 10.1094/MPMI-21-4-0404; CRESPI MD, 1994, EMBO J, V13, P5099, DOI 10.1002/j.1460-2075.1994.tb06839.x; delaPena TC, 1997, PLANT J, V11, P407, DOI 10.1046/j.1365-313X.1997.11030407.x; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; El Yahyaoui F, 2004, PLANT PHYSIOL, V136, P3159, DOI 10.1104/pp.104.043612; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Engler JD, 2001, METHODS, V23, P325, DOI 10.1006/meth.2000.1144; Ferguson GP, 2005, MOL MICROBIOL, V56, P68, DOI 10.1111/j.1365-2958.2005.04536.x; FORTIN MG, 1987, NUCLEIC ACIDS RES, V15, P813, DOI 10.1093/nar/15.2.813; Gamas P, 1996, MOL PLANT MICROBE IN, V9, P233, DOI 10.1094/MPMI-9-0233; GLAZEBROOK J, 1993, GENE DEV, V7, P1485, DOI 10.1101/gad.7.8.1485; Gonzalez-Sama A, 2006, MOL PLANT MICROBE IN, V19, P173, DOI 10.1094/MPMI-19-0173; Gyorgyey J, 2000, MOL PLANT MICROBE IN, V13, P62, DOI 10.1094/MPMI.2000.13.1.62; HIRSCH AM, 1983, J BACTERIOL, V155, P367, DOI 10.1128/JB.155.1.367-380.1983; Hogslund N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006556; Jones KM, 2008, P NATL ACAD SCI USA, V105, P704, DOI 10.1073/pnas.0709338105; Jones KM, 2007, NAT REV MICROBIOL, V5, P619, DOI 10.1038/nrmicro1705; Kannenberg EL, 2001, MOL MICROBIOL, V39, P379, DOI 10.1046/j.1365-2958.2001.02225.x; Kardailsky IV, 1996, PLANT PHYSIOL, V111, P49, DOI 10.1104/pp.111.1.49; Kevei Z, 2002, MOL PLANT MICROBE IN, V15, P922, DOI 10.1094/MPMI.2002.15.9.922; Kiers ET, 2008, ANNU REV ECOL EVOL S, V39, P215, DOI 10.1146/annurev.ecolsys.39.110707.173423; Krusell L, 2005, PLANT CELL, V17, P1625, DOI 10.1105/tpc.104.030106; LEONG SA, 1985, NUCLEIC ACIDS RES, V13, P5965, DOI 10.1093/nar/13.16.5965; Limpens E, 2009, PLANT CELL, V21, P2811, DOI 10.1105/tpc.108.064410; Liu JQ, 2006, PLANT PHYSIOL, V141, P167, DOI 10.1104/pp.106.076711; Lohar DP, 2006, PLANT PHYSIOL, V140, P221, DOI 10.1104/pp.105.070326; Manthey K, 2004, MOL PLANT MICROBE IN, V17, P1063, DOI 10.1094/MPMI.2004.17.10.1063; Marsh JF, 2007, PLANT PHYSIOL, V144, P324, DOI 10.1104/pp.106.093021; Mathis R, 1999, MOL PLANT MICROBE IN, V12, P544, DOI 10.1094/MPMI.1999.12.6.544; Maunoury N., 2008, V7, P153; McKhann HI, 1997, PLANT MOL BIOL, V34, P771, DOI 10.1023/A:1005899410389; Mergaert P, 2006, P NATL ACAD SCI USA, V103, P5230, DOI 10.1073/pnas.0600912103; Mergaert P, 2003, PLANT PHYSIOL, V132, P161, DOI 10.1104/pp.102.018192; Mithofer A, 1996, PLANTA, V199, P270, DOI 10.1007/BF00196568; Mitra RM, 2004, PLANT PHYSIOL, V134, P595, DOI 10.1104/pp.103.031518; Morandi D, 2005, MYCORRHIZA, V15, P283, DOI 10.1007/s00572-004-0331-4; Newton W.E., 1998, BIOL NITROGEN FIXATI, P317; Niehaus K, 1998, MOL PLANT MICROBE IN, V11, P906, DOI 10.1094/MPMI.1998.11.9.906; NIEHAUS K, 1993, PLANTA, V190, P415; NORRIS JH, 1988, PLANT PHYSIOL, V88, P321, DOI 10.1104/pp.88.2.321; Pellock BJ, 2000, J BACTERIOL, V182, P4310, DOI 10.1128/JB.182.15.4310-4318.2000; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Rickman DS, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng109; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; SAGAN M, 1995, PLANT SCI, V111, P63, DOI 10.1016/0168-9452(95)04229-N; Shi LF, 1997, PLANT CELL, V9, P1339, DOI 10.1105/tpc.9.8.1339; Starker CG, 2006, PLANT PHYSIOL, V140, P671, DOI 10.1104/pp.105.072132; Tellstrom V, 2007, PLANT PHYSIOL, V143, P825, DOI 10.1104/pp.106.090985; Timmers ACJ, 2000, MOL PLANT MICROBE IN, V13, P1204, DOI 10.1094/MPMI.2000.13.11.1204; Van de Velde W, 2006, PLANT PHYSIOL, V141, P711, DOI 10.1104/pp.106.078691; VANDEVELDE W, 2010, SCIENCE IN PRESS; VANDEWIEL C, 1990, EMBO J, V9, P1; VASSE J, 1990, J BACTERIOL, V172, P4295, DOI 10.1128/jb.172.8.4295-4306.1990; Verma DPS, 1996, TRENDS MICROBIOL, V4, P364, DOI 10.1016/0966-842X(96)10053-6; Vernoud V, 1999, MOL PLANT MICROBE IN, V12, P604, DOI 10.1094/MPMI.1999.12.7.604; Vinardell JM, 2003, PLANT CELL, V15, P2093, DOI 10.1105/tpc.014373; Wais RJ, 2002, MOL PLANT MICROBE IN, V15, P1245, DOI 10.1094/MPMI.2002.15.12.1245; WANG D, 2010, SCIENCE IN PRESS; Weihofen A, 2002, SCIENCE, V296, P2215, DOI 10.1126/science.1070925; Woo HH, 1999, PLANT CELL, V11, P2303, DOI 10.1105/tpc.11.12.2303	75	112	115	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2010	5	3							e9519	10.1371/journal.pone.0009519	http://dx.doi.org/10.1371/journal.pone.0009519			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	564EW	20209049	gold, Green Published, Green Submitted			2022-12-25	WOS:000275197100007
J	Li, YW; Tao, W; Luo, LY; Huang, DQ; Kauper, K; Stabila, P; LaVail, MM; Laties, AM; Wen, R				Li, Yiwen; Tao, Weng; Luo, Lingyu; Huang, Deqiang; Kauper, Konrad; Stabila, Paul; LaVail, Matthew M.; Laties, Alan M.; Wen, Rong			CNTF Induces Regeneration of Cone Outer Segments in a Rat Model of Retinal Degeneration	PLOS ONE			English	Article							CILIARY NEUROTROPHIC FACTOR; ROD PHOTORECEPTORS; GANGLION-CELLS; PHOTOTRANSDUCTION MACHINERY; AXONAL REGENERATION; ANIMAL-MODELS; GENE-TRANSFER; SURVIVAL; DEATH; DIFFERENTIATION	Background: Cone photoreceptors are responsible for color and central vision. In the late stage of retinitis pigmentosa and in geographic atrophy associated with age-related macular degeneration, cone degeneration eventually causes loss of central vision. In the present work, we investigated cone degeneration secondary to rod loss in the S334ter-3 transgenic rats carrying the rhodopsin mutation S334ter. Methodology/Principal Findings: Recombinant human ciliary neurotrophic factor (CNTF) was delivered by intravitreal injection to the left eye of an animal, and vehicle to the right eye. Eyes were harvested 10 days after injection. Cone outer segments (COS), and cell bodies were identified by staining with peanut agglutinin and cone arrestin antibodies in whole-mount retinas. For long-term treatment with CNTF, CNTF secreting microdevices were implanted into the left eyes at postnatal day (PD) 20 and control devices into the right eyes. Cone ERG was recorded at PD 160 from implanted animals. Our results demonstrate that an early sign of cone degeneration is the loss of COS, which concentrated in many small areas throughout the retina and is progressive with age. Treatment with CNTF induces regeneration of COS and thus reverses the degeneration process in early stages of cone degeneration. Sustained delivery of CNTF prevents cones from degeneration and helps them to maintain COS and light-sensing function. Conclusions/Significance: Loss of COS is an early sign of secondary cone degeneration whereas cell death occurs much later. At early stages, degenerating cones are capable of regenerating outer segments, indicating the reversal of the degenerative process. Sustained delivery of CNTF preserves cone cells and their function. Long-term treatment with CNTF starting at early stages of degeneration could be a viable strategy for preservation of central vision for patients with retinal degenerations.	[Li, Yiwen; Luo, Lingyu; Huang, Deqiang; Wen, Rong] Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, Miami, FL 33136 USA; [LaVail, Matthew M.] Univ Calif San Francisco, Beckman Vis Ctr, San Francisco, CA 94143 USA; [Tao, Weng; Kauper, Konrad; Stabila, Paul] Neurotech USA, Lincoln, RI USA; [Laties, Alan M.] Univ Penn, Sch Med, Dept Ophthalmol, Philadelphia, PA 19104 USA	Bascom Palmer Eye Institute; University of Miami; University of California System; University of California San Francisco; University of Pennsylvania	Li, YW (corresponding author), Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, Miami, FL 33136 USA.	rwen@med.miami.edu			National Institutes of Health (NIH) [R01EY015289, R01EY018586, R01EY001919, R01EY006842, P30EY14801, P30EY002162]; James and Esther King Biomedical Research Program of the State of Florida; Department of Defense [08192003]; Foundation Fighting Blindness; Research to Prevent Blindness Inc.; NATIONAL EYE INSTITUTE [R01EY006842, R01EY001919, P30EY014801, R01EY018586, P30EY002162, R01EY015289] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James and Esther King Biomedical Research Program of the State of Florida; Department of Defense(United States Department of Defense); Foundation Fighting Blindness(European Commission); Research to Prevent Blindness Inc.(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health (NIH) grants R01EY015289 (RW), R01EY018586 (RW), R01EY001919 (MML), R01EY006842 (MML), Hope for Vision (RW), a grant from the James and Esther King Biomedical Research Program of the State of Florida (YL) and a grant from the Department of Defense (USAMRMC NO: 08192003, RW). It was also supported by NIH Core Grants P30EY14801 and P30EY002162, the Foundation Fighting Blindness (MML), and unrestricted grants from Research to Prevent Blindness Inc. to Bascom Palmer Eye Institute and Beckman Vision Center. The above funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Neurotech USA supplied the CNTF intraocular implants for this study. Neurotech USA is developing CNTF intraocular implants. As some of the authors are employed by Neurotech USA, this company had a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER R, 1979, SCIENCE, V204, P1434, DOI 10.1126/science.451576; Bhattacharya S, 2004, MOL CELL NEUROSCI, V27, P32, DOI 10.1016/j.mcn.2004.05.004; BLANKS JC, 1983, J COMP NEUROL, V221, P31, DOI 10.1002/cne.902210103; Bok D, 2002, EXP EYE RES, V74, P719, DOI 10.1006/exer.2002.1176; Caffe AR, 2001, INVEST OPHTH VIS SCI, V42, P275; Cayouette M, 1997, HUM GENE THER, V8, P423, DOI 10.1089/hum.1997.8.4-423; Cayouette M, 1998, J NEUROSCI, V18, P9282; Chong NHV, 1999, INVEST OPHTH VIS SCI, V40, P1298; Chrysostomou V, 2009, INVEST OPHTH VIS SCI, V50, P3017, DOI 10.1167/iovs.08-3004; Cui Q, 1999, INVEST OPHTH VIS SCI, V40, P760; Delyfer MN, 2004, BIOL CELL, V96, P261, DOI 10.1016/j.biolcel.2004.01.006; Ezzeddine ZD, 1997, DEVELOPMENT, V124, P1055; FUHRMANN S, 1995, DEVELOPMENT, V121, P2695; Goureau O, 2004, DEV NEUROSCI-BASEL, V26, P359, DOI 10.1159/000082278; Gupta N, 2003, EXP EYE RES, V76, P463, DOI 10.1016/S0014-4835(02)00332-9; HAGEMAN GS, 1986, J COMP NEUROL, V249, P499, DOI 10.1002/cne.902490406; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Jo SA, 1999, NEUROSCIENCE, V89, P579, DOI 10.1016/S0306-4522(98)00546-6; Kirsch M, 1996, NEUROREPORT, V7, P697, DOI 10.1097/00001756-199602290-00004; Komeima K, 2006, P NATL ACAD SCI USA, V103, P11300, DOI 10.1073/pnas.0604056103; Langmann T, 2007, J LEUKOCYTE BIOL, V81, P1345, DOI 10.1189/jlb.0207114; LAVAIL MM, 1992, P NATL ACAD SCI USA, V89, P11249, DOI 10.1073/pnas.89.23.11249; LaVail MM, 1998, INVEST OPHTH VIS SCI, V39, P592; Leveillard T, 2004, NAT GENET, V36, P755, DOI 10.1038/ng1386; Liang FQ, 2001, MOL THER, V4, P461, DOI 10.1006/mthe.2001.0473; LIN LFH, 1989, SCIENCE, V246, P1023, DOI 10.1126/science.2587985; Liu CD, 1999, J NEUROSCI, V19, P4778; MEYERFRANKE A, 1995, NEURON, V15, P805, DOI 10.1016/0896-6273(95)90172-8; Neophytou C, 1997, DEVELOPMENT, V124, P2345; Punzo C, 2009, NAT NEUROSCI, V12, P44, DOI 10.1038/nn.2234; Schulz-Key S, 2002, INVEST OPHTH VIS SCI, V43, P3099; Shen JK, 2005, J CELL PHYSIOL, V203, P457, DOI 10.1002/jcp.20346; Sieving PA, 2006, P NATL ACAD SCI USA, V103, P3896, DOI 10.1073/pnas.0600236103; STOCKLI KA, 1989, NATURE, V342, P920, DOI 10.1038/342920a0; Stone J, 1999, PROG RETIN EYE RES, V18, P689, DOI 10.1016/S1350-9462(98)00032-9; Tao W, 2002, INVEST OPHTH VIS SCI, V43, P3292; TAO W, 2006, INTRAOCULAR DRUG DEL; TAO W, 2007, RETINAL DEGENERATION; Tao Weng, 2006, Expert Opin Biol Ther, V6, P717, DOI 10.1517/14712598.6.7.717; VARON S, 1979, BRAIN RES, V173, P29, DOI 10.1016/0006-8993(79)91093-X; Weise J, 2000, NEUROBIOL DIS, V7, P212, DOI 10.1006/nbdi.2000.0285; Wen R, 2008, ADV EXP MED BIOL, V613, P407, DOI 10.1007/978-0-387-74904-4_48; Wen R, 2006, J NEUROSCI, V26, P13523, DOI 10.1523/JNEUROSCI.4021-06.2006; Wenzel A, 2005, PROG RETIN EYE RES, V24, P275, DOI 10.1016/j.preteyeres.2004.08.002; Xie HQ, 2000, INVEST OPHTH VIS SCI, V41, P4317; Zhu XM, 2002, MOL VIS, V8, P462	46	93	97	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2010	5	3							e9495	10.1371/journal.pone.0009495	http://dx.doi.org/10.1371/journal.pone.0009495			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	562OY	20209167	Green Published, Green Submitted, gold			2022-12-25	WOS:000275063300011
J	Marongiu, M; Deiana, M; Meloni, A; Marcia, L; Puddu, A; Cao, A; Schlessinger, D; Crisponi, L				Marongiu, Mara; Deiana, Manila; Meloni, Alessandra; Marcia, Loredana; Puddu, Alessandro; Cao, Antonio; Schlessinger, David; Crisponi, Laura			The Forkhead Transcription Factor Foxl2 Is Sumoylated in Both Human and Mouse: Sumoylation Affects Its Stability, Localization, and Activity	PLOS ONE			English	Article							GRANULOSA-CELLS; SEX REVERSAL; EXPRESSION; RECEPTOR; PROTEIN; SUMO-1; SOX9; SPERMATOGENESIS; INDUCTION; REPRESSES	The FOXL2 forkhead transcription factor is expressed in ovarian granulosa cells, and mutated FOXL2 causes the blepharophimosis, ptosis and epicanthus inversus syndrome (BPES) and predisposes to premature ovarian failure. Inactivation of Foxl2 in mice demonstrated its indispensability for female gonadal sex determination and ovary development and revealed its antagonism of Sox9, the effector of male testis development. To help to define the regulatory activities of FOXL2, we looked for interacting proteins. Based on yeast two-hybrid screening, we found that FOXL2 interacts with PIAS1 and UBC9, both parts of the sumoylation machinery. We showed that human FOXL2 is sumoylated in transfected cell lines, and that endogenous mouse Foxl2 is comparably sumoylated. This modification changes its cellular localization, stability and transcriptional activity. It is intriguing that similar sumoylation and regulatory consequences have also been reported for SOX9, the male counterpart of FOXL2 in somatic gonadal tissues.	[Marongiu, Mara; Deiana, Manila; Meloni, Alessandra; Marcia, Loredana; Puddu, Alessandro; Cao, Antonio; Crisponi, Laura] CNR, Ist Neurogenet & Neurofarmacol, Cagliari, Italy; [Puddu, Alessandro] Univ Cagliari, Cagliari, Italy; [Schlessinger, David] NIA, NIH, Baltimore, MD 21224 USA	Consiglio Nazionale delle Ricerche (CNR); University of Cagliari; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Marongiu, M (corresponding author), CNR, Ist Neurogenet & Neurofarmacol, Cagliari, Italy.	laura.crisponi@inn.cnr.it	Marongiu, Mara/H-9437-2019; Crisponi, Laura/AAC-2642-2019	Marongiu, Mara/0000-0002-7321-2384; Crisponi, Laura/0000-0001-9128-8537; Puddu, Alessandro/0000-0002-9415-0477	Telethon Grant [GP0049Y01]; National Institute on Aging, National Institutes of Health (NIH); NATIONAL INSTITUTE ON AGING [ZIAAG000647] Funding Source: NIH RePORTER	Telethon Grant(Fondazione Telethon); National Institute on Aging, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by Telethon Grant GP0049Y01 to LC and in part by the Intramural Research Program of the National Institute on Aging, National Institutes of Health (NIH) to DS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benayoun BA, 2008, PROTEOMICS, V8, P3118, DOI 10.1002/pmic.200800084; Crisponi L, 2004, GENOMICS, V83, P757, DOI 10.1016/j.ygeno.2003.11.010; Crisponi L, 2001, NAT GENET, V27, P159, DOI 10.1038/84781; Ellsworth BS, 2003, MOL CELL ENDOCRINOL, V206, P93, DOI 10.1016/S0303-7207(03)00235-1; Ellsworth BS, 2006, MOL ENDOCRINOL, V20, P2796, DOI 10.1210/me.2005-0303; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Hattori T, 2006, J BIOL CHEM, V281, P14417, DOI 10.1074/jbc.M511330200; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Kuo FT, 2009, CELL SIGNAL, V21, P1935, DOI 10.1016/j.cellsig.2009.09.001; Oh HJ, 2007, MOL REPROD DEV, V74, P1446, DOI 10.1002/mrd.20737; Ottolenghi C, 2005, HUM MOL GENET, V14, P2053, DOI 10.1093/hmg/ddi210; Ottolenghi C, 2007, HUM MOL GENET, V16, P2795, DOI 10.1093/hmg/ddm235; Ottolenghi C, 2007, BIOESSAYS, V29, P15, DOI 10.1002/bies.20515; Pisarska MD, 2004, ENDOCRINOLOGY, V145, P3424, DOI 10.1210/en.2003-1141; Seeler JS, 2001, MOL CELL BIOL, V21, P3314, DOI 10.1128/MCB.21.10.3314-3324.2001; Shao RJ, 2006, MOL REPROD DEV, V73, P50, DOI 10.1002/mrd.20386; Shao RJ, 2004, ENDOCRINOLOGY, V145, P384, DOI 10.1210/en.2003-0527; Uda M, 2004, HUM MOL GENET, V13, P1171, DOI 10.1093/hmg/ddh124; Vigodner M, 2006, AM J PHYSIOL-ENDOC M, V290, pE1022, DOI 10.1152/ajpendo.00527.2005; Vigodner M, 2005, DEV BIOL, V282, P480, DOI 10.1016/j.ydbio.2005.03.034; Voet D., 2005, BIOCHEMISTRY-US; WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8; Zhong S, 2000, BLOOD, V95, P2748, DOI 10.1182/blood.V95.9.2748.009k31a_2748_2752	23	20	20	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2010	5	3							e9477	10.1371/journal.pone.0009477	http://dx.doi.org/10.1371/journal.pone.0009477			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	562OY	20209145	Green Submitted, gold, Green Published			2022-12-25	WOS:000275063300004
J	Kugelberg, E; Gollan, B; Farrance, C; Bratcher, H; Lucidarme, J; Ibarz-Pavon, AB; Maiden, MCJ; Borrow, R; Tang, CM				Kugelberg, Elisabeth; Gollan, Bridget; Farrance, Christopher; Bratcher, Holly; Lucidarme, Jay; Ibarz-Pavon, Ana Belen; Maiden, Martin C. J.; Borrow, Ray; Tang, Christoph M.			The Influence of IS 1301 in the Capsule Biosynthesis Locus on Meningococcal Carriage and Disease	PLOS ONE			English	Article							C CONJUGATE VACCINE; NEISSERIA-MENINGITIDIS; SIALIC-ACID; EXPRESSION; BACTERIOPHAGE; TRANSCRIPTION; EPIDEMIOLOGY; EFFICACY; RECEPTOR; ENGLAND	Previously we have shown that insertion of IS1301 in the sia/ctr intergenic region (IGR) of serogroup C Neisseria meningitidis (MenC) isolates from Spain confers increased resistance against complement-mediated killing. Here we investigate the significance of IS1301 in the same location in N. meningitidis isolates from the UK. PCR and sequencing was used to screen a collection of more than 1500 meningococcal carriage and disease isolates from the UK for the presence of IS1301 in the IGR. IS1301 was not identified in the IGR among vaccine failure strains but was frequently found in serogroup B isolates (MenB) from clonal complex 269 (cc269). Almost all IS1301 insertions in cc269 were associated with novel polymorphisms, and did not change capsule expression or resistance to human complement. After excluding sequence types (STs) distant from the central genotype within cc269, there was no significant difference for the presence of IS1301 in the IGR of carriage isolates compared to disease isolates. Isolates with insertion of IS1301 in the IGR are not responsible for MenC disease in UK vaccine failures. Novel polymorphisms associated with IS1301 in the IGR of UK MenB isolates do not lead to the resistance phenotype seen for IS1301 in the IGR of MenC isolates.	[Kugelberg, Elisabeth; Gollan, Bridget; Farrance, Christopher; Tang, Christoph M.] Univ London Imperial Coll Sci Technol & Med, Dept Microbiol, Ctr Mol Microbiol & Infect, London, England; [Bratcher, Holly; Ibarz-Pavon, Ana Belen; Maiden, Martin C. J.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Lucidarme, Jay; Borrow, Ray] Hlth Protect Agcy, Manchester Royal Infirm, Manchester, Lancs, England	Imperial College London; University of Oxford; Health Protection Agency; University of Manchester	Kugelberg, E (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Microbiol, Ctr Mol Microbiol & Infect, London, England.	c.tang@imperial.ac.uk	Maiden, Martin C J/C-5055-2014; Maiden, Martin/N-6805-2019	Maiden, Martin C J/0000-0001-6321-5138; Maiden, Martin/0000-0001-6321-5138; Kugelberg, Elisabeth/0000-0002-8302-3595; Bratcher, Holly/0000-0002-7246-7772	EMBO Longterm Fellowship; MRC [G0601195]; Wellcome Trust [84369]; Medical Research Council [G0601195] Funding Source: researchfish	EMBO Longterm Fellowship(European Molecular Biology Organization (EMBO)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	E. K. was the recipient of an EMBO Longterm Fellowship. Work in CMTs laboratory is supported by grants from the MRC (G0601195) and Wellcome Trust (84369). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews N, 2003, CLIN DIAGN LAB IMMUN, V10, P780, DOI 10.1128/CDLI.10.5.780-786.2003; Auckland C, 2006, J INFECT DIS, V194, P1745, DOI 10.1086/509619; Balmer P, 2002, J MED MICROBIOL, V51, P717, DOI 10.1099/0022-1317-51-9-717; Bille E, 2005, J EXP MED, V201, P1905, DOI 10.1084/jem.20050112; Bille E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003885; CARTWRIGHT KAV, 1987, EPIDEMIOL INFECT, V99, P591, DOI 10.1017/S0950268800066449; CAUGANT DA, 1994, J CLIN MICROBIOL, V32, P323, DOI 10.1128/JCM.32.2.323-330.1994; Diggle MA, 2005, J CLIN MICROBIOL, V43, P4649, DOI 10.1128/JCM.43.9.4649-4653.2005; El-Robh MS, 2002, BIOCHEM J, V368, P835, DOI 10.1042/BJ20021003; GOLDSCHNEIDER I, 1969, J EXP MED, V129, P1307, DOI 10.1084/jem.129.6.1307; Gray SJ, 2006, J MED MICROBIOL, V55, P887, DOI 10.1099/jmm.0.46288-0; Hammerschmidt S, 1996, EMBO J, V15, P192, DOI 10.1002/j.1460-2075.1996.tb00347.x; Harrison OB, 2009, J INFECT DIS, V200, P94, DOI 10.1086/599377; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Uria MJ, 2008, J EXP MED, V205, P1423, DOI 10.1084/jem.20072577; Kugelberg E, 2008, VACCINE, V26, pI34, DOI 10.1016/j.vaccine.2008.11.059; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lucidarme J, 2009, J CLIN MICROBIOL, V47, P3577, DOI 10.1128/JCM.00936-09; Maiden MCJ, 2008, J INFECT DIS, V197, P737, DOI 10.1086/527401; Maiden MCJ, 2002, LANCET, V359, P1829, DOI 10.1016/S0140-6736(02)08679-8; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Miller E, 2001, VACCINE, V20, pS58, DOI 10.1016/S0264-410X(01)00299-7; Ramsay ME, 2001, LANCET, V357, P195, DOI 10.1016/S0140-6736(00)03594-7; Russell JE, 2008, MICROBIOL-SGM, V154, P1170, DOI 10.1099/mic.0.2007/014761-0; Swartley JS, 1996, J BACTERIOL, V178, P4052, DOI 10.1128/jb.178.14.4052-4059.1996; Trotter CL, 2007, FEMS MICROBIOL REV, V31, P101, DOI 10.1111/j.1574-6976.2006.00053.x; Trotter CL, 2004, LANCET, V364, P365, DOI 10.1016/S0140-6736(04)16725-1; von Loewenich FD, 2001, INT J MED MICROBIOL, V291, P361, DOI 10.1078/1438-4221-00142; Yazdankhah SP, 2004, J MED MICROBIOL, V53, P821, DOI 10.1099/jmm.0.45529-0	29	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2010	5	2							e9413	10.1371/journal.pone.0009413	http://dx.doi.org/10.1371/journal.pone.0009413			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SY	20195528	Green Published, gold, Green Submitted			2022-12-25	WOS:000274924300005
J	Fuerer, C; Nusse, R				Fuerer, Christophe; Nusse, Roel			Lentiviral Vectors to Probe and Manipulate the Wnt Signaling Pathway	PLOS ONE			English	Article							PSEUDOTYPED RETROVIRAL VECTORS; HEMATOPOIETIC STEM-CELLS; CENTRAL POLYPURINE TRACT; VIVO GENE DELIVERY; HIGH-TITER; IN-VIVO; NONDIVIDING CELLS; TRANSDUCTION; ACTIVATION; CARCINOMA	Background: The Wnt signaling pathway plays key roles in development, adult tissue homeostasis and stem cell maintenance. Further understanding of the function of Wnt signaling in specific cell types could benefit from lentiviral vectors expressing reporters for the Wnt pathway or vectors interfering with signaling. Methodology/Principal Findings: We have developed a set of fluorescent and luminescent lentiviral vectors that report Wnt signaling activity and discriminate between negative and uninfected cells. These vectors possess a 7xTcf-eGFP or 7xTcf-FFluc ( Firefly Luciferase) reporter cassette followed by either an SV40-mCherry or SV40-Puro(R) ( puromycin N-acetyltransferase) selection cassette. We have also constructed a vector that allows drug-based selection of cells with activated Wnt signaling by placing Puro(R) under the control of the 7xTcf promoter. Lastly, we have expressed dominantnegative Tcf4 (dnTcf4) or constitutively active beta-catenin (beta-catenin(4A)) from the hEF1 alpha promoter in a SV40-Puro(R) or SV40-mCherry backbone to create vectors that inhibit or activate the Wnt signaling pathway. These vectors will be made available to the scientific community through Addgene. Conclusions: These novel lentiviruses are efficient tools to probe and manipulate Wnt signaling. The use of a selection cassette in Wnt-reporter viruses enables discriminating between uninfected and non-responsive cells, an important requirement for experiments where selection of clones is not possible. The use of a chemiluminescent readout enables quantification of signaling. Finally, selectable vectors can be used to either inhibit or activate the Wnt signaling pathway. Altogether, these vectors can probe and modulate the Wnt signaling pathway in experimental settings where persistence of the transgene or gene transfer cannot be accomplished by non-viral techniques.	[Fuerer, Christophe; Nusse, Roel] Stanford Univ, Howard Hughes Med Inst, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University	Fuerer, C (corresponding author), Stanford Univ, Howard Hughes Med Inst, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA.	rnusse@stanford.edu		Fuerer, Christophe/0000-0003-1717-6718	Howard Hughes Medical Institute; Swiss National Science Foundation [PA00A3-115379]	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	These studies were supported by the Howard Hughes Medical Institute and by the Swiss National Science Foundation (grant PA00A3-115379 to C. Fuerer). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkina RK, 1996, J VIROL, V70, P2581, DOI 10.1128/JVI.70.4.2581-2585.1996; Al Yacoub N, 2007, J GENE MED, V9, P579, DOI 10.1002/jgm.1052; Bilechele Travis L., 2008, V468, P99, DOI 10.1007/978-1-59745-249-6_8; Blitzer JT, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-28; Brugmann SA, 2007, DEVELOPMENT, V134, P3283, DOI 10.1242/dev.005132; BURNS JC, 1993, P NATL ACAD SCI USA, V90, P8033, DOI 10.1073/pnas.90.17.8033; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; DasGupta R, 2005, SCIENCE, V308, P826, DOI 10.1126/science.1109374; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Fuerer C, 2010, DEV DYNAM, V239, P184, DOI 10.1002/dvdy.22067; Higashimoto T, 2007, GENE THER, V14, P1298, DOI 10.1038/sj.gt.3302979; Hu M, 2007, GASTROENTEROLOGY, V133, P1579, DOI 10.1053/j.gastro.2007.08.036; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Kumar M, 2001, HUM GENE THER, V12, P1893, DOI 10.1089/104303401753153947; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Mosimann C, 2009, NAT REV MOL CELL BIO, V10, P276, DOI 10.1038/nrm2654; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Nusse R, 2008, COLD SH Q B, V73, P59, DOI 10.1101/sqb.2008.73.035; Reiser J, 1996, P NATL ACAD SCI USA, V93, P15266, DOI 10.1073/pnas.93.26.15266; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Sirven A, 2000, BLOOD, V96, P4103; Snow GE, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-383; ten Berge D, 2008, CELL STEM CELL, V3, P508, DOI 10.1016/j.stem.2008.09.013; Trono D, 2002, LENTIVIRAL VECTORS; VandenDriessche T, 2002, BLOOD, V100, P813, DOI 10.1182/blood.V100.3.813; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Wurtzer S, 2006, J VIROL, V80, P3679, DOI 10.1128/JVI.80.7.3679-3683.2006; YEE JK, 1994, METHOD CELL BIOL, V43, P99; Zufferey R, 1998, J VIROL, V72, P9873, DOI 10.1128/JVI.72.12.9873-9880.1998	30	195	196	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2010	5	2							e9370	10.1371/journal.pone.0009370	http://dx.doi.org/10.1371/journal.pone.0009370			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SV	20186325	Green Published, gold, Green Submitted			2022-12-25	WOS:000274924000013
J	Sun, X; Wang, X; Chen, TX; Li, TY; Cao, K; Lu, A; Chen, YX; Sun, DM; Luo, JH; Fan, JQ; Young, W; Ren, Y				Sun, Xin; Wang, Xi; Chen, Tianxiang; Li, Tianyi; Cao, Kai; Lu, Andrew; Chen, Yongxiong; Sun, Dongming; Luo, Jianhong; Fan, Jianqing; Young, Wise; Ren, Yi			Myelin Activates FAK/Akt/NF-kappa B Pathways and Provokes CR3-Dependent Inflammatory Response in Murine System	PLOS ONE			English	Article							SPINAL-CORD-INJURY; CENTRAL-NERVOUS-SYSTEM; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; WALLERIAN DEGENERATION; MACROPHAGE RESPONSES; FUNCTIONAL RECOVERY; CYTOKINE SYNTHESIS; DOWN-REGULATION; PHAGOCYTOSIS; REGENERATION	Inflammatory response following central nervous system (CNS) injury contributes to progressive neuropathology and reduction in functional recovery. Axons are sensitive to mechanical injury and toxic inflammatory mediators, which may lead to demyelination. Although it is well documented that degenerated myelin triggers undesirable inflammatory responses in autoimmune diseases such as multiple sclerosis ( MS) and its animal model, experimental autoimmune encephalomyelitis (EAE), there has been very little study of the direct inflammatory consequences of damaged myelin in spinal cord injury (SCI), i.e., there is no direct evidence to show that myelin debris from injured spinal cord can trigger undesirable inflammation in vitro and in vivo. Our data showed that myelin can initiate inflammatory responses in vivo, which is complement receptor 3 (CR3)-dependent via stimulating macrophages to express pro-inflammatory molecules and down-regulates expression of anti-inflammatory cytokines. Mechanism study revealed that myelin-increased cytokine expression is through activation of FAK/PI3K/Akt/NF-kappa B signaling pathways and CR3 contributes to myelin-induced PI3K/Akt/NF-kappa B activation and cytokine production. The myelin induced inflammatory response is myelin specific as sphingomyelin ( the major lipid of myelin) and myelin basic protein (MBP, one of the major proteins of myelin) are not able to activate NF-kappa B signaling pathway. In conclusion, our results demonstrate a crucial role of myelin as an endogenous inflammatory stimulus that induces pro-inflammatory responses and suggest that blocking myelin-CR3 interaction and enhancing myelin debris clearance may be effective interventions for treating SCI.	[Sun, Xin; Wang, Xi; Chen, Tianxiang; Li, Tianyi; Cao, Kai; Lu, Andrew; Chen, Yongxiong; Sun, Dongming; Young, Wise; Ren, Yi] Rutgers State Univ, Dept Cell Biol & Neurosci, WM Keck Ctr Collaborat Neurosci, Piscataway, NJ 08854 USA; [Sun, Xin; Luo, Jianhong] Zhejiang Univ, Sch Med, Inst Neurosci, Dept Neurobiol, Hangzhou 310003, Zhejiang, Peoples R China; [Fan, Jianqing] Princeton Univ, Stat Lab, Princeton, NJ 08544 USA	Rutgers State University New Brunswick; Zhejiang University; Princeton University	Sun, X (corresponding author), Rutgers State Univ, Dept Cell Biol & Neurosci, WM Keck Ctr Collaborat Neurosci, Piscataway, NJ 08854 USA.	ren@dls.rutgers.edu	Luo, jian/HGE-7331-2022; Fan, Jianqing/B-2115-2008		National Science Foundation [DMS-0714589]; National Institutes of Health (NIH) [R01-GM072611]; Joyce and Les Goodman scholarship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072611] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Joyce and Les Goodman scholarship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Science Foundation (DMS-0714589), National Institutes of Health (NIH) (R01-GM072611) and Joyce and Les Goodman scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brambilla R, 2005, J EXP MED, V202, P145, DOI 10.1084/jem.20041918; Campbell IL, 1998, NEUROIMMUNOMODULAT, V5, P126, DOI 10.1159/000026329; Chatzizacharias NA, 2008, TOXICOLOGY, V245, P1, DOI 10.1016/j.tox.2007.12.003; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; Donnelly DJ, 2008, EXP NEUROL, V209, P378, DOI 10.1016/j.expneurol.2007.06.009; Eugster HP, 1998, EUR J IMMUNOL, V28, P2178, DOI 10.1002/(SICI)1521-4141(199807)28:07<2178::AID-IMMU2178>3.0.CO;2-D; Fife BT, 2001, J IMMUNOL, V166, P7617, DOI 10.4049/jimmunol.166.12.7617; FLEMING TJ, 1993, J IMMUNOL, V151, P2399; GEORGE R, 1994, EXP NEUROL, V129, P225, DOI 10.1006/exnr.1994.1164; GRIFFIN JW, 1992, J NEUROIMMUNOL, V40, P153, DOI 10.1016/0165-5728(92)90129-9; Halder RC, 2007, NEUROCHEM RES, V32, P257, DOI 10.1007/s11064-006-9145-4; Hanks SK, 2003, FRONT BIOSCI-LANDMRK, V8, pD982, DOI 10.2741/1114; Harvey R Donald, 2007, Future Oncol, V3, P639, DOI 10.2217/14796694.3.6.639; Hausmann O, 2003, SPINAL CORD, V41, P369, DOI 10.1038/sj.sc.3101483; He ZG, 2004, ANNU REV NEUROSCI, V27, P341, DOI 10.1146/annurev.neuro.27.070203.144340; HENDRIKS JJ, 2008, J NEUROIMMUNOL; Hoek RM, 2000, SCIENCE, V290, P1768, DOI 10.1126/science.290.5497.1768; Jeon SB, 2008, J IMMUNOL, V181, P8077, DOI 10.4049/jimmunol.181.11.8077; Kanter JL, 2006, NAT MED, V12, P138, DOI 10.1038/nm1344; Kaplin AI, 2005, J CLIN INVEST, V115, P2731, DOI 10.1172/JCI25141; Kerschensteiner M, 2005, NAT MED, V11, P572, DOI 10.1038/nm1229; Koning N, 2007, ANN NEUROL, V62, P504, DOI 10.1002/ana.21220; Kotter MR, 2006, J NEUROSCI, V26, P328, DOI 10.1523/JNEUROSCI.2615-05.2006; MCKERRACHER L, 1994, NEURON, V13, P805, DOI 10.1016/0896-6273(94)90247-X; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Muller M, 2007, J IMMUNOL, V179, P2774, DOI 10.4049/jimmunol.179.5.2774; MURPHY M, 1991, P NATL ACAD SCI USA, V88, P3498, DOI 10.1073/pnas.88.8.3498; NORTON WT, 1973, J NEUROCHEM, V21, P749, DOI 10.1111/j.1471-4159.1973.tb07519.x; Pan JZ, 2002, J NEUROSCI RES, V68, P315, DOI 10.1002/jnr.10215; Pineau I, 2007, J COMP NEUROL, V500, P267, DOI 10.1002/cne.21149; Popovich PG, 1997, J COMP NEUROL, V377, P443, DOI 10.1002/(SICI)1096-9861(19970120)377:3<443::AID-CNE10>3.0.CO;2-S; Profyris C, 2004, NEUROBIOL DIS, V15, P415, DOI 10.1016/j.nbd.2003.11.015; Qian L, 2008, J IMMUNOL, V181, P660, DOI 10.4049/jimmunol.181.1.660; Reichert F, 1996, J NEUROIMMUNOL, V70, P153, DOI 10.1016/S0165-5728(96)00112-9; Rotshenker S, 2003, J MOL NEUROSCI, V21, P65, DOI 10.1385/JMN:21:1:65; Rotshenker S, 2008, GLIA, V56, P1607, DOI 10.1002/glia.20713; Rubel C, 2003, EUR J IMMUNOL, V33, P1429, DOI 10.1002/eji.200323512; Segal BM, 1998, J EXP MED, V187, P537, DOI 10.1084/jem.187.4.537; vanderLaan LJW, 1996, J NEUROIMMUNOL, V70, P145, DOI 10.1016/S0165-5728(96)00110-5; Vargas ME, 2007, ANNU REV NEUROSCI, V30, P153, DOI 10.1146/annurev.neuro.30.051606.094354; WANG P, 1995, J BIOL CHEM, V270, P9558, DOI 10.1074/jbc.270.16.9558; Zhang H, 2003, INFLAMM RES, V52, P86, DOI 10.1007/s000110300006; [No title captured]	43	89	92	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2010	5	2							e9380	10.1371/journal.pone.0009380	http://dx.doi.org/10.1371/journal.pone.0009380			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SV	20186338	gold, Green Published, Green Submitted			2022-12-25	WOS:000274924000021
J	Berwick, DC; Diss, JKJ; Budhram-Mahadeo, VS; Latchman, DS				Berwick, Daniel C.; Diss, James K. J.; Budhram-Mahadeo, Vishwanie S.; Latchman, David S.			A Simple Technique for the Prediction of Interacting Proteins Reveals a Direct Brn-3a-Androgen Receptor Interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BRN-3A TRANSCRIPTION FACTOR; ANDROGEN RECEPTOR; FUNCTIONAL INTERACTION; NEURITE OUTGROWTH; ESTROGEN-RECEPTOR; NEURONAL CELLS; IN-VIVO; ACTIVATION; EXPRESSION; PROMOTER	The formation of multiprotein complexes constitutes a key step in determining the function of any translated gene product. Thus, the elucidation of interacting partners for a protein of interest is of fundamental importance to cell biology. Here we describe a simple methodology for the prediction of novel interactors. We have applied this to the developmental transcription factor Brn-3a to predict and verify a novel interaction between Brn-3a and the androgen receptor (AR). We demonstrate that these transcription factors form complexes within the nucleus of ND7 neuroblastoma cells, while in vitro pull-down assays show direct association. As a functional consequence of the Brn-3a-AR interaction, the factors bind cooperatively to multiple elements within the promoter of the voltage-gated sodium channel, Nav1.7, leading to a synergistic increase in its expression. Thus, these data define AR as a direct Brn-3a interactor and verify a simple interacting protein prediction methodology that is likely to be useful for many other proteins.	[Berwick, Daniel C.; Diss, James K. J.; Budhram-Mahadeo, Vishwanie S.; Latchman, David S.] UCL, Inst Child Hlth, Med Mol Biol Unit, London WC1N 1EH, England; [Latchman, David S.] Univ London, London WC1E 7HX, England	University of London; University College London; University of London	Berwick, DC (corresponding author), Univ London, Sch Pharm, Dept Pharmacol, 29-39 Brunswick Sq, London WC1N 1AX, England.	daniel.berwick@live.pharmacy.ac.uk	Berwick, Dan/J-2378-2012; Diss, James K/C-5994-2008; Berwick, Dan/AAJ-7779-2021	Berwick, Dan/0000-0002-7144-7841; Diss, James K/0000-0003-4988-257X; Berwick, Dan/0000-0002-7144-7841	Biotechnology and Biological Science Research Center; Prostate UK; BBSRC [BB/D521314/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D521314/1] Funding Source: researchfish	Biotechnology and Biological Science Research Center(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Prostate UK; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by the Biotechnology and Biological Science Research Center and Prostate UK.	Arndt HD, 2006, ANGEW CHEM INT EDIT, V45, P4552, DOI 10.1002/anie.200600285; Asthana S, 2004, GENOME RES, V14, P1170, DOI 10.1101/gr.2203804; Ben-Hur A, 2005, BIOINFORMATICS, V21, pI38, DOI 10.1093/bioinformatics/bti1016; Berwick DC, 2009, BRAIN RES, V1256, P8, DOI 10.1016/j.brainres.2008.12.009; Breitkreutz BJ, 2008, NUCLEIC ACIDS RES, V36, pD637, DOI 10.1093/nar/gkm1001; Budhram-Mahadeo V, 1999, J BIOL CHEM, V274, P15237, DOI 10.1074/jbc.274.21.15237; Budhram-Mahadeo V, 1998, MOL CELL BIOL, V18, P1029, DOI 10.1128/MCB.18.2.1029; BUDHRAMMAHADEO V, 1995, J BIOL CHEM, V270, P2853, DOI 10.1074/jbc.270.6.2853; Budram-Mahadeo V, 2002, ONCOGENE, V21, P6123, DOI 10.1038/sj.onc.1205842; Burgdorf S, 2004, J BIOL CHEM, V279, P17524, DOI 10.1074/jbc.M313703200; Calissano M, 2005, MOL BRAIN RES, V141, P10, DOI 10.1016/j.molbrainres.2005.07.013; Calissano M, 2003, ONCOGENE, V22, P5408, DOI 10.1038/sj.onc.1206635; Chan HM, 2001, J CELL SCI, V114, P2363; Cook PR, 2003, J CELL SCI, V116, P4483, DOI 10.1242/jcs.00819; Dehm SM, 2007, MOL ENDOCRINOL, V21, P2855, DOI 10.1210/me.2007-0223; Dennis JH, 2002, BIOCHEM BIOPH RES CO, V294, P487, DOI 10.1016/S0006-291X(02)00500-4; Dib-Hajj SD, 2007, TRENDS NEUROSCI, V30, P555, DOI 10.1016/j.tins.2007.08.004; Diss JKJ, 2008, MOL CELL NEUROSCI, V37, P537, DOI 10.1016/j.mcn.2007.12.002; Diss JKJ, 2006, PROSTATE CANCER P D, V9, P83, DOI 10.1038/sj.pcan.4500837; Eder IE, 2000, CANCER GENE THER, V7, P997, DOI 10.1038/sj.cgt.7700202; Emami KH, 2004, P NATL ACAD SCI USA, V101, P12682, DOI 10.1073/pnas.0404875101; Eng SR, 2001, J NEUROSCI, V21, P541, DOI 10.1523/JNEUROSCI.21-02-00541.2001; Ensor E, 2001, J BIOL CHEM, V276, P5204, DOI 10.1074/jbc.M007068200; Estrada M, 2006, J CELL SCI, V119, P733, DOI 10.1242/jcs.02775; Farooqui-Kabir SR, 2004, CELL DEATH DIFFER, V11, P1242, DOI 10.1038/sj.cdd.4401478; Gascoyne DM, 2004, ONCOGENE, V23, P3830, DOI 10.1038/sj.onc.1207497; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Haag P, 2005, J STEROID BIOCHEM, V96, P251, DOI 10.1016/j.jsbmb.2005.04.029; Hudson CD, 2008, CELL DEATH DIFFER, V15, P1266, DOI 10.1038/cdd.2008.45; Hudson CD, 2005, J BIOL CHEM, V280, P11851, DOI 10.1074/jbc.M408679200; Kawaguchi A, 2007, NEUROCHEM RES, V32, P1469, DOI 10.1007/s11064-007-9334-9; KEMPPAINEN JA, 1992, J BIOL CHEM, V267, P968; Klein C, 2004, BRIT J CANCER, V91, P1415, DOI 10.1038/sj.bjc.6602164; Koentges G, 2008, NATURE, V451, P658, DOI 10.1038/451658a; LAKIN ND, 1995, J BIOL CHEM, V270, P15858, DOI 10.1074/jbc.270.26.15858; Latchman DS, 1998, INT J BIOCHEM CELL B, V30, P1153, DOI 10.1016/S1357-2725(98)00090-9; Lin DY, 2004, MOL CELL BIOL, V24, P10529, DOI 10.1128/MCB.24.24.10529-10541.2004; Luo H, 2008, HISTOCHEM CELL BIOL, V129, P525, DOI 10.1007/s00418-008-0380-4; Marron TU, 2005, J NEUROCHEM, V92, P10, DOI 10.1111/j.1471-4159.2004.02836.x; McEvilly RJ, 1996, NATURE, V384, P574, DOI 10.1038/384574a0; Panne D, 2008, CURR OPIN STRUC BIOL, V18, P236, DOI 10.1016/j.sbi.2007.12.002; Perez-Sanchez C, 2002, NUCLEIC ACIDS RES, V30, P4872, DOI 10.1093/nar/gkf610; Ruland J, 2001, P NATL ACAD SCI USA, V98, P1859, DOI 10.1073/pnas.98.4.1859; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Smith MD, 1997, J BIOL CHEM, V272, P21325, DOI 10.1074/jbc.272.34.21325; Smith MD, 1998, J BIOL CHEM, V273, P16715, DOI 10.1074/jbc.273.27.16715; Smith MD, 2001, MOL CELL NEUROSCI, V17, P460, DOI 10.1006/mcne.2000.0927; Smith MD, 1997, MOL CELL BIOL, V17, P345, DOI 10.1128/MCB.17.1.345; Smith MD, 1998, NUCLEIC ACIDS RES, V26, P4100, DOI 10.1093/nar/26.18.4100; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Theil T, 1995, J BIOL CHEM, V270, P30958, DOI 10.1074/jbc.270.52.30958; Wiggins AK, 2004, J CELL BIOL, V167, P257, DOI 10.1083/jcb.200406131; WOOD JN, 1990, P ROY SOC B-BIOL SCI, V241, P187, DOI 10.1098/rspb.1990.0084; Yu HY, 2006, BIOINFORMATICS, V22, P823, DOI 10.1093/bioinformatics/btl014	54	8	11	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15286	15295		10.1074/jbc.M109.071456	http://dx.doi.org/10.1074/jbc.M109.071456			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20228055	Green Published, hybrid			2022-12-25	WOS:000277399000049
J	Chichili, GR; Westmuckett, AD; Rodgers, W				Chichili, Gurunadh R.; Westmuckett, Andrew D.; Rodgers, William			T Cell Signal Regulation by the Actin Cytoskeleton	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE PROTEIN-KINASE; GPI-ANCHORED PROTEINS; ENRICHED MEMBRANE DOMAINS; RESONANCE ENERGY-TRANSFER; SINGLE-MOLECULE MICROSCOPY; IMMUNOLOGICAL SYNAPSE; PLASMA-MEMBRANE; LIPID RAFTS; IMMUNE SYNAPSE; LIVE CELLS	T cells form an immunological synapse (IS) that sustains and regulates signals for cell stimulation. Enriched in the IS is the Src family kinase Lck. Conversely, the membrane phosphatase CD45, which activates Src family kinases, is excluded, and this is necessary to avoid quenching of T cell receptor phosphosignals. Data suggest that this arrangement occurs by an enrichment of cholesterol-dependent rafts in the IS. However, the role of rafts in structuring the IS remains unclear. To address this question, we used fluorescence resonance energy transfer (FRET) to interrogate the nanoscopic structure of the IS. The FRET probes consisted of membrane-anchored fluorescent proteins with distinct affinities for rafts. Both the raft and nonraft probes exhibited clustering in the IS. However, co-clustering of raft donor-acceptor pairs was 10-fold greater than co-clustering of raft-nonraft pairs. We measured the effect of disrupting rafts in the IS on CD45 localization and Lck regulation by treating stimulated T cells with filipin. The filipin specifically disrupted co-clustering of the raft FRET pairs in the IS and allowed targeting of CD45 to the IS and dephosphorylation of the regulatory tyrosine of Lck. Clustering of the raft probes was also sensitive to latrunctulin B, which disrupts actin filaments. Strikingly, enriching the cortical cytoskeleton using jasplakinolide maintained raft probe co-clustering, CD45 exclusion, and Lck regulation in the IS following the addition of filipin. These data show the actin cytoskeleton maintains a membrane raft environment in the IS that promotes Lck regulation by excluding CD45.	[Chichili, Gurunadh R.; Westmuckett, Andrew D.; Rodgers, William] Oklahoma Med Res Fdn, Cardiovasc Biol Res Program, Oklahoma City, OK 73104 USA; [Rodgers, William] Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK 73104 USA; [Rodgers, William] Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK 73104 USA	Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Rodgers, W (corresponding author), Oklahoma Med Res Fdn, Cardiovasc Biol Res Program, 825 NE 13th St,MS 45, Oklahoma City, OK 73104 USA.	william-rodgers@omrf.org			National Institutes of Health [R01 GM070001]; Oklahoma Center for the Advancement of Science and Technology [HR08-084]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070001] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oklahoma Center for the Advancement of Science and Technology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM070001 (to W. R.). This work was also supported by Oklahoma Center for the Advancement of Science and Technology Grant HR08-084 (to W. R.).	ABRAHAM N, 1990, MOL CELL BIOL, V10, P5197, DOI 10.1128/MCB.10.10.5197; AMREIN KE, 1988, P NATL ACAD SCI USA, V85, P4247, DOI 10.1073/pnas.85.12.4247; Arrieumerlou C, 2000, J IMMUNOL, V165, P3182, DOI 10.4049/jimmunol.165.6.3182; Bader AN, 2009, BIOPHYS J, V97, P2613, DOI 10.1016/j.bpj.2009.07.059; Brdicka T, 2000, J EXP MED, V191, P1591, DOI 10.1084/jem.191.9.1591; Burack WR, 2002, J IMMUNOL, V169, P2837, DOI 10.4049/jimmunol.169.6.2837; Cemerski S, 2008, IMMUNITY, V29, P414, DOI 10.1016/j.immuni.2008.06.014; Chichili GR, 2007, J BIOL CHEM, V282, P36682, DOI 10.1074/jbc.M702959200; Chichili GR, 2009, CELL MOL LIFE SCI, V66, P2319, DOI 10.1007/s00018-009-0022-6; Choudhuri K, 2005, NATURE, V436, P578, DOI 10.1038/nature03843; CHOW LML, 1993, NATURE, V365, P156, DOI 10.1038/365156a0; Costello PS, 2002, NAT IMMUNOL, V3, P1082, DOI 10.1038/ni848; Davis SJ, 2006, NAT IMMUNOL, V7, P803, DOI 10.1038/ni1369; Dietrich C, 2001, BIOPHYS J, V80, P1417, DOI 10.1016/S0006-3495(01)76114-0; Douglass AD, 2005, CELL, V121, P937, DOI 10.1016/j.cell.2005.04.009; Edmonds SD, 2002, J IMMUNOL, V169, P5036, DOI 10.4049/jimmunol.169.9.5036; Eggeling C, 2009, NATURE, V457, P1159, DOI 10.1038/nature07596; Freiberg BA, 2002, NAT IMMUNOL, V3, P911, DOI 10.1038/ni836; Friedrichson T, 1998, NATURE, V394, P802, DOI 10.1038/29570; Gaus K, 2006, MOL MEMBR BIOL, V23, P41, DOI 10.1080/09687860500466857; Gaus K, 2005, J CELL BIOL, V171, P121, DOI 10.1083/jcb.200505047; Glebov OO, 2004, NAT CELL BIOL, V6, P238, DOI 10.1038/ncb1103; Gordy C, 2004, J IMMUNOL, V172, P2030, DOI 10.4049/jimmunol.172.4.2030; Goswami D, 2008, CELL, V135, P1085, DOI 10.1016/j.cell.2008.11.032; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Hancock JF, 2006, NAT REV MOL CELL BIO, V7, P456, DOI 10.1038/nrm1925; Harriague J, 2002, NAT IMMUNOL, V3, P1090, DOI 10.1038/ni847; Hundt M, 2009, J IMMUNOL, V183, P1685, DOI 10.4049/jimmunol.0803921; Huppa JB, 2003, NAT REV IMMUNOL, V3, P973, DOI 10.1038/nri1245; Huppa JB, 2003, NAT IMMUNOL, V4, P749, DOI 10.1038/ni951; Ilani T, 2007, J CELL BIOL, V179, P733, DOI 10.1083/jcb.200707199; Johnson KG, 2000, P NATL ACAD SCI USA, V97, P10138, DOI 10.1073/pnas.97.18.10138; Kawabuchi M, 2000, NATURE, V404, P999, DOI 10.1038/35010121; Kenworthy AK, 1998, J CELL BIOL, V142, P69, DOI 10.1083/jcb.142.1.69; Kenworthy AK, 2008, EMBO REP, V9, P531, DOI 10.1038/embor.2008.92; KORETZKY GA, 1991, P NATL ACAD SCI USA, V88, P2037, DOI 10.1073/pnas.88.6.2037; Kusumi A, 2004, TRAFFIC, V5, P213, DOI 10.1111/j.1600-0854.2004.0178.x; Lee KH, 2003, SCIENCE, V302, P1218, DOI 10.1126/science.1086507; Lee KH, 2002, SCIENCE, V295, P1539, DOI 10.1126/science.1067710; Lenne PF, 2006, EMBO J, V25, P3245, DOI 10.1038/sj.emboj.7601214; Lillemeier BF, 2010, NAT IMMUNOL, V11, P90, DOI 10.1038/ni.1832; Lin J, 2003, J CELL BIOL, V162, P673, DOI 10.1083/jcb.200303040; Liu AP, 2006, BIOPHYS J, V91, P4064, DOI 10.1529/biophysj.106.090852; Milstein O, 2008, J BIOL CHEM, V283, P34414, DOI 10.1074/jbc.M804756200; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; MUSTELIN T, 1989, P NATL ACAD SCI USA, V86, P6302, DOI 10.1073/pnas.86.16.6302; Nolz JC, 2007, J IMMUNOL, V179, P1104, DOI 10.4049/jimmunol.179.2.1104; OSTERGAARD HL, 1989, P NATL ACAD SCI USA, V86, P8959, DOI 10.1073/pnas.86.22.8959; PARASASSI T, 1991, BIOPHYS J, V60, P179, DOI 10.1016/S0006-3495(91)82041-0; Plowman SJ, 2005, P NATL ACAD SCI USA, V102, P15500, DOI 10.1073/pnas.0504114102; Rentero C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002262; Rodgers W, 2005, TRENDS IMMUNOL, V26, P97, DOI 10.1016/j.it.2004.11.016; RODGERS W, 1994, MOL CELL BIOL, V14, P5384, DOI 10.1128/MCB.14.8.5384; Rodgers W, 1996, J CELL BIOL, V135, P1515, DOI 10.1083/jcb.135.6.1515; Rodgers W, 2001, EXP CELL RES, V267, P173, DOI 10.1006/excr.2001.5253; Schutz GJ, 2000, EMBO J, V19, P892, DOI 10.1093/emboj/19.5.892; Sengupta P, 2007, BIOPHYS J, V92, P3564, DOI 10.1529/biophysj.106.094730; Sharma P, 2004, CELL, V116, P577, DOI 10.1016/S0092-8674(04)00167-9; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Sohn HW, 2006, P NATL ACAD SCI USA, V103, P8143, DOI 10.1073/pnas.0509858103; Tavano R, 2006, NAT CELL BIOL, V8, P1270, DOI 10.1038/ncb1492; Thaler C, 2006, NAT METHODS, V3, P491, DOI 10.1038/NMETH0706-491A; Varma R, 1998, NATURE, V394, P798, DOI 10.1038/29563; Villalba M, 2001, J CELL BIOL, V155, P331, DOI 10.1083/jcb.200107080; Wilson BS, 2004, MOL BIOL CELL, V15, P2580, DOI 10.1091/mbc.E03-08-0574; Xavier R, 1998, IMMUNITY, V8, P723, DOI 10.1016/S1074-7613(00)80577-4; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zech T, 2009, EMBO J, V28, P466, DOI 10.1038/emboj.2009.6; Zhang WG, 1998, IMMUNITY, V9, P239, DOI 10.1016/S1074-7613(00)80606-8	69	25	26	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14737	14746		10.1074/jbc.M109.097311	http://dx.doi.org/10.1074/jbc.M109.097311			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20194498	Green Published, hybrid			2022-12-25	WOS:000277299700071
J	Zoudilova, M; Min, J; Richards, HL; Carter, D; Huang, T; Defea, KA				Zoudilova, Maria; Min, Jungah; Richards, Heddie L.; Carter, David; Huang, Timothy; Defea, Kathryn A.			beta-Arrestins Scaffold Cofilin with Chronophin to Direct Localized Actin Filament Severing and Membrane Protrusions Downstream of Protease-activated Receptor-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTESTINAL INFLAMMATION; CANCER-CELLS; CHEMOTAXIS; BETA-ARRESTIN-1; STIMULATION; MIGRATION; PATHWAY; EGF; POLYMERIZATION; PHOSPHATASE	Protease-activated receptor-2 (PAR-2) mediates pro-inflammatory signals in a number of organs, including enhancing leukocyte recruitment to sites of injury and infection. At the cellular level, PAR-2 promotes activation of the actin filament-severing protein cofilin, which is crucial for the reorganization of the actin cytoskeleton and chemotaxis. These responses require the scaffolding functions of beta-arrestins; however, the mechanism by which beta-arrestins spatially regulate cofilin activity and the role of this pathway in primary cells has not been investigated. Here, using size-exclusion chromatography and co-immunoprecipitation, we demonstrate that PAR-2 promotes the formation of a complex containing beta-arrestins, cofilin, and chronophin (CIN) in primary leukocytes and cultured cells. Both association of cofilin with CIN and cell migration are inhibited in leukocytes from beta-arrestin-2(-/-) mice. We show that, in response to PAR-2 activation, beta-arrestins scaffold cofilin with its upstream activator CIN, to facilitate the localized generation of free actin barbed ends, leading to membrane protrusion. These studies suggest that a major role of beta-arrestins in chemotaxis is to spatially regulate cofilin activity to facilitate the formation of a leading edge, and that this pathway may be important for PAR-2-stimulated immune cell migration.	[Richards, Heddie L.; Defea, Kathryn A.] Univ Calif Riverside, Div Biomed Sci, Riverside, CA 92521 USA; [Zoudilova, Maria; Min, Jungah; Defea, Kathryn A.] Univ Calif Riverside, Cell Mol & Dev Biol Program, Riverside, CA 92521 USA; [Carter, David] Univ Calif Riverside, Integrat Inst Genome Biol, Riverside, CA 92521 USA; [Huang, Timothy] Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA	University of California System; University of California Riverside; University of California System; University of California Riverside; University of California System; University of California Riverside; Scripps Research Institute	Defea, KA (corresponding author), Univ Calif Riverside, Div Biomed Sci, B605 Stat Rd, Riverside, CA 92521 USA.	kathryn.defea@ucr.edu		DeFea, Kathryn/0000-0001-6056-907X	National Institutes of Health [R01GM066151, 1R21HL092388]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL092388] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066151] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM066151 and 1R21HL092388.	Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Barnes WG, 2005, J BIOL CHEM, V280, P8041, DOI 10.1074/jbc.M412924200; Cenac N, 2002, AM J PATHOL, V161, P1903, DOI 10.1016/S0002-9440(10)64466-5; Chan AY, 2000, J CELL BIOL, V148, P531, DOI 10.1083/jcb.148.3.531; Chan AY, 1998, J CELL SCI, V111, P199; Chin AC, 2008, J IMMUNOL, V181, P5702, DOI 10.4049/jimmunol.181.8.5702; Cho SY, 2002, J CELL BIOL, V156, P725, DOI 10.1083/jcb.200111032; Cooper JA, 2000, CURR OPIN CELL BIOL, V12, P97, DOI 10.1016/S0955-0674(99)00062-9; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; DeFea KA, 2000, P NATL ACAD SCI USA, V97, P11086, DOI 10.1073/pnas.190276697; DeFea KA, 2007, ANNU REV PHYSIOL, V69, P535, DOI 10.1146/annurev.physiol.69.022405.154804; Delorme V, 2007, DEV CELL, V13, P646, DOI 10.1016/j.devcel.2007.08.011; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Ebeling C, 2005, J ALLERGY CLIN IMMUN, V115, P623, DOI 10.1016/j.jaci.2004.11.042; Ferrell WR, 2003, J CLIN INVEST, V111, P35, DOI 10.1172/JCI200316913; Fong AM, 2002, P NATL ACAD SCI USA, V99, P7478, DOI 10.1073/pnas.112198299; Ge L, 2004, J BIOL CHEM, V279, P55419, DOI 10.1074/jbc.M410312200; Ge L, 2003, J BIOL CHEM, V278, P34418, DOI 10.1074/jbc.M300573200; Ghosh M, 2004, SCIENCE, V304, P743, DOI 10.1126/science.1094561; Gohla A, 2005, NAT CELL BIOL, V7, P21, DOI 10.1038/ncb1201; Hunton DL, 2005, MOL PHARMACOL, V67, P1229, DOI 10.1124/mol.104.006270; Hyun E, 2008, GUT, V57, P1222, DOI 10.1136/gut.2008.150722; Kohout TA, 2001, P NATL ACAD SCI USA, V98, P1601, DOI 10.1073/pnas.041608198; KUMAR P, 2007, AM J PHYSL CELL PHYS; Lagane B, 2008, BLOOD, V112, P34, DOI 10.1182/blood-2007-07-102103; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; MATSUZAKI F, 1988, J BIOL CHEM, V263, P11564; McGuire JJ, 2004, J PHARMACOL EXP THER, V309, P1124, DOI 10.1124/jpet.103.064584; Milano SK, 2006, J BIOL CHEM, V281, P9812, DOI 10.1074/jbc.M512703200; Mouneimne G, 2004, J CELL BIOL, V166, P697, DOI 10.1083/jcb.200405156; Mouneimne G, 2006, CURR BIOL, V16, P2193, DOI 10.1016/j.cub.2006.09.016; Nagata-Ohashi K, 2004, J CELL BIOL, V165, P465, DOI 10.1083/jcb.200401136; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Ponti A, 2004, SCIENCE, V305, P1782, DOI 10.1126/science.1100533; Schmidlin F, 2002, J IMMUNOL, V169, P5315, DOI 10.4049/jimmunol.169.9.5315; Sidani M, 2007, J CELL BIOL, V179, P777, DOI 10.1083/jcb.200707009; Song XY, 2006, J CELL SCI, V119, P2871, DOI 10.1242/jcs.03017; Tohgo AK, 2002, J BIOL CHEM, V277, P9429, DOI 10.1074/jbc.M106457200; Walker JKL, 2003, J CLIN INVEST, V112, P566, DOI 10.1172/JCI200317265; Wang P, 2006, BIOCHEMISTRY-US, V45, P9374, DOI 10.1021/bi0602617; Wang W, 2006, J CELL BIOL, V173, P395, DOI 10.1083/jcb.200510115; Zoudilova M, 2007, J BIOL CHEM, V282, P20634, DOI 10.1074/jbc.M701391200	42	56	56	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14318	14329		10.1074/jbc.M109.055806	http://dx.doi.org/10.1074/jbc.M109.055806			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20207744	Green Published, hybrid			2022-12-25	WOS:000277299700029
J	Hsu, FF; Lin, TY; Chen, JY; Shieh, SY				Hsu, F-F; Lin, T-Y; Chen, J-Y; Shieh, S-Y			p53-Mediated transactivation of LIMK2b links actin dynamics to cell cycle checkpoint control	ONCOGENE			English	Article						cell cycle checkpoint; LIMK2; p53	TISSUE-SPECIFIC EXPRESSION; PROTEIN-KINASE; COFILIN PHOSPHORYLATION; ALTERNATIVE TRANSCRIPTS; DEPOLYMERIZING FACTOR; TARGET-GENE; P53; ROCK; RHO; ACTIVATION	The p53 tumor suppressor protein is widely known for its role as a sequence-specific transcription factor that regulates the expression of stress response genes. Here, we report the identification of LIMK2, which encodes a kinase that regulates actin dynamics through phosphorylation of cofilin, as a p53 target upregulated by DNA damage. Interestingly, the splice variant LIMK2b, but not LIMK2a, was induced in a p53-dependent manner through an intronic consensus p53-binding site. Depletion of LIMK2b leads to early exit of G2/M arrest after DNA damage, whereas its overexpression prolongs the arrest. These responses are recapitulated by ectopic expression of the active cofilin S3A mutant and the inactive cofilin S3D mutant, respectively, suggesting that LIMK2b may modulate G2/M arrest through cofilin phosphorylation. Furthermore, in support of its potential role as a tumor suppressor, LIMK2b was downregulated in esophageal and thyroid cancers, as well as in a number of established cancer cell lines, and its expression suppresses cancer cell migration. Taken together, our results unveil a novel pathway whereby LIMK2b, acting downstream of p53, ensures proper execution of checkpoint arrest by modulating the dynamics of actin polymerization. Oncogene (2010) 29, 2864-2876; doi: 10.1038/onc.2010.40; published online 1 March 2010	[Hsu, F-F; Lin, T-Y; Chen, J-Y; Shieh, S-Y] Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan; [Hsu, F-F] Natl Yang Ming Univ, Program Mol Med, Inst Biochem & Mol Biol, Taipei 112, Taiwan	Academia Sinica - Taiwan; National Yang Ming Chiao Tung University	Shieh, SY (corresponding author), Acad Sinica, Inst Biomed Sci, 128,Sec 2,Acad Rd, Taipei 115, Taiwan.	sy88@ibms.sinica.edu.tw	Chen, Joanne Jeou-Yuan/S-7022-2018; Shieh, Sheau-Yann/N-9512-2018	Shieh, Sheau-Yann/0000-0002-5351-4430	Academia Sinica	Academia Sinica(Academia Sinica - Taiwan)	We thank Hsiu-Ting Lin for her expert technical assistance with the RT-PCR. This work was supported by funding from Academia Sinica to S-Y Shieh.	Abe H, 1996, J CELL BIOL, V132, P871, DOI 10.1083/jcb.132.5.871; Amano T, 2002, J BIOL CHEM, V277, P22093, DOI 10.1074/jbc.M201444200; Amano T, 2001, BIOCHEM J, V354, P149, DOI 10.1042/0264-6021:3540149; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Croft DR, 2006, MOL CELL BIOL, V26, P4612, DOI 10.1128/MCB.02061-05; Gadea G, 2002, EMBO J, V21, P2373, DOI 10.1093/emboj/21.10.2373; Gadea G, 2007, J CELL BIOL, V178, P23, DOI 10.1083/jcb.200701120; Goyal P, 2005, J BIOL CHEM, V280, P27569, DOI 10.1074/jbc.M504448200; GUNSALUS KC, 1995, J CELL BIOL, V131, P1243, DOI 10.1083/jcb.131.5.1243; Guo FK, 2003, J BIOL CHEM, V278, P14414, DOI 10.1074/jbc.M300341200; Harms K, 2004, CELL MOL LIFE SCI, V61, P822, DOI 10.1007/s00018-003-3304-4; Hotulainen P, 2005, MOL BIOL CELL, V16, P649, DOI 10.1091/mbc.E04-07-0555; Ikebe C, 1997, GENOMICS, V46, P504, DOI 10.1006/geno.1997.5060; Jetten Anton M, 2009, Nucl Recept Signal, V7, pe003, DOI 10.1621/nrs.07003; Lavin MF, 2006, CELL DEATH DIFFER, V13, P941, DOI 10.1038/sj.cdd.4401925; Lee S, 2004, J BIOL CHEM, V279, P1885, DOI 10.1074/jbc.M306968200; Li ZP, 2006, MOL CELL BIOL, V26, P4240, DOI 10.1128/MCB.02124-05; Lu Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001149; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Murray-Zmijewski F, 2008, NAT REV MOL CELL BIO, V9, P702, DOI 10.1038/nrm2451; Nomoto S, 1999, GENE, V236, P259, DOI 10.1016/S0378-1119(99)00280-2; Ohashi K, 2000, J BIOL CHEM, V275, P3577, DOI 10.1074/jbc.275.5.3577; Okano I, 1995, J BIOL CHEM, V270, P31321, DOI 10.1074/jbc.270.52.31321; Olivier M, 2002, HUM MUTAT, V19, P607, DOI 10.1002/humu.10081; Olsson A, 2007, CELL DEATH DIFFER, V14, P1561, DOI 10.1038/sj.cdd.4402196; Ongusaha PP, 2006, CURR BIOL, V16, P2466, DOI 10.1016/j.cub.2006.10.056; Osada H, 1996, BIOCHEM BIOPH RES CO, V229, P582, DOI 10.1006/bbrc.1996.1847; Ou YH, 2007, EMBO J, V26, P3968, DOI 10.1038/sj.emboj.7601825; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Sahai E, 2001, EMBO J, V20, P755, DOI 10.1093/emboj/20.4.755; Scott RW, 2007, J MOL MED, V85, P555, DOI 10.1007/s00109-007-0165-6; Smolich B, 1997, J BIOCHEM-TOKYO, V121, P382; Sumi T, 1999, J CELL BIOL, V147, P1519, DOI 10.1083/jcb.147.7.1519; Sumi T, 2001, J BIOL CHEM, V276, P670, DOI 10.1074/jbc.M007074200; Takahashi T, 2001, DEV BIOL, V229, P554, DOI 10.1006/dbio.2000.9999; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Vardouli L, 2005, J BIOL CHEM, V280, P11448, DOI 10.1074/jbc.M402651200; Zhu Y, 2006, ONCOGENE, V25, P2901, DOI 10.1038/sj.onc.1209314	39	33	35	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAY	2010	29	19					2864	2876		10.1038/onc.2010.40	http://dx.doi.org/10.1038/onc.2010.40			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	595DW	20190821				2022-12-25	WOS:000277591900011
J	Lin, Y; Chen, NT; Shih, YP; Liao, YC; Xue, L; Lo, SH				Lin, Y.; Chen, N-T; Shih, Y-P; Liao, Y-C; Xue, L.; Lo, S. H.			DLC2 modulates angiogenic responses in vascular endothelial cells by regulating cell attachment and migration	ONCOGENE			English	Article						DLC2; RhoGAP; tumor suppressor; angiogenesis	GTPASE-ACTIVATING PROTEIN; TUMOR-SUPPRESSOR; HEPATOCELLULAR-CARCINOMA; LIVER; CANCER; EXPRESSION; GROWTH; LOCALIZATION; INHIBITION; RHOGAP	Deleted in liver cancer 1 (DLC1) is a RhoGTPase activation protein-containing tumor suppressor that associates with various types of cancer. Although DLC2 shares a similar domain structure with that of DLC1, the function of DLC2 is not well characterized. Here, we describe the expression and ablation of DLC2 in mice using a reporter-knockout approach. DLC2 is expressed in several tissues and in endothelial cells (ECs) of blood vessels. Although ECs and blood vessels show no histological abnormalities and mice appear overall healthy, DLC2-mutant mice display enhanced angiogenic responses induced by matrigel and by tumor cells. Silencing of DLC2 in human ECs has reduced cell attachment, increased migration, and tube formation. These changes are rescued by silencing of RhoA, suggesting that the process is RhoA pathway dependent. These results indicate that DLC2 is not required for mouse development and normal vessel formation, but may protect mouse from unwanted angiogenesis induced by, for example, tumor cells. Oncogene (2010) 29, 3010-3016; doi:10.1038/onc.2010.54; published online 8 March 2010	[Lin, Y.; Chen, N-T; Shih, Y-P; Liao, Y-C; Lo, S. H.] Univ Calif Davis, Dept Biochem & Mol Med, Sacramento, CA 95817 USA; [Lin, Y.; Xue, L.] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Pathol, Guangzhou 510275, Guangdong, Peoples R China	University of California System; University of California Davis; Sun Yat Sen University	Lo, SH (corresponding author), Univ Calif Davis, Dept Biochem & Mol Med, 4635 2nd Ave,Room 3002, Sacramento, CA 95817 USA.	shlo@ucdavis.edu	Hsiao, Wei-Hung/B-9931-2013; Liao, Yi-Chun/H-2383-2014	Liao, Yi-Chun/0000-0002-0399-0201; Lo, Su Hao/0000-0002-2675-9387	National Institutes of Health [CA102537]; NATIONAL CANCER INSTITUTE [R01CA102537, R56CA102537] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the Knockout Mouse Project Repository for DLC2 ES cells. This work is supported in part by grants from the National Institutes of Health (CA102537) to SHL.	Ching YP, 2003, J BIOL CHEM, V278, P10824, DOI 10.1074/jbc.M208310200; Durkin ME, 2007, ONCOGENE, V26, P4580, DOI 10.1038/sj.onc.1210244; Durkin ME, 2007, J CELL MOL MED, V11, P1185, DOI 10.1111/j.1582-4934.2007.00098.x; Durkin ME, 2005, FEBS LETT, V579, P1191, DOI 10.1016/j.febslet.2004.12.090; Durkin ME, 2002, GENE, V288, P119, DOI 10.1016/S0378-1119(02)00462-6; Leung THY, 2005, P NATL ACAD SCI USA, V102, P15207, DOI 10.1073/pnas.0504501102; Li XR, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-205; Liao YC, 2008, CANCER RES, V68, P7718, DOI 10.1158/0008-5472.CAN-08-2042; Liao YC, 2008, INT J BIOCHEM CELL B, V40, P843, DOI 10.1016/j.biocel.2007.04.008; Liao YC, 2007, J CELL BIOL, V176, P43, DOI 10.1083/jcb.200608015; Masson V, 2004, FASEB J, V18, P234, DOI 10.1096/fj.04-2140fje; Qian XL, 2007, P NATL ACAD SCI USA, V104, P9012, DOI 10.1073/pnas.0703033104; Testa G, 2004, GENESIS, V38, P151, DOI 10.1002/gene.20012; Ullmannova V, 2006, INT J ONCOL, V29, P1127; Xue W, 2008, GENE DEV, V22, P1439, DOI 10.1101/gad.1672608; Yau TO, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006566; Yuan BZ, 1998, CANCER RES, V58, P2196	17	31	32	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2010	29	20					3010	3016		10.1038/onc.2010.54	http://dx.doi.org/10.1038/onc.2010.54			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	599DM	20208559	Green Accepted, Green Submitted			2022-12-25	WOS:000277890400011
J	Batulan, Z; Haddad, GA; Blunck, R				Batulan, Zarah; Haddad, Georges A.; Blunck, Rikard			An Intersubunit Interaction between S4-S5 Linker and S6 Is Responsible for the Slow Off-gating Component in Shaker K+ Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POTASSIUM CHANNELS; OPEN-STATE; PACEMAKER CHANNELS; CHARGE MOVEMENT; ACTIVATION GATE; VOLTAGE SENSOR; ION CONDUCTION; WILD-TYPE; CURRENTS; INACTIVATION	Voltage-gated ion channels are controlled by the membrane potential, which is sensed by peripheral, positively charged voltage sensors. The movement of the charged residues in the voltage sensor may be detected as gating currents. In Shaker K+ channels, the gating currents are asymmetric; although the on-gating currents are fast, the off-gating currents contain a slow component. This slow component is caused by a stabilization of the activated state of the voltage sensor and has been suggested to be linked to ion permeation or C-type inactivation. The molecular determinants responsible for the stabilization, however, remain unknown. Here, we identified an interaction between Arg-394, Glu-395, and Leu-398 on the C termini of the S4-S5 linker and Tyr-485 on the S6 of the neighboring subunit, which is responsible for the development of the slow off-gating component. Mutation of residues involved in this intersubunit interaction modulated the strength of the associated interaction. Impairment of the interaction still led to pore opening but did not exhibit slow gating kinetics. Development of this interaction occurs under physiological ion conduction and is correlated with pore opening. We, thus, suggest that the above residues stabilize the channel in the open state.	[Blunck, Rikard] Univ Montreal, Dept Phys, Montreal, PQ H3C 3J7, Canada; Univ Montreal, Grp Etud Prot Membranaires, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Universite de Montreal	Blunck, R (corresponding author), Univ Montreal, Dept Phys, CP 6128,Succ Ctr Ville, Montreal, PQ H3C 3J7, Canada.	rikard.blunck@umontreal.ca	Blunck, Rikard/AAM-3078-2020; Blunck, Rikard/L-4226-2013	Blunck, Rikard/0000-0003-4484-2907; Blunck, Rikard/0000-0003-4484-2907	Canadian Institutes for Health Research [MOP-81351]; Canada Research Chairs [202965]; Canada Foundation for Innovation [202965]; Groupe d'Etude des Proteines Membranaires scholarship	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs(Canada Research ChairsCGIAR); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Groupe d'Etude des Proteines Membranaires scholarship	This work was supported by a grant from the Canadian Institutes for Health Research (MOP-81351), Canada Research Chairs (202965), and the Canada Foundation for Innovation (202965).; Supported by a Groupe d'Etude des Proteines Membranaires scholarship.	ARMSTRONG CM, 1973, J GEN PHYSIOL, V62, P375, DOI 10.1085/jgp.62.4.375; Armstrong CM, 2001, BIOPHYS J, V81, P895, DOI 10.1016/S0006-3495(01)75749-9; Barghaan J, 2009, J GEN PHYSIOL, V133, P205, DOI 10.1085/jgp.200810073; BEZANILLA F, 1974, SCIENCE, V183, P753, DOI 10.1126/science.183.4126.753; BEZANILLA F, 1994, BIOPHYS J, V66, P1011, DOI 10.1016/S0006-3495(94)80882-3; Bezanilla F, 2008, NAT REV MOL CELL BIO, V9, P323, DOI 10.1038/nrm2376; Cha A, 1998, J GEN PHYSIOL, V112, P391, DOI 10.1085/jgp.112.4.391; Cha A, 1997, NEURON, V19, P1127, DOI 10.1016/S0896-6273(00)80403-1; Chen FSP, 1997, J GEN PHYSIOL, V110, P87, DOI 10.1085/jgp.110.2.87; Chen J, 2001, P NATL ACAD SCI USA, V98, P11277, DOI 10.1073/pnas.201250598; Coquiere D, 2009, P NATL ACAD SCI USA, V106, P10449, DOI 10.1073/pnas.0811663106; Decher N, 2004, J BIOL CHEM, V279, P13859, DOI 10.1074/jbc.M313704200; del Camino D, 2005, J GEN PHYSIOL, V126, P419, DOI 10.1085/jgp.200509385; Ding SH, 2003, BIOPHYS J, V84, P295, DOI 10.1016/S0006-3495(03)74850-4; Hackos DH, 2002, J GEN PHYSIOL, V119, P521, DOI 10.1085/jgp.20028569; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; HOSHI T, 1994, J GEN PHYSIOL, V103, P249, DOI 10.1085/jgp.103.2.249; Imbrici P, 2006, EUR J NEUROSCI, V24, P3073, DOI 10.1111/j.1460-9568.2006.05186.x; Kanevsky M, 1999, J GEN PHYSIOL, V114, P215, DOI 10.1085/jgp.114.2.215; Labro AJ, 2008, J GEN PHYSIOL, V132, P667, DOI 10.1085/jgp.200810048; Ledwell JL, 1999, J GEN PHYSIOL, V113, P389, DOI 10.1085/jgp.113.3.389; Loboda A, 2001, BIOPHYS J, V81, P905, DOI 10.1016/S0006-3495(01)75750-5; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Lu Z, 2001, NATURE, V413, P809, DOI 10.1038/35101535; Lu Z, 2002, J GEN PHYSIOL, V120, P663, DOI 10.1085/jgp.20028696; Mannuzzu LM, 1996, SCIENCE, V271, P213, DOI 10.1126/science.271.5246.213; MCCORMACK K, 1994, NEURON, V12, P301, DOI 10.1016/0896-6273(94)90273-9; Ogielska EM, 1995, BIOPHYS J, V69, P2449, DOI 10.1016/S0006-3495(95)80114-1; Okumura A, 2007, FEBS LETT, V581, P5255, DOI 10.1016/j.febslet.2007.10.015; Pathak M, 2005, J GEN PHYSIOL, V125, P57, DOI 10.1085/jgp.200409197; PEROZO E, 1993, NEURON, V11, P353, DOI 10.1016/0896-6273(93)90190-3; Schoppa NE, 1998, J GEN PHYSIOL, V111, P313, DOI 10.1085/jgp.111.2.313; Sigg D, 1999, BIOPHYS J, V76, P782, DOI 10.1016/S0006-3495(99)77243-7; SLESINGER PA, 1993, NEURON, V11, P739, DOI 10.1016/0896-6273(93)90083-4; Soler-Llavina GJ, 2006, NEURON, V52, P623, DOI 10.1016/j.neuron.2006.10.005; Starkus JG, 1997, J GEN PHYSIOL, V110, P539, DOI 10.1085/jgp.110.5.539; Starkus JG, 1998, J GEN PHYSIOL, V112, P85, DOI 10.1085/jgp.112.1.85; STEFANI E, 1994, BIOPHYS J, V66, P996, DOI 10.1016/S0006-3495(94)80881-1; TAGLIALATELA M, 1992, BIOPHYS J, V62, P34, DOI 10.1016/S0006-3495(92)81770-8; Tristani-Firouzi M, 2002, J BIOL CHEM, V277, P18994, DOI 10.1074/jbc.M200410200; TYTGAT J, 1992, NATURE, V359, P420, DOI 10.1038/359420a0; Umezawa Y, 1999, BIOORGAN MED CHEM, V7, P2021, DOI 10.1016/S0968-0896(99)00123-6; Varga Z, 2002, J GEN PHYSIOL, V119, P467, DOI 10.1085/jgp.20028520; Yang YS, 1997, J GEN PHYSIOL, V109, P779, DOI 10.1085/jgp.109.6.779; ZAGOTTA WN, 1990, J GEN PHYSIOL, V95, P29, DOI 10.1085/jgp.95.1.29; ZAGOTTA WN, 1990, SCIENCE, V250, P568, DOI 10.1126/science.2122520; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P321, DOI 10.1085/jgp.103.2.321; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P279, DOI 10.1085/jgp.103.2.279	48	69	70	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					14005	14019		10.1074/jbc.M109.097717	http://dx.doi.org/10.1074/jbc.M109.097717			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20202932	hybrid, Green Published			2022-12-25	WOS:000276987700074
J	Carrera, S; de Verdier, PJ; Khan, Z; Zhao, B; Mahale, A; Bowman, KJ; Zainol, M; Jones, GDD; Lee, SW; Aaronson, SA; Macip, S				Carrera, Samantha; de Verdier, Petra J.; Khan, Zahid; Zhao, Bo; Mahale, Alka; Bowman, Karen J.; Zainol, Muri; Jones, George D. D.; Lee, Sam W.; Aaronson, Stuart A.; Macip, Salvador			Protection of Cells in Physiological Oxygen Tensions against DNA Damage-induced Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOXIA-INDUCED APOPTOSIS; REPLICATIVE LIFE-SPAN; TUMOR-SUPPRESSOR P53; ACTIVATION; FIBROBLASTS; PROTEIN; STRESS; EXPRESSION; CARCINOMA; RADIATION	Oxygen availability has important effects on cell physiology. Although hyperoxic and hypoxic stresses have been well characterized, little is known about cellular functions in the oxygen levels commonly found in vivo. Here, we show that p53-dependent apoptosis in response to different DNA-damaging agents was reduced when normal and cancer cells were cultured at physiological oxygen tensions instead of the usual atmospheric levels. Different from what has been described in hypoxia, this was neither determined by decreases in p53 induction or its transactivation activity, nor by differences in the intracellular accumulation of reactive oxygen species. At these physiological oxygen levels, we found a constitutive activation of the ERK1/2 MAPK in all the models studied. Inhibition of this signaling pathway reversed the protective effect in some but not all cell lines. We conclude that a stress-independent constitutive activation of prosurvival pathways, including but probably not limited to MAPK, can protect cells in physiological oxygen tensions against genotoxic stress. Our results underscore the need of considering the impact of oxygen levels present in the tissue microenvironment when studying cell sensitivity to treatments such as chemotherapy and radiotherapy.	[Carrera, Samantha; Macip, Salvador] Univ Leicester, Dept Biochem, Leicester LE1 9HN, Leics, England; [de Verdier, Petra J.] Karolinska Inst, Dept Mol Med & Surg, Urol Lab, S-17176 Stockholm, Sweden; [Khan, Zahid; Zhao, Bo; Mahale, Alka; Aaronson, Stuart A.] Mt Sinai Sch Med, Dept Oncol Sci, New York, NY 10029 USA; [Bowman, Karen J.; Zainol, Muri; Jones, George D. D.] Univ Leicester, Radiat & Oxidat Stress Grp, Dept Canc Studies & Mol Med, Leicester LE1 7RH, Leics, England; [Lee, Sam W.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Harvard Cutaneous Biol Res Ctr, Boston, MA 02129 USA	University of Leicester; Karolinska Institutet; Icahn School of Medicine at Mount Sinai; University of Leicester; Harvard University; Harvard Medical School; Massachusetts General Hospital	Macip, S (corresponding author), Univ Leicester, Dept Biochem, Lancaster Rd, Leicester LE1 9HN, Leics, England.	sm460@le.ac.uk	Macip, Salvador/S-6358-2019; Macip, Salvador/P-4233-2019; Macip, Salvador/K-5985-2014	Macip, Salvador/0000-0003-1963-8840; Zainol, Murizal/0000-0001-7372-0672; Jones, George/0000-0002-9543-2206	National Institutes of Health [CA80058, CA85214, CA78356, CA82211]; Medical Research Council; NATIONAL CANCER INSTITUTE [R01CA085214, R01CA078356, R01CA082211, R01CA085681, R01CA149477, P01CA080058] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work supported, in whole or in part, by National Institutes of Health Grants CA80058 and CA85214 (to S. A. A.) and CA78356 and CA82211 (to S. W. L.). This work was also supported by the Medical Research Council (New Blood Lectureship Research support funding).	Achison M, 2003, ONCOGENE, V22, P3431, DOI 10.1038/sj.onc.1206434; Akiri G, 2009, ONCOGENE, V28, P2163, DOI 10.1038/onc.2009.82; An WG, 1998, NATURE, V392, P405, DOI 10.1038/32925; Aubry JP, 1999, CYTOMETRY, V37, P197, DOI 10.1002/(SICI)1097-0320(19991101)37:3<197::AID-CYTO6>3.0.CO;2-L; Bhandari V, 2006, NAT MED, V12, P1286, DOI 10.1038/nm1494; Brown JM, 2004, NAT REV CANCER, V4, P437, DOI 10.1038/nrc1367; Chandel NS, 2000, ONCOGENE, V19, P3840, DOI 10.1038/sj.onc.1203727; Chow DC, 2001, BIOPHYS J, V81, P675, DOI 10.1016/S0006-3495(01)75732-3; Cuisnier O, 2003, INT J ONCOL, V23, P1033; Duarte TL, 2009, FREE RADICAL BIO MED, V46, P78, DOI 10.1016/j.freeradbiomed.2008.09.028; Duncia JV, 1998, BIOORG MED CHEM LETT, V8, P2839, DOI 10.1016/S0960-894X(98)00522-8; Gewirtz DA, 1999, BIOCHEM PHARMACOL, V57, P727, DOI 10.1016/S0006-2952(98)00307-4; GRAEBER TG, 1994, MOL CELL BIOL, V14, P6264, DOI 10.1128/MCB.14.9.6264; HALL EJ, 2005, RADIOBIOLOGY RADIOLO, P89; Hammond EM, 2005, BIOCHEM BIOPH RES CO, V331, P718, DOI 10.1016/j.bbrc.2005.03.154; Hammond EM, 2002, MOL CELL BIOL, V22, P1834, DOI 10.1128/MCB.22.6.1834-1843.2002; Jeong HJ, 2005, J NEUROIMMUNOL, V163, P84, DOI 10.1016/j.jneuroim.2005.02.019; Koumenis C, 2001, MOL CELL BIOL, V21, P1297, DOI 10.1128/MCB.21.4.1297-1310.2001; Kurz EU, 2004, J BIOL CHEM, V279, P53272, DOI 10.1074/jbc.M406879200; Latonen L, 2005, BBA-REV CANCER, V1755, P71, DOI 10.1016/j.bbcan.2005.04.003; Lee SW, 2000, P NATL ACAD SCI USA, V97, P8302, DOI 10.1073/pnas.150024397; Mahale AM, 2008, CANCER RES, V68, P1417, DOI 10.1158/0008-5472.CAN-07-3021; Matsuda N, 2000, PHOTOCHEM PHOTOBIOL, V72, P334, DOI 10.1562/0031-8655(2000)072<0334:DAOEAJ>2.0.CO;2; Minet E, 2000, FEBS LETT, V468, P53, DOI 10.1016/S0014-5793(00)01181-9; Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024; Renton A, 2003, CARCINOGENESIS, V24, P1177, DOI 10.1093/carcin/bgg044; RILEY PA, 1994, INT J RADIAT BIOL, V65, P27, DOI 10.1080/09553009414550041; SAITO H, 1995, EXP CELL RES, V217, P272, DOI 10.1006/excr.1995.1087; Sasabe E, 2005, CANCER SCI, V96, P394, DOI 10.1111/j.1349-7006.2005.00065.x; SCHROY PC, 1995, CANCER, V76, P201, DOI 10.1002/1097-0142(19950715)76:2<201::AID-CNCR2820760207>3.0.CO;2-T; STEFANELLI C, 1995, BIOCHEM BIOPH RES CO, V212, P300, DOI 10.1006/bbrc.1995.1970; Steurer J, 1997, RESPIRATION, V64, P200; VONZGLINICKI T, 1995, EXP CELL RES, V220, P186, DOI 10.1006/excr.1995.1305; Zhang QZ, 2004, J CELL PHYSIOL, V199, P89, DOI 10.1002/jcp.10452	34	21	22	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13658	13665		10.1074/jbc.M109.062562	http://dx.doi.org/10.1074/jbc.M109.062562			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20228054	Green Submitted, Green Published, hybrid			2022-12-25	WOS:000276987700040
J	Weinman, EJ; Biswas, R; Steplock, D; Douglass, TS; Cunningham, R; Shenolikar, S				Weinman, Edward J.; Biswas, Rajatsubhra; Steplock, Deborah; Douglass, Tia S.; Cunningham, Rochelle; Shenolikar, Shirish			Sodium-Hydrogen Exchanger Regulatory Factor 1 (NHERF-1) Transduces Signals That Mediate Dopamine Inhibition of Sodium-Phosphate Co-transport in Mouse Kidney	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RENAL PROXIMAL TUBULE; PARATHYROID-HORMONE; FACTOR-I; RECEPTOR INTERACTS; ADAPTER PROTEINS; NA+/H+ EXCHANGE; NAPI-IIA; CELLS; PHOSPHORYLATION; INTERNALIZATION	Dopamine inhibited phosphate transport in isolated renal brush border membrane vesicles and in cultured renal proximal tubule cells from wild-type but not from NHERF-1 null mice. Co-immunoprecipitation experiments established that NHERF-1 associated with D1-like receptors. In wild-type mice, dopamine stimulated cAMP accumulation and protein kinase C (PKC) activity in renal proximal tubule cells, an effect that was abolished by SCH-23390, a D1-like receptor antagonist. In NHERF-1 null kidney tissue; however, dopamine failed to stimulate either cAMP accumulation or PKC activity. Infection of proximal tubule cells from NHERF-1 null mice with adenovirus-green fluorescent protein-NHERF-1 restored the ability of dopamine to stimulate cAMP and PKC. Finally, in P-32-labeled wild-type proximal tubule cells and in opossum kidney cells, dopamine increased NHERF-1 phosphorylation at serine 77 of the PDZ I domain of NHERF-1, a site previously shown to attenuate binding of cellular targets including the Npt2a (sodium-dependent phosphate transporter 2a). Together, these studies establish that NHERF-1 plays a key role in dopamine signaling and is also a downstream target of D1-like receptors in the mouse kidney. These studies suggest a novel role for the PDZ adapter protein NHERF-1 in coordinating dopamine signals that inhibit renal phosphate transport.	[Weinman, Edward J.; Biswas, Rajatsubhra; Steplock, Deborah; Douglass, Tia S.; Cunningham, Rochelle] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Weinman, Edward J.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; [Weinman, Edward J.; Cunningham, Rochelle] Dept Vet Affairs Med Ctr, Med Serv, Baltimore, MD 21201 USA; [Shenolikar, Shirish] Duke Natl Univ Singapore, Grad Sch Med, Program Neurosci & Behav Disorders, Singapore 169857, Singapore	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; National University of Singapore	Weinman, EJ (corresponding author), Univ Maryland Hosp, Div Nephrol, UMH, Rm N3W143,22 S Greene St, Baltimore, MD 21201 USA.	eweinman1440@yahoo.com			National Institutes of Health [DK55881]; Department of Veterans Affairs; Kidney Foundation of Maryland; Robert Wood Johnson Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055881] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); Kidney Foundation of Maryland; Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK55881 (to E. J. W.). This work was also supported by funds from the Department of Veterans Affairs (to E. J. W.) and the Kidney Foundation of Maryland (to R. C.).; Recipient of a Harold Amos Faculty Development Award from the Robert Wood Johnson Foundation.	Bacic D, 2005, AM J PHYSIOL-RENAL, V288, pF740, DOI 10.1152/ajprenal.00380.2004; Cunningham R, 2006, AM J PHYSIOL-RENAL, V291, pF896, DOI 10.1152/ajprenal.00036.2006; Cunningham R, 2009, AM J PHYSIOL-RENAL, V296, pF355, DOI 10.1152/ajprenal.90426.2008; Deliot N, 2005, AM J PHYSIOL-CELL PH, V289, pC159, DOI 10.1152/ajpcell.00456.2004; Gomes P, 2002, AM J PHYSIOL-RENAL, V282, pF1084, DOI 10.1152/ajprenal.00318.2001; Hall RA, 1998, NATURE, V392, P626, DOI 10.1038/33458; Hall RA, 2002, CIRC RES, V91, P672, DOI 10.1161/01.RES.0000037000.74258.03; Hernando N, 2005, J PHYSIOL-LONDON, V567, P21, DOI 10.1113/jphysiol.2005.087049; Hernando N, 2002, P NATL ACAD SCI USA, V99, P11957, DOI 10.1073/pnas.182412699; Heydorn A, 2004, FEBS LETT, V556, P276, DOI 10.1016/S0014-5793(03)01431-5; Huang P, 2004, J BIOL CHEM, V279, P25002, DOI 10.1074/jbc.M313366200; Lederer ED, 1998, J AM SOC NEPHROL, V9, P975; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mahon MJ, 2002, NATURE, V417, P858, DOI 10.1038/nature00816; Mahon MJ, 2004, J BIOL CHEM, V279, P23550, DOI 10.1074/jbc.M313229200; Murtazina R, 2007, J BIOL CHEM, V282, P25141, DOI 10.1074/jbc.M701910200; Pedrosa R, 2004, CELL PHYSIOL BIOCHEM, V14, P91, DOI 10.1159/000076930; Rochdi MD, 2002, J BIOL CHEM, V277, P40751, DOI 10.1074/jbc.M207910200; Shenolikar S, 2002, P NATL ACAD SCI USA, V99, P11470, DOI 10.1073/pnas.162232699; Voltz JW, 2007, J BIOL CHEM, V282, P33879, DOI 10.1074/jbc.M703481200; Wade JB, 2003, AM J PHYSIOL-CELL PH, V285, pC1494, DOI 10.1152/ajpcell.00092.2003; Wang XY, 2008, PEDIATR NEPHROL, V23, P2131, DOI 10.1007/s00467-008-0901-3; Weinman EJ, 2007, J CLIN INVEST, V117, P3412, DOI 10.1172/JCI32738; Weinman EJ, 2006, ANNU REV PHYSIOL, V68, P491, DOI 10.1146/annurev.physiol.68.040104.131050; Weinman EJ, 2003, FEBS LETT, V536, P141, DOI 10.1016/S0014-5793(03)00043-7; Wheeler D, 2008, MOL ENDOCRINOL, V22, P1163, DOI 10.1210/me.2007-0461; Zhang JP, 2007, J BIOL CHEM, V282, P15778, DOI 10.1074/jbc.M611485200	27	33	34	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13454	13460		10.1074/jbc.M109.094359	http://dx.doi.org/10.1074/jbc.M109.094359			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20200151	Green Published, hybrid			2022-12-25	WOS:000276987700017
J	Savas, JN; Ma, B; Deinhardt, K; Culver, BP; Restituito, S; Wu, LG; Belasco, JG; Chao, MV; Tanese, N				Savas, Jeffrey N.; Ma, Bin; Deinhardt, Katrin; Culver, Brady P.; Restituito, Sophie; Wu, Ligang; Belasco, Joel G.; Chao, Moses V.; Tanese, Naoko			A Role for Huntington Disease Protein in Dendritic RNA Granules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; HIPPOCAMPAL-NEURONS; P-BODIES; RIBONUCLEOPROTEIN-PARTICLES; TRANSLATION; TRANSPORT; LOCALIZATION; DEGRADATION; TRAFFICKING; EXPRESSION	Regulated transport and local translation of mRNA in neurons are critical for modulating synaptic strength, maintaining proper neural circuitry, and establishing long term memory. Neuronal RNA granules are ribonucleoprotein particles that serve to transport mRNA along microtubules and control local protein synthesis in response to synaptic activity. Studies suggest that neuronal RNA granules share similar structures and functions with somatic P-bodies. We recently reported that the Huntington disease protein huntingtin (Htt) associates with Argonaute (Ago) and localizes to cytoplasmic P-bodies, which serve as sites of mRNA storage, degradation, and small RNA-mediated gene silencing. Here we report that wild-type Htt associates with Ago2 and components of neuronal granules and co-traffics with mRNA in dendrites. Htt was found to co-localize with RNA containing the 3'-untranslated region sequence of known dendritically targeted mRNAs. Knockdown of Htt in neurons caused altered localization of mRNA. When tethered to a reporter construct, Htt down-regulated reporter gene expression in a manner dependent on Ago2, suggesting that Htt may function to repress translation of mRNAs during transport in neuronal granules.	[Belasco, Joel G.; Tanese, Naoko] NYU, Dept Microbiol, Sch Med, New York, NY 10016 USA; [Deinhardt, Katrin; Chao, Moses V.] NYU, Dept Cell Biol, Sch Med, Mol Neurobiol Program, New York, NY 10016 USA; [Deinhardt, Katrin; Belasco, Joel G.; Chao, Moses V.] NYU, Kimmel Ctr, Sch Med, Skirball Inst Biomol Med, New York, NY 10016 USA; [Restituito, Sophie] NYU, Dept Biochem, Sch Med, New York, NY 10016 USA; [Savas, Jeffrey N.; Tanese, Naoko] Natl Inst Hlth Grad Partnership Program Struct Bi, New York, NY 10016 USA	New York University; New York University; New York University; New York University; National Institutes of Health (NIH) - USA	Tanese, N (corresponding author), NYU, Dept Microbiol, Sch Med, 550 1st Ave, New York, NY 10016 USA.	tanesn01@med.nyu.edu		Tanese, Naoko/0000-0002-1946-3211; Deinhardt, Katrin/0000-0002-6473-5298; Chao, Moses/0000-0002-6969-3744	National Institutes of Health [NS061917]; Hereditary Disease Foundation; CHDI Foundation, Inc; NIH [S10 RR017970]; Vilcek Endowment Fellowship Award; Human Frontier Science Program; Alzheimer's Association [NIRG-06-25401]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR017970] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079477] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS061917] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hereditary Disease Foundation; CHDI Foundation, Inc; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vilcek Endowment Fellowship Award; Human Frontier Science Program(Human Frontier Science Program); Alzheimer's Association(Alzheimer's Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS061917 (to N. T.). This work was also supported by the Hereditary Disease Foundation (to N. T.) and CHDI Foundation, Inc. (to N. T. and M. V. C.). Purchase of the confocal microscope was through a Shared Instrumentation Grant from NIH (Grant S10 RR017970).; Supported in part by the Vilcek Endowment Fellowship Award. Current address: Dept. of Chemical Physiology, The Scripps Research Institute, La Jolla, CA 92037.; Supported by the Human Frontier Science Program.; Supported by the Alzheimer's Association (Grant NIRG-06-25401).	Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Banerjee S, 2009, NEURON, V64, P871, DOI 10.1016/j.neuron.2009.11.023; Bannai H, 2004, J BIOL CHEM, V279, P53427, DOI 10.1074/jbc.M409732200; Barbee SA, 2006, NEURON, V52, P997, DOI 10.1016/j.neuron.2006.10.028; Bramham CR, 2007, NAT REV NEUROSCI, V8, P776, DOI 10.1038/nrn2150; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Cattaneo E, 2005, NAT REV NEUROSCI, V6, P919, DOI 10.1038/nrn1806; Caviston JP, 2007, P NATL ACAD SCI USA, V104, P10045, DOI 10.1073/pnas.0610628104; Caviston JP, 2009, TRENDS CELL BIOL, V19, P147, DOI 10.1016/j.tcb.2009.01.005; Colin E, 2008, EMBO J, V27, P2124, DOI 10.1038/emboj.2008.133; Coller J, 2007, METHOD ENZYMOL, V429, P299, DOI 10.1016/S0076-6879(07)29014-7; Cook HA, 2004, CELL, V116, P817, DOI 10.1016/S0092-8674(04)00250-8; Cougot N, 2008, J NEUROSCI, V28, P13793, DOI 10.1523/JNEUROSCI.4155-08.2008; Daigle N, 2007, NAT METHODS, V4, P633, DOI 10.1038/NMETH1065; Eberwine J, 2002, NEUROCHEM RES, V27, P1065, DOI 10.1023/A:1020956805307; Engelender S, 1997, HUM MOL GENET, V6, P2205, DOI 10.1093/hmg/6.13.2205; Gauthier LR, 2004, CELL, V118, P127, DOI 10.1016/j.cell.2004.06.018; Glynn MW, 2006, NAT PROTOC, V1, P1287, DOI 10.1038/nprot.2006.220; Hickey MA, 2003, CYTOGENET GENOME RES, V100, P276, DOI 10.1159/000072863; Hillebrand Jens, 2007, ScientificWorldJournal, V7, P178; Huttelmaier S, 2005, NATURE, V438, P512, DOI 10.1038/nature04115; Imarisio S, 2008, BIOCHEM J, V412, P191, DOI 10.1042/BJ20071619; Janas J, 2006, METHOD ENZYMOL, V406, P593, DOI 10.1016/S0076-6879(06)06046-0; Jeong H, 2009, CELL, V137, P60, DOI 10.1016/j.cell.2009.03.018; Job C, 2001, NAT REV NEUROSCI, V2, P889, DOI 10.1038/35104069; Kedersha N, 2007, METHOD ENZYMOL, V431, P61, DOI 10.1016/S0076-6879(07)31005-7; Kiebler MA, 2006, NEURON, V51, P685, DOI 10.1016/j.neuron.2006.08.021; Kim M, 1999, NEUROSCIENCE, V89, P1159, DOI 10.1016/S0306-4522(98)00400-X; Kohrmann M, 1999, MOL BIOL CELL, V10, P2945, DOI 10.1091/mbc.10.9.2945; Krichevsky AM, 2001, NEURON, V32, P683, DOI 10.1016/S0896-6273(01)00508-6; Landles C, 2004, EMBO REP, V5, P958, DOI 10.1038/sj.embor.7400250; Levine MS, 2004, TRENDS NEUROSCI, V27, P691, DOI 10.1016/j.tins.2004.08.008; Li SH, 1998, J NEUROSCI, V18, P1261, DOI 10.1523/jneurosci.18-04-01261.1998; LI XJ, 1995, NATURE, V378, P398, DOI 10.1038/378398a0; Luthi-Carter R, 2003, CLIN NEUROSCI RES, V3, P165, DOI 10.1016/S1566-2772(03)00059-8; Mallardo M, 2003, P NATL ACAD SCI USA, V100, P2100, DOI 10.1073/pnas.0334355100; Martin KC, 2009, CELL, V136, P719, DOI 10.1016/j.cell.2009.01.044; Martin KC, 2006, J NEUROSCI, V26, P7131, DOI 10.1523/JNEUROSCI.1801-06.2006; McGuire JR, 2006, J BIOL CHEM, V281, P3552, DOI 10.1074/jbc.M509806200; Osten P, 1998, NEURON, V21, P99, DOI 10.1016/S0896-6273(00)80518-8; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Perluigi M, 2005, MOL CELL PROTEOMICS, V4, P1849, DOI 10.1074/mcp.M500090-MCP200; Ross CA, 2002, NEURON, V35, P819, DOI 10.1016/S0896-6273(02)00872-3; Rubinsztein DC, 2002, TRENDS GENET, V18, P202, DOI 10.1016/S0168-9525(01)02625-7; Savas JN, 2008, P NATL ACAD SCI USA, V105, P10820, DOI 10.1073/pnas.0800658105; Sugars KL, 2003, TRENDS GENET, V19, P233, DOI 10.1016/S0168-9525(03)00074-X; Tanese N, 1997, METHODS, V12, P224, DOI 10.1006/meth.1997.0475; Taylor AM, 2009, J NEUROSCI, V29, P4697, DOI 10.1523/JNEUROSCI.6130-08.2009; Thonberg H, 2004, BIOCHEM BIOPH RES CO, V318, P927, DOI 10.1016/j.bbrc.2004.04.119; Tiruchinapalli DM, 2003, J NEUROSCI, V23, P3251; Wilson AC, 1997, MOL CELL BIOL, V17, P6139, DOI 10.1128/MCB.17.10.6139; Wu LG, 2008, CURR BIOL, V18, P1327, DOI 10.1016/j.cub.2008.07.072; Zabel C, 2002, MOL CELL PROTEOMICS, V1, P366, DOI 10.1074/mcp.M200016-MCP200; Zabel C, 2009, MOL CELL PROTEOMICS, V8, P720, DOI 10.1074/mcp.M800277-MCP200; Zeitelhofer M, 2008, J NEUROSCI, V28, P7555, DOI 10.1523/JNEUROSCI.0104-08.2008; ZEITLIN S, 1995, NAT GENET, V11, P155, DOI 10.1038/ng1095-155	56	56	56	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					13142	13153		10.1074/jbc.M110.114561	http://dx.doi.org/10.1074/jbc.M110.114561			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20185826	hybrid, Green Published			2022-12-25	WOS:000276787800070
J	Miranda, KC; Karet, FE; Brown, D				Miranda, Kevin C.; Karet, Fiona E.; Brown, Dennis			An Extended Nomenclature for Mammalian V-ATPase Subunit Genes and Splice Variants	PLOS ONE			English	Article							VACUOLAR H+-ATPASE; PROTON-TRANSLOCATING ATPASE; RENAL TUBULAR-ACIDOSIS; TISSUE-SPECIFIC ISOFORMS; MOLECULAR-CLONING; CHROMAFFIN GRANULES; LUMINAL ACIDIFICATION; MESSENGER-RNA; CDNA CLONING; C-SUBUNIT	The vacuolar-type H(+)-ATPase (V-ATPase) is a multisubunit proton pump that is involved in both intra-and extracellular acidification processes throughout the body. Multiple homologs and splice variants of V-ATPase subunits are thought to explain its varied spatial and temporal expression pattern in different cell types. Recently subunit nomenclature was standardized with a total of 22 subunit variants identified. However this standardization did not accommodate the existence of splice variants and is therefore incomplete. Thus, we propose here an extension of subunit nomenclature along with a literature and sequence database scan for additional V-ATPase subunits. An additional 17 variants were pulled from a literature search while 4 uncharacterized potential subunit variants were found in sequence databases. These findings have been integrated with the current V-ATPase knowledge base to create a new V-ATPase subunit catalogue. It is envisioned this catalogue will form a new platform on which future studies into tissue-and organelle-specific V-ATPase expression, localization and function can be based.	[Miranda, Kevin C.; Brown, Dennis] Massachusetts Gen Hosp, Program Membrane Biol, Boston, MA 02114 USA; [Miranda, Kevin C.; Brown, Dennis] Massachusetts Gen Hosp, Div Nephrol, Ctr Syst Biol, Boston, MA 02114 USA; [Miranda, Kevin C.; Brown, Dennis] Harvard Univ, Sch Med, Boston, MA USA; [Karet, Fiona E.] Univ Cambridge, Dept Med Genet, Cambridge, England	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Cambridge	Miranda, KC (corresponding author), Massachusetts Gen Hosp, Program Membrane Biol, Boston, MA 02114 USA.	fek1000@cam.ac.uk; brown@receptor.mgh.harvard.edu		Karet, Fiona/0000-0002-2457-2869	National Kidney Foundation; Wellcome Trust; National Institutes of Health [DK42956]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK042956, R01DK042956, P30DK043351] Funding Source: NIH RePORTER	National Kidney Foundation; Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	KCM is funded through a National Kidney Foundation Research Fellowship. FEK is funded through the Wellcome Trust, while DB is funded by a National Institutes of Health grant DK42956 (DB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERNASCONI P, 1990, J BIOL CHEM, V265, P17428; BLAIR HC, 1989, SCIENCE, V245, P855, DOI 10.1126/science.2528207; Blake-Palmer KG, 2007, GENE, V393, P94, DOI 10.1016/j.gene.2007.01.020; Breton S, 1996, NAT MED, V2, P470, DOI 10.1038/nm0496-470; Brown D, 2000, J EXP BIOL, V203, P137; Crider BP, 1997, J BIOL CHEM, V272, P10721; Eyre TA, 2006, NUCLEIC ACIDS RES, V34, pD319, DOI 10.1093/nar/gkj147; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Frattini A, 2000, NAT GENET, V25, P343, DOI 10.1038/77131; FUJIWARA T, 1995, INT J RAPID PUBLICAT, V2, P107; Futai M, 2000, J EXP BIOL, V203, P107; Heinemann T, 1999, GENOMICS, V57, P398, DOI 10.1006/geno.1999.5751; HIRSCH S, 1988, P NATL ACAD SCI USA, V85, P3004, DOI 10.1073/pnas.85.9.3004; Hu RM, 2000, P NATL ACAD SCI USA, V97, P9543, DOI 10.1073/pnas.160270997; Imai-Senga Y, 2002, GENE, V289, P7, DOI 10.1016/S0378-1119(02)00542-5; Karet FE, 1999, NAT GENET, V21, P84, DOI 10.1038/5022; Kawasaki-Nishi S, 2007, BIOCHEM BIOPH RES CO, V364, P1032, DOI 10.1016/j.bbrc.2007.10.118; Kennell JA, 2001, CYTOGENET CELL GENET, V92, P337, DOI 10.1159/000056924; Kornak U, 2008, NAT GENET, V40, P32, DOI 10.1038/ng.2007.45; Li YP, 1996, BIOCHEM BIOPH RES CO, V218, P813, DOI 10.1006/bbrc.1996.0145; Ludwig J, 1998, J BIOL CHEM, V273, P10939, DOI 10.1074/jbc.273.18.10939; MANDEL M, 1988, P NATL ACAD SCI USA, V85, P5521, DOI 10.1073/pnas.85.15.5521; McGinnis S, 2004, NUCLEIC ACIDS RES, V32, pW20, DOI 10.1093/nar/gkh435; NELSON H, 1990, J BIOL CHEM, V265, P20390; Nelson N, 1999, PHYSIOL REV, V79, P361, DOI 10.1152/physrev.1999.79.2.361; Neville MJ, 1999, J IMMUNOL, V162, P4745; Nishi T, 2000, J BIOL CHEM, V275, P6824, DOI 10.1074/jbc.275.10.6824; Nishigori H, 1998, GENOMICS, V50, P222, DOI 10.1006/geno.1998.5310; PENG SB, 1994, J BIOL CHEM, V269, P17262; Peng SB, 1999, J BIOL CHEM, V274, P2549, DOI 10.1074/jbc.274.4.2549; Poea-Guyon S, 2006, J BIOL CHEM, V281, P17164, DOI 10.1074/jbc.M600927200; Ryan MC, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-313; Sayers EW, 2009, NUCLEIC ACIDS RES, V37, pD5, DOI 10.1093/nar/gkp967; Smith AN, 2003, MOL CELL, V12, P801, DOI 10.1016/S1097-2765(03)00397-6; Smith AN, 2002, GENE, V297, P169, DOI 10.1016/S0378-1119(02)00884-3; Smith AN, 2000, NAT GENET, V26, P71, DOI 10.1038/79208; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; SUDHOF TC, 1989, P NATL ACAD SCI USA, V86, P6067, DOI 10.1073/pnas.86.16.6067; Supekova L, 1996, J EXP BIOL, V199, P1147; Wagner CA, 2004, PHYSIOL REV, V84, P1263, DOI 10.1152/physrev.00045.2003; WANG SY, 1988, J BIOL CHEM, V263, P17638; WANG ZQ, 1990, J BIOL CHEM, V265, P21957; Zhou ZM, 1998, J BIOL CHEM, V273, P5878, DOI 10.1074/jbc.273.10.5878	44	27	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2010	5	3							e9531	10.1371/journal.pone.0009531	http://dx.doi.org/10.1371/journal.pone.0009531			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565XE	20224822	gold, Green Submitted, Green Published			2022-12-25	WOS:000275328800004
J	Kimmel, CB; DeLaurier, A; Ullmann, B; Dowd, J; McFadden, M				Kimmel, Charles B.; DeLaurier, April; Ullmann, Bonnie; Dowd, John; McFadden, Marcie			Modes of Developmental Outgrowth and Shaping of a Craniofacial Bone in Zebrafish	PLOS ONE			English	Article							NEURAL CREST; OSTEOBLAST DIFFERENTIATION; MANDIBULAR MORPHOLOGY; EPITHELIAL INFLUENCES; GENE-EXPRESSION; EMBRYONIC CHICK; HEAD SKELETON; EVOLUTION; ARCH; SKELETOGENESIS	The morphologies of individual bones are crucial for their functions within the skeleton, and vary markedly during evolution. Recent studies have begun to reveal the detailed molecular genetic pathways that underlie skeletal morphogenesis. On the other hand, understanding of the process of morphogenesis itself has not kept pace with the molecular work. We examined, through an extended period of development in zebrafish, how a prominent craniofacial bone, the opercle (Op), attains its adult morphology. Using high-resolution confocal imaging of the vitally stained Op in live larvae, we show that the bone initially appears as a simple linear spicule, or spur, with a characteristic position and orientation, and lined by osteoblasts that we visualize by transgenic labeling. The Op then undergoes a stereotyped sequence of shape transitions, most notably during the larval period occurring through three weeks postfertilization. New shapes arise, and the bone grows in size, as a consequence of anisotropic addition of new mineralized bone matrix along specific regions of the pre-existing bone surfaces. We find that two modes of matrix addition, spurs and veils, are primarily associated with change in shape, whereas a third mode, incremental banding, largely accounts for growth in size. Furthermore, morphometric analyses show that shape development and growth follow different trajectories, suggesting separate control of bone shape and size. New osteoblast arrangements are associated with new patterns of matrix outgrowth, and we propose that fine developmental regulation of osteoblast position is a critical determinant of the spatiotemporal pattern of morphogenesis.	[Kimmel, Charles B.; DeLaurier, April; Ullmann, Bonnie; Dowd, John; McFadden, Marcie] Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA	University of Oregon	Kimmel, CB (corresponding author), Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA.	kimmel@uoneuro.uoregon.edu			National Institutes of Health [RO1DE13834, PO1HD22486, IF32DE019345]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD022486] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE013834] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [F32DE019345] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The research was supported by research grants RO1DE13834 and PO1HD22486 and a postdoctoral fellowship IF32DE019345 (AD) from the National Institutes of Health. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATCHLEY WR, 1992, SYST BIOL, V41, P196, DOI 10.2307/2992521; ATCHLEY WR, 1991, BIOL REV, V66, P101, DOI 10.1111/j.1469-185X.1991.tb01138.x; Atchley WR, 1993, SKULL, V1, P207; Bookstein F L, 1997, Med Image Anal, V1, P225; Bromage TG, 2009, CALCIFIED TISSUE INT, V84, P388, DOI 10.1007/s00223-009-9221-2; Cheverud JM, 1997, EVOLUTION, V51, P2006, DOI [10.1111/j.1558-5646.1997.tb05122.x, 10.2307/2411021]; CHEVERUD JM, 1991, J CRAN GENET DEV BIO, V11, P122; Clouthier David E, 2004, Birth Defects Res C Embryo Today, V72, P190, DOI 10.1002/bdrc.20007; Clouthier DE, 1998, DEVELOPMENT, V125, P813; Crump JG, 2004, PLOS BIOL, V2, P1432, DOI 10.1371/journal.pbio.0020244; Cubbage CC, 1996, J MORPHOL, V229, P121, DOI 10.1002/(SICI)1097-4687(199608)229:2<121::AID-JMOR1>3.0.CO;2-4; Ehrich TH, 2003, J EXP ZOOL PART B, V296B, P58, DOI 10.1002/jez.b.00009; Fawcett D., 1994, TXB HISTOLOGY; Funato N, 2009, DEVELOPMENT, V136, P615, DOI 10.1242/dev.029355; Gregory W. K., 1933, FISH SKULLS STUDY EV; HALL B.K, 2005, BONES CARTILAGE; Hall BK, 2000, BIOESSAYS, V22, P138, DOI 10.1002/(SICI)1521-1878(200002)22:2<138::AID-BIES5>3.3.CO;2-W; HALL BK, 1992, ANAT EMBRYOL, V186, P107; JOLLIE M, 1975, J MORPHOL, V147, P61, DOI 10.1002/jmor.1051470106; JONES SJ, 1976, CELL TISSUE RES, V166, P101, DOI 10.1007/BF00215129; Kimmel CB, 2003, DEVELOPMENT, V130, P1339, DOI 10.1242/dev.00338; Kimmel CB, 2001, DEV BIOL, V233, P239, DOI 10.1006/dbio.2001.0201; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kimmel CB, 2007, J EXP ZOOL PART B, V308B, P609, DOI 10.1002/jez.b.21155; Klingenberg CP, 2009, EVOL DEV, V11, P405, DOI 10.1111/j.1525-142X.2009.00347.x; Laue K, 2008, DEVELOPMENT, V135, P1935, DOI 10.1242/dev.017160; Li N, 2009, DEV DYNAM, V238, P459, DOI 10.1002/dvdy.21838; Miller CT, 2007, DEV BIOL, V308, P144, DOI 10.1016/j.ydbio.2007.05.018; Miller CT, 2003, DEVELOPMENT, V130, P1353, DOI 10.1242/dev.00339; Nair S, 2007, DEVELOPMENT, V134, P335, DOI 10.1242/dev.02704; NELSON E, 1949, J MORPHOL, V85, P229; PARENTI LR, 1986, ZOOL J LINN SOC-LOND, V87, P37, DOI 10.1111/j.1096-3642.1986.tb01329.x; Parichy DM, 2009, DEV DYNAM, V238, P2975, DOI 10.1002/dvdy.22113; Raff R. A., 1996, SHAPE LIFE GENES DEV; ROHLF FJ, 2005, TPS DIG VERSION 2 04; ROHLF FJ, 2004, TPS THIN PLATE SPLIN; ROHLF FJ, 2005, TPS RELATIVE WARPS V; Rose C, 2009, BIOESSAYS, V31, P287, DOI 10.1002/bies.200800059; Ruest LB, 2004, DEVELOPMENT, V131, P4413, DOI 10.1242/dev.01291; Sisson BE, 2009, GENE EXPR PATTERNS, V9, P520, DOI 10.1016/j.gep.2009.07.003; Smolyar IV, 2004, ICES J MAR SCI, V61, P992, DOI 10.1016/j.icesjms.2004.07.013; THOMPSON DW, 1942, GROWTH FORM NEW EDIT; TYLER MS, 1978, ANAT REC, V192, P225, DOI 10.1002/ar.1091920203; TYLER MS, 1977, ANAT REC, V188, P229, DOI 10.1002/ar.1091880208; Verzi MP, 2007, DEV CELL, V12, P645, DOI 10.1016/j.devcel.2007.03.007; von Dassow G, 1999, J EXP ZOOL, V285, P307, DOI 10.1002/(SICI)1097-010X(19991215)285:4<307::AID-JEZ2>3.3.CO;2-M; WAGNER GP, 1996, AM ZOOL, V291, P116; Walker MB, 2006, DEV BIOL, V295, P194, DOI 10.1016/j.ydbio.2006.03.028; Walker MB, 2007, DEV BIOL, V304, P194, DOI 10.1016/j.ydbio.2006.12.027; WEINER S, 1992, FASEB J, V6, P879, DOI 10.1096/fasebj.6.3.1740237; WEISEL GF, 1967, J MORPHOL, V121, P1, DOI 10.1002/jmor.1051210102; Westerfield M., 2007, ZEBRAFISH BOOK GUIDE; Zelditch M.L., 2004, GEOMETRIC MORPHOMETR, DOI DOI 10.1016/B978-0-12-778460-1.X5000-5	53	92	97	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2010	5	3							e9475	10.1371/journal.pone.0009475	http://dx.doi.org/10.1371/journal.pone.0009475			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	564EX	20221441	Green Published, Green Submitted, gold			2022-12-25	WOS:000275197200002
J	Gruaz, L; Delucinge-Vivier, C; Descombes, P; Dayer, JM; Burger, D				Gruaz, Lyssia; Delucinge-Vivier, Celine; Descombes, Patrick; Dayer, Jean-Michel; Burger, Danielle			Blockade of T Cell Contact-Activation of Human Monocytes by High-Density Lipoproteins Reveals a New Pattern of Cytokine and Inflammatory Genes	PLOS ONE			English	Article							IL-1 RECEPTOR ANTAGONIST; NECROSIS-FACTOR-ALPHA; DIFFERENTIAL REGULATION; RHEUMATOID-ARTHRITIS; TISSUE-INHIBITOR; DENDRITIC CELLS; TH17 CELLS; LYMPHOCYTES; INDUCE; INTERLEUKIN-1-BETA	Background: Cellular contact with stimulated T cells is a potent inducer of cytokine production in human monocytes and is likely to play a substantial part in chronic/sterile inflammatory diseases. High-density lipoproteins (HDL) specifically inhibit the production of pro-inflammatory cytokines induced by T cell contact. Methodology/Principal Findings: To further elucidate the pro-inflammatory functions of cellular contact with stimulated T cells and its inhibition by HDL, we carried out multiplex and microarray analyses. Multiplex analysis of monocyte supernatant revealed that 12 out of 27 cytokines were induced upon contact with stimulated T cells, which cytokines included IL-1Ra, G-CSF, GM-CSF, IFN gamma, CCL2, CCL5, TNF, IL-1 beta, IL-6, IL-8, CCL3, and CCL4, but only the latter six were inhibited by HDL. Microarray analysis showed that 437 out of 54,675 probe sets were enhanced in monocytes activated by contact with stimulated T cells, 164 probe sets (i.e., 38%) being inhibited by HDL. These results were validated by qPCR. Interestingly, the cytokines induced by T cell contact in monocytes comprised IL-1 beta, IL-6 but not IL-12, suggesting that this mechanism might favor TH17 polarization, which emphasizes the relevance of this mechanism to chronic inflammatory diseases and highlights the contrast with acute inflammatory conditions that usually involve lipopolysaccharides (LPS). In addition, the expression of miR-155 and production of prostaglandin E(2)-both involved in inflammatory response-were triggered by T cell contact and inhibited in the presence of HDL. Conclusions/Significance: These results leave no doubt as to the pro-inflammatory nature of T cell contact-activation of human monocytes and the anti-inflammatory functions of HDL.	[Gruaz, Lyssia; Burger, Danielle] Univ Geneva, Dept Internal Med, Hans Wilsdorf Lab, Div Immunol & Allergy,Inflammat & Allergy Res Grp, Geneva, Switzerland; [Gruaz, Lyssia; Dayer, Jean-Michel; Burger, Danielle] Univ Geneva, Fac Med, Geneva, Switzerland; [Delucinge-Vivier, Celine; Descombes, Patrick] Univ Geneva, Natl Ctr Competence Res Frontiers Genet, Geneva, Switzerland	University of Geneva; University of Geneva; University of Geneva	Gruaz, L (corresponding author), Univ Geneva, Dept Internal Med, Hans Wilsdorf Lab, Div Immunol & Allergy,Inflammat & Allergy Res Grp, Geneva, Switzerland.	danielle.Burger@hcuge.ch	Burger, Danielle/A-1996-2008		Swiss National Science Foundation [320000-116259]; Swiss Society for Multiple Sclerosis; Hans Wilsdorf Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Society for Multiple Sclerosis; Hans Wilsdorf Foundation	This work was supported by grants from the Swiss National Science Foundation (#320000-116259), the Swiss Society for Multiple Sclerosis, and the Hans Wilsdorf Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Asirvatham AJ, 2009, CYTOKINE, V45, P58, DOI 10.1016/j.cyto.2008.11.010; Aste-Amezaga M, 1998, J IMMUNOL, V160, P5936; Belostotsky D, 2009, CURR OPIN CELL BIOL, V21, P352, DOI 10.1016/j.ceb.2009.04.011; Beutler B, 2007, IMMUNOL REV, V220, P113, DOI 10.1111/j.1600-065X.2007.00577.x; Boniface K, 2009, J EXP MED, V206, P535, DOI 10.1084/jem.20082293; Brennan FM, 2002, ARTHRITIS RHEUM, V46, P31, DOI 10.1002/1529-0131(200201)46:1<31::AID-ART10029>3.0.CO;2-5; Bresnihan B, 2004, ARTHRITIS RES THER, V6, pR563, DOI 10.1186/ar1443; Burger D, 2000, EUR CYTOKINE NETW, V11, P346; Burger D, 1998, ARTHRITIS RHEUM, V41, P1748, DOI 10.1002/1529-0131(199810)41:10<1748::AID-ART7>3.3.CO;2-V; Burger D, 2003, RHEUMATOLOGY, V42, P89, DOI 10.1093/rheumatology/keg038; BURGER D, 2007, CONT TARGETED THERAP, P85; Burger D, 2009, P NATL ACAD SCI USA, V106, P4355, DOI 10.1073/pnas.0812183106; Ceppi M, 2009, P NATL ACAD SCI USA, V106, P2735, DOI 10.1073/pnas.0811073106; Chizzolini C, 1997, EUR J IMMUNOL, V27, P171, DOI 10.1002/eji.1830270125; Coclet-Ninin J, 1997, EUR CYTOKINE NETW, V8, P345; Deage V, 1998, EUR CYTOKINE NETW, V9, P663; Dinarello CA, 2007, ARTHRITIS RHEUM-US, V56, P2817, DOI 10.1002/art.22841; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Foey A, 2002, ARTHRITIS RES, V4, P64, DOI 10.1186/ar385; Gerosa F, 2008, J EXP MED, V205, P1447, DOI 10.1084/jem.20071450; Hyka N, 2001, BLOOD, V97, P2381, DOI 10.1182/blood.V97.8.2381; Jungo F, 2001, CYTOKINE, V14, P272, DOI 10.1006/cyto.2001.0884; MALEFYT RD, 1991, J EXP MED, V174, P1209; Malefyt RW., 2000, CYTOKINE REFERENCE, P165; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Miossec P, 2009, MICROBES INFECT, V11, P625, DOI 10.1016/j.micinf.2009.04.003; Molnarfi N, 2008, MOL IMMUNOL, V45, P3419, DOI 10.1016/j.molimm.2008.04.001; Molnarfi N, 2007, J IMMUNOL, V178, P446, DOI 10.4049/jimmunol.178.1.446; Moser M, 2000, NAT IMMUNOL, V1, P199, DOI 10.1038/79734; Sallusto F, 2009, MICROBES INFECT, V11, P620, DOI 10.1016/j.micinf.2009.04.004; Scanu A, 2008, J LEUKOCYTE BIOL, V83, P921, DOI 10.1189/jlb.0807551; Sebbag M, 1997, EUR J IMMUNOL, V27, P624, DOI 10.1002/eji.1830270308; VEY E, 1992, J IMMUNOL, V149, P2040; Vey E, 1997, CYTOKINE, V9, P480, DOI 10.1006/cyto.1997.0191; Vey E, 1996, EUR J IMMUNOL, V26, P2404, DOI 10.1002/eji.1830261021	36	34	34	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2010	5	2							e9418	10.1371/journal.pone.0009418	http://dx.doi.org/10.1371/journal.pone.0009418			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SY	20195532	Green Submitted, gold, Green Published			2022-12-25	WOS:000274924300008
J	Ben-Shahar, Y; Lu, B; Collier, DM; Snyder, PM; Schnizler, M; Welsh, MJ				Ben-Shahar, Yehuda; Lu, Beika; Collier, Daniel M.; Snyder, Peter M.; Schnizler, Mikael; Welsh, Michael J.			The Drosophila Gene CheB42a Is a Novel Modifier of Deg/ENaC Channel Function	PLOS ONE			English	Article							PHEROMONE PERCEPTION; ION CHANNELS; PROTEIN; SUBUNIT; NEURONS; TOUCH; ORGANIZATION; CONTRIBUTES; EXPRESSION; COURTSHIP	Degenerin/epithelial Na+ channels (DEG/ENaC) represent a diverse family of voltage-insensitive cation channels whose functions include Na+ transport across epithelia, mechanosensation, nociception, salt sensing, modification of neurotransmission, and detecting the neurotransmitter FMRFamide. We previously showed that the Drosophila melanogaster Deg/ENaC gene lounge lizard (llz) is co-transcribed in an operon-like locus with another gene of unknown function, CheB42a. Because operons often encode proteins in the same biochemical or physiological pathway, we hypothesized that CHEB42A and LLZ might function together. Consistent with this hypothesis, we found both genes expressed in cells previously implicated in sensory functions during male courtship. Furthermore, when coexpressed, LLZ coprecipitated with CHEB42A, suggesting that the two proteins form a complex. Although LLZ expressed either alone or with CHEB42A did not generate ion channel currents, CHEB42A increased current amplitude of another DEG/ENaC protein whose ligand (protons) is known, acid-sensing ion channel 1a (ASIC1a). We also found that CHEB42A was cleaved to generate a secreted protein, suggesting that CHEB42A may play an important role in the extracellular space. These data suggest that CHEB42A is a modulatory subunit for sensory-related Deg/ENaC signaling. These results are consistent with operon-like transcription of CheB42a and llz and explain the similar contributions of these genes to courtship behavior.	[Ben-Shahar, Yehuda; Welsh, Michael J.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Collier, Daniel M.; Snyder, Peter M.; Schnizler, Mikael; Welsh, Michael J.] Univ Iowa, Dept Internal Med, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Collier, Daniel M.; Snyder, Peter M.; Welsh, Michael J.] Univ Iowa, Dept Mol Physiol & Biophys, Roy J & Lucille A Carver Coll Med, Iowa City, IA USA; [Ben-Shahar, Yehuda; Lu, Beika] Washington Univ, Dept Biol, St Louis, MO 63130 USA	Howard Hughes Medical Institute; University of Iowa; University of Iowa; Washington University (WUSTL)	Ben-Shahar, Y (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD USA.	michael-welsh@uiowa.edu	Collier, Daniel/GVU-0199-2022	Welsh, Michael/0000-0002-1646-6206	National Heart, Lung and Blood Institute; Cystic Fibrosis Foundation [R458-CR02, ENGLH9850]; National Institutes of Diabetes and Digestive and Kidney Diseases [DK54759]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK054759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R03DC010244] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); National Institutes of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The University of Iowa In Vitro Models and Cell Culture Core is supported in part by the National Heart, Lung and Blood Institute, the Cystic Fibrosis Foundation (R458-CR02 and ENGLH9850), and the National Institutes of Diabetes and Digestive and Kidney Diseases (DK54759)]. Y.B.S. was an Associate and M.J.W. is an Investigator of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott GW, 1999, CELL, V97, P175, DOI 10.1016/S0092-8674(00)80728-X; Adams CM, 1998, J CELL BIOL, V140, P143, DOI 10.1083/jcb.140.1.143; Askwith CC, 2000, NEURON, V26, P133, DOI 10.1016/S0896-6273(00)81144-7; Askwith CC, 2001, P NATL ACAD SCI USA, V98, P6459, DOI 10.1073/pnas.111155398; Barolo S, 2004, BIOTECHNIQUES, V36, P436, DOI 10.2144/04363ST03; Ben-Shahar Y, 2002, SCIENCE, V296, P741, DOI 10.1126/science.1069911; Ben-Shahar Y, 2007, P NATL ACAD SCI USA, V104, P222, DOI 10.1073/pnas.0609683104; Blumenthal T, 2003, NAT REV GENET, V4, P110, DOI 10.1038/nrg995; Boll W, 2002, DEVELOPMENT, V129, P5667, DOI 10.1242/dev.00157; Chelur DS, 2002, NATURE, V420, P669, DOI 10.1038/nature01205; Greenspan RJ, 2000, ANNU REV GENET, V34, P205, DOI 10.1146/annurev.genet.34.1.205; Hanlon MR, 2002, BIOCHEMISTRY-US, V41, P2886, DOI 10.1021/bi0119565; Heusser K, 2005, CURR OPIN NEUROBIOL, V15, P364, DOI 10.1016/j.conb.2005.04.001; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Lai EC, 2004, DEV BIOL, V269, P1, DOI 10.1016/j.ydbio.2004.01.032; Lawrence JG, 2003, ANNU REV MICROBIOL, V57, P419, DOI 10.1146/annurev.micro.57.030502.090816; Lawrence JG, 2002, CELL, V110, P407, DOI 10.1016/S0092-8674(02)00900-5; LIN H, 2005, P NATL ACAD SCI US; Lin HP, 2005, P NATL ACAD SCI USA, V102, P12831, DOI 10.1073/pnas.0506420102; LINGUEGLIA E, 1995, NATURE, V378, P730, DOI 10.1038/378730a0; Liu L, 2003, NEURON, V39, P133, DOI 10.1016/S0896-6273(03)00394-5; Mano I, 1999, BIOESSAYS, V21, P568, DOI 10.1002/(SICI)1521-1878(199907)21:7&lt;568::AID-BIES5&gt;3.0.CO;2-L; Matsunami H, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-220; O'Hagan R, 2005, NAT NEUROSCI, V8, P43, DOI 10.1038/nn1362; Park SK, 2006, CURR BIOL, V16, P1154, DOI 10.1016/j.cub.2006.04.028; Phelps CB, 1998, METHODS, V14, P367, DOI 10.1006/meth.1998.0592; Price MP, 2001, NEURON, V32, P1071, DOI 10.1016/S0896-6273(01)00547-5; Sakaguchi M, 1997, CURR OPIN BIOTECH, V8, P595, DOI 10.1016/S0958-1669(97)80035-3; Schild L, 2004, REV PHYSIOL BIOCH P, V151, P93, DOI 10.1007/s10254-004-0023-7; Shimada Y, 2003, J LIPID RES, V44, P342, DOI 10.1194/jlr.M200234-JLR200; Slone J, 2007, CURR BIOL, V17, P1809, DOI 10.1016/j.cub.2007.09.027; Starostina E, 2009, J BIOL CHEM, V284, P585, DOI 10.1074/jbc.M806474200; SWICK AG, 1992, P NATL ACAD SCI USA, V89, P1812, DOI 10.1073/pnas.89.5.1812; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Wang Y, 2008, EMBO J, V27, P2388, DOI 10.1038/emboj.2008.161; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Wemmie JA, 2006, TRENDS NEUROSCI, V29, P578, DOI 10.1016/j.tins.2006.06.014; White K, 1996, SCIENCE, V271, P805, DOI 10.1126/science.271.5250.805; Wolfe MS, 2004, SCIENCE, V305, P1119, DOI 10.1126/science.1096187; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Xu A, 2002, CELL TISSUE RES, V307, P381, DOI 10.1007/s00441-002-0524-0; Xu PX, 2005, NEURON, V45, P193, DOI 10.1016/j.neuron.2004.12.031; Zha XM, 2009, P NATL ACAD SCI USA, V106, P3573, DOI 10.1073/pnas.0813402106	44	18	18	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2010	5	2							e9395	10.1371/journal.pone.0009395	http://dx.doi.org/10.1371/journal.pone.0009395			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SX	20195381	Green Published, gold			2022-12-25	WOS:000274924200017
J	Kao, HT; Buka, SL; Kelsey, KT; Gruber, DF; Porton, B				Kao, Hung-Teh; Buka, Stephen L.; Kelsey, Karl T.; Gruber, David F.; Porton, Barbara			The Correlation between Rates of Cancer and Autism: An Exploratory Ecological Investigation	PLOS ONE			English	Article							SPECTRUM DISORDER; EDUCATION DATA; PREVALENCE; STATES; TESTS; RISK; LOCI; AGE	Background: Autism is associated with high rates of genomic aberrations, including chromosomal rearrangements and de novo copy-number variations. These observations are reminiscent of cancer, a disease where genomic rearrangements also play a role. We undertook a correlative epidemiological study to explore the possibility that shared risk factors might exist for autism and specific types of cancer. Methodology/Principal Findings: To determine if significant correlations exist between the prevalence of autism and the incidence of cancer, we obtained and analyzed state-wide data reported by age and gender throughout the United States. Autism data were obtained from the U. S. Department of Education via the Individuals with Disabilities Education Act ( IDEA) (2000-2007, reported annually by age group) and cancer incidence data were obtained from the Centers for Disease Control and Prevention (CDC) (1999-2005). IDEA data were further subdivided depending on the method used to diagnose autism (DSM IV or the Code of Federal Regulations, using strict or expanded criteria). Spearman rank correlations were calculated for all possible pairwise combinations of annual autism rates and the incidence of specific cancers. Following this, Bonferroni's correction was applied to significance values. Two independent methods for determining an overall combined p-value based on dependent correlations were obtained for each set of calculations. High correlations were found between autism rates and the incidence of in situ breast cancer (p <= 10(-10), modified inverse chi square, n = 16) using data from states that adhere strictly to the Code of Federal Regulations for diagnosing autism. By contrast, few significant correlations were observed between autism prevalence and the incidence of 23 other female and 22 male cancers. Conclusions: These findings suggest that there may be an association between autism and specific forms of cancer.	[Kao, Hung-Teh; Gruber, David F.; Porton, Barbara] Brown Univ, Dept Psychiat & Human Behav, Providence, RI 02912 USA; [Buka, Stephen L.; Kelsey, Karl T.] Brown Univ, Dept Community Hlth, Providence, RI 02912 USA; [Gruber, David F.] CUNY, Dept Nat Sci, Baruch Coll, New York, NY 10021 USA; [Gruber, David F.] CUNY, Grad Ctr, New York, NY 10021 USA	Brown University; Brown University; City University of New York (CUNY) System; Baruch College (CUNY); City University of New York (CUNY) System	Kao, HT (corresponding author), Brown Univ, Dept Psychiat & Human Behav, Providence, RI 02912 USA.	Hung-Teh_Kao@brown.edu	Buka, Stephen/H-7335-2014; Kelsey, Karl T/I-1252-2014	Buka, Stephen/0000-0002-8578-9308; 	NIH [NS047209, CA121147, CA100679, CA078609, CA126939, MH070898]; Stanley Medical Research Institute; NATIONAL CANCER INSTITUTE [R01CA126939, R01CA100679, R01CA078609, R01CA121147] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047209] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanley Medical Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by the NIH NS047209 (H.-T.K); CA121147, CA100679, CA078609 and CA126939 (K.T.K.); MH070898 (B.P.) and the Stanley Medical Research Institute (S.L.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amant F, 2005, LANCET, V366, P491, DOI 10.1016/S0140-6736(05)67063-8; [Anonymous], 1932, STAT METHODS RES WOR; BROWN MB, 1975, BIOMETRICS, V31, P987, DOI 10.2307/2529826; Chakrabarti S, 2001, JAMA-J AM MED ASSOC, V285, P3093, DOI 10.1001/jama.285.24.3093; Christian SL, 2008, BIOL PSYCHIAT, V63, P1111, DOI 10.1016/j.biopsych.2008.01.009; Curtin F, 1998, BIOL PSYCHIAT, V44, P775, DOI 10.1016/S0006-3223(98)00043-2; Durkin MS, 2008, AM J EPIDEMIOL, V168, P1268, DOI 10.1093/aje/kwn250; Gernsbacher MA, 2005, CURR DIR PSYCHOL SCI, V14, P55, DOI 10.1111/j.0963-7214.2005.00334.x; Laidler JR, 2005, PEDIATRICS, V116, pE120, DOI 10.1542/peds.2004-2341; MACFARLANE JR, 2009, J CHILD FAM STUD; Mandell DS, 2005, ARCH PEDIAT ADOL MED, V159, P266, DOI 10.1001/archpedi.159.3.266; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Morrow EM, 2008, SCIENCE, V321, P218, DOI 10.1126/science.1157657; Newschaffer CJ, 2005, PEDIATRICS, V115, pE277, DOI 10.1542/peds.2004-1958; Newschaffer CJ, 2003, PUBLIC HEALTH REP, V118, P393, DOI 10.1093/phr/118.5.393; Reichenberg A, 2006, ARCH GEN PSYCHIAT, V63, P1026, DOI 10.1001/archpsyc.63.9.1026; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Shattuck PT, 2006, PEDIATRICS, V117, P1438, DOI 10.1542/peds.2005-2911; SIMES RJ, 1986, BIOMETRIKA, V73, P751, DOI 10.2307/2336545; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Vorstman JAS, 2006, MOL PSYCHIATR, V11, P18, DOI 10.1038/sj.mp.4001757; WRIGHT SP, 1992, BIOMETRICS, V48, P1005, DOI 10.2307/2532694; Yager JD, 2006, NEW ENGL J MED, V354, P270, DOI 10.1056/NEJMra050776; ZAR JH, 1972, J AM STAT ASSOC, V67, P578, DOI 10.2307/2284441; Zhao X, 2007, P NATL ACAD SCI USA, V104, P12831, DOI 10.1073/pnas.0705803104	25	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2010	5	2							e9372	10.1371/journal.pone.0009372	http://dx.doi.org/10.1371/journal.pone.0009372			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	560SV	20186340	Green Published, gold			2022-12-25	WOS:000274924000014
J	Kistner, O; Crowe, BA; Wodal, W; Kerschbaum, A; Savidis-Dacho, H; Sabarth, N; Falkner, FG; Mayerhofer, I; Mundt, W; Reiter, M; Grillberger, L; Tauer, C; Graninger, M; Sachslehner, A; Schwendinger, M; Bruhl, P; Kreil, TR; Ehrlich, HJ; Barrett, PN				Kistner, Otfried; Crowe, Brian A.; Wodal, Walter; Kerschbaum, Astrid; Savidis-Dacho, Helga; Sabarth, Nicolas; Falkner, Falko G.; Mayerhofer, Ines; Mundt, Wolfgang; Reiter, Manfred; Grillberger, Leopold; Tauer, Christa; Graninger, Michael; Sachslehner, Alois; Schwendinger, Michael; Bruehl, Peter; Kreil, Thomas R.; Ehrlich, Hartmut J.; Barrett, P. Noel			A Whole Virus Pandemic Influenza H1N1 Vaccine Is Highly Immunogenic and Protective in Active Immunization and Passive Protection Mouse Models	PLOS ONE			English	Article							CELL-CULTURE; H5N1 VACCINE; MICE; INFECTION; RESPONSES; TRIAL; TRANSMISSION; PATHOGENESIS; ANTIBODIES; FERRETS	The recent emergence and rapid spread of a novel swine-derived H1N1 influenza virus has resulted in the first influenza pandemic of this century. Monovalent vaccines have undergone preclinical and clinical development prior to initiation of mass immunization campaigns. We have carried out a series of immunogenicity and protection studies following active immunization of mice, which indicate that a whole virus, nonadjuvanted vaccine is immunogenic at low doses and protects against live virus challenge. The immunogenicity in this model was comparable to that of a whole virus H5N1 vaccine, which had previously been demonstrated to induce high levels of seroprotection in clinical studies. The efficacy of the H1N1 pandemic vaccine in protecting against live virus challenge was also seen to be equivalent to that of the H5N1 vaccine. The protective efficacy of the H1N1 vaccine was also confirmed using a severe combined immunodeficient ( SCID) mouse model. It was demonstrated that mouse and guinea pig immune sera elicited following active H1N1 vaccination resulted in 100% protection of SCID mice following passive transfer of immune sera and lethal challenge. The immune responses to a whole virus pandemic H1N1 and a split seasonal H1N1 vaccine were also compared in this study. It was demonstrated that the whole virus vaccine induced a balanced Th-1 and Th-2 response in mice, whereas the split vaccine induced mainly a Th-2 response and only minimal levels of Th-1 responses. These data supported the initiation of clinical studies with the same low doses of whole virus vaccine that had previously been demonstrated to be immunogenic in clinical studies with a whole virus H5N1 vaccine.	[Kistner, Otfried; Crowe, Brian A.; Wodal, Walter; Kerschbaum, Astrid; Savidis-Dacho, Helga; Sabarth, Nicolas; Falkner, Falko G.; Mayerhofer, Ines; Mundt, Wolfgang; Reiter, Manfred; Grillberger, Leopold; Tauer, Christa; Graninger, Michael; Sachslehner, Alois; Schwendinger, Michael; Bruehl, Peter; Kreil, Thomas R.; Ehrlich, Hartmut J.; Barrett, P. Noel] Baxter BioSci, Global Res & Dev, Vienna, Austria		Kistner, O (corresponding author), Baxter BioSci, Global Res & Dev, Vienna, Austria.	noel_barrett@baxter.com	Sabarth, Nicolas/GQQ-0093-2022; Sabarth, Nicolas/GQP-7376-2022	Sabarth, Nicolas/0000-0003-3844-6297; 	Baxter Bioscience	Baxter Bioscience	This study was funded by Baxter Bioscience. The funders were involved in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	AICHINGER G, 2009, 3 INT C INFL VACC WO; Arguedas A, 2010, NEW ENGL J MED, V362, P370, DOI 10.1056/NEJMc0909988; Bodewes R, 2010, EXPERT REV VACCINES, V9, P59, DOI [10.1586/erv.09.148, 10.1586/ERV.09.148]; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P467; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P521; Clark TW, 2009, NEW ENGL J MED, V361, P2424, DOI 10.1056/NEJMoa0907650; DORMITZER PR, 2009, PLOS CURR INFLUENZA; Ehrlich HJ, 2008, NEW ENGL J MED, V358, P2573, DOI 10.1056/NEJMoa073121; Ehrlich HJ, 2009, J INFECT DIS, V200, P1113, DOI 10.1086/605608; GASPARINI R, 2009, INT J CLIN IN PRESS; Greenberg ME, 2009, NEW ENGL J MED, V361, P2405, DOI 10.1056/NEJMoa0907413; Gupta M, 2001, J VIROL, V75, P4649, DOI 10.1128/JVI.75.10.4649-4654.2001; HOBSON D, 1972, J HYG-CAMBRIDGE, V70, P767, DOI 10.1017/S0022172400022610; HOWARD MK, 2008, BIOL CHEM; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Kistner O, 1998, VACCINE, V16, P960, DOI 10.1016/S0264-410X(97)00301-0; Kistner O, 2007, VACCINE, V25, P6028, DOI 10.1016/j.vaccine.2007.05.013; Kundi M, 1999, ANTIVIR RES, V41, P145, DOI 10.1016/S0166-3542(99)00008-X; LIANG XF, 2009, LANCET, V375, P49; Maines TR, 2009, SCIENCE, V325, P484, DOI 10.1126/science.1177238; Munster VJ, 2009, SCIENCE, V325, P481, DOI 10.1126/science.1177127; NICHOLSON KG, 1979, J BIOL STAND, V7, P123, DOI 10.1016/S0092-1157(79)80044-X; Nolan T, 2010, JAMA-J AM MED ASSOC, V303, P37, DOI 10.1001/jama.2009.1911; PALLADINO G, 1995, J VIROL, V69, P2075, DOI 10.1128/JVI.69.4.2075-2081.1995; Plennevaux E, 2010, LANCET, V375, P41, DOI 10.1016/S0140-6736(09)62026-2; ROMAN F, 2009, VACCINE IN PRESS; SCHERLE PA, 1992, J IMMUNOL, V148, P212; Treanor JJ, 2006, NEW ENGL J MED, V354, P1343, DOI 10.1056/NEJMoa055778; VAJO Z, 2009, LANCET, V375, P56; *WHO, 2010, PAND HINI 2009 UPD 8; WOOD JM, 1977, J BIOL STAND, V5, P237, DOI 10.1016/S0092-1157(77)80008-5; Zhu FC, 2009, NEW ENGL J MED, V361, P2414, DOI 10.1056/NEJMoa0908535	32	39	44	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2010	5	2							e9349	10.1371/journal.pone.0009349	http://dx.doi.org/10.1371/journal.pone.0009349			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SV	20186321	gold, Green Published, Green Submitted			2022-12-25	WOS:000274924000005
J	Rajagopalan, M; Dziedzic, R; Al Zayer, M; Stankowska, D; Ouimet, MC; Bastedo, DP; Marczynski, GT; Madiraju, MV				Rajagopalan, Malini; Dziedzic, Renata; Al Zayer, Maha; Stankowska, Dorota; Ouimet, Marie-Claude; Bastedo, D. Patrick; Marczynski, Gregory T.; Madiraju, Murty V.			Mycobacterium tuberculosis Origin of Replication and the Promoter for Immunodominant Secreted Antigen 85B Are the Targets of MtrA, the Essential Response Regulator	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION; ESCHERICHIA-COLI; MCE1 OPERON; IN-VITRO; BINDING; 2-COMPONENT; DNAA; INITIATION; CHROMOSOME; EXPRESSION	Efficient proliferation of Mycobacterium tuberculosis (Mtb) inside macrophage requires that the essential response regulator MtrA be optimally phosphorylated. However, the genomic targets of MtrA have not been identified. We show by chromatin immunoprecipitation and DNase I footprinting that the chromosomal origin of replication, oriC, and the promoter for the major secreted immunodominant antigen Ag85B, encoded by fbpB, are MtrA targets. DNase I footprinting analysis revealed that MtrA recognizes two direct repeats of GTCACAgcg-like sequences and that MtrA similar to P, the phosphorylated form of MtrA, binds preferentially to these targets. The oriC contains several MtrA motifs, and replacement of all motifs or of a single select motif with TATATA compromises the ability of oriC plasmids to maintain stable autonomous replication in wild type and MtrA-overproducing strains, indicating that the integrity of the MtrA motif is necessary for oriC replication. The expression of the fbpB gene is found to be down-regulated in Mtb cells upon infection when these cells overproduce wild type MtrA but not when they overproduce a nonphosphorylated MtrA, indicating that MtrA similar to P regulates fbpB expression. We propose that MtrA is a regulator of oriC replication and that the ability of MtrA to affect apparently unrelated targets, i.e. oriC and fbpB, reflects its main role as a coordinator between the proliferative and pathogenic functions of Mtb.	[Rajagopalan, Malini; Dziedzic, Renata; Al Zayer, Maha; Stankowska, Dorota; Madiraju, Murty V.] Univ Texas Hlth Sci Ctr, Tyler, TX 75708 USA; [Ouimet, Marie-Claude; Bastedo, D. Patrick; Marczynski, Gregory T.] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3A 2B4, Canada	University of Texas System; University of Texas at Tyler; University of Texas-Health Sciences Center at Tyler (UTHSCT); McGill University	Madiraju, MV (corresponding author), Univ Texas Hlth Sci Ctr, Tyler, TX 75708 USA.	murty.madiraju@uthct.edu			National Institutes of Health [AI 084734, AI 73966, AI 48417]; Canadian Institutes for Health Research [MT-13453]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI073966, R01AI048417, R01AI084734] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI 084734 and AI 73966 ( to M. V. M.) and AI 48417 ( to M. R.). This work was also supported by Canadian Institutes for Health Research Operating Grant MT-13453 ( to M.-C. O.,D. P. B., and G. T. M.).	ABOUZEID C, 1991, INFECT IMMUN, V59, P2712, DOI 10.1128/IAI.59.8.2712-2718.1991; Belisle JT, 1997, SCIENCE, V276, P1420, DOI 10.1126/science.276.5317.1420; Blanco AG, 2002, STRUCTURE, V10, P701, DOI 10.1016/S0969-2126(02)00761-X; BRAMHILL D, 1988, CELL, V54, P915, DOI 10.1016/0092-8674(88)90102-X; BRAMHILL D, 1988, CELL, V52, P743, DOI 10.1016/0092-8674(88)90412-6; BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333; Casali N, 2006, J BACTERIOL, V188, P441, DOI 10.1128/JB.188.2.441-449.2006; Chauhan A, 2006, J BACTERIOL, V188, P1856, DOI 10.1128/JB.188.5.1856-1865.2006; Chauhan A, 2006, MOL MICROBIOL, V62, P132, DOI 10.1111/j.1365-2958.2006.05333.x; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; CONTENT J, 1991, INFECT IMMUN, V59, P3205, DOI 10.1128/IAI.59.9.3205-3212.1991; Dasgupta S, 2004, PLASMID, V52, P151, DOI 10.1016/j.plasmid.2004.08.001; Dziadek J, 2002, J BACTERIOL, V184, P3848, DOI 10.1128/JB.184.14.3848-3855.2002; Farhana A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002087; Fol M, 2006, MOL MICROBIOL, V60, P643, DOI 10.1111/j.1365-2958.2006.05137.x; GOREN MB, 1972, BACTERIOL REV, V36, P33, DOI 10.1128/MMBR.36.1.33-64.1972; Harth G, 2002, P NATL ACAD SCI USA, V99, P15614, DOI 10.1073/pnas.242612299; Hoch JA, 2000, CURR OPIN MICROBIOL, V3, P165, DOI 10.1016/S1369-5274(00)00070-9; Kana BD, 2004, TUBERCULOSIS, V84, P63, DOI 10.1016/j.tube.2003.08.006; Kaufmann SHE, 2005, J EXP MED, V201, P1693, DOI 10.1084/jem.20050842; Leonard AC, 2005, MOL MICROBIOL, V55, P978, DOI 10.1111/j.1365-2958.2004.04467.x; Madiraju MVVS, 2006, MOL MICROBIOL, V59, P1876, DOI 10.1111/j.1365-2958.2006.05068.x; Mustafa AS, 2000, INFECT IMMUN, V68, P3933, DOI 10.1128/IAI.68.7.3933-3940.2000; North RJ, 2004, ANNU REV IMMUNOL, V22, P599, DOI 10.1146/annurev.immunol.22.012703.104635; Pai SR, 2000, MICROB PATHOGENESIS, V28, P335, DOI 10.1006/mpat.2000.0353; Qin MH, 1997, J BACTERIOL, V179, P6311, DOI 10.1128/jb.179.20.6311-6317.1997; Qin MH, 1999, GENE, V233, P121, DOI 10.1016/S0378-1119(99)00148-1; RAJAGOPALAN M, 1995, J BACTERIOL, V177, P6527, DOI 10.1128/jb.177.22.6527-6535.1995; Rajagopalan M, 2005, BIOCHEM BIOPH RES CO, V331, P1171, DOI 10.1016/j.bbrc.2005.03.239; Riber L, 2009, MOL MICROBIOL, V71, P107, DOI 10.1111/j.1365-2958.2008.06516.x; Shi L, 2004, INFECT IMMUN, V72, P2420, DOI 10.1128/IAI.72.4.2420-2424.2004; Shi LB, 2003, P NATL ACAD SCI USA, V100, P241, DOI 10.1073/pnas.0136863100; Shimono N, 2003, P NATL ACAD SCI USA, V100, P15918, DOI 10.1073/pnas.2433882100; Siam R, 2000, EMBO J, V19, P1138, DOI 10.1093/emboj/19.5.1138; Siam R, 2003, J BACTERIOL, V185, P5563, DOI 10.1128/JB.185.18.5563-5572.2003; Smith I, 2003, CLIN MICROBIOL REV, V16, P463, DOI 10.1128/CMR.16.3.463-496.2003; Sola-Landa A, 2008, NUCLEIC ACIDS RES, V36, P1358, DOI 10.1093/nar/gkm1150; Via LE, 1996, J BACTERIOL, V178, P3314, DOI 10.1128/jb.178.11.3314-3321.1996; WIKER HG, 1992, MICROBIOL REV, V56, P648, DOI 10.1128/MMBR.56.4.648-661.1992; Wilkinson RJ, 2001, MOL MICROBIOL, V39, P813, DOI 10.1046/j.1365-2958.2001.02280.x; Yamamoto K, 2001, BIOCHEM BIOPH RES CO, V280, P898, DOI 10.1006/bbrc.2000.4202; Yuan ZC, 2006, NUCLEIC ACIDS RES, V34, P2686, DOI 10.1093/nar/gkl365; Zahrt TC, 2000, J BACTERIOL, V182, P3832, DOI 10.1128/JB.182.13.3832-3838.2000; Zundel CJ, 1998, FEBS LETT, V441, P242, DOI 10.1016/S0014-5793(98)01556-7; ZYSKIND JW, 1986, CELL, V46, P489, DOI 10.1016/0092-8674(86)90873-1	45	61	63	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					15816	15827		10.1074/jbc.M109.040097	http://dx.doi.org/10.1074/jbc.M109.040097			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20223818	Green Published, hybrid			2022-12-25	WOS:000277715900019
J	Joly, N; Buck, M				Joly, Nicolas; Buck, Martin			Engineered Interfaces of an AAA(+) ATPase Reveal a New Nucleotide-dependent Coordination Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INCLUSION-BODY MYOPATHY; VALOSIN-CONTAINING PROTEIN; ENHANCER-BINDING PROTEINS; FRONTOTEMPORAL DEMENTIA; PAGET-DISEASE; RNA-POLYMERASE; PORE LOOPS; TRANSCRIPTION; ACTIVATOR; BONE	Homohexameric ring AAA(+) ATPases are found in all kingdoms of life and are involved in all cellular processes. To accommodate the large spectrum of substrates, the conserved AAA(+) core has become specialized through the insertion of specific substrate-binding motifs. Given their critical roles in cellular function, understanding the nucleotide-driven mechanisms of action is of wide importance. For one type of member AAA(+) protein (phage shock protein F, PspF), we identified and established the functional significance of strategically placed arginine and glutamate residues that form interacting pairs in response to nucleotide binding. We show that these interactions are critical for "cis" and "trans" subunit communication, which support coordination between subunits for nucleotide-dependent substrate remodeling. Using an allele-specific suppression approach for ATPase and substrate remodeling, we demonstrate that the targeted residues directly interact and are unlikely to make any other pairwise critical interactions. We then propose a mechanistic rationale by which the nucleotide-bound state of adjacent subunits can be sensed without direct involvement of R-finger residues. As the structural AAA(+) core is conserved, we propose that the functional networks established here could serve as a template to identify similar residue pairs in other AAA(+) proteins.	[Joly, Nicolas; Buck, Martin] Univ London Imperial Coll Sci Technol & Med, Div Biol, London SW7 2AZ, England	Imperial College London	Joly, N (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Biol, Sir Alexander Fleming Bldg,Exhibit Rd, London SW7 2AZ, England.	n.joly@imperial.ac.uk; m.buck@imperial.ac.uk	Joly, Nicolas/H-6851-2018	Joly, Nicolas/0000-0003-2731-3827	Biotechnology and Biological Sciences Research Council [BB/G001278/1]; BBSRC [BB/G001278/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D521922/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council Grant BB/G001278/1.	Augustin S, 2009, MOL CELL, V35, P574, DOI 10.1016/j.molcel.2009.07.018; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Bochman ML, 2008, MOL CELL, V31, P287, DOI 10.1016/j.molcel.2008.05.020; Bordes P, 2003, P NATL ACAD SCI USA, V100, P2278, DOI 10.1073/pnas.0537525100; Bose D, 2008, MOL CELL, V32, P337, DOI 10.1016/j.molcel.2008.09.015; Briggs LC, 2008, J BIOL CHEM, V283, P13745, DOI 10.1074/jbc.M709632200; Burrows PC, 2009, MOL MICROBIOL, V73, P519, DOI 10.1111/j.1365-2958.2009.06744.x; Cannon WV, 2000, NAT STRUCT BIOL, V7, P594; Chaney M, 2001, GENE DEV, V15, P2282, DOI 10.1101/gad.205501; Darwin AJ, 2005, MOL MICROBIOL, V57, P621, DOI 10.1111/j.1365-2958.2005.04694.x; Forsburg SL, 2004, MICROBIOL MOL BIOL R, V68, P109, DOI 10.1128/MMBR.68.1.109-131.2004; Greenleaf WB, 2008, J VIROL, V82, P6017, DOI 10.1128/JVI.00387-08; Guinto JB, 2007, ACTA NEUROPATHOL, V114, P55, DOI 10.1007/s00401-007-0224-7; Iyer LM, 2004, J STRUCT BIOL, V146, P11, DOI 10.1016/j.jsb.2003.10.010; Joly N, 2008, J BIOL CHEM, V283, P13725, DOI 10.1074/jbc.M800801200; Joly N, 2006, J BIOL CHEM, V281, P34997, DOI 10.1074/jbc.M606628200; Kim TK, 2000, SCIENCE, V288, P1418, DOI 10.1126/science.288.5470.1418; Kimonis VE, 2005, ALZ DIS ASSOC DIS, V19, pS44, DOI 10.1097/01.wad.0000183081.76820.5a; Konakova M, 2005, J MOL NEUROSCI, V25, P105, DOI 10.1385/JMN:25:1:105; Lin YC, 2005, NAT STRUCT MOL BIOL, V12, P603, DOI 10.1038/nsmb949; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Martin A, 2005, NATURE, V437, P1115, DOI 10.1038/nature04031; Martin A, 2008, NAT STRUCT MOL BIOL, V15, P1147, DOI 10.1038/nsmb.1503; Martin A, 2008, MOL CELL, V29, P441, DOI 10.1016/j.molcel.2008.02.002; Moreau MJ, 2007, MOL CELL, V28, P304, DOI 10.1016/j.molcel.2007.08.013; Mott ML, 2008, CELL, V135, P623, DOI 10.1016/j.cell.2008.09.058; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; Ogura T, 2008, BIOCHEM SOC T, V36, P68, DOI 10.1042/BST0360068; Rappas M, 2006, J MOL BIOL, V357, P481, DOI 10.1016/j.jmb.2005.12.052; Rappas M, 2005, SCIENCE, V307, P1972, DOI 10.1126/science.1105932; Rappas M, 2007, CURR OPIN STRUC BIOL, V17, P110, DOI 10.1016/j.sbi.2006.11.002; Watts GDJ, 2007, CLIN GENET, V72, P420, DOI 10.1111/j.1399-0004.2007.00887.x; Watts GDJ, 2005, HUM GENET, V118, P508, DOI 10.1007/s00439-005-0075-z; Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332; Weihl CC, 2006, HUM MOL GENET, V15, P189, DOI 10.1093/hmg/ddi426; Wigneshweraraj SR, 2003, METHOD ENZYMOL, V370, P646; Zhang X, 2002, MOL MICROBIOL, V45, P895, DOI 10.1046/j.1365-2958.2002.03065.x; Zhang XD, 2008, NAT STRUCT MOL BIOL, V15, P1223, DOI 10.1038/nsmb.1501; Zou JX, 2009, CANCER RES, V69, P3339, DOI 10.1158/0008-5472.CAN-08-3440	40	16	16	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15178	15186		10.1074/jbc.M110.103150	http://dx.doi.org/10.1074/jbc.M110.103150			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20197281	Green Published, hybrid			2022-12-25	WOS:000277399000039
J	Yan, WS; Chen, XB				Yan, Wensheng; Chen, Xinbin			Characterization of Functional Domains Necessary for Mutant p53 Gain of Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LI-FRAUMENI-SYNDROME; WILD-TYPE P53; GENE-EXPRESSION; P53-MEDIATED APOPTOSIS; FAMILY PROTEINS; TERMINAL DOMAIN; TARGET GENES; ACTIVATION; CELLS; IDENTIFICATION	Tumor cells, including SW480 carcinoma cells that carry a mutant p53, are addicted to the mutant for their survival and resistance to growth suppression by chemotherapeutic agents. Here, we investigated whether various classes of p53 mutants share a common property and functional domains necessary for mutant p53 gain of function. To test this, we generated SW480 cell lines in which endogenous mutant R273H/P309S can be inducibly or stably knocked down, whereas a small interfering RNA-resistant mutant p53 along with a mutated functional domain can be inducibly or stably expressed. We found that both contact-site (R248W and R273H) and conformation (G245S and R249S) mutants are able to maintain the transformed phenotypes of SW480 cells conferred by endogenous mutant p53. We also found that activation domains 1-2 and the proline-rich domain are required for mutant p53 gain of function. Interestingly, we showed that the C-terminal basic domain, which is required for wild-type p53 activity, is an inhibitory domain for mutant p53. Furthermore, we showed that deletion of the basic domain enhances, whereas a mutation in activation domains 1-2 and deletion of the proline-rich domain abolish mutant p53 to regulate Gro1 and Id2, both of which are regulated by and mediate endogenous mutant p53 gain of function. These results indicate that both conformation and contact-site mutants share a property for cell transformation, and the domains critical for wild-type p53 tumor suppression are also required for mutant p53 tumor promotion. Thus, the inhibitory basic domain and the common property for p53 mutants can be explored for targeting tumors with mutant p53.	[Yan, Wensheng; Chen, Xinbin] Univ Calif Davis, Comparat Canc Ctr, Davis, CA 95616 USA	University of California System; University of California Davis	Chen, XB (corresponding author), Univ Calif Davis, Comparat Canc Ctr, Davis, CA 95616 USA.	xbchen@ucdavis.edu			National Institutes of Health [CA121137]; NATIONAL CANCER INSTITUTE [R01CA121137] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Institutes of Health Grant CA121137 (to X. C.).	Baptiste-Okoh N, 2008, P NATL ACAD SCI USA, V105, P1937, DOI 10.1073/pnas.0711800105; Bossi G, 2006, ONCOGENE, V25, P304, DOI 10.1038/sj.onc.1209026; Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; Brosh R, 2009, NAT REV CANCER, V9, P701, DOI 10.1038/nrc2693; Candau R, 1997, ONCOGENE, V15, P807, DOI 10.1038/sj.onc.1201244; Chen XB, 1996, GENE DEV, V10, P2438, DOI 10.1101/gad.10.19.2438; Donehower LA, 2009, NAT REV CANCER, V9, P830, DOI 10.1038/nrc2731; Frazier MW, 1998, MOL CELL BIOL, V18, P3735, DOI 10.1128/MCB.18.7.3735; Gaidarenko O, 2009, ONCOGENE, V28, P4397, DOI 10.1038/onc.2009.290; Hammond EM, 2006, MOL CELL BIOL, V26, P3492, DOI 10.1128/MCB.26.9.3492-3504.2006; Harms KL, 2006, CELL DEATH DIFFER, V13, P890, DOI 10.1038/sj.cdd.4401904; Harms KL, 2005, MOL CELL BIOL, V25, P2014, DOI 10.1128/MCB.25.5.2014-2030.2005; HAUPT Y, 1995, GENE DEV, V9, P2170, DOI 10.1101/gad.9.17.2170; Irwin MS, 2003, CANCER CELL, V3, P403, DOI 10.1016/S1535-6108(03)00078-3; Johnson TM, 2006, CELL DEATH DIFFER, V13, P902, DOI 10.1038/sj.cdd.4401902; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; LIN JY, 1995, ONCOGENE, V10, P2387; Liu G, 2006, MOL CELL BIOL, V26, P1398, DOI 10.1128/MCB.26.4.1398-1413.2006; Matas D, 2001, EMBO J, V20, P4163, DOI 10.1093/emboj/20.15.4163; MILNER J, 1991, CELL, V65, P765, DOI 10.1016/0092-8674(91)90384-B; Nister M, 2005, ONCOGENE, V24, P3563, DOI 10.1038/sj.onc.1208354; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Scian MJ, 2005, MOL CELL BIOL, V25, P10097, DOI 10.1128/MCB.25.22.10097-10110.2005; Slatter TL, 2010, CELL DEATH DIFFER, V17, P540, DOI 10.1038/cdd.2009.136; Toledo F, 2006, CANCER CELL, V9, P273, DOI 10.1016/j.ccr.2006.03.014; Venot C, 1998, EMBO J, V17, P4668, DOI 10.1093/emboj/17.16.4668; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Walker KK, 1996, P NATL ACAD SCI USA, V93, P15335, DOI 10.1073/pnas.93.26.15335; Willis A, 2004, ONCOGENE, V23, P2330, DOI 10.1038/sj.onc.1207396; Yan WS, 2008, CANCER RES, V68, P6789, DOI 10.1158/0008-5472.CAN-08-0810; Yan WS, 2007, CANCER RES, V67, P9117, DOI 10.1158/0008-5472.CAN-07-0996; Yan WS, 2009, J BIOL CHEM, V284, P12178, DOI 10.1074/jbc.M900994200; Yap DBS, 2004, CANCER RES, V64, P4749, DOI 10.1158/0008-5472.CAN-1305-2; Zalcenstein A, 2003, ONCOGENE, V22, P5667, DOI 10.1038/sj.onc.1206724; Zhu JH, 1998, J BIOL CHEM, V273, P13030, DOI 10.1074/jbc.273.21.13030; Zhu JH, 2000, J BIOL CHEM, V275, P39927, DOI 10.1074/jbc.M005676200; Zhu JH, 1999, ONCOGENE, V18, P2149, DOI 10.1038/sj.onc.1202533	39	25	28	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14229	14238		10.1074/jbc.M109.097253	http://dx.doi.org/10.1074/jbc.M109.097253			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20212049	Green Published, hybrid			2022-12-25	WOS:000277299700019
J	Luo, P; Yang, X; Ying, M; Chaudhry, P; Wang, A; Shimada, H; May, WA; Adams, GB; Mock, D; Triche, TJ; He, Q; Wu, L				Luo, P.; Yang, X.; Ying, M.; Chaudhry, P.; Wang, A.; Shimada, H.; May, W. A.; Adams, G. B.; Mock, D.; Triche, T. J.; He, Q.; Wu, L.			Retinoid-suppressed phosphorylation of RAR alpha mediates the differentiation pathway of osteosarcoma cells	ONCOGENE			English	Article						RA response pathways; decreased CAK phosphorylation of RAR alpha; cell-cycle G(1) exit; RA-RAR alpha-FGF8f signaling; transcriptional expression of RA target genes	KINASE-ACTIVATING KINASE; ACID RECEPTOR-ALPHA; FGF SIGNALING PATHWAYS; IN-VITRO; HUMAN OSTEOBLASTS; TRANSCRIPTION FACTOR; GENE-EXPRESSION; GROWTH-FACTOR; CYCLE CONTROL; TARGET GENES	Although retinoic acid (RA) is a potent agent that coordinates inhibition of proliferation with differentiation of many cell types, RA-mediated signaling pathways in osteosarcoma cell differentiation are uncharacterized. In this study, we show that in human U2OS osteosarcoma cells, decreased phosphorylation of RA receptor alpha (RAR alpha) by RA treatment or overexpressing a phosphorylation- defective mutant RAR alpha S77A results in the inhibition of proliferation and induction of differentiation, and that U2OS cells transduced with RAR alpha S77A suppresses tumor formation in nude mice. Moreover, using different human primary osteosarcoma cells and human mesenchymal stem cells for gene expression analysis, we found that either RA or RAR alpha S77A induces many of the same differentiation response pathways and signaling molecules involved in U2OS cell differentiation. In addition, overexpression of the fibroblast growth factor 8f (FGF8f), one of the downstream targets induced by both RA and RAR alpha S77A in U2OS cells, inhibits proliferation and induces expression of osteoblastic differentiation regulators. Hence, these data strongly suggest that RA-suppressed phosphorylation of RAR alpha induces FGF8f expression to mediate differentiation response pathway in U2OS osteosarcoma cells. Oncogene (2010) 29, 2772-2783; doi: 10.1038/onc.2010.50; published online 1 March 2010	[Wu, L.] Univ So Calif, Dept Pathol, Childrens Hosp Los Angeles, Keck Sch Med, Los Angeles, CA 90027 USA; [Luo, P.; Yang, X.; Ying, M.; Chaudhry, P.; Wang, A.; Shimada, H.; Mock, D.; Triche, T. J.; Wu, L.] Childrens Hosp Los Angeles, Dept Pathol, Saban Res Inst, Los Angeles, CA 90027 USA; [May, W. A.] Childrens Hosp Los Angeles, Dept Pediat, Saban Res Inst, Los Angeles, CA 90027 USA; [Adams, G. B.] Univ So Calif, Keck Sch Med, Ctr Stem Cell & Regenerat Med, Los Angeles, CA 90027 USA; [He, Q.] Zhejiang Univ, Inst Pharmacol & Toxicol, Sch Pharmaceut Sci, Hangzhou 310003, Zhejiang, Peoples R China	Children's Hospital Los Angeles; University of Southern California; Children's Hospital Los Angeles; Children's Hospital Los Angeles; University of Southern California; Zhejiang University	Wu, L (corresponding author), Univ So Calif, Dept Pathol, Childrens Hosp Los Angeles, Keck Sch Med, MS 103,4650 Sunset Blvd, Los Angeles, CA 90027 USA.	lingtaow@usc.edu	he, qiaojun/F-3198-2010; Chaudhry, Parvesh/I-4417-2015		National Institutes of Health [R21 CA111440, R01 CA120512, 1 UO1 CA114757-01]; NATIONAL CANCER INSTITUTE [R21CA111440, U01CA114757, R21CA137485, R01CA120512] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by Grants from the National Institutes of Health R21 CA111440 and R01 CA120512 to L Wu, and 1 UO1 CA114757-01 to TJ Triche.	Aranda A, 2001, PHYSIOL REV, V81, P1269, DOI 10.1152/physrev.2001.81.3.1269; Bacci G, 2001, EUR J CANCER, V37, P32, DOI 10.1016/S0959-8049(00)00361-0; Barroga E, 1999, J VET MED A, V46, P573, DOI 10.1046/j.1439-0442.1999.00251.x; Barroga EF, 2000, VET J, V159, P186, DOI 10.1053/tvjl.1999.0441; Bastien J, 2004, GENE, V328, P1, DOI 10.1016/j.gene.2003.12.005; BEERE HM, 1993, ANTI-CANCER DRUG DES, V8, P299; BENAYAHU D, 1994, J CELL BIOCHEM, V56, P62, DOI 10.1002/jcb.240560111; Brondani V, 2000, BIOCHEM BIOPH RES CO, V272, P98, DOI 10.1006/bbrc.2000.2740; Brondani V, 2002, J MOL BIOL, V319, P715, DOI 10.1016/S0022-2836(02)00376-5; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Clark JCM, 2008, J CANCER RES CLIN, V134, P281, DOI 10.1007/s00432-007-0330-x; Crowe David L, 2002, Cancer Cell Int, V2, P15, DOI 10.1186/1475-2867-2-15; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; Fisher RP, 2005, J CELL SCI, V118, P5171, DOI 10.1242/jcs.02718; FISHER RP, 1994, CELL, V78, P713, DOI 10.1016/0092-8674(94)90535-5; Franceschi RT, 2003, J CELL BIOCHEM, V88, P446, DOI 10.1002/jcb.10369; GAZIT D, 1993, MOL ENDOCRINOL, V7, P189, DOI 10.1210/me.7.2.189; Gemel J, 1996, GENOMICS, V35, P253, DOI 10.1006/geno.1996.0349; He QJ, 2004, FASEB J, V18, P1734, DOI 10.1096/fj.04-2182fje; Hoffman UM, 2003, J BONE JOINT SURG AM, V85A, P124, DOI 10.2106/00004623-200300002-00017; Hong SH, 2000, RES VET SCI, V68, P57, DOI 10.1053/rvsc.1999.0338; Hong SH, 2000, AM J VET RES, V61, P69, DOI 10.2460/ajvr.2000.61.69; Horowitz MC, 2005, IMMUNOL REV, V208, P141, DOI 10.1111/j.0105-2896.2005.00328.x; Jackson RA, 2006, GENE, V379, P79, DOI 10.1016/j.gene.2006.04.028; Jacobson A, 2004, BIOCHEM BIOPH RES CO, V322, P162, DOI 10.1016/j.bbrc.2004.07.092; Katoh M, 2006, CANCER BIOL THER, V5, P1059, DOI 10.4161/cbt.5.9.3151; LEROY P, 1991, EMBO J, V10, P59, DOI 10.1002/j.1460-2075.1991.tb07921.x; Li ZX, 2006, TRENDS BIOCHEM SCI, V31, P589, DOI 10.1016/j.tibs.2006.08.001; Liu F, 2008, CELL SIGNAL, V20, P999, DOI 10.1016/j.cellsig.2007.11.011; Luo PH, 2007, STEM CELLS, V25, P2628, DOI 10.1634/stemcells.2007-0264; MANGELSDORF DJ, 1991, CELL, V66, P555, DOI 10.1016/0092-8674(81)90018-0; Mattila MA, 2007, CYTOKINE GROWTH F R, V18, P257, DOI 10.1016/j.cytogfr.2007.04.010; Mayack SR, 2008, BLOOD, V112, P519, DOI 10.1182/blood-2008-01-133710; Melnick A, 1999, BLOOD, V93, P3167, DOI 10.1182/blood.V93.10.3167.410k44_3167_3215; Nigg EA, 1996, CURR OPIN CELL BIOL, V8, P312, DOI 10.1016/S0955-0674(96)80003-2; Orimo H, 2005, BONE, V36, P866, DOI 10.1016/j.bone.2005.02.010; Ornitz DM, 2002, GENE DEV, V16, P1446, DOI 10.1101/gad.990702; Rochette-Egly C, 2000, MOL ENDOCRINOL, V14, P1398, DOI 10.1210/me.14.9.1398; RochetteEgly C, 1997, CELL, V90, P97, DOI 10.1016/S0092-8674(00)80317-7; SONG LN, 1994, ONCOL RES, V6, P111; Studzinski GP, 1999, INT REV CYTOL, V189, P1, DOI 10.1016/S0074-7696(08)61384-4; Taichman RS, 1996, BLOOD, V87, P518, DOI 10.1182/blood.V87.2.518.bloodjournal872518; TAICHMAN RS, 1994, J EXP MED, V179, P1677, DOI 10.1084/jem.179.5.1677; Taneja R, 1997, EMBO J, V16, P6452, DOI 10.1093/emboj/16.21.6452; TASSAN JP, 1995, EMBO J, V14, P5608, DOI 10.1002/j.1460-2075.1995.tb00248.x; Thomas D, 2006, J CELL BIOCHEM, V98, P757, DOI 10.1002/jcb.20850; TRAIANEDES K, 1993, J CELL PHYSIOL, V157, P243, DOI 10.1002/jcp.1041570206; WANG A, 2009, FASEB J; Wang JG, 2006, FASEB J, V20, P2142, DOI 10.1096/fj.06-5900fje; Wang JW, 2002, J BIOL CHEM, V277, P43369, DOI 10.1074/jbc.M206792200; Wang XD, 2005, ALCOHOL, V35, P251, DOI 10.1016/j.alcohol.2005.04.006; Wu LT, 2001, MOL CELL BIOL, V21, P260, DOI 10.1128/MCB.21.1.260-270.2001; WU LT, 1994, ONCOGENE, V9, P2089; Zhang SN, 2004, CANCER RES, V64, P2977, DOI 10.1158/0008-5472.CAN-03-4018; ZHANG XK, 1992, NATURE, V358, P587, DOI 10.1038/358587a0; Zhu L, 2001, CURR OPIN GENET DEV, V11, P91, DOI 10.1016/S0959-437X(00)00162-3	57	30	32	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2010	29	19					2772	2783		10.1038/onc.2010.50	http://dx.doi.org/10.1038/onc.2010.50			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	595DW	20190807				2022-12-25	WOS:000277591900003
J	Zhang, P; Yang, Y; Nolo, R; Zweidler-McKay, PA; Hughes, DPM				Zhang, P.; Yang, Y.; Nolo, R.; Zweidler-McKay, P. A.; Hughes, D. P. M.			Regulation of NOTCH signaling by reciprocal inhibition of HES1 and Deltex 1 and its role in osteosarcoma invasiveness	ONCOGENE			English	Article						NOTCH; HES1; Deltex1(DTX1); osteosarcoma; invasion	UBIQUITIN LIGASE; CELL; ACTIVATION; RECEPTOR; SUPPRESSOR; REPRESSION; PROMOTER; PATHWAY; DOMAIN	The highly conserved NOTCH signaling pathway has many essential functions in the development of diverse cells, tissues and organs from Drosophila to humans, and dysregulated NOTCH signaling contributes to several disorders, including vascular and bone defects, as well as several cancers. Here we describe a novel mechanism of NOTCH regulation by reciprocal inhibition of two NOTCH downstream effectors: Deltex1 and HES1. This mechanism appears to regulate invasion of osteosarcoma cells, as Deltex1 blocks osteosarcoma invasiveness by downregulating NOTCH/HES1 signaling. The inhibitory effect of endogenous Deltex1 on NOTCH signaling is mediated through binding with the intracellular domain of NOTCH and ubiquitination and degradation of NOTCH receptors. Conversely, we show that the NOTCH target gene HES1 causes transcriptional inhibition of Deltex1 by directly binding to the promoter of Deltex1. An HES1 binding site is identified 400 bp upstream of the transcription start site of Deltex1. HES1-mediated repression of Deltex1 requires the C-terminal H3/H4 and WRPW domains of HES1, which associate with the TLE/Groucho corepressors. Taken together, we define a molecular mechanism regulating NOTCH signaling by reciprocal inhibition of the NOTCH target genes HES1 and Deltex1 in mammalian cells. This mechanism may have important clinical implications for targeting NOTCH signaling in osteosarcoma and other cancers. Oncogene (2010) 29, 2916-2926; doi:10.1038/onc.2010.62; published online 8 March 2010	[Zhang, P.; Yang, Y.; Nolo, R.; Zweidler-McKay, P. A.; Hughes, D. P. M.] Univ Texas MD Anderson Canc Ctr, Dept Pediat Res, Childrens Canc Hosp, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Hughes, DPM (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Pediat Res, Childrens Canc Hosp, 1515 Holcombe Blvd, Houston, TX 77030 USA.	dphughes@mdanderson.org		Zweidler-McKay, Patrick/0000-0001-6621-523X	UT MD Anderson Cancer Center; NIH [K08CA118730-04]; Jori Zemel Children's Bone Cancer Foundation; Hope Street Kids Foundation; NATIONAL CANCER INSTITUTE [K08CA118730] Funding Source: NIH RePORTER	UT MD Anderson Cancer Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jori Zemel Children's Bone Cancer Foundation; Hope Street Kids Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Tetsuo Sudo, Dr Anders Strom and Dr Iannis Aifantis for providing reagents, and to Dr Shufang Jia and Dr Wendy Fang for technical assistance. This work was supported by Physician Scientist Awards from UT MD Anderson Cancer Center to Dr D Hughes and Dr P Zweidler-McKay and by NIH Grant K08CA118730-04 to Dr Dennis Hughes. Dr P Zhang was supported by the Jori Zemel Children's Bone Cancer Foundation (www.JoriZemel.com) and Hope Street Kids Foundation (www.hopestreetkids.org).	Allenspach EJ, 2002, CANCER BIOL THER, V1, P466, DOI 10.4161/cbt.1.5.159; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Axelson H, 2004, CANCER LETT, V204, P171, DOI 10.1016/S0304-3835(03)00453-1; Castella P, 2000, MOL CELL BIOL, V20, P6170, DOI 10.1128/MCB.20.16.6170-6183.2000; Chen YY, 1997, J BIOL CHEM, V272, P14110, DOI 10.1074/jbc.272.22.14110; Cinnamon E, 2008, CURR OPIN GENET DEV, V18, P435, DOI 10.1016/j.gde.2008.07.010; Fortini ME, 2002, NAT REV MOL CELL BIO, V3, P673, DOI 10.1038/nrm910; Hori K, 2004, DEVELOPMENT, V131, P5527, DOI 10.1242/dev.01448; Hughes DPM, 2004, CANCER RES, V64, P2047, DOI 10.1158/0008-5472.CAN-03-3096; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Itoh M, 2003, DEV CELL, V4, P67, DOI 10.1016/S1534-5807(02)00409-4; Izon DJ, 2002, IMMUNITY, V16, P231, DOI 10.1016/S1074-7613(02)00271-6; Jackson PK, 2000, TRENDS CELL BIOL, V10, P429, DOI 10.1016/S0962-8924(00)01834-1; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Liu WH, 2005, MOL CELL BIOL, V25, P1367, DOI 10.1128/MCB.25.4.1367-1378.2005; Matsuno K, 2002, DEVELOPMENT, V129, P1049; Matsuno K, 1998, NAT GENET, V19, P74, DOI 10.1038/ng0598-74; Mukherjee A, 2005, NAT CELL BIOL, V7, P1191, DOI 10.1038/ncb1327; Radtke F, 2003, NAT REV CANCER, V3, P756, DOI 10.1038/nrc1186; Sestan N, 1999, SCIENCE, V286, P741, DOI 10.1126/science.286.5440.741; Struhl G, 1998, CELL, V93, P649, DOI 10.1016/S0092-8674(00)81193-9; TAKEBAYASHI K, 1994, J BIOL CHEM, V269, P5150; Thompson BJ, 2008, J EXP MED, V205, P1395, DOI 10.1084/jem.20080277; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Wilkin M, 2008, DEV CELL, V15, P762, DOI 10.1016/j.devcel.2008.09.002; Wu GY, 2001, MOL CELL BIOL, V21, P7403, DOI 10.1128/MCB.21.21.7403-7415.2001; Zhang PY, 2008, CLIN CANCER RES, V14, P2962, DOI 10.1158/1078-0432.CCR-07-1992; Zweidler-McKay PA, 2005, BLOOD, V106, P3898, DOI 10.1182/blood-2005-01-0355; Zweidler-McKay PA, 2004, SEMIN CANCER BIOL, V14, P329, DOI 10.1016/j.semcancer.2004.04.012; Zweifel ME, 2005, STRUCTURE, V13, P1599, DOI 10.1016/j.str.2005.07.015	30	76	79	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2010	29	20					2916	2926		10.1038/onc.2010.62	http://dx.doi.org/10.1038/onc.2010.62			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	599DM	20208568	Green Accepted			2022-12-25	WOS:000277890400003
J	Krol, E; Mentzel, T; Chinchilla, D; Boller, T; Felix, G; Kemmerling, B; Postel, S; Arents, M; Jeworutzki, E; Al-Rasheid, KAS; Becker, D; Hedrich, R				Krol, Elzbieta; Mentzel, Tobias; Chinchilla, Delphine; Boller, Thomas; Felix, Georg; Kemmerling, Birgit; Postel, Sandra; Arents, Michael; Jeworutzki, Elena; Al-Rasheid, Khaled A. S.; Becker, Dirk; Hedrich, Rainer			Perception of the Arabidopsis Danger Signal Peptide 1 Involves the Pattern Recognition Receptor AtPEPR1 and Its Close Homologue AtPEPR2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPERSENSITIVE CELL-DEATH; DEFENSE RESPONSES; INNATE IMMUNITY; ABSCISIC-ACID; CALCIUM; CHANNEL; REGULATOR; ELICITORS; TRANSPORT; PATHWAYS	Plasma membrane-borne pattern recognition receptors, which recognize microbe-associated molecular patterns and endogenous damage-associated molecular patterns, provide the first line of defense in innate immunity. In plants, leucine-rich repeat receptor kinases fulfill this role, as exemplified by FLS2 and EFR, the receptors for the microbe-associated molecular patterns flagellin and elongation factor Tu. Here we examined the perception of the damage-associated molecular pattern peptide 1 (AtPep1), an endogenous peptide of Arabidopsis identified earlier and shown to be perceived by the leucine-rich repeat protein kinase PEPR1. Using seedling growth inhibition, elicitation of an oxidative burst and induction of ethylene biosynthesis, we show that wild type plants and the pepr1 and pepr2 mutants, affected in PEPR1 and in its homologue PEPR2, are sensitive to AtPep1, but that the double mutant pepr1/pepr2 is completely insensitive. As a central body of our study, we provide electrophysiological evidence that at the level of the plasma membrane, AtPep1 triggers a receptor-dependent transient depolarization through activation of plasma membrane anion channels, and that this effect is absent in the double mutant pepr1/pepr2. The double mutant also fails to respond to AtPep2 and AtPep3, two distant homologues of AtPep1 on the basis of homology screening, implying that the PEPR1 and PEPR2 are responsible for their perception too. Our findings provide a basic framework to study the biological role of AtPep1-related danger signals and their cognate receptors.	[Becker, Dirk] Univ Wurzburg, Julius von Sachs Inst Biosci Mol Plant Physi & Bi, Dept Mol Plant Physiol & Biophys, D-97082 Wurzburg, Germany; [Mentzel, Tobias; Chinchilla, Delphine; Boller, Thomas] Univ Basel, Inst Bot, Zuerich Basel Plant Sci Ctr, CH-4056 Basel, Switzerland; [Felix, Georg; Kemmerling, Birgit; Postel, Sandra] Univ Tubingen, Zentrum Mol Biol Pflanzen Plant Biochem, D-72076 Tubingen, Germany; [Al-Rasheid, Khaled A. S.] King Saud Univ, Coll Sci, Dept Zool, Riyadh 11451, Saudi Arabia; [Krol, Elzbieta] UMCS Lublin, Dept Biophys, Inst Biol, PL-20033 Lublin, Poland	University of Wurzburg; University of Basel; Eberhard Karls University of Tubingen; King Saud University; Maria Curie-Sklodowska University	Becker, D (corresponding author), Univ Wurzburg, Julius von Sachs Inst Biosci Mol Plant Physi & Bi, Dept Mol Plant Physiol & Biophys, D-97082 Wurzburg, Germany.	dbecker@botanik.uni-wuerzburg.de	Becker, Dirk/F-7826-2010; Hedrich, Rainer/G-8771-2011; AL-Rasheid, Khaled/C-2486-2008; Boller, Thomas/G-3500-2012	Hedrich, Rainer/0000-0003-3224-1362; AL-Rasheid, Khaled/0000-0002-3404-3397; Boller, Thomas/0000-0001-6768-7503; Becker, Dirk/0000-0003-0723-4160	Polish Ministry of Education [N N301 464534]; Swiss National Science Foundation; German Research Foundation Graduierten Kolleg [1342, SFB567]; Alexander von Humboldt Foundation	Polish Ministry of Education; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); German Research Foundation Graduierten Kolleg(German Research Foundation (DFG)); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation)	This work supported in part by Polish Ministry of Education Grant N N301 464534, the Swiss National Science Foundation, and German Research Foundation Graduierten Kolleg 1342 "Lipid Signalling" and SFB567.; Supported by the Alexander von Humboldt Foundation.	Ali R, 2007, PLANT CELL, V19, P1081, DOI 10.1105/tpc.106.045096; Batistic O, 2010, PLANT J, V61, P211, DOI 10.1111/j.1365-313X.2009.04045.x; Boller T, 2009, SCIENCE, V324, P742, DOI 10.1126/science.1171647; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Chinchilla D, 2007, NATURE, V448, P497, DOI 10.1038/nature05999; De Angeli A, 2009, PHILOS T R SOC B, V364, P195, DOI 10.1098/rstb.2008.0128; Genger RK, 2008, MOL PLANT MICROBE IN, V21, P1285, DOI 10.1094/MPMI-21-10-1285; Hedrich R, 2006, PLANTA, V224, P725, DOI 10.1007/s00425-006-0341-x; Hrabak EM, 2003, PLANT PHYSIOL, V132, P666, DOI 10.1104/pp.102.011999; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Huffaker A, 2006, P NATL ACAD SCI USA, V103, P10098, DOI 10.1073/pnas.0603727103; Jeworutzki E, 2010, PLANT J, V62, P367, DOI 10.1111/j.1365-313X.2010.04155.x; Klusener B, 2002, PLANT PHYSIOL, V130, P2152, DOI 10.1104/pp.012187; Knight H, 1996, PLANT CELL, V8, P489, DOI 10.1105/tpc.8.3.489; Kovermann P, 2007, PLANT J, V52, P1169, DOI 10.1111/j.1365-313X.2007.03367.x; Kurusu T, 2005, PLANT J, V42, P798, DOI 10.1111/j.1365-313X.2005.02415.x; Kwak JM, 2003, EMBO J, V22, P2623, DOI 10.1093/emboj/cdg277; Lecourieux D, 2006, NEW PHYTOL, V171, P249, DOI 10.1111/j.1469-8137.2006.01777.x; Negi J, 2008, NATURE, V452, P483, DOI 10.1038/nature06720; Pearce G, 2001, NATURE, V411, P817, DOI 10.1038/35081107; Pei ZM, 2000, NATURE, V406, P731, DOI 10.1038/35021067; Postel S, 2010, EUR J CELL BIOL, V89, P169, DOI 10.1016/j.ejcb.2009.11.001; Ranf S, 2008, PLANT J, V53, P287, DOI 10.1111/j.1365-313X.2007.03342.x; Ryan CA, 2003, P NATL ACAD SCI USA, V100, P14577, DOI 10.1073/pnas.1934788100; Ryan CA, 2007, CELL MICROBIOL, V9, P1902, DOI 10.1111/j.1462-5822.2007.00991.x; Schulze B, 2010, J BIOL CHEM, V285, P9444, DOI 10.1074/jbc.M109.096842; Torres MA, 2002, P NATL ACAD SCI USA, V99, P517, DOI 10.1073/pnas.012452499; Vahisalu T, 2008, NATURE, V452, P487, DOI 10.1038/nature06608; Van Wees SCM, 2008, CURR OPIN PLANT BIOL, V11, P443, DOI 10.1016/j.pbi.2008.05.005; Ward JM, 2009, ANNU REV PHYSIOL, V71, P59, DOI 10.1146/annurev.physiol.010908.163204; Wendehenne D, 2002, PLANT CELL, V14, P1937, DOI 10.1105/tpc.002295; Yamaguchi Y, 2006, P NATL ACAD SCI USA, V103, P10104, DOI 10.1073/pnas.0603729103; Yamaguchi Y, 2010, PLANT CELL, V22, P508, DOI 10.1105/tpc.109.068874; Zipfel C, 2009, CURR OPIN PLANT BIOL, V12, P414, DOI 10.1016/j.pbi.2009.06.003	34	250	262	3	78	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13471	13479		10.1074/jbc.M109.097394	http://dx.doi.org/10.1074/jbc.M109.097394			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20200150	hybrid, Green Published			2022-12-25	WOS:000276987700019
J	Hou, YB; Zhang, H; Miranda, L; Lin, SJ				Hou, Yubo; Zhang, Huan; Miranda, Lilibeth; Lin, Senjie			Serious Overestimation in Quantitative PCR by Circular (Supercoiled) Plasmid Standard: Microalgal pcna as the Model Gene	PLOS ONE			English	Article							REAL-TIME PCR; RT-PCR; PFIESTERIA-PISCICIDA; QUANTIFICATION; VALIDATION; EXPRESSION; EFFICIENCY	Quantitative real-time PCR (qPCR) has become a gold standard for the quantification of nucleic acids and microorganism abundances, in which plasmid DNA carrying the target genes are most commonly used as the standard. A recent study showed that supercoiled circular confirmation of DNA appeared to suppress PCR amplification. However, to what extent to which different structural types of DNA (circular versus linear) used as the standard may affect the quantification accuracy has not been evaluated. In this study, we quantitatively compared qPCR accuracies based on circular plasmid (mostly in supercoiled form) and linear DNA standards (linearized plasmid DNA or PCR amplicons), using proliferating cell nuclear gene (pcna), the ubiquitous eukaryotic gene, in five marine microalgae as a model gene. We observed that PCR using circular plasmids as template gave 2.65-4.38 more of the threshold cycle number than did equimolar linear standards. While the documented genome sequence of the diatom Thalassiosira pseudonana shows a single copy of pcna, qPCR using the circular plasmid as standard yielded an estimate of 7.77 copies of pcna per genome whereas that using the linear standard gave 1.02 copies per genome. We conclude that circular plasmid DNA is unsuitable as a standard, and linear DNA should be used instead, in absolute qPCR. The serious overestimation by the circular plasmid standard is likely due to the undetected lower efficiency of its amplification in the early stage of PCR when the supercoiled plasmid is the dominant template.	[Hou, Yubo; Zhang, Huan; Miranda, Lilibeth; Lin, Senjie] Univ Connecticut, Dept Marine Sci, Groton, CT 06340 USA	University of Connecticut	Hou, YB (corresponding author), New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12237 USA.	yhou@wadsworth.org	Guo, chentao/G-7320-2016; zhang, yaqun/J-8478-2014; Lin, Senjie/A-7466-2011		National Science Foundation [OCE0452780]; National Oceanic and Atmospheric Administration Ecology and Oceanography of Harmful Algal Blooms [NA05NOS4781196]	National Science Foundation(National Science Foundation (NSF)); National Oceanic and Atmospheric Administration Ecology and Oceanography of Harmful Algal Blooms	The work was supported by the National Science Foundation Grant OCE0452780 (to S.L.) and National Oceanic and Atmospheric Administration Ecology and Oceanography of Harmful Algal Blooms Grant NA05NOS4781196 ( to S.L. and H.Z.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Chen J, 2007, NUCLEIC ACIDS RES, V35, P1377, DOI 10.1093/nar/gkm010; Cooke JR, 2004, J BIOTECHNOL, V114, P239, DOI 10.1016/j.jbiotec.2004.06.011; Freeman WM, 1999, BIOTECHNIQUES, V26, P112, DOI 10.2144/99261rv01; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Kibbe WA, 2007, NUCLEIC ACIDS RES, V35, pW43, DOI 10.1093/nar/gkm234; Klein D, 2002, TRENDS MOL MED, V8, P257, DOI 10.1016/S1471-4914(02)02355-9; Lin SJ, 2003, APPL ENVIRON MICROB, V69, P343, DOI 10.1128/AEM.69.1.343-349.2003; Lin SJ, 2002, J MOL BIOL, V320, P727, DOI 10.1016/S0022-2836(02)00468-0; Liu WH, 2002, BIOCHEM BIOPH RES CO, V294, P347, DOI 10.1016/S0006-291X(02)00478-3; Nogva HK, 2004, BIOTECHNIQUES, V37, P246, DOI 10.2144/04372RR01; Pielberg G, 2003, GENOME RES, V13, P2171, DOI 10.1101/gr.1188203; Rajeevan MS, 2001, J MOL DIAGN, V3, P26, DOI 10.1016/S1525-1578(10)60646-0; Tichopad A, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng122; Wong ML, 2005, BIOTECHNIQUES, V39, P75, DOI 10.2144/05391RV01; Yuan JS, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S7-S6; Yuan Joshua S., 2008, Biotechnology Journal, V3, P112, DOI 10.1002/biot.200700169; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85; Zhang H, 2006, J EUKARYOT MICROBIOL, V53, P142, DOI 10.1111/j.1550-7408.2005.00085.x; Zhang H, 2005, APPL ENVIRON MICROB, V71, P7053, DOI 10.1128/AEM.71.11.7053-7063.2005; Zhang H, 2007, P NATL ACAD SCI USA, V104, P4618, DOI 10.1073/pnas.0700258104	23	173	176	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2010	5	3							e9545	10.1371/journal.pone.0009545	http://dx.doi.org/10.1371/journal.pone.0009545			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	564EX	20221433	Green Published, gold, Green Submitted			2022-12-25	WOS:000275197200007
J	Zhu, J; Braun, EL; Kohno, S; Antenos, M; Xu, EY; Cook, RW; Lin, SJ; Moore, BC; Guillette, LJ; Jardetzky, TS; Woodruff, TK				Zhu, Jie; Braun, Edward L.; Kohno, Satomi; Antenos, Monica; Xu, Eugene Y.; Cook, Robert W.; Lin, S. Jack; Moore, Brandon C.; Guillette, Louis J., Jr.; Jardetzky, Theodore S.; Woodruff, Teresa K.			Phylogenomic Analyses Reveal the Evolutionary Origin of the Inhibin alpha-Subunit, a Unique TGF beta Superfamily Antagonist	PLOS ONE			English	Article							FOLLICLE-STIMULATING-HORMONE; ACTIVIN-A; POSITIVE SELECTION; GENOME DUPLICATION; GRANULOSA-CELLS; GENE-EXPRESSION; FEMALE RAT; 2 ROUNDS; PROTEINS; VERTEBRATE	Transforming growth factor-beta (TGF beta) homologues form a diverse superfamily that arose early in animal evolution and control cellular function through membrane-spanning, conserved serine-threonine kinases (RII and RI receptors). Activin and inhibin are related dimers within the TGF beta superfamily that share a common beta-subunit. The evolution of the inhibin alpha-subunit created the only antagonist within the TGF beta superfamily and the only member known to act as an endocrine hormone. This hormone introduced a new level of complexity and control to vertebrate reproductive function. The novel functions of the inhibin alpha-subunit appear to reflect specific insertion-deletion changes within the inhibin b-subunit that occurred during evolution. Using phylogenomic analysis, we correlated specific insertions with the acquisition of distinct functions that underlie the phenotypic complexity of vertebrate reproductive processes. This phylogenomic approach presents a new way of understanding the structure-function relationships between inhibin, activin, and the larger TGFb superfamily.	[Zhu, Jie; Antenos, Monica; Xu, Eugene Y.; Cook, Robert W.; Woodruff, Teresa K.] Northwestern Univ, Feinberg Sch Med, Dept Obstet & Gynecol, Chicago, IL 60611 USA; [Braun, Edward L.; Kohno, Satomi; Moore, Brandon C.; Guillette, Louis J., Jr.] Univ Florida, Dept Biol, Gainesville, FL USA; [Lin, S. Jack; Jardetzky, Theodore S.] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA	Northwestern University; Feinberg School of Medicine; State University System of Florida; University of Florida; Stanford University	Zhu, J (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Obstet & Gynecol, Chicago, IL 60611 USA.	tkw@northwestern.edu	Antenos, Monica/J-8985-2017	Antenos, Monica/0000-0001-6350-2911; Kohno, Satomi/0000-0001-6184-3616; Braun, Edward/0000-0003-1643-5212; Woodruff, Teresa/0000-0002-1197-3399; Xu, Eugene/0000-0002-4344-6606	National Institutes of Health [R01HD37096, R21ES014053]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD037096] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES014053] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by grant numbers R01HD37096 and R21ES014053 from the National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abbasi AA, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-239; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Antenos M, 2007, MOL ENDOCRINOL, V21, P1670, DOI 10.1210/me.2007-0050; Arnason U, 2008, GENE, V421, P37, DOI 10.1016/j.gene.2008.05.024; Bakewell MA, 2007, P NATL ACAD SCI USA, V104, P7489, DOI 10.1073/pnas.0701705104; Benner Steven A., 2007, V75, P1; BILEZIKJIAN LM, 1993, ENDOCRINOLOGY, V133, P2545, DOI 10.1210/en.133.6.2545; Braun Edward L, 2003, Appl Bioinformatics, V2, P13; Braun EL, 2001, MOL BIOL EVOL, V18, P1401, DOI 10.1093/oxfordjournals.molbev.a003924; Chang H, 2002, ENDOCR REV, V23, P787, DOI 10.1210/er.2002-0003; Chang H, 2001, MOL CELL ENDOCRINOL, V180, P39, DOI 10.1016/S0303-7207(01)00513-5; Chapman SC, 2003, ENDOCRINOLOGY, V144, P5640, DOI 10.1210/en.2003-0670; Cook RW, 2005, J BIOL CHEM, V280, P40177, DOI 10.1074/jbc.M504591200; CULLER MD, 1988, MOL CELL ENDOCRINOL, V58, P263, DOI 10.1016/0303-7207(88)90163-3; DAGOSTINO J, 1989, ENDOCRINOLOGY, V124, P310, DOI 10.1210/endo-124-1-310; Daughdrill GW, 2007, J MOL EVOL, V65, P277, DOI 10.1007/s00239-007-9011-2; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; Fang JM, 1996, BIOCHEM BIOPH RES CO, V228, P669, DOI 10.1006/bbrc.1996.1715; Fang JM, 1997, BIOCHEM BIOPH RES CO, V231, P655, DOI 10.1006/bbrc.1997.6162; Farnworth PG, 2007, ENDOCRINOLOGY, V148, P5355, DOI 10.1210/en.2007-0155; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Force A, 1999, GENETICS, V151, P1531; Ge W, 2000, CAN J PHYSIOL PHARM, V78, P1077, DOI 10.1139/cjpp-78-12-1077; GE W, 1993, BIOCHEM BIOPH RES CO, V193, P711, DOI 10.1006/bbrc.1993.1683; GE W, 1992, ENDOCRINOLOGY, V131, P1922, DOI 10.1210/en.131.4.1922; Grant T, 2007, MOL PHYLOGENET EVOL, V44, P483, DOI 10.1016/j.ympev.2006.11.027; Gribaldo S, 2002, THEOR POPUL BIOL, V61, P391, DOI 10.1006/tpbi.2002.1593; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hallstrom BM, 2009, MOL BIOL EVOL, V26, P463, DOI 10.1093/molbev/msn271; Han MV, 2009, GENOME RES, V19, P859, DOI 10.1101/gr.085951.108; Harrison CA, 2004, J BIOL CHEM, V279, P28036, DOI 10.1074/jbc.M402782200; He XL, 2005, GENETICS, V169, P1157, DOI 10.1534/genetics.104.037051; Herpin A, 2004, DEV COMP IMMUNOL, V28, P461, DOI 10.1016/j.dci.2003.09.007; HOLLAND PWH, 1994, DEVELOPMENT, P125; Hughes AL, 2005, EVOL DEV, V7, P196, DOI 10.1111/j.1525-142X.2005.05022.x; Hughes AL, 1999, J MOL EVOL, V48, P565, DOI 10.1007/PL00006499; Hughes Austin L., 2003, Journal of Structural and Functional Genomics, V3, P85, DOI 10.1023/A:1022681600462; Hurles M, 2004, PLOS BIOL, V2, P900, DOI 10.1371/journal.pbio.0020206; Janke A, 1996, J MOL EVOL, V42, P153, DOI 10.1007/BF02198841; Johnson PA, 2005, GEN COMP ENDOCR, V141, P233, DOI 10.1016/j.ygcen.2005.01.006; JOHNSON PA, 1993, GEN COMP ENDOCR, V90, P43, DOI 10.1006/gcen.1993.1058; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kenny HA, 2002, J ENDOCRINOL, V174, DOI 10.1677/joe.0.1740085; KIMURA M, 1974, P NATL ACAD SCI USA, V71, P2848, DOI 10.1073/pnas.71.7.2848; Kirkbride KC, 2008, J BIOL CHEM, V283, P7628, DOI 10.1074/jbc.M704883200; Kuraku S, 2009, MOL BIOL EVOL, V26, P47, DOI 10.1093/molbev/msn222; Lapraz F, 2006, DEV BIOL, V300, P132, DOI 10.1016/j.ydbio.2006.08.048; Larhammar D, 2002, GENOME RES, V12, P1910, DOI 10.1101/gr.445702; Lebrun JJ, 1999, MOL ENDOCRINOL, V13, P15, DOI 10.1210/me.13.1.15; Lewis KA, 2000, NATURE, V404, P411, DOI 10.1038/35006129; Li MD, 1998, J ENDOCRINOL, V156, P529, DOI 10.1677/joe.0.1560529; LING N, 1986, NATURE, V321, P779, DOI 10.1038/321779a0; Lovell TM, 2000, BIOL REPROD, V63, P213, DOI 10.1095/biolreprod63.1.213; Lovell TM, 2002, REPRODUCTION, V124, P649, DOI 10.1530/reprod/124.5.649; Lovell TM, 2001, BIOL REPROD, V64, P188, DOI 10.1095/biolreprod64.1.188; Lynch M, 2007, NAT REV GENET, V8, P803, DOI 10.1038/nrg2192; Maddison DR, 1997, SYST BIOL, V46, P590, DOI 10.2307/2413497; MANN GE, 1989, J ENDOCRINOL, V123, P383, DOI 10.1677/joe.0.1230383; Marques AC, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r54; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Matus DQ, 2006, P NATL ACAD SCI USA, V103, P11195, DOI 10.1073/pnas.0601257103; Muller GB, 2005, J EXP ZOOL PART B, V304B, P487, DOI 10.1002/jez.b.21081; Nei M, 2007, P NATL ACAD SCI USA, V104, P12235, DOI 10.1073/pnas.0703349104; Ohno S., 1970, EVOLUTION GENE DUPLI; Philippe H, 1998, CURR OPIN GENET DEV, V8, P616, DOI 10.1016/S0959-437X(98)80028-2; Philippe H, 2009, CURR BIOL, V19, P706, DOI 10.1016/j.cub.2009.02.052; Pigliucci M, 2007, EVOLUTION, V61, P2743, DOI 10.1111/j.1558-5646.2007.00246.x; Piontkivska H, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-31; RIVERA MC, 1992, SCIENCE, V257, P74, DOI 10.1126/science.1621096; RIVIER C, 1987, HORM RES, V28, P104, DOI 10.1159/000180934; RIVIER C, 1987, ENDOCRINOLOGY, V120, P1688, DOI 10.1210/endo-120-4-1688; ROBERTSON DM, 1995, J ENDOCRINOL, V144, P261, DOI 10.1677/joe.0.1440261; Roth C, 2007, J EXP ZOOL PART B, V308B, P58, DOI 10.1002/jez.b.21124; Sassi SO, 2007, MOL BIOL EVOL, V24, P1012, DOI 10.1093/molbev/msm020; Satterlee DG, 2002, POULTRY SCI, V81, P519, DOI 10.1093/ps/81.4.519; Schierwater B, 2009, PLOS BIOL, V7, P36, DOI 10.1371/journal.pbio.1000020; Silva JRV, 2004, J ENDOCRINOL, V183, P405, DOI 10.1677/joe.1.05756; Suszko MI, 2003, MOL ENDOCRINOL, V17, P318, DOI 10.1210/me.2002-0081; Taylor MS, 2004, GENOME RES, V14, P555, DOI 10.1101/gr.1977804; Thompson TB, 2005, DEV CELL, V9, P535, DOI 10.1016/j.devcel.2005.09.008; Thompson TB, 2004, MOL CELL ENDOCRINOL, V225, P9, DOI 10.1016/j.mce.2004.02.007; Thompson TB, 2003, EMBO J, V22, P1555, DOI 10.1093/emboj/cdg156; Trombly DJ, 2009, SEMIN REPROD MED, V27, P14, DOI 10.1055/s-0028-1108006; VALE W, 1986, NATURE, V321, P776, DOI 10.1038/321776a0; Van der Zee M, 2008, DEV GENES EVOL, V218, P203, DOI 10.1007/s00427-007-0179-7; Vandepoele K, 2004, P NATL ACAD SCI USA, V101, P1638, DOI 10.1073/pnas.0307968100; Wetterbom A, 2006, J MOL EVOL, V63, P682, DOI 10.1007/s00239-006-0045-7; WIATER E, 2009, MOL ENDOCRINOL; WOODRUFF TK, 1988, SCIENCE, V239, P1296, DOI 10.1126/science.3125611; WOODRUFF TK, 1989, ENDOCRINOLOGY, V124, P2193, DOI 10.1210/endo-124-5-2193; Wu MY, 2009, DEV CELL, V16, P329, DOI 10.1016/j.devcel.2009.02.012; Wu TT, 2000, BIOL REPROD, V62, P1585, DOI 10.1095/biolreprod62.6.1585; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237	97	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2010	5	3							e9457	10.1371/journal.pone.0009457	http://dx.doi.org/10.1371/journal.pone.0009457			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	564EW	20209104	Green Published, gold, Green Submitted			2022-12-25	WOS:000275197100003
J	Miranda, C; Fumagalli, T; Anania, MC; Vizioli, MG; Pagliardini, S; Pierotti, MA; Greco, A				Miranda, Claudia; Fumagalli, Tiziana; Anania, Maria Chiara; Vizioli, Maria Grazia; Pagliardini, Sonia; Pierotti, Marco A.; Greco, Angela			Role of STAT3 in In Vitro Transformation Triggered by TRK Oncogenes	PLOS ONE			English	Article							PAPILLARY THYROID-CARCINOMA; SERINE PHOSPHORYLATION; TYROSINE KINASE; CELLULAR-TRANSFORMATION; SIGNAL TRANSDUCER; GENE-REGULATION; ACTIVATION; TRANSCRIPTION-3; PROTEIN; CELLS	TRK oncoproteins are chimeric versions of the NTRK1/NGF receptor and display constitutive tyrosine kinase activity leading to transformation of NIH3T3 cells and neuronal differentiation of PC12 cells. Signal Transducer and Activator of Transcription (STAT) 3 is activated in response to cytokines and growth factors and it has been recently identified as a novel signal transducer for TrkA, mediating the functions of NGF in nervous system. In this paper we have investigated STAT3 involvement in signalling induced by TRK oncogenes. We showed that TRK oncogenes trigger STAT3 phosphorylation both on Y705 and S727 residues and STAT3 transcriptional activity. MAPK pathway was involved in the induction of STAT3 phosphorylation. Interestingly, we have shown reduced STAT3 protein level in NIH3T3 transformed foci expressing TRK oncogenes. Overall, we have unveiled a dual role for STAT3 in TRK oncogenes-induced NIH3T3 transformation: i) decreased STAT3 protein levels, driven by TRK oncoproteins activity, are associated to morphological transformation; ii) residual STAT3 transcriptional activity is required for cell growth.	[Miranda, Claudia; Fumagalli, Tiziana; Anania, Maria Chiara; Vizioli, Maria Grazia; Pagliardini, Sonia; Greco, Angela] Ist Nazl Tumori, Operat Unit Mol Mech, Dept Expt Oncol & Mol Med, IRCCS Fdn, I-20133 Milan, Italy; [Pierotti, Marco A.] Ist Nazl Tumori, IRCCS Fdn, Sci Directorate, I-20133 Milan, Italy	Fondazione IRCCS Istituto Nazionale Tumori Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; Fondazione IRCCS Istituto Nazionale Tumori Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico	Miranda, C (corresponding author), Ist Nazl Tumori, Operat Unit Mol Mech, Dept Expt Oncol & Mol Med, IRCCS Fdn, Via Venezian 1, I-20133 Milan, Italy.	claudia.miranda@istitutotumori.mi.it; angela.greco@istitutotumori.mi.it	Anania, Maria Chiara/B-9339-2017; Pierotti, Marco Alessandro/AAC-4728-2022; Anania, Maria Chiara/N-4853-2019; Greco, Angela/C-1953-2017	Anania, Maria Chiara/0000-0003-4012-1870; Pierotti, Marco Alessandro/0000-0002-7431-8332; Anania, Maria Chiara/0000-0003-4012-1870; Greco, Angela/0000-0003-2994-0349	AIRC (Italian Association for Cancer Research); ACC (Alliance Against Cancer); Italian Ministry of Health	AIRC (Italian Association for Cancer Research)(Fondazione AIRC per la ricerca sul cancro); ACC (Alliance Against Cancer); Italian Ministry of Health(Ministry of Health, Italy)	This work was supported by AIRC (Italian Association for Cancer Research), ACC (Alliance Against Cancer), and Italian Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 2001, ONCOGENE, V20, P3464, DOI 10.1038/sj.onc.1204461; Akira S, 1999, STEM CELLS, V17, P138, DOI 10.1002/stem.170138; Bienvenu F, 2001, J BIOL CHEM, V276, P16840, DOI 10.1074/jbc.M100795200; BONGARZONE I, 1989, ONCOGENE, V4, P1457; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Bromberg JF, 1998, MOL CELL BIOL, V18, P2553, DOI 10.1128/MCB.18.5.2553; Chiarle R, 2005, NAT MED, V11, P623, DOI 10.1038/nm1249; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Decker T, 2000, ONCOGENE, V19, P2628, DOI 10.1038/sj.onc.1203481; GAO SP, 2006, SCI STKE, pE30; Germain D, 2007, CLIN CANCER RES, V13, P5665, DOI 10.1158/1078-0432.CCR-06-2491; Greco A, 2004, CANC TREAT, V122, P207; GRECO A, 1995, MOL CELL BIOL, V15, P6118; GRECO A, 1992, ONCOGENE, V7, P237; GRECO A, 1993, CELL GROWTH DIFFER, V4, P539; GRECO A, 2004, MOL BASIS THYROID CA, P207; Gunning PT, 2008, CHEMBIOCHEM, V9, P2800, DOI 10.1002/cbic.200800291; Hwang JH, 2003, MOL ENDOCRINOL, V17, P1155, DOI 10.1210/me.2002-0401; Ishiyama T, 2006, NEC TECH J, V1, P47; Lim CP, 1999, J BIOL CHEM, V274, P31055, DOI 10.1074/jbc.274.43.31055; Lin L, 2009, ONCOGENE, V28, P961, DOI 10.1038/onc.2008.448; Liu HS, 2008, NEOPLASIA, V10, P52, DOI 10.1593/neo.07691; Lo RKH, 2003, J BIOL CHEM, V278, P52154, DOI 10.1074/jbc.M307299200; MARTINZANCA D, 1986, NATURE, V319, P743, DOI 10.1038/319743a0; Miranda C, 2001, J CELL PHYSIOL, V186, P35; Ng DCH, 2006, J CELL BIOL, V172, P245, DOI 10.1083/jcb.200503021; Ng YP, 2006, J BIOL CHEM, V281, P15636, DOI 10.1074/jbc.M601863200; Qin HR, 2008, CANCER RES, V68, P7736, DOI 10.1158/0008-5472.CAN-08-1125; Ranzi V, 2003, ENDOCRINOLOGY, V144, P922, DOI 10.1210/en.2002-221002; Roccato E, 2005, J BIOL CHEM, V280, P3382, DOI 10.1074/jbc.M407522200; Roccato E, 2002, BRIT J CANCER, V87, P645, DOI 10.1038/sj.bjc.6600544; Schindler C, 2007, J BIOL CHEM, V282, P20059, DOI 10.1074/jbc.R700016200; Schubert WH, 2001, J HYDROMETEOROL, V2, P3, DOI 10.1175/1525-7541(2001)002<0005:>2.0.CO;2; Teng TS, 2009, J CELL SCI, V122, P4150, DOI 10.1242/jcs.057109; Verma NK, 2009, J BIOL CHEM, V284, P12349, DOI 10.1074/jbc.M807761200; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275	38	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2010	5	3							e9446	10.1371/journal.pone.0009446	http://dx.doi.org/10.1371/journal.pone.0009446			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	562OZ	20209132	Green Submitted, Green Published, gold			2022-12-25	WOS:000275063400002
J	Biessmann, H; Andronopoulou, E; Biessmann, MR; Douris, V; Dimitratos, SD; Eliopoulos, E; Guerin, PM; Iatrou, K; Justice, RW; Krober, T; Marinotti, O; Tsitoura, P; Woods, DF; Walter, MF				Biessmann, Harald; Andronopoulou, Evi; Biessmann, Max R.; Douris, Vassilis; Dimitratos, Spiros D.; Eliopoulos, Elias; Guerin, Patrick M.; Iatrou, Kostas; Justice, Robin W.; Kroeber, Thomas; Marinotti, Osvaldo; Tsitoura, Panagiota; Woods, Daniel F.; Walter, Marika F.			The Anopheles gambiae Odorant Binding Protein 1 (AgamOBP1) Mediates Indole Recognition in the Antennae of Female Mosquitoes	PLOS ONE			English	Article							PHEROMONE-BINDING; OVIPOSITION ATTRACTANTS; CULEX-QUINQUEFASCIATUS; SEXUAL ATTRACTION; MALARIA MOSQUITO; CRYSTAL-STRUCTURE; SILKWORM MOTH; IDENTIFICATION; EXPRESSION; RESPONSES	Haematophagous insects are frequently carriers of parasitic diseases, including malaria. The mosquito Anopheles gambiae is the major vector of malaria in sub-Saharan Africa and is thus responsible for thousands of deaths daily. Although the role of olfaction in A. gambiae host detection has been demonstrated, little is known about the combinations of ligands and odorant binding proteins (OBPs) that can produce specific odor-related responses in vivo. We identified a ligand, indole, for an A. gambiae odorant binding protein, AgamOBP1, modeled the interaction in silico and confirmed the interaction using biochemical assays. RNAi-mediated gene silencing coupled with electrophysiological analyses confirmed that AgamOBP1 binds indole in A. gambiae and that the antennal receptor cells do not respond to indole in the absence of AgamOBP1. This case represents the first documented instance of a specific A. gambiae OBP-ligand pairing combination, demonstrates the significance of OBPs in odor recognition, and can be expanded to the identification of other ligands for OBPs of Anopheles and other medically important insects.	[Biessmann, Harald; Biessmann, Max R.; Marinotti, Osvaldo; Walter, Marika F.] Univ Calif Irvine, Dept Mol Biol & Biochem, Ctr Dev Biol, Irvine, CA 92717 USA; [Andronopoulou, Evi; Douris, Vassilis; Iatrou, Kostas; Tsitoura, Panagiota] Natl Ctr Sci Res Demokritos, Inst Biol, Insect Mol Genet & Biotechnol Grp, Athens, Greece; [Dimitratos, Spiros D.; Justice, Robin W.; Woods, Daniel F.] Inscent Inc, Irvine, CA USA; [Eliopoulos, Elias] Agr Univ Athens, Dept Agr Biotechnol, Athens, Greece; [Guerin, Patrick M.; Kroeber, Thomas] Univ Neuchatel, Fac Sci, Inst Biol, CH-2000 Neuchatel, Switzerland; [Justice, Robin W.] Claremont Coll, Joint Sci Dept, Claremont, CA USA; [Justice, Robin W.] Claremont Mckenna Coll, Claremont, CA 91711 USA; [Justice, Robin W.] Pitzer Coll, Claremont, CA 91711 USA; [Justice, Robin W.] Scripps Coll, Claremont, CA 91711 USA	University of California System; University of California Irvine; National Centre of Scientific Research "Demokritos"; Agricultural University of Athens; University of Neuchatel; Claremont Colleges; Claremont Graduate School; Claremont Colleges; Claremont Graduate School; Claremont McKenna College; Claremont Colleges; Pitzer College; Claremont Colleges; Scripps College		mfwalter@uci.edu	Douris, Vassilis/AAG-9423-2020	Douris, Vassilis/0000-0003-4608-7482; Eliopoulos, Elias/0000-0002-0919-0571; KROBER, Thomas/0000-0001-6798-4946; Marinotti, Osvaldo/0000-0002-7173-7160	General Secretariat of Science and Technology; Greek Ministry of Development [GRUSA 052]; National Institute of Health [2R01AI051485-06A1, R56AI051485]; Director's Initiative Fund; UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR); European Community's Seventh Framework Programme [FP7/2007-2013, FP7-222927]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051485, R56AI051485] Funding Source: NIH RePORTER	General Secretariat of Science and Technology; Greek Ministry of Development; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Director's Initiative Fund; UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR); European Community's Seventh Framework Programme; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the General Secretariat of Science and Technology, Greek Ministry of Development to K. I. (grant number GRUSA 052); the National Institute of Health (NIAID grant 2R01AI051485-06A1 to H. B. and grant R56AI051485 to H. B. and M. F. W.); the Director's Initiative Fund, UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR) to P. M. G.; the European Community's Seventh Framework Programme (FP7/2007-2013 to K. I., P. M. G., E. E. and D. F. W. under grant agreement FP7-222927). The funders had a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Abraham EG, 2005, INSECT MOL BIOL, V14, P271, DOI 10.1111/j.1365-2583.2004.00557.x; Allen FH, 2002, ACTA CRYSTALLOGR B, V58, P380, DOI 10.1107/S0108768102003890; Andronopoulou E, 2006, INSECT MOL BIOL, V15, P797, DOI 10.1111/j.1365-2583.2006.00685.x; ARN H, 1975, Z NATURFORSCH C, V30, P722; Biessmann H, 2002, INSECT MOL BIOL, V11, P123, DOI 10.1046/j.1365-2583.2002.00316.x; Biessmann H, 2005, INSECT MOL BIOL, V14, P575, DOI 10.1111/j.1365-2583.2005.00590.x; Blackwell A, 2000, ANN TROP MED PARASIT, V94, P389, DOI 10.1080/00034983.2000.11813554; BLACKWELL A, 1993, PHYSIOL ENTOMOL, V18, P343, DOI 10.1111/j.1365-3032.1993.tb00607.x; Blandin S, 2002, EMBO REP, V3, P852, DOI 10.1093/embo-reports/kvf180; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Costantini C, 2001, MED VET ENTOMOL, V15, P259, DOI 10.1046/j.0269-283x.2001.00297.x; Dekker T, 2002, MED VET ENTOMOL, V16, P91, DOI 10.1046/j.0269-283x.2002.00345.x; Dekker T, 2001, J MED ENTOMOL, V38, P868, DOI 10.1603/0022-2585-38.6.868; FOSTER WA, 1995, ANNU REV ENTOMOL, V40, P443, DOI 10.1146/annurev.en.40.010195.002303; Fujita Y, 2005, BIOORG MED CHEM LETT, V15, P4317, DOI 10.1016/j.bmcl.2005.06.047; Grosse-Wilde E, 2006, CHEM SENSES, V31, P547, DOI 10.1093/chemse/bjj059; Ha TS, 2006, J NEUROSCI, V26, P8727, DOI 10.1523/JNEUROSCI.0876-06.2006; Hallem EA, 2006, ANNU REV ENTOMOL, V51, P113, DOI 10.1146/annurev.ento.51.051705.113646; HAYES RO, 1953, J ECON ENTOMOL, V46, P624, DOI 10.1093/jee/46.4.624; Iatrou K, 2008, INSECT BIOCHEM MOLEC, V38, P268, DOI 10.1016/j.ibmb.2007.11.008; Ishida Y, 2002, J CHEM ECOL, V28, P867, DOI 10.1023/A:1015253214273; Justice RW, 2003, INSECT MOL BIOL, V12, P581, DOI 10.1046/j.1365-2583.2003.00443.x; Justice RW, 2003, BIOESSAYS, V25, P1011, DOI 10.1002/bies.10331; Kaissling K.-E, 1995, EXPT CELL BIOL TASTE, P361; Klusak V, 2003, CHEM BIOL, V10, P331, DOI 10.1016/S1074-5521(03)00074-7; Lartigue A, 2004, J BIOL CHEM, V279, P4459, DOI 10.1074/jbc.M311212200; Laughlin JD, 2008, CELL, V133, P1255, DOI 10.1016/j.cell.2008.04.046; Leal WS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003045; Matsui M, 2007, EUR NEUROL, V57, P57, DOI 10.1159/000097120; Meijerink J, 1999, J INSECT PHYSIOL, V45, P365, DOI 10.1016/S0022-1910(98)00135-8; Meijerink J, 2001, J INSECT PHYSIOL, V47, P455, DOI 10.1016/S0022-1910(00)00136-0; Meijerink J, 2000, J CHEM ECOL, V26, P1367, DOI 10.1023/A:1005475422978; MILLAR JG, 1992, J AM MOSQUITO CONTR, V8, P11; Mohl Claudia, 2002, Invertebrate Neuroscience, V4, P165, DOI 10.1007/s10158-002-0018-5; Moita LF, 2005, IMMUNITY, V23, P65, DOI 10.1016/j.immuni.2005.05.006; MORDUE AJ, 1992, EXPERIENTIA, V48, P1109, DOI 10.1007/BF01947999; Olagbemiro TO, 2004, J CHEM ECOL, V30, P965, DOI 10.1023/B:JOEC.0000028461.86243.19; Pelosi P, 2006, CELL MOL LIFE SCI, V63, P1658, DOI 10.1007/s00018-005-5607-0; Sandler BH, 2000, CHEM BIOL, V7, P143, DOI 10.1016/S1074-5521(00)00078-8; Syed Z, 2006, P NATL ACAD SCI USA, V103, P16538, DOI 10.1073/pnas.0607874103; Takken W, 1999, ANNU REV ENTOMOL, V44, P131, DOI 10.1146/annurev.ento.44.1.131; Tegoni M, 2004, TRENDS BIOCHEM SCI, V29, P257, DOI 10.1016/j.tibs.2004.03.003; van den Broek IVF, 1999, J INSECT PHYSIOL, V45, P1001, DOI 10.1016/S0022-1910(99)00081-5; van Naters WVG, 2007, CURR BIOL, V17, P606, DOI 10.1016/j.cub.2007.02.043; Vogt RG, 2002, J CHEM ECOL, V28, P2371, DOI 10.1023/A:1021009311977; VOGT RG, 1981, NATURE, V293, P161, DOI 10.1038/293161a0; VOGT RG, 1991, J NEUROBIOL, V22, P74, DOI 10.1002/neu.480220108; VOGT RG, 1985, P NATL ACAD SCI USA, V82, P8827, DOI 10.1073/pnas.82.24.8827; Vogt Richard G., 2003, P391, DOI 10.1016/B978-012107151-6/50016-5; Wogulis M, 2006, BIOCHEM BIOPH RES CO, V339, P157, DOI 10.1016/j.bbrc.2005.10.191; Xu PX, 2003, INSECT MOL BIOL, V12, P549, DOI 10.1046/j.1365-2583.2003.00440.x; Xu PX, 2005, NEURON, V45, P193, DOI 10.1016/j.neuron.2004.12.031	52	162	173	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2010	5	3							e9471	10.1371/journal.pone.0009471	http://dx.doi.org/10.1371/journal.pone.0009471			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	561RT	20208991	Green Published, Green Submitted, gold			2022-12-25	WOS:000274997100017
J	Livolsi, A; Niederhoffer, N; Dali-Youcef, N; Rambaud, C; Olexa, C; Mokni, W; Gies, JP; Bousquet, P				Livolsi, Angelo; Niederhoffer, Nathalie; Dali-Youcef, Nassim; Rambaud, Caroline; Olexa, Catherine; Mokni, Walid; Gies, Jean-Pierre; Bousquet, Pascal			Cardiac Muscarinic Receptor Overexpression in Sudden Infant Death Syndrome	PLOS ONE			English	Article							BRAIN-STEM; GUINEA-PIG; RISK; VICTIMS; BINDING; NUCLEUS; REFLEX; SIDS	Background: Sudden infant death syndrome (SIDS) remains the leading cause of death among infants less than 1 year of age. Disturbed expression of some neurotransmitters and their receptors has been shown in the central nervous system of SIDS victims but no biological abnormality of the peripheral vago-cardiac system has been demonstrated to date. The present study aimed to seek vago-cardiac abnormalities in SIDS victims. The cardiac level of expression of muscarinic receptors, as well as acetylcholinesterase enzyme activity were investigated. Methodology/Principal Findings: Left ventricular samples and blood samples were obtained from autopsies of SIDS and children deceased from non cardiac causes. Binding experiments performed with [H-3] NMS, a selective muscarinic ligand, in cardiac membrane preparations showed that the density of cardiac muscarinic receptors was increased as shown by a more than doubled B-max value in SIDS (n = 9 SIDS versus 8 controls). On average, the erythrocyte acetylcholinesterase enzyme activity was also significantly increased (n = 9 SIDS versus 11 controls). Conclusions: In the present study, it has been shown for the first time that cardiac muscarinic receptor overexpression is associated with SIDS. The increase of acetylcholinesterase enzyme activity appears as a possible regulatory mechanism.	[Livolsi, Angelo; Niederhoffer, Nathalie; Olexa, Catherine; Mokni, Walid; Bousquet, Pascal] Univ Strasbourg, Lab Neurobiol & Pharmacol Cardiovasc, Strasbourg, France; [Niederhoffer, Nathalie; Gies, Jean-Pierre] Univ Strasbourg, CNRS, UMR 7213, Lab Biophoton & Pharmacol, Illkirch Graffenstaden, France; [Dali-Youcef, Nassim] Univ Strasbourg, CNRS, INSERM, IGBMC, Illkirch Graffenstaden, France; [Dali-Youcef, Nassim] Hop Univ, Lab Biochim Gen & Specialisee, Strasbourg, France; [Rambaud, Caroline] Hop Raymond Poincare, Serv Anat Pathol & Med Legale, Garches, France; [Mokni, Walid; Bousquet, Pascal] Hop Univ, INSERM, Ctr Invest Clin, Strasbourg, France	UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; CHU Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Livolsi, A (corresponding author), Univ Strasbourg, Lab Neurobiol & Pharmacol Cardiovasc, Strasbourg, France.	Pascal.Bousquet@medecine.u-strasbg.fr	Niederhoffer, Nathalie/AAF-1343-2020; DALI-YOUCEF, Nassim/O-2549-2016	DALI-YOUCEF, Nassim/0000-0001-6958-1331	French Ministery of Research	French Ministery of Research(Ministry of Research, France)	This study was funded by the French Ministery of Research. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERGSTROM L, 1984, BRAIN RES, V323, P279, DOI 10.1016/0006-8993(84)90298-1; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Duncan JR, 2008, BRAIN PATHOL, V18, P21, DOI 10.1111/j.1750-3639.2007.00093.x; Duncan JR, 2009, J APPL PHYSIOL, V107, P1579, DOI 10.1152/japplphysiol.91629.2008; Edner A, 2000, ACTA PAEDIATR, V89, P1326, DOI 10.1080/080352500300002516; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; FILIANO JJ, 1994, BIOL NEONATE, V65, P194; GIES JP, 1989, J PHARMACOL EXP THER, V250, P309; Gorini C, 2009, J NEUROPHYSIOL, V102, P1443, DOI 10.1152/jn.00287.2009; HADDAD EB, 1991, AM J PHYSIOL, V261, pL327, DOI 10.1152/ajplung.1991.261.4.L327; Kattwinkel J, 2005, PEDIATRICS, V116, P1245, DOI 10.1542/peds.2005-1499; KINNEY HC, 1995, SCIENCE, V269, P1446, DOI 10.1126/science.7660131; Krous HF, 2004, PEDIATRICS, V114, P234, DOI 10.1542/peds.114.1.234; Mallard C, 1999, J NEUROPATH EXP NEUR, V58, P255, DOI 10.1097/00005072-199903000-00005; Malloy MH, 2004, NEW ENGL J MED, V351, P957, DOI 10.1056/NEJMp048194; Matturri L, 2005, J CLIN PATHOL, V58, P77, DOI 10.1136/jcp.2004.020867; Paterson DS, 2006, JAMA-J AM MED ASSOC, V296, P2124, DOI 10.1001/jama.296.17.2124; Schwartz PJ, 1998, NEW ENGL J MED, V338, P1709, DOI 10.1056/NEJM199806113382401; Shapiro-Mendoza CK, 2006, AM J EPIDEMIOL, V163, P762, DOI 10.1093/aje/kwj117; Vennemann M, 2007, ARCH DIS CHILD, V92, P133, DOI 10.1136/adc.2006.101337	20	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2010	5	3							e9464	10.1371/journal.pone.0009464	http://dx.doi.org/10.1371/journal.pone.0009464			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	561RT	20209124	Green Published, Green Submitted, gold			2022-12-25	WOS:000274997100011
J	Adli, M; Merkhofer, E; Cogswell, P; Baldwin, AS				Adli, Mazhar; Merkhofer, Evan; Cogswell, Patricia; Baldwin, Albert S.			IKK alpha and IKK beta Each Function to Regulate NF-kappa B Activation in the TNF-Induced/Canonical Pathway	PLOS ONE			English	Article							SEVERE LIVER DEGENERATION; KINASE COMPLEX; MICE LACKING; GENE-EXPRESSION; DEFICIENT MICE; PHOSPHORYLATION; INHIBITION; SUBUNIT; TRANSCRIPTION; APOPTOSIS	Background: Activation of the transcription factor NF-kappa B by cytokines is rapid, mediated through the activation of the IKK complex with subsequent phosphorylation and degradation of the inhibitory I kappa B proteins. The IKK complex is comprised of two catalytic subunits, IKK alpha and IKK beta, and a regulatory protein known as NEMO. Using cells from mice that are genetically deficient in IKK beta or IKK alpha, or using a kinase inactive mutant of IKK beta, it has been proposed that IKK beta is critical for TNF-induced I kappa B phosphorylation/degradation through the canonical pathway while IKK alpha has been shown to be involved in the non-canonical pathway for NF-kappa B activation. These conclusions have led to a focus on development of IKK beta inhibitors for potential use in inflammatory disorders and cancer. Methodology: Analysis of NF-kappa B activation in response to TNF in MEFs reveals that IKK beta is essential for efficient phosphorylation and subsequent degradation of I kappa B alpha, yet IKK alpha contributes to the NF-kappa B activation response in these cells as measured via DNA binding assays. In HeLa cells, both IKK alpha and IKK beta contribute to I kappa B alpha phosphorylation and NF-kappa B activation. A kinase inactive mutant of IKK beta, which has been used as evidence for the critical importance of IKK beta in TNF-induced signaling, blocks activation of NF-kappa B induced by IKK alpha, even in cells that are deficient in IKK beta. Conclusions: These results demonstrate the importance of IKK alpha in canonical NF-kappa B activation, downstream of cytokine treatment of cells. The experiments suggest that IKK alpha will be a therapeutic target in inflammatory disorders.	[Adli, Mazhar; Baldwin, Albert S.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27515 USA; [Merkhofer, Evan; Baldwin, Albert S.] Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC USA; [Adli, Mazhar; Merkhofer, Evan; Cogswell, Patricia; Baldwin, Albert S.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Adli, M (corresponding author), Univ N Carolina, Dept Biol, Chapel Hill, NC 27515 USA.	abaldwin@med.unc.edu			National Institutes of Health (NIH) [AI35098, CA75080]; Waxman Cancer Research Foundation; NATIONAL CANCER INSTITUTE [R01CA075080, R01CA073756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI035098, R37AI035098] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Waxman Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (NIH) grants AI35098 and CA75080, and by support from the Waxman Cancer Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adli M, 2006, J BIOL CHEM, V281, P26976, DOI 10.1074/jbc.M603133200; Anest V, 2003, NATURE, V423, P659, DOI 10.1038/nature01648; Basseres DS, 2006, ONCOGENE, V25, P6817, DOI 10.1038/sj.onc.1209942; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; Greten FR, 2007, CELL, V130, P918, DOI 10.1016/j.cell.2007.07.009; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hu YL, 1999, SCIENCE, V284, P316, DOI 10.1126/science.284.5412.316; Izmailova ES, 2007, ARTHRITIS RHEUM-US, V56, P117, DOI 10.1002/art.22303; Jimi E, 2004, NAT MED, V10, P617, DOI 10.1038/nm1054; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Lam LT, 2008, P NATL ACAD SCI USA, V105, P20798, DOI 10.1073/pnas.0806491106; Li QT, 1999, SCIENCE, V284, P321, DOI 10.1126/science.284.5412.321; Li QT, 1999, GENE DEV, V13, P1322, DOI 10.1101/gad.13.10.1322; Li ZW, 1999, J EXP MED, V189, P1839, DOI 10.1084/jem.189.11.1839; Luedde T, 2005, J CLIN INVEST, V115, P849, DOI 10.1172/JCI200523493; Luedde T, 2008, P NATL ACAD SCI USA, V105, P9733, DOI 10.1073/pnas.0800198105; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; O'Mahony A, 2000, MOL CELL BIOL, V20, P1170, DOI 10.1128/MCB.20.4.1170-1178.2000; Perkins ND, 2006, ONCOGENE, V25, P6717, DOI 10.1038/sj.onc.1209937; Rothwarf DM, 1998, NATURE, V395, P297, DOI 10.1038/26261; Rudolph D, 2000, GENE DEV, V14, P854; Sasaki CY, 2005, J BIOL CHEM, V280, P34538, DOI 10.1074/jbc.M504943200; Scheidereit C, 2006, ONCOGENE, V25, P6685, DOI 10.1038/sj.onc.1209934; Takeda K, 1999, SCIENCE, V284, P313, DOI 10.1126/science.284.5412.313; Tanaka M, 1999, IMMUNITY, V10, P421, DOI 10.1016/S1074-7613(00)80042-4; Westerheide SD, 2001, MOL CELL BIOL, V21, P8428, DOI 10.1128/MCB.21.24.8428-8436.2001; Yamamoto Y, 2003, NATURE, V423, P655, DOI 10.1038/nature01576; Yamamoto Y, 2000, MOL CELL BIOL, V20, P3655, DOI 10.1128/MCB.20.10.3655-3666.2000; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7; Ziegelbauer K, 2005, BRIT J PHARMACOL, V145, P178, DOI 10.1038/sj.bjp.0706176	33	80	85	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2010	5	2							e9428	10.1371/journal.pone.0009428	http://dx.doi.org/10.1371/journal.pone.0009428			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SY	20195534	Green Submitted, Green Published, gold			2022-12-25	WOS:000274924300016
J	Safran, RJ; McGraw, KJ; Wilkins, MR; Hubbard, JK; Marling, J				Safran, Rebecca J.; McGraw, Kevin J.; Wilkins, Matthew R.; Hubbard, Joanna K.; Marling, Julie			Positive Carotenoid Balance Correlates with Greater Reproductive Performance in a Wild Bird	PLOS ONE			English	Article							HISTORY TRADE-OFFS; MALE BARN SWALLOWS; OXIDATIVE STRESS; IMMUNE FUNCTION; DIETARY ANTIOXIDANTS; HIRUNDO-RUSTICA; SITE SELECTION; EGG-PRODUCTION; ZEBRA FINCHES; PLUMAGE COLOR	Background: Carotenoids can confer somatic and reproductive benefits, but most evidence is from captive animal experimentation or single time-point sampling. Another perhaps more informative means by which to assess physiological contributions to animal performance is by tracking an individual's ability to increase or sustain carotenoids or other health-related molecules over time, as these are likely to be temporally variable. Methodology/Principal Findings: In a field study of North American barn swallows (Hirundo rustica erythrogaster), we analyzed within-individual changes in carotenoid concentrations by repeatedly sampling the carotenoid profiles of individuals over the course of the breeding season. Our results demonstrate that carotenoid concentrations of individuals are temporally dynamic and that season-long balance of these molecules, rather than single time-point samples, predict reproductive performance. This was true even when controlling for two important variables associated with reproductive outcomes: (1) timing of breeding and (2) sexually selected plumage coloration, which is itself positively correlated with and concomitantly changes with circulating carotenoid concentrations. Conclusions/Significance: While reproduction itself is purported to impose health stress on organisms, these data suggest that free-ranging, high-quality individuals can mitigate such costs, by one or several genetic, environmental (diet), or physiological mechanisms. Moreover, the temporal variations in both health-linked physiological measures and morphological traits we uncover here merit further examination in other species, especially when goals include the estimation of signal information content or the costs of trait expression.	[Safran, Rebecca J.; Wilkins, Matthew R.; Hubbard, Joanna K.; Marling, Julie] Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA; [McGraw, Kevin J.] Arizona State Univ, Sch Life Sci, Tempe, AZ USA	University of Colorado System; University of Colorado Boulder; Arizona State University; Arizona State University-Tempe	Safran, RJ (corresponding author), Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA.	Rebecca.Safran@colorado.edu	Hubbard, Joanna K./H-5206-2019	Hubbard, Joanna K./0000-0002-7234-8001; Wilkins, Matthew/0000-0002-3162-6749				Alonso-Alvarez C, 2004, ECOL LETT, V7, P363, DOI 10.1111/j.1461-0248.2004.00594.x; Alonso-Alvarez C, 2004, AM NAT, V164, P651, DOI 10.1086/424971; Ardia DR, 2005, J ANIM ECOL, V74, P517, DOI 10.1111/j.1365-2656.2005.00950.x; Bertrand S, 2006, OECOLOGIA, V147, P576, DOI 10.1007/s00442-005-0317-8; Blount JD, 2003, SCIENCE, V300, P125, DOI 10.1126/science.1082142; Catoni C, 2008, ANIM BEHAV, V76, P1107, DOI 10.1016/j.anbehav.2008.05.027; Costantini D, 2008, FUNCT ECOL, V22, P367, DOI 10.1111/j.1365-2435.2007.01366.x; Costantini D, 2009, FUNCT ECOL, V23, P506, DOI 10.1111/j.1365-2435.2009.01546.x; Dowling DK, 2009, P ROY SOC B-BIOL SCI, V276, P1737, DOI 10.1098/rspb.2008.1791; Hasegawa Masaru, 2008, Ornithological Science, V7, P117, DOI 10.2326/1347-0558-7.2.117; Horak P, 2007, AM NAT, V170, P625, DOI 10.1086/521232; Hughes DA, 2001, NUTRITION, V17, P823, DOI 10.1016/S0899-9007(01)00638-4; Krinsky NI, 2001, NUTRITION, V17, P815, DOI 10.1016/S0899-9007(01)00651-7; Maguire SE, 2010, J AVIAN BIOL, V41, P74, DOI 10.1111/j.1600-048X.2009.04806.x; McGraw KJ, 2008, BEHAV ECOL SOCIOBIOL, V62, P1991, DOI 10.1007/s00265-008-0622-4; McGraw KJ, 2004, BEHAV ECOL, V15, P889, DOI 10.1093/beheco/arh109; McGraw KJ, 2003, AM NAT, V162, P704, DOI 10.1086/378904; Monaghan P, 2009, ECOL LETT, V12, P75, DOI 10.1111/j.1461-0248.2008.01258.x; Ninni P, 2004, OIKOS, V105, P55, DOI 10.1111/j.0030-1299.2004.12516.x; Pike TW, 2007, P ROY SOC B-BIOL SCI, V274, P1591, DOI 10.1098/rspb.2007.0317; Rubenstein DR, 2008, TRENDS ECOL EVOL, V23, P655, DOI 10.1016/j.tree.2008.07.010; Safran RJ, 2008, CURR BIOL, V18, pR461, DOI 10.1016/j.cub.2008.03.031; Safran RJ, 2008, BEHAV ECOL SOCIOBIOL, V62, P427, DOI 10.1007/s00265-007-0470-7; Safran RJ, 2006, CAN J ZOOL, V84, P1533, DOI 10.1139/Z06-176; Safran RJ, 2005, SCIENCE, V309, P2210, DOI 10.1126/science.1115090; Safran RJ, 2004, AM NAT, V164, P121, DOI 10.1086/422198; Safran RJ, 2004, BEHAV ECOL, V15, P455, DOI 10.1093/beheco/arh035; Saino N, 1999, AM NAT, V154, P441, DOI 10.1086/303246; Saino N, 2003, P ROY SOC B-BIOL SCI, V270, P2485, DOI 10.1098/rspb.2003.2534; Wang Y, 2001, EXP GERONTOL, V36, P1349, DOI 10.1016/S0531-5565(01)00095-X; Wiersma P, 2004, P ROY SOC B-BIOL SCI, V271, pS360, DOI 10.1098/rsbl.2004.0171	31	32	32	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2010	5	2							e9420	10.1371/journal.pone.0009420	http://dx.doi.org/10.1371/journal.pone.0009420			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SY	20195540	gold, Green Published			2022-12-25	WOS:000274924300010
J	Chen, XJ; Larson, CS; West, J; Zhang, XM; Kaufman, DB				Chen, Xiaojuan; Larson, Courtney S.; West, Jason; Zhang, Xiaomin; Kaufman, Dixon B.			In Vivo Detection of Extrapancreatic Insulin Gene Expression in Diabetic Mice by Bioluminescence Imaging	PLOS ONE			English	Article							OVAL CELL ACTIVATION; LIVER; TRANSDIFFERENTIATION; DIFFERENTIATION; ELEMENTS; ISLETS; PDX-1	Background: Extrapancreatic tissues such as liver may serve as potential sources of tissue for generating insulin-producing cells. The dynamics of insulin gene promoter activity in extrapancreatic tissues may be monitored in vivo by bioluminescence-imaging (BLI) of transgenic mice Tg(RIP-luc) expressing the firefly luciferase (luc) under a rat-insulin gene promoter (RIP). Methods: The Tg(RIP-luc) mice were made diabetic by a single injection of the pancreatic beta-cell toxin streptozotocin. Control mice were treated with saline. Mice were subject to serum glucose measurement and bioluminescence imaging daily. On day eight of the treatment, mice were sacrificed and tissues harvested for quantitative luciferase activity measurement, luciferase protein cellular localization, and insulin gene expression analysis. Results: Streptozotocin-induced diabetic Tg(RIP-luc) mice demonstrated a dramatic decline in the BLI signal intensity in the pancreas and a concomitant progressive increase in the signal intensity in the liver. An average of 5.7 fold increase in the liver signal intensity was detected in the mice that were exposed to hyperglycemia for 8 days. Ex vivo quantitative assays demonstrated a 34-fold induction of the enzyme activity in the liver of streptozotocin-treated mice compared to that of the buffer-treated controls. Luciferase-positive cells with oval-cell-like morphology were detected by immunohistochemistry in the liver samples of diabetic mice, but not in that of non-treated control transgenic mice. Gene expression analyses of liver RNA confirmed an elevated expression of insulin genes in the liver tissue exposed to hyperglycemia. Conclusions: BLI is a sensitive method for monitoring insulin gene expression in extrapancreatic tissues in vivo. The BLI system may be used for in vivo screening of biological events or pharmacologic activators that have the potential of stimulating the generation of extrapancreatic insulin-producing cells.	[Chen, Xiaojuan; Larson, Courtney S.; West, Jason; Zhang, Xiaomin; Kaufman, Dixon B.] Northwestern Univ, Feinberg Sch Med, Dept Surg, Chicago, IL 60611 USA; [Chen, Xiaojuan; Zhang, Xiaomin; Kaufman, Dixon B.] Northwestern Univ, Feinberg Sch Med, Comprehens Transplantat Ctr, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Chen, XJ (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Surg, Chicago, IL 60611 USA.	x-chen@northwestern.edu	Kaufman, Dixon B/E-4524-2016		National Institutes of Health [DK063565]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063565] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant DK063565 (D. B. K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen Xiaojuan, 2004, Current Medicinal Chemistry - Immunology Endocrine & Metabolic Agents, V4, P301, DOI 10.2174/1568013043357365; Chen XJ, 2006, TRANSPLANTATION, V81, P1421, DOI 10.1097/01.tp.0000206109.71181.bf; Contag CH, 2002, J MAGN RESON IMAGING, V16, P378, DOI 10.1002/jmri.10178; Contag CH, 2002, ANNU REV BIOMED ENG, V4, P235, DOI 10.1146/annurev.bioeng.4.111901.093336; DELTOUR L, 1993, P NATL ACAD SCI USA, V90, P527, DOI 10.1073/pnas.90.2.527; EDLUND T, 1985, SCIENCE, V230, P912, DOI 10.1126/science.3904002; Ferber S, 2000, NAT MED, V6, P568, DOI 10.1038/75050; Kim S, 2007, LAB INVEST, V87, P702, DOI 10.1038/labinvest.3700561; Kojima H, 2004, P NATL ACAD SCI USA, V101, P2458, DOI 10.1073/pnas.0308690100; Lamotte L, 2004, TRANSGENIC RES, V13, P463, DOI 10.1007/s11248-004-9587-x; Ohneda K, 2000, SEMIN CELL DEV BIOL, V11, P227, DOI 10.1006/scdb.2000.0171; Poitout V, 2006, J NUTR, V136, P873, DOI 10.1093/jn/136.4.873; Porat Shay, 2007, Curr Diab Rep, V7, P304, DOI 10.1007/s11892-007-0049-8; Shternhall-Ron K, 2007, J AUTOIMMUN, V28, P134, DOI 10.1016/j.jaut.2007.02.010; Tang DQ, 2006, LAB INVEST, V86, P829, DOI 10.1038/labinvest.3700434; Vorobeychik M, 2008, J MOL HISTOL, V39, P463, DOI 10.1007/s10735-008-9185-y; Wang AY, 2007, MOL THER, V15, P255, DOI 10.1038/sj.mt.6300032; WENTWORTH BM, 1986, J MOL EVOL, V23, P305, DOI 10.1007/BF02100639; WHELAN J, 1989, MOL CELL BIOL, V9, P3253, DOI 10.1128/MCB.9.8.3253; Yang LJ, 2002, P NATL ACAD SCI USA, V99, P8078, DOI 10.1073/pnas.122210699; Yechoor V, 2009, DEV CELL, V16, P358, DOI 10.1016/j.devcel.2009.01.012	21	13	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2010	5	2							e9397	10.1371/journal.pone.0009397	http://dx.doi.org/10.1371/journal.pone.0009397			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SX	20195523	gold, Green Published, Green Submitted			2022-12-25	WOS:000274924200019
J	Prill, RJ; Marbach, D; Saez-Rodriguez, J; Sorger, PK; Alexopoulos, LG; Xue, XW; Clarke, ND; Altan-Bonnet, G; Stolovitzky, G				Prill, Robert J.; Marbach, Daniel; Saez-Rodriguez, Julio; Sorger, Peter K.; Alexopoulos, Leonidas G.; Xue, Xiaowei; Clarke, Neil D.; Altan-Bonnet, Gregoire; Stolovitzky, Gustavo			Towards a Rigorous Assessment of Systems Biology Models: The DREAM3 Challenges	PLOS ONE			English	Article							REGULATORY NETWORKS; BENCHMARKING; EXPRESSION; INFERENCE; YEAST	Background: Systems biology has embraced computational modeling in response to the quantitative nature and increasing scale of contemporary data sets. The onslaught of data is accelerating as molecular profiling technology evolves. The Dialogue for Reverse Engineering Assessments and Methods ( DREAM) is a community effort to catalyze discussion about the design, application, and assessment of systems biology models through annual reverse-engineering challenges. Methodology and Principal Findings: We describe our assessments of the four challenges associated with the third DREAM conference which came to be known as the DREAM3 challenges: signaling cascade identification, signaling response prediction, gene expression prediction, and the DREAM3 in silico network challenge. The challenges, based on anonymized data sets, tested participants in network inference and prediction of measurements. Forty teams submitted 413 predicted networks and measurement test sets. Overall, a handful of best-performer teams were identified, while a majority of teams made predictions that were equivalent to random. Counter-intuitively, combining the predictions of multiple teams ( including the weaker teams) can in some cases improve predictive power beyond that of any single method. Conclusions: DREAM provides valuable feedback to practitioners of systems biology modeling. Lessons learned from the predictions of the community provide much-needed context for interpreting claims of efficacy of algorithms described in the scientific literature.	[Prill, Robert J.; Stolovitzky, Gustavo] IBM TJ Watson Res Ctr, Yorktown Hts, NY 10598 USA; [Marbach, Daniel] Ecole Polytech Fed Lausanne, Lab Intelligent Syst, Lausanne, Switzerland; [Saez-Rodriguez, Julio; Sorger, Peter K.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA USA; [Saez-Rodriguez, Julio; Sorger, Peter K.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Alexopoulos, Leonidas G.] Natl Tech Univ Athens, Dept Mech Engn, Athens, Greece; [Xue, Xiaowei; Clarke, Neil D.] Genome Inst Singapore, Singapore, Singapore; [Altan-Bonnet, Gregoire] Mem Sloan Kettering Canc Ctr, Program Computat Biol & Immunol, New York, NY 10021 USA	International Business Machines (IBM); Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); National Technical University of Athens; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Memorial Sloan Kettering Cancer Center	Prill, RJ (corresponding author), IBM TJ Watson Res Ctr, Yorktown Hts, NY 10598 USA.	gustavo@us.ibm.com	Clarke, Neil/D-9613-2014; Alexopoulos, Leonidas/AAN-1148-2021; Saez-Rodriguez, Julio/H-7114-2019	Saez-Rodriguez, Julio/0000-0002-8552-8976; Altan-Bonnet, Gregoire/0000-0002-7283-3162; Sorger, Peter/0000-0002-3364-1838; Alexopoulos, Leonidas G/0000-0003-0425-166X	National Institutes of Health (NIH) Roadmap Initiative [P50-GM68762, U54-CA11296, AI083408]; Columbia University Center for Multiscale Analysis Genomic and Cellular Networks (MAGNet); IBM Computational Biology Center; Marie Curie [MIRG-CT-2007-46531]; National Science Foundation (NSF) [0848030]; NATIONAL CANCER INSTITUTE [U54CA112967] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM068762] Funding Source: NIH RePORTER	National Institutes of Health (NIH) Roadmap Initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Columbia University Center for Multiscale Analysis Genomic and Cellular Networks (MAGNet); IBM Computational Biology Center(International Business Machines (IBM)); Marie Curie(European Commission); National Science Foundation (NSF)(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	G. S. and R. P. acknowledge support of the National Institutes of Health (NIH) Roadmap Initiative, the Columbia University Center for Multiscale Analysis Genomic and Cellular Networks (MAGNet), and the IBM Computational Biology Center. L. A. acknowledges funding from the Marie Curie MIRG-CT-2007-46531 grant. J.R. acknowledges funding from NIH P50-GM68762 and U54-CA11296 grants. G.A.-B. acknowledges funding from a National Science Foundation (NSF) grant 0848030 and NIH grant AI083408. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXOPOULOS L, 2009, NETWORKS RE IN PRESS; Anastassiou D, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100124; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Bonneau R, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r36; BOURQUE G, PLOS ONE UNPUB; Butte A J, 2000, Pac Symp Biocomput, P418; Butte AJ, 2000, P NATL ACAD SCI USA, V97, P12182, DOI 10.1073/pnas.220392197; Camacho D, 2007, ANN NY ACAD SCI, V1115, P73, DOI 10.1196/annals.1407.006; Cantone I, 2009, CELL, V137, P172, DOI 10.1016/j.cell.2009.01.055; David LA, 2007, ANN NY ACAD SCI, V1115, P90, DOI 10.1196/annals.1407.009; Feinerman O, 2008, SCIENCE, V321, P1081, DOI 10.1126/science.1158013; Granek JA, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r87; GUEX N, PLOS ONE IN PRESS; GUSTAFSSON M, PLOS ONE IN PRESS; Hache H, 2009, BIOINFORMATICS, V25, P1205, DOI 10.1093/bioinformatics/btp115; Haynes BC, 2009, BIOINFORMATICS, V25, P801, DOI 10.1093/bioinformatics/btp068; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; JIANHUA R, PLOS BIOL UNPUB; Kim HD, 2009, SCIENCE, V325, P429, DOI 10.1126/science.1171347; Kremling A, 2004, GENOME RES, V14, P1773, DOI 10.1101/gr.1226004; MADAR A, PLOS ONE UNPUB; Marbach D, 2009, J COMPUT BIOL, V16, P229, DOI 10.1089/cmb.2008.09TT; Margolin LG, 2006, J TURBUL, V7, P1, DOI 10.1080/14685240500331595; Moult J, 2006, PHILOS T R SOC B, V361, P453, DOI 10.1098/rstb.2005.1810; Natarajan K, 2001, MOL CELL BIOL, V21, P4347, DOI 10.1128/MCB.21.13.4347-4368.2001; Rice JJ, 2005, BIOINFORMATICS, V21, P765, DOI 10.1093/bioinformatics/bti064; Saez-Rodriguez J, 2008, BIOINFORMATICS, V24, P840, DOI 10.1093/bioinformatics/btn018; Saez-Rodriguez J, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.87; Stolovitzky G, 2007, ANN NY ACAD SCI, V1115, P1, DOI 10.1196/annals.1407.021; Stolovitzky G, 2009, ANN NY ACAD SCI, V1158, P159, DOI 10.1111/j.1749-6632.2009.04497.x; YIP K, PLOS ONE IN PRESS; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x; 2009, DREAM	33	292	295	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2010	5	2							e9202	10.1371/journal.pone.0009202	http://dx.doi.org/10.1371/journal.pone.0009202			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SV	20186320	Green Published, gold, Green Submitted			2022-12-25	WOS:000274924000002
J	Sultan, S; Mandairon, N; Kermen, F; Garcia, S; Sacquet, J; Didier, A				Sultan, S.; Mandairon, N.; Kermen, F.; Garcia, S.; Sacquet, J.; Didier, A.			Learning-dependent neurogenesis in the olfactory bulb determines long-term olfactory memory	FASEB JOURNAL			English	Article						plasticity; associative learning; Zif268	D-CYCLOSERINE; ADULT NEUROGENESIS; ODOR RECOGNITION; MAMMALIAN BRAIN; GRANULE CELL; NEURONS; DISCRIMINATION; PLASTICITY; EXPERIENCE; INCREASES	Inhibitory interneurons of the olfactory bulb are subjected to permanent adult neurogenesis. Their number is modulated by learning, suggesting that they could play a role in plastic changes of the bulbar network associated with olfactory memory. Adult male C57BL/6 mice were trained in an associative olfactory task, and we analyzed long-term retention of the task 5, 30, and 90 d post-training. In parallel, we assessed the fate of these newborn cells, mapped their distribution in the olfactory bulb and measured their functional implication using the immediate early gene Zif268. In a second set of experiments, we pharmacologically modulated glutamatergic transmission and using the same behavioral task assessed the consequences on memory retention and neurogenesis. Finally, by local infusion of an antimitotic drug, we selectively blocked neurogenesis during acquisition of the task and looked at the effects on memory retention. First we demonstrated that retrieval of an associative olfactory task recruits the newborn neurons in odor-specific areas of the olfactory bulb selected to survive during acquisition of the task and that it does this in a manner that depends on the strength of learning. We then demonstrated that acquisition is not dependent on neurogenesis if long-term retention of the task is abolished by blocking neurogenesis. Adult-born neurons are thus involved in changes in the neural representation of an odor; this underlies long-term olfactory memory as the strength of learning is linked to the duration of this memory. Neurogenesis thus plays a crucial role in long-term olfactory memory.-Sultan, S., Mandairon, N., Kermen, F., Garcia, S., Sacquet, J., Didier, A. Learning-dependent neurogenesis in the olfactory bulb determines long-term olfactory memory. FASEB J. 24, 2355-2363 (2010). www.fasebj.org	[Didier, A.] Univ Lyon 1, F-69007 Lyon, France; Ctr Natl Rech Sci, Unite Mixte Rech 5020, F-69007 Lyon, France	UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS)	Didier, A (corresponding author), Univ Lyon 1, F-69007 Lyon, France.	didier@olfac.univ-lyon1.fr	Mandairon, Nathalie/H-4439-2017; DIDIER, Anne/H-4413-2017	Mandairon, Nathalie/0000-0001-7935-5215; DIDIER, Anne/0000-0003-3118-9961; GARCIA, Samuel/0000-0001-6389-9779; KERMEN, Florence/0000-0002-2247-9636	Centre National de la Recherche Scientifique et Universite Lyon 1; French Ministry of Research and Technology; Region Rhone-Alpes	Centre National de la Recherche Scientifique et Universite Lyon 1(Centre National de la Recherche Scientifique (CNRS)); French Ministry of Research and Technology; Region Rhone-Alpes(Region Auvergne-Rhone-Alpes)	The authors thank Dr. M. Richard for her helpful comments on the manuscript. This work was supported by the Centre National de la Recherche Scientifique et Universite Lyon 1, the French Ministry of Research and Technology (doctoral fellowship to S. S.) and the Region Rhone-Alpes.	Alonso M, 2006, J NEUROSCI, V26, P10508, DOI 10.1523/JNEUROSCI.2633-06.2006; Bruel-Jungerman E, 2006, J NEUROSCI, V26, P5888, DOI 10.1523/JNEUROSCI.0782-06.2006; Buck LB, 1996, ANNU REV NEUROSCI, V19, P517, DOI 10.1146/annurev.ne.19.030196.002505; Buonviso N, 2000, NEUROSCIENCE, V95, P325; Burton S, 2000, J NEUROSCI, V20, P5468, DOI 10.1523/JNEUROSCI.20-14-05468.2000; Busto GU, 2009, EUR J NEUROSCI, V29, P1431, DOI 10.1111/j.1460-9568.2009.06689.x; Enwere E, 2004, J NEUROSCI, V24, P8354, DOI 10.1523/JNEUROSCI.2751-04.2004; FREEMAN WJ, 1982, PSYCHOPHYSIOLOGY, V19, P44, DOI 10.1111/j.1469-8986.1982.tb02598.x; Golden GJ, 2007, PHARMACOL BIOCHEM BE, V86, P587, DOI 10.1016/j.pbb.2007.02.004; Griesbach GS, 1998, BEHAV BRAIN RES, V97, P29, DOI 10.1016/S0166-4328(98)00015-1; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; Jonasson Z, 2004, HIPPOCAMPUS, V14, P28, DOI 10.1002/hipo.10146; Kaut KP, 2001, COGN AFFECT BEHAV NE, V1, P270, DOI 10.3758/CABN.1.3.270; Kaut KP, 2003, BEHAV NEUROSCI, V117, P304, DOI 10.1037/0735-7044.117.2.304; Kay LM, 1999, NAT NEUROSCI, V2, P1003, DOI 10.1038/14801; Knapska E, 2004, PROG NEUROBIOL, V74, P183, DOI 10.1016/j.pneurobio.2004.05.007; Lazarini F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007017; Leon M, 2003, BRAIN RES REV, V42, P23, DOI 10.1016/S0165-0173(03)00142-5; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; Magavi SSP, 2005, J NEUROSCI, V25, P10729, DOI 10.1523/JNEUROSCI.2250-05.2005; Mandairon N, 2006, NEUROSCIENCE, V141, P443, DOI 10.1016/j.neuroscience.2006.03.066; Mandairon N, 2008, NEUROBIOL LEARN MEM, V90, P178, DOI 10.1016/j.nlm.2008.02.008; Mandairon N, 2006, EUR J NEUROSCI, V24, P3578, DOI 10.1111/j.1460-9568.2006.05235.x; Mandairon N, 2009, J NEUROSCI METH, V180, P296, DOI 10.1016/j.jneumeth.2009.04.008; Martin C, 2006, EUR J NEUROSCI, V23, P1801, DOI 10.1111/j.1460-9568.2006.04711.x; Martin C, 2004, J NEUROSCI, V24, P389, DOI 10.1523/JNEUROSCI.3433-03.2004; Mombaerts P, 2004, CURR OPIN NEUROBIOL, V14, P31, DOI 10.1016/j.conb.2004.01.014; Moreno MM, 2009, P NATL ACAD SCI USA, V106, P17980, DOI 10.1073/pnas.0907063106; Mouly AM, 2001, NEUROSCIENCE, V102, P11, DOI 10.1016/S0306-4522(00)00476-0; Mouret A, 2008, J NEUROSCI, V28, P11511, DOI 10.1523/JNEUROSCI.2954-08.2008; Nissant A, 2009, NAT NEUROSCI, V12, P728, DOI 10.1038/nn.2298; Nunnink M, 2007, PHARMACOL BIOCHEM BE, V87, P321, DOI 10.1016/j.pbb.2007.05.006; Rochefort C, 2002, J NEUROSCI, V22, P2679, DOI 10.1523/JNEUROSCI.22-07-02679.2002; Sheinin A, 2001, NEUROPHARMACOLOGY, V41, P151, DOI 10.1016/S0028-3908(01)00073-9; Shepherd GM, 2007, BRAIN RES REV, V55, P373, DOI 10.1016/j.brainresrev.2007.03.005; Weber M, 2007, NEUROBIOL LEARN MEM, V87, P476, DOI 10.1016/j.nlm.2006.12.010	37	116	119	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2010	24	7					2355	2363		10.1096/fj.09-151456	http://dx.doi.org/10.1096/fj.09-151456			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	618HV	20215526				2022-12-25	WOS:000279343600022
J	Witte, F; Bernatik, O; Kirchner, K; Masek, J; Mahl, A; Krejci, P; Mundlos, S; Schambony, A; Bryja, V; Stricker, S				Witte, Florian; Bernatik, Ondrej; Kirchner, Katharina; Masek, Jan; Mahl, Annika; Krejci, Pavel; Mundlos, Stefan; Schambony, Alexandra; Bryja, Vitezslav; Stricker, Sigmar			Negative regulation of Wnt signaling mediated by CK1-phosphorylated Dishevelled via Ror2	FASEB JOURNAL			English	Article						Wnt/beta-catenin signaling; casein kinase; Wnt5a; Xenopus	RECEPTOR TYROSINE KINASE; BETA-ARRESTIN; PHOSPHORYLATION; DIFFERENTIATION; LOCALIZATION; BRANCHES; PATHWAY	Dishevelled (Dv1) is a multifunctional effector of different Wnt cascades. Both canonical Wnt3a and noncanonical Wnt5a stimulate casein-kinase-1 (CK1) -mediated phosphorylation of Dv1, visualized as electrophoretic mobility shift [phosphorylated and shifted Dv1 (ps-Dv1)]. However, the role of this phosphorylation remains obscure. Here we report the functional interaction of ps-Dv1 with the receptor tyrosine kinase Ror2, which is an alternative Wnt receptor and is able to inhibit canonical Wnt signaling. We demonstrate interaction between Ror2 and ps-Dv1 at the cell membrane after Wnt3a or Wnt5a stimulus dependent on CK1. Ps-Dv1 interacts with the C-terminal proline-serine-threonine-rich domain of Ror2, which is required for efficient inhibition of canonical Wnt signaling. We further show that the Dv1 C terminus, which seems to be exposed in ps-Dv1 and efficiently binds Ror2, is an intrinsic negative regulator of the canonical Wnt pathway downstream of beta-catenin. The Dv1 C terminus is necessary and sufficient to inhibit canonical Wnt/beta-catenin signaling, which is dependent on the presence of Ror2. Furthermore, both the Dv1 C terminus and CK1 epsilon can inhibit the Wnt5a/Ror2/ATF2 pathway in mammalian cells and Xenopus explant cultures. This suggests that phosphorylation of Dv1 triggers negative feedback regulation for different branches of Wnt signaling in a Ror2-dependent manner.-Witte, F., Bernatik, O., Kirchner, K., Masek, J., Mahl, A., Krejci, P., Mundlos, S., Schambony, A., Bryja, V., Stricker, S. Negative regulation of Wnt signaling mediated by CK1-phosphorylated Dishevelled via Ror2. FASEB J. 24, 2417-2426 (2010). www.fasebj.org	[Witte, Florian; Mahl, Annika; Mundlos, Stefan; Stricker, Sigmar] Max Planck Inst Mol Genet, Dev & Dis Grp, D-14195 Berlin, Germany; [Witte, Florian; Mahl, Annika; Mundlos, Stefan; Stricker, Sigmar] Charite, Inst Med Genet, D-13353 Berlin, Germany; [Witte, Florian; Mahl, Annika] Free Univ Berlin, Inst Chem Biochem, D-1000 Berlin, Germany; [Bernatik, Ondrej; Masek, Jan; Krejci, Pavel; Bryja, Vitezslav] Masaryk Univ, Fac Sci, Inst Expt Biol, CS-61137 Brno, Czech Republic; [Bernatik, Ondrej; Masek, Jan; Krejci, Pavel; Bryja, Vitezslav] Acad Sci Czech Republ, Inst Biophys, Dept Cytokinet, CS-61265 Brno, Czech Republic; [Kirchner, Katharina; Schambony, Alexandra] Univ Erlangen Nurnberg, Dept Biol, Dev Biol Unit, Erlangen, Germany	Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Masaryk University Brno; Czech Academy of Sciences; Institute of Biophysics of the Czech Academy of Sciences; University of Erlangen Nuremberg	Stricker, S (corresponding author), Max Planck Inst Mol Genet, Dev & Dis Grp, Ihnestr 73, D-14195 Berlin, Germany.	bryja@sci.muni.cz; strick_s@molgen.mpg.de	Krejčí, Pavel/I-4285-2014; Masek, Jan/I-9029-2014; Bryja, Vít?zslav/H-1925-2014; Stricker, Sigmar/B-9169-2009; Mundlos, Stefan/ABH-9585-2020; Mašek, Jan/N-3169-2019; Bryja, Vítězslav/P-4217-2019	Bryja, Vít?zslav/0000-0002-9136-5085; Stricker, Sigmar/0000-0002-7174-5363; Mašek, Jan/0000-0003-2904-3808; Bryja, Vítězslav/0000-0002-9136-5085; Mundlos, Stefan/0000-0002-9788-3166; Krejci, Pavel/0000-0003-0618-9134; Schambony, Alexandra/0000-0001-8771-5487; Bernatik, Ondrej/0000-0002-2188-332X	Deutsche Forschungsgemeinschaft (DFG) [SFB 577, SCHA965/2-3, 6-1]; Ministry of Education, Youth and Sports of the Czech Republic [MSM0021622430]; Academy of Sciences of the Czech Republic [KJB501630801, AVOZ50040507, AVOZ50040702]; Czech Science Foundation [204/09/H058, 204/09/0498, 204/09/J030]; EMBO; Berlin-Brandenburg School for Regenerative Therapies (BSRT)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Academy of Sciences of the Czech Republic(Czech Academy of Sciences); Czech Science Foundation(Grant Agency of the Czech Republic); EMBO(European Molecular Biology Organization (EMBO)); Berlin-Brandenburg School for Regenerative Therapies (BSRT)	The authors thank Kathrin Seidel for excellent technical assistance. This work was funded by grants from the Deutsche Forschungsgemeinschaft (DFG) to S.S. and S.M. (SFB 577) and to A.S. (SCHA965/2-3 and 6-1). V.B. is supported by MSM0021622430 (Ministry of Education, Youth and Sports of the Czech Republic), KJB501630801, AVOZ50040507, AVOZ50040702 (Academy of Sciences of the Czech Republic), 204/09/H058, 204/09/0498, 204/09/J030 (Czech Science Foundation), and an EMBO installation grant. A.M. is supported by the Berlin-Brandenburg School for Regenerative Therapies (BSRT).	Angers S, 2006, NAT CELL BIOL, V8, P348, DOI 10.1038/ncb1381; Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Billiard J, 2005, MOL ENDOCRINOL, V19, P90, DOI 10.1210/me.2004-0153; Bryja V, 2007, J CELL SCI, V120, P586, DOI 10.1242/jcs.03368; Bryja V, 2007, P NATL ACAD SCI USA, V104, P6690, DOI 10.1073/pnas.0611356104; Bryja V, 2008, EMBO REP, V9, P1244, DOI 10.1038/embor.2008.193; Chen W, 2003, SCIENCE, V301, P1391, DOI 10.1126/science.1082808; Cong F, 2004, MOL CELL BIOL, V24, P2000, DOI 10.1128/MCB.24.5.2000-2011.2004; Gonzalez-Sancho JM, 2004, MOL CELL BIOL, V24, P4757, DOI 10.1128/MCB.24.11.4757-4768.2004; Green JL, 2007, DEVELOPMENT, V134, P4053, DOI 10.1242/dev.005363; Hikasa H, 2002, DEVELOPMENT, V129, P5227; Hollemann T, 1999, ADV MOLEC BIOL, P279; Kani S, 2004, J BIOL CHEM, V279, P50102, DOI 10.1074/jbc.M409039200; Kibardin A, 2006, DEVELOPMENT, V133, P2845, DOI 10.1242/dev.02445; Kishida M, 2001, J BIOL CHEM, V276, P33147, DOI 10.1074/jbc.M103555200; Liu Y, 2007, MOL ENDOCRINOL, V21, P3050, DOI 10.1210/me.2007-0323; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; MASIAKOWSKI P, 1992, J BIOL CHEM, V267, P26181; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Nieuwkoop P. D., 1975, NORMAL TABLE XENOPUS; Oishi I, 2003, GENES CELLS, V8, P645, DOI 10.1046/j.1365-2443.2003.00662.x; Ossipova O, 2005, DEV CELL, V8, P829, DOI 10.1016/j.devcel.2005.04.011; Peters JM, 1999, NATURE, V401, P345, DOI 10.1038/43830; Rothbacher U, 2000, EMBO J, V19, P1010, DOI 10.1093/emboj/19.5.1010; Sammar M, 2004, GENES CELLS, V9, P1227, DOI 10.1111/j.1365-2443.2004.00799.x; Schambony A, 2007, DEV CELL, V12, P779, DOI 10.1016/j.devcel.2007.02.016; Schulte G, 2005, J NEUROCHEM, V92, P1550, DOI 10.1111/j.1471-4159.2004.03022.x; Schwabe GC, 2000, AM J HUM GENET, V67, P822, DOI 10.1086/303084; Schwarz-Romond T, 2007, NAT STRUCT MOL BIOL, V14, P484, DOI 10.1038/nsmb1247; Schwarzer W, 2009, HUM MOL GENET, V18, P4013, DOI 10.1093/hmg/ddp345; Semenov MV, 2007, CELL, V131, DOI 10.1016/j.cell.2007.12.011; Sun H, 2001, IEEE ASME INT C ADV, P636, DOI 10.1109/AIM.2001.936541; Swiatek W, 2004, J BIOL CHEM, V279, P13011, DOI 10.1074/jbc.M304682200; Wallingford JB, 2002, DEV CELL, V2, P695, DOI 10.1016/S1534-5807(02)00197-1; Wallingford JB, 2005, DEVELOPMENT, V132, P4421, DOI 10.1242/dev.02068; Willert K, 1997, EMBO J, V16, P3089, DOI 10.1093/emboj/16.11.3089; Winkel A, 2008, CELL SIGNAL, V20, P2134, DOI 10.1016/j.cellsig.2008.08.009; Yamamoto H, 2007, GENES CELLS, V12, P1215, DOI 10.1111/j.1365-2443.2007.01128.x	39	56	56	0	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2010	24	7					2417	2426		10.1096/fj.09-150615	http://dx.doi.org/10.1096/fj.09-150615			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	618HV	20215527	Bronze			2022-12-25	WOS:000279343600028
J	Pletneva, NV; Pletnev, VZ; Lukyanov, KA; Gurskaya, NG; Goryacheva, EA; Martynov, VI; Wlodawer, A; Dauter, Z; Pletnev, S				Pletneva, Nadya V.; Pletnev, Vladimir Z.; Lukyanov, Konstantin A.; Gurskaya, Nadya G.; Goryacheva, Ekaterina A.; Martynov, Vladimir I.; Wlodawer, Alexander; Dauter, Zbigniew; Pletnev, Sergei			Structural Evidence for a Dehydrated Intermediate in Green Fluorescent Protein Chromophore Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; GFP; MECHANISM; CYCLIZATION; EXCITATION; EXTENSION; VARIANTS; PROGRAM	The acGFPL is the first-identified member of a novel, colorless and non-fluorescent group of green fluorescent protein (GFP)-like proteins. Its mutant aceGFP, with Gly replacing the invariant catalytic Glu-222, demonstrates a relatively fast maturation rate and bright green fluorescence (lambda(ex) = 480 nm, lambda(em) = 505 nm). The reverse G222E single mutation in aceGFP results in the immature, colorless variant aceGFP-G222E, which undergoes irreversible photoconversion to a green fluorescent state under UV light exposure. Here we present a high resolution crystallographic study of aceGFP and aceGFP-G222E in the immature and UV-photoconverted states. A unique and striking feature of the colorless aceGFP-G222E structure is the chromophore in the trapped intermediate state, where cyclization of the protein backbone has occurred, but Tyr-66 still stays in the native, non-oxidized form, with C-alpha and C-beta atoms in the sp(3) hybridization. This experimentally observed immature aceGFP-G222E structure, characterized by the non-coplanar arrangement of the imidazolone and phenolic rings, has been attributed to one of the intermediate states in the GFP chromophore biosynthesis. The UV irradiation (lambda = 250-300 nm) of aceGFP-G222E drives the chromophore maturation further to a green fluorescent state, characterized by the conventional coplanar bicyclic structure with the oxidized double Tyr-66 C-alpha = C-beta bond and the conjugated system of pi-electrons. Structure-based site-directed mutagenesis has revealed a critical role of the proximal Tyr-220 in the observed effects. In particular, an alternative reaction pathway via Tyr-220 rather than conventional wild type Glu-222 has been proposed for aceGFP maturation.	[Pletnev, Sergei] SAIC Frederick Inc, Basic Res Program, Argonne, IL 60439 USA; [Pletneva, Nadya V.; Pletnev, Vladimir Z.; Lukyanov, Konstantin A.; Gurskaya, Nadya G.; Goryacheva, Ekaterina A.; Martynov, Vladimir I.] Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow 117997, Russia; [Dauter, Zbigniew; Pletnev, Sergei] NCI, Synchrotron Radiat Res Sect, Macromol Crystallog Lab, NIH, Argonne, IL 60439 USA; [Wlodawer, Alexander] NCI, Prot Struct Sect, Macromol Crystallog Lab, NIH, Frederick, MD 21702 USA	Science Applications International Corporation (SAIC); SAIC-Frederick; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Pletnev, S (corresponding author), SAIC Frederick Inc, Basic Res Program, 9700 S Cass Ave, Argonne, IL 60439 USA.	pletnevs@mail.nih.gov	Pletnev, Vladimir/Q-6151-2016; Pletneva, Nadya/F-7839-2014; Lukyanov, Konstantin A/D-4030-2013; Martynov, Vladimir I./S-3483-2016; Gurskaya, Nadya G/Q-1750-2016	Lukyanov, Konstantin A/0000-0001-9845-2088; Martynov, Vladimir I./0000-0003-4923-6842; Gurskaya, Nadya G/0000-0002-8028-8176; Pletneva, Nadya/0000-0001-9681-4022	National Institutes of Health, NCI, Center for Cancer Research; National Institutes of Health, NCI [HHSN261200800001E]; Russian Foundation for Basic Research [09-04-00212, 08-04-01702-a]; Russian Academy of Sciences; Russian Federation [MD-2780.2009.4]; NATIONAL CANCER INSTITUTE [ZIABC010348, ZIABC010378] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R24MD002780] Funding Source: NIH RePORTER	National Institutes of Health, NCI, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Academy of Sciences(Russian Academy of Sciences); Russian Federation(Russian Federation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported in part by the Intramural Research Program of the National Institutes of Health, NCI, Center for Cancer Research, and with federal funds from the National Institutes of Health, NCI, under Contract HHSN261200800001E. This project also was supported in part by the Russian Foundation for Basic Research (Grants 09-04-00212 and 08-04-01702-a), Molecular and Cell Biology Program Russian Academy of Sciences, and by Grant MD-2780.2009.4 from the President of the Russian Federation.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barondeau DP, 2006, J AM CHEM SOC, V128, P4685, DOI 10.1021/ja056635l; Barondeau DP, 2006, J AM CHEM SOC, V128, P3166, DOI 10.1021/ja0552693; Barondeau DP, 2003, P NATL ACAD SCI USA, V100, P12111, DOI 10.1073/pnas.2133463100; Barondeau DP, 2005, BIOCHEMISTRY-US, V44, P1960, DOI 10.1021/bi0479205; Brejc K, 1997, P NATL ACAD SCI USA, V94, P2306, DOI 10.1073/pnas.94.6.2306; Bulina ME, 2002, BMC BIOCHEM, V3, DOI 10.1186/1472-2091-3-7; Chudakov DM, 2005, TRENDS BIOTECHNOL, V23, P605, DOI 10.1016/j.tibtech.2005.10.005; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; EHRIG T, 1995, FEBS LETT, V367, P163, DOI 10.1016/0014-5793(95)00557-P; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gurskaya NG, 2003, BIOCHEM J, V373, P403, DOI 10.1042/BJ20021966; Gurskaya NG, 2001, FEBS LETT, V507, P16, DOI 10.1016/S0014-5793(01)02930-1; HEIM R, 1994, P NATL ACAD SCI USA, V91, P12501, DOI 10.1073/pnas.91.26.12501; Henderson JN, 2009, J AM CHEM SOC, V131, P4176, DOI 10.1021/ja808851n; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Palm GJ, 1997, NAT STRUCT BIOL, V4, P361, DOI 10.1038/nsb0597-361; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Perrakis A, 1997, ACTA CRYSTALLOGR D, V53, P448, DOI 10.1107/S0907444997005696; Pouwels LJ, 2008, BIOCHEMISTRY-US, V47, P10111, DOI 10.1021/bi8007164; Prescott M, 2003, STRUCTURE, V11, P275, DOI 10.1016/S0969-2126(03)00028-5; Remington SJ, 2006, CURR OPIN STRUC BIOL, V16, P714, DOI 10.1016/j.sbi.2006.10.001; Rosenow MA, 2004, BIOCHEMISTRY-US, V43, P4464, DOI 10.1021/bi0361315; Shu X, 2007, PROTEIN SCI, V16, P2703, DOI 10.1110/ps.073112007; Sniegowski JA, 2005, J BIOL CHEM, V280, P26248, DOI 10.1074/jbc.M412327200; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; van Thor JJ, 2002, NAT STRUCT BIOL, V9, P37, DOI 10.1038/nsb739; Verkhusha VV, 2004, NAT BIOTECHNOL, V22, P289, DOI 10.1038/nbt943; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wang YX, 2008, ANNU REV BIOMED ENG, V10, P1, DOI 10.1146/annurev.bioeng.010308.161731; Yang F, 1996, NAT BIOTECHNOL, V14, P1246, DOI 10.1038/nbt1096-1246; ZUBOVA NN, 2005, USP BIOL KHIM, V45, P1	36	21	22	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					15978	15984		10.1074/jbc.M109.092320	http://dx.doi.org/10.1074/jbc.M109.092320			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20220148	Green Published, hybrid			2022-12-25	WOS:000277715900035
J	Lee, SB; Park, JH; Woster, PM; Casero, RA; Park, MH				Lee, Seung Bum; Park, Jong Hwan; Woster, Patrick M.; Casero, Robert A., Jr.; Park, Myung Hee			Suppression of Exogenous Gene Expression by Spermidine/Spermine N-1-Acetyltransferase 1 (SSAT1) Cotransfection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENHANCES CELL-MIGRATION; POLYAMINE CATABOLISM; LUNG-CARCINOMA; ANALOGS; METABOLISM; INDUCTION; SPERMIDINE/SPERMINE-N-1-ACETYLTRANSFERASE-2; UBIQUITINATION; IDENTIFICATION; ACETYLATION	Spermidine/spermine N-1-acetyltransferase 1 (SSAT1), which catalyzes the N-1-acetylation of spermidine and spermine to form acetyl derivatives, is a rate-limiting enzyme in polyamine catabolism. We now report a novel activity of transiently transfected SSAT1 in suppressing the exogenous expression of other proteins, i.e. green fluorescent protein (GFP) or GFP-eIF5A. Spermidine/spermine N-1-acetyltransferase 2 (SSAT2) or inactive SSAT1 mutant enzymes (R101A or R101K) were without effect. The loss of exogenous gene expression is not due to accelerated protein degradation, because various inhibitors of proteases, lysosome, or autophagy did not mitigate the effects. This SSAT1 effect cannot be attributed to the depletion of overall cellular polyamines or accumulation of N-1-acetylspermidine (N-1-AcSpd) because of the following: (i) addition of putrescine, spermidine, spermine, or N-1-AcSpd did not restore the expression of GFP or GFP-eIF5A; (ii) depletion of cellular polyamines with alpha-difluoromethylornithine, an inhibitor of ornithine decarboxylase, did not inhibit exogenous gene expression; and (iii) N-1, N-11-bis(ethyl)norspermine caused a drastic depletion of cellular polyamines through induction of endogenous SSAT1 but did not block exogenous gene expression. SSAT1 transient transfection did not affect stable expression of GFP, and stably expressed SSAT1 did not affect exogenous expression of GFP, suggesting that only transiently (episomally) expressed SSAT1 blocks exogenous (episomal) expression of other proteins. SSAT1 may regulate exogenous gene expression by blocking steps involved in transcription/translation from an episomal vector by targeting non-polyamine substrate(s) critical for this pathway.	[Park, Myung Hee] NIDCR, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD 20892 USA; [Woster, Patrick M.] Wayne State Univ, Dept Pharmaceut Sci, Detroit, MI 48201 USA; [Casero, Robert A., Jr.] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Wayne State University; Johns Hopkins University; Johns Hopkins Medicine	Park, MH (corresponding author), NIDCR, Oral & Pharyngeal Canc Branch, NIH, Bldg 30,Rm 211, Bethesda, MD 20892 USA.	mhpark@nih.gov	Woster, Patrick M/A-5604-2010	Woster, Patrick M/0000-0002-9471-1916; Casero, Robert/0000-0001-5653-3306	National Institutes of Health [CA51085]; NIDCR; NATIONAL CANCER INSTITUTE [R01CA051085, R01CA149095] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000608] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grant CA51085 (extramural) and the NIDCR Intramural Research Program.	Babbar N, 2007, BIOCHEM SOC T, V35, P300, DOI 10.1042/BST0350300; Baek JH, 2007, J BIOL CHEM, V282, P33358, DOI 10.1074/jbc.M705627200; Baek JH, 2007, J BIOL CHEM, V282, P23572, DOI 10.1074/jbc.M703504200; BERGERON RJ, 1988, J MED CHEM, V31, P1183, DOI 10.1021/jm00401a019; Bewley MC, 2006, P NATL ACAD SCI USA, V103, P2063, DOI 10.1073/pnas.0511008103; Bras APM, 2001, DRUG METAB DISPOS, V29, P676; CASERO RA, 1990, BIOCHEM J, V270, P615, DOI 10.1042/bj2700615; CASERO RA, 1989, CANCER RES, V49, P3829; Chen C, 2004, J CELL BIOL, V167, P161, DOI 10.1083/jcb.200312166; Clement PMJ, 2003, EUR J BIOCHEM, V270, P4254, DOI 10.1046/j.1432-1033.2003.03806.x; COLEMAN CS, 1995, BIOCHEMISTRY-US, V34, P13423, DOI 10.1021/bi00041a020; Coleman CS, 2004, BIOCHEM J, V384, P139, DOI 10.1042/BJ20040790; Coleman CS, 1997, J BIOL CHEM, V272, P12164, DOI 10.1074/jbc.272.18.12164; Coleman CS, 1996, BIOCHEM J, V316, P697, DOI 10.1042/bj3160697; Coleman CS, 2001, BIOCHEM J, V358, P137, DOI 10.1042/0264-6021:3580137; Dehart GW, 2008, P NATL ACAD SCI USA, V105, P7188, DOI 10.1073/pnas.0708044105; FOLK JE, 1980, J BIOL CHEM, V255, P3695; Gabrielson EW, 1999, CLIN CANCER RES, V5, P1638; Hyvonen MT, 2007, BIOCHEM SOC T, V35, P326, DOI 10.1042/BST0350326; Jell J, 2007, J BIOL CHEM, V282, P8404, DOI 10.1074/jbc.M610265200; Kramer DL, 2008, J BIOL CHEM, V283, P4241, DOI 10.1074/jbc.M706806200; Lee SB, 2009, BIOCHEM BIOPH RES CO, V383, P497, DOI 10.1016/j.bbrc.2009.04.049; LIBBY PR, 1989, CANCER RES, V49, P6226; Lu L, 1996, J BIOL CHEM, V271, P18920, DOI 10.1074/jbc.271.31.18920; McCloskey DE, 2003, J BIOL CHEM, V278, P13881, DOI 10.1074/jbc.M205689200; Murray-Stewart T, 2003, BIOCHEM J, V373, P629, DOI 10.1042/BJ20021895; Park JH, 2006, P NATL ACAD SCI USA, V103, P51, DOI 10.1073/pnas.0509348102; Pegg AE, 2003, BIOCHEM SOC T, V31, P356, DOI 10.1042/BST0310356; Pegg AE, 2008, AM J PHYSIOL-ENDOC M, V294, pE995, DOI 10.1152/ajpendo.90217.2008; Pirinen E, 2007, MOL CELL BIOL, V27, P4953, DOI 10.1128/MCB.02034-06; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; Uemura T, 2008, J BIOL CHEM, V283, P26428, DOI 10.1074/jbc.M804714200	32	7	8	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15548	15556		10.1074/jbc.M109.092007	http://dx.doi.org/10.1074/jbc.M109.092007			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20212040	Green Published, hybrid			2022-12-25	WOS:000277399000073
J	Muratoglu, SC; Mikhailenko, I; Newton, C; Migliorini, M; Strickland, DK				Muratoglu, Selen Catania; Mikhailenko, Irina; Newton, Christopher; Migliorini, Mary; Strickland, Dudley K.			Low Density Lipoprotein Receptor-related Protein 1 (LRP1) Forms a Signaling Complex with Platelet-derived Growth Factor Receptor-beta in Endosomes and Regulates Activation of the MAPK Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							2 DISTINCT PHASES; TYROSINE PHOSPHORYLATION; PDGF RECEPTOR; INTIMAL HYPERPLASIA; CORECEPTOR FUNCTION; PORCINE ARTERIES; PHOSPHOLIPASE-C; DEFICIENT MICE; IN-VIVO; B GENE	In addition to its endocytic function, the low density lipoprotein receptor-related protein 1 (LRP1) also contributes to cell signaling events. In the current study, the potential of LRP1 to modulate the platelet-derived growth factor (PDGF) signaling pathway was investigated. PDGF is a key regulator of cell migration and proliferation and mediates the tyrosine phosphorylation of LRP1 within its cytoplasmic domain. In WI-38 fibroblasts, PDGF-mediated LRP1 tyrosine phosphorylation occurred at 37 C but not at 4 C, where endocytosis is minimized. Furthermore, blockade of endocytosis with the dynamin inhibitor, dynasore, also prevented PDGF-mediated LRP1 tyrosine phosphorylation. Immunofluorescence studies revealed co-localization of LRP1 with the PDGF receptor after PDGF treatment within endosomal compartments, whereas surface biotinylation experiments confirmed that phosphorylated LRP1 primarily originates from intracellular compartments. Together, the data reveal the association of these two receptors in endosomal compartments where they form a signaling complex. To study the contribution of LRP1 to PDGF signaling, we used mouse embryonic fibroblasts genetically deficient in LRP1 and identified phenotypic changes in these cell lines in response to PDGF stimulation by performing phospho-site profiling. Of 38 phosphorylated proteins analyzed, 8 were significantly different in LRP1 deficient fibroblasts and were restored when LRP1 was expressed back in these cells. Importantly, the results revealed that LRP1 expression is necessary for PDGF-mediated activation of ERK. Overall, the studies reveal that LRP1 associates with the PDGF receptor in endosomal compartments and modulates its signaling properties affecting the MAPK and Akt/phosphatidylinositol 3-kinase pathways.	[Muratoglu, Selen Catania; Mikhailenko, Irina; Newton, Christopher; Migliorini, Mary; Strickland, Dudley K.] Univ Maryland, Sch Med, Ctr Vasc & Inflammatory Dis, Baltimore, MD 21201 USA; [Mikhailenko, Irina; Strickland, Dudley K.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; [Strickland, Dudley K.] Univ Maryland, Sch Med, Dept Surg, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Strickland, DK (corresponding author), Univ Maryland, Sch Med, Ctr Vasc & Inflammatory Dis, 800 W Baltimore St,R219, Baltimore, MD 21201 USA.	dstrickland@som.umaryland.edu		Muratoglu Catania, Selen/0000-0002-1804-4875	National Institutes of Health [PO1 HL54710, PO1 HL50784]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL054710, R01HL050784] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants PO1 HL54710 and HL50784 (both to D. K. S.).	Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Balciunaite E, 2000, CURR BIOL, V10, P261, DOI 10.1016/S0960-9822(00)00358-4; BISHAYEE S, 1989, J BIOL CHEM, V264, P11699; Bostrom H, 1996, CELL, V85, P863, DOI 10.1016/S0092-8674(00)81270-2; Boucher P, 2003, SCIENCE, V300, P329, DOI 10.1126/science.1082095; Boucher P, 2002, J BIOL CHEM, V277, P15507, DOI 10.1074/jbc.M200428200; Boucher P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000448; De Donatis A, 2008, J BIOL CHEM, V283, P19948, DOI 10.1074/jbc.M709428200; DIGUGLIELMO GM, 1994, EMBO J, V13, P4269, DOI 10.1002/j.1460-2075.1994.tb06747.x; Fambrough D, 1999, CELL, V97, P727, DOI 10.1016/S0092-8674(00)80785-0; Fayard B, 2009, CANCER RES, V69, P5690, DOI 10.1158/0008-5472.CAN-08-4573; FERNS GAA, 1991, SCIENCE, V253, P1129, DOI 10.1126/science.1653454; FRACKELTON AR, 1984, J BIOL CHEM, V259, P7909; Giese NA, 1999, ARTERIOSCL THROM VAS, V19, P900, DOI 10.1161/01.ATV.19.4.900; Hart CE, 1999, CIRCULATION, V99, P564, DOI 10.1161/01.CIR.99.4.564; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; Hoshino R, 1999, ONCOGENE, V18, P813, DOI 10.1038/sj.onc.1202367; Huang SS, 2003, FASEB J, V17, P2068, DOI 10.1096/fj.03-0256com; Jain RK, 2008, PLOS MED, V5, P20, DOI 10.1371/journal.pmed.0050024; JAWIEN A, 1992, J CLIN INVEST, V89, P507, DOI 10.1172/JCI115613; JOLY M, 1995, J BIOL CHEM, V270, P13225, DOI 10.1074/jbc.270.22.13225; JOLY M, 1994, SCIENCE, V263, P684, DOI 10.1126/science.8303278; Jones SM, 2001, NAT CELL BIOL, V3, P165, DOI 10.1038/35055073; Karlsson L, 2000, DEVELOPMENT, V127, P3457; KOWAL RC, 1989, P NATL ACAD SCI USA, V86, P5810, DOI 10.1073/pnas.86.15.5810; KUMJIAN DA, 1989, P NATL ACAD SCI USA, V86, P8232, DOI 10.1073/pnas.86.21.8232; Lampugnani MG, 2006, J CELL BIOL, V174, P593, DOI 10.1083/jcb.200602080; Levitzki A, 2004, CYTOKINE GROWTH F R, V15, P229, DOI 10.1016/j.cytogfr.2004.03.010; Li YH, 2003, FEBS LETT, V555, P346, DOI 10.1016/S0014-5793(03)01272-9; Lillis AP, 2008, PHYSIOL REV, V88, P887, DOI 10.1152/physrev.00033.2007; Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242; Liu PS, 1996, J BIOL CHEM, V271, P10299, DOI 10.1074/jbc.271.17.10299; Loukinova E, 2002, J BIOL CHEM, V277, P15499, DOI 10.1074/jbc.M200427200; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Mettlen M, 2009, BIOCHEM SOC T, V37, P1022, DOI 10.1042/BST0371022; NABEL EG, 1993, J CLIN INVEST, V91, P1822, DOI 10.1172/JCI116394; Newton AJ, 2006, P NATL ACAD SCI USA, V103, P17955, DOI 10.1073/pnas.0606212103; Newton CS, 2005, J BIOL CHEM, V280, P27872, DOI 10.1074/jbc.M505410200; Pennock S, 2003, MOL CELL BIOL, V23, P5803, DOI 10.1128/MCB.23.16.5803-5815.2003; POMPILI VJ, 1995, ARTERIOSCL THROM VAS, V15, P2254, DOI 10.1161/01.ATV.15.12.2254; Sacco F, 2009, J BIOL CHEM, V284, P22048, DOI 10.1074/jbc.M109.002758; Salicioni AM, 2002, J BIOL CHEM, V277, P16160, DOI 10.1074/jbc.M201401200; Scotton CJ, 2007, CHEST, V132, P1311, DOI 10.1378/chest.06-2568; SILVERSTEIN SC, 1977, ANNU REV BIOCHEM, V46, P669, DOI 10.1146/annurev.bi.46.070177.003321; Tseng WF, 2004, FEBS LETT, V562, P71, DOI 10.1016/S0014-5793(04)00185-1; WAHL MI, 1989, MOL CELL BIOL, V9, P2934, DOI 10.1128/MCB.9.7.2934; Wang Y, 2004, J BIOL CHEM, V279, P8038, DOI 10.1074/jbc.M311494200	47	67	70	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14308	14317		10.1074/jbc.M109.046672	http://dx.doi.org/10.1074/jbc.M109.046672			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20220145	Green Published, hybrid			2022-12-25	WOS:000277299700028
J	Marcel, V; Vijayakumar, V; Fernandez-Cuesta, L; Hafsi, H; Sagne, C; Hautefeuille, A; Olivier, M; Hainaut, P				Marcel, V.; Vijayakumar, V.; Fernandez-Cuesta, L.; Hafsi, H.; Sagne, C.; Hautefeuille, A.; Olivier, M.; Hainaut, P.			p53 regulates the transcription of its Delta 133p53 isoform through specific response elements contained within the TP53 P2 internal promoter	ONCOGENE			English	Article						p53; Delta 133p53 isoform; promoter; transcriptional regulation; genotoxic stress	CANCER-CELLS; GENE; ACTIVATION; ZEBRAFISH; DIFFERENTIATION; DELTA-113P53; SUPPRESSION; EXPRESSION; DELTA-NP73; MUTATIONS	The tumor suppressor p53 protein is activated by genotoxic stress and regulates genes involved in senescence, apoptosis and cell-cycle arrest. Nine p53 isoforms have been described that may modulate suppressive functions of the canonical p53 protein. Among them, Delta 133p53 lacks the 132 proximal residues and has been shown to modulate p53-induced apoptosis and cell-cycle arrest. Delta 133p53 is expressed from a specific mRNA, p53I4, driven by an alternative promoter P2 located between intron 1 and exon 5 of TP53 gene. Here, we report that the P2 promoter is regulated in a p53-dependent manner. Delta 133p53 expression is increased in response to DNA damage by doxorubicin in p53 wild-type cell lines, but not in p53-mutated cells. Chromatin immunoprecipitation and luciferase assays using P2 promoter deletion constructs indicate that p53 binds functional response elements located within the P2 promoter. We also show that Delta 133p53 does not bind specifically to p53 consensus DNA sequence in vitro, but competes with wild-type p53 in specific DNA-binding assays. Finally, we report that Delta 133p53 counteracts p53-dependent growth suppression in clonogenic assays. These observations indicate that D133p53 is a novel target of p53 that may participate in a negative feedback loop controlling p53 function. Oncogene (2010) 29, 2691-2700; doi:10.1038/onc.2010.26; published online 1 March 2010	[Marcel, V.; Vijayakumar, V.; Fernandez-Cuesta, L.; Hafsi, H.; Sagne, C.; Hautefeuille, A.; Olivier, M.; Hainaut, P.] Int Agcy Res Canc, Mol Carcinogenesis Grp, F-69372 Lyon 08, France	World Health Organization; International Agency for Research on Cancer (IARC)	Hainaut, P (corresponding author), Int Agcy Res Canc, Mol Carcinogenesis & Biomarkers Grp, 150 Cours Albert Thomas, F-69372 Lyon 08, France.	hainaut@iarc.fr	Fernandez-Cuesta, Lynnette/O-2415-2017; MARCEL, Virginie/ABF-1904-2020; Fernandez-Cuesta, Lynnette/Z-1875-2019; Marcel, Virginie/H-3037-2011; Olivier, Magali/G-3728-2010; Hainaut, Pierre/B-6018-2012	Fernandez-Cuesta, Lynnette/0000-0002-0724-6703; MARCEL, Virginie/0000-0002-9557-8221; Fernandez-Cuesta, Lynnette/0000-0002-0724-6703; Marcel, Virginie/0000-0002-9557-8221; Olivier, Magali/0000-0002-8202-342X; Hainaut, Pierre/0000-0002-1303-1610; Vijayakumar, Vineetha/0000-0002-4295-7009	Association for International Cancer Research (AICR); Ligue Regionale du Rhone Contre le Cancer	Association for International Cancer Research (AICR); Ligue Regionale du Rhone Contre le Cancer	VM is supported by la Ligue National Contre le Cancer. LF-C is supported by The Association for International Cancer Research (AICR). This project is funded by la Ligue Regionale du Rhone Contre le Cancer.	Bacus SS, 1996, ONCOGENE, V12, P2535; Boldrup L, 2007, EUR J CANCER, V43, P617, DOI 10.1016/j.ejca.2006.10.019; Bourdon JC, 2007, BRIT J CANCER, V97, P277, DOI 10.1038/sj.bjc.6603886; Bourdon JC, 2005, GENE DEV, V19, P2122, DOI 10.1101/gad.1339905; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chen J, 2005, GENE DEV, V19, P2900, DOI 10.1101/gad.1366405; Chen J, 2009, GENE DEV, V23, P278, DOI 10.1101/gad.1761609; CHO YJ, 1994, SCIENCE, V265, P346, DOI 10.1126/science.8023157; Courtois S, 2002, ONCOGENE, V21, P6722, DOI 10.1038/sj.onc.1205874; Danilova N, 2008, BLOOD, V112, P5228, DOI 10.1182/blood-2008-01-132290; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Ghosh A, 2004, MOL CELL BIOL, V24, P7987, DOI 10.1128/MCB.24.18.7987-7997.2004; Grob TJ, 2001, CELL DEATH DIFFER, V8, P1213, DOI 10.1038/sj.cdd.4400962; Harmes DC, 2003, ONCOGENE, V22, P7607, DOI 10.1038/sj.onc.1207129; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hurd C, 1997, ONCOGENE, V15, P991, DOI 10.1038/sj.onc.1201233; Ishimoto O, 2002, CANCER RES, V62, P636; Kaghad M, 1997, CELL, V90, P809, DOI 10.1016/S0092-8674(00)80540-1; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Marcel V, 2009, CELL MOL LIFE SCI, V66, P391, DOI 10.1007/s00018-008-8336-3; Menendez D, 2007, ONCOGENE, V26, P2191, DOI 10.1038/sj.onc.1210277; MIYASHITA T, 1995, CELL, V80, P293; Murray-Zmijewski F, 2006, CELL DEATH DIFFER, V13, P962, DOI 10.1038/sj.cdd.4401914; Petitjean A, 2007, ONCOGENE, V26, P2157, DOI 10.1038/sj.onc.1210302; TUCK SP, 1989, MOL CELL BIOL, V9, P2163, DOI 10.1128/MCB.9.5.2163; Verhaegh GW, 1997, MOL CELL BIOL, V17, P5699, DOI 10.1128/MCB.17.10.5699; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Vousden KH, 2006, J CELL SCI, V119, P5015, DOI 10.1242/jcs.03293; WALDMAN T, 1995, CANCER RES, V55, P5187; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0	31	53	57	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAY 6	2010	29	18					2691	2700		10.1038/onc.2010.26	http://dx.doi.org/10.1038/onc.2010.26			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	592DC	20190805				2022-12-25	WOS:000277354600009
J	El Hour, M; Moncada-Pazos, A; Blacher, S; Masset, A; Cal, S; Berndt, S; Detilleux, J; Host, L; Obaya, AJ; Maillard, C; Foidart, JM; Ectors, F; Noel, A; Lopez-Otin, C				El Hour, M.; Moncada-Pazos, A.; Blacher, S.; Masset, A.; Cal, S.; Berndt, S.; Detilleux, J.; Host, L.; Obaya, A. J.; Maillard, C.; Foidart, J. M.; Ectors, F.; Noel, A.; Lopez-Otin, C.			Higher sensitivity of Adamts12-deficient mice to tumor growth and angiogenesis	ONCOGENE			English	Article						ADAMTS-12; angiogenesis; tumor suppression	MATRIX METALLOPROTEINASES; ADAMTS METALLOPROTEINASES; EMERGING ROLES; CANCER; VASCULARIZATION; SUSCEPTIBILITY; PROGRESSION; EXPRESSION; PROTEASES; STROMA	ADAMTS (a disintegrin and metalloproteinase domain with thrombospondin motifs) constitute a family of endopeptidases related to matrix metalloproteinases. These proteases have been largely implicated in tissue remodeling and angiogenesis associated with physiological and pathological processes. To elucidate the in vivo functions of ADAMTS-12, we have generated a knockout mouse strain (Adamts12(-/-)) in which Adamts12 gene was deleted. The mutant mice had normal gestations and no apparent defects in growth, life span and fertility. By applying three different in vivo models of angiogenesis (malignant keratinocyte transplantation, Matrigel plug and aortic ring assays) to Adamts12(-/-) mice, we provide evidence for a protective effect of this host enzyme toward angiogenesis and cancer progression. In the absence of Adamts-12, both the angiogenic response and tumor invasion into host tissue were increased. Complementing results were obtained by using medium conditioned by cells overexpressing human ADAMTS-12, which inhibited vessel outgrowth in the aortic ring assay. This angioinhibitory effect of ADAMTS-12 was independent of its enzymatic activity as a mutated inactive form of the enzyme was similarly efficient in inhibiting endothelial cell sprouting in the aortic ring assay than the wild-type form. Altogether, our results show that ADAMTS-12 displays antiangiogenic properties and protect the host toward tumor progression. Oncogene (2010) 29, 3025-3032; doi:10.1038/onc.2010.49; published online 8 March 2010	[Noel, A.] Univ Liege, Lab Tumor & Dev Biol, GIGA Canc, CHU Sart Tilman, B-4000 Liege, Belgium; [Moncada-Pazos, A.; Cal, S.; Obaya, A. J.; Lopez-Otin, C.] Univ Oviedo, Inst Univ Oncol, Dept Bioquim & Biol Mol, Asturias, Spain; [Ectors, F.] Univ Liege, GIGA Transgenesis, B-4000 Liege, Belgium	University of Liege; University of Oviedo; Instituto Universitario de Oncologia de Asturias; University of Liege	Noel, A (corresponding author), Univ Liege, Lab Tumor & Dev Biol, GIGA Canc, CHU Sart Tilman, Tour Pathol B23, B-4000 Liege, Belgium.	agnes.noel@ulg.ac.be	López-Otín, Carlos/AAB-2106-2020; Obaya, Alvaro J./AAQ-6115-2021	López-Otín, Carlos/0000-0001-6964-1904; Obaya, Alvaro J./0000-0002-4163-2173; Noel, Agnes/0000-0002-7670-6179; MONCADA PAZOS, ANGELA/0000-0002-3871-2965	Ministerio de Ciencia e Innovacion, Fundacion M. Botin (Spain) [201279]; FP7-HEALTH-2007-A [201279]; Fonds de la Recherche Scientifique-FNRS (FRS-FNRS, Belgium); Foundation against Cancer; DGTRE from the SPW (Region Wallonne, Belgium); Interuniversity Attraction Poles Programme-Belgian Science Policy (Brussels, Belgium)	Ministerio de Ciencia e Innovacion, Fundacion M. Botin (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); FP7-HEALTH-2007-A; Fonds de la Recherche Scientifique-FNRS (FRS-FNRS, Belgium)(Fonds de la Recherche Scientifique - FNRS); Foundation against Cancer; DGTRE from the SPW (Region Wallonne, Belgium); Interuniversity Attraction Poles Programme-Belgian Science Policy (Brussels, Belgium)(Belgian Federal Science Policy Office)	The authors acknowledge F Olivier, G Roland and L Volders for their excellent technical assistance. This work was supported by grants from Ministerio de Ciencia e Innovacion, Fundacion M. Botin (Spain), the FP7-HEALTH-2007-A-Project No. 201279 'MICROENVIMET', the Fonds de la Recherche Scientifique-FNRS (FRS-FNRS, Belgium), the Foundation against Cancer (foundation of public interest, Belgium), the DGTRE from the SPW (Region Wallonne, Belgium), the Interuniversity Attraction Poles Programme-Belgian Science Policy (Brussels, Belgium). MEH, AM, JD, LH and FE are recipients of grants from the Fonds de la Recherche Scientifique (FRS-FNRS, Belgium).	Bai XH, 2009, CELL MOL LIFE SCI, V66, P667, DOI 10.1007/s00018-008-8633-x; Balbin M, 2003, NAT GENET, V35, P252, DOI 10.1038/ng1249; Berndt S, 2006, FASEB J, V20, P2630, DOI 10.1096/fj.06-5885fje; Berndt Sarah, 2008, P305, DOI 10.1007/978-0-387-69057-5_16; Blacher S, 2008, MICROVASC RES, V75, P169, DOI 10.1016/j.mvr.2007.09.002; Cal S, 2001, J BIOL CHEM, V276, P17932, DOI 10.1074/jbc.M100534200; Cauwe B, 2007, CRIT REV BIOCHEM MOL, V42, P113, DOI 10.1080/10409230701340019; Dunn JR, 2006, BRIT J CANCER, V94, P1186, DOI 10.1038/sj.bjc.6603006; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; FUSENIG NE, 1983, J INVEST DERMATOL, V81, P168; Iruela-Arispe ML, 2003, ANN NY ACAD SCI, V995, P183, DOI 10.1111/j.1749-6632.2003.tb03221.x; Jost M, 2007, AM J PATHOL, V171, P1369, DOI 10.2353/ajpath.2007.070074; Jost M, 2006, CANCER RES, V66, P5234, DOI 10.1158/0008-5472.CAN-05-4315; Jost Maud, 2008, P327, DOI 10.1007/978-0-387-69057-5_17; Kurz T, 2006, J ALLERGY CLIN IMMUN, V118, P396, DOI 10.1016/j.jaci.2006.04.036; Lambert V, 2003, FASEB J, V17, P2290, DOI 10.1096/fj.03-0113fje; Liu YJ, 2006, ONCOGENE, V25, P2452, DOI 10.1038/sj.onc.1209287; Llamazares M, 2007, J CELL SCI, V120, P3544, DOI 10.1242/jcs.005751; Lopez-Otin C, 2007, NAT REV CANCER, V7, P800, DOI 10.1038/nrc2228; Luque A, 2003, J BIOL CHEM, V278, P23656, DOI 10.1074/jbc.M212964200; Masson Veronique, 2002, Biological Procedures Online, V4, P24, DOI 10.1251/bpo30; Moncada-Pazos A, 2009, J CELL SCI, V122, P2906, DOI 10.1242/jcs.050468; Mueller MM, 2004, NAT REV CANCER, V4, P839, DOI 10.1038/nrc1477; Noel A, 2008, SEMIN CELL DEV BIOL, V19, P52, DOI 10.1016/j.semcdb.2007.05.011; Nyberg P, 2008, FRONT BIOSCI, V13, P6537, DOI 10.2741/3173; Overall CM, 2007, NAT REV MOL CELL BIO, V8, P245, DOI 10.1038/nrm2120; Porter S, 2004, CLIN CANCER RES, V10, P2429, DOI 10.1158/1078-0432.CCR-0398-3; Porter S, 2005, BIOCHEM J, V386, P15, DOI 10.1042/BJ20040424; Rocks N, 2008, BIOCHIMIE, V90, P369, DOI 10.1016/j.biochi.2007.08.008; Vazquez F, 1999, J BIOL CHEM, V274, P23349, DOI 10.1074/jbc.274.33.23349	30	69	69	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAY	2010	29	20					3025	3032		10.1038/onc.2010.49	http://dx.doi.org/10.1038/onc.2010.49			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	599DM	20208563	Green Published, Green Submitted			2022-12-25	WOS:000277890400013
J	Bie, JH; Zhao, B; Song, JM; Ghosh, S				Bie, Jinghua; Zhao, Bin; Song, Jingmei; Ghosh, Shobha			Improved Insulin Sensitivity in High Fat- and High Cholesterol-fed Ldlr(-/-) Mice with Macrophage-specific Transgenic Expression of Cholesteryl Ester Hydrolase ROLE OF MACROPHAGE INFLAMMATION AND INFILTRATION INTO ADIPOSE TISSUE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; HIGH-DENSITY-LIPOPROTEIN; NF-KAPPA-B; IN-VIVO; ABCA1-DEFICIENT MACROPHAGES; CARDIOVASCULAR-DISEASE; RESISTANCE; CELLS; INTERLEUKIN-1-BETA; ATHEROSCLEROSIS	Cellular cholesterol balance induces changes in the inflammatory status of macrophages, and low grade chronic inflammation is increasingly being recognized as one of the key steps in the development of atherosclerosis as well as insulin resistance. Cholesteryl ester hydrolase (CEH) catalyzes the hydrolysis of intracellular stored cholesteryl esters (CEs) and thereby enhances free cholesterol efflux and reduces cellular CE content. We have earlier reported reduced atherosclerosis and lesion necrosis in macrophage-specific CEH transgenic mice on a Ldlr(-/-) background. In the present study, we tested the hypothesis that reduced intracellular accumulation of CE in macrophages from CEH transgenic mice will attenuate expression of proinflammatory mediators, thereby reducing infiltration into adipose tissue, alleviating inflammation, and resulting in improved insulin sensitivity. Western diet fed Ldlr(-/-) CEH transgenic mice showed improved insulin sensitivity as assessed by glucose and insulin tolerance tests. Macrophages from CEH transgenic mice expressed significantly lower levels of proinflammatory cytokines (interleukin-1 beta and interleukin-6) and chemokine (MCP-1; monocyte chemoattractant protein). Attenuation of NF-kappa B- and AP-1-driven gene expression was determined to be the underlying mechanism. Infiltration of macrophages into the adipose tissue that increases inflammation and impairs insulin signaling was also significantly reduced in Ldlr(-/-) CEH transgenic mice. In the OP-9 adipocyte peritoneal macrophage co-culture system, macrophages from CEH transgenic mice had a significantly reduced effect on insulin signaling as measured by Akt phosphorylation compared with nontransgenic macrophages. Taken together, these studies demonstrate that macrophage-specific overexpression of CEH decreases expression of proinflammatory mediators and attenuates macrophage infiltration into the adipose tissue, resulting in decreased circulating cytokines and improved insulin sensitivity.	[Ghosh, Shobha] Virginia Commonwealth Univ, Med Ctr, Div Pulm & Crit Care, Dept Internal Med, Richmond, VA 23298 USA	Virginia Commonwealth University	Ghosh, S (corresponding author), Virginia Commonwealth Univ, Med Ctr, Div Pulm & Crit Care, Dept Internal Med, Med Coll Virginia Campus, Richmond, VA 23298 USA.	shobha@vcu.edu			NHLBI [HL-069946]; American Diabetes Association [7-08-RA-51]; NATIONAL CANCER INSTITUTE [P30CA016059] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069946] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Diabetes Association(American Diabetes Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Research Grant HL-069946 from NHLBI. This work was also supported by Research Award 7-08-RA-51 from the American Diabetes Association (to S. G.).	Alvarez B, 2002, BBA-MOL CELL RES, V1542, P66, DOI 10.1016/S0167-4889(01)00167-7; BESEDOVSKY HO, 1990, ANN NY ACAD SCI, V594, P214; Bouloumie A, 2005, CURR OPIN CLIN NUTR, V8, P347, DOI 10.1097/01.mco.0000172571.41149.52; Brown JM, 2004, J BIOL CHEM, V279, P26735, DOI 10.1074/jbc.M401766200; Chait A, 2005, J LIPID RES, V46, P389, DOI 10.1194/jlr.R400017-JLR200; Fazio S, 2001, AM J CARDIOL, V88, p12E; Ferreira V, 2007, ATHEROSCLEROSIS, V192, P283, DOI 10.1016/j.atherosclerosis.2006.07.018; Francone OL, 2005, ARTERIOSCL THROM VAS, V25, P1198, DOI 10.1161/01.ATV.0000166522.69552.99; Ghosh S, 2003, J LIPID RES, V44, P1833, DOI 10.1194/jlr.M300162-JLR200; Gustafson B, 2007, ARTERIOSCL THROM VAS, V27, P2276, DOI 10.1161/ATVBAHA.107.147835; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Jager J, 2007, ENDOCRINOLOGY, V148, P241, DOI 10.1210/en.2006-0692; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Kim DH, 2008, AM J PHYSIOL-ENDOC M, V295, pE1038, DOI 10.1152/ajpendo.00061.2008; Koseki M, 2007, J LIPID RES, V48, P299, DOI 10.1194/jlr.M600428-JLR200; Lagathu C, 2003, BIOCHEM BIOPH RES CO, V311, P372, DOI 10.1016/j.bbrc.2003.10.013; LEVINE DM, 1993, P NATL ACAD SCI USA, V90, P12040, DOI 10.1073/pnas.90.24.12040; Maedler K, 2009, EXPERT OPIN BIOL TH, V9, P1177, DOI 10.1517/14712590903136688; McGillicuddy FC, 2009, CIRCULATION, V119, P1135, DOI 10.1161/CIRCULATIONAHA.108.810721; Nam JS, 2008, DIABETES RES CLIN PR, V81, P25, DOI 10.1016/j.diabres.2008.01.032; Patel S, 2009, J AM COLL CARDIOL, V53, P962, DOI 10.1016/j.jacc.2008.12.008; Persson J, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-70; Subramanian S, 2008, ARTERIOSCL THROM VAS, V28, P685, DOI 10.1161/ATVBAHA.107.157685; Taishi P, 2008, BRAIN RES, V1226, P89, DOI 10.1016/j.brainres.2008.05.067; Tang CR, 2009, BBA-MOL CELL BIOL L, V1791, P563, DOI 10.1016/j.bbalip.2009.03.011; Trayhurn P, 2004, BRIT J NUTR, V92, P347, DOI 10.1079/BJN20041213; Vozarova B, 2001, OBES RES, V9, P414, DOI 10.1038/oby.2001.54; Wisse BE, 2004, J AM SOC NEPHROL, V15, P2792, DOI 10.1097/01.ASN.0000141966.69934.21; Wolins NE, 2006, J LIPID RES, V47, P450, DOI 10.1194/jlr.D500037-JLR200; Zhao B, 2007, J CLIN INVEST, V117, P2983, DOI 10.1172/JCI30485; Zhu X, 2008, J BIOL CHEM, V283, P22930, DOI 10.1074/jbc.M801408200	31	37	39	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13630	13637		10.1074/jbc.M109.069781	http://dx.doi.org/10.1074/jbc.M109.069781			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20189995	hybrid, Green Published			2022-12-25	WOS:000276987700037
J	Kozlov, G; Safaee, N; Rosenauer, A; Gehring, K				Kozlov, Guennadi; Safaee, Nozhat; Rosenauer, Angelika; Gehring, Kalle			Structural Basis of Binding of P-body-associated Proteins GW182 and Ataxin-2 by the Mlle Domain of Poly(A)-binding Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA DEADENYLATION; C-TERMINAL DOMAIN; TRANSLATIONAL REPRESSION; POLY(A) NUCLEASE; UBIQUITIN LIGASE; MAMMALIAN-CELLS; GENE-EXPRESSION; DECAY; PABC; RECOGNITION	Poly(A)-binding protein (PABPC1) is involved in multiple aspects of mRNA processing and translation. It is a component of RNA stress granules and binds the RNA-induced silencing complex to promote degradation of silenced mRNAs. Here, we report the crystal structures of the C-terminal Mlle (or PABC) domain in complex with peptides from GW182 (TNRC6C) and Ataxin-2. The structures reveal overlapping binding sites but with unexpected diversity in the peptide conformation and residues involved in binding. The mutagenesis and binding studies show low to submicromolar binding affinity with overlapping but distinct specificity determinants. These results rationalize the role of the Mlle domain of PABPC1 in microRNA-mediated mRNA deadenylation and suggest a more general function in the assembly of cytoplasmic RNA granules.	[Gehring, Kalle] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; McGill Univ, Grp Rech Axe Struct Prot, Montreal, PQ H3G 1Y6, Canada	McGill University; McGill University	Gehring, K (corresponding author), McGill Univ, Dept Biochem, 3655 Promenade Sir William Osler, Montreal, PQ H3G 1Y6, Canada.	kalle.gehring@mcgill.ca	Gehring, Kalle/I-4403-2013; Gehring, Kalle/N-2945-2019	Gehring, Kalle/0000-0001-6500-1184; Gehring, Kalle/0000-0001-6500-1184	National Science Foundation [DMR 0225180]; National Institutes of Health [RR-01646]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001646] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Data acquisition at the Macromolecular Diffraction Facility at the Cornell High Energy Synchrotron Source (Cornell High Energy Synchrotron Source) was supported by National Science Foundation Award DMR 0225180 and National Institutes of Health Award RR-01646.	Anderson P, 2009, NAT REV MOL CELL BIO, V10, P430, DOI 10.1038/nrm2694; Balagopal V, 2009, CURR OPIN CELL BIOL, V21, P403, DOI 10.1016/j.ceb.2009.03.005; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Behm-Ansmant I, 2006, GENE DEV, V20, P1885, DOI 10.1101/gad.1424106; Beilharz TH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006783; Chekulaeva M, 2009, RNA, V15, P794, DOI 10.1261/rna.1364909; Chen CYA, 2009, NAT STRUCT MOL BIOL, V16, P1160, DOI 10.1038/nsmb.1709; Ciosk R, 2004, DEVELOPMENT, V131, P4831, DOI 10.1242/dev.01352; Deo RC, 2001, P NATL ACAD SCI USA, V98, P4414, DOI 10.1073/pnas.071552198; Ding L, 2007, TRENDS CELL BIOL, V17, P411, DOI 10.1016/j.tcb.2007.06.003; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; Eulalio A, 2009, RNA, V15, P21, DOI 10.1261/rna.1399509; Ezzeddine N, 2007, MOL CELL BIOL, V27, P7791, DOI 10.1128/MCB.01254-07; Fabian MR, 2009, MOL CELL, V35, P868, DOI 10.1016/j.molcel.2009.08.004; Funakoshi Y, 2007, GENE DEV, V21, P3135, DOI 10.1101/gad.1597707; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Horiuchi M, 2009, J BIOL CHEM, V284, P13244, DOI 10.1074/jbc.M809250200; Hoshino S, 1999, J BIOL CHEM, V274, P16677, DOI 10.1074/jbc.274.24.16677; Huynh DP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006235; Katzenellenbogen RA, 2007, J VIROL, V81, P3786, DOI 10.1128/JVI.02007-06; Khaleghpour K, 2001, MOL CELL, V7, P205, DOI 10.1016/S1097-2765(01)00168-X; Konig J, 2009, EMBO J, V28, P1855, DOI 10.1038/emboj.2009.145; Kozlov G, 2001, P NATL ACAD SCI USA, V98, P4409, DOI 10.1073/pnas.071024998; Kozlov G, 2004, EMBO J, V23, P272, DOI 10.1038/sj.emboj.7600048; Kozlov G, 2007, J BIOL CHEM, V282, P35787, DOI 10.1074/jbc.M705655200; Kuhn U, 2004, BBA-GENE STRUCT EXPR, V1678, P67, DOI 10.1016/j.bbaexp.2004.03.008; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lessing D, 2008, PLOS BIOL, V6, P266, DOI 10.1371/journal.pbio.0060029; Lim NS, 2006, J BIOL CHEM, V281, P14376, DOI 10.1074/jbc.M600307200; Mangus DA, 2004, MOL CELL BIOL, V24, P5521, DOI 10.1128/MCB.24.12.5521-5533.2004; Mangus DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-223; Mangus DA, 1998, MOL CELL BIOL, V18, P7383, DOI 10.1128/MCB.18.12.7383; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mauxion F, 2009, TRENDS BIOCHEM SCI, V34, P640, DOI 10.1016/j.tibs.2009.07.008; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Nonhoff U, 2007, MOL BIOL CELL, V18, P1385, DOI 10.1091/mbc.E06-12-1120; Okochi K, 2005, GENES CELLS, V10, P151, DOI 10.1111/j.1365-2443.2005.00826.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ralser M, 2005, J MOL BIOL, V346, P203, DOI 10.1016/j.jmb.2004.11.024; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Satterfield TF, 2006, HUM MOL GENET, V15, P2523, DOI 10.1093/hmg/ddl173; Siddiqui N, 2007, J BIOL CHEM, V282, P25067, DOI 10.1074/jbc.M701256200; Simon E, 2007, NUCLEIC ACIDS RES, V35, P6017, DOI 10.1093/nar/gkm452; Tasaki T, 2005, MOL CELL BIOL, V25, P7120, DOI 10.1128/MCB.25.16.7120-7136.2005; TROTTIER Y, 1995, NATURE, V378, P403, DOI 10.1038/378403a0; Uchida N, 2004, J BIOL CHEM, V279, P1383, DOI 10.1074/jbc.M309125200; Wakiyama M, 2007, GENE DEV, V21, P1857, DOI 10.1101/gad.1566707; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Wu LG, 2006, P NATL ACAD SCI USA, V103, P4034, DOI 10.1073/pnas.0510928103; Yoshida M, 2006, EMBO J, V25, P1934, DOI 10.1038/sj.emboj.7601079; Zekri L, 2009, MOL CELL BIOL, V29, P6220, DOI 10.1128/MCB.01081-09; Zheng DH, 2008, J CELL BIOL, V182, P89, DOI 10.1083/jcb.200801196; Zipprich JT, 2009, RNA, V15, P781, DOI 10.1261/rna.1448009	54	65	65	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13599	13606		10.1074/jbc.M109.089540	http://dx.doi.org/10.1074/jbc.M109.089540			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20181956	Green Published, hybrid			2022-12-25	WOS:000276987700033
J	Suzuki, A; Sanda, N; Miyawaki, Y; Fujimori, Y; Yamada, T; Takagi, A; Murate, T; Saito, H; Kojima, T				Suzuki, Atsuo; Sanda, Naomi; Miyawaki, Yuhri; Fujimori, Yuta; Yamada, Takayuki; Takagi, Akira; Murate, Takashi; Saito, Hidehiko; Kojima, Tetsuhito			Down-regulation of PROS1 Gene Expression by 17 beta-Estradiol via Estrogen Receptor alpha (ER alpha)-Sp1 Interaction Recruiting Receptor-interacting Protein 140 and the Corepressor-HDAC3 Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							K-DEPENDENT PROTEIN; BREAST-CANCER CELLS; C4B-BINDING PROTEIN; S DEFICIENCY; TRANSCRIPTION FACTORS; SP1; BINDING; PLASMA; BIOSYNTHESIS; ORGANIZATION	Pregnant women show a low level of protein S (PS) in plasma, which is known to be a risk for deep venous thrombosis. 17 beta-Estradiol (E-2), an estrogen that increases in concentration in the late stages of pregnancy, regulates the expression of various genes via the estrogen receptor (ER). Here, we investigated the molecular mechanisms behind the reduction in PS levels caused by E-2 in HepG2-ER alpha cells, which stably express ER alpha, and also the genomic ER signaling pathway, which modulates the ligand-dependent repression of the PS alpha gene (PROS1). We observed that E-2 repressed the production of mRNA and antigen of PS. A luciferase reporter assay revealed that E-2 down-regulated PROS1 promoter activity and that this E-2-dependent repression disappeared upon the deletion or mutation of two adjacent GC-rich motifs in the promoter. An electrophoretic mobility shift assay and DNA pulldown assay revealed that the GC-rich motifs were associated with Sp1, Sp3, and ER alpha. In a chromatin immunoprecipitation assay, we found ER alpha-Sp protein-promoter interaction involved in the E-2-dependent repression of PROS1 transcription. Furthermore, we demonstrated that E-2 treatment recruited RIP140 and the NCoR-SMRT-HDAC3 complex to the PROS1 promoter, which hypoacetylated chromatin. Taken together, this suggested that E-2 might repress PROS1 transcription depending upon ER alpha-Sp1 recruiting transcriptional repressors in HepG2-ER alpha cells and, consequently, that high levels of E-2 leading to reduced levels of plasma PS would be a risk for deep venous thrombosis in pregnant women.	[Takagi, Akira; Murate, Takashi; Kojima, Tetsuhito] Nagoya Univ, Sch Hlth Sci, Dept Med Technol, Higashi Ku, Nagoya, Aichi 4618673, Japan; [Suzuki, Atsuo; Miyawaki, Yuhri; Fujimori, Yuta; Yamada, Takayuki; Takagi, Akira; Murate, Takashi; Kojima, Tetsuhito] Nagoya Univ, Grad Sch Med, Dept Pathophysiol Lab Sci, Nagoya, Aichi 4618673, Japan; [Sanda, Naomi] Nagoya Univ Hosp, Dept Clin Lab, Nagoya, Aichi 4668550, Japan; [Saito, Hidehiko] Nagoya Cent Hosp, Nagoya, Aichi 4530801, Japan	Nagoya University; Nagoya University; Nagoya University	Kojima, T (corresponding author), Nagoya Univ, Sch Hlth Sci, Dept Med Technol, Higashi Ku, 1-1-20,Daiko Minami, Nagoya, Aichi 4618673, Japan.	kojima@met.nagoya-u.ac.jp	Kojima, Tetsuhito/I-6271-2014	Kojima, Tetsuhito/0000-0002-1905-1065	Ministry of Education, Culture, Sports, Science, and Technology [19590553]; Ministry of Health and Welfare; Kitamura Memorial Foundation, Japan	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health and Welfare(Ministry of Health, Labour and Welfare, Japan); Kitamura Memorial Foundation, Japan	This study was supported by grants-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology (19590553), the Ministry of Health and Welfare (Health Sciences Research Grant, Research on Specific Disease), and the Kitamura Memorial Foundation, Japan.	Benzakour O, 2000, BLOOD, V95, P2008, DOI 10.1182/blood.V95.6.2008; CAVAILLES V, 1995, EMBO J, V14, P3741, DOI 10.1002/j.1460-2075.1995.tb00044.x; COMP PC, 1986, BLOOD, V68, P881; DAHLBACK B, 1991, THROMB HAEMOSTASIS, V66, P49; DAHLBACK B, 1981, P NATL ACAD SCI-BIOL, V78, P2512, DOI 10.1073/pnas.78.4.2512; DANGELO A, 1988, J CLIN INVEST, V81, P1445, DOI 10.1172/JCI113475; De Wolf CJF, 2005, J THROMB HAEMOST, V3, P410, DOI 10.1111/j.1538-7836.2005.01138.x; de Wolf CJF, 2006, J BIOL CHEM, V281, P17635, DOI 10.1074/jbc.M603094200; Delfino F, 1999, MOL CELL ENDOCRINOL, V157, P1, DOI 10.1016/S0303-7207(99)00127-6; EDENBRANDT CM, 1990, BIOCHEMISTRY-US, V29, P7861, DOI 10.1021/bi00486a012; ENGESSER L, 1987, ANN INTERN MED, V106, P677, DOI 10.7326/0003-4819-106-5-677; FAIR DS, 1986, BLOOD, V67, P64; FAIR DS, 1986, BLOOD, V67, P1168; Frasor J, 2003, ENDOCRINOLOGY, V144, P4562, DOI 10.1210/en.2003-0567; Furuhata A, 2009, LEUKEMIA, V23, P1270, DOI 10.1038/leu.2009.13; Gandrille S, 2000, THROMB HAEMOSTASIS, V84, P918; GRIFFIN JH, 1992, BLOOD, V79, P3203; Gruber CJ, 2002, NEW ENGL J MED, V346, P340, DOI 10.1056/NEJMra000471; Guenther MG, 2000, GENE DEV, V14, P1048; Hall JM, 2001, J BIOL CHEM, V276, P36869, DOI 10.1074/jbc.R100029200; HEEB MJ, 1994, P NATL ACAD SCI USA, V91, P2728, DOI 10.1073/pnas.91.7.2728; HEEB MJ, 1993, J BIOL CHEM, V268, P2872; Higgins KJ, 2008, MOL ENDOCRINOL, V22, P388, DOI 10.1210/me.2007-0319; Higgins KJ, 2006, ENDOCRINOLOGY, V147, P3285, DOI 10.1210/EN.2006-0081; Higuchi R, 1990, PCR PROTOCOLS GUIDE, P177; Jepsen K, 2002, J CELL SCI, V115, P689; Jones PL, 2001, J BIOL CHEM, V276, P8807, DOI 10.1074/jbc.C000879200; Kokame K, 2001, J BIOL CHEM, V276, P9199, DOI 10.1074/jbc.M010486200; Kushner PJ, 2000, J STEROID BIOCHEM, V74, P311, DOI 10.1016/S0960-0760(00)00108-4; Levin CS, 2005, EUR J NUCL MED MOL I, V32, pS325, DOI 10.1007/s00259-005-1973-y; Li JW, 2000, EMBO J, V19, P4342, DOI 10.1093/emboj/19.16.4342; MAILLARD C, 1992, ENDOCRINOLOGY, V130, P1599, DOI 10.1210/en.130.3.1599; Makris M, 2000, BLOOD, V95, P1935, DOI 10.1182/blood.V95.6.1935; MALM J, 1994, BIOCHEM J, V302, P845, DOI 10.1042/bj3020845; MALM J, 1988, BRIT J HAEMATOL, V68, P437, DOI 10.1111/j.1365-2141.1988.tb04232.x; OGURA M, 1987, BLOOD, V70, P301; Owen GI, 1998, J BIOL CHEM, V273, P10696, DOI 10.1074/jbc.273.17.10696; Porter W, 1997, MOL ENDOCRINOL, V11, P1569, DOI 10.1210/me.11.11.1569; Safe S, 2004, PROG NUCLEIC ACID RE, V77, P1, DOI 10.1016/S0079-6603(04)77001-4; Safe S, 2008, J MOL ENDOCRINOL, V41, P263, DOI 10.1677/JME-08-0103; Sanda N, 2007, BRIT J HAEMATOL, V138, P663, DOI 10.1111/j.1365-2141.2007.06668.x; SCHMIDEL DK, 1990, BIOCHEMISTRY-US, V29, P7845, DOI 10.1021/bi00486a010; SCHWARZ HP, 1984, BLOOD, V64, P1297; Sobue S, 2005, J NEUROCHEM, V95, P940, DOI 10.1111/j.1471-4159.2005.03399.x; Stossi F, 2006, J BIOL CHEM, V281, P16272, DOI 10.1074/jbc.M513405200; SUZUKI T, 1993, P NATL ACAD SCI USA, V90, P610, DOI 10.1073/pnas.90.2.610; Tans G, 2000, THROMB HAEMOSTASIS, V84, P15, DOI 10.1055/s-0037-1613960; Tatewaki H, 2003, THROMB HAEMOSTASIS, V90, P1029, DOI 10.1160/TH03-07-0443; VANAMSTEL HKP, 1990, BIOCHEMISTRY-US, V29, P7853, DOI 10.1021/bi00486a011; Varshochi R, 2005, J BIOL CHEM, V280, P3185, DOI 10.1074/jbc.M408063200; Wei LN, 2000, J BIOL CHEM, V275, P40782, DOI 10.1074/jbc.M004821200; Wen YD, 2000, P NATL ACAD SCI USA, V97, P7202, DOI 10.1073/pnas.97.13.7202; White JH, 2004, VITAM HORM, V68, P123	53	60	60	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13444	13453		10.1074/jbc.M109.062430	http://dx.doi.org/10.1074/jbc.M109.062430			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20200160	hybrid, Green Published			2022-12-25	WOS:000276987700016
J	Yin, H; Gui, Y; Du, GW; Frohman, MA; Zheng, XL				Yin, Hao; Gui, Yu; Du, Guangwei; Frohman, Michael A.; Zheng, Xi-Long			Dependence of Phospholipase D1 Multi-monoubiquitination on Its Enzymatic Activity and Palmitoylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDIC-ACID; PLASMA-MEMBRANE; UBIQUITIN ISOPEPTIDASE; D DEFINES; ENDOCYTOSIS; ACTIVATION; GOLGI; TRANSLOCATION; DEGRADATION; PROTEASOME	Phospholipase D(PLD) is an important lipase in many cellular processes, including vesicular trafficking, cell survival, and cell migration. In the present study, we show that PLD1, but not PLD2, is posttranslationally modified by multi-monoubiquitination. Intriguingly, suppression of lipase activity either by mutation of the HKD motif (PLD1 H896R, K898R, or D903A) or the phosphatidylinositol 4,5-bisphosphate binding motif (PLD1 R691G,R695G) or through use of PLD-selective inhibitors impaired the ubiquitination of PLD1, although stimulation of lipase activity by phorbol 12-myristate 13-acetate did not enhance its ubiquitination. A palmitoylation-deficient mutant PLD1 allele, which exhibits altered patterns of vesicular trafficking, had significantly lower levels of monoubiquitination. In addition, the expression of ubiquitin-fused PLD1 induced aberrantly enlarged vesicles partially co-localized with the Golgi complex but not with early endosomes. The altered localization was reduced by the K898R mutation, suggesting a role of multi-monoubiquitination in PLD1 subcellular localization. Surprisingly, the degradation of PLD1, but not of PLD1 K898R or PLD2, was blocked by inhibitors of proteasomes but not by inhibitors of lysosomes or other proteases, suggesting a role of the ubiquitination in proteasomal degradation of PLD1. In summary, our studies show that PLD1, but not PLD2, is multi-monoubiquitinated. The ubiquitination modification might represent a novel regulatory mechanism in PLD1 functioning, particularly in the context of subcellular trafficking between different membrane compartments.	[Yin, Hao] Univ Calgary, Fac Med, Dept Biochem & Mol Biol, Smooth Muscle Res Grp,Libin Cardiovasc Inst Alber, Calgary, AB T2N 4N1, Canada; [Du, Guangwei] Univ Texas Houston, Hlth Sci Ctr, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA; [Frohman, Michael A.] SUNY Stony Brook, Dept Pharmacol, Stony Brook, NY 11794 USA; [Frohman, Michael A.] SUNY Stony Brook, Ctr Dev Genet, Stony Brook, NY 11794 USA	Libin Cardiovascular Institute Of Alberta; University of Calgary; University of Texas System; University of Texas Health Science Center Houston; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Zheng, XL (corresponding author), Univ Calgary, Fac Med, Dept Biochem & Mol Biol, Smooth Muscle Res Grp,Libin Cardiovasc Inst Alber, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	xlzheng@ucalgary.ca		Zheng, Xi-Long/0000-0002-0889-1827; Du, Guangwei/0000-0003-4193-6975	Canadian Institutes of Health Research; Pfizer Canada Inc	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Pfizer Canada Inc	This work was supported by the Canadian Institutes of Health Research and Pfizer Canada Inc. ( to X.-L. Z.).	Bishop N, 2000, MOL BIOL CELL, V11, P227, DOI 10.1091/mbc.11.1.227; Colley WC, 1997, CURR BIOL, V7, P191, DOI 10.1016/S0960-9822(97)70090-3; De Domenico I, 2006, EMBO J, V25, P5396, DOI 10.1038/sj.emboj.7601409; Du GW, 2004, MOL BIOL CELL, V15, P1024, DOI 10.1091/mbc.E03-09-0673; Du GW, 2003, J CELL BIOL, V162, P305, DOI 10.1083/jcb.200302033; Emoto M, 2000, J BIOL CHEM, V275, P7144, DOI 10.1074/jbc.275.10.7144; Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015; Gaynor EC, 1998, MOL BIOL CELL, V9, P653, DOI 10.1091/mbc.9.3.653; Haglund K, 2003, NAT CELL BIOL, V5, P461, DOI 10.1038/ncb983; HAMMOND SM, 1995, J BIOL CHEM, V270, P29640; Huang P, 2007, EXPERT OPIN THER TAR, V11, P707, DOI 10.1517/14728222.11.5.707; Jenkins GM, 2005, CELL MOL LIFE SCI, V62, P2305, DOI 10.1007/s00018-005-5195-z; Jura N, 2006, MOL CELL, V21, P679, DOI 10.1016/j.molcel.2006.02.011; Klemm RW, 2009, J CELL BIOL, V185, P601, DOI 10.1083/jcb.200901145; Lee CS, 2006, NAT CELL BIOL, V8, P477, DOI 10.1038/ncb1401; McCullough J, 2004, J CELL BIOL, V166, P487, DOI 10.1083/jcb.200401141; Mor A, 2009, MOL CELL BIOL, V29, P3297, DOI 10.1128/MCB.00366-09; MORITZ A, 1992, J BIOL CHEM, V267, P7207; Rizzo MA, 1999, J BIOL CHEM, V274, P1131, DOI 10.1074/jbc.274.2.1131; Roos-Mattjus P, 2004, ANN MED, V36, P285, DOI 10.1080/07853890310016324; Row PE, 2006, J BIOL CHEM, V281, P12618, DOI 10.1074/jbc.M512615200; Sciorra VA, 1999, EMBO J, V18, P5911, DOI 10.1093/emboj/18.21.5911; Scott SA, 2009, NAT CHEM BIOL, V5, P108, DOI 10.1038/nchembio.140; Shen YJ, 2001, MOL CELL BIOL, V21, P595, DOI 10.1128/MCB.21.2.595-602.2001; Su WJ, 2006, CELL SIGNAL, V18, P469, DOI 10.1016/j.cellsig.2005.05.027; Sugars JM, 1999, J BIOL CHEM, V274, P30023, DOI 10.1074/jbc.274.42.30023; Sung TC, 1997, EMBO J, V16, P4519, DOI 10.1093/emboj/16.15.4519; van der Zee J, 2008, HUM MOL GENET, V17, P313, DOI 10.1093/hmg/ddm309; Xie Z, 2001, J BIOL CHEM, V276, P9383, DOI 10.1074/jbc.M009425200	29	29	30	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13580	13588		10.1074/jbc.M109.046359	http://dx.doi.org/10.1074/jbc.M109.046359			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20189990	Green Published, hybrid			2022-12-25	WOS:000276987700031
J	Potdar, AA; Jeon, J; Weaver, AM; Quaranta, V; Cummings, PT				Potdar, Alka A.; Jeon, Junhwan; Weaver, Alissa M.; Quaranta, Vito; Cummings, Peter T.			Human Mammary Epithelial Cells Exhibit a Bimodal Correlated Random Walk Pattern	PLOS ONE			English	Article							FLIGHT SEARCH PATTERNS; WANDERING ALBATROSSES; SCALING LAWS; LEVY WALK; DISTRIBUTIONS; STRATEGIES; SIMULATION; MIGRATION; DISPERSAL; MOVEMENTS	Background: Organisms, at scales ranging from unicellular to mammals, have been known to exhibit foraging behavior described by random walks whose segments confirm to Levy or exponential distributions. For the first time, we present evidence that single cells (mammary epithelial cells) that exist in multi-cellular organisms (humans) follow a bimodal correlated random walk (BCRW). Methodology/Principal Findings: Cellular tracks of MCF-10A pBabe, neuN and neuT random migration on 2-D plastic substrates, analyzed using bimodal analysis, were found to reveal the BCRW pattern. We find two types of exponentially distributed correlated flights (corresponding to what we refer to as the directional and re-orientation phases) each having its own correlation between move step-lengths within flights. The exponential distribution of flight lengths was confirmed using different analysis methods (logarithmic binning with normalization, survival frequency plots and maximum likelihood estimation). Conclusions/Significance: Because of the presence of non-uniform turn angle distribution of move step-lengths within a flight and two different types of flights, we propose that the epithelial random walk is a BCRW comprising of two alternating modes with varying degree of correlations, rather than a simple persistent random walk. A BCRW model rather than a simple persistent random walk correctly matches the super-diffusivity in the cell migration paths as indicated by simulations based on the BCRW model.	[Potdar, Alka A.; Jeon, Junhwan; Cummings, Peter T.] Vanderbilt Univ, Dept Chem & Biomol Engn, Nashville, TN 37203 USA; [Potdar, Alka A.; Jeon, Junhwan; Weaver, Alissa M.; Quaranta, Vito; Cummings, Peter T.] Vanderbilt Integrat Canc Biol Ctr, Nashville, TN USA; [Weaver, Alissa M.; Quaranta, Vito] Vanderbilt Univ, Med Ctr, Dept Canc Biol, Nashville, TN USA; [Cummings, Peter T.] Oak Ridge Natl Lab, Ctr Nanophase Mat Sci, Oak Ridge, TN USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; United States Department of Energy (DOE); Oak Ridge National Laboratory; Center for Nanophase Materials Sciences	Potdar, AA (corresponding author), Vanderbilt Univ, Dept Chem & Biomol Engn, Nashville, TN 37203 USA.	peter.cummings@vanderbilt.edu	Cummings, Peter T/B-8762-2013; Quaranta, Vito/G-6512-2016; Potdar, Alka/E-6882-2012	Cummings, Peter T/0000-0002-9766-2216; Quaranta, Vito/0000-0001-7491-8672; 	National Cancer Institute grant [5U54CA113007-02]; NATIONAL CANCER INSTITUTE [U54CA113007] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075126] Funding Source: NIH RePORTER	National Cancer Institute grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was funded by National Cancer Institute grant: Multiscale Mathematical Modeling of Cancer Invasion (grant number: 5U54CA113007-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartumeus F, 2005, ECOLOGY, V86, P3078, DOI 10.1890/04-1806; Bartumeus F, 2003, P NATL ACAD SCI USA, V100, P12771, DOI 10.1073/pnas.2137243100; Bartumeus F, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.097901; Benhamou S, 2007, ECOLOGY, V88, P1962, DOI 10.1890/06-1769.1; Benichou O, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.020102; Berg H C, 1974, Antibiot Chemother (1971), V19, P55; Berg H. C., 1983, RANDOM WALKS BIOL; BERG HC, 1972, NATURE, V239, P500, DOI 10.1038/239500a0; Bosgraaf L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005253; Bosgraaf L, 2009, CELL MOTIL CYTOSKEL, V66, P156, DOI 10.1002/cm.20338; Bray D, 2001, CELL MOVEMENTS MOL M; Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292; Byers JA, 2001, ECOLOGY, V82, P1680, DOI 10.2307/2679810; CAIN ML, 1985, ECOLOGY, V66, P876, DOI 10.2307/1940550; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Edwards AM, 2008, J ANIM ECOL, V77, P1212, DOI 10.1111/j.1365-2656.2008.01428.x; Edwards AM, 2007, NATURE, V449, P1044, DOI 10.1038/nature06199; LEDOUARIN NM, 1984, CELL, V38, P353, DOI 10.1016/0092-8674(84)90490-2; Levandowsky M, 1997, ACTA PROTOZOOL, V36, P237; Li L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002093; Lomholt MA, 2008, P NATL ACAD SCI USA, V105, P11055, DOI 10.1073/pnas.0803117105; Luster AD, 2005, NAT IMMUNOL, V6, P1182, DOI 10.1038/ni1275; Newman MEJ, 2005, CONTEMP PHYS, V46, P323, DOI 10.1080/00107510500052444; OTHMER HG, 1988, J MATH BIOL, V26, P263, DOI 10.1007/BF00277392; Potdar AA, 2009, ANN BIOMED ENG, V37, P230, DOI 10.1007/s10439-008-9592-y; Ramos-Fernandez G, 2004, BEHAV ECOL SOCIOBIOL, V55, P223, DOI 10.1007/s00265-003-0700-6; SHIESINGER MF, 1986, GROWTH FORM FRACTAL, P279; Shlesinger M., 1995, LEVY FLIGHTS RELATED, Ved, DOI [10.1007/3-540-59222-9, DOI 10.1007/3-540-59222-9]; Sims DW, 2008, NATURE, V451, P1098, DOI 10.1038/nature06518; Sims DW, 2007, J ANIM ECOL, V76, P222, DOI 10.1111/j.1365-2656.2006.01208.x; STOKES CL, 1991, J CELL SCI, V99, P419; Tsallis C, 1997, PHYS WORLD, V10, P42; Upadhyaya A, 2001, PHYSICA A, V293, P549, DOI 10.1016/S0378-4371(01)00009-7; Van Haastert PJM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006814; Viswanathan GM, 1996, NATURE, V381, P413, DOI 10.1038/381413a0; Viswanathan GM, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.011111; Viswanathan GM, 1999, NATURE, V401, P911, DOI 10.1038/44831	37	31	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2010	5	3							e9636	10.1371/journal.pone.0009636	http://dx.doi.org/10.1371/journal.pone.0009636			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565XE	20224792	gold, Green Published, Green Submitted			2022-12-25	WOS:000275328800030
J	Cohn, B; Manque, P; Lara, AM; Serrano, M; Sheth, N; Buck, G				Cohn, Benjamin; Manque, Patricio; Lara, Ana M.; Serrano, Myrna; Sheth, Nihar; Buck, Gregory			Putative cis-Regulatory Elements Associated with Heat Shock Genes Activated During Excystation of Cryptosporidium parvum	PLOS ONE			English	Article							IDENTIFICATION; INFECTION; PROTEINS; SEQUENCE; OOCYSTS; GENOME; EXPRESSION; RISK	Background: Cryptosporidiosis is a ubiquitous infectious disease, caused by the protozoan parasites Cryptosporidium hominis and C. parvum, leading to acute, persistent and chronic diarrhea worldwide. Although the complications of this disease can be serious, even fatal, in immunocompromised patients of any age, they have also been found to lead to long term effects, including growth inhibition and impaired cognitive development, in infected immunocompetent children. The Cryptosporidium life cycle alternates between a dormant stage, the oocyst, and a highly replicative phase that includes both asexual vegetative stages as well as sexual stages, implying fine genetic regulatory mechanisms. The parasite is extremely difficult to study because it cannot be cultured in vitro and animal models are equally challenging. The recent publication of the genome sequence of C. hominis and C. parvum has, however, significantly advanced our understanding of the biology and pathogenesis of this parasite. Methodology/Principal Findings: Herein, our goal was to identify cis-regulatory elements associated with heat shock response in Cryptosporidium using a combination of in silico and real time RT-PCR strategies. Analysis with Gibbs-Sampling algorithms of upstream non-translated regions of twelve genes annotated as heat shock proteins in the Cryptosporidium genome identified a highly conserved over-represented sequence motif in eleven of them. RT-PCR analyses, described herein and also by others, show that these eleven genes bearing the putative element are induced concurrent with excystation of parasite oocysts via heat shock. Conclusions/Significance: Our analyses suggest that occurrences of a motif identified in the upstream regions of the Cryptosporidium heat shock genes represent parts of the transcriptional apparatus and function as stress response elements that activate expression of these genes during excystation, and possibly at other stages in the life cycle of the parasite. Since heat shock and excystation represent a critical step in the development of the infectious sporozoite form of Cryptosporidium, these results provide important insight into the pathogenicity of the parasite.	[Cohn, Benjamin; Manque, Patricio; Lara, Ana M.; Serrano, Myrna; Buck, Gregory] Virginia Commonwealth Univ, Dept Microbiol & Immunol, Richmond, VA 23298 USA; [Cohn, Benjamin; Manque, Patricio; Lara, Ana M.; Serrano, Myrna; Sheth, Nihar; Buck, Gregory] Virginia Commonwealth Univ, Ctr Study Biol Complex, Richmond, VA 23298 USA	Virginia Commonwealth University; Virginia Commonwealth University	Cohn, B (corresponding author), Virginia Commonwealth Univ, Dept Microbiol & Immunol, Richmond, VA 23298 USA.	gabuck@vcu.edu		manque, patricio/0000-0002-6606-0896	NSF [EEC-0234101]; NIH-NIAID [U34 AI57168, 1R01 AI55347.]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI055347, U54AI057168] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH-NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by grants from NSF EEC-0234101, NIH-NIAID U34 AI57168, and NIH-NIAID 1R01 AI55347. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsen MS, 2004, SCIENCE, V304, P441, DOI 10.1126/science.1094786; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bailey T L, 1995, Proc Int Conf Intell Syst Mol Biol, V3, P21; Bailey TL, 1998, BIOINFORMATICS, V14, P48, DOI 10.1093/bioinformatics/14.1.48; FAYER R, 1986, MICROBIOL REV, V50, P458, DOI 10.1128/MMBR.50.4.458-483.1986; Gophna U, 2003, INT J MED MICROBIOL, V292, P453, DOI 10.1078/1438-4221-00230; Guerrant RL, 1997, EMERG INFECT DIS, V3, P51, DOI 10.3201/eid0301.970106; Guerrant RL, 2002, TRENDS PARASITOL, V18, P191, DOI 10.1016/S1471-4922(02)02253-5; Heikkila JJ, 2007, BIOTECHNOL ADV, V25, P385, DOI 10.1016/j.biotechadv.2007.03.003; Hughes JD, 2000, J MOL BIOL, V296, P1205, DOI 10.1006/jmbi.2000.3519; Hunter PR, 2002, CLIN MICROBIOL REV, V15, P145, DOI 10.1128/CMR.15.1.145-154.2002; Kibe MK, 2005, NUCLEIC ACIDS RES, V33, P1722, DOI 10.1093/nar/gki314; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; MACKENZIE WR, 1995, CLIN INFECT DIS, V21, P57, DOI 10.1093/clinids/21.1.57; Militello KT, 2004, MOL BIOCHEM PARASIT, V134, P75, DOI 10.1016/j.molbiopara.2003.11.004; Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788; Mullapudi N, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-13; Navin TR, 1999, J ACQ IMMUN DEF SYND, V20, P154, DOI 10.1097/00042560-199902010-00007; REDUKER DW, 1985, J PARASITOL, V71, P112, DOI 10.2307/3281988; Saibil HR, 2008, CURR OPIN STRUC BIOL, V18, P35, DOI 10.1016/j.sbi.2007.11.006; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Snelling WJ, 2007, MOL CELL PROTEOMICS, V6, P346, DOI 10.1074/mcp.M600372-MCP200; Thompson RCA, 2005, ADV PARASIT, V59, P77, DOI 10.1016/S0065-308X(05)59002-X; VANDERPLOEG LHT, 1985, SCIENCE, V228, P1443, DOI 10.1126/science.4012301; WAGNERWIENING C, 1995, APPL ENVIRON MICROB, V61, P4514, DOI 10.1128/AEM.61.12.4514-4516.1995; Widmer G, 2007, PARASITOLOGY, V134, P1583, DOI 10.1017/S0031182007002922; Wolska-Kusnierz B, 2007, J PEDIATR GASTR NUTR, V45, P458, DOI 10.1097/MPG.0b013e318054b09b; Xiao LH, 2004, CLIN MICROBIOL REV, V17, P72, DOI 10.1128/CMR.17.1.72-97.2004; Xu P, 2004, NATURE, V431, P1107, DOI 10.1038/nature02977; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478; Zugel U, 1999, CLIN MICROBIOL REV, V12, P19, DOI 10.1128/CMR.12.1.19	31	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2010	5	3							e9512	10.1371/journal.pone.0009512	http://dx.doi.org/10.1371/journal.pone.0009512			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	564EW	20209102	Green Published, gold, Green Submitted			2022-12-25	WOS:000275197100006
J	Lefevre, T; Gouagna, LC; Dabire, KR; Elguero, E; Fontenille, D; Renaud, F; Costantini, C; Thomas, F				Lefevre, Thierry; Gouagna, Louis-Clement; Dabire, Kounbobr Roch; Elguero, Eric; Fontenille, Didier; Renaud, Francois; Costantini, Carlo; Thomas, Frederic			Beer Consumption Increases Human Attractiveness to Malaria Mosquitoes	PLOS ONE			English	Article							VECTOR ANOPHELES-GAMBIAE; DIFFERENTIAL ATTRACTIVENESS; PREGNANT-WOMEN; HOST SELECTION; ALCOHOL; DIPTERA; CULICIDAE; BEHAVIOR; ETHANOL; S.S.	Background: Malaria and alcohol consumption both represent major public health problems. Alcohol consumption is rising in developing countries and, as efforts to manage malaria are expanded, understanding the links between malaria and alcohol consumption becomes crucial. Our aim was to ascertain the effect of beer consumption on human attractiveness to malaria mosquitoes in semi field conditions in Burkina Faso. Methodology/Principal Findings: We used a Y tube-olfactometer designed to take advantage of the whole body odour (breath and skin emanations) as a stimulus to gauge human attractiveness to Anopheles gambiae (the primary African malaria vector) before and after volunteers consumed either beer (n = 25 volunteers and a total of 2500 mosquitoes tested) or water (n = 18 volunteers and a total of 1800 mosquitoes). Water consumption had no effect on human attractiveness to An. gambiae mosquitoes, but beer consumption increased volunteer attractiveness. Body odours of volunteers who consumed beer increased mosquito activation (proportion of mosquitoes engaging in take-off and up-wind flight) and orientation (proportion of mosquitoes flying towards volunteers' odours). The level of exhaled carbon dioxide and body temperature had no effect on human attractiveness to mosquitoes. Despite individual volunteer variation, beer consumption consistently increased attractiveness to mosquitoes. Conclusions/Significance: These results suggest that beer consumption is a risk factor for malaria and needs to be integrated into public health policies for the design of control measures.	[Lefevre, Thierry; Elguero, Eric; Renaud, Francois; Thomas, Frederic] CNRS, UMR IRD 2724, Montpellier, France; [Gouagna, Louis-Clement; Fontenille, Didier; Costantini, Carlo] IRD UR 016, Montpellier, France; [Gouagna, Louis-Clement; Dabire, Kounbobr Roch] Inst Rech Sci Sante, Bobo Dioulasso, Burkina Faso; [Dabire, Kounbobr Roch] Ctr Muraz, Lab Parasitol & Entomol Med, Bobo Dioulasso, Burkina Faso; [Costantini, Carlo] Org Coordinat Lutte Endemies Afrique Cent, Yaounde, Cameroon; [Thomas, Frederic] Univ Montreal, Inst Rech Biol Vegetale, Montreal, PQ H1X 2B2, Canada	Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Institut de Recherche pour le Developpement (IRD); Centre Muraz; Universite de Montreal	Lefevre, T (corresponding author), CNRS, UMR IRD 2724, Montpellier, France.	telefev@emory.edu	Costantini, Carlo/F-3470-2012; FONTENILLE, didier/G-4091-2013; Lefèvre, Thierry/E-2157-2011; Dabire, Roch Kounbobr/ABF-3525-2020; Elguero, Eric/J-3014-2012	Costantini, Carlo/0000-0003-1016-129X; Lefèvre, Thierry/0000-0002-9736-6142; FONTENILLE, didier/0000-0002-0544-3885; Gouagna, Louis Clement/0000-0003-0957-4484; THOMAS, Frederic/0000-0003-2238-1978	French National Research Agency (ANR) [FI-071215-01-01]	French National Research Agency (ANR)(French National Research Agency (ANR))	The study was supported by the French National Research Agency (ANR) number FI-071215-01-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JC, 2006, J APPL PHYSIOL, V100, P649, DOI 10.1152/japplphysiol.00927.2005; Ansell J, 2002, T ROY SOC TROP MED H, V96, P113, DOI 10.1016/S0035-9203(02)90271-3; Besansky NJ, 2004, TRENDS PARASITOL, V20, P249, DOI 10.1016/j.pt.2004.03.007; Brady J, 1997, ANN TROP MED PARASIT, V91, pS121, DOI 10.1080/00034989761436; Braks MAH, 1999, PARASITOL TODAY, V15, P409, DOI 10.1016/S0169-4758(99)01514-8; BURKOT TR, 1988, PARASITOL TODAY, V4, P156, DOI 10.1016/0169-4758(88)90151-2; Casswell S, 2009, LANCET, V373, P2247, DOI 10.1016/S0140-6736(09)60745-5; Coetzee M, 2004, AM J TROP MED HYG, V70, P103, DOI 10.4269/ajtmh.2004.70.103; Costantini C, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P209; Crawley M.J., 2007, R BOOK; CURTIS CF, 1987, MED VET ENTOMOL, V1, P109, DOI 10.1111/j.1365-2915.1987.tb00331.x; Dabire KR, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-188; Dekker T, 2001, PHYSIOL ENTOMOL, V26, P124, DOI 10.1046/j.1365-3032.2001.00225.x; DYE C, 1992, ANNU REV ENTOMOL, V37, P1, DOI 10.1146/annurev.en.37.010192.000245; Feachem R, 2008, LANCET, V371, P1633, DOI 10.1016/S0140-6736(08)60424-9; Gibson G, 1999, MED VET ENTOMOL, V13, P2, DOI 10.1046/j.1365-2915.1999.00163.x; GILLIES MT, 1980, B ENTOMOL RES, V70, P525, DOI 10.1017/S0007485300007811; Greenwood BM, 2005, LANCET, V365, P1487, DOI 10.1016/S0140-6736(05)66420-3; Havlicek J, 2008, CHEM SIGNAL, V11, P199, DOI 10.1007/978-0-387-73945-8_19; Havlicek J, 2006, CHEM SENSES, V31, P747, DOI 10.1093/chemse/bjl017; Himeidan YE, 2004, ANN TROP MED PARASIT, V98, P631, DOI 10.1179/000349804225021307; Kelly DW, 2001, TRENDS PARASITOL, V17, P578, DOI 10.1016/S1471-4922(01)02116-X; KENNEDY JS, 1978, PHYSIOL ENTOMOL, V3, P91, DOI 10.1111/j.1365-3032.1978.tb00138.x; Killeen GF, 2007, PLOS MED, V4, P1246, DOI 10.1371/journal.pmed.0040229; Knols BGJ, 1995, T ROY SOC TROP MED H, V89, P604, DOI 10.1016/0035-9203(95)90406-9; Lefevre T, 2009, AM J TROP MED HYG, V81, P1023, DOI 10.4269/ajtmh.2009.09-0124; Lefevre T, 2009, TROP MED INT HEALTH, V14, P228, DOI 10.1111/j.1365-3156.2009.02206.x; Lehane M.J., 2005, BIOL BLOOD SUCKING I, V2nd; Lenochova P, 2008, CHEM SIGNAL, V11, P189, DOI 10.1007/978-0-387-73945-8_18; Lindsay S, 2000, LANCET, V355, P1972, DOI 10.1016/S0140-6736(00)02334-5; LINDSAY SW, 1993, J MED ENTOMOL, V30, P368, DOI 10.1093/jmedent/30.2.368; Macdonald G, 1957, EPIDEMIOLOGY CONTROL; Mukabana Wolfgang R., 2002, Malaria Journal, V1, pUnpaginated, DOI 10.1186/1475-2875-1-17; Mukabana WR, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-1; Nelson S, 2002, NAT REV IMMUNOL, V2, P205, DOI 10.1038/nri744; Odunfa S. A., 1985, Microbiology of fermented foods. Vol. 2., P155; Qiu YT, 2006, MED VET ENTOMOL, V20, P280, DOI 10.1111/j.1365-2915.2006.00627.x; Rehm J, 2009, LANCET, V373, P2223, DOI 10.1016/S0140-6736(09)60746-7; Roberts SC, 2005, CHEM SENSES, V30, P651, DOI 10.1093/chemse/bji058; Ross R., 1911, PREVENTION MALARIA; Sawadogo-Lingani H, 2007, J APPL MICROBIOL, V103, P765, DOI 10.1111/j.1365-2672.2007.03306.x; Shirai Y, 2002, J AM MOSQUITO CONTR, V18, P91; Smith DL, 2007, PLOS BIOL, V5, P531, DOI 10.1371/journal.pbio.0050042; Smith DL, 2005, NATURE, V438, P492, DOI 10.1038/nature04024; Takken W, 1997, ANN TROP MED PARASIT, V91, pS119, DOI 10.1080/00034989761427; Takken W, 1999, ANNU REV ENTOMOL, V44, P131, DOI 10.1146/annurev.ento.44.1.131; WHO, 2004, GLOB STAT REP ALC; WILKINSON PK, 1980, ALCOHOL CLIN EXP RES, V4, P6, DOI 10.1111/j.1530-0277.1980.tb04785.x; World Health Organization, 2008, WORLD MAL REP	49	41	42	0	150	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2010	5	3							e9546	10.1371/journal.pone.0009546	http://dx.doi.org/10.1371/journal.pone.0009546			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	564EW	20209056	Green Published, Green Submitted, gold			2022-12-25	WOS:000275197100024
J	Shirinian, M; Grabbe, C; Popovic, M; Varshney, G; Hugosson, F; Bos, H; Rehmann, H; Palmer, RH				Shirinian, Margret; Grabbe, Caroline; Popovic, Milica; Varshney, Gaurav; Hugosson, Fredrik; Bos, Hans; Rehmann, Holger; Palmer, Ruth H.			The Rap1 Guanine Nucleotide Exchange Factor C3G Is Required for Preservation of Larval Muscle Integrity in Drosophila melanogaster	PLOS ONE			English	Article							RECEPTOR TYROSINE KINASE; REGULATES CELL-SHAPE; MYOBLAST FUSION; PDZ-GEF; MUSCULAR-DYSTROPHY; PROTEIN; ACTIVATION; CRK; CAVEOLIN-3; GTPASE	C3G is a guanine nucleotide exchange factor (GEF) and modulator of small G-protein activity, which primarily acts on members of the Rap GTPase subfamily. Via promotion of the active GTP bound conformation of target GTPases, C3G has been implicated in the regulation of multiple cellular and developmental events including proliferation, differentiation and apoptosis. The Drosophila C3G orthologue exhibits a domain organization similar to that of vertebrate C3G. Through deletion of the C3G locus, we have observed that loss of C3G causes semi-lethality, and that escaping adult flies are characterized by a reduction in lifespan and general fitness. In situ hybridization reveals C3G expression in the developing embryonic somatic and visceral muscles, and indeed analysis of C3G mutants suggests essential functions of C3G for normal body wall muscle development during larval stages. C3G mutants display abnormal muscle morphology and attachment, as well as failure to properly localize beta PS integrins to muscle attachment sites. Moreover, we show that C3G stimulates guanine nucleotide exchange on Drosophila Rap GTPases in vitro. Taken together, we conclude that Drosophila C3G is a Rap1-specific GEF with important functions in maintaining muscle integrity during larval stages.	[Shirinian, Margret; Grabbe, Caroline; Varshney, Gaurav; Hugosson, Fredrik; Palmer, Ruth H.] Umea Univ, Dept Mol Biol, Umea, Sweden; [Popovic, Milica; Bos, Hans; Rehmann, Holger] Univ Med Ctr, Dept Physiol Chem, Ctr Biomed Genet, Utrecht, Netherlands; [Popovic, Milica; Bos, Hans; Rehmann, Holger] Univ Med Ctr, Canc Genom Ctr, Utrecht, Netherlands	Umea University; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Shirinian, M (corresponding author), Umea Univ, Dept Mol Biol, Umea, Sweden.	Ruth.Palmer@ucmp.umu.se	Varshney, Gaurav/L-5261-2014	Varshney, Gaurav K./0000-0002-0429-1904	TI Pharma [T3-106]; Netherlands Organization for Scientific Research (NWO-CW); Swedish Research Council [621-2003-3399]; Swedish Cancer Research Society [09 0741]; Association for International Cancer Research	TI Pharma; Netherlands Organization for Scientific Research (NWO-CW)(Netherlands Organization for Scientific Research (NWO)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Research Society; Association for International Cancer Research	MP was supported by TI Pharma Project T3-106 and HR by the Chemical Sciences of the Netherlands Organization for Scientific Research (NWO-CW), RHP is a Swedish Cancer Foundation Research Fellow and was supported by the Swedish Research Council (621-2003-3399), the Swedish Cancer Research Society (09 0741) and the Association for International Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Balzac F, 2005, J CELL SCI, V118, P4765, DOI 10.1242/jcs.02584; Blake DJ, 2002, PHYSIOL REV, V82, P291, DOI 10.1152/physrev.00028.2001; Bloor JW, 1998, GENETICS, V148, P1127; Boettner B, 2007, MOL CELL BIOL, V27, P7966, DOI 10.1128/MCB.01275-07; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; BROWN NH, 1993, BIOESSAYS, V15, P383, DOI 10.1002/bies.950150604; Brown NH, 2002, DEV CELL, V3, P569, DOI 10.1016/S1534-5807(02)00290-3; Campos-Ortega J, 1997, EMBRYONIC DEV DROSOP; Caswell PT, 2008, J CELL BIOL, V183, P143, DOI 10.1083/jcb.200804140; Chen EH, 2003, CELL, V114, P751, DOI 10.1016/S0092-8674(03)00720-7; Clark KA, 2003, DEVELOPMENT, V130, P2611, DOI 10.1242/dev.00492; Dupuy AG, 2005, ONCOGENE, V24, P4509, DOI 10.1038/sj.onc.1208647; Englund C, 2003, NATURE, V425, P512, DOI 10.1038/nature01950; Erickson MRS, 1997, J CELL BIOL, V138, P589, DOI 10.1083/jcb.138.3.589; Ervasti JM, 2003, J BIOL CHEM, V278, P13591, DOI 10.1074/jbc.R200021200; Fukuyama T, 2005, J BIOL CHEM, V280, P815, DOI 10.1074/jbc.M411099200; Galbiati F, 2001, J BIOL CHEM, V276, P21425, DOI 10.1074/jbc.M100828200; Gotoh T, 1997, J BIOL CHEM, V272, P18602, DOI 10.1074/jbc.272.30.18602; GOTOH T, 1995, MOL CELL BIOL, V15, P6746; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Hogan C, 2004, MOL CELL BIOL, V24, P6690, DOI 10.1128/mcb.24.15.6690-6700.2004; Huelsmann S, 2006, DEVELOPMENT, V133, P2915, DOI 10.1242/dev.02449; Ishimaru S, 1999, EMBO J, V18, P145, DOI 10.1093/emboj/18.1.145; Jani K, 2007, J CELL BIOL, V179, P1583, DOI 10.1083/jcb.200707045; KNUDSEN BS, 1994, J BIOL CHEM, V269, P32781; Kopczynski CC, 1996, SCIENCE, V271, P1867, DOI 10.1126/science.271.5257.1867; Lee EY, 2002, SCIENCE, V297, P1193, DOI 10.1126/science.1071362; Lee HH, 2003, NATURE, V425, P507, DOI 10.1038/nature01916; Lee JH, 2002, MOL CELL BIOL, V22, P7658, DOI 10.1128/MCB.22.21.7658-7666.2002; LEISS D, 1988, DEVELOPMENT, V104, P525; Loren CE, 2003, EMBO REP, V4, P781, DOI 10.1038/sj.embor.embor897; McNally EM, 1998, HUM MOL GENET, V7, P871, DOI 10.1093/hmg/7.5.871; Ohba Y, 2001, EMBO J, V20, P3333, DOI 10.1093/emboj/20.13.3333; Okino K, 2006, INT J GYNECOL CANCER, V16, P763, DOI 10.1111/j.1525-1438.2006.00352.x; Pannekoek WJ, 2009, BBA-BIOMEMBRANES, V1788, P790, DOI 10.1016/j.bbamem.2008.12.010; PARDO JV, 1983, P NATL ACAD SCI-BIOL, V80, P1008, DOI 10.1073/pnas.80.4.1008; Parton RG, 1997, J CELL BIOL, V136, P137, DOI 10.1083/jcb.136.1.137; PATEL NH, 1994, METHOD CELL BIOL, V44, P445, DOI 10.1016/S0091-679X(08)60927-9; Pellinen T, 2008, DEV CELL, V15, P371, DOI 10.1016/j.devcel.2008.08.001; Radha V, 2007, EXP CELL RES, V313, P2476, DOI 10.1016/j.yexcr.2007.03.019; REEDY MC, 1993, DEV BIOL, V160, P443, DOI 10.1006/dbio.1993.1320; Rehmann H, 2006, METHOD ENZYMOL, V407, P159, DOI 10.1016/S0076-6879(05)07014-X; ROULIER EM, 1992, J CELL BIOL, V116, P911, DOI 10.1083/jcb.116.4.911; RUSHTON E, 1995, DEVELOPMENT, V121, P1979; Schwander M, 2003, DEV CELL, V4, P673, DOI 10.1016/S1534-5807(03)00118-7; Tamada M, 2004, DEV CELL, V7, P709, DOI 10.1016/j.devcel.2004.08.021; TANAKA S, 1994, P NATL ACAD SCI USA, V91, P3443, DOI 10.1073/pnas.91.8.3443; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; vandenBerghe N, 1997, ONCOGENE, V15, P845, DOI 10.1038/sj.onc.1201407; VOLK T, 1990, CELL, V63, P525, DOI 10.1016/0092-8674(90)90449-O; Voss AK, 2003, DEVELOPMENT, V130, P355, DOI 10.1242/dev.00217; Voss AK, 2006, EMBO J, V25, P3652, DOI 10.1038/sj.emboj.7601234; Yagi R, 2001, EMBO REP, V2, P814, DOI 10.1093/embo-reports/kve178	54	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2010	5	3							e9403	10.1371/journal.pone.0009403	http://dx.doi.org/10.1371/journal.pone.0009403			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	562OZ	20209136	Green Submitted, Green Published, gold			2022-12-25	WOS:000275063400001
J	Francischetti, IMB; Kotsyfakis, M; Andersen, JF; Lukszo, J				Francischetti, Ivo M. B.; Kotsyfakis, Michalis; Andersen, John F.; Lukszo, Jan			Cyr61/CCN1 Displays High-Affinity Binding to the Somatomedin B (1-44) Domain of Vitronectin	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR-1; UROKINASE RECEPTOR; EXTRACELLULAR-MATRIX; CELL-ADHESION; INTEGRIN ALPHA-V-BETA-3; SALIVARY-GLAND; CCN FAMILY; EXPRESSION; PROTEINS; GROWTH	Background: Cyr61 is a member of the CCN (Cyr61, connective tissue growth, NOV) family of extracellular-associated (matricellular) proteins that present four distinct functional modules, namely insulin-like growth factor binding protein (IGFBP), von Willebrand factor type C (vWF), thrombospondin type 1 (TSP), and C-terminal growth factor cysteine knot (CT) domain. While heparin sulphate proteoglycans reportedly mediate the interaction of Cyr61 with the matrix and cell surface, the role of other extracellular associated proteins has not been revealed. Methods and Findings: In this report, surface plasmon resonance (SPR) experiments and solid-phase binding assays demonstrate that recombinant Cyr61 interacts with immobilized monomeric or multimeric vitronectin (VTNC) with K-D in the nanomolar range. Notably, the binding site for Cyr61 was identified as the somatomedin B domain (SMTB (1-44)) of VTNC, which mediates its interaction with PAI-1, uPAR, and integrin alpha v beta 3. Accordingly, PAI-1 outcompetes Cyr61 for binding to immobilized SMTB (1-44), and Cyr61 attenuates uPAR-mediated U937 adhesion to VTNC. In contrast, isothermal titration calorimetry shows that Cyr61 does not display high-affinity binding for SMTB (1-44) in solution. Nevertheless, competitive ELISA revealed that multimeric VTNC, heat-modified monomeric VTNC, or SMTB (1-44) at high concentrations attenuate Cyr61 binding to immobilized VTNC, while monomeric VTNC was ineffective. Therefore, immobilization of VTNC exposes cryptic epitopes that recognize Cyr61 with high affinity, as reported for a number of antibodies, beta-endorphin, and other molecules. Conclusions: The finding that Cyr61 interacts with the SMTB (1-44) domain suggests that VTNC represent a point of anchorage for CCN family members to the matrix. Results are discussed in the context of the role of CCN and VTNC in matrix biology and angiogenesis.	[Francischetti, Ivo M. B.; Andersen, John F.] NIAID, Sect Vector Biol, Lab Malaria & Vector Res, Res Technol Branch,NIH, Bethesda, MD 20892 USA; [Lukszo, Jan] NIAID, Peptide Synth & Anal Lab, Res Technol Branch, NIH, Bethesda, MD 20892 USA; [Kotsyfakis, Michalis] Natl Acad Sci Czech Republ, Inst Parasitol, Ctr Biol, Ceske Budejovice, Czech Republic	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences	Francischetti, IMB (corresponding author), NIAID, Sect Vector Biol, Lab Malaria & Vector Res, Res Technol Branch,NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	ifrancischetti@niaid.nih.gov	Kotsyfakis, Michail/G-9525-2014	Kotsyfakis, Michail/0000-0002-7526-1876	NIH/NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000810, ZIAAI001012] Funding Source: NIH RePORTER	NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding provided by Intramural Research Program - NIH/NIAID. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaboe M, 2003, BBA-MOL BASIS DIS, V1638, P72, DOI 10.1016/S0925-4439(03)00059-0; Bach LA, 2005, TRENDS ENDOCRIN MET, V16, P228, DOI 10.1016/j.tem.2005.05.005; Bafetti LM, 1998, J BIOL CHEM, V273, P143, DOI 10.1074/jbc.273.1.143; Brigstock DR, 1999, ENDOCR REV, V20, P189, DOI 10.1210/er.20.2.189; BROOKS PC, 1994, SCIENCE, V264, P569, DOI 10.1126/science.7512751; Calvo E, 2007, J BIOL CHEM, V282, P26928, DOI 10.1074/jbc.M705669200; Carreiras F, 1996, GYNECOL ONCOL, V62, P260, DOI 10.1006/gyno.1996.0225; Cate JM, 2007, CURR DRUG TARGETS, V8, P971, DOI 10.2174/138945007781662337; Chavakis T, 1998, BLOOD, V91, P2305, DOI 10.1182/blood.V91.7.2305.2305_2305_2312; Dellas C, 2005, THROMB HAEMOSTASIS, V93, P631, DOI 10.1160/TH05-01-0033; Deng G, 2001, J CELL PHYSIOL, V189, P23, DOI 10.1002/jcp.1133; Deng G, 1996, J CELL BIOL, V134, P1563, DOI 10.1083/jcb.134.6.1563; Desnoyers L, 2001, J BIOL CHEM, V276, P47599, DOI 10.1074/jbc.M108339200; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Francischetti IMB, 2002, BLOOD, V99, P3602, DOI 10.1182/blood-2001-12-0237; Francischetti IMB, 2008, MICROCIRCULATION, V15, P81, DOI 10.1080/10739680701451516; HILDEBRAND A, 1989, J BIOL CHEM, V264, P15429; Holbourn KP, 2008, TRENDS BIOCHEM SCI, V33, P461, DOI 10.1016/j.tibs.2008.07.006; Huai Q, 2008, NAT STRUCT MOL BIOL, V15, P422, DOI 10.1038/nsmb.1404; Hynes RO, 2007, J THROMB HAEMOST, V5, P32, DOI 10.1111/j.1538-7836.2007.02569.x; JASKIEWICZ K, 1993, ANTICANCER RES, V13, P2229; Kamikubo Y, 2006, BIOCHEMISTRY-US, V45, P3297, DOI 10.1021/bi052278f; Kenny HA, 2008, J CLIN INVEST, V118, P1367, DOI 10.1172/JCI33775; Kjaergaard M, 2008, FRONT BIOSCI-LANDMRK, V13, P5441, DOI 10.2741/3092; Kjaergaard M, 2007, PROTEIN SCI, V16, P1934, DOI 10.1110/ps.072949607; Kleinman HK, 2003, CURR OPIN BIOTECH, V14, P526, DOI 10.1016/j.copbio.2003.08.002; KOST C, 1992, J BIOL CHEM, V267, P12098; Kotsyfakis M, 2006, J BIOL CHEM, V281, P26298, DOI 10.1074/jbc.M513010200; Leask A, 2006, J CELL SCI, V119, P4803, DOI 10.1242/jcs.03270; Leavitt S, 2001, CURR OPIN STRUC BIOL, V11, P560, DOI 10.1016/S0959-440X(00)00248-7; Madsen CD, 2007, J CELL BIOL, V177, P927, DOI 10.1083/jcb.200612058; Mayasundari A, 2004, J BIOL CHEM, V279, P29359, DOI 10.1074/jbc.M401279200; McMahon GA, 2001, J BIOL CHEM, V276, P33964, DOI 10.1074/jbc.M105980200; Mo FE, 2002, MOL CELL BIOL, V22, P8709, DOI 10.1128/MCB.22.24.8709-8720.2002; Mohan S, 2002, J ENDOCRINOL, V175, P19, DOI 10.1677/joe.0.1750019; MORTON TA, 1995, ANAL BIOCHEM, V227, P176, DOI 10.1006/abio.1995.1268; Nam T, 2002, ENDOCRINOLOGY, V143, P30, DOI 10.1210/en.143.1.30; NIP J, 1992, J CLIN INVEST, V90, P1406, DOI 10.1172/JCI116007; Nishida T, 2003, J CELL PHYSIOL, V196, P265, DOI 10.1002/jcp.10277; NUSRAT AR, 1991, J CLIN INVEST, V87, P1091, DOI 10.1172/JCI115070; O'Kelly J, 2008, INT J ONCOL, V33, P59; Okumura Y, 2002, J BIOL CHEM, V277, P9395, DOI 10.1074/jbc.M111225200; PREISSNER KT, 1991, ANNU REV CELL BIOL, V7, P275, DOI 10.1146/annurev.cellbio.7.1.275; ROVERA G, 1979, P NATL ACAD SCI USA, V76, P2779, DOI 10.1073/pnas.76.6.2779; Schar CR, 2008, J BIOL CHEM, V283, P28487, DOI 10.1074/jbc.M804257200; Schar CR, 2008, J BIOL CHEM, V283, P10297, DOI 10.1074/jbc.M708017200; SEIFFERT D, 1995, FEBS LETT, V368, P155, DOI 10.1016/0014-5793(95)00630-R; SEIFFERT D, 1994, J BIOL CHEM, V269, P2659; Seiffert D, 1997, HISTOL HISTOPATHOL, V12, P787; STOCKMANN A, 1993, J BIOL CHEM, V268, P22874; Wei Y, 2005, J CELL BIOL, V168, P501, DOI 10.1083/jcb.200404112; WEI Y, 1994, J BIOL CHEM, V269, P32380; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; YANG GP, 1991, CELL GROWTH DIFFER, V2, P351; Zhou AW, 2003, NAT STRUCT BIOL, V10, P541, DOI 10.1038/nsb943	55	11	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2010	5	2							e9356	10.1371/journal.pone.0009356	http://dx.doi.org/10.1371/journal.pone.0009356			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	561RS	20195466	Green Published, Green Submitted, gold			2022-12-25	WOS:000274997000003
J	Torri, A; Beretta, O; Ranghetti, A; Granucci, F; Ricciardi-Castagnoli, P; Foti, M				Torri, Anna; Beretta, Ottavio; Ranghetti, Anna; Granucci, Francesca; Ricciardi-Castagnoli, Paola; Foti, Maria			Gene Expression Profiles Identify Inflammatory Signatures in Dendritic Cells	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; BREAST-CANCER; 1,25-DIHYDROXYVITAMIN D-3; MICROARRAY DATA; IL-1 RECEPTOR; RANDOM FOREST; IFN-ALPHA; CLASSIFICATION; INNATE; IDENTIFICATION	Dendritic cells (DCs) constitute a heterogeneous group of antigen-presenting leukocytes important in activation of both innate and adaptive immunity. We studied the gene expression patterns of DCs incubated with reagents inducing their activation or inhibition. Total RNA was isolated from DCs and gene expression profiling was performed with oligonucleotide microarrays. Using a supervised learning algorithm based on Random Forest, we generated a molecular signature of inflammation from a training set of 77 samples. We then validated this molecular signature in a testing set of 38 samples. Supervised analysis identified a set of 44 genes that distinguished very accurately between inflammatory and non inflammatory samples. The diagnostic performance of the signature genes was assessed against an independent set of samples, by qRT-PCR. Our findings suggest that the gene expression signature of DCs can provide a molecular classification for use in the selection of anti-inflammatory or adjuvant molecules with specific effects on DC activity.	[Torri, Anna; Ranghetti, Anna; Granucci, Francesca; Foti, Maria] Univ Milano Bicocca, Dept Biosci & Biotechnol, Milan, Italy; [Beretta, Ottavio; Ricciardi-Castagnoli, Paola] Singapore Immunol Network, Singapore, Singapore	University of Milano-Bicocca; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN)	Torri, A (corresponding author), Univ Milano Bicocca, Dept Biosci & Biotechnol, Milan, Italy.	maria.foti@unimib.it	Foti, Maria/AAB-9961-2022; Castagnoli, Paola/E-8288-2010; Ranghetti, Anna/AAO-2867-2020; GRANUCCI, Francesca/K-6150-2019	granucci, francesca/0000-0002-7046-4914; FOTI, MARIA/0000-0002-4481-1900	European Commission; Italian Ministry of Education and Research [PRIN-COFIN 20077NFBH8_003]	European Commission(European CommissionEuropean Commission Joint Research Centre); Italian Ministry of Education and Research(Ministry of Education, Universities and Research (MIUR))	This work was supported by the grants from European Commission 6th Framework Program (AIDS-CoVAC), the Italian Ministry of Education and Research PRIN-COFIN 20077NFBH8_003. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham SM, 2006, J EXP MED, V203, P1883, DOI 10.1084/jem.20060336; Aebischer T, 2005, EUR J IMMUNOL, V35, P476, DOI 10.1002/eji.200425674; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Allantaz F, 2007, J EXP MED, V204, P2131, DOI 10.1084/jem.20070070; Alon U, 1999, P NATL ACAD SCI USA, V96, P6745, DOI 10.1073/pnas.96.12.6745; ALROY I, 1995, MOL CELL BIOL, V15, P5789; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bhattacharyya S, 2004, BLOOD, V104, P1100, DOI 10.1182/blood-2003-12-4302; Blanco P, 2008, CYTOKINE GROWTH F R, V19, P41, DOI 10.1016/j.cytogfr.2007.10.004; Das Sarma J, 2008, CELL COMMUN ADHES, V15, P65, DOI 10.1080/15419060802014305; Diaz-Uriarte R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-3; Dillon S, 2006, J CLIN INVEST, V116, P916, DOI 10.1172/JCI27203; Ein-Dor L, 2005, BIOINFORMATICS, V21, P171, DOI 10.1093/bioinformatics/bth469; Foti M, 2006, E SCHERING RES FDN W, V56, P61; Foti M, 2004, TRENDS IMMUNOL, V25, P650, DOI 10.1016/j.it.2004.10.007; Foti Maria, 2007, Methods Mol Biol, V380, P215; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Granucci F, 2001, NAT IMMUNOL, V2, P882, DOI 10.1038/ni0901-882; Huang LT, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-25; Hutton JJ, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-82; Hyatt G, 2006, NAT IMMUNOL, V7, P686, DOI 10.1038/ni0706-686; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jiang WY, 2008, STAT APPL GENET MOL, V7; Ju XS, 2004, IMMUNOBIOLOGY, V209, P155, DOI 10.1016/j.imbio.2004.02.005; Kong J, 2006, J IMMUNOL, V176, P3780, DOI 10.4049/jimmunol.176.6.3780; LACEY DL, 1993, J CLIN INVEST, V91, P1731, DOI 10.1172/JCI116383; Lehtonen A, 2007, J LEUKOCYTE BIOL, V82, P710, DOI 10.1189/jlb.0307194; Lossos IS, 2004, NEW ENGL J MED, V350, P1828, DOI 10.1056/NEJMoa032520; Luft T, 2002, INT IMMUNOL, V14, P367, DOI 10.1093/intimm/14.4.367; Marshak-Rothstein A, 2006, NAT REV IMMUNOL, V6, P823, DOI 10.1038/nri1957; Mathieu C, 2006, CLIN NEPHROL, V66, P275; McIlroy D, 2005, J LEUKOCYTE BIOL, V78, P794, DOI 10.1189/jlb.0105029; Medzhitov R, 2000, NEW ENGL J MED, V343, P338, DOI 10.1056/NEJM200008033430506; Paik S, 2006, J CLIN ONCOL, V24, P3726, DOI 10.1200/JCO.2005.04.7985; Pavelka N, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-203; Peng YX, 2006, CANCER INFORM, V2, P301; PIRAMI L, 1991, P NATL ACAD SCI USA, V88, P7543, DOI 10.1073/pnas.88.17.7543; PREHN JL, 1989, TRANSPL P, V21, P90; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Ritter M, 2005, BIOCHEM BIOPH RES CO, V334, P254, DOI 10.1016/j.bbrc.2005.06.084; Schoeters E, 2006, TOXICOL APPL PHARM, V216, P131, DOI 10.1016/j.taap.2006.04.009; Shaffer AL, 2001, IMMUNITY, V15, P375, DOI 10.1016/S1074-7613(01)00194-7; Shyamsundar R, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-r22; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; Svane IM, 2006, SCAND J IMMUNOL, V63, P217, DOI 10.1111/j.1365-3083.2006.01728.x; SYMMANS WF, 1995, HUM PATHOL, V26, P210, DOI 10.1016/0046-8177(95)90039-X; Trottein F, 2004, J IMMUNOL, V172, P3011, DOI 10.4049/jimmunol.172.5.3011; Tsan MF, 2004, J LEUKOCYTE BIOL, V76, P514, DOI 10.1189/jlb.0304127; van Etten E, 2005, J STEROID BIOCHEM, V97, P93, DOI 10.1016/j.jsbmb.2005.06.002; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Vizzardelli C, 2006, EUR J IMMUNOL, V36, P1504, DOI 10.1002/eji.200535488; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Whitney AR, 2003, P NATL ACAD SCI USA, V100, P1896, DOI 10.1073/pnas.252784499; Winzler C, 1997, J EXP MED, V185, P317, DOI 10.1084/jem.185.2.317; Yamagata T, 2006, IMMUNOL REV, V210, P52, DOI 10.1111/j.0105-2896.2006.00371.x; Yanai I, 2005, BIOINFORMATICS, V21, P650, DOI 10.1093/bioinformatics/bti042; Yang F, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S22; Zaslona Z, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-2; ZHANG WW, 1994, CANCER GENE THER, V1, P5; Zhong WX, 2009, CELL MOL BIOL LETT, V14, P587, DOI 10.2478/s11658-009-0023-3; Zilliox MJ, 2006, P NATL ACAD SCI USA, V103, P3363, DOI 10.1073/pnas.0511345103	62	37	37	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2010	5	2							e9404	10.1371/journal.pone.0009404	http://dx.doi.org/10.1371/journal.pone.0009404			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SX	20195376	gold, Green Published, Green Submitted			2022-12-25	WOS:000274924200024
J	Bulchand, S; Menon, SD; George, SE; Chia, W				Bulchand, Sarada; Menon, Sree Devi; George, Simi Elizabeth; Chia, William			The Intracellular Domain of Dumbfounded Affects Myoblast Fusion Efficiency and Interacts with Rolling Pebbles and Loner	PLOS ONE			English	Article							DROSOPHILA-MELANOGASTER; MUSCLE DEVELOPMENT; IMMUNOGLOBULIN SUPERFAMILY; FOUNDER CELL; BLOWN-FUSE; D-TITIN; PROTEIN; MYOGENESIS; GENE; MEMBRANE	Drosophila body wall muscles are multinucleated syncytia formed by successive fusions between a founder myoblast and several fusion competent myoblasts. Initial fusion gives rise to a bi/trinucleate precursor followed by more fusion cycles forming a mature muscle. This process requires the functions of various molecules including the transmembrane myoblast attractants Dumbfounded (Duf) and its paralogue Roughest (Rst), a scaffold protein Rolling pebbles (Rols) and a guanine nucleotide exchange factor Loner. Fusion completely fails in a duf, rst mutant, and is blocked at the bi/trinucleate stage in rols and loner single mutants. We analysed the transmembrane and intracellular domains of Duf, by mutating conserved putative signaling sites and serially deleting the intracellular domain. These were tested for their ability to translocate and interact with Rols and Loner and to rescue the fusion defect in duf, rst mutant embryos. Studying combinations of double mutants, further tested the function of Rols, Loner and other fusion molecules. Here we show that serial truncations of the Duf intracellular domain successively compromise its function to translocate and interact with Rols and Loner in addition to affecting myoblast fusion efficiency in embryos. Putative phosphorylation sites function additively while the extreme C terminus including a PDZ binding domain is dispensable for its function. We also show that fusion is completely blocked in a rols, loner double mutant and is compromised in other double mutants. These results suggest an additive function of the intracellular domain of Duf and an early function of Rols and Loner which is independent of Duf.	[Bulchand, Sarada; Menon, Sree Devi; George, Simi Elizabeth; Chia, William] Natl Univ Singapore, Temasek Lifesci Lab, Singapore 117548, Singapore	National University of Singapore	Bulchand, S (corresponding author), Natl Univ Singapore, Temasek Lifesci Lab, Singapore 117548, Singapore.	sbulchand@gmail.com			Temasek Lifesciences Laboratory; Singapore Millenium Foundation	Temasek Lifesciences Laboratory; Singapore Millenium Foundation	Temasek Lifesciences Laboratory. Singapore Millenium Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abmayr SM, 2003, INT REV CYTOL, V225, P33, DOI 10.1016/S0074-7696(05)25002-7; Artero RD, 2001, DEVELOPMENT, V128, P4251; BATE M, 1990, DEVELOPMENT, V110, P791; Baylies MK, 2001, CURR OPIN GENET DEV, V11, P431, DOI 10.1016/S0959-437X(00)00214-8; Baylies MK, 1998, CELL, V93, P921, DOI 10.1016/S0092-8674(00)81198-8; Beckett K, 2007, DEV BIOL, V309, P113, DOI 10.1016/j.ydbio.2007.06.024; BOUR BA, 1995, GENE DEV, V9, P730, DOI 10.1101/gad.9.6.730; Bour BA, 2000, GENE DEV, V14, P1498; BRAND AH, 1993, DEVELOPMENT, V118, P401; BROADIE KS, 1993, J NEUROSCI, V13, P167; CARMENA A, 1995, GENE DEV, V9, P2373, DOI 10.1101/gad.9.19.2373; Chen EH, 2001, DEV CELL, V1, P705, DOI 10.1016/S1534-5807(01)00084-3; Chen EH, 2003, CELL, V114, P751, DOI 10.1016/S0092-8674(03)00720-7; Cohen SM., 1993, DEV DROSOPHILA MELAN; Doberstein SK, 1997, J CELL BIOL, V136, P1249, DOI 10.1083/jcb.136.6.1249; Donaldson JG, 2003, J BIOL CHEM, V278, P41573, DOI 10.1074/jbc.R300026200; Dworak HA, 2001, DEVELOPMENT, V128, P4265; Dyer N, 2007, DEVELOPMENT, V134, P4437, DOI 10.1242/dev.010983; Erickson MRS, 1997, J CELL BIOL, V138, P589, DOI 10.1083/jcb.138.3.589; FRASCH M, 1987, EMBO J, V6, P749, DOI 10.1002/j.1460-2075.1987.tb04817.x; Frasch M, 1999, CURR OPIN GENET DEV, V9, P522, DOI 10.1016/S0959-437X(99)00014-3; Galletta BJ, 2004, MECH DEVELOP, V121, P1455, DOI 10.1016/j.mod.2004.08.001; Kesper DA, 2007, DEV DYNAM, V236, P404, DOI 10.1002/dvdy.21035; KIEHART DP, 1986, J CELL BIOL, V103, P1517, DOI 10.1083/jcb.103.4.1517; Kim S, 2007, DEV CELL, V12, P571, DOI 10.1016/j.devcel.2007.02.019; Kocherlakota KS, 2008, GENETICS, V178, P1371, DOI 10.1534/genetics.107.083808; Kosman D, 1998, DEV GENES EVOL, V208, P290, DOI 10.1007/s004270050184; Massarwa R, 2007, DEV CELL, V12, P557, DOI 10.1016/j.devcel.2007.01.016; Menon SD, 2005, J CELL BIOL, V169, P909, DOI 10.1083/jcb.200501126; Menon SD, 2001, DEV CELL, V1, P691, DOI 10.1016/S1534-5807(01)00075-2; Radhakrishna H, 1999, J CELL SCI, V112, P855; Rau A, 2001, DEVELOPMENT, V128, P5061; Richardson B, 2008, BIOESSAYS, V30, P423, DOI 10.1002/bies.20756; Richardson BE, 2007, DEVELOPMENT, V134, P4357, DOI 10.1242/dev.010678; Richardson Brian E., 2008, V475, P263, DOI 10.1007/978-1-59745-250-2_15; Ruiz-Gomez M, 2000, CELL, V102, P189, DOI 10.1016/S0092-8674(00)00024-6; RUSHTON E, 1995, DEVELOPMENT, V121, P1979; Schroter RH, 2004, DEVELOPMENT, V131, P4501, DOI 10.1242/dev.01309; Shelton C, 2009, DEVELOPMENT, V136, P1159, DOI 10.1242/dev.026302; Spradling AC, 1986, DROSOPHILA PRACTICAL, P175; Strunkelnberg M, 2003, J MOL EVOL, V56, P187, DOI 10.1007/s00239-002-2393-2; Strunkelnberg M, 2001, DEVELOPMENT, V128, P4229; Taylor MV, 1998, CURR BIOL, V8, pR356, DOI 10.1016/S0960-9822(98)70221-0; Taylor MV, 2002, CURR BIOL, V12, pR224, DOI 10.1016/S0960-9822(02)00757-1; Tepass U, 1996, GENE DEV, V10, P672, DOI 10.1101/gad.10.6.672; Ungermann C, 2005, J CELL SCI, V118, P3819, DOI 10.1242/jcs.02561; Vishnu S, 2006, DEV BIOL, V289, P296, DOI 10.1016/j.ydbio.2005.09.016; Yu HH, 1998, NEURON, V20, P207, DOI 10.1016/S0896-6273(00)80450-X; Zhang Y, 2000, J CELL SCI, V113, P3103	49	20	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2010	5	2							e9374	10.1371/journal.pone.0009374	http://dx.doi.org/10.1371/journal.pone.0009374			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SV	20186342	Green Published, Green Submitted, gold			2022-12-25	WOS:000274924000016
J	Chen, P; Dendorfer, A; Finol-Urdaneta, RK; Terlau, H; Olivera, BM				Chen, Ping; Dendorfer, Andreas; Finol-Urdaneta, Rocio K.; Terlau, Heinrich; Olivera, Baldomero M.			Biochemical Characterization of kappa M-RIIIJ, a Kv1.2 Channel Blocker EVALUATION OF CARDIOPROTECTIVE EFFECTS OF kappa M-CONOTOXINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							K+ CHANNELS; POTASSIUM CHANNELS; SODIUM-CHANNELS; PEPTIDE TOXINS; INFARCT SIZE; SNAIL VENOM; REPERFUSION; INHIBITOR; SUBUNIT; IDENTIFICATION	Conus snail (Conus) venoms are a valuable source of pharmacologically active compounds; some of the peptide toxin families from the snail venoms are known to interact with potassium channels. We report the purification, synthesis, and characterization of kappa M-conotoxin RIIIJ from the venom of a fish-hunting species, Conus radiatus. This conopeptide, like a previously characterized peptide in the same family, kappa M-RIIIK, inhibits the homotetrameric human Kv1.2 channels. When tested in Xenopus oocytes, kappa M-RIIIJ has an order of magnitude higher affinity (IC50 = 33 nM) to Kv1.2 than kappa M-RIIIK (IC50 = 352 nM). Chimeras of RIIIK and RIIIJ tested on the human Kv1.2 channels revealed that Lys-9 from kappa M-RIIIJ is a determinant of its higher potency against hKv1.2. However, when compared in a model of ischemia/reperfusion, kappa M-RIIIK (100 mu g/kg of body weight), administered just before reperfusion, significantly reduces the infarct size in rat hearts in vivo without influencing hemodynamics, providing a potential compound for cardioprotective therapeutics. In contrast, kappa M-RIIIJ does not exert any detectable cardioprotective effect. kappa M-RIIIJ shows more potency for Kv1.2-Kv1.5 and Kv1.2-Kv1.6 heterodimers than kappa M-RIIIK, whereas the affinity of kappa M-RIIIK to Kv1.2-Kv1.7 heterodimeric channels is higher (IC50 = 680 nM) than that of kappa M-RIIIJ (IC50 = 3.15 mu M). Thus, the cardioprotection seems to correlate to antagonism to heteromultimeric channels, involving the Kv1.2 alpha-subunit rather than antagonism to Kv1.2 homotetramers. Furthermore, kappa M-RIIIK and kappa M-RIIIJ provide a valuable set of probes for understanding the underlying mechanism of cardioprotection.	[Finol-Urdaneta, Rocio K.; Terlau, Heinrich] Univ Kiel, Inst Physiol, D-24098 Kiel, Germany; [Chen, Ping; Olivera, Baldomero M.] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Dendorfer, Andreas; Terlau, Heinrich] Univ Klinikum Schleswig Holstein, Inst Expt & Clin Pharmacol & Toxicol, D-23538 Lubeck, Germany; [Finol-Urdaneta, Rocio K.] Univ Calgary, Dept Physiol & Pharmacol, Calgary, AB T2N 4N1, Canada; [Finol-Urdaneta, Rocio K.] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB T2N 4N1, Canada	University of Kiel; Utah System of Higher Education; University of Utah; University of Kiel; Schleswig Holstein University Hospital; University of Calgary; University of Calgary	Terlau, H (corresponding author), Univ Kiel, Inst Physiol, Olshausenstr 40, D-24098 Kiel, Germany.	h.terlau@physiologie.uni-kiel.de	Finol-Urdaneta, Rocio K./AAH-6447-2019	Finol-Urdaneta, Rocio K./0000-0003-2157-4532; Terlau, Heinrich/0000-0002-2206-1221	National Institutes of Health [GM48677]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM048677] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM48677 ( to B.M.O.).	Al-Sabi A, 2004, BIOCHEMISTRY-US, V43, P8625, DOI 10.1021/bi0495681; Brinckmann J, 2005, MATRIX BIOL, V24, P459, DOI 10.1016/j.matbio.2005.07.002; Cartier GE, 1996, J BIOL CHEM, V271, P7522, DOI 10.1074/jbc.271.13.7522; Coetzee WA, 1999, ANN NY ACAD SCI, V868, P233, DOI 10.1111/j.1749-6632.1999.tb11293.x; Cohen MV, 2007, CIRCULATION, V115, P1895, DOI 10.1161/CIRCULATIONAHA.106.675710; Dixon JE, 1996, EUR J NEUROSCI, V8, P183, DOI 10.1111/j.1460-9568.1996.tb01179.x; Ferber M, 2004, TOXICON, V43, P915, DOI 10.1016/j.toxicon.2003.12.010; Ferber M, 2003, J BIOL CHEM, V278, P2177, DOI 10.1074/jbc.M205953200; Finol-Urdaneta RK, 2006, J GEN PHYSIOL, V128, P133, DOI 10.1085/jgp.200609498; Gulbis JM, 2002, NOVART FDN SYMP, V245, P127; Hill JM, 1996, BIOCHEMISTRY-US, V35, P8824, DOI 10.1021/bi960073o; Hopkins WF, 1998, J PHARMACOL EXP THER, V285, P1051; Imperial JS, 2006, BIOCHEMISTRY-US, V45, P8331, DOI 10.1021/bi060263r; Jan LY, 1997, ANNU REV NEUROSCI, V20, P91, DOI 10.1146/annurev.neuro.20.1.91; KAPLAN SH, 1995, CARDIOVASC RES, V29, P231, DOI 10.1016/S0008-6363(96)88575-0; Keizer DW, 2003, J BIOL CHEM, V278, P46805, DOI 10.1074/jbc.M309222200; Koch ED, 2004, BIOPHYS J, V86, P191, DOI 10.1016/S0006-3495(04)74096-5; LANCELIN JM, 1991, BIOCHEMISTRY-US, V30, P6908, DOI 10.1021/bi00242a014; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Lubbers NL, 2005, J CARDIOVASC PHARM, V46, P141, DOI 10.1097/01.fjc.0000167015.84715.27; Nesti E, 2004, MOL BIOL CELL, V15, P4073, DOI 10.1091/mbc.E03-11-0788; Nielsen KJ, 2002, J BIOL CHEM, V277, P27247, DOI 10.1074/jbc.M201611200; Olivera BM, 2006, J BIOL CHEM, V281, P31173, DOI 10.1074/jbc.R600020200; Plane F, 2005, CIRC RES, V96, P216, DOI 10.1161/01.RES.0000154070.06421.25; Qiu MH, 2003, J NEUROCHEM, V87, P1509, DOI 10.1046/j.1471-4159.2003.02110.x; Rockel D, 1995, MANUAL LIVING CONIDA; SCHLUTER KD, 1991, AM J PHYSIOL, V261, pH416, DOI 10.1152/ajpheart.1991.261.2.H416; Shon KJ, 1998, J BIOL CHEM, V273, P33, DOI 10.1074/jbc.273.1.33; Terlau H, 1996, NATURE, V381, P148, DOI 10.1038/381148a0; Terlau H, 2004, PHYSIOL REV, V84, P41, DOI 10.1152/physrev.00020.2003; Vacher H, 2008, PHYSIOL REV, V88, P1407, DOI 10.1152/physrev.00002.2008; Verdier L, 2005, J BIOL CHEM, V280, P21246, DOI 10.1074/jbc.M502376200; Wolfrum S, 2001, BRIT J PHARMACOL, V134, P370, DOI 10.1038/sj.bjp.0704236; Zhang SJ, 2003, J CARDIOVASC PHARM, V42, P764, DOI 10.1097/00005344-200312000-00011	34	34	37	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					14882	14889		10.1074/jbc.M109.068486	http://dx.doi.org/10.1074/jbc.M109.068486			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20220134	Green Published, hybrid			2022-12-25	WOS:000277399000009
J	Qiu, WM; Hu, YH; Andersen, TE; Jafari, A; Li, N; Chen, W; Kassem, M				Qiu, Weimin; Hu, Yuhui; Andersen, Tom E.; Jafari, Abbas; Li, Na; Chen, Wei; Kassem, Moustapha			Tumor Necrosis Factor Receptor Superfamily Member 19 (TNFRSF19) Regulates Differentiation Fate of Human Mesenchymal (Stromal) Stem Cells through Canonical Wnt Signaling and C/EBP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE-MINERAL DENSITY; TNF RECEPTOR; BETA-CATENIN; OSTEOBLAST DIFFERENTIATION; TRANSCRIPTIONAL ACTIVATION; OSTEOCLAST DIFFERENTIATION; MISSENSE MUTATIONS; FAMILY-MEMBER; MASS; LRP5	Mechanisms controlling human multipotent mesenchymal (stromal) stem cell (hMSC) differentiation into osteoblasts or adipocytes are poorly understood. We have previously demonstrated that Wnt signaling in hMSC enhanced osteoblast differentiation and inhibited adipogenesis by comparing two hMSC cell lines overexpressing mutated forms of the Wnt co-receptor LRP5:T253I (hMSC-LRP5(T253)) and T244M (hMSC-LRP5(T244)) conducting high and low level of Wnt signaling, respectively. To explore the underlying molecular mechanisms, we compared gene expression profiles of hMSC-LRP5(T253) and hMSC-LRP5(T244) treated with Wnt3a using whole genome expression microarrays and found that TNFRSF19 is differentially up-regulated between the two cells lines. Bioinformatic analysis and dual luciferase assay of its promoter revealed that TNFRSF19 transcript 2 (TNFRSF19.2) is a target of canonical Wnt signaling. Knocking down TNFRSF19 in hMSC-LRP5(T253) cells decreased Wnt3a-induced osteoblast differentiation marker alkaline phosphate activity and its overexpression in hMSC-LRP5(T244) cells increased alkaline phosphate activity. In addition, TNFRSF19 was negatively regulated by adipogenic transcription factor CCAAT/enhancer-binding proteins (C/EBP). Knocking down TNFRSF19 in hMSC-LRP5(T253) cells or its overexpression in hMSC-LRP5(T244) cells significantly increased or decreased adipogenesis, respectively. In conclusion, we revealed a novel function of TNFRSF19 as a factor mediating differentiation signals that determine the hMSC differentiating fate into osteoblasts or adipocytes.	[Qiu, Weimin; Andersen, Tom E.; Jafari, Abbas; Kassem, Moustapha] Odense Univ Hosp, Dept Endocrinol & Metab, Lab Mol Endocrinol KMEB, DK-5000 Odense C, Denmark; [Hu, Yuhui; Li, Na; Chen, Wei] Berlin Insitute Med Syst Biol, Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Kassem, Moustapha] King Saud Univ, Dept Anat, Stem Cell Unit, Riyadh 11451, Saudi Arabia	University of Southern Denmark; Odense University Hospital; Helmholtz Association; Max Delbruck Center for Molecular Medicine; King Saud University	Kassem, M (corresponding author), Odense Univ Hosp, Dept Endocrinol & Metab, Lab Mol Endocrinol KMEB, JB Winslows Vej 25,1, DK-5000 Odense C, Denmark.	mkassem@health.sdu.dk	Jafari Kermani, Abbas/I-5074-2015; Jafari, Abbas/AAF-6256-2019; Chen, Wei/C-1273-2011; Kassem, Moustapha/J-7688-2013; Kassem, Moustapha/O-3819-2019	Jafari Kermani, Abbas/0000-0003-2443-6231; Kassem, Moustapha/0000-0003-1557-0869; Kassem, Moustapha/0000-0003-1557-0869; Chen, Wei/0000-0003-3263-1627; Li, Na/0000-0001-6163-1648	Danish Medical Research Council; Danish Stem Cell Center; Novo Nordisk Foundation; local government of the region of Southern Denmark	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Stem Cell Center; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); local government of the region of Southern Denmark	This work was supported in part by grants from the Danish Medical Research Council, the Danish Stem Cell Center, the Novo Nordisk Foundation, and a grant from the local government of the region of Southern Denmark.	Ai M, 2005, MOL CELL BIOL, V25, P4946, DOI 10.1128/MCB.25.12.4946-4955.2005; Ai MR, 2005, AM J HUM GENET, V77, P741, DOI 10.1086/497706; Albagha OME, 2002, HUM MOL GENET, V11, P2289, DOI 10.1093/hmg/11.19.2289; Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593; Arch RH, 1998, GENE DEV, V12, P2821, DOI 10.1101/gad.12.18.2821; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; BARON R, 2009, IBMS BONEKEY, V6, P86; Bennett CN, 2005, P NATL ACAD SCI USA, V102, P3324, DOI 10.1073/pnas.0408742102; Bonewald LF, 2008, BONE, V42, P606, DOI 10.1016/j.bone.2007.12.224; Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444; DYNAN WS, 1986, TRENDS GENET, V2, P196, DOI 10.1016/0168-9525(86)90226-X; Eby MT, 2000, J BIOL CHEM, V275, P15336, DOI 10.1074/jbc.275.20.15336; Ellies DL, 2006, J BONE MINER RES, V21, P1738, DOI 10.1359/JBMR.060810; Gimble JM, 2006, J CELL BIOCHEM, V98, P251, DOI 10.1002/jcb.20777; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; Glass DA, 2007, ENDOCRINOLOGY, V148, P2630, DOI 10.1210/en.2006-1372; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Hisaoka T, 2003, DEV BRAIN RES, V143, P105, DOI 10.1016/S0165-3806(03)00101-9; Hong JH, 2006, CELL CYCLE, V5, P176, DOI 10.4161/cc.5.2.2362; Hu SM, 1999, GENOMICS, V62, P103, DOI 10.1006/geno.1999.5979; Justesen J, 2001, BIOGERONTOLOGY, V2, P165, DOI 10.1023/A:1011513223894; Kahler RA, 2003, J BIOL CHEM, V278, P11937, DOI 10.1074/jbc.M211443200; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; Kojima T, 2000, J BIOL CHEM, V275, P20742, DOI 10.1074/jbc.M002691200; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Little RD, 2002, AM J HUM GENET, V70, P11, DOI 10.1086/338450; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Marie PJ, 2006, PPAR RES, V2006, DOI 10.1155/PPAR/2006/64807; McManus MT, 2002, RNA, V8, P842, DOI 10.1017/S1355838202024032; Moon RT, 2002, SCIENCE, V296, P1644, DOI 10.1126/science.1071549; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Mullin BH, 2008, OSTEOPOROSIS INT, V19, P961, DOI 10.1007/s00198-007-0517-7; Park JB, 2005, NEURON, V45, P345, DOI 10.1016/j.neuron.2004.12.040; Pispa J, 2003, GENE EXPR PATTERNS, V3, P675, DOI 10.1016/S1567-133X(03)00092-9; Pispa J, 2008, HUM MOL GENET, V17, P3380, DOI 10.1093/hmg/ddn232; Qiu WM, 2007, J BONE MINER RES, V22, P1720, DOI 10.1359/JBMR.070721; Rodriguez JP, 2004, J CELL BIOCHEM, V93, P721, DOI 10.1002/jcb.20234; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Semenov MV, 2006, J BIOL CHEM, V281, P38276, DOI 10.1074/jbc.M609509200; Shao ZH, 2005, NEURON, V45, P353, DOI 10.1016/j.neuron.2004.12.050; Si WK, 2006, MOL CELL BIOL, V26, P2955, DOI 10.1128/MCB.26.8.2955-2964.2006; Spotila LD, 2003, CALCIFIED TISSUE INT, V73, P140, DOI 10.1007/s00223-002-2079-1; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Tasker PN, 2004, OSTEOPOROSIS INT, V15, P903, DOI 10.1007/s00198-004-1617-2; van der Horst G, 2005, J BONE MINER RES, V20, P1867, DOI 10.1359/JBMR.050614; Van Wesenbeeck L, 2003, AM J HUM GENET, V72, P763, DOI 10.1086/368277; Wang Y, 2004, J CELL SCI, V117, P1525, DOI 10.1242/jcs.00994; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110; Westendorf JJ, 2004, GENE, V341, P19, DOI 10.1016/j.gene.2004.06.044; Winkler DG, 2005, J BIOL CHEM, V280, P2498, DOI 10.1074/jbc.M400524200; Yang TL, 2007, ANN HUM GENET, V71, P152, DOI 10.1111/j.1469-1809.2006.00313.x; Zhang YH, 2004, MOL CELL BIOL, V24, P4677, DOI 10.1128/MCB.24.11.4677-4684.2004	55	53	56	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14438	14449		10.1074/jbc.M109.052001	http://dx.doi.org/10.1074/jbc.M109.052001			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20223822	Green Published, hybrid			2022-12-25	WOS:000277299700040
J	Shaw, FL; Elliott, KA; Kinch, LN; Fuell, C; Phillips, MA; Michael, AJ				Shaw, Frances L.; Elliott, Katherine A.; Kinch, Lisa N.; Fuell, Christine; Phillips, Margaret A.; Michael, Anthony J.			Evolution and Multifarious Horizontal Transfer of an Alternative Biosynthetic Pathway for the Alternative Polyamine sym-Homospermidine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							S-ADENOSYLMETHIONINE DECARBOXYLASE; ORNITHINE-DECARBOXYLASE; ESCHERICHIA-COLI; DEOXYHYPUSINE SYNTHASE; CRYSTAL-STRUCTURE; GLUTATHIONYLSPERMIDINE METABOLISM; SUBSTRATE-SPECIFICITY; DISTRIBUTION PROFILES; LYSINE BIOSYNTHESIS; STRUCTURAL BASIS	Polyamines are small flexible organic polycations found in almost all cells. They likely existed in the last universal common ancestor of all extant life, and yet relatively little is understood about their biological function, especially in bacteria and archaea. Unlike eukaryotes, where the predominant polyamine is spermidine, bacteria may contain instead an alternative polyamine, sym-homospermidine. We demonstrate that homospermidine synthase (HSS) has evolved vertically, primarily in the alpha-Proteobacteria, but enzymatically active, diverse HSS orthologues have spread by horizontal gene transfer to other bacteria, bacteriophage, archaea, eukaryotes, and viruses. By expressing diverse HSS orthologues in Escherichia coli, we demonstrate in vivo the production of co-products diaminopropane and N-1-aminobutylcadaverine, in addition to sym-homospermidine. We show that sym-homospermidine is required for normal growth of the alpha-proteobacterium Rhizobium leguminosarum. However, sym-homospermidine can be replaced, for growth restoration, by the structural analogues spermidine and sym-norspermidine, suggesting that the symmetrical or unsymmetrical form and carbon backbone length are not critical for polyamine function in growth. We found that the HSS enzyme evolved from the alternative spermidine biosynthetic pathway enzyme carboxyspermidine dehydrogenase. The structure of HSS is related to lysine metabolic enzymes, and HSS and carboxyspermidine dehydrogenase evolved from the aspartate family of pathways. Finally, we show that other bacterial phyla such as Cyanobacteria and some alpha-Proteobacteria synthesize sym-homospermidine by an HSS-independent pathway, very probably based on deoxyhypusine synthase orthologues, similar to the alternative homospermidine synthase found in some plants. Thus, bacteria can contain alternative biosynthetic pathways for both spermidine and sym-norspermidine and distinct alternative pathways for sym-homospermidine.	[Shaw, Frances L.; Elliott, Katherine A.; Fuell, Christine; Michael, Anthony J.] Inst Food Res, Norwich NR4 7UA, Norfolk, England; [Kinch, Lisa N.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Phillips, Margaret A.; Michael, Anthony J.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University of East Anglia; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Michael, AJ (corresponding author), Inst Food Res, Norwich Res Pk, Norwich NR4 7UA, Norfolk, England.	anthony.michael@utsouthwestern.edu		Kinch, Lisa/0000-0003-3041-2615	National Institutes of Health [RO1 AI34432]; Biotechnology and Biological Sciences Research Council UK; Institute Development Fellowship [BB/E024467/1]; BBSRC [BBS/E/F/00044403] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/F/00044403] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI034432, R01AI034432] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Institute Development Fellowship; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 AI34432 (to M. A. P.). This work was also supported by a Biotechnology and Biological Sciences Research Council UK Competitive Strategic Grant and an Institute Development Fellowship (BB/E024467/1) (to A.J.M.).	Aury JM, 2006, NATURE, V444, P171, DOI 10.1038/nature05230; BACCHI CJ, 1993, ACTA TROP, V54, P225, DOI 10.1016/0001-706X(93)90095-S; Bale S, 2008, BIOCHEMISTRY-US, V47, P13404, DOI 10.1021/bi801732m; Baumann S, 2007, VIROLOGY, V360, P209, DOI 10.1016/j.virol.2006.10.010; BEY P, 1978, J MED CHEM, V21, P50, DOI 10.1021/jm00199a009; BOLLINGER JM, 1995, J BIOL CHEM, V270, P14031, DOI 10.1074/jbc.270.23.14031; BOTTCHER F, 1994, CAN J CHEM, V72, P80, DOI 10.1139/v94-013; Brochier C, 2004, GENE, V330, P169, DOI 10.1016/j.gene.2004.01.018; CACCIAPUOTI G, 1986, EUR J BIOCHEM, V161, P263, DOI 10.1111/j.1432-1033.1986.tb10442.x; CARON F, 1985, NATURE, V314, P185, DOI 10.1038/314185a0; Carr M, 2008, P NATL ACAD SCI USA, V105, P16641, DOI 10.1073/pnas.0801667105; Chattopadhyay MK, 2009, J BACTERIOL, V191, P5549, DOI 10.1128/JB.00381-09; Chattopadhyay MK, 2001, J BIOL CHEM, V276, P21235, DOI 10.1074/jbc.M010643200; Chin KJ, 2001, INT J SYST EVOL MICR, V51, P1965, DOI 10.1099/00207713-51-6-1965; Cohen S.S., 1998, GUIDE POLYAMINES, V1st ed.; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Deppenmeier U, 2002, J MOL MICROB BIOTECH, V4, P453; Ekstrom JL, 1999, STRUCTURE, V7, P583, DOI 10.1016/S0969-2126(99)80074-4; Foerstner KU, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003976; Fondi M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S2-S3; FUJIHARA S, 1995, J BIOL CHEM, V270, P9932, DOI 10.1074/jbc.270.17.9932; FUKUCHI J, 1994, J BIOL CHEM, V269, P22581; GILLIN FD, 1984, J PROTOZOOL, V31, P161, DOI 10.1111/j.1550-7408.1984.tb04308.x; GuevaraOlvera L, 1997, MICROBIOL-UK, V143, P2237, DOI 10.1099/00221287-143-7-2237; Gupta RS, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-106; HAMANA K, 1983, BIOCHEM BIOPH RES CO, V112, P606, DOI 10.1016/0006-291X(83)91507-3; HAMANA K, 1984, J BIOCHEM-TOKYO, V95, P1105, DOI 10.1093/oxfordjournals.jbchem.a134698; Hamana K., 1998, MICROBIOL CULT COLL, V14, P1; Hamana K, 2008, J GEN APPL MICROBIOL, V54, P229, DOI 10.2323/jgam.54.229; Heydari M, 2004, APPL ENVIRON MICROB, V70, P937, DOI 10.1128/AEM.70.2.937-942.2004; Higashi K, 2008, J BIOL CHEM, V283, P32989, DOI 10.1074/jbc.M806027200; Hosoya R, 2004, J GEN APPL MICROBIOL, V50, P271, DOI 10.2323/jgam.50.271; Hosoya R, 2004, J GEN APPL MICROBIOL, V50, P255, DOI 10.2323/jgam.50.255; Hosoya R., 2006, MICROBIOL CULT; Hottes AK, 2004, J BACTERIOL, V186, P1448, DOI 10.1128/JB.186.5.1448-1461.2004; Jiang YQ, 1999, J BIOL CHEM, V274, P3781, DOI 10.1074/jbc.274.6.3781; Jin Y, 2002, MOL MICROBIOL, V46, P801, DOI 10.1046/j.1365-2958.2002.03201.x; Johansson E, 2000, STRUCTURE, V8, P1037, DOI 10.1016/S0969-2126(00)00512-8; Kaiser A, 1999, VIROLOGY, V263, P254, DOI 10.1006/viro.1999.9972; Kaiser A, 1999, PLANT J, V19, P195, DOI 10.1046/j.1365-313X.1999.00509.x; KALLIO A, 1981, BIOCHEM J, V200, P69, DOI 10.1042/bj2000069; Kaneko T, 2002, DNA RES, V9, P189, DOI 10.1093/dnares/9.6.189; Lee J, 2007, J BIOL CHEM, V282, P27115, DOI 10.1074/jbc.M704066200; Lee J, 2009, J BIOL CHEM, V284, P9899, DOI 10.1074/jbc.M900110200; Li F, 1996, MOL BIOCHEM PARASIT, V78, P227, DOI 10.1016/S0166-6851(96)02630-8; Lindemose S, 2005, NUCLEIC ACIDS RES, V33, P1790, DOI 10.1093/nar/gki319; Lu ZCJ, 2004, J BIOL CHEM, V279, P265, DOI 10.1074/jbc.M308793200; MOMANY C, 1995, PROTEIN SCI, V4, P849; NAKAO H, 1991, J GEN MICROBIOL, V137, P1737, DOI 10.1099/00221287-137-7-1737; Nishimura K, 2002, GENES CELLS, V7, P41, DOI 10.1046/j.1356-9597.2001.00494.x; NORGAARD E, 1983, FEMS MICROBIOL LETT, V20, P159; O'Kelly CJ, 2003, PROTIST, V154, P281; Ober D, 2003, PHYTOCHEMISTRY, V62, P339, DOI 10.1016/S0031-9422(02)00553-8; Ober D, 1999, J BIOL CHEM, V274, P32040, DOI 10.1074/jbc.274.45.32040; Ober D, 1999, P NATL ACAD SCI USA, V96, P14777, DOI 10.1073/pnas.96.26.14777; OSHIMA T, 1987, J BIOL CHEM, V262, P11979; PAULIN L, 1983, FEMS MICROBIOL LETT, V19, P299, DOI 10.1111/j.1574-6968.1983.tb00561.x; Pendeville H, 2001, MOL CELL BIOL, V21, P6549, DOI 10.1128/MCB.21.19.6549-6558.2001; POOLE PS, 1994, MICROBIOL-SGM, V140, P2797, DOI 10.1099/00221287-140-10-2797; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; SCHERER P, 1983, J BACTERIOL, V154, P1315, DOI 10.1128/JB.154.3.1315-1322.1983; SCHWARTZ B, 1995, BIOCHEM J, V312, P83, DOI 10.1042/bj3120083; Shah R, 2004, J BIOL CHEM, V279, P35760, DOI 10.1074/jbc.M405366200; SMITH K, 1995, BIOCHEM J, V312, P465, DOI 10.1042/bj3120465; TABOR CW, 1987, J BIOL CHEM, V262, P16037; Tait GH, 1979, BIOCHEM SOC T, V7, P199, DOI 10.1042/bst0070199; TAIT GH, 1976, BIOCHEM SOC T, V4, P610, DOI 10.1042/bst0040610; Tholl D, 1996, EUR J BIOCHEM, V240, P373, DOI 10.1111/j.1432-1033.1996.0373h.x; Toms AV, 2004, J BIOL CHEM, V279, P33837, DOI 10.1074/jbc.M403369200; Urano K, 2005, FEBS LETT, V579, P1557, DOI 10.1016/j.febslet.2005.01.048; Wallace HM, 2004, AMINO ACIDS, V26, P353, DOI 10.1007/s00726-004-0092-6; Whitaker JW, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r36; Willert EK, 2007, P NATL ACAD SCI USA, V104, P8275, DOI 10.1073/pnas.0701111104; Williams KP, 2007, J BACTERIOL, V189, P4578, DOI 10.1128/JB.00269-07; WOLFF EC, 1990, J BIOL CHEM, V265, P4793; Woolridge DP, 1999, BIOCHEM J, V340, P753, DOI 10.1042/0264-6021:3400753; Wu H, 2008, J BIOL CHEM, V283, P16135, DOI 10.1074/jbc.M710323200; Wu H, 2007, BIOCHEMISTRY-US, V46, P8331, DOI 10.1021/bi602498k; Yamada T, 2010, VIROLOGY, V398, P135, DOI 10.1016/j.virol.2009.11.043; YAMAMOTO S, 1986, CAN J MICROBIOL, V32, P99, DOI 10.1139/m86-021; YAMAMOTO S, 1989, FEMS MICROBIOL LETT, V61, P225, DOI 10.1016/0378-1097(89)90201-2; YAMAMOTO S, 1993, J BIOCHEM-TOKYO, V114, P45, DOI 10.1093/oxfordjournals.jbchem.a124137	82	43	43	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14711	14723		10.1074/jbc.M110.107219	http://dx.doi.org/10.1074/jbc.M110.107219			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20194510	Green Published, hybrid			2022-12-25	WOS:000277299700069
J	Mazars, R; Gonzalez-De-Peredo, A; Cayrol, C; Lavigne, AC; Vogel, JL; Ortega, N; Lacroix, C; Gautier, V; Huet, G; Ray, A; Monsarrat, B; Kristie, TM; Girard, JP				Mazars, Raoul; Gonzalez-de-Peredo, Anne; Cayrol, Corinne; Lavigne, Anne-Claire; Vogel, Jodi L.; Ortega, Nathalie; Lacroix, Chrystelle; Gautier, Violette; Huet, Gaelle; Ray, Aurelie; Monsarrat, Bernard; Kristie, Thomas M.; Girard, Jean-Philippe			The THAP-Zinc Finger Protein THAP1 Associates with Coactivator HCF-1 and O-GlcNAc Transferase A LINK BETWEEN DYT6 AND DYT3 DYSTONIAS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINKED DYSTONIA-PARKINSONISM; CELL-PROLIFERATION; TORSION DYSTONIA; GENE; EXPRESSION; PROMOTERS; MODULE; DOMAIN; VP16	THAP1 is a sequence-specific DNA binding factor that regulates cell proliferation through modulation of target genes such as the cell cycle-specific gene RRM1. Mutations in the THAP1 DNA binding domain, an atypical zinc finger (THAP-zf), have recently been found to cause DYT6 dystonia, a neurological disease characterized by twisting movements and abnormal postures. In this study, we report that THAP1 shares sequence characteristics, in vivo expression patterns and protein partners with THAP3, another THAP-zf protein. Proteomic analyses identified HCF-1, a potent transcriptional coactivator and cell cycle regulator, and O-GlcNAc transferase (OGT), the enzyme that catalyzes the addition of O-GlcNAc, as major cellular partners of THAP3. THAP3 interacts with HCF-1 through a consensus HCF-1-binding motif (HBM), a motif that is also present in THAP1. Accordingly, THAP1 was found to bind HCF-1 in vitro and to associate with HCF-1 and OGT in vivo. THAP1 and THAP3 belong to a large family of HCF-1 binding factors since seven other members of the human THAP-zf protein family were identified, which harbor evolutionary conserved HBMs and bind to HCF-1. Chromatin immunoprecipitation (ChIP) assays and RNA interference experiments showed that endogenous THAP1 mediates the recruitment of HCF-1 to the RRM1 promoter during endothelial cell proliferation and that HCF-1 is essential for transcriptional activation of RRM1. Together, our findings suggest HCF-1 is an important cofactor for THAP1. Interestingly, our results also provide an unexpected link between DYT6 and DYT3 (X-linked dystonia-parkinsonism) dystonias because the gene encoding the THAP1/DYT6 protein partner OGT maps within the DYT3 critical region on Xq13.1.	[Mazars, Raoul; Gonzalez-de-Peredo, Anne; Cayrol, Corinne; Lavigne, Anne-Claire; Ortega, Nathalie; Lacroix, Chrystelle; Gautier, Violette; Huet, Gaelle; Ray, Aurelie; Monsarrat, Bernard; Girard, Jean-Philippe] CNRS, IPBS, F-31077 Toulouse, France; [Mazars, Raoul; Gonzalez-de-Peredo, Anne; Cayrol, Corinne; Lavigne, Anne-Claire; Ortega, Nathalie; Lacroix, Chrystelle; Gautier, Violette; Huet, Gaelle; Ray, Aurelie; Monsarrat, Bernard; Girard, Jean-Philippe] Univ Toulouse, UPS, IPBS, F-31077 Toulouse, France; [Vogel, Jodi L.; Kristie, Thomas M.] NIAID, Viral Dis Lab, NIH, Bethesda, MD 20892 USA	Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Girard, JP (corresponding author), CNRS, IPBS, 205 Route Narbonne, F-31077 Toulouse, France.	Jean-Philippe.Girard@ipbs.fr	CAYROL, Corinne/C-2106-2011; GIRARD, Jean-Philippe/F-5229-2010; Ortega, Nathalie/C-3382-2019; Lavigne, Anne-Claire/O-8805-2015	CAYROL, Corinne/0000-0002-7813-4397; GIRARD, Jean-Philippe/0000-0002-9154-1691; Gonzalez de Peredo, Anne/0000-0001-6152-6311	Ligue Nationale contre le Cancer; INCA; ANR; National Institutes of Health, Laboratory of Viral Diseases, NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000711] Funding Source: NIH RePORTER	Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); INCA(Institut National du Cancer (INCA) France); ANR(French National Research Agency (ANR)); National Institutes of Health, Laboratory of Viral Diseases, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was supported by grants from Ligue Nationale contre le Cancer (Equipe labellise e Ligue 2009), INCA, and ANR-Programme Blanc "Regulome." This work was also supported, in part, by the Intramural Research Program of the National Institutes of Health, Laboratory of Viral Diseases, NIAID.	Bessiere D, 2008, J BIOL CHEM, V283, P4352, DOI 10.1074/jbc.M707537200; Breakefield XO, 2008, NAT REV NEUROSCI, V9, P222, DOI 10.1038/nrn2337; Bressman SB, 2009, LANCET NEUROL, V8, P441, DOI 10.1016/S1474-4422(09)70081-X; Cayrol C, 2007, BLOOD, V109, P584, DOI 10.1182/blood-2006-03-012013; Clouaire T, 2005, P NATL ACAD SCI USA, V102, P6907, DOI 10.1073/pnas.0406882102; Dejosez M, 2008, CELL, V133, P1162, DOI 10.1016/j.cell.2008.05.047; Djarmati A, 2009, LANCET NEUROL, V8, P447, DOI 10.1016/S1474-4422(09)70083-3; Freiman RN, 1997, GENE DEV, V11, P3122, DOI 10.1101/gad.11.23.3122; Fuchs T, 2009, NAT GENET, V41, P286, DOI 10.1038/ng.304; Goto H, 1997, GENE DEV, V11, P726, DOI 10.1101/gad.11.6.726; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Julien E, 2003, EMBO J, V22, P2360, DOI 10.1093/emboj/cdg242; Kristie TM, 2010, BBA-GENE REGUL MECH, V1799, P257, DOI 10.1016/j.bbagrm.2009.08.003; Lefebvre T, 2001, BIOCHEM J, V360, P179, DOI 10.1042/0264-6021:3600179; Luciano RL, 2003, J BIOL CHEM, V278, P51116, DOI 10.1074/jbc.M303470200; Makino S, 2007, AM J HUM GENET, V80, P393, DOI 10.1086/512129; Muller U, 2009, BRAIN, V132, P2005, DOI 10.1093/brain/awp172; Nakatani Y, 2003, METHOD ENZYMOL, V370, P430; Narayanan A, 2007, P NATL ACAD SCI USA, V104, P10835, DOI 10.1073/pnas.0704351104; Nolte D, 2003, P NATL ACAD SCI USA, V100, P10347, DOI 10.1073/pnas.1831949100; Ozelius LJ, 1997, NAT GENET, V17, P40, DOI 10.1038/ng0997-40; Roussigne M, 2003, ONCOGENE, V22, P2432, DOI 10.1038/sj.onc.1206271; Roussigne M, 2003, TRENDS BIOCHEM SCI, V28, P66, DOI 10.1016/S0968-0004(02)00013-0; Tamiya G, 2009, LANCET NEUROL, V8, P416, DOI 10.1016/S1474-4422(09)70087-0; Tyagi S, 2007, MOL CELL, V27, P107, DOI 10.1016/j.molcel.2007.05.030; Wysocka J, 2003, TRENDS BIOCHEM SCI, V28, P294, DOI 10.1016/S0968-0004(03)00088-4; Wysocka J, 2003, GENE DEV, V17, P896, DOI 10.1101/gad.252103	27	76	87	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13364	13371		10.1074/jbc.M109.072579	http://dx.doi.org/10.1074/jbc.M109.072579			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20200153	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000276987700007
J	Muylaert, I; Elias, P				Muylaert, Isabella; Elias, Per			Contributions of Nucleotide Excision Repair, DNA Polymerase eta, and Homologous Recombination to Replication of UV-irradiated Herpes Simplex Virus Type 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							XERODERMA-PIGMENTOSUM VARIANT; ORIGIN-BINDING-PROTEIN; DAMAGE RESPONSE; TRANSLESION SYNTHESIS; PROCESSIVITY FACTOR; CRYSTAL-STRUCTURE; CELLULAR-DNA; RECONSTITUTION; LOCALIZATION; GENOME	The effects of UV irradiation on herpes simplex virus type 1 (HSV-1) gene expression and DNA replication were examined in cell lines containing mutations inactivating the XPA gene product required for nucleotide-excision repair, the DNA polymerase eta responsible for translesion synthesis, or the Cockayne syndrome A and B (CSA and CSB) gene products required for transcription-coupled nucleotide excision repair. In the absence of XPA and CSA and CSB gene products, virus replication was reduced 10(6)-, 400-, and 100-fold, respectively. In DNA polymerase eta mutant cells HSV-1 plaque efficiency was reduced 10(4)-fold. Furthermore, DNA polymerase eta was strictly required for virus replication at low multiplicities of infection but dispensable at high multiplicities of infection. Knock down of Rad 51, Rad 52, and Rad 54 levels by RNA interference reduced replication of UV-irradiated HSV-1 150-, 100-, and 50-fold, respectively. We find that transcription-coupled repair efficiently supports expression of immediate early and early genes from UV-irradiated HSV-1 DNA. In contrast, the progression of the replication fork appears to be impaired, causing a severe reduction of late gene expression. Since the HSV-1 replisome does not make use of proliferating cell nuclear antigen, we attribute the replication defect to an inability to perform proliferating cell nuclear antigen-dependent translesion synthesis by polymerase switching at the fork. Instead, DNA polymerase eta may act during postreplication gap filling. Homologous recombination, finally, might restore the physical and genetic integrity of the virus chromosome.	[Muylaert, Isabella; Elias, Per] Univ Gothenburg, Inst Biomed, Dept Med Biochem & Cell Biol, Sahlgrenska Acad, S-40530 Gothenburg, Sweden	University of Gothenburg	Elias, P (corresponding author), Univ Gothenburg, Inst Biomed, Dept Med Biochem & Cell Biol, Sahlgrenska Acad, Box 440, S-40530 Gothenburg, Sweden.	per.elias@medkem.gu.se			Swedish Cancer Foundation; Swedish Research Council; Sahlgrenska University Hospital Lakarutbildningsavtal	Swedish Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Sahlgrenska University Hospital Lakarutbildningsavtal	This work was supported by grants from the Swedish Cancer Foundation, the Swedish Research Council, and the Sahlgrenska University Hospital Lakarutbildningsavtal.	Arana ME, 2004, DNA REPAIR, V3, P659, DOI 10.1016/j.dnarep.2004.02.006; Bogani F, 2009, J BIOL CHEM, V284, P16784, DOI 10.1074/jbc.M109.010413; Bowden R, 2004, INFECT GENET EVOL, V4, P115, DOI 10.1016/j.meegid.2004.01.009; BRUCKNER RC, 1991, J BIOL CHEM, V266, P2669; Cavanaugh NA, 2009, BIOCHEMISTRY-US, V48, P3554, DOI 10.1021/bi8022202; Chaurushiya MS, 2009, DNA REPAIR, V8, P1166, DOI 10.1016/j.dnarep.2009.04.016; Cleaver JE, 2009, NAT REV GENET, V10, P756, DOI 10.1038/nrg2663; COMPTON T, 1984, J VIROL, V49, P594, DOI 10.1128/JVI.49.2.594-597.1984; ELIAS P, 1986, P NATL ACAD SCI USA, V83, P6322, DOI 10.1073/pnas.83.17.6322; Elmroth K, 2003, DNA REPAIR, V2, P363, DOI 10.1016/S1568-7864(02)00235-5; Falkenberg M, 2000, P NATL ACAD SCI USA, V97, P3896, DOI 10.1073/pnas.97.8.3896; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Friedberg EC, 2005, MOL CELL, V18, P499, DOI 10.1016/j.molcel.2005.03.032; Gregory DA, 2008, VIROLOGY, V373, P124, DOI 10.1016/j.virol.2007.12.005; Groisman R, 2006, GENE DEV, V20, P1429, DOI 10.1101/gad.378206; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; HERNANDEZ TR, 1990, J BIOL CHEM, V265, P11227; HONESS RW, 1974, J VIROL, V14, P8, DOI 10.1128/JVI.14.1.8-19.1974; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jiang CY, 2009, J VIROL, V83, P7573, DOI 10.1128/JVI.00193-09; Kannouche P, 2001, GENE DEV, V15, P158, DOI 10.1101/gad.187501; Knipe DM, 2008, NAT REV MICROBIOL, V6, P211, DOI 10.1038/nrmicro1794; Knipe DM, 2007, FIELDS VIROLOGY, P2501; Kudoh A, 2009, J VIROL, V83, P6641, DOI 10.1128/JVI.00049-09; Le Gac NT, 1998, J BIOL CHEM, V273, P13801, DOI 10.1074/jbc.273.22.13801; LeesMiller SP, 1996, J VIROL, V70, P7471, DOI 10.1128/JVI.70.11.7471-7477.1996; Lehman IR, 1999, J BIOL CHEM, V274, P28059, DOI 10.1074/jbc.274.40.28059; Lehmann AR, 2007, DNA REPAIR, V6, P891, DOI 10.1016/j.dnarep.2007.02.003; Lilley CE, 2005, P NATL ACAD SCI USA, V102, P5844, DOI 10.1073/pnas.0501916102; Liu SP, 2006, J BIOL CHEM, V281, P18193, DOI 10.1074/jbc.M602414200; Makhov AM, 2009, J MOL BIOL, V386, P273, DOI 10.1016/j.jmb.2008.12.059; Masutani C, 2000, COLD SPRING HARB SYM, V65, P71, DOI 10.1101/sqb.2000.65.71; Muylaert I, 2007, J BIOL CHEM, V282, P10865, DOI 10.1074/jbc.M611834200; Nimonkar AV, 2003, P NATL ACAD SCI USA, V100, P10201, DOI 10.1073/pnas.1534569100; Norberg P, 2004, J VIROL, V78, P10755, DOI 10.1128/JVI.78.19.10755-10764.2004; OLIVO PD, 1989, J VIROL, V63, P196, DOI 10.1128/JVI.63.1.196-204.1989; Olsson M, 2009, J BIOL CHEM, V284, P16246, DOI 10.1074/jbc.M807551200; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; SARISKY RT, 1994, J VIROL, V68, P34, DOI 10.1128/JVI.68.1.34-47.1994; Shachar S, 2009, EMBO J, V28, P383, DOI 10.1038/emboj.2008.281; Shirata N, 2005, J BIOL CHEM, V280, P30336, DOI 10.1074/jbc.M500976200; Song LP, 2004, J BIOL CHEM, V279, P18535, DOI 10.1074/jbc.M309848200; Strang BL, 2005, J VIROL, V79, P12487, DOI 10.1128/JVI.79.19.12487-12494.2005; TAIN W, 2009, J VIROL, V83, P7194; Taylor TJ, 2004, J VIROL, V78, P5856, DOI 10.1128/JVI.78.11.5856-5866.2004; Waters LS, 2009, MICROBIOL MOL BIOL R, V73, P134, DOI 10.1128/MMBR.00034-08; WILCOCK D, 1991, NATURE, V349, P429, DOI 10.1038/349429a0; Wilkinson DE, 2004, J VIROL, V78, P4783, DOI 10.1128/JVI.78.9.4783-4796.2004; Wilkinson DE, 2006, J CELL SCI, V119, P2695, DOI 10.1242/jcs.02981; Yao XD, 2001, J BIOL CHEM, V276, P2905, DOI 10.1074/jbc.M005627200; YAO XD, 1999, THESIS U GOTHENBURG; Zuccola HJ, 2000, MOL CELL, V5, P267, DOI 10.1016/S1097-2765(00)80422-0	53	23	24	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13761	13768		10.1074/jbc.M110.107920	http://dx.doi.org/10.1074/jbc.M110.107920			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20215648	hybrid, Green Published			2022-12-25	WOS:000276987700051
J	Bragg, JG; Dutkiewicz, S; Jahn, O; Follows, MJ; Chisholm, SW				Bragg, Jason G.; Dutkiewicz, Stephanie; Jahn, Oliver; Follows, Michael J.; Chisholm, Sallie W.			Modeling Selective Pressures on Phytoplankton in the Global Ocean	PLOS ONE			English	Article							PROCHLOROCOCCUS ECOTYPES; MARINE SYNECHOCOCCUS; NITROGEN; BIOGEOGRAPHY; LINEAGES; DYNAMICS; GENOME; FORMS	Our view of marine microbes is transforming, as culture-independent methods facilitate rapid characterization of microbial diversity. It is difficult to assimilate this information into our understanding of marine microbe ecology and evolution, because their distributions, traits, and genomes are shaped by forces that are complex and dynamic. Here we incorporate diverse forces-physical, biogeochemical, ecological, and mutational-into a global ocean model to study selective pressures on a simple trait in a widely distributed lineage of picophytoplankton: the nitrogen use abilities of Synechococcus and Prochlorococcus cyanobacteria. Some Prochlorococcus ecotypes have lost the ability to use nitrate, whereas their close relatives, marine Synechococcus, typically retain it. We impose mutations for the loss of nitrogen use abilities in modeled picophytoplankton, and ask: in which parts of the ocean are mutants most disadvantaged by losing the ability to use nitrate, and in which parts are they least disadvantaged? Our model predicts that this selective disadvantage is smallest for picophytoplankton that live in tropical regions where Prochlorococcus are abundant in the real ocean. Conversely, the selective disadvantage of losing the ability to use nitrate is larger for modeled picophytoplankton that live at higher latitudes, where Synechococcus are abundant. In regions where we expect Prochlorococcus and Synechococcus populations to cycle seasonally in the real ocean, we find that model ecotypes with seasonal population dynamics similar to Prochlorococcus are less disadvantaged by losing the ability to use nitrate than model ecotypes with seasonal population dynamics similar to Synechococcus. The model predictions for the selective advantage associated with nitrate use are broadly consistent with the distribution of this ability among marine picocyanobacteria, and at finer scales, can provide insights into interactions between temporally varying ocean processes and selective pressures that may be difficult or impossible to study by other means. More generally, and perhaps more importantly, this study introduces an approach for testing hypotheses about the processes that underlie genetic variation among marine microbes, embedded in the dynamic physical, chemical, and biological forces that generate and shape this diversity.	[Bragg, Jason G.; Chisholm, Sallie W.] MIT, Dept Civil & Environm Engn, Cambridge, MA 02139 USA; [Dutkiewicz, Stephanie; Jahn, Oliver; Follows, Michael J.] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; [Chisholm, Sallie W.] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Bragg, JG (corresponding author), CSIRO Plant Ind, Canberra, ACT, Australia.	mick@mit.edu; chisholm@mit.edu	Bragg, Jason/P-7675-2019; Bragg, Jason G/A-4473-2012; Bragg, Jason/R-5611-2016; Follows, Michael/G-9824-2011	Bragg, Jason/0000-0002-7621-7295; Bragg, Jason G/0000-0003-0093-4981; Bragg, Jason/0000-0002-7621-7295; Jahn, Oliver/0000-0002-0130-5186; Chisholm, Sallie/0000-0003-1480-2445	Gordon and Betty Moore Foudation; United States Department of Energy; Center for Microbial Oceanography; United States National Science Foundation	Gordon and Betty Moore Foudation; United States Department of Energy(United States Department of Energy (DOE)); Center for Microbial Oceanography; United States National Science Foundation(National Science Foundation (NSF))	This work was supported in part by the Gordon and Betty Moore Foudation, the United States Department of Energy, and the Center for Microbial Oceanography: Research and Education and Biological Oceanography Programs of the United States National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlgren NA, 2006, APPL ENVIRON MICROB, V72, P7193, DOI 10.1128/AEM.00358-06; Aiken J, 2000, PROG OCEANOGR, V45, P257, DOI 10.1016/S0079-6611(00)00005-7; Casey JR, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028725; Cooper VS, 2000, NATURE, V407, P736, DOI 10.1038/35037572; DUGDALE RC, 1967, LIMNOL OCEANOGR, V12, P685, DOI 10.4319/lo.1967.12.4.0685; DUGDALE RC, 1967, LIMNOL OCEANOGR, V12, P196, DOI 10.4319/lo.1967.12.2.0196; DuRand MD, 2001, DEEP-SEA RES PT II, V48, P1983, DOI 10.1016/S0967-0645(00)00166-1; Dutkiewicz S, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003405; EPPLEY RW, 1969, LIMNOL OCEANOGR, V14, P194, DOI 10.4319/lo.1969.14.2.0194; Flynn KJ, 1997, PHILOS T ROY SOC B, V352, P1625, DOI 10.1098/rstb.1997.0145; Follows MJ, 2007, SCIENCE, V315, P1843, DOI 10.1126/science.1138544; Garcia-Fernandez JM, 2004, MICROBIOL MOL BIOL R, V68, P630, DOI 10.1128/MMBR.68.4.630-638.2004; Haldane JBS, 1937, AM NAT, V71, P337, DOI 10.1086/280722; Herrero A, 2001, J BACTERIOL, V183, P411, DOI 10.1128/JB.183.2.411-425.2001; Johnson ZI, 2006, SCIENCE, V311, P1737, DOI 10.1126/science.1118052; Kettler GC, 2007, PLOS GENET, V3, P2515, DOI 10.1371/journal.pgen.0030231; Ludwig CA, 1938, AM J BOT, V25, P448, DOI 10.2307/2436419; Martiny AC, 2009, ENVIRON MICROBIOL, V11, P823, DOI 10.1111/j.1462-2920.2008.01803.x; Martiny AC, 2009, P NATL ACAD SCI USA, V106, P10787, DOI 10.1073/pnas.0902532106; Miller SR, 2001, APPL ENVIRON MICROB, V67, P3002, DOI 10.1128/AEM.67.7.3002-3009.2001; Moore LR, 2002, LIMNOL OCEANOGR, V47, P989, DOI 10.4319/lo.2002.47.4.0989; Palenik B, 2003, NATURE, V424, P1037, DOI 10.1038/nature01943; Partensky F, 1999, MICROBIOL MOL BIOL R, V63, P106, DOI 10.1128/MMBR.63.1.106-127.1999; Rippka R, 2000, INT J SYST EVOL MICR, V50, P1833, DOI 10.1099/00207713-50-5-1833; Rocap G, 2003, NATURE, V424, P1042, DOI 10.1038/nature01947; Salihoglu B, 2007, J MAR RES, V65, P219; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; TILMAN D, 1982, ANNU REV ECOL SYST, V13, P349, DOI 10.1146/annurev.es.13.110182.002025; WROBLEWSKI JS, 1977, J MAR RES, V35, P357; Zwirglmaier K, 2008, ENVIRON MICROBIOL, V10, P147, DOI 10.1111/j.1462-2920.2007.01440.x; Zwirglmaier K, 2007, ENVIRON MICROBIOL, V9, P1278, DOI 10.1111/j.1462-2920.2007.01246.x	31	17	17	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2010	5	3							e9569	10.1371/journal.pone.0009569	http://dx.doi.org/10.1371/journal.pone.0009569			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565XE	20224766	Green Published, Green Submitted, gold			2022-12-25	WOS:000275328800010
J	McCollum, ED; Preidis, GA; Kabue, MM; Singogo, EBM; Mwansambo, C; Kazembe, PN; Kline, MW				McCollum, Eric D.; Preidis, Geoffrey A.; Kabue, Mark M.; Singogo, Emmanuel B. M.; Mwansambo, Charles; Kazembe, Peter N.; Kline, Mark W.			Task Shifting Routine Inpatient Pediatric HIV Testing Improves Program Outcomes in Urban Malawi: A Retrospective Observational Study	PLOS ONE			English	Article							TO-CHILD TRANSMISSION; ANTIRETROVIRAL THERAPY; DISEASE PROGRESSION; INFECTED MOTHERS; FREE SURVIVAL; MORTALITY; INFANTS; CARE; PREVENTION; AIDS	Background: This study evaluated two models of routine HIV testing of hospitalized children in a high HIV-prevalence resource-constrained African setting. Both models incorporated "task shifting,'' or the allocation of tasks to the least-costly, capable health worker. Methods and Findings: Two models were piloted for three months each within the pediatric department of a referral hospital in Lilongwe, Malawi between January 1 and June 30, 2008. Model 1 utilized lay counselors for HIV testing instead of nurses and clinicians. Model 2 further shifted program flow and advocacy responsibilities from counselors to volunteer parents of HIV-infected children, called "patient escorts.'' A retrospective review of data from 6318 hospitalized children offered HIV testing between January-December 2008 was conducted. The pilot quarters of Model 1 and Model 2 were compared, with Model 2 selected to continue after the pilot period. There was a 2-fold increase in patients offered HIV testing with Model 2 compared with Model 1 (43.1% vs 19.9%, p < 0.001). Furthermore, patients in Model 2 were younger (17.3 vs 26.7 months, p < 0.001) and tested sooner after admission (1.77 vs 2.44 days, p < 0.001). There were no differences in test acceptance or enrollment rates into HIV care, and the program trends continued 6 months after the pilot period. Overall, 10244 HIV antibody tests (4779 maternal; 5465 child) and 453 DNA-PCR tests were completed, with 97.8% accepting testing. 19.6% of all mothers (n = 1112) and 8.5% of all children (n = 525) were HIV-infected. Furthermore, 6.5% of children were HIV-exposed (n = 405). Cumulatively, 72.9% (n = 678) of eligible children were evaluated in the hospital by a HIV-trained clinician, and 68.3% (n = 387) successfully enrolled into outpatient HIV care. Conclusions/Significance: The strategy presented here, task shifting from lay counselors alone to lay counselors and patient escorts, greatly improved program outcomes while only marginally increasing operational costs. The wider implementation of this strategy could accelerate pediatric HIV care access in high-prevalence settings.	[McCollum, Eric D.] Baylor Coll Med, Baylor Int Pediat AIDS Initiat, Lilongwe, Malawi; [Preidis, Geoffrey A.] Baylor Coll Med, Dept Pediat, Interdepartmental Program Translat Biol & Mol Med, Houston, TX 77030 USA; [Kabue, Mark M.; Singogo, Emmanuel B. M.; Kazembe, Peter N.] Baylor Coll Med, Baylor Childrens Fdn Malawi, Lilongwe, Malawi; [Mwansambo, Charles] Kamuzu Cent Hosp, Dept Pediat, Lilongwe, Malawi; [Kline, Mark W.] Baylor Coll Med, Baylor Int Pediat AIDS Initiat, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	McCollum, ED (corresponding author), Baylor Coll Med, Baylor Int Pediat AIDS Initiat, Lilongwe, Malawi.	ericdmccollum@gmail.com	McCollum, Eric D./AAE-7120-2020; Kabue, Mark/ABD-3878-2021; Preidis, Geoffrey A./W-5538-2019	Kabue, Mark/0000-0002-4918-5558; Preidis, Geoffrey A./0000-0002-2206-6452; Singogo, Emmanuel/0000-0002-2015-335X	Baylor International Pediatric AIDS Initiative (BIPAI); Abbott Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL072748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036211] Funding Source: NIH RePORTER	Baylor International Pediatric AIDS Initiative (BIPAI); Abbott Fund(Abbott Laboratories); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for the PITC program and operational study was provided by Baylor International Pediatric AIDS Initiative (BIPAI) and the Abbott Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedri A, 2008, LANCET, V372, P300, DOI 10.1016/S0140-6736(08)61114-9; Bronzan RN, 2007, J INFECT DIS, V195, P895, DOI 10.1086/511437; Chandisarewa W, 2007, B WORLD HEALTH ORGAN, V85, P843, DOI 10.2471/BLT.06.035188; Chilongozi D, 2008, PEDIATR INFECT DIS J, V27, P808, DOI 10.1097/INF.0b013e31817109a4; Chinkhumba J, 2008, T ROY SOC TROP MED H, V102, P639, DOI 10.1016/j.trstmh.2008.04.028; Cockcroft Anne, 2007, BMC Int Health Hum Rights, V7, P5, DOI 10.1186/1472-698X-7-5; Coovadia HM, 2007, LANCET, V369, P1107, DOI 10.1016/S0140-6736(07)60283-9; Creek TL, 2007, JAIDS-J ACQ IMM DEF, V45, P102, DOI 10.1097/QAI.0b013e318047df88; Diaz C, 1998, J ACQ IMMUN DEF SYND, V18, P221, DOI 10.1097/00042560-199807010-00004; Dunn DT, 2003, LANCET, V362, P1605, DOI 10.1016/S0140-6736(03)14793-9; Fox MP, 2009, INT J EPIDEMIOL, V38, P569, DOI 10.1093/ije/dyn249; GEUBBELS E, 2006, MALAWI MED J, V3, P99; Huicho L, 2008, LANCET, V372, P910, DOI 10.1016/S0140-6736(08)61401-4; *JOINT UN PROGR HI, 2008, 2008 REP GLOB AIDS E; Kankasa C, 2009, JAIDS-J ACQ IMM DEF, V51, P202, DOI 10.1097/QAI.0b013e31819c173f; Kilewo C, 2008, JAIDS-J ACQ IMM DEF, V48, P315, DOI 10.1097/QAI.0b013e31816e395c; Kline MW, 2009, PEDIATRICS, V123, P134, DOI 10.1542/peds.2008-0402; Kline MW, 2006, PEDIATRICS, V117, P1388, DOI 10.1542/peds.2005-1348; Kuhn L, 2008, NEW ENGL J MED, V359, P130, DOI 10.1056/NEJMoa073788; Kuhn L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006059; Kuhn L, 2009, CURR OPIN PEDIATR, V21, P83, DOI 10.1097/MOP.0b013e328320d894; Kumwenda NI, 2008, NEW ENGL J MED, V359, P119, DOI 10.1056/NEJMoa0801941; McPake B, 2008, LANCET, V372, P870, DOI 10.1016/S0140-6736(08)61375-6; *MIN HLTH MAL HIV, 2008, GUID PAED HIV TEST C; *MIN HLTH MAL HIV, 2008, ANN REP HIV UN 2008; Mofenson LM, 2009, JAIDS-J ACQ IMM DEF, V52, P305, DOI 10.1097/QAI.0b013e3181bbfe14; Molyneux E, 2006, B WORLD HEALTH ORGAN, V84, P314, DOI 10.2471/BLT.04.019505; Moses A, 2008, AIDS, V22, P83, DOI 10.1097/QAD.0b013e3282f163b5; Mullan F, 2007, LANCET, V370, P2158, DOI 10.1016/S0140-6736(07)60785-5; Nateniyom S, 2008, INT J TUBERC LUNG D, V12, P955; Newell ML, 2004, LANCET, V364, P1236, DOI 10.1016/S0140-6736(04)17140-7; Pope DS, 2008, JAIDS-J ACQ IMM DEF, V48, P190, DOI 10.1097/QAI.0b013e3181775926; Rogerson SR, 2004, T ROY SOC TROP MED H, V98, P544, DOI 10.1016/j.trstmh.2003.12.011; Rollins N, 2009, AIDS, V23, P1851, DOI 10.1097/QAD.0b013e32832d84fd; Sanjana P, 2009, HUM RESOUR HEALTH, V7, DOI 10.1186/1478-4491-7-44; Spensley A, 2009, AM J PUBLIC HEALTH, V99, P631, DOI 10.2105/AJPH.2007.114421; Thurstans S, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-22; TOVO PA, 1992, LANCET, V339, P1249, DOI 10.1016/0140-6736(92)91592-V; United Nations Children's Fund/ United Nations Programme on HIV/ AIDS/ World Health Organiza-tion/ United Nations Population Fund (UNICEF/ UNAIDS/ WHO/ UNFPA), 2008, CHILDR AIDS 3 STOCKT; Violari A, 2008, NEW ENGL J MED, V359, P2233, DOI 10.1056/NEJMoa0800971; Wanyenze RK, 2008, B WORLD HEALTH ORGAN, V86, P302, DOI 10.2471/BLT.07.042580; Waxman MJ, 2007, AIDS PATIENT CARE ST, V21, P981, DOI 10.1089/apc.2007.0075; Weigel R, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-80; World Health Organisation, 2008, TASK SHIFT GLOB REC; World Health Organization, 2007, GUID PROV IN HIV TES; Zachariah R, 2009, T ROY SOC TROP MED H, V103, P549, DOI 10.1016/j.trstmh.2008.09.019	46	57	57	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2010	5	3							e9626	10.1371/journal.pone.0009626	http://dx.doi.org/10.1371/journal.pone.0009626			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565XE	20224782	Green Submitted, Green Published, gold			2022-12-25	WOS:000275328800021
J	Hubert, MA; Sherritt, SL; Bachurski, CJ; Handwerger, S				Hubert, Michael A.; Sherritt, Susan L.; Bachurski, Cindy J.; Handwerger, Stuart			Involvement of Transcription Factor NR2F2 in Human Trophoblast Differentiation	PLOS ONE			English	Article							HUMAN CHORIONIC-GONADOTROPIN; LACTOGEN GENE-EXPRESSION; RETINOIC ACID; IN-VITRO; ACTIVATOR PROTEIN-2; HORMONE-SECRETION; BETA-CATENIN; RXR-ALPHA; RECEPTOR; PLACENTA	Background: During the in vitro differentiation of human villous cytotrophoblast (CTB) cells to a syncytiotrophoblast (STB) phenotype, mRNA levels for the nuclear hormone receptor NR2F2 (ARP-1, COUP-TFII) increase rapidly, reaching a peak at day 1 of differentiation that is 8.8-fold greater than that in undifferentiated CTB cells. To examine whether NR2F2 is involved in the regulation of villous CTB cell differentiation, studies were performed to determine whether NR2F2 regulates the expression of TFAP2A (AP-2 alpha), a transcription factor that is critical for the terminal differentiation of these cells to a STB phenotype. Methodology/Primary Findings: Overexpression of NR2F2 in primary cultures of human CTB cells and JEG-3 human choriocarcinoma cells induced dose-dependent increases in TFAP2A promoter activity. Conversely, siRNA mediated silencing of the NR2F2 gene in villous CTB undergoing spontaneous differentiation blocked the induction of the mRNAs for TFAP2A and several STB cell specific marker genes, including human placental lactogen (hPL), pregnancy specific glycoprotein 1 (PSG1) and corticotropin releasing hormone (CRH) by 51-59%. The induction of TFAP2A promoter activity by NR2F2 was potentiated by the nuclear hormone receptors retinoic acid receptor alpha (RARA) and retinoid X receptor alpha (RXRA). Conclusions/Significance: Taken together, these results strongly suggest that NR2F2 is involved in villous CTB cell differentiation and that NR2F2 acts, at least in part, by directly activating TFAP2A gene expression and by potentiating the transactivation of TFAP2A by RARA and RXRA.	[Hubert, Michael A.; Sherritt, Susan L.; Bachurski, Cindy J.; Handwerger, Stuart] Univ Cincinnati, Dept Pediat, Cincinnati, OH 45221 USA; [Hubert, Michael A.; Sherritt, Susan L.; Handwerger, Stuart] Childrens Hosp Med Ctr, Div Endocrinol, Cincinnati, OH USA; [Bachurski, Cindy J.] Childrens Hosp Med Ctr, Div Pulm Biol, Cincinnati, OH USA	University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center	Hubert, MA (corresponding author), Univ Cincinnati, Dept Pediat, Cincinnati, OH 45221 USA.	stuart.handwerger@cchmc.org		Bachurski, Cindy/0000-0002-3118-0636	National Institutes of Health (NIH) [HD-07447]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007447] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD007447, R56HD007447] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	National Institutes of Health (NIH) HD-07447 (www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achatz G, 1997, MOL CELL BIOL, V17, P4914, DOI 10.1128/MCB.17.9.4914; Aronow BJ, 2001, PHYSIOL GENOMICS, V6, P105, DOI 10.1152/physiolgenomics.2001.6.2.105; Cheng YH, 2005, BIOL REPROD, V73, P500, DOI 10.1095/biolreprod.105.039941; Cheng YH, 2004, PHYSIOL GENOMICS, V18, P99, DOI 10.1152/physiolgenomics.00181.2003; Cheng YH, 2002, MOL CELL ENDOCRINOL, V191, P127, DOI 10.1016/S0303-7207(02)00081-3; GARCIALLORET MI, 1994, EXP CELL RES, V214, P46, DOI 10.1006/excr.1994.1232; Getsios S, 2001, MOL REPROD DEV, V59, P168, DOI 10.1002/mrd.1019; Getsios S, 2000, J REPROD FERTIL, V119, P59, DOI 10.1530/reprod/119.1.59; GHERSA P, 1994, GENE, V151, P331, DOI 10.1016/0378-1119(94)90681-5; Guibourdenche J, 1998, J CLIN ENDOCR METAB, V83, P1384, DOI 10.1210/jc.83.4.1384; HUPPERTZ B, 2006, MICRON; Iwanaga K, 2003, FEBS LETT, V552, P120, DOI 10.1016/S0014-5793(03)00897-4; Johnson W, 1997, J BIOL CHEM, V272, P15405, DOI 10.1074/jbc.272.24.15405; Kang S, 2003, J BIOL CHEM, V278, P30478, DOI 10.1074/jbc.M304201200; KATO Y, 1991, ENDOCRINOLOGY, V128, P401, DOI 10.1210/endo-128-1-401; KLIEWER SA, 1992, NATURE, V358, P771, DOI 10.1038/358771a0; KOJIMA K, 1995, HUM REPROD, V10, P1907, DOI 10.1093/oxfordjournals.humrep.a136205; KUSHNER PJ, 1994, MOL ENDOCRINOL, V8, P405, DOI 10.1210/me.8.4.405; Lazennec G, 1997, MOL CELL BIOL, V17, P5053, DOI 10.1128/MCB.17.9.5053; Lee K, 2006, J STEROID BIOCHEM, V102, P41, DOI 10.1016/j.jsbmb.2006.09.006; LUSCHER B, 1989, GENE DEV, V3, P1507, DOI 10.1101/gad.3.10.1507; MALIK S, 1995, NUCLEIC ACIDS RES, V23, P1536, DOI 10.1093/nar/23.9.1536; Maruo T, 1995, Early Pregnancy, V1, P54; Masuzaki H, 1997, NAT MED, V3, P1029, DOI 10.1038/nm0997-1029; Matsuo H, 1993, Nihon Sanka Fujinka Gakkai Zasshi, V45, P23; Mi S, 2000, NATURE, V403, P785, DOI 10.1038/35001608; NAAR EM, 1991, BIOL REPROD, V45, P178, DOI 10.1095/biolreprod45.1.178; Peng Chun, 2003, J Obstet Gynaecol Can, V25, P834; Petit FG, 2007, P NATL ACAD SCI USA, V104, P6293, DOI 10.1073/pnas.0702039104; PIAO YS, 1995, MOL ENDOCRINOL, V9, P1633, DOI 10.1210/me.9.12.1633; Power SC, 1996, MOL CELL BIOL, V16, P778; Richardson BD, 2000, MOL CELL ENDOCRINOL, V160, P183, DOI 10.1016/S0303-7207(99)00209-9; Schaiff WT, 2000, J CLIN ENDOCR METAB, V85, P3874, DOI 10.1210/jc.85.10.3874; SHI QJ, 1993, ENDOCRINOLOGY, V132, P1387, DOI 10.1210/en.132.3.1387; Stephanou A, 1996, J MOL ENDOCRINOL, V16, P221, DOI 10.1677/jme.0.0160221; STRAUSS JF, 1992, PLACENTA, V13, P389, DOI 10.1016/0143-4004(92)90047-W; Stroobandt D, 2000, IEEE CIRCUITS SYSTEM, V11, P4; Suzuki T, 2000, MOL CELL ENDOCRINOL, V164, P69, DOI 10.1016/S0303-7207(00)00242-2; WADA N, 1993, J BIOL CHEM, V268, P14003; Wang Q, 2004, CANCER LETT, V214, P81, DOI 10.1016/j.canlet.2004.03.032; WIDOM RL, 1992, MOL CELL BIOL, V12, P3380, DOI 10.1128/MCB.12.8.3380; YAMADA K, 1995, J BIOL CHEM, V270, P25064, DOI 10.1074/jbc.270.42.25064; Yamamoto E, 2005, MOL HUM REPROD, V11, P825, DOI 10.1093/molehr/gah239; ZHANG XK, 1992, NATURE, V355, P441, DOI 10.1038/355441a0	44	22	23	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2010	5	2							e9417	10.1371/journal.pone.0009417	http://dx.doi.org/10.1371/journal.pone.0009417			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SY	20195529	Green Submitted, Green Published, gold			2022-12-25	WOS:000274924300007
J	Kourmpetis, YAI; van Dijk, ADJ; Bink, MCAM; van Ham, RCHJ; ter Braak, CJF				Kourmpetis, Yiannis A. I.; van Dijk, Aalt D. J.; Bink, Marco C. A. M.; van Ham, Roeland C. H. J.; ter Braak, Cajo J. F.			Bayesian Markov Random Field Analysis for Protein Function Prediction Based on Network Data	PLOS ONE			English	Article							GENE; ALGORITHM; INTEGRATION; QUEST; MODEL	Inference of protein functions is one of the most important aims of modern biology. To fully exploit the large volumes of genomic data typically produced in modern-day genomic experiments, automated computational methods for protein function prediction are urgently needed. Established methods use sequence or structure similarity to infer functions but those types of data do not suffice to determine the biological context in which proteins act. Current high-throughput biological experiments produce large amounts of data on the interactions between proteins. Such data can be used to infer interaction networks and to predict the biological process that the protein is involved in. Here, we develop a probabilistic approach for protein function prediction using network data, such as protein-protein interaction measurements. We take a Bayesian approach to an existing Markov Random Field method by performing simultaneous estimation of the model parameters and prediction of protein functions. We use an adaptive Markov Chain Monte Carlo algorithm that leads to more accurate parameter estimates and consequently to improved prediction performance compared to the standard Markov Random Fields method. We tested our method using a high quality S. cereviciae validation network with 1622 proteins against 90 Gene Ontology terms of different levels of abstraction. Compared to three other protein function prediction methods, our approach shows very good prediction performance. Our method can be directly applied to protein-protein interaction or coexpression networks, but also can be extended to use multiple data sources. We apply our method to physical protein interaction data from S. cerevisiae and provide novel predictions, using 340 Gene Ontology terms, for 1170 unannotated proteins and we evaluate the predictions using the available literature.	[Kourmpetis, Yiannis A. I.; Bink, Marco C. A. M.; ter Braak, Cajo J. F.] Univ Wageningen & Res Ctr, Wageningen, Netherlands; [van Dijk, Aalt D. J.; van Ham, Roeland C. H. J.] Plant Res Int, Appl Bioinformat, Wageningen, Netherlands; [van Ham, Roeland C. H. J.] Wageningen Univ, Lab Bioinformat, Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research	Kourmpetis, YAI (corresponding author), Univ Wageningen & Res Ctr, Wageningen, Netherlands.	cajo.terbraak@wur.nl	Braak, Cajo J. F. ter/G-7006-2011	Braak, Cajo J. F. ter/0000-0002-0414-8745; van Dijk, Aalt-Jan/0000-0002-8872-5123	Netherlands Bioinformatics Centre (NBIC); BSIK; EU [FOOD-CT-2006-016214]	Netherlands Bioinformatics Centre (NBIC); BSIK(Ministry of Economic Affairs, Netherlands); EU(European Commission)	This work is part of the BioRange program of the Netherlands Bioinformatics Centre (NBIC), which is supported by a BSIK grant through the Netherlands Genomics Initiative (NGI). CtB and RvH kindly acknowledge financial support from the EU 6th FP project EU-SOL (FOOD-CT-2006-016214). ADJvD kindly acknowledges the Netherlands Organization for Scientific Research (NWO, VENI Grant 863.08.027). Funder's URL: http://www.nbic.nl. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 2002, DIFFUSION KERNELS GR; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Barutcuoglu Z, 2006, BIOINFORMATICS, V22, P830, DOI 10.1093/bioinformatics/btk048; BESAG J, 1986, J R STAT SOC B, V48, P259; CASTILLO LP, 2008, GENOME BIOL S1, V9, pS2, DOI DOI 10.1186/GB-2008-9-S1-S2; Cheeseman LM, 2002, CELL, V111, P163, DOI 10.1016/S0092-8674(02)00973-X; Chen XL, 2007, GENETICS, V177, P17, DOI 10.1534/genetics.107.074708; Chen YJ, 2005, MOL CANCER RES, V3, P669, DOI 10.1158/1541-7786.MCR-05-0181; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; Deng MH, 2004, J COMPUT BIOL, V11, P463, DOI 10.1089/1066527041410346; Deng MH, 2003, J COMPUT BIOL, V10, P947, DOI 10.1089/106652703322756168; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Federovitch CM, 2008, MOL BIOL CELL, V19, P4506, DOI 10.1091/mbc.E07-11-1188; Ferre S, 2006, J COMPUT BIOL, V13, P719, DOI 10.1089/cmb.2006.13.719; Gabaldon T, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-403; GEMAN S, 1984, IEEE T PATTERN ANAL, V6, P721, DOI 10.1109/TPAMI.1984.4767596; Guan YF, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s3; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Karaoz U, 2004, P NATL ACAD SCI USA, V101, P2888, DOI 10.1073/pnas.0307326101; Kosmidis I., 2007, BRGLM BIAS REDUCTION; Kuzniar A, 2008, TRENDS GENET, V24, P539, DOI 10.1016/j.tig.2008.08.009; Lanckriet GRG, 2003, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2004, P300; Lee H, 2006, OMICS, V10, P40, DOI 10.1089/omi.2006.10.40; Letovsky S, 2003, BIOINFORMATICS, V19, pi197, DOI 10.1093/bioinformatics/btg1026; LI S, 1995, MARKOV RANDOM FIELD; MacKay D. J. C., 2002, INFORM THEORY INFERE; McCullagh P., 1989, GEN LINEAR MODELS; Milligan L, 2008, MOL CELL BIOL, V28, P5446, DOI 10.1128/MCB.00463-08; Moler C, 2003, SIAM REV, V45, P3, DOI 10.1137/S00361445024180; Mostafavi S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s4; Mulder NJ, 2005, NUCLEIC ACIDS RES, V33, pD201, DOI 10.1093/nar/gki106; Nariai N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000337; Punta M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000160; Sharan R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100129; Ter Braak CJF, 2006, STAT COMPUT, V16, P239, DOI 10.1007/s11222-006-8769-1; ter Braak CJF, 2008, STAT COMPUT, V18, P435, DOI 10.1007/s11222-008-9104-9; Ulitsky I, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.42; Vazquez A, 2003, NAT BIOTECHNOL, V21, P697, DOI 10.1038/nbt825; Vethantham V, 2007, MOL CELL BIOL, V27, P8848, DOI 10.1128/MCB.01186-07; Wei Z, 2007, BIOINFORMATICS, V23, P1537, DOI 10.1093/bioinformatics/btm129	42	68	70	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2010	5	2							e9293	10.1371/journal.pone.0009293	http://dx.doi.org/10.1371/journal.pone.0009293			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SX	20195360	Green Published, gold, Green Submitted			2022-12-25	WOS:000274924200003
J	Cheng, ZJ; Singh, RD; Holicky, EL; Wheatley, CL; Marks, DL; Pagano, RE				Cheng, Zhi-Jie; Singh, Raman Deep; Holicky, Eileen L.; Wheatley, Christine L.; Marks, David L.; Pagano, Richard E.			Co-regulation of Caveolar and Cdc42-dependent Fluid Phase Endocytosis by Phosphocaveolin-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLATHRIN-INDEPENDENT ENDOCYTOSIS; TYROSINE PHOSPHORYLATION; SRC KINASE; CELLS; MEMBRANE; DYNAMIN; INTERNALIZATION; ACTIVATION; PROTEIN; GLYCOSPHINGOLIPIDS	Several clathrin-independent endocytosis mechanisms have been identified that can be distinguished by specific requirements for certain proteins, such as caveolin-1 (Cav1) and the Rho GTPases, RhoA and Cdc42, as well as by specific cargo. Some endocytic pathways may be co-regulated such that disruption of one pathway leads to the up-regulation of another; however, the underlying mechanisms for this are unclear. Cav1 has been reported to function as a guanine nucleotide dissociation inhibitor (GDI), which inhibits Cdc42 activation. We tested the hypothesis that Cav1 can regulate Cdc42-dependent, fluid phase endocytosis. We demonstrate that Cav1 overexpression decreases fluid phase endocytosis, whereas silencing of Cav1 enhances this pathway. Enhancement of Cav1 phosphorylation using a phosphatase inhibitor reduces Cdc42-regulated pinocytosis while stimulating caveolar endocytosis. Fluid phase endocytosis was inhibited by expression of a putative phosphomimetic mutant, Cav1-Y14E, but not by the phospho-deficient mutant, Cav1-Y14F. Overexpression of Cav2, or a Cav1 mutant in which the GDI region was altered to the corresponding sequence in Cav2, did not suppress fluid phase endocytosis. These results suggest that the Cav1 expression level and phosphorylation state regulates fluid phase endocytosis via the interaction between the Cav1 GDI region and Cdc42. These data define a novel molecular mechanism for co-regulation of two distinct clathrin-independent endocytic pathways.	Mayo Clin, Coll Med, Thorac Dis Res Unit, Dept Med, Rochester, MN 55905 USA; Mayo Clin, Coll Med, Thorac Dis Res Unit, Dept Biochem & Mol Biol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Pagano, RE (corresponding author), Stabile 8,200 1st St SW, Rochester, MN 55905 USA.	pagano.richard@mayo.edu	Takhter, Ramandeep/AAG-8977-2019	Takhter, Ramandeep/0000-0002-1441-2722	National Institutes of Health [GM22942]; USPHS; NIDDK, National Institutes of Health [F32-DK068985]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK068985] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM022942, R37GM022942] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant GM22942 from USPHS (to R. E. P.).; Supported by National Research Service Award F32-DK068985 from NIDDK, National Institutes of Health. Present address: Promega Corporation, 2800 Woods Hollow Rd., Madison, WI 53711.	Aoki T, 1999, EXP CELL RES, V253, P629, DOI 10.1006/excr.1999.4652; Cheng ZJ, 2006, MOL BIOL CELL, V17, P3197, DOI 10.1091/mbc.E05-12-1101; DAMKE H, 1995, J CELL BIOL, V131, P69, DOI 10.1083/jcb.131.1.69; del Pozo MA, 2005, NAT CELL BIOL, V7, P901, DOI 10.1038/ncb1293; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; Fagerholm S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005985; Galbiati F, 1998, P NATL ACAD SCI USA, V95, P10257, DOI 10.1073/pnas.95.17.10257; Grande-Garcia A, 2007, J CELL BIOL, V177, P683, DOI 10.1083/jcb.200701006; Henley JR, 1998, J CELL BIOL, V141, P85, DOI 10.1083/jcb.141.1.85; Kirkham M, 2005, BBA-MOL CELL RES, V1746, P349, DOI 10.1016/j.bbamcr.2005.11.005; Kirkham M, 2005, J CELL BIOL, V168, P465, DOI 10.1083/jcb.200407078; Kumari S, 2008, NAT CELL BIOL, V10, P30, DOI 10.1038/ncb1666; Labrecque L, 2004, J BIOL CHEM, V279, P52132, DOI 10.1074/jbc.M409617200; Lavie Y, 1998, J BIOL CHEM, V273, P32380, DOI 10.1074/jbc.273.49.32380; LI SW, 1995, J BIOL CHEM, V270, P15693, DOI 10.1074/jbc.270.26.15693; Li SW, 1996, J BIOL CHEM, V271, P29182, DOI 10.1074/jbc.271.46.29182; MARTIN OC, 1994, J CELL BIOL, V125, P769, DOI 10.1083/jcb.125.4.769; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; Medina FA, 2006, CELL CYCLE, V5, P1865, DOI 10.4161/cc.5.16.3132; Mineo C, 2001, HISTOCHEM CELL BIOL, V116, P109; Nevins AK, 2006, J BIOL CHEM, V281, P18961, DOI 10.1074/jbc.M603604200; Nichols BJ, 2001, TRENDS CELL BIOL, V11, P406, DOI 10.1016/S0962-8924(01)02107-9; Oh P, 1998, J CELL BIOL, V141, P101, DOI 10.1083/jcb.141.1.101; Orlichenko L, 2006, J BIOL CHEM, V281, P4570, DOI 10.1074/jbc.M512088200; Parton RG, 2006, J CELL SCI, V119, P787, DOI 10.1242/jcs.02853; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Pelkmans L, 2002, SCIENCE, V296, P535, DOI 10.1126/science.1069784; Pelkmans L, 2005, NATURE, V436, P78, DOI 10.1038/nature03571; Peng FF, 2007, J AM SOC NEPHROL, V18, P189, DOI 10.1681/ASN.2006050498; Radel C, 2005, AM J PHYSIOL-HEART C, V288, pH936, DOI 10.1152/ajpheart.00519.2004; Sabharanjak S, 2002, DEV CELL, V2, P411, DOI 10.1016/S1534-5807(02)00145-4; Sharma DK, 2005, CANCER RES, V65, P8233, DOI 10.1158/0008-5472.CAN-05-0803; Sharma DK, 2004, MOL BIOL CELL, V15, P3114, DOI 10.1091/mbc.E04-03-0189; Singh RD, 2007, J CELL BIOL, V176, P895, DOI 10.1083/jcb.200609149; Singh RD, 2003, MOL BIOL CELL, V14, P3254, DOI 10.1091/mbc.E02-12-0809; Song KS, 1996, J BIOL CHEM, V271, P9690, DOI 10.1074/jbc.271.16.9690; Volonte D, 2001, J BIOL CHEM, V276, P8094, DOI 10.1074/jbc.M009245200; Witkiewicz AK, 2009, AM J PATHOL, V174, P2023, DOI 10.2353/ajpath.2009.080873	38	37	37	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15119	15125		10.1074/jbc.M109.069427	http://dx.doi.org/10.1074/jbc.M109.069427			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20228056	hybrid, Green Published			2022-12-25	WOS:000277399000033
J	Kilili, GK; Kyriakis, JM				Kilili, Geoffrey K.; Kyriakis, John M.			Mammalian Ste20-like Kinase (Mst2) Indirectly Supports Raf-1/ERK Pathway Activity via Maintenance of Protein Phosphatase-2A Catalytic Subunit Levels and Consequent Suppression of Inhibitory Raf-1 Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR; CELL-PROLIFERATION; B-RAF; APOPTOSIS; HIPPO; 2A; ACTIVATION; GROWTH; EXPRESSION; DROSOPHILA	Many tumor suppressor proteins act to blunt the effects of mitogenic signaling pathways. Loss of function mutations in the merlin tumor suppressor underlie neurofibromatosis type 2 (NF2), a familial autosomal dominant cancer syndrome. Studies of Drosophila suggest that Hippo (hpo) is required for inhibition of cell proliferation mediated by dMer, the orthologue of human merlin. Mammalian sterile 20-like kinase-2 (Mst2) is a mammalian Hpo orthologue, and numerous studies implicate Mst2 as a tumor suppressor. Mst2 is negatively regulated by the proto-oncoprotein Raf-1 in a manner independent of the kinase activity of Raf-1. We sought to determine whether, in mammalian cells, merlin could positively regulate Mst2. We also sought to determine whether Mst2, in addition to being negatively regulated by Raf-1, might itself reciprocally regulate Raf-1. In contrast to findings from Drosophila, we find no evidence that mammalian merlin positively regulates mammalian Mst2. Instead, surprisingly, RNA interference silencing of Mst2 leads to elevated inhibitory phosphorylation of Raf-1 at Ser-259 and impaired Raf-1 kinase activity. Consequent to this, ERK pathway activation and cell proliferation are attenuated. Phosphatase-2A (PP2A) dephosphorylates Raf-1 Ser-259 in response to mitogens. Interestingly RNA interference silencing of Mst2 triggers a striking proteasome-dependent decrease in the levels of the catalytic subunit of PP2A (PP2A-C). A similar effect is achieved upon silencing of large tumor suppressor (LATS)-1 and LATS2, direct substrates of Mst2. Our studies reveal a more complex role for Mst2 than previously thought. The Mst2 -> LATS1/2 pathway, by maintaining PP2A-C levels, may, in some situations, positively affect mitogenic signaling.	[Kyriakis, John M.] Tufts Univ, Sackler Sch Grad Biomed Sci, Tufts Med Ctr, Mol Cardiol Res Inst, Boston, MA 02111 USA; Tufts Univ, Sackler Sch Grad Biomed Sci, Dept Biochem, Boston, MA 02111 USA	Tufts Medical Center; Tufts University; Tufts University	Kyriakis, JM (corresponding author), Tufts Univ, Sackler Sch Grad Biomed Sci, Tufts Med Ctr, Mol Cardiol Res Inst, 800 Washington St,Box 8486, Boston, MA 02111 USA.	jkyriakis@tuftsmedicalcenter.org			National Institutes of Health [CA112399]; Tufts Medical Center; NATIONAL CANCER INSTITUTE [R01CA112399] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tufts Medical Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA112399 (to J. M. K.).; We thank Philip Tsichlis (Tufts Medical Center) for the akt2/3<SUP>-/-</SUP>; akt-1<SUP>flox/flox</SUP> cells, Andrea McClatchey (Massachusetts General Hospital) for merlin-expressing recombinant adenovirus, and Joseph Avruch (Massachusetts General Hospital) for the phospho-specific Mst2 antibody. We thank Michael Mendelsohn (Tufts Medical Center) for the Cre recombinase adenovirus and for continued support.	Abraham D, 2000, J BIOL CHEM, V275, P22300, DOI 10.1074/jbc.M003259200; Adams DG, 2005, J BIOL CHEM, V280, P42644, DOI 10.1074/jbc.M502464200; Andrabi S, 2007, P NATL ACAD SCI USA, V104, P19011, DOI 10.1073/pnas.0706696104; Avruch J, 2006, METHOD ENZYMOL, V407, P290, DOI 10.1016/S0076-6879(05)07025-4; Baccarini M, 2005, FEBS LETT, V579, P3271, DOI 10.1016/j.febslet.2005.03.024; Baharians Z, 1998, J BIOL CHEM, V273, P19019, DOI 10.1074/jbc.273.30.19019; Brown MD, 2009, CELL SIGNAL, V21, P462, DOI 10.1016/j.cellsig.2008.11.013; Chadee DN, 2006, P NATL ACAD SCI USA, V103, P4463, DOI 10.1073/pnas.0510651103; Chadee DN, 2004, NAT CELL BIOL, V6, P770, DOI 10.1038/ncb1152; Chaudhary A, 2000, CURR BIOL, V10, P551, DOI 10.1016/S0960-9822(00)00475-9; Cinar B, 2007, EMBO J, V26, P4523, DOI 10.1038/sj.emboj.7601872; Clark GJ, 1997, J BIOL CHEM, V272, P20990, DOI 10.1074/jbc.272.34.20990; Cooper WN, 2009, ONCOGENE, V28, P2988, DOI 10.1038/onc.2009.152; Cox AD, 2003, ONCOGENE, V22, P8999, DOI 10.1038/sj.onc.1207111; Dan I, 2001, TRENDS CELL BIOL, V11, P220, DOI 10.1016/S0962-8924(01)01980-8; Dhillon AS, 2007, CELL CYCLE, V6, P3, DOI 10.4161/cc.6.1.3593; Dhillon AS, 2002, MOL CELL BIOL, V22, P3237, DOI 10.1128/MCB.22.10.3237-3246.2002; Dhillon AS, 2002, EMBO J, V21, P64, DOI 10.1093/emboj/21.1.64; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Eichhorn PJA, 2009, BBA-REV CANCER, V1795, P1, DOI 10.1016/j.bbcan.2008.05.005; Garnett MJ, 2005, MOL CELL, V20, P963, DOI 10.1016/j.molcel.2005.10.022; Graves JD, 1998, EMBO J, V17, P2224, DOI 10.1093/emboj/17.8.2224; Hamaratoglu F, 2006, NAT CELL BIOL, V8, P27, DOI 10.1038/ncb1339; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Ikeda M, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000300; Jaumot M, 2001, ONCOGENE, V20, P3949, DOI 10.1038/sj.onc.1204526; King AJ, 1998, NATURE, V396, P180, DOI 10.1038/24184; KING BL, 1992, AM J PATHOL, V140, P23; Kubicek M, 2002, J BIOL CHEM, V277, P7913, DOI 10.1074/jbc.M108733200; Kyriakis JM, 2007, BBA-MOL CELL RES, V1773, P1238, DOI 10.1016/j.bbamcr.2006.11.003; Lehtinen MK, 2006, CELL, V125, P987, DOI 10.1016/j.cell.2006.03.046; Lepont P, 2008, MUTAT RES-FUND MOL M, V637, P142, DOI 10.1016/j.mrfmmm.2007.07.015; Ling P, 2008, CELL SIGNAL, V20, P1237, DOI 10.1016/j.cellsig.2007.12.019; LOWY DR, 1993, ANNU REV BIOCHEM, V62, P851, DOI 10.1146/annurev.bi.62.070193.004223; Matallanas D, 2007, MOL CELL, V27, P962, DOI 10.1016/j.molcel.2007.08.008; Mikula M, 2001, EMBO J, V20, P1952, DOI 10.1093/emboj/20.8.1952; Millward TA, 1999, TRENDS BIOCHEM SCI, V24, P186, DOI 10.1016/S0968-0004(99)01375-4; O'Neill E, 2004, SCIENCE, V306, P2267, DOI 10.1126/science.1103233; Ohama T, 2010, J BIOL CHEM, V285, P8711, DOI 10.1074/jbc.M109.099788; Oka T, 2008, J BIOL CHEM, V283, P27534, DOI 10.1074/jbc.M804380200; Pantalacci S, 2003, NAT CELL BIOL, V5, P921, DOI 10.1038/ncb1051; Pombo CM, 2007, FRONT BIOSCI-LANDMRK, V12, P850, DOI 10.2741/2107; Radu M, 2009, CURR BIOL, V19, pR421, DOI 10.1016/j.cub.2009.04.022; Rushworth LK, 2006, MOL CELL BIOL, V26, P2262, DOI 10.1128/MCB.26.6.2262-2272.2006; Saucedo LJ, 2007, NAT REV MOL CELL BIO, V8, P613, DOI 10.1038/nrm2221; Scoles DR, 2008, BBA-REV CANCER, V1785, P32, DOI 10.1016/j.bbcan.2007.10.001; Sun CX, 2002, HUM MOL GENET, V11, P3167, DOI 10.1093/hmg/11.25.3167; Tzivion G, 1998, NATURE, V394, P88, DOI 10.1038/27938; Westermarck J, 2008, TRENDS MOL MED, V14, P152, DOI 10.1016/j.molmed.2008.02.001; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; XU GF, 1990, CELL, V63, P835, DOI 10.1016/0092-8674(90)90149-9; Zhou DW, 2009, CANCER CELL, V16, P425, DOI 10.1016/j.ccr.2009.09.026; Zhou DW, 2008, P NATL ACAD SCI USA, V105, P20321, DOI 10.1073/pnas.0810773105; Zimmermann S, 1999, SCIENCE, V286, P1741, DOI 10.1126/science.286.5445.1741	54	33	34	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15076	15087		10.1074/jbc.M109.078915	http://dx.doi.org/10.1074/jbc.M109.078915			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20212043	hybrid, Green Published			2022-12-25	WOS:000277399000029
J	Zhang, Y; Liu, R; Ni, M; Gill, P; Lee, AS				Zhang, Yi; Liu, Ren; Ni, Min; Gill, Parkash; Lee, Amy S.			Cell Surface Relocalization of the Endoplasmic Reticulum Chaperone and Unfolded Protein Response Regulator GRP78/BiP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER-CELLS; ENDOTHELIAL-CELLS; INDUCED APOPTOSIS; DRUG-RESISTANCE; ER CHAPERONE; STRESS; ACTIVATION; RECEPTOR; BINDING; EXPRESSION	The recent discovery that GRP78/BiP, a typical endoplasmic reticulum (ER) lumenal chaperone, can be expressed on the cell surface, interacting with an increasing repertoire of surface proteins and acting as receptor in signaling pathways, represents a paradigm shift in its biological function. However, the mechanism of GRP78 trafficking from the ER to the cell surface is not well understood. Using a combination of cellular, biochemical, and mutational approaches, we tested multiple hypotheses. Here we report that ER stress actively promotes GRP78 localization on the cell surface, whereas ectopic expression of GRP78 is also able to cause cell surface relocation in the absence of ER stress. Moreover, deletion of the C-terminal ER retention motif in GRP78 alters its cell surface presentation in a dose-dependent manner; however, mutation of the putative O-linked glycosylation site Thr(648) of human GRP78 is without effect. We also identified the exposure of multiple domains of GRP78 on the cell surface and determined that binding of extracellular GRP78 to the cell surface is unlikely. Anew topology model for cell surface GRP78 is presented.	[Zhang, Yi; Ni, Min; Lee, Amy S.] Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, USC Norris Comprehens Canc Ctr, Los Angeles, CA 90089 USA; [Liu, Ren; Gill, Parkash] Univ So Calif, Keck Sch Med, Dept Pathol, USC Norris Comprehens Canc Ctr, Los Angeles, CA 90089 USA	University of Southern California; University of Southern California	Lee, AS (corresponding author), Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, USC Norris Comprehens Canc Ctr, 1441 Eastlake Ave, Los Angeles, CA 90089 USA.	amylee@ccnt.usc.edu		Lee, Amy/0000-0002-0378-5443	National Institutes of Health [CA027607, CA111700]; NATIONAL CANCER INSTITUTE [R01CA027607, R01CA111700, R37CA027607] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA027607 and CA111700 (to A. S. L.).	Arap MA, 2004, CANCER CELL, V6, P275, DOI 10.1016/j.ccr.2004.08.018; Baumeister P, 2009, MOL CANCER THER, V8, P1086, DOI 10.1158/1535-7163.MCT-08-1166; Burikhanov R, 2009, CELL, V138, P377, DOI 10.1016/j.cell.2009.05.022; Davidson DJ, 2005, CANCER RES, V65, P4663, DOI 10.1158/0008-5472.CAN-04-3426; Fu Y, 2006, CANCER BIOL THER, V5, P741, DOI 10.4161/cbt.5.7.2970; Gonzalez-Gronow M, 2006, CANCER RES, V66, P11424, DOI 10.1158/0008-5472.CAN-06-1721; Gonzalez-Gronow M, 2009, ANTIOXID REDOX SIGN, V11, P2299, DOI [10.1089/ars.2009.2568, 10.1089/ARS.2009.2568]; Hendershot LM, 2004, MT SINAI J MED, V71, P289; Jakobsen CG, 2007, CANCER RES, V67, P9507, DOI 10.1158/0008-5472.CAN-06-4686; Jindadamrongwech S, 2004, ARCH VIROL, V149, P915, DOI 10.1007/s00705-003-0263-x; Kelber JA, 2009, ONCOGENE, V28, P2324, DOI 10.1038/onc.2009.97; Kim Y, 2006, BIOCHEMISTRY-US, V45, P9434, DOI 10.1021/bi060264j; Laverriere A, 2009, MOL HUM REPROD, V15, P569, DOI 10.1093/molehr/gap037; Lee AS, 2007, CANCER RES, V67, P3496, DOI 10.1158/0008-5472.CAN-07-0325; Lee AS, 2009, CANCER BIOL THER, V8, P2103, DOI 10.4161/cbt.8.22.10140; Lee AS, 2005, METHODS, V35, P373, DOI 10.1016/j.ymeth.2004.10.010; Li J, 2008, CELL DEATH DIFFER, V15, P1460, DOI 10.1038/cdd.2008.81; Li JZ, 2006, J BIOL CHEM, V281, P7260, DOI 10.1074/jbc.M509868200; Liu C, 2003, AM J PATHOL, V163, P1859, DOI 10.1016/S0002-9440(10)63545-6; Liu Y, 2007, MOL PHARMACEUT, V4, P435, DOI 10.1021/mp060122j; Matsumoto A, 2000, CANCER RES, V60, P3921; McFarland BC, 2009, CANCER RES, V69, P5537, DOI 10.1158/0008-5472.CAN-08-4841; Misra UK, 2006, J BIOL CHEM, V281, P13694, DOI 10.1074/jbc.M511694200; Misra UK, 2005, J IMMUNOL, V174, P2092, DOI 10.4049/jimmunol.174.4.2092; Misra UK, 2004, CELL SIGNAL, V16, P929, DOI 10.1016/j.cellsig.2004.01.003; Misra UK, 2002, J BIOL CHEM, V277, P42082, DOI 10.1074/jbc.M206174200; MUNRO S, 1986, CELL, V46, P291, DOI 10.1016/0092-8674(86)90746-4; Ni M, 2007, FEBS LETT, V581, P3641, DOI 10.1016/j.febslet.2007.04.045; Ni M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006868; Okazaki Y, 2000, J BIOL CHEM, V275, P35751, DOI 10.1074/jbc.M007476200; Philippova M, 2008, MOL CELL BIOL, V28, P4004, DOI 10.1128/MCB.00157-08; Pyrko P, 2007, CANCER RES, V67, P9809, DOI 10.1158/0008-5472.CAN-07-0625; Ranganathan AC, 2006, CANCER RES, V66, P1702, DOI 10.1158/0008-5472.CAN-05-3092; Rauschert N, 2008, LAB INVEST, V88, P375, DOI 10.1038/labinvest.2008.2; Reddy RK, 2003, J BIOL CHEM, V278, P20915, DOI 10.1074/jbc.M212328200; Shani G, 2008, MOL CELL BIOL, V28, P666, DOI 10.1128/MCB.01716-07; Shin BK, 2003, J BIOL CHEM, V278, P7607, DOI 10.1074/jbc.M210455200; Sun FC, 2006, BIOCHEM J, V396, P31, DOI 10.1042/BJ20051916; Triantafilou K, 2002, J VIROL, V76, P633, DOI 10.1128/JVI.76.2.633-643.2002; Virrey JJ, 2008, MOL CANCER RES, V6, P1268, DOI 10.1158/1541-7786.MCR-08-0060; Wang M, 2009, ANTIOXID REDOX SIGN, V11, P2307, DOI [10.1089/ars.2009.2485, 10.1089/ARS.2009.2485]	41	225	243	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15065	15075		10.1074/jbc.M109.087445	http://dx.doi.org/10.1074/jbc.M109.087445			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20208072	Green Published, hybrid			2022-12-25	WOS:000277399000028
J	Legleiter, J; Mitchell, E; Lotz, GP; Sapp, E; Ng, C; DiFiglia, M; Thompson, LM; Muchowski, PJ				Legleiter, Justin; Mitchell, Emily; Lotz, Gregor P.; Sapp, Ellen; Ng, Cheping; DiFiglia, Marian; Thompson, Leslie M.; Muchowski, Paul J.			Mutant Huntingtin Fragments Form Oligomers in a Polyglutamine Length-dependent Manner in Vitro and in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INCLUSION-BODY FORMATION; NEURONAL INTRANUCLEAR INCLUSIONS; AMYLOID-LIKE FIBRILS; AGGREGATION NUCLEATION; MONOCLONAL-ANTIBODIES; TRINUCLEOTIDE REPEAT; DISEASE PATHOLOGY; PROTEIN CONTEXT; SHEET FORMATION; MOUSE MODEL	Huntington disease (HD) is caused by an expansion of more than 35-40 polyglutamine (polyQ) repeats in the huntingtin (htt) protein, resulting in accumulation of inclusion bodies containing fibrillar deposits of mutant htt fragments. Intriguingly, polyQ length is directly proportional to the propensity for htt to form fibrils and the severity of HD and is inversely correlated with age of onset. Although the structural basis for htt toxicity is unclear, the formation, abundance, and/or persistence of toxic conformers mediating neuronal dysfunction and degeneration in HD must also depend on polyQ length. Here we used atomic force microscopy to demonstrate mutant htt fragments and synthetic polyQ peptides form oligomers in a polyQ length-dependent manner. By time-lapse atomic force microscopy, oligomers form before fibrils, are transient in nature, and are occasionally direct precursors to fibrils. However, the vast majority of fibrils appear to form by monomer addition coinciding with the disappearance of oligomers. Thus, oligomers must undergo a major structural transition preceding fibril formation. In an immortalized striatal cell line and in brain homogenates from a mouse model of HD, a mutant htt fragment formed oligomers in a polyQ length-dependent manner that were similar in size to those formed in vitro, although these structures accumulated over time in vivo. Finally, using immunoelectron microscopy, we detected oligomeric-like structures in human HD brains. These results demonstrate that oligomer formation by a mutant htt fragment is strongly polyQ length-dependent in vitro and in vivo, consistent with a causative role for these structures, or subsets of these structures, in HD pathogenesis.	[Legleiter, Justin; Lotz, Gregor P.; Ng, Cheping; Muchowski, Paul J.] Univ Calif San Francisco, Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA; [Legleiter, Justin; Lotz, Gregor P.; Muchowski, Paul J.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA; [Muchowski, Paul J.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Muchowski, Paul J.] Univ Calif Irvine, Taube Koret Ctr Huntingtons Dis Res, Irvine, CA 92697 USA; [Mitchell, Emily; Thompson, Leslie M.] Univ Calif Irvine, Dept Psychiat & Human Behav, Irvine, CA 92697 USA; [Mitchell, Emily; Thompson, Leslie M.] Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92697 USA; [Mitchell, Emily; Thompson, Leslie M.] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92697 USA; [Sapp, Ellen; DiFiglia, Marian] Massachusetts Gen Hosp, Dept Neurol, Lab Cellular Neurobiol, Charlestown, MA 02114 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; Harvard University; Massachusetts General Hospital	Muchowski, PJ (corresponding author), Univ Calif San Francisco, Gladstone Inst Neurol Dis, 1650 Owens St, San Francisco, CA 94158 USA.	pmuchowski@gladstone.ucsf.edu	Sontag, Emily/L-5232-2019	Sontag, Emily/0000-0003-3068-6253; Lotz, Gregor/0000-0002-0231-5503; Legleiter, Justin/0000-0002-5262-1867	National Institutes of Health [R01NS054753, R01NS047237]; Hereditary Disease Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054753, R01NS047237] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hereditary Disease Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01NS054753 and R01NS047237.; Supported by a post-doctoral fellowship from the Hereditary Disease Foundation. Present address: The C. Eugene Bennett Dept. of Chemistry, WV University, Morgantown, WV 26505.	Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Bhattacharyya A, 2006, J MOL BIOL, V355, P524, DOI 10.1016/j.jmb.2005.10.053; Bhattacharyya AM, 2005, P NATL ACAD SCI USA, V102, P15400, DOI 10.1073/pnas.0501651102; Blackley HKL, 2000, J MOL BIOL, V298, P833, DOI 10.1006/jmbi.2000.3711; Bulone D, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000111; Chen S, 2001, J MOL BIOL, V311, P173, DOI 10.1006/jmbi.2001.4850; Chen SM, 2002, P NATL ACAD SCI USA, V99, P11884, DOI 10.1073/pnas.182276099; Chen SM, 2002, BIOCHEMISTRY-US, V41, P7391, DOI 10.1021/bi011772q; CUMMINGS DM, 2008, SOC NEUR ABSTR, V34; Darnell G, 2007, J MOL BIOL, V374, P688, DOI 10.1016/j.jmb.2007.09.023; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Duennwald ML, 2006, P NATL ACAD SCI USA, V103, P11045, DOI 10.1073/pnas.0604547103; Duennwald ML, 2006, P NATL ACAD SCI USA, V103, P11051, DOI 10.1073/pnas.0604548103; Gutekunst CA, 1999, J NEUROSCI, V19, P2522; Hackam AS, 1998, J CELL BIOL, V141, P1097, DOI 10.1083/jcb.141.5.1097; Ignatova Z, 2006, J BIOL CHEM, V281, P12959, DOI 10.1074/jbc.M511523200; Kazantsev A, 1999, P NATL ACAD SCI USA, V96, P11404, DOI 10.1073/pnas.96.20.11404; Kim MW, 2009, STRUCTURE, V17, P1205, DOI 10.1016/j.str.2009.08.002; Ko J, 2001, BRAIN RES BULL, V56, P319, DOI 10.1016/S0361-9230(01)00599-8; Kowalewski T, 1999, P NATL ACAD SCI USA, V96, P3688, DOI 10.1073/pnas.96.7.3688; La Spada AR, 2003, NEURON, V38, P681, DOI 10.1016/S0896-6273(03)00328-3; Legleiter J, 2004, J COLLOID INTERF SCI, V278, P96, DOI 10.1016/j.jcis.2004.05.009; Legleiter J, 2009, J BIOL CHEM, V284, P21647, DOI 10.1074/jbc.M109.016923; Lunkes A, 1998, HUM MOL GENET, V7, P1355, DOI 10.1093/hmg/7.9.1355; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Menon RP, 2006, CELL MOL LIFE SCI, V63, P1677, DOI 10.1007/s00018-006-6097-4; Meriin AB, 2007, FASEB J, V21, P1915, DOI 10.1096/fj.06-6878com; Miller J, 2009, STRUCTURE, V17, P1151, DOI 10.1016/j.str.2009.08.004; Muchowski PJ, 2000, P NATL ACAD SCI USA, V97, P7841, DOI 10.1073/pnas.140202897; Muchowski PJ, 2002, P NATL ACAD SCI USA, V99, P727, DOI 10.1073/pnas.022628699; Nagai Y, 2007, NAT STRUCT MOL BIOL, V14, P332, DOI 10.1038/nsmb1215; Nekooki-Machida Y, 2009, P NATL ACAD SCI USA, V106, P9679, DOI 10.1073/pnas.0812083106; Nozaki K, 2001, NEUROREPORT, V12, P3357, DOI 10.1097/00001756-200110290-00042; Penney JB, 1997, ANN NEUROL, V41, P689, DOI 10.1002/ana.410410521; Poirier MA, 2002, J BIOL CHEM, V277, P41032, DOI 10.1074/jbc.M205809200; Qin ZH, 2004, J NEUROSCI, V24, P269, DOI 10.1523/JNEUROSCI.1409-03.2004; Ratovitski T, 2009, J BIOL CHEM, V284, P10855, DOI 10.1074/jbc.M804813200; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Scherzinger E, 1999, P NATL ACAD SCI USA, V96, P4604, DOI 10.1073/pnas.96.8.4604; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; SNELL RG, 1993, NAT GENET, V4, P393, DOI 10.1038/ng0893-393; Southwell AL, 2009, J NEUROSCI, V29, P13589, DOI 10.1523/JNEUROSCI.4286-09.2009; Starling AJ, 2005, J NEUROSCI RES, V82, P377, DOI 10.1002/jnr.20651; Steffan JS, 2004, SCIENCE, V304, P100, DOI 10.1126/science.1092194; Takahashi T, 2008, HUM MOL GENET, V17, P345, DOI 10.1093/hmg/ddm311; Takahashi Y, 2007, J BIOL CHEM, V282, P24039, DOI 10.1074/jbc.M704789200; Tanaka M, 2001, J BIOL CHEM, V276, P45470, DOI 10.1074/jbc.M107502200; Thakur AK, 2002, P NATL ACAD SCI USA, V99, P17014, DOI 10.1073/pnas.252523899; Thakur AK, 2009, NAT STRUCT MOL BIOL, V16, P380, DOI 10.1038/nsmb.1570; Tobin AJ, 2000, TRENDS CELL BIOL, V10, P531, DOI 10.1016/S0962-8924(00)01853-5; TROTTIER Y, 1995, NATURE, V378, P403, DOI 10.1038/378403a0; Wacker JL, 2004, NAT STRUCT MOL BIOL, V11, P1215, DOI 10.1038/nsmb860; Weiss A, 2008, J NEUROCHEM, V104, P846, DOI 10.1111/j.1471-4159.2007.05032.x; Wong SLA, 2008, FASEB J, V22, P3348, DOI 10.1096/fj.07-103887; Zeron MM, 2002, NEURON, V33, P849, DOI 10.1016/S0896-6273(02)00615-3; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	58	148	149	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14777	14790		10.1074/jbc.M109.093708	http://dx.doi.org/10.1074/jbc.M109.093708			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20220138	Green Published, hybrid			2022-12-25	WOS:000277299700075
J	Tallant, C; Garcia-Castellanos, R; Baumann, U; Gomis-Ruth, FX				Tallant, Cynthia; Garcia-Castellanos, Raquel; Baumann, Ulrich; Xavier Gomis-Rueth, F.			On the Relevance of the Met-turn Methionine in Metzincins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL INTEGRITY; FAMILY; METALLOPROTEASE; SERRALYSINS; GELATINASE; EXPRESSION; PROTEINS; ASTACINS; ULILYSIN; SEQUENCE	The metzincins are a clan of metallopeptidases consisting of families that share a series of structural elements. Among them is the Met-turn, a tight 1,4-turn found directly below the zinc-binding site, which is structurally and spatially conserved and invariantly shows a methionine at position 3 in all metzincins identified. The reason for this conservation has been a matter of debate since its discovery. We have studied this structural element in Methanosarcina acetivorans ulilysin, the structural prototype of the pappalysin family, by generating 10 mutants that replaced methionine with proteogenic amino acids. We compared recombinant overexpression yields, autolytic and tryptic activation, proteolytic activity, thermal stability, and three-dimensional structure with those of the wild type. All forms were soluble and could be purified, although with varying yields, and three variants underwent autolysis, could be activated by trypsin, and displayed significant proteolytic activity. All variants were analyzed for the thermal stability of their zymogens. None of the mutants analyzed proved more stable or active than the wild type. Both bulky and small side chains, as well as hydrophilic ones, showed diminished thermal stability. Two mutants, leucine and cysteine, crystallized and showed three-dimensional structures that were indistinguishable from the wild type. These studies reveal that the Met-turn acts as a plug that snugly inserts laterally into a core structure created by the protein segment engaged in zinc binding and thus contributes to its structural integrity, which is indispensable for function. Replacement of the methionine with residues that deviate in size, side-chain conformation, and chemical properties impairs the plug-core interaction and prejudices molecular stability and activity.	[Tallant, Cynthia; Garcia-Castellanos, Raquel; Baumann, Ulrich; Xavier Gomis-Rueth, F.] CSIC, Mol Biol Inst Barcelona, Proteolysis Lab, Dept Biol Struct, E-08028 Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB)	Gomis-Ruth, FX (corresponding author), CSIC, Mol Biol Inst Barcelona, Proteolysis Lab, Dept Biol Struct, Barcelona Sci Pk,Helix Bldg,C Baldiri Reixac 15-2, E-08028 Barcelona, Spain.	fxgr@ibmb.csic.es	Baumann, Ulrich/B-1220-2013	Tallant, Cynthia/0000-0001-5645-435X; Garcia-Castellanos, Raquel/0000-0001-6225-5373; Gomis-Ruth, F. Xavier/0000-0002-6848-6874	Swiss National Science Foundation; ESRF; European Union;  [SAB2002-0102];  [BIO2009-10336];  [BIO2008-04080-E];  [2009SGR1036];  [PSE-010000-2009-8];  [CSD2006-00015]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); ESRF; European Union(European Commission); ; ; ; ; ; 	This work was supported by grants and fellowships from European, Catalan, and Spanish public agencies: SAB2002-0102, BIO2009-10336, BIO2008-04080-E, 2009SGR1036, PSE-010000-2009-8, CSD2006-00015, FP7 Strep Project 223101 "AntiPathoGN." This work was also supported by the Swiss National Science Foundation. Funding for x-ray diffraction data collection at European Synchrotron Radiation Facility (ESRF) synchrotron was provided by ESRF and the European Union.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BODE W, 1993, FEBS LETT, V331, P134, DOI 10.1016/0014-5793(93)80312-I; Boldt HB, 2001, BIOCHEM J, V358, P359, DOI 10.1042/0264-6021:3580359; Butler GS, 2004, J BIOL CHEM, V279, P15615, DOI 10.1074/jbc.M312727200; Carranza C., 1999, AFMB ACTIVITY REPORT, P89; CHOTHIA C, 1986, EMBO J, V5, P823, DOI 10.1002/j.1460-2075.1986.tb04288.x; Chun YJ, 1998, ARCH PHARM RES, V21, P305, DOI 10.1007/BF02975292; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ericsson UB, 2006, ANAL BIOCHEM, V357, P289, DOI 10.1016/j.ab.2006.07.027; Evans P. R., 1993, DATA COLLECTION PROC, P114; Garcia-Castellanos R, 2003, J BIOL CHEM, V278, P39897, DOI 10.1074/jbc.M307199200; Garcia-Castellanos R, 2007, ARCH BIOCHEM BIOPHYS, V457, P57, DOI 10.1016/j.abb.2006.10.004; Gomis-Ruth FX, 2003, MOL BIOTECHNOL, V24, P157, DOI 10.1385/MB:24:2:157; Hege T, 2001, J MOL BIOL, V314, P187, DOI 10.1006/jmbi.2001.5124; Kabsch W., 2001, INT TABLES CRYSTALLO, P730, DOI [10.1107/97809553602060000001, DOI 10.1107/97809553602060000001]; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kurisu G, 1997, J BIOCHEM, V121, P304; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lovell SC, 2000, PROTEINS, V40, P389, DOI 10.1002/1097-0134(20000815)40:3<389::AID-PROT50>3.0.CO;2-2; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Oberholzer AE, 2009, BIOL CHEM, V390, P875, DOI 10.1515/BC.2009.100; Perez L, 2007, BIOCHEM CELL BIOL, V85, P141, DOI 10.1139/O06-179; Pieper M, 1997, J PROTEIN CHEM, V16, P637, DOI 10.1023/A:1026327125333; Rost B, 1999, PROTEIN ENG, V12, P85, DOI 10.1093/protein/12.2.85; SCHEEF ED, 2003, STRUCTURAL BIOINFORM, P15; STOCKER W, 1995, PROTEIN SCI, V4, P823; Tallant C, 2007, BIOL CHEM, V388, P1243, DOI 10.1515/BC.2007.143; Tallant C, 2006, J BIOL CHEM, V281, P17920, DOI 10.1074/jbc.M600907200; Tourasse NJ, 2000, MOL BIOL EVOL, V17, P656, DOI 10.1093/oxfordjournals.molbev.a026344; Walasek Paula, 2005, BMC Biochem, V6, P21, DOI 10.1186/1471-2091-6-21; Gomis-Ruth FX, 2009, J BIOL CHEM, V284, P15353, DOI 10.1074/jbc.R800069200; Zappacosta F, 1996, PROTEIN SCI, V5, P802, DOI 10.1002/pro.5560050502	33	31	32	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13951	13957		10.1074/jbc.M109.083378	http://dx.doi.org/10.1074/jbc.M109.083378			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20202937	Green Published, hybrid			2022-12-25	WOS:000276987700069
J	Kim, DH; Kim, EH; Na, HK; Sun, Y; Surh, YJ				Kim, D-H; Kim, E-H; Na, H-K; Sun, Y.; Surh, Y-J			15-Deoxy-Delta(12,14)-prostaglandin J(2) stabilizes, but functionally inactivates p53 by binding to the cysteine 277 residue	ONCOGENE			English	Article						cyclopentenone prostaglandin; 15-deoxy-Delta(12,14)-prostaglandin J(2); p53; thiol modification	WILD-TYPE P53; NF-KAPPA-B; PROLIFERATOR-ACTIVATED RECEPTOR; BREAST-CANCER CELLS; TUMOR-SUPPRESSOR PROTEIN; DNA-BINDING; CYCLOPENTENONE PROSTAGLANDINS; MOUSE SKIN; COVALENT MODIFICATION; OXIDATIVE STRESS	15-Deoxy-Delta(12,14)-prostaglandin J(2) (15d-PGJ(2)), a representative cyclopentenone prostaglandin, has many interesting biological effects. In this study, treatment of human breast cancer cells (MCF-7) with 15d-PGJ(2) led to accumulation of p53 protein. However, the p53 DNA binding and its transcriptional activity were significantly reduced. 15d-PGJ(2) directly modified p53 as verified by reacting recombinant p53 with biotinylated 15d-PGJ(2). 9,10-Dihydro-15-deoxy-Delta(12,14)-prostaglandin J(2) lacking the electrophilic alpha,beta-unsaturated functionality failed to inhibit p53 DNA binding as well as to modify p53. Moreover, by conducting an in vitro [S-35]-labeled p53 translation assay, we identified cysteine 277 as a putative site of p53 modification by 15d-PGJ(2). The DNA-binding ability of a mutant p53 in which cysteine 277 was substituted by alanine was virtually unaffected by 15d-PGJ(2). Likewise, p53 binding activity of biotinylated 15d-PGJ(2) was abolished in mutant cells. In addition, cells expressing wild-type p53 exhibited p53 protein stability to a greater extent than mutant C277A cells. In conclusion, 15d-PGJ(2) can undergo nucleophilic addition to p53, presumably at the cysteine 277 residue, rendering this tumor suppressor less susceptible to proteasomal degradation. Oncogene (2010) 29, 2560-2576; doi:10.1038/onc.2010.8; published online 8 March 2010	[Kim, D-H; Kim, E-H; Surh, Y-J] Seoul Natl Univ, Coll Pharm, Seoul 151742, South Korea; [Na, H-K] Sungshin Womens Univ, Dept Food & Nutr, Seoul, South Korea; [Sun, Y.] Univ Michigan, Ctr Comprehens Canc, Dept Radiat Oncol, Ann Arbor, MI 48109 USA; [Surh, Y-J] Seoul Natl Univ, Dept Mol Med & Biopharmaceut Sci, Grad Sch Convergence Sci & Technol, Seoul 151742, South Korea; [Surh, Y-J] Seoul Natl Univ, Canc Res Inst, Seoul 151742, South Korea	Seoul National University (SNU); Sungshin Women's University; University of Michigan System; University of Michigan; Seoul National University (SNU); Seoul National University (SNU)	Surh, YJ (corresponding author), Seoul Natl Univ, Coll Pharm, 599 Kwanak Ro, Seoul 151742, South Korea.	surh@plaza.snu.ac.kr			IDRC [R11-2007-107-01002-0]; WCU, National Research Foundation, Republic of Korea [R31-008-000-10103-0]	IDRC; WCU, National Research Foundation, Republic of Korea	This work was supported by the Outstanding Scholar Support grant, IDRC Grant (R11-2007-107-01002-0), and the WCU project Grant (R31-008-000-10103-0) from the National Research Foundation, Republic of Korea.	Agarwal ML, 1998, J BIOL CHEM, V273, P1, DOI 10.1074/jbc.273.1.1; Asher G, 2006, ISR MED ASSOC J, V8, P229; ATSMON J, 1990, CANCER RES, V50, P1879; Azuma Y, 2004, J PHARMACOL SCI, V94, P261, DOI 10.1254/jphs.94.261; Bar-Or RL, 2000, P NATL ACAD SCI USA, V97, P11250, DOI 10.1073/pnas.210171597; BARAK Y, 1993, EMBO J, V12, P461, DOI 10.1002/j.1460-2075.1993.tb05678.x; Biramijamal F, 2001, CANCER RES, V61, P3119; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Brooks CL, 2007, J BIOL CHEM, V282, P22804, DOI 10.1074/jbc.M700961200; Bureau F, 2002, J IMMUNOL, V168, P5318, DOI 10.4049/jimmunol.168.10.5318; Buzek J, 2002, NUCLEIC ACIDS RES, V30, P2340, DOI 10.1093/nar/30.11.2340; CAGEN LM, 1975, BIOCHIM BIOPHYS ACTA, V398, P205, DOI 10.1016/0005-2760(75)90184-8; Calmels S, 1997, CANCER RES, V57, P3365; Cernuda-Morollon E, 2001, J BIOL CHEM, V276, P35530, DOI 10.1074/jbc.M104518200; Chene P, 1999, BIOCHEM BIOPH RES CO, V263, P1, DOI 10.1006/bbrc.1999.1294; Chinery R, 1999, CANCER RES, V59, P2739; CHO YJ, 1994, SCIENCE, V265, P346, DOI 10.1126/science.8023157; Clay CE, 2001, J BIOL CHEM, V276, P47131, DOI 10.1074/jbc.C100339200; de Moraes E, 2007, INT J CANCER, V121, P929, DOI 10.1002/ijc.22899; DELPHIN C, 1994, EUR J BIOCHEM, V223, P683, DOI 10.1111/j.1432-1033.1994.tb19041.x; Emi M, 2004, BIOCHEM PHARMACOL, V67, P1259, DOI 10.1016/j.bcp.2003.10.037; Fischer Susan M., 2002, Journal of Environmental Pathology Toxicology and Oncology, V21, P183; Furstenberger G, 2003, PROG EXP TUMOR RES, V37, P72; Gayarre J, 2005, FEBS LETT, V579, P5803, DOI 10.1016/j.febslet.2005.09.069; Giaccia AJ, 1998, GENE DEV, V12, P2973, DOI 10.1101/gad.12.19.2973; Gilroy DW, 1999, NAT MED, V5, P698, DOI 10.1038/9550; HAINAUT P, 1993, CANCER RES, V53, P4469; Han JA, 2002, EMBO J, V21, P5635, DOI 10.1093/emboj/cdf591; HOSODA S, 1974, J BIOL CHEM, V249, P6416; Kastan MB, 2003, CELL, V112, P1, DOI 10.1016/S0092-8674(02)01281-3; Kim EH, 2008, CARCINOGENESIS, V29, P688, DOI 10.1093/carcin/bgm299; Kim EH, 2006, ANN NY ACAD SCI, V1090, P375, DOI 10.1196/annals.1378.041; Kim EH, 2008, BIOCHEM PHARMACOL, V76, P1544, DOI 10.1016/j.bcp.2008.07.043; Kim HJ, 2007, CANCER RES, V67, P2595, DOI 10.1158/0008-5472.CAN-06-3043; Kim WJ, 2007, EMBO J, V26, P5020, DOI 10.1038/sj.emboj.7601920; Klatt P, 2002, METHOD ENZYMOL, V348, P157, DOI 10.1016/S0076-6879(02)48635-1; Kondo M, 2002, P NATL ACAD SCI USA, V99, P7367, DOI 10.1073/pnas.112212599; Kundu JK, 2006, CARCINOGENESIS, V27, P1465, DOI 10.1093/carcin/bgi349; Lambert JMR, 2009, CANCER CELL, V15, P376, DOI 10.1016/j.ccr.2009.03.003; Leung WK, 2001, BRIT J CANCER, V84, P335, DOI 10.1054/bjoc.2000.1607; LEVINE AJ, 1991, NATURE, V351, P453, DOI 10.1038/351453a0; Levonen AL, 2004, BIOCHEM J, V378, P373, DOI 10.1042/BJ20031049; Levonen AL, 2001, ARTERIOSCL THROM VAS, V21, P1846, DOI 10.1161/hq1101.098488; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; Liu B, 2008, FREE RADICAL BIO MED, V44, P1529, DOI 10.1016/j.freeradbiomed.2008.01.011; Merwin JR, 2002, CARCINOGENESIS, V23, P1609, DOI 10.1093/carcin/23.10.1609; Millan O, 2006, CARCINOGENESIS, V27, P328, DOI 10.1093/carcin/bgi213; MOLL UM, 1995, P NATL ACAD SCI USA, V92, P4407, DOI 10.1073/pnas.92.10.4407; MOLL UM, 1992, P NATL ACAD SCI USA, V89, P7262, DOI 10.1073/pnas.89.15.7262; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; Moos PJ, 2000, P NATL ACAD SCI USA, V97, P9215, DOI 10.1073/pnas.160241897; Mullally JE, 2001, J BIOL CHEM, V276, P30366, DOI 10.1074/jbc.M102198200; Muller-Decker K, 2002, P NATL ACAD SCI USA, V99, P12483, DOI 10.1073/pnas.192323799; Na HK, 2003, BIOCHEM PHARMACOL, V66, P1381, DOI 10.1016/S0006-2952(03)00488-X; NOYORI R, 1993, SCIENCE, V259, P44, DOI 10.1126/science.8418493; Oh JY, 2008, BIOCHEM J, V411, P297, DOI [10.1042/BJ20071189, 10.1042/bj20071189]; Oliva JL, 2003, P NATL ACAD SCI USA, V100, P4772, DOI 10.1073/pnas.0735842100; Pande V, 2005, BIOORG MED CHEM LETT, V15, P4057, DOI 10.1016/j.bmcl.2005.06.025; PARKER J, 1992, BIOCHEM PHARMACOL, V43, P1053, DOI 10.1016/0006-2952(92)90612-M; Perez-Sala D, 2003, J BIOL CHEM, V278, P51251, DOI 10.1074/jbc.M309409200; Pignatelli M, 2005, CARCINOGENESIS, V26, P81, DOI 10.1093/carcin/bgh308; RAINWATER R, 1995, MOL CELL BIOL, V15, P3892; Rajakariar R, 2007, P NATL ACAD SCI USA, V104, P20979, DOI 10.1073/pnas.0707394104; Rossi A, 2000, NATURE, V403, P103, DOI 10.1038/47520; Scher JU, 2009, J INVEST MED, V57, P703, DOI 10.2310/JIM.0b013e31819aaa76; Seemann S, 2005, ONCOGENE, V24, P3853, DOI 10.1038/sj.onc.1208549; Shibata T, 2003, J BIOL CHEM, V278, P26046, DOI 10.1074/jbc.M303690200; Shigemasa K, 2003, INT J ONCOL, V22, P99; Shiraki T, 2005, J BIOL CHEM, V280, P14145, DOI 10.1074/jbc.M500901200; SMITH WL, 1992, AM J PHYSIOL, V263, P181; Straus DS, 2000, P NATL ACAD SCI USA, V97, P4844, DOI 10.1073/pnas.97.9.4844; Straus DS, 2001, MED RES REV, V21, P185, DOI 10.1002/med.1006.abs; Tiano HF, 2002, CANCER RES, V62, P3395; Tsujii M, 1998, CELL, V93, P705, DOI 10.1016/S0092-8674(00)81433-6; Velu CS, 2007, BIOCHEMISTRY-US, V46, P7765, DOI 10.1021/bi700425y; Verhaegh GW, 1997, MOL CELL BIOL, V17, P5699, DOI 10.1128/MCB.17.10.5699; VOGELSTEIN B, 1992, CELL, V70, P523, DOI 10.1016/0092-8674(92)90421-8; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wu H.H., 1999, GEN THER MOL BIOL, V4, P119; Wu HH, 2000, BIOCHEM J, V351, P87, DOI 10.1042/0264-6021:3510087; WU XW, 1993, GENE DEV, V7, P1126, DOI 10.1101/gad.7.7a.1126	81	26	26	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	APR	2010	29	17					2560	2576		10.1038/onc.2010.8	http://dx.doi.org/10.1038/onc.2010.8			17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	589RB	20208557				2022-12-25	WOS:000277169400011
J	Diedrich, CR; Mattila, JT; Klein, E; Janssen, C; Phuah, J; Sturgeon, TJ; Montelaro, RC; Lin, PL; Flynn, JL				Diedrich, Collin R.; Mattila, Joshua T.; Klein, Edwin; Janssen, Chris; Phuah, Jiayao; Sturgeon, Timothy J.; Montelaro, Ronald C.; Lin, Philana Ling; Flynn, JoAnne L.			Reactivation of Latent Tuberculosis in Cynomolgus Macaques Infected with SIV Is Associated with Early Peripheral T Cell Depletion and Not Virus Load	PLOS ONE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; MYCOBACTERIUM-TUBERCULOSIS; PULMONARY TUBERCULOSIS; HIV-1 REPLICATION; DISEASE PROGRESSION; LYMPHOID-TISSUES; MACROPHAGES; EXPRESSION; VACCINE; MANIFESTATIONS	HIV-infected individuals with latent Mycobacterium tuberculosis (Mtb) infection are at significantly greater risk of reactivation tuberculosis (TB) than HIV-negative individuals with latent TB, even while CD4 T cell numbers are well preserved. Factors underlying high rates of reactivation are poorly understood and investigative tools are limited. We used cynomolgus macaques with latent TB co-infected with SIVmac251 to develop the first animal model of reactivated TB in HIV-infected humans to better explore these factors. All latent animals developed reactivated TB following SIV infection, with a variable time to reactivation (up to 11 months post-SIV). Reactivation was independent of virus load but correlated with depletion of peripheral T cells during acute SIV infection. Animals experiencing reactivation early after SIV infection (<17 weeks) had fewer CD4 T cells in the periphery and airways than animals reactivating in later phases of SIV infection. Co-infected animals had fewer T cells in involved lungs than SIV-negative animals with active TB despite similar T cell numbers in draining lymph nodes. Granulomas from these animals demonstrated histopathologic characteristics consistent with a chronically active disease process. These results suggest initial T cell depletion may strongly influence outcomes of HIV-Mtb co-infection.	[Diedrich, Collin R.; Mattila, Joshua T.; Phuah, Jiayao; Flynn, JoAnne L.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15213 USA; [Klein, Edwin; Janssen, Chris] Univ Pittsburgh, Sch Med, Div Lab Anim Resources, Pittsburgh, PA 15213 USA; [Sturgeon, Timothy J.; Montelaro, Ronald C.] Univ Pittsburgh, Sch Med, Ctr Vaccine Res, Pittsburgh, PA 15213 USA; [Lin, Philana Ling] Univ Pittsburgh, Childrens Hosp Pittsburgh, Dept Pediat, Med Ctr, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Diedrich, CR (corresponding author), Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15213 USA.	joanne@pitt.edu	Flynn, JoAnne/ABC-7371-2020	Diedrich, Collin/0000-0002-7635-9699; , Joshua/0000-0002-6384-1291; Phuah, Jia Yao/0000-0003-2240-536X	NIH [RO1 HL075845-04, T32 AI060525-05, F32AI077183-01A1]; Heiser Program for Research in Leprosy and Tuberculosis; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075845] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI060525, F32AI077183, R01AI050732] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Heiser Program for Research in Leprosy and Tuberculosis; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the NIH (RO1 HL075845-04 [JLF], T32 AI060525-05 [JLF, supporting CRD]), F32AI077183-01A1 [JTM]) and the Heiser Program for Research in Leprosy and Tuberculosis (JTM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bezuidenhout J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004228; Capuano SV, 2003, INFECT IMMUN, V71, P5831, DOI 10.1128/IAI.71.10.5831-5844.2003; Ciccone EJ, 2010, MUCOSAL IMMUNOL, V3, P172, DOI 10.1038/mi.2009.129; Collins Kalonji R., 2002, AIDS Reviews, V4, P165; Collins KR, 2002, J VIROL, V76, P1697, DOI 10.1128/JVI.76.4.1697-1706.2002; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Croix DA, 2000, AIDS RES HUM RETROV, V16, P1895, DOI 10.1089/08892220050195856; Dioszeghy V, 2006, J VIROL, V80, P236, DOI 10.1128/JVI.80.1.236-245.2006; Goletti D, 2004, J INFECT DIS, V189, P624, DOI 10.1086/381554; HANSON DL, 1995, ARCH INTERN MED, V155, P1537, DOI 10.1001/archinte.155.14.1537; Harries AD, 2006, ANN TROP MED PARASIT, V100, P415, DOI 10.1179/136485906X91477; Hertoghe T, 2000, CLIN EXP IMMUNOL, V122, P350, DOI 10.1046/j.1365-2249.2000.01385.x; Hoshino Y, 2004, J IMMUNOL, V172, P6251, DOI 10.4049/jimmunol.172.10.6251; Hoshino Y, 2002, J EXP MED, V195, P495, DOI 10.1084/jem.20011614; Hoshino Y, 2007, J INFECT DIS, V195, P1303, DOI 10.1086/513438; Karlsson I, 2007, J VIROL, V81, P13456, DOI 10.1128/JVI.01619-07; Langermans JAM, 2005, VACCINE, V23, P2740, DOI 10.1016/j.vaccine.2004.11.051; Law KF, 1996, AM J RESP CRIT CARE, V153, P1377, DOI 10.1164/ajrccm.153.4.8616569; Lawn SD, 2002, MICROBES INFECT, V4, P635, DOI 10.1016/S1286-4579(02)01582-4; Lawn SD, 2009, AIDS, V23, P1717, DOI 10.1097/QAD.0b013e32832d3b6d; Le Tortorec A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001792; Leutenegger CM, 2001, AIDS RES HUM RETROV, V17, P243, DOI 10.1089/088922201750063160; Lewinsohn DM, 2006, MICROBES INFECT, V8, P2587, DOI 10.1016/j.micinf.2006.07.007; Lin PL, 2010, ARTHRITIS RHEUM-US, V62, P340, DOI 10.1002/art.27271; Lin PL, 2009, INFECT IMMUN, V77, P4631, DOI 10.1128/IAI.00592-09; Lopez-Gatell H, 2008, AIDS, V22, P1869, DOI 10.1097/QAD.0b013e32830e010c; LUCAS S, TUBERCULOSIS PATHOGE, P503; Mankatittham W, 2009, SE ASIAN J TROP MED, V40, P93; MUKADI Y, 1993, LANCET, V342, P143, DOI 10.1016/0140-6736(93)91346-N; Nakata K, 1997, AM J RESP CRIT CARE, V155, P996, DOI 10.1164/ajrccm.155.3.9117038; Nath BM, 2000, TRENDS MICROBIOL, V8, P426, DOI 10.1016/S0966-842X(00)01816-3; Park IW, 2009, J LEUKOCYTE BIOL, V86, P1171, DOI 10.1189/jlb.0409261; Pawar SN, 2008, AIDS RES HUM RETROV, V24, P643, DOI 10.1089/aid.2007.0238; Peruchon S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005966; Post FA, 1995, TUBERCLE LUNG DIS, V76, P518, DOI 10.1016/0962-8479(95)90527-8; Qin SL, 2008, J MED PRIMATOL, V37, P46, DOI 10.1111/j.1600-0684.2008.00327.x; Reimann KA, 2005, J VIROL, V79, P8878, DOI 10.1128/JVI.79.14.8878-8885.2005; Safi H, 2003, AIDS RES HUM RETROV, V19, P585, DOI 10.1089/088922203322230950; Shen Y, 2002, INFECT IMMUN, V70, P869, DOI 10.1128/IAI.70.2.869-877.2002; Silvestri G, 2008, J MED PRIMATOL, V37, P6, DOI 10.1111/j.1600-0684.2008.00328.x; Sonnenberg P, 2005, J INFECT DIS, V191, P150, DOI 10.1086/426827; Toossi Z, 2003, J INFECT DIS, V188, P1146, DOI 10.1086/378676; Ulrichs T, 2005, J INFECT DIS, V192, P89, DOI 10.1086/430621; Vajdy M, 2001, J INFECT DIS, V184, P1007, DOI 10.1086/323615; Verreck FAW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005264; Via LE, 2008, INFECT IMMUN, V76, P2333, DOI 10.1128/IAI.01515-07	46	120	124	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2010	5	3							e9611	10.1371/journal.pone.0009611	http://dx.doi.org/10.1371/journal.pone.0009611			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565XE	20224771	Green Published, Green Accepted, gold			2022-12-25	WOS:000275328800014
J	Khanna, S; Biswas, S; Shang, YL; Collard, E; Azad, A; Kauh, C; Bhasker, V; Gordillo, GM; Sen, CK; Roy, S				Khanna, Savita; Biswas, Sabyasachi; Shang, Yingli; Collard, Eric; Azad, Ali; Kauh, Courtney; Bhasker, Vineet; Gordillo, Gayle M.; Sen, Chandan K.; Roy, Sashwati			Macrophage Dysfunction Impairs Resolution of Inflammation in the Wounds of Diabetic Mice	PLOS ONE			English	Article							APOPTOTIC CELLS; CARDIAC FIBROBLASTS; RECEPTOR-ACTIVITY; BETA-CELLS; FAS LIGAND; KEY ROLE; MOUSE; MODEL; MECHANISMS; EXPRESSION	Background: Chronic inflammation is a characteristic feature of diabetic cutaneous wounds. We sought to delineate novel mechanisms involved in the impairment of resolution of inflammation in diabetic cutaneous wounds. At the wound-site, efficient dead cell clearance (efferocytosis) is a pre-requisite for the timely resolution of inflammation and successful healing. Methodology/Principal Findings: Macrophages isolated from wounds of diabetic mice showed significant impairment in efferocytosis. Impaired efferocytosis was associated with significantly higher burden of apoptotic cells in wound tissue as well as higher expression of pro-inflammatory and lower expression of anti-inflammatory cytokines. Observations related to apoptotic cell load at the wound site in mice were validated in the wound tissue of diabetic and non-diabetic patients. Forced Fas ligand driven elevation of apoptotic cell burden at the wound site augmented pro-inflammatory and attenuated anti-inflammatory cytokine response. Furthermore, successful efferocytosis switched wound macrophages from pro-inflammatory to an anti-inflammatory mode. Conclusions/Significance: Taken together, this study presents first evidence demonstrating that diabetic wounds suffer from dysfunctional macrophage efferocytosis resulting in increased apoptotic cell burden at the wound site. This burden, in turn, prolongs the inflammatory phase and complicates wound healing.	[Khanna, Savita; Biswas, Sabyasachi; Shang, Yingli; Collard, Eric; Azad, Ali; Kauh, Courtney; Bhasker, Vineet; Gordillo, Gayle M.; Sen, Chandan K.; Roy, Sashwati] Ohio State Univ, Med Ctr, Davis Heart & Lung Res Inst, Dept Surg,Comprehens Wound Ctr, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Khanna, S (corresponding author), Ohio State Univ, Med Ctr, Davis Heart & Lung Res Inst, Dept Surg,Comprehens Wound Ctr, Columbus, OH 43210 USA.	sashwati.roy@osumc.edu	Khanna, Savita/E-3378-2011; Roy, sashwati/E-3990-2011; Gordillo, Gayle M/E-3136-2011; Sen, Chandan K/A-8762-2013		National Institutes of Health (NIH) [DK076566, GM077185]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025755] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076566, R56DK076566] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077185] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) RO1 award DK076566 to SR, and in part by GM077185 to CKS (http:// www2. niddk. nih. gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRASS CK, 1984, J IMMUNOL, V133, P1307; ALBINA JE, 1988, AM J PHYSIOL, V254, pE459, DOI 10.1152/ajpendo.1988.254.4.E459; Benoit M, 2008, J IMMUNOL, V181, P3733, DOI 10.4049/jimmunol.181.6.3733; Bouma G, 2005, EUR J IMMUNOL, V35, P225, DOI 10.1002/eji.200425513; Brem H, 2007, J CLIN INVEST, V117, P1219, DOI 10.1172/JCI32169; Breyer MD, 2005, J AM SOC NEPHROL, V16, P27, DOI [10.1681/ASN.2009070721, 10.1681/ASN.2004080648]; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Bystrom J, 2008, BLOOD, V112, P4117, DOI 10.1182/blood-2007-12-129767; Chen H, 1996, CELL, V84, P491, DOI 10.1016/S0092-8674(00)81294-5; Chow F, 2004, KIDNEY INT, V65, P116, DOI 10.1111/j.1523-1755.2004.00367.x; COHEN JJ, 1991, ADV IMMUNOL, V50, P55; Cooper L, 2005, GENOME BIOL, V6; Darby IA, 1997, INT J BIOCHEM CELL B, V29, P191, DOI 10.1016/S1357-2725(96)00131-8; deCathelineau AM, 2003, ESSAYS BIOCHEM, V39, P105, DOI 10.1042/bse0390105; Depraetere V, 2000, NAT CELL BIOL, V2, pE104, DOI 10.1038/35014098; DESMOULIERE A, 1995, AM J PATHOL, V146, P56; Devitt A., 2004, METH MOL B, V282, P207; Efron DT, 2003, METH MOLEC MED, V78, P83; Eming SA, 2007, J INVEST DERMATOL, V127, P514, DOI 10.1038/sj.jid.5700701; ERWIG LP, 2007, CELL DEATH DIFFER; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Fadok VA, 1999, J MAMMARY GLAND BIOL, V4, P203, DOI 10.1023/A:1011384009787; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Gardai SJ, 2006, J LEUKOCYTE BIOL, V79, P896, DOI 10.1189/jlb.1005550; Gillitzer R, 2001, J LEUKOCYTE BIOL, V69, P513; Gittes C, 2000, J PEDIATR SURG, V35, P872; GLASS EJ, 1987, DIABETOLOGIA, V30, P228, DOI 10.1007/BF00270420; GLASS EJ, 1986, CLIN EXP IMMUNOL, V65, P614; Goren I, 2007, J INVEST DERMATOL, V127, P2259, DOI 10.1038/sj.jid.5700842; HASLETT C, 1992, CLIN SCI, V83, P639, DOI 10.1042/cs0830639; Hubner G, 1996, CYTOKINE, V8, P548, DOI 10.1006/cyto.1996.0074; HUMMEL KP, 1966, SCIENCE, V153, P1127, DOI 10.1126/science.153.3740.1127; Huynh MLN, 2002, J CLIN INVEST, V109, P41, DOI 10.1172/JCI200211638; Kaneto H, 1999, DIABETES, V48, P2398, DOI 10.2337/diabetes.48.12.2398; KHANNA S, 2007, J BIOL CHEM     0614; Kiener PA, 1997, J EXP MED, V185, P1511, DOI 10.1084/jem.185.8.1511; Lawrence T, 2002, NAT REV IMMUNOL, V2, P787, DOI 10.1038/nri915; Liechty KW, 2000, J PEDIATR SURG, V35, P866, DOI 10.1053/jpsu.2000.6868; Liles WC, 1996, J EXP MED, V184, P429, DOI 10.1084/jem.184.2.429; Liu BF, 1999, DIABETES, V48, P2074, DOI 10.2337/diabetes.48.10.2074; Lundberg JE, 1998, ARCH DERMATOL RES, V290, P669, DOI 10.1007/s004030050371; Manfredi AA, 2002, APOPTOSIS, V7, P153, DOI 10.1023/A:1014366531885; Maree AFM, 2005, J THEOR BIOL, V233, P533, DOI 10.1016/j.jtbi.2004.10.030; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Maruyama K, 2007, AM J PATHOL, V170, P1178, DOI 10.2353/ajpath.2007.060018; Matalka KZ, 2005, NEUROENDOCRINOL LETT, V26, P231; MATSUE H, 1995, ARCH DERMATOL RES, V287, P315, DOI 10.1007/BF01105085; Meszaros AJ, 1999, J LEUKOCYTE BIOL, V65, P35, DOI 10.1002/jlb.65.1.35; Michlewska S, 2009, FASEB J, V23, P844, DOI 10.1096/fj.08-121228; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; O'Brien BA, 2002, CELL DEATH DIFFER, V9, P457, DOI 10.1038/sj.cdd.4400973; Peters T, 2005, EMBO J, V24, P3400, DOI 10.1038/sj.emboj.7600809; Pierce GF, 2001, AM J PATHOL, V159, P399, DOI 10.1016/S0002-9440(10)61709-9; Porcheray F, 2005, CLIN EXP IMMUNOL, V142, P481, DOI 10.1111/j.1365-2249.2005.02934.x; Ramsey SD, 1999, DIABETES CARE, V22, P382, DOI 10.2337/diacare.22.3.382; Ren Y, 1998, CELL DEATH DIFFER, V5, P563, DOI 10.1038/sj.cdd.4400407; Rosen A, 1999, CELL DEATH DIFFER, V6, P6, DOI 10.1038/sj.cdd.4400460; Roy S, 2006, MOL THER, V13, P211, DOI 10.1016/j.ymthe.2005.07.684; Roy S, 2003, CIRC RES, V92, P264, DOI 10.1161/01.RES.0000056770.30922.E6; ROY S, 2008, PHYSL GENOMICS; Roy S, 2007, MOL BIOL CELL, V18, P4837, DOI 10.1091/mbc.E07-03-0270; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; Savill John, 2000, Kidney and Blood Pressure Research, V23, P173; Schaffer MR, 2004, J SURG RES, V122, P43, DOI 10.1016/j.jss.2004.05.009; Sen CK, 2002, J BIOL CHEM, V277, P33284, DOI 10.1074/jbc.M203391200; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; STEIN M, 1992, J EXP MED, V176, P287, DOI 10.1084/jem.176.1.287; Sudo Chiaki, 2007, Lab Hematol, V13, P108; Sullivan SR, 2004, PLAST RECONSTR SURG, V113, P953, DOI 10.1097/01.PRS.0000105044.03230.F4; Trousdale RK, 2009, J SURG RES, V151, P100, DOI 10.1016/j.jss.2008.01.023; Underwood RA, 2001, J HISTOCHEM CYTOCHEM, V49, P1285, DOI 10.1177/002215540104901011; Vandivier RW, 2006, CHEST, V129, P1673, DOI 10.1378/chest.129.6.1673; VERHOVEN B, 1995, J EXP MED, V182, P1597, DOI 10.1084/jem.182.5.1597; Voll RE, 1997, NATURE, V390, P350, DOI 10.1038/37022; Wang J, 1999, J CLIN INVEST, V103, P27, DOI 10.1172/JCI4431; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; Wetzler C, 2000, J INVEST DERMATOL, V115, P245, DOI 10.1046/j.1523-1747.2000.00029.x; WHEAT LJ, 1980, DIABETES CARE, V3, P187, DOI 10.2337/diacare.3.1.187; ZHANG Z, 2009, FASEB J	81	396	407	4	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2010	5	3							e9539	10.1371/journal.pone.0009539	http://dx.doi.org/10.1371/journal.pone.0009539			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	564EW	20209061	Green Submitted, gold, Green Published			2022-12-25	WOS:000275197100019
J	Guerreiro, RJ; Beck, J; Gibbs, JR; Santana, I; Rossor, MN; Schott, JM; Nalls, MA; Ribeiro, H; Santiago, B; Fox, NC; Oliveira, C; Collinge, J; Mead, S; Singleton, A; Hardy, J				Guerreiro, Rita J.; Beck, John; Gibbs, J. Raphael; Santana, Isabel; Rossor, Martin N.; Schott, Jonathan M.; Nalls, Michael A.; Ribeiro, Helena; Santiago, Beatriz; Fox, Nick C.; Oliveira, Catarina; Collinge, John; Mead, Simon; Singleton, Andrew; Hardy, John			Genetic Variability in CLU and Its Association with Alzheimer's Disease	PLOS ONE			English	Article							MULTILOCUS GENOTYPE DATA; GENOME-WIDE ASSOCIATION; APOLIPOPROTEIN-J; AMYLOID-BETA; CEREBROSPINAL-FLUID; IDENTIFIES VARIANTS; SENILE PLAQUES; CLUSTERIN GENE; BRAIN; EXPRESSION	Background: Recently, two large genome wide association studies in Alzheimer disease (AD) have identified variants in three different genes (CLU, PICALM and CR1) as being associated with the risk of developing AD. The strongest association was reported for an intronic single nucleotide polymorphism (SNP) in CLU. Methodology/Principal Findings: To further characterize this association we have sequenced the coding region of this gene in a total of 495 AD cases and 330 healthy controls. A total of twenty-four variants were found in both cases and controls. For the changes found in more than one individual, the genotypic frequencies were compared between cases and controls. Coding variants were found in both groups (including a nonsense mutation in a healthy subject), indicating that the pathogenicity of variants found in this gene must be carefully evaluated. We found no common coding variant associated with disease. In order to determine if common variants at the CLU locus effect expression of nearby (cis) mRNA transcripts, an expression quantitative loci (eQTL) analysis was performed. No significant eQTL associations were observed for the SNPs previously associated with AD. Conclusions/Significance: We conclude that common coding variability at this locus does not explain the association, and that there is no large effect of common genetic variability on expression in brain tissue. We surmise that the most likely mechanism underpinning the association is either small effects of genetic variability on resting gene expression, or effects on damage induced expression of the protein.	[Guerreiro, Rita J.; Gibbs, J. Raphael; Nalls, Michael A.; Singleton, Andrew] NIA, Neurogenet Lab, NIH, Bethesda, MD 20892 USA; [Guerreiro, Rita J.; Ribeiro, Helena; Oliveira, Catarina] Univ Coimbra, Ctr Neurosci & Cell Biol, Coimbra, Portugal; [Beck, John; Collinge, John; Mead, Simon] UCL Inst Neurol, Dept Neurodegenerat Dis, MRC, Prion Unit, London, England; [Gibbs, J. Raphael; Hardy, John] Reta Lila Weston Inst, London, England; [Gibbs, J. Raphael; Hardy, John] Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England; [Gibbs, J. Raphael; Hardy, John] Inst Neurol, Dept Neurodegenerat Dis, London WC1N 3BG, England; [Santana, Isabel; Ribeiro, Helena; Santiago, Beatriz; Oliveira, Catarina] Coimbra Univ Hosp, Neurol Serv, Coimbra, Portugal; [Rossor, Martin N.; Schott, Jonathan M.; Fox, Nick C.] UCL, Inst Neurol, Dementia Res Ctr, London, England	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Universidade de Coimbra; University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; Universidade de Coimbra; Centro Hospitalar e Universitario de Coimbra (CHUC); University of London; University College London	Guerreiro, RJ (corresponding author), NIA, Neurogenet Lab, NIH, Bethesda, MD 20892 USA.	Singleta@mail.nih.gov	Mead, Simon/E-9414-2011; Fox, Nick C/AAE-1849-2021; Fox, Nick C/B-1319-2009; Hardy, John/C-2451-2009; Schott, Jonathan M/A-9065-2011; Singleton, Andrew B/C-3010-2009; Guerreiro, Rita J L/A-1327-2011; Gibbs, J. Raphael/A-3984-2010; Rossor, Martin/C-1598-2008; Oliveira, Catarina R./F-3685-2010	Mead, Simon/0000-0002-4326-1468; Fox, Nick C/0000-0002-6660-657X; Fox, Nick C/0000-0002-6660-657X; Hardy, John/0000-0002-3122-0423; Schott, Jonathan M/0000-0003-2059-024X; Gibbs, J. Raphael/0000-0002-6985-0658; Guerreiro, Rita/0000-0001-5879-3486; Rossor, Martin/0000-0001-8215-3120; Oliveira, Catarina/0000-0001-6942-4328; Santana, Isabel/0000-0002-8114-9434	Intramural Research Program of the National Institute on Aging; National Institutes of Health, Department of Health and Human Services [Z01 AG000950-06]; MRC Prion Unit and Fundacao para a Ciencia e Tecnologia, Portugal [SFRH/BD/29647/2006, PIC/IC/83206/2007]; UK cohort; Department of Health National Institute for Health Research Biomedical Research Centres; MRC; HEFCE/NHS Senior lecturership; NATIONAL INSTITUTE ON AGING [ZIAAG000950, Z01AG000950] Funding Source: NIH RePORTER; Alzheimers Research UK [ART-PG2010-1] Funding Source: researchfish; Medical Research Council [G0601846, G0701075, MC_U123160651, MC_U123192748] Funding Source: researchfish; MRC [G0701075, G0601846, MC_U123192748, MC_U123160651] Funding Source: UKRI	Intramural Research Program of the National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC Prion Unit and Fundacao para a Ciencia e Tecnologia, Portugal(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK cohort; Department of Health National Institute for Health Research Biomedical Research Centres(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); HEFCE/NHS Senior lecturership(UK Research & Innovation (UKRI)Higher Education Funding Council for England (HEFCE)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported in part by the Intramural Research Program of the National Institute on Aging, National Institutes of Health, Department of Health and Human Services, project number Z01 AG000950-06; MRC Prion Unit and Fundacao para a Ciencia e Tecnologia, Portugal [grant SFRH/BD/29647/2006 and project PIC/IC/83206/2007]. The UK Medical Research Council funded the analysis of the UK cohort. Some of this work was done at University College London Hospitals/University College London which received a proportion of funding from the Department of Health National Institute for Health Research Biomedical Research Centres funding scheme. The Dementia Research Centre in the Department of Neurodegenerative Disease, UCL is an Alzheimer Research Trust Coordinating Centre. NCF is funded by the MRC; JMS is in receipt of a HEFCE/NHS Senior lecturership and JH of a MRC Returning Scientist Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERTRAND P, 1995, MOL BRAIN RES, V33, P174, DOI 10.1016/0169-328X(95)00097-C; DANIK M, 1993, J COMP NEUROL, V334, P209, DOI 10.1002/cne.903340205; DESILVA HV, 1990, BIOCHEMISTRY-US, V29, P5380, DOI 10.1021/bi00474a025; Falush D, 2003, GENETICS, V164, P1567; GHISO J, 1993, BIOCHEM J, V293, P27, DOI 10.1042/bj2930027; GOLABEK A, 1995, NEUROSCI LETT, V191, P79, DOI 10.1016/0304-3940(95)11565-7; GUERREIRO RJ, 2008, NEUROBIOL A IN PRESS; Hardy J, 2009, NEW ENGL J MED, V360, P1759, DOI 10.1056/NEJMra0808700; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; JENNE DE, 1992, TRENDS BIOCHEM SCI, V17, P154, DOI 10.1016/0968-0004(92)90325-4; Jones SE, 2002, INT J BIOCHEM CELL B, V34, P427, DOI 10.1016/S1357-2725(01)00155-8; KIDA E, 1995, BRAIN RES, V685, P211, DOI 10.1016/0006-8993(95)00482-6; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; MAY PC, 1990, NEURON, V5, P831, DOI 10.1016/0896-6273(90)90342-D; MCGEER PL, 1992, BRAIN RES, V579, P337, DOI 10.1016/0006-8993(92)90071-G; MCGEER PL, 1994, TOHOKU J EXP MED, V174, P269, DOI 10.1620/tjem.174.269; Miwa Y, 2005, BIOCHEM BIOPH RES CO, V331, P1587, DOI 10.1016/j.bbrc.2005.04.069; Myers AJ, 2007, NAT GENET, V39, P1494, DOI 10.1038/ng.2007.16; Nestlerode CS, 1999, HUM BIOL, V71, P197; ODA T, 1994, BIOCHEM BIOPH RES CO, V204, P1131, DOI 10.1006/bbrc.1994.2580; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Rogaeva E, 2002, NEUROMOL MED, V2, P1, DOI 10.1385/NMM:2:1:01; Ross OA, 2007, MECH AGEING DEV, V128, P378, DOI 10.1016/j.mad.2007.04.002; Schadt EE, 2001, J CELL BIOCHEM, V84, P120, DOI 10.1002/jcb.10073; Sunyaev S, 2000, TRENDS GENET, V16, P198, DOI 10.1016/S0168-9525(00)01988-0; Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591; Swaroop A, 2009, ANNU REV GENOM HUM G, V10, P19, DOI 10.1146/annurev.genom.9.081307.164350; Takamaru Yuji, 1994, Hokkaido Journal of Medical Science, V69, P191; Tseng GC, 2001, NUCLEIC ACIDS RES, V29, P2549, DOI 10.1093/nar/29.12.2549; Tycko B, 1996, HUM GENET, V98, P430, DOI 10.1007/s004390050234; Webster JA, 2009, AM J HUM GENET, V84, P445, DOI 10.1016/j.ajhg.2009.03.011; WONG P, 1993, J BIOL CHEM, V268, P5021; WORKMAN C, 2002, GENOME BIOL, V0003; Zlokovic BV, 1996, LIFE SCI, V59, P1483, DOI 10.1016/0024-3205(96)00310-4	36	45	45	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2010	5	3							e9510	10.1371/journal.pone.0009510	http://dx.doi.org/10.1371/journal.pone.0009510			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	562OZ	20209083	Green Published, Green Submitted, gold			2022-12-25	WOS:000275063400016
J	Greganova, E; Heller, M; Butikofer, P				Greganova, Eva; Heller, Manfred; Buetikofer, Peter			A Structural Domain Mediates Attachment of Ethanolamine Phosphoglycerol to Eukaryotic Elongation Factor 1A in Trypanosoma brucei	PLOS ONE			English	Article							TANDEM AFFINITY PURIFICATION; BLOOD-STREAM FORMS; PROTEIN-SYNTHESIS; POSTTRANSLATIONAL MODIFICATION; SURFACE GLYCOPROTEIN; ACTIN CYTOSKELETON; ADP-RIBOSYLATION; H-3 ETHANOLAMINE; DIPHTHERIA-TOXIN; AMINO-ACID	Ethanolamine phosphoglycerol (EPG) represents a protein modification that so far has only been found in eukaryotic elongation factor 1A (eEF1A). In mammals and plants, EPG is covalently attached to two conserved glutamate residues located in domains II and III of eEF1A. In contrast, Trypanosoma brucei eEF1A contains a single EPG attached to Glu362 in domain III. The sequence and/or structural requirements for covalent linkage of EPG to eEF1A have not been determined for any organism. Using a combination of biosynthetic labelling of parasites with tritiated ethanolamine and mass spectrometry analyses, we demonstrate that replacement of Glu362 in T. brucei eEF1A by site-directed mutagenesis prevents EPG attachment, whereas single or multiple amino acid substitutions around the attachment site are not critical. In addition, by expressing a series of eEF1A deletion mutants in T. brucei procyclic forms, we demonstrate that a peptide consisting of 80 amino acids of domain III of eEF1A is sufficient for EPG attachment to occur. Furthermore, EPG addition also occurs if domain III of eEF1A is fused to a soluble reporter protein. To our knowledge, this is the first report addressing amino acid sequence, or structure, requirements for EPG modification of eEF1A in any organism. Using T. brucei as a model organism, we show that amino acid substitutions around the modification site are not critical for EPG attachment and that a truncated version of domain III of eEF1A is sufficient to mediate EPG addition.	[Greganova, Eva; Buetikofer, Peter] Univ Bern, Inst Biochem & Mol Med, Bern, Switzerland; [Heller, Manfred] Univ Hosp Bern, Dept Clin Res, CH-3010 Bern, Switzerland	University of Bern; University of Bern; University Hospital of Bern	Greganova, E (corresponding author), Univ Bern, Inst Biochem & Mol Med, Bern, Switzerland.	peter.buetikofer@mci.unibe.ch		Heller, Manfred/0000-0002-6364-7325	Swiss National Science Foundation [31003A-116627]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The work was supported by Swiss National Science Foundation grant 31003A-116627 to P. B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand M, 2003, J BIOL CHEM, V278, P6985, DOI 10.1074/jbc.M209224200; Anand M, 2006, J BIOL CHEM, V281, P32318, DOI 10.1074/jbc.M601899200; Andersen GR, 2000, MOL CELL, V6, P1261, DOI 10.1016/S1097-2765(00)00122-2; Andersen GR, 2003, TRENDS BIOCHEM SCI, V28, P434, DOI 10.1016/S0968-0004(03)00162-2; Andersen GR, 2001, NAT STRUCT BIOL, V8, P531, DOI 10.1038/88598; Bouzaidi-Tiali N, 2007, EMBO J, V26, P4302, DOI 10.1038/sj.emboj.7601857; Bunai F, 2006, J BIOCHEM, V140, P393, DOI 10.1093/jb/mvj169; Butikofer P, 1997, BIOCHEM J, V326, P415; CAVALLIUS J, 1993, BIOCHIM BIOPHYS ACTA, V1163, P75, DOI 10.1016/0167-4838(93)90281-U; Chang YWE, 1998, EUR J BIOCHEM, V251, P201, DOI 10.1046/j.1432-1327.1998.2510201.x; CLAYTON CE, 1989, J BIOL CHEM, V264, P15088; DEVER TE, 1989, J BIOL CHEM, V264, P20518; Dinman JD, 1997, RNA, V3, P870; EDMONDS BT, 1995, J BIOL CHEM, V270, P15222, DOI 10.1074/jbc.270.25.15222; Edmonds BT, 1996, J CELL SCI, V109, P2705; Ejiri S, 2002, BIOSCI BIOTECH BIOCH, V66, P1, DOI 10.1271/bbb.66.1; FONZI WA, 1985, MOL CELL BIOL, V5, P1100, DOI 10.1128/MCB.5.5.1100; Gross SR, 2005, NAT STRUCT MOL BIOL, V12, P772, DOI 10.1038/nsmb979; Gross SR, 2007, MOL CELL BIOL, V27, P1974, DOI 10.1128/MCB.00832-06; Gupta PK, 2008, CELL MICROBIOL, V10, P1687, DOI 10.1111/j.1462-5822.2008.01159.x; Jao DLE, 2006, J CELL BIOCHEM, V97, P583, DOI 10.1002/jcb.20658; JOE YA, 1994, J BIOL CHEM, V269, P25916; Jorgensen R, 2006, BIOCHEM SOC T, V34, P1; Khacho M, 2008, MOL BIOL CELL, V19, P5296, DOI 10.1091/mbc.E08-06-0562; KINZY TG, 1992, J BIOL CHEM, V267, P1623; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee SB, 2009, BIOCHEM BIOPH RES CO, V383, P497, DOI 10.1016/j.bbrc.2009.04.049; Merrick WC, 2000, COLD SPRING HARBOR M, V39, P89; Merrick WC., 1996, TRANSLATION CONTROL, P31; Morita K, 2008, ZOOL SCI, V25, P22, DOI 10.2108/zsj.25.22; Ortiz PA, 2006, J BIOL CHEM, V281, P32639, DOI 10.1074/jbc.M607076200; Panasyuk G, 2008, INT J BIOCHEM CELL B, V40, P63, DOI 10.1016/j.biocel.2007.08.014; PETERS HI, 1995, EUR J BIOCHEM, V234, P550, DOI 10.1111/j.1432-1033.1995.550_b.x; Ransom WD, 1998, PLANT PHYSIOL, V117, P949, DOI 10.1104/pp.117.3.949; RIFKIN MR, 1985, MOL BIOCHEM PARASIT, V15, P245, DOI 10.1016/0166-6851(85)90088-X; ROSENBERRY TL, 1989, J BIOL CHEM, V264, P7096; Saini P, 2009, NATURE, V459, P118, DOI 10.1038/nature08034; Schimanski B, 2005, EUKARYOT CELL, V4, P1942, DOI 10.1128/EC.4.11.1942-1950.2005; SHIBA T, 1971, BIOCHIM BIOPHYS ACTA, V244, P523, DOI 10.1016/0304-4165(71)90069-9; Signorell A, 2008, J BIOL CHEM, V283, P20320, DOI 10.1074/jbc.M802430200; Utz S, 2006, EUKARYOT CELL, V5, P1430, DOI 10.1128/EC.00067-06; VANNESS BG, 1980, J BIOL CHEM, V255, P717; vanOostveen I, 1997, ANAL BIOCHEM, V247, P310, DOI 10.1006/abio.1997.2052; Vassella E, 1996, MOL BIOCHEM PARASIT, V82, P91, DOI 10.1016/0166-6851(96)02727-2; Vassella E, 2000, GENE DEV, V14, P615; Vassella E, 2003, MOL BIOL CELL, V14, P1308, DOI 10.1091/mbc.E02-10-0694; WHITEHEART SW, 1994, ARCH BIOCHEM BIOPHYS, V309, P387, DOI 10.1006/abbi.1994.1128; WHITEHEART SW, 1989, J BIOL CHEM, V264, P14334; Wolff EC, 2007, AMINO ACIDS, V33, P341, DOI 10.1007/s00726-007-0525-0; Zanelli CF, 2007, AMINO ACIDS, V33, P351, DOI 10.1007/s00726-007-0533-0; Zhang Y, 2008, BIOCHEM J, V413, P163, DOI 10.1042/BJ20071083; Zobel-Thropp P, 2000, J BIOL CHEM, V275, P37150, DOI 10.1074/jbc.M001005200	52	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2010	5	3							e9486	10.1371/journal.pone.0009486	http://dx.doi.org/10.1371/journal.pone.0009486			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	562OY	20209157	Green Published, Green Submitted, gold			2022-12-25	WOS:000275063300006
J	Vo, ATT; van Duijkeren, E; Gaastra, W; Fluit, AC				Vo, An T. T.; van Duijkeren, Engeline; Gaastra, Wim; Fluit, Ad C.			Antimicrobial Resistance, Class 1 Integrons, and Genomic Island 1 in Salmonella Isolates from Vietnam	PLOS ONE			English	Article							MULTIPLE ANTIBIOTIC-RESISTANCE; ENTERICA SEROTYPE TYPHIMURIUM; MULTIDRUG-RESISTANCE; QUINOLONE RESISTANCE; SEROVAR TYPHIMURIUM; GENE CASSETTES; HUMANS; MECHANISMS; MUTATIONS; ANIMALS	Background: The objective was to investigate the phenotypic and genotypic resistance and the horizontal transfer of resistance determinants from Salmonella isolates from humans and animals in Vietnam. Methodology/Principal Findings: The susceptibility of 297 epidemiologically unrelated non-typhoid Salmonella isolates was investigated by disk diffusion assay. The isolates were screened for the presence of class 1 integrons and Salmonella genomic island 1 by PCR. The potential for the transfer of resistance determinants was investigated by conjugation experiments. Resistance to gentamicin, kanamycin, chloramphenicol, streptomycin, trimethoprim, ampicillin, nalidixic acid, sulphonamides, and tetracycline was found in 13 to 50% of the isolates. Nine distinct integron types were detected in 28% of the isolates belonging to 11 Salmonella serovars including S. Tallahassee. Gene cassettes identified were aadA1, aadA2, aadA5, bla(PSE-1), bla(OXA-30), dfrA1, dfrA12, dfrA17, and sat, as well as open reading frames with unknown functions. Most integrons were located on conjugative plasmids, which can transfer their antimicrobial resistance determinants to Escherichia coli or Salmonella Enteritidis, or with Salmonella Genomic Island 1 or its variants. The resistance gene cluster in serovar Emek identified by PCR mapping and nucleotide sequencing contained SGI1-J3 which is integrated in SGI1 at another position than the majority of SGI1. This is the second report on the insertion of SGI1 at this position. High-level resistance to fluoroquinolones was found in 3 multiresistant S. Typhimurium isolates and was associated with mutations in the gyrA gene leading to the amino acid changes Ser83Phe and Asp87Asn. Conclusions: Resistance was common among Vietnamese Salmonella isolates from different sources. Legislation to enforce a more prudent use of antibiotics in both human and veterinary medicine should be implemented by the authorities in Vietnam.	[Vo, An T. T.; van Duijkeren, Engeline; Gaastra, Wim] Univ Utrecht, Fac Vet Med, Dept Immunol & Infect Dis, Utrecht, Netherlands; [Fluit, Ad C.] Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands; [Vo, An T. T.] Nong Lam Univ, Fac Anim Husb & Vet Med, Ho Chi Minh City, Vietnam	Utrecht University; Utrecht University; Utrecht University Medical Center; Nong Lam University	Vo, ATT (corresponding author), Univ Utrecht, Fac Vet Med, Dept Immunol & Infect Dis, Utrecht, Netherlands.	e.vanduijkeren@uu.nl			Vietnamese government [322]	Vietnamese government	This study was supported by a grant from the Vietnamese government in the Project 322. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abouzeed YM, 2008, ANTIMICROB AGENTS CH, V52, P2428, DOI 10.1128/AAC.00084-08; Bangtrakulnonth A, 2004, EMERG INFECT DIS, V10, P131, DOI 10.3201/eid1001.02-0781; Boyd D, 2002, ANTIMICROB AGENTS CH, V46, P1714, DOI 10.1128/AAC.46.6.1714-1722.2002; Boyd DA, 2000, FEMS MICROBIOL LETT, V189, P285, DOI 10.1111/j.1574-6968.2000.tb09245.x; Clinical and Laboratory Standards Institute (CLSI), 2004, M100S14 CLSI; DINH TT, 2003, J VET SCI TECH, V10, P50; Doublet B, 2005, MOL MICROBIOL, V55, P1911, DOI 10.1111/j.1365-2958.2005.04520.x; Doublet B, 2003, EMERG INFECT DIS, V9, P585, DOI 10.3201/eid0905.020609; Doublet B, 2009, ANTIMICROB AGENTS CH, V53, P824, DOI 10.1128/AAC.01015-08; Ebner P, 2004, J ANTIMICROB CHEMOTH, V53, P1004, DOI 10.1093/jac/dkh192; Edrington TS, 2004, MICROB DRUG RESIST, V10, P51, DOI 10.1089/107662904323047808; Esaki H, 2004, J ANTIMICROB CHEMOTH, V53, P266, DOI 10.1093/jac/dkh081; *FAO, 2003, JOINTAO OIE WHO EXP; Fisher IST, 2005, EPIDEMIOL INFECT, V133, P1, DOI 10.1017/S095026880400305X; Fluit AC, 1999, EUR J CLIN MICROBIOL, V18, P761, DOI 10.1007/s100960050398; Gales AC, 2001, J CLIN MICROBIOL, V39, P183, DOI 10.1128/JCM.39.1.183-190.2001; Giraud E, 1999, ANTIMICROB AGENTS CH, V43, P2131, DOI 10.1128/AAC.43.9.2131; GUINEE PAM, 1974, ZBL BAKT-INT J MED M, V226, P194; HALL RM, 1994, J BACTERIOL, V176, P6286, DOI 10.1128/jb.176.20.6286-6294.1994; HALL RM, 1995, MOL MICROBIOL, V15, P593, DOI 10.1111/j.1365-2958.1995.tb02368.x; Hooper DC, 1999, DRUG RESIST UPDATE, V2, P38, DOI 10.1054/drup.1998.0068; Hopkins KL, 2005, INT J ANTIMICROB AG, V25, P358, DOI 10.1016/j.ijantimicag.2005.02.006; Huang TM, 2004, VET MICROBIOL, V100, P247, DOI 10.1016/j.vetmic.2004.03.003; Isenbarger DW, 2002, EMERG INFECT DIS, V8, P175; Kwon HJ, 2002, VET MICROBIOL, V89, P303, DOI 10.1016/S0378-1135(02)00257-2; Leverstein-van Hall MA, 2003, J INFECT DIS, V187, P251, DOI 10.1086/345880; Leverstein-van Hall MA, 2002, J CLIN MICROBIOL, V40, P3038, DOI 10.1128/JCM.40.8.3038-3040.2002; Leverstein-van Hall MA, 2002, J INFECT DIS, V186, P49, DOI 10.1086/341078; LEVESQUE C, 1995, ANTIMICROB AGENTS CH, V39, P185, DOI 10.1128/AAC.39.1.185; Levings RS, 2008, ANTIMICROB AGENTS CH, V52, P2529, DOI 10.1128/AAC.00189-08; Levings RS, 2005, J BACTERIOL, V187, P4401, DOI 10.1128/JB.187.13.4401-4409.2005; Meunier D, 2002, EMERG INFECT DIS, V8, P430; Miko A, 2005, J ANTIMICROB CHEMOTH, V56, P1025, DOI 10.1093/jac/dki365; *NAT COMM CLIN LAB, 2001, M31A2 NCCLS; O'Mahony R, 2005, FOODBORNE PATHOG DIS, V2, P274, DOI 10.1089/fpd.2005.2.274; Paauw A, 2006, EMERG INFECT DIS, V12, P807; Randall LP, 2004, J ANTIMICROB CHEMOTH, V53, P208, DOI 10.1093/jac/dkh070; Ruiz J, 1997, J MED MICROBIOL, V46, P623, DOI 10.1099/00222615-46-7-623; Threlfall E J, 2003, Euro Surveill, V8, P41; Vo ATT, 2006, INT J ANTIMICROB AG, V28, P172, DOI 10.1016/j.ijantimicag.2006.05.027; Vo ATT, 2006, VET MICROBIOL, V113, P153, DOI 10.1016/j.vetmic.2005.10.034; Weill FX, 2006, J CLIN MICROBIOL, V44, P700, DOI 10.1128/JCM.44.3.700-708.2006; Yang SJ, 2002, VET MICROBIOL, V86, P295, DOI 10.1016/S0378-1135(02)00009-3; Zhao S, 2006, J FOOD PROTECT, V69, P500, DOI 10.4315/0362-028X-69.3.500; Zhao S, 2005, FOODBORNE PATHOG DIS, V2, P169, DOI 10.1089/fpd.2005.2.169	45	69	72	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2010	5	2							e9440	10.1371/journal.pone.0009440	http://dx.doi.org/10.1371/journal.pone.0009440			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	561RS	20195474	Green Published, gold, Green Submitted			2022-12-25	WOS:000274997000009
J	de Groot, NS; Ventura, S				de Groot, Natalia S.; Ventura, Salvador			Protein Aggregation Profile of the Bacterial Cytosol	PLOS ONE			English	Article							AMYLOID FIBRIL FORMATION; CODON ADAPTATION INDEX; BOVINE SERUM-ALBUMIN; ESCHERICHIA-COLI; INCLUSION-BODIES; SUBCELLULAR-LOCALIZATION; GLOBULAR-PROTEINS; EXPRESSION LEVELS; BETA-AGGREGATION; GENE-EXPRESSION	Background: Protein misfolding is usually deleterious for the cell, either as a consequence of the loss of protein function or the buildup of insoluble and toxic aggregates. The aggregation behavior of a given polypeptide is strongly influenced by the intrinsic properties encoded in its sequence. This has allowed the development of effective computational methods to predict protein aggregation propensity. Methodology/Principal Findings: Here, we use the AGGRESCAN algorithm to approximate the aggregation profile of an experimental cytosolic Escherichia coli proteome. The analysis indicates that the aggregation propensity of bacterial proteins is associated with their length, conformation, location, function, and abundance. The data are consistent with the predictions of other algorithms on different theoretical proteomes. Conclusions/Significance: Overall, the study suggests that the avoidance of protein aggregation in functional environments acts as a strong evolutionary constraint on polypeptide sequences in both prokaryotic and eukaryotic organisms.	[de Groot, Natalia S.; Ventura, Salvador] Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, E-08193 Barcelona, Spain	Autonomous University of Barcelona	Ventura, S (corresponding author), Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, E-08193 Barcelona, Spain.	salvador.ventura@uab.es	Ventura, Salvador/AAY-3170-2021; de Groot, Natalia Sanchez/AFN-2768-2022; de Groot, Natalia Sanchez/J-8212-2014; Ventura, Salvador/C-7021-2008	Ventura, Salvador/0000-0002-9652-6351; de Groot, Natalia Sanchez/0000-0002-0492-5532; de Groot, Natalia Sanchez/0000-0002-0492-5532; Ventura, Salvador/0000-0002-9652-6351	Ministerio de Ciencia y Innovacion (Spain) [BIO2007-68046-C02-02]; Agencia de Gestio d'Ajuts Universitaris i de Recerca (Generalitat de Catalunya) [2009-SGR-760]; Ministerio de Ciencia y Innovacion (Spain)	Ministerio de Ciencia y Innovacion (Spain); Agencia de Gestio d'Ajuts Universitaris i de Recerca (Generalitat de Catalunya)(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)Generalitat de Catalunya); Ministerio de Ciencia y Innovacion (Spain)	This work was supported by grants BIO2007-68046-C02-02 from Ministerio de Ciencia y Innovacion (Spain) and 2009-SGR-760 from Agencia de Gestio d'Ajuts Universitaris i de Recerca (Generalitat de Catalunya). NSdG was beneficiary of a Formacion del Personal Investigador fellowship awarded by the Ministerio de Ciencia y Innovacion (Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alix E, 2009, MOL MICROBIOL, V72, P5, DOI 10.1111/j.1365-2958.2009.06626.x; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bairoch A, 2005, NUCLEIC ACIDS RES, V33, pD154, DOI 10.1093/nar/gki070; Baneyx F, 2004, NAT BIOTECHNOL, V22, P1399, DOI 10.1038/nbt1029; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; Bolon DN, 2001, BIOCHEMISTRY-US, V40, P10047, DOI 10.1021/bi010427y; Bryan AW, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000333; Carrio M, 2005, J MOL BIOL, V347, P1025, DOI 10.1016/j.jmb.2005.02.030; Chen JW, 2006, J PROTEOME RES, V5, P888, DOI 10.1021/pr060049p; Chen YW, 2008, MOL BIOL EVOL, V25, P1530, DOI 10.1093/molbev/msn122; Chiti F, 2003, NATURE, V424, P805, DOI 10.1038/nature01891; Chiti F, 2002, P NATL ACAD SCI USA, V99, P16419, DOI 10.1073/pnas.212527999; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Conchillo-Sole O, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-65; COWAN SW, 1992, NATURE, V358, P727, DOI 10.1038/358727a0; de Groot NS, 2006, J BIOTECHNOL, V125, P110, DOI 10.1016/j.jbiotec.2006.02.026; de Groot NS, 2005, BMC STRUCT BIOL, V5, DOI 10.1186/1472-6807-5-18; de Groot NS, 2006, FEBS J, V273, P658, DOI 10.1111/j.1742-4658.2005.05102.x; Dougan DA, 2002, CELL MOL LIFE SCI, V59, P1607, DOI 10.1007/PL00012487; Ellis RJ, 2000, TRENDS BIOCHEM SCI, V25, P210, DOI 10.1016/S0968-0004(00)01576-0; Fandrich M, 2001, NATURE, V410, P165, DOI 10.1038/35065514; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; Galzitskaya OV, 2006, PLOS COMPUT BIOL, V2, P1639, DOI 10.1371/journal.pcbi.0020177; Gardy JL, 2005, BIOINFORMATICS, V21, P617, DOI 10.1093/bioinformatics/bti057; Gerdes SY, 2003, J BACTERIOL, V185, P5673, DOI 10.1128/JB.185.19.5673-5684.2003; Guijarro JI, 1998, P NATL ACAD SCI USA, V95, P4224, DOI 10.1073/pnas.95.8.4224; Huerta AM, 1998, NUCLEIC ACIDS RES, V26, P55, DOI 10.1093/nar/26.1.55; Irback A, 2000, BIOPHYS J, V79, P2252, DOI 10.1016/S0006-3495(00)76472-1; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Ishihama Y, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-102; Ivankov DN, 2003, PROTEIN SCI, V12, P2057, DOI 10.1110/ps.0302503; Jansen R, 2003, NUCLEIC ACIDS RES, V31, P2242, DOI 10.1093/nar/gkg306; Kajander T, 2000, STRUCTURE, V8, P1203, DOI 10.1016/S0969-2126(00)00520-7; Kiraga J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-163; Knowles TJ, 2009, NAT REV MICROBIOL, V7, P206, DOI 10.1038/nrmicro2069; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lawrence MS, 2007, J AM CHEM SOC, V129, P10110, DOI 10.1021/ja071641y; Linding R, 2004, J MOL BIOL, V342, P345, DOI 10.1016/j.jmb.2004.06.088; Liu Y, 2004, BIOCHEM BIOPH RES CO, V316, P795, DOI 10.1016/j.bbrc.2004.02.125; Maier T, 2009, FEBS LETT, V583, P3966, DOI 10.1016/j.febslet.2009.10.036; Militello V, 2004, BIOPHYS CHEM, V107, P175, DOI 10.1016/j.bpc.2003.09.004; Monsellier E, 2007, EMBO REP, V8, P737, DOI 10.1038/sj.embor.7401034; Monsellier E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000199; Morell M, 2008, BBA-MOL CELL RES, V1783, P1815, DOI 10.1016/j.bbamcr.2008.06.007; Quijano FAR, 2006, BIOCHEMISTRY-US, V45, P4638, DOI 10.1021/bi052226q; Reumers J, 2009, HUM MUTAT, V30, P431, DOI 10.1002/humu.20905; Rey S, 2005, NUCLEIC ACIDS RES, V33, pD164, DOI 10.1093/nar/gki027; Rousseau F, 2006, J MOL BIOL, V355, P1037, DOI 10.1016/j.jmb.2005.11.035; Ruepp A, 2004, NUCLEIC ACIDS RES, V32, P5539, DOI 10.1093/nar/gkh894; Saiki M, 2006, BIOCHEM BIOPH RES CO, V343, P1262, DOI 10.1016/j.bbrc.2006.03.089; de Groot NS, 2007, BIOPHYS J, V92, P1732, DOI 10.1529/biophysj.106.096677; de Groot NS, 2006, FEBS LETT, V580, P6471, DOI 10.1016/j.febslet.2006.10.071; Sandelin E, 2004, BIOPHYS J, V86, P23, DOI 10.1016/S0006-3495(04)74080-1; Santoni V, 2000, ELECTROPHORESIS, V21, P1054, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1054::AID-ELPS1054>3.3.CO;2-#; Schirmer T, 1998, J STRUCT BIOL, V121, P101, DOI 10.1006/jsbi.1997.3946; Selinger DW, 2000, NAT BIOTECHNOL, V18, P1262, DOI 10.1038/82367; Seo MJ, 2009, PROTEIN SCI, V18, P259, DOI 10.1002/pro.31; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Shen MY, 2005, CHEM PHYS LETT, V405, P224, DOI 10.1016/j.cplett.2005.02.029; Shirota M, 2008, PROTEIN SCI, V17, P1596, DOI 10.1110/ps.035592.108; Srikakulam R, 1999, J BIOL CHEM, V274, P27265, DOI 10.1074/jbc.274.38.27265; Tartaglia GG, 2005, PROTEIN SCI, V14, P2735, DOI 10.1110/ps.051473805; Tartaglia GG, 2005, PROTEIN SCI, V14, P2723, DOI 10.1110/ps.051471205; Tartaglia GG, 2008, CHEM SOC REV, V37, P1395, DOI 10.1039/b706784b; Tartaglia GG, 2007, PROTEINS, V68, P273, DOI 10.1002/prot.21427; Tartaglia GG, 2007, TRENDS BIOCHEM SCI, V32, P204, DOI 10.1016/j.tibs.2007.03.005; Tartaglia GG, 2009, MOL BIOSYST, V5, P1873, DOI 10.1039/b913099n; Tartaglia GG, 2009, J MOL BIOL, V388, P381, DOI 10.1016/j.jmb.2009.03.002; TELLER DC, 1976, NATURE, V260, P729, DOI 10.1038/260729a0; Thompson MJ, 2006, P NATL ACAD SCI USA, V103, P4074, DOI 10.1073/pnas.0511295103; Thulasiraman V, 1999, EMBO J, V18, P85, DOI 10.1093/emboj/18.1.85; Trovato A, 2006, PLOS COMPUT BIOL, V2, P1608, DOI 10.1371/journal.pcbi.0020170; Vendruscolo M, 2007, NATURE, V449, P555, DOI 10.1038/449555a; Ventura S, 2004, P NATL ACAD SCI USA, V101, P7258, DOI 10.1073/pnas.0308249101; Vetri V, 2007, EUR BIOPHYS J BIOPHY, V36, P717, DOI 10.1007/s00249-007-0196-5; Vucetic S, 2005, BIOINFORMATICS, V21, P137, DOI 10.1093/bioinformatics/bth476; Wang L, 2008, PLOS BIOL, V6, P1791, DOI 10.1371/journal.pbio.0060195; WASMER C, 2009, ANGEW CHEM IN PRESS; Wilks JC, 2007, J BACTERIOL, V189, P5601, DOI 10.1128/JB.00615-07; Yoon S, 2004, PROTEIN SCI, V13, P2149, DOI 10.1110/ps.04790604; Zibaee S, 2007, PROTEIN SCI, V16, P906, DOI 10.1110/ps.062624507	83	48	48	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2010	5	2							e9383	10.1371/journal.pone.0009383	http://dx.doi.org/10.1371/journal.pone.0009383			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SY	20195530	Green Published, gold			2022-12-25	WOS:000274924300001
J	Iwata, T; Schultz, D; Hicks, J; Hubbard, GK; Mutton, LN; Lotan, TL; Bethel, C; Lotz, MT; Yegnasubramanian, S; Nelson, WG; Dang, CV; Xu, MM; Anele, U; Koh, CM; Bieberich, CJ; De Marzo, AM				Iwata, Tsuyoshi; Schultz, Denise; Hicks, Jessica; Hubbard, Gretchen K.; Mutton, Laura N.; Lotan, Tamara L.; Bethel, Carlise; Lotz, Matthew T.; Yegnasubramanian, Srinivasan; Nelson, William G.; Dang, Chi V.; Xu, MengMeng; Anele, Uzoma; Koh, Cheryl M.; Bieberich, Charles J.; De Marzo, Angelo M.			MYC Overexpression Induces Prostatic Intraepithelial Neoplasia and Loss of Nkx3.1 in Mouse Luminal Epithelial Cells	PLOS ONE			English	Article							PROLIFERATIVE INFLAMMATORY ATROPHY; GENETICALLY-ENGINEERED MICE; IN-SITU HYBRIDIZATION; HOMEOBOX GENE NKX3.1; C-MYC; STEM-CELL; HIGH-GRADE; TRANSGENIC ADENOCARCINOMA; NEUROENDOCRINE CARCINOMA; CHROMOSOMAL-ANOMALIES	Lo-MYC and Hi-MYC mice develop prostatic intraepithelial neoplasia (PIN) and prostatic adenocarcinoma as a result of MYC overexpression in the mouse prostate[1]. However, prior studies have not determined precisely when, and in which cell types, MYC is induced. Using immunohistochemistry (IHC) to localize MYC expression in Lo-MYC transgenic mice, we show that morphological and molecular alterations characteristic of high grade PIN arise in luminal epithelial cells as soon as MYC overexpression is detected. These changes include increased nuclear and nucleolar size and large scale chromatin remodeling. Mouse PIN cells retained a columnar architecture and abundant cytoplasm and appeared as either a single layer of neoplastic cells or as pseudo-stratified/multilayered structures with open glandular lumina-features highly analogous to human high grade PIN. Also using IHC, we show that the onset of MYC overexpression and PIN development coincided precisely with decreased expression of the homeodomain transcription factor and tumor suppressor, Nkx3.1. Virtually all normal appearing prostate luminal cells expressed high levels of Nkx3.1, but all cells expressing MYC in PIN lesions showed marked reductions in Nkx3.1, implicating MYC as a key factor that represses Nkx3.1 in PIN lesions. To determine the effects of less pronounced overexpression of MYC we generated a new line of mice expressing MYC in the prostate under the transcriptional control of the mouse Nkx3.1 control region. These "`Super-Lo-MYC'' mice also developed PIN, albeit a less aggressive form. We also identified a histologically defined intermediate step in the progression of mouse PIN into invasive adenocarcinoma. These lesions are characterized by a loss of cell polarity, multi-layering, and cribriform formation, and by a "`paradoxical'' increase in Nkx3.1 protein. Similar histopathological changes occurred in Hi-MYC mice, albeit with accelerated kinetics. Our results using IHC provide novel insights that support the contention that MYC overexpression is sufficient to transform prostate luminal epithelial cells into PIN cells in vivo. We also identified a novel histopathologically identifiable intermediate step prior to invasion that should facilitate studies of molecular pathway alterations occurring during early progression of prostatic adenocarcinomas.	[Iwata, Tsuyoshi; Schultz, Denise; Hicks, Jessica; Lotan, Tamara L.; Bethel, Carlise; Lotz, Matthew T.; Nelson, William G.; Dang, Chi V.; Xu, MengMeng; Anele, Uzoma; Koh, Cheryl M.; De Marzo, Angelo M.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Lotan, Tamara L.; Nelson, William G.; De Marzo, Angelo M.] Johns Hopkins Univ, Sch Med, Dept Urol, Baltimore, MD 21205 USA; [Lotan, Tamara L.; Yegnasubramanian, Srinivasan; Nelson, William G.; Dang, Chi V.; De Marzo, Angelo M.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Bethel, Carlise; Yegnasubramanian, Srinivasan; Nelson, William G.; De Marzo, Angelo M.] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Baltimore, MD USA; [Nelson, William G.; De Marzo, Angelo M.] Johns Hopkins Univ, Sch Med, Brady Urol Res Inst, Baltimore, MD USA; [Dang, Chi V.] Johns Hopkins Univ, Sch Med, Dept Hematol & Med, Baltimore, MD USA; [Hubbard, Gretchen K.; Mutton, Laura N.; Bieberich, Charles J.] Univ Maryland Baltimore Cty, Dept Biol Sci, Baltimore, MD 21228 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins University; University System of Maryland; University of Maryland Baltimore County	Iwata, T (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA.	ademarz@jhmi.edu	Dang, Chi/Y-3375-2019; Anele, Uzoma/Q-9855-2019	Anele, Uzoma/0000-0002-3509-7856; Lotan, Tamara/0000-0002-0494-9067; Bieberich, Charles/0000-0002-9208-5077; Dang, Chi/0000-0002-4031-2522	Patrick C. Walsh Prostate Cancer Research Fund; NIH/NCI SPORE [P50 CA58236]; NATIONAL CANCER INSTITUTE [P50CA058236] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [22791489] Funding Source: KAKEN	Patrick C. Walsh Prostate Cancer Research Fund; NIH/NCI SPORE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The Patrick C. Walsh Prostate Cancer Research Fund, NIH/NCI SPORE No. P50 CA58236 (Pathology Core). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Competing Interests: The authors have declared that no competing interests	Abate-Shen C, 2000, GENE DEV, V14, P2410, DOI 10.1101/gad.819500; Abate-Shen C, 2008, DIFFERENTIATION, V76, P717, DOI 10.1111/j.1432-0436.2008.00292.x; Abdulkadir SA, 2002, MOL CELL BIOL, V22, P1495, DOI 10.1128/MCB.22.5.1495-1503.2002; Allam CK, 1996, MODERN PATHOL, V9, P742; Asatiani E, 2005, CANCER RES, V65, P1164, DOI 10.1158/0008-5472.CAN-04-2688; Barclay WW, 2008, STEM CELLS, V26, P600, DOI 10.1634/stemcells.2007-0309; Bethel CR, 2006, CANCER RES, V66, P10683, DOI 10.1158/0008-5472.CAN-06-0963; Bhatia-Gaur R, 1999, GENE DEV, V13, P966, DOI 10.1101/gad.13.8.966; Bieberich CJ, 1996, J BIOL CHEM, V271, P31779, DOI 10.1074/jbc.271.50.31779; Blum R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005722; BONKHOFF H, 1994, HUM PATHOL, V25, P42, DOI 10.1016/0046-8177(94)90169-4; BONKHOFF H, 1994, PROSTATE, V24, P114, DOI 10.1002/pros.2990240303; Bostwick DG, 1996, PROSTATE, V29, P117; Bowen C, 2000, CANCER RES, V60, P6111; Bradshaw MS, 1995, NUCLEIC ACIDS RES, V23, P4850, DOI 10.1093/nar/23.23.4850; Chen H, 2005, DEV DYNAM, V234, P961, DOI 10.1002/dvdy.20596; Chiaverotti T, 2008, AM J PATHOL, V172, P236, DOI 10.2353/ajpath.2008.070602; Chuang AY, 2007, AM J SURG PATHOL, V31, P1246, DOI 10.1097/PAS.0b013e31802f5d33; Copeland NG, 2001, NAT REV GENET, V2, P769, DOI 10.1038/35093556; Cotterman R, 2008, CANCER RES, V68, P9654, DOI 10.1158/0008-5472.CAN-08-1961; Dang CV, 2006, SEMIN CANCER BIOL, V16, P253, DOI 10.1016/j.semcancer.2006.07.014; De Marzo AM, 1998, J UROLOGY, V160, P2381, DOI 10.1016/S0022-5347(01)62196-7; De Marzo AM, 1998, AM J PATHOL, V153, P911, DOI 10.1016/S0002-9440(10)65632-5; De Marzo AM, 2007, J UROLOGY, V177, P373, DOI 10.1016/S0022-5347(18)31345-4; De Marzo AM, 2007, NAT REV CANCER, V7, P256, DOI 10.1038/nrc2090; Drayton S, 2003, CANCER CELL, V4, P301, DOI 10.1016/S1535-6108(03)00242-3; Egevad L, 2006, MODERN PATHOL, V19, P180, DOI 10.1038/modpathol.3800522; Ellwood-Yen K, 2003, CANCER CELL, V4, P223, DOI 10.1016/S1535-6108(03)00197-1; Elo JP, 2001, ANN MED, V33, P130, DOI 10.3109/07853890109002068; EPSTEIN JI, 2004, BLADDER BIOPSY INTER; Epstein JI, 2009, VIRCHOWS ARCH, V454, P1, DOI 10.1007/s00428-008-0707-5; FLEMING WH, 1986, CANCER RES, V46, P1535; Freie BW, 2008, CANCER CELL, V14, P425, DOI 10.1016/j.ccr.2008.11.008; Frese KK, 2007, NAT REV CANCER, V7, P645, DOI 10.1038/nrc2192; Gandarillas A, 1997, GENE DEV, V11, P2869, DOI 10.1101/gad.11.21.2869; Gil J, 2005, CANCER RES, V65, P2179, DOI 10.1158/0008-5472.CAN-03-4030; Gingrich JR, 1996, CANCER RES, V56, P4096; Goldstein AS, 2008, P NATL ACAD SCI USA, V105, P20882, DOI 10.1073/pnas.0811411106; Gonzalgo ML, 2003, J UROLOGY, V170, P2444, DOI 10.1097/01.ju.0000085381.20139.b6; GORDON JW, 1980, P NATL ACAD SCI-BIOL, V77, P7380, DOI 10.1073/pnas.77.12.7380; Gurel B, 2008, MODERN PATHOL, V21, P1156, DOI 10.1038/modpathol.2008.111; Hoffman B, 2008, ONCOGENE, V27, P6462, DOI 10.1038/onc.2008.312; Huss WJ, 2007, NEOPLASIA, V9, P938, DOI 10.1593/neo.07562; Jenkins RB, 1997, CANCER RES, V57, P524; Kim J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000542; Knoepfler PS, 2008, CELL STEM CELL, V2, P18, DOI 10.1016/j.stem.2007.12.004; Knoepfler PS, 2007, CANCER RES, V67, P5061, DOI 10.1158/0008-5472.CAN-07-0426; Knoepfler PS, 2006, EMBO J, V25, P2723, DOI 10.1038/sj.emboj.7601152; Korkmaz CG, 2004, J UROLOGY, V172, P1134, DOI 10.1097/01.ju.0000136526.78535.b8; Lawson DA, 2007, J CLIN INVEST, V117, P2044, DOI 10.1172/JCI32810; Lei QY, 2006, CANCER CELL, V9, P367, DOI 10.1016/j.ccr.2006.03.031; Leong KG, 2008, NATURE, V456, P804, DOI 10.1038/nature07427; Li X, 2006, MOL CELL BIOL, V26, P3008, DOI 10.1128/MCB.26.8.3008-3017.2006; Markowski MC, 2008, CANCER RES, V68, P6896, DOI 10.1158/0008-5472.CAN-08-0578; Masumori N, 2001, CANCER RES, V61, P2239; MCNEAL JE, 1995, PROSTATE, V27, P258, DOI 10.1002/pros.2990270505; MCNEAL JE, 1988, AM J CLIN PATHOL, V90, P23, DOI 10.1093/ajcp/90.1.23; Meeker AK, 2002, CANCER RES, V62, P6405; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Murphy DJ, 2008, CANCER CELL, V14, P447, DOI 10.1016/j.ccr.2008.10.018; Nakayama M, 2003, AM J PATHOL, V163, P923, DOI 10.1016/S0002-9440(10)63452-9; Nelson WG, 2003, NEW ENGL J MED, V349, P366, DOI 10.1056/NEJMra021562; Nesbit CE, 1999, ONCOGENE, V18, P3004, DOI 10.1038/sj.onc.1202746; Park JH, 2002, AM J PATHOL, V161, P727, DOI 10.1016/S0002-9440(10)64228-9; Pritchard C, 2009, CANCER RES, V69, P1739, DOI 10.1158/0008-5472.CAN-07-6817; Qian JQ, 1997, MODERN PATHOL, V10, P1113; Sato K, 1999, JNCI-J NATL CANCER I, V91, P1574, DOI 10.1093/jnci/91.18.1574; Schneider A, 2000, MECH DEVELOP, V95, P163, DOI 10.1016/S0925-4773(00)00355-5; Shappell SB, 2004, CANCER RES, V64, P2270, DOI 10.1158/0008-5472.CAN-03-0946; Shen MM, 2003, DEV DYNAM, V228, P767, DOI 10.1002/dvdy.10397; Signoretti S, 2005, P NATL ACAD SCI USA, V102, P11355, DOI 10.1073/pnas.0500165102; SONG H, 2009, ONCOGENE; Sun C, 2008, ONCOGENE, V27, P5348, DOI 10.1038/onc.2008.183; Tanaka M, 2000, DEV DYNAM, V219, P248, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1054>3.3.CO;2-5; Tomlins SA, 2006, ANNU REV PATHOL-MECH, V1, P243, DOI 10.1146/annurev.pathol.1.110304.100047; van Leenders GJLH, 2003, AM J PATHOL, V162, P1529, DOI 10.1016/S0002-9440(10)64286-1; VERHAGEN APM, 1992, CANCER RES, V52, P6182; Wang LZ, 2009, CANCER CELL, V16, P336, DOI 10.1016/j.ccr.2009.08.016; Wang SY, 2006, P NATL ACAD SCI USA, V103, P1480, DOI 10.1073/pnas.0510652103; Wang X, 2009, NATURE, V461, P495, DOI 10.1038/nature08361; West AG, 2005, HUM MOL GENET, V14, pR101, DOI 10.1093/hmg/ddi104; Williams K, 2005, PROSTATE, V63, P369, DOI 10.1002/pros.20200; Xu LL, 2000, J UROLOGY, V163, P972, DOI 10.1016/S0022-5347(05)67867-6; Yan Y, 1997, PROSTATE, V32, P129; Zhang HF, 2007, CANCER CELL, V11, P407, DOI 10.1016/j.ccr.2007.04.001; Zhang XJ, 2000, PROSTATE, V43, P278	86	89	90	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2010	5	2							e9427	10.1371/journal.pone.0009427	http://dx.doi.org/10.1371/journal.pone.0009427			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SY	20195545	Green Published, gold, Green Submitted			2022-12-25	WOS:000274924300015
J	Yam, AY; Gao, CM; Wang, XM; Wu, P; Peretz, D				Yam, Alice Y.; Gao, Carol Man; Wang, Xuemei; Wu, Ping; Peretz, David			The Octarepeat Region of the Prion Protein Is Conformationally Altered in PrPSc	PLOS ONE			English	Article							CREUTZFELDT-JAKOB-DISEASE; REPEAT INSERTIONAL MUTATION; SCRAPIE PRION; N-TERMINUS; GENE; FEATURES; DOMAIN; AGGREGATION; COEXISTENCE; ASSAY	Background: Prion diseases are fatal neurodegenerative disorders characterized by misfolding and aggregation of the normal prion protein PrPC. Little is known about the details of the structural rearrangement of physiological PrPC into a still-elusive disease-associated conformation termed PrPSc. Increasing evidence suggests that the amino-terminal octapeptide sequences of PrP (huPrP, residues 59-89), though not essential, play a role in modulating prion replication and disease presentation. Methodology/Principal Findings: Here, we report that trypsin digestion of PrPSc from variant and sporadic human CJD results in a disease-specific trypsin-resistant PrPSc fragment including amino acids similar to 49-231, thus preserving important epitopes such as the octapeptide domain for biochemical examination. Our immunodetection analyses reveal that several epitopes buried in this region of PrPSc are exposed in PrPC. Conclusions/Significance: We conclude that the octapeptide region undergoes a previously unrecognized conformational transition in the formation of PrPSc. This phenomenon may be relevant to the mechanism by which the amino terminus of PrPC participates in PrPSc conversion, and may also be exploited for diagnostic purposes.	[Yam, Alice Y.; Gao, Carol Man; Wang, Xuemei; Wu, Ping; Peretz, David] Novartis Vaccines & Diagnost Inc, Res & Dev, Emeryville, CA USA	Novartis	Yam, AY (corresponding author), Novartis Vaccines & Diagnost Inc, Res & Dev, Emeryville, CA USA.	alice.yam@novartis.com	Wang, Xuemei/GXF-3702-2022		Novartis Vaccines & Diagnostics, Inc	Novartis Vaccines & Diagnostics, Inc	This work was funded by Novartis Vaccines & Diagnostics, Inc. The authors are or were employed by the funder and, as such, the funders played a role in the study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Aguzzi A, 2004, CELL, V116, P313, DOI 10.1016/S0092-8674(03)01031-6; Aguzzi A, 2008, ANNU REV NEUROSCI, V31, P439, DOI 10.1146/annurev.neuro.31.060407.125620; Aguzzi A, 2009, PHYSIOL REV, V89, P1105, DOI 10.1152/physrev.00006.2009; BOLTON DC, 1982, SCIENCE, V218, P1309, DOI 10.1126/science.6815801; Cali I, 2009, BRAIN, V132, P2643, DOI 10.1093/brain/awp196; Campbell TA, 1996, NEUROLOGY, V46, P761, DOI 10.1212/WNL.46.3.761; Chiesa R, 1998, NEURON, V21, P1339, DOI 10.1016/S0896-6273(00)80653-4; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; Cooper JK, 2007, VOX SANG, V92, P302, DOI 10.1111/j.1423-0410.2007.00904.x; Dong JJ, 2007, J BIOL CHEM, V282, P34204, DOI 10.1074/jbc.M704952200; Donne DG, 1997, P NATL ACAD SCI USA, V94, P13452, DOI 10.1073/pnas.94.25.13452; DUCHEN LW, 1993, BRAIN, V116, P555, DOI 10.1093/brain/116.3.555; Flechsig E, 2000, NEURON, V27, P399, DOI 10.1016/S0896-6273(00)00046-5; Frankenfield KN, 2005, PROTEIN SCI, V14, P2154, DOI 10.1110/ps.051434005; Leclerc E, 2001, EMBO J, V20, P1547, DOI 10.1093/emboj/20.7.1547; Leliveld SR, 2006, J BIOL CHEM, V281, P3268, DOI 10.1074/jbc.M510606200; MCKINLEY MP, 1991, J VIROL, V65, P1340, DOI 10.1128/JVI.65.3.1340-1351.1991; MCKINLEY MP, 1983, CELL, V35, P57, DOI 10.1016/0092-8674(83)90207-6; Millhauser GL, 2007, ANNU REV PHYS CHEM, V58, P299, DOI 10.1146/annurev.physchem.58.032806.104657; Minor P, 2004, J GEN VIROL, V85, P1777, DOI 10.1099/vir.0.79959-0; Moore RA, 2006, PROTEIN SCI, V15, P609, DOI 10.1110/ps.051822606; Notari S, 2007, LAB INVEST, V87, P1103, DOI 10.1038/labinvest.3700676; Novitskaya V, 2006, J BIOL CHEM, V281, P15536, DOI 10.1074/jbc.M601349200; Peretz D, 1997, J MOL BIOL, V273, P614, DOI 10.1006/jmbi.1997.1328; Pietrini V, 2003, NEUROLOGY, V61, P1288, DOI 10.1212/01.WNL.0000092017.74772.CA; Polymenidou M, 2005, LANCET NEUROL, V4, P805, DOI 10.1016/S1474-4422(05)70225-8; Polymenidou M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003872; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; Rossi G, 2000, NEUROLOGY, V55, P405, DOI 10.1212/WNL.55.3.405; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; SERBAN D, 1990, NEUROLOGY, V40, P110, DOI 10.1212/WNL.40.1.110; Shmerling D, 1998, CELL, V93, P203, DOI 10.1016/S0092-8674(00)81572-X; Yanagihara C, 2002, J NEUROL NEUROSUR PS, V72, P788, DOI 10.1136/jnnp.72.6.788; Zahn R, 2000, P NATL ACAD SCI USA, V97, P145, DOI 10.1073/pnas.97.1.145	34	21	21	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2010	5	2							e9316	10.1371/journal.pone.0009316	http://dx.doi.org/10.1371/journal.pone.0009316			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SX	20195363	Green Submitted, gold, Green Published			2022-12-25	WOS:000274924200004
J	Yang, HH; Hu, N; Wang, CY; Ding, T; Dunn, BK; Goldstein, AM; Taylor, PR; Lee, MP				Yang, Howard H.; Hu, Nan; Wang, Chaoyu; Ding, Ti; Dunn, Barbara K.; Goldstein, Alisa M.; Taylor, Philip R.; Lee, Maxwell P.			Influence of Genetic Background and Tissue Types on Global DNA Methylation Patterns	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; DROSOPHILA-TRITHORAX; ESOPHAGEAL CANCER; FAMILY-HISTORY; HYPERMETHYLATION; TRANSLOCATIONS; WIDE	Recent studies have shown a genetic influence on gene expression variation, chromatin, and DNA methylation. However, the effects of genetic background and tissue types on DNA methylation at the genome-wide level have not been characterized extensively. To study the effect of genetic background and tissue types on global DNA methylation, we performed DNA methylation analysis using the Affymetrix 500K SNP array on tumor, adjacent normal tissue, and blood DNA from 30 patients with esophageal squamous cell carcinoma (ESCC). The use of multiple tissues from 30 individuals allowed us to evaluate variation of DNA methylation states across tissues and individuals. Our results demonstrate that blood and esophageal tissues shared similar DNA methylation patterns within the same individual, suggesting an influence of genetic background on DNA methylation. Furthermore, we showed that tissue types are important contributors of DNA methylation states.	[Yang, Howard H.; Lee, Maxwell P.] NCI, Lab Populat Genet, Ctr Canc Res, Bethesda, MD 20892 USA; [Hu, Nan; Wang, Chaoyu; Goldstein, Alisa M.; Taylor, Philip R.] NCI, Genet Epidemiol Branch, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Ding, Ti] Shanxi Canc Hosp, Taiyuan, Shanxi, Peoples R China; [Dunn, Barbara K.] NCI, Basic Prevent Sci Res Grp, Canc Prevent Div, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Yang, HH (corresponding author), NCI, Lab Populat Genet, Ctr Canc Res, Bethesda, MD 20892 USA.	ptaylor@mail.nih.gov; leemax@mail.nih.gov			Intramural Research Program of the National Institutes of Health; National Cancer Institute; NATIONAL CANCER INSTITUTE [ZIABC011253, ZIABC011250, ZIABC010986] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Intramural Research Program of the National Institutes of Health and the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An Q, 2002, CANCER LETT, V188, P109, DOI 10.1016/S0304-3835(02)00496-2; BIBIKOVA M, 2006, GENOME RES; Bird A, 2004, COLD SPRING HARB SYM, V69, P113, DOI 10.1101/sqb.2004.69.113; Bjornsson HT, 2008, JAMA-J AM MED ASSOC, V299, P2877, DOI 10.1001/jama.299.24.2877; Chang-Claude J, 1997, INT J EPIDEMIOL, V26, P1159, DOI 10.1093/ije/26.6.1159; Cui HM, 2003, SCIENCE, V299, P1753, DOI 10.1126/science.1080902; Esteller M, 2003, LANCET ONCOL, V4, P351, DOI 10.1016/S1470-2045(03)01115-X; FEINBERG AP, 1983, NATURE, V301, P89, DOI 10.1038/301089a0; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; GAMASOSA MA, 1983, NUCLEIC ACIDS RES, V11, P6883, DOI 10.1093/nar/11.19.6883; GREGER V, 1989, HUM GENET, V83, P155, DOI 10.1007/BF00286709; GU Y, 1992, CELL, V71, P701, DOI 10.1016/0092-8674(92)90603-A; HERMAN JG, 1995, CANCER RES, V55, P4525; Hu N, 1999, CLIN CANCER RES, V5, P3476; HU N, 1991, EUR J CANCER, V27, P1336, DOI 10.1016/0277-5379(91)90116-U; Hu N, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-299; Hu N, 2009, CANCER RES, V69, P5908, DOI 10.1158/0008-5472.CAN-08-4622; Huang THM, 1999, HUM MOL GENET, V8, P459, DOI 10.1093/hmg/8.3.459; Irizarry RA, 2008, GENOME RES, V18, P780, DOI 10.1101/gr.7301508; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Kadota M, 2007, PLOS GENET, V3, P768, DOI 10.1371/journal.pgen.0030081; Kaminsky ZA, 2009, NAT GENET, V41, P240, DOI 10.1038/ng.286; Kerkel K, 2008, NAT GENET, V40, P904, DOI 10.1038/ng.174; Khulan B, 2006, GENOME RES, V16, P1046, DOI 10.1101/gr.5273806; SAKAI T, 1991, AM J HUM GENET, V48, P880; Sanchez-Cespedes M, 2000, CANCER RES, V60, P892; TKACHUK DC, 1992, CELL, V71, P691, DOI 10.1016/0092-8674(92)90602-9; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Yuan E, 2006, CANCER RES, V66, P3443, DOI 10.1158/0008-5472.CAN-05-3739; ZIEMINVANDERPOEL S, 1991, P NATL ACAD SCI USA, V88, P10735, DOI 10.1073/pnas.88.23.10735	32	22	23	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2010	5	2							e9355	10.1371/journal.pone.0009355	http://dx.doi.org/10.1371/journal.pone.0009355			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SV	20186319	Green Submitted, Green Published, gold			2022-12-25	WOS:000274924000006
J	Sloss, CM; Wang, F; Palladino, MA; Cusack, JC				Sloss, C. M.; Wang, F.; Palladino, M. A.; Cusack, J. C., Jr.			Activation of EGFR by proteasome inhibition requires HB-EGF in pancreatic cancer cells	ONCOGENE			English	Article						proteasome inhibition; NPI-0052; EGFR; HB-EGF; pancreatic cancer	EPIDERMAL-GROWTH-FACTOR; BREAST-CANCER; EXPRESSION; BORTEZOMIB; RESISTANCE; P38; CHEMOTHERAPY; CONTRIBUTES; SENSITIVITY; ERLOTINIB	Resistance to drug treatments underlies the high lethality of pancreatic ductal adenocarcinoma. Along with others, we have recently identified that proteasome inhibition is a promising therapeutic option in this highly refractory disease. The pleiotropic effects of proteasome inhibition include the activation of apoptotic signaling pathways and also antiapoptotic signaling pathways such as EGFR, AKT and the MAP kinases that reduce the apoptotic potential of this class of drug. In this study, we sought to determine the mechanism behind the activation of EGFR in response to proteasome inhibition in pancreatic cancer cells. We found that the second-generation proteasome inhibitor NPI-0052 induced the mRNA transcription of several EGFR family ligands (EGF, HB-EGF and epiregulin), however only increases in HB-EGF were detected at the protein level. Using both pharmacological inhibitors and lentiviral-mediated shRNA knockdown of EGFR ligand expression, we discovered that ligand cleavage by MMP/ADAMs and HB-EGF expression is required for activation of EGFR in response to proteasome inhibition. Furthermore, we discover that induction of HB-EGF is dependent on reactive oxygen species and p38-MAPK signaling but not ERK and that the transcription factor SP-1 is involved in NPI-0052-induced HB-EGF transcription. Together, these results indicate that stress signaling leading to induction of HB-EGF expression and increases in MMP/ADAM-dependent HB-EGF cleavage are responsible for proteasome inhibitor-induced activation of EGFR in pancreatic cancer cells. Oncogene (2010) 29, 3146-3152; doi: 10.1038/onc.2010.52; published online 8 March 2010	[Sloss, C. M.; Wang, F.; Cusack, J. C., Jr.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Surg Oncol,Dept Surg, Boston, MA 02114 USA; [Palladino, M. A.] Nereus Pharmaceut, San Diego, CA USA	Harvard University; Harvard Medical School; Massachusetts General Hospital	Cusack, JC (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Surg Oncol,Dept Surg, Yawkey Bldg 7th Floor,55 Fruit St, Boston, MA 02114 USA.	jcusack@partners.org			NIH [CA98871]; NATIONAL CANCER INSTITUTE [R01CA098871] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by NIH Grant no. CA98871 (JC Cusack).	Blaine SA, 2009, AM J PHYSIOL-GASTR L, V297, pG434, DOI 10.1152/ajpgi.00152.2009; Buck E, 2006, MOL CANCER THER, V5, P2051, DOI 10.1158/1535-7163.MCT-06-0007; Codony-Servat J, 2006, MOL CANCER THER, V5, P665, DOI 10.1158/1535-7163.MCT-05-0147; D'Addario M, 2006, GENE, V379, P51, DOI 10.1016/j.gene.2006.04.012; Edwards JP, 2009, J IMMUNOL, V182, P1929, DOI 10.4049/jimmunol.0802703; Fischer OM, 2004, MOL CELL BIOL, V24, P5172, DOI 10.1128/MCB.24.12.5172-5183.2004; Giovannetti E, 2006, MOL CANCER THER, V5, P1387, DOI 10.1158/1535-7163.MCT-06-0004; Hansel DE, 2003, ANNU REV GENOM HUM G, V4, P237, DOI 10.1146/annurev.genom.4.070802.110341; Ingram JL, 2003, AM J PHYSIOL-LUNG C, V284, pL774, DOI 10.1152/ajplung.00189.2002; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Liu XG, 2007, CANCER RES, V67, P4981, DOI 10.1158/0008-5472.CAN-06-4274; Lorch JH, 2007, CANCER RES, V67, P727, DOI 10.1158/0008-5472.CAN-06-2162; McConkey DJ, 2008, DRUG RESIST UPDATE, V11, P164, DOI 10.1016/j.drup.2008.08.002; Means AL, 2003, GASTROENTEROLOGY, V124, P1020, DOI 10.1053/gast.2003.50150; Milano A, 2007, EUR J CANCER, V43, P1125, DOI 10.1016/j.ejca.2007.01.038; Miyamoto H, 2004, PANCREAS, V28, P38, DOI 10.1097/00006676-200401000-00006; Miyamoto S, 2006, CANCER SCI, V97, P341, DOI 10.1111/j.1349-7006.2006.00188.x; Moore MJ, 2007, J CLIN ONCOL, V25, P1960, DOI 10.1200/JCO.2006.07.9525; Nishi E, 2004, GROWTH FACTORS, V22, P253, DOI 10.1080/08977190400008448; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; RAAB G, 1997, BIOCHIM BIOPHYS ACTA, V1333, P179; Reznik TE, 2008, MOL CANCER RES, V6, P139, DOI 10.1158/1541-7786.MCR-07-0236; Shi YY, 2006, BREAST CANCER RES TR, V100, P33, DOI 10.1007/s10549-006-9232-x; Sloss CM, 2008, CLIN CANCER RES, V14, P5116, DOI 10.1158/1078-0432.CCR-07-4506; Suganuma K, 2003, CANCER SCI, V94, P355, DOI 10.1111/j.1349-7006.2003.tb01446.x; Takenobu H, 2003, J BIOL CHEM, V278, P17255, DOI 10.1074/jbc.M211835200; Wang F, 2007, ONCOGENE, V26, P2006, DOI 10.1038/sj.onc.1209999; Wang F, 2007, CANCER RES, V67, P8486, DOI 10.1158/0008-5472.CAN-07-0498; Zhu KY, 2009, CANCER RES, V69, P1836, DOI 10.1158/0008-5472.CAN-08-4103; Zhu ZW, 2000, BIOCHEM BIOPH RES CO, V273, P1019, DOI 10.1006/bbrc.2000.3033	30	14	16	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAY 27	2010	29	21					3146	3152		10.1038/onc.2010.52	http://dx.doi.org/10.1038/onc.2010.52			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	602IQ	20208558	Green Accepted			2022-12-25	WOS:000278133100011
J	Higashi, T; Ikeda, T; Murakami, T; Shirakawa, R; Kawato, M; Okawa, K; Furuse, M; Kimura, T; Kita, T; Horiuchi, H				Higashi, Tomohito; Ikeda, Tomoyuki; Murakami, Takaaki; Shirakawa, Ryutaro; Kawato, Mitsunori; Okawa, Katsuya; Furuse, Mikio; Kimura, Takeshi; Kita, Toru; Horiuchi, Hisanori			Flightless-I (Fli-I) Regulates the Actin Assembly Activity of Diaphanous-related Formins (DRFs) Daam1 and mDia1 in Cooperation with Active Rho GTPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; DROSOPHILA-MELANOGASTER; CAENORHABDITIS-ELEGANS; EMBRYONIC-DEVELOPMENT; BINDING PROTEIN; GELSOLIN-LIKE; MECHANISM; NUCLEATION; PROFILIN; DOMAINS	Eukaryotic cells dynamically reorganize the actin cytoskeleton to regulate various cellular activities, such as cell shape change, cell motility, cytokinesis, and vesicular transport. Diaphanous-related formins (DRFs), such as Daam1 and mDia1, play central roles in actin dynamics through assembling linear actin filaments. It has been reported that the GTP-bound active Rho binds directly to DRFs and partially unleashes the intramolecular autoinhibition of DRFs. However, whether proteins other than Rho involve the regulation of the actin assembly activity of DRFs has been unclear. Here, we show that Flightless-I (Fli-I), a gelsolin family protein essential for early development, binds directly to Daam1 and mDia1. Fli-I enhances the intrinsic actin assembly activity of Daam1 and mDia1 in vitro and is required for Daam1-induced actin assembly in living cells. Furthermore, Fli-I promotes the GTP-bound active Rho-mediated relief of the autoinhibition of Daam1 and mDia1. Thus, Fli-I is a novel positive regulator of Rho-induced linear actin assembly mediated by DRFs.	[Higashi, Tomohito; Ikeda, Tomoyuki; Murakami, Takaaki; Shirakawa, Ryutaro; Kawato, Mitsunori; Kimura, Takeshi; Kita, Toru; Horiuchi, Hisanori] Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Kyoto 6068507, Japan; [Higashi, Tomohito; Furuse, Mikio] Kobe Univ, Grad Sch Med, Dept Cell Biol, Kobe, Hyogo 6500017, Japan; [Okawa, Katsuya] Kyoto Univ, Grad Sch Med, Frontier Technol Ctr, Kyoto 6068501, Japan; [Shirakawa, Ryutaro; Horiuchi, Hisanori] Tohoku Univ, Inst Dev Aging & Canc, Dept Mol & Cellular Biol, Sendai, Miyagi 9808575, Japan	Kyoto University; Kobe University; Kyoto University; Tohoku University	Horiuchi, H (corresponding author), Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Kyoto 6068507, Japan.	horiuchi@idac.tohoku.ac.jp	Higashi, Tomohito/AHE-7942-2022	Furuse, Mikio/0000-0003-2847-8156; Higashi, Tomohito/0000-0001-5616-1477	Ministry of Education, Culture, Sports, Science, and Technology of Japan [20013201]; Takeda Science Foundation; Novartis Foundation (Japan) for the Promotion of Science; Grants-in-Aid for Scientific Research [22501009] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Novartis Foundation (Japan) for the Promotion of Science(Novartis); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the Ministry of Education, Culture, Sports, Science, and Technology of Japan Research Grant 20013201 (to H. H.), the Takeda Science Foundation (to H. H.), Novartis Foundation (Japan) for the Promotion of Science (to H. H.), and Global COE Program "Center for Frontier Medicine" from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Afshar K, 2000, DEVELOPMENT, V127, P1887; Alberts AS, 2002, CURR BIOL, V12, pR796, DOI 10.1016/S0960-9822(02)01309-X; Alberts AS, 2001, J BIOL CHEM, V276, P2824, DOI 10.1074/jbc.M006205200; CAMPBELL HD, 1993, P NATL ACAD SCI USA, V90, P11386, DOI 10.1073/pnas.90.23.11386; Campbell HD, 2002, MOL CELL BIOL, V22, P3518, DOI 10.1128/MCB.22.10.3518-3526.2002; Christoforidis S, 1999, NATURE, V397, P621, DOI 10.1038/17618; Deng H, 2007, GENETICS, V177, P847, DOI 10.1534/genetics.107.078964; Faix J, 2006, DEV CELL, V10, P693, DOI 10.1016/j.devcel.2006.05.001; Goode BL, 2007, ANNU REV BIOCHEM, V76, P593, DOI 10.1146/annurev.biochem.75.103004.142647; Goshima M, 1999, BIOCHEM BIOPH RES CO, V257, P111, DOI 10.1006/bbrc.1999.0420; Habas R, 2001, CELL, V107, P843, DOI 10.1016/S0092-8674(01)00614-6; Higashi T, 2008, J BIOL CHEM, V283, P8746, DOI 10.1074/jbc.M707839200; Higgs HN, 2005, TRENDS BIOCHEM SCI, V30, P342, DOI 10.1016/j.tibs.2005.04.014; Imamura H, 1997, EMBO J, V16, P2745, DOI 10.1093/emboj/16.10.2745; Kawato M, 2008, J BIOL CHEM, V283, P166, DOI 10.1074/jbc.M705340200; Kohno H, 1996, EMBO J, V15, P6060, DOI 10.1002/j.1460-2075.1996.tb00994.x; Kovar DR, 2003, J CELL BIOL, V161, P875, DOI 10.1083/jcb.200211078; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li F, 2005, J BIOL CHEM, V280, P6986, DOI 10.1074/jbc.M411605200; Li F, 2003, CURR BIOL, V13, P1335, DOI 10.1016/S0960-9822(03)00540-2; Liu R, 2010, BBA-MOL CELL RES, V1803, P207, DOI 10.1016/j.bbamcr.2008.09.016; Liu W, 2008, P NATL ACAD SCI USA, V105, P210, DOI 10.1073/pnas.0707277105; Matusek T, 2006, DEVELOPMENT, V133, P957, DOI 10.1242/dev.02266; Moseley JB, 2005, J BIOL CHEM, V280, P28023, DOI 10.1074/jbc.M503094200; Moseley JB, 2004, MOL BIOL CELL, V15, P896, DOI 10.1091/mbc.E03-08-0621; Ozaki-Kuroda K, 2001, MOL CELL BIOL, V21, P827, DOI 10.1128/MCB.21.3.827-839.2001; Paul AS, 2009, CELL MOTIL CYTOSKEL, V66, P606, DOI 10.1002/cm.20379; PERRIMON N, 1989, GENETICS, V121, P313; Pruyne D, 2002, SCIENCE, V297, P612, DOI 10.1126/science.1072309; Sagot I, 2002, NAT CELL BIOL, V4, P626, DOI 10.1038/ncb834; Straub KL, 1996, J CELL SCI, V109, P263; Watanabe N, 1999, NAT CELL BIOL, V1, P136, DOI 10.1038/11056; Westendorf JJ, 1999, GENE, V232, P173, DOI 10.1016/S0378-1119(99)00127-4; Yamashita M, 2007, GENES CELLS, V12, P1255, DOI 10.1111/j.1365-2443.2007.01132.x	34	30	33	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					16231	16238		10.1074/jbc.M109.079236	http://dx.doi.org/10.1074/jbc.M109.079236			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20223827	Green Published, hybrid			2022-12-25	WOS:000277715900059
J	Radhakrishnan, Y; Busby, WH; Shen, XC; Maile, LA; Clemmons, DR				Radhakrishnan, Yashwanth; Busby, Walker H., Jr.; Shen, Xinchun; Maile, Laura A.; Clemmons, David R.			Insulin-like Growth Factor-I-stimulated Insulin Receptor Substrate-1 Negatively Regulates Src Homology 2 Domain-containing Protein-tyrosine Phosphatase Substrate-1 Function in Vascular Smooth Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTEGRIN-ASSOCIATED PROTEIN; IRS-1 PTB DOMAIN; PHOSPHATIDYLINOSITOL 3-KINASE; SIGNAL-TRANSDUCTION; HIGH GLUCOSE; SERINE PHOSPHORYLATION; SKELETAL-MUSCLE; DOWN-REGULATION; ANGIOTENSIN-II; RAT ADIPOCYTES	Vascular smooth muscle cells maintained in normal (5.6 mM) glucose respond to insulin-like growth factor-I (IGF-I) with increased protein synthesis but do not proliferate. In contrast, hyperglycemia alters responsiveness to IGF-I, resulting in increased SHPS-1 phosphorylation and assembly of a signaling complex that enhances MAPK and phosphatidylinositol 3-kinase pathways. Hyperglycemia also reduces the basal IRS-1 concentration and IGF-I-stimulated IRS-1-linked signaling. To determine if failure to down-regulate IRS-1 alters vascular smooth muscle cell (VSMC) responses to IGF-I, we over-expressed IRS-1 in VSMCs maintained in high glucose. These cultures showed reduced SHPS-1 phosphorylation, transfer of SHP-2 to SHPS-1, and impaired Shc and MAPK phosphorylation and cell proliferation in response to IGF-I. In vitro studies demonstrated that SHPS-1 was a substrate for type I IGF receptor (IGF-IR) and that IRS-1 competitively inhibited SHPS-1 phosphorylation. Exposure of VSMC cultures to a peptide that inhibited IRS-1/IGF-IR interaction showed that IRS-1 binding to IGF-IR impairs SHPS-1 phosphorylation in vivo. IRS-1 also sequestered SHP-2. Expression of an IRS-1 mutant (Y1179F/Y1229F) reduced IRS-1/SHP-2 association, and exposure of cells expressing the mutant to the inhibitory peptide enhanced SHPS-1 phosphorylation and SHP-2 transfer. This result was confirmed by expressing an IRS-1 mutant that had both impaired binding to IGF-IR and to SHP-2 IGF-I increased SHPS-1 phosphorylation, SHP-2 association with SHPS-1, Shc MAPK phosphorylation, and proliferation in cells expressing the mutant. We conclude that IRS-1 is an important factor for maintaining VSMCs in the non-proliferative state and that its down-regulation is a component of the VSMC response to hyperglycemic stress that results in an enhanced response to IGF-I.	[Clemmons, David R.] Univ N Carolina, Div Endocrinol, Sch Med, Dept Med, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Clemmons, DR (corresponding author), Univ N Carolina, Div Endocrinol, Sch Med, Dept Med, CB 7170,8024 Burnett Womack, Chapel Hill, NC 27599 USA.	endo@med.unc.edu			National Institutes of Health [HL56580, AG02331]; NATIONAL INSTITUTE ON AGING [R01AG002331, R37AG002331] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants HL56580 and AG02331.	Baserga R, 2007, CELL CYCLE, V6, P814, DOI 10.4161/cc.6.7.4049; Bifulco G, 2002, J BIOL CHEM, V277, P24306, DOI 10.1074/jbc.M202962200; BLAKESLEY VA, 1995, J BIOL CHEM, V270, P2764, DOI 10.1074/jbc.270.6.2764; Brozinick JT, 2003, DIABETES, V52, P935, DOI 10.2337/diabetes.52.4.935; Buren J, 2003, EUR J ENDOCRINOL, V148, P157, DOI 10.1530/eje.0.1480157; Carvalho E, 2000, MOL CELL BIOCHEM, V206, P7, DOI 10.1023/A:1007009723616; Carvalho E, 1999, FASEB J, V13, P2173, DOI 10.1096/fasebj.13.15.2173; Catalano PM, 2002, AM J PHYSIOL-ENDOC M, V282, pE522, DOI 10.1152/ajpendo.00124.2001; Chu A, 2006, AM J PHYSIOL-CELL PH, V291, pC1014, DOI 10.1152/ajpcell.00191.2006; Eck MJ, 1996, CELL, V85, P695, DOI 10.1016/S0092-8674(00)81236-2; Folli F, 1997, J CLIN INVEST, V100, P2158, DOI 10.1172/JCI119752; Fujioka Y, 1996, MOL CELL BIOL, V16, P6887; GIORGETTI S, 1993, J BIOL CHEM, V268, P7358; GOODYEAR LJ, 1995, J CLIN INVEST, V95, P2195, DOI 10.1172/JCI117909; Gual P, 2005, BIOCHIMIE, V87, P99, DOI 10.1016/j.biochi.2004.10.019; GUSTAFSON TA, 1995, MOL CELL BIOL, V15, P2500; Guvakova MA, 1997, CANCER RES, V57, P2606; Hanke S, 2009, MOL CELL PROTEOMICS, V8, P519, DOI 10.1074/mcp.M800407-MCP200; Hayashi K, 2004, J BIOL CHEM, V279, P40807, DOI 10.1074/jbc.M405100200; Imai Y, 1999, ENDOCRINOLOGY, V140, P4228, DOI 10.1210/en.140.9.4228; Jones JI, 1996, P NATL ACAD SCI USA, V93, P2482, DOI 10.1073/pnas.93.6.2482; Kawabe J, 2000, J HYPERTENS, V18, P1457, DOI 10.1097/00004872-200018100-00014; Kharitonenkov A, 1997, NATURE, V386, P181, DOI 10.1038/386181a0; Kim B, 2009, APOPTOSIS, V14, P665, DOI 10.1007/s10495-009-0331-0; Klein J, 1999, J BIOL CHEM, V274, P34795, DOI 10.1074/jbc.274.49.34795; Lieskovska J, 2006, J BIOL CHEM, V281, P25041, DOI 10.1074/jbc.M602866200; Lima MHM, 2002, ENDOCRINE, V18, P1, DOI 10.1385/ENDO:18:1:01; Ling Y, 2005, MOL BIOL CELL, V16, P3353, DOI 10.1091/mbc.E04-10-0918; Maile LA, 2003, MOL BIOL CELL, V14, P3519, DOI 10.1091/mbc.E03-04-0239; Maile LA, 2002, J BIOL CHEM, V277, P8955, DOI 10.1074/jbc.M109258200; Maile LA, 2008, DIABETES, V57, P2637, DOI 10.2337/db08-0326; Maile LA, 2008, MOL ENDOCRINOL, V22, P1226, DOI 10.1210/me.2007-0552; Maile LA, 2007, ENDOCRINOLOGY, V148, P2435, DOI 10.1210/en.2006-1440; Martin KA, 2007, J BIOL CHEM, V282, P36112, DOI 10.1074/jbc.M703914200; Mitsuhashi H, 2008, J NEUROCHEM, V105, P101, DOI 10.1111/j.1471-4159.2007.05121.x; Motley ED, 2001, CELL MOL BIOL, V47, P1059; MYERS MG, 1993, ENDOCRINOLOGY, V132, P1421, DOI 10.1210/en.132.4.1421; Myers MG, 1998, J BIOL CHEM, V273, P26908, DOI 10.1074/jbc.273.41.26908; Nakajima K, 2000, J BIOL CHEM, V275, P20880, DOI 10.1074/jbc.M905410199; Nam TJ, 2000, ENDOCRINOLOGY, V141, P1100, DOI 10.1210/en.141.3.1100; Neese RA, 2002, P NATL ACAD SCI USA, V99, P15345, DOI 10.1073/pnas.232551499; NOGUCHI T, 1994, MOL CELL BIOL, V14, P6674, DOI 10.1128/MCB.14.10.6674; OBERMEIER A, 1994, EMBO J, V13, P1585, DOI 10.1002/j.1460-2075.1994.tb06421.x; Ochi F, 1997, BIOCHEM BIOPH RES CO, V239, P483, DOI 10.1006/bbrc.1997.7489; Ogawa W, 1998, MOL CELL BIOCHEM, V182, P13, DOI 10.1023/A:1006862807598; PELICCI G, 1992, CELL, V70, P93, DOI 10.1016/0092-8674(92)90536-L; Peruzzi F, 1999, MOL CELL BIOL, V19, P7203, DOI 10.1128/mcb.19.10.7203; Potashnik R, 2003, DIABETOLOGIA, V46, P639, DOI 10.1007/s00125-003-1097-5; PRONK GJ, 1993, J BIOL CHEM, V268, P5748; Radhakrishnan Y, 2008, J BIOL CHEM, V283, P16320, DOI 10.1074/jbc.M801687200; Renstrom F, 2005, ENDOCRINOLOGY, V146, P3044, DOI 10.1210/en.2004-1675; Renstrom F, 2007, METABOLISM, V56, P190, DOI 10.1016/j.metabol.2006.09.012; Rice KM, 1999, BIOCHEM BIOPH RES CO, V255, P614, DOI 10.1006/bbrc.1999.0238; ROSS R, 1971, J CELL BIOL, V50, P172, DOI 10.1083/jcb.50.1.172; ROZAKISADCOCK M, 1992, NATURE, V360, P689, DOI 10.1038/360689a0; Rzucidlo EM, 2007, J VASC SURG, V45, p25A, DOI 10.1016/j.jvs.2007.03.001; SAAD MJA, 1992, J CLIN INVEST, V90, P1839, DOI 10.1172/JCI116060; Sadagurski M, 2007, J CELL PHYSIOL, V213, P519, DOI 10.1002/jcp.21131; SEGATTO O, 1993, ONCOGENE, V8, P2105; Shen XC, 2009, MOL CELL PROTEOMICS, V8, P1539, DOI 10.1074/mcp.M800543-MCP200; Stofega MR, 1998, J BIOL CHEM, V273, P7112, DOI 10.1074/jbc.273.12.7112; SUN XJ, 1991, NATURE, V352, P73, DOI 10.1038/352073a0; Taniyama Y, 2005, ARTERIOSCL THROM VAS, V25, P1142, DOI 10.1161/01.ATV.0000164313.17167.df; TARTAREDECKERT S, 1995, J BIOL CHEM, V270, P23456, DOI 10.1074/jbc.270.40.23456; Tsuda M, 1998, J BIOL CHEM, V273, P13223, DOI 10.1074/jbc.273.21.13223; Vainshtein I, 2001, J BIOL CHEM, V276, P8073, DOI 10.1074/jbc.M008436200; Valverde AM, 2001, MOL CELL BIOL, V21, P2269, DOI 10.1128/MCB.21.7.2269-2280.2001; WANG LM, 1993, SCIENCE, V261, P1591, DOI 10.1126/science.8372354; WHITE MF, 1994, J BIOL CHEM, V269, P1; WOLF G, 1995, J BIOL CHEM, V270, P27407, DOI 10.1074/jbc.270.46.27407; YONEZAWA K, 1994, J BIOL CHEM, V269, P4634; Zhande R, 2002, MOL CELL BIOL, V22, P1016, DOI 10.1128/MCB.22.4.1016-1026.2002; Zhang H, 2000, J BIOL CHEM, V275, P22558, DOI 10.1074/jbc.M000412200; Zhou MM, 1996, NAT STRUCT BIOL, V3, P388, DOI 10.1038/nsb0496-388	74	21	21	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					15682	15695		10.1074/jbc.M109.092270	http://dx.doi.org/10.1074/jbc.M109.092270			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20207740	Green Published, hybrid			2022-12-25	WOS:000277715900003
J	Saini, V; Marchese, A; Majetschak, M				Saini, Vikas; Marchese, Adriano; Majetschak, Matthias			CXC Chemokine Receptor 4 Is a Cell Surface Receptor for Extracellular Ubiquitin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXOGENOUS UBIQUITIN; FACTOR-I; PROTEIN; INJURY; AGONIST; APOPTOSIS; AMD3100; LIGAND; ASSOCIATION; ANTAGONIST	Ubiquitin is one of the most highly conserved proteins in eukaryotes and plays major biological roles as a post-translational protein modifier. Ubiquitin is also a natural constituent of plasma, and several lines of evidence suggest that extracellular ubiquitin is an immune modulator with anti-inflammatory properties. In addition, ubiquitin treatment has been shown to limit inflammation and reduce organ injury in various disease models and species in vivo. However, its mechanism of action is unknown. Here we show that extracellular ubiquitin is a natural CXC chemokine receptor 4 (CXCR4 and CD184) agonist. Extracellular ubiquitin promotes intracellular Ca2+ flux and reduces cAMP levels through a G protein-coupled receptor that signals via a G alpha(i/o) protein in THP1 cells. Toll-like receptor 4 stimulation reduces ubiquitin-binding sites, which enabled identification of four G alpha(i/o) PCRs as ubiquitin receptor candidates. Overexpression of candidate genes in HEK293 cells, gene silencing in THP1 cells, competition binding, and signaling studies with the CXCR4 agonist stromal cell-derived factor-1 alpha (chemokine (CXC motif) ligand 12) and inhibitor AMD3100 identify CXCR4 as a functional ubiquitin receptor. Our finding uncovers a fundamentally new aspect of the role of ubiquitin in biology, has implications for the understanding of CXCR4-mediated events, and is expected to facilitate development of new therapeutic avenues for a variety of diseases.	Loyola Univ, Chicago Stritch Sch Med, Burn & Shock Trauma Inst, Dept Surg, Maywood, IL 60153 USA; [Marchese, Adriano; Majetschak, Matthias] Loyola Univ, Chicago Stritch Sch Med, Dept Mol Pharmacol & Therapeut, Maywood, IL 60153 USA	Loyola University Chicago; Loyola University Chicago	Majetschak, M (corresponding author), 2160 S 1st Ave, Maywood, IL 60153 USA.	mmajetschak@lumc.edu			Deutsche Forschungsgemeinschaft [MA 2474/2-2]; National Institutes of Health [GM075159]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075159] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA026040] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by Deutsche Forschungsgemeinschaft Grant MA 2474/2-2 (to M. M.). This work was also supported in part by National Institutes of Health Grant GM075159 (to A. M.). The therapeutic use of ubiquitin has been patented (United States Patent 7,262,162), and M. M. is an inventor. Based on the results of this work, Loyola University Chicago has filed a provisional patent application (serial number 61/222,267). The authors are the inventors. None of the authors has received any income related to the patent or patent application.	Ahn HC, 2009, EXP NEUROL, V220, P120, DOI 10.1016/j.expneurol.2009.07.031; Akarsu E, 2001, NEPHRON, V88, P280, DOI 10.1159/000046005; ASSEMAN C, 1994, J IMMUNOL METHODS, V173, P93, DOI 10.1016/0022-1759(94)90286-0; Balabanian K, 2005, J BIOL CHEM, V280, P35760, DOI 10.1074/jbc.M508234200; Bayer P, 1998, J MOL BIOL, V280, P275, DOI 10.1006/jmbi.1998.1839; BAYEWITCH M, 1995, FEBS LETT, V375, P143, DOI 10.1016/0014-5793(95)01207-U; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; Bhandari D, 2007, J BIOL CHEM, V282, P36971, DOI 10.1074/jbc.M705085200; Burger JA, 2006, BLOOD, V107, P1761, DOI 10.1182/blood-2005-08-3182; Busillo JM, 2007, BBA-BIOMEMBRANES, V1768, P952, DOI 10.1016/j.bbamem.2006.11.002; Chen WJ, 1998, MOL PHARMACOL, V53, P177, DOI 10.1124/mol.53.2.177; Daino H, 2000, BLOOD, V95, P2577; Di Salvo J, 2000, EUR J PHARMACOL, V409, P143, DOI 10.1016/S0014-2999(00)00846-3; Earle SA, 2005, SURGERY, V138, P431, DOI 10.1016/j.surg.2005.06.026; Earle SA, 2006, TRANSPLANTATION, V82, P1544, DOI 10.1097/01.tp.0000236057.56721.d0; Fricker SP, 2006, BIOCHEM PHARMACOL, V72, P588, DOI 10.1016/j.bcp.2006.05.010; Gao H, 2009, STEM CELLS, V27, P857, DOI 10.1002/stem.23; Garcia-Covarrubias L, 2008, CRIT CARE MED, V36, P979, DOI 10.1097/CCM.0B013E318164E417; GOLDSTEIN G, 1975, P NATL ACAD SCI USA, V72, P11, DOI 10.1073/pnas.72.1.11; Griebenow M, 2007, J NEUROTRAUM, V24, P1529, DOI 10.1089/neu.2007.0306; Gupta SK, 1999, J IMMUNOL, V163, P2368; HAAS AL, 1991, ADV EXP MED BIOL, V307, P191; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hesselgesser J, 1998, J IMMUNOL, V160, P877; Hesselgesser J, 1997, CURR BIOL, V7, P112, DOI 10.1016/S0960-9822(06)00055-8; Hu XF, 2007, CIRCULATION, V116, P654, DOI 10.1161/CIRCULATIONAHA.106.672451; Jaremko L, 2009, BIOPOLYMERS, V91, P423, DOI 10.1002/bip.21160; KAGAN WA, 1977, BLOOD, V50, P275; Kieffer AE, 2003, FASEB J, V17, P776, DOI 10.1096/fj.02-0699fje; Lattin Jane E, 2008, Immunome Res, V4, P5, DOI 10.1186/1745-7580-4-5; Loetscher P, 1998, J BIOL CHEM, V273, P22279, DOI 10.1074/jbc.273.35.22279; Majetschak M, 2006, IMMUNOL CELL BIOL, V84, P59, DOI 10.1111/j.1440-1711.2005.01399.x; Majetschak M, 2005, CRIT CARE MED, V33, P1589, DOI 10.1097/01.CCM.0000169883.41245.23; Majetschak M, 2004, SURGERY, V135, P536, DOI 10.1016/j.surg.2003.09.006; Majetschak M, 2004, J TRAUMA, V56, P991, DOI 10.1097/01.TA.0000127770.29009.5A; Majetschak M, 2003, BLOOD, V101, P1882, DOI 10.1182/blood-2002-03-0918; Majetschak M, 2008, J TRAUMA, V64, P586, DOI 10.1097/TA.0b013e3181641bc5; McCudden CR, 2005, CELL MOL LIFE SCI, V62, P551, DOI 10.1007/s00018-004-4462-3; Meiron M, 2008, J EXP MED, V205, P2643, DOI 10.1084/jem.20080730; PANCRE V, 1991, EUR J IMMUNOL, V21, P2735, DOI 10.1002/eji.1830211113; Rosenkilde MM, 2006, J BIOL CHEM, V281, P13199, DOI 10.1074/jbc.M602245200; Rosenkilde MM, 2004, J BIOL CHEM, V279, P3033, DOI 10.1074/jbc.M309546200; Shyu WC, 2008, J PHARMACOL EXP THER, V324, P834, DOI 10.1124/jpet.107.127746; Singh M, 2010, CARDIOVASC RES, V86, P20, DOI 10.1093/cvr/cvp402; Takada K, 1997, CLIN CHEM, V43, P1188; Takagi M, 1999, ALCOHOL CLIN EXP RES, V23, p76S, DOI 10.1111/j.1530-0277.1999.tb04539.x; Taniguchi Y, 2006, FEBS LETT, V580, P5003, DOI 10.1016/j.febslet.2006.08.015; Xiao QZ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004061; Zhang WB, 2002, J BIOL CHEM, V277, P24515, DOI 10.1074/jbc.M200889200; Zheng H, 2008, ATHEROSCLEROSIS, V201, P36, DOI 10.1016/j.atherosclerosis.2008.02.011	50	125	133	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15566	15576		10.1074/jbc.M110.103408	http://dx.doi.org/10.1074/jbc.M110.103408			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20228059	hybrid, Green Published			2022-12-25	WOS:000277399000075
J	Goranovic, D; Kosec, G; Mrak, P; Fujs, S; Horvat, J; Kuscer, E; Kopitar, G; Petkovic, H				Goranovic, Dusan; Kosec, Gregor; Mrak, Peter; Fujs, Stefan; Horvat, Jaka; Kuscer, Enej; Kopitar, Gregor; Petkovic, Hrvoje			Origin of the Allyl Group in FK506 Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACYL CARRIER PROTEIN; GENE-CLUSTER; STREPTOMYCES-COELICOLOR; RAPAMYCIN BIOSYNTHESIS; ERYTHROMYCIN ANALOGS; POLYKETIDE; GENOME; METHIONINE; DOMAIN; UNIT	FK506 (tacrolimus) is a secondary metabolite with a potent immunosuppressive activity, currently registered for use as immunosuppressant after organ transplantation. FK506 and FK520 are biogenetically related natural products that are synthesized by combined polyketide synthase/nonribosomal peptide synthetase systems. The entire gene cluster for biosynthesis of FK520 from Streptomyces hygroscopicus var. ascomyceticus has been cloned and sequenced. On the other hand, the FK506 gene cluster from Streptomyces sp. MA6548 (ATCC55098) was sequenced only partially, and it was reasonable to expect that additional genes would be required for the provision of substrate supply. Here we report the identification of a previously unknown region of the FK506 gene cluster from Streptomyces tsukubaensis NRRL 18488 containing genes encoding the provision of unusual building blocks for FK506 biosynthesis as well as a regulatory gene. Among others, we identified a group of genes encoding biosynthesis of the extender unit that forms the allyl group at carbon 21 of FK506. Interestingly, we have identified a small independent diketide synthase system involved in the biosynthesis of the allyl group. Inactivation of one of these genes, encoding an unusual ketosynthase domain, resulted in an FK506 nonproducing strain, and the production was restored when a synthetic analog of the allylmalonyl-CoA extender unit was added to the cultivation medium. Based on our results, we propose a biosynthetic pathway for the provision of an unusual five-carbon extender unit, which is carried out by a novel diketide synthase complex.	[Petkovic, Hrvoje] Univ Ljubljana, Biotech Fac, Dept Food Sci & Technol, Chair Biotechnol, SI-1000 Ljubljana, Slovenia; [Goranovic, Dusan; Kosec, Gregor; Fujs, Stefan; Horvat, Jaka; Kuscer, Enej; Petkovic, Hrvoje] Acies Bio Doo, SI-1000 Ljubljana, Slovenia; [Mrak, Peter; Kopitar, Gregor] Lek Pharmaceut Dd, SI-1526 Ljubljana, Slovenia	University of Ljubljana; Novartis	Petkovic, H (corresponding author), Univ Ljubljana, Biotech Fac, Dept Food Sci & Technol, Chair Biotechnol, Jamnikarjeva 101, SI-1000 Ljubljana, Slovenia.	hrvoje.petkovic@bf.uni-lj.si			Government of Slovenia Ministry of Higher Education, Science and Technology [Z4-1054]; Ministry of the Economy [J4-9331, L4-7117]; Public Agency of the Republic of Slovenia; Foreign Investments Agency; European Social Fund [102/2008]	Government of Slovenia Ministry of Higher Education, Science and Technology; Ministry of the Economy; Public Agency of the Republic of Slovenia; Foreign Investments Agency; European Social Fund(European Social Fund (ESF))	This work was supported by Government of Slovenia Ministry of Higher Education, Science and Technology Postdoctoral Fellowship Z4-1054 (to S. F.) and Grants J4-9331 and L4-7117 (to H. P.) funds from the Ministry of the Economy and the Public Agency of the Republic of Slovenia for Entrepreneurship and Foreign Investments Agency and European Social Fund Contract 102/2008 (to G. K.).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Chuck JA, 1997, CHEM BIOL, V4, P757, DOI 10.1016/S1074-5521(97)90314-8; Easton JB, 2004, EXPERT OPIN THER TAR, V8, P551, DOI 10.1517/14728222.8.6.551; Fang A, 1995, FOLIA MICROBIOL, V40, P607, DOI 10.1007/BF02818516; Flett F, 1997, FEMS MICROBIOL LETT, V155, P223, DOI 10.1111/j.1574-6968.1997.tb13882.x; Frykman S, 2001, BIOTECHNOL BIOENG, V76, P303, DOI 10.1002/bit.10086; Gatto GJ, 2005, BIOCHEMISTRY-US, V44, P5993, DOI 10.1021/bi050230w; Graziani EI, 2009, NAT PROD REP, V26, P602, DOI 10.1039/b804602f; Gregory MA, 2006, ORG BIOMOL CHEM, V4, P3565, DOI 10.1039/b608813a; Henne A, 2004, NAT BIOTECHNOL, V22, P547, DOI 10.1038/nbt956; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P14240, DOI 10.1073/pnas.0403302101; Hopwood DA, 1997, CHEM REV, V97, P2465, DOI 10.1021/cr960034i; Husain S, 2002, CLIN INFECT DIS, V35, P53, DOI 10.1086/340867; Iniesta AA, 2006, P NATL ACAD SCI USA, V103, P10935, DOI 10.1073/pnas.0604554103; Ishikawa J, 1999, FEMS MICROBIOL LETT, V174, P251, DOI 10.1111/j.1574-6968.1999.tb13576.x; Jacobsen JR, 1997, SCIENCE, V277, P367, DOI 10.1126/science.277.5324.367; Kato Y, 2002, J AM CHEM SOC, V124, P5268, DOI 10.1021/ja0127483; Kieser T, 2000, PRACTICAL STREPTOMYC, P161; KOLLING R, 1985, J BACTERIOL, V164, P310; KUMAR P, 2007, Patent No. 1751272; Li YL, 2005, J BACTERIOL, V187, P3795, DOI 10.1128/JB.187.11.3795-3799.2005; Lowden PAS, 2001, ANGEW CHEM INT EDIT, V40, P777, DOI 10.1002/1521-3773(20010216)40:4<777::AID-ANIE7770>3.3.CO;2-0; Mamaeva DV, 2005, ACTA CRYSTALLOGR F, V61, P546, DOI 10.1107/S1744309105015447; Mandoli A, 2004, TETRAHEDRON-ASYMMETR, V15, P3233, DOI 10.1016/j.tetasy.2004.08.015; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; McDaniel R, 2005, CHEM REV, V105, P543, DOI 10.1021/cr0301189; McLeod MP, 2006, P NATL ACAD SCI USA, V103, P15582, DOI 10.1073/pnas.0607048103; Motamedi H, 1996, J BACTERIOL, V178, P5243, DOI 10.1128/jb.178.17.5243-5248.1996; Motamedi H, 1998, EUR J BIOCHEM, V256, P528, DOI 10.1046/j.1432-1327.1998.2560528.x; Motamedi H, 1997, EUR J BIOCHEM, V244, P74, DOI 10.1111/j.1432-1033.1997.00074.x; PAIVA NL, 1991, J NAT PROD, V54, P167, DOI 10.1021/np50073a015; Podust LM, 2004, PROTEIN SCI, V13, P255, DOI 10.1110/ps.03384804; Sambrook J, 2001, MOL CLONING LAB MANU; SCHWECKE T, 1995, P NATL ACAD SCI USA, V92, P7839, DOI 10.1073/pnas.92.17.7839; SHAFIEE A, 1993, Patent No. 5264355; SHIRLING E. B., 1966, INT J SYST BACTERIOL, V16, P313; Stassi DL, 1998, P NATL ACAD SCI USA, V95, P7305, DOI 10.1073/pnas.95.13.7305; Staunton J, 2001, NAT PROD REP, V18, P380, DOI 10.1039/a909079g; Wu K, 2000, GENE, V251, P81, DOI 10.1016/S0378-1119(00)00171-2; Yuan J, 2008, J CHROMATOGR B, V868, P34, DOI 10.1016/j.jchromb.2008.04.028; Zhang WW, 2001, J BACTERIOL, V183, P2071, DOI 10.1128/JB.183.6.2071-2080.2001	41	61	67	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14292	14300		10.1074/jbc.M109.059600	http://dx.doi.org/10.1074/jbc.M109.059600			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20194504	Green Published, hybrid			2022-12-25	WOS:000277299700026
J	Kim, MS; Yoon, SK; Bollig, F; Kitagaki, J; Hur, W; Whye, NJ; Wu, YP; Rivera, MN; Park, JY; Kim, HS; Malik, K; Bell, DW; Englert, C; Perantoni, AO; Lee, SB				Kim, Myoung Shin; Yoon, Seung Kew; Bollig, Frank; Kitagaki, Jirouta; Hur, Wonhee; Whye, Nathan J.; Wu, Yun-Ping; Rivera, Miguel N.; Park, Jik Young; Kim, Ho-Shik; Malik, Karim; Bell, Daphne W.; Englert, Christoph; Perantoni, Alan O.; Lee, Sean Bong			A Novel Wilms Tumor 1 (WT1) Target Gene Negatively Regulates the WNT Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CATENIN; CTNNB1 MUTATIONS; SUPPRESSOR; IDENTIFICATION; INHIBITION; IDAX	Mammalian kidney development requires the functions of the Wilms tumor gene WT1 and the WNT/beta-catenin signaling pathway. Recent studies have shown that WT1 negatively regulates WNT/beta-catenin signaling, but the molecular mechanisms by which WT1 inhibits WNT/beta-catenin signaling are not completely understood. In this study, we identified a gene, CXXC5, which we have renamed WID (WT1-induced Inhibitor of Dishevelled), as a novel WT1 transcriptional target that negatively regulates WNT/beta-catenin signaling. WT1 activates WID transcription through the upstream enhancer region. In the developing kidney, Wid and Wt1 are coexpressed in podocytes of maturing nephrons. Structure-function analysis demonstrated that WID interacts with Dishevelled via its C-terminal CXXC zinc finger and Dishevelled binding domains and potently inhibits WNT/beta-catenin signaling in vitro and in vivo. WID is evolutionarily conserved, and ablation of wid in zebrafish embryos with antisense morpholino oligonucleotides perturbs embryonic kidney development. Taken together, our results demonstrate that the WT1 negatively regulates WNT/beta-catenin pathway via its target gene WID and further suggest a role for WID in nephrogenesis.	[Kim, Myoung Shin; Whye, Nathan J.; Wu, Yun-Ping; Park, Jik Young; Kim, Ho-Shik; Lee, Sean Bong] NIDDK, Genet Dev & Dis Branch, NIH, Bethesda, MD 20892 USA; [Yoon, Seung Kew; Hur, Wonhee] Catholic Univ Korea, Dept Internal Med, World Hlth Org,Catholic Res Inst Med Sci, Collaborating Ctr Viral Hepatitis, Seoul 137701, South Korea; [Bollig, Frank; Englert, Christoph] Fritz Lipmann Inst, Leibniz Inst Age Res, D-07745 Jena, Germany; [Kitagaki, Jirouta; Perantoni, Alan O.] NCI, Canc & Dev Biol Lab, NIH, Frederick, MD 21702 USA; [Rivera, Miguel N.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Canc, Charlestown, MA 02129 USA; [Malik, Karim] Univ Bristol, Canc & Leukaemia Childhood Sargent Unit, Dept Cellular & Mol Med, Bristol BS8 1TD, Avon, England; [Bell, Daphne W.] NHGRI, Canc Genet Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Catholic University of Korea; World Health Organization; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Massachusetts General Hospital; University of Bristol; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Lee, SB (corresponding author), NIDDK, Genet Dev & Dis Branch, NIH, 9000 Rockville Pike,Bldg 10,9D11, Bethesda, MD 20892 USA.	seanL@mail.nih.gov		Lee, Sean/0000-0001-6211-3498; Malik, Karim/0000-0002-8965-200X; Englert, Christoph/0000-0002-5931-3189	National Institutes of Health, NIDDK; National Human Genome Research Institute; NCI; Deutsche Forschungsgemeinschaft; 21st Century Frontier Functional Human Genome Project in Korea [FG06-11-11]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200338] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK056002] Funding Source: NIH RePORTER	National Institutes of Health, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); 21st Century Frontier Functional Human Genome Project in Korea; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health grants from the Intramural Research Program, NIDDK (to S. B. L.), National Human Genome Research Institute (to D. W. B.), and NCI (to A.O.P.). This work was also supported by the Deutsche Forschungsgemeinschaft (to C. E.) and Grant FG06-11-11 of the 21st Century Frontier Functional Human Genome Project in Korea (to S.K.Y.).	Abdulkadyrov K. M., 2004, Voprosy Onkologii (St. Petersburg), V50, P668; Andersson T, 2009, J BIOL CHEM, V284, P3672, DOI 10.1074/jbc.M808119200; Chang H, 2008, DEVELOPMENT, V135, P1875, DOI 10.1242/dev.018572; Davies JA, 2004, HUM MOL GENET, V13, P235, DOI 10.1093/hmg/ddh015; Fukuzawa R, 2007, J CLIN PATHOL, V60, P1013, DOI 10.1136/jcp.2006.043083; Guo JK, 2002, HUM MOL GENET, V11, P651, DOI 10.1093/hmg/11.6.651; HABER DA, 1991, P NATL ACAD SCI USA, V88, P9618, DOI 10.1073/pnas.88.21.9618; Hammes A, 2001, CELL, V106, P319, DOI 10.1016/S0092-8674(01)00453-6; Han M, 2007, GENE CHROMOSOME CANC, V46, P909, DOI 10.1002/gcc.20476; Hino SI, 2001, MOL CELL BIOL, V21, P330, DOI 10.1128/MCB.21.1.330-342.2001; Hohenstein P, 2006, HUM MOL GENET, V15, pR196, DOI 10.1093/hmg/ddl196; Katoh M, 2004, INT J ONCOL, V25, P1193; KELLY GM, 1995, DEVELOPMENT, V121, P1787; Kim HS, 2007, J BIOL CHEM, V282, P16278, DOI 10.1074/jbc.M700215200; Kim MKH, 2009, P NATL ACAD SCI USA, V106, P11154, DOI 10.1073/pnas.0901591106; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kohn AD, 2005, CELL CALCIUM, V38, P439, DOI 10.1016/j.ceca.2005.06.022; KREIDBERG JA, 1993, CELL, V74, P679, DOI 10.1016/0092-8674(93)90515-R; Lee SB, 2001, EXP CELL RES, V264, P74, DOI 10.1006/excr.2000.5131; Li CM, 2004, AM J PATHOL, V165, P1943, DOI 10.1016/S0002-9440(10)63246-4; London TBC, 2004, BIOCHEM BIOPH RES CO, V322, P326, DOI 10.1016/j.bbrc.2004.07.113; Maiti S, 2000, CANCER RES, V60, P6288; Major MB, 2007, SCIENCE, V316, P1043, DOI 10.1126/science/1141515; Menke AL, 2003, J PATHOL, V200, P667, DOI 10.1002/path.1390; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Nachtigal MW, 1998, CELL, V93, P445, DOI 10.1016/S0092-8674(00)81172-1; Nusse R, 2007, SCIENCE, V316, P988, DOI 10.1126/science.1143337; Perner B, 2007, DEV BIOL, V309, P87, DOI 10.1016/j.ydbio.2007.06.022; Rivera MN, 2007, SCIENCE, V315, P642, DOI 10.1126/science.1137509; Rivera MN, 2005, NAT REV CANCER, V5, P699, DOI 10.1038/nrc1696; Ruteshouser EC, 2008, GENE CHROMOSOME CANC, V47, P461, DOI 10.1002/gcc.20553; Saadi-Kheddouci S, 2001, ONCOGENE, V20, P5972, DOI 10.1038/sj.onc.1204825; Schedl A, 2007, NAT REV GENET, V8, P791, DOI 10.1038/nrg2205; Simons M, 2005, NAT GENET, V37, P537, DOI 10.1038/ng1552; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Zhang TF, 2003, ANTICANCER RES, V23, P3575	36	77	78	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14585	14593		10.1074/jbc.M109.094334	http://dx.doi.org/10.1074/jbc.M109.094334			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20220130	Green Published, hybrid			2022-12-25	WOS:000277299700055
J	Jeffery, JM; Urquhart, AJ; Subramaniam, VN; Parton, RG; Khanna, KK				Jeffery, J. M.; Urquhart, A. J.; Subramaniam, V. N.; Parton, R. G.; Khanna, K. K.			Centrobin regulates the assembly of functional mitotic spindles	ONCOGENE			English	Article						Centrobin; mitosis; mitotic spindle; spindle assembly checkpoint	CENTROSOME INTEGRITY; CG-NAP; CHECKPOINT; PROTEIN; PHOSPHORYLATION; ANAPHASE; NEK2; NIP2/CENTROBIN; ORGANIZATION; SUBSTRATE	The proper function of the spindle is crucial to the high fidelity of chromosome segregation and is indispensable for tumor suppression in humans. Centrobin is a recently identified centrosomal protein that has a role in stabilizing the microtubule structure. Here we functionally characterize the defects in centrosome integrity and spindle assembly in Centrobin-depleted cells. Centrobin-depleted cells show a range of spindle abnormalities including unfocused poles that are not associated with centrosomes, S-shaped spindles and mini spindles. These cells undergo mitotic arrest and subsequently often die by apoptosis, as determined by live cell imaging. Co-depletion of Mad2 relieves the mitotic arrest, indicating that cells arrest due to a failure to silence the spindle checkpoint in metaphase. Consistent with this, Centrobin-depleted metaphase cells stained positive for BubR1 and BubR1 S676. Staining with a panel of centrosome markers showed a loss of centrosome anchoring to the mitotic spindle. Furthermore, these cells show less cold-stable microtubules and a shorter distance between kinetochore pairs. These results show a requirement of Centrobin in maintaining centrosome integrity, which in turn promotes anchoring of mitotic spindle to the centrosomes. Furthermore, this anchoring is required for the stability of microtubule-kinetochore attachments and biogenesis of tension-ridden and properly functioning mitotic spindle. Oncogene (2010) 29, 2649-2658; doi:10.1038/onc.2010.37; published online 1 March 2010	[Jeffery, J. M.; Urquhart, A. J.; Khanna, K. K.] Queensland Inst Med Res, Signal Transduct Lab, Canc & Cell Biol Div, Brisbane, Qld 4006, Australia; [Subramaniam, V. N.] Queensland Inst Med Res, Membrane Transport Lab, Canc & Cell Biol Div, Brisbane, Qld 4006, Australia; [Parton, R. G.] Univ Queensland, Mol Cell Biol Div, Inst Mol Biosci, Brisbane, Qld, Australia; [Parton, R. G.] Univ Queensland, Ctr Microscopy & Microanal, Brisbane, Qld, Australia	QIMR Berghofer Medical Research Institute; QIMR Berghofer Medical Research Institute; University of Queensland; University of Queensland	Khanna, KK (corresponding author), Queensland Inst Med Res, Signal Transduct Lab, Canc & Cell Biol Div, 300 Herston Rd, Brisbane, Qld 4006, Australia.	kumkum.khanna@qimr.edu.au	Parton, Robert G/C-5673-2009; Khanna, Kum Kum/I-1747-2013; Subramaniam, V. Nathan/A-1901-2010	Parton, Robert G/0000-0002-7494-5248; Subramaniam, V. Nathan/0000-0002-4583-7790; Khanna, Kum Kum/0000-0001-8650-5381	National Health and Research Council of Australia	National Health and Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	We thank Sabine Elowe for the BubR1 S676 antibody, Duane Compton for the NuMA antibody, Andreas Merdes for the PCM1 antibody, Yoshitaka Ono for CG-NAP nd Kendrin antibodies, and Kunsoo Rhee for the myc-Centrobin constructs. We also thank Randy Poon and Uttam Surana for critical reading of the article and helpful suggestions. This work is supported in part by Program grant from the National Health and Research Council of Australia (K Khanna).	Andreassen PR, 2003, MUTAT RES-FUND MOL M, V532, P245, DOI 10.1016/j.mrfmmm.2003.08.020; Casenghi M, 2005, J CELL SCI, V118, P5101, DOI 10.1242/jcs.02622; Chung EN, 2003, NAT CELL BIOL, V5, P748, DOI 10.1038/ncb1022; Dammermann A, 2002, J CELL BIOL, V159, P255, DOI 10.1083/jcb.200204023; Elowe S, 2007, GENE DEV, V21, P2205, DOI 10.1101/gad.436007; Emdad L, 2005, FRONT BIOSCI-LANDMRK, V10, P728; Fabbro M, 2005, DEV CELL, V9, P477, DOI 10.1016/j.devcel.2005.09.003; GAGLIO T, 1995, J CELL BIOL, V131, P693, DOI 10.1083/jcb.131.3.693; Garrett S, 2002, CURR BIOL, V12, P2055, DOI 10.1016/S0960-9822(02)01277-0; Hinchcliffe EH, 2001, SCIENCE, V291, P1547, DOI 10.1126/science.1056866; Jeong Y, 2007, J CELL SCI, V120, P2106, DOI 10.1242/jcs.03458; Khodjakov A, 2001, J CELL BIOL, V153, P237, DOI 10.1083/jcb.153.1.237; Lampson MA, 2005, NAT CELL BIOL, V7, P93, DOI 10.1038/ncb1208; Lawo S, 2009, CURR BIOL, V19, P816, DOI 10.1016/j.cub.2009.04.033; Li Y, 1996, SCIENCE, V274, P246, DOI 10.1126/science.274.5285.246; Meraldi P, 2004, DEV CELL, V7, P45, DOI 10.1016/j.devcel.2004.06.006; Morrison EE, 2001, EUR J CELL BIOL, V80, P749, DOI 10.1078/0171-9335-00221; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Oshimori N, 2006, NAT CELL BIOL, V8, P1095, DOI 10.1038/ncb1474; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; Rapley J, 2005, MOL CELL BIOL, V25, P1309, DOI 10.1128/MCB.25.4.1309-1324.2005; RIEDER CL, 1994, J CELL BIOL, V127, P1301, DOI 10.1083/jcb.127.5.1301; Roh M, 2003, CANCER RES, V63, P8079; Shimizu H, 2009, J CELL SCI, V122, P3145, DOI 10.1242/jcs.052795; Sonn S, 2009, MOL REPROD DEV, V76, P587, DOI 10.1002/mrd.20990; Stucke VM, 2002, EMBO J, V21, P1723, DOI 10.1093/emboj/21.7.1723; Sumara I, 2004, CURR BIOL, V14, P1712, DOI 10.1016/j.cub.2004.09.049; Takahashi M, 2002, MOL BIOL CELL, V13, P3235, DOI 10.1091/mbc.E02-02-0112; Takahashi M, 1999, J BIOL CHEM, V274, P17267, DOI 10.1074/jbc.274.24.17267; Tang CJC, 2009, NAT CELL BIOL, V11, P825, DOI 10.1038/ncb1889; Wong J, 2006, J CELL BIOL, V173, P879, DOI 10.1083/jcb.200511132; Zou CZ, 2005, J CELL BIOL, V171, P437, DOI 10.1083/jcb.200506185	32	29	29	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 6	2010	29	18					2649	2658		10.1038/onc.2010.37	http://dx.doi.org/10.1038/onc.2010.37			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	592DC	20190801				2022-12-25	WOS:000277354600005
J	Ndisang, D; Khan, A; Lorenzato, F; Sindos, M; Singer, A; Latchman, DS				Ndisang, D.; Khan, A.; Lorenzato, F.; Sindos, M.; Singer, A.; Latchman, D. S.			The cellular transcription factor Brn-3a and the smoking-related substance nicotine interact to regulate the activity of the HPV URR in the cervix	ONCOGENE			English	Article						Brn-3a cellular transactivator; nicotine; environmental smoking-related substance; HPV variants; cervical intraepithelial neoplasia	HUMAN-PAPILLOMAVIRUS; INTRAEPITHELIAL NEOPLASIA; GENE-EXPRESSION; CANCER CELLS; FACTOR PLAYS; NONSMOKERS; PROMOTER; SMOKERS; GROWTH; SMEARS	The cellular transcription factor Brn-3a differentially regulates different human papilloma virus (HPV)-16 variants that are associated with different risks of progression to cervical carcinoma in infected humans. The upstream regulatory regions (URRs) of high- and intermediate-risk HPV-16 variants are activated by the cellular transcription factor Brn-3a, whereas the URR of a low-risk HPV-16 variant is not. In this study, we show in transfection assays that Brn-3a and the smoking-related substance nicotine produce stronger responsiveness of the URR of the low- and high-risk variants than with either factor alone, but not the intermediate-risk variant. We determined that this synergistic activity of Brn-3a/nicotine is due to two nucleotide differences in the URR, crucial for oncogenic E6/E7 transactivation. Mutant constructs in which the nucleotide residues were substituted alter Brn-3a/nicotine responsiveness. Importantly, women smokers with high levels of Brn-3a infected with low- or high-risk HPV-16 variants have augmented E6 levels, and were more frequently diagnosed with higher grades of cervical intraepithelial neoplasia (CIN) and cancer, as compared with non-smokers who were infected with similar variants and expressed similar levels of Brn-3a. Therefore, this study defines the specific interplay between the cellular transactivator Brn-3a, the environmental smoking-related substance nicotine and specific HPV variants in cervical carcinogenesis, and thus helps to explain why some women are susceptible to rapid CIN progression and cancer and others are not. Oncogene (2010) 29, 2701-2711; doi:10.1038/onc.2010.33; published online 1 March 2010	[Ndisang, D.; Khan, A.; Sindos, M.; Latchman, D. S.] UCL, Inst Child Hlth, Med Mol Biol Unit, London WC1N 1EH, England; [Lorenzato, F.] Whittington Hosp, Dept Womens & Childrens Hlth, London N19 5NF, England; [Latchman, D. S.] Univ London, London, England	University of London; University College London; University of London; University College London; University of London	Ndisang, D (corresponding author), UCL, Inst Child Hlth, Med Mol Biol Unit, 30 Guilford St,Guilford St, London WC1N 1EH, England.	d.ndisang@ich.ucl.ac.uk			Association for International Cancer Research (AICR)	Association for International Cancer Research (AICR)	This study was funded by the Association for International Cancer Research (AICR).	ANTHONY SG, 2006, CANCER EPIDEM BIOMAR, V15, P2141; Bible JM, 2000, J GEN VIROL, V81, P1517, DOI 10.1099/0022-1317-81-6-1517; BOSCH FX, 1995, JNCI-J NATL CANCER I, V87, P796, DOI 10.1093/jnci/87.11.796; BURGHARDT E, 1991, CANCER-AM CANCER SOC, V67, P1037, DOI 10.1002/1097-0142(19910215)67:4<1037::AID-CNCR2820670429>3.0.CO;2-2; COX MF, 1986, LANCET, V2, P157; CRIPE TP, 1987, EMBO J, V6, P3745, DOI 10.1002/j.1460-2075.1987.tb02709.x; Dasgupta P, 2006, P NATL ACAD SCI USA, V103, P6332, DOI 10.1073/pnas.0509313103; Dasgupta P, 2006, J CLIN INVEST, V116, P2208, DOI 10.1172/JCI28164; Harkness PC, 2002, J NEUROSCI, V22, P10172; HELLBERG D, 1988, AM J OBSTET GYNECOL, V158, P910, DOI 10.1016/0002-9378(88)90093-2; Lane D, 2005, AM J REPROD IMMUNOL, V53, P153, DOI 10.1111/j.1600-0897.2005.00259.x; Lee SA, 2005, CANCER RES, V65, P3072, DOI 10.1158/0008-5472.CAN-04-2865; LILLYCROP KA, 1992, NUCLEIC ACIDS RES, V20, P5093, DOI 10.1093/nar/20.19.5093; MCCANN MF, 1992, CANCER EPIDEM BIOMAR, V1, P125; Miller AB, 2001, LANCET, V357, P1816, DOI 10.1016/S0140-6736(00)05008-X; MORRIS PJ, 1994, MOL CELL BIOL, V14, P6907, DOI 10.1128/MCB.14.10.6907; MORRIS PJ, 1993, NUCLEIC ACIDS RES, V21, P1019, DOI 10.1093/nar/21.4.1019; Ndisang D, 2006, ONCOGENE, V25, P51, DOI 10.1038/sj.onc.1209006; Ndisang D, 2006, GYNECOL ONCOL, V100, P89, DOI 10.1016/j.ygyno.2005.07.109; Ndisang D, 1999, J BIOL CHEM, V274, P28521, DOI 10.1074/jbc.274.40.28521; Ndisang D, 2000, CLIN SCI, V98, P601, DOI 10.1042/CS19990350; Ndisang D, 2001, ONCOGENE, V20, P4899, DOI 10.1038/sj.onc.1204634; Prokopczyk B, 1997, J NATL CANCER I, V89, P868, DOI 10.1093/jnci/89.12.868; Sindos M, 2003, GYNECOL ONCOL, V90, P366, DOI 10.1016/S0090-8258(03)00261-0; Sindos M, 2003, INT J GYNECOL CANCER, V13, P515, DOI 10.1046/j.1525-1438.2003.13303.x; Tsai HT, 2007, GYNECOL ONCOL, V105, P181, DOI 10.1016/j.ygyno.2006.11.012; zur Hausen H, 2009, VIROLOGY, V392, P1, DOI 10.1016/j.virol.2009.06.001	27	5	6	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAY 6	2010	29	18					2701	2711		10.1038/onc.2010.33	http://dx.doi.org/10.1038/onc.2010.33			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	592DC	20190800				2022-12-25	WOS:000277354600010
J	Eltit, JM; Yang, TZ; Li, HL; Molinski, TF; Pessah, IN; Allen, PD; Lopez, JR				Eltit, Jose M.; Yang, Tianzhong; Li, Hongli; Molinski, Tadeusz F.; Pessah, Isaac N.; Allen, Paul D.; Lopez, Jose R.			RyR1-mediated Ca2+ Leak and Ca2+ Entry Determine Resting Intracellular Ca2+ in Skeletal Myotubes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RYANODINE RECEPTOR PROTEIN; CA-2+ RELEASE CHANNEL; MALIGNANT HYPERTHERMIA; SARCOPLASMIC-RETICULUM; MUSCLE FIBERS; CALCIUM; RYR1; MOUSE; EXPRESSION; MODULATION	The control of resting free Ca2+ in skeletal muscle is thought to be a balance of channels, pumps, and exchangers in both the sarcolemma and sarcoplasmic reticulum. We explored these mechanisms using pharmacologic and molecular perturbations of genetically engineered (dyspedic) muscle cells that constitutively lack expression of the skeletal muscle sarcoplasmic reticulum Ca2+ release channels, RyR1 and RyR3. We demonstrate here that expression of RyR1 is responsible for more than half of total resting Ca2+ concentration ([Ca2+](rest)) measured in wild type cells. The elevated [Ca2+](rest) in RyR1-expressing cells is not a result of active gating of the RyR1 channel but instead is accounted for by the RyR1 ryanodine-insensitive Ca2+ leak conformation. In addition, we demonstrate that basal sarcolemmal Ca2+ influx is also governed by RyR1 expression and contributes in the regulation of [Ca2+](rest) in skeletal myotubes.	[Eltit, Jose M.; Yang, Tianzhong; Li, Hongli; Allen, Paul D.; Lopez, Jose R.] Brigham & Womens Hosp, Dept Anesthesiol Perioperat & Pain Med, Boston, MA 02115 USA; [Eltit, Jose M.] Univ Chile, Fac Med, Programa Biol Mol & Celular, Inst Ciencias Biomed, Santiago 7, Chile; [Molinski, Tadeusz F.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Molinski, Tadeusz F.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Pessah, Isaac N.] Univ Calif Davis, Dept Mol Biosci, Sch Vet Med, Davis, CA 95616 USA	Harvard University; Brigham & Women's Hospital; Universidad de Chile; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California Davis	Allen, PD (corresponding author), Brigham & Womens Hosp, Dept Anesthesiol Perioperat & Pain Med, 75 Francis St, Boston, MA 02115 USA.		Pessah, Isaac N/K-7985-2017; Molinski, Tadeusz F/P-2125-2018	Pessah, Isaac N/0000-0002-8149-588X; 	National Institutes of Health [2R01AR43140, 5P01 AR052354]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR043140, P01AR052354] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 2R01AR43140 and 5P01 AR052354 (to P.D.A. and I.N.P.).	BUCK E, 1992, J BIOL CHEM, V267, P23560; Buck ED, 1997, J BIOL CHEM, V272, P7360, DOI 10.1074/jbc.272.11.7360; Fessenden JD, 2001, P NATL ACAD SCI USA, V98, P2865, DOI 10.1073/pnas.041608898; KING J, 1971, J MOL BIOL, V62, P465, DOI 10.1016/0022-2836(71)90148-3; Kurebayashi N, 2001, J PHYSIOL-LONDON, V533, P185, DOI 10.1111/j.1469-7793.2001.0185b.x; Lee EH, 2004, AM J PHYSIOL-CELL PH, V286, pC179, DOI 10.1152/ajpcell.00176.2003; Lopez JR, 2005, AM J PHYSIOL-CELL PH, V288, pC606, DOI 10.1152/ajpcell.00297.2004; LOPEZ JR, 1987, MUSCLE NERVE, V10, P77, DOI 10.1002/mus.880100114; LOPEZ JR, 1983, BIOPHYS J, V43, P1, DOI 10.1016/S0006-3495(83)84316-1; MACK MM, 1994, J BIOL CHEM, V269, P23236; Masuno MN, 2006, J MED CHEM, V49, P4497, DOI 10.1021/jm050708u; MEISSNER G, 1986, J BIOL CHEM, V261, P6300; Moore RA, 1998, J CELL BIOL, V140, P843, DOI 10.1083/jcb.140.4.843; Perez CF, 2005, AM J PHYSIOL-CELL PH, V288, pC640, DOI 10.1152/ajpcell.00407.2004; Pessah IN, 1997, AM J PHYSIOL-CELL PH, V272, pC601, DOI 10.1152/ajpcell.1997.272.2.C601; PESSAH IN, 1991, MOL PHARMACOL, V39, P679; Protasi F, 1998, J CELL BIOL, V140, P831, DOI 10.1083/jcb.140.4.831; Quattrini A, 2001, J NEUROIMMUNOL, V114, P213, DOI 10.1016/S0165-5728(00)00452-5; RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275; Ward CW, 2000, J PHYSIOL-LONDON, V525, P91, DOI 10.1111/j.1469-7793.2000.t01-2-00091.x; Ward CW, 2001, BIOPHYS J, V81, P3216, DOI 10.1016/S0006-3495(01)75957-7; Yang TZ, 2006, ANESTHESIOLOGY, V105, P1164, DOI 10.1097/00000542-200612000-00016; Yang TZ, 2007, AM J PHYSIOL-CELL PH, V292, pC1591, DOI 10.1152/ajpcell.00133.2006; Yang TZ, 2003, J BIOL CHEM, V278, P25722, DOI 10.1074/jbc.M302165200; Zhou JS, 2006, AM J PHYSIOL-CELL PH, V290, pC539, DOI 10.1152/ajpcell.00592.2004	25	38	38	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13781	13787		10.1074/jbc.M110.107300	http://dx.doi.org/10.1074/jbc.M110.107300			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20207743	Green Published, hybrid			2022-12-25	WOS:000276987700053
J	Hyvarinen, J; Hassinen, IE; Sormunen, R; Maki, JM; Kivirikko, KI; Koivunen, P; Myllyharju, J				Hyvarinen, Jaana; Hassinen, Ilmo E.; Sormunen, Raija; Maki, Joni M.; Kivirikko, Kari I.; Koivunen, Peppi; Myllyharju, Johanna			Hearts of Hypoxia-inducible Factor Prolyl 4-Hydroxylase-2 Hypomorphic Mice Show Protection against Acute Ischemia-Reperfusion Injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROXYLASE DOMAIN PROTEIN-2; PROLINE HYDROXYLATION; MYOCARDIAL-ISCHEMIA; OXYGEN HOMEOSTASIS; FACTOR-ALPHA; HIF-ALPHA; FACTOR-I; HIF-1-ALPHA; CARDIOPROTECTION; GENE	Hypoxia-inducible factor (HIF) has a pivotal role in oxygen homeostasis and cardioprotection mediated by ischemic preconditioning. Its stability is regulated by HIF prolyl 4-hydroxylases (HIF-P4Hs), the inhibition of which is regarded as a promising strategy for treating diseases such as anemia and ischemia. We generated a viable Hif-p4h-2 hypomorph mouse line (Hif-p4h-2(gt/gt)) that expresses decreased amounts of wild-type Hif-p4h-2 mRNA: 8% in the heart; 15% in the skeletal muscle; 34-47% in the kidney, spleen, lung, and bladder; 60% in the brain; and 85% in the liver. These mice have no polycythemia and show no signs of the dilated cardiomyopathy or hyperactive angiogenesis observed in mice with broad spectrum conditional Hif-p4h-2 inactivation. We focused here on the effects of chronic Hif-p4h-2 deficiency in the heart. Hif-1 and Hif-2 were stabilized, and the mRNA levels of glucose transporter-1, several enzymes of glycolysis, pyruvate dehydrogenase kinase 1, angiopoietin-2, and adrenomedullin were increased in the Hif-p4h-2(gt/gt) hearts. When isolated Hif-p4h-2(gt/gt) hearts were subjected to ischemia-reperfusion, the recovery of mechanical function and coronary flow rate was significantly better than in wild type, while cumulative release of lactate dehydrogenase reflecting the infarct size was reduced. The preischemic amount of lactate was increased, and the ischemic versus preischemic [CrP]/[Cr] and [ATP] remained at higher levels in Hif-p4h-2(gt/gt) hearts, indicating enhanced glycolysis and an improved cellular energy state. Our data suggest that chronic stabilization of Hif-1 alpha and Hif-2 alpha by genetic knockdown of Hif-p4h-2 promotes cardioprotection by induction of many genes involved in glucose metabolism, cardiac function, and blood pressure.	[Hyvarinen, Jaana; Maki, Joni M.; Kivirikko, Kari I.; Koivunen, Peppi; Myllyharju, Johanna] Univ Oulu, Bioctr Oulu, Oulu Ctr Cell Matrix Res, FIN-90014 Oulu, Finland; [Hyvarinen, Jaana; Hassinen, Ilmo E.; Maki, Joni M.; Kivirikko, Kari I.; Koivunen, Peppi; Myllyharju, Johanna] Univ Oulu, Dept Med Biochem & Mol Biol, FIN-90014 Oulu, Finland; [Sormunen, Raija] Univ Oulu, Dept Pathol, FIN-90014 Oulu, Finland	University of Oulu; University of Oulu; University of Oulu	Myllyharju, J (corresponding author), Univ Oulu, Bioctr Oulu, Oulu Ctr Cell Matrix Res, Aapistie 7,POB 5000, FIN-90014 Oulu, Finland.	johanna.myllyharju@oulu.fi			Academy of Finland [200471, 202469, 120156]; S. Juselius Foundation; FibroGen Inc.	Academy of Finland(Academy of Finland); S. Juselius Foundation; FibroGen Inc.	This work was supported by Health Science Council Grants 200471 and 202469 (to J. M.) and 120156 (to P. K.) from the Academy of Finland and by funds from the S. Juselius Foundation and FibroGen Inc. (to J. M.).	Appelhoff RJ, 2004, J BIOL CHEM, V279, P38458, DOI 10.1074/jbc.M406026200; Aragones J, 2008, NAT GENET, V40, P170, DOI 10.1038/ng.2007.62; Bellot G, 2009, MOL CELL BIOL, V29, P2570, DOI 10.1128/MCB.00166-09; BERGMEYER HU, 1970, METHODEN ENZYMATISCH, P533; BERNT E, 1970, METHODEN ENZYMATISCH, P1724; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Bishop T, 2008, MOL CELL BIOL, V28, P3386, DOI 10.1128/MCB.02041-07; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Burley DS, 2007, HEART FAIL REV, V12, P279, DOI 10.1007/s10741-007-9029-y; Cai Z, 2008, CARDIOVASC RES, V77, P463, DOI 10.1093/cvr/cvm035; Cormier-Regard S, 1998, J BIOL CHEM, V273, P17787, DOI 10.1074/jbc.273.28.17787; Czibik G, 2009, CARDIOVASC RES, V82, P107, DOI 10.1093/cvr/cvp035; Eckle T, 2008, CIRCULATION, V118, P166, DOI 10.1161/CIRCULATIONAHA.107.758516; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Fraisl P, 2009, NAT REV DRUG DISCOV, V8, P139, DOI 10.1038/nrd2761; Halestrap AP, 2009, J BIOENERG BIOMEMBR, V41, P113, DOI 10.1007/s10863-009-9206-x; Huang M, 2008, CIRCULATION, V118, pS226, DOI 10.1161/CIRCULATIONAHA.107.760785; Ivan M, 2002, P NATL ACAD SCI USA, V99, P13459, DOI 10.1073/pnas.192342099; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jurgensen JS, 2004, FASEB J, V18, P1415, DOI 10.1096/fj.04-1605fje; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Karpanen T, 2008, CIRC RES, V103, P1018, DOI 10.1161/CIRCRESAHA.108.178459; Kleinz MJ, 2008, REGUL PEPTIDES, V146, P271, DOI 10.1016/j.regpep.2007.10.002; Koivunen P, 2007, J BIOL CHEM, V282, P30544, DOI 10.1074/jbc.M704988200; Lamprecht W., 1970, METHODEN ENZYMATISCH, P2024; LAMPRECHT W, 1970, METHODEN ENZYMATISCH, P1729; Lim KHH, 2002, J PHYSIOL-LONDON, V545, P961, DOI 10.1113/jphysiol.2002.031484; MATTHEWS JNS, 1990, BRIT MED J, V300, P230, DOI 10.1136/bmj.300.6719.230; Mazzone M, 2009, CELL, V136, P839, DOI 10.1016/j.cell.2009.01.020; Metzen E, 2003, J CELL SCI, V116, P1319, DOI 10.1242/jcs.00318; Minamishima YA, 2008, BLOOD, V111, P3236, DOI 10.1182/blood-2007-10-117812; Minamishima YA, 2009, MOL CELL BIOL, V29, P5729, DOI 10.1128/MCB.00331-09; Myllyharju J, 2008, ANN MED, V40, P402, DOI 10.1080/07853890801986594; Myllyharju J, 2009, CURR PHARM DESIGN, V15, P3878, DOI 10.2174/138161209789649457; Natarajan R, 2006, CIRC RES, V98, P133, DOI 10.1161/01.RES.0000197816.63513.27; NOLL F, 1970, METHODEN ENZYMATISCH, P1433; Oehme F, 2002, BIOCHEM BIOPH RES CO, V296, P343, DOI 10.1016/S0006-291X(02)00862-8; Opie LH, 2002, J MOL CELL CARDIOL, V34, P1077, DOI 10.1006/jmcc.2002.2066; Rankin EB, 2008, ONCOGENE, V27, P5354, DOI 10.1038/onc.2008.160; Ronkainen VP, 2007, FASEB J, V21, P1821, DOI 10.1096/fj.06-7294com; Schafer C, 2001, CARDIOVASC RES, V51, P241, DOI 10.1016/S0008-6363(01)00282-6; Semenza GL, 2007, J BIOENERG BIOMEMBR, V39, P231, DOI 10.1007/s10863-007-9081-2; Semenza GL, 2009, PHYSIOLOGY, V24, P97, DOI 10.1152/physiol.00045.2008; Takeda K, 2008, BLOOD, V111, P3229, DOI 10.1182/blood-2007-09-114561; Takeda K, 2007, CIRCULATION, V116, P774, DOI 10.1161/CIRCULATIONAHA.107.701516; Takeda K, 2006, MOL CELL BIOL, V26, P8336, DOI 10.1128/MCB.00425-06; Voss AK, 1998, DEV DYNAM, V212, P258; WURST W, 2000, GENE TARGETING PRACT, P234; Yoshida T, 2001, CIRCULATION, V103, P1695, DOI 10.1161/01.CIR.103.12.1695; Yu F, 2001, P NATL ACAD SCI USA, V98, P9630, DOI 10.1073/pnas.181341498; Yuan HT, 2009, MOL CELL BIOL, V29, P2011, DOI 10.1128/MCB.01472-08	52	83	89	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13646	13657		10.1074/jbc.M109.084855	http://dx.doi.org/10.1074/jbc.M109.084855			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20185832	Green Published, hybrid			2022-12-25	WOS:000276987700039
J	Zhang, J; Li, HF; Herrup, K				Zhang, Jie; Li, Huifang; Herrup, Karl			Cdk5 Nuclear Localization Is p27-dependent in Nerve Cells IMPLICATIONS FOR CELL CYCLE SUPPRESSION AND CASPASE-3 ACTIVATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIN-DEPENDENT KINASE-5; PREVENTS NEURONAL APOPTOSIS; ALZHEIMERS-DISEASE; PARKINSONS-DISEASE; EXPORT SIGNALS; DEATH; PHOSPHORYLATION; CRM1; P25; NEURODEGENERATION	Initiation of a cell cycle in an adult neuron leads to cell death, placing great importance on the mechanisms that normally suppress the neuronal cell cycle. We have previously shown that the cyclin-dependent kinase Cdk5 is an important part of this process, but only when it is present in the nucleus. We report here that Cdk5 nuclear localization relies on its binding to the cyclin-dependent kinase inhibitor p27. Cdk5 has no intrinsic nuclear localization signal; in the absence of p27, two weak nuclear export signals that bind CRM1 cause it to shuttle to the cytoplasm. When a neuron is subjected to stress, such as exposure to beta-amyloid, the Cdk5-p27 interaction is lost, reducing Cdk5 levels in the nucleus and depriving the neuron of a major cell cycle suppression mechanism. Caspase-3 is activated within hours, but death is not immediate; elevated levels of cytoplasmic Cdk5 appear to retard neuronal death by a mechanism that may involve Bcl2. These data suggest a model in which Cdk5 exerts a double protective function in neurons: chronically suppressing the cell cycle when located in the nucleus and transiently delaying cell death in the cytoplasm.	[Zhang, Jie; Li, Huifang; Herrup, Karl] Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick	Herrup, K (corresponding author), Rutgers State Univ, Dept Cell Biol & Neurosci, 604 Allison Rd, Piscataway, NJ 08854 USA.	herrup@biology.rutgers.edu	Zhang, Jie/A-5426-2010; Herrup, Karl/C-5313-2014	Herrup, Karl/0000-0001-7786-5844	National Institutes of Health [R01NS020591]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS020591] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01NS020591.	ALBANESE C, 1995, J BIOL CHEM, V270, P23589, DOI 10.1074/jbc.270.40.23589; Boehm M, 2002, EMBO J, V21, P3390, DOI 10.1093/emboj/cdf343; Busser J, 1998, J NEUROSCI, V18, P2801; Cheung ZH, 2008, J NEUROSCI, V28, P4872, DOI 10.1523/JNEUROSCI.0689-08.2008; Cicero S, 2005, J NEUROSCI, V25, P9658, DOI 10.1523/JNEUROSCI.1773-05.2005; Cruz JC, 2003, NEURON, V40, P471, DOI 10.1016/S0896-6273(03)00627-5; Cruz JC, 2004, TRENDS MOL MED, V10, P452, DOI 10.1016/j.molmed.2004.07.001; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; Di Giovanni S, 2005, P NATL ACAD SCI USA, V102, P8333, DOI 10.1073/pnas.0500989102; Engel K, 1998, EMBO J, V17, P3363, DOI 10.1093/emboj/17.12.3363; FEDDERSEN RM, 1992, NEURON, V9, P955, DOI 10.1016/0896-6273(92)90247-B; FEDDERSEN RM, 1995, MOL CELL NEUROSCI, V6, P153, DOI 10.1006/mcne.1995.1014; Feddersen RM, 1997, MOL CELL NEUROSCI, V9, P42, DOI 10.1006/mcne.1997.0601; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Fu XR, 2006, J BIOL CHEM, V281, P39014, DOI 10.1074/jbc.M512663200; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; Gong XM, 2003, NEURON, V38, P33, DOI 10.1016/S0896-6273(03)00191-0; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Henderson BR, 2000, EXP CELL RES, V256, P213, DOI 10.1006/excr.2000.4825; Hoglinger GU, 2007, P NATL ACAD SCI USA, V104, P3585, DOI 10.1073/pnas.0611671104; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; Li BS, 2002, EMBO J, V21, P324, DOI 10.1093/emboj/21.3.324; Nikolic M, 1996, GENE DEV, V10, P816, DOI 10.1101/gad.10.7.816; O'Hare MJ, 2005, J NEUROSCI, V25, P8954, DOI 10.1523/JNEUROSCI.2899-05.2005; OssarehNazari B, 1997, SCIENCE, V278, P141, DOI 10.1126/science.278.5335.141; Park DS, 1997, J NEUROSCI, V17, P8975; Park DS, 1997, J NEUROSCI, V17, P1256, DOI 10.1523/jneurosci.17-04-01256.1997; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Tang XL, 2005, J NEUROSCI, V25, P4823, DOI 10.1523/JNEUROSCI.1331-05.2005; TSAI LH, 1993, DEVELOPMENT, V119, P1029; Turner NC, 2008, EMBO J, V27, P1368, DOI 10.1038/emboj.2008.61; VANDENHEUVEL S, 1993, SCIENCE, V262, P2050, DOI 10.1126/science.8266103; Vecchi M, 2001, J CELL BIOL, V153, P1511, DOI 10.1083/jcb.153.7.1511; Vincent I, 1996, J CELL BIOL, V132, P413, DOI 10.1083/jcb.132.3.413; Wang CX, 2006, CELL DEATH DIFFER, V13, P1203, DOI 10.1038/sj.cdd.4401804; Wang L, 2007, J NEUROSCI, V27, P12555, DOI 10.1523/JNEUROSCI.3681-07.2007; West AB, 2005, TRENDS NEUROSCI, V28, P348, DOI 10.1016/j.tins.2005.05.002; Yang Y, 2005, J NEUROSCI, V25, P2522, DOI 10.1523/JNEUROSCI.4946-04.2005; Yang Y, 2003, J NEUROSCI, V23, P2557; Zhang J, 2008, P NATL ACAD SCI USA, V105, P8772, DOI 10.1073/pnas.0711355105; Zhang YP, 2001, SCIENCE, V292, P1910, DOI 10.1126/science.1058637	41	46	47	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					14052	14061		10.1074/jbc.M109.068262	http://dx.doi.org/10.1074/jbc.M109.068262			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20189989	Green Published, hybrid			2022-12-25	WOS:000276987700078
J	Wu, S; Huang, S; Ding, J; Zhao, Y; Liang, L; Liu, T; Zhan, R; He, X				Wu, S.; Huang, S.; Ding, J.; Zhao, Y.; Liang, L.; Liu, T.; Zhan, R.; He, X.			Multiple microRNAs modulate p21Cip1/Waf1 expression by directly targeting its 3 ' untranslated region	ONCOGENE			English	Article						miRNA; p21Cip1/Waf1; 3 ' untranslated region	P21; INHIBITOR; MECHANISM; KINASES; CANCER; GENES	Cyclin-dependent kinase inhibitor 1A ( CDKN1A), also known as p21Cip1/Waf1, is a master downstream effector of tumor suppressors.In this study, we experimentally demonstrate through a high-throughput luciferase reporter screen that p21Cip1/Waf1 can be directly targeted by nearly 28 microRNAs ( miRNAs). The results were further confirmed by a series of mutational analyses and luciferase reporter assays. These 28 miRNAs can substantially inhibit p21Cip1/Waf1 expression, predominantly at translational level. Many of these miRNAs were upregulated in cancers and might serve as modulators of oncogenesis. Furthermore, 8 of these 28 p21-regulating miRNAs are located in the chromosome 19 miRNA cluster, the largest miRNA gene cluster in humans, and they can clearly promote cell proliferation and cell-cycle progression in choriocarcinoma cells. In conclusion, our screening strategy provides an alternative approach to uncovering miRNA modulators of an individual mRNA, and it has identified multiple miRNAs that can suppress p21Cip1/Waf1 expression by directly targeting its 30 untranslated region. Oncogene (2010) 29, 2302-2308; doi: 10.1038/onc.2010.34; published online 1 March 2010	[Wu, S.; Huang, S.; Ding, J.; Zhao, Y.; Liang, L.; He, X.] Shanghai Jiao Tong Univ, Sch Med, Shanghai Canc Inst, State Key Lab Oncogenes & Related Genes, Shanghai 200032, Peoples R China; [Wu, S.; Zhan, R.] Fujian Med Univ, Union Hosp, Fujian Inst Hematol, Dept Hematol, Fuzhou 350001, Peoples R China; [Liu, T.] Shanghai Jiao Tong Univ, Sch Med, Int Peace Matern & Child Hlth Hosp, Shanghai 200032, Peoples R China	Shanghai Jiao Tong University; Fujian Medical University; Shanghai Jiao Tong University	He, X (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Canc Inst, State Key Lab Oncogenes & Related Genes, 25 Ln 2200,Xie Tu Rd, Shanghai 200032, Peoples R China.	deanzhanrong@yahoo.com.cn; xhhe@shsci.org	liang, linhui/AAW-4176-2021; He, Xianghuo/I-1497-2014; Huang, Shenglin/N-9472-2018	He, Xianghuo/0000-0001-8872-668X; Huang, Shenglin/0000-0003-1279-0794	Science & Technology Commission of Shanghai Municipality [07DJ14006]; Ministry of Health of China [2008ZX10002-017]; Ministry of Human Resources and Social Security of China [2007-170]; Doctoral Program of Higher Education of China [200802480076]	Science & Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Ministry of Health of China; Ministry of Human Resources and Social Security of China; Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	We are most grateful for Dr T Didier's gifts of the pWPXL, psPAX2 and pMD2. G lentivirus plasmids. This work was supported by grants from the Science & Technology Commission of Shanghai Municipality (07DJ14006), the Ministry of Health of China (2008ZX10002-017), the Ministry of Human Resources and Social Security of China (2007-170) and the Doctoral Program of Higher Education of China (200802480076).	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Bortolin-Cavaille ML, 2009, NUCLEIC ACIDS RES, V37, P3464, DOI 10.1093/nar/gkp205; Gartel AL, 1999, EXP CELL RES, V246, P280, DOI 10.1006/excr.1998.4319; Gottardo F, 2007, UROL ONCOL-SEMIN ORI, V25, P387, DOI 10.1016/j.urolonc.2007.01.019; Guled M, 2009, GENE CHROMOSOME CANC, V48, P615, DOI 10.1002/gcc.20669; HARPER JW, 1993, CELL, V75, P805; Hausser J, 2009, NUCLEIC ACIDS RES, V37, pW266, DOI 10.1093/nar/gkp412; Ivanovska I, 2008, MOL CELL BIOL, V28, P2167, DOI 10.1128/MCB.01977-07; Jongen-Lavrencic M, 2008, BLOOD, V111, P5078, DOI 10.1182/blood-2008-01-133355; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lionetti M, 2009, BLOOD, V114, pE20, DOI 10.1182/blood-2009-08-237495; Lv K, 2008, BIOCHEM BIOPH RES CO, V374, P101, DOI 10.1016/j.bbrc.2008.06.102; Martin-Caballero J, 2001, CANCER RES, V61, P6234; Petrocca F, 2008, CANCER CELL, V13, P272, DOI 10.1016/j.ccr.2008.02.013; Topley GI, 1999, P NATL ACAD SCI USA, V96, P9089, DOI 10.1073/pnas.96.16.9089; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Wong TS, 2008, CLIN CANCER RES, V14, P2588, DOI 10.1158/1078-0432.CCR-07-0666; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0	23	288	303	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	APR	2010	29	15					2302	2308		10.1038/onc.2010.34	http://dx.doi.org/10.1038/onc.2010.34			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	583NT	20190813				2022-12-25	WOS:000276685200015
J	Merceron, G; Escarguel, G; Angibault, JM; Verheyden-Tixier, H				Merceron, Gildas; Escarguel, Gilles; Angibault, Jean-Marc; Verheyden-Tixier, Helene			Can Dental Microwear Textures Record Inter-Individual Dietary Variations?	PLOS ONE			English	Article							DEER CAPREOLUS-CAPREOLUS; TOOTH MICROWEAR; ENAMEL; HABITAT; PATTERN; ERROR; CAVE	Background: Dental microwear analyses are commonly used to deduce the diet of extinct mammals. Conventional methods rely on the user identifying features within a 2D image. However, recent interdisciplinary research has lead to the development of an advanced methodology that is free of observer error, based on the automated quantification of 3D surfaces by combining confocal microscopy with scale-sensitive fractal analysis. This method has already proved to be very efficient in detecting dietary differences between species. Focusing on a finer, intra-specific scale of analysis, the aim of this study is to test this method's ability to track such differences between individuals from a single population. Methodology/Principal Findings: For the purposes of this study, the 3D molar microwear of 78 individuals from a well-known population of extant roe deer (Capreolus caprelous) is quantified. Multivariate statistical analyses indicate significant seasonal and sexual differences in individual dental microwear design. These are probably the consequence of seasonal variations in fruit, seed and leaf availability, as well as differences in feeding preference between males and females due to distinct energy requirements during periods of rutting, gestation or giving birth. Nevertheless, further investigations using two-block Partial Least-Squares analysis show no strong relationship between individual stomach contents and microwear texture. This is an expected result, assuming that stomach contents are composed of food items ingested during the last few hours whereas dental microwear texture records the physical properties of items eaten over periods of days or weeks. Conclusions/Significance: Microwear 3D scale-sensitive fractal analysis does detect differences in diet ranging from the inter-feeding styles scale to the intra-population between-season and between-sex scales. It is therefore a possible tool, to be used with caution, in the further exploration of the feeding biology and ecology of extinct mammals.	[Merceron, Gildas; Escarguel, Gilles] Univ Lyon 1, CNRS, UMR 5125, F-69622 Villeurbanne, France; [Angibault, Jean-Marc; Verheyden-Tixier, Helene] INRA, Lab Comportement & Ecol Faune Sauvage, F-31326 Castanet Tolosan, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; INRAE	Merceron, G (corresponding author), Univ Lyon 1, CNRS, UMR 5125, Campus La Doua, F-69622 Villeurbanne, France.	gildas.merceron@univ-lyon1.fr	Escarguel, Gilles/C-3297-2011; Merceron, Gildas/C-8648-2012	Merceron, Gildas/0000-0001-5777-7126; Escarguel, Gilles/0000-0003-0985-6369	Singer-Polignac Foundation, Paris France; Fyssen Foundation, Paris, France	Singer-Polignac Foundation, Paris France; Fyssen Foundation, Paris, France	The Singer-Polignac Foundation (http://www.singer-polignac.org/; Paris, France) and the Fyssen Foundation ( http://www.fondation-fyssen.org/; Paris, France) funded this study through postdoctoral fellowships to G. M.. These two funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitchison J., 2003, STAT ANAL COMPOSITIO; Calandra I, 2008, NATURWISSENSCHAFTEN, V95, P831, DOI 10.1007/s00114-008-0391-y; CHAYES F, 1960, J GEOPHYS RES, V65, P4185, DOI 10.1029/JZ065i012p04185; CIBIEN C, 1989, ACTA THERIOL, V34, P111, DOI 10.4098/AT.arch.89-7; CONOVER WJ, 1981, AM STAT, V35, P124, DOI 10.2307/2683975; Cornelis J, 1999, J ZOOL, V248, P195, DOI 10.1111/j.1469-7998.1999.tb01196.x; COVERT HH, 1981, AM J PHYS ANTHROPOL, V55, P331, DOI 10.1002/ajpa.1330550307; Cransac N, 2001, MAMMALIA, V65, P1, DOI 10.1515/mamm.2001.65.1.1; Duncan P, 1998, EUROPEAN ROE DEER: THE BIOLOGY OF SUCCESS, P91; Fincham AG, 1999, J STRUCT BIOL, V126, P270, DOI 10.1006/jsbi.1999.4130; Grine FE, 2002, SCANNING, V24, P144, DOI 10.1002/sca.4950240307; Janis C.M., 1990, P241; Legendre P., 1998, NUMERICAL ECOLOGY, V24; Linnell JDC, 1998, EUROPEAN ROE DEER: THE BIOLOGY OF SUCCESS, P11; Lucas P., 2004, DENT FUNCTIONAL MORP; Lucas PW, 2000, ANN BOT-LONDON, V86, P913, DOI 10.1006/anbo.2000.1261; MAILLARD D, 1987, Gibier Faune Sauvage, V4, P1; Marshall AJ, 2007, INT J PRIMATOL, V28, P1218, DOI 10.1007/s10764-007-9218-5; MCNAUGHTON SJ, 1985, ECOLOGY, V66, P528, DOI 10.2307/1940401; Merceron G, 2004, SMALL RUMINANT RES, V53, P125, DOI [10.1016/j.smallrumres.2003.10.002, 10.1016/j.smallrumers.2003.10.002]; Merceron G, 2007, J HUM EVOL, V53, P331, DOI 10.1016/j.jhevol.2007.04.008; Morellet N, 1999, FOREST ECOL MANAG, V123, P11, DOI 10.1016/S0378-1127(99)00007-9; Oleffe P., 1993, Gibier Faune Sauvage, V10, P303; Ozbek M, 2009, J VET MED SCI, V71, P1273, DOI 10.1292/jvms.001273; Peigne S, 2009, P NATL ACAD SCI USA, V106, P15390, DOI 10.1073/pnas.0907373106; Porto IM, 2009, ARCH ORAL BIOL, V54, P313, DOI 10.1016/j.archoralbio.2009.01.007; Rivals Florent, 2007, Journal of Mammalian Evolution, V14, P182, DOI 10.1007/s10914-007-9044-8; Robinson BW, 1998, AM NAT, V151, P223, DOI 10.1086/286113; Rohlf FJ, 2000, SYST BIOL, V49, P740, DOI 10.1080/106351500750049806; SANDFORD RF, 1993, MATH GEOL, V25, P59, DOI DOI 10.1007/BF00890676; Schubert BW, 2006, PALAEOGEOGR PALAEOCL, V241, P301, DOI 10.1016/j.palaeo.2006.04.004; Scott RS, 2006, J HUM EVOL, V51, P339, DOI 10.1016/j.jhevol.2006.04.006; Scott RS, 2005, NATURE, V436, P693, DOI 10.1038/nature03822; Sokal RR, 1998, BIOMETRY PRINCIPLES; Solounias N, 2002, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2002)366<0001:AITROU>2.0.CO;2; SOLOUNIAS N, 1988, PALEOBIOLOGY, V14, P287, DOI 10.1017/S009483730001201X; TEAFORD MF, 1989, AM J PHYS ANTHROPOL, V80, P391, DOI 10.1002/ajpa.1330800312; TEAFORD MF, 1989, AM J PHYS ANTHROPOL, V80, P447, DOI 10.1002/ajpa.1330800405; TEAFORD MF, 1984, AM J PHYS ANTHROPOL, V64, P191, DOI 10.1002/ajpa.1330640213; Tixier H, 1997, J ZOOL, V242, P229, DOI 10.1111/j.1469-7998.1997.tb05799.x; Tixier H, 1996, REV ECOL-TERRE VIE, V51, P3; TIXIER H, 1996, DETERMINANTS ONTOGEN; Ungar P.S., 2008, TECHNIQUE APPL DENT, P389, DOI DOI 10.1017/CBO9780511542442.017; Ungar PS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002044; Ungar Peter S., 2007, Journal of Mammalian Evolution, V14, P163, DOI 10.1007/s10914-007-9050-x; VINCENT JP, 1994, MAMMALIA, V58, P293, DOI 10.1515/mamm.1994.58.2.293; VINCENT JP, 1995, J ZOOL, V236, P371, DOI 10.1111/j.1469-7998.1995.tb02719.x; WALKER A, 1978, SCIENCE, V201, P908, DOI 10.1126/science.684415; WALKER ARP, 1983, J TROP MED HYG, V86, P201	49	109	110	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2010	5	3							e9542	10.1371/journal.pone.0009542	http://dx.doi.org/10.1371/journal.pone.0009542			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	564EW	20209051	gold, Green Published, Green Submitted			2022-12-25	WOS:000275197100021
J	Albin, KC; Simons, CT				Albin, Kelly C.; Simons, Christopher T.			Psychophysical Evaluation of a Sanshool Derivative (Alkylamide) and the Elucidation of Mechanisms Subserving Tingle	PLOS ONE			English	Article							STIMULUS-INDUCED RECOVERY; ORAL CHEMICAL IRRITANTS; ROOT GANGLION NEURONS; CROSS-DESENSITIZATION; SELF-DESENSITIZATION; TRIGEMINAL CAUDALIS; CAPSAICIN SENSITIZATION; POTASSIUM CHANNELS; SENSORY NEURONS; SALT STIMULI	Previous studies investigated the neural and molecular underpinnings of the tingle sensation evoked by sanshool and other natural or synthetic alkylamides. Currently, we sought to characterize the psychophysical properties associated with administration of these compounds. Like other chemesthetic stimuli, the synthetic tingle analog isobutylalkylamide (IBA) evoked a sensation that was temporally dynamic. Repeated IBA application at short (30 sec) interstimulus intervals (ISI) resulted in a tingle sensation that increased across trials. Application at longer ISIs (similar to 30 min) resulted in a sensation of decreased intensity consistent with self-desensitization. Prior treatment with the TRPV1 or TRPA1 agonists, capsaicin and mustard oil did not cross-desensitize the tingle sensation evoked by IBA suggesting that neither TRPV1 nor TRPA1 participate in the transduction mechanism sub-serving tingle. When evaluated over 30-min time period, lingual IBA evoked a sensation that was described initially as tingling and pungent but after approximately 15 min, as a cooling sensation. Further, we found that the sensation evoked by lingual IBA was potentiated by simultaneous application of cold (0 degrees C) and cool (21 degrees C) thermal stimuli but was unaffected by warm (33 degrees C) and hot (41 degrees C) temperatures. Finally, to test the hypothesis that the tingling sensation is subserved by the activation of mechanosensitve fibers, we evaluated lingual tactile thresholds in the presence and absence of lingual IBA. The presence of IBA significantly raised lingual tactile thresholds, whereas capsaicin did not, identifying a role for mechanosensitive fibers in conveying the tingle sensation evoked by sanshool-like compounds. Collectively, these results show that lingual alkylamide evokes a complex sensation that is temporally dynamic and consistent with in vitro and in vivo experiments suggesting these compounds activate mechanosensitve neurons via blockade of KCNK two-pore potassium channels to induce the novel tingling sensation.	[Albin, Kelly C.; Simons, Christopher T.] Givaudan Flavors Corp, Cincinnati, OH USA; [Albin, Kelly C.] Univ Calif San Diego, Sch Med, San Diego, CA 92103 USA	Givaudan SA; University of California System; University of California San Diego	Albin, KC (corresponding author), Givaudan Flavors Corp, Cincinnati, OH USA.	christopher.simons@givaudan.com	Simons, Christopher/B-3036-2013		Givaudan Flavors Corporation	Givaudan Flavors Corporation	Funding for this work came from Givaudan Flavors Corporation. The authors are paid employees of Givaudan Flavors Corp., and they participated in study design, data collection, decision to publish and preparation of the manuscript.	Albin KC, 2008, CHEM SENSES, V33, P3, DOI 10.1093/chemse/bjm056; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Bartoshuk LM, 2004, PHYSIOL BEHAV, V82, P109, DOI 10.1016/j.physbeh.2004.02.033; Bautista DM, 2008, NAT NEUROSCI, V11, P772, DOI 10.1038/nn.2143; BROWN J, 1974, BRIT J PSYCHOL, V65, P13, DOI 10.1111/j.2044-8295.1974.tb02766.x; Bryant BP, 1999, BRAIN RES, V842, P452, DOI 10.1016/S0006-8993(99)01878-8; Carstens E, 2002, FOOD QUAL PREFER, V13, P431, DOI 10.1016/S0950-3293(01)00067-2; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Cervero F, 1996, PAIN, V68, P13, DOI 10.1016/S0304-3959(96)03165-X; CHARD PS, 1995, NEUROSCIENCE, V65, P1099, DOI 10.1016/0306-4522(94)00548-J; CHOLEWINSKI A, 1993, NEUROSCIENCE, V55, P1015, DOI 10.1016/0306-4522(93)90315-7; CLARK CC, 1994, CHEM SENSES, V19, P583, DOI 10.1093/chemse/19.6.583; Cliff MA, 1996, PHYSIOL BEHAV, V59, P487, DOI 10.1016/0031-9384(95)02089-6; Dessirier JM, 1997, CHEM SENSES, V22, P483, DOI 10.1093/chemse/22.5.483; Dessirier JM, 2001, PHYSIOL BEHAV, V72, P317, DOI 10.1016/S0031-9384(00)00412-1; Dessirier JM, 2000, CHEM SENSES, V25, P769, DOI 10.1093/chemse/25.6.769; Dessirier JM, 2000, J NEUROPHYSIOL, V84, P1851, DOI 10.1152/jn.2000.84.4.1851; Galopin CC, 2004, ACS SYM SER, V867, P139; GREEN BG, 1989, NEUROSCI LETT, V107, P173, DOI 10.1016/0304-3940(89)90812-4; GREEN BG, 1991, PHYSIOL BEHAV, V49, P501, DOI 10.1016/0031-9384(91)90271-O; Green BG, 2005, CHEM SENSES, V30, pI201, DOI 10.1093/chemse/bjh184; GREEN BG, 1985, PHYSIOL BEHAV, V35, P427, DOI 10.1016/0031-9384(85)90319-1; GREEN BG, 1986, CHEM SENSES, V11, P371, DOI 10.1093/chemse/11.3.371; GREEN BG, 1988, PERCEPT PSYCHOPHYS, V44, P108, DOI 10.3758/BF03208702; Hollander M, 1973, NONPARAMETRIC STAT M; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; KARRER T, 1991, PHYSIOL BEHAV, V49, P757, DOI 10.1016/0031-9384(91)90315-F; Kauppila T, 1998, BRAIN RES, V797, P361, DOI 10.1016/S0006-8993(98)00431-4; KOLTZENBURG M, 1992, PAIN, V51, P207, DOI 10.1016/0304-3959(92)90262-A; Koo JY, 2007, EUR J NEUROSCI, V26, P1139, DOI 10.1111/j.1460-9568.2007.05743.x; Lawless H. T., 1988, SENSORY EVALUATION F; LAWLESS HT, 1988, PERCEPT PSYCHOPHYS, V43, P72, DOI 10.3758/BF03208975; Lenfant F, 2009, APPETITE, V52, P659, DOI 10.1016/j.appet.2009.03.003; Liu L, 1996, AM J PHYSIOL-CELL PH, V270, pC1807, DOI 10.1152/ajpcell.1996.270.6.C1807; Liu L, 1996, J NEUROPHYSIOL, V75, P1503, DOI 10.1152/jn.1996.75.4.1503; Liu L, 2000, PHYSIOL BEHAV, V69, P177, DOI 10.1016/S0031-9384(00)00200-6; Madrid R, 2009, J NEUROSCI, V29, P3120, DOI 10.1523/JNEUROSCI.4778-08.2009; Noel J, 2009, EMBO J, V28, P1308, DOI 10.1038/emboj.2009.57; OMAHONY M, 1992, J SENS STUD, V7, P147; Pineau N, 2009, FOOD QUAL PREFER, V20, P450, DOI 10.1016/j.foodqual.2009.04.005; Prescott J, 1996, PHYSIOL BEHAV, V60, P617, DOI [10.1016/S0031-9384(96)80039-4, 10.1016/0031-9384(96)00064-9]; Prescott J, 1996, PHYSIOL BEHAV, V60, P1473, DOI 10.1016/S0031-9384(96)00248-X; RAJA SN, 1988, ANESTHESIOLOGY, V68, P571, DOI 10.1097/00000542-198804000-00016; Ramsewak RS, 1999, PHYTOCHEMISTRY, V51, P729, DOI 10.1016/S0031-9422(99)00101-6; RAVINDRAN PN, 2004, HDB HERBS SPICES, V2, P53; Riera CE, 2009, BRIT J PHARMACOL, V157, P1398, DOI 10.1111/j.1476-5381.2009.00307.x; Sawyer CM, 2009, J NEUROPHYSIOL, V101, P1742, DOI 10.1152/jn.91311.2008; Shin WJ, 2003, ANESTH ANALG, V96, P1340, DOI 10.1213/01.ANE.0000055365.31940.0A; Simons CT, 2004, PAIN, V110, P64, DOI 10.1016/j.pain.2004.03.009; Simons CT, 2003, CHEM SENSES, V28, P459, DOI 10.1093/chemse/28.6.459; Simons CT, 1999, J NEUROSCI, V19, P8134; SIMONS CT, 2008, AM CHEM SOC S SERIES, V979; STEVENS DA, 1987, PHYSIOL BEHAV, V39, P63, DOI 10.1016/0031-9384(87)90344-1; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Sudo S, 2003, BRAIN RES, V969, P237, DOI 10.1016/S0006-8993(03)02341-2; Sudo S, 2002, PAIN, V98, P277, DOI 10.1016/S0304-3959(02)00025-8; Sugai E, 2005, BIOSCI BIOTECH BIOCH, V69, P1951, DOI 10.1271/bbb.69.1951; Willis WD, 2009, EXP BRAIN RES, V196, P5, DOI 10.1007/s00221-009-1760-2; Yang XG, 2008, J AGR FOOD CHEM, V56, P1689, DOI 10.1021/jf0728101; Zanotto KL, 2007, J NEUROPHYSIOL, V97, P966, DOI 10.1152/jn.00996.2006	60	36	41	5	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2010	5	3							e9520	10.1371/journal.pone.0009520	http://dx.doi.org/10.1371/journal.pone.0009520			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	562OZ	20209090	gold, Green Submitted, Green Published			2022-12-25	WOS:000275063400024
J	Bath, ML				Bath, Mary L.			Inhibition of In Vitro Fertilizing Capacity of Cryopreserved Mouse Sperm by Factors Released by Damaged Sperm, and Stimulation by Glutathione	PLOS ONE			English	Article							ZONA-PELLUCIDA; SPERMATOZOA; SULFHYDRYL; OOCYTES; ABILITY; CELLS; SEMEN; MICE	Background: In vitro fertilization (IVF) of eggs by frozen and thawed C57BL/6J mouse sperm is inhibited by dead sperm and enhanced by preincubation of the sperm in calcium-free medium. In other species, the presence of sperm killed by freezing and thawing has been associated with the generation of hydrogen peroxide. Methodology/Principal Findings: The proportion of eggs fertilized by cryopreserved C57BL/6J mouse sperm was increased significantly by increasing the volume of fertilization medium in which sperm and eggs were coincubated. Enhanced fertilization occurred even though the concentration of potentially fertile sperm was decreased fivefold. This suggested that if a putative soluble factor was inhibiting fertilization, dilution of that factor, but not the sperm, should increase the fertilization rate. This was achieved by coincubation of the gametes in cell culture inserts (Transwells (R)) that during incubation were transferred progressively to wells containing fresh fertilization medium. Fertilization rates using inserts were high (66.6 +/- 2.4% versus 27.3% +/- 2.8% in wells alone). On the assumption that the soluble factor could be H(2)O(2), reduced glutathione was added to the fertilization medium. This enhanced fertilization rate significantly (76.6% +/- 2.0% versus 21.2% +/- 1.9%), while addition of oxidized glutathione did not (82.7% +/- 6.5% with reduced glutathione; 44.5 +/- 8.8% with oxidized glutathione; 47.8% +/- 12.1% with no glutathione). Positive effects of reduced glutathione on IVF were also seen with frozen 129S1, FVB, and C3H sperm, and sperm from two lines of genetically modified C57BL/6J mice. Conclusions/Significance: IVF in cell culture inserts and addition of glutathione to fertilization medium significantly increased the proportion of eggs fertilized by cryopreserved mouse sperm from four inbred strains, suggesting that reactive oxygen species generated during fertilization inhibit fertilization. The modified IVF techniques developed here enhance the feasibility and efficiency of using cryopreserved sperm from genetically modified lines of inbred mice.	Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Div Mol Genet Canc, Parkville, Vic 3050, Australia	Royal Melbourne Hospital; Walter & Eliza Hall Institute	Bath, ML (corresponding author), Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Div Mol Genet Canc, Parkville, Vic 3050, Australia.	bath@wehi.edu.au			Australian National Health and Medical Research Council [461221]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was carried out under Australian National Health and Medical Research Council Program grant #461221 (http://www.nhmrc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey JL, 2000, J ANDROL, V21, P1; Ball BA, 2001, AM J VET RES, V62, P508, DOI 10.2460/ajvr.2001.62.508; Bath ML, 2003, BIOL REPROD, V68, P19, DOI 10.1095/biolreprod.102.007344; de Lamirande E, 1998, FREE RADICAL BIO MED, V25, P803, DOI 10.1016/S0891-5849(98)00156-7; De Lamirande E, 2003, FREE RADICAL BIO MED, V35, P1271, DOI 10.1016/S0891-5849(03)00501-X; Fan ZQ, 2009, LAB ANIM-UK, V43, P72, DOI 10.1258/la.2008.008029; Franco R., 2007, Archives of Physiology and Biochemistry, V113, P234, DOI 10.1080/13813450701661198; GORDON JW, 1986, J EXP ZOOL, V239, P347, DOI 10.1002/jez.1402390306; GREVE JM, 1985, J MOL BIOL, V181, P253, DOI 10.1016/0022-2836(85)90089-0; Kasai S, 2003, DEV BIOL, V264, P202, DOI 10.1016/S0012-1606(03)00400-7; Kim IH, 1999, THERIOGENOLOGY, V52, P537, DOI 10.1016/S0093-691X(99)00150-8; Kito S, 2005, ZYGOTE, V13, P145, DOI 10.1017/S0967199405003205; Lane M, 2004, LAB GUIDE MAMMALIAN, P24; Liu L, 2009, J AM ASSOC LAB ANIM, V48, P39; Luberda Zofia, 2005, Reprod Biol, V5, P5; Nakagata N, 1997, BIOL REPROD, V57, P1050, DOI 10.1095/biolreprod57.5.1050; National Health and Medical Research Council, 2004, AUSTR COD PRACT CAR; Nishizono H, 2004, BIOL REPROD, V71, P973, DOI 10.1095/biolreprod.103.024422; Ostermeier GC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002792; SHANNON P, 1972, J DAIRY SCI, V55, P614, DOI 10.3168/jds.S0022-0302(72)85544-9; Smith DP, 2005, ONCOGENE, V24, P3544, DOI 10.1038/sj.onc.1208399; Suzuki-Migishima R, 2009, J REPROD DEVELOP, V55, P386, DOI 10.1262/jrd.20163; Taguma K, 2009, EXP ANIM TOKYO, V58, P395, DOI 10.1538/expanim.58.395; Takeo T, 2008, BIOL REPROD, V78, P546, DOI 10.1095/biolreprod.107.065359; Talevi R, 2007, BIOL REPROD, V76, P728, DOI 10.1095/biolreprod.106.056028; VASUDEVAN K, 2009, TRANSGENIC RES; Yoda Y., 1971, JAPANESE J ANIM REPR, V16, P147, DOI [DOI 10.1262/JRD1955.16.147, 10.1262/jrd1955.16.147]	27	42	43	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2010	5	2							e9387	10.1371/journal.pone.0009387	http://dx.doi.org/10.1371/journal.pone.0009387			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SX	20195370	Green Published, gold, Green Submitted			2022-12-25	WOS:000274924200014
J	Eckenrode, EF; Yang, J; Velmurugan, GV; Foskett, JK; White, C				Eckenrode, Emily F.; Yang, Jun; Velmurugan, Gopal V.; Foskett, J. Kevin; White, Carl			Apoptosis Protection by Mcl-1 and Bcl-2 Modulation of Inositol 1,4,5-Trisphosphate Receptor-dependent Ca2+ Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL PROLIFERATION; OLIGOMERIZES BAK; CALCIUM-RELEASE; BCL-X(L); ER; TRANSDUCTION; INVOLVEMENT; ACTIVATION; PROTEINS; BINDING	Members of the Bcl-2 protein family play a central role in the regulation of apoptosis. An interaction between anti-apoptotic Bcl-x(L) and the endoplasmic reticulum (ER)-localized inositol trisphosphate receptor Ca2+ release channel (InsP(3)R) enables Bcl-x(L) to be fully efficacious as an anti-apoptotic mediator (White, C., Li, C., Yang, J., Petrenko, N. B., Madesh, M., Thompson, C. B., and Foskett, J. K. (2005) Nat. Cell Biol. 7, 1021-1028). Physiologically, Bcl-x(L) binds to the InsP(3)R to enhance its gating and Ca2+ signaling. Here we have discovered that structurally related proteins Bcl-2 and Mcl-1 function similarly. Bcl-2, Mcl-1 and Bcl-x(L) bind with comparable affinity to the carboxyl termini of all three mammalian InsP(3)R isoforms with important functional consequences. Stable expression of Bcl-2 or Mcl-1 lowered ER Ca2+ content and enhanced the rate of InsP(3)-mediated Ca2+ release in response to submaximal InsP(3) stimulation in permeabilized wild-type DT40 cells but not in cells lacking InsP(3)R. In addition, expression of either Bcl-2 or Mcl-1 enhanced spontaneous InsP(3)R-dependent Ca2+ oscillations and spiking in intact cells in the absence of agonist stimulation. Bcl-2- and Mcl-1-mediated protection from apoptosis induced by staurosporine or etoposide was enhanced in cells expressing InsP(3)R, demonstrating that their interactions with InsP(3)R enable Bcl-2 and Mcl-1 to be fully efficacious anti-apoptotic mediators. Our data suggest a molecular mechanism that is shared by several anti-apoptotic Bcl-2 proteins that provides apoptosis resistance by direct interactions at the ER with the InsP(3)R that impinges on cellular Ca2+ homeostasis.	[Eckenrode, Emily F.; Velmurugan, Gopal V.; White, Carl] Rosalind Franklin Univ Med & Sci, Dept Physiol & Biophys, N Chicago, IL 60064 USA; [Yang, Jun; Foskett, J. Kevin] Univ Penn, Dept Physiol, Philadelphia, PA 19104 USA; [Foskett, J. Kevin] Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	Rosalind Franklin University Medical & Science; University of Pennsylvania; University of Pennsylvania	White, C (corresponding author), Rosalind Franklin Univ Med & Sci, Dept Physiol & Biophys, 3333 Green Bay Rd, N Chicago, IL 60064 USA.	carl.white@rosalindfranklin.edu	Foskett, Kevin/R-2549-2019	White, Carl/0000-0002-0535-6968	National Institutes of Health [GM/DK56328]; Schweppe Foundation; Rosalind Franklin University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056328] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Schweppe Foundation; Rosalind Franklin University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM/DK56328 (to J. K. F.) and funding from the Schweppe Foundation and Rosalind Franklin University (to C. W.).	Betzenhauser MJ, 2008, METHODS, V46, P177, DOI 10.1016/j.ymeth.2008.09.014; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Chen R, 2004, J CELL BIOL, V166, P193, DOI 10.1083/jcb.200309146; Danial NN, 2007, CLIN CANCER RES, V13, P7254, DOI 10.1158/1078-0432.CCR-07-1598; Day CL, 2005, J BIOL CHEM, V280, P4738, DOI 10.1074/jbc.M411434200; Decaudin D, 1997, CANCER RES, V57, P62; Distelhorst CW, 2004, ONCOGENE, V23, P2875, DOI 10.1038/sj.onc.1207519; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; Fadeel B, 2005, J INTERN MED, V258, P479, DOI 10.1111/j.1365-2796.2005.01570.x; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; Foyouzi-Youssefi R, 2000, P NATL ACAD SCI USA, V97, P5723, DOI 10.1073/pnas.97.11.5723; Gyorgy H, 2006, CELL CALCIUM, V40, P553, DOI 10.1016/j.ceca.2006.08.016; Hammerman PS, 2004, TRENDS BIOCHEM SCI, V29, P586, DOI 10.1016/j.tibs.2004.09.008; Hanson CJ, 2008, CELL CALCIUM, V44, P324, DOI 10.1016/j.ceca.2008.01.003; Jones RG, 2007, IMMUNITY, V27, P268, DOI 10.1016/j.immuni.2007.05.023; Khan MT, 2007, J BIOL CHEM, V282, P32983, DOI 10.1074/jbc.M705183200; Korfali N, 2004, J BIOL CHEM, V279, P1030, DOI 10.1074/jbc.M306277200; Korsmeyer SJ, 2000, CELL DEATH DIFFER, V7, P1166, DOI 10.1038/sj.cdd.4400783; Li C, 2007, P NATL ACAD SCI USA, V104, P12565, DOI 10.1073/pnas.0702489104; Li JA, 2006, J AM SOC NEPHROL, V17, P1848, DOI 10.1681/ASN.2005080894; Palmer AE, 2004, P NATL ACAD SCI USA, V101, P17404, DOI 10.1073/pnas.0408030101; Pinton P, 2006, CELL DEATH DIFFER, V13, P1409, DOI 10.1038/sj.cdd.4401960; Pinton P, 2000, J CELL BIOL, V148, P857, DOI 10.1083/jcb.148.5.857; Rong YP, 2008, MOL CELL, V31, P255, DOI 10.1016/j.molcel.2008.06.014; Rong YP, 2009, P NATL ACAD SCI USA, V106, P14397, DOI 10.1073/pnas.0907555106; Sugawara H, 1997, EMBO J, V16, P3078, DOI 10.1093/emboj/16.11.3078; Wei MC, 2000, GENE DEV, V14, P2060; White C, 2005, NAT CELL BIOL, V7, P1021, DOI 10.1038/ncb1302; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Zhong F, 2006, J CELL BIOL, V172, P127, DOI 10.1083/jcb.200506189	31	132	139	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13678	13684		10.1074/jbc.M109.096040	http://dx.doi.org/10.1074/jbc.M109.096040			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20189983	hybrid, Green Published			2022-12-25	WOS:000276987700042
J	Wu, YY; Williams, M; Bernard, S; Driouich, A; Showalter, AM; Faik, A				Wu, Yingying; Williams, Matthew; Bernard, Sophie; Driouich, Azeddine; Showalter, Allan M.; Faik, Ahmed			Functional Identification of Two Nonredundant Arabidopsis alpha(1,2)Fucosyltransferases Specific to Arabinogalactan Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUCOSE-DEFICIENT MUTANT; CELL WALL BIOSYNTHESIS; GOLGI-APPARATUS; XYLOGLUCAN OLIGOSACCHARIDES; GROWTH; GLYCOPROTEINS; GENES; POLYSACCHARIDE; TRANSFERASES; THALIANA	Virtually nothing is known about the mechanisms and enzymes responsible for the glycosylation of arabinogalactan proteins (AGPs). The glycosyltransferase 37 family contains plant-specific enzymes, which suggests involvement in plant-specific organs such as the cell wall. Our working hypothesis is that AtFUT4 and AtFUT6 genes encode alpha(1,2)fucosyltransferases (FUTs) for AGPs. Multiple lines of evidence support this hypothesis. First, overexpression of the two genes in tobacco BY2 cells, known to contain nonfucosylated AGPs, resulted in a staining of transgenic cells with eel lectin, which specifically binds to terminal alpha-linked fucose. Second, monosaccharide analysis by high pH anion exchange chromatography and electrospray ionization mass spectrometry indicated the presence of fucose in AGPs from transgenic cell lines but not in AGPs from wild type cells. Third, detergent extracts from microsomal membranes prepared from transgenic lines were able to fucosylate, in vitro, purified AGPs from BY2 wild type cells. Susceptibility of [C-14]fucosylated AGPs to alpha(1,2)fucosidase, and not to alpha(1,3/4)fucosidase, indicated that an alpha(1,2) linkage is formed. Furthermore, dearabinosylated AGPs were not substrate acceptors for these enzymes, indicating that arabinosyl residues represent the fucosylation sites on these molecules. Testing of several polysaccharides, oligosaccharides, and glycoproteins as potential substrate acceptors in the fucosyl transfer reactions indicated that the two enzymes are specific for AGPs but are not functionally redundant because they differentially fucosylate certain AGPs. AtFUT4 and AtFUT6 are the first enzymes to be characterized for AGP glycosylation and further our understanding of cell wall biosynthesis.	[Wu, Yingying; Williams, Matthew; Showalter, Allan M.; Faik, Ahmed] Ohio Univ, Dept Environm & Plant Biol, Athens, OH 45701 USA; [Showalter, Allan M.; Faik, Ahmed] Ohio Univ, Mol & Cellular Biol Program, Athens, OH 45701 USA; [Bernard, Sophie; Driouich, Azeddine] Univ Rouen, Lab Glycobiol & Matrice Extracellulaire Vegetale, UFR Sci & Tech, UPRES EA 4358,IFRMP 23, F-76821 Mont St Aignan, France	University System of Ohio; Ohio University; University System of Ohio; Ohio University; Universite de Rouen Normandie	Faik, A (corresponding author), Ohio Univ, Dept Environm & Plant Biol, 512 Porter Hall, Athens, OH 45701 USA.	faik@ohio.edu	Faik, Ahmed/ABB-9120-2020		United States Department of Agriculture National Institute of Food and Agriculture [2008-35318-04563, 2008-35318-04572]	United States Department of Agriculture National Institute of Food and Agriculture(United States Department of Agriculture (USDA))	This work was supported by National Research Initiative Competitive Grants 2008-35318-04563 and 2008-35318-04572 from the United States Department of Agriculture National Institute of Food and Agriculture.	AUGUR C, 1992, PLANT PHYSIOL, V99, P180, DOI 10.1104/pp.99.1.180; Bianchet MA, 2002, NAT STRUCT BIOL, V9, P628, DOI 10.1038/nsb817; CARPITA NC, 1993, PLANT J, V3, P1, DOI 10.1111/j.1365-313X.1993.tb00007.x; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Egelund J, 2007, PLANT MOL BIOL, V64, P439, DOI 10.1007/s11103-007-9162-y; Faik A, 2000, J BIOL CHEM, V275, P15082, DOI 10.1074/jbc.M000677200; Farrokhi N, 2006, PLANT BIOTECHNOL J, V4, P145, DOI 10.1111/j.1467-7652.2005.00169.x; GARDINER M, 1975, PLANT PHYSIOL, V55, P536, DOI 10.1104/pp.55.3.536; Gille S, 2009, P NATL ACAD SCI USA, V106, P14699, DOI 10.1073/pnas.0905434106; Hakomori S, 2002, P NATL ACAD SCI USA, V99, P10231, DOI 10.1073/pnas.172380699; JOHNSON KD, 1987, PLANT PHYSIOL, V84, P1301, DOI 10.1104/pp.84.4.1301; KIELISZEWSKI M, 1992, PLANT PHYSIOL, V98, P919, DOI 10.1104/pp.98.3.919; LEVY S, 1991, PLANT J, V1, P195; MCDOUGALL GJ, 1990, PLANT PHYSIOL, V93, P1042, DOI 10.1104/pp.93.3.1042; Misawa H, 1996, PLANT PHYSIOL, V110, P665, DOI 10.1104/pp.110.2.665; O'Neill M., 1990, METHODS PLANT BIOCH, V2, P415, DOI DOI 10.1016/B978-0-12-461012-5.50018-5; O'Neill MA, 2001, SCIENCE, V294, P846, DOI 10.1126/science.1062319; OWENS RJ, 1981, BIOCHEM J, V195, P661, DOI 10.1042/bj1950661; Perrin RM, 1999, SCIENCE, V284, P1976, DOI 10.1126/science.284.5422.1976; Rayon C, 1999, PLANT PHYSIOL, V119, P725, DOI 10.1104/pp.119.2.725; Reiter WD, 1997, PLANT J, V12, P335, DOI 10.1046/j.1365-313X.1997.12020335.x; REITER WD, 1993, SCIENCE, V261, P1032, DOI 10.1126/science.261.5124.1032; Saint-Jore CM, 2002, PLANT J, V29, P661, DOI 10.1046/j.0960-7412.2002.01252.x; Sarria R, 2001, PLANT PHYSIOL, V127, P1595, DOI 10.1104/pp.010596; Schultz CJ, 2000, PLANT CELL, V12, P1751, DOI 10.1105/tpc.12.9.1751; Shida K, 2009, GLYCOBIOLOGY, V19, P1018, DOI 10.1093/glycob/cwp083; Showalter AM, 2001, CELL MOL LIFE SCI, V58, P1399, DOI 10.1007/PL00000784; Tan L, 2004, J BIOL CHEM, V279, P13156, DOI 10.1074/jbc.M311864200; TSUMURAYA Y, 1984, CARBOHYD RES, V134, P215, DOI 10.1016/0008-6215(84)85039-9; TSUMURAYA Y, 1988, PLANT PHYSIOL, V86, P155, DOI 10.1104/pp.86.1.155; van Hengel AJ, 2002, PLANT J, V32, P105, DOI 10.1046/j.1365-313X.2002.01406.x; WARNECK HM, 1997, PLANTA, V204, P78; Zablackis E, 1996, SCIENCE, V272, P1808, DOI 10.1126/science.272.5269.1808; Zeng W, 2008, PLANT PHYSIOL, V147, P78, DOI 10.1104/pp.107.115576	34	68	70	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13638	13645		10.1074/jbc.M110.102715	http://dx.doi.org/10.1074/jbc.M110.102715			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20194500	Green Published, hybrid			2022-12-25	WOS:000276987700038
J	Torosyan, Y; Dobi, A; Glasman, M; Mezhevaya, K; Naga, S; Huang, W; Paweletz, C; Leighton, X; Pollard, HB; Srivastava, M				Torosyan, Y.; Dobi, A.; Glasman, M.; Mezhevaya, K.; Naga, S.; Huang, W.; Paweletz, C.; Leighton, X.; Pollard, H. B.; Srivastava, M.			Role of multi-hnRNP nuclear complex in regulation of tumor suppressor ANXA7 in prostate cancer cells	ONCOGENE			English	Article						Annexin A7, ANXA7 (or synexin); heterogeneous nuclear ribonucleoprotein; hnRNP; prostate cancer; DNA affinity enrichment/identification of nuclear proteins; mass spectrometry	ELEMENT-BINDING-PROTEIN; ANNEXIN-VII GENE; IN-VIVO; RIBONUCLEOPROTEIN-K; ANDROGEN RECEPTOR; MESSENGER-RNA; TRANSCRIPTIONAL ACTIVITY; GLUCOCORTICOID-RECEPTOR; CORE PROMOTER; EXPRESSION	Annexin-A7 (ANXA7) tumor suppressor role has been shown in various tumors, and ANXA7 expression has been particularly lost in androgen-resistant prostate cancers. In this study, we studied ANXA7 regulation in normal prostate versus androgen-sensitive and -resistant prostate cancer cells. Deletion mapping analysis showed lowest ANXA7-promoter activities in androgen-sensitive LNCaP prostate cancer cells. Genomatix analysis of ANXA7 promoter identified a cluster of steroid nuclear hormone receptor elements, including V$GREF (V$GRE.02/ARE.02). Gelshift analysis clearly indicated distinct nuclear protein occupancy at this ANXA7-promoter site (-1086/-890) in prostate cancer (LNCaP, DU145, and PC3) versus normal prostate (PrEC) cells. In matrix-assisted laser desorption time-of-light mass spectrometry-based search for ANXA7 nuclear regulators, we identified several heterogeneous nuclear ribonucleoproteins (hnRNPs) (A1, A2/B1 and K) attached to the steroid-associated ANXA7-promoter site in the androgen-resistant PC3 prostate cancer cells with high ANXA7 gene copy number, but not in PrEC. The hnPNP role in ANXA7 regulation (that was validated by hnRNPA2/B1 antibody interference) resulted in multiple ANXA7 cDNA and protein products in PC3, but not in PrEC. Ingenuity pathways analysis showed plausible molecular paths between ANXA7 and the hnRNP-associated network in prostate cancer progression. Thus, a multi-hnRNP complex can be responsible for aberrant ANXA7 transcription and splicing, thereby affecting ANXA7 expression pattern and tumor suppressor function in prostate cancer. Oncogene (2010) 29, 2457-2466; doi:10.1038/onc.2010.2; published online 1 March 2010	[Torosyan, Y.; Glasman, M.; Mezhevaya, K.; Naga, S.; Huang, W.; Paweletz, C.; Leighton, X.; Pollard, H. B.; Srivastava, M.] Uniformed Serv Univ Sch Med USUHS, Dept Anat Physiol & Genet, Inst Mol Med, Bethesda, MD USA; [Dobi, A.] CPDR, Sect Gene Regulat & Bioinformat, Rockville, MD USA		Srivastava, M (corresponding author), USU Sch Med, Dept Anat Physiol & Genet, 4301 Jones Bridge Rd,B2-034, Bethesda, MD 20814 USA.	msrivastava@usuhs.mil			US Department of Defense (DoD)	US Department of Defense (DoD)(United States Department of Defense)	We thank Dr Gideon Dreyfuss (University of Pennsylvania School of Medicine) for providing hnRNPA2/B1 antibody. This work was supported by grants funded by the US Department of Defense (DoD).	Adachi K, 1999, ENDOCRINOLOGY, V140, P618, DOI 10.1210/en.140.2.618; Auboeuf D, 2002, SCIENCE, V298, P416, DOI 10.1126/science.1073734; Barboro P, 2009, BRIT J CANCER, V100, P1608, DOI 10.1038/sj.bjc.6605057; BURD CG, 1989, P NATL ACAD SCI USA, V86, P9788, DOI 10.1073/pnas.86.24.9788; Caron D, 2008, J PROTEOME RES, V7, P4492, DOI 10.1021/pr8002497; Carpenter B, 2006, BBA-REV CANCER, V1765, P85, DOI 10.1016/j.bbcan.2005.10.002; Chen H, 2005, ENDOCRINOLOGY, V146, P4266, DOI 10.1210/en.2005-0160; Chen SY, 1997, J BIOL CHEM, V272, P14087, DOI 10.1074/jbc.272.22.14087; Chen TC, 2000, CLIN CANCER RES, V6, P901; Cooper TA, 2009, CELL, V136, P777, DOI 10.1016/j.cell.2009.02.011; Courchet J, 2008, J BIOL CHEM, V283, P32131, DOI 10.1074/jbc.M802927200; Dobi A, 2002, BIOTECHNIQUES, V33, P868, DOI 10.2144/02334rr03; Duncan R, 2008, BRIT J CANCER, V98, P426, DOI 10.1038/sj.bjc.6604128; Eggert H, 2001, J STEROID BIOCHEM, V78, P59, DOI 10.1016/S0960-0760(01)00074-7; Enge M, 2009, CANCER CELL, V15, P171, DOI 10.1016/j.ccr.2009.01.019; Graveley BR, 2009, NAT STRUCT MOL BIOL, V16, P13, DOI 10.1038/nsmb0109-13; He YW, 2005, J CELL SCI, V118, P3173, DOI 10.1242/jcs.02448; Heemers HV, 2006, MOL ENDOCRINOL, V20, P2265, DOI 10.1210/me.2005-0479; Hellwinkel OJC, 2008, BJU INT, V101, P1454, DOI 10.1111/j.1464-410X.2008.07540.x; Hilbe W, 2004, EUR J CANCER PREV, V13, P425, DOI 10.1097/00008469-200410000-00011; Juven-Gershon T, 2008, CURR OPIN CELL BIOL, V20, P253, DOI 10.1016/j.ceb.2008.03.003; Kang HS, 2007, PHYSIOL GENOMICS, V31, P281, DOI 10.1152/physiolgenomics.00098.2007; KARAGIANNI N, 1994, ONCOGENE, V9, P2327; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Kimura E, 2003, BIOSCI BIOTECH BIOCH, V67, P1786, DOI 10.1271/bbb.67.1786; Lee BJ, 2006, CELL, V126, P543, DOI 10.1016/j.cell.2006.05.049; Li TW, 2004, P NATL ACAD SCI USA, V101, P8551, DOI 10.1073/pnas.0402889101; MAGENDZO K, 1991, J BIOL CHEM, V266, P3228; Mikula M, 2006, PROTEOMICS, V6, P2395, DOI 10.1002/pmic.200500632; Mukhopadhyay NK, 2009, CANCER RES, V69, P2210, DOI 10.1158/0008-5472.CAN-08-2308; Myslinski E, 2006, J BIOL CHEM, V281, P39953, DOI 10.1074/jbc.M608507200; Nakielny S, 1999, CELL, V99, P677, DOI 10.1016/S0092-8674(00)81666-9; Patry C, 2003, CANCER RES, V63, P7679; Pollard H B, 1998, Adv Pharmacol, V42, P81; Reed R, 2002, CELL, V108, P523, DOI 10.1016/S0092-8674(02)00627-X; Rizzo G, 2006, CURR OPIN PHARMACOL, V6, P421, DOI 10.1016/j.coph.2006.03.012; Rozanov DV, 2008, CANCER RES, V68, P4086, DOI 10.1158/0008-5472.CAN-07-6458; Sakaguchi M, 2007, J BIOL CHEM, V282, P35679, DOI 10.1074/jbc.M707538200; Shi LH, 2008, J BIOL CHEM, V283, P36474, DOI 10.1074/jbc.M805980200; Shi Y, 2007, MOL CELL, V28, P79, DOI 10.1016/j.molcel.2007.08.028; SHIRVAN A, 1994, BIOCHEMISTRY-US, V33, P6888, DOI 10.1021/bi00188a019; Srivastava M, 2003, P NATL ACAD SCI USA, V100, P14287, DOI 10.1073/pnas.2235927100; Srivastava M, 2000, CELL BIOL INT, V24, P475, DOI 10.1006/cbir.2000.0511; Srivastava M, 1999, P NATL ACAD SCI USA, V96, P13783, DOI 10.1073/pnas.96.24.13783; Srivastava M, 2007, INT J CANCER, V121, P2628, DOI 10.1002/ijc.23008; Tokusumi Y, 2007, MOL CELL BIOL, V27, P1844, DOI 10.1128/MCB.01363-06; Torosyan Y, 2006, CANCER RES, V66, P9609, DOI 10.1158/0008-5472.CAN-06-1574; Torosyan Y, 2009, INT J CANCER, V125, P2528, DOI 10.1002/ijc.24592; Yemelyanov A, 2007, ONCOGENE, V26, P1885, DOI 10.1038/sj.onc.1209991; Zheng Z, 2006, J BIOL CHEM, V281, P4002, DOI 10.1074/jbc.M509260200	51	25	28	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	APR	2010	29	17					2457	2466		10.1038/onc.2010.2	http://dx.doi.org/10.1038/onc.2010.2			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	589RB	20190808				2022-12-25	WOS:000277169400001
J	Heupel, MR; Simpfendorfer, CA; Fitzpatrick, R				Heupel, Michelle R.; Simpfendorfer, Colin A.; Fitzpatrick, Richard			Large-Scale Movement and Reef Fidelity of Grey Reef Sharks	PLOS ONE			English	Article							NEGAPRION-BREVIROSTRIS; LEMON SHARKS; BIOENERGETICS; POPULATIONS; TELEMETRY; PATTERNS; ISLANDS; BRAZIL	Despite an Indo-Pacific wide distribution, the movement patterns of grey reef sharks (Carcharhinus amblyrhynchos) and fidelity to individual reef platforms has gone largely unstudied. Their wide distribution implies that some individuals have dispersed throughout tropical waters of the Indo-Pacific, but data on large-scale movements do not exist. We present data from nine C. amblyrhynchos monitored within the Great Barrier Reef and Coral Sea off the coast of Australia. Shark presence and movements were monitored via an array of acoustic receivers for a period of six months in 2008. During the course of this monitoring few individuals showed fidelity to an individual reef suggesting that current protective areas have limited utility for this species. One individual undertook a large-scale movement (134 km) between the Coral Sea and Great Barrier Reef, providing the first evidence of direct linkage of C. amblyrhynchos populations between these two regions. Results indicate limited reef fidelity and evidence of large-scale movements within northern Australian waters.	[Heupel, Michelle R.; Simpfendorfer, Colin A.] James Cook Univ, Sch Earth & Environm Sci, Fishing & Fisheries Res Ctr, Townsville, Qld, Australia; [Fitzpatrick, Richard] Reef Channel, Cairns, Qld, Australia	James Cook University	Heupel, MR (corresponding author), James Cook Univ, Sch Earth & Environm Sci, Fishing & Fisheries Res Ctr, Townsville, Qld, Australia.	michelle.heupel@jcu.edu.au	Simpfendorfer, Colin A/G-9681-2011	Simpfendorfer, Colin A/0000-0002-0295-2238; Heupel, Michelle/0000-0002-8245-7332	Digital Dimensions, Townsville, Australia	Digital Dimensions, Townsville, Australia	Funding for this research was made available by Digital Dimensions, Townsville, Australia through the production of the documentary 'Mysteries of the Shark Coast' for Discovery Channel. The Reef Channel (employer of co-author Fitzpatrick) is a division of Digital Dimensions. Consequently, the funders had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chapman DD, 2005, MAR TECHNOL SOC J, V39, P42, DOI 10.4031/002533205787521640; Friedlander AM, 2002, MAR ECOL PROG SER, V230, P253, DOI 10.3354/meps230253; Garla RC, 2006, MAR BIOL, V149, P189, DOI 10.1007/s00227-005-0201-4; Heupel MR, 2009, FISH RES, V95, P350, DOI 10.1016/j.fishres.2008.10.005; Heupel MR, 2004, ENVIRON BIOL FISH, V71, P135, DOI 10.1023/B:EBFI.0000045710.18997.f7; Heupel MR, 2002, CAN J FISH AQUAT SCI, V59, P624, DOI 10.1139/F02-036; Lowe CG, 2002, J EXP MAR BIOL ECOL, V278, P141, DOI 10.1016/S0022-0981(02)00331-3; RANDALL JE, 1977, PAC SCI, V31, P143; Robbins WD, 2006, CURR BIOL, V16, P2314, DOI 10.1016/j.cub.2006.09.044; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; Sundstrom LF, 1998, HYDROBIOLOGIA, V372, P241; Wetherbee BM, 2007, MAR ECOL PROG SER, V343, P283, DOI 10.3354/meps06920	12	104	107	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2010	5	3							e9650	10.1371/journal.pone.0009650	http://dx.doi.org/10.1371/journal.pone.0009650			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565XE	20224793	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000275328800035
J	Schwartz, MS; Benci, JL; Selote, DS; Sharma, AK; Chen, AGY; Dang, H; Fares, H; Vatamaniuk, OK				Schwartz, Marc S.; Benci, Joseph L.; Selote, Devarshi S.; Sharma, Anuj K.; Chen, Andy G. Y.; Dang, Hope; Fares, Hanna; Vatamaniuk, Olena K.			Detoxification of Multiple Heavy Metals by a Half-Molecule ABC Transporter, HMT-1, and Coelomocytes of Caenorhabditis elegans	PLOS ONE			English	Article							PHYTOCHELATIN SYNTHASE; GAMMA-GLUTAMYLCYSTEINE; CADMIUM TOLERANCE; BINDING PEPTIDES; ARABIDOPSIS; GLUTATHIONE; MEMBRANE; IDENTIFICATION; TRANSFORMATION; ENDOCYTOSIS	Background: Developing methods for protecting organisms in metal-polluted environments is contingent upon our understanding of cellular detoxification mechanisms. In this regard, half-molecule ATP-binding cassette (ABC) transporters of the HMT-1 subfamily are required for cadmium (Cd) detoxification. HMTs have conserved structural architecture that distinguishes them from other ABC transporters and allows the identification of homologs in genomes of different species including humans. We recently discovered that HMT-1 from the simple, unicellular organism, Schizosaccharomyces pombe, SpHMT1, acts independently of phytochelatin synthase (PCS) and detoxifies Cd, but not other heavy metals. Whether HMTs from multicellular organisms confer tolerance only to Cd or also to other heavy metals is not known. Methodology/Principal Findings: Using molecular genetics approaches and functional in vivo assays we showed that HMT1 from a multicellular organism, Caenorhabditis elegans, functions distinctly from its S. pombe counterpart in that in addition to Cd it confers tolerance to arsenic (As) and copper (Cu) while acting independently of pcs-1. Further investigation of hmt-1 and pcs-1 revealed that these genes are expressed in different cell types, supporting the notion that hmt-1 and pcs-1 operate in distinct detoxification pathways. Interestingly, pcs-1 and hmt-1 are co-expressed in highly endocytic C. elegans cells with unknown function, the coelomocytes. By analyzing heavy metal and oxidative stress sensitivities of the coelomocyte-deficient C. elegans strain we discovered that coelomocytes are essential mainly for detoxification of heavy metals, but not of oxidative stress, a by-product of heavy metal toxicity. Conclusions/Significance: We established that HMT-1 from the multicellular organism confers tolerance to multiple heavy metals and is expressed in liver-like cells, the coelomocytes, as well as head neurons and intestinal cells, which are cell types that are affected by heavy metal poisoning in humans. We also showed that coelomocytes are involved in detoxification of heavy metals. Therefore, the HMT-1-dependent detoxification pathway and coelomocytes of C. elegans emerge as novel models for studies of heavy metal-promoted diseases.	[Schwartz, Marc S.; Benci, Joseph L.; Selote, Devarshi S.; Sharma, Anuj K.; Chen, Andy G. Y.; Vatamaniuk, Olena K.] Cornell Univ, Dept Crop & Soil Sci, Ithaca, NY 14853 USA; [Dang, Hope; Fares, Hanna] Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA	Cornell University; University of Arizona	Schwartz, MS (corresponding author), Cornell Univ, Dept Crop & Soil Sci, Ithaca, NY 14853 USA.	okv2@cornell.edu	Selote, Devarshi/F-1560-2015; Sharma, Anuj/G-3043-2011	Sharma, Anuj/0000-0001-5061-9731; Benci, Joseph/0000-0002-1759-4621	National Science Foundation [MCB-0923731]; President's Council of Cornell Women Affinito/Stewart Program	National Science Foundation(National Science Foundation (NSF)); President's Council of Cornell Women Affinito/Stewart Program	This work was co-funded by Cornell Start-up, National Science Foundation (MCB-0923731) and President's Council of Cornell Women (PCCW) Affinito/Stewart Program grants awarded to O.K.V. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRENNER S, 1974, GENETICS, V77, P71; Bressler JP, 2007, HUM EXP TOXICOL, V26, P221, DOI 10.1177/0960327107070573; Clemens S, 1999, EMBO J, V18, P3325, DOI 10.1093/emboj/18.12.3325; DELANGE RJ, 1979, J BIOL CHEM, V254, P5838; Fares H, 2002, TRAFFIC, V3, P11, DOI 10.1034/j.1600-0854.2002.30103.x; Fares H, 2001, GENETICS, V159, P133; Fernandez SBM, 2002, J BIOL CHEM, V277, P31048, DOI 10.1074/jbc.M204267200; FIRE A, 1990, NUCLEIC ACIDS RES, V18, P4269, DOI 10.1093/nar/18.14.4269; GRILL E, 1989, P NATL ACAD SCI USA, V86, P6838, DOI 10.1073/pnas.86.18.6838; Ha SB, 1999, PLANT CELL, V11, P1153, DOI 10.1105/tpc.11.6.1153; Hanikenne M, 2001, FEMS MICROBIOL LETT, V196, P107; HOWDEN R, 1995, PLANT PHYSIOL, V107, P1067, DOI 10.1104/pp.107.4.1067; Hughes SL, 2009, J PROTEOME RES, V8, P3512, DOI 10.1021/pr9001806; Hyman MH, 2004, ALTERN THER HEALTH M, V10, P70; Jalil YA, 2008, AM J PHYSIOL-CELL PH, V294, pC579, DOI 10.1152/ajpcell.00612.2006; Krishnamurthy PC, 2006, NATURE, V443, P586, DOI 10.1038/nature05125; MADURO M, 1995, GENETICS, V141, P977; Mason DL, 2002, MOL BIOL CELL, V13, P4443, DOI 10.1091/mbc.E02-07-0405; Mello C, 1995, METHOD CELL BIOL, V48, P451; Mitsuhashi N, 2000, J BIOL CHEM, V275, P17536, DOI 10.1074/jbc.275.23.17536; Nordberg GF, 2007, HANDBOOK ON THE TOXICOLOGY OF METALS, 3RD EDITION, P445, DOI 10.1016/B978-012369413-3/50078-1; ORTIZ DF, 1992, EMBO J, V11, P3491, DOI 10.1002/j.1460-2075.1992.tb05431.x; ORTIZ DF, 1995, J BIOL CHEM, V270, P4721, DOI 10.1074/jbc.270.9.4721; Preveral S, 2009, J BIOL CHEM, V284, P4936, DOI 10.1074/jbc.M808130200; Rea PA, 2007, ANNU REV PLANT BIOL, V58, P347, DOI 10.1146/annurev.arplant.57.032905.105406; Romanyuk ND, 2006, PLANT PHYSIOL, V141, P858, DOI 10.1104/pp.106.082131; Schaheen L, 2006, DEVELOPMENT, V133, P3939, DOI 10.1242/dev.02575; Sooksa-Nguan T, 2009, J BIOL CHEM, V284, P354, DOI 10.1074/jbc.M806501200; Takeda A, 2003, BRAIN RES REV, V41, P79, DOI 10.1016/S0165-0173(02)00234-5; Uriu-Adams Janet Y., 2005, Molecular Aspects of Medicine, V26, P268, DOI 10.1016/j.mam.2005.07.015; Valko M, 2005, CURR MED CHEM, V12, P1161, DOI 10.2174/0929867053764635; VALLEE BL, 1972, ANNU REV BIOCHEM, V41, P91, DOI 10.1146/annurev.bi.41.070172.000515; Vatamaniuk OK, 2005, J BIOL CHEM, V280, P23684, DOI 10.1074/jbc.M503362200; Vatamaniuk OK, 2001, J BIOL CHEM, V276, P20817, DOI 10.1074/jbc.C100152200; Vatamaniuk OK, 2000, J BIOL CHEM, V275, P31451, DOI 10.1074/jbc.M002997200; Vatamaniuk OK, 1999, P NATL ACAD SCI USA, V96, P7110, DOI 10.1073/pnas.96.12.7110; Vatamaniuk OK, 2004, J BIOL CHEM, V279, P22449, DOI 10.1074/jbc.M313142200; Vivares D, 2005, P NATL ACAD SCI USA, V102, P18848, DOI 10.1073/pnas.0505833102; Waalkes MP, 2000, J INORG BIOCHEM, V79, P241, DOI 10.1016/S0162-0134(00)00009-X; Wilm T, 1999, GENE, V229, P31, DOI 10.1016/S0378-1119(99)00043-8; Zhao ZY, 2004, J MOL BIOL, V344, P409, DOI 10.1016/j.jmb.2004.09.052	41	46	51	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2010	5	3							e9564	10.1371/journal.pone.0009564	http://dx.doi.org/10.1371/journal.pone.0009564			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	564EX	20221439	Green Published, Green Submitted, gold			2022-12-25	WOS:000275197200014
J	Sunagawa, S; Woodley, CM; Medina, M				Sunagawa, Shinichi; Woodley, Cheryl M.; Medina, Monica			Threatened Corals Provide Underexplored Microbial Habitats	PLOS ONE			English	Article							METAGENOMIC ANALYSIS; DIVERSITY; BACTERIA; EVOLUTION; MUCUS; COMMUNITIES; WORLDS; TREE	Contemporary in-depth sequencing of environmental samples has provided novel insights into microbial community structures, revealing that their diversity had been previously underestimated. Communities in marine environments are commonly composed of a few dominant taxa and a high number of taxonomically diverse, low-abundance organisms. However, studying the roles and genomic information of these "rare'' organisms remains challenging, because little is known about their ecological niches and the environmental conditions to which they respond. Given the current threat to coral reef ecosystems, we investigated the potential of corals to provide highly specialized habitats for bacterial taxa including those that are rarely detected or absent in surrounding reef waters. The analysis of more than 350,000 small subunit ribosomal RNA (16S rRNA) sequence tags and almost 2,000 nearly full-length 16S rRNA gene sequences revealed that rare seawater biosphere members are highly abundant or even dominant in diverse Caribbean corals. Closely related corals (in the same genus/family) harbored similar bacterial communities. At higher taxonomic levels, however, the similarities of these communities did not correlate with the phylogenetic relationships among corals, opening novel questions about the evolutionary stability of coral-microbial associations. Large proportions of OTUs (28.7-49.1%) were unique to the coral species of origin. Analysis of the most dominant ribotypes suggests that many uncovered bacterial taxa exist in coral habitats and await future exploration. Our results indicate that coral species, and by extension other animal hosts, act as specialized habitats of otherwise rare microbes in marine ecosystems. Here, deep sequencing provided insights into coral microbiota at an unparalleled resolution and revealed that corals harbor many bacterial taxa previously not known. Given that two of the coral species investigated are listed as threatened under the U.S. Endangered Species Act, our results add an important microbial diversity-based perspective to the significance of conserving coral reefs.	[Sunagawa, Shinichi; Medina, Monica] Univ Calif Merced, Sch Nat Sci, Merced, CA USA; [Woodley, Cheryl M.] NOAA, Hollings Marine Lab, Ctr Coastal Environm Hlth & Biomol Res, Natl Ocean Serv, Charleston, SC USA	University of California System; University of California Merced; National Oceanic Atmospheric Admin (NOAA) - USA; National Ocean Service, NOAA	Sunagawa, S (corresponding author), Univ Calif Merced, Sch Nat Sci, Merced, CA USA.	mmedina@ucmerced.edu	Sunagawa, Shinichi/Q-5950-2019	Sunagawa, Shinichi/0000-0003-3065-0314	International Census of Marine Microbes; W.M. Keck Foundation award to the Marine Biological Laboratory in Woods Hole, MA; National Oceanic and Atmospheric Administration (NOAA) Coral Reef Conservation Program; Coral Disease and Health Consortium [1939-2009]; Sigma Xi Grant; National Science Foundation [IOS-0644438, OCE-0313708]; Division Of Integrative Organismal Systems [1402065] Funding Source: National Science Foundation	International Census of Marine Microbes; W.M. Keck Foundation award to the Marine Biological Laboratory in Woods Hole, MA; National Oceanic and Atmospheric Administration (NOAA) Coral Reef Conservation Program(National Oceanic Atmospheric Admin (NOAA) - USA); Coral Disease and Health Consortium; Sigma Xi Grant; National Science Foundation(National Science Foundation (NSF)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This project was supported by the International Census of Marine Microbes and the W.M. Keck Foundation award to the Marine Biological Laboratory in Woods Hole, MA, the National Oceanic and Atmospheric Administration (NOAA) Coral Reef Conservation Program, Coral Disease and Health Consortium Project 1939-2009 to C. M. W., a Sigma Xi Grant to S. S., and National Science Foundation grants IOS-0644438 and OCE-0313708 to M. M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apprill A, 2009, ISME J, V3, P685, DOI 10.1038/ismej.2009.3; Becking L.G.M.B, 1934, GEOBIOLOGIE INLEIDIN; Bent SJ, 2008, ISME J, V2, P689, DOI 10.1038/ismej.2008.44; Bourne DG, 2009, TRENDS MICROBIOL, V17, P554, DOI 10.1016/j.tim.2009.09.004; Bourne DG, 2005, ENVIRON MICROBIOL, V7, P1162, DOI 10.1111/j.1462-2920.2005.00793.x; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; DeSantis TZ, 2006, NUCLEIC ACIDS RES, V34, pW394, DOI 10.1093/nar/gkl244; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; DeSantis TZ, 2007, MICROB ECOL, V53, P371, DOI 10.1007/s00248-006-9134-9; Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245; Dunbar J, 2002, APPL ENVIRON MICROB, V68, P3035, DOI 10.1128/AEM.68.6.3035-3045.2002; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fraune S, 2007, P NATL ACAD SCI USA, V104, P13146, DOI 10.1073/pnas.0703375104; Frias-Lopez J, 2002, APPL ENVIRON MICROB, V68, P2214, DOI 10.1128/AEM.68.5.2214-2228.2002; Geffen Y, 2009, FEMS MICROBIOL LETT, V295, P103, DOI 10.1111/j.1574-6968.2009.01590.x; Gilbert JA, 2009, ENVIRON MICROBIOL, V11, P3132, DOI 10.1111/j.1462-2920.2009.02017.x; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Howe K, 2002, BIOINFORMATICS, V18, P1546, DOI 10.1093/bioinformatics/18.11.1546; Huber JA, 2007, SCIENCE, V318, P97, DOI 10.1126/science.1146689; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Koren O, 2006, APPL ENVIRON MICROB, V72, P5254, DOI 10.1128/AEM.00554-06; KUHL M, 1995, MAR ECOL PROG SER, V117, P159, DOI 10.3354/meps117159; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Kuramitsu HK, 2007, MICROBIOL MOL BIOL R, V71, P653, DOI 10.1128/MMBR.00024-07; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Ley RE, 2008, NAT REV MICROBIOL, V6, P776, DOI 10.1038/nrmicro1978; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Littman RA, 2009, FEMS MICROBIOL ECOL, V68, P152, DOI 10.1111/j.1574-6941.2009.00666.x; Medina M, 2006, P NATL ACAD SCI USA, V103, P9096, DOI 10.1073/pnas.0602444103; Moran NA, 2006, CURR BIOL, V16, pR866, DOI 10.1016/j.cub.2006.09.019; Pedros-Alio C, 2007, SCIENCE, V315, P192, DOI 10.1126/science.1135933; Pedros-Alio C, 2006, TRENDS MICROBIOL, V14, P257, DOI 10.1016/j.tim.2006.04.007; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Reshef L, 2006, ENVIRON MICROBIOL, V8, P2068, DOI 10.1111/j.1462-2920.2006.01148.x; Ritchie KB, 2004, CORAL HEALTH AND DISEASE, P259; Ritchie KB, 2006, MAR ECOL PROG SER, V322, P1, DOI 10.3354/meps322001; Rohwer F, 2002, MAR ECOL PROG SER, V243, P1, DOI 10.3354/meps243001; Romano SL, 1996, SCIENCE, V271, P640, DOI 10.1126/science.271.5249.640; Rosenberg E, 2007, NAT REV MICROBIOL, V5, P355, DOI 10.1038/nrmicro1635; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; SHASHAR N, 1993, BIOL BULL, V185, P455, DOI 10.2307/1542485; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Sunagawa S, 2009, ISME J, V3, P512, DOI 10.1038/ismej.2008.131; Taylor MW, 2004, ENVIRON MICROBIOL, V6, P121, DOI 10.1046/j.1462-2920.2003.00545.x; Thurber RLV, 2008, P NATL ACAD SCI USA, V105, P18413, DOI 10.1073/pnas.0808985105; Thurber RV, 2009, ENVIRON MICROBIOL, V11, P2148, DOI 10.1111/j.1462-2920.2009.01935.x; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Webster NS, 2010, ENVIRON MICROBIOL, V12, P2070, DOI 10.1111/j.1462-2920.2009.02065.x; Wegley L, 2007, ENVIRON MICROBIOL, V9, P2707, DOI 10.1111/j.1462-2920.2007.01383.x; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Wild C, 2004, NATURE, V428, P66, DOI 10.1038/nature02344; Wu DY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002566; Yooseph S, 2007, PLOS BIOL, V5, P432, DOI 10.1371/journal.pbio.0050016	56	222	225	4	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2010	5	3							e9554	10.1371/journal.pone.0009554	http://dx.doi.org/10.1371/journal.pone.0009554			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	564EX	20221265	Green Submitted, Green Published, gold			2022-12-25	WOS:000275197200009
J	Tanaka, S; Honda, M				Tanaka, Susumu; Honda, Makoto			IgG Abnormality in Narcolepsy and Idiopathic Hypersomnia	PLOS ONE			English	Article							HYPOCRETIN; ANTIBODIES; SLEEP; IMMUNOGLOBULINS; AUTOANTIBODIES; CATAPLEXY; IMMUNITY; SERIES; RISK	Background: A close association between narcolepsy and the Human Leukocyte Antigen (HLA)-DQB1*0602 allele suggests the involvement of the immune system, or possibly an autoimmune process. We investigated serum IgG levels in narcolepsy. Methodology/Principal Findings: We measured the serum total IgG levels in 159 Japanese narcolepsy-cataplexy patients positive for the HLA-DQB1*0602 allele, 28 idiopathic hypersomnia patients with long sleep time, and 123 healthy controls (the HLA-DQB1*0602 allele present in 45 subjects). The serum levels of each IgG subclass were subsequently measured. The distribution of serum IgG was significantly different among healthy controls negative for the HLA-DQB1*0602 allele (11.66 +/- 3.55 mg/ml), healthy controls positive for the HLA-DQB1*0602 allele (11.45 +/- 3.43), narcolepsy patients (9.67 +/- 3.38), and idiopathic hypersomnia patients (13.81 +/- 3.80). None of the following clinical variables, age, disease duration, Epworth Sleepiness Scale, smoking habit and BMI at the time of blood sampling, were associated with IgG levels in narcolepsy or idiopathic hypersomnia. Furthermore we found the decrease in IgG1 and IgG2 levels, stable expression of IgG3, and the increase in the proportion of IgG4 in narcolepsy patients with abnormally low IgG levels. The increase in the proportion of IgG4 levels was also found in narcolepsy patients with normal serum total IgG levels. Idiopathic hypersomnia patients showed a different pattern of IgG subclass distribution with high IgG3 and IgG4 level, low IgG2 level, and IgG1/IgG2 imbalance. Conclusions/Significance: Our study is the first to determine IgG abnormalities in narcolepsy and idiopathic hypersomnia by measuring the serum IgG levels in a large number of hypersomnia patients. The observed IgG abnormalities indicate humoral immune alterations in narcolepsy and idiopathic hypersomnia. Different IgG profiles suggest immunological differences between narcolepsy and idiopathic hypersomnia.	[Tanaka, Susumu; Honda, Makoto] Tokyo Inst Psychiat, Tokyo, Japan	Tokyo Institute of Psychiatry	Tanaka, S (corresponding author), Tokyo Inst Psychiat, Tokyo, Japan.	stanaka@prit.go.jp	Tanaka, Susumu/AAC-4739-2019	Tanaka, Susumu/0000-0003-4804-7839	Ministry of Education, Science and Culture of Japan [20790868, 19390310]; Mitsubishi Pharma Research Foundation	Ministry of Education, Science and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mitsubishi Pharma Research Foundation	This work was supported by Grants-in-Aid for Scientific Research (no. 20790868 to S. Tanaka, no. 19390310 to M. Honda) from the Ministry of Education, Science and Culture of Japan, and in part by grants from the Mitsubishi Pharma Research Foundation (to S. Tanaka), and on Priority Areas "Comprehensive Genomics'' from the Ministry of Education, Science and Culture of Japan (to M. Honda). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Academy of Sleep Medicine, 2005, INT CLASS SLEEP DISO; Aran A, 2009, SLEEP, V32, P979, DOI 10.1093/sleep/32.8.979; Baba T, 2009, J NEUROL, V256, P287, DOI 10.1007/s00415-009-0139-4; Bassetti C, 1997, BRAIN, V120, P1423, DOI 10.1093/brain/120.8.1423; Billiard M, 1998, PSYCHIAT CLIN NEUROS, V52, P125, DOI 10.1111/j.1440-1819.1998.tb00987.x; Black JL, 2005, BIOL PSYCHIAT, V58, P504, DOI 10.1016/j.biopsych.2005.04.026; Black JL, 2005, SLEEP, V28, P427, DOI 10.1093/sleep/28.4.427; Carlander B, 2008, J NEUROL NEUROSUR PS, V79, DOI 10.1136/jnnp.2007.135228; CEJKA J, 1974, CLIN CHEM, V20, P656; Dauvilliers Y, 2006, ANN NEUROL, V60, P153, DOI 10.1002/ana.20892; Dhabhar FS, 2002, BRAIN BEHAV IMMUN, V16, P785, DOI 10.1016/S0889-1591(02)00036-3; FRENCH MAH, 1984, CLIN EXP IMMUNOL, V56, P473; Honda M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004254; Honda Y, 1998, Nihon Rinsho, V56, P371; Hui L, 2007, BRAIN BEHAV IMMUN, V21, P308, DOI 10.1016/j.bbi.2006.09.005; Ichihara K, 2008, CLIN CHEM, V54, P356, DOI 10.1373/clinchem.2007.091843; Jackson MW, 2008, J NEUROSCI, V28, P13303, DOI 10.1523/JNEUROSCI.4489-08.2008; Knudsen S, 2007, NEUROREPORT, V18, P77, DOI 10.1097/WNR.0b013e328010baad; Lange T, 2006, ARCH INTERN MED, V166, P1695, DOI 10.1001/archinte.166.16.1695; Martinez-Rodriguez JE, 2007, SLEEP, V30, P27, DOI 10.1093/sleep/30.1.27; MIGNOT E, 1994, SLEEP, V17, pS68, DOI 10.1093/sleep/17.suppl_8.S68; Mignot E, 2001, AM J HUM GENET, V68, P686, DOI 10.1086/318799; Nozaki H, 2009, SLEEP MED, V10, P253, DOI 10.1016/j.sleep.2007.11.022; Overeem S, 2006, J NEUROIMMUNOL, V174, P187, DOI 10.1016/j.jneuroim.2006.02.010; OXELIUS VA, 1984, AM J MED, V76, P7, DOI 10.1016/0002-9343(84)90314-0; Singh SM, 1996, J CLIN IMMUNOL, V16, P208, DOI 10.1007/BF01541226; Tanaka S, 2006, SLEEP, V29, P633, DOI 10.1093/sleep/29.5.633; Tanaka S, 2009, SLEEP BIOL RHYTHMS, V7, P66, DOI 10.1111/j.1479-8425.2009.00387.x; Ton TGN, 2009, NEUROEPIDEMIOLOGY, V32, P114, DOI 10.1159/000177037; Valko PO, 2008, J NEUROL, V255, P1900, DOI 10.1007/s00415-008-0996-2; Vernet C, 2009, SLEEP, V32, P753, DOI 10.1093/sleep/32.6.753; Zager A, 2007, AM J PHYSIOL-REG I, V293, pR504, DOI 10.1152/ajpregu.00105.2007; ZALCMAN S, 1991, BEHAV NEUROSCI, V105, P669, DOI 10.1037/0735-7044.105.5.669	33	21	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2010	5	3							e9555	10.1371/journal.pone.0009555	http://dx.doi.org/10.1371/journal.pone.0009555			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	564EX	20221267	gold, Green Published, Green Submitted			2022-12-25	WOS:000275197200010
J	Atencio, CA; Schreiner, CE				Atencio, Craig A.; Schreiner, Christoph E.			Columnar Connectivity and Laminar Processing in Cat Primary Auditory Cortex	PLOS ONE			English	Article							RAT BARREL CORTEX; RECEPTIVE-FIELD PROPERTIES; THALAMOCORTICAL SYSTEM; IN-VITRO; SYNAPTIC CONNECTIONS; CORTICAL-NEURONS; CEREBRAL-CORTEX; NEURAL ACTIVITY; INTRACELLULAR-RECORDINGS; SPECTRAL INTEGRATION	Background: Radial intra- and interlaminar connections form a basic microcircuit in primary auditory cortex (AI) that extracts acoustic information and distributes it to cortical and subcortical networks. Though the structure of this microcircuit is known, we do not know how the functional connectivity between layers relates to laminar processing. Methodology/Principal Findings: We studied the relationships between functional connectivity and receptive field properties in this columnar microcircuit by simultaneously recording from single neurons in cat AI in response to broadband dynamic moving ripple stimuli. We used spectrotemporal receptive fields (STRFs) to estimate the relationship between receptive field parameters and the functional connectivity between pairs of neurons. Interlaminar connectivity obtained through cross-covariance analysis reflected a consistent pattern of information flow from thalamic input layers to cortical output layers. Connection strength and STRF similarity were greatest for intralaminar neuron pairs and in supragranular layers and weaker for interlaminar projections. Interlaminar connection strength co-varied with several STRF parameters: feature selectivity, phase locking to the stimulus envelope, best temporal modulation frequency, and best spectral modulation frequency. Connectivity properties and receptive field relationships differed for vertical and horizontal connections. Conclusions/Significance: Thus, the mode of local processing in supragranular layers differs from that in infragranular layers. Therefore, specific connectivity patterns in the auditory cortex shape the flow of information and constrain how spectrotemporal processing transformations progress in the canonical columnar auditory microcircuit.	[Atencio, Craig A.; Schreiner, Christoph E.] Univ Calif Berkeley, Berkeley Bioengn Grad Grp, Berkeley, CA 94720 USA; [Atencio, Craig A.; Schreiner, Christoph E.] Univ Calif San Francisco, Dept Otolaryngol Head & Neck Surg, Coleman Mem Lab, San Francisco, CA 94143 USA; [Atencio, Craig A.; Schreiner, Christoph E.] WM Keck Fdn Ctr Integrat Neurosci, San Francisco, CA USA	University of California System; University of California Berkeley; University of California System; University of California San Francisco	Atencio, CA (corresponding author), Univ Calif Berkeley, Berkeley Bioengn Grad Grp, Berkeley, CA 94720 USA.	craig@phy.ucsf.edu		Schreiner, Christoph/0000-0002-4571-4328	National Institutes of Health [DC02260, MH077970]; Coleman Memorial Fund; Hearing Research, Inc. (San Francisco, California); NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH077970] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002260] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Coleman Memorial Fund; Hearing Research, Inc. (San Francisco, California); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the National Institutes of Health (DC02260, MH077970; www.nih.gov), the Coleman Memorial Fund, and Hearing Research, Inc. (San Francisco, California). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AERTSEN AMHJ, 1980, BIOL CYBERN, V38, P223, DOI 10.1007/BF00337015; Alonso JM, 1998, NAT NEUROSCI, V1, P395, DOI 10.1038/1609; ATENCIO CA, 2009, P NATL ACAD IN PRESS; ATENCIO CA, 2009, J NEUROPHYS IN PRESS; Atencio CA, 2008, NEURON, V58, P956, DOI 10.1016/j.neuron.2008.04.026; Atencio CA, 2008, J NEUROSCI, V28, P3897, DOI 10.1523/JNEUROSCI.5366-07.2008; Barbour DL, 2008, J NEUROSCI, V28, P11174, DOI 10.1523/JNEUROSCI.2093-08.2008; Brillinger DR, 1979, SELECTA STAT CANADIA, VV, P1; Brosch M, 1999, EUR J NEUROSCI, V11, P3517, DOI 10.1046/j.1460-9568.1999.00770.x; Bruno RM, 2002, J NEUROSCI, V22, P10966; Bureau I, 2006, PLOS BIOL, V4, P2361, DOI 10.1371/journal.pbio.0040382; CODE RA, 1986, HEARING RES, V23, P205, DOI 10.1016/0378-5955(86)90110-3; deCharms RC, 1998, SCIENCE, V280, P1439, DOI 10.1126/science.280.5368.1439; deCharms RC, 1996, NATURE, V381, P610, DOI 10.1038/381610a0; Depireux DA, 2001, J NEUROPHYSIOL, V85, P1220, DOI 10.1152/jn.2001.85.3.1220; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; EGGERMONT JJ, 1991, J NEUROPHYSIOL, V66, P1549, DOI 10.1152/jn.1991.66.5.1549; EGGERMONT JJ, 1995, NEUROREPORT, V6, P2121, DOI 10.1097/00001756-199511000-00006; Eggermont JJ, 2000, J NEUROPHYSIOL, V83, P2708, DOI 10.1152/jn.2000.83.5.2708; EGGERMONT JJ, 1994, J NEUROPHYSIOL, V71, P246, DOI 10.1152/jn.1994.71.1.246; EGGERMONT JJ, 1995, NEUROREPORT, V6, P2125, DOI 10.1097/00001756-199511000-00007; Eggermont JJ, 1996, EXP BRAIN RES, V110, P379; EGGERMONT JJ, 1992, J NEUROPHYSIOL, V68, P1216, DOI 10.1152/jn.1992.68.4.1216; Eggermont JJ, 2006, J NEUROPHYSIOL, V96, P746, DOI 10.1152/jn.00059.2006; EPPING WJM, 1987, J NEUROPHYSIOL, V57, P1464, DOI 10.1152/jn.1987.57.5.1464; Escabi MA, 2002, J NEUROSCI, V22, P4114, DOI 10.1523/JNEUROSCI.22-10-04114.2002; Feldmeyer D, 1999, J PHYSIOL-LONDON, V521, P169, DOI 10.1111/j.1469-7793.1999.00169.x; Feldmeyer D, 2002, J PHYSIOL-LONDON, V538, P803, DOI 10.1113/jphysiol.2001.012959; Feldmeyer D, 2006, J PHYSIOL-LONDON, V575, P583, DOI 10.1113/jphysiol.2006.105106; Halliday D.M., 1999, TIME FREQUENCY DOMAI, P503, DOI DOI 10.1007/978-3-642-58552-4_18; Hefri BJ, 2003, JARO-J ASSOC RES OTO, V4, P106, DOI 10.1007/s10162-002-3012-z; Holmgren C, 2003, J PHYSIOL-LONDON, V551, P139, DOI 10.1113/jphysiol.2003.044784; Huang CL, 2000, J COMP NEUROL, V427, P302, DOI 10.1002/1096-9861(20001113)427:2<302::AID-CNE10>3.0.CO;2-J; Imaizumi K, 2007, J NEUROPHYSIOL, V98, P2933, DOI 10.1152/jn.00511.2007; IMIG TJ, 1981, J COMP NEUROL, V203, P1, DOI 10.1002/cne.902030102; IMIG TJ, 1980, J COMP NEUROL, V192, P293, DOI 10.1002/cne.901920208; Jones EG, 2000, P NATL ACAD SCI USA, V97, P5019, DOI 10.1073/pnas.97.10.5019; Kaur S, 2005, NEUROSCIENCE, V134, P1033, DOI 10.1016/j.neuroscience.2005.04.052; Klein DJ, 2000, J COMPUT NEUROSCI, V9, P85, DOI 10.1023/A:1008990412183; Kubota M, 1997, NEUROSCI LETT, V237, P77, DOI 10.1016/S0304-3940(97)00806-9; Lee CC, 2008, J COMP NEUROL, V507, P1879, DOI 10.1002/cne.21611; LEWICKI MS, 1994, NEURAL COMPUT, V6, P1005, DOI 10.1162/neco.1994.6.5.1005; Linden JF, 2003, CEREB CORTEX, V13, P83, DOI 10.1093/cercor/13.1.83; Martinez LM, 2001, NEURON, V32, P515, DOI 10.1016/S0896-6273(01)00489-5; MATSUBARA JA, 1988, J COMP NEUROL, V268, P38, DOI 10.1002/cne.902680105; Mendelson JR, 1997, J COMP PHYSIOL A, V181, P615, DOI 10.1007/s003590050145; Miller LM, 2001, NEURON, V32, P151, DOI 10.1016/S0896-6273(01)00445-7; Miller LM, 2001, J NEUROSCI, V21, P8136, DOI 10.1523/JNEUROSCI.21-20-08136.2001; Miller LM, 2002, J NEUROPHYSIOL, V87, P516, DOI 10.1152/jn.00395.2001; Miller LM, 2000, J NEUROSCI, V20, P7011, DOI 10.1523/JNEUROSCI.20-18-07011.2000; MITANI A, 1985, J COMP NEUROL, V235, P430, DOI 10.1002/cne.902350403; MITANI A, 1985, J COMP NEUROL, V235, P417, DOI 10.1002/cne.902350402; OJIMA H, 1992, CEREB CORTEX, V2, P197, DOI 10.1093/cercor/2.3.197; Ojima H, 1991, CEREB CORTEX, V1, P80, DOI 10.1093/cercor/1.1.80; PHILLIPS DP, 1981, J NEUROPHYSIOL, V45, P48, DOI 10.1152/jn.1981.45.1.48; Read HL, 2001, P NATL ACAD SCI USA, V98, P8042, DOI 10.1073/pnas.131591898; ROCKEL AJ, 1980, BRAIN, V103, P221, DOI 10.1093/brain/103.2.221; ROSENBERG JR, 1989, PROG BIOPHYS MOL BIO, V53, P1, DOI 10.1016/0079-6107(89)90004-7; ROUILLER EM, 1991, EXP BRAIN RES, V86, P483, DOI 10.1007/BF00230523; Schneidman E, 2006, NATURE, V440, P1007, DOI 10.1038/nature04701; Schofield BR, 2006, JARO-J ASSOC RES OTO, V7, P95, DOI 10.1007/s10162-005-0025-4; Shepherd GMG, 2005, J NEUROSCI, V25, P5670, DOI 10.1523/JNEUROSCI.1173-05.2005; Shlens J, 2006, J NEUROSCI, V26, P8254, DOI 10.1523/JNEUROSCI.1282-06.2006; Smith PH, 2001, J COMP NEUROL, V436, P508, DOI 10.1002/cne.1084; SZENTAGOTHAI J, 1978, PROC R SOC SER B-BIO, V201, P219, DOI 10.1098/rspb.1978.0043; SZENTAGOTHAI J, 1975, BRAIN RES, V95, P475, DOI 10.1016/0006-8993(75)90122-5; Szymanski FD, 2009, J NEUROPHYSIOL, V102, P1483, DOI 10.1152/jn.00240.2009; Tang A, 2008, J NEUROSCI, V28, P505, DOI 10.1523/JNEUROSCI.3359-07.2008; Theunissen FE, 2000, J NEUROSCI, V20, P2315; Thomson AM, 2002, CEREB CORTEX, V12, P936, DOI 10.1093/cercor/12.9.936; Thomson AM, 2003, CEREB CORTEX, V13, P5, DOI 10.1093/cercor/13.1.5; Thomson AM, 1997, CEREB CORTEX, V7, P510, DOI 10.1093/cercor/7.6.510; Tomita M, 2005, J NEUROPHYSIOL, V93, P378, DOI 10.1152/jn.00643.2004; VOIGT HF, 1990, J NEUROPHYSIOL, V64, P1590, DOI 10.1152/jn.1990.64.5.1590; VOLKOV IO, 1989, NEUROPHYSIOLOGY+, V21, P432; Wallace MN, 2008, EXP BRAIN RES, V184, P179, DOI 10.1007/s00221-007-1092-z; WALLACE MN, 1991, EXP BRAIN RES, V86, P527; Winer J.A., 1992, Springer Handbook of Auditory Research, V1, P222; WINER JA, 1984, J COMP NEUROL, V224, P535, DOI 10.1002/cne.902240405; Winer JA, 2005, HEARING RES, V207, P1, DOI 10.1016/j.heares.2005.06.007; Winer JA, 2001, J COMP NEUROL, V434, P379, DOI 10.1002/cne.1183; WINGUTH SD, 1986, J COMP NEUROL, V248, P36, DOI 10.1002/cne.902480104; Wise KD, 2005, IEEE ENG MED BIOL, V24, P22, DOI 10.1109/MEMB.2005.1511497; Yoshimura Y, 2005, NATURE, V433, P868, DOI 10.1038/nature03252; ZHANG M, 2005, EXP BRAIN RES, P1; Zhang ML, 2004, J NEUROPHYSIOL, V92, P1464, DOI 10.1152/jn.01272.2003	86	67	68	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2010	5	3							e9521	10.1371/journal.pone.0009521	http://dx.doi.org/10.1371/journal.pone.0009521			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	562OZ	20209092	Green Published, gold			2022-12-25	WOS:000275063400025
J	Oyane, NM; Ursin, R; Pallesen, S; Holsten, F; Bjorvatn, B				Oyane, Nicolas M.; Ursin, Reidun; Pallesen, Stale; Holsten, Fred; Bjorvatn, Bjorn			Increased Health Risk in Subjects with High Self-Reported Seasonality	PLOS ONE			English	Article							PATTERN ASSESSMENT QUESTIONNAIRE; CORONARY HEART-DISEASE; AFFECTIVE-DISORDER; CARDIOVASCULAR-DISEASE; DEPRESSIVE SYMPTOMS; GENERAL-POPULATION; METABOLIC SYNDROME; SERUM-CHOLESTEROL; WINTER DEPRESSION; HORDALAND HEALTH	Background: Seasonal variations in mood and behaviour, termed seasonality, are commonly reported in the general population. As a part of a large cross-sectional health survey in Hordaland, Norway, we investigated the relationship between seasonality, objective health measurements and health behaviours. Methodology/Principal Findings: A total of 11,545 subjects between 40-44 years old participated, completing the Global Seasonality Score, measuring seasonality. Waist/hip circumference, BMI and blood pressure were measured, and blood samples were analyzed for total cholesterol, HDL cholesterol, triglycerides and glucose. Subjects also completed a questionnaire on miscellaneous health behaviours (exercise, smoking, alcohol consumption). Hierarchical linear regression analyses were used to investigate associations between seasonality and objective health measurements, while binary logistic regression was used for analysing associations between seasonality and health behaviours. Analyses were adjusted for sociodemographic factors, month of questionnaire completion and sleep duration. Seasonality was positively associated with high waist-hip-ratio, BMI, triglyceride levels, and in men high total cholesterol. Seasonality was negatively associated with HDL cholesterol. In women seasonality was negatively associated with prevalence of exercise and positively associated with daily cigarette smoking. Conclusions/Significance: High seasonality was associated with objective health risk factors and in women also with health behaviours associated with an increased risk for cardiovascular disease.	[Oyane, Nicolas M.; Bjorvatn, Bjorn] Univ Bergen, Dept Publ Hlth & Primary Hlth Care, Bergen, Norway; [Ursin, Reidun] Univ Bergen, Dept Biomed, Bergen, Norway; [Pallesen, Stale] Univ Bergen, Dept Psychosocial Sci, Bergen, Norway; [Holsten, Fred] Univ Bergen, Dept Psychiat, Bergen, Norway; [Oyane, Nicolas M.; Ursin, Reidun; Pallesen, Stale; Holsten, Fred; Bjorvatn, Bjorn] Haukeland Hosp, Norwegian Competence Ctr Sleep Disorders, N-5021 Bergen, Norway	University of Bergen; University of Bergen; University of Bergen; University of Bergen; University of Bergen; Haukeland University Hospital	Oyane, NM (corresponding author), Univ Bergen, Dept Publ Hlth & Primary Hlth Care, Bergen, Norway.	Nicolas.Oyane@isf.uib.no			University of Bergen	University of Bergen	This work was supported by the University of Bergen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacon SL, 2009, THROMB HAEMOSTASIS, V101, P452, DOI 10.1160/TH08-10-0630; BOOKER JM, 1992, AM J PSYCHIAT, V149, P1176; BROWN SL, 1994, BRIT MED J, V308, P1328, DOI 10.1136/bmj.308.6940.1328; Dam H, 1998, ACTA PSYCHIAT SCAND, V97, P1, DOI 10.1111/j.1600-0447.1998.tb09954.x; Davidovic Lazar B, 2005, World J Surg Oncol, V3, P10, DOI 10.1186/1477-7819-3-10; Eagles JM, 1999, BRIT J PSYCHIAT, V175, P472, DOI 10.1192/bjp.175.5.472; FREEDMAN DS, 1995, AM J EPIDEMIOL, V141, P507, DOI 10.1093/oxfordjournals.aje.a117465; GLUECK CJ, 1994, AM J MED SCI, V308, P218; Goldfinger Tedd M., 2003, Cardiology Clinics, V21, P449, DOI 10.1016/S0733-8651(03)00081-X; Hansen V, 2001, AM J EPIDEMIOL, V154, P891, DOI 10.1093/aje/154.10.891; HARDIN TA, 1991, J PSYCHIAT RES, V25, P75, DOI 10.1016/0022-3956(91)90001-Q; Hildrum B, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-220; HOLMEN J, 1990, Tidsskrift for den Norske Laegeforening, V110, P1973; KASPER S, 1989, ARCH GEN PSYCHIAT, V46, P823; Lam RW, 2001, J AFFECT DISORDERS, V63, P123, DOI 10.1016/S0165-0327(00)00196-8; Laposky AD, 2008, FEBS LETT, V582, P142, DOI 10.1016/j.febslet.2007.06.079; Lavie CJ, 2006, ARCH INTERN MED, V166, P1878, DOI 10.1001/archinte.166.17.1878; Magnusson A, 1996, J AFFECT DISORDERS, V40, P121, DOI 10.1016/0165-0327(96)00036-5; Mersch PPA, 1999, BIOL PSYCHIAT, V45, P1013, DOI 10.1016/S0006-3223(98)00220-0; Miller TD, 1997, ANN BEHAV MED, V19, P220, DOI 10.1007/BF02892287; MORGAN RE, 1993, LANCET, V341, P75, DOI 10.1016/0140-6736(93)92556-9; Mykletun A, 2007, PSYCHOSOM MED, V69, P323, DOI 10.1097/PSY.0b013e31803cb862; Nakao M, 2004, TOHOKU J EXP MED, V204, P273, DOI 10.1620/tjem.204.273; Oyane NMF, 2008, J AFFECT DISORDERS, V105, P147, DOI 10.1016/j.jad.2007.05.002; Oyane NMF, 2005, EUR J EPIDEMIOL, V20, P929, DOI 10.1007/s10654-005-2952-0; Patberg WR, 2004, J RHEUMATOL, V31, P1327; Pjrek E, 2007, EUR ARCH PSY CLIN N, V257, P197, DOI 10.1007/s00406-006-0706-y; REICHBORNKJENNE.T, 2001, SEASONAL AFFECTIVE D, P19; Rintamaki R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001482; ROSEN LN, 1990, PSYCHIAT RES, V31, P131, DOI 10.1016/0165-1781(90)90116-M; ROSENTHAL NE, 1984, ARCH GEN PSYCHIAT, V41, P72; SELTZER CC, 1973, NEW ENGL J MED, V288, P1186; Sher L, 2001, MED HYPOTHESES, V56, P104, DOI 10.1054/mehy.2000.1122; Storms WW, 2003, MED SCI SPORT EXER, V35, P1464, DOI 10.1249/01.MSS.0000084533.75912.B4; Terao T, 2000, ACTA PSYCHIAT SCAND, V101, P231; THOMPSON C, 1988, J AFFECT DISORDERS, V14, P257, DOI 10.1016/0165-0327(88)90043-2; WATSON D, 1989, PSYCHOL REV, V96, P234, DOI 10.1037/0033-295X.96.2.234; Yanovski JA, 2000, NEW ENGL J MED, V342, P861, DOI 10.1056/NEJM200003233421206; YOUNG MA, 1991, J AFFECT DISORDERS, V22, P191, DOI 10.1016/0165-0327(91)90065-Z	39	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2010	5	3							e9498	10.1371/journal.pone.0009498	http://dx.doi.org/10.1371/journal.pone.0009498			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	562OZ	20209129	Green Submitted, gold, Green Published			2022-12-25	WOS:000275063400008
J	Schokraie, E; Hotz-Wagenblatt, A; Warnken, U; Mali, B; Frohme, M; Forster, F; Dandekar, T; Hengherr, S; Schill, RO; Schnolzer, M				Schokraie, Elham; Hotz-Wagenblatt, Agnes; Warnken, Uwe; Mali, Brahim; Frohme, Marcus; Foerster, Frank; Dandekar, Thomas; Hengherr, Steffen; Schill, Ralph O.; Schnoelzer, Martina			Proteomic Analysis of Tardigrades: Towards a Better Understanding of Molecular Mechanisms by Anhydrobiotic Organisms	PLOS ONE			English	Article							GLUTATHIONE S-TRANSFERASES; MILNESIUM-TARDIGRADUM; DESICCATION TOLERANCE; RICHTERSIUS-CORONIFER; ARABIDOPSIS-THALIANA; ARTEMIA-FRANCISCANA; BRINE SHRIMP; HEAT-SHOCK; PROTEIN; TREHALOSE	Background: Tardigrades are small, multicellular invertebrates which are able to survive times of unfavourable environmental conditions using their well-known capability to undergo cryptobiosis at any stage of their life cycle. Milnesium tardigradum has become a powerful model system for the analysis of cryptobiosis. While some genetic information is already available for Milnesium tardigradum the proteome is still to be discovered. Principal Findings: Here we present to the best of our knowledge the first comprehensive study of Milnesium tardigradum on the protein level. To establish a proteome reference map we developed optimized protocols for protein extraction from tardigrades in the active state and for separation of proteins by high resolution two-dimensional gel electrophoresis. Since only limited sequence information of M. tardigradum on the genome and gene expression level is available to date in public databases we initiated in parallel a tardigrade EST sequencing project to allow for protein identification by electrospray ionization tandem mass spectrometry. 271 out of 606 analyzed protein spots could be identified by searching against the publicly available NCBInr database as well as our newly established tardigrade protein database corresponding to 144 unique proteins. Another 150 spots could be identified in the tardigrade clustered EST database corresponding to 36 unique contigs and ESTs. Proteins with annotated function were further categorized in more detail by their molecular function, biological process and cellular component. For the proteins of unknown function more information could be obtained by performing a protein domain annotation analysis. Our results include proteins like protein member of different heat shock protein families and LEA group 3, which might play important roles in surviving extreme conditions. Conclusions: The proteome reference map of Milnesium tardigradum provides the basis for further studies in order to identify and characterize the biochemical mechanisms of tolerance to extreme desiccation. The optimized proteomics workflow will enable application of sensitive quantification techniques to detect differences in protein expression, which are characteristic of the active and anhydrobiotic states of tardigrades.	[Schokraie, Elham; Hotz-Wagenblatt, Agnes; Warnken, Uwe; Schnoelzer, Martina] German Canc Res Ctr, D-6900 Heidelberg, Germany; [Mali, Brahim; Frohme, Marcus] Univ Appl Sci Wildau, Dept Mol Biol & Funct Genom, Wildau, Germany; [Foerster, Frank; Dandekar, Thomas] Univ Wurzburg, Dept Bioinformat, Wurzburg, Germany; [Hengherr, Steffen; Schill, Ralph O.] Univ Stuttgart, Dept Zool, Stuttgart, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); University of Applied Sciences Wildau; University of Wurzburg; University of Stuttgart	Schokraie, E (corresponding author), German Canc Res Ctr, D-6900 Heidelberg, Germany.	m.schnoelzer@dkfz.de	Dandekar, Thomas/A-4431-2017; Förster, Frank/A-2181-2010; Mondragon, Angel/F-3972-2017; Frohme, Marcus/HCH-4031-2022	Dandekar, Thomas/0000-0003-1886-7625; Förster, Frank/0000-0003-4166-5423; Mondragon, Angel/0000-0002-6721-2054; 	German Federal Ministry of Education and Research; BMBF; FUNCRYPTA [FKY 0313838D]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); BMBF(Federal Ministry of Education & Research (BMBF)); FUNCRYPTA	This work was supported by the German Federal Ministry of Education and Research, BMBF, as part of FUNCRYPTA (FKY 0313838D). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Attwood TK, 2003, NUCLEIC ACIDS RES, V31, P400, DOI 10.1093/nar/gkg030; BAUMANN H, 1922, ANABIOSE TARDIGRADEN, P501; Berkowitz O, 2008, PLANT CELL, V20, P3430, DOI 10.1105/tpc.108.061010; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; Britton C, 2002, MOL BIOCHEM PARASIT, V122, P21, DOI 10.1016/S0166-6851(02)00066-X; Browne J, 2002, NATURE, V416, P38, DOI 10.1038/416038a; Browne JA, 2004, EUKARYOT CELL, V3, P966, DOI 10.1128/EC.3.4.966-975.2004; Caprioli M, 2004, COMP BIOCHEM PHYS A, V139, P527, DOI 10.1016/j.cbpb.2004.10.019; CLEGG JS, 1992, FEBS LETT, V303, P45, DOI 10.1016/0014-5793(92)80474-U; CLEGG JS, 1964, J EXP BIOL, V41, P879; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; CONTE FP, 1977, J EXP ZOOL, V202, P339, DOI 10.1002/jez.1402020306; del Val C, 2007, NUCLEIC ACIDS RES, V35, pW444, DOI 10.1093/nar/gkm364; DUMAS C, 1993, J BIOL CHEM, V268, P21599; Dure L, 2001, PROTEIN PEPTIDE LETT, V8, P115, DOI 10.2174/0929866013409643; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; GORG A, 1988, ELECTROPHORESIS, V9, P531, DOI 10.1002/elps.1150090913; Goyal K, 2005, BIOCHEM J, V388, P151, DOI 10.1042/BJ20041931; Haslekas C, 1998, PLANT MOL BIOL, V36, P833, DOI 10.1023/A:1005900832440; Hengherr S, 2009, J EXP BIOL, V212, P802, DOI 10.1242/jeb.025973; HENGHERR S, 2008, J ZOOLOGY L IN PRESS; Hengherr S, 2008, FEBS J, V275, P281, DOI 10.1111/j.1742-4658.2007.06198.x; Henikoff S, 1999, BIOINFORMATICS, V15, P471, DOI 10.1093/bioinformatics/15.6.471; Horikawa DD, 2006, INT J RADIAT BIOL, V82, P843, DOI 10.1080/09553000600972956; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Jonsson KI, 2008, CURR BIOL, V18, pR729, DOI 10.1016/j.cub.2008.06.048; Jonsson KI, 2007, COMP BIOCHEM PHYS B, V146, P456, DOI 10.1016/j.cbpb.2006.10.111; Kato Y, 2004, GENE, V334, P157, DOI 10.1016/j.gene.2004.03.030; KEILIN D, 1959, PROC R SOC SER B-BIO, V150, P149, DOI 10.1098/rspb.1959.0013; KIM KW, 1988, J BIOL CHEM, V263, P4704; KUZMICH S, 1991, INT J PEPT PROT RES, V37, P565; Lapinski J, 2003, FEBS LETT, V553, P387, DOI 10.1016/S0014-5793(03)01062-7; LEPRINCE O, 1994, PLANT PHYSIOL, V104, P1333, DOI 10.1104/pp.104.4.1333; Leprince O., 1993, Seed Science Research, V3, P231, DOI 10.1017/S0960258500001859; Martin RM, 1997, INT J PARASITOL, V27, P1561, DOI 10.1016/S0020-7519(97)00146-X; Michalak M, 2009, BIOCHEM J, V417, P651, DOI 10.1042/BJ20081847; Miyata S, 1997, DEV GROWTH DIFFER, V39, P111; Mommsen T.P., 1988, P347; Morrison J. F., 1973, ENZYMES, V8, P457, DOI 10.1016/S1874-6047; Mulder N.J., 2008, CURR PROTOC BIOINFOR, V2, P2, DOI DOI 10.1002/0471250953.BI0207S21; Nelson DR, 2002, INTEGR COMP BIOL, V42, P652, DOI 10.1093/icb/42.3.652; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Ramlov H, 2001, ZOOL ANZ, V240, P517, DOI 10.1078/0044-5231-00062; RAMLOV H, 1992, CRYOBIOLOGY, V29, P125, DOI 10.1016/0011-2240(92)90012-Q; Salinas AE, 1999, CURR MED CHEM, V6, P279; Schill RO, 2008, J ZOOL, V276, P103, DOI 10.1111/j.1469-7998.2008.00474.x; Schill RO, 2004, J EXP BIOL, V207, P1607, DOI 10.1242/jeb.00935; Seki K, 1998, NATURE, V395, P853, DOI 10.1038/27576; Sinha P, 2001, PROTEOMICS, V1, P835, DOI 10.1002/1615-9861(200107)1:7<835::AID-PROT835>3.3.CO;2-U; Solomon A, 2000, PARASITOLOGY, V121, P409, DOI 10.1017/S0031182099006563; Suzuki AC, 2003, ZOOL SCI, V20, P49, DOI 10.2108/zsj.20.49; Tew KD, 1999, DRUG RESIST UPDATE, V2, P143, DOI 10.1054/drup.1999.0086; Tunnacliffe A, 2003, PHILOS T ROY SOC B, V358, P1755, DOI 10.1098/rstb.2002.1214; WARNER AH, 1995, CELL TISSUE RES, V282, P21; Wernersson R, 2006, NUCLEIC ACIDS RES, V34, pW385, DOI 10.1093/nar/gkl252; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; WILCE MCJ, 1994, BBA-PROTEIN STRUCT M, V1205, P1, DOI 10.1016/0167-4838(94)90086-8	59	46	47	5	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2010	5	3							e9502	10.1371/journal.pone.0009502	http://dx.doi.org/10.1371/journal.pone.0009502			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	562OZ	20224743	Green Published, gold, Green Submitted			2022-12-25	WOS:000275063400010
J	Hur, C; Hayeck, TJ; Yeh, JM; Richards, EB; Spechler, SJ; Gazelle, GS; Kong, CY				Hur, Chin; Hayeck, Tristan J.; Yeh, Jennifer M.; Richards, Ethan B.; Spechler, Stuart J.; Gazelle, G. Scott; Kong, Chung Yin			Development, Calibration, and Validation of a US White Male Population-Based Simulation Model of Esophageal Adenocarcinoma	PLOS ONE			English	Article							GASTROESOPHAGEAL-REFLUX DISEASE; BARRETTS-ESOPHAGUS; GASTRIC CARDIA; CLINICAL SPECTRUM; UNITED-STATES; CANCER-RISK; PREVALENCE; SYMPTOMS; SURVEILLANCE; TRENDS	Background: The incidence of esophageal adenocarcinoma (EAC) has risen rapidly in the U. S. and western world. The aim of the study was to begin the investigation of this rapid rise by developing, calibrating, and validating a mathematical disease simulation model of EAC using available epidemiologic data. Methods: The model represents the natural history of EAC, including the essential biologic health states from normal mucosa to detected cancer. Progression rates between health states were estimated via calibration, which identified distinct parameter sets producing model outputs that fit epidemiologic data; specifically, the prevalence of pre-cancerous lesions and EAC cancer incidence from the published literature and Surveillance, Epidemiology, and End Results (SEER) data. As an illustrative example of a clinical and policy application, the calibrated and validated model retrospectively analyzed the potential benefit of an aspirin chemoprevention program. Results: Model outcomes approximated calibration targets; results of the model's fit and validation are presented. Approximately 7,000 cases of EAC could have been prevented over a 30-year period if all white males started aspirin chemoprevention at age 40 in 1965. Conclusions: The model serves as the foundation for future analyses to determine a cost-effective screening and management strategy to prevent EAC morbidity and mortality.	[Hur, Chin; Hayeck, Tristan J.; Gazelle, G. Scott; Kong, Chung Yin] Massachusetts Gen Hosp, Inst Technol Assessment, Boston, MA 02114 USA; [Hur, Chin; Hayeck, Tristan J.; Richards, Ethan B.] Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA; [Hur, Chin; Gazelle, G. Scott; Kong, Chung Yin] Harvard Univ, Sch Med, Boston, MA USA; [Yeh, Jennifer M.; Gazelle, G. Scott] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Spechler, Stuart J.] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; University of Texas System; University of Texas Southwestern Medical Center Dallas	Hur, C (corresponding author), Massachusetts Gen Hosp, Inst Technol Assessment, Boston, MA 02114 USA.	chur@mgh-ita.org		Hur, Chin/0000-0002-2819-7576	NIH/NCI [CA107060, CA133141]; NATIONAL CANCER INSTITUTE [K07CA107060, K25CA133141, K07CA143044] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Grant support: NIH/NCI Grant CA107060 (C. H.) and NIH/NCI Grant CA133141 (C. Y. K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BROWN LM, 2008, J NATL CANC I; CAMERON AJ, 1992, GASTROENTEROLOGY, V103, P1241, DOI 10.1016/0016-5085(92)91510-B; Chak A, 2006, CANCER-AM CANCER SOC, V107, P2160, DOI 10.1002/cncr.22245; Chiocca JC, 2005, ALIMENT PHARM THER, V22, P331, DOI 10.1111/j.1365-2036.2005.02565.x; Clark G W, 1997, J Gastrointest Surg, V1, P113; COLLEN MJ, 1995, AM J GASTROENTEROL, V90, P1053; Corey KE, 2003, AM J GASTROENTEROL, V98, P2390, DOI 10.1016/j.amjgastroenterol.2003.08.008; Corley DA, 2002, GASTROENTEROLOGY, V122, P633, DOI 10.1053/gast.2002.31879; Corley DA, 2003, GASTROENTEROLOGY, V124, P47, DOI 10.1053/gast.2003.50008; Diaz-Rubio M, 2004, ALIMENT PHARM THER, V19, P95, DOI 10.1046/j.1365-2036.2003.01769.x; El-Serag HB, 2007, CLIN GASTROENTEROL H, V5, P17, DOI 10.1016/j.cgh.2006.09.016; El-Serag HB, 2004, GASTROENTEROLOGY, V126, P1692, DOI 10.1053/j.gastro.2004.03.077; Gerson LB, 2004, CLIN GASTROENTEROL H, V2, P868, DOI 10.1016/S1542-3565(04)00394-5; Gerson LB, 2002, GASTROENTEROLOGY, V123, P461, DOI 10.1053/gast.2002.34748; Goldie SJ, 2006, VACCINE S3, V24; GUANREI Y, 1988, ENDOSCOPY, V20, P95, DOI 10.1055/s-2007-1018145; Hur C, 2004, J NATL CANCER I, V96, P316, DOI 10.1093/jnci/djh039; HUR C, 2007, ADV EVIDENCE BASED A; Inadomi JM, 2003, ANN INTERN MED, V138, P176, DOI 10.7326/0003-4819-138-3-200302040-00009; ISOLAURI J, 1995, ANN MED, V27, P67, DOI 10.3109/07853899509031939; Jankowski J, 2004, JNCI-J NATL CANCER I, V96, P885, DOI 10.1093/jnci/djh171; Jeon J, 2006, CANCER CAUSE CONTROL, V17, P971, DOI 10.1007/s10552-006-0037-3; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Locke GR, 1997, GASTROENTEROLOGY, V112, P1448, DOI 10.1016/S0016-5085(97)70025-8; MENKEPLUYMERS MBE, 1993, CANCER, V72, P1155, DOI 10.1002/1097-0142(19930815)72:4<1155::AID-CNCR2820720404>3.0.CO;2-C; Mohammed I, 2003, GUT, V52, P1085, DOI 10.1136/gut.52.8.1085; O'Connor JB, 1999, AM J GASTROENTEROL, V94, P2037; Pera M, 2003, WORLD J SURG, V27, P999, DOI 10.1007/s00268-003-7052-2; Provenzale D, 1999, AM J GASTROENTEROL, V94, P2043; PROVENZALE D, 1994, AM J GASTROENTEROL, V89, P670; Rex DK, 2003, GASTROENTEROLOGY, V125, P1670, DOI 10.1053/j.gastro.2003.09.030; RIES LAG, 2008, SEER 1975 2005 SEER; Ronkainen J, 2005, GASTROENTEROLOGY, V129, P1825, DOI 10.1053/j.gastro.2005.08.053; Shaheen NJ, 2000, GASTROENTEROLOGY, V119, P333, DOI 10.1053/gast.2000.9302; Stout NK, 2009, PHARMACOECONOMICS, V27, P533, DOI 10.2165/11314830-000000000-00000; TALLEY NJ, 1992, GASTROENTEROLOGY, V102, P1259; Terry P, 2000, NUTR CANCER, V38, P186, DOI 10.1207/S15327914NC382_7; Valle C, 1999, DIGEST DIS SCI, V44, P1848, DOI 10.1023/A:1018846807296; Westhoff B, 2005, GASTROINTEST ENDOSC, V61, P226, DOI 10.1016/S0016-5107(04)02589-1; WILLIAMSON WA, 1991, ARCH INTERN MED, V151, P2212, DOI 10.1001/archinte.151.11.2212; ZHENG TZ, 1994, CANCER, V74, P1556, DOI 10.1002/1097-0142(19940901)74:5<1556::AID-CNCR2820740511>3.0.CO;2-0	41	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2010	5	3							e9483	10.1371/journal.pone.0009483	http://dx.doi.org/10.1371/journal.pone.0009483			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	561RT	20208996	Green Published, Green Submitted, gold			2022-12-25	WOS:000274997100022
J	Rodriguez-Garcia, M; Climent, N; Oliva, H; Casanova, V; Franco, R; Leon, A; Gatell, JM; Garcia, F; Gallart, T				Rodriguez-Garcia, Marta; Climent, Nuria; Oliva, Harold; Casanova, Victor; Franco, Rafael; Leon, Agathe; Gatell, Jose M.; Garcia, Felipe; Gallart, Teresa			Increased alpha-Defensins 1-3 Production by Dendritic Cells in HIV-Infected Individuals Is Associated with Slower Disease Progression	PLOS ONE			English	Article							COPY NUMBER VARIATION; ANTIRETROVIRAL THERAPY; BETA-DEFENSIN; ANTIMICROBIAL DEFENSINS; UNINFECTED INDIVIDUALS; ANTIGEN PRESENTATION; INNATE IMMUNITY; PLASMA-LEVELS; HOST-DEFENSE; T-CELLS	Background: Defensins are natural endogenous antimicrobial peptides with potent anti-HIV activity and immunomodulatory effects. We recently demonstrated that immature dendritic cells (DC) produce alpha-defensins1-3 and that alpha-defensins1- 3 modulate DC generation and maturation. Since DC-HIV interaction plays a critical role during the first steps of HIV infection, we investigated the possible impact of alpha-defensins1-3 production by DC on disease progression. Methodology/Principal Findings: Monocyte-derived DC (MDDC) were analyzed comparatively in healthy controls (HC) and HIV-infected patients, including untreated "elite'' and "viremic'' controllers, untreated viremic non-controllers and antiretroviral-treated patients. We found that production of alpha-defensins1-3 was significantly increased in MDDC from HIV-infected patients versus HC, and this increase was mainly due to that observed in controllers, while in non-controllers the increase was not statistically significant (controllers vs. HC, p<0.005; controllers vs. non-controllers p<0.05). Secreted alpha-defensins1-3 by immature MDDC positively correlated with CD4 T cell counts in controllers, but not in non-controllers. Moreover, independently of their clinical classification, HIV-infected patients with higher alpha-defensins1-3 secretion by immature MDDC showed slower disease progression, measured as no decrease in the number of CD4+ T-cells below 350 cell/mm(3), lower increase of plasma viral load and no initiation of treatment over time. Plasma alpha-defensins1-3 levels lacked any relationship with immunologic and virologic parameters. Conclusions/Significance: High production of alpha-defensins1-3 by immature DCs appears as a host protective factor against progression of HIV-1infection, suggesting potential diagnostic, therapeutic and preventive implications. This protective effect may arise from the activity of alpha-defensins1-3 to damage the virions prior and/or after their internalization by immature DC, and hence favoring a more efficient viral processing and presentation to HIV-specific CD4+ T cells, without or with a minor rate of transmission of infectious HIV-1 virions.	[Rodriguez-Garcia, Marta; Climent, Nuria; Oliva, Harold; Gallart, Teresa] Hosp Clin Barcelona, Serv Immunol, Barcelona, Spain; [Rodriguez-Garcia, Marta; Climent, Nuria; Oliva, Harold; Leon, Agathe; Gatell, Jose M.; Garcia, Felipe; Gallart, Teresa] IDIBAPS, AIDS Res Grp, Barcelona, Spain; [Rodriguez-Garcia, Marta; Climent, Nuria; Oliva, Harold; Leon, Agathe; Gatell, Jose M.; Garcia, Felipe; Gallart, Teresa] Catalonian Ctr HIV Vaccines HIVACAT, Barcelona, Spain; [Casanova, Victor; Franco, Rafael] Univ Barcelona, Sch Med, Hosp Clin Barcelona, Barcelona, Spain; [Casanova, Victor; Franco, Rafael] Dept Biochem & Mol Biol, Barcelona, Spain; [Franco, Rafael] Univ Barcelona, Fac Biol, Barcelona, Spain; [Franco, Rafael] Univ Navarra, Ctr Invest Med Aplicada, E-31080 Pamplona, Spain; [Leon, Agathe; Gatell, Jose M.; Garcia, Felipe] Hosp Clin Barcelona, Infect Dis & AIDS Unit, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; University of Navarra; University of Barcelona; Hospital Clinic de Barcelona	Rodriguez-Garcia, M (corresponding author), Massachusetts Gen Hosp, MIT, Ragon Inst, Boston, MA 02114 USA.	TGALLART@clinic.ub.es	Gatell, Jose M/ABC-3607-2020; Leon, Agathe/K-9851-2015; , Felipe/F-4242-2014; Franco, Rafael/C-3694-2015; Climent, Núria/AAF-8161-2021	Leon, Agathe/0000-0002-1198-5090; , Felipe/0000-0001-7658-5832; Franco, Rafael/0000-0003-2549-4919; Climent, Núria/0000-0002-0791-656X; Casanova, Victor/0000-0002-4917-260X	Spanish Ministry of Health [FIS2003-1200, FIS2006-1259]; Spanish Ministry of Education and Science [SAF2005-05566, FIPSE36536-2005]; Foundation for the Investigation and Prevention of AIDS in Spain; Ministry of Health [ISCIII-RETIC RD06/006]; "Prof. Maximo Soriano Foundation'';  [FIPSE36750]	Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); Spanish Ministry of Education and Science(Spanish Government); Foundation for the Investigation and Prevention of AIDS in Spain; Ministry of Health; "Prof. Maximo Soriano Foundation''; 	This study was mainly supported by Research Grants FIS2003-1200 and FIS2006-1259 (T. G.) from the Spanish Ministry of Health. Additional support was also received from the research grants SAF2005-05566 (J.M.G.) from the Spanish Ministry of Education and Science, FIPSE36536-2005 (T. G.), the Foundation for the Investigation and Prevention of AIDS in Spain, ISCIII-RETIC RD06/006 from the Spanish Cooperative Network of AIDS Research Groups from the Ministry of Health (J.M.G., F. G., T. G.), and FIPSE36750 (R. F.). "Prof. Maximo Soriano Foundation'' contributed in the financial support of the PhD studies of H. A. This Foundation honors the memory of Maximo Soriano, a full Professor of Medicine of the Faculty of Medicine of the University of Barcelona. It is totally academic and aimed to promote biomedical and clinical research in the field of infectious diseases. M. R-G. is the recipient of a research award "Emili Letang'' (Hospital Clinic, Barcelona). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agerberth B, 2000, BLOOD, V96, P3086, DOI 10.1182/blood.V96.9.3086.h8003086_3086_3093; Aldred PMR, 2005, HUM MOL GENET, V14, P2045, DOI 10.1093/hmg/ddi209; Ballantyne C, 2007, EUR J CARDIOV PREV R, V14, P3; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Baroncelli S, 2008, JAIDS-J ACQ IMM DEF, V47, P647, DOI 10.1097/QAI.0b013e31815f3c4c; Baroncelli S, 2007, AIDS RES HUM RETROV, V23, P287, DOI 10.1089/aid.2006.0142; Chalifour A, 2004, BLOOD, V104, P1778, DOI 10.1182/blood-2003-08-2820; Chaly YV, 2000, EUR CYTOKINE NETW, V11, P257; Chang TL, 2005, J CLIN INVEST, V115, P765, DOI 10.1172/JCI200521948; Chang TL, 2004, AIDS REV, V6, P161; Chang TLY, 2003, J VIROL, V77, P6777, DOI 10.1128/JVI.77.12.6777-6784.2003; Cole AM, 2008, AM J REPROD IMMUNOL, V59, P27, DOI 10.1111/j.1600-0897.2007.00561.x; Deeks SG, 2007, IMMUNITY, V27, P406, DOI 10.1016/j.immuni.2007.08.010; Fang XM, 2003, EUR J CLIN INVEST, V33, P82, DOI 10.1046/j.1365-2362.2003.01076.x; Folkvord JM, 2005, AIDS RES HUM RETROV, V21, P363, DOI 10.1089/aid.2005.21.363; Folkvord JM, 2006, JAIDS-J ACQ IMM DEF, V42, P529, DOI 10.1097/01.qai.0000225010.68815.1b; Furci L, 2007, BLOOD, V109, P2928, DOI 10.1182/blood-2006-05-024489; GANZ T, 1985, J CLIN INVEST, V76, P1427, DOI 10.1172/JCI112120; GANZ T, 1987, INFECT IMMUN, V55, P568, DOI 10.1128/IAI.55.3.568-571.1987; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Garcia F, 2005, J INFECT DIS, V191, P1680, DOI 10.1086/429340; Garcia F, 2001, AIDS, V15, P131, DOI 10.1097/00002030-200101050-00023; Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2; Groth M, 2008, HUM MUTAT, V29, P1247, DOI 10.1002/humu.20751; Guermonprez P, 2002, ANNU REV IMMUNOL, V20, P621, DOI 10.1146/annurev.immunol.20.100301.064828; Guo CJ, 2004, AIDS, V18, P1217, DOI 10.1097/00002030-200405210-00020; Izaguirre A, 2003, J LEUKOCYTE BIOL, V74, P1125, DOI 10.1189/jlb.0603255; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kitahata MM, 2009, NEW ENGL J MED, V360, P1815, DOI 10.1056/NEJMoa0807252; Klotman ME, 2006, NAT REV IMMUNOL, V6, P447, DOI 10.1038/nri1860; Lanzavecchia A, 2001, CELL, V106, P263, DOI 10.1016/S0092-8674(01)00455-X; Larsson M, 2003, CURR TOP MICROBIOL, V276, P261; Lee AW, 2002, VACCINE, V20, pA8, DOI 10.1016/S0264-410X(02)00382-1; Leon B, 2007, IMMUNITY, V26, P519, DOI 10.1016/j.immuni.2007.01.017; Levinson P, 2009, AIDS, V23, P309, DOI 10.1097/QAD.0b013e328321809c; Linzmeier RM, 2005, GENOMICS, V86, P423, DOI 10.1016/j.ygeno.2005.06.003; Mackewicz CE, 2003, AIDS, V17, pF23, DOI 10.1097/00002030-200309260-00001; McDonald D, 2003, SCIENCE, V300, P1295, DOI 10.1126/science.1084238; Milanese M, 2009, JAIDS-J ACQ IMM DEF, V50, P331, DOI 10.1097/QAI.0b013e3181945f39; OGARRA A, 1992, ANN NY ACAD SCI, V651, P182; Okazaki T, 2007, J OBSTET GYNAECOL RE, V33, P645, DOI 10.1111/j.1447-0756.2007.00626.x; Pacheco R, 2005, P NATL ACAD SCI USA, V102, P9583, DOI 10.1073/pnas.0501050102; Pacheco R, 2006, J IMMUNOL, V177, P6695, DOI 10.4049/jimmunol.177.10.6695; PANYUTICH AV, 1993, J LAB CLIN MED, V122, P202; Randolph GJ, 2008, CURR OPIN IMMUNOL, V20, P52, DOI 10.1016/j.coi.2007.10.010; Rinaldo CR, 2009, J INTERN MED, V265, P138, DOI 10.1111/j.1365-2796.2008.02047.x; Rodriguez-Garcia M, 2007, J LEUKOCYTE BIOL, V82, P1143, DOI 10.1189/jlb.0507295; Rodriguez-Garcia M, 2009, CLIN IMMUNOL, V131, P374, DOI 10.1016/j.clim.2009.01.012; Sabado RL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004256; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; Sterne JAC, 2009, LANCET, V373, P1352, DOI 10.1016/S0140-6736(09)60612-7; Trabattoni D, 2004, JAIDS-J ACQ IMM DEF, V35, P455, DOI 10.1097/00126334-200404150-00003; Vaschetto R, 2007, J LEUKOCYTE BIOL, V81, P1022, DOI 10.1189/jlb.0706435; Vernazza PL, 1999, AIDS, V13, P155, DOI 10.1097/00002030-199902040-00003; Wu L, 2007, IMMUNITY, V26, P741, DOI 10.1016/j.immuni.2007.06.006; Wu L, 2006, NAT REV IMMUNOL, V6, P859, DOI 10.1038/nri1960; Yang D, 2000, J LEUKOCYTE BIOL, V68, P9; Yang D, 2004, ANNU REV IMMUNOL, V22, P181, DOI 10.1146/annurev.immunol.22.012703.104603; Yu HJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000134; Zapata W, 2008, CURR HIV RES, V6, P531, DOI 10.2174/157016208786501463; ZHANG LY, 2002, J PLANT, V1, P2	61	36	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2010	5	2							e9436	10.1371/journal.pone.0009436	http://dx.doi.org/10.1371/journal.pone.0009436			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SY	20195543	Green Published, gold, Green Submitted			2022-12-25	WOS:000274924300021
J	Bonomi, HR; Marchesini, MI; Klinke, S; Ugalde, JE; Zylberman, V; Ugalde, RA; Comerci, DJ; Goldbaum, FA				Ruy Bonomi, Hernan; Ines Marchesini, Maria; Klinke, Sebastian; Ugalde, Juan E.; Zylberman, Vanesa; Ugalde, Rodolfo A.; Comerci, Diego J.; Alberto Goldbaum, Fernando			An Atypical Riboflavin Pathway Is Essential for Brucella abortus Virulence	PLOS ONE			English	Article							LUMAZINE SYNTHASE; ACTINOBACILLUS-PLEUROPNEUMONIAE; TRANSPOSON MUTAGENESIS; ENDOPLASMIC-RETICULUM; RHODOCOCCUS-EQUI; BIOSYNTHESIS; RIBOSWITCHES; ADAPTATION; MACROPHAGE; MECHANISM	Brucellosis is a worldwide zoonosis that affects livestock and humans and is caused by closely related Brucella spp., which are adapted to intracellular life within cells of a large variety of mammals. Brucella can be considered a furtive pathogen that infects professional and non-professional phagocytes. In these cells Brucella survives in a replicative niche, which is characterized for having a very low oxygen tension and being deprived from nutrients such as amino acids and vitamins. Among these vitamins, we have focused on riboflavin (vitamin B2). Flavin metabolism has been barely implicated in bacterial virulence. We have recently described that Brucella and other Rhizobiales bear an atypical riboflavin metabolic pathway. In the present work we analyze the role of the flavin metabolism on Brucella virulence. Mutants on the two lumazine synthases (LS) isoenzymes RibH1 and RibH2 and a double RibH mutant were generated. These mutants and different complemented strains were tested for viability and virulence in cells and in mice. In this fashion we have established that at least one LS must be present for B. abortus survival and that RibH2 and not RibH1 is essential for intracellular survival due to its LS activity in vivo. In summary, we show that riboflavin biosynthesis is essential for Brucella survival inside cells or in mice. These results highlight the potential use of flavin biosynthetic pathway enzymes as targets for the chemotherapy of brucellosis.	[Ruy Bonomi, Hernan; Klinke, Sebastian; Zylberman, Vanesa; Alberto Goldbaum, Fernando] Consejo Nacl Invest Cient & Tecn, Fdn Inst Leloir, RA-1033 Buenos Aires, DF, Argentina; [Ines Marchesini, Maria; Ugalde, Juan E.; Ugalde, Rodolfo A.; Comerci, Diego J.] Univ Nacl Gen San Martin, CONICET, Inst Invest Biotecnol, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Leloir Institute; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Bonomi, HR (corresponding author), Consejo Nacl Invest Cient & Tecn, Fdn Inst Leloir, RA-1033 Buenos Aires, DF, Argentina.	fgoldbaum@leloir.org.ar	Klinke, Sebastián/N-6174-2018; Bonomi, Hernán Ruy/D-8826-2019	Klinke, Sebastián/0000-0002-8777-0870; Bonomi, Hernán Ruy/0000-0002-1550-6181; Marchesini, Ines/0000-0002-8540-2337; Goldbaum, Fernando/0000-0001-6235-3002; Comerci, Diego J./0000-0003-1949-4226	Consejo Nacional de Investigaciones Cientificas y Tecnologicas (CONICET); Agencia Nacional de Promocion Cientifica y Tecnologica [PICT2004 21193, PICT2005 38272, PICT2006 651]; National Institutes of Health [NIAID-NIH-RO1AI078891-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI078891] Funding Source: NIH RePORTER	Consejo Nacional de Investigaciones Cientificas y Tecnologicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by a grant from the Howard Hughes Medical Institute to Dr. Fernando A. Goldbaum. Part of the work was supported by the Consejo Nacional de Investigaciones Cientificas y Tecnologicas (CONICET), the Agencia Nacional de Promocion Cientifica y Tecnologica (project PICT2004 21193, PICT2005 38272 & PICT2006 651) and from the National Institutes of Health (grant NIAID-NIH-RO1AI078891-01). http://www.hhmi.org/; http://www.conicet.gov.ar/; http://www.agencia.mincyt.gov.ar/; http://www.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu-Goodger C, 2005, NUCLEIC ACIDS RES, V33, pW690, DOI 10.1093/nar/gki445; Al Dahouk S, 2008, PROTEOMICS, V8, P3862, DOI 10.1002/pmic.200800026; Ashour J, 2003, J BACTERIOL, V185, P2644, DOI 10.1128/JB.185.8.2644-2652.2003; Braden BC, 2000, J MOL BIOL, V297, P1031, DOI 10.1006/jmbi.2000.3640; Celli J, 2006, RES MICROBIOL, V157, P93, DOI 10.1016/j.resmic.2005.10.002; Celli J, 2003, J EXP MED, V198, P545, DOI 10.1084/jem.20030088; Fischer M, 2005, NAT PROD REP, V22, P324, DOI 10.1039/b210142b; Fischer M, 2008, ARCH BIOCHEM BIOPHYS, V474, P252, DOI 10.1016/j.abb.2008.02.008; Fuller TE, 1996, INFECT IMMUN, V64, P4659, DOI 10.1128/IAI.64.11.4659-4664.1996; Fuller TE, 2000, VACCINE, V18, P2867, DOI 10.1016/S0264-410X(00)00076-1; GARCIARAMIREZ JJ, 1995, J BIOL CHEM, V270, P23801, DOI 10.1074/jbc.270.40.23801; Gelfand MS, 1999, TRENDS GENET, V15, P439, DOI 10.1016/S0168-9525(99)01856-9; GERHARDT P, 1958, BACTERIOL REV, V22, P81, DOI 10.1128/MMBR.22.2.81-98.1958; GOLDBAUM FA, 1993, J CLIN MICROBIOL, V31, P2141, DOI 10.1128/JCM.31.8.2141-2145.1993; Imlay JA, 2002, ADV MICROB PHYSIOL, V46, P111, DOI 10.1016/S0065-2911(02)46003-1; de Bagues MPJ, 2007, INFECT IMMUN, V75, P531, DOI 10.1128/IAI.01185-06; Joosten V, 2007, CURR OPIN CHEM BIOL, V11, P195, DOI 10.1016/j.cbpa.2007.01.010; Klinke S, 2005, J MOL BIOL, V353, P124, DOI 10.1016/j.jmb.2005.08.017; Klinke S, 2007, J MOL BIOL, V373, P664, DOI 10.1016/j.jmb.2007.08.021; KOVACH ME, 1994, BIOTECHNIQUES, V16, P800; Larnontagne J, 2009, J PROTEOME RES, V8, P1594, DOI 10.1021/pr800978p; Lopez AM, 2008, VACCINE, V26, P998, DOI 10.1016/j.vaccine.2007.10.069; Moriyon I, 2004, VET RES, V35, P1, DOI 10.1051/vetres:2003037; Pappas G, 2006, LANCET INFECT DIS, V6, P91, DOI 10.1016/S1473-3099(06)70382-6; Pizarro-Cerda J, 1998, INFECT IMMUN, V66, P5711; Roop RM, 2004, MOL MICROBIOL, V52, P621, DOI 10.1111/j.1365-2958.2004.04017.x; Schurig GG, 2002, VET MICROBIOL, V90, P479, DOI 10.1016/S0378-1135(02)00255-9; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Starr T, 2008, TRAFFIC, V9, P678, DOI 10.1111/j.1600-0854.2008.00718.x; Swartz TE, 2007, SCIENCE, V317, P1090, DOI 10.1126/science.1144306; Taga ME, 2007, NATURE, V446, P449, DOI 10.1038/nature05611; Viadas C, 2009, MICROB PATHOGENESIS, V47, P189, DOI 10.1016/j.micpath.2009.06.002; Vitreschak AG, 2004, TRENDS GENET, V20, P44, DOI 10.1016/j.tig.2003.11.008; Zylberman V, 2004, J BIOL CHEM, V279, P8093, DOI 10.1074/jbc.M312035200; Zylberman V, 2006, J BACTERIOL, V188, P6135, DOI 10.1128/JB.00207-06	35	43	47	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2010	5	2							e9435	10.1371/journal.pone.0009435	http://dx.doi.org/10.1371/journal.pone.0009435			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SY	20195542	Green Published, gold, Green Submitted			2022-12-25	WOS:000274924300020
J	Geraci, G; D'Elia, I; del Gaudio, R; Di Giaimo, R				Geraci, Giuseppe; D'Elia, Ida; del Gaudio, Rosanna; Di Giaimo, Rossella			Evidence of Genetic Instability in Tumors and Normal Nearby Tissues	PLOS ONE			English	Article							AQUATICUS DNA-POLYMERASE; HPRT MUTATIONS; MEL CELLS; MULTIPLE MUTATIONS; MUTATOR PHENOTYPE; HUMAN CANCERS; STEM-CELLS; IN-VIVO; GENOME; DIFFERENTIATION	Background: Comprehensive analyses have recently been performed on many human cancer tissues, leading to the identification of a number of mutated genes but providing no information on the variety of mutations present in each of them. This information is of interest to understand the possible origin of gene mutations that cause tumors. Methodology/Principal Findings: We have analyzed the sequence heterogeneity of the transcripts of the human HPRT and G6PD single copy genes that are not considered tumor markers. Analyses have been performed on different colon cancers and on the nearby histologically normal tissues of two male patients. Several copies of each cDNA, which were produced by cloning the RT-PCR-amplified fragments of the specific mRNA, have been sequenced. Similar analyses have been performed on blood samples of two ostensibly healthy males as reference controls. The sequence heterogeneity of the HPRT and G6PD genes was also determined on DNA from tumor tissues. The employed analytical approach revealed the presence of low-frequency mutations not detectable by other procedures. The results show that genetic heterogeneity is detectable in HPRT and G6PD transcripts in both tumors and nearby healthy tissues of the two studied colon tumors. Similar frequencies of mutations are observed in patient genomic DNA, indicating that mutations have a somatic origin. HPRT transcripts show genetic heterogeneity also in healthy individuals, in agreement with previous results on human T-cells, while G6PD transcript heterogeneity is a characteristic of the patient tissues. Interestingly, data on TP53 show little, if any, heterogeneity in the same tissues. Conclusions/Significance: These findings show that genetic heterogeneity is a peculiarity not only of cancer cells but also of the normal tissue where a tumor arises.	[Geraci, Giuseppe; D'Elia, Ida; del Gaudio, Rosanna; Di Giaimo, Rossella] Univ Naples Federico 2, Dept Biol Sci, Naples, Italy; [Geraci, Giuseppe] Ceinge Biotecnol Avanzate Scarl, Naples, Italy	University of Naples Federico II; CEINGE Biotecnologie Avanzate	Geraci, G (corresponding author), Univ Naples Federico 2, Dept Biol Sci, Naples, Italy.	digiaimo@unina.it	del GAUDIO, ROSANNA/C-9240-2014; Di Giaimo, Rossella/A-3521-2014	del GAUDIO, ROSANNA/0000-0003-1208-6270; Di Giaimo, Rossella/0000-0003-3604-3697	Department of Biological Sciences, University of Naples Federico II	Department of Biological Sciences, University of Naples Federico II	This work was supported by research fundings of the Department of Biological Sciences, University of Naples Federico II. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertini RJ, 1998, MUTAT RES-FUND MOL M, V400, P381, DOI 10.1016/S0027-5107(98)00063-3; Albertini RJ, 2001, MUTAT RES-REV MUTAT, V489, P1, DOI 10.1016/S1383-5742(01)00064-3; Allegretta M, 2005, ENVIRON MOL MUTAGEN, V45, P326, DOI 10.1002/em.20120; Bielas JH, 2006, P NATL ACAD SCI USA, V103, P18238, DOI 10.1073/pnas.0607057103; COLEMAN WB, 1995, CLIN CHEM, V41, P644; Ferrari R, 2009, NAT REV GENET, V10, P290, DOI 10.1038/nrg2539; Foresti M, 1997, MUTAT RES-FUND MOL M, V374, P269, DOI 10.1016/S0027-5107(96)00242-4; FORESTI M, 1993, MUTAT RES, V294, P69, DOI 10.1016/0921-8777(93)90059-P; FORESTI M, 1992, MUTAT RES, V265, P195, DOI 10.1016/0027-5107(92)90048-7; Fraser P, 2007, NATURE, V447, P413, DOI 10.1038/nature05916; Grant BW, 1999, MUTAT RES-FUND MOL M, V431, P183, DOI 10.1016/S0027-5107(99)00161-X; Green P, 2003, NAT GENET, V33, P514, DOI 10.1038/ng1103; Heng HHQ, 2009, J CELL PHYSIOL, V220, P538, DOI 10.1002/jcp.21799; HESS ST, 1994, J MOL BIOL, V236, P1022, DOI 10.1016/0022-2836(94)90009-4; INNIS MA, 1988, P NATL ACAD SCI USA, V85, P9436, DOI 10.1073/pnas.85.24.9436; Jackson AL, 1998, SEMIN CANCER BIOL, V8, P421, DOI 10.1006/scbi.1998.0113; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Loeb KR, 2000, CARCINOGENESIS, V21, P379, DOI 10.1093/carcin/21.3.379; Loeb LA, 2001, CANCER RES, V61, P3230; Majewski J, 2003, AM J HUM GENET, V73, P688, DOI 10.1086/378134; Meaburn KJ, 2007, NATURE, V445, P379, DOI 10.1038/445379a; MOHANDAS T, 1984, AM J HUM GENET, V36, P916; Nicklas JA, 2006, ENVIRON MOL MUTAGEN, V47, P212, DOI 10.1002/em.20187; Olivier M, 2002, HUM MUTAT, V19, P607, DOI 10.1002/humu.10081; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Suzuki M, 2000, J BIOL CHEM, V275, P32728, DOI 10.1074/jbc.M000097200; Takizawa T, 2008, CELL, V135, P9, DOI 10.1016/j.cell.2008.09.026; Turner BM, 2009, PHILOS T R SOC B, V364, P3403, DOI 10.1098/rstb.2009.0125; Vermeulen L, 2008, P NATL ACAD SCI USA, V105, P13427, DOI 10.1073/pnas.0805706105; Wilson VL, 2000, CANCER RES, V60, P1830; You FM, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-253	31	2	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2010	5	2							e9343	10.1371/journal.pone.0009343	http://dx.doi.org/10.1371/journal.pone.0009343			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SV	20186333	Green Submitted, gold, Green Published			2022-12-25	WOS:000274924000004
J	Shima-Sano, T; Yamada, R; Sekita, K; Hankins, RW; Hori, H; Seto, H; Sudo, K; Kondo, M; Kawahara, K; Tsukahara, Y; Inaba, N; Kato, S; Imai, M				Shima-Sano, Takako; Yamada, Rika; Sekita, Kazuyo; Hankins, Raleigh W.; Hori, Hiromasa; Seto, Hiroshi; Sudo, Koji; Kondo, Makiko; Kawahara, Kazuo; Tsukahara, Yuki; Inaba, Noriyuki; Kato, Shingo; Imai, Mitsunobu			A Human Immunodeficiency Virus Screening Algorithm to Address the High Rate of False-Positive Results in Pregnant Women in Japan	PLOS ONE			English	Article							COMBINED P24 ANTIGEN; ANTIBODY-ASSAYS; HIV; SPECIFICITY; INFECTION; TESTS	Background: Prenatal human immunodeficiency virus (HIV) testing is essential for the prevention of mother-to-child transmission. However, false-positive results of screening testing are a concern as they may cause unnecessary emotional stress to pregnant women waiting for confirmatory test results. In regions with an extremely low prevalence, the positive predictive values of screening are unacceptably low rate. Here, we propose a HIV screening algorithm consisting of serial two fourth-generation enzyme immunoassays to reduce the number of false-positive screening results. Methodology/Principal Findings: When 6461 pregnant women presenting to two maternity hospitals located in the Tokyo metropolitan area of Japan from September, 2004 to January, 2006 were tested using Enzygnost HIV Integral as a first screening test, 27 showed positive reactions. When these positive reaction samples were tested using VIDAS HIV DUO Quick as a second screening test, only one of them had a positive reaction, and the remaining 26 were nonreactive. Confirmatory Western blots and nucleic acid amplification test also showed that one was positive and the remaining 26 were negative; the subject who was positive with the confirmatory tests was identical to the subject who was positive with the second screening test. Thus, by adding the second screening test, the false-positive rate was improved from 0.4% to 0%, and the positive predictive value from 3.7% to 100%, compared with the single screening test. Conclusion: By applying our serial screening algorithm to HIV testing in maternity hospitals, many uninfected pregnant women would not need to receive confirmatory tests and be subjected to emotional turmoil while waiting for their confirmatory test results. This algorithm would be suitable for HIV testing of pregnant women living in low prevalence regions such as Japan.	[Shima-Sano, Takako; Sudo, Koji; Kondo, Makiko; Imai, Mitsunobu] Kanagawa Prefectural Inst Publ Hlth, Div Microbiol, Kanagawa, Japan; [Shima-Sano, Takako; Kawahara, Kazuo] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Hlth Care Management & Planning, Tokyo, Japan; [Yamada, Rika] Ishikawa Prefectural Cent Hosp, Dept Obstet & Gynecol, Ctr Womens & Childrens Hlth, Kanazawa, Ishikawa, Japan; [Sekita, Kazuyo; Hankins, Raleigh W.] Hlth Sci Res Inst Inc, Kanagawa, Japan; [Hori, Hiromasa] Hori Matern Hosp, Kanagawa, Japan; [Seto, Hiroshi] Seto Hosp, Saitama, Japan; [Tsukahara, Yuki] Natl Ctr Child Hlth & Dev, Div Obstet, Tokyo, Japan; [Inaba, Noriyuki] Dokkyo Med Univ, Dept Obstet & Gynecol, Mibu, Tochigi, Japan; [Sudo, Koji; Kato, Shingo] Keio Univ, Sch Med, Dept Microbiol & Immunol, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); Ishikawa Prefectural Central Hospital; National Center for Child Health & Development - Japan; Dokkyo Medical University; Keio University	Shima-Sano, T (corresponding author), Kanagawa Prefectural Inst Publ Hlth, Div Microbiol, Kanagawa, Japan.	sano.ipn@pref.kanagawa.jp			National Cooperative Study Group on HIV Infected Pregnant Women and Mother-to-child Transmission; Ministry of Health, Labour, and Welfare of Japan; Health Science Research Institute	National Cooperative Study Group on HIV Infected Pregnant Women and Mother-to-child Transmission; Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Health Science Research Institute	This study was supported in part by grants-in-aid for the National Cooperative Study Group on HIV Infected Pregnant Women and Mother-to-child Transmission, and the Study Group on the improvement of HIV Testing and Counseling Services from the Ministry of Health, Labour, and Welfare of Japan. This was also supported by Health Science Research Institute, Incorporated, due to employment of two authors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chou R, 2005, ANN INTERN MED, V143, P38, DOI 10.7326/0003-4819-143-1-200507050-00009; Doran TI, 2000, ARCH FAM MED, V9, P924, DOI 10.1001/archfami.9.9.924; Grimes DA, 2002, LANCET, V359, P881, DOI 10.1016/S0140-6736(02)07948-5; Guinn D, 2007, JAMA-J AM MED ASSOC, V297, P947, DOI 10.1001/jama.297.9.947-a; Joint United Nations Programme on HIV/AIDS & World Health Organization, 2008, EP FACT SHEET HIV AI; Ly TD, 2004, J VIROL METHODS, V122, P185, DOI 10.1016/j.jviromet.2004.08.018; Ly TD, 2007, J VIROL METHODS, V143, P86, DOI 10.1016/j.jviromet.2007.02.013; Magee LA, 1999, CAN MED ASSOC J, V160, P1285; *MIN HLTH LAB WELF, 2007, GUID PREV MOTH TO CH; *MIN HLTH LAB WELF, 2007, HIV TEST PREGN WOM N; *MIN HLTH LAB WELF, 2007, ANN RES REP COOP STU; Mylonakis E, 2000, AM J MED, V109, P568, DOI 10.1016/S0002-9343(00)00583-0; *NAT I INF DIS JAP, 2008, IASR, V29, P145; Owen SM, 2008, J CLIN MICROBIOL, V46, P1588, DOI 10.1128/JCM.02196-07; Saville RD, 2001, J CLIN MICROBIOL, V39, P2518, DOI 10.1128/JCM.39.7.2518-2524.2001; TAMASHIRO H, 1993, LANCET, V342, P87, DOI 10.1016/0140-6736(93)91289-X; Weber B, 2002, J CLIN MICROBIOL, V40, P1420, DOI 10.1128/JCM.40.4.1420-1426.2002; Weber B, 2002, J CLIN MICROBIOL, V40, P1938, DOI 10.1128/JCM.40.6.1938-1946.2002; YAMADA R, 2008, NIHON SEIKANSENSYO G, V81, P562; Zacharias Nikolaos M, 2004, J Perinatol, V24, P743, DOI 10.1038/sj.jp.7211184	20	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2010	5	2							e9382	10.1371/journal.pone.0009382	http://dx.doi.org/10.1371/journal.pone.0009382			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SV	20186348	Green Published, Green Submitted, gold			2022-12-25	WOS:000274924000022
J	Harper, JM; Wilkinson, JE; Miller, RA				Harper, James M.; Wilkinson, J. Erby; Miller, Richard A.			Macrophage migration inhibitory factor-knockout mice are long lived and respond to caloric restriction	FASEB JOURNAL			English	Article						MIF; CR; life span; cancer; inflammation	AUGSBURG CASE-COHORT; FACTOR MIF; LIFE-SPAN; FACTOR GENE; RHEUMATOID-ARTHRITIS; PROSTATE-CANCER; GROWTH; INFLAMMATION; EXPRESSION; GLUCOSE	Macrophage migration inhibitory factor (MIF) affects inflammation, glucose homeostasis, and cellular proliferation in mammals. Previously, we found that MIF was significantly elevated in multiple long-lived mouse models, including calorie restriction (CR), which led us to hypothesize that MIF might be important in the control of mammalian life span and be necessary for the life-extending effects of CR. To test this hypothesis, we examined the life span of mice with a targeted deletion of the Mif gene on a segregating B6 x 129/Sv background (MIF-KO) under ad libitum (AL) feeding and CR conditions. Control mice were generated by mating C57BL/6J females with 129/SvJ males to make an F1 hybrid, and crossing F1 males to F1 females to produce segregating F2 mice homozygous for the normal MIF allele. Not only did MIF-KO mice show a life span extension in response to CR, they were, unexpectedly, longer lived than controls under standard AL conditions. MIF-KO mice were significantly protected against lethal hemangiosarcoma, but more likely than controls to die of disseminated amyloid, an age-related inflammatory syndrome. Overall, these data refute the suggestion that MIF is required for the CR effect on life span, but raise the possibility that MIF may limit life span in normal mice.-Harper, J.M., Wilkinson, J.E., Miller, R.A. Macrophage migration inhibitory factor-knockout mice are long lived and respond to caloric restriction. FASEB J. 24, 2436-2442 (2010). www.fasebj.org	[Harper, James M.; Miller, Richard A.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Harper, James M.; Miller, Richard A.] Univ Michigan, Geriatr Ctr, Ann Arbor, MI 48109 USA; [Wilkinson, J. Erby] Univ Michigan, Unit Lab Anim Med, Ann Arbor, MI 48109 USA; [Miller, Richard A.] Ann Arbor Vet Affairs Med Ctr, Geriatr Res Educ & Clin Ctr, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System	Harper, JM (corresponding author), Rm 3005,BSRB,Box 2200,109 Zina Pitcher Pl, Ann Arbor, MI 48109 USA.	jmharper@umich.edu		Harper, James/0000-0003-0765-8828	U.S. National Institutes of Health [AG023122, AG024824, AG013283]; NATIONAL INSTITUTE ON AGING [P30AG013283, U19AG023122, P30AG024824] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank Melissa Burns, Maggie Lauderdale, and Jessica Sewald for technical assistance. The work was supported by U.S. National Institutes of Health grants AG023122, AG024824, and AG013283. The authors report no conflict of interest.	Al-Regaiey KA, 2007, J GERONTOL A-BIOL, V62, P18, DOI 10.1093/gerona/62.1.18; Anahara R, 2006, REPROD TOXICOL, V21, P167, DOI 10.1016/j.reprotox.2005.08.001; Awandare GA, 2009, J INFECT DIS, V200, P629, DOI 10.1086/600894; Bach JP, 2008, ONCOLOGY-BASEL, V75, P127, DOI 10.1159/000155223; Bacher M, 1997, AM J PATHOL, V150, P235; Bartke A, 2001, NATURE, V414, P412, DOI 10.1038/35106646; Bell EL, 2007, MOL CELL BIOL, V27, P5737, DOI 10.1128/MCB.02265-06; Bocheva A., 2008, Autonomic & Autacoid Pharmacology, V28, P117, DOI 10.1111/j.1474-8673.2008.00425.x; Bozza M, 1999, J EXP MED, V189, P341, DOI 10.1084/jem.189.2.341; Bucala R, 1996, FASEB J, V10, P1607, DOI 10.1096/fasebj.10.14.9002552; Burger-Kentischer A, 2002, CIRCULATION, V105, P1561, DOI 10.1161/01.CIR.0000012942.49244.82; CALANDRA T, 1994, J EXP MED, V179, P1895, DOI 10.1084/jem.179.6.1895; Cavigelli SA, 2003, P NATL ACAD SCI USA, V100, P16131, DOI 10.1073/pnas.2535721100; Cavigelli SA, 2006, HORM BEHAV, V50, P454, DOI 10.1016/j.yhbeh.2006.06.001; Cvetkovic I, 2006, INT IMMUNOPHARMACOL, V6, P1527, DOI 10.1016/j.intimp.2006.06.009; de Jong YP, 2001, NAT IMMUNOL, V2, P1061, DOI 10.1038/ni720; Denz A, 2010, J SURG RES, V160, P29, DOI 10.1016/j.jss.2009.03.048; Ding GX, 2009, J SURG ONCOL, V100, P106, DOI 10.1002/jso.21304; Fingerle-Rowson G, 2003, AM J PATHOL, V162, P47, DOI 10.1016/S0002-9440(10)63797-2; Fingerle-Rowson GR, 2001, IMMUNOL CELL BIOL, V79, P368, DOI 10.1046/j.1440-1711.2001.01024.x; Fingerle-Rowson G, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-22; Flaster H, 2007, MOL ENDOCRINOL, V21, P1267, DOI 10.1210/me.2007-0065; GANGULY R, 1986, ALLERGOL IMMUNOPATH, V14, P1; GANGULY R, 1985, Allergie und Immunologie (Leipzig), V31, P203; Hagemann T, 2007, MOL CANCER THER, V6, P1993, DOI 10.1158/1535-7163.MCT-07-0118; Hardman MJ, 2005, AM J PATHOL, V167, P1561, DOI 10.1016/S0002-9440(10)61241-2; Herder C, 2008, DIABETOLOGIA, V51, P276, DOI 10.1007/s00125-007-0800-3; Herder C, 2006, DIABETES CARE, V29, P368, DOI 10.2337/diacare.29.02.06.dc05-1474; HOGENESCH H, 1993, VIRCHOWS ARCH B, V64, P37, DOI 10.1007/BF02915094; Honda A, 2009, CARCINOGENESIS, V30, P1597, DOI 10.1093/carcin/bgp160; Honma N, 2000, IMMUNOLOGY, V100, P84, DOI 10.1046/j.1365-2567.2000.00011.x; HUAXIANG XH, 2009, CANCER, V115, P5441; Koska J, 2009, INT J OBESITY, V33, P842, DOI 10.1038/ijo.2009.106; Magalhaes ES, 2009, FASEB J, V23, P1262, DOI 10.1096/fj.08-124248; Martin J, 2009, FASEB J, V23, P720, DOI 10.1096/fj.08-119628; Masternak MM, 2006, EXP GERONTOL, V41, P417, DOI 10.1016/j.exger.2006.01.009; Mehta R, 2009, SCIENCE, V324, P1196, DOI 10.1126/science.1173507; Meyer-Siegler KL, 2006, J IMMUNOL, V177, P8730, DOI 10.4049/jimmunol.177.12.8730; Miller RA, 2005, AGING CELL, V4, P119, DOI 10.1111/j.1474-9726.2005.00152.x; Miller RA, 2002, MOL ENDOCRINOL, V16, P2657, DOI 10.1210/me.2002-0142; Mitchell RA, 2004, CELL SIGNAL, V16, P13, DOI 10.1016/j.cellsig.2003.07.002; Mizue Y, 2000, INT J MOL MED, V5, P397; Morand EF, 2006, NAT REV DRUG DISCOV, V5, P399, DOI 10.1038/nrd2029; Morand EF, 2005, INTERN MED J, V35, P419, DOI 10.1111/j.1445-5994.2005.00853.x; Nemajerova A, 2007, EMBO J, V26, P987, DOI 10.1038/sj.emboj.7601564; Ohkawara T, 2008, SCAND J GASTROENTERO, V43, P1497, DOI 10.1080/00365520802273017; Paiva CN, 2009, J LEUKOCYTE BIOL, V85, P855, DOI 10.1189/jlb.0108009; Pan JH, 2004, CIRCULATION, V109, P3149, DOI 10.1161/01.CIR.0000134704.84454.D2; RACHELLE D, 2002, ARTHRITIS RHEUM, V46, P2402; Radstake TRDJ, 2005, ARTHRITIS RHEUM, V52, P3020, DOI 10.1002/art.21285; Rendon BE, 2009, EXP MOL PATHOL, V86, P180, DOI 10.1016/j.yexmp.2009.01.001; Rohrbach S, 2008, BIOGERONTOLOGY, V9, P169, DOI 10.1007/s10522-008-9126-x; Satoskar AR, 2001, INFECT IMMUN, V69, P906, DOI 10.1128/IAI.69.2.906-911.2001; Simpson EM, 1997, NAT GENET, V16, P19, DOI 10.1038/ng0597-19; Stosic-Grujicic S, 2008, J CELL PHYSIOL, V215, P665, DOI 10.1002/jcp.21346; Stosic-Grujicic S, 2009, AUTOIMMUN REV, V8, P244, DOI 10.1016/j.autrev.2008.07.037; Taylor JA, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-135; Thorand B, 2007, DIABETES CARE, V30, P854, DOI 10.2337/dc06-1693; Toso C, 2008, DIABETOLOGIA, V51, P1937, DOI 10.1007/s00125-008-1063-3; Turturro A, 2002, J GERONTOL A-BIOL, V57, pB379, DOI 10.1093/gerona/57.11.B379; Verschuren L, 2009, CIRC RES, V105, P99, DOI 10.1161/CIRCRESAHA.109.199166; Wang CX, 2004, MECH AGEING DEV, V125, P629, DOI 10.1016/j.mad.2004.07.003; Weindruch R., 1988, RETARDATION AGING DI; Welford SM, 2006, GENE DEV, V20, P3366, DOI 10.1101/gad.1471106; Wilson JM, 2005, GASTROENTEROLOGY, V129, P1485, DOI 10.1053/j.gastro.2005.07.061; Winner M, 2008, CANCER RES, V68, P7253, DOI 10.1158/0008-5472.CAN-07-6227; Xu XD, 2008, CANCER LETT, V261, P147, DOI 10.1016/j.canlet.2007.11.028; Yabunaka N, 2000, DIABETES CARE, V23, P256, DOI 10.2337/diacare.23.2.256; Yee JR, 2008, PSYCHOSOM MED, V70, P1050, DOI 10.1097/PSY.0b013e31818425fb; YOSHITAKA S, 2003, GASTROENTEROLOGY, V124, P725; Zhang Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006348	71	50	52	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2010	24	7					2436	2442		10.1096/fj.09-152223	http://dx.doi.org/10.1096/fj.09-152223			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	618HV	20219983	Green Submitted, Green Published			2022-12-25	WOS:000279343600030
J	Kalinowski, A; Plowes, NJR; Huang, QH; Berdejo-Izquierdo, C; Russell, RR; Russell, KS				Kalinowski, April; Plowes, Nicola J. R.; Huang, Qunhua; Berdejo-Izquierdo, Carla; Russell, Raymond R.; Russell, Kerry S.			Metalloproteinase-dependent cleavage of neuregulin and autocrine stimulation of vascular endothelial cells	FASEB JOURNAL			English	Article						epidermal growth factors; cytokines; inflammation; angiogenesis	AMYLOID PRECURSOR PROTEIN; NECROSIS-FACTOR-ALPHA; GROWTH-FACTOR; INTERFERON-GAMMA; CYTOPLASMIC TAIL; KINASE-C; HB-EGF; ANGIOGENESIS; INTERLEUKIN-6; EXPRESSION	Inflammation is often accompanied by robust angiogenesis. Vascular endothelial cells (ECs) express erbB receptors and their ligand, neuregulin-1, and can respond to neuregulin by proliferation and angiogenesis. We hypothesized that some growth factor-like responses of ECs to inflammatory cytokines can be explained by cleavage of transmembrane neuregulin with subsequent release of its extracellular epidermal growth factor-like-containing domain and autocrine activation. Using a model of cultured human ECs, we found that interleukin-6 or interferon-gamma causes rapid cleavage and release of transmembrane neuregulin. Inhibitors of metalloproteinases abolish this effect. The addition of an inhibitor of tumor necrosis factor-alpha converting enzyme (TACE) blocks cytokine-induced neuregulin release. Silencing of TACE expression increases the amount of basal proneuregulin present in ECs but does not block neuregulin release in response to phorbol myristate acetate (PMA), suggesting that other proteinases are responsible for mediating protein kinase C-dependent cleavage. Cytokines capable of inducing neuregulin cleavage stimulated ERK activation and in vitro angiogenesis (Matrigel cord formation). This effect is blocked by inhibitors that block neuregulin cleavage, erbB protein tyrosine kinase inhibitors, or antineuregulin-neutralizing antibodies. Cytokine-activated metalloproteinase cleavage of neuregulin may play an important role in autocrine activation of EC signaling pathways, contributing to key biological effects, perhaps including inflammation-associated angiogenesis.-Kalinowski, A., Plowes, N.J.R., Huang, Q., Berdejo-Izquierdo, C., Russell, R. R., Russell, K. S. Metalloproteinase-dependent cleavage of neuregulin and autocrine stimulation of vascular endothelial cells. FASEB J. 24, 2567-2575 (2010). www.fasebj.org	[Kalinowski, April; Plowes, Nicola J. R.; Huang, Qunhua; Berdejo-Izquierdo, Carla; Russell, Raymond R.; Russell, Kerry S.] Yale Univ, Sch Med, Dept Internal Med, Sect Cardiovasc Med, New Haven, CT 06510 USA	Yale University	Russell, KS (corresponding author), 316 FMP,333 Cedar St, New Haven, CT 06520 USA.	kerry.russell@yale.edu	Plowes, Nicola/N-9748-2019	Plowes, Nicola/0000-0003-2187-499X	U.S. National Heart, Lung, and Blood Institute [K08 HL004429, R01 HL080176]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080176, K08HL004429] Funding Source: NIH RePORTER	U.S. National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank Lawrence H. Young, David F. Stern, and Jeffrey R. Bender for helpful suggestions. This study was supported by U.S. National Heart, Lung, and Blood Institute grants K08 HL004429 and R01 HL080176 (to K.S.R.).	Barillari G, 1999, J IMMUNOL, V163, P1929; Ben-Hur T, 2006, J NEUROIMMUNOL, V175, P12, DOI 10.1016/j.jneuroim.2006.02.002; BURGESS TL, 1995, J BIOL CHEM, V270, P19188, DOI 10.1074/jbc.270.32.19188; Cote GM, 2005, EXP CELL RES, V311, P135, DOI 10.1016/j.yexcr.2005.08.017; Dethlefsen SM, 1998, J CELL BIOCHEM, V69, P143, DOI 10.1002/(SICI)1097-4644(19980501)69:2<143::AID-JCB5>3.0.CO;2-S; EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734; Esteve PO, 2002, J BIOL CHEM, V277, P35150, DOI 10.1074/jbc.M108600200; Fan F, 2004, CANCER RES, V64, P3186, DOI 10.1158/0008-5472.CAN-03-0407; Hernandez-Rodriguez J, 2003, CIRCULATION, V107, P2428, DOI 10.1161/01.CIR.0000066907.83923.32; Herrlich A, 2004, P NATL ACAD SCI USA, V101, P15799, DOI 10.1073/pnas.0406853101; Herrlich A, 2008, FASEB J, V22, P4281, DOI 10.1096/fj.08-113852; Jackson LF, 2003, EMBO J, V22, P2704, DOI 10.1093/emboj/cdg264; Kuramochi Y, 2004, J BIOL CHEM, V279, P51141, DOI 10.1074/jbc.M408662200; Kurohara K, 2004, DEV BIOL, V267, P14, DOI 10.1016/j.ydbio.2003.10.021; Kuwano T, 2004, FASEB J, V18, P300, DOI 10.1096/fj.03-0473com; Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922; Liao YF, 2004, J BIOL CHEM, V279, P49523, DOI 10.1074/jbc.M402034200; Liu XF, 1998, J BIOL CHEM, V273, P34335, DOI 10.1074/jbc.273.51.34335; Liu XF, 1998, P NATL ACAD SCI USA, V95, P13024, DOI 10.1073/pnas.95.22.13024; Montero JC, 2000, MOL CELL NEUROSCI, V16, P631, DOI 10.1006/mcne.2000.0896; Montero JC, 2002, BIOCHEM J, V363, P211, DOI 10.1042/0264-6021:3630211; Penkowa M, 2003, J NEUROSCI RES, V73, P481, DOI 10.1002/jnr.10681; PFAU S, 1995, J CELL BIOL, V128, P969, DOI 10.1083/jcb.128.5.969; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; Russell KS, 1999, AM J PHYSIOL-HEART C, V277, pH2205, DOI 10.1152/ajpheart.1999.277.6.H2205; Sanderson MP, 2006, GROWTH FACTORS, V24, P121, DOI 10.1080/08977190600634373; Shirakabe K, 2001, J BIOL CHEM, V276, P9352, DOI 10.1074/jbc.M007913200; Singh RJR, 2005, CARDIOVASC RES, V67, P39, DOI 10.1016/j.cardiores.2005.02.020; Trompezinski S, 2002, EXP DERMATOL, V11, P224, DOI 10.1034/j.1600-0625.2002.110305.x; Wei LH, 2003, ONCOGENE, V22, P1517, DOI 10.1038/sj.onc.1206226; Wessely R, 2005, CARDIOVASC RES, V66, P433, DOI 10.1016/j.cardiores.2005.03.013; Wu AJ, 1997, J CELL PHYSIOL, V171, P117, DOI 10.1002/(SICI)1097-4652(199705)171:2<117::AID-JCP1>3.0.CO;2-R; Zhou HM, 2004, MOL CELL BIOL, V24, P96, DOI 10.1128/MCB.24.1.96-104.2004	33	35	36	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2010	24	7					2567	2575		10.1096/fj.08-129072	http://dx.doi.org/10.1096/fj.08-129072			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	618HV	20215529	Green Published			2022-12-25	WOS:000279343600043
J	Biterova, EI; Barycki, JJ				Biterova, Ekaterina I.; Barycki, Joseph J.			Structural Basis for Feedback and Pharmacological Inhibition of Saccharomyces cerevisiae Glutamate Cysteine Ligase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-GLUTAMYLCYSTEINE SYNTHETASE; GLUTATHIONE SYNTHESIS; KINETIC MECHANISM; INTRACELLULAR GLUTATHIONE; BUTHIONINE SULFOXIMINE; ARABIDOPSIS-THALIANA; BINDING DETERMINANTS; RAT; SUBUNIT; POTENT	Structural characterization of glutamate cysteine ligase (GCL), the enzyme that catalyzes the initial, rate-limiting step in glutathione biosynthesis, has revealed many of the molecular details of substrate recognition. To further delineate the mechanistic details of this critical enzyme, we have determined the structures of two inhibited forms of Saccharomyces cerevisiae GCL (ScGCL), which shares significant sequence identity with the human enzyme. In vivo, GCL activity is feedback regulated by glutathione. Examination of the structure of ScGCL-glutathione complex (2.5 angstrom; R = 19.9%, R-free = 25.1%) indicates that the inhibitor occupies both the glutamate-and the presumed cysteine-binding site and disrupts the previously observed Mg2+ coordination in the ATP-binding site. L-Buthionine-S-sulfoximine (BSO) is a mechanism-based inhibitor of GCL and has been used extensively to deplete glutathione in cell culture and in vivo model systems. Inspection of the ScGCL-BSO structure (2.2 angstrom; R = 18.1%, R-free = 23.9%) confirms that BSO is phosphorylated on the sulfoximine nitrogen to generate the inhibitory species and reveals contacts that likely contribute to transition state stabilization. Overall, these structures advance our understanding of the molecular regulation of this critical enzyme and provide additional details of the catalytic mechanism of the enzyme.	[Barycki, Joseph J.] Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA; Univ Nebraska, Redox Biol Ctr, Lincoln, NE 68588 USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Barycki, JJ (corresponding author), Univ Nebraska, Dept Biochem, 1901 Vine St, Lincoln, NE 68588 USA.	jbarycki2@unl.edu			National Institutes of Health [1R01 GM077289, RR07707]; United States Department of Energy, Basic Energy Sciences, Office of Science [W-31-109-Eng-38]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR007707, P20RR017675] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077289] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 1R01 GM077289 (to J. J. B.) and RR07707. This work was also supported by United States Department of Energy, Basic Energy Sciences, Office of Science Contract W-31-109-Eng-38.	Abbott JJ, 2002, BIOCHEMISTRY-US, V41, P2741, DOI 10.1021/bi0159128; Abbott JJ, 2001, J BIOL CHEM, V276, P42099, DOI 10.1074/jbc.M104672200; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Anderson ME, 1998, CHEM-BIOL INTERACT, V112, P1; ARRICK BA, 1981, J EXP MED, V153, P720, DOI 10.1084/jem.153.3.720; Biterova EI, 2009, J BIOL CHEM, V284, P32700, DOI 10.1074/jbc.M109.025114; Brekken DL, 1998, J BIOL CHEM, V273, P26317, DOI 10.1074/jbc.273.41.26317; CAMPBELL EB, 1991, ANAL BIOCHEM, V194, P268, DOI 10.1016/0003-2697(91)90229-M; Copley SD, 2002, GENOME BIOL, V3; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fraser JA, 2002, J BIOL CHEM, V277, P1158, DOI 10.1074/jbc.M106683200; Galant A, 2009, PLANT CELL, V21, P3450, DOI 10.1105/tpc.109.071183; GODWIN AK, 1992, P NATL ACAD SCI USA, V89, P3070, DOI 10.1073/pnas.89.7.3070; Gogos A, 2002, STRUCTURE, V10, P1669, DOI 10.1016/S0969-2126(02)00906-1; GRIFFITH OW, 1982, J BIOL CHEM, V257, P13704; Griffith OW, 1999, ADV ENZYMOL RAMB, V73, P209, DOI 10.1002/9780470123195.ch7; Griffith OW, 1999, FREE RADICAL BIO MED, V27, P922, DOI 10.1016/S0891-5849(99)00176-8; GRIFFITH OW, 1979, J BIOL CHEM, V254, P7558; Herrera K, 2007, J BIOL CHEM, V282, P17157, DOI 10.1074/jbc.M700804200; Hibi T, 2004, P NATL ACAD SCI USA, V101, P15052, DOI 10.1073/pnas.0403277101; Hothorn M, 2006, J BIOL CHEM, V281, P27557, DOI 10.1074/jbc.M602770200; HUANG CS, 1993, J BIOL CHEM, V268, P19675; HUANG CS, 1993, J BIOL CHEM, V268, P20578; HUANG CS, 1988, P NATL ACAD SCI USA, V85, P2464, DOI 10.1073/pnas.85.8.2464; Jez JM, 2004, J BIOL CHEM, V279, P33463, DOI 10.1074/jbc.M405127200; Krajewski WW, 2005, P NATL ACAD SCI USA, V102, P10499, DOI 10.1073/pnas.0502248102; LIAW SH, 1994, BIOCHEMISTRY-US, V33, P675, DOI 10.1021/bi00169a007; Lu SC, 2009, MOL ASPECTS MED, V30, P42, DOI 10.1016/j.mam.2008.05.005; Luersen K, 2000, BIOCHEM J, V346, P545, DOI 10.1042/0264-6021:3460545; MARTENSSON J, 1991, P NATL ACAD SCI USA, V88, P9360, DOI 10.1073/pnas.88.20.9360; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; Misra I, 1998, PROTEIN EXPRES PURIF, V13, P268, DOI 10.1006/prep.1998.0897; MULCAHY RT, 1994, CANCER CHEMOTH PHARM, V34, P67, DOI 10.1007/s002800050105; MULCAHY RT, 1995, CANCER RES, V55, P4771; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; ORLOWSKI M, 1971, J BIOL CHEM, V246, P7095; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Polekhina G, 1999, EMBO J, V18, P3204, DOI 10.1093/emboj/18.12.3204; Rappa G, 2003, EUR J CANCER, V39, P120, DOI 10.1016/S0959-8049(02)00447-1; RICHMAN PG, 1975, J BIOL CHEM, V250, P1422; RODGERS DW, 1994, STRUCTURE, V2, P1135, DOI 10.1016/S0969-2126(94)00116-2; STRUMEYER DH, 1960, J BIOL CHEM, V235, pPC27; TATEISHI N, 1974, J BIOCHEM, V75, P93, DOI 10.1093/oxfordjournals.jbchem.a130387; Townsend DM, 2003, ONCOGENE, V22, P7369, DOI 10.1038/sj.onc.1206940; Wild AC, 1999, BIOCHEM J, V338, P659, DOI 10.1042/0264-6021:3380659; YIP B, 1976, J BIOL CHEM, V251, P3563	48	20	22	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14459	14466		10.1074/jbc.M110.104802	http://dx.doi.org/10.1074/jbc.M110.104802			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20220146	Green Published, hybrid			2022-12-25	WOS:000277299700042
J	Kondo, N; Miyauchi, K; Meng, FX; Iwamoto, A; Matsuda, Z				Kondo, Naoyuki; Miyauchi, Kosuke; Meng, Fanxia; Iwamoto, Aikichi; Matsuda, Zene			Conformational Changes of the HIV-1 Envelope Protein during Membrane Fusion Are Inhibited by the Replacement of Its Membrane-spanning Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GREEN FLUORESCENT PROTEIN; MEDIATED FUSION; 6-HELIX BUNDLE; GP41; LUCIFERASE; VIRION; CELLS	To help understand the dynamic nature of membrane fusion induced by the human immunodeficiency virus-1 (HIV-1) envelope protein, we developed a new cell-based real-time assay system employing a pair of novel reporter proteins. The reporter proteins consist of a pair of split Renilla luciferase (spRL) fused to split green fluorescent protein (spGFP). The spGFP modules were chosen not only to compensate weak self-association of spRL but also to provide visual reporter signals during membrane fusion. Use of this reporter together with a membrane permeable substrate for Renilla luciferase achieved a simple real-time monitoring of membrane fusion using live cells. We analyzed the HIV-1 envelope mutants whose membrane-spanning domains were replaced with that of glycophorin A or vesicular stomatitis virus G-protein. These mutants showed a slower kinetics of membrane fusion. The analysis of membrane fusion in the presence of fusion inhibitors, soluble CD4 and C34, revealed that these replacements prolonged the period during which the mutants were sensitive to the inhibitors, as compared with the wild type. These results suggest that the mutations within the membrane-spanning domains exerted an allosteric effect on the HIV-1 envelope protein, probably affecting the receptor-induced conformational changes of the ectodomain of the protein.	[Kondo, Naoyuki; Iwamoto, Aikichi; Matsuda, Zene] Univ Tokyo, Res Ctr Asian Infect Dis, Inst Med Sci, Minato Ku, Tokyo 1088639, Japan; [Iwamoto, Aikichi] Univ Tokyo, Div Infect Dis, Inst Med Sci,Adv Clin Res Ctr, Minato Ku, Tokyo 1088639, Japan; [Kondo, Naoyuki; Meng, Fanxia; Matsuda, Zene] Chinese Acad Sci, Inst Biophys, China Japan Joint Lab Struct Virol & Immunol, Beijing 100101, Peoples R China; [Miyauchi, Kosuke] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA; [Miyauchi, Kosuke] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA	University of Tokyo; University of Tokyo; Chinese Academy of Sciences; Institute of Biophysics, CAS; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Matsuda, Z (corresponding author), Univ Tokyo, Res Ctr Asian Infect Dis, Inst Med Sci, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	zmatsuda@ims.u-tokyo.ac.jp	Kondo, Naoyuki/W-5845-2019	Kondo, Naoyuki/0000-0002-6624-5989	Ministry of Education, Culture, Sports, Science, and Technology of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a contract grant from the Ministry of Education, Culture, Sports, Science, and Technology of Japan for the Program of Founding Research Centers for Emerging and Reemerging Infectious Diseases.	Blumenthal R, 2002, CHEM PHYS LIPIDS, V116, P39, DOI 10.1016/S0009-3084(02)00019-1; Cabantous S, 2005, NAT BIOTECHNOL, V23, P102, DOI 10.1038/nbt1044; Campbell RE, 2004, TRENDS BIOTECHNOL, V22, P208, DOI 10.1016/j.tibtech.2004.03.012; Cavrois M, 2002, NAT BIOTECHNOL, V20, P1151, DOI 10.1038/nbt745; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; DIMITROV DS, 1992, VIROLOGY, V187, P398, DOI 10.1016/0042-6822(92)90441-Q; Gabrijel M, 2004, BIOCHEM BIOPH RES CO, V314, P717, DOI 10.1016/j.bbrc.2003.12.154; Gallo SA, 2001, BIOCHEMISTRY-US, V40, P12231, DOI 10.1021/bi0155596; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; Holland AU, 2004, VIROLOGY, V319, P343, DOI 10.1016/j.virol.2003.11.012; HUSSEY RE, 1988, NATURE, V331, P78, DOI 10.1038/331078a0; Loening AM, 2007, J MOL BIOL, V374, P1017, DOI 10.1016/j.jmb.2007.09.078; Markosyan RM, 2005, MOL BIOL CELL, V16, P5502, DOI 10.1091/mbc.E05-06-0496; Mayer A, 2002, ANNU REV CELL DEV BI, V18, P289, DOI 10.1146/annurev.cellbio.18.032202.114809; Melikyan GB, 2000, J CELL BIOL, V151, P413, DOI 10.1083/jcb.151.2.413; Melikyan GB, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-111; Miyauchi K, 2005, J VIROL, V79, P4720, DOI 10.1128/JVI.79.8.4720-4729.2005; OSHEA EK, 1993, CURR BIOL, V3, P658, DOI 10.1016/0960-9822(93)90063-T; Paulmurugan R, 2003, ANAL CHEM, V75, P1584, DOI 10.1021/ac020731c; Roux KH, 2007, CURR OPIN STRUC BIOL, V17, P244, DOI 10.1016/j.sbi.2007.03.008; Sollner TH, 2004, CURR OPIN CELL BIOL, V16, P429, DOI 10.1016/j.ceb.2004.06.015; Wang JQ, 2009, J VIROL METHODS, V161, P216, DOI 10.1016/j.jviromet.2009.06.017	22	73	73	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14681	14688		10.1074/jbc.M109.067090	http://dx.doi.org/10.1074/jbc.M109.067090			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20197275	hybrid, Green Published			2022-12-25	WOS:000277299700066
J	Block, ER; Tolino, MA; Klarlund, JK				Block, Ethan R.; Tolino, Michael A.; Klarlund, Jes K.			Pyk2 Activation Triggers Epidermal Growth Factor Receptor Signaling and Cell Motility after Wounding Sheets of Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE 2; FOCAL ADHESION KINASE; SMOOTH-MUSCLE-CELLS; EGF RECEPTOR; C-SRC; BREAST-CANCER; FAMILY; PHOSPHORYLATION; TRANSACTIVATION; PROLIFERATION	Activation of the epidermal growth factor receptor (EGFR) is a key signaling event that promotes cells to move and cover wounds in many epithelia. We have previously shown that wounding activates the EGFR through activation of the Src family kinases (SFKs), which induce proteolytic shedding of epidermal growth factor-like ligands from the cell surface. A major goal in wound healing research is to identify early signals that promote motility, and here we examined the hypothesis that members of the focal adhesion kinase family are upstream activators of the SFKs after wounding. We found that focal adhesion kinase is not activated by wounding but that a different family member, Pyk2 (PTK2B/RAFTK/CAK beta), is activated rapidly and potently. Pyk2 interaction with c-Src is increased after wounding, as determined by co-immunoprecipitation experiments. Disruption of Pyk2 signaling either by small interfering RNA or by expression of a dominant negative mutant led to inhibition of wound-induced activation of the SFKs and the EGFR, and conversely, overexpression of wild-type Pyk2 stimulated SFK and EGFR kinase activities in cells. In wound healing studies, Pyk2 small interfering RNA or dominant negative inhibited cell migration. These results show that activation of Pyk2 is an early signal that promotes wound healing by stimulating the SFK/EGFR signaling pathway.	[Klarlund, Jes K.] Univ Pittsburgh, Sch Med, Dept Ophthalmol, Ophthalmol & Visual Sci Res Ctr, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Klarlund, JK (corresponding author), Univ Pittsburgh, Sch Med, Dept Ophthalmol, Ophthalmol & Visual Sci Res Ctr, 203 Lothrop St, Pittsburgh, PA 15213 USA.	klarlundjk@upmc.edu			National Institutes of Health [EY013463, EY08098, T32 EY017271]; Research to Prevent Blindness; Eye and Ear Foundation (Pittsburgh, PA); NATIONAL EYE INSTITUTE [P30EY008098, R01EY013463, T32EY017271] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Eye and Ear Foundation (Pittsburgh, PA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants EY013463, EY08098, and T32 EY017271. This work was also supported by grants from Research to Prevent Blindness and the Eye and Ear Foundation (Pittsburgh, PA).	Abram CL, 2000, EXP CELL RES, V254, P1, DOI 10.1006/excr.1999.4732; ADEREM A, 1992, CELL, V71, P713, DOI 10.1016/0092-8674(92)90546-O; Andreev J, 2001, J BIOL CHEM, V276, P20130, DOI 10.1074/jbc.M102307200; [Anonymous], 2003, NAT CELL BIOL, V5, P489, DOI 10.1038/ncb0603-490; Avraham H, 2000, CELL SIGNAL, V12, P123, DOI 10.1016/S0898-6568(99)00076-5; Behmoaram E, 2008, AM J PATHOL, V173, P1540, DOI 10.2353/ajpath.2008.080292; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Block ER, 2004, J BIOL CHEM, V279, P24307, DOI 10.1074/jbc.M401058200; Block ER, 2008, MOL BIOL CELL, V19, P4909, DOI 10.1091/mbc.E08-01-0097; Boucher I, 2007, EXP EYE RES, V85, P130, DOI 10.1016/j.exer.2007.03.009; Burdick AD, 2006, CARCINOGENESIS, V27, P2331, DOI 10.1093/carcin/bgl083; Daub H, 1996, NATURE, V379, P557, DOI 10.1038/379557a0; De Amicis F, 2006, J CELL PHYSIOL, V209, P74, DOI 10.1002/jcp.20709; Dewar BJ, 2007, MOL PHARMACOL, V72, P1146, DOI 10.1124/mol.107.037549; Dikic I, 1996, NATURE, V383, P547, DOI 10.1038/383547a0; Duong LT, 1998, J CLIN INVEST, V102, P881, DOI 10.1172/JCI3212; Farooqui R, 2005, J CELL SCI, V118, P51, DOI 10.1242/jcs.01577; Fini ME, 2005, CORNEA, V24, pS2, DOI 10.1097/01.ico.0000178743.06340.2c; Friedl P, 2004, CURR OPIN CELL BIOL, V16, P14, DOI 10.1016/j.ceb.2003.11.001; Gipson IK, 2003, INVEST OPHTH VIS SCI, V44, P2496, DOI 10.1167/iovs.02-0851; Hansen LA, 1997, AM J PATHOL, V150, P1959; Hirotani S, 2004, J MOL CELL CARDIOL, V36, P799, DOI 10.1016/j.yjmcc.2004.03.002; Iiizumi M, 2008, CANCER RES, V68, P7613, DOI 10.1158/0008-5472.CAN-07-6700; Iwasaki H, 2000, AM J PHYSIOL-HEART C, V278, pH521, DOI 10.1152/ajpheart.2000.278.2.H521; Jacinto A, 2001, NAT CELL BIOL, V3, pE117, DOI 10.1038/35074643; Jorissen RN, 2003, EXP CELL RES, V284, P31, DOI 10.1016/S0014-4827(02)00098-8; Kanno H, 2003, AM J PHYSIOL-CELL PH, V284, pC988, DOI 10.1152/ajpcell.00582.2001; Klepeis VE, 2001, J CELL SCI, V114, P4185; Kodama H, 2002, J MOL CELL CARDIOL, V34, P139, DOI 10.1006/jmcc.2001.1496; Kuwabara K, 2004, ENDOCRINOLOGY, V145, P3324, DOI 10.1210/en.2003-1433; Li X, 1997, J BIOL CHEM, V272, P14341, DOI 10.1074/jbc.272.22.14341; Lipinski CA, 2005, NEOPLASIA, V7, P435, DOI 10.1593/neo.04712; Martin P, 2004, DEVELOPMENT, V131, P3021, DOI 10.1242/dev.01253; Menashi EB, 2009, CELL TISSUE RES, V337, P243, DOI 10.1007/s00441-009-0807-9; Montiel M, 2007, CELL SIGNAL, V19, P2138, DOI 10.1016/j.cellsig.2007.06.010; Moro L, 2002, J BIOL CHEM, V277, P9405, DOI 10.1074/jbc.M109101200; Myhre GM, 2004, AM J PHYSIOL-GASTR L, V287, pG1213, DOI 10.1152/ajpgi.00149.2004; Netto MV, 2005, CORNEA, V24, P509, DOI 10.1097/01.ico.0000151544.23360.17; Nikolic DL, 2006, AM J PHYSIOL-CELL PH, V291, pC68, DOI 10.1152/ajpcell.00411.2005; Ohtsu H, 2006, AM J PHYSIOL-CELL PH, V291, pC1, DOI 10.1152/ajpcell.00620.2005; Owen KA, 2007, J CELL BIOL, V179, P1275, DOI 10.1083/jcb.200708093; Park SY, 2007, CELL SIGNAL, V19, P289, DOI 10.1016/j.cellsig.2006.07.005; Park SY, 2006, CELL SIGNAL, V18, P1063, DOI 10.1016/j.cellsig.2005.08.018; Puddicombe SM, 2000, FASEB J, V14, P1362, DOI 10.1096/fj.14.10.1362; Repertinger SK, 2004, J INVEST DERMATOL, V123, P982, DOI 10.1111/j.0022-202X.2004.23478.x; Roelle S, 2008, ONCOGENE, V27, P1737, DOI 10.1038/sj.onc.1210819; Roskoski R, 2005, BIOCHEM BIOPH RES CO, V331, P1, DOI 10.1016/j.bbrc.2005.03.012; Sammak PJ, 1997, J CELL SCI, V110, P465; Sanderson MP, 2006, GROWTH FACTORS, V24, P121, DOI 10.1080/08977190600634373; Schauwienold D, 2008, J BIOL CHEM, V283, P27748, DOI 10.1074/jbc.M801431200; Schlaepfer DD, 1999, PROG BIOPHYS MOL BIO, V71, P435, DOI 10.1016/S0079-6107(98)00052-2; Schwiebert EM, 2003, BBA-BIOMEMBRANES, V1615, P7, DOI 10.1016/S0005-2736(03)00210-4; Shi CS, 2004, J BIOL CHEM, V279, P17224, DOI 10.1074/jbc.M311875200; Sieg DJ, 1998, EMBO J, V17, P5933, DOI 10.1093/emboj/17.20.5933; Soe NN, 2009, J ATHEROSCLER THROMB, V16, P230, DOI 10.5551/jat.E422; STUMPO DJ, 1989, P NATL ACAD SCI USA, V86, P4012, DOI 10.1073/pnas.86.11.4012; Sun CK, 2008, CARCINOGENESIS, V29, P2096, DOI 10.1093/carcin/bgn203; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Vermeer PD, 2003, NATURE, V422, P322, DOI 10.1038/nature01440; Wells A, 1999, INT J BIOCHEM CELL B, V31, P637, DOI 10.1016/S1357-2725(99)00015-1; Wilson SA, 2004, AM FAM PHYSICIAN, V70, P123; Xie JJ, 2008, MOL ENDOCRINOL, V22, P2322, DOI 10.1210/me.2008-0061; Xiong WC, 1998, J CELL SCI, V111, P1981; Xu KP, 2006, INVEST OPHTH VIS SCI, V47, P2832, DOI 10.1167/iovs.05-1361; Xu KP, 2004, INVEST OPHTH VIS SCI, V45, P4277, DOI 10.1167/iovs.04-0119; Yamada T, 2000, CELL STRUCT FUNCT, V25, P351, DOI 10.1247/csf.25.351; Yin J, 2007, J CELL SCI, V120, P815, DOI 10.1242/jcs.03389; Zaidel-Bar R, 2003, J CELL SCI, V116, P4605, DOI 10.1242/jcs.00792; Zieske JD, 2000, INVEST OPHTH VIS SCI, V41, P1346; Zrihan-Licht S, 2000, ONCOGENE, V19, P1318, DOI 10.1038/sj.onc.1203422; Zwick E, 1999, J BIOL CHEM, V274, P20989, DOI 10.1074/jbc.274.30.20989	72	16	16	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13372	13379		10.1074/jbc.M109.083089	http://dx.doi.org/10.1074/jbc.M109.083089			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20215112	hybrid, Green Published			2022-12-25	WOS:000276987700008
J	Garcia-Hoz, C; Sanchez-Fernandez, G; Diaz-Meco, MT; Moscat, J; Mayor, F; Ribas, C				Garcia-Hoz, Carlota; Sanchez-Fernandez, Guzman; Diaz-Meco, Maria Teresa; Moscat, Jorge; Mayor, Federico; Ribas, Catalina			G alpha(q) Acts as an Adaptor Protein in Protein Kinase C zeta (PKC zeta)-mediated ERK5 Activation by G Protein-coupled Receptors (GPCR)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-REGULATED KINASE-5; NF-KAPPA-B; PKC-ZETA; CELL-PROLIFERATION; INDEPENDENT PATHWAY; GROWTH-FACTOR; DOMAIN; SRC; PHOSPHORYLATION; ISOFORMS	G(q)-coupled G protein-coupled receptors (GPCR) mediate the actions of a variety of messengers that are key regulators of different cellular functions. These receptors can regulate a highly interconnected network of biochemical routes that control the activity of several members of the mitogen-activated protein kinase (MAPK) family. The ERK5 MAPK has been shown to be activated by G(q)-coupled GPCR via unknown mechanisms. We find that the atypical protein kinase C (PKC zeta), previously reported to interact with the ERK5 activator MEK5 and to be involved in epidermal growth factor-mediated ERK5 stimulation, plays a crucial role in the activation of the ERK5 pathway by G(q)-coupled GPCR. Stimulation of ERK5 by G(q)-coupled GPCR is abolished upon pharmacological inhibition of PKC zeta as well as in embryonic fibroblasts obtained from PKC zeta-deficient mice. Both PKC zeta and MEK5 associate to G alpha(q) upon activation of GPCR, thus forming a ternary complex that seems essential for the activation of ERK5. These data put forward a novel function of G alpha(q) as a scaffold protein involved in the modulation of the ERK5 cascade by GPCR that could be relevant in G(q)-mediated physiological functions.	[Garcia-Hoz, Carlota; Sanchez-Fernandez, Guzman; Mayor, Federico; Ribas, Catalina] Univ Autonoma Madrid, Dept Biol Mol, Madrid 28049, Spain; [Garcia-Hoz, Carlota; Sanchez-Fernandez, Guzman; Mayor, Federico; Ribas, Catalina] Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, CSIC, Madrid 28049, Spain; [Diaz-Meco, Maria Teresa; Moscat, Jorge] Univ Cincinnati, Dept Genome Sci, Genome Res Inst, Cincinnati, OH 45221 USA	Autonomous University of Madrid; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); University System of Ohio; University of Cincinnati	Mayor, F (corresponding author), Univ Autonoma Madrid, Dept Biol Mol, Madrid 28049, Spain.	fmayor@cbm.uam.es; cribas@cbm.uam.es	Mayor, Federico/N-7644-2016	Diaz-Meco, Maria/0000-0003-0147-0998; Garcia-Hoz, Carlota/0000-0001-8268-4159	Ministerio de Educacion y Ciencia [SAF2008-00552]; Fundacion Ramon Areces; Cardiovascular Network (RECAVA) of Instituto de Salud Carlos III [RD06-0014/0037]; Comunidad de Madrid [S-SAL-0159-2006]; Migration and Inflammation (MAIN) European Network [LSHG-CT-2003-502935]; Instituto de Salud Carlos III [PI080461]	Ministerio de Educacion y Ciencia(Spanish Government); Fundacion Ramon Areces; Cardiovascular Network (RECAVA) of Instituto de Salud Carlos III(Instituto de Salud Carlos III); Comunidad de Madrid(Comunidad de Madrid); Migration and Inflammation (MAIN) European Network; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	This work was supported by grants from Ministerio de Educacion y Ciencia (Grant SAF2008-00552), Fundacion Ramon Areces, The Cardiovascular Network (RECAVA) of Instituto de Salud Carlos III (Grant RD06-0014/0037), Comunidad de Madrid (Grant S-SAL-0159-2006), and the Migration and Inflammation (MAIN) European Network (Grant LSHG-CT-2003-502935) (to F. M.) and Instituto de Salud Carlos III (Grant PI080461) (to C. R.).	Cogolludo A, 2003, CIRC RES, V93, P656, DOI 10.1161/01.RES.0000095245.97945.FE; CRESPO P, 1994, J BIOL CHEM, V269, P21103; Diaz-Meco MT, 2001, MOL CELL BIOL, V21, P1218, DOI 10.1128/MCB.21.4.1218-1227.2001; Elorza A, 2000, MOL PHARMACOL, V57, P778, DOI 10.1124/mol.57.4.778; Fan GF, 2003, J BIOL CHEM, V278, P52432, DOI 10.1074/jbc.M310982200; Fukuhara S, 2000, J BIOL CHEM, V275, P21730, DOI 10.1074/jbc.M002410200; Geetha T, 2003, J BIOL CHEM, V278, P4730, DOI 10.1074/jbc.M208468200; Godeny MD, 2006, AM J PHYSIOL-CELL PH, V291, pC1297, DOI 10.1152/ajpcell.00617.2005; Goldsmith ZG, 2007, ONCOGENE, V26, P3122, DOI 10.1038/sj.onc.1210407; Golebiewska U, 2008, BIOPHYS J, V95, P2575, DOI 10.1529/biophysj.108.129353; GUTKIND JS, 2000, SCI STKE, V40, P1; Hayashi M, 2004, J MOL MED, V82, P800, DOI 10.1007/s00109-004-0602-8; Hirai T, 2003, J BIOCHEM, V133, P1, DOI 10.1093/jb/mvg017; Hirano Y, 2004, J BIOL CHEM, V279, P31883, DOI 10.1074/jbc.M403092200; Jimenez E, 2005, J CELL PHYSIOL, V204, P678, DOI 10.1002/jcp.20326; Kato M, 2005, IMMUNOLOGY, V116, P193, DOI 10.1111/j.1365-2567.2005.02210.x; Lamark T, 2003, J BIOL CHEM, V278, P34568, DOI 10.1074/jbc.M303221200; Leitges M, 2001, MOL CELL, V8, P771, DOI 10.1016/S1097-2765(01)00361-6; Liggett SB, 2006, J CLIN INVEST, V116, P875, DOI 10.1172/JCI28234; Lutz S, 2007, SCIENCE, V318, P1923, DOI 10.1126/science.1147554; Ma YC, 1998, P NATL ACAD SCI USA, V95, P12197, DOI 10.1073/pnas.95.21.12197; Mariggio S, 2006, CELL SIGNAL, V18, P2004, DOI 10.1016/j.cellsig.2006.03.004; Marinissen MJ, 2003, J BIOL CHEM, V278, P46814, DOI 10.1074/jbc.M305709200; Marinissen MJ, 1999, MOL CELL BIOL, V19, P4289; May LT, 2008, INT J BIOCHEM CELL B, V40, P2013, DOI 10.1016/j.biocel.2008.04.001; Moscat J, 2000, EMBO REP, V1, P399, DOI 10.1093/embo-reports/kvd098; Moscat J, 2006, CELL DEATH DIFFER, V13, P702, DOI 10.1038/sj.cdd.4401823; Moscat J, 2006, MOL CELL, V23, P631, DOI 10.1016/j.molcel.2006.08.002; Muscella A, 2003, J CELL PHYSIOL, V197, P61, DOI 10.1002/jcp.10336; Nishimoto S, 2006, EMBO REP, V7, P782, DOI 10.1038/sj.embor.7400755; Obara Y, 2010, MOL PHARMACOL, V77, P10, DOI 10.1124/mol.109.060236; Olson ER, 2008, HYPERTENSION, V51, P704, DOI 10.1161/HYPERTENSIONAHA.107.098459; Parmentier JH, 2006, AM J PHYSIOL-HEART C, V291, pH1602, DOI 10.1152/ajpheart.01363.2005; Parmentier JH, 2003, HYPERTENSION, V41, P794, DOI 10.1161/01.HYP.0000047873.76255.0B; Ribas C, 2007, BBA-BIOMEMBRANES, V1768, P913, DOI 10.1016/j.bbamem.2006.09.019; Rozengurt E, 2007, J CELL PHYSIOL, V213, P589, DOI 10.1002/jcp.21246; Shankaranarayanan A, 2008, J BIOL CHEM, V283, P34923, DOI 10.1074/jbc.M805860200; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Sumimoto H, 2007, SCI STKE, V401, pre6; Sun WY, 2003, MOL CELL BIOL, V23, P2298, DOI 10.1128/MCB.23.7.2298-2308.2003; Sun WY, 2001, J BIOL CHEM, V276, P5093, DOI 10.1074/jbc.M003719200; Takeishi Y, 1999, CIRC RES, V85, P264, DOI 10.1161/01.RES.85.3.264; Turjanski AG, 2007, ONCOGENE, V26, P3240, DOI 10.1038/sj.onc.1210415; Wang X, 2006, CELL SIGNAL, V18, P753, DOI 10.1016/j.cellsig.2005.11.003; Wang YB, 2007, CIRCULATION, V116, P1413, DOI 10.1161/CIRCULATIONAHA.106.679589; Xu BE, 2004, J BIOL CHEM, V279, P7826, DOI 10.1074/jbc.M313465200	46	25	26	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13480	13489		10.1074/jbc.M109.098699	http://dx.doi.org/10.1074/jbc.M109.098699			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20200162	hybrid, Green Published			2022-12-25	WOS:000276987700020
J	Reich, S; Golbik, RP; Geissler, R; Behrens, SE				Reich, Stefan; Golbik, Ralph Peter; Geissler, Rene; Behrens, Sven-Erik			Mechanisms of Activity and Inhibition of the Hepatitis C Virus RNA-dependent RNA Polymerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STATE KINETIC-ANALYSIS; DE-NOVO INITIATION; CRYSTAL-STRUCTURE; RIBONUCLEOTIDE INCORPORATION; NONNUCLEOSIDE POLYMERASE; FULL-LENGTH; NS5B; RNA-POLYMERASE-(3D(POL)); IDENTIFICATION; NUCLEOSIDE	The RNA-dependent RNA polymerase NS5B is a key enzyme of the replication of hepatitis C virus (HCV) and a major therapeutic target. Applying a novel continuous assay with highly purified protein and a fluorescent RNA-template we provide for the first time a comprehensive mechanistic description of the enzymatic reaction. Using fluorescence spectroscopy, the kinetics of NS5B was confirmed to consist of two half-reactions, namely substrate binding and turnover. Determining the binding constants of the substrates and the rate constants of individual reaction steps, NS5B was shown to bind the template single-stranded RNA with high affinity (nanomolar range) and in a stepwise process that reflects the substrate positioning. As demonstrated by CD, NTP(s) binding caused a tertiary structural change of the enzyme into an active conformation. The second half-reaction was dissected into a sequential polymerization and a subsequent, rate-limiting product release reaction. Taking advantage of these tools, we analyzed the mechanism of action of the NS5B inhibitor HCV-796, which was shown to interfere with the formation of double-stranded RNA by blocking the second half-reaction.	[Reich, Stefan; Golbik, Ralph Peter; Geissler, Rene; Behrens, Sven-Erik] Univ Halle Wittenberg, Fac Life Sci, Inst Biochem & Biotechnol, Dept Microbial Biotechnol, D-06120 Halle, Germany	Martin Luther University Halle Wittenberg	Behrens, SE (corresponding author), Univ Halle Wittenberg, Fac Life Sci, Inst Biochem & Biotechnol, Dept Microbial Biotechnol, Kurt Mothes Str 3, D-06120 Halle, Germany.	sven.behrens@biochemtech.uni-halle.de		Reich, Stefan/0000-0001-8822-2908	National Institutes of Health [RO1DK062847]; Deutsche Forschungsgemeinschaft at the Martin-Luther-University Halle-Wittenberg [GRK 1026]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062847] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft at the Martin-Luther-University Halle-Wittenberg(German Research Foundation (DFG)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1DK062847 (to R. G.). This work was also supported by Grant GRK 1026 of the Deutsche Forschungsgemeinschaft at the Martin-Luther-University Halle-Wittenberg.	Ago H, 1999, STRUCTURE, V7, P1417, DOI 10.1016/S0969-2126(00)80031-3; Arnold JJ, 2004, BIOCHEMISTRY-US, V43, P5126, DOI 10.1021/bi035212y; Arnold JJ, 2004, BIOCHEMISTRY-US, V43, P5138, DOI 10.1021/bi035213q; Beaulieu PL, 2007, CURR OPIN INVEST DR, V8, P614; Behrens SE, 1996, EMBO J, V15, P12, DOI 10.1002/j.1460-2075.1996.tb00329.x; Bressanelli S, 1999, P NATL ACAD SCI USA, V96, P13034, DOI 10.1073/pnas.96.23.13034; Choi KH, 2004, P NATL ACAD SCI USA, V101, P4425, DOI 10.1073/pnas.0400660101; D'Abramo CM, 2006, J BIOL CHEM, V281, P24991, DOI 10.1074/jbc.M600474200; De Francesco R, 2007, ADV DRUG DELIVER REV, V59, P1242, DOI 10.1016/j.addr.2007.04.016; Deval J, 2007, J BIOL CHEM, V282, P16907, DOI 10.1074/jbc.M701973200; Friebe P, 2005, J VIROL, V79, P380, DOI 10.1128/JVI.79.1.380-392.2005; Hang JQ, 2009, J BIOL CHEM, V284, P15517, DOI 10.1074/jbc.M808889200; Hong Z, 2001, VIROLOGY, V285, P6, DOI 10.1006/viro.2001.0948; Howe AYM, 2008, ANTIMICROB AGENTS CH, V52, P3327, DOI 10.1128/AAC.00238-08; KATI WM, 1992, J BIOL CHEM, V267, P25988; Kneteman NM, 2009, HEPATOLOGY, V49, P745, DOI 10.1002/hep.22717; Le Pogam S, 2008, J ANTIMICROB CHEMOTH, V61, P1205, DOI 10.1093/jac/dkn085; Lesburg CA, 1999, NAT STRUCT BIOL, V6, P937; Lindenbach BD, 2007, FIELDS VIROLOGY, P1101; Lohmann V, 1999, J BIOL CHEM, V274, P10807, DOI 10.1074/jbc.274.16.10807; Lohmann V, 1997, J VIROL, V71, P8416, DOI 10.1128/JVI.71.11.8416-8428.1997; Makeyev EV, 2000, EMBO J, V19, P6275, DOI 10.1093/emboj/19.22.6275; McCown MF, 2008, ANTIMICROB AGENTS CH, V52, P1604, DOI 10.1128/AAC.01317-07; McHutchison JG, 2006, J HEPATOL, V44, P411, DOI 10.1016/j.jhep.2005.12.001; Oh JW, 1999, J VIROL, V73, P7694, DOI 10.1128/JVI.73.9.7694-7702.1999; Pawlotsky JM, 2006, HEPATOLOGY, V43, pS207, DOI 10.1002/hep.21064; Ranjith-Kumar CT, 2003, J MOL BIOL, V330, P675, DOI 10.1016/S0022-2836(03)00613-2; RITTINGER K, 1995, P NATL ACAD SCI USA, V92, P8046, DOI 10.1073/pnas.92.17.8046; Sun XL, 2000, BIOCHEM BIOPH RES CO, V268, P798, DOI 10.1006/bbrc.2000.2120; Vo NV, 2004, BIOCHEMISTRY-US, V43, P10579, DOI 10.1021/bi049773g; Zhong WD, 2000, J VIROL, V74, P2017, DOI 10.1128/JVI.74.4.2017-2022.2000	31	20	20	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13685	13693		10.1074/jbc.M109.082206	http://dx.doi.org/10.1074/jbc.M109.082206			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20194503	hybrid, Green Published			2022-12-25	WOS:000276987700043
J	Quaia, C; Ying, HS; Optican, LM				Quaia, Christian; Ying, Howard S.; Optican, Lance M.			The Viscoelastic Properties of Passive Eye Muscle in Primates. III: Force Elicited by Natural Elongations	PLOS ONE			English	Article							MODEL; TISSUE	We have recently shown that in monkey passive extraocular muscles the force induced by a stretch does not depend on the entire length history, but to a great extent is only a function of the last elongation applied. This led us to conclude that Fung's quasi-linear viscoelastic (QLV) model, and more general nonlinear models based on a single convolution integral, cannot faithfully mimic passive eye muscles. Here we present additional data about the mechanical properties of passive eye muscles in deeply anesthetized monkeys. We show that, in addition to the aforementioned failures, previous models also grossly overestimate the force exerted by passive eye muscles during smooth elongations similar to those experienced during normal eye movements. Importantly, we also show that the force exerted by a muscle following an elongation is largely independent of the elongation itself, and it is mostly determined by the final muscle length. These additional findings conclusively rule out the use of classical viscoelastic models to mimic the mechanical properties of passive eye muscles. We describe here a new model that extends previous ones using principles derived from research on thixotropic materials. This model is able to account reasonably well for our data, and could thus be incorporated into models of the eye plant.	[Quaia, Christian; Optican, Lance M.] NEI, Sensorimotor Res Lab, Bethesda, MD 20892 USA; [Ying, Howard S.] Johns Hopkins Univ Hosp, Wilmer Eye Inst, Dept Ophthalmol, Baltimore, MD 21287 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); Johns Hopkins University; Johns Hopkins Medicine	Quaia, C (corresponding author), NEI, Sensorimotor Res Lab, Bldg 10, Bethesda, MD 20892 USA.	quaiac@nei.nih.gov			National Eye Institute (CQ, LMO); National Institutes of Health (NIH) [EY19347, EY15025]; Knights Templar Eye Foundation Young Investigator Award; Research to Prevent Blindness Core Grant; NATIONAL EYE INSTITUTE [ZIAEY000302, K12EY015025, R01EY019347] Funding Source: NIH RePORTER	National Eye Institute (CQ, LMO)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Knights Templar Eye Foundation Young Investigator Award; Research to Prevent Blindness Core Grant; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the intramural research program of the National Eye Institute (CQ, LMO), by National Institutes of Health (NIH) grants NIH EY19347 and NIH EY15025 (HSY), the Knights Templar Eye Foundation Young Investigator Award (HSY), and Research to Prevent Blindness Core Grant (HSY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACIERNO D, 1976, J NON-NEWTON FLUID, V1, P125, DOI 10.1016/0377-0257(76)80012-2; BAHILL A T, 1975, Mathematical Biosciences, V24, P191, DOI 10.1016/0025-5564(75)90075-9; Barnes HA, 1997, J NON-NEWTON FLUID, V70, P1, DOI 10.1016/S0377-0257(97)00004-9; Collins CC, 1971, CONTROL EYE MOVEMENT, P283, DOI DOI 10.1016/B978-0-12-071050-8.50015-X; Doehring TC, 2004, ANN BIOMED ENG, V32, P223, DOI 10.1023/B:ABME.0000012742.01261.b0; Fung Y.-C., 2004, BIOMECHANICS MECH PR; Fung Y.C.B, 1971, BIOMECHANICS ITS FDN, P181; KAPOULA Z, 1989, J NEUROPHYSIOL, V61, P879, DOI 10.1152/jn.1989.61.5.879; Marmarelis VZ, 2004, NONLINEAR DYNAMIC MO; Mujumdar A, 2002, J NON-NEWTON FLUID, V102, P157, DOI 10.1016/S0377-0257(01)00176-8; Nekouzadeh A, 2008, J BIOMECH, V41, P2964, DOI 10.1016/j.jbiomech.2008.07.033; Nekouzadeh A, 2007, J BIOMECH, V40, P3070, DOI 10.1016/j.jbiomech.2007.03.019; NEUBERT HKP, 1963, AERONAUT QUART, V14, P187, DOI 10.1017/S0001925900002754; OPTICAN LM, 1985, J NEUROPHYSIOL, V54, P940, DOI 10.1152/jn.1985.54.4.940; PIPKIN AC, 1968, J MECH PHYS SOLIDS, V16, P59, DOI 10.1016/0022-5096(68)90016-1; Popper, 1959, LOGIC SCI DISCOVERY; Pryse KM, 2003, ANN BIOMED ENG, V31, P1287, DOI 10.1114/1.1615571; Quaia C, 2000, EXP BRAIN RES, V132, P39, DOI 10.1007/s002219900324; Quaia Christian, 2003, Strabismus, V11, P17, DOI 10.1076/stra.11.1.17.14088; Quaia C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006480; Quaia C, 2008, PROG BRAIN RES, V171, P47, DOI 10.1016/S0079-6123(08)00607-9; Quaia C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004850; Robinson D.A., 1981, MODELS OCULOMOTOR BE, P21; ROBINSON DA, 1975, INVEST OPHTH VISUAL, V14, P801; Shan XY, 2007, INVEST OPHTH VIS SCI, V48, P2612, DOI 10.1167/iovs.06-1318; Yoo L, 2009, INVEST OPHTH VIS SCI, V50, P3721, DOI 10.1167/iovs.08-3245	26	16	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2010	5	3					A236	A254	e9595	10.1371/journal.pone.0009595	http://dx.doi.org/10.1371/journal.pone.0009595			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565WZ	20221406	Green Submitted, Green Published, gold			2022-12-25	WOS:000275328200022
J	Quintana, FJ; Iglesias, AH; Farez, MF; Caccamo, M; Burns, EJ; Kassam, N; Oukka, M; Weiner, HL				Quintana, Francisco J.; Iglesias, Antonio H.; Farez, Mauricio F.; Caccamo, Mario; Burns, Evan J.; Kassam, Nasim; Oukka, Mohamed; Weiner, Howard L.			Adaptive Autoimmunity and Foxp3-Based Immunoregulation in Zebrafish	PLOS ONE			English	Article							REGULATORY T-CELLS; ARYL-HYDROCARBON RECEPTOR; FOXP3; EVOLUTION; EXPRESSION; TOLERANCE; SYSTEM; GENE; ENTEROPATHY; VERTEBRATES	Background: Jawed vertebrates generate their immune-receptor repertoire by a recombinatorial mechanism that has the potential to produce harmful autoreactive lymphocytes. In mammals, peripheral tolerance to self-antigens is enforced by Foxp3(+) regulatory T cells. Recombinatorial mechanisms also operate in teleosts, but active immunoregulation is thought to be a late incorporation to the vertebrate lineage. Methods/Principal Findings: Here we report the characterization of adaptive autoimmunity and Foxp3-based immunoregulation in the zebrafish. We found that zebrafish immunization with an homogenate of zebrafish central nervous system (zCNS) triggered CNS inflammation and specific antibodies. We cloned the zebrafish ortholog for mammalian Foxp3 (zFoxp3) which induced a regulatory phenotype on mouse T cells and controlled IL-17 production in zebrafish embryos. Conclusions/Significance: Our findings demonstrate the acquisition of active mechanisms of self-tolerance early in vertebrate evolution, suggesting that active regulatory mechanisms accompany the development of the molecular potential for adaptive autoimmunity. Moreover, they identify the zebrafish as a tool to study the molecular pathways controlling adaptive immunity.	[Quintana, Francisco J.; Iglesias, Antonio H.; Farez, Mauricio F.; Burns, Evan J.; Weiner, Howard L.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA; [Caccamo, Mario] European Bioinformat Inst, EMBL Outstn Hinxton, Cambridge, England; [Kassam, Nasim; Oukka, Mohamed] Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Neurol Dis, Cambridge, MA 02138 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; European Molecular Biology Laboratory (EMBL); Harvard University; Brigham & Women's Hospital	Quintana, FJ (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA.	fquintana@rics.bwh.harvard.edu; hweiner@rics.bwh.harvard.edu	Quintana, Francisco Javier/AAB-6915-2020		National Institutes of Health [AI435801, NS38037, R01AI073542-01, AI075285-01A2]; National Multiple Sclerosis Society [RG-3882-A-1, RG4111A1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K99AI075285, R00AI075285, R01AI073542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS038037] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants AI435801 and NS38037 from the National Institutes of Health to HLW, R01AI073542-01 from the National Institutes of Health and RG-3882-A-1 from the National Multiple Sclerosis Society to MO, and AI075285-01A2 from the National Institutes of Health and RG4111A1 from the National Multiple Sclerosis Society to FJQ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alder MN, 2008, NAT IMMUNOL, V9, P319, DOI 10.1038/ni1562; Alder MN, 2005, SCIENCE, V310, P1970, DOI 10.1126/science.1119420; Amemiya CT, 2007, CURR OPIN IMMUNOL, V19, P535, DOI 10.1016/j.coi.2007.08.003; Bacchetta R, 2006, J CLIN INVEST, V116, P1713, DOI 10.1172/JCI25112; Bajoghli B, 2009, CELL, V138, P186, DOI 10.1016/j.cell.2009.04.017; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Bettelli E, 2005, P NATL ACAD SCI USA, V102, P5138, DOI 10.1073/pnas.0501675102; Boehm T, 2006, NAT REV IMMUNOL, V6, P79, DOI 10.1038/nri1749; Boehm T, 2007, NAT IMMUNOL, V8, P131, DOI 10.1038/ni1435; Boehm T, 2006, CELL, V125, P845, DOI 10.1016/j.cell.2006.05.017; Bouaziz JD, 2008, IMMUNOL REV, V224, P201, DOI 10.1111/j.1600-065X.2008.00661.x; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Chae WJ, 2006, P NATL ACAD SCI USA, V103, P9631, DOI 10.1073/pnas.0600225103; Chatila TA, 2000, J CLIN INVEST, V106, pR75, DOI 10.1172/JCI11679; Clay H, 2008, IMMUNITY, V29, P283, DOI 10.1016/j.immuni.2008.06.011; Cooper MD, 2006, CELL, V124, P815, DOI 10.1016/j.cell.2006.02.001; Flores MV, 2007, GENE EXPR PATTERNS, V7, P535, DOI 10.1016/j.modgep.2007.02.001; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; FOREY P, 1993, NATURE, V361, P129, DOI 10.1038/361129a0; Funatake CJ, 2005, J IMMUNOL, V175, P4184, DOI 10.4049/jimmunol.175.7.4184; Gunimaladevi I, 2006, FISH SHELLFISH IMMUN, V21, P393, DOI 10.1016/j.fsi.2006.01.004; Guo P, 2009, NATURE, V459, P796, DOI 10.1038/nature08068; Hogquist KA, 2005, NAT REV IMMUNOL, V5, P772, DOI 10.1038/nri1707; Honjo T, 2005, NAT IMMUNOL, V6, P655, DOI 10.1038/ni1218; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Kassiotis G, 2003, J EXP MED, V197, P1007, DOI 10.1084/jem.20021812; Langenau DM, 2005, NAT REV IMMUNOL, V5, P307, DOI 10.1038/nri1590; Lemaitre B, 2004, NAT REV IMMUNOL, V4, P521, DOI 10.1038/nri1390; Pancer Z, 2006, ANNU REV IMMUNOL, V24, P497, DOI 10.1146/annurev.immunol.24.021605.090542; Patton EE, 2001, NAT REV GENET, V2, P956, DOI 10.1038/35103567; Quintana FJ, 2004, P NATL ACAD SCI USA, V101, P14615, DOI 10.1073/pnas.0404848101; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Robertsen B, 2006, FISH SHELLFISH IMMUN, V20, P172, DOI 10.1016/j.fsi.2005.01.010; Roncarolo MG, 2007, NAT REV IMMUNOL, V7, P585, DOI 10.1038/nri2138; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Saltis M, 2008, IMMUNOGENETICS, V60, P105, DOI 10.1007/s00251-007-0268-9; Stefanova I, 2002, NATURE, V420, P429, DOI 10.1038/nature01146; Stekel D, 2003, MICROARRAY BIOINFORM; Stroud JC, 2006, STRUCTURE, V14, P159, DOI 10.1016/j.str.2005.10.005; Takizawa F, 2008, MOL IMMUNOL, V45, P127, DOI 10.1016/j.molimm.2007.05.005; Traver D, 2003, NAT IMMUNOL, V4, P1238, DOI 10.1038/ni1007; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Wan YSY, 2007, NATURE, V445, P766, DOI 10.1038/nature05479; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Ziegler SF, 2006, ANNU REV IMMUNOL, V24, P209, DOI 10.1146/annurev.immunol.24.021605.090547; Zon LI, 2005, NAT REV DRUG DISCOV, V4, P35, DOI 10.1038/nrd1606	47	61	66	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2010	5	3							e9478	10.1371/journal.pone.0009478	http://dx.doi.org/10.1371/journal.pone.0009478			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	564EX	20221429	Green Submitted, Green Published, gold			2022-12-25	WOS:000275197200004
J	Flower, K; Hellen, E; Newport, MJ; Jones, S; Sinclair, AJ				Flower, Kirsty; Hellen, Elizabeth; Newport, Melanie J.; Jones, Susan; Sinclair, Alison J.			Evaluation of a Prediction Protocol to Identify Potential Targets of Epigenetic Reprogramming by the Cancer Associated Epstein Barr Virus	PLOS ONE			English	Article							LYTIC TRANSACTIVATOR ZTA; LATENT MEMBRANE-PROTEIN; DNA-BINDING SPECIFICITY; CYCLE ACTIVATOR ZTA; DIMERIZATION DOMAIN; BURKITTS-LYMPHOMA; NUCLEAR ANTIGEN-2; LEUCINE ZIPPER; SWITCH PROTEIN; EARLY PROMOTER	Background: Epstein Barr virus (EBV) infects the majority of the human population, causing fatal diseases in a small proportion in conjunction with environmental factors. Following primary infection, EBV remains latent in the memory B cell population for life. Recurrent reactivation of the virus occurs, probably due to activation of the memory B-lymphocytes, resulting in viral replication and re-infection of B-lymphocytes. Methylation of the viral DNA at CpG motifs leads to silencing of viral gene expression during latency. Zta, the key viral protein that mediates the latency/reactivation balance, interacts with methylated DNA. Zta is a transcription factor for both viral and host genes. A sub-set of its DNA binding sites (ZREs) contains a CpG motif, which is recognised in its methylated form. Detailed analysis of the promoter of the viral gene BRLF1 revealed that interaction with a methylated CpG ZRE (RpZRE3) is key to overturning the epigenetic silencing of the gene. Methodology and Principal Findings: Here we question whether we can use this information to identify which host genes contain promoters with similar response elements. A computational search of human gene promoters identified 274 targets containing the 7-nucleotide RpZRE3 core element. DNA binding analysis of Zta with 17 of these targets revealed that the flanking context of the core element does not have a profound effect on the ability of Zta to interact with the methylated sites. A second juxtaposed ZRE was observed for one promoter. Zta was able to interact with this site, although co-occupancy with the RpZRE3 core element was not observed. Conclusions/Significance: This research demonstrates 274 human promoters have the potential to be regulated by Zta to overturn epigenetic silencing of gene expression during viral reactivation from latency.	[Flower, Kirsty; Jones, Susan; Sinclair, Alison J.] Univ Sussex, Sch Life Sci, Brighton, E Sussex, England; [Hellen, Elizabeth; Newport, Melanie J.] Brighton & Sussex Med Sch, Brighton, E Sussex, England	University of Sussex; University of Brighton; University of Sussex	Flower, K (corresponding author), Univ Sussex, Sch Life Sci, Brighton, E Sussex, England.	a.j.sinclair@sussex.ac.uk	Hellen, Elizabeth/C-1046-2013	Newport, Melanie/0000-0002-8946-7525; Sinclair, Alison/0000-0001-8510-8691; Flower, Kirsty/0000-0002-5473-1197; Montague-Hellen, Beth/0000-0003-0946-1842	University of Sussex; Brighton and Sussex Medical School; Medical Research Council [G0400735] Funding Source: researchfish; MRC [G0400735] Funding Source: UKRI	University of Sussex; Brighton and Sussex Medical School; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by studentships from the University of Sussex and the Brighton and Sussex Medical School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Babcock GJ, 1998, IMMUNITY, V9, P395, DOI 10.1016/S1074-7613(00)80622-6; Bhende PM, 2005, J VIROL, V79, P7338, DOI 10.1128/JVI.79.12.7338-7348.2005; Bhende PM, 2004, NAT GENET, V36, P1099, DOI 10.1038/ng1424; Chang Y, 2006, J VIROL, V80, P7748, DOI 10.1128/JVI.02608-05; CHANG YN, 1990, J VIROL, V64, P3358, DOI 10.1128/JVI.64.7.3358-3369.1990; Dickerson SJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000356; ERNBERG I, 1989, J GEN VIROL, V70, P2989, DOI 10.1099/0022-1317-70-11-2989; Farre D, 2003, NUCLEIC ACIDS RES, V31, P3651, DOI 10.1093/nar/gkg605; FARRELL PJ, 1989, EMBO J, V8, P127, DOI 10.1002/j.1460-2075.1989.tb03356.x; Feng WH, 2004, J VIROL, V78, P1893, DOI 10.1128/JVI.78.4.1893-1902.2004; FLEMINGTON E, 1990, J VIROL, V64, P1227, DOI 10.1128/JVI.64.3.1227-1232.1990; Flicek P, 2008, NUCLEIC ACIDS RES, V36, pD707, DOI 10.1093/nar/gkm988; Haider S, 2009, NUCLEIC ACIDS RES, V37, pW23, DOI 10.1093/nar/gkp265; Heather J, 2009, J GEN VIROL, V90, P1450, DOI 10.1099/vir.0.007922-0; Hsu M, 2008, J VIROL, V82, P3679, DOI 10.1128/JVI.02301-07; Hubbard TJP, 2007, NUCLEIC ACIDS RES, V35, pD610, DOI 10.1093/nar/gkl996; Israel BF, 2003, ONCOGENE, V22, P5122, DOI 10.1038/sj.onc.1206548; Jones RJ, 2007, J BIOL CHEM, V282, P8317, DOI 10.1074/jbc.M608667200; Karlsson QH, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000005; Karlsson QH, 2008, BIOCHEM SOC T, V36, P637, DOI 10.1042/BST0360637; KOUZARIDES T, 1991, ONCOGENE, V6, P195; Lenhard B, 2002, BIOINFORMATICS, V18, P1135, DOI 10.1093/bioinformatics/18.8.1135; Li D, 2009, J IMMUNOL, V182, P1799, DOI 10.4049/jimmunol.0802686; LIEBERMAN PM, 1990, J VIROL, V64, P1143, DOI 10.1128/JVI.64.3.1143-1155.1990; LIEBERMAN PM, 1990, J VIROL, V64, P2560, DOI 10.1128/JVI.64.6.2560-2568.1990; Mahot S, 2003, J GEN VIROL, V84, P965, DOI 10.1099/vir.0.18845-0; MASUCCI MG, 1989, J VIROL, V63, P3135, DOI 10.1128/JVI.63.7.3135-3141.1989; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; MILLER G, 1989, YALE J BIOL MED, V62, P205; Minarovits J, 2006, CURR TOP MICROBIOL, V310, P61; MURRAY PG, 2001, EXPERT REV MOL MED, P1; Niller HH, 2009, SEMIN CANCER BIOL, V19, P158, DOI 10.1016/j.semcancer.2009.02.012; QUINLIVAN EB, 1993, NUCLEIC ACIDS RES, V21, P1999, DOI 10.1093/nar/21.8.1999; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Schelcher C, 2005, J VIROL, V79, P13822, DOI 10.1128/JVI.79.21.13822-13828.2005; Sinclair AJ, 2003, J GEN VIROL, V84, P1941, DOI 10.1099/vir.0.19112-0; SINCLAIR AJ, 1991, J VIROL, V65, P2237, DOI 10.1128/JVI.65.5.2237-2244.1991; Sinclair AJ, 2006, TRENDS MICROBIOL, V14, P289, DOI 10.1016/j.tim.2006.05.003; Speck SH, 1997, TRENDS MICROBIOL, V5, P399, DOI 10.1016/S0966-842X(97)01129-3; Talbot SJ, 2004, EUR J CANCER, V40, P1998, DOI 10.1016/j.ejca.2003.11.039; Tao Q, 2003, CLIN IMMUNOL, V109, P53, DOI 10.1016/S1521-6616(03)00198-0; Tao YX, 1997, MOL CELL BIOL, V17, P6994, DOI 10.1128/MCB.17.12.6994; TAYLOR N, 1991, J VIROL, V65, P4033, DOI 10.1128/JVI.65.8.4033-4041.1991; Thorley-Lawson DA, 2008, NAT REV MICROBIOL, V6, P913, DOI 10.1038/nrmicro2015; Tsai SC, 2009, BLOOD, V114, P109, DOI 10.1182/blood-2008-12-193375; URIER G, 1989, EMBO J, V8, P1447, DOI 10.1002/j.1460-2075.1989.tb03527.x; Wang P, 2005, J VIROL, V79, P13298, DOI 10.1128/JVI.79.21.13298-13309.2005; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452; Zetterberg H, 2002, J GEN VIROL, V83, P2007, DOI 10.1099/0022-1317-83-8-2007	50	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2010	5	2							e9443	10.1371/journal.pone.0009443	http://dx.doi.org/10.1371/journal.pone.0009443			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	561RS	20195470	gold, Green Accepted, Green Published			2022-12-25	WOS:000274997000012
J	Vergu, E; Busson, H; Ezanno, P				Vergu, Elisabeta; Busson, Henri; Ezanno, Pauline			Impact of the Infection Period Distribution on the Epidemic Spread in a Metapopulation Model	PLOS ONE			English	Article							BASIC REPRODUCTION NUMBER; REALISTIC DISTRIBUTIONS; SPATIAL SPREAD; PERSISTENCE; DISEASE; DYNAMICS; SYNCHRONY	Epidemic models usually rely on the assumption of exponentially distributed sojourn times in infectious states. This is sometimes an acceptable approximation, but it is generally not realistic and it may influence the epidemic dynamics as it has already been shown in one population. Here, we explore the consequences of choosing constant or gamma-distributed infectious periods in a metapopulation context. For two coupled populations, we show that the probability of generating no secondary infections is the largest for most parameter values if the infectious period follows an exponential distribution, and we identify special cases where, inversely, the infection is more prone to extinction in early phases for constant infection durations. The impact of the infection duration distribution on the epidemic dynamics of many connected populations is studied by simulation and sensitivity analysis, taking into account the potential interactions with other factors. The analysis based on the average nonextinct epidemic trajectories shows that their sensitivity to the assumption on the infectious period distribution mostly depends on R-0, the mean infection duration and the network structure. This study shows that the effect of assuming exponential distribution for infection periods instead of more realistic distributions varies with respect to the output of interest and to other factors. Ultimately it highlights the risk of misleading recommendations based on modelling results when models including exponential infection durations are used for practical purposes.	[Vergu, Elisabeta; Busson, Henri] INRA, Math & Informat Appl UR341, Jouy En Josas, France; [Busson, Henri; Ezanno, Pauline] INRA, Bioagress Epidemiol & Anal Risques UMR1300, F-44026 Nantes, France; [Busson, Henri; Ezanno, Pauline] ENVN, Bioagress Epidemiol & Anal Risques UMR1300, Nantes, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique	Vergu, E (corresponding author), INRA, Math & Informat Appl UR341, Jouy En Josas, France.	elisabeta.vergu@jouy.inra.fr	Ezanno, Pauline/A-4699-2009	Ezanno, Pauline/0000-0002-0034-8950	ANR (French National Research Agency [ANR-05-PADD-014]	ANR (French National Research Agency(French National Research Agency (ANR))	This work was carried out with the financial support of the ANR (French National Research Agency, http://www.agence-nationale-recherche.fr) under the Programme Agriculture et Developpement Durable, project ANR-05-PADD-014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez FP, 2007, METHOD INFORM MED, V46, P19; ARINO J., 2003, MATH POPUL STUD, V10, P175, DOI DOI 10.1080/08898480306720; Balenghien T, 2004, ACTA BIOTHEOR, V52, P365, DOI 10.1023/B:ACBI.0000046603.79561.70; Chowell G, 2008, PHYS LIFE REV, V5, P50, DOI 10.1016/j.plrev.2007.12.001; Feng ZL, 2007, B MATH BIOL, V69, P1511, DOI 10.1007/s11538-006-9174-9; Ferguson NM, 2003, NATURE, V422, P428, DOI 10.1038/nature01509; Flahault A, 2006, VACCINE, V24, P6751, DOI 10.1016/j.vaccine.2006.05.079; Fulford GR, 2002, THEOR POPUL BIOL, V61, P15, DOI 10.1006/tpbi.2001.1553; Hsieh YH, 2007, B MATH BIOL, V69, P1355, DOI 10.1007/s11538-006-9169-6; JESSE M, 2008, J THEOR BIOL; Keeling MJ, 2005, J R SOC INTERFACE, V2, P295, DOI 10.1098/rsif.2005.0051; Keeling MJ, 1998, MATH BIOSCI, V147, P207, DOI 10.1016/S0025-5564(97)00101-6; Keeling MJ, 1997, SCIENCE, V275, P65, DOI 10.1126/science.275.5296.65; Keeling MJ, 2002, P ROY SOC B-BIOL SCI, V269, P335, DOI 10.1098/rspb.2001.1898; Keeling MJ., 2008, MODELING INFECT DIS, DOI [DOI 10.1515/9781400841035, 10.1515/9781400841035]; Koelle K, 2006, SCIENCE, V314, P1898, DOI 10.1126/science.1132745; Lloyd AL, 2001, THEOR POPUL BIOL, V60, P59, DOI 10.1006/tpbi.2001.1525; Lloyd AL, 2004, MATH BIOSCI, V188, P1, DOI 10.1016/j.mbs.2003.09.003; Lloyd AL, 2001, P ROY SOC B-BIOL SCI, V268, P985, DOI 10.1098/rspb.2001.1599; MALICE MP, 1989, IMA J MATH APPL MED, V6, P233; Mccormack Robert K., 2007, Journal of Biological Dynamics, V1, P63, DOI 10.1080/17513750601032711; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Roberts MG, 2007, J MATH BIOL, V55, P803, DOI 10.1007/s00285-007-0112-8; Saltelli A., 2008, GLOBAL SENSITIVITY A; SATTENSPIEL L, 1995, MATH BIOSCI, V128, P71, DOI 10.1016/0025-5564(94)00068-B; TAKACS L, 1957, ACTA MATH ACAD SCI H, V8, P169, DOI [10.1007/BF02025241, DOI 10.1007/BF02025241]; Viboud C, 2006, SCIENCE, V312, P447, DOI 10.1126/science.1125237; Wallinga J, 2007, P ROY SOC B-BIOL SCI, V274, P599, DOI 10.1098/rspb.2006.3754; Wearing HJ, 2005, PLOS MED, V2, P621, DOI 10.1371/journal.pmed.0020174; Yan P, 2008, J THEOR BIOL, V251, P238, DOI 10.1016/j.jtbi.2007.11.027	30	33	33	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2010	5	2							e9371	10.1371/journal.pone.0009371	http://dx.doi.org/10.1371/journal.pone.0009371			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	561RS	20195473	Green Published, gold			2022-12-25	WOS:000274997000006
J	Donnini, S; Solito, R; Cetti, E; Corti, F; Giachetti, A; Carra, S; Beltrame, M; Cotelli, F; Ziche, M				Donnini, Sandra; Solito, Raffaella; Cetti, Elisa; Corti, Federico; Giachetti, Antonio; Carra, Silvia; Beltrame, Monica; Cotelli, Franco; Ziche, Marina			A beta peptides accelerate the senescence of endothelial cells in vitro and in vivo, impairing angiogenesis	FASEB JOURNAL			English	Article						aging; cerebral amyloid angiopathy; Alzheimer's disease	CEREBRAL AMYLOID ANGIOPATHY; CELLULAR SENESCENCE; ALZHEIMERS-DISEASE; PLAQUE-FORMATION; BRAIN; EXPRESSION; ZEBRAFISH; DUTCH; MECHANISMS; DEPOSITION	Cerebral amyloid angiopathy (CAA) caused by amyloid beta (A beta) deposition around brain microvessels results in vascular degenerative changes. Antiangiogenic A beta properties are known to contribute to the compromised cerebrovascular architecture. Here we hypothesize that A beta peptides impair angiogenesis by causing endothelial cells to enter senescence at an early stage of vascular development. Wild-type (WT) A beta and its mutated variant E22Q peptide, endowed with marked vascular tropism, were used in this study. In vivo, in zebrafish embryos, the WT or E22Q peptides reduced embryo survival with an IC50 of 6.1 and 4.7 mu M, respectively. The 2.5 mu M concentration, showing minimal toxicity, was chosen. Alkaline phosphatase staining revealed disorganized vessel patterning, narrowing, and reduced branching of vessels. beta-Galactosidase staining and the cyclin-dependent kinase inhibitor p21 expression, indicative of senescence, were increased. In vitro, WT and E22Q reduced endothelial cell survival with an IC50 of 12.3 and 8.8 mu M, respectively. The 5 mu M concentration, devoid of acute effects on the endothelium, was applied chronically to long-term cultured human umbilical vein endothelial cells (HUVECs). We observed reduced cumulative population doubling, which coincided with beta-galactosidase accumulation, down-regulation of telomerase reverse-transcriptase mRNA expression, decreased telomerase activity, and p21 activation. Senescent HUVECs showed marked angiogenesis impairment, as A beta treatment reduced tube sprouting. The endothelial injuries caused by the E22Q peptide were much more aggressive than those induced by the WT peptide. Premature A beta-induced senescence of the endothelium, producing progressive alterations of microvessel morphology and functions, may represent one of the underlying mechanisms for sporadic or heritable CAA.-Donnini, S., Solito, R., Cetti, E., Corti, F., Giachetti, A., Carra, S., Beltrame, M., Cotelli, F., Ziche, M. A beta peptides accelerate the senescence of endothelial cells in vitro and in vivo, impairing angiogenesis. FASEB J. 24, 2385-2395 (2010). www.fasebj.org	[Donnini, Sandra; Solito, Raffaella; Cetti, Elisa; Corti, Federico; Giachetti, Antonio; Ziche, Marina] Univ Siena, Dept Mol Biol, I-53100 Siena, Italy; [Carra, Silvia; Cotelli, Franco] Univ Milan, Dept Biol, Milan, Italy; [Beltrame, Monica] Univ Milan, Dept Biomol Sci & Biotechnol, Milan, Italy	University of Siena; University of Milan; University of Milan	Ziche, M (corresponding author), Univ Siena, Dept Mol Biol, Via Aldo Moro 2, I-53100 Siena, Italy.	ziche@unisi.it	Carra, Silvia/K-4643-2016; Corti, Federico/A-8918-2011; Beltrame, Monica/D-8093-2017; Donnini, Sandra/K-9252-2019; Carra, Silvia/P-2627-2019; Corti, Federico/R-6262-2016	Carra, Silvia/0000-0002-9321-9508; Donnini, Sandra/0000-0001-6617-1644; Carra, Silvia/0000-0002-9321-9508; Corti, Federico/0000-0003-2160-245X; Beltrame, Monica/0000-0001-5094-3494	Telethon [GGP06148]; CARIPLO Foundation [2006.0807]; CARIPLO N.O.B.E.L Biological and Molecular Characterization of Cancer Stem Cells	Telethon(Fondazione Telethon); CARIPLO Foundation(Fondazione Cariplo); CARIPLO N.O.B.E.L Biological and Molecular Characterization of Cancer Stem Cells	The authors thank Dr. M. Mione (University of Milan, Milan, Italy) for kindly providing the p21 probe for ISH, and Dr. E. Foglia for the technical assistance for histological analysis in zebrafish. This work was supported by Telethon-Project No. GGP06148. M. B. and F. C. acknowledge financial support from the CARIPLO Foundation (grant 2006.0807) and CARIPLO N.O.B.E.L Biological and Molecular Characterization of Cancer Stem Cells, respectively.	Bell RD, 2009, ACTA NEUROPATHOL, V118, P103, DOI 10.1007/s00401-009-0522-3; Cantara S, 2004, FASEB J, V18, P1943, DOI 10.1096/fj.04-2114fje; Cirrito JR, 2005, J CLIN INVEST, V115, P3285, DOI 10.1172/JCI25247; Donnini S, 2006, CELL DEATH DIFFER, V13, P1088, DOI 10.1038/sj.cdd.4401803; Erusalimsky JD, 2009, EXP PHYSIOL, V94, P299, DOI 10.1113/expphysiol.2008.043133; Farris W, 2007, AM J PATHOL, V171, P241, DOI 10.2353/ajpath.2007.070105; Garcia-Osta A, 2009, LEARN MEMORY, V16, P267, DOI 10.1101/lm.1310209; Hayashi S, 2009, ARTERIOSCL THROM VAS, V29, P1909, DOI 10.1161/ATVBAHA.109.188516; Hull MA, 1999, GUT, V45, P529, DOI 10.1136/gut.45.4.529; Iadecola C, 2004, NAT REV NEUROSCI, V5, P347, DOI 10.1038/nrn1387; Isogai S, 2001, DEV BIOL, V230, P278, DOI 10.1006/dbio.2000.9995; JOWETT T, 1994, TRENDS GENET, V10, P73, DOI 10.1016/0168-9525(94)90220-8; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kishi S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000152; Kurz DJ, 2004, J CELL SCI, V117, P2417, DOI 10.1242/jcs.01097; Kurz DJ, 2003, ARTERIOSCL THROM VAS, V23, P748, DOI 10.1161/01.ATV.0000069624.55424.61; Kurz DJ, 2000, J CELL SCI, V113, P3613; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Leissring MA, 2003, NEURON, V40, P1087, DOI 10.1016/S0896-6273(03)00787-6; Maat-Schieman M, 2005, NEUROPATHOLOGY, V25, P288, DOI 10.1111/j.1440-1789.2005.00631.x; Maia LF, 2007, J NEUROL SCI, V257, P23, DOI 10.1016/j.jns.2007.01.054; Miao J, 2005, AM J PATHOL, V167, P505, DOI 10.1016/S0002-9440(10)62993-8; Miravalle L, 2000, J BIOL CHEM, V275, P27110; Muller M, 2009, ANTIOXID REDOX SIGN, V11, P59, DOI 10.1089/ars.2008.2104; Murakami M, 2008, J CLIN INVEST, V118, P3355, DOI 10.1172/JCI35298; Paris D, 2005, MOL BRAIN RES, V136, P212, DOI 10.1016/j.molbrainres.2005.02.011; Paris D, 2003, NEUROL RES, V25, P642, DOI 10.1179/016164103101201940; Paris Daniel, 2004, Angiogenesis, V7, P75, DOI 10.1023/B:AGEN.0000037335.17717.bf; Patel NS, 2010, J NEUROCHEM, V112, P66, DOI 10.1111/j.1471-4159.2009.06426.x; Pezzatini S, 2007, BONE, V41, P523, DOI 10.1016/j.bone.2007.06.016; Puzzo D, 2008, J NEUROSCI, V28, P14537, DOI 10.1523/JNEUROSCI.2692-08.2008; Revesz T, 2003, J NEUROPATH EXP NEUR, V62, P885, DOI 10.1093/jnen/62.9.885; Revesz T, 2009, ACTA NEUROPATHOL, V118, P115, DOI 10.1007/s00401-009-0501-8; Santoriello C, 2009, DIS MODEL MECH, V2, P56, DOI 10.1242/dmm.001016; Serbedzija G N, 1999, Angiogenesis, V3, P353, DOI 10.1023/A:1026598300052; Solito R, 2009, EXP CELL RES, V315, P385, DOI 10.1016/j.yexcr.2008.11.002; THISSE C, 1993, DEVELOPMENT, V119, P1203; Weller RO, 2008, BRAIN PATHOL, V18, P253, DOI 10.1111/j.1750-3639.2008.00133.x; WISNIEWSKI T, 1991, BIOCHEM BIOPH RES CO, V179, P1247, DOI 10.1016/0006-291X(91)91706-I; Zacchigna S, 2008, NAT REV NEUROSCI, V9, P169, DOI 10.1038/nrn2336; Zipfel GJ, 2009, STROKE, V40, pS16, DOI 10.1161/STROKEAHA.108.533174; Zon LI, 2005, NAT REV DRUG DISCOV, V4, P35, DOI 10.1038/nrd1606	42	67	68	0	20	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2010	24	7					2385	2395		10.1096/fj.09-146456	http://dx.doi.org/10.1096/fj.09-146456			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	618HV	20207941				2022-12-25	WOS:000279343600025
J	Krishnamurthy, P; Lambers, E; Verma, S; Thorne, T; Qin, GJ; Losordo, DW; Kishore, R				Krishnamurthy, Prasanna; Lambers, Erin; Verma, Suresh; Thorne, Tina; Qin, Gangjian; Losordo, Douglas W.; Kishore, Raj			Myocardial knockdown of mRNA-stabilizing protein HuR attenuates post-MI inflammatory response and left ventricular dysfunction in IL-10-null mice	FASEB JOURNAL			English	Article						myocardial infarction; cytokines; inflammation; fibrosis; apoptosis	NECROSIS-FACTOR-ALPHA; TO-MESENCHYMAL TRANSITION; HEART-FAILURE; NITRIC-OXIDE; KAPPA-B; TARGETED DELETION; CARDIAC-FUNCTION; INFARCTION; INTERLEUKIN-10; EXPRESSION	Prolonged inflammatory response is associated with left ventricular (LV) dysfunction and adverse remodeling following myocardial infarction (MI). IL-10 inhibits inflammation by suppressing HuR-mediated mRNA stabilization of proinflammatory cytokines. Here we report that following MI, IL-10(-/-) mice showed exaggerated LV dysfunction, fibrosis, and cardiomyocyte apoptosis. Short-hairpin RNA (shRNA)-mediated knockdown of HuR in the myocardium significantly reversed MI-induced LV dysfunctions and LV remodeling. HuR knockdown significantly reduced MI-induced cardiomyocyte apoptosis concomitant with reduced p53 expression. Moreover, HuR knockdown significantly reduced infarct size and fibrosis area, which in turn was associated with decreased TGF-beta expression. In vitro, stable knockdown of HuR in mouse macrophage cell line RAW 264.7 corroborated in vivo data and revealed reduced mRNA expression of TNF-alpha, TGF-beta, and p53 following LPS challenge, which was associated with a marked reduction in the mRNA stability of these genes. Taken together, our studies suggest that HuR is a direct target of IL-10, and HuR knockdown mimics anti-inflammatory effects of IL10.-Krishnamurthy, P., Lambers, E., Verma, S., Thorne, T., Qin, G., Losordo, D. W., Kishore, R. Myocardial knockdown of mRNA-stabilizing protein HuR attenuates post-MI inflammatory response and left ventricular dysfunction in IL-10-null mice. FASEB J. 24, 2484-2494 (2010). www.fasebj.org	[Krishnamurthy, Prasanna; Lambers, Erin; Verma, Suresh; Thorne, Tina; Qin, Gangjian; Losordo, Douglas W.; Kishore, Raj] Northwestern Univ, Feinberg Sch Med, Div Cardiol, Feinberg Cardiovasc Res Inst, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Krishnamurthy, P (corresponding author), Northwestern Univ, Feinberg Sch Med, Div Cardiol, Feinberg Cardiovasc Res Inst, 303 E Chicago Ave, Chicago, IL 60611 USA.	p-krishnamurthy@northwestern.edu; r-kishore@northwestern.edu	Losordo, Douglas W/F-9782-2011; Verma, Suresh/AAU-9979-2020	Losordo, Douglas/0000-0002-6857-7506; Verma, Suresh Kumar/0000-0002-0739-1302; KRISHNAMURTHY, PRASANNA/0000-0002-4842-6364	American Heart Association-Davee Foundation [0930219N]; National Institute of Health [AA014575, HL091983]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093439, R01HL091983, R01HL053354, R01HL080137, R01HL095874] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA014575] Funding Source: NIH RePORTER	American Heart Association-Davee Foundation(American Heart Association); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	The reported work was supported in part by American Heart Association-Davee Foundation scientist development grant (SDG) 0930219N (P.K.) and National Institute of Health grants AA014575 and HL091983 (R.K.). The authors declare no competing interests. All authors contributed substantially to this work. R.K. and P.K. conceptualized the experiments. P. K. performed all animal surgical procedures and histological analysis. E.L., S.V., and T.T. generated stable clones, performed Western blots, and provided technical assistance with in vitro experiments. P.K. wrote the manuscript, and R.K. edited it. G.Q. and D.W.L. read the manuscript and provided critical appraisal and conceptual insights. All authors discussed the results and implications and commented on the manuscript at all stages.	Abdelmohsen K, 2008, P NATL ACAD SCI USA, V105, P20297, DOI 10.1073/pnas.0809376106; Bates RC, 2003, MOL BIOL CELL, V14, P1790, DOI 10.1091/mbc.E02-09-0583; Birks EJ, 2008, CARDIOVASC RES, V79, P472, DOI 10.1093/cvr/cvn083; Bujak M, 2007, CIRCULATION, V116, P2127, DOI 10.1161/CIRCULATIONAHA.107.704197; Burchfield JS, 2008, CIRC RES, V103, P203, DOI 10.1161/CIRCRESAHA.108.178475; Carballo E, 2001, J BIOL CHEM, V276, P42580, DOI 10.1074/jbc.M104953200; Chen CYA, 2002, MOL CELL BIOL, V22, P7268, DOI 10.1128/MCB.22.20.7268-7278.2002; Cohen SL, 2004, INFLAMM BOWEL DIS, V10, P557, DOI 10.1097/00054725-200409000-00009; Di Marco S, 2005, MOL CELL BIOL, V25, P6533, DOI 10.1128/MCB.25.15.6533-6545.2005; Duncan DJ, 2007, BRIT J PHARMACOL, V150, P720, DOI 10.1038/sj.bjp.0707147; Finsen AV, 2005, J APPL PHYSIOL, V98, P680, DOI 10.1152/japplphysiol.00924.2004; Frangogiannis NG, 2000, J IMMUNOL, V165, P2798, DOI 10.4049/jimmunol.165.5.2798; Frangogiannis NG, 2006, CURR MED CHEM, V13, P1877, DOI 10.2174/092986706777585086; Girndt M, 2002, KIDNEY INT, V62, P949, DOI 10.1046/j.1523-1755.2002.00504.x; Hamid T, 2009, CIRCULATION, V119, P1386, DOI 10.1161/CIRCULATIONAHA.108.802918; Hasegawa H, 2009, BRIT J CANCER, V100, P1943, DOI 10.1038/sj.bjc.6605084; Hilfiker-Kleiner D, 2004, CIRC RES, V95, P187, DOI 10.1161/01.RES.0000134921.50377.61; Huwiler A, 2003, J BIOL CHEM, V278, P51758, DOI 10.1074/jbc.M305722200; Ii M, 2005, CIRCULATION, V111, P1114, DOI 10.1161/01.CIR.0000157144.24888.7E; Ing DJ, 1999, CIRC RES, V84, P21; Kishore R, 1999, J IMMUNOL, V162, P2457; Krishnamurthy P, 2006, HEART, V92, P1309, DOI 10.1136/hrt.2005.071001; Kuga S, 1996, EXP HEMATOL, V24, P151; Li YW, 2006, CARDIOVASC RES, V71, P684, DOI 10.1016/j.cardiores.2006.06.003; Li ZH, 2006, AM J PHYSIOL-HEART C, V291, pH1972, DOI 10.1152/ajpheart.00043.2006; Long XL, 1997, J CLIN INVEST, V99, P2635, DOI 10.1172/JCI119452; Lopes SMCDS, 2004, DEV DYNAM, V231, P542, DOI 10.1002/dvdy.20162; Matsumura S, 2005, J CLIN INVEST, V115, P599, DOI 10.1172/JCI200522304; Matsusaka H, 2006, CARDIOVASC RES, V70, P457, DOI 10.1016/j.cardiores.2006.02.001; Mayer B, 2005, INT J CARDIOL, V103, P182, DOI 10.1016/j.ijcard.2004.08.053; Ono K, 1998, CIRCULATION, V98, P149, DOI 10.1161/01.CIR.98.2.149; Qin GJ, 2006, P NATL ACAD SCI USA, V103, P11015, DOI 10.1073/pnas.0509533103; Rajasingh J, 2006, FASEB J, V20, P2112, DOI 10.1096/fj.06-6084fje; Sugishita K, 1999, J MOL CELL CARDIOL, V31, P1457, DOI 10.1006/jmcc.1999.0989; Sun M, 2004, CIRCULATION, V110, P3221, DOI 10.1161/01.CIR.0000147233.10318.23; Sun M, 2007, CIRCULATION, V115, P1398, DOI 10.1161/CIRCULATIONAHA.106.643585; SUZUKI K, 2001, CIRCULATION S1, V104, P308; Tao ZY, 2004, LIFE SCI, V74, P1561, DOI 10.1016/j.lfs.2003.09.042; Timmers L, 2008, CIRC RES, V102, P257, DOI 10.1161/CIRCRESAHA.107.158220; Wang MJ, 2005, ANN THORAC SURG, V80, P2235, DOI 10.1016/j.athoracsur.2005.05.070; Yang ZQ, 2000, CIRCULATION, V101, P1019, DOI 10.1161/01.CIR.101.9.1019; Yao L, 2008, INT J CARDIOL, V123, P366, DOI 10.1016/j.ijcard.2007.06.069; Yarovinsky TO, 2006, J IMMUNOL, V177, P4426, DOI 10.4049/jimmunol.177.7.4426; Yeh CH, 2005, J SURG RES, V125, P109, DOI 10.1016/j.jss.2004.11.009; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613; Zhao J, 2008, CANCER RES, V68, P4133, DOI 10.1158/0008-5472.CAN-08-0432; Zhu W, 2001, AM J PHYSIOL-LUNG C, V281, pL499, DOI 10.1152/ajplung.2001.281.2.L499	47	57	57	4	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JUL	2010	24	7					2484	2494		10.1096/fj.09-149815	http://dx.doi.org/10.1096/fj.09-149815			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	618HV	20219984	Green Published			2022-12-25	WOS:000279343600035
J	Xu, RJ; Sun, W; Jin, JF; Obeid, LM; Mao, CG				Xu, Ruijuan; Sun, Wei; Jin, Junfei; Obeid, Lina M.; Mao, Cungui			Role of alkaline ceramidases in the generation of sphingosine and its phosphate in erythrocytes	FASEB JOURNAL			English	Article						ceramide; erythroid cells; S1P; and S1P lyase	MOLECULAR-CLONING; NEUTRAL CERAMIDASE; ACID CERAMIDASE; FARBER-DISEASE; SPHINGOSINE-1-PHOSPHATE LYASE; FUNCTIONAL-CHARACTERIZATION; CELLS; GENE; SPHINGOMYELINASE; DIFFERENTIATION	Plasma sphingosine-1-phosphate (S1P) has been suggested to mainly originate from erythrocytes; however, within the erythrocyte, how sphingosine (SPH) generation-the precursor to S1P-is controlled is unknown. SPH is only generated from the hydrolysis of ceramides via ceramidases. Five human ceramidases have been identified: 1 acid, 1 neutral, and 3 alkaline ceramidases (ACER1, ACER2, and ACER3). Here, we demonstrate that only alkaline ceramidase activity is expressed in erythrocytes and that it is instrumental for SPH generation. Erythrocytes have alkaline but not acid or neutral ceramidase activity on D-e-C-18:1-ceramide, a common substrate of ceramidases. Not only alkaline ceramidase activity but also the generation of SPH and S1P are increased during erythroid differentiation in K562 erythroleukemic cells. Such SPH and S1P increases were inhibited by the alkaline ceramidase inhibitor D-e-MAPP, suggesting that alkaline ceramidases have a role in the generation of SPH and S1P in erythroid cells. Alkaline ceramidase activity is highly expressed in mouse erythrocytes, and intravenous administration of D-e-MAPP decreased both SPH and S1P in erythrocytes and plasma. Collectively, these results suggest that alkaline ceramidase activity is important for the generation of SPH, the S1P precursor in erythrocytes.-Xu, R., Sun, W., Jin, J., Obeid, L. M., Mao, C. Role of alkaline ceramidases in the generation of sphingosine and its phosphate in erythrocytes. FASEB J. 24, 2507-2515 (2010). www.fasebj.org	[Mao, Cungui] Med Univ S Carolina, Dept Med, Div Gen Internal Med, Charleston, SC 29425 USA; [Obeid, Lina M.; Mao, Cungui] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Obeid, Lina M.] Med Univ S Carolina, Ralph H Johnson Vet Adm Hosp, Charleston, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Mao, CG (corresponding author), Med Univ S Carolina, Dept Med, Div Gen Internal Med, 114 Doughty St,Rm 646,STB,POB 250779, Charleston, SC 29425 USA.	maoc@musc.edu	xu, rui/GRX-5734-2022	obeid, lina/0000-0002-0734-0847; Jin, Junfei/0000-0002-9237-9024	U.S. National Institutes of Health [R01CA104834, P20RR017677, GM062887]; Veterans Affairs merit award; NATIONAL CANCER INSTITUTE [R01CA104834] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062887] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs merit award(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by U.S. National Institutes of Health grants R01CA104834 (C.M.), P20RR017677 (C.M.), and GM062887 (L.M.O.), and a Veterans Affairs merit award (L.M.O.). The authors thank Dr. Jennifer Schnellmann for English proofreading and editing of the manuscript.	Bandhuvula P, 2007, J LIPID RES, V48, P2769, DOI 10.1194/jlr.D700010-JLR200; Bielawska A, 1996, J BIOL CHEM, V271, P12646, DOI 10.1074/jbc.271.21.12646; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; Burek C, 2001, ONCOGENE, V20, P6493, DOI 10.1038/sj.onc.1204841; El Bawab S, 2000, J BIOL CHEM, V275, P21508, DOI 10.1074/jbc.M002522200; El Bawab S, 1999, J BIOL CHEM, V274, P27948, DOI 10.1074/jbc.274.39.27948; English D, 2001, CARDIOVASC RES, V49, P588, DOI 10.1016/S0008-6363(00)00230-3; Graler MH, 2002, BBA-MOL CELL BIOL L, V1582, P168, DOI 10.1016/S1388-1981(02)00152-X; Hanel P, 2007, FASEB J, V21, P1202, DOI 10.1096/fj.06-7433com; Hofmann K, 2000, P NATL ACAD SCI USA, V97, P5895, DOI 10.1073/pnas.97.11.5895; Hu W, 2010, J BIOL CHEM, V285, P7964, DOI 10.1074/jbc.M109.063586; Hwang YH, 2005, BIOCHEM BIOPH RES CO, V331, P37, DOI 10.1016/j.bbrc.2005.03.134; Ito K, 2007, BIOCHEM BIOPH RES CO, V357, P212, DOI 10.1016/j.bbrc.2007.03.123; Kimura T, 2001, J BIOL CHEM, V276, P31780, DOI 10.1074/jbc.M104353200; Koch J, 1996, J BIOL CHEM, V271, P33110, DOI 10.1074/jbc.271.51.33110; Kohama T, 1998, J BIOL CHEM, V273, P23722, DOI 10.1074/jbc.273.37.23722; Kono M, 2006, J BIOL CHEM, V281, P7324, DOI 10.1074/jbc.M508382200; Liu H, 2000, J BIOL CHEM, V275, P19513, DOI 10.1074/jbc.M002759200; Liu YJ, 2000, J CLIN INVEST, V106, P951, DOI 10.1172/JCI10905; LUISIDELUCA C, 1984, J CLIN INVEST, V74, P821, DOI 10.1172/JCI111498; Mandala SM, 2000, P NATL ACAD SCI USA, V97, P7859, DOI 10.1073/pnas.120146897; Mao CG, 2003, J BIOL CHEM, V278, P31184, DOI 10.1074/jbc.M303875200; MOMOI T, 1982, BIOCHEM J, V205, P419, DOI 10.1042/bj2050419; Monick MM, 2004, J IMMUNOL, V173, P123, DOI 10.4049/jimmunol.173.1.123; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; Obeid L.M., 2001, J BIOL CHEM, V16, P16; Ogawa C, 2003, J BIOL CHEM, V278, P1268, DOI 10.1074/jbc.M209514200; ORKIN SH, 1975, P NATL ACAD SCI USA, V72, P98, DOI 10.1073/pnas.72.1.98; Pappu R, 2007, SCIENCE, V316, P295, DOI 10.1126/science.1139221; Pyne S, 2004, SEMIN CELL DEV BIOL, V15, P491, DOI 10.1016/j.semcdb.2004.05.007; QUINTERN LE, 1989, EMBO J, V8, P2469, DOI 10.1002/j.1460-2075.1989.tb08382.x; Sun W, 2008, J INVEST DERMATOL, V128, P389, DOI 10.1038/sj.jid.5701025; Sun W, 2010, J BIOL CHEM, V285, P8995, DOI 10.1074/jbc.M109.069203; Sun W, 2009, FASEB J, V23, P656, DOI 10.1096/fj.08-115634; Tani M, 2000, J BIOL CHEM, V275, P11229, DOI 10.1074/jbc.275.15.11229; Tomiuk S, 1998, P NATL ACAD SCI USA, V95, P3638, DOI 10.1073/pnas.95.7.3638; Van Veldhoven PP, 2000, BBA-MOL CELL BIOL L, V1487, P128, DOI 10.1016/S1388-1981(00)00079-2; Xu RJ, 2006, FASEB J, V20, P1813, DOI 10.1096/fj.05-5689com; Zhou JH, 1998, BIOCHEM BIOPH RES CO, V242, P502, DOI 10.1006/bbrc.1997.7993	39	34	34	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2010	24	7					2507	2515		10.1096/fj.09-153635	http://dx.doi.org/10.1096/fj.09-153635			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	618HV	20207939	Green Published			2022-12-25	WOS:000279343600037
J	Brocker, C; Lassen, N; Estey, T; Pappa, A; Cantore, M; Orlova, VV; Chavakis, T; Kavanagh, KL; Oppermann, U; Vasiliou, V				Brocker, Chad; Lassen, Natalie; Estey, Tia; Pappa, Aglaia; Cantore, Miriam; Orlova, Valeria V.; Chavakis, Triantafyllos; Kavanagh, Kathryn L.; Oppermann, Udo; Vasiliou, Vasilis			Aldehyde Dehydrogenase 7A1 (ALDH7A1) Is a Novel Enzyme Involved in Cellular Defense against Hyperosmotic Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PIPECOLIC ACID METABOLISM; TURGOR-RESPONSIVE GENE; MOLECULAR-CLONING; TISSUE DISTRIBUTION; BACULOVIRUS EXPRESSION; SEABREAM ANTIQUITIN; LIPID-PEROXIDATION; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; HUMAN LIVER	Mammalian ALDH7A1 is homologous to plant ALDH7B1, an enzyme that protects against various forms of stress, such as salinity, dehydration, and osmotic stress. It is known that mutations in the human ALDH7A1 gene cause pyridoxine-dependent and folic acid-responsive seizures. Herein, we show for the first time that human ALDH7A1 protects against hyperosmotic stress by generating osmolytes and metabolizing toxic aldehydes. Human ALDH7A1 expression in Chinese hamster ovary cells attenuated osmotic stress-induced apoptosis caused by increased extracellular concentrations of sucrose or sodium chloride. Purified recombinant ALDH7A1 efficiently metabolized a number of aldehyde substrates, including the osmolyte precursor, betaine aldehyde, lipid peroxidation-derived aldehydes, and the intermediate lysine degradation product, alpha-aminoadipic semialdehyde. The crystal structure for ALDH7A1 supports the enzyme's substrate specificities. Tissue distribution studies in mice showed the highest expression of ALDH7A1 protein in liver, kidney, and brain, followed by pancreas and testes. ALDH7A1 protein was found in the cytosol, nucleus, and mitochondria, making it unique among the aldehyde dehydrogenase enzymes. Analysis of human and mouse cDNA sequences revealed mitochondrial and cytosolic transcripts that are differentially expressed in a tissue-specific manner in mice. In conclusion, ALDH7A1 is a novel aldehyde dehydrogenase expressed in multiple subcellular compartments that protects against hyperosmotic stress by generating osmolytes and metabolizing toxic aldehydes.	[Brocker, Chad; Lassen, Natalie; Estey, Tia; Pappa, Aglaia; Cantore, Miriam; Vasiliou, Vasilis] Univ Colorado Denver, Dept Pharmaceut Sci, Mol Toxicol & Environm Hlth Sci Program, Aurora, CO 80045 USA; [Orlova, Valeria V.; Chavakis, Triantafyllos] NCI, Expt Immunol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Kavanagh, Kathryn L.; Oppermann, Udo] Univ Oxford, Struct Genom Consortium, Headington OX3 7DQ, England; [Oppermann, Udo] Univ Oxford, Nuffield Dept Orthoped Surg Rheumatol & Musculosk, Botnar Res Ctr, Biomed Res Unit, Oxford OX3 7LD, England	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Oxford; University of Oxford	Vasiliou, V (corresponding author), Univ Colorado Denver, Dept Pharmaceut Sci, Mol Toxicol & Environm Hlth Sci Program, C238-P15,12700 E 19th Ave, Aurora, CO 80045 USA.	vasilis.vasiliou@ucdenver.edu	Pappa, Aglaia/E-8663-2011; Orlova, Valeria V/C-6065-2014; Pappa, Aglaia/P-4663-2019; Chavakis, Triantafyllos/ABE-8845-2020	Orlova, Valeria V/0000-0002-1169-2802; Pappa, Aglaia/0000-0003-0913-4315; Brocker, Chad/0000-0003-4262-3567; vasiliou, vasilis/0000-0003-2552-3118	National Institutes of Health [EY11490, EY17963]; Canadian Institutes for Health Research; Canadian Foundation for Innovation; Genome Canada through the Ontario Genomics Institute; GlaxoSmithKline; Karolinska Institutet; Knut and Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Merck Co., Inc.; Novartis Research Foundation; Swedish Agency for Innovation Systems; Swedish Foundation for Strategic Research; Wellcome Trust; Oxford BIHR Biomedical Research Unit; NATIONAL EYE INSTITUTE [R01EY011490, R29EY011490, R01EY017963] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Genome Canada through the Ontario Genomics Institute(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Karolinska Institutet(Karolinska Institutet); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Merck Co., Inc.(Merck & Company); Novartis Research Foundation; Swedish Agency for Innovation Systems(Vinnova); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Wellcome Trust(Wellcome TrustEuropean Commission); Oxford BIHR Biomedical Research Unit; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants EY11490 and EY17963. The Structural Genomics Consortium is a registered charity (number 1097737) that receives funds from the Canadian Institutes for Health Research, the Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck & Co., Inc., the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research, and the Wellcome Trust. This work was also supported by the Oxford BIHR Biomedical Research Unit. Portions of this work were presented at the 48th Annual Meeting of the Society of Toxicology, Baltimore, MD, March 2009 (50).	Akagawa M, 2002, EUR J BIOCHEM, V269, P5451, DOI 10.1046/j.1432-1033.2002.03243.x; Akagawa M, 2006, CHEM RES TOXICOL, V19, P1059, DOI 10.1021/tx060026p; Alfieri RR, 2007, PFLUG ARCH EUR J PHY, V454, P173, DOI 10.1007/s00424-006-0195-x; Andreucci M, 2009, CELL PROLIFERAT, V42, P554, DOI 10.1111/j.1365-2184.2009.00617.x; BROCKER C, 2009, TOXICOLOGIST, V108, P1556; Bunting KD, 1996, J BIOL CHEM, V271, P11884, DOI 10.1074/jbc.271.20.11884; Burg MB, 2007, PHYSIOL REV, V87, P1441, DOI 10.1152/physrev.00056.2006; CHANG YF, 1990, BIOCHIM BIOPHYS ACTA, V1038, P300, DOI 10.1016/0167-4838(90)90241-7; CHANG YF, 1976, BIOCHEM BIOPH RES CO, V69, P174, DOI 10.1016/S0006-291X(76)80288-4; CHANG YF, 1982, NEUROCHEM RES, V7, P577, DOI 10.1007/BF00965124; Chavakis T, 1998, BLOOD, V91, P2305, DOI 10.1182/blood.V91.7.2305.2305_2305_2312; Chern MK, 2000, BIOCHEM PHARMACOL, V60, P1629, DOI 10.1016/S0006-2952(00)00469-X; Comporti MM, 1998, FREE RADICAL RES, V28, P623, DOI 10.3109/10715769809065818; Craig SAS, 2004, AM J CLIN NUTR, V80, P539; de Marco A, 2005, CELL STRESS CHAPERON, V10, P329, DOI 10.1379/CSC-139R.1; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ESTERBAUER H, 1989, FREE RADICAL BIO MED, V7, P197, DOI 10.1016/0891-5849(89)90015-4; Gallagher RC, 2009, ANN NEUROL, V65, P550, DOI 10.1002/ana.21568; Gruez A, 2004, J MOL BIOL, V343, P29, DOI 10.1016/j.jmb.2004.08.030; GUERRERO FD, 1990, PLANT MOL BIOL, V15, P11, DOI 10.1007/BF00017720; HUTZLER J, 1968, BIOCHIM BIOPHYS ACTA, V158, P62, DOI 10.1016/0304-4165(68)90072-X; IJlst L, 2000, BIOCHEM BIOPH RES CO, V270, P1101, DOI 10.1006/bbrc.2000.2575; Izaguirre G, 1997, COMP BIOCHEM PHYS B, V118, P59, DOI 10.1016/S0305-0491(97)00022-9; Jia SJ, 2007, FASEB J, V21, P3318, DOI 10.1096/fj.07-8172com; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Kharbanda KK, 2007, J HEPATOL, V46, P1119, DOI 10.1016/j.jhep.2007.01.026; Kultz D, 2001, COMP BIOCHEM PHYS A, V130, P421, DOI 10.1016/S1095-6433(01)00440-8; Lassen N, 2005, DRUG METAB DISPOS, V33, P649, DOI 10.1124/dmd.104.002964; Lassen N, 2006, FREE RADICAL BIO MED, V41, P1459, DOI 10.1016/j.freeradbiomed.2006.08.009; LEE P, 1994, GENOMICS, V21, P371, DOI 10.1006/geno.1994.1279; Li ZY, 2008, J LIPID RES, V49, P1187, DOI 10.1194/jlr.R700019-JLR200; Lowe ED, 2008, J MED CHEM, V51, P4482, DOI 10.1021/jm800488j; Malik HS, 2003, NAT STRUCT BIOL, V10, P882, DOI 10.1038/nsb996; Manzer R, 2003, DNA CELL BIOL, V22, P329, DOI 10.1089/104454903322216671; Marchitti SA, 2008, EXPERT OPIN DRUG MET, V4, P697, DOI [10.1517/17425255.4.6.697, 10.1517/17425255.4.6.697 ]; Marchitti SA, 2007, BIOCHEM BIOPH RES CO, V356, P792, DOI 10.1016/j.bbrc.2007.03.046; Mills PB, 2006, NAT MED, V12, P307, DOI 10.1038/nm1366; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NODA C, 1978, BIOCHIM BIOPHYS ACTA, V525, P307, DOI 10.1016/0005-2744(78)90225-5; Nosek TM, 1998, PFLUG ARCH EUR J PHY, V435, P394, DOI 10.1007/s004240050529; O'Brien PJ, 2005, CRIT REV TOXICOL, V35, P609, DOI 10.1080/10408440591002183; Pappa A, 2005, J BIOL CHEM, V280, P27998, DOI 10.1074/jbc.M503698200; Pappa A, 2003, BIOCHEM J, V376, P615, DOI 10.1042/BJ20030810; Pappa A, 2003, FREE RADICAL BIO MED, V34, P1178, DOI 10.1016/S0891-5849(03)00070-4; Perez-Miller SJ, 2003, BIOCHEMISTRY-US, V42, P7100, DOI 10.1021/bi034182w; Plecko B, 2007, HUM MUTAT, V28, P19, DOI 10.1002/humu.20433; RAO VV, 1990, BIOCHIM BIOPHYS ACTA, V1038, P295, DOI 10.1016/0167-4838(90)90240-G; Rodrigues SM, 2006, J EXP BOT, V57, P1909, DOI 10.1093/jxb/erj132; Schliess F, 2006, BIOL CHEM, V387, P1363, DOI 10.1515/BC.2006.171; Schonbrunn E, 2001, P NATL ACAD SCI USA, V98, P1376, DOI 10.1073/pnas.98.4.1376; Sell DR, 2007, BIOCHEM J, V404, P269, DOI 10.1042/BJ20061645; Shin JH, 2009, PLANT PHYSIOL, V149, P905, DOI 10.1104/pp.108.130716; Siegel R C, 1979, Int Rev Connect Tissue Res, V8, P73; Singh RP, 2003, CANCER EPIDEM BIOMAR, V12, P933; Skvorak AB, 1997, GENOMICS, V46, P191, DOI 10.1006/geno.1997.5026; Stewart BJ, 2009, BBA-MOL CELL BIOL L, V1791, P772, DOI 10.1016/j.bbalip.2009.04.004; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; STROEHER VL, 1995, PLANT MOL BIOL, V27, P541, DOI 10.1007/BF00019320; Tang WK, 2008, FEBS LETT, V582, P3090, DOI 10.1016/j.febslet.2008.07.059; Tang WK, 2005, FEBS LETT, V579, P3759, DOI 10.1016/j.febslet.2005.05.070; TSAI CH, 1974, J BIOL CHEM, V249, P5790; Ueland PM, 2005, CLIN CHEM LAB MED, V43, P1069, DOI 10.1515/CCLM.2005.187; Valente MAS, 2009, J EXP BOT, V60, P533, DOI 10.1093/jxb/ern296; Yancey PH, 2005, J EXP BIOL, V208, P2819, DOI 10.1242/jeb.01730; YANCEY PH, 1982, SCIENCE, V217, P1214, DOI 10.1126/science.7112124	65	138	143	2	29	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18452	18463		10.1074/jbc.M109.077925	http://dx.doi.org/10.1074/jbc.M109.077925			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20207735	Green Published, hybrid			2022-12-25	WOS:000278453900039
J	Bachert, C; Linstedt, AD				Bachert, Collin; Linstedt, Adam D.			Dual Anchoring of the GRASP Membrane Tether Promotes trans Pairing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PDZ DOMAINS; GOLGI; STACKING; GM130; SECRETION	GRASP proteins share an N-terminal GRASP domain and mediate homotypic tethering of Golgi cisternae to form extended Golgi ribbons. The golgin GM130 is thought to bind the C-terminal side of the GRASP domain to recruit GRASP65 onto the Golgi whereas stable membrane association appears to also depend on anchoring of the N terminus by myristoylation. Here, we examine the nature of the GM130/GRASP65 interaction and test whether the dual membrane contacts of the GRASP domain have a role in tethering beyond membrane recruitment. GM130 was found to contain a C-terminal PDZ ligand that binds the putative groove of the second PDZ-like domain in GRASP65. To test tethering activity independent of targeting, we took advantage of a tethering assay carried out on the mitochondrial membrane in which the GRASP membrane attachment points were individually or simultaneously substituted with mitochondrially targeted transmembrane sequences. N-terminally anchored constructs tethered only if the C terminus was also anchored; and likewise, C-terminally anchored constructs tethered only if the N terminus was anchored. One explanation for the role of this dual anchoring is that it orients the GRASP domain to prevent cis interactions within the same membrane thereby favoring trans interactions between adjacent membranes. Indeed, singly anchored GRASP constructs, although nonfunctional in tethering, interacted with one another and also bound and inhibited dually anchored constructs. This work thus elucidates the GM130/GRASP65 interaction and supports a novel orientation-based model of membrane tether regulation in which dual membrane contact orients the tethering interaction interface to favor trans over cis interactions.	[Bachert, Collin; Linstedt, Adam D.] Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA	Carnegie Mellon University	Linstedt, AD (corresponding author), 4400 5th Ave, Pittsburgh, PA 15213 USA.	linstedt@cmu.edu			National Institutes of Health [GM-56779]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056779, R01GM095549] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-56779 (to A. D. L.).	Barr FA, 1998, EMBO J, V17, P3258, DOI 10.1093/emboj/17.12.3258; Barr FA, 1997, CELL, V91, P253, DOI 10.1016/S0092-8674(00)80407-9; Barr FA, 2001, J CELL BIOL, V155, P885, DOI 10.1083/jcb.200108102; D'Angelo G, 2009, J BIOL CHEM, V284, P34849, DOI 10.1074/jbc.M109.068403; Diao A, 2008, J BIOL CHEM, V283, P6957, DOI 10.1074/jbc.M708401200; Dumas JJ, 2001, MOL CELL, V8, P947, DOI 10.1016/S1097-2765(01)00385-9; Feinstein TN, 2008, MOL BIOL CELL, V19, P2696, DOI 10.1091/mbc.E07-11-1200; Guo YS, 2008, MOL BIOL CELL, V19, P2830, DOI 10.1091/mbc.E07-12-1236; HARLOW E, 1988, ANTIBODIES LAB MANUA, P522; Harris BZ, 2001, J CELL SCI, V114, P3219; Hung AY, 2002, J BIOL CHEM, V277, P5699, DOI 10.1074/jbc.R100065200; Jelen F, 2003, ACTA BIOCHIM POL, V50, P985; Jesch SA, 1998, MOL BIOL CELL, V9, P623, DOI 10.1091/mbc.9.3.623; Kinseth MA, 2007, CELL, V130, P524, DOI 10.1016/j.cell.2007.06.029; Kuo A, 2000, EMBO J, V19, P6427, DOI 10.1093/emboj/19.23.6427; Murwantoko, 2004, BIOCHEM J, V381, P895, DOI 10.1042/BJ20040435; Nourry Claire, 2003, Sci STKE, V2003, pRE7; Panic B, 2003, MOL CELL, V12, P863, DOI 10.1016/S1097-2765(03)00356-3; Puthenveedu MA, 2006, NAT CELL BIOL, V8, P238, DOI 10.1038/ncb1366; Runyon ST, 2007, PROTEIN SCI, V16, P2454, DOI 10.1110/ps.073049407; Schotman H, 2008, DEV CELL, V14, P171, DOI 10.1016/j.devcel.2007.12.006; Sengupta D, 2009, J CELL BIOL, V186, P41, DOI 10.1083/jcb.200902110; Short B, 2001, J CELL BIOL, V155, P877, DOI 10.1083/jcb.200108079; Shorter J, 1999, EMBO J, V18, P4949, DOI 10.1093/emboj/18.18.4949; Wang YZ, 2005, J BIOL CHEM, V280, P4921, DOI 10.1074/jbc.M412407200; Waters MG, 1999, CURR OPIN CELL BIOL, V11, P453, DOI 10.1016/S0955-0674(99)80065-9; Whiteheart SW, 2001, INT REV CYTOL, V207, P71; Xiang Y, 2010, J CELL BIOL, V188, P237, DOI 10.1083/jcb.200907132	28	39	39	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					16294	16301		10.1074/jbc.M110.116129	http://dx.doi.org/10.1074/jbc.M110.116129			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20228057	Green Published, hybrid			2022-12-25	WOS:000277715900066
J	Movitz, C; Brive, L; Hellstrand, K; Rabiet, MJ; Dahlgren, C				Movitz, Charlotta; Brive, Lars; Hellstrand, Kristoffer; Rabiet, Marie-Josephe; Dahlgren, Claes			The Annexin I Sequence Gln(9)-Ala(10)-Trp(11)-Phe(12) Is a Core Structure for Interaction with the Formyl Peptide Receptor 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; NEUTROPHIL NADPH-OXIDASE; LIGAND-BINDING SITE; MET-LEU-PHE; CRYSTAL-STRUCTURE; ACTIVATES NEUTROPHILS; FPR FAMILY; MEMBRANE; IDENTIFICATION; RESOLUTION	The N-terminal part of the calcium-regulated and phospholipid-binding protein annexin AI contains peptide sequences with pro-and anti-inflammatory activities. We have earlier shown that a proinflammatory signal triggered by one of these peptides, Gln(9)-Lys(25), is mediated by FPR1, a member of the formyl peptide receptor family expressed in human neutrophils. To determine the core structure in Gln(9)-Lys(25), smaller peptides were generated, and their capacity to activate neutrophils was determined. A peptide spanning from amino acid Glu(14) to Lys(25) was inactive, whereas the activity was retained in the Gln(9)-Tyr(20) peptide. Removal of amino acids from the C and N terminus of Gln(9)-Tyr(20) revealed that the first amino acid (Gln(9)) was of the utmost importance for activity. The core structure that activated the neutrophil NADPH oxidase to release superoxide anions was Gln(9)-Ala(10)-Trp(11)-Phe(12). This peptide also inhibited the activity induced by N-formyl-Met-Leu-Phe and WKYMVM. A structural model of the peptide agonist-FPR1 complex suggests that the transmembrane part of the binding pocket of the receptor binds optimally to a tetrapeptide. According to the model and the results presented, the N-terminal amino acid glutamine in Gln(9)-Phe(12) is located close to the bottom of the binding cleft, leaving for steric reasons insufficient space to extend the peptide at the N terminus. The addition of amino acids at the C terminus will not affect binding. The model presented may be helpful in developing specific FPR1 ligands.	[Movitz, Charlotta; Hellstrand, Kristoffer] Univ Gothenburg, Dept Infect Med, SE-41346 Gothenburg, Sweden; [Brive, Lars] Univ Gothenburg, Dept Cell & Mol Biol, SE-41346 Gothenburg, Sweden; [Dahlgren, Claes] Univ Gothenburg, Dept Rheumatol & Inflammat Res, SE-41346 Gothenburg, Sweden; [Rabiet, Marie-Josephe] CEA, Inst Rech Technol & Sci Vivant, Lab Biochim & Biophys Syst Integres, F-38054 Grenoble 9, France	University of Gothenburg; University of Gothenburg; University of Gothenburg; CEA; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA)	Movitz, C (corresponding author), Univ Gothenburg, Dept Infect Med, Guldhedsgatan, SE-41346 Gothenburg, Sweden.	charlotta.movitz@microbio.gu.se		Hellstrand, Kristoffer/0000-0002-6617-5976	Swedish Cancer Foundation (Cancer-fonden); Swedish Research Council; Wallenberg Foundation; Swedish Foundation for Strategic research; Torsten and Ragnar Soderberg Foundation; Anna-Lisa and Bror Bjornsson Foundation; Medical Faculty of Gothenburg; Swedish Government; King Gustaf V's 80-Years Foundation; Inga-Britt and Arne Lundberg Research Foundation	Swedish Cancer Foundation (Cancer-fonden)(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Wallenberg Foundation(European Commission); Swedish Foundation for Strategic research(Swedish Foundation for Strategic Research); Torsten and Ragnar Soderberg Foundation; Anna-Lisa and Bror Bjornsson Foundation; Medical Faculty of Gothenburg; Swedish Government; King Gustaf V's 80-Years Foundation; Inga-Britt and Arne Lundberg Research Foundation	This work was supported by the Swedish Cancer Foundation (Cancer-fonden), the Swedish Research Council, the Wallenberg Foundation, the Swedish Foundation for Strategic research, the Torsten and Ragnar Soderberg Foundation, the Anna-Lisa and Bror Bjornsson Foundation, the Medical Faculty of Gothenburg, the Swedish Government under the ALF-agreement, King Gustaf V's 80-Years Foundation, and the Inga-Britt and Arne Lundberg Research Foundation.	ABAGYAN R, 1994, J MOL BIOL, V235, P983, DOI 10.1006/jmbi.1994.1052; Bae YS, 2004, J IMMUNOL, V173, P607, DOI 10.4049/jimmunol.173.1.607; Boyum A, 1968, Scand J Clin Lab Invest Suppl, V97, P77; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Christophe T, 2001, J BIOL CHEM, V276, P21585, DOI 10.1074/jbc.M007769200; Dahlgren C, 2000, BLOOD, V95, P1810, DOI 10.1182/blood.V95.5.1810.005k06_1810_1818; Ernst S, 2004, J IMMUNOL, V172, P7669, DOI 10.4049/jimmunol.172.12.7669; Fu HM, 2004, IMMUNOLOGY, V112, P201, DOI 10.1111/j.1365-2567.2004.01884.x; Fu HM, 2006, J LEUKOCYTE BIOL, V79, P247, DOI 10.1189/jlb.0905498; Heo J, 2007, CHEMBIOCHEM, V8, P1527, DOI 10.1002/cbic.200700188; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Karlsson J, 2005, J LEUKOCYTE BIOL, V78, P762, DOI 10.1189/jlb.0305153; KLOTZ KN, 1994, BIOESSAYS, V16, P193, DOI 10.1002/bies.950160310; Lin JC, 2003, BIOCHEMISTRY-US, V42, P293, DOI 10.1021/bi026766o; Lundqvist H, 1996, FREE RADICAL BIO MED, V20, P785, DOI 10.1016/0891-5849(95)02189-2; Miettinen HM, 1997, J IMMUNOL, V159, P4045; Mills JS, 1998, J BIOL CHEM, V273, P10428, DOI 10.1074/jbc.273.17.10428; Mills JS, 2000, J BIOL CHEM, V275, P39012, DOI 10.1074/jbc.M003081200; Movitz C, 2000, BBA-BIOMEMBRANES, V1468, P231, DOI 10.1016/S0005-2736(00)00261-3; Murakami M, 2008, NATURE, V453, P363, DOI 10.1038/nature06925; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; PEREZ HD, 1993, J BIOL CHEM, V268, P2292; Perretti M, 2003, TRENDS PHARMACOL SCI, V24, P574, DOI 10.1016/j.tips.2003.09.010; Perretti M, 2001, AM J PATHOL, V158, P1969, DOI 10.1016/S0002-9440(10)64667-6; QUEHENBERGER O, 1993, J BIOL CHEM, V268, P18167; Rabiet MJ, 2007, BIOCHIMIE, V89, P1089, DOI 10.1016/j.biochi.2007.02.015; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rescher U, 2002, J IMMUNOL, V169, P1500, DOI 10.4049/jimmunol.169.3.1500; Rosengarth A, 2001, J MOL BIOL, V306, P489, DOI 10.1006/jmbi.2000.4423; SKLAR LA, 1990, BIOCHEMISTRY-US, V29, P313, DOI 10.1021/bi00454a002; Umanah GKE, 2009, BIOCHEMISTRY-US, V48, P2033, DOI 10.1021/bi802061z; Vong L, 2007, J BIOL CHEM, V282, P29998, DOI 10.1074/jbc.M702876200; Walther A, 2000, MOL CELL, V5, P831, DOI 10.1016/S1097-2765(00)80323-8; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; WENG XW, 1993, PROTEIN SCI, V2, P448; Ye RD, 2009, PHARMACOL REV, V61, P119, DOI 10.1124/pr.109.001578	37	27	30	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14338	14345		10.1074/jbc.M109.080465	http://dx.doi.org/10.1074/jbc.M109.080465			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20220135	Green Published, hybrid			2022-12-25	WOS:000277299700031
J	Zotova, L; Aleschko, M; Sponder, G; Baumgartner, R; Reipert, S; Prinz, M; Schweyen, RJ; Nowikovsky, K				Zotova, Ludmila; Aleschko, Markus; Sponder, Gerhard; Baumgartner, Roland; Reipert, Siegfried; Prinz, Monika; Schweyen, Rudolf J.; Nowikovsky, Karin			Novel Components of an Active Mitochondrial K+/H+ Exchange	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WOLF-HIRSCHHORN-SYNDROME; SACCHAROMYCES-CEREVISIAE; YEAST MITOCHONDRIA; PROTEIN COMPLEXES; MAMMALIAN-CELLS; CANDIDATE GENE; LETM1; EXPRESSION; TRANSPORT; PHOSPHATE	Defects of the mitochondrial K+/H+ exchanger (KHE) result in increased matrix K+ content, swelling, and autophagic decay of the organelle. We have previously identified the yeast Mdm38 and its human homologue LETM1, the candidate gene for seizures in Wolf-Hirschhorn syndrome, as essential components of the KHE. In a genome-wide screen for multicopy suppressors of the pet(-) (reduced growth on nonfermentable substrate) phenotype of mdm38 Delta mutants, we now characterized the mitochondrial carriers PIC2 and MRS3 as moderate suppressors and MRS7 and YDL183c as strong suppressors. Like Mdm38p, Mrs7p and Ydl183cp are mitochondrial inner membrane proteins and constituents of similar to 500-kDa protein complexes. Triple mutant strains (mdm38 Delta mrs7 Delta ydl183c Delta) exhibit a remarkably stronger pet(-) phenotype than mdm38 Delta and a general growth reduction. They totally lack KHE activity, show a dramatic drop of mitochondrial membrane potential, and heavy fragmentation of mitochondria and vacuoles. Nigericin, an ionophore with KHE activity, fully restores growth of the triple mutant, indicating that loss of KHE activity is the underlying cause of its phenotype. Mdm38p or overexpression of Mrs7p, Ydl183cp, or LETM1 in the triple mutant rescues growth and KHE activity. ALETM1 human homologue, HCCR-1/LETMD1, described as an oncogene, partially suppresses the yeast triple mutant phenotype. Based on these results, we propose that Ydl183p and the Mdm38p homologues Mrs7p, LETM1, and HCCR-1 are involved in the formation of an active KHE system.	[Sponder, Gerhard; Schweyen, Rudolf J.; Nowikovsky, Karin] Univ Vienna, Max F Perutz Labs, Dept Microbiol Immunobiol & Genet, A-1030 Vienna, Austria; [Reipert, Siegfried] Univ Vienna, Max F Perutz Labs, Dept Mol Cell Biol, A-1030 Vienna, Austria	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL)	Sponder, G (corresponding author), Univ Vienna, Max F Perutz Labs, Dept Microbiol Immunobiol & Genet, Dr Bohr Gasse 9, A-1030 Vienna, Austria.	gerhard.sponder@univie.ac.at; karin.nowikovsky@univie.ac.at	Reipert, Siegfried/A-4406-2014	Reipert, Siegfried/0000-0002-2043-3562; Nowikovsky, Karin/0000-0001-8435-8410; Baumgartner, Roland/0000-0003-1780-2424	Austrian Science Fund; SYSMO	Austrian Science Fund(Austrian Science Fund (FWF)); SYSMO	This work was supported by the Austrian Science Fund (to R. J. S.) and SYSMO (to R. J. S. and K. N.).	Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127; Bonangelino CJ, 2002, J CELL BIOL, V156, P1015, DOI 10.1083/jcb.200201002; Cho GW, 2006, GENE, V384, P18, DOI 10.1016/j.gene.2006.07.006; Cormack BP, 1997, MICROBIOL-UK, V143, P303, DOI 10.1099/00221287-143-2-303; Cortes P, 2000, BBA-BIOENERGETICS, V1456, P67, DOI 10.1016/S0005-2728(99)00109-7; DAUM G, 1982, J BIOL CHEM, V257, P3075; Dimmer KS, 2008, HUM MOL GENET, V17, P201, DOI 10.1093/hmg/ddm297; Frazier AE, 2006, J CELL BIOL, V172, P553, DOI 10.1083/jcb.200505060; Froschauer E, 2005, BBA-BIOMEMBRANES, V1711, P41, DOI 10.1016/j.bbamem.2005.02.018; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; Ha SA, 2008, INT J CANCER, V122, P501, DOI 10.1002/ijc.23146; Hamel P, 2004, MOL MICROBIOL, V51, P307, DOI 10.1046/j.1365-2958.2003.03810.x; Hasegawa A, 2007, HUM MOL GENET, V16, P2061, DOI 10.1093/hmg/ddm154; Jiang DW, 2009, SCIENCE, V326, P144, DOI 10.1126/science.1175145; Junttila MR, 2005, PROTEOMICS, V5, P1199, DOI 10.1002/pmic.200400991; Kissova I, 2007, AUTOPHAGY, V3, P329, DOI 10.4161/auto.4034; Lee WK, 2005, AM J PHYSIOL-CELL PH, V289, pC656, DOI 10.1152/ajpcell.00049.2005; McQuibban AG, 2010, HUM MOL GENET, V19, P987, DOI 10.1093/hmg/ddp563; MITCHELL P, 1966, BIOL REV, V41, P445, DOI 10.1111/j.1469-185X.1966.tb01501.x; Muhlenhoff U, 2003, J BIOL CHEM, V278, P40612, DOI 10.1074/jbc.M307847200; Nowikovsky K, 2007, CELL DEATH DIFFER, V14, P1647, DOI 10.1038/sj.cdd.4402167; Nowikovsky K, 2004, J BIOL CHEM, V279, P30307, DOI 10.1074/jbc.M403607200; Nowikovsky K, 2009, METHOD ENZYMOL, V457, P305, DOI 10.1016/S0076-6879(09)05017-4; Okamoto K, 2005, ANNU REV GENET, V39, P503, DOI 10.1146/annurev.genet.38.072902.093019; Pang TX, 2001, J BIOL CHEM, V276, P17367, DOI 10.1074/jbc.M100296200; RASHEED BKA, 1984, EUR J BIOCHEM, V144, P643, DOI 10.1111/j.1432-1033.1984.tb08513.x; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; SCHAMEL WW, 2008, CURR PROTOC CELL BIO, V6; Sesaki H, 2003, MOL BIOL CELL, V14, P2342, DOI 10.1091/mbc.E02-12-0788; Thorpe HM, 1998, P NATL ACAD SCI USA, V95, P5505, DOI 10.1073/pnas.95.10.5505; Volckaert G, 2003, YEAST, V20, P79, DOI 10.1002/yea.932; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; WALDHERR M, 1993, CURR GENET, V24, P301, DOI 10.1007/BF00336780; Weinman EJ, 2005, J PHYSIOL-LONDON, V567, P27, DOI 10.1113/jphysiol.2005.086777; Westermann B, 2000, YEAST, V16, P1421, DOI 10.1002/1097-0061(200011)16:15<1421::AID-YEA624>3.3.CO;2-L; Wojtczak L, 1996, BIOCHEM BIOPH RES CO, V223, P468, DOI 10.1006/bbrc.1996.0917; Zhang Y, 2007, FEBS LETT, V581, P2168, DOI 10.1016/j.febslet.2007.01.095; ZINSER E, 1995, YEAST, V11, P493, DOI 10.1002/yea.320110602; Zollino M, 2003, AM J HUM GENET, V72, P590, DOI 10.1086/367925	40	42	42	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14399	14414		10.1074/jbc.M109.059956	http://dx.doi.org/10.1074/jbc.M109.059956			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20197279	Green Published, hybrid			2022-12-25	WOS:000277299700037
J	Aramini, JM; Tubbs, JL; Kanugula, S; Rossi, P; Ertekin, A; Maglaqui, M; Hamilton, K; Ciccosanti, CT; Jiang, M; Xiao, R; Soong, TT; Rost, B; Acton, TB; Everett, JK; Pegg, AE; Tainer, JA; Montelione, GT				Aramini, James M.; Tubbs, Julie L.; Kanugula, Sreenivas; Rossi, Paolo; Ertekin, Asli; Maglaqui, Melissa; Hamilton, Keith; Ciccosanti, Colleen T.; Jiang, Mei; Xiao, Rong; Soong, Ta-Tsen; Rost, Burkhard; Acton, Thomas B.; Everett, John K.; Pegg, Anthony E.; Tainer, John A.; Montelione, Gaetano T.			Structural Basis of O-6-Alkylguanine Recognition by a Bacterial Alkyltransferase-like DNA Repair Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCISION-REPAIR; TORSION ANGLE DYNAMICS; O-6-METHYLGUANINE-DNA METHYLTRANSFERASE; DAMAGE RECOGNITION; BACKBONE DYNAMICS; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; SOFTWARE SUITE; BINDING; VALIDATION	Alkyltransferase-like proteins (ATLs) are a novel class of DNA repair proteins related to O-6-alkylguanine-DNA alkyltransferases (AGTs) that tightly bind alkylated DNA and shunt the damaged DNA into the nucleotide excision repair pathway. Here, we present the first structure of a bacterial ATL, from Vibrio parahaemolyticus (vpAtl). We demonstrate that vpAtl adopts an AGT-like fold and that the protein is capable of tightly binding to O-6-methylguanine-containing DNA and disrupting its repair by human AGT, a hallmark of ATLs. Mutation of highly conserved residues Tyr(23) and Arg(37) demonstrate their critical roles in a conserved mechanism of ATL binding to alkylated DNA. NMR relaxation data reveal a role for conformational plasticity in the guanine-lesion recognition cavity. Our results provide further evidence for the conserved role of ATLs in this primordial mechanism of DNA repair.	[Aramini, James M.; Rossi, Paolo; Ertekin, Asli; Maglaqui, Melissa; Hamilton, Keith; Ciccosanti, Colleen T.; Jiang, Mei; Xiao, Rong; Acton, Thomas B.; Everett, John K.; Montelione, Gaetano T.] Rutgers State Univ, Dept Mol Biol & Biochem, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA; [Tubbs, Julie L.; Tainer, John A.] Scripps Res Inst, Dept Mol Biol, NE Struct Genom Consortium, La Jolla, CA 92037 USA; [Tubbs, Julie L.; Tainer, John A.] Scripps Res Inst, Skaggs Inst Chem Biol, NE Struct Genom Consortium, La Jolla, CA 92037 USA; [Kanugula, Sreenivas; Pegg, Anthony E.] Penn State Univ, Coll Med, Milton S Hershey Med Ctr, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA; [Soong, Ta-Tsen; Rost, Burkhard] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Tainer, John A.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, NE Struct Genom Consortium, Berkeley, CA 94720 USA; [Montelione, Gaetano T.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Scripps Research Institute; Scripps Research Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Columbia University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Rutgers State University New Brunswick; Rutgers State University Medical Center	Aramini, JM (corresponding author), Rutgers State Univ, Dept Mol Biol & Biochem, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA.	jma@cabm.rutgers.edu; guy@cabm.rutgers.edu	Rost, Burkhard/A-1908-2016; Tainer, John/GWQ-4878-2022	Rost, Burkhard/0000-0003-0179-8424; Tainer, John/0000-0003-1659-2429; Montelione, Gaetano/0000-0002-9440-3059	NIGMS [U54-GM074958];  [CA097209];  [CA018137]; NATIONAL CANCER INSTITUTE [R01CA018137, R01CA097209, R37CA018137] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM074958] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant U54-GM074958 (to G. T. M.) from NIGMS (Protein Structure Initiative) and Grants CA097209 (to J. A. T. and A. E. P.) and CA018137 (to S. K.).	Acton TB, 2005, METHOD ENZYMOL, V394, P210, DOI 10.1016/S0076-6879(05)94008-1; Bahrami A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000307; Bhattacharya A, 2007, PROTEINS, V66, P778, DOI 10.1002/prot.21165; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Daniels DS, 2000, EMBO J, V19, P1719, DOI 10.1093/emboj/19.7.1719; Daniels DS, 2004, NAT STRUCT MOL BIOL, V11, P714, DOI 10.1038/nsmb791; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Duguid EM, 2005, J MOL BIOL, V350, P657, DOI 10.1016/j.jmb.2005.05.028; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Goodtzova K, 1998, BIOCHEMISTRY-US, V37, P12489, DOI 10.1021/bi9811718; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Hashimoto H, 1999, J MOL BIOL, V292, P707, DOI 10.1006/jmbi.1999.3100; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Huang YJ, 2005, J AM CHEM SOC, V127, P1665, DOI 10.1021/ja047109h; Huffman JL, 2005, MUTAT RES-FUND MOL M, V577, P55, DOI 10.1016/j.mrfmmm.2005.03.012; KANUGULA S, 1995, BIOCHEMISTRY-US, V34, P7113, DOI 10.1021/bi00021a024; Kanugula S, 2001, ENVIRON MOL MUTAGEN, V38, P235, DOI 10.1002/em.1077; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; Liu JF, 2007, NAT BIOTECHNOL, V25, P850, DOI 10.1038/nbt0807-849; MANDEL AM, 1995, J MOL BIOL, V246, P144, DOI 10.1006/jmbi.1994.0073; Margison GP, 2007, DNA REPAIR, V6, P1222, DOI 10.1016/j.dnarep.2007.03.014; Mazon G, 2009, DNA REPAIR, V8, P697, DOI 10.1016/j.dnarep.2009.01.022; MOORE MH, 1994, EMBO J, V13, P1495, DOI 10.1002/j.1460-2075.1994.tb06410.x; Morita R, 2008, J BIOCHEM, V144, P267, DOI 10.1093/jb/mvn065; Moseley HNB, 2004, J BIOMOL NMR, V28, P341, DOI 10.1023/B:JNMR.0000015420.44364.06; Moseley HNB, 2001, METHOD ENZYMOL, V339, P91, DOI 10.1016/S0076-6879(01)39311-4; PALMER AG, 1991, J AM CHEM SOC, V113, P4371, DOI 10.1021/ja00012a001; Pearson SJ, 2005, NUCLEIC ACIDS RES, V33, P3837, DOI 10.1093/nar/gki696; Pearson SJ, 2006, NUCLEIC ACIDS RES, V34, P2347, DOI 10.1093/nar/gkl270; PELTON JG, 1993, PROTEIN SCI, V2, P543; Reissner T, 2009, ANGEW CHEM INT EDIT, V48, P7293, DOI 10.1002/anie.200904042; Roberts A, 2006, MAGN RESON CHEM, V44, pS71, DOI 10.1002/mrc.1823; Rocchia W, 2001, J PHYS CHEM B, V105, P6507, DOI 10.1021/jp010454y; Tubbs JL, 2007, DNA REPAIR, V6, P1100, DOI 10.1016/j.dnarep.2007.03.011; Tubbs JL, 2009, NATURE, V459, P808, DOI 10.1038/nature08076; Verbeek B, 2008, BRIT MED BULL, V85, P17, DOI 10.1093/bmb/ldm036; Wibley JEA, 2000, NUCLEIC ACIDS RES, V28, P393, DOI 10.1093/nar/28.2.393	39	21	22	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13736	13741		10.1074/jbc.M109.093591	http://dx.doi.org/10.1074/jbc.M109.093591			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20212037	Green Published, hybrid			2022-12-25	WOS:000276987700048
J	Martinez-Poveda, B; Verotta, L; Bombardelli, E; Quesada, AR; Medina, MA				Martinez-Poveda, Beatriz; Verotta, Luisella; Bombardelli, Ezio; Quesada, Ana R.; Angel Medina, Miguel			Tetrahydrohyperforin and Octahydrohyperforin Are Two New Potent Inhibitors of Angiogenesis	PLOS ONE			English	Article							ST-JOHNS-WORT; IN-VITRO; HYPERFORIN ANALOGS; EFFICACY; CANCER	Background: We have previously shown that hyperforin, a phloroglucinol derivative found in St. John's wort, behaves as a potent anti-angiogenic compound. To identify the reactive group(s) mainly involved in this anti-angiogenic effect, we have investigated the anti-angiogenic properties of a series of stable derivatives obtained by oxidative modification of the natural product. In addition, in the present work we have studied the role of the four carbonyl groups present in hyperforin by investigating the potential of some other chemically stable derivatives. Methodology/Principal Findings: The experimental procedures included the analysis of the effects of treatment of endothelial cells with these compounds in cell growth, cell viability, cell migration and zymographic assays, as well as the tube formation assay on Matrigel. Our study with hyperforin and eight derivatives shows that the enolized beta-dicarbonyl system contained in the structure of hyperforin has a dominant role in its antiangiogenic activity. On the other hand, two of the tested hyperforin derivatives, namely, tetrahydrohyperforin and octahydrohyperforin, behave as potent inhibitors of angiogenesis. Additional characterization of these compounds included a cell specificity study of their effects on cell growth, as well as the in vivo Matrigel plug assay. Conclusions/Significance: These observations could be useful for the rational design and chemical synthesis of more effective hyperforin derivatives as anti-angiogenic drugs. Altogether, the results indicate that octahydrohyperforin is a more specific and slightly more potent antiangiogenic compound than hyperforin.	[Martinez-Poveda, Beatriz; Quesada, Ana R.; Angel Medina, Miguel] Univ Malaga, Fac Ciencias, Dept Biol Mol & Bioquim, E-29071 Malaga, Spain; [Verotta, Luisella] Univ Milan, Dipartimento Chim Organ & Ind, Milan, Italy; [Bombardelli, Ezio] Indena SPA, I-20141 Milan, Italy; [Quesada, Ana R.; Angel Medina, Miguel] CIBER Enfermedades Raras, Unidad 741, Malaga, Spain	Universidad de Malaga; University of Milan; CIBER - Centro de Investigacion Biomedica en Red; CIBERER	Martinez-Poveda, B (corresponding author), Univ Malaga, Fac Ciencias, Dept Biol Mol & Bioquim, E-29071 Malaga, Spain.	luisella.verotta@unimi.it; medina@uma.es	Medina, Miguel Ángel/K-1763-2014; Verotta, Luisella/O-5953-2016; Martinez-Poveda, Beatriz/T-6973-2017	Medina, Miguel Ángel/0000-0001-7275-6462; Verotta, Luisella/0000-0002-5739-6291; Martinez-Poveda, Beatriz/0000-0003-3927-3877; Rodriguez Quesada, Ana Maria/0000-0002-6419-8867	EEC [018834]; Spanish Ministry of Science and Innovation [CTQ2006-15279-C03-03/BQU, PS09/02216, TRACE PT2008-0145]; Fundacion Ramon Areces [PIE CTS-3759, P07-CVI-02999]; Andalusian Government [BIO-267]	EEC; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacion Ramon Areces; Andalusian Government	Work supported in part by EEC (Contract 018834: Antimal), as well as grants CTQ2006-15279-C03-03/BQU, PS09/02216 and TRACE PT2008-0145 (Spanish Ministry of Science and Innovation), Fundacion Ramon Areces and PIE CTS-3759, P07-CVI-02999 and funds from group BIO-267 (Andalusian Government). The "CIBER de Enfermedades Raras'' is an initiative from the ISCIII (Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bilia AR, 2002, LIFE SCI, V70, P3077, DOI 10.1016/S0024-3205(02)01566-7; Cabrelle A, 2008, J LEUKOCYTE BIOL, V83, P212, DOI 10.1189/jlb.0707469; Cardenas C, 2006, CELL MOL LIFE SCI, V63, P3083, DOI 10.1007/s00018-006-6399-6; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Dell'Aica I, 2007, J PHARMACOL EXP THER, V321, P492, DOI 10.1124/jpet.106.116459; Di Carlo G, 2001, TRENDS PHARMACOL SCI, V22, P292, DOI 10.1016/S0165-6147(00)01716-8; Dona M, 2004, CANCER RES, V64, P6225, DOI 10.1158/0008-5472.CAN-04-0280; Feisst Christian, 2005, Med Chem, V1, P287, DOI 10.2174/1573406053765503; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Lee J, 2006, PHYTOCHEMISTRY, V67, P2550, DOI 10.1016/j.phytochem.2006.09.018; MARTINEZPOVEDA B, 2005, INT J CANC, V117; Medina MA, 2006, LIFE SCI, V79, P105, DOI 10.1016/j.lfs.2005.12.027; Mennini T, 2004, LIFE SCI, V75, P1021, DOI 10.1016/j.lfs.2004.04.005; Quesada AR, 2006, MED RES REV, V26, P483, DOI 10.1002/med.20059; Rodriguez-Nieto S, 2001, FASEB J, V15, P261, DOI 10.1096/fj.01-0427fje; Rothley M, 2009, INT J CANCER, V125, P34, DOI 10.1002/ijc.24295; Schempp CM, 2005, PLANTA MED, V71, P999, DOI 10.1055/s-2005-871303; Verotta L, 2000, J NAT PROD, V63, P412, DOI 10.1021/np9903752; Verotta L, 2004, J ORG CHEM, V69, P7869, DOI 10.1021/jo048857s; Verotta L, 2003, CURR TOP MED CHEM, V3, P187, DOI 10.2174/1568026033392589; Verotta L, 2002, J NAT PROD, V65, P433, DOI 10.1021/np0105681; Verotta L, 1999, J NAT PROD, V62, P770, DOI 10.1021/np980470v; Verotta L, 2007, BIOORG MED CHEM LETT, V17, P1544, DOI 10.1016/j.bmcl.2006.12.100; Verotta Luisella, 2002, Phytochemistry Reviews, V1, P389, DOI 10.1023/A:1026069624278; Verotta L, 2006, EUR J ORG CHEM, V2006, P5479, DOI 10.1002/ejoc.200600644; Wolfender JL, 2003, PHYTOCHEM ANALYSIS, V14, P290, DOI 10.1002/pca.718	27	14	14	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2010	5	3							e9558	10.1371/journal.pone.0009558	http://dx.doi.org/10.1371/journal.pone.0009558			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565XA	20224821	Green Submitted, Green Published, gold			2022-12-25	WOS:000275328300006
J	Baker, SS; Baker, RD; Liu, WS; Nowak, NJ; Zhu, LX				Baker, Susan S.; Baker, Robert D.; Liu, Wensheng; Nowak, Norma J.; Zhu, Lixin			Role of Alcohol Metabolism in Non-Alcoholic Steatohepatitis	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; FATTY LIVER-DISEASE; FACTOR-ALPHA PRODUCTION; INSULIN-RESISTANCE; ETHANOL-PRODUCTION; DEHYDROGENASE; ACTIVATION; SYSTEM; CELLS; RAT	Background: Non-alcoholic steatohepatitis (NASH) is a serious form of non-alcoholic fatty liver disease (NAFLD), associated with obesity and insulin resistance. Previous studies suggested that intestinal bacteria produced more alcohol in obese mice than lean animals. Methodology/Principal Findings: To investigate whether alcohol is involved in the pathogenesis of NASH, the expression of inflammation, fibrosis and alcohol metabolism related genes in the liver tissues of NASH patients and normal controls (NCs) were examined by microarray (NASH, n = 7; NC, n = 4) and quantitative real-time PCR (NASH, n = 6; NC, n = 6). Genes related to liver inflammation and fibrosis were found to be elevated in NASH livers compared to normal livers. The most striking finding is the increased gene transcription of alcohol dehydrogenase (ADH) genes, genes for catalase and cytochrome P450 2E1, and aldehyde dehydrogenase genes. Immunoblot analysis confirmed the increased expression of ADH1 and ADH4 in NASH livers (NASH, n = 9; NC, n = 4). Conclusions/Significance: The augmented activity of all the available genes of the pathways for alcohol catabolism suggest that 1) alcohol concentration was elevated in the circulation of NASH patients; 2) there was a high priority for the NASH livers to scavenge alcohol from the circulation. Our data is the first human evidence that suggests alcohol may contribute to the development of NAFLD.	[Baker, Susan S.; Baker, Robert D.; Liu, Wensheng; Zhu, Lixin] SUNY Buffalo, Dept Pediat, Digest Dis & Nutr Ctr, Buffalo, NY 14260 USA; [Nowak, Norma J.] SUNY Buffalo, Dept Biochem, Buffalo, NY 14260 USA; [Nowak, Norma J.] SUNY Buffalo, New York State Ctr Excellence Bioinformat & Life, Buffalo, NY 14260 USA; [Nowak, Norma J.] Roswell Pk Canc Inst, Microarray & Genom Facil, Buffalo, NY 14263 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Roswell Park Cancer Institute	Baker, SS (corresponding author), SUNY Buffalo, Dept Pediat, Digest Dis & Nutr Ctr, Buffalo, NY 14260 USA.	lixinzhu@buffalo.edu	liu, wen/HGE-3071-2022	Zhu, Lixin/0000-0001-7904-1769	Peter and Tommy Fund, Inc., Buffalo, New York	Peter and Tommy Fund, Inc., Buffalo, New York	This work was supported by an unrestricted grant from the Peter and Tommy Fund, Inc., Buffalo, New York. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARAONA E, 1986, GASTROENTEROLOGY, V90, P103, DOI 10.1016/0016-5085(86)90081-8; Begriche K, 2006, MITOCHONDRION, V6, P1, DOI 10.1016/j.mito.2005.10.004; Bode C, 2005, ALCOHOL CLIN EXP RES, V29, p166S, DOI 10.1097/01.alc.0000189280.19073.28; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Cope K, 2000, GASTROENTEROLOGY, V119, P1340, DOI 10.1053/gast.2000.19267; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; DIEHL AM, 1988, GASTROENTEROLOGY, V95, P1056, DOI 10.1016/0016-5085(88)90183-7; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI23621; Galli A, 1999, HEPATOLOGY, V29, P1164, DOI 10.1002/hep.510290420; Gervois P, 2007, NAT CLIN PRACT ENDOC, V3, P145, DOI 10.1038/ncpendmet0397; HONCHEL R, 1992, ALCOHOL CLIN EXP RES, V16, P665, DOI 10.1111/j.1530-0277.1992.tb00656.x; Kawaratani H, 2008, WORLD J GASTROENTERO, V14, P6655, DOI 10.3748/wjg.14.6655; Kishore R, 2002, AM J PHYSIOL-GASTR L, V282, pG6, DOI 10.1152/ajpgi.00328.2001; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; LIEBER CS, 1961, J CLIN INVEST, V40, P394, DOI 10.1172/JCI104266; Lieber CS, 1999, ALCOHOL CLIN EXP RES, V23, P991, DOI 10.1111/j.1530-0277.1999.tb04217.x; Lindinger W, 1997, ALCOHOL CLIN EXP RES, V21, P939; LUDWIG J, 1980, MAYO CLIN PROC, V55, P434; Mandrekar P, 1999, INT IMMUNOL, V11, P1781, DOI 10.1093/intimm/11.11.1781; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; MCCLAIN CJ, 1989, HEPATOLOGY, V9, P349, DOI 10.1002/hep.1840090302; NELSON S, 1989, LIFE SCI, V44, P673, DOI 10.1016/0024-3205(89)90472-4; Nosova T, 1996, ALCOHOL ALCOHOLISM, V31, P555; Parola M, 2001, J HEPATOL, V35, P297, DOI 10.1016/S0168-8278(01)00142-8; Rozen S, 2000, Methods Mol Biol, V132, P365; Sanyal AJ, 2001, GASTROENTEROLOGY, V120, P1183, DOI 10.1053/gast.2001.23256; SCHRECK R, 1991, EMBO J, V10, P2247, DOI 10.1002/j.1460-2075.1991.tb07761.x; Shi L, 2002, J BIOL CHEM, V277, P14777, DOI 10.1074/jbc.M108967200; Szabo G, 2005, ALCOHOL CLIN EXP RES, V29, p140S, DOI 10.1097/01.alc.0000189287.83544.33; TSUTSUMI M, 1989, HEPATOLOGY, V10, P437, DOI 10.1002/hep.1840100407; Weltman MD, 1998, HEPATOLOGY, V27, P128, DOI 10.1002/hep.510270121; YOKOYAMA H, 1994, BIOCHEM BIOPH RES CO, V203, P219, DOI 10.1006/bbrc.1994.2170; YOKOYAMA S, 1994, FEBS LETT, V351, P411, DOI 10.1016/0014-5793(94)00895-7; Zhang Z, 2001, ALCOHOL CLIN EXP RES, V25, P444, DOI 10.1097/00000374-200103000-00018; Zhang ZL, 2000, J BIOL CHEM, V275, P15839, DOI 10.1074/jbc.M000604200	35	121	126	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2010	5	3					A82	A92	e9570	10.1371/journal.pone.0009570	http://dx.doi.org/10.1371/journal.pone.0009570			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565WZ	20221393	Green Submitted, Green Published, gold			2022-12-25	WOS:000275328200008
J	Woc-Colburn, L; Smultea, L; Ramachandra, L; Canaday, DH				Woc-Colburn, Laila; Smultea, Lavinia; Ramachandra, Lakshmi; Canaday, David H.			Preserved MHC Class II Antigen Processing in Monocytes from HIV-Infected Individuals	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; PERIPHERAL-BLOOD MONOCYTES; T-CELL HYBRIDOMAS; COMPLEX CLASS-II; HLA-DR; SURFACE EXPRESSION; INTERFERON-GAMMA; LANGERHANS CELLS; DENDRITIC CELLS; TYPE-1	Background: MHC-II restricted CD4+ T cells are dependent on antigen presenting cells (APC) for their activation. APC dysfunction in HIV-infected individuals could accelerate or exacerbate CD4+ T cell dysfunction and may contribute to increased levels of immunodeficiency seen in some patients regardless of their CD4+ T cell numbers. Here we test the hypothesis that APC from HIV-infected individuals have diminished antigen processing and presentation capacity. Methodology/Principal Findings: Monocytes (MN) were purified by immuno-magnetic bead isolation techniques from HLA-DR1.01+ or DR15.01+ HIV-infected and uninfected individuals. MN were analyzed for surface MHC-II expression and for antigen processing and presentation capacity after overnight incubation with soluble antigen or peptide and HLA-DR matched T cell hybridomas. Surface expression of HLA-DR was 20% reduced (p < 0.03) on MN from HIV-infected individuals. In spite of this, there was no significant difference in antigen processing and presentation by MN from 14 HIV-infected donors (8 HLA-DR1.01+ and 6 HLA-DR15.01+) compared to 24 HIV-uninfected HLA-matched subjects. Conclusions/Significance: We demonstrated that MHC class II antigen processing and presentation is preserved in MN from HIV-infected individuals. This further supports the concept that this aspect of APC function does not further contribute to CD4+ T cell dysfunction in HIV disease.	[Woc-Colburn, Laila; Smultea, Lavinia; Canaday, David H.] Case Western Reserve Univ, Sch Med, Div Infect Dis & HIV Med, Cleveland, OH 44106 USA; [Ramachandra, Lakshmi] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA; [Canaday, David H.] Cleveland Vet Affairs, Geriatr Res Educ & Clin Ctr, Cleveland, OH USA	Case Western Reserve University; Case Western Reserve University; Geriatric Research Education & Clinical Center	Woc-Colburn, L (corresponding author), Case Western Reserve Univ, Sch Med, Div Infect Dis & HIV Med, Cleveland, OH 44106 USA.	dxc44@case.edu	Woc-Colburn, Laila/U-7357-2019	Woc-Colburn, Laila/0000-0003-2888-7806	Cleveland Veterans Affairs Geriatric Research Education; Clinical Center (Canaday); Case Western Reserve University/University Hospitals of Cleveland Center for AIDS Research [AI-36219]; National Institutes of Health Pulmonary training [HL-07889];  [AI-73217]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007889] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI073217, P30AI036219] Funding Source: NIH RePORTER	Cleveland Veterans Affairs Geriatric Research Education; Clinical Center (Canaday); Case Western Reserve University/University Hospitals of Cleveland Center for AIDS Research; National Institutes of Health Pulmonary training; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by AI-73217 and Cleveland Veterans Affairs Geriatric Research Education and Clinical Center (Canaday) and Case Western Reserve University/University Hospitals of Cleveland Center for AIDS Research, AI-36219. LWC is supported by National Institutes of Health Pulmonary training grant HL-07889. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLAUVELT A, 1995, J IMMUNOL, V154, P3506; Blauvelt A, 1996, J CLIN INVEST, V97, P1550, DOI 10.1172/JCI118578; BORN W, 1988, IMMUNOL RES, V7, P279, DOI 10.1007/BF02935533; Canaday DH, 2006, CELL IMMUNOL, V243, P96, DOI 10.1016/j.cellimm.2007.01.003; Canaday DH, 2003, J IMMUNOL METHODS, V281, P129, DOI 10.1016/j.jim.2003.07.004; Fidler SJ, 1996, IMMUNOLOGY, V89, P46, DOI 10.1046/j.1365-2567.1996.d01-715.x; Gascon RL, 2002, J ACQ IMMUN DEF SYND, V30, P146, DOI [10.1097/01.QA1.0000017720.31903.6E, 10.1097/00042560-200206010-00002]; HEAGY W, 1984, J CLIN INVEST, V74, P2089, DOI 10.1172/JCI111633; Hussain A, 2008, J VIROL, V82, P893, DOI 10.1128/JVI.01373-07; Jones L, 2007, AIDS RES HUM RETROV, V23, P812, DOI 10.1089/aid.2006.0280; KOETHE SM, 1989, J MED VIROL, V29, P82, DOI 10.1002/jmv.1890290203; LOCHER C, 1994, CLIN EXP IMMUNOL, V98, P115, DOI 10.1111/j.1365-2249.1994.tb06616.x; MCILROY D, 1995, J VIROL, V69, P4737, DOI 10.1128/JVI.69.8.4737-4745.1995; McIlroy D, 1996, RES VIROLOGY, V147, P115, DOI 10.1016/0923-2516(96)80225-1; PETIT AJC, 1988, J IMMUNOL, V140, P1485; Polyak S, 1997, J IMMUNOL, V159, P2177; Schindler M, 2003, J VIROL, V77, P10548, DOI 10.1128/JVI.77.19.10548-10556.2003; Sonza S, 1996, J VIROL, V70, P3863, DOI 10.1128/JVI.70.6.3863-3869.1996; Stumptner-Cuvelette P, 2001, P NATL ACAD SCI USA, V98, P12144, DOI 10.1073/pnas.221256498; WASSERMAN K, 1994, CHEST, V105, P1324, DOI 10.1378/chest.105.5.1324; ZWILLING BS, 1990, CLIN EXP IMMUNOL, V82, P553, DOI 10.1111/j.1365-2249.1990.tb05489.x	21	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2010	5	3							e9491	10.1371/journal.pone.0009491	http://dx.doi.org/10.1371/journal.pone.0009491			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	562OZ	20209134	Green Published, gold, Green Submitted			2022-12-25	WOS:000275063400006
J	Juhlin, CC; Kiss, NB; Villablanca, A; Haglund, F; Nordenstrom, J; Hoog, A; Larsson, C				Juhlin, C. Christofer; Kiss, Nimrod B.; Villablanca, Andrea; Haglund, Felix; Nordenstrom, Jorgen; Hoog, Anders; Larsson, Catharina			Frequent Promoter Hypermethylation of the APC and RASSF1A Tumour Suppressors in Parathyroid Tumours	PLOS ONE			English	Article							ADENOMATOUS-POLYPOSIS-COLI; DNA METHYLATION; ABERRANT METHYLATION; MALIGNANT BEHAVIOR; GENE PROMOTER; HUMAN PAF1; CYCLIN D1; MEN1 GENE; RAR-BETA; C-MYC	Background: Parathyroid adenomas constitute the most common entity in primary hyperparathyroidism, and although recent advances have been made regarding the underlying genetic cause of these lesions, very little data on epigenetic alterations in this tumour type exists. In this study, we have determined the levels of promoter methylation regarding the four tumour suppressor genes APC, RASSF1A, p16(INK4A) and RAR-beta in parathyroid adenomas. In addition, the levels of global methylation were assessed by analyzing LINE-1 repeats. Methodology/Principal Findings: The sample collection consisted of 55 parathyroid tumours with known HRPT2 and/or MEN1 genotypes. Using Pyrosequencing analysis, we demonstrate APC promoter 1A and RASSF1A promoter hypermethylation in the majority of parathyroid tumours (71% and 98%, respectively). Using TaqMan qRT-PCR, all tumours analyzed displayed lower RASSF1A mRNA expression and higher levels of total APC mRNA than normal parathyroid, the latter of which was largely conferred by augmented APC 1B transcription levels. Hypermethylation of p16(INK4A) was demonstrated in a single adenoma, whereas RAR-b hypermethylation was not observed in any sample. Moreover, based on LINE-1 analyses, parathyroid tumours exhibited global methylation levels within the range of non-neoplastic parathyroid tissues. Conclusions/Significance: The results demonstrate that APC and RASSF1A promoter hypermethylation are common events in parathyroid tumours. While RASSF1A mRNA levels were found downregulated in all tumours investigated, APC gene expression was retained through APC 1B mRNA levels. These findings suggest the involvement of the Ras signaling pathway in parathyroid tumorigenesis. Additionally, in contrast to most other human cancers, parathyroid tumours were not characterized by global hypomethylation, as parathyroid tumours exhibited LINE-1 methylation levels similar to that of normal parathyroid tissues.	[Juhlin, C. Christofer; Kiss, Nimrod B.; Villablanca, Andrea; Haglund, Felix; Nordenstrom, Jorgen; Larsson, Catharina] Karolinska Univ Hosp Solna, Karolinska Inst, Ctr Mol Med, Dept Mol Med & Surg, Stockholm, Sweden; [Juhlin, C. Christofer; Hoog, Anders] Karolinska Univ Hosp Solna, Karolinska Inst, Ctr Mol Med, Dept Oncol Pathol, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital	Juhlin, CC (corresponding author), Karolinska Univ Hosp Solna, Karolinska Inst, Ctr Mol Med, Dept Mol Med & Surg, Stockholm, Sweden.	christofer.juhlin@ki.se	Juhlin, Carl Christofer/C-1125-2016	Juhlin, Carl Christofer/0000-0002-5945-9081	Swedish Cancer Foundation; Cancer Society in Stockholm; Gustav V. Jubilee Foundation; Goran Gustavsson Foundation for Research in Natural Sciences and Medicine; Swedish Research Council; Stockholm County Council; Karolinska Institutet	Swedish Cancer Foundation; Cancer Society in Stockholm; Gustav V. Jubilee Foundation; Goran Gustavsson Foundation for Research in Natural Sciences and Medicine; Swedish Research Council(Swedish Research CouncilEuropean Commission); Stockholm County Council(Stockholm County Council); Karolinska Institutet(Karolinska Institutet)	The study was financially supported by the Swedish Cancer Foundation, the Cancer Society in Stockholm, the Gustav V. Jubilee Foundation, the Goran Gustavsson Foundation for Research in Natural Sciences and Medicine, the Swedish Research Council, the Stockholm County Council, and the Karolinska Institutet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belshaw NJ, 2008, BRIT J CANCER, V99, P136, DOI 10.1038/sj.bjc.6604432; Bjorklund P, 2007, J CLIN ENDOCR METAB, V92, P338, DOI 10.1210/jc.2006-1197; Carpten JD, 2002, NAT GENET, V32, P676, DOI 10.1038/ng1048; Chandrasekharappa SC, 1997, SCIENCE, V276, P404, DOI 10.1126/science.276.5311.404; Chen G, 2008, MOL CANCER RES, V6, P1894, DOI 10.1158/1541-7786.MCR-07-2206; Chen J, 2005, CARCINOGENESIS, V26, P37, DOI 10.1093/carcin/bgh280; DELELLIS RA, 2004, WHO CLASSIFICATION T, P124; Donninger H, 2007, J CELL SCI, V120, P3163, DOI 10.1242/jcs.010389; Esteller M, 2000, CANCER RES, V60, P4366; Fackler MJ, 2003, INT J CANCER, V107, P970, DOI 10.1002/ijc.11508; Farnebo F, 1999, J CLIN ENDOCR METAB, V84, P3775, DOI 10.1210/jc.84.10.3775; Farnebo F, 1998, J CLIN ENDOCR METAB, V83, P2627, DOI 10.1210/jc.83.8.2627; FEINBERG AP, 1983, NATURE, V301, P89, DOI 10.1038/301089a0; Fischer JR, 2006, LUNG CANCER, V54, P109, DOI 10.1016/j.lungcan.2006.06.017; Geli J, 2008, CLIN CANCER RES, V14, P2551, DOI 10.1158/1078-0432.CCR-07-1867; Geli J, 2007, ENDOCR-RELAT CANCER, V14, P125, DOI 10.1677/ERC-06-0031; GRODEN J, 1991, CELL, V66, P589, DOI 10.1016/0092-8674(81)90021-0; Hayes MJ, 2008, CLIN CANCER RES, V14, P4038, DOI 10.1158/1078-0432.CCR-07-4379; He ML, 2009, PROSTATE, V69, P1643, DOI 10.1002/pros.21013; Hsi ED, 1996, J CLIN ENDOCR METAB, V81, P1736, DOI 10.1210/jc.81.5.1736; Jeronimo C, 2004, CLIN CANCER RES, V10, P4010, DOI 10.1158/1078-0432.CCR-03-0643; Juhlin C, 2006, ENDOCR-RELAT CANCER, V13, P509, DOI 10.1677/erc.1.01058; Juhlin CC, 2007, ENDOCR-RELAT CANCER, V14, P501, DOI 10.1677/ERC-07-0021; Juhlin CC, 2009, INT J ONCOL, V34, P481, DOI 10.3892/ijo_00000173; Kiss NB, 2008, ENDOCR-RELAT CANCER, V15, P609, DOI 10.1677/ERC-07-0285; Lee JJ, 2008, INT J ONCOL, V33, P861, DOI 10.3892/ijo_00000074; Lemmens I, 1997, GENOMICS, V44, P94, DOI 10.1006/geno.1997.4872; Lin L, 2008, P NATL ACAD SCI USA, V105, P17420, DOI 10.1073/pnas.0710725105; MIKI Y, 1992, CANCER RES, V52, P643; MIYOSHI Y, 1992, P NATL ACAD SCI USA, V89, P4452, DOI 10.1073/pnas.89.10.4452; Mosimann C, 2006, CELL, V125, P327, DOI 10.1016/j.cell.2006.01.053; Mould AW, 2009, INT J CANCER, V124, P1122, DOI 10.1002/ijc.24057; Ogino S, 2008, J NATL CANCER I, V100, P1734, DOI 10.1093/jnci/djn359; Romermann D, 2008, LEUKEMIA, V22, P1954, DOI 10.1038/leu.2008.76; Rozenblatt-Rosen O, 2005, MOL CELL BIOL, V25, P612, DOI 10.1128/MCB.25.2.612-620.2005; Segditsas S, 2008, EXP MOL PATHOL, V85, P201, DOI 10.1016/j.yexmp.2008.09.006; Shen WJ, 2008, WORLD J GASTROENTERO, V14, P595, DOI 10.3748/wjg.14.595; Shivakumar L, 2002, MOL CELL BIOL, V22, P4309, DOI 10.1128/MCB.22.12.4309-4318.2002; Tahara H, 1996, J CLIN ENDOCR METAB, V81, P3663, DOI 10.1210/jc.81.10.3663; Tominaga Y, 1999, KIDNEY INT, V55, P1375, DOI 10.1046/j.1523-1755.1999.00396.x; Van der Auwera I, 2008, BRIT J CANCER, V99, P1735, DOI 10.1038/sj.bjc.6604705; Virmani AK, 2001, CLIN CANCER RES, V7, P1998; Yang AS, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh032; Yart A, 2005, MOL CELL BIOL, V25, P5052, DOI 10.1128/MCB.25.12.5052-5060.2005; ZEKI K, 1994, J CLIN ENDOCR METAB, V79, P1317, DOI 10.1210/jc.79.5.1317; Zysman M, 2002, CANCER RES, V62, P3663	46	46	49	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2010	5	3							e9472	10.1371/journal.pone.0009472	http://dx.doi.org/10.1371/journal.pone.0009472			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	561RT	20208994	gold, Green Published, Green Submitted			2022-12-25	WOS:000274997100018
J	Brown, DE; McCoy, MW; Pilonieta, MC; Nix, RN; Detweiler, CS				Brown, Diane E.; McCoy, Melissa W.; Pilonieta, M. Carolina; Nix, Rebecca N.; Detweiler, Corrella S.			Chronic Murine Typhoid Fever Is a Natural Model of Secondary Hemophagocytic Lymphohistiocytosis	PLOS ONE			English	Article							SALMONELLA-TYPHIMURIUM; MALIGNANT HISTIOCYTOSIS; IRON-DEFICIENCY; MUTANT MICE; IN-VIVO; INFECTION; MACROPHAGES; DIAGNOSIS; SPECTRUM; GENES	Hemophagocytic lymphohistiocytosis (HLH) is a hyper-inflammatory clinical syndrome associated with neoplastic disorders especially lymphoma, autoimmune conditions, and infectious agents including bacteria, viruses, protozoa and fungi. In both human and veterinary medicine, hemophagocytic histiocytic disorders are clinically important and frequently fatal. HLH in humans can be a primary (familial, autosomal recessive) or secondary (acquired) condition, with both types generally precipitated by an infectious agent. Previously, no mouse model for secondary HLH has been reported. Using Salmonella enterica serotype Typhimurium by oral gavage to mimic naturally-occurring infection in Sv129S6 mice, we characterized the clinical, hematologic and morphologic host responses to disease thereby describing an animal model with the clinicopathologic features of secondary HLH as set forth by the Histiocyte Society: fever, splenomegaly, cytopenias (anemia, thrombocytopenia), hemophagocytosis in bone marrow and spleen, hyperferritinemia, and hypofibrinogenemia. Disease severity correlates with high splenic and hepatic bacterial load, and we show disease course can be monitored and tracked in live animals. Whereby secondary HLH is known to occur in human patients with typhoid fever and other infectious diseases, our characterization of a viable natural disease model of secondary HLH offers an important means to elucidate pathogenesis of poorly understood mechanisms of secondary HLH and investigation of novel therapies. We characterize previously unreported secondary HLH in a chronic mouse model of typhoid fever, and novel changes in hematology including decreased tissue ferric iron storage that differs from classically described anemia of chronic disease. Our studies demonstrate S. Typhimurium infection of mice is a natural infectious disease model of secondary HLH that may have utility for elucidating disease pathogenesis and developing novel therapies.	[Brown, Diane E.; McCoy, Melissa W.; Pilonieta, M. Carolina; Nix, Rebecca N.; Detweiler, Corrella S.] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; [Brown, Diane E.] Univ Colorado, Museum Nat Hist, Paleontol Sect, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Brown, DE (corresponding author), Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA.	diane.brown@colorado.edu; corrella.detweiler@colorado.edu	DETWEILER, CORRELLA S/ABG-2625-2021	DETWEILER, CORRELLA S/0000-0002-7783-0876	National Institutes of Health [AI076682, AI072492]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI076682, R01AI072492] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants AI076682 and AI072492 (C. S. D.) from the National Institutes of Health (www3.niaid.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajioka RS, 2002, BLOOD, V100, P1465, DOI 10.1182/blood-2001-11-0037; Allen CE, 2008, PEDIATR BLOOD CANCER, V50, P1227, DOI 10.1002/pbc.21423; Anderson G, 2005, J CLIN PATHOL, V58, P1305, DOI 10.1136/jcp.2005.027045; BESSMAN D, 1978, JAMA-J AM MED ASSOC, V239, P2475, DOI 10.1001/jama.239.23.2475; Biermann H, 1999, J LEUKOCYTE BIOL, V65, P217, DOI 10.1002/jlb.65.2.217; BROWN DE, 1994, AM J PATHOL, V144, P1412; Burkhard MJ, 2001, VET CLIN PATH, V30, P76, DOI 10.1111/j.1939-165X.2001.tb00262.x; Car BD, 2001, VET PATHOL, V38, P20, DOI 10.1354/vp.38-1-20; Castillo L, 2009, PEDIATR CRIT CARE ME, V10, P387, DOI 10.1097/PCC.0b013e3181a1ae08; Chan CB, 2009, P NATL ACAD SCI USA, V106, P468, DOI 10.1073/pnas.0809824105; Creput C, 2008, INTENS CARE MED, V34, P1177, DOI 10.1007/s00134-008-1111-y; Crozat K, 2007, J EXP MED, V204, P853, DOI 10.1084/jem.20062447; Delaby C, 2005, EXP CELL RES, V310, P43, DOI 10.1016/j.yexcr.2005.07.002; Dupic F, 2002, GUT, V51, P648, DOI 10.1136/gut.51.5.648; ESUMI N, 1988, CANCER, V61, P2071, DOI 10.1002/1097-0142(19880515)61:10<2071::AID-CNCR2820611023>3.0.CO;2-6; Everds N.E., 2007, MOUSE BIOMEDICAL RES, V3, P133; FAVARA BE, 1992, SEMIN DIAGN PATHOL, V9, P63; FEINGOLD KR, 1994, ARTERIOSCLER THROMB, V14, P1866, DOI 10.1161/01.ATV.14.11.1866; Fink SL, 2007, CELL MICROBIOL, V9, P2562, DOI 10.1111/j.1462-5822.2007.01036.x; Fisman DN, 2000, EMERG INFECT DIS, V6, P601, DOI 10.3201/eid0606.000608; Friedrichs KR, 2008, VET CLIN PATH, V37, P121, DOI 10.1111/j.1939-165X.2008.00005.x; Golde WT, 2005, LAB ANIMAL, V34, P39, DOI 10.1038/laban1005-39; Henter JI, 2007, PEDIATR BLOOD CANCER, V48, P124, DOI 10.1002/pbc.21039; HENTER JI, 1993, ACTA PAEDIATR, V82, P369, DOI 10.1111/j.1651-2227.1993.tb12699.x; HENTER JI, 1991, ACTA PAEDIATR SCAND, V80, P675, DOI 10.1111/j.1651-2227.1991.tb11928.x; HORMAECHE CE, 1985, J INFECT DIS, V152, P1050, DOI 10.1093/infdis/152.5.1050; Horne A, 2008, BRIT J HAEMATOL, V140, P327, DOI 10.1111/j.1365-2141.2007.06922.x; Janka GE, 2007, BLOOD REV, V21, P245, DOI 10.1016/j.blre.2007.05.001; Johansson C, 2006, MICROB PATHOGENESIS, V41, P49, DOI 10.1016/j.micpath.2006.03.004; Jordan MB, 2004, BLOOD, V104, P735, DOI 10.1182/blood-2003-10-3413; Kirino Y, 2005, ARTHRITIS RES THER, V7, pR616, DOI 10.1186/ar1721; Monack DM, 2004, J EXP MED, V199, P231, DOI 10.1084/jem.20031319; Moore PF, 2006, VET PATHOL, V43, P632, DOI 10.1354/vp.43-5-632; Nahum E, 2000, Pediatr Crit Care Med, V1, P51, DOI 10.1097/00130478-200007000-00010; Nairz M, 2007, CELL MICROBIOL, V9, P2126, DOI 10.1111/j.1462-5822.2007.00942.x; NAUCIEL C, 1988, INFECT IMMUN, V56, P2407, DOI 10.1128/IAI.56.9.2407-2411.1988; Nawabi P, 2008, MOL MICROBIOL, V68, P173, DOI 10.1111/j.1365-2958.2008.06142.x; NEWLANDS CE, 1994, J AM VET MED ASSOC, V205, P849; Nix RN, 2007, PLOS PATHOG, V3, P1982, DOI 10.1371/journal.ppat.0030193; Ohgami RS, 2005, BLOOD, V106, P3625, DOI 10.1182/blood-2005-01-0379; Percy DH, 2007, PATHOLOGY LAB RODENT, P3; Prophet E. B., 1992, LAB METHODS HISTOTEC; RichterDahlfors A, 1997, J EXP MED, V186, P569, DOI 10.1084/jem.186.4.569; Roy MF, 2007, J EXP MED, V204, P2949, DOI 10.1084/jem.20062606; Roy MF, 2002, GENES IMMUN, V3, P381, DOI 10.1038/sj.gene.6363924; Saegusa T, 2003, J VET MED SCI, V65, P1365, DOI 10.1292/jvms.65.1365; Santos RL, 2001, MICROBES INFECT, V3, P1335, DOI 10.1016/S1286-4579(01)01495-2; Schaer DJ, 2006, EUR J HAEMATOL, V77, P432, DOI 10.1111/j.1600-0609.2006.00730.x; Schmid JP, 2008, EUR J IMMUNOL, V38, P3219, DOI 10.1002/eji.200838488; Shin Bo-Moon, 1994, Journal of Korean Medical Science, V9, P57; Singh ZN, 2005, CLIN LAB HAEMATOL, V27, P312, DOI 10.1111/j.1365-2257.2005.00717.x; SMITH BP, 1984, AM J VET RES, V45, P59; Socolovsky M, 2001, BLOOD, V98, P3261, DOI 10.1182/blood.V98.12.3261; Soe-Lin S, 2009, P NATL ACAD SCI USA, V106, P5960, DOI 10.1073/pnas.0900808106; Spangler WL, 1999, VET PATHOL, V36, P583, DOI 10.1354/vp.36-6-583; SPENCER DC, 1988, J INFECTION, V16, P153, DOI 10.1016/S0163-4453(88)93972-2; Tsolis RM, 1999, ADV EXP MED BIOL, V473, P261; Vazquez-Torres A, 1999, NATURE, V401, P804, DOI 10.1038/44593; Veerakul Gavivann, 2002, Journal of the Medical Association of Thailand, V85, pS530; Weiss DJ, 2007, JAVMA-J AM VET MED A, V230, P697, DOI 10.2460/javma.230.5.697; Weiss G, 2009, BBA-GEN SUBJECTS, V1790, P682, DOI 10.1016/j.bbagen.2008.08.006; Wickham ME, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-65	62	42	44	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2010	5	2							e9441	10.1371/journal.pone.0009441	http://dx.doi.org/10.1371/journal.pone.0009441			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	561RS	20195482	gold, Green Published, Green Submitted			2022-12-25	WOS:000274997000010
J	Perin, L; Sedrakyan, S; Giuliani, S; Da Sacco, S; Carraro, G; Shiri, L; Lemley, KV; Rosol, M; Wu, S; Atala, A; Warburton, D; De Filippo, RE				Perin, Laura; Sedrakyan, Sargis; Giuliani, Stefano; Da Sacco, Stefano; Carraro, Gianni; Shiri, Liron; Lemley, Kevin V.; Rosol, Michael; Wu, Sam; Atala, Anthony; Warburton, David; De Filippo, Roger E.			Protective Effect of Human Amniotic Fluid Stem Cells in an Immunodeficient Mouse Model of Acute Tubular Necrosis	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; ACUTE KIDNEY INJURY; T-CELLS; REPAIR; DIFFERENTIATION; PROLIFERATION; INFLAMMATION; PROTEIN; IL-10	Acute Tubular Necrosis (ATN) causes severe damage to the kidney epithelial tubular cells and is often associated with severe renal dysfunction. Stem-cell based therapies may provide alternative approaches to treating of ATN. We have previously shown that clonal c-kit(pos) stem cells, derived from human amniotic fluid (hAFSC) can be induced to a renal fate in an ex-vivo system. Herein, we show for the first time the successful therapeutic application of hAFSC in a mouse model with glycerol-induced rhabdomyolysis and ATN. When injected into the damaged kidney, luciferase-labeled hAFSC can be tracked using bioluminescence. Moreover, we show that hAFSC provide a protective effect, ameliorating ATN in the acute injury phase as reflected by decreased creatinine and BUN blood levels and by a decrease in the number of damaged tubules and apoptosis therein, as well as by promoting proliferation of tubular epithelial cells. We show significant immunomodulatory effects of hAFSC, over the course of ATN. We therefore speculate that AFSC could represent a novel source of stem cells that may function to modulate the kidney immune milieu in renal failure caused by ATN.	[Perin, Laura; Sedrakyan, Sargis; Giuliani, Stefano; Da Sacco, Stefano; Carraro, Gianni; Shiri, Liron; Lemley, Kevin V.; Rosol, Michael; Wu, Sam; Warburton, David; De Filippo, Roger E.] Childrens Hosp Los Angeles, Saban Res Inst, Dev Biol & Regenerat Med Program, Los Angeles, CA 90027 USA; [Perin, Laura; Sedrakyan, Sargis; Giuliani, Stefano; Da Sacco, Stefano; Carraro, Gianni; Shiri, Liron; Lemley, Kevin V.; Rosol, Michael; Wu, Sam; Warburton, David; De Filippo, Roger E.] Univ So Calif, Keck Sch Med, Inst Urol, Los Angeles, CA 90033 USA; [Atala, Anthony] Wake Forest Univ, Sch Med, Wake Forest Inst Regenerat Med, Winston Salem, NC 27109 USA	Children's Hospital Los Angeles; University of Southern California; Wake Forest University	Perin, L (corresponding author), Childrens Hosp Los Angeles, Saban Res Inst, Dev Biol & Regenerat Med Program, Los Angeles, CA 90027 USA.	redefilippo@chla.usc.edu	Warburton, David/AAD-5709-2020; Da Sacco, Stefano/G-6346-2011	Da Sacco, Stefano/0000-0001-9654-6822; Giuliani, Stefano/0000-0002-4555-3093; Atala, Anthony/0000-0001-8186-2160; Carraro, Gianni/0000-0003-0824-7692	California Institute Regenerative Medicine (CIRM); American Urology Association (AUA); GOFARR; Pasadena Guild of Childrens Hospital Los Angeles	California Institute Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); American Urology Association (AUA); GOFARR; Pasadena Guild of Childrens Hospital Los Angeles	Funding was receive from the California Institute Regenerative Medicine (CIRM), American Urology Association (AUA), GOFARR, and The Pasadena Guild of Childrens Hospital Los Angeles. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonventre JV, 2003, SEMIN NEPHROL, V23, P439, DOI 10.1016/S0270-9295(03)00115-3; Carraro G, 2008, STEM CELLS, V26, P2902, DOI 10.1634/stemcells.2008-0090; DANDREA A, 1993, J EXP MED, V178, P1041, DOI 10.1084/jem.178.3.1041; De Coppi P, 2007, NAT BIOTECHNOL, V25, P100, DOI 10.1038/nbt1274; de Haan G, 2000, BRIT J HAEMATOL, V110, P638, DOI 10.1046/j.1365-2141.2000.02252.x; Duffield JS, 2005, KIDNEY INT, V68, P1956, DOI 10.1111/j.1523-1755.2005.00629.x; Duffield JS, 2005, J CLIN INVEST, V115, P1743, DOI 10.1172/JCI22593; Herrera MB, 2004, INT J MOL MED, V14, P1035; HULI J, 1987, J EXP MED, V165, P157, DOI 10.1084/jem.165.1.157; Humphreys BD, 2008, ANNU REV MED, V59, P311, DOI 10.1146/annurev.med.59.061506.154239; Kennedy J, 1996, J INTERF CYTOK RES, V16, P611, DOI 10.1089/jir.1996.16.611; Koch F, 1996, J EXP MED, V184, P741, DOI 10.1084/jem.184.2.741; LIN F, 2007, PEDIAT NEPHROL; LIU CL, 1995, J INTERF CYTOK RES, V15, P985, DOI 10.1089/jir.1995.15.985; MALISZEWSKI CR, 1988, MOL IMMUNOL, V25, P843, DOI 10.1016/0161-5890(88)90120-4; Morigi M, 2004, J AM SOC NEPHROL, V15, P1794, DOI 10.1097/01.ASN.0000128974.07460.34; Morigi M, 2008, STEM CELLS, V26, P2075, DOI 10.1634/stemcells.2007-0795; *NAT KIDN UR DIS I, KIDN UR DIS STAT US; Perin L, 2007, CELL PROLIFERAT, V40, P936, DOI 10.1111/j.1365-2184.2007.00478.x; Pflanz S, 2002, IMMUNITY, V16, P779, DOI 10.1016/S1074-7613(02)00324-2; Schwabe M, 1996, CELL IMMUNOL, V168, P117, DOI 10.1006/cimm.1996.0056; Semedo P, 2009, INT IMMUNOPHARMACOL, V9, P677, DOI 10.1016/j.intimp.2008.12.008; SHIROZU M, 1995, GENOMICS, V28, P495, DOI 10.1006/geno.1995.1180; Thadhani R, 1996, NEW ENGL J MED, V334, P1448, DOI 10.1056/NEJM199605303342207; Togel F, 2005, AM J PHYSIOL-RENAL, V289, pF31, DOI 10.1152/ajprenal.00007.2005; Wang XL, 2003, BLOOD, V102, P3478, DOI 10.1182/blood-2003-05-1432; Xing Z, 1998, J CLIN INVEST, V101, P311, DOI 10.1172/JCI1368; Yokoo T, 2006, J AM SOC NEPHROL, V17, P1026, DOI 10.1681/ASN.2005101043; 1989, IMMUNODEFICIENT RODE	29	123	134	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2010	5	2							e9357	10.1371/journal.pone.0009357	http://dx.doi.org/10.1371/journal.pone.0009357			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SX	20195358	Green Accepted, gold, Green Published			2022-12-25	WOS:000274924200010
J	Grosse, SM; Tagalakis, AD; Mustapa, MFM; Elbs, M; Meng, QH; Mohammadi, A; Tabor, AB; Hailes, HC; Hart, SL				Grosse, Stephanie M.; Tagalakis, Aristides D.; Mustapa, M. Firouz Mohd; Elbs, Martin; Meng, Qing-Hai; Mohammadi, Atefeh; Tabor, Alethea B.; Hailes, Helen C.; Hart, Stephen L.			Tumor-specific gene transfer with receptor-mediated nanocomplexes modified by polyethylene glycol shielding and endosomally cleavable lipid and peptide linkers	FASEB JOURNAL			English	Article						integrin-targeting peptides; PEGylated lipids; cleavable linkers; systemic delivery; nonviral vectors; gene expression	SYNTHETIC VECTOR SYSTEM; AIRWAY EPITHELIAL-CELLS; DELIVERY VECTOR; VASCULAR CELLS; PHAGE DISPLAY; IN-VITRO; INTEGRIN; BINDING; PEG; DNA	Synthetic nanoparticle formulations have the potential for tumor-targeted gene delivery. Receptor-targeted nanocomplex (RTN) formulations comprise mixtures of cationic liposomes and targeting peptides that self-assemble on mixing with nucleic acids. RTN formulations were prepared containing different polyethylene glycol (PEG)ylated lipids with esterase-cleavable linkers (e. g., ME42) to promote intracellular PEG detachment and nanoparticle disassembly. In addition, integrin-targeting peptides (peptide ME27) were tested with endosomal furin-and cathepsin B-cleavable peptide linkers located between the integrin-binding ligand and the K-16 nucleic acid-binding domain to promote intracellular disengagement from the receptor. ME42/ME27 RTNs formed stable particles of <200 nm in isotonic salt buffers, compared with 4-mu m particles formed by un-PEGylated RTNs. Transfection efficiency by PEG-modified, cleavable RTNs improved similar to 2-fold in 4 different cell lines, with 80% efficiency in murine neuroblastoma cells. In an in vivo model of neuroblastoma, ME42/ME27 RTNs delivering luciferase genes were tumor specific, with little expression in other organs tested. PEGylation of the RTNs enhanced luciferase transfection 5-fold over non-PEG formulations, whereas the cleavability of the peptide ME27 enhanced transfection 4-fold over that of RTNs with noncleavable peptides. Cleavability of the lipid for in vivo transfections had no effect. PEGylated, cleavable RTN formulations offer prospects for tumor-specific therapeutic gene transfer.-Grosse, S. M., Tagalakis, A. D., Firouz Mohd Mustapa, M., Elbs, M., Meng, Q.-H., Mohammadi, A., Tabor, A. B., Hailes, H. C., Hart, S. L. Tumor-specific gene transfer with receptor-mediated nanocomplexes modified by polyethylene glycol shielding and endosomally cleavable lipid and peptide linkers. FASEB J. 24, 2301-2313 (2010). www.fasebj.org	[Grosse, Stephanie M.; Tagalakis, Aristides D.; Meng, Qing-Hai; Hart, Stephen L.] UCL, Mol Immunol Unit, Inst Child Hlth, London, England; [Mustapa, M. Firouz Mohd; Elbs, Martin; Mohammadi, Atefeh; Tabor, Alethea B.; Hailes, Helen C.] UCL, Dept Chem, London, England; [Hart, Stephen L.] Genex Biosyst Ltd, London, England	University of London; University College London; University of London; University College London	Hart, SL (corresponding author), UCL Inst Child Hlth, Wolfson Ctr Gene Therapy Childhood Dis, 30 Guilford St, London WC1N 1EH, England.	shart@ich.ucl.ac.uk	Hart, Stephen L/C-1615-2008; Tagalakis, Aristides/E-8883-2011	Hart, Stephen L/0000-0001-8254-376X; Hailes, Helen/0000-0001-5574-4742	Biotechnology and Biological Sciences Research Council; Biotechnology and Biological Sciences Research Council [BBS/B/03645] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors thank Jo Sinclair [University College London (UCL) Institute of Child Health, London, UK] for her help in flow cytometry analysis and Dyanne Rampling (UCL Institute of Child Health, London, UK) for technical assistance in tumor paraffin sections. This work was funded by the Biotechnology and Biological Sciences Research Council.	ALLEN TM, 1994, TRENDS PHARMACOL SCI, V15, P215, DOI 10.1016/0165-6147(94)90314-X; Band AM, 2001, FEBS LETT, V505, P118, DOI 10.1016/S0014-5793(01)02798-3; Barker SE, 2007, BRIT J CANCER, V97, P210, DOI 10.1038/sj.bjc.6603857; Chonn A, 1998, ADV DRUG DELIVER REV, V30, P73, DOI 10.1016/S0169-409X(97)00108-7; COZENS AL, 1994, AM J RESP CELL MOL, V10, P38, DOI 10.1165/ajrcmb.10.1.7507342; Cunningham S, 2002, J GENE MED, V4, P438, DOI 10.1002/jgm.270; DEDUVE C, 1974, BIOCHEM PHARMACOL, V23, P2495, DOI 10.1016/0006-2952(74)90174-9; Ebert DH, 2002, J BIOL CHEM, V277, P24609, DOI 10.1074/jbc.M201107200; Erbacher P, 1996, EXP CELL RES, V225, P186, DOI 10.1006/excr.1996.0169; GU ML, 1995, FEBS LETT, V365, P95, DOI 10.1016/0014-5793(95)00447-H; Hart S, 1999, EXP NEPHROL, V7, P193; Hart SL, 1997, GENE THER, V4, P1225, DOI 10.1038/sj.gt.3300513; Hart SL, 1998, HUM GENE THER, V9, P575, DOI 10.1089/hum.1998.9.4-575; Hurley CA, 2004, J ORG CHEM, V69, P980, DOI 10.1021/jo035422g; Hurley CA, 2008, ORG BIOMOL CHEM, V6, P2554, DOI 10.1039/b719702k; Irvine SA, 2008, MOL THER, V16, P508, DOI 10.1038/sj.mt.6300381; Isberg Ralph R., 1994, Trends in Microbiology, V2, P10, DOI 10.1016/0966-842X(94)90338-7; Jenkins RG, 2003, GENE THER, V10, P1026, DOI 10.1038/sj.gt.3301963; Jenkins RG, 2000, GENE THER, V7, P393, DOI 10.1038/sj.gt.3301095; KOIVUNEN E, 1993, J BIOL CHEM, V268, P20205; KOIVUNEN E, 1995, BIO-TECHNOL, V13, P265, DOI 10.1038/nbt0395-265; Lee M, 2005, PHARM RES-DORDR, V22, P1, DOI 10.1007/s11095-004-9003-5; Meng QH, 2004, J GENE MED, V6, P210, DOI 10.1002/jgm.483; Meng QH, 2006, HUM GENE THER, V17, P717, DOI 10.1089/hum.2006.17.717; Mustapa MFM, 2007, BIOCHEMISTRY-US, V46, P12930, DOI 10.1021/bi701014y; Mustapa MFM, 2009, BIOCONJUGATE CHEM, V20, P518, DOI 10.1021/bc800450r; Ogris M, 2001, AAPS PHARMSCI, V3, part. no.; ONEIL KT, 1992, PROTEINS, V14, P509, DOI 10.1002/prot.340140411; Parkes R, 2002, J GENE MED, V4, P292, DOI 10.1002/jgm.265; Pilkington-Miksa MA, 2008, EUR J ORG CHEM, V2008, P2900, DOI 10.1002/ejoc.200701188; PRESSMAN BC, 1976, ANNU REV BIOCHEM, V45, P501, DOI 10.1146/annurev.bi.45.070176.002441; Rao GA, 2008, J DRUG TARGET, V16, P79, DOI 10.1080/10611860701733328 ; ROSS R, 1971, J CELL BIOL, V50, P172, DOI 10.1083/jcb.50.1.172; Semple SC, 1998, ADV DRUG DELIVER REV, V32, P3, DOI 10.1016/S0169-409X(97)00128-2; Siapati KE, 2003, BRIT J CANCER, V88, P1641, DOI 10.1038/sj.bjc.6600928; Tagalakis AD, 2008, MOL THER, V16, P907, DOI 10.1038/mt.2008.38; Torchilin VP, 2007, PHARM RES-DORDR, V24, P1, DOI 10.1007/s11095-006-9132-0; Uduehi A, 2003, BIOTECHNOL APPL BIOC, V38, P201, DOI 10.1042/BA20030062; White RE, 2003, J GENE MED, V5, P883, DOI 10.1002/jgm.420; Wong JB, 2008, MOL BIOSYST, V4, P532, DOI 10.1039/b719782a; Workman P, 1998, BRIT J CANCER, V77, P1; Writer M, 2006, J LIPOSOME RES, V16, P373, DOI 10.1080/08982100600992500; Writer MJ, 2004, J DRUG TARGET, V12, P185, DOI 10.1080/10611860410001724459; Yu W, 2004, GENE THER, V11, P1434, DOI 10.1038/sj.gt.3302304	44	49	54	2	32	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2010	24	7					2301	2313		10.1096/fj.09-144220	http://dx.doi.org/10.1096/fj.09-144220			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	618HV	20203088				2022-12-25	WOS:000279343600017
J	Sato, M; Kawakami, T; Kondoh, M; Takiguchi, M; Kadota, Y; Himeno, S; Suzuki, S				Sato, Masao; Kawakami, Takashige; Kondoh, Masuo; Takiguchi, Masufumi; Kadota, Yoshito; Himeno, Seiichiro; Suzuki, Shinya			Development of high-fat-diet-induced obesity in female metallothionein-null mice	FASEB JOURNAL			English	Article						mesoderm-specific transcript; adipose tissues; leptin resistance; oxidative stress	ENDOPLASMIC-RETICULUM STRESS; MESSENGER-RNA EXPRESSION; INSULIN-RESISTANCE; PPAR-GAMMA; GENE-EXPRESSION; OXIDATIVE STRESS; ADIPOCYTE DIFFERENTIATION; METABOLIC SYNDROME; ADIPOSE-TISSUE; ER STRESS	Oxidative stress accelerates adipocyte differentiation and lipid accumulation, leading to endoplasmic reticulum (ER) stress, which causes insulin resistance. Because metallothionein (MT) has a role in prevention of oxidative and ER stress, we examined the effects of MT on the development of obesity induced by 27 wk of a high-fat diet (HFD) in female MT-I- and MT-II-null (MT-/-) and wild-type (MT+/+) mice. Body weight, fat mass, and plasma cholesterol increased at a greater rate in MT-/- mice fed an HFD than in MT-/- mice fed a control diet (CD) and MT+/+ mice fed an HFD, indicating that MT-/- mice fed an HFD became obese and hypercholesterolemic and that MT could prevent HFD-induced obesity. The observed increases in the levels of plasma leptin and leptin mRNA in the white adipose tissue of MT-/- mice fed the HFD suggested a leptin-resistant state. Enhanced expression of a mesoderm-specific transcript, which regulates the enlargement of fat cells, was accompanied by enlarged adipocytes in the white adipose tissue of young MT-/- mice before obesity developed after 3 and 8 wk of feeding the HFD. Thus, MT may have a preventive role against HFD-induced obesity by regulating adipocyte enlargement and leptin signaling.-Sato, M., Kawakami, T., Kondoh, M., Takiguchi, M., Kadota, Y., Himeno, S., Suzuki, S. Development of high-fat-diet-induced obesity in female metallothionein-null mice. FASEB J. 24, 2375-2384 (2010). www.fasebj.org	[Sato, Masao; Kawakami, Takashige; Kondoh, Masuo; Takiguchi, Masufumi; Kadota, Yoshito; Himeno, Seiichiro; Suzuki, Shinya] Tokushima Bunri Univ, Fac Pharmaceut Sci, Tokushima 7708514, Japan	Tokushima Bunri University	Sato, M (corresponding author), Tokushima Bunri Univ, Fac Pharmaceut Sci, 180 Yamashiro Cho, Tokushima 7708514, Japan.	msato@ph.bunri-u.ac.jp	Himeno, Seiichiro/AAW-3421-2020	Himeno, Seiichiro/0000-0002-0773-2373	Ministry of Education, Science, Sports, and Culture of Japan [1430767]	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The authors thank K. Setsu, M. Inoue, T. Abe (Tokushima Bunri University, Tokushima, Japan) and K. Suzuki (Gunma University, Maebashi, Japan) for their assistance in histology, and M. Higashimoto, M. Mori, S. Ishibashi, Y. Wakuta, Y. Tsubakizaki, and K. Yoshikawa (Tokushima Bunri University) and M. Mita (Kitasato University, Tokyo, Japan) for their excellent technical assistance and mouse husbandry. This work was supported in part by a Grant-in-Aid for General Scientific Research from the Ministry of Education, Science, Sports, and Culture of Japan (1430767; to M. S.). All authors contributed equally to this work.	Beattie JH, 1996, AM J PHYSIOL-REG I, V270, pR971, DOI 10.1152/ajpregu.1996.270.5.R971; Beattie JH, 1998, P NATL ACAD SCI USA, V95, P358, DOI 10.1073/pnas.95.1.358; Binz PA, 1999, METALLOTHIONEIN IV, P7; Davis SR, 2000, J NUTR, V130, P1085; Do MS, 2002, HORM METAB RES, V34, P348, DOI 10.1055/s-2002-33254; Dong F, 2007, DIABETES, V56, P2201, DOI 10.2337/db06-1596; Ellis CD, 2004, J CELL BIOL, V166, P325, DOI 10.1083/jcb.200401157; Feng W, 2005, BIOCHEM BIOPH RES CO, V332, P853, DOI 10.1016/j.bbrc.2005.04.170; Friedman JM, 2003, SCIENCE, V299, P856, DOI 10.1126/science.1079856; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; Futakawa N, 2006, BIOL PHARM BULL, V29, P2016, DOI 10.1248/bpb.29.2016; Guo KY, 2004, AM J PHYSIOL-REG I, V287, pR112, DOI 10.1152/ajpregu.00028.2004; Jones JR, 2005, P NATL ACAD SCI USA, V102, P6207, DOI 10.1073/pnas.0306743102; Kim DS, 2007, BIOCHEM BIOPH RES CO, V363, P140, DOI 10.1016/j.bbrc.2007.08.151; Kita K, 2006, HUM GENET, V120, P553, DOI 10.1007/s00439-006-0238-6; Kondoh M, 2004, TOXICOL LETT, V148, P133, DOI 10.1016/j.toxlet.2003.12.066; Koza RA, 2006, PLOS GENET, V2, P769, DOI 10.1371/journal.pgen.0020081; Kubota N, 1999, MOL CELL, V4, P597, DOI 10.1016/S1097-2765(00)80210-5; Kuo LE, 2007, NAT MED, V13, P803, DOI 10.1038/nm1611; Lee H, 2009, J BIOL CHEM, V284, P10601, DOI 10.1074/jbc.M808742200; Levin BE, 2003, AM J PHYSIOL-ENDOC M, V285, pE949, DOI 10.1152/ajpendo.00186.2003; Lin S, 2000, BRAIN RES, V875, P89, DOI 10.1016/S0006-8993(00)02580-4; MASTERS BA, 1994, P NATL ACAD SCI USA, V91, P584, DOI 10.1073/pnas.91.2.584; MICHALSKA AE, 1993, P NATL ACAD SCI USA, V90, P8088, DOI 10.1073/pnas.90.17.8088; Miura N, 2005, BIOCHEM BIOPH RES CO, V332, P949, DOI 10.1016/j.bbrc.2005.05.043; Mocchegiani E, 2007, ANN NY ACAD SCI, V1119, P129, DOI 10.1196/annals.1404.030; Nakatani Y, 2005, J BIOL CHEM, V280, P847, DOI 10.1074/jbc.M411860200; Netea MG, 2006, NAT MED, V12, P650, DOI 10.1038/nm1415; Nikonova L, 2008, FASEB J, V22, P3925, DOI 10.1096/fj.08-108266; OH SH, 1978, AM J PHYSIOL, V234, pE282, DOI 10.1152/ajpendo.1978.234.3.E282; Oike Y, 2005, NAT MED, V11, P400, DOI 10.1038/nm1214; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Palmiter RD, 1998, P NATL ACAD SCI USA, V95, P8428, DOI 10.1073/pnas.95.15.8428; Rosen ED, 2000, GENE DEV, V14, P1293; Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702; Rosen ED, 2001, J BIOL CHEM, V276, P37731, DOI 10.1074/jbc.R100034200; Sato M, 2002, TOHOKU J EXP MED, V196, P9, DOI 10.1620/tjem.196.9; Schoonjans K, 1996, EMBO J, V15, P5336, DOI 10.1002/j.1460-2075.1996.tb00918.x; Schott-Ohly P, 2004, EXP BIOL MED, V229, P1177, DOI 10.1177/153537020422901113; Sekiya M, 2008, BIOCHEM BIOPH RES CO, V375, P602, DOI 10.1016/j.bbrc.2008.08.068; Snyder EE, 2004, OBES RES, V12, P369, DOI 10.1038/oby.2004.47; SUGIHARA H, 1987, J LIPID RES, V28, P1038; Takahashi M, 2005, AM J PHYSIOL-ENDOC M, V288, pE117, DOI 10.1152/ajpendo.00244.2004; Tanaka T, 1997, EMBO J, V16, P7432, DOI 10.1093/emboj/16.24.7432; Trayhurn P, 2000, AM J PHYSIOL-REG I, V279, pR2329, DOI 10.1152/ajpregu.2000.279.6.R2329; Wallenius V, 2002, NAT MED, V8, P75, DOI 10.1038/nm0102-75; Wang MY, 2005, P NATL ACAD SCI USA, V102, P18011, DOI 10.1073/pnas.0509001102; Ye B, 2001, P NATL ACAD SCI USA, V98, P2317, DOI 10.1073/pnas.041619198; Yoshida M, 1998, BIOL TRACE ELEM RES, V63, P167, DOI 10.1007/BF02778875; Zhang XQ, 2008, CELL, V135, P61, DOI 10.1016/j.cell.2008.07.043	51	54	57	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2010	24	7					2375	2384		10.1096/fj.09-145466	http://dx.doi.org/10.1096/fj.09-145466			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	618HV	20219986				2022-12-25	WOS:000279343600024
J	Ziebarth, TD; Gonzalez-Soltero, R; Makowska-Grzyska, MM; Nunez-Ramirez, R; Carazo, JM; Kaguni, LS				Ziebarth, Tawn D.; Gonzalez-Soltero, Rocio; Makowska-Grzyska, Magdalena M.; Nunez-Ramirez, Rafael; Carazo, Jose-Maria; Kaguni, Laurie S.			Dynamic Effects of Cofactors and DNA on the Oligomeric State of Human Mitochondrial DNA Helicase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MINICHROMOSOME MAINTENANCE PROTEIN; SINGLE-STRANDED-DNA; REPLICATIVE HELICASE; CRYSTAL-STRUCTURE; PRIMASE-HELICASE; BACTERIOPHAGE-T7; HYDROLYSIS; MECHANISM; HEXAMER; DOMAIN	We examined the effects of cofactors and DNA on the stability, oligomeric state and conformation of the human mitochondrial DNA helicase. We demonstrate that low salt conditions result in protein aggregation that may cause dissociation of oligomeric structure. The low salt sensitivity of the mitochondrial DNA helicase is mitigated by the presence of magnesium, nucleotide, and increased temperature. Electron microscopic and glutaraldehyde cross-linking analyses provide the first evidence of a heptameric oligomer and its interconversion from a hexameric form. Limited proteolysis by trypsin shows that binding of nucleoside triphosphate produces a conformational change that is distinct from the conformation observed in the presence of nucleoside diphosphate. We find that single-stranded DNA binding occurs in the absence of cofactors and renders the mitochondrial DNA helicase more susceptible to proteolytic digestion. Our studies indicate that the human mitochondrial DNA helicase shares basic properties with the SF4 replicative helicases, but also identify common features with helicases outside the superfamily, including dynamic conformations similar to other AAA(+) ATPases.	[Ziebarth, Tawn D.; Makowska-Grzyska, Magdalena M.; Kaguni, Laurie S.] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 49924 USA; [Ziebarth, Tawn D.; Makowska-Grzyska, Magdalena M.; Kaguni, Laurie S.] Michigan State Univ, Ctr Mitochondrial Sci & Med, E Lansing, MI 49924 USA; [Gonzalez-Soltero, Rocio; Nunez-Ramirez, Rafael; Carazo, Jose-Maria] CSIC, Ctr Nacl Biotecnol, Unidad Biocomputac, E-28049 Madrid, Spain	Michigan State University; Michigan State University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Kaguni, LS (corresponding author), Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 49924 USA.	lskaguni@msu.edu	Garcia, Jose Maria Carazo/E-9234-2016; Gonzalez-Soltero, Rocio/Z-2702-2019; González-Soltero, Rocío/O-7686-2019; Physics, Biophym IEM-CSIC Macromolecular/C-7939-2011	Garcia, Jose Maria Carazo/0000-0003-0788-8447; Gonzalez-Soltero, Rocio/0000-0001-9799-0570; González-Soltero, Rocío/0000-0001-9799-0570; Nunez, Rafael/0000-0002-2949-8709	National Institutes of Health [GM45295]; MEC [CSD2006-00023, BIO2007-67150-C03-1]; CAM [S-GEN-0166-2006]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045295] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MEC(European Commission); CAM; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by Grant GM45295 from the National Institutes of Health (to L. S. K.). This work was also supported by Grants CSD2006-00023 and BIO2007-67150-C03-1 from MEC and S-GEN-0166-2006 from CAM (to J.-M.C.).	ARAI K, 1981, J BIOL CHEM, V256, P5260; ARAI K, 1981, J BIOL CHEM, V256, P5247; Barcena M, 1998, J MOL BIOL, V283, P809, DOI 10.1006/jmbi.1998.2128; Bird LE, 1997, NUCLEIC ACIDS RES, V25, P2620, DOI 10.1093/nar/25.13.2620; BUJALOWSKI W, 1994, J BIOL CHEM, V269, P31350; Chong JPJ, 2000, P NATL ACAD SCI USA, V97, P1530, DOI 10.1073/pnas.030539597; Costa A, 2008, BIOCHEM SOC T, V36, P136, DOI 10.1042/BST0360136; Crampton DJ, 2006, MOL CELL, V21, P165, DOI 10.1016/j.molcel.2005.11.027; Crampton DJ, 2006, J MOL BIOL, V360, P667, DOI 10.1016/j.jmb.2006.05.037; DONG F, 1995, J BIOL CHEM, V270, P7462, DOI 10.1074/jbc.270.13.7462; Edgell DR, 1997, CELL, V89, P995, DOI 10.1016/S0092-8674(00)80285-8; EGELMAN EH, 1995, P NATL ACAD SCI USA, V92, P3869, DOI 10.1073/pnas.92.9.3869; Farge G, 2008, NUCLEIC ACIDS RES, V36, P393, DOI 10.1093/nar/gkm1025; HACKENBR.CR, 1968, P NATL ACAD SCI USA, V61, P598, DOI 10.1073/pnas.61.2.598; Kelman Z, 1999, P NATL ACAD SCI USA, V96, P14783, DOI 10.1073/pnas.96.26.14783; Korhonen JA, 2003, J BIOL CHEM, V278, P48627, DOI 10.1074/jbc.M306981200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li DW, 2003, NATURE, V423, P512, DOI 10.1038/nature01691; LIU CC, 1981, J BIOL CHEM, V256, P2813; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; MARABINI R, 1994, BIOPHYS J, V66, P1804, DOI 10.1016/S0006-3495(94)80974-9; MATSON SW, 1985, J BIOL CHEM, V260, P2281; Miyata T, 2000, J STRUCT BIOL, V131, P83, DOI 10.1006/jsbi.2000.4290; NAKAYAMA N, 1984, J BIOL CHEM, V259, P88; Pascual-Montano A, 2001, J STRUCT BIOL, V133, P233, DOI 10.1006/jsbi.2001.4369; PATEL SS, 1993, J BIOL CHEM, V268, P10668; Picha KM, 1998, J BIOL CHEM, V273, P27315, DOI 10.1074/jbc.273.42.27315; SANMARTIN MC, 1995, J STRUCT BIOL, V114, P167, DOI 10.1006/jsbi.1995.1016; Sawaya MR, 1999, CELL, V99, P167, DOI 10.1016/S0092-8674(00)81648-7; Scheres SHW, 2005, J MOL BIOL, V348, P139, DOI 10.1016/j.jmb.2005.02.031; Scheres SHW, 2008, NAT PROTOC, V3, P977, DOI 10.1038/nprot.2008.62; Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5; Sorzano COS, 2004, J STRUCT BIOL, V148, P194, DOI 10.1016/j.jsb.2004.06.006; Toth EA, 2003, MOL CELL, V12, P1113, DOI 10.1016/S1097-2765(03)00442-8; Wang YX, 1997, J BIOL CHEM, V272, P13640, DOI 10.1074/jbc.272.21.13640; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576; YONG YQ, 1995, J BIOL CHEM, V270, P24509, DOI 10.1074/jbc.270.41.24509; Yu X, 1996, J MOL BIOL, V259, P7, DOI 10.1006/jmbi.1996.0297; Yu X, 2002, EMBO REP, V3, P792, DOI 10.1093/embo-reports/kvf160; Ziebarth TD, 2007, J MOL BIOL, V367, P1382, DOI 10.1016/j.jmb.2007.01.079	40	25	25	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14639	14647		10.1074/jbc.M109.099663	http://dx.doi.org/10.1074/jbc.M109.099663			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20212038	Green Published, hybrid			2022-12-25	WOS:000277299700061
J	Liu, Q; Basu, S; Qiu, Y; Tang, F; Dong, F				Liu, Q.; Basu, S.; Qiu, Y.; Tang, F.; Dong, F.			A role of Miz-1 in Gfi-1-mediated transcriptional repression of CDKN1A	ONCOGENE			English	Article						Gfi-1; Miz-1; CKD inhibitors; proliferation	ZINC-FINGER PROTEIN; GROWTH-FACTOR INDEPENDENCE-1; HEMATOPOIETIC STEM-CELLS; TGF-BETA RECEPTOR; C-MYC; T-CELLS; FACTOR GFI1; DIFFERENTIATION; EXPRESSION; SMAD	Zinc-finger (ZF) transcriptional repressor growth factor independence 1 (Gfi-1) has an important role in hematopoiesis and inner ear development, and also functions as an oncoprotein that cooperates with c-Myc in lymphomagenesis. Gfi-1 represses transcription by directly binding to conserved sequences in the promoters of its target genes. CDKN1A encoding p21(Cip1) has been identified as a Gfi-1 target gene and has been shown to contain Gfi-1 binding sites in the upstream promoter region. We show here that Gfi-1 represses CDKN1A in a manner that is independent of its DNA binding activity. Gfi-1 interacts with POZ-ZF transcription factor Miz-1, originally shown to be a c-Myc-interacting partner, and through Miz-1 binds to the CDKN1A core promoter. Interestingly, Gfi-1 and c-Myc, through Miz-1, form a ternary complex on the CDKN1A promoter, and function in collaboration to repress CDKN1A. Gfi-1 knockdown results in enhanced levels of p21(Cip1) and attenuated cell proliferation. Notably, similar to c-Myc, the expression of Gfi-1 is downregulated by transforming growth factor-beta (TGF beta) and the level of Gfi-1 influences the response of cells to the cytostatic effect of TGF beta(.) Our data reveal an important mechanism by which Gfi-1 regulates cell proliferation and may also have implications for understanding the role of Gfi-1 in lymphomagenesis. Oncogene (2010) 29, 2843-2852; doi: 10.1038/onc.2010.48; published online 1 March 2010	[Liu, Q.; Basu, S.; Qiu, Y.; Tang, F.; Dong, F.] Univ Toledo, Dept Biol Sci, Toledo, OH 43606 USA	University System of Ohio; University of Toledo	Dong, F (corresponding author), Univ Toledo, Dept Biol Sci, 2801 W Bancroft St,MS 601, Toledo, OH 43606 USA.	fdong@utnet.utoledo.edu			National Institutes of Health [R15HL091511]; American Cancer Society [RSG-08-307-01]; Ohio Cancer Research Associates Inc; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R15HL091511] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Ohio Cancer Research Associates Inc; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank Drs M Eilers, PN Tsichlis, XF Wang and Jinfang Zhu for providing the reagents used in this study, and Dr A Quinn and S Rasche for help with [3H] thymidine incorporation assays. This work was supported in part by grants R15HL091511 (FD) from the National Institutes of Health, RSG-08-307-01 (FD) from The American Cancer Society and a grant (FD) from Ohio Cancer Research Associates Inc.	Basu S, 2009, P NATL ACAD SCI USA, V106, P1433, DOI 10.1073/pnas.0804863106; Chen CR, 2002, CELL, V110, P19, DOI 10.1016/S0092-8674(02)00801-2; DATTO MB, 1995, J BIOL CHEM, V270, P28623, DOI 10.1074/jbc.270.48.28623; Duan ZJ, 2005, MOL CELL BIOL, V25, P10338, DOI 10.1128/MCB.25.23.10338-10351.2005; Duan ZJ, 2003, P NATL ACAD SCI USA, V100, P5932, DOI 10.1073/pnas.1031694100; Dwivedi PP, 2005, ENDOCR-RELAT CANCER, V12, P351, DOI 10.1677/erc.1.00920; Frederick JP, 2004, MOL CELL BIOL, V24, P2546, DOI 10.1128/MCB.24.6.2546-2559.2004; GILKS CB, 1993, MOL CELL BIOL, V13, P1759, DOI 10.1128/MCB.13.3.1759; Grimes HL, 1996, P NATL ACAD SCI USA, V93, P14569, DOI 10.1073/pnas.93.25.14569; Grimes HL, 1996, MOL CELL BIOL, V16, P6263; Herold S, 2002, MOL CELL, V10, P509, DOI 10.1016/S1097-2765(02)00633-0; Hock H, 2004, NATURE, V431, P1002, DOI 10.1038/nature02994; Hock H, 2003, IMMUNITY, V18, P109, DOI 10.1016/S1074-7613(02)00501-0; Horman SR, 2009, BLOOD, V113, P5466, DOI 10.1182/blood-2008-09-179747; Karsunky H, 2002, NAT GENET, V30, P295, DOI 10.1038/ng831; Karsunky H, 2002, ONCOGENE, V21, P1571, DOI 10.1038/sj/onc/1205216; Kazanjian A, 2004, CANCER RES, V64, P6874, DOI 10.1158/0008-5472.CAN-04-0633; Kim SJ, 2003, LEUKEMIA, V17, P1731, DOI 10.1038/sj.leu.2403069; Kime L, 2003, BIOCHEM J, V370, P291, DOI 10.1042/BJ20021679; Letterio JJ, 2005, ONCOGENE, V24, P5701, DOI 10.1038/sj.onc.1208922; Lin HK, 2005, ONCOGENE, V24, P5693, DOI 10.1038/sj.onc.1208923; Luo KX, 1996, EMBO J, V15, P4485, DOI 10.1002/j.1460-2075.1996.tb00826.x; McGhee L, 2003, J CELL BIOCHEM, V89, P1005, DOI 10.1002/jcb.10548; Moroy T, 2005, INT J BIOCHEM CELL B, V37, P541, DOI 10.1016/j.biocel.2004.08.011; Pargmann D, 2007, EUR J IMMUNOL, V37, P3551, DOI 10.1002/eji.200737130; Person RE, 2003, NAT GENET, V34, P308, DOI 10.1038/ng1170; Peukert K, 1997, EMBO J, V16, P5672, DOI 10.1093/emboj/16.18.5672; Rodel B, 2000, EMBO J, V19, P5845, DOI 10.1093/emboj/19.21.5845; Saleque S, 2007, MOL CELL, V27, P562, DOI 10.1016/j.molcel.2007.06.039; Scheijen B, 1997, J VIROL, V71, P9, DOI 10.1128/JVI.71.1.9-16.1997; Schmidt T, 1998, ONCOGENE, V17, P2661, DOI 10.1038/sj.onc.1202191; Seoane J, 2002, NATURE, V419, P729, DOI 10.1038/nature01119; Seoane J, 2001, NAT CELL BIOL, V3, P400, DOI 10.1038/35070086; Shroyer NF, 2005, GENE DEV, V19, P2412, DOI 10.1101/gad.1353905; Staller P, 2001, NAT CELL BIOL, V3, P392, DOI 10.1038/35070076; Wallis D, 2003, DEVELOPMENT, V130, P221, DOI 10.1242/dev.00190; Wanzel M, 2003, TRENDS CELL BIOL, V13, P146, DOI 10.1016/S0962-8924(03)00003-5; Wu SQ, 2003, ONCOGENE, V22, P351, DOI 10.1038/sj.onc.1206145; Yagi K, 2002, J BIOL CHEM, V277, P854, DOI 10.1074/jbc.M104170200; Zeng H, 2004, EMBO J, V23, P4116, DOI 10.1038/sj.emboj.7600419; Zhu JF, 2002, IMMUNITY, V16, P733, DOI 10.1016/S1074-7613(02)00317-5; Zhu JF, 2006, P NATL ACAD SCI USA, V103, P18214, DOI 10.1073/pnas.0608981103; Zhu JF, 2009, J EXP MED, V206, P329, DOI 10.1084/jem.20081666; Zhuang DZ, 2006, J BIOL CHEM, V281, P10745, DOI 10.1074/jbc.M510924200; Zornig M, 1996, ONCOGENE, V12, P1789	45	19	22	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAY	2010	29	19					2843	2852		10.1038/onc.2010.48	http://dx.doi.org/10.1038/onc.2010.48			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	595DW	20190815	Green Accepted			2022-12-25	WOS:000277591900009
J	Bannasch, D; Young, A; Myers, J; Truve, K; Dickinson, P; Gregg, J; Davis, R; Bongcam-Rudloff, E; Webster, MT; Lindblad-Toh, K; Pedersen, N				Bannasch, Danika; Young, Amy; Myers, Jeffrey; Truve, Katarina; Dickinson, Peter; Gregg, Jeffrey; Davis, Ryan; Bongcam-Rudloff, Eric; Webster, Matthew T.; Lindblad-Toh, Kerstin; Pedersen, Niels			Localization of Canine Brachycephaly Using an Across Breed Mapping Approach	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; DOMESTIC DOG; COAT COLOR; MUTATION; GENE; LINKAGE; TISSUE; SMOC-2; SPARC; FGF4	The domestic dog, Canis familiaris, exhibits profound phenotypic diversity and is an ideal model organism for the genetic dissection of simple and complex traits. However, some of the most interesting phenotypes are fixed in particular breeds and are therefore less tractable to genetic analysis using classical segregation-based mapping approaches. We implemented an across breed mapping approach using a moderately dense SNP array, a low number of animals and breeds carefully selected for the phenotypes of interest to identify genetic variants responsible for breed-defining characteristics. Using a modest number of affected (10-30) and control (20-60) samples from multiple breeds, the correct chromosomal assignment was identified in a proof of concept experiment using three previously defined loci; hyperuricosuria, white spotting and chondrodysplasia. Genome-wide association was performed in a similar manner for one of the most striking morphological traits in dogs: brachycephalic head type. Although candidate gene approaches based on comparable phenotypes in mice and humans have been utilized for this trait, the causative gene has remained elusive using this method. Samples from nine affected breeds and thirteen control breeds identified strong genome-wide associations for brachycephalic head type on Cfa 1. Two independent datasets identified the same genomic region. Levels of relative heterozygosity in the associated region indicate that it has been subjected to a selective sweep, consistent with it being a breed defining morphological characteristic. Genotyping additional dogs in the region confirmed the association. To date, the genetic structure of dog breeds has primarily been exploited for genome wide association for segregating traits. These results demonstrate that non-segregating traits under strong selection are equally tractable to genetic analysis using small sample numbers.	[Bannasch, Danika; Young, Amy; Myers, Jeffrey] Univ Calif Davis, Sch Vet Med, Dept Populat Hlth & Reprod, Davis, CA 95616 USA; [Truve, Katarina; Bongcam-Rudloff, Eric] Swedish Univ Agr Sci, Dept Anim Breeding & Genet, Biomed Ctr, S-75007 Uppsala, Sweden; [Dickinson, Peter] Univ Calif Davis, Sch Vet Med, Dept Surg & Radiol Sci, Davis, CA 95616 USA; [Gregg, Jeffrey; Davis, Ryan] Univ Calif Davis, Sch Med, Dept Pathol, Davis, CA 95616 USA; [Webster, Matthew T.; Lindblad-Toh, Kerstin] Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden; [Lindblad-Toh, Kerstin] Broad Inst Harvard, Cambridge, MA USA; [Lindblad-Toh, Kerstin] MIT, Cambridge, MA 02139 USA; [Pedersen, Niels] Univ Calif Davis, Sch Vet Med, Dept Med & Epidemiol, Davis, CA 95616 USA	University of California System; University of California Davis; Swedish University of Agricultural Sciences; University of California System; University of California Davis; University of California System; University of California Davis; Uppsala University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); University of California System; University of California Davis	Bannasch, D (corresponding author), Univ Calif Davis, Sch Vet Med, Dept Populat Hlth & Reprod, Davis, CA 95616 USA.	dlbannasch@ucdavis.edu	Bannasch, Danika/GZL-8044-2022; Dickinson, Peter/GPT-0703-2022	Truve, Katarina/0000-0002-2449-8283; Davis, Ryan/0000-0001-7439-6683; Webster, Matthew/0000-0003-1141-2863; Bannasch, Danika/0000-0002-7614-7207; Young, Amy/0000-0002-4181-4233; Bongcam-Rudloff, Erik/0000-0002-1947-8288	Center for Companion Animal Health; Veterinary Genetics Laboratory, School of Veterinary Medicine, University of California Davis; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [R21 DK074954]; Swedish Research Council; National Cancer Institute (NCI) [3 P30 CA093373]; NATIONAL CANCER INSTITUTE [P30CA093373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK074954] Funding Source: NIH RePORTER	Center for Companion Animal Health; Veterinary Genetics Laboratory, School of Veterinary Medicine, University of California Davis(University of California System); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Swedish Research Council(Swedish Research CouncilEuropean Commission); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the Center for Companion Animal Health and the Veterinary Genetics Laboratory, School of Veterinary Medicine, University of California Davis and in part by a grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (R21 DK074954), the Swedish Research Council and a Cancer Center Support Grant from the National Cancer Institute (NCI) (3 P30 CA093373). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alford AI, 2006, BONE, V38, P749, DOI 10.1016/j.bone.2005.11.017; American Kennel Club, 2006, COMPL DOG BOOK, Vtwentieth; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0812297106, 10.1073/pnas.0905845106]; Bannasch D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000246; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Drogemuller C, 2008, SCIENCE, V321, P1462, DOI 10.1126/science.1162525; Ellis JL, 2009, J ANAT, V214, P362, DOI 10.1111/j.1469-7580.2008.01042.x; Foley CW, 1979, ABNORMALITIES COMPAN, P119; Haworth KE, 2001, MAMM GENOME, V12, P622, DOI 10.1007/s00335-001-3011-0; HAYES HM, 1975, INT J CANCER, V15, P39, DOI 10.1002/ijc.2910150106; Hedan Benoit, 2006, BMC Vet Res, V2, P9, DOI 10.1186/1746-6148-2-9; Hillbertz NHCS, 2007, NAT GENET, V39, P1318, DOI 10.1038/ng.2007.4; Hunemeier T, 2009, ANIM GENET, V40, P357, DOI 10.1111/j.1365-2052.2008.01838.x; Jones P, 2008, GENETICS, V179, P1033, DOI 10.1534/genetics.108.087866; Karlsson EK, 2008, NAT REV GENET, V9, P713, DOI 10.1038/nrg2382; Karlsson EK, 2007, NAT GENET, V39, P1321, DOI 10.1038/ng.2007.10; KARMI N, 2009, VALIDATION URINE TES; Kerns JA, 2004, MAMM GENOME, V15, P798, DOI 10.1007/s00335-004-2377-1; Kerns JA, 2007, GENETICS, V176, P1679, DOI 10.1534/genetics.107.074237; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; LIUP LJ, 2008, MOL BIOL CELL, V19, P248; LUGINBUHL H., 1965, ACTA NEUROCHIR SUPPL, V10, P173; Neff MW, 2004, P NATL ACAD SCI USA, V101, P11725, DOI 10.1073/pnas.0402374101; NELSON RW, 2003, SMALL ANIMAL INTERNA, P248; Nielsen R, 2005, ANNU REV GENET, V39, P197, DOI 10.1146/annurev.genet.39.073003.112420; Nishiwaki T, 2006, J BONE MINER RES, V21, P596, DOI 10.1359/JBMR.051216; NOLLER G, 2002, NEW ASPECTS BRACHYCE; Parker HG, 2009, SCIENCE, V325, P995, DOI 10.1126/science.1173275; Parker HG, 2004, SCIENCE, V304, P1160, DOI 10.1126/science.1097406; Philipp U, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-34; PORTER PL, 1995, J HISTOCHEM CYTOCHEM, V43, P791, DOI 10.1177/43.8.7622842; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rocnik EF, 2006, J BIOL CHEM, V281, P22855, DOI 10.1074/jbc.M513463200; Schmutz SM, 2002, MAMM GENOME, V13, P380, DOI 10.1007/s00335-001-2147-2; Smith FO, 2007, THERIOGENOLOGY, V68, P348, DOI 10.1016/j.theriogenology.2007.04.041; Stockard Charles Rupert, 1941, GENETIC ENDOCRINE BA; Sutter NB, 2004, GENOME RES, V14, P2388, DOI 10.1101/gr.3147604; Vannahme C, 2003, BIOCHEM J, V373, P805, DOI 10.1042/BJ20030532; Zangerl B, 2006, GENOMICS, V88, P551, DOI 10.1016/j.ygeno.2006.07.007; Zedda M, 2006, ANAT HISTOL EMBRYOL, V35, P319, DOI 10.1111/j.1439-0264.2006.00687.x	40	76	76	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2010	5	3							e9632	10.1371/journal.pone.0009632	http://dx.doi.org/10.1371/journal.pone.0009632			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565XE	20224736	Green Submitted, Green Published, gold			2022-12-25	WOS:000275328800026
J	Rodriguez-Carres, M; Findley, K; Sun, S; Dietrich, FS; Heitman, J				Rodriguez-Carres, Marianela; Findley, Keisha; Sun, Sheng; Dietrich, Fred S.; Heitman, Joseph			Morphological and Genomic Characterization of Filobasidiella depauperata: A Homothallic Sibling Species of the Pathogenic Cryptococcus Species Complex	PLOS ONE			English	Article							MATING-TYPE LOCI; BASIDIOMYCETOUS YEAST; SEXUAL REPRODUCTION; NEOFORMANS; EVOLUTION; DNA; REARRANGEMENTS; ORGANIZATION; ASSOCIATION; DYNAMICS	The fungal species Cryptococcus neoformans and Cryptococcus gattii cause respiratory and neurological disease in animals and humans following inhalation of basidiospores or desiccated yeast cells from the environment. Sexual reproduction in C. neoformans and C. gattii is controlled by a bipolar system in which a single mating type locus (MAT) specifies compatibility. These two species are dimorphic, growing as yeast in the asexual stage, and producing hyphae, basidia, and basidiospores during the sexual stage. In contrast, Filobasidiella depauperata, one of the closest related species, grows exclusively as hyphae and it is found in association with decaying insects. Examination of two available strains of F. depauperata showed that the life cycle of this fungal species shares features associated with the unisexual or same-sex mating cycle in C. neoformans. Therefore, F. depauperata may represent a homothallic and possibly an obligately sexual fungal species. RAPD genotyping of 39 randomly isolated progeny from isolate CBS7855 revealed a new genotype pattern in one of the isolated basidiospores progeny, therefore suggesting that the homothallic cycle in F. depauperata could lead to the emergence of new genotypes. Phylogenetic analyses of genes linked to MAT in C. neoformans indicated that two of these genes in F. depauperata, MYO2 and STE20, appear to form a monophyletic clade with the MATa alleles of C. neoformans and C. gattii, and thus these genes may have been recruited to the MAT locus before F. depauperata diverged. Furthermore, the ancestral MATa locus may have undergone accelerated evolution prior to the divergence of the pathogenic Cryptococcus species since several of the genes linked to the MATa locus appear to have a higher number of changes and substitutions than their MATa counterparts. Synteny analyses between C. neoformans and F. depauperata showed that genomic regions on other chromosomes displayed conserved gene order. In contrast, the genes linked to the MAT locus of C. neoformans showed a higher number of chromosomal translocations in the genome of F. depauperata. We therefore propose that chromosomal rearrangements appear to be a major force driving speciation and sexual divergence in these closely related pathogenic and saprobic species.	[Rodriguez-Carres, Marianela; Findley, Keisha; Sun, Sheng; Dietrich, Fred S.; Heitman, Joseph] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27706 USA	Duke University	Rodriguez-Carres, M (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27706 USA.	heitm001@duke.edu	Heitman, Joseph/ABC-6006-2021		National Institute of Allergy and Infectious Diseases (NIAID) [RO1 AI50113, RO1 AI063443]; Molecular Mycology Pathogenesis Training Program [2T32-AI052080-06A1]; National Institutes of Health (NIH) [5R01-AI063443-04 S1, 1-P30]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063443, R01AI050113, T32AI052080] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Molecular Mycology Pathogenesis Training Program; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institute of Allergy and Infectious Diseases (NIAID) RO1 grants AI50113 and AI063443. Marianela Rodriguez-Carres was supported by Molecular Mycology Pathogenesis Training Program grant 2T32-AI052080-06A1. Keisha Findley was supported by National Institutes of Health (NIH) Minority Supplement grant 5R01-AI063443-04 S1 Sub no. 1-P30. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahn YS, 2007, NAT REV MICROBIOL, V5, P57, DOI 10.1038/nrmicro1578; Butler G, 2009, NATURE, V459, P657, DOI 10.1038/nature08064; Casselton LA, 1998, MICROBIOL MOL BIOL R, V62, P55, DOI 10.1128/MMBR.62.1.55-70.1998; Chung SY, 2002, EUKARYOT CELL, V1, P432, DOI 10.1128/EC.1.3.432-439.2002; Davidson RC, 2003, MOL MICROBIOL, V49, P469, DOI 10.1046/j.1365-2958.2003.03563.x; Dietrich FS, 2004, SCIENCE, V304, P304, DOI 10.1126/science.1095781; Eichler EE, 2003, SCIENCE, V301, P793, DOI 10.1126/science.1086132; Findley K, 2009, EUKARYOT CELL, V8, P353, DOI 10.1128/EC.00373-08; Fraser JA, 2005, NATURE, V437, P1360, DOI 10.1038/nature04220; Fraser JA, 2005, EUKARYOT CELL, V4, P401, DOI 10.1128/EC.4.2.401-406.2005; Fraser JA, 2004, PLOS BIOL, V2, P2243, DOI 10.1371/journal.pbio.0020384; Fries BC, 1999, INFECT IMMUN, V67, P6076, DOI 10.1128/IAI.67.11.6076-6083.1999; Fries BC, 2002, MICROBES INFECT, V4, P1345, DOI 10.1016/S1286-4579(02)00006-0; Fries BC, 1996, J CLIN MICROBIOL, V34, P1531, DOI 10.1128/JCM.34.6.1531-1534.1996; Galagan JE, 2005, NATURE, V438, P1105, DOI 10.1038/nature04341; Garcia-Hermoso D, 2004, INFECT IMMUN, V72, P3359, DOI 10.1128/IAI.72.6.3359-3365.2004; GORDON D, 2004, CURRENT PROTOCOLS BI; Gunde-Cimerman Nina, 2006, Reviews in Environmental Science and Bio/Technology, V5, P323, DOI 10.1007/s11157-006-9105-0; Hsueh YP, 2008, EUKARYOT CELL, V7, P1847, DOI 10.1128/EC.00271-08; Hsueh YP, 2006, PLOS GENET, V2, P1702, DOI 10.1371/journal.pgen.0020184; Hull CM, 2005, EUKARYOT CELL, V4, P526, DOI 10.1128/EC.4.3.526-535.2005; Hull CM, 2002, ANNU REV GENET, V36, P557, DOI 10.1146/annurev.genet.36.052402.152652; Hurst LD, 2004, NAT REV GENET, V5, P299, DOI 10.1038/nrg1319; Idnurm A, 2005, PLOS BIOL, V3, P615, DOI 10.1371/journal.pbio.0030095; KAHMANN R, 1995, CURR OPIN GENET DEV, V5, P559, DOI 10.1016/0959-437X(95)80023-9; Kavanaugh LA, 2006, MOL BIOL EVOL, V23, P1879, DOI 10.1093/molbev/msl070; Kent CR, 2008, APPL ENVIRON MICROB, V74, P6248, DOI 10.1128/AEM.00970-08; Kronstad JW, 1997, ANNU REV GENET, V31, P245, DOI 10.1146/annurev.genet.31.1.245; Kurtzman C.P., 1998, YEASTS TAXONOMIC STU; KwonChung KJ, 1995, STUD MYCOL, P67; KWONCHUNG KJ, 1976, J BACTERIOL, V126, P524, DOI 10.1128/JB.126.1.524-528.1976; KwonChung KJ, 1997, MYCOLOGIA, V89, P244, DOI 10.2307/3761078; Lengeler KB, 2002, EUKARYOT CELL, V1, P704, DOI 10.1128/EC.1.5.704-718.2002; Lengeler KB, 2000, MICROBIOL MOL BIOL R, V64, P746, DOI 10.1128/MMBR.64.4.746-785.2000; Lin Xiaorong, 2007, P35; Lin XR, 2006, ANNU REV MICROBIOL, V60, P69, DOI 10.1146/annurev.micro.60.080805.142102; Lin XR, 2009, INFECT GENET EVOL, V9, P401, DOI 10.1016/j.meegid.2009.01.013; Lin XR, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000283; Lin XR, 2005, NATURE, V434, P1017, DOI 10.1038/nature03448; Loftus BJ, 2005, SCIENCE, V307, P1321, DOI 10.1126/science.1103773; MADDISON WP, 2003, MACCLADE, V4; Marra RE, 2004, GENETICS, V167, P619, DOI 10.1534/genetics.103.023408; McClelland CM, 2004, TRENDS MICROBIOL, V12, P208, DOI 10.1016/j.tim.2004.03.003; MCLAUGHLIN DJ, 1995, STUD MYCOL, V38, P87; MITCHELL TG, 1992, J MED VET MYCOL, V30, P207; MOORE RT, 1962, AM J BOT, V49, P86, DOI 10.2307/2439393; Onofri S, 2007, ADV SPACE RES, V40, P1657, DOI 10.1016/j.asr.2007.06.004; Paoletti M, 2007, CURR BIOL, V17, P1384, DOI 10.1016/j.cub.2007.07.012; Poggeler S, 1997, GENETICS, V147, P567; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rieseberg LH, 2001, TRENDS ECOL EVOL, V16, P351, DOI 10.1016/S0169-5347(01)02187-5; Rydholm C, 2007, EUKARYOT CELL, V6, P868, DOI 10.1128/EC.00319-06; SAMSON RA, 1983, A VAN LEEUW J MICROB, V49, P447; Sivakumaran S, 2003, MYCOPATHOLOGIA, V156, P157, DOI 10.1023/A:1023309311643; Swofford D.L., 1999, PAUP PHYLOGENETIC AN; Tesler G, 2002, J COMPUT SYST SCI, V65, P587, DOI 10.1016/S0022-0000(02)00011-9; Tesler G, 2002, BIOINFORMATICS, V18, P492, DOI 10.1093/bioinformatics/18.3.492; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Velegraki A, 1999, MED MYCOL, V37, P69; Wickes BL, 1996, P NATL ACAD SCI USA, V93, P7327, DOI 10.1073/pnas.93.14.7327; Xue CY, 2007, CELL HOST MICROBE, V1, P263, DOI 10.1016/j.chom.2007.05.005; Yun SH, 1999, P NATL ACAD SCI USA, V96, P5592, DOI 10.1073/pnas.96.10.5592; Yun SH, 2000, FUNGAL GENET BIOL, V31, P7, DOI 10.1006/fgbi.2000.1226; Zhao XH, 2007, EUKARYOT CELL, V6, P1701, DOI 10.1128/EC.00216-07; [No title captured]	65	29	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2010	5	3							e9620	10.1371/journal.pone.0009620	http://dx.doi.org/10.1371/journal.pone.0009620			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565XE	20224779	Green Published, Green Submitted, gold			2022-12-25	WOS:000275328800017
J	Wang, V; Davis, DA; Veeranna, RP; Haque, M; Yarchoan, R				Wang, Victoria; Davis, David A.; Veeranna, Ravindra P.; Haque, Muzammel; Yarchoan, Robert			Characterization of the Activation of Protein Tyrosine Phosphatase, Receptor-Type, Z Polypeptide 1 (PTPRZ1) by Hypoxia Inducible Factor-2 Alpha	PLOS ONE			English	Article							RENAL-CELL CARCINOMA; TRANSCRIPTION FACTORS; HIF-2-ALPHA PROMOTES; ENDOTHELIAL-CELLS; RESPONSE ELEMENTS; BINDING-SITES; BETA-CATENIN; C-MYC; GENE; EXPRESSION	Background: Hypoxia inducible factors (HIFs) are the principal means by which cells upregulate genes in response to hypoxia and certain other stresses. There are two major HIFs, HIF-1 and HIF-2. We previously found that certain genes are preferentially activated by HIF-2. One was protein tyrosine phosphatase, receptor-type, Z polypeptide 1 (PTPRZ1). PTPRZ1 is overexpressed in a number of tumors and has been implicated in glioblastoma pathogenesis. Methodology/Principal Findings: To understand the preferential activation of PTPRZ1 by HIF-2, we studied the PTPRZ1 promoter in HEK293T cells and Hep3B cells. Through deletion and mutational analysis, we identified the principal hypoxia response element. This element bound to both HIF-1 and HIF-2. We further identified a role for ELK1, an E26 transformation-specific (Ets) factor that can bind to HIF-2 alpha but not HIF-1 alpha, in the HIF-2 responsiveness. Knock-down experiments using siRNA to ELK1 decreased HIF-2 activation by over 50%. Also, a deletion mutation of one of the two Ets binding motifs located near the principal hypoxia response element similarly decreased activation of the PTPRZ1 promoter by HIF-2. Finally, chromatin immunoprecipitation assays showed binding of HIF and ELK1 to the PTPRZ1 promoter region. Conclusions/Significance: These results identify HIF-binding and Ets-binding motifs on the PTPRZ1 promoter and provide evidence that preferential activation of PTPRZ1 by HIF-2 results at least in part from cooperative binding of HIF-2 and ELK1 to nearby sites on the PTPRZ1 promoter region. These results may have implications in tumor pathogenesis and in understanding neurobiology, and may help inform the development of novel tumor therapy.	[Wang, Victoria] NCI, HIV, NIH, Bethesda, MD 20892 USA; NCI, AIDS Malignancy Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Wang, V (corresponding author), NCI, HIV, NIH, Bethesda, MD 20892 USA.	yarchoan@helix.nih.gov		Veeranna, Ravindra/0000-0003-4228-1843	National Institutes of Heath, National Cancer Institute; NATIONAL CANCER INSTITUTE [ZIABC010885] Funding Source: NIH RePORTER	National Institutes of Heath, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was supported by the Intramural Research Program of the National Institutes of Heath, National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aprelikova O, 2006, CANCER RES, V66, P5641, DOI 10.1158/0008-5472.CAN-05-3345; De Zhu J, 2006, CELL RES, V16, P780, DOI 10.1038/sj.cr.7310092; Dioum EM, 2009, SCIENCE, V324, P1289, DOI 10.1126/science.1169956; Elvert G, 2003, J BIOL CHEM, V278, P7520, DOI 10.1074/jbc.M211298200; Ema M, 1997, P NATL ACAD SCI USA, V94, P4273, DOI 10.1073/pnas.94.9.4273; Foehr ED, 2006, CANCER RES, V66, P2271, DOI 10.1158/0008-5472.CAN-05-1221; Garwood J, 2003, J BIOL CHEM, V278, P24164, DOI 10.1074/jbc.M211721200; Gordan JD, 2007, CANCER CELL, V11, P335, DOI 10.1016/j.ccr.2007.02.006; Graves BJ, 1998, ADV CANCER RES, V75, P1, DOI 10.1016/S0065-230X(08)60738-1; Haque M, 2003, J VIROL, V77, P6761, DOI 10.1128/JVI.77.12.6761-6768.2003; Haque M, 2006, J VIROL, V80, P7037, DOI 10.1128/JVI.00553-06; Harroch S, 2002, NAT GENET, V32, P411, DOI 10.1038/ng1004; Holmquist-Mengelbier L, 2006, CANCER CELL, V10, P413, DOI 10.1016/j.ccr.2006.08.026; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Huang LE, 2008, CELL DEATH DIFFER, V15, P672, DOI 10.1038/sj.cdd.4402302; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Kondo K, 2003, PLOS BIOL, V1, P439, DOI 10.1371/journal.pbio.0000083; Kondo K, 2002, CANCER CELL, V1, P237, DOI 10.1016/S1535-6108(02)00043-0; Le Bras A, 2007, ONCOGENE, V26, P7480, DOI 10.1038/sj.onc.1210566; Liu YT, 2007, AM J PATHOL, V171, P1978, DOI 10.2353/ajpath.2007.070741; LIU YX, 1995, CIRC RES, V77, P638, DOI 10.1161/01.RES.77.3.638; Lofstedt T, 2007, CELL CYCLE, V6, P919, DOI 10.4161/cc.6.8.4133; Maranchie JK, 2002, CANCER CELL, V1, P247, DOI 10.1016/S1535-6108(02)00044-2; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Meng K, 2000, P NATL ACAD SCI USA, V97, P2603, DOI 10.1073/pnas.020487997; Muller S, 2004, EXPERT OPIN THER TAR, V8, P211, DOI 10.1517/14728222.8.3.211; Muller S, 2003, ONCOGENE, V22, P6661, DOI 10.1038/sj.onc.1206763; Ohradanova A, 2008, BRIT J CANCER, V99, P1348, DOI 10.1038/sj.bjc.6604685; Perez-Pinera P, 2007, BIOCHEM BIOPH RES CO, V362, P5, DOI 10.1016/j.bbrc.2007.06.050; Raval RR, 2005, MOL CELL BIOL, V25, P5675, DOI 10.1128/MCB.25.13.5675-5686.2005; Richard DE, 1999, BIOCHEM BIOPH RES CO, V266, P718, DOI 10.1006/bbrc.1999.1889; Salnikow K, 2008, CARCINOGENESIS, V29, P1493, DOI 10.1093/carcin/bgn088; Semenza GL, 1996, J BIOL CHEM, V271, P32529, DOI 10.1074/jbc.271.51.32529; Semenza GL, 2000, J APPL PHYSIOL, V88, P1474, DOI 10.1152/jappl.2000.88.4.1474; Semenza GL, 1999, ANN NY ACAD SCI, V874, P262, DOI 10.1111/j.1749-6632.1999.tb09241.x; Semenza GL, 1998, CURR OPIN GENET DEV, V8, P588, DOI 10.1016/S0959-437X(98)80016-6; Tian H, 1997, GENE DEV, V11, P72, DOI 10.1101/gad.11.1.72; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Ulbricht U, 2003, J NEUROPATH EXP NEUR, V62, P1265, DOI 10.1093/jnen/62.12.1265; Ulbricht U, 2006, J NEUROCHEM, V98, P1497, DOI 10.1111/j.1471-4159.2006.04022.x; WANG GL, 1993, J BIOL CHEM, V268, P21513; Wang V, 2005, CANCER RES, V65, P3299, DOI 10.1158/0008-5472.CAN-04-4130; Wenger Roland H, 2005, Sci STKE, V2005, pre12, DOI 10.1126/stke.3062005re12; Wiesener MS, 2002, FASEB J, V16, P271, DOI 10.1096/fj.02-0445fje; Wu CW, 2006, CANCER LETT, V242, P95, DOI 10.1016/j.canlet.2005.10.046	45	22	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2010	5	3							e9641	10.1371/journal.pone.0009641	http://dx.doi.org/10.1371/journal.pone.0009641			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565XE	20224786	gold, Green Published, Green Submitted			2022-12-25	WOS:000275328800032
J	Du, QS; Huang, RB; Wang, SQ; Chou, KC				Du, Qi-Shi; Huang, Ri-Bo; Wang, Shu-Qing; Chou, Kuo-Chen			Designing Inhibitors of M2 Proton Channel against H1N1 Swine Influenza Virus	PLOS ONE			English	Article							A VIRUS; ION-CHANNEL; RESISTANCE; MECHANISM; PROTEIN; SURVEILLANCE; COMBINATION; PREDICTION	Background: M2 proton channel of H1N1 influenza A virus is the target protein of anti-flu drugs amantadine and rimantadine. However, the two once powerful adamantane-based drugs lost their 90% bioactivity because of mutations of virus in recent twenty years. The NMR structure of the M2 channel protein determined by Schnell and Chou ( Nature, 2008, 451, 591-595) may help people to solve the drug-resistant problem and develop more powerful new drugs against H1N1 influenza virus. Methodology: Docking calculation is performed to build the complex structure between receptor M2 proton channel and ligands, including existing drugs amantadine and rimantadine, and two newly designed inhibitors. The computer-aided drug design methods are used to calculate the binding free energies, with the computational biology techniques to analyze the interactions between M2 proton channel and adamantine-based inhibitors. Conclusions: 1) The NMR structure of M2 proton channel provides a reliable structural basis for rational drug design against influenza virus. 2) The channel gating mechanism and the inhibiting mechanism of M2 proton channel, revealed by the NMR structure of M2 proton channel, provides the new ideas for channel inhibitor design. 3) The newly designed adamantane-based inhibitors based on the modeled structure of H1N1-M2 proton channel have two pharmacophore groups, which act like a "barrel hoop'', holding two adjacent helices of the H1N1-M2 tetramer through the two pharmacophore groups outside the channel. 4) The inhibitors with such binding mechanism may overcome the drug resistance problem of influenza A virus to the adamantane-based drugs.	[Du, Qi-Shi; Huang, Ri-Bo] Guangxi Acad Sci, Nanning, Guangxi, Peoples R China; [Du, Qi-Shi; Huang, Ri-Bo] Guangxi Univ, Coll Life Sci & Tech, Nanning 530004, Guangxi, Peoples R China; [Wang, Shu-Qing] Tianjin Med Univ, Sch Pharmaceut Sci, Tianjin, Peoples R China; [Du, Qi-Shi; Chou, Kuo-Chen] Gordon Life Sci Inst, San Diego, CA USA	Guangxi University; Tianjin Medical University	Du, QS (corresponding author), Guangxi Acad Sci, Nanning, Guangxi, Peoples R China.	qishi_du@yahoo.com.cn	Chou, Kuo-Chen/A-8340-2009		National High-tech Research and Development Program ('863') of China [2006AA020103]; Chinese National Science Foundation (NSFC) [30970562]	National High-tech Research and Development Program ('863') of China(National High Technology Research and Development Program of China); Chinese National Science Foundation (NSFC)(National Natural Science Foundation of China (NSFC))	This work is financially supported by the National High-tech Research and Development Program ('863') of China under the project 2006AA020103, and by the Chinese National Science Foundation (NSFC) under the project 30970562. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayton GS, 2007, J STRUCT BIOL, V157, P570, DOI 10.1016/j.jsb.2006.10.020; Borman S, 2008, CHEM ENG NEWS, V86, P53, DOI 10.1021/cen-v086n006.p053; Bright RA, 2006, JAMA-J AM MED ASSOC, V295, P891, DOI 10.1001/jama.295.8.joc60020; Chou KC, 2004, J PROTEOME RES, V3, P1284, DOI 10.1021/pr049849v; Chou KC, 2004, CURR MED CHEM, V11, P2105, DOI 10.2174/0929867043364667; Chou KC, 2004, BIOCHEM BIOPH RES CO, V319, P433, DOI 10.1016/j.bbrc.2004.05.016; Chou KC, 1997, FEBS LETT, V419, P49, DOI 10.1016/S0014-5793(97)01246-5; Clariana J, 2000, TETRAHEDRON-ASYMMETR, V11, P4549, DOI 10.1016/S0957-4166(00)00428-6; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Deyde VM, 2007, J INFECT DIS, V196, P249, DOI 10.1086/518936; Du QS, 2009, J THEOR BIOL, V259, P159, DOI 10.1016/j.jtbi.2009.03.003; Hay A.J., 1992, SEMIN VIROL, V3, P21, DOI DOI 10.1016/J.BMC.2015.06.030; HOLSINGER LJ, 1994, J VIROL, V68, P1551, DOI 10.1128/JVI.68.3.1551-1563.1994; Hu J, 2006, P NATL ACAD SCI USA, V103, P6865, DOI 10.1073/pnas.0601944103; Hu J, 2007, BIOPHYS J, V93, P276, DOI 10.1529/biophysj.106.102103; Huang RB, 2008, BIOCHEM BIOPH RES CO, V377, P1243, DOI 10.1016/j.bbrc.2008.10.148; Kolocouris A, 1999, BIOORG MED CHEM LETT, V9, P3465, DOI 10.1016/S0960-894X(99)00631-9; Kolocouris N, 2007, BIOORG MED CHEM LETT, V17, P4358, DOI 10.1016/j.bmcl.2007.04.108; KUMPF RA, 1993, SCIENCE, V261, P1708, DOI 10.1126/science.8378771; Li H, 2004, PROTEINS, V55, P689, DOI 10.1002/prot.20032; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; MORTON CC, 2008, HARVARD FOCUS NEWS; Pielak RM, 2009, P NATL ACAD SCI USA, V106, P7379, DOI 10.1073/pnas.0902548106; Schnell JR, 2008, NATURE, V451, P591, DOI 10.1038/nature06531; Shinde V, 2009, NEW ENGL J MED, V360, P2616, DOI 10.1056/NEJMoa0903812; Smith BJ, 2002, J MED CHEM, V45, P2207, DOI 10.1021/jm010528u; Stamatiou G, 2001, BIOORG MED CHEM LETT, V11, P2137, DOI 10.1016/S0960-894X(01)00388-2; SUGRUE RJ, 1991, VIROLOGY, V180, P617, DOI 10.1016/0042-6822(91)90075-M; Takeuchi H, 2003, FEBS LETT, V552, P35, DOI 10.1016/S0014-5793(03)00781-6; Tataridis D, 2007, BIOORG MED CHEM LETT, V17, P692, DOI 10.1016/j.bmcl.2006.10.092; Trifonov V, 2009, NEW ENGL J MED, V361, P115, DOI 10.1056/NEJMp0904572; Turner JV, 2004, PHARM RES-DORDR, V21, P68, DOI 10.1023/B:PHAM.0000012154.09631.26; Wei H, 2009, MED CHEM, V5, P305, DOI 10.2174/157340609788681430	35	97	98	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2010	5	2							e9388	10.1371/journal.pone.0009388	http://dx.doi.org/10.1371/journal.pone.0009388			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SV	20186344	gold, Green Published, Green Submitted			2022-12-25	WOS:000274924000024
J	Kim, JB; Urban, K; Cochran, E; Lee, S; Ang, A; Rice, B; Bata, A; Campbell, K; Coffee, R; Gorodinsky, A; Lu, Z; Zhou, H; Kishimoto, TK; Lassota, P				Kim, Jae-Beom; Urban, Konnie; Cochran, Edward; Lee, Steve; Ang, Angel; Rice, Bradley; Bata, Adam; Campbell, Kenneth; Coffee, Richard; Gorodinsky, Alex; Lu, Zhan; Zhou, He; Kishimoto, Takashi Kei; Lassota, Peter			Non-Invasive Detection of a Small Number of Bioluminescent Cancer Cells In Vivo	PLOS ONE			English	Article							MOUSE MODEL; STEM-CELLS; PROSTATE-CANCER; BREAST-CANCER; TUMOR-GROWTH; UBIQUITIN-C; EXPRESSION; METASTASIS; VECTOR; PROLIFERATION	Early detection of tumors can significantly improve the outcome of tumor treatment. One of the most frequently asked questions in cancer imaging is how many cells can be detected non-invasively in a live animal. Although many factors limit such detection, increasing the light emission from cells is one of the most effective ways of overcoming these limitations. Here, we describe development and utilization of a lentiviral vector containing enhanced firefly luciferase (luc2) gene. The resulting single cell clones of the mouse mammary gland tumor (4T1-luc2) showed stable light emission in the range of 10,000 photons/sec/cell. In some cases individual 4T1-luc2 cells inserted under the skin of a nu/nu mouse could be detected non-invasively using a cooled CCD camera in some cases. In addition, we showed that only few cells are needed to develop tumors in these mice and tumor progression can be monitored right after the cells are implanted. Significantly higher luciferase activity in these cells allowed us to detect micrometastases in both, syngeneic Balb/c and nu/nu mice.	[Kim, Jae-Beom; Urban, Konnie; Lee, Steve; Ang, Angel; Rice, Bradley; Lassota, Peter] Caliper Life Sci Inc, Alameda, CA USA; [Bata, Adam; Campbell, Kenneth; Coffee, Richard; Gorodinsky, Alex; Lu, Zhan] Caliper Life Sci Inc, Cranbury, NJ USA; [Cochran, Edward; Zhou, He; Kishimoto, Takashi Kei] Momenta Pharmaceut Inc, Cambridge, MA USA		Kim, JB (corresponding author), Caliper Life Sci Inc, Alameda, CA USA.	jae.kim@caliperls.com; peter.lassota@caliperls.com			Caliper Life Sciences and Momenta Pharmaceuticals	Caliper Life Sciences and Momenta Pharmaceuticals	This work was funded internally at Caliper Life Sciences and Momenta Pharmaceuticals. The funders provided reagents, research space, and resources for this study. However, authors are solely involved in study design, data collection and analyses, or preparation of the manuscript. Caliper Life Sciences and Momenta Biopharma agreed to publish these data in a scientific journal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam M, 2008, J CANCER RES CLIN, V134, P137, DOI 10.1007/s00432-007-0260-7; Brakenhielm E, 2007, INT J CANCER, V121, P2153, DOI 10.1002/ijc.22900; Cao YA, 2004, P NATL ACAD SCI USA, V101, P221, DOI 10.1073/pnas.2637010100; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Dylla SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002428; Fomicheva EV, 2008, MOL THER, V16, P1594, DOI 10.1038/mt.2008.136; Gill DR, 2001, GENE THER, V8, P1539, DOI 10.1038/sj.gt.3301561; Hirsch FR, 2001, CLIN CANCER RES, V7, P5; HOLMGREN L, 1995, NAT MED, V1, P149, DOI 10.1038/nm0295-149; Iyer M, 2004, MOL THER, V10, P545, DOI 10.1016/j.ymthe.2004.06.118; Jenkins DE, 2003, CLIN EXP METASTAS, V20, P733, DOI 10.1023/B:CLIN.0000006815.49932.98; Killion JJ, 1998, CANCER METAST REV, V17, P279, DOI 10.1023/A:1006140513233; Kondo T, 2004, P NATL ACAD SCI USA, V101, P781, DOI 10.1073/pnas.0307618100; Kuo C, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2717898; Pfeifer A, 2000, P NATL ACAD SCI USA, V97, P12227, DOI 10.1073/pnas.220399597; Pfeifer A, 2001, MOL THER, V3, P319, DOI 10.1006/mthe.2001.0276; *PROM, 2007, PGL4 LUC REP VECT PR; Rabinovich BA, 2008, P NATL ACAD SCI USA, V105, P14342, DOI 10.1073/pnas.0804105105; Ray S, 2008, MOL THER, V16, P1848, DOI 10.1038/mt.2008.180; Roda A, 2003, ANAL BIOANAL CHEM, V377, P826, DOI 10.1007/s00216-003-2096-6; Scatena CD, 2004, PROSTATE, V59, P292, DOI 10.1002/pros.20003; Schorpp M, 1996, NUCLEIC ACIDS RES, V24, P1787, DOI 10.1093/nar/24.9.1787; Sommer G, 2003, P NATL ACAD SCI USA, V100, P6706, DOI 10.1073/pnas.1037763100; Song H, 2008, CLIN CANCER RES, V14, P6116, DOI 10.1158/1078-0432.CCR-07-4672; Tao K, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-228; Troy Tamara, 2004, Mol Imaging, V3, P9, DOI 10.1162/153535004773861688; Uhrbom L, 2004, NAT MED, V10, P1257, DOI 10.1038/nm1120; VAUPEL P, 1989, CANCER RES, V49, P6449; Zhang GJ, 2004, NAT MED, V10, P643, DOI 10.1038/nm1047; Zheng M, 2006, ONCOLOGY-BASEL, V70, P418, DOI 10.1159/000098954; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	31	119	125	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2010	5	2							e9364	10.1371/journal.pone.0009364	http://dx.doi.org/10.1371/journal.pone.0009364			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SV	20186331	gold, Green Published, Green Submitted			2022-12-25	WOS:000274924000008
J	Ishino, K; Wakita, C; Shibata, T; Toyokuni, S; Machida, S; Matsuda, S; Matsuda, T; Uchida, K				Ishino, Kousuke; Wakita, Chika; Shibata, Takahiro; Toyokuni, Shinya; Machida, Sachiko; Matsuda, Shun; Matsuda, Tomonari; Uchida, Koji			Lipid Peroxidation Generates Body Odor Component trans-2-Nonenal Covalently Bound to Protein in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; ALDEHYDE-MODIFIED PROTEINS; NONENZYMATICALLY GLYCOSYLATED PROTEINS; LIVER ENDOTHELIAL-CELLS; SCAVENGER RECEPTOR; FERRIC NITRILOTRIACETATE; OXIDATIVE INACTIVATION; RENAL CARCINOGEN; LDL RECEPTOR; MACROPHAGES	trans-2-Nonenal is an unsaturated aldehyde with an unpleasant greasy and grassy odor endogenously generated during the peroxidation of polyunsaturated fatty acids. 2-Nonenal covalently modified human serum albumin through a reaction in which the aldehyde preferentially reacted with the lysine residues. Modified proteins were immunogenic, and a specific monoclonal antibody (mAb) 27Q4 that cross-reacted with the protein covalently modified with 2-nonenal was raised from mouse. To verify the presence of the protein-bound 2-nonenal in vivo, the mAb 27Q4 against the 2-nonenal-modified keyhole limpet hemocyanin was raised. It was found that a novel 2-nonenal-lysine adduct, cis- and trans-N-epsilon-3-[(hept-1-enyl)-4-hexyl-pyridinium]lysine (HHP-lysine), constitutes an epitope of the antibody. The immunoreactive materials with mAb 27Q4 were detected in the kidney of rats exposed to ferric nitrilotriacetate, an iron chelate that induces free radical-mediated oxidative tissue damage. Using high performance liquid chromatography with on-line electrospray ionization tandem mass spectrometry, we also established a highly sensitive method for detection of the cis- and trans-HHP-lysine and confirmed that the 2-nonenal-lysine adducts were indeed formed during the lipid peroxidation-mediated modification of protein in vitro and in vivo. Furthermore, we examined the involvement of the scavenger receptor lectin-like oxidized low density lipoprotein receptor-1 in the recognition of 2-nonenal-modified proteins and established that the receptor recognized the HHP-lysine adducts as a ligand.	[Uchida, Koji] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan; [Toyokuni, Shinya] Nagoya Univ, Grad Sch Med, Dept Pathol & Biol Responses, Nagoya, Aichi 4668550, Japan; [Machida, Sachiko] Natl Food Res Inst, Tsukuba, Ibaraki 3058642, Japan; [Matsuda, Shun; Matsuda, Tomonari] Kyoto Univ, Res Ctr Environm Qual Management, Kyoto 5200811, Japan	Nagoya University; Nagoya University; National Agriculture & Food Research Organization - Japan; National Food Research Institute - Japan; Kyoto University	Uchida, K (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan.	uchidak@agr.nagoya-u.ac.jp	Toyokuni, Shinya/C-1358-2010; Toyokuni, Shinya/ABE-7714-2021; Matsuda, Shun/A-4017-2011; Ishino, Kousuke/G-8473-2018; Shibata, Takahiro/I-6872-2014	Toyokuni, Shinya/0000-0002-5757-1109; Toyokuni, Shinya/0000-0002-5757-1109; Matsuda, Shun/0000-0002-4181-2772; Ishino, Kousuke/0000-0002-6862-9898; Uchida, Koji/0000-0003-3894-5299; Shibata, Takahiro/0000-0003-3194-607X	Ministry of Education, Culture, Sports, Science and Technology, Japan	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant-in-aid for scientific research on innovative areas (research in a proposed research area), from the Ministry of Education, Culture, Sports, Science and Technology, Japan (to K. U.).	ALAIZ M, 1995, CHEM PHYS LIPIDS, V77, P217, DOI 10.1016/0009-3084(95)02470-4; AWAI M, 1979, AM J PATHOL, V95, P663; Baker A, 1998, CHEM RES TOXICOL, V11, P730, DOI 10.1021/tx970167e; BROWN MS, 1980, J SUPRAMOL STR CELL, V13, P67, DOI 10.1002/jss.400130107; Chen MY, 2001, BIOCHEM BIOPH RES CO, V287, P962, DOI 10.1006/bbrc.2001.5674; Chen XP, 2007, CARDIOVASC DRUG REV, V25, P146, DOI 10.1111/j.1527-3466.2007.00009.x; DEMONTARBY L, 1988, TETRAHEDRON LETT, V29, P3937, DOI 10.1016/S0040-4039(00)80387-1; Duryee MJ, 2005, MOL PHARMACOL, V68, P1423, DOI 10.1124/mol.105.016121; Duryee MJ, 2003, BIOCHEM PHARMACOL, V66, P1045, DOI 10.1016/S0006-2952(03)00416-7; EBINA Y, 1986, J NATL CANCER I, V76, P107; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Furuhata A, 2003, J BIOL CHEM, V278, P48658, DOI 10.1074/jbc.M309401200; HABEEB AFS, 1966, ANAL BIOCHEM, V14, P328, DOI 10.1016/0003-2697(66)90275-2; Haze S, 2001, J INVEST DERMATOL, V116, P520, DOI 10.1046/j.0022-202x.2001.01287.x; Hernandez-Hernandez A, 1999, FREE RADICAL BIO MED, V26, P1218, DOI 10.1016/S0891-5849(98)00306-2; HORIUCHI S, 1986, J BIOL CHEM, V261, P4962; Ichihashi K, 2001, J BIOL CHEM, V276, P23903, DOI 10.1074/jbc.M101947200; LI JL, 1987, CANCER RES, V47, P1867; Lougheed M, 1996, J BIOL CHEM, V271, P11798, DOI 10.1074/jbc.271.20.11798; Marnett LJ, 2003, J CLIN INVEST, V111, P583, DOI 10.1172/JCI200318022; MARNETT LJ, 1980, CANCER RES, V40, P276; Matsunaga S, 2007, EXP CELL RES, V313, P1203, DOI 10.1016/j.yexcr.2007.01.007; OHYASHIKI T, 1995, J BIOCHEM-TOKYO, V118, P508, DOI 10.1093/oxfordjournals.jbchem.a124937; Rindgen D, 1999, CHEM RES TOXICOL, V12, P1195, DOI 10.1021/tx990034o; Sawamura T, 1997, NATURE, V386, P73, DOI 10.1038/386073a0; Shi XH, 2001, J CELL SCI, V114, P1273; STEINBRECHER UP, 1989, J BIOL CHEM, V264, P15216; STEPHAN ZF, 1993, J LIPID RES, V34, P325; TAKATA K, 1988, J BIOL CHEM, V263, P14819; TAKATA K, 1989, BIOCHIM BIOPHYS ACTA, V986, P18, DOI 10.1016/0005-2736(89)90267-8; Thomas J.A., 1989, British Wildlife, V1, P2; Toyoda K, 2007, J BIOL CHEM, V282, P25769, DOI 10.1074/jbc.M703039200; Toyokuni S, 1996, FREE RADICAL BIO MED, V20, P553, DOI 10.1016/0891-5849(95)02111-6; TOYOKUNI S, 1994, P NATL ACAD SCI USA, V91, P2616, DOI 10.1073/pnas.91.7.2616; Toyokuni S, 1997, FREE RADICAL BIO MED, V22, P1019, DOI 10.1016/S0891-5849(96)00489-3; Toyokuni S, 2009, CANCER SCI, V100, P9, DOI 10.1111/j.1349-7006.2008.01001.x; Uchida K, 2000, FREE RADICAL BIO MED, V28, P1685, DOI 10.1016/S0891-5849(00)00226-4; Yoshida H, 1998, BIOCHEM J, V334, P9, DOI 10.1042/bj3340009	38	55	56	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15302	15313		10.1074/jbc.M109.068023	http://dx.doi.org/10.1074/jbc.M109.068023			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20215107	hybrid, Green Published			2022-12-25	WOS:000277399000051
J	Masuda, M; Maruyama, T; Ohta, T; Ito, A; Hayashi, T; Tsukasaki, K; Kamihira, S; Yamaoka, S; Hoshino, H; Yoshida, T; Watanabe, T; Stanbridge, EJ; Murakami, Y				Masuda, Mari; Maruyama, Tomoko; Ohta, Tsutomu; Ito, Akihiko; Hayashi, Tomayoshi; Tsukasaki, Kunihiko; Kamihira, Shimeru; Yamaoka, Shoji; Hoshino, Hiroo; Yoshida, Teruhiko; Watanabe, Toshiki; Stanbridge, Eric J.; Murakami, Yoshinori			CADM1 Interacts with Tiam1 and Promotes Invasive Phenotype of Human T-cell Leukemia Virus Type I-transformed Cells and Adult T-cell Leukemia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADHESION MOLECULE; TUMOR-SUPPRESSOR; IMMUNOGLOBULIN SUPERFAMILY; TSLC1; EXPRESSION; RHO; PROTEIN; GENE; RAC; HOMOLOGY	CADM1 encodes a multifunctional immunoglobulin-like cell adhesion molecule whose cytoplasmic domain contains a type II PSD95/Dlg/ZO-1 (PDZ)-binding motif (BM) for associating with other intracellular proteins. Although CADM1 lacks expression in T lymphocytes of healthy individuals, it is overexpressed in adult T-cell leukemia-lymphoma (ATL) cells. It has been suggested that the expression of CADM1 protein promotes infiltration of leukemic cells into various organs and tissues, which is one of the frequent clinical manifestations of ATL. Amino acid sequence alignment revealed that Tiam1 (T-lymphoma invasion and metastasis 1), a Rac-specific guanine nucleotide exchange factor, has a type II PDZ domain similar to those of membrane-associated guanylate kinase homologs (MAGUKs) that are known to bind to the PDZ-BM of CADM1. In this study, we demonstrated that the cytoplasmic domain of CADM1 directly interacted with the PDZ domain of Tiam1 and induced formation of lamellipodia through Rac activation in HTLV-I-transformed cell lines as well as ATL cell lines. Our results indicate that Tiam1 integrates signals from CADM1 to regulate the actin cytoskeleton through Rac activation, which may lead to tissue infiltration of leukemic cells in ATL patients.	[Masuda, Mari] Natl Canc Ctr, Res Inst, Div Chemotherapy, Tumor Suppress & Funct Genom Project,Chuo Ku, Tokyo 1040045, Japan; [Masuda, Mari; Ohta, Tsutomu; Yoshida, Teruhiko] Natl Canc Ctr, Res Inst, Div Genet, Tokyo 1040045, Japan; [Maruyama, Tomoko; Ito, Akihiko; Murakami, Yoshinori] Univ Tokyo, Inst Med Sci, Dept Canc Biol, Div Mol Pathol, Tokyo 1088639, Japan; [Watanabe, Toshiki] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Tumor Cell Biol Lab, Tokyo 1088639, Japan; [Hayashi, Tomayoshi] Nagasaki Univ, Grad Sch Biomed Sci, Dept Pathol, Nagasaki 8528523, Japan; [Tsukasaki, Kunihiko] Nagasaki Univ, Grad Sch Biomed Sci, Dept Mol Med & Hematol, Nagasaki 8528523, Japan; [Kamihira, Shimeru] Nagasaki Univ, Grad Sch Biomed Sci, Dept Lab Med, Nagasaki 8528523, Japan; [Yamaoka, Shoji] Tokyo Med & Dent Univ, Grad Sch Med, Dept Mol Virol, Tokyo 1138510, Japan; [Hoshino, Hiroo] Gunma Univ, Grad Sch Med, Dept Virol & Prevent Med, Maebashi, Gunma 3718511, Japan; [Stanbridge, Eric J.] Univ Calif Irvine, Coll Med, Dept Microbiol & Mol Genet, Irvine, CA 92697 USA	National Cancer Center - Japan; National Cancer Center - Japan; University of Tokyo; University of Tokyo; Nagasaki University; Nagasaki University; Nagasaki University; Tokyo Medical & Dental University (TMDU); Gunma University; University of California System; University of California Irvine	Masuda, M (corresponding author), Natl Canc Ctr, Res Inst, Div Chemotherapy, Tumor Suppress & Funct Genom Project,Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	mamasuda@ncc.go.jp; ymurakam@ims.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology, Japan [17015048]; Ministry of Health, Labor, and Welfare, Japan; National Institute of Biomedical Innovation [05-10]	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); National Institute of Biomedical Innovation(National Institute of Biomedical Innovation)	This work was supported by Grant-in-aid for Scientific Research on Priority Areas for Cancer 17015048 (to Y. M.) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; a Grant-in-Aid for the Third Term Comprehensive Control Research for Cancer from the Ministry of Health, Labor, and Welfare, Japan (to Y. M.), and a Grant for the Promotion of Fundamental Studies in Health Sciences from the National Institute of Biomedical Innovation (Grant 05-10) (to Y. M.).	Arase N, 2005, INT IMMUNOL, V17, P1227, DOI 10.1093/intimm/dxh299; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; Boles KS, 2005, BLOOD, V106, P779, DOI 10.1182/blood-2005-02-0817; Boxus M, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-76; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Ceccarelli DFJ, 2007, J BIOL CHEM, V282, P13864, DOI 10.1074/jbc.M700505200; Dewan MZ, 2008, J VIROL, V82, P11958, DOI 10.1128/JVI.01149-08; Engers R, 2000, INT J CANCER, V88, P369, DOI 10.1002/1097-0215(20001101)88:3<369::AID-IJC8>3.0.CO;2-K; Fogel AI, 2007, J NEUROSCI, V27, P12516, DOI 10.1523/JNEUROSCI.2739-07.2007; Fukuhara H, 2003, ONCOGENE, V22, P6160, DOI 10.1038/sj.onc.1206744; Furuno T, 2005, J IMMUNOL, V174, P6934, DOI 10.4049/jimmunol.174.11.6934; Galibert L, 2005, J BIOL CHEM, V280, P21955, DOI 10.1074/jbc.M502095200; Garcia-Mata R, 2007, TRENDS CELL BIOL, V17, P36, DOI 10.1016/j.tcb.2006.11.004; Gerard A, 2007, J CELL BIOL, V176, P863, DOI 10.1083/jcb.200608161; Gomyo H, 1999, GENOMICS, V62, P139, DOI 10.1006/geno.1999.6001; HABETS GGM, 1994, CELL, V77, P537, DOI 10.1016/0092-8674(94)90216-X; Hordijk PL, 1997, SCIENCE, V278, P1464, DOI 10.1126/science.278.5342.1464; HOSHINO H, 1983, P NATL ACAD SCI-BIOL, V80, P6061, DOI 10.1073/pnas.80.19.6061; Ishida T, 2006, CANCER SCI, V97, P1139, DOI 10.1111/j.1349-7006.2006.00307.x; Ishioka K, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-71; Ito A, 2003, LAB INVEST, V83, P1175, DOI 10.1097/01.LAB.0000081391.28136.80; Ito A, 2003, BLOOD, V101, P2601, DOI 10.1182/blood-2002-07-2265; Ito A, 2007, HEPATOLOGY, V45, P684, DOI 10.1002/hep.21501; Kuramochi M, 2001, NAT GENET, V27, P427, DOI 10.1038/86934; Malliri A, 2003, CURR OPIN CELL BIOL, V15, P583, DOI 10.1016/S0955-0674(03)00098-X; Malliri A, 2002, NATURE, V417, P867, DOI 10.1038/nature00848; Mao XL, 2003, CANCER RES, V63, P7979; Masuda M, 2005, J BIOL CHEM, V280, P42164, DOI 10.1074/jbc.M507136200; Masuda M, 2002, J BIOL CHEM, V277, P31014, DOI 10.1074/jbc.M203620200; Matsuoka M, 2003, ONCOGENE, V22, P5131, DOI 10.1038/sj.onc.1206551; Matsuoka M, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-27; Mertens AE, 2003, FEBS LETT, V546, P11, DOI 10.1016/S0014-5793(03)00435-6; MICHIELS F, 1995, NATURE, V375, P338, DOI 10.1038/375338a0; Michiels F, 1997, J CELL BIOL, V137, P387, DOI 10.1083/jcb.137.2.387; Minard ME, 2004, BREAST CANCER RES TR, V84, P21, DOI 10.1023/B:BREA.0000018421.31632.e6; Murakami Y, 2005, CANCER SCI, V96, P543, DOI 10.1111/j.1349-7006.2005.00089.x; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Sanchez-Madrid F, 1999, EMBO J, V18, P501, DOI 10.1093/emboj/18.3.501; Sasaki H, 2005, BLOOD, V105, P1204, DOI 10.1182/blood-2004-03-1222; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; Shingai T, 2003, J BIOL CHEM, V278, P35421, DOI 10.1074/jbc.M305387200; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Stam JC, 1998, EMBO J, V17, P4066, DOI 10.1093/emboj/17.14.4066; TAJIMA K, 1990, INT J CANCER, V45, P237, DOI 10.1002/ijc.2910450206; Urase K, 2001, NEUROREPORT, V12, P3217, DOI 10.1097/00001756-200110290-00015; Wakayama T, 2003, BIOL REPROD, V68, P1755, DOI 10.1095/biolreprod.102.012344; Wakayama T, 2001, MOL REPROD DEV, V60, P158, DOI 10.1002/mrd.1072; Wu KL, 2004, J BIOL CHEM, V279, P495, DOI 10.1074/jbc.M310069200; Yageta M, 2002, CANCER RES, V62, P5129; Yamada Y, 2001, BRIT J HAEMATOL, V113, P375, DOI 10.1046/j.1365-2141.2001.02737.x; Yasunaga JI, 2007, REV MED VIROL, V17, P301, DOI 10.1002/rmv.548; Yoshie O, 2005, LEUKEMIA LYMPHOMA, V46, P185, DOI 10.1080/10428190400007607	52	54	58	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15511	15522		10.1074/jbc.M109.076653	http://dx.doi.org/10.1074/jbc.M109.076653			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20215110	Green Published, hybrid			2022-12-25	WOS:000277399000070
J	McNicholl, ET; Das, R; SilDas, S; Taylor, SS; Melacini, G				McNicholl, E. Tyler; Das, Rahul; SilDas, Soumita; Taylor, Susan S.; Melacini, Giuseppe			Communication between Tandem cAMP Binding Domains in the Regulatory Subunit of Protein Kinase A-I alpha as Revealed by Domain-silencing Mutations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE MUTATIONS; PKA; ACTIVATION; ANCIENT; STABILITY; MECHANISM; ALLOSTERY; DYNAMICS; MUTANT	Protein kinase A (PKA) is the main receptor for the universal cAMP second messenger. PKA is a tetramer with two catalytic (C) and two regulatory (R) subunits, each including two tandem cAMP binding domains, i.e. CBD-A and -B. Structural investigations of RI alpha have revealed that although CBD-A plays a pivotal role in the cAMP-dependent inhibition of C, the main function of CBD-B is to regulate the access of cAMP to site A. To further understand the mechanism underlying the cross-talk between CBD-A and -B, we report here the NMR investigation of a construct of R, RI alpha-(119-379), which unlike previous fragments characterized by NMR, spans in full both CBDs. Our NMR studies were also extended to two mutants, R209K and the corresponding R333K, which severely reduce the affinity of cAMP for CBD-A and -B, respectively. The comparative NMR analysis of wild-type RI alpha-(119-379) and of the two domain silencing mutations has led to the definition at an unprecedented level of detail of both intra- and interdomain allosteric networks, revealing several striking differences between the two CBDs. First, the two domains, although homologous in sequence and structure, exhibit remarkably different responses to the R/K mutations especially at the beta 2-3 allosteric "hot spot." Second, although the two CBDs are reciprocally coupled at the level of local unfolding of the hinge, the A-to-B and B-to-A pathways are dramatically asymmetrical at the level of global unfolding. Such an asymmetric interdomain cross-talk ensures efficiency and robustness in both the activation and de-activation of PKA.	[McNicholl, E. Tyler; Das, Rahul; SilDas, Soumita; Melacini, Giuseppe] McMaster Univ, Dept Chem & Chem Biol, Hamilton, ON L8S 4M1, Canada; [McNicholl, E. Tyler; Das, Rahul; SilDas, Soumita; Melacini, Giuseppe] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8S 4M1, Canada; [Taylor, Susan S.] Univ Calif San Diego, Dept Pharmacol, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Taylor, Susan S.] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA	McMaster University; McMaster University; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego	Melacini, G (corresponding author), McMaster Univ, Dept Chem, 1280 Main St W, Hamilton, ON L8S 4M1, Canada.	melacin@mcmaster.ca	Das, Rahul/AAU-5123-2020	Das, Rahul/0000-0001-7841-8229	Canadian Institute of Health Research; National Institutes of Health [GM34921]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034921] Funding Source: NIH RePORTER	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Canadian Institute of Health Research. This paper is dedicated to the memory of Captain George A. McNicholl.; Supported by National Institutes of Health Grant GM34921.	Abu-Abed M, 2007, PROTEINS, V69, P112, DOI 10.1002/prot.21446; Anand G, 2007, BIOCHEMISTRY-US, V46, P9283, DOI 10.1021/bi700421h; Berman HM, 2005, P NATL ACAD SCI USA, V102, P45, DOI 10.1073/pnas.0408579102; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Canaves JM, 2000, BIOCHEMISTRY-US, V39, P15022, DOI 10.1021/bi001563q; Cheng CY, 2009, J BIOL CHEM, V284, P35916, DOI 10.1074/jbc.M109.059493; Das R, 2007, P NATL ACAD SCI USA, V104, P93, DOI 10.1073/pnas.0609033103; Das R, 2007, J BIOL CHEM, V282, P581, DOI 10.1074/jbc.M607706200; Das R, 2006, J AM CHEM SOC, V128, P8406, DOI 10.1021/ja060046d; Das R, 2009, J BIOL CHEM, V284, P23682, DOI 10.1074/jbc.M109.011700; Das R, 2008, J BIOL CHEM, V283, P19691, DOI 10.1074/jbc.M802164200; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dodge KL, 2001, EMBO J, V20, P1921, DOI 10.1093/emboj/20.8.1921; Eghbalnia HR, 2005, J BIOMOL NMR, V32, P71, DOI 10.1007/s10858-005-5705-1; Englander J, 2006, BIOPOLYMERS, V84, P508, DOI 10.1002/bip.20546; Esposito V, 2006, J BIOMOL NMR, V36, P64, DOI 10.1007/s10858-006-9050-9; Goddard T. D., 2006, SPARKY 3; Herberg FW, 1996, BIOCHEMISTRY-US, V35, P2934, DOI 10.1021/bi951647c; HERBERG FW, 1994, BIOCHEMISTRY-US, V33, P7485, DOI 10.1021/bi00189a057; Kannan N, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-r264; Kim C, 2005, SCIENCE, V307, P690, DOI 10.1126/science.1104607; Kim C, 2007, CELL, V130, P1032, DOI 10.1016/j.cell.2007.07.018; Kopperud R, 2003, FEBS LETT, V546, P121, DOI 10.1016/S0014-5793(03)00563-5; Kornev AP, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000056; Luque I, 2002, ANNU REV BIOPH BIOM, V31, P235, DOI 10.1146/annurev.biophys.31.082901.134215; Mazhab-Jafari MT, 2007, J AM CHEM SOC, V129, P14482, DOI 10.1021/ja0753703; Neal S, 2003, J BIOMOL NMR, V26, P215, DOI 10.1023/A:1023812930288; Rehmann H, 2007, NAT REV MOL CELL BIO, V8, P63, DOI 10.1038/nrm2082; Scott JD, 2006, BIOCHEM SOC T, V34, P465, DOI 10.1042/BST0340465; Segui-Lines G, 2007, ANALYST, V132, P741, DOI 10.1039/b705469f; Shabb JB, 2001, CHEM REV, V101, P2381, DOI 10.1021/cr000236l; SU Y, 1995, SCIENCE, V269, P807, DOI 10.1126/science.7638597; Taylor SS, 2005, BBA-PROTEINS PROTEOM, V1754, P25, DOI 10.1016/j.bbapap.2005.08.024; Tollinger M, 2001, J AM CHEM SOC, V123, P11341, DOI 10.1021/ja011300z; Vigil D, 2005, J BIOL CHEM, V280, P35521, DOI 10.1074/jbc.M506769200; Wu J, 2004, BIOCHEMISTRY-US, V43, P6620, DOI 10.1021/bi0302503; Wu J, 2004, STRUCTURE, V12, P1057, DOI 10.1016/j.str.2004.03.022	37	45	46	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15523	15537		10.1074/jbc.M110.105783	http://dx.doi.org/10.1074/jbc.M110.105783			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20202931	hybrid, Green Published			2022-12-25	WOS:000277399000071
J	Andreou, A; Gobel, C; Hamberg, M; Feussner, I				Andreou, Alexandra; Goebel, Cornelia; Hamberg, Mats; Feussner, Ivo			A Bisallylic Mini-lipoxygenase from Cyanobacterium Cyanothece sp That Has an Iron as Cofactor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALLENE OXIDE SYNTHASE; FATTY-ACID HYDROPEROXIDE; NOSTOC SP PCC-7120; POSITIONAL SPECIFICITY; MANGANESE LIPOXYGENASE; FUSION PROTEIN; 3-DIMENSIONAL STRUCTURE; SOYBEAN LIPOXYGENASE-1; LIQUID-CHROMATOGRAPHY; PRIMARY DETERMINANT	Lipoxygenases are enzymes that are found ubiquitously in higher animals and plants, but have only recently been identified in a number of bacteria. The genome of the diazotrophic unicellular cyanobacterium Cyanothece sp. harbors two genes with homology to lipoxygenases. Here we describe the isolation of one gene, formerly named csplox2. It was cloned, and the protein was expressed in Escherichia coli and purified. The purified enzyme belongs to the group of prokaryotic mini lipoxygenases, because it had a molecular mass of 65 kDa. Interestingly, it catalyzed the conversion of linoleic acid, the only endogenously found polyunsaturated fatty acid, primarily to the bisallylic hydroperoxide 11R-hydroperoxyoctadecadienoic acid. This product had previously only been described for the manganese lipoxygenase from the take all fungus, Gaeumannomyces graminis. By contrast, CspLOX2 was shown to be an iron lipoxygenase. In addition, CspLOX2 formed a mixture of typical conjugated lipoxygenase products, e. g. 9R- and 13S-hydroperoxide. The conversion of linoleic acid took place with a maximum reaction rate of 31 s(-1). Incubation of the enzyme with [(11S)-H-2] linoleic acid led to the formation of hydroperoxides that had lost the deuterium label, thus suggesting that CspLOX2 catalyzes antarafacial oxygenation as opposed to the mechanism of manganese lipoxygenase. CspLOX2 could also oxidize diarachidonylglycerophosphatidylcholine with similar specificity as the free fatty acid, indicating that binding of the substrate takes place with a "tail-first" orientation. We conclude that CspLOX2 is a novel iron mini-lipoxygenase that catalyzes the formation of bisallylic hydroperoxide as the major product.	Univ Gottingen, Albrecht von Haller Inst Plant Sci, Dept Plant Biochem, D-37077 Gottingen, Germany; [Hamberg, Mats] Karolinska Inst, Dept Med Biochem & Biophys, Div Chem 2, SE-17177 Stockholm, Sweden	University of Gottingen; Karolinska Institutet		ifeussn@uni-goettingen.de	Feussner, Ivo/H-9320-2013	Feussner, Ivo/0000-0002-9888-7003; Hamberg, Mats/0000-0002-8910-7810	IRTG [1422]; International M.Sc./Ph.D. Program Molecular Biology (Goettingen)	IRTG; International M.Sc./Ph.D. Program Molecular Biology (Goettingen)	This work was supported by IRTG 1422 Metal Sites in Biomolecules: Structures, Regulation, and Mechanisms.; Supported by the International M.Sc./Ph.D. Program Molecular Biology (Goettingen) and by IRTG 1422 Metal Sites in Biomolecules: Structures, Regulation, and Mechanisms.	Aleem AM, 2008, J MOL BIOL, V376, P193, DOI 10.1016/j.jmb.2007.11.086; Andreou A, 2009, PHYTOCHEMISTRY, V70, P1504, DOI 10.1016/j.phytochem.2009.05.008; Andreou A, 2009, PROG LIPID RES, V48, P148, DOI 10.1016/j.plipres.2009.02.002; Andreou AZ, 2008, PHYTOCHEMISTRY, V69, P1832, DOI 10.1016/j.phytochem.2008.03.002; Andreou AZ, 2009, LIPIDS, V44, P207, DOI 10.1007/s11745-008-3264-4; Axelrod B., 1981, METH ENZYMOL, V441, P451, DOI [10.1016/0076-6879(81)71055-3, DOI 10.1016/0076-6879(81)71055-3]; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boeglin WE, 2008, LIPIDS, V43, P979, DOI 10.1007/s11745-008-3230-1; Borngraber S, 1996, J MOL BIOL, V264, P1145, DOI 10.1006/jmbi.1996.0702; Boutaud O, 1999, J BIOL CHEM, V274, P33764, DOI 10.1074/jbc.274.47.33764; BOYINGTON JC, 1993, SCIENCE, V260, P1482, DOI 10.1126/science.8502991; Brash AR, 2000, LIPIDS, V35, P947, DOI 10.1007/s11745-000-0604-0; Brodhun F, 2009, J BIOL CHEM, V284, P11792, DOI 10.1074/jbc.M809152200; BRODOWSKY ID, 1993, BIOCHIM BIOPHYS ACTA, V1168, P68, DOI 10.1016/0005-2760(93)90267-D; Choi J, 2008, PROTEINS, V70, P1023, DOI 10.1002/prot.21590; Coffa G, 2005, BIOCHEM BIOPH RES CO, V338, P87, DOI 10.1016/j.bbrc.2005.07.185; Cristea M, 2006, J BIOL CHEM, V281, P17612, DOI 10.1074/jbc.M510311200; Feussner I, 1997, J BIOL CHEM, V272, P21635, DOI 10.1074/jbc.272.34.21635; Gao BL, 2010, BBA-MOL CELL BIOL L, V1801, P58, DOI 10.1016/j.bbalip.2009.09.004; Gao BL, 2009, J BIOL CHEM, V284, P22087, DOI 10.1074/jbc.M109.013151; GARDNER HW, 1989, BIOCHIM BIOPHYS ACTA, V1001, P274, DOI 10.1016/0005-2760(89)90111-2; Gillmor SA, 1997, NAT STRUCT BIOL, V4, P1003, DOI 10.1038/nsb1297-1003; Hamberg M, 1998, J BIOL CHEM, V273, P13080, DOI 10.1074/jbc.273.21.13080; HAMBERG M, 1992, LIPIDS, V27, P487, DOI 10.1007/BF02536128; Hornung E, 2002, EUR J BIOCHEM, V269, P4852, DOI 10.1046/j.1432-1033.2002.03184.x; Jisaka M, 2000, J BIOL CHEM, V275, P1287, DOI 10.1074/jbc.275.2.1287; Kitaguchi H, 2005, J AM CHEM SOC, V127, P6605, DOI 10.1021/ja044345j; Koeduka T, 2007, CURR MICROBIOL, V54, P315, DOI 10.1007/s00284-006-0512-9; Kuhn H, 2005, MOL NUTR FOOD RES, V49, P1014, DOI 10.1002/mnfr.200500131; Kuhn H, 2005, BIOCHEM BIOPH RES CO, V338, P93, DOI 10.1016/j.bbrc.2005.08.238; KUHN H, 1995, J LIPID MEDIAT CELL, V12, P157, DOI 10.1016/0929-7855(95)00016-J; Lang I, 2008, BIOCHEM J, V410, P347, DOI 10.1042/BJ20071277; Lang I, 2007, PHYTOCHEMISTRY, V68, P1120, DOI 10.1016/j.phytochem.2007.02.028; Liavonchanka A, 2009, J BIOL CHEM, V284, P8005, DOI 10.1074/jbc.M809060200; Minor W, 1996, BIOCHEMISTRY-US, V35, P10687, DOI 10.1021/bi960576u; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Neau DB, 2009, BIOCHEMISTRY-US, V48, P7906, DOI 10.1021/bi900084m; Oldham ML, 2005, P NATL ACAD SCI USA, V102, P297, DOI 10.1073/pnas.0406352102; Oliw EH, 2006, ANAL BIOCHEM, V354, P111, DOI 10.1016/j.ab.2006.04.010; Oliw EH, 1998, LIPIDS, V33, P843, DOI 10.1007/s11745-998-0280-0; Oliw EH, 2004, LIPIDS, V39, P319, DOI 10.1007/s11745-004-1235-1; Oliw EH, 2002, PROSTAG OTH LIPID M, V68-9, P313, DOI 10.1016/S0090-6980(02)00037-0; Oliw EH, 2008, J LIPID RES, V49, P420, DOI 10.1194/jlr.M700514-JLR200; Palmieri-Thiers C, 2009, BBA-MOL CELL BIOL L, V1791, P339, DOI 10.1016/j.bbalip.2009.02.012; Prigge ST, 1996, PROTEINS, V24, P275; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Schneider C, 2007, P NATL ACAD SCI USA, V104, P18941, DOI 10.1073/pnas.0707148104; Schneider C, 2007, CHEM BIOL, V14, P473, DOI 10.1016/j.chembiol.2007.04.007; Shureiqi I, 2001, CANCER RES, V61, P6307; Skrzypczak-Jankun E, 2001, J AM CHEM SOC, V123, P10814, DOI 10.1021/ja011759t; SkrzypczakJankun E, 1997, PROTEINS, V29, P15, DOI [10.1002/(SICI)1097-0134(199709)29:1&lt;15::AID-PROT2&gt;3.0.CO;2-E, 10.1002/(SICI)1097-0134(199709)29:1<15::AID-PROT2>3.3.CO;2-F]; SLOANE DL, 1991, NATURE, V354, P149, DOI 10.1038/354149a0; Su C, 2000, J BIOL CHEM, V275, P18830, DOI 10.1074/jbc.M001408200; Tallman KA, 2001, J AM CHEM SOC, V123, P11827, DOI 10.1021/ja0169724; Vogel R, 2010, J BIOL CHEM, V285, P5369, DOI 10.1074/jbc.M109.057802; Youn B, 2006, PROTEINS, V65, P1008, DOI 10.1002/prot.21182; Zheng YX, 2008, J BIOL CHEM, V283, P5138, DOI 10.1074/jbc.M705780200	57	41	42	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14178	14186		10.1074/jbc.M109.094771	http://dx.doi.org/10.1074/jbc.M109.094771			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20223828	Green Published, hybrid			2022-12-25	WOS:000277299700014
J	Noam, Y; Zha, QQ; Phan, L; Wu, RL; Chetkovich, DM; Wadman, WJ; Baram, TZ				Noam, Yoav; Zha, Qinqin; Phan, Lise; Wu, Rui-Lin; Chetkovich, Dane M.; Wadman, Wytse J.; Baram, Tallie Z.			Trafficking and Surface Expression of Hyperpolarization-activated Cyclic Nucleotide-gated Channels in Hippocampal Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THALAMOCORTICAL RELAY NEURONS; N-LINKED GLYCOSYLATION; HCN CHANNELS; I-H; PYRAMIDAL NEURONS; PACEMAKER CHANNELS; EXCITABILITY; HETEROMERIZATION; LOCALIZATION; MODULATION	Hyperpolarization-activated cyclic nucleotide-gated (HCN) channels mediate the hyperpolarization-activated current I-h and thus play important roles in the regulation of brain excitability. The subcellular distribution pattern of the HCN channels influences the effects that they exert on the properties and activity of neurons. However, little is known about the mechanisms that control HCN channel trafficking to subcellular compartments or that regulate their surface expression. Here we studied the dynamics of HCN channel trafficking in hippocampal neurons using dissociated cultures coupled with time lapse imaging of fluorophore-fused HCN channels. HCN1-green fluorescence protein (HCN1-GFP) channels resided in vesicle-like organelles that moved in distinct patterns along neuronal dendrites, and these properties were isoform-specific. HCN1 trafficking required intact actin and tubulin and was rapidly inhibited by activation of either NMDA or AMPA-type ionotropic glutamate receptors in a calcium-dependent manner. Glutamate-induced inhibition of the movement of HCN1-GFP-expressing puncta was associated with increased surface expression of both native and transfected HCN1 channels, and this surface expression was accompanied by augmented I-h. Taken together, the results reveal the highly dynamic nature of HCN1 channel trafficking in hippocampal neurons and provide a novel potential mechanism for rapid regulation of I-h, and hence of neuronal properties, via alterations of HCN1 trafficking and surface expression.	[Noam, Yoav; Zha, Qinqin; Phan, Lise; Wu, Rui-Lin; Baram, Tallie Z.] Univ Calif Irvine, Dept Pediat, Irvine, CA 92697 USA; [Baram, Tallie Z.] Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92697 USA; [Baram, Tallie Z.] Univ Calif Irvine, Dept Neurol, Irvine, CA 92697 USA; [Chetkovich, Dane M.] Northwestern Univ, Dept Neurol & Clin Neurosci, Chicago, IL 60611 USA; [Wadman, Wytse J.] Univ Amsterdam, Ctr Neurosci, Swammerdam Inst Life Sci, NL-1098 XH Amsterdam, Netherlands	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; Northwestern University; University of Amsterdam	Baram, TZ (corresponding author), Univ Calif Irvine, Dept Pediat, ZOT 4475, Irvine, CA 92697 USA.	tallie@uci.edu	Baram, Tallie Z/J-6447-2014; Chetkovich, Dane/AAV-5457-2021		National Institutes of Health [R37 NS35439, K02NS05595, R01NS059934]; Dutch Epilepsy Fund [NEF 08-02]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS035439, R21NS052595, K08NS041956, R01NS059934, R21NS065391] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dutch Epilepsy Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R37 NS35439 (to T.Z.B. and Y.N.) and K02NS05595 and R01NS059934 (to D. M. C.). This work was also supported by Dutch Epilepsy Fund Grant NEF 08-02 (to W.J.W. and Y.N.).	Beattie EC, 2000, NAT NEUROSCI, V3, P1291, DOI 10.1038/81823; Beck H, 2008, NAT REV NEUROSCI, V9, P357, DOI 10.1038/nrn2371; Bender RA, 2007, J NEUROSCI, V27, P4697, DOI 10.1523/JNEUROSCI.4699-06.2007; Bezzerides VJ, 2004, NAT CELL BIOL, V6, P709, DOI 10.1038/ncb1150; Brewster A, 2002, J NEUROSCI, V22, P4591, DOI 10.1523/JNEUROSCI.22-11-04591.2002; Brewster AL, 2005, NEUROBIOL DIS, V19, P200, DOI 10.1016/j.nbd.2004.12.015; Brewster AL, 2007, CEREB CORTEX, V17, P702, DOI 10.1093/cercor/bhk021; BUBB MR, 1994, J BIOL CHEM, V269, P14869; Budde T, 2008, PFLUG ARCH EUR J PHY, V456, P1061, DOI 10.1007/s00424-008-0482-9; Chen C, 2001, J GEN PHYSIOL, V117, P491, DOI 10.1085/jgp.117.5.491; Chung HJ, 2009, P NATL ACAD SCI USA, V106, P629, DOI 10.1073/pnas.0811615106; de Wit J, 2006, TRAFFIC, V7, P1060, DOI 10.1111/j.1600-0854.2006.00442.x; de Wit J, 2009, J NEUROSCI, V29, P23, DOI 10.1523/JNEUROSCI.3931-08.2009; El-Husseini AE, 2002, CELL, V108, P849, DOI 10.1016/S0092-8674(02)00683-9; Fan Y, 2005, NAT NEUROSCI, V8, P1542, DOI 10.1038/nn1568; Gravante B, 2004, J BIOL CHEM, V279, P43847, DOI 10.1074/jbc.M401598200; Green EM, 2007, NEURON, V55, P615, DOI 10.1016/j.neuron.2007.07.024; Kennedy MJ, 2006, ANNU REV NEUROSCI, V29, P325, DOI 10.1146/annurev.neuro.29.051605.112808; Kim JY, 2007, NEURON, V54, P933, DOI 10.1016/j.neuron.2007.05.026; Lewis AS, 2009, J NEUROSCI, V29, P6250, DOI 10.1523/JNEUROSCI.0856-09.2009; LINDAU M, 1988, PFLUG ARCH EUR J PHY, V411, P137, DOI 10.1007/BF00582306; Lorincz A, 2002, NAT NEUROSCI, V5, P1185, DOI 10.1038/nn962; MacLean JN, 2005, J NEUROPHYSIOL, V94, P3601, DOI 10.1152/jn.00281.2005; MacLean JN, 2003, NEURON, V37, P109, DOI 10.1016/S0896-6273(02)01104-2; Magee JC, 1999, NAT NEUROSCI, V2, P508, DOI 10.1038/9158; Meuth SG, 2006, J NEUROPHYSIOL, V96, P1517, DOI 10.1152/jn.01212.2005; Misonou H, 2005, J NEUROSCI METH, V144, P165, DOI 10.1016/j.jneumeth.2004.11.007; Misonou H, 2004, NAT NEUROSCI, V7, P711, DOI 10.1038/nn1260; Moroni A, 2001, J BIOL CHEM, V276, P29233, DOI 10.1074/jbc.M100830200; Much B, 2003, J BIOL CHEM, V278, P43781, DOI 10.1074/jbc.M306958200; Murphy DD, 1998, J NEUROSCI, V18, P2550; Ogoshi F, 2003, J NEUROSCI, V23, P10521; Proenza C, 2002, J BIOL CHEM, V277, P29634, DOI 10.1074/jbc.M200504200; Richichi C, 2008, NEUROBIOL DIS, V29, P297, DOI 10.1016/j.nbd.2007.09.003; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Santoro B, 2004, J NEUROSCI, V24, P10750, DOI 10.1523/JNEUROSCI.3300-04.2004; Santoro B, 2003, TRENDS NEUROSCI, V26, P550, DOI 10.1016/j.tins.2003.08.003; Santoro B, 2000, J NEUROSCI, V20, P5264, DOI 10.1523/JNEUROSCI.20-14-05264.2000; Santoro B, 2009, NEURON, V62, P802, DOI 10.1016/j.neuron.2009.05.009; Shin M, 2007, J BIOL CHEM, V282, P33168, DOI 10.1074/jbc.M703736200; Spector I, 1999, MICROSC RES TECHNIQ, V47, P18, DOI 10.1002/(SICI)1097-0029(19991001)47:1<18::AID-JEMT3>3.0.CO;2-E; Surges R, 2006, EUR J NEUROSCI, V24, P94, DOI 10.1111/j.1460-9568.2006.04880.x; Ulens C, 2001, J BIOL CHEM, V276, P6069, DOI 10.1074/jbc.C000738200; van Welie I, 2004, P NATL ACAD SCI USA, V101, P5123, DOI 10.1073/pnas.0307711101; Vasilyev DV, 2002, J NEUROSCI, V22, P8992; Wainger BJ, 2001, NATURE, V411, P805, DOI 10.1038/35081088; Yin HZ, 1999, J COMP NEUROL, V409, P250; Zha QQ, 2008, J NEUROCHEM, V105, P68, DOI 10.1111/j.1471-4159.2007.05110.x; Zhang W, 2003, NAT REV NEUROSCI, V4, P885, DOI 10.1038/nrn1248; Zolles G, 2009, NEURON, V62, P814, DOI 10.1016/j.neuron.2009.05.008	50	53	54	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14724	14736		10.1074/jbc.M109.070391	http://dx.doi.org/10.1074/jbc.M109.070391			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20215108	Green Published, hybrid			2022-12-25	WOS:000277299700070
J	Radaev, S; Zou, ZC; Huang, T; Lafer, EM; Hinck, AP; Sun, PD				Radaev, Sergei; Zou, Zhongcheng; Huang, Tao; Lafer, Eileen M.; Hinck, Andrew P.; Sun, Peter D.			Ternary Complex of Transforming Growth Factor-beta 1 Reveals Isoform-specific Ligand Recognition and Receptor Recruitment in the Superfamily	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA-ISOFORMS; CRYSTAL-STRUCTURE; SIGNALING COMPLEXES; BINDING-SPECIFICITY; STRUCTURAL BASIS; CLEFT-PALATE; AFFINITY; MICE; MECHANISMS; SOFTWARE	Transforming growth factor (TGF)-beta 1, -beta 2, and -beta 3 are 25-kDa homodimeric polypeptides that play crucial nonover-lapping roles in embryogenesis, tissue development, carcinogenesis, and immune regulation. Here we report the 3.0-angstrom resolution crystal structure of the ternary complex between human TGF-beta 1 and the extracellular domains of its type I and type II receptors, T beta RI and T beta RII. The TGF-beta 1 ternary complex structure is similar to previously reported TGF-beta 3 complex except with a 10 degrees rotation in T beta RI docking orientation. Quantitative binding studies showed distinct kinetics between the receptors and the isoforms of TGF-beta. T beta RI showed significant binding to TGF-beta 2 and TGF-beta 3 but not TGF-beta 1, and the binding to all three isoforms of TGF-beta was enhanced considerably in the presence of T beta RII. The preference of TGF-beta 2 to T beta RI suggests a variation in its receptor recruitment in vivo. Although TGF-beta 1 and TGF-beta 3 bind and assemble their ternary complexes in a similar manner, their structural differences together with differences in the affinities and kinetics of their receptor binding may underlie their unique biological activities. Structural comparisons revealed that the receptor-ligand pairing in the TGF-beta superfamily is dictated by unique insertions, deletions, and disulfide bonds rather than amino acid conservation at the interface. The binding mode of T beta RII on TGF-beta is unique to TGF-beta s, whereas that of type II receptor for bone morphogenetic protein on bone morphogenetic protein appears common to all other cytokines in the superfamily. Further, extensive hydrogen bonds and salt bridges are present at the high affinity cytokine-receptor interfaces, whereas hydrophobic interactions dominate the low affinity receptor-ligand interfaces.	[Radaev, Sergei; Zou, Zhongcheng; Sun, Peter D.] NIAID, Struct Immunol Sect, Immunogenet Lab, NIH, Rockville, MD 20852 USA; [Huang, Tao; Lafer, Eileen M.; Hinck, Andrew P.] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Texas System; University of Texas Health San Antonio	Sun, PD (corresponding author), 12441 Parklawn Dr, Rockville, MD 20852 USA.	psun@nih.gov		Hinck, Andrew/0000-0003-3320-8054; Lafer, Eileen/0000-0002-0493-6522	National Institutes of Health [GM58670]; NIAID; Robert A. Welch Foundation [AQ1431]; NATIONAL CANCER INSTITUTE [P30CA054174] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000820] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058670] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Robert A. Welch Foundation(The Welch Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM58670 (to A. P. H.). This work was also supported by NIAID intramural research funding and by Robert A. Welch Foundation Grant AQ1431 (to A. P. H.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Allendorph GP, 2007, BIOCHEMISTRY-US, V46, P12238, DOI 10.1021/bi700907k; Allendorph GP, 2006, P NATL ACAD SCI USA, V103, P7643, DOI 10.1073/pnas.0602558103; Baardsnes J, 2009, BIOCHEMISTRY-US, V48, P2146, DOI 10.1021/bi8019004; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brown MA, 2005, J BIOL CHEM, V280, P25111, DOI 10.1074/jbc.M503328200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cerletti A, 2000, J DRUG TARGET, V8, P435, DOI 10.3109/10611860008997919; DAOPIN S, 1992, SCIENCE, V257, P369, DOI 10.1126/science.1631557; De Crescenzo G, 2006, J MOL BIOL, V355, P47, DOI 10.1016/j.jmb.2005.10.022; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Derynck R, 1997, BIOCHIM BIOPHYS ACTA, V1333, P105; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Greenwald J, 2003, MOL CELL, V11, P605, DOI 10.1016/S1097-2765(03)00094-7; Groppe J, 2008, MOL CELL, V29, P157, DOI 10.1016/j.molcel.2007.11.039; Harrington AE, 2006, EMBO J, V25, P1035, DOI 10.1038/sj.emboj.7601000; Hinck AP, 2000, J BIOMOL NMR, V18, P369, DOI 10.1023/A:1026775321886; Hinck AP, 1996, BIOCHEMISTRY-US, V35, P8517, DOI 10.1021/bi9604946; Itoh S, 2000, EUR J BIOCHEM, V267, P6954, DOI 10.1046/j.1432-1327.2000.01828.x; Itoh S, 2007, CURR OPIN CELL BIOL, V19, P176, DOI 10.1016/j.ceb.2007.02.015; KAARTINEN V, 1995, NAT GENET, V11, P415, DOI 10.1038/ng1295-415; Kirsch T, 2000, NAT STRUCT BIOL, V7, P492; Kissinger CR, 1999, ACTA CRYSTALLOGR D, V55, P484, DOI 10.1107/S0907444998012517; Kleywegt GJ, 1997, METHOD ENZYMOL, V277, P208, DOI 10.1016/S0076-6879(97)77013-7; KULKARNI AB, 1993, P NATL ACAD SCI USA, V90, P770, DOI 10.1073/pnas.90.2.770; LaPorte SL, 2008, CELL, V132, P259, DOI 10.1016/j.cell.2007.12.030; Laverty HG, 2009, CYTOKINE GROWTH F R, V20, P305, DOI 10.1016/j.cytogfr.2009.07.002; LOPEZCASILLAS F, 1993, CELL, V73, P1435, DOI 10.1016/0092-8674(93)90368-Z; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mittl PRE, 1996, PROTEIN SCI, V5, P1261, DOI 10.1002/pro.5560050705; Moustakas A, 2001, J CELL SCI, V114, P4359; Nickel J, 2005, J MOL BIOL, V349, P933, DOI 10.1016/j.jmb.2005.04.015; OKane S, 1997, INT J BIOCHEM CELL B, V29, P63, DOI 10.1016/S1357-2725(96)00120-3; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Radaev S, 2001, J BIOL CHEM, V276, P16478, DOI 10.1074/jbc.M100351200; Rickert M, 2004, J MOL BIOL, V339, P1115, DOI 10.1016/j.jmb.2004.04.038; Sanford LP, 1997, DEVELOPMENT, V124, P2659; SCHLUNEGGER MP, 1992, NATURE, V358, P430, DOI 10.1038/358430a0; SHAH M, 1995, J CELL SCI, V108, P985; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; Snyder GA, 1999, P NATL ACAD SCI USA, V96, P3864, DOI 10.1073/pnas.96.7.3864; Taya Y, 1999, DEVELOPMENT, V126, P3869; WANG QH, 1992, J APPL PHYS, V71, P1014, DOI 10.1063/1.350437; Wang XQ, 2009, ANNU REV IMMUNOL, V27, P29, DOI 10.1146/annurev.immunol.24.021605.090616; Weber D, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-6; Zou ZC, 2004, PROTEIN EXPRES PURIF, V37, P265, DOI 10.1016/j.pep.2003.06.001; Zuniga JE, 2005, J MOL BIOL, V354, P1052, DOI 10.1016/j.jmb.2005.10.014	50	109	119	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14806	14814		10.1074/jbc.M109.079921	http://dx.doi.org/10.1074/jbc.M109.079921			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20207738	Green Published, hybrid			2022-12-25	WOS:000277299700077
J	Cobbold, LC; Wilson, LA; Sawicka, K; King, HA; Kondrashov, AV; Spriggs, KA; Bushell, M; Willis, AE				Cobbold, L. C.; Wilson, L. A.; Sawicka, K.; King, H. A.; Kondrashov, A. V.; Spriggs, K. A.; Bushell, M.; Willis, A. E.			Upregulated c-myc expression in multiple myeloma by internal ribosome entry results from increased interactions with and expression of PTB-1 and YB-1	ONCOGENE			English	Article						translation; IRES; c-myc; protein synthesis	BINDING-PROTEIN; SITE FUNCTION; CELL-LINE; SEGMENT; TRANSLATION; INITIATION; IDENTIFICATION; MECHANISM; FAMILY; GROWTH	The 5' untranslated region of the proto-oncogene c-myc contains an internal ribosome entry segment (IRES) and c-myc translation can therefore be initiated by internal ribosome entry as well as by cap-dependent mechanisms. It has been shown previously that in patients with multiple myeloma (MM) and in MM-derived cell lines there is a C to T mutation in the c-myc IRES that increases IRES activity and the corresponding synthesis of c-myc protein although it is not fully understood how this occurs. Our data show that two recently identified c-myc IRES transacting factors, Y-box binding protein 1 (YB-1) and polypyrimidine tract-binding protein 1 (PTB-1), bind more strongly (approximately 3.5- and 2-fold respectively) to the mutated version of the c-myc IRES and in vitro these proteins exert their effect synergistically to stimulate IRES activity of the mutant IRES 4.5-fold more than the wild-type version. Importantly, we show that there is a strong correlation between the expression of PTB-1, YB-1 and c-myc in MM-derived cell lines, suggesting that by reducing either PTB-1 or YB-1 protein levels it is possible to decrease c-myc expression and inhibit cell proliferation of MM-derived cell lines. Oncogene (2010) 29, 2884-2891; doi: 10.1038/onc.2010.31; published online 1 March 2010	[Cobbold, L. C.; Wilson, L. A.; Sawicka, K.; King, H. A.; Kondrashov, A. V.; Spriggs, K. A.; Bushell, M.; Willis, A. E.] Univ Nottingham, Sch Pharm, Ctr Biomol Sci, Nottingham NG7 2RD, England	University of Nottingham	Willis, AE (corresponding author), Univ Nottingham, Sch Pharm, Ctr Biomol Sci, Univ Pk, Nottingham NG7 2RD, England.	anne.willis@nottingham.ac.uk		Kondrashov, Alexander/0000-0003-3428-5975; Sawicka, Kirsty/0000-0003-4195-6327; Willis, Anne/0000-0002-1470-8531	BBSRC; CRUK; Biotechnology and Biological Sciences Research Council [BB/F006926/1] Funding Source: researchfish; Medical Research Council [MC_UP_A600_1023] Funding Source: researchfish; BBSRC [BB/F006926/1] Funding Source: UKRI; MRC [MC_UP_A600_1023] Funding Source: UKRI	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); CRUK(Cancer Research UK); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by grants from the BBSRC (LCC, HAK) and CRUK (LAW, AVK). Martin Bushell is a BBSRC David Philips fellow and Anne Willis holds a BBSRC professorial fellowship. We thank Professor Dalton (Moffitt Cancer Center, Florida, USA) for providing the cell line 8226/R5.	Bader AG, 2008, ONCOGENE, V27, P1179, DOI 10.1038/sj.onc.1210719; BLACKWOOD EM, 1991, SCIENCE, V251, P1211, DOI 10.1126/science.2006410; Boutz PL, 2007, GENE DEV, V21, P71, DOI 10.1101/gad.1500707; Chappell SA, 2000, ONCOGENE, V19, P4437, DOI 10.1038/sj.onc.1203791; Chatterjee M, 2008, BLOOD, V111, P3714, DOI 10.1182/blood-2007-05-089151; Cobbold LC, 2008, MOL CELL BIOL, V28, P40, DOI 10.1128/MCB.01298-07; DALTON WS, 1986, CANCER RES, V46, P5125; Drach J, 2000, J CANCER RES CLIN, V126, P441, DOI 10.1007/s004320050011; Evans JR, 2003, ONCOGENE, V22, P8012, DOI 10.1038/sj.onc.1206645; Evdokimova V, 2009, CANCER CELL, V15, P402, DOI 10.1016/j.ccr.2009.03.017; He X, 2007, ONCOGENE, V26, P4961, DOI 10.1038/sj.onc.1210307; Herold S, 2009, NAT REV CANCER, V9, P441, DOI 10.1038/nrc2640; Ho P Joy, 2002, Rev Clin Exp Hematol, V6, P276, DOI 10.1046/j.1468-0734.2002.00081.x; Jo OD, 2008, J BIOL CHEM, V283, P23274, DOI 10.1074/jbc.M801185200; Johannes G, 1998, RNA, V4, P1500, DOI 10.1017/S1355838298981080; Kuehl WM, 2002, NAT REV CANCER, V2, P175, DOI 10.1038/nrc746; Le Quesne JPC, 2001, J MOL BIOL, V310, P111, DOI 10.1006/jmbi.2001.4745; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Mitchell SA, 2005, GENE DEV, V19, P1556, DOI 10.1101/gad.339105; Mitchell SA, 2003, MOL CELL, V11, P757, DOI 10.1016/S1097-2765(03)00093-5; Nanbru C, 1997, J BIOL CHEM, V272, P32061, DOI 10.1074/jbc.272.51.32061; Paulin FEM, 1996, ONCOGENE, V13, P505; Paulin FEM, 1998, NUCLEIC ACIDS RES, V26, P3097, DOI 10.1093/nar/26.13.3097; Shi YJ, 2008, CANCER RES, V68, P10215, DOI 10.1158/0008-5472.CAN-08-1066; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Spriggs KA, 2009, MOL CELL BIOL, V29, P1565, DOI 10.1128/MCB.01283-08; Stoneley M, 2000, MOL CELL BIOL, V20, P1162, DOI 10.1128/MCB.20.4.1162-1169.2000; Stoneley M, 2004, ONCOGENE, V23, P3200, DOI 10.1038/sj.onc.1207551; Stoneley M, 1998, ONCOGENE, V16, P423, DOI 10.1038/sj.onc.1201763; Subkhankulova T, 2001, BIOCHEM J, V359, P183, DOI 10.1042/0264-6021:3590183; Sutherland BW, 2005, ONCOGENE, V24, P4281, DOI 10.1038/sj.onc.1208590; Vafa O, 2002, MOL CELL, V9, P1031, DOI 10.1016/S1097-2765(02)00520-8; Wang C, 2008, J BIOL CHEM, V283, P20277, DOI 10.1074/jbc.M803682200	33	76	80	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2010	29	19					2884	2891		10.1038/onc.2010.31	http://dx.doi.org/10.1038/onc.2010.31			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	595DW	20190818				2022-12-25	WOS:000277591900013
J	Cooper, SJ; Zou, H; LeGrand, SN; Marlow, LA; von Roemeling, CA; Radisky, DC; Wu, KJ; Hampel, N; Margulis, V; Tun, HW; Blobe, GC; Wood, CG; Copland, JA				Cooper, S. J.; Zou, H.; LeGrand, S. N.; Marlow, L. A.; von Roemeling, C. A.; Radisky, D. C.; Wu, K. J.; Hampel, N.; Margulis, V.; Tun, H. W.; Blobe, G. C.; Wood, C. G.; Copland, J. A.			Loss of type III transforming growth factor-beta receptor expression is due to methylation silencing of the transcription factor GATA3 in renal cell carcinoma	ONCOGENE			English	Article						transcriptional regulation; GATA3; type III transforming growth factor-beta receptor; methylation; clear cell renal cell carcinoma	TGF-BETA; BETAGLYCAN EXPRESSION; CANCER; GENE; DIFFERENTIATION; INVASIVENESS; INHIBITION; MOTILITY	Loss of transforming growth factor-beta receptor III (TbRIII) correlates with loss of transforming growth factor-beta (TGF-beta) responsiveness and suggests a role for dysregulated TGF-beta signaling in clear cell renal cell carcinoma (ccRCC) progression and metastasis. Here we identify that for all stages of ccRCC TbRIII expression is downregulated in patient-matched tissue samples and cell lines. We find that this loss of expression is not due to methylation of the gene and we define GATA3 as the first transcriptional factor to positively regulate TbRIII expression in human cells. We localize GATA3's binding to a 10-bp region of the TbRIII proximal promoter. We demonstrate that GATA3 mRNA is downregulated in all stages, of ccRCC, mechanistically show that GATA3 is methylated in ccRCC patient tumor tissues as well as cell lines, and that inhibiting GATA3 expression in normal renal epithelial cells downregulates TbRIII mRNA and protein expression. These data support a sequential model whereby loss of GATA3 expression through epigenetic silencing decreases TbRIII expression during ccRCC progression. Oncogene (2010) 29, 2905-2915; doi:10.1038/onc.2010.64; published online 8 March 2010	[Copland, J. A.] Mayo Clin, Dept Canc Biol, Mayo Clin Comprehens Canc Ctr, Coll Med, Jacksonville, FL 32224 USA; [Zou, H.] Mayo Clin Rochester, Dept Gastroenterol & Hepatol, Rochester, MN USA; [Wu, K. J.] Mayo Clin, Dept Pathol, Jacksonville, FL 32224 USA; [Hampel, N.; Blobe, G. C.] Duke Univ, Med Ctr, Dept Med & Pharmacol, Durham, NC 27710 USA; [Hampel, N.; Blobe, G. C.] Duke Univ, Med Ctr, Dept Canc Biol, Durham, NC 27710 USA; [Margulis, V.; Wood, C. G.] Univ Texas MD Anderson Canc Ctr, Dept Urol, Houston, TX 77030 USA; [Tun, H. W.] Mayo Clin, Dept Hematol & Oncol, Jacksonville, FL 32224 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Duke University; Duke University; University of Texas System; UTMD Anderson Cancer Center; Mayo Clinic	Copland, JA (corresponding author), Mayo Clin, Dept Canc Biol, Mayo Clin Comprehens Canc Ctr, Coll Med, 4500 San Pablo Rd,Griffin Bld Rm 309, Jacksonville, FL 32224 USA.	copland.john@mayo.edu	Hempel, Nadine/F-1700-2014; Blobe, Gerard/AAJ-5945-2020; Radisky, Derek/B-6569-2018	Hempel, Nadine/0000-0002-5574-8783; Blobe, Gerard/0000-0002-4274-8901; Radisky, Derek/0000-0002-1962-8784; Marlow, Laura/0000-0002-4726-9889; von Roemeling, Christina/0000-0002-3754-5544	NIH [CA104505, 3RO1CA104505-05S1, CA106307]; Dr Ellis and Dona Brunton Rare Cancer Research Fund; NATIONAL CANCER INSTITUTE [R01CA104505, R01CA106307] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dr Ellis and Dona Brunton Rare Cancer Research Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Holly Hammond for her close editing of the manuscript. We also thank Tam How, Brandy Edenfield and Gregory Kennedy for their technical support. This work was funded in part by NIH Grant CA104505 (JAC and CGW), 3RO1CA104505-05S1 (JAC), Dr Ellis and Dona Brunton Rare Cancer Research Fund ( JAC), NIH Grant CA106307 (GCB) and a generous gift from Susan A Olde, OBE.	Chakravarthy D, 1999, INT J ONCOL, V15, P187; Cooper S, 2005, MOL CARCINOGEN, V43, P108, DOI 10.1002/mc.20101; Copland JA, 2006, ONCOGENE, V25, P2304, DOI 10.1038/sj.onc.1209267; Copland JA, 2003, ONCOGENE, V22, P8053, DOI 10.1038/sj.onc.1206835; Dong M, 2007, J CLIN INVEST, V117, P206, DOI 10.1172/JCI29293; Elliott RL, 2005, J CLIN ONCOL, V23, P2078, DOI 10.1200/JCO.2005.02.047; Finger EC, 2008, CARCINOGENESIS, V29, P528, DOI 10.1093/carcin/bgm289; Florio P, 2005, EUR J ENDOCRINOL, V152, P277, DOI 10.1530/eje.1.01849; Gordon KJ, 2008, CARCINOGENESIS, V29, P252, DOI 10.1093/carcin/bgm249; Grote D, 2006, DEVELOPMENT, V133, P53, DOI 10.1242/dev.02184; Gulbinas A, 2006, J HISTOCHEM CYTOCHEM, V54, P161, DOI 10.1369/jhc.5A6626.2005; Gumz ML, 2007, CLIN CANCER RES, V13, P4740, DOI 10.1158/1078-0432.CCR-07-0143; Hempel N, 2008, CARCINOGENESIS, V29, P905, DOI 10.1093/carcin/bgn049; Hempel N, 2007, CANCER RES, V67, P5231, DOI 10.1158/0008-5472.CAN-07-0035; Ho IC, 2007, CELL MOL IMMUNOL, V4, P15; Kouros-Mehr H, 2008, CURR OPIN CELL BIOL, V20, P164, DOI 10.1016/j.ceb.2008.02.003; Kouros-Mehr H, 2008, CANCER CELL, V13, P141, DOI 10.1016/j.ccr.2008.01.011; Kouros-Mehr H, 2006, CELL, V127, P1041, DOI 10.1016/j.cell.2006.09.048; LABASTIE MC, 1995, KIDNEY INT, V47, P1597, DOI 10.1038/ki.1995.223; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Casillas F, 2003, J BIOL CHEM, V278, P382, DOI 10.1074/jbc.M208520200; Margulis V, 2008, CLIN CANCER RES, V14, P5722, DOI 10.1158/1078-0432.CCR-08-0546; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; McCarthy TL, 2007, MOL ENDOCRINOL, V21, P2713, DOI 10.1210/me.2007-0210; Mehra R, 2005, CANCER RES, V65, P11259, DOI 10.1158/0008-5472.CAN-05-2495; Motzer RJ, 1999, J CLIN ONCOL, V17, P2530, DOI 10.1200/JCO.1999.17.8.2530; Mythreye K, 2009, P NATL ACAD SCI USA, V106, P8221, DOI 10.1073/pnas.0812879106; Pantuck AJ, 2001, J UROLOGY, V166, P1611, DOI 10.1016/S0022-5347(05)65640-6; Sharifi N, 2007, PROSTATE, V67, P301, DOI 10.1002/pros.20526; Stenvers KL, 2003, MOL CELL BIOL, V23, P4371, DOI 10.1128/MCB.23.12.4371-4385.2003; Tavares TS, 2008, CANCER BIOL THER, V7, P1607, DOI 10.4161/cbt.7.10.6584; Turley RS, 2007, CANCER RES, V67, P1090, DOI 10.1158/0008-5472.CAN-06-3117; Van Esch H, 2000, NATURE, V406, P419, DOI 10.1038/35019088; Wood CG, 2007, CLIN CANCER RES, V13, p697S, DOI 10.1158/1078-0432.CCR-06-2109; You HJ, 2009, CARCINOGENESIS, V30, P1281, DOI 10.1093/carcin/bgp071	35	37	40	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2010	29	20					2905	2915		10.1038/onc.2010.64	http://dx.doi.org/10.1038/onc.2010.64			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	599DM	20208565	Green Accepted			2022-12-25	WOS:000277890400002
J	Nilsson, MB; Zage, PE; Zeng, L; Xu, L; Cascone, T; Wu, HK; Saigal, B; Zweidler-McKay, PA; Heymach, JV				Nilsson, M. B.; Zage, P. E.; Zeng, L.; Xu, L.; Cascone, T.; Wu, H. K.; Saigal, B.; Zweidler-McKay, P. A.; Heymach, J. V.			Multiple receptor tyrosine kinases regulate HIF-1 alpha and HIF-2 alpha in normoxia and hypoxia in neuroblastoma: implications for antiangiogenic mechanisms of multikinase inhibitors	ONCOGENE			English	Article						neuroblastoma; sunitinib; sorafenib; HIF-1 alpha; HIF-2 alpha; RTKs	EPIDERMAL-GROWTH-FACTOR; BONE-MARROW-TRANSPLANTATION; TUMOR ANGIOGENESIS; PROSTATE-CANCER; FACTOR VEGF; EXPRESSION; CELLS; ACTIVATION; PATHWAY; ANTITUMOR	Novel treatment approaches are needed for children with advanced neuroblastoma. Studies with neuroblastoma cells have indicated the presence of a hypoxiadriven vascular endothelial growth factor (VEGF)/VEGF receptor (VEGFR)-1 autocrine loop modulating hypoxia-inducible factor-1alpha (HIF-1 alpha). Whether other receptor tyrosine kinases (RTKs) are capable of modulating HIF-1 alpha levels and whether RTKs can regulate HIF-2 alpha as well is largely unknown. We evaluated neuroblastoma cell lines for expression of various RTKs. Although cell lines were heterogeneous in the expression of VEGFR-1, -3, c-Kit and RET, most cells expressed PDGFR-alpha and -beta. Ligand-induced activation of multiple RTKs upregulated HIF-1 alpha levels, whereas activation of VEGFR-1 alone upregulated HIF-2 alpha. Multitargeted tyrosine kinase inhibitor sunitinib reduced hypoxia-induced rises in HIF-1 alpha and HIF-2 alpha through mechanisms involving effects on both mRNA levels and protein stability. In addition, sunitinib and sorafenib had direct effects on tumor cell viability in vitro. In a neuroblastoma xenograft model, tumor growth inhibition by sunitinib was associated with inhibition of angiogenesis and reduced HIF-1 alpha levels. These findings show that multiple RTKs may regulate the HIF axis in normoxia and hypoxia and suggest that multikinase inhibitors may exert antiangiogenic effects not only by direct effects on endothelial cells, but also by blocking compensatory hypoxia- and ligand-induced changes in HIF-1 alpha and HIF-2 alpha. Oncogene (2010) 29, 2938-2949; doi:10.1038/onc.2010.60; published online 8 March 2010	[Nilsson, M. B.; Xu, L.; Cascone, T.; Wu, H. K.; Saigal, B.; Heymach, J. V.] Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA; [Zage, P. E.; Zeng, L.; Zweidler-McKay, P. A.] Univ Texas MD Anderson Canc Ctr, Childrens Canc Hosp, Div Pediat, Houston, TX 77030 USA; [Heymach, J. V.] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Heymach, JV (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Unit 432,1515 Holcombe Blvd, Houston, TX 77030 USA.	jheymach@mdanderson.org	Heymach, John/AAG-2361-2019	Heymach, John/0000-0001-9068-8942; Zweidler-McKay, Patrick/0000-0001-6621-523X	Damon Runyon Cancer Research Foundation [CI 24-04]; MD Anderson Cancer Center Physician Scientist; Lorrie Olivier Neuroblastoma Research Fund; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	Damon Runyon Cancer Research Foundation; MD Anderson Cancer Center Physician Scientist; Lorrie Olivier Neuroblastoma Research Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	JVH is a Damon Runyon-Lilly Clinical Investigator supported in part by the Damon Runyon Cancer Research Foundation (CI 24-04) and the MD Anderson Cancer Center Physician Scientist Award. This work was also supported in part by the Lorrie Olivier Neuroblastoma Research Fund.	Beaudry P, 2008, MOL CANCER THER, V7, P418, DOI 10.1158/1535-7163.MCT-07-0568; Beppu K, 2004, JNCI-J NATL CANCER I, V96, P46, DOI 10.1093/jnci/djh004; Bruns CJ, 2000, CANCER RES, V60, P2926; Canete A, 2000, J CLIN ONCOL, V18, P27, DOI 10.1200/JCO.2000.18.1.27; COHEN PS, 1994, BLOOD, V84, P3465; Das B, 2005, CANCER RES, V65, P7267, DOI 10.1158/0008-5472.CAN-04-4575; Donfrancesco A, 2004, ACTA PAEDIATR, V93, P6, DOI 10.0180/08035320310021165; Eggert A, 2000, CLIN CANCER RES, V6, P1900; Fakhari M, 2002, J PEDIATR SURG, V37, P582, DOI 10.1053/jpsu.2002.31614; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Hishiki T, 1998, CANCER RES, V58, P2158; Holmquist-Mengelbier L, 2006, CANCER CELL, V10, P413, DOI 10.1016/j.ccr.2006.08.026; KAIPAINEN A, 1995, P NATL ACAD SCI USA, V92, P3566, DOI 10.1073/pnas.92.8.3566; Kane RC, 2009, ONCOLOGIST, V14, P95, DOI 10.1634/theoncologist.2008-0185; Kaneko M, 2002, J PEDIAT HEMATOL ONC, V24, P613, DOI 10.1097/00043426-200211000-00004; Katzenstein HM, 2001, MED PEDIATR ONCOL, V36, P190, DOI 10.1002/1096-911X(20010101)36:1<190::AID-MPO1045>3.0.CO;2-I; Kaushal V, 2005, CLIN CANCER RES, V11, P584; Kim WY, 2009, J CLIN INVEST, V119, P2160, DOI 10.1172/JCI38443; Komuro H, 2001, J CANCER RES CLIN, V127, P739; Kushner BH, 2000, MED PEDIATR ONCOL, V35, P468, DOI 10.1002/1096-911X(20001101)35:5<468::AID-MPO5>3.0.CO;2-P; Ladenstein R, 1998, J CLIN ONCOL, V16, P953, DOI 10.1200/JCO.1998.16.3.953; Langer I, 2000, MED PEDIATR ONCOL, V34, P386, DOI 10.1002/(SICI)1096-911X(200006)34:6<386::AID-MPO2>3.0.CO;2-3; Lesslie DP, 2006, BRIT J CANCER, V94, P1710, DOI 10.1038/sj.bjc.6603143; Maris JM, 2008, PEDIATR BLOOD CANCER, V50, P581, DOI 10.1002/pbc.21232; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Matthay KK, 1999, NEW ENGL J MED, V341, P1165, DOI 10.1056/NEJM199910143411601; Meister B, 1999, EUR J CANCER, V35, P445, DOI 10.1016/S0959-8049(98)00387-6; Meitar D, 1996, J CLIN ONCOL, V14, P405, DOI 10.1200/JCO.1996.14.2.405; NAKAMURA T, 1994, J PATHOL, V172, P255, DOI 10.1002/path.1711720305; O'Farrell AM, 2003, BLOOD, V101, P3597, DOI 10.1182/blood-2002-07-2307; Peddinti R, 2007, CLIN CANCER RES, V13, P3499, DOI 10.1158/1078-0432.CCR-07-0237; Peng XH, 2006, J BIOL CHEM, V281, P25903, DOI 10.1074/jbc.M603414200; Pennacchietti S, 2003, CANCER CELL, V3, P347, DOI 10.1016/S1535-6108(03)00085-0; Phillips RJ, 2005, J BIOL CHEM, V280, P22473, DOI 10.1074/jbc.M500963200; Pickering LM, 2009, NAT CLIN PRACT ONCOL, V6, P6, DOI 10.1038/ncponc1283; Richardson DS, 2006, ONCOGENE, V25, P3206, DOI 10.1038/sj.onc.1209349; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Shusterman S, 2005, CANCER LETT, V228, P171, DOI 10.1016/j.canlet.2005.01.049; Stommel JM, 2007, SCIENCE, V318, P287, DOI 10.1126/science.1142946; Wey JS, 2005, CANCER-AM CANCER SOC, V104, P427, DOI 10.1002/cncr.21145; Wilhelm SM, 2004, CANCER RES, V64, P7099, DOI 10.1158/0008-5472.CAN-04-1443; Witte D, 2002, ANTICANCER RES, V22, P1463; Yamagata K, 2002, GLIA, V37, P1, DOI 10.1002/glia.10003; Yang AD, 2006, CANCER RES, V66, P46, DOI 10.1158/0008-5472.CAN-05-3086; Yang JC, 2004, CLIN CANCER RES, V10, p6367S, DOI 10.1158/1078-0432.CCR-050006; Yoshida D, 2006, J NEURO-ONCOL, V76, P13, DOI 10.1007/s11060-005-3279-0; Zhang LB, 2009, NEOPLASIA, V11, P426, DOI 10.1593/neo.09166; Zhong H, 2000, CANCER RES, V60, P1541	49	58	64	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2010	29	20					2938	2949		10.1038/onc.2010.60	http://dx.doi.org/10.1038/onc.2010.60			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	599DM	20208561				2022-12-25	WOS:000277890400005
J	Griggs, AM; Hahne, K; Hrycyna, CA				Griggs, Amy M.; Hahne, Kalub; Hrycyna, Christine A.			Functional Oligomerization of the Saccharomyces cerevisiae Isoprenylcysteine Carboxyl Methyltransferase, Ste14p	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HELICAL MEMBRANE-PROTEINS; C-TERMINAL METHYLATION; GXXXG MOTIF; A-FACTOR; ENDOPLASMIC-RETICULUM; MUTATIONAL ANALYSIS; COUPLED RECEPTORS; KINETIC MECHANISM; ESCHERICHIA-COLI; GLYCOPHORIN-A	The isoprenylcysteine carboxyl methyltransferase (Icmt) from Saccharomyces cerevisiae, also designated Ste14p, is a 26-kDa integral membrane protein that contains six transmembrane spanning segments. This protein is localized to the endoplasmic reticulum membrane where it performs the methylation step of the CAAX post-translational processing pathway. Sequence analysis reveals a putative GXXXG dimerization motif located in transmembrane 1 of Ste14p, but it is not known whether Ste14p forms or functions as a dimer or higher order oligomer. We determined that Ste14p predominantly formed a homodimer in the presence of the cross-linking agent, bis-sulfosuccinimidyl suberate. Wild-type untagged Ste14p also co-immunoprecipitated and co-purified with N-terminal-tagged His(10)-myc(3)-Ste14p (His-Ste14p). Furthermore, enzymatically inactive His-Ste14p variants L81F and E213Q both exerted a dominant-negative effect on methyltransferase activity when co-expressed and co-purified with untagged wild-type Ste14p. Together, these data, although indirect, suggest that Ste14p forms and functions as a homodimer or perhaps a higher oligomeric species.	[Griggs, Amy M.; Hahne, Kalub; Hrycyna, Christine A.] Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA; [Griggs, Amy M.; Hahne, Kalub; Hrycyna, Christine A.] Purdue Univ, Purdue Ctr Canc Res, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Hrycyna, CA (corresponding author), 560 Oval Dr, W Lafayette, IN 47907 USA.	hrycyna@purdue.edu						Ambroziak P., 2001, ENZYMES, P155; Ambudkar SV, 1998, METHOD ENZYMOL, V292, P492; Anderson JL, 2006, ENZYMES, V24, P245, DOI 10.1016/S1874-6047(06)80011-9; Anderson JL, 2005, J BIOL CHEM, V280, P29454, DOI 10.1074/jbc.M504982200; Anderson JL, 2005, J BIOL CHEM, V280, P7336, DOI 10.1074/jbc.M410292200; Arselin G, 2003, EUR J BIOCHEM, V270, P1875, DOI 10.1046/j.1432-1033.2003.03557.x; Baron Rudi A., 2004, BMC Biochemistry, V5, P19, DOI 10.1186/1471-2091-5-19; Bergo MO, 2004, J CLIN INVEST, V113, P539, DOI 10.1172/JCI200418829; Blum R, 2008, RECENT PAT ANTI-CANC, V3, P31; Casey PJ, 1996, J BIOL CHEM, V271, P5289, DOI 10.1074/jbc.271.10.5289; CLARKE S, 1992, ANNU REV BIOCHEM, V61, P355, DOI 10.1146/annurev.bi.61.070192.002035; Curran AR, 2003, CURR OPIN STRUC BIOL, V13, P412, DOI 10.1016/S0959-440X(03)00102-7; Dai Q, 1998, J BIOL CHEM, V273, P15030, DOI 10.1074/jbc.273.24.15030; Davidson AL, 1997, J BACTERIOL, V179, P5458, DOI 10.1128/jb.179.17.5458-5464.1997; DESCHENES RJ, 1989, J BIOL CHEM, V264, P11865; ELBLE R, 1992, BIOTECHNIQUES, V13, P18; Filizola M, 2002, BIOPOLYMERS, V66, P317, DOI 10.1002/bip.10311; Gelb MH, 2006, NAT CHEM BIOL, V2, P518, DOI 10.1038/nchembio818; Gerber D, 2001, J BIOL CHEM, V276, P31229, DOI 10.1074/jbc.M101889200; Guo W, 2003, J BIOL CHEM, V278, P4385, DOI 10.1074/jbc.C200679200; HRYCYNA CA, 1993, PHARMACOL THERAPEUT, V59, P281, DOI 10.1016/0163-7258(93)90071-K; HRYCYNA CA, 1995, METHOD ENZYMOL, V250, P251; HRYCYNA CA, 1990, MOL CELL BIOL, V10, P5071, DOI 10.1128/MCB.10.10.5071; HRYCYNA CA, 1991, EMBO J, V10, P1699, DOI 10.1002/j.1460-2075.1991.tb07694.x; Liang Y, 2003, J BIOL CHEM, V278, P21655, DOI 10.1074/jbc.M302536200; MacKenzie KR, 1997, SCIENCE, V276, P131, DOI 10.1126/science.276.5309.131; MARR RS, 1990, J BIOL CHEM, V265, P20057; Mcclain MS, 2003, J BIOL CHEM, V278, P12101, DOI 10.1074/jbc.M212595200; Overton MC, 2003, J BIOL CHEM, V278, P49369, DOI 10.1074/jbc.M308654200; Polgar O, 2004, BIOCHEMISTRY-US, V43, P9448, DOI 10.1021/bi0497953; Romano JD, 1998, MOL BIOL CELL, V9, P2231, DOI 10.1091/mbc.9.8.2231; Romano JD, 2001, MOL BIOL CELL, V12, P1957, DOI 10.1091/mbc.12.7.1957; Russ WP, 1999, P NATL ACAD SCI USA, V96, P863, DOI 10.1073/pnas.96.3.863; Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489; SAPPERSTEIN S, 1994, MOL CELL BIOL, V14, P1438, DOI 10.1128/MCB.14.2.1438; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; Schneider D, 2004, J MOL BIOL, V343, P799, DOI 10.1016/j.jmb.2004.08.083; Senes A, 2000, J MOL BIOL, V296, P921, DOI 10.1006/jmbi.1999.3488; Senes A, 2004, CURR OPIN STRUC BIOL, V14, P465, DOI 10.1016/j.sbi.2004.07.007; SHI YQ, 1992, J BIOL CHEM, V267, P9547; STEPHENSON RC, 1992, J BIOL CHEM, V267, P13314; STEPHENSON RC, 1990, J BIOL CHEM, V265, P16248; Ugolini S, 2002, PLASMID, V47, P94, DOI 10.1006/plas.2001.1557; Wahlstrom AM, 2008, BLOOD, V112, P1357, DOI 10.1182/blood-2007-06-094060; Whittington DA, 2001, P NATL ACAD SCI USA, V98, P9545, DOI 10.1073/pnas.161301298; Winter-Vann AM, 2005, P NATL ACAD SCI USA, V102, P4336, DOI 10.1073/pnas.0408107102; Wright LP, 2009, MOL CELL BIOL, V29, P1826, DOI 10.1128/MCB.01719-08; Zhang FL, 1996, ANNU REV BIOCHEM, V65, P241, DOI 10.1146/annurev.bi.65.070196.001325	48	12	12	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13380	13387		10.1074/jbc.M109.061366	http://dx.doi.org/10.1074/jbc.M109.061366			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20202940	hybrid, Green Published			2022-12-25	WOS:000276987700009
J	Bista, P; Zeng, WK; Ryan, S; Bailly, V; Browning, JL; Lukashev, ME				Bista, Pradeep; Zeng, Weike; Ryan, Sarah; Bailly, Veronique; Browning, Jeffrey L.; Lukashev, Matvey E.			TRAF3 Controls Activation of the Canonical and Alternative NF kappa B by the Lymphotoxin Beta Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; CELLS IN-VIVO; DENDRITIC CELLS; SIGNALING PATHWAY; ADAPTIVE IMMUNITY; NF-KAPPA-B2 P100; GENE-EXPRESSION; FACTOR-BINDING; IKK-ALPHA; KINASE	Components of lymphotoxin beta receptor (LTBR)-associated signaling complexes, including TRAF2, TRAF3, NIK, IKK1, and IKK2 have been shown to participate in the coupling of LTBR to NF kappa B. Here, we report that TRAF3 functions as a negative regulator of LTBR signaling via both canonical and non-canonical NF kappa B pathways by two distinct mechanisms. Analysis of NF kappa B signaling in cell lines with functionally intact NF kappa B pathway but lacking LTBR-mediated induction of NF kappa B target genes revealed an inverse association of cellular TRAF3 levels with LTBR-specific defect in canonical NF kappa B activation. Increased expression of TRAF3 correlated with its increased recruitment to LTBR-induced signaling complexes, decreased recruitment of TRAF2, and attenuated phosphorylation of I kappa B alpha and RelA. In contrast, activation of NF kappa B by TNF did not depend on TRAF3 levels. siRNA-mediated depletion of TRAF3 promoted recruitment of TRAF2 and IKK1 to activated LTBR, enabling LTBR-inducible canonical NF kappa B signaling and NF kappa B target gene expression. TRAF3 knock-down also increased mRNA and protein expression of several non-canonical NF kappa B components, including NF kappa B2/p100, RelB, and NIK, accompanied by processing of NF kappa B2/p100 into p52. These effects of TRAF3 depletion did not require LTBR signaling and were consistent with autonomous activation of the non-canonical NF kappa B pathway. Our data illustrate the function of TRAF3 as a dual-mode repressor of LTBR signaling that controls activation of canonical NF kappa B, and de-repression of the intrinsic activity of non-canonical NF kappa B. Modulation of cellular TRAF3 levels may thus contribute to regulation of NF kappa B-dependent gene expression by LTBR by affecting the balance of LTBR-dependent activation of canonical and non-canonical NF kappa B pathways.	Biogen Idec Inc, Dept Immunol, Cambridge, MA 02142 USA; [Bailly, Veronique] Biogen Idec Inc, Dept Prot Biochem, Cambridge, MA 02142 USA	Biogen; Biogen		matvey.lukashev@biogenidec.com		Browning, Jeffrey/0000-0001-9168-5233				Basak S, 2007, CELL, V128, P369, DOI 10.1016/j.cell.2006.12.033; Beinke S, 2004, BIOCHEM J, V382, P393, DOI 10.1042/BJ20040544; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Bradley JR, 2001, ONCOGENE, V20, P6482, DOI 10.1038/sj.onc.1204788; Brown KD, 2002, J BIOL CHEM, V277, P19433, DOI 10.1074/jbc.M111522200; Browning JL, 1996, J EXP MED, V183, P867, DOI 10.1084/jem.183.3.867; Chung JY, 2002, J CELL SCI, V115, P679; Dejardin E, 2002, IMMUNITY, V17, P525, DOI 10.1016/S1074-7613(02)00423-5; Derudder E, 2003, J BIOL CHEM, V278, P23278, DOI 10.1074/jbc.M300106200; Force WR, 1997, J BIOL CHEM, V272, P30835, DOI 10.1074/jbc.272.49.30835; Force WR, 2000, J BIOL CHEM, V275, P11121, DOI 10.1074/jbc.275.15.11121; Franzoso G, 1998, J EXP MED, V187, P147, DOI 10.1084/jem.187.2.147; Franzoso G, 1997, GENE DEV, V11, P3482, DOI 10.1101/gad.11.24.3482; Fujii SI, 2004, J EXP MED, V199, P1607, DOI 10.1084/jem.20040317; Gommerman JL, 2003, NAT REV IMMUNOL, V3, P642, DOI 10.1038/nri1151; Grech AP, 2004, IMMUNITY, V21, P629, DOI 10.1016/j.immuni.2004.09.011; Hacker H, 2006, NATURE, V439, P204, DOI 10.1038/nature04369; Hauer J, 2005, P NATL ACAD SCI USA, V102, P2874, DOI 10.1073/pnas.0500187102; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; He JQ, 2006, J EXP MED, V203, P2413, DOI 10.1084/jem.20061166; He LS, 2004, J BIOL CHEM, V279, P55855, DOI 10.1074/jbc.M407284200; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Hostager BS, 1999, J IMMUNOL, V162, P6307; Hu YL, 1999, SCIENCE, V284, P316, DOI 10.1126/science.284.5412.316; Kim YS, 2005, MOL CELL BIOL, V25, P2130, DOI 10.1128/MCB.25.6.2130-2137.2005; Kuai J, 2003, J BIOL CHEM, V278, P14363, DOI 10.1074/jbc.M208672200; Li QT, 2000, GENE DEV, V14, P1729; Liao GX, 2004, J BIOL CHEM, V279, P26243, DOI 10.1074/jbc.M403286200; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Lutz MB, 2002, TRENDS IMMUNOL, V23, P445, DOI 10.1016/S1471-4906(02)02281-0; MacDonald TT, 2005, SCIENCE, V307, P1920, DOI 10.1126/science.1106442; Moore CR, 2005, J IMMUNOL, V175, P3780, DOI 10.4049/jimmunol.175.6.3780; Moore F, 2007, J IMMUNOL, V178, P1301, DOI 10.4049/jimmunol.178.3.1301; Morrison MD, 2005, J BIOL CHEM, V280, P10018, DOI 10.1074/jbc.M413634200; Muller JR, 2003, J BIOL CHEM, V278, P12006, DOI 10.1074/jbc.M210768200; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Nolte MA, 2007, J EXP MED, V204, P1487, DOI 10.1084/jem.20070325; Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374; Sousa CR, 2006, NAT REV IMMUNOL, V6, P476, DOI 10.1038/nri1845; Saitoh T, 2003, J BIOL CHEM, V278, P36005, DOI 10.1074/jbc.M304266200; Sakurai H, 2003, J BIOL CHEM, V278, P36916, DOI 10.1074/jbc.M301598200; Schneider K, 2004, IMMUNOL REV, V202, P49, DOI 10.1111/j.0105-2896.2004.00206.x; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Sizemore N, 2002, J BIOL CHEM, V277, P3863, DOI 10.1074/jbc.M110572200; Summers-DeLuca LE, 2007, J EXP MED, V204, P1071, DOI 10.1084/jem.20061968; SUN SC, 1993, SCIENCE, V259, P1912, DOI 10.1126/science.8096091; Vallabhapurapu S, 2008, NAT IMMUNOL, V9, P1364, DOI 10.1038/ni.1678; VanArsdale TL, 1997, P NATL ACAD SCI USA, V94, P2460, DOI 10.1073/pnas.94.6.2460; Xiao GT, 2001, MOL CELL, V7, P401, DOI 10.1016/S1097-2765(01)00187-3; Xie P, 2004, J EXP MED, V199, P661, DOI 10.1084/jem.20031255; Xu LG, 2002, J IMMUNOL, V169, P6883, DOI 10.4049/jimmunol.169.12.6883; Zarnegar BJ, 2008, NAT IMMUNOL, V9, P1371, DOI 10.1038/ni.1676	52	56	60	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12971	12978		10.1074/jbc.M109.076091	http://dx.doi.org/10.1074/jbc.M109.076091			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20185819	Green Published, hybrid			2022-12-25	WOS:000276787800055
J	Han, KJ; Yang, Y; Xu, LG; Shu, HB				Han, Ke-Jun; Yang, Yan; Xu, Liang-Guo; Shu, Hong-Bing			Analysis of a TIR-less Splice Variant of TRIF Reveals an Unexpected Mechanism of TLR3-mediated Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; DOMAIN-CONTAINING ADAPTER; REGULATORY FACTOR-3 ACTIVATION; TOLL-LIKE-RECEPTORS; CUTTING EDGE; BETA; PATHWAY; KINASE; TANK; IDENTIFICATION	Recognition of viral RNA by Toll-like receptor 3 (TLR3) triggers activation of the transcription factors NF-kappa B and IRF3 and induction of type I interferons. TRIF is a Toll-interleukin 1 receptor (TIR) domain-containing adapter protein critically involved in TLR3-mediated signaling. It has been shown that TRIF interacts with TLR3 through their respective TIR domains. In this study, we identified a splice variant of TRIF lacking the TIR domain, which is designated as TRIS. Overexpression of TRIS activates NF-kappa B, interferon-stimulated response element (ISRE), and the interferon-beta promoter, whereas knockdown of TRIS inhibited TLR3-mediated signaling, suggesting that TRIS is involved in TLR3-mediated signaling. Furthermore, we identified an N-terminal TBK1-binding motif of TRIS or TRIF that was important for its interaction with TBK1 and ability to activate ISRE. Activation of ISRE by TRIS also needs its dimerization or oligomerization mediated by its C-terminal RIP homotypic interaction motif. Finally, we demonstrated that TRIS was associated with TRIF upon TLR3 activation by poly(I-C). These findings reveal an unexpected mechanism of TLR3-mediated signaling.	[Yang, Yan; Shu, Hong-Bing] Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China; [Han, Ke-Jun; Xu, Liang-Guo] Natl Jewish Med & Res Ctr, Denver, CO 80206 USA	Wuhan University; National Jewish Health	Shu, HB (corresponding author), Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China.	shuh@whu.edu.cn		Xu, Liangguo/0000-0003-1991-2889	Chinese 973 Program [2006CB504301, 2010CB911802]; National Natural Science Foundation of China [30630019, 30921001]; 111 Project [B06018]	Chinese 973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 111 Project(Ministry of Education, China - 111 Project)	This work was supported by Chinese 973 Program Grants 2006CB504301 and 2010CB911802, National Natural Science Foundation of China Grants 30630019 and 30921001, and the 111 Project B06018.	Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Cusson-Hermance N, 2005, J BIOL CHEM, V280, P36560, DOI 10.1074/jbc.M506831200; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Fujita F, 2003, MOL CELL BIOL, V23, P7780, DOI 10.1128/MCB.23.21.7780-7793.2003; Funami K, 2008, J BIOL CHEM, V283, P18283, DOI 10.1074/jbc.M801013200; Gohda J, 2004, J IMMUNOL, V173, P2913, DOI 10.4049/jimmunol.173.5.2913; Hacker H, 2006, NATURE, V439, P204, DOI 10.1038/nature04369; Han KJ, 2004, J BIOL CHEM, V279, P15652, DOI 10.1074/jbc.M311629200; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Jiang ZF, 2004, P NATL ACAD SCI USA, V101, P3533, DOI 10.1073/pnas.0308496101; Jin MS, 2008, IMMUNITY, V29, P182, DOI 10.1016/j.immuni.2008.07.007; Kaiser WJ, 2005, J IMMUNOL, V174, P4942, DOI 10.4049/jimmunol.174.8.4942; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Kawai T, 2009, INT IMMUNOL, V21, P317, DOI 10.1093/intimm/dxp017; Meylan E, 2004, NAT IMMUNOL, V5, P503, DOI 10.1038/ni1061; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; Pomerantz JL, 1999, EMBO J, V18, P6694, DOI 10.1093/emboj/18.23.6694; Ryzhakov G, 2007, EMBO J, V26, P3180, DOI 10.1038/sj.emboj.7601743; Sasai M, 2005, J IMMUNOL, V174, P27, DOI 10.4049/jimmunol.174.1.27; Sato S, 2003, J IMMUNOL, V171, P4304, DOI 10.4049/jimmunol.171.8.4304; Seth RB, 2006, CELL RES, V16, P141, DOI 10.1038/sj.cr.7310019; Uematsu S, 2007, J BIOL CHEM, V282, P15319, DOI 10.1074/jbc.R700009200; Xu YW, 2000, NATURE, V408, P111, DOI 10.1038/35040600; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yamamoto M, 2002, J IMMUNOL, V169, P6668, DOI 10.4049/jimmunol.169.12.6668; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003	29	21	23	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12543	12550		10.1074/jbc.M109.072231	http://dx.doi.org/10.1074/jbc.M109.072231			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20200155	Green Published, hybrid			2022-12-25	WOS:000276787800011
J	Schuster-Bockler, B; Conrad, D; Bateman, A				Schuster-Bockler, Benjamin; Conrad, Donald; Bateman, Alex			Dosage Sensitivity Shapes the Evolution of Copy-Number Varied Regions	PLOS ONE			English	Article							GENE-REGULATION; COMPENSATION; DUPLICATIONS; RESOURCE; BALANCE; CONSEQUENCES; DATABASE; ORIGIN; SERIES; FATES	Dosage sensitivity is an important evolutionary force which impacts on gene dispensability and duplicability. The newly available data on human copy-number variation (CNV) allow an analysis of the most recent and ongoing evolution. Provided that heterozygous gene deletions and duplications actually change gene dosage, we expect to observe negative selection against CNVs encompassing dosage sensitive genes. In this study, we make use of several sources of population genetic data to identify selection on structural variations of dosage sensitive genes. We show that CNVs can directly affect expression levels of contained genes. We find that genes encoding members of protein complexes exhibit limited expression variation and overlap significantly with a manually derived set of dosage sensitive genes. We show that complexes and other dosage sensitive genes are underrepresented in CNV regions, with a particular bias against frequent variations and duplications. These results suggest that dosage sensitivity is a significant force of negative selection on regions of copy-number variation.	[Schuster-Bockler, Benjamin] Ctr Genom Regulat, European Mol Biol Lab, Ctr Genom Regulat Syst Biol Unit, Barcelona, Spain; [Conrad, Donald; Bateman, Alex] Wellcome Trust Genome Campus, Wellcome Trust Sanger Inst, Cambridge, England	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); European Molecular Biology Laboratory (EMBL); Wellcome Trust Sanger Institute	Schuster-Bockler, B (corresponding author), Ctr Genom Regulat, European Mol Biol Lab, Ctr Genom Regulat Syst Biol Unit, Barcelona, Spain.	agb@sanger.ac.uk	Bateman, Alex/E-6518-2011; Bateman, Alex/H-2861-2019; Schuster-Böckler, Benjamin/H-8339-2019	Bateman, Alex/0000-0002-6982-4660; Schuster-Böckler, Benjamin/0000-0002-8892-5133	Wellcome Trust [WT077044/Z/05/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	This study was funded by the Wellcome Trust [grant number WT077044/Z/05/Z]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], GENE ONTOLOGY ANNOTA; Aury JM, 2006, NATURE, V444, P171, DOI 10.1038/nature05230; Birchler JA, 2005, TRENDS GENET, V21, P219, DOI 10.1016/j.tig.2005.02.010; BIRCHLER JA, 1981, GENETICS, V97, P625; Birchler JA, 2001, DEV BIOL, V234, P275, DOI 10.1006/dbio.2001.0262; BIRCHLER JA, 1979, GENETICS, V92, P1211; BIRCHLER JA, 1981, GENETICS, V99, P247; Birchler JA, 2007, BBA-GENE STRUCT EXPR, V1769, P422, DOI 10.1016/j.bbaexp.2006.12.002; Birchler JA, 2007, PLANT CELL, V19, P395, DOI 10.1105/tpc.106.049338; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Bock-Axelsen J, 2007, P NATL ACAD SCI USA, V104, P13122, DOI 10.1073/pnas.0705824104; Bruford EA, 2008, NUCLEIC ACIDS RES, V36, pD445, DOI 10.1093/nar/gkm881; Camon E, 2004, NUCLEIC ACIDS RES, V32, pD262, DOI 10.1093/nar/gkh021; Cheung SW, 2005, GENET MED, V7, P422, DOI 10.1097/01.GIM.0000170992.63691.32; Conrad DF, 2007, NAT GENET, V39, pS30, DOI 10.1038/ng2042; Cooper GM, 2007, NAT GENET, V39, pS22, DOI 10.1038/ng2054; Dang VT, 2008, EUR J HUM GENET, V16, P1350, DOI 10.1038/ejhg.2008.111; Deutschbauer AM, 2005, GENETICS, V169, P1915, DOI 10.1534/genetics.104.036871; DEVLIN RH, 1982, P NATL ACAD SCI-BIOL, V79, P1200, DOI 10.1073/pnas.79.4.1200; Dopman EB, 2007, P NATL ACAD SCI USA, V104, P19920, DOI 10.1073/pnas.0709888104; Ewing RM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100134; Freeling M, 2008, GENOME RES, V18, P1924, DOI 10.1101/gr.081026.108; Hahn A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-112; Hermjakob H, 2004, NUCLEIC ACIDS RES, V32, pD452, DOI 10.1093/nar/gkh052; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Jansen R, 2002, GENOME RES, V12, P37, DOI 10.1101/gr.205602; Kondrashov FA, 2004, TRENDS GENET, V20, P287, DOI 10.1016/j.tig.2004.05.001; Kondrashov FA, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-2-research0008; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Lee JA, 2006, NEURON, V52, P103, DOI 10.1016/j.neuron.2006.09.027; Lemos B, 2004, NAT GENET, V36, P1059, DOI 10.1038/ng1427; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; McCarroll SA, 2007, NAT GENET, V39, pS37, DOI 10.1038/ng2080; Mintseris J, 2005, P NATL ACAD SCI USA, V102, P10930, DOI 10.1073/pnas.0502667102; Nguyen DQ, 2006, PLOS GENET, V2, P198, DOI 10.1371/journal.pgen.0020020; ORR HA, 1991, P NATL ACAD SCI USA, V88, P11413, DOI 10.1073/pnas.88.24.11413; Papp B, 2003, NATURE, V424, P194, DOI 10.1038/nature01771; Platzer P, 2002, CANCER RES, V62, P1134; Prince VE, 2002, NAT REV GENET, V3, P827, DOI 10.1038/nrg928; R Development Core Team, 2006, R LANG ENV STAT COMP; REDON, CNV DATA; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Ruepp A, 2008, NUCLEIC ACIDS RES, V36, pD646, DOI 10.1093/nar/gkm936; Schuster-Bockler B, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r9; She XW, 2004, NATURE, V431, P927, DOI 10.1038/nature03062; Sopko R, 2006, MOL CELL, V21, P319, DOI 10.1016/j.molcel.2005.12.011; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Van Dongen SM, 2000, THESIS U UTRECHT NET; Veitia RA, 2005, TRENDS GENET, V21, P33, DOI 10.1016/j.tig.2004.11.002; Veitia RA, 2002, BIOESSAYS, V24, P175, DOI 10.1002/bies.10023; Wright S, 1934, AM NAT, V68, P24, DOI 10.1086/280521; Yang J, 2003, P NATL ACAD SCI USA, V100, P15661, DOI 10.1073/pnas.2536672100; DATABASE GENETIC VAR; SEGMENTAL DUPLICATIO; GENE EXPRESSION VARI	58	69	69	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2010	5	3							e9474	10.1371/journal.pone.0009474	http://dx.doi.org/10.1371/journal.pone.0009474			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565XE	20224824	Green Published, gold, Green Submitted			2022-12-25	WOS:000275328800001
J	Xu, PJ; Lu, ZL; Wang, XP; Dosher, B; Zhou, JN; Zhang, DR; Zhou, YF				Xu, Pengjing; Lu, Zhong-Lin; Wang, Xiaoping; Dosher, Barbara; Zhou, Jiangning; Zhang, Daren; Zhou, Yifeng			Category and Perceptual Learning in Subjects with Treated Wilson's Disease	PLOS ONE			English	Article							EXTERNAL NOISE; DISCRIMINATION; ORIENTATION; DEFICITS; SYSTEMS; IMPROVEMENT; MECHANISMS; ATTENTION; DISPLAYS; V1	To explore the relationship between category and perceptual learning, we examined both category and perceptual learning in patients with treated Wilson's disease (WD), whose basal ganglia, known to be important in category learning, were damaged by the disease. We measured their learning rate and accuracy in rule-based and information-integration category learning, and magnitudes of perceptual learning in a wide range of external noise conditions, and compared the results with those of normal controls. The WD subjects exhibited deficits in both forms of category learning and in perceptual learning in high external noise. However, their perceptual learning in low external noise was relatively spared. There was no significant correlation between the two forms of category learning, nor between perceptual learning in low external noise and either form of category learning. Perceptual learning in high external noise was, however, significantly correlated with information-integration but not with rule-based category learning. The results suggest that there may be a strong link between information-integration category learning and perceptual learning in high external noise. Damage to brain structures that are important for information-integration category learning may lead to poor perceptual learning in high external noise, yet spare perceptual learning in low external noise. Perceptual learning in high and low external noise conditions may involve separate neural substrates.	[Xu, Pengjing; Wang, Xiaoping; Zhou, Jiangning; Zhang, Daren; Zhou, Yifeng] Univ Sci & Technol China, Dept Neurobiol & Biophys, Sch Life Sci, Hefei 230026, Anhui, Peoples R China; [Lu, Zhong-Lin] Univ So Calif, Dept Psychol, Lab Brain Proc LOBES, Los Angeles, CA 90089 USA; [Lu, Zhong-Lin] Univ So Calif, Dept Biomed Engn, Lab Brain Proc LOBES, Los Angeles, CA 90089 USA; [Lu, Zhong-Lin] Univ So Calif, Grad Program Neurosci, Los Angeles, CA USA; [Dosher, Barbara] Univ Calif Irvine, Dept Cognit Sci, Irvine, CA 92717 USA; [Zhou, Yifeng] Chinese Acad Sci, Inst Biophys, Visual Informat Proc Lab, Beijing 100080, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; University of Southern California; University of Southern California; University of Southern California; University of California System; University of California Irvine; Chinese Academy of Sciences; Institute of Biophysics, CAS	Xu, PJ (corresponding author), Univ Sci & Technol China, Dept Neurobiol & Biophys, Sch Life Sci, Hefei 230026, Anhui, Peoples R China.	zhonglin@usc.edu	XU, PENGJING/GZM-8511-2022	Lu, Zhong-Lin/0000-0002-7295-727X; Zhou, Jiang-Ning/0000-0003-1225-2873	National Natural Science Foundation of China [30128006]; Foundation of Chinese Academy of Sciences [KSCX2-SW-217]; US National Institute of Mental Health [1 R01 MH61834]; National Science Foundation [BCS-9911801]; National Eye Institute [9 R01 EY017491]; NATIONAL EYE INSTITUTE [R01EY017491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061834] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation of Chinese Academy of Sciences(Chinese Academy of Sciences); US National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Science Foundation(National Science Foundation (NSF)); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by grants from the National Natural Science Foundation of China (30128006), Foundation of Chinese Academy of Sciences (KSCX2-SW-217), US National Institute of Mental Health (1 R01 MH61834), National Science Foundation (BCS-9911801), and National Eye Institute (9 R01 EY017491). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ala A, 2007, LANCET, V369, P397, DOI 10.1016/S0140-6736(07)60196-2; Ashby FG, 2001, TRENDS COGN SCI, V5, P204, DOI 10.1016/S1364-6613(00)01624-7; Ashby FG, 2005, TRENDS COGN SCI, V9, P83, DOI 10.1016/j.tics.2004.12.003; Ashby FG, 1998, PSYCHOL REV, V105, P442, DOI 10.1037/0033-295X.105.3.442; Ashby FG, 2003, NEUROPSYCHOLOGY, V17, P115, DOI 10.1037/0894-4105.17.1.115; BALL K, 1982, SCIENCE, V218, P697, DOI 10.1126/science.7134968; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; BULL PC, 1993, NAT GENET, V5, P327, DOI 10.1038/ng1293-327; Crist RE, 2001, NAT NEUROSCI, V4, P519, DOI 10.1038/87470; CUMMINGS JL, 1986, BRIT J PSYCHIAT, V149, P682, DOI 10.1192/bjp.149.6.682; Dosher BA, 1998, P NATL ACAD SCI USA, V95, P13988, DOI 10.1073/pnas.95.23.13988; Dosher BA, 2005, P NATL ACAD SCI USA, V102, P5286, DOI 10.1073/pnas.0500492102; Dosher BA, 1999, VISION RES, V39, P3197, DOI 10.1016/S0042-6989(99)00059-0; Dosher Barbara Anne, 2009, Learn Percept, V1, P37; Erickson MA, 1998, J EXP PSYCHOL GEN, V127, P107, DOI 10.1037/0096-3445.127.2.107; FIORENTINI A, 1980, NATURE, V287, P43, DOI 10.1038/287043a0; Gajda J, 1994, J NEUROL S, V1, P161; Ghose GM, 2002, J NEUROPHYSIOL, V87, P1867, DOI 10.1152/jn.00690.2001; GIBSON JJ, 1967, PRINCIPLES PERCEPTUA; Gilbert CD, 2001, NEURON, V31, P681, DOI 10.1016/S0896-6273(01)00424-X; Goldstone RL, 1998, ANNU REV PSYCHOL, V49, P585, DOI 10.1146/annurev.psych.49.1.585; HAWKINS RA, 1987, NEUROLOGY, V37, P1707, DOI 10.1212/WNL.37.11.1707; HINTZMAN DL, 1986, PSYCHOL REV, V93, P411, DOI 10.1037/0033-295X.93.4.411; JOANNA S, 2002, MOVEMENT DISORD, V17, P1077; KARNI A, 1991, P NATL ACAD SCI USA, V88, P4966, DOI 10.1073/pnas.88.11.4966; KNEHR CA, 1956, J NERV MENT DIS, V124, P251, DOI 10.1097/00005053-195609000-00005; Law CT, 2008, NAT NEUROSCI, V11, P505, DOI 10.1038/nn2070; Li XR, 2003, J NEUROSCI METH, V130, P9, DOI 10.1016/S0165-0270(03)00174-2; Lu ZL, 2008, PSYCHOL REV, V115, P44, DOI 10.1037/0033-295X.115.1.44; Lu ZL, 2006, VISION RES, V46, P2315, DOI 10.1016/j.visres.2006.01.012; Lu ZL, 2010, VISION RES, V50, P375, DOI 10.1016/j.visres.2009.08.027; Lu Zhong-Lin, 2009, Learn Percept, V1, P19; Lu ZL, 1999, J OPT SOC AM A, V16, P764, DOI 10.1364/JOSAA.16.000764; Lu ZL, 1998, VISION RES, V38, P1183, DOI 10.1016/S0042-6989(97)00273-3; Maddox WT, 2004, BEHAV PROCESS, V66, P309, DOI 10.1016/j.beproc.2004.03.011; MCKEE SP, 1978, PERCEPT PSYCHOPHYS, V24, P258, DOI 10.3758/BF03206097; NOSOFSKY RM, 1984, J EXP PSYCHOL LEARN, V10, P104, DOI 10.1037/0278-7393.10.1.104; Petrov AA, 2005, PSYCHOL REV, V112, P715, DOI 10.1037/0033-295X.112.4.715; POGGIO T, 1992, SCIENCE, V256, P1018, DOI 10.1126/science.1589770; Poldrack RA, 1999, NEUROPSYCHOLOGY, V13, P564, DOI 10.1037/0894-4105.13.4.564; POSNER MI, 1968, J EXP PSYCHOL, V77, P353, DOI 10.1037/h0025953; RAMACHANDRAN VS, 1973, PERCEPTION, V2, P371, DOI 10.1068/p020371; Reber PJ, 1998, P NATL ACAD SCI USA, V95, P747, DOI 10.1073/pnas.95.2.747; REBER PJ, 1994, LEARN MEMORY, V1, P217; RECANZONE GH, 1993, J NEUROSCI, V13, P87; SAGI D, 1994, CURR OPIN NEUROBIOL, V4, P195, DOI 10.1016/0959-4388(94)90072-8; Schacter D., 2000, OXFORD HDB MEMORY; Schoups A, 2001, NATURE, V412, P549, DOI 10.1038/35087601; Smith EE, 1981, CATEGORIES CONCEPTS; Sperling AJ, 2005, NAT NEUROSCI, V8, P862, DOI 10.1038/nn1474; Sperling AJ, 2004, ANN DYSLEXIA, V54, P281, DOI 10.1007/s11881-004-0014-z; Sperling AJ, 2006, PSYCHOL SCI, V17, P1047, DOI 10.1111/j.1467-9280.2006.01825.x; Squire L.R., 2002, NEUROPSYCHOLOGY MEMO; STAROSTARUBINSTEIN S, 1987, ARCH NEUROL-CHICAGO, V44, P365, DOI 10.1001/archneur.1987.00520160007005; WALSHE JM, 1986, WILSON DIS, P223; Wilson SAK, 1911, BRAIN, V34, P295; Yang TM, 2004, J NEUROSCI, V24, P1617, DOI 10.1523/JNEUROSCI.4442-03.2004	57	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2010	5	3							e9635	10.1371/journal.pone.0009635	http://dx.doi.org/10.1371/journal.pone.0009635			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	565XE	20224790	Green Published, gold			2022-12-25	WOS:000275328800029
J	Kedar, VP; Darby, MK; Williams, JG; Blackshear, PJ				Kedar, Vishram P.; Darby, Martyn K.; Williams, Jason G.; Blackshear, Perry J.			Phosphorylation of Human Tristetraprolin in Response to Its Interaction with the CbI Interacting Protein CIN85	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; MESSENGER-RNA DECAY; ZINC-FINGER PROTEINS; GROWTH-FACTOR RECEPTORS; MAP KINASE PATHWAY; AU-RICH ELEMENTS; DOWN-REGULATION; TRANSCRIPTION FACTOR; DEFICIENCY SYNDROME; SIGNALING PATHWAY	Background: Tristetraprolin (TTP) is the prototype member of a family of CCCH tandem zinc finger proteins and is considered to be an anti-inflammatory protein in mammals. TTP plays a critical role in the decay of tumor necrosis factor alpha (TNF) mRNA, among others, by binding AU-rich RNA elements in the 3'-untranslated regions of this transcript and promoting its deadenylation and degradation. Methodology/Principal Findings: We used yeast two-hybrid analysis to identify potential protein binding partners for human TTP (hTTP). Various regions of hTTP recovered 31 proteins that fell into 12 categories based on sequence similarities. Among these, the interactions between hTTP and CIN85, cytoplasmic poly (A) binding protein (PABP), nucleolin and heat shock protein 70 were confirmed by co-immunoprecipitation experiments. CIN85 and hTTP co-localized in the cytoplasm of cells as determined by confocal microscopy. CIN85 contains three SH3 domains that specifically bind a unique proline-arginine motif (PXXXPR) found in several CIN85 effectors. We found that the SH3 domains of CIN85 bound to a PXXXPR motif located near the C-terminus of hTTP. Co-expression of CIN85 with hTTP resulted in the increased phosphorylation of hTTP at serine residues in positions 66 and 93, possibly due in part to the demonstrated association of mitogen-activated protein kinase kinase kinase 4 (MEKK4) to both proteins. The presence of CIN85 did not appear to alter hTTP's binding to RNA probes or its stimulated breakdown of TNF mRNA. Conclusions/Significance: These studies describe interactions between hTTP and nucleolin, cytoplasmic PABP, heat shock protein 70 and CIN85; these interactions were initially discovered by two-hybrid analysis, and confirmed by coimmunoprecipitation. We found that CIN85 binding to a C-terminal motif within hTTP led to the increased phosphorylation of hTTP, possibly through enhanced association with MEKK4. The functional consequences to each of the members of this putative complex remain to be determined.	[Kedar, Vishram P.; Darby, Martyn K.; Blackshear, Perry J.] Natl Inst Environm Hlth Sci, Lab Signal Transduct, Res Triangle Pk, NC USA; [Williams, Jason G.] Natl Inst Environm Hlth Sci, Prot Microcharacterizat Core Facil, Res Triangle Pk, NC USA; [Blackshear, Perry J.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Blackshear, Perry J.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Duke University; Duke University	Kedar, VP (corresponding author), Natl Inst Environm Hlth Sci, Lab Signal Transduct, Res Triangle Pk, NC USA.	black009@niehs.nih.gov	Blackshear, Perry J./C-6206-2019	Blackshear, Perry J./0000-0002-9561-8529	NIH; NIEHS; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZICES102488, ZIAES090080] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This project was entirely supported by the Intramural Research Program of the NIH, NIEHS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abell AN, 2005, J BIOL CHEM, V280, P35793, DOI 10.1074/jbc.C500260200; Afonina E, 1998, J BIOL CHEM, V273, P13015, DOI 10.1074/jbc.273.21.13015; Aissouni Y, 2005, BIOCHEM BIOPH RES CO, V338, P808, DOI 10.1016/j.bbrc.2005.10.032; BECKMANN RP, 1990, SCIENCE, V248, P850, DOI 10.1126/science.2188360; Bettinger BT, 2007, J CELL BIOCHEM, V101, P34, DOI 10.1002/jcb.21289; Blackshear PJ, 2002, BIOCHEM SOC T, V30, P945, DOI 10.1042/BST0300945; Blackshear PJ, 2005, BIOL REPROD, V73, P297, DOI 10.1095/biolreprod.105.040527; Blackshear PJ, 2003, J BIOL CHEM, V278, P19947, DOI 10.1074/jbc.M301290200; Brewer BY, 2004, J BIOL CHEM, V279, P27870, DOI 10.1074/jbc.M402551200; Cao H, 2007, EXPERT REV PROTEOMIC, V4, P711, DOI 10.1586/14789450.4.6.711; Cao HP, 2006, BIOCHEM J, V394, P285, DOI 10.1042/BJ20051316; Cao HP, 2004, BIOCHEMISTRY-US, V43, P13724, DOI 10.1021/bi049014y; Cao HP, 2003, ARCH BIOCHEM BIOPHYS, V412, P106, DOI 10.1016/S0003-9861(03)00012-2; Carballo E, 1997, J CLIN INVEST, V100, P986, DOI 10.1172/JCI119649; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Carballo E, 2001, J BIOL CHEM, V276, P42580, DOI 10.1074/jbc.M104953200; Carballo E, 2001, BLOOD, V98, P2389, DOI 10.1182/blood.V98.8.2389; Carman JA, 2004, BIOCHEM BIOPH RES CO, V315, P445, DOI 10.1016/j.bbrc.2004.01.080; Chrestensen CA, 2004, J BIOL CHEM, V279, P10176, DOI 10.1074/jbc.M310486200; DeGrado-Warren J, 2008, BIOTECHNIQUES, V44, P265, DOI 10.2144/000112674; Dikic I, 2002, FEBS LETT, V529, P110, DOI 10.1016/S0014-5793(02)03188-5; Dikic I, 2003, CURR OPIN CELL BIOL, V15, P128, DOI 10.1016/S0955-0674(03)00004-8; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; FREDERICK ED, 2008, J BIOL CHEM; Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2; Gerwins P, 1997, J BIOL CHEM, V272, P8288, DOI 10.1074/jbc.272.13.8288; Ginisty H, 1999, J CELL SCI, V112, P761; Goldstrohm AC, 2008, NAT REV MOL CELL BIO, V9, P337, DOI 10.1038/nrm2370; GOMPERTS M, 1990, ONCOGENE, V5, P1081; Gout I, 2000, EMBO J, V19, P4015, DOI 10.1093/emboj/19.15.4015; Horner TJ, 2009, MOL CELL BIOL, V29, P1999, DOI 10.1128/MCB.00982-08; Jing Q, 2005, CELL, V120, P623, DOI 10.1016/j.cell.2004.12.038; Johnson BA, 2002, J BIOL CHEM, V277, P18029, DOI 10.1074/jbc.M110465200; Kirsch KH, 2001, J BIOL CHEM, V276, P4957, DOI 10.1074/jbc.M005784200; KOLODZIEJ PA, 1991, METHOD ENZYMOL, V194, P508; Kowanetz K, 2004, MOL BIOL CELL, V15, P3155, DOI 10.1091/mbc.E03-09-0683; Kowanetz K, 2003, J BIOL CHEM, V278, P39735, DOI 10.1074/jbc.M304541200; Kuhn U, 2004, BBA-GENE STRUCT EXPR, V1678, P67, DOI 10.1016/j.bbaexp.2004.03.008; Lai WS, 2006, MOL CELL BIOL, V26, P9196, DOI 10.1128/MCB.00945-06; Lai WS, 2001, J BIOL CHEM, V276, P23144, DOI 10.1074/jbc.M100680200; Lai WS, 2003, MOL CELL BIOL, V23, P3798, DOI 10.1128/MCB.23.11.3798-3812.2003; Lai WS, 2005, J BIOL CHEM, V280, P34365, DOI 10.1074/jbc.M506757200; LAI WS, 1995, J BIOL CHEM, V270, P25266, DOI 10.1074/jbc.270.42.25266; LAI WS, 1990, J BIOL CHEM, V265, P16556; Lai WS, 1999, MOL CELL BIOL, V19, P4311; Laroia G, 1999, SCIENCE, V284, P499, DOI 10.1126/science.284.5413.499; Laroia G, 2002, P NATL ACAD SCI USA, V99, P1842, DOI 10.1073/pnas.042575699; LISCHWE MA, 1981, EXP CELL RES, V136, P101, DOI 10.1016/0014-4827(81)90041-0; Lykke-Andersen J, 2005, GENE DEV, V19, P351, DOI 10.1101/gad.1282305; Mahtani KR, 2001, MOL CELL BIOL, V21, P6461, DOI 10.1128/MCB.21.9.6461-6469.2001; Marchler-Bauer A, 2007, NUCLEIC ACIDS RES, V35, pD237, DOI 10.1093/nar/gkl951; Marcotrigiano J, 2001, MOL CELL, V7, P193, DOI 10.1016/S1097-2765(01)00167-8; Ming XF, 1998, EMBO J, V17, P6039, DOI 10.1093/emboj/17.20.6039; Ming XF, 2001, MOL CELL BIOL, V21, P5778, DOI 10.1128/MCB.21.17.5778-5789.2001; Murata T, 2002, BIOCHEM BIOPH RES CO, V293, P1242, DOI 10.1016/S0006-291X(02)00363-7; Narita T, 2005, EXP CELL RES, V304, P256, DOI 10.1016/j.yexcr.2004.11.005; Neininger A, 2002, J BIOL CHEM, V277, P3065, DOI 10.1074/jbc.C100685200; Ogilvie RL, 2005, J IMMUNOL, V174, P953, DOI 10.4049/jimmunol.174.2.953; Petrelli A, 2002, NATURE, V416, P187, DOI 10.1038/416187a; Phillips RS, 2002, J BIOL CHEM, V277, P11606, DOI 10.1074/jbc.M111457200; Reed R, 2003, CURR OPIN CELL BIOL, V15, P326, DOI 10.1016/S0955-0674(03)00048-6; Soubeyran P, 2002, NATURE, V416, P183, DOI 10.1038/416183a; Steen H, 2005, P NATL ACAD SCI USA, V102, P3948, DOI 10.1073/pnas.0409536102; Stoecklin G, 2004, EMBO J, V23, P1313, DOI 10.1038/sj.emboj.7600163; Sun L, 2007, J BIOL CHEM, V282, P3766, DOI 10.1074/jbc.M607347200; Szymkiewicz I, 2002, J BIOL CHEM, V277, P39666, DOI 10.1074/jbc.M205535200; Take H, 2000, BIOCHEM BIOPH RES CO, V268, P321, DOI 10.1006/bbrc.2000.2147; TAYLOR GA, 1995, J BIOL CHEM, V270, P13341, DOI 10.1074/jbc.270.22.13341; Taylor GA, 1996, MOL ENDOCRINOL, V10, P140, DOI 10.1210/me.10.2.140; Vabulas RM, 2002, J BIOL CHEM, V277, P15107, DOI 10.1074/jbc.M111204200; Vabulas RM, 2001, J BIOL CHEM, V276, P31332, DOI 10.1074/jbc.M103217200; VARNUM BC, 1991, MOL CELL BIOL, V11, P1754, DOI 10.1128/MCB.11.3.1754; Wilusz CJ, 2001, NAT REV MOL CELL BIO, V2, P237, DOI 10.1038/35067025; Winzen R, 1999, EMBO J, V18, P4969, DOI 10.1093/emboj/18.18.4969; Worthington MT, 2002, J BIOL CHEM, V277, P48558, DOI 10.1074/jbc.M206505200; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492; Zheng DH, 2008, J CELL BIOL, V182, P89, DOI 10.1083/jcb.200801196; ZUBIAGA AM, 1995, MOL CELL BIOL, V15, P2219	78	20	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2010	5	3					A213	A227	e9588	10.1371/journal.pone.0009588	http://dx.doi.org/10.1371/journal.pone.0009588			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565WZ	20221403	Green Published, Green Submitted, gold			2022-12-25	WOS:000275328200020
J	Morita, M; Morokami, S; Morita, H				Morita, Masahiko; Morokami, Shigemitsu; Morita, Hiromi			Attribute Pair-Based Visual Recognition and Memory	PLOS ONE			English	Article							SHORT-TERM-MEMORY; BINDING PROBLEM; FEATURE-INTEGRATION; BINOCULAR-RIVALRY; OBJECT; ATTENTION; HYPOTHESIS; CAPACITY; INFORMATION; NEURONS	Background: In the human visual system, different attributes of an object, such as shape, color, and motion, are processed separately in different areas of the brain. This raises a fundamental question of how are these attributes integrated to produce a unified perception and a specific response. This "binding problem'' is computationally difficult because all attributes are assumed to be bound together to form a single object representation. However, there is no firm evidence to confirm that such representations exist for general objects. Methodology/Principal Findings: Here we propose a paired-attribute model in which cognitive processes are based on multiple representations of paired attributes. In line with the model's prediction, we found that multiattribute stimuli can produce an illusory perception of a multiattribute object arising from erroneous integration of attribute pairs, implying that object recognition is based on parallel perception of paired attributes. Moreover, in a change-detection task, a feature change in a single attribute frequently caused an illusory perception of change in another attribute, suggesting that multiple pairs of attributes are stored in memory. Conclusions/Significance: The paired-attribute model can account for some novel illusions and controversial findings on binocular rivalry and short-term memory. Our results suggest that many cognitive processes are performed at the level of paired attributes rather than integrated objects, which greatly facilitates the binding problem and provides simpler solutions for it.	[Morita, Masahiko] Univ Tsukuba, Grad Sch Syst & Informat Engn, Dept Intelligent Interact Technol, Tsukuba, Ibaraki, Japan; [Morokami, Shigemitsu] Aichi Shukutoku Univ, Fac Letters, Aichi, Japan; [Morita, Hiromi] Univ Tsukuba, Grad Sch Lib Informat & Media Studies, Tsukuba, Ibaraki, Japan	University of Tsukuba; Aichi Shukutoku University; University of Tsukuba	Morita, M (corresponding author), Univ Tsukuba, Grad Sch Syst & Informat Engn, Dept Intelligent Interact Technol, Tsukuba, Ibaraki, Japan.	mor@bcl.esys.tsukuba.ac.jp	Morita, Masahiko/R-6324-2019	Morita, Hiromi/0000-0003-4571-7315	Japan Society for the Promotion of Science [19650059]; Ministry of Education, Culture, Sports, Science and Technology of Japan [21013007]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid for Scientific Research for Challenging Exploratory Research (19650059) from the Japan Society for the Promotion of Science and a Grant-in-Aid for Scientific Research on Priority Areas (21013007) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez GA, 2004, PSYCHOL SCI, V15, P106, DOI 10.1111/j.0963-7214.2004.01502006.x; Blake R, 2002, NAT REV NEUROSCI, V3, P13, DOI 10.1038/nrn701; Blaser E, 2000, NATURE, V408, P196, DOI 10.1038/35041567; Bonneh Y, 2001, VISION RES, V41, P981, DOI 10.1016/S0042-6989(01)00013-X; Davis G, 2005, MEM COGNITION, V33, P185, DOI 10.3758/BF03195307; Holcombe AO, 2001, NAT NEUROSCI, V4, P127, DOI 10.1038/83945; HOPFIELD JJ, 1984, P NATL ACAD SCI-BIOL, V81, P3088, DOI 10.1073/pnas.81.10.3088; KAHNEMAN D, 1992, COGNITIVE PSYCHOL, V24, P175, DOI 10.1016/0010-0285(92)90007-O; Kanwisher N, 2000, NAT REV NEUROSCI, V1, P91, DOI 10.1038/35039043; Lee SH, 1999, VISION RES, V39, P1447, DOI 10.1016/S0042-6989(98)00269-7; Logothetis NK, 1996, NATURE, V380, P621, DOI 10.1038/380621a0; Luck SJ, 1997, NATURE, V390, P279, DOI 10.1038/36846; MCLEAN JP, 1983, Q J EXP PSYCHOL-A, V35, P171, DOI 10.1080/14640748308402123; Mitchell JF, 2004, NATURE, V429, P410, DOI 10.1038/nature02584; Naya Y, 1996, P NATL ACAD SCI USA, V93, P2664, DOI 10.1073/pnas.93.7.2664; O'Craven KM, 1999, NATURE, V401, P584, DOI 10.1038/44134; Olson IR, 2002, PERCEPT PSYCHOPHYS, V64, P1055, DOI 10.3758/BF03194756; Reynolds JH, 1999, NEURON, V24, P19, DOI 10.1016/S0896-6273(00)80819-3; Shadlen MN, 1999, NEURON, V24, P67, DOI 10.1016/S0896-6273(00)80822-3; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.ne.18.030195.003011; SUEMITSU A, 2006, P IJCNN 06, P293; Treisman A, 1996, CURR OPIN NEUROBIOL, V6, P171, DOI 10.1016/S0959-4388(96)80070-5; Treisman A, 1999, NEURON, V24, P105, DOI 10.1016/S0896-6273(00)80826-0; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; von der Malsburg C., 1994, MODELS NEURAL NETWOR, P95, DOI [DOI 10.1007/978-1-4612-4320-5_2, 10.1007/978-1-4612-4320-5_2]; WOLFE JM, 1989, J EXP PSYCHOL HUMAN, V15, P419, DOI 10.1037/0096-1523.15.3.419; Wolfe JM, 1999, NEURON, V24, P11, DOI 10.1016/S0896-6273(00)80818-1	27	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2010	5	3							e9571	10.1371/journal.pone.0009571	http://dx.doi.org/10.1371/journal.pone.0009571			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	564EX	20221425	Green Published, gold			2022-12-25	WOS:000275197200017
J	Mengshol, JA; Golden-Mason, L; Arikawa, T; Smith, M; Niki, T; McWilliams, R; Randall, JA; McMahan, R; Zimmerman, MA; Rangachari, M; Dobrinskikh, E; Busson, P; Polyak, SJ; Hirashima, M; Rosen, HR				Mengshol, John A.; Golden-Mason, Lucy; Arikawa, Tomohiro; Smith, Maxwell; Niki, Toshiro; McWilliams, Ryan; Randall, Jessica A.; McMahan, Rachel; Zimmerman, Michael A.; Rangachari, Manu; Dobrinskikh, Evgenia; Busson, Pierre; Polyak, Stephen J.; Hirashima, Mitsuomi; Rosen, Hugo R.			A Crucial Role for Kupffer Cell-Derived Galectin-9 in Regulation of T Cell Immunity in Hepatitis C Infection	PLOS ONE			English	Article							VIRUS-INFECTION; LIVER-INJURY; HEPATOCELLULAR-CARCINOMA; GLYCAN INTERACTIONS; CD127 EXPRESSION; HCV INFECTION; LYMPHOCYTES; TOLERANCE; TIM-3; APOPTOSIS	Approximately 200 million people throughout the world are infected with hepatitis C virus (HCV). One of the most striking features of HCV infection is its high propensity to establish persistence (similar to 70-80%) and progressive liver injury. Galectins are evolutionarily conserved glycan-binding proteins with diverse roles in innate and adaptive immune responses. Here, we demonstrate that galectin-9, the natural ligand for the T cell immunoglobulin domain and mucin domain protein 3 (Tim-3), circulates at very high levels in the serum and its hepatic expression (particularly on Kupffer cells) is significantly increased in patients with chronic HCV as compared to normal controls. Galectin-9 production from monocytes and macrophages is induced by IFN-gamma, which has been shown to be elevated in chronic HCV infection. In turn, galectin-9 induces proinflammatory cytokines in liver-derived and peripheral mononuclear cells; galectin-9 also induces anti-inflammatory cytokines from peripheral but not hepatic mononuclear cells. Galectin-9 results in expansion of CD4(+) CD25(+) FoxP3(+) CD127(low) regulatory T cells, contraction of CD4+ effector T cells, and apoptosis of HCV-specific CTLs. In conclusion, galectin-9 production by Kupffer cells links the innate and adaptive immune response, providing a potential novel immunotherapeutic target in this common viral infection.	[Mengshol, John A.; Golden-Mason, Lucy; McWilliams, Ryan; Randall, Jessica A.; McMahan, Rachel; Dobrinskikh, Evgenia; Rosen, Hugo R.] Univ Colorado, Sch Med, Dept Med, Div Gastroenterol & Hepatol, Aurora, CO USA; [Mengshol, John A.; Rosen, Hugo R.] Denver Vet Affairs Med Ctr, Denver, CO USA; [Golden-Mason, Lucy; Rosen, Hugo R.] Univ Colorado, Sch Med, Div Clin Immunol, Denver, CO USA; [Golden-Mason, Lucy; Rosen, Hugo R.] Natl Jewish Hosp, Denver, CO USA; [Smith, Maxwell] Univ Colorado, Sch Med, Dept Pathol, Denver, CO 80262 USA; [Arikawa, Tomohiro; Hirashima, Mitsuomi] Kagawa Med Univ, Dept Immunol & Immunopathol, Kagawa, Japan; [Niki, Toshiro] GalPharma, Kagawa, Japan; [Zimmerman, Michael A.] Univ Colorado, Sch Med, Div Transplant Surg, Aurora, CO USA; [Rangachari, Manu] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA; [Busson, Pierre] Inst Cancerol Gustave Roussy, Villejuif, France; [Polyak, Stephen J.] Univ Washington, Div Lab Med, Seattle, WA 98195 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Kagawa University; University of Colorado System; University of Colorado Anschutz Medical Campus; Harvard University; Brigham & Women's Hospital; Harvard Medical School; UNICANCER; Gustave Roussy; University of Washington; University of Washington Seattle	Mengshol, JA (corresponding author), Univ Colorado, Sch Med, Dept Med, Div Gastroenterol & Hepatol, Aurora, CO USA.	Hugo.Rosen@ucdenver.edu	Mengshol, John/ABG-2751-2021; Polyak, Stephen/B-5743-2011	Golden-Mason, Lucy/0000-0002-2087-4405; Golden-Mason, Lucy/0000-0003-3347-4192; Busson, Pierre/0000-0003-1027-3400	National Institutes of Health (NIH) [RO1 DK060590, U19 A 1066328-01]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060590] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research is supported by National Institutes of Health (NIH) grants RO1 DK060590 and U19 A 1066328-01 (HCV center grant) to HRR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Dr Niki from Galpharma provided antibodies.	Anderson AC, 2007, SCIENCE, V318, P1141, DOI 10.1126/science.1148536; Anderson AC, 2006, CURR OPIN IMMUNOL, V18, P665, DOI 10.1016/j.coi.2006.09.009; Andersson J, 2008, J EXP MED, V205, P1975, DOI 10.1084/jem.20080308; Cabrera R, 2004, HEPATOLOGY, V40, P1062, DOI 10.1002/hep.20454; Calne RY, 2000, IMMUNOL REV, V174, P280, DOI 10.1034/j.1600-0528.2002.017419.x; Chagan-Yasutan H, 2009, TOHOKU J EXP MED, V218, P285, DOI 10.1620/tjem.218.285; Dai SY, 2005, J IMMUNOL, V175, P2974, DOI 10.4049/jimmunol.175.5.2974; Dolganiuc A, 2007, GASTROENTEROLOGY, V133, P1627, DOI 10.1053/j.gastro.2007.08.003; Franceschini D, 2009, J CLIN INVEST, V119, P551, DOI 10.1172/JCI36604; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Fu JL, 2007, GASTROENTEROLOGY, V132, P2328, DOI 10.1053/j.gastro.2007.03.102; Golden-Mason L, 2007, J VIROL, V81, P9249, DOI 10.1128/JVI.00409-07; Golden-Mason L, 2009, J VIROL, V83, P9122, DOI 10.1128/JVI.00639-09; Hirofumi A, 2002, J IMMUNOL, V169, P5912, DOI 10.4049/jimmunol.169.10.5912; Imaizumi T, 2002, J LEUKOCYTE BIOL, V72, P486; Kashio Y, 2003, J IMMUNOL, V170, P3631, DOI 10.4049/jimmunol.170.7.3631; Keating R, 2007, J IMMUNOL, V178, P2737, DOI 10.4049/jimmunol.178.5.2737; Kim WR, 2002, HEPATOLOGY, V36, P227, DOI 10.1053/jhep.2002.34734; Klibi J, 2009, BLOOD, V113, P1957, DOI 10.1182/blood-2008-02-142596; KNOLLE P, 1995, J HEPATOL, V22, P226, DOI 10.1016/0168-8278(95)80433-1; Krammer PH, 2007, NAT REV IMMUNOL, V7, P532, DOI 10.1038/nri2115; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Mengshol JA, 2007, NAT CLIN PRACT GASTR, V4, P622, DOI 10.1038/ncpgasthep0961; Napoli J, 1996, HEPATOLOGY, V24, P759; Neuman MG, 2002, CYTOKINE, V17, P108, DOI 10.1006/cyto.2001.0997; O'Garra A, 2004, NAT MED, V10, P801, DOI 10.1038/nm0804-801; Rabinovich GA, 2009, NAT REV IMMUNOL, V9, P338, DOI 10.1038/nri2536; Racanelli V, 2007, CLIN IMMUNOL, V124, P5, DOI 10.1016/j.clim.2007.04.009; Radziewicz H, 2008, J VIROL, V82, P9808, DOI 10.1128/JVI.01075-08; Radziewicz H, 2007, J VIROL, V81, P2545, DOI 10.1128/JVI.02021-06; Rehermann B, 1999, J VIRAL HEPATITIS, V6, P31, DOI 10.1046/j.1365-2893.1999.00008.x; Rosen HR, 2008, GASTROENTEROLOGY, V134, P1789, DOI 10.1053/j.gastro.2008.02.062; Sato M, 2002, GLYCOBIOLOGY, V12, P191, DOI 10.1093/glycob/12.3.191; Seki M, 2008, CLIN IMMUNOL, V127, P78, DOI 10.1016/j.clim.2008.01.006; Seki M, 2007, ARTHRITIS RHEUM-US, V56, P3968, DOI 10.1002/art.23076; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Smyk-Pearson S, 2008, J INFECT DIS, V197, P46, DOI 10.1086/523651; Tang QZ, 2008, NAT IMMUNOL, V9, P239, DOI 10.1038/ni1572; Tu Z, 2007, CLIN EXP IMMUNOL, V149, P186, DOI 10.1111/j.1365-2249.2007.03415.x; Tu Z, 2008, J EXP MED, V205, P233, DOI 10.1084/jem.20072195; Unitt E, 2005, HEPATOLOGY, V41, P722, DOI 10.1002/hep.20644; van Kooyk Y, 2008, NAT IMMUNOL, V9, P593, DOI 10.1038/ni.f.203; Vollmar B, 2009, PHYSIOL REV, V89, P1269, DOI 10.1152/physrev.00027.2008; Wada J, 1997, J BIOL CHEM, V272, P6078, DOI 10.1074/jbc.272.9.6078; Wang CC, 2007, J INFECT DIS, V196, P1474, DOI 10.1086/522608; Wang F, 2008, BIOINTERPHASES, V3, P9, DOI 10.1116/1.2840054; Wang F, 2009, IMMUNOBIOLOGY, V214, P342, DOI 10.1016/j.imbio.2008.10.007; Yoshida H, 2001, NEUROREPORT, V12, P3755, DOI 10.1097/00001756-200112040-00030; Zhang JL, 2009, COMPUT OPER RES, V36, P823, DOI 10.1016/j.cor.2007.11.001; Zhu C, 2005, NAT IMMUNOL, V6, P1245, DOI 10.1038/ni1271; 2004, WKLY EPIDEMIOL REC, V79, P314	52	148	157	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2010	5	3							e9504	10.1371/journal.pone.0009504	http://dx.doi.org/10.1371/journal.pone.0009504			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	564EW	20209097	Green Submitted, Green Published, gold			2022-12-25	WOS:000275197100005
J	Silvestre, DC; Gil, GA; Tomasini, N; Bussolino, DF; Caputto, BL				Silvestre, David C.; Gil, German A.; Tomasini, Nicolas; Bussolino, Daniela F.; Caputto, Beatriz L.			Growth of Peripheral and Central Nervous System Tumors Is Supported by Cytoplasmic c-Fos in Humans and Mice	PLOS ONE			English	Article							PHOSPHOLIPID-SYNTHESIS; ENDOPLASMIC-RETICULUM; PC12 CELLS; NEUROFIBROMATOSIS 1; MOUSE MODELS; GENE; LIGHT; NF1; COMPLEX; RETINA	Background: We have previously shown that the transcription factor c-Fos is also capable of associating to endoplasmic reticulum membranes (ER) and activating phospholipid synthesis. Herein we examined phospholipid synthesis status in brain tumors from human patients and from NPcis mice, an animal model of the human disease Neurofibromatosis Type 1 (NF1). Principal Findings: In human samples, c-Fos expression was at the limit of detection in non-pathological specimens, but was abundantly expressed associated to ER membranes in tumor cells. This was also observed in CNS of adult tumor-bearing NPcis mice but not in NPcis fos(-/-) KO mice. A glioblastoma multiforme and a malignant PNS tumor from a NF1 patient (MPNST) showed a 2-and 4-fold c-Fos-dependent phospholipid synthesis activation, respectively. MPNST samples also showed increased cell proliferation rates and abundant c-Fos expression. Conclusions: Results highlight a role of cytoplasmic c-Fos as an activator of phospholipid synthesis in events demanding high rates of membrane biogenesis as occurs for the exacerbated growth of tumors cells. They also disclose this protein as a potential target for controlling tumor growth in the nervous system.	[Silvestre, David C.; Gil, German A.; Tomasini, Nicolas; Bussolino, Daniela F.; Caputto, Beatriz L.] Univ Nacl Cordoba, CIQUIBIC, Fac Ciencias Quim, Dept Quim Biol, RA-5000 Cordoba, Argentina	National University of Cordoba	Silvestre, DC (corresponding author), CEA, DSV iRCM SCSR, Lab RadioPathol, Fontenay Aux Roses, France.	bcaputto@dqb.fcq.unc.edu.ar	GIL, GERMAN A./T-3018-2019	GIL, GERMAN A./0000-0001-6714-2693	James S. McDonnell Foundation, Argentina; Ministerio de Ciencia, Tecnologia e Innovacion Productiva (FONCyT and CONICET), Argentina; SeCyT, Argentina; Universidad Nacional de Cordoba, Argentina	James S. McDonnell Foundation, Argentina; Ministerio de Ciencia, Tecnologia e Innovacion Productiva (FONCyT and CONICET), Argentina; SeCyT, Argentina(Secretaria de Ciencia y Tecnologia (SECYT)); Universidad Nacional de Cordoba, Argentina	This work was supported by the James S. McDonnell Foundation (www. jsmf. org), the Ministerio de Ciencia, Tecnologia e Innovacion Productiva (FONCyT and CONICET) (www. agencia. gov. ar and www. conicet. gov. ar) and SeCyT, Universidad Nacional de Cordoba, Argentina (www. secyt. unc. edu. ar). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; Borioli GA, 2001, BIOCHEM BIOPH RES CO, V280, P9, DOI 10.1006/bbrc.2000.4081; Bussolino DF, 2001, FASEB J, V15, P556; Bussolino DF, 1998, MOL BRAIN RES, V58, P10, DOI 10.1016/S0169-328X(98)00065-5; CAMMER W, 1989, GLIA, V2, P223, DOI 10.1002/glia.440020403; Caputto BL, 2000, NEUROCHEM RES, V25, P153, DOI 10.1023/A:1007508020173; Chipuk JE, 2003, CANCER CELL, V4, P371, DOI 10.1016/S1535-6108(03)00272-1; Cichowski K, 2001, CELL, V104, P593, DOI 10.1016/S0092-8674(01)00245-8; Cichowski K, 1999, SCIENCE, V286, P2172, DOI 10.1126/science.286.5447.2172; Costa RM, 2003, TRENDS MOL MED, V9, P19, DOI 10.1016/S1471-4914(02)00008-4; Crespo PM, 2008, J BIOL CHEM, V283, P31163, DOI 10.1074/jbc.M709257200; Ferner RE, 2002, CANCER RES, V62, P1573; Fleischmann A, 2000, GENE DEV, V14, P2695, DOI 10.1101/gad.187900; Gil GA, 2004, MOL BIOL CELL, V15, P1881, DOI 10.1091/mbc.e03-09-0705; Green DR, 2009, NATURE, V458, P1127, DOI 10.1038/nature07986; Guha A, 1996, ONCOGENE, V12, P507; GUIDO ME, 1990, J NEUROCHEM, V55, P1855, DOI 10.1111/j.1471-4159.1990.tb05768.x; Guido ME, 1996, J NEUROSCI RES, V43, P93, DOI 10.1002/jnr.490430112; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; JOHNSON RS, 1992, CELL, V71, P577, DOI 10.1016/0092-8674(92)90592-Z; Scerbo MJ, 2009, J NEUROSCI RES, V87, P2273, DOI 10.1002/jnr.22048; KOUZARIDES T, 1989, NATURE, V340, P568, DOI 10.1038/340568a0; Leppa S, 2001, MOL CELL BIOL, V21, P4369, DOI 10.1128/MCB.21.13.4369-4378.2001; Moenner M, 2007, CANCER RES, V67, P10631, DOI 10.1158/0008-5472.CAN-07-1705; MORGAN JI, 1995, TRENDS NEUROSCI, V18, P66; Penner MR, 2002, DEV BRAIN RES, V135, P71, DOI 10.1016/S0165-3806(02)00308-5; Portal MM, 2007, ONCOGENE, V26, P3551, DOI 10.1038/sj.onc.1210137; Rasmussen SA, 2001, AM J HUM GENET, V68, P1110, DOI 10.1086/320121; Reilly KM, 2000, NAT GENET, V26, P109, DOI 10.1038/79075; Serra E, 1997, AM J HUM GENET, V61, P512, DOI 10.1086/515504; Silvestre DC, 2009, J NEUROSCI RES, V87, P857, DOI 10.1002/jnr.21915; SMEYNE RJ, 1992, NEURON, V8, P13, DOI 10.1016/0896-6273(92)90105-M; Wang Z, 2006, TOXICOL APPL PHARM, V214, P263, DOI 10.1016/j.taap.2005.12.014; WANG ZQ, 1992, NATURE, V360, P741, DOI 10.1038/360741a0; Zerpa GAD, 1999, J NEUROCHEM, V73, P1228, DOI 10.1046/j.1471-4159.1999.0731228.x; Zhu Y, 2002, SCIENCE, V296, P920, DOI 10.1126/science.1068452; Zhu YA, 2002, NAT REV CANCER, V2, P616, DOI 10.1038/nrc866	37	20	21	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2010	5	3							e9544	10.1371/journal.pone.0009544	http://dx.doi.org/10.1371/journal.pone.0009544			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	564EW	20209053	Green Published, Green Submitted, gold			2022-12-25	WOS:000275197100023
J	Zi, ZK; Liebermeister, W; Klipp, E				Zi, Zhike; Liebermeister, Wolfram; Klipp, Edda			A Quantitative Study of the Hog1 MAPK Response to Fluctuating Osmotic Stress in Saccharomyces cerevisiae	PLOS ONE			English	Article							PROTEIN-TYROSINE PHOSPHATASES; MARKUP LANGUAGE SBML; YEAST OSMOREGULATION; PARAMETER-ESTIMATION; KINASE; PATHWAY; CELLS; SIZE; ACCUMULATION; ADAPTATION	Background: Yeast cells live in a highly fluctuating environment with respect to temperature, nutrients, and especially osmolarity. The Hog1 mitogen-activated protein kinase (MAPK) pathway is crucial for the adaption of yeast cells to external osmotic changes. Methodology/Principal Findings: To better understand the osmo-adaption mechanism in the budding yeast Saccharomyces cerevisiae, we have developed a mathematical model and quantitatively investigated the Hog1 response to osmotic stress. The model agrees well with various experimental data for the Hog1 response to different types of osmotic changes. Kinetic analyses of the model indicate that budding yeast cells have evolved to protect themselves economically: while they show almost no response to fast pulse-like changes of osmolarity, they respond periodically and are well-adapted to osmotic changes with a certain frequency. To quantify the signal transduction efficiency of the osmo-adaption network, we introduced a measure of the signal response gain, which is defined as the ratio of output change integral to input (signal) change integral. Model simulations indicate that the Hog1 response gain shows bell-shaped response curves with respect to the duration of a single osmotic pulse and to the frequency of periodic square osmotic pulses, while for up-staircase (ramp) osmotic changes, the gain depends on the slope. Conclusions/Significance: The model analyses suggest that budding yeast cells have selectively evolved to be optimized to some specific types of osmotic changes. In addition, our work implies that the signaling output can be dynamically controlled by fine-tuning the signal input profiles.	[Zi, Zhike] Univ Freiburg, Ctr Biol Signalling Studies Bioss, Freiburg, Germany; [Zi, Zhike] Univ Freiburg, Ctr Biol Syst Anal ZBSA, Freiburg, Germany; [Liebermeister, Wolfram; Klipp, Edda] Humboldt Univ, Inst Biol, Berlin, Germany	University of Freiburg; University of Freiburg; Humboldt University of Berlin	Zi, ZK (corresponding author), Univ Freiburg, Ctr Biol Signalling Studies Bioss, Freiburg, Germany.	zhike.zi@bioss.uni-freiburg.de; edda.klipp@rz.hu-berlin.de	Liebermeister, Wolfram/AAC-7326-2020; Zi, Zhike/B-4185-2012; Zi, Zhike/I-2756-2019	Liebermeister, Wolfram/0000-0002-2568-2381; Zi, Zhike/0000-0002-7601-915X	German Federal and State Governments [(EXC 294,]; European Commission [201142]	German Federal and State Governments; European Commission(European CommissionEuropean Commission Joint Research Centre)	This study was supported by the Excellence Initiative of the German Federal and State Governments (EXC 294, Z. Z.) and the European Commission within the seventh Framework Programme, theme 1 Health (UNICELLSYS project, grant agreement no.: 201142, E. K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balsa-Canto E, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-26; Biswas SK, 2003, J ELECTRON MICROSC, V52, P133, DOI 10.1093/jmicro/52.2.133; Elston TC, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.142pe47; Escote X, 2004, NAT CELL BIOL, V6, P997, DOI 10.1038/ncb1174; Ferrigno P, 1998, EMBO J, V17, P5606, DOI 10.1093/emboj/17.19.5606; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Hao N, 2007, CURR BIOL, V17, P659, DOI 10.1016/j.cub.2007.02.044; Hao N, 2008, J BIOL CHEM, V283, P33798, DOI 10.1074/jbc.C800179200; Hersen P, 2008, P NATL ACAD SCI USA, V105, P7165, DOI 10.1073/pnas.0710770105; Hohmann S, 2002, MICROBIOL MOL BIOL R, V66, P300, DOI 10.1128/MMBR.66.2.300-372.2002; Hucka M, 2003, BIOINFORMATICS, V19, P524, DOI 10.1093/bioinformatics/btg015; Jacoby T, 1997, J BIOL CHEM, V272, P17749, DOI 10.1074/jbc.272.28.17749; Jorgensen P, 2002, SCIENCE, V297, P395, DOI 10.1126/science.1070850; Jorgensen P, 2007, MOL BIOL CELL, V18, P3523, DOI 10.1091/mbc.E06-10-0973; Klipp E, 2005, NAT BIOTECHNOL, V23, P975, DOI 10.1038/nbt1114; Krantz M, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.36; Macia J, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000056; Mattison CP, 2000, GENE DEV, V14, P1229; Mettetal JT, 2008, SCIENCE, V319, P482, DOI 10.1126/science.1151582; Muzzey D, 2009, CELL, V138, P160, DOI 10.1016/j.cell.2009.04.047; O'Rourke SM, 2002, TRENDS GENET, V18, P405, DOI 10.1016/S0168-9525(02)02723-3; Reiser V, 1999, MOL BIOL CELL, V10, P1147, DOI 10.1091/mbc.10.4.1147; Tamaki H, 2005, GENES CELLS, V10, P193, DOI 10.1111/j.1365-2443.2005.00828.x; Tamas MJ, 1999, MOL MICROBIOL, V31, P1087, DOI 10.1046/j.1365-2958.1999.01248.x; TYSON CB, 1979, J BACTERIOL, V138, P92, DOI 10.1128/JB.138.1.92-98.1979; Westfall PJ, 2008, P NATL ACAD SCI USA, V105, P12212, DOI 10.1073/pnas.0805797105; Westfall PJ, 2004, SCIENCE, V306, P1511, DOI 10.1126/science.1104879; WurglerMurphy SM, 1997, MOL CELL BIOL, V17, P1289, DOI 10.1128/MCB.17.3.1289; Zi Z, 2006, BIOINFORMATICS, V22, P2704, DOI 10.1093/bioinformatics/btl443; Zi ZK, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-342	30	46	47	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2010	5	3							e9522	10.1371/journal.pone.0009522	http://dx.doi.org/10.1371/journal.pone.0009522			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	564EW	20209100	gold, Green Submitted, Green Published			2022-12-25	WOS:000275197100008
J	Tocchetti, A; Soppo, CBE; Zani, F; Bianchi, F; Gagliani, MC; Pozzi, B; Rozman, J; Elvert, R; Ehrhardt, N; Rathkolb, B; Moerth, C; Horsch, M; Fuchs, H; Gailus-Durner, V; Beckers, J; Klingenspor, M; Wolf, E; de Angelis, MH; Scanziani, E; Tacchetti, C; Scita, G; Di Fiore, PP; Offenhauser, N				Tocchetti, Arianna; Soppo, Charlotte Blanche Ekalle; Zani, Fabio; Bianchi, Fabrizio; Gagliani, Maria Cristina; Pozzi, Benedetta; Rozman, Jan; Elvert, Ralf; Ehrhardt, Nicole; Rathkolb, Birgit; Moerth, Corinna; Horsch, Marion; Fuchs, Helmut; Gailus-Durner, Valerie; Beckers, Johannes; Klingenspor, Martin; Wolf, Eckhard; de Angelis, Martin Hrabe; Scanziani, Eugenio; Tacchetti, Carlo; Scita, Giorgio; Di Fiore, Pier Paolo; Offenhaeuser, Nina			Loss of the Actin Remodeler Eps8 Causes Intestinal Defects and Improved Metabolic Status in Mice	PLOS ONE			English	Article							MECHANISMS LINKING OBESITY; ADIPOSE-TISSUE; MICROARRAY DATA; CARDIOVASCULAR-DISEASE; CALORIE RESTRICTION; DIETARY RESTRICTION; BODY-TEMPERATURE; INSULIN-RECEPTOR; BRUSH-BORDER; LIFE-SPAN	Background: In a variety of organisms, including mammals, caloric restriction improves metabolic status and lowers the incidence of chronic-degenerative diseases, ultimately leading to increased lifespan. Methodology/Principal Findings: Here we show that knockout mice for Eps8, a regulator of actin dynamics, display reduced body weight, partial resistance to age-or diet-induced obesity, and overall improved metabolic status. Alteration in the liver gene expression profile, in behavior and metabolism point to a calorie restriction-like phenotype in Eps8 knockout mice. Additionally, and consistent with a calorie restricted metabolism, Eps8 knockout mice show increased lifespan. The metabolic alterations in Eps8 knockout mice correlated with a significant reduction in intestinal fat absorption presumably caused by a 25% reduction in intestinal microvilli length. Conclusions/Significance: Our findings implicate actin dynamics as a novel variable in the determination of longevity. Additionally, our observations suggest that subtle differences in energy balance can, over time, significantly affect bodyweight and metabolic status in mice.	[Tocchetti, Arianna; Soppo, Charlotte Blanche Ekalle; Zani, Fabio; Bianchi, Fabrizio; Gagliani, Maria Cristina; Pozzi, Benedetta; Tacchetti, Carlo; Scita, Giorgio; Di Fiore, Pier Paolo; Offenhaeuser, Nina] Fdn Inst FIRC Oncol Mol, Milan, Italy; [Bianchi, Fabrizio; Scita, Giorgio; Di Fiore, Pier Paolo] Univ Milan, Dipartimento Med Chirurg Odontoiatria, Milan, Italy; [Gagliani, Maria Cristina; Tacchetti, Carlo] Univ Genoa, Dept Expt Med, Genoa, Italy; [Rozman, Jan; Elvert, Ralf; Ehrhardt, Nicole; Rathkolb, Birgit; Moerth, Corinna; Horsch, Marion; Fuchs, Helmut; Gailus-Durner, Valerie; Beckers, Johannes; de Angelis, Martin Hrabe] Helmholtz Zentrum Munchen, German Mouse Clin, Munich, Germany; [Beckers, Johannes; de Angelis, Martin Hrabe] Tech Univ Munich, Lehrstuhl Expt Genet, D-8050 Freising Weihenstephan, Germany; [Rathkolb, Birgit; Moerth, Corinna; Wolf, Eckhard] Univ Munich, Inst Mol Anim Breeding & Biotechnol, Munich, Germany; [Scanziani, Eugenio] Univ Milan, Fac Med Vet, Milan, Italy; [Di Fiore, Pier Paolo] Ist Europeo Oncol, Milan, Italy	IFOM - FIRC Institute of Molecular Oncology; University of Milan; University of Genoa; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; University of Munich; University of Milan; IRCCS European Institute of Oncology (IEO)	Tocchetti, A (corresponding author), KtedoGen Srl, Milan, Italy.	pierpaolo.difiore@ifom-ieo-campus.it; nina.offenhauser@ifom-ieo-campus.it	Rathkolb, Birgit/F-7041-2013; Gailus-Durner, Valerie/M-7337-2014; Di Fiore, Pier Paolo/K-2130-2012; Bianchi, Fabrizio/B-5995-2017; Beckers, Johannes/K-7237-2012; Klingenspor, Martin/K-5033-2019; Soppo, Charlotte Blanche Ekalle/ABI-1362-2020; Klingenspor, Martin/D-6930-2011; Scita, Giorgio/J-9670-2012; Bianchi, Fabrizio/W-7037-2019; Rozman, Jan/A-2540-2010; Fuchs, Helmut/M-7347-2014; de Angelis, Martin Hrabe/F-5531-2012; Scanziani, Eugenio/G-8046-2017	Di Fiore, Pier Paolo/0000-0002-2252-0950; Bianchi, Fabrizio/0000-0001-7412-8638; Beckers, Johannes/0000-0001-7874-3822; Klingenspor, Martin/0000-0002-4502-6664; Bianchi, Fabrizio/0000-0001-7412-8638; Rozman, Jan/0000-0002-8035-8904; Fuchs, Helmut/0000-0002-5143-2677; de Angelis, Martin Hrabe/0000-0002-7898-2353; Scita, Giorgio/0000-0001-7984-1889; TACCHETTI, CARLO/0000-0003-4602-000X; Scanziani, Eugenio/0000-0003-3996-5048; gagliani, maria cristina/0000-0002-2902-2719; Offenhauser, Nina/0000-0002-3316-3047; Wolf, Eckhard/0000-0002-0430-9510; Tocchetti, Arianna/0000-0001-7004-7582	Associazione Italiana per la Ricerca sul Cancro [4874]; European Community; Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR); Cariplo Foundation; Ferrari Foundation; Monzino Foundation; Bundesministerium fuer Bildung und Forschung [01GS0869, 01GS0851, 01GS0850];  [LSHG-2006-037188]	Associazione Italiana per la Ricerca sul Cancro; European Community; Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR); Cariplo Foundation; Ferrari Foundation; Monzino Foundation; Bundesministerium fuer Bildung und Forschung; 	This work was supported by grants from the Associazione Italiana per la Ricerca sul Cancro to PPDF, NO (4874) and GS (http://www.airc.it/); the European Community (VI Framework) to PPDF and LSHG-2006-037188 to the German Mouse Clinic (http://ec.europa.eu/grants/index_en.htm); the Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR) to PPDF and GS (http://www.miur.it/DefaultDesktop.aspx); the Cariplo Foundation to PPDF and NO (http://www.fondazionecariplo.it/portal/page148a.do&link=oln643a.redirect&seu311a.oid.set=26); the Ferrari Foundation and the Monzino Foundation to PPDF; the Bundesministerium fuer Bildung und Forschung to MK (01GS0869), EW (01GS0851), and to JB and MHA (01GS0850) (http://www.bmbf.de/de/99.php). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An GY, 2007, J EXP MED, V204, P1417, DOI 10.1084/jem.20061929; Arellano C, 2004, J CHROMATOGR B, V807, P263, DOI 10.1016/j.jchromb.2004.04.015; ARPIN M, 1994, J CELL BIOL, V127, P1995, DOI 10.1083/jcb.127.6.1995; Bauer M, 2004, PHYSIOL GENOMICS, V17, P230, DOI 10.1152/physiolgenomics.00203.2003; Berg AH, 2005, CIRC RES, V96, P939, DOI 10.1161/01.RES.0000163635.62927.34; Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; Bluher M, 2002, DEV CELL, V3, P25, DOI 10.1016/S1534-5807(02)00199-5; Chen D, 2005, SCIENCE, V310, P1641, DOI 10.1126/science.1118357; Chu G., 2002, SAM SIGNIFICANCE ANA; Croce A, 2004, NAT CELL BIOL, V6, P1173, DOI 10.1038/ncb1198; DEBEAUREGARD MAC, 1995, EMBO J, V14, P409, DOI 10.1002/j.1460-2075.1995.tb07017.x; Dhahbi JM, 2004, P NATL ACAD SCI USA, V101, P5524, DOI 10.1073/pnas.0305300101; Disanza A, 2004, NAT CELL BIOL, V6, P1180, DOI 10.1038/ncb1199; Disanza A, 2006, NAT CELL BIOL, V8, P1337, DOI 10.1038/ncb1502; Duivenvoorden I, 2006, AM J CLIN NUTR, V84, P312; Ferguson M, 2007, MECH AGEING DEV, V128, P539, DOI 10.1016/j.mad.2007.07.005; Friebe A, 2007, P NATL ACAD SCI USA, V104, P7699, DOI 10.1073/pnas.0609778104; Grimm-Gunter EMS, 2009, MOL BIOL CELL, V20, P2549, DOI 10.1091/mbc.E08-10-1030; Guarente L, 2005, CELL, V120, P473, DOI 10.1016/j.cell.2005.01.029; Hauner H, 2004, PHYSIOL BEHAV, V83, P653, DOI 10.1016/j.physbeh.2004.09.016; HERTZOG M, 2009, DEADLY EMBRACE UNPUB; Horsch M, 2008, PROTEOMICS, V8, P1248, DOI 10.1002/pmic.200700725; Innocenti M, 2003, J CELL BIOL, V160, P17, DOI 10.1083/jcb.200206079; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Khanday FA, 2006, J CELL BIOL, V172, P817, DOI 10.1083/jcb.200506001; Loomis PA, 2003, J CELL BIOL, V163, P1045, DOI 10.1083/jcb.200309093; Marshall Stephen, 2006, Sci STKE, V2006, pre7; Menna E, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000138; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; Murphy KG, 2006, NATURE, V444, P854, DOI 10.1038/nature05484; Offenhauser N, 2004, MOL BIOL CELL, V15, P91, DOI 10.1091/mbc.E03-06-0427; Offenhauser N, 2006, CELL, V127, P213, DOI 10.1016/j.cell.2006.09.011; Pohjanvirta R, 2008, TOXICOL APPL PHARM, V230, P41, DOI 10.1016/j.taap.2008.02.002; Pugh TD, 1999, NEUROBIOL AGING, V20, P157, DOI 10.1016/S0197-4580(99)00043-3; Quackenbush J, 2002, NAT GENET, V32, P496, DOI 10.1038/ng1032; QUARRIE JK, 2004, SCI AGING KNOWLEDGE, pRE5; Rikke BA, 2003, MECH AGEING DEV, V124, P663, DOI 10.1016/S0047-6374(03)00003-4; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sato T, 2007, NATURE, V448, P366, DOI 10.1038/nature05929; Scita G, 1999, NATURE, V401, P290, DOI 10.1038/45822; Scita G, 2001, J CELL BIOL, V154, P1031, DOI 10.1083/jcb.200103146; Selman C, 2005, MECH AGEING DEV, V126, P783, DOI 10.1016/j.mad.2005.02.004; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Tyska MJ, 2002, BIOPHYS J, V82, P1869, DOI 10.1016/S0006-3495(02)75537-9; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; WEINDRUCH R, 1986, J NUTR, V116, P641, DOI 10.1093/jn/116.4.641; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15	48	36	37	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2010	5	3							e9468	10.1371/journal.pone.0009468	http://dx.doi.org/10.1371/journal.pone.0009468			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	562OY	20209148	Green Published, Green Submitted, gold			2022-12-25	WOS:000275063300003
J	Denapaite, D; Bruckner, R; Nuhn, M; Reichmann, P; Henrich, B; Maurer, P; Schahle, Y; Selbmann, P; Zimmermann, W; Wambutt, R; Hakenbeck, R				Denapaite, Dalia; Brueckner, Reinhold; Nuhn, Michael; Reichmann, Peter; Henrich, Bernhard; Maurer, Patrick; Schaehle, Yvonne; Selbmann, Peter; Zimmermann, Wolfgang; Wambutt, Rolf; Hakenbeck, Regine			The Genome of Streptococcus mitis B6-What Is a Commensal?	PLOS ONE			English	Article							ARGININE TRANSLOCATION SYSTEM; SURFACE GLYCOPROTEINS GSPB; STAPHYLOCOCCUS-AUREUS; MOSAIC CHROMOSOMES; INSERTION-SEQUENCE; ALLELIC VARIATION; BINDING PROTEINS; SIGNAL PEPTIDES; S-MITIS; PNEUMONIAE	Streptococcus mitis is the closest relative of the major human pathogen S. pneumoniae. The 2,15 Mb sequence of the Streptococcus mitis B6 chromosome, an unusually high-level beta-lactam resistant and multiple antibiotic resistant strain, has now been determined to encode 2100 genes. The accessory genome is estimated to represent over 40%, including 75 mostly novel transposases and IS, the prophage phi B6 and another seven phage related regions. Tetracycline resistance mediated by Tn5801, and an unusual and large gene cluster containing three aminoglycoside resistance determinants have not been described in other Streptococcus spp. Comparative genomic analyses including hybridization experiments on a S. mitis B6 specific microarray reveal that individual S. mitis strains are almost as distantly related to the B6 strain as S. pneumoniae. Both species share a core of over 900 genes. Most proteins described as pneumococcal virulence factors are present in S. mitis B6, but the three choline binding proteins PcpA, PspA and PspC, and three gene clusters containing the hyaluronidase gene, ply and lytA, and the capsular genes are absent in S. mitis B6 and other S. mitis as well and confirm their importance for the pathogenetic potential of S. pneumoniae. Despite the close relatedness between the two species, the S. mitis B6 genome reveals a striking X-alignment when compared with S. pneumoniae.	[Denapaite, Dalia; Brueckner, Reinhold; Reichmann, Peter; Henrich, Bernhard; Maurer, Patrick; Schaehle, Yvonne; Hakenbeck, Regine] Univ Kaiserslautern, Dept Microbiol, Kaiserslautern, Germany; [Nuhn, Michael; Reichmann, Peter; Maurer, Patrick; Hakenbeck, Regine] Univ Kaiserslautern, Nano Bio Ctr, Kaiserslautern, Germany; [Selbmann, Peter; Zimmermann, Wolfgang; Wambutt, Rolf] AGOWA Genom, Berlin, Germany	University of Kaiserslautern; University of Kaiserslautern	Denapaite, D (corresponding author), Univ Kaiserslautern, Dept Microbiol, Kaiserslautern, Germany.	hakenb@rhrk.uni-kl.de	Denapaite, Dalia/E-2657-2018	Denapaite, Dalia/0000-0002-0700-3437; Nuhn, Michael/0000-0001-9753-7995	Bundesministerium fur Bildung und Forschung (BMBF) [PTJ-BIO/0313134, 0313801 1]; EU [LSHM-CT-2003-503413]; Network of Excellence EuroPathoGenomics [LSHB-CT-2005-512061]; AGOWA company; Stiftung Rheinland Pfalz fur Innovation [15202-386261/580]	Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); EU(European Commission); Network of Excellence EuroPathoGenomics; AGOWA company; Stiftung Rheinland Pfalz fur Innovation	This work was supported by a grant from the Bundesministerium fur Bildung und Forschung (BMBF No. PTJ-BIO/0313134) and 0313801 1, the EU (Pneumococcal Resistance Epidemicity and Virulence, An International Study [PREVIS], LSHM-CT-2003-503413 and the Network of Excellence EuroPathoGenomics, LSHB-CT-2005-512061), the AGOWA company, and the Stiftung Rheinland Pfalz fur Innovation 15202-386261/580. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar SI, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-41; Ajdic D, 2002, P NATL ACAD SCI USA, V99, P14434, DOI 10.1073/pnas.172501299; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; An FY, 2002, J BACTERIOL, V184, P1880, DOI 10.1128/JB.184.7.1880-1887.2002; Baba T, 2008, J BACTERIOL, V190, P300, DOI 10.1128/JB.01000-07; Bagnoli F, 2008, J BACTERIOL, V190, P5480, DOI 10.1128/JB.00384-08; Bendtsen JD, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-167; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bergmann S, 2006, MICROBIOL-SGM, V152, P295, DOI 10.1099/mic.0.28610-0; Berks BC, 2005, CURR OPIN MICROBIOL, V8, P174, DOI 10.1016/j.mib.2005.02.010; Bishop CJ, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-3; BLACK LW, 1989, ANNU REV MICROBIOL, V43, P267, DOI 10.1146/annurev.micro.43.1.267; Bolotin A, 2004, NAT BIOTECHNOL, V22, P1554, DOI 10.1038/nbt1034; BOURGAULT AM, 1979, J INFECT DIS, V140, P316, DOI 10.1093/infdis/140.3.316; BRANDENBURG RO, 1983, J AM COLL CARDIOL, V1, P280, DOI 10.1016/S0735-1097(83)80029-1; Bruckner R, 2004, INT J MED MICROBIOL, V294, P157, DOI 10.1016/j.ijmm.2004.06.019; Brussow H, 2004, MICROBIOL MOL BIOL R, V68, P560, DOI 10.1128/MMBR.68.3.560-602.2004; Burrus V, 2002, MOL MICROBIOL, V46, P601, DOI 10.1046/j.1365-2958.2002.03191.x; CAMPBELL AM, 1992, J BACTERIOL, V174, P7495, DOI 10.1128/JB.174.23.7495-7499.1992; Cerda P, 2007, INT MICROBIOL, V10, P57, DOI 10.2436/20.1501.01.8; Chen C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000315; Chi F, 2007, INT J MED MICROBIOL, V297, P503, DOI 10.1016/j.ijmm.2007.02.009; Claverys JP, 2007, MOL MICROBIOL, V64, P1423, DOI 10.1111/j.1365-2958.2007.05757.x; Croucher NJ, 2009, J BACTERIOL, V191, P1480, DOI 10.1128/JB.01343-08; Culebras Esther, 1999, Frontiers in Bioscience, V4, pD1, DOI 10.2741/culebras; Dagerhamn J, 2008, J CLIN MICROBIOL, V46, P863, DOI 10.1128/JCM.01438-07; Dai LX, 2003, NUCLEIC ACIDS RES, V31, P424, DOI 10.1093/nar/gkg049; Dawid S, 2007, INFECT IMMUN, V75, P443, DOI 10.1128/IAI.01775-05; de Saizieu A, 2000, J BACTERIOL, V182, P4696, DOI 10.1128/JB.182.17.4696-4703.2000; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; DIAZ E, 1992, J BACTERIOL, V174, P5516; Ding F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-158; Eisen JA, 2000, GENOME BIOL, V1; Ermolaeva MD, 2000, J MOL BIOL, V301, P27, DOI 10.1006/jmbi.2000.3836; Fatholahzadeh B, 2009, INT J ANTIMICROB AG, V33, P264, DOI 10.1016/j.ijantimicag.2008.09.018; Ferrandiz MJ, 2005, ANTIMICROB AGENTS CH, V49, P2237, DOI 10.1128/AAC.49.6.2237-2245.2005; Franz CMAP, 2000, MICROBIOL-SGM, V146, P621, DOI 10.1099/00221287-146-3-621; Gattiker Alexandre, 2002, Appl Bioinformatics, V1, P107; Griffiths-Jones S, 2005, NUCLEIC ACIDS RES, V33, pD121, DOI 10.1093/nar/gki081; Guiral S, 2005, P NATL ACAD SCI USA, V102, P8710, DOI 10.1073/pnas.0500879102; Hakenbeck R, 1998, J BACTERIOL, V180, P1831, DOI 10.1128/JB.180.7.1831-1840.1998; Hakenbeck R, 2001, INFECT IMMUN, V69, P2477, DOI 10.1128/IAI.69.4.2477-2486.2001; Hakenbeck R, 2009, FEMS MICROBIOL REV, V33, P572, DOI 10.1111/j.1574-6976.2009.00172.x; HAMMERSCHMIDT S, 2007, MOL BIOL STREPTOCOCC, P141; Havarstein LS, 2006, MOL MICROBIOL, V59, P1297, DOI 10.1111/j.1365-2958.2005.05021.x; Hendrickson H, 2006, J MOL EVOL, V62, P615, DOI 10.1007/s00239-005-0192-2; HENRICHSEN J, 1995, J CLIN MICROBIOL, V33, P2759, DOI 10.1128/JCM.33.10.2759-2762.1995; Hiller NL, 2007, J BACTERIOL, V189, P8186, DOI 10.1128/JB.00690-07; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Hoskins J, 1999, J BACTERIOL, V181, P6552, DOI 10.1128/JB.181.20.6552-6555.1999; Hoskins J, 2001, J BACTERIOL, V183, P5709, DOI 10.1128/JB.183.19.5709-5717.2001; Jedrzejas MJ, 2001, MICROBIOL MOL BIOL R, V65, P187, DOI 10.1128/MMBR.65.2.187-207.2001; Jefferies J, 2007, J BACTERIOL, V189, P627, DOI 10.1128/JB.01092-06; Kearns AM, 2000, J CLIN MICROBIOL, V38, P1309, DOI 10.1128/JCM.38.3.1309-1310.2000; Kilian M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002683; Konig A, 1998, MICROB DRUG RESIST, V4, P45, DOI 10.1089/mdr.1998.4.45; Krauss J, 1997, ANTIMICROB AGENTS CH, V41, P936, DOI 10.1128/AAC.41.5.936; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kuroda M, 2001, LANCET, V357, P1225, DOI 10.1016/S0140-6736(00)04403-2; Lavander M, 2006, INFECT IMMUN, V74, P1768, DOI 10.1128/IAI.74.3.1768-1776.2006; Le Bourgeois P, 2007, PLOS GENET, V3, P1190, DOI 10.1371/journal.pgen.0030117; Llull D, 2006, J CLIN MICROBIOL, V44, P1250, DOI 10.1128/JCM.44.4.1250-1256.2006; LOCK RA, 1992, MICROB PATHOGENESIS, V12, P137, DOI 10.1016/0882-4010(92)90116-6; Loeffler JM, 2006, INFECT IMMUN, V74, P4486, DOI 10.1128/IAI.00020-06; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Lux T, 2007, J BACTERIOL, V189, P7741, DOI 10.1128/JB.00474-07; MARTIN B, 1992, NUCLEIC ACIDS RES, V20, P3479, DOI 10.1093/nar/20.13.3479; Mitchell TJ, 2003, NAT REV MICROBIOL, V1, P219, DOI 10.1038/nrmicro771; MITCHELL TJ, 2007, MOL BIOL STREPTOCOCC, P205; Molina R, 2009, EMBO REP, V10, P246, DOI 10.1038/embor.2008.245; Morrison DA, 2007, J BACTERIOL, V189, P6497, DOI 10.1128/JB.00687-07; Oggioni MR, 1999, MICROBIOL-SGM, V145, P2647, DOI 10.1099/00221287-145-10-2647; Pagliero E, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-19; Paik J, 1999, J BACTERIOL, V181, P3852, DOI 10.1128/JB.181.12.3852-3856.1999; Park IH, 2007, J CLIN MICROBIOL, V45, P1225, DOI 10.1128/JCM.02199-06; Raskin DM, 2006, CELL, V124, P703, DOI 10.1016/j.cell.2006.02.002; Reichmann P, 2002, J MOL MICROB BIOTECH, V4, P101; Reichmann P, 2000, FEMS MICROBIOL LETT, V190, P231, DOI 10.1016/S0378-1097(00)00340-2; Rey S, 2005, NUCLEIC ACIDS RES, V33, pD164, DOI 10.1093/nar/gki027; Romero P, 2004, J BACTERIOL, V186, P8229, DOI 10.1128/JB.186.24.8229-8239.2004; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SanchezBeato AR, 1997, J BACTERIOL, V179, P2459, DOI 10.1128/jb.179.7.2459-2463.1997; Schneeberger PM, 1996, INFECTION, V24, P29, DOI 10.1007/BF01780647; SIBOLD C, 1994, MOL MICROBIOL, V12, P1013, DOI 10.1111/j.1365-2958.1994.tb01089.x; Smith AM, 2005, ANTIMICROB AGENTS CH, V49, P2002, DOI 10.1128/AAC.49.5.2002-2007.2005; Standish AJ, 2005, P NATL ACAD SCI USA, V102, P7701, DOI 10.1073/pnas.0409377102; Sutcliffe IC, 2004, ANTON LEEUW INT J G, V85, P305; Sutcliffe IC, 2002, MICROBIOL-SGM, V148, P2065, DOI 10.1099/00221287-148-7-2065; Takamatsu D, 2006, INFECT IMMUN, V74, P1933, DOI 10.1128/IAI.74.3.1933-1940.2006; Takamatsu D, 2005, MOL MICROBIOL, V58, P380, DOI 10.1111/j.1365-2958.2005.04830.x; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Tillier ERM, 2000, NAT GENET, V26, P195, DOI 10.1038/79918; Ton-That H, 2004, BBA-MOL CELL RES, V1694, P269, DOI 10.1016/j.bbamcr.2004.04.014; VANDERMEER JTM, 1991, EUR J CLIN MICROBIOL, V10, P728; Voulhoux R, 2001, EMBO J, V20, P6735, DOI 10.1093/emboj/20.23.6735; Whatmore AM, 2000, INFECT IMMUN, V68, P1374, DOI 10.1128/IAI.68.3.1374-1382.2000; Whatmore AM, 1999, INFECT IMMUN, V67, P4551, DOI 10.1128/IAI.67.9.4551-4556.1999; Xu P, 2007, J BACTERIOL, V189, P3166, DOI 10.1128/JB.01808-06; Yadegar A, 2009, MICROB DRUG RESIST, V15, P109, DOI 10.1089/mdr.2009.0897; ZHOU LX, 1995, PLASMID, V33, P127, DOI 10.1006/plas.1995.1014; Zysk G, 2001, INFECT IMMUN, V69, P845, DOI 10.1128/IAI.69.2.845-852.2001	103	89	94	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2010	5	2							e9426	10.1371/journal.pone.0009426	http://dx.doi.org/10.1371/journal.pone.0009426			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SY	20195536	Green Submitted, Green Published, gold			2022-12-25	WOS:000274924300014
J	van Cleef, BA; Verkade, EJM; Wulf, MW; Buiting, AG; Voss, A; Huijsdens, XW; van Pelt, W; Mulders, MN; Kluytmans, JA				van Cleef, Brigitte A.; Verkade, Erwin J. M.; Wulf, Mireille W.; Buiting, Anton G.; Voss, Andreas; Huijsdens, Xander W.; van Pelt, Wilfrid; Mulders, Mick N.; Kluytmans, Jan A.			Prevalence of Livestock-Associated MRSA in Communities with High Pig-Densities in The Netherlands	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; HUMANS; ORIGIN; CC398	Background: Recently, livestock-associated methicillin-resistant Staphylococcus aureus CC398 has been discovered in animals, livestock farmers and retail meat. This cross-sectional study aimed to determine the spread to persons not in direct contact with livestock in areas with a high density of pig farms. Methodology/Principal Findings: With a random mailing in 3 selected municipalities in the Netherlands, adult persons were asked to fill in a questionnaire and to take a nose swab. In total, complete information was obtained on 583 persons. Of the 534 persons without livestock-contact, one was positive for MRSA (0.2%; 95% confidence interval, <0.01-1.2). Of the 49 persons who did indicate to be working at or living on a livestock farm, 13 were positive for MRSA (26.5%; 95% confidence interval, 16.1-40.4). All spa-types belonged to CC398. Conclusions/Significance: Livestock-associated MRSA has a high prevalence in people with direct contact with animals. At this moment it has not spread from the farms into the community.	[van Cleef, Brigitte A.; Huijsdens, Xander W.; van Pelt, Wilfrid; Mulders, Mick N.] RIVM Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control Netherlands, Bilthoven, Netherlands; [van Cleef, Brigitte A.; Kluytmans, Jan A.] Vrije Univ Amsterdam Med Ctr, Dept Med Microbiol, Amsterdam, Netherlands; [van Cleef, Brigitte A.; Voss, Andreas] 7th Framework Programme, EU HEALTH Project PILGRIM, Nijmegen, Netherlands; [Verkade, Erwin J. M.; Kluytmans, Jan A.] Amphia Hosp, Lab Microbiol & Infect Control, Breda, Netherlands; [Wulf, Mireille W.] Catharina Hosp, Veldhoven, Netherlands; [Wulf, Mireille W.] PAMM Lab Med Microbiol, Veldhoven, Netherlands; [Verkade, Erwin J. M.; Buiting, Anton G.] St Elizabeth Hosp, Lab Med Microbiol & Immunol, Tilburg, Netherlands; [Voss, Andreas] Canisius Wilhelmina Hosp, Dept Med Microbiol & Infect Control, Nijmegen, Netherlands; [Voss, Andreas] Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, NL-6525 ED Nijmegen, Netherlands	Netherlands National Institute for Public Health & the Environment; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Amphia Hospital; Catharina Hospital; Elisabeth-TweeSteden Ziekenhuis (ETZ); Canisius-Wilhelmina Hospital; Radboud University Nijmegen	van Cleef, BA (corresponding author), RIVM Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control Netherlands, Bilthoven, Netherlands.	brigitte.van.cleef@rivm.nl	Voss, A./H-8111-2014		EU	EU(European Commission)	This study was supported by the EU-HEALTH project PILGRIM of the 7th Framework Programme (www.fp7-pilgrim.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*CBS, CBS STAT NETH ANN CO; Cuny C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006800; de Boer E, 2009, INT J FOOD MICROBIOL, V134, P52, DOI 10.1016/j.ijfoodmicro.2008.12.007; de Neeling AJ, 2007, VET MICROBIOL, V122, P366, DOI 10.1016/j.vetmic.2007.01.027; Declercq P, 2008, INFECTION, V36, P590, DOI 10.1007/s15010-007-7029-4; DOLEE K, 2008, ARCH PHARM RES, V31, P1016; DONKER GSE, 2008, HUISARTS WETENSCHAP, V51; Ekkelenkamp M B, 2006, Ned Tijdschr Geneeskd, V150, P2442; Fanoy E, 2009, EUROSURVEILLANCE, V14; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Huijsdens Xander W, 2006, Ann Clin Microbiol Antimicrob, V5, P26, DOI 10.1186/1476-0711-5-26; HUIJSDENS XW, 2009, EURO SURVEILL, V14; Kluytmans J, 1997, CLIN MICROBIOL REV, V10, P505, DOI 10.1128/CMR.10.3.505; Kluytmans-VandenBergh MFQ, 2006, CLIN MICROBIOL INFEC, V12, P9, DOI 10.1111/j.1469-0691.2006.01341.x; Lautenbach E, 2009, INFECT CONT HOSP EP, V30, P380, DOI 10.1086/596045; Lewis HC, 2008, EMERG INFECT DIS, V14, P1383, DOI 10.3201/eid1409.071576; Lin J, 2009, J FOOD PROTECT, V72, P608, DOI 10.4315/0362-028X-72.3.608; *MUN HLTH SERV GGD, BEING LIV HLTH AMST; Pereira V, 2009, FOOD MICROBIOL, V26, P278, DOI 10.1016/j.fm.2008.12.008; Pu SH, 2009, APPL ENVIRON MICROB, V75, P265, DOI 10.1128/AEM.01110-08; Robicsek A, 2008, J CLIN MICROBIOL, V46, P588, DOI 10.1128/JCM.01746-07; *SWAB, SWAB NETHMAP 2008 CO; Van Den Broek IVF, 2009, EPIDEMIOL INFECT, V137, P700, DOI 10.1017/S0950268808001507; van der Klis FRM, 2009, NETH J MED, V67, P301; van Griethuysen A, 1999, J CLIN MICROBIOL, V37, P2789, DOI 10.1128/JCM.37.9.2789-2792.1999; van Loo I, 2007, EMERG INFECT DIS, V13, P1834, DOI 10.3201/eid1312.070384; Van Loo IHM, 2007, EMERG INFECT DIS, V13, P1753, DOI 10.3201/eid1311.070358; van Rijen MML, 2008, CLIN INFECT DIS, V46, P261, DOI 10.1086/524672; VIET AL, 2002, RISK FACTORS HLTH NE; Voss A, 2005, EMERG INFECT DIS, V11, P1965, DOI 10.3201/eid1112.050428; Wassenberg M W M, 2008, Ned Tijdschr Geneeskd, V152, P2681; Wayne P.A, 1997, PERF VOL ANT SUSC FL, Vsixth; Wertheim HFL, 2004, J HOSP INFECT, V56, P321, DOI 10.1016/j.jhin.2004.01.026; Witte W, 2007, EMERG INFECT DIS, V13, P255, DOI 10.3201/eid1302.060924; Wulf MWH, 2008, CLIN MICROBIOL INFEC, V14, P29, DOI 10.1111/j.1469-0691.2007.01873.x; Wulf MW, 2008, EURO SURVEILL, V13; 2009, EFSA SCI REPORT, V301, P1	37	98	99	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2010	5	2							e9385	10.1371/journal.pone.0009385	http://dx.doi.org/10.1371/journal.pone.0009385			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SY	20195538	Green Submitted, Green Published, gold			2022-12-25	WOS:000274924300002
J	Kulkarni, MA; Desrochers, RE; Kerr, JT				Kulkarni, Manisha A.; Desrochers, Rachelle E.; Kerr, Jeremy T.			High Resolution Niche Models of Malaria Vectors in Northern Tanzania: A New Capacity to Predict Malaria Risk?	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; ANOPHELES-GAMBIAE COMPLEX; DIHYDROFOLATE-REDUCTASE; USAMBARA MOUNTAINS; TRANSMISSION RISK; SAMPLE-SIZE; AFRICA; CULICIDAE; DIPTERA; AREA	Background: Malaria transmission rates in Africa can vary dramatically over the space of a few kilometres. This spatial heterogeneity reflects variation in vector mosquito habitat and presents an important obstacle to the efficient allocation of malaria control resources. Malaria control is further complicated by combinations of vector species that respond differently to control interventions. Recent modelling innovations make it possible to predict vector distributions and extrapolate malaria risk continentally, but these risk mapping efforts have not yet bridged the spatial gap to guide on-the-ground control efforts. Methodology/Principal Findings: We used Maximum Entropy with purpose-built, high resolution land cover data and other environmental factors to model the spatial distributions of the three dominant malaria vector species in a 94,000 km(2) region of east Africa. Remotely sensed land cover was necessary in each vector's niche model. Seasonality of precipitation and maximum annual temperature also contributed to niche models for Anopheles arabiensis and An. funestus s.l. (AUC 0.989 and 0.991, respectively), but cold season precipitation and elevation were important for An. gambiae s.s. (AUC 0.997). Although these niche models appear highly accurate, the critical test is whether they improve predictions of malaria prevalence in human populations. Vector habitat within 1.5 km of community-based malaria prevalence measurements interacts with elevation to substantially improve predictions of Plasmodium falciparum prevalence in children. The inclusion of the mechanistic link between malaria prevalence and vector habitat greatly improves the precision and accuracy of prevalence predictions (r(2) = 0.83 including vector habitat, or r(2) = 0.50 without vector habitat). Predictions including vector habitat are unbiased (observations vs. model predictions of prevalence: slope = 1.02). Using this model, we generate a high resolution map of predicted malaria prevalence throughout the study region. Conclusions/Significance: The interaction between mosquito niche space and microclimate along elevational gradients indicates worrisome potential for climate and land use changes to exacerbate malaria resurgence in the east African highlands. Nevertheless, it is possible to direct interventions precisely to ameliorate potential impacts.	[Kulkarni, Manisha A.; Desrochers, Rachelle E.; Kerr, Jeremy T.] Univ Ottawa, Dept Biol, Canadian Facil Ecoinformat Res, Ottawa, ON, Canada	University of Ottawa	Kulkarni, MA (corresponding author), Univ Ottawa, Dept Biol, Canadian Facil Ecoinformat Res, Ottawa, ON, Canada.	manisha.kulkarni@uottawa.ca		Kulkarni, Manisha/0000-0002-5084-4960; Desrochers, Rachelle/0000-0001-5169-3853	Ontario Ministry of Research Innovation; NSERC	Ontario Ministry of Research Innovation(Ministry of Research and Innovation, Ontario); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by a postdoctoral fellowship to MAK from the Ontario Ministry of Research & Innovation (www.mri.gov.on.ca) and a NSERC (www.nserc.gc.ca) grant to JTK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alifrangis M, 2003, AM J TROP MED HYG, V69, P601, DOI 10.4269/ajtmh.2003.69.601; [Anonymous], 2008, WORLD MAL REP 2008; Balls MJ, 2004, T ROY SOC TROP MED H, V98, P400, DOI 10.1016/j.trstmh.2003.11.005; Bayoh MN, 2004, MED VET ENTOMOL, V18, P174, DOI 10.1111/j.0269-283X.2004.00495.x; Beier JC, 1999, AM J TROP MED HYG, V61, P109, DOI 10.4269/ajtmh.1999.61.109; Bodker R, 2003, J MED ENTOMOL, V40, P706, DOI 10.1603/0022-2585-40.5.706; Bodker R, 2000, GLOBAL CHANGE HUMAN, V1, P134, DOI DOI 10.1023/A:1010077105257; Bogh C, 2007, AM J TROP MED HYG, V76, P875; Carter R, 2000, B WORLD HEALTH ORGAN, V78, P1401; Chandramohan D, 2001, B WORLD HEALTH ORGAN, V79, P375; Coetzee M, 2000, PARASITOL TODAY, V16, P74, DOI 10.1016/S0169-4758(99)01563-X; Cohen JM, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-40; COLUZZI M, 1984, B WORLD HEALTH ORGAN, V62, P107; Drakeley CJ, 2005, J INFECT DIS, V191, P1589, DOI 10.1086/429669; Ellman R, 1998, ANN TROP MED PARASIT, V92, P741, DOI 10.1080/00034989858989; Ernst KC, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-78; *FAO, 2004, AFR PROJ; Gillies M, 1987, ANOPHELINAE AFRICA S; Hansen MC, 2000, INT J REMOTE SENS, V21, P1331, DOI 10.1080/014311600210209; Hay SI, 2000, T ROY SOC TROP MED H, V94, P113, DOI 10.1016/S0035-9203(00)90246-3; Hay SI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000048; Hendrickx G, 2001, B ENTOMOL RES, V91, P333, DOI 10.1079/BER2001103; Hernandez PA, 2008, BIODIVERS CONSERV, V17, P1353, DOI 10.1007/s10531-007-9314-z; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Ijumba JN, 2002, MED VET ENTOMOL, V16, P28, DOI 10.1046/j.0269-283x.2002.00337.x; Kerr JT, 2007, SCIENCE, V316, P1581, DOI 10.1126/science.1133267; Kristan M, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-231; Kuhn KG, 2002, J MED ENTOMOL, V39, P621, DOI 10.1603/0022-2585-39.4.621; KULKARNI MA, 2006, THESIS MCGILL U MONT; Kweka EJ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-59; Lindblade KA, 2000, TROP MED INT HEALTH, V5, P263, DOI 10.1046/j.1365-3156.2000.00551.x; Lindsay SW, 1998, B WORLD HEALTH ORGAN, V76, P33; Lindsay SW, 2004, PHYSIOL ENTOMOL, V29, P204, DOI 10.1111/j.0307-6962.2004.00405.x; Lindsay SW, 1996, ANN TROP MED PARASIT, V90, P573, DOI 10.1080/00034983.1996.11813087; Lindsay SW, 2000, LANCET, V355, P989, DOI 10.1016/S0140-6736(00)90022-9; Lindsay SW, 1998, P ROY SOC B-BIOL SCI, V265, P847, DOI 10.1098/rspb.1998.0369; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Martens WJM, 1997, CLIMATIC CHANGE, V35, P145, DOI 10.1023/A:1005365413932; MNZAVA AEP, 1986, ACTA TROP, V43, P277; MNZAVA AEP, 1995, MED VET ENTOMOL, V9, P316, DOI 10.1111/j.1365-2915.1995.tb00140.x; Moffett A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000824; Molineaux L, 2020, GARKI PROJECT RES EP, V8; Mouchet J, 1998, J AM MOSQUITO CONTR, V14, P121; Mushinzimana E, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-13; MUTUKU FM, 2009, INT J HEALTH GEOGR, V8, pE19; Oesterholt MJAM, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-98; Pearce RJ, 2003, ANTIMICROB AGENTS CH, V47, P1347, DOI 10.1128/AAC.47.4.1347-1354.2003; Peterson AT, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-59; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; *PMI, 2009, PRES MAL IN 3 ANN RE; Rangel TFLVB, 2006, GLOBAL ECOL BIOGEOGR, V15, P321, DOI 10.1111/j.1466-822x.2006.00237.x; Riley EM, 2001, PARASITE IMMUNOL, V23, P51, DOI 10.1046/j.1365-3024.2001.00364.x; ROGERS DJ, 1991, NATURE, V351, P739, DOI 10.1038/351739a0; Rogers DJ, 2002, NATURE, V415, P710, DOI 10.1038/415710a; Shanks GD, 2005, EMERG INFECT DIS, V11, P1425, DOI 10.3201/eid1109.041131; Takken W, 1998, B ENTOMOL RES, V88, P561, DOI 10.1017/S0007485300026080; Teklehaimanot HD, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-41; Temu EA, 1998, T ROY SOC TROP MED H, V92, P152, DOI 10.1016/S0035-9203(98)90724-6; Zhou GF, 2004, J MED ENTOMOL, V41, P1001, DOI 10.1603/0022-2585-41.6.1001; Zhou G, 2007, AM J TROP MED HYG, V77, P29, DOI 10.4269/ajtmh.2007.77.29	61	60	60	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2010	5	2							e9396	10.1371/journal.pone.0009396	http://dx.doi.org/10.1371/journal.pone.0009396			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SX	20195366	Green Published, Green Submitted, gold			2022-12-25	WOS:000274924200018
J	Krebiehl, G; Ruckerbauer, S; Burbulla, LF; Kieper, N; Maurer, B; Waak, J; Wolburg, H; Gizatullina, Z; Gellerich, FN; Woitalla, D; Riess, O; Kahle, PJ; Proikas-Cezanne, T; Kruger, R				Krebiehl, Guido; Ruckerbauer, Sabine; Burbulla, Lena F.; Kieper, Nicole; Maurer, Brigitte; Waak, Jens; Wolburg, Hartwig; Gizatullina, Zemfira; Gellerich, Frank N.; Woitalla, Dirk; Riess, Olaf; Kahle, Philipp J.; Proikas-Cezanne, Tassula; Krueger, Rejko			Reduced Basal Autophagy and Impaired Mitochondrial Dynamics Due to Loss of Parkinson's Disease-Associated Protein DJ-1	PLOS ONE			English	Article							CYSTEINE-SULFINIC ACID; ENERGETIC DEPRESSION; FUSION; DEGRADATION; MUTATIONS; PATHOLOGY; FISSION; MUSCLE; PINK1; GENE	Background: Mitochondrial dysfunction and degradation takes a central role in current paradigms of neurodegeneration in Parkinson's disease (PD). Loss of DJ-1 function is a rare cause of familial PD. Although a critical role of DJ-1 in oxidative stress response and mitochondrial function has been recognized, the effects on mitochondrial dynamics and downstream consequences remain to be determined. Methodology/Principal Findings: Using DJ-1 loss of function cellular models from knockout ( KO) mice and human carriers of the E64D mutation in the DJ-1 gene we define a novel role of DJ-1 in the integrity of both cellular organelles, mitochondria and lysosomes. We show that loss of DJ-1 caused impaired mitochondrial respiration, increased intramitochondrial reactive oxygen species, reduced mitochondrial membrane potential and characteristic alterations of mitochondrial shape as shown by quantitative morphology. Importantly, ultrastructural imaging and subsequent detailed lysosomal activity analyses revealed reduced basal autophagic degradation and the accumulation of defective mitochondria in DJ-1 KO cells, that was linked with decreased levels of phospho-activated ERK2. Conclusions/Significance: We show that loss of DJ-1 leads to impaired autophagy and accumulation of dysfunctional mitochondria that under physiological conditions would be compensated via lysosomal clearance. Our study provides evidence for a critical role of DJ-1 in mitochondrial homeostasis by connecting basal autophagy and mitochondrial integrity in Parkinson's disease.	[Ruckerbauer, Sabine; Proikas-Cezanne, Tassula] Univ Tubingen, Interfac Inst Cell Biol, Autophagy Lab, Tubingen, Germany; [Krebiehl, Guido; Burbulla, Lena F.; Kieper, Nicole; Maurer, Brigitte; Waak, Jens; Kahle, Philipp J.; Krueger, Rejko] Univ Tubingen, Ctr Neurol, Tubingen, Germany; [Krebiehl, Guido; Burbulla, Lena F.; Kieper, Nicole; Maurer, Brigitte; Waak, Jens; Kahle, Philipp J.; Krueger, Rejko] Univ Tubingen, Hertie Inst Clin Brain Res, Tubingen, Germany; [Burbulla, Lena F.] Univ Tubingen, Grad Sch Cellular & Mol Neurosci, Tubingen, Germany; [Wolburg, Hartwig] Univ Tubingen, Inst Pathol, D-7400 Tubingen, Germany; [Gizatullina, Zemfira] Otto VonGuericke Univ Magdegurg, Dept Neurol, D-39016 Magdeburg, Germany; [Gellerich, Frank N.] KeyNeurotek Pharmaceut AG, ZENIT, Magdeburg, Germany; [Woitalla, Dirk] Ruhr Univ Bochum, St Josef Hosp, Dept Neurol, D-4630 Bochum, Germany; [Riess, Olaf] Univ Tubingen, Dept Med Genet, D-7400 Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Otto von Guericke University; Ruhr University Bochum; Eberhard Karls University of Tubingen	Proikas-Cezanne, T (corresponding author), Univ Tubingen, Interfac Inst Cell Biol, Autophagy Lab, Tubingen, Germany.	tassula.proikas-cezanne@uni-tuebingen.de; rejko.krueger@uni-tuebingen.de	Predoi, Daniela/C-4294-2011	Predoi, Daniela/0000-0003-3024-6290; Proikas-Cezanne, Prof. Dr. Tassula/0000-0001-6934-132X; Krueger, Rejko/0000-0003-4258-6241	German Research Council [KR2119/3-1, SFB773]; Federal Ministry for Education and Research [BMBF] [Federal Ministry for Education and Research [BMBF, NGFNplus; 01GS08134]; Faculty of Medicine, University of Tubingen [1709-0-0]; Federal Ministry for Education and Research [BMBF]; Landesstiftung Baden Wuerttemberg	German Research Council(German Research Foundation (DFG)); Federal Ministry for Education and Research [BMBF](Federal Ministry of Education & Research (BMBF)); Faculty of Medicine, University of Tubingen; Federal Ministry for Education and Research [BMBF](Federal Ministry of Education & Research (BMBF)); Landesstiftung Baden Wuerttemberg	This work was supported by grants from the German Research Council [DFG, KR2119/3-1]; the Federal Ministry for Education and Research [BMBF, NGFNplus; 01GS08134]; and the Faculty of Medicine, University of Tubingen [Fortuene 1709-0-0] to RK; and grants of the Federal Ministry for Education and Research [BMBF, BioProfile]; Landesstiftung Baden Wuerttemberg; and the German Research Council [SFB773] to TPC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beal MF, 2005, ANN NEUROL, V58, P495, DOI 10.1002/ana.20624; Blackinton J, 2009, J BIOL CHEM, V284, P6476, DOI 10.1074/jbc.M806599200; Bonifati V, 2003, NEUROL SCI, V24, P159, DOI 10.1007/s10072-003-0108-0; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Canet-Aviles RM, 2004, P NATL ACAD SCI USA, V101, P9103, DOI 10.1073/pnas.0402959101; Cataldo AM, 1996, J NEUROPATH EXP NEUR, V55, P704, DOI 10.1097/00005072-199606000-00004; Cerveny KL, 2007, TRENDS CELL BIOL, V17, P563, DOI 10.1016/j.tcb.2007.08.006; Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200; Cookson MR, 2003, NEURON, V37, P7, DOI 10.1016/S0896-6273(02)01166-2; DAGDA RK, 2009, MITOCHONDRION; Dagda RK, 2008, AUTOPHAGY, V4, P770, DOI 10.4161/auto.6458; Deng HS, 2008, P NATL ACAD SCI USA, V105, P14503, DOI 10.1073/pnas.0803998105; Exner N, 2007, J NEUROSCI, V27, P12413, DOI 10.1523/JNEUROSCI.0719-07.2007; FARRE JC, 2009, CURR OPIN CELL BIOL; Gellerich FN, 2004, MOL CELL BIOCHEM, V256, P391, DOI 10.1023/B:MCBI.0000009885.34498.e6; Gorner K, 2007, J BIOL CHEM, V282, P13680, DOI 10.1074/jbc.M609821200; Gomes LC, 2008, BBA-BIOENERGETICS, V1777, P860, DOI 10.1016/j.bbabio.2008.05.442; Gonzalez-Polo RA, 2009, J NEUROCHEM, V109, P889, DOI 10.1111/j.1471-4159.2009.06020.x; Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100; Gu L, 2009, BIOCHEM BIOPH RES CO, V383, P469, DOI 10.1016/j.bbrc.2009.04.037; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hering R, 2004, HUM MUTAT, V24, P321, DOI 10.1002/humu.20089; Jennings JJ, 2006, J BIOL CHEM, V281, P39041, DOI 10.1074/jbc.M607982200; JUNN E, 2008, J NEUROSCI RES; KANKI T, 2008, J BIOL CHEM; Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034; Kim RH, 2005, P NATL ACAD SCI USA, V102, P5215, DOI 10.1073/pnas.0501282102; Klein C, 2007, CURR OPIN NEUROL, V20, P453, DOI 10.1097/WCO.0b013e3281e6692b; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Koopman WJH, 2005, AM J PHYSIOL-CELL PH, V288, pC1440, DOI 10.1152/ajpcell.00607.2004; Kuznetsov AV, 2008, NAT PROTOC, V3, P965, DOI 10.1038/nprot.2008.61; KUZNETSOV AV, 2009, J CELL MOL MED; Mandemakers W, 2007, J CELL SCI, V120, P1707, DOI 10.1242/jcs.03443; Meijer Alfred J., 2006, Molecular Aspects of Medicine, V27, P411, DOI 10.1016/j.mam.2006.08.002; Melendez A, 2003, SCIENCE, V301, P1387, DOI 10.1126/science.1087782; Meulener M, 2005, CURR BIOL, V15, P1572, DOI 10.1016/j.cub.2005.07.064; Mizushima N, 2002, CELL STRUCT FUNCT, V27, P421, DOI 10.1247/csf.27.421; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Poole AC, 2008, P NATL ACAD SCI USA, V105, P1638, DOI 10.1073/pnas.0709336105; Proikas-Cezanne T, 2004, ONCOGENE, V23, P9314, DOI 10.1038/sj.onc.1208331; Proikas-Cezanne T, 2007, FEBS LETT, V581, P3396, DOI 10.1016/j.febslet.2007.06.040; Proikas-Cezanne T, 2009, METHOD ENZYMOL, V452, P247, DOI 10.1016/S0076-6879(08)03616-1; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Rubinsztein DC, 2009, AUTOPHAGY, V5, P585, DOI 10.4161/auto.5.5.8823; Schapira AHV, 2005, J NEUROL NEUROSUR PS, V76, P1472, DOI 10.1136/jnnp.2004.035980; Schapira AHV, 2008, NEUROCHEM RES, V33, P2502, DOI 10.1007/s11064-008-9855-x; Scherz-Shouval R, 2007, TRENDS CELL BIOL, V17, P422, DOI 10.1016/j.tcb.2007.07.009; Schiesling C, 2008, NEUROPATH APPL NEURO, V34, P255, DOI 10.1111/j.1365-2990.2008.00952.x; Seppet E, 2009, INT J MOL SCI, V10, P2252, DOI 10.3390/ijms10052252; Settembre C, 2008, AUTOPHAGY, V4, P113, DOI 10.4161/auto.5227; Settembre C, 2008, HUM MOL GENET, V17, P119, DOI 10.1093/hmg/ddm289; Shacka JJ, 2006, AUTOPHAGY, V2, P228, DOI 10.4161/auto.2703; Stephenson LM, 2009, AUTOPHAGY, V5, P625, DOI 10.4161/auto.5.5.8133; Strauss KM, 2005, HUM MOL GENET, V14, P2099, DOI 10.1093/hmg/ddi215; Sulzer D, 2008, J NEUROCHEM, V106, P24, DOI 10.1111/j.1471-4159.2008.05385.x; Taira T, 2004, EMBO REP, V5, P213, DOI 10.1038/sj.embor.7400074; THOMAS KJ, 2008, PARKINSONISM ASS PTE; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; van Ham TJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000027; Vasseur S, 2009, P NATL ACAD SCI USA, V106, P1111, DOI 10.1073/pnas.0812745106; Vergne I, 2009, EMBO J, V28, P2244, DOI 10.1038/emboj.2009.159; Xue LZ, 1999, MOL CELL NEUROSCI, V14, P180, DOI 10.1006/mcne.1999.0780; Yang YF, 2006, P NATL ACAD SCI USA, V103, P10793, DOI 10.1073/pnas.0602493103; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707; Zhu JH, 2007, AM J PATHOL, V170, P75, DOI 10.2353/ajpath.2007.060524	67	263	279	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2010	5	2							e9367	10.1371/journal.pone.0009367	http://dx.doi.org/10.1371/journal.pone.0009367			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SV	20186336	Green Published, Green Submitted, gold			2022-12-25	WOS:000274924000010
J	Shina, MC; Muller, R; Blau-Wasser, R; Glockner, G; Schleicher, M; Eichinger, L; Noegel, AA; Kolanus, W				Shina, Maria Christina; Mueller, Rolf; Blau-Wasser, Rosemarie; Gloeckner, Gernot; Schleicher, Michael; Eichinger, Ludwig; Noegel, Angelika A.; Kolanus, Waldemar			A Cytohesin Homolog in Dictyostelium Amoebae	PLOS ONE			English	Article							NUCLEOTIDE EXCHANGE FACTORS; CELL-ADHESION MOLECULE; ACTIN-BINDING; FACTOR ARNO; PROTEIN; ARF; DISCOIDEUM; FAMILY; SYSTEM; MORPHOGENESIS	Background: Dictyostelium, an amoeboid motile cell, harbors several paralogous Sec7 genes that encode members of three distinct subfamilies of the Sec7 superfamily of Guanine nucleotide exchange factors. Among them are proteins of the GBF/BIG family present in all eukaryotes. The third subfamily represented with three members in D. discoideum is the cytohesin family that has been thought to be metazoan specific. Cytohesins are characterized by a Sec7 PH tandem domain and have roles in cell adhesion and migration. Principal Findings: Dictyostelium SecG exhibits highest homologies to the cytohesins. It harbors at its amino terminus several ankyrin repeats that are followed by the Sec7 PH tandem domain. Mutants lacking SecG show reduced cell-substratum adhesion whereas cell-cell adhesion that is important for development is not affected. Accordingly, multicellular development proceeds normally in the mutant. During chemotaxis secG 2 cells elongate and migrate in a directed fashion towards cAMP, however speed is moderately reduced. Significance: The data indicate that SecG is a relevant factor for cell-substrate adhesion and reveal the basic function of a cytohesin in a lower eukaryote.	[Shina, Maria Christina; Mueller, Rolf; Blau-Wasser, Rosemarie; Gloeckner, Gernot; Eichinger, Ludwig; Noegel, Angelika A.] Univ Cologne, Ctr Mol Med Cologne, Fac Med, Ctr Biochem, Cologne, Germany; [Shina, Maria Christina; Mueller, Rolf; Blau-Wasser, Rosemarie; Gloeckner, Gernot; Eichinger, Ludwig; Noegel, Angelika A.] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, Cologne, Germany; [Gloeckner, Gernot] Fritz Lipmann Inst eV, Leibniz Inst Age Res, Jena, Germany; [Schleicher, Michael] Univ Munich, Inst Anat & Cell Biol, Munich, Germany; [Schleicher, Michael] Univ Munich, Ctr Integrated Prot Sci CIPSM, Munich, Germany; [Kolanus, Waldemar] Univ Bonn, LIMES Inst, Lab Mol Immunol, D-5300 Bonn, Germany	University of Cologne; University of Cologne; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); University of Munich; University of Munich; University of Bonn	Shina, MC (corresponding author), Univ Cologne, Ctr Mol Med Cologne, Fac Med, Ctr Biochem, Cologne, Germany.	noegel@uni-koeln.de; wkolanus@uni-bonn.de	Glöckner, Gernot/A-7800-2010; Eichinger, Ludwig/AAJ-8895-2021	Glöckner, Gernot/0000-0002-9061-1061; Eichinger, Ludwig/0000-0003-1594-6117				Arnaout MA, 2007, CURR OPIN CELL BIOL, V19, P495, DOI 10.1016/j.ceb.2007.08.002; Beraud-Dufour S, 1998, EMBO J, V17, P3651, DOI 10.1093/emboj/17.13.3651; Bloomfield G, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r75; Bozzaro S, 1995, EXPERIENTIA, V51, P1175, DOI 10.1007/BF01944735; BRINK M, 1990, J CELL BIOL, V111, P1477, DOI 10.1083/jcb.111.4.1477; Bukahrova T, 2005, J CELL SCI, V118, P4295, DOI 10.1242/jcs.02557; Casanova JE, 2007, TRAFFIC, V8, P1476, DOI 10.1111/j.1600-0854.2007.00634.x; Cherfils J, 1998, NATURE, V392, P101, DOI 10.1038/32210; Cornillon S, 2008, EUKARYOT CELL, V7, P1600, DOI 10.1128/EC.00155-08; Cornillon S, 2006, EMBO REP, V7, P617, DOI 10.1038/sj.embor.7400701; Cox R, 2004, MOL BIOL CELL, V15, P1487, DOI 10.1091/mbc.E03-06-0443; CROWLEY E, 1995, J CELL BIOL, V131, P525, DOI 10.1083/jcb.131.2.525; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; DiNitto JP, 2007, MOL CELL, V28, P569, DOI 10.1016/j.molcel.2007.09.017; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; Faix J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh136; Fey P, 2002, J CELL BIOL, V159, P1109, DOI 10.1083/jcb.200206067; Friedl P, 2004, CURR OPIN CELL BIOL, V16, P14, DOI 10.1016/j.ceb.2003.11.001; GERISCH G, 1981, J CELL SCI, V52, P1; Gillingham AK, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000842; HARLOFF C, 1989, GENE DEV, V3, P2011, DOI 10.1101/gad.3.12a.2011; Jeon TJ, 2009, DEV BIOL, V328, P210, DOI 10.1016/j.ydbio.2009.01.016; Khurana B, 2002, EMBO J, V21, P5331, DOI 10.1093/emboj/cdf550; Knuth M, 2004, J CELL SCI, V117, P5013, DOI 10.1242/jcs.01366; Kolanus W, 1996, CELL, V86, P233, DOI 10.1016/S0092-8674(00)80095-1; Kolanus W, 2007, IMMUNOL REV, V218, P102, DOI 10.1111/j.1600-065X.2007.00542.x; Mouratou B, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-20; MULLER K, 1979, EUR J BIOCHEM, V99, P419, DOI 10.1111/j.1432-1033.1979.tb13271.x; Myers KR, 2008, TRENDS CELL BIOL, V18, P184, DOI 10.1016/j.tcb.2008.02.002; Niewohner J, 1997, J CELL BIOL, V138, P349, DOI 10.1083/jcb.138.2.349; Noegel AA, 2004, MOL BIOL CELL, V15, P934, DOI 10.1091/mbc.E03-05-0269; Norman JC, 1998, J CELL BIOL, V143, P1981, DOI 10.1083/jcb.143.7.1981; Parkinson K, 2009, J CELL SCI, V122, P335, DOI 10.1242/jcs.036822; Ponte E, 1998, P NATL ACAD SCI USA, V95, P9360, DOI 10.1073/pnas.95.16.9360; Quast T, 2009, BLOOD, V113, P5801, DOI 10.1182/blood-2008-08-176123; Schaap P, 2007, BIOESSAYS, V29, P635, DOI 10.1002/bies.20599; Schreiner T, 2002, EUKARYOT CELL, V1, P906, DOI 10.1128/EC.1.6.906-914.2002; Sillo A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-291; SIMPSON PA, 1984, J CELL BIOL, V99, P287, DOI 10.1083/jcb.99.1.287; Thomason PA, 2006, PLASMID, V56, P145, DOI 10.1016/j.plasmid.2006.04.001; WEINER OH, 1993, J CELL BIOL, V123, P23, DOI 10.1083/jcb.123.1.23; Wessels D, 1998, CELL MOTIL CYTOSKEL, V41, P225, DOI 10.1002/(SICI)1097-0169(1998)41:3<225::AID-CM4>3.3.CO;2-9; WITKE W, 1992, CELL, V68, P53, DOI 10.1016/0092-8674(92)90205-Q; Wolf K, 2003, BLOOD, V102, P3262, DOI 10.1182/blood-2002-12-3791; Wong E, 2002, DEVELOPMENT, V129, P3839; Wong EFS, 1996, J BIOL CHEM, V271, P16399, DOI 10.1074/jbc.271.27.16399	46	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2010	5	2							e9378	10.1371/journal.pone.0009378	http://dx.doi.org/10.1371/journal.pone.0009378			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SV	20186335	Green Published, Green Submitted, gold			2022-12-25	WOS:000274924000019
J	Saha, T; Rih, JK; Roy, R; Ballal, R; Rosen, EM				Saha, Tapas; Rih, Jeong Keun; Roy, Rabindra; Ballal, Rahul; Rosen, Eliot M.			Transcriptional Regulation of the Base Excision Repair Pathway by BRCA1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE DNA-DAMAGE; MAMMARY EPITHELIAL-CELLS; BREAST-CANCER; IONIZING IRRADIATION; MAMMALIAN-CELLS; GENE-EXPRESSION; OVARIAN-CANCER; DIFFERENTIATION; INHIBITION; STRESS	Inactivation of the breast cancer susceptibility gene BRCA1 plays a significant role in the development of a subset of breast cancers, although the major tumor suppressor function of this gene remains unclear. Previously, we showed that BRCA1 induces antioxidant-response gene expression and protects cells against oxidative stress. We now report that BRCA1 stimulates the base excision repair pathway, a major mechanism for the repair of oxidized DNA, by stimulating the activity of key base excision repair (BER) enzymes, including 8-oxoguanine DNA glycosylase (OGG1), the DNA glycosylase NTH1, and the apurinic endonuclease redox factor 1/apurinic endonuclease 1 (REF1/APE1), in human breast carcinoma cells. The increase in BER enzyme activity appears to be due, primarily, to an increase in enzyme expression. The ability of BRCA1 to stimulate the expression of the three BER enzymes and to enhance NTH1 promoter activity was dependent upon the octamer-binding transcription factor OCT1. Finally, we found that OGG1, NTH1, and REF1/APE1 each contribute to the BRCA1 protection against oxidative stress due to hydrogen peroxide and that hydrogen peroxide stimulates the expression of BRCA1 and the three BER enzymes. These findings identify a novel mechanism through which BRCA1 may regulate the repair of oxidative DNA damage.	[Saha, Tapas; Rih, Jeong Keun; Roy, Rabindra; Ballal, Rahul; Rosen, Eliot M.] Georgetown Univ, Lombardi Comprehens Canc Ctr, Dept Oncol, Washington, DC 20057 USA	Georgetown University	Rosen, EM (corresponding author), Georgetown Univ, Lombardi Comprehens Canc Ctr, Dept Oncol, 3970 Reservoir Rd NW,Box 571469, Washington, DC 20057 USA.	emr36@georgetown.edu			National Institutes of Health, USPHS [RO1-CA80000, RO1-CA104546, R01-CA82599]; Susan G. Komen Breast Cancer Foundation [PDF0403044]; NATIONAL CANCER INSTITUTE [R01CA104546, R01CA092306, R01CA082599, R01CA080000] Funding Source: NIH RePORTER	National Institutes of Health, USPHS(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); Susan G. Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1-CA80000, RO1-CA104546, and R01-CA82599 from USPHS (to E. M. R.). This work was also supported by Grant PDF0403044 from the Susan G. Komen Breast Cancer Foundation (to E. M. R. and J. K. R.).	Adhikari S, 2006, J BIOL CHEM, V281, P29525, DOI 10.1074/jbc.M602673200; ALLEY MC, 1988, CANCER RES, V48, P589; Alli E, 2009, CANCER RES, V69, P3589, DOI 10.1158/0008-5472.CAN-08-4016; Arlt MF, 2004, MOL CELL BIOL, V24, P6701, DOI 10.1128/mcb.24.15.6701-6709.2004; Bae I, 2005, CELL CYCLE, V4, P1641, DOI 10.4161/cc.4.11.2152; Bae I, 2004, CANCER RES, V64, P7893, DOI 10.1158/0008-5472.CAN-04-1119; Cao L, 2003, GENE DEV, V17, P201, DOI 10.1101/gad.1050003; Chaudhry MA, 2007, CANCER CELL INT, V7, DOI 10.1186/1475-2867-7-15; Chen YM, 1996, CANCER RES, V56, P3168; D'Errico M, 2008, MUTAT RES-REV MUTAT, V659, P4, DOI 10.1016/j.mrrev.2007.10.003; Fan SJ, 2001, ONCOGENE, V20, P77, DOI 10.1038/sj.onc.1204073; Fan SJ, 2001, ONCOGENE, V20, P8215, DOI 10.1038/sj.onc.1205033; Fan SJ, 1998, ONCOGENE, V16, P3069, DOI 10.1038/sj.onc.1202116; Fan WH, 2002, J BIOL CHEM, V277, P8061, DOI 10.1074/jbc.M110225200; Galli F, 2005, CONTRIB NEPHROL, V149, P240, DOI 10.1159/000085686; Goto M, 2009, CARCINOGENESIS, V30, P1345, DOI 10.1093/carcin/bgp108; Gudas JM, 1996, CELL GROWTH DIFFER, V7, P717; Hegde ML, 2008, CELL RES, V18, P27, DOI 10.1038/cr.2008.8; Izumi T, 2003, TOXICOLOGY, V193, P43, DOI 10.1016/S0300-483X(03)00289-0; Jayaraman L, 1997, GENE DEV, V11, P558, DOI 10.1101/gad.11.5.558; Jeng YM, 2007, ONCOGENE, V26, P6160, DOI 10.1038/sj.onc.1210451; Kang JS, 2009, GENE DEV, V23, P208, DOI 10.1101/gad.1750709; Kelley MR, 2001, ANTIOXID REDOX SIGN, V3, P671, DOI 10.1089/15230860152543014; Kubista M, 2002, ONCOGENE, V21, P4747, DOI 10.1038/sj.onc.1205580; Litman R, 2008, ANTI-CANCER AGENT ME, V8, P426, DOI 10.2174/187152008784220285; MARQUIS ST, 1995, NAT GENET, V11, P17, DOI 10.1038/ng0995-17; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Mitra S, 1997, MOL CELLS, V7, P305; Moynahan ME, 1999, MOL CELL, V4, P511, DOI 10.1016/S1097-2765(00)80202-6; Nyaga SG, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-297; Rajan JV, 1997, DEV BIOL, V184, P385, DOI 10.1006/dbio.1997.8526; Rajan JV, 1996, P NATL ACAD SCI USA, V93, P13078, DOI 10.1073/pnas.93.23.13078; Rosen EM, 2006, CANCER LETT, V236, P175, DOI 10.1016/j.canlet.2005.04.037; Ruffner H, 2001, P NATL ACAD SCI USA, V98, P5134, DOI 10.1073/pnas.081068398; Saha T, 2009, FEBS LETT, V583, P1535, DOI 10.1016/j.febslet.2009.04.005; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Seo YR, 2002, P NATL ACAD SCI USA, V99, P14548, DOI 10.1073/pnas.212319799; Staff S, 2003, CANCER RES, V63, P4978; Starita LM, 2006, CANCER BIOL THER, V5, P137, DOI 10.4161/cbt.5.2.2479; Stark JM, 2004, MOL CELL BIOL, V24, P9305, DOI 10.1128/MCB.24.21.9305-9316.2004; Tantin D, 2005, CANCER RES, V65, P10750, DOI 10.1158/0008-5472.CAN-05-2399; Ting NSY, 2004, DNA REPAIR, V3, P935, DOI 10.1016/j.dnarep.2004.03.026; Trzeciak AR, 2004, CARCINOGENESIS, V25, P1359, DOI 10.1093/carcin/bgh144; Turner NC, 2007, ONCOGENE, V26, P2126, DOI 10.1038/sj.onc.1210014; Vaughn JP, 1996, CELL GROWTH DIFFER, V7, P711; Vijg J, 2001, ANN NY ACAD SCI, V928, P85; Wang VEH, 2004, MOL CELL BIOL, V24, P1022, DOI 10.1128/MCB.24.3.1022-1032.2004; Weberpals JI, 2008, J CLIN ONCOL, V26, P3259, DOI 10.1200/JCO.2007.11.3902; Wilson CA, 1999, NAT GENET, V21, P236, DOI 10.1038/6029; Windhofer F, 2007, INT J RADIAT ONCOL, V68, P1462, DOI 10.1016/j.ijrobp.2007.04.038; Xiong JB, 2003, MOL CELL BIOL, V23, P8668, DOI 10.1128/MCB.23.23.8668-8690.2003; Xu B, 2001, MOL CELL BIOL, V21, P3445, DOI 10.1128/MCB.21.10.3445-3450.2001; Yacoub A, 1997, CANCER RES, V57, P5457	53	55	60	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19092	19105		10.1074/jbc.M110.104430	http://dx.doi.org/10.1074/jbc.M110.104430			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20185827	Green Published, hybrid			2022-12-25	WOS:000278727800019
J	Krapf, G; Kaindl, U; Kilbey, A; Fuka, G; Inthal, A; Joas, R; Mann, G; Neil, JC; Haas, OA; Panzer-Grumayer, ER				Krapf, G.; Kaindl, U.; Kilbey, A.; Fuka, G.; Inthal, A.; Joas, R.; Mann, G.; Neil, J. C.; Haas, O. A.; Panzer-Gruemayer, E. R.			ETV6/RUNX1 abrogates mitotic checkpoint function and targets its key player MAD2L1	ONCOGENE			English	Article						ETV6/RUNX1; t(12;21); acute lymphoblastic leukemia; mitotic checkpoint MAD2L1; tetraploidy	ACUTE LYMPHOBLASTIC-LEUKEMIA; PROMOTES ANEUPLOIDY; NEAR-TETRAPLOIDY; CBF ONCOPROTEINS; CELL BIOLOGY; DNA-BINDING; FUSION; CANCER; PROTEIN; GENE	Approximately 25% of childhood B-cell precursor acute lymphoblastic leukemia have an ETV6/RUNX1 (E/R) gene fusion that results from a t(12;21). This genetic subgroup of leukemia is associated with near-triploidy, near-tetraploidy, and trisomy 21 as rather specific types of secondary changes. Here, we show that, unlike various controls, E/R-expressing Ba/F3 clones acquire a tetraploid karyotype on prolonged culture, corroborating the assumption that E/R may attenuate the mitotic checkpoint (MC). Consistent with this notion, E/R-expressing diploid murine and human cell lines have decreased proportions of cells with 4N DNA content and a lower mitotic index when treated with spindle toxins. Moreover, both RUNX1 and E/R regulate mitotic arrest-deficient 2 L1 (MAD2L1), an essential MC component, by binding to promoter-inherent RUNX1 sites, which results in down-regulation of MAD2L1 mRNA and protein in E/R-expressing cells. Forced expression of E/R also abolishes RUNX1-induced reporter activation, whereas E/R with a mutant DNA-binding site leads to only minor effects. Our data link for the first time E/R, MC, and MAD2L1 and provide new insights into the function of the E/R fusion gene product. Although tetraploidy is an almost exclusive feature of E/R-positive leukemias, its rarity within this particular subgroup implies that further yet unknown factors are required for its manifestation. Oncogene (2010) 29, 3307-3312; doi: 10.1038/onc.2010.53; published online 1 March 2010	[Panzer-Gruemayer, E. R.] Childrens Canc Res Inst, Leukemia Biol Grp, A-1090 Vienna, Austria; [Kilbey, A.; Neil, J. C.] Fac Vet Med, Inst Comparat Med, Mol Oncol Lab, Glasgow, Lanark, Scotland; [Mann, G.; Haas, O. A.; Panzer-Gruemayer, E. R.] St Anna Childrens Hosp, Vienna, Austria	Saint Anna Children's Hospital; University of Glasgow; Saint Anna Children's Hospital	Panzer-Grumayer, ER (corresponding author), Childrens Canc Res Inst, Leukemia Biol Grp, Zimmermannpl 10, A-1090 Vienna, Austria.	renate.panzer@ccri.at	Haas, Oskar/AAM-5794-2020		FWF [P17551-B14]; Austrian Ministry for Education, Science and Culture; St Anna Kinderkrebsforschung; Leukaemia Research Fund	FWF(Austrian Science Fund (FWF)); Austrian Ministry for Education, Science and Culture; St Anna Kinderkrebsforschung; Leukaemia Research Fund	We thank O Williams for expression vectors containing E/R or the mutant E/R, D-E Zhang for the RUNX1-expression vector, A Friedman for CBFb-expression vector, D Guardavaccaro for the luciferase reporter plasmid for the MAD2L1 promoter in pGL3, JD Rowley for AT-2 cell line, L Orel for the Myc-ETV6/RUNX1 vector, Idriss M Bennani-Baiti for stimulating discussions, and Marion Zavadil for proofreading the paper. This study was supported in part by a grant from the FWF P17551-B14 and the Austrian Ministry for Education, Science and Culture (GENAU-Ch.I.L.D) and the St Anna Kinderkrebsforschung to ER P-G. A Kilbey is funded by the Leukaemia Research Fund. GK participated in the design of the study, performed experiments, interpreted data, and wrote the paper. UK, GF, AI, RJ performed research and interpreted data. AK performed and interpreted ChIP experiments. JCN participated in study design and interpretation of ChIP data. GM contributed patient samples. OAH participated in the interpretation of data and writing of the paper. ER P-G designed and supervised research and wrote the paper.	Attarbaschi A, 2006, GENE CHROMOSOME CANC, V45, P608, DOI 10.1002/gcc.20324; Attarbaschi A, 2004, LEUKEMIA, V18, P1611, DOI 10.1038/sj.leu.2403471; Boyapati A, 2007, BLOOD, V109, P3963, DOI 10.1182/blood-2006-09-045583; Diakos C, 2007, BLOOD, V109, P2607, DOI 10.1182/blood-2006-04-019612; Fang Y, 2006, ONCOGENE, V25, P3598, DOI 10.1038/sj.onc.1209392; Ford AM, 2009, J CLIN INVEST, V119, P826, DOI 10.1172/JCI36428; Friedman AD, 1999, LEUKEMIA, V13, P1932, DOI 10.1038/sj.leu.2401590; Guardavaccaro D, 2008, NATURE, V452, P365, DOI 10.1038/nature06641; Ha GH, 2007, CANCER RES, V67, P7155, DOI 10.1158/0008-5472.CAN-06-3392; Hiebert SW, 1996, MOL CELL BIOL, V16, P1349; Hong DL, 2008, SCIENCE, V319, P336, DOI 10.1126/science.1150648; Kops GJPL, 2005, NAT REV CANCER, V5, P773, DOI 10.1038/nrc1714; Li Z, 2003, J BIOL CHEM, V278, P33088, DOI 10.1074/jbc.M303973200; Lou JR, 2000, ONCOGENE, V19, P2695, DOI 10.1038/sj.onc.1203588; Michel L, 2004, CELL CYCLE, V3, P990; Morrow M, 2007, ONCOGENE, V26, P4404, DOI 10.1038/sj.onc.1210227; Perez de Castro I, 2007, CARCINOGENESIS, V28, P899, DOI 10.1093/carcin/bgm019; Peters JM, 2007, NATURE, V446, P868, DOI 10.1038/446868a; Pines J, 2006, TRENDS CELL BIOL, V16, P55, DOI 10.1016/j.tcb.2005.11.006; Pui C, 2004, NEW ENGL J MED, V350, P1535, DOI 10.1056/NEJMra023001; Raimondi SC, 2006, CANCER GENET CYTOGEN, V169, P50, DOI 10.1016/j.cancergencyto.2006.04.006; Ross ME, 2003, BLOOD, V102, P2951, DOI 10.1182/blood-2003-01-0338; Roudaia L, 2009, BLOOD, V113, P3070, DOI 10.1182/blood-2008-03-147207; Sasaki A, 2004, BIOCHEM BIOPH RES CO, V317, P1128, DOI 10.1016/j.bbrc.2004.03.172; Song WJ, 1999, NAT GENET, V23, P166, DOI 10.1038/13793; Sotillo R, 2007, CANCER CELL, V11, P9, DOI 10.1016/j.ccr.2006.10.019; Speck NA, 2002, NAT REV CANCER, V2, P502, DOI 10.1038/nrc840; Strom DK, 2000, J BIOL CHEM, V275, P3438, DOI 10.1074/jbc.275.5.3438; Weaver BAA, 2005, CANCER CELL, V8, P7, DOI 10.1016/j.ccr.2005.06.011; Wolyniec K, 2009, ONCOGENE, V28, P2502, DOI 10.1038/onc.2009.101; Wotton S, 2008, ONCOGENE, V27, P5856, DOI 10.1038/onc.2008.195; Zelent A, 2004, ONCOGENE, V23, P4275, DOI 10.1038/sj.onc.1207672	32	15	15	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUN 3	2010	29	22					3307	3312		10.1038/onc.2010.53	http://dx.doi.org/10.1038/onc.2010.53			6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	605BA	20190817	Green Accepted			2022-12-25	WOS:000278321100013
J	Li, P; Wang, D; Yao, H; Doret, P; Hao, G; Shen, Q; Qiu, H; Zhang, X; Wang, Y; Chen, G; Wang, Y				Li, P.; Wang, D.; Yao, H.; Doret, P.; Hao, G.; Shen, Q.; Qiu, H.; Zhang, X.; Wang, Y.; Chen, G.; Wang, Y.			Coordination of PAD4 and HDAC2 in the regulation of p53-target gene expression	ONCOGENE			English	Article						histone citrullination; histone deacetylation; PAD4; HDAC2; p53	TRANSCRIPTIONAL REGULATION; CHROMATIN MODIFICATIONS; ARGININE METHYLATION; STRUCTURAL BASIS; HISTONE; P53; ACTIVATION; ACETYLATION; NUCLEOSOME; REPRESSION	Histone Arg methylation and Lys acetylation have been found to cooperatively regulate the expression of p53-target genes. Peptidylarginine deiminase 4 (PAD4) is an enzyme that citrullinates histone arginine and monomethyl-arginine residues thereby regulating histone Arg methylation. We have recently found that PAD4 serves as a p53 corepressor to regulate histone Arg methylation at the p53-target gene p21/WAF1/CIP1 promoter. However, it has not been tested whether histone Arg citrullination coordinates with other histone modifications to repress transcription. Here, we show that histone deacetylase (HDAC2) and PAD4 interact with p53 through distinct domains and simultaneously associate with the p21 promoter to regulate gene expression. After DNA damage, PAD4 and HDAC2 dissociate from several p53-target gene promoters (for example, p21, GADD45, and PUMA) with a concomitant increase in histone Lys acetylation and Arg methylation at these promoters. Furthermore, PAD4 promoter association and histone Arg modifications are regulated by p53 and HDAC activity. In contrast, HDAC2 promoter association and histone Lys acetylation are affected by p53 and PAD4 activity at minor degrees. Importantly, PAD4 inhibitor Cl-amidine and HDAC inhibitor suberoylanilide hydroxamic acid show additive effects in inducing p21, GADD45, and PUMA expression and inhibiting cancer cell growth in a p53-dependent manner. Our results unveil an important crosstalk between histone deacetylation and citrullination, suggesting that a combination of PAD4 and HDAC2 inhibitors as a potential strategy for cancer treatment. Oncogene (2010) 29, 3153-3162; doi: 10.1038/onc.2010.51; published online 1 March 2010	[Li, P.; Wang, D.; Yao, H.; Doret, P.; Shen, Q.; Wang, Y.] Penn State Univ, Dept Biochem & Mol Biol, Ctr Eukaryot Gene Regulat, 454 N Frear, University Pk, PA 16802 USA; [Hao, G.] Cornell Univ, Dept Pharmacol, Weill Med Coll, New York, NY 10021 USA; [Qiu, H.; Wang, Y.] Univ Calif Riverside, Dept Chem 027, Riverside, CA 92521 USA; [Zhang, X.] Univ S Florida, Coll Med, Dept Pathol & Cell Biol, Tampa, FL USA; [Chen, G.] Penn State Univ, Dept Chem, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Cornell University; University of California System; University of California Riverside; State University System of Florida; University of South Florida; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Wang, Y (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, Ctr Eukaryot Gene Regulat, 454 N Frear, University Pk, PA 16802 USA.	yuw12@psu.edu	Chen, Gong/A-8063-2013	Chen, Gong/0000-0002-5067-9889; Wang, Yanming/0000-0002-0710-043X	PSU; NIH [R01 CA136856, R01 CA116522]; NATIONAL CANCER INSTITUTE [R01CA116522, R01CA136856] Funding Source: NIH RePORTER	PSU; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to Drs JC Reese, DS Gilmour, BF Pugh, and S Tan for discussions and helpful comments. Research is supported in part by a PSU start-up fund and NIH Grants R01 CA136856 to YW (PSU) and R01 CA116522 to YW (UC Riverside).	An W, 2004, CELL, V117, P735, DOI 10.1016/j.cell.2004.05.009; Arita K, 2004, NAT STRUCT MOL BIOL, V11, P777, DOI 10.1038/nsmb799; Baek HJ, 2002, MOL CELL BIOL, V22, P2842, DOI 10.1128/MCB.22.8.2842-2852.2002; Barlev NA, 2001, MOL CELL, V8, P1243, DOI 10.1016/S1097-2765(01)00414-2; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Causey CP, 2008, TETRAHEDRON LETT, V49, P4383, DOI 10.1016/j.tetlet.2008.05.021; Chang XT, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-40; Chang XT, 2006, MOL CARCINOGEN, V45, P183, DOI 10.1002/mc.20169; Cuthbert GL, 2004, CELL, V118, P545, DOI 10.1016/j.cell.2004.08.020; Dannenberg JH, 2005, GENE DEV, V19, P1581, DOI 10.1101/gad.1286905; Espinosa JM, 2001, MOL CELL, V8, P57, DOI 10.1016/S1097-2765(01)00283-0; Fischle W, 2003, CURR OPIN CELL BIOL, V15, P172, DOI 10.1016/S0955-0674(03)00013-9; Gui CY, 2004, P NATL ACAD SCI USA, V101, P1241, DOI 10.1073/pnas.0307708100; Harms KL, 2007, CANCER RES, V67, P3145, DOI 10.1158/0008-5472.CAN-06-4397; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Ho J, 2003, CELL DEATH DIFFER, V10, P404, DOI 10.1038/sj.cdd.4401191; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kitayner M, 2006, MOL CELL, V22, P741, DOI 10.1016/j.molcel.2006.05.015; Klose RJ, 2007, NAT REV MOL CELL BIO, V8, P307, DOI 10.1038/nrm2143; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Laptenko O, 2006, CELL DEATH DIFFER, V13, P951, DOI 10.1038/sj.cdd.4401916; Levesque AA, 2007, CARCINOGENESIS, V28, P13, DOI 10.1093/carcin/bgl214; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li PX, 2008, MOL CELL BIOL, V28, P4745, DOI 10.1128/MCB.01747-07; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Luo JY, 2000, NATURE, V408, P377, DOI 10.1038/35042612; Marks PA, 2007, NAT BIOTECHNOL, V25, P84, DOI 10.1038/nbt1272; Minucci S, 2006, NAT REV CANCER, V6, P38, DOI 10.1038/nrc1779; Shi YH, 2001, GENE DEV, V15, P1140, DOI 10.1101/gad.871201; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Turner BM, 2000, BIOESSAYS, V22, P836, DOI 10.1002/1521-1878(200009)22:9<836::AID-BIES9>3.0.CO;2-X; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wang Y, 2004, SCIENCE, V306, P279, DOI 10.1126/science.1101400; Yao HJ, 2008, J BIOL CHEM, V283, P20060, DOI 10.1074/jbc.M802940200	38	91	98	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 27	2010	29	21					3153	3162		10.1038/onc.2010.51	http://dx.doi.org/10.1038/onc.2010.51			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	602IQ	20190809	Green Accepted			2022-12-25	WOS:000278133100012
J	Oh, SJ; Santy, LC				Oh, Seung Ja; Santy, Lorraine C.			Differential Effects of Cytohesins 2 and 3 on beta 1 Integrin Recycling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-ADHESION; ACTIN CYTOSKELETON; INTEGRIN BETA-1; GROWTH-FACTOR; SEC7 FAMILY; ARF; PROTEIN; ACTIVATION; MEMBRANE; TRANSLOCATION	ADP-ribosylation actor 6 (ARF6) regulates the endocytosis and recycling of a variety of proteins and also promotes peripheral actin rearrangements and cell motility. ARF6 is activated by a large number of guanine nucleotide exchange factors, which likely regulate ARF6 at different locations and during different processes. In this study we investigate the roles of the cytohesin ADP-ribosylation factor (ARF)-guanine nucleotide exchange factors during the recycling of integrin beta 1. Intriguingly, we find that knockdown and overexpression of ARNO/cytohesin 2 and GRP1/cytohesin 3 have opposing effects on cell adhesion and spreading on fibronectin and on cell migration. We find that ARNO/cytohesin 2 is required for integrin beta 1 recycling, whereas GRP1/cytohesin 3 is dispensable for this process. This is the first demonstration of unique roles for these proteins.	[Oh, Seung Ja; Santy, Lorraine C.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Santy, LC (corresponding author), 408 S Frear, University Pk, PA 16802 USA.	lcsanty@psu.edu	Oh, Seung Ja/ABC-6168-2021	Oh, Seung Ja/0000-0002-4572-0656; Santy, Lorraine/0000-0002-4795-0738	American Heart Association [SDG 0730229N]; Pennsylvania State University	American Heart Association(American Heart Association); Pennsylvania State University	This work was supported by American Heart Association Grant SDG 0730229N (to L. C. S.) and by funds from The Pennsylvania State University.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Boehm T, 2003, EMBO J, V22, P1014, DOI 10.1093/emboj/cdg101; Boshans RL, 2000, MOL CELL BIOL, V20, P3685, DOI 10.1128/MCB.20.10.3685-3694.2000; BRETSCHER MS, 1992, EMBO J, V11, P405, DOI 10.1002/j.1460-2075.1992.tb05068.x; Casanova JE, 2007, TRAFFIC, V8, P1476, DOI 10.1111/j.1600-0854.2007.00634.x; Caswell P, 2008, TRENDS CELL BIOL, V18, P257, DOI 10.1016/j.tcb.2008.03.004; Chavrier P, 1999, CURR OPIN CELL BIOL, V11, P466, DOI 10.1016/S0955-0674(99)80067-2; Clodi M, 1998, ENDOCRINOLOGY, V139, P4984, DOI 10.1210/en.139.12.4984; Cox R, 2004, MOL BIOL CELL, V15, P1487, DOI 10.1091/mbc.E03-06-0443; D'Souza-Schorey C, 2005, TRENDS CELL BIOL, V15, P19, DOI 10.1016/j.tcb.2004.11.002; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Dahl KDC, 2005, MOL BIOL CELL, V16, P1901; DiNitto JP, 2007, MOL CELL, V28, P569, DOI 10.1016/j.molcel.2007.09.017; Donaldson JG, 2000, CURR OPIN CELL BIOL, V12, P475, DOI 10.1016/S0955-0674(00)00119-8; Dunphy JL, 2006, CURR BIOL, V16, P315, DOI 10.1016/j.cub.2005.12.032; Frank SR, 1998, MOL BIOL CELL, V9, P3133, DOI 10.1091/mbc.9.11.3133; Geiger C, 2000, EMBO J, V19, P2525, DOI 10.1093/emboj/19.11.2525; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; Grant BD, 2009, NAT REV MOL CELL BIO, V10, P597, DOI 10.1038/nrm2755; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Hafner M, 2006, NATURE, V444, P941, DOI 10.1038/nature05415; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jackson CL, 2000, TRENDS CELL BIOL, V10, P60, DOI 10.1016/S0962-8924(99)01699-2; Klarlund JK, 2001, J BIOL CHEM, V276, P40065, DOI 10.1074/jbc.M105260200; Klarlund JK, 1997, SCIENCE, V275, P1927, DOI 10.1126/science.275.5308.1927; Kolanus W, 1996, CELL, V86, P233, DOI 10.1016/S0092-8674(00)80095-1; LAWSON MA, 1995, NATURE, V377, P75, DOI 10.1038/377075a0; Le TL, 2002, AM J PHYSIOL-CELL PH, V283, pC489, DOI 10.1152/ajpcell.00566.2001; Li J, 2005, DEV CELL, V9, P663, DOI 10.1016/j.devcel.2005.09.012; Mansour M, 2002, J BIOL CHEM, V277, P32302, DOI 10.1074/jbc.M202898200; Nevrivy DJ, 2000, J BIOL CHEM, V275, P16827, DOI 10.1074/jbc.275.22.16827; Ogasawara M, 2000, J BIOL CHEM, V275, P3221, DOI 10.1074/jbc.275.5.3221; Powelka AM, 2004, TRAFFIC, V5, P20, DOI 10.1111/j.1600-0854.2004.00150.x; Radhakrishna H, 1996, J CELL BIOL, V134, P935, DOI 10.1083/jcb.134.4.935; Santy LC, 2001, J CELL BIOL, V154, P599, DOI 10.1083/jcb.200104019; Turner CE, 2001, CURR BIOL, V11, pR875, DOI 10.1016/S0960-9822(01)00521-8; van der Flier A, 2001, CELL TISSUE RES, V305, P285, DOI 10.1007/s004410100417; Venkateswarlu K, 2003, J BIOL CHEM, V278, P43460, DOI 10.1074/jbc.M304078200; Venkateswarlu K, 1998, BIOCHEM J, V335, P139, DOI 10.1042/bj3350139	39	37	37	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14610	14616		10.1074/jbc.M109.043935	http://dx.doi.org/10.1074/jbc.M109.043935			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20223830	Green Published, hybrid			2022-12-25	WOS:000277299700058
J	Gao, Y; Yao, A; Zhang, W; Lu, S; Yu, Y; Deng, L; Yin, A; Xia, Y; Sun, B; Wang, X				Gao, Y.; Yao, A.; Zhang, W.; Lu, S.; Yu, Y.; Deng, L.; Yin, A.; Xia, Y.; Sun, B.; Wang, X.			Human mesenchymal stem cells overexpressing pigment epithelium-derived factor inhibit hepatocellular carcinoma in nude mice	ONCOGENE			English	Article						mesenchymal stem cells; PEDF; lentiviral vectors; hepatocellular carcinoma; angiogenesis	LUNG METASTASIS MODEL; GENE-THERAPY; TARGETED-DELIVERY; FACTOR EXPRESSION; PROSTATE-CANCER; INTERFERON-BETA; TUMOR STROMA; IN-VITRO; ANGIOGENESIS; GROWTH	The poor outcome of cancer gene therapy in clinical trials relates in part to insufficient gene delivery to tumor sites. Mesenchymal stem cells (MSCs) represent a new tool for the delivery of therapeutic agents to tumor cells. This study used an orthotopic nude mice model of hepatocellular carcinoma (HCC) to evaluate the potential of genetically modified human MSCs (hMSCs), to function as an effective delivery vehicle for therapeutic genes. hMSCs derived from the bone marrow were efficiently engineered to express human pigment epithelium-derived factor (PEDF) by lentiviral transduction, then tested in vitro for high-level expression and bioactivity of the transgenic protein. The preferential homing of hMSCs toward HCC was confirmed by in vitro and in vivo migration assays. in vivo efficacy experiments showed that intravenous (i.v.) injection of PEDF-expressing hMSCs significantly suppressed both the growth of primary liver tumors and the development of pulmonary metastases. Moreover, hMSCs-based PEDF gene delivery moderately increased the systemic levels of human PEDF. Immunohistochemistry of primary liver tumors demonstrated lower microvessel density in mice treated with hMSCs-PEDF than in control mice. This is the first study to show the potential of hMSCs as an effective delivery vehicle for therapeutic genes in the treatment of HCC. Oncogene (2010) 29, 2784-2794; doi: 10.1038/onc.2010.38; published online 1 March 2010	[Wang, X.] Nanjing Med Univ, Liver Transplantat Ctr, Affiliated Hosp 1, Nanjing 210029, Jiangsu, Peoples R China; Nanjing Med Univ, Ctr Canc, Nanjing 210029, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Wang, X (corresponding author), Nanjing Med Univ, Liver Transplantat Ctr, Affiliated Hosp 1, Nanjing 210029, Jiangsu, Peoples R China.	sunbc@njmu.edu.cn; wangxh@njmu.edu.cn			Jiangsu Province's Outstanding Medical Academic Leader program [RC2007057]; Jiangsu Province's Key Medical Centre [2006-50]; Natural Science Foundation of China [30672367, 30772003]; Ministry of Health, China [Wkj2006-2-021]; New Century Excellent Talents in University; Ministry of Education	Jiangsu Province's Outstanding Medical Academic Leader program; Jiangsu Province's Key Medical Centre; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Health, China; New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Ministry of Education	This study was supported by grants from Jiangsu Province's Outstanding Medical Academic Leader program (RC2007057 to BS and YG), Jiangsu Province's Key Medical Centre (2006-50 to XW) and grants from the Natural Science Foundation of China (30672367 and 30772003 to BS), Ministry of Health, China (Wkj2006-2-021 to BS), New Century Excellent Talents in University, the Ministry of Education (To BS).	Bernardo ME, 2007, CANCER RES, V67, P9142, DOI 10.1158/0008-5472.CAN-06-4690; Cai J, 2006, CLIN CANCER RES, V12, P3510, DOI 10.1158/1078-0432.CCR-06-0094; Chang CJ, 2007, HEPATOLOGY, V45, P746, DOI 10.1002/hep.21560; Chen QR, 2001, MOL GENET METAB, V74, P120, DOI 10.1006/mgme.2001.3223; Dawson DW, 1999, SCIENCE, V285, P245, DOI 10.1126/science.285.5425.245; Dwyer RM, 2007, CLIN CANCER RES, V13, P5020, DOI 10.1158/1078-0432.CCR-07-0731; Ek ETH, 2007, CANCER GENE THER, V14, P616, DOI 10.1038/sj.cgt.7701044; Filleur S, 2005, CANCER RES, V65, P5144, DOI 10.1158/0008-5472.CAN-04-3744; Fritz V, 2008, CURR STEM CELL RES T, V3, P32, DOI 10.2174/157488808783489462; GAO Yun, 2009, Zhonghua Gan Zang Bing Za Zhi, V17, P363; Garcia M, 2004, CANCER RES, V64, P5632, DOI 10.1158/0008-5472.CAN-04-0230; Guan M, 2003, J CLIN PATHOL, V56, P277, DOI 10.1136/jcp.56.4.277; Halin S, 2004, CANCER RES, V64, P5664, DOI 10.1158/0008-5472.CAN-04-0835; HARALABOPOULOS GC, 1994, LAB INVEST, V71, P575; Hung SC, 2005, CLIN CANCER RES, V11, P7749, DOI 10.1158/1078-0432.CCR-05-0876; Kanehira M, 2007, CANCER GENE THER, V14, P894, DOI 10.1038/sj.cgt.7701079; Khakoo AY, 2006, J EXP MED, V203, P1235, DOI 10.1084/jem.20051921; Kidd S, 2009, STEM CELLS, V27, P2614, DOI 10.1002/stem.187; Kikuchi E, 2004, CLIN CANCER RES, V10, P1835, DOI 10.1158/1078-0432.CCR-03-0099; Komarova S, 2006, MOL CANCER THER, V5, P755, DOI 10.1158/1535-7163.MCT-05-0334; Lau WY, 2008, HEPATOB PANCREAT DIS, V7, P237; Lee TK, 2005, CLIN CANCER RES, V11, P8458, DOI 10.1158/1078-0432.CCR-05-0447; Matsumoto K, 2004, HEPATOLOGY, V40, P252, DOI 10.1002/hep.20259; Mittler J, 2008, TRANSPLANTATION, V86, P895, DOI 10.1097/TP.0b013e318186ad7a; Mizuguchi H, 2005, BIOCHEM BIOPH RES CO, V332, P1101, DOI 10.1016/j.bbrc.2005.05.055; Nakamizo A, 2005, CANCER RES, V65, P3307, DOI 10.1158/0008-5472.CAN-04-1874; Ou-Yang F, 2006, CANCER RES, V66, P378, DOI 10.1158/0008-5472.CAN-05-1578; Persano L, 2007, MOL ASPECTS MED, V28, P87, DOI 10.1016/j.mam.2006.12.005; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Ren C, 2008, GENE THER, V15, P1446, DOI 10.1038/gt.2008.101; Ren CC, 2008, STEM CELLS, V26, P2332, DOI 10.1634/stemcells.2008-0084; Sotiropoulou PA, 2006, STEM CELLS, V24, P462, DOI 10.1634/stemcells.2004-0331; Streck CJ, 2005, J PEDIATR SURG, V40, P236, DOI 10.1016/j.jpedsurg.2004.09.049; Studeny M, 2004, JNCI-J NATL CANCER I, V96, P1593, DOI 10.1093/jnci/djh299; Studeny M, 2002, CANCER RES, V62, P3603; TOMBRANTINK J, 1989, INVEST OPHTH VIS SCI, V30, P1700; Uehara H, 2004, CANCER RES, V64, P3533, DOI 10.1158/0008-5472.CAN-03-3725; Van Damme A, 2006, STEM CELLS, V24, P896, DOI 10.1634/stemcells.2003-0106; Yang ZF, 2008, ANAT REC, V291, P721, DOI 10.1002/ar.20668; Yoon SK, 2001, CANCER GENE THER, V8, P573, DOI 10.1038/sj.cgt.7700345	40	75	92	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2010	29	19					2784	2794		10.1038/onc.2010.38	http://dx.doi.org/10.1038/onc.2010.38			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	595DW	20190814				2022-12-25	WOS:000277591900004
J	Appledorn, DM; Aldhamen, YA; DePas, W; Seregin, SS; Liu, CJJ; Schuldt, N; Quach, D; Quiroga, D; Godbehere, S; Zlatkin, I; Kim, S; McCormick, JJ; Amalfitano, A				Appledorn, Daniel M.; Aldhamen, Yasser A.; DePas, William; Seregin, Sergey S.; Liu, Chyong-Jy J.; Schuldt, Nathan; Quach, Darin; Quiroga, Dionisia; Godbehere, Sarah; Zlatkin, Igor; Kim, Sungjin; McCormick, J. Justin; Amalfitano, Andrea			A New Adenovirus Based Vaccine Vector Expressing an Eimeria tenella Derived TLR Agonist Improves Cellular Immune Responses to an Antigenic Target	PLOS ONE			English	Article							DENDRITIC CELLS; T-CELLS; IN-VIVO; ACTIVATION; EXPANSION; EFFICACY; PROTEIN; CD4; NK	Background: Adenoviral based vectors remain promising vaccine platforms for use against numerous pathogens, including HIV. Recent vaccine trials utilizing Adenovirus based vaccines expressing HIV antigens confirmed induction of cellular immune responses, but these responses failed to prevent HIV infections in vaccinees. This illustrates the need to develop vaccine formulations capable of generating more potent T-cell responses to HIV antigens, such as HIV-Gag, since robust immune responses to this antigen correlate with improved outcomes in long-term non-progressor HIV infected individuals. Methodology/Principal Findings: In this study we designed a novel vaccine strategy utilizing an Ad-based vector expressing a potent TLR agonist derived from Eimeria tenella as an adjuvant to improve immune responses from a [E1-]Ad-based HIV-Gag vaccine. Our results confirm that expression of rEA elicits significantly increased TLR mediated innate immune responses as measured by the influx of plasma cytokines and chemokines, and activation of innate immune responding cells. Furthermore, our data show that the quantity and quality of HIV-Gag specific CD8(+) and CD8(-) T-cell responses were significantly improved when coupled with rEA expression. These responses also correlated with a significantly increased number of HIV-Gag derived epitopes being recognized by host T cells. Finally, functional assays confirmed that rEA expression significantly improved antigen specific CTL responses, in vivo. Moreover, we show that these improved responses were dependent upon improved TLR pathway interactions. Conclusion/Significance: The data presented in this study illustrate the potential utility of Ad-based vectors expressing TLR agonists to improve clinical outcomes dependent upon induction of robust, antigen specific immune responses.	[Appledorn, Daniel M.; Aldhamen, Yasser A.; DePas, William; Seregin, Sergey S.; Liu, Chyong-Jy J.; Schuldt, Nathan; Quach, Darin; Quiroga, Dionisia; Godbehere, Sarah; Kim, Sungjin; McCormick, J. Justin; Amalfitano, Andrea] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA; [Zlatkin, Igor; McCormick, J. Justin] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA	Michigan State University; Michigan State University	Appledorn, DM (corresponding author), Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA.	amalfit1@msu.edu	Quiroga, Dionisia/ABH-7893-2020	Quiroga, Dionisia/0000-0003-3388-7069; Aldhamen, Yasser/0000-0002-9560-8013; Quach, Darin/0000-0002-3244-5376; Schuldt, Nathan/0000-0001-7692-4814; DePas, William/0000-0001-8532-2567	National Institutes of Health [RO1DK-069884, P01 CA078673]; Michigan State University (MSU) Foundation; Osteopathic Heritage Foundation; Michigan State University Center; National Institute of Environmental Health Sciences [T32ES007255]; NATIONAL CANCER INSTITUTE [P01CA078673] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069884] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007255] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michigan State University (MSU) Foundation; Osteopathic Heritage Foundation; Michigan State University Center; National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	A. A. was supported by the National Institutes of Health grants RO1DK-069884 and P01 CA078673, the Michigan State University (MSU) Foundation, as well the Osteopathic Heritage Foundation. D. M. A. was supported by the Michigan State University Center for Integrative Toxicology (MSU-CIT) program through award number T32ES007255 from the National Institute of Environmental Health Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appledorn DM, 2008, GENE THER, V15, P885, DOI 10.1038/gt.2008.18; Appledorn DM, 2009, J INNATE IMMUN, V1, P376, DOI 10.1159/000207194; Appledorn DM, 2008, J IMMUNOL, V181, P2134, DOI 10.4049/jimmunol.181.3.2134; Benlahrech A, 2009, P NATL ACAD SCI USA, V106, P19940, DOI 10.1073/pnas.0907898106; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Casimiro DR, 2003, J VIROL, V77, P6305, DOI 10.1128/JVI.77.11.6305-6313.2003; Cerullo V, 2007, MOL THER, V15, P378, DOI 10.1038/sj.mt.6300031; Dyer WB, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-112; Fujii S, 2003, J EXP MED, V198, P267, DOI 10.1084/jem.20030324; Gowen BB, 2006, ANTIMICROB AGENTS CH, V50, P2023, DOI 10.1128/AAC.01473-05; Hartman ZC, 2008, VIRUS RES, V132, P1, DOI 10.1016/j.virusres.2007.10.005; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hedhli D, 2009, VACCINE, V27, P2274, DOI 10.1016/j.vaccine.2009.01.100; Hutnick NA, 2009, NAT MED, V15, P876, DOI 10.1038/nm.1989; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Kalinski P, 2006, IMMUNOL RES, V36, P137, DOI 10.1385/IR:36:1:137; Karan D, 2007, INT J CANCER, V121, P1520, DOI 10.1002/ijc.22873; KUMAR H, 2009, BIOCH BIOPHYS RES CO; Lee Y, 2004, EUR J BIOCHEM, V271, P1094, DOI 10.1111/j.1432-1033.2004.04011.x; Liu JY, 2009, NATURE, V457, P87, DOI 10.1038/nature07469; Ng Philip, 2002, Methods Mol Med, V69, P389; Pepper M, 2008, J IMMUNOL, V180, P6229, DOI 10.4049/jimmunol.180.9.6229; Rader JS, 2008, CLIN CANCER RES, V14, P3089, DOI 10.1158/1078-0432.CCR-07-4250; Rosenberg B, 2005, INT J CANCER, V114, P756, DOI 10.1002/ijc.20801; Rosenberg ES, 1997, SCIENCE, V278, P1447, DOI 10.1126/science.278.5342.1447; Terme M, 2008, NAT IMMUNOL, V9, P486, DOI 10.1038/ni1580; Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038; Wolska A, 2009, CELL MOL BIOL LETT, V14, P248, DOI 10.2478/s11658-008-0048-z; Yarovinsky F, 2005, SCIENCE, V308, P1626, DOI 10.1126/science.1109893; Zhu JA, 2008, MOL THER, V16, P1300, DOI 10.1038/mt.2008.88	30	29	31	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2010	5	3					A130	A139	e9579	10.1371/journal.pone.0009579	http://dx.doi.org/10.1371/journal.pone.0009579			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565WZ	20221448	Green Submitted, Green Published, gold			2022-12-25	WOS:000275328200012
J	Gomard, T; Michaud, HA; Tempe, D; Thiolon, K; Pelegrin, M; Piechaczyk, M				Gomard, Tiphanie; Michaud, Henri-Alexandre; Tempe, Denis; Thiolon, Kevin; Pelegrin, Mireia; Piechaczyk, Marc			An NF-kappa B-Dependent Role for JunB in the Induction of Proinflammatory Cytokines in LPS-Activated Bone Marrow-Derived Dendritic Cells	PLOS ONE			English	Article							C-JUN; IN-VIVO; TRANSCRIPTIONAL ACTIVITY; SIGNAL-TRANSDUCTION; GENE-EXPRESSION; DOWN-REGULATION; AP-1; LIPOPOLYSACCHARIDE; FOS; MATURATION	Background: Dendritic cells (DCs) play a key role in the induction of adaptive and memory immune responses. Upon encounter with pathogens, they undergo a complex maturation process and migrate toward lymphoid organs where they stimulate immune effector cells. This process is associated with dramatic transcriptome changes, pointing to a paramount role for transcription factors in DC activation and function. The regulation and the role of these transcription factors are however ill-defined and require characterization. Among those, AP-1 is a family of dimeric transcription complexes with an acknowledged role in the control of immunity. However, it has not been studied in detail in DCs yet. Methodology/Principal Findings: Here, we have investigated the regulation and function of one of its essential components, JunB, in primary bone marrow-derived DCs induced to maturate upon stimulation by Escherichia coli lipopolysaccharide (LPS). Our data show fast and transient NF-kappa B-dependent transcriptional induction of the junb gene correlating with the induction of the TNF alpha, IL-6, and IL-12 proinflammatory cytokines. Inhibition of JunB protein induction by RNA interference hampered the transcriptional activation of the TNF-alpha, IL-6, and IL-12p40 genes. Consistently, chromatin immunoprecipitation experiments showed LPS-inducible binding of JunB at AP-1-responsive sites found in promoter regions of these genes. Concomitant LPS-inducible NF-kappa B/p65 binding to these promoters was also observed. Conclusions/Significance: We identified a novel role for JunB-that is, induction of proinflammatory cytokines in LPS-activated primary DCs with NF-kappa B acting not only as an inducer of JunB, but also as its transcriptional partner.	[Gomard, Tiphanie; Michaud, Henri-Alexandre; Tempe, Denis; Thiolon, Kevin; Pelegrin, Mireia; Piechaczyk, Marc] CNRS, Inst Genet Mol, Montpellier, France; [Gomard, Tiphanie; Michaud, Henri-Alexandre; Tempe, Denis; Thiolon, Kevin; Pelegrin, Mireia; Piechaczyk, Marc] Univ Montpellier 2, Montpellier, France; [Gomard, Tiphanie; Michaud, Henri-Alexandre; Tempe, Denis; Thiolon, Kevin; Pelegrin, Mireia; Piechaczyk, Marc] Univ Montpellier 1, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Universite de Montpellier; Universite de Montpellier	Gomard, T (corresponding author), CNRS, Inst Genet Mol, Montpellier, France.	marc.piechaczyk@igmm.cnrs.fr	PIECHACZYK, Marc/E-7896-2013; Michaud, Henri-Alexandre/Z-1417-2019	PIECHACZYK, Marc/0000-0003-1367-2597; Pelegrin, Mireia/0000-0002-0117-2010; Michaud, Henri-Alexandre/0000-0002-6165-1929	French Ligue Nationale contre le Cancer; Programme Blanc of the French Agence Nationale pour la Recherche (ANR)	French Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); Programme Blanc of the French Agence Nationale pour la Recherche (ANR)(French National Research Agency (ANR))	MP's laboratory is funded by the French Ligue Nationale contre le Cancer. This work was also supported by the CNRS and a grant from the Programme Blanc of the French Agence Nationale pour la Recherche (ANR). TG is recipient of a fellowship from the Ligue Nationale contre le Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aida M, 2006, MOL CELL BIOL, V26, P6094, DOI 10.1128/MCB.02366-05; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Andrecht S, 2002, J BIOL CHEM, V277, P35961, DOI 10.1074/jbc.M202847200; Baccam M, 2003, J IMMUNOL, V170, P3099, DOI 10.4049/jimmunol.170.6.3099; Basbous J, 2007, MOL CELL BIOL, V27, P3936, DOI 10.1128/MCB.01776-06; Bossis G, 2005, MOL CELL BIOL, V25, P6964, DOI 10.1128/MCB.25.16.6964-6979.2005; Brown RT, 1995, J BIOL CHEM, V270, P31129, DOI 10.1074/jbc.270.52.31129; Casals C, 2007, J IMMUNOL, V178, P6307, DOI 10.4049/jimmunol.178.10.6307; Chinenov Y, 2001, ONCOGENE, V20, P2438, DOI 10.1038/sj.onc.1204385; Dillon S, 2004, J IMMUNOL, V172, P4733, DOI 10.4049/jimmunol.172.8.4733; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Farras R, 2008, MOL CELL BIOL, V28, P4173, DOI 10.1128/MCB.01620-07; Florin L, 2006, J INVEST DERMATOL, V126, P902, DOI 10.1038/sj.jid.5700123; Frazier-Jessen MR, 2002, FEBS LETT, V513, P203, DOI 10.1016/S0014-5793(02)02295-0; Fujihara M, 1998, J IMMUNOL, V161, P3659; Fujioka S, 2004, MOL CELL BIOL, V24, P7806, DOI 10.1128/MCB.24.17.7806-7819.2004; Garaude J, 2008, J IMMUNOL, V180, P5983, DOI 10.4049/jimmunol.180.9.5983; Granucci F, 2005, ADV IMMUNOL, V88, P193, DOI 10.1016/S0065-2776(05)88006-X; Hartenstein B, 2002, EMBO J, V21, P6321, DOI 10.1093/emboj/cdf648; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; Hu XT, 2001, CANCER RES, V61, P6290; Jenner RG, 2005, NAT REV MICROBIOL, V3, P281, DOI 10.1038/nrmicro1126; Kaisho T, 2008, TRENDS IMMUNOL, V29, P329, DOI 10.1016/j.it.2008.03.005; Koga K, 2009, IMMUNITY, V30, P372, DOI 10.1016/j.immuni.2008.12.021; Krappmann D, 2004, MOL CELL BIOL, V24, P6488, DOI 10.1128/MCB.24.14.6488-6500.2004; Li BY, 1999, EMBO J, V18, P420, DOI 10.1093/emboj/18.2.420; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; MALNOU CE, 2010, J BIOL CHEM; Malnou CE, 2007, J BIOL CHEM, V282, P31046, DOI 10.1074/jbc.M702833200; Mannucci Pier M, 2002, Hematology Am Soc Hematol Educ Program, P1; Meixner A, 2008, NAT CELL BIOL, V10, P1003, DOI 10.1038/ncb1761; Mizumoto N, 2005, J INVEST DERMATOL, V124, P718, DOI 10.1111/j.0022-202X.2005.23616.x; Monje P, 2005, J BIOL CHEM, V280, P35081, DOI 10.1074/jbc.C500353200; Muller S, 2000, J BIOL CHEM, V275, P13321, DOI 10.1074/jbc.275.18.13321; O'Neill LAJ, 2008, IMMUNITY, V29, P12, DOI 10.1016/j.immuni.2008.06.004; Pierce JW, 1997, J BIOL CHEM, V272, P21096, DOI 10.1074/jbc.272.34.21096; Sousa CR, 2006, NAT REV IMMUNOL, V6, P476, DOI 10.1038/nri1845; Roach JC, 2007, P NATL ACAD SCI USA, V104, P16245, DOI 10.1073/pnas.0707757104; Scaife CL, 2002, CANCER RES, V62, P6870; Schmidt D, 2007, EMBO J, V26, P710, DOI 10.1038/sj.emboj.7601539; Shen H, 2008, J IMMUNOL, V181, P1849, DOI 10.4049/jimmunol.181.3.1849; Shen ZH, 1997, J IMMUNOL, V158, P2723; Szabowski A, 2000, CELL, V103, P745, DOI 10.1016/S0092-8674(00)00178-1; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Textor B, 2007, J IMMUNOL, V179, P6873, DOI 10.4049/jimmunol.179.10.6873; TREIER M, 1994, CELL, V78, P787, DOI 10.1016/S0092-8674(94)90502-9; Vinson C, 2006, BBA-GENE STRUCT EXPR, V1759, P4, DOI 10.1016/j.bbaexp.2005.12.005; Wagner EF, 2005, IMMUNOL REV, V208, P126, DOI 10.1111/j.0105-2896.2005.00332.x; Winzler C, 1997, J EXP MED, V185, P317, DOI 10.1084/jem.185.2.317; Yao J, 1997, J BIOL CHEM, V272, P17795, DOI 10.1074/jbc.272.28.17795; Zagariya A, 1998, MOL CELL BIOL, V18, P2815, DOI 10.1128/MCB.18.5.2815; Zhu C, 2001, J BIOL CHEM, V276, P18519, DOI 10.1074/jbc.M100440200	52	27	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2010	5	3					A178	A188	e9585	10.1371/journal.pone.0009585	http://dx.doi.org/10.1371/journal.pone.0009585			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565WZ	20221401	Green Submitted, Green Published, gold			2022-12-25	WOS:000275328200017
J	Wang, JL; Wang, JT; Chen, SY; Chen, YC; Chang, SC				Wang, Jiun-Ling; Wang, Jann-Tay; Chen, Shey-Ying; Chen, Yee-Chun; Chang, Shan-Chwen			Distribution of Staphylococcal Cassette Chromosome mec Types and Correlation with Comorbidity and Infection Type in Patients with MRSA Bacteremia	PLOS ONE			English	Article							PANTON-VALENTINE LEUKOCIDIN; SCCMEC TYPE-IV; METHICILLIN-RESISTANT; AUREUS INFECTION; COMMUNITY; CLONES; EMERGENCE; CHILDREN; STRAINS; TAIWAN	Background: Molecular epidemiological definitions that are based on staphylococcal cassette chromosome mec (SCCmec) typing and phylogenetic analysis of methicillin-resistant Staphylococcus aureus (MRSA) isolates are considered a reliable way to distinguish between healthcare-associated MRSA (HA-MRSA) and community-associated MRSA (CA-MRSA). However, there is little information regarding the clinical features and outcomes of bacteremia patients with MRSA carrying different SCCmec types. Methods: From January 1 through December 31, 2006, we recorded the demographic data and outcomes of 159 consecutive adult MRSA bacteremia patients from whom isolates for SCCmec analysis were collected. All participants were patients at a tertiary care center in Taiwan. Principal Findings: The following SCCmec types were identified in MRSA isolates: 30 SCCmec II (18.9%), 87 SCCmec III (54.7%), 22 SCCmec IV (13.8%), and 20 SCCmec V (12.6%). The time from admission to the first MRSA-positive blood culture for patients infected with isolates with the SCCmec III element (mean/median, 50.7/26 days) was significantly longer than for patients infected with isolates carrying SCCmec IV or V (mean/median, 6.7/3 days for SCCmec IV; 11.1/10.5 days for SCCmec V) (P < 0.05). In univariate analysis, community onset, soft tissue infection, and deep-seated infection were predictors for SCCmec IV/V. In multivariate analysis, length of stay before index culture, diabetes mellitus, and being bedridden were independent risk factors associated with SCCmec II/III. Conclusions: These findings are in agreement with previous studies of the genetic characteristics of CA-MRSA. MRSA bacteremia with SCCmec II/III isolates occurred more among patients with serious comorbidities and prolonged hospitalization. Community onset, skin and soft tissue infection, and deep-seated infection best predicted SCCmec IV/V MRSA bacteremia.	[Wang, Jiun-Ling; Wang, Jann-Tay; Chen, Yee-Chun; Chang, Shan-Chwen] Natl Taiwan Univ, Dept Internal Med, Natl Taiwan Univ Hosp, Taipei 10764, Taiwan; [Wang, Jiun-Ling] I Shou Univ, E Da Hosp, Dept Internal Med, Kaohsiung Cty, Taiwan; [Chen, Shey-Ying] Natl Taiwan Univ, Dept Emergency Med, Natl Taiwan Univ Hosp, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University Hospital; E-Da Hospital; I Shou University; National Taiwan University; National Taiwan University Hospital	Wang, JL (corresponding author), Natl Taiwan Univ, Dept Internal Med, Natl Taiwan Univ Hosp, Taipei 10764, Taiwan.	dtmed111wang@ntu.edu.tw; changsc@ntu.edu.tw	Chen, Yee-Chun/AGW-7535-2022; Wang, 竣令王 Jiun-Ling/L-9627-2015	Chen, Yee-Chun/0000-0002-1816-9010; Wang, 竣令王 Jiun-Ling/0000-0002-9465-8692; CHANG, SHAN-CHWEN/0000-0001-6505-4139; WANG, JANN-TAY/0000-0002-0924-3469; CHEN, SHEY-YING/0000-0002-5855-6170	National Science Council in Taiwan [96-2314-B-002-031]	National Science Council in Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by a grant from the National Science Council (96-2314-B-002-031-) in Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adem PV, 2005, NEW ENGL J MED, V353, P1245, DOI 10.1056/NEJMoa044194; Bannerman TM, 2003, MANUAL CLIN MICROBIO, P384; Bocchini CE, 2006, PEDIATRICS, V117, P433, DOI 10.1542/peds.2005-0566; Boyle-Vavra S, 2005, J CLIN MICROBIOL, V43, P4719, DOI 10.1128/JCM.43.9.4719-4730.2005; Boyle-Vavra S, 2007, LAB INVEST, V87, P3, DOI 10.1038/labinvest.3700501; Chen FJ, 2005, EMERG INFECT DIS, V11, P1761, DOI 10.3201/eid1111.050367; Davis SL, 2006, INFECT CONT HOSP EP, V27, P1025, DOI 10.1086/507918; Diep BA, 2008, TRENDS MICROBIOL, V16, P361, DOI 10.1016/j.tim.2008.05.002; Edgeworth JD, 2007, CLIN INFECT DIS, V44, P493, DOI 10.1086/511034; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Fowler VG, 2007, J INFECT DIS, V196, P738, DOI 10.1086/520088; Francis JS, 2005, CLIN INFECT DIS, V40, P100, DOI 10.1086/427148; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Huang YC, 2006, J CLIN MICROBIOL, V44, P2268, DOI 10.1128/JCM.00776-06; Ito T, 2004, ANTIMICROB AGENTS CH, V48, P2637, DOI 10.1128/AAC.48.7.2637-2651.2004; Ito T, 2001, ANTIMICROB AGENTS CH, V45, P1323, DOI 10.1128/AAC.45.5.1323-1336.2001; Jarraud S, 2002, INFECT IMMUN, V70, P631, DOI 10.1128/IAI.70.2.631-641.2002; King MD, 2006, ANN INTERN MED, V144, P309, DOI 10.7326/0003-4819-144-5-200603070-00005; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Kluytmans-VandenBergh MFQ, 2006, CLIN MICROBIOL INFEC, V12, P9, DOI 10.1111/j.1469-0691.2006.01341.x; Laurent F, 2001, J ANTIMICROB CHEMOTH, V47, P277, DOI 10.1093/jac/47.3.277; Li JS, 2000, CLIN INFECT DIS, V30, P633, DOI 10.1086/313753; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Ma XX, 2002, ANTIMICROB AGENTS CH, V46, P1147, DOI 10.1128/AAC.46.4.1147-1152.2002; Maree CL, 2007, EMERG INFECT DIS, V13, P236, DOI 10.3201/eid1302.060781; Mermel LA, 2001, CLIN INFECT DIS, V32, P1249, DOI 10.1086/320001; Miller LG, 2005, NEW ENGL J MED, V352, P1445, DOI 10.1056/NEJMoa042683; Naimi TS, 2003, JAMA-J AM MED ASSOC, V290, P2976, DOI 10.1001/jama.290.22.2976; Okuma K, 2002, J CLIN MICROBIOL, V40, P4289, DOI 10.1128/JCM.40.11.4289-4294.2002; Pannaraj PS, 2006, CLIN INFECT DIS, V43, P953, DOI 10.1086/507637; Popovich KJ, 2008, CLIN INFECT DIS, V46, P787, DOI 10.1086/528716; Seybold U, 2006, CLIN INFECT DIS, V42, P647, DOI 10.1086/499815; Seybold U, 2007, CLIN INFECT DIS, V44, P502, DOI 10.1086/511047; Takano T, 2008, ANTIMICROB AGENTS CH, V52, P837, DOI 10.1128/AAC.01001-07; Vandenesch F, 2003, EMERG INFECT DIS, V9, P978; Wang JL, 2008, CLIN INFECT DIS, V46, P799, DOI 10.1086/527389; Zetola N, 2005, LANCET INFECT DIS, V5, P275, DOI 10.1016/S1473-3099(05)70112-2	38	49	49	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2010	5	3							e9489	10.1371/journal.pone.0009489	http://dx.doi.org/10.1371/journal.pone.0009489			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	564EX	20221428	Green Published, gold, Green Submitted			2022-12-25	WOS:000275197200005
J	Humbert, M; Casteran, N; Letard, S; Hanssens, K; Iovanna, J; Finetti, P; Bertucci, F; Bader, T; Mansfield, CD; Moussy, A; Hermine, O; Dubreuil, P				Humbert, Martine; Casteran, Nathalie; Letard, Sebastien; Hanssens, Katia; Iovanna, Juan; Finetti, Pascal; Bertucci, Francois; Bader, Thomas; Mansfield, Colin D.; Moussy, Alain; Hermine, Olivier; Dubreuil, Patrice			Masitinib Combined with Standard Gemcitabine Chemotherapy: In Vitro and In Vivo Studies in Human Pancreatic Tumour Cell Lines and Ectopic Mouse Model	PLOS ONE			English	Article							CANCER; INHIBITION; EXPRESSION; CARCINOMA; GROWTH; PROGRESSION; METASTASIS; SURVIVAL; THERAPY	Background: Tyrosine kinases are attractive targets for pancreatic cancer therapy because several are over-expressed, including PDGFR alpha/beta, FAK, Src and Lyn. A critical role of mast cells in the development of pancreatic cancer has also been reported. Masitinib is a tyrosine kinase inhibitor that selectively targets c-Kit, PDGFR alpha/beta, Lyn, and to a lesser extent the FAK pathway, without inhibiting kinases of known toxicities. Masitinib is particularly efficient in controlling the proliferation, differentiation and degranulation of mast cells. This study evaluates the therapeutic potential of masitinib in pancreatic cancer, as a single agent and in combination with gemcitabine. Methodology/Findings: Proof-of-concept studies were performed in vitro on human pancreatic tumour cell lines and then in vivo using a mouse model of human pancreatic cancer. Molecular mechanisms were investigated via gene expression profiling. Masitinib as a single agent had no significant antiproliferative activity while the masitinib/gemcitabine combination showed synergy in vitro on proliferation of gemcitabine-refractory cell lines Mia Paca2 and Panc1, and to a lesser extent in vivo on Mia Paca2 cell tumour growth. Specifically, masitinib at 10 mu M strongly sensitised Mia Paca2 cells to gemcitabine (> 400-fold reduction in IC50); and moderately sensitised Panc1 cells (10-fold reduction). Transcriptional analysis identified the Wnt/beta-catenin signalling pathway as down-regulated in the cell lines resensitised by the masitinib/gemcitabine combination. Conclusions: These data establish proof-of-concept that masitinib can sensitise gemcitabine-refractory pancreatic cancer cell lines and warrant further in vivo investigation. Indeed, such an effect has been recently observed in a phase 2 clinical study of patients with pancreatic cancer who received a masitinib/gemcitabine combination.	[Humbert, Martine; Casteran, Nathalie; Hanssens, Katia; Bader, Thomas; Mansfield, Colin D.; Moussy, Alain] AB Sci SA, Paris, France; [Letard, Sebastien; Dubreuil, Patrice] Ctr Reference Mastocytoses, Ctr Rech Cancerol Marseille Signalisat Hematopoie, INSERM, U891, Marseille, France; [Letard, Sebastien; Finetti, Pascal; Bertucci, Francois; Dubreuil, Patrice] Univ Mediterranee, Marseille, France; [Iovanna, Juan] INSERM, U624, F-13258 Marseille, France; [Finetti, Pascal; Bertucci, Francois] Inst J Paoli I Calmettes, Dept Med Oncol, Dept Mol Oncol, Ctr Rech Cancerol Marseille,INSERM,U891, F-13009 Marseille, France; [Hermine, Olivier] Univ Paris 05, CNRS, UMR 8147, Ctr Reference Mastocytoses,Serv Hematol,Hop Necke, F-75270 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Humbert, M (corresponding author), AB Sci SA, Paris, France.	olivier.hermine@nck.aphp.fr; patrice.dubreuil@inserm.fr	Hermine, Olivier/Q-7072-2018; Dubreuil, Patrice/V-4816-2019; Iovanna, Juan/M-9805-2017; dubreuil, patrice/F-5346-2011; Finetti, Pascal/O-8669-2017	Dubreuil, Patrice/0000-0003-1155-1150; Iovanna, Juan/0000-0003-1822-2237; dubreuil, patrice/0000-0003-1155-1150; Bertucci, Francois/0000-0002-0157-0959; Hermine, Olivier/0000-0003-2574-3874; LETARD, Sebastien/0000-0002-6508-7376; Finetti, Pascal/0000-0002-2674-3123	la Ligue Nationale Contre le Cancer; equipe labellisee; INCa; Institut National du Cancer; Agence Nationale pour la Recherche; AB Science, S. A., Paris, France	la Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); equipe labellisee; INCa(Institut National du Cancer (INCA) France); Institut National du Cancer(Institut National du Cancer (INCA) France); Agence Nationale pour la Recherche(French National Research Agency (ANR)); AB Science, S. A., Paris, France	This work was supported in part by funds from: INSERM (Institut National de la Sante de la Recherche Medicale), la Ligue Nationale Contre le Cancer, equipe labellisee (P. D. and J. I.); INCa (Institut National du Cancer - PACA in PACA project), Institut National du Cancer (O. H. and P. D.); and the Agence Nationale pour la Recherche, RIB project (P. D.). This study was financially supported by AB Science, S. A., Paris, France. The sponsor was involved in the study design, data analysis and interpretation, manuscript preparation and in the decision to submit the manuscript.	Bertucci F, 2006, CANCER RES, V66, P4636, DOI 10.1158/0008-5472.CAN-06-0031; Burris HA, 1997, J CLIN ONCOL, V15, P2403, DOI 10.1200/JCO.1997.15.6.2403; Chen J, 2006, CANCER LETT, V233, P328, DOI 10.1016/j.canlet.2005.03.027; Dubreuil P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007258; Duxbury MS, 2004, J AM COLL SURGEONS, V198, P953, DOI 10.1016/j.jamcollsurg.2004.01.037; Duxbury MS, 2003, BIOCHEM BIOPH RES CO, V311, P786, DOI 10.1016/j.bbrc.2003.10.060; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Esposito I, 2004, J CLIN PATHOL, V57, P630, DOI 10.1136/jcp.2003.014498; Force T, 2007, NAT REV CANCER, V7, P332, DOI 10.1038/nrc2106; Giroux V, 2006, CLIN CANCER RES, V12, P235, DOI 10.1158/1078-0432.CCR-05-1700; Hahn KA, 2008, J VET INTERN MED, V22, P1301, DOI 10.1111/j.1939-1676.2008.0190.x; Hammel P, 2009, J CLIN ONCOL, V27; Hammond JR, 1999, J PHARMACOL EXP THER, V288, P1185; Hwang RF, 2003, CLIN CANCER RES, V9, P6534; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Li DH, 2004, LANCET, V363, P1049, DOI 10.1016/S0140-6736(04)15841-8; Moore MJ, 2007, J CLIN ONCOL, V25, P1960, DOI 10.1200/JCO.2006.07.9525; Murtaugh L Charles, 2008, Organogenesis, V4, P81; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Ozawa F, 2001, TERATOGEN CARCIN MUT, V21, P27, DOI 10.1002/1520-6866(2001)21:1<27::AID-TCM4>3.0.CO;2-9; Saif MW, 2006, J PANCREAS, V7, P337; Soucek L, 2007, NAT MED, V13, P1211, DOI 10.1038/nm1649; Sultana A, 2007, BRIT J CANCER, V96, P1183, DOI 10.1038/sj.bjc.6603719; Sultana A, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-192; Summy JM, 2003, CANCER METAST REV, V22, P337, DOI 10.1023/A:1023772912750; Tebib J, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2740; Trevino JG, 2006, AM J PATHOL, V168, P962, DOI 10.2353/ajpath.2006.050570; Yasuda A, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-46; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366; Yokoi K, 2005, CANCER RES, V65, P10371, DOI 10.1158/0008-5472.CAN-05-1698	30	57	59	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2010	5	3							e9430	10.1371/journal.pone.0009430	http://dx.doi.org/10.1371/journal.pone.0009430			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	564EW	20209107	gold, Green Published, Green Submitted			2022-12-25	WOS:000275197100002
J	Klett, D; Cahoreau, C; Villeret, M; Combarnous, Y				Klett, Daniele; Cahoreau, Claire; Villeret, Melanie; Combarnous, Yves			Effect of Pharmaceutical Potential Endocrine Disruptor Compounds on Protein Disulfide Isomerase Reductase Activity Using Di-Eosin-Oxidized-Glutathion	PLOS ONE			English	Article							HORMONE-BINDING; ENDOPLASMIC-RETICULUM; RISK-ASSESSMENT; BISPHENOL-A; INHIBITION; CHEMICALS; DISEASE; BACITRACIN; EVOLUTION; ESTROGENS	Background: Protein Disulfide Isomerase (PDI) in the endoplasmic reticulum of all cells catalyzes the rearrangement of disulfide bridges during folding of membrane and secreted proteins. As PDI is also known to bind various molecules including hormones such as estradiol and thyroxin, we considered the hypothesis that adverse effects of endocrine-disrupter compounds (EDC) could be mediated through their interaction with PDI leading to defects in membrane or secreted proteins. Methodology/Principal Findings: Taking advantage of the recent description of the fluorescence self quenched substrate di-eosin-oxidized-glutathion (DiE-GSSG), we determined kinetically the effects of various potential pharmaceutical EDCs on the in-vitro reductase activity of bovine liver PDI by measuring the fluorescence of the reaction product (E-GSH). Our data show that estrogens (ethynylestradiol and bisphenol-A) as well as indomethacin exert an inhibition whereas medroxyprogesteroneacetate and nortestosterone exert a potentiation of bovine PDI reductase activity. Conclusions: The present data indicate that the tested EDCs could not only affect endocrine target cells through nuclear receptors as previously shown, but could also affect these and all other cells by positively or negatively affecting PDI activity. The substrate DiE-GSSG has been demonstrated to be a convenient substrate to measure PDI reductase activity in the presence of various potential EDCs. It will certainely be usefull for the screening of potential effect of all kinds of chemicals on PDI reductase activity.	[Klett, Daniele; Cahoreau, Claire; Villeret, Melanie; Combarnous, Yves] CNRS, INRA, Unit Physiol Reprod & Comportements, Nouzilly, France	Centre National de la Recherche Scientifique (CNRS); Universite de Tours; INRAE	Klett, D (corresponding author), CNRS, INRA, Unit Physiol Reprod & Comportements, Nouzilly, France.	combarno@tours.inra.fr	Combarnous, Yves/K-4161-2019	Combarnous, Yves/0000-0002-0574-2025	European Community [2004-513953]	European Community(European Commission)	This work was supported by European Community contract # 2004-513953 Food & Fertility - Pharmaceutical Products in the Environment (2004-2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABELL BA, 1993, J VIROL, V67, P5496, DOI 10.1128/JVI.67.9.5496-5501.1993; Crews D, 2006, ENDOCRINOLOGY, V147, pS4, DOI 10.1210/en.2005-1122; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; Fu XM, 2009, J STEROID BIOCHEM, V115, P20, DOI 10.1016/j.jsbmb.2009.02.008; Gilbert H F, 1991, Protein Expr Purif, V2, P194, DOI 10.1016/1046-5928(91)90071-P; Gruber CW, 2006, TRENDS BIOCHEM SCI, V31, P455, DOI 10.1016/j.tibs.2006.06.001; Guthapfel R, 1996, EUR J BIOCHEM, V242, P315, DOI 10.1111/j.1432-1033.1996.0315r.x; Hashimoto S, 2008, J BIOCHEM, V144, P335, DOI 10.1093/jb/mvn075; Hatahet F, 2007, FEBS J, V274, P5223, DOI 10.1111/j.1742-4658.2007.06058.x; Hiroi T, 2006, ENDOCRINOLOGY, V147, P2773, DOI 10.1210/en.2005-1235; Jacobs MN, 2004, TOXICOLOGY, V205, P43, DOI 10.1016/j.tox.2004.06.036; Kavlock RJ, 1996, ENVIRON HEALTH PERSP, V104, P715, DOI 10.1289/ehp.96104s4715; Kim PS, 1998, ENDOCR REV, V19, P173, DOI 10.1210/er.19.2.173; Klappa P, 1998, EUR J BIOCHEM, V254, P63, DOI 10.1046/j.1432-1327.1998.2540063.x; MANDEL R, 1993, P NATL ACAD SCI USA, V90, P4112, DOI 10.1073/pnas.90.9.4112; Pendurthi UR, 2008, THROMB RES, V122, pS14, DOI 10.1016/S0049-3848(08)70012-4; PIERSMA AHP, 2005, PRIORITIZATION LIST; Primm TP, 2001, J BIOL CHEM, V276, P281, DOI 10.1074/jbc.M007670200; Raturi A, 2005, BIOCHEM J, V391, P351, DOI 10.1042/BJ20050770; Raturi A, 2007, FREE RADICAL BIO MED, V43, P62, DOI 10.1016/j.freeradbiomed.2007.03.025; ROTH RA, 1981, BIOCHEM BIOPH RES CO, V98, P431, DOI 10.1016/0006-291X(81)90858-5; Tabb MM, 2006, MOL ENDOCRINOL, V20, P475, DOI 10.1210/me.2004-0513; THOMAS PJ, 1995, TRENDS BIOCHEM SCI, V20, P456, DOI 10.1016/S0968-0004(00)89100-8; Toppari J, 2008, SEX DEV, V2, P260, DOI 10.1159/000152042; TSIBRIS JCM, 1989, J BIOL CHEM, V264, P13967; van Meeuwen JA, 2007, TOXICOL LETT, V170, P165, DOI 10.1016/j.toxlet.2007.03.003; Vandenberg LN, 2009, ENDOCR REV, V30, P75, DOI 10.1210/er.2008-0021; Vosges M, 2008, REPROD TOXICOL, V25, P161, DOI 10.1016/j.reprotox.2007.12.002; Walker KW, 1996, BIOCHEMISTRY-US, V35, P1972, DOI 10.1021/bi952157n	29	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2010	5	3							e9507	10.1371/journal.pone.0009507	http://dx.doi.org/10.1371/journal.pone.0009507			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	562OZ	20209080	Green Submitted, Green Published, gold			2022-12-25	WOS:000275063400013
J	Fernandes, JMO; Ruangsri, J; Kiron, V				Fernandes, Jorge M. O.; Ruangsri, Jareeporn; Kiron, Viswanath			Atlantic Cod Piscidin and Its Diversification through Positive Selection	PLOS ONE			English	Article							AMINO-ACID SITES; ANTIMICROBIAL PEPTIDES; ONCORHYNCHUS-MYKISS; MAXIMUM-LIKELIHOOD; PHYLOGENETIC ANALYSIS; SKIN SECRETIONS; IMMUNE-SYSTEM; RAINBOW-TROUT; FISH; GENES	Piscidins constitute a family of cationic antimicrobial peptides that are thought to play an important role in the innate immune response of teleosts. On the one hand they show a remarkable diversity, which indicates that they are shaped by positive selection, but on the other hand they are ancient and have specific targets, suggesting that they are constrained by purifying selection. Until now piscidins had only been found in fish species from the superorder Acanthopterygii but we have recently identified a piscidin gene in Atlantic cod (Gadus morhua), thus showing that these antimicrobial peptides are not restricted to evolutionarily modern teleosts. Nucleotide diversity was much higher in the regions of the piscidin gene that code for the mature peptide and its pro domain than in the signal peptide. Maximum likelihood analyses with different evolution models revealed that the piscidin gene is under positive selection. Charge or hydrophobicity-changing amino acid substitutions observed in positively selected sites within the mature peptide influence its amphipathic structure and can have a marked effect on its function. This diversification might be associated with adaptation to new habitats or rapidly evolving pathogens.	[Fernandes, Jorge M. O.; Ruangsri, Jareeporn; Kiron, Viswanath] Bodo Univ Coll, Fac Biosci & Aquaculture, Bodo, Nordland, Norway	Nord University	Fernandes, JMO (corresponding author), Bodo Univ Coll, Fac Biosci & Aquaculture, Bodo, Nordland, Norway.	Jorge.fernandes@hibo.no	Fernandes, Jorge/AAC-4632-2022; Fernandes, Jorge MO/A-3526-2013	Fernandes, Jorge/0000-0002-2550-1640; Fernandes, Jorge MO/0000-0002-2550-1640; Viswanath, Kiron/0000-0003-4640-1910	Research Council of Norway; Prince of Songkla University (Thailand)	Research Council of Norway(Research Council of Norway); Prince of Songkla University (Thailand)	This study was partially funded by a research grant to VK from the Research Council of Norway (Ref. 184703/S40). JR was supported by a PhD fellowship from the Prince of Songkla University (Thailand). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLY JE, 1991, VET IMMUNOL IMMUNOP, V28, P365, DOI 10.1016/0165-2427(91)90127-X; Campagna S, 2007, BIOCHEMISTRY-US, V46, P1771, DOI 10.1021/bi0620297; Campos C, 2010, J EXP BIOL, V213, P200, DOI 10.1242/jeb.033126; Chang CI, 2005, INFECT IMMUN, V73, P5053, DOI 10.1128/IAI.73.8.5053-5064.2005; Chinchar VG, 2004, VIROLOGY, V323, P268, DOI 10.1016/j.virol.2004.02.029; Cole AM, 1997, J BIOL CHEM, V272, P12008, DOI 10.1074/jbc.272.18.12008; Douglas SE, 2003, DEV COMP IMMUNOL, V27, P589, DOI 10.1016/S0145-305X(03)00036-3; Du Pasquier L, 2001, COMP BIOCHEM PHYS B, V129, P1, DOI 10.1016/S1096-4959(01)00306-2; Fernandes JMO, 2004, DEV COMP IMMUNOL, V28, P127, DOI 10.1016/S0145-305X(03)00120-4; Fernandes JMO, 2004, FISH SHELLFISH IMMUN, V16, P1, DOI 10.1016/S1050-4648(03)00027-5; Guindon S, 2009, METHODS MOL BIOL, V537, P113, DOI 10.1007/978-1-59745-251-9_6; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; HAWKES JW, 1974, CELL TISSUE RES, V149, P147, DOI 10.1007/BF00222270; KORBER B, 2000, COMPUTATIONAL ANAL H, P55, DOI DOI 10.1007/B112102; Lee SA, 2007, BIOCHEMISTRY-US, V46, P3653, DOI 10.1021/bi062233u; Miya M, 2003, MOL PHYLOGENET EVOL, V26, P121, DOI 10.1016/S1055-7903(02)00332-9; Mukherjee S, 2009, P NATL ACAD SCI USA, V106, P7073, DOI 10.1073/pnas.0811357106; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nicolas P, 2003, PEPTIDES, V24, P1669, DOI 10.1016/j.peptides.2003.08.017; Padhi A, 2007, MOL DIVERS, V11, P119, DOI 10.1007/s11030-007-9066-4; Park Y, 2005, J BIOCHEM MOL BIOL, V38, P507; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Silphaduang U, 2006, DIS AQUAT ORGAN, V72, P241, DOI 10.3354/dao072241; Silphaduang U, 2001, NATURE, V414, P268, DOI 10.1038/35104690; Smith Valerie J., 2008, P241; Sun BJ, 2007, J FISH DIS, V30, P335, DOI 10.1111/j.1365-2761.2007.00789.x; Sung WS, 2008, BIOCHEM BIOPH RES CO, V371, P551, DOI 10.1016/j.bbrc.2008.04.107; Swofford D.L., 2003, PAUP VERSION 4 0B10; Tennessen JA, 2005, J MOL EVOL, V61, P445, DOI 10.1007/s00239-004-0330-2; Tomasinsig L, 2005, CURR PROTEIN PEPT SC, V6, P23, DOI 10.2174/1389203053027520; Vanhoye D, 2003, EUR J BIOCHEM, V270, P2068, DOI 10.1046/j.1432-1033.2003.03584.x; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	36	79	82	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2010	5	3							e9501	10.1371/journal.pone.0009501	http://dx.doi.org/10.1371/journal.pone.0009501			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	562OY	20209162	Green Accepted, gold, Green Published, Green Submitted			2022-12-25	WOS:000275063300015
J	Cunningham, TM; Koehl, JL; Summers, JS; Haydel, SE				Cunningham, Tanya M.; Koehl, Jennifer L.; Summers, Jack S.; Haydel, Shelley E.			pH-Dependent Metal Ion Toxicity Influences the Antibacterial Activity of Two Natural Mineral Mixtures	PLOS ONE			English	Article							ESCHERICHIA-COLI; CLAY-MINERALS; HYDROGEN-PEROXIDE; ADSORPTION; GROWTH; SOILS; ACID; MICROORGANISMS; INACTIVATION; BIOCHEMISTRY	Background: Recent studies have demonstrated that several mineral products sold for medicinal purposes demonstrate antimicrobial activity, but little is known about the physicochemical properties involved in antibacterial activity. Methodology/Principal Findings: Using in vitro mineral suspension testing, we have identified two natural mineral mixtures, arbitrarily designated BY07 and CB07, with antibacterial activity against a broad-spectrum of bacterial pathogens. Mineral-derived aqueous leachates also exhibited antibacterial activity, revealing that chemical, not physical, mineral characteristics were responsible for the observed activity. The chemical properties essential for bactericidal activity against Escherichia coli were probed by testing antibacterial activity in the presence of metal chelators, the hydroxyl radical scavenger, thiourea, and varying pH levels. Chelation of the BY07 minerals with EDTA or desferrioxamine eliminated or reduced BY07 toxicity, respectively, suggesting a role of an acid-soluble metal species, particularly Fe(3+) or other sequestered metal cations, in mineral toxicity. This conclusion was supported by NMR relaxation data, which indicated that BY07 and CB07 leachates contained higher concentrations of chemically accessible metal ions than leachates from non-bactericidal mineral samples. Conclusions/Significance: We conclude that the acidic environment of the hydrated minerals significantly contributes to antibacterial activity by increasing the availability and toxicity of metal ions. These findings provide impetus for further investigation of the physiological effects of mineral products and their applications in complementary antibacterial therapies.	[Cunningham, Tanya M.; Koehl, Jennifer L.; Haydel, Shelley E.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Cunningham, Tanya M.; Haydel, Shelley E.] Arizona State Univ, Ctr Infect Dis & Vaccinol, Biodesign Inst, Tempe, AZ USA; [Summers, Jack S.] Western Carolina Univ, Dept Chem, Cullowhee, NC 28723 USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; University of North Carolina; Western Carolina University	Cunningham, TM (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA.	Shelley.Haydel@asu.edu		Haydel, Shelley/0000-0001-5542-5469	Public Health Service [AT004690, AT003618]; NIH National Center for Complementary and Alternative Medicine; Howard Hughes Medical Institute through the Undergraduate Science Education Program; ASU School of Life Sciences; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [R01AT004690] Funding Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R21AT003618] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NIH National Center for Complementary and Alternative Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); Howard Hughes Medical Institute through the Undergraduate Science Education Program(Howard Hughes Medical Institute); ASU School of Life Sciences; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	This research was supported by Public Health Service grants AT004690 and AT003618 to S. E. Haydel from the NIH National Center for Complementary and Alternative Medicine (http://nccam.nih.gov/) and in part by funds from the Howard Hughes Medical Institute through the Undergraduate Science Education Program (http://www.hhmi.org/) and from the ASU School of Life Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABELSON PH, 1950, J BACTERIOL, V60, P401, DOI 10.1128/JB.60.4.401-413.1950; ANTONIADIS V, 2006, TRACE ELEMENTS ENV, P39; ASAD NR, 1991, J BACTERIOL, V173, P2562, DOI 10.1128/jb.173.8.2562-2568.1991; BABICH H, 1977, APPL ENVIRON MICROB, V33, P696, DOI 10.1128/AEM.33.3.696-705.1977; BABICH H, 1983, AQUAT TOXICOL, V3, P195, DOI 10.1016/0166-445X(83)90040-1; BLUNDELL MR, 1969, BIOCHEM J, V115, P213, DOI 10.1042/bj1150213; Braun S., 1998, 150 MORE BASIC NMR E; Carretero MI, 2002, APPL CLAY SCI, V21, P155, DOI 10.1016/S0169-1317(01)00085-0; Cherny RA, 2000, J STRUCT BIOL, V130, P209, DOI 10.1006/jsbi.2000.4285; CHIO KS, 1969, BIOCHEMISTRY-US, V8, P2827, DOI 10.1021/bi00835a020; Collins Y. E., 1989, METAL IONS BACTERIA, P31; Eberl D.D., 2003, OPEN FILE REPORT 03, P1; Falkinham JO, 2009, APPL ENVIRON MICROB, V75, P2735, DOI 10.1128/AEM.00104-09; Foster JW, 2004, NAT REV MICROBIOL, V2, P898, DOI 10.1038/nrmicro1021; GARDNER PR, 1991, J BIOL CHEM, V266, P1478; Gupta C. K., 2003, CHEM METALLURGY, P811; Haydel SE, 2008, J ANTIMICROB CHEMOTH, V61, P353, DOI 10.1093/jac/dkm468; Hu CH, 2005, VET MICROBIOL, V109, P83, DOI 10.1016/j.vetmic.2005.04.021; IMLAY JA, 1988, SCIENCE, V240, P640, DOI 10.1126/science.2834821; Jiang W, 2009, ENVIRON POLLUT, V157, P1619, DOI 10.1016/j.envpol.2008.12.025; Jucker BA, 1997, COLLOID SURFACE B, V9, P331, DOI 10.1016/S0927-7765(97)00038-6; KEBERLE H, 1964, ANN NY ACAD SCI, V119, P758; Kiipli T, 2000, OIL SHALE, V17, P215; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; LIN JS, 1995, J BACTERIOL, V177, P4097, DOI 10.1128/jb.177.14.4097-4104.1995; LIPSON SM, 1984, APPL ENVIRON MICROB, V48, P525, DOI 10.1128/AEM.48.3.525-530.1984; Lo IMC, 1999, WATER AIR SOIL POLL, V109, P219, DOI 10.1023/A:1005000520321; Magana SM, 2008, J MOL CATAL A-CHEM, V281, P192, DOI 10.1016/j.molcata.2007.10.024; MCLAREN AD, 1963, SCIENCE, V141, P1141, DOI 10.1126/science.141.3586.1141; Mpuchane SF, 2008, FRESEN ENVIRON BULL, V17, P547; NESSE W, 2000, SILICATES INTRO MINE, P183; NESSE W, 2000, SHEET SILICATES INTR, P235; Smith B, 2000, J GEOL SOC LONDON, V157, P885, DOI 10.1144/jgs.157.4.885; STOHS SJ, 1995, FREE RADICAL BIO MED, V18, P321, DOI 10.1016/0891-5849(94)00159-H; Summers JS, 2008, J AM CHEM SOC, V130, P1727, DOI 10.1021/ja077193b; SWIFT TJ, 1962, J CHEM PHYS, V37, P307, DOI 10.1063/1.1701321; Top A, 2004, APPL CLAY SCI, V27, P13, DOI 10.1016/j.clay.2003.12.002; Velde B., 1995, Origin and mineralogy of clays: clays and the environment., P8; VERMEER DE, 1985, SCIENCE, V227, P634, DOI 10.1126/science.3969552; World Health Organization, 2002, 5 WHO ADV GROUP M BU; Wypych F, 2002, ENCY SURFACE COLLOID, P995; Yee N, 2000, GEOCHIM COSMOCHIM AC, V64, P609, DOI 10.1016/S0016-7037(99)00342-7; Yoshida N., 2004, J BIOL SCI, V4, P532; Yu TS, 2004, J MICROBIOL, V42, P47; Ziegler JL, 1997, TROP MED INT HEALTH, V2, P609, DOI 10.1046/j.1365-3156.1997.d01-359.x	45	30	31	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2010	5	3							e9456	10.1371/journal.pone.0009456	http://dx.doi.org/10.1371/journal.pone.0009456			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	561RT	20209160	gold, Green Published, Green Submitted			2022-12-25	WOS:000274997100006
J	Storr, M; Emmerdinger, D; Diegelmann, J; Pfennig, S; Ochsenkuhn, T; Goke, B; Lohse, P; Brand, S				Storr, Martin; Emmerdinger, Dominik; Diegelmann, Julia; Pfennig, Simone; Ochsenkuehn, Thomas; Goeke, Burkhard; Lohse, Peter; Brand, Stephan			The Cannabinoid 1 Receptor (CNR1) 1359 G/A Polymorphism Modulates Susceptibility to Ulcerative Colitis and the Phenotype in Crohn's Disease	PLOS ONE			English	Article							ENDOCANNABINOID SYSTEM; WORKING PARTY; CB1; GENE; ASSOCIATION; PROTECTS; CARD15; LIVER; RISK; CLASSIFICATION	Background: Recent evidence suggests a crucial role of the endocannabinoid system, including the cannabinoid 1 receptor (CNR1), in intestinal inflammation. We therefore investigated the influence of the CNR1 1359 G/A (p.Thr453Thr; rs1049353) single nucleotide polymorphism (SNP) on disease susceptibility and phenotype in patients with ulcerative colitis (UC) and Crohn's disease (CD). Methods: Genomic DNA from 579 phenotypically well-characterized individuals was analyzed for the CNR1 1359 G/A SNP. Amongst these were 166 patients with UC, 216 patients with CD, and 197 healthy controls. Results: Compared to healthy controls, subjects A/A homozygous for the CNR1 1359 G/A SNP had a reduced risk to develop UC (p = 0.01, OR 0.30, 95% CI 0.12-0.78). The polymorphism did not modulate CD susceptibility, but carriers of the minor A allele had a lower body mass index than G/G wildtype carriers (p = 0.0005). In addition, homozygous carriers of the G allele were more likely to develop CD before 40 years of age (p = 5.9x10(-7)) than carriers of the A allele. Conclusion: The CNR1 p.Thr453Thr polymorphism appears to modulate UC susceptibility and the CD phenotype. The endocannabinoid system may influence the manifestation of inflammatory bowel diseases, suggesting endocannabinoids as potential target for future therapies.	[Storr, Martin] Univ Calgary, Div Gastroenterol, Dept Med, Calgary, AB, Canada; [Emmerdinger, Dominik; Diegelmann, Julia; Pfennig, Simone; Ochsenkuehn, Thomas; Goeke, Burkhard; Brand, Stephan] Univ Munich, Dept Med Grosshadern 2, Munich, Germany; [Lohse, Peter] Univ Munich, Dept Clin Chem Grosshadern, Munich, Germany	University of Calgary; University of Munich; University of Munich	Storr, M (corresponding author), Univ Calgary, Div Gastroenterol, Dept Med, Calgary, AB, Canada.	mstorr@ucalgary.ca	Storr, Martin/A-6329-2011		Deutsche Forschungsgemeinschaft [DFG STO645/2-2, BR 1912/5-1]; Crohn's and Colitis Foundation of Canada (CCFC); University of Calgary [URGC-1011592]; University of Munich (Promotionsstipendium); Else Kraner-Fresenius-Stiftung [P50/05/EKMS05/62]; Ludwig-Maximilians University Munich	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Crohn's and Colitis Foundation of Canada (CCFC); University of Calgary; University of Munich (Promotionsstipendium); Else Kraner-Fresenius-Stiftung; Ludwig-Maximilians University Munich	M. Storr is supported by grants from the Deutsche Forschungsgemeinschaft (DFG STO645/2-2), the Crohn's and Colitis Foundation of Canada (CCFC), and a grant from the University of Calgary (URGC-1011592). J. Diegelmann received a grant from the University of Munich (Promotionsstipendium). S. Brand is supported by grants from the DFG (BR 1912/5-1), the Else Kraner-Fresenius-Stiftung (Else Kraner Fresenius Memorial Stipendium 2005; P50/05/EKMS05/62), by the Ludwig-Demling Grant 2007 from DCCV e. V., and grants from the Ludwig-Maximilians University Munich (Excellence Initiative - Investment Fund 2008 and FaFoLe program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbuti R, 2002, FUND INFORM, V51, P1; Barmada MM, 2004, INFLAMM BOWEL DIS, V10, P513, DOI 10.1097/00054725-200409000-00004; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Brand S, 2005, INFLAMM BOWEL DIS, V11, P645, DOI 10.1097/01.MIB.0000168372.94907.d2; Caraceni P, 2009, GUT, V58, P1135, DOI 10.1136/gut.2007.147652; D'Argenio G, 2006, FASEB J, V20, P568, DOI 10.1096/fj.05-4943fje; De Jager PL, 2007, GENES IMMUN, V8, P387, DOI 10.1038/sj.gene.6364398; De Petrocellis L, 2004, BRIT J PHARMACOL, V141, P765, DOI 10.1038/sj.bjp.0705666; Di Carlo G, 2003, EXPERT OPIN INV DRUG, V12, P39, DOI 10.1517/eoid.12.1.39.21246; Gadzicki D, 1999, MOL CELL PROBE, V13, P321, DOI 10.1006/mcpr.1999.0249; Gasche C, 2000, INFLAMM BOWEL DIS, V6, P8, DOI 10.1097/00054725-200002000-00002; Gazzerro P, 2007, INT J OBESITY, V31, P908, DOI 10.1038/sj.ijo.0803510; Glas JN, 2009, AM J GASTROENTEROL, V104, P1737, DOI 10.1038/ajg.2009.163; Glas J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000819; Glas J, 2009, AM J GASTROENTEROL, V104, P665, DOI 10.1038/ajg.2008.65; Glas J, 2008, AM J GASTROENTEROL, V103, P682, DOI 10.1111/j.1572-0241.2007.01694.x; Grinspoon L, 1999, FORSCH KOMPLEMENTMED, V6, P40, DOI 10.1159/000057156; GRINSPOON L, 1995, JAMA-J AM MED ASSOC, V273, P1875, DOI 10.1001/jama.273.23.1875; HILEY CR, 2009, J CARDIOVASC PHARM; HOEHE MR, 1991, NEW BIOL, V3, P880; Horne AW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003969; Idris AI, 2005, NAT MED, V11, P774, DOI 10.1038/nm1255; Izzo AA, 2008, GUT, V57, P1140, DOI 10.1136/gut.2008.148791; Jin WZ, 1999, J NEUROSCI, V19, P3773; Kimball ES, 2006, AM J PHYSIOL-GASTR L, V291, pG364, DOI 10.1152/ajpgi.00407.2005; King AL, 2000, ANN HUM GENET, V64, P479, DOI 10.1046/j.1469-1809.2000.6460479.x; Komar AA, 2007, PHARMACOGENOMICS, V8, P1075, DOI 10.2217/14622416.8.8.1075; Leroy S, 2001, AM J MED GENET, V105, P749, DOI 10.1002/ajmg.10038; Maresz K, 2007, NAT MED, V13, P492, DOI 10.1038/nm1561; Massa F, 2004, J CLIN INVEST, V113, P1202, DOI 10.1172/JCI200419465; Mayer EA, 2002, GASTROENTEROLOGY, V122, P2032, DOI 10.1053/gast.2002.33584; Sarzani R, 2009, METABOLISM, V58, P361, DOI 10.1016/j.metabol.2008.10.009; Scheen AJ, 2009, CURR PROTEIN PEPT SC, V10, P56, DOI 10.2174/138920309787315149; Schmidt LG, 2002, DRUG ALCOHOL DEPEN, V65, P221, DOI 10.1016/S0376-8716(01)00164-8; Schnitzler F, 2006, IMMUNOGENETICS, V58, P99, DOI 10.1007/s00251-005-0073-2; Seiderer J, 2006, SCAND J GASTROENTERO, V41, P1421, DOI 10.1080/00365520600703900; Sibaev A, 2006, J MOL MED, V84, P513, DOI 10.1007/s00109-006-0040-x; Siegfried Z, 2004, AM J MED GENET B, V125B, P126, DOI 10.1002/ajmg.b.20089; Silverberg MS, 2005, CAN J GASTROENTEROL, V19, p5A, DOI 10.1155/2005/269076; Storr M, 2006, Z GASTROENTEROL, V44, P185, DOI 10.1055/s-2005-858931; Storr M, 2009, ALIMENT PHARM THER, V29, P542, DOI 10.1111/j.1365-2036.2008.03910.x; Storr MA, 2008, NEUROGASTROENT MOTIL, V20, P857, DOI 10.1111/j.1365-2982.2008.01175.x; Storr MA, 2008, J MOL MED, V86, P925, DOI 10.1007/s00109-008-0359-6; Storr MA, 2009, INFLAMM BOWEL DIS, V15, P1678, DOI 10.1002/ibd.20960; Teixeira-Clerc F, 2006, NAT MED, V12, P671, DOI 10.1038/nm1421; Ujike H, 2002, MOL PSYCHIATR, V7, P515, DOI 10.1038/sj.mp.4001029	46	43	44	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2010	5	2							e9453	10.1371/journal.pone.0009453	http://dx.doi.org/10.1371/journal.pone.0009453			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	561RS	20195480	gold, Green Published, Green Submitted			2022-12-25	WOS:000274997000017
J	Tio, M; Tan, KH; Lee, W; Wang, TT; Udolph, G				Tio, Murni; Tan, Kian Hwa; Lee, Wendy; Wang, Ting Ting; Udolph, Gerald			Roles of db-cAMP, IBMX and RA in Aspects of Neural Differentiation of Cord Blood Derived Mesenchymal-Like Stem Cells	PLOS ONE			English	Article							IN-VITRO DIFFERENTIATION; MARROW STROMAL CELLS; TYROSINE-HYDROXYLASE ISOFORMS; INTRACELLULAR CYCLIC-AMP; C6 GLIOMA-CELLS; PROTEIN-KINASE; NERVOUS-SYSTEM; SH-SY5Y CELLS; PHOSPHORYLATION; NEURONS	Mesenchymal stem cells (MSCs) have multilineage differentiation potential which includes cell lineages of the central nervous system; hence MSCs might be useful in the treatment of neurodegenerative diseases such as Parkinson's disease. Although mesenchymal stem cells have been shown to differentiate into the neural lineage, there is still little knowledge about the underlying mechanisms of differentiation particularly towards specialized neurons such as dopaminergic neurons. Here, we show that MSCs derived from human umbilical cord blood (MSChUCBs) are capable of expressing tyrosine hydroxylase (TH) and Nurr1, markers typically associated with DA neurons. We also found differential phosphorylation of TH isoforms indicating the presence of post-translational mechanisms possibly activating and modifying TH in MSChUCB. Furthermore, functional dissection of components in the differentiation medium revealed that dibutyryl-cAMP (db-cAMP), 3-isobutyl-1-methylxanthine (IBMX) and retinoic acid (RA) are involved in the regulation of Nurr1 and Neurofilament-L expression as well as in the differential phosphorylation of TH. We also demonstrate a possible inhibitory role of the protein kinase A signaling pathway in the phosphorylation of specific TH isoforms.	[Tio, Murni; Tan, Kian Hwa; Lee, Wendy; Wang, Ting Ting; Udolph, Gerald] Inst Med Biol, Inst Biomed Sci, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB)	Tio, M (corresponding author), Inst Med Biol, Inst Biomed Sci, Singapore, Singapore.	gerald.udolph@imb.a-star.edu.sg	wang, tingting/AAK-2640-2020		Biomedical Research Council (BMRC), Singapore; Institute of Medical Biology (IMB), Singapore	Biomedical Research Council (BMRC), Singapore(Agency for Science Technology & Research (A*STAR)); Institute of Medical Biology (IMB), Singapore	Funding was received from the Biomedical Research Council (BMRC), Singapore, and the Institute of Medical Biology (IMB), Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alterio J, 1998, J BIOL CHEM, V273, P10196, DOI 10.1074/jbc.273.17.10196; BANG YJ, 1994, P NATL ACAD SCI USA, V91, P5330, DOI 10.1073/pnas.91.12.5330; Barzilay R, 2008, STEM CELLS DEV, V17, P547, DOI 10.1089/scd.2007.0172; Castro DS, 2001, J BIOL CHEM, V276, P43277, DOI 10.1074/jbc.M107013200; Cheah TB, 1999, J NEUROSCI METH, V87, P167, DOI 10.1016/S0165-0270(99)00002-3; Croft AP, 2006, STEM CELLS, V24, P1841, DOI 10.1634/stemcells.2005-0609; Deng WW, 2001, BIOCHEM BIOPH RES CO, V282, P148, DOI 10.1006/bbrc.2001.4570; Fallahi-Sichani M, 2007, CELL BIOL INT, V31, P299, DOI 10.1016/j.cellbi.2006.11.011; Fraser John K, 2006, Nat Clin Pract Cardiovasc Med, V3 Suppl 1, pS33, DOI 10.1038/ncpcardio0444; Ghosh P, 1997, CELL BIOL INT, V21, P551, DOI 10.1006/cbir.1997.0193; Goridis C, 2002, NAT REV NEUROSCI, V3, P531, DOI 10.1038/nrn871; Greschat S, 2008, STEM CELLS DEV, V17, P221, DOI 10.1089/scd.2007.0118; Iacovitti L, 2001, BRAIN RES, V912, P99, DOI 10.1016/S0006-8993(01)02723-8; Imamura K, 2006, J NEUROSCI RES, V84, P1376, DOI 10.1002/jnr.21021; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kao HT, 2002, NAT NEUROSCI, V5, P431, DOI 10.1038/nn840; Kessler MA, 2003, MOL BRAIN RES, V112, P8, DOI 10.1016/S0169-328X(02)00694-0; Kim G, 2002, MOL BRAIN RES, V109, P134, DOI 10.1016/S0169-328X(02)00550-8; Kogler G, 2004, J EXP MED, V200, P123, DOI 10.1084/jem.20040440; LEBOURDELLES B, 1991, J BIOL CHEM, V266, P17124; Lehmann IT, 2006, J BIOL CHEM, V281, P17644, DOI 10.1074/jbc.M512194200; LEWIS DA, 1993, NEUROSCIENCE, V54, P477, DOI 10.1016/0306-4522(93)90267-J; Lindgren N, 2001, EUR J NEUROSCI, V13, P773, DOI 10.1046/j.0953-816x.2000.01443.x; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Lu P, 2004, J NEUROSCI RES, V77, P174, DOI 10.1002/jnr.20148; Maden M, 2007, NAT REV NEUROSCI, V8, P755, DOI 10.1038/nrn2212; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Moore KD, 1996, MOL CHEM NEUROPATHOL, V29, P107, DOI 10.1007/BF02814996; MORGENROTH VH, 1975, J BIOL CHEM, V250, P1946; Neuhoff S, 2007, EXP HEMATOL, V35, P1119, DOI 10.1016/j.exphem.2007.03.019; Neuhuber B, 2004, J NEUROSCI RES, V77, P192, DOI 10.1002/jnr.20147; OMALLEY KL, 1987, BIOCHEMISTRY-US, V26, P6910, DOI 10.1021/bi00396a007; Panepucci RA, 2004, STEM CELLS, V22, P1263, DOI 10.1634/stemcells.2004-0024; Pansky A, 2007, CLIN LAB, V53, P81; PERLMANN T, 1995, GENE DEV, V9, P769, DOI 10.1101/gad.9.7.769; SHARMA SK, 1987, J NEUROSCI RES, V17, P135, DOI 10.1002/jnr.490170207; SHAW G, 1982, NATURE, V298, P277, DOI 10.1038/298277a0; Sun W, 2005, STEM CELLS, V23, P931, DOI 10.1634/stemcells.2004-0316; Takahashi T, 1997, J NEURAL TRANSM, V104, P59, DOI 10.1007/BF01271294; Talens-Visconti R, 2007, TOXICOL IN VITRO, V21, P324, DOI 10.1016/j.tiv.2006.08.009; Wang TT, 2007, BIOCHEM BIOPH RES CO, V357, P1021, DOI 10.1016/j.bbrc.2007.04.046; Zetterstrom RH, 1997, SCIENCE, V276, P248, DOI 10.1126/science.276.5310.248	42	53	55	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2010	5	2							e9398	10.1371/journal.pone.0009398	http://dx.doi.org/10.1371/journal.pone.0009398			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SX	20195526	Green Published, gold, Green Submitted			2022-12-25	WOS:000274924200020
J	D'Arcy, S; Davies, OR; Blundell, TL; Bolanos-Garcia, VM				D'Arcy, Sheena; Davies, Owen R.; Blundell, Tom L.; Bolanos-Garcia, Victor M.			Defining the Molecular Basis of BubR1 Kinetochore Interactions and APC/C-CDC20 Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPINDLE ASSEMBLY CHECKPOINT; N-TERMINAL REGION; MITOTIC CHECKPOINT; CENP-E; PROTEIN-STRUCTURE; CRYSTAL-STRUCTURE; ANAPHASE; CDC20; MUTATIONS; COMPLEX	BubR1 is essential for the mitotic checkpoint that prevents aneuploidy in cellular progeny by triggering anaphase delay in response to kinetochores incorrectly/not attached to the mitotic spindle. Here, we define the molecular architecture of the functionally significant N-terminal region of human BubR1 and present the 1.8 angstrom crystal structure of its tetratricopeptide repeat (TPR) domain. The structure reveals divergence from the classical TPR fold and is highly similar to the TPR domain of budding yeast Bub1. Shared distinctive features include a disordered loop insertion, a 3(10)-helix, a tight turn involving glycine positive Phi angles, and noncanonical packing of and between the TPR motifs. We also define the molecular determinants of the interaction between BubR1 and kinetochore protein Blinkin. We identify a shallow groove on the concave surface of the BubR1 TPR domain that forms multiple discrete and potentially cooperative interactions with Blinkin. Finally, we present evidence for a direct interaction between BubR1 and Bub1 mediated by regions C-terminal to their TPR domains. This interaction provides a mechanism for Bub1-dependent kinetochore recruitment of BubR1. We thus present novel molecular insights into the structure of BubR1 and its interactions at the kinetochore-microtubule interface. Our studies pave the way for future structure-directed engineering aimed at dissecting the roles of kinetochore-bound and other pools of BubR1 in vivo.	[D'Arcy, Sheena; Davies, Owen R.; Blundell, Tom L.; Bolanos-Garcia, Victor M.] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England; [Davies, Owen R.] Univ Edinburgh, Inst Stem Cell Res, Ctr Regenerat Med, MRC, Edinburgh EH9 3JQ, Midlothian, Scotland	University of Cambridge; University of Edinburgh	Bolanos-Garcia, VM (corresponding author), 80 Tennis Court Rd, Cambridge CB2 1GA, England.	victor@cryst.bioc.cam.ac.uk	Davies, Owen/J-4820-2019; Bolanos-Garcia, Victor M./AAN-8575-2020; D'Arcy, Sheena/C-8592-2018	Davies, Owen/0000-0002-3806-5403; Bolanos-Garcia, Victor M./0000-0003-2700-1479; D'Arcy, Sheena/0000-0001-5055-988X	Wellcome Trust [RG44650]; Royal Commission for the Exhibition of 1851; University of Sydney, Kings College London; Cambridge Commonwealth Trust	Wellcome Trust(Wellcome TrustEuropean Commission); Royal Commission for the Exhibition of 1851; University of Sydney, Kings College London(University of Sydney); Cambridge Commonwealth Trust	This work was supported by Wellcome Trust Programme Grant RG44650 (to T. L. B.) and funding from the Royal Commission for the Exhibition of 1851 (to O.R.D.), the University of Sydney, Kings College London, and the Cambridge Commonwealth Trust (to S. D.).	Babu JR, 2003, J CELL BIOL, V160, P341, DOI 10.1083/jcb.200211048; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker DJ, 2004, NAT GENET, V36, P744, DOI 10.1038/ng1382; Bolanos-Garcia VM, 2009, STRUCTURE, V17, P105, DOI 10.1016/j.str.2008.10.015; Bolanos-Garcia VM, 2005, BIOPHYS J, V89, P2640, DOI 10.1529/biophysj.105.063511; Burton JL, 2007, GENE DEV, V21, P655, DOI 10.1101/gad.1511107; Cahill DP, 1998, NATURE, V392, P300, DOI 10.1038/32688; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; Choi E, 2009, EMBO J, V28, P2077, DOI 10.1038/emboj.2009.123; Cliff MJ, 2006, STRUCTURE, V14, P415, DOI 10.1016/j.str.2005.12.009; D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007; Dai W, 2004, CANCER RES, V64, P440, DOI 10.1158/0008-5472.CAN-03-3119; Das AK, 1998, EMBO J, V17, P1192, DOI 10.1093/emboj/17.5.1192; Davenport J, 2006, EXP CELL RES, V312, P1831, DOI 10.1016/j.yexcr.2006.02.018; Deane CM, 1999, PROTEIN ENG, V12, P1025, DOI 10.1093/protein/12.12.1025; Elowe S, 2010, J CELL SCI, V123, P84, DOI 10.1242/jcs.056507; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fang GW, 2002, MOL BIOL CELL, V13, P755, DOI 10.1091/mbc.01-09-0437; Hanks S, 2004, NAT GENET, V36, P1159, DOI 10.1038/ng1449; Hardwick KC, 2000, J CELL BIOL, V148, P871, DOI 10.1083/jcb.148.5.871; Herzog F, 2009, SCIENCE, V323, P1477, DOI 10.1126/science.1163300; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Homer H, 2009, SCIENCE, V326, P991, DOI 10.1126/science.1175326; Howell BJ, 2004, CURR BIOL, V14, P953, DOI 10.1016/j.cub.2004.05.053; Imami K, 2008, ANAL SCI, V24, P161, DOI 10.2116/analsci.24.161; Johnson VL, 2004, J CELL SCI, V117, P1577, DOI 10.1242/jcs.01006; Kiyomitsu T, 2007, DEV CELL, V13, P663, DOI 10.1016/j.devcel.2007.09.005; Kops GJPL, 2008, FRONT BIOSCI-LANDMRK, V13, P3606, DOI 10.2741/2953; Kulukian A, 2009, DEV CELL, V16, P105, DOI 10.1016/j.devcel.2008.11.005; Larsen NA, 2007, P NATL ACAD SCI USA, V104, P1201, DOI 10.1073/pnas.0610358104; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Logarinho E, 2008, CELL CYCLE, V7, P1763, DOI 10.4161/cc.7.12.6180; MACDONALD PN, 2001, METHOD MOL BIOL, V177, pR5; Main ERG, 2003, STRUCTURE, V11, P497, DOI 10.1016/S0969-2126(03)00076-5; Malureanu LA, 2009, DEV CELL, V16, P118, DOI 10.1016/j.devcel.2008.11.004; Mao YH, 2005, J CELL BIOL, V170, P873, DOI 10.1083/jcb.200505040; Mao YH, 2003, CELL, V114, P87, DOI 10.1016/S0092-8674(03)00475-6; Matsuura S, 2006, AM J MED GENET A, V140A, P358, DOI 10.1002/ajmg.a.31069; Millband DN, 2002, MOL CELL BIOL, V22, P2728, DOI 10.1128/MCB.22.8.2728-2742.2002; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nilsson J, 2008, NAT CELL BIOL, V10, P1411, DOI 10.1038/ncb1799; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Peranen J, 1996, ANAL BIOCHEM, V236, P371, DOI 10.1006/abio.1996.0187; Perrakis A, 1997, ACTA CRYSTALLOGR D, V53, P448, DOI 10.1107/S0907444997005696; Pfleger CM, 2000, GENE DEV, V14, P655; Rao CV, 2005, P NATL ACAD SCI USA, V102, P4365, DOI 10.1073/pnas.0407822102; Rice LM, 1999, MOL CELL, V4, P85, DOI 10.1016/S1097-2765(00)80190-2; Royou A, 2010, CELL, V140, P235, DOI 10.1016/j.cell.2009.12.043; SIKORSKI RS, 1990, CELL, V60, P307, DOI 10.1016/0092-8674(90)90745-Z; Sudakin V, 2001, J CELL BIOL, V154, P925, DOI 10.1083/jcb.200102093; Thornton BR, 2003, NAT CELL BIOL, V5, P1090, DOI 10.1038/ncb1066; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; Vanoosthuyse V, 2009, GENE DEV, V23, P2799, DOI 10.1101/gad.1882109; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Wang XS, 2001, J BIOL CHEM, V276, P26559, DOI 10.1074/jbc.M101083200; Weaver BAA, 2006, CURR OPIN CELL BIOL, V18, P658, DOI 10.1016/j.ceb.2006.10.002; Yang J, 2005, EMBO J, V24, P1, DOI 10.1038/sj.emboj.7600496; Yoon J, 2005, PROTEIN EXPRES PURIF, V44, P1, DOI 10.1016/j.pep.2005.04.020; Zich J, 2010, TRENDS BIOCHEM SCI, V35, P18, DOI 10.1016/j.tibs.2009.09.002	60	28	29	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14764	14776		10.1074/jbc.M109.082016	http://dx.doi.org/10.1074/jbc.M109.082016			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20220147	hybrid, Green Published			2022-12-25	WOS:000277299700074
J	Pagano, K; Bemporad, F; Fogolari, F; Esposito, G; Viglino, P; Chiti, F; Corazza, A				Pagano, Katiuscia; Bemporad, Francesco; Fogolari, Federico; Esposito, Gennaro; Viglino, Paolo; Chiti, Fabrizio; Corazza, Alessandra			Structural and Dynamics Characteristics of Acylphosphatase from Sulfolobus solfataricus in the Monomeric State and in the Initial Native-like Aggregates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID FORMATION; MOLECULAR-DYNAMICS; DIFFUSION MEASUREMENTS; GLOBULAR-PROTEINS; MECHANISM; SUPPRESSION; INCLUSION; INSIGHTS; PROGRAM; PATHWAY	It has previously been shown that the acylphosphatase from Sulfolobus solfataricus is capable of forming amyloid-like aggregates under conditions in which the native structure is maintained and via the transient formation of native-like aggregates. Based on the previously determined NMR structure of the native protein, showing a ferredoxin-like fold and the peculiar presence of an unstructured N-terminal segment, we show here, at a molecular level using NMR spectroscopy, that indeed S. solfataricus acylphosphatase remains in a native-like conformation when placed in aggregating conditions and that such a native-like structure persists when the protein forms the initial aggregates, at least within the low molecular weight species. The analysis carried out under different solution conditions, based on the measurement of the combined H-1 and N-15 chemical shifts and hydrogen/deuterium exchange rates, enabled the most significant conformational changes to be monitored upon transfer of the monomeric state into aggregating conditions and upon formation of the initial native-like aggregates. Important increases of the hydrogen/deuterium exchange rates throughout the native protein, accompanied by small and localized structural changes, in the monomeric protein were observed. The results also allow the identification of the intermolecular interaction regions within the native-like aggregates, that involve, in particular, the N-terminal unstructured segment, the apical region including strands S4 and S5 with the connecting loop, and the opposite active site.	[Pagano, Katiuscia; Fogolari, Federico; Esposito, Gennaro; Viglino, Paolo; Corazza, Alessandra] Univ Udine, Dept Biomed Sci & Technol, I-33100 Udine, Italy; [Bemporad, Francesco; Chiti, Fabrizio] Univ Florence, Dept Biochem Sci, I-50134 Florence, Italy; [Fogolari, Federico; Esposito, Gennaro; Viglino, Paolo; Chiti, Fabrizio; Corazza, Alessandra] Consorzio Interuniv Ist Nazl Biostrutture & Biosi, I-00136 Rome, Italy	University of Udine; University of Florence	Corazza, A (corresponding author), Univ Udine, Dept Biomed Sci & Technol, Ple Kolbe 4, I-33100 Udine, Italy.	alessandra.corazza@uniud.it	Corazza, Alessandra/AGB-1457-2022; Pagano, Katiuscia/AAB-9495-2020	Corazza, Alessandra/0000-0003-2272-1928; Bemporad, Francesco/0000-0002-0643-6249; pagano, katiuscia/0000-0002-0462-2056; Fogolari, Federico/0000-0001-9862-250X	MIUR [XY59ZJ, M3E2T2, RBNE03PX83, RBRN07BMCT]; European Union [LSHM-CT-2005-037525]; Accademia dei Lincei; Federation of the European Biochemical Societies	MIUR(Ministry of Education, Universities and Research (MIUR)); European Union(European Commission); Accademia dei Lincei; Federation of the European Biochemical Societies	This work was supported by MIUR Grants PRIN 2007 XY59ZJ, PRIN M3E2T2, FIRB RBNE03PX83, and FIRB RBRN07BMCT and European Union EURAMY Project LSHM-CT-2005-037525.; Supported in part by the Accademia dei Lincei and by a long term fellowship from the Federation of the European Biochemical Societies. Present address: Dept. of Chemistry, University of Cambridge, Lensfield Road, Cambridge CB2 1EW, United Kingdom.	BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110; Baldwin AJ, 2008, ANGEW CHEM INT EDIT, V47, P3385, DOI 10.1002/anie.200703915; Bemporad F, 2008, BBA-PROTEINS PROTEOM, V1784, P1986, DOI 10.1016/j.bbapap.2008.08.021; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Chiti F, 2009, NAT CHEM BIOL, V5, P15, DOI 10.1038/nchembio.131; Corazza A, 2006, PROTEINS, V62, P64, DOI 10.1002/prot.20703; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Einstein A, 1956, INVESTIGATIONS THEOR; Fischer H, 2004, PROTEIN SCI, V13, P2825, DOI 10.1110/ps.04688204; Fogolari F, 2007, BIOPHYS J, V92, P1673, DOI 10.1529/biophysj.106.098483; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; HWANG TL, 1995, J MAGN RESON SER A, V112, P275, DOI 10.1006/jmra.1995.1047; Jahn TR, 2005, FEBS J, V272, P5962, DOI 10.1111/j.1742-4658.2005.05021.x; Jerschow A, 1997, J MAGN RESON, V125, P372, DOI 10.1006/jmre.1997.1123; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Modesti A, 1995, PROTEIN EXPRES PURIF, V6, P799, DOI 10.1006/prep.1995.0011; Mulder FAA, 1999, J MOL BIOL, V292, P111, DOI 10.1006/jmbi.1999.3034; Plakoutsi G, 2005, J MOL BIOL, V351, P910, DOI 10.1016/j.jmb.2005.06.043; Plakoutsi G, 2004, J BIOL CHEM, V279, P14111, DOI 10.1074/jbc.M312961200; Plakoutsi G, 2006, STRUCTURE, V14, P993, DOI 10.1016/j.str.2006.03.014; Poling B.E., 2001, PROPERTIES GASES LIQ, DOI DOI 10.1-10.70; Soldi G, 2006, J MED CHEM, V49, P6057, DOI 10.1021/jm0606488; Soldi G, 2008, J AM CHEM SOC, V130, P4295, DOI 10.1021/ja076628s; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; Stefani M, 1997, CELL MOL LIFE SCI, V53, P141, DOI 10.1007/PL00000585; STEJSKAL EO, 1965, J CHEM PHYS, V42, P288, DOI 10.1063/1.1695690; Uversky VN, 2004, BBA-PROTEINS PROTEOM, V1698, P131, DOI 10.1016/j.bbapap.2003.12.008; Ventura S, 2006, TRENDS BIOTECHNOL, V24, P179, DOI 10.1016/j.tibtech.2006.02.007	30	21	21	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14689	14700		10.1074/jbc.M109.082156	http://dx.doi.org/10.1074/jbc.M109.082156			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20223823	hybrid, Green Published			2022-12-25	WOS:000277299700067
J	Por, E; Byun, HJ; Lee, EJ; Lim, JH; Jung, SY; Park, I; Kim, YM; Jeoung, DI; Lee, H				Por, Elaine; Byun, Hee-Jung; Lee, Eun-Ju; Lim, Jeong-Hee; Jung, So-Young; Park, Iha; Kim, Young-Myeong; Jeoung, Doo-Il; Lee, Hansoo			The Cancer/Testis Antigen CAGE with Oncogenic Potential Stimulates Cell Proliferation by Up-regulating Cyclins D1 and E in an AP-1-and E2F-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOLYTIC T-LYMPHOCYTES; C-JUN; HUMAN-MELANOMA; TERMINAL PHOSPHORYLATION; PHASE PROGRESSION; GENE CAGE; EXPRESSION; ACTIVATION; CANCER; IDENTIFICATION	A cancer/testis antigen, CAGE, is widely expressed in various cancer tissues and cancer cell lines but not in normal tissues except the testis. In the present study, ectopic expression of CAGE in fibroblast cells resulted in foci formation, suggesting its cell-transforming ability. Using stable HeLa transfectant clones with the tetracycline-inducible CAGE gene, we found that CAGE overexpression stimulated both anchorage-dependent and -independent cell growth in vitro and promoted tumor growth in a xenograft mouse model. Cell cycle analysis showed that CAGE augments the levels of cyclin D1 and E, thereby activating cyclin-associated cyclin-dependent kinases and subsequently accelerating the G1 to S progression. Moreover, increased cyclin D1 and E levels in CAGE-overexpressing cells were observed even in a growth arrested state, indicating a direct effect of CAGE on G1 cyclin expression. CAGE-induced expression of cyclins D1 and E was found to be mediated by AP-1 and E2F-1 transcription factors, and among the AP-1 members, c-Jun and JunD appeared to participate in CAGE-mediated upregulation of cyclin D1. CAGE overexpression also enhanced retinoblastoma phosphorylation and subsequent E2F-1 nuclear translocation. In contrast, small interfering RNA-mediated knockdown of CAGE suppressed the expression of G1 cyclins, activation of AP-1 and E2F-1, and cell proliferation in both HeLa cervical cancer cells and Malme-3M melanoma cells. These results suggest that the cancer/testis antigen CAGE possesses oncogenic potential and promotes cell cycle progression by inducing AP-1- and E2F-dependent expression of cyclins D1 and E.	[Por, Elaine; Byun, Hee-Jung; Lee, Eun-Ju; Lim, Jeong-Hee; Jung, So-Young; Jeoung, Doo-Il; Lee, Hansoo] Kangwon Natl Univ, Coll Nat Sci, Div Life Sci, Sch Med, Chunchon 200701, Kangwon Do, South Korea; [Por, Elaine; Byun, Hee-Jung; Lee, Eun-Ju; Lim, Jeong-Hee; Jung, So-Young; Park, Iha; Jeoung, Doo-Il; Lee, Hansoo] Kangwon Natl Univ, Coll Nat Sci, Med & Biomat Res Ctr, Sch Med, Chunchon 200701, Kangwon Do, South Korea; [Kim, Young-Myeong] Kangwon Natl Univ, Coll Nat Sci, Dept Mol & Cellular Biochem, Sch Med, Chunchon 200701, Kangwon Do, South Korea	Kangwon National University; Kangwon National University; Kangwon National University	Lee, H (corresponding author), Kangwon Natl Univ, Coll Nat Sci, Div Life Sci, Sch Med, Chunchon 200701, Kangwon Do, South Korea.	hslee@kangwon.ac.kr		Por, Elaine/0000-0001-8025-5713	Korea Research Foundation [KRF-2006-312-C00677]; Korea Science and Engineering Foundation [R01-2007-000-11397-0]; Korean Ministry of Education, Science, and Technology	Korea Research Foundation(National Research Foundation of Korea); Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); Korean Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by Grants KRF-2006-312-C00677 from the Korea Research Foundation and R01-2007-000-11397-0 from the Korea Science and Engineering Foundation. This work was also supported by a grant from the Korean Ministry of Education, Science, and Technology (Regional Core Research Program/Medical & Bio-Materials Research Center).	Bakiri L, 2000, EMBO J, V19, P2056, DOI 10.1093/emboj/19.9.2056; Behrens A, 2000, ONCOGENE, V19, P2657, DOI 10.1038/sj.onc.1203603; Behrens A, 1999, NAT GENET, V21, P326, DOI 10.1038/6854; BODRUG SE, 1994, EMBO J, V13, P2124, DOI 10.1002/j.1460-2075.1994.tb06488.x; BOEL P, 1995, IMMUNITY, V2, P167, DOI 10.1016/S1074-7613(95)80053-0; Boon T, 1997, CURR OPIN IMMUNOL, V9, P681, DOI 10.1016/S0952-7915(97)80049-0; Chen YT, 1997, CYTOGENET CELL GENET, V79, P237, DOI 10.1159/000134734; Cho B, 2002, BIOCHEM BIOPH RES CO, V292, P715, DOI 10.1006/bbrc.2002.6701; Cho BS, 2003, BIOCHEM BIOPH RES CO, V307, P52, DOI 10.1016/S0006-291X(03)01121-5; De Backer O, 1999, CANCER RES, V59, P3157; Duxbury MS, 2004, ONCOGENE, V23, P465, DOI 10.1038/sj.onc.1207036; Garnovskaya MN, 2004, J BIOL CHEM, V279, P24899, DOI 10.1074/jbc.M311622200; Geng Y, 1996, ONCOGENE, V12, P1173; Giacinti C, 2006, ONCOGENE, V25, P5220, DOI 10.1038/sj.onc.1209615; Hah N, 2003, BIOCHEM BIOPH RES CO, V305, P428, DOI 10.1016/S0006-291X(03)00788-5; HERBER B, 1994, ONCOGENE, V9, P1295; Hong IK, 2006, J BIOL CHEM, V281, P24279, DOI 10.1074/jbc.M601209200; HUNTER T, 1994, CELL, V79, P573, DOI 10.1016/0092-8674(94)90543-6; Keenan SM, 2004, J BIOL CHEM, V279, P5387, DOI 10.1074/jbc.M310383200; KING RW, 1994, CELL, V79, P563, DOI 10.1016/0092-8674(94)90542-8; Lucas S, 1998, CANCER RES, V58, P743; Musgrove EA, 2006, GROWTH FACTORS, V24, P13, DOI 10.1080/08977190500361812; Rodriguez-Puebla ML, 1999, MOL CARCINOGEN, V24, P1, DOI 10.1002/(SICI)1098-2744(199901)24:1<1::AID-MC1>3.0.CO;2-E; Sadanaga N, 2001, CLIN CANCER RES, V7, P2277; Scanlan Matthew J, 2004, Cancer Immun, V4, P1; Scanlan MJ, 2002, IMMUNOL REV, V188, P22, DOI 10.1034/j.1600-065X.2002.18803.x; Schorpp-Kistner M, 1999, EMBO J, V18, P934, DOI 10.1093/emboj/18.4.934; Schreiber M, 1999, GENE DEV, V13, P607, DOI 10.1101/gad.13.5.607; Sgambato A, 1998, TUMORI, V84, P421, DOI 10.1177/030089169808400401; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; Shim E, 2006, BIOTECHNOL LETT, V28, P515, DOI 10.1007/s10529-006-0008-5; Surjit M, 2006, J BIOL CHEM, V281, P10669, DOI 10.1074/jbc.M509233200; Vandel L, 1996, MOL CELL BIOL, V16, P1881; VANDENEYNDE B, 1995, J EXP MED, V182, P689, DOI 10.1084/jem.182.3.689; VANDERBRUGGEN P, 1991, SCIENCE, V254, P1643, DOI 10.1126/science.1840703; Weitzman JB, 2000, MOL CELL, V6, P1109, DOI 10.1016/S1097-2765(00)00109-X; Wisdom R, 1999, EMBO J, V18, P188, DOI 10.1093/emboj/18.1.188; Zendman AJW, 2003, J CELL PHYSIOL, V194, P272, DOI 10.1002/jcp.10215	39	55	57	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14475	14485		10.1074/jbc.M109.084400	http://dx.doi.org/10.1074/jbc.M109.084400			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20220142	Green Published, hybrid			2022-12-25	WOS:000277299700044
J	Bargeton, B; Kellenberger, S				Bargeton, Benoite; Kellenberger, Stephan			The Contact Region between Three Domains of the Extracellular Loop of ASIC1a Is Critical for Channel Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSING ION CHANNELS; ACID; PORE; 1A; ION-CHANNEL-1; CONTRIBUTES; EXPRESSION; ISCHEMIA; H+	Acid-sensing ion channels are members of the epithelial Na+ channel/degenerin family. They are neuronal nonvoltage-gated Na+ channels that are activated by extracellular acidification. In this study, we investigated the role of a highly conserved region of the extracellular part of ASIC1a that forms the contact between the finger domain, the adjacent beta-ball, and the upper palm domain in ASIC1a. The finger domain contributes to the pH-dependent gating and is linked via this contact zone to the rest of the protein. We found that mutation to Cys of residues in this region led to decreased channel expression and current amplitudes. Exposure of the engineered Cys residues to Cd2+ or to charged methane thiosulfonate sulfhydryl reagents further reduced current amplitudes. This current inhibition was not due to changes in acid-sensing ion channel pH dependence or unitary conductance and was likely due to a decrease of the probability of channel opening. For some mutants, the effect of sulfhydryl reagents depended on the pH of exposure in the range 7.4 to 6.8, suggesting that this zone undergoes conformational changes during inactivation. Our study identifies a region in ASIC1a whose integrity is required for normal channel function.	[Bargeton, Benoite; Kellenberger, Stephan] Univ Lausanne, Dept Pharmacol & Toxicol, CH-1005 Lausanne, Switzerland	University of Lausanne	Kellenberger, S (corresponding author), Univ Lausanne, Dept Pharmacol & Toxicol, Rue Bugnon 27, CH-1005 Lausanne, Switzerland.	Stephan.Kellenberger@unil.ch		Kellenberger, Stephan/0000-0003-1755-6198	Swiss National Science Foundation [31003A0-117717]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by Grant 31003A0-117717 from the Swiss National Science Foundation (to S. K.).	Babini E, 2002, J BIOL CHEM, V277, P41597, DOI 10.1074/jbc.M205877200; Baron A, 2001, J BIOL CHEM, V276, P35361, DOI 10.1074/jbc.M105208200; Bassler EL, 2001, J BIOL CHEM, V276, P33782, DOI 10.1074/jbc.M104030200; Coscoy S, 1999, J BIOL CHEM, V274, P10129, DOI 10.1074/jbc.274.15.10129; Deval E, 2008, EMBO J, V27, P3047, DOI 10.1038/emboj.2008.213; Gonzales EB, 2009, NATURE, V460, P599, DOI 10.1038/nature08218; Heinz U, 2003, J BIOL CHEM, V278, P20659, DOI 10.1074/jbc.M212581200; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Kadurin I, 2008, BIOCHEM J, V412, P469, DOI 10.1042/BJ20071614; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Kellenberger S, 1999, P NATL ACAD SCI USA, V96, P4170, DOI 10.1073/pnas.96.7.4170; Kellenberger S, 1996, J BIOL CHEM, V271, P30971, DOI 10.1074/jbc.271.48.30971; Krishtal O, 2003, TRENDS NEUROSCI, V26, P477, DOI 10.1016/S0166-2236(03)00210-8; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li TB, 2009, J BIOL CHEM, V284, P4689, DOI 10.1074/jbc.M805302200; Liechti LA, 2010, J BIOL CHEM, V285, P16315, DOI 10.1074/jbc.M109.092015; Martinez GL, 2000, J ELECTRON MATER, V29, P325, DOI 10.1007/s11664-000-0072-x; Melo F, 1997, J MOL BIOL, V267, P207, DOI 10.1006/jmbi.1996.0868; Mogil JS, 2005, J NEUROSCI, V25, P9893, DOI 10.1523/JNEUROSCI.2019-05.2005; Passero CJ, 2009, J BIOL CHEM, V284, P36473, DOI 10.1074/jbc.M109.055418; Paukert M, 2008, J BIOL CHEM, V283, P572, DOI 10.1074/jbc.M706811200; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Salinas M, 2006, J PHYSIOL-LONDON, V570, P339, DOI 10.1113/jphysiol.2005.095810; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Sluka KA, 2003, PAIN, V106, P229, DOI 10.1016/S0304-3959(03)00269-0; Sutherland SP, 2001, P NATL ACAD SCI USA, V98, P711, DOI 10.1073/pnas.011404498; Vukicevic M, 2006, J BIOL CHEM, V281, P714, DOI 10.1074/jbc.M510472200; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Wemmie JA, 2003, J NEUROSCI, V23, P5496; Wemmie JA, 2006, TRENDS NEUROSCI, V29, P578, DOI 10.1016/j.tins.2006.06.014; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Yang HY, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000151; Zhang P, 2002, J GEN PHYSIOL, V120, P553, DOI 10.1085/jgp.20028574; Zhang ZR, 2005, J BIOL CHEM, V280, P41997, DOI 10.1074/jbc.M510242200	34	17	17	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13816	13826		10.1074/jbc.M109.086843	http://dx.doi.org/10.1074/jbc.M109.086843			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20215117	Green Published, hybrid			2022-12-25	WOS:000276987700057
J	Buscher, K; Riese, SB; Shakibaei, M; Reich, C; Dernedde, J; Tauber, R; Ley, K				Buscher, Konrad; Riese, Sebastian B.; Shakibaei, Mehdi; Reich, Christian; Dernedde, Jens; Tauber, Rudolf; Ley, Klaus			The Transmembrane Domains of L-selectin and CD44 Regulate Receptor Cell Surface Positioning and Leukocyte Adhesion under Flow	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-SELECTIN; GLYCOPROTEIN LIGAND-1; CYTOPLASMIC DOMAIN; IN-VITRO; PHYSIOLOGICAL FLOW; EPITHELIAL-CELLS; MICROVILLI; MEMBRANE; POLARITY; BINDING	During inflammation and immune surveillance, initial contacts (tethering) between free-flowing leukocytes and the endothelium are vitally dependent on the presentation of the adhesion receptor L-selectin on leukocyte microvilli. Determinants that regulate receptor targeting to microvilli are, however, largely elusive. Therefore, we systematically swapped the extracellular (EC), transmembrane (TM), and intracellular (IC) domains of L-selectin and CD44, a hyaluronan receptor expressed on the cell body and excluded from microvilli. Electron microscopy of transfected human myeloid K562 cells showed that the highly conserved TM domains are responsible for surface positioning. The TM segment of L-selectin forced chimeric molecules to microvilli, and the CD44 TM domain evoked expression on the cell body, whereas the IC and EC domains hardly influenced surface localization. Transfectants with microvillus-based chimeras showed a significantly higher adhesion rate under flow but not under static conditions compared with cells with cell body-expressed receptors. Substitution of the IC domain of L-selectin caused diminished tethering but no change in surface distribution, indicating that both microvillus positioning and cytoskeletal anchoring contribute to leukocyte tethering. These findings demonstrate that TM domains of L-selectin and CD44 play a crucial role in cell adhesion under flow by targeting receptors to microvilli or the cell body, respectively.	[Buscher, Konrad; Ley, Klaus] La Jolla Inst Allergy & Immunol, Div Inflammat Biol, La Jolla, CA 92037 USA; [Buscher, Konrad; Riese, Sebastian B.; Reich, Christian; Dernedde, Jens; Tauber, Rudolf] Charite, Cent Dept Lab Med & Pathobiochem, D-10117 Berlin, Germany; [Reich, Christian] Charite, Dept Anesthesiol & Intens Care Med, D-10117 Berlin, Germany; [Shakibaei, Mehdi] Univ Munich, Dept Anat, D-80539 Munich, Germany	La Jolla Institute for Immunology; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Munich	Ley, K (corresponding author), La Jolla Inst Allergy & Immunol, Div Inflammat Biol, 9420 Athena Circle Dr, La Jolla, CA 92037 USA.	klaus@liai.org	Dernedde, Jens/H-4097-2017; Prof. Dr. Shakibaei, Mehdi/AAA-7004-2020	Dernedde, Jens/0000-0001-5319-7677; Prof. Dr. Shakibaei, Mehdi/0000-0002-6304-7506	National Institutes of Health [EB 02185]; Deutsche Forschungsgemeinschaft [Sonderforschungsbereich 449]; Boehringer Ingelheim Fonds; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB002185] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Boehringer Ingelheim Fonds(Boehringer Ingelheim); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported, in whole or in part, by National Institutes of Health Grant EB 02185. This work was also supported by Deutsche Forschungsgemeinschaft Grant Sonderforschungsbereich 449 and Boehringer Ingelheim Fonds.	Abitorabi MA, 1997, J CELL BIOL, V139, P563, DOI 10.1083/jcb.139.2.563; ARBONES ML, 1994, IMMUNITY, V1, P247, DOI 10.1016/1074-7613(94)90076-0; Azuma H, 2002, CANCER RES, V62, P1410; BERLIN C, 1995, CELL, V80, P413, DOI 10.1016/0092-8674(95)90491-3; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Brenner B, 1996, P NATL ACAD SCI USA, V93, P15376, DOI 10.1073/pnas.93.26.15376; Bruehl RE, 1997, J LEUKOCYTE BIOL, V61, P489, DOI 10.1002/jlb.61.4.489; CANNISTRA SA, 1993, CANCER RES, V53, P3830; Chhabra ES, 2007, NAT CELL BIOL, V9, P1110, DOI 10.1038/ncb1007-1110; Corbeil D, 1999, J CELL SCI, V112, P1023; DeGrendele HC, 1996, J EXP MED, V183, P1119, DOI 10.1084/jem.183.3.1119; Dow LE, 2007, INT REV CYTOL, V262, P253, DOI 10.1016/S0074-7696(07)62006-3; Dwir O, 2007, J IMMUNOL, V179, P1030, DOI 10.4049/jimmunol.179.2.1030; ERLANDSEN SL, 1993, J HISTOCHEM CYTOCHEM, V41, P327, DOI 10.1177/41.3.7679125; Foti M, 2002, P NATL ACAD SCI USA, V99, P2008, DOI 10.1073/pnas.042689099; Hanley WD, 2006, FASEB J, V20, P337, DOI 10.1096/fj.05-4574fje; Hocde SA, 2009, BIOPHYS J, V97, P379, DOI 10.1016/j.bpj.2009.04.035; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Ivetic A, 2004, J BIOL CHEM, V279, P33263, DOI 10.1074/jbc.M312212200; KANSAS GS, 1989, J IMMUNOL, V142, P3050; KANSAS GS, 1993, J EXP MED, V177, P833, DOI 10.1084/jem.177.3.833; Krasik EF, 2004, BIOPHYS J, V87, P2919, DOI 10.1529/biophysj.104.039693; Legg JW, 1998, CURR BIOL, V8, P705, DOI 10.1016/S0960-9822(98)70277-5; LEY K, 1995, J EXP MED, V181, P669, DOI 10.1084/jem.181.2.669; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Li XJ, 2007, CELL RES, V17, P985, DOI 10.1038/cr.2007.98; MATTER K, 1994, CURR OPIN CELL BIOL, V6, P545, DOI 10.1016/0955-0674(94)90075-2; Matter K, 2000, CURR BIOL, V10, pR39, DOI 10.1016/S0960-9822(99)00256-0; Miner JJ, 2008, BLOOD, V112, P2035, DOI 10.1182/blood-2008-04-149468; Moore DT, 2008, STRUCTURE, V16, P991, DOI 10.1016/j.str.2008.05.007; PAVALKO FM, 1995, J CELL BIOL, V129, P1155, DOI 10.1083/jcb.129.4.1155; PERSCHL A, 1995, J CELL SCI, V108, P1033; SHAKIBAEI M, 1993, J STRUCT BIOL, V111, P180, DOI 10.1006/jsbi.1993.1048; Siegelman MH, 1999, J LEUKOCYTE BIOL, V66, P315, DOI 10.1002/jlb.66.2.315; Singer II, 2001, J VIROL, V75, P3779, DOI 10.1128/JVI.75.8.3779-3790.2001; Snapp KR, 1998, J CELL BIOL, V142, P263, DOI 10.1083/jcb.142.1.263; Sperandio M, 2003, J EXP MED, V197, P1355, DOI 10.1084/jem.20021854; Spertini O, 1996, J CELL BIOL, V135, P523, DOI 10.1083/jcb.135.2.523; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Stein JV, 1999, J EXP MED, V189, P37, DOI 10.1084/jem.189.1.37; VONANDRIAN UH, 1992, AM J PHYSIOL, V263, pH1034, DOI 10.1152/ajpheart.1992.263.4.H1034; VONANDRIAN UH, 1995, CELL, V82, P989, DOI 10.1016/0092-8674(95)90278-3; Walcheck B, 1996, J CLIN INVEST, V98, P1081, DOI 10.1172/JCI118888; 2006, CANC RES, V66, P1536	44	28	32	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13490	13497		10.1074/jbc.M110.102640	http://dx.doi.org/10.1074/jbc.M110.102640			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20212041	Green Published, hybrid			2022-12-25	WOS:000276987700021
J	Zou, WQ; Langeveld, J; Xiao, XZ; Chen, SG; McGeer, PL; Yuan, J; Payne, MC; Kang, HE; McGeehan, J; Sy, MS; Greenspan, NS; Kaplan, D; Wang, GX; Parchi, P; Hoover, E; Kneale, G; Telling, G; Surewicz, WK; Kong, QZ; Guo, JP				Zou, Wen-Quan; Langeveld, Jan; Xiao, Xiangzhu; Chen, Shugui; McGeer, Patrick L.; Yuan, Jue; Payne, Michael C.; Kang, Hae-Eun; McGeehan, John; Sy, Man-Sun; Greenspan, Neil S.; Kaplan, David; Wang, Gong-Xian; Parchi, Piero; Hoover, Edward; Kneale, Geoff; Telling, Glenn; Surewicz, Witold K.; Kong, Qingzhong; Guo, Jian-Ping			PrP Conformational Transitions Alter Species Preference of a PrP-specific Antibody	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CREUTZFELDT-JAKOB-DISEASE; PATHOLOGICAL PRION PROTEIN; MONOCLONAL-ANTIBODY; N-TERMINUS; SCRAPIE; EPITOPE; BINDING; BRAIN; RECOGNITION; STRAIN	The epitope of the 3F4 antibody most commonly used inhuman prion disease diagnosis is believed to consist of residues Met-LysHis-Met (MKHM) corresponding to human PrP-(109-112). This assumption is based mainly on the observation that 3F4 reacts with human and hamster PrP but not with PrP from mouse, sheep, and cervids, in which Met at residue 112 is replaced by Val. Here we report that, by brain histoblotting, 3F4 did not react with PrP of uninfected transgenic mice expressing elk PrP; however, it did show distinct immunoreactivity in transgenic mice infected with chronic wasting disease. Compared with human PrP, the 3F4 reactivity with the recombinant elk PrP was 2 orders of magnitude weaker, as indicated by both Western blotting and surface plasmon resonance. To investigate the molecular basis of these species-and conformer-dependent preferences of 3F4, the epitope was probed by peptide membrane array and antigen competition experiments. Remarkably, the 3F4 antibody did not react with MKHM but reacted strongly with KTNMK(corresponding to human PrP( 106-110)), a sequence that is also present in cervids, sheep, and cattle. 3F4 also reacted with elk PrP peptides containing KTNMKHV. We concluded that the minimal sequence for the 3F4 epitope consists of residues KTNMK, and the species-and conformer-dependent preferences of 3F4 arise largely from the interactions between Met(112) (human PrP) or Val(115) (cervid PrP) and adjacent residues.	[Zou, Wen-Quan; Xiao, Xiangzhu; Yuan, Jue; Payne, Michael C.; Sy, Man-Sun; Greenspan, Neil S.; Kaplan, David; Kong, Qingzhong] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA; [Zou, Wen-Quan; Xiao, Xiangzhu; Yuan, Jue] Case Western Reserve Univ, Sch Med, Natl Prion Dis Pathol Surveillance Ctr, Cleveland, OH 44106 USA; [Chen, Shugui; Surewicz, Witold K.] Case Western Reserve Univ, Sch Med, Dept Physiol & Biophys, Cleveland, OH 44106 USA; [Langeveld, Jan] Wageningen UR, Cent Vet Inst, NL-8221 RA Lelystad, Netherlands; [McGeer, Patrick L.; Guo, Jian-Ping] Univ British Columbia, Fac Med, Kinsmen Lab Neurol Res, Vancouver, BC V6T 1Z3, Canada; [Kang, Hae-Eun; Telling, Glenn] Univ Kentucky, Med Ctr, Sanders Brown Ctr Aging, Dept Microbiol, Lexington, KY 40536 USA; [Kang, Hae-Eun; Telling, Glenn] Univ Kentucky, Med Ctr, Sanders Brown Ctr Aging, Dept Immunol, Lexington, KY 40536 USA; [Kang, Hae-Eun; Telling, Glenn] Univ Kentucky, Med Ctr, Sanders Brown Ctr Aging, Dept Mol Genet, Lexington, KY 40536 USA; [Kang, Hae-Eun; Telling, Glenn] Univ Kentucky, Med Ctr, Sanders Brown Ctr Aging, Dept Neurol, Lexington, KY 40536 USA; [McGeehan, John; Kneale, Geoff] Univ Portsmouth, Biophys Labs, Inst Biomed & Biomol Sci, Portsmouth PO1 2DT, Hants, England; [Zou, Wen-Quan; Wang, Gong-Xian] Nanchang Univ, Sch Med, Affiliated Hosp 1, Nanchang 330006, Jiangxi Prov, Peoples R China; [Parchi, Piero] Univ Bologna, Dipartimento Sci Neurol, Bologna, Italy; [Hoover, Edward] Univ Colorado, Dept Mol Biol Immunol & Pathol, Ft Collins, CO 80523 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Wageningen University & Research; University of British Columbia; University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky; University of Portsmouth; Nanchang University; University of Bologna	Zou, WQ (corresponding author), Case Western Reserve Univ, Inst Pathol, 2085 Adelbert Rd, Cleveland, OH 44106 USA.	wenquan.zou@case.edu	Zou, Wenquan/ABF-2875-2020; Greenspan, Neil/AAJ-4795-2020; xiao, xiangzhu/B-9300-2014; Telling, Glenn C/G-1217-2019; Parchi, Piero/L-9833-2015; Zou, Wenquan/GWQ-3489-2022	xiao, xiangzhu/0000-0002-8013-9074; Telling, Glenn C/0000-0002-6294-1805; Parchi, Piero/0000-0002-9444-9524; McGeehan, John/0000-0002-6750-1462	National Institutes of Health [R01NS062787, R01NS052319, R01NS44158]; NIA [AG-14359]; CJD Foundation; Alliance BioSecure; University Center on Aging and Health; McGregor Foundation; Case Western Reserve University; Centers for Disease Control and Prevention [UR8/CCU515004]; Dutch Ministry of Agriculture, Nature and Food Quality, UK [DEFRA SE1700]; NeuroPrion EC [FOOD-CT-2004-506579];  [RR016789]; Engineering and Physical Sciences Research Council [EP/E500595/1] Funding Source: researchfish; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR016789] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062787, R01NS044158, R01NS052319] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG014359] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); CJD Foundation; Alliance BioSecure; University Center on Aging and Health; McGregor Foundation; Case Western Reserve University; Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Dutch Ministry of Agriculture, Nature and Food Quality, UK; NeuroPrion EC; ; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01NS062787 (to W.-Q.Z.), R01NS052319 (to Q. K.), R01NS44158 (to W. K. S.), AG-14359 from the NIA (to J.-P.G.), and RR016789 to the Biacore facilities at Cleveland Clinic Foundation, grants from the CJD Foundation (to W.-Q.Z.), Alliance BioSecure (to W.-Q.Z.), the University Center on Aging and Health, with support of the McGregor Foundation and the President's Discretionary Fund (Case Western Reserve University) (to W.-Q.Z.), Centers for Disease Control and Prevention Grant UR8/CCU515004 (to J.-P.G.), grants from the Dutch Ministry of Agriculture, Nature and Food Quality, UK project DEFRA SE1700 (to J. L.), and NeuroPrion EC FOOD-CT-2004-506579 (to J. L.).	BOLTON DC, 1991, J VIROL, V65, P3667, DOI 10.1128/JVI.65.7.3667-3675.1991; Cali I, 2009, BRAIN, V132, P2643, DOI 10.1093/brain/awp196; CHEN SG, 1995, J BIOL CHEM, V270, P19173, DOI 10.1074/jbc.270.32.19173; Cobb NJ, 2009, BIOCHEMISTRY-US, V48, P2574, DOI 10.1021/bi900108v; Cohen FE, 1998, ANNU REV BIOCHEM, V67, P793, DOI 10.1146/annurev.biochem.67.1.793; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; FORLONI G, 1993, NATURE, V362, P543, DOI 10.1038/362543a0; Gambetti P, 2003, BRIT MED BULL, V66, P213, DOI 10.1093/bmb/66.1.213; Gambetti P, 2008, ANN NEUROL, V63, P697, DOI 10.1002/ana.21420; Glatzel M, 2003, NEW ENGL J MED, V349, P1812, DOI 10.1056/NEJMoa030351; Greenspan NS, 2001, CURR TOP MICROBIOL, V260, P65; Guo JP, 2004, VIROLOGY, V324, P251, DOI 10.1016/j.virol.2004.04.017; Haigh CL, 2009, CELL RES, V19, P1062, DOI 10.1038/cr.2009.86; Kanyo ZF, 1999, J MOL BIOL, V293, P855, DOI 10.1006/jmbi.1999.3193; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; Kim SJ, 2001, J BIOL CHEM, V276, P26132, DOI 10.1074/jbc.M101638200; Kong QZ, 2008, J VIROL, V82, P3697, DOI 10.1128/JVI.02561-07; Kong QZ, 2005, J NEUROSCI, V25, P7944, DOI 10.1523/JNEUROSCI.2467-05.2005; Korth C, 1997, NATURE, V390, P74, DOI 10.1038/36337; LANGEVELD JPM, 1994, VACCINE, V12, P1473, DOI 10.1016/0264-410X(94)90158-9; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Leclerc E, 2003, J MOL BIOL, V326, P475, DOI 10.1016/S0022-2836(02)01365-7; Li RL, 2000, J MOL BIOL, V301, P567, DOI 10.1006/jmbi.2000.3986; Lund C, 2007, J NEUROSCI METH, V165, P183, DOI 10.1016/j.jneumeth.2007.06.005; Morillas M, 1999, J BIOL CHEM, V274, P36859, DOI 10.1074/jbc.274.52.36859; Norstrom EM, 2005, J BIOL CHEM, V280, P27236, DOI 10.1074/jbc.M413441200; Oliver AW, 2000, J MOL BIOL, V301, P575, DOI 10.1006/jmbi.2000.3991; Peretz D, 1997, J MOL BIOL, V273, P614, DOI 10.1006/jmbi.1997.1328; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Sy MS, 2009, CELL RES, V19, P1039, DOI 10.1038/cr.2009.102; TARABOULOS A, 1992, P NATL ACAD SCI USA, V89, P7620, DOI 10.1073/pnas.89.16.7620; Wadsworth JDF, 2001, LANCET, V358, P171, DOI 10.1016/S0140-6736(01)05403-4; Yuan J, 2008, CELL MOL LIFE SCI, V65, P631, DOI 10.1007/s00018-007-7478-z; Yuan J, 2005, BIOCHEM BIOPH RES CO, V326, P652, DOI 10.1016/j.bbrc.2004.11.088; Yuan J, 2006, J BIOL CHEM, V281, P34848, DOI 10.1074/jbc.M602238200; Zanusso G, 2003, NEW ENGL J MED, V348, P711, DOI 10.1056/NEJMoa022043; Zou WQ, 2004, P NATL ACAD SCI USA, V101, P1380, DOI 10.1073/pnas.0307825100; Zou WQ, 2002, J BIOL CHEM, V277, P43942, DOI 10.1074/jbc.M203611200	39	47	49	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13874	13884		10.1074/jbc.M109.088831	http://dx.doi.org/10.1074/jbc.M109.088831			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20194495	Green Published, hybrid			2022-12-25	WOS:000276987700062
J	Goehler, H; Droge, A; Lurz, R; Schnoegl, S; Chernoff, YO; Wanker, EE				Goehler, Heike; Droege, Anja; Lurz, Rudi; Schnoegl, Sigrid; Chernoff, Yury O.; Wanker, Erich E.			Pathogenic Polyglutamine Tracts Are Potent Inducers of Spontaneous Sup35 and Rnq1 Amyloidogenesis	PLOS ONE			English	Article							AMYLOID-LIKE FIBRILS; PRION-LIKE FACTOR; YEAST PSI+ PRION; SACCHAROMYCES-CEREVISIAE; NEURODEGENERATIVE DISEASE; GLUTAMINE-RICH; IN-VITRO; COMMON MECHANISM; ASPARAGINE-RICH; PROTEIN	The glutamine/asparagine (Q/N)-rich yeast prion protein Sup35 has a low intrinsic propensity to spontaneously self-assemble into ordered, beta-sheet-rich amyloid fibrils. In yeast cells, de novo formation of Sup35 aggregates is greatly facilitated by high protein concentrations and the presence of preformed Q/N-rich protein aggregates that template Sup35 polymerization. Here, we have investigated whether aggregation-promoting polyglutamine (polyQ) tracts can stimulate the de novo formation of ordered Sup35 protein aggregates in the absence of Q/N-rich yeast prions. Fusion proteins with polyQ tracts of different lengths were produced and their ability to spontaneously self-assemble into amlyloid structures was analyzed using in vitro and in vivo model systems. We found that Sup35 fusions with pathogenic (>= 54 glutamines), as opposed to non-pathogenic (19 glutamines) polyQ tracts efficiently form seeding-competent protein aggregates. Strikingly, polyQ-mediated de novo assembly of Sup35 protein aggregates in yeast cells was independent of pre-existing Q/N-rich protein aggregates. This indicates that increasing the content of aggregation-promoting sequences enhances the tendency of Sup35 to spontaneously self-assemble into insoluble protein aggregates. A similar result was obtained when pathogenic polyQ tracts were linked to the yeast prion protein Rnq1, demonstrating that polyQ sequences are generic inducers of amyloidogenesis. In conclusion, long polyQ sequences are powerful molecular tools that allow the efficient production of seeding-competent amyloid structures.	[Goehler, Heike; Droege, Anja; Schnoegl, Sigrid; Wanker, Erich E.] Max Delbruck Ctr Mol Med, Berlin, Germany; [Lurz, Rudi] Max Planck Inst Mol Genet, Berlin, Germany; [Chernoff, Yury O.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Chernoff, Yury O.] Georgia Inst Technol, Inst Bioengn & Biosci, Atlanta, GA 30332 USA	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Max Planck Society; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Goehler, H (corresponding author), Protagen AG, Dortmund, Germany.	ewanker@mdc-berlin.de	Chernoff, Yury O/J-2833-2014	Chernoff, Yury/0000-0002-8934-9051; Wanker, Erich/0000-0001-8072-1630	HDSA, DFG [WA1151/5-1]; BMBF [NGFN1/2, 01GS08170, 0311853]; National Institutes of Health [R01GM58763]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058763] Funding Source: NIH RePORTER	HDSA, DFG(German Research Foundation (DFG)); BMBF(Federal Ministry of Education & Research (BMBF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from HDSA, DFG (WA1151/5-1) and BMBF (NGFN1/2 and NGFNplus 01GS08170 as well as the BioFuture project 0311853) to EEW. YOC was supported by grant R01GM58763 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrov IM, 2008, J BIOL CHEM, V283, P15185, DOI 10.1074/jbc.M802071200; Behrends C, 2006, MOL CELL, V23, P887, DOI 10.1016/j.molcel.2006.08.017; Bitan G, 2001, J BIOL CHEM, V276, P35176, DOI 10.1074/jbc.M102223200; BOEKE JD, 1984, MOL GEN GENET, V197, P345, DOI 10.1007/BF00330984; Bousset L, 2008, CURR ALZHEIMER RES, V5, P251, DOI 10.2174/156720508784533303; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Chernoff YO, 2002, METHOD ENZYMOL, V351, P499; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; COX BS, 1988, YEAST, V4, P159, DOI 10.1002/yea.320040302; Derkatch IL, 2004, P NATL ACAD SCI USA, V101, P12934, DOI 10.1073/pnas.0404968101; Derkatch IL, 1997, GENETICS, V147, P507; Derkatch IL, 1996, GENETICS, V144, P1375; Derkatch IL, 2001, CELL, V106, P171, DOI 10.1016/S0092-8674(01)00427-5; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Ehrnhoefer DE, 2006, HUM MOL GENET, V15, P2743, DOI 10.1093/hmg/ddl210; Fowler DM, 2007, TRENDS BIOCHEM SCI, V32, P217, DOI 10.1016/j.tibs.2007.03.003; Glover JR, 1997, CELL, V89, P811, DOI 10.1016/S0092-8674(00)80264-0; Green JD, 2004, J BIOL CHEM, V279, P12206, DOI 10.1074/jbc.M312452200; Guo L, 2007, P NATL ACAD SCI USA, V104, P4297, DOI 10.1073/pnas.0608041104; Gusella JF, 2000, NAT REV NEUROSCI, V1, P109, DOI 10.1038/35039051; Holz C, 2001, GENOME RES, V11, P1730, DOI 10.1101/gr.181501; Hwang W, 2004, P NATL ACAD SCI USA, V101, P12916, DOI 10.1073/pnas.0402634101; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kim MW, 2009, STRUCTURE, V17, P1205, DOI 10.1016/j.str.2009.08.002; King CY, 2004, NATURE, V428, P319, DOI 10.1038/nature02391; Klein FAC, 2007, J MOL BIOL, V371, P235, DOI 10.1016/j.jmb.2007.05.028; Krishnan R, 2005, NATURE, V435, P765, DOI 10.1038/nature03679; Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a; Meriin AB, 2002, J CELL BIOL, V157, P997, DOI 10.1083/jcb.200112104; Michelitsch MD, 2000, P NATL ACAD SCI USA, V97, P11910, DOI 10.1073/pnas.97.22.11910; Nagai Y, 2007, NAT STRUCT MOL BIOL, V14, P332, DOI 10.1038/nsmb1215; Nakayashiki T, 2005, P NATL ACAD SCI USA, V102, P10575, DOI 10.1073/pnas.0504882102; Nekooki-Machida Y, 2009, P NATL ACAD SCI USA, V106, P9679, DOI 10.1073/pnas.0812083106; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; Ness F, 2002, MOL CELL BIOL, V22, P5593, DOI 10.1128/MCB.22.15.5593-5605.2002; Osherovich LZ, 2004, PLOS BIOL, V2, P442, DOI 10.1371/journal.pbio.0020086; Osherovich LZ, 2001, CELL, V106, P183, DOI 10.1016/S0092-8674(01)00440-8; Patino MM, 1996, SCIENCE, V273, P622, DOI 10.1126/science.273.5275.622; Pawar AP, 2005, J MOL BIOL, V350, P379, DOI 10.1016/j.jmb.2005.04.016; Pellarin R, 2007, J MOL BIOL, V374, P917, DOI 10.1016/j.jmb.2007.09.090; Perutz MF, 2002, P NATL ACAD SCI USA, V99, P5596, DOI 10.1073/pnas.042681599; Rochet JC, 2000, CURR OPIN STRUC BIOL, V10, P60, DOI 10.1016/S0959-440X(99)00049-4; Salnikova AB, 2005, J BIOL CHEM, V280, P8808, DOI 10.1074/jbc.M410150200; Scherzinger E, 1999, P NATL ACAD SCI USA, V96, P4604, DOI 10.1073/pnas.96.8.4604; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317; Shorter J, 2004, SCIENCE, V304, P1793, DOI 10.1126/science.1098007; Shorter J, 2006, MOL CELL, V23, P425, DOI 10.1016/j.molcel.2006.05.042; Sondheimer N, 2000, MOL CELL, V5, P163, DOI 10.1016/S1097-2765(00)80412-8; Soto C, 2006, TRENDS BIOCHEM SCI, V31, P150, DOI 10.1016/j.tibs.2006.01.002; Taylor JP, 2002, SCIENCE, V296, P1991, DOI 10.1126/science.1067122; TERAVANESYAN MD, 1994, GENETICS, V137, P671; True HL, 2000, NATURE, V407, P477, DOI 10.1038/35035005; TUITE MF, 1981, GENETICS, V98, P691; Wacker JL, 2004, NAT STRUCT MOL BIOL, V11, P1215, DOI 10.1038/nsmb860; Walsh DM, 1997, J BIOL CHEM, V272, P22364, DOI 10.1074/jbc.272.35.22364; Wanker EE, 1999, METHOD ENZYMOL, V309, P375; Wu YX, 2005, P NATL ACAD SCI USA, V102, P12789, DOI 10.1073/pnas.0506384102	58	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2010	5	3							e9642	10.1371/journal.pone.0009642	http://dx.doi.org/10.1371/journal.pone.0009642			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565XE	20224794	gold, Green Accepted, Green Published			2022-12-25	WOS:000275328800033
J	Hong, JH; Min, CH; Jeong, B; Kojiya, T; Morioka, E; Nagai, T; Ikeda, M; Lee, KJ				Hong, Jin Hee; Min, Cheol Hong; Jeong, Byeongha; Kojiya, Tomoyoshi; Morioka, Eri; Nagai, Takeharu; Ikeda, Masayuki; Lee, Kyoung J.			Intracellular Calcium Spikes in Rat Suprachiasmatic Nucleus Neurons Induced by BAPTA-Based Calcium Dyes	PLOS ONE			English	Article							CIRCADIAN-RHYTHMS; CLOCK; CA2+; MODULATION; EXPRESSION; CHANNELS; CELLS; TRANSIENTS; CALBINDIN; DYNAMICS	Background: Circadian rhythms in spontaneous action potential (AP) firing frequencies and in cytosolic free calcium concentrations have been reported for mammalian circadian pacemaker neurons located within the hypothalamic suprachiasmatic nucleus (SCN). Also reported is the existence of "Ca2+ spikes" (i.e., [Ca2+](c) transients having a bandwidth of 10,100 seconds) in SCN neurons, but it is unclear if these SCN Ca2+ spikes are related to the slow circadian rhythms. Methodology/Principal Findings: We addressed this issue based on a Ca2+ indicator dye (fluo-4) and a protein Ca2+ sensor (yellow cameleon). Using fluo-4 AM dye, we found spontaneous Ca2+ spikes in 18% of rat SCN cells in acute brain slices, but the Ca2+ spiking frequencies showed no day/night variation. We repeated the same experiments with rat (and mouse) SCN slice cultures that expressed yellow cameleon genes for a number of different circadian phases and, surprisingly, spontaneous Ca2+ spike was barely observed (< 3%). When fluo-4 AM or BAPTA-AM was loaded in addition to the cameleon-expressing SCN cultures, however, the number of cells exhibiting Ca2+ spikes was increased to 13 similar to 14%. Conclusions/Significance: Despite our extensive set of experiments, no evidence of a circadian rhythm was found in the spontaneous Ca2+ spiking activity of SCN. Furthermore, our study strongly suggests that the spontaneous Ca2+ spiking activity is caused by the Ca2+ chelating effect of the BAPTA-based fluo-4 dye. Therefore, this induced activity seems irrelevant to the intrinsic circadian rhythm of [Ca2+](c) in SCN neurons. The problems with BAPTA based dyes are widely known and our study provides a clear case for concern, in particular, for SCN Ca2+ spikes. On the other hand, our study neither invalidates the use of these dyes as a whole, nor undermines the potential role of SCN Ca2+ spikes in the function of SCN.	[Hong, Jin Hee; Min, Cheol Hong; Jeong, Byeongha; Lee, Kyoung J.] Korea Univ, Ctr Cell Dynam, Seoul, South Korea; [Hong, Jin Hee; Min, Cheol Hong; Jeong, Byeongha; Lee, Kyoung J.] Korea Univ, Dept Phys, Seoul 136701, South Korea; [Kojiya, Tomoyoshi; Morioka, Eri; Ikeda, Masayuki] Toyama Univ, Grad Sch Innovat Life Sci, Toyama 930, Japan; [Nagai, Takeharu] Hokkaido Univ, Lab Nanosyst Physiol, Res Inst Elect Sci, Sapporo, Hokkaido, Japan	Korea University; Korea University; University of Toyama; Hokkaido University	Hong, JH (corresponding author), Korea Univ, Ctr Cell Dynam, Seoul, South Korea.	kyoung@korea.ac.kr		Nagai, Takeharu/0000-0003-2650-9895	Korea Ministry of Science and Technology [R17-2007-017-01000-0]; Ministry of Education, Culture, Sports, Science and Technology Japan [16300104, 18021012]; Brain Science Foundation	Korea Ministry of Science and Technology(Ministry of Science & Technology (MOST), Republic of Korea); Ministry of Education, Culture, Sports, Science and Technology Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Brain Science Foundation	This research was supported by the Acceleration Project (R17-2007-017-01000-0) of the Korea Ministry of Science and Technology (K. L.) and by a grant-in-aid for scientific research (16300104 and 18021012) from the Ministry of Education, Culture, Sports, Science and Technology Japan (M. I.) and a grant from the Brain Science Foundation (M. I.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Roblero R, 2007, EUR J NEUROSCI, V26, P575, DOI 10.1111/j.1460-9568.2007.05679.x; Colwell CS, 2000, EUR J NEUROSCI, V12, P571, DOI 10.1046/j.1460-9568.2000.00939.x; EILERS J, 2005, IMAGING NEUROSCIENCE, P277; Grant SK, 2001, ANAL BIOCHEM, V294, P27, DOI 10.1006/abio.2001.5157; GREEN DJ, 1982, BRAIN RES, V245, P198, DOI 10.1016/0006-8993(82)90361-4; Haak LL, 1999, J NEUROPHYSIOL, V81, P1308, DOI 10.1152/jn.1999.81.3.1308; Hamada T, 2003, J NEUROSCI, V23, P8820; Herzog ED, 1997, BRAIN RES, V757, P285, DOI 10.1016/S0006-8993(97)00337-5; Honma S, 2003, TRENDS NEUROSCI, V26, P650, DOI 10.1016/j.tins.2003.09.012; Ikeda M, 2004, NEUROSCIENTIST, V10, P315, DOI 10.1177/10738584031262149; Ikeda M, 2003, EUR J NEUROSCI, V17, P1111, DOI 10.1046/j.1460-9568.2003.02515.x; Ikeda M, 2003, NEURON, V38, P253, DOI 10.1016/S0896-6273(03)00164-8; Ikeda M, 2003, EUR J NEUROSCI, V17, P58, DOI 10.1046/j.1460-9568.2003.02427.x; Ikegaya Y, 2005, NEUROSCI RES, V52, P132, DOI 10.1016/j.neures.2005.02.004; Irwin RP, 2007, J NEUROSCI, V27, P11748, DOI 10.1523/JNEUROSCI.1840-07.2007; Kim DY, 2005, EUR J NEUROSCI, V21, P1215, DOI 10.1111/j.1460-9568.2005.03950.x; Klein D.C., 1991, SUPRACHIASMATIC NUCL; Kohsaka A, 2007, TRENDS ENDOCRIN MET, V18, P4, DOI 10.1016/j.tem.2006.11.005; Kornmann B, 2007, PLOS BIOL, V5, P179, DOI 10.1371/journal.pbio.0050034; Laemle LK, 2002, BRAIN RES, V953, P73, DOI 10.1016/S0006-8993(02)03272-9; LeSauter J, 1999, J NEUROSCI, V19, P5574; Mahoney MM, 2000, NEUROSCIENCE, V99, P565, DOI 10.1016/S0306-4522(00)00212-8; Meredith AL, 2006, NAT NEUROSCI, V9, P1041, DOI 10.1038/nn1740; Miyawaki A, 1999, P NATL ACAD SCI USA, V96, P2135, DOI 10.1073/pnas.96.5.2135; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; NEHER E, 1995, NEUROPHARMACOLOGY, V34, P1423, DOI 10.1016/0028-3908(95)00144-U; NEHER E, 1992, J PHYSIOL-LONDON, V450, P273, DOI 10.1113/jphysiol.1992.sp019127; Nimmerjahn A, 2004, NAT METHODS, V1, P31, DOI 10.1038/nmeth706; Obrietan K, 1996, J NEUROSCI, V16, P3521; Park D, 2003, NAT NEUROSCI, V6, P337, DOI 10.1038/nn1033; Pennartz CMA, 1998, J PHYSIOL-LONDON, V506, P775, DOI 10.1111/j.1469-7793.1998.775bv.x; Pennartz CMA, 2002, NATURE, V416, P286, DOI 10.1038/nature728; REGEHR WD, 1992, CURR OPIN NEUROBIOL, V4, P373; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Schaap J, 1999, BRAIN RES, V815, P154, DOI 10.1016/S0006-8993(98)01025-7; Silver R, 1999, NEUROREPORT, V10, P3165, DOI 10.1097/00001756-199910190-00008; Silver R, 1996, NEUROREPORT, V7, P1224, DOI 10.1097/00001756-199604260-00026; Sugiyama T, 2004, BIOCHEM BIOPH RES CO, V323, P479, DOI 10.1016/j.bbrc.2004.08.126; VANDENPOL AN, 1980, J COMP NEUROL, V191, P661, DOI 10.1002/cne.901910410; VANDENPOL AN, 1992, J NEUROSCI, V12, P2648; Wang Z, 1997, J NEUROSCI, V17, P7359; Welsh DK, 2004, CURR BIOL, V14, P2289, DOI 10.1016/j.cub.2004.11.057	42	12	12	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2010	5	3							e9634	10.1371/journal.pone.0009634	http://dx.doi.org/10.1371/journal.pone.0009634			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565XE	20224788	Green Published, gold			2022-12-25	WOS:000275328800028
J	Lindstrom, MS; Nister, M				Lindstrom, Mikael S.; Nister, Monica			Silencing of Ribosomal Protein S9 Elicits a Multitude of Cellular Responses Inhibiting the Growth of Cancer Cells Subsequent to p53 Activation	PLOS ONE			English	Article							DIAMOND-BLACKFAN ANEMIA; HUMAN-MALIGNANT GLIOMA; P53-DEPENDENT CHECKPOINT; CYCLE ARREST; NUCLEOLAR DISRUPTION; DOWN-REGULATION; DNA-DAMAGE; MDM2; L11; DEGRADATION	Background: Disruption of the nucleolus often leads to activation of the p53 tumor suppressor pathway through inhibition of MDM2 that is mediated by a limited set of ribosomal proteins including RPL11 and RPL5. The effects of ribosomal protein loss in cultured mammalian cells have not been thoroughly investigated. Here we characterize the cellular stress response caused by depletion of ribosomal protein S9 (RPS9). Methodology/Principal Findings: Depletion of RPS9 impaired production of 18S ribosomal RNA and induced p53 activity. It promoted p53-dependent morphological differentiation of U343MGa Cl2:6 glioma cells as evidenced by intensified expression of glial fibrillary acidic protein and profound changes in cell shape. U2OS osteosarcoma cells displayed a limited senescence response with increased expression of DNA damage response markers, whereas HeLa cervical carcinoma cells underwent cell death by apoptosis. Knockdown of RPL11 impaired p53-dependent phenotypes in the different RPS9 depleted cell cultures. Importantly, knockdown of RPS9 or RPL11 also markedly inhibited cell proliferation through p53-independent mechanisms. RPL11 binding to MDM2 was retained despite decreased levels of RPL11 protein following nucleolar stress. In these settings, RPL11 was critical for maintaining p53 protein stability but was not strictly required for p53 protein synthesis. Conclusions: p53 plays an important role in the initial restriction of cell proliferation that occurs in response to decreased level of RPS9. Our results do not exclude the possibility that other nucleolar stress sensing molecules act upstream or in parallel to RPL11 to activate p53. Inhibiting the expression of certain ribosomal proteins, such as RPS9, could be one efficient way to reinitiate differentiation processes or to induce senescence or apoptosis in rapidly proliferating tumor cells.	[Lindstrom, Mikael S.; Nister, Monica] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden	Karolinska Institutet	Lindstrom, MS (corresponding author), Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden.	mikael.lindstrom@ki.se	Lindström, Mikael S/AAA-1451-2019	Lindström, Mikael S/0000-0003-1148-8497	Ake Wiberg's foundation; Magnus Bergvall's foundation; Swedish Cancer Society (Cancerfonden); Swedish Cancer Society; Cancer Society in Stockholm; Swedish Research Council; Swedish Childhood Cancer Foundation; Karolinska University Hospital FoUU	Ake Wiberg's foundation; Magnus Bergvall's foundation; Swedish Cancer Society (Cancerfonden)(Swedish Cancer Society); Swedish Cancer Society(Swedish Cancer Society); Cancer Society in Stockholm; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Childhood Cancer Foundation(European Commission); Karolinska University Hospital FoUU	This study was made possible with the financial support to ML from Ake Wiberg's foundation, Karolinska Institutet funds and the Magnus Bergvall's foundation. ML is a recipient of a fellowship award from the Swedish Cancer Society (Cancerfonden). Work was carried out in the laboratory of MN, supported by the Swedish Cancer Society, the Cancer Society in Stockholm, the Swedish Research Council, the Swedish Childhood Cancer Foundation and Karolinska University Hospital FoUU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsterdam A, 2004, PLOS BIOL, V2, P690, DOI 10.1371/journal.pbio.0020139; Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; Anderson SJ, 2007, IMMUNITY, V26, P759, DOI 10.1016/j.immuni.2007.04.012; Badhai J, 2009, FEBS LETT, V583, P2049, DOI 10.1016/j.febslet.2009.05.023; Barkic M, 2009, MOL CELL BIOL, V29, P2489, DOI 10.1128/MCB.01588-08; Bhat KP, 2004, EMBO J, V23, P2402, DOI 10.1038/sj.emboj.7600247; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Candeias MM, 2008, NAT CELL BIOL, V10, P1098, DOI 10.1038/ncb1770; Chakraborty A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004152; Chen D, 2007, ONCOGENE, V26, P5029, DOI 10.1038/sj.onc.1210327; Choesmel V, 2007, BLOOD, V109, P1275, DOI 10.1182/blood-2006-07-038372; Cmejla R, 2009, HUM MUTAT, V30, P321, DOI 10.1002/humu.20874; Dai MS, 2004, J BIOL CHEM, V279, P44475, DOI 10.1074/jbc.M403722200; Dai MS, 2004, MOL CELL BIOL, V24, P7654, DOI 10.1128/MCB.24.17.7654-7668.2004; Dai MS, 2008, MOL CELL BIOL, V28, P4365, DOI 10.1128/MCB.01662-07; Dai MS, 2007, CELL CYCLE, V6, P2735, DOI 10.4161/cc.6.22.4895; Danilova N, 2008, BLOOD, V112, P5228, DOI 10.1182/blood-2008-01-132290; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Draptchinskaia N, 1999, NAT GENET, V21, P169, DOI 10.1038/5951; Enge M, 2009, CANCER CELL, V15, P171, DOI 10.1016/j.ccr.2009.01.019; Farrar JE, 2008, BLOOD, V112, P1582, DOI 10.1182/blood-2008-02-140012; Flygare J, 2005, BLOOD, V105, P4627, DOI 10.1182/blood-2004-08-3115; Fumagalli S, 2009, NAT CELL BIOL, V11, P501, DOI 10.1038/ncb1858; Ganapathi KA, 2008, BRIT J HAEMATOL, V141, P376, DOI 10.1111/j.1365-2141.2008.07095.x; Hengstermann A, 2001, P NATL ACAD SCI USA, V98, P1218, DOI 10.1073/pnas.031470698; Hietanen S, 2000, P NATL ACAD SCI USA, V97, P8501, DOI 10.1073/pnas.97.15.8501; Holzel M, 2005, J CELL BIOL, V170, P367, DOI 10.1083/jcb.200501141; Horn HF, 2008, ONCOGENE, V27, P5774, DOI 10.1038/onc.2008.189; Jin A, 2004, MOL CELL BIOL, V24, P7669, DOI 10.1128/MCB.24.17.7669-7680.2004; Kurki S, 2004, CANCER CELL, V5, P465, DOI 10.1016/S1535-6108(04)00110-2; Lam YW, 2007, CURR BIOL, V17, P749, DOI 10.1016/j.cub.2007.03.064; Langlois A, 2002, GLIA, V40, P85, DOI 10.1002/glia.10127; Lindstrom MS, 2008, J BIOL CHEM, V283, P15568, DOI 10.1074/jbc.M801151200; Lindstrom MS, 2007, CELL CYCLE, V6, P434, DOI 10.4161/cc.6.4.3861; Lindstrom MS, 2007, MOL CELL BIOL, V27, P1056, DOI 10.1128/MCB.01307-06; Lindstrom MS, 2009, BIOCHEM BIOPH RES CO, V379, P167, DOI 10.1016/j.bbrc.2008.12.083; Liu JJ, 2006, J CELL PHYSIOL, V207, P287, DOI 10.1002/jcp.20589; Lohrum MAE, 2003, CANCER CELL, V3, P577, DOI 10.1016/S1535-6108(03)00134-X; Ma HH, 2007, MOL BIOL CELL, V18, P2630, DOI 10.1091/mbc.E07-03-0244; MacInnes AW, 2008, P NATL ACAD SCI USA, V105, P10408, DOI 10.1073/pnas.0805036105; Matsson H, 2004, MOL CELL BIOL, V24, P4032, DOI 10.1128/MCB.24.9.4032-4037.2004; McGowan KA, 2008, NAT GENET, V40, P963, DOI 10.1038/ng.188; Montanaro L, 2008, AM J PATHOL, V173, P301, DOI 10.2353/ajpath.2008.070752; Naski N, 2009, CELL CYCLE, V8, P31, DOI 10.4161/cc.8.1.7326; NISTER M, 1986, CANCER RES, V46, P332; Ofir-Rosenfeld Y, 2008, MOL CELL, V32, P180, DOI 10.1016/j.molcel.2008.08.031; Olson Mark O J, 2004, Sci STKE, V2004, ppe10; Olson MOJ, 2000, TRENDS CELL BIOL, V10, P189, DOI 10.1016/S0962-8924(00)01738-4; Panic L, 2006, MOL CELL BIOL, V26, P8880, DOI 10.1128/MCB.00751-06; Pederson T, 1998, NUCLEIC ACIDS RES, V26, P3871, DOI 10.1093/nar/26.17.3871; Pestov DG, 2001, MOL CELL BIOL, V21, P4246, DOI 10.1128/MCB.21.13.4246-4255.2001; Robledo S, 2008, RNA, V14, P1918, DOI 10.1261/rna.1132008; Romanova L, 2009, J BIOL CHEM, V284, P4968, DOI 10.1074/jbc.M804594200; Rubbi CP, 2003, EMBO J, V22, P6068, DOI 10.1093/emboj/cdg579; Saxena A, 2006, ONCOGENE, V25, P7274, DOI 10.1038/sj.onc.1209714; Sulic S, 2005, GENE DEV, V19, P3070, DOI 10.1101/gad.359305; Sundqvist A, 2009, EMBO REP, V10, P1132, DOI 10.1038/embor.2009.178; Svechnikova I, 2008, INT J ONCOL, V32, P821; Takagi M, 2005, CELL, V123, P49, DOI 10.1016/j.cell.2005.07.034; Uechi T, 2008, HUM MOL GENET, V17, P3204, DOI 10.1093/hmg/ddn216; Volarevic S, 2000, SCIENCE, V288, P2045, DOI 10.1126/science.288.5473.2045; Warner JR, 2009, MOL CELL, V34, P3, DOI 10.1016/j.molcel.2009.03.006; WARNER JR, 1977, J MOL BIOL, V115, P315, DOI 10.1016/0022-2836(77)90157-7; WESTERMARK B, 1973, INT J CANCER, V12, P438, DOI 10.1002/ijc.2910120215; WESTERMARK B, 1982, J NEUROSCI RES, V8, P491, DOI 10.1002/jnr.490080236; Yuan XJ, 2005, MOL CELL, V19, P77, DOI 10.1016/j.molcel.2005.05.023; Zhang YP, 2009, CANCER CELL, V16, P369, DOI 10.1016/j.ccr.2009.09.024; Zhang YP, 1998, CELL, V92, P725, DOI 10.1016/S0092-8674(00)81401-4; Zhang YP, 2003, MOL CELL BIOL, V23, P8902, DOI 10.1128/MCB.23.23.8902-8912.2003; Zhu Y, 2009, MOL CELL, V35, P316, DOI 10.1016/j.molcel.2009.07.014	70	63	68	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2010	5	3					A116	A129	e9578	10.1371/journal.pone.0009578	http://dx.doi.org/10.1371/journal.pone.0009578			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565WZ	20221446	Green Published, gold, Green Submitted			2022-12-25	WOS:000275328200011
J	Ng, SK; Lo, WS; Pun, FW; Zhao, CY; Yu, ZL; Chen, JH; Tong, KL; Xu, ZW; Tsang, SY; Yang, Q; Yu, WC; Nimgaonkar, V; Stober, G; Harano, M; Xue, H				Ng, Siu-Kin; Lo, Wing-Sze; Pun, Frank W.; Zhao, Cunyou; Yu, Zhiliang; Chen, Jianhuan; Tong, Ka-Lok; Xu, Zhiwen; Tsang, Shui-Ying; Yang, Qiang; Yu, Weichuan; Nimgaonkar, Vishwajit; Stoeber, Gerald; Harano, Mutsuo; Xue, Hong			A Recombination Hotspot in a Schizophrenia-Associated Region of GABRB2	PLOS ONE			English	Article							RECEPTOR BETA(2) GENE; HUMAN GENOME; NUCLEOTIDE SUBSTITUTIONS; LINKAGE-DISEQUILIBRIUM; MEIOTIC RECOMBINATION; POSITIVE SELECTION; POPULATION; SUBUNIT; SITES; POLYMORPHISMS	Background: Schizophrenia is a major disorder with complex genetic mechanisms. Earlier, population genetic studies revealed the occurrence of strong positive selection in the GABRB2 gene encoding the beta(2) subunit of GABA(A) receptors, within a segment of 3,551 bp harboring twenty-nine single nucleotide polymorphisms (SNPs) and containing schizophrenia-associated SNPs and haplotypes. Methodology/Principal Findings: In the present study, the possible occurrence of recombination in this `S1-S29' segment was assessed. The occurrence of hotspot recombination was indicated by high resolution recombination rate estimation, haplotype diversity, abundance of rare haplotypes, recurrent mutations and torsos in haplotype networks, and experimental haplotyping of somatic and sperm DNA. The sub-segment distribution of relative recombination strength, measured by the ratio of haplotype diversity (H(d)) over mutation rate (theta), was indicative of a human specific Alu-Yi6 insertion serving as a central recombining sequence facilitating homologous recombination. Local anomalous DNA conformation attributable to the Alu-Yi6 element, as suggested by enhanced DNase I sensitivity and obstruction to DNA sequencing, could be a contributing factor of the increased sequence diversity. Linkage disequilibrium (LD) analysis yielded prominent low LD points that supported ongoing recombination. LD contrast revealed significant dissimilarity between control and schizophrenic cohorts. Among the large array of inferred haplotypes, H26 and H73 were identified to be protective, and H19 and H81 risk-conferring, toward the development of schizophrenia. Conclusions/Significance: The co-occurrence of hotspot recombination and positive selection in the S1-S29 segment of GABRB2 has provided a plausible contribution to the molecular genetics mechanisms for schizophrenia. The present findings therefore suggest that genome regions characterized by the co-occurrence of positive selection and hotspot recombination, two interacting factors both affecting genetic diversity, merit close scrutiny with respect to the etiology of common complex disorders.	[Ng, Siu-Kin; Lo, Wing-Sze; Pun, Frank W.; Zhao, Cunyou; Chen, Jianhuan; Xu, Zhiwen; Tsang, Shui-Ying; Xue, Hong] Hong Kong Univ Sci & Technol, Dept Biochem, Hong Kong, Hong Kong, Peoples R China; [Ng, Siu-Kin; Lo, Wing-Sze; Pun, Frank W.; Zhao, Cunyou; Yu, Zhiliang; Chen, Jianhuan; Tong, Ka-Lok; Xu, Zhiwen; Tsang, Shui-Ying; Yang, Qiang; Yu, Weichuan; Xue, Hong] Hong Kong Univ Sci & Technol, Appl Genom Ctr, Fok Ying Tung Grad Sch, Hong Kong, Hong Kong, Peoples R China; [Chen, Jianhuan; Tong, Ka-Lok; Yang, Qiang; Yu, Weichuan; Xue, Hong] Hong Kong Univ Sci & Technol, HKH Bioinformat Ctr, Hong Kong, Hong Kong, Peoples R China; [Yang, Qiang] Hong Kong Univ Sci & Technol, Dept Comp Sci & Engn, Hong Kong, Hong Kong, Peoples R China; [Yu, Weichuan] Hong Kong Univ Sci & Technol, Dept Elect & Comp Engn, Hong Kong, Hong Kong, Peoples R China; [Nimgaonkar, Vishwajit] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA USA; [Nimgaonkar, Vishwajit] Univ Pittsburgh, Sch Med, Dept Human Genet, Pittsburgh, PA USA; [Nimgaonkar, Vishwajit] Univ Pittsburgh, Sch Med, Grad Sch Publ Hlth, Pittsburgh, PA USA; [Stoeber, Gerald] Univ Wurzburg, Dept Psychiat & Psychotherapy, Wurzburg, Germany; [Harano, Mutsuo] Kurume Univ, Sch Med, Dept Neuropsychiat, Fukuoka, Japan	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Wurzburg; Kurume University	Ng, SK (corresponding author), Hong Kong Univ Sci & Technol, Dept Biochem, Hong Kong, Hong Kong, Peoples R China.	hxue@ust.hk	Chen, Jian-Huan/ABB-9660-2021; Lo, Cario Wing Sze/DGZ-8810-2022; yang, qiang/GYJ-0971-2022; ZHAO, Cunyou/Q-5076-2016; Chen, Jian-Huan/L-7188-2017	Chen, Jian-Huan/0000-0001-8714-2543; ZHAO, Cunyou/0000-0001-6116-4584; Chen, Jian-Huan/0000-0001-8714-2543; Yu, Weichuan/0000-0002-5510-6916; Yang, Qiang/0000-0001-5059-8360; Xue, Hong/0000-0002-8133-9828	Fok Ying Tung Foundation; University Grants Council; Innovation and Technology Fund of Hong Kong Special Administrative Region Government	Fok Ying Tung Foundation(Fok Ying Tung Education Foundation); University Grants Council; Innovation and Technology Fund of Hong Kong Special Administrative Region Government	This work was supported by the fundings from the Fok Ying Tung Foundation, the University Grants Council, and the Innovation and Technology Fund of Hong Kong Special Administrative Region Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Batzer MA, 2002, NAT REV GENET, V3, P370, DOI 10.1038/nrg798; Berchowitz LE, 2009, GENOME RES, V19, P2245, DOI 10.1101/gr.096297.109; Chowdari KV, 2002, HUM MOL GENET, V11, P1373, DOI 10.1093/hmg/11.12.1373; Crespi B, 2007, P ROY SOC B-BIOL SCI, V274, P2801, DOI 10.1098/rspb.2007.0876; Crow TJ, 2000, BRAIN RES REV, V31, P118, DOI 10.1016/S0165-0173(99)00029-6; de Massy B, 2003, TRENDS GENET, V19, P514, DOI 10.1016/S0168-9525(03)00201-4; Freudenberg J, 2007, EUR J HUM GENET, V15, P1071, DOI 10.1038/sj.ejhg.5201876; Freudenberg J, 2007, BIOINFORMATICS, V23, P1441, DOI 10.1093/bioinformatics/btm137; GOTTESMAN II, 1989, SCHIZOPHRENIA BULL, V15, P5, DOI 10.1093/schbul/15.1.5; Jeffreys AJ, 2005, NAT GENET, V37, P601, DOI 10.1038/ng1565; JINKSROBERTSON S, 1993, MOL CELL BIOL, V13, P3937, DOI 10.1128/MCB.13.7.3937; Leonhard K., 1999, CLASSIFICATION ENDOG, V2nd; Li N, 2003, GENETICS, V165, P2213; Liu JX, 2005, BIOCHEM BIOPH RES CO, V334, P817, DOI 10.1016/j.bbrc.2005.06.167; Lo WS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000462; Lo WS, 2007, BIOL PSYCHIAT, V61, P653, DOI 10.1016/j.biopsych.2006.05.003; Lo WS, 2004, MOL PSYCHIATR, V9, P603, DOI 10.1038/sj.mp.4001461; Lupski JR, 2008, NATURE, V455, P178, DOI 10.1038/455178a; McGuffin Peter, 2003, Curr Psychiatry Rep, V5, P121, DOI 10.1007/s11920-003-0028-y; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; Myers S, 2006, BIOCHEM SOC T, V34, P526, DOI 10.1042/BST0340526; NEI M, 1983, GENETICS, V105, P207; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Ng MYM, 2009, MOL PSYCHIATR, V14, P774, DOI 10.1038/mp.2008.135; Ng SK, 2006, GENE, V368, P110, DOI 10.1016/j.gene.2005.10.034; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; NURNBERGER JI, 1994, ARCH GEN PSYCHIAT, V51, P849, DOI 10.1001/archpsyc.1994.03950110009002; Otto SP, 1997, GENETICS, V147, P879; Petryshen TL, 2005, MOL PSYCHIATR, V10, P1074, DOI 10.1038/sj.mp.4001739; Ptak SE, 2004, PLOS BIOL, V2, P849, DOI 10.1371/journal.pbio.0020155; Purcell SM, 2009, NATURE; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Sawa A, 2002, SCIENCE, V296, P692, DOI 10.1126/science.1070532; SHERRINGTON R, 1988, NATURE, V336, P164, DOI 10.1038/336164a0; STEFANSSON H, 2009, NATURE; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Tiemann-Boege I, 2006, PLOS GENET, V2, P682, DOI 10.1371/journal.pgen.0020070; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Winckler W, 2005, SCIENCE, V308, P107, DOI 10.1126/science.1105322; Yu ZL, 2006, CLIN BIOCHEM, V39, P210, DOI 10.1016/j.clinbiochem.2006.01.009; Zaykin DV, 2006, AM J HUM GENET, V78, P737, DOI 10.1086/503710; ZHANG Y, 2009, HDB ANAL HUMAN GENET, P25; Zhao C, 2006, MOL PSYCHIATR, V11, P1092, DOI 10.1038/sj.mp.4001899	45	20	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2010	5	3					A18	A30	e9547	10.1371/journal.pone.0009547	http://dx.doi.org/10.1371/journal.pone.0009547			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565WZ	20221451	Green Submitted, gold, Green Published, Green Accepted			2022-12-25	WOS:000275328200002
J	Stevens, JC; Chia, R; Hendriks, WT; Bros-Facer, V; van Minnen, J; Martin, JE; Jackson, GS; Greensmith, L; Schiavo, G; Fisher, EMC				Stevens, James C.; Chia, Ruth; Hendriks, William T.; Bros-Facer, Virginie; van Minnen, Jan; Martin, Joanne E.; Jackson, Graham S.; Greensmith, Linda; Schiavo, Giampietro; Fisher, Elizabeth M. C.			Modification of Superoxide Dismutase 1 (SOD1) Properties by a GFP Tag - Implications for Research into Amyotrophic Lateral Sclerosis (ALS)	PLOS ONE			English	Article							FAMILIAL ALS; MUTANT SOD1; HUMAN-CELLS; MUTATIONS; PROTEIN; ULTRACENTRIFUGATION; DEATH; MODEL; GENE; MICE	Background: Since the discovery that mutations in the enzyme SOD1 are causative in human amyotrophic lateral sclerosis (ALS), many strategies have been employed to elucidate the toxic properties of this ubiquitously expressed mutant protein, including the generation of GFP-SOD1 chimaeric proteins for studies in protein localization by direct visualization using fluorescence microscopy. However, little is known about the biochemical and physical properties of these chimaeric proteins, and whether they behave similarly to their untagged SOD1 counterparts. Methodology/Principal Findings: Here we compare the physicochemical properties of SOD1 and the effects of GFP-tagging on its intracellular behaviour. Immunostaining demonstrated that SOD1 alone and GFP-SOD1 have an indistinguishable intracellular distribution in PC12 cells. Cultured primary motor neurons expressing GFP or GFP-SOD1 showed identical patterns of cytoplasmic expression and of movement within the axon. However, GFP tagging of SOD1 was found to alter some of the intrinsic properties of SOD1, including stability and specific activity. Evaluation of wildtype and mutant SOD1, tagged at either the N- or C-terminus with GFP, in PC12 cells demonstrated that some chimaeric proteins were degraded to the individual proteins, SOD1 and GFP. Conclusions/Significance: Our findings indicate that most, but not all, properties of SOD1 remain the same with a GFP tag.	[Stevens, James C.; Chia, Ruth; Fisher, Elizabeth M. C.] UCL Inst Neurol, Dept Neurodegenerat Dis, London, England; [Hendriks, William T.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Regenerat Med, Boston, MA USA; [Bros-Facer, Virginie; Greensmith, Linda] UCL Inst Neurol, Sobell Dept Motor Sci & Movement Disorders, London, England; [van Minnen, Jan] Univ Calgary, Hotchkiss Brain Inst, Dept Cell Biol & Anat, Calgary, AB, Canada; [Martin, Joanne E.] Queen Mary Univ London, ICMS Pathol Grp, London, England; [Jackson, Graham S.] UCL Inst Neurol, MRC Prion Unit, London, England; [Schiavo, Giampietro] Canc Res UK, Mol Neuropathobiol Lab, London, England	University of London; University College London; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of London; University College London; University of Calgary; University of London; Queen Mary University London; University of London; University College London; Cancer Research UK	Stevens, JC (corresponding author), UCL Inst Neurol, Dept Neurodegenerat Dis, London, England.	e.fisher@prion.ucl.ac.uk	Chia, Ruth/AAF-4900-2021; Fisher, Elizabeth MC/C-2168-2008	Chia, Ruth/0000-0002-4709-7423; Fisher, Elizabeth MC/0000-0003-2850-9936; Jackson, Graham/0000-0002-3125-2011; Schiavo, Giampietro/0000-0002-4319-8745	Ipsen Fund; UK Motor Neurone Disease Association; Research Advisory Board of St Bartholomew's and the Royal London Charitable Foundation [RAB04/F7]; Brain Research Trust; Biotechnology and Biological Sciences Research Council; Cancer Research UK; EU FP6 NEST [12702]; Medical Research Council [MC_U123170362, G0601943B, G0500288, G0601943] Funding Source: researchfish; MRC [G0601943, G0500288, MC_U123170362] Funding Source: UKRI	Ipsen Fund(Ipsen); UK Motor Neurone Disease Association; Research Advisory Board of St Bartholomew's and the Royal London Charitable Foundation; Brain Research Trust; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); EU FP6 NEST(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by research grants from The Ipsen Fund, the UK Motor Neurone Disease Association, the Research Advisory Board of St Bartholomew's and the Royal London Charitable Foundation (RAB04/F7), The Brain Research Trust, the Biotechnology and Biological Sciences Research Council, Cancer Research UK and EU FP6 NEST grant 12702. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arce V, 1999, J NEUROSCI RES, V55, P119, DOI 10.1002/(SICI)1097-4547(19990101)55:1<119::AID-JNR13>3.3.CO;2-Y; Arnesano F, 2004, J BIOL CHEM, V279, P47998, DOI 10.1074/jbc.M406021200; Banci L, 2007, P NATL ACAD SCI USA, V104, P11263, DOI 10.1073/pnas.0704307104; Banci L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001677; CHIA R, 2008, THESIS U COLL LONDON; CHIA R, 2010, PRION LIKE PRO UNPUB; Corti S, 2004, BRAIN, V127, P2518, DOI 10.1093/brain/awh273; CRAPO JD, 1992, P NATL ACAD SCI USA, V89, P10405, DOI 10.1073/pnas.89.21.10405; De Vos KJ, 2007, HUM MOL GENET, V16, P2720, DOI 10.1093/hmg/ddm226; DENG HX, 1993, SCIENCE, V261, P1047, DOI 10.1126/science.8351519; Durer ZAO, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005004; Durham HD, 1997, J NEUROPATH EXP NEUR, V56, P523, DOI 10.1097/00005072-199705000-00008; Gros-Louis F, 2006, BBA-MOL BASIS DIS, V1762, P956, DOI 10.1016/j.bbadis.2006.01.004; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; HAYES DB, 2003, SEDNTERP SEDIMENTIAT; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; LIEMANHURWITZ J, 1982, P NATL ACAD SCI-BIOL, V79, P2808, DOI 10.1073/pnas.79.9.2808; Matsumoto G, 2006, J BIOL CHEM, V281, P4477, DOI 10.1074/jbc.M509201200; Matsumoto G, 2005, J CELL BIOL, V171, P75, DOI 10.1083/jcb.200504050; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; PARDO CA, 1995, P NATL ACAD SCI USA, V92, P954, DOI 10.1073/pnas.92.4.954; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Takeuchi H, 2002, J BIOL CHEM, V277, P50966, DOI 10.1074/jbc.M209356200; Zhang FJ, 2006, BBA-GEN SUBJECTS, V1760, P404, DOI 10.1016/j.bbagen.2005.11.024	26	52	56	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2010	5	3					A8	A17	e9541	10.1371/journal.pone.0009541	http://dx.doi.org/10.1371/journal.pone.0009541			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565WZ	20221404	Green Published, gold, Green Submitted			2022-12-25	WOS:000275328200001
J	Mannige, RV; Brooks, CL				Mannige, Ranjan V.; Brooks, Charles L., III			Periodic Table of Virus Capsids: Implications for Natural Selection and Design	PLOS ONE			English	Article							ELECTRON CRYOMICROSCOPY; RELATIONAL DATABASE; STRUCTURAL VIROLOGY; PROTEIN; TRANSITION; INSIGHTS; HEAD	Background: For survival, most natural viruses depend upon the existence of spherical capsids: protective shells of various sizes composed of protein subunits. So far, general evolutionary pressures shaping capsid design have remained elusive, even though an understanding of such properties may help in rationally impeding the virus life cycle and designing efficient nano- assemblies. Principal Findings: This report uncovers an unprecedented and species-independent evolutionary pressure on virus capsids, based on the the notion that the simplest capsid designs (or those capsids with the lowest "hexamer complexity'', C(h)) are the fittest, which was shown to be true for all available virus capsids. The theories result in a physically meaningful periodic table of virus capsids that uncovers strong and overarching evolutionary pressures, while also offering geometric explanations to other capsid properties (rigidity, pleomorphy, auxiliary requirements, etc.) that were previously considered to be unrelatable properties of the individual virus. Significance: Apart from describing a universal rule for virus capsid evolution, our work (especially the periodic table) provides a language with which highly diverse virus capsids, unified only by geometry, may be described and related to each other. Finally, the available virus structure databases and other published data reiterate the predicted geometry-derived rules, reinforcing the role of geometry in the natural selection and design of virus capsids.	[Mannige, Ranjan V.; Brooks, Charles L., III] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA; [Mannige, Ranjan V.; Brooks, Charles L., III] Univ Michigan, Biophys Program, Ann Arbor, MI 48109 USA; [Mannige, Ranjan V.; Brooks, Charles L., III] Univ Calif San Diego, Ctr Theoret Biol Phys, La Jolla, CA 92093 USA; [Mannige, Ranjan V.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of California System; University of California San Diego; Scripps Research Institute	Mannige, RV (corresponding author), Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA.	ranjan@umich.edu; brookscl@umich.edu			National Institutes of Health [RR012255]; National Science Foundation [PHY0216576]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR012255] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by grants from the National Institutes of Health (RR012255) and the National Science Foundation (PHY0216576). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carrillo-Tripp M, 2009, NUCLEIC ACIDS RES, V37, pD436, DOI 10.1093/nar/gkn840; CASPAR DLD, 1962, COLD SPRING HARB SYM, V27, P1, DOI 10.1101/sqb.1962.027.001.005; Choi KH, 2006, STRUCTURE, V14, P1723, DOI 10.1016/j.str.2006.09.007; Conway JF, 2007, J STRUCT BIOL, V158, P224, DOI 10.1016/j.jsb.2006.11.006; Conway JF, 2001, SCIENCE, V292, P744, DOI 10.1126/science.1058069; CRICK FHC, 1956, NATURE, V177, P473, DOI 10.1038/177473a0; Dokland T, 1997, NATURE, V389, P308, DOI 10.1038/38537; Ferreira D, 2003, VIROLOGY, V307, P54, DOI 10.1016/S0042-6822(02)00034-X; Fokine A, 2005, J MOL BIOL, V352, P117, DOI 10.1016/j.jmb.2005.07.018; Goldberg M., 1937, TOHOKU MATH J, V43, P104; Henrick K, 2003, J STRUCT BIOL, V144, P228, DOI 10.1016/j.jsb.2003.09.009; HORNE R, 1961, VIROLOGY, V28, P348; Huiskonen JT, 2009, J VIROL, V83, P3762, DOI 10.1128/JVI.02483-08; Jaalinoja HT, 2008, P NATL ACAD SCI USA, V105, P8008, DOI 10.1073/pnas.0801758105; Johnson JE, 1997, J MOL BIOL, V269, P665, DOI 10.1006/jmbi.1997.1068; Libersou S, 2008, J VIROL, V82, P2844, DOI 10.1128/JVI.02268-07; Lidmar J, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.051910; LIN C, 1988, MATH APPL DETERMINIS, P490; Mannige RV, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.051902; Mannige RV, 2009, P NATL ACAD SCI USA, V106, P8531, DOI 10.1073/pnas.0811517106; Mettenleiter TC, 2009, VIRUS RES, V143, P222, DOI 10.1016/j.virusres.2009.03.018; Nandhagopal N, 2002, P NATL ACAD SCI USA, V99, P14758, DOI 10.1073/pnas.232580699; Neuman BW, 2005, J VIROL, V79, P3822, DOI 10.1128/JVI.79.6.3822-3830.2005; Nguyen TL, 2005, J STRUCT BIOL, V151, P30, DOI 10.1016/j.jsb.2005.02.013; Nguyen TT, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.051923; Overby AK, 2008, P NATL ACAD SCI USA, V105, P2375, DOI 10.1073/pnas.0708738105; Rice G, 2004, P NATL ACAD SCI USA, V101, P7716, DOI 10.1073/pnas.0401773101; RUX J, 2008, CURR OPIN STRUC BIOL, V8, P142; Shepherd CM, 2006, NUCLEIC ACIDS RES, V34, pD386, DOI 10.1093/nar/gkj032; Tang JH, 2006, J STRUCT BIOL, V154, P59, DOI 10.1016/j.jsb.2005.10.013; Twarock R, 2004, J THEOR BIOL, V226, P477, DOI 10.1016/j.jtbi.2003.10.006; Yan XD, 2005, J VIROL, V79, P9236, DOI 10.1128/JVI.79.14.9236-9243.2005; Yan XD, 2000, NAT STRUCT BIOL, V7, P101, DOI 10.1038/72360; Zandi R, 2006, BIOPHYS J, V90, P1939, DOI 10.1529/biophysj.105.072975; Zlotnick A, 2000, VIROLOGY, V277, P450, DOI 10.1006/viro.2000.0619	35	53	54	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2010	5	3							e9423	10.1371/journal.pone.0009423	http://dx.doi.org/10.1371/journal.pone.0009423			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	564EW	20209096	Green Published, gold, Green Submitted			2022-12-25	WOS:000275197100001
J	Yao, JK; Dougherty, GG; Reddy, RD; Keshavan, MS; Montrose, DM; Matson, WR; McEvoy, J; Kaddurah-Daouk, R				Yao, Jeffrey K.; Dougherty, George G., Jr.; Reddy, Ravinder D.; Keshavan, Matcheri S.; Montrose, Debra M.; Matson, Wayne R.; McEvoy, Joseph; Kaddurah-Daouk, Rima			Homeostatic Imbalance of Purine Catabolism in First-Episode Neuroleptic-Naive Patients with Schizophrenia	PLOS ONE			English	Article							SERUM URIC-ACID; PERFORMANCE LIQUID-CHROMATOGRAPHY; IMPAIRED GLUTATHIONE SYNTHESIS; MULTIPLE-SCLEROSIS PATIENTS; PLASMA ANTIOXIDANTS; OXIDATIVE STRESS; RISK-FACTOR; BRAIN; PEROXYNITRITE; SYSTEM	Background: Purine catabolism may be an unappreciated, but important component of the homeostatic response of mitochondria to oxidant stress. Accumulating evidence suggests a pivotal role of oxidative stress in schizophrenia pathology. Methodology/Principal Findings: Using high-pressure liquid chromatography coupled with a coulometric multi-electrode array system, we compared 6 purine metabolites simultaneously in plasma between first-episode neuroleptic-naive patients with schizophrenia (FENNS, n = 25) and healthy controls (HC, n = 30), as well as between FENNS at baseline (BL) and 4 weeks (4w) after antipsychotic treatment. Significantly higher levels of xanthosine (Xant) and lower levels of guanine (G) were seen in both patient groups compared to HC subjects. Moreover, the ratios of G/guanosine (Gr), uric acid (UA)/Gr, and UA/Xant were significantly lower, whereas the ratio of Xant/G was significantly higher in FENNS-BL than in HC. Such changes remained in FENNS-4w with exception that the ratio of UA/Gr was normalized. All 3 groups had significant correlations between G and UA, and Xan and hypoxanthine (Hx). By contrast, correlations of UA with each of Xan and Hx, and the correlation of Xan with Gr were all quite significant for the HC but not for the FENNS. Finally, correlations of Gr with each of UA and G were significant for both HC and FENNS-BL but not for the FENNS-4w. Conclusions/Significance: During purine catabolism, both conversions of Gr to G and of Xant to Xan are reversible. Decreased ratios of product to precursor suggested a shift favorable to Xant production from Xan, resulting in decreased UA levels in the FENNS. Specifically, the reduced UA/Gr ratio was nearly normalized after 4 weeks of antipsychotic treatment. In addition, there are tightly correlated precursor and product relationships within purine pathways; although some of these correlations persist across disease or medication status, others appear to be lost among FENNS. Taken together, these results suggest that the potential for steady formation of antioxidant UA from purine catabolism is altered early in the course of illness.	[Yao, Jeffrey K.; Dougherty, George G., Jr.; Reddy, Ravinder D.] VA Pittsburgh Healthcare Syst, Pittsburgh, PA USA; [Yao, Jeffrey K.; Dougherty, George G., Jr.; Reddy, Ravinder D.; Keshavan, Matcheri S.; Montrose, Debra M.] Univ Pittsburgh, Western Psychiat Inst & Clin, Med Ctr, Dept Psychiat, Pittsburgh, PA 15213 USA; [Yao, Jeffrey K.] Univ Pittsburgh, Sch Pharm, Dept Pharmaceut Sci, Pittsburgh, PA 15213 USA; [Keshavan, Matcheri S.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Keshavan, Matcheri S.] Harvard Univ, Boston, MA 02115 USA; [Matson, Wayne R.] Bedford VA Med Ctr, Bedford, MA USA; [McEvoy, Joseph; Kaddurah-Daouk, Rima] Duke Univ, Med Ctr, Durham, NC USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Western Psychiatric Institute & Clinic of UPMC; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Duke University	Yao, JK (corresponding author), VA Pittsburgh Healthcare Syst, Pittsburgh, PA USA.	jkyao@pitt.edu		Kaddurah-Daouk, Rima/0000-0003-1858-5732	Department of Veterans Affairs (VA); Veterans Health Administration; Office of Research and Development; Biomedical Laboratory Research Development; VA Pittsburgh Healthcare System; National Institute of Health [MH58141, MH64118, MH45203, R24 GM078233, c UL1 RR024153]; NIH/NCRR/GCRC [M01 RR00056]; Metabolomics Research Network (RKD); Stanley Medical Research Institute (RKD); National Alliance for Research on Schizophrenia and Affective Disorders (RKD); NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024153, M01RR000056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R24GM078233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K08MH064118, R01MH058141, R01MH045203] Funding Source: NIH RePORTER	Department of Veterans Affairs (VA)(US Department of Veterans Affairs); Veterans Health Administration(US Department of Veterans Affairs); Office of Research and Development; Biomedical Laboratory Research Development(US Department of Veterans Affairs); VA Pittsburgh Healthcare System(US Department of Veterans Affairs); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NCRR/GCRC(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Metabolomics Research Network (RKD); Stanley Medical Research Institute (RKD); National Alliance for Research on Schizophrenia and Affective Disorders (RKD)(NARSAD); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This material is based upon work supported in part by the grants from the Department of Veterans Affairs (VA), Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research & Development [Merit Reviews (JKY) and Senior Research Career Scientist Award (JKY)], VA Pittsburgh Healthcare System (JKY, GGD, RDR), National Institute of Health [MH58141 (JKY), MH64118 (RDR), MH45203 (MSK), R24 GM078233 (RKD), c UL1 RR024153 and NIH/NCRR/GCRC Grant M01 RR00056], Metabolomics Research Network (RKD); Stanley Medical Research Institute (RKD), and National Alliance for Research on Schizophrenia and Affective Disorders (RKD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akyol O, 2005, PROG NEURO-PSYCHOPH, V29, P123, DOI 10.1016/j.pnpbp.2004.10.014; AMES BN, 1981, P NATL ACAD SCI-BIOL, V78, P6858, DOI 10.1073/pnas.78.11.6858; Andreasen N. C., 1984, SCALE ASSESSMENT POS; Andreasen NC, 1983, SCALE ASSESSMENT NEG; BECKER BF, 1993, FREE RADICAL BIO MED, V14, P615, DOI 10.1016/0891-5849(93)90143-I; Ben Othmen L, 2008, PROG NEURO-PSYCHOPH, V32, P155, DOI 10.1016/j.pnpbp.2007.08.003; Ben-Shachar D, 2004, INT REV NEUROBIOL, V59, P273; Bogdanov M, 2008, BRAIN, V131, P389, DOI 10.1093/brain/awm304; Bos MJ, 2006, STROKE, V37, P1503, DOI 10.1161/01.STR.0000221716.55088.d4; Bubber P, 2004, J MOL NEUROSCI, V24, P315, DOI 10.1385/JMN:24:2:315; Choi HK, 2005, ANN INTERN MED, V143, P499, DOI 10.7326/0003-4819-143-7-200510040-00009; CHOW KC, 1992, VITAMIN E HLTH DIS, P683; CHURCH WH, 1994, BRAIN RES BULL, V33, P419, DOI 10.1016/0361-9230(94)90285-2; CORY JG, 1982, TXB BIOCH CLIN CORRE, P489; DAVIES KJA, 1986, BIOCHEM J, V235, P747, DOI 10.1042/bj2350747; de Lau LML, 2005, ANN NEUROL, V58, P797, DOI 10.1002/ana.20663; Du YZ, 2007, GLIA, V55, P463, DOI 10.1002/glia.20472; ENDICOTT J, 1976, ARCH GEN PSYCHIAT, V33, P766; Eriksson L., 2001, MULTI MEGAVARIATE DA; ERNSTER I, 1993, ACTIVE OXYGEN SPECIE, P11; Fendri C, 2006, ENCEPHALE, V32, P244; FISCHBACH FT, 1999, MANUAL LAB DIAGNOSTI; FREEDMAN DS, 1995, AM J EPIDEMIOL, V141, P637, DOI 10.1093/oxfordjournals.aje.a117479; Guerreiro S, 2009, J NEUROCHEM, V109, P1118, DOI 10.1111/j.1471-4159.2009.06040.x; Gysin R, 2007, P NATL ACAD SCI USA, V104, P16621, DOI 10.1073/pnas.0706778104; Gysin R, 2009, BRAIN RES BULL, V79, P46, DOI 10.1016/j.brainresbull.2008.10.015; Hanihara T, 1997, J CLIN PSYCHIAT, V58, P256, DOI 10.4088/JCP.v58n0604; HASTIE T, 2001, ELEMENTS STAT LEARNI, P95; Hatzimanikatis V, 2004, CURR OPIN STRUC BIOL, V14, P300, DOI 10.1016/j.sbi.2004.04.004; Hayden Melvin R, 2004, Nutr Metab (Lond), V1, P10, DOI 10.1186/1743-7075-1-10; Hooper DC, 2000, FASEB J, V14, P691, DOI 10.1096/fasebj.14.5.691; JOSSA F, 1994, J HUM HYPERTENS, V8, P677; Kaddurah-Daouk R, 2008, ANNU REV PHARMACOL, V48, P653, DOI 10.1146/annurev.pharmtox.48.113006.094715; Kang DH, 2002, J AM SOC NEPHROL, V13, P2888, DOI 10.1097/01.ASN.0000034910.58454.FD; Keller JN, 1998, J NEUROSCI, V18, P687; KENDALL M, 1990, RANK CORRELATION MET, P60; Kim TS, 2006, INT J GERIATR PSYCH, V21, P344, DOI 10.1002/gps.1469; Knapp CM, 2004, MULT SCLER, V10, P278, DOI 10.1191/1352458504ms1042oa; Kristal Bruce S., 2007, V358, P159, DOI 10.1007/978-1-59745-244-1_10; Kristal BS, 1999, ARCH BIOCHEM BIOPHYS, V370, P22, DOI 10.1006/abbi.1999.1387; Kutzing MK, 2008, J PHARMACOL EXP THER, V324, P1, DOI 10.1124/jpet.107.129031; LEHMANN EL, 1975, NONPARAMETRICS STAT, P20; Linden J., 2006, BASIC NEUROCHEMISTRY, P303; Liu F, 2006, SPINAL CORD, V44, P421, DOI 10.1038/sj.sc.3101878; LOHR JB, 1992, SCHIZOPHR RES, V8, P93, DOI 10.1016/0920-9964(92)90024-Y; Maes M, 1997, PSYCHIAT RES, V66, P1, DOI 10.1016/S0165-1781(96)02915-0; Maes M, 2000, EUR NEUROPSYCHOPHARM, V10, P119, DOI 10.1016/S0924-977X(99)00062-0; MAHADIK SP, 2003, PHOSPHOLIPID SPECTRU, P277; Mannelli P, 2009, HUM PSYCHOPHARM CLIN, V24, P666, DOI 10.1002/hup.1068; Matsuzawa D, 2009, AM J MED GENET B, V150B, P86, DOI 10.1002/ajmg.b.30776; Matsuzawa D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001944; Mount DB, 2006, RHEUM DIS CLIN N AM, V32, P313, DOI 10.1016/j.rdc.2006.02.006; Muraoka S, 2003, PHARMACOL TOXICOL, V93, P284, DOI 10.1111/j.1600-0773.2003.pto930606.x; OVERALL JE, 1962, PSYCHOL REP, V10, P799; PACHER P, 2007, PHYSIOL REV, V315, P424; Papas AM, 1996, LIPIDS, V31, pS77, DOI 10.1007/BF02637055; Patkar AA, 2009, PSYCHOPHARMACOLOGY, V206, P479, DOI 10.1007/s00213-009-1625-1; PILLAI A, 2007, FATTY ACIDS OXIDATIV, P29; PRYOR WA, 1992, ANN NY ACAD SCI, V686, P29; Ranjekar PK, 2003, PSYCHIAT RES, V121, P109, DOI 10.1016/S0165-1781(03)00220-8; Reddy R, 2003, SCHIZOPHR RES, V62, P205, DOI 10.1016/S0920-9964(02)00407-3; Reddy RD, 1996, PROSTAG LEUKOTR ESS, V55, P33, DOI 10.1016/S0952-3278(96)90143-X; Rozen S, 2005, METABOLOMICS, V1, P101, DOI 10.1007/s11306-005-4810-1; SAITO I, 1978, J AM GERIATR SOC, V26, P241, DOI 10.1111/j.1532-5415.1978.tb02396.x; Schiavo S, 2008, ANAL CHEM, V80, P5912, DOI 10.1021/ac800507y; Scott GS, 2002, P NATL ACAD SCI USA, V99, P16303, DOI 10.1073/pnas.212645999; Shi HL, 2002, ANAL BIOCHEM, V302, P239, DOI 10.1006/abio.2001.5568; Spitsin S, 2001, MULT SCLER, V7, P313, DOI 10.1191/135245801681138013; STEGMAYR B, 1993, INT J VITAM NUTR RES, V63, P195; Strazzullo P, 2007, NUTR METAB CARDIOVAS, V17, P409, DOI 10.1016/j.numecd.2007.02.011; Toncev G, 2002, EUR J NEUROL, V9, P221, DOI 10.1046/j.1468-1331.2002.00384.x; vanderVeen RC, 1997, J NEUROIMMUNOL, V77, P1, DOI 10.1016/S0165-5728(97)00013-1; Virit O, 2009, NEUROPSYCHOBIOLOGY, V60, P87, DOI 10.1159/000239684; Walss-Bass C, 2009, AM J MED GENET B, V150B, P219, DOI 10.1002/ajmg.b.30791; Waring WS, 2000, QJM-INT J MED, V93, P707, DOI 10.1093/qjmed/93.11.707; Watkins SM, 2000, ISRAEL MED ASSOC J, V2, P722; Whatley SA, 1998, MOL PSYCHIATR, V3, P227, DOI 10.1038/sj.mp.4000375; Yao J. K., 2009, MOL PSYCHIAT; Yao JK, 2006, DIS MARKERS, V22, P83, DOI 10.1155/2006/248387; Yao JK, 1998, PSYCHIAT RES, V80, P29, DOI 10.1016/S0165-1781(98)00051-1; Yao JK, 2004, SCHIZOPHRENIA BULL, V30, P923, DOI 10.1093/oxfordjournals.schbul.a007142; Yao JK, 2004, J CHROMATOGR B, V810, P93, DOI 10.1016/j.jchromb.2004.07.021; Yao JK, 2001, CNS DRUGS, V15, P287, DOI 10.2165/00023210-200115040-00004	83	56	56	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2010	5	3							e9508	10.1371/journal.pone.0009508	http://dx.doi.org/10.1371/journal.pone.0009508			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	562OZ	20209081	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000275063400014
J	Liu, HG; Ren, G; Miao, Z; Zhang, XF; Tang, XD; Han, PZ; Gambhir, SS; Cheng, Z				Liu, Hongguang; Ren, Gang; Miao, Zheng; Zhang, Xiaofen; Tang, Xiaodong; Han, Peizhen; Gambhir, Sanjiv S.; Cheng, Zhen			Molecular Optical Imaging with Radioactive Probes	PLOS ONE			English	Article							RGD-BOMBESIN HETERODIMER; SMALL-ANIMAL PET; BREAST-CANCER; NUCLEAR-MEDICINE; BREMSSTRAHLUNG; LIGHT; EXPRESSION; SYMPORTER; ELECTRONS; RADIATION	Background: Optical imaging (OI) techniques such as bioluminescence and fluorescence imaging have been widely used to track diseases in a non-invasive manner within living subjects. These techniques generally require bioluminescent and fluorescent probes. Here we demonstrate the feasibility of using radioactive probes for in vivo molecular OI. Methodology/ Principal Findings: By taking the advantages of low energy window of light (1.2-3.1 eV, 400-1000 nm) resulting from radiation, radionuclides that emit charged particles such as b + and b 2 can be successfully imaged with an OI instrument. In vivo optical images can be obtained for several radioactive probes including 2-deoxy-2-[F-18] fluoro-D-glucose ([F-18] FDG), Na F-18, (NaI)-I-131, (YCI3)-Y-90 and a Y-90 labeled peptide that specifically target tumors. Conclusions/Significance: These studies demonstrate generalizability of radioactive OI technique. It provides a new molecular imaging strategy and will likely have significant impact on both small animal and clinical imaging.	[Liu, Hongguang; Ren, Gang; Miao, Zheng; Zhang, Xiaofen; Gambhir, Sanjiv S.; Cheng, Zhen] Stanford Univ, Dept Radiol, Mol Imaging Program Stanford, Stanford, CA 94305 USA; [Liu, Hongguang; Ren, Gang; Miao, Zheng; Zhang, Xiaofen; Gambhir, Sanjiv S.; Cheng, Zhen] Stanford Univ, Bio X Program, Stanford, CA 94305 USA; [Gambhir, Sanjiv S.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Tang, Xiaodong] Univ Notre Dame, Dept Phys, Notre Dame, IN 46556 USA; [Liu, Hongguang; Zhang, Xiaofen; Han, Peizhen] Tsinghua Univ, Peking Union Med Coll, Chinese Acad Med Sci, Inst Radiat Med, Tianjin, Peoples R China	Stanford University; Stanford University; Stanford University; University of Notre Dame; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Radiation Medicine - CAMS; Peking Union Medical College; Tsinghua University	Liu, HG (corresponding author), Stanford Univ, Dept Radiol, Mol Imaging Program Stanford, Stanford, CA 94305 USA.	zcheng@stanford.edu	Cheng, Zhen/K-2843-2012; Tang, Xiaodong/F-4891-2016; miao, zheng/A-8851-2012; Ren, Gang/C-1315-2010	Cheng, Zhen/0000-0001-8177-9463; 	Department of Radiology, Stanford University; China Scholarship Council; National Cancer Institute (NCI) [P50 CA114747, R01 CA119053]; NATIONAL CANCER INSTITUTE [R01CA119053, P50CA114747] Funding Source: NIH RePORTER	Department of Radiology, Stanford University(Stanford University); China Scholarship Council(China Scholarship Council); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in part, by the Department of Radiology, Stanford University (to Z. C.), a China Scholarship Council fellowship (to H. L.), the National Cancer Institute (NCI) In Vivo Cellular Molecular Imaging Center (ICMIC) grant P50 CA114747 (to S. S. G.), and R01 CA119053 (to Z. C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Breeman WAP, 2004, NUCL MED BIOL, V31, P821, DOI 10.1016/j.nucmedbio.2004.03.008; Buscombe J, 2008, EXPERT REV ANTICANC, V8, P1425, DOI 10.1586/14737140.8.9.1425; Cerenkov PA, 1937, PHYS REV, V52, P0378, DOI 10.1103/PhysRev.52.378; Cheng Z, 2008, J NUCL MED, V49, P804, DOI 10.2967/jnumed.107.047381; Chung JK, 2002, J NUCL MED, V43, P1188; Gambhir SS, 2002, NAT REV CANCER, V2, P683, DOI 10.1038/nrc882; Iagaru A, 2009, J NUCL MED, V50, P501, DOI 10.2967/jnumed.108.058339; Kogai T, 2006, ENDOCR-RELAT CANCER, V13, P797, DOI 10.1677/erc.1.01143; Liu ZF, 2009, J NUCL MED, V50, P1168, DOI 10.2967/jnumed.108.061739; Liu ZF, 2009, EUR J NUCL MED MOL I, V36, P1483, DOI 10.1007/s00259-009-1123-z; Liu ZF, 2009, J MED CHEM, V52, P425, DOI 10.1021/jm801285t; Massoud TF, 2003, GENE DEV, V17, P545, DOI 10.1101/gad.1047403; Minarik D, 2008, PHYS MED BIOL, V53, P5689, DOI 10.1088/0031-9155/53/20/008; NAKEL W, 1994, PHYS REP, V243, P317, DOI 10.1016/0370-1573(94)00068-9; Okarvi SM, 2001, EUR J NUCL MED, V28, P929, DOI 10.1007/s002590100508; Oriuchi N, 2005, ANN NUCL MED, V19, P355, DOI 10.1007/BF03027399; Quon A, 2005, J CLIN ONCOL, V23, P1664, DOI 10.1200/JCO.2005.11.024; Robertson R, 2009, PHYS MED BIOL, V54, pN355, DOI 10.1088/0031-9155/54/16/N01; ROSS HH, 1969, ANAL CHEM, V41, P1260, DOI 10.1021/ac60279a011; SELTZER SM, 1985, NUCL INSTRUM METH B, V12, P95, DOI 10.1016/0168-583X(85)90707-4; Sevick-Muraca EM, 2008, RADIOLOGY, V246, P734, DOI 10.1148/radiol.2463070962; SHEN S, 1994, J NUCL MED, V35, P1381; Siegel JA, 1996, J NUCL MED, V37, P495; van Essen M, 2009, NAT REV ENDOCRINOL, V5, P382, DOI 10.1038/nrendo.2009.105; Weissleder R, 2006, SCIENCE, V312, P1168, DOI 10.1126/science.1125949; Weissleder R, 2002, NAT REV CANCER, V2, P11, DOI 10.1038/nrc701; Weissleder R, 2003, NAT MED, V9, P123, DOI 10.1038/nm0103-123	27	167	174	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2010	5	3							e9470	10.1371/journal.pone.0009470	http://dx.doi.org/10.1371/journal.pone.0009470			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	561RT	20208993	gold, Green Submitted, Green Published			2022-12-25	WOS:000274997100016
J	Arbab, AS; Janic, B; Jafari-Khouzani, K; Iskander, ASM; Kumar, S; Varma, NRS; Knight, RA; Soltanian-Zadeh, H; Brown, SL; Frank, JA				Arbab, Ali S.; Janic, Branislava; Jafari-Khouzani, Kourosh; Iskander, A. S. M.; Kumar, Sanath; Varma, Nadimpalli R. S.; Knight, Robert A.; Soltanian-Zadeh, Hamid; Brown, Stephen L.; Frank, Joseph A.			Differentiation of Glioma and Radiation Injury in Rats Using In Vitro Produce Magnetically Labeled Cytotoxic T-Cells and MRI	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; MESENCHYMAL STEM-CELLS; DENDRITIC CELLS; TUMOR RECURRENCE; RESONANCE-SPECTROSCOPY; IMMUNE-RESPONSES; MALIGNANT GLIOMA; GRADE GLIOMAS; SPINAL-CORD; F-18 FDG	Background: A limitation with current imaging strategies of recurrent glioma undergoing radiotherapy is that tumor and radiation injury cannot be differentiated with post contrast CT or MRI, or with PET or other more complex parametric analyses of MRI data. We propose to address the imaging limitation building on emerging evidence indicating that effective therapy for recurrent glioma can be attained by sensitized T-cells following vaccination of primed dendritic cells (DCs). The purpose of this study was to determine whether cord blood T-cells can be sensitized against glioma cells (U-251) and if these sensitized cytotoxic T-cells (CTLs) can be used as cellular magnetic resonance imaging probes to identify and differentiate glioma from radiation necrosis in rodent models. Methodology/Principal Findings: Cord blood T and CD14+ cells were collected. Isolated CD14+ cells were then converted to dendritic cells (DCs), primed with glioma cell lysate and used to sensitize T-cells. Phenotypical expression of the generated DCs were analyzed to determine the expression level of CD14, CD86, CD83 and HLA-DR. Cells positive for CD25, CD4, CD8 were determined in generated CTLs. Specificity of cytotoxicity of the generated CTLs was also determined by lactate dehydrogenase (LDH) release assay. Secondary proliferation capacity of magnetically labeled and unlabeled CTLs was also determined. Generated CTLs were magnetically labeled and intravenously injected into glioma bearing animals that underwent MRI on days 3 and 7 post-injection. CTLs were also administered to animals with focal radiation injury to determine whether these CTLs accumulated non-specifically to the injury sites. Multi-echo T2- and T2*-weighted images were acquired and R2 and R2* maps created. Our method produced functional, sensitized CTLs that specifically induced U251 cell death in vitro. Both labeled and unlabeled CTLs proliferated equally after the secondary stimulation. There were significantly higher CD25 positive cells (p = <0.006) in CTLs. In addition, T2- and T2*-weighted MR images showed increased low signal intensity areas in animals that received labeled CTLs as compared to the images from animals that received control cells. Histological analysis confirmed the presence of iron positive cells in sites corresponding to MRI low signal intensity regions. Significant differences (p = <0.001) in tumor R2 and R2* values were observed among the groups of animals. Animals with radiation injury exhibited neither MRI hypointense areas nor presence of iron positive cells. Conclusion: Our results indicate that T-cells can be effectively sensitized by in vitro methods and used as cellular probes to identify and differentiate glioma from radiation necrosis.	[Arbab, Ali S.; Janic, Branislava; Jafari-Khouzani, Kourosh; Iskander, A. S. M.; Varma, Nadimpalli R. S.; Soltanian-Zadeh, Hamid] Henry Ford Hosp, Dept Radiol, Cellular & Mol Imaging Lab, Detroit, MI 48202 USA; [Knight, Robert A.] Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA; [Kumar, Sanath; Brown, Stephen L.] Henry Ford Hosp, Dept Radiat Oncol, Detroit, MI 48202 USA; [Frank, Joseph A.] NIH, Frank Lab Radiol & Imaging Sci, Ctr Clin, Bethesda, MD 20892 USA; [Frank, Joseph A.] Natl Inst Biomed Imaging & Bioengn, Frank Lab, NIH, Bethesda, MD USA	Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital; National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA; NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)	Arbab, AS (corresponding author), Henry Ford Hosp, Dept Radiol, Cellular & Mol Imaging Lab, Detroit, MI 48202 USA.	saali@rad.hfh.edu	Arbab, Ali/AAS-1933-2020; Frank, Joseph/W-2021-2019; Soltanian-Zadeh, Hamid/AAD-7027-2022; Soltanian-Zadeh, Hamid/K-2903-2016	Soltanian-Zadeh, Hamid/0000-0002-7302-6856; Soltanian-Zadeh, Hamid/0000-0002-7302-6856	National Institutes of Health (NIH) [R21NS058589, R01CA122031, 1R21CA129801]; NATIONAL CANCER INSTITUTE [R21CA129801, R01CA122031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS058589] Funding Source: NIH RePORTER; CLINICAL CENTER [ZIACL090007] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); CLINICAL CENTER	The work is supported by National Institutes of Health (NIH) grants R21NS058589, R01CA122031 and 1R21CA129801. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agger R, 2007, J IMMUNOTHER, V30, P29, DOI 10.1097/01.cji.0000211326.38149.7e; Anderson SA, 2005, BLOOD, V105, P420, DOI 10.1182/blood-2004-06-2222; Anderson SA, 2004, ANN NEUROL, V55, P654, DOI 10.1002/ana.20066; Arbab AS, 2007, MAGN RESON MED, V58, P519, DOI 10.1002/mrm.21343; Arbab AS, 2006, STEM CELLS, V24, P671, DOI 10.1634/stemcells.2005-0017; Arbab Ali Syed, 2004, Mol Imaging, V3, P24, DOI 10.1162/153535004773861697; Arbab AS, 2005, NMR BIOMED, V18, P553, DOI 10.1002/nbm.991; Arbab AS, 2003, TRANSPLANTATION, V76, P1123, DOI 10.1097/01.TP.0000089237.39220.83; Arbab AS, 2004, BLOOD, V104, P3412; Arbab AS, 2004, BLOOD, V104, P1217, DOI 10.1182/blood-2004-02-0655; Arbab AS, 2004, HUM GENE THER, V15, P351, DOI 10.1089/104303404322959506; Bolus NE, 2009, J NUCL MED TECHNOL, V37, P63, DOI 10.2967/jnmt.108.060848; BUCHPIGUEL CA, 1995, J NUCL MED, V36, P159; Callera F, 2007, STEM CELLS DEV, V16, P461, DOI 10.1089/scd.2007.0083; Chang Susan M, 2006, Neurosurg Focus, V20, pE4; Dahnke H, 2008, MAGN RESON MED, V60, P595, DOI 10.1002/mrm.21478; Daldrup-Link HE, 2005, EUR RADIOL, V15, P4, DOI 10.1007/s00330-004-2526-7; de Vries IJM, 2005, NAT BIOTECHNOL, V23, P1407, DOI 10.1038/nbt1154; Dhermain F, 2005, B CANCER, V92, P333; DOOMS GC, 1986, RADIOLOGY, V158, P149, DOI 10.1148/radiology.158.1.3940373; DOYLE WK, 1987, J COMPUT ASSIST TOMO, V11, P563, DOI 10.1097/00004728-198707000-00001; Fields RC, 1998, P NATL ACAD SCI USA, V95, P9482, DOI 10.1073/pnas.95.16.9482; Hein PA, 2004, AM J NEURORADIOL, V25, P201; Hentschel Stephen J, 2003, Cancer Control, V10, P109; Hoehn M, 2002, P NATL ACAD SCI USA, V99, P16267, DOI 10.1073/pnas.242435499; IWAMA T, 1991, Neurological Research, V13, P48; Izumiyama Hitoshi, 2004, Brain Tumor Pathol, V21, P39, DOI 10.1007/BF02482176; Janic B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005873; Johnson L. A., 2009, BLOOD; KIM EE, 1992, RADIOGRAPHICS, V12, P269, DOI 10.1148/radiographics.12.2.1561416; Kim JH, 1999, INT J RADIAT ONCOL, V45, P1035, DOI 10.1016/S0360-3016(99)00273-4; Kircher MF, 2003, CANCER RES, V63, P6838; Lazovic J, 2008, CLIN CANCER RES, V14, P3832, DOI 10.1158/1078-0432.CCR-07-5067; Liu W, 2008, NMR BIOMED, V21, P242, DOI 10.1002/nbm.1187; Munter MW, 1999, RADIOLOGY, V212, P475; Nelson SJ, 2003, MOL CANCER THER, V2, P497; Phuphanich S, 1996, SURG NEUROL, V45, P362, DOI 10.1016/0090-3019(95)00243-X; Rad AM, 2007, BIOTECHNIQUES, V43, P627, DOI 10.2144/000112599; Rad AM, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-28; Remer Sandra, 2004, Clin J Oncol Nurs, V8, P368, DOI 10.1188/04.CJON.368-376; Rock JP, 2004, NEUROSURGERY, V54, P1111, DOI 10.1227/01.NEU.0000119328.56431.A7; Rosenberg SA, 2008, NAT REV CANCER, V8, P299, DOI 10.1038/nrc2355; Tada Y, 2003, CANCER GENE THER, V10, P451, DOI 10.1038/sj.cgt.7700584; Toso C, 2008, AM J TRANSPLANT, V8, P701, DOI 10.1111/j.1600-6143.2007.02120.x; WATANABE M, 1992, NEURORADIOLOGY, V34, P463, DOI 10.1007/BF00598951; Wurker M, 1996, EUR J NUCL MED, V23, P583; Yaghoubi SS, 2009, NAT CLIN PRACT ONCOL, V6, P53, DOI 10.1038/ncponc1278; Yamanaka R, 2003, INT J ONCOL, V23, P5; Yamanaka R, 2003, BRIT J CANCER, V89, P1172, DOI 10.1038/sj.bjc.6601268; Yu JS, 2001, CANCER RES, V61, P842; Yu JS, 2004, CANCER RES, V64, P4973, DOI 10.1158/0008-5472.CAN-03-3505; Zhu JH, 2006, NEW ENGL J MED, V355, P2376, DOI 10.1056/NEJMc055304	52	13	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2010	5	2							e9365	10.1371/journal.pone.0009365	http://dx.doi.org/10.1371/journal.pone.0009365			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	561RS	20195476	Green Published, gold, Green Submitted			2022-12-25	WOS:000274997000005
J	Pavankumar, TL; Sinha, AK; Ray, MK				Pavankumar, Theetha L.; Sinha, Anurag K.; Ray, Malay K.			All Three Subunits of RecBCD Enzyme Are Essential for DNA Repair and Low-Temperature Growth in the Antarctic Pseudomonas syringae Lz4W	PLOS ONE			English	Article							GRAM-NEGATIVE BACTERIA; ESCHERICHIA-COLI; HOMOLOGOUS RECOMBINATION; CHI-RECOGNITION; RECA PROTEIN; SCHIRMACHER OASIS; NUCLEASE ACTIVITY; GENE REPLACEMENT; MUTANTS; REPLICATION	Background: The recD mutants of the Antarctic Pseudomonas syringae Lz4W are sensitive to DNA-damaging agents and fail to grow at 4 degrees C. Generally, RecD associates with two other proteins (RecB and RecC) to produce RecBCD enzyme, which is involved in homologous recombination and DNA repair in many bacteria, including Escherichia coli. However, RecD is not essential for DNA repair, nor does its deletion cause any growth defects in E. coli. Hence, the assessment of the P. syringae RecBCD pathway was imperative. Methodology/Principal Findings: Mutational analysis and genetic complementation studies were used to establish that the individual null-mutations of all three genes, recC, recB, and recD, or the deletion of whole recCBD operon of P. syringae, lead to growth inhibition at low temperature, and sensitivity to UV and mitomycin C. Viability of the mutant cells dropped drastically at 4 degrees C, and the mutants accumulated linear chromosomal DNA and shorter DNA fragments in higher amounts compared to 22 degrees C. Additional genetic data using the mutant RecBCD enzymes that were inactivated either in the ATPase active site of RecB (RecB(K29Q)) or RecD (RecD(K229Q)), or in the nuclease center of RecB (RecB(D1118A) and RecB(Delta nuc)) suggested that, while the nuclease activity of RecB is not so critical in vivo, the ATP-dependent functions of both RecB and RecD are essential. Surprisingly, E. coli recBCD or recBC alone on plasmid could complement the defects of the Delta recCBD strain of P. syringae. Conclusions/Significance: All three subunits of the RecBCD(Ps) enzyme are essential for DNA repair and growth of P. syringae at low temperatures (4 degrees C). The RecD requirement is only a function of the RecBCD complex in the bacterium. The RecBCD pathway protects the Antarctic bacterium from cold-induced DNA damages, and is critically dependent on the helicase activities of both RecB and RecD subunits, but not on the nuclease of RecBCD(Ps) enzyme.	[Pavankumar, Theetha L.; Sinha, Anurag K.; Ray, Malay K.] CSIR, Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Pavankumar, TL (corresponding author), CSIR, Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India.	malay@ccmb.res.in	Sinha, Anurag/L-3936-2019; Sinha, Anurag/GXA-0049-2022; Pavankumar, Theetha L/R-6118-2017	Sinha, Anurag/0000-0002-6051-4930; Pavankumar, Theetha L/0000-0003-1845-9592	Institute, Centre for Cellular and Molecular Biology, Hyderabad; Council of Scientific and Industrial Research (CSIR)	Institute, Centre for Cellular and Molecular Biology, Hyderabad; Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India)	The work was an in-house project of the Institute, Centre for Cellular and Molecular Biology, Hyderabad, which is funded by the Council of Scientific and Industrial Research (CSIR), an autonomous body under the Government of India. The Centre is a nonprofit research organization devoted to basic research. The funders has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amundsen SK, 2000, P NATL ACAD SCI USA, V97, P7399, DOI 10.1073/pnas.130192397; AMUNDSEN SK, 1990, GENETICS, V126, P25; Amundsen SK, 2003, CELL, V112, P741, DOI 10.1016/S0092-8674(03)00197-1; AMUNDSEN SK, 1986, P NATL ACAD SCI USA, V83, P5558, DOI 10.1073/pnas.83.15.5558; Amundsen SK, 2007, GENE DEV, V21, P3296, DOI 10.1101/gad.1605807; Anderson DG, 1999, J BIOL CHEM, V274, P27139, DOI 10.1074/jbc.274.38.27139; Bidle KA, 1999, J BACTERIOL, V181, P2330, DOI 10.1128/JB.181.8.2330-2337.1999; Cano DA, 2002, J BACTERIOL, V184, P592, DOI 10.1128/JB.184.2.592-595.2002; CAPALDOK.F, 1971, J BACTERIOL, V106, P204, DOI 10.1128/JB.106.1.204-212.1971; CHAUDHURY AM, 1984, J BACTERIOL, V160, P788, DOI 10.1128/JB.160.2.788-791.1984; Churchill JJ, 1999, GENE DEV, V13, P901, DOI 10.1101/gad.13.7.901; Cox MM, 2001, ANNU REV GENET, V35, P53, DOI 10.1146/annurev.genet.35.102401.090016; Dermic D, 2006, GENETICS, V172, P2057, DOI 10.1534/genetics.105.052076; Dillingham MS, 2003, NATURE, V423, P893, DOI 10.1038/nature01673; EMMERSON PT, 1968, GENETICS, V60, P19; Feller G, 2003, NAT REV MICROBIOL, V1, P200, DOI 10.1038/nrmicro773; Handa N, 2003, BMC MOL BIOL, V4, DOI 10.1186/1471-2199-4-5; Hebraud Michel, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P211; Hinds J, 1999, MICROBIOL-UK, V145, P519, DOI 10.1099/13500872-145-3-519; Ivancic-Bace I, 2005, J BACTERIOL, V187, P1350, DOI 10.1128/JB.187.4.1350-1356.2005; Ivancic-Bace I, 2003, GENETICS, V163, P485; Jockovich ME, 2001, MOL MICROBIOL, V41, P949, DOI 10.1046/j.1365-2958.2001.02573.x; KEYER K, 1995, J BACTERIOL, V177, P6782, DOI 10.1128/jb.177.23.6782-6790.1995; Kowalczykowski SC, 2000, TRENDS BIOCHEM SCI, V25, P156, DOI 10.1016/S0968-0004(00)01569-3; KUSHNER SR, 1974, P NATL ACAD SCI USA, V71, P3593, DOI 10.1073/pnas.71.9.3593; Kuzminov A, 1999, MICROBIOL MOL BIOL R, V63, P751, DOI 10.1128/MMBR.63.4.751-813.1999; LOVETT ST, 1988, GENETICS, V120, P37; MCKITTRICK NH, 1989, J MOL BIOL, V210, P485, DOI 10.1016/0022-2836(89)90125-3; Michel B, 1997, EMBO J, V16, P430, DOI 10.1093/emboj/16.2.430; Miranda A, 2003, GENETICS, V163, P1255; MORALES VM, 1991, GENE, V97, P39, DOI 10.1016/0378-1119(91)90007-X; OLIVER DB, 1977, J MOL BIOL, V116, P877, DOI 10.1016/0022-2836(77)90276-5; Purusharth RI, 2007, J BIOL CHEM, V282, P16267, DOI 10.1074/jbc.M605588200; QUANDT J, 1993, GENE, V127, P15, DOI 10.1016/0378-1119(93)90611-6; Ray MK, 1998, J BIOSCIENCES, V23, P423, DOI 10.1007/BF02936136; Ray MK, 2006, STRESS RESPONSE MOL, P1; Regha K, 2005, GENETICS, V170, P1473, DOI 10.1534/genetics.104.038943; Russell N J, 1998, Adv Biochem Eng Biotechnol, V61, P1; Salaj-Smic E, 2000, RES MICROBIOL, V151, P769, DOI 10.1016/S0923-2508(00)01142-6; SAMBROOK J, 1989, 10ML LITER; SASAKI M, 1982, BIOCHEM BIOPH RES CO, V109, P414, DOI 10.1016/0006-291X(82)91737-5; Satapathy AK, 2008, FEBS J, V275, P1835, DOI 10.1111/j.1742-4658.2008.06342.x; SCHULTZ DW, 1983, J BACTERIOL, V155, P664, DOI 10.1128/JB.155.2.664-680.1983; Shivaji S, 2004, CELL MOL BIOL, V50, P525; SHIVAJI S, 1989, APPL ENVIRON MICROB, V55, P767, DOI 10.1128/AEM.55.3.767-770.1989; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Singh AK, 2009, APPL ENVIRON MICROB, V75, P4419, DOI 10.1128/AEM.01523-08; Smirnova G. V., 2001, Mikrobiologiya, V70, P55; Smith GR, 2001, ANNU REV GENET, V35, P243, DOI 10.1146/annurev.genet.35.102401.090509; Spek EJ, 2001, J BACTERIOL, V183, P131, DOI 10.1128/JB.183.1.131-138.2001; Spies M, 2006, MOL CELL, V21, P573, DOI 10.1016/j.molcel.2006.01.007; Spies M, 2005, J BIOL CHEM, V280, P37078, DOI 10.1074/jbc.M505521200; Spies M, 2007, CELL, V131, P694, DOI 10.1016/j.cell.2007.09.023; STAHL FW, 1977, GENETICS, V86, P715; Stohl EA, 2006, J BACTERIOL, V188, P7645, DOI 10.1128/JB.00801-06; Taylor AF, 2003, NATURE, V423, P889, DOI 10.1038/nature01674; Viswanathan M, 1998, GENETICS, V149, P7; Yu M, 1998, P NATL ACAD SCI USA, V95, P981, DOI 10.1073/pnas.95.3.981	58	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2010	5	2							e9412	10.1371/journal.pone.0009412	http://dx.doi.org/10.1371/journal.pone.0009412			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SY	20195537	Green Published, Green Submitted, gold			2022-12-25	WOS:000274924300004
J	Saegerman, C; Mellor, P; Uyttenhoef, A; Hanon, JB; Kirschvink, N; Haubruge, E; Delcroix, P; Houtain, JY; Pourquier, P; Vandenbussche, F; Verheyden, B; De Clercq, K; Czaplicki, G				Saegerman, Claude; Mellor, Philip; Uyttenhoef, Aude; Hanon, Jean-Baptiste; Kirschvink, Nathalie; Haubruge, Eric; Delcroix, Pierre; Houtain, Jean-Yves; Pourquier, Philippe; Vandenbussche, Frank; Verheyden, Bart; De Clercq, Kris; Czaplicki, Guy			The Most Likely Time and Place of Introduction of BTV8 into Belgian Ruminants	PLOS ONE			English	Article							BLUETONGUE-VIRUS SEROTYPE-8; 2006 EPIDEMIC; ANTIBODIES; CATTLE; ELISA; PCR	Background: In northern Europe, bluetongue (BT) caused by the BT virus (BTV), serotype 8, was first notified in August 2006 and numerous ruminant herds were affected in 2007 and 2008. However, the origin and the time and place of the original introduction have not yet been determined. Methods and Principal Findings: Four retrospective epidemiological surveys have been performed to enable determination of the initial spatiotemporal occurrence of this emerging disease in southern Belgium: investigations of the first recorded outbreaks near to the disease epicenter; a large anonymous, random postal survey of cattle herds and sheep flocks; a random historical milk tank survey of samples tested with an indirect ELISA and a follow-up survey of nonspecific health indicators. The original introduction of BTV into the region probably occurred during spring 2006 near to the National Park of Hautes Fagnes and Eifel when Culicoides become active. Conclusions/Significance: The determination of the most likely time and place of introduction of BTV8 into a country is of paramount importance to enhance awareness and understanding and, to improve modeling of vector-borne emerging infectious diseases.	[Saegerman, Claude; Uyttenhoef, Aude; Hanon, Jean-Baptiste] Univ Liege, Fac Vet Med, Dept Infect & Parasit Dis, Liege, Belgium; [Mellor, Philip] Inst Anim Hlth, Dept Arbovirol, Woking, Surrey, England; [Kirschvink, Nathalie] Univ Namur, Vet Dept, Namur, Belgium; [Haubruge, Eric] Univ Liege, Dept Funct & Evolutionary Entomol, Gembloux, Belgium; [Delcroix, Pierre] Fed Agcy Safety Food Chain, Brussels, Belgium; [Houtain, Jean-Yves; Czaplicki, Guy] Assoc Reg Sante & Identificat Anim, Loncin, Belgium; [Pourquier, Philippe] ID VET, Montpellier, France; [Vandenbussche, Frank; Verheyden, Bart; De Clercq, Kris] Vet & Agrochem Res Ctr, Dept Virol, Brussels, Belgium	University of Liege; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; University of Namur; University of Liege	Saegerman, C (corresponding author), Univ Liege, Fac Vet Med, Dept Infect & Parasit Dis, Liege, Belgium.	claude.saegerman@ulg.ac.be		Saegerman, Claude/0000-0001-9087-7436; Kirschvink, Nathalie/0000-0003-1788-4212; Haubruge, Eric/0000-0002-8138-0476; Hanon, Jean-Baptiste/0000-0003-1601-9980	Direction Generale de Agriculture, des Ressources Naturelles et de l'Environnement (DGARNE) de la Region Wallonne [D31-1180]; Fonds speciaux pour la Recherche - Credit de demarrage [D-08/02]; University of Liege, Belgium	Direction Generale de Agriculture, des Ressources Naturelles et de l'Environnement (DGARNE) de la Region Wallonne; Fonds speciaux pour la Recherche - Credit de demarrage; University of Liege, Belgium(University of Liege)	This research was funded by the "Direction Generale de Agriculture, des Ressources Naturelles et de l'Environnement (DGARNE) de la Region Wallonne'' (contract D31-1180) and by the "Fonds speciaux pour la Recherche - Credit de demarrage'' (contract D-08/02), University of Liege, Belgium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartsch S, 2009, PARASITOL RES, V105, P373, DOI 10.1007/s00436-009-1408-y; Bexiga R., 2008, Bluetongue in northern Europe, P57; Carpenter S, 2008, VET REC, V163, P589, DOI 10.1136/vr.163.20.589; Czaplicki G, 2006, OBSERVATION TERRAIN; Dagnelie P, 1998, STAT THEORIQUE APPL, V2, P659; Dal Pozzo F, 2009, VET MICROBIOL, V136, P352, DOI 10.1016/j.vetmic.2008.11.012; Dufour B., 1994, EPIDEMIOL SANTE ANIM, V25, P101; Elbers ARW, 2008, VET MICROBIOL, V129, P156, DOI 10.1016/j.vetmic.2007.10.034; Enserink M, 2006, SCIENCE, V313, P1218; Fassotte C, 2008, PREV VET MED, V87, P74, DOI 10.1016/j.prevetmed.2008.06.007; Gerbier G, 2008, PREV VET MED, V87, P119, DOI 10.1016/j.prevetmed.2008.06.012; GERBIER G, 2007, B TECH VET, V39, P81; Guyot H., 2008, Bluetongue in northern Europe, P34; KRAMER M, 2006, BERICHT ERSTEN KLIN; Kramps JA, 2008, VET MICROBIOL, V130, P80, DOI 10.1016/j.vetmic.2008.01.004; Lefever S, 2009, NUCLEIC ACIDS RES, V37, P2065, DOI 10.1093/nar/gkp056; Linden A, 2008, VET REC, V162, P459, DOI 10.1136/vr.162.14.459-a; LOSSON B, 2009, VET REC IN PRESS; Meroc E, 2008, VET MICROBIOL, V131, P133, DOI 10.1016/j.vetmic.2008.03.012; Mintiens K, 2008, PREV VET MED, V87, P131, DOI 10.1016/j.prevetmed.2008.06.011; RIEB JP, 1982, THESIS UER VIE TERRE; Saegerman C, 2007, REV SCI TECH OIE, V26, P395, DOI 10.20506/rst.26.2.1747; Saegerman C, 2005, J CLIN MICROBIOL, V43, P862, DOI 10.1128/JCM.43.2.862-869.2005; SAEGERMAN C, 2007, RENC RECH RUMINANTS, V14, P215; Saegerman C, 2008, EMERG INFECT DIS, V14, P539, DOI 10.3201/eid1404.071441; Thiry E, 2006, VET REC, V159, P327, DOI 10.1136/vr.159.10.327; Toussaint JF, 2007, J VIROL METHODS, V140, P115, DOI 10.1016/j.jviromet.2006.11.007; Toussaint JF, 2007, EMERG INFECT DIS, V13, P614, DOI 10.3201/eid1304.061136; van Schaik G, 2008, VET REC, V163, P441, DOI 10.1136/vr.163.15.441; Vandenbussche F, 2008, VET MICROBIOL, V129, P15, DOI 10.1016/j.vetmic.2007.10.029; VELTHUIS AG, 2009, PREV VET MED	31	36	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2010	5	2							e9405	10.1371/journal.pone.0009405	http://dx.doi.org/10.1371/journal.pone.0009405			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SX	20195379	Green Submitted, gold, Green Published			2022-12-25	WOS:000274924200025
J	Edwards, TL; Turner, SD; Torstenson, ES; Dudek, SM; Martin, ER; Ritchie, MD				Edwards, Todd L.; Turner, Stephen D.; Torstenson, Eric S.; Dudek, Scott M.; Martin, Eden R.; Ritchie, Marylyn D.			A General Framework for Formal Tests of Interaction after Exhaustive Search Methods with Applications to MDR and MDR-PDT	PLOS ONE			English	Article							MULTIFACTOR-DIMENSIONALITY REDUCTION; LONGITUDINAL DATA-ANALYSIS; LINKAGE DISEQUILIBRIUM; ASSOCIATION ANALYSIS; VALIDATION; EPISTASIS; PATTERNS; POWER; STRATEGIES; PEDIGREES	The initial presentation of multifactor dimensionality reduction (MDR) featured cross-validation to mitigate over-fitting, computationally efficient searches of the epistatic model space, and variable construction with constructive induction to alleviate the curse of dimensionality. However, the method was unable to differentiate association signals arising from true interactions from those due to independent main effects at individual loci. This issue leads to problems in inference and interpretability for the results from MDR and the family-based compliment the MDR-pedigree disequilibrium test (PDT). A suggestion from previous work was to fit regression models post hoc to specifically evaluate the null hypothesis of no interaction for MDR or MDR-PDT models. We demonstrate with simulation that fitting a regression model on the same data as that analyzed by MDR or MDR-PDT is not a valid test of interaction. This is likely to be true for any other procedure that searches for models, and then performs an uncorrected test for interaction. We also show with simulation that when strong main effects are present and the null hypothesis of no interaction is true, that MDR and MDR-PDT reject at far greater than the nominal rate. We also provide a valid regression-based permutation test procedure that specifically tests the null hypothesis of no interaction, and does not reject the null when only main effects are present. The regression-based permutation test implemented here conducts a valid test of interaction after a search for multilocus models, and can be applied to any method that conducts a search to find a multilocus model representing an interaction.	[Edwards, Todd L.] Vanderbilt Univ, Sch Med, Vanderbilt Epidemiol Ctr, Dept Med,Div Epidemiol, Nashville, TN 37212 USA; [Edwards, Todd L.; Turner, Stephen D.; Torstenson, Eric S.; Dudek, Scott M.; Ritchie, Marylyn D.] Vanderbilt Univ, Med Ctr, Ctr Human Genet Res, Nashville, TN USA; [Edwards, Todd L.; Martin, Eden R.] Univ Miami, Miller Sch Med, John P Hussman Inst Human Genom, Ctr Genet Epidemiol & Stat Genet, Miami, FL 33136 USA	Vanderbilt University; Vanderbilt University; University of Miami	Edwards, TL (corresponding author), Vanderbilt Univ, Sch Med, Vanderbilt Epidemiol Ctr, Dept Med,Div Epidemiol, Nashville, TN 37212 USA.	ritchie@chgr.mc.vanderbilt.edu	Turner, Stephen/GXM-4654-2022; Edwards, Todd/B-9750-2012; Ritchie, Marylyn/C-1114-2012		National Institutes of Health (NIH) [R01 AG019757-06, R01 AG020135-06]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM080178] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG020135, R01AG019757] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health (NIH) grants R01 AG019757-06 and R01 AG020135-06. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baksh MF, 2007, GENET EPIDEMIOL, V31, P1, DOI 10.1002/gepi.20183; Bass MP, 2003, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2004, P93; Bellman R.E, 1961, DYNAMIC PROGRAMMING; Bush WS, 2006, BIOINFORMATICS, V22, P2173, DOI 10.1093/bioinformatics/btl347; Bush WS, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-238; Coffey CS, 2004, NUTRITION, V20, P69, DOI 10.1016/j.nut.2003.09.012; Culverhouse R, 2004, GENET EPIDEMIOL, V27, P141, DOI 10.1002/gepi.20006; Dudek Scott M, 2006, Pac Symp Biocomput, P499, DOI 10.1142/9789812701626_0046; EDWARDS TL, 2009, GENET EPIDEMIOL; EDWARDS TL, 2008, HUMAN HEREDITY; Edwards TL, 2008, LECT NOTES COMPUT SC, V4973, P24, DOI 10.1007/978-3-540-78757-0_3; Edwards TL, 2009, AM J MED GENET B, V150B, P721, DOI 10.1002/ajmg.b.30899; Evans DM, 2006, PLOS GENET, V2, P1424, DOI 10.1371/journal.pgen.0020157; Feng Z, 2004, PHARMACOGENOMICS, V5, P709, DOI 10.1517/14622416.5.6.709; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-21606-5; Hahn LW, 2003, BIOINFORMATICS, V19, P376, DOI 10.1093/bioinformatics/btf869; Hancock DB, 2007, GENET EPIDEMIOL, V31, P883, DOI 10.1002/gepi.20249; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Marchini J, 2005, NAT GENET, V37, P413, DOI 10.1038/ng1537; Martin ER, 2006, GENET EPIDEMIOL, V30, P111, DOI 10.1002/gepi.20128; Martin ER, 2003, GENET EPIDEMIOL, V25, P203, DOI 10.1002/gepi.10258; MICHALSKI RS, 1983, ARTIF INTELL, V20, P111, DOI 10.1016/0004-3702(83)90016-4; Millstein J, 2006, AM J HUM GENET, V78, P15, DOI 10.1086/498850; Milne RL, 2008, CARCINOGENESIS, V29, P1215, DOI 10.1093/carcin/bgn120; MOORE J. H., 2007, KNOWLEDGE DISCOVERY; Moore JH, 2006, J THEOR BIOL, V241, P252, DOI 10.1016/j.jtbi.2005.11.036; Moore JH, 2004, EXPERT REV MOL DIAGN, V4, P795, DOI 10.1586/14737159.4.6.795; Moore JH, 2004, APPL SOFT COMPUT, V4, P79, DOI 10.1016/j.asoc.2003.08.003; Motsinger AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-39; Motsinger AA, 2006, GENET EPIDEMIOL, V30, P546, DOI 10.1002/gepi.20166; Owens JD, 2007, COMPUT GRAPH FORUM, V26, P80, DOI 10.1111/j.1467-8659.2007.01012.x; Pattin KA, 2009, GENET EPIDEMIOL, V33, P87, DOI 10.1002/gepi.20360; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Ritchie MD, 2001, AM J HUM GENET, V69, P138, DOI 10.1086/321276; Ritchie MD, 2003, GENET EPIDEMIOL, V24, P150, DOI 10.1002/gepi.10218; SCHLICTING P, 1998, PHENOTYPIC EVOLUTION; Schmidt M, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1133; Siegmund KD, 2000, AM J HUM GENET, V67, P244, DOI 10.1086/302973; Templeton A., 2000, EPISTASIS EVOLUTIONA; Velez DR, 2007, GENET EPIDEMIOL, V31, P306, DOI 10.1002/gepi.20211; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	42	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2010	5	2							e9363	10.1371/journal.pone.0009363	http://dx.doi.org/10.1371/journal.pone.0009363			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SV	20186329	gold, Green Published, Green Submitted			2022-12-25	WOS:000274924000007
J	Soundararajan, V; Raman, R; Raguram, S; Sasisekharan, V; Sasisekharan, R				Soundararajan, Venkataramanan; Raman, Rahul; Raguram, S.; Sasisekharan, V.; Sasisekharan, Ram			Atomic Interaction Networks in the Core of Protein Domains and Their Native Folds	PLOS ONE			English	Article							STRUCTURE PREDICTION; SECONDARY STRUCTURE; SEQUENCE; EVOLUTION; RECOGNITION; DATABASE; PACKING; YOPM	Vastly divergent sequences populate a majority of protein folds. In the quest to identify features that are conserved within protein domains belonging to the same fold, we set out to examine the entire protein universe on a fold-by-fold basis. We report that the atomic interaction network in the solvent-unexposed core of protein domains are fold-conserved, extraordinary sequence divergence notwithstanding. Further, we find that this feature, termed protein core atomic interaction network (or PCAIN) is significantly distinguishable across different folds, thus appearing to be "signature'' of a domain's native fold. As part of this study, we computed the PCAINs for 8698 representative protein domains from families across the 1018 known protein folds to construct our seed database and an automated framework was developed for PCAIN-based characterization of the protein fold universe. A test set of randomly selected domains that are not in the seed database was classified with over 97% accuracy, independent of sequence divergence. As an application of this novel fold signature, a PCAIN-based scoring scheme was developed for comparative (homology-based) structure prediction, with 1-2 angstroms (mean 1.61A) C-alpha RMSD generally observed between computed structures and reference crystal structures. Our results are consistent across the full spectrum of test domains including those from recent CASP experiments and most notably in the 'twilight' and 'midnight' zones wherein <30% and <10% target-template sequence identity prevails (mean twilight RMSD of 1.69A). We further demonstrate the utility of the PCAIN protocol to derive biological insight into protein structure-function relationships, by modeling the structure of the YopM effector novel E3 ligase (NEL) domain from plague-causative bacterium Yersinia Pestis and discussing its implications for host adaptive and innate immune modulation by the pathogen. Considering the several high-throughput, sequence-identity-independent applications demonstrated in this work, we suggest that the PCAIN is a fundamental fold feature that could be a valuable addition to the arsenal of protein modeling and analysis tools.	[Soundararajan, Venkataramanan] MIT, Koch Inst Integrat Canc Res, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; MIT, Dept Biol Engn, Cambridge, MA 02139 USA	Harvard University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Soundararajan, V (corresponding author), MIT, Koch Inst Integrat Canc Res, Harvard Mit Div Hlth Sci & Technol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	rams@mit.edu			Singapore - Massachusetts Institute of Technology (MIT) Alliance for Research and Technology	Singapore - Massachusetts Institute of Technology (MIT) Alliance for Research and Technology	The authors would like to acknowledge support from the Singapore - Massachusetts Institute of Technology (MIT) Alliance for Research and Technology to Ram Sasisekharan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander PA, 2007, P NATL ACAD SCI USA, V104, P11963, DOI 10.1073/pnas.0700922104; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Baldwin RL, 2007, J MOL BIOL, V371, P283, DOI 10.1016/j.jmb.2007.05.078; Bartoli Lisa, 2008, V413, P199; Bernal-Bayard J, 2009, J BIOL CHEM, V284, P27587, DOI 10.1074/jbc.M109.010363; Bloom JD, 2006, MOL BIOL EVOL, V23, P1751, DOI 10.1093/molbev/msl040; Bonneau R, 2001, ANNU REV BIOPH BIOM, V30, P173, DOI 10.1146/annurev.biophys.30.1.173; BOWIE JU, 1991, SCIENCE, V253, P164, DOI 10.1126/science.1853201; Cheung MS, 2002, P NATL ACAD SCI USA, V99, P685, DOI 10.1073/pnas.022387699; Choi IG, 2006, P NATL ACAD SCI USA, V103, P14056, DOI 10.1073/pnas.0606239103; Chung SY, 1996, STRUCTURE, V4, P1123, DOI 10.1016/S0969-2126(96)00119-0; Cuff JA, 1998, BIOINFORMATICS, V14, P892, DOI 10.1093/bioinformatics/14.10.892; Ding F, 2006, PLOS COMPUT BIOL, V2, P725, DOI 10.1371/journal.pcbi.0020085; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Evdokimov AG, 2001, J MOL BIOL, V312, P807, DOI 10.1006/jmbi.2001.4973; Friedberg I, 2004, CURR OPIN STRUC BIOL, V14, P307, DOI 10.1016/j.sbi.2004.04.005; Friedberg I, 2002, PROTEIN SCI, V11, P350, DOI 10.1110/ps.18602; FRIEDBERG I, 2000, INT SYS MOL BIOL, P162; Greene LH, 2007, NUCLEIC ACIDS RES, V35, pD291, DOI 10.1093/nar/gkl959; Gromiha MM, 2004, PROG BIOPHYS MOL BIO, V86, P235, DOI 10.1016/j.pbiomolbio.2003.09.003; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; IOERGER TR, 1995, MACH LEARN, V21, P151, DOI 10.1007/BF00993383; JACOB F, 1977, SCIENCE, V196, P1161, DOI 10.1126/science.860134; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KAUZMANN W, 1959, ADV PROTEIN CHEM, V14, P1, DOI 10.1016/S0065-3233(08)60608-7; Kerschen EJ, 2004, INFECT IMMUN, V72, P4589, DOI 10.1128/IAI.72.8.4589-4602.2004; Kingsford CL, 2005, BIOINFORMATICS, V21, P1028, DOI 10.1093/bioinformatics/bti144; Lapaque N, 2009, P NATL ACAD SCI USA, V106, P14052, DOI 10.1073/pnas.0906735106; Lazar GA, 1998, CURR OPIN CHEM BIOL, V2, P675, DOI 10.1016/S1367-5931(98)80102-6; LEE C, 1991, NATURE, V352, P448, DOI 10.1038/352448a0; MADEJ T, 1995, PROTEINS, V23, P356, DOI 10.1002/prot.340230309; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Pang CNI, 2008, NUCLEIC ACIDS RES, V36, P578, DOI 10.1093/nar/gkm1070; Petsko G., 2004, PROTEIN STRUCTURE FU; PRATT LR, 1977, J CHEM PHYS, V67, P3683, DOI 10.1063/1.435308; Quezada CM, 2009, P NATL ACAD SCI USA, V106, P4864, DOI 10.1073/pnas.0811058106; Ramachandran G N, 1968, Adv Protein Chem, V23, P283, DOI 10.1016/S0065-3233(08)60402-7; RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6; Rojnuckarin A, 1998, P NATL ACAD SCI USA, V95, P4288, DOI 10.1073/pnas.95.8.4288; ROST B, 1994, PROTEINS, V20, P216, DOI 10.1002/prot.340200303; ROST B, 1993, J MOL BIOL, V232, P584, DOI 10.1006/jmbi.1993.1413; Rumbley J, 2001, P NATL ACAD SCI USA, V98, P105, DOI 10.1073/pnas.98.1.105; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; SASISEKHARAN V, 1970, BIOPOLYMERS, V9, P1249, DOI 10.1002/bip.1970.360091005; Schueler-Furman O, 2003, PROTEINS, V52, P225, DOI 10.1002/prot.10365; Selkoe DJ, 2003, NATURE, V426, P900, DOI 10.1038/nature02264; Sheffler W, 2009, PROTEIN SCI, V18, P229, DOI 10.1002/pro.8; Singer AU, 2008, NAT STRUCT MOL BIOL, V15, P1293, DOI 10.1038/nsmb.1511; Vendruscolo M, 1997, FOLD DES, V2, P295, DOI 10.1016/S1359-0278(97)00041-2; Zhou RH, 2004, SCIENCE, V305, P1605, DOI 10.1126/science.1101176	51	36	36	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2010	5	2							e9391	10.1371/journal.pone.0009391	http://dx.doi.org/10.1371/journal.pone.0009391			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SV	20186337	Green Published, Green Submitted, gold			2022-12-25	WOS:000274924000027
J	Chinopoulos, C; Gerencser, AA; Mandi, M; Mathe, K; Torocsik, B; Doczi, J; Turiak, L; Kiss, G; Konrad, C; Vajda, S; Vereczki, V; Oh, RJ; Adam-Vizi, V				Chinopoulos, Christos; Gerencser, Akos A.; Mandi, Miklos; Mathe, Katalin; Torocsik, Beata; Doczi, Judit; Turiak, Lilla; Kiss, Gergely; Konrad, Csaba; Vajda, Szilvia; Vereczki, Viktoria; Oh, Richard J.; Adam-Vizi, Vera			Forward operation of adenine nucleotide translocase during F0F1-ATPase reversal: critical role of matrix substrate-level phosphorylation	FASEB JOURNAL			English	Article						adenine nucleotide carrier; ATP synthasome; systems biology of mitochondria; SUCLA2; bioenergetics	HEART-RATE HEARTS; MITOCHONDRIAL ADENOSINE 5'-TRIPHOSPHATASE; CA-2&-INDUCED MEMBRANE TRANSITION; ALPHA-KETOGLUTARATE DEHYDROGENASE; CULTURED CORTICAL-NEURONS; SUCCINYL-COA SYNTHETASES; K-ATP CHANNELS; INTRACELLULAR ATP; IN-VITRO; CALCIUM DEREGULATION	In pathological conditions, F0F1-ATPase hydrolyzes ATP in an attempt to maintain mitochondrial membrane potential. Using thermodynamic assumptions and computer modeling, we established that mitochondrial membrane potential can be more negative than the reversal potential of the adenine nucleotide translocase (ANT) but more positive than that of the F0F1-ATPase. Experiments on isolated mitochondria demonstrated that, when the electron transport chain is compromised, the F0F1-ATPase reverses, and the membrane potential is maintained as long as matrix substrate-level phosphorylation is functional, without a concomitant reversal of the ANT. Consistently, no cytosolic ATP consumption was observed using plasmalemmal K-ATP channels as cytosolic ATP biosensors in cultured neurons, in which their in situ mitochondria were compromised by respiratory chain inhibitors. This finding was further corroborated by quantitative measurements of mitochondrial membrane potential, oxygen consumption, and extracellular acidification rates, indicating nonreversal of ANT of compromised in situ neuronal and astrocytic mitochondria; and by bioluminescence ATP measurements in COS-7 cells transfected with cytosolic- or nuclear-targeted luciferases and treated with mitochondrial respiratory chain inhibitors in the presence of glycolytic plus mitochondrial vs. only mitochondrial substrates. Our findings imply the possibility of a rescue mechanism that is protecting against cytosolic/nuclear ATP depletion under pathological conditions involving impaired respiration. This mechanism comes into play when mitochondria respire on substrates that support matrix substrate-level phosphorylation.-Chinopoulos, C., Gerencser, A.A., Mandi, M., Mathe, K., Torocsik, B., Doczi, J., Turiak, L., Kiss, G., Konrad, C., Vajda, S., Vereczki, V., Oh, R. J., Adam-Vizi, V. Forward operation of adenine nucleotide translocase during F0F1-ATPase reversal: critical role of matrix substrate-level phosphorylation. FASEB J. 24, 2405-2416 (2010). www.fasebj.org	[Chinopoulos, Christos; Mandi, Miklos; Mathe, Katalin; Torocsik, Beata; Doczi, Judit; Turiak, Lilla; Kiss, Gergely; Konrad, Csaba; Vajda, Szilvia; Adam-Vizi, Vera] Semmelweis Univ, Hungarian Acad Sci, Szentagothai Knowledge Ctr, Dept Med Biochem,Neurobiochem Grp, H-1094 Budapest, Hungary; [Vereczki, Viktoria] Semmelweis Univ, Fac Med, Dept Anat Histol & Embryol, H-1094 Budapest, Hungary; [Gerencser, Akos A.; Oh, Richard J.] Buck Inst Age Res, Novato, CA USA	Hungarian Academy of Sciences; Semmelweis University; Semmelweis University; Buck Institute for Research on Aging	Chinopoulos, C (corresponding author), Semmelweis Univ, Hungarian Acad Sci, Szentagothai Knowledge Ctr, Dept Med Biochem,Neurobiochem Grp, Tuzolto St 37-47,Room 4-521, H-1094 Budapest, Hungary.	chinopoulos.christos@eok.sote.hu; veronika.adam@eok.sote.hu	Mándi, Miklós/AGF-9798-2022	Torocsik, Beata/0000-0002-9838-3710; Adam-Vizi, Vera/0000-0002-8350-8701; Chinopoulos, Christos/0000-0003-0183-4149; Mandi, Miklos/0000-0002-0971-7695	Hungarian Scientific Research Fund (OTKA); Magyar Tudomanyos Akademia (MTA); National Office for Research and Technology (NKTH); Egeszsegugyi Tudomanyos Tanacs (ETT); Semmelweis University [63320]; OTKA-NKTH [NF68294, NNF78905]; U.S. National Institutes of Health [PL1-AG032118]; NATIONAL INSTITUTE ON AGING [PL1AG032118] Funding Source: NIH RePORTER	Hungarian Scientific Research Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Magyar Tudomanyos Akademia (MTA); National Office for Research and Technology (NKTH)(National Office for Research and Technology); Egeszsegugyi Tudomanyos Tanacs (ETT); Semmelweis University; OTKA-NKTH(National Office for Research and TechnologyOrszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank Dr. Pal Bauer (Semmelweis University) for providing the cytosolic and nuclear-targeted luciferase plasmids (originally made by the group of Dr. Giovanni Manfredi), Dr. James Remington (University of California-San Diego, La Jolla, CA, USA) for the mito-roGFP1 plasmid (67), Dr. Laszlo Buday (Semmelweis University) for providing the COS-7 cell line, Dr. Andras Szollosi and Professor Erzsebet Ligeti for helpful discussions, Dr. Laszlo Csanady for valuable theoretical advice, Andras Mathe for generating the Windows-based software, and Katalin Zolde for excellent technical assistance. This work was supported by grants from the Hungarian Scientific Research Fund (OTKA), Magyar Tudomanyos Akademia (MTA), National Office for Research and Technology (NKTH), and Egeszsegugyi Tudomanyos Tanacs (ETT) to V.A.V., Semmelweis University research grant 63320, OTKA-NKTH grant NF68294, and OTKA NNF78905 to C.C. A.A.G. was supported at the Buck Institute by U.S. National Institutes of Health grant PL1-AG032118.	AKERMAN KEO, 1976, FEBS LETT, V68, P191, DOI 10.1016/0014-5793(76)80434-6; AKERMAN KEO, 1981, EUR J BIOCHEM, V115, P67; Allen TGJ, 2004, J PHYSIOL-LONDON, V554, P353, DOI 10.1113/jphysiol.2003.055889; APRILLE JR, 1993, J BIOENERG BIOMEMBR, V25, P473, DOI 10.1007/BF01108404; Bajic D, 2002, P NATL ACAD SCI USA, V99, P14494, DOI 10.1073/pnas.222379999; Ballanyi K, 1996, J PHYSIOL-LONDON, V495, P769, DOI 10.1113/jphysiol.1996.sp021632; Bernardi P, 2006, FEBS J, V273, P2077, DOI 10.1111/j.1742-4658.2006.05213.x; Chinopoulos C, 2004, J NEUROCHEM, V91, P471, DOI 10.1111/j.1471-4159.2004.02732.x; Chinopoulos C, 1999, J NEUROCHEM, V73, P220, DOI 10.1046/j.1471-4159.1999.0730220.x; Chinopoulos C, 2010, BBA-MOL BASIS DIS, V1802, P221, DOI 10.1016/j.bbadis.2009.08.008; Chinopoulos C, 2009, BIOPHYS J, V96, P2490, DOI 10.1016/j.bpj.2008.12.3915; Choi SW, 2009, J NEUROCHEM, V109, P1179, DOI 10.1111/j.1471-4159.2009.06055.x; Coskun PE, 2004, P NATL ACAD SCI USA, V101, P10726, DOI 10.1073/pnas.0403649101; Cross RL, 2004, FEBS LETT, V576, P1, DOI 10.1016/j.febslet.2004.08.065; Dooley CT, 2004, J BIOL CHEM, V279, P22284, DOI 10.1074/jbc.M312847200; Dzeja PP, 2002, P NATL ACAD SCI USA, V99, P10156, DOI 10.1073/pnas.152259999; Gajewski CD, 2003, MOL BIOL CELL, V14, P3628, DOI 10.1091/mbc.E02-12-0796; Gerencser AA, 2005, BIOPHYS J, V88, P698, DOI 10.1529/biophysj.104.050062; Gerencser AA, 2009, J NEUROCHEM, V110, P990, DOI 10.1111/j.1471-4159.2009.06194.x; Halestrap AP, 2009, J MOL CELL CARDIOL, V46, P821, DOI 10.1016/j.yjmcc.2009.02.021; HAWORTH RA, 1979, ARCH BIOCHEM BIOPHYS, V195, P460, DOI 10.1016/0003-9861(79)90372-2; HUNTER DR, 1979, ARCH BIOCHEM BIOPHYS, V195, P468, DOI 10.1016/0003-9861(79)90373-4; Jiang C, 1997, J NEUROPHYSIOL, V77, P93, DOI 10.1152/jn.1997.77.1.93; Johnson JD, 1998, J BIOL CHEM, V273, P27580, DOI 10.1074/jbc.273.42.27580; Karschin A, 1998, J PHYSIOL-LONDON, V509, P339, DOI 10.1111/j.1469-7793.1998.339bn.x; Karschin C, 1997, FEBS LETT, V401, P59, DOI 10.1016/S0014-5793(96)01438-X; KAUFMAN S, 1953, J BIOL CHEM, V203, P869; LABBE RF, 1965, BIOCHIM BIOPHYS ACTA, V111, P403, DOI 10.1016/0304-4165(65)90050-4; Lambeth David O, 2002, IUBMB Life, V54, P143; Lambeth DO, 2004, J BIOL CHEM, V279, P36621, DOI 10.1074/jbc.M406884200; Mannella CA, 2001, IUBMB LIFE, V52, P93, DOI 10.1080/15216540152845885; MCMILLIN JB, 1988, MOL CELL BIOCHEM, V81, P121; Metelkin E, 2009, FEBS J, V276, P6942, DOI 10.1111/j.1742-4658.2009.07394.x; Nicholls DG, 2006, J BIOL CHEM, V281, P14864, DOI 10.1074/jbc.M510916200; O'Reilly CM, 2003, BIOPHYS J, V85, P3350, DOI 10.1016/S0006-3495(03)74754-7; OHNOSHOSAKU T, 1992, PFLUG ARCH EUR J PHY, V422, P260, DOI 10.1007/BF00376211; Ostergaard E, 2008, J INHERIT METAB DIS, V31, P226, DOI 10.1007/s10545-008-0828-7; OTTAWAY JH, 1981, INT J BIOCHEM, V13, P401, DOI 10.1016/0020-711X(81)90111-7; Pelletier MR, 2000, J NEUROPHYSIOL, V84, P2291, DOI 10.1152/jn.2000.84.5.2291; PETRONILLI V, 1988, BIOCHIM BIOPHYS ACTA, V932, P306, DOI 10.1016/0005-2728(88)90167-3; Phillips D, 2009, BIOCHEMISTRY-US, V48, P7140, DOI 10.1021/bi900725c; Porter RK, 2001, BBA-BIOENERGETICS, V1504, P120, DOI 10.1016/S0005-2728(00)00246-2; PULLMAN ME, 1963, J BIOL CHEM, V238, P3762; Rouslin W, 1996, J BIOL CHEM, V271, P23638, DOI 10.1074/jbc.271.39.23638; ROUSLIN W, 1987, AM J PHYSIOL, V252, pH622, DOI 10.1152/ajpheart.1987.252.3.H622; ROUSLIN W, 1990, AM J PHYSIOL, V259, pH1759, DOI 10.1152/ajpheart.1990.259.6.H1759; ROUSLIN W, 1995, J BIOENERG BIOMEMBR, V27, P117, DOI 10.1007/BF02110339; ROUSLIN W, 1990, ARCH BIOCHEM BIOPHYS, V280, P103, DOI 10.1016/0003-9861(90)90524-3; ROUSLIN W, 1986, AM J PHYSIOL, V250, P503; Sasaki N, 2001, AM J PHYSIOL-HEART C, V280, pH1882, DOI 10.1152/ajpheart.2001.280.4.H1882; Schnopp NM, 1996, CLIN NEUROPATHOL, V15, P348; Schwimmer C, 2005, J BIOL CHEM, V280, P30751, DOI 10.1074/jbc.M501831200; SCOTT ID, 1980, BIOCHEM J, V186, P21, DOI 10.1042/bj1860021; STUMPF DA, 1980, PEDIATR RES, V14, P1127, DOI 10.1203/00006450-198010000-00008; Taivassalo T, 1999, HUM MOL GENET, V8, P1047, DOI 10.1093/hmg/8.6.1047; TANG XD, 1995, NEUROSCI LETT, V193, P93, DOI 10.1016/0304-3940(95)11675-M; Tomashek JJ, 2000, J BIOENERG BIOMEMBR, V32, P493, DOI 10.1023/A:1005617024904; TRAPP S, 1995, J PHYSIOL-LONDON, V487, P37, DOI 10.1113/jphysiol.1995.sp020859; Tretter L, 2000, J NEUROSCI, V20, P8972; Tyler D. D., 1967, METHOD ENZYMOL, V10, P75, DOI DOI 10.1016/0076-6879(67)10014-1; WALLACE DC, 1988, CELL, V55, P601, DOI 10.1016/0092-8674(88)90218-8; WILSON DF, 1983, J BIOL CHEM, V258, P464; WISNIEWSKI E, 1993, J BIOL CHEM, V268, P9343; Wu F, 2008, J PHYSIOL-LONDON, V586, P4193, DOI 10.1113/jphysiol.2008.154732; ZOLLNER H, 1990, HDB ENZYME INHIBITOR	65	73	74	2	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JUL	2010	24	7					2405	2416		10.1096/fj.09-149898	http://dx.doi.org/10.1096/fj.09-149898			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	618HV	20207940	Green Published			2022-12-25	WOS:000279343600027
J	Caldwell, SA; Jackson, SR; Shahriari, KS; Lynch, TP; Sethi, G; Walker, S; Vosseller, K; Reginato, MJ				Caldwell, S. A.; Jackson, S. R.; Shahriari, K. S.; Lynch, T. P.; Sethi, G.; Walker, S.; Vosseller, K.; Reginato, M. J.			Nutrient sensor O-GlcNAc transferase regulates breast cancer tumorigenesis through targeting of the oncogenic transcription factor FoxM1	ONCOGENE			English	Article						O-GlcNAc; OGT; FoxM1; breast cancer; glucose metabolism; p27(Kip1)	LINKED N-ACETYLGLUCOSAMINE; INSULIN-RESISTANCE; NUCLEOCYTOPLASMIC PROTEINS; GLYCOSYLATION; CELLS; BETA; PHOSPHORYLATION; INHIBITORS; EXPRESSION; GLUCOSE	Cancer cells upregulate glycolysis, increasing glucose uptake to meet energy needs. A small fraction of a cell's glucose enters the hexosamine biosynthetic pathway (HBP), which regulates levels of O-linked beta-N-acetylglucosamine (O-GlcNAc), a carbohydrate posttranslational modification of diverse nuclear and cytosolic proteins. We discovered that breast cancer cells upregulate the HBP, including increased O-GlcNAcation and elevated expression of O-GlcNAc transferase (OGT), which is the enzyme catalyzing the addition of O-GlcNAc to proteins. Reduction of O-GlcNAcation through RNA interference of OGT in breast cancer cells leads to inhibition of tumor growth both in vitro and in vivo and is associated with decreased cell-cycle progression and increased expression of the cell-cycle inhibitor p27(Kip1). Elevation of p27(Kip1) was associated with decreased expression and activity of the oncogenic transcription factor FoxM1, a known regulator of p27(Kip1) stability through transcriptional control of Skp2. Reducing O-GlcNAc levels in breast cancer cells decreased levels of FoxM1 protein and caused a decrease in multiple FoxM1-specific targets, including Skp2. Moreover, reducing O-GlcNAcation decreased cancer cell invasion and was associated with the downregulation of matrix metallo-proteinase- 2, a known FoxM1 target. Finally, pharmacological inhibition of OGT in breast cancer cells had similar anti-growth and anti-invasion effects. These findings identify O-GlcNAc as a novel mechanism through which alterations in glucose metabolism regulate cancer growth and invasion and suggest that OGT may represent novel therapeutic targets for breast cancer. Oncogene (2010) 29, 2831-2842; doi: 10.1038/onc.2010.41; published online 1 March 2010	[Caldwell, S. A.; Jackson, S. R.; Shahriari, K. S.; Lynch, T. P.; Sethi, G.; Vosseller, K.; Reginato, M. J.] Drexel Univ, Coll Med, Dept Biochem & Mol Biol, Philadelphia, PA 19104 USA; [Walker, S.] Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA	Drexel University; Harvard University; Harvard Medical School	Reginato, MJ (corresponding author), Drexel Univ, Coll Med, Dept Biochem & Mol Biol, 245 N 15th St, Philadelphia, PA 19104 USA.	Mauricio.Reginato@drexelmed.edu	Reginato, Mauricio/I-6155-2013; Sethi, Gautam/F-2372-2011	Reginato, Mauricio/0000-0002-7541-4094; Sethi, Gautam/0000-0002-8677-8475	Department of Defense [BC086596, BC074374]	Department of Defense(United States Department of Defense)	This study was supported by the Department of Defense, Breast Cancer Research Program Concept Award: BC086596 to MJR and Synergistic Idea Award: BC074374 to MJR and KV.	Bektas N, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-42; Boehmelt G, 2000, EMBO J, V19, P5092, DOI 10.1093/emboj/19.19.5092; Buse MG, 2002, AM J PHYSIOL-ENDOC M, V283, pE241, DOI 10.1152/ajpendo.00060.2002; Cheng XG, 2001, J BIOL CHEM, V276, P10570, DOI 10.1074/jbc.M010411200; Chu IM, 2008, NAT REV CANCER, V8, P253, DOI 10.1038/nrc2347; Comer FI, 1999, BBA-GEN SUBJECTS, V1473, P161, DOI 10.1016/S0304-4165(99)00176-2; Comer FI, 2001, ANAL BIOCHEM, V293, P169, DOI 10.1006/abio.2001.5132; Dang CV, 1999, TRENDS BIOCHEM SCI, V24, P68, DOI 10.1016/S0968-0004(98)01344-9; Duffy MJ, 2000, BREAST CANCER RES, V2, P252, DOI 10.1186/bcr65; Gallagher SM, 2007, CANCER RES, V67, P4182, DOI 10.1158/0008-5472.CAN-06-3184; Gartel AL, 2008, EXPERT OPIN THER TAR, V12, P663, DOI 10.1517/14728222.12.6.663 ; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gross BJ, 2005, J AM CHEM SOC, V127, P14588, DOI 10.1021/ja0555217; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Han I, 1997, MOL CELL BIOL, V17, P2550, DOI 10.1128/MCB.17.5.2550; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Housley MP, 2008, J BIOL CHEM, V283, P16283, DOI 10.1074/jbc.M802240200; Kawauchi K, 2009, P NATL ACAD SCI USA, V106, P3431, DOI 10.1073/pnas.0813210106; Laoukili J, 2008, CELL CYCLE, V7, P2720, DOI 10.4161/cc.7.17.6580; Liu F, 2004, P NATL ACAD SCI USA, V101, P10804, DOI 10.1073/pnas.0400348101; Liu MG, 2006, CANCER RES, V66, P3593, DOI 10.1158/0008-5472.CAN-05-2912; Lubas WA, 2000, J BIOL CHEM, V275, P10983, DOI 10.1074/jbc.275.15.10983; Ma RYM, 2005, J CELL SCI, V118, P795, DOI 10.1242/jcs.01657; Macauley MS, 2005, J BIOL CHEM, V280, P25313, DOI 10.1074/jbc.M413819200; Major ML, 2004, MOL CELL BIOL, V24, P2649, DOI 10.1128/MCB.24.7.2649-2661.2004; MARSHALL S, 1991, J BIOL CHEM, V266, P4706; Marshall Stephen, 2006, Sci STKE, V2006, pre7; Myatt SS, 2008, NAT REV CANCER, V8, P244, DOI 10.1038/nrc2223-c2; Myatt SS, 2007, NAT REV CANCER, V7, P847, DOI 10.1038/nrc2223; O'Donnell N, 2004, MOL CELL BIOL, V24, P1680, DOI 10.1128/MCB.24.4.1680-1690.2004; Park HJ, 2008, MOL CELL BIOL, V28, P5162, DOI 10.1128/MCB.00387-08; Reginato MJ, 2005, MOL CELL BIOL, V25, P4591, DOI 10.1128/MCB.25.11.4591-4601.2005; Reginato MJ, 2003, NAT CELL BIOL, V5, P733, DOI 10.1038/ncb1026; Roos MD, 1997, MOL CELL BIOL, V17, P6472, DOI 10.1128/MCB.17.11.6472; Rubio CA, 2003, EUR J CLIN INVEST, V33, P406, DOI 10.1046/j.1365-2362.2003.01151.x; Shaw RJ, 2006, CURR OPIN CELL BIOL, V18, P598, DOI 10.1016/j.ceb.2006.10.005; Slawson C, 2005, J BIOL CHEM, V280, P32944, DOI 10.1074/jbc.M503396200; Vosseller K, 2002, P NATL ACAD SCI USA, V99, P5313, DOI 10.1073/pnas.072072399; WANG XD, 2005, J ORGAN DYSFUNCT, V1, P2; Wang ZW, 2007, CANCER RES, V67, P8293, DOI 10.1158/0008-5472.CAN-07-1265; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wells L, 2001, SCIENCE, V291, P2376, DOI 10.1126/science.1058714; Wonsey DR, 2005, CANCER RES, V65, P5181, DOI 10.1158/0008-5472.CAN-04-4059; Yakes FM, 2002, CANCER RES, V62, P4132; Yang WH, 2006, NAT CELL BIOL, V8, P1074, DOI 10.1038/ncb1470; Yang XY, 2008, NATURE, V451, P964, DOI 10.1038/nature06668; Zhu WJ, 2001, EMBO J, V20, P5999, DOI 10.1093/emboj/20.21.5999	47	277	300	0	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2010	29	19					2831	2842		10.1038/onc.2010.41	http://dx.doi.org/10.1038/onc.2010.41			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	595DW	20190804				2022-12-25	WOS:000277591900008
J	Rocher-Ros, V; Marco, S; Mao, JH; Gines, S; Metzger, D; Chambon, P; Balmain, A; Saura, CA				Rocher-Ros, V.; Marco, S.; Mao, J-H; Gines, S.; Metzger, D.; Chambon, P.; Balmain, A.; Saura, C. A.			Presenilin modulates EGFR signaling and cell transformation by regulating the ubiquitin ligase Fbw7	ONCOGENE			English	Article						carcinogenesis; epidermis; Fbw7; Notch; gamma-secretase	GROWTH-FACTOR RECEPTOR; AMYLOID PRECURSOR PROTEIN; TUMOR-SUPPRESSOR; NEGATIVE REGULATOR; DOWN-REGULATION; NOTCH; DEGRADATION; SEL-10; ENDOCYTOSIS; ACTIVATION	The epidermal growth factor receptor (EGFR) and Notch signaling pathways have antagonistic roles during epidermal differentiation and carcinogenesis. The molecular mechanisms regulating the crosstalk between EGFR and Notch during epidermal transformation are largely unknown. We found enhanced EGFR-dependent signaling, proliferation and oncogenic transformation caused by loss of presenilins (PS), the catalytic components of gamma-secretase that generates the Notch1 intracellular domain (NICD). The underlying mechanism for abnormal EGFR signaling in PS-deficient cells involves gamma-secretase-independent transcriptional upregulation of the E3 ubiquitin ligase Fbw7. Fbw7 alpha, which targets NICD for degradation, regulates positively EGFR by affecting a proteasome-dependent ubiquitination step essential for constitutive degradation and stability of EGFR. To investigate the pathological relevance of this findings in vivo, we generated a novel epidermal conditional PS-deficient (ePS cDKO) mouse by deleting both PS in keratinocytes of the basal layer of the epidermis. The ePS cDKO mice develop epidermal hyperplasia associated with enhanced expression of both EGFR and Fbw7 and reduced NICD levels in keratinocytes. These findings establish a novel role for PS on epidermal growth and transformation by reciprocally regulating the EGFR and Notch signaling pathways through Fbw7. Oncogene (2010) 29, 2950-2961; doi:10.1038/onc.2010.57; published online 8 March 2010	[Saura, C. A.] Univ Autonoma Barcelona, Inst Neurociencies, Dept Bioquim & Biol Mol,Fac Med M2 120, Ctr Invest Biomed Red Enfermedades Neurodegenerat, E-08193 Barcelona, Spain; [Mao, J-H; Balmain, A.] Univ Calif San Francisco, Canc Res Inst, San Francisco, CA 94143 USA; [Gines, S.] Univ Barcelona, Dept Biol Cellular Inmunol & Neurociencies, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Barcelona, Spain; [Metzger, D.; Chambon, P.] Univ Strasbourg, Strasbourg, France; [Metzger, D.; Chambon, P.] Coll France, Dept Funct Genom, Inst Genet & Biol Mol & Cellulaire, Inserm U964,CNRS, Illkirch Graffenstaden, France	Autonomous University of Barcelona; CIBERNED; University of California System; University of California San Francisco; CIBERNED; University of Barcelona; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Saura, CA (corresponding author), Univ Autonoma Barcelona, Inst Neurociencies, Dept Bioquim & Biol Mol,Fac Med M2 120, Ctr Invest Biomed Red Enfermedades Neurodegenerat, E-08193 Barcelona, Spain.	carlos.saura@uab.es	Mao, Jian-Hua/EIZ-8595-2022; Saura, Carlos A/D-2727-2011; Saura, Carlos A/AFM-9239-2022; Gines, Silvia/L-1943-2015	Mao, Jian-Hua/0000-0001-9320-6021; Saura, Carlos A/0000-0003-3692-5657; Gines, Silvia/0000-0002-9479-8185; Metzger, Daniel/0000-0002-5555-046X; Marco, Sergi/0000-0002-9747-0388	Fundacio Marato-TV3 [050710]; Spanish Ministerio de Ciencia e Innovacion [SAF2007-64115, CIBERNED CB06/05/0042]; European Union [IRG-014860]; Generalitat de Catalunya; NATIONAL CANCER INSTITUTE [R01CA116481] Funding Source: NIH RePORTER	Fundacio Marato-TV3; Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); European Union(European Commission); Generalitat de Catalunya(Generalitat de Catalunya); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank B De Strooper for providing the immortalized PS fibroblasts, J Shen for PS1 (f/f); PS2-/- mice, G Thinakaran for the pAG3zeo-PS1 Delta loop plasmid, R Kopan for the mNICD-myc plasmid, BE Clurman for the Fbw7 alpha/beta-Flag cDNAs and A Johnson for the pER1-luc plasmid. We thank S Aznar-Benitah for histological expertise advice and E Martin and M Castillo for technical assistance. We thank Servei de Microscopia and Servei de Genomica de la UAB for the excellent technical support. This study was supported by grants from Fundacio Marato-TV3 (050710), Spanish Ministerio de Ciencia e Innovacion (SAF2007-64115, CIBERNED CB06/05/0042 and Programa Ramon y Cajal) and 6th Framework Programme of the European Union (Marie Curie International Reintegration Grant IRG-014860). VRR received a doctoral fellowship from Generalitat de Catalunya.	Alwan HAJ, 2003, J BIOL CHEM, V278, P35781, DOI 10.1074/jbc.M301326200; Bhoumik A, 2008, P NATL ACAD SCI USA, V105, P1674, DOI 10.1073/pnas.0706057105; Blanpain C, 2006, GENE DEV, V20, P3022, DOI 10.1101/gad.1477606; Chen ZJJ, 2009, MOL CELL, V33, P275, DOI 10.1016/j.molcel.2009.01.014; de Souza N, 2007, DEVELOPMENT, V134, P691, DOI 10.1242/dev.02767; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; De Strooper B, 2007, EMBO REP, V8, P141, DOI 10.1038/sj.embor.7400897; Demehri S, 2008, PLOS BIOL, V6, P992, DOI 10.1371/journal.pbio.0060123; Deng Y, 2006, J NEUROSCI, V26, P3845, DOI 10.1523/JNEUROSCI.5384-05.2006; DIFIORE PP, 1987, CELL, V51, P1063, DOI 10.1016/0092-8674(87)90592-7; Grim JE, 2008, J CELL BIOL, V181, P913, DOI 10.1083/jcb.200802076; Gupta-Rossi N, 2001, J BIOL CHEM, V276, P34371, DOI 10.1074/jbc.M101343200; Huang F, 2007, P NATL ACAD SCI USA, V104, P16904, DOI 10.1073/pnas.0707416104; Huang FT, 2006, MOL CELL, V21, P737, DOI 10.1016/j.molcel.2006.02.018; Indra AK, 1999, NUCLEIC ACIDS RES, V27, P4324, DOI 10.1093/nar/27.22.4324; Jost M, 2000, EUR J DERMATOL, V10, P505; Kalyankrishna S, 2006, J CLIN ONCOL, V24, P2666, DOI 10.1200/JCO.2005.04.8306; Kang DE, 2002, CELL, V110, P751, DOI 10.1016/S0092-8674(02)00970-4; Kolev V, 2008, NAT CELL BIOL, V10, DOI 10.1038/ncb1750; Koo EH, 2004, NAT MED, V10, pS26, DOI 10.1038/nm1065; Kopan R, 1996, P NATL ACAD SCI USA, V93, P1683, DOI 10.1073/pnas.93.4.1683; Lefort K, 2004, SEMIN CANCER BIOL, V14, P374, DOI 10.1016/j.semcancer.2004.04.017; Li JH, 2002, J NEUROCHEM, V82, P1540, DOI 10.1046/j.1471-4159.2002.01105.x; Li M, 2000, NATURE, V407, P633, DOI 10.1038/35036595; Li T, 2007, J BIOL CHEM, V282, P32264, DOI 10.1074/jbc.M703649200; Longva KE, 2002, J CELL BIOL, V156, P843, DOI 10.1083/jcb.200106056; Mao JH, 2004, NATURE, V432, P775, DOI 10.1038/nature03155; Marmor MD, 2004, ONCOGENE, V23, P2057, DOI 10.1038/sj.onc.1207390; Mosesson Y, 2003, J BIOL CHEM, V278, P21323, DOI 10.1074/jbc.C300096200; Nicolas M, 2003, NAT GENET, V33, P416, DOI 10.1038/ng1099; O'Neil J, 2007, J EXP MED, V204, P1813, DOI 10.1084/jem.20070876; Pan YH, 2004, DEV CELL, V7, P731, DOI 10.1016/j.devcel.2004.09.014; Perez-Losada J, 2005, CANCER RES, V65, P6488, DOI 10.1158/0008-5472.CAN-05-1294; Pirrone A, 2004, METH MOL B, V289, P3; Proweller A, 2006, CANCER RES, V66, P7438, DOI 10.1158/0008-5472.CAN-06-0793; Repetto E, 2007, J BIOL CHEM, V282, P31504, DOI 10.1074/jbc.M704273200; Rikiyama T, 2003, BBA-GENE STRUCT EXPR, V1629, P15, DOI 10.1016/S0167-4781(03)00156-8; Saura CA, 2000, J BIOL CHEM, V275, P17136, DOI 10.1074/jbc.M909624199; Saura CA, 2004, NEURON, V42, P23, DOI 10.1016/S0896-6273(04)00182-5; Shaye DD, 2002, NATURE, V420, P686, DOI 10.1038/nature01234; Shen J, 1997, CELL, V89, P629, DOI 10.1016/S0092-8674(00)80244-5; Soriano S, 2001, J CELL BIOL, V152, P785, DOI 10.1083/jcb.152.4.785; STOSCHECK CM, 1984, J CELL BIOL, V98, P1048, DOI 10.1083/jcb.98.3.1048; To MD, 2006, ONCOGENE, V25, P3557, DOI 10.1038/sj.onc.1209397; Tournoy J, 2004, HUM MOL GENET, V13, P1321, DOI 10.1093/hmg/ddh151; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; Wang JW, 2004, ONCOGENE, V23, P4089, DOI 10.1038/sj.onc.1207567; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Welcker M, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-7; Wu GY, 2001, MOL CELL BIOL, V21, P7403, DOI 10.1128/MCB.21.21.7403-7415.2001; Wu GY, 1998, P NATL ACAD SCI USA, V95, P15787, DOI 10.1073/pnas.95.26.15787; Xia XF, 2001, P NATL ACAD SCI USA, V98, P10863, DOI 10.1073/pnas.191284198; Zhang YW, 2007, P NATL ACAD SCI USA, V104, P10613, DOI 10.1073/pnas.0703903104	54	35	35	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2010	29	20					2950	2961		10.1038/onc.2010.57	http://dx.doi.org/10.1038/onc.2010.57			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	599DM	20208556	Green Accepted			2022-12-25	WOS:000277890400006
J	Schneider, G; Henrich, A; Greiner, G; Wolf, V; Lovas, A; Wieczorek, M; Wagner, T; Reichardt, S; von Werder, A; Schmid, RM; Weih, F; Heinzel, T; Saur, D; Kramer, OH				Schneider, G.; Henrich, A.; Greiner, G.; Wolf, V.; Lovas, A.; Wieczorek, M.; Wagner, T.; Reichardt, S.; von Werder, A.; Schmid, R. M.; Weih, F.; Heinzel, T.; Saur, D.; Kraemer, O. H.			Cross talk between stimulated NF-kappa B and the tumor suppressor p53	ONCOGENE			English	Article						NF-kappa B; p53; S-phase; hydroxyurea; TNF-alpha; apoptosis	ACID PHENETHYL ESTER; NECROSIS-FACTOR-ALPHA; DNA-DAMAGE; CELL-CYCLE; INDUCED APOPTOSIS; GENE-EXPRESSION; MOUSE MODEL; ACTIVATION; CANCER; PATHWAY	Nuclear factor-kappa B (NF-kappa B) and p53 critically determine cancer development and progression. Defining the cross talk between these transcription factors can expand our knowledge on molecular mechanisms of tumorigenesis. Here, we show that induction of replicational stress activates NF-kappa B p65 and triggers its interaction with p53 in the nucleus. Experiments with knockout cells show that p65 and p53 are both required for enhanced NF-kappa B activity during S-phase checkpoint activation involving ataxiatelangiectasia mutated and checkpoint kinase-1. Accordingly, the pro-inflammatory cytokine tumor necrosis factora alpha (TNF-alpha) also triggers formation of a transcriptionally active complex containing nuclear p65 and p53 on jB response elements. Gene expression analyses revealed that, independent of NF-kappa B activation in the cytosol, TNFinduced NF-kappa B-directed gene expression relies on p53. Hence, p53 is unexpectedly necessary for NF-kappa B-mediated gene expression induced by atypical and classical stimuli. Remarkably, data from gain- and loss-of function approaches argue that anti-apoptotic NF-kappa B p65 activity is constitutively evoked by a p53 hot-spot mutant frequently found in tumors. Our observations suggest explanations for the outstanding question why p53 mutations rather than p53 deletions arise in tumors of various origins. Oncogene (2010) 29, 2795-2806; doi: 10.1038/onc.2010.46; published online 1 March 2010	[Greiner, G.; Wolf, V.; Wieczorek, M.; Wagner, T.; Reichardt, S.; Heinzel, T.; Kraemer, O. H.] Univ Jena, Ctr Mol Biomed, Inst Biochem & Biophys, Dept Biochem, D-07743 Jena, Germany; [Schneider, G.; Henrich, A.; von Werder, A.; Schmid, R. M.; Saur, D.] Tech Univ Munich, Med Klin, Klinikum Rechts Isar 2, Munich, Germany; [Lovas, A.; Weih, F.] Fritz Lipmann Inst, Leibniz Inst Age Res, Jena, Germany	Friedrich Schiller University of Jena; Technical University of Munich; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI)	Kramer, OH (corresponding author), Univ Jena, Ctr Mol Biomed, Inst Biochem & Biophys, Dept Biochem, Hans Knoll Str 2, D-07743 Jena, Germany.	oliver.kraemer@uni-jena.de	Heinzel, Thorsten/B-1013-2015; Krämer, Oliver H/L-9266-2015; Saur, Dieter/G-4629-2011; Saur, Dieter/O-8355-2015	Krämer, Oliver H/0000-0003-3973-045X; Saur, Dieter/0000-0001-5874-0210	DFG [SCHN 959/1-2, SFB456]; Landesprogramm 'ProExzellenz' [PE 123-2-1]; Deutsche Krebshilfe	DFG(German Research Foundation (DFG)); Landesprogramm 'ProExzellenz'; Deutsche Krebshilfe(Deutsche Krebshilfe)	We thank Dr B Vogelstein for HCT-116 cells, Dr A Hoffmann for wild-type and Rel A/ MEFs, Dr T Jacks and Dr D Tuveson for LSL-KRAS<SUP>G12D</SUP> and LSL-p53<SUP>R172H</SUP> mice, Dr A Berns for TP53<SUP>lox/lox</SUP> mice, Dr H Nakhai for Ptf1a/p48<SUP>ex1Cre/+</SUP> mice, Dr R Bernards and Dr R Agami for shRNA against p53, M Buchwald for help with electroporation, Dr A Licht for help with EMSAs, Dr Z-Q Wang and Dr W-K Min for wild-type and p53/ MEFs and very helpful discussions and suggestions. This study was supported by DFG (SCHN 959/1-2) and SFB456 grants to GS, Landesprogramm 'ProExzellenz' (PE 123-2-1) to OHK, and a grant from Deutsche Krebshilfe to GS and OHK.	Alsafadi S, 2009, CURR MED CHEM, V16, P4328, DOI 10.2174/092986709789578196; Ansari SA, 2001, EXP CELL RES, V265, P221, DOI 10.1006/excr.2001.5168; ARMSTRONG JF, 1995, CURR BIOL, V5, P931, DOI 10.1016/S0960-9822(95)00183-7; Armstrong MB, 2006, NEOPLASIA, V8, P967, DOI 10.1593/neo.06574; Bar J, 2009, ONCOGENE, V28, P933, DOI 10.1038/onc.2008.445; Bohuslav J, 2004, J BIOL CHEM, V279, P26115, DOI 10.1074/jbc.M313509200; Bug G, 2005, CANCER, V104, P2717, DOI 10.1002/cncr.21589; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Deppert W, 2007, ONCOGENE, V26, P2142, DOI 10.1038/sj.onc.1210276; Dornan D, 2006, SCIENCE, V313, P1122, DOI 10.1126/science.1127335; Finkel T, 2007, NATURE, V448, P767, DOI 10.1038/nature05985; Fritsche P, 2009, GUT, V58, P1399, DOI 10.1136/gut.2009.180711; Gapuzan MER, 2005, ONCOGENE, V24, P6574, DOI 10.1038/sj.onc.1208809; Gilmore TD, 2006, ONCOGENE, V25, P6887, DOI 10.1038/sj.onc.1209982; Gottifredi V, 2001, P NATL ACAD SCI USA, V98, P1036, DOI 10.1073/pnas.021282898; Grallert B, 2008, CELL CYCLE, V7, P2315, DOI 10.4161/cc.6389; Ha J, 2009, INT IMMUNOPHARMACOL, V9, P774, DOI 10.1016/j.intimp.2009.03.001; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hayashi T, 2007, J IMMUNOL, V178, P7385, DOI 10.4049/jimmunol.178.11.7385; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Ho CC, 2006, CANCER RES, V66, P2233, DOI 10.1158/0008-5472.CAN-05-1790; Hoffman WH, 2002, J BIOL CHEM, V277, P3247, DOI 10.1074/jbc.M106643200; Huang WC, 2007, MOL CELL, V26, P75, DOI 10.1016/j.molcel.2007.02.019; Hung MW, 2003, ANTICANCER RES, V23, P4773; Janssens S, 2006, CELL DEATH DIFFER, V13, P773, DOI 10.1038/sj.cdd.4401843; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Karl S, 2009, J CELL MOL MED, V13, P4239, DOI 10.1111/j.1582-4934.2009.00888.x; Kashatus D, 2006, GENE DEV, V20, P225, DOI 10.1101/gad.1352206; Kaustov L, 2006, CELL CYCLE, V5, P489, DOI 10.4161/cc.5.5.2489; Kawauchi K, 2008, NAT CELL BIOL, V10, P611, DOI 10.1038/ncb1724; Kawauchi K, 2008, BIOCHEM BIOPH RES CO, V372, P137, DOI 10.1016/j.bbrc.2008.05.021; Knauer SK, 2007, FASEB J, V21, P207, DOI 10.1096/fj.06-5741com; Kramer OH, 2008, ONCOGENE, V27, P732, DOI 10.1038/sj.onc.1210677; Kramer OH, 2009, TRENDS PHARMACOL SCI, V30, P647, DOI 10.1016/j.tips.2009.09.007; Kramer OH, 2009, GENE DEV, V23, P223, DOI 10.1101/gad.479209; Kramer OH, 2006, GENE DEV, V20, P473, DOI 10.1101/gad.364306; Lee YJ, 2003, BIOCHEM PHARMACOL, V66, P2281, DOI 10.1016/j.bcp.2003.07.014; Levine AJ, 2009, VIROLOGY, V384, P285, DOI 10.1016/j.virol.2008.09.034; Li J, 2007, J CLIN INVEST, V117, P3283, DOI 10.1172/JCI31772; LOWE SW, 1993, GENE DEV, V7, P535, DOI 10.1101/gad.7.4.535; Marusyk A, 2007, CELL CYCLE, V6, P2148, DOI 10.4161/cc.6.17.4732; Moll UM, 2005, CURR OPIN CELL BIOL, V17, P631, DOI 10.1016/j.ceb.2005.09.007; Natarajan K, 1996, P NATL ACAD SCI USA, V93, P9090, DOI 10.1073/pnas.93.17.9090; Nayak BK, 2002, ONCOGENE, V21, P7226, DOI 10.1038/sj.onc.1205889; Nesic D, 2008, MOL CANCER RES, V6, P1193, DOI 10.1158/1541-7786.MCR-07-2125; O'Brien DI, 2005, EXPERT OPIN THER TAR, V9, P1031, DOI 10.1517/14728222.9.5.1031; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Ravi R, 1998, CANCER RES, V58, P4531; Reinhardt HC, 2007, CANCER CELL, V11, P175, DOI 10.1016/j.ccr.2006.11.024; Renner F, 2009, TRENDS BIOCHEM SCI, V34, P128, DOI 10.1016/j.tibs.2008.12.003; Royds JA, 1998, J CLIN PATHOL-MOL PA, V51, P55; Ryan KM, 2000, NATURE, V404, P892, DOI 10.1038/35009130; Schafer T, 2003, FASEB J, V17, P660, DOI 10.1096/fj.02-0774com; Scheidereit C, 2006, ONCOGENE, V25, P6685, DOI 10.1038/sj.onc.1209934; Schneider G, 2006, EMBO J, V25, P3801, DOI 10.1038/sj.emboj.7601259; Schrell UMH, 1996, LANCET, V348, P888, DOI 10.1016/S0140-6736(05)64757-5; Schumm K, 2006, EMBO J, V25, P4820, DOI 10.1038/sj.emboj.7601343; Scian MJ, 2005, MOL CELL BIOL, V25, P10097, DOI 10.1128/MCB.25.22.10097-10110.2005; Seidler B, 2008, P NATL ACAD SCI USA, V105, P10137, DOI 10.1073/pnas.0800487105; Soussi T, 2007, CANCER CELL, V12, P303, DOI 10.1016/j.ccr.2007.10.001; Spange S, 2009, INT J BIOCHEM CELL B, V41, P185, DOI 10.1016/j.biocel.2008.08.027; Szoltysek K, 2008, ACTA BIOCHIM POL, V55, P741; Tergaonkar V, 2002, CANCER CELL, V1, P493, DOI 10.1016/S1535-6108(02)00068-5; Tergaonkar V, 2006, INT J BIOCHEM CELL B, V38, P1647, DOI 10.1016/j.biocel.2006.03.023; Tsai CJ, 2009, TRENDS BIOCHEM SCI, V34, P594, DOI 10.1016/j.tibs.2009.07.007; Viale A, 2009, NATURE, V457, P51, DOI 10.1038/nature07618; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Wadgaonkar R, 1999, J BIOL CHEM, V274, P1879, DOI 10.1074/jbc.274.4.1879; Wang W, 2008, CURR OPIN ONCOL, V20, P90, DOI 10.1097/CCO.0b013e3282f31d6f; Webster GA, 1999, MOL CELL BIOL, V19, P3485; Weisz L, 2007, CANCER RES, V67, P2396, DOI 10.1158/0008-5472.CAN-06-2425; Wietek C, 2007, TRENDS BIOCHEM SCI, V32, P311, DOI 10.1016/j.tibs.2007.05.003; WU HY, 1994, J BIOL CHEM, V269, P20067; Wu ZH, 2008, EMBO J, V27, P1963, DOI 10.1038/emboj.2008.127; Yan B, 2006, CANCER RES, V66, P11565, DOI 10.1158/0008-5472.CAN-06-2540; Yazdanpanah B, 2009, NATURE, V460, P1159, DOI 10.1038/nature08206; Yilmaz ZB, 2003, EMBO J, V22, P121, DOI 10.1093/emboj/cdg004; Yoshida K, 2008, ONCOGENE, V27, P1183, DOI 10.1038/sj.onc.1210722; Zhang XP, 2009, P NATL ACAD SCI USA, V106, P12245, DOI 10.1073/pnas.0813088106	82	112	114	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2010	29	19					2795	2806		10.1038/onc.2010.46	http://dx.doi.org/10.1038/onc.2010.46			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	595DW	20190799				2022-12-25	WOS:000277591900005
J	Schonherr, C; Yang, HL; Vigny, M; Palmer, RH; Hallberg, B				Schoenherr, C.; Yang, H-L; Vigny, M.; Palmer, R. H.; Hallberg, B.			Anaplastic lymphoma kinase activates the small GTPase Rap1 via the Rap1-specific GEF C3G in both neuroblastoma and PC12 cells	ONCOGENE			English	Article						ALK; PC12 cells; neurite outgrowth; small GTPase; Rap1; neuroblastoma	RECEPTOR TYROSINE KINASE; NERVE GROWTH-FACTOR; NUCLEOTIDE EXCHANGE FACTOR; NON-HODGKINS-LYMPHOMA; MAP KINASE; NEURONAL DIFFERENTIATION; DROSOPHILA-MELANOGASTER; SUSTAINED ACTIVATION; PHOSPHORYLATED RAP1B; CANCER METASTASIS	Many different types of cancer originate from aberrant signaling from the anaplastic lymphoma kinase (ALK) receptor tyrosine kinase (RTK), arising through different translocation events and overexpression. Further, activating point mutations in the ALK domain have been recently reported in neuroblastoma. To characterize signaling in the context of the full-length receptor, we have examined whether ALK is able to activate Rap1 and contribute to differentiation/proliferation processes. We show that ALK activates Rap1 via the Rap1-specific guanine-nucleotide exchange factor C3G, which binds in a constitutive complex with CrkL to activated ALK. The activation of the C3G/Rap1 pathway results in neurite outgrowth of PC12 cells, which is inhibited by either overexpression of Rap1GAP or siRNA-mediated knockdown of Rap1 itself or the guanine nucleotide exchange factor C3G. Significantly, this pathway also appears to function in the regulation of proliferation of neuroblastoma cells such as SK-N-SH and SH-SY5Y, because abrogation of Rap1 activity by Rap1-specific siRNA or overexpression of Rap1GAP reduces cellular growth. These results suggest that ALK activation of Rap1 may contribute to cell proliferation and oncogenesis of neuroblastoma driven by gain-of-function mutant ALK receptors. Oncogene (2010) 29, 2817-2830; doi: 10.1038/onc.2010.27; published online 1 March 2010	[Schoenherr, C.; Palmer, R. H.; Hallberg, B.] Umea Univ, Dept Mol Biol, S-90187 Umea, Norrland, Sweden; [Yang, H-L] Beijing Forestry Univ, Coll Biol Sci & Biotechnol, Beijing, Peoples R China; [Vigny, M.] UPMC, INSERM, IFM, U839, Paris, France	Umea University; Beijing Forestry University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Hallberg, B (corresponding author), Umea Univ, Dept Mol Biol, Buil 6L, S-90187 Umea, Norrland, Sweden.	Bengt.Hallberg@molbiol.umu.se			Swedish Cancer Foundation [08-0597]; Lions Cancer Research Foundation, Umea; Swedish Childhood Cancer Foundation [08/084]; Swedish Research Council [621-2003-3399]; Association for International Cancer Research [AICR 08-0177]	Swedish Cancer Foundation; Lions Cancer Research Foundation, Umea; Swedish Childhood Cancer Foundation(European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); Association for International Cancer Research	We thank Caroline Grabbe for comments and critical reading of the paper and Lovisa Olofsson for initial experiments. BH is supported by a Grant (08-0597) from the Swedish Cancer Foundation, Lions Cancer Research Foundation, Umea, and Grant (08/084) from the Swedish Childhood Cancer Foundation. RHP is a Swedish Cancer Foundation Research Fellow and is supported by grants from the Swedish Research Council (621-2003-3399), the Swedish Childhood Cancer Foundation (08/074) and the Association for International Cancer Research (AICR 08-0177).	Altschuler DL, 1998, P NATL ACAD SCI USA, V95, P7475, DOI 10.1073/pnas.95.13.7475; Bailey CL, 2009, CANCER RES, V69, P4962, DOI 10.1158/0008-5472.CAN-08-4269; Bazigou E, 2007, CELL, V128, P961, DOI 10.1016/j.cell.2007.02.024; Bilsland JG, 2008, NEUROPSYCHOPHARMACOL, V33, P685, DOI 10.1038/sj.npp.1301446; Bos JL, 2001, NAT REV MOL CELL BIO, V2, P369, DOI 10.1038/35073073; Caren H, 2008, BIOCHEM J, V416, P153, DOI 10.1042/BJ20081834; Chen YY, 2008, NATURE, V455, P971, DOI 10.1038/nature07399; de Jong R, 1998, ONCOGENE, V17, P2805, DOI 10.1038/sj.onc.1202207; Degoutin J, 2007, FEBS LETT, V581, P727, DOI 10.1016/j.febslet.2007.01.039; Englund C, 2003, NATURE, V425, P512, DOI 10.1038/nature01950; FELLER SM, 1995, ONCOGENE, V10, P1465; Franke B, 1997, EMBO J, V16, P252, DOI 10.1093/emboj/16.2.252; Galkin AV, 2007, P NATL ACAD SCI USA, V104, P270, DOI 10.1073/pnas.0609412103; Gao L, 2006, CANCER RES, V66, P7880, DOI 10.1158/0008-5472.CAN-06-0254; George RE, 2008, NATURE, V455, P975, DOI 10.1038/nature07397; GOTOH Y, 1990, EUR J BIOCHEM, V193, P661, DOI 10.1111/j.1432-1033.1990.tb19384.x; Gouzi JY, 2005, J CELL SCI, V118, P5811, DOI 10.1242/jcs.02695; GREENE LA, 1995, CURR OPIN NEUROBIOL, V5, P579, DOI 10.1016/0959-4388(95)80062-X; Guerrero C, 2004, ONCOGENE, V23, P4885, DOI 10.1038/sj.onc.1207622; Gyan E, 2005, LEUKEMIA, V19, P1678, DOI 10.1038/sj.leu.2403882; Hallberg B, 1998, ONCOGENE, V17, P691, DOI 10.1038/sj.onc.1201980; Hemmeryckx B, 2001, CANCER RES, V61, P1398; Henriksson ML, 2002, BIOCHEM J, V367, P617, DOI 10.1042/BJ20020714; Hisata S, 2007, J CELL BIOL, V178, P843, DOI 10.1083/jcb.200610073; Hong K, 2008, J BIOL CHEM, V283, P23129, DOI 10.1074/jbc.M800478200; Ichiba T, 1999, J BIOL CHEM, V274, P14376, DOI 10.1074/jbc.274.20.14376; Ishida D, 2003, CANCER CELL, V4, P55, DOI 10.1016/S1535-6108(03)00163-6; Ishihara T, 2002, CELL, V109, P639, DOI 10.1016/S0092-8674(02)00748-1; Iwahara T, 1997, ONCOGENE, V14, P439, DOI 10.1038/sj.onc.1200849; Janoueix-Lerosey I, 2008, NATURE, V455, P967, DOI 10.1038/nature07398; Kao SC, 2001, J BIOL CHEM, V276, P18169, DOI 10.1074/jbc.M008870200; Lamant L, 2000, AM J PATHOL, V156, P1711, DOI 10.1016/S0002-9440(10)65042-0; Lee HH, 2003, NATURE, V425, P507, DOI 10.1038/nature01916; Liao EH, 2004, NATURE, V430, P345, DOI 10.1038/nature02647; Lin YL, 2000, FEBS LETT, V467, P184, DOI 10.1016/S0014-5793(00)01150-9; Lopes SS, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000026; Loren CE, 2003, EMBO REP, V4, P781, DOI 10.1038/sj.embor.embor897; Loren CE, 2001, GENES CELLS, V6, P531, DOI 10.1046/j.1365-2443.2001.00440.x; Lou LG, 2002, J BIOL CHEM, V277, P32799, DOI 10.1074/jbc.M201491200; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Matsuse M, 2009, ENDOCR J, V56, P161, DOI 10.1507/endocrj.K08E-244; McDermott U, 2008, CANCER RES, V68, P3389, DOI 10.1158/0008-5472.CAN-07-6186; Minato N, 2009, CANCER SCI, V100, P17, DOI 10.1111/j.1349-7006.2008.01011.x; Miyake I, 2002, ONCOGENE, V21, P5823, DOI 10.1038/sj.onc.1205735; Moog-Lutz C, 2005, J BIOL CHEM, V280, P26039, DOI 10.1074/jbc.M501972200; MORRIS SW, 1994, SCIENCE, V263, P1281, DOI 10.1126/science.8122112; Morris SW, 1997, ONCOGENE, V14, P2175, DOI 10.1038/sj.onc.1201062; Mosse YP, 2008, NATURE, V455, P930, DOI 10.1038/nature07261; Motegi A, 2004, J CELL SCI, V117, P3319, DOI 10.1242/jcs.01183; Muramatsu T, 2002, J BIOCHEM, V132, P359, DOI 10.1093/oxfordjournals.jbchem.a003231; Osajima-Hakomori Y, 2005, AM J PATHOL, V167, P213, DOI 10.1016/S0002-9440(10)62966-5; Palmer RH, 2009, BIOCHEM J, V420, P345, DOI 10.1042/BJ20090387; Piccinini G, 2002, J BIOL CHEM, V277, P22231, DOI 10.1074/jbc.M111145200; QIU MS, 1991, NEURON, V7, P937, DOI 10.1016/0896-6273(91)90339-2; Raaijmakers JH, 2009, J BIOL CHEM, V284, P10995, DOI 10.1074/jbc.R800061200; Radha V, 2008, J NEUROCHEM, V107, P1424, DOI 10.1111/j.1471-4159.2008.05710.x; Reiner DJ, 2008, CURR BIOL, V18, P1101, DOI 10.1016/j.cub.2008.06.060; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Ribeiro-Neto F, 2002, P NATL ACAD SCI USA, V99, P5418, DOI 10.1073/pnas.082122499; Schmitt JM, 2002, MOL CELL, V9, P85, DOI 10.1016/S1097-2765(01)00432-4; Schmitt JM, 2001, MOL CELL BIOL, V21, P3671, DOI 10.1128/MCB.21.11.3671-3683.2001; Schwamborn JC, 2004, NAT NEUROSCI, V7, P923, DOI 10.1038/nn1295; SHIOTA M, 1994, ONCOGENE, V9, P1567; SHIOTA M, 1995, BLOOD, V86, P1954, DOI 10.1182/blood.V86.5.1954.bloodjournal8651954; Shirinian M, 2007, DIFFERENTIATION, V75, P418, DOI 10.1111/j.1432-0436.2006.00148.x; Souttou B, 2001, J BIOL CHEM, V276, P9526, DOI 10.1074/jbc.M007333200; Stoica GE, 2002, J BIOL CHEM, V277, P35990, DOI 10.1074/jbc.M205749200; Stoica GE, 2001, J BIOL CHEM, V276, P16772, DOI 10.1074/jbc.M010660200; Stork PJS, 2003, TRENDS BIOCHEM SCI, V28, P267, DOI 10.1016/S0968-0004(03)00087-2; Stute C, 2004, DEVELOPMENT, V131, P743, DOI 10.1242/dev.00972; TRAVERSE S, 1992, BIOCHEM J, V288, P351, DOI 10.1042/bj2880351; Tsygankova OA, 2007, MOL CELL BIOL, V27, P6647, DOI 10.1128/MCB.00155-07; Varshney GK, 2006, BIOCHEM BIOPH RES CO, V351, P839, DOI 10.1016/j.bbrc.2006.10.117; Vernersson E, 2006, GENE EXPR PATTERNS, V6, P448, DOI 10.1016/j.modgep.2005.11.006; Voss AK, 2003, DEVELOPMENT, V130, P355, DOI 10.1242/dev.00217; Voss AK, 2008, DEVELOPMENT, V135, P2139, DOI 10.1242/dev.016725; Voss AK, 2006, EMBO J, V25, P3652, DOI 10.1038/sj.emboj.7601234; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; WIENECKE R, 1995, J BIOL CHEM, V270, P16409, DOI 10.1074/jbc.270.27.16409; Wu CB, 2001, J NEUROSCI, V21, P5406, DOI 10.1523/JNEUROSCI.21-15-05406.2001; Yajnik V, 2003, CELL, V112, P673, DOI 10.1016/S0092-8674(03)00155-7; Yang HL, 2007, J EXP ZOOL PART B, V308B, P269, DOI 10.1002/jez.b.21146; York RD, 1998, NATURE, V392, P622, DOI 10.1038/33451; Zemojtel T, 2006, LEUKEMIA, V20, P145, DOI 10.1038/sj.leu.2404040; Zwartkruis FJT, 1998, EMBO J, V17, P5905, DOI 10.1093/emboj/17.20.5905	86	35	37	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAY	2010	29	19					2817	2830		10.1038/onc.2010.27	http://dx.doi.org/10.1038/onc.2010.27			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	595DW	20190816				2022-12-25	WOS:000277591900007
J	Koon, JC; Kubiseski, TJ				Koon, Janet C.; Kubiseski, Terrance J.			Developmental Arrest of Caenorhabditis elegans BRAP-2 Mutant Exposed to Oxidative Stress Is Dependent on BRC-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE; KINASE INHIBITOR; GROWTH ARREST; DNA-REPAIR; C-ELEGANS; PROTEIN; BRCA1; PATHWAY; IDENTIFICATION; NEMATODE	Oxidative damage by reactive oxygen species is believed to be a contributor to the development of cancer and the physiological deterioration associated with aging. In this report, we describe the effect of reactive oxygen species exposure to a developing Caenorhabditis elegans organism containing a deletion in the homolog of BRCA1-associated protein 2 (BRAP-2). A mutant containing a deletion of brap-2 was highly sensitive to oxidizing conditions and demonstrated early larval arrest and lethality at low concentrations of the oxidative stress-inducing drug paraquat compared with the wild-type. This developmental arrest occurred early in the L1 stage and was dependent specifically on the function of the C. elegans ortholog of BRCA-1 tumor suppressor brc-1. We also show that developmental arrest in brap-2 mutants when exposed to oxidative stress was due to enhanced expression levels of the cell cycle inhibitor cki-1, and this increase in the expression levels of cki-1 requires brc-1 in brap-2 mutant animals. Our findings demonstrate that BRAP-2 is necessary for preventing an inappropriate response to elevated levels of reactive oxygen species by countering premature activation of BRC-1 and CKI-1.	[Koon, Janet C.; Kubiseski, Terrance J.] York Univ, Dept Biol, Toronto, ON M3J 1P3, Canada; [Kubiseski, Terrance J.] York Univ, Dept Neurosci, Toronto, ON M3J 1P3, Canada	York University - Canada; York University - Canada	Kubiseski, TJ (corresponding author), York Univ, Dept Biol, 4700 Keele St, Toronto, ON M3J 1P3, Canada.	tkubises@yorku.ca		Kubiseski, Terrance/0000-0001-9388-8608	Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by a grant from the Natural Sciences and Engineering Research Council of Canada.	Adamo A, 2008, EMBO REP, V9, P287, DOI 10.1038/sj.embor.7401167; Aprelikova ON, 1999, P NATL ACAD SCI USA, V96, P11866, DOI 10.1073/pnas.96.21.11866; Asada M, 2004, MOL CELL BIOL, V24, P8236, DOI 10.1128/MCB.24.18.8236-8243.2004; Baugh LR, 2006, CURR BIOL, V16, P780, DOI 10.1016/j.cub.2006.03.021; Boulton SJ, 2004, CURR BIOL, V14, P33, DOI 10.1016/j.cub.2003.11.029; BRENNER S, 1974, GENETICS, V77, P71; Burhans WC, 2009, FREE RADICAL BIO MED, V47, P1282, DOI 10.1016/j.freeradbiomed.2009.05.026; Chen JS, 2009, BIOTECHNOL LETT, V31, P615, DOI 10.1007/s10529-009-9914-7; Deng CX, 2006, NUCLEIC ACIDS RES, V34, P1416, DOI 10.1093/nar/gkl010; Fukuyama M, 2003, DEV BIOL, V260, P273, DOI 10.1016/S0012-1606(03)00239-2; Henderson ST, 2006, J GERONTOL A-BIOL, V61, P444, DOI 10.1093/gerona/61.5.444; Hong Y, 1998, DEVELOPMENT, V125, P3585; Jaya P, 2001, BBA-MOL CELL RES, V1499, P171, DOI 10.1016/S0167-4889(00)00132-4; Kniazeva M, 2008, GENE DEV, V22, P2102, DOI 10.1101/gad.1692008; Li S, 1998, J BIOL CHEM, V273, P6183, DOI 10.1074/jbc.273.11.6183; MacLachlan TK, 2002, MOL CELL BIOL, V22, P4280, DOI 10.1128/MCB.22.12.4280-4292.2002; Martindale JL, 2002, J CELL PHYSIOL, V192, P1, DOI 10.1002/jcp.10119; Matheny SA, 2004, NATURE, V427, P256, DOI 10.1038/nature02237; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; Moore R, 2004, GENESIS, V38, P1, DOI 10.1002/gene.10243; Polanowska J, 2006, EMBO J, V25, P2178, DOI 10.1038/sj.emboj.7601102; Somasundaram K, 1997, NATURE, V389, P187, DOI 10.1038/38291; Steele RJC, 1998, BRIT J SURG, V85, P1460; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; Tawe WN, 1998, NUCLEIC ACIDS RES, V26, P1621, DOI 10.1093/nar/26.7.1621; Thompson D, 2002, JNCI-J NATL CANCER I, V94, P1358, DOI 10.1093/jnci/94.18.1358; Weinberg F, 2009, CELL MOL LIFE SCI, V66, P3663, DOI 10.1007/s00018-009-0099-y	27	12	16	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13437	13443		10.1074/jbc.M110.107011	http://dx.doi.org/10.1074/jbc.M110.107011			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20207739	Green Published, hybrid			2022-12-25	WOS:000276987700015
J	Lendrihas, T; Hunter, GA; Ferreira, GC				Lendrihas, Thomas; Hunter, Gregory A.; Ferreira, Gloria C.			Targeting the Active Site Gate to Yield Hyperactive Variants of 5-Aminolevulinate Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOTODYNAMIC THERAPY; AMINOLEVULINIC-ACID; ESCHERICHIA-COLI; ENZYME; MECHANISM; BINDING; PHOTOSENSITIZER; BIOSYNTHESIS; PERSPECTIVE; LOOP	The rate of porphyrin biosynthesis in mammals is controlled by the activity of the pyridoxal 5'-phosphate-dependent enzyme 5-aminolevulinate synthase (EC 2.3.1.37). Based on the postulate that turnover in this enzyme is controlled by conformational dynamics associated with a highly conserved active site loop, we constructed a variant library by targeting imperfectly conserved noncatalytic loop residues and examined the effects on product and porphyrin production. Functional loop variants of the enzyme were isolated via genetic complementation in Escherichia coli strain HU227. Colony porphyrin fluorescence varied widely when bacterial cells harboring the loop variants were grown on inductive media; this facilitated identification of clones encoding unusually active enzyme variants. Nine loop variants leading to high in vivo porphyrin production were purified and characterized kinetically. Steady state catalytic efficiencies for the two substrates were increased by up to 100-fold. Presteady state single turnover reaction data indicated that the second step of quinonoid intermediate decay, previously assigned as reaction rate-limiting, was specifically accelerated such that in three of the variants this step was no longer kinetically significant. Overall, our data support the postulate that the active site loop controls the rate of product and porphyrin production in vivo and suggest the possibility of an as yet undiscovered means of allosteric regulation.	[Lendrihas, Thomas; Hunter, Gregory A.; Ferreira, Gloria C.] Univ S Florida, Coll Med, Dept Mol Med, Tampa, FL 33612 USA; [Ferreira, Gloria C.] Univ S Florida, Dept Chem, Tampa, FL 33612 USA; [Ferreira, Gloria C.] Univ S Florida, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Ferreira, GC (corresponding author), Univ S Florida, Coll Med, Dept Mol Med, MDC 7, Tampa, FL 33612 USA.	gferreir@health.usf.edu	Ferreira, Gloria C/A-4709-2012	Ferreira, Gloria C/0000-0001-9279-2217	National Institutes of Health [DK63191, GM080270]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063191] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080270] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK63191 and GM080270 (to G. C. F.).	Astner I, 2005, EMBO J, V24, P3166, DOI 10.1038/sj.emboj.7600792; BARSHOP BA, 1983, ANAL BIOCHEM, V130, P134, DOI 10.1016/0003-2697(83)90660-7; Benkovic SJ, 2003, SCIENCE, V301, P1196, DOI 10.1126/science.1085515; Benkovic SJ, 2008, BIOCHEMISTRY-US, V47, P3317, DOI 10.1021/bi800049z; Boehr DD, 2006, CHEM REV, V106, P3055, DOI 10.1021/cr050312q; Dolmans DEJGJ, 2003, NAT REV CANCER, V3, P380, DOI 10.1038/nrc1071; Eisenmesser EZ, 2005, NATURE, V438, P117, DOI 10.1038/nature04105; Eliot AC, 2004, ANNU REV BIOCHEM, V73, P383, DOI 10.1146/annurev.biochem.73.011303.074021; FERREIRA GC, 1993, J BIOL CHEM, V268, P584; Fukuda H, 2005, INT J BIOCHEM CELL B, V37, P272, DOI 10.1016/j.biocel.2004.04.018; Gagnebin J, 1999, GENE THER, V6, P1742, DOI 10.1038/sj.gt.3300992; GONG J, 1995, BIOCHEMISTRY-US, V34, P1678, DOI 10.1021/bi00005a024; Hanson JA, 2007, P NATL ACAD SCI USA, V104, P18055, DOI 10.1073/pnas.0708600104; HUA ZX, 1995, CANCER RES, V55, P1723; Hunter GA, 2005, ARCH BIOCHEM BIOPHYS, V437, P128, DOI 10.1016/j.abb.2005.03.007; HUNTER GA, 1995, ANAL BIOCHEM, V226, P221, DOI 10.1006/abio.1995.1217; Hunter GA, 1999, J BIOL CHEM, V274, P12222, DOI 10.1074/jbc.274.18.12222; Hunter GA, 2007, J BIOL CHEM, V282, P23025, DOI 10.1074/jbc.M609330200; JORDAN PM, 1991, BIOSYNTHESIS TETRAPY; Kelty CJ, 2002, PHOTOCH PHOTOBIO SCI, V1, P158, DOI 10.1039/b201027p; Lendrihas T, 2009, PROTEIN SCI, V18, P1847, DOI 10.1002/pro.195; Li JC, 2003, BBA-GENE STRUCT EXPR, V1626, P102, DOI 10.1016/S0167-4781(03)00041-1; NANDI DL, 1978, J BIOL CHEM, V253, P8872; Ness JE, 2002, NAT BIOTECHNOL, V20, P1251, DOI 10.1038/nbt754; Ostermeier M, 2003, TRENDS BIOTECHNOL, V21, P244, DOI 10.1016/S0167-7799(03)00089-1; Raber ML, 2009, J BIOL CHEM, V284, P207, DOI 10.1074/jbc.M805390200; Rozovsky S, 2001, J MOL BIOL, V310, P259, DOI 10.1006/jmbi.2001.4672; Sasaki K, 2002, APPL MICROBIOL BIOT, V58, P23, DOI 10.1007/s00253-001-0858-7; Tan DW, 1996, BIOCHEMISTRY-US, V35, P8934, DOI 10.1021/bi952918m; Tan DW, 1998, BIOCHEMISTRY-US, V37, P1478, DOI 10.1021/bi971928f; Wang LJ, 2004, PHYSIOL PLANTARUM, V121, P258, DOI 10.1111/j.0031-9317.2004.00319.x; Webster SP, 2000, BIOCHEMISTRY-US, V39, P516, DOI 10.1021/bi991620j; Whatley SD, 2008, AM J HUM GENET, V83, P408, DOI 10.1016/j.ajhg.2008.08.003; Zha DX, 2003, CHEMBIOCHEM, V4, P34, DOI 10.1002/cbic.200390011; Ziolkowski Piotr, 2004, J Exp Ther Oncol, V4, P121	35	25	25	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13704	13711		10.1074/jbc.M109.074237	http://dx.doi.org/10.1074/jbc.M109.074237			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20194506	Green Published, hybrid			2022-12-25	WOS:000276987700045
J	Tsika, RW; Ma, LX; Kehat, I; Schramm, C; Simmer, G; Morgan, B; Fine, DM; Hanft, LM; McDonald, KS; Molkentin, JD; Krenz, M; Yang, S; Ji, J				Tsika, Richard W.; Ma, Lixin; Kehat, Izhak; Schramm, Christine; Simmer, Gretchen; Morgan, Brandon; Fine, Deborah M.; Hanft, Laurin M.; McDonald, Kerry S.; Molkentin, Jeffery D.; Krenz, Maike; Yang, Steve; Ji, Juan			TEAD-1 Overexpression in the Mouse Heart Promotes an Age-dependent Heart Dysfunction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYOSIN HEAVY-CHAIN; CREATINE-KINASE ENHANCER; GLYCOGEN-SYNTHASE KINASE-3-BETA; QUANTITATIVE PROTEOMIC IDENTIFICATION; TRANSCRIPTION FACTOR RTEF-1; INDUCED CARDIAC-HYPERTROPHY; RETICULUM CALCIUM-ATPASE; GENE-EXPRESSION; CARDIOMYOCYTE HYPERTROPHY; TRANSGENIC MICE	TEA domain transcription factor-1 (TEAD-1) is essential for proper heart development and is implicated in cardiac specific gene expression and the hypertrophic response of primary cardiomyocytes to hormonal and mechanical stimuli, and its activity increases in the pressure-overloaded hypertrophied rat heart. To investigate whether TEAD-1 is an in vivo modulator of cardiac specific gene expression and hypertrophy, we developed transgenic mice expressing hemagglutinin-tagged TEAD-1 under the control of the muscle creatine kinase promoter. We show that a sustained increase in TEAD-1 protein leads to an age-dependent dysfunction. Magnetic resonance imaging revealed decreases in cardiac output, stroke volume, ejection fraction, and fractional shortening. Isolated TEAD-1 hearts revealed decreased left ventricular power output that correlated with increased beta MyHC protein. Histological analysis showed altered alignment of cardiomyocytes, septal wall thickening, and fibrosis, although electrocardiography displayed a left axis shift of mean electrical axis. Transcripts representing most members of the fetal heart gene program remained elevated from fetal to adult life. Western blot analyses revealed decreases in p-phospholamban, SERCA2a, p-CX43, p-GSK-3 alpha/beta, nuclear beta-catenin, GATA4, NFATc3/c4, and increased NCX1, nuclear DYKR1A, and Pur alpha/beta protein. TEAD-1 mice did not display cardiac hypertrophy. TEAD-1 mice do not tolerate stress as they die over a 4-day period after surgical induction of pressure overload. These data provide the first in vivo evidence that increased TEAD-1 can induce characteristics of cardiac remodeling associated with cardiomyopathy and heart failure.	[Tsika, Richard W.] Univ Missouri, Dept Biochem, Columbia Bond Life Sci Ctr 440D, Sch Med, Columbia, MO 65211 USA; [Tsika, Richard W.; Schramm, Christine; Simmer, Gretchen; Yang, Steve; Ji, Juan] Univ Missouri, Coll Vet Med, Dept Biomed Sci, Columbia, MO 65211 USA; [Ma, Lixin; Morgan, Brandon] Harry S Truman Mem Vet Affairs Hosp, Dept Radiol, Columbia, MO 65211 USA; [Ma, Lixin; Morgan, Brandon] Harry S Truman Mem Vet Affairs Hosp, Nucl Sci & Engn Inst, Columbia, MO 65211 USA; [Ma, Lixin; Morgan, Brandon] Harry S Truman Mem Vet Affairs Hosp, Res Serv, Columbia, MO 65211 USA; [Kehat, Izhak; Molkentin, Jeffery D.] Cincinnati Childrens Med Ctr, Div Mol Cardiovasc Biol, Cincinnati, OH 45267 USA; [Fine, Deborah M.] Univ Missouri, Dept Cardiol, Coll Vet Med, Columbia, MO 65211 USA; [Hanft, Laurin M.; McDonald, Kerry S.; Krenz, Maike] Univ Missouri, Dept Med Pharmacol & Physiol, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harry S. Truman Memorial Veterans' Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harry S. Truman Memorial Veterans' Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harry S. Truman Memorial Veterans' Hospital; Cincinnati Children's Hospital Medical Center; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Tsika, RW (corresponding author), Univ Missouri, Dept Biochem, Columbia Bond Life Sci Ctr 440D, Sch Med, Columbia, MO 65211 USA.	tsikar@missouri.edu		Ma, Lixin/0000-0003-2171-1226; Krenz, Maike/0000-0003-3784-287X; kehat, izhak/0000-0002-4388-1579; Molkentin, Jeffery/0000-0002-3558-6529; McDonald, Kerry/0000-0002-1588-1782	USPHS, NIAMS [AR41464, AR47197]; National Institutes of Health Clinical Biodetectives Graduate Program [T90DK071510]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR041464, R01AR047197] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R90DK071510] Funding Source: NIH RePORTER	USPHS, NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)United States Public Health Service); National Institutes of Health Clinical Biodetectives Graduate Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants AR41464 and AR47197 (to R. W. T.) from USPHS, NIAMS.; Supported in part by National Institutes of Health Clinical Biodetectives Graduate Program Trainee Grant T90DK071510. Present address: Physics Services Inc., Buffalo, NY 14203.	Akazawa H, 2003, CIRC RES, V92, P1079, DOI 10.1161/01.RES.0000072977.86706.23; AMACHER SL, 1993, MOL CELL BIOL, V13, P2753, DOI 10.1128/MCB.13.5.2753; Antos CL, 2002, P NATL ACAD SCI USA, V99, P907, DOI 10.1073/pnas.231619298; Barry SP, 2008, INT J BIOCHEM CELL B, V40, P2023, DOI 10.1016/j.biocel.2008.02.020; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Cernohorsky J, 1998, AM J PHYSIOL-HEART C, V275, pH264, DOI 10.1152/ajpheart.1998.275.1.H264; Chen HH, 2004, CIRCULATION, V110, P2980, DOI 10.1161/01.CIR.0000146902.84099.26; CHEN Z, 1994, GENE DEV, V8, P2293, DOI 10.1101/gad.8.19.2293; Clerk A, 2007, J CELL PHYSIOL, V212, P311, DOI 10.1002/jcp.21094; del Monte F, 2002, CIRCULATION, V105, P904, DOI 10.1161/hc0802.105564; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Donoviel DB, 1996, MOL CELL BIOL, V16, P1649; Dorn GW, 2007, HYPERTENSION, V49, P962, DOI 10.1161/HYPERTENSIONAHA.106.079426; Dorn GW, 2003, CIRC RES, V92, P1171, DOI 10.1161/01.RES.0000077012.11088.BC; Eastman Q, 1999, CURR OPIN CELL BIOL, V11, P233, DOI 10.1016/S0955-0674(99)80031-3; FabreSuver C, 1996, J BIOL CHEM, V271, P4646, DOI 10.1074/jbc.271.9.4646; Fine DM, 2006, VET MED-US, V101, P28; Forde JE, 2007, CELL MOL LIFE SCI, V64, P1930, DOI 10.1007/s00018-007-7045-7; Giordano FJ, 1997, CIRCULATION, V96, P400; Gurtl B, 2009, INT J EXP PATHOL, V90, P338, DOI 10.1111/j.1365-2613.2009.00647.x; Gupta M, 2003, J BIOL CHEM, V278, P44935, DOI 10.1074/jbc.M307696200; Gupta M, 2001, J BIOL CHEM, V276, P10413, DOI 10.1074/jbc.M008625200; Hajjar RJ, 2002, NEW ENGL J MED, V347, P1196, DOI 10.1056/NEJMe020105; Haq S, 2000, J CELL BIOL, V151, P117, DOI 10.1083/jcb.151.1.117; Hasegawa K, 1997, CIRCULATION, V96, P3943; He HP, 1997, J CLIN INVEST, V100, P380, DOI 10.1172/JCI119544; Heiberg E, 2005, COMPUT CARDIOL, V32, P599; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Herron TJ, 2002, CIRC RES, V90, P1150, DOI 10.1161/01.RES.0000022879.57270.11; Herron TJ, 2001, AM J PHYSIOL-HEART C, V281, pH1217, DOI 10.1152/ajpheart.2001.281.3.H1217; Herron TJ, 2007, CIRC RES, V100, P1182, DOI 10.1161/01.RES.0000264102.00706.4e; Himeda CL, 2008, MOL CELL BIOL, V28, P6521, DOI 10.1128/MCB.00306-08; Himeda CL, 2004, MOL CELL BIOL, V24, P2132, DOI 10.1128/MCB.24.5.2132-2143.2004; Hirotani S, 2007, CIRC RES, V101, P1164, DOI 10.1161/CIRCRESAHA.107.160614; Hubbell E, 2002, BIOINFORMATICS, V18, P1585, DOI 10.1093/bioinformatics/18.12.1585; Irizarry RA, 2006, BIOINFORMATICS, V22, P789, DOI 10.1093/bioinformatics/btk046; Jacquemin P, 1997, TRENDS CARDIOVAS MED, V7, P192, DOI 10.1016/S1050-1738(97)00052-2; Ji Y, 2000, J BIOL CHEM, V275, P38073, DOI 10.1074/jbc.M004804200; JOHNSON JE, 1989, MOL CELL BIOL, V9, P3393, DOI 10.1128/MCB.9.8.3393; Kaneko KJ, 2007, GENESIS, V45, P577, DOI 10.1002/dvg.20330; Karasseva N, 2003, MOL CELL BIOL, V23, P5143, DOI 10.1128/MCB.23.15.5143-5164.2003; KARIYA K, 1993, J BIOL CHEM, V268, P26658; KARIYA K, 1994, J BIOL CHEM, V269, P3775; KARNS LR, 1995, J BIOL CHEM, V270, P410, DOI 10.1074/jbc.270.1.410; Kawase Y, 2008, NAT CLIN PRACT CARD, V5, P554, DOI 10.1038/ncpcardio1301; Kerkela R, 2007, TRENDS CARDIOVAS MED, V17, P91, DOI 10.1016/j.tcm.2007.01.004; KOMURO I, 1990, J BIOL CHEM, V265, P3595; KOMURO I, 1993, ANNU REV PHYSIOL, V55, P55, DOI 10.1146/annurev.ph.55.030193.000415; Korte FS, 2005, AM J PHYSIOL-HEART C, V289, pH801, DOI 10.1152/ajpheart.01227.2004; Koss KL, 1996, CIRC RES, V79, P1059, DOI 10.1161/01.RES.79.6.1059; Krenz M, 2003, J BIOL CHEM, V278, P17466, DOI 10.1074/jbc.M210804200; Kuhn C, 2009, J BIOL CHEM, V284, P17320, DOI 10.1074/jbc.M109.006759; LARKIN SB, 1999, HEART DEV, P307; Liang QR, 2001, J BIOL CHEM, V276, P30245, DOI 10.1074/jbc.M102174200; Liao WQ, 2005, FEBS J, V272, P1845, DOI 10.1111/j.1742-4658.2005.04614.x; Liu WM, 2002, BIOINFORMATICS, V18, P1593, DOI 10.1093/bioinformatics/18.12.1593; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; Luk A, 2009, J CLIN PATHOL, V62, P219, DOI 10.1136/jcp.2008.060731; LUO WS, 1994, CIRC RES, V75, P401, DOI 10.1161/01.RES.75.3.401; LYONS GE, 1994, TRENDS CARDIOVAS MED, V4, P70, DOI 10.1016/1050-1738(94)90012-4; Maeda T, 2002, J BIOL CHEM, V277, P24346, DOI 10.1074/jbc.M201171200; Maeda T, 2002, BIOCHEM BIOPH RES CO, V294, P791, DOI 10.1016/S0006-291X(02)00556-9; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; McLean BG, 2003, J MOL CELL CARDIOL, V35, P461, DOI 10.1016/S0022-2828(03)00049-X; Michael A, 2004, J BIOL CHEM, V279, P21383, DOI 10.1074/jbc.M401413200; Minamisawa S, 1999, CELL, V99, P313, DOI 10.1016/S0092-8674(00)81662-1; MOLKENTIN JD, 1994, MOL CELL BIOL, V14, P5056, DOI 10.1128/MCB.14.8.5056; Morisco C, 2001, J BIOL CHEM, V276, P28586, DOI 10.1074/jbc.M103166200; Neely J R, 1975, Methods Enzymol, V39, P43; Nguyen QGV, 2003, J BIOL CHEM, V278, P46494, DOI 10.1074/jbc.M308194200; Nguyen QGV, 2003, TRANSGENIC RES, V12, P337, DOI 10.1023/A:1023369225799; Nishioka N, 2008, MECH DEVELOP, V125, P270, DOI 10.1016/j.mod.2007.11.002; Oka T, 2007, SEMIN CELL DEV BIOL, V18, P117, DOI 10.1016/j.semcdb.2006.11.012; Opie LH, 2006, LANCET, V367, P356, DOI 10.1016/S0140-6736(06)68074-4; Periasamy M, 1999, J BIOL CHEM, V274, P2556, DOI 10.1074/jbc.274.4.2556; Periasamy M, 2001, J MOL CELL CARDIOL, V33, P1053, DOI 10.1006/jmcc.2001.1366; Philips AS, 2007, J BIOL CHEM, V282, P24915, DOI 10.1074/jbc.M701789200; Rajamannan NM, 2006, DRUG DISCOV TODAY, V3, P291; Reed TD, 2000, J MOL CELL CARDIOL, V32, P453, DOI 10.1006/jmcc.1999.1095; ROVETTO MJ, 1980, P SOC EXP BIOL MED, V164, P13; SADOSHIMA J, 1992, J BIOL CHEM, V267, P10551; Sanbe A, 2003, CIRC RES, V92, P609, DOI 10.1161/01.RES.0000065442.64694.9F; Sawada A, 2008, MOL CELL BIOL, V28, P3177, DOI 10.1128/MCB.01759-07; Simmerman HKB, 1998, PHYSIOL REV, V78, P921, DOI 10.1152/physrev.1998.78.4.921; Solan JL, 2009, BIOCHEM J, V419, P261, DOI 10.1042/BJ20082319; Soor GS, 2009, J CLIN PATHOL, V62, P226, DOI 10.1136/jcp.2008.061655; Stewart AFR, 1998, CIRC RES, V83, P43, DOI 10.1161/01.RES.83.1.43; STUDER R, 1994, CIRC RES, V75, P443, DOI 10.1161/01.RES.75.3.443; Sugden PH, 2008, BRIT J PHARMACOL, V153, pS137, DOI 10.1038/sj.bjp.0707659; Swynghedauw B, 2006, J EXP BIOL, V209, P2320, DOI 10.1242/jeb.02084; TALMADGE RJ, 1993, J APPL PHYSIOL, V75, P2337, DOI 10.1152/jappl.1993.75.5.2337; Thuerauf DJ, 1997, J BIOL CHEM, V272, P7464, DOI 10.1074/jbc.272.11.7464; Tsika RW, 2008, J BIOL CHEM, V283, P36154, DOI 10.1074/jbc.M807461200; Ueyama T, 2000, J BIOL CHEM, V275, P17476, DOI 10.1074/jbc.M001970200; VETTER R, 1995, J MOL CELL CARDIOL, V27, P1689, DOI 10.1016/S0022-2828(95)90788-2; Wilkins BJ, 2004, BIOCHEM BIOPH RES CO, V322, P1178, DOI 10.1016/j.bbrc.2004.07.121; Yagi R, 2007, DEVELOPMENT, V134, P3827, DOI 10.1242/dev.010223; Yoshida T, 2008, ARTERIOSCL THROM VAS, V28, P8, DOI 10.1161/ATVBAHA.107.155788; Zhai PY, 2007, J BIOL CHEM, V282, P33181, DOI 10.1074/jbc.M705133200	99	37	39	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13721	13735		10.1074/jbc.M109.063057	http://dx.doi.org/10.1074/jbc.M109.063057			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20194497	Green Published, hybrid			2022-12-25	WOS:000276987700047
J	Yang, ZY; Funabashi, M; Nonaka, K; Hosobuchi, M; Shibata, T; Pahari, P; Van Lanen, SG				Yang, Zhaoyong; Funabashi, Masanori; Nonaka, Koichi; Hosobuchi, Masahiko; Shibata, Tomoyuki; Pahari, Pallab; Van Lanen, Steven G.			Functional and Kinetic Analysis of the Phosphotransferase CapP Conferring Selective Self-resistance to Capuramycin Antibiotics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL TRANSLOCASE-I; BIOSYNTHETIC GENE-CLUSTER; PENTAPEPTIDE TRANSLOCASE; ESCHERICHIA-COLI; AMINOGLYCOSIDIC ANTIBIOTICS; PEPTIDOGLYCAN SYNTHESIS; STREPTOMYCES-CAPREOLUS; INHIBITORS; A-500359S; TUBERCULOSIS	Capuramycin-related compounds, including A-500359s and A-503083s, are nucleoside antibiotics that inhibit the enzyme bacterial translocase I involved in peptidoglycan cell wall biosynthesis. Within the biosynthetic gene cluster for the A-500359s exists a gene encoding a putative aminoglycoside 3-phosphotransferase that was previously demonstrated to be highly expressed during the production of A-500359s and confers selective resistance to capuramycins when expressed in heterologous hosts. A similar gene (capP) was identified within the biosynthetic gene cluster for the A-503083s, and CapP is now shown to similarly confer selective resistance to capuramycins. Recombinant CapP was produced and purified from Escherichia coli, and the function of CapP is established as an ATP-dependent capuramycin phosphotransferase that regio-specifically transfers the gamma-phosphate to the 3 ''-hydroxyl of the unsaturated hexuronic acid moiety of A-503083 B. Kinetic analysis with the three major A-503083 congeners suggests that CapP preferentially phosphorylates A-503083s containing an aminocaprolactam moiety attached to the hexuronic acid, and bi-substrate kinetic analysis was consistent with CapP employing a sequential kinetic mechanism similar to most known aminoglycoside 3-phosphotransferases. The purified CapP product lost its antibiotic activity against Mycobacterium smegmatis, and this loss in bioactivity is primarily due to a 272-fold increase in the IC50 in the bacterial translocase I-catalyzed reaction. The results establish CapP-mediated phosphorylation as a mechanism of resistance to capuramycins and now set the stage to explore this strategy of resistance as a potential mechanism inherent to pathogens and provide the impetus for preparing second generation analogues as a preemptive strike to such resistance strategies.	[Funabashi, Masanori; Nonaka, Koichi; Hosobuchi, Masahiko] Daiichi Sankyo Co Ltd, Bioengn Res Grp 1, Proc Technol Res Labs, Iwaki, Fukushima 9718183, Japan; [Yang, Zhaoyong; Pahari, Pallab; Van Lanen, Steven G.] Univ Kentucky, Coll Pharm, Dept Pharmaceut Sci, Lexington, KY 40536 USA; [Shibata, Tomoyuki] Daiichi Sankyo Co Ltd, Exploratory Res Labs, Grp 5, Shinagawa Ku, Tokyo 1408710, Japan	Daiichi Sankyo Company Limited; University of Kentucky; Daiichi Sankyo Company Limited	Nonaka, K (corresponding author), Daiichi Sankyo Co Ltd, Bioengn Res Grp 1, Proc Technol Res Labs, 389-4 Aza Ohtsurugi,Izumi Machi, Iwaki, Fukushima 9718183, Japan.	nonaka.koichi.k2@daiichisankyo.co.jp; svanlanen@uky.edu	Pahari, Pallab/AAF-5664-2019; Funabashi, Masanori/GQZ-8735-2022	Pahari, Pallab/0000-0003-3662-2015	Kentucky Science and Education Foundation	Kentucky Science and Education Foundation	This work was supported by the Kentucky Science and Education Foundation (S. G. V. L.).	Barrasa MI, 1997, EUR J BIOCHEM, V245, P54, DOI 10.1111/j.1432-1033.1997.00054.x; BENVENISTE R, 1973, P NATL ACAD SCI USA, V70, P2276, DOI 10.1073/pnas.70.8.2276; Bouhss A, 1999, MOL MICROBIOL, V34, P576, DOI 10.1046/j.1365-2958.1999.01623.x; Bouhss A, 2008, FEMS MICROBIOL REV, V32, P208, DOI 10.1111/j.1574-6976.2007.00089.x; Bugg Timothy D. H., 2006, Infectious Disorders - Drug Targets, V6, P85, DOI 10.2174/187152606784112128; Demain AL, 2009, MED RES REV, V29, P821, DOI 10.1002/med.20154; DISTLER J, 1987, NUCLEIC ACIDS RES, V15, P8041, DOI 10.1093/nar/15.19.8041; DOI O, 1968, APPL MICROBIOL, V16, P1282, DOI 10.1128/AEM.16.9.1282-1284.1968; Fischbach MA, 2009, SCIENCE, V325, P1089, DOI 10.1126/science.1176667; FUNABASHI M, 2010, NAT CHEM BI IN PRESS; Funabashi M, 2009, J ANTIBIOT, V62, P325, DOI 10.1038/ja.2009.38; HEYDANEK MG, 1969, BIOCHEMISTRY-US, V8, P1214, DOI 10.1021/bi00831a056; Huang FL, 2005, ORG BIOMOL CHEM, V3, P1410, DOI 10.1039/b501199j; Johnston JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006914; Kimura K, 2003, NAT PROD REP, V20, P252, DOI 10.1039/b202149h; Koga T, 2004, J ANTIMICROB CHEMOTH, V54, P755, DOI 10.1093/jac/dkh417; Lloyd AJ, 2004, J BACTERIOL, V186, P1747, DOI 10.1128/JB.186.6.1747-1757.2004; Lyutzkanova D, 1997, MICROBIOL-SGM, V143, P2135, DOI 10.1099/00221287-143-7-2135; MCKAY GA, 1994, BIOCHEMISTRY-US, V33, P6936, DOI 10.1021/bi00188a024; MENARD R, 1993, ANTIMICROB AGENTS CH, V37, P78, DOI 10.1128/AAC.37.1.78; Muramatsu Y, 2004, J ANTIBIOT, V57, P639, DOI 10.7164/antibiotics.57.639; Muramatsu Y, 2003, J ANTIBIOT, V56, P243, DOI 10.7164/antibiotics.56.243; Muramatsu Y, 2003, J ANTIBIOT, V56, P259, DOI 10.7164/antibiotics.56.259; Muramatsu Y, 2003, J ANTIBIOT, V56, P253, DOI 10.7164/antibiotics.56.253; NAGANAWA H, 1971, J ANTIBIOT, V24, P823, DOI 10.7164/antibiotics.24.823; Nikonenko BV, 2009, ANTIMICROB AGENTS CH, V53, P3138, DOI 10.1128/AAC.00366-09; PEREZGONZALEZ JA, 1990, GENE, V86, P129, DOI 10.1016/0378-1119(90)90125-B; Reddy VM, 2008, ANTIMICROB AGENTS CH, V52, P719, DOI 10.1128/AAC.01469-07; Saugar I, 2002, EUR J BIOCHEM, V269, P5527, DOI 10.1046/j.1432-1033.2002.03258.x; Segel IH, 1975, ENZYME KINETICS BEHA; SETO H, 1988, TETRAHEDRON LETT, V29, P2343, DOI 10.1016/S0040-4039(00)86055-4; Subba B, 2005, MOL CELLS, V20, P90; TRIEUCUOT P, 1986, J ANTIMICROB CHEMOTH, V18, P93, DOI 10.1093/jac/18.Supplement_C.93; Tsai SF, 1998, ANTIMICROB AGENTS CH, V42, P1229, DOI 10.1128/AAC.42.5.1229; UMEZAWA H, 1967, SCIENCE, V157, P1559; Walsh C, 2005, CHEM REV, V105, P391, DOI 10.1021/cr030100y; *WHO INT UN TUB LU, 2007, 4 WHO INT UN TUB LUN; WRIGHT GD, 1999, FRONT BIOSCI, V4, P9; YAMAGUCHI H, 1986, J ANTIBIOT, V39, P1047, DOI 10.7164/antibiotics.39.1047; Zawadzke LE, 2003, ANAL BIOCHEM, V314, P243, DOI 10.1016/S0003-2697(02)00622-X	40	18	18	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12899	12905		10.1074/jbc.M110.104141	http://dx.doi.org/10.1074/jbc.M110.104141			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20202936	Green Published, hybrid			2022-12-25	WOS:000276787800048
J	Schirmer, P; Lucero, C; Oda, G; Lopez, J; Holodniy, M				Schirmer, Patricia; Lucero, Cynthia; Oda, Gina; Lopez, Jessica; Holodniy, Mark			Effective Detection of the 2009 H1N1 Influenza Pandemic in US Veterans Affairs Medical Centers Using a National Electronic Biosurveillance System	PLOS ONE			English	Article							SYNDROMIC SURVEILLANCE; EPIDEMICS; ILLNESS	Background: The 2008-09 influenza season was the time in which the Department of Veterans Affairs (VA) utilized an electronic biosurveillance system for tracking and monitoring of influenza trends. The system, known as ESSENCE or Electronic Surveillance System for the Early Notification of Community-based Epidemics, was monitored for the influenza season as well as for a rise in influenza cases at the start of the H1N1 2009 influenza pandemic. We also describe trends noted in influenza-like illness (ILI) outpatient encounter data in VA medical centers during the 2008-09 influenza season, before and after the recognition of pandemic H1N1 2009 influenza virus. Methodology/Principal Findings: We determined prevalence of ILI coded visits using VA's ESSENCE for 2008-09 seasonal influenza (Sept. 28, 2008-April 25, 2009 corresponding to CDC 2008-2009 flu season weeks 40-16) and the early period of pandemic H1N1 2009 (April 26, 2009-July 31, 2009 corresponding to CDC 2008-2009 flu season weeks 17-30). Differences in diagnostic ICD-9-CM code frequencies were analyzed using Chi-square and odds ratios. There were 649,574 ILI encounters captured representing 633,893 patients. The prevalence of VA ILI visits mirrored the CDC's Outpatient ILI Surveillance Network (ILINet) data with peaks in late December, early February, and late April/early May, mirroring the ILINet data; however, the peaks seen in the VA were smaller. Of 31 ILI codes, 6 decreased and 11 increased significantly during the early period of pandemic H1N1 2009. The ILI codes that significantly increased were more likely to be symptom codes. Although influenza with respiratory manifestation (487.1) was the most common code used among 150 confirmed pandemic H1N1 2009 cases, overall it significantly decreased since the start of the pandemic. Conclusions/Significance: VA ESSENCE effectively detected and tracked changing ILI trends during pandemic H1N1 2009 and represents an important temporal alerting system for monitoring health events in VA facilities.	[Schirmer, Patricia; Lucero, Cynthia; Oda, Gina; Lopez, Jessica; Holodniy, Mark] Off Publ Hlth Surveillance & Res, Dept Vet Affairs, Palo Alto, CA USA; [Schirmer, Patricia; Holodniy, Mark] Stanford Univ, Sch Med, Div Infect Dis & Geog Med, Stanford, CA 94305 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University	Schirmer, P (corresponding author), Off Publ Hlth Surveillance & Res, Dept Vet Affairs, Palo Alto, CA USA.	pschirme@stanford.edu		Holodniy, Mark/0000-0002-6655-7982	Department of Veterans Affairs	Department of Veterans Affairs(US Department of Veterans Affairs)	Funding has been from the Department of Veterans Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babcock HM, 2006, INFECT CONT HOSP EP, V27, P266, DOI 10.1086/501539; Battegay M, 2020, SWISS MED WKLY, V150, DOI [10.4414/smw.w20203, 10.4414/smw.2020.20203]; Boivin G, 2000, CLIN INFECT DIS, V31, P1166, DOI 10.1086/317425; Brownstein JS, 2009, NEW ENGL J MED, V360, P2153, DOI 10.1056/NEJMp0904012; BUCK C, 2008, CLIN MODIFICATION IC, V2, P3; BUCK C, 2008, CLIN MODIFICATION IC, V1, P3; Buck CB, 2008, CELL HOST MICROBE, V3, P3, DOI 10.1016/j.chom.2007.12.006; Burkom Howard S, 2004, MMWR Suppl, V53, P67; *CDC, 2009, 2008 2009 INFL SEAS; *CDC, CDC FLU ACT SURV; *CDC, CDC AB BIOSENSE; *CDC, 2009, CDC H1N1 REP QUEST A; *CDC, 2009, CDC INT GUID INFL SU; *CDC, CDC INFL CLIN INF PR; Chan M., 2009, WORLD NOW START 2009; Chapman WW, 2004, J BIOMED INFORM, V37, P120, DOI 10.1016/j.jbi.2004.03.002; Clothier HJ, 2005, COMMUN DIS INTELL, V29, P231; Dailey L, 2007, J AM MED INFORM ASSN, V14, P626, DOI 10.1197/jamia.M2328; Eysenbach Gunther, 2006, AMIA Annu Symp Proc, P244; FROEHLING D, 2008, AMIA ANN S P; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Gundlapalli AV, 2007, AM J INFECT CONTROL, V35, P163, DOI 10.1016/j.ajic.2006.08.003; Heffernan R, 2004, EMERG INFECT DIS, V10, P858, DOI 10.3201/eid1005.030646; Heffernan Richard, 2004, MMWR Suppl, V53, P23; Marsden-Haug N, 2007, EMERG INFECT DIS, V13, P207, DOI 10.3201/eid1302.060557; ODA G, 2007, ADV DIS SURVEILL, V4, P260; *OFF ASS DEP SECR, 2009, SEL VHA STAT FY2008; Pattie David C, 2009, Qual Manag Health Care, V18, P91, DOI 10.1097/QMH.0b013e3181a0274d; Polgreen PM, 2008, CLIN INFECT DIS, V47, P1443, DOI 10.1086/593098; Shimoni Z, 2006, MED HYPOTHESES, V67, P709, DOI 10.1016/j.mehy.2006.04.018; Smith G E, 2006, Euro Surveill, V11, P220; Watts G, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a3076; WHO, 2009, WHO PAND H1N1 2009 U, P112; Yih WK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005260	34	14	15	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2010	5	3							e9533	10.1371/journal.pone.0009533	http://dx.doi.org/10.1371/journal.pone.0009533			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	564EW	20209055	gold, Green Published, Green Submitted			2022-12-25	WOS:000275197100015
J	Abhary, S; Burdon, KP; Kuot, A; Javadiyan, S; Whiting, MJ; Kasmeridis, N; Petrovsky, N; Craig, JE				Abhary, Sotoodeh; Burdon, Kathryn P.; Kuot, Abraham; Javadiyan, Shahrbanou; Whiting, Malcolm J.; Kasmeridis, Nicholas; Petrovsky, Nikolai; Craig, Jamie E.			Sequence Variation in DDAH1 and DDAH2 Genes Is Strongly and Additively Associated with Serum ADMA Concentrations in Individuals with Type 2 Diabetes	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; ASYMMETRIC DIMETHYLARGININE ADMA; ENDOTHELIAL-CELLS; INSULIN-RESISTANCE; DIMETHYLAMINOHYDROLASE; DYSFUNCTION; RETINOPATHY; APOPTOSIS; PATHWAY; PLASMA	Background: Asymmetric dimethylarginine (ADMA), present in human serum, is an endogenous inhibitor of nitric oxide synthase and contributes to vascular disease. Dimethylarginine dimethylaminohydrolase (DDAH) is an ADMA degrading enzyme that has two isoforms: DDAHI and DDAHII. We sought to determine whether serum ADMA levels in type 2 diabetes are influenced by common polymorphisms in the DDAH1 and DDAH2 genes. Methodology/Principal Findings: Relevant clinical parameters were measured and peripheral whole blood obtained for serum and genetic analysis on 343 participants with type 2 diabetes. Serum ADMA concentrations were determined by mass spectroscopy. Twenty six tag SNPs in the DDAH1 and 10 in the DDAH2 gene were genotyped in all subjects and tested for association with serum ADMA levels. Several SNPs and haplotypes in the DDAH genes were strongly associated with ADMA levels. Most significantly in the DDAH1 gene, rs669173 (p = 2.96 x 10(-7)), rs7521189 (p = 6.40 x 10(-7)), rs2474123 (p = 0.00082) and rs13373844 (p = 0.00027), and in the DDAH2 gene, rs3131383 (p = 0.0029) and the TGCCCAGGAG haplotype (p = 0.0012) were significantly associated with ADMA levels. Sub-analysis by diabetic retinopathy (DR) status revealed these variants were associated with ADMA levels predominantly in participants without DR. Combined analysis of the most strongly associated SNPs in DDAH1 (rs669173) and DDAH2 (rs3131383) revealed an additive effect (p = 1.37 x 10(-8)) on ADMA levels. Conclusions/Significance: Genetic variation in the DDAH1 and 2 genes is significantly associated with serum ADMA levels. Further studies are required to determine the pathophysiological significance of elevated serum ADMA in type 2 diabetes and to better understand how DDAH gene variation influences ADMA levels.	[Abhary, Sotoodeh; Burdon, Kathryn P.; Kuot, Abraham; Javadiyan, Shahrbanou; Craig, Jamie E.] Flinders Med Ctr, Dept Ophthalmol, Adelaide, SA, Australia; [Abhary, Sotoodeh; Burdon, Kathryn P.; Kuot, Abraham; Javadiyan, Shahrbanou; Kasmeridis, Nicholas; Petrovsky, Nikolai; Craig, Jamie E.] Flinders Univ S Australia, Adelaide, SA 5001, Australia; [Kasmeridis, Nicholas; Petrovsky, Nikolai] Flinders Med Ctr, Dept Endocrinol, Adelaide, SA, Australia; [Whiting, Malcolm J.] SA Pathol, Chem Pathol Lab, Adelaide, SA, Australia	Flinders Medical Centre; Flinders University South Australia; Flinders Medical Centre; SA Pathology	Abhary, S (corresponding author), Flinders Med Ctr, Dept Ophthalmol, Adelaide, SA, Australia.	sotoodeh.abhary@health.sa.gov.au	Burdon, Kathryn/AAD-2334-2022; Burdon, Kathryn/A-5026-2009; Petrovsky, Nikolai/P-1912-2017; Kuot, Abraham/W-7246-2019	Burdon, Kathryn/0000-0001-8217-1249; Burdon, Kathryn/0000-0001-8217-1249; Petrovsky, Nikolai/0000-0002-1580-5245; Craig, Jamie/0000-0001-9955-9696	Ophthalmic Research Institute of Australia	Ophthalmic Research Institute of Australia	This research was supported by a grant from the Ophthalmic Research Institute of Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi F, 2001, AM J CARDIOL, V88, P1201, DOI 10.1016/S0002-9149(01)02063-X; ABHARY S, 2009, DIABETES CARE; Achan V, 2003, ARTERIOSCL THROM VAS, V23, P1455, DOI 10.1161/01.ATV.0000081742.92006.59; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Boger RH, 1998, CIRCULATION, V98, P1842, DOI 10.1161/01.CIR.98.18.1842; Carmo A, 2000, NITRIC OXIDE-BIOL CH, V4, P590, DOI 10.1006/niox.2000.0312; Connell P, 2007, ENDOTHELIUM-J ENDOTH, V14, P17, DOI 10.1080/10623320601177213; Dayoub H, 2003, CIRCULATION, V108, P3042, DOI 10.1161/01.CIR.0000101924.04515.2E; Dimmeler S, 1999, ARTERIOSCL THROM VAS, V19, P656, DOI 10.1161/01.ATV.19.3.656; Ducharme G, 2007, EUR J NEUROSCI, V26, P2119, DOI 10.1111/j.1460-9568.2007.05802.x; Duplain H, 2001, CIRCULATION, V104, P342, DOI 10.1161/01.CIR.104.3.342; El-Asrar AM, 2001, AM J OPHTHALMOL, V132, P551, DOI 10.1016/S0002-9394(01)01127-8; Fanucchi S, 2008, BIOCHEMISTRY-US, V47, P11674, DOI 10.1021/bi801147r; Forbes SP, 2008, BIOCHEMISTRY-US, V47, P1819, DOI 10.1021/bi701659n; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; GRADON JD, 1991, PEDIATR INFECT DIS J, V10, P786; Hanai K, 2009, NEPHROL DIAL TRANSPL, V24, P1884, DOI 10.1093/ndt/gfn716; Ito A, 1999, CIRCULATION, V99, P3092, DOI 10.1161/01.CIR.99.24.3092; Jones LC, 2003, BIOCHEM BIOPH RES CO, V310, P836, DOI 10.1016/j.bbrc.2003.09.097; Leiper JM, 1999, BIOCHEM J, V343, P209, DOI 10.1042/0264-6021:3430209; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; Lin KY, 2002, CIRCULATION, V106, P987, DOI 10.1161/01.CIR.0000027109.14149.67; MacAllister RJ, 1996, BRIT J PHARMACOL, V119, P1533, DOI 10.1111/j.1476-5381.1996.tb16069.x; Makino N, 2005, J DIABETES COMPLICAT, V19, P347, DOI 10.1016/j.jdiacomp.2005.04.002; Malecki MT, 2007, DIABETES CARE, V30, P2899, DOI 10.2337/dc07-1138; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Oelze M, 2000, CIRC RES, V87, P999, DOI 10.1161/01.RES.87.11.999; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Sakurada M, 2008, HYPERTENSION, V52, P903, DOI 10.1161/HYPERTENSIONAHA.108.114207; Schwedhelm E, 2005, CLIN CHEM, V51, P1268, DOI 10.1373/clinchem.2004.046037; Shankar RR, 2000, DIABETES, V49, P684, DOI 10.2337/diabetes.49.5.684; STAMLER J, 1989, CIRC RES, V65, P789, DOI 10.1161/01.RES.65.3.789; Stuhlinger MC, 2001, CIRCULATION, V104, P2569, DOI 10.1161/hc4601.098514; Stuhlinger MC, 2002, JAMA-J AM MED ASSOC, V287, P1420, DOI 10.1001/jama.287.11.1420; Sugai M, 2007, ENDOCR J, V54, P303, DOI 10.1507/endocrj.K06-140; Sydow K, 2008, ARTERIOSCL THROM VAS, V28, P692, DOI 10.1161/ATVBAHA.108.162073; Teerlink T, 2005, VASC MED, V10, pS73, DOI 10.1191/1358863x05vm597oa; Toda N, 2007, PROG RETIN EYE RES, V26, P205, DOI 10.1016/j.preteyeres.2007.01.004; Tran CTL, 2000, GENOMICS, V68, P101, DOI 10.1006/geno.2000.6262; Tran CTL, 2003, ATHEROSCLEROSIS SUPP, V4, P33, DOI 10.1016/S1567-5688(03)00032-1; Tsai DC, 2003, OPHTHALMOLOGICA, V217, P342, DOI 10.1159/000071349; Valenzuela SM, 2000, J PHYSIOL-LONDON, V529, P541, DOI 10.1111/j.1469-7793.2000.00541.x; Wang BY, 1999, CIRCULATION, V99, P1236, DOI 10.1161/01.CIR.99.9.1236; Wojciak-Stothard B, 2009, MOL BIOL CELL, V20, P33, DOI 10.1091/mbc.E08-04-0395; Yuan Ai-hua, 2007, Nan Fang Yi Ke Da Xue Xue Bao, V27, P454	45	49	52	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2010	5	3							e9462	10.1371/journal.pone.0009462	http://dx.doi.org/10.1371/journal.pone.0009462			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	561RT	20209122	Green Published, gold, Green Submitted			2022-12-25	WOS:000274997100009
J	Fournier, GP; Neumann, JE; Gogarten, JP				Fournier, Gregory P.; Neumann, Justin E.; Gogarten, J. Peter			Inferring the Ancient History of the Translation Machinery and Genetic Code via Recapitulation of Ribosomal Subunit Assembly Orders	PLOS ONE			English	Article							TRANSFER-RNA-SYNTHETASE; ORIGIN; SELECTION; ALIGNMENT; EVOLUTION	Universally conserved positions in ribosomal proteins have significant biases in amino acid usage, likely indicating the expansion of the genetic code at the time leading up to the most recent common ancestor(s) (MRCA). Here, we apply this principle to the evolutionary history of the ribosome before the MRCA. It has been proposed that the experimentally determined order of assembly for ribosomal subunits recapitulates their evolutionary chronology. Given this model, we produce a probabilistic evolutionary ordering of the universally conserved small subunit (SSU) and large subunit (LSU) ribosomal proteins. Optimizing the relative ordering of SSU and LSU evolutionary chronologies with respect to minimizing differences in amino acid usage bias, we find strong compositional evidence for a more ancient origin for early LSU proteins. Furthermore, we find that this ordering produces several trends in specific amino acid usages compatible with models of genetic code evolution.	[Fournier, Gregory P.; Gogarten, J. Peter] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA; [Neumann, Justin E.] Univ Connecticut, Dept Comp Sci & Engn, Storrs, CT 06269 USA	University of Connecticut; University of Connecticut	Fournier, GP (corresponding author), Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA.	gregory.fournier@uconn.edu		Gogarten, Johann Peter/0000-0001-6459-6518	NASA Exobiology [NNX07AK15G]; NSF Assembling the Tree of Life Program [DEB 0830024]; Division Of Environmental Biology [0830024] Funding Source: National Science Foundation	NASA Exobiology(National Aeronautics & Space Administration (NASA)); NSF Assembling the Tree of Life Program(National Science Foundation (NSF)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The reported work was supported through the NASA Exobiology (NNX07AK15G) (http://exobiology.nasa.gov/) and NSF Assembling the Tree of Life Program (DEB 0830024) (http://www.nsf.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Blaise M, 2005, BIOCHIMIE, V87, P847, DOI 10.1016/j.biochi.2005.03.007; Cai W, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-33; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fournier GP, 2007, J MOL EVOL, V65, P425, DOI 10.1007/s00239-007-9024-x; Fox GF, 2004, MOL B INT U, P92; Grondek JF, 2004, RNA, V10, P1861, DOI 10.1261/rna.7130504; Harris JK, 2003, GENOME RES, V13, P407, DOI 10.1101/gr.652803; HARTMAN H, 1995, J MOL EVOL, V40, P541; Ibba M, 1997, TRENDS BIOCHEM SCI, V22, P39, DOI 10.1016/S0968-0004(96)20033-7; JUKES TH, 1974, BIOCHEM BIOPH RES CO, V58, P80, DOI 10.1016/0006-291X(74)90893-6; Moretti S, 2007, NUCLEIC ACIDS RES, V35, pW645, DOI 10.1093/nar/gkm333; Mushegian A, 2005, RNA, V11, P1400, DOI 10.1261/rna.2180205; NAGEL GM, 1991, P NATL ACAD SCI USA, V88, P8121, DOI 10.1073/pnas.88.18.8121; Taylor WR, 2006, J THEOR BIOL, V243, P393, DOI 10.1016/j.jtbi.2006.06.015; Taylor WR, 2006, PHILOS T R SOC B, V361, P1751, DOI 10.1098/rstb.2006.1910; Terribilini M, 2006, RNA, V12, P1450, DOI 10.1261/rna.2197306; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Trifonov EN, 2000, GENE, V261, P139, DOI 10.1016/S0378-1119(00)00476-5; Tumbula-Hansen D, 2002, J BIOL CHEM, V277, P37184, DOI 10.1074/jbc.M204767200; Wolf YI, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-14	21	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2010	5	3							e9437	10.1371/journal.pone.0009437	http://dx.doi.org/10.1371/journal.pone.0009437			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	561RT	20208990	Green Published, Green Submitted, gold			2022-12-25	WOS:000274997100001
J	Bradley, WEC; Raelson, JV; Dubois, DY; Godin, E; Fournier, H; Prive, C; Allard, R; Pinchuk, V; Lapalme, M; Paulussen, RJA; Belouchi, A				Bradley, W. Edward C.; Raelson, John V.; Dubois, Daniel Y.; Godin, Eric; Fournier, Helene; Prive, Charles; Allard, Rene; Pinchuk, Vadym; Lapalme, Micheline; Paulussen, Rene J. A.; Belouchi, Abdelmajid			Hotspots of Large Rare Deletions in the Human Genome	PLOS ONE			English	Article							GENE; PARKIN; ASSOCIATION; DISEASE; BREAKPOINTS; DISRUPTION; PATIENT; CANCER	Background: We have examined the genomic distribution of large rare autosomal deletions in a sample of 440 parent-parent-child trios from the Quebec founder population (QFP) which was recruited for a study of Attention Deficit Hyperactivity Disorder. Methodology/Principal Findings: DNA isolated from blood was genotyped on Illumina Hap300 arrays. PennCNV combined with visual evaluation of images generated by the Beadstudio program was used to determine deletion boundary definition of sufficient precision to discern independent events, with near-perfect concordance between parent and child in about 98% of the 399 events detected in the offspring; the remaining 7 deletions were considered de novo. We defined several genomic regions of very high deletion frequency ('hotspots'), usually of 0.4-0.6 Mb in length where independent rare deletions were found at frequencies of up to 100 fold higher than the average for the genome as a whole. Five of the 7 de novo deletions were in these hotspots. The same hotspots were also observed in three other studies on members of the QFP, those with schizophrenia, with endometriosis and those from a longevity cohort. Conclusions/Significance: Nine of the 13 hotspots carry one gene (7 of which are very long), while the rest contain no known genes. All nine genes have been implicated in disease. The patterns of exon deletions support the proposed roles for some of these genes in human disease, such as NRXN1 and PARKIN, and suggest limited roles or no role at all, for others, including MACROD2 and CTNNA3. Our results also offer an alternative interpretation for the observations of deletions in tumors which have been proposed as reflecting tumor-suppressive activity of genes in these hotspots.	[Bradley, W. Edward C.; Belouchi, Abdelmajid] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada; [Raelson, John V.; Dubois, Daniel Y.; Godin, Eric; Fournier, Helene; Prive, Charles; Allard, Rene; Pinchuk, Vadym; Lapalme, Micheline; Paulussen, Rene J. A.; Belouchi, Abdelmajid] Genizon Biosci Inc, St Laurent, PQ, Canada	Universite de Montreal	Bradley, WEC (corresponding author), Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada.	edward.bradley@umontreal.ca			Cancer Research Society; Genizon Biosciences Inc	Cancer Research Society; Genizon Biosciences Inc	This work was supported in part by the Cancer Research Society (Montreal; www.src-crs.ca) and Genizon Biosciences Inc (Montreal; www.genizon.com). Raw genotyping data collection and analysis were performed by Genizon Biosciences Inc. in the course of research projects designed to identify genes involved in various clinical conditions, and individual employees of Genizon participated in the study as outlined in the Contributions section. Otherwise, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asakawa S, 2009, BIOCHEM BIOPH RES CO, V389, P181, DOI 10.1016/j.bbrc.2009.08.115; Bashyam MD, 2005, NEOPLASIA, V7, P556, DOI 10.1593/neo.04586; Blcuw HM, 2008, LANCET NEUROL, V7, P319, DOI 10.1016/S1474-4422(08)70048-6; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Cesari R, 2003, P NATL ACAD SCI USA, V100, P5956, DOI 10.1073/pnas.0931262100; Davison EJ, 2005, GENE CHROMOSOME CANC, V44, P384, DOI 10.1002/gcc.20252; Denison SR, 2003, ONCOGENE, V22, P8370, DOI 10.1038/sj.onc.1207072; Hedrich K, 2004, MOVEMENT DISORD, V19, P1146, DOI 10.1002/mds.20234; Inzelberg R, 2007, NEUROLOGY, V69, P1542, DOI 10.1212/01.wnl.0000277638.63767.b8; Kim HG, 2008, AM J HUM GENET, V82, P199, DOI 10.1016/j.ajhg.2007.09.011; Kirov G, 2008, HUM MOL GENET, V17, P458, DOI 10.1093/hmg/ddm323; Knudson AG, 1996, J CANCER RES CLIN, V122, P135, DOI 10.1007/BF01366952; Maas NMC, 2007, J MED GENET, V44, DOI 10.1136/jmg.2007.049510; McAvoy S, 2007, CYTOGENET GENOME RES, V118, P260, DOI 10.1159/000108309; Miyashita A, 2007, HUM MOL GENET, V16, P2854, DOI 10.1093/hmg/ddm244; Raelson JV, 2007, P NATL ACAD SCI USA, V104, P14747, DOI 10.1073/pnas.0706645104; Rujescu D, 2009, HUM MOL GENET, V18, P988, DOI 10.1093/hmg/ddn351; Sironi M, 2006, FASEB J, V20, P1910, DOI 10.1096/fj.05-5635fje; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Vrijenhoek T, 2008, AM J HUM GENET, V83, P504, DOI 10.1016/j.ajhg.2008.09.011; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Zahir FR, 2008, J MED GENET, V45, P239, DOI 10.1136/jmg.2007.054437	24	44	44	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2010	5	2							e9401	10.1371/journal.pone.0009401	http://dx.doi.org/10.1371/journal.pone.0009401			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SY	20195527	Green Published, Green Submitted, gold			2022-12-25	WOS:000274924300003
J	Hou, YL; Wang, YC; Lust, G; Zhu, L; Zhang, ZW; Todhunter, RJ				Hou, Yali; Wang, Yachun; Lust, George; Zhu, Lan; Zhang, Zhiwu; Todhunter, Rory J.			Retrospective Analysis for Genetic Improvement of Hip Joints of Cohort Labrador Retrievers in the United States: 1970-2007	PLOS ONE			English	Article							DORSOLATERAL SUBLUXATION; COXOFEMORAL JOINT; DYSPLASIA SCORE; GORDON SETTERS; DOGS; LAXITY; HERITABILITY; PHENOTYPE; TRAITS	Background: Canine Hip Dysplasia (CHD) is a common inherited disease that affects dog wellbeing and causes a heavy financial and emotional burden to dog owners and breeders due to secondary hip osteoarthritis. The Orthopedic Foundation for Animals (OFA) initiated a program in the 1960's to radiograph hip and elbow joints and release the OFA scores to the public for breeding dogs against CHD. Over last four decades, more than one million radiographic scores have been released. Methodology/Principal Findings: The pedigrees in the OFA database consisted of 258,851 Labrador retrievers, the major breed scored by the OFA (25% of total records). Of these, 154,352 dogs had an OFA hip score reported between 1970 and 2007. The rest of the dogs (104,499) were the ancestors of the 154,352 dogs to link the pedigree relationships. The OFA hip score is based on a 7-point scale with the best ranked as 1 (excellent) and the worst hip dysplasia as 7. A mixed linear model was used to estimate the effects of age, sex, and test year period and to predict the breeding value for each dog. Additive genetic and residual variances were estimated using the average information restricted maximum likelihood procedure. The analysis also provided an inbreeding coefficient for each dog. The hip scores averaged 1.93 (+/-SD = 0.59) and the heritability was 0.21. A steady genetic improvement has accrued over the four decades. The breeding values decreased (improved) linearly. By the end of 2005, the total genetic improvement was 0.1 units, which is equivalent to 17% of the total phenotypic standard deviation. Conclusion/Significance: A steady genetic improvement has been achieved through the selection based on the raw phenotype released by the OFA. As the heritability of the hip score was on the low end (0.21) of reported ranges, we propose that selection based on breeding values will result in more rapid genetic improvement than breeding based on phenotypic selection alone.	[Hou, Yali; Wang, Yachun] China Agr Univ, Coll Anim Sci & Technol, Beijing 100094, Peoples R China; [Lust, George] Cornell Univ, Coll Vet Med, Baker Inst Anim Hlth, Ithaca, NY 14853 USA; [Zhu, Lan] Oklahoma State Univ, Dept Stat, Stillwater, OK 74078 USA; [Zhang, Zhiwu] Cornell Univ, Inst Genom Divers, Ithaca, NY USA; [Todhunter, Rory J.] Cornell Univ, Coll Vet Med, Dept Clin Sci, Ithaca, NY 14853 USA	China Agricultural University; Cornell University; Oklahoma State University System; Oklahoma State University - Stillwater; Cornell University; Cornell University	Hou, YL (corresponding author), China Agr Univ, Coll Anim Sci & Technol, Beijing 100094, Peoples R China.	zz19@cornell.edu	Zhang, Zhiwu/P-6156-2016; Zhang, zs/GXN-3521-2022	Zhang, Zhiwu/0000-0002-5784-9684; 	National Institutes of Health [1R21AR055228-01A1]; Chinese National Key Technologies RD Program [2006BAD04A01, 2006BAD14B07]; Chinese National Department Public Benefit Research Foundation [NYHYZX07-035]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR055228] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese National Key Technologies RD Program(National Key Technology R&D Program); Chinese National Department Public Benefit Research Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The study was supported by National Institutes of Health (1R21AR055228-01A1), Chinese National Key Technologies R&D Program (No. 2006BAD04A01, No. 2006BAD14B07) and Chinese National Department Public Benefit Research Foundation (No. NYHYZX07-035). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CORLEY EA, 1992, VET CLIN N AM-SMALL, V22, P579, DOI 10.1016/S0195-5616(92)50057-2; CRUDEN D, 1949, J HERED, V40, P248, DOI 10.1093/oxfordjournals.jhered.a106039; EMIK LO, 1949, J HERED, V40, P51, DOI 10.1093/oxfordjournals.jhered.a105986; Farese JP, 1998, VET SURG, V27, P393, DOI 10.1111/j.1532-950X.1998.tb00146.x; Farese JP, 1999, AM J VET RES, V60, P1571; Fluckiger MA, 1999, VET SURG, V28, P1, DOI 10.1053/jvet.1999.0001; Gianola D, 2006, GENETICS, V173, P2247, DOI 10.1534/genetics.105.054197; Ginja MMD, 2008, J SMALL ANIM PRACT, V49, P641, DOI 10.1111/j.1748-5827.2008.00629.x; Henderson C. R, 1984, APPL LINEAR MODELS A; Henricson B, 1966, J Small Anim Pract, V7, P673, DOI 10.1111/j.1748-5827.1966.tb04393.x; HENRY GA, 1992, VET CLIN N AM-SMALL, V22, P559, DOI 10.1016/S0195-5616(92)50056-0; Janutta V, 2008, BERL MUNCH TIERARZTL, V121, P102, DOI 10.2376/0005-9366-121-102; Kaneene JB, 1997, J AM VET MED ASSOC, V211, P1542; Kaneene JB, 2009, VET SURG, V38, P398, DOI 10.1111/j.1532-950X.2008.00475.x; Leighton EA, 1997, J AM VET MED ASSOC, V210, P1474; Lust G, 2001, AM J VET RES, V62, P1711, DOI 10.2460/ajvr.2001.62.1711; Madsen P., 2006, WORLD C GENETICS APP; MADSEN P, 2007, USERS GUIDE DMU DENM; Smith GK, 1997, J AM VET MED ASSOC, V210, P1451; Swenson L, 1997, J AM VET MED ASSOC, V210, P207; Todhunter RJ, 2003, J HERED, V94, P39, DOI 10.1093/jhered/esg006; VANVLECK LD, 1991, J DAIRY SCI, V74, P4082, DOI 10.3168/jds.S0022-0302(91)78603-7; Wood JLN, 2000, PREV VET MED, V46, P75, DOI 10.1016/S0167-5877(00)00140-9; Wood JLN, 2000, PREV VET MED, V46, P87, DOI 10.1016/S0167-5877(00)00141-0; Wood JLN, 2003, VET REC, V152, P69, DOI 10.1136/vr.152.3.69; Zhang ZW, 2009, AM J VET RES, V70, P483, DOI 10.2460/ajvr.70.4.483; Zhu L, 2009, VET J, V181, P97, DOI 10.1016/j.tvjl.2009.02.008	27	37	40	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2010	5	2							e9410	10.1371/journal.pone.0009410	http://dx.doi.org/10.1371/journal.pone.0009410			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SX	20195372	Green Submitted, gold, Green Published			2022-12-25	WOS:000274924200030
J	Lubos, E; Mahoney, CE; Leopold, JA; Zhang, YY; Loscalzo, J; Handy, DE				Lubos, Edith; Mahoney, Christopher E.; Leopold, Jane A.; Zhang, Ying-Yi; Loscalzo, Joseph; Handy, Diane E.			Glutathione peroxidase-1 modulates lipopolysaccharide-induced adhesion molecule expression in endothelial cells by altering CD14 expression	FASEB JOURNAL			English	Article						innate immunity; inflammation; ICAM-1; ROS	ACCELERATES ATHEROSCLEROSIS; SURFACE EXPRESSION; MICE DEFICIENT; RECEPTOR 4; KAPPA-B; LPS; ACTIVATION; RESPONSIVENESS; MD-2; GLUTATHIONE-PEROXIDASE-1	CD14 contributes to LPS signaling in leukocytes through formation of toll-like receptor 4/CD14 receptor complexes; however, a specific role for endogenous cell-surface CD14 in endothelial cells is unclear. We have found that suppression of glutathione peroxidase-1 (GPx-1) in human microvascular endothelial cells increases CD14 gene expression compared to untreated or siControl (siCtrl)-treated conditions. Following LPS treatment, GPx-1 deficiency augmented LPS-induced intracellular reactive oxygen species accumulation, CD14 expression, and intercellular adhesion molecule-1 (ICAM-1) mRNA and protein expression compared to LPS-treated control cells. GPx-1 deficiency also transiently augmented LPS-induced vascular cell adhesion molecule-1 (VCAM-1) expression. Adenoviral overexpression of GPx-1 significantly diminished LPS-mediated responses in adhesion molecule expression. Consistent with these findings, LPS responses were also greater in endothelial cells derived from GPx-1-knockout mice, whereas adhesion molecule expression was decreased in cells from GPx-1-overexpressing transgenic mice. Knockdown of CD14 attenuated LPS-mediated up-regulation of ICAM-1 and VCAM-1 mRNA and protein, and it mitigated the effects of GPx-1 deficiency on LPS-induced adhesion molecule expression. Taken together, these data suggest that GPx-1 modulates the endothelial cell response to LPS, in part, by altering CD14-mediated effects.-Lubos, E., Mahoney, C.E., Leopold, J.A., Zhang, Y.-Y., Loscalzo, J., Handy, D. E. Glutathione peroxidase-1 modulates lipopolysaccharide-induced adhesion molecule expression in endothelial cells by altering CD14 expression. FASEB J. 24, 2525-2532 (2010). www.fasebj.org	[Lubos, Edith; Mahoney, Christopher E.; Leopold, Jane A.; Zhang, Ying-Yi; Loscalzo, Joseph; Handy, Diane E.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Cardiovasc Div, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Handy, DE (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Cardiovasc Div, 77 Ave Louis Pasteur,NRB 0630L, Boston, MA 02115 USA.	dhandy@rics.bwh.harvard.edu	Loscalzo, Joseph/ABD-8980-2021	Handy, Diane/0000-0002-4310-8527	National Heart, Lung, and Blood Institute (NHLBI), U.S. National Institutes of Health [HL 61795, HV 28178, HL 81587]; Deutsche Forschungsgemeinschaft [LU 1452/1-1]; DIVISION OF HEART AND VASCULAR DISEASES [N01HV028178] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL028178, P01HL081587, R37HL061795, R01HL061795] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI), U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank Stephanie Tribuna for expert assistance with manuscript preparation, and all other lab members for technical assistance and helpful discussions. In addition, the authors acknowledge Scott R. Oldebeken for his assistance with the design, execution, and analysis of experiments crucial to the completion of this report. This work was supported by U.S. National Institutes of Health grants HL 61795, HV 28178, and HL 81587 from the National Heart, Lung, and Blood Institute (NHLBI), and by Deutsche Forschungsgemeinschaft grant LU 1452/1-1 (to E.L.).	Akashi S, 2003, J EXP MED, V198, P1035, DOI 10.1084/jem.20031076; Akira S, 2004, SEMIN IMMUNOL, V16, P1, DOI 10.1016/j.smim.2003.10.001; Allport JR, 2002, J LEUKOCYTE BIOL, V71, P821; Antal-Szalmas P, 2000, EUR J CLIN INVEST, V30, P167; BEEKHUIZEN H, 1991, J IMMUNOL, V147, P3761; Bjorkbacka H, 2004, NAT MED, V10, P416, DOI 10.1038/nm1008; Blankenberg S, 2003, NEW ENGL J MED, V349, P1605, DOI 10.1056/NEJMoa030535; Cai H, 2000, CIRC RES, V87, P840, DOI 10.1161/01.RES.87.10.840; Crack PJ, 2001, J NEUROCHEM, V78, P1389, DOI 10.1046/j.1471-4159.2001.00535.x; Devitt A, 1998, NATURE, V392, P505, DOI 10.1038/33169; FERRERO E, 1990, J IMMUNOL, V145, P331; FERRERO E, 1993, P NATL ACAD SCI USA, V90, P2380, DOI 10.1073/pnas.90.6.2380; FLOHE L, 1984, METHOD ENZYMOL, V105, P114; Forgione MA, 2002, CIRCULATION, V106, P1154, DOI 10.1161/01.CIR.0000026820.87824.6A; Forgione MA, 2002, AM J PHYSIOL-HEART C, V282, pH1255, DOI 10.1152/ajpheart.00598.2001; GOLENBOCK DT, 1993, J BIOL CHEM, V268, P22055; Hack CE, 2001, CRIT CARE MED, V29, pS21, DOI 10.1097/00003246-200107001-00011; HAZIOT A, 1993, J IMMUNOL, V151, P1500; Haziot A, 1996, IMMUNITY, V4, P407, DOI 10.1016/S1074-7613(00)80254-X; Ho YS, 1997, J BIOL CHEM, V272, P16644, DOI 10.1074/jbc.272.26.16644; Jersmann HPA, 2001, INFECT IMMUN, V69, P479, DOI 10.1128/IAI.69.1.479-485.2001; Jersmann HPA, 2005, IMMUNOL CELL BIOL, V83, P462, DOI 10.1111/j.1440-1711.2005.01370.x; Jia HP, 2004, AM J PHYSIOL-LUNG C, V287, pL428, DOI 10.1152/ajplung.00377.2003; Jiang QQ, 2000, J IMMUNOL, V165, P3541, DOI 10.4049/jimmunol.165.7.3541; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Landmann R, 1998, INFECT IMMUN, V66, P2264, DOI 10.1128/IAI.66.5.2264-2271.1998; Lapenna D, 1998, CIRCULATION, V97, P1930, DOI 10.1161/01.CIR.97.19.1930; Lehr HA, 2001, CIRCULATION, V104, P914, DOI 10.1161/hc3401.093153; Leopold JA, 2007, NAT MED, V13, P189, DOI 10.1038/nm1545; Lewis P, 2007, CIRCULATION, V115, P2178, DOI 10.1161/CIRCULATIONAHA.106.664250; Li Q, 2001, ANTIOXID REDOX SIGN, V3, P415, DOI 10.1089/15230860152409068; Lloyd KL, 2006, AM J PHYSIOL-HEART C, V291, pH473, DOI 10.1152/ajpheart.01234.2005; Lloyd-Jones KL, 2008, J IMMUNOL, V181, P1446, DOI 10.4049/jimmunol.181.2.1446; Michelsen KS, 2004, P NATL ACAD SCI USA, V101, P10679, DOI 10.1073/pnas.0403249101; Moore KJ, 2000, J IMMUNOL, V165, P4272, DOI 10.4049/jimmunol.165.8.4272; Mullick AE, 2006, IMMUNOL RES, V34, P193, DOI 10.1385/IR:34:3:193; Nareika A, 2008, J ENDOCRINOL, V196, P45, DOI 10.1677/JOE-07-0145; Ostos MA, 2002, FEBS LETT, V519, P23, DOI 10.1016/S0014-5793(02)02692-3; PUGIN J, 1993, P NATL ACAD SCI USA, V90, P2744, DOI 10.1073/pnas.90.7.2744; PUGIN J, 1994, IMMUNITY, V1, P509, DOI 10.1016/1074-7613(94)90093-0; RAES M, 1987, FREE RADICAL BIO MED, V3, P3, DOI 10.1016/0891-5849(87)90032-3; Resman N, 2009, J BIOL CHEM, V284, P15052, DOI 10.1074/jbc.M901429200; Roncon-Albuquerque R, 2008, LIFE SCI, V83, P502, DOI 10.1016/j.lfs.2008.07.021; Sawa Y, 2008, J HISTOCHEM CYTOCHEM, V56, P97, DOI 10.1369/jhc.7A7299.2007; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Song PI, 2001, INVEST OPHTH VIS SCI, V42, P2867; Sugawara S, 1998, INFECT IMMUN, V66, P3043, DOI 10.1128/IAI.66.7.3043-3049.1998; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Torzewski M, 2007, ARTERIOSCL THROM VAS, V27, P850, DOI 10.1161/01.ATV.0000258809.47285.07; URSINI F, 1995, METHOD ENZYMOL, V252, P38; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Yamada H, 2006, LIFE SCI, V78, P926, DOI 10.1016/j.lfs.2005.05.106; Zhang YF, 2005, CIRC RES, V96, P831, DOI 10.1161/01.RES.0000164401.21929.CF	53	30	30	1	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2010	24	7					2525	2532		10.1096/fj.09-147421	http://dx.doi.org/10.1096/fj.09-147421			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	618HV	20219985	Green Published			2022-12-25	WOS:000279343600039
J	Tu, H; Hsuchou, H; Kastin, AJ; Wu, XJ; Pan, WH				Tu, Hong; Hsuchou, Hung; Kastin, Abba J.; Wu, Xiaojun; Pan, Weihong			Unique leptin trafficking by a tailless receptor	FASEB JOURNAL			English	Article						ObR; endocytosis motif	BLOOD-BRAIN-BARRIER; SIGNAL-TRANSDUCTION; OBESE MICE; OB-R; ENDOCYTOSIS; TRANSPORT; EXPRESSION; ISOFORMS; ACTIVATION; UROCORTIN	Impairment in blood-to-brain transport of leptin is a major cause as well as consequence of obesity. Leptin crosses the blood-brain barrier by transcytosis rather than undergoing intracellular degradation. Results from previous studies have indicated that the membrane juxtapositional cytoplasmic sequence of the leptin receptor ObR is responsible for leptin transport. To identify the specific structural domains, we generated a series of ObR truncates with different lengths of the intracellular sequence, overexpressed them in 3 types of mammalian cells including cerebral endothelia, and quantified leptin binding and endocytosis. All mutant ObRs were able to bind and mediate the internalization of leptin. Surprisingly, ObR860, a construct with no cytoplasmic sequence, could act like the classical ObRa transporter in internalizing leptin. There were some cell type-dependent variations in the intracellular trafficking of Alexa-labeled leptin when mediated by ObR860 or ObRa because of differential involvement of membrane microdomains, as shown by use of the clathrin inhibitor chlorpromazine and the dynamin inhibitor Dynasore. The clathrin-and dynamin-mediated endocytosis of leptin contrasts with the lack of effect of the caveolae inhibitors nystatin and filipin. Thus, leptin-induced internalization of the ligand-receptor complex can occur without specific sorting signals in the cytoplasmic region of ObR. This novel finding may have significant implications for leptin transport.-Tu, H., Hsuchou, H., Kastin, A. J., Wu, X., Pan, W. Unique leptin trafficking by a tailless receptor. FASEB J. 24, 2281-2291 (2010). www.fasebj.org	[Tu, Hong; Hsuchou, Hung; Kastin, Abba J.; Wu, Xiaojun; Pan, Weihong] Pennington Biomed Res Ctr, Blood Brain Barrier Grp, Baton Rouge, LA 70808 USA; [Tu, Hong] Shanghai Jiao Tong Univ, Inst Canc, State Key Lab Oncogene & Related Genes, Shanghai 200030, Peoples R China	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Shanghai Jiao Tong University	Pan, WH (corresponding author), Pennington Biomed Res Ctr, Blood Brain Barrier Grp, 6400 Perkins Rd, Baton Rouge, LA 70808 USA.	weihong.pan@pbrc.edu		Tu, Hong/0000-0002-8298-5207	U.S. National Institutes of Health [DK54880, NS62291, NS46528]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054880, R56DK054880] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062291, R01NS046528] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by U.S. National Institutes of Health grants (DK54880 to A.J.K.; NS62291 and NS46528 to W. P.). The ObR plasmids were kindly provided by Dr. Christian Bjorbaek (Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA). The RBE4 cells were kindly provided by Dr. Pierre-Olivier Couraud (Institut Cochin, INSERM, Paris, France).	Ahima RS, 2004, PHYSIOL BEHAV, V81, P223, DOI 10.1016/j.physbeh.2004.02.014; Banks WA, 1996, PEPTIDES, V17, P305, DOI 10.1016/0196-9781(96)00025-3; Banks WA, 2002, BRAIN RES, V950, P130, DOI 10.1016/S0006-8993(02)03013-5; Barr VA, 1999, J BIOL CHEM, V274, P21416, DOI 10.1074/jbc.274.30.21416; Belouzard S, 2006, EMBO J, V25, P932, DOI 10.1038/sj.emboj.7600989; Belouzard S, 2004, J BIOL CHEM, V279, P28499, DOI 10.1074/jbc.M400508200; Benmerah A, 2007, TRAFFIC, V8, P970, DOI 10.1111/j.1600-0854.2007.00585.x; Bjorbaek C, 1997, J BIOL CHEM, V272, P32686, DOI 10.1074/jbc.272.51.32686; Bjorbaek C, 1998, ENDOCRINOLOGY, V139, P3485, DOI 10.1210/en.139.8.3485; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Caro JF, 1996, LANCET, V348, P159, DOI 10.1016/S0140-6736(96)03173-X; El-Haschimi K, 2000, J CLIN INVEST, V105, P1827, DOI 10.1172/JCI9842; Halaas JL, 1997, P NATL ACAD SCI USA, V94, P8878, DOI 10.1073/pnas.94.16.8878; Harrold JA, 2006, PEPTIDES, V27, P365, DOI 10.1016/j.peptides.2005.01.030; Hegyi K, 2004, CELL BIOL INT, V28, P159, DOI 10.1016/j.cellbi.2003.12.003; Kastin AJ, 2006, ENDOCRINOLOGY, V147, P2086, DOI 10.1210/en.2006-0208; Kastin AJ, 2002, PEPTIDES, V23, P2189, DOI 10.1016/S0196-9781(02)00247-4; Kastin AJ, 1999, PEPTIDES, V20, P1449, DOI 10.1016/S0196-9781(99)00156-4; Kastin AJ, 2000, PEPTIDES, V21, P1811, DOI 10.1016/S0196-9781(00)00349-1; Kirchhausen T, 2008, METHOD ENZYMOL, V438, P77, DOI 10.1016/S0076-6879(07)38006-3; Lee GH, 1996, NATURE, V379, P632, DOI 10.1038/379632a0; LETOURNEUR F, 1992, CELL, V69, P1143, DOI 10.1016/0092-8674(92)90636-Q; Li C, 1999, P NATL ACAD SCI USA, V96, P9677, DOI 10.1073/pnas.96.17.9677; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Myers MG, 2004, RECENT PROG HORM RES, V59, P287, DOI 10.1210/rp.59.1.287; Pan WH, 2008, ENDOCRINOLOGY, V149, P2798, DOI 10.1210/en.2007-1673; Pan WH, 2008, ENDOCRINOLOGY, V149, P877, DOI 10.1210/en.2007-0893; Pan WH, 2007, CELL PHYSIOL BIOCHEM, V20, P559, DOI 10.1159/000107539; Pan WH, 2006, PEPTIDES, V27, P911, DOI 10.1016/j.peptides.2005.12.014; Pan WH, 2005, ENDOCRINOLOGY, V146, P4898, DOI 10.1210/en.2005-0587; Rosenblum CI, 1996, ENDOCRINOLOGY, V137, P5178, DOI 10.1210/en.137.11.5178; Schwartz MW, 1996, NAT MED, V2, P589, DOI 10.1038/nm0596-589; Signoret N, 2000, J CELL BIOL, V151, P1281, DOI 10.1083/jcb.151.6.1281; SUBTIL A, 1994, J CELL SCI, V107, P3461; SWEEP F, 1991, ACTA ENDOCRINOL-COP, V125, P84; Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5; Tu H, 2008, J CELL PHYSIOL, V214, P301, DOI 10.1002/jcp.21195; Tu H, 2007, J CELL PHYSIOL, V212, P215, DOI 10.1002/jcp.21020; Tu H, 2007, J MOL NEUROSCI, V31, P171, DOI 10.1385/JMN/31:02:171; Tu H, 2007, MOL ENDOCRINOL, V21, P700, DOI 10.1210/me.2005-0503; Uotani S, 1999, DIABETES, V48, P279, DOI 10.2337/diabetes.48.2.279; Van Hamme E, 2008, J GEN VIROL, V89, P2147, DOI 10.1099/vir.0.2008/001602-0; VAN HM, 1997, J CLIN INVEST, V99, P385; WANG LH, 1993, J CELL BIOL, V123, P1107, DOI 10.1083/jcb.123.5.1107; Wang YP, 1997, J BIOL CHEM, V272, P16216, DOI 10.1074/jbc.272.26.16216; Wilcke M, 2000, EUR J HISTOCHEM, V44, P325	46	29	30	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2010	24	7					2281	2291		10.1096/fj.09-143487	http://dx.doi.org/10.1096/fj.09-143487			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	618HV	20223942	Green Published			2022-12-25	WOS:000279343600015
J	Bystrom, R; Andersen, PM; Grobner, G; Oliveberg, M				Bystrom, Roberth; Andersen, Peter M.; Grobner, Gerhard; Oliveberg, Mikael			SOD1 Mutations Targeting Surface Hydrogen Bonds Promote Amyotrophic Lateral Sclerosis without Reducing Apo-state Stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CU/ZN SUPEROXIDE-DISMUTASE; PROTEIN AGGREGATION; HUNTINGTONS-DISEASE; DISULFIDE REDUCTION; TRANSGENIC MICE; MUTANT SOD1; GENE; ALS; FORM; CU	In good accord with the protein aggregation hypothesis for neurodegenerative diseases, ALS-associated SOD1 mutations are found to reduce structural stability or net repulsive charge. Moreover there are weak indications that the ALS disease progression rate is correlated with the degree of mutational impact on the apoSOD1 structure. A bottleneck for obtaining more conclusive information about these structure-disease relationships, however, is the large intrinsic variability in patient survival times and insufficient disease statistics for the majority of ALS- provoking mutations. As an alternative test of the structure- disease relationship we focus here on the SOD1 mutations that appear to be outliers in the data set. The results identify several ALS- provoking mutations whose only effect on apoSOD1 is the elimination or introduction of a single charge, i.e. D76V/Y, D101N, and N139D/K. The thermodynamic stability and folding behavior of these mutants are indistinguishable from the wild-type control. Moreover, D101N is an outlier in the plot of stability loss versus patient survival time by having rapid disease progression. Commonto the identified mutations is that they truncate conserved salt-links and/or H-bond networks in the functional loops IV or VII. The results show that the local impact of ALS- associated mutations on the SOD1 molecule can sometimes overrun their global effects on apo-state stability and net repulsive charge, and point at the analysis of property outliers as an efficient strategy for mapping out new ALS- provoking features.	[Oliveberg, Mikael] Stockholm Univ, Dept Biochem & Biophys, Arrhenius Labs Nat Sci, S-10691 Stockholm, Sweden; [Bystrom, Roberth; Grobner, Gerhard] Umea Univ, Dept Chem, S-90187 Umea, Sweden; [Andersen, Peter M.] Umea Univ, Dept Clin Neurosci, S-90187 Umea, Sweden	Stockholm University; Umea University; Umea University	Oliveberg, M (corresponding author), Stockholm Univ, Dept Biochem & Biophys, Arrhenius Labs Nat Sci, S-10691 Stockholm, Sweden.	mikael.oliveberg@dbb.su.se			Swedish Research Council; Knut and Alice Wallenberg Foundation; Bertil Hallsten Foundation, and Hjarnfonden	Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Bertil Hallsten Foundation, and Hjarnfonden	This work was supported in part by the Swedish Research Council, the Knut and Alice Wallenberg Foundation, the Bertil Hallsten Foundation, and Hjarnfonden.	*ALS, 2009, ALS ONL DAT; Andersen PM, 2006, CURR NEUROL NEUROSCI, V6, P37, DOI 10.1007/s11910-996-0008-9; Andersen PM, 2003, AMYOTROPH LATERAL SC, V4, P62, DOI 10.1080/14660820310011700; Andersen PM, 1997, BRAIN, V120, P1723, DOI 10.1093/brain/120.10.1723; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Banci L, 2009, P NATL ACAD SCI USA, V106, P6980, DOI 10.1073/pnas.0809845106; Chen SM, 2002, P NATL ACAD SCI USA, V99, P11884, DOI 10.1073/pnas.182276099; Chiti F, 2003, NATURE, V424, P805, DOI 10.1038/nature01891; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DiDonato M, 2003, J MOL BIOL, V332, P601, DOI 10.1016/S0022-2836(03)00889-1; Ding F, 2008, P NATL ACAD SCI USA, V105, P19696, DOI 10.1073/pnas.0803266105; Ferguson N, 2001, P NATL ACAD SCI USA, V98, P13008, DOI 10.1073/pnas.221467398; Ferraroni M, 1999, J MOL BIOL, V288, P413, DOI 10.1006/jmbi.1999.2681; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; Furukawa Y, 2005, J BIOL CHEM, V280, P17266, DOI 10.1074/jbc.M500482200; Furukawa Y, 2008, J BIOL CHEM, V283, P24167, DOI 10.1074/jbc.M802083200; Hubbard SJ, 1998, PROTEIN ENG, V11, P349, DOI 10.1093/protein/11.5.349; JONES CT, 1994, MOL CELL PROBE, V8, P329, DOI 10.1006/mcpr.1994.1046; Jonsson PA, 2004, BRAIN, V127, P73, DOI 10.1093/brain/awh005; Khare SD, 2006, P NATL ACAD SCI USA, V103, P3147, DOI 10.1073/pnas.0511266103; Landles C, 2004, EMBO REP, V5, P958, DOI 10.1038/sj.embor.7400250; Levy Y, 2004, P NATL ACAD SCI USA, V101, P511, DOI 10.1073/pnas.2534828100; Lindberg MJ, 2005, P NATL ACAD SCI USA, V102, P9754, DOI 10.1073/pnas.0501957102; Lindberg MJ, 2002, P NATL ACAD SCI USA, V99, P16607, DOI 10.1073/pnas.262527099; Lindberg MJ, 2004, P NATL ACAD SCI USA, V101, P15893, DOI 10.1073/pnas.0403979101; Luheshi LM, 2007, PLOS BIOL, V5, P2493, DOI 10.1371/journal.pbio.0050290; Luheshi LM, 2008, CURR OPIN CHEM BIOL, V12, P25, DOI 10.1016/j.cbpa.2008.02.011; Nogales-Gadea G, 2004, J NEUROL SCI, V219, P1, DOI 10.1016/j.jns.2003.10.018; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Orrell RW, 1997, NEUROLOGY, V48, P746, DOI 10.1212/WNL.48.3.746; Otzen DE, 2000, P NATL ACAD SCI USA, V97, P9907, DOI 10.1073/pnas.160086297; PRAMATAROVA A, 1995, AM J HUM GENET, V56, P592; Richardson JS, 2002, P NATL ACAD SCI USA, V99, P2754, DOI 10.1073/pnas.052706099; Rodriguez JA, 2005, P NATL ACAD SCI USA, V102, P10516, DOI 10.1073/pnas.0502515102; Rousseau F, 2006, CURR OPIN STRUC BIOL, V16, P118, DOI 10.1016/j.sbi.2006.01.011; Sandelin E, 2007, J BIOL CHEM, V282, P21230, DOI 10.1074/jbc.M700765200; Sato T, 2005, NEUROLOGY, V65, P1954, DOI 10.1212/01.wnl.0000188760.53922.05; Shaw BF, 2008, J BIOL CHEM, V283, P8340, DOI 10.1074/jbc.M707751200; Shaw BF, 2007, TRENDS BIOCHEM SCI, V32, P78, DOI 10.1016/j.tibs.2006.12.005; SHIBATA N, 1993, ACTA HISTOCHEM CYTOC, V26, P619, DOI 10.1267/ahc.26.619; SHIBATA N, 1994, NEUROSCI LETT, V179, P149, DOI 10.1016/0304-3940(94)90956-3; Stathopulos PB, 2006, J BIOL CHEM, V281, P6184, DOI 10.1074/jbc.M509496200; Stathopulos PB, 2003, P NATL ACAD SCI USA, V100, P7021, DOI 10.1073/pnas.1237797100; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; Strange RW, 2003, J MOL BIOL, V328, P877, DOI 10.1016/S0022-2836(03)00355-3; Svensson AKE, 2006, J MOL BIOL, V364, P1084, DOI 10.1016/j.jmb.2006.09.005; Thirumalai D, 2003, CURR OPIN STRUC BIOL, V13, P146, DOI 10.1016/S0959-440X(03)00032-0; Tiwari A, 2003, J BIOL CHEM, V278, P5984, DOI 10.1074/jbc.M210419200; Tiwari A, 2005, NEURODEGENER DIS, V2, P115, DOI 10.1159/000089616; Vassall KA, 2006, BIOCHEMISTRY-US, V45, P7366, DOI 10.1021/bi0600953; Wang Q, 2008, PLOS BIOL, V6, P1508, DOI 10.1371/journal.pbio.0060170; Watanabe M, 2001, NEUROBIOL DIS, V8, P933, DOI 10.1006/nbdi.2001.0443; 2009, HOMOLOGENE	54	63	65	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19544	19552		10.1074/jbc.M109.086074	http://dx.doi.org/10.1074/jbc.M109.086074			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20189984	Green Published, hybrid			2022-12-25	WOS:000278727800064
J	Smithson, DC; Lee, J; Shelat, AA; Phillips, MA; Guy, RK				Smithson, David C.; Lee, Jeongmi; Shelat, Anang A.; Phillips, Margaret A.; Guy, R. Kiplin			Discovery of Potent and Selective Inhibitors of Trypanosoma brucei Ornithine Decarboxylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-STRUCTURE; ALPHA-DIFLUOROMETHYLORNITHINE; POLYAMINE BIOSYNTHESIS; SUBSTRATE-BINDING; TRIAL; ENZYME; FORMS; GENE; EFLORNITHINE; SPECIFICITY	Human African trypanosomiasis, caused by the eukaryotic parasite Trypanosoma brucei, is a serious health problem in much of central Africa. The only validated molecular target for treatment of human African trypanosomiasis is ornithine decarboxylase (ODC), which catalyzes the first step in polyamine metabolism. Here, we describe the use of an enzymatic high throughput screen of 316,114 unique molecules to identify potent and selective inhibitors of ODC. This screen identified four novel families of ODC inhibitors, including the first inhibitors selective for the parasitic enzyme. These compounds display unique binding modes, suggesting the presence of allosteric regulatory sites on the enzyme. Docking of a subset of these inhibitors, coupled with mutagenesis, also supports the existence of these allosteric sites.	St Jude Childrens Hosp, Dept Chem Biol & Therapeut, Memphis, TN 38105 USA; [Smithson, David C.] Univ Calif San Francisco, Grad Program Chem & Chem Biol, San Francisco, CA 94143 USA; [Lee, Jeongmi; Phillips, Margaret A.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA	St Jude Children's Research Hospital; University of California System; University of California San Francisco; University of Texas System; University of Texas Southwestern Medical Center Dallas	Guy, RK (corresponding author), 262 Danny Thomas Pl,Mail Stop 1000, Memphis, TN 38105 USA.	kip.guy@stjude.org	Lee, Jeongmi/AAJ-7720-2020; Guy, Rodney/J-7107-2013; Shelat, Anang/J-4995-2013	Lee, Jeongmi/0000-0002-9948-7554; Guy, Rodney/0000-0002-9638-2060; Shelat, Anang/0000-0002-6266-2910	National Institutes of Health [R01 AI34432]; American Lebanese Syrian Associated Charities; St. Jude Children's Research Hospital; Welch Foundation [I-1257]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI034432, R01AI034432] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); St. Jude Children's Research Hospital; Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AI34432 (to M. A. P.). This work was also supported by the American Lebanese Syrian Associated Charities, St. Jude Children's Research Hospital, and Welch Foundation Grant I-1257 (to M. A. P.).	ABDELMONEM MM, 1974, J MED CHEM, V17, P447, DOI 10.1021/jm00250a016; Almrud JJ, 2000, J MOL BIOL, V295, P7, DOI 10.1006/jmbi.1999.3331; Amadasi A, 2007, CURR MED CHEM, V14, P1291, DOI 10.2174/092986707780597899; Athri P, 2006, BIOORGAN MED CHEM, V14, P3144, DOI 10.1016/j.bmc.2005.12.029; Baldwin J, 2005, J BIOL CHEM, V280, P21847, DOI 10.1074/jbc.M501100200; Barrett MP, 2007, BRIT J PHARMACOL, V152, P1155, DOI 10.1038/sj.bjp.0707354; Bemis GW, 1996, J MED CHEM, V39, P2887, DOI 10.1021/jm9602928; BEY P, 1987, INHIBITION POLYAMINE, P32; BITONTI AJ, 1982, BIOCHEM J, V208, P435, DOI 10.1042/bj2080435; BITONTI AJ, 1986, BIOCHEM J, V237, P685, DOI 10.1042/bj2370685; Carbone PP, 2000, CLIN CANCER RES, V6, P3850; Casero RA, 2007, NAT REV DRUG DISCOV, V6, P373, DOI 10.1038/nrd2243; Childs AC, 2003, CELL MOL LIFE SCI, V60, P1394, DOI 10.1007/s00018-003-2332-4; Coffino P, 2001, NAT REV MOL CELL BIO, V2, P188, DOI 10.1038/35056508; FAIRLAMB AH, 1987, MOL BIOCHEM PARASIT, V24, P185, DOI 10.1016/0166-6851(87)90105-8; Ganendren R, 2004, ANTIMICROB AGENTS CH, V48, P1561, DOI 10.1128/AAC.48.5.1561-1569.2004; GARVEY EP, 1994, J BIOL CHEM, V269, P26669; GHODA L, 1990, J BIOL CHEM, V265, P11823; GRIFFIN CA, 1987, INVEST NEW DRUG, V5, P177; Grishin NV, 1999, BIOCHEMISTRY-US, V38, P15174, DOI 10.1021/bi9915115; Hann M, 1999, J CHEM INF COMP SCI, V39, P897, DOI 10.1021/ci990423o; Hendlich M, 1997, J MOL GRAPH MODEL, V15, P359, DOI 10.1016/S1093-3263(98)00002-3; HENLEY CM, 1988, BIOCHEM PHARMACOL, V37, P1679, DOI 10.1016/0006-2952(88)90427-3; HOAGLIN DC, 1983, UNDERSTANDING ROBUST, P57; ITEN M, 1995, TROP MED PARASITOL, V46, P190; IWAMI K, 1990, AM J PHYSIOL, V258, pG308, DOI 10.1152/ajpgi.1990.258.2.G308; Jackson LK, 2000, BIOCHEMISTRY-US, V39, P11247, DOI 10.1021/bi001209s; Jackson LK, 2003, J BIOL CHEM, V278, P22037, DOI 10.1074/jbc.M300188200; Jackson LK, 2004, BIOCHEMISTRY-US, V43, P12990, DOI 10.1021/bi048933l; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; Lee J, 2007, J BIOL CHEM, V282, P27115, DOI 10.1074/jbc.M704066200; Lemoff A, 2008, J COMB CHEM, V10, P746, DOI 10.1021/cc800100g; Lor LA, 2007, J BIOMOL SCREEN, V12, P881, DOI 10.1177/1087057107304113; Mathis AM, 2006, ANTIMICROB AGENTS CH, V50, P2185, DOI 10.1128/AAC.00192-06; METCALF BW, 1978, J AM CHEM SOC, V100, P2551, DOI 10.1021/ja00476a050; Meyskens FL, 2008, CANCER PREV RES, V1, P32, DOI 10.1158/1940-6207.CAPR-08-0042; MILORD F, 1992, LANCET, V340, P652, DOI 10.1016/0140-6736(92)92180-N; OSTERMAN A, 1994, BIOCHEMISTRY-US, V33, P13662, DOI 10.1021/bi00250a016; OSTERMAN AL, 1995, J BIOL CHEM, V270, P11797, DOI 10.1074/jbc.270.20.11797; Pays E, 1998, MOL BIOCHEM PARASIT, V91, P3, DOI 10.1016/S0166-6851(97)00183-7; PEGG AE, 1979, BIOCHIM BIOPHYS ACTA, V568, P416, DOI 10.1016/0005-2744(79)90310-3; PHILLIPS MA, 1987, J BIOL CHEM, V262, P8721; Priotto G, 2009, LANCET, V374, P56, DOI 10.1016/S0140-6736(09)61117-X; ROSE FL, 1956, J CHEM SOC, P4422, DOI 10.1039/jr9560004422; ROUSSEEUW P, 2006, ROBUSTBASE BASIC ROB; RUSSELL D, 1968, P NATL ACAD SCI USA, V60, P1420, DOI 10.1073/pnas.60.4.1420; SEGEL IH, 1975, ENZYME KINETICS BEHA, P249; Shantz LM, 2007, AMINO ACIDS, V33, P213, DOI 10.1007/s00726-007-0531-2; Shelat AA, 2007, CURR OPIN CHEM BIOL, V11, P244, DOI 10.1016/j.cbpa.2007.05.003; Simoneau AR, 2008, CANCER EPIDEM BIOMAR, V17, P292, DOI 10.1158/1055-9965.EPI-07-0658; SMITHSON DC, 2010, ASSAY DRUG IN PRESS; SOLANO F, 1985, FEBS LETT, V190, P324, DOI 10.1016/0014-5793(85)81311-9; Steglich C, 2006, INFECT GENET EVOL, V6, P205, DOI 10.1016/j.meegid.2005.05.004; TEAM RDC, 2007, R LANGUAGE ENV STAT; Thyssen SM, 2002, NEUROSCI LETT, V323, P65, DOI 10.1016/S0304-3940(02)00097-6; Wallace HM, 2003, BIOCHEM J, V376, P1, DOI 10.1042/BJ20031327; Willert EK, 2007, P NATL ACAD SCI USA, V104, P8275, DOI 10.1073/pnas.0701111104; Willert EK, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000183; World Health Organization, 2006, AFR TRYP SLEEP SICKN; Xiao YJ, 2009, EUKARYOT CELL, V8, P747, DOI 10.1128/EC.00047-09; Yan B, 2007, ANAL CHEM, V79, P718, DOI 10.1021/ac061682x; Yip KW, 2006, MOL CANCER THER, V5, P2234, DOI 10.1158/1535-7163.MCT-06-0134; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	63	31	37	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16771	16781		10.1074/jbc.M109.081588	http://dx.doi.org/10.1074/jbc.M109.081588			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20220141	hybrid, Green Published			2022-12-25	WOS:000277982600040
J	Gencic, S; Duin, EC; Grahame, DA				Gencic, Simonida; Duin, Evert C.; Grahame, David A.			Tight Coupling of Partial Reactions in the Acetyl-CoA Decarbonylase/Synthase (ACDS) Multienzyme Complex from Methanosarcina thermophila ACETYL C-C BOND FRAGMENTATION AT THE A CLUSTER PROMOTED BY PROTEIN CONFORMATIONAL CHANGES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBON-MONOXIDE DEHYDROGENASE; SYNTHASE ACTIVE-SITE; COENZYME-A; CLOSTRIDIUM-THERMOACETICUM; ENZYME COMPLEX; SUBUNIT-BETA; MOORELLA-THERMOACETICA; ALPHA-SUBUNIT; MECHANISM; CLEAVAGE	Direct synthesis and cleavage of acetyl-CoA are carried out by the bifunctional CO dehydrogenase/acetyl-CoA synthase enzyme in anaerobic bacteria and by the acetyl-CoA decarbonylase/synthase (ACDS) multienzyme complex in Archaea. In both systems, a nickel- and Fe/S-containing active site metal center, the A cluster, catalyzes acetyl C-C bond formation/breakdown. Carbonyl group exchange of [1-C-14]acetyl-CoA with unlabeled CO, a hallmark of CODH/ACS, is weakly active in ACDS, and exchange with CO2 was up to 350 times faster, indicating tight coupling of CO release at the A cluster to CO oxidation to CO2 at the C cluster in CO dehydrogenase. The basis for tight coupling was investigated by analysis of three recombinant A cluster proteins, ACDS beta subunit from Methanosarcina thermophila, acetyl-CoA synthase of Carboxydothermus hydrogenoformans (ACS(Ch)), and truncated ACS(Ch) lacking its 317-amino acid N-terminal domain. A comparison of acetyl-CoA synthesis kinetics, CO exchange, acetyltransferase, and A cluster Ni+-CO EPR characteristics demonstrated a direct role of the ACS N-terminal domain in promoting acetyl C-C bond fragmentation. Protein conformational changes, related to "open/closed" states previously identified crystallographically, were indicated to have direct effects on the coordination geometry and stability of the A cluster Ni2+-acetyl intermediate, controlling Ni2+-acetyl fragmentation and Ni2+ (CO)(CH3) condensation. EPR spectral changes likely reflect variations in the Ni+-CO equatorial coordination environment in closed buried hydrophobic and open solvent-exposed states. The involvement of subunit-subunit interactions in ACDS, versus interdomain contacts in ACS, ensures that CO is not released from the ACDS beta subunit in the absence of appropriate interactions with the alpha(2)epsilon(2) CO dehydrogenase component. The resultant high efficiency CO transfer explains the low rate of CO exchange relative to CO2.	[Gencic, Simonida; Grahame, David A.] Uniformed Serv Univ Hlth Sci, Dept Biochem & Mol Biol, Bethesda, MD 20814 USA; [Duin, Evert C.] Auburn Univ, Dept Chem & Biochem, Auburn, AL 36849 USA	Uniformed Services University of the Health Sciences - USA; Auburn University System; Auburn University	Grahame, DA (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Biochem & Mol Biol, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	dgrahame@usuhs.mil			National Science Foundation [MCB-0923766, CHE-0848196]; United States Department of Energy [DE-FG02-00ER15108]	National Science Foundation(National Science Foundation (NSF)); United States Department of Energy(United States Department of Energy (DOE))	This work was supported by National Science Foundation Grant MCB-0923766, United States Department of Energy Grant DE-FG02-00ER15108 (to D. A. G.), and by National Science Foundation Grant CHE-0848196 (to E. C. D.).	Amara P, 2005, J AM CHEM SOC, V127, P2776, DOI 10.1021/ja0439221; Benkovic SJ, 2008, BIOCHEMISTRY-US, V47, P3317, DOI 10.1021/bi800049z; Bhaskar B, 1998, BIOCHEMISTRY-US, V37, P14491, DOI 10.1021/bi9812423; Darnault C, 2003, NAT STRUCT BIOL, V10, P271, DOI 10.1038/nsb912; DAS A, 2000, ENCY MICROBIOLOGY, V1, P18; DEAN JA, 1992, LANGES HDB CHEM, P51; Doukov TI, 2002, SCIENCE, V298, P567, DOI 10.1126/science.1075843; Doukov TI, 2008, BIOCHEMISTRY-US, V47, P3474, DOI 10.1021/bi702386t; Drake HL, 2008, ANN NY ACAD SCI, V1125, P100, DOI 10.1196/annals.1419.016; Eckert NA, 2007, J AM CHEM SOC, V129, P9286, DOI 10.1021/ja072063o; Ferry James G., 1993, P304; FISCHER R, 1990, ARCH MICROBIOL, V153, P156, DOI 10.1007/BF00247814; Funk T, 2004, J AM CHEM SOC, V126, P88, DOI 10.1021/ja0366033; Gencic S, 2003, J BIOL CHEM, V278, P6101, DOI 10.1074/jbc.M210484200; Gencic S, 2008, BIOCHEMISTRY-US, V47, P5544, DOI 10.1021/bi7024035; George SJ, 2005, J AM CHEM SOC, V127, P13500, DOI 10.1021/ja0528329; Gong W, 2008, P NATL ACAD SCI USA, V105, P9558, DOI 10.1073/pnas.0800415105; Graham DE, 2000, P NATL ACAD SCI USA, V97, P3304, DOI 10.1073/pnas.050564797; Grahame DA, 2005, ARCH MICROBIOL, V184, P32, DOI 10.1007/s00203-005-0006-3; GRAHAME DA, 1995, BIOCHEMISTRY-US, V34, P4617, DOI 10.1021/bi00014a015; Grahame DA, 1996, BIOCHEMISTRY-US, V35, P593, DOI 10.1021/bi9511494; Grahame DA, 1996, J BIOL CHEM, V271, P8352, DOI 10.1074/jbc.271.14.8352; GRAHAME DA, 1991, J BIOL CHEM, V266, P22227; Gu WW, 2003, J AM CHEM SOC, V125, P15343, DOI 10.1021/ja036602a; Ito M, 2009, P NATL ACAD SCI USA, V106, P11862, DOI 10.1073/pnas.0900433106; Kocsis E, 1999, J STRUCT BIOL, V128, P165, DOI 10.1006/jsbi.1999.4163; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LINDAHL PA, 1990, J BIOL CHEM, V265, P3873; Loke HK, 2002, J AM CHEM SOC, V124, P8667, DOI 10.1021/ja025924w; Maynard EL, 2001, BIOCHEMISTRY-US, V40, P13262, DOI 10.1021/bi015604+; Maynard EL, 2001, J AM CHEM SOC, V123, P4697, DOI 10.1021/ja004017t; Murakami E, 2000, J BIOL CHEM, V275, P4699, DOI 10.1074/jbc.275.7.4699; PERKINS SJ, 1986, EUR J BIOCHEM, V157, P169, DOI 10.1111/j.1432-1033.1986.tb09653.x; Peters D G, 1974, CHEM SEPARATIONS MEA, P19; Ragsdale SW, 2008, BBA-PROTEINS PROTEOM, V1784, P1873, DOI 10.1016/j.bbapap.2008.08.012; Ragsdale SW, 2004, CRIT REV BIOCHEM MOL, V39, P165, DOI 10.1080/10409230490496577; RAGSDALE SW, 1982, BIOCHEM BIOPH RES CO, V108, P658, DOI 10.1016/0006-291X(82)90880-4; RAGSDALE SW, 1985, J BIOL CHEM, V260, P3970; RAGSDALE SW, 1983, BIOCHEM BIOPH RES CO, V115, P658, DOI 10.1016/S0006-291X(83)80195-8; RAGSDALE SW, 1985, P NATL ACAD SCI USA, V82, P6811, DOI 10.1073/pnas.82.20.6811; RAYBUCK SA, 1991, J BACTERIOL, V173, P929, DOI 10.1128/jb.173.2.929-932.1991; Segel I, 1975, ENZYME KINETICS; Seravalli J, 2004, BIOCHEMISTRY-US, V43, P3944, DOI 10.1021/bi036194n; Seravalli J, 2000, BIOCHEMISTRY-US, V39, P1274, DOI 10.1021/bi991812e; Seravalli J, 2008, J BIOL CHEM, V283, P8384, DOI 10.1074/jbc.M709470200; Svetlitchnyi V, 2004, P NATL ACAD SCI USA, V101, P446, DOI 10.1073/pnas.0304262101; Tan XS, 2008, J BIOL INORG CHEM, V13, P771, DOI 10.1007/s00775-008-0363-x; Tan XS, 2005, J AM CHEM SOC, V127, P5833, DOI 10.1021/ja043701v; TERLESKY KC, 1987, J BIOL CHEM, V262, P15392; TERLESKY KC, 1986, J BACTERIOL, V168, P1053, DOI 10.1128/jb.168.3.1053-1058.1986; THAUER RK, 1988, EUR J BIOCHEM, V176, P497, DOI 10.1111/j.1432-1033.1988.tb14307.x; Thauer RK, 2008, NAT REV MICROBIOL, V6, P579, DOI 10.1038/nrmicro1931; Volbeda A, 2004, J BIOL INORG CHEM, V9, P525, DOI 10.1007/s00775-004-0565-9; Volbeda A, 2009, BIOCHEMISTRY-US, V48, P7916, DOI 10.1021/bi9003952; Webster CE, 2004, J AM CHEM SOC, V126, P3410, DOI 10.1021/ja038083h; XIA JQ, 1995, BIOCHEMISTRY-US, V34, P6037, DOI 10.1021/bi00018a005; Xia JQ, 1996, J AM CHEM SOC, V118, P483, DOI 10.1021/ja952845u; ZOU XA, 1995, INORG CHEM, V34, P1634, DOI 10.1021/ic00111a003	58	25	26	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15450	15463		10.1074/jbc.M109.080994	http://dx.doi.org/10.1074/jbc.M109.080994			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20202935	Green Published, hybrid			2022-12-25	WOS:000277399000065
J	Horn, D; Zhou, W; Trevisson, E; Al-Ali, H; Harris, TK; Salviati, L; Barrientos, A				Horn, Darryl; Zhou, Wen; Trevisson, Eva; Al-Ali, Hassan; Harris, Thomas K.; Salviati, Leonardo; Barrientos, Antoni			The Conserved Mitochondrial Twin Cx(9)C Protein Cmc2 Is a Cmc1 Homologue Essential for Cytochrome c Oxidase Biogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; SUPEROXIDE-DISMUTASE; COPPER CHAPERONE; INTERMEMBRANE SPACE; MEMBRANE SYSTEM; ASSEMBLY FACTOR; YEAST; SCO1; COX17; METALLOCHAPERONE	Mitochondrial copper metabolism and delivery to cytochrome c oxidase and mitochondrially localized CuZn-superoxide dismutase (Sod1) requires a growing number of intermembrane space proteins containing a twin Cx(9)C motif. Among them, Cmc1 was recently identified by our group. Here we describe another conserved mitochondrial metallochaperone-like protein, Cmc2, a close homologue of Cmc1, whose function affects both cytochrome c oxidase and Sod1. In the yeast Saccharomyces cerevisiae, Cmc2 localizes to the mitochondrial inner membrane facing the intermembrane space. In the absence of Cmc2, cytochrome c oxidase activity measured spectrophotometrically and cellular respiration measured polarographically are undetectable. Additionally, mutant cmc2 cells display 2-fold increased mitochondrial Sod1 activity, whereas CMC2 overexpression results in Sod1 activity decreased to 60% of wild-type levels. CMC1 overexpression does not rescue the respiratory defect of cmc2 mutants or vice versa. However, Cmc2 physically interacts with Cmc1 and the absence of Cmc2 induces a 5-fold increase in Cmc1 accumulation in the mitochondrial membranes. Cmc2 function is conserved from yeast to humans. Human CMC2 localizes to the mitochondria and CMC2 expression knockdown produces cytochrome c oxidase deficiency in Caenorhabditis elegans. We conclude that Cmc1 and Cmc2 have cooperative but nonoverlapping functions in cytochrome c oxidase biogenesis.	[Horn, Darryl; Zhou, Wen; Al-Ali, Hassan; Harris, Thomas K.; Barrientos, Antoni] Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, Miami, FL 33136 USA; [Barrientos, Antoni] Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA; [Trevisson, Eva; Salviati, Leonardo] Univ Padua, Dipartimento Pediat, Lab Oncoematol Pediat, I-35128 Padua, Italy	University of Miami; University of Miami; University of Padua	Barrientos, A (corresponding author), 1600 NW 10th Ave,RMSB 2067, Miami, FL 33136 USA.	abarrientos@med.miami.edu	Salviati, Leonardo/L-1007-2016; Trevisson, Eva/K-8462-2016; Zhou, Wen/A-5763-2010	Salviati, Leonardo/0000-0001-5642-9963; Trevisson, Eva/0000-0002-5380-6265; Zhou, Wen/0000-0002-5496-5815; Al-Ali, Hassan/0000-0002-8899-3443	National Institutes of Health [GM071775A]; Muscular Dystrophy Association [GM071775A]; Muscular Dystrophy Association; Italian Telethon [GGP06256]; American Heart Association; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071775] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); Muscular Dystrophy Association(Muscular Dystrophy Association); Italian Telethon(Fondazione Telethon); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM071775A(to A. B.), a Research Grant from the Muscular Dystrophy Association (to A. B.), Italian Telethon Grant GGP06256 (to L. S.), and an American Heart Association Predoctoral Fellowship (to D. H.).	Banci L, 2008, P NATL ACAD SCI USA, V105, P6803, DOI 10.1073/pnas.0800019105; Banci L, 2006, P NATL ACAD SCI USA, V103, P8595, DOI 10.1073/pnas.0601375103; Barrientos A, 2002, METHODS, V26, P307, DOI 10.1016/S1046-2023(02)00036-1; Barrientos A, 2004, EMBO J, V23, P3472, DOI 10.1038/sj.emboj.7600358; Barrientos A, 2002, EMBO J, V21, P43, DOI 10.1093/emboj/21.1.43; Barros MH, 2004, J BIOL CHEM, V279, P31943, DOI 10.1074/jbc.M405014200; Beers J, 1997, J BIOL CHEM, V272, P33191, DOI 10.1074/jbc.272.52.33191; Beers J, 2002, J BIOL CHEM, V277, P22185, DOI 10.1074/jbc.M202545200; Carr HS, 2005, J BIOL CHEM, V280, P22664, DOI 10.1074/jbc.M414077200; Carr HS, 2002, J BIOL CHEM, V277, P31237, DOI 10.1074/jbc.M204854200; Chevtzoff C, 2010, J BIOL CHEM, V285, P1733, DOI 10.1074/jbc.M109.019570; Cobine PA, 2004, J BIOL CHEM, V279, P14447, DOI 10.1074/jbc.M312693200; Cobine PA, 2006, J BIOL CHEM, V281, P36552, DOI 10.1074/jbc.M606839200; Cobine PA, 2006, BBA-MOL CELL RES, V1763, P759, DOI 10.1016/j.bbamcr.2006.03.002; Culotta VC, 1997, J BIOL CHEM, V272, P23469, DOI 10.1074/jbc.272.38.23469; FAYE G, 1974, J MOL BIOL, V88, P105, DOI 10.1016/0022-2836(74)90304-0; Field LS, 2003, J BIOL CHEM, V278, P28052, DOI 10.1074/jbc.M304296200; FLOHE L, 1984, METHOD ENZYMOL, V105, P93; Furukawa Y, 2004, EMBO J, V23, P2872, DOI 10.1038/sj.emboj.7600276; Glerum DM, 1996, J BIOL CHEM, V271, P20531, DOI 10.1074/jbc.271.34.20531; Glerum DM, 1996, J BIOL CHEM, V271, P14504, DOI 10.1074/jbc.271.24.14504; Grad Leslie I, 2007, Methods Mol Biol, V372, P51, DOI 10.1007/978-1-59745-365-3_4; Hell K, 2000, J BIOL CHEM, V275, P4571, DOI 10.1074/jbc.275.7.4571; Hiser L, 2000, J BIOL CHEM, V275, P619, DOI 10.1074/jbc.275.1.619; Horn D, 2008, IUBMB LIFE, V60, P421, DOI 10.1002/iub.50; Horn D, 2008, MOL CELL BIOL, V28, P4354, DOI 10.1128/MCB.01920-07; Horng YC, 2004, J BIOL CHEM, V279, P35334, DOI 10.1074/jbc.M404747200; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Khalimonchuk O, 2008, EUKARYOT CELL, V7, P1427, DOI 10.1128/EC.00132-08; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lamb AL, 2001, NAT STRUCT BIOL, V8, P751, DOI 10.1038/nsb0901-751; Lamb AL, 2000, BIOCHEMISTRY-US, V39, P14720, DOI 10.1021/bi002207a; Leary SC, 2009, HUM MOL GENET, V18, P2230, DOI 10.1093/hmg/ddp158; Longen S, 2009, J MOL BIOL, V393, P356, DOI 10.1016/j.jmb.2009.08.041; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Manthey GM, 1998, EUR J BIOCHEM, V255, P156, DOI 10.1046/j.1432-1327.1998.2550156.x; Mashkevich G, 1997, J BIOL CHEM, V272, P14356, DOI 10.1074/jbc.272.22.14356; Mesecke N, 2005, CELL, V121, P1059, DOI 10.1016/j.cell.2005.04.011; MYERS AM, 1985, EMBO J, V4, P2087, DOI 10.1002/j.1460-2075.1985.tb03896.x; NOBREGA MP, 1990, J BIOL CHEM, V265, P14220; Nobrega MP, 2002, J BIOL CHEM, V277, P40206, DOI 10.1074/jbc.M207348200; Rea SL, 2007, PLOS BIOL, V5, P2312, DOI 10.1371/journal.pbio.0050259; Rigby K, 2007, J BIOL CHEM, V282, P10233, DOI 10.1074/jbc.M610082200; ROTHSTEIN RJ, 1983, METHOD ENZYMOL, V101, P202; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; SOLANS A, 2004, PRECLINICA, V2, P336; Soto IC, 2009, BBA-MOL CELL RES, V1793, P1776, DOI 10.1016/j.bbamcr.2009.09.002; Sturtz LA, 2001, J BIOL CHEM, V276, P38084; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; TSUKIHARA T, 1995, SCIENCE, V269, P1069, DOI 10.1126/science.7652554; TZAGOLOFF A, 1975, J BIOL CHEM, V250, P8228; TZAGOLOFF A, 1975, J BIOL CHEM, V250, P8236; Wood WB, 1988, NEMATODE CAENORHABDI; Xie GF, 1995, GENET ANAL-BIOMOL E, V12, P95, DOI 10.1016/1050-3862(95)00112-3	55	29	33	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15088	15099		10.1074/jbc.M110.104786	http://dx.doi.org/10.1074/jbc.M110.104786			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20220131	Green Published, hybrid			2022-12-25	WOS:000277399000030
J	Czirjak, G; Enyedi, P				Czirjak, Gabor; Enyedi, Peter			TRESK Background K+ Channel Is Inhibited by Phosphorylation via Two Distinct Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOMAIN POTASSIUM CHANNEL; ROOT GANGLION NEURONS; FUNCTIONAL EXPRESSION; ANESTHETIC PROPERTIES; 14-3-3 PROTEINS; CALCINEURIN; TASK-3; MODULATION; ACTIVATION; TRANSPORT	The two-pore domain K+ channel, TRESK (TWIK-related spinal cord K+ channel, KCNK18) is directly regulated by the calcium/calmodulin-dependent phosphatase calcineurin and 14-3-3 adaptor proteins. The calcium signal robustly activates the channel via calcineurin, whereas the anchoring of 14-3-3 interferes with the return of the current to the resting state after the activation in Xenopus oocytes. In the present study, we report that the phosphorylation of TRESK at two distinct regulatory regions, the 14-3-3 binding site (Ser-264) and the cluster of three adjacent serine residues (Ser-274, Ser-276, and Ser-279), are responsible for channel inhibition. The phosphorylation of Ser-264 by protein kinase A accelerated the return of the current of S276E mutant TRESK to the resting state after the calcineurin-dependent activation. In the presence of 14-3-3, the basal current of the S276E mutant was reduced, and its calcineurin-dependent activation was augmented, suggesting that the direct binding of the adaptor protein to TRESK contributed to the basal inhibition of the channel under resting conditions. Unexpectedly, we found that 14-3-3 impeded the recovery of the current of S264E mutant TRESK to the resting state after the calcineurin-dependent activation, despite of the mutated 14-3-3 binding site. This suggests that 14-3-3 inhibited the kinase phosphorylating the regulatory cluster of Ser-274, Ser-276, and Ser-279, independently of the direct interaction between TRESK and 14-3-3. In conclusion, two distinct inhibitory kinase pathways converge on TRESK, and their effect on the calcineurin-dependent regulation is differentially modulated by the functional availability of 14-3-3.	[Czirjak, Gabor; Enyedi, Peter] Semmelweis Univ, Dept Physiol, Budapest, Hungary	Semmelweis University	Enyedi, P (corresponding author), Semmelweis Univ, Dept Physiol, POB 259, Budapest, Hungary.	enyedi@eok.sote.hu		Czirjak, Gabor/0000-0002-5485-2327	OTKA [F-67743, K75239]; Hungarian Academy of Sciences	OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Hungarian Academy of Sciences(Hungarian Academy of Sciences)	This work was supported by the Hungarian National Research Fund OTKA F-67743 (to G. C.) and OTKA K75239 (to P. E.).; Supported by the Janos Bolyai fellowship of the Hungarian Academy of Sciences.	Bautista DM, 2008, NAT NEUROSCI, V11, P772, DOI 10.1038/nn.2143; Brosnan R, 2006, ANESTH ANALG, V103, P86, DOI 10.1213/01.ane.0000221437.87338.af; Brosnan RJ, 2007, ANESTH ANALG, V104, P1430, DOI 10.1213/01.ane.0000264072.97705.0f; Czirjak B, 2004, J BIOL CHEM, V279, P18550, DOI 10.1074/jbc.M312229200; Czirjak G, 2002, J BIOL CHEM, V277, P5426, DOI 10.1074/jbc.M107138200; Czirjak G, 2008, J BIOL CHEM, V283, P15672, DOI 10.1074/jbc.M800712200; Czirjak G, 2006, J BIOL CHEM, V281, P14677, DOI 10.1074/jbc.M602495200; Dobler T, 2007, J PHYSIOL-LONDON, V585, P867, DOI 10.1113/jphysiol.2007.145649; Duprat F, 1997, EMBO J, V16, P5464, DOI 10.1093/emboj/16.17.5464; Egenberger B, 2010, BIOCHEM BIOPH RES CO, V391, P1262, DOI 10.1016/j.bbrc.2009.12.056; Fink M, 1998, EMBO J, V17, P3297, DOI 10.1093/emboj/17.12.3297; Fink M, 1996, EMBO J, V15, P6854, DOI 10.1002/j.1460-2075.1996.tb01077.x; Gerhold KA, 2009, ANN NY ACAD SCI, V1170, P184, DOI 10.1111/j.1749-6632.2009.03895.x; Girard C, 2001, BIOCHEM BIOPH RES CO, V282, P249, DOI 10.1006/bbrc.2001.4562; Han J, 2009, BIOCHEM BIOPH RES CO, V390, P1102, DOI 10.1016/j.bbrc.2009.10.076; Huang Dong-Yue, 2008, Neurosci Bull, V24, P166, DOI 10.1007/s12264-008-0225-0; Kang D, 2004, J BIOL CHEM, V279, P28063, DOI 10.1074/jbc.M402940200; Kang D, 2008, BIOCHEM BIOPH RES CO, V367, P609, DOI 10.1016/j.bbrc.2008.01.008; Kang D, 2006, AM J PHYSIOL-CELL PH, V291, pC138, DOI 10.1152/ajpcell.00629.2005; Keshavaprasad B, 2005, ANESTH ANALG, V101, P1042, DOI 10.1213/01.ane.0000168447.87557.5a; Kim Y, 2000, J BIOL CHEM, V275, P9340, DOI 10.1074/jbc.275.13.9340; Li HM, 2004, J MOL BIOL, V342, P1659, DOI 10.1016/j.jmb.2004.07.068; Li HM, 2007, J MOL BIOL, V369, P1296, DOI 10.1016/j.jmb.2007.04.032; Liu CH, 2004, ANESTH ANALG, V99, P1715, DOI 10.1213/01.ANE.0000136849.07384.44; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; O'Kelly I, 2002, CELL, V111, P577, DOI 10.1016/S0092-8674(02)01040-1; O'Kelly I, 2008, TRAFFIC, V9, P72, DOI 10.1111/j.1600-0854.2007.00663.x; Patel AJ, 1999, NAT NEUROSCI, V2, P422, DOI 10.1038/8084; Pottosin II, 2008, PFLUG ARCH EUR J PHY, V456, P1037, DOI 10.1007/s00424-008-0481-x; Rajan S, 2002, J PHYSIOL-LONDON, V545, P13, DOI 10.1113/jphysiol.2002.027052; Reyes R, 1998, J BIOL CHEM, V273, P30863, DOI 10.1074/jbc.273.47.30863; Sano Y, 2003, J BIOL CHEM, V278, P27406, DOI 10.1074/jbc.M206810200; Smith HS, 2009, PAIN PHYSICIAN, V12, pE309; Thorson JA, 1998, MOL CELL BIOL, V18, P5229, DOI 10.1128/MCB.18.9.5229; Valencia-Cruz G, 2009, AM J PHYSIOL-CELL PH, V297, pC1544, DOI 10.1152/ajpcell.00064.2009; Yang L, 2007, ANESTH ANALG, V105, P673, DOI 10.1213/01.ane.0000278127.68312.dc; Yoo S, 2009, NEUROSCI LETT, V465, P79, DOI 10.1016/j.neulet.2009.08.062	38	23	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14549	14557		10.1074/jbc.M110.102020	http://dx.doi.org/10.1074/jbc.M110.102020			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20215114	Green Published, hybrid			2022-12-25	WOS:000277299700051
J	Gurtner, A; Starace, G; Norelli, G; Piaggio, G; Sacchi, A; Bossi, G				Gurtner, Aymone; Starace, Giuseppe; Norelli, Giuseppe; Piaggio, Giulia; Sacchi, Ada; Bossi, Gianluca			Mutant p53-induced Up-regulation of Mitogen-activated Protein Kinase Kinase 3 Contributes to Gain of Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LI-FRAUMENI-SYNDROME; GENE-EXPRESSION; P53 GAIN; TUMOR MALIGNANCY; RNA INTERFERENCE; PATIENT SURVIVAL; TERMINAL DOMAIN; HUMAN CANCER; MUTATIONS; CELLS	Mitogen-activated protein kinase kinase 3 (MAP2K3) is a member of the dual specificity kinase group. Growing evidence links MAP2K3 to invasion and tumor progression. Here, we identify MAP2K3 as a transcriptional target of endogenous gain-of-function p53 mutants R273H, R175H, and R280K. We show that MAP2K3 modulation occurred at the mRNA and protein levels and that endogenous mutant p53 proteins are capable of binding to and activate the MAP2K3 promoter. In addition, we found that the studied p53 mutants regulate MAP2K3 gene expression through the involvement of the transcriptional cofactors NF-Y and NF-kappa B. Finally, functional studies showed that endogenous MAP2K3 knockdown inhibits proliferation and survival of human tumor cells, whereas the ectopic expression of MAP2K3 can rescue the proliferative defect induced by mutant p53 knockdown. Taken together, our findings define a novel player through which mutant p53 exerts its gain-of-function activity in cancer cells.	[Bossi, Gianluca] Regina Elena Inst Canc Res, Dept Expt Oncol, Mol Oncogenesis Lab, I-00158 Rome, Italy; [Starace, Giuseppe] Ist Neurobiol & Med Mol, Natl Res Council, I-00133 Rome, Italy	IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena	Bossi, G (corresponding author), Regina Elena Inst Canc Res, Dept Expt Oncol, Mol Oncogenesis Lab, Via Messi dOro 156, I-00158 Rome, Italy.	bossi@ifo.it	Bossi, Gianluca/B-9394-2017; Gurtner, Aymone/J-7217-2018; gurtner, aymone/AAB-8843-2020; Bossi, Gianluca/G-8375-2016; Piaggio, Giulia/J-7214-2018; Bossi, Gianluca/ABH-6846-2020; Piaggio, Giulia/AAD-7336-2022	Bossi, Gianluca/0000-0002-2947-1063; Gurtner, Aymone/0000-0002-7661-9059; gurtner, aymone/0000-0002-7661-9059; Bossi, Gianluca/0000-0002-2947-1063; Piaggio, Giulia/0000-0003-2114-1892; Bossi, Gianluca/0000-0002-2947-1063; 	Associazione Italiana per la Ricerca sul Cancro (AIRC) Italia-USA [IG 8804, IG 5408]; Ministero della Salute; Istituto Superiore di Sanita (ISS); Alleanza Contro il Cancro (ACC) [ICS-120.4/RA00-90, R.F.02/184]; community's sixth framework program	Associazione Italiana per la Ricerca sul Cancro (AIRC) Italia-USA(Fondazione AIRC per la ricerca sul cancro); Ministero della Salute(Ministry of Health, Italy); Istituto Superiore di Sanita (ISS); Alleanza Contro il Cancro (ACC); community's sixth framework program(European Commission)	This work was supported by Grant IG 8804 (to G. B.) and IG 5408 (to G. P.) from the Associazione Italiana per la Ricerca sul Cancro (AIRC) Italia-USA project, Ministero della Salute, Istituto Superiore di Sanita (ISS), and Alleanza Contro il Cancro (ACC) (ICS-120.4/RA00-90 and R.F.02/184 to G. P.). This study is part of the mutant p53 project, which has received research funding from the community's sixth framework program.	Aas T, 1996, NAT MED, V2, P811, DOI 10.1038/nm0796-811; Blandino G, 1999, ONCOGENE, V18, P477, DOI 10.1038/sj.onc.1202314; Bossi G, 2006, ONCOGENE, V25, P304, DOI 10.1038/sj.onc.1209026; Bossi G, 2008, CELL CYCLE, V7, P1870, DOI 10.4161/cc.7.12.6161; Brazdova M, 2009, NUCLEIC ACIDS RES, V37, P1486, DOI 10.1093/nar/gkn1085; Bullock AN, 2001, NAT REV CANCER, V1, P68, DOI 10.1038/35094077; Demuth T, 2007, MOL CANCER THER, V6, P1212, DOI 10.1158/1535-7163.MCT-06-0711; DERIJARD B, 1995, SCIENCE, V267, P682, DOI 10.1126/science.7839144; Di Agostino S, 2006, CANCER CELL, V10, P191, DOI 10.1016/j.ccr.2006.08.013; Fontemaggi G, 2009, NAT STRUCT MOL BIOL, V16, P1086, DOI 10.1038/nsmb.1669; Frazier MW, 1998, MOL CELL BIOL, V18, P3735, DOI 10.1128/MCB.18.7.3735; Gilmore TD, 2006, ONCOGENE, V25, P6887, DOI 10.1038/sj.onc.1209982; Gurtner A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002047; Hainaut P, 2000, ADV CANCER RES, V77, P81; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Kim E, 2004, J CELL BIOCHEM, V93, P878, DOI 10.1002/jcb.20271; KOZMA SC, 1987, NUCLEIC ACIDS RES, V15, P5963; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; LIN JY, 1995, ONCOGENE, V10, P2387; Manni I, 2001, J BIOL CHEM, V276, P5570, DOI 10.1074/jbc.M006052200; Mantovani R, 1998, NUCLEIC ACIDS RES, V26, P1135, DOI 10.1093/nar/26.5.1135; Matas D, 2001, EMBO J, V20, P4163, DOI 10.1093/emboj/20.15.4163; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Mizuarai S, 2006, CANCER RES, V66, P6319, DOI 10.1158/0008-5472.CAN-05-4629; Notterman DA, 2001, CANCER RES, V61, P3124; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Olson A, 2006, NUCLEIC ACIDS RES, V34, pD153, DOI 10.1093/nar/gkj051; OREN M, 2003, CELL DEATH DIFFER, V10, P413; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Sampath J, 2001, J BIOL CHEM, V276, P39359, DOI 10.1074/jbc.M103429200; Scian MJ, 2005, MOL CELL BIOL, V25, P10097, DOI 10.1128/MCB.25.22.10097-10110.2005; Scian MJ, 2004, CANCER RES, V64, P7447, DOI 10.1158/0008-5472.CAN-04-1568; Weisz L, 2007, ONCOGENE, V26, P2202, DOI 10.1038/sj.onc.1210294; Weisz L, 2004, CANCER RES, V64, P8318, DOI 10.1158/0008-5472.CAN-04-1145; Weisz L, 2007, CANCER RES, V67, P2396, DOI 10.1158/0008-5472.CAN-06-2425; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Yan WS, 2008, CANCER RES, V68, P6789, DOI 10.1158/0008-5472.CAN-08-0810; Yan WS, 2009, J BIOL CHEM, V284, P12178, DOI 10.1074/jbc.M900994200; Zalcenstein A, 2006, ONCOGENE, V25, P359, DOI 10.1038/sj.onc.1209061; Zalcenstein A, 2003, ONCOGENE, V22, P5667, DOI 10.1038/sj.onc.1206724	40	67	67	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14160	14169		10.1074/jbc.M109.094813	http://dx.doi.org/10.1074/jbc.M109.094813			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20223820	hybrid, Green Published			2022-12-25	WOS:000277299700012
J	Romero, G; Sneddon, WB; Yang, YM; Wheeler, D; Blair, HC; Friedman, PA				Romero, Guillermo; Sneddon, W. Bruce; Yang, Yanmei; Wheeler, David; Blair, Harry C.; Friedman, Peter A.			Parathyroid Hormone Receptor Directly Interacts with Dishevelled to Regulate beta-Catenin Signaling and Osteoclastogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED-RECEPTORS; FRIZZLED-RELATED PROTEIN-1; BONE-FORMATION; PDZ DOMAIN; KINASE-A; WNT; PHOSPHORYLATION; PATHWAY; ACTIVATION; CELLS	Bone growth and remodeling depend upon the opposing rates of bone formation and resorption. These functions are regulated by intrinsic seven transmembrane-spanning receptors, the parathyroid hormone receptor (PTH1R) and frizzled (FZD), through their respective ligands, parathyroid hormone (PTH) and Wnt. FZD activation of canonical beta-catenin signaling requires the adapter protein Dishevelled (Dvl). We identified a Dvl-binding motif in the PTH1R. Here, we report that the PTH1R activates the beta-catenin pathway by directly recruiting Dvl, independent of Wnt or LRP5/6. PTH1R coimmunoprecipitated with Dvl. Deleting the carboxyl-terminal PTH1R PDZ-recognition domain did not abrogate PTH1R-Dvl interactions; nor did truncating the receptor at position 480. However, further deletion eliminating the putative Dvl recognition domain abolished PTH1R interactions with Dvl. PTH activated beta-catenin in a time-and concentration-dependent manner and translocated beta-catenin to the nucleus. beta-Catenin activation was inhibited by Dvl2 dominant negatives and by short hairpin RNA sequences targeted against Dvl2. PTH-induced osteoclastogenesis was also inhibited by Dvl2 dominant negative mutants. These findings demonstrate that G protein-coupled receptors other than FZD directly activate beta-catenin signaling, thereby mimicking many of the functions of the canonical Wnt-FZD pathway. The distinct modes whereby FZD and PTH1R activate beta-catenin control convergent or divergent effects on osteoblast differentiation, and osteoclastogenesis may arise from PTH1R-induced second messenger phosphorylation.	[Romero, Guillermo; Sneddon, W. Bruce; Yang, Yanmei; Wheeler, David; Friedman, Peter A.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Lab G Prot Coupled Receptor Biol, Pittsburgh, PA 15261 USA; [Blair, Harry C.] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Friedman, PA (corresponding author), Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Lab G Prot Coupled Receptor Biol, W1340 Biomed Sci Tower,200 Lothrop St, Pittsburgh, PA 15261 USA.	paf10@pitt.edu			National Institutes of Health [DK54171, GM08208]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008208] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK54171 (to P. A. F.) and GM08208 (to D. W.).	Barnes MR, 1998, TRENDS PHARMACOL SCI, V19, P399, DOI 10.1016/S0165-6147(98)01246-2; Baron R, 2007, ENDOCRINOLOGY, V148, P2635, DOI 10.1210/en.2007-0270; Bodine PVN, 2006, REV ENDOCR METAB DIS, V7, P33, DOI 10.1007/s11154-006-9002-4; Bodine PVN, 2007, J CELL PHYSIOL, V210, P352, DOI 10.1002/jcp.20834; Bryja V, 2007, P NATL ACAD SCI USA, V104, P6690, DOI 10.1073/pnas.0611356104; Castellone MD, 2005, SCIENCE, V310, P1504, DOI 10.1126/science.1116221; CHAN SDH, 1992, J BIOL CHEM, V267, P25202; Chen W, 2001, P NATL ACAD SCI USA, V98, P14889, DOI 10.1073/pnas.211572798; Ek ETH, 2006, CRIT REV ONCOL HEMAT, V60, P1, DOI 10.1016/j.critrevonc.2006.03.006; Fang XJ, 2000, P NATL ACAD SCI USA, V97, P11960, DOI 10.1073/pnas.220413597; Fu Q, 2002, J BIOL CHEM, V277, P48868, DOI 10.1074/jbc.M208494200; Gao C, 2010, CELL SIGNAL, V22, P717, DOI 10.1016/j.cellsig.2009.11.021; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; Guo J, 2010, CELL METAB, V11, P161, DOI 10.1016/j.cmet.2009.12.007; Haq S, 2003, P NATL ACAD SCI USA, V100, P4610, DOI 10.1073/pnas.0835895100; Hartmann C, 2006, TRENDS CELL BIOL, V16, P151, DOI 10.1016/j.tcb.2006.01.001; Hay E, 2005, J BIOL CHEM, V280, P13616, DOI 10.1074/jbc.M411999200; Hecht A, 2000, EMBO J, V19, P1839, DOI 10.1093/emboj/19.8.1839; Hino S, 2005, MOL CELL BIOL, V25, P9063, DOI 10.1128/MCB.25.20.9063-9072.2005; Hogarth DK, 2004, AM J PHYSIOL-CELL PH, V287, pC449, DOI 10.1152/ajpcell.00547.2003; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Kulkarni NH, 2005, J CELL BIOCHEM, V95, P1178, DOI 10.1002/jcb.20506; Lanske B, 1996, SCIENCE, V273, P663, DOI 10.1126/science.273.5275.663; Li J, 2000, P NATL ACAD SCI USA, V97, P1566, DOI 10.1073/pnas.97.4.1566; London TBC, 2004, BIOCHEM BIOPH RES CO, V322, P326, DOI 10.1016/j.bbrc.2004.07.113; Malbon CC, 2006, CURR TOP DEV BIOL, V72, P153, DOI 10.1016/S0070-2153(05)72002-0; Malbon CC, 2004, FRONT BIOSCI-LANDMRK, V9, P1048, DOI 10.2741/1308; Malecz N, 1998, MOL ENDOCRINOL, V12, P1846, DOI 10.1210/me.12.12.1846; Schulte G, 2007, TRENDS PHARMACOL SCI, V28, P518, DOI 10.1016/j.tips.2007.09.001; Schwarz-Romond T, 2007, J CELL SCI, V120, P2402, DOI 10.1242/jcs.002956; Sneddon WB, 2003, J BIOL CHEM, V278, P43787, DOI 10.1074/jbc.M306019200; Sokol SY, 1996, CURR BIOL, V6, P1456, DOI 10.1016/S0960-9822(96)00750-6; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Suzuki A, 2008, J CELL BIOCHEM, V104, P304, DOI 10.1002/jcb.21626; Takemaru KI, 2000, J CELL BIOL, V149, P249, DOI 10.1083/jcb.149.2.249; Taurin S, 2006, J BIOL CHEM, V281, P9971, DOI 10.1074/jbc.M508778200; Tawfeek HAW, 2002, MOL ENDOCRINOL, V16, P1, DOI 10.1210/me.16.1.1; Tobimatsu T, 2006, ENDOCRINOLOGY, V147, P2583, DOI 10.1210/en.2005-1627; Umbhauer M, 2000, EMBO J, V19, P4944, DOI 10.1093/emboj/19.18.4944; Wan M, 2008, GENE DEV, V22, P2968, DOI 10.1101/gad.1702708; Wang B, 2008, MOL BIOL CELL, V19, P1637, DOI 10.1091/mbc.E07-11-1114; Wang B, 2007, J BIOL CHEM, V282, P36214, DOI 10.1074/jbc.M707263200; Wang SS, 1998, FEBS LETT, V427, P103, DOI 10.1016/S0014-5793(98)00402-5; Weinman EJ, 2006, ANNU REV PHYSIOL, V68, P491, DOI 10.1146/annurev.physiol.68.040104.131050; Westendorf JJ, 2004, GENE, V341, P19, DOI 10.1016/j.gene.2004.06.044; Wheeler D, 2007, J BIOL CHEM, V282, P25076, DOI 10.1074/jbc.M701544200; Wong HC, 2003, MOL CELL, V12, P1251, DOI 10.1016/S1097-2765(03)00427-1; Yang M, 2005, P NATL ACAD SCI USA, V102, P6027, DOI 10.1073/pnas.0501535102; Yao W, 2010, J BONE MINER RES, V25, P190, DOI 10.1359/jbmr.090719; Yu A, 2007, DEV CELL, V12, P129, DOI 10.1016/j.devcel.2006.10.015	52	66	69	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14756	14763		10.1074/jbc.M110.102970	http://dx.doi.org/10.1074/jbc.M110.102970			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20212039	Green Published, hybrid			2022-12-25	WOS:000277299700073
J	Zielonka, J; Sikora, A; Joseph, J; Kalyanaraman, B				Zielonka, Jacek; Sikora, Adam; Joseph, Joy; Kalyanaraman, Balaraman			Peroxynitrite Is the Major Species Formed from Different Flux Ratios of Co-generated Nitric Oxide and Superoxide DIRECT REACTION WITH BORONATE-BASED FLUORESCENT PROBE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE NITRATION; XANTHINE-OXIDASE; PULSE-RADIOLYSIS; BIOLOGICAL-ACTIVITY; ENDOTHELIAL-CELLS; RELAXING FACTOR; CHEMISTRY; NO; MECHANISM; OXIDATION	There is much interest in the nitration and oxidation reaction mechanisms initiated by superoxide radical anion (O(2)radical anion) and nitric oxide ((NO)-N-center dot). It is well known that O(2)radical anion and (NO)-N-center dot rapidly react to form a potent oxidant, peroxynitrite anion (ONOO-). However, indirect measurements with the existing probes (e.g. dihydrorhodamine) previously revealed a bell-shaped response to co-generated (NO)-N-center dot and O(2)radical anion fluxes, with the maximal yield of the oxidation or nitration product occurring at a 1:1 ratio. These results raised doubts on the formation of ONOO- per se at various fluxes of (NO)-N-center dot and O(2)radical anion. Using a novel fluorogenic probe, coumarin-7-boronic acid, that reacts stoichiometrically and rapidly with ONOO- (k = 1.1 x 10(6) M(-1)s(-1)), we report that ONOO- formation increased linearly and began to plateau after reaching a 1:1 ratio of co-generated (NO)-N-center dot and O(2)radical anion fluxes. We conclude that ONOO- is formed as the primary intermediate during the reaction between (NO)-N-center dot and O(2)radical anion co-generated at different fluxes.	[Zielonka, Jacek; Sikora, Adam; Joseph, Joy; Kalyanaraman, Balaraman] Med Coll Wisconsin, Dept Biophys, Milwaukee, WI 53226 USA; [Zielonka, Jacek; Sikora, Adam; Joseph, Joy; Kalyanaraman, Balaraman] Med Coll Wisconsin, Free Radical Res Ctr, Milwaukee, WI 53226 USA; [Sikora, Adam] Tech Univ Lodz, Inst Appl Radiat Chem, PL-90924 Lodz, Poland	Medical College of Wisconsin; Medical College of Wisconsin; Lodz University of Technology	Kalyanaraman, B (corresponding author), Med Coll Wisconsin, Dept Biophys, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	balarama@mcw.edu	Zielonka, Jacek/N-9546-2014; Sikora, Adam B/I-2756-2014	Zielonka, Jacek/0000-0002-2524-0145; Sikora, Adam B/0000-0002-4962-8945	National Institutes of Health [HL063119]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063119] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL063119 (to B. K.).	Augusto O, 2002, FREE RADICAL BIO MED, V32, P841, DOI 10.1016/S0891-5849(02)00786-4; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; BLOUGH NV, 1985, INORG CHEM, V24, P3502, DOI 10.1021/ic00216a003; Brown DI, 2009, FREE RADICAL BIO MED, V47, P1239, DOI 10.1016/j.freeradbiomed.2009.07.023; Burner U, 2000, J BIOL CHEM, V275, P20597, DOI 10.1074/jbc.M000181200; Du LP, 2008, TETRAHEDRON LETT, V49, P3045, DOI 10.1016/j.tetlet.2008.03.063; Ferrer-Sueta G, 2009, ACS CHEM BIOL, V4, P161, DOI 10.1021/cb800279q; Goldstein S, 2000, J BIOL CHEM, V275, P3031, DOI 10.1074/jbc.275.5.3031; GOLDSTEIN S, 1995, FREE RADICAL BIO MED, V19, P505, DOI 10.1016/0891-5849(95)00034-U; Goldstein S, 1999, CHEM RES TOXICOL, V12, P132, DOI 10.1021/tx9802522; Goldstein S, 2008, METHOD ENZYMOL, V436, P49, DOI 10.1016/S0076-6879(08)36004-2; GRYGLEWSKI RJ, 1986, NATURE, V320, P454, DOI 10.1038/320454a0; Gunther MR, 2002, TOXICOLOGY, V177, P1, DOI 10.1016/S0300-483X(02)00191-9; Hodges GR, 2000, CHEM RES TOXICOL, V13, P1287, DOI 10.1021/tx0001272; Houston M, 1998, ARCH BIOCHEM BIOPHYS, V355, P1, DOI 10.1006/abbi.1998.0675; HUIE RE, 1993, FREE RADICAL RES COM, V18, P195, DOI 10.3109/10715769309145868; Ianni JC, 2003, COMPUTATIONAL FLUID AND SOLID MECHANICS 2003, VOLS 1 AND 2, PROCEEDINGS, P1368; Ichimori K, 1999, J BIOL CHEM, V274, P7763, DOI 10.1074/jbc.274.12.7763; IGNARRO LJ, 1988, J PHARMACOL EXP THER, V244, P181; Jourd'heuil D, 2001, J BIOL CHEM, V276, P28799, DOI 10.1074/jbc.M102341200; Kirsch M, 2003, ARCH BIOCHEM BIOPHYS, V418, P133, DOI 10.1016/j.abb.2003.07.002; Kissner R, 1999, METHOD ENZYMOL, V301, P342; Kissner R, 1997, CHEM RES TOXICOL, V10, P1285, DOI 10.1021/tx970160x; KOBAYASHI K, 1995, J CHEM SOC DALTON, P2885, DOI 10.1039/dt9950002885; Lee CI, 2000, J BIOL CHEM, V275, P9369, DOI 10.1074/jbc.275.13.9369; Liochev SI, 2002, ARCH BIOCHEM BIOPHYS, V402, P166, DOI 10.1016/S0003-9861(02)00074-7; LYMAR SV, 1995, J AM CHEM SOC, V117, P8867, DOI 10.1021/ja00139a027; MASSEY V, 1959, BIOCHIM BIOPHYS ACTA, V34, P255, DOI 10.1016/0006-3002(59)90259-8; Miles AM, 1996, J BIOL CHEM, V271, P40, DOI 10.1074/jbc.271.1.40; MURPHY ME, 1994, METHOD ENZYMOL, V233, P240; PACHER P, 2007, PHYSIOL REV, V315, P424; Palazzolo-Ballance AM, 2007, BIOCHEMISTRY-US, V46, P7536, DOI 10.1021/bi700123s; PALMER RMJ, 1988, NATURE, V333, P664, DOI 10.1038/333664a0; Pfeiffer S, 2001, J BIOL CHEM, V276, P34051, DOI 10.1074/jbc.M100585200; Quijano C, 2005, FREE RADICAL BIO MED, V39, P728, DOI 10.1016/j.freeradbiomed.2005.04.014; Reiter CD, 2000, J BIOL CHEM, V275, P32460, DOI 10.1074/jbc.M910433199; ROYALL JA, 1993, ARCH BIOCHEM BIOPHYS, V302, P348, DOI 10.1006/abbi.1993.1222; Sawa T, 2000, J BIOL CHEM, V275, P32467, DOI 10.1074/jbc.M910169199; Sikora A, 2009, FREE RADICAL BIO MED, V47, P1401, DOI 10.1016/j.freeradbiomed.2009.08.006; Squadrito GL, 2000, ARCH BIOCHEM BIOPHYS, V376, P333, DOI 10.1006/abbi.2000.1721; Thomas DD, 2002, P NATL ACAD SCI USA, V99, P12691, DOI 10.1073/pnas.202312699; Thomas DD, 2002, METHOD ENZYMOL, V359, P84; Thomas DD, 2006, J BIOL CHEM, V281, P25984, DOI 10.1074/jbc.M602242200; Wardman P, 2007, FREE RADICAL BIO MED, V43, P995, DOI 10.1016/j.freeradbiomed.2007.06.026; ZIELONKA J, 2009, FREE RADIC BIOL MED, V47, pS40	46	167	171	1	54	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14210	14216		10.1074/jbc.M110.110080	http://dx.doi.org/10.1074/jbc.M110.110080			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20194496	hybrid, Green Published			2022-12-25	WOS:000277299700017
J	Courter, D; Cao, HB; Kwok, S; Kong, C; Banh, A; Kuo, PW; Bouley, DM; Vice, C; Brustugun, OT; Denko, NC; Koong, AC; Giaccia, A; Le, QT				Courter, Donald; Cao, Hongbin; Kwok, Shirley; Kong, Christina; Banh, Alice; Kuo, Peiwen; Bouley, Donna M.; Vice, Carmen; Brustugun, Odd Terje; Denko, Nicholas C.; Koong, Albert C.; Giaccia, Amato; Le, Quynh-Thu			The RGD Domain of Human Osteopontin Promotes Tumor Growth and Metastasis through Activation of Survival Pathways	PLOS ONE			English	Article							MUSCLE-CELL-MIGRATION; INTEGRIN MONOCLONAL-ANTIBODY; PROMATRIX METALLOPROTEINASE-2; HEPATOCELLULAR-CARCINOMA; DOWN-REGULATION; BREAST-CANCER; NULL MICE; EXPRESSION; BINDING; ALPHA-V-BETA-3	Background: Human osteopontin (OPN), a known tumor associated protein, exists in different isoforms, whose function is unclear. It also possesses a RGD domain, which has been implicated in diverse function. Here, we use genetic approaches to systematically investigate the function of the RGD domain in different OPN isoforms on tumor progression and metastasis for 2 different solid tumor models. Methodology/Principal Findings: Using isoform-specific qRT-PCR, we found that OPN-A and B were the main isoforms overexpressed in evaluated human tumors, which included 4 soft tissue sarcomas, 24 lung and 30 head and neck carcinomas. Overexpression of either OPN-A or B in two different cell types promoted local tumor growth and lung metastasis in SCID mouse xenografts. However, expression of either isoform with the RGD domain either mutated or deleted decreased tumor growth and metastasis, and resulted in increased apoptosis by TUNEL staining. In vitro, whereas mutation of the RGD domain did not affect cell-cell adhesion, soft agar growth or cell migration, it increased apoptosis under hypoxia and serum starvation. This effect could be mitigated when the RGD mutant cells were treated with condition media containing WT OPN. Mechanistically, the RGD region of OPN inhibited apoptosis by inducing NF-kappa B activation and FAK phosphorylation. Inhibition of NF-kappa B (by siRNA to the p65 subunit) or FAK activation (by a inhibitor) significantly increased apoptosis under hypoxia in WT OPN cells, but not in RGD mutant cells. Conclusion/Significance: Unlike prior reports, our data suggest that the RGD domain of both OPN-A and B promote tumor growth and metastasis mainly by protecting cells against apoptosis under stressed conditions and not via migration or invasion. Future inhibitors directed against OPN should target multiple isoforms and should inhibit cell survival mechanisms that involve the RGD domain, FAK phosphorylation and NF-kappa B activation.	[Courter, Donald; Cao, Hongbin; Banh, Alice; Kuo, Peiwen; Vice, Carmen; Denko, Nicholas C.; Koong, Albert C.; Giaccia, Amato; Le, Quynh-Thu] Stanford Univ, Dept Radiat Oncol, Stanford, CA 94305 USA; [Kwok, Shirley; Kong, Christina] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Bouley, Donna M.] Stanford Univ, Dept Comparat Med, Stanford, CA 94305 USA; [Brustugun, Odd Terje] Norwegian Radium Hosp, Oslo Univ Hosp, Dept Oncol, Oslo, Norway	Stanford University; Stanford University; Stanford University; University of Oslo	Courter, D (corresponding author), Stanford Univ, Dept Radiat Oncol, Stanford, CA 94305 USA.	Qle@stanford.edu	denko, nicholas/F-8444-2010	Koong, Albert/0000-0001-9824-1643; Le, Quynh Thu/0000-0002-3682-1439	Public Health Service [CA09302]; National Cancer Institute, Department of Health and Human Services [P01-CA67166]; NATIONAL CANCER INSTITUTE [P01CA067166, T32CA009302] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); National Cancer Institute, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This investigation was supported by Public Health Service Grant Number CA09302 (DC) and P01-CA67166 (QTL, AB, HC, DC, PK, NCD, AK, AJG) awarded by the National Cancer Institute, Department of Health and Human Services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan AL, 2006, AM J PATHOL, V169, P233, DOI 10.2353/ajpath.2006.051152; Ashkar S, 2000, SCIENCE, V287, P860, DOI 10.1126/science.287.5454.860; BLASBERG JD, 2009, J THORAC CARDIOVASC; Burdo TH, 2007, J LEUKOCYTE BIOL, V81, P1504, DOI 10.1189/jlb.1106711; Cao ZG, 2008, MOL IMMUNOL, V45, P3683, DOI 10.1016/j.molimm.2008.06.008; Chae S, 2009, INT J ONCOL, V35, P1409, DOI 10.3892/ijo_00000458; Chakraborty G, 2008, CANCER RES, V68, P152, DOI 10.1158/0008-5472.CAN-07-2126; Christensen B, 2005, BIOCHEM J, V390, P285, DOI 10.1042/BJ20050341; Christensen B, 2007, J BIOL CHEM, V282, P19463, DOI 10.1074/jbc.M703055200; Cui R, 2007, LUNG CANCER, V57, P302, DOI 10.1016/j.lungcan.2007.03.019; Da Silva APB, 2006, J CELL PHYSIOL, V208, P629, DOI 10.1002/jcp.20701; Denhardt DT, 1998, J CELL BIOCHEM, P92, DOI 10.1002/(SICI)1097-4644(1998)72:30/31+<92::AID-JCB13>3.0.CO;2-A; Denhardt DT, 2001, J CLIN INVEST, V107, P1055, DOI 10.1172/JCI12980; Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695; Fan KX, 2008, ARTHRITIS RHEUM-US, V58, P2041, DOI 10.1002/art.23490; FONG YC, 2008, LUNG CANC; Furger KA, 2003, MOL CANCER RES, V1, P810; Geissinger E, 2002, CANCER RES, V62, P4820; GONG M, 2008, CANC LETT; Gravallese EM, 2003, J CLIN INVEST, V112, P147, DOI 10.1172/JCI200310109; Graves EE, 2007, TECHNOL CANCER RES T, V6, P111, DOI 10.1177/153303460700600207; Gu T, 2009, LUNG CANCER, V66, P176, DOI 10.1016/j.lungcan.2009.02.004; He B, 2006, ONCOGENE, V25, P2192, DOI 10.1038/sj.onc.1209248; Hehlgans S, 2007, BBA-REV CANCER, V1775, P163, DOI 10.1016/j.bbcan.2006.09.001; Hood JD, 2002, NAT REV CANCER, V2, P91, DOI 10.1038/nrc727; Hsieh YH, 2006, CANCER RES, V66, P7119, DOI 10.1158/0008-5472.CAN-06-1002; HU DD, 1995, ANN NY ACAD SCI, V760, P312, DOI 10.1111/j.1749-6632.1995.tb44644.x; HU DD, 1995, J BIOL CHEM, V270, P26232, DOI 10.1074/jbc.270.44.26232; Hur EM, 2007, NAT IMMUNOL, V8, P74, DOI 10.1038/ni1415; Ivanov SV, 2009, BIOCHEM BIOPH RES CO, V382, P514, DOI 10.1016/j.bbrc.2009.03.042; Kazanecki CC, 2007, J CELL BIOCHEM, V102, P912, DOI 10.1002/jcb.21558; Khan SA, 2002, J CELL BIOCHEM, V85, P728, DOI 10.1002/jcb.10170; Kim HJ, 2009, P NATL ACAD SCI USA, V106, P15326, DOI 10.1073/pnas.0903704106; Le QT, 2003, CLIN CANCER RES, V9, P59; Le QT, 2007, INT J RADIAT ONCOL, V69, P167, DOI 10.1016/j.ijrobp.2007.01.071; Li JJ, 2007, BIOCHEM BIOPH RES CO, V356, P13, DOI 10.1016/j.bbrc.2007.02.092; LIAW L, 1994, CIRC RES, V74, P214, DOI 10.1161/01.RES.74.2.214; LIAW L, 1995, J CLIN INVEST, V95, P713, DOI 10.1172/JCI117718; Lin YH, 2001, J BIOL CHEM, V276, P46024, DOI 10.1074/jbc.M105132200; Loster K, 1997, ANAL BIOCHEM, V244, P96, DOI 10.1006/abio.1996.9883; Martin PL, 2005, CLIN CANCER RES, V11, P6959, DOI 10.1158/1078-0432.CCR-04-2623; Mi ZY, 2006, CARCINOGENESIS, V27, P1134, DOI 10.1093/carcin/bgi352; Mirza M, 2008, INT J CANCER, V122, P889, DOI 10.1002/ijc.23204; MIYAUCHI A, 1991, J BIOL CHEM, V266, P20369; NASU K, 1995, BIOCHEM J, V307, P257, DOI 10.1042/bj3070257; Ning SC, 2008, MOL CANCER THER, V7, P1569, DOI 10.1158/1535-7163.MCT-08-0288; Nystrom T, 2007, EXP CELL RES, V313, P1149, DOI 10.1016/j.yexcr.2006.12.026; OLDBERG A, 1986, P NATL ACAD SCI USA, V83, P8819, DOI 10.1073/pnas.83.23.8819; Philip S, 2001, J BIOL CHEM, V276, P44926, DOI 10.1074/jbc.M103334200; Philip S, 2003, J BIOL CHEM, V278, P14487, DOI 10.1074/jbc.M207309200; Rice J, 2006, J VASC RES, V43, P422, DOI 10.1159/000094884; Rittling SR, 2004, BRIT J CANCER, V90, P1877, DOI 10.1038/sj.bjc.6601839; Rittling SR, 2002, J BIOL CHEM, V277, P9175, DOI 10.1074/jbc.M109028200; Scatena M, 1998, J CELL BIOL, V141, P1083, DOI 10.1083/jcb.141.4.1083; SENGER DR, 1994, MOL BIOL CELL, V5, P565, DOI 10.1091/mbc.5.5.565; Trikha M, 2004, INT J CANCER, V110, P326, DOI 10.1002/ijc.20116; Tuck AB, 2000, J CELL BIOCHEM, V78, P465, DOI 10.1002/1097-4644(20000901)78:3<465::AID-JCB11>3.0.CO;2-C; Tuck AB, 2007, J CELL BIOCHEM, V102, P859, DOI 10.1002/jcb.21520; Wai PY, 2008, CANCER METAST REV, V27, P103, DOI 10.1007/s10555-007-9104-9; Wai PY, 2004, J SURG RES, V121, P228, DOI 10.1016/j.jss.2004.03.028; Yokosaki Y, 2005, MATRIX BIOL, V24, P418, DOI 10.1016/j.matbio.2005.05.005; YUE TL, 1994, EXP CELL RES, V214, P459, DOI 10.1006/excr.1994.1282; Zhao J, 2008, GASTROENTEROLOGY, V135, P956, DOI 10.1053/j.gastro.2008.05.025; ZHU Y, 2005, ONCOGENE; Zohar R, 2004, AM J PHYSIOL-HEART C, V287, pH1730, DOI 10.1152/ajpheart.00098.2004	65	44	48	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2010	5	3							e9633	10.1371/journal.pone.0009633	http://dx.doi.org/10.1371/journal.pone.0009633			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565XE	20224789	Green Published, Green Submitted, gold			2022-12-25	WOS:000275328800027
J	Collins, SC; Coffee, B; Benke, PJ; Berry-Kravis, E; Gilbert, F; Oostra, B; Halley, D; Zwick, ME; Cutler, DJ; Warren, ST				Collins, Stephen C.; Coffee, Brad; Benke, Paul J.; Berry-Kravis, Elizabeth; Gilbert, Fred; Oostra, Ben; Halley, Dicky; Zwick, Michael E.; Cutler, David J.; Warren, Stephen T.			Array-Based FMR1 Sequencing and Deletion Analysis in Patients with a Fragile X Syndrome-Like Phenotype	PLOS ONE			English	Article							MENTAL-RETARDATION; POINT MUTATION; GENE; REGION	Background: Fragile X syndrome (FXS) is caused by loss of function mutations in the FMR1 gene. Trinucleotide CGG-repeat expansions, resulting in FMR1 gene silencing, are the most common mutations observed at this locus. Even though the repeat expansion mutation is a functional null mutation, few conventional mutations have been identified at this locus, largely due to the clinical laboratory focus on the repeat tract. Methodology/Principal Findings: To more thoroughly evaluate the frequency of conventional mutations in FXS-like patients, we used an array-based method to sequence FMR1 in 51 unrelated males exhibiting several features characteristic of FXS but with normal CGG-repeat tracts of FMR1. One patient was identified with a deletion in FMR1, but none of the patients were found to have other conventional mutations. Conclusions/Significance: These data suggest that missense mutations in FMR1 are not a common cause of the FXS phenotype in patients who have normal-length CGG-repeat tracts. However, screening for small deletions of FMR1 may be of clinically utility.	[Collins, Stephen C.; Coffee, Brad; Zwick, Michael E.; Cutler, David J.; Warren, Stephen T.] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA; [Benke, Paul J.] Joe DiMaggio Childrens Hosp, Hollywood, FL USA; [Berry-Kravis, Elizabeth] Rush Univ, Med Ctr, Dept Pediat, Chicago, IL 60612 USA; [Berry-Kravis, Elizabeth] Rush Univ, Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA; [Gilbert, Fred] Weill Cornell Med Coll, Dept Pediat, New York, NY USA; [Oostra, Ben; Halley, Dicky] Erasmus Univ, Dept Clin Genet, NL-3000 DR Rotterdam, Netherlands; [Warren, Stephen T.] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA USA; [Warren, Stephen T.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA	Emory University; Rush University; Rush University; Cornell University; Erasmus University Rotterdam; Emory University; Emory University	Collins, SC (corresponding author), Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA.	swarren@emory.edu	Warren, Stephen T/A-2498-2012		National Institutes of Heath [HD020521, HD024064]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD020521, R01HD020521] Funding Source: NIH RePORTER	National Institutes of Heath(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	National Institutes of Heath HD020521 and HD024064 to STW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Castellvi-Bel S, 1999, AM J MED GENET, V84, P262, DOI 10.1002/(SICI)1096-8628(19990528)84:3<262::AID-AJMG18>3.0.CO;2-V; Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001; CHIURAZZI P, 1994, AM J MED GENET, V51, P309, DOI 10.1002/ajmg.1320510405; Coffee B, 2008, AM J MED GENET A, V146A, P1358, DOI 10.1002/ajmg.a.32261; Cutler DJ, 2001, GENOME RES, V11, P1913, DOI 10.1101/gr.197201; DEBOULLE K, 1993, NAT GENET, V3, P31, DOI 10.1038/ng0193-31; DEGRAAFF E, 1995, HUM MOL GENET, V4, P45; Garber KB, 2008, EUR J HUM GENET, V16, P666, DOI 10.1038/ejhg.2008.61; GEDEON AK, 1992, NAT GENET, V1, P341, DOI 10.1038/ng0892-341; Gronskov K, 1998, HUM GENET, V102, P440, DOI 10.1007/s004390050718; LUGENBEEL KA, 1995, NAT GENET, V10, P483, DOI 10.1038/ng0895-483; Okou DT, 2007, NAT METHODS, V4, P907, DOI 10.1038/NMETH1109; Reyniers E, 1996, AM J MED GENET, V64, P408, DOI 10.1002/(SICI)1096-8628(19960809)64:2<408::AID-AJMG35>3.3.CO;2-L; Shinahara Kumi, 2004, Journal of Medical Investigation, V51, P52, DOI 10.2152/jmi.51.52; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; TARLETON J, 1993, HUM MOL GENET, V2, P1973, DOI 10.1093/hmg/2.11.1973; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; Vincent JB, 1996, MOL PSYCHIATR, V1, P227; Wang YC, 1997, HUM MUTAT, V10, P393, DOI 10.1002/(SICI)1098-1004(1997)10:5<393::AID-HUMU10>3.3.CO;2-Q; WOHRLE D, 1992, AM J HUM GENET, V51, P299	20	22	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2010	5	3							e9476	10.1371/journal.pone.0009476	http://dx.doi.org/10.1371/journal.pone.0009476			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	564EX	20221430	Green Published, gold			2022-12-25	WOS:000275197200003
J	Han, YS; Ogut, O				Han, Young Soo; Ogut, Ozgur			Regulation of Fibre Contraction in a Rat Model of Myocardial Ischemia	PLOS ONE			English	Article							BINDING-PROTEIN-C; SKELETAL-MUSCLE FIBERS; TROPONIN-I PHOSPHORYLATION; CARDIAC TROPONIN; THIN-FILAMENT; HEART-FAILURE; RABBIT PSOAS; KINASE-C; INORGANIC-PHOSPHATE; FORCE GENERATION	Background: The changes in the actomyosin crossbridge cycle underlying altered contractility of the heart are not well described, despite their importance to devising rational treatment approaches. Methodology/Principal Findings: A rat ischemia-reperfusion model was used to determine the transitions of the crossbridge cycle impacted during ischemia. Compared to perfused hearts, the maximum force per cross-sectional area and Ca(2+) sensitivity of fibers from ischemic hearts were both reduced. Muscle activation by photolytic release of Ca(2+) and ATP suggested that the altered contractility was best described as a reduction in the rate of activation of noncycling actomyosin crossbridges to activated, cycling states. More specifically, the apparent forward rate constant of the transition between the nonforce bearing A-M.ADP.Pi state and the bound, force bearing AM*.ADP.Pi state was reduced in ischemic fibers, suggesting that this transition is commensurate with initial crossbridge activation. These results suggested an alteration in the relationship between the activation of thin filament regulatory units and initial crossbridge attachment, prompting an examination of the post-translational state of troponin (Tn) T and I. These analyses indicated a reduction in the diphosphorylated form of TnT during ischemia, along with lower Ser23/24 phosphorylation of Tnl. Treatment of perfused fibers by 8-Br-cAMP increased Ser23/24 phosphorylation of Tnl, altering the reverse rate constant of the Pi isomerization in a manner consistent with the lusitropic effect of beta-adrenergic stimulation. However, similar treatment of ischemic fibers did not change TnI phosphorylation or the kinetics of the Pi isomerization. Conclusions: Ischemia reduces the isomerization from A-M. ADP.Pi to AM*.ADP.Pi, altering the kinetics of crossbridge activation through a mechanism that may be mediated by altered TnT and TnI phosphorylation.	[Han, Young Soo; Ogut, Ozgur] Mayo Clin, Div Cardiovasc Dis, Rochester, MN 55905 USA	Mayo Clinic	Han, YS (corresponding author), Mayo Clin, Div Cardiovasc Dis, Rochester, MN 55905 USA.	Ogut.Ozgur@Mayo.edu			NIH [HL78845, 78845-S1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL078845] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by NIH grant HL78845 and 78845-S1 to O. O. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo A, 1996, BIOPHYS J, V70, P2316, DOI 10.1016/S0006-3495(96)79797-7; Belin RJ, 2006, AM J PHYSIOL-HEART C, V291, pH2344, DOI 10.1152/ajpheart.00541.2006; Bell MG, 2006, BIOPHYS J, V90, P531, DOI 10.1529/biophysj.105.072769; Bers DM, 2008, ANNU REV PHYSIOL, V70, P23, DOI 10.1146/annurev.physiol.70.113006.100455; Biesiadecki BJ, 2002, J BIOL CHEM, V277, P50275, DOI 10.1074/jbc.M206369200; Bodor GS, 1997, CIRCULATION, V96, P1495, DOI 10.1161/01.CIR.96.5.1495; Bowling N, 1999, CIRCULATION, V99, P384, DOI 10.1161/01.CIR.99.3.384; BRENNER B, 1988, P NATL ACAD SCI USA, V85, P3265, DOI 10.1073/pnas.85.9.3265; Brickson S, 2007, AM J PHYSIOL-HEART C, V292, pH1747, DOI 10.1152/ajpheart.01037.2006; BRISTOW MR, 1982, NEW ENGL J MED, V307, P205, DOI 10.1056/NEJM198207223070401; Campbell K, 1997, BIOPHYS J, V72, P254, DOI 10.1016/S0006-3495(97)78664-8; Caremani M, 2008, BIOPHYS J, V95, P5798, DOI 10.1529/biophysj.108.130435; CHASE PB, 1995, AM J PHYSIOL-CELL PH, V268, pC480, DOI 10.1152/ajpcell.1995.268.2.C480; Chen FC, 2006, AM J PHYSIOL-CELL PH, V290, pC719, DOI 10.1152/ajpcell.00419.2005; Christopher B, 2009, J MUSCLE RES CELL M, V30, P111, DOI 10.1007/s10974-009-9180-2; Decker RS, 2005, CIRCULATION, V111, P906, DOI 10.1161/01.CIR.0000155609.95618.75; El-Armouche A, 2007, J MOL CELL CARDIOL, V43, P223, DOI 10.1016/j.yjmcc.2007.05.003; FORD LE, 1977, J PHYSIOL-LONDON, V269, P441, DOI 10.1113/jphysiol.1977.sp011911; GAO WD, 1995, CIRC RES, V76, P1036, DOI 10.1161/01.RES.76.6.1036; GARVEY JL, 1988, BIOCHEM J, V249, P709, DOI 10.1042/bj2490709; GEEVES MA, 1994, BIOPHYS J, V67, P273, DOI 10.1016/S0006-3495(94)80478-3; Gillis TE, 2007, J PHYSIOL-LONDON, V580, P561, DOI 10.1113/jphysiol.2007.128975; GODT RE, 1989, J PHYSIOL-LONDON, V412, P155, DOI 10.1113/jphysiol.1989.sp017609; GOLDMAN YE, 1982, NATURE, V300, P701, DOI 10.1038/300701a0; GOLDMAN YE, 1984, J PHYSIOL-LONDON, V354, P577, DOI 10.1113/jphysiol.1984.sp015394; GORDON AM, 1987, J GEN PHYSIOL, V90, P321, DOI 10.1085/jgp.90.3.321; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; HIBBERD MG, 1985, SCIENCE, V228, P1317, DOI 10.1126/science.3159090; HOFMANN PA, 1993, CIRC RES, V72, P50, DOI 10.1161/01.RES.72.1.50; Jideama NM, 1996, J BIOL CHEM, V271, P23277, DOI 10.1074/jbc.271.38.23277; Lu Z, 2001, BIOPHYS J, V81, P334, DOI 10.1016/S0006-3495(01)75703-7; Lymperopoulos A, 2007, NAT MED, V13, P315, DOI 10.1038/nm1553; Manni S, 2008, J BIOL CHEM, V283, P24145, DOI 10.1074/jbc.M802278200; MARTIN H, 1994, BIOPHYS J, V67, P1933, DOI 10.1016/S0006-3495(94)80676-9; MARTIN H, 1994, BIOPHYS J, V66, P1115, DOI 10.1016/S0006-3495(94)80892-6; MCDONALD KS, 1995, CIRC RES, V77, P964, DOI 10.1161/01.RES.77.5.964; McDonald KS, 1998, J MOL CELL CARDIOL, V30, P285, DOI 10.1006/jmcc.1997.0603; MCKILLOP DFA, 1993, BIOPHYS J, V65, P693, DOI 10.1016/S0006-3495(93)81110-X; MERCADIER JJ, 1983, CIRC RES, V53, P52, DOI 10.1161/01.RES.53.1.52; Messer AE, 2007, J MOL CELL CARDIOL, V42, P247, DOI 10.1016/j.yjmcc.2006.08.017; MILLAR NC, 1992, AM J PHYSIOL, V262, pC1239, DOI 10.1152/ajpcell.1992.262.5.C1239; Nguyen TTT, 1996, CIRC RES, V79, P222, DOI 10.1161/01.RES.79.2.222; Razumova MV, 2000, BIOPHYS J, V78, P3120, DOI 10.1016/S0006-3495(00)76849-4; Sanada S, 2004, CIRCULATION, V110, P51, DOI 10.1161/01.CIR.0000133390.12306.C7; SCHIER JJ, 1982, J CLIN INVEST, V69, P816, DOI 10.1172/JCI110521; Scruggs SB, 2009, J BIOL CHEM, V284, P5097, DOI 10.1074/jbc.M807414200; SIEMANKOWSKI RF, 1985, P NATL ACAD SCI USA, V82, P658, DOI 10.1073/pnas.82.3.658; Solaro RJ, 2008, J BIOL CHEM, V283, P26829, DOI 10.1074/jbc.R800037200; Solis RS, 2008, J MUSCLE RES CELL M, V29, P203, DOI 10.1007/s10974-009-9168-y; Solzin J, 2007, BIOPHYS J, V93, P3917, DOI 10.1529/biophysj.107.111146; Stelzer JE, 2007, CIRC RES, V101, P503, DOI 10.1161/CIRCRESAHA.107.153650; Sumandea MP, 2003, J BIOL CHEM, V278, P35135, DOI 10.1074/jbc.M306325200; Swartz DR, 1996, BIOPHYS J, V71, P1891, DOI 10.1016/S0006-3495(96)79388-8; SWARTZ DR, 1992, J BIOL CHEM, V267, P20497; Tesi C, 2002, J PHYSIOL-LONDON, V541, P187, DOI 10.1113/jphysiol.2001.013418; Tobacman LS, 1996, ANNU REV PHYSIOL, V58, P447, DOI 10.1146/annurev.physiol.58.1.447; VOCI P, 1995, CIRCULATION, V91, P1714, DOI 10.1161/01.CIR.91.6.1714; Yagi N, 2002, PFLUG ARCH EUR J PHY, V445, P238, DOI 10.1007/s00424-002-0927-5; Yuan C, 2006, PROTEOMICS, V6, P4176, DOI 10.1002/pmic.200500894; Zakhary DR, 1999, CIRCULATION, V99, P505, DOI 10.1161/01.CIR.99.4.505	60	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2010	5	3							e9528	10.1371/journal.pone.0009528	http://dx.doi.org/10.1371/journal.pone.0009528			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	564EW	20209103	Green Published, gold, Green Submitted			2022-12-25	WOS:000275197100013
J	Meik, JM; Lawing, AM; Pires-daSilva, A				Meik, Jesse M.; Lawing, A. Michelle; Pires-daSilva, Andre			Body Size Evolution in Insular Speckled Rattlesnakes (Viperidae: Crotalus mitchellii)	PLOS ONE			English	Article							ISLAND RULE; MAINLAND POPULATIONS; BAJA-CALIFORNIA; TIGER SNAKES; NOTECHIS; MAMMALS; AREA; BIOGEOGRAPHY; DIMORPHISM; SELECTION	Background: Speckled rattlesnakes (Crotalus mitchellii) inhabit multiple islands off the coast of Baja California, Mexico. Two of the 14 known insular populations have been recognized as subspecies based primarily on body size divergence from putative mainland ancestral populations; however, a survey of body size variation from other islands occupied by these snakes has not been previously reported. We examined body size variation between island and mainland speckled rattlesnakes, and the relationship between body size and various island physical variables among 12 island populations. We also examined relative head size among giant, dwarfed, and mainland speckled rattlesnakes to determine whether allometric differences conformed to predictions of gape size (and indirectly body size) evolving in response to shifts in prey size. Methodology/Principal Findings: Insular speckled rattlesnakes show considerable variation in body size when compared to mainland source subspecies. In addition to previously known instances of gigantism on Angel de la Guarda and dwarfism on El Muerto, various degrees of body size decrease have occurred frequently in this taxon, with dwarfed rattlesnakes occurring mostly on small, recently isolated, land-bridge islands. Regression models using the Akaike information criterion (AIC) showed that mean SVL of insular populations was most strongly correlated with island area, suggesting the influence of selection for different body size optima for islands of different size. Allometric differences in head size of giant and dwarf rattlesnakes revealed patterns consistent with shifts to larger and smaller prey, respectively. Conclusions/Significance: Our data provide the first example of a clear relationship between body size and island area in a squamate reptile species; among vertebrates this pattern has been previously documented in few insular mammals. This finding suggests that selection for body size is influenced by changes in community dynamics that are related to graded differences in area over what are otherwise similar bioclimatic conditions. We hypothesize that in this system shifts to larger prey, episodic saturation and depression of primary prey density, and predator release may have led to insular gigantism, and that shifts to smaller prey and increased reproductive efficiency in the presence of intense intraspecific competition may have led to insular dwarfism.	[Meik, Jesse M.; Pires-daSilva, Andre] Univ Texas Arlington, Dept Biol, Arlington, TX 76019 USA; [Lawing, A. Michelle] Indiana Univ, Dept Geol Sci, Bloomington, IN 47405 USA	University of Texas System; University of Texas Arlington; Indiana University System; Indiana University Bloomington	Meik, JM (corresponding author), Univ Texas Arlington, Dept Biol, Arlington, TX 76019 USA.	jmeik@uta.edu	Silva, André/HHN-2071-2022; da Silva, Andre Pires/B-1066-2008; Lawing, Michelle/F-7453-2019	da Silva, Andre Pires/0000-0002-0741-7197; Lawing, Michelle/0000-0003-4041-6177	TE Inc; California Academy of Sciences	TE Inc; California Academy of Sciences	Partial funding for this research was provided by a grant from T&E Inc. and by a Stearns Grants-in-Aid of Herpetological Research from the California Academy of Sciences to JMM, and a Phi Sigma Biological Honor Society Grant to AML. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RP, 2002, EVOLUTION, V56, P1045; Aubret F, 2004, NATURE, V431, P261, DOI 10.1038/431261a; Barton NH, 1996, PHILOS T R SOC B, V351, P785, DOI 10.1098/rstb.1996.0073; Boback SM, 2006, COPEIA, P261, DOI 10.1643/0045-8511(2006)6[261:AMCOIA]2.0.CO;2; Boback SM, 2003, EVOLUTION, V57, P345; Bolnick DI, 2007, P NATL ACAD SCI USA, V104, P10075, DOI 10.1073/pnas.0703743104; Bonnet X, 2002, AUSTRAL ECOL, V27, P442, DOI 10.1046/j.1442-9993.2002.01198.x; BROWN JH, 1993, AM NAT, V142, P573, DOI 10.1086/285558; BURNHAM KP, 2002, MODEL SELECTION MULT, pR26; CALDER WA, 1996, SIZE FUNCTION LIFE H, pR16; CAMPBELL JA, 2004, VENOMOUS REPTILES W, pR18; Carreno Ana Luisa, 2002, P14; Case Ted J., 2002, P221; CASE TJ, 1978, ECOLOGY, V59, P1, DOI 10.2307/1936628; CASE TJ, 2002, NEW ISLAND BIOGEOGRA, pR17; Clegg SM, 2002, P ROY SOC B-BIOL SCI, V269, P1359, DOI 10.1098/rspb.2002.2024; DARWIN CR, 1845, VOYAGE BEAGLE; Douglas ME, 2006, MOL ECOL, V15, P3353, DOI 10.1111/j.1365-294X.2006.03007.x; DUNHAM AE, 1978, ECOLOGY, V59, P1230, DOI 10.2307/1938236; FORSMAN A, 1991, J ANIM ECOL, V60, P253, DOI 10.2307/5458; FORSMAN A, 1993, FUNCT ECOL, V7, P183, DOI 10.2307/2389885; Grant Peter R., 1998; GRISMER LL, 2002, AMPHIBIANS REPTILES, pR13; Harmon LJ, 2006, EVOLUTION, V60, P2622; Hasegawa M., 1989, P414; Hasegawa Masami, 2008, South American Journal of Herpetology, V3, P145, DOI 10.2994/1808-9798(2008)3[145:DAGISG]2.0.CO;2; HEANEY LR, 1978, EVOLUTION, V32, P29, DOI 10.1111/j.1558-5646.1978.tb01096.x; Jaeger RG, 1998, HERPETOLOGICA, V54, pS64; Keogh JS, 2005, EVOLUTION, V59, P226; King RB, 2002, FUNCT ECOL, V16, P766, DOI 10.1046/j.1365-2435.2002.00678.x; Klauber L. M., 1963, Transactions of the San Diego Society for Natural History, V13, P73; Klauber L. M., 1938, Occasional Papers of the San Diego Society of Natural History, VNo. 4, P1; KLAUBER LAURENCE M, 1940, OCCAS PAPERS SAN DIEGO SOC NAT HIST, V6, P1; KLAUBER LM, 1949, T SAN DIEGO SOC NAT, V13, P73; LAWLOR TE, 1982, AM NAT, V119, P54, DOI 10.1086/283890; Lawlor Timothy E., 2002, P326; LEVITON AE, 1985, COPEIA, P802; Lomolino MV, 2005, J BIOGEOGR, V32, P1683, DOI 10.1111/j.1365-2699.2005.01314.x; LOMOLINO MV, 1985, AM NAT, V125, P310, DOI 10.1086/284343; LONDSDALE P, 1989, E PACIFIC OCEAN HAWA, P449; MAC ARTHUR ROBERT H., 1967; Meiri S, 2005, ECOL LETT, V8, P1211, DOI 10.1111/j.1461-0248.2005.00825.x; Meiri S, 2008, GLOBAL ECOL BIOGEOGR, V17, P724, DOI 10.1111/j.1466-8238.2008.00414.x; Meiri S, 2008, P ROY SOC B-BIOL SCI, V275, P141, DOI 10.1098/rspb.2007.1056; Meiri S, 2007, GLOBAL ECOL BIOGEOGR, V16, P702, DOI 10.1111/j.1466-8238.2007.00327.x; MELTON R H, 1982, Evolutionary Theory, V6, P113; Millien V, 2006, PLOS BIOL, V4, P1863, DOI 10.1371/journal.pbio.0040321; MILLIMAN JD, 1968, SCIENCE, V162, P1121, DOI 10.1126/science.162.3858.1121; Murphy Robert W., 2002, P181; Murphy Robert W., 2002, P447; Pafilis P, 2009, NATURWISSENSCHAFTEN, V96, P1107, DOI 10.1007/s00114-009-0564-3; Palkovacs EP, 2003, OIKOS, V103, P37, DOI 10.1034/j.1600-0706.2003.12502.x; Pergams ORW, 1999, EVOLUTION, V53, P1573, DOI 10.1111/j.1558-5646.1999.tb05420.x; Petren K, 1997, EVOLUTION, V51, P206, DOI 10.1111/j.1558-5646.1997.tb02402.x; Schillaci MA, 2009, J BIOGEOGR, V36, P362, DOI 10.1111/j.1365-2699.2008.01984.x; SCHWANER TD, 1988, J HERPETOL, V22, P24, DOI 10.2307/1564353; SCHWANER TD, 1990, J HERPETOL, V24, P320, DOI 10.2307/1564405; SHINE R, 1987, HERPETOLOGICA, V43, P233; SMITH FA, 1992, FUNCT ECOL, V6, P265, DOI 10.2307/2389516; SOULE M, 1970, American Naturalist, V104, P85, DOI 10.1086/282642; SOULE M, 1966, AM NAT, V100, P47, DOI 10.1086/282399; STOCK JM, 1989, TECTONICS, V8, P99, DOI 10.1029/TC008i001p00099; Sun LX, 2002, J ZOOL, V256, P511, DOI 10.1017/S095283692000560; Van Valen L, 1973, EVOL THEORY, V49, P31, DOI DOI 10.1007/S13398-014-0173-7.2; Wallace AR, 1880, ISLAND LIFE; White TA, 2007, J BIOGEOGR, V34, P356, DOI 10.1111/j.1365-2699.2006.01599.x; WILCOX BA, 1978, SCIENCE, V199, P996, DOI 10.1126/science.199.4332.996	67	24	28	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2010	5	3							e9524	10.1371/journal.pone.0009524	http://dx.doi.org/10.1371/journal.pone.0009524			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	564EW	20209105	Green Published, Green Submitted, gold			2022-12-25	WOS:000275197100010
J	Bansal, S; Pourbohloul, B; Hupert, N; Grenfell, B; Meyers, LA				Bansal, Shweta; Pourbohloul, Babak; Hupert, Nathaniel; Grenfell, Bryan; Meyers, Lauren Ancel			The Shifting Demographic Landscape of Pandemic Influenza	PLOS ONE			English	Article							HONG-KONG INFLUENZA; TRANSMISSION PARAMETERS; ASIAN INFLUENZA; MORTALITY; EPIDEMIC; SPREAD; VIRUS; AGE; SCHOOLCHILDREN; PROTECTION	Background: As Pandemic (H1N1) 2009 influenza spreads around the globe, it strikes school-age children more often than adults. Although there is some evidence of pre-existing immunity among older adults, this alone may not explain the significant gap in age-specific infection rates. Methods and Findings: Based on a retrospective analysis of pandemic strains of influenza from the last century, we show that school-age children typically experience the highest attack rates in primarily naive populations, with the burden shifting to adults during the subsequent season. Using a parsimonious network-based mathematical model which incorporates the changing distribution of contacts in the susceptible population, we demonstrate that new pandemic strains of influenza are expected to shift the epidemiological landscape in exactly this way. Conclusions: Our analysis provides a simple demographic explanation for the age bias observed for H1N1/09 attack rates, and suggests that this bias may shift in coming months. These results have significant implications for the allocation of public health resources for H1N1/09 and future influenza pandemics.	[Bansal, Shweta] Penn State Univ, Ctr Infect Dis Dynam, University Pk, PA 16802 USA; [Bansal, Shweta; Grenfell, Bryan] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Pourbohloul, Babak] British Columbia Ctr Dis Control, Div Math Modeling, Vancouver, BC, Canada; [Pourbohloul, Babak] Univ British Columbia, Fac Med, Sch Populat & Publ Hlth, Vancouver, BC, Canada; [Hupert, Nathaniel] Weill Cornell Med Coll, Dept Publ Hlth, New York, NY USA; [Hupert, Nathaniel] US Ctr Dis Control & Prevent, Preparedness Modeling Unit, Atlanta, GA USA; [Grenfell, Bryan] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Meyers, Lauren Ancel] Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA; [Meyers, Lauren Ancel] Santa Fe Inst, Santa Fe, NM 87501 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); University of British Columbia; Cornell University; Centers for Disease Control & Prevention - USA; Princeton University; University of Texas System; University of Texas Austin; The Santa Fe Institute	Bansal, S (corresponding author), Penn State Univ, Ctr Infect Dis Dynam, University Pk, PA 16802 USA.	shweta@sbansal.com	Bansal, Shweta/GPW-8977-2022; Bansal, Shweta/AFV-6623-2022	Bansal, Shweta/0000-0002-1740-5421; Meyers, Lauren/0000-0002-5828-8874	Research and Policy for Infectious Disease Dynamics (RAPIDD) program of the Science and Technology Directorate; Department of Homeland Security; Fogarty International Center; National Institutes of Health (NIH); James F. McDonnell Foundation; National Science Foundation [DEB-0749097]; NIH Models of Infectious Disease Agent Study (MIDAS) [U01-GM087719-01]; Canadian Institutes of Health Research [PTL97125, PAP93425]; Michael Smith Foundation for Health Research; Direct For Biological Sciences [0749097] Funding Source: National Science Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD047879] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM087719] Funding Source: NIH RePORTER	Research and Policy for Infectious Disease Dynamics (RAPIDD) program of the Science and Technology Directorate; Department of Homeland Security(United States Department of Homeland Security (DHS)); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James F. McDonnell Foundation; National Science Foundation(National Science Foundation (NSF)); NIH Models of Infectious Disease Agent Study (MIDAS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Research and Policy for Infectious Disease Dynamics (RAPIDD) program of the Science and Technology Directorate, Department of Homeland Security, and the Fogarty International Center, National Institutes of Health (NIH); grants from the James F. McDonnell Foundation, National Science Foundation (DEB-0749097), and NIH Models of Infectious Disease Agent Study (MIDAS) (U01-GM087719-01) to L. A. M.; and support from the Canadian Institutes of Health Research (PTL97125 and PAP93425) and the Michael Smith Foundation for Health Research to B. P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON R M, 1991; BANSAL S, 2009, 09102008 ARX; Bansal S, 2007, J R SOC INTERFACE, V4, P879, DOI 10.1098/rsif.2007.1100; Bansal S, 2006, PLOS MED, V3, P1816, DOI 10.1371/journal.pmed.0030387; Barbour A., 1990, STOCHASTIC PROCESSES, P86; Barry JM, 2008, J INFECT DIS, V198, P1427, DOI 10.1086/592454; Barthelemy M., 2004, PHYS REV LETT, V92; Beutels P, 2006, EPIDEMIOL INFECT, V134, P1158, DOI 10.1017/S0950268806006418; *CDC ADV COMM IMM, 2009, NOV H1N1 VACC REC; *CDCP, 2009, FLU VIEW 2009 2010 I; *CDCP, 2009, S OIV CAS COUNT AG S; *CDCP, 2009, CDC EST 2009 H1N1 IN; Centers for Disease Control and Prevention, 2009, 2009 H1N1 FLU NEWS; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P521; Chan M, 2009, INFLUENZA A H1N1 LES; COLLINS S, 1957, PUBLIC HLTH MONOGRAP, V48; Collins SD, 1931, PUBLIC HEALTH REP, V46, P1909, DOI 10.2307/4580139; COUCH RB, 1983, ANNU REV MICROBIOL, V37, P529, DOI 10.1146/annurev.mi.37.100183.002525; COUCH RB, 1974, J INFECT DIS, V129, P411, DOI 10.1093/infdis/129.4.411; DAUER CC, 1961, AM REV RESPIR DIS, V83, P15; DAVIS LE, 1970, AM J EPIDEMIOL, V92, P240, DOI 10.1093/oxfordjournals.aje.a121203; DENNISTON G, 1962, 70 COMM DIS CTR; Dezso Z, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.055103; Eubank S, 2008, NDSSLTR07003 VIRG PO; Ferrari MJ, 2006, P ROY SOC B-BIOL SCI, V273, P2743, DOI 10.1098/rspb.2006.3636; Finkenstadt BF, 2005, STAT MED, V24, P3447, DOI 10.1002/sim.2196; Fiore AE, 2010, JAMA-J AM MED ASSOC, V303, P73, DOI 10.1001/jama.2009.1929; FOY HM, 1976, J INFECT DIS, V134, P362, DOI 10.1093/infdis/134.4.362; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Frost W.H., 1920, PUB HLTH REP, V35, P584, DOI DOI 10.2307/4575511; Gani R, 2005, EMERG INFECT DIS, V11, P1355; Garcia-Garcia L, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3928; GILBERT VE, 1962, AM J PUBLIC HEALTH N, V52, P1432, DOI 10.2105/AJPH.52.9.1432; Glezen WP, 1996, EPIDEMIOL REV, V18, P64, DOI 10.1093/oxfordjournals.epirev.a017917; GLEZEN WP, 1997, VIRAL INFECT HUMANS, P473; GREENBERG M, 2009, NEJM, V361; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Jordan EO., 1927, EPIDEMIC INFLUENZA S; Keeling MJ, 2005, J R SOC INTERFACE, V2, P295, DOI 10.1098/rsif.2005.0051; Keeling MJ, 1999, P ROY SOC B-BIOL SCI, V266, P859, DOI 10.1098/rspb.1999.0716; LONGINI IM, 1982, AM J EPIDEMIOL, V115, P736, DOI 10.1093/oxfordjournals.aje.a113356; Longini IM, 2005, AM J EPIDEMIOL, V161, P303, DOI 10.1093/aje/kwi053; Longini IM, 2004, AM J EPIDEMIOL, V159, P623, DOI 10.1093/aje/kwh092; Luk J, 2001, CLIN INFECT DIS, V33, P1375, DOI 10.1086/322662; MEDLOCK J, 2009, SCIENCE; Meltzer MI, 1999, EMERG INFECT DIS, V5, P659, DOI 10.3201/eid0505.990507; MEYERS L, 2003, EMERG INFECT DIS, V9; Meyers LA, 2005, J THEOR BIOL, V232, P71, DOI 10.1016/j.jtbi.2004.07.026; MONTO AS, 1975, AM J EPIDEMIOL, V102, P553, DOI 10.1093/oxfordjournals.aje.a112193; MONTO AS, 1985, AM J EPIDEMIOL, V121, P811, DOI 10.1093/oxfordjournals.aje.a114052; Moss OR, 2008, INT J NANOTECHNOL, V5, P3, DOI 10.1504/IJNT.2008.016547; MURPHY BR, 1972, NEW ENGL J MED, V286, P1329, DOI 10.1056/NEJM197206222862502; Newman M.E.J., 2002, PHYS REV E, V66; Nguyen-Van-Tam JS, 2003, VACCINE, V21, P1762, DOI 10.1016/S0264-410X(03)00069-0; Nichol KL, 2003, VACCINE, V21, P1769, DOI 10.1016/S0264-410X(03)00070-7; NISHIURA H, 2009, EUROSURVEILLANCE, V14, P22; NOBLE GR, 1974, AM J EPIDEMIOL, V100, P517; PEASE CM, 1987, THEOR POPUL BIOL, V31, P422, DOI 10.1016/0040-5809(87)90014-1; PERROTT GS, 1958, PUBLIC HEALTH REP, V73, P121, DOI 10.2307/4590059; Pourbohloul B, 2009, INFLUENZA OTHER RESP, V3, P215, DOI 10.1111/j.1750-2659.2009.00100.x; Read JM, 2008, J R SOC INTERFACE, V5, P1001, DOI 10.1098/rsif.2008.0013; Reichert TA, 2001, NEW ENGL J MED, V344, P889, DOI 10.1056/NEJM200103223441204; SCHULMAN JL, 1969, P NATL ACAD SCI USA, V63, P326, DOI 10.1073/pnas.63.2.326; SCHULMAN JL, 1970, PROG MED VIROL, V12, P128; *SECR SAL, EST INFL; Simonsen L, 1998, J INFECT DIS, V178, P53, DOI 10.1086/515616; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; TABER LH, 1981, J HYG-CAMBRIDGE, V86, P303, DOI 10.1017/S0022172400069059; Taubenberger JK, 2006, EMERG INFECT DIS, V12, P15, DOI 10.3201/eid1209.05-0979; TAYLOR M, 1971, J R COLL GEN PRACTIT, V21; Vazquez A, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.066130; Viboud C, 2006, SCIENCE, V312, P447, DOI 10.1126/science.1125237; Wallinga J, 1999, TRENDS MICROBIOL, V7, P372, DOI 10.1016/S0966-842X(99)01546-2; Wallinga J, 2006, AM J EPIDEMIOL, V164, P936, DOI 10.1093/aje/kwj317; Woolhouse MEJ, 1997, P NATL ACAD SCI USA, V94, P338, DOI 10.1073/pnas.94.1.338	75	61	62	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2010	5	2							e9360	10.1371/journal.pone.0009360	http://dx.doi.org/10.1371/journal.pone.0009360			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	561RS	20195468	gold, Green Published, Green Submitted			2022-12-25	WOS:000274997000004
J	Hong, CC; Song, MZ				Hong, Chung-Chien; Song, Mingzhou			Optimal In Silico Target Gene Deletion through Nonlinear Programming for Genetic Engineering	PLOS ONE			English	Article							LYCOPENE BIOSYNTHESIS; REGULATORY NETWORKS; SIGNAL-TRANSDUCTION; YEAST	Background: Optimal selection of multiple regulatory genes, known as targets, for deletion to enhance or suppress the activities of downstream genes or metabolites is an important problem in genetic engineering. Such problems become more feasible to address in silico due to the availability of more realistic dynamical system models of gene regulatory and metabolic networks. The goal of the computational problem is to search for a subset of genes to knock out so that the activity of a downstream gene or a metabolite is optimized. Methodology/Principal Findings: Based on discrete dynamical system modeling of gene regulatory networks, an integer programming problem is formulated for the optimal in silico target gene deletion problem. In the first result, the integer programming problem is proved to be NP-hard and equivalent to a nonlinear programming problem. In the second result, a heuristic algorithm, called GKONP, is designed to approximate the optimal solution, involving an approach to prune insignificant terms in the objective function, and the parallel differential evolution algorithm. In the third result, the effectiveness of the GKONP algorithm is demonstrated by applying it to a discrete dynamical system model of the yeast pheromone pathways. The empirical accuracy and time efficiency are assessed in comparison to an optimal, but exhaustive search strategy. Significance: Although the in silico target gene deletion problem has enormous potential applications in genetic engineering, one must overcome the computational challenge due to its NP-hardness. The presented solution, which has been demonstrated to approximate the optimal solution in a practical amount of time, is among the few that address the computational challenge. In the experiment on the yeast pheromone pathways, the identified best subset of genes for deletion showed advantage over genes that were selected empirically. Once validated in vivo, the optimal target genes are expected to achieve higher genetic engineering effectiveness than a trial-and-error procedure.	[Hong, Chung-Chien; Song, Mingzhou] New Mexico State Univ, Dept Comp Sci, Las Cruces, NM 88003 USA	New Mexico State University	Hong, CC (corresponding author), Natl Cheng Kung Univ, Dept Stat, Tainan 70101, Taiwan.	joemsong@cs.nmsu.edu		Song, Mingzhou/0000-0002-6883-6547	National Cancer Institute [5U54CA132383]; NATIONAL CANCER INSTITUTE [U54CA132383] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors were supported in part by the National Cancer Institute grant number 5U54CA132383 and the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alper H, 2005, METAB ENG, V7, P155, DOI 10.1016/j.ymben.2004.12.003; Bornstein BJ, 2008, BIOINFORMATICS, V24, P880, DOI 10.1093/bioinformatics/btn051; COLE GM, 1990, MOL CELL BIOL, V10, P510, DOI 10.1128/MCB.10.2.510; Deutscher D, 2006, NAT GENET, V38, P993, DOI 10.1038/ng1856; Dewey T. Gregory, 2001, Functional and Integrative Genomics, V1, P269, DOI 10.1007/s101420000035; Dohlman HG, 2001, ANNU REV BIOCHEM, V70, P703, DOI 10.1146/annurev.biochem.70.1.703; FARYABI B, 2008, EURASIP J BIOINFORMA, V1, P1; Goutsias J, 2004, BIOPHYS J, V86, P1922, DOI 10.1016/S0006-3495(04)74257-5; Holter NS, 2001, P NATL ACAD SCI USA, V98, P1693, DOI 10.1073/pnas.98.4.1693; Jin YS, 2007, METAB ENG, V9, P337, DOI 10.1016/j.ymben.2007.03.003; Kofahl B, 2004, YEAST, V21, P831, DOI 10.1002/yea.1122; LAMPINEN J, 1999, P NOSTR 99, V2, P45; Maguire CA, 2008, MOL THER, V16, P1695, DOI 10.1038/mt.2008.168; Meir E, 2002, J EXP ZOOL, V294, P216, DOI 10.1002/jez.10187; Nakae J, 2008, FEBS LETT, V582, P54, DOI 10.1016/j.febslet.2007.11.025; Shmulevich I, 2002, J BIOL SYST, V10, P431, DOI 10.1142/S0218339002000706; Song M, 2009, IET SYST BIOL, V3, P203, DOI 10.1049/iet-syb.2008.0089; Sticklen MB, 2008, NAT REV GENET, V9, P433, DOI 10.1038/nrg2336; Storn R.M., 1995, DIFFERENTIAL EVOLUTI, V23; Takahashi K, 2005, FEBS LETT, V579, P1783, DOI 10.1016/j.febslet.2005.01.072; Wang Y, 2006, BIOINFORMATICS, V22, P2413, DOI 10.1093/bioinformatics/btl396; Zhan XL, 1997, GENE DEV, V11, P1690, DOI 10.1101/gad.11.13.1690	22	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2010	5	2							e9331	10.1371/journal.pone.0009331	http://dx.doi.org/10.1371/journal.pone.0009331			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SX	20195367	Green Published, Green Submitted, gold			2022-12-25	WOS:000274924200007
J	Tregoning, JS; Pribul, PK; Pennycook, AMJ; Hussell, T; Wang, B; Lukacs, N; Schwarze, J; Culley, FJ; Openshaw, PJM				Tregoning, John S.; Pribul, Philippa K.; Pennycook, Alasdair M. J.; Hussell, Tracy; Wang, Belinda; Lukacs, Nicholas; Schwarze, Jurgen; Culley, Fiona J.; Openshaw, Peter J. M.			The Chemokine MIP1 alpha/CCL3 Determines Pathology in Primary RSV Infection by Regulating the Balance of T Cell Populations in the Murine Lung	PLOS ONE			English	Article							RESPIRATORY-SYNCYTIAL-VIRUS; MACROPHAGE INFLAMMATORY PROTEIN-1-ALPHA; MICE; BRONCHIOLITIS; RESPONSES; DISEASE; IMMUNOPATHOLOGY; PATHOGENESIS; ENHANCEMENT; EXPRESSION	Background: CD8 T cells assist in the clearance of respiratory syncytial virus (RSV) infection from the lungs. However, disease after RSV infection is in part caused by excessive T cell activity, and a balance is therefore needed between beneficial and harmful cellular immune responses. The chemokine CCL3 (MIP1 alpha) is produced following RSV infection and is broadly chemotactic for both T cells and natural killer (NK) cells. We therefore investigated its role in RSV disease. Methodology/Principal Findings: CCL3 was produced biphasically, in both the early (day 1) and late (day 6-7) stages of infection. CCL3 depletion did not alter the recruitment of natural killer (NK) cells to the lungs during the early stage, but depletion did affect the later adaptive phase. While fewer T cells were recruited to the lungs of either CCL3 knockout or anti-CCL3 treated RSV infected mice, more RSV-specific pro-inflammatory T cells were recruited to the lung when CCL3 responses were impaired. This increase in RSV-specific pro-inflammatory T cells was accompanied by increased weight loss and illness after RSV infection. Conclusions/Significance: CCL3 regulates the balance of T cell populations in the lung and can alter the outcome of RSV infection. Understanding the role of inflammatory mediators in the recruitment of pathogenic T cells to the lungs may lead to novel methods to control RSV disease.	[Tregoning, John S.; Pribul, Philippa K.; Pennycook, Alasdair M. J.; Hussell, Tracy; Wang, Belinda; Culley, Fiona J.; Openshaw, Peter J. M.] Univ London Imperial Coll Sci Technol & Med, Dept Resp Med, Ctr Resp Infect Res, London, England; [Tregoning, John S.; Pribul, Philippa K.; Pennycook, Alasdair M. J.; Hussell, Tracy; Wang, Belinda; Culley, Fiona J.; Openshaw, Peter J. M.] Univ London Imperial Coll Sci Technol & Med, MRC & Asthma UK Ctr Allerg Mech Asthma, Natl Heart & Lung Inst, London, England; [Schwarze, Jurgen] Univ Edinburgh, Ctr Inflammat Res, Queens Med Res Inst, Edinburgh, Midlothian, Scotland; [Lukacs, Nicholas] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI USA	Imperial College London; Imperial College London; University of London; King's College London; University of Edinburgh; University of Michigan System; University of Michigan	Tregoning, JS (corresponding author), St Georges Univ London, Div Cellular & Mol Med, Ctr Infect, London, England.	p.openshaw@imperial.ac.uk	Lukacs, Nicholas W/ABH-5583-2020; Hussell, Tracy/O-4630-2014; Schwarze, Jürgen/F-7396-2011; Openshaw, Peter/AAL-9442-2020	Hussell, Tracy/0000-0001-7186-6141; Openshaw, Peter/0000-0002-7220-2555; Wang, Belinda Lei/0000-0002-6963-4963; Tregoning, John/0000-0001-8093-8741; Culley, Fiona/0000-0001-5208-4259; Schwarze, Jurgen/0000-0002-6899-748X	Wellcome Trust [54797/Z/98/Z, 071381/Z/03/Z, 055303/Z/98/Z]; University of London; NIH [036302]; MRC [G0400795] Funding Source: UKRI; Medical Research Council [G0400795, G9900991B] Funding Source: researchfish; Asthma UK [S06/001] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI036302] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); University of London; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Asthma UK; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Wellcome Trust program grants to PJMO (54797/Z/98/Z and 071381/Z/03/Z) and by a Wellcome Trust prize studentship (055303/Z/98/Z). The purchase of anti-TNF antibodies was covered by a grant from the University of London. NL was supported by NIH grant #036302. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonville CA, 1999, PEDIATR ALLERGY IMMU, V10, P39, DOI 10.1034/j.1399-3038.1999.101005.x; CANNON MJ, 1988, J EXP MED, V168, P1163, DOI 10.1084/jem.168.3.1163; Castellino F, 2006, NATURE, V440, P890, DOI 10.1038/nature04651; Collins PL, 2008, J VIROL, V82, P2040, DOI 10.1128/JVI.01625-07; Culley FJ, 2006, J VIROL, V80, P8151, DOI 10.1128/JVI.00496-06; Culley FJ, 2006, J VIROL, V80, P4521, DOI 10.1128/JVI.80.9.4521-4527.2006; Garofalo RP, 2001, J INFECT DIS, V184, P393, DOI 10.1086/322788; GRAHAM BS, 1991, J CLIN INVEST, V88, P1026, DOI 10.1172/JCI115362; Haeberle HA, 2001, J VIROL, V75, P878, DOI 10.1128/JVI.75.2.878-890.2001; Hussell T, 2001, EUR J IMMUNOL, V31, P2566, DOI 10.1002/1521-4141(200109)31:9<2566::AID-IMMU2566>3.0.CO;2-L; Kota S, 2008, J BIOL CHEM, V283, P22417, DOI 10.1074/jbc.M710415200; McNamara PS, 2005, J INFECT DIS, V191, P1225, DOI 10.1086/428855; Miller AL, 2004, J INFECT DIS, V189, P1419, DOI 10.1086/382958; Openshaw PJM, 2005, CLIN MICROBIOL REV, V18, P541, DOI 10.1128/CMR.18.3.541-555.2005; Pribul PK, 2008, J VIROL, V82, P4441, DOI 10.1128/JVI.02541-07; Ruckwardt TJ, 2009, J VIROL, V83, P3019, DOI 10.1128/JVI.00036-09; Rutigliano JA, 2004, J IMMUNOL, V173, P3408, DOI 10.4049/jimmunol.173.5.3408; Smyth RL, 2006, LANCET, V368, P312, DOI 10.1016/S0140-6736(06)69077-6; Sun J, 2009, NAT MED, V15, P277, DOI 10.1038/nm.1929; Topham PS, 1999, J CLIN INVEST, V104, P1549, DOI 10.1172/JCI7707; Tregoning JS, 2008, J VIROL, V82, P4115, DOI 10.1128/JVI.02313-07; Tregoning JS, 2010, CLIN MICROBIOL REV, V23, P74, DOI 10.1128/CMR.00032-09	22	37	38	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2010	5	2							e9381	10.1371/journal.pone.0009381	http://dx.doi.org/10.1371/journal.pone.0009381			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SX	20195359	gold, Green Published, Green Accepted			2022-12-25	WOS:000274924200012
J	Luo, JJ; Wang, J; Ma, TM; Sun, ZR				Luo, Junjie; Wang, Jun; Ma, Ting Martin; Sun, Zhirong			Reverse Engineering of Bacterial Chemotaxis Pathway via Frequency Domain Analysis	PLOS ONE			English	Article							BEHAVIORAL VARIABILITY; ESCHERICHIA-COLI; SINGLE-CELL; ADAPTATION; MODEL; ROBUSTNESS; RESPONSES; NOISE	Chemotaxis is defined as a behavior involving organisms sensing attractants or repellents and leading towards or away from them. Therefore, it is possible to reengineer chemotaxis network to control the movement of bacteria to our advantage. Understanding the design principles of chemotaxis pathway is a prerequisite and an important topic in synthetic biology. Here, we provide guidelines for chemotaxis pathway design by employing control theory and reverse engineering concept on pathway dynamic design. We first analyzed the mathematical models for two most important kinds of E. coli chemotaxis pathway-adaptive and non-adaptive pathways, and concluded that the control units of the pathway de facto function as a band-pass filter and a low-pass filter, respectively, by abstracting the frequency response properties of the pathways. The advantage of the band-pass filter is established, and we demonstrate how to tune the three key parameters of it-A (max amplification), omega(1) (down cut-off frequency) and omega(2) (up cut-off frequency) to optimize the chemotactic effect. Finally, we hypothesized a similar but simpler version of the dynamic pathway model based on the principles discovered and show that it leads to similar properties with native E. coli chemotactic behaviors. Our study provides an example of simulating and designing biological dynamics in silico and indicates how to make use of the native pathway's features in this process. Furthermore, the characteristics we discovered and tested through reverse engineering may help to understand the design principles of the pathway and promote the design of artificial chemotaxis pathways.	[Luo, Junjie; Ma, Ting Martin; Sun, Zhirong] Tsinghua Univ, Minist Educ Key Lab Bioinformat, Dept Biol Sci & Biotechnol, Beijing 100084, Peoples R China; [Wang, Jun] Tsinghua Univ, Dept Comp Sci, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University	Luo, JJ (corresponding author), Tsinghua Univ, Minist Educ Key Lab Bioinformat, Dept Biol Sci & Biotechnol, Beijing 100084, Peoples R China.	sunzhr@mail.tsinghua.edu.cn	Luo, Junjie/L-3285-2019	Long, Yicheng/0000-0002-0714-2322; Long, Yicheng/0000-0003-3578-5197	Hi-Tech Research and Development 863 Program of China [2006AA02003]; 973 project [2009CB918801]; National Science Foundation of China [30770498]	Hi-Tech Research and Development 863 Program of China(National High Technology Research and Development Program of China); 973 project(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Hi-Tech Research and Development 863 Program of China (No. 2006AA02003), Foundational Science Research Grant from the 973 project (No. 2009CB918801) and National Science Foundation of China Grant (No. 30770498). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon U, 1999, NATURE, V397, P168, DOI 10.1038/16483; Alon U, 1998, EMBO J, V17, P4238, DOI 10.1093/emboj/17.15.4238; Armitage JP, 1997, MICROBIOL-UK, V143, P3671, DOI 10.1099/00221287-143-12-3671; Armitage JP, 1997, ARCH MICROBIOL, V168, P249, DOI 10.1007/s002030050496; Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; BLOCK SM, 1983, J BACTERIOL, V154, P312, DOI 10.1128/JB.154.1.312-323.1983; BLOCK SM, 1982, CELL, V31, P215, DOI 10.1016/0092-8674(82)90421-4; Bourret RB, 2002, J BIOL CHEM, V277, P9625, DOI 10.1074/jbc.R100066200; Bren A, 2000, J BACTERIOL, V182, P6865, DOI 10.1128/JB.182.24.6865-6873.2000; CHIKOFSKY EJ, 1990, IEEE SOFTWARE, V7, P13, DOI 10.1109/52.43044; Cluzel P, 2000, SCIENCE, V287, P1652, DOI 10.1126/science.287.5458.1652; Emonet T, 2005, BIOINFORMATICS, V21, P2714, DOI 10.1093/bioinformatics/bti391; Emonet T, 2008, P NATL ACAD SCI USA, V105, P3304, DOI 10.1073/pnas.0705463105; Goldstein RA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000084; HOSNI YA, 1994, COMPUT IND ENG, V26, P341, DOI 10.1016/0360-8352(94)90066-3; Ingolia NT, 2008, NATURE, V454, P1059, DOI 10.1038/4541059a; ISHIHARA A, 1983, J BACTERIOL, V155, P228, DOI 10.1128/JB.155.1.228-237.1983; Korobkova E, 2004, NATURE, V428, P574, DOI 10.1038/nature02404; LAUB AJ, 1981, IEEE T AUTOMAT CONTR, V26, P407, DOI 10.1109/TAC.1981.1102602; Lauffenburger DA, 2000, P NATL ACAD SCI USA, V97, P5031, DOI 10.1073/pnas.97.10.5031; Liu ZW, 1996, BIOTECHNOL BIOENG, V51, P120, DOI 10.1002/(SICI)1097-0290(19960705)51:1<120::AID-BIT14>3.0.CO;2-U; Rao CV, 2002, NATURE, V420, P231, DOI 10.1038/nature01258; Scharf BE, 1998, J BACTERIOL, V180, P5123, DOI 10.1128/JB.180.19.5123-5128.1998; Scharf BE, 1998, P NATL ACAD SCI USA, V95, P201, DOI 10.1073/pnas.95.1.201; Sourjik V, 2002, P NATL ACAD SCI USA, V99, P123, DOI 10.1073/pnas.011589998; Soyer OS, 2006, J THEOR BIOL, V241, P223, DOI 10.1016/j.jtbi.2005.11.024; Spiro PA, 1997, P NATL ACAD SCI USA, V94, P7263, DOI 10.1073/pnas.94.14.7263; Tindall MJ, 2008, B MATH BIOL, V70, P1570, DOI 10.1007/s11538-008-9322-5; Tindall MJ, 2008, B MATH BIOL, V70, P1525, DOI 10.1007/s11538-008-9321-6; Topp S, 2007, J AM CHEM SOC, V129, P6807, DOI 10.1021/ja0692480; Tu YH, 2008, P NATL ACAD SCI USA, V105, P14855, DOI 10.1073/pnas.0807569105; Wadhams GH, 2004, NAT REV MOL CELL BIO, V5, P1024, DOI 10.1038/nrm1524; Yi TM, 2000, P NATL ACAD SCI USA, V97, P4649, DOI 10.1073/pnas.97.9.4649	33	36	38	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2010	5	3							e9182	10.1371/journal.pone.0009182	http://dx.doi.org/10.1371/journal.pone.0009182			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565XA	20231879	Green Submitted, Green Published, gold			2022-12-25	WOS:000275328300001
J	Sweeney, E; Roberts, D; Corbo, T; Jacenko, O				Sweeney, Elizabeth; Roberts, Douglas; Corbo, Tina; Jacenko, Olena			Congenic Mice Confirm That Collagen X Is Required for Proper Hematopoietic Development	PLOS ONE			English	Article							SEVERE COMBINED IMMUNODEFICIENCY; IMMUNO-OSSEOUS DYSPLASIA; STEM-CELL NICHE; HEPARAN-SULFATE PROTEOGLYCANS; CARTILAGE-HAIR-HYPOPLASIA; MARROW-STROMAL CELLS; BONE-MARROW; PROGENITOR CELLS; B LYMPHOPOIESIS; NULL MICE	The link between endochondral skeletal development and hematopoiesis in the marrow was established in the collagen X transgenic (Tg) and null (KO) mice. Disrupted function of collagen X, a major hypertrophic cartilage matrix protein, resulted in skeletal and hematopoietic defects in endochondrally derived tissues. Manifestation of the disease phenotype was variable, ranging from perinatal lethality in a subset of mice, to altered lymphopoiesis and impaired immunity in the surviving mice. To exclude contribution of strain specific modifiers to this variable manifestation of the skeleto-hematopoietic phenotype, C57Bl/6 and DBA/2J collagen X congenic lines were established. Comparable disease manifestations confirmed that the skeleto-hematopoietic alterations are an inherent outcome of disrupted collagen X function. Further, colony forming cell assays, complete blood count analysis, serum antibody ELISA, and organ outgrowth studies established altered lymphopoiesis in all collagen X Tg and KO mice and implicated opportunistic infection as a contributor to the severe disease phenotype. These data support a model where endochondral ossification-specific collagen X contributes to the establishment of a hematopoietic niche at the chondro-osseous junction.	[Sweeney, Elizabeth; Roberts, Douglas; Corbo, Tina; Jacenko, Olena] Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA	University of Pennsylvania	Sweeney, E (corresponding author), Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA.	jacenko@vet.upenn.edu		Sweeney, Timothy/0000-0002-3596-1093	National Institutes of Health [DK57904, AR053804 NRSA]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F32AR053804] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057904, R01DK088334] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was funded by National Institutes of Health; DK57904 (to OJ) and AR053804 NRSA (to ES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams GB, 2006, NATURE, V439, P599, DOI 10.1038/nature04247; Aguila HL, 2005, IMMUNOL REV, V208, P7, DOI 10.1111/j.0105-2896.2005.00333.x; Akintoye SO, 2006, BONE, V38, P758, DOI 10.1016/j.bone.2005.10.027; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Balduino A, 2005, CELL TISSUE RES, V319, P255, DOI 10.1007/s00441-004-1006-3; Borghesi LA, 1999, BLOOD, V93, P140, DOI 10.1182/blood.V93.1.140.401k40_140_148; Broxmeyer HE, 2001, INT J HEMATOL, V74, P9, DOI 10.1007/BF02982544; BRUNO E, 1995, EXP HEMATOL, V23, P1212; BUCHINSKY FJ, 1995, J BONE MINER RES, V10, P1556; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Campbell MR, 2004, AM J PATHOL, V164, P487, DOI 10.1016/S0002-9440(10)63139-2; CastriotaScanderbeg A, 1997, J MED GENET, V34, P854, DOI 10.1136/jmg.34.10.854; CEDERBAUM SD, 1976, J PEDIATR-US, V89, P737, DOI 10.1016/S0022-3476(76)80793-7; Cham B, 2002, SEMIN HEMATOL, V39, P107, DOI 10.1053/shem.2002.31916; Chan C.K., 2008, NATURE; Chan D, 1998, MATRIX BIOL, V17, P169, DOI 10.1016/S0945-053X(98)90056-7; Chung KS, 1997, DEV DYNAM, V208, P544; CORDER WT, 1995, AM J MED GENET, V57, P626, DOI 10.1002/ajmg.1320570422; Cumano A, 2007, ANNU REV IMMUNOL, V25, P745, DOI 10.1146/annurev.immunol.25.022106.141538; Dianzani I, 2000, Paediatr Drugs, V2, P345, DOI 10.2165/00128072-200002050-00002; ENG VM, 1995, J EXP MED, V181, P1893, DOI 10.1084/jem.181.5.1893; Gress CJ, 2000, J CELL BIOL, V149, P983, DOI 10.1083/jcb.149.4.983; Guggenheim R, 2006, BONE MARROW TRANSPL, V38, P751, DOI 10.1038/sj.bmt.1705520; Gupta P, 1998, BLOOD, V92, P4641, DOI 10.1182/blood.V92.12.4641.424k10_4641_4651; Hermanns P, 2006, AM J MED GENET A, V140A, P2121, DOI 10.1002/ajmg.a.31331; Hirose J, 2002, IMMUNOL REV, V189, P28, DOI 10.1034/j.1600-065X.2002.18904.x; Hubbard V, 2006, PEDIATR DERMATOL, V23, P373, DOI 10.1111/j.1525-1470.2006.00260.x; Jacenko O, 1996, ANN NY ACAD SCI, V785, P278, DOI 10.1111/j.1749-6632.1996.tb56283.x; JACENKO O, 1993, PROG CLIN BIOL RES, V383, P427; Jacenko O, 2002, AM J PATHOL, V160, P2019, DOI 10.1016/S0002-9440(10)61152-2; JACENKO O, 1993, NATURE, V365, P56, DOI 10.1038/365056a0; Jacenko O, 2001, AM J PATHOL, V159, P2257, DOI 10.1016/S0002-9440(10)63076-3; JACENKO O, 1991, Critical Reviews in Eukaryotic Gene Expression, V1, P327; JACENKO O, 1998, CELLS MAT, V8, P123; JACOBSEN SEW, 1994, J EXP MED, V180, P75, DOI 10.1084/jem.180.1.75; Johansson C, 2006, MICROB PATHOGENESIS, V41, P49, DOI 10.1016/j.micpath.2006.03.004; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; KLEIN G, 1995, EXPERIENTIA, V51, P914, DOI 10.1007/BF01921741; Kuijpers TW, 2004, PEDIATRICS, V114, pE387, DOI 10.1542/peds.2003-0651-F; Lefebvre Veronique, 2005, Birth Defects Research, V75, P200, DOI 10.1002/bdrc.20048; Lemoli RM, 2008, HAEMATOLOGICA, V93, P321, DOI 10.3324/haematol.12616; Linder CC, 2006, ILAR J, V47, P132, DOI 10.1093/ilar.47.2.132; Lucke T, 2007, AM J MED GENET A, V143A, P2040, DOI 10.1002/ajmg.a.31878; Marrella V, 2008, TRENDS IMMUNOL, V29, P133, DOI 10.1016/j.it.2007.12.001; Massberg S, 2007, CELL, V131, P994, DOI 10.1016/j.cell.2007.09.047; Mayack SR, 2008, BLOOD, V112, P519, DOI 10.1182/blood-2008-01-133710; Nilsson SK, 1997, BLOOD, V89, P4013, DOI 10.1182/blood.V89.11.4013; Nilsson SK, 2001, BLOOD, V97, P2293, DOI 10.1182/blood.V97.8.2293; Osmond D G, 1990, Semin Immunol, V2, P173; PATCHEN ML, 1991, BLOOD, V77, P472; Rodgers KD, 2008, DEV DYNAM, V237, P2622, DOI 10.1002/dvdy.21593; ROSATI R, 1994, NAT GENET, V8, P129, DOI 10.1038/ng1094-129; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Sekhar RV, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.3.e54; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Siebertz B, 1999, BIOCHEM J, V344, P937, DOI 10.1042/0264-6021:3440937; Sipkins DA, 2005, NATURE, V435, P969, DOI 10.1038/nature03703; SOYER AD, 1995, SPINE, V20, P2335, DOI 10.1097/00007632-199511000-00012; Spencer CT, 2006, PEDIATRICS, V118, pE337, DOI 10.1542/peds.2005-2667; Sweeney E, 2008, DEV DYNAM, V237, P2693, DOI 10.1002/dvdy.21594; Taichman RS, 1996, BLOOD, V87, P518, DOI 10.1182/blood.V87.2.518.bloodjournal872518; Tischkowitz MD, 2003, J MED GENET, V40, P1, DOI 10.1136/jmg.40.1.1; Verfaillie CATHERINE M., 1999, Hematology, V4, P321; Wu JY, 2008, P NATL ACAD SCI USA, V105, P16976, DOI 10.1073/pnas.0802898105; Yoshimoto M, 2003, EXP HEMATOL, V31, P733, DOI 10.1016/S0301-472X(03)00108-5; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zhu J, 2007, BLOOD, V109, P3706, DOI 10.1182/blood-2006-08-041384; JACKSON LABS CONGENI	68	62	63	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2010	5	3							e9518	10.1371/journal.pone.0009518	http://dx.doi.org/10.1371/journal.pone.0009518			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	562OZ	20657826	Green Submitted, Green Published, gold			2022-12-25	WOS:000275063400023
